From 6004c46e532a70a765939050ab9d75e7d33a8695 Mon Sep 17 00:00:00 2001 From: "vladimir.buzalka" Date: Mon, 1 Jun 2026 12:37:36 +0200 Subject: [PATCH] z230 --- ...sponsor-study-35472-samples-allSamples.csv | 1189 -------------- ...sponsor-study-35472-samples-allSamples.csv | 1189 -------------- ...sponsor-study-36940-samples-allSamples.csv | 1445 ----------------- ...sponsor-study-36940-samples-allSamples.csv | 1445 ----------------- ...36940-kit-inventory-on-hand-expiration.csv | 544 ------- ...35472-kit-inventory-on-hand-expiration.csv | 285 ---- .../BrowserMetrics-6A19775F-5F30.pma | Bin 4194304 -> 0 bytes .../Default/Cache/Cache_Data/data_0 | Bin 45056 -> 45056 bytes .../Default/Cache/Cache_Data/data_1 | Bin 270336 -> 270336 bytes .../Default/Cache/Cache_Data/data_2 | Bin 1056768 -> 1056768 bytes .../Default/Cache/Cache_Data/data_3 | Bin 4202496 -> 4202496 bytes .../Default/Code Cache/js/5be62acc646c7188_0 | Bin 206 -> 498 bytes .../Default/Code Cache/js/a0ae8d57174d5be0_0 | Bin 246 -> 246 bytes .../Code Cache/js/index-dir/the-real-index | Bin 10512 -> 11280 bytes Covance_UCO3001/browser_profile/Default/DIPS | Bin 36864 -> 36864 bytes .../Default/DawnGraphiteCache/data_1 | Bin 270336 -> 270336 bytes .../Default/DawnWebGPUCache/data_1 | Bin 270336 -> 270336 bytes .../Default/Extension State/LOG | 6 +- .../Default/Extension State/LOG.old | 6 +- .../browser_profile/Default/Favicons | Bin 94208 -> 98304 bytes .../Default/GCM Store/000003.log | Bin 1735 -> 1821 bytes .../browser_profile/Default/GCM Store/LOG | 6 +- .../browser_profile/Default/GCM Store/LOG.old | 6 +- .../browser_profile/Default/GPUCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile/Default/History | Bin 589824 -> 622592 bytes .../000003.log | Bin 1568 -> 1587 bytes .../LOG | 6 +- .../LOG.old | 6 +- .../Default/Local Storage/leveldb/000162.ldb | Bin 30021 -> 0 bytes .../Default/Local Storage/leveldb/000164.log | Bin 2682 -> 0 bytes .../Default/Local Storage/leveldb/000165.ldb | Bin 20511 -> 0 bytes .../Default/Local Storage/leveldb/LOG | 26 +- .../Default/Local Storage/leveldb/LOG.old | 21 +- .../Local Storage/leveldb/MANIFEST-000001 | Bin 9427 -> 10081 bytes .../Default/Network Action Predictor | Bin 53248 -> 53248 bytes .../browser_profile/Default/Network/Cookies | Bin 20480 -> 20480 bytes .../Default/Network/Network Persistent State | 2 +- .../Default/Network/Reporting and NEL | Bin 36864 -> 36864 bytes .../Default/Network/TransportSecurity | 2 +- .../browser_profile/Default/Preferences | 2 +- .../Default/Secure Preferences | 2 +- .../Default/Session Storage/000007.log | Bin 50432 -> 0 bytes .../Default/Session Storage/LOG | 6 +- .../Default/Session Storage/LOG.old | 9 +- .../Default/Session Storage/MANIFEST-000001 | Bin 187 -> 254 bytes .../Sessions/Session_13424527059825092 | Bin 39544 -> 0 bytes .../Sessions/Session_13424527458527069 | Bin 155802 -> 0 bytes .../Default/Sessions/Tabs_13424527060091353 | Bin 639190 -> 0 bytes .../Default/Sessions/Tabs_13424527458837129 | Bin 640282 -> 0 bytes .../Site Characteristics Database/000003.log | Bin 10384 -> 11104 bytes .../Default/Site Characteristics Database/LOG | 6 +- .../Site Characteristics Database/LOG.old | 6 +- .../Default/Sync Data/LevelDB/LOG | 6 +- .../Default/Sync Data/LevelDB/LOG.old | 6 +- .../browser_profile/Default/Top Sites | Bin 20480 -> 20480 bytes .../browser_profile/Default/Web Data | Bin 155648 -> 155648 bytes .../Default/WebStorage/QuotaManager | Bin 40960 -> 40960 bytes .../Default/shared_proto_db/000003.log | Bin 452643 -> 0 bytes .../Default/shared_proto_db/LOG | 6 +- .../Default/shared_proto_db/LOG.old | 9 +- .../Default/shared_proto_db/MANIFEST-000001 | Bin 41 -> 157 bytes .../shared_proto_db/metadata/000003.log | Bin 2658 -> 2760 bytes .../Default/shared_proto_db/metadata/LOG | 6 +- .../Default/shared_proto_db/metadata/LOG.old | 6 +- .../browser_profile/GrShaderCache/data_0 | Bin 45056 -> 45056 bytes .../browser_profile/GrShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile/GraphiteDawnCache/data_1 | Bin 270336 -> 270336 bytes Covance_UCO3001/browser_profile/Local State | 2 +- .../browser_profile/ShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile/first_party_sets.db | Bin 49152 -> 49152 bytes .../segmentation_platform/ukm_db | Bin 114688 -> 114688 bytes .../BrowserMetrics-6A198005-764.pma | Bin 4194304 -> 0 bytes .../Default/Cache/Cache_Data/data_0 | Bin 45056 -> 45056 bytes .../Default/Cache/Cache_Data/data_1 | Bin 270336 -> 270336 bytes .../Default/Cache/Cache_Data/data_2 | Bin 1056768 -> 1056768 bytes .../Default/Cache/Cache_Data/data_3 | Bin 4202496 -> 4202496 bytes .../Default/Code Cache/js/0cac568a67962276_0 | Bin 265 -> 10961 bytes .../Default/Code Cache/js/1f3f5d78da75e490_0 | Bin 252 -> 252 bytes .../Default/Code Cache/js/4b8939c9f36bbeb9_0 | Bin 206 -> 206 bytes .../Default/Code Cache/js/5be62acc646c7188_0 | Bin 498 -> 206 bytes .../Default/Code Cache/js/79fced940f0d6da1_0 | Bin 249 -> 249 bytes .../Default/Code Cache/js/8354ba6fce482b8b_0 | Bin 258 -> 298 bytes .../Default/Code Cache/js/8484823b1f8ea286_0 | Bin 256 -> 256 bytes .../Default/Code Cache/js/933a4257bd9d7793_0 | Bin 289 -> 0 bytes .../Default/Code Cache/js/a0ae8d57174d5be0_0 | Bin 206 -> 206 bytes .../Default/Code Cache/js/bfdcb80b271f0023_0 | Bin 292 -> 0 bytes .../Default/Code Cache/js/d1cfb4612631154e_0 | Bin 251 -> 291 bytes .../Default/Code Cache/js/d4649b8735ba61e9_0 | Bin 4120 -> 0 bytes .../Default/Code Cache/js/f1c90221f3458d8c_0 | Bin 298 -> 0 bytes .../Code Cache/js/index-dir/the-real-index | Bin 888 -> 936 bytes .../browser_profile_1/Default/DIPS | Bin 36864 -> 36864 bytes .../Default/DawnGraphiteCache/data_1 | Bin 270336 -> 270336 bytes .../Default/DawnWebGPUCache/data_1 | Bin 270336 -> 270336 bytes .../Default/Extension State/LOG | 6 +- .../Default/Extension State/LOG.old | 6 +- .../browser_profile_1/Default/Favicons | Bin 36864 -> 36864 bytes .../Default/GCM Store/000003.log | Bin 1157 -> 1243 bytes .../browser_profile_1/Default/GCM Store/LOG | 6 +- .../Default/GCM Store/LOG.old | 6 +- .../browser_profile_1/Default/GPUCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_1/Default/History | Bin 196608 -> 229376 bytes .../Default/Local Storage/leveldb/000003.log | Bin 34558 -> 52668 bytes .../Default/Local Storage/leveldb/LOG | 6 +- .../Default/Local Storage/leveldb/LOG.old | 6 +- .../Default/Network Action Predictor | Bin 53248 -> 53248 bytes .../browser_profile_1/Default/Network/Cookies | Bin 20480 -> 20480 bytes .../Default/Network/Network Persistent State | 2 +- .../Default/Network/Reporting and NEL | Bin 36864 -> 36864 bytes .../Default/Network/TransportSecurity | 2 +- .../browser_profile_1/Default/Preferences | 2 +- .../Default/Secure Preferences | 2 +- .../Default/Session Storage/000003.log | Bin 8819 -> 11646 bytes .../Default/Session Storage/LOG | 6 +- .../Default/Session Storage/LOG.old | 6 +- .../Default/Sessions/Tabs_13424528936015748 | Bin 40086 -> 0 bytes .../Site Characteristics Database/000003.log | Bin 520 -> 592 bytes .../Default/Site Characteristics Database/LOG | 6 +- .../Site Characteristics Database/LOG.old | 6 +- .../Default/Sync Data/LevelDB/LOG | 6 +- .../Default/Sync Data/LevelDB/LOG.old | 6 +- .../browser_profile_1/Default/Top Sites | Bin 20480 -> 20480 bytes .../browser_profile_1/Default/Web Data | Bin 155648 -> 155648 bytes .../Default/passkey_enclave_state | Bin 66 -> 66 bytes .../Default/shared_proto_db/000003.log | Bin 54773 -> 79943 bytes .../Default/shared_proto_db/LOG | 6 +- .../Default/shared_proto_db/LOG.old | 6 +- .../shared_proto_db/metadata/000003.log | Bin 1060 -> 1094 bytes .../Default/shared_proto_db/metadata/LOG | 6 +- .../Default/shared_proto_db/metadata/LOG.old | 6 +- .../browser_profile_1/GrShaderCache/data_0 | Bin 45056 -> 45056 bytes .../browser_profile_1/GrShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_1/GrShaderCache/data_3 | Bin 4202496 -> 4202496 bytes .../GraphiteDawnCache/data_1 | Bin 270336 -> 270336 bytes Covance_UCO3001/browser_profile_1/Local State | 2 +- .../browser_profile_1/ShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_1/first_party_sets.db | Bin 49152 -> 49152 bytes .../segmentation_platform/ukm_db | Bin 49152 -> 49152 bytes .../BrowserMetrics-6A19800D-7484.pma | Bin 4194304 -> 0 bytes .../Default/Cache/Cache_Data/data_0 | Bin 45056 -> 45056 bytes .../Default/Cache/Cache_Data/data_1 | Bin 270336 -> 270336 bytes .../Default/Cache/Cache_Data/data_2 | Bin 1056768 -> 1056768 bytes .../Default/Cache/Cache_Data/data_3 | Bin 4202496 -> 4202496 bytes .../Default/Code Cache/js/1f3f5d78da75e490_0 | Bin 252 -> 252 bytes .../Default/Code Cache/js/4b8939c9f36bbeb9_0 | Bin 206 -> 206 bytes .../Default/Code Cache/js/5be62acc646c7188_0 | Bin 206 -> 206 bytes .../Default/Code Cache/js/79fced940f0d6da1_0 | Bin 249 -> 249 bytes .../Default/Code Cache/js/8484823b1f8ea286_0 | Bin 256 -> 256 bytes .../Default/Code Cache/js/a0ae8d57174d5be0_0 | Bin 246 -> 246 bytes .../Code Cache/js/index-dir/the-real-index | Bin 672 -> 792 bytes .../browser_profile_2/Default/DIPS | Bin 36864 -> 36864 bytes .../Default/DawnGraphiteCache/data_1 | Bin 270336 -> 270336 bytes .../Default/DawnWebGPUCache/data_1 | Bin 270336 -> 270336 bytes .../Default/Extension State/LOG | 6 +- .../Default/Extension State/LOG.old | 6 +- .../browser_profile_2/Default/Favicons | Bin 28672 -> 36864 bytes .../Default/GCM Store/000003.log | Bin 1157 -> 1243 bytes .../browser_profile_2/Default/GCM Store/LOG | 6 +- .../Default/GCM Store/LOG.old | 6 +- .../browser_profile_2/Default/GPUCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_2/Default/History | Bin 196608 -> 196608 bytes .../Default/Local Storage/leveldb/000003.log | Bin 18600 -> 35311 bytes .../Default/Local Storage/leveldb/LOG | 6 +- .../Default/Local Storage/leveldb/LOG.old | 6 +- .../Default/Network Action Predictor | Bin 53248 -> 53248 bytes .../browser_profile_2/Default/Network/Cookies | Bin 20480 -> 20480 bytes .../Default/Network/Network Persistent State | 2 +- .../Default/Network/Reporting and NEL | Bin 36864 -> 36864 bytes .../Default/Network/TransportSecurity | 2 +- .../browser_profile_2/Default/Preferences | 2 +- .../Default/Secure Preferences | 2 +- .../Default/Session Storage/000003.log | Bin 6216 -> 9390 bytes .../Default/Session Storage/LOG | 6 +- .../Default/Session Storage/LOG.old | 6 +- .../Sessions/Session_13424528943685870 | Bin 61691 -> 0 bytes .../Default/Sessions/Tabs_13424528944018355 | Bin 16618 -> 0 bytes .../Site Characteristics Database/000003.log | Bin 376 -> 592 bytes .../Default/Site Characteristics Database/LOG | 6 +- .../Site Characteristics Database/LOG.old | 6 +- .../Default/Sync Data/LevelDB/LOG | 6 +- .../Default/Sync Data/LevelDB/LOG.old | 6 +- .../browser_profile_2/Default/Web Data | Bin 155648 -> 155648 bytes .../Default/shared_proto_db/000003.log | Bin 41003 -> 57893 bytes .../Default/shared_proto_db/LOG | 6 +- .../Default/shared_proto_db/LOG.old | 6 +- .../shared_proto_db/metadata/000003.log | Bin 1060 -> 1094 bytes .../Default/shared_proto_db/metadata/LOG | 6 +- .../Default/shared_proto_db/metadata/LOG.old | 6 +- .../browser_profile_2/GrShaderCache/data_0 | Bin 45056 -> 45056 bytes .../browser_profile_2/GrShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_2/GrShaderCache/data_3 | Bin 4202496 -> 4202496 bytes .../GraphiteDawnCache/data_1 | Bin 270336 -> 270336 bytes Covance_UCO3001/browser_profile_2/Local State | 2 +- .../browser_profile_2/ShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_2/first_party_sets.db | Bin 49152 -> 49152 bytes .../segmentation_platform/ukm_db | Bin 49152 -> 49152 bytes .../BrowserMetrics-6A198017-5878.pma | Bin 4194304 -> 0 bytes .../Default/Cache/Cache_Data/data_0 | Bin 45056 -> 45056 bytes .../Default/Cache/Cache_Data/data_1 | Bin 270336 -> 270336 bytes .../Default/Cache/Cache_Data/data_2 | Bin 1056768 -> 1056768 bytes .../Default/Cache/Cache_Data/data_3 | Bin 4202496 -> 4202496 bytes .../Default/Code Cache/js/1f3f5d78da75e490_0 | Bin 252 -> 252 bytes .../Default/Code Cache/js/4b8939c9f36bbeb9_0 | Bin 206 -> 206 bytes .../Default/Code Cache/js/5be62acc646c7188_0 | Bin 206 -> 206 bytes .../Default/Code Cache/js/79fced940f0d6da1_0 | Bin 249 -> 249 bytes .../Default/Code Cache/js/8484823b1f8ea286_0 | Bin 256 -> 256 bytes .../Default/Code Cache/js/a0ae8d57174d5be0_0 | Bin 246 -> 246 bytes .../Code Cache/js/index-dir/the-real-index | Bin 744 -> 888 bytes .../browser_profile_3/Default/DIPS | Bin 36864 -> 36864 bytes .../Default/DawnGraphiteCache/data_1 | Bin 270336 -> 270336 bytes .../Default/DawnWebGPUCache/data_1 | Bin 270336 -> 270336 bytes .../Default/Extension State/LOG | 6 +- .../Default/Extension State/LOG.old | 6 +- .../browser_profile_3/Default/Favicons | Bin 36864 -> 36864 bytes .../Default/GCM Store/000003.log | Bin 1157 -> 1243 bytes .../browser_profile_3/Default/GCM Store/LOG | 6 +- .../Default/GCM Store/LOG.old | 6 +- .../browser_profile_3/Default/GPUCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_3/Default/History | Bin 229376 -> 229376 bytes .../Default/Local Storage/leveldb/000003.log | Bin 39284 -> 58122 bytes .../Default/Local Storage/leveldb/LOG | 6 +- .../Default/Local Storage/leveldb/LOG.old | 6 +- .../Default/Network Action Predictor | Bin 53248 -> 53248 bytes .../browser_profile_3/Default/Network/Cookies | Bin 20480 -> 20480 bytes .../Default/Network/Network Persistent State | 2 +- .../Default/Network/Reporting and NEL | Bin 36864 -> 36864 bytes .../Default/Network/TransportSecurity | 2 +- .../browser_profile_3/Default/Preferences | 2 +- .../Default/Secure Preferences | 2 +- .../Default/Session Storage/000003.log | Bin 16682 -> 19905 bytes .../Default/Session Storage/LOG | 6 +- .../Default/Session Storage/LOG.old | 6 +- .../Sessions/Session_13424528953862629 | Bin 74312 -> 0 bytes .../Default/Sessions/Tabs_13424528954259422 | Bin 28273 -> 0 bytes .../Site Characteristics Database/000003.log | Bin 520 -> 736 bytes .../Default/Site Characteristics Database/LOG | 6 +- .../Site Characteristics Database/LOG.old | 6 +- .../Default/Sync Data/LevelDB/LOG | 6 +- .../Default/Sync Data/LevelDB/LOG.old | 6 +- .../browser_profile_3/Default/Top Sites | Bin 20480 -> 20480 bytes .../browser_profile_3/Default/Web Data | Bin 153600 -> 153600 bytes .../Default/shared_proto_db/000003.log | Bin 59849 -> 87543 bytes .../Default/shared_proto_db/LOG | 6 +- .../Default/shared_proto_db/LOG.old | 6 +- .../shared_proto_db/metadata/000003.log | Bin 1060 -> 1094 bytes .../Default/shared_proto_db/metadata/LOG | 6 +- .../Default/shared_proto_db/metadata/LOG.old | 6 +- .../browser_profile_3/GrShaderCache/data_0 | Bin 45056 -> 45056 bytes .../browser_profile_3/GrShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_3/GrShaderCache/data_3 | Bin 4202496 -> 4202496 bytes .../GraphiteDawnCache/data_1 | Bin 270336 -> 270336 bytes Covance_UCO3001/browser_profile_3/Local State | 2 +- .../browser_profile_3/ShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_3/first_party_sets.db | Bin 49152 -> 49152 bytes .../segmentation_platform/ukm_db | Bin 57344 -> 57344 bytes .../BrowserMetrics-6A198021-65D8.pma | Bin 4194304 -> 0 bytes .../Default/Cache/Cache_Data/data_0 | Bin 45056 -> 45056 bytes .../Default/Cache/Cache_Data/data_1 | Bin 270336 -> 270336 bytes .../Default/Cache/Cache_Data/data_2 | Bin 1056768 -> 1056768 bytes .../Default/Cache/Cache_Data/data_3 | Bin 4202496 -> 4202496 bytes .../Default/Code Cache/js/0cac568a67962276_0 | Bin 265 -> 10961 bytes .../Default/Code Cache/js/1f3f5d78da75e490_0 | Bin 252 -> 292 bytes .../Default/Code Cache/js/4b8939c9f36bbeb9_0 | Bin 206 -> 298 bytes .../Default/Code Cache/js/5be62acc646c7188_0 | Bin 498 -> 206 bytes .../Default/Code Cache/js/79fced940f0d6da1_0 | Bin 249 -> 289 bytes .../Default/Code Cache/js/8354ba6fce482b8b_0 | Bin 258 -> 298 bytes .../Default/Code Cache/js/8484823b1f8ea286_0 | Bin 256 -> 4120 bytes .../Default/Code Cache/js/933a4257bd9d7793_0 | Bin 289 -> 0 bytes .../Default/Code Cache/js/a0ae8d57174d5be0_0 | Bin 246 -> 246 bytes .../Default/Code Cache/js/bfdcb80b271f0023_0 | Bin 292 -> 0 bytes .../Default/Code Cache/js/d1cfb4612631154e_0 | Bin 251 -> 291 bytes .../Default/Code Cache/js/d4649b8735ba61e9_0 | Bin 4120 -> 0 bytes .../Default/Code Cache/js/f1c90221f3458d8c_0 | Bin 298 -> 0 bytes .../Code Cache/js/index-dir/the-real-index | Bin 2040 -> 2856 bytes .../browser_profile_4/Default/DIPS | Bin 36864 -> 36864 bytes .../Default/DawnGraphiteCache/data_1 | Bin 270336 -> 270336 bytes .../Default/DawnWebGPUCache/data_1 | Bin 270336 -> 270336 bytes .../Default/Extension State/LOG | 6 +- .../Default/Extension State/LOG.old | 6 +- .../browser_profile_4/Default/Favicons | Bin 36864 -> 36864 bytes .../Default/GCM Store/000003.log | Bin 1157 -> 1243 bytes .../browser_profile_4/Default/GCM Store/LOG | 6 +- .../Default/GCM Store/LOG.old | 6 +- .../browser_profile_4/Default/GPUCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_4/Default/History | Bin 196608 -> 196608 bytes .../Default/Local Storage/leveldb/000003.log | Bin 30873 -> 48655 bytes .../Default/Local Storage/leveldb/LOG | 6 +- .../Default/Local Storage/leveldb/LOG.old | 6 +- .../Default/Network Action Predictor | Bin 53248 -> 53248 bytes .../browser_profile_4/Default/Network/Cookies | Bin 20480 -> 20480 bytes .../Default/Network/Network Persistent State | 2 +- .../Default/Network/Reporting and NEL | Bin 36864 -> 36864 bytes .../Default/Network/TransportSecurity | 2 +- .../browser_profile_4/Default/Preferences | 2 +- .../Default/Secure Preferences | 2 +- .../Default/Session Storage/000003.log | Bin 8410 -> 11192 bytes .../Default/Session Storage/LOG | 6 +- .../Default/Session Storage/LOG.old | 6 +- .../Default/Sessions/Tabs_13424528961453569 | Bin 38990 -> 0 bytes .../Site Characteristics Database/000003.log | Bin 520 -> 736 bytes .../Default/Site Characteristics Database/LOG | 6 +- .../Site Characteristics Database/LOG.old | 6 +- .../Default/Sync Data/LevelDB/LOG | 6 +- .../Default/Sync Data/LevelDB/LOG.old | 6 +- .../browser_profile_4/Default/Web Data | Bin 153600 -> 153600 bytes .../Default/shared_proto_db/000003.log | Bin 51500 -> 73508 bytes .../Default/shared_proto_db/LOG | 6 +- .../Default/shared_proto_db/LOG.old | 6 +- .../shared_proto_db/metadata/000003.log | Bin 1060 -> 1094 bytes .../Default/shared_proto_db/metadata/LOG | 6 +- .../Default/shared_proto_db/metadata/LOG.old | 6 +- .../browser_profile_4/GrShaderCache/data_0 | Bin 45056 -> 45056 bytes .../browser_profile_4/GrShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_4/GrShaderCache/data_3 | Bin 4202496 -> 4202496 bytes .../GraphiteDawnCache/data_1 | Bin 270336 -> 270336 bytes Covance_UCO3001/browser_profile_4/Local State | 2 +- .../browser_profile_4/ShaderCache/data_1 | Bin 270336 -> 270336 bytes .../browser_profile_4/first_party_sets.db | Bin 49152 -> 49152 bytes .../segmentation_platform/ukm_db | Bin 49152 -> 49152 bytes 318 files changed, 297 insertions(+), 6383 deletions(-) delete mode 100644 Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv delete mode 100644 Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv delete mode 100644 Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv delete mode 100644 Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv delete mode 100644 Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv delete mode 100644 Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv delete mode 100644 Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A19775F-5F30.pma delete mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000162.ldb delete mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000164.log delete mode 100644 Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000165.ldb delete mode 100644 Covance_UCO3001/browser_profile/Default/Session Storage/000007.log delete mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Session_13424527059825092 delete mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Session_13424527458527069 delete mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527060091353 delete mode 100644 Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527458837129 delete mode 100644 Covance_UCO3001/browser_profile/Default/shared_proto_db/000003.log delete mode 100644 Covance_UCO3001/browser_profile_1/BrowserMetrics/BrowserMetrics-6A198005-764.pma delete mode 100644 Covance_UCO3001/browser_profile_1/Default/Code Cache/js/933a4257bd9d7793_0 delete mode 100644 Covance_UCO3001/browser_profile_1/Default/Code Cache/js/bfdcb80b271f0023_0 delete mode 100644 Covance_UCO3001/browser_profile_1/Default/Code Cache/js/d4649b8735ba61e9_0 delete mode 100644 Covance_UCO3001/browser_profile_1/Default/Code Cache/js/f1c90221f3458d8c_0 delete mode 100644 Covance_UCO3001/browser_profile_1/Default/Sessions/Tabs_13424528936015748 delete mode 100644 Covance_UCO3001/browser_profile_2/BrowserMetrics/BrowserMetrics-6A19800D-7484.pma delete mode 100644 Covance_UCO3001/browser_profile_2/Default/Sessions/Session_13424528943685870 delete mode 100644 Covance_UCO3001/browser_profile_2/Default/Sessions/Tabs_13424528944018355 delete mode 100644 Covance_UCO3001/browser_profile_3/BrowserMetrics/BrowserMetrics-6A198017-5878.pma delete mode 100644 Covance_UCO3001/browser_profile_3/Default/Sessions/Session_13424528953862629 delete mode 100644 Covance_UCO3001/browser_profile_3/Default/Sessions/Tabs_13424528954259422 delete mode 100644 Covance_UCO3001/browser_profile_4/BrowserMetrics/BrowserMetrics-6A198021-65D8.pma delete mode 100644 Covance_UCO3001/browser_profile_4/Default/Code Cache/js/933a4257bd9d7793_0 delete mode 100644 Covance_UCO3001/browser_profile_4/Default/Code Cache/js/bfdcb80b271f0023_0 delete mode 100644 Covance_UCO3001/browser_profile_4/Default/Code Cache/js/d4649b8735ba61e9_0 delete mode 100644 Covance_UCO3001/browser_profile_4/Default/Code Cache/js/f1c90221f3458d8c_0 delete mode 100644 Covance_UCO3001/browser_profile_4/Default/Sessions/Tabs_13424528961453569 diff --git a/Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv b/Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv deleted file mode 100644 index 94fee19..0000000 --- a/Covance_MDD3003/Source/2026-05-29_100908 sponsor-study-35472-samples-allSamples.csv +++ /dev/null @@ -1,1189 +0,0 @@ -Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,1,622535097101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,2,622535097102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,3,622535097103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,4,622535097104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,5,622535097105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,6,622535097106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,7,622535097107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,12-Aug-2025,6225350971,8,622535097108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,9,622535097109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,10,622535097110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,1,622535097201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,3,622535097203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,4,622535097204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,2,622535097202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,5,622535097205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,6,622535097206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,7,622535097207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,24-Sep-2025,6225350972,8,622535097208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,9,622535097209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,10,622535097210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,1,622535097501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,2,622535097502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,3,622535097503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,5,622535097505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,6,622535097506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,4,622535097504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,7,622535097507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,12-Nov-2025,6225350975,8,622535097508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,9,622535097509,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,10,622535097510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,1,622535097701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,2,622535097702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,3,622535097703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,4,622535097704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,5,622535097705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,6,622535097706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,7,622535097707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,15-Oct-2025,6225350977,8,622535097708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,9,622535097709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,10,622535097710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,1,622535098101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,2,622535098102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,09-Sep-2025,6225350981,3,622535098103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,4,622535098104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,5,622535098105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,6,622535098106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,2,622535098202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,12-Nov-2025,6225350982,3,622535098203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,1,622535098201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,7,622535098107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,4,622535098204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,5,622535098205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,6,622535098206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,7,622535098207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,1,622535098401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,2,622535098402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,22-Oct-2025,6225350984,3,622535098403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,4,622535098404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,5,622535098405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,6,622535098406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,7,622535098407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,5,622535098805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,6,622535098806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,7,622535098807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,8,622535098808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,1,622535098801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,9,622535098809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,2,622535098802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,22-Oct-2025,6225350988,3,622535098803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,4,622535098804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,1,622535100201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,2,622535100202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,3,622535100203,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,4,622535100204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,5,622535100205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,21-Aug-2025,6225351002,6,622535100206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,7,622535100207,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,8,622535100208,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,9,622535100209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,10,622535100210,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,1,622535100401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,2,622535100402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,3,622535100403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,4,622535100404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,5,622535100405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,6,622535100406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,7,622535100407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,8,622535100408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,9,622535100409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,10,622535100410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,2,622535100602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,1,622535100601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,3,622535100603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,4,622535100604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,5,622535100605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,6,622535100606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,7,622535100607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,8,622535100608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,9,622535100609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,10,622535100610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,1,622535103601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,3,622535103603,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,4,622535103604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,2,622535103602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,5,622535103605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,7,622535103607,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,8,622535103608,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,6,622535103606,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,2,622535103702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,9,622535103609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,3,622535103703,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,10,622535103610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,1,622535103701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,6,622535103706,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,9,622535103709,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,8,622535103708,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,10,622535103710,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,7,622535103707,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,4,622535103704,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,5,622535103705,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,2,622535104002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,1,622535104001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,5,622535104005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,4,622535104004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,6,622535104006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,8,622535104008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,9,622535104009,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,3,622535104003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,7,622535104007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,3,622535104103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,5,622535104105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,6,622535104106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,4,622535104104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,7,622535104107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,8,622535104108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,1,622535104101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,10,622535104010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,2,622535104102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,9,622535104109,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,10,622535104110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,1,622535104201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,4,622535104204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,3,622535104203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,5,622535104205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,6,622535104206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,2,622535104202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,10,622535104210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,28-Aug-2025,6225351042,8,622535104208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,9,622535104209,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,7,622535104207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,1,622535104401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,2,622535104402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,3,622535104403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,4,622535104404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,5,622535104405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,6,622535104406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,7,622535104407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,9,622535104409,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,10,622535104410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,1,622535104501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,2,622535104502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,3,622535104503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,8,622535104408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,4,622535104504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,5,622535104505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,7,622535104507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,8,622535104508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,6,622535104506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,9,622535104509,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,10,622535104510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,1,622535104601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,3,622535104603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,4,622535104604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,5,622535104605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,6,622535104606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,8,622535104608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,2,622535104602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,9,622535104609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,10,622535104610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,7,622535104607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,2,622535104702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,3,622535104703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,4,622535104704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,5,622535104705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,6,622535104706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,8,622535104708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,1,622535104701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,7,622535104707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,9,622535104709,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,10,622535104710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,1,622535104901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,2,622535104902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,3,622535104903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,4,622535104904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,5,622535104905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,6,622535104906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,7,622535104907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,1,622535105001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,2,622535105002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,4,622535105004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,5,622535105005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,6,622535105006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,3,622535105003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,1,622535105101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,2,622535105102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,28-Aug-2025,6225351051,3,622535105103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,7,622535105007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,4,622535105104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,6,622535105106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,5,622535105105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,7,622535105107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,3,622535105203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,5,622535105205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,6,622535105206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,2,622535105202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,4,622535105204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,1,622535105201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,7,622535105207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,1,622535105601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,2,622535105602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,3,622535105603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,4,622535105604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,5,622535105605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,6,622535105606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,7,622535105607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,8,622535105608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,9,622535105609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,1,622535105701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,2,622535105702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,3,622535105703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,4,622535105704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,5,622535105705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,6,622535105706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,7,622535105707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,8,622535105708,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,9,622535105709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,1,622535106601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,3,622535106603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,4,622535106604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,7,622535106607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,8,622535106608,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,9,622535106609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,6,622535106606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,5,622535106605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,2,622535106602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,3,622535107003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,09-Sep-2025,6225351070,4,622535107004,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,2,622535107002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,5,622535107005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,6,622535107006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,1,622535107001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,9,622535107009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,8,622535107008,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,7,622535107007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,10,622535107010,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,2,622535107202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,3,622535107203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,4,622535107204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,5,622535107205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,6,622535107206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,7,622535107207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,1,622535107201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,10,622535107210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,9,622535107209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,8,622535107208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,2,622535107402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,3,622535107403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,4,622535107404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,1,622535107401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,7,622535107407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,10,622535107410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,9,622535107409,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,6,622535107406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,5,622535107405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,2,622535107602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,1,622535107601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,8,622535107408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,3,622535107603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,5,622535107605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,6,622535107606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,4,622535107604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,7,622535107607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,9,622535107609,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,10,622535107610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,07-Aug-2025,6225351076,8,622535107608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,3,622535107703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,1,622535107701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,4,622535107704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,5,622535107705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,6,622535107706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,7,622535107707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,8,622535107708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,9,622535107709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,10,622535107710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,2,622535107702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,5,622535107805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,6,622535107806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,7,622535107807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,8,622535107808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,9,622535107809,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,4,622535107804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,3,622535107803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,2,622535107802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,1,622535107801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,10,622535107810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,1,622535108001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,2,622535108002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,7,622535108007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,06-Nov-2025,6225351080,8,622535108008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,9,622535108009,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,3,622535108003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,10,622535108010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,1,622535108101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,3,622535108103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,4,622535108004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,4,622535108104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,2,622535108102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,5,622535108105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,5,622535108005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,6,622535108006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,8,622535108108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,10,622535108110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,9,622535108109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,2,622535108202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,7,622535108107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,3,622535108203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,4,622535108204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,6,622535108106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,5,622535108205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,6,622535108206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,1,622535108301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,2,622535108302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,3,622535108303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,4,622535108304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,5,622535108305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,1,622535108201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,6,622535108306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,7,622535108207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,7,622535108307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,1,622535108401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,4,622535108404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,3,622535108403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,5,622535108405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,2,622535108402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,7,622535108407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,6,622535108406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,2,622535109302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,1,622535109301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,3,622535109303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,5,622535109305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,4,622535109304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,6,622535109306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,7,622535109307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,8,622535109308,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,9,622535109309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,1,622535109401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,3,622535109403,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,2,622535109402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,4,622535109404,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,5,622535109405,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,6,622535109406,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,7,622535109407,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,8,622535109408,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,1,622535109501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,2,622535109502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,3,622535109503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,5,622535109505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,7,622535109507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,8,622535109508,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,4,622535109504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,6,622535109506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,9,622535109409,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,9,622535109509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,1,622535110601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,2,622535110602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,4,622535110604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,5,622535110605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,3,622535110603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,6,622535110606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,7,622535110607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,08-Aug-2025,6225351106,8,622535110608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,9,622535110609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,10,622535110610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,1,622535110901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,4,622535110904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,5,622535110905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,6,622535110906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,7,622535110907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,05-Sep-2025,6225351109,8,622535110908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,2,622535110902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,9,622535110909,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,10,622535110910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,1,622535111001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,2,622535111002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,3,622535111003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,4,622535111004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,5,622535111005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,6,622535111006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,7,622535111007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,3,622535110903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,9,622535111009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351110,8,622535111008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,10,622535111010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,1,622535111101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,2,622535111102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,3,622535111103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,4,622535111104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,5,622535111105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,6,622535111106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351111,8,622535111108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,9,622535111109,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,7,622535111107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,10,622535111110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,1,622535112001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,2,622535112002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,24-Oct-2025,6225351120,3,622535112003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,4,622535112004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,5,622535112005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,6,622535112006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,7,622535112007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,2,622535112602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,1,622535112601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,3,622535112603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,4,622535112604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,10-Dec-2025,6225351126,5,622535112605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,6,622535112606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,8,622535112608,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,7,622535112607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,9,622535112609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,2,622631362502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,1,622631362501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,3,622631362503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,5,622631362505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,4,622631362504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,6,622631362506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,7,622631362507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,2,622655064602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,1,622655064601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,7,622655064607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,5,622655064605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,4,622655064604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,6,622655064606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,3,622655064603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,4,622655169704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,5,622655169705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,1,622655169701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,6,622655169706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,7,622655169707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,1,622655169801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,3,622655169703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,4,622655169804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,2,622655169702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,2,622655169802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,6,622655169806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,3,622655169803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,5,622655169805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,7,622655169807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,4,622656088704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,20-May-2026,6226560887,3,622656088703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,2,622656088702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,1,622656088701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,5,622656088705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,6,622656088706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,1,622656088801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,7,622656088707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,3,622656088803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,7,622656088807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,9,622656088809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226560888,5,622656088805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,4,622656088804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,8,622656088808,"Red Cells, Clot",Not Received,,,TSH,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,2,622656088802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,6,622656088806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,2,622656089102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,3,622656089103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,1,622656089101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,4,622656089104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,6,622656089106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,8,622656089108,"Red Cells, Clot",Not Received,,,TSH,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,20-May-2026,6226560891,5,622656089105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,14:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,7,622656089107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,9,622656089109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,17-Feb-2026,6226561517,3,622656151703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,4,622656151704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,5,622656151705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,2,622656151702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,1,622656151701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,6,622656151706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,7,622656151707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,1,622668695201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,2,622668695202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,3,622668695203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,4,622668695204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,5,622668695205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,6,622668695206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,7,622668695207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,1,622668695301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,2,622668695302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,3,622668695303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,4,622668695304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,5,622668695305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,6,622668695306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,7,622668695407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,8,622668695308,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,9,622668695309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,7,622668695307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,1,622668695401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,3,622668695403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,4,622668695404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,5,622668695405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,6,622668695406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,2,622668695402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,6,622675255406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,2,622675255502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,5,622675255405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,3,622675255503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,4,622675255404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,7,622675255407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,4,622675255504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226752555,5,622675255505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,2,622675255402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,3,622675255403,"Plasma, EDTA",Received,Frozen,Default Return Ambient,INSULIN,FROZEN,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,1,622675255401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,1,622675255501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,7,622675255507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,8,622675255508,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,9,622675255509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,6,622675255506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,1,622678085301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,5,622678085305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,2,622678085302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,3,622678085303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,4,622678085304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,8,622678085308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,9,622678085309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,6,622678085306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,7,622678085307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,1,622678085501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,2,622678085502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,4,622678085504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,5,622678085505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,6,622678085506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,7,622678085507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,8,622678085508,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,9,622678085509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,3,622678085503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,1,622678085601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,2,622678085602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,3,622678085603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,4,622678085604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,6,622678085606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,7,622678085607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,8,622678085608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,9,622678085609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,3,622678085703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,6,622678085706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,5,622678085705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,7,622678085707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,8,622678085708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,9,622678085709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,1,622678085701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,4,622678085704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,2,622678085702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,5,622678085605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,3,622678573903,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,2,622678573902,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,4,622678573904,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,7,622678573907,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,9,622678573909,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,5,622678573905,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,6,622678573906,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,8,622678573908,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,1,622678573901,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,19-Feb-2026,6226785739,10,622678573910,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,1,622678574001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,7,622678574007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,5,622678574005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,8,622678574008,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,2,622678574002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,6,622678574006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,3,622678574003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,4,622678574004,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,9,622678574009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,10,622678574010,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,2,622680496102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,4,622680496104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,3,622680496103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,5,622680496205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,7,622680496207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,9,622680496209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,6,622680496106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,5,622680496105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,3,622680496203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,1,622680496101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,4,622680496204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,8,622680496208,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,7,622680496107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,6,622680496206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,2,622680496202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,1,622680496201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,2,622693560602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,4,622693560604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,3,622693560603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,5,622693560605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,1,622693560601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,7,622693560607,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,16-Dec-2025,6226935606,6,622693560606,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,8,622693560608,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,9,622693560609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,1,622697694301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,2,622697694302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,31-Jan-2026,6226976943,3,622697694303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,4,622697694304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,6,622697694306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,7,622697694307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,5,622697694305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,4,622699131104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,5,622699131105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,6,622699131106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,7,622699131107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,3,622699131103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,1,622699131101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,2,622699131102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,1,622704330201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,4,622704330204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,5,622704330205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,19-Nov-2025,6227043302,3,622704330203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,2,622704330202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,6,622704330206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,7,622704330207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,1,622707241901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,2,622707241902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,4,622707241904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,6,622707241906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,3,622707241903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,7,622707241907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,5,622707241905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,2,622710690502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,1,622710690501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,03-Dec-2025,6227106905,3,622710690503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,4,622710690504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,6,622710690506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,5,622710690505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,7,622710690507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,8,622710690508,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,9,622710690509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,1,622710690601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,2,622710690602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,23-Dec-2025,6227106906,3,622710690603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,4,622710690604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,5,622710690605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,6,622710690606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,9,622710690609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,7,622710690607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,8,622710690608,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,6,622714456006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,7,622714456007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,1,622714456001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,2,622714456102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,5,622714456005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,1,622714456101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,4,622714456104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,3,622714456103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,5,622714456105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,3,622714456003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,6,622714456106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,4,622714456004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,2,622714456002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,1,622714456201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,5,622714456205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,7,622714456107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,7,622714456207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,4,622714456204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,2,622714456202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,16-Dec-2025,6227144562,3,622714456203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:13,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,6,622714456206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,7,622717890807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,9,622717890809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,3,622717890903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,6,622717890806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,4,622717890904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,2,622717890802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,1,622717890901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,8,622717890808,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,1,622717890801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,2,622717890902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,04-Feb-2026,6227178909,5,622717890905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,4,622717890804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,3,622717890803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,6,622717890906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,8,622717890908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,9,622717890909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,7,622717890907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,1,622717891001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,3,622717891003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,4,622717891004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,2,622717891002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,20-May-2026,6227178910,5,622717891005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178908,5,622717890805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,8,622717891008,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,9,622717891009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,2,622717891102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,7,622717891007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,1,622717891101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,4,622717891104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,11-Mar-2026,6227178911,5,622717891105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,6,622717891106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,7,622717891107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,9,622717891109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,6,622717891006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,3,622717891103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,1,622717891201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,8,622717891108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,2,622717891202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,3,622717891203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178912,5,622717891205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,4,622717891204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,7,622717891207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,8,622717891208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,6,622717891206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,9,622717891209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,1,622726123001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,2,622726123002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,4,622726123004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,5,622726123005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,10-Dec-2025,6227261230,3,622726123003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,6,622726123006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,7,622726123007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,1,622726183501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,2,622726183502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,21-May-2026,6227261835,3,622726183503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,4,622726183504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,5,622726183505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,6,622726183506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,7,622726183507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,1,622726183601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,2,622726183602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,3,622726183603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,4,622726183604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,5,622726183605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,6,622726183606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,7,622726183607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,8,622726183608,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,9,622726183609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,3,622749837903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,1,622749837901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,2,622749837902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,8,622749838008,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,7,622749838007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,7,622749837907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,9,622749838009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,9,622749837909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,1,622749838001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,6,622749838006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,3,622749838003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,5,622749837905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,2,622749838002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,5,622749838005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,4,622749837904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,4,622749838004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,8,622749837908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,6,622749837906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,9,622752024209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,3,622752024203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,7,622752024307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,5,622752024305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,4,622752024204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,1,622752024201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,3,622752024303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,6,622752024306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,1,622752024301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,4,622752024304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,8,622752024308,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,2,622752024202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,6,622752024206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,5,622752024205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,2,622752024302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,8,622752024208,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,7,622752024207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,9,622752024309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,2,622752024502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,3,622752024503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,8,622752024508,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,1,622752024501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,9,622752024509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,4,622752024504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,5,622752024505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,6,622752024506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,7,622752024507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,1,622754124901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,2,622754124902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,3,622754124903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,6,622754124906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,4,622754124904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,7,622754124907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,5,622754124905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,1,622754125101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,2,622754125102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,10,622754124910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,30-Jan-2026,6227541249,8,622754124908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,9,622754124909,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,6,622754125206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,1,622754125201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,7,622754125107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,25-Feb-2026,6227541252,3,622754125203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,4,622754125104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,2,622754125202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,4,622754125204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,6,622754125106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,5,622754125205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,7,622754125207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,5,622754125105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,1,622754125601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,5,622754125605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,2,622754125602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,4,622754125604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,7,622754125607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227541256,3,622754125603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,3,622754125103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,6,622754125606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,9,622754125609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,21-Jan-2026,6227541257,3,622754125703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,8,622754125608,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,8,622754125708,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,1,622754125701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,5,622754125705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,6,622754125706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,4,622754125704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,7,622754125707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,9,622754125709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,2,622754125802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,4,622754125904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,2,622754125702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,18-Feb-2026,6227541259,3,622754125903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,9,622754125809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,6,622754125906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,7,622754125907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,1,622754125801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,4,622754125804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,6,622754125806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,1,622754125901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,5,622754125805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,7,622754125807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,3,622754125803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,5,622754125905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,1,622754126001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,5,622754126005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,2,622754126002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,21-Jan-2026,6227541260,3,622754126003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:40,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,8,622754125808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,2,622754125902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,1,622754126101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,4,622754126004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,6,622754126006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,2,622754126102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,4,622754126104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,7,622754126007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,5,622754126105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,6,622754126106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,20-May-2026,6227541261,3,622754126103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,7,622754126107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,2,622754126402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,1,622754126401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,4,622754126404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,3,622754126403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,6,622754126406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,5,622754126405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,7,622754126407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,6,622754216006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,7,622754216007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,5,622754216005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,9,622754216009,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,2,622754216002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,10,622754216010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,1,622754216101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,8,622754216008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,1,622754216001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,4,622754216104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,2,622754216102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,8,622754216108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,3,622754216103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,6,622754216106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,10,622754216110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,4,622754216004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,3,622754216003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,9,622754216109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,7,622754216107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,5,622754216105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,5,622754217005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,1,622754217001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,7,622754217007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,3,622754217003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,8,622754217008,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,2,622754217002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,6,622754217006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,1,622754217101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,9,622754217009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,3,622754217103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,4,622754217004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,5,622754217105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,2,622754217102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,6,622754217106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,8,622754217108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,7,622754217107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,9,622754217109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,2,622754217202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,4,622754217104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,3,622754217203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,1,622754217201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,5,622754217205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,6,622754217206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,9,622754217209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,7,622754217207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,4,622754217204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,8,622754217208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,1,622754217301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,5,622754217305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,6,622754217306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,7,622754217307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,8,622754217308,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,2,622754217302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,9,622754217309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,3,622754217303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,4,622754217304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,2,622754218202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,3,622754218203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,4,622754218204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,5,622754218205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,8,622754218208,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,1,622754218201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,7,622754218207,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,9,622754218209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,6,622754218206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,10,622754218210,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,10,622693560610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,11,622693560611,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,2,622754732902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,3,622754732903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,4,622754732904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,6,622754732906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,7,622754732907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,5,622754732905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,04-Mar-2026,6227547329,8,622754732908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,10,622754732910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,9,622754732909,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,2,622754733002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,1,622754733001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,3,622754733003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,4,622754733004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,5,622754733005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,6,622754733006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,7,622754733007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,04-Feb-2026,6227547330,8,622754733008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:40,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,9,622754733009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,10,622754733010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,2,622754733102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,1,622754732901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,3,622754733103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,4,622754733104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,5,622754733105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,6,622754733106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,7,622754733107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,11-Mar-2026,6227547331,8,622754733108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,1,622754733201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,2,622754733202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,04-Mar-2026,6227547332,3,622754733203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,4,622754733204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,5,622754733205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,6,622754733206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,7,622754733207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,1,622754733101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,1,622754733301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,2,622754733302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,3,622754733303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,4,622754733304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,6,622754733306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,5,622754733305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,7,622754733307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,9,622754733109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,10,622754733110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,1,622754733601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,2,622754733602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,3,622754733603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,4,622754733604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,5,622754733605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,6,622754733606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,7,622754733607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,15-Apr-2026,6227547336,8,622754733608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,9,622754733609,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,2,622754733702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,15-Apr-2026,6227547337,3,622754733703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,4,622754733704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,6,622754733706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,5,622754733705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,9,622754733709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,2,622754733802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227547338,3,622754733803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,1,622754733801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,4,622754733804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,7,622754733807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,5,622754733805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,6,622754733806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,8,622754733708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,7,622754733707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,8,622754733808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,9,622754733809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,1,622754733701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,10,622754733610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,3,622776726703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,4,622776726704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,1,622776726701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,2,622776726702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,7,622776726707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,5,622776726705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,6,622776726706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,9,622776726709,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,04-Feb-2026,6227767267,8,622776726708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,10,622776726710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,2,622776845802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,4,622776845804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,1,622776845801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,3,622776845803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,20-May-2026,6227768458,5,622776845805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,6,622776845806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,8,622776845808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,7,622776845807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,1,622776845901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,3,622776845903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,4,622776845904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,9,622776845809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,4,622776846004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,6,622776845906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,08-Apr-2026,6227768460,5,622776846005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,2,622776846002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,7,622776845907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,3,622776846003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,8,622776845908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,18-Mar-2026,6227768459,5,622776845905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,9,622776845909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,7,622776846007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,8,622776846008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,1,622776846001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,9,622776846009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,2,622776845902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,6,622776846006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,1,622777550501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,5,622777550505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,4,622777550504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,6,622777550506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,7,622777550507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,2,622777550502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,3,622777550503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,9,622777550509,"Red Cells, Clot",Not Received,,,TSH,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,2,622777550802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,1,622777550701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,5,622777550805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775507,3,622777550703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:30,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,4,622777550704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775508,3,622777550803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:10,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,6,622777550706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,7,622777550707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,5,622777550705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,7,622777550807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,6,622777550806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,1,622777550801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,2,622777550702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,10,622777550510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,4,622777550804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,31-Jan-2026,6227775505,8,622777550508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:50,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,3,622779740603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,6,622779740606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,5,622779740605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,4,622779740604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,8,622779740608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,9,622779740609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,7,622779740607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,2,622779740602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,1,622779740601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,1,622779740701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,3,622779740703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,4,622779740704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,10,622779740610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,5,622779740705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,6,622779740706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,7,622779740707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,9,622779740709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,5,622779740805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,6,622779740806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,4,622779740804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,10,622779740710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,2,622779740702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,8,622779740708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,1,622779740801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,8,622779740808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,2,622779740802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,3,622779740803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,7,622779740807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,9,622779740809,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,10,622779740810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,3,622784472503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,6,622784472506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,5,622784472505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,4,622784472504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,7,622784472507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,1,622784472501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,2,622784472502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,11,622777550511,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,1,622811446001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,4,622811446004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,5,622811446005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,6,622811446006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,2,622811446002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,3,622811446003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,7,622811446007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,10,622680496210,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,8,622811446008,"Urine, no preservative",Not Received,Ambient,,,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,02-Apr-2026,6228232037,5,622823203705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,6,622823203706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,8,622823203708,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,9,622823203709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,7,622823203707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,1,622823203701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,3,622823203703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,4,622823203704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,2,622823203702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,1,622823429701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,2,622823429702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,3,622823429703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,7,622823429707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,8,622823429708,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,1,622823429801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,06-May-2026,6228234297,5,622823429705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,6,622823429706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,9,622823429709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,6,622823429806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,5,622823429805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,2,622823429802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,9,622823429809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,4,622823429804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,4,622823429704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,8,622823429808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,3,622823429803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,5,622823430005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,7,622823429807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,2,622823430002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,1,622823430001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,3,622823430003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,6,622823430006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,9,622823430009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,8,622823430008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,4,622823430004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,7,622823430007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,10,622656088810,"Urine, no preservative",Not Received,Ambient,,,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,10,622675255510,"Urine, no preservative",Not Received,Ambient,,,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,8,622631362508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,10,622668695410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,9,622668695409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,8,622668695408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,10,622754126410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,8,622754126408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,9,622754126409,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,10,622754125810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,11,622754218211,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,10,622754733710,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,8,622675255408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,8,622656088708,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,8,622754126108,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,10,622754125610,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,10,622754733810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,2,622860565202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,4,622860565204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,27-May-2026,6228605653,5,622860565305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,1,622860565201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,9,622860565209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,1,622860565301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,3,622860565203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,8,622860565308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,9,622860565309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,8,622860565208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,6,622860565206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,6,622860565306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,7,622860565307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,2,622860565302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,7,622860565207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,4,622860565304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,27-May-2026,6228605652,5,622860565205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,3,622860565303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,8,622726183508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, diff --git a/Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv b/Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv deleted file mode 100644 index 94fee19..0000000 --- a/Covance_MDD3003/Source/2026-05-29_111722 sponsor-study-35472-samples-allSamples.csv +++ /dev/null @@ -1,1189 +0,0 @@ -Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,1,622535097101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,2,622535097102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,3,622535097103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,4,622535097104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,5,622535097105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,6,622535097106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,7,622535097107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,12-Aug-2025,6225350971,8,622535097108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,,6225350971,9,622535097109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,08-Aug-2025,P1SCR,09-Aug-2025,09-Aug-2025,6225350971,10,622535097110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,1,622535097201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,3,622535097203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,4,622535097204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,2,622535097202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,5,622535097205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,6,622535097206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,7,622535097207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,24-Sep-2025,6225350972,8,622535097208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,,6225350972,9,622535097209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,19-Sep-2025,P1SCR,20-Sep-2025,20-Sep-2025,6225350972,10,622535097210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,22:00,Czech Republic,,22:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,1,622535097501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,2,622535097502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,3,622535097503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,5,622535097505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,6,622535097506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,4,622535097504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,7,622535097507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,12-Nov-2025,6225350975,8,622535097508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,,6225350975,9,622535097509,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,07-Nov-2025,P1SCR,08-Nov-2025,08-Nov-2025,6225350975,10,622535097510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,1,622535097701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,2,622535097702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,3,622535097703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,4,622535097704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,5,622535097705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,6,622535097706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,7,622535097707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,15-Oct-2025,6225350977,8,622535097708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,,6225350977,9,622535097709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,10-Oct-2025,P1SCR,11-Oct-2025,11-Oct-2025,6225350977,10,622535097710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,1,622535098101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,2,622535098102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,09-Sep-2025,6225350981,3,622535098103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,,6225350981,4,622535098104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,5,622535098105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,6,622535098106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,2,622535098202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,12-Nov-2025,6225350982,3,622535098203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,1,622535098201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,05-Sep-2025,P1DBBL,06-Sep-2025,06-Sep-2025,6225350981,7,622535098107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,,6225350982,4,622535098204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,5,622535098205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,6,622535098206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,07-Nov-2025,P1DBBL,08-Nov-2025,08-Nov-2025,6225350982,7,622535098207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,1,622535098401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,2,622535098402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,22-Oct-2025,6225350984,3,622535098403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,,6225350984,4,622535098404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,5,622535098405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,6,622535098406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,17-Oct-2025,P1DBBL,18-Oct-2025,18-Oct-2025,6225350984,7,622535098407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,5,622535098805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,6,622535098806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,7,622535098807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,8,622535098808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,1,622535098801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,18-Oct-2025,6225350988,9,622535098809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,2,622535098802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,22-Oct-2025,6225350988,3,622535098803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,17-Oct-2025,P2OLBL,18-Oct-2025,,6225350988,4,622535098804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,1,622535100201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,2,622535100202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,3,622535100203,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,4,622535100204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,5,622535100205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,21-Aug-2025,6225351002,6,622535100206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,7,622535100207,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,8,622535100208,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,9,622535100209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,19-Aug-2025,P1SCR,21-Aug-2025,,6225351002,10,622535100210,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,1,622535100401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,2,622535100402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,3,622535100403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,4,622535100404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,5,622535100405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,6,622535100406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,7,622535100407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,8,622535100408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,,6225351004,9,622535100409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351004,10,622535100410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,2,622535100602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,1,622535100601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,3,622535100603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,4,622535100604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,5,622535100605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,6,622535100606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,7,622535100607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,8,622535100608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,,6225351006,9,622535100609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,09-Sep-2025,P1SCR,10-Sep-2025,10-Sep-2025,6225351006,10,622535100610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,1,622535103601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,3,622535103603,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,4,622535103604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,2,622535103602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,5,622535103605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,7,622535103607,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,8,622535103608,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,6,622535103606,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,2,622535103702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,,6225351036,9,622535103609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,3,622535103703,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050001,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351036,10,622535103610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,1,622535103701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,6,622535103706,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,9,622535103709,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,8,622535103708,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,12-Nov-2025,6225351037,10,622535103710,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,7,622535103707,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,4,622535103704,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10005,Dr.Lubos Janu,CZ100050002,11-Nov-2025,P1SCR,12-Nov-2025,,6225351037,5,622535103705,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,2,622535104002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,1,622535104001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,5,622535104005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,4,622535104004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,6,622535104006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,8,622535104008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,9,622535104009,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,3,622535104003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,,6225351040,7,622535104007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,3,622535104103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,5,622535104105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,6,622535104106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,4,622535104104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,7,622535104107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,8,622535104108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,1,622535104101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,16-Sep-2025,P1SCR,17-Sep-2025,17-Sep-2025,6225351040,10,622535104010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,2,622535104102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,,6225351041,9,622535104109,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:43,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080003,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351041,10,622535104110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:43,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,1,622535104201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,4,622535104204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,3,622535104203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,5,622535104205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,6,622535104206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,2,622535104202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,27-Aug-2025,6225351042,10,622535104210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,28-Aug-2025,6225351042,8,622535104208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:08,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,9,622535104209,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,26-Aug-2025,P1SCR,27-Aug-2025,,6225351042,7,622535104207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:08,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,1,622535104401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,2,622535104402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,3,622535104403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,4,622535104404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,5,622535104405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,6,622535104406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,7,622535104407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,,6225351044,9,622535104409,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,10,622535104410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,1,622535104501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,2,622535104502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,3,622535104503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,10-Dec-2025,P1SCR,11-Dec-2025,11-Dec-2025,6225351044,8,622535104408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,4,622535104504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,5,622535104505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,7,622535104507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,8,622535104508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,6,622535104506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,,6225351045,9,622535104509,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,05-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351045,10,622535104510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,1,622535104601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,3,622535104603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,4,622535104604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,5,622535104605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,6,622535104606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,8,622535104608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,2,622535104602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,9,622535104609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,11-Sep-2025,6225351046,10,622535104610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:31,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,10-Sep-2025,P1SCR,11-Sep-2025,,6225351046,7,622535104607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:31,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,2,622535104702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,3,622535104703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,4,622535104704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,5,622535104705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,6,622535104706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,8,622535104708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,1,622535104701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,7,622535104707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,,6225351047,9,622535104709,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:12,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,02-Jul-2025,P1SCR,03-Jul-2025,03-Jul-2025,6225351047,10,622535104710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:12,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,1,622535104901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,2,622535104902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,3,622535104903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,,6225351049,4,622535104904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:55,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,5,622535104905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,6,622535104906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,30-Jul-2025,P1DBBL,31-Jul-2025,31-Jul-2025,6225351049,7,622535104907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:55,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,1,622535105001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,2,622535105002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,,6225351050,4,622535105004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:19,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,5,622535105005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,6,622535105006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,3,622535105003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,1,622535105101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,2,622535105102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,28-Aug-2025,6225351051,3,622535105103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,08-Oct-2025,P1DBBL,09-Oct-2025,09-Oct-2025,6225351050,7,622535105007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:19,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,,6225351051,4,622535105104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:47,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,6,622535105106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,5,622535105105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,26-Aug-2025,P1DBBL,27-Aug-2025,27-Aug-2025,6225351051,7,622535105107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:47,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,3,622535105203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,5,622535105205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,6,622535105206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,2,622535105202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,,6225351052,4,622535105204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,1,622535105201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,16-Sep-2025,P1DBBL,17-Sep-2025,17-Sep-2025,6225351052,7,622535105207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,1,622535105601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,2,622535105602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,3,622535105603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,4,622535105604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,5,622535105605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,6,622535105606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,7,622535105607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,,6225351056,8,622535105608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,10-Sep-2025,P2OLBL,11-Sep-2025,11-Sep-2025,6225351056,9,622535105609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,1,622535105701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,2,622535105702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,3,622535105703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,4,622535105704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,5,622535105705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,6,622535105706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,7,622535105707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,,6225351057,8,622535105708,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:02,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Oct-2025,P2OLBL,08-Oct-2025,08-Oct-2025,6225351057,9,622535105709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:02,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,1,622535106601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,3,622535106603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,4,622535106604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,7,622535106607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,8,622535106608,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,9,622535106609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,,6225351066,6,622535106606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,5,622535106605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,14-Oct-2025,EW,15-Oct-2025,15-Oct-2025,6225351066,2,622535106602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Early Withdrawal,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,3,622535107003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,09-Sep-2025,6225351070,4,622535107004,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,2,622535107002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,5,622535107005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,6,622535107006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,1,622535107001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,9,622535107009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,8,622535107008,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,7,622535107007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080004,08-Sep-2025,P1SCR,09-Sep-2025,,6225351070,10,622535107010,"Serum, SST",Not Received,Ambient,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,2,622535107202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,3,622535107203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,4,622535107204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,5,622535107205,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,6,622535107206,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,7,622535107207,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,1,622535107201,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,10,622535107210,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,,6225351072,9,622535107209,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351072,8,622535107208,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,2,622535107402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,3,622535107403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,4,622535107404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,1,622535107401,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,7,622535107407,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,10,622535107410,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,,6225351074,9,622535107409,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:40,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,6,622535107406,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,5,622535107405,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,2,622535107602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,1,622535107601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110005,03-Nov-2025,P1SCR,04-Nov-2025,04-Nov-2025,6225351074,8,622535107408,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:40,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,3,622535107603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,5,622535107605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,6,622535107606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,4,622535107604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,7,622535107607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,,6225351076,9,622535107609,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,06-Aug-2025,6225351076,10,622535107610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,03-Aug-2025,P1SCR,06-Aug-2025,07-Aug-2025,6225351076,8,622535107608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,3,622535107703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,1,622535107701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,4,622535107704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,5,622535107705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,6,622535107706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,7,622535107707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,8,622535107708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,,6225351077,9,622535107709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:33,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,10,622535107710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110004,03-Oct-2025,P1SCR,04-Oct-2025,04-Oct-2025,6225351077,2,622535107702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:33,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,5,622535107805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,6,622535107806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,7,622535107807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,8,622535107808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,9,622535107809,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,4,622535107804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,3,622535107803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,2,622535107802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,,6225351078,1,622535107801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,14-Nov-2025,P1SCR,15-Nov-2025,15-Nov-2025,6225351078,10,622535107810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,1,622535108001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,2,622535108002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,7,622535108007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,06-Nov-2025,6225351080,8,622535108008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,,6225351080,9,622535108009,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:03,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,3,622535108003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,10,622535108010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,1,622535108101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,3,622535108103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,4,622535108004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,4,622535108104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,2,622535108102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,5,622535108105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,5,622535108005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,04-Nov-2025,P1SCR,05-Nov-2025,05-Nov-2025,6225351080,6,622535108006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,07:03,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,8,622535108108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,10,622535108110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,9,622535108109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,2,622535108202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,,6225351081,7,622535108107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,3,622535108203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351082,4,622535108204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,26-Sep-2025,P1SCR,27-Sep-2025,27-Sep-2025,6225351081,6,622535108106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,5,622535108205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,6,622535108206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,1,622535108301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,2,622535108302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,3,622535108303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,,6225351083,4,622535108304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:07,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,5,622535108305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,1,622535108201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,6,622535108306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351082,7,622535108207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,28-Aug-2025,P1DBBL,29-Aug-2025,29-Aug-2025,6225351083,7,622535108307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:07,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,1,622535108401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,4,622535108404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,3,622535108403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,5,622535108405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351084,2,622535108402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,7,622535108407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351084,6,622535108406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,2,622535109302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,1,622535109301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,3,622535109303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,5,622535109305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,4,622535109304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,6,622535109306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,7,622535109307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,,6225351093,8,622535109308,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:23,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351093,9,622535109309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:23,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,1,622535109401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,3,622535109403,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,2,622535109402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,4,622535109404,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,5,622535109405,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,6,622535109406,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,7,622535109407,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,,6225351094,8,622535109408,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,1,622535109501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,2,622535109502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,3,622535109503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,5,622535109505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,7,622535109507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,8,622535109508,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,4,622535109504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,,6225351095,6,622535109506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110001,08-Oct-2025,EOT,09-Oct-2025,09-Oct-2025,6225351094,9,622535109409,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,09-Oct-2025,EOT,10-Oct-2025,10-Oct-2025,6225351095,9,622535109509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,1,622535110601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,2,622535110602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,4,622535110604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,5,622535110605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,3,622535110603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,6,622535110606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,7,622535110607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,08-Aug-2025,6225351106,8,622535110608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,,6225351106,9,622535110609,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120001,06-Aug-2025,P1SCR,07-Aug-2025,07-Aug-2025,6225351106,10,622535110610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,1,622535110901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,4,622535110904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,5,622535110905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,6,622535110906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,7,622535110907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,05-Sep-2025,6225351109,8,622535110908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,2,622535110902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,,6225351109,9,622535110909,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,10,622535110910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,1,622535111001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,2,622535111002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,3,622535111003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,4,622535111004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,5,622535111005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,6,622535111006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,7,622535111007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120002,03-Sep-2025,P1SCR,04-Sep-2025,04-Sep-2025,6225351109,3,622535110903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,,6225351110,9,622535111009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351110,8,622535111008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120003,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351110,10,622535111010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,1,622535111101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,2,622535111102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,3,622535111103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,4,622535111104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,5,622535111105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,6,622535111106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,03-Oct-2025,6225351111,8,622535111108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,9,622535111109,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,,6225351111,7,622535111107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,01-Oct-2025,P1SCR,02-Oct-2025,02-Oct-2025,6225351111,10,622535111110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,1,622535112001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,2,622535112002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,24-Oct-2025,6225351120,3,622535112003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,,6225351120,4,622535112004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,5,622535112005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,6,622535112006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,22-Oct-2025,P1DBBL,23-Oct-2025,23-Oct-2025,6225351120,7,622535112007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,2,622535112602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,1,622535112601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,3,622535112603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,4,622535112604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,10-Dec-2025,6225351126,5,622535112605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,6,622535112606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,,6225351126,8,622535112608,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,7,622535112607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,05-Dec-2025,EOT,06-Dec-2025,06-Dec-2025,6225351126,9,622535112609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,2,622631362502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,1,622631362501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,3,622631362503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,5,622631362505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,4,622631362504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,6,622631362506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,02-Apr-2026,6226313625,7,622631362507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,2,622655064602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,1,622655064601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,7,622655064607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,5,622655064605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,,6226550646,4,622655064604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,6,622655064606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Feb-2026,P2OLD29,17-Feb-2026,17-Feb-2026,6226550646,3,622655064603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,4,622655169704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,5,622655169705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,1,622655169701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,6,622655169706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,7,622655169707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,1,622655169801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,22-Jan-2026,6226551697,3,622655169703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,4,622655169804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,21-Jan-2026,P1DBBL,22-Jan-2026,,6226551697,2,622655169702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,,6226551698,2,622655169802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,6,622655169806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,3,622655169803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,5,622655169805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,29-Oct-2025,P1DBBL,30-Oct-2025,30-Oct-2025,6226551698,7,622655169807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,4,622656088704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,20-May-2026,6226560887,3,622656088703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,2,622656088702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,1,622656088701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,5,622656088705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,6,622656088706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,1,622656088801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,25-Apr-2026,6226560887,7,622656088707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,3,622656088803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,7,622656088807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,9,622656088809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226560888,5,622656088805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,4,622656088804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,8,622656088808,"Red Cells, Clot",Not Received,,,TSH,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226560888,2,622656088802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,17:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,6,622656088806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,2,622656089102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,3,622656089103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,1,622656089101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,4,622656089104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,6,622656089106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,,6226560891,8,622656089108,"Red Cells, Clot",Not Received,,,TSH,,,,,,14:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,20-May-2026,6226560891,5,622656089105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,14:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,7,622656089107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,06-Mar-2026,P2DBW25,07-Mar-2026,07-Mar-2026,6226560891,9,622656089109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,14:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 DB Every 12 Weeks,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,17-Feb-2026,6226561517,3,622656151703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,4,622656151704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,5,622656151705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,,6226561517,2,622656151702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:23,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,1,622656151701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,6,622656151706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,03-Feb-2026,P2OLD29,04-Feb-2026,04-Feb-2026,6226561517,7,622656151707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:23,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,1,622668695201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,2,622668695202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,3,622668695203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,,6226686952,4,622668695204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,5,622668695205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,6,622668695206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,08-Oct-2025,P2OLD29,09-Oct-2025,09-Oct-2025,6226686952,7,622668695207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,1,622668695301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,2,622668695302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,3,622668695303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,4,622668695304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,5,622668695305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,6,622668695306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,7,622668695407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,,6226686953,8,622668695308,"Red Cells, Clot",Not Received,,,TSH,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,9,622668695309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,13-Jan-2026,P2DBBL,14-Jan-2026,14-Jan-2026,6226686953,7,622668695307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,1,622668695401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,3,622668695403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,4,622668695404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,5,622668695405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6226686954,6,622668695406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:01,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,2,622668695402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,6,622675255406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,2,622675255502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,5,622675255405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,3,622675255503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,4,622675255404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,7,622675255407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,4,622675255504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,20-May-2026,6226752555,5,622675255505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,2,622675255402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,3,622675255403,"Plasma, EDTA",Received,Frozen,Default Return Ambient,INSULIN,FROZEN,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,23-Apr-2026,6226752554,1,622675255401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,1,622675255501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,7,622675255507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,8,622675255508,"Red Cells, Clot",Not Received,,,TSH,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,26-Mar-2026,6226752555,9,622675255509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,15:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,6,622675255506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,1,622678085301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,5,622678085305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,2,622678085302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,3,622678085303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,4,622678085304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,8,622678085308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,9,622678085309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,,6226780853,6,622678085306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080001,05-Nov-2025,EOT,06-Nov-2025,06-Nov-2025,6226780853,7,622678085307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,1,622678085501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,2,622678085502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,4,622678085504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,5,622678085505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,6,622678085506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,7,622678085507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,,6226780855,8,622678085508,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,9,622678085509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,09-Dec-2025,EOT,10-Dec-2025,10-Dec-2025,6226780855,3,622678085503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,1,622678085601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,2,622678085602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,3,622678085603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,4,622678085604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,6,622678085606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,7,622678085607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,,6226780856,8,622678085608,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:06,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,9,622678085609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,3,622678085703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,6,622678085706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,5,622678085705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,7,622678085707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,8,622678085708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,9,622678085709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,1,622678085701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,,6226780857,4,622678085704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:18,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,14-Jan-2026,EOT,15-Jan-2026,15-Jan-2026,6226780857,2,622678085702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:18,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,18-Nov-2025,EOT,19-Nov-2025,19-Nov-2025,6226780856,5,622678085605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:06,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,3,622678573903,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,2,622678573902,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,4,622678573904,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,7,622678573907,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,9,622678573909,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,5,622678573905,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,6,622678573906,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,8,622678573908,"Serum, SST",Not Received,Ambient,,TSH,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,,6226785739,1,622678573901,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,18-Feb-2026,P1DBBL,19-Feb-2026,19-Feb-2026,6226785739,10,622678573910,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,1,622678574001,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,7,622678574007,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,5,622678574005,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,8,622678574008,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,2,622678574002,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,6,622678574006,"Plasma, EDTA",Not Received,Frozen,,INSULIN,FROZEN,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,3,622678574003,"Urine, Cargile Preservative UA",Not Received,Ambient,,URINALYSIS,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,4,622678574004,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,,6226785740,9,622678574009,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:53,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,15-Dec-2025,P1SCR,16-Dec-2025,16-Dec-2025,6226785740,10,622678574010,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:53,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,2,622680496102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,,6226804961,4,622680496104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,3,622680496103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,5,622680496205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,7,622680496207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,9,622680496209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,6,622680496106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,5,622680496105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,3,622680496203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,1,622680496101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,4,622680496204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,8,622680496208,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,04-Nov-2025,P2OLD29,05-Nov-2025,05-Nov-2025,6226804961,7,622680496107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,6,622680496206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,2,622680496202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,11-Mar-2026,6226804962,1,622680496201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,2,622693560602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,4,622693560604,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,3,622693560603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,5,622693560605,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,1,622693560601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,7,622693560607,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,16-Dec-2025,6226935606,6,622693560606,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,8,622693560608,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,,6226935606,9,622693560609,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,1,622697694301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,2,622697694302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,31-Jan-2026,6226976943,3,622697694303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,,6226976943,4,622697694304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,6,622697694306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,7,622697694307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120004,02-Jan-2026,P2OLD29,03-Jan-2026,03-Jan-2026,6226976943,5,622697694305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,4,622699131104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,5,622699131105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,6,622699131106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,7,622699131107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,3,622699131103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,07-Nov-2025,6226991311,1,622699131101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:14,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,06-Nov-2025,P2OLD29,07-Nov-2025,,6226991311,2,622699131102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:14,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,1,622704330201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,4,622704330204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,5,622704330205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,19-Nov-2025,6227043302,3,622704330203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,,6227043302,2,622704330202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,6,622704330206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,14-Nov-2025,P2OLD29,15-Nov-2025,15-Nov-2025,6227043302,7,622704330207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,1,622707241901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,2,622707241902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,,6227072419,4,622707241904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:17,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,6,622707241906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,3,622707241903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,7,622707241907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080005,17-Dec-2025,P2OLD29,18-Dec-2025,18-Dec-2025,6227072419,5,622707241905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:17,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,2,622710690502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,1,622710690501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,03-Dec-2025,6227106905,3,622710690503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,4,622710690504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,6,622710690506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,5,622710690505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,7,622710690507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,,6227106905,8,622710690508,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,28-Nov-2025,P2OLBL,29-Nov-2025,29-Nov-2025,6227106905,9,622710690509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,1,622710690601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,2,622710690602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,23-Dec-2025,6227106906,3,622710690603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,4,622710690604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,5,622710690605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,6,622710690606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,9,622710690609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,20-Dec-2025,6227106906,7,622710690607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,19-Dec-2025,P2OLBL,20-Dec-2025,,6227106906,8,622710690608,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:25,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,6,622714456006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,7,622714456007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,1,622714456001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,2,622714456102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,5,622714456005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,1,622714456101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,,6227144561,4,622714456104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:04,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,3,622714456103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,5,622714456105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,28-Jan-2026,6227144560,3,622714456003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,6,622714456106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,4,622714456004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,27-Jan-2026,P1DBBL,28-Jan-2026,,6227144560,2,622714456002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,1,622714456201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,5,622714456205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,25-Nov-2025,P1DBBL,26-Nov-2025,26-Nov-2025,6227144561,7,622714456107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:04,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,7,622714456207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,4,622714456204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,,6227144562,2,622714456202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:13,,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,16-Dec-2025,6227144562,3,622714456203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:13,05:55,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,11-Dec-2025,P1DBBL,13-Dec-2025,13-Dec-2025,6227144562,6,622714456206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:13,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,7,622717890807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,9,622717890809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,3,622717890903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,6,622717890806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,4,622717890904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,2,622717890802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,1,622717890901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,8,622717890808,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,1,622717890801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,2,622717890902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,04-Feb-2026,6227178909,5,622717890905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,,6227178908,4,622717890804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:20,,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178908,3,622717890803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:20,08:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,6,622717890906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,,6227178909,8,622717890908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,9,622717890909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227178909,7,622717890907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,1,622717891001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,3,622717891003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,4,622717891004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,2,622717891002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,20-May-2026,6227178910,5,622717891005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178908,5,622717890805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:20,07:00,Czech Republic,,08:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,8,622717891008,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,9,622717891009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,2,622717891102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,06-May-2026,6227178910,7,622717891007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,1,622717891101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,4,622717891104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,11-Mar-2026,6227178911,5,622717891105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,6,622717891106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,7,622717891107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,9,622717891109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-May-2026,EOT,06-May-2026,,6227178910,6,622717891006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,07-Mar-2026,6227178911,3,622717891103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,1,622717891201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040002,06-Mar-2026,EOT,07-Mar-2026,,6227178911,8,622717891108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,2,622717891202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,3,622717891203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,14-Jan-2026,6227178912,5,622717891205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:10,07:00,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,4,622717891204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,7,622717891207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,8,622717891208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,,6227178912,6,622717891206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:10,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,09-Jan-2026,EOT,10-Jan-2026,10-Jan-2026,6227178912,9,622717891209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:10,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,1,622726123001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,2,622726123002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,,6227261230,4,622726123004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,5,622726123005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,10-Dec-2025,6227261230,3,622726123003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,6,622726123006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,05-Dec-2025,P1DBBL,06-Dec-2025,06-Dec-2025,6227261230,7,622726123007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,1,622726183501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,2,622726183502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,21-May-2026,6227261835,3,622726183503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,4,622726183504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,5,622726183505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,6,622726183506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,20-May-2026,6227261835,7,622726183507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,00:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,1,622726183601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,2,622726183602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,3,622726183603,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,4,622726183604,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,5,622726183605,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,6,622726183606,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,7,622726183607,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,,6227261836,8,622726183608,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,06-Jan-2026,EOT,08-Jan-2026,08-Jan-2026,6227261836,9,622726183609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,3,622749837903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,1,622749837901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,2,622749837902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,8,622749838008,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,7,622749838007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,7,622749837907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,9,622749838009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,9,622749837909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,1,622749838001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,6,622749838006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,3,622749838003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,03-Jan-2026,6227498379,5,622749837905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,2,622749838002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,31-Jan-2026,6227498380,5,622749838005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:36,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,4,622749837904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Jan-2026,EOT,31-Jan-2026,,6227498380,4,622749838004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:36,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,8,622749837908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110002,02-Jan-2026,EOT,03-Jan-2026,,6227498379,6,622749837906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:28,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,9,622752024209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,3,622752024203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,7,622752024307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,5,622752024305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,4,622752024204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,1,622752024201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,3,622752024303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,6,622752024306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,1,622752024301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,4,622752024304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,,6227520243,8,622752024308,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:20,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,2,622752024202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,6,622752024206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,5,622752024205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,2,622752024302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,,6227520242,8,622752024208,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,13-Jan-2026,EOT,14-Jan-2026,14-Jan-2026,6227520242,7,622752024207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,29-Apr-2026,EOT,30-Apr-2026,30-Apr-2026,6227520243,9,622752024309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:20,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,2,622752024502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,3,622752024503,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,8,622752024508,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,1,622752024501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,9,622752024509,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,4,622752024504,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,5,622752024505,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,,6227520245,6,622752024506,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,04-Mar-2026,EOT,05-Mar-2026,05-Mar-2026,6227520245,7,622752024507,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,1,622754124901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,2,622754124902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,3,622754124903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,6,622754124906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,4,622754124904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,7,622754124907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,5,622754124905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,1,622754125101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,2,622754125102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,28-Jan-2026,6227541249,10,622754124910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,30-Jan-2026,6227541249,8,622754124908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,27-Jan-2026,P1SCR,28-Jan-2026,,6227541249,9,622754124909,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,6,622754125206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,1,622754125201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,7,622754125107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,25-Feb-2026,6227541252,3,622754125203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:45,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,,6227541251,4,622754125104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,06:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,2,622754125202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,,6227541252,4,622754125204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:45,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,6,622754125106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,5,622754125205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,20-Feb-2026,P1DBBL,21-Feb-2026,21-Feb-2026,6227541252,7,622754125207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,5,622754125105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,1,622754125601,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,5,622754125605,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,2,622754125602,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,4,622754125604,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,7,622754125607,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227541256,3,622754125603,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227541251,3,622754125103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,06:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,6,622754125606,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227541256,9,622754125609,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,21-Jan-2026,6227541257,3,622754125703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,07:55,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,8,622754125608,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,8,622754125708,"Red Cells, Clot",Not Received,,,TSH,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,1,622754125701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,5,622754125705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,6,622754125706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,4,622754125704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,7,622754125707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,17-Jan-2026,6227541257,9,622754125709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,07:55,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,2,622754125802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,4,622754125904,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,16-Jan-2026,P2OLBL,17-Jan-2026,,6227541257,2,622754125702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,07:55,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,18-Feb-2026,6227541259,3,622754125903,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,9,622754125809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,6,622754125906,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,7,622754125907,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,1,622754125801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,4,622754125804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,6,622754125806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,1,622754125901,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,5,622754125805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,7,622754125807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,08-Apr-2026,6227541258,3,622754125803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,14-Feb-2026,6227541259,5,622754125905,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,1,622754126001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,5,622754126005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,2,622754126002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,21-Jan-2026,6227541260,3,622754126003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:40,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,8,622754125808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Feb-2026,P2OLD29,14-Feb-2026,,6227541259,2,622754125902,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,1,622754126101,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,,6227541260,4,622754126004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:40,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,6,622754126006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,2,622754126102,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,4,622754126104,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,16-Jan-2026,P2OLD29,17-Jan-2026,17-Jan-2026,6227541260,7,622754126007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:40,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,5,622754126105,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,6,622754126106,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,20-May-2026,6227541261,3,622754126103,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,06-May-2026,6227541261,7,622754126107,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,2,622754126402,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,1,622754126401,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,4,622754126404,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,3,622754126403,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,6,622754126406,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,5,622754126405,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,08-Apr-2026,6227541264,7,622754126407,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:35,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,6,622754216006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,7,622754216007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,5,622754216005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,9,622754216009,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,2,622754216002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,10,622754216010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,1,622754216101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,8,622754216008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,,6227542160,1,622754216001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:11,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,4,622754216104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,2,622754216102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,8,622754216108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,3,622754216103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,6,622754216106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,10,622754216110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,4,622754216004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110009,21-Jan-2026,P1SCR,22-Jan-2026,22-Jan-2026,6227542160,3,622754216003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,10:11,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,9,622754216109,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,,6227542161,7,622754216107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:58,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,05-Jan-2026,P1SCR,06-Jan-2026,06-Jan-2026,6227542161,5,622754216105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:58,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,5,622754217005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,1,622754217001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,7,622754217007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,3,622754217003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,8,622754217008,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,2,622754217002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,6,622754217006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,1,622754217101,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,11-Mar-2026,6227542170,9,622754217009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,3,622754217103,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,10-Mar-2026,EOT,11-Mar-2026,,6227542170,4,622754217004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,5,622754217105,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,2,622754217102,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,6,622754217106,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,8,622754217108,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,7,622754217107,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,17-Mar-2026,6227542171,9,622754217109,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:16,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,2,622754217202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Mar-2026,EOT,17-Mar-2026,,6227542171,4,622754217104,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:16,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,3,622754217203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,1,622754217201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,5,622754217205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,6,622754217206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,9,622754217209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,31-Mar-2026,6227542172,7,622754217207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:31,07:15,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,4,622754217204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,30-Mar-2026,EOT,31-Mar-2026,,6227542172,8,622754217208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:31,,Czech Republic,,07:15,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,1,622754217301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,5,622754217305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,6,622754217306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,7,622754217307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,8,622754217308,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,2,622754217302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,9,622754217309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,17-Jan-2026,6227542173,3,622754217303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:48,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,16-Jan-2026,EOT,17-Jan-2026,,6227542173,4,622754217304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:48,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,2,622754218202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,3,622754218203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,4,622754218204,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,5,622754218205,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,8,622754218208,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,1,622754218201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,7,622754218207,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,,6227542182,9,622754218209,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:16,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,6,622754218206,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,10,622754218210,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,10,622693560610,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110003,11-Dec-2025,EOT,13-Dec-2025,13-Dec-2025,6226935606,11,622693560611,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,09:05,21:00,Czech Republic,,21:00,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,2,622754732902,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,3,622754732903,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,4,622754732904,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,6,622754732906,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,7,622754732907,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,5,622754732905,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,04-Mar-2026,6227547329,8,622754732908,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,28-Feb-2026,6227547329,10,622754732910,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,9,622754732909,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,2,622754733002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,1,622754733001,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,3,622754733003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,4,622754733004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,5,622754733005,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,6,622754733006,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,7,622754733007,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,04-Feb-2026,6227547330,8,622754733008,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:40,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,,6227547330,9,622754733009,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:40,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,30-Jan-2026,P1SCR,31-Jan-2026,31-Jan-2026,6227547330,10,622754733010,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:40,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,2,622754733102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,27-Feb-2026,P1SCR,28-Feb-2026,,6227547329,1,622754732901,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,3,622754733103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,4,622754733104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,5,622754733105,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,6,622754733106,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,7,622754733107,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,11-Mar-2026,6227547331,8,622754733108,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,1,622754733201,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,2,622754733202,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,04-Mar-2026,6227547332,3,622754733203,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:35,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,,6227547332,4,622754733204,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:35,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,5,622754733205,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,6,622754733206,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,27-Feb-2026,P1DBBL,28-Feb-2026,28-Feb-2026,6227547332,7,622754733207,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:35,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,1,622754733101,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,1,622754733301,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,2,622754733302,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,3,622754733303,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,,6227547333,4,622754733304,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,6,622754733306,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,5,622754733305,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,25-Mar-2026,P1DBBL,26-Mar-2026,26-Mar-2026,6227547333,7,622754733307,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,,6227547331,9,622754733109,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227547331,10,622754733110,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,1,622754733601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,2,622754733602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,3,622754733603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,4,622754733604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,5,622754733605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,6,622754733606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,7,622754733607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,15-Apr-2026,6227547336,8,622754733608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,,6227547336,9,622754733609,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,2,622754733702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,15-Apr-2026,6227547337,3,622754733703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:15,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,4,622754733704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,6,622754733706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,5,622754733705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,9,622754733709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,2,622754733802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,20-May-2026,6227547338,3,622754733803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,1,622754733801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,4,622754733804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,7,622754733807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,5,622754733805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,6,622754733806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,8,622754733708,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,7,622754733707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,8,622754733808,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,06-May-2026,6227547338,9,622754733809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227547337,1,622754733701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,10-Apr-2026,P2SCR,11-Apr-2026,11-Apr-2026,6227547336,10,622754733610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,3,622776726703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,4,622776726704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,1,622776726701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,2,622776726702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,7,622776726707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,5,622776726705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,6,622776726706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,,6227767267,9,622776726709,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:25,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,04-Feb-2026,6227767267,8,622776726708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,01-Feb-2026,P1SCR,03-Feb-2026,03-Feb-2026,6227767267,10,622776726710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:25,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,2,622776845802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,4,622776845804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,1,622776845801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,3,622776845803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,20-May-2026,6227768458,5,622776845805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,6,622776845806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,,6227768458,8,622776845808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,7,622776845807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,1,622776845901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,3,622776845903,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,4,622776845904,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040008,05-May-2026,EOT,06-May-2026,06-May-2026,6227768458,9,622776845809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:45,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,4,622776846004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,6,622776845906,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,08-Apr-2026,6227768460,5,622776846005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,2,622776846002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,7,622776845907,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,3,622776846003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,,6227768459,8,622776845908,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,18-Mar-2026,6227768459,5,622776845905,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:00,07:00,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,9,622776845909,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,7,622776846007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,8,622776846008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,1,622776846001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,28-Mar-2026,6227768460,9,622776846009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040004,13-Mar-2026,EOT,14-Mar-2026,14-Mar-2026,6227768459,2,622776845902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:00,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040003,27-Mar-2026,EOT,28-Mar-2026,,6227768460,6,622776846006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:00,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,1,622777550501,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,5,622777550505,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,4,622777550504,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,6,622777550506,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,7,622777550507,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,2,622777550502,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,3,622777550503,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,,6227775505,9,622777550509,"Red Cells, Clot",Not Received,,,TSH,,,,,,16:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,2,622777550802,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,1,622777550701,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,5,622777550805,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775507,3,622777550703,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,13:30,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,4,622777550704,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,18-Feb-2026,6227775508,3,622777550803,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,15:10,07:10,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,6,622777550706,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,7,622777550707,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775507,5,622777550705,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,13:30,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,7,622777550807,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,6,622777550806,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,17-Feb-2026,6227775508,1,622777550801,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,15:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775507,2,622777550702,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,13:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,10,622777550510,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,15-Feb-2026,P1DBBL,17-Feb-2026,,6227775508,4,622777550804,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,15:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,31-Jan-2026,6227775505,8,622777550508,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,16:50,07:20,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,3,622779740603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,6,622779740606,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,5,622779740605,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,4,622779740604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,8,622779740608,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,9,622779740609,"Red Cells, Clot",Not Received,,,TSH,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,7,622779740607,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,2,622779740602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,,6227797406,1,622779740601,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,11:03,,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,1,622779740701,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,3,622779740703,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,4,622779740704,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,17-Feb-2026,P1SCR,18-Feb-2026,18-Feb-2026,6227797406,10,622779740610,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,11:03,07:10,Czech Republic,,07:10,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,5,622779740705,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,6,622779740706,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,7,622779740707,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,,6227797407,9,622779740709,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:22,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,5,622779740805,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,6,622779740806,"Urine, no preservative",Received,Ambient,Default Return Ambient,URINE DRUG SCREEN,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,4,622779740804,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,10,622779740710,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,2,622779740702,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110012,06-Mar-2026,P1SCR,07-Mar-2026,07-Mar-2026,6227797407,8,622779740708,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:22,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,1,622779740801,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,8,622779740808,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,2,622779740802,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,3,622779740803,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,"HEMATOLOGY, A1C, &",RETICULOCYTES,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,7,622779740807,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,,6227797408,9,622779740809,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:05,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110011,02-Mar-2026,P1SCR,03-Mar-2026,03-Mar-2026,6227797408,10,622779740810,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:05,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,3,622784472503,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,6,622784472506,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,5,622784472505,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,4,622784472504,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,7,622784472507,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,11-Mar-2026,6227844725,1,622784472501,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Mar-2026,P1DBBL,11-Mar-2026,,6227844725,2,622784472502,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 DB Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,28-Jan-2026,P1SCR,30-Jan-2026,30-Jan-2026,6227775505,11,622777550511,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,16:50,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 1 Screening,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,1,622811446001,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,4,622811446004,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,5,622811446005,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,6,622811446006,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY &,RETICULOCYTES,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,2,622811446002,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,3,622811446003,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,08-Apr-2026,6228114460,7,622811446007,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:21,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080006,10-Mar-2026,P2DBBL,11-Mar-2026,,6226804962,10,622680496210,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,07-Apr-2026,P2OLD29,08-Apr-2026,,6228114460,8,622811446008,"Urine, no preservative",Not Received,Ambient,,,,,,,,09:21,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,02-Apr-2026,6228232037,5,622823203705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,6,622823203706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,8,622823203708,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,9,622823203709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,7,622823203707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,1,622823203701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,3,622823203703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,,6228232037,4,622823203704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110006,31-Mar-2026,EOT,01-Apr-2026,01-Apr-2026,6228232037,2,622823203702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:10,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,1,622823429701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,2,622823429702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,3,622823429703,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,7,622823429707,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,8,622823429708,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,1,622823429801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,06-May-2026,6228234297,5,622823429705,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,6,622823429706,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,05-May-2026,6228234297,9,622823429709,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:44,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,6,622823429806,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,5,622823429805,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,2,622823429802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,9,622823429809,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,4,622823429804,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110008,04-May-2026,EOT,05-May-2026,,6228234297,4,622823429704,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,08:44,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,,6228234298,8,622823429808,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,3,622823429803,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,5,622823430005,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110007,13-May-2026,EOT,14-May-2026,14-May-2026,6228234298,7,622823429807,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,08:15,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,2,622823430002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,1,622823430001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,3,622823430003,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,6,622823430006,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,9,622823430009,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,8,622823430008,"Red Cells, Clot",Not Received,,,TSH,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,,6228234300,4,622823430004,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,10:37,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,21-Apr-2026,EOT,23-Apr-2026,23-Apr-2026,6228234300,7,622823430007,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,10:37,07:00,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,25-Mar-2026,EOT,26-Mar-2026,,6226560888,10,622656088810,"Urine, no preservative",Not Received,Ambient,,,,,,,,17:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,25-Mar-2026,EOT,26-Mar-2026,,6226752555,10,622675255510,"Urine, no preservative",Not Received,Ambient,,,,,,,,15:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080007,01-Apr-2026,P2OLD29,02-Apr-2026,,6226313625,8,622631362508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:10,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,10,622668695410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,9,622668695409,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10008,Dr.Zdenek Solle,CZ100080002,07-Apr-2026,P2DBW13,08-Apr-2026,,6226686954,8,622668695408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,12:01,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,10,622754126410,"Serum, SST",Cancelled,Ambient,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,8,622754126408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040001,07-Apr-2026,P2DBW13,08-Apr-2026,,6227541264,9,622754126409,"Red Cells, Clot",Not Received,,,TSH,,,,,,08:35,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 DB Week 13,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,07-Apr-2026,P2OLBL,08-Apr-2026,,6227541258,10,622754125810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:45,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,10-Apr-2026,P2OLBL,11-Apr-2026,11-Apr-2026,6227542182,11,622754218211,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,08:16,07:20,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Retest,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,10-Apr-2026,P2OLBL,11-Apr-2026,,6227547337,10,622754733710,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,11:15,,Czech Republic,,07:20,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120006,22-Apr-2026,P2OLD29,23-Apr-2026,,6226752554,8,622675255408,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,15:30,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10012,Dr.Ales Urban,CZ100120005,23-Apr-2026,P2OLD29,25-Apr-2026,,6226560887,8,622656088708,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,16:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,05-May-2026,P2OLD29,06-May-2026,,6227541261,8,622754126108,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,13:15,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040007,05-May-2026,P2OLBL,06-May-2026,,6227541256,10,622754125610,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,07:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040009,05-May-2026,P2OLBL,06-May-2026,,6227547338,10,622754733810,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,09:50,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Baseline,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,2,622860565202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,4,622860565204,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,27-May-2026,6228605653,5,622860565305,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,12:00,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,1,622860565201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,9,622860565209,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,1,622860565301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,3,622860565203,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,8,622860565308,"Red Cells, Clot",Not Received,,,TSH,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,9,622860565309,"Serum, SST",Received,Ambient,Default Return Ambient,TSH,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,8,622860565208,"Red Cells, Clot",Not Received,,,TSH,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,,6228605652,6,622860565206,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,09:20,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,6,622860565306,"Red Cells, Clot",Not Received,,,CHEMISTRY,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,7,622860565307,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,2,622860565302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,23-May-2026,6228605652,7,622860565207,"Serum, SST",Received,Ambient,Default Return Ambient,CHEMISTRY,,,,,,09:20,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,,6228605653,4,622860565304,"Whole Blood, EDTA, Dry",Not Received,,,INSULIN,,,,,,12:00,,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040005,22-May-2026,EOT,23-May-2026,27-May-2026,6228605652,5,622860565205,"Plasma, EDTA",Received,Frozen,Default Return Frozen,INSULIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10004,Dr. Erik Herman,CZ100040006,22-May-2026,EOT,23-May-2026,23-May-2026,6228605653,3,622860565303,"Urine, Cargile Preservative UA",Received,Ambient,Default Return Ambient,URINALYSIS,,,,,,12:00,07:30,Czech Republic,,07:30,,,212396,EMEA,,,,,,,,End of Phase/Treatment,, -42847922MDD3003,CZ10011,Dr. Marta Lendlova,CZ100110010,19-May-2026,P2OLD29,20-May-2026,,6227261835,8,622726183508,"Urine, no preservative",Not Received,Ambient,,URINE DRUG SCREEN,,,,,,00:00,,Czech Republic,,07:00,,,212396,EMEA,,,,,,,,Part 2 OL Induction Day 29,, diff --git a/Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv b/Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv deleted file mode 100644 index 7fe468b..0000000 --- a/Covance_UCO3001/Source/2026-05-29_100908 sponsor-study-36940-samples-allSamples.csv +++ /dev/null @@ -1,1445 +0,0 @@ -Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,1,622732320301,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,2,622732320302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,3,622732320303,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,7,622732320307,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,8,622732320308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,5,622732320305,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,6,622732320306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,11,622732320311,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,4,622732320304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,14,622732320314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,12,622732320312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,15,622732320315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,1,622732320401,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,9,622732320309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,3,622732320403,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,4,622732320404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,2,622732320402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,6,622732320406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,7,622732320407,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,5,622732320405,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,,6227323203,10,622732320310,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,13,622732320313,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,9,622732320409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,10,622732320410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,11,622732320411,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,13,622732320413,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,14,622732320414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,15,622732320415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,8,622732320408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,1,622732320501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,12,622732320412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,2,622732320502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,4,622732320504,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,7,622732320507,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,3,622732320503,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,6,622732320506,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,10,622732320510,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,9,622732320509,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,8,622732320508,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,5,622732320505,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,11,622732320511,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,13,622732320513,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,14,622732320514,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,15,622732320515,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,16,622732320516,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,18,622732320518,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,1,622732320601,"Whole Blood, EDTA, Dry",Cancelled,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,17,622732320517,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,12,622732320512,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,4,622732320604,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,7,622732320607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,8,622732320608,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,9,622732320609,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,10,622732320610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,11,622732320611,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,12,622732320612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,2,622732320602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,6,622732320606,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,3,622732320603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,5,622732320605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,17,622732320617,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,14,622732320614,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,18,622732320618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,2,622732320702,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,16,622732320616,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,3,622732320703,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,1,622732320701,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,15,622732320615,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,13,622732320613,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,4,622732320704,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,5,622732320705,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,6,622732320706,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,7,622732320707,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,8,622732320708,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,9,622732320709,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,10,622732320710,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,11,622732320711,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,12,622732320712,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,13,622732320713,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,14,622732320714,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,16,622732320716,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,17,622732320717,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,1,622732320801,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,2,622732320802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,3,622732320803,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,5,622732320805,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,4,622732320804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,7,622732320807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,8,622732320808,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,10,622732320810,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,15,622732320715,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,11,622732320811,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,9,622732320809,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,12,622732320812,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-5,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,13,622732320813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,14,622732320814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,15,622732320815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,16,622732320816,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,17,622732320817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,6,622732320806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,2,622732321002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,4,622732321004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,1,622732321001,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,3,622732321003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,6,622732321006,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-1,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,5,622732321005,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,7,622732321007,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-2,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,8,622732321008,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-3,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,9,622732321009,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-4,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,10,622732321010,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,12,622732321012,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,14,622732321014,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,11,622732321011,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,13,622732321013,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,15,622732321015,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,16,622732321016,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,17,622732321017,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,18,622732321018,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,19,622732321019,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,21,622732321021,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,20,622732321020,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,22,622732321022,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,1,622732321101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,2,622732321102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,3,622732321103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,4,622732321104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,1,622732321201,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,3,622732321203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,4,622732321204,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,2,622732321202,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,1,622732321301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,2,622732321302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,3,622732321303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,4,622732321304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,DNA,20-Feb-2026,20-Feb-2026,6227323217,1,622732321701,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,DNA,19-Mar-2026,19-Mar-2026,6227323219,1,622732321901,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,1,622732322301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,2,622732322302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,3,622732322303,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,,6227323223,4,622732322304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,2,622732322402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,1,622732322401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,3,622732322403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,,6227323224,4,622732322404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,2,622732323102,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,3,622732323103,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,4,622732323104,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323231,5,622732323105,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,6,622732323106,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,23-Apr-2026,6227323231,8,622732323108,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,7,622732323107,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,1,622732323101,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,9,622732323109,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,10,622732323110,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,12,622732323112,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,14,622732323114,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,13,622732323113,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,17,622732323117,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,18,622732323118,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,15,622732323115,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,16,622732323116,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,11,622732323111,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,19,622732323119,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,20,622732323120,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,22,622732323122,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,21,622732323121,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,25,622732323125,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,26,622732323126,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,24,622732323124,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,23,622732323123,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,27,622732323127,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,28,622732323128,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,29,622732323129,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,30,622732323130,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,3,622732323203,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,4,622732323204,"Serum, SST",Cancelled,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,5,622732323205,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,6,622732323206,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,7,622732323207,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,8,622732323208,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,1,622732323201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,2,622732323202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,10,622732323210,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,12,622732323212,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,14,622732323214,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,13,622732323213,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,11,622732323211,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,15,622732323215,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,9,622732323209,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,16,622732323216,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,17,622732323217,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,21,622732323221,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,23,622732323223,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,26,622732323226,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,20,622732323220,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,24,622732323224,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,22,622732323222,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,27,622732323227,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,25,622732323225,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,19,622732323219,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,28,622732323228,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,18,622732323218,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,29,622732323229,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,2,622732323302,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,4,622732323304,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,30,622732323230,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,3,622732323303,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,6,622732323306,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,7,622732323307,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,1,622732323301,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,5,622732323305,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,8,622732323308,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,9,622732323309,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,10,622732323310,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,13,622732323313,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,12,622732323312,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,16,622732323316,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,14,622732323314,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,15,622732323315,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,11,622732323311,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,17,622732323317,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,19,622732323319,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,24,622732323324,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,20,622732323320,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,23,622732323323,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,26,622732323326,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,25,622732323325,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,22,622732323322,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,27,622732323327,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,21,622732323321,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,18,622732323318,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,29,622732323329,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,30,622732323330,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,28,622732323328,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,2,622732323402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,3,622732323403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,4,622732323404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,5,622732323405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,1,622732323401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,6,622732323406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,10,622732323410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,8,622732323408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,11,622732323411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,7,622732323407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,9,622732323409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,15,622732323415,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,14,622732323414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,13,622732323413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,12,622732323412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,2,622732323602,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,1,622732323601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,3,622732323603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,4,622732323604,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,8,622732323608,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,5,622732323605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,9,622732323609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,7,622732323607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,6,622732323606,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,11,622732323611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,12,622732323612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,10,622732323610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,13,622732323613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,14,622732323614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,15,622732323615,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,2,622732323702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,4,622732323704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,1,622732323701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,3,622732323703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,7,622732323707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,8,622732323708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,5,622732323705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,6,622732323706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,11,622732323711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,12,622732323712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,9,622732323709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,13,622732323713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,10,622732323710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,15,622732323715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,14,622732323714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,17,622732323717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,18,622732323718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,16,622732323716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,1,622732323801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,2,622732323802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,4,622732323804,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,5,622732323805,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,7,622732323807,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,8,622732323808,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,6,622732323806,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,10,622732323810,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,11,622732323811,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,13,622732323813,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,12,622732323812,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,9,622732323809,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,16,622732323816,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,15,622732323815,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,14,622732323814,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,18,622732323818,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,17,622732323817,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,2,622732324002,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,1,622732324001,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,15,622732324015,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,13,622732324013,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,16,622732324016,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,14,622732324014,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,5,622732324005,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,4,622732324004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,8,622732324008,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,9,622732324009,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,6,622732324006,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,3,622732324003,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,10,622732324010,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,7,622732324007,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,17,622732324017,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,12,622732324012,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,11,622732324011,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,3,622732323803,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,1,622732324201,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,2,622732324202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,3,622732324203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,4,622732324204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,5,622732324205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,9,622732324209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,10,622732324210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,7,622732324207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,8,622732324208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,11,622732324211,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,6,622732324206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,13,622732324213,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,12,622732324212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,15,622732324215,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,16,622732324216,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,17,622732324217,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,19,622732324219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,14,622732324214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,21,622732324221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,18,622732324218,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,20,622732324220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,22,622732324222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,1,622732324301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,3,622732324303,"Culture, Stool",Cancelled,Ambient,,STOOL CULTURE,,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,1,622732324401,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,4,622732324304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,2,622732324402,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,18-Mar-2026,6227323243,2,622732324302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,3,622732324403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,4,622732324404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,12-Mar-2026,6227323245,3,622732324503,"Culture, Stool",Received,Ambient,Default Return Frozen,STOOL CULTURE,,,,,,09:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,4,622732324504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,1,622732324501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,2,622732324502,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,DNA,21-Mar-2026,21-Mar-2026,6227323251,1,622732325101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,1,622732325201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,2,622732325202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,3,622732325203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,4,622732325204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,5,622732325205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,6,622732325206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,7,622732325207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,8,622732325208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,2,622732325302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,1,622732325301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,6,622732325306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,5,622732325305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,3,622732325303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,8,622732325308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,7,622732325307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,2,622732325402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,1,622732325401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,,6227323254,4,622732325404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,4,622732325304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,3,622732325403,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,1,622732325601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,2,622732325602,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,3,622732325603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,,6227323256,4,622732325604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,7,622732326407,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,6,622732326406,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,1,622732326401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,2,622732326402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,9,622732326409,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,10,622732326410,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,3,622732326403,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,8,622732326408,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,11,622732326411,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,4,622732326404,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,13,622732326413,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,12,622732326412,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,15,622732326415,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,14,622732326414,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,17,622732326417,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,16,622732326416,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,18,622732326418,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,20,622732326420,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,5,622732326405,"Serum, SST",Not Received,Ambient,,FSH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,22,622732326422,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,21,622732326421,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,23,622732326423,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,24,622732326424,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,25,622732326425,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,19,622732326419,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,26,622732326426,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,27,622732326427,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,28,622732326428,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,29,622732326429,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,30,622732326430,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,1,622732326501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,3,622732326503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,4,622732326504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,2,622732326502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,5,622732326505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,8,622732326508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,6,622732326506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,7,622732326507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,9,622732326509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,10,622732326510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,11,622732326511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,12,622732326512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,13,622732326513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,14,622732326514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,15,622732326515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,21,622732326521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,18,622732326518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,17,622732326517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,25,622732326525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,22,622732326522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,20,622732326520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,29,622732326529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,27,622732326527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,24,622732326524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,16,622732326516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,19,622732326519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,28,622732326528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,26,622732326526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,30,622732326530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,23,622732326523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,1,622732326601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,3,622732326603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,2,622732326602,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,5,622732326605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,7,622732326607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,6,622732326606,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,9,622732326609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,10,622732326610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,8,622732326608,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,4,622732326604,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,12,622732326612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,13,622732326613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,11,622732326611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,14,622732326614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,15,622732326615,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,1,622732326801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,2,622732326802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,3,622732326803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,4,622732326804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,5,622732326805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,6,622732326806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,7,622732326807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,12,622732326812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,13,622732326813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,14,622732326814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,15,622732326815,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,8,622732326808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,10,622732326810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,9,622732326809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,11,622732326811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,3,622732327003,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,2,622732327002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,4,622732327004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,5,622732327005,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,6,622732327006,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,1,622732327001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,8,622732327008,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,7,622732327007,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,10,622732327010,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,9,622732327009,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,11,622732327011,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,12,622732327012,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,13,622732327013,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,14,622732327014,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,15,622732327015,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,18,622732327018,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,17,622732327017,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,16,622732327016,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,1,622732327201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,2,622732327202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,12,622732327212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,13,622732327213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,3,622732327203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,11,622732327211,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,14,622732327214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,15,622732327215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,17,622732327217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,10,622732327210,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,16,622732327216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,5,622732327205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,6,622732327206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,4,622732327204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,7,622732327207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,8,622732327208,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,9,622732327209,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,1,622732327401,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,2,622732327402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,3,622732327403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,5,622732327405,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,4,622732327404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,6,622732327406,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,7,622732327407,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,8,622732327408,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,9,622732327409,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,11,622732327411,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,10,622732327410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,12,622732327412,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,20,622732327420,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,21,622732327421,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,13,622732327413,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,22,622732327422,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,15,622732327415,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,19,622732327419,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,16,622732327416,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,14,622732327414,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,17,622732327417,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,18,622732327418,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,1,622732327601,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,2,622732327602,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,4,622732327604,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,3,622732327603,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,1,622732327701,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,3,622732327703,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,2,622732327702,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:10,12:40,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,4,622732327704,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,DNA,10-Mar-2026,10-Mar-2026,6227323283,1,622732328301,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,1,622732328601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,10:20,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,3,622732328603,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,2,622732328602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,,6227323286,4,622732328604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,1,622732328701,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,3,622732328703,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:45,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,,6227323287,4,622732328704,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,2,622732328702,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,2,622732329502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,3,622732329503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,1,622732329501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,6,622732329506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,5,622732329505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,7,622732329507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,8,622732329508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,11,622732329511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,9,622732329509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,10,622732329510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323295,4,622732329504,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:40,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,12,622732329512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,13,622732329513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,14,622732329514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,16,622732329516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,15,622732329515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,17,622732329517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,19,622732329519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,18,622732329518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,20,622732329520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,23,622732329523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,22,622732329522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,21,622732329521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,25,622732329525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,26,622732329526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,27,622732329527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,24,622732329524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,29,622732329529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,30,622732329530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,28,622732329528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,2,622732329702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323297,4,622732329704,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:45,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,6,622732329706,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,5,622732329705,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,1,622732329701,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,3,622732329703,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,7,622732329707,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,8,622732329708,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,10,622732329710,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,9,622732329709,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,11,622732329711,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,12,622732329712,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,14,622732329714,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,13,622732329713,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,18,622732329718,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,16,622732329716,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,15,622732329715,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,20,622732329720,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,19,622732329719,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,17,622732329717,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,21,622732329721,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,23,622732329723,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,25,622732329725,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,27,622732329727,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,26,622732329726,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,28,622732329728,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,29,622732329729,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,30,622732329730,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,22,622732329722,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,24,622732329724,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,1,622732329901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,3,622732329903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,4,622732329904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,5,622732329905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,2,622732329902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,7,622732329907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,8,622732329908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,9,622732329909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,6,622732329906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,11,622732329911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,12,622732329912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,10,622732329910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,13,622732329913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,15,622732329915,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,14,622732329914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,1,622732330901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,2,622732330902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,4,622732330904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,3,622732330903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,1,622732332001,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,2,622732332002,Biopsy RNA Later,Not Received,Frozen,,SM13/BIOPSY RNA,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,3,622732332003,"Biopsy, Frozen Tissue",Not Received,Frozen,,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,4,622732332004,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,1,622732333001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,2,622732333002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,3,622732333003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,5,622732333005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,4,622732333004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,7,622732333007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,8,622732333008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,9,622732333009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,6,622732333006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,10,622732333010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,11,622732333011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,13,622732333013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,12,622732333012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,15,622732333015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,14,622732333014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,1,622732333201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,2,622732333202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,3,622732333203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,6,622732333206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,4,622732333204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,8,622732333208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,9,622732333209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,5,622732333205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,10,622732333210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,7,622732333207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,11,622732333211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,12,622732333212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,14,622732333214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,13,622732333213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,15,622732333215,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,1,622732333401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,4,622732333404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,2,622732333402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,5,622732333405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,3,622732333403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,6,622732333406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,7,622732333407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,8,622732333408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,9,622732333409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,10,622732333410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,11,622732333411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,12,622732333412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,13,622732333413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,14,622732333414,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,15,622732333415,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,16,622732333416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,17,622732333417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,18,622732333418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,2,622732333502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,3,622732333503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,5,622732333505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,1,622732333501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,7,622732333507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,6,622732333506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,4,622732333504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,8,622732333508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,9,622732333509,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,11,622732333511,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,10,622732333510,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,13,622732333513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,15,622732333515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,16,622732333516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,17,622732333517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,14,622732333514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,12,622732333512,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,2,622732334002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,4,622732334004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,3,622732334003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,1,622732334001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,1,622732334101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,2,622732334102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,3,622732334103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,4,622732334104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,DNA,06-May-2026,06-May-2026,6227323346,1,622732334601,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,1,622732334801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,2,622732334802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,3,622732334803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,4,622732334804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,5,622732334805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,7,622732334807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,6,622732334806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,8,622732334808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,,6227323351,4,622732335104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,3,622732335103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,2,622732335102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,1,622732335101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,,6227323355,1,622732335501,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,06-May-2026,6227323355,2,622732335502,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,1,622763513901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,3,622763513903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,8,622763513908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,4,622763513904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,2,622763513902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,5,622763514005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,8,622763514008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,13,622763513913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,6,622763513906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,6,622763514006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,7,622763514007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,9,622763514009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,10,622763513910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,15,622763513915,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,12,622763513912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,9,622763513909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,7,622763513907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,4,622763514004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,11,622763513911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,2,622763514002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,3,622763514003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,1,622763514001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,5,622763513905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,14,622763513914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,12,622763514012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,14,622763514014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,1,622763514101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,15,622763514015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,2,622763514102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,11,622763514011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,10,622763514010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,3,622763514103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,13,622763514013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,8,622763514108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,9,622763514109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,11,622763514111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,12,622763514112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,10,622763514110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,13,622763514113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,7,622763514107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,6,622763514106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,3,622763514203,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,4,622763514204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,13,622763514213,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,5,622763514205,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,5,622763514105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,4,622763514104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,6,622763514206,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,14,622763514214,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,2,622763514202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,10,622763514210,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,1,622763514201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,15,622763514215,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,7,622763514207,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,9,622763514209,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,16,622763514216,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,17,622763514217,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,14,622763514114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,15,622763514115,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,12,622763514212,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,11,622763514211,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,8,622763514208,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,18,622763514218,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,7,622763514407,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,6,622763514406,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,3,622763514403,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,2,622763514402,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,1,622763514401,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,15,622763514415,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,16,622763514416,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,8,622763514408,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,10,622763514410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,4,622763514404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,17,622763514417,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,12,622763514412,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,11,622763514411,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,14,622763514414,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,13,622763514413,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,5,622763514405,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,9,622763514409,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,2,622763514602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,3,622763514603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,8,622763514608,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,9,622763514609,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-4,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,10,622763514610,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,16,622763514616,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,14,622763514614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,21,622763514621,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,4,622763514604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,5,622763514605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,15,622763514615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,18,622763514618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,11,622763514611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,13,622763514613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,6,622763514606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,22,622763514622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,7,622763514607,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,19,622763514619,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,1,622763514601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,17,622763514617,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,12,622763514612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,20,622763514620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,3,622763514803,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,4,622763514804,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,1,622763514801,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,2,622763515002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,3,622763515003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,2,622763514902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,4,622763515004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,2,622763514802,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,1,622763514901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,4,622763514904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,3,622763514903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,1,622763515001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,DNA,26-Mar-2026,26-Mar-2026,6227635156,1,622763515601,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,DNA,27-May-2026,27-May-2026,6227635155,1,622763515501,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,,6227635159,4,622763515904,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,1,622763515901,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,2,622763515902,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,3,622763515903,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,3,622763516103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,,6227635161,4,622763516104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,1,622763516101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,2,622763516102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,1,622763517101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,2,622763517102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,5,622763517105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,7,622763517107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,3,622763517103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,6,622763517106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,4,622763517104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,10,622763517110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,14,622763517114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,15,622763517115,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,11,622763517111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,8,622763517108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,9,622763517109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,13,622763517113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,12,622763517112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,2,622763517302,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,6,622763517306,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,7,622763517307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,8,622763517308,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,5,622763517305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,10,622763517310,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,4,622763517304,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,9,622763517309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,1,622763517301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,3,622763517303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,14,622763517314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,13,622763517313,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,1,622763517401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,15,622763517315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,3,622763517403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,11,622763517311,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,2,622763517402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,12,622763517312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,9,622763517409,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,5,622763517405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,11,622763517411,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,6,622763517406,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,12,622763517412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,4,622763517404,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,7,622763517407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,8,622763517408,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,13,622763517413,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,10,622763517410,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,14,622763517414,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,18,622763517418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,17,622763517417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,15,622763517415,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,16,622763517416,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,1,622763518001,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,28-May-2026,6227635180,3,622763518003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,4,622763518004,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,2,622763518002,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,4,622763518204,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,25-Apr-2026,6227635182,3,622763518203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:45,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,1,622763518201,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,2,622763518202,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,2,622763519302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,1,622763519301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,3,622763519303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,,6227635193,4,622763519304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,1,622763520401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,2,622763520402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,3,622763520403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,15,622763520415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,9,622763520409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,10,622763520410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,11,622763520411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,12,622763520412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,13,622763520413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,5,622763520405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,4,622763520404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,14,622763520414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,7,622763520407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,6,622763520406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,8,622763520408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,2,622763520702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,8,622763520708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,5,622763520705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,4,622763520704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,9,622763520709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,1,622763520701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,11,622763520711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,3,622763520703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,6,622763520706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,17,622763520717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,18,622763520718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,2,622763520802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,3,622763520803,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,13,622763520713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,1,622763520801,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,7,622763520707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,10,622763520710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,12,622763520712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,16,622763520716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,7,622763520807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,9,622763520809,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,10,622763520810,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,11,622763520811,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,14,622763520714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,15,622763520715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,12,622763520812,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,4,622763520804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,6,622763520806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,8,622763520808,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,17,622763520817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,14,622763520814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,5,622763520805,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,13,622763520813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,16,622763520816,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,15,622763520815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,2,622763521102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,3,622763521103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,4,622763521104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,1,622763521101,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,8,622763521108,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,10,622763521110,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,6,622763521106,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,5,622763521105,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,11,622763521111,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,13,622763521113,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,14,622763521114,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,7,622763521107,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,19,622763521119,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,16,622763521116,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,20,622763521120,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,9,622763521109,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,21,622763521121,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,22,622763521122,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,17,622763521117,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,18,622763521118,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,12,622763521112,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,2,622763521302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,3,622763521303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,4,622763521304,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,15,622763521115,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,1,622763521301,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,DNA,09-Apr-2026,09-Apr-2026,6227635218,1,622763521801,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,2,622763522302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,1,622763522301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,3,622763522303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,,6227635223,4,622763522304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,2,622769771802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,3,622769771803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,5,622769771805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,1,622769771801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,6,622769771806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,4,622769771804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,7,622769771807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,11,622769771811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,13,622769771813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,10,622769771810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,14,622769771814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,15,622769771815,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,8,622769771808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,1,622769771901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,2,622769771902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,4,622769771904,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,5,622769771905,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,3,622769771903,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,8,622769771908,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,7,622769771907,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,6,622769771906,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,10,622769771910,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,9,622769771809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,11,622769771911,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,12,622769771812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,9,622769771909,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,12,622769771912,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,13,622769771913,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,14,622769771914,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,17,622769771917,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,15,622769771915,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,16,622769771916,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,18,622769771918,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,6,622769772206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,7,622769772207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,13,622769772213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,10,622769772210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,12,622769772212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,11,622769772211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,14,622769772214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,8,622769772208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,15,622769772215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,9,622769772209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,2,622769772202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,5,622769772205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,3,622769772203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,4,622769772204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,1,622769772201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,1,622769772301,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,4,622769772304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,2,622769772302,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,3,622769772303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,5,622769772305,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,7,622769772307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,16,622769772216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,17,622769772217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,21,622769772321,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,6,622769772306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,12,622769772312,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,13,622769772313,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,14,622769772314,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,9,622769772309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,18,622769772318,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,16,622769772316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,17,622769772317,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,8,622769772308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,15,622769772315,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,19,622769772319,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,10,622769772310,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,20,622769772320,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,22,622769772322,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,11,622769772311,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,1,622769772501,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,3,622769772503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,4,622769772504,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,2,622769772502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,2,622769773602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,DNA,08-Apr-2026,08-Apr-2026,6227697731,1,622769773101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,1,622769773601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,,6227697736,4,622769773604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,3,622769773603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,5,622769774505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,1,622769774501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,6,622769774506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,4,622769774504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,8,622769774508,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,3,622769774503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,2,622769774502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,7,622769774507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,9,622769774509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,14,622769774514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,16,622769774516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,18,622769774518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,17,622769774517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,13,622769774513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,12,622769774512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,11,622769774511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,15,622769774515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,19,622769774519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,10,622769774510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,30,622769774530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,20,622769774520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,22,622769774522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,25,622769774525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,23,622769774523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,26,622769774526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,21,622769774521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,29,622769774529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,27,622769774527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,24,622769774524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,28,622769774528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,1,622781089901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,3,622781089903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,2,622781089902,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,4,622781089904,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,5,622781089905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,6,622781089906,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,10,622781089910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,11,622781089911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,12,622781089912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,13,622781089913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,14,622781089914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,15,622781089915,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,8,622781089908,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,9,622781089909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,2,622781090002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,4,622781090004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,6,622781090006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,7,622781090007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,8,622781090008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,9,622781090009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,10,622781090010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,3,622781090003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,5,622781090005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,12,622781090012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,14,622781090014,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,13,622781090013,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,15,622781090015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,1,622781090101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,2,622781090102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,3,622781090103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,4,622781090104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,1,622781090001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,6,622781090106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,7,622781090107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,8,622781090108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,9,622781090109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,10,622781090110,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,11,622781090111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,12,622781090112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,14,622781090114,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,13,622781090113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,7,622781089907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,11,622781090011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,5,622781090105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,15,622781090115,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,2,622781090402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,3,622781090403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,4,622781090404,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,1,622781090501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,2,622781090502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,3,622781090503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,4,622781090504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,1,622781090401,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,5,622732322305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:01,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,3,622793314203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,5,622793314205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,2,622793314202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,4,622793314204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,6,622793314206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,1,622793314201,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,7,622793314207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,10,622793314210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,12,622793314212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,9,622793314209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,11,622793314211,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,8,622793314208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,14,622793314214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,17,622793314217,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,13,622793314213,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,18,622793314218,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,1,622793314301,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,15,622793314215,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,19,622793314219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,2,622793314302,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,21,622793314221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,22,622793314222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,20,622793314220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,16,622793314216,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,4,622793314304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,8,622793314308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,7,622793314307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,3,622793314303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,20,622793314320,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,6,622793314306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,9,622793314309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,11,622793314311,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-12TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,19,622793314319,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,17,622793314317,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,22,622793314322,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,EXPEDITED FRZN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,10,622793314310,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,16,622793314316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,23,622793314323,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,18,622793314318,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,12,622793314312,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,15,622793314315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,14,622793314314,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,13,622793314313,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMAPK I-12 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,5,622793314305,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-12,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,21,622793314321,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,5,622732328705,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,12:52,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,2,622799396202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,15,622799396215,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,4,622799396204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,1,622799396201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,10,622799396210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,14,622799396214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,3,622799396203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,8,622799396208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,12,622799396212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,11,622799396211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,7,622799396207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,9,622799396209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,5,622799396205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,6,622799396206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,13,622799396213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,14,622799396614,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,17,622799396617,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,2,622799396602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,3,622799396603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,12,622799396612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,1,622799396601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,13,622799396613,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,7,622799396607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,15,622799396615,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,8,622799396608,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,4,622799396604,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,10,622799396610,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,11,622799396611,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,6,622799396606,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,5,622799396605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,16,622799396616,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,18,622799396618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,9,622799396609,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,4,622799397104,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,3,622799397103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,1,622799397101,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,2,622799397102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,DNA,20-May-2026,20-May-2026,6227993977,1,622799397701,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,1,622799398401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,3,622799398403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,,6227993984,4,622799398404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,2,622799398402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,20-May-2026,6227993987,2,622799398702,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,,6227993987,1,622799398701,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,5,622732324405,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,6,622732324406,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,5,622732328605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,15:49,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,2,622802395102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,1,622802395101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,3,622802395103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,,6228023951,4,622802395104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,5,622732325405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:49,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,3,622803655303,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,5,622803655305,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,7,622803655307,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,8,622803655308,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,4,622803655304,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,1,622803655301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,6,622803655306,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,2,622803655302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,12,622803655312,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,13,622803655313,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,15,622803655315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,11,622803655311,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,17,622803655317,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,18,622803655318,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,14,622803655314,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,9,622803655309,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,16,622803655316,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,4,622803655404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,5,622803655405,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,1,622803655401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,6,622803655406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,7,622803655407,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,9,622803655409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,10,622803655410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,8,622803655408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,10,622803655310,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,3,622803655403,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,11,622803655411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,2,622803655402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,12,622803655412,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,13,622803655413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,14,622803655414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,15,622803655415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,16,622803655416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,17,622803655417,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,18,622803655418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,1,622811460801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,7,622811460807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,3,622811460803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,6,622811460806,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,8,622811460808,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,9,622811460809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,4,622811460804,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,5,622811460805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,11,622811460811,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,10,622811460810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,2,622811460802,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,12,622811460812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,14,622811460814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,15,622811460815,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,13,622811460813,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,1,622811461001,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,2,622811461002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,5,622811461005,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,3,622811461003,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,6,622811461006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,4,622811461004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,10,622811461010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,11,622811461011,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,9,622811461009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,7,622811461007,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,12,622811461012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,13,622811461013,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,14,622811461014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,8,622811461008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,,6228114610,15,622811461015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,3,622813735903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,1,622813735901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,4,622813735904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,2,622813735902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,1,622817339701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,4,622817339704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,3,622817339703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,2,622817339702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,6,622817339706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,8,622817339708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,5,622817339705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,7,622817339707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,12,622817339712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,16,622817339716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,18,622817339718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,17,622817339717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,9,622817339709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,14,622817339714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,11,622817339711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,10,622817339710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,15,622817339715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,13,622817339713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,14,622817993214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,9,622817993209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,15,622817993215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,16,622817993216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,12,622817993212,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,13,622817993213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,17,622817993217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,10,622817993210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,11,622817993211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,1,622817993201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,3,622817993203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,4,622817993204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,7,622817993207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,2,622817993202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,8,622817993208,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,1,622817993601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,2,622817993602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,6,622817993606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,4,622817993604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,10,622817993610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,5,622817993605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,14,622817993614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,11,622817993611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,12,622817993612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,13,622817993613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,16,622817993616,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,15,622817993615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,9,622817993609,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,19,622817993619,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,18,622817993618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,3,622817993603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,17,622817993617,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,6,622817993206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,5,622817993205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,20,622817993620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,21,622817993621,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,8,622817993608,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,7,622817993607,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,22,622817993622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,DNA,10-Apr-2026,10-Apr-2026,6228179942,1,622817994201,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,3,622817994503,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,4,622817994504,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,1,622817994501,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,2,622817994502,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,1,622819434101,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,4,622819434104,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,3,622819434103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,2,622819434102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,5,622763516105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:58,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,5,622763522305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:49,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,31,622732323331,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,5,622732322405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:46,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,3,622825207203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,1,622825207201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,08:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,,6228252073,4,622825207304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,2,622825207302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,4,622825207204,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,2,622825207202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,3,622825207303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,1,622825207301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,5,622769773605,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:15,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,1,622830822401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,2,622830822402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,5,622830822405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,6,622830822406,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,7,622830822407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,9,622830822409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,10,622830822410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,8,622830822408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,11,622830822411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,13,622830822413,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,3,622830822403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,4,622830822404,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,14,622830822414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,16,622830822416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,15,622830822415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,12,622830822412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,17,622830822417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,18,622830822418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,5,622802395105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:31,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,3,622839811503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,2,622839811502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,4,622839811504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,6,622839811506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,5,622839811505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,7,622839811507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,8,622839811508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,10,622839811510,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,9,622839811509,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,11,622839811511,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,12,622839811512,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,13,622839811513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,14,622839811514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,1,622839811501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,17,622839811517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,15,622839811515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,16,622839811516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,19,622817339719,,Cancelled,,,,,,,,,10:35,13:56,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,5,622799398405,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:04,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,5,622763515905,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:18,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,1,622850173201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,2,622850173202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,,6228501732,4,622850173204,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,3,622850173203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,5,622732335105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:22,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,1,622861056401,"Stool, ova & parasites(form)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,3,622861056403,"Culture, Stool",Cancelled,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,4,622861056404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,07-May-2026,6228610564,2,622861056402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,5,622825207205,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:52,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,31,622769774531,,In Inventory,,Default Return Frozen,,,,,,,,16:05,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,5,622825207305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,12:51,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,5,622732325605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:06,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,5,622763519305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:34,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,5,622817994505,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:59,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,5,622850173205,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:03,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,5,622732332005,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, diff --git a/Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv b/Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv deleted file mode 100644 index 7fe468b..0000000 --- a/Covance_UCO3001/Source/2026-05-29_111722 sponsor-study-36940-samples-allSamples.csv +++ /dev/null @@ -1,1445 +0,0 @@ -Protocol Code,Investigator No.,Investigator Name,Patient No.,Collection Date,Protocol Visit Code,Kit Receipt Date,Container Receipt Date,Accession,Container No.,Container Barcode No.,Specimen Type,Sample Status,Expected Receipt Condition,Actual Receipt Condition,Container Label Line 1,Container Label Line 2,SM Sample Status,SMART Specimen Class Description,Aliquot Created Date,Aliquoted Date,Collection Time,Container Receipt Time,Country,Courier,Kit Receipt Time,Parent Barcode Number,Parent Sample Type,Project,Region,Screening No.,Shipped To Organization Name,Site Waybill No.,Site - Scheduled Shipment Date,Site - Shipment Created Date,Site - Shipment Details Entered Date,SMART Specimen Class,Visit Description,Parent Barcode,Children Barcode -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,1,622732320301,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,2,622732320302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,3,622732320303,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,7,622732320307,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,8,622732320308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,5,622732320305,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,6,622732320306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,11,622732320311,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,24-Jan-2026,6227323203,4,622732320304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,12:40,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,14,622732320314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,12,622732320312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,15,622732320315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,1,622732320401,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,9,622732320309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,3,622732320403,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,4,622732320404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,2,622732320402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,6,622732320406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,7,622732320407,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,5,622732320405,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,,6227323203,10,622732320310,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Jan-2026,SCRN,23-Jan-2026,23-Jan-2026,6227323203,13,622732320313,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,08:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,9,622732320409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,10,622732320410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,11,622732320411,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,13,622732320413,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM PANEL, BETA",HCG & FSH,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,14,622732320414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,15,622732320415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,04-Mar-2026,6227323204,8,622732320408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,1,622732320501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227323204,12,622732320412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,2,622732320502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,4,622732320504,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,7,622732320507,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,3,622732320503,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,6,622732320506,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,10,622732320510,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,9,622732320509,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,8,622732320508,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,5,622732320505,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,11,622732320511,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,13,622732320513,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,14,622732320514,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,15,622732320515,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,16,622732320516,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,18,622732320518,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,1,622732320601,"Whole Blood, EDTA, Dry",Cancelled,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,17,622732320517,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,I-0,20-Feb-2026,20-Feb-2026,6227323205,12,622732320512,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,4,622732320604,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,7,622732320607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,8,622732320608,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,9,622732320609,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,10,622732320610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,11,622732320611,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,12,622732320612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,2,622732320602,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,6,622732320606,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,3,622732320603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,5,622732320605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,17,622732320617,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,14,622732320614,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,23-Apr-2026,6227323206,18,622732320618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,2,622732320702,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,16,622732320616,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,3,622732320703,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,1,622732320701,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,15,622732320615,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,23-Apr-2026,,6227323206,13,622732320613,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,4,622732320704,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,5,622732320705,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,6,622732320706,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,7,622732320707,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,8,622732320708,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,9,622732320709,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,10,622732320710,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,11,622732320711,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,,6227323207,12,622732320712,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,13,622732320713,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,14,622732320714,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,16,622732320716,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,17,622732320717,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,1,622732320801,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,2,622732320802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,3,622732320803,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,5,622732320805,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,4,622732320804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,7,622732320807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,8,622732320808,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,10,622732320810,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,23-Apr-2026,I-2,24-Apr-2026,24-Apr-2026,6227323207,15,622732320715,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,11,622732320811,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,9,622732320809,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,,6227323208,12,622732320812,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-5,,,,,07:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,13,622732320813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,14,622732320814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,15,622732320815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,16,622732320816,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,17,622732320817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,04-Mar-2026,I-2,05-Mar-2026,05-Mar-2026,6227323208,6,622732320806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,2,622732321002,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,4,622732321004,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,1,622732321001,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,3,622732321003,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,6,622732321006,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-1,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,5,622732321005,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,7,622732321007,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-2,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,8,622732321008,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-3,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,,6227323210,9,622732321009,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-4,77242113UCO3001-4,,,,,07:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,10,622732321010,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,12,622732321012,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,14,622732321014,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,11,622732321011,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,13,622732321013,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,15,622732321015,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,16,622732321016,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,17,622732321017,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,18,622732321018,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,19,622732321019,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,21,622732321021,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,20,622732321020,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,I-4,19-Mar-2026,19-Mar-2026,6227323210,22,622732321022,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,1,622732321101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,2,622732321102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,3,622732321103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,28-Jan-2026,SCRNSTOOL,29-Jan-2026,29-Jan-2026,6227323211,4,622732321104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:00,07:40,Czech Republic,,07:40,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,1,622732321201,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,3,622732321203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,4,622732321204,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,03-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227323212,2,622732321202,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,13:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,1,622732321301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,2,622732321302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,30-Apr-2026,6227323213,3,622732321303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRNSTOOL,30-Apr-2026,,6227323213,4,622732321304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,19-Feb-2026,DNA,20-Feb-2026,20-Feb-2026,6227323217,1,622732321701,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,18-Mar-2026,DNA,19-Mar-2026,19-Mar-2026,6227323219,1,622732321901,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,07:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,1,622732322301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,2,622732322302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,07-Feb-2026,6227323223,3,622732322303,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,,6227323223,4,622732322304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,2,622732322402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,1,622732322401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,20-Mar-2026,6227323224,3,622732322403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,,6227323224,4,622732322404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,2,622732323102,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,3,622732323103,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,4,622732323104,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323231,5,622732323105,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,6,622732323106,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,23-Apr-2026,6227323231,8,622732323108,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,7,622732323107,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,1,622732323101,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,9,622732323109,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,10,622732323110,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,12,622732323112,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,14,622732323114,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,13,622732323113,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,17,622732323117,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,18,622732323118,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,15,622732323115,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,16,622732323116,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,11,622732323111,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,19,622732323119,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,20,622732323120,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,22,622732323122,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,21,622732323121,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,25,622732323125,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,26,622732323126,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,24,622732323124,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,23,622732323123,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,27,622732323127,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,28,622732323128,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,29,622732323129,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323231,30,622732323130,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,3,622732323203,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,4,622732323204,"Serum, SST",Cancelled,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,5,622732323205,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,6,622732323206,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,7,622732323207,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,8,622732323208,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,1,622732323201,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,2,622732323202,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,10,622732323210,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,12,622732323212,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,14,622732323214,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,13,622732323213,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,11,622732323211,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,15,622732323215,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,9,622732323209,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,16,622732323216,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,17,622732323217,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,21,622732323221,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,23,622732323223,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,26,622732323226,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,20,622732323220,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,24,622732323224,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,22,622732323222,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,27,622732323227,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,25,622732323225,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,19,622732323219,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,28,622732323228,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,18,622732323218,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,29,622732323229,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,2,622732323302,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,4,622732323304,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCH,23-Apr-2026,,6227323232,30,622732323230,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,3,622732323303,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,6,622732323306,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,7,622732323307,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,1,622732323301,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,5,622732323305,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,8,622732323308,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,9,622732323309,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,10,622732323310,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,13,622732323313,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,12,622732323312,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,16,622732323316,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,14,622732323314,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,15,622732323315,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,11,622732323311,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,17,622732323317,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,19,622732323319,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,24,622732323324,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,20,622732323320,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,23,622732323323,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,26,622732323326,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,25,622732323325,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,22,622732323322,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,27,622732323327,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,21,622732323321,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,18,622732323318,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,29,622732323329,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,30,622732323330,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,,6227323233,28,622732323328,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,2,622732323402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,3,622732323403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,4,622732323404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,5,622732323405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,1,622732323401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,6,622732323406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,10,622732323410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,22-Apr-2026,6227323234,8,622732323408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,11,622732323411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,7,622732323407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,9,622732323409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,15,622732323415,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,14,622732323414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,,6227323234,13,622732323413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRN,21-Apr-2026,21-Apr-2026,6227323234,12,622732323412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,2,622732323602,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,1,622732323601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,3,622732323603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,4,622732323604,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,8,622732323608,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,5,622732323605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,9,622732323609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,7,622732323607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,6,622732323606,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,11,622732323611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,12,622732323612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,10,622732323610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,,6227323236,13,622732323613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,14,622732323614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRN,18-Feb-2026,18-Feb-2026,6227323236,15,622732323615,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,2,622732323702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,4,622732323704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,1,622732323701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,3,622732323703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,7,622732323707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,8,622732323708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,5,622732323705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,6,622732323706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,11,622732323711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,12,622732323712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,9,622732323709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,13,622732323713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,10,622732323710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,15,622732323715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,14,622732323714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,,6227323237,17,622732323717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:00,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,18,622732323718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,I-0,21-Mar-2026,21-Mar-2026,6227323237,16,622732323716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,1,622732323801,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,2,622732323802,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,4,622732323804,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,5,622732323805,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,7,622732323807,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,8,622732323808,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,6,622732323806,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,10,622732323810,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,11,622732323811,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,13,622732323813,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,12,622732323812,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,9,622732323809,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,16,622732323816,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,15,622732323815,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,14,622732323814,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,27-May-2026,6227323238,18,622732323818,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,17,622732323817,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,2,622732324002,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,1,622732324001,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,15,622732324015,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,13,622732324013,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,16,622732324016,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,14,622732324014,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,5,622732324005,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,4,622732324004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,8,622732324008,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,9,622732324009,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,6,622732324006,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,3,622732324003,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,10,622732324010,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,7,622732324007,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,17,622732324017,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,09-Apr-2026,6227323240,12,622732324012,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,08-Apr-2026,I-2,09-Apr-2026,,6227323240,11,622732324011,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,26-May-2026,I-0,27-May-2026,,6227323238,3,622732323803,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,1,622732324201,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,2,622732324202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,3,622732324203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,4,622732324204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,5,622732324205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,9,622732324209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,10,622732324210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,7,622732324207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,8,622732324208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,11,622732324211,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,6,622732324206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,13,622732324213,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,12,622732324212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,15,622732324215,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,16,622732324216,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,17,622732324217,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,19,622732324219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,14,622732324214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,21,622732324221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,,6227323242,18,622732324218,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,20,622732324220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,15-Apr-2026,I-4,16-Apr-2026,16-Apr-2026,6227323242,22,622732324222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,1,622732324301,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,3,622732324303,"Culture, Stool",Cancelled,Ambient,,STOOL CULTURE,,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,1,622732324401,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,,6227323243,4,622732324304,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,2,622732324402,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCSTOOL,18-Mar-2026,18-Mar-2026,6227323243,2,622732324302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,3,622732324403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:20,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,,6227323244,4,622732324404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,07:20,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,12-Mar-2026,6227323245,3,622732324503,"Culture, Stool",Received,Ambient,Default Return Frozen,STOOL CULTURE,,,,,,09:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,4,622732324504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,1,622732324501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCSTOOL,12-Mar-2026,,6227323245,2,622732324502,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,09:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,20-Mar-2026,DNA,21-Mar-2026,21-Mar-2026,6227323251,1,622732325101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:00,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,1,622732325201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,2,622732325202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,3,622732325203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,4,622732325204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,5,622732325205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,6,622732325206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,,6227323252,7,622732325207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:03,,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,TB,18-Feb-2026,18-Feb-2026,6227323252,8,622732325208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:03,07:10,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,2,622732325302,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,1,622732325301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,6,622732325306,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,5,622732325305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,3,622732325303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,8,622732325308,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,,6227323253,7,622732325307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,2,622732325402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,1,622732325401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,,6227323254,4,622732325404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,TB,12-Mar-2026,12-Mar-2026,6227323253,4,622732325304,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,3,622732325403,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,1,622732325601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,2,622732325602,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,3,622732325603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,,6227323256,4,622732325604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,7,622732326407,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,6,622732326406,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,1,622732326401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,12-Mar-2026,6227323264,2,622732326402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,9,622732326409,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,10,622732326410,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,3,622732326403,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,8,622732326408,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,11,622732326411,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,4,622732326404,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,13,622732326413,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,12,622732326412,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,15,622732326415,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,14,622732326414,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,17,622732326417,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,16,622732326416,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,18,622732326418,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,20,622732326420,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,5,622732326405,"Serum, SST",Not Received,Ambient,,FSH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,22,622732326422,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,21,622732326421,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,23,622732326423,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,24,622732326424,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,25,622732326425,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,19,622732326419,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,26,622732326426,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,27,622732326427,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,28,622732326428,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,29,622732326429,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,11-Mar-2026,UNSCH,12-Mar-2026,,6227323264,30,622732326430,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,1,622732326501,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,3,622732326503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,4,622732326504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,18-Mar-2026,6227323265,2,622732326502,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,5,622732326505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,8,622732326508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,6,622732326506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,7,622732326507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,9,622732326509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,10,622732326510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,11,622732326511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,12,622732326512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,13,622732326513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,14,622732326514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,15,622732326515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,21,622732326521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,18,622732326518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,17,622732326517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,25,622732326525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,22,622732326522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,20,622732326520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,29,622732326529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,27,622732326527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,24,622732326524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,16,622732326516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,19,622732326519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,28,622732326528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,26,622732326526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,30,622732326530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,17-Mar-2026,UNSCH,18-Mar-2026,,6227323265,23,622732326523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,1,622732326601,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,3,622732326603,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,2,622732326602,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,5,622732326605,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,7,622732326607,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,6,622732326606,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,9,622732326609,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,10,622732326610,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,8,622732326608,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,17-Jan-2026,6227323266,4,622732326604,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,16:45,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,12,622732326612,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,13,622732326613,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,11,622732326611,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,16-Jan-2026,6227323266,14,622732326614,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,16:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRN,16-Jan-2026,,6227323266,15,622732326615,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,16:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,1,622732326801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,2,622732326802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,3,622732326803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,4,622732326804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,5,622732326805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,6,622732326806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,7,622732326807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,12,622732326812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,13,622732326813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,14,622732326814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,15,622732326815,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,30-Jan-2026,6227323268,8,622732326808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,10,622732326810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,24-Jan-2026,6227323268,9,622732326809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRN,24-Jan-2026,,6227323268,11,622732326811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,3,622732327003,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,2,622732327002,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,4,622732327004,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,5,622732327005,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,6,622732327006,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,1,622732327001,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,8,622732327008,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,7,622732327007,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,10,622732327010,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,9,622732327009,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,11,622732327011,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,12,622732327012,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,13,622732327013,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,14,622732327014,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,15,622732327015,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,18,622732327018,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,,6227323270,17,622732327017,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,I-0,10-Mar-2026,10-Mar-2026,6227323270,16,622732327016,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,1,622732327201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,2,622732327202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,12,622732327212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,13,622732327213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,3,622732327203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,11,622732327211,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-4,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,14,622732327214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,15,622732327215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,17,622732327217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,10,622732327210,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-3,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,16,622732327216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,5,622732327205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,6,622732327206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,4,622732327204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,28-Mar-2026,6227323272,7,622732327207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,07:10,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,8,622732327208,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-1,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,27-Mar-2026,I-2,28-Mar-2026,,6227323272,9,622732327209,"Stool, unpreserved",Cancelled,Frozen,,STOOL I-2,77242113UCO3001-2,,,,,07:10,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,1,622732327401,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,2,622732327402,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,3,622732327403,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,5,622732327405,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,4,622732327404,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,6,622732327406,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,7,622732327407,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,8,622732327408,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,9,622732327409,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,11,622732327411,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,10,622732327410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,12,622732327412,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,20,622732327420,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,21,622732327421,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,13,622732327413,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,22,622732327422,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,15,622732327415,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,19,622732327419,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,16,622732327416,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,14,622732327414,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,09-Apr-2026,6227323274,17,622732327417,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,08-Apr-2026,I-4,09-Apr-2026,,6227323274,18,622732327418,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,1,622732327601,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,2,622732327602,"Stool, unpreserved",Cancelled,Frozen,,C-DIFF TOXIN,& PCR FROZEN,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,,6227323276,4,622732327604,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,16:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,15-Jan-2026,SCRNSTOOL,16-Jan-2026,16-Jan-2026,6227323276,3,622732327603,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,16:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,1,622732327701,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,3,622732327703,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,24-Jan-2026,6227323277,2,622732327702,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:10,12:40,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222002,23-Jan-2026,SCRNSTOOL,24-Jan-2026,,6227323277,4,622732327704,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,10:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,09-Mar-2026,DNA,10-Mar-2026,10-Mar-2026,6227323283,1,622732328301,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,1,622732328601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,10:20,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,3,622732328603,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,21-Feb-2026,6227323286,2,622732328602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,,6227323286,4,622732328604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,1,622732328701,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,3,622732328703,"Biopsy, Frozen Tissue",Shipped,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:45,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,,6227323287,4,622732328704,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,14-Feb-2026,6227323287,2,622732328702,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,05:55,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,2,622732329502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,3,622732329503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,1,622732329501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,6,622732329506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,5,622732329505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,7,622732329507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,8,622732329508,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,11,622732329511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,9,622732329509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,10,622732329510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323295,4,622732329504,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,08:40,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,12,622732329512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,13,622732329513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,14,622732329514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,16,622732329516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,15,622732329515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,17,622732329517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,19,622732329519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,18,622732329518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,20,622732329520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,23,622732329523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,22,622732329522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,21,622732329521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,25,622732329525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,26,622732329526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,27,622732329527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,24,622732329524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,29,622732329529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,30,622732329530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,13-Mar-2026,SCRN,14-Mar-2026,,6227323295,28,622732329528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,08:40,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,2,622732329702,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,14-Mar-2026,6227323297,4,622732329704,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,07:45,07:20,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,6,622732329706,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,5,622732329705,"Serum, SST",Not Received,Ambient,,FSH,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,1,622732329701,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,3,622732329703,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,7,622732329707,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,8,622732329708,"Feces, unpreserved",Not Received,Frozen,,FECAL CALPROTECTIN,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,10,622732329710,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,9,622732329709,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,11,622732329711,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,12,622732329712,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,14,622732329714,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,13,622732329713,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,18,622732329718,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,16,622732329716,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,15,622732329715,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,20,622732329720,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,19,622732329719,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,17,622732329717,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,21,622732329721,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,23,622732329723,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,25,622732329725,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,27,622732329727,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,26,622732329726,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,28,622732329728,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,29,622732329729,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,30,622732329730,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,22,622732329722,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,13-Mar-2026,SCRN,14-Mar-2026,,6227323297,24,622732329724,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,07:45,,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,1,622732329901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,3,622732329903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,4,622732329904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,5,622732329905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,2,622732329902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,7,622732329907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,8,622732329908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,9,622732329909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,15-May-2026,6227323299,6,622732329906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,11,622732329911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,12,622732329912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,10,622732329910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,,6227323299,13,622732329913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,15,622732329915,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRN,14-May-2026,14-May-2026,6227323299,14,622732329914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,1,622732330901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,2,622732330902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,4,622732330904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,13-May-2026,SCRNSTOOL,14-May-2026,14-May-2026,6227323309,3,622732330903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,1,622732332001,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,2,622732332002,Biopsy RNA Later,Not Received,Frozen,,SM13/BIOPSY RNA,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,3,622732332003,"Biopsy, Frozen Tissue",Not Received,Frozen,,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,,6227323320,4,622732332004,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,1,622732333001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,2,622732333002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,3,622732333003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,5,622732333005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,4,622732333004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,7,622732333007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,8,622732333008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,9,622732333009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,03-Apr-2026,6227323330,6,622732333006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,10,622732333010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,11,622732333011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,13,622732333013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,12,622732333012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,,6227323330,15,622732333015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,31-Mar-2026,SCRN,01-Apr-2026,01-Apr-2026,6227323330,14,622732333014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,1,622732333201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,2,622732333202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,3,622732333203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,6,622732333206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,4,622732333204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,21-Apr-2026,6227323332,8,622732333208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,9,622732333209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,5,622732333205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,10,622732333210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,7,622732333207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,11,622732333211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,12,622732333212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,14,622732333214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,,6227323332,13,622732333213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,16-Apr-2026,SCRN,17-Apr-2026,17-Apr-2026,6227323332,15,622732333215,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,1,622732333401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,4,622732333404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,2,622732333402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,5,622732333405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,3,622732333403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,6,622732333406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,7,622732333407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,8,622732333408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,9,622732333409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,10,622732333410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,11,622732333411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,12,622732333412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,13,622732333413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,14,622732333414,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,15,622732333415,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,16,622732333416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,,6227323334,17,622732333417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,I-0,06-May-2026,06-May-2026,6227323334,18,622732333418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,2,622732333502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,3,622732333503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,5,622732333505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,1,622732333501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,7,622732333507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,6,622732333506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,4,622732333504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,8,622732333508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,9,622732333509,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,11,622732333511,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,10,622732333510,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,13,622732333513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,15,622732333515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,,6227323335,16,622732333516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,17,622732333517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,14,622732333514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,19-May-2026,I-2,20-May-2026,20-May-2026,6227323335,12,622732333512,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,10:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,2,622732334002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,4,622732334004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,3,622732334003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,02-Apr-2026,SCRNSTOOL,03-Apr-2026,03-Apr-2026,6227323340,1,622732334001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,1,622732334101,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,2,622732334102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,3,622732334103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6227323341,4,622732334104,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,06:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,DNA,06-May-2026,06-May-2026,6227323346,1,622732334601,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,1,622732334801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,2,622732334802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,3,622732334803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,4,622732334804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,5,622732334805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,,6227323348,7,622732334807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,6,622732334806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092002,05-May-2026,TB,07-May-2026,07-May-2026,6227323348,8,622732334808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,TB Testing,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,,6227323351,4,622732335104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,3,622732335103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,2,622732335102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,1,622732335101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,,6227323355,1,622732335501,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,11:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,05-May-2026,BDL,06-May-2026,06-May-2026,6227323355,2,622732335502,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,11:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,1,622763513901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,3,622763513903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,8,622763513908,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,4,622763513904,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,2,622763513902,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,5,622763514005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,8,622763514008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,13,622763513913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,03-Apr-2026,6227635139,6,622763513906,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,6,622763514006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,7,622763514007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,9,622763514009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,10,622763513910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,15,622763513915,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,12,622763513912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,9,622763513909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,7,622763513907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,4,622763514004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,11,622763513911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,28-Feb-2026,6227635140,2,622763514002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,13:20,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,3,622763514003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,1,622763514001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,,6227635139,5,622763513905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,08:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRN,02-Apr-2026,02-Apr-2026,6227635139,14,622763513914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,08:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,12,622763514012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,14,622763514014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,1,622763514101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,15,622763514015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,2,622763514102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,11,622763514011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,27-Feb-2026,6227635140,10,622763514010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,13:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,3,622763514103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRN,27-Feb-2026,,6227635140,13,622763514013,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,13:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,8,622763514108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,9,622763514109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,11,622763514111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,12,622763514112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,10,622763514110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,13,622763514113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,7,622763514107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,6,622763514106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,3,622763514203,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,4,622763514204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,13,622763514213,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,5,622763514205,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,5,622763514105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,08-May-2026,6227635141,4,622763514104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,6,622763514206,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,14,622763514214,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,2,622763514202,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,10,622763514210,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,1,622763514201,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,15,622763514215,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,7,622763514207,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,9,622763514209,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,16,622763514216,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,17,622763514217,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,07-May-2026,6227635141,14,622763514114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,06-May-2026,SCRN,07-May-2026,,6227635141,15,622763514115,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,,6227635142,12,622763514212,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:40,,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,11,622763514211,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,8,622763514208,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,I-0,26-Mar-2026,26-Mar-2026,6227635142,18,622763514218,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,7,622763514407,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,6,622763514406,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,3,622763514403,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,2,622763514402,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,1,622763514401,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,15,622763514415,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,16,622763514416,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,8,622763514408,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,10,622763514410,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-3,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,4,622763514404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,17,622763514417,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,12,622763514412,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,11,622763514411,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-4,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,08-Apr-2026,6227635144,14,622763514414,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,13,622763514413,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,,6227635144,5,622763514405,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:50,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,07-Apr-2026,I-2,08-Apr-2026,09-Apr-2026,6227635144,9,622763514409,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-2,,,,,08:50,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,2,622763514602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,3,622763514603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,8,622763514608,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,9,622763514609,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-4,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,10,622763514610,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-5,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,16,622763514616,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,14,622763514614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,21,622763514621,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,4,622763514604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,5,622763514605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,15,622763514615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,18,622763514618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,11,622763514611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,13,622763514613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,6,622763514606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,22,622763514622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,23-Apr-2026,6227635146,7,622763514607,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,19,622763514619,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,,6227635146,1,622763514601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,17,622763514617,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,12,622763514612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,21-Apr-2026,I-4,22-Apr-2026,22-Apr-2026,6227635146,20,622763514620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,3,622763514803,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,4,622763514804,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,1,622763514801,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,2,622763515002,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,3,622763515003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,2,622763514902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,4,622763515004,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,01-Apr-2026,SCRNSTOOL,02-Apr-2026,02-Apr-2026,6227635148,2,622763514802,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,08:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,1,622763514901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,4,622763514904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,26-Feb-2026,SCRNSTOOL,27-Feb-2026,27-Feb-2026,6227635149,3,622763514903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,07-May-2026,SCRNSTOOL,08-May-2026,08-May-2026,6227635150,1,622763515001,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,05:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,24-Mar-2026,DNA,26-Mar-2026,26-Mar-2026,6227635156,1,622763515601,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:40,05:55,Czech Republic,,05:55,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,DNA,27-May-2026,27-May-2026,6227635155,1,622763515501,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,,6227635159,4,622763515904,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,1,622763515901,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,2,622763515902,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,23-Apr-2026,6227635159,3,622763515903,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,3,622763516103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,,6227635161,4,622763516104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,1,622763516101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,14-Mar-2026,6227635161,2,622763516102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:20,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,1,622763517101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,2,622763517102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,5,622763517105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,7,622763517107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,3,622763517103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,6,622763517106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,4,622763517104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,10,622763517110,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,14,622763517114,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,15,622763517115,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,11,622763517111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,23-Apr-2026,6227635171,8,622763517108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,9,622763517109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,,6227635171,13,622763517113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,21-Apr-2026,SCRN,22-Apr-2026,22-Apr-2026,6227635171,12,622763517112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,2,622763517302,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,6,622763517306,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,7,622763517307,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,8,622763517308,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,5,622763517305,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,10,622763517310,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,4,622763517304,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,9,622763517309,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,1,622763517301,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,3,622763517303,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,14,622763517314,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,13,622763517313,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,1,622763517401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,15,622763517315,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,3,622763517403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,,6227635173,11,622763517311,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,2,622763517402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRN,28-May-2026,28-May-2026,6227635173,12,622763517312,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,9,622763517409,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,5,622763517405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,11,622763517411,Whole Blood PAXgene RNA,Not Received,Frozen,Specimen not submitted,SM07/WB RNA,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,6,622763517406,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,12,622763517412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,4,622763517404,"Plasma, EDTA",Not Received,Frozen,Specimen not submitted,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,7,622763517407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,8,622763517408,"Serum, SST",Not Received,Frozen,Specimen not submitted,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,13,622763517413,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,10,622763517410,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,SM10/FECAL,BIOMARKERS,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,14,622763517414,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,29-May-2026,6227635174,18,622763517418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,17,622763517417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,15,622763517415,"Serum, SST",Not Received,Frozen,Specimen not submitted,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,,28-May-2026,,29-May-2026,,6227635174,16,622763517416,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,1,622763518001,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,28-May-2026,6227635180,3,622763518003,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,13:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,4,622763518004,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162002,27-May-2026,SCRNSTOOL,28-May-2026,,6227635180,2,622763518002,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,13:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,4,622763518204,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,25-Apr-2026,6227635182,3,622763518203,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,08:45,07:30,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,1,622763518201,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,24-Apr-2026,SCRNSTOOL,25-Apr-2026,,6227635182,2,622763518202,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,C-DIFF TOXIN,& PCR FROZEN,,,,,08:45,,Czech Republic,,07:30,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,2,622763519302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,1,622763519301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,21-May-2026,6227635193,3,622763519303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,,6227635193,4,622763519304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,1,622763520401,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,2,622763520402,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,3,622763520403,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,15,622763520415,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,9,622763520409,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,10,622763520410,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,11,622763520411,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,12,622763520412,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,13,622763520413,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,5,622763520405,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,4,622763520404,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,26-Feb-2026,6227635204,14,622763520414,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,,6227635204,7,622763520407,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,6,622763520406,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,25-Feb-2026,SCRN,26-Feb-2026,03-Mar-2026,6227635204,8,622763520408,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,2,622763520702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,8,622763520708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,5,622763520705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,4,622763520704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,9,622763520709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,1,622763520701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,11,622763520711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,3,622763520703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,6,622763520706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,17,622763520717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227635207,18,622763520718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,2,622763520802,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,3,622763520803,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,13,622763520713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,1,622763520801,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,7,622763520707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,10,622763520710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,,6227635207,12,622763520712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:37,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,16,622763520716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,7,622763520807,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,9,622763520809,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,10,622763520810,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,11,622763520811,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,14,622763520714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,I-0,08-Apr-2026,09-Apr-2026,6227635207,15,622763520715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,12,622763520812,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,4,622763520804,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,6,622763520806,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,8,622763520808,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-1,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,17,622763520817,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,14,622763520814,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,5,622763520805,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,28-Apr-2026,6227635208,13,622763520813,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,,6227635208,16,622763520816,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,08:43,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,20-Apr-2026,I-2,21-Apr-2026,21-Apr-2026,6227635208,15,622763520815,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:43,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,2,622763521102,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,3,622763521103,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,06-May-2026,6227635211,4,622763521104,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,1,622763521101,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,8,622763521108,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,10,622763521110,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,6,622763521106,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,5,622763521105,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,11,622763521111,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,13,622763521113,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,14,622763521114,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,7,622763521107,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,19,622763521119,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,16,622763521116,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,20,622763521120,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,9,622763521109,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,21,622763521121,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,22,622763521122,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,17,622763521117,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,18,622763521118,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,07-May-2026,6227635211,12,622763521112,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,10:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,2,622763521302,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,3,622763521303,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,4,622763521304,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,05-May-2026,I-4,06-May-2026,,6227635211,15,622763521115,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,01-Mar-2026,SCRNSTOOL,03-Mar-2026,03-Mar-2026,6227635213,1,622763521301,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,14:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,07-Apr-2026,DNA,09-Apr-2026,09-Apr-2026,6227635218,1,622763521801,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:37,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,2,622763522302,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,1,622763522301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,3,622763522303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,,6227635223,4,622763522304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,2,622769771802,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,3,622769771803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,5,622769771805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,1,622769771801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,6,622769771806,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,4,622769771804,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,7,622769771807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,11,622769771811,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,,6227697718,13,622769771813,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:18,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,10,622769771810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,14,622769771814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,15,622769771815,"Serum, SST",Received,Ambient,Default Return Ambient,FSH,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,20-Mar-2026,6227697718,8,622769771808,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,1,622769771901,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,2,622769771902,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,4,622769771904,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,5,622769771905,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,3,622769771903,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,8,622769771908,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,7,622769771907,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,6,622769771906,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,10,622769771910,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,9,622769771809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,11,622769771911,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,18-Mar-2026,SCRN,19-Mar-2026,19-Mar-2026,6227697718,12,622769771812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:18,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,9,622769771909,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,12,622769771912,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,13,622769771913,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,14,622769771914,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,,6227697719,17,622769771917,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,11:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,15,622769771915,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,16,622769771916,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,I-0,08-Apr-2026,08-Apr-2026,6227697719,18,622769771918,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,6,622769772206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,7,622769772207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,13,622769772213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,10,622769772210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,12,622769772212,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001-5,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,11,622769772211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,14,622769772214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,8,622769772208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-1,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,15,622769772215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,9,622769772209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,2,622769772202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,5,622769772205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,3,622769772203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,4,622769772204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,1,622769772201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,1,622769772301,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,4,622769772304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,2,622769772302,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,3,622769772303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,5,622769772305,"Feces, unpreserved",Not Received,Frozen,Specimen not submitted,FECAL CALPROTECTIN,FROZEN,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,7,622769772307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,,6227697722,16,622769772216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6227697722,17,622769772217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,21,622769772321,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,6,622769772306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-1,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,12,622769772312,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,13,622769772313,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,14,622769772314,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,9,622769772309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,18,622769772318,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,16,622769772316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,17,622769772317,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,8,622769772308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,15,622769772315,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,19,622769772319,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,10,622769772310,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,20,622769772320,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,08-May-2026,6227697723,22,622769772322,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,12:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-May-2026,I-4,08-May-2026,,6227697723,11,622769772311,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,12:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,1,622769772501,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,3,622769772503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,,6227697725,4,622769772504,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,17:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,17-Mar-2026,SCRNSTOOL,19-Mar-2026,19-Mar-2026,6227697725,2,622769772502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,17:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,2,622769773602,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,07-Apr-2026,DNA,08-Apr-2026,08-Apr-2026,6227697731,1,622769773101,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,11:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,1,622769773601,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,,6227697736,4,622769773604,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,26-Mar-2026,6227697736,3,622769773603,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,5,622769774505,"Serum, SST",Not Received,Ambient,,FSH,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,1,622769774501,"Whole Blood, EDTA, Dry",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,6,622769774506,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,4,622769774504,"Serum, SST",Not Received,Ambient,,"CHEM, LIPID PANEL",BETA HCG & CRP,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,8,622769774508,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,3,622769774503,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL,","BHCG, FSH & CRP",,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,2,622769774502,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,7,622769774507,"Serum, SST",Not Received,Ambient,,"HIV SCREEN,",HEPATITIS B & C,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,9,622769774509,"Whole Blood, EDTA, Dry",Not Received,,,HCV RNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,14,622769774514,Whole Blood PAXgene RNA,Not Received,Frozen,,SM07/WB RNA,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,16,622769774516,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,18,622769774518,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,17,622769774517,"Serum, SST",Not Received,Frozen,,SM06/SERUM BIOM,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,13,622769774513,"Stool, unpreserved",Not Received,Frozen,,SM10/FECAL,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,12,622769774512,"Plasma, EDTA",Not Received,Frozen,,HBV DNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,11,622769774511,"Whole Blood, EDTA, Dry",Not Received,,,HBV DNA COBAS 6800,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,15,622769774515,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,19,622769774519,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,10,622769774510,"Plasma, EDTA",Not Received,Frozen,,HCV RNA COBAS 6800,FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,30,622769774530,"Plasma, EDTA",Not Received,Frozen,,HIV-1/HIV-2 QUAL,RNA FROZEN,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,20,622769774520,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,22,622769774522,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-4,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,25,622769774525,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-1,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,23,622769774523,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-5,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,26,622769774526,"Serum, SST",Not Received,Frozen,,SERUM ADA,77242113UCO3001-2,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,21,622769774521,"Stool, unpreserved",Not Received,Frozen,,STOOL,77242113UCO3001-3,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,29,622769774529,"Whole Blood, EDTA, Dry",Not Received,,,HIV-1/HIV-2,QUALITATIVE RNA,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,27,622769774527,"Whole Blood, EDTA, Dry",Not Received,,,SM03/PLASMA PK,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,24,622769774524,"Red Cells, Clot",Not Received,,,SM05/SERUM ADA,,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,,6227697745,28,622769774528,"Plasma, EDTA",Not Received,Frozen,,PLASMA PK,77242113UCO3001,,,,,,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,1,622781089901,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,3,622781089903,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,2,622781089902,"Plasma, QuantiFERON Nil",Cancelled,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,4,622781089904,"Plasma, QuantiFERON TB1",Cancelled,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,5,622781089905,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,6,622781089906,"Plasma, QuantiFERON TB2",Cancelled,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,10,622781089910,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,11,622781089911,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,12,622781089912,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,13,622781089913,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,14,622781089914,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,15,622781089915,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,8,622781089908,"Plasma, QuantiFERON Mitoge",Cancelled,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,03-Mar-2026,6227810899,9,622781089909,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,11:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,2,622781090002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,4,622781090004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,6,622781090006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,7,622781090007,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,06-Mar-2026,6227810900,8,622781090008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,9,622781090009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,10,622781090010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,3,622781090003,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,5,622781090005,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,05-Mar-2026,6227810900,12,622781090012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,14,622781090014,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,13,622781090013,"Red Cells, Clot",Not Received,,,"CHEM PANEL, BETA",HCG & FSH,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,15,622781090015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,1,622781090101,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,2,622781090102,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,3,622781090103,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,4,622781090104,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,1,622781090001,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,6,622781090106,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,7,622781090107,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,05-Mar-2026,6227810901,8,622781090108,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,9,622781090109,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,10,622781090110,"Slides, Hematology",Not Received,Ambient,,HEMATOLOGY,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,11,622781090111,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,04-Mar-2026,6227810901,12,622781090112,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,14,622781090114,"Serum, SST",Cancelled,Ambient,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,13,622781090113,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,02-Mar-2026,SCRN,03-Mar-2026,,6227810899,7,622781089907,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,11:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRN,05-Mar-2026,,6227810900,11,622781090011,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,09:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,5,622781090105,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRN,04-Mar-2026,,6227810901,15,622781090115,"Serum, SST",Cancelled,Ambient,,FSH,,,,,,12:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,2,622781090402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,05-Mar-2026,6227810904,3,622781090403,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,09:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,4,622781090404,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,1,622781090501,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,2,622781090502,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,04-Mar-2026,6227810905,3,622781090503,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222004,03-Mar-2026,SCRNSTOOL,04-Mar-2026,,6227810905,4,622781090504,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,04-Mar-2026,SCRNSTOOL,05-Mar-2026,,6227810904,1,622781090401,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,09:10,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,05-Feb-2026,BXSCR,06-Feb-2026,06-Feb-2026,6227323223,5,622732322305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:01,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,3,622793314203,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,5,622793314205,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,2,622793314202,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,4,622793314204,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,6,622793314206,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,1,622793314201,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,7,622793314207,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,10,622793314210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,12,622793314212,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,9,622793314209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,11,622793314211,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,,6227933142,8,622793314208,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,14,622793314214,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,17,622793314217,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,13,622793314213,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,18,622793314218,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,1,622793314301,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,15,622793314215,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,19,622793314219,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,2,622793314302,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,21,622793314221,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,22,622793314222,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,20,622793314220,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,06-May-2026,I-4,07-May-2026,07-May-2026,6227933142,16,622793314216,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,4,622793314304,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,8,622793314308,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-4,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,7,622793314307,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-3,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,3,622793314303,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,20,622793314320,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,6,622793314306,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-2,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,,6227933143,9,622793314309,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-12,77242113UCO3001-5,,,,,08:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,11,622793314311,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-12TROUGH,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,19,622793314319,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,17,622793314317,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,22,622793314322,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,EXPEDITED FRZN,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,10,622793314310,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,16,622793314316,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-2,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,23,622793314323,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,18,622793314318,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,12,622793314312,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,15,622793314315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-12 PRE,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,14,622793314314,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,13,622793314313,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMAPK I-12 PEAK,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,5,622793314305,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-12,77242113UCO3001-1,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,13-May-2026,I-12,14-May-2026,14-May-2026,6227933143,21,622793314321,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,08:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 12,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,11-Feb-2026,BXSCR,12-Feb-2026,12-Feb-2026,6227323287,5,622732328705,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,12:52,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,2,622799396202,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,15,622799396215,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,4,622799396204,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,1,622799396201,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,10,622799396210,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,14,622799396214,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,3,622799396203,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,8,622799396208,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,12,622799396212,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,11,622799396211,"Red Cells, Clot",Not Received,,,"HIV SCREEN,",HEPATITIS B & C,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,7,622799396207,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,14-Apr-2026,6227993962,9,622799396209,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,5,622799396205,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,16-Apr-2026,6227993962,6,622799396206,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,12:20,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRN,14-Apr-2026,,6227993962,13,622799396213,"Red Cells, Clot",Not Received,,,CHEM PANEL &,BETA HCG,,,,,12:20,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,14,622799396614,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,17,622799396617,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,2,622799396602,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,3,622799396603,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,12,622799396612,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,1,622799396601,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,13,622799396613,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,7,622799396607,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,15,622799396615,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,8,622799396608,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,4,622799396604,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,10,622799396610,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,11,622799396611,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,6,622799396606,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,,6227993966,5,622799396605,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,16,622799396616,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,19-May-2026,6227993966,18,622799396618,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,I-0,19-May-2026,20-May-2026,6227993966,9,622799396609,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,4,622799397104,"Stool, ova & parasites(PVA)",Not Received,Ambient,,OVA & PARASITES 2,PVA,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,3,622799397103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,,6227993971,1,622799397101,"Stool, ova & parasites(form)",Not Received,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,06:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,13-Apr-2026,SCRNSTOOL,14-Apr-2026,14-Apr-2026,6227993971,2,622799397102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,06:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,DNA,20-May-2026,20-May-2026,6227993977,1,622799397701,"Whole Blood, EDTA, Dry",In Inventory,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,1,622799398401,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,3,622799398403,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,,6227993984,4,622799398404,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,17-Apr-2026,6227993984,2,622799398402,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,20-May-2026,6227993987,2,622799398702,"Serum, SST",Shipped,Frozen,Default Return Frozen,"ADA, GOL, INF",UST OR VED FROZEN,,,,,09:28,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,18-May-2026,BDL,20-May-2026,,6227993987,1,622799398701,"Red Cells, Clot",Not Received,,,DRUG LEVEL TESTING,,,,,,09:28,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biologic Drug Level,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,5,622732324405,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,16-Feb-2026,SCRNSTOOL,18-Feb-2026,18-Feb-2026,6227323244,6,622732324406,,Cancelled,,,,,,,,,07:20,12:28,Czech Republic,,07:10,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222001,18-Feb-2026,BXSCR,19-Feb-2026,19-Feb-2026,6227323286,5,622732328605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,15:49,Czech Republic,,10:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,2,622802395102,Biopsy RNA Later,Shipped,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,1,622802395101,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,04-Apr-2026,6228023951,3,622802395103,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,,6228023951,4,622802395104,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062001,19-Feb-2026,BXSCR,21-Feb-2026,21-Feb-2026,6227323254,5,622732325405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:49,Czech Republic,,07:20,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,3,622803655303,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,5,622803655305,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,7,622803655307,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,8,622803655308,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,4,622803655304,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,1,622803655301,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,6,622803655306,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,2,622803655302,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,12,622803655312,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,13,622803655313,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,15,622803655315,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,11,622803655311,Whole Blood PAXgene RNA,In Inventory,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,17,622803655317,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,18,622803655318,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,14,622803655314,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,9,622803655309,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,16,622803655316,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,4,622803655404,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,5,622803655405,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,SM02/PLASMAPK PEAK,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,1,622803655401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,6,622803655406,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,7,622803655407,"Red Cells, Clot",Received,,Default Discard/Not Return,SM04/SERUM ADA PRE,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,9,622803655409,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,10,622803655410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,8,622803655408,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,27-May-2026,I-0,28-May-2026,28-May-2026,6228036553,10,622803655310,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,07:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,3,622803655403,"Whole Blood, EDTA, Dry",Received,,Default Discard/Not Return,PLASMA PK TROUGH,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,11,622803655411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,2,622803655402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,12,622803655412,"Red Cells, Clot",Received,,Default Discard/Not Return,SM06/SERUM,BIOMARKERS,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,13,622803655413,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,14,622803655414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,15,622803655415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,16,622803655416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,17,622803655417,"Red Cells, Clot",Received,,Default Discard/Not Return,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,08-Apr-2026,I-0,09-Apr-2026,09-Apr-2026,6228036554,18,622803655418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,07:10,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,1,622811460801,Whole Blood QuantiFERON Nil,Not Received,,,QUANTIFERON PLUS,NIL-GRAY,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,7,622811460807,Whole Blood QuantiFERON Mitoge,Not Received,,,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,3,622811460803,Whole Blood QuantiFERON TB1,Not Received,,,QUANTIFERON PLUS,TB1-GREEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,6,622811460806,"Plasma, QuantiFERON TB2",Not Received,Frozen,,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,8,622811460808,"Plasma, QuantiFERON Mitoge",Not Received,Frozen,,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,9,622811460809,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,4,622811460804,"Plasma, QuantiFERON TB1",Not Received,Frozen,,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,5,622811460805,Whole Blood QuantiFERON TB2,Not Received,,,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,11,622811460811,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,10,622811460810,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,2,622811460802,"Plasma, QuantiFERON Nil",Not Received,Frozen,,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,12,622811460812,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,14,622811460814,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,,6228114608,15,622811460815,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,28-May-2026,,29-May-2026,29-May-2026,6228114608,13,622811460813,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,1,622811461001,Whole Blood QuantiFERON Nil,Received,,Default Discard/Not Return,QUANTIFERON PLUS,NIL-GRAY,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,2,622811461002,"Plasma, QuantiFERON Nil",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,NIL-GRAY FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,5,622811461005,Whole Blood QuantiFERON TB2,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB2-YELLOW,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,3,622811461003,Whole Blood QuantiFERON TB1,Received,,Default Discard/Not Return,QUANTIFERON PLUS,TB1-GREEN,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,6,622811461006,"Plasma, QuantiFERON TB2",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB2-YELLOW FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,4,622811461004,"Plasma, QuantiFERON TB1",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,TB1-GREEN FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,10,622811461010,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,11,622811461011,"Red Cells, Clot",Received,,Default Discard/Not Return,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,9,622811461009,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,7,622811461007,Whole Blood QuantiFERON Mitoge,Received,,Default Discard/Not Return,QUANTIFERON PLUS,MITOGEN-PURPLE,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,12,622811461012,"Serum, SST",Received,Ambient,Default Return Ambient,"HIV SCREEN,",HEPATITIS B & C,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,13,622811461013,"Red Cells, Clot",Received,,Default Discard/Not Return,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,30-Apr-2026,6228114610,14,622811461014,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,BETA HCG,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,01-May-2026,6228114610,8,622811461008,"Plasma, QuantiFERON Mitoge",Received,Frozen,Default Return Frozen,QUANTIFERON PLUS,MITOGEN-PURPLE FRZ,,,,,07:55,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,29-Apr-2026,SCRN,30-Apr-2026,,6228114610,15,622811461015,"Serum, SST",Cancelled,Ambient,,FSH,FROZEN,,,,,07:55,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Screening,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,3,622813735903,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,1,622813735901,"Stool, ova & parasites(form)",Received,Ambient,Default Return Ambient,OVA & PARASITES 1,FORMALIN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,4,622813735904,"Stool, ova & parasites(PVA)",Received,Ambient,Default Return Ambient,OVA & PARASITES 2,PVA,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,22-Apr-2026,UNSCSTOOL,23-Apr-2026,23-Apr-2026,6228137359,2,622813735902,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,1,622817339701,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,4,622817339704,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,3,622817339703,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,2,622817339702,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,6,622817339706,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,8,622817339708,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,5,622817339705,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,7,622817339707,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,12,622817339712,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,16,622817339716,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,18,622817339718,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,,6228173397,17,622817339717,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:35,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,9,622817339709,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,14,622817339714,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,11,622817339711,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,10,622817339710,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,15,622817339715,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,13,622817339713,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,14,622817993214,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,9,622817993209,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,15,622817993215,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,16,622817993216,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,12,622817993212,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,13,622817993213,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,17,622817993217,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,10,622817993210,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,11,622817993211,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,1,622817993201,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,3,622817993203,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,4,622817993204,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,7,622817993207,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,2,622817993202,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,8,622817993208,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,1,622817993601,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,2,622817993602,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,6,622817993606,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-4,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,4,622817993604,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,10,622817993610,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-5,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,5,622817993605,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,14,622817993614,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMA PK I-4 PEAK,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,11,622817993611,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,12,622817993612,"Plasma, EDTA",Shipped,Frozen,Default Return Frozen,PLASMPK I-4 TROUGH,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,13,622817993613,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,16,622817993616,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,15,622817993615,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,9,622817993609,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-4,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,19,622817993619,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,18,622817993618,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,3,622817993603,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,17,622817993617,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-4 PRE,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,23-Apr-2026,6228179932,6,622817993206,"Serum, SST",Shipped,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,14:15,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,22-Apr-2026,I-2,23-Apr-2026,,6228179932,5,622817993205,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,14:15,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,20,622817993620,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,21,622817993621,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,8,622817993608,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-3,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,,6228179936,7,622817993607,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-4,77242113UCO3001-2,,,,,07:40,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,05-May-2026,I-4,06-May-2026,06-May-2026,6228179936,22,622817993622,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,07:40,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 4,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,DNA,10-Apr-2026,10-Apr-2026,6228179942,1,622817994201,"Whole Blood, EDTA, Dry",Shipped,Frozen,Default Return Frozen,SM08/WB DNA,77242113UCO3001,,,,,10:35,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,DNA,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,3,622817994503,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,4,622817994504,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,1,622817994501,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,23-May-2026,6228179945,2,622817994502,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,1,622819434101,"Stool, ova & parasites(form)",Cancelled,Ambient,,OVA & PARASITES 1,FORMALIN,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,,6228194341,4,622819434104,"Stool, ova & parasites(PVA)",Cancelled,Ambient,,OVA & PARASITES 2,PVA,,,,,07:45,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,3,622819434103,"Culture, Stool",Received,Ambient,Default Return Ambient,STOOL CULTURE,,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,20-Apr-2026,SCRNSTOOL,21-Apr-2026,21-Apr-2026,6228194341,2,622819434102,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,07:45,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132001,12-Mar-2026,BXSCR,13-Mar-2026,13-Mar-2026,6227635161,5,622763516105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:58,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10021,Dr.Martin Bortlik,CZ100212001,16-Mar-2026,BXSCR,18-Mar-2026,18-Mar-2026,6227635223,5,622763522305,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,13:49,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,,,,19-Mar-2026,19-Mar-2026,6227323233,31,622732323331,"Serum, SST",Received,Ambient,Default Return Ambient,,,,,,,,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012002,18-Mar-2026,BXSCR,19-Mar-2026,19-Mar-2026,6227323224,5,622732322405,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:46,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,3,622825207203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,1,622825207201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,08:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,,6228252073,4,622825207304,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,2,622825207302,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,4,622825207204,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,BIOPSY PK,77242113UCO3001,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,09-May-2026,6228252072,2,622825207202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:30,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,15-May-2026,6228252073,3,622825207303,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,1,622825207301,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,CZ100122001,23-Mar-2026,BXSCR,24-Mar-2026,24-Mar-2026,6227697736,5,622769773605,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:15,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,1,622830822401,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,2,622830822402,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,5,622830822405,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,6,622830822406,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-0 PEAK,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,7,622830822407,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,9,622830822409,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,10,622830822410,"Stool, unpreserved",In Inventory,Frozen,Default Return Frozen,SM10/FECAL,BIOMARKERS,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,8,622830822408,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-0 PRE,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,11,622830822411,Whole Blood PAXgene RNA,Shipped,Frozen,Default Return Frozen,SM07/WB RNA,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,13,622830822413,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-1,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,3,622830822403,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,4,622830822404,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-0 TROUGH,77242113UCO3001,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,14,622830822414,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-2,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,16,622830822416,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,15,622830822415,"Serum, SST",Shipped,Frozen,Default Return Frozen,SM06/SERUM BIOM,77242113UCO3001-3,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,12,622830822412,"Red Cells, Clot",Not Received,,,SM06/SERUM,BIOMARKERS,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,,6228308224,17,622830822417,"Red Cells, Clot",Not Received,,,"CHEM, LIPID PANEL",& CRP,,,,,10:25,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,12-May-2026,I-0,13-May-2026,13-May-2026,6228308224,18,622830822418,"Serum, SST",Received,Ambient,Default Return Ambient,"CHEM, LIPID PANEL",& CRP,,,,,10:25,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,01-Apr-2026,BXSCR,02-Apr-2026,02-Apr-2026,6228023951,5,622802395105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:31,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,3,622839811503,"Whole Blood, EDTA, Dry",Not Received,,,SM02/PLASMAPK PEAK,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,2,622839811502,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMPK I-2 TROUGH,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,4,622839811504,"Plasma, EDTA",In Inventory,Frozen,Default Return Frozen,PLASMA PK I-2 PEAK,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,6,622839811506,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-1,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,5,622839811505,"Red Cells, Clot",Not Received,,,SM04/SERUM ADA PRE,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,7,622839811507,"Serum, SST",In Inventory,Frozen,Default Return Frozen,SERUM ADA I-2 PRE,77242113UCO3001-2,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,8,622839811508,"Stool, unpreserved",Shipped,Frozen,Default Return Frozen,STOOL I-2,77242113UCO3001,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,10,622839811510,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-3,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,9,622839811509,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-2,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,11,622839811511,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-4,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,12,622839811512,"Stool, unpreserved",Not Received,Frozen,Specimen not submitted,STOOL I-2,77242113UCO3001-5,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,13,622839811513,"Feces, unpreserved",Received,Frozen,Default Return Frozen,FECAL CALPROTECTIN,FROZEN,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,14,622839811514,"Whole Blood, EDTA, Dry",Received,Ambient,Default Return Ambient,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,1,622839811501,"Whole Blood, EDTA, Dry",Not Received,,,PLASMA PK TROUGH,,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,17,622839811517,"Serum, SST",Received,Ambient,Default Return Ambient,CHEM PANEL &,CRP,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,27-May-2026,6228398115,15,622839811515,"Slides, Hematology",Received,Ambient,No Orders Attached,HEMATOLOGY,,,,,,09:05,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,26-May-2026,I-2,27-May-2026,,6228398115,16,622839811516,"Red Cells, Clot",Not Received,,,CHEM PANEL &,CRP,,,,,09:05,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 2,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222005,09-Apr-2026,I-0,10-Apr-2026,10-Apr-2026,6228173397,19,622817339719,,Cancelled,,,,,,,,,10:35,13:56,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Induction Week 0,, -77242113UCO3001,CZ10020,Dr.Lucie Gonsorcikova,CZ100201001,15-Apr-2026,BXSCR,16-Apr-2026,16-Apr-2026,6227993984,5,622799398405,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:04,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132002,21-Apr-2026,BXSCR,22-Apr-2026,22-Apr-2026,6227635159,5,622763515905,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:18,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,1,622850173201,Wet Tissue Biopsy,Removed,Ambient,Default Return Ambient,SM11/BIOPSY,HISTOLOGY,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,2,622850173202,Biopsy RNA Later,In Inventory,Frozen,Default Return Frozen,SM13/BIOPSY RNA,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,,6228501732,4,622850173204,"Biopsy, Frozen Tissue",Not Received,Frozen,,BIOPSY PK,77242113UCO3001,,,,,00:00,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,28-May-2026,6228501732,3,622850173203,"Biopsy, Frozen Tissue",In Inventory,Frozen,Default Return Frozen,SM14/BIOPSY CRYO,FROZEN,,,,,00:00,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10009,Dr. Jiri Pumprla,CZ100092001,24-Apr-2026,BXSCR,28-Apr-2026,28-Apr-2026,6227323351,5,622732335105,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,14:22,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,1,622861056401,"Stool, ova & parasites(form)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,3,622861056403,"Culture, Stool",Cancelled,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,,6228610564,4,622861056404,"Stool, ova & parasites(PVA)",Not Received,Ambient,,,,,,,,09:30,,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,06-May-2026,SCRNSTOOL,07-May-2026,07-May-2026,6228610564,2,622861056402,"Stool, unpreserved",Received,Frozen,Default Return Frozen,C-DIFF TOXIN,& PCR FROZEN,,,,,09:30,07:00,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Stool Pathogens,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012001,06-May-2026,BX12,07-May-2026,07-May-2026,6228252072,5,622825207205,"Tissue , Paraffin Block",Shipped,,Default Return Ambient,,,,,,,00:00,15:52,Czech Republic,,08:30,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10012,Dr.Stefan Konecny,,,,08-May-2026,08-May-2026,6227697745,31,622769774531,,In Inventory,,Default Return Frozen,,,,,,,,16:05,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Unscheduled,, -77242113UCO3001,CZ10001,Dr. Matej Falc,CZ100012003,13-May-2026,BXSCR,14-May-2026,14-May-2026,6228252073,5,622825207305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,12:51,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10006,Dr. Michal Konecny,CZ100062002,14-May-2026,BXSCR,15-May-2026,15-May-2026,6227323256,5,622732325605,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:06,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10016,Dr.Robert Mudr,CZ100162001,19-May-2026,BXSCR,20-May-2026,20-May-2026,6227635193,5,622763519305,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,17:34,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10022,Dr. Petr Hrabak,CZ100222003,20-May-2026,BX12,21-May-2026,21-May-2026,6228179945,5,622817994505,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:59,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10013,Dr.David Stepek,CZ100132003,25-May-2026,BXSCR,26-May-2026,26-May-2026,6228501732,5,622850173205,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,13:03,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, -77242113UCO3001,CZ10003,Dr. Leksa Vaclav,CZ100032001,27-May-2026,BXSCR,28-May-2026,28-May-2026,6227323320,5,622732332005,"Tissue , Paraffin Block",In Inventory,,Default Return Ambient,,,,,,,00:00,14:30,Czech Republic,,07:00,,,213069,EMEA,,,,,,,,Biopsy,, diff --git a/Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv b/Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv deleted file mode 100644 index b405441..0000000 --- a/Covance_UCO3001/Source/2026-05-29_112154 sponsor-study-36940-kit-inventory-on-hand-expiration.csv +++ /dev/null @@ -1,544 +0,0 @@ -Project No.,Region,Country,Site,Kit Type,Description,Accession,Shipped Date,Expiration Date,Days to Expiration -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,1,Screening,6227323202,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,1,Screening,6228114609,"Mar 10, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228036552,"Feb 27, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462182,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462184,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,2,Induction Week 0,6228462183,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6227933141,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462185,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462186,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,3,Induction Week 2,6228462187,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6227323209,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6228462189,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,4,Induction Week 4,6228462188,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6227810906,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6227933144,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6228462190,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,5,Induction Week 12,6228462191,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,6,Maintenance Week 4,6227933145,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,6,Maintenance Week 4,6227933146,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,7,Maintenance Week 12,6227933147,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,7,Maintenance Week 12,6227933148,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228137358,"Mar 12, 2026","Jan 29, 2027",244 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228137357,"Mar 12, 2026","Jan 29, 2027",244 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462192,"Apr 28, 2026","May 25, 2027",360 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462193,"Apr 28, 2026","May 25, 2027",360 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462194,"Apr 28, 2026","May 25, 2027",360 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462196,"Apr 28, 2026","May 25, 2027",360 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462197,"Apr 28, 2026","May 25, 2027",360 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-1,Stool Pathogens,6228462195,"Apr 28, 2026","May 25, 2027",360 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-2,TB Testing,6227323220,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-2,TB Testing,6227323221,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-3,Biopsy,6227323222,"Nov 21, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-3,Biopsy,6228252071,"Mar 26, 2026","Jul 20, 2027",416 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-4,Induction ED,6227323225,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-4,Induction ED,6227323226,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-5,Biologic Drug Level,6227323227,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-5,Biologic Drug Level,6227323228,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810907,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810909,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-6,Maintenance ED,6227810908,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-8,Liver Function Tests,6227323229,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-8,Liver Function Tests,6227323230,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810910,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810911,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-9,LTE Maintenance ED,6227810912,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-10,Safety FU,6227323214,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-10,Safety FU,6227323215,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-11,DILI,6227323216,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6227323218,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252069,"Mar 26, 2026","Mar 31, 2027",305 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252070,"Mar 26, 2026","Mar 31, 2027",305 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,T-12,DNA,6228252068,"Mar 26, 2026","Mar 31, 2027",305 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462198,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462199,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462200,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462202,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462201,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462203,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462206,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462205,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462204,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228462207,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489756,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489757,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489758,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489761,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489760,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489759,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489763,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10001 - Dr. Matej Falc,U,Unscheduled,6228489762,"May 1, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,1,Screening,6227323298,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,1,Screening,6227323300,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,2,Induction Week 0,6227323301,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,2,Induction Week 0,6227323302,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,3,Induction Week 2,6227323303,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,3,Induction Week 2,6227323304,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,4,Induction Week 4,6227323306,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,4,Induction Week 4,6227323305,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,5,Induction Week 12,6228676757,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-1,Stool Pathogens,6227323307,"Nov 21, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-1,Stool Pathogens,6227323308,"Nov 21, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-2,TB Testing,6227323316,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-2,TB Testing,6227323317,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-3,Biopsy,6227323319,"Nov 21, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-3,Biopsy,6227323318,"Nov 21, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-4,Induction ED,6227323321,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-4,Induction ED,6227323322,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-5,Biologic Drug Level,6227323323,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-5,Biologic Drug Level,6227323324,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676759,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676760,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-6,Maintenance ED,6228676758,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-8,Liver Function Tests,6227323326,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-8,Liver Function Tests,6227323325,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676762,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676763,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-9,LTE Maintenance ED,6228676761,"May 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-10,Safety FU,6227323310,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-10,Safety FU,6227323311,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-11,DILI,6227323312,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323313,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323314,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,T-12,DNA,6227323315,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323328,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323327,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10003 - Dr. Leksa Vaclav,U,Unscheduled,6227323329,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6227323235,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492883,"Apr 23, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492884,"Apr 23, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,1,Screening,6228492885,"Apr 23, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265099,"Mar 27, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265098,"Mar 27, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,2,Induction Week 0,6228265100,"Mar 27, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6227323239,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407563,"Apr 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407564,"Apr 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,3,Induction Week 2,6228407565,"Apr 15, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6227323241,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461735,"Apr 21, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461736,"Apr 21, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,4,Induction Week 4,6228461734,"Apr 21, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,5,Induction Week 12,6228013269,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,5,Induction Week 12,6228492886,"Apr 23, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,6,Maintenance Week 4,6228194338,"Mar 23, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,6,Maintenance Week 4,6228690541,"May 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-1,Stool Pathogens,6228194340,"Mar 23, 2026","Mar 5, 2027",279 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-1,Stool Pathogens,6228194339,"Mar 23, 2026","Mar 5, 2027",279 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6227323255,"Nov 21, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690542,"May 19, 2026","Aug 7, 2027",434 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690544,"May 19, 2026","Aug 7, 2027",434 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-3,Biopsy,6228690543,"May 19, 2026","Aug 7, 2027",434 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-4,Induction ED,6227323257,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-4,Induction ED,6227323258,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-5,Biologic Drug Level,6227323260,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-5,Biologic Drug Level,6227323259,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013270,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013271,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-6,Maintenance ED,6228013272,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-8,Liver Function Tests,6227323261,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-8,Liver Function Tests,6227323262,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013275,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013273,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-9,LTE Maintenance ED,6228013274,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-10,Safety FU,6227323246,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-10,Safety FU,6227323247,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-11,DILI,6227323248,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-12,DNA,6227323250,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,T-12,DNA,6227323249,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10006 - Dr. Michal Konecny,U,Unscheduled,6227323263,"Nov 21, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227323331,"Nov 23, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765941,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765942,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,1,Screening,6227765943,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227323333,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765944,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765945,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,2,Induction Week 0,6227765946,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227323336,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765948,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765947,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,3,Induction Week 2,6227765949,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227323337,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227323338,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765950,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765951,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,4,Induction Week 4,6227765952,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765953,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765954,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,5,Induction Week 12,6227765955,"Jan 29, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227323339,"Nov 23, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765956,"Jan 29, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765957,"Jan 29, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765958,"Jan 29, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-1,Stool Pathogens,6227765959,"Jan 29, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227323349,"Nov 23, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765963,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765964,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765965,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-2,TB Testing,6227765966,"Jan 29, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227323350,"Nov 23, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227323352,"Nov 23, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765967,"Jan 29, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765968,"Jan 29, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765970,"Jan 29, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-3,Biopsy,6227765969,"Jan 29, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-4,Induction ED,6227323353,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-4,Induction ED,6227323354,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227323356,"Nov 23, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765973,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765972,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765974,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-5,Biologic Drug Level,6227765971,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357528,"Apr 7, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357529,"Apr 7, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-6,Maintenance ED,6228357530,"Apr 7, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-8,Liver Function Tests,6227323357,"Nov 23, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-8,Liver Function Tests,6227323358,"Nov 23, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357532,"Apr 7, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357533,"Apr 7, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-9,LTE Maintenance ED,6228357531,"Apr 7, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-10,Safety FU,6227323342,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-10,Safety FU,6227323343,"Nov 23, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-11,DILI,6227323344,"Nov 23, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227323347,"Nov 23, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227323345,"Nov 23, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765961,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765962,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,T-12,DNA,6227765960,"Jan 29, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323359,"Nov 23, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323361,"Nov 23, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227323360,"Nov 23, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765975,"Jan 29, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765976,"Jan 29, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10009 - Dr. Jiri Pumprla,U,Unscheduled,6227765977,"Jan 29, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993930,"Feb 17, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993931,"Feb 17, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,1,Screening,6227993932,"Feb 17, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,2,Induction Week 0,6227993933,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,2,Induction Week 0,6227993934,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,3,Induction Week 2,6227993935,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,3,Induction Week 2,6227993936,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,4,Induction Week 4,6227993937,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,4,Induction Week 4,6227993938,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993941,"Feb 17, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993940,"Feb 17, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-1,Stool Pathogens,6227993939,"Feb 17, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-2,TB Testing,6227993949,"Feb 17, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-2,TB Testing,6227993948,"Feb 17, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993952,"Feb 17, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993951,"Feb 17, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-3,Biopsy,6227993950,"Feb 17, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-4,Induction ED,6227993954,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-4,Induction ED,6227993953,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-5,Biologic Drug Level,6227993955,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-5,Biologic Drug Level,6227993956,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-8,Liver Function Tests,6227993957,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-8,Liver Function Tests,6227993958,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-10,Safety FU,6227993943,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-10,Safety FU,6227993942,"Feb 17, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-11,DILI,6227993944,"Feb 17, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993945,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993946,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,T-12,DNA,6227993947,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993959,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993960,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10010 - Dr.Nabil El Lababidi,U,Unscheduled,6227993961,"Feb 17, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,1,Screening,6227697716,"Jan 12, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,1,Screening,6227697717,"Jan 12, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6227697720,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398468,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398470,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,2,Induction Week 0,6228398469,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6227697721,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512528,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512526,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,3,Induction Week 2,6228512527,"Apr 28, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6227697724,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628517,"May 11, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628515,"May 11, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,4,Induction Week 4,6228628516,"May 11, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,5,Induction Week 12,6228251912,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,6,Maintenance Week 4,6228628518,"May 11, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-1,Stool Pathogens,6227697726,"Jan 12, 2026","Jan 14, 2027",229 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-1,Stool Pathogens,6227697727,"Jan 12, 2026","Jan 14, 2027",229 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-2,TB Testing,6227697735,"Jan 12, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-2,TB Testing,6227697734,"Jan 12, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-3,Biopsy,6227697737,"Jan 12, 2026","May 11, 2027",346 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-3,Biopsy,6227697738,"Jan 12, 2026","May 11, 2027",346 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-4,Induction ED,6227697740,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-4,Induction ED,6227697739,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-5,Biologic Drug Level,6227697741,"Jan 12, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-5,Biologic Drug Level,6227697742,"Jan 12, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251914,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251913,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-6,Maintenance ED,6228251915,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-8,Liver Function Tests,6227697743,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-8,Liver Function Tests,6227697744,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251918,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251916,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-9,LTE Maintenance ED,6228251917,"Mar 26, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-10,Safety FU,6227697728,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-10,Safety FU,6227697729,"Jan 12, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-11,DILI,6227697730,"Jan 12, 2026","Jul 31, 2026",62 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-12,DNA,6227697733,"Jan 12, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,T-12,DNA,6227697732,"Jan 12, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,U,Unscheduled,6227697747,"Jan 12, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10012 - Dr.Stefan Konecny,U,Unscheduled,6227697746,"Jan 12, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367755,"Apr 8, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367756,"Apr 8, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,1,Screening,6228367757,"Apr 8, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6227635143,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6228308225,"Apr 1, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,2,Induction Week 0,6228308226,"Apr 1, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6227635145,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6228398114,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,3,Induction Week 2,6228398116,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6227635147,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501725,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501727,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,4,Induction Week 4,6228501726,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228308227,"Apr 1, 2026","Jan 31, 2027",246 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,5,Induction Week 12,6228367758,"Apr 8, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,6,Maintenance Week 4,6228501728,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,6,Maintenance Week 4,6228501729,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367759,"Apr 8, 2026","Mar 5, 2027",279 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367760,"Apr 8, 2026","Mar 5, 2027",279 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-1,Stool Pathogens,6228367761,"Apr 8, 2026","Mar 5, 2027",279 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-2,TB Testing,6227635158,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-2,TB Testing,6227635157,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6227635160,"Jan 5, 2026","Oct 15, 2026",138 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6228501731,"Apr 26, 2026","Aug 7, 2027",434 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-3,Biopsy,6228501730,"Apr 26, 2026","Aug 7, 2027",434 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-4,Induction ED,6227635163,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-4,Induction ED,6227635162,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-5,Biologic Drug Level,6227635164,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-5,Biologic Drug Level,6227635165,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095872,"Mar 5, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095870,"Mar 5, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-6,Maintenance ED,6228095871,"Mar 5, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-8,Liver Function Tests,6227635167,"Jan 5, 2026","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-8,Liver Function Tests,6227635166,"Jan 5, 2026","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095874,"Mar 5, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095873,"Mar 5, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-9,LTE Maintenance ED,6228095875,"Mar 5, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-10,Safety FU,6227635151,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-10,Safety FU,6227635152,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-11,DILI,6227635153,"Jan 5, 2026","Jul 31, 2026",62 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,T-12,DNA,6227635154,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635168,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635169,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10013 - Dr.David Stepek,U,Unscheduled,6227635170,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259263,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259264,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6227259265,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6228510217,"Apr 30, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,1,Screening,6228510218,"Apr 30, 2026","Nov 30, 2026",184 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6227259267,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6227259266,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6228510219,"Apr 30, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,2,Induction Week 0,6228510220,"Apr 30, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6227259268,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6227259269,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6228510221,"Apr 30, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,3,Induction Week 2,6228510222,"Apr 30, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,4,Induction Week 4,6227259270,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,4,Induction Week 4,6227259271,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259274,"Nov 13, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259273,"Nov 13, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-1,Stool Pathogens,6227259272,"Nov 13, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-2,TB Testing,6227259281,"Nov 13, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-2,TB Testing,6227259282,"Nov 13, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259283,"Nov 13, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259284,"Nov 13, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-3,Biopsy,6227259285,"Nov 13, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-4,Induction ED,6227259286,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-4,Induction ED,6227259287,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-5,Biologic Drug Level,6227259289,"Nov 13, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-5,Biologic Drug Level,6227259288,"Nov 13, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-8,Liver Function Tests,6227259290,"Nov 13, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-8,Liver Function Tests,6227259291,"Nov 13, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-10,Safety FU,6227259276,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-10,Safety FU,6227259275,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-11,DILI,6227259277,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-12,DNA,6227259280,"Nov 13, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,T-12,DNA,6227259278,"Nov 13, 2025","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259294,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259293,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10015 - Dr.Jan Matous,U,Unscheduled,6227259292,"Nov 13, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,1,Screening,6227635172,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,2,Induction Week 0,6227635175,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,3,Induction Week 2,6227635176,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,3,Induction Week 2,6227635177,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,4,Induction Week 4,6227635178,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,4,Induction Week 4,6227635179,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,5,Induction Week 12,6228501793,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-1,Stool Pathogens,6227635181,"Jan 5, 2026","Jan 14, 2027",229 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-2,TB Testing,6227635189,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-2,TB Testing,6227635190,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-3,Biopsy,6227635191,"Jan 5, 2026","Oct 15, 2026",138 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-3,Biopsy,6227635192,"Jan 5, 2026","Oct 15, 2026",138 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-4,Induction ED,6227635195,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-4,Induction ED,6227635194,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-5,Biologic Drug Level,6227635197,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-5,Biologic Drug Level,6227635196,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501795,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501794,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-6,Maintenance ED,6228501796,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-8,Liver Function Tests,6227635198,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-8,Liver Function Tests,6227635199,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501797,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501798,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-9,LTE Maintenance ED,6228501799,"Apr 26, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-10,Safety FU,6227635183,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-10,Safety FU,6227635184,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-11,DILI,6227635185,"Jan 5, 2026","Jul 31, 2026",62 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635188,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635186,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,T-12,DNA,6227635187,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635200,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635202,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10016 - Dr.Robert Mudr,U,Unscheduled,6227635201,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,1,Screening,6227993964,"Feb 18, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,1,Screening,6227993963,"Feb 18, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6227993965,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707090,"May 22, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707091,"May 22, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228707092,"May 22, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,2,Induction Week 0,6228711855,"May 29, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,3,Induction Week 2,6227993967,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,3,Induction Week 2,6227993968,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,4,Induction Week 4,6227993969,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,4,Induction Week 4,6227993970,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,5,Induction Week 12,6228436352,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-1,Stool Pathogens,6227993973,"Feb 18, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-1,Stool Pathogens,6227993972,"Feb 18, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-2,TB Testing,6227993980,"Feb 18, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-2,TB Testing,6227993981,"Feb 18, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-3,Biopsy,6227993983,"Feb 18, 2026","May 11, 2027",346 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-3,Biopsy,6227993982,"Feb 18, 2026","May 11, 2027",346 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-4,Induction ED,6227993985,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-4,Induction ED,6227993986,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-5,Biologic Drug Level,6227993988,"Feb 18, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-5,Biologic Drug Level,6228711856,"May 29, 2026","May 31, 2027",366 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436354,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436353,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-6,Maintenance ED,6228436355,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-8,Liver Function Tests,6227993989,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-8,Liver Function Tests,6227993990,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436356,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436357,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-9,LTE Maintenance ED,6228436358,"Apr 19, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-10,Safety FU,6227993974,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-10,Safety FU,6227993975,"Feb 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-11,DILI,6227993976,"Feb 18, 2026","Sep 30, 2026",123 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-12,DNA,6227993978,"Feb 18, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,T-12,DNA,6227993979,"Feb 18, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993991,"Feb 18, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993992,"Feb 18, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10020 - Dr.Lucie Gonsorcikova,U,Unscheduled,6227993993,"Feb 18, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,1,Screening,6227635205,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,1,Screening,6227635203,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6227635206,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398426,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398427,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,2,Induction Week 0,6228398428,"Apr 14, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6227635209,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492827,"Apr 23, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492828,"Apr 23, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,3,Induction Week 2,6228492826,"Apr 23, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6227635210,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605821,"May 7, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605823,"May 7, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,4,Induction Week 4,6228605822,"May 7, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,5,Induction Week 12,6228084840,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,6,Maintenance Week 4,6228605824,"May 7, 2026","Feb 28, 2027",274 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-1,Stool Pathogens,6227635214,"Jan 5, 2026","Jan 14, 2027",229 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-1,Stool Pathogens,6227635212,"Jan 5, 2026","Jan 14, 2027",229 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-2,TB Testing,6227635221,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-2,TB Testing,6227635222,"Jan 5, 2026","Aug 31, 2026",93 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-3,Biopsy,6227635224,"Jan 5, 2026","Nov 25, 2026",179 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-3,Biopsy,6227635225,"Jan 5, 2026","Nov 25, 2026",179 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-4,Induction ED,6227635226,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-4,Induction ED,6227635227,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-5,Biologic Drug Level,6227635228,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-5,Biologic Drug Level,6227635229,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084843,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084842,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-6,Maintenance ED,6228084841,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-8,Liver Function Tests,6227635230,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-8,Liver Function Tests,6227635231,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084845,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084844,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-9,LTE Maintenance ED,6228084846,"Mar 4, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-10,Safety FU,6227635215,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-10,Safety FU,6227635216,"Jan 5, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-11,DILI,6227635217,"Jan 5, 2026","Jul 31, 2026",62 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-12,DNA,6227635219,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,T-12,DNA,6227635220,"Jan 5, 2026","Dec 31, 2026",215 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635234,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635233,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10021 - Dr.Martin Bortlik,U,Unscheduled,6227635232,"Jan 5, 2026","Oct 31, 2026",154 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6227323267,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137352,"Mar 11, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137353,"Mar 11, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228137354,"Mar 11, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179928,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179930,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,1,Screening,6228179929,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6227323269,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6228173395,"Mar 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,2,Induction Week 0,6228173396,"Mar 18, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6227323271,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6228179931,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,3,Induction Week 2,6228179933,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6227323273,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6228179934,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,4,Induction Week 4,6228179935,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6227752380,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6227810902,"Jan 28, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6228137356,"Mar 11, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,5,Induction Week 12,6228137355,"Mar 11, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,6,Maintenance Week 4,6228023948,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,6,Maintenance Week 4,6228023949,"Feb 25, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,12,LTE Maintenance Wk56,6228179938,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,12,LTE Maintenance Wk56,6228179937,"Mar 23, 2026","Oct 11, 2026",134 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6227323275,"Nov 21, 2025","Dec 26, 2026",210 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6227810903,"Jan 28, 2026","Jan 15, 2027",230 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6228179939,"Mar 23, 2026","Jan 29, 2027",244 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-1,Stool Pathogens,6228179940,"Mar 23, 2026","Jan 29, 2027",244 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-2,TB Testing,6227323284,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-2,TB Testing,6227323285,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6227323288,"Nov 21, 2025","Sep 12, 2026",105 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228023950,"Feb 25, 2026","Nov 28, 2026",182 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228023952,"Feb 25, 2026","May 11, 2027",346 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228179946,"Mar 23, 2026","Jul 20, 2027",416 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-3,Biopsy,6228179944,"Mar 23, 2026","Jul 20, 2027",416 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-4,Induction ED,6227323289,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-4,Induction ED,6227323290,"Nov 21, 2025","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-5,Biologic Drug Level,6227323291,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-5,Biologic Drug Level,6227323292,"Nov 21, 2025","Jun 30, 2026",31 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752381,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752383,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-6,Maintenance ED,6227752382,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-8,Liver Function Tests,6227323293,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-8,Liver Function Tests,6227323294,"Nov 21, 2025","Jul 1, 2026",32 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752385,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752386,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-9,LTE Maintenance ED,6227752384,"Jan 20, 2026","Oct 7, 2026",130 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-10,Safety FU,6227323279,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-10,Safety FU,6227323278,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-11,DILI,6227323280,"Nov 21, 2025","May 31, 2026",1 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6227323281,"Nov 21, 2025","Jul 31, 2026",62 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6227323282,"Nov 21, 2025","Jul 31, 2026",62 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6228179941,"Mar 23, 2026","Mar 31, 2027",305 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,T-12,DNA,6228179943,"Mar 23, 2026","Mar 31, 2027",305 -213069,EMEA,CZE,CZ10022 - Dr. Petr Hrabak,U,Unscheduled,6227323296,"Nov 21, 2025","Aug 31, 2026",93 -title,value,,,,,,,, -Search,,,,,,,,, -Site,"CZ10001 Dr. Matej Falc, CZ10010 Dr.Nabil El Lababidi, CZ10022 Dr. Petr Hrabak, CZ10020 Dr.Lucie Gonsorcikova, CZ10012 Dr.Stefan Konecny, CZ10021 Dr.Martin Bortlik, CZ10016 Dr.Robert Mudr, CZ10003 Dr. Leksa Vaclav, CZ10009 Dr. Jiri Pumprla, CZ10015 Dr.Jan Matous, CZ10013 Dr.David Stepek, CZ10006 Dr. Michal Konecny",,,,,,,, -Expiration Date Range,From - To - ,,,,,,,, -Shipped Date Range,From - To - ,,,,,,,, -Kit Type,,,,,,,,, -Ignore Record Limit,TRUE,,,,,,,, diff --git a/Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv b/Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv deleted file mode 100644 index 9cfdc22..0000000 --- a/Covance_UCO3001/Source/2026-05-29_112211 sponsor-study-35472-kit-inventory-on-hand-expiration.csv +++ /dev/null @@ -1,285 +0,0 @@ -Project No.,Region,Country,Site,Kit Type,Description,Accession,Shipped Date,Expiration Date,Days to Expiration -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350973,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350970,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350974,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350976,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350978,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6225350979,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6227541248,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6227541247,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149461,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149462,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,1,Part 1 Screening,6228149463,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6225350980,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6225350983,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227261232,"Nov 18, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227261231,"Nov 18, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227541250,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,2,Part 1 DB Baseline,6227541253,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350985,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350986,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6225350987,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6227547334,"Dec 31, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,3,Part 2 Screening,6227547335,"Dec 31, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6225350989,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227541255,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227541254,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,4,Part 2 OL Induction Baseline,6227547339,"Dec 31, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6226573502,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6226889397,"Oct 7, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227261233,"Nov 18, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227541263,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,5,Part 2 OL Induction Day 29,6227541262,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6226573503,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6226889398,"Oct 7, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6227043303,"Oct 23, 2025","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6227261234,"Nov 18, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6228149464,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,6,Part 2 DB Baseline,6228149465,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6226649754,"Aug 29, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6226889399,"Oct 7, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541265,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541267,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541268,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,7,Part 2 DB Week 13,6227541266,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573504,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573505,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573507,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573506,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6226573508,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541269,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541270,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541272,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-1,Part 2 DB Every 12 Weeks,6227541271,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350990,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350991,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350992,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350993,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6225350994,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6227768461,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6228605654,"May 7, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-2,End of Phase/Treatment,6228605655,"May 7, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350996,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350995,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350997,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350998,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6225350999,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768462,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768463,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768464,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-3,Early Withdrawal,6227768465,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6225351000,"Feb 24, 2025","Sep 1, 2025",-270 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6227547340,"Dec 31, 2025","Sep 12, 2026",105 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-4,Liver Monitoring,6227768466,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6225351001,"Feb 24, 2025","Jul 31, 2025",-302 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6227547341,"Dec 31, 2025","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,T-5,Suspected Liver Event FU,6227768467,"Jan 27, 2026","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6225351003,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6226649755,"Aug 29, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6226649756,"Aug 29, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178914,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178913,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178915,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178916,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178917,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178919,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10004 - Dr. Erik Herman,U,Retest,6227178918,"Nov 14, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351038,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351039,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6225351043,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520226,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520225,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,1,Part 1 Screening,6227520227,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6225351048,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551696,"Aug 22, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551699,"Aug 22, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226551700,"Aug 22, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655163,"Sep 5, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655166,"Sep 5, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655165,"Sep 5, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655162,"Sep 5, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,2,Part 1 DB Baseline,6226655164,"Sep 5, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351053,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351054,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6225351055,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520230,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520228,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,3,Part 2 Screening,6227520229,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780849,"Sep 24, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780851,"Sep 24, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780848,"Sep 24, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780852,"Sep 24, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6226780850,"Sep 24, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520231,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520233,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,4,Part 2 OL Induction Baseline,6227520232,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6226550654,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6226561520,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072416,"Oct 20, 2025","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072415,"Oct 20, 2025","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072418,"Oct 20, 2025","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,5,Part 2 OL Induction Day 29,6227072417,"Oct 20, 2025","Jul 31, 2026",62 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226313626,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226550655,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6226561521,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520234,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520235,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,6,Part 2 DB Baseline,6227520236,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226313627,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226550656,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226561522,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,7,Part 2 DB Week 13,6226804963,"Sep 25, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313628,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313629,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313630,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313631,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6226313632,"Jul 14, 2025","Apr 17, 2026",-42 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520237,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520239,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520240,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520241,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-1,Part 2 DB Every 12 Weeks,6227520238,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351058,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351059,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351061,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351062,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6225351060,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6226780854,"Sep 24, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6227520244,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-2,End of Phase/Treatment,6227520246,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351065,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351067,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351064,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6225351063,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520248,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520250,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520247,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520249,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-3,Early Withdrawal,6227520251,"Dec 26, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-4,Liver Monitoring,6225351068,"Feb 24, 2025","Sep 1, 2025",-270 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,T-5,Suspected Liver Event FU,6225351069,"Feb 24, 2025","Jul 31, 2025",-302 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6225351071,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6228023802,"Feb 25, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10008 - Dr.Zdenek Solle,U,Retest,6228023803,"Feb 25, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351073,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351075,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6225351079,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6227542163,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6227542162,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149810,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149812,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,1,Part 1 Screening,6228149811,"Mar 13, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6225351085,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6225351086,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227542165,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227542164,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227844727,"Feb 1, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,2,Part 1 DB Baseline,6227844726,"Feb 1, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351087,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351088,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6225351089,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542167,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542168,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542169,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,3,Part 2 Screening,6227542166,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,4,Part 2 OL Induction Baseline,6225351091,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,4,Part 2 OL Induction Baseline,6225351090,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,5,Part 2 OL Induction Day 29,6226935605,"Oct 14, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,5,Part 2 OL Induction Day 29,6228013045,"Feb 26, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226550647,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226561518,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6226991312,"Oct 26, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228013046,"Feb 26, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228114461,"Mar 11, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,6,Part 2 DB Baseline,6228398393,"Apr 15, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226550648,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226561519,"Aug 21, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6226991313,"Oct 26, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6227261837,"Nov 20, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6227261838,"Nov 20, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,7,Part 2 DB Week 13,6228114462,"Mar 11, 2026","Oct 11, 2026",134 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550649,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550650,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550652,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550651,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-1,Part 2 DB Every 12 Weeks,6226550653,"Aug 18, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6225351092,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6225351096,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6227498378,"Dec 22, 2025","Aug 31, 2026",93 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228232036,"Mar 25, 2026","Jan 3, 2027",218 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228232038,"Mar 25, 2026","Jan 3, 2027",218 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-2,End of Phase/Treatment,6228234299,"Mar 30, 2026","Jan 3, 2027",218 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351097,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351099,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351101,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351100,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6225351098,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542174,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542176,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542175,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-3,Early Withdrawal,6227542177,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6225351102,"Feb 24, 2025","Sep 1, 2025",-270 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6227542179,"Dec 25, 2025","Sep 12, 2026",105 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-4,Liver Monitoring,6227542178,"Dec 25, 2025","Sep 12, 2026",105 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6225351103,"Feb 24, 2025","Jul 31, 2025",-302 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6227542180,"Dec 25, 2025","Jun 30, 2026",31 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,T-5,Suspected Liver Event FU,6227542181,"Dec 25, 2025","Jun 30, 2026",31 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6225351104,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6225351105,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6227542183,"Dec 25, 2025","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6228417882,"Apr 15, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10011 - Dr. Marta Lendlova,U,Retest,6228417883,"Apr 15, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351107,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351108,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351112,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351113,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351114,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6225351115,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227767268,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227775503,"Jan 23, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,1,Part 1 Screening,6227775504,"Jan 23, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351117,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351116,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351118,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6225351119,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227767269,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227767270,"Jan 27, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,2,Part 1 DB Baseline,6227775506,"Jan 23, 2026","Oct 7, 2026",130 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351123,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351122,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6225351121,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6228742569,"May 25, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,3,Part 2 Screening,6228742568,"May 25, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,4,Part 2 OL Induction Baseline,6225351124,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,4,Part 2 OL Induction Baseline,6225351125,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,6,Part 2 DB Baseline,6226976944,"Oct 26, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,6,Part 2 DB Baseline,6228521304,"Apr 30, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226560889,"Aug 20, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226752556,"Sep 17, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,7,Part 2 DB Week 13,6226976945,"Oct 26, 2025","May 31, 2026",1 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560890,"Aug 20, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560892,"Aug 20, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560894,"Aug 20, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6226560893,"Aug 20, 2025","Jul 1, 2026",32 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6228389162,"Apr 15, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-1,Part 2 DB Every 12 Weeks,6228389161,"Apr 15, 2026","Feb 28, 2027",274 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351129,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351128,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351130,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-2,End of Phase/Treatment,6225351127,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351131,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351132,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351133,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351134,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-3,Early Withdrawal,6225351135,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-4,Liver Monitoring,6225351136,"Feb 24, 2025","Sep 1, 2025",-270 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,T-5,Suspected Liver Event FU,6225351137,"Feb 24, 2025","Jul 31, 2025",-302 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,U,Retest,6225351139,"Feb 24, 2025","Dec 1, 2025",-179 -212396,EMEA,CZE,CZ10012 - Dr.Ales Urban,U,Retest,6225351138,"Feb 24, 2025","Dec 1, 2025",-179 -title,value,,,,,,,, -Search,,,,,,,,, -Site,"CZ10004 Dr. Erik Herman, CZ10012 Dr.Ales Urban, CZ10011 Dr. Marta Lendlova, CZ10008 Dr.Zdenek Solle",,,,,,,, -Expiration Date Range,From - To - ,,,,,,,, -Shipped Date Range,From - To - ,,,,,,,, -Kit Type,,,,,,,,, -Ignore Record Limit,TRUE,,,,,,,, diff --git a/Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A19775F-5F30.pma b/Covance_UCO3001/browser_profile/BrowserMetrics/BrowserMetrics-6A19775F-5F30.pma deleted file mode 100644 index ac308e366a220e07491550e268a14191a552b761..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 4194304 zcmeEv2Ygh;_Wx{X0Td#Lf{27BMH8wJK!r^LBuF3jn)2?FF5)c-}HtVp7eLQHNaKu7~MW`g7pQeDb54 z{2XU$t`P`&f+52ja+a0(id-RIAa#N(P*#%#uCFBEDi5aGan&Ib!gWUPub$-iD9r>A zJ#$M?D^P1t8&D#sEvOx+J?Ie7p`Z?+jv$iDVW3W+&Y;6VT|h^Gjs$fDbpss*IvR8g zC>hin)E9ItXaHysCB6;rLzyAVQViAbt zz5)+L&*lV?&CgQ+er3BMYrzuvGmkyxg}djT2$nSDF9E)pZ?YqnRqmRgv%Q|sbR$?% z7LtC`aBYs98GjN4O5t+PZ8v;1gqrY!LnJ===?yQp?$l-Ih!awWq>dUnd|2wpl#wG+ z+(xBQ)^**-cW-UoyOrTh$Yd6LnayC3Xj*w_J)kIq-Pf&(ls&JF+ePI zh|3*fjl)cGox?G?-J#`u#+=<{>!lyh#{Jcgp7vmuzaKey9PV3n*z;4D+QsL;lq=>W zQetVy@mhy`t`!ck*RiNiZ35(@jAK!PxH_Tlh~cgg?qQ<~Q{2U_VJRbu(+X2YyGD#m zDK>@;KVfLG;XYx=@YM;c4t*eDwZnbP=r?bAIrpSdAFo~T{30=E!IpJpJ8l?$SNo+K z25;Y#a{sLOXu zRULDF%_(a<#~dh;-`yMpO;pL~7s73=p; z`SH-RzE8-#AwPe5$9YRo4^i-`3{f4)GfK))$z`^jlTjM*l^auhRrzRcCU{F+B?dWC z{ml0UjWVMsWS~N{M5UszR0l2L^9)y@sFVWBx<1wCHCm$59S?t0Ppy7SeSW{kTOxg{ zc41nm6d|Mds7_nLWCVP{V5U*&DKaP+wF^^y7A6oQyqRXb@KlG&jV!}eSwrEeEsCT$ zLbVUw?P;py@~S+cB0^VB7UNYr($5|)fBKY}o}j9?<$fyl(_P-V^7-n;k*V6DWP2RB zu3)gr7jWmeym+txVJ4YR^@Yx9z)7@3rs6R~PkTI>u8^zH6*QcFPez#sIU2109A=s5 zWe=;$1SK6U5b#s)8O*eM)C=z`_xplIE=rbx##=3E^$OQ;45m72@&V zp>rGQ5LcY%5dU}+8pV?mr2I(6fMU^?tw-E|6DePSB6Wewz<+Xh%GKn*@|@#4ypep` z<#bPm{L|IWmuy@blQZUsp5mIQ!VHg6PtFuK#1hd<66O`AKhmq#Lhw3Xh)wD(bHRV} znb%3xDDqZ(+_m%Q)lbts8OCepD_0?Ax&j`lXbGlHsD^6QZMgGX#YT?LZKS3ft|Fgz zqNmKrgEGc&hF}Fk6@Cg!<=b9P?Dz>E%e~h0PtP$PlVklkXbw$fj3&(=9{ufybbIO} zw>`S-_qL=Wm4=_g&S!V3*BNDo%R8ak6H>r4d|st4E~*(W>tH;1sa~_*lyEWrWw@vC zgnuhd?qQrD!bS6bssnpLtlyqi@m|os>)1rFq+$GaKD%rA5RrdIz!fab3!!e#&GZC| z0*2q^Eviu=P~;~hBc0V0*NfJSnM&S|SEE}KQ8^WWYq)J#uQ29)T zMREzR`h00MaOmk!8oJyPp>T_ZbLB-7Z+Pv}OI}m4bNLnGdK;hJo4`5IfO>4A%Trbn zV6;LcBOv1)06cnngtyvsr+nT5cj7rgWb=AK82q90^WO$bymRJ*-p?xk$RKwzWYanZ z^CeTeP&u984F!Dunmk`cpvag}^4ZR3 zNE)6gK9?IyYvnF4w6I#Enc=HILDl*!3Y!ILET6f4aKEItqtw0=ZZ5}qJxhdwHdc9P zzip}Wn;T2+LU?IZIffieKBBf5?fFPgoKfoXdW|v>DW}w44M4hjycB0Gi0jvCxD(F_ zBAcI2um2lg898;@_I~x`Zs#MoG#aj4Uzw+f#7j%4rW)Fkel2=*J$+t(900!S-9BGZ zg#CW){qo}@E_j0cks+JfALdJ@cG1$$GYmK7eRNO)f3rY;CVy$1cqjWU1G6ScK5!nS>Z<{JseMtd<>; zDMH5;oxEK~28!sO%vAGg=Swy&TDns_<(^P5HNrvDljoUdq-Gk$E?y@6m&=!)fn=<= zU;gCS?bmw=XC3+5Bfq@B&!NhXL)iK3o@W$QpmC~6omAy_23_7%CyHz(MuqOw92c#| z^UAv!K<}p#d&S1n>FgVm2md~cntEv%kDbr%P2kDJAk{UG9t(~};$ zlG9OuIte?U-DBXe)QfN&=|ApWIb`L&;yHbk00h|%T$#`5vOS{|!&Y~$&sUb3kCvAv zovuL5X|B0Og`b6xigAQdf)z5a+cNIT>SL{^JSOi7{yFcxD(3_%9-eXMo|n2`L2WV_ zg4F_7=1Zn_!I;Yk_yeAxkx^3uf0b@~ zdH1JE>8 z*zqu5gCcLEi7L5e2Qz);E{}Jz54#}T*8XyP9O+jXr)~(}{9Q|X`pl1+zE`Es{`7XQ zw4dTSVNv{mS8ransO1|~QwDytgT^srs2;V%mHCpXU2=?aU!W${)}}=MPWSmjG;zjE zjoNx4!U)UxvFlhB5#vefuka*-zt?mA^6GA##N9V1-&D7M^m$NgNV5pQX@J9glO3`0 zu;TBokd2F~Vi>StHc?h)1XPnOx26OtU1gaS0XeZxb$V-3c}sz)Lrn3OcOJjd*p2#i z>eH#egc?fjbHeaQ?rWmC3)Q31piI!IpaM_;bQvfNdJ6P0=ny>L$)I_lr$Jp%X=*@w zKnqZLj%_K#cc2ei3Gok9{0WIdyp4(Yy%;=xgn`9^B+S{M|I5Z4{BDfX>yoi23v#8p ziRdlzA2N_Q(fYXy@l%;t1pkBY{piFM|7<6EE#7_Qn=K6h9QsCSN4J34+N1264!AcYG4P0 zs7#IkjRK7Uodg;W$^cCSO$O2UXgX*n=ycFIAd;~M~R~Le=1FZpV0&N5B1|_0A^#P3o zodr4%^fwSxsp1n*Ta<;Npff;=K#zi`d~i8hjkLKQZzsXPI6;V7mbYQBxgKvl^hoiK zMF|s!Ia^etxJtwInE56uU?| z`nD|VcNqZZtSbP3YI7HO?Jd; z22O7i;?7APA;ZR;tZDWDwC zRM0d~E{OV9YIE~IGeG$uYJX1y(foZjh}z;aKxcx^0-X(_wz&Z00u_RaKyDC~mxkKC ztue|~Y0LKF!o5GI9lNY>`q~AE1cu8$^A$IGJ@9g6tpWP{vXnY27?P_4WN%Maw`niV ze0*2-(gzc=Ug$_ZqvfCZiW|K)g)`e-W;E6w>$v2g2vIUFd;5{qw!QFP@ObNuZ#;O! z!nal0Ps5_|2lJzd)Lq=Ttl|>22+sXkEedf0{xdGRZvoQhEv|D{E*rCP01X+WA-R%t z?R?3`rT#p@oVQR#fmsCN^b=8mVx_+#u<9KMsh=_KrYc1J^4>?2)jk)Z?-zl^NAT1lAm`I+ zGw)bF_IgEW49W`@od47SYI39@{PYxdzGUMvEiWTb;}4}`*FF?uMe?53pxM0^H=OG^~{nUxA)%jd@!eA)ZJS;`_Gf$Jz_= zDaNArc0jl!jHvJG$H1qqx%_y zof9iiNiRYEqXF)MNky0EQI6^`=h%;VWN(La1(gG2 z@dXfrMUS?N1PS8=K^*n^A#&S(-La>AJ+}SBcw}kFUpx3_zR8YQ(N;|9U!3!>n(53W z^$RV^R|F+HT7&fR>&Ku3SrNfQ_f$&tcK(ddI~m1i_IaFekRhAeS>{WocCq8h4k}I1 z44;Y2^sD383mg=$6GS$$U%qEm06_d+(lz&9TmE6U?q?H5GUSi+{mhq4?PAAaz6GRI zue_)V|Fs})PpUCMizSaw`yLvY-(%orPKt048atoe?KrZ7Q}AY5S)|LUg-1?*Zyf1& z*!J0VJC3iI&+&8mc0Ri|l75b>s1yo1+w-Tze*Uaiew}oB#+)lTeoo)cXLn~2sdhbu z(05~T09{@MRs(8GZ8tpW<$wmpvE={S6Yb`|yS3~B)z2#ZoCEqf=5xAi>;0P#ucYCX zz${k~tHDL2>dnpPg`jl^!1=HaIOw^YAhOXsiB=$e-_Me)>`Qm2Ul{^h8kU2d&+fEo zL+bWP?eFyav9u?(Z%%h5jRo8&m?6BXgjESuZ8Ht}3$(N{S%QTD?C_8)1ZIS~+|n?a zh$XilR<1m*%cO^XWju`6&S&>LPl*>@uroIs%TzfodXXqN5#toJF4G7i@AIiffQZ~o z9OJ>G_z9D}Jvn#p_1_#aFL?mDks+Jb#hEXe+J*K*$Ql!QwNN?M!s2xOm`G82P7vAc zK)wV2E<&F^J z;g`~HXg>ozGnW~3XOZ>{-I>HjeM2(tDLkz+F9S~AZ!q)KWb90{?lW19&X;%@AhLUd z`hXI_Kk1=x&$Le*;_9h$QbKz!Uv~lt6o%%8G|phYWNH^Yhgm1(GJen;%84-i9O!eA z%&Fg^u?4#8X1@>H9bwR=iyok3K1bo|)vPm;0oX!Gv*wNG{ax(sK+!|Nq;} zP3PiPj17;w;oYJ4m786!^miz(%qKs(q4H+Fw47%I=&e00(qXmGRYps-(SEcJf#Q)9 z^<|XrBo_={#^~;w1SxL1c5;*4x7?ranHuZe-8- zfFTV%Zwov%^G$ZdGW%m{*8F9znr!z(ylkh|t+L(lRSV+ulg7nP-@k9o=0Mf=Kibo0 zek5V@rit|BmLR>Htw8!zt@!!r9@$|TC%t#+q2GOQ&+&ee4;iwlePO<2YL`j5`RIrO z?kc>=M|~vLXJmgs8!Mx|qjmf^V0>&GGrc1}oPPVV33eRJ*C5E-JZvb+4*JT}QcyNl zsX_+&OmkU!S^#_cu=yl9Ki1{44tU70T;F3X*9j&-#-D2P zO?JeJANNc;EkVB9N`aF>j5`^)^mHlBTGO4{gW3%IfpLONJT0l+4I^BOV_!Ir+>Y2* zHGAb(b6l&a1B9XM?}RJ!B~!ahHA1PGQ}a?Yy}>MB5Zh$rwqm(tDt*=AO8A=UZz(Bi zYpMUCIW6@k{XuDQO>`i$?kl z%uU9k)Ljw~;?g^yquq_Y>9ZZ;%^w}Yhq>Xf!!aNHtd*#_BvEua^$=0=>S5x9C%TD_ zL;Hyvo<2dm^FWUHF2^r6PQO*Gy6G$NXpcNce*do=hgUvFB56r|8f?q{hV7ZeiOM&8 zsY9((L+<;x)jdUScf8T!$EPw^UqX?PA)Cfg%$H2Gdr0KSE?BETUbOE8J@r5#UVv_8>v)U_kfDnWj1?fg9ydc5{{s5T zU$EAh<`5(=maE=gjh_e*FisHZT9a>SBjs8!0prBVlk3PW;o1S`eE03MztVhwjFN9c zgs-^KYdyJ62!=f6XeE>$kEa(6%9$_(@a!G&?9YIf;Q1@tKu-Y~+>L^aWf^fP%A*s5 zsnL){70P8x$m5$MQ6^Ei_aB4xfIcX{1F%M#g7M%8_#2D-%z(_NK<|GV-jgW8SObHL z7i)$1>(!9yD&)lm=;gMfE&d16?&=VmvEaUK4rF$tLmcrgW>ZHdh_Sh+pa*XdK%S1X0VeD8wt*ZXi;*ZVfStmqAD2;VuImgF-_4 z6FMU=??gUsM;?BRGTaT3{D4Z*5d+#&5y@`M@2}6nTJ&6u9Z)gGy)MLGdOE~+OB~Q& zC5SKfCkO+LQJ>AN#Fm6aF|kK`v2<=n@sYcWxaZy;qAGQuc%=7eF=oOv;rOjw%9Z7> z_baoq01l=x`L9k&5S||5qwvq->0^PH46;VbpZSuhUE-4eG_UFmgP1HCo=V#PqvP5W z16Nk31d&qy=Ak8Bu3p&jbhUMhaWP+mByZ!wHQhM30^4X!a5CH?T)DhfXRC6`@@fG$ zWMxFJJ_Jh3wM*}OYR7xmJw8N+R&5<*zn}RgJ7UTAO-PZ>8~k!<;-4oEZct4FcA)3` zE&9QAr&w`7d~)qAaWeKv%pUVAMc(0!k&C9MB;L;nq4>c#>hal~#+fFBDV|~jZIdyf z5|txZfAmS&CH|~l8O_zdZT?4XL|;%p(6ONYAXKaWy7gG9^LqJBL&HSnfXgqsihBE& zcf9ypyZ)`;K?|hJ5z;zB*!k?P^=sHcR_rOE6&X55DK!I!qhPk6ves)Xu+aYX^N}D3w2Zg<=Rm9 znFgkiD$p`mT(84uYjwGB*_;LbAuqmf69cqH9??JcG;Q3;d-+DWmHr4uE2EtKarN8(3^Rkm)xL{3S z4cO9<32l|-Ra04?D`A_{iWF3DQAaN)I}|b<*^0nl5v6vQ$y>c zS&!}e^v7q`JVuzvkiRy#GG8*aOQZE+q9+gxS<}x#siycieS5z~(VjGPL%9FIA)j*+ zJl?hQ*`4wuGl0H58=ZW)uab1q`V3f?`=&V3@0Rn=<x-L>@d^U|X! zC&L4mhdQLo<)MB5nqx=?x;sq<+5P-3wO#D)$(nnYl9z_%BYZ80^EC{23gZNk-B5XY zVDzddN=9X+!dV*fN51WR$;O4(oilTxaz}?<>2aflV{Nll4>V-DHGOVB^!I#MoiyY5 z^WS?3E1JrXP4$fVCOcwr`dFGsrw#WJ2+)R2r$ZbKY#G+@=>5-n8y-wu#`BqI89ERo9 zU^~5a=bFva?_H>TM&*@d*R1;a zo?1?)rMzh=?0j}N&l^w!6AWH(G~Zl$CBUc-@%|%|o9FVn3w_npjw*J3h!zPTO)T3C!K=xvr73~GZslQi7eR^SO3G!?*knO=-L^m@L2wu*}Jke-X$ z;qAbA+m>u-?64Pg(sdKt?X0>)`Q&ng_cv{Pc5fI@1OTA}Oq|M+S0Q&C6jxxI0Rq>7 zNKQ@Zjk*8iew_O+D)TgF=m1Irbpjm@IuZnxq|^=dg53`^2s9XU0_a3g1_;x6x&M|1 zH*-PNpvyoctGhv)K-)po2p@(F84iMKSzHWy81xNj5HiyT+5mzoPE>$?o5byNJP{()oi`agT` z51&CprwrkvaRc*BcEqYbPn2(@8d%?;B|b~OC7v0({(iIXjN(myJil1UMd79T%lt^f z=1u+doo=^$>lJT)d4o!4iY2X}zSxMcR5m%^!X~cq;Hl@ewkwOSPY{P!Z*8}I@%OZZ zB26N$G@oa_$&Of4Pn`e_0{S0sXj&om-Bx0hYj!}VVrvjK2|+#gA>h^KXQQ4B=12mHCpXU2?GkN*i;r+K-c)b6nLq zo}z${bPre%Euw8N$}^@Gf4V(66mbw{s>6CazRsKlIpIcl#bwvDpfPOX*{JtB+ixb; zgO1PV89z)QSejW55tGHgmK%zFVfa@z-3j>68MoY+*p;AGb(+^vx~e+Qpkh-Y=huTeFfJ zhrgKN$ZK<>8G-S=M|Pd*~=VK84ZwF{LSITWOo6xIp?}KkGayd}BDs_2cZebeXke z$$a2WJwz(-5ENf(*Lgfo+(ZzKZ)iM2bvDT)y6+1@^^xr={iiVz`E76Bqx#7&GZiGWO`hWJr?*9r* z9M?hn|1SxIk@@!e!cQ>Vyy5aey7$Q@Z>nk2c!YW6kLnAS>!smvR8F~mm`;&$s{f~Z z3d7;(zg}+X|9_h~*q*8KU@r&ye|wqH%g=vXdHHXD-enK~&+Ghilr)^Ms7%<$Y2>=3 z*GYFKe09n1T%O1u&3BnkesrUM^CU8t%AZ>v8LQCLoW>?*phd75&)yh#{O@Cr%&9ls zUzPRk(@IxmG;w5HHO`_4m8hTy@6n*9J;k+VL=7gCcJucxL$2 zt8R?|NrrD~M`)i(8gTHwfs;RVx1)TjHr;98>pHj-kLA`-K0bN-sK4wl>^sPgllcg4 zG3I-C%AzeeRVvT){2C8ER;+Y0Uh+Ks`n1>RSR`r4CjBwL#l3_X7`N|dNyjXD3 zfGZEmp^&)+v=Lx(N2rQHuXoFUkJ4i~Qkz6`R{gw*+dlg7=s(Ikk5i$|eIMBUVdt~E zH6O93Fw0X?D$l5M1w&F;%4ZlB%V|i36^Fe&TG9G2@#&8*EbqJXOF!WwLs)5i$b8Av zE>m5Vo)Xz2qIq=V6(_uEt3CyYPsZWRXmE>sbTB13;CSm2e9KM~lO-S5RjPdqF0SyL?2VqNspvMb?-UA(r0)g%7qB|O#_dz@HASWV2x+0<*p(JdDLFnxm zcz%vSrYjlyJ&(is*tqor`K@j!W?pLP1tT_X>A8C zO2;WvQh9E#KXspt+3p_IV>Co54f&^e7V}MZ#9~|ujjTAnvS4Fqtn-@!>a1WGPebp^ z&KdmKx3$kdkVR#J4B?^uh|HHv?P9LwMTY5U84HcTwBiZXMTYDz%(hscC+r0dikESq z_|zL;+@Imby%{#McTi4v2i6;UG~N8Y1uRExR@USWZuMw3zOx5 z`LZM4$HQx&W(YBZxU~Aw)qAO*AVc`*{9@)yrgn)hKj|a| zdB%j=p^orj5SOzR=f#%Sl-lq4_~yO$OPiu!P6^oM#{2`rN8jv0Pp>AA7JPcX=3W$Aemir%yyD&thaYXP zr_4Vvd{hr`o&vt$#^7{)#NIe?%`H1>$xky+>0rmj`~$-k9fwTAV7%Nj&(`}}>qYV< zDitRz!a@5-X+2=s#W*M7T(N^(|Ng{~7YnLeoJjX%6kbO?zH*J(KSZYqsYP&0%SO3h4xC9@`0o>8D)J=nFdqlm?mzIt_$rs9g711N&_dy)Z^+hW`!J z0t4uUpk8?P#`f8+k3&x3OGb5nyr}v!L@y1?$9%e_>^=7dG* zHI#opUGn()ieox_$>}mKJD=T~k4w&wE$zmhIB-qLTpGT|m2GNLqUFlYKX6=mbPk=* zJIyQih3oZm#bqkirsTFPn0@uk{&iHmq+z+)`Rv|&xyk&DsvFFR*1_iXcO5C`U>K(x z_oPnB0{^4*&+^G_Y|_-fmVR5%mF~$fPCH+@9zgv}<@bGR8U$R5hzak3)LW>HboPS;XUOd3?%Ks8IOpYl1nSNw*@7EXdQMWi1L@8SMTT2E{6jQKW{_zytw~k zF9&ztmZ5w`pV!W3_xQ^zPB+1vo5Sh2w#I?$ng!Y4-~avy^oYuEKG^x}9zU)*m~-PJ zn3!`@SRGgC6)Lu->fWZztrt;I31U`GB&P5KfC$wGuz$t zDu-uWc0Ri|7nj+MSmd=L4qQ9l_$KY{>{CwWbQzbO&+g5}rMeLdt|5z6Y)$3kkdnKG zOxyC%Tuzs9+4<}qKdur3D?Unng1~zJu{{o4i~BCQrf_1vL7Xn*vh&&ffN-T$c|xTr zzQ**f{v|5*rsQ{in^qmpe!SfsjDvC7`RpD)PA`4om~}iB`E^|y8&}2TL&wfIu@_Yz zX&9HC&+hT#a$)SA62t*~MWK`;1D}SIAPqAjy}quC1Lu}jl|@GQ^@|w?yp~2Xr$eG`w^-+tf+%4bw=c0Rkuk1H4~lkG{0+uYeA$4q*^k#wz!wW)l4 z=A8c5d7MM%aQZAaJD=U-$4BK3Z64Z`a#@3M-~?XkE%vAqsORtMIB@QF-t)r+*Z;nW zaWGChpWWlfi4Rbu6w=puWz7g90?yy8>r`w_$uDhHx1qC#J@7rI^wJP6TCZci$&Og@ z;|k&xx)j4(g3&O&BW1=AhRyhP#ewhX(#7r1I&-zutxyy!H#?u)$i$D&jqm&6bO^M} zQg^0;Tk6N6zba-^@>`hnz`0%CfA(`Tcm$uF&+hT#s|XgR6qWjXcnLHG$Evzi3}IL- zzX8h?uPJ;5ci+7Hgvx=}E1yyM+4<}qKfXd<7)U9hl>sw?Fl@%RB@TR}F3Uc5=AN}w z?WN)Twe#7%8TcY=18DucX18l;mkX#8!!#wocT=3s?q6=E>9jPA&(3G}`0-J{L2Cml zWEd99O{`SBrf^+!e$F$;zOnjAQU<9&a(WEnCK;tK-1e zZp4NomR{ket>fW(KMrNXDL3vEbAY4v6o(NJ*PGhE zsaTtm<85CXM&}ow>DR&pK=^3?1@ldI#EKuE8g1DJ4m3q#d`UN{Xq&>feDjmXv_5Y| z9|pkkv-8=p1l2gq!E4p6y;XN;Nx-2I%WFFK;q+qdLfV&h8Q z)%mvB!{^j;x{S-tXZQGVp?s0p{2sif6_8zTid%i0g5nB;xPESm1LrMo@9lH+?k%Lo zmxgiL`Rv{doKO;APHBEEh{NmkV%DvS>x4z=Hncvl@ttwA-%MXMmBTYWJD=U-$A|Ge zzLvsS97Y5zx4m)TdTP(UNuQ3IcnPP=xa@p(Z#FL5ltah2;x-j)Q*wJ|)T|wyI)7Ej z=`%h%pWWlf7oBeei!j|aH~Q%LIz+ByH9elcdFoYjuIfJWADlkpv-8p@_)QGmu*8X-~95{PyFUSp-jOxfZ7^j`j?(yUF7DEGR&=;9Vk*4<>v+h)} zHI=__-Scc()%7iUak`Al&S&@daYgHG{ZeR^-<~*d4t=CB;f!xypT#&Br=8F4@#Dle z%3tVXO@=PN74!$DDfw-C(wEULu=6hEGg?3Fe0Gl?R}f#uODPQCXmK=oDHQ=|O-qfU zx#r|T9~TcWQ*R1qO2={Mzft#!hjFm{?0j~QA7`c1Kk9ha$AQONm6LhWLv8D=YuNeC z$K#TC^n5H>qhe`FKItn~ojLiWW4d#CEFU|c-Q$;!-j2{Krj};J(jLph50OAqI9J@* zVs6zH>waMzjML6%_xN#|`p`&AtYQem;{GChx8gO0@BM8Z?&v5sXDOf2`e5g?`+?$P zokbWCF~0Hls92lAcjd^O?$5dC#C>I0es(^)A22>sR}n@;jIS;Zd?(zR{`2~Adr9>s z4db)(+5Ld=IfHU9fL>1)tyQt=@*4)0em-fSDyIkfZt6*y=3{OZtcL>2~des666r+wdOi}HO>)_(Tf z`;3F-Y3H+h{PI*wx+#8_Hzfo$WXe3BuiT2yf1ip~&u=@vmoI(1Qd;*< zVmyr3&S&@d@#_6w8D3^qnglnL2zZqkYj8C(N?pEPABc_ji6@VL!|R>2hw(68JD=ST z46mA%G_V|J(HpIc1MdybeLSz{^GC_GZo z-+z2$QH#sIKVp>f8O3GivwQq(wUrojIaZRGR%eE<8-@j13x{GhaZ=5dU zvh&$Jeq8!K#1vBc;$SX%Css9CI?i=*;C$s#SFaZ9|59)KW#=~^Cyu44z=z@GJjEYM zDZ^P|71(QHMx^&61?v^FDS4JWdH1tR&+Gme<6wE(`Rsmx^3*zQbl5nHgyRe2hU<+m zQ8b13h>fY93U38IW1u!CM8(M+s*W@FaTR-0a-5J_R`5WFh5H!?nM{m!En7d(`!uiqX{#P#8 zI`b3`&p7RTc8?z?cFcHET!ko{6jpD4>f*pPA^nIKKYD7>9h@%Xvh&$Jeq13sp#{@F ze4`{%66v4(*a5#TZ5fZ%ZcwQ-CC650KfCajum3oW@i1OHpWWlfOXGj{nB9$-Wa3Z~#-J~j20QR(s=vPs3>B+lxV zyCz)P`b@^b;ed{5;cU+xy{>vPmaohRq{-~&!9>zZt8*f_QA7%{S{idmri_RnM{O02=!ufwF3K*GG1d5@{!iuJ>X)2~LEN;K* z;=sA{vd$l_`f9$}^G0#n`OU{ke35lfAH+@_4Ma< ze)I7K{f3Knn5b8d)b2DZzU1d(N_4_}hIazc?}dOAgQV#?EK=`0LGFqed=crqIS%i+(Eic@ge9x&v}KnM@IB~c7F5mhUlPdS_-!8-_+Z|tQS>+-6nw#v*(WSW&#Z}?<$hE;RBII(J_M(ctDV)=nO#LDA;fx%{ z!Sb~8**$)onx2>5u*G32v|y*pu`UjLr+%?x%li+N)N=Za&(3G}KZh?`Fm;@ZUQ)3) zCC3wXR==Eg$JgI74#sKcv-_XK87Y|h_$ zmiey#6%|`kay;Xii?^L!^2iCCF5|NE**$(-(7!+n?8g)$h>t|#GkbE#qvvz-tFiIz z{QLTuw~pBSGpEn^?0j~QAD?x+gI)&*zhV=dSA8p&m0Dp$%@#)0pJD;!^}fBLQ?IepH5JD=U-&wuonfeLg$O%Lh9h?wQ+ z->On+syrO^_TnB}A1x&+hT(uLmC< zLT8QPn(Q9ELDdDBIi}+bzZF}aZ8nJFH5-hz%Z>+RS$ zf4OQ*S;EBGyBG)KwDZ|Lew@*%Blk-Z*e>dL`HW@Sv01GY-aS z=d*kKI2)5^u+&#&4&yL{t3|}zPFBAY`yBZ(6Ej}>etY6r#>05+e0ERAsfOjQz+8Mg z!n{j&;Y$O+;FVsMY3Z-qrb0PkQM~j$2vSrezAMC&*)3$6KTH{OTV+l^vt?3v>1yYz zm~b|n%9_-f__zu>-6foOm{3^Won1~d+o37QPb1(9Oz zED&|i<)BJXE$DL4b)Z{7_kw6?iiYJoK;ME$uw6jMfigg6foec2K#zfTf?8s6A{BH7 z=t|JjpkG00(00rRJqtRlCDI0M0`+NyZz6ykm>w?xwQ3{8a?lBhI4={l90EEU0y+T# zItBtd3IZAg0p&tKOCX@nA)wPCoNo>n;^rfSsOT!hxkur9$4BGcEo@Yr(+lU}^;PA8 z&x2cpN8xgtww)d8^7Ml(^m>&0o(k@SMe#QzkJgv;KDeatPO1Tn363J%3F+@_oASadvfz(esf9uyftvRQ`8@Z|86t0|4a+n4ws8`gV| zT`tTgKe{pTyPJ3>RQt;?@DHiKk#8!=Pqfhy))pLlfP)OAHF*Zq^fe+x!@J*s6whR~ED}iXRb_vgV{?t~Os z+z(OSuetwCaxHlD>Sq^RHTYyshjG~X>~6(jrVczVx7qHHSm*d!U=pn5{%3 zyB&>eIr?EA`rkj$_nwIU_6)RWE6~4=$Dre3jIXF0>pmX#sX|;(BE*FkVSI9@5Yyg9 zKYyr0JUi1NE_u))3I-+!k|+1SE08w#zqxhz1LFh%hG?k$==8$tm7pw1PF<*lu zZ{xv*KHJj1Zn2e1yL^^?EJXGLefD+T^VF5pSCgSJC1kyy`I4z!2uEHBBUU==0C$F; zntFV~tG-BNC|xe4AE}5~F820y(`Q25vu@V9%PLyGJk3m#@i1S5B5!SY>@ZSi<`Bl9 zMJ{`7IP7vM_(F)?0~Y5!@%55HcDXRWX&e)(jiL%_M;jH6UXGW2rD9{b*zu6-^8;SG zL8MDZ$Ke#eK z!f4{AIewdn=AhF-3H(P$AdCV{{n60;UU_yvTu-RX+snP#9od5%{QobOz`^$HUo6mr z(fyy6KrNn*$Ja?;t4DRhqV_9%sYB_vGB8Hmrgj~l`}?9#ejIamWS*zmIft&+gImX#f1UQy?UfMTG4lEA??!};LtTr#2y>=s|QCIg>c*pOBq#Bim@!0w7 z9>tT7x2Vkz1=&#L8rZS!4M8E8k2h3QNL_ES1-QsCu7>1v=TId+$CO*n>7mw^dVf+Bk?tSrZK?m~d9|K@oA$sF z#t9-h9FGeXyRN&1IQo7kEh~s$pPcx`;`c6DNcUt|UUt56jZ0n@IsLoWLz*k6WIRYO zP;XElP+w3#(6ONYpaGzPph2MHKq;WXprIgYM@|5Z0*wZZ1)T&M2XcbYoQescNuX@d z6cEjSr-SlAvp`f)&IY+aloutSxgZ}X2&w|j2VDTV2t@Pl#h|M}%Rx7SZUNm1S_^s* z^caX5t<9iUK~TNO^_ov$Q`7q+=yy;n2iBE9r1R+wqVmAyCJcA(FABcL9~dVHUK-T@ zx9fh_qRGF_BG}T9Kk{woOExZAy>G0Zu@@}xah1!4euAW;)}|O=oeiITp6$m2f3pAP zufP9T{QjGpYMhc8=|h+=ncBsse_(wGsbZw5#g)@9_(AblK6d>__#bGG(th~cm&=!= z52p$WL-|MPGhZ^bi#2^D8_{?uPqnZ({W@Fv_U9kJ7v(Fpw#BB$6Hejh=k%GcB`t5Q z>09+4c72rpHx-(n-=2P5xFpWGm)bKLQ*wKz=MCMHp*Z-S z{@Z15|4)9%FrRJ3{hz%ym3C8Z|Fb9$ruM%jfm$TY1%g%Y)*OzSED_xT>)&C1m6n<#MMPY-|?9bTu_Y z9__9zU

zCCB)L&ptnG+pDEGEIm;iRdk5xeQ}Z)bjRUh*ygTc>=#FijKp5zl!5(3 z-sFMe%(*GTedSP5w)O-OdTq2gfA>k^lB9I8c<4lN-So-grr=bu>e}hz-iK$3N8UYM zZ2afh;)Sk7;`PxbV%zC+McsU#*mYx2?AcHy_I@}Y`BE#|_PQ8pFB08~t`xm4UWT-< zMcOOGm@jS=>4~=>?K_b6UE++nYemtO_ap6xk@jQayxkkb#YxW~?afI0CGof5YvPV; z-$dH)BJKCZQ~&%>Z0`CA(*6Qze=Yt#f4BJJ#vhUPKasW^tU8d@G^MhvAExb7Il<+| zK8`2XW3PYex~}`LqG`7@s`w<-UXEE;Fl4L{+opX~K>qhU^!!;zc6*qnlF~39JD=S#V&*cDN@aMu z5v(W+S@mJt_gmAYDGSx1EbtSms(zxlfceaMIPzmuy_j{Y>fVL-O*t z1MHBLpU85R1+mVoShNpq8rCu+2Y<2t!d`CaIeE-MeIAc7{+)UiDl;_y=KLwZ^AZj& zFN{gw_q9AY^nyQbuO+pFG%P1OpWRJ4VY`l@?e?OhE!5wJ^n`ojz>$-kB$x!5U*HAqcdlECQSX#23 z{E^}G?R@15Jq{g#K;OF#rmCt;`y|epZWQB;fl_$V%SCm9_4#S6M&q_wIhcpO`2I+W z^X8>PU)a+nL{m^{IDI>x-ShC7r7}bAxx+3=H`;nYp*>9Aq8hHl6I)nu za2@H|2m4sxdo_jp*S_2%eUQ-`np9;Nhn>&vYF}GwMyU@aG}9=oC`rxt&h=vZwN zYO>{)DlVoLJS%K?8Y&kFyFcsdI0t*}H9WMRmHCW=ZQ99&ZEa;4F2Ab~iuRBP%6}-< zrEJ_LrW{wO2;Vy)-I^|+0WGcaX$Vi+ozIt5z5I`#?0A^ZIM{9w&qM?18x5eb;#qIQ zLvto-&kB%uWxFA3DUI{_%a5|qj#T0^iGgX@ zb``*lHlWgRYyl36mvPWNJ-^=04!ZY-n!ar}wa|LUFiSRzX@Kv zii&nN5Wt}!Zsl1oFSA-(<&+f5sWYF2|(<(wmJ~ck5 zML_Od?_xy+YL z?PAsYMfQP3w$|3dFQ-4NjWvCHJG-TyL)`gh;?fagjwpQaDdqQe6lzMJ`C8KQ)|!6g zZ3}a^m$jX(v!!p>JC^o$2>7T4PM`Trr*GAJMudPsdb#i?TIFEJL1{cW zKz~*>-z$s)I2UKHocPt!(m;TbX@8|(_ zoDSo#^Vz*29Mj9@aq^b+!K8N9`bt>r?ZzD|AD!_=my2g|{AxNE6m~wlH<-RrQURG@ z5*8UHn6kl6a1XZ1BXAhR^=2J##gfbLiNEftJ-fii>8cXu5OzMhGcKp6d_oyssh53W zO{#Wpo{DaLr(r@h#t`((t2KPH(2B;wm%S@#{?w7iFPuK(v-8>gPvN7Tsew?1ACc+x zZWnM;x=s+;_V##}r-k@E?b!}Xj=N$R_m}is)c!CZe=R0%oMvCO0--ryYY%A}&wx2C z#Ns#hfBxv}JD;-SVZH?n{xlO$L{hq(lCbZZ49lsZ_NjZ-z}oHG?mg|zmeQ+~XJ1^I zuei}`gY6TT`uiBpV!U1CQ3n+0?b8b2Aw-O)p>fW&=bifY%<41FqdX-;{#)V7e96=< zc}6IN5gules;J~*woStv=97Mhj4qb}wD<|bIP7v+F~}hvo;<(Z$KQST&ki(*hvD+W ze8r7kA-7HramAXSM(znEIf`l00W%In zIG8V)+NBX3x~Qb@T3orlZMWg5H~zqji8tJRY1Ps9_gy;LEJ%!l`5FXyYsC>sKC=3% z%b_62Du;UM_i%{NKaU&y+dEgy&sSa}`N90A)7P>gfD1rZJ34~ENslRDxo!lHM$$CM$dHPRvh4z`4-5&0u z^@Q&^9M?JN>EPvnByg}jJ0P(g4D??r0egL+zL)!Y>c6=!C-IOQ_swKed&PY`+h9q< z{`mhv`=A8=FGwJs{-5iH{=77d=YF2+hHmq{9_HYE^CfVwJ!`(q4u<&em4LmzoPvhv zVsz$LKqLVW>9earb3mtpXwjM8L74)|135wCLDN9AfnXG95a?JCZEQ#d4FwGb4FUBB z4Fr+DY!LaQy{a8e;&~Ibl{9yvu?UYd=w3H^o2lRHe)v8fcS?te#xqP5mUSN#ACHfS zA1hw+f6)Bjkw8=Z|77zqxm?i3rb9skK)ImXK_|hH?jM4EH*9+Ei|PiIe^PO3#O)ckACyOW-ZXX(Z}p7sx1J*ylBb~`ZNE;Zia zmV=KD%eOhq9Xa|s<`$$&@i=8%(Y{4L?{sfn|G^V)di-%}^U08Z+BeI5$o{@;TX9f7LVbbD|FpA6X)iusbMT^hz= zo`s0hlp&W=AAsmMwgU$lCy4GEIv;XmUdisG=KpjAjl0N@bvUlfmrU)_FpjAeHEAu5& zyVS!Ww|uK}rAaEhkL7>z90l4#LfaPUj0qa!CWCr|`hsYFHwZ*yB_1QuT#v?8wAUg7 zlm*HGO$W^a(U{Btm4Skw`JjtIi$Tjlw}9>etp`01dJFV1=m!wCkjwL?2f#iNG#%st zEd>1y^f>4}(668#s0`_#IiTx6&w^+p_W%^!0?>`14?xK+5eMi|P&*8gia^hR`eQ(S z4X6zUl^229BqAQr@mL^#4KyEv^bzfa_yzO|27hZY_`3;*i zm21D=|KO_h@xV`ptdnqMzGP~bdgUd@RozgL(d$pw;VN>c8NYqs3Ppe0&yS7S{nkxy zKwQ#L2x?E5Z?Yp+Jsk4gzU?Gk)LwTeUP@>w*(+Rh>E{bN~p)@`0co+_^{WUfoK&w7Xe5B$?!7!JvdeZ zui?pEa21jLgX~Yov1p_fM)n37k0jKMOfSW zfpn-hjRo8|2AEC-o8z_<>=!r654i9e0; zH%(@Gxmz6vuC}+AIF?i;J#7JnKaKI@!j)l`yS$1* ze7Dwvk39JzZLXP+UcZNoi9NnQJow`AogbfZHnl@!$R?>XUoy2zw4HIg@rpz+H9Kg& zGRZrYm1iBt`Z#brap}~(AKdjbc9<%|IGC?Nkhc*W^wzBhhxZ5E4MNe&c`nYgruNGT zqWBwXcN4$7Z_N3{U6SoMm@gC8E)g8Lt{QrUQjPC}sTq|;=3(d!3rNS6l^z?{*+okq zZa4I-SM9i%uR)TxjpBl!(haXs>e z4b`QFc+HLXp#OssXpRK*elKaFDuGT!An$DNGf=!+QhwfZ$k1*B&DTt&zYe%E-=21Z z?-78hzsF_H@v^<@q?ycgMDm|rk4ZjCTJ|SC`2U~;{^upI3`z3*HXNfK=Vm#?6W4{q zgC;$Tkbl}&0+qJhgGKvHXwL%uCxrloA)@~jMm;@l4$%DB@CTUe z!C(g^Ai^ko)ZRAq-WG|+UN%XOOLc*b-JSV!`R1VgrzCK&J^NGQI~e%COairdULHSg z#khp}XD5i-DY~b=Uq27)!w;6{TyyrzXK*`4HtDIEkG~cZ(SJ6iNSB)iS&{qYNzoGEWeB$XQ&nO{vuskdz7l-K-`vT?ifJ%IX*GJ!& zjjkutHwkh095be1y9y4$Gb7V+CS!8|CC)f$yps&#?}H>~v=)Dz==y8ID+{vetavgc zOB!c0Uoy2zgE;eyGIbo{L>D&DxUp^*#LM6 z;2e_KTBLX`x%j#n&NMz~jq;mtGGBuzZ<~Qr9pgkG5mLvMo7c4b5+}A6?|%K}>`Pue zx0M|i^ZyL4QlHq{Zc=OETNBvy?DoX{c3jN=6Sy)0zF;uZpfYF* z4Uy^imd$8dZtJsKi_C>99{7jnFrOVC^Zx`sIu5ej$TD1&bSN-oDohx}@*9%hG``Z3 zB=Jh#vAbWJ_x+E@QeYUa7tB}O=(QQ;O^GhA%0q`Dn(!>`%k~)fDAmjft4{u;?P1T+ z`SfI{o*#xQ^CeTeGy`A$^eHnvL3K24xm+`x?(*WR!7{cmt}MrDe9N|}_GQ^Am`Qy* zy!-Oxk2>1(nfV$-dD{$}wygsyuXTJ~Piq<!&`@0?{1}=xpH`x)Z8TeHDOk&d-=P+Voe6wc7 zmfxMdJEh$><&$)JY#jcgqjTD9?q_PA zlzb@Hna}aEZJt9s!#CIPN(gj_x3jEFGJ??VL=MxM=_>PJrQIBugb@Lkt98Id`M~*x zTgP}@^nEzSn-f2K_Vv@~H6e>>j33v22s3kOdka@ij$D^p7DkP+@I5yCyR~yZ?c?Y0 zY&XV_51*$5NBLTy>EpRQap1aX-F<0ECw1Duc-U@?-wa&l{sbJnT? zGgU3){B3A_eB}2vhyT>q`2pi2y&GxY?0j~gl#yc|?=LGI>VQj@EIr@ES+UD|r=90c zT)A>JZ;O`sOu5Z`PLFMKn}&IKB({uXxV$;8x!B4jw{M{2`>G6gdJPWXEY^3l=(tt@ zmtLOeSzCeh{p*X@ZG8FmD;}H3=_(02gq_dsdH4`_0JSSMD-`kvCwcQxjd<2FlZ0 z3%ayWp>Oe9YIN$=l}OGY=4-fI)HuUoB!``Bl4Om+wA@b@`<_7~ID= zRQbYwU>l#^Bl#$+JT{buYQU1)c0)7>(94l1jGcc|!t>vHv3Ssh96zUT=d*hxecr{| zz_$>{uciG14vN-zYU= z%jf=|U-*CQy$O6%)z&_IIsgSl5aoiR5=68JMg&9@ho%%LbEO5U2sE^zjg%%PEfi6S zh+4#ax)82bB z%oj}M!TTE`Q?YahsVMn`t13KMe#Jy5_w$5x(3GVg% zasC5!pPlAnJ+OS{ivW~|Rlao{Mi>p;tLbC&6|r$p@W)L#CD3*H^7qQ9B7-3x4m_DJ zn9752a0j#D^%oID`aC7=1*6PM4bM|R-9Quttw3Z)<3RML_Erjr)>6>iawC)Ie}c;Y zQ+uBcVVA#HzWIOl!|u$V%K!eaya@~8(DDAS2tO?3|BMEzkWi=`i?;4!kohY(jnlt0 zu1o(90dZ%JN>&>9B0lA-!{*-Np84cPHQ^hBf=)Vd1LLXKwCMMhV4;Ax5>#!MZHq(xH5ucV4?W`hb9MR5S7p<; zjeIB1AeX~!SPwy~9tvPb19>z^F#eV+sR?IvyJo;nZ~tj`>NuEBZd6kr2Zd-ISFedf z?&c$VpIFegEfrD1NTk^Rpz+yWk&9id;x0=eI0Og$d(%p-zc*UEU!At>#H_-JRFn$C za&8~)wB%k1SQIJdMf9(=)C@#iUlA=nW6K}yEiJfJpr0e z7(Q_#j}^(0^N@lscZ&V^N5z_Xm+jd)n2w7RM&^e^L+7)-g3kgZ+C8f~Am1)sNl!}WB*e3r{^MSl1*5YN#~8*K{J$4CtInG$b}qbh$KsAtKl|=_%0pyi zeo8QyFS(JYf+xd0Etu`a{kP)I=3*K>fP4f%>GfYduY>xK)aGpoqCOIq=h-1I<|FY6;^ zx;>svuVigKdQ8)6Ssvrj`E1`Xo*uS%7R7;Q`LA!Bvo7O$`WeD79-Ytj4dXHOLk=3y zPwG|n`svhY`AZ2YNwZiUvXuO&=_m7Qd;N5M`t0)8%I^J|<*|NrKHE2p$JCF8$I||d15bCmCpR%y9m{fwo;u$ihpCT|C4MZr;_Hzu>7{&zy3|ZSJsCvZsg}Ux!^16(l+P;`X%>-c>kIrZNhVf+i{B#Q}&D;Ai-JliB zDz54{aE+U>WMA(A`8@4`7$bvuSB-z@xab!|3PcrG+O_ujda<@m_4r-u6D1y*p2!#T z84thX*OxWptGIT=fvfyU-@40o-QJJovc7aa+sBW~n!u_M0H?3=nfCg6Zo#g7gYK(6 zo#iqvozM31cS_nY4yJMAfQM~3m~d}&*Myuk0L z7LK)_UUZ$k+*ZFL($4!6$w9Du4S-#F^drf{8%6{x)i698UVfgo7Z~yyGD{FiIHyx^j96rm}`E0Mt zH@60bHK5Ah8;AV%6F)8fY0l`;96rm}`E0Mr5C0oY|3x?0|NhxW{PoQ*PqnJI9zy5a z$(O0$I)7akhx}HfH?%m|tqXS-!ueh2+sP+IP%XlGP|Ka78}0RQ^%X--828X{Z{^DJ=@Fon))%k3%$xRRVrlQ<&RZqIsf_bZd=m}6lWkIrX%6;Ct}YP?j& zA^)`N7B64^z?S_SKFinnY_G_dt81~B#amKO4VLuLc8z(nY1-1!UwzDS7>CYhdj&@(c3=ASB%!9y)SK<~&@RdKqx;7* zzvu8-zRqWRMSfpjAW-Hn4RdmQrP$mcCmA?-TJ%vJ2cCJmyV$!JYg7*&S(3u zbgT)Tf=Q)fY^4<+lv#ix1c#hIQg5->$G#a;9^UtAlL;I?%h&mAugIr%8^+T`hNVSx zLI-O8SQUr-b50!FVdW`3=WzHeU+1&EA|Hi?xs4&c*q1*EJ4?lgl`ObI@W6WLcB{P} z-n(Ml+S<}FLs$;u(D`g16^9~UO_w!s$S)h-f6j)zcW>wLS-#F^dqw_GBmp-Hi9+Wv zbXTX~h<)>a0mt;9#!KdH_WF3H|Cz5Zy?@z3mdAK>KHDpJum)aiBPsS$+t!@uFsl&L*ui3gE+XBGl5jW1E&vvrTx6m5rwZGKR9_$3d>;}I-l)F zVr9Ro#@OWC$U=7++l+_yPx#N1XUg z?JF#w@#%cFcjeP2eD4G=hBl@-2Tn%mF~mK=Q_KaKnqJCpm!Y}fnZ5`jsgV)~&ky&z zdm=C8GWBy<#Ze*C?2@IcT{vULenqPE=I(&pctcQcZfoX_v|Chco z6=69i;m98rp3x_#`6Ci>1PAls++wob6FnRow8v&5_WzZ50^#xZ5L~nT^11f%|FOBv zzDFKAy@-WK90`WbXZ!l{`;`>AF)3xH1GOAUnP)Hmt%rAbf3EHME{D(Zbw1lSEZ;f8 zQ-}dDZNotb9$6n1z(d9bqOZ_*y+pd$R)#ye25ss_c6Sy2TD0?@?>l(`GPyevu9;76 zRAcTVa*ER+JaSWry5k`P$1Fc(zID6?Q%qtmUEPN<>z2;fHaq^se439VL+hIo@npVW zDi4c3M)eex8*SKuHiBivrIzxm67ucR<8|JmnLQrO8_yz0KB3V0Y#&WNcIgQmVh5_} zP)!#O>=LlU@#=%4f@>GvxsK(?m`gBpKHJ;kaE=TVXX7M~l0xA{EibC$z%#k)3p`g$A$cr?kz4xD}nq}fmlxtOxD}w_s4d0Z_~8h)`{eo4CB%H(iZ0g zsP&*(?pewm%I|%H1-$hm+`=;hP}9{a;3Ii1Q*JWejX>%=&B&E~<{f<4zft0f)YHs| zbBn>^nH-<5IEd2%E8XNf31INl873zM(=W0}!#kXr|cTpMI;F|NM8^<4b9?>xBp3E4*9B z*VN=ANQ;Su&nc>RtM1sd10RgL61Y^kgga!~(>*9Hm)Pfr&+~8FGicKGS@0&z+2&K{ zo7M)W^YG>pu`8DHK#`k@t|~a>cwGhgWLzNnik7~1tz1}faO{gI$&eAx?{py=hT~r*7*!BZd}>e`KCm52mx?9 zYdk3F<&s1$LJz=X%NG~d=^E{G`}brv*3p0 z^1c-LJETYTTL~)Wr}{f`tE_sY-#`nH)qA1J@9Fx<`rLybC7Yp=%w(iH=9}#BYnZ2W zsxN?b7TodeOGg!0%aMbSYgexi8N4pPZg!xCeu>{pDPr4x!hG~HYx)=A@V4H^=_dIuWtHT_rN&GB1)uaxQnkG{4cf@vIJ(K75` zykL(w`()WoKXz_)#im!m7DoC=FmyiK*TXm1GYyI=5O>~*CG_Ge*dM1RQTH6vMV9jc zYY`CP`@8Eku@q6P)1)<;$AD-8i`Hh+y37usQ$bxp^gF4OK)-!3XcUMhU9SMm1kswy zhe0oaJ_RM>ho^$FK{So|JctU_L5ScgP$Duw0CWI!BN9;V1IXU@dQi|lWVm-RRJ7iTp;?2c1~6G%$~oTe%sKUPYW^iRD@C{XDTk2Dw#s3P9enyGjKdkN#PLpG+!CzO|`sAdBB=3 zkc7lIN864VpWFGy8JizYFi!8?ugigEL#jzGncWFeKJx`rc}V$ETwkPv476{HVDA9Y z@22)-D&+D#f0M_2)2lV?)PBG^4Hrp9a<`1v)vf)-b=tda|6!^{q$m0{%!hM}p#xSX zn$4l0bF{al028=$W|w);0Lm_O0nAzpKGpP+_MlZy(eh8#)}!`s**d5<3zfLA-dy9e zeRMo#sV2b)r>b7IX*l%wA`j>PTyx%#(ta;8POq5z&FCZhb~sy|EZ&1*b{(i0idPZFNY7fj{R03J`N7(=2IP9>d$BkDBx<@{Yy zEw%3gkG`Vq7y9X4_ZN>JyMVT13PW!?H;DNrJN%OQ%Upioq`g8oz=&=t^p@hR2k({0 z>wSI2;<%S7nEnp1#}GakSIP=&yivL10i_HwjM7Wa`?cjq2}bLqzn!xA;^)&SKFJU+ zD*u=-n94)qvWN~}KTFQkcv=Mclpa_w(eigq^6pi4{4qi*5N;QUmgjc{ zVEn^FwNtvU9Oq1-1whj&150?hz6DQ9bJU;l==DMBLkY(GN2Y%8*1M~hjLwwu2oLFl z`H~xXTJd0g#6%oqOyl#;oPfvU9Es^2I-CPH&r+&E-Hu;M@x$#>YBx5AVs=CE$K%}| z_HTkmZHaE6qd+MjiXT!E>5$$s{m5_npACJh|1&?@J6?Cu{QkG{DB9Kdq2KxPfdr!i zMZ_VPMR3dcuo~%(bnODsTQ5JmjY&5CJZr+TguCuo@fSrb%yEclN_Whc+{knIBQ=>YKu=oIMcCsfk!p*=kANYv%P50%wx7q@*Bj$vFN`ik~DJw0vjDwOC?Ey>0My;v2N4W86_>T9UIs1jD&*t)& z+&6|V=93%Mu)Z^V`8Wi+q%<3Yp4dZ&l2GbjjKgBGFa%GG!|@n}8o?1wA3ImiD{Z^w zo_gyhb-oA)55~cAWxO*gYdfnt4*Bg1FMl*p(Yh6fFA?LMEsf9i(d7>>!Ei7R+{5A6 zRQbWE@zHISy&j(Wsbk~c=UkO7eMi!T&S(4RIM9B`r_BPsa6PT!SQiJ5b+26e@TS?f z9bh@E51r5U4dC!$_gHypnY);CWC$KOUG!dUuaBHt#y&Xg$?w{+9LAyZ**-dsbf0h1 zWOo2PM^*m1IOK1B^P9XL$A9@KhtKkLKHE1Szsy@)DrT6}cu0HP{`Y_CeP_sDwU>_L z@L9gjXZz^#&2r-6GOz4CTlG*A2aanWZL&TqI3vVz7>CYh`{+2#!4x>6fH)nbt+Cg` zZ9U$4sOa%|JZ&E?FLi!w`P|G8TJq&)$R`9Y5WSN@R4=IWLw%MT7d$`dt#i!kQn;h` zJ@et*V)*x8>IwMFGLnlbr&4KJaAZAUuZO9XpPt<2vhU}xFzF+~(D`i7I9RwWClyqt zL$w`U8wZZdMrU+5VaU)YSq|gS`D`B@2kp2nHWQ~6lbTP8*4pc3$^IJG)?KGu%JLYG z&S(4RcuXk$G3+!=x>Rx0#et*al}Ww#J-oKw`d*zM8%KW+x}ms8n@de=e(^tP-_N;j z!p^L-KP;Kda#$ZapY2&6=y3*0oul0)rLG`OWgqIMOB90WN5CQH*OpIN<3sP)P?-Li zPcGTu7_f=H$*_E#FKr|BxpJH@Mt&)^I%VHVu6Mz7YeAWufAWN}Q5cr?Zyfk;S@yfb zb@9&^wlM(^K02q7`6fI3V*S|R%f>hYhOqmVnfv$EaWUg*tKO&`M7=b}I`jjt*hfRW zhWE4Qn>~H%Nds9h>rLmgJ>$aibfFK@7}?c=D83qM_i`CW?LIVTMH`sR_`lH zT(ahipHI5_Gq8o}Y(90qX>AP8?i-lqFLjDsfK-=H{~<;47<7)0E-kRO?^-^C9|z+C z(U+bt9M2{gZ{#nyB{*Q|`sw5l<}?uXyO=MS%7f$ACf!-a9jbtXf#AWJ?>If9emh++RKRva&$+vgkgkoD5a-RZU%s1KLmpRfbr`garrPbfG`4qdZ zvi(@AXpXF6G#po*p^{t&pIn|)Z?MO6_O6e<3!Ggwmjx0YigBIK_I7wAP|U&60EfBy zMGSP&5&M^TO6B_C02rtH+Ruda{UY8`}$Riu?IsK9KJ8<-tFr-ha zADC~l!>&q33P6^In>l zCd0UxFS(It!?>_sL>zF0F>6cgyD+<2Si(2hRUjzFSM-96Jx+ho<~!QGHY4ZNzGNef z7}iINPUo}zF!vO1p{Td8lA5NRM|*K@dnqMB+9OdKD9ab4Cn}D*IB>kwZ|@K7+H~5& za!604EuGKy^>EOHM?DnQc1GKm?Des9Qtwax%76M#meWambTV{4+t-(-hhR{8wP!^fgq$A9qq$Tal(S8Yi! zJ{@sS<0l5ppU=OaZB5VZ}dZX%HqAwJ?T4Y_TIA4iafogCJ{f0PEQkeI0)Hou9+@Rt-ce�|KclaYBLp&nn_(tZ|Ne_k-kjZL)J_fw3%X!tTi zxdX5M_^#tED-IeP$C5;&4)}`4yf-FqTY_=D=*OGN_d^}er~Va>*U-2=uK}TUGxfV@jGx9v zX&nyz9zYfAS!(dD)+dATKN;%39g1-risOHy+iHXrZr3B;s19_2C|c;7%3gJTVCv`3 z4_e^-gj68R81t#~O>09rnaJ6%+>b?fG;-lC#sTZJ0dEx6Nc#G^{WOb*ZHwYS5Kloy znJ34GF_~K!s|7Y#K+}GMM4#uhT+1>`HtE|8q7tU1(koDaW+s>vXx8+ydHV}Z!SqhR zY%23jcK8*(yfx^gMP{^viUu^oi!LkRlJjX5?pA~OaB4A8nrtj^YPFh2~y{7`UUqJnm z|G_7xzPaWnvm;3_(hKuN0Lp^~{ssnpSeuB+bn{dd8W{A@xh~~iPtaVzKx+v&9p~<} z>P4TQpy0n<+oyEw&lBm20AUC@?FV7L$qv5;miWuCYSrhZYGPqjb%ZLfjeP_`aFq*o^U5DvRItbzakX+UiUY(sfV`NajIH_b^>TR`1+*!#YY z3!j`{N?mDTXl)y?8*^3g%k^Q(r}ntUx%Thg zdPnCuB$Eu|()rT1AzV-mPI^Nd0SzV36=m39(hxp%eMMCq_#P}uzjIXMzaD4#j8EsY zeS>JJj5C|qcY|{&8YFU7x6{L1){HL>GzapHx>SR#QAH;9T}<5K8DVhwuTWc z{bqOz#PV}$hN3wtoT@ndU&O{y+xuwazNxFn^=Ns{6I5oBp{-xkA7Q@aMxN1dkbIQT zg%}G7;&`PJ+(%$ZzXxq_q%BM`Rxf`1zLBn)g|kgj=i^N{m>)qPztr?=RRhjy^_GZ? zMJ}sATplmlZOuo~`bDl@_bl1zX*VdJJi~MVCE>|@!BietcZXgy9X1i^)?-vN%r?8% zBRpk6k829E{G11Z;r~gP=u(k_!d=(pqBI1btqgCm?=EakA{8+)7yC7T}X@>$o{7zg9j z`D`C41DqC|ICe)2orzU!F<`3exmE!mAq?vg-!%7E(H?8KlaF##4NW%cvft`Bc#C&7 zA6$01Y;l^!0zv0f!X%Q$D+x3Tf`9+qsh zy05y@_0{y_bUe(rfWbd;;mO95Rtd;bpKk^piVxNgeN&s1=LdHVIU!RWIg28QLc@oOUH&pG5(&l z3+s62t$sWAtR!Q2o43QO_jf{k!T)&YV8yhepRs zc@DfNeKKEiBhQF1F^{I}LrJ01k2>Daa(`?*y?Z4Y_l}!&apAU8U(@k0KY~Pl#f?YP zl&YsH8(cfEi@o`*jjQHA+v>>Q(xhA}Pe@P9m)ywH4i^=1X5T<~s=|}gaoT~{dMZCR z$$0L-%G)l8rm-`fgg@=cgguW_Q3nr5EOtf7K{* zv(cZF#Y==KnlEa{R?SyMKgPyGaw;c0cV*A7wublnuNA`A*5fm#2KqU2Z+Qe)rn{t| z*aLJt{-DNBEpWwZCy=bc??3sh(W;>N08=o%6N~|2zR3>1Mhf{i+;BL?r7tL?lyznPi9_0%LRlaS$>n!@0D#{bE5K#TBbT_v5(&=zzYh^q5;AX-;M zZBJ^4cK~$+bplZbursI&=nN2@QE(QhCy34}I1fZ+Wg4h2i1OuN&~Olqb<;w%%Rp|> zM9?JA6`-l0t3k6sb3k)Ji$V8-9s<#T=X%g4&^FMApxvPTpua#zBI=F@bq1Xa8VI@+ zR1BH{ng^-|(H40uV=~YLH&PIJRL`V=#(}N@-2>VP+5nE<*Cv;njabSetx zv7m*ZcR{T&;C2aU8R#2O9}G0#3fc`yZ(!B`uFNV^Y_mY9qCd=O~?w_(hlh~F>?{TW2sR7BcZMB0E^sKe)AjW8nZ zL`2%@_rf0{?N&ru9U^V(CSZ9BeVC7+qdkW4>;Z~zoPpmw!8q71!FcoZ1Y^>93C7Mr z*hhC+f{{~#^R%x;nY#dX4<#7wUPv(JVvS5+v`a5KBGI_x)I?)U-$Y}XJJFbaEg}l} zl*%+D14}=v_wUwnjo0L==dw+|w(Z$x&1!Sh@#Gl>q2XK(3Rm(4Q+c3%bNl_cagDdN z($WrbM6c4=fcpv%w>N4u90joRfcU&le4_oZ_&o0!E5hqr2nW@I%qKUhK^t%)R#Q98 z^>b99PVqQV+L#vXHiQqxk%q(dknF?dDw47o8&ucH-Fn4}k(1V6NZDB!!a-Wm`GSoH zF!4c{J!IoFX@{MvX^-3e8I*e zT6<%7$taYra=cs&-H5pb>0=dMtdG#2_U()V-aaQ@wJH5>w<(a`2`IgoZ?eO$NW#ES zKKh;5+>C0+9mp?|7kYx5?<*-mH3SPRtu^nV_4|i-CwYpe4J^Too~JMXMN%rU_RCuS zMOusKk6a)dhu0bIK!G*zhYv=zyzbfO?k9&Zo#2J)MdnLxnLR5~d1I!oz&YjXdMUgLWg; znwET)Dspc`KRTZ3{G*K>?T>T4`_8g1Qj;=$5gz78kjO8)^u_a5AvouBm6<4WjSD=I zqsLP_mk&7e$3kQScgNUUYHMW79-E+9Z4w%V<}k3CXeXmY*ugG*p-0L4CQ?) z>X45SQW~fNU{IBaI{yZ|QPqgOo~V*c&B^~!g^B;^S5W&1RfzEiXb|W)6dEt$JsOT~ zU?t*zGTOhAY4T&)u|swvwPzR?v&DbGJA~iB>0>j}2mMADh<-DDQ(4U8p!hTnoN(!z z3zjv0hrY>3-6YiGOIx(950RF(#s}bTv&80*j~-Ixk*yPEMLzj&IFRkDg!1!^v|d4NGj>$BmmNKz16!2ggfZvVFXK+3NGLm!7sZll@CP zNruj6`+7LC%lv+vT^7vD7(s4AAeLVX`SiOuUK-;YO-DmLPwL8B7q5F^(Y2SD(IVVa zt&_+&;8tx1~WneKMcisK!i&&K&3g z*N)QuC1I`p{wnIAz_>v4`{-Wlu};=_ReRDy^)mE2QbiPGiY>3`ChMby@A38H$R`kB4x#lt>{PIk3QM+=p&&cIvSPZq*HMB)Wr$L9oHuq zkD|ZQtVyDA+~`DO=9)yK>q%&r-I-(*oR(}{z9rdsuA-5Vk>A(|jc;PyKQqNx^>$O^ z_EAR|{r}P2Xx6TUah>mIt-y6Pn9RJc19Pv(<<)oAHOUc6zJspO8@2P}VG z9P%g4-B{Z0%<p@M1ygyje3})e#7Rp!sj!d>@36~HyCsdiR^o$kWj3?d zOUlK$e{>7{`gXb*0OMjlhs*DJxO5cPDCWSpK^?>ypdap3uJP0{5~lpndXyMl-A z&t*R2;5Xwj^R>7^$<&wFa!Xrp$*roFJoKf>sOd#7U)=k)oK^neqSI(Bg$%t;#*_Ji zsXQ15IurEEmGT8Q3k{s?$MnA0a+jW}@#1(&Ins(JTDzo0QpRcTKmOdC zH|Y9fz6d~hMAskV8j5qP6l_>(U0muGzExb?;=q;q#wB%a&RVsns}ir&-ekT4Nqk1f z)vpALn9Drq912vlYK_iC#|zuNMO<3a|4~+bMXO(@4fu5Wn2TDCT&3VT1-O{6Q5Cc7t3EA4b$zvn||D0uz>Jj^FIs>#NZ zWgL`0n(m;(NCZY5Fb0i;Ug*WfBRct5a&X?Lxb7v4P-F}-FfFq{6$0gaS`C~eo^fKx zQH&F3Vjwng>eL_bud(mA&AXnsaymu>rIBzG>halL?$^q|B9>CzsS?0^aCwfeEWb!J z&Vpv6*;9}{P41Y&oprLq!~R3~V0@{#>q^B(Wf~QJ>Udk9#l>HFRyG-p>RlLmCm8(< z=9}#Bi^sVlb4b>~wh&yh{JqCmLaw9z?y3r^5D>{%_lxXc ziMEzs|FXpXPx%5v0XdUp>-qfMlHVn#)`u*%jKHU86jUBtmz-fYq zrgJl`yx;p$OTFV^#x^ssLkIWGys$d8VI5}uEC%oAXFp9Fwk&N z7KrAfMu4(GIiQiCQJ~SFTo8?4UJ4om!f>H67Bmht9+U@igC>CTK?NWWXd(#7Q?C2M z`*IM9H=`Id8B_xDf&8E=KmicNZz-q@GzCQCrIgO7ioOyw9ds4wYS1+x8Ym2bt_95m zT?d*4x*l``=tdCL4>aa_6KD?TX3#C5TS2#hDnYk{=7Q#d=7Sc1?f@+WEdt#Mq7L6( zpe3NCpu0i$fT}>tK=*>~1KkgL0Q4YeIj9=60`w5*VbCL>m7qsKkAYT!R)Zb~tpPm& zS_^s-^b}|v=xNY1pl3nrLC=An2WJ;0F=!X)6HqPaQ_yFie}X;-eF54H z+5_4P`V#aN=xfk7pl?CnfxZXTf%bv+gARax0R0I13G_4QAm|s+ub|&Rzk~h&{R#RD zL}d+%kr{1Mto0dL{kNH8|BwBk=D^$S5HKSO|0_&W^H&`8U-4`H^L|9qe;%a6hz@Ju zum=7EHBbdi+%Ky*Em0tJ;fZELz45P#VMiNpOqtyF_28?G1~e8<#a01-~d-nKMsM~myFMWaUC*@Prv7^yzkLQ=eeI< zmio(rZan@)bqwKSz6d~h*y3vdSp~ufLWxU#&1oCH*a6ocdxMj*F;Ox&-E>=yH{sxM3MGhopHik| zOT_h@#LZBDf3@=aNrpZyNrB!!cIJaW{r=DL3r!I8qWN3qlN;6Wjl$TxVJd+}19N<| z9w0mk)ZID{ns&O@&xV525NIVD#g8=ZeguWTe(19F!c9l?KK2@!fC&frVm`T1%@EHN zPjN=N6Vv>3e&S>-6T)b%xS!9w7%zwknIfz>qv6w1Uxpbms(v;D7a13b05`WaxDQp3E0a<&otM2B-Q01-!Y0|0iwXL}bi!%hA&+_~CR~)WxcwWY{$V z@p`7zTM~_DUb$_}2dBMLz->)>Q~qH-{p0G&7?Ys1 zWnJ9-XgNo?W!KpF@_=vFr$cTzc>J16bbQRWfWtqr@zJ%>154t7X_;@Y22L^@pZa{Q ze{iz#`gP5I{=9m^?D^Elhap{)9+@wg%0tH)Rb}!hS}z7yDT0M>wR}uFBewohD-(?s zuTN=x*1S*G>H1^70!e)8xcGmO&Q!$}V}(Z~T8%3B=5$wUgDVfXTF>0{<%;30D|B4U zKQvtR<5hzv#uXS}r89PXlI*=*i!a-L>V-?y{P_>$Pv+aV36cj=;AU9Eq+?3Sn**x4O}* zC1c;}OhYijFdm)H_9mVY9tfqYYz2(qz>OIw6xmcLjaHqBjJid7$h0#UW%U}t=W*A}Vi ztl}(t9J{}JVbAoR_M@dE4dc-HY#+wq@|xoNm6T%bhq<~5S2F~Iv`!j0(Ezg6?~d;F zcxL@PV8kQ6o}a<;7>~|p`?&GY%ph(tbYmkgmAtB+R>gtqo0Y5Yc5FUC!=l14E}hTz z@#13lYCVwI!(LA}9`*F{^=G_6LzKcW9-Ytjc6c%Z*oPJf4#6^&610fS*puVGobUF= zfvaRni``8&+})PtGA^CZ_J@c|i$!ZZmiM&R+mxo`$KJa9pqj3#;=nWJ)Y7ANY=8SvmdAK>KHJBO zM~^tQyiDz7uctxxU%zSCgyt()F5}YqY#%2sOS`Zp4jjLoa9`>-O}lhuIgCT+v%MXT zVWJ7)E*>a~@o=i*0e>%s%#`>jpLdauefV zoI0QF|ArogR~1*$dG`8yJT!IkxTR~Svs}id^V!}G*9cDm9d}wUW~&eY$7>30YJqWq zNM5vd-}>5@UU+r?8!O2j8OEjarLEHLYoNVl#Z^B>)ppLJIPjfYa!u>k5=zWoZv>yt z|6BOrNsY&D=iBRR*3zYY2W>pPh~=@qbUxeL#bf_sZ(&g>mV}`>DA!8Mnz9N3a6E2{ z1J}TF5-ZQY|BW|TF5}YqY=7vutZ}L8t>^-Kz3ravUwP8Hwe|WxI{$CuGd-&Hc%6nz zAKxV}Uwpshsgqh?u$bkt-gG|OhxH}~ENG05j!zJa(wsv)h3@=m(xsZtLl;{06Aj1t z^EX0Mmg8@lbhf6>E7vmC~u z^VvQQ9JHsx(tcSL2aX$749mG`Nvkd_hjHk9wvPh`9kHt=TiU0 z#~yd)Z7h%R=zO-1g(t^{i}_54YB{ql4je7&I{opyt0^s;5r%Q-e73j6L7ODp#jXNT z-J01wXzf?!rCaq=fWR@8U|9!Sy2(h{Uo-d?mdm(wKHJB_CC2-TvF(PAZ=K?ycr!xq z$n{07h9_FR|8!=Drf1F?lf&{DkIrX%4G*?W7I;f(q{m#3tEQKtzE*uili%d>Js+gr zklcjBXZbpx?PJT2G;P)NVwk7kxDW`19}P$9;8$t}zObiWKSk#s3Jy#~mKF{3=1(f2 zn31LmFOHw8IB@N}u<5o}?sE(@y@%UnI-l+1(T~72ummHSUeUXgjYk=R8h@$%?Bnmc zODy6-snj+C!Ox?D6<7zv$r7NhiF+@)(cKXZ!FeBA9{_ zfTCg1)+f|zIE)+TC6R7Y#$g@z$47`Uke^4rP&$3h?@P~;0EAv>KQ!}MKEJcCC>GH) z0he7m&Dd~)iEAL~+DDp1G?yn(B#JC9ysGi#A8egZr1gWzAU+>%$I2$go7cZ|d!yBT zvQ9JwQ--JcZ04Kn@GBGhjD3M=Slom2ENA`EIDg7`Q%#tOm3WxX;qp5w9#p8=m<$VAZd1agy#Q92jyYsR zP89@DdC2Q)NFK}Nun)ig-)SHO(Oh4p4zn)@S0C7OeDj$zY5R>ZGCmUw=9}#BD+9x_ z#aMF`$z%hA=Dj>(qmP=8)LsBbpY0pKxTjozM1mxYDuq2)WwQZ!gNS*Uz~x@4KONLnUpo z5QcH+e728?!#sqlymY9$m<}m}CpErmFSeG$)F85%%fez1E3s_BZ+RMX6P; z0}>3K&-StOPWc47#~|p`&f8LFC(W0g;O(My&aBhY{{pq`qX;HG15MreDuQYr#!bPG=}9c z4xP{Tv2aAv38S(06RUuSj0;3^qSZ5Ft1i4KWzaqK)&=N%3WrQAJY=uNOX?_leJsrK zU1j`!9c`HthV`NI**=zhsSoK=Ex&6t94+C52A=sIsMOmNjb`p{nSXtBUa*}hh}zlI zj%L2e4!^L{cmPfX_G2A1=7tOSU+SKv2fPJ1(`Tr+P+nPOIj2C?Pv&TA{OJ9Tic1m= z-&5(n!mpqF@JLfK`5;`(4+AnksNaDuDUNf*aTWOT_@j3g@Nee=+R{< zXDZxQJ?Zg9(%LQk;OnDYV;`6KN#=hVS73ewk^JJgvFIeyxCSb;(wqV)4$i{;12cldo+1OIIrs6yh`^Nao)_57j#ue(3||G!TIhs(2npDquF^xv-m zwf)#~g8g}0uU-A-pMPb0e|_1ws_n(X*~(9b7@CjiMExz_oDjfXh9jjq4+Vqye0prKVIPta5?`l9VF zex0`dHQ(BwA}s2B0Lhqj{^CErt9xUc#1U!tF`wM1W`M_6j2#_fXOje?aI(dDc-Rok z2lQf}@MLc=2<+6yC_@vz3W1S+X@5+b#~$BFm)u?1JN>9!9Ut>mZ1k<5amK)>1LJEz z47x8tkAGc8L;p9FM&fnPzp)|r|1bC<2<7;yL3~mAam4_VRGQgg!MrlJx#dW>C+Eo~ zU-wGq1*RiKO`-v2Y$2lak;PHm^7uBx0S_df@@p;RbNCbv>B|9Pdt+k6o)+}!_727V z*(mmDiv4=iUhUuQfIWrjGVQ1fN99u1KX9(l#;qse)A(W9>23CWTq5=;)Boh2o;qK! z@v!{<{vL6WKn`x7l!E|4C+%y;N^*423%X-;82kqu75I#lBXtC*it$V^ReFnNjQ=ialLGqx(-&?CCsC-9AsTFN$Ix zQtX3K?5h-eI@DATzecgYDT;lqVt;ECd!sn=`|pZk?@;WQM6pj(?C*|ZpQqU0AH_bT z*wg(c_%j?JPCr$OJ)K9d+t(=eG!UoT*DCf;M6ov}M}GgaQS2Rx{fklT(-iwxqS)st z_FJOZhZOs*QS7S}dunjv&rtPKqu9S2#lBXtr#nD(|3*pV_is1t)%JNM?8%P{L~m-# zP#wk!&G?%n(g=$j0=qo>XnY&@u(k=62WpI_EM&hQsb1VB9*uENm_w$ziU zJ}aISgx3_5)hoex?TG8>ctYdaeP`}$wd1$X$&L)Y6YyldU@DK{lS{lf>)4440mQK) zSY9QT!KF`=_ZQMKFtpCy;=W1cHZ8TC)7BpwR}FCI-q&j2&j*s86n%i(~+rG7}I_Is()?Lh%3^YzPrxxjtQ#QpCd zMSK{NeH5O|7fj`${oe4BHdW85S6KBNP44F{ZmRjTWb76Wn$x4sXZvV!oo2hTAR9}# zBcg%dZ?`Z z#k_#MzIxw2`<-C-EyuH5#-;PwJ}R!TzQo0!G4ZMGsl9RF>otF9PT~tc+{@z`gs(Bu z5%U=rzoX(4Ye;cbERN-2cPb8l&|XioCZ`_w=Ftg{aJfP_QhhvEUfBu*}>MjezxO6_-9}+IQti|-G;>w$1udgf5df?V?XAG~mUrgu6 z#Fbq(A&5gw%BYL0m7NSt#dR6Ut`m%#ojR3fQtD0)B zuO3(Zuw;9|vo$Q2ap`=vkBW;Ey;w0w8XAtXM6kL6=N~mx@u)a6%k6Q_PaSsI*Eg5G z!Z;YG&S(3mIFi3@_19Ex3U;`R_~vr*fCOdbSMy#6a&by;FzuLdFFm{p#llR$YVjzll9BzvcV1^IWD+=rFDZd^fE%x_vWp5-nJ;uy`5C4TXN?IF^eiYIh+Y&^MFHa6y@4nFwjU2BV+ z8Xo3bz~CPX9u!cKi-w{jQt`CJ?5d%B4t^5YwjH4l$G^1_7lGc`QSSD=Vb3!Z5D(GXQ3p+xK7>fzG= zl%|+ed*YFaW=Fq}?S-Smk3-Tx6_j^4ehx`x|ErEekjCxYyqWg%@6X@!!qGofy|sq( zgv>Ju2J?0B$ij3Ouydpz2WEPBV_swfu%-PE`D9!m3Rhoenet#`W9B*SlLuxMcil^a zk1$O@RQ@wxFqMaS59tUTzl#pPEN?S?K`hnvW8;a*F!z);RL)ggXKlws8~0p$*RS5M zFZtpRvzQb3lkjA|0!e&AG9ADo*A6>z_ZF5X&?*F+%!0#}aYMX33x%4lxaGxhq{hs>rHw49`|;91Z-hgKRTc7t@yO~sfWfoKbUrdeSCdz z=WSoibabUIfiR3m=d-;Pj~ZWAFstB!Q8*lEZ#~brmKEJIv zV#k|AMho?Ee0+Yf8;!mImI2ZHf}cm=st_>at-R4b9*5nK-+IM)@7%+9SZ_L??X7s# zc#H>~b)7(Jg?+p}cVnxHKHoeOp08zmIzKwTaJ<@rt3m**x6Qz17tjA(nOK?uY^M^|3_u-!$eL{*uP4-1J)gLB1#iC)zlUliogW>a8n0F~ zDvlk%L5A}~v~u*PiKS26xMk>PEQjMy=d-<4PvQ8pf`H>H5XV>fO;#KQu%q#kgCM>S zv!H3&myhRkrtZHmj6>(MJ*^@11oAyj)Mxn~aVaKZ1sfa?HTa;xEgFK$4|x5w7Ea9X zgzqyzAk`qo=a^$3Ur%&8@s3%iEpAU`3K@DQ;K_W!R33bOyG+;tao#db_|d)$k9wYa z^z-`phyly_>D%JKd3w=n_YHEq{-lnR`3gkw85?K)^WAOWTJ&0evo+rJ{&w2vWaE<4 zJIsEj)f+S4F@X_oYHucvr-4YvTZEmvBt5vY}*m_*UmT2px>N&YwB?wZ*|QiJ2Lc6z?1ocsXV9#7u)gl zbAS2;0=|HAgvVVl!jq2*BPcy_KbG@9ab+DDc`Lz(?NlCrvp@d-UwJbwDkpO1+OHE_ zxH9j)jw}4b7z4i-nS31!76XbCY;fvMUr(UaJCWAf%Y%||uBf~-h{hA;`gL5TKEfkb z4>}MKm3y=NuDm24H?Ljwt%!^Jy~D;Z`kA z%kQw)$A&p~T>bIa4-Tw{!{i?Vj%-gM^~veZpRigi>89mEdpxtxJigbZqyCw$<6-`x z;K7wT;XCL0`bs8x3nRGHbh9W9T#LqS`ElL0h4u8r{DyE@(+$ohERA3wKPnE#B5S)q zA2%iUFC?^hE&ufu4*Dk3$b9O2!NvpY?(x&9NDL02fX*5gBB0WvK~%b?kg7j9q!5Bz z?x$4&2epS>poYvd=hwZL->#tNRpTFej*bUUNRcj|HTk-~k%Nai&2kXy(S3fur@%>T zF;R(Rx`RcA10J{@seybBe`fXFmfdxzxIHZ0U^CdU(w9KQ84q*LA4ys;vf!Sgk$@PWPik^>NJ?AG~PZrzc-q3oBtL4Ej|%U$F78oG*eH?d$VR@_ND} z0laL(NQGO%$?YpjXGFSD%dxb(ta^=>FFGCD<&S$ijc&u?j1?ba4V};S!`xH6SZj$P z3ulHezl;hlS1{)_b-+XVVEsi)e|d!+2jwPS+I)g3 zklqQ#1cUh|JN%;bC$|j-Ie!Q{2c8_SJ0O?y#qF=JzJS($sCp_|V%1Z$aj0MOj=Lc1 z)@8qn!10(bPT`v0Oy{#b4XR?};sjjoRyvIuSmHuA9OLP9<>mxD9<0=Xo_y0df>k^R zfrk*Wp6FXoXSMy;Uvk?+7k$luEj;b`ji2PK6NPkprELv)h=b3Lt%^N=GblMgtjKh5Dd})jIHiv*m9LwxO zGiG7{2Q$l@tG27U-EED(XzBdf-*R?_E*WE%9&!y3J#{|gi&p+;;P_>%q$u>zVV1bR zGTW1nBO*(uQQO{QdQ{VU#XVMBo8gAyyBc^)FaGX@Z5JjP8=F5+{@Ixqy~Yy{4%kz< z#(ey1F*x`K=V!W6IiVSaWQEPL1-_~O^XIg+1_~-9jsww}{S!g$K_`Pcfv9}y0&;@r zH`4kmT60CeD+5GpsA#>^NYG`Vd=M=@rb7X*2Hgmn3%VQhFz9Iz=?kiuftL{iae7Rt zimg|FT9Wb5lQTNqbIhJfU9ZfiFjZsGtK3Jxsuj-Ecn#UeZ<(HCFEcZt-un-VLo-fv=wsAbERlV zT6}WS5)dljkmXmzA%A1=+qa&p{qQpm-yuF6hR$bu{BA{lmKW=k=x{3w267t$F^-gb z?e&m5=HpY2eR2C}@=L~HK6Soe<6+VNz!HH;i3Ur3u_zAtdpixA(|u}qI5sR_=PU9R zJ@hRLmii{+D9wWUF(Q4a@#478ULS4d@0jfqoiAX&3}SbV}~E#6H3@H1Lq3PbuKJj@qN<)Ppat2lCeQXT9>O(&TTSoNXHuj`*= zoci^m=!?9@4SxLt{-BHKEe3sAeh%8!C z62QHyQV&ivdOU?VIj@B7{Gm1(CgglnYfGQ1eu^H9t)Fg#l8jzcGOnE2re;$6_R_xt zFNz=LOK#-ZATCQPvFgWI9vjED!N4*4gvTk38eS5iJI*6kK^L zV(TYsM3OOX)s7xduNro|j*IybMDi;xTrpx$EwAfr@YQ7}8E1uzcjpawbm=o~rF?3K zQv5OhZ{bt&Vif}5c&vOVw!SJyCK->czVM;>t`pzT@i6~i!&5&-S1I_?9*&K#+vp@? z!MFh}HZJqOqT^%!zlbkJ%*v3}{JGf%@3vf&Yc0N?-*(EX+Lszh|6KnuKL%bgD97dg zNOWh5Wfee8WJ~_cdnC5r{Ff#f@4EJV-~NRwM(a43|95cIk4Zsb}lBnE$tM#fU{U{wjbk0RnhjA{pNlP3r#lbH91`f~hOs4Z|2CzQ!0jpB*UW zM?ZIqg5fZjZ?eNL3oaV45f^EMhol?CMd4C8M)Qk1fQ!e!rfz?}J>@CY{-9$2M?tLZ%A?fe#@l`KZQ48t~8%I-?TQ+w=z%m3Of6h`*H3L4JEpZaYPw@ zB<4xYsZUd`6F&K2ulO_)=TZ}&5g6?Z0}fk>)3}Aq<4exP`%20lO2A=#ADvNM~+n-n{9BU z%x!Lb)#vt)zOMM<0UZbP!vM^Wm^j3(h{H>Y(biYn8M%+g)&~W>zvjo2ldE5$ZGXaW z{OEkPkBP%_7oqf_;@KMqo~s&K?wAh}`e^IkBcqdSZBe zrh}MdIjpv69p8uZv=AUR!E*Wm;F<){cPnMruK(2 z#5lN`FC0(B{+)~5$;QagMW^<^-09|m%mJK~4w)bMh4QQ6-duxR>C;Ur_PtQ*k>J?Zw%`l6ILT~hGh6AW1vk( zrPepS*V*Ign|W~bEhqeO56h!;K&e6Jv%MW2R*Z_H1~^C`tQTru(fT{fxsMa_&Rje< zMAII^FpeKIKHEpbf#C>R@lQtNa9=)l!zqco+739;1n0n;a5LXz zhhKja_b42W;p^-6mzD)QxPdSVa8p7J-i*KE+1PsD3;ZLWo;vNa)UMy@_?aIDZhrht z{I0SBZ(R7*a;EKiEBU+rzzb3fyBh!2OM^V!~9?1R&P=&%+niNv`?blD2# z=y3-i9Wd(&P{RP-5#dGc_pJgRGMvBld4_H!$;MmR)!$@$+pVh>4F$uXelev7=8FK7 zhh<%eSXW#x=XP zNazC3X?QYUfg(QR#KRfg(jUov-l`ux-g1M<#;o(k!O8!yOdpLfWZ?eNL1y2s{yDKe4eM#5W_KI7Hc(PG8KI+{iN;E?LLt_-MVESlgf=QuUPja%?@-g_4c4 zPH%OS>(~uF45XM!&z@$N!Ks|4Oq84&!2e z1d;rThAXU}9G|RT6+NkVGB?H66G?ck_4wWQIPQFj<&vIATRNZZqv07?Sc1g{h_gTd zvj)YOOo-$^HQs7%@N_FkGUnx6`_Qv*-BhWUQ_N=^{Emi4lvDl6^NZ2QMkCfU5$Hym zw-__BY6QULLd7ew^|Z~CWV~|iIT!t-+XC0c4k?*lR4y=IawE?}#ARs{sQOdmv+d^C zI4fr+8=vO?{&jBIhA&?=p>VoqegvWXiiXpS&w)6cq+X0x!5iysoeiFDvy%Tm_U-~K zimre7_#led*sa)&*c~V;Hg*RB3Q9?+nAqLj*xlXO-QC^Yt?&2D?t$46S-kK2x$fux zKFoD}c6QI~%>3renU148^naY9;?y%uMi@tIOIzfdOgAQnx1t%(Z}UrA-kcAc?$?QZ z+4ks`pY!w0R_t=VW2KZ>cRkmqT$eh{*R8i?dU#;QFVT#T!$RsU4djfGvA&V{&*ansJ%tnFTat)yeIe%=9nXU&SyKjF)sw|`4k82oy-?!Y)(x=Nf z4DUm56F0*K7%G-=cdM@6cW&4z*XF|%#xIW5#QgbPV-@1mzt@V%AJ!WGU>HB=xs2)h z{;0dAl6YAkW3TQLz<#EeIM>gfp5|P;=*Jc!AH?Ot;?Woy})>gDA zX&jNrFR{GKbYpUOOS8O(FVlAF;q9;UYw-!w^x|9<2Qhw`t|n?em@~#_JWQ@)%Zo{dlSTZ$Ekr*2C$0|=o=H9C_9xBH?;33^ zCpBwPzJZ(+IluMkvU{Y7gQ3-J?koBa#JKW%Bra_LMQ^1g!-yP6jl-9n7r#eD^* z=x)Jpxqj2nk541xD%o8hSY}+ftE%y|nRhT<-o%+DKyi8>> ze&^QnFBNwfC8edSfmI2I9aGNP90CL`xZ9rr->LGZ@h(a_$L%ZlP?L%kVEy*eJO^K7JX0y&(4>ajj52W)5iL;qGGy z#Mpy&J>hZMe16nF@nmlHGuJQc^FyY~IAmL1)78IcCP2NLoMNM9km+&OCtV!+^@JF< zBNi#}a;*T>Ps-KCT9jH)=V%6sQr0s_PfaEwc=HeW){nC44l@qEj_ zv39;i>x_2=N6aUEy7_oSWD&t=_j_&5nvbJcXwjr&T0K1^$0PGapDw%0G0FK;-#sY6 zJ&KIc#uFNic)B#bUL=)$${;yD8IL|)c8?++H8lNv3ZX~2eX%`fK7TG9&ZZoz{oAH9vJ%h=Xfbj9^vqcG|2RUCZ zMI(+|d)mynH6buejz`9!PnX^QFkh(4(Z^NZI3b3i&8M~(%;!^qhSu?NwJ4WGj$g*7 zPnX>zkB=+Y4gEO}&pxF%2++mxC>n7*Tj*NdD^vay&8)eY)%}Hhye%YVo=gyGA~oD0SnKnpmXk`qbuD7B9n*hMl@x z8SAK5d)3Aj8jZMa^bU005HKkGek2)}K0UIyM2yjk%JjbGl9$crSLodHMOM$>Jy?!c z#-&e}-J_Xb+#D-%F(Svb`E@E9amBk>ecHoPIF5&)NEF)aM_>IOFFo)?jk6xaAG`W!Uc!@BNYKGA`NHyx_;odw;}|U_3!V z&)WGJN?f9GfEaIN%jK9x^K(sDcC?cCpJ?R#)TbM|@@#Ol-$$gz6@I;28&}C|=8wl8 z9lw@xUir-hTZtROXc8D&%41`?@n?9;_;MEYdWy4`OCaY^y=5&M>I%b=YaP5CB$&%m zuI_vjD@z(%$m5`<#3jdTL%PU|&BpHHILPL@`T4vh_R;eWbFGdT@-bpQ%X9{3(nLRQ z`T7|*!;S6KfX#JLZ*GO`D)w=x^^KEv;<~Y6@L{y%cD?Bh)8!{U-Nbd_Q%p~*=F1lI zRaxnHxI%aTk@ECdcsbCgi~ouy`fznciTo%>H5hbJd~ zQLIuT6}TN#NrSXV2a!MGSe=&X{J&{_d798+TB@g2{X6LAzf2dy)HZ)1AC0x|7&eE$ z%fHo(M9%*(;ueuRK*S}!i_^#2_dK`DbpP#&f(3qgU%E`^?LEDEWdo*}o)PtVRtL5pr(>bXPoD;m)j>sy(wCTc$ZV0w(NfeK#^ zxz*Lrk9`&OP(!=EsCe7_a#!i;ET@NWRvMooHpD4D_31Ly=*JoLa%U1W1J{<9SHvwE z2Z(%&Y`d}Je9yK$a%|rhTl|qm{4X}2GF?s7eEfyDP0G1GUTt}pa>smm2)eha^yJO2 zy+xd&5p7W(WV)KD`G|hJn)0m=lHu7xmg~*LDa*B3=ZF}z)6w>>`RQmj;L^M|L*iKL zr$eSQNR#FdrsJ1#t=5WYJb>1g>ooVwmutUgw=Q&YX*XX6V~E#6(WlGq(T~$ixz+~F zz_sQ25OIsf0V1Br%JswSSJ$4*(5<53pN9X5sg>!Xe{J&@;x;YUx_CnwxLnV9+&5ny zR&JRQFL{A!_WJT5)3vdR@6nG}TdpI5v}G8wJP#p0S)RoLVljaZN*OzBQB?t|=dh+U|@cIU|<@y!zifM3wXh*i6G__b*B4v)t zFULRnbQyH?x0+kbLd0!<=TCKUr>U+bxMfo5{+n!e3t2IqUPf-#BEZp_3>)g zb54)Umy1EWtLH7ArBx1nyfR%As`@qh@oLJoK1haS3t7HBh*Oqt@p4`fi#FfWJT^Za zMXQEgKa%~eqkcMMI)gN6{$M)v<(u1n{Coq%%MQGGD%1GHQ5Zv)>yt~wE8=i~Xh&AQ z&$f1Kd;9HIu^X&5hPW*heY)%({dl7;-;oB-NVLo6m?!4TdEm;~ou*}|aM}=eL^+q~ zGH%)a3-Ozj^WVj-E$=0tnlC4XQgyelSN)Z!u3l|KTP&Y4-IyHSihkUh@*YXBV;G_= zABUn5=dR(NJHLKLi?#(v=Q2G!K;sumVZb>X*Mp{$A=s-{N4$TdggkzKai!BdEha z#HY+>kLTu>!$XVGPbweF%3B6!h~Gldr_1iqk2~t+Fv^KwWMPogk^6=D1;4#_xzFxs*l`Mol~JY;=ke<8`yUaO3~tJ5xWK%XwV zM?dbUmxtd?gf`!Ezc#-dT)*GjdtuWr4fMy$GF`?k+kYW`ljY!dahsHX;x7tux zq91qE<^OjRVN(9znJ@nCu;e-7O-96G>sl=@HjcJU*B&_j@6Vstt}^~h}&Gb zZ&#^ni7)5(?9!JLnJ(j%?dZp?Dfhn%mVw$rmit%4E6e@sNXmWaC-c+uy;UjCNhPPP z&`*y{m(wBJe=t4zaxX3)w{r<_ckuJ9?B&T7IdT6;807lC?Pv4lKFO75=X1q-V=dz` z#BHJI(`EPQ#~XFIk2H8jqAmAnzL+ofvpS}nJE2OPc+4)f5%G(9W@WlDIlT23;x{Sx zzl&RY93Dp8=E{B1pEKf(TD5nxzMRPP@PLh9q93=W+(#0uEyI)L{T6Y`^8O)`@;>IP z`RT}?rRLF*p`Z8Zr$eUyjp@*rcf%z}v3l2Bgbp)Kk66z;e=}d+n@*ehJgI9@c{_Lb zdS0I{lts1lWnY%iOust%KoOx+ubicSo4sfAlIEaXp_ryIHe$BkJknlIb!Y+5VHb z)b}TK;7!$4e1hZ&p-=`S^KHye^ZC~FmDkAFUskQx$0yTeT(bR_;^PjFAaQdRjduBQ zQqQVHoM(yby4!%Vp~K=NX*yP(R}|$j0c!!7t`1c55ovs)3N$3YrvHO+MsoGXG~Q3q zh}Y`HqV1)EawXEoE7SkMcq2J`Z@QeVwltr=r?M|}ymRuVl|EjX{tw0*#aT_$xIJQ< zk2_VZ7xR~Q-}g(okm>(m+)gnT_>HlEdksbwV_hUk=%;$6MXRdo|*|h$wk5{JugYibP_imcM_HoU} z`zl4&y}7cMb&?{33U zwv6vZ<^87_1$05UDit&>hY(rxe=AZxpXr8RNr}BIQ$K? z;_r(IM#S+?-KQ*Wz!vu>i~C;1J%Zx8skm2LJg}G*IguCQdUz3(M0q%(CK{k6#Csz; zqZfuj9A}Ar#w|F8+xUcJ#9t6~;g6{h2eEIFi^GbxmKbDL;}|EFN@dMU$ijs&=na)p>Mz;~O zi+FBT9D|sy&ukN!me0hlIzZ>1e zI!%-ZSwC6Md7Y2;=$Ys~NopgeUmRWN)74}?jL(f#bLW)^qKZlJ++0=9ZibiIHS%+y z-Y4#fP>-|KUbOL4OdNH7(CKa8>_nox-4SEh?JZKHYLfHQCT@#R$w zu7N!J5#a09#a+}`V7j?6ISU;9)kRa1Lu^4q1Y&)WW1PfvOdvS474LMY6l+k{a?$0P{u5mt29YX%S~j<)xK$i zW7`dKb&&zfzz#*9@|dd z8Itm@AuyJBvF))?WV(z?wxbcB`jTElNX9}<&!Ld{=A6uYzEy10HCD;7pXNB|JazQ zy)Dkpcmti`gqAqO^Ww!7zkl*ed)%}+8gXCfRLk;vfbB2$1jO0v~Hr}vk#Jg_!HixU<#vaqhE7N71vi-N>jpR(0c6sZT%6$H|I&yRKkBxI5 z>f@E^GEUk4Tk%G5CQBQ)eQNV@->|AuZgz?Z3-xi!bQ!N~|E;*AIFqG~`%yIFuGu9~ z-##ncdh6qs=`vo~{#$WJaVAR}cW4^(`Msoy)8^PM;y2UBEz@PZvi-N>*6oBF?szc_ zS-U(sr!^njr5F`VaT?$#P&p-xADkm8U9|YoK6ce9H3h$0gCQ&f4UfH9Ga>)OjSf3 zG2#$I?AD8EP6Q5Z)hj{b+L=fbdn=;5m{vi2|6L=xi+*C7=;eTZ{y5Sbrw!EkBjyXI z7S#D6@>JwIrx?`vCFhyQZ!v!a`JJ!7ZDQunZ?h)S4ns(l`)jXQzC_~yk<pTd>^6 zb=etV0UHH%lpRTAEKadT=i7~QeT+2Xu*KxO<15{G zLncj8&!gO`%KHf0zF!ua$5MHo^6i8i$@?!_*}Akk^b9!+LDju^w}c~SQQXuwTvDN)3y)BW^P=h*QR912)c&;P!^YP9cB5m9U;GZHs?RjG{?)eDAZrs9cJjN4jQM-)q zN={)cuQFZquWceLuQJWoUwy%+UA-U|`MN$Ogq~$QxwD$j_uLt`+9i)WR6Js)Hlh`e zAK~eSj! z4QXzPenlhN7JSNdHBs|nKF+#9fpy!nXDHStrtwV4VOoyDa>Y}xx4a_G&|6uu(5hk)B?imw&d#XAGz)# z_WML!VgVQD*~Rr1@!+dCx0(fF70IOt#U8~WZceNMaT2O2+#s&8gkUV@V=K<$C6cg^ z6+uf3gLsJSGsLnv1iY3k@QVf__BM%L)28K{w@sR*S5P@*pSoP333Ug%qVrNkw^HK~Y?sxSmr_Q4Vw6B(W#o zyYRlBL0lVRBeH0@qV(L$^^@z0GX0C9>|*6o#lb?^-N{0^Hr+yLaK=LUktCLKx=}3U z*8EtCEBC_faJ5u=U$9iXn#NX!K8>xU8y81eTgOT%lbt);Q&}sbJcxA=A3w>Yqv7?Nl3kQzi|};uA8qpo<;Jd>uWtu0_a>f!9u8i9K2BU+GQI!s zl$rRN_O?`32K4B^Z~r7?%^ZgPPf@OAx;8fP{m} zw0KDPeMq8Qi@0REVW<(GBCgt;OY}4>SG+Kj4OaNVXM7E9V`rPp<0g8WdnSJ&x9mTvwqe>0$Iq++)x63@VkXv+-&h}h zWBu5g@8b5?+N5{lKQ$oM*|retcX7-v@>!HvRhZyPSXeJQVr-Pd3`+*&~0{<@VGkE9LYt_vd{_Y|JO-wP-{p^k+ zE3TuT3Sv85@e?swN|{!3kaGCd+P!?&p8GiGFMm*95pBJaX?*OX9tm-$xFF6w;S z+|f!&*`-Gh-#uf`>*JE?e?Kn6oL1*B1JmZ)CE^q1+X132);(hTAa)Q%z0tWlB~z|1 zt^K&A-^i`3e$+;6M?`s(>Bi*nR@C_>%NuV#_H*I&M1~cq=y@?@zNIM>^>QHozterz zy5|`amXOP%Xj`x}$aL`^ZS&i>s&wPw2+l&t(5mwiY2)pB?rsh~ZoJgmk)=Wot0Z4U zoO1mj(+%U7zkY3plEIPnr~Rjx2SRij`CqZ!if%vA8Sek;f1)#g^m!xm-LUVV?`rrh z{*x49xsm@D$6sQ3ikWw0LNuG0`4i2I`j`Ipcjk{=E`Arfe)*Bho9NG6zrP#i|5|#? z{Q2*mS@*~dqi(^E&9Q}9a%zsC8G4toYV?O*Y3hntHzYeCyHDcdO9NRb- zw@{8G=zm@ebxPTgW8rtGIhd9?Mx{2ji{Et&Z>h(FpH9A8#v0o{=iAJ6a z62lhb5#8kY_^LLdo9r&Xiw^RCqAi9ae~WH0O-v5_Q#lYy!O|};qO6JMfMS||KL=vw z&%ZwpqKY79{zR2K|9-c~=8uR$ zM(lHndpgB@75_;EaotAlZ}ByzF_Qx^^T$jE{mY$W=Fh)81IpO`_*Y1eOJ z9jEoX{$kQ2av)~@MC8SP0(<6Mb|DXRG+&YQ{SyyQ7F zu}>z>mx^!O|}jHi23{{b3i|T#BY3uUUp6VJpolWzC7Lf$5+Ok@a!?T(Id+ML#W~7m+Ac7r1^FH4R|Kl7=!UK*M`A< zA{4dJ#$)4Y{=G8i?5_n^pO&!uA!Gj{-$ZlXm~QwL@hP9PckuMC;^o=Fvz@1xXJD|M z<~z@f`tce7_sYDbNl|R+RpgKQ{v+bij!%qB`@HL+XvEuZ?ezpb%6+M-kGH=uJt9)W zw?B*5@S5--KhwB9I$A2)@rt-BLVI7V%r`Ms?RW7zvZf-5f2aRYWB;PuTX!=5JnrRw z9cJ02p8t;C)W#5_g`!WF-TxrpSU5Vk+j$1GaaRk3ms%DVGa$KKtd2%}X)C-OFeT;W z{&M^>K7G3E{#WAjb8Fuw$j^&cQb&Xus)^It%X~f#9c+C*^iG}2G7cH1K3#VI<2VCY zz3>{1Hl95B-_5i>7scCrd{%>s|8#HExxO5~j8C5~yZ>=~%x5=ucfU3P>N|-eGSWD} z)wILsdo<$x*0O4^V`E$XlArqYzZ0*gcx_yp4u&cLMBZu&s&@V3UjQ?{d@zotu2CRLeZ!Hh3SZLjjJu+w(L}j<9i3=_{Ddzo7t9= zGL7f271i@7ALjVgE%5kSBk^4{GERNEp)2orGroV+{QjQYcM|Kd-)|wb<>OE^;+^pF zbi9Tqy3~^K$awYXvil#zOPs&oGHCPFDcF3zHV$dCc*2Mr;g3bhIQ8j&Ax>G2ql`C{ z5sKwf|K1ZhK2a7VktV*&M#L)0NiOt@LtRFkjHacu7YCv-%|DU@`sYp!<>T)SS`I_D z#n9w;G5^Hzr+jurbc<AwmP+Ab(f)h${B%8hG$JHn+;YK7sDt0$C#) zUq`EiGEBL@Hl};jah}>1S7}hC;pFSytB0L4u7E|H;{20L*Mz8k{cCZmFUoEZ7}U<> z{K_LyX&%k*@-ggb66JA{g!hi$3Q~Tk|1{*Ih)<>)lfzqo9A76-7tynReJGxh7yF7a zO-v5NVs8%ZoTLm)jSy525Zy{O@K@%#_FEfJqMM zmly4EW6bhml2tK3Vsb#yo*$et#PqnTVx=VN@#$)6c6jr7m$)TfX*gkgmaPqXJ&;*v z*#21jk}kV9pkgDpATLq>Wq@Z8^RZPoN7DNG~USS%bNe9YU&1EhZKlq+-Qn;^Rm^H>2kQTEl*O) zQ5$ZOpi)~u^^I)R-3*t7P41UiO&nsl4iIgz&Jp{yZP~Hy65oD>bwMlTL>%w>`KHI~ z^3=@`^MgZ%<7Ju7-%T1#zR8;;g1r4iR@LOHrMthZ%&Jj!LvLef$$Y6eEb4edTPIOo zUP_z1&&M^>+BP)we~y<0i{oRNZW0VXq8m^3x`sZr*CV@)Fr82O`ot~~Z=LM(?^I|N z`lYZqfTn2!5syq)6Ez=^)^`|QV}qe?FRB@>>g(UAlegh4h}w53Ge~=WS)Py=^X;E% z#IVF&Iby2Cv5ojG+k90Uk@ioH(>U1w^DS+;u^Ab4xe*iF|G~f~jW4wCCnub0duTHK zk}kV9ac^f>4+RF)ZAXQ8U09SHJ>ArWyRm0L5Vgh!*YWkK;_Vk0tgRqVyL^S};)-m& z^DJT7PXQji&U`dXf;z9odPkXo7-yS0-^AKf zri=e*8OO|Qa-Er#fQV09Z=GCUh#16X zOI!mH>l3+M5gTH094IbpiPfdJJ|fy1yM7{U`)mm?7&$(gEhg4I%BHC7owiLBM>V%Q4d!i9D%6HQk+JZ9vmie+wDL zRz)d)ikKfM%1KKLrASr_C5NMhlBA=B;yJ-W*~HxvBR^Rvc|l4W)b~T$JdCN6FYq@+;|fXS|>MN9e))EX^brVIFp69%f{qm6&gd80abrUPtEB zI11autP}$Z*o4y5?Z&()<;r;aQXkx6>e0BOC~K%>agaaD(j5yWG$598g@d&$xne7e zJH%1WSjScKF|z!&8PCXR96&g~+z)#wwUu(KiSgn3)0lqWjg;u&BWu8)=KFY%YXEuVtv=l7BAPOk@3iM zLu$mQnRwc_*9By<{-0pFzbEEpdvwcBeO1j??6OX8rDVG^I*aXxc6MLXyC)*zk?9eU z7`~Z_N92#Ono{mbqZeC<@+j`7aV8#FKj^G)iJFTn7-H-$?(@7vchSiC`Aa>o&aoBm z3HQgP+}P+Xi;~)O<5SE}nQlmp_^j;Z>FyKgMCGypc2(V}@}(Awi;rt?8)tv__M*BW z<6pILw4E4r9ASHGl(Q99uTALu<(OFKiblpE(+#N+pHao(uhxPjYDH3%5PFf@rCVm= zs8~O?((%%_Z3Si@o9v*=51Aejf#KV4<7ns`=;CEM{vnf0%a6zvF`7`;yM=l*IwyvB z@l4R3D)oGai}i(QM4Kf!JY7xHeAIF2;@LsH1ZgL#ZFk_VMJ_k`a~x>6%R4v!71J;8 z^I#RDzK2>f2=(h`5^?W!eL%BzEG1luxjaE(#8#>qZ7oQE(frql9(oP?nHFf(e z%8?+ZmsP2{KBHyQ7VEf}=0BSQ+Vz0PRMT>$KR)%lXrnXVY}#A8R};-{8XQLbdV zKH7*fVprFvl6!k!fA>aemCAKF;_!&5d37;8%JqQFw5a2-xoo3k@=Cb1ZQMHr^>N7b zzZ3`i8rl$@Tzojq;a}gq165X0ZJQed4bj9ohB(Fe#rpeq&Bdg7L-yJBus)G<;r8$3 zll<=`W4gXSCr0Jl!QaK(uA#4QZ5N;5N=v5D7xLb8eKv}H$kDK$&UUH7yJof(;wYj&4=c}8=a;c_NYkI4BQZZ^x|*o@sKhC( zPGVJ7**A!LC;ZvSxC93Iy9XHmRH{#7yEN!8!Ptp#qqDm4_jmbyJYIVUUu3!kQ3}atH%O)Xy-*fu&baR8`#k< z2$ARPUaR}HMQ9gAF%$>8-0JZ|DcbDnDP&=k!;wks{r60Oi0ZO|4jXa`rgLF}i9{h|)= zfG0YFLk0D?$D6hfeBp=A@Q0Ykfe1nua9E-42L#jZjvnZVUg(WJ2ti-;Lw^jwKn%iQ zi1p7<48w4Yz(|b3XpF&FjKg?LfGDYxFd0)Y71J;sGcXggFdLzmgSnW8`B;F3SOl@& zS%RflhUHj+l~{$#}E93*q~b=7C6*YVj~W$5EtS&Iv(O90TLn+ z5<}E;ZG)sphU7?rlt_itNQ1OU2U&l8M!si4X4oPNvLYL@BL{Lq9KYvA9^^$nMwXo99_hURDiQ73pSv_>1Wg$vrj6>e}xdvt&YJi(#A z(g|Mhh7ZJf4L@`ShpS2e0uh8R5XZ&c5RC5Vfu87v-spo6^hH1P#{dk(APmM348<@E z#|VtXD2&D!jKw&N#{^8oBuvH>OvN-z#|+HGEX+nI=3p-7VLldMAr@gVmS8ECVL4V{ zC01cI)?h8xVLdirBQ{|(wqPr^VLNtUCw3tWyRip*u@C!k00(ghhj9c)aSX?C0w-|_ zr*Q^naSrEk0T*!zmvIGGaShjT12=ICw{Zt|aS!+L01xp9kMRUg@eI%L0x$6juki+N z@ec3t0Uz-RpYa7>@eSYc13w{l@GTGvmWYiwutHo|BOc--0TLn+5`*gD6&oZ)G9*U| zq(myDMjE6=I;2MiWJD%phApxnE3zRwav&#iAvf|MFY+Nj3cwBpVUI#63{HnBMNtgJ zQ354V3Z+p7;@n?3lt%?rgaay}G8|C_RZ$I2sE!(_iCUCfi zG(&T=KufejYqUXIxS$3~(fsq)6(HMiV7>DtgfQgud$(Vwvn1<_FymeVLuMwAP(U$j^HSc;W$pMCT`(2 z?%*!&;XWSVAs*o|p5Q5-;W=L5C0^k*-rz0X;XOX!BR=6XzThjq;X8idC&a}+3&esY zVj~W$5Es^nhxkZPU@g{RJvLw?HeoZiU@Nv^J9c0vb|DPAu?Ksx5BqTd2XP38aRf(k499T- zCvgg=aRz5`4(D+J7jX%faRpa#4cBo4H*pKMaR+yC5BKo^5Ag_(@dQut4A1cbFYyYm z@dj`44)5^+AMpvF@daP;4d3wtKcU2C`G>gg#1gR)2Uds+Ys5o*BtSwWLSiI=4U!@m zk|PCDA{A024bmbV(jx;hA`>#h7Fm!L*^nJMkP}>TQF0>>@**GdqX6t6PA=J_5DG(F z_bG~ED2@^k=jBVGG|HeXcrA%i9u-g#;#_qlRE9WlRs~g24Nj)aV-40~9oAz5HewSt zV+*!o8@6Kyc48O8up4`@7yGau2XGLFa2Q8$6vuEJCvXy{a2jWD7Uyst7jO}ma2Z!{ z71wYbH*gcTa2t1U7x!=<5AYC=@EA|<6wmM+FYpqt@EULM7Vq#LAMg>M@EKq572oh3 zKkySu9F~8?f+b=j4y+It)`*ArNPvV$gv3Y!8zeLL@)G4AB3PU`k_AtU?2uz zFos|#hG95HU?fIiG{#^o#$h}rU?L`AGNxcEreQi}U?yf^HbOB6b1@I|u>cFP2#c`< zOR)^gu>vcx3ahaOYq1XNu>l*g37fG6Td@t>u>(7?3t`xeJ=lwV*pCA^h(kDxBRGm< zIF1uIiBmX@GdPQLIFAdsh)cMPE4YelxQ-jRiCeghJGhH`xQ_>Th(~ygCwPiyc#ao% ziC1`yH+YM8c#jYGh)?*8FZhaY_>Ld=3B`)#AF*JG*oXrw#Dz8DAwI-CF$s|fiID_0 zNQz`gjuc3VRN!_8B@MXEKuHHK?<*OQ5t)z~w#b64$cF65ft<*N+{lBx$cOwW06TEI zs$!2qD2yT~iee~^5-5pMD2*~Gi*hKB3aAJNR6=Dqq6(^_8k|raHBb|^P#bkn7tW}M z`e=ZLXoSXSf~IJO=4gSIXoc2jgSK!%JGjCP?r4t=@PH>eq7%Hp34cl^Ll zC~;Z-5et@xjX1DETyVRS5)bi_011%@iID_0NQz`gjuc3VR7j09NQ-nxj|>p^Wo1HU z*dhzEA{(+J2XZ18aw8A&A|LXj0PIi@_9%qHD1xFWhT4JD1)*nhw`X^if}+B zRE8s}pem}t3Dr>pHBk$-Q3rM5jC!b#255*zXpAOkie_kz7HEl9XpJ^#3m3G5E8O6Y z_UHf)c%maZ!3*B-fiL{f8U6@BAcD{ZUC|A}=#C!fiC*Z9J_tcy^h19Pz(5SbU<|=f z48w4Yz(|b3XpF&FjKg?Lz(h>KWK6+SOv7}{z)Z}-Y=mMC=3*Y^V*wUo5f)r6Sr_1cW@W?a32rw5RdQ}Pw*7a@EkAj60h(Y zZ}1lH@E#xV5uflGU+@**@Et$!6XF373&esYVj~W$5Es^nhxkZeq7%fu$lmaQFZ|FM{s=%Ig3twB(G9`qjvnZV zUg(WJ2ti-;Lw^jwKn%iQ48c$g!*GniNQ}a0jKNrp!+1=~qXH_z0pdRK%5X##R7Ev7p*m`y zCTgKJ>Yy&1Q4jUe01eRyjnM>6(G1Pe0xi)Btg&W+_9vvW_JMctDbb=SW z;R9dzp)>pufItMH3%a5kg3%p4&=bAT8+{OhzUYVk7=VEoguxhsp%{kY7=e)(h0z#; zu^5N(n1G3xgvpqKshEc8n1Pv?h1m$j9L&W$%*O&O#3C%l5-i0sEXNA0#44=D8mz@S ztj7jy#3pRU7Hq{fY{w4l#4dzkH}+sJ_F+E`;2;j+Fpl6Tj^Q{?;3Q7rG|u2G&fz>R z;36*JGOpk%uHiav;3jV2Htygq?%_Tj;2|F2F`nQlp5ZxO;3Zz+HQwMY-r+qy;3Gca zGrr&}zTrE5;3vcbIu?ipOTb93@Z^r6ArESq5cM z4&_k+72$wNs0>F`K~+?P6RM*IYN8fuqYmoA8TC*f4bTvc&=^h76wS~aEzlCJ&>C&f z7A|N9SGd6)?a=`q@I*&+f)~8u17G-|GyD;NKm?%+x}qC`(H%X|6TQ$IeGr1a=!gCo zfPol3~(fsq)6(HMiV7>DtgfQgud$(Vwvn1<_FymeVLuMwAP(U$ zj^HSc;W$pMCT`(2?%*!&;XWSVAs*o|p5Q5- z;W=L5C0^k*-rz0X;XOX!BR=6XzThjq;X8idC&a^f7KjB)#6}!gAug;D5Al%z36Thi zkpwnKieyNR6iA6wNR2c|i*!hj49JK~$P8O#K~`i#cH}@#+B~TKjP#R@W7UfVL6;KflsD#RJL={v;H8`O@+p*HHEE}T&h_0a$g z(Fl#v1WnNl&Cvoa(F(2625sSjc5sCo+|eE#-~mr`L??K`8$R%bA3DPy0SH78x}Yn% zAsF4!13l3Tz0n6D=!<^nj{z8nK^Tl77>Z#Sju9A%Q5cOe7>jWjj|rHFNtlc&n2Kqb zjv1JVS(uGb%)wmD!+b2jLM*~!EWuJN!*Z;^O02?atif8W!+LDMMr^`nY{6D+!*=Yz zPV7P$c4H6rVjuS701o014&w-p;uwzO1Ww`2Yy04m}`Mp zutaRcffeGy8u1Vx36K!tdCJ5{0vjYnG9*U|q(myDMjE6=I;2MiWJD%phApxnE3zRw zav&#iAvf|MFY+Nj3cwBpVUI!(?_(%}q9}&qD1nkFh0-X4vM7i0sDO%aKqXX$BdVY( zs=*1>Q3Ewm3$;-Pb>WP9sE-C{h(>6PCTNOgXpR)a zV-40~9oAz5HewStV+*!o8@6Kyc48O8up4`@7yGau2XGLFa2Q8$6vuEJCvXy{a2jWD z7Uyst7jO}ma2Z!{71wYbH*gcTa2t1U7x!=<5AYC=@EA|<6wmM+FYpqt@EULM7Vq#L zAMg>M@EKq572oh3KkyUcp?nL(f+b=j4y+It)`*ArNPvV$gv3Y!8ze8KuMHB zX_P@(ltXz`Kt(v95-P(HRZtbx;DqX^ftsj=+NguNa7I1UM*}oOBQ!=6G(|HsM+>w> zE3`%%w1o@W!4+V01?h^h7W8MjwQr zFZ!WB24EltVK9bZD28D;MqngHVKl~IEXH9xCSW2aVKSy*DyCsNW?&{}VKzcB2XiqG z^RWO6u?UN?1WU0D%drA0u?nlP25Yen>#+eFu?d^81zWKV+pz;Xu?u0?jXl_leb|o! zIEX_yj3YRTV>pfzIEhm@jWallb2yI+xQI)*j4QZ`Yq*XZxQSc1jXSuDd$^AWc!)=M zj3;=CXLybmc!^hdjW>9UcX*Ev_=r#Vj4$|#Z}^TM_z6*AmIY$L60s2nR)`C0#6x@} zKtd!!VkChLk|G(BBLz|-6;dM&(jpzwBLgxb6EedVS&$XkkR3UY6STQ4LP0jvAPNQ`eOhFVh{#n2!>)9hGPUqViZPW48~#{#$y5|ViG1} z3Z`Njreg+XVism26mu{a^DrL^un>!|7)!7e%di|PuoA1V8f&l?>#!ahuo0WE8C$Rw z+prxwuoJrwhTYhMz1WBSIDmsVgu^(3qd11+IDwNmh0{2Lvp9$IxPXhegv+>stGI^i zxPhCvh1@?7 zkqz0A138fkxseBXkq`M%0Cp${dlW)p6hToGLvfTqNt8lqltEdPLwQs{ML2+02r8A~ zh$^UxYH&hz)Id$tLT%JRT{xp2>Z1V~q7fRS37VoAnxh3;q7`_xozezv;evK>g&W+_ z9v$ETPjo~lc)=S!@P!{b!yf?%L=d{5E4m>V-O&R*(F?uN2O;Q-e&~+@7>Gd_j3F3` zVHl1P7>Q9BjWHODaTt#Yn21T3j47CkX_$@~n2A}KjZnq5B6do_TvB!;t&qw2#(?yj^hMQ z;uKEf49?;l&f@|u;u0?73a;WBuHy!7;udb>4({R}?&AR-;t?L>37+B^p5p~x;uT)w z4c_7%-s1y4;uAjO3%=qTzT*deLOj54fmpCaY{Y>T;=&s75FZJU5Q&f&NnnGdNQUG{ zfs{yv)JTK0NQd;ufQ-n5%&PAsC8b7>*GbiBTAhF&K++7>@~iFz)GybYOKLptiyV2z(#DsW^BP$Y{Pc!z)tK!7$k7>c6=N}?1>qYTQT9Ll2tD#8JkP#KP>f~u$nCsaob)I=@R zMjh0JGwPu}8lWK>p)s1EDVm`julvmRalKRSc`R7j}6#} zP1uYr*otk~jvd&ET?oT&?7?2_!+spVK^($i9Klf>!*QIzNu0uIoWWU~!+Bi5MO?yV zT)|ab!*$%iP29q5+`(Pk!+ku!Lp;J`Ji${u!*jgAOT5Bsyun+%!+U(dM|{F(e8E?I z!*~3^Ply-ySRfWG5gTz}g}AUrJj6!=Bt#-4MiST{DUu;MQXnN#AvMwI zpb{#>5#pVmRZ$I2sE!(_iCUCfiG(&T=KufejYqUXIxS$pTcMGIV^`S;7j-l zzJ_n$TlfxE!1wS2{0Kk6&+rTU3M=6^_#OU$KjAO<8~y=Vw5t&`h9=MywtzH9hi1?m zTELdj5?aAl&>AveYuE<1g*LDqY!5p?Ti6kHf}LR(*cEnz-60e9fIVR^*c#bopeGy-z2FGQf^6sweV{M&gZ?l8 za$q1F2}i*o7z{%o7xLg}7z+7N0K?!I7!D)gSQrVT;5Zl!$HN#H3w{^}g-`?m7!Soz z0zsGn6QL9)K?uT729qHIDcbfpg(Jm<#8_1#lr;1Q)|4a4F1#%iwaj0Gd+zEHV0=OIQfqUUT_z&C<55Pir5FUd6!o%=Ccmy7WMerCr4o|?7 z@Dw}^&%k1M7M_FW;RSdRUV@il3A_TY!vDc*@H)H!Z^BY|3*Lrz;9YnR-iHrh8GHyI z!N>3kd0SdF3=SYf^Kjy90J|pP&f>FKu)6;KINU@A<5Dwqx@z=?1Y z%z%@j8cu;zVJ4ggv*2_%17^dSa2A{m=fE5|7tVvZa6ViB7s5qwFc1Uv~(!PD>zEQV*{Id~pkfEVE zEQPn=ZFmRXh4y$PuL6ghJBzNw1*C`FYE^$VSnfZJ~#k6!-3ER zy23%w4GxAwpgSB2hd~eM35P>3I0CXD8+t<@=nMUzKMa5z7zjtgQ7{Mw!w|@YJUAML zLOvA0FgON=!w5JQM#3mK4o1WAFb2kgAI3o;6hQ#SLot*<5GKGxD1}K7f-sc9WQagH zR6r$6fvGSJs$e>t04KspFau78YB&W>g_&>~%!1S5444gP!dY-OoC9;){5t5pIH;VLsdfx5903JKOuo#|&=iqsG0bYcc z;AL0>ufVJDfAAW-4sXDluoT{cx8WUl7v6*S;R9F(AHqlQF?<4_!e{U~EQc@POZW=D zhHv0o_zqUU_wWP!2tUEk@C*D3E8#cz9sYnn;V<|b{sC)y>OVAwCeReNfHX*lX3!j3 zz?RSwTESM(8ZuyO*ao(RHn1IR4?93x*b#PuonaT)6?TK&Artn1Jz+1{8}@;A&>lL# zzOWy3g#Dot_}~EO33Y{SEIg&_UGMtzrQ>(UZ+6sQ*2V9@qExcvWH!iN;y4d< zz3X`_G9>41ogHf4f9e^8z;5!M3a4^gXlzzl?^^zZ&0Zcqe&y?G&e8SD^H>1O)I--D zosWKh6jl_^XCaLfJAU5$h4!D``(sxLNm-Zm@^C7*g~nzTJ@|*Dz9V9bZ_7FclD@a@ zHuVm>Wr37~-p~j7LODw_ybMd=6?hf?4_<@U;SG2b zmcm=`HoODx!h7&Od;rVfL-+_jhEL#A_zXUW;}6-ChP%w!d|d9>;vtfJ#>J5VL#{y`$H%2!2!@24umcs zP2@q)4GxAwpgSB2hd~eM35P>3I0CXD8+t<@=nMUzKMa5z7zjtgQ7{Mw!w|@YJUAML zLOvA0FgON=!w5JQM#3mK4o1WAFb2kgAI3o;6hQ#SLot*<5GKGxD1}K7f-sc9WQagH zR6r$6fvGSJs$e>t04KspFau78YB&W>g_&>~%!1S5444gP!dY-OoC9;w#O_$xg76hjFFVFFBqQkVoG2tyf6h6s?o-hC1qc=t)~KIz>j zH_iLx4crKCgqz@Im=CwWt#BLM4tKzva2G6qyWt+V7w&`q!2R$5EQAN)A^0ym4F7{i z;89ovkHO>c1Uv~(!PD>zEQV*{Id~pkfEVEEQPn=ZFmRX zh4Uj`1-imP&pTcMGIV^`S;7j-lzJ_n$TlfxE z!1wS2{0Kk6&+rTU3M=6^_#OU$KjAO<8~y>S3H2WuLlbBUTR{E$j$8!OpM?><#-sJ7^CbU|-k|I>P?Y z34Cw>bcO?=3v`8ppc@2vV16wkpcSpe^r`#LPXc*L|e z=gY$sPR6E)=O2~ZLSwVab8vPjI7$9F+x0v=k8@OyrLE(i$1lL|LYUU7srBRHgJk&2 znsV1y_XZowEbw?&mwXjH__yRq!SeE8I8>e&E)5n|`Hl&OOPznn?HA(zK?~*a&%Q5s z;O%DR3&xgwtRaoDOGz)TcAyEI1p^fjMw4oCkB^e2_9N^-q3lxi85` zUGDGODpb8gMspc{h;wzx>rw8rOH0F3yF_C%^;uaDeGVMdbVy~|d86f;#O(@OuvNJ& zG&c3nCx?II4Md^})o`xbXWrJS?Q_h%#b?fbetM;mq*k9z6f4IyyDk~lPHlIz=6%@CI=oj;t8Dma>)UJQGQVS)^-Pyh zje7mGW8+h2W;e;I+;WQ#Sy6cBal5o^|I8EHENZdsuD_0K+3Bdj3;o1yQa4b|u5X(E z3%5^h-?rN|wMIWzaplyPzqq02>+$wgxx{I@I_&HGv3OAzd;D0^*Z)N~&rNiU8CP+M zWM&|_DnYt|N*c#P3&;S;L(i>hff|gvI{D*{!OR=;*bL|8k7ku)N-0DUqQISU)rZ6P&iS#bevQT+RqugOT2xG@DuyU zT#GStrq9ipoMyc_@1eIBl$Q6r+zD#+#82#_a(>3Sm_2+2C6RDNMQNZSNyQg=X$>64#I5uaD4UUPSiw@V_u zcH8^;EA8zb-unL;_WH>Cs{L z)b_aWzg>>`?=FK**K|}5w_N?*dJGH%Cb?}PVa@Wg$fZZ3^0M=&H->l0ZX?53wv&3q z=%nSA+hR6}%FC2Ms3KLNG4&de8E>CNdVO8?OJ4uaLsx3Ls+U`?{&nfqw=!anY1LJh zO}$p2mpp%DgXD)C^EhaY-HCD38}5;*8dmYZmD}DibXLBjk622=_NHR|GQE~0g(92!J3&M_?cCC+Zjhy*{+D>=gGqt@k+h29?9Rt5Abjr75*G5=O z<+Tb$5Ap+%DZ#?P@Ni@zhRO|TxtA8Gvdou1F<2HCBsbJQ7%8uaT~0I}^ZvF7Jtck3 zR~ZZ7(cT&{m~nw;-#%DQd9uTV?CjIuxO}Yqz-2-cwkj8y>2fE9g5$!|=x+NXg(Y;q z#|LPre0pH(7%Cnb@Rx@}(iWQSWzJsl`Y;vBY7HHjkTZ3}mVQa+$ViLHyMI^k_~G&c zC;LWhRc;H7O+IaQBv?`9i&-MtV5`rdz?49#Rl_-&f6LJ$Re2ANZ1v__fxVl%%e%@A z73{;fyL?XG&;sAU5Dj*5kP#!}uzxs`AFxNCb0dSog?1IS&o}dJ+TN-4%bC^Vs$sM5 z{Xq55cET-J|D^imjvrr85*QjN3`dHhC)BW4d$rvswLXXaRCU?G`NL}4b=Ai$ua`bC z(}}%|{*ye;*|)#Ae&zgn=vVrCw;3(Z&yt}q+o^tTx%!)_`rP?BBwS$+o(76~S2-^c z;@YjOcB$=EaOMqJz0P=cYj^olx$2?&6#5JZhl}ai(ZicWXVV{&XJh+Rv;HlvhhB&7 zIJaj12inRsW80~n+;a6#s#o;$0E$8d zxN2ur6M>fVW$4w2-`OC0xd+M}sAfmrah@>jH4d#_r#}Dmmk$h($4uL4|JN;7f8&1V z>qA2oETsRRGn5V`4LgC%dM|$jZl*6|w!1-Dho;s(=e~JI+ln;n`t~DdeST-lFFQy; zoY+PB|0=hI#wN}#(VL2PyM57?vM<^MLrzw4dp zOMZQVTZ-)@f12=oqVlM?cDI`L@!8LAyaT8v1}!&j_lwWBME$2X|8MU%hHw4shnjGv zeUNFn2o*h;}6+d^z~Qx$N9^hMwrmmpmtc?G2RY);kP$rBJcZii@!Ov=6&_wOAh}2-T!1o z%Wo#K7U-dJ31hlAJ!hium|i3a{Y40b zd*#~dNcTT5t)dTi^x|-&Dtd~kPj#nwedN7JI<&>GW8QkP(})9`S;a@yO#JARi!JMWck<9NB^a1$za1?I=kpdIkUgH^68xO;6T+MM zw*);>wUZ^+?|$8%PhG@YPsfS9q-MM2jxTeLjNYkpb8v35(pvMlE1iwf!G0c*(s%cN?9o^TAN*BaY{SS?Y;c;I$G+QWJZ8SN?b6il7fL%>m)o+-`!^jo;Hqxw zAI(0irAw~<1N=e1FT1j$q`y2*GXyY*!M^OmLK&+q_tCodi$ubaKH(zyhzOSnl5aIP zeRf`V^fA+uw5p^2b~}N;$g)B98L&0X#&|hRx60(u>QeUYp+nzV-a(GVNjTZM<+hkj zey}(c48>{L-ybZkj6{0|)r8S<)xB$c`jX3AfWH6Z&}!U$+?*pn{j5xm#Ys7oty^x3 z*+kQqXVy?*kTE1*F5g(io~Nq`qv~ z+?u_-XOQq6huyPu=Dq#;%dt4k54YU$rH>E^k0%>^LnJW3r^d?JaUfZMHr7Vt2i0Qkg(!(@BB)>by~96Ig(cGAYbxRHz{B9 zelm~tTWpjKvKO0+9n5j61Ip(N>Cvd)nTT!Y*tC)5ma9K+%fpchf2e}D)&ZYvh6c(? z{e|r82cm*VCGT#Fj`8z!By}5otyKCj{%Qv` z^_cI{!+oEZ6W;pbqmKssvg>7}SLtT{bnh8|e|7ikCGM?9-!!B1 z@K)cBi6$iZvmLpq@~F6W7q7=~MiK+HH+*;A$Vt^u+y6r}QbM{Sm}Z+dU4GI=yBykkn}z(h$Ty zQ5eLVjjQHLw7f1pqN&}cWy{rJ#70?8n_hzapj#rDBvIO8=7w?GnSB&zB!I)r!ARCW;Buvp;|YR zs?9?}BY9A0#vWvnbt8GXn!z4Kr$%69u?MPA-1jzlS*fqD>kYZrz5MDCyIF0C2Perl zXIm?`rLj$->l?@bTVxUwB)Mq4&T39kJ1?n+9xq-q_n&u)cD&l^;G`wxzBzaMTDc>x z-6qmwXgFM<>1PsB(wFDf6{P?4E@zEzKXPjMUC71MHBoLWXt7uq5Osd}!^b;oqyb-wX zLpi&qTYJyEwbRHw@*3~MJ1%i@gO+w*<+jk+B-c+0+!TLl??A=WKp`Dw?=+HrGJ7x4uuBRkC z_sF@6`|o@Cb*hik(b;Vkx%wy7(;SyFmEvUcec1dIde!h}?_Gas`r?^4?^z)EFHY)* z41M`jN0^n0jUPOKz{M=3Dcv=NXy%omeh^^=dmUcPfu*(%pXVidXGCD3y!MbcWuwuV`TpQ@33Gjr4W+e$}@^tF$8V<5$fFq}HqL!oRw8Yd52Iyi?1+TdsPo zI#0ItV<)p}*n_ijP9|tRc0eD^$M-uf>mg~G{mq5=OL^CPls=T)rpJ<@Q(APsgF|b} zr7N%casF7pqo>pEHKO%Xxr8xY5`FD&vh0z^zJbD^d|Aqgran12@%l*DL3GmhSdvb7 z{||hf_TS}cITok(bIToH#y?k?XIyK)m_9Ow96h0iy|%l{(MO!x$9-S0{azbBztg^t z=xe!JeX?D0J0do*a+Y7oFenoW!XY1nf80tZ**C3nJ1d=gt37#!87i@p;@$(y9hh3b zRyREN;cFQ^e44)6%Pm*`SWe{Bv&vRQ4M>wW9K7N>)H121I~Y~ z!Yt(E|=w}*7udSUcBg_DKCES z)>q|8^p%+*!AO7`DxW^`XrEB=5|`fY_}sti$_IBi_wO1CvuPjGU-~$iAU2fgLW0y- z=~Hh3W=6X^+cVcI6;C1OwKkVz%cl`@Yk^s8ymeD$XZs?zgM|izl7sclwsFEkaY9y zQ{Cm+9iRSQoj%y=gw^=HePRoE`IFc#8;dj(MWnrv_cb-tXB~HY;nnBMWG;tU-^)fN zukT}@%&@`-w2SQXNZ$$3>Ta*0E%jaH?(61nM(l~=%!14vSI*l7nPKOj66AAHMwt5X z1!+~E5`UVoxFu8iIX+VvTL<)Fa2~k<<`W)2~U9e%ALb zt!EFLJbGNs^>5m;R-%f4l;W?Fp19-q|annDym)lcvjZ&$?YR4 z{(jp#)6YKmo-f?@W0kL>pE5wJf4^7Z#m3YG@>z@nmRaG)X*ER>nc_WWV{ z&6^#SS&kOhL%*9k&dBK2r>e8+A?004y<4vS_BvWa0#jpka(J+!B;P+Nkjs47Ur*+L1XY{Jy$74^)Kb!y^Rq#!tsG0WG2ipd-0Ib9 zCeP`z)1k=4$-WU=mD@sNlfzIu#e~Hq%gLmoLBY_(a_7gOFyrAx@*2-vjKtKZWNdu> z7MsiSvCfY!`7F&UKk1r#=I(R!b_LNiMIWhGDvye5clFVyfDc8{)_!48&6!%ya>m8$ zBW;b$rLuNl-P~Qid4EOQR@O7Ock6Xkt3z6AK1iO3J}Q^sro#$M7q9JI_T}}pU5I5e zhJ;%HlD<3tb$rB(OVc!E>-)GaeYIYj`fLpPn&oY&D}UYZqgHlK=l>zU|0{CzVb#N< z7oz#Aa`XD+I9C5-?_hn>UiAwV^Y}1{w$%9$KYF5$Ps;e-yu$eM=DyF$DSMrF*v+4e z-G&t@9Osma9;?XJKcPMaCBaBh9v@UOaW6bE80cNfz#s3SjD;OL5P?|^Gx#mvO1NDn z0&UM0qQCZwvJUKVR1iP&`tpiWw>P7Id$h;sMW_F$=}5aIEsk5R{~ zH!AQnkoC!Tpm56i&hJA3=35G-G}c>FiJpVY81$^BgEo^!^F}V@3nm2?a1mcJ__=_> zbo(}}FW!bVr)f*~r8M`)u8(E1-um9$hxTPYbtl&6=*n8sH1IiDtTjG>b))kbI~~bd z9Yy3(8RyMlJ?=TIHGUQAs4qbN6zgWZ$J)-nVyo>MSxxv}^W%|?tbI;vWaaV43@iCV zgQs?HY(>U4wq9XD_vcxVyqJZupL?*0)st^?_rJBN)vfy$)?ROJVf{8c&H6bv-MY%x z%q|aP^~sngt~_TJbJ4hLNK|ezCZt=Bv|4`8#BpQJ@kMK_wjV0DBQQ4gE;j{XXSj-G zS!KwI%dfp}ElHtQ)}(Z6`j}g`+Uk-s4!L(nCvnwF<%UZ3;cDnLB+Mv85hL@3tQqCZ z7>j<==`SrENB>bGoDWjorQMrWlH87EW$9KRy+!jA@1An|AeX)>x0N(DYo~9lW}13t z29xVqQ=V>p+G?xp(L+Djy)kt_oZ408jx@GiGd%-E=4Y`Io7v7TOrhuO#_86!Lk2A` zK0NDvx_Q`1OYb{Hq#+ms# zcVcq;bv`NGI&JLZyLam`@QlBrA3CdkDtBUyZC69TzCoUlb%Z>VDD=L+0KN3S|9W=Y z3`ui#)L-g%_tMn&{UP68zU=(|f6A%0a}IX1+;a72au1804)#|$k5>bDewRxzyYhC> zOtz}$2=q`rpE{veSkkDD`iq`R@#i*I`#dD??YM=-&6j#N|GYPTYI1Q6w;|g}98D+% zDvye5ce?r#3q?5#G}*ns*vp1$LTdS25>9QW2frASGvVN4j?e_uPHwsS$MVc%07G*mn_WTdH(!w&R?lT zdMx=Z$aO2?FVCIQglid~8)L5_F8#1*)6S9S*3<%K`!J#`b-laxnl|TM@Wvxc(b%r6N~4LN~p*lGP+Sr0ufny}yW3o<)>=G42` zdnA<`D%gjK^x%uKN*3^9ydiEHyN?F8e=rm*FNr-O#6PD@PHm^0vaBl(zHD+h+WcFx zZ^TyR_0dlTUn|RH{Ayr`VG+Nyw8KIZLt?ZVB2asEh{WzkQit5{wXzP`+PeMavCVv6 zKO}!OW;^X?s5~mJ-6gUY)Ba*6iz(+kQ5VU>wY?ID9Y-cx(ND(dbI@A{vCDqGl;=!sC#9`aXCAA}+pjwdnB}CpGI@P#yDZIWzI*>| z?)_)ml2K8Wda;-Cs&cocv8KituNv&1)<43~b?mcF`+vH%-sen7uE)yibZd(fzFXSu z|2{dbdo)35FGUZP*GrGM@pRw7;!rpupE$?@Hw^6<^V5u1VfLe2LD;njw!QL;%v4+q zdL0>4lV8WYQ`4>GN8S7NO|9Sgsb5rKy$+Q(@O8MFo$0_D@EFxjek9pIQ=f~KWGprtOyp)@DY>z7K zr)qwvd|h5g?3Ge&af%yv$*D@N|I%6M))zb6|JKbv?f>*ePSD!tN0m3Q{;Q}gV|{9G zYkG2hr=5{*ZFA~jkG22%pR-yqRwqvFt#U^i+a_#J>R*qeMMalLi-phVyma~ji}#GahOV{0 z%Gb?x=(wE@G8)#2W{I@xQjYYwaZi40pVO_A`P+S-JZIJCJQ=6bayvJL-4=IhZB3l` z@`MTBynM~s(ZnSUx&Np!lXl-3m`P46&Z*@525ai-iAC)`O*tXvK$j3#6sL4~k zoSg}xm)-wGFCFi=II>&1)Pb6)zl?V*$6uWGf8G7}5&Wms?9PXOvh%$CZYi=u#=bjI zc~o4xGxU~{QW^{e+Yx_PC&PeZa^BKG!5GU`$ zB%f7o3yn=8{gU3ST>6>$o_TU|{j66qtjssB|NN16uD;$08PiYYhHCah~Ty{50V6{@-sY&9&_gjc(oYsJ9h2?<>2AFFg9PSVH)q&IdUm zX0y}umy*8ZcQ(j=XORBc68<24^vK)hb7;M~UFKK&=O1#j9E;160>suW7pb_~_b&G0 zGyHK;?VK;VMNGAEhB4#&W7Ez^t;ZJcTwS%roC_atQsMvB?SmgIw_N?}r-v`Q!cnVF z^c8*IV0oFW)*Cne+-!F2{+MXK!-xygt%LsDYr;*Hd7T%F5pnw5rE*6a+t%vGbfj`w z%>vsPqd5g(TW)vB?UN)kG~X7a&}a6=>DG(04*Rgj_$S_X>!b3RCeG1n=wmNbE#tW? zOKZ&gbmB4f9C2oHyDglTZZ-L;>Y4sSUtHnVQ{{E)sq>zkb>QufHuEWK^)e=rn*E;@ zDfC=^MY^@;l~0B;2MnI>)>Gvv^{i_ilq;uA`z^IwYo~rDDtF7yX=Tm+Ysl>UE5CVf zr|7%^=`YE1fXY+qCG&~Hg<)2!KJdWRu;1+aobss8!R~bG^E+Bq?7Cv!cVv#&x^`kN zO+QguQhyu5t;xG!X@iB$(M5~tW^-v;hRpK2v0j{(Dc!G$p7qT?v5VS9_iK`#cTU4v zz{`u6JT;VxJ+Djm%}KtoQ~A#n%|)#uop@>#E?zV{soul0I$&e3!l zdhc#;MJJV|(og+0{OahoCjHLUiQgSob#=?@`n@)NkhNF05(U zS=} zpUNH$*`G<3Rw{q7=fbo)Oq`Iw-{rY%^u|BS2L!}{g)Ln+mwxc21)D3lQYnpDN z_N}fy?3$*rIh^-zEF1OBH_tZpwbZKZkNZq_`{efbes5eBFw4G|cNWirKfh( z0@5yP+gz7X6191Cg z$Fsotv_P`Hfz<1bp>D5Fdn8M1L*9q#Ge0ev?w+4#0nY-S1vaz=bWPq3t%sNX#%%$w z@3C>`&$`lXT|URvHAXJ|x@3Jj_0#>jy7mnb@8)<-8^VqoLz>cNy34rx`Ax>v%(1oA z(c2wYeb1F=%!Zn;ne2JBzWV$d!nw;qeXm*C1F^B!F4Wgz>n@zuH`#mTe%;yGi`lb) zX93Rwo&`J$coy(1;90=4fM)^E0-gmt3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2z_Wm7 z0nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E0-gmt3wRdrEZ|wdvw&v- z&jOwWJPUXh@GRh2z_Wm70nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E z0-gmt3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2Ah`u*-)C9D3#t|$IBbvn=AYO_ZKL}&NzXf{VJ+b0Ma-UN8C9wL2V}DUf!t7aSM~Gujs-TB zd{~>dRP$2r2@Tcf(0DheeSPmca?M(=H-@&(t%F>L%2HjE`fK>r$ zTVB`ihNw4n#qG&Ayamkm**sob&7>}@Y1vubGP<_9y3ZHARd@4P!f72>fA_f?^7n?e zTSH&F+PJPZQsg@}bfW7qz832-Ei)-C!=}tT_AKDGfcAIY^7{Tx_Iy^~IM!u2cRkSd zW^K}R$C)Uu`h-bz-ujZsePmtgSl{QTRL}US?9q_@nN(?|@)vtMbu1#^j zKHgz$igu~5&QeF+<=SjJ{*C1;QTtX`AGW@B-Wbi#dgsJP?`aD0TDj#|;UK>5?(yyW9>tYN` z`e18w&1zSPNBeWSZ>Z~D+j!RI`qnmWIbYIOJJlyX(|+c0ea>CmFzY+Lwbgf1J>T8; zsOvgbr`*&P$EGN+&)AY_!$fsFRaq9>COU6@+bfX{qMPccWkA~zy;rSIJyi!YO_j;s zM8e2#vA;g|tG~z+<%{@xZu7T*jHCVA$I_(yn{8Kpa^0&R^|8{12_x-tqBh*rCQ+Mb z`mgU}ZJ*agx*OZIu8V8jT;lZF70YUzBs0ZNaR*b|>E7+Xx%^(=*S8`1w+)?Fb=j;g zc|)gf#;0lO-t^mCj@Nb$z=p8Hy3CJt8TW>;m6zt4Ss>ZHZOvj_w`Zm5M{DZ!4X5EZ z=KZF8EgO2i!lrDyjk!$z8+4O<uVT-|Y^^_g#}Y?sPEk*;2SPGpr$OJ+X5tw|Z! zRIYY&80Xp;u3AvTrr=IQBKz_dWJzJb*1jiGLv`fkYM4S64`&-}CvX&WzX&jOwW zJPV|%Lu&%Ys@yByT_nx#Du8*dKn!lr%= zTHj>vmHYaZU@x3!0nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E0-gmt z3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2z_Wm70nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$ zcoy(1;90=4fM)^E0-gmt3wRdrEZ|wdvw&v-&jOwWJPUXh@GRh2z_Wm70nY-S1w0FQ z7Vs?KS-`V^X93Rwo&`J$coy(1;90=4fM)^E0-gmt3wRdrEZ|wdvp_>zpmQtB3SLmP z_`qR%X&Q{_+);olg^szxu)l>j&6y<>UD2S z|EIPtY@yeg$OdkilvTy;SJ&?~)p1MN)dwfQF%j&|uSv$*G z89eFIC9h{#f1lp#qSLk+c{z_+wmX#VKRA^~#kITPfpLApp^8ALqC9t8c_1<+5b+fR zD@p^y{pI_7m%*1kr3py-mUZYVa`jJyq% zdH&+Sps>Hl*Kb-`AQGH}Vf>{&kro6e1w+NYp@H&nWu(v!gec%E3Kv#NFei>ocA{U+ zO`n}NAN?Ncx#IQ0or?~dVLhHFY0r=POMd1xiPztqp9Hnu%xHg8m)xzgZkkEdiEWss$p^|m_q`!mod;$lE_Rw zYnrB6(#O>LA;&TA7S&qWvgR4rk&&Kex06~Pw#2U`c zcBnIU&~|8Ehwl%Uc+Gabq1MBh<+e)+IQ zB=!p1!%s?J#Q<>fNh`+$XHTakmpCa?mb{1*cUp1+&>S2!=W!6 z1u`&s9E^v_a1xvim&0xF2>c&>2~AOQ56FfhI2-PV&tMmn9}btnN6?irHV3|kv0TtQ zP{c+32{&?KW4W--T-Xj=*bZD+S1v3}fqjV!%Wq9vwzXw_%!U2Rh4trt_QsBubth%{ zjonFSFU#sde_&2W%R08RW!>J*vM%nywf45G&_K&N?P$xIG19Usi!5ta*s@+cfw<4K ztn;Zb$KS$rVD*JdEbHFSE$iS$jjS_wZDjr4vyt`Tm`0YA2eSHPF4wAo+IFHve7TYP zFVR~i=QXkRp7Zky99k!TSpNIT|9iRBQ(V6|%wlzBt8!atYzBsc6+wR~-GX5Qx!0C* zEACxcQ9&!#r^FvB4oE{Vt~4+>Tofn>%N-$)?m@-CP=1A7jN7KK{azK+!6_gz~~ju#7%}dB4irGG;$1$BWuG zx9zvAsHt`8`wNbncYV4wr&q^cA3b~8F!wPWa;RHtFqezmqa8PW4o|BaLlS>e(keX;QEv zpY}hgo)q;}+SM7zE{i1{b92Pc)42JAvW*Q+St%dZL*=9UFQd6B?)x#dd9C7h{8_g0P`S;$2X znghF?%cJpn_3@YOoIfd}-SnSFEk!fOU2E^IwcK*`PpC(ql0f0ae!2ZAot33zGOil5 zJ}-3Xp>1nt+L1SNKO9R?>#dH*?z`gL(LLo@oMY$9R*^ftN$e5T!L&oxRc5wHH zXHRTq?R4nH?Z%%K=-DosfTS<=LFJmR?pLux-(dMf$&YB~Qp1^gWVTMO$HHl8R`=~L z@$Y*2Z_Ou0%X@Pa7Clt1@#=mRJ^F+qdL~G^_c9GhW+&yH=k&rIdSp)V?Z@rR*H7lD_0~pVDx7AU>l_JrK)^HoR6u{de>Wb2mOVm5tBB4Hj*`}1rsz5RS1pn`<~-@wq6@WepT zz`Q=ufOFYvxmb)IVuNg`%O2DER}Q}M=kEtcPq+J6($jLw)xQos`b{dUsLJzKl;nm6 z1S?;2 z^Ze|k44V119KFOoY9}epblt4B^uflw^^K06+sqM2@yDzFnwL9^=v!bcVzL9m7rSdo>_`z+rEX)9bJVq9fErb0b z9>XF$j)g0WO9lrf$>2h?OE2e|&s$kL#MkQ@`m9BS8QZy$b;p=TKVH6Dn)T8)mA{O8 z>c{g!VnCeeBX&`_Ei^WD>EmcJtQ_TrmjptldiL3!smNwKYDBrw9Y#$Nr15yzJ$iMDZcEo%%_5Qy23%8r0iurWP>Uw;bxJ zWsW|qq-#N6}Je_g-UEPN_so7V4@oY>X%3!NJH=8``WPB7af%>&H`%?pCn+Fbku4J&@0OKgEG44A0?Bo3Wgs^wbu<{2t8 z^F`~B_^H3-sW=TMzf~q>L!8rdaLR}LmUA_X{Fbt$PRfwPrT%iRo-b{H_({B)p2TI= zdpS?_^ZUvtx{p2dunP%*lksBd&#K%O8k>~kUi9_j-!JOO zp%Y16{n{>g509oJx_ZvDfM)^AT7VI>J}-9FXZQG`*elc5uH=bF+FYZybLvu~RpjbF zkjLdng+FAEVfYwk;pIhex;>~@`-ZD`I6QHZKQeJ}AW|GC%CC%!_ZJ3oBMgu6l+BBa z2oJFupV<%3+bh2PaqFA+Zie;V^3cGYhJQ6#?k(cFg0w#>w}r;0KKf>tmRgydBX*N{ z3}xt{?+-88{_Wyj@H59Ds@ui%lzw(rt0wk)HH-Ff|I9zStvEW(+9CWwt25`9SKraY zvFKvLiJmIwXPm3+xj*(6v0UwIpSO&y=xe?|6kX&wS)K=^A1Zy+ona4<#};Wbd%++$ z9%P*7JdiT86k4F_0Js3Yg|XbYzlM1jyOf)J88`R^T>4?$>~|xv2#MvA*lQ%#fllxV z7^>M`q{}nX$pCr2lD>_UDY2pFQd_{Rx6RteKR-+D zkba(9I5u|MA?eq%bW`1^!2?s;ZOO>g;Wl|Uw2mD@sN z6CD9W9p26jVoFrSVEe>s!f3iyhvezbo{(YnSUC9iTV8wU&6$-_>YQ}t`c-ZVjZIv- z*;D+%Qop4k-$HO#?Jp0%?9vyK^nzhTe!7bb0ckUlIQ$NMY zbxZmxw}r+gE`28V6f!JKvpuXl!F;I>`^I0tyWN&(XJ0+wt8IRGD_4`4WgpC1MXvtQ zJhz8sOL%KkB=fo=;Zi9D*-Z1963{^uZ5Dmmq1ut!fwk$(CqlK;5|^IKsqjVk&u(v7 z2i*B#&t(UsS!ccQP{zs!zUcXfG!i(`Q|zR2TWD<7K+pUV?w~rRteTp7PTMcFJ<|u= z`@-9wU%?Cq$EiKta`msjp1I@4_bIEa%c^p(Po*7-!tnl*e%N}{I^!Q$l zV|t1`Rj&H!evS1^Xw~@n2TNS~CMu`Hj{6`~{LHx%RUfshTdw}Ap>HUOS>xtOOxr)X zU9%2Ovocm5*t*9pSC0JOwvHxRPF1e@>3&W1beq*IrxErrdi9HoH+iuvpd|q zNE&>c>Zx)^8r!a>p0Sq6RsGF!x+I033wowmuW$8D?mY`XJi@J~%3~TjM{BO9+oDc< z=6j_QUwr<%%jw+ZEv;v>^AD*Wde`X>OT&*-yQ*VWBef*1=A6!#1)DCKmWheDr<&HGAt+!r@&1TWPwDmLli91W@4p&Z} zbrKzsN3XK1{iAkreCpoL#!Ig^t6%E(jbAo*hBw{Zn?w)ux-<@RFU{%}AUPv&$+cs2;-{A_ z$Ab8aBYGQ^OE}X{&yzSMehn{sO+(~zzV!7}F2Chm*_%%MHBLESj`g>OS6$ranqkd2 zy<^V;Y5{kBkuoNe$Mykv2A1bKLCThvRoR}Dl zqJzY1!p~YKX^5YDuewM;iBFt{bAH9*)ZgCTvp^yXWKlrt(;rK8ZbQqo9wds_Ec4>; z{+;NY`pVqtY8^MzQJJ<4>L=%F9Tb`PYu(p)^&GR#YdawGDP)XR+94UQ)%h>tuW54V zxsB8UUj141USpP9t*0u}x**x9^~0+_8)@NQ4{D|AuQh}UW*OA@wCqW_6es0UoEcV+ z#ZSU%+0}C-yp-L#&ed|Q;UzvfR#XQ>aq){>+kXiw$Eu6`)_6Fyoys(f2<2FR>#_be z(>KGazg~~{d2ZvfKn9t#HvKitWAmyK$xQ!^`FL&Z;l4Jth3?({=I{E1F~hHqWAi=6 za>jY3?Z{4&@X;ro_)V)`S$oP@wm7|}p;5W})cioPy_SZI?dFyGD_A3864Pb;k-`$* zp+>MS`*FKSOd3oP}d`Vc}tj#1k&DX_8^4+YV zhnKHztH-~eFFPuAz8<#g|7Oi8{Ue|;iA}}zaLFAh-=`*OhvoaiNddmtol>Q)J+nev-^9HBR*H;P;zHyI^ABHss&DU35a`jJ`uX+CR@~PoSQS>9u`sS^~ znF(5NtB0gnraldkzj{5AmbyeT_1oC@=DfRkc`_;&n-}1oudot(-uif_In#Ihy~BRD zI#<@6hbw89RqjY*+x*F;zA59&?d2q7*)jF0!Dy0Csoslgc(;w^UBWRS?*y-fb|90e z%HJQjjY&kELHB$TOhqnOwZqqlJ_Uok!iZys~N( zezT+gvK~nm^Q6UPf#j3B+$_E>&D#2g#w(w?yx9zv*s)z1TPZgxccigx;&l;Z*@^gt z5$1A==qY+EK@Ukk8)PrvSjrf4_k$X-j#0;b+y2_ZI{J!zPQCfys+&KFX7DHYiykWH zXPg@xo)ET|@CnhWAI?%_eAHeTVA|qfmZ4)JWpqKhf~qp7XlHV^+HG!r%x>2=zHNV* z%Uz#xuj3I?9<{7$xfDxFJo|u@@eGh_l(H_@E92>Mj?U$fxWpEM#Nj?h0((kqP9=*LMAs&WmM7o9 zT*uEhga=N(FgEpCR1dx0d+7JQdhcHJqNb~Qx#j9#U%iG6jMuB02(OpvPb*{KGb( z_a4?Ox0@Aezgw>U^{LPKfx^m2V2r&2o3pG>{P$~%Qs}kd?F{Rb$NDxpyZZKX9DSUA zgY=gK49a=iBU18|%@lr)8hfX4&DRq6QLu#6BulJ#-(hkKG}x zopNpJQbT+V(f*2Bg7n?AZP9+A=qkunN;@RS63*=BsZ8UMbLIHo?#$=j6_gXPNjAt{ z>?!?c{qBuJtML>2@A1Y({#jyMagL1}*UBAfY+K+T=Nk|SSITg5LBt=DrK!T9E^+<1 z*~iDHD|zLvFZ(t2&HiZdQw18clXs0Qw_N?>%jc@~B~hCq=bH7n?U>~CM#8r|{kKW) zRu=y?OMc))uN~N`+!h*}c)jB5O(LC4edeQ&#GehaPh_V9SLVLi>iWiV3%1=p(XCq^ z^>+2AR<)Da#>qKmyV7}V3j2(1ZFN3z)W_XMoUrKj_D+hTkF+Z)ccigxGW(din0hQs zr3cZ!``hTr|G8v`PMVU~Pps&ct3Tz|F1F5y4ezs9@>pek!j-yQe4IV9{3+}~aS@=^^lb>Rb;9Wr^n)Y=<#LVg^w;je9yNv9o54vSAR`3s)xNI zVv!0BP0W1B8<*N1Z(NmeN$+LF&uTiVhg+`xnq*Xup)6=u5l~?rdMvGn9!EU(__ZHA zz2AIINA+;a)nAj0>fwCCsX|*1-+_JoRdMY}NnvVx_}+hYuX7){_B2gL^>EA8Uz3cp zN1fWl*WVTO(C5Jyx}Ru`cy5`dr~0_%>hIDgktT<@?NVKo+AfQqe&UW%2VQ%rrlWee zTz$ESkLNy)^5P$IAD6 zV4we-Kf?)XEhk}V_f@WX=sx-?}hW4T9~>%lI)`P8;q#gin6?VNs0W6Ld9fB7qhf#qRlJkV`nLG#LT{u&}w zgpRop=OcP1H%K66I#iajZa4wDaI!QcIvzBlH2%IV^L|-sqV|6bIJCYP*`e$585RF) zD?e~zwx(=VZVQb~bePOprawAZmctwjUw#=&o<;?O{Z->=947{(xS@V*?eL+2$(4cf z3Z6+Y)SC3q#lESWgfY?ZiOx+V)A0Z1y_Y{5ckX-nvvKE-d4E_zJDlqNaMGn0pZe)Z zWA4?f())v3uKw}&hrz*e78J2>0=Z?fuv8^~hf&2U-j$&uAAi&^zV?5xs)<1F4;kV3 z`>A`Jd>-pjKQrT^TfX1&rJeKvM$VA?smfI!-N%}GpR)#aei@@^avPfx7}`H)joW>V zU-r^w%e_qAGs`%Ej>ov$a`~-rXdgRvm0zAqWC8OzYF>)+QTpqS{*nHU zIQg#uDIY4gg~rAxAAN&G_Me8x-=@*8i7%&S{pnnmy8isM)5-lGz4(@kG^tGcAk%Wo z)!)#=>B|Hn&R@vTt@5!(0(~m}37|~g6gqz%H7q3mDHHcxwFte$WrLJ6cl{B+pK@3J zv|^j3#d0i8>?2#Z+!nJ*^uKm$C`0GkI&J3H@OH`271 zUyl7|#H2KqXEhjLP5N`1PNKb|TfC19Flkwf_wjxuvw&Hjs>@TClT#jBn)Ti9TRf_9 zYB_Ps)jw7)cvvZxf3SzBHQ>{~RgTD@((ab!cksbMBjW$i@A4^6o70{&v;#@&hMf(%Guq78;wl|HF$u zRBADy1ldoCeR)z0hMXth{E5M`GN$v7AP%#g>2Aa+hj*=E<6w?^%;S2+WrLKnMD6+) zw~hLvNuV%K!ijUrz^;~C?)X}kQ4XC_=k$&W!qIDW7eeznK5J@neKMa&w@QXxa?!Gq zA>Z;>Z?+SCq+X~zDz4ob`a~bvV-n2=r@FeUjntIb|EikzpT+2zs-HWj;GgEtJrvkY z*3A?r`$lY4ZVQb~o#PGm|7KQ}IV0rp<7o3viZ8EX6PdF$g8yG?I{tvS7r&KewQoH7 z>PaoPyY|m$hfwqod#T(|!9Gl>N8doHziMc}UoQWO$=DA_IW^Z6m9iwsNfFgPtK_Wo zVVi->9h0?HbeyIY$2zwxgJZc4R7|+8=gs)Z9HTZM@k?Bio}?pAjs8lS1>-0JxIbP<7s<>=pJ z``hoYc{Rg2YWj2EJ@ww*FR7j~Z&>tHxyGyeHPCZ#peR^5Nhh>MRc*-s$rYXTekAu* zSvphhJ9163R<_KGZVNI#vlGb6A$e}oexvlCGhq+d6ZV3=LEh1~gZ9t?_J#eRBgnFs zG6v-Xd5PT_4g`7UA@l#_-q#HdhC@L5g@?jn&;xqH;m`|?fGm*m)EoLhU+4$@VF2WS zWb%=46bu3>Q$rvZq~muq4266sfMFotM9Ab?>8BnG@=b)y*FO$MgY+}Tz*z9ZIFK?z z5wP#;W_jv_}?E%!NJXIPJXJmb)F4w(A9>Z#>ko`cqqwzIe*Z}aEE_(0i0Y|! zRe4N9=V(p!ti!Bv?;Dq+ZzGbCdL{b+j0asmdv;c9>!z$X&lxm%%#U5AalolvRqjY* z+tt)J@jA9x*0k%q(~|3%HKDb2{Y$S8$o*^Q(-$;#bWyviJf@*@wB~vyw(LBj)%w+W zR(v^dw*%deZf%Wx^U+WL${6^we+c6C1i9a-+!h*}dh3aTm1o9Bq1%H82K4UwBJnLL%BrmcI4SJT(M_{p*C zr3#pGekOGiR-K&RP_C}HMDF%enaXv)wz`<{>ap5Mf9rm2(^`}B8!~N)Yfapmp65<0 zQ9NpEci6h*5-w3Z?(^&OTjSAvs&gcqk|?bDX?*5yJx+9<$jo!<3bVTMRB@`mJAIYQ z-aKBD^fe#XCZ5$z*BxH3L-*=0x`}hk-MZ>;C-mBFH7-qi?P81Nj~S1qVahg_W4X4? z`TA1j)4%!JQ`yGz_blL9z_Wm70nY-S1w0FQ7Vs?KS-`V^X93Rwo&`J$cotaq7O3In zlKI|K=BUVA9GNF5@11ndVS_t~Uup2jHzn zD`*Ciw=#W5+Fse4b(^2IOO)4%WE$Sv*Utjx{Hd~Alb4r8Po`UYoLg}JiEVznPUq1{ zUP*aTxjR*(yy)jLeFNhI5xd;TCo|EnYP96&`Lj9Da=hsF_<3lerF;uwu6wrRq^Ebg zymf~bQl7*)Wva2Iaz`55)}>b@P}FZqpmzDFRldWPxw46zmPOqs3ggKd-U1zn((KP| z!SC(~k}=Cu&K=3Wzsf0YX6?}OUhD0<4}VABXX%zNV9s6{;b>BU6tV8Dxu3YJpkg@hz<&HGA zHS~}wCg08Zi>eC3&RRHKVhwZjl(_nTXL5b4#p%{n2e%mgOuK`&ck83_m?q9qef9AT z2~3TJjsH%~x+}R}3o_HKGr#Tp!AIj7O=%o$0Hhp9yQK2f)yw`XmT21~=hlF>M>Q$* z$=fsCdarQ*oau`WztOFa$|X+I#jf3#FyBml+_sW<%=>=l1@ZQB-}lQX-y;v0Ip~c? zroSNVs5mX(DtDx@t)X8&>nl0MDJHa=bMu2`vs^7sp^v0e6+Gsu-@o2ks)Fq#|75jL zx7-%9i6!l`KM9R4`o!0T0a;2ZH-s`3kwAcjSHorbQ~mN$Y;I*m+;`Mt?@n$fNo(QN zAN70Wh9htIfA+2fzNupCPuW_5LJ`Cwh-DK*jb#;Z>qad|q0$0HKpNW62GXP^DYUp% zajAPzpW<_iK9{Pf^@)l*>Qe!iS5Xu1&&cvx`h7=n>auThFFbYh7OH>Aa6V+d!4268 zE>m-a;ijf%@o?mD>5YNEJ+op;pUci0HZ!B+*3%wJrC=oN?>PxVo7q`eX^Y74%8E&0&H zD|H;q=kWO&6^B+B2Jj-M*PKTp%ViTvzcPQHvPXU6r|Ec@&p7xR9Z$B$>nMdrU3ZCD zedKwa9%$gNmR_jskj5zZYF>{QTNh=DXCA5PaF$lDF`seqwOM>>1%ijw@}}(3$Z|?) zj2E}`9c}w)Xnm%RgZUgjUt5Gji#vKZ0OI&dcq}rmm2bq0caNXwNh*A>pN@<9>Qq^5!wLH7~ke7_yTXoi;JHVpZ+%Yk`Hx!%vZ6|{Z8U* zK4MLe)%dM?+$vAK9X0BhcoE3D=*!=-2d+1Acc{K&egwQ`J!~|kf_gJaEe!O4dCeE= zab@|XJQ2CyLa#Ku`^@S&YkH)bugm(EQ0aVjSLCPRah7DbJjL^&=u>L3pc)aJ`2ltpWa^>Lu-3_!VZT}dqUUU?*TyN4tYE`GQTw}*m^dAk!5 zQ0wdDXCjwNjf1*~7b?bgnEayOL*uDrXfHX{JIt3%#ZvM$_2pbnH%2W;;ZuP})$5j5 zX7@RU1Pd!`zq39HE(-4ZYiF0g^un>vbI^o~(CK`34~HufAho`!dO5P33NMcrhuzWo zq^{-TD`-zV8I}|C4Q|M88J+@9=s8nykEN`9>hlJ$H?Aq@bLZX4>GQ#nZaFjgKy z2>ZZ-ILx3o+H^4VZ-}BrP1SOPs)b;P6AQL|2L*O4F3aiTFMiHxR~N zFlv7^VO8}0-!s17>()K>*>Z+P@kg+`O%_Lq(b6({sH8#2 zdOk_TYHRyy<-h~v{8b%r&Z!(dcEzpnV)g8MpSk?SgBG#EZo)(DQ07Zd70ZgJ+==#Q z2p6}Z@cbqa^*5vG4WzP~)(_En4pes2+5?)?>j$DKwc|k(K@QMj5FHo&At(h2d?9Ev z=u9N~F-ZKwP&h5b2OJ7dGvH|=Jbe%q_B>S1S7RXlZ+($JjuzrtC{sECijYPZBb@V4 z-k}r!%zHvS)GJP0cr6X*k|>KD%4x96sJ@iUPXGWyIIwMIMK!1s*c#Ac#leriVD*3vY`T*K8bg z$!G7roqaj@WH{cLZ*W7lg2xOte8dOv3gZ~`iWP@G?mehHL2OAobJ+V&d_DCO#0wc3 zi=gz!e92U-Je-wGibri@t128`^n~0vSjt9Rbc;y)HWn&)D!s+>Avx>i3@MF=KZxoe zzDD4q@{;AmWv6=H$(I8^Ncc4Gtk)TWvA$rm(E041@9-{g7CWYSyz_A~Z?@A7ZT6%_ z*elh)Vt^*oS)rTEkqIVi* zjhr&OU&G12njTQR_eAV7-(&|bbe?*a-EW_R{vzfKii>d!wGB+1#3Ikgf@HCP2&ZnZymt?X*6tB#eOvNHR=+F8c6r;FvRLIB+La4#B z9DdPjR(a^-e)Vs(6Sw{SiD{b_pJIE0A{AyVh{9*SWGa?5d>O25YA)gM$*0u(wOI>a zkB^);+lkqkH??|VO3mf`{Tx2?m7wLVHT7ozP1@q|{)ew#*>4H)OA0VV5LJ=wBMLi#w+K7aV!ZO7#uL<~1Wj&QO z+9P_qjK1;XAz7=>2u!6S zO`06j*7>HhI)99oJq|T2bGk}!h&j8f?XsG8tnDE^{Hn{7MEQj_&zfiY%;J1G03K1h zkooK{U&EbaV=MrYv#xSI8;*0ZtoKP+9~npL|JsRnPZ)E}v0wFBLG2$hjDz_GH)JdQ zFC}=I^rh1!yp_cm7NDoqd8j}X9Q1rqpU>a>G4L!6UrUo>+B)BGwan*hIOI7xhCCD( zeow_U3g;G(Ne59msK*nzwZ8Jal4r$>|D}5}hQ6y_P56eZ1y}U-hFK23y|_%is3nuq;w>^R6H@>$s_g@6BS$injtR`(s!!DXwl#{p>V9Y^ z4qMk_?H37`eoNy#WD-D>-G8+lk6s z+9Yn=HuwW`*g~Y>eM+y)*S|VU2a;M6wF66Qg!C zOoJt?eur^5@s!CEraHVO&SHPQ8~`=m(9;!h`+_Jf#nK8%W8WIJT~zmJ^m?r9;{%JDxZ0LWjFpG?YgtiNAoY{{@0X%ny&|a7CB!Re%?-8 z^0=q#+5_g*J#C7M@-?+Pn6FDw$=BG2Vq{<1)|llfuB0gx)xFY~e3D+Iz@~bP)&b`L z*AvHYU02+*WcZU8Jl>VkzUm%O+*kCyc{=66QRe$Reo608AIRtj;ieg*%3~D1m-2Xe zGtUxx^`e1aUUAxpLVkq8A+tu~8(j4N919EVb7&sWmWxjDR3|3NaRTnd%JMl5@1(hz zl|H|xyugXGJ14obonD`RqQ8RPO#!hywr_4{375hQz*6gdu!4rlC5l-lE~AJ~hTbQN znLQ@~wY^pQUu!X(hdI1HtWrS>waRb)#~gUpoC%oLbr)CL08@(5 zhou9?zI?F% zMz7|8)O@d&Z^6MbGmJ===E@H)7x>D4a2cZW**$jsV!{x4w55im$0Mzej5ao> zz8|~avl7tbhsrG~8)9bvkboXPbUrZ6eehb4{R8D+7ex&|o!bd3Q4dFJpMP6^Z;z?J zUT_PSmBv0HA-0)(U6K`FbQIz@ z44yoO1b-I>ZP#|i`czaPzXRHVXjohX;mz$QuufBme_+5j1&cMukAiBl$^^f#=LJrrxZ(&9v?vN$p2T3la> z6QBMXC;onXE75jwE74ZAJEJ?ZjBW>ME_qBid%i9P`9BvQebGAZk&pVtt$*p{xDMSb;&M*AIqsHY8sjF7J)qT*MdMlx zpS7gbjl(}~b?~ppx4vu3?X6#!e^8q~JO0*&;vZ3aF2z$Vh|_V(Pm$9JJ)d!Rb-#X3 zTzBR_so@1 zh*T4cCsi7I?_O`0Q#=^C*@_|Db9x-o8!JFuF07zJ8YUeio`2s7_JDX&(iB4XPWtCzaY%w1XWuU7- zFM>MbqbosiDD$2Jt;WX1U!|{^$i#1;K@d-RC2Gm^DZ+XpCH>^cHNrvKY2yEs{reZ<4 z%K|&b9Xgq>e;wCg43a zr-8Plh+p!qI<#)s&%LRfCnM7pY~~x>kR9B|pln@0tH{($!+Vfz6HUc%VcQ>sh4vxS zybQ%VB~>&ni=2+%R0k)RVnCxcD}%>+3?RiH~iH-Y{MdIj`3C>|ej z6lf~wBG6NypF!zJH%mZYgQg(;yb8+4$5UJAW~3ztL^clTDHjQ|5^3rsfX(iR_6)#o z0oZ{^Uk_j)r4EOzucy5^D1g`Z72@H67!x}h^*9<{k7A$BCmFzu1pL-i_&o)A@on%heJ@5xr; z+(TQ7TP|-cMs;W-7TnlIymnGs(f*gV;`GLLV*U&9V(R(?@pjktV#1jn#QJWDqVn@j zqWdpNVohOJ@t^kHMgK#4i0^LdC9b(4MU?d)AhJ#!EFK@3D$@g}XFv<4=Y-#^^S?=O zqd2NXdoQO=rxe_Z`$k>y$q{Wbmx3h?UE{FJo%tp^c$soat_^F_vI?^uc7LVUk?-*P zY*}6p=})7F8bF+%Rv>&b=^#W|6a9rbS@B}}i&B()03ledrGi<&h4snJ<}&)ujHL;IPj}Ej<*9S5YZ@ z6Yy95(tm`0!EFLNkr#CX8NT)}9xGOX=m5g#4*XKTK;4LxCEzK)yu3S@b^ zbGWVhdh1(&r{Tdjp1fzw@dMDzl!oNk8FFO4$qrtc$3x4if&#SmE~Ic(L0j8rh1gS0 zCLI(mz8k;lC?;)u;>i!6kGq=M%w(t?KGlw>|UU<%QHIAw$n4!e+i?DpvD&%_Ir^*glUt-ES46 zSP4HES897JF6#TBOCcH#h!>w+{CrjpI=1WAE_^uo#ivtgUWg33D^iZkmrTWK9@hlB z&!0;RN&FtS!%)Dm)43-!o*k)Q&+R`-CDgx1H%g`xY8#>}CHsA}jDeB{_bt$^l6^p$ zqo#2H3^NOKvE-Uzk_(cK94A%dbyXDk4H^Xbc7HK<`5iBGby9@FP(OvzA@e0uv35m% z^m+=2;+5tBHUk&0PdezD8O{R{w(6eHA>`ig?UTweJYn7c0(Ua$AiUaSy+hi)UBzWj zcRzmNLo<7ke94fE>ARROnTll{=gIJT7W$xdU>qxw&$U-&Vi3WPUXeMhW4>F5YcRcb zwBn+9grRU>Ux@MlRpZVrTa+NYYx2j{-n{KOqX!ql#e4;lyp>2C&`ZnYI!>26kO{+!Q9}at4*&E;iHm&o!;*c>nZamu4}hxhAwrYEqZ;LKKiwsn-2Rmhw&Kg(w;)+vwIMyMeor#cSR)^KE}PG z*wpBKWa5YfFKS$yITlOMPe$VvW5+hL(V%wi)O@!c-$ACi^iaPgUUW%+q38H#7RKr6 zf%%M|ufgxwspLz2)q?5@M^pXfYWY=nP-ML8x5bNZ3woV#^@Wp9Kf`Vy;(h@087E(Z zczL{A>gk{4b(T8aQ166=N=^?dy^z<;T_jfy-r_Ozq!=>_oN`0Nr?oDt- z%~RA*#aO)A;Z@^#6Y!B~E}j#9j2CB*NdI-c`=%T{o|(_M_}T=Y(b%))6ck`0Zf7Fj z@KMEEcW`99qkf7P@BMt(ge|kn?$+xm<}*&dwj6H@Dld2%00rYeIWpe*U*pA1Pi=nU z!{Y0=>+)qjZ-g_9*zaw@wh>{`ktMx3+yWTF1wH#>Lkr_;M>< zekT^qQ&y(75*0_YQ)kQ3Cg$yYvJmQbtn3k4&V%9;g!{vB>l)uGEYiP&`HY{hE&2|8 zmhAP-9y;6Oojq(9lDB2vuHul$-%*v6BpyF|)y3)mdL>t{=a|p<`P$?=&<^l>iajn{ z&X6Iy09ehBDLo_OE&RT-cxCPdzbzj1_wNUr?MAMbna?=++H$-t%a3Y0*&GFLa$`V&h8r$^R2uZE) zYI=p_9tUS#zhc9h&SFMN#=^@B?^=G#Ame?~qfYH1<{R9Q9YkztXAsxy<22E)I2Ri} z5H`G^@{Y!B0>IU-CTH>4_h0`b^|`4ot2Nze{pKJj=p?*U-_VuEwP>JfL$9wlB)u0e zoLk=bd&ZiJzUT*cGPJINa5G;r6)VGDJRft*3(*$Ogl-RqEi-dsJ~pFx<~tpkWp+1) z9B6Zl1?Sd&p>c*M`hPC>w*>%*zJvF-DM9R!TN=9~8Bwp3WI@L463ctyF<&zN;#Mqv z_U{Bh#f+MNsC^x74tRIsacA=b*7M z_Pv{qEWYQ2ukSHxM{YkdU&T)MyNKV?4&NRH*H)}=efQ>jHh22GthCh+#y2o7=C>SI z)OqA^g16wUKRmJ=3Cp>QJFlus8U5maQVnF34$_bgm~U`HcJp#H2anL*+==OAOTReb z2x~i#=P`Lcd23^5;h%W^M=1|ozhkUfaI<`wA3|!}HIG-HPYx?iu?gO&^%wcNGj#?( z%U61Te=?f@W>>$DavsT_%>Md)HNeK@VlC1anRF20)#ste?bMnJI()ln33oHhws)&0 ze0r9QQ5@!A=pE|PX^h(3+-|sr=Jn-1wZYc(P4c7mkY!%=!h=RQ*Jb@;lxnQ!rj=M` z^4VX$s^L$mD8bJ9u?w(rT@F9cGgTn|{(6K@hQFWI645;KcF^oA7S-V*rd>1Yie(9v zuj}D6pPo@o)9~}1iyX#Y12tXIx`YMli{`!B4@^DMicgQ9`sG-^ar(_)XMb_bS;nlM z;V1P2nXd;CnxA(-D@qA^ebgBopKr@{_>0Se98rT8Sx$vVTXB%y2$EF;@Qvs_bWzTu z@gie=_V-I2|4DiE;2|>N{Vf%)-8gwt{CD7-fP6+roPzC4#(2t<; z0J03!8wvIfP#OUJ2wDSB&jZwd0BQsPJ&Oj%WtiZ)0}*~O7Po(gj`}zNvH{Q&SR`-& z038QF3jpYI0D2yPGV>tYS-@0|`5mlAY5g}LzP%sc_6qL52DWZ-;=7DE@pDz2=&&MA z+=GoOOQ*FGo3Vyp3~4PMe7v39YtvFv${3B|C%(~8PvzAWu@s?3t6UFSc_pV)9`d~ZS|3HTFJEarmOQvFlMr%== z$m9G>Rb1+Mz@Z&MB7k=}-PYQy=~l->dl-JHPCRhd!oOds<6*u6Mc(cto+cAA>bT(g z)X4a%x+jXSej0QBuu&;49Ut>|7hh<(8Ye zk|;j8YIaSxQ_t!*66G-&+P_NW4D%&Zv4ZVl%eZbRw>MeAqD~%}=S@kL>8FY}Wmsgq zd50#7PGVGbaYd{ak6#=Gh8L~(xnbX!Tc4&Ohl;bs0GiZ_aUH$}mlG&oV5mi^%G z{-b;SZli_8Fq|HkZ*W8QuF5x*BTb!tXxx*pYI>*}8Ckw*M<`&M#j4-wTrl+XV(Q!kMrCy&4k2wnIA%G-0d7* zCApe_^(3L<-5LdNMQWm$`p&7(K7Q%u?2|P4GJlux%ItMUC06JJOW<%hPQ@D-6W?|kgTQ#JWAfA{ce@&#aBzAF#_*RO@6BjerLzq6P!IQ^9y9~@gj&xPwxrR64y?0~S6WTh=C6v3ki2Ldq6DOm-*>N%Us!TS-;o?X zjfv1|BAw6fL3xG8RgD$Gax>c;Cys)xwq;h9n>x+%%baul`NhVnd~1IsB{MqCixwaJ zUB_v?E@m8zQ|Gh$AAmDdjlom3ebS)e)#n`~hWp>IzxPA;YQ{tPLFNjL&+arAM62xc z%k0?Z#{cLTU>7tWLJc|X2*d;Yyqf-MPqxZ09G(|%?~!oDxFM7bq+vWdpWPWjcs%(I z7uuQ_i?Y$6gHOR0KnPTB?C$!vAW#Ohlh;V^Qt4-Uoj1f#YXV*{8ZELD3kyw>fIS zndGj!Szw05j=AMCqiv+{f_m@ zcjQbOTuk2)0C7B3jW^~c(!itgkMbF%7j-?s37vla?b3k{e8+PibdAGI2=npRVw!wM ze&rmTP9{%~qHz-1s)6GUum*jB(^Kh_`uht!#{MVrC;(!7$)^}{P6Lndg=?=|b8qAF zv{X^at=A9} zBBzt0(-TGNx9@*;#o%{u(bEa@;hn`a!M{8EU?QX>^*dHY`Hnh!qR6j4=f!i@7R2k{ z!F;!s7IllN*W;N>AKh*xs&{_}e$O1uIK1-Zu8q)0Vtadr1Ak z33wvZZ(+Vi!~=mNFL^8w{*9-l3}ME>&`{Y%3KwcS`V(JG&C_@-?;EdKjfzcrfM z@PhH_{D}Bk08VXRCryfu>#%2U&Yw2p=mR-i#-;PwJ*?a!2uqbyJ@8QaNe9uD8sT$6 zRYzf8%Jlo6#jW^tQ0uF{>vttMhG9H9pWVaaNq1piJx2XVDPl3DD;gKbsP;R2h-KqV z6<1nbbX?=UzGB^)&G%p>jbRv<&S&=);es;uh3J{6$kh02IMo_|qA_0fI~#%bhjYiC zxV04PHm*xw@Z5si8oJFRiH7nW^BE6cBjZ8_NH0-QiA{Ks%7K>X$Dy20^?D+R^lNqp zQQ3Yth*oQ*f$~8v&=sH+psk?MfW8#e6&2}n(1oZ>uR~7xsjUz%Lj--`=@58&3_P6! zPY1%&?E{4H!_#?bLVN~KPcDc4(<`9|{&67|ek;UzW8%a=Zio|?9n?yE^Jpv4_mbA) ztG~Aq7yk}VAxBKn%XLL52%qbvM#!7%rLNyqCsQ1&@liB6dOEpa!f*Api)RJ!sx+KV zbUwR>j}K$3I32lL;qm&@OR^kpABF+&l8R?5@Q_IdQS9sGPMtGRyjyN-<$d$qTgaUZ z;i2^j%$H2XYJ#Vr%;_z`-aZUM7_ALDT8MUYK_OJhP*H<-xt^%Vx5|gwL{#9Z=WLeE z*f_y|S^OAtSV`h(1)KSJ++u=wFi47pggDd4?WYx5ekwd*Qa~JkbqJs1Z`8J|PV}v+ zdxPRWr#!oZ?%t@lmz-8Ukla;y7Zq6LT>^J~9H{rTpW4$unRN!7q#-{@>N;PtVFka> zvK}PgGgmn|jwB9UM)DQPGc51zQ>=Ja&NA>MgFokBr%0WjD12AGvv%eSZ+FNxs^wt( zGoNwrHHc?|T_1xYol0Sbp=|jMpAXt#ra7UxZlUdDd&Q8{)YNhxhJC6=$UBnJCJ^Cn zNjXAa#bpVWG)lc%R6$XBLgUwcK!ZTY{_^bC99(I>dLHOJ(9IyKOg4jh#GzaOQ3jy( zly;Oa{{fwc#F>V~IS9o8RAq~$2=rL2qqKEEoTIF%OhOrhIps0QsHafg+}n?I{$btz zaOgWe2|AQ>g&=uzIkF02alEXY8aZAXU6{9isMU_!9-R7s9xu#?cNPhw_jQoYUXde*02;Z77o>Ms6y z)DK;{e51ANnXf>Rx8d=~23Tlrgw?83m>`bd1_ckvDctz$=nvkxHGAy5|H4@sns=q0 z%{pJQVP)W?-T5|*#N^>b8Aq`(xgRP{E%QX9PP4`jiUZl6;r-A#3ll}_)7Sj^h`-H{ zhs^*uewfeU@-@6Xg7HIBWmG&`);BZ)2bpwGxOk}tj`OxXbKQG~zU=v*7B9?~9w=6L z9L>aw4Gn0Se5~UN6*D5^qTm|+{Yzh+Rn(#opzVRZ}^;o3zxH1 zz|HMEZ`DN}!c=3r)A-SLxU1=a|2XAHf;EK-V<%$0K@WU zzQGOI`8ZU_OEYn_p(He7Vap$zIc4%#YdK$gdgSmM&PfzU-Z$&)hsWRWLY)~tni#U2 zXMQMT0%yhSDen1h&q8ArvsE4mv#ofjO@$_oU_EG6-3}B(<_|6`-n4Yl zA~Rr?2lGvK@DjvB8F;L_#83|#6o(}~Y7st}bP&Z0*E2kRwE4V5aewL7ZA+g$Zulcw zdB%KtUp2w-Y0PMnn@|i5g>Eeul8UU~PiPWAMQ8^uXrFpN`P=r+-x_*<-1foK=no8i ze{0yxmrTV9hR-(>919#S+axz~VFjidDZP)U{aLyre~ep>v5oO4!`e{Hn(js9~R z^rD$h&!~ojm#ayXcxWbBSjx*m_Q>&)j00#II%h1~)_d{T=}9Cp0}r)Fn6F}?`yd`m zyfj6Vf@e8D=Ku%i=T&EArcs@)mg|jhSMxJvnYN%hEbe=1*wI(#)MDNBl7rLN47%EOtY?T+Sfh0g%{~ae>GuF+h zfxOKJ!};ez1*Ad0vf& zT7*xA(hH^EaP8T99H+gM{?obd(sN{t^wL}Ce8V+tdcmRwmI~5~+0IvSBsrqv7_e;P zSL-@n@(72+ICMU{bBId*0glNi1ZAoL_azNI_>gDjbsBly;j1Vt0|)j% zntTqQuVHX-dNAhBpmL}Zl>)2@0fdRW?dGgLo%G- znQw4Ib{L%Fd|@R!&P}Q;edgHQ1XJFe04((%a7K&&+$YwYdUx_&v+wQxz=+>a&v5)t zH2EQf#$7m^ZXCjHcNNgWUq9pF_fl}fa$N~L93IQn68~k<@zzY4bKc)yxF%c2d!EVX zaQPYruZ({kt%|b@I5-@}smis;Y0cl%q3j0Qj`w;Ef8zlP`=`YpT)y@0r;nz4GMvA4 zzTw(zIb)Hjq0h^R=`y@Xa^0EnJ?dX$xJ|Z2N#_KO@ljpX14Q`xg9d}>dyo|5c)j}F zTk+kLp1FKYz&-hyH!@DF>9BZREzMrHpV18j=|i8@}f&^JCYT1opNB z_C&+p`V+g4N#Ku^fSzCeNWYu&i~BD$9z&$(i*R`* z9IrY5WBix|_LKznMSh{t9~$?d_88SKL~5Q1mp8)k@LJ5oB(PT{urKlpeISiHQhuRv zGR`x&4H`Xv=>LNc#%^K~*ozXNg-bNvO!GdCORVGHR1eS?co7mbuWPvW-_LgFx8b|N zl*Y*zbwew`e1jXZgY)npFN3z=G&;eQ2SS0Mo_qv z9%A{ABw-jmekkvd{HP5tH;W<5i_VhQ?xS=|~8jF|65)T(Y zR0dIdg$(B*mLsQqz8X)(>^&ucaPdR+0j*J`_5s%uYW#4V?I}z#e?t<`66O9HX{vbQ813+MlX1OoU7 z?niCEJ=BjP{U%NHyn{EW{I?S}{BU_Oor6h+E`4D$UosUds7HkLbf7=w_Y`|vww$5Z z;_daZa{Q3Ki~^73OYN{CfB^LI8^!yux7^n;A;1oP_z3saV1M-9*n76itwF zWO=|a)R2T!CX)sVo6leEa=@Q`QD4(|35}ufI57P;B!e5%gc~E}w9C)Lt}zMhZ3*c4 zh0?8_E-CG*>6hH;zdlX~R`6YN=jYfzy2eaQ0)J)+1dxcswI9Rfg+KFm{#mgH0G!(= zwaX*7PioIg5C^1QUUl)2?GB;%BSTkepDC@9C(d$1IZbovM+st=Z%G#jwL`d^ zRj+)%%bx#5UQESzs`;CA29VCa=1jQwq&T3I$7KSw3)v7)uN&DdcKzcepvO-df{5jX zKVHte>Z2Y%(fpzO!~5Upo`~`nw?}a+4aYHGna@||^OgB@4aZa6|4R3I{M-`d<4JZg z`9%@ZALyI{zo@<K;o>Y7mk`h%HhTYi zcY<@Z@a1rE-NIL+KBoK4|M|)u{L%l}-T%)Xa^y029{8(E(zq3sly`1T3&CiY|GhW_53P5A5{n)b6n!MxW~ zj6-WO?8Wm-y*OH@#8EO7s=Ko$<+2u2oVaKl;2o(P4p&x$;}Hg(PyeYNrhVwN2ZsLZ z&wv#(F$w&sB*6P1Xn%Tr3-YmV{IHaiE%7h$M~;*?BZbaqcbw=~?v&?E`D~V{KzSC2 zEtIA6tKG%O>KQIi@q9-~R;8oBlV0qvwEGR6>gu}g^((FW=qW$ayd>+9rLbp=zV06n zPncM9ICUst=o$x``35&+(=id_d>+y;k7LV99CCWnHZ46r*OuWZv(q82UV574#rx)I zOo@VEedP4a{!lKc@+x}HI(|y$IgpOt#!4Yd$G??|J?@wiN>#K z{$vxzx5=b~D4py3sK~9=o0s-4_SMm{9chgG5Z8py?z_BBd9K%9j*V0)@QBCX#k=w1 zrCyiL9eCP8-&*h~Y;~TX7Vc!yLFAT}(OJ$Dq@EzeFH={Zkye!;%1+ui_^#ycy=Wek z49&^YJOT41Q?W8Vp7~CPJZG71eCfqBlZ!LYGw7`IeCHxyB%|U;`XDlniudA0!?iDe z+u`gNmmO)m9>l?XlO4P?i=)8fx4TSKI2y4CZ>aMTyx)yHQt#y39NjM%fgE&+92L%o&`_58f~+ywD?+j~+5t^NI}{zn@8Ueqg?iBx-(c zvLn*)A%F{)GdUlI@<+J+*eRaQ;@7s``#O!E_HNc0Mk=CtHNwSw!`F}<#FgbKt}J)B z{pL2!&^n9)kG|ew>;gQO?ex;h3sr7OA4SHus;;xR>G}BVX=C2J`uZhSe9R9aGwxb~ zZvs|)@Nb5oLF!tsDaQXj_#6vMcX@#UsDV4&Dt)+qxV#Xo?H6L&KCUQPbehK;b z?d4Am@jo&qX#~wYh1Lx)-{Lv`1oLs8-5Iu!L3!fykE2~y@(F%FmXBEy#u_wgi>Uc{ zPnRE|&|`Oh1_|uz{Ib8KN2=qfuR{G4&M!ubWEP>@K_nR)NjqMrAvq@6)MTu=t4c4=wtH zeKYEtIHB{|J=mYKEbbrYuBhY@B;(!_8c31~{A`(?1r9HIc{Vzy&Qs~1;&XUUcKH02 zUWbj9teeNz(fCp<-?PMH{lAbTVt36+AeLXOlA*p|%)}(noCIR|B_x?xyD}t;*j;!D z?CbopH^xE2f4P+#8(*}_Bla)61Oi}lKP=(b$n$D>-p=A5OD}uhaov(``usif^-zNS zFxIC&!C{||?$uD6*70gOjW4}Y@vS#c`AmmPxb+3wujwqV@%XOVbkL+_`usifcLQH= z8eeu44Ydxj{+}YySpBRBBX%2B0*&Buc~c*kAfIV2Ki5=t7QeK4`@RVe4SQBEZb4ON}R?`s?Sb(r_O zSN|U7@6z|+^D?1+#y@-LY>#*LFxzf?&q@H`_!-qY^7jn7zO#7zxCi2UG_LtZFK?N@ zOW(5-@e?eR&GlX?{=)W=@fZHRvpDjnNehQ`JTyVa&-`7&zZ3DH#ACJ*h+F`jPy|f8+7N$?cboxZE75rgHyq ztkPvZJ)@c??JxEGtlemr)FTkay`lxUmkn?G)w|n!ef&2KH}h4@bib>(_4>O(!CBTZ zx_mFVZu$C$2OQA2Si{Nuox&M$?W(DgaBihbUBIg1%}I)mcf{61>&`7NerKHtjM76d zqzC5jGTzV`Y6Tv-);2ueSa~0kaIAe4l11z;yaX)k=9Tz)f$arAd8`qR< zyJjjaOof>aqWw9{mrTVny5DQ|6*?ioRCp93(m)6xPKRten3KB%ejc-=JvSH*^JRi>c zHhLg!--z%jU8RHQO6#m?S4bTcD?K&r=&Nxnmao33 zr0j|9!^n*c;b?^)^CeTUg5gi_6x&@nj!Li7=XVzSY`L_5)KQY|_j{dlkm$^JYH?*e zh20{{qhWbxQT2swSmTv%6}(`+-y2s-@60#Z!AlU2DUYDm%OJFZ>I#R?BA3lkaO6GO zS)AX$>sQ;;&I#hkH*qjO2*AA2aRlSVCnLr-xzZg(gl(-BJXHrpmJ0=u`RvFJH7V;C zn!$-_@@85SKD$T5W0X}=tEzk@0Gs0}xw{pQp6^#3ks#bt*C+NoBm2A=W_dXV?^8T6 zUwW!oK|I!cr52OENpqEKrWTs;rv}9Mw)U{5>wm+I#v_*k_pFoeajw50LELvm?Nigr zuc)T^5;Byo2_N$%Q?V3$#g*6(o$YkEN^H`m1SASEu}I<1==;S}{2Jvc@|WfuId73T zXf}x?NNct!d}^;yxk$P?X`?ym>r4XCc@YPKx`OD8Dbjb=9Yke)GN=dW5D=~5?FAy; zwv->JEK33P0rds-1N8?D0HNv-s7Ayf&=H`)pd&#?fsO{*K*xYmK|?@8LBl}9K_ft< zKloVCD9~sS#p`jP<3ZSVE=~lU1WE&?gEBywpe)c>P&VjfP!4DuXguf?&;(E}Xd-A5 zC=YZhi0Tc>TLqvgps65A+l3%1t4{;X0L=u=0-X+;4JrcJL32RGpb`+3Ideg!pfZpX zG!HZ%dfzAe<13DK}13C|MK4>xM z0?>t^i$E8HYC)HPE(Ki%x*T)`=t|I4pgPbJ(AA)8K-Yr)2D%P(J!mQD2GHL@H-c^g z-3+<~bSo$Tx(#$Y=pUdvKzD-f0^JR&2i*g@7jz$J8R&k{1E2>%4WNfW{{%e@S`K;y z^eE^t&RdRwOZ6%E6jLBIoO}%M!$(Q4intQ|Z`)+SAK0tw5BonJ<}&6(wKW^3nL2gw~Oh z5(W&#JC`%tfrm^wC=R5TgXFf&*=E(I(I=DGq@m~NX`L_Gu<|P$E>~umqj=sC2G{&2q0gGwI=s!j-p}3e0zS7dVR@HVY0a zj~GWnZ)-m62DgJi6+gy_n;tG1L4N1Acb)fH+g{g^Y{(dL!uXiUH@G2N295?I()~22 zy9BLiq<^oc+#%bM4qtv{MTN)fA8O0+_{;Dbm4A#U&;mR^ZoB7*&C^#6$?c;0K*crcu;_AHo$>h65v8wx&fzjHozLzq#x)Tt-4{4aR90M#Ex`5G zo#!PTnmLth84q8>;0m#t zNn7-80L1Alp-*&N2cLB54<~v%QWYx=%S-38dk91@y@yyjE-j6bAFA8}Ex@<+vGIr9 zV|UX=Pe`nbwer_bp(%I^R^nBtSqfe3nt8MjuUP_yvMcw zy5}Pu2lICgheb5fiyGLRe@0<^j7&O+$~Ar5m)yQT>e|1}Ev)~A?#a+t2-!McvS9_& zuRiW;j4xXH(Pc+k+cQ+>wFBjK7h>)6|L#qG-co#_E3wZnE9st$(T;D`gm1XgJh9KW z5IxmgyBn*Ry>i+^R=-dkh%==y+l|=}ha4)CuLSVn&DF>B0M)l#=ThCA2s*$d!b)-@ zOoW~8$?(zL*vK&@UN)TOLjdxXaxamSYeC7uOHg6(^uSg;V&yyVJ{OU5`c;fi2>xz4p z3?K2>%!!nDt4w#PCl~Hy(m_k8? zQvsrInJ<}&6%3a~xg6e8D;?fysPL@7IG=+aQ@?vX!jIO@Z9j6;+Kkf{=W`JB-SqW3 zpWTDu%aCok4k%M7fnyDbzdJC*D(}EWaYny66W{jErf2FN?<}S-d-C*kCl)VBJ<#x( z<;{G98?v=zd$jm&(yJV?Kt$*Zaq75Z8x>yoq`jz!Ur(X+y2?*9LA>U-SI( z(h&*bs=l>t&iH0rN9t#jp)187^CeTU^mYdS&-Y`E1)WamaMQG$%O&TVF`7BSgRy(F z5d?qgL5y#66nu@q*RgKQ@>jdq-qP_gUx6lX84tIE_`iX#(&_S#bGHDd1!vu`=;<&w zXHuIjH@*L$k#hLV+XTVSfj<)>DV$uptel~zuo@v9Q<9zDnbyq(9;k{lRC-Zj> zXN%;i!nMeCGw_n(a!uD4Om45;dew%Z4`-fC_hgJW5}NQ0*QV`YYy3x%>jW$hau?Gu zvPG^5BctQI{?H>kR(*3dTJVNpoI0P~8P{&4Q=0-;&IhaIhY>!@i$iUCrFv~w-m5j= zqxz{1@}aVY;;}i?_PB{V?jCyQFPmth0>&t((eE+&1~+7DvRa<}7W-P}q44(97Y1i!;*7jRtX z*nL@cza5ZjnPr687P^62R4u59+OkGo%8}lW;m+;7Qy!X;N;0Z9-6@@lG10%v zmGjCCMRi-=z-!X*ca>{=b`Q!|`>sUET&{EPCTDe#c5qg{uzwH0kE+dLAHGyoA1|%H$iNhV16P$7bY%@QDqtr+^rDJ#eYv5^gm;3Y) z8SZ4#LG-R(Pi=i5L3}o0#%WLfXVAgqPKLgd+U?AjOvTdM8yKc^WH|f_9S*l_8mGHU zjL$RQQSnrr7#UApLxNb<|Jjli4{WK?@i1S3B5!p(M&P0H);G=WRH{+SxW70lGM=Tq zJB!@cpX_?`sn;L3o(#3q$kzFi4Xa7KpbO`6kg`EHR$|exa;eA9 z59yJH$4X3(YH=kwQF?9w&N%!}2hmj@M@ao=g6Mt!H)&^ncF2KAa3@1COzD~VlBrk> zf!oiFkk%K=3ft`2t2nB%tT<>agTg6-U>CGcrR8^G%ZB4GP2Bu74`)cMgjna(vt)D} z7-(OBS#OWq?#j0>aAafT2^t!QiU2;Gu z!&l>9%-)j{Q0t?Fv6O2=cVLce=*8u}jC;m18Um6e)O@>w%p7P<#Hwx{ZaDE^3ir)coF(w9?!& z&G8lZQE&eUKcWT_dmtu({Y(O}e7K)QNDR(jQUbAj_?L|K*hlYY5{Tu){VYOaaQ>1K zQ2Vp%(SM}=X*!7dX>?EH4eEZj^8eg@$oF^O`2pC{82!08q4U{2*q;q;q_gE?>;HTQ zZU3Q_%^0InR{W{sWMXP`JlD70mQhi8a2@w6=}P?0vAf50$X6rLtr&1bF(@{O#$)tnG zO`pd|UY;P%x#8oyj;|f_jyX&d9H(JEy|0>3I&zki+SE|;KH1@>G=*eM&!>PG=PKaf zar&7{l1@ERbKk7EzjH?EowWBweLrDZ=>4r{7FJ)NxetOn%i+ak$9icIh&pe$67JFR z_pe`!`0>KVr4^L#$;f*@|wO5eMzV9rybZcnWiSBG2*F}(E02hjGrJ7qomQ-px599 ziXWOESf$~haaO{@>(p>7%8nWz_r&;5i|C#Vr~xO@$UPdB_wz!sX{ z%JjHga-M)nKdc`J;6;|lb`1~h$8Q9&{tVoT-w)Z?ZF@r-JAMFk=zEn(*469FC2L- z-IL*Tuk#I8RgO-ZIh2jHreiUP?XR9v;q!YP_VP@-yTnPVu(GkiJD5L=1vYBFNIBgq z#}ow82UIZ=`wq6By*Xi4f_QVtoUx}S|Iqbi69Dbuq;YoUo9y5v6wk)~DsyAXxN_QE zPOGP!UPrmZZSEQkm81L9J_LN;xygty$`3rBNAX97uj)PX=&Ig_dxm&y)MwRucBd=z zRo=e5SL?kMNI%i)z4yNObiiF#{BEua|iLJonw`2A@01vqQDx7Ui*HqSb0o5Lc^>S@GrQlY)|F6`!+xk9;6@i8!Ib&5@ zkZ-bsmmn^46O9F)Twd?3#-8qC=Uiv81gNETwO-z&;iI+y)rkRY$Q^R#6uG3KU(eC^ zK6dGbZ47|R1)b0C5%DQ4a5es_imc^RIQ=RoU3Bu5^*63uz~L|sozLz;9CFnOHA`q; zniNpFpB+j6hPC}*X-_53wZ`A^h@2BZN%jQcytSWEp1 z99n2N2W$Im48!D^%f(Sdxondv%r+(#C_;fh)(@beLg{LMDxdn`qxypSf%=06fDQ+d zFb08+01XCFJNPKj(I6Y>7*Hx`2#BURhk=HJNTJ9`(6OLVpwXZ)pyNQtgH8ZZoB1SA z8Ymr<0m=krfyRQeK_`Q9K;uB;L8pKwfO0_-L6bmvAlhp=8I%ty08If+1x*7Lf~JE` z1I+-<1kD1S4w?-r0@*=xK*b=c-yNX2pi)p7$O)PUnh&CdF|@9fIt?CB1?UWr7eswh zL~%^-6lCxyXm9A9YD741fYyTE1ib}X2YMUy4ro2-UC?`=_dzru@*!vgXd`G7=p)d_ zp#OkA0euSk4D>l@Gw8pdFF;>{z5;y>`UbQGv=#I%XdCD|(D$GpKtF>12igw$3G_4Q z7tjvSub|&Rzk{ekjsvv5Io)sN-S20!7~L6dv0|$HLGH^8I=R-{vUz)}Py1 z^qrcps9@>F({+5z-#vV2WI9T{Sm(>*V|iYu$BVAAMUJc7Ryl_2r(fmn|8vQEUnX`i z0a5(Zcn9+%;H0J4E~ndpPE2r>S%C+|2exK}q$guPq;yp;7itkeB8b8zVx!(i;;~!o z`o~B>kDourS8Lp|p9kZH>ez5`&CkTHRtc!(_NWSL{w_k}a3~%x^dyKck9pzCik?ZL z$9V8dBB7nmu%4G&3y7xHB)laZFxRNWr-)Kx2i>= zSJOe!8KHF09-glpXzb$JRMJMAzoB7fL+>Op@LwY~p4932t(&qSAQ(;u%$H2XYEe3% z8o=kbmsbq8)H}l5rJWA{5KU5^YPzIgQkJ}Sw!3q;0%|{!q32q`X1-)9RuB)Ldz$I> z_Pvm?R##=%4*J4*Y%Sw#y604fQ>n0t1$ioVYxA;hj@0n{brsD)syBaEx8W68}oy~Q)L?AJL9hPMULl`kCMb~ zmt?;7d&bDibll93in}G}JMQ}DSk8AW^hf@lyibxu&oLKX+4Z3rgZ1xW{w{rwexBfN ze9sCcel}G{{vN`5?Zu_9*vHrkU6i0;DBTZ&&3wsJtS0FSZD*R8bJ=o+?nbiOqv!0> zHyQcan3ttIPM=GCX(Ia1JdzmI3B+#;BE#-<&wi=*%%kVX@Rj&v_-g!XYV-5zv(esZ z>PuwKAMIb{&|xiq0;%14U6$ewP6aVDU&DosQJ#%sd8!1aDjj=&yeQvG`0ZG-`^TNp`qjLGcGcNBs@t##rzNw<1Q+m zq0QqdIybs}zWDaup4Dlsm)I0M9f61WJB??U6;CZZ;PQ9SVk@3->G;sIAL;z={LasD zxJIYGc;C8<976& zXsXKb$vQMH_3|!S85GSO-p5Q#0x=21BoLE8OaeP4fmnUCQ{sv}9Fssy0x=21B(R4h zu)SB){!wp)MQcv>gxOR6?g^~n{G>i+OU>?l>(0Kb_F2{YmSWwXp4-`P-=DC@u*4(~ zlfa)(02QnesIzqkSs@-Uq1eyAFq_x%g_1AI^`K@B(;<_s4A3_MiM4ZjB&S z-}yHaZkzk&d!0I*0zMhSa|&$cOQvG64p*tnHIn{yi@x(obLX0V1aM`1wU1f%$ArTt z?mPcq9UP9gSx$7N^DvlidKce+Fwqhf5vl%;c4a@+>kBRqE%Md z(&s{Vn)#=|?wc=FD>+K!>7DBS+#0;f@tXFy6;HVRl|SVs59|K%Lnrh8I>Jr*b(kMQ zV%#-{M`}36BWk>D*235Kg{9unS)_eG@V3iNA92EeI~u#+d%zFcU(b9!{NTPY*6)LZ z7v|zj2s@6lX5E>pvK-nNhJzwXT=HyZQyCsS4S-lqwNF^(q~mP7v$L4vdGCwVo4Xb2 zIGO*);WT_w@eO)1GQLe4JBwB)PAvJf@V=VcNQo&7%aQq#saP$M#1>MYMfx64RuaLacta$vWgRUhm67T|IB z`#dx7+mq`!JjSE***zQ{^Q0Igdmzbn*-JGXMNdbU%jF%{X7zYFF{rkLap?RO9|W}s%0c9j^vfrb^z~tEv#xM z+RQ!XJ@Wg&+%F&gdi9Om%#rml$wTKe4pP%k$|f>go;kKmoF3wLWZ{U8Vp7f#(z+bl zw@dYW9dJ;;E}cCIbKT^ve(A!eZ~6GlUM1tn*^mcxcbk0um1$0QiD#h?yN3P6WfL3= z9Hh7%CIv+4lJq?{AY9d7^0UTtCtRt|MaMNNx#FG^7I_z+*~@OhHQMCEJBw+G>lBaSz1Q>!CjT4HH8{Q1yDvUOJQsL3-D`Kb9Ih;vi)w6Sqp@x} zW`gQGGF2ch-|}9F{{0W-ocH2qT{^QG5E%~?6FOgd4vTT57f-NPJG?%l*`URL3&LG_ z-ptZ})=ejs8PXVXh!Z-W-8tMzZbz0ErFnj}yBKX$zr#j%!Oyp(!=ish|Ncq8-JkZ> zJ&k|ka2SWqXZPlDWI25E{m@2Yz){;LbuUH7F?K`8^nvz{&w^X*{H)Z3D zhN2(tqc`$T>^Z8W?u?`E{m&250}6Kt!ezc>Di(#CS>`C74;AT|E{~fI6ZAprs!J0< z4c=k-*8xYg`fKVvmpyoW#_+p1D8fNf(E04n`4!h8L#9-edeL1S>vERTK~MCIT3)2A zjvjuu?B{wN{@{fE>_3OE^V!`JevaK+ve52zsAo6XGV`WLK^bqTcp6%Or~aZ5=hUv4 zyu-j@qz9_cna?=*8XZqA4!-hMGb9yH+M4L{x$&xRHaxL${u&(*^BD(UqvOeP`sOnl zYkW1f08e1tlUELEQ+gPO$ML1}**!WQsNXK9NHj31@+o>Hx_n+->{zlS|MoQ;9^=vZ z>>eFYL0)c1JR*P>IX{V4t>p=v;?iK%;n107?S_)N8*%5xZMU_){sSJ?BbGGH@nzFF zD}(yxUQd;?94!GP7^swU(G>{?N0$T-z)E-KdP*EFsY=N7R~^?_+5&vf^?Bo%Epcm> zo395i&GB1=&pgQ3;a%V?mZgAIpHb>-(dAZjV%NFfw(Heon`U$T7U9aMEGebB!i^r2 z*Z9;1TsS^A0T-Ec5TzSxd+OsYU;X0yTfg%TdKXU8aQf2u?4IxN`_Y)i86b8j(yY#@ zoMTI$Q|UuXZ=%Ofhs{Y9i5LVdr_Q6tJ=w9qWALa;S3DnwkoslvGY2Tu_^o=~idS5G zO>4rO0HtkJA9i?&Fii4Zc3k04y{3I-0wTOU@pa5M*}+Tx87^D!ptbzUV&nXhGw48Q zoUJB%B{*cw4<%6RH8duOlNx$H*d_IrZKs(bQ(a8srpyllGH(c% ztX`=Jh&xAxRF~BRii)FF!=aBKZ+bI9JbX{T4ZnUe^Fh)#MTY8q!ohsWR4gkFEqL41 zTtY@&HnrSJ#`lupbfw2r%{u7u`e=2=(*;vrWqB|T=1UJ0%Zg)cm7_S=YYZDdYPxAy z9~ln?Gkw`x^CsE<^S~G8z&fRyK1esrSD?t-u<3?Uj65{OZFhx_uCV&KjXY)KK{Xua ztGsCUyYfynKV$AO3G6Eg1dyPqzKYb}Tz-xE=Tr{3K+3ue2@Ios$dQ7q@S?NRLz7S9A`PJfq`G@k{&g46_9h&rB^nUBJ z&NY4i<^Jd@4%-MTPUw7g&vleI?KWw%%4lx3kF7$V!JIa*v_k{HLH?$j-$HFnYIm#W ze*W(_&##wVe|&$l*(b+~=-f}{<8h0b=>B2@b4z$=Q>|{1dGCzM`qK^`6(IloMH}dyY`)= zmx%^Ua(>4g(!zz`lOM18rhYJJ@#N!424v_v+rehOWGdDKd!@U$Or~Zzlcl!r>pqB{ z-nxE2YW?(uV=iPbS*|*t-7~zH-NOo=g-*=xA$Bv%ppx8Sq8R5R1?Ac!#+zzBNdC|& zcYU1-y>aZ%AKY+A!AJR-PZ{r18a*7nGUglHkS*ie;li9v2`wu^it~Ftm`H+VWqV0= zXk}3iUg7vy3LNyk9RHLD+Jbl-IB7$ISU&9Su>)?uY$@jh!a?N>^YPbW2*+ecDRQ1M z{w&92sKZK1lVQ|!p9BBNaQNZU-^9D#ue@@{mj7e#Jiw!x}R{;qiT|-qs zLYEJFG~DO z%l+blD7fEWFb-l>!PqyKrPgDiO%MAx$bpZ;RgJiVzjR2uBthy!30e;=H>H84O%H8> zf)Nm_9V+oZCB%T(+nz3&pN6ac!$xnvb&KnHyB)M#4zq^f>j#g2SdC%zkG#){)fjk`BT7Owpx3-n+{xA7S2m3ZHcjABE0#14M&)d*B!~c#2a`~&e zT^99uaC^kwE)%Q#?ya*qVetjiWnF?5FlGO6U55GF+e!5*=vg=0=$Vlx;4=vrCT+Tt(erx!z!TpTSD8xU9xG%!hrqvY_ zuGz~<$8P3_OR%~E!Y(KZt(>3hV?FHtVufktG;tn3x(yGhYNtu zcPn1!tm=UtD~Mvf0W^e0a1k_yCLogyn}Kw`T0l#<7-RrNCP21=)*wcc!GdoFKTSrXa$pKfg=rv}YzFX&bTt!Z!ECq=a$yc!4>!PEm2*x8rHy_a2KqFyCDzO!9B1Z?uGl{es};jz(&{v55i{H z0uRB%uoWJGN8vHp2HW9rcmj67PIwZYf~Vmbcov?6UGO}-0J~uiya;>YCCG<;@G`st zufl8aI_!r7@CF=&H{mTf1aHG(I08rE9e5Xx!F%vNd;rJcLpT8+!N>3kd_H*gxxz_;)nd=EdskMI+mg`eRU_!WMG-{BAV6QtmEK?sCGDF}noPzJ&w z0?I-;C=ZcP0pweam7p?IfvOFc1boA|%0J7y?6K7z~H2VFZkXQ7{_Dz*tCzagYM3 z;D+%q0n#8Hu7Qb=0h7Q3UdV*W;Dap4h8&mzQ(+oRhZ%4!%!FAm8?J*~m;=|t4KNqx z!F*T%3tKy`~+v=XZQtvh2P+J_yhg~ z8PIe=2!ui@2!qm42Eri%%0f9P50Ov-Dnccw3{{{iRDxGNG=*l+99lq2xEL;hXlMnkp$)W!cF-O!h0CA=bc9ZDIdq0ApbK0H zU7;JqKzE3R9?%ndfjoR02l3Dcu7bYM5BkFZNPvMb2ofO)2Ez~-3d3MHTn!^&B#eU5 zFb2j#GK_;1NCh{HhY64d>2M89gbbJj9`HgYOa>ohK{n*T6qpLrU^>izYhfnLg4u8# z z@GLwByWn|v0d~V4coFu(OOOxy;AMCPUWM1-b=VIF;0-tkZ^Bz}2;PRna0HIRJMbhj0Quf{)=7_!LgUDfkRNhcDnu_zJ#;Z{ReXfp6hE_#S?MAK@oB3qQjz z@GJZVzr!E!C&&P;3ql|iN zu7#N}3ueQ0kPCC*dbk1R!aSG{3t%BEf*WBm+ypnnEwBWZ!ZKJ6D_|wu3b(=SunO*g z)vyNcgu7rZ+zolK4(@^Va4*~k_rn9Q0XD)Wcn~(j7I+9AhOO`jJPMD&HrNi2!xOLr zcEXeJ6g&;jz_aii?1Jav1=tOH;6>OAFF`)+gO}kIcoklQ*I_>#fH&YEya{i?A$S`O z!x1GTrWQevR_S>T5bp}i$d@FAhg~WOz<&DL!QLtxP_qgiTbT*eRljF zu0~y!F?vhi>}vIo9bpm1!ROOMHa>U3pbm3yAHGi7{t_g*kfoLzLd!z*&?9f> zzb_cjs5QPT>7wt`^V7J;UYc00B}g@-gO=&v)>yXvrv~|t<)ISDx}g87*hJevWb#}8 zSG^CS0-3Bk;lI-Yc_g?szgYjJ)kp09A-}cXwDljPeMiUEb2;n(m<8m9l3M@&^t84|;z|d%M+%!C_}s!`D3h%Q*utrU5Aj(Lwzjx$LX2f5diud%HQRe1uB-V@n%Xwfet(APqReNRaDmxgoSHg0C-^ zEod?uds+JrWBGp)V!$XHZO?t~ii}V-%Pk6B6V`H!{{Q;=T5g=cvIxF@aJ#v{2<&h5 zi_?{g)*qd(Yom5ldD5Pju2LM=ChmWAk{J@WkR=72`_dPYuF4#ezoNx7cX zI}!`J4Jom12grVY^$KFyS7dUm^iuS1eZ2lHu@2UCt4z91LK%>KG^`c`eXNcPHn38d zOtu$x9_w*>pOVPz`#8V&CgqSW zqwHmnF3XB5&!oJNa>yyqFoF~QD=c7bkK|SkZjad8W%7sb7{7S#@OXJRt*&$A zdV2ydWlK((9&NP93K}L%@HZdxiH`TAX9u1#QYx1Nbvsd2i7@Ku7-VuC$)A#st&h7OzsB}t%zet0 z$7S2Gs25V+Sh49NU7nkIxC-R5k2Mr}{Xn-N`2SZ8Twl&xSb9A3)R;Bp;zQ+jo)Kg} zd4IE(`^5!Oq1Trwh11O!q%34l{r?x1;QGDO7M01oEq<@Qfd2n>x!zvr_2b;h8QE$5 z6Yo`y}~A=sEH$>|x%FZPeYxN0ms@r(&nfTk}O;F?uD`ickk;Y<=Q}cUqhd zc~Dvm=3G?iziPQfC1W+X|5(s}K1UU+9?fb7+s9r$MfCcy@ZnrJ??WtH;$u z4=pcRkKoH&d(_r?V~0%-dpbqcqdz^dUa6!XW420 zj~r3?+pxG1t(uRo=`T3NJn|lXEjP~^SQhFx=RBu&u4eZ3sMKNMAYLJt_9u%G%epSd zSuK#sx&-UKrsO|ssrA=d+kb1h6aVj8AP=XI@?YP_wOT^=rLBG=?Lo;?W{x-amhIMk zOsTW{J1pRoX8|kPea!wlu&1;3ziNSL{Bhl$&8J-=J`w{GOW7su0R7$!R@JSqj(EPu z1s}ANbqS_Vxz3TBTbW1b9-o|(k?ntXi1A(?w`_|7-OfJ6b#tHWQ)y#J?z0c>s+%O| zwCXjsLGgMW-m~)3y(b=?z@bLadfDZAdqR(1(SF^G*G_7=wf%aE>xvCx^u|KsFCPut zJzzzCvfgA~m$|7nx!x}C@#q(uXnq|i@ctbAiXC2FWbPS7r0o;lFhW_cBiG3FZ~J-?jWYR6$0MHuO# z(^2%7wuANi6R%DF>5t^4^_ytDB$n|cE$3%Ykk`^0nU9y$^6`#|^199mKE?%j`%0EK zhi4+QjQy>894~<$YnFEUr24Q%^X+VnD8w3Np9oER4B%hIBR6nF*ga>vGxk@<^T$OnvxnnoX{^ z`@b*4UHWwMz3%SRX#W>6^ry;#^mJ=HG@ddqWRf8g>)w+2uv)LB1NFKEa>eb3Demto`U!CD5bC$@T}Q ze9c?a{h!}y^JiB;%g8w>_K2lF=dCBw$*dj5->ys)y55r15 zRan2#e$IczZ!;g5<=MaDdjIa%u=>gIV*Et@OVstxuHg%7Y5ISe_GI3RO|G{WR<8KJ z=wT^Eg7Zz<#YOw8oV(@B(fyxXbKzWl9j%95uD2JaM?s;MtUDc?M3R5Xf#X)@jZko?$mSjS$IkDc6rb{rc&fvx$@|_5wt#bx!zu+ zK76bpNEr^Y+NV}@@%rSI>wBWPca1zcZv?H6U9Ptmt&fM-A7=7?es_WISnI{DCD3R2 z+(Y;6>$HERzMj^{F4x-&(+9I8dHsqcW~XOl_#IlOnH-x3QtnCnJE2wacG_9vrJOj$ZzbULooQ>36yW`u+6Y$s?ZTi;wH;YyIqUy}d;G z6(|<(NlbHRj4w#l;PPNv>)?K#%o~w8XSL{6>G!EVKeqRsEBn-uN4$+7vGfnL+%GPO zg6{|frsl~l=Yq~2dt3cIyiM`#@~B#SUb-sjA$i4v5kybX)-E^1EY7Eg@qXXr6!~Ia zFK%iUd@#-G?|JAWAqM3C%Dr%DpC1{+Lpu z#2o3o&2onEHp^&fePkthV>8^zyeie}Z=1@oR=qm5E#6Mu-&{I-?cAFuoBEjgOL}R! z)t!e;%E?RyzTv@#xBcS@*7VCqFA3USg|$!byy(>i`!AU`OJ7&p%P!a33%zg7 zmn!r;3VB^?f;ThA_^by9Z2(;^WVS0_pG!OL|KpWqxdr8w*=`O|c6mwlVK%gUuv*el zK9S3f;B0x5@f5dlFFG*e!Q!~f?U5x%~xzKLPk)p=0eQiM+)*HHWdN=z%%z90nOC=nuz5_m|I+XOLmNlED50t@%-P zC_eq}d}Gmj$3~TEuE!H4=I*r8a;=Y!@p1cS&(~^Ppxq>wn9! zrG&NWxdA;TXumHkKlXY2h1l|w_U_Pn==8M9_4Xm@ZoYEcpKl(UFT{@SpED`eo8k4L zp7Fl5tbp3`F+vPGz|$XXr?`{Sn1eGoGgUH4P`e_oW3ZlumA6+d`E%`CM|1AcdT2fE za=rZ=J*CJ>dwol<$C*& zj(iczlRC~jO&%XQR`Z_ueT#s>0Mn??) zk$G#qyBoViv6TNS^LmDHeSQA8Qf3)#EhkQ~U4piU{rQ}@2g<9aKhHaqu9lXIZ)WUj zlwXoBwcL~jmZG00IWsHGo6QGT-9Do+;U45o%%m0HFFnQQrNs4mQq9rW;C5f;<-z(C zmOeXj&b)iw=7$pX6?OX9<$62%3{B3OWPWoF-!^JLujeZF^sL03%uHT*ZSHBci|QP# zhutn6e=M)2MeO)?S<7Sd%QP^Lmm|b3TCT6Jspuzo_s4If)VSnF!Ztn>7 z{PHEIXY5$>@Gtn81buxiH>H6kZEjz7PG&*95iJjPN#5pxE@Q5m@eOeKel$HVvq@ka zGAPH>*Xzv;YFFhKqhC~fgnGB_Z50kqUcRh~I2A$br{$(Juspwh^tv+qpSv@5I*)?> zQ{@rsbWH0~v>kW#iBLOkJ$T=bcdUF_-XkSJ>#60YG_X9sp630Ae#zX+^GgfZ%uGi^ec3Y?v>usP zn)PxwWMYQG%7Mj;=QY^TYEi4IY?mOhi=~zuLd&B6z@9;_Zhp0}pqmxsPqn%h-!4dd zw$toM?drza+XY%~xwNtRkG2c4GQFOx!0<;xEygWl+|OY<%ZC*&>vwLlAcAMA+>M1XJS^g%o#O4-PzaenUI|}z$3jJw@+FK`cP~6 z*{xf!UUok^o5=mkIo->yJy@fmehw#`6G{20<@&rj?w>p*eS+CoikTp@Xw7yXwSRA) zmvY1?F5HYlNP~fctnKt8=p+AL+o>>rx?}nc89hF#x=mm29%JPmWtZ#iF$wX;cT$*; z9Frn*YomMkzw2#&aa}rFGSjzUyZ=C|UYRk)>(%Gwo1U$?{c3pyq!F}UcDdeue!b#7 zeD6fkv@o@T`dO-b(dj4G8g|#s`(L`@#l`x%S}(g?Z?~jhkfC_5Z#qMtlP0BS2X^5g zt3NF*MxWgN5vtCdx3jMscCfZr5|<$Qh(Bq$A+#(47Yj}}8Rj@g8IH>ZT|QNcE!sX& z2@z_~AEockdv)<@dB>Urt&f(Q(!jDi{i=!nYX=+1?4w)lkyp(1cMW8o?*$#7-u=YL5qBG2tc?+@ka18ROKlH@{iU2PDt~o(WB7%ymKz|&j}c}X z^~cOGyIgM%9xt#A5cHE#DC5&m1AEFAE)=R%m0^u=kn)u`*JM(MF}w=wzBspW!sJARn__RkIa^J31+{% z@;P#IEAM|b+S}Yt&*TBgBri?KOzy8_(WW%p+jjp*;y`KFNqH%4Izifll1Bw;+es|j zrEOPO-bL($zsUmj^clo?C4D4Kq+ZkQYFU@GlD4|uCf+3JB-;ch|6zo`IoQ*uKj)V` zDQO`#mo$*{(D}(pAB^!Y4Aya|RfCHkhuYJy!=Bx~{#_)^BuMOHspW>yvgpef!d^afwdq)tAvH^Rw05k}+2N_dS`n&@(mgZQ6S@TS}rncu#7|LTL&ND=uvI%KxAbm^Evpzo(yh68#71r^aSI3W4a&GaYXU@ zxGH^oD&nW>+vw|cH&(hUyIgO#=wlssFGQsnPb!o7GWhZ!ipP7#d;NC{;)4prg`8OH zyQ?^T->s~kxNuYUi7FFEKj2rW3$f%kE!TSL_YbKkrB#w z@8|E|UR8B&?!VA#V$nm(_4RdZ(W5U@2{U>O=x4t2CfYC~b5F8;-syq+yY_s4JtwLJ z(*6{5-qtZ9C;SU7VD*=%u|@k!?&t_L<8@!-x;r}O|IpV|Qv0oz+f}#ti*8p$OYOig zfIHfF9wb^%95fEK`-}a2CH*b_R1%+(eZ(K7f279_ST*h=iA=UjJyeo&vD<%r$m1Ut zlyk-S%h~55)%Fwbl~0Jgw6lDNQG(oulk!E&4WVUGq`wSJW*)9*LN8;sq}=?M`4GHY zFUNeDo}9+ozZ#ZYv_GpY<<%XnPv1THz`>yx_;t|wX}Lu;W3@>A%*hZk6Cy|_InY`^ z97iwlrx=h}%0clx{a(Kf9V@D4Q_sdmR*s67ITaFgKGSkj8dw&lmw!f=7>V4LWz?-! z`%D{Gv>r#$Xl1PZ2+nG!spw zoRA>pgdXdXG?gIgiCmE2SJ(XEEdOZ>L~#a5ADMT10KYk0xkc`tsB6P}HT%7rq=B`5 zJ5{@^VgDH9k`A{p>0k-8=7U*{yM8}>tUE%V*$qkjs+YG zI2Ld$;8?)1fMWs20*(b73pf^VEZ|tcv4CR%#{!N8{#Fa<`xAfbNu8597H}-!SirG> zV*$qkjs^aUE#S1D{)-dW`D=~^91A!Wa4g_hz_Ea10mlN41sn@F7H}-!SirG>V*$qk zjs+YGI2Ld$;8?)1fMWs20*(b73pf^VEZ|tcv4CR%#{!N891A!Wa4g_hpoA81<`b6C zP|j|S1sn@F7H}-!SirG>V*$qkjs+YGI2QOPEFgU^r~ma&7|=P?v4CR%#{!N891A!W za4g_hz_Ea10mlN41sn@F7H}-!SirG>V*$qkjs+YGI2Ld$;8?)1fMWs20*(b73pf^V zEZ|tcv4CR%#{!N891A!Wa4g_hz_Ea10mlN41sn@F7H}-!SirG>V*$qkjs+YGI2Ld$ z;8?)1fMWs20*(b73pf^VEZ|tcv4CR%#{!N891A!Wa4g_hz_Ea10mlN41sn@F7H}-! zSirG>V*$qkjs+YGI2Ld$;8?)1fMWs20{=r6SjvA*Up_s*>hRPvwd$5N{&@^b7j)}h zQMDy*-9@QihwPd>?SiuE;aT+tmYsP2CF}l>J(QXQe-gCZ5Ly;PIz}gYk~6c?yxBe6 zS#Do?az^?LcdXZw?Vgt1FFnQQO?0PtJ*ip#WAZqy=+kC!gG9?|{BoYSxAAE1op{WkDs=U$oqQDf}hYJ1H|g z!=0GoOV2#VMeP1@l+#uUQ|cWO?rPSLbHaMW_Y&U;UKj(HLv@g}uL(_{0W^h%5C!Ex z{*m}Y84#b4pnXDOPHhD3FZ#D%{68N}!vfkr5~7OskFEGm{r3;=^S=MoPwnDO)44FH zlqXtlH)y~=f(sA3U+Ci`og~lWBB~ll8cW)if=CcqJrIA8@&NZV(!T<+_5nGEq`e%Y z(_3P_&Z-lNu|O`{wO=f45bPI{FQq&_z2BuWMjRS(0KaMSRIi_AeRglP$D-Ik(B+1f zo6^8C;1_1O5gnVHlIHI2PD`GW?#=P3UF>SDS0wGulE~s460S5OV=4MbxZ8}3rTB{W z3GpF&NVg0A=HJ$OdRL=h``PR1sD{+jQL%qay8YxMY2TWPyg+2s(|);KJ-hv^xhuNA z*RW>vfb2B4&ph&c`OSJ>$unYK$v;x2iv2`$$yX9rgt|}}s)FRb2++q!e$#o6)q--^ zn(wUJWgjP)7RV*i`R#b)V1LQIZI#ikJKjsF&SQUgu-iptRrfzHU;5>t(wXD0mKxHm z8^vF=+z?t80e|V6JY%}mTg;tG;vbgN6|72nO8QD{$6Ehd*X3Y2#_AVZR#+@D9qi}P z^8faDA%9T&M|iVf|ESbd8U7L8gfcRH*6nFc%Bl{Lo6ElYTGas$`VBLKSo}lF?e@Yy z`g&86Glr&nQoU0XeBNo(qho#U-zmfh`sD|MCBWrEaeQm2Ux#9w7wxPLv&9}_v@|Ih-toLiS~-C73wNh;gg!dVz| z^9*ruwg02-4c4t#vr5(_jPx(iP_1%>@l%fS+U+6Pj-->=9l35 zEe@C8(*3}l;wDDW*SE{{_VZj{XB|<&2-f^^`jTKf*xLaK7nfB#U61WO_QK@)4=reA z9A6QQq@34seSIBw&q()7jP945?&;-Ap5%@moS8})FZm=o!RPK3o8aHko?rCwe@fh)LsK)w2*u%Q?L6d-LOkD^v#v^S{$%m5vB$goObAo9BtDn?rU9_J} zi!Q5fY+b9z6*s+^UOJ<#Va9oMio{Q}+-}#R{KT7;UEnBxho8u`rQIO?G-=IB+SdXp zn`P{$KXgayFbe1Ah&Mn}coX?4xDCXA#LvVM;xl9eqhG>qM$obU=l@J(Z4YcH#!oWW zMymO>p8TW!ZOyhE%8NE^BxxXiqUCnO72zi_6DIiF6DVC$EhUQ-*ahW$o1*=;QeLFm zqK>S&`Ox|`oxElWYJIf4aD8M*(wjvqz%zl>N$J_va;{jtjufNU)^(9;z{9m`j;*yf zY`_hs23jvIFIKO3Pi9Vb)?d;qvu)A#N?0GMp2=u5`e2I>7P(hTjxzI*q@R`-u2=k| z%nWTaudgH~%i}~k9V@jfTCdahMye;8mi>Nx-zT15*2vUA+e^#OqZhXwd|A}iG&l#0 z<95W9WLYiNYLpQc{dN?iU$d_&t9#m1n}2p*Za-buX#KSOFX2 zzDw_qRL^I$Ty*v7su#51Z(3H{Rm-)WIyUu9pnX!b;jHCa?xjWBZP=zrHR`~Nw|@H5 z!v4K32-ZW(_4Re^*Td&7UKQgIt6jn`D_Wnk4@RmbGiF4r|2F!HlNZQHWgwqwxgoSH zOnnlwr)LDU+0H4;tae#dj2^4DM5;RzKWP5ThtnfRkCzd@fF4?IQNdU>_2`>C-J4T% z0{IWLmiMhY6m6G|4@as?hrZco?kxP6n- zvt)RyXNG$c1<7C5bt@;->D=*(V)SI+ypzkT{Ce=7Q(6ygN4s2aH}#D1q@;O$ejWR{ zvwi6)S$|noUJw>l%8WUm?*~+Lv1H7Z*gPzUC;ykaYLd zOs_ALd-dEt6dR;RdAjaom(lX`Bg z8|Ya5)qc1X)Pjt6%Kba*Jv^yV^fp;HYZz9X@DE$S>c<_s740tvN>x#1bJz3>dG_kn zeai;7%e36Ci0Q}0`O7)YMP=3NKrwpBHRpI&ebv9*_4<~3K|ODmYyC{UjC%u~>>l2f z94S@Jj8?C*AKdM(= zY|(nD?q$_?sjDk~dVSUnW6frxs)GWO@3ma(qhnLAKzrl-CJW?!IrgvSe>q0yaj}?; znaOYI9qIhfsuTVu3*>PgUC(ywQMBLW?ub-xb!xEPbM(Wcm!C6dujqPA%k65F+;7e; z1LR!R{C1=m{bc`38-`u@?V=sMWnF@9x7g+8Ry_`p$Ouk)iu?RdeU5T@oIu-cTF;{G zw&Tf2)qmEMV@)^Dk9gi+X=%G@xzz~(~-*k z=(ag+OSe1S*MI9s>!;;fFCCluB_uNnW;6p5)7_8I)moAc@E2fFU8 z=5H`-y|i5GqhnLAn3NPZ&E;|F8R^+Yx0$T%_qg6g+exm`<*QQD^25I=n9`;F%PtSr zC&4S)Fc)9!!_?(eZn1eY%%QlpMOHb+siv{i{x&wgXgzoFKc3CHVZS^3qK$iA zmzk^F)8gipl5(Q~O2kRYm*7ar|b~ zV?Eb)?*H?ctT~c`O0A%R6~EAOLugrOzZjR3p5brkC;8mQjag%_^VRQCUuVH|xEIEP z%;AtUmHTEBVHAkJ#6kk}1o5ecAn7ghAHqSJDAL-Lc@VNLHIK;UAINoZE2l4j4GIg^ z^0rdnVE?es&&r=rLCt&d;PC;cr?od*_vV~t@eeJxUt^Hllj`;{B-V>ZF}PLFxT0^m zvEIWw$=|$|kso)edE_c0?XMe((Z@IxJg@?{I*mG<_2YtNO%P!a3gY`u7U)Ce!`)Fj5h>|e?r5f`_>xm(YxmV9{RZ+=^x14 zdtDxgokS+(f*|(Nzoop;>k`Xvv7?~n^3P;lj??J!MPdp1xB1Jwj+{gGmupIpb&<)w z_Wfm>J{PO!1lcaZzK@pc*xak|Wl8oa{76Uo-(&%6c^fyl=zLpiP+7IC!uy9O-u=Q0 zY&-#QZa$WLqw}%kKk~B3r+6mTt z%ui#x`6wcz`%mQ1{N7uj2h6m?knSYte_N^_;s7o(wJL4?*d~S5< zm*cwDsWATP$1an*>p}hV%;X&3k$kl*0FV;^BsRax%F6C*ZYb7 z=L<52wf*@vI`aQ-7O>{;@KHtQ?<3^@AHMlMwDvn2j{J1$0VBC}{?>B)AJO?V+H7B! zIDgx_2l~AKX#SS`rt_4n3sQ$mT`m23-M7~YYaJJ+ zo6e_&ZL`bdzg7nMpZ~7^*{-wm`&q3We>9xX_^Ym2+8xmh0HM&AwieeeB0LzyJFzuz|m% z+udo&Md#aG#^F|!yX{u*%0sDD`~#?$bG+nREw@{!WcgN}X_PsM$=NAs_Q679VyW6? z(X-jOU_I^qgZ%Q$XFYbZ^XN7G@BHDT-z$kuT2Cz(nKjt-ENDO23YcOQJzs}m7Z=lZ zK2?nVTc0eimZgWZeREi=xMe~W-wTuW z$R;C*{UsIbazo7GoagjlWhalu^=jaj#31PMM9WQSU|E!($X>xw>{-m%h-LLmUlh) z`=TV%;M(3={(q={p)EFRy%RO5tkJ)WK?y0>rO1%Hn#W6I+FU#MEml?9#R+f4dz zbqVq;xGe2*L(HO|_ZlyaVQynHDxTtI3ZE}JCe@pnosgdCW}G}H!yG8L>an2&dVIDh zW6GuZ17r$~5wsq5x!zuw9{t?D3GM_Qcu3C3(yHWgfKJbR@44wI?N|Mtr)HkAYEz%~ zorbh(HMd<=Gd(k_nf0)i>+9>-oR=4ylaYZrtP=(OJJ`$DBod+(g=i{?QJ(b`>?e)X zPv8cAzXK;(KL*di?JyhSpb5x(;AH-g{1YjAr3{vOTC^27+(>64CzQYfRzFS149+iN zV`)dX?yS_|0UwT))Aju&vRa!PGWMDM3A2CcqSVrI*~c0ZyT@jva|Y=iV&M#vp^Io*$H-2&Owq;EpdQd!%k^`rdcB_^fLd!xw^)99; zm^;LSHavE2cDenNH0}Auatg!8W!$_qbb@X$3kIXY5Hdj};@A1T1V+OpAoE$}-w3+B zVrq=Q34hrFRzF#YpGesg17cHIm%2vJ<6>1cc;SsJF1{u+D@uM4qQJ#c%SC1l+Be!q z_s+~2l+3g;U-}HAU)+P0tr1QM5ZLlXRlSzQo0OG?NK>P2~X~Fu~{r5EbuD+qe*^%`QKK!R- zGJ>m;>AzZTN&`!sj~FHJx&1duqj~IhJX4mEJt^+!#HqY}9DzmF)06F+9`E594H<_r z&t>=Pc{I>oWYaicdZbaNQuG_Kv`6Hhh>r_S_`kP+)vw3S3~tA`x%_yTb}{3q!?!#a zHNC8Qa&`EZ-pnQUeKFG1tpSN9<)D_^HP(KV$XkO`b24Z$Xo(CqC8hD|%2XMvG$!S6 za5u^;YdN@<@=xk)@eL`;bel$sMfol6tk-3mM)sE=zh%2VUXBspvc|HHKDWerUsjDE z+vONJk3ahaokMSvShmYKBuFe+<+5&-^RwVwa;%{D(Xs5K&!f+!_tQFwTnFoMvY!O| zaasr2ChI!r^H_D!+azzweOD*^`&u9u)pWfOH!HYa$Y&efQgxhszVMVgnN>CZmyZu^ zeCLjtvM%8Y|I#iu#4LD^XHTEc>&qhRdZ&6Q{f*i3)6CvG;{xm>*B{aF^QZMO+V{lI z#9t*pNgGDyl*#QX>6c1-hT#Pj1ua0zgI+KKrod_t{V8g$BMO>-e}Mlf*N6d$mxJ_= zr$v@h-{rSI#HxCv|MOY<$2|71_TPHQ!gxcymdifYQ1HB=@x~>JtzNuiH;2~@c{9>e zrbow7Y#FcYw$3L`n_YB!Hg|kwHFeCxU%$Cx!W6oOMi6^T`Kjf8aY1D25tp8o?e$HM z=KTlhyr-=%?}p5Zj?YR=&dBcN^G*s3)=H{mXJ@#Bo)cBq1=~mLFJ+wW7w+0zUe!w3 za?{A}ZMNLwzw%&W(M!wy;)19zgLgUf1P5oah?eIIGqbgfS0Ly|D6D%K$8KP${c{6) zNjam_P1eOntnL48TR!MjwM)HCh>c)$VtK;OF4x-=bH@4HS-hD(#oa4CgVulG9hy?j zL=U14Vp3*&R?L*-^bF|{#CWF1@ZvJ_jb(k^Q`{MHu7#lWY@HiyKkdhQJZ#l-k?PP* z{f~Y3)7o(Z{EA5Wiv6_QFD{6TmpCVqsA4`{CB{%28uP(<-rc{awSL}Jj2`*u@yN)H zPv3KS51*MkgWU3N62<}A8gDi>Zg5J{nkP9xr1fik zeXxG^c6!I%k!ss3qkH!GvH$1S_;t|wX}Lu;W7X78KYe_jyR1oGH7Pf1XkfjLFA)#(M)9M)s02SFT@Nc`oINl{Ezw&1@hk-LL;~c z8bcFk3eBK7v;eUWu4dF1xvb0ou=cM9B9l7C8v0m%h)#aDwMhT5Rck%5bgoz@Q103D zP2Ao{RqJ5p8}%35a5`HILeS}`<)$>SH2pF$CD}vi%iWj^d`~h=+h~ym(lpxt(rtZY zE-Tuu-Wk?Z18snYq^%TD7b#obwVu)>M=)OyJSbjDk}e*M;gt1W!h8MOM(z?1Mv?n zH-wgj=^y>vlW6{$AIll!<~f{n-iFQ?li3@7w6$u9h8!nEt|erE6u*SL0?XVUevmfO!?oS*2drH?DAzv%t# zG1}daJ zjrJEUx2s_KOK^M6=4Poy0v{TuNMDKEI?X5jbldFd95aSbc{ix-pG_Xue9`EkX2w|4>hP@u0(lrua zuB9VybsM7qu(tP_NI_r=8J6EUmUX>4SFaG$T>Os;*7ANU=^`Npq+GQ3$4>8yRFBQ~ zT-$eY|FzNwmZ1BIT5d`MOG|k_Fvp!^eDgt?PFd0_D5RTc)u-EvV14ZE|D~@)s=D18 z-u}kXtV_Oo&%CDAN6Q16m}{m!h4ottCL;%RS*`jUu<2vBPwUqh59xPkc-3mR3~1rM zu+~S*OR7&HrZEn+=A*QgMce1V>yfI}2v1`Dm)v!0>@lyb_0jT@>Jw=57H%hNJ+Sn) zV7=^iI*r~_LPyTb-`we)X01#OHj(e7eW~Sz>!q8Ny8RpLO?4Y>&c3`&-IFq%b~uh} z&Cf6LTiS=x4%GMcr2dz_zWkPQUdD~2ogi6Xknw7XB@gIeU6*47X*URZe>q0ZV?CG1 ztigI7tNedu-I|}GZV&bo`}a?`-c>2(wlBtD1$*g@e?h#+b!@tOS5lg z{h}p9o!$%_#X97@ixcR6+i{ydcE8O$5UDD!Yue$8U`f zC>k$s^zmxKY(^pETQo+I_!q}(w_5aHx+>V7_VTjQ!AP}Y{fO)896Yu^CssT-P=0H< zA+#(k1I4D60m0Dp>@@yE@}w+NbM6mi^Sy;+pK*gdX?mvHHnuFMwd&jLj$nQ5_TKs? z->pflR{6>%VcoCxXC!TJEw`v@tOnGRu^p^x-dQl`KmA49$_cIhdcdZyeO~+7!;z}X z%cHJ899wI|j~h+Rw7yzyN&`#NKjM=5^%ZxJ#*27ClDCI@yxZray3CoBndIee1h1_0 zwO1;aL$$wdSRLGslD>_kYQkkM^>Voz4kfTX?e$r0ZdvxyC3pDkx1a5jf3%#RK|$A# zGOoe!hB1i(tt2&#{f4o$maqC?v6Bu`#$Bm@lrXl|AFbB}|1VvxTJO_U7`5odig#b! zU7y~(-j&KO*W3B}q%pI|EETfMPayLOIzIL%FH$E%%4^Sp(|eaq4@pbuBgFkl{V;Xv z_j2x}$L8Ljrq;hG^_K+EqZ~^uH-wf&;d=D{Hc6ExZ zKlJyr<2`&W(H$84<0RH{;w*ZJePTdjX(LE`Lyt=?e4m!bW5-{q(6Y-{(pHcl^8`dM zEjNUgg_$pl8V(+?^RJPFBWSup5Jc* z{T-{z*!?ANCev3Wzl)aA$FTMftou3Z|92L!`pd%g!Tw@zXNnf>-);2Ujw;g&=8%cM zh}YQVhM2|q{Ke95x4KJExwq@SV14Z6UevujKYM2X_rILj{zq^B1-1WbxzpOpQfOgM_Tf)>EUp#a9*FDUO=<92_<#DbVx+Tp!G%9J>Whdyu>^o4%V9|k}I41__D2uUy)hQLr52GS3$x%lm;*P!JXipWU@_bbOF-JpE8teR z9qxcNa2MPS>tH?H4;x`KJPeP*cGv+=!L#r@?17iyWq1t^z?<+k9ED@>0i1wO;4}CN z&cF}wGyD!N7j-^FKqOR#>QEc%fjrXH7~~U;GOwgPbb>1(7UG~E41%FB5|Uv&WPp6D zVH(Vaxo{&ah1=jxxCi80*bl?w@C@vMSKuHVh2wA%zJZ_MPbfoSUlD3TeP{};p%Zk6 zt3Vzf9|hyV3)4ZqEpap44(s4ScpRRGSK%<6fUn?ZkY~gyLp^8?mqK?K03#tCrodcS z4tekpJOi)7yYM;u3=yTUD>R2r&<9392F!vbunr!By>Jx1gg>Eb82=GELjt&A1}ug9 z;c0jiJ_i?_xZ2PL;$a+I3%A0u?6DMerR47zuOW0eB6*hdLCou^^B9-wMycXHbnn>~4?&cfd>VBQ!2gzJ>W9_tHLx zdXeO9m=90E8E8hwZ!FvaZ$gEN*b?T$Zjk457ik|9|iZrY3N*) zJPU6@!)o{}?1t*qnX?biK-C&bT?4zJ9+Ri0!69f@i+l~=!_eC32o0E^Dc?{z10(A& zPZTbz%k`jUJ@kM-VG0$>*N|49^nh_u_#UJ-pdJEGL+k>%jkwQy5#X8cbW*PQ-)3(^M$w$Fw~< z!1hZiyDlRScc7f^$XwG->7%0;fsAJFRtQ$_GO=b_+Nk0C;>eNQZ5W)-$e5AVDucq^@nmVZ@5yK zS5uaapk5e78916eGghhllF0)p_;4!6j^~>(6Y!yQ%B_h?ZOh>Qd$4aN<;G;CR%VgL zIn+~AX&X*g>Z2K4ccxNL%*H;sl(E-io4KUde9F#+ky<{EdA-|i+&*O5=|RqEIK`Oh1v123R%*`#`BrPayl0^!^Ng`igq-3}wdmO1*FvTmL5Y zi%U%{5OCs0sVrJ(+-i%T8s z?o#`EyVUW%E)_;WeI*6;O%&*6{p;8NdHP~T2LJ&=OB0R?q91$7w;>UtE^S5Z(e zr=b3pf_macm->T(`aue69|d(11@%A*>T4*d@1~$WO+h{SluLb1LA`>4dISY^3 z3hE3B>PIQ4Yc&f|c@)&~6x7uzs6#2Jt5Z;4ML~TZ1@%RlA!;85^-2orc@)%ZDX2f7 zppM%dqTZpPzKw!<76tVZ3hLJ=s5^WeqF$$7&IHSd~G6+SIg?V1;=9$FEq-dY!`+HMV1`Ok)`Rj-Ar^~XZhXJ3S>iNA)bmgP#R z=5-&~c_l_#1PI*eH$+@Le*X5;D;=QHR!;cg1E2UzNl~OalDW(1l zp}klmOnuuTOpWUrrWz%Msms#C)LpZ~)UcIdDt!~%cZI3thr`sCui0L@wED4LY1QoHShqskhqxP3peLpWv`Cdk4G$^C;x|C6|SC>&kr4xPTe!-8J6xsx9IigC8==m0i%>VZ zBhV02UdFz)`lddYKYELVt za_%dq=Dk^tdbPZIxlMT$Hm*M2y&_UI;oke^KOj&D-l?YI zE~%~}=2TZT-mb2)F0P@P%&no?y;no6>rfMYYN|(1*Hp;^YN-Ve*HXZd% ztv{pH<2zfaX;WIOi!N)U_MUB{u6eets=J__IytDlI?~`$_1kxssxkX6Qx)#%plZzS zsOFC9q{erVSE%{lbWzuSe5LC2URSmMXgAgOof!4p``uN?ld!TL0x=JnB-B&gIuAiFJbby*UHbEt?9jID;I7t1{ zEJ+>88LSSyG(<(#AEs7ZJ6v7+-qq^e9wSx$Bcs&ti^iz+caBxhUNBDWTAQMFHFK-O zJI1TJ1JcxnFVfYDTPCWXI!sbupY*6@YctiaBYdiNRJL0BMUFc2%v81D_UXzq?OL^a z>@2lD;W~A3+#EHl_YG=W|9R^4s0C_J&LZ{m%EhYmGdHU>UoBBbn=Dr+(pIXYkKLwD zl(|Dix!0&2uiT~fcg|BcZofxW>~x=+zxM%Eee@>v@t>Pj-OUfHPscr~GA`P#j-Gx( z4b6X2ReA6k)!~j^>bvE;RradA>eR-4YW7R7stITIt2djzslLDFZS~ueN7aS3-cz?+ ze_ZAM@{wwhds4kn^$T^~_OI0)?r&B6ML(*2XMR?Rum7$ZJ?V1gY!7oS*cIWr?cGS% ziPBYEo4eO=wO?|9>zOYvbS)au$o2laOkq$s2;A- zW8+J^<>?2*O{#zSH}_Au9J0UxQ2dro$JF7=ea&S zx!AQWY`JSk=T)x0H?DOZJaeyWv+qGy*T_d*r=Q>9YP#$>SKn**x?awG%@ujiTdo^E zc-M7jr;l9wwtnuK+4Eah%dmhgMM!*~b|Llu z=o~WktsWsOU+Wjr>+>NYAuY#-3|X2U^5z9uA?0708FKr&`61=*UK--svpS?^<@-WD zpZ{=3-6l_l4E$zKNc2bhLq>(X8?vb1ry*lrJQK3)n%_g-=n@h7cGv2m!zVWgt?}k1 zp|7|v552ra@6cuql0rval^nW$qbD@~ikYEzh20qXQ>j&cJ)_N>!fvL#cPFMufHhqi)!s4sF6RcJ&N=@ywa2iB*q|JI=KSO-t39w&Jftc1_NUszApeQq>aokFhkg9CTf+*f$C8D8t{#x_l=S5!Xg##t zlm?c?=uwa`Rz2c&7HyB?jVh?7*VkNe#p6@g4YBE=gsT5a1-F0Gc)tbxls}G)SUQF9V%PlGxt3~Tk;HE+L zI9-e$-L9&jrne{MiJ)`9!vxdM_nS!UQqkH(0 zr|K6!%Kw#+#|6(fPF;%a;ZO;ppc~|Zp=1cLe+NGIr*=Vac6=K$D>K$mg|P@&h@Qi$ zk-pWjG2<%TYBI)Bi+*u!&RIvPopl*c#kh0oGtLmj_g)(?4$+VoXV+@i8XAxIxHl#{I5GuldLqqsLOlGj2oQI~fnUhyTSm zz!LiZp-(b4x0`tbukrVf@*h9p8Qkv~N2cE%R@0@fz1XGZ^`u{&;!=6@>0>|YQY5E} zhz?QZ7Kf;Ak)dkoflyVQK4jFoGDe#scP<8yKOu_9$v8l_N1|{HNgqAWMa*B4Aju3GtV`O;HgTwOAaXgTJcx|i+_?89`w4ox>?7Mqas!glcwU(#EO`DY zmGv8eVG3ism#(&Y7i2v6Rpgm4z)yQ(p#{_f(V65|Q9v>qx0tDKQGXu(RK>&R8b`~dZb*po!2&yvOt0yA^jRHH-wgjS^wGR!)vqjaAzb> zH>#XGj?sE_+gtqmPkJr>s*4 zcoKYG`7}I=8}Fzns1J2{`x|wbE+g#Ma(@5oEnxNIwEUv|I3NFN)1z_PdsFXt|7+SD z62yPRkG0&C2A1dZW79n>evDIC>*XPwViYndSb73Y6r;_E`xMMy(e-a`$&*&5@bKUudb`)w*(!VznrDjPfp_}VxJhlouthpZ5ciPbyzs_`cFRj z+`Q%ETF*i*p(+Q6pJ=%$4J-?rr<`g&$wm@9S0@-dU(4~Lhn5F4FxQHl9~^ibpPGxQuN;!c|FZh6{e1t5-(q`7 z1IZ7%Z7O~*NIKa=VKTjsv_0tp{MUqO{1aV2Ryq{yx5LQv!(kPE^v%gl7uBj;Lya2I zd1sZLT|=g{GfRtg7*za4%k74d_Do!McBZcInbqg#3DfgDaa##T?fm`jy`%Z2rmUg?; zm8)S5(9JgHNv$Qm8}eWs+ym?3UbqkLhX-H-Y=lklAZ&&$@DMxJnF}Lb5;%%@U z9tUpU8*{C864RYG=3G5Z{0uw`&%rKu9$tXmum@g*z3>v`!#;Q!UV&GEApzt4>HCQf zz#DK7-h{W{5WEeC;Rqasci>$(2JgZ9@Bti$58(uS1RujE@F|>xQ}7vl4qw2R@D+Rw z-@s`&1K+}T@ICwhKf+IN7Ji0b;8*w!euqEcPmqGx1tB2s7Giiqg+Xa3158mc=985r zE(hg7=9X1}iXiWjmw9GYKJo?s8FOe2ZJ;f*1Exx-OW`u;03D$dTn?S#3Sb(A zG3Tu-aW{y8?jUpEdO%O;1-&5-;-L>*1${y0$n}Q-kN^W=5F|np81LC99ty)?ILPqx z2p9>{ejE*BU@S0oLyZH5l2j_VVLVKLG)RYQU?OC|B=CS2GGQ|KAPce~2d2POU>b;; z4m03dmi^Z0!v^iEQ95+0#?GUa2wnX ztKbe;4Qt>|xC_?8-H-?C;2u~H_riT}KRf^%U?XgT2Vpa8frsE>*b0xpqwpAPgYED* zJOMjkCp-yH!PD>zJPXgkE_fbZfZebMUWC2y66C`^co|-SSK&2y9rnWkcmoc?oA4GK zg16x?9D$?o4!jG;;5~RBK7ix!A)J7Z;A8j%K82HT3O<9+;S2Z@zJjme8#oPT;9K|( zzK0*+NB9ZO!q4yv{0hIp@9+ow2{IVwf)EIWQV<5Ef$2Uf93r4Bl!NjR2^B!*Y*vEG zPzB_ZFx8+s)BvUlsajAQE`T~v7wW-Og~a>pe?k6_HZd&1|6Uybb`yFGh6{(;7aHU-5>_KLoD=wp3n<=Lmb3IA7FZu z>I?m#KMa5b7zl$P5oDg~U>E{JLE3UO)2@?xP`CFs(B4C=V$9;#SPy00`kZOhD`z$i zzIxK5_VExcXZN6>Uu4QiP-;$!+wyu?-2#kHh?N(K^2lfU`02(gOXS7AR=v8tUA$fi z4R&QMuK($Us~ee@m)NCNH`4MTrTAfXND}xmR`g)`A{JvX$-e1BdCzH1X5fwmuRC>{ z?-Tof>|Fe-coec(uF8_X zs;SAB_{jSg!40qAjwL=jA3c36|NB_@zTm1&Ev;gxPl#J@|1@P|OXX=^_RCLA9{YJ% zP>=cWx!w@I$RU1YdF&ID>NW+DxCRwcFS76U1{BjD{1zbUXzyUSIeb>ldxlAjr@VCZ zC2TQv;Igy%cA$#?*`%EB3vRc*;f#~a%`Meko7eStEYSar5&POdnYblRgl{S$GEPFc zwRYan|4f{4%;bDK6Vw&7A1E2r3`A_igD5RALt8;&n3y3k%y!p#%uC0#bd1;22v7GJ zj=Au0qw-B>`enBP71qF?p&dN_K{JtIXWex{5I>)#E> z4d1)!h4|d9Emd-xBOdGePD}N{nUAmO``}4gYZ7h!yq{p>M);=IfSa-I8G|d!xR>q6 zJ3TYYtt4AG_2DHna zvyZvtwok4*^`j~FFR4NwqTYpX{=NqFo;3|8SmXRFoQmbB9@;eWVWKP^ zr`j~DyoXt}=C9Nco16p_XU#F_M{|uy6RC`y%@?Vx7;pE}fZl)8KMC)@=6mba=-+#t z``V@@H*~r5R&H9tN&gkTsi8*o-+UZi7tCmmv$U5whH1yS55Ydy52QQp8Paic=KH^) zt+a&uAHV2$sr@`0FQ&a;3p~AXQm;!7KVVarKB>*DUoPXU@J)3zh!^V<2h-ZuxAzyI z!07-?8_-nHD%{iFUkbVvv=($Fh-1O&pwmE?1@C?ET_6rkr29e4cMj+*5Z8RuKzD-v z1u6jXJ`Z#PXgp{LXbfmDXdsBg67kCLaiGINn6_H)(b6Y%3Q}kI+%xF{;@Hv_bTEkH z3dav>umy;FZS0B5({3{dtLFdoS8Tv!ZFTN!n>CORhz9xK&sa?$d z4xSfjzK4~M_pk!UBkR;9wc&Qe+~3#^IZFpTSUhc*@8Sh*IGe)rGk}~3XakB@C{*mwW{jvTS`{Jdn+)G24#WVpaKx>1H+R*9D4?U(n0LQhk!bR z*e^Nf<1eBr${9Pf$`@s|1r;oZQIu2Ou*=Sv$^F>9o&tjt}6f7a+G zR%*})`g(%pNV~F~bYfi0{ka+lpgOT5ncsxlGj4@)yp{h)Sb1-v`r_gFNh?ORn7wzf zQ=NbgMw|#A$-`WP|3`=?kXY|qRwaD@xH2)p>a$rWfqj>@Vme6vU-d@FSG{HFxmVxv z>N}5ff&s^8_N-s{HaB#Y=fzR~Up1htKby_O@6vJ0d7EyNn&F-*Abx3M=nJkTj=tC^ z;qjj7Nn)SGXBzUwm$YD6j(nz-ddZZ$^d*kI$i*~zeZrS~A_vn6k7-D9FFw;qdh+yi zA`|)I^n6T9XXX>x7{{^G?JG6k@q4uee#6QIS_fAvoMby$1t%i zbrJ89k9^iopZP@=rjh!XR^lWb<0LHQ(Pw_9)#DfzVj4Q#XCB@QnfJ^~N1t&d;pyeD zUJ`i{k6_IG%`{;47vkOp;v9}^aPH4?PDs46Kd`+8Q+nI7jivp~Frpltp@FV4qlumd~Wl5Tb{789YSZ_#My9eLwFYFJx6MN4-!~Vj)B708kL$uYh)|GKa z#ucVzdAf~fm^dS!>3Prbh-I@J-jgqJ#GjPIuwI_rlPBqKjt>_2>t#Qwy&G5b%apq~n#yqNp@YM=%Ut&cyCK~%nnk_<`$ z$=r$dlSKQ~98c-9eVK=0$%|m!*sG7bl9uTtkL2UM)Ipv&^5~eCj&ULrdA#R%PM`NWNqOWE zv%Hr)3^R|&A$-Y?C@U@HCr{Gr^)qbVgB5dsGYteF5AE4LClr0Pq%}vV(0lhhr;U3y z+jH=2cyN>O5(l4~2;b(0u6X`C(lw*RJ!f>8AIJR7 zcjK7KGMCRSDQW;R-JaseV>JyE%qk?{+>`hf{0q+LlgQVd+|$=dPZJC8m<9q!F8ElL z((%^~;@zFB)ceAs7*HHZ&0zkW|la2+%hbSda`NZ4I;01yP4o4GO-};V6 zc}+nNqihd|&m4{c9SP#|ZqDU658!xDO>xX;5tJ)fR2`PV+AUlFze4b_F`2)*Vf&HM zHbE`PZgo+gV{UF$&VRH5C-@M)#ndkK@DcnJ#vM#k!#38wk31HN{t@lD0(1oEScudF z?K%&WvkKfNqjBcq{$jNAB8YG;(tClAc(gIUBhLkWin7lFjRtiB@tqsa*(tG%foxMG zts7f;Pe&dp=4=fF;0Zpq^Pk_qWr3(8^ZlYp`y{B^FW((9wp*+D2RvC$RoCG|_~hxX z9zLx16Zs;#ovH>E>G;s|HWX&Xe1Cj6s5|l>0&E-(d+;Od!ddtU9|1?70!NR5t_O8P zNAC{)<%oX(>G}dw_-aM z;Q#988HiihBudMR~Ztg{G|A7e^J=J==wC#5N$0_5e-1!%o_i8O3hw za3Q;ShAR9%!A0eP;kZE5UT$2L056@}ly}VBKS8~8=oiD*z5l}dmvbP8TNlKI@GYix z0WR`grA5=cmF}X!l{gR^A6VuQ8*X2@oSn|(JWqvkIDJn?EO4GmJPb-417;V56dUN7$UhP<9&5d+CckiENw; zGYWQXD&FPyLhgSe|1~)KW;M>A*@E)+#{Wplh*KYx$Ep9~V3?zEm`UfdCTiseP1Gr~ zo2uFE_EKx`KY;o?-ArxVg8%7*f0$N&UkladyacuO-d3u^kR-Kr!amCX(|&5j=mXRW zf2w+V;i2k|SC3Hd&+VhiS7)kqpN>%Ro)dAfO^M2Fca|Dje5Kkv@&Wbk%^TIG^0>HV zU-yh_zIbNbDM`!Y#+Ju5d8zxfCP%b?waG{K;GY`-3+Vo5W+0^7`DdXMI<^V>t?8gj z%W=L2b8gvKwjm3IYOQ?i=VEVJ9OLLDFT+eLj(igFAZf&B8uGbEL?TXTXT&ibc`T3n zNe6-`d(6c&@JDK(3WbZE-PkeQ&bkp-#L5o>|BIRHmv%@{{~oTJu z$6w*w+|ZTtGn}>TnwyWEO)8jI;44YNl|{8s}L3KjGblQq^+gY?897d(dM$h zvybt+4fb!&rD%iM-?;A%Q)t;^Zej3!6zOlY&-|W=>$p@tsj$!c`M`9inX|*HcNz6~%%X}mWOMaFiajb{;EQj&*i4Ddxjy~gw6UIw< zQYL+-V?Nfa%glR8PoMdjUig%o_sl~cZ8^gt5A%@EG%TOQG^Ci@JvC5;pC$IS`VeRP zTF@y$eSX2={aT+`ec@+iwm#+oG_mRwB!k2d_7(d^EZht(fP6P-%|s6zs>FD z+;3A3O;F3*J@`P*mcHxxf3oSM-wNO6hOW;2c7!)LEvh%(-U1*MqnJZL9DnF2o#2ms zO~xV$U=HMKEdxDMzai8fp5Xb6V&?wM25O!Rw@8(Z|?*p9*Iu}$8!WNKqmiYbf z*MVLEeE|9%lmG*g3hE2W1I+|gfq4Ef&;I3EyZd3F&H{NsH-KIT;a^m%JP^;?*#bHo zw(M-s+n^li{T@&k7_}Qg-C?L60ZoaA&B8=sEvO2HtpH6r43mMum=ui1B>q%PBp$+I zF9{QjbFk>x2MSt;Mcx(IaI3~bhzvu$|E<%87m+qir zLF+(ogU$iX0A+y=0d)gW|6EIQUc)xvT9b1dB93bxncqNc%TD9xTWbgWRLlO-Cl6|< zv&T@I<;aV|8sV%M~8sH{y!; z+M2>;z+I3?i z_v^T)OP}+fR8TsI^Be9xqy_!n!SJE*JA*ob7^aQjGZjn)ET7{z({jw`_)TKD9J~3f zjy}hBj_Xn<$8=0Dto;a%>)exI8fp_$7AqZj%tL#`eB^Wgg6T1psUz|+ow3RwpK0hb zKhugHr~`)Si$16uAp~P?H`YKEew*~$%#2XK<=HFzKe@dSUoaT+>p915twFy&w%@mj zqo*(EUf`R+>8P3y&~X1y_~hxXuHWXmU1j+${{Kg-v*LvDSsp(Qb_^!2LFc3#at=M& zJ2QR?u9=@0<~*3VXIUi1i({BPreWV>-(}xoKVTn`KEuAsxp;2S?*yNH{sPd;p!uMC zK>^U&AP)4d^&o zew;H-lJIiv&|g33AAj{v&n>y{Ic}TO*%9HJ5=FqtNLQt2R>dqGC92;0c~TDh{Ej$c zi1vl9vEz-M+8%c#%yKvm(WeuiJkH}d7SVnQWgtu(bF7*Op~*i}1VQ+J-39OiWV}fq z7=GRs$5zg_bAN-L=Fa^#FTb@Kc*dwps>;rIFF>Wh$v%MaZEolaoZ!99oOy*MZX9&) zD)*MAo#3q~ogpbI5s>RE_(fX#isq@Sc2-T^#U=#c?p}DwXp4JzlaqQe>(4zL0oSf0vZ9zM&i%mUj)hr z4Fqw|HWeh}kY29+3lJG|^)wIwM{rS`=T^tOu8P3y34y8L?kt zd%%jh9n?So>Fe+@Bpe?~WmUD_-6Gw zJ_b*p?kV)(zue3V;bUvC{%G$LbG+cVLd+#B&N!<)eA;c==T zK2{ise;zpXnDf1EQ<;zYqK&1k zq~8|Ae#bqPn6ouN9SZ)dbDi;Di~e!JtVK%>N}Y1Wk?W4L3K0AY-_&aZ_^)Rwop8c3 z1uJIx*&r9_LQpqk!l$g3eP#dQ`i{1hd8h&QG0s<`ALAb#3`t!KXbRhQ*Ux7q~=PK0lBLsuOqIbQ34Xq*Z? z*5!AHY$a1K2NAEb@05#s_H&Mf;%GaF3;JwRwkP8$bqa{cJsI>a68s3C_Jy|Lk8rx) z@`gLlizkh1t;Rf*_WpU5kGBjE%y6PN;oIEMRo5H#UVL@`z|5E=2arYjdD)2Y_A}?l z8zAT2KhCS2cJY&koAYDgha|8=4ayOmESvp157`a_aV%rs)915d!`Xf$s)Fsvz8sq; zLkWL?t45iEkD5`=_)sGg)Vb%4cMU!7!PVwGS@@=i4dSETNMPqQ@e-Rin;QLV?{&Ov z$P32{=YPE*p3IxmM<=MV`%gc2X364H&3Uu%&0o_XULsARk=ewHULMB+I{Gp$$aq2f z5}RjIJAbTOg5t%##OFKXrFaa^1sHSs@`1NKaIZPf6uv2KWAGBm)HvaWbqIFM`pA#X zJ58p69b3@oS;iDc9V(ar?vs^~!TCzuWJo8(Q}N%GMIk$Kdl~;oIEM75W=j z;hW|i;wtTV{5X&N+tIrBvZC#4aBfHY%lRGWfSk)yO0K;)FXY_44JZl3IXdTnoHKI0 z!FMmX_UHPI^LlJ$So;86I~`$$^`Mf+5*sQ&^e&XL3e;21-%OT473*pvx7hxpmCtt zplZ-^5YICBFQ`2RzAVrwpvypygT4ZFf-#!_S^#Myp8~jtp;`{k&@cnU${SaO3 zOlVf+LBG0vAui8A+a3nG8{z%ne+OECum?06G#rGVZDEx2uBo7-LHPOByWQ*`XdVmi z2gB$37b>>$kx$3{GZbs(L9<#8D!2M3;9%{)^@ZON1eIH3AL~60lnElQ07S=p?2F7t z2iVm)G<%%`H0s=;b)ir`jTH;VG!WB3Oan0u?4Sm!kzVG1l?ArN%>s|M-aKz>Bj$(0 zw?4XI+prDipWDo?h~p0Df5Nx9p{q9klM@~B53fd-=KJw4=*POtN^qJ3k9Uw`9&1pZ zKEAP}?jQ`)*7!sp!?!i><6I9@2W#xY6eZ^V1P$nTSvt)bFY&GfHSF=}hfer+S?BqM zn8?8iUW9Lo+*rKGv5%4PVwU-P?=j`Fo*QE7X{|3fN9qCMdH~Z(i(0@Z7MYgw8kyU$ zAJOS^9GkOeT$kWyihbEyANNcMSSmJ91vkbZmFFabwzpwm z@NpaFfSaK?!%7Q%)~v-5Px`Qxen1LsVFH)letlvX4mi%^^A%VmrshQL4#91d9OzJrZ2b<+|UAkw;ZCpv*+PZQqFNWf95=yYjr+j zz#}1R?%WkV=h1vdkqJ5;ghx8oIW6)t|cjO$rgL)yJ!Q2QT*5EneTX+t(SDZQ&5Bg4Y$Eh=J zj8pACiBn%5+eD?-G*Jib(^NfmWm7e;?_TP#+P&1Q_080ZC!4ELU+k@J8`eV2+S*b* z^KhcN?UUB(+qrF3^NN3{pTBLV`r(1u51Ug}?Yu+PzHN?B=dC+RUHVi8~tJ*91BvQqpdF!2r!-)SShvu|gaQLhzy2RIu2r>Wz z%Moi_uj!5$lz5I~F&EQ-XrKxKv9Fo@hca+kpdjA%qJ5Qf>Nh;pR?T~E{oRwl>$2^H zK{k?xBcAqE__z&ou&;IJ)aR6y@hkmE$JATjMu;3sPc`KT*yo->zDu9Gt!-H)_Hn0- z{^`9l-fMp7iVUm1#kf)q;fD!<8(ofZzKU|33=mO{owfJux7?fK`Xvd(cRtt;xgW=M zerHfOP&$YbQ^zAfwE5FPb3rh(ss^+gv=Q_Zs0$im9Oxp@vml;JHVee}BXZFM{{fZ3 z?stRD=S22L&_S^KUfBH~Ak-5O>U9W}4ZEKVyFU>R*AF>BsfE~hc%X|?_jSiNGZX%a z)1*@T$N<~9p1mKAn8rG&@o(=ME2G$TK)~v=S%3Rq78CHV)Ib20i=8bv)7j2;JuLyx zJ9^%5Z{iCNq<>EX6Piy8-(qSP-Olm=1=Gly=btqe=UNp}gTJRt=50)V_BT373lnR7 zt4EtJeUkAp7t_G5&_E>$k$#(WPI$jH&n?`Detmq(nXlcy-yui(f&i8MIN_Tzq2CV8 zk&U;JIJuz2ZEd!h{gwGJ#jxIS;QkpUp^s^Zg?kx?SS|a3^bZ8X!g9}eNlRYL#Wb)x zXdr+eA^o*FN`K|={p`xQ=e2unZ!Qlk$NtJ)bdztfaWVVr;4)8%cSeO<;sXds{ki8m z+l!=sCa9AV&wuWTFU}jqJtR7@7s9u>p=-VR=ePVd@8P@M9 z3YIdKz2WRbY=v%Pgh!u_`RU|7ns29$U1J*fduTu(=hsH-w-b|9#q*oTy?NJ^>pBI+ zmwqdJ^H-Vu7DK+Lyx2aAL+nM_Mb7pjqbfm7&F=r-)eEN2vL2YB5~;V2Z&Ym7%l8zR z#IzIGvar6XVIOCor=1X6L0|eef|is1E%%Xprjfjop7#t(oP?QQcns6=K9XyQA1Q5& z7t_G5)Ib1*Nq?=4(qCEc^mN~yZTdFjV<^kX{KDi*yxCv#eBQA6g>I*6E_JpS#S0Qt z>$5tx|9a?(vt*x6?1k{9Uh&QP^XIzVWr#HGMQ8B1{?OMT(wD_&nX$e~EyUcOs(}E0 zxY&zHi=6vwYITCDUOH;(t;b#7{j}iVEB#gYrXH>Ss=cohd=D|dVwRoK?6*l^bBrgk z@3I51rg>Nyn3;OLuSNW{Lr87LG?vZZ4tH|Yd z<$LD4kN0FV+3$HCN@@8_l<&cCf1G`u?S6EqZBTm#C+;^P(29Bg*-e>r^xdI36p0?$=n<{||@Y!rUjTKurd z_+cIK!}iAy%f$nLmH1(W_+eA=!*1`0bKCI4PR0*=3qNdgFQp1HlnNY&wi%4)w|EHL zZ9LleB>V=f!&>_BKhFa=%kUCB$Gr||?!ouikK^~guGFS4@C-OUPF;%cvdag@sTYdz zV}JoZ4@H(boYY)F&4-@jo8Qf;%M(?~JsPs!#EI`21Y>HaBzyPUPGK z`EE`=k+TxjKosIs-pAw~@qyq~LcjOH9|@X>um}Di&=rWE0Llar2TTuknA7j|a9E<) zO`|jrKq|2#Yp-<1N9vLUb=RRUuAG$Cd2`KwUbM;=d4lQ=7>i4QaXj@}aw z=!(`iDHGvWgVymL5wk!AARJ+!-U07^(9@ugL2rR*D=I+8gU}tV^EhaqSRUsh==Rop zgg%O>hfA<_I~Tw&5`1jE+8H02S0yOV(S>(;mMs5n`1k14aDorvTTJZ|0Uz?T$x77_ zK3F>21*X<|XXaw~uYmfaVMc)1&KaNqAle)LZ@(s>n~){|$^mr&;q@1*U8Q}IB<6NN z0|BHJe5mWf@nL@dR&Wi@)qkInD<`_!!=e3<1l=AHs^ z%sBx>yFuL0W}FGi1a$;`13qoZKA`6iz8xgzl<*y1;)z<|xW%a!af<1~9_y;`%LN}@ zYn<^>1^j&dYPNg(uRS`O_z=FS$O!nz@s<`=_r8mgM>wD1GBVP-2ke+@qy_>=C*#hNTf=c;u6wrwM;nH<>~YZWE+xNgw<~xF4ZwA; z@Xcz06Z~Tzyj10RPwrpeeYkvE)473#V9_TaB^PsN4 z2Im%Mg1E=p9z+B)FKt20{XPvWL3Y7M!5!iFC_)@*+ZoMO)BWyzApN!kwJmS(9f#cU zUczl$D8Q`+5g)=QPj~r+#qOet5`1!>X8$V{%u4)tR#t+4u0E`ʤO=knuZ__UGk zB2UGvw9)=zw+{tG`ah!F3&S>&H6E~f5-~s`CO9q-OT-56i7oyjQYwh)X_Ejci{Lpr zrek_KhUvsN!{)u7j&b4|;!AwYk7;0MG{AM5^yBI~!~3y$jzul{`Oq8k?hgF?Na@!> zKt8;$-H(ND$^bi$|JN1ydvxuw7QR)t-&?6cxs*rtJGW!+_f!vFA)B3I49$*Rk*GcI)HjW~5PK?HXI07kilZ*xP}#>!>APoW7`i6W$bW!&xje?Kzu zu;aH=ZaX)@m3>csZ~)0ge##~MkVJOKmMiT4;qk18uZ47p{nR z_ocOv>y;NCZ2ClQ&e$s-vj=FYSNKl#j`PfN=X**E-6LG(ep?hv2IevQvsuory4U-< ztn-3RYuO2^lYIIz*7KJ#EOSXo57r*zbbMCc7mgFt{%-`1Qu8law&13>t9xEXpv8 zs0D7CPiT4T>W?<980WP$A-E8}sUH&;G6DF#xQNz1jAt85UuQeZyq~|4BAme5!iV1OdYHM`p3?4YPtG6dlW6 z_n0$ImIFuQ7JfP0wYpn*a}M}$f)nA}+|bntC;AlC#0g8#+lXP3;D)w>BJjQqNah>l z>lk4ku^R|Rbb37z6U3Nd`(l+(IOAj^aCF1ZZ>+lOp=Y025Y(OEMEIskop2)GS}~7_ zldjCw`p%^(9GFcy2}~_C)wLH*|HvNtWL` z%Ts8lHE|LuArvBZ#7@Zg!+VZ3qUT!$sLbhO|AcN_c~tkUU0_Ca^R`&u=`K@=$Q5Une$oUo02vHFZ#5$9$vbl zz}URj)aqY%ua85O8=Ud75qN5n-!;DNncMF+=e5E&e@P?oVoh(&afo&#Hm^0c`Pbd+ zc4g^H&NzwxPlB5G_!UJHx}CM}YEBs7hJyIoitsI_c5%W{%cph-&M@r{j}h66aXNJ@Lx-%C97oOn08P27E`cM_{?ytg!jth~QZB9ExyTfPc__sIK_q$?yaJ$F30DiIH zW5XNH_(_H{Bz2FA0Kh|;)^X^2|k2xDlig0hWOm>qMgJ?q;}QoY)o6S44uRl zkQWc4-JnlxusrhV6En0Uk{-d`-UaXr1s}Crobi$OW`g?WwJz;iPyYJONv{@Jx)FQ` z-&B~6kCE63@0EVc*Rjo4vZvHjSWIXB>Ie0(+M z5YW+}<3Te)oR4n=^+x8Epb``?8wI?N0=`87@1lT2H2U}W2R{WENXB)=H@*1ZIhA8@ zHWR)HU3@dnLit#!c{rTp;*D|Ymg}3S>sL2bFO6uX=2h*jepuO3J=?d9>VCt%YM(V7 z)VufgP%GLWrw$rCN!?d*x|%oUK2_%XMP1#GhdZezn4~w@xj!sHe;NN`|DVP^+rIs(x1O@}CH+D8rV<;`A9C!& zFr-J=CH&d*Fu@9IXPCskN1r%h|4Raq$9_l~OAPI)PPe1$qu_=*y6&jXlY346`F&U# z9zkP0m+gUTh)-_FH3ByyU6ny2ifmP&x^e#lXB_9fk8{8uZNKuWYur8@D23Bzwp4gP0{&Y3GPrt|!Eix2HKBx2fBlaT53t-(x*@ z>B8sc&OiP68(yvEBufIc1V|Fa3%IbN^xpPaDBt?T?0ra_2+(S)*rraw-oXnJ#Eq_ z)4TmRCRKcT(TZJw3LxDea4fwXhPIDO)q zVYz1+OvAY$e^s+TCw-Jw5w`Z#q0cjfe0de6xxM@KNuR z0~04=<5(WUbast)INDY6(;gB(Lc|doZhc8Ys2-m4FXYLUB66F*$=*cbv68?vxfg) z+ng6Bdpp|Vh`xkx3K>~n6WyK}#r}}>RjL>nskg@NQ&1l~7w9lh1}G1NZ3cA<=yMSN zH}FTG)le{hhwK-a?SrIYj{2t)pY6kTV4HAngc>4|&$g95ir^pOs!^)oIq;Qp`)ok_ zjgN1+aM`(2`{Q2>TTa?X_@%d zozL$GbV*j7H|Wq@Tl^IrJ7n_q<=B>1S>?u?IZz|VxOIm5=Z zEdSIz=R^3WejM?kePQ`~aT2Y)7|%8r8^Cs#u|>uljz5eih8QP!VP3%%f);M*?@3O_ z$?_kaagy{yf;#iJHpN#xzP6Ql?uYPA-8thV^h$a|IMLf*53?S&tF%Acm2)xrB#sTV z2Qn9vc9!&JSx8#XH6~5HOuH#V$H~T@opF-!Q-XT4^ssC5t~hRmdH#p+O*J{=MBe^u zcwXYvR$?2(XWhgGaYB4>9N``{?`a#zBVL3AXJFMir~2v=?STOuC+at6oD}?$pk99W z(G!227C78|4_)}C3Y~Eh`ohw*Cu}dV3$znl*3*}9LB<5#PB5%v2Df|U7{TAYtDU}n zO^@Slf9U@&ne*3b;Ar1pl6$`#ci{`>`5?kKw-uK#TF zyb$4=T52p_WNK^Tg>56_1%28YX)oUE_C;{Qc%~ys8v2441naOOWr@$YNG@7@q&&ML zPv2Kr(##nz+kvOU3tv29nSbGO^LtC-n>uPVUP4n`s|XV}Wa@3kFo`%I(S~rY!f@;y z5h&pgcDkKezqd1Px;9T#uMQb?$1%T5nz0}#S1x>hCm?)N+(zRjIOR3*(iH{j`(8R$ zh!MFr>y>-P$K0;dfR2~#Eu8T(DLzp>e9q#VH~;j_k>-3?_@-oy#!Kv6JX3Xl%X=L! zT@#)0Qq?k16?~ubS^N9We8fCgMEK^9Y&2eihm4r^#Vn8av>9SIWL)CC%yBtiG3POy z)^J|$=p}4#Iy|42|gOz{*6s%m%e*nb=)jTa>mVe;A+c; zU!QNf`I$@2`LFOzZS5#-WExz9Mlzo(>g~obi8v4}#OA-I_W!th9XA`2opF=iHc{ zSp+}ZqTq+6_v>)$aoI1gt#>|&$!A)+ox+a{TFAc?B=V)VcgA;hN}`%EIWReH^Z4%O zc_qT9OuE}C`OL#hP@su(y$*(nRnzJCWthad8v6zD%wJ2Ay>IpbncM4m!H&5o8qoI* z3Jwg%ky7E`L97MNj{N16ft_D#mTjJ2B7C#D25}VWFcV~sh8MH^U45_HONNOnVv3G9 z|AllH=OnYo2!^d{bc!;zd3V)Xv6XUemrbroGKN8*|S#7pI5GBQ|7hKrApUa~|3n zhWXx+%!kbUh}vyk4St!}m-ItSyo8^BQr$UGUEJ-L!qWR{KQYfg5x%LY2JzCE!%$F| zi6684KkA-15gc%SLPvbW&I_?rQFp09Nbpm3m@|Gh0AG2}d@*9h%7lZ>^FoAQS8y<} zqxdnussFR_BbcH143lVI=uaV|{Tv?q;E__<-O26uv=q^{2RVa7|FsbxKv z9eNCC`IbWdeWo1xLT$h1iRL*X!VgJihoZ|D;ZPA| z{j+f`a!0a@9Mg$u8E1)W&f~>#yxr5Bj+?;Y&bZkMT;=`r?7cVL(&Je3ToK`$`fD_9 z41@S*X2l0xclSI>yGq~GS3?ken=ua)Sz6E4j(}lU7n3cntBS~cgsjiR1-cL z`HwY|_Ilque?<6=mnXtuB*<*`D`Hr;m1g<8XWyXhl=TRG_6N=lNW5nmOvAY+`%APk zktF6KXh82*Nxhu$QkI^mI`sW;zb!rcCY$Gx2;Z!tVf=>h66q5M6F0g#N+~FERCJ zmM48qeD*!|7xtgO;yjTW)GONqrL40n=W3`Ge2Azs}>L1}+!G_o#$# zF|~`XPaesTmQz;7Xw%M?~WjqjYBxt$FFC%6#4%?(}a;lg^>9|Q-IMZyR7q-D;> zYNV}MD%)8w!?tEve8C9s>4b0J+1D5*bZtZr2arVYu_OvUx*nFS796@P_lw;0%+bN3 z1s}pUYpjQl;ETCpKlJ)j`a9!ueb;2w_QjGW`*wLb`vneOa8keUZEomVuYT)Y8L3^V z0Fu`I{wVbqcTZONb8hXw|G=r;It8nc`h_2=*$&mKpDzlAst>Dw)v?aMKV?9o>c8ou zqjKh6Gi)dgBb?MPe487(>h&8Voh60YKiU5{CtzQbz9;>SeT!lGOh*w&5|(&94a0hV z+{WAvXrKyd1)rJ6IpZV#@MM+HB>mDJj~#YKM$ixnK7?;p?Sv2AlZA|d zbm($yj3URj^kj90@7Wa}uX+B>PQj`~4&jF+utQFA=q5y$qaf2+A631Q)e+teA77J^ zRL=jOKqqnt-{yv{PIB0vblJvCUk}wrk)!KT$*NV-`=4}Qbkw3n!Ky?K;fEx!LyeF_ zhilkAS|H0=FYAv^R+n7y_J-ltOzdRhRrot0j}F@~d6Kf7SvFZ4b$Bg?Qi!rxiB z!Ws{SRDon%*giO1UrL4V6HgkHsQ$6N$(rw)uAF4PpDBDNxgxxhS*Id%{$Q5#N8bm{ zm{kqKGG`%!O|YlGm#O0QT-(sRfQE96x2)$axNd5OI1 zs1;Ecl>SVgZN_$#Fxyg|lZelFIuj2zH+F4|2K4pf+B|1`q~cJue&w6*_;=FcSB~M~ z`f!2|;oIEMwE=uY+5)pOnRsE}rgO6G#Dr%^ZZEJqf~A`JI~+pZ8xB(^>C(I?I*dr(Y-cCFL(mYyH3H}g4lU~HoLDRu87o`3d?xATI)7rhDJ zlrFN~v`5oH%|+51`vv<5eIZK7enj1nr2jGeXFC18n)Oliw(ZztHT3!iFKXNW+mH4R z3MzUNzA3w--Ws%0;q&y`@!{=hKIhFFm#FU8KA=~(z#BQ{b6(*)$rbj0B?89qFWZ_trX`QQ@TK2~kEob)(170WQzkj%q;f){x^C}D zqh2X}aewo9CAV$Xj~js7+F`aEoD6r3zME?G_M)y2Kccg4l# zKDqGCU*U|Cuq|>ctB%|B6P$6Ik(sRiyYaOxw{^X5q4_*m_&X*~XqQ!&V^tJ6HfG`Z z&MUw9r zKhr*Q>=v6(`%I$KZN7{RV(Z1eOM27ROMa`M*rm}L(C00IDb9GQ%t=-k_E@`M(yYri zn9qxaZ&uu3e>U+F8Um~$bh%QdI?I(ZI9YWpKKI9|-#`9e)6NKgr{ywCjxN{oC~~bD zlB~M)xcG*bvo5~de4Z@)ot7(Pdg|#b_atY1P0CGH&wbi%(Xsu$n{C=3;qSCuAyZUO zuB}nz+CD5ubsJ$;!K5>(;)BKejfX zKMVi&%4NVmOup0tXZbQl0{5x&ibp&OI9D;ox_sd<{Izu0es)KWd`Lw<Mtn72_yf+t@na{U{Zz)#0G&tW8+!znL z|0=xbI1%xQlh|`^(T45oc**cM<7El(^nZ8%vee}-o@+km7Jhi?4(Im?UW|v{JBpV` z?X1f{`w-2s44uTDkQWc4U7;U)-W~ouZt+ZKysQVFUKsk&R~2*DFEgKa3m<9?a}C;; z1|EK!cxg;~hgI0f8y#nQnAwR9uHQ+-4t?3nZ59l3kB?!>XXXcMw{^OGSu)ERFWZ5q z)Y~`a-{0@XcII<$;hTzT5HFD)f+Mqu7pLb{Y$s_iwx{gTNZZQuZ}AyVw_48o!dARV+`WwWJ)5CET zvK*v87j&{WdY!}uu|=Xi`Lmvn>v}Bkh3nCLKE51!Ub(SHS+ki5CFb*S;Y0K=*9bk< ze^`zZBI%L+hI*1`<@6~r`x$jclK%N;+vFP5E&B_q+*yy4#wV+S;}3se^p-Wt%;)98 zM{!}U@p_D8&6KJ{X(C^xAzuf?9Sq9-4f>lq_uKdh$?E%uYLgeey7|BPL51cbp6{ax zAGcx7l8>8y!Hu=CZdbXt6yq;aNxdolM5}$Wz>~J3tt@Ddb;Hf~;p{J^#(aF#8y#Lc zOt#gOn@n6yzQx8R*Ht=WqRU@c?DnM%D<4W&nEGP1re2H(gd|I>V5-vqSB40s8 zbp4$@Yt$o&o8Ep(>KFM;zQi|LKDMj3+~fE9BI>b9lXF`XIm=30tE;Yis``t8$CMuw z6l5%X;!F4jHrfSPAd#OGjG*g4-@2y&#)1(k`GJ;_2rlmqIq=I(h=_Dhey*de2=wMugR=l)Muth~8zurk4$ z@Pq6+&jD{aE?Aop0AEGfSa*3viJuLxuX}0@d1&MI0@duVRL@h#zrso?C%0VFzjpiA z!~z}tI9!EqF|~_>JVQLba=(qpvF_OwFmK4G_s5h|L;WC9J5|n0R3jcv9PfY8Kc2dy z>knc-5WdCKE@%}$x?#TC@As6>C{N2ODe=zDhjnnxaAy_L;^xmQEyQm|h3pUVzF-E* z5G+uZnEPur5J2@}FEdVe#>o=k=*V;W&+jwvy#Ir_u^iVn#EI~O>^g6Rx6oA*#6{Xj z?a@gexDE5IQT!;gb#(8BmU`2&cOS# zi@zH1)u8*kz7ecn@F9Ftta|v!_sn+>D?L6tm~bn6b3A3c(}sv$6?@Np84QWm`hXKi zj=60>$)J5fFu&IL-U)tJ(2*dH2U(yIpc6nI&}pE5f$ju71Ns7#f=Y*h&H+6QY6k&0 zCVv1bh9FH~;2#7nfH3FdN8b%$T4I566UOI%LT#&CD>WVy05`^H>J44S8c$99bDY@K z4&sJ6^FAyxb`z!neOzB};NP6@Fyna-jdPdz`oD$n0Q7eO%8wE4)9ZKH9|Uk9lulKC&WbkWeLP!O)Zdj?u?{Q%wh=tyuin0<={-+n;emD7}n=gOcR;lWaAHZ=<_#&71 z_I%8KNMTI~vEZEJD)AIqy36xIx_Q0QhG3Rt=g5UeeaSpX$`St?C{5<3!i(gGwf{NM z_1HsBtvkt7|$CnnnN{dR|MT08~-DQMAj<=%JKddygL=B%` zR-PM=A<`(?#N$X=3-gRs*{ITzbAUPU6o?RJU~eYWa-SMdjSvqw54BPK0kU zwTp%m+fG^e`wi*8cHoYcby#|d#dHY6;*q>1@|tOoS)ul6EmeB@n-b5jR* z=(Az!ydU=oiY4QY@J(s!;e+FhWlqMrXL*-w2tLL3Md#An$O7T>HdcK^p{Ab?`U zj+8BM#!2QgiR$!}Z!fO7X2R)Q6Vgou(T)h;VrrLqII#yB%mQb5=Kv-8xTh|TK2Q7T z>6x=v$A36ns<8LP4^k#y;mzXa z5^LSCbqMzT3jVvS67t?x@j<`u<_&ym#B969_c5`eK7=oFh@bDDSAxCp($E~(UMra6 zE!W`bpd&z;Aa*EJYwd#%g-^Zr1YruVu$67C;p5@6--_efg7Z8&u9q3s`$;dDssgf#oBh z;dlE=@z^HcJ6(h6=n8+K7mG^0zob`(9M5=cSL?K8jGVoQ;oW_4pDWWt}~q z4-2iub}&N?e6b%J8X?cLPqyE2%+T++-DJ5ImV#QunS6;K<@TqIA3K7oar23q*Y7WJ z53Y0isrqP|fzUBJ0JZ*%l+>a+6cw(C6_q%76`OC+b`aRgy z#ag#;Bp<%^3VYtL4f3!LW`U>%hS^a1e!#82-B^3Zrw6X19CY;Ka23AI4P7J4GsIO= zGR;*ua|jlwMONYfuF`JB|8mArWl?K&)@4tA3s#~{iJ^3*Hs)0IM$zLSz#-sE=T1e zXFV`O*GWJ17?f9VPp}&6c@&>YnS6;4mm_~(Ie;Op5mbehG=QtL$9BjO4HvaX9k()2 zzM4aU<){zJVe&0DE+bu~p6Phxm6q!&$D@8c9`?^mE5(QyOb~!C^;a&AUjGRzzEA2| z{Opoo_BuV7e2I@(KSo@i|71%Fy&cqL(d%#fraIg8Sa9KkO62#Oe8>8W+~tKnkF|9p z=>iCd9s-S!}&yn(_9ZbH&NBsR>pNFq1(4tGa00Pnu z@mECGL(XM2*B(3Wt)C>n$YJs&KB63+LT_pC+#p>K)s3kC5tpyUg2N8ILduu=O}@lO ztRH9$&O?Jzgtte^lIVJP?!y5eEIfIiRH;YgF!>T6S&m|t&wVmLIl~>?mJP#2O(W!J zzv!B>_5=5MTj~)xOuocNl%ov8y|>U?aVsDFcIkR$bbUOr?z5Q-efMxWZ8?#{ zPwHfkJ$#0(6KWs_$8QqLa5BEOeUo88xj#n-F@cfq- z+VzL*gz%Y0cXe{)xqRjBVMX>E6yf$E^(yD_s=8SlbyU%{3r=0L$UiDLaN<=LYupyT zUMIs7-P5d5I=jSGI&+-6(w|@Koomgr?36V4(l1vIK6n!+{^xW%K+qpw_+T=@o zgn4j9Ss5N$lw+TL4y;5u=6raQ!hYnE=kk>LdoynhNaUJyb+}&SeWr9wUVfUe)>^4u zHb3`=7G*zAW?nkMg~_*Lm2#5HnzFkJX}-#>M*ya9C`8v=Z4~)7_>)!1soy>I$zdmr zC9dcwALm=bx0u?+Nj_U|ktM4^8KSr9Yohn3!W-VXxXZ?@AEj#1o5`2>=yKW08tEx7 zN3&Y*=vb{9EI^;Xr(WwUUoGBW`oGFC&Cl=u^aZBggfDW5AKD1uY|Pr~%&(X>%YzAg zku6z%g>Sm6&^>t8H13Y;@+^lubkgt5=Za->lGSkuPmH>J>VQQT_plcfe6GZH6uwn} zcG2X~D<0@Y=L{gliu51TbZ?yDeUP9bL+JX4m`aq#K;&N=a#>PM$iT-?Ja4-)71sd`%=P zXv)QBzSz`kK(26nZjB;O&H6;O`myJyCwl|a_za#-^dx+n8@g)pu&MYIc%r8W^EXRj zIVIk5yQ?lm7U`!|H#+NurMKR=^us&S+R3!V+MnPqg~=C5u+pF7Dx8-#Xjoo;+8~$T zH4P1wHX7?qYkHqH#8ZO(t$dH)UCy0X9toC(k#mj}t92w@&h(q2%Q^J&CUZR9Kb!e3N4Nk|b^n2kde5TP|n4HVyv{Mh>zkMF_RYcD{MjYm!kNAEa_n3Ic+$R^ zH%Hgo(XHbDc}m4GT?A*8zd7U)zFlhQ8YYh|fi2Y_x3z-Q$D{SApTCp#pdokBhJ&x| zpStiYiD&(E3k<%^#TcUF%dVOGYZaJy6}i(!c`dt$#Hk?aq2|^PFWm+?^mT z2}NHO-xA(#=6JRAg+#UFm89IM)!*KGBl6M7JX-iRH*^h?lbylZlcbRL(oVW2Zq=^40;bz{$=5FTF*Ps_%8;@BdbIns?q zXHjtKGunquU(5=F@5Qn#UCwPwo%P1_FAv@FeZ|tBC*RH+ILf&{uEMvN+9h1hi9Q&r zK@~yU)mRx>Tn#EB{u+9ZNvraA2iZ0xI=db0aO~Q!2K4?{dAl=?sjW=-07oHYYe=6rk$QB;ACb7l<1%&{yj2OnVh?TL$(Rkxe!4rh6~{+OsX z54r5KSKG(s@_k)8J_n^e5WdCKE}A^DC56|l!jc3(S|E z_ul-@)>hRW25$>C6leF;i|{QWv`Yke##WT#tCcbgD?UHgUG`TaR8=T#uW%tzp5A_I z4LMDF&gxHF=6QZ?MQ=XBwH)!pS)R$a*tmr1PO~O=){8hYw<~pX474VA0i>-P|L+Xf zS424;yJFMg?Z?;6o9g5+_|fICo*agat2K8=um8$Rrk(iCnJwz}ucdyIAEAD$LQNUg z-f?E|_lw=_5X?wi((zfjlQZo$@gvxdlux&}dN@+r81MIMpawCopR;_$za*-> z8BdJ={JziDo8yY`rCjkFA)nnP48crXbDx2IErwaq>|g7bp&`uqBEMr5*G~d5f0t+= zZ2q?*yq}u;h4H^7sy@dZusOFVeZ->RL|f)L!Z(Go_Y3n2U8Py2Fcxm>(-7DZ%pAb0 zn?B%mAAYP+5;pIOU+FAQMqDfP#Xo-?bl=%4zWS6OZ^4N?!ne7htAjkjsb8HaRwi9P zOAL9;dBnyht<=yHdt4U3uIyj7eGSPY{E#Ges3CdkYsOBm+tu{@o%K_>S1XmasQsAu zPA%3?j<@rReuUpxd3xd96|3@h?|hx$^Zb+kyg!T*5cy z((JuGU$;l4;Iv0(?Ynlp$-N+|jeA#IUl8(aSMq6+Vq*rBu!F8E((Cq}?M^aXIuxv@ zGvgb3&vufwV*9b}NDOn_r@uFdY3SI#B*`cJm~k-|)4<6>8H@yu|fd-6=Dm)TI9$={XtT=oW+zPqy6SXsYQ1Ajz+ zk@*>YS;r9P#30|X;J8Js^Iq`Id(z*%7jyrJ zaUF9r&baH5am;2pp2frynM}UL#zosdvi6MZ59!hd;foJ`kY=A*W4$1ZeM-ERQG(M0 z@saGX(&^r`(SDp38Z4*^zR0=tS!X%7w`rxO<_+IACVl${ZG-tKC!fO#Kgh20G&!~B zdfGWA!4HOOpcs9BgnFVapkp}Z{#p%~?UMy@l0fkwX(vh;Yb$Eu&vyY-DgC(MIp==7 zq-`tp@Pi$?9l0^@PL92F98=kkg>Nyni`I{|ooc*ff=_dqY!yiAPkBE2`+>h+KYZ>r zb0$1GrNzS09NT#;9Nlk0zI_+E^4)Bl2R7H`E3%K93OfpSe5o5JltKS_)K<%tt4 zo$2wFTKtT6mo+!@FVW(U|K8Krj9;b2fB3}(UHK}#4TiE?Qt{$Ih>Bbd% zd`0-y$vY0$n5mDuDI3D|ZodCia8DcM zJ7xIyX(es@Ol?A|YtNV2Uxgo%#16^J4A$A-c&UN@2z)8*=a=>4@%6gLZ+#aUKyvA~ zOCSf^GYdqYcAY<8e?Ro6l$-YPW!+dq?9ee?6I_LFF||vMZ(f<-n>NAY^H;b^j(5+? z$7f%`v&WfC*F)-mqT7uVSN*#9_E(QOshesM;O}SsbW?(S`z~}1)<3Rnmi3~p2x7mc z2XQ22Dgt5$G9iav59`qJvjOq^{aGOU_uIPCzwdviDD%@h10&x<63f|g#wn98@gis5 z$k03WL8YaQa?gdNmdN-#XmHM;{H(C=LULaUZ#T9X?YjP*;%&EWJoc3BUyZTlu;u2t z6~Y%e#1F|6Y_M_jtfQwZkwEaW)~GiUUe?dJu;(4i9;AwCKW_!2#|+XfWbM_$*U*)>Jty{Ii9$aX!zC z8EzlOopC-_X*oY;mOQBl2wsw2#djS8YF{lppy;SsS9G?%?W=*J887dvB_lo8wEA2L zw=wq@Xsp0!oboBXMoA52BcHt)!oI@g`01>mi(WIueTW7K%i{ z40`(&zaCwlGmg0Mu4Qdq{iQyU$K*@AgFKwg;N>1~sii$bE`2F;O&0Cd?3bc{ zOTD(aYNkxS#OJzQWf;z7IfAzUo4L z&S^OruS~wgPxO=)dFPg=<+%M>b6lPh*3P&9Ncz>bM$}tg_T~GROz!n1^U_JZCf|<5 z_lm)K2bUI>xaPRi@`p}J(*+11q10czDf;hz{*GhGlspx3{x z5%piR{g{5u`_AcV*Bcs_g)jArZ`MB{J72FpY(7=CIr{J4mY#U|rZJ~nBjwBQH~A7D zq5f=Fxu-Bp2qf0=w+(V|PLd^sMDS-uj#m_f^nh`UyyHR5jleR_xgsoW_e2H zsZ=Cn`*S@P|3)IdV+fVYGIcw)1o6@A*wxDyUA=Tl+W}I)Emxc}`4V4GuHYojGvE3W z5?>w6!Wz~c?5^Q@N_sQ8JZ&en82(Vx6}O0f=yM(?e33(ZktY|^H{Tq*^M>;-IEm5i z=Tg+mafOwEI{K_v_!d*U1V5}qWjv-D#uCSQ*%rf| z$`&!kRf6L%uvGU2=a~2qUvHm`Ez$K+_3)ipRpmcTG364zCXyAz*Pb+A`q05UwT0F&}U%&vmwUsDze ztSme|0LEAv;J>H z-_vHESUsrI^;TwFYO>5$hKRfqaQxC$I zdc_x9k1xXs`R*Nuv~Cyk-iC5s;Ms9O%2@ft@!UFmB0ClE2Vr;>Eu?`s8yaPL0|p zer6^wtzS^~QOo>mcwpL__fH$0Ja^7H=wcgX;)Om|j~G#*gA@o>p~dy#W-p$OlcKu> zM^f3JjM-6ieO!_QJ#)6&eB9<=e(}2GC;T$;;*b85d&O96%p{ym!4n~d1u=8r2!4tz zH-g@tRDaxZ{jg`xW4CGP6fF)NuqpF7~Q^l~!K zQDWjnZyq|ic;h!l?BWtaYje;cc!tqUiVl$+V|vsfqgCJOyIJemTvYrNN z1hZJ*$o%L;@FCyj1^LMFBHLgwbQ9<&hYaV!?_9!29-f`zKqH*e9xO8SH~>GwveP$I zoj1Sp!R4P6s6Etsk8ZrQ-ysuRhO=Sde7oTBm}XMvCitBDR9V|aBcTxQvBl*(N$nnm z8ZS}f8ydxIlNB8~#!Y2DY@u(~=c#&zbL7yw*1pD?ilEdOxU#A2MKV6xo8sZ3&IE&^`X7BCRI7h zr^d;vo6^SJeZOd#?!W#J$UpqNn?E<{7Q9X~-EE-TPGTPZg`aA9%XD=){<4x?w|?%E z$6RG3KMw#u1#c&+{WVV)TmB>uM?@nvDfZbMZo+Uo)%M(v*pcgqj!c_Yyq>dzbD$CQ ziGDXizbRKm0NPaHLO_2Us^NcY$4}u@UrznGu=-zr-beOgGu);KEqI2}P4oKg){f4F z=tc3&>YO(ISp45q{lk3C@nqv`1#0gxzSA2{?ba*e5-}Av+Z(~_w9(Cz=|;vPAq>6) zJgv)_?mM#F=UidO?M0eL8E(3<=O=Lz3l4xq{Qdy)Px>p|0K+^@v#RwH-#1s&ny|U1 z>4oz+uqHXs2qD(>iv4~XPqrOCtnGiZd{zfNGOpV|OWZ4ejTu>-dcS?H`{h&-!jpeI zAD!d0dHX8$?T=5|Yx^q>?f0jd$9?PWsuDfRQzl-r)W&Jfd{n>+U?cyuqNvA3~F7uRac#<->h-To2~HHE-|Q>f?K^DVyb! zYrI^-QP*-ctqGfJn!kr|ttlU`ep~Y;-kS0ub*%F^8fCwf?GXDYUOfmVtR|zctIhA~ z%svz$FY1ap571{tcXe{NgKqurii74!eZ(^2Jb>U$GTr+gEPNwruPe(LZoGa5y9t|| znbul)VSZf4AV`1K*=tIl%!V|3rfnQB%ZK0Tc>HV|FIPt_vwWBb_ZCt=Sf{csrS8hO zAI?@8#ueRfRYWha&4EniqqBx(#d=KYFqV_>oVJu7oSsd_VcI2l^d-LxV#M%Z=@!;2mu0f7~D+Z`j4X4Y({DS7we1Rz)ND_#qMwU~@k% zKEt)z&Rluwb|h!P)=8rTmOg*C0?(8g8qrH(REJwH6N$CBNg)PuE;lJHg{O%>zcZX~}qTD4w z=n{M@=#suj8c8}m6E;fcli5FFUO#;K)Z1h3Soo;qOM0laCSLrT<5Q|@ltxb4dUl_U z)9EqGZRN`D>W@#yuK4S_^WQPcP4Gg8*v-+C;r!M#!ulftT`v3JIeD3>Bo14byLq6W zGFt?o%`@ilNuetF4Sk9kGgj1{*HdlzdarKdSJw9%=yo!gF6B<}cuX_)KCUQwmbP}q ze7yD%`^@aiefR~>=m_=^;LZr%edsKaInigq61^X^NjhImy)P{5t^zy%Dg52W|J-W2 zQ^0n8O}Yf1Mid@WdOr-G1mNDa5H5YwmEVn^%Uhp5+3A>fba!>rigSv+Rg|F9x+&{&>H;pbAy4&&f{?`Nt%<_>uSsq@Q2shTA-CX&s4vO?L_sTvu z4twR38=uxzD6f3h7Uy%zw=aURe_)?~h5o&qV>0iZq8ipg`uJ!O{D~_9(B_5$?zdJL z;J?4km+#ZL%PUV$s@(UUtz>-1aJ&aq@C>7yGJh;KBN7d`9|H3RNuF$g`&e-ng&((~ z;(Uy9AVL<;W(o5uJKOZdztCN_Ws2^9{_X3{IW(K-`pbSjxs!qPw1?5hMN5!B(=7tf zE(D~VM{{n0+Wh4^{?Txj?_}wFkw%Ws1dqowWAeq_|L*XGTQH{JUSju59!Bg75Pqnw zQvB%Ze|ijQ(*1`Vnesog(*t$%H^)`HAB1=Ujo8jp`oBKko-JH@tn{bm;t}7RUwR7O zlgEKI#{pAc)bg4L!g~WFLa!^#YPm*cpO+O99SFr(j9L~UGel~trWSJ=_+tw zZRm^MzOcv~Z=4y+Of)`q_5?Te`!d>IobdLs5Jy|5SAyrh#xI_}tU`f$QCBMm*0jEG-#{+_^+cab1}<95D68Ip1;Zzd8GBp7A))(Kygi^o8w~ z*LHO@>G0?=IbiCG>EF?wSEo*Kj~7Aa>}Y%KTt}0DwM&ory%pt=-(s7_)2kFmJiSWs z!gFQjfTu4hzIghQ;)UnR%mGhdQhf3BCB+NRm6-#%_S@znI=?UIbxh!!W%z!8rU<}( z-o($G``vaPgY^OU5|H9w?rRj9@KJWniSK>zb ztG@D0pFO%z_3Qo64)>nAIRA!Yos(IFzk;_D)&8>3J#usz55IB(>vYUB=rHf$>Qi5+ zPTl18>t36-+vSua8lgk*4mS0losKb+C&w%vx1Dz1&!TbZ{4nWYcx&(7_et!z!Pq_d z07E)D;a~7JQv1t7$LK_jCTTGzlG(1T$?-3BY)u>PnWkhBxSlFwe>iPJnq-~TMR}IT zfg}e!eMz6^_Vgtw8lEEq2TXm*5TwJPq&*T_CoB_A_otg}3k~<|@T@SlF}i-_k_Mu9 zWxb#%$R+Z)~~P}kO+_S*}${`I&|zIS?VoSWwN*Mc`$ znd~3Z;SNObDY`W!8cBo$GTiVLO~z=Y49DBsomM2G)75x#cDm-hTcCQKbJ(1d4;*^# zI}4ms^Mo$Jw~?;#!FaV!R+I0$&2&53^Xjex)@1*^qw&_Gr)3VTOYJe=W_9X|H;>q| zysYmbJbg(?fTu4hUU;s|9Psod#TQRsQoQh7nK`ho=}YFfaQbOxU(I|rdX_;yNo}SI};rCu1e>zSH zo8{BiwNA54`OLEw_4Ldz9fu1YmlCghI&RsJvURb)Mm;oj(R|Ltb?KjZ>sgt&SrCQcdTdY0hLJd^8L#i1Z}qQ!ir#bsr_ zku_M|DvkI9*k@N34Mw8Dc)f2#)H*rA-F0Io7gfa*{!m$j7d=n6e7H4Qr*k>zBz;8y z+7@6kpbnd`W*u|alYOo(RQLbkwsQ*4SvYw%1HcHKf_Jc~|5nh6+o>i810dAOK$FlP?|InaZWQ)T7^-R69NPf46UNTjx2`41NpVNj3G~e(!-jj;Yu1?dxW-0JhLS zD3P812{#t1_v*fy|J#Ef{W{c*FY+RI7oD_PL4S(6Ch`K>(@QDI{|4kF^v?(VG$QYr z?%TTfzMCp{UC_zhH7MUeZLLhaoe=(<`>kwc9E)4mqPSjtL?j$9#wxSDq&y2@B>y4P zTh8AzGXT_`Egfkk{=C-ApBT7vt@oeEwX&(?duu1X$ul79bZ<~Bt zz$d5Q;zRF6@D4WhpKM=-*VW>hyc+bK{2`yySTx-ZRAEK&$$~#LE{GnJoyZ^z^hux8 z7adim^?5rI?$p;QK6oyV18b54>#E*twI-S5<>hg};J~`re>7gfeq=joww30y8INN{ z8gHG{;e+?zG6#My`ocFg^}~ENx#8)H$r10lB@PTi0DU~ebbI%2ww|lw@l~GyL@y1 z?kgWYcw?6i^0gEADtH&2wAxCi6&TA^s#x45bZxZb{BDtVpt2q1{0U{2?<+=k>$psK z@%Lky=OlBi7Nuo&IeHL%MQp>FK&GHn{cW- zmKx? z%Qm(3Oz04un~09WxLfW!jA@^Bz_l9|o!sMX$w$_mOuYDKqyr~_OyX*0D1;gu6}zv@ zAB|b4$`c{^&T}>rka}^z6(3I z%lz7B{;}~}-kGzvh!Z5y4QMWBauZxMj`WU7Zx=<)8z zh1-q~+mYRH3~l1YKS@v1@=DzWuN9b1&%`+`)3fsVA8vbO?h8%YCllW~dQt_Z)3Y4( zkT1fYOzq{yWlsekt=njn(JeXqa-}a-)OJ#R@h|*sydlNkGsm93 zFL~J>;}QK`>`a^alW@&=uU0hQ)iWLkR+R&dNI>*`$c?Fa2FiBB)z>KQhg>p3sY51y ze@Dr)J=Fa_9r)-`H=lpSPYHOyaK8ulYYN^*YJX#`aKMUM(ekQlE073TQQy%CD`8>Z zYw|3Y;dSw-Rbz$f?Gqc_-LR6xEI5R|g$8{?h8EcKOY^Yl@!KDt>{j+-54D&7^wTze zc=F0iw{TL}2^Q%Syre7ksL0faZ+JLR5y78(x@Bd|S6m$o1xAjksE(r3!mx7zLdSr) z2A^A)mJehLj-v;C#SfJ+Izgv9VMW6ii*WQfn%u$dI!8_R0e`+?%CoCJA2$x18 zwfgKWwWAY#uen}YG>|b!slXLv!yZFKBnKp2srSfS*l4(&g zl@D=Tt6{H6+9F1huwoOpz8k&2JK-UtpK0{R=c6C`&EJMjC|$YVyEnU)68X!1rr=F} zI^Ug?MJ@Z3LSJQV0P{_p;r8Kcv-pVOGB-jla*}JgF`Qm!nlyROt>-{4<&#UQW*M5# zk_PeAVb;g8-m3Rsnu{m#*EhSp%BL-Sld_=A8btaoEH}?M99SLYBYe+=$E**jODr44 zll~2ywrNdT66g11w^Tlv_|qJYI>528^dB>Y6W(R>lQ5o*bqp|SRp*(S<8^a*o$m}o z{b9LsUdiiUfC-v0%ZF|Cs+de=!ZgWymVxvMBoBtq6i58mciSu<@`L=6c7S7E@|Mr5 zT6RdnGp*!+Sw8EsEcd{>>vQj|WJQMzuCMzqYhj!`pmR^v^|}`x3_LM%_5`<~pnh?j zEO_%JopCa59;mVcxk8$Z? z9ZGrxpP8N`{nP!is%Wq_J}gp|;78HU06sHKOrt&ISeJde^=FgLOwaln1YehR8cl1{ zabo?x{&l%o_I!4^;hSId-q(F^J*MoUeOxw>m-*nR;9Ydma^#p-7OQYlgl?Dxs+!vVUomqj%GPv>UFaL+tEWWJNCWVrVw7-gJADx$c(M-== zE0n%9_1p}@c%Eq+2L>RTK7J*iw*)lzOu7 z?7y(SlQQ&p-5j^t58qt*bVn94pUrY0u#BWk#0JVUtC0h>V6?5;((Pu}cPI~9%z2H>e z+~4`0Bi|l&9@`cgmPcp&3*JU*f6h2=lvRUILyG;_Op9%z)BT|!mhZ8rzbq08R@D#m zVO>8I@dtdx<>mIIMR~R5TmFZqkzI)2+!+EE+vf;yi`OHY8bQIfyp4`tc2yeS7F18{l<9B6I%kbmSO^@?pjfxMM^ zOXn}$o>?^xw6=V5&5h+{8oj*qax}xqvmRb>>zl2w%Qw8;^0@5w+dm&teC&z!)EgS| za0C1c-bQMF&bX{J7@k&wFEjBuDQ{8XV~nS>IJi+btVN>K!6D=F{{Kp+hjY5@YYaF< zskg^0od~CT>+Ku%N?f@i@>D2lV-z1%{roeKqIL9=iFjgLi#k%wv+S zBd1-Ii5LIe=5w0Pn>8WiiS)`~790KdhdbclKr*|GUV&hk^8Q-;v<$1hhYgzBInzJg!Ir`=XrF zx%ll6!Z$+E^?5HXi8eV|Z)9qdB{8pF5l-Z0oAbYHr^U2}mu1_xZ#fGMp6ziU8wYZg zQR$~hTDiny7#$ebj3@rm_mT8XTaTx^C0wpJ3Ex&*&qsGNJw6N0v|Gwg!kg)|6mM1h z^*mQ49WSoO0gnS72RsgV9Pl{calqq%#{rK69tS)QcpUIJ;Bmm?fX4xk10DxF4tN~! zIN))>$hz2%=$H#coK%T?$+}WKi0*}qd6n->94ybe6BbN-&R}CM|U$l zJ`2vYTa%xjj>MDn+s0 zSA_s?Ewd#~wa!16@-b6nd9ge^{V_Sy{?BbGAC^t;_9w+lF#`v3DIf1%i42TeLnv>* z-5O%Fm(4oIfpxVn)e_yhKi%fD6qJq^Tx)GfLu|%3_c!W(^f#Z0GmRO>e9jhL!ip_n z`79tf+9tiknQ@70tI0L3T*74wlj%KLLvyyYTa%6#*5iQ30gnS72RsgV9Pl{calqq% z#{rK69tS)QcpUIJ;Bmm?fX4xk10DxF4tN~!IIu2pU`?O*)Esa0wHmqwxCX?#7u#Ngf^P|@`+M%p9B6I%NGehWwAmKuM*LdB z>HeNOGY9g)OtXI5i5=E8Xf|1cc{P`n#|MWq`hD|#k4eA(xNujc0tlA>mQs(6?0m>_ z+>gA+oeyug;o!n^?)}cu(o%dB!~2f~Z}Qu@|G1=LROtwREMDf1SC{#tG2A;}o~Wv_ zVzJ4Ikd5Fq$O94C?62lQUatcz0Q3MngfLeE?g88dxC{_=?K5Fd1so0-}jx9J&eY%Ss$EEA9d4Ksl=y%0cJ4UxC-R$oJ^2%(2MSlfv zzD2J3TOOQA^=k1RbLzu>0QPsE18fC&7GOa+q#2rqXUg&wfLg$K2=8IA`F2A9^m`9L zxum-vfTqf^GX7IfskiI9X#@jAUX~m3!up!&4IeDb_G6ZdJvDk+82~L}@T?jfw=Ukgu{f;E!7f<4+G{`?3j8jYvc2 zn|*wDyNru~ld`6a%tj^r*uHyR4yXD@=WmOnH@0^D$I=;`2N}cr1%X{^O|I@F2x9?^56mGGfTZvAGKif;eyU8XkN8d(S zHIZn2vA?R?@{P5o`$IwS4a_Wygo0J|1AQZFz+yX&c`v=x?fv0fnoPB2$2ABdd{-xC ze=nvMdUMhEETNy?%_y1L^7v z=@GopBX(|d6~*eqRpnLDU~Sxu*Z^Dj)#s$_^)92Fe*eeUyl`{P7wm7)kgkpKFL)cN z{W)}vw&F7)(P=)ri!{t1_g9WBwbev5AgttnO%C}lIen|kyZpKLpi8JgFwB25{0rVj zYJchZ+gV3LrB--KyxI<>>p}mCEx-Sw=bl+IX0HohG~ZwFTGqBRJ%984eU;&W72Rh5 zO>wm!9l%+LCH$C|13kMOvgx70F1vL$`62l1^rZ14O<;982Kig&%MsR9o8CC4%T$vu zg3nGz6TT!X23>C!G%BqoEl~b2x0vx_{?;bk2}KVgpUOU0SQmB0#3+ABttpbr*emKGj4l4lgcdsJpg<= z_D@(B5%0VK9G+>G1G@h7nVeldn8<@C4~o8V{`8}F;vfsg;eTEd?_g8^PQ5b1idR*m zWj#4z#o}YFSR@gxvg{$KEinjg$_e|9EX&pyy}WgIYtrz-X6Arizs)n`r0 z@H(q1;dFG_f7Ru8(3JFk6!T_XFcE{Eakt#ZA&oj{Ozkb(&v}u@QA~Z>T09I}%Ev%^kE@vjx<09?>Gdv~ zPL2y#0#3Sk=Im;JPc`c2e_Y$WSAf%Vwqbd)T^78HPFjvWmHO)=iMTJ>JQqh2;ka*P zcuXR0MQb9l_$YrcJR<6cBDqGV>l%YDbABVgs;Bz?o~i-!MvuGcF%HCFgf785*wlY! zx+)@Ze~9ftv$QoL3DK`X)6)56(ls~GQ~COAJz&GDx*jmD%*k8m5`2mx$K}vf8MAB_ zVZPKM$v@2sldchw=vb>Z5{*OI2l_??!@*d!6<~MJ)_$cHYxEU{veQ>Gxu+V~uXN4@ z|2zGchuuj*p-=Fc=^GZQO4L~4cxl9s{Ev~<^e6u+e6`&LPLq~!RIqb~n!LM;LaW$_~g=FK&GHn~bu<^$RM0*?PAZLVSQB z-@4#m@HSHWlbMss7-lAXMVQ;KjSH?Q9GFlODv8&Gh_OSYjqB@b)A=Lw=j=$ozs;9u z#g*!H;8mAImwnLxaW_xW(-rgx-bE*^il{#v3t`^ICsd?nqy#h0iUubKt88JDi2dQv z#|Qi4In&y_*`7)K*4nH;IV9)2DEkHkwt>V;-3q5?TFHSS2(OnT%aHTVG`aA#4&kJJ z?{ji`{h4W=bZPkUr4J_hme?8K&*{f>QYK#f9sMo0;>D53w4goqu)R$Aqnu}=SJ&sc z27Q_Oztbj`j{4hSelCyM#z`|znRxNns^JmEWpvcJk2UNgxZ zST`b~@T(-6&aWXu3+#2od0345_Qxl?EvoFT9)4reb_b1{HGtz}8uE+%2f^D&?XMhD zp@BpQt(&hn5{_G#|3NKWHLa-X3B>&j|s-C`ynqR;4;=Yld zs^7VP`RVA{B4Ir7iOpTfGH z>X93J+_mzAEB}Ti1KaRDn7`m%bkdT-a3;%Qz7l_I%ycU{nFDcjT!M9$!-`pmA$+Kd zr})5fGW%6b{Id6YF1-KKvNxXo(2;1;(+4ZLf@c`rm~><$0uglm%1>nH#~|=yn=8K< zx!>Fi=bHQwyiNn%CLQVgDE8OZ>Rd^m-<%D4XheQ9@#X9@PdIhl9gKI8C*?%&8VR=3kyEGRI4)?-U>|oR^c{N! zoaLmkSQ?32c7;UQjX6P;S#J(PYK}yt=a42}b?JPBrrCP7taxKp@Z|GD7lZ!jec^-u z`ADMhU02V>Avw}7`1I7VufSfp@eK>cs!$d9Cxxt{P$=T`F=UODaT-A!p^?GT@De3Yn?ZkjX zmHK(yf|DCT_tU#o%(>v_{8whU^WUO>f){$kmU>`6hZ={r3V&?cumng!D_a@!m7x(n zqBdbiG38j&SrwZ@AdUeDT(_r99Oqxjdr$tsgdB}t-&LQMU0xPKo`&pqaq!{`yH=R; zB6u^~T;zqa;>n50xsLU$*DHNb&)%-DgdA;u>m~1>ch<4tz1-K3dPVT&+Z9J@Y9s8Y zqwa7jmD1v}Vt+Wmoeh?=SXY7;6CG%K?$2z`xo1@J($j9hgY*|0K{xA$A^>gH7aUvb z`$bNeG5D#^yWMjz>7}8K*>)v(8>#)JWVUpxWevxY?Ui@X= ze|W$t%ko+)6e_N^s-|JCGFoK!(Mp3gL2Q{pW8o`_V7Au^Iej;#(Et$o${JcOugkAG z{Dy75-l4}I7#W6k9{vSyBelPxL_9J%7z)|zc%{Ku+&6qW+D;i}rL~_8XJxMsmw>)U z>;Cb`Wphf#ui!uo<~RWRe}cD>+Fvq%jIki=Wl^gt7~?eZWGhQstaO4?G ze%PIlem4B>H_maz#oh;;hkwDFBqZf!cwIc|uZlxFYR1e6TLI{{6$;q1|IDKiAbPX- zymUIu`IWh#vuc~Kx4v%WW-k=E0>FL~~V3Cx!M&?4l`Xr?AjvIgJ%E=?HpmzU#X9+?u+n zHDT99Ui_YEo`;tcJ#V}uyPnrx)Lq?v;kDb{`^05iKJaWmn=PW}f;V|3n(A}f?N;jf zurZ^Y)f8t1AC-=$-zJB1dv2?awl!XERC%FRHwWsFf#~=A+3EUi&c~9LjV}6Y-5h9{snI%wZGK(+UKtg`uzM5f!>XX$b4n}K#Q_U&gSHicg-36FcFgBaj@&mvIt1S=9qHpnXH|}aS!Xp|qcVo=Kv;MVPOdNW z$71-rB_Qu&_cq-OI#N5N>jd3wlL?$(lxMC75i*4ZI-`-WOiMR{7hCr;-MNG@<9N@% zKMpL!D@i-l_u6zlH^-C9Q4j2U>$sPnm~+}IEIl=2J}gLzwG98 zz0b5i`T3(_Pk;P=;Dnvr_hPvhqVxrCzOFs)#MVsgq#Yj&2O=|Kz7)#c%_>`he50}0 zJKY)+4%Igqm-5_$8_`iNg1}u2_Y26VE9@s=b8K=Jzz^U$_|5>1F}a4x^)tG;?$2k+ zE27zbZn`rW`g^>BE$^fFE${IQc01vn&E#zz@;fOL zFaB-Vx8TlG&yl_!Zb^S;E$5j4!;=p3yX?RQk z`{{zWk=kDwJ|>NqL_z^>WFHx>O~jprul?LG`nuoZyVL8LiJv+9MJGh^)#rOZ^ZB5= zx~tkpU%mey+f?5hbHDpP$IV~xTGqC+44>EY^a13JkK)k($H3d6z@cWC74p~bn|Xbh z>`3LlB*S(=+YB0sXsyYwka6$Y9bbJo=*zLMAzTDZ)UF1aYCP^*H31kLGU-@flAuBY$hjxZ?+MLPe z*IXRpc~;U+fIa}KDCeW7FP>SyIiTxr-Tmq94C_wTqZ3hSPTy$2UH##I{fx$F{=)c< zJV%a3`jdipu&MuKe=>FILh=BUa{IVC?8T4P;Fy!DX;u_xw;(FpJ$+t}sp)+fwtu-A znJ47A(nB6f)lW>%obM`ppu76NzF+OKTf=KljCV7T_Y=ICZ}R=p_l=nIT}N1Pn*njm zbMbwf)KmKV>25PW^H~quoZF1!J$oEj*Epc>KkoZzx*nVJTg##6-~DsaJ-tsj{>T0Q z@QD4YqQ`>g~Wdk{ScE!9qC!G>x3@i2wopwII`~8x_+xCv+MUF z=>I31?EUm5J+|EJ`0PZ0P-*NcZ#d;eYwI)`B{Ise1vq8I_Cr94B!uj_(Na&sYpQ)A$DHjHWq#U|`V$u_Xa{ZtGluq|+L^5rJjC za?w-i{ClhaWqc2s@^v$fUc*7tc6zQP8BL zE%h<$5K_)Mm~}7fT(&3t7N8$sR{-hc+QwkO2mrrJIuTF+`jdJixY4aER76rIpe`~WD#gxPpB6t6+iF92cZg0R;>*r_1w zauBvNHlL5gWb9@;;;aoQTd%!wCgK4~?QuBn?i;DpGZjd0l2VVKtkhFyD|Is}n!nEj zyrk42Un=!V&pcIeSe|;aHc#zxN1l55t30*Gp`Fxsb2_Q5^E#`~XLeQ_=66vu@93gl ztKLBEI&4FA(9o`GR&~CLKi*B9RI;&pyT_*LnH>w%O&9b~_m%Zl)~qemB}2DXZ(Xsy z+Uv@l)TonoR~4J>qZ0obq+WctNKp<@#P+!$4d9K)OUd)u<)!ZRp6awy_IUlxHwWMQ z_Y=Pd2bIDr+43TI;&hWHFQ$+npf0bATF8IyTRqigOU8V-&3B1!|F``Ob~d}?pYker zJ#V_x^0(y`Ti9YaD#VajosJ0$v-4r`J3ZCydw(!+;ddwBv+(?z>@4@hKj{#>jnw{{ z(lHjt58+T)gOJ&XBjqvc#dJE%b-HDs^Y9+GJ^Jlg+YPyv2Q$K)10WrOw~^Xkmi3pi zXoNRkVgZqhFm9Yilrrg&`CBf_kSgjZ`%Uamv2O*{vHMqIv#%uv>SY^SU^F+w5+~q# z*_Oo7am~5)bejwFd&TSWGXJIQ^3vz;-PJ$dfB4~79{6ql{_cdh$cx}jK4p;?N=Zdz zv{i@eQ?dB$#5Co_OfS>3lpo8SazjA1YuEqmbF;6_XZAbUXQ%8@?sOTU4CZR|c)7;; zy@YGTi%9)4;pOb|lK);$weQVGe%bxOM|Qiqzrz8k=LB!^#W_FJ?KWZ$Ko~WOk4La2 z_XXhewNd^$yFQd&r4MJ(au^pwzd@rGd`?3|L?uV9%<4i`1YZ%!e2Xv zr=3vh#P@(w^$B&8AI0ea?wf7r2B8-GUc-#cn^k zArnYc=X2jh+3B72VNbQ;jEnMKoiK2@)CWSZ;Dt`H+fJ`7!AB>ogndZ9!DglNc~J{= z_y4G;y3_xD(UyI-y~m_m@ItTH?MAo5<}^OfdNn(r7k=DRb=tMG_kRZ+`uLqLLBeOj z3!P%OhTbGoDJe2a{;|3{GUaHc&=zkvAGwAp$*#$BI`USBSME4zG^z1dwY%^Uw^!3);2 zrhEzB#R(2#rj9ao~E16Qg?B@L6G`Hucv_aOgnHuZ@;hk zS9ZBt3Ay|2xi>fHRT+NBlq#mCPbP;u*0WwuEq^b&Je9rMUA?&C#?!x= z{_8;%Mm;5X^X+n!r&N`MUQ|WIS!J=uV@<0lJBv(mrPn)pKZ$h|=SWyLv2R5`y1n`d zOju1uucwAA$u3uo?{`<*zOwtI=mEptGv!L~CYkLcSIO>FlXW`g=gE`F^|kk`%hU1} zf z&Hhh!HM8=yC5N4MaM+Y5!JDM4sys=J@5zzL*^c$B_e*Cj%PvRDAZIVVbwankEB|=? zGx^SYNWCO@^X+n!Bcos1V)c|${iM@k)>W*Fq<_l2QtYR)&LWOs-EKEro@omQ^!9G? zXW8Xy(5Ky1<*z*&{_y-ye>CMv@ForIBv(>RdGcg3xPv|G^3?y!?D910^X}@XaCG~k z*N(eBub=ZGQcnrqe7zjyDSdHGx~1t;dv?-hyC?l4dg^YWL+Tvb(odqzJ{0RBy4jBs zH*JE%gVQ#|V%IdTA{?o#5vddBb<=xdz{oefH(#N-s+|u8nN$MrRo0PUjj*|N= zS{~jtkt;LbmYykJB5N|f;~przj$+-#X9)|ZU1!nG#W3FbYV`K*nxC@ERo%DU)fT6{ zz5ka#?!2ifSAsYB*iLeltf(4MSo(fUGryLeMMl_udGgc}w_5LSmXGke^(lEVRtE>n z@?jp*zgr#od1{h6{vO>ISFniUStw4z+sPz?wu`40Fc zJ>LNQ1_D+BPP%yJ?Af5}_7@j#IimFc_T^k44P}V=3f@L)e@?!*n0>lG<{O>B^-XkH zF>HzECkoB>v%U6LW8zwLHX?74k42CVmUj_=wKmiQYn77Mg0=Ii%wdjteQx)-dE<2PV-L+ zStDzpRKD@iVBGSRL&?*=(_7GqU&uT8uRsCHxm$I=byvTf|M!b$U)odcx%UyO&&@aX znz_G|h2$@I2b=oOlE3yUh8(0bc+P#enB3zzV>z zsCX6v4#(hm0pKVsOnd-17wawiV}Sh~U;!2^Zo)@ymu#ZcWmsUv@w;jVI0E`uO@hwf*D3FU?c0ckQH} z+NYB$JgJlFI=hql=GjiF@2{QI=ZADw_nqEZz5BP$YH{x_YWrXpHSpOk>c(9*P(RMz zKz-VIL$zJQhHAowUDf0{UDdAp<*Prum#?nBvYQGYyOBCzz{YCu7MrM#3O7~vZr9zG z1BjUYU1_F%LaMae$HjRN6qkL51Bys-9)y6Rck2r{Jd=?FtXQSKo86_ru7`_&gDNG@ zxR}tnK%KEvUAz!>k0Ga?bp016^eTg_({zHaus#vIgH8QA?RD~NCDgSwwUHRAlRy$T z!XFGJqSjb^1sj3HJEj&E>1xY&<51OBo#R1SUFhZ~-?t7#osh|#p9!hqp48lQUT8e8 z?#BjXAmurrYkGN7Cs16f&yMJSz4P*3g&P#8KY#b?H(w@(9@ZcA7|jn*AeN`#9c=2~ zEYD;qI>)c55(H)b!pBpXDa=R+RC7FaLZtr>!lRxJn-A)9OD0==Lz$NPfossH{_Qnr zrb{;=mpl;6HfC7!S;BdCiUSRBihM3J{=vkPp>r{EoI z>R-+=+0S=GZNl!oRMv)Y9yRvd#?hoIQ?3~EQ#bmduARx64W!UrmtSDZNfB@)i{*}P zMOwf0w$c~sdxc(MG~1AFQg7lNU!}6r?Xy4ADveZ48;>uutN8n{_Z#lH&42UpN8WD}qS(169|bRTh@GNGT)wf)J6hq7O|!qg zNPe_CCW6XZr{@~b!(560vLipxc!~0uOb?pGR2DG;8k?tV~H9ZSs)Sgc5TtdP5EPwLyN(Kx0gIIV50&R z?|kc%vupo3{>_~oiVj3ViP9$b_dK@tKUoZ_Yncob?5#%gvG=>GdDmoymZ@Jy8c9bJvrNkgLA0R|Ia|uVnG= ztQ=uPZUpaOQ~$Zh4eJ}sgH>^(F{Z+7GX%oWTz!*DJ+muQIcKUH7&}u~JynsNOt_Zf z>T$#^bVyvW>EE1N;_9{;R?=k{aWjk=&V1JOjB&+ZY{BuFLksr9sk5Hx*c_M(@}%F_ zzju0j!1*rrBL<-3`1800C(r6xpfH^ar!u;Bk|$RA(xfW(D0htc)fFCm3`Ju5l;MY5^IED>3WW-rZsAGIhTwx z;lyu!v*+Q3MULignJ!1{uj~EM#gMc9+Ya9A)qeZ!Q0_8HoMrFTkd#k$v$rOwXoT)3*MxvJXlj3vWoq?t1ta{nOI<}m7(#!@3U(~kgeChjSC%c_0dmrJhxc4=Nf90_iT@IKY{`FgzAX)P1f^|Mq*fQv)6mbAL*m(d3f$M#{pfBWUeh9vKI-2lfoD~gDu6I?r5ee$!0ZHFX zuQ|LKF4yPwPA}Jd*R^nsAUIji?vO68vX5fkzDj-j zZem_5<}0=Q)1dqVxkV*rIY+5PiYEEP0kmwRtr=tD)mAh$es*7KWEiiE6`+75t+#U} z{ZjnTM0dk6J=DNgPrduLey5%J8b7dyVYNa23*JU*f32b$@#X?V9+tO2&%EP%sPfl; zo_gPNkB!bNbTSos1h0`|JDaD6Vo)I*91)Gwq?l)OS7S6%ng$-eXI(gxeGD4mtKc1M>c4q9k&DCv2(`fJ>JPxey95D5zBlE+pTI@EtEp$r!w#4<~cpM-H1_1PaCvj|B zq@CfjZuEZBvi;NhBMo02;M`OG^M>l^l6ki`{HH)Y_Ua>r(NVA5+2w7g1Il#SjtX8+ zo9<*gI=l|^C+I3+Z8hYqz+l^nH6@DkM+3--~|R zx&b`h5l*cgJ5%|vOt?nN^;!bQT$Duu{RH5&-LyTkdN^S2V_+F@FDHi;vi8B8MUTWL z&NChd)^`q=`ont7)1UQSD!lj4l>@U8Q0Ber4rqB^f8y@pZ%;Y-Urp9I1aIamvs>~p zA`a*aB(T#NlbT%T@Q21)RTl11k_k+mp1B97`n_!T%=Js=_4Yn9_TI}kcgZep#&$Tg zmV$TDNh=FI!>o|Mo)d+Y;p$+(-DlW{1T*z-lL@xL(OerYc(L1%^m-S?99NNd1bl*+ z(KHtxQ>7V=S^n&owNySW`De_?L$-+neG!ZL*?8;6mo7woQF6m|&wah&$V1t8=Gdme z_2)Xyvcc)~iMbxtr&FQY0b3y(XO1qnlo@*#K|sr_l|l@-<4)f(WcWi%2B;U;SPiyz!WjjxZU`$Ngemh$RI zH12a3_$o&_iOqv0?evnvv(vfw$O85HZ5!YE{CUw)!zgSpLZ{#zZ0bLEI>)4a#^K9I zZBw}~LRKV&<6F)1To@y%C(G#r95&Igck{#9z1RM_^kidGNUl zfN6?NH-Y^h;&?UzZO?RU4(RR1;<4%L@f_kz2FUkYCF2UzpY};?J#V{XhMe8oc`wm( z!JBW}NM%Oh7OPsjPH1)J3uHYmr@n#z0XNGlhO3^6(g4fd#oNhN4o?$Zi z5huVf@(y$hp0@rD^z%%|;Xo#RVVlD3j~wz7_^g+sxPfj`w)8ViCLF_u!eEG^I77Uc=K6k5ZmqWbR6p??H8Qrv{{AqK|ns|<>Y4mb;Fq!{z4VO9g`iX7CYs)-pU3vC-uUW?w zsQg3s-n#14owmMxZ--wjPtNxW-od8+vyF#G20~W$SzgSWA}OJ-PenR?=J)i=Pb^T6 zf4$|EC%*N_0fQ+-FdWm9KEc~a?aw`jG;P=4_#i$qnGy4q_@jXlT(*dfNQ5Q_F-IN1 zc)i@Jii87_#B4Z(zPX@}GFSwl&Aj#bge4pGQ2vIuDwozBbk7P3I*iaKcn6#M&qg2j zEP^bnG9C;CXWHLvnLj)-5bw-wxsdn&ChZtuY?}Krzmk;#buSgjLbU9 ziiWL_eKs^h&H@Nu=C?q{qN)P*>7h5gSp4-*+n&+W$w%lAyn{{sH%mt)K5a@;k^Y_Q zl2fwtgQ>qa^4@I^c(il?^QWPmhkwD_NbN5x9S%>%vScL65L9gBi=3M%_}191t>+}X z*saN{xv+X#y1TjXI-cRpIOemo5fV?2V}_M5v?bgIaJwpI<0#%tlQ!{m)8_bwIB9d> z^h^ilK&JlpnkHA5Ki!>)j$Hh8Ih8a-j&(o5Nt(K!$g>$=p6O4}jUHdp7Jtd3xo6@f z4AT*}g!k-@!GRKxVYWAJ6Kj_lk2B1r>>3fsOs6ex$h-)Y8IeDcUE=9xeJo)lyx0;J zLF_ORme1?6DZ|T~<<+ZZ;X2gE7mS-=T7?lY5D|Z-IR0_>AR2 zV0%lPw7bkkFJnA5F%l+6lA6R{pAkdAbhEsLALKjBgnb+C*J8P`Y-kIPJf~aAjd2); z{UG`=zF9sD8smh%0t>0GjHO>WQr$#x!RHjZE>^S5_hiYc;VJO2O3dG zrv9wya^qQ1(jQy%9O&3Nn*D)}O6}^D8IGMf#+JT0^YZGKjw%Ujmo86VoVg}XU)HW1 zt}D5F`r_%!x+1F`flg0fJbmd1a=5P0pr3DDcV=pzA?GyB^Q}uZC{&ZWzH;@wZq?gQB{R&M(^TogV zU-RT#gA(^}J{gMyF%QIq7s*@ShBj@BJD6i&GOT z2F<+jNV;i+4ioSAHl5s z4ihi_S@|&{>aTGbqSLYL+;o1hufzR918`W_+hdkaWZG|D_VpjnANBAzvd4gQYyhqZ zo?&!j(jokSBE{nVa20t$Bl=_RgLmH33B!N$Ipwo@T>AGMb?3FrpUrB*>M8q?Iv>bX673 zz>b%r9z;zk=`?8cU1QM4o-yf|jgI4E`|fo)oNDgf(~kPB->2`a{;Klt#$hi~zfq%ZlKc=0#Oi?46R@R12C8dtbShI!Y?Tzz zX(w_c5;oWMNDIePo>}`G(A$fKi(2kaR0O(@uXuY@smKlOJV=h<%{Q`#!NZ37Dr*C1 zDBTW?dlc$0f80L__f|2EuIKYEPL0ngmzmB%oi=gHtG@np>D`i_Lr*7V;>Ew*nqr^% z&y!foLjE|e%c=1R0luO@pt8n4%8EyWRZfgda?AcG+j2*TCFRs}bNEz9$Hj1F*i2ze z9G_c?mnqKg5vSL8C6}bji+P_n-+%JQU)*ri!kP=K*a?CmAGgN8;BBP#XV!PTu56eU zx8x|_@RX26+*m7C8wukAv*1iyjvJANwCBq}7xO6s(9Tp3zxLSEd)@N-@fX6|HVntm zCf-KlFFReOk;t?}Z8=)=bm~B*eL81)e`D6A>3lQ4w`HD#9tkXbV&BJaxWy%a^z{aP zf_KqLD?5EnDJzTO6W2N`CJ8jcA^ht4cb(~!t0M;-uL@r15<5G6ML0mZekO#i*#h>~ z1)T9Y)tqBcr+sp4X|sgap6zkK(-%))JT1tb1D?Kk`jWe}cp*J~@$|*hg4{VU7eQrw zHQ=Vy_>cX0bDzfYuL{&npMQ4k!U4Nq+38ZwDmwFu+@~RU8>#)Zd7lP%XJ~sf^!bN{ z8l4>H^?kCF;__74`$TQ}hUZ`q58yqO=@$oy$fT!sJApZn!Beg&G zT&?o@Slp^{9!jx76~p0H)&2yK0l9}FhBLn^s)NyZy>s$c%y+C6jW95i)9GB$0-Z|^ zEmXh0b9(1r-~Zu*N|zR)Q}7yzwsTeJ91*oFp;MnfE&F43e&*j=s16_U$>vL|i-z1t z0%3$s!8_R0f3tK}L~xO6l9!l3!D73yKHTU3(&q!)wE`=8kSxw3{rb?E4S z&D!p%Eua7PH%do}9>Lp4?XOvS$P}tcF&DFx8Ulf$93I#2v&SSlWsGwH%!#$e1^~_# z@VpD2e^ChFUMQZ4u_M3-7z`K<;Ck}8fV%)60Cq)UX99izT#7`;A<<)z=v_#33KG2y ziOxZy(~#&?B>EK+t=UPbv-U=uLzVhR8SY#ODiyy#sp0o4^~$G8eLWyg-G6bOx@W^q zYUVAS)bMC$b;s#l)ckihP{n`ls_tFcO%2W4RQ3F!Q2n;u=IYsZwo!j<+*xhVYah@w zL`|(PS4Y1eQvdni#p-$A!|IlEzES`D<>0(+U%f7`|KGRhG~&faI!!(4(#}UU-qL02 zLESg3fBmDbv5!hOx}bMt(;rLE?Xk^E?`+O8f_j~y*C&lFlw-r;g=+VMKAX00(a%S8 zyJHJ*CsmGuw~^Xkv*k!7)XGtp@7mk4%hR$V$kWWpZ*98YmB)0R$XWXo9fH?Lu$|4) zF)9)WP7dN^z?4ieLLo9V8pXOPpxP_DV&PdTT1eKKD8bnMdB^?Ar0>H2K; zpZF%X9&`UsSD$xpe)u!zy;y(mhFV+Vb+4@v(|-xsszj7y5I{Oy(% zlCRKZ;>BOGll_uublKI7Y%&-gu8P*za{obj+#gT4E1o*v3hzp<2Q%?);&0bZU0U+g zUnPH`&%}$rNgsx5JW|-+=9DYn=7BEeQv{%$iEsPOx+i$m%U_-*`3hYoUi`Dtl>^@z zk&u*Y+1=@UGw(5Eo`s1{rRUD*J)dqGq0huSzD?zAXkrqCt2|L#i|t|DG>qE}?fr5w zYtd7S&^}eChpnb#FSKGSRWDWa_-Lrm3WS2^}WBB|46>>NP6br@zeh)G0T~ zz3Fqxr+r-OOB=4s$t=hT`CJ5`T?n8Y%-UY5k}lo*!l~|ic8_R}H-6y|*)|TJIyJ$I zf90qmUr{(792blxV$MdZ80w~DT++QJhJf<1a!Cqgvb#lT=ZC6gy*ICGydCB`{%GYhl z$Q<8t&*uITz_ZsX2h8&6;!;EX$Omw|FS6-+CBN+xyrZ*C!%2A0ZaW9e@;S&&$}69? z^Rzu-%kinlkvWpC2}U`sS5xDstX|;L{Sv13!SoL_)}S zbi#_(qX&=fG?rJLPo+i$!wLJVNTvECtlp1gx|!r8*Kqp0@t`Nt-^*M#o_}1Sx?q#P zT{>b#P0_CI3&=XB;9Ydm8XCpTP#BVo@(05e)lthIh~apKDR?)I`Nt;0VeGx;Cr@q+ zeg0-q3-mC`%}*5{mMGcbC6Qy=9Ipu8O*U!eOpiUP3Hn2B%)YS6cdozBUQnPO8NB?> zs;vY2^}1}=6S)t-)Zc76=O&renr`@VzlIojS9un@IlTBcXSX$8bLn+Nysp1}o=TT< zbKa&A{%_A&e$1iMx^C&Lx;k|z_eTice8=)&O>M|3_E%L~zT!v#J34}~Y4)a$QhcWs zt`hmy=~(itGaes;#8?Kbuk!&Dq0rMe8o(uSwa}Vp-TBr#bLpmW6FSQ4 z!&NpN+N1yioAS!|tVeQ{gr~44oe3&`M%r43t=tNRUESXVSY0=1>aV=Q*kbBOvBs1 zE1Y!pM|H!a=$_cA5T0v&=fDCmK=e8P#gsm0+P^!uSD`A|=H3r>IR3x^*Kh6YP?B+n z;7xvV8y2^``sAE7KA=mE#U>o$gTosJ`pQ`AxVvQalh$ykS}g9KwTAP5>|j2`!*#D= zeAmmRyY&5@WiMr?fAQvp>b$M~@~5Lu-G8DsqeMfPBb&+=UlkeH!QE zbpIi5r2J!Aid95-RGD^sW!iq032(Mc z&tXIMK4XVRivKM62|XrW{FC$lNqQ=9q8(1yGze)x1gRGn=Rn70wVyxohn?nsAo&O# zCSLrT(vePpp8tfmTIR!Vr(Jr;X(K*P?qihvO?>nD<8VrhN2DxtxmcD%{vVDW@M_~T zqm%pZB!3g%eEua?B5LnObcaM(w-90wNvEgo?UwnmQQ4>^CtdPJazCulW8#~qhb2@M z;cRoZfHFRR7b>6!mif$H*7_`n(4U3>CbZib|X^W1_LI>c@&ALUkb zx)n8JZ7rQAPI5-qV;|~RA+76c^4TvE6 zlK)P2elYC^XMWu0`K@+IF5gJ`n0SVzX-Wr9p4AA@_uuvXFnj(he<@JUz8C-ZS$BPS z_jv{%1n=aU`p=Mmh-+3IalDbD+HtwBn6aG|KRpiHV`-N;rpPv)$P`~s%X51i&^fR! z=!;HobM9Q^UMe@*)FJkl8ISr!lS>*-Nbi4r#VcO*yrSi59zlq)B25>)_s;&6sr7# zfBN~2BQLz*yuCQl%Yf2g#$Y-DVtePoLrbzN-F^?FX;KNs6;&vW6D7bY7A`odG{ zqeal;I|>JGvDFh(yZ8C+lit)(-G9M%1?tFKZhj{6_8vXOKa;-YBOVRqTH0nC;r>Zm zEp0Sy;@A(>_dB}5ZA-%HIM3~IU|r)tBM8>}&zb1YChOV!GNsj8Tqb?amIlX>n`aB) z`FR}p9dn?y`to~Z1>0`6+pG(uZKqA}jK=|;1Lph${n(}vxJtslct6hmuVTRo&F?n?CoK$q(=Pg)*fz`X#+zFL;yMZ2kJ?R}s_KI~Qwou{{p}%=1oX{8rHWumgTLQ}UN}L=!Lm+3Bi} zB;q5(xNv(?Fcgf}`-&4a3GU*XZk1ODC&$Zi2*2f|q<@z%E3eQ-7U91+IuCkf`8B$-{H)0a6VARb<{)FTb@3)x3sPM>6!gcetRu-JbN&d z8-i|}HcrQQ?$yNsuRcq0mh-nf|3l=@tJ6}v@mvlEJbg(?0`)~-TlVxN#T(D%aKO`- zlq7iVONtksD>DZ?eM#|!`oeLh*B?vq#B-%{z|)r$KRkU&@xpUu=77H5v}6aKc$zxL zr90f*S=RpqrDjan*v}LW>N@ze8{!Xax;r0WXy@Ty@HSHW!>wWVMRm@)4NpVB!OJ{) zFyI>+id5ka?V`zXoIhTPL&!&lYZJJ_*f!Pp*Z1FVX8IqxNevn?aY zyccbGmU%I;C5~seKL@<>X@8!!XNtdvcAa|M-iG^2x$eTbbEYqK2b`W+k2%nYcbD(e z8~Ua1gP8c4vtMIEBwu~L_cNa_tSM9rKX`e}_!sW`?N*m(Y-hPYT<|VBX=U37VPDSa zuj2L$_gG^4j8?mOA7+L8ylbHrAoMKav8^E?@>2Izwq)B7`Kd_I%s(!UWqQ#cbR@ys}aXL!@kOk-_5 zdwj{v`39gxUh{p}=Y{7Y0QXvrMx?SED z{sqr4x=G4wNjzSQt4C@h;h4pXQQSbwFp$iIU@qVy z@DN}=;9V?3z-NHZ0bc;V1bhYf8n7Jj4d7eAcYqau?*Tsm{tH+M_!00E;Ag=90KWi!1^fnJ zV~_{v1n3Ol*@GJZHUxA9*$2iPBQ0N_BtAizO@g8_#C1_OAp?_q$$0Yd;qfT4h5z%amYzzDz*fD*t+z>$EX z0HuIYfYE?4fHJ_*fU$sbKn0)@Fb*&tFadB3;8?(Mfa3ut08Rv)1egf$1115g00Dpn zm<*T#s0Q#t;HiLVfDoVt5C%j5wSbcWQ9uk32P6Q~0W$z~fO^18z$t)J0jB{@2b=+D z0GtUp3vf2z9KgAN^8n`qW&th$TnM-b@CU%ffJ*?E0%ij)16&Tc0&peZD!|o%Ie=>b z*8;8sTo1Sba3kO*z|DY0z#jpB0{kD~7QmkYw*qbh%mw@fa68}*z@31*0CxlK0n7v3 z3%Cz(Ki~ntUjYvS9sUnxe*r52KLUON z{0#UX;1|HJfZqTd%;W(&0XhS^05$+@2#XcN8>ofJ?)&T{{PS3mB2?)Wc^CG!Xbo!h$lfr;=vFOF^Wn;2n6H^gd?Cr zhGaqpCNptn0s#-=3Ep_DvZCv_ctin>$0{n9=(@OyvR>c`>gS4z3SNu%_kZ2}W~wWl znMp_xq3idnuIg9SRsVkVUR_;X)h9NNX`kMG-$_%xO;K?$U4o!_3a;>dUt`^@dltj=po^i`QPdelXp@5WZ%(GF>A|moP44?=Foi6I_)+BTf}u z&Oa^P%$F2|b%M=(B~dK-%1>PbvALk_!lY9#IYi|P(S4oBZMYvAo|^RN;4Nv%=U=+A+!H$H7@e+Frem5kXg( zBVUW4r$Bu>#+BDMHeZg<{Iva-Tkuq0;Q1Ha)aK+bzWP~}6Q)Oy=sxY;>DLGLjB?F!c^nK=LrG_uR3SR! zDClSAOACaN%;t4Lo3P>4W8f9lw@$wKn45Z1_fIoAe-5oh=WxzY*IY*)?JTV^!Vnp` zTuM(#)*j>fL~Qt?Z9hUkY^_54dOicI;_xSr`mlTA4P zAvoVEEMd8?a(iQGR{8|?Q|OYG-sfFpMtjK z3iNmWiFWX~1aT`m0Z(6^C@xstO#FOx3(@VgB+<5iJJI{_6tVE_BShafdx_r<8zfSe zPZr}kTq=(FcD?v?@G%J;AFNIok~k-E@xAvo8+O~Q7F|+WClMd1?gpfo|3gxox(x9F zuc6iXcqQ#y5AlNJgzjy#_Z*PxPcbm||2-c$zv`aT?8?Wez92(x0Fk19=jqzYHAw~|ja*IR871{K5E zY3M@_YWH7w(T55izqCdAcd2v(LwK6w%5;q=U99;u8WSF;Xt5UI%K0yeBmZL;=Rf^o z&eH!<{XvFwsX4Ap*ND<3O8%ykjAb0D8L|2Bh}`M`7ug655eBXUNT z`Mm5hrI#zIoO|JPX&)FVb{X82EV4lJ__3rjF}7j3GBIG(0i~YVA9X9cR)}_fKkoC zs8?XC!K|C1O3&&RW!=eP=M_)4tWoZ+6+eR1f%+O!&tmK#y-b^ zPrWdXIuUaK=!JLhi!tN?@a;6DdnV=(hG1+x9R07+=zrxS-KpTU6K#1Z#-HUF`=Sae zzYOE*>yR!g>~HSDc=i#DZP$S@uVSpV4P)kA2yd1k26RmjXF70#`LG0W&-4Uw_5}%| z+h5^6l^}k{Ai4|#)=d}`PQ^egAMO2bPb7+azeN8$t(kC?HWSaUXeQSE&`ex2thu=J zj^-lxV{@_OycXh)7ttp;tEG79nU-Qob}O;?%~oPqAW0M*-CBJ3Mr*O@_BLWfd0TPA zq;_KWm_x+7Q`?KTF6bbxc`R8x*DOWM_I46WzV9p+E$t%io6%KVKl%ufJpCv!@b+Uc zUhFP5-rhr8GxK<{!gGT7>q94t!~3O+iNEw0@26ylM=m%+j65?-ESok=WPf_L7_n`f zs2p1$va_a(ch{DPvtIX#+^gq`=XX_!i#lH;CN{rSOxb+5c;~8z#O2wm#f2ST5*M|8 zSNt$!r|7fgH&OOsNK&7tz4CvzH(NXR<7N-7>)ZU&K36tBKKsMw zIaS#$4w<{MMYHF+wfwa0(v}ajOl=jM^Kh$|dXG$cw!`kEAsz2+eevlt+sv-cXgl-z zBij9XYWqW8Y;$P)g^SWV{ASM;9kV{~(CLxt8#))<(!0y!?RFm4`tD7Kckle> zky8s>9MfvGGqva6zC8B)=T`Lmxc{=WJ96JVY3QTF`+T|J_kNchpLptvizaF+$NjEU zhz8XQv_Etq>LcDCIwx>zZ>npmjPOoVig)J?C9RK)tBc|92fGJ$`gQXcSI$iqm!5sg z%t7})v+h&S$Z&ndbe$Txay8``QZWOoX>g*ZAIBMbCb?a6wVI3cmhj2vi$PU2LvC}! zlAq~XpmaeJwrL^`l!EDM`Rr|0^(n7-;*wl&JXGzPoDhv2&nw8U)WlQ$Uacuwo!+{W>P<=-2U21{3y;IKv+?b{kYC5yvhv1Cj8-rgPVaj?B$PlDxd?HTan6SByL9RZsMI~jI5 zEIuD=|F&ERcOmR8uz!cer(^LfEPY@9FYM2-Dc~9LjlUl*295cfJT*Fh3ocI?+yqJ;o4e&|6DeXSg_-%WHG(jC3EKQ{^Dlt zM>8&_bGqzC#TA&~3u48zj7i3mJl%|^>eeM1p6$c1&Z+SG<&?)Gb264D9r?u+&QIr8 zLM=LnXZw7!-P->J9#=l?KteiAqyYXvb_HF56jwi4Yvt?;7Bt^s`{erFW

@$a^my$P?l^rY(3pY3+}G}b+e*9x(jPH|+D@0wYLh4tEM_B?D|UxG#Cj$tlm z5KG>%g1U$xV$pk!-|zD~hPvjsi(L70-NB+#{r6$hdE*6zW_(o0C9suPB(`YEN?Nrf zGJL1|0^?pDj-^hTA$(JTkLd{#NX<&mD8N-VplR@pJt<@aGZX@v_VS%jCd!dZh9 znU6_MbGfSD0V(s(1|O9-?aH%1XCQ==xUSMUJRY1wEByLj0~&q>r6a$hh`4Pe7=p`q ztAUsD&w?e_im#cYdtcrEh}XVAux1#qO6Tx+@Isd>JV8ggf>cW)ge&9Aoe>*f{?}W- zeWKuUTKcCM#;4LbydL=a#=^HF4tyW4dH23ulQu!Kb;I~nI)~Q-U%y!R78S+j-^5uT zdM|X3$mIMPpGxQOdf@9H3tw7sYYxPhuu1sfK?A8O{saE*p`g#@ck;#H3zF5`Q>%Ym~v8*&@sLQCaDPCX1 zW;$+7CLVm@`daHIC@7WsTE<(6%?>Dk#%tA1Z~oi$LtlO??Ry4A@#*bUI)}%F*Hz*~ zg^gx=jvE_%(63OzihzRKNH7^0QvEHj!{odg>gw+hd0M@XgzSI5YCz)lEY+Q?ttHHg z0`swB&!5<3!P(p7eilW4+@PzET9%)=Kjp~t1*q`2&o#kUKFT=*Khx1#B6OKG)k{Uf zgp=0yW&)>-gZM4K#}0&(q4%ILE4{gF=izVu^7~5z&-;>M>hVZ#n66VJSIhUv_Bhc^ z8`5NImD#;m_$=Ney(mWbBeA}Z-1Tbd7HKgk>U4@~G`a|+cavRG;lT$TJy{ELPyz4R?pItc~$;jRst917^P5XJ9 z12zY24%i&9Iq+xZfK`8u+RMhae`X&2k=U)uhx%+Oe-FW?Drgy=P4IoY@Vmg9MVDCE2O4B_PqFU9ev^!1K-Mgef6iAY1raIGvpix zZD6`ija>P=zy5JuKkZ}e3>@ZxUAd%XMm$#;o~F#Nm=Vx6B`Vg_N`=Gogc(;w<_SZ8 z+tY!@vTD6dbC>a$x^$N4R%2bF^E2$mlh45(XK(*Am-(*pQZ9$O%8Z`jdYj|WbL^MX zV3&I|?(AKdT|RrqzovfLE}y36@ZP0wm(Sku zuc@D2gbb*kO8cCwM?aNJ7A&8EC|Pt`dSc78pC4;;3Pps$wszY3UZ!hA>B9YK z%l{&1yIr@h*j=QbUBNgCu%8MU#-Xm~EvQKrZ)H|5Sh3*6wZ|KIF%G61-EW^ z$2T)>`|8VgUwyOFBNtnZ6Od(-8_JjZA!ND#K`tBl8#T$v!EDs}tp}K4)ki;=dGtrV zyF6d89{NRP!}SWwcOmxQoOI8l+7g<6{ond@;vr}FczqVR30MiwboE_~b@_BWR({au zcg}Q8b_YwfO^QdkyfcHPScOH)^hZ0r2=kBj&GMB^@H^f33CA>LP>F=O{>!+*T>n|E zzq%_o*Rf`8!BW;ga_N5@rmHxOUCs5yRmNVh6sHQ7^IfIn8@e(<|Gy&}b^Mm?YbkzE zT(|VWHb3toIVVH;9)c^=HKKH>mG5}k^ge+9JoHHNd#5js{ob#WkXH5|lRQtI{cq4CkvYW>YgqxcuH} zH^zSN;ZICE-3_AI>O>!-6iT&P3 ze)0XMuRS7WaJrnYO6PFSH~eR#g?ttKHFm!5WZl){gOT6V`fo#}tNCV?muJ%nj7$#! zFqJc}CnWr`<#-KobzU^&N&6Y*KxVVr<-=jN`^R%Y9!vc3Xlw*32iAkY?O4X&&Go7} zE~jU2`~0#y`Y#$!+X-k!ufq~*(K)=fKQ+IyWyPIQpy&qd+IaIGChZ-zcdIyA|7vnqc zc$XJD8DO%Ieu~e<|M8Cea;M)FnYvqoXSlxIsNk^r-jcfV{s(&e`1#kI6@5FRFMTSV z!}FabE)5Iqf;4`DBio6skBpB%j`1$1X98LS90`n%-$4x(y*P}FtMGx?->WY8c;w35 z>-u%qpXP6mIG0tSb9hu-*&Y{8u`CBXfGwtN3X2n+K=?l&x2 z9-AK-cb}5}!u78|!TB%_mCoTNelRy!jx~9iSWcqM@#XIhVuiWAraF)M1@iggUtU@0 z*fae8lUTn=p6J|BrgOUN4$qtD7}|em-+snkW7@IN2&{r-eXdgSwb~b=;4Am|A0L?< zr2NQ`OW#kKt`Vh6INx0N%u?)9kzeXW1*2`qrD?9Lw_R77%YhU~t=BHe`tsUif{&f5 z^IzAG1ZWAz@_2kWNgP|N=POk&A za_%`esHoU68mCzMiU<)R%W|5IbwsgnZ13}rZq4W48g3>Thf0qFhjxq-ZTO~f&A=n` zWzQqA@qC$ZefmB3F8>GT$9Pmahv&MS<@&cOY5+!fji$(vOIuqy@kwE{54+Z)%FV*BK=?e7oj36` zhtb_Mv>VS=8~VJr`#jTnMuON0_E1>b-xm>L*O5W z?GC0bh3(Noh-YAnp%C5Cuzw5tK@!eZ#-CS77@Uv6B*9aMz{Sg?;APt2WzN9MJdBr_ zg_o(o%e<3{JzDWH@8M-`!ppplmw6a3lQ9^3k`6=I803i!sy91vu5=mBd&cp14=+T2 z@irm;SuMnAtAX`DLUj8a@6jSboYEsf{A*}}ICWNn*mHA&xOzi^nEyk9C`rc)Kprqv zvjDGbYLC{(kekYHlf~RqTTg#9?e^;j-%L;IazpbzOxLNAYYe&3$0y+tih2L7(tpI3 z<4ca2_DI{MkNv-@m{t@o? zGES9FX_Kih&KztQ%$uLl^KyN#BnH0fACg62Pw=%Z+wc5zVGnvbQm#zbsgY|8d}!9q z{F3pcJsF)}TYpRzcdU8q%Ky8){fwTFeKN!^k~5}jMClR(&%~hHgKwu1OfsHTG4Le) znk-V^EV$tHhd*` zCza0OG4PBHVngBxn%e(m(s%_`p>6gP4ygSxDjza-8R>lZqpynqfZK=U)zS4i13jEO zcMhDr&NJ)B<@6v7*Dp-hsgY|8eb$!SQf#@N3&p@u+N`7a>f4{6Tyf-m>r@;}k08)} z@!*jD7dPQaUt^vZp}rn*D(x5{oNx8`jB;pw(!a2PcEVHW7HNj~(gxgNxS1iFKoAvXa#PB7gdhaJ?pLEq3Jj)~>Pm@F{%Fvpg&+D^2H6>DFNc=bKrcwt~s zJdK%Flx*xEn*;UcKq{VKeGdIAqR-c~c`QE(VQRaHA=p9t4GOQm-x;-hd_bseV6xvK zJvafWjGtMN6r zuH^i5*-8*9ox^M6;d7e&BfL)fM&>%(H4k$kb%2z=Czifw9xtftp7LHw7BAbCpEl$XF2S;EnMWyzY zQ=dC#zNP*wAeWxk#w&7Kb!Z06w z%9~SqwfOyI@{=LlbXDmZ8JDy>1&siIG4bgQpNspZUc z#=~xGT>5VmfF&2RC`STR&iq}H(!*4~#wT6&iPCr`)_AY+a@zk>qB$*+N1AdaUXyD~ zzrtr5n*(B>>t_gpDAxzvziNuQz%JkVb3iR0d_oP^AN5boexk8CVAZ}+pNV=!whlEm zx9#-)>>N<*vvj-=f9tdRLVtYes^vp#leivZ_m4+;@FK9wXa6pHwS10~^k@G@esG{u z%crkVK6c%hzA{y^R+qbX7w7rV_5nKK`Jk0G61V`f!cYNIre;eK`;qJOSI_{b?JBk6Bo>ie$ zJ)c%_Gd(8m@UC{+*L9!2U&F!ECwlC4>va_c>8DaHYjxa0MAB2XTBHVEY<+JafcZq zS*^SLY<=)=-Cp_l-`v*gWtkwDuD(9@f6uDGPn6!E8yk{fnI(3(DDpVxXuJ3F>6my( z#!>l=d7T@5*Q0+F3Q^I{X_LM(4dK16eQepRif8i}2lo$|9verV+l#-fU2~lt?H^&| zfjqeKIu`x?)YRg?uQJl3|D^UP?}cCGweR~OC`I23CcZ(be)QuRSG{r0ZEMI+MqlIK zx)xmz6=FnLITp4$y}@B_kIO-q@vd@@vj|S0!V@(8r&XCmI|fA7HLB&CdiG&r=)(I> zTeJA?ueAkch)elXzdKB)1SDh5e=;^=c1fig`#&uyse{%_vdeN@7ZYNI*Y%uD|8sFb z?O*=6(8rIK>c09KTL(JTUHZ}x`8x2qRred(x>YxC4y2H}^yQCyN0L3BL$T%X zk1Pp0Z;XklDuvl}fght(%8KXb6T)p%i^Ur%jqo`0?SYM{0^>*fj}W{!LzeS2m{G55Vw z#txh$E^m8+&MBVPX1dD1$N~oAe|&5}o9}Y^i%N66Gu>WSWC;KQA~#vVpsTDLf9?le z{y9#M5UB=E+V5+9hmPU>zNY@Q`yd)it8#WEXt89}mJcv#ADK)Pl3b5O%XR<)X}!8_ zY!28Q&^e&iZ~Xtd&7b{)10lfRcC;|r+>T}r>7ccv>1PV@^Q86X6XJEHDGRpkc=JST z6RsI*iw+S9VY)#MJJ_w=ywEPYydozMbeCx#ttU7Gv&U7qDsbox&N88cHh9x_PC(wL zWltRV)*Lmi=z?wi{_%>D0O3mkKBjZJ?8e5YZEac$UI+;=-9h$vOcpHVYgMl0|2+Sb?tv#3-arvy7$4JhYUCOl z-((y^Qj2Y-{aDun7xi@*7x}4AB%g~i{Fy5{FYS3HZPlt7!bRv*x<A3OQfVCH8xE-gMXe7smA&Pwz*DTsnt|=^9bGX!%Zddy9Q@`Bk;hDqQ(} ztK!J_;d4Lx?}o3t_E+;|x|F5nRr8fzSqqojhpva2-%(i|K(`%kEgX zV&s!+$xlYdkx+}ShZ_7IT2bzyWmc|0PGym&f=)*thNDR6SkZt(V}~OjG>=PX5Iq}$ zWxlKeF3KkhmRzfP<(gG{t~&GU&qD~-4C7Mi9Io*tDlS7KuorbLa7ZKs%lHbq#^&2+ zb8}Cd^InhNIe*5d(m6afKAmqk8w!6Elwf_8&O77yEEB#xz(@II!IEpmzlDj{lsxR8 zg`MPd!}wG>hsVYz@y`OJysob5@YwwOwbeyGe_wpY-JCz;Q|TP8;HyK*%ZNBU3DhAi-V;cwjCbggM1zm~pYNV84XLaXz9O>>04+r656&ubbQR)GY;JNk&MG=9Rfvmv=={Qx$pwID;_EK(6|lnc1{k&0e{TEfhVyT` zFKq=qOQs!g(^aJtm5gz2GiLSzfeOD%JMNI$61hA}k2dFv*Vgv5TnzlH`}ZdHiXQ#? z&)WRboY91j47t?KGF>A|7dr1S+lR%c0e28h3LSK)g;wFpa^3Y9bH3{P?f|YImOuIN z_%7bJDU1xcwBD5I8d18?IfvP$Zcj04V>-Llfn~hdixh`v`>-1+)|(hGby zkCaTiy4^Q&9zaYp5`d%svVVo(M@&-tr#4!6i(JAqLzEpxpbLjGi;z5nnb zm$WZG@uu+kI-I{skCJ~rmMa%KJwC5XVnr1mU_PX##>O%3zfV0frbqJ^I3LEL(mC9M z52%u6;G{*pn<%#n)ySXJj`=`-l1q8KcSOS9fBENk?F&KH4Ck-XIou+Di4Tz?k#VGV zkBy^KtInTKoqV)|^I;q+ox?3~7<`Ceptwt5xjZ%k2N~vvm0tY&@sgb{&Q6=AMZ|@1 zsB{jm8^^?e%Rkf|z#{f}RI3;#=&`6&BLT)$er#-9)82h!Wv?+?zTkWrmrCdG`r;bl z4FoZP;3^(6kAO2w5t48w_lS*i`W3_8I-$+TfsBK3s&o#I8>b{?x}@tV)JXW&$ARyy zk8`i@GPwIF&Y$tAbPjI-zPebcB`LRO8ONFV8M-n-ucx!oc5KxFKSI2JYywh!#7u$i#*Un?P{Oy|H} z4SP52YS?#SX#jTuUScZjEwEc)>AcA**e_sbqC(ySdp9~WB`t&)g}z$>`ffKS3Go~H zZq)$vR{(k+fGz=`TdA)GK!pG_^jIN&?1g7hYr3Fu!NKScK~knn!g-Zo?4=dh$r}@( zJMIFmr*W3$+d{nks}QMa3Bo@mLHv9Z+WWT>MDcNn;;99RV(90I;`)+i;+p?86Ay)& zi(gzVL@xlkAAq(2P}c9Q#l;V_6|2yR-0(pMG4rw%v1ZAk;_AMKi${x&7VC456;;3W z5|7{S5TAMmijs>4i|NTDMW2#MV&{v+!f|tjI4+H5WJA<9()yKExZ`>-uUBmO_-Vr5 z91py;`5)U}?TsgO`Irj%V7f+>F1mbV&2hRt^zXPyMkrbpEa$%&`J;Hk?E{r*39LLH zdF8u5&&}xda1jrrDE`JadUnXVC~i=O{* zk8g(4GXbCKeSW8ZUY^hA$#>5u{)UhM<%#%7@uuCT)Q5vj8&@r#hvF!lIHEKy=z}PAwY@orUfuFltz^%NX8Ev9Jm5KC>x;RF zt#reRW`4@PJ6JfNw*UL;y;%m?-Bbc=L|Ki2kV*> zJO9(Kb-j4~tf_Qtmu5JBmCoU{@;3tFkxN;2$S=>;Vp>?cSLvKDxfCX+A&1%i=p2yO z8-*Yj_?)hN$F1wB8y8lsdA)pN)?nkjZhUIj%uNPeeJ-nrR_VECxIOORJO>tlX620t zIEK4|Sie{9@(1Tla(XK8K{FK(l749a9|H&HGZf$ANe1NgD&@n>@>_N55^ep*_F-7B zS@`|(>Jc5qxkvu%Ujw@JSof_VOjsVEtt(_YZcWCF6W^Wr2QS9l&w(W^#>wFU2bLjD z$D2$ao-+X|Ha0J3{DdjfCuNPAsDIt1FZB_9PabZ@tNz!Ndv-@LI5&IK*`C!KHqgt$ z5MOB>B-1sbbcu;K2E-83;`*pY!KdbNhY+h_&AUPp?OgG43Cni2? zevZkSG-7zxgdCGREY6L{Lnh>*1#;o_G5q~ot^=B~F33gR@^>mKu7>0%>s?pKE14`K zE!r0V%TUCgmWkpoUpZ)bj9B{F8Siv{=aZM0YdhiUc}_&mOs6=qG4o&F3jhn$9Q3E# zL~O?E!BQuGP?-L6OUpCk;C0_g#{-M|qT49_>Taz%>>ljQKFi3A-n|oWFx?=Bow{() zc@5aRARuF*heAkD<}W8?#bct$Z3V@(iWe;n4zu0(I8ayl(9?DCo^^!7*^Ty$949_x zb}ZsRwDO_wy7)?TwiM4cO~Zj$<-@sBy(X6x-$yGWwJzkeY&U)mQ2&PeMXQwdQ0=!- zsxyc6dhf96+wS8W^fF7RMdxsHdnoraN4xwpU0DSa{4UqT@?!dllb(_Ly`|&K?Xwl0 z4&SYL?Tu5*wyiPxk%Z?kND|W-2fKCSF&5sNB8+x=(Qf-sKYgs%MAt@t0s2=)=HDI# zZ|b^4t)HHU70Zine&jX6@cR4HuKVqzDFtl|K!i65c$sdH!;UFihnBDLClLMvqRvf! z#~2?r!^crh+A}hqMdM@h?~_MzCLR6d__LQ&2N#C$bj6kF8d18K@yO+wi@#hvD9{LR z=rQiM(*H&xKlZxS9lP#Gxb4#0-r_7-zEnDgoAF@0H8N{*J_4&?S+1+%$oJe?lkPcc zQsR70m-AKW99}EmF-||WFYx(|2=aUHi6j5Zy8oxu(I2f^#p!eYDxJe?=Rav^76Pka z`MoPA#OC)!w~xsx8}R=9oG$09(mA|VzWEgx)_Q$&oO+BZIGq2UIP!nv$Cj%L9f#9! zRWqEwO6Txe`Hyza^twyjE`#w^h{*X@PK^EjgYW9RXZh;qCvf_lze?xuTKP})`N}4^ zDs}BM|6e91#m>L$@u9<4T{dZeo-g-F5(LvZUv_Kdugxz^9DzeeeEQxkddw;~%!jHt zaQv_1w!x1sT|SHRVLqsI4zGnH9|xYyo_Drup8ltJwUmF_WOF^Fj<<6We%78FPCTUi ziRNK;6hy||{W0z)9)xhA za2|Ja{&l(BZ>cNXrZ+AJmLNHn^X=0kaz^dz`d+QId4=u8&Bdi3)SOE>Z*iQk;i{Dn zefqdj<4_qpP|{4NII^jA&f+MSb2j<}{Tz8tf54^9DopTY%|PRavwm{j#l}&%UAxk{qeb;bMen88IsLD zxH4TMN|(CZJ!71V$?OTfNPEY4;^`+@>4gUpA2v2aoAO!wU`dP5#(to=2p|_@W zEAf8|Hw=YW{QStYG2^?WPo)2P$xytuxH4TMN|(C%Gs=lmm9cM9Ac!3whPd!u%~iX5 zAT}Z`##cHcQht>0`t$Vf<6S4V5;G2SYq|b)evhOg^Lr3jnj_f*%lmxg47z;NQCA$Y79`E^d#H2{kMbUIyaf91 zNQm*}y3BGws*nU*h)z45vk0%acCCNtwU5uM(sAi>K>NZlo#MzQ-&ItBLjdPF@|`8F z;JgX$@_+*;5>^DYeKfO6T}88L+Zc~4=)!=6KMZH%?|1AEhlE1Ni14xA@V5gw58MC8 zalkabfc((-E(@0AgZxxp@;)iQZ*<)CTZghK#&o0>o`5UU5#3~r+7u^q7Q6h$%wDc9 z5OfSfHIiRi5yZxR-Vr5vK3Y_O6EC$L43I(ymgTy-#4OjOg({i+)uQX6Lev-6P#5+u8SioieA@6w+y6k8YvR`+PF!+j{$|cJ*B@5j zW4|gKnDx?--N*9=FqAI6J=3M6HE(3Uc&H`u*yV>lVz*3#*OQ&@ptc+8Xs6qY%>&C^ zdI}*p%-`(_t{q?=)oWV|gjlw5gtk9Hr(N4VIrOX#j>V^A&5&$#fP^sJAcq}eAFH7i zW#vFJ#|>nTVLp$?Hy87|ObPUJ6ctUMKD@kQL>b1MLvgx&u`AnIRO&MAS5sMPE`O_f z?Yhow9c!+9n~ym)WH(VTJq*n7SmJYgo%9_&SP_T|SIsPQd8+e1$?lFK^XH1UAHL(% zsl2X+_(tTGt^m?xV;T7-x z{#cFp;IPMyY*|j2uA;G&lSsWM@{Ihsza~G=-}KbIN#r=HzX}9?pN&4V+^h9vnzy6) zWa)~lNA{X_^=~uul=yv^uBLDGKH>Tjk=6buKQGsXvY*4PT#84!LhIFNdX@G^qJBma ztZf>`fe;>J`AG6dmygnN$j9+dmp`8R;E0|^p;28#^&-<%6jt(~)2M5r^^CMdpq12N z(z+?seZp+_kcyHLd~~ZzemEahcGP={$24~NS=-%v4lF_vEI;YN=<>4|^0obpk3W9$ z+{&&~jd>!f%Se8ht|E#pKl&3^azf=z^#vKKC&*9oN{0L#PBilCW0r`^&mzb+d&z-n zJkN4cImav~YX561VA%tqH&cp93L8WjX3PH+uh!QvGDqn}=QBGcBt#-N29>wZN6>8d17f%2A|$hW$u!#9LjB z719a8GQNU&W;s{;TdRP-{kE1LUA%qHduxpE#VqGcm!N50D}3SpR!npamv0pZ-E(`& zt}X9YT&f>Up0C=a$d6i2Qp!hkShefWyC(KK*2sp+pgmeQrW@q2VH>y?VlzOO$AWWCyPaddgfy{Mxo`S_a0 zIBumIZbrIorOb>>f^3$J72!>nThYE8lbp7X1YNRJ63XIRUcal4^olkI<+cxy?p%h{oTK; z?vulFNrbNjq?_qsV1~yMpHwf`g-dQP@-8*=P3;HO0QW;l*UawF_Oz`91PF%pjp;fy za<#%0sh?}3idWAfIYjr_^>cLo)HhU?m+dj+h0^YK+H0o_o^@7>WkyCMFNZ*Cm~N26 zj+MOVv~c}ADPu&yhgA#O7dlz5Dlaq3ua(}9y8eh2-Df6V%X71ghv{J;hQ|tzmEM~` z;aQnaNtegg_xsQ3-{pvtTK%r-JJaLBCF#40$29+QrI}Bvo-YR8kA6BnboBR6<`o%} zEv)BEj|Wdg&m(9WTfYg1t>bEGH2hxHr;Uo7Sn1PE|NQs6zivKmG@TnvhV_Z*IyG{Q zSD&z|dNysqpC9z&LwLZXPX!BO>r?f4yM8_L)iWPc$2ClkAkux7xFmgwhG)@L(e-Hu z@P^*|^!MxE8Mb7uqEAeZ2Tw$wR5Xo0t|2_OUa6(h@OxRWQm;14i zE2hVV%R;ZL@MK&8#UU^+~JX?YH z@ojfJ_xR*hBj*|!bGym(c<|_D8Sd|($bvX*&gaDehQ1;rfe;Fa#yeKupVd6ndn#M9 zwrM&J$oigqy;*Lo^nLk>HE-#eR_Oo`r;F&*hI3M6f^3n!U!*msmmAokR@eq&O zJA3SmS*{}eur!w+?Pv%I@%&TLO=etH`kr=pX8X&}Ew1ch03cj#fs5$|IqX>BvKoh4 zf3aP{WN3C~a2t?E6~@tDb2;*<0~9$Z^*G4oB;|BRbEiV=O6 z=Y$?xH+He2|4cW5!i^QKi2m1w%B}}gKJIV#ayyoETXeZ8{Yyu2|G=?ZZ=A6qy}j`w z+-@*keLpL?(P`m+nI=5Lv-KxKP^4)6G14EN|w78uY zx0`WV$Brfx{8hEK(xqPkK{p}lDpSLTq<{?$i zm>w5iNzNLAGjFMxuU2w6v~OnlXIYQ8N~A@`FjW2|hfLRq(#5L$BXSroO7nb4)t%9C zZpVAv+vnNA(@risQJycM^$bjxAZlJKoT{8Uy>p!U?kaWnQ>dKDu&dwM*L}?ax!pWh-$PmL>F`@e0D z5M#Pgt9MABnH~=gMW6Ls{dYdgb*)rJwjQgT{bTOsar6#FUaa)_+p=qKTQ}pV4($xM z+)rV;`WEr(vq@->h%CpIe~+!#*Ix4cC6D(za-FKzOpgnfq}S2#BrS`sSCm)VpSI60 zK5y7DXDRy4^my<@^jk$^=1<1G(eW$+-j^=!KB9At-dT@uHeO-E$qlu2meH);JuH^?b7;FIIYfdqtbqGJm?QP}L`^iO70hcwcNi|F`dnvA^8jY`%(%>2cwb^gJ4##nsXEY8UW6`nq>{ z&RXA3+ax_Fy<&Picp`ePqG_03sd?6QPkLwTUR~UYj~+ra9zUl)5M5p<#rN9`zVFno ztG1j&H!xHW(>yuTHKKH}(krDNHh)ibWEB_tvBgb(xwFV+9xrcI@LB2oN3(9a^5u0e zdXo$cgs(a9F~dwEOAQp zKz;CaT^_rf-w5^|u=Jd}MolpW%EZUc;3Lx|XqwjwU!-1$h0a`$=B|v6uNwGQFZurT z?(cm6_18uP!2JQH$AeFi!_m%0`kt@m&2<#JYPfx0e-6m)?p8%!tm=isUg_JtVp`TM z^1KiISHpA_ft5U4)e9^%@;JWmq1gI=tLvlVFWqv%@v9v2=-|E+NB01h%)uq1m{ zLVcVXYZd910M~8whOvkOsSn(yI=ZwPqeY5IeGY+fr>9Bi6;sZMa4;a(f zKtOFvqF}lS1a7QwSe4JDjC^U<*j&#f*TgQT6Z_A(-7{m*C92#oJuX~QIYq-00v%K)P79CA@@Ko9rhfG*1&5XV2XAK`QMgdmbEY#cb}jMAdL9R^&A>$_n%)p*25pH;0g<5J7BdQT^D$u|E5e}C)P$E);$4A%opmmq0g z16NKZPP4$ND&C;e6W%Zo+q%yz#eS}Ne)k;wexyeo=JN&1@sC2#kskE*D|74H9*U$o z>IK>_FdjqSW@STl1GjlHo&3hDspS3QJ_Ho3f2mKI%S+wYanb)$#1R!mZ`|NIIq_LT zj_5lW)!R&0Uusf@V|ccH9u9V-b$ch2`d!Xq$FK^I$1#lL+&$mr7~w7QyTXN8Tv23{ z9TKaN@FlH@jxX)U6ft}E(t%@keEf`xkLity4>N*(*G#{!!duMgX5hn9yzLFQCtO!h z8cd@%%AqYp#z}oMK96(R2D=`s`kF z=0(+pk}*!EHzLjfL0?7~r#wDM-eAT_=d)3TRnuRHZ+=|YdOP0Zs66rZwqK@we}z*= zMD+milj*f^`eykYIo{$4K3t6By(iL^+WOwTRMl&b>~H5q)VCh1Z+w|gv7U_;E~jPt z4-O8<(q_W^}6bXj^glZm%m!LpC%BV-JZBZ{rcjhb##-q%-FSdQiAWPej){iD*BziU-(iY_-bkgI~K zg2(6O_}s-G&C=L448Tcln6AD@9C9Z zu4oUb&rn>V$(C^PIG4l8JrK;k>Tgq7Ft3T1^f`gcmjsXesPVt!;Umg?)pkcvA}!8()F))6r=jRRP*X@8}9D;cy}#FZkL&^ z!od6|ohyZ1KqGU7quoV*9}cAQd5Z&%$mv*^1`WFK-HML;64g)u>TjQO?B}aFP0|V0 zE7Cct$0&dPPl)CbX&rM1So$xH{#~Yh7YS(^Y&z`eu+%0@gq;a{5$tWSPr|+r+ZLH* z!!Cq<8}z!eMW%janv6^bA=8e?^dHz1B|jDaqV*DD zN*^J{;IQCxa)j8OkMAiiq%&WL*KR>L4tq#=M~HV?C5VE-3F6XA6U57}CkV&DM3J>J zQA|Ixnb`D2Gx7P_=EA$Sg?RYemf|OOlK9opMhwqyCqDeVy=dD$MWnuSsJPF6gt#*? zRdiT;yx8-xL)^SRLmXE#R7^fLUyT1-v3T%b^TavDH;ZP)kBa+uY!M^IwMbYu?2Lp{ zU%EJ<`RG>@&RLV5`1bPq65pJ8O0&n(K5F*JS&uc}GrFe5;kSO&^48pmNw@Akw9SJ* z3}~00{z7|_3pA-zm3tPSuF;ecGeZ*4tRIob60XkIiUyX3d)5Q8!Mu_KR5 zbGJm-V|tB@_kN$$dC2qO^F*oNLfWj-H8L*H#;)bnenLKJ2nIF z>nSN?F8l8EA4{pT1k)Xs>J_GIMCmfx`g;fU?R)`u(C0VeHg!G1xX=wwj3r#! zxn_BO*Rbq7<3Uwkh^*FcY98^%v3ky?)sF+Ryoe8@%S++5j$-qX&o2IK`=rjVb<*>p zc|?*IrmMNfBQH3XIV>=$ypXKOb%>gNL+ckdD{0)#{pSh3O|W1FY6&sOP)Jn<55K! zr_j6u8R{#Oyf9rON|$)#C0hL=C8c>|$%!pXD#sf4UY3_#G314E&dNPJwBe1E-|jSE zP`{JT!(h5W4m-NMj3_JjM23RVx-c@H)E&{~x9YzgMavQ0-}~y7>tD_>I>6+R{4zZZ z#PGz4CoIBh`>3W@*L^Ixrsv{`Q&;*nUFU!-FL|FwmzNsIQ~$HxuipJZ!R_*XHY6`h zSNUql3w?PCV8dLj{~9|Z;PT`D30ewPyB8i!UgYwY{c4`}ebaG3o?l4b$ym7lIixUt7^jMaAQ&w&sg zVfiWjI=1{Q`efw=Yft|jD+F|-mt}LI(m6b;{ET#B!_6YUyIkM!-AaP0kPzeB5eL4n zC--UAac-YqXgxIA|7ad<7etR$rFwb38Aui`%x+^w+Ivn;;cIenHkF_`Y zeUyI+@@Kk~wdSoWe^#JHQvQp-iJt#1;CuY_<9=B3-i5b3V`N10vDA-Xx>+JIaznL-u}K( zD5S?ECrnon=yH-Doab?w)RgtaNbh5DL%px-Ih!6o2dWU2pL6F z;eHU)Ri5eck?ZspdtBP5hMYOrq@sS`8z@bZLpD^Fc6l;4_N^<+OZqP{6oa!IU2ngrmIMGIho`RR5(5Q*QTK^k8_?y%cDQ3$_u4WO&iIEEFZF8 ze=_#9A$7MTTb~#8{$jzD zUoz8s8k`{>wm}InU1gZA&$;g41Z>1N)K^qN+q&tBZK=~Tp3QAy<4O3>dA$b@+0c&n z+9NzPFVFOb;^E$lD!(L0`@&Gai!8}2<;n63uV!r7)%l>759v1XhOHi}VON{S4da{q zl)U~R>5%C9T-r889NDVh9Xnro<$h!Mp~*jeKVZ6?Hu?4XWg?cS48<;=E^m}7hE-Zi zLX{gLT9vmIO-sPOG${w<@yOyBazj9#Er0Ak=S_Y3SE?_`P`M@I%5;q=U39t0Dk{QJ zBJLS(4>q>4Y>#9dnVq7`Z&&<#KA`>1P3`9F%1koyqWXyBm+2A&%^M2`3#}@zs$BAW ztLfYK`-TI#$VMKw@_KY^iy$tn2L!d8kK>7Eq@k91J(9JfHWCNa^3m&=MoQdHX0JI= zgA{l^e3w#Rr>;vB{Scn_0nYij`H|Nsv&*)uoHTsc$eXVwMTMdAJO)>$Yeeai=bY&p z<-?BE`VqtdN1n@H;`5g|z1XDM=|!mDF~&K^JyTmSJJ}s9#fM{hz*Rf~pMV^r-IcE5 zA;X6aH`0{bmtCD{MNeejtr&h6Y|=;}f>Tcai5?l3R(<%?PIDKYNH;JP|3qAwt`VgR zww0-%T^k+w?w~8jI}-qD1m?(hmbilRCb-L|kMVhtNhO|<>n|w@&3m*#p!^!s$nRfy zsQLYA%`%Pa3PxjY@x^xrQobMd`Sgp|O16Hd|1Yk;e@nbS(-P1Br{N*dh97_L<-bcP6+TM29xsu#CfP?8W2J(k-&@YT* zy@aM;Z4^SJA}*Cf=)V8nkkmCrJblKlH;axe9&pRVB?Z*RtL@A((8w4t^qV-YArz!q z-ZaV5>SAG-(oi!nsk6kwVzFauR5Im%xou(A;E;!m;PpIdH z&@;{(*FM<%nd_@qH>vDeK)aYuaby$MxgqGvn2!#bS>bW|wPdPsWqi5E#>Thy*0~!$ z%W)l};$ymujr@Co&va^tD(6>X|2$gNL3IyV)ezsJ$$hjiH7)x-HV4%5Da6Mms)uO4 zlC};acN#277=3r5ei^qL)Q+&;Y};a-w&$R+ z&IDh!#}{z*Gagp;M^1BJ`02mKllMhNf6_c`{m~1~mec)PfYtKJ1YD}RjOxn-p6h>h zDNy!X-J24yZ|cnfwR~tEkIII|Ys7o<%Vog#3O~pnEbL&VHtAf%avu zIG~mf&96|s#q}E{&irSWXtE(XmkGOaxb1H^2h{S(L{i-DsHrmV*`;vVZ*{MxVc*w} z18VtX<8jg*E2EZ$RUDhvxExT+$L=3AE`RqnHMM+BK!WuBi~0bhFLHkXx8c44`J;`I zDBL!C&jGc3X#7KC8Xmh)8F4v~%l$ekH~NN2_vGjA-{dF5&+)xZwXgN%0IyT!eG}*l z9j!Ma-cvu0T`C*mIrAOfKg6i=lnE4sjb%s%MOewOtNN|(iDsLIb3iR0d%nHlyljdm z)$+0XGflzehNr2Pk3HYsa9%dWlWO^7A``p)X$np^EKRk1?D_VF@v*6%Qp?9~f0~NZ z4NF%oAA7#NVSH?=r_}PX=i8f#(+x{kEuTyzWA_gl#>=L7N-dvkWMa>^HwC8~mZn-h zcK@JZd~B+x)bg?C+nb8h4NF%oAA7#NVSH?=r~Yj7?e>2dx+G-aLzDd9_emhrcP#ow zLWaLT$ln_D5c_I#;Naze+8)u~9;_<|FIV=TH?IN|{vW;c+!SprlobVDX4{DuZ0WUZ z7DpLic(N2ahfj9R$j0Uw4&D#Z;i_~M(Z1U_iGt#!!czXU&&;CPDMC)4(pKe%_xVPU zW~hHdhF$&6zV0gysO3ZXavR9*zQSVXQ=0>7`EZ%ATl)!{vM)KHmJjU#V3*ClEP?2G zS(Q)pCmI%NmwChZrj}2`QZYY8YYoZD>km1GT~5r2_}qq;5Am7yt>H4T#|-iDyS}m1 z@`<)LU0rEYS&=23;r|sWE|;0DGsKOC8MS<v+kM8@lj)d|a2<>D# z#gWZ;m$%sE$7aEKejn{YKgx~$c(Gkle@9MPd2n8>{VqxVl31~&gciZi^9Xx@lk&}i zC70`kJnSL&+J;w;S%vU_pE4^qt@Opv0|+P67nb%3Wx7U`E|@YX_hCyXw|Ayvh-;?X zI~qrtYkPD$$T!{V3K=I>oc=7%(A^@7q{dX>QM{UZb{RF@8>1-M{xuOVCdKwQ6{%Pgc@ZjJjpN z1g$++=^QS%gZinyZfu7?+Kp3iyfe`kDR=pU^Tzm!UD$d%$D^GUFoOCz>b}~PPdvs- z-r{>Qp49C)d&>c}eD*fIrg*+H5~Y3-$^XG-((uA^zj_qzds#3c-gqG+J#Acbp}C(; zdQNu7#Vtj%E-Ri8^Kh=f`MplN+~>T6`qyM=9HN~oV9+(9bjdF&brn~5Xt*$;)bDZ@ zXZyTCzt7{rP$#P>h$GrYc!Mtg9H(b!gi-6v_w+dTaRwB|$@B<9-B%Bs-Y76@)j!nc*yl{B+_vv+4(J?^ z^?J$W=JARPQA%JdvEllnDJ$0%T#_RC4!iP^)U5y8u+pf2Sg)C`^0l6Njcw_RaJ(5# z*D`l2M5fZOXzVdaW2dL`f$#TKK9nEj6)QhAT)n4scpi>iIZeK&Z;e*Z(X+PMKR6)I zOB7sz_8G9UV5!{5Pvf&fDD$Ly9z81^;XUs>H0iz*U+~j^tYoMir*Q+*HKKIk^@{mL zes_5=;Fy##%2(v{&~$~{Kf-xR$&1Cf z;eOH%;3M31;iu=0pIp?x|K{CA8jE-GA?o8AMWzHFywL35X*$8YM~hqjd$qG zpGA0)+~)05;T2zWS-U!A^PL}@MmI3D7j!dRnXVC~i+--~Xjd6da??2F$oBgJ0bUNO zk#HDdz*m6^vp?p|@q+5OOG>U$y@Z_%mDT=cWI3t1%G^)Q9MVDi4wZhU5I;{^e}3|! z6tVQ{GrHv57+QA|{g?nl%^Jx$(>0=W!8uWeOzV<9+Fj)L;c!Tww-{%M`hCR}MTTVS z4~60=7t%d8T&L>t%GAbln=0MLL%45KszP>LuWY`?EH9xe6Eu0*lMR{JvVCp()hS}( zGuN(otYF&vd(PHzvb-=|MK8&V%kOr2-1A+s$kbY=tv-5Aq`dhJlFkO9D$OqRN+$L)B5zwoYeI_4NFHk*1 z)~+MeQmXsjs(wFQicaGr+x&4HQ0Jo^fWq=kuIz6pN=~Dp&)d)09N1qtU>Yah9DSTf zm~RiA^q*AU&Al0aAI;OJ7M;U$o!*&~ok0x!{EiU;{S#Ae1->@%f;wY8onypUJSO* z^jenIyU_TI=@BHlkJ(_c-cesC=osUhSPpbFxd~&{e(NC(zfvEH`p|3$IgOQx-{f-t zn&|pl!DAas4yf(7Wu!lt$mK~exIBr*G9dS><#5tHk_QSW*-+(%p66%b)zaqY$(1dK zlS_uj= zgCr5c3)iqN4FXPhc^`F_dDb72P1d6@2zZEIm)zDxm!G%&HV6L990&nC>v_^$(e<3( zbNnF*DXw>(TTOm4q~~;1=^7aqD?QIHbrsEa`Dgf?{$lj6WEGb*T2Dc)hgK>0s1B09 zE7KFZ-|7ARnnfe^?lA5dpGv2=Wa7X#K&o-{KCwhl0f&$#^K}QrHJ=_f93y{ zCjRe7URTHUCesO{Y^?B(bb4pYOpFFnttYu&l=}zNWw)v;WgNEO=D@+k0eRja?H;pU zTh&9(4>y&)`{AH6=8-a>#}lq^j33oxTq{`nP~DDj{U6XjD_iR&ta;|ajjgAD~EBK1{>rclb_>R zr6EV8aJ5gy&&u)Yvcv=biLjKz5jXlVeKZr*lWzQie58a zee-zrTJ1cj?KQW>B#&fS2UtFt&i9Oi<8pj*Igb1c`{_CMv&(r~g)vQb$uAp9hYY*= zUG4k2=<0JEk6p&e_tD%~X+?Y14*ThGsrdDio-vPbh9@_0a{bGVgW zTa8olUFTQ0yx7sicu>Yw`bhNph8`LFoA=D_+d6IHd>NNY=kPdiX;qDiD})4ioRait zY+Pf$I&ZNNY=kPdijd8h($2$Y~8`1)yjITNle5vEEdoZK*;X62g#;4Lb zJYIZQM&>WJz$cIM%AbhNzx2ma#3xs*Ij-5xDQj05008I)W}5YrHucZW0a>q8*GAXt?a=!T?Z*20bjz<)$9YUw`4O*Pt6c}R zz2>nN$s<|PaWX8QOy_$&G!mENlgn}BXV}ka@;$knw^bO^WS9K1p)|;_tKZeWuZyle z$MM*u@K|x=xa_yx1D6BTf97#Z*A3D2dMot)-Td|6?SA)-)k6%H&|U`A?`FEnsrdDp zS4xK0=ZwLU%{eaKLn{2iO3y*nd(v07tcP@OWuoapy!v64u1&K!@Mqyb2tZlyS1Ed5 zj4=8Z&Fk{u6_*zNZ&S(NpPod1GNku(Rp}ZT7c0H5HNO)@!{zllrO!pLmnhFGum0(S zNw;P_%lR`tmCoUD;Imk-Q#ashB+UHG{g)Z9%FpEIQ^Z9VPg(H$j7|$qFaU8q%5=ub zt`*)o*6Y*_5{aqncH}yf>qVNHx9dUXyzSZ?5F!L7uzsh$6kWe}K>sT<&b;m9nj@Bm z3`Ju7X1dB#EB&^f*NFV^;~1YcjMGu|I-355v3X#5?|leTkF-w+AG{q!VOVZdq?Aj4Z{aI26v$u?v!B)O)7K$0IbG6@v?zsj9lu+P<>0XMSh~uJ@rd?JizrP zKZl^0hM$QU@c@iqm(TuPsA~Bn11`xw_r>MW6JO_7pX zJ|`d(Y8z~QXbNuEKTW%Q>d&)%`Gi_NwC6va&&&EFkADdl(Mi8p$2cCl6vsA=#{s*1 z8jqJvk&;?IU6Bdt3|TU)7v%Ez#wtvUY+o9k19tf|I!hZhL3w>=+V1G@Fie8OEj3_0YK1>6_MrsSstp zrT<{YSBy*uBmYOR2l%Iy7A*ee@GYnExno=}GM#a;YsI%(>%vq}cvxKz%jwDUwLCuH zFk9c56SjM>av+2k=lW)|qR&?KP4n*ee00ghU*E+1($|n3DpWd$>*q6Md5cPY{v401 z42P>~2e>@4a2Y^))zKuVb>l-V4+q#_m z+R23-pa0J2a1g%Zu+oj`jEmiR;2Y`=1fAHLW|-esmgjfPar-I)c|M#h>GBWt&GpKt z@&5oS7y0{BL+Tp!8NTOn8r5y8p*U>SF!i3(Q|Sl8yUBxZu`Ea~+*$9^8(%bfIxsvFWv%AWG3?_{*5jrNH>1eVTY z?E-rg>~XLT*g>$PU}wNCfV~Iy4cHVUI0N=Y*fB`>C)lk>{0AgniiC5J@Jb}S5edJ9 zg!drf`;W$1ug44F!G_?Q1`BcCcp)at5@P68LY(r55dZu?oUPj{K@7VnL7ciXL6l#R zC?*YPCR+DsE{LCC6+x&~ZxJn)p?8nR)D@5TXPfvqP=jdPUZ-oP_(sklR`p`>Z`hY3 z<@_s-I_JnCZ~jY9pX8GCg6V3m7J3o+AtOBd5TCA4+G;(k=4W+Zmz-F|wW8Hmp13`= zO6x$Uh46wbPvwdF$;w%v5f4>)+6;O7%Zu+0cwo#YuD&lI0t}rYMDoORjVN6#c`(b5JWsl+d35>d+N_g!@AEI;*|z4chj;y3=N_#oA^BlC^ORi+`H@Ed z`=1=ib&u@l_lf2n%yK0EZ@8mnbUDgx(Mg;<`mE{ae{|GumBl(oxxdGBmCqJ(RJ(sS z!G~yN?jRm+NV}!x*^ql#X1IQmX`H4Njl&KGH-wkub}OxQba`3Ss*^bK?6R*a$Byhk z{U0(cFHF~|k!!u=#eq{Yi#@Ip-tvlI&Kyi}1Zv3-l_ixK+el8f?~mYsJiaV!8(n_Z zL%#anJvga**Y~&l(-0t*AEvACP(S(6JJv2FqSiZH2dL@q&AnWAG)4M*gKd9*HUxlN z?}QGCE;piGC-KtT<6n96(3^VBSLBB2>igDDZt{ckJTCb-*(Q@8S!QHESeIK0z@_1`ea&-BjlzzBo%d_8XSUH4KCHbM=k4oq8`pHjL5q9bixM#RM!FjS2 zna}@OpAsEsYR67ue#OpS=@0CgoPs${GA!pz*Qt?f{cz%QO*tlU(Xm(MyRq6oS*Gjq zN6_28x;PL*0N0P=(CBhg*r}6f{rAE%#{YQX2mdpe&T_+aHJ|#)4adf5qgvZ$fe93Yor)m4^=78L<&p0f){49ZdExGXROD2CYZ}EzDdYUXhOjmPaiSYTu-;L^? zM{wlnl@1cw7xfNdjU_X&!qxXZSnfl3QLc9?505T4TOn6Hzu&#_-dhJH@9d#-h~~zkz zBQHstV`Rzl!*mr%{p2US>;Y|C5Gx^qPJhs)&9paEj#zdWS3~PBe%^MiIUvhXZfbNn zs)n2${hykNcdkzO-{`aT^k}?K-{Y9B=3*g7R_g=m?h_das&b^}(^U7e9Ljz*zi44< z+yn7mUUwNfHo6>%?w!PW3sxMm=ZSAV=I<*kM@(0FwAXTE@y&(uu#zh(OSUQw`+nbY zKwiJJ>$vE0mDi(_XuJG}|4ew{oR<9Eh2@IrD*C;btH`$)O4~}F)I9h0Uao8GcCmik zl;tV2S9Ey__3R|3w%C4Y!J5ju`Fjk@6Vuh)_g zrfY9M?cTECotJa0geO{AuJZYO!|@b+4o5Br6-Qaiy%YJ0i@SHw?+4x9mgjG{95A2d zWxwHa2j+ArPPH6xIt}$@?ALYN&@>K&`{i=5-DZua^rNFir;?8*EG+#(@VpM=iTSF| z8jdH9Au!iNY19{24Qap0_)_y12?y7JJl>Ho#2Qx>$3%Yt>1WuF$Yv%9I0~D6;?5$hSmE*oma0vP{Oi(Dj#Z%qwT=i%C4^0OGhix7mfKM^$6Mnn@wjO5>AH!%U;3%@Q#>!k zxMIGVcSgmY+b8o}QA6;=&s_CYnIqvn*FZIH<$1=$1ZzC`PKXv?^m}aU>}J2T=XoN= z6Z2I`8jh#B=Z+|?J;fJeisfxcJB#Cp__Z}q0T$z{c(^sbHUocKZ%avUJ$2bPUm0H{ zqvd-vf5dz>g&_E%_W}PC^F@p~6^m*f55%zC4zC_*jhna;IDcCI#~;h=8%Oqt9OH)h zIydlNZ`_1AKSa-zo@eBl26VkQk9_=ynXrfS(}@6FxCw-j+n3J zrT#dwo)2Q1pr+H1u#83dxFK;KDEIo1QN~YVk~MyOz}Nax&zu{|*RJC6d&Up*RlU_8 zKi2aC-Si>ett^b0Ror&F&k%jPuG=Yy5N>7cK6){-GPE%zfuN{^l&> zhxux*>W?43!+QQE6plijSLKX^8>RtyykXk}YaFGHj~1mJpKurC*BtSyVuzToO2ep- z#z(Ek8|s*^X)Ii*Z8J5j${z^_*MMw);wM|h;S0Yiu#lq9`+#$ZU?#3tZ}pvID2Di-g9eqob8-xB+WQtzA6!;B7FN} zJs(pa{HSX*2aQ!tP&+k=FwZ>0edbF6nyu)>4mX6+RH|2ebD-Ne z*&e0Ou*Od%@YS_huX(AvpL&|#+u`>Jncrym*@O9*1N~X5y5AdNxt(1x%NkERfw%LY zc(#Anv^B%{eI3RV^VK};u|2Zw-FcZv{ii-j>#&TYnp3TDlz2+CILNhq?P+T|*V;FY z`D$u=j-!2JekNk;)F&D|EaPb4>DD+ZJ1tsV;z;T|cT>^NJU_$si1}(NdyXUPc^Y2l zpr%*fu#6M=xW4fm=-12bq|G64M7lcvjz{l2Xw`OFCagKa5$#f@@-;U8_8dpS=WAr# z$7NaLzVwV}k-7cD0p(-gKb_ylVcavHn8xo&SyboCv=3Coi{?Qk~X#S_!;)7JYPE!ZS0DJI??P>wHHp~_iPwP%vU90>r(%Et!d_WR18JNx6~)rIN?%6 z!|kQ&d~00AtC|$d!?_a6uP?#{o6zqJ2 zSAPwZ;}*upc9%6i(hH(R#<>gU54`Y~V^n-FUzH#TK7zf^?#E07FRBLjt#B#CVZ3zl zSmVX*jutzXM7?&?U!7mM#>fWQd3s-u`3BqX1;GogpKDTl_!EyDG*|;=h=K8u;I+m_ z1@Lpo#8uy+y8PSW(=!Jd%Hnnn^TWW6sWH=7 z^-!?!xC8Nds`_teShg#<%dGLS4)|H{&h6Wd`Q)5GReUgCl_!W@3D%A=VTR&};6~Nt zz7>}H)!Rehh9v*|@(W(tv9o7PmXQrA&z(dwKi^>cy&$-u_De0C$nB`O3#{>5dS0}+ z;-HixPA-c2O~o(s{Q?*VLFAC@#ai-2aI0!?-wMn2Zq`NCc&P%OuDtBK7U0+Ixdxb9>>Qf~%y6YfzZ zF64I9$}(%*w7EE1BtHMgr^#K`{&NPs;0DL-DCXYCvA+6TjRVKjoKU-s|Z;+ooJ`?D=Xv#(Xv1Ao!8nJ^O?mV*Iclsn^t} z7&F|BNMy9%9Nmxp22B=sI)hH*pwfrt@GOFMZtXudbf+-HOih^%NOr%va?IK%yZyGw?<8yE4FxFUh8O>`OS^rfO#~<`{RJ zUVVIyqdxcSZ`W2MLyWh|>#XtC<=SZR@x=SCihXhI3A+#0HNkjezN()9LK=cM?E}RG zDx|GqsOpyj9<8jkmaaqDA4)Eq2fS zZRT4i7*R3an6IYLgm??uXWbLLF=b0KQ#~a3D*a+jPv@$zrS6pJ|EIaoBb`5|Ka>pLUy(f@vE%u zL-~Wz;>t_D*;|Xd$IV_JS$j5wsfA{6~jjz%g zPvYTdQQ4_xe4F@5*BwU{4IJZ%`8qf7-)MN+N5&5#bwuFV?#Ypiw=R!b3mbFe;jlknOqGb2#cSfGH zQ@_-2-5R~0Spm^Jm>?j6d?C%>=D!}wypDrMv1Yv1et ztNFDG6Q+%3t<`1w^|>nKj_p~+v(|Xq2|Uhg_Rzt3B{Tk~u7_s6s;nS*lh@V%=lhw2 zpAj5QKRE(AL?%&hAluhi z<1YQBXc0f9wR=&?ZJ(*@rkStmx$$wgZ}vYUwoiTX=CF*jS!=CvR`qhU$mzAE`nTbE z6V&z7%s0m#bRV{cwbyL^1^TA7)atyGDo3y|VS{W<1S7$;)3`jj9^JUk8fWpZMvKL( z4$4hE?aKb@I%?*t(lvoS!+6KO*B`A}=>5@B=z#kT+h4QBUHbZHQ8pp(+MUTm z20b-aw+g&|pZQ_nF4N_;=NWG!HOYEZRfdL!+5WL#AB;6L?Y(_}1q5Jx41B{HA7!sc zi?(Y%%R2qhC&qr%TGtkR_m=j*X1yeIw;D**w{HJlk_C?L>{v0kx<`^fX zZ(HM}1~|$Z{r!`t&n#K-a|gZVZj1W~C(KuM6$B@8`+Be8r6IO}?F!?iA#tht+SkJ} zUMk@ zI1Al&Z+32j>md@0h~|;_d8#r+!h5a(880=PtnrfgUbKjM|FCK8MQU1=(J^4WFkh9# z3NH*2+7F~4$Ki2!8o%8_m?7*ij#T*~;reMnZtwQkY>k)V_oKxl2QO>2;mlfK0oH*mEVKA1A<9m9=mqh=Xz^-#|F%y}Y&+l?@X2xg#C)9__#fx7yK|k{g|>`*m&==5 z;3zD#r8_*?*a?CTnk>xs=udC!6HROZ`E5W;)P@INUpTioZo zcI`)5-_S8RD)02K@-;U8f|d8=Tu1gohi9(K?#V%mVyG=h$zF+j*$$O{62cDQ+W#vU z{n zU~*2d7c3karhQDP!#=XzqI#Z=BXuWhJmN<*fPOKQz~wsk3v;<{k8>SBslA1GY($5z zcB0%*>@~XZ=-rR>%Q6PTe#HgU?_xeKH#u(I!2a2|H*TAhoRaA%_M)F|&&zWyapX*M z*b7|+6Vsi=j=aKSZIfI}Qqsq3@wo9Xw|hE}KyX8K&-DL}Fp;=TP zB4jgwx196<|~ z;97tPH_X?V(qApy94ieF_^T$HHl;&2(&vs{8JGw(PxBaY`tZQz{)LoOgAe6;M8=hT z+~7p^^9ba2P~tDvc=G)eEnfQV!l_#y?lZO{PjYB6%LMUsrG`LJjeI~cae9@Vk|o;)RItf z#dSKJJkX!1`V96)SnfY3M8#+#BpJ^per8K?ERM5wbrYkGifvQzPqgr6Rjv8)i@Tzq zG9Dz`C+4ep2!Lo$aixQg#-Pbr;Yq)uasMM2t)D(+Je4)K#?v<7t>nBn2d`Z%o_yZu zKQo?~ucqE`JY{%G@*LCMId(5$>fgo_=O=x zUjH?(#pm-4$I~QxiL1!VfRgL!?cvD#-lkiQNIz@{%j1_<;q&>1%bS#)jm4qPxz0Rq z2}>=6tmnkm)_V4}j1f=0`q?dm);w|J8A?6Ce3qB}hRcob`nv7T05oJH6I*~ zV2m|k_GSB&(8(G{6&--1TWl3o8xH#9%)|6}{5UfB=GcS2w;q62Sp8|foW3qz_c)E* zpH^k~H^UK}>DrdtQDt4MakUM&+f}~foM+3rA2Zl^Sd1&?tIv>8vFG+lZ}Xwm>hPe- zYYaOTdG_j4YP@hYqVkXXb+g7(YS$Q1(7$>4j=9zOv4#kYC+4e?H5^a=We%tlz1WM) zYxj5^Ih@X(;wyqF)?m~6K19#>DvP$p7fG_dbkXLAU;J+L)gvjSkKrCJqWpZF8~6`` zFLl1L?zR-7k?m^>> zmmGE74LqJo^7eqd%$G#f4jU$KU@TSEYk6#Fy(a(Ux_`_aN6q1JI+C*& zqqt>x6T63&x6i`|efjMvi|=K*bbAsdR6d_?m|o3eKoqCkzT6pxy#LI~J$uyJu6M9J zEU(Jv^9_?X_!tnyE#udBP-s1mm~hO3OYi&kE*=MB{4$^AWxru^2gZP8Jf!ysE$5Hd zuXm1`Q*P(+1(Ne1;FtLsXM*`eV@P#4w^7C&RfBf&gb}TdmBe}amZsxPR><5uMzzX!2!PEP~ zvOMv9BM3xB2g4 zuOM=yp8@!1zQ&aPg2)qK1@wcBT6M89T}jzq=VJek4nD-i^0^NQt*;523$A^ndDV}q ze9V_b(+&f|)TysJWupixKrCOIKB47%`bf{ABhq@!Td$?A>yO?BV!pxldqLz2umbus zD-CzcII9Rlu7?+%cjNzUpYgIP7xVoB83zF&>eQP_CfVL?i?h~K>Y*`WLGz9qE_m;h z&K{#d%>6;;hapcu#DJdgEDf=+Nm|g4jTjO80Bm}$jj@l2Dyus7MP(@B>Zbv@T~glH z8c!7SrL)TWUNPaM)qfbuCXd=t%vVznfTvD;hlQnTM9lVK`(f5{ruT~x_Z)xLxaC8} z_U-+PE)nCN`C-Tz5IunVpis|rpi{ICg^GLWl5OE{x zpdrUKxS8>{eV{e|(g(zdR_(rjlb$aF=FYFecx;|@9#T)(l7O|FJ``~gQmmZzVp2u&U3^T zvL@>GWxQ=X+8S^1N5zPgyBw|u3!d>A(++;TF<(uo3Gvow-+yJB6R9`Vr`P!58brzV zEj`{EZa7pfO%!4`1GIf>vFmc=xzv1`Dsr$H24PF?=?|=g0>YX(Han! ztHk3&=O?lE1qXe6aZSe(!;n&bXq^D_5j44`%TMUKhy;z($W z%yi~CCff__^Bo@TcznTPd!7?79ywhFN%+zT-Q$A*Bu`_Ek5gXurrX=;H$~nn5h>%P z3V0!x1fsmE??=+P$=@%JdhgH6CY@y{gYXg!)G(i}ksaejnqQs*fGh@nU2ccRTM`%> z3~P@ec|2c?u$DLL#2E2>hs2RjWS`r5a8F$-l9%2SX1**d9oIu%%XM9iiF;MXaKnsO z_QSpJK)6nBuU3V?5$PkXZ0%#qF6p|Kb;EX2<@5PQ!BLR)cXD~n9chh!l4afS&MVwY zUTMj4vD_-3&o_?TdZDJFTUpO>Cxw>x`#-jLe!udX6)X?StMd7L|97|yRo-B9V=+JUMn3=TjzUG4;XSrBzmCxrn#fIs*_By_5B*1p0 zCJecU6`pnFsKHNUvRo{;%IEWqBX`~F`DA>TCx_Piw!_DH|F>XSaf#BdWj@Qzem&%` z_xg|Yl+f~?R@~j&;`~?Np7pgZ5$SsXtO@g3PWI~|?;ee#)gU3p%f_+R^2d*f5#v_& zzH93>SGF6b14Xlg)GlW}%guh1${)sfT2r^@33icoIzR3D``d5}<8Rh@Yy4G>ixDGt z#s0l<&`j}~@g^6+knqQRRf49)U-;vmO^rh}-}MPcFf7DoD2#EqaiTR2<0r(3&pjV> zAGYl8vhR&~5XK?%RsAibux=-bg~?Y_hD z&wN#~rpI0V=X=(LkP3`h)#!=WJ$~)kZB8PA;K-x#d**9Q>2IB%9!1&SyK5uV3KHphj+$ig*bgEfT!Q>in zi)h^<_PZ&ZF3Y9z`MiZ((+k{&WRgs>JYA-RAqX`B`MTvXmz#Jj;G^;@ z&$H`sb4;QA`d%M8#>f>B4eXm5*pq%mT{+oXzSFaa|8eS`l`S@Bvw+{CcAPRWAp6u>8fIo zY)?totZ(+|y2f^;h>-K0HQSu;Ryfxh)Z;L$EBo+`qkG`|M@i0kAFbaof@PxiJdI;A zA3>7~mhaI;w6nc_St`7`@@uqS;<>fQCu8*�tH9%(SA?N*O=0uDQW8e`k!kC`og5RS}N1-mfOwS6}f2Y zfr?$52|{>J8U82T@Yk>(o?5-J;}hIoB|i!+R_4<+vIDB-VHu_^gZ8|36{Hk-wB?s1 zp>ayTx)dHiKX;Z{KczpMpgq5hco$^;gthT>M`rqKXLRV7dJY|v)1PBhExvwM2qS&H z3*(m}(^Zt6OJ-Hbde|98`i?$VugExP<{FNl(^vU?zK-;1jKHf2U|cBoA9ClK^&n>V zZ%KG6v&V>Y7oT`K-LgJoh4Y-&ryag(oemU|<1lE0`E-r!g32-3UOXhlUSgZ+^yXqO z^;Bn}7lSGpB?Z}{1~=1lIj!Hf&vHDJ2HA0{!>B$ZyHDna>O5LE+#56qM8o;4Q=G4@3vp6U@L zp1U6F;nSOm_}R@x&ZjNJBi&nzS0}a;XZ+Ghlvl-y^DjSCYPw0B402)4ZHHv zmM1>9{vTOB(i8K;lFt@eFd0v&j?j90`PD0aDEaxzmt?s}Z_E!%F4mi&r^$tL{o`;x zM8MB+n<7szJ-u`7`3avs^4qPlJftV)tMa7V3k#RHJUP71-grhCFd%3zOfPhJ&~WfN z{1!LEIlsV>lZFpA;1nX`c5L)1IXklEne`P+zRZ!`le#}RE=`q>`Ko+D@s5jpAl8eR zAEVi`YVc&+meos$8FxK03T*LS_jO-vnLm`wm*&W)_5$+_w%<#iJ~;`m3(ZHJXU|Kv zyY2Yi0|uxag7=+7XwFhnT+Eux#sk#T|o8FP7uF8a^2VgzmDuVDiJKr>3YI`S_+@f8|mY15g^53 zn_l370v0BD!=S69YEp4ZNP^Y4E$oPR#%ss4%5lI5+& zd8(gSUtCwo&-2@KcgG$dez6#rX^!Pp`Fx%p=VS*)^Ro-lpjzyt2D9GiODmY~LfdbW zYrZxtNg2RRJ`g{@ET_4jMCa#$ijP8Fe#%2H;86VDZ}rd@Mo%3^$K+TZm9L)_LTcf0 z(W4TTSyTX7ASum?WZ0olYFvydAgRzw#d|qMJ>x?}ET32qTE6?vUa<4qU!DJO`YfNy z=kwO`jkbHe4od;$daw-gg?gT!%--7Kh+AHn&*`&#Dxc4DyEMg_lL8ESTqOoa?~rBW z7I|}AOA1W5>aoyV4ubV7&hInrk=fH`p~b8_mP6(9dBafJGIH(cba5!HfCaFj)0nX+ zPb&>HB`M>4CFBXEmp@;5c2tkqXRYJ(SRR$n=UIX};{%JQtljf|u8ywLKvKKtsB z#NH3&a(XO}%IEVT{amQUsL`SArgj$%hn z%4mE(y};`z_AN#BZT-M?b9r}#r@N!K_@IIN}ywMEQiY1 z&kAAmEo{ko4!dWx$F-yo_A15hwc9f7g$uPYktDxtxTzGx&uyUFED!fTe0XlpZ?6IWj8L?<}M9x!j1NZdyCV2i#mbym|}iHT=- zYfR~HT>5k#8KWU5FXpASA)OjrL%6W&7q`SU)GMdHF^vg#0mXu-e|!XpK01~JngOD= zFfBMBL){ia%>lg)%7vUXcXlHB%GV>p`H1ihMEEBnJf^DcM%OD4ryEYzkxug7OpYu6Lh^@W9--@7!&AjrPPhbAOY>25jh>o#=C_mp| z`#sVt2*r;E9WxysEQQcUhN!zx6nI~_6nC&3Wr`g12+0P>?Yie*Z2wyRr#J1O^vRJ= z<)8T)Q~D!0lBSHCGzP0g+-{f0TbMFy-1s4Lw16o0Zhp1Y7{j3m5`c#AJqlIXh7v*_P{WIY;=buU&;o1FLl(_lP zoZ~6Z;g^5jZ0mEL$5b3JpRSP|r9WoeBrI=m=h;g#OWY3qY$-g>cPY}PXPpG1`~-XM zEl&LI*JkI>xnIw(ejPn`=HoV#^XEI+UN9!VC=Y#9fFQ&Fp1EvSb}IP}_S`@J`llh^ zclh{k^|>?OlsE#EKAt$5Svh(eU4PuBc0g%S=zQlaKBIEPrd0$5&GGYA`FvhW*NM)S zmshT#hiXeh3kvElG|B*4P35?O_1|T2XgLl)wqNJJ&tImENm5!Yhsw8>Bh~K7S%QXe zZF%J9F>r|)hkX%gKTsLu?AdM|nNhK1?ywJjw|(`xibLkpHL@eUj7P&LZ=Aab9Xxc@ zbu9XD5$Pe6oo7t6!S!q(sjWnIpTWaA{oiib83r!=4(vpkMuHb z(s)`um(M$_(&Oj~w|_KAEpErN7`f4dBy_YdQV$Fw%da zdd>Ik7oP1e-?|)8Lgljvlzs-js6E$(Rx_Bgp4*g|@yE}b9w66;|LgV7<#*fL^Xo%e zew*Q+`J4{>T6zne_R;q2g&0@x8$!7ru0G4$zM=U*lC2WC`st4s+LlAEDJLagR-N_D z=iX!Vn9(HA=3AN1>9IfAwZLT?L)%;7&)7<4dZBHGb1B;g7d1_^HVEmvDciw1CiFQ4 zDo0eeQ@LV$Pd*V{M||=rOpfoRW9G@nGLQImIf^IZA{uC@1}YE%+oxG)o6Bw73(d5C zNjh52<=3o!htjG@x?%c&{H4zp7zq;&y8+eAH`snpdlRO}O>Jn~B$u&5)o4v8V{aQ; z3!UjgWfo}Bk*P4vn`{q5uCwyL^%dUx)Q9L&XpZEf??^D;VEetGawWOldCqKZ-h1$s zvRZ=4?TylNLhGyj&0{-Fbf0|3Oe1BMi}`+mjDw(ZCFf$$2wMa>Ypbdh_wn;vSsIXs z+IQvXoN3BDH%7eFreFaj@zwHmRcoIqeR&K8;7A^tuV=o-l>X?sf&5QLe_*ugc?Owm zu@Vtb`f|I2(hj$sLHz=1Ur_s;+7;BMpnfN{A^L&(gN_8*KvXFvfJT8*Kodb3AbRHW zK#M?UgDwRTu2+Jd0&M_&3fc+k26=6u$siZ#TF?ui??G`ezOz8rfwq8-fMG8Ny$7Ox z?R}ubk+}y!qmjX{LARivI}eor?L=@Q8ZzV1m|BF!)YE889f5|_<7h~^(1@CWN8?80 z>BSz{0|gDHzGx_o>MO)UhocQRP>8#aLcd`M=Almz;%AIo9X=ZJrV6nv9sTQBLhQDq zos}oVm?eY~WJBznn1Hz!5-nz}=pH!DL-tdHt2DFE>|8JC;M`^Z8J6B+byHD#i_rkBwo-am(xrejE|k?{KXVjC;wC!awslefFum z=%tlvW$eQ;&sm%XgIbCUINkIM&HV?eUDR=uK|Sv5`ue#GPR+hRkNFtbz>eaWcFfng zfqx@i%pvKoYEVA{BkMu?5gRWyr%!bOh7ZMN$TcE*!`o#S#fZ@p#ru=yT=b#w$^cT< z`w`3!q^uvQ>FdQ+lVvQeF!UNXz^rO|kn1&iwx|}g_CBftjF*L9&vn7IT|uY{8q}Ze zhx-o$q1w>KW=SVx<5M9VJvZ+6keuX>hCU)Ld<~T2QpSH)S?KaVW5b|x`ycWrsb6#C zQ$5LigYEaYw@S0$#$ck}iOq4O+r7EAezZAjQbA4z-sGicEz7e#40+z$`s?dsmJXw4 zjpkS$<{NCk7gC<2`SU%F`KUff8gsk6@)B$Pl;M2AmVR${?)G3N%kwm>J@EPu^ZkMt z2eLdFMV@)~YzIr=@=$%2>~fb(b1W*tJXj$n@A=y~1988M|EG`+rzxl5Gp?g`Jn5HO z%TM>+ef|*_T+#LOm+6=s$xr_(pSa{g%Af8mcH~WVEd~I_I`go)K+c8vyP7-0kWXCm z#pzF;T>877dO$vv&*$qSAKB&{Y%dv1P9GxVa#C?wXgxmAQJk8THfJQu!Fp8rd_JU{ z(+eE=a~(NoQcc4+6jteCftMqoOS%5+a=E!4L318+KA1B_XM^WspK&j`xL3_I>Mm%G zUet9v)xcBSFJq@Za?|B zN*6|4y){sQI~X4oS6ky_C-5_W{HX6Xwi}d{d8n>%st3uQFkcm*PJEK|nJBxmnV9`ZGtusYX5xX} z&BQ7Fn~Nb+n~U^wnv3@yYA!zcq`9~{riJJ>sfD=kq81|hb9*or=V)Gg`&&^W@3c*);ZR(i z|6}`^NA2?bJOxGxj>dsUu37oZ!58$MVz%SVmy*^Fq?UqHjhVn1~M0z0ofbFkuC{A2r=|Y{iym>!9Dc4WAHwDTA=}T?*u0whGuvPM{ z-M+Z^`N~strEvYkd{tHE@}Mo+vf-U{thUB$J%Jvh|HX}9_WMqN{1{;Edpvl;M8xeq z4fv2W+wV3vo9(v)=jMUr_f#%en{(?;clKNWw&to}zws95@hV?GYaX{z?5DP8mpzY0 zuSJ5sJyP3rB`+T1uz7aQ!dx(cUhNf%FE7cFS>2e^_AJ2FK$n$ zd_Es$xgJyO_1NWdEw_ua?lrfIOV_NAIu;4kK;D1S?B7=39U~6?{DRZ_)~uNP3B66&h`e9HfOC)qWz?vs8~!{Y>>R)y?RhY5hd1`)N)15uoEh z6F^STwV-!FgK;yh89N0LWFmqpL{Nzc&O`)@P%(FkM!XmdnTU#fJk~<}G70O#@-Y^8 zBi`BgAI1((h!R&;MTtw@7zZk9F1mf)LJax2m5ATcRxJL#qquHEv^cqIZ}I;60piU0 z31Z2wY2t=c7KtSf`^1~;KNp{WGdha&SXVz0B8KHCkL>6eqH6h`0{^{ZqCP3LX~u&3fk=-OrhYZ`xk=AipjjXck!fv)aqtfmCzsRs zmF99v*dtw)V^HGRp+{f66Xm64;;Q!RCg0j+B-YcBzI ztf!+0uSmU=8=ika-FzyV`Ra*($P`8G?nkglINoNxfryZ@3H4=*j13M-$Zs&#tY$@(~_b!kH0=>EjQiw?d~hv zHoLI()P6=JEG)|Uu0 zWqFgtsq>JY6_rKmGjn;Y^Wp>WL@DyjIH{3vLSv+Hx3|{b&&V2scd8eUsv-4w9!=}` zhy9T!c>IHKLTF*W7L@*i;AC{3Yp%A1_h?)vm4r zTnD0)aT5QiHBQQbqqon0FMjD+&daXot80sK!hBVS!EvJXR%Dpe8z=o~rXaXcC$$RAy=UZaNTnqW@7F4#2@ z-hW>MrN{!8SKm|C{i$M{fBd}*{`@Pu^_%(q^}JWZr}D~tRU=ehGd=c#Ld>*ky+6GC z@5SzE+<_Wsq|fu383=RSa$It|WZg4nyQ1#fIq>Niao>?UZhB_PKU>Z|4Fi!zoFpgn z<+$m%ww$y?GQ)|T$|u3xV6Q{{4j&4JT>o@MnAXrxxuv!SwLLn4hJxMztw$gO*DM9C z099fzkcL(c1JT?qwOOc4Q#q$NXg-nRq2VVwN5^!I>Y6wZjZt!XY!kqWI70*SxW>-s ztZ_2y*%)zpi&-V@zPe=7{p~N*Oee2f@&(vVj!Z997S85R2dV=!SrcwxTI z4g6*nM2?Q*Kp0xr;-R?+;?Z@4og+XzKS6wQ90&OnKRLn_T7w&@{L1U#Nd~gpR2IojvrWfz zXsva(RQDea8VsVg0@?0ypiEFUs0ef!=x)#&(AOZ^^I{BW8HnZ(d!rDRf_?*?2b(bv zh3x-8n;^(H5F{Q#JPIMO1YX<>Ar6Jn=n3O-8yXiI(2#f@b6qzcfplP8)*Pqn52mcn zb?^`&YzOh`bY#C?164xiV<6`@P*@Adnhn1gVF&Wi4d-H!uX7O5OSpCcC=E0K#B1!y z#*xl(xnJ*eOho#}?b@@TFkNR%?cwOZ@5+z`Zntk<8z={)cXeJb;guM1Z?8vei#k2m zil;TX957$i2(@$4@RDx6+g0eqmg%%FG`<>y*Ico|w{xCT+oTLP`H-MokKK8^-gZ^v zi-h-%2Fj5v1mNqC|54fEAp z5Ki=Uwu}{ey)1(+Q#2|T@V>ius%di7O1-nf{aNMM}?^EIaQ7aT7-RIpuwwoNyG=sz|sxip*nL8&g0cqt#3^^liR|K8}@NJ;`TrTrMQRjv-3?e zeiA26(#Ch=Ug;#V2YmVVI^Zk2@}q%Ae$eg0|Gj;lmfC&zCws$ujVb-n`&ruJeGJVk zw4t>&x~Q;3Ldd=}{ws<7uN@M80efu?AC(8P-!ykjZ7%8q%414oKhfOM>?j=*Q7P6- zG7chczt@1=j;wmeJpQo`xnB<|eJe&>IeHbDPjTh)qjqliJX?FWlET!Eq<@u9TyoT( z8tcF)s=gEt-(heSIJCF5XpfJKqPb`y&~-c>BKM~V%Y;S3CAZ-TuY_-E-%}HX#yqGW zK)9xU7LA#aU8nI8o>w94lO-bjQ+c2|fXYTs5RIo&e*&)_YGZHIFQa}!9H=j-ALua9 z;h-Zx{Xqjj13`m8M}h`}XnY1kH`;r`$H0#V;T0XNeKi#RaUfFF2_SmMlE!jQ1Pup` z08#(%BoMl=;$%=FC$^|(=)Gu2I$^+$t zXbj5*a)TCuJfK1lJ>(+LV$c#$F{lKz6m%x&EYR7Yb3o^UN!cebP?!c zP#NeF(50ZuK$nA-gRTHw2`UF&1-cq^4QK`ETF`Z%>p>Nu8$dULZUWs5x&?GA=r)iK zbUWw{(4C;WKzD=g0o@B)3Azt-Kj;C_gP?~%t3VHfDnYA3kANNpJqCIl^aSWhP!;GY z(9@u2K+l4n13eFV0aOio5%dyh4d`XiE1>z4GRck2Y&Y*K$9Q`NWf*zf~{ob4B}(;6r(MkItBs z#|9^zax&3==5k{@*v=}H}KaFV<3a@ zyr3ZONx;_xl!a4)AAtA+fGzrVU4NuwBwMSWOT4CZu@pJ-Hy8P$@sUfAmlP1~&$1l( zTnKsx`R)%IitAp%i=*<+OBZG~6B$kewL?93%qw7Xu?5 zK(x2*ZNSJCAZ)84%5k3F(Qg5I3D;i)It7$s(DCqxf#N{}L2;k~hEI4w(b4KTc>9GT z`_Fh8xWyVTWt(Hf^6GClueE)#RFwDtd*az24Lfln{F!7M@XVKi+JVl*`CWMK-+|r*oe63K zx)=9e4VnugdppG-vcY6K$c79B9R(s>91S8&kl!D4q~SCFaD>Tj^#l=S*v|LC@&4j` z$Oz*m_akfEtOKro8hM8&>Wncj#N549Qvuhv%vbdi9&S<`ZrUubARAjK7P|5l$|g0_GT$Musy*MTkvc|ij} zD{<~D&^%BAh%kfdRKrVO_=JtaK!jxKX5+ef$_6)t2KVwd>kX5p8oR-)pP#pe(ov9X}M?oFke+k9r&pY7;R5{#rPmH z6+aYz6bKN~+HzD++yJ^1%vNAt0Q>R@Y|c%nbKZmfp|+O`_GdHrv=`W`xUM;<0QV3^ z4h0b&sQp20Kz`O_Gte~C>;`Fth-?V?oj`OgVS(C@NJ8uDQ5Z>TVd9Z(Bsr11h8;Rb zJTw9K8zNZ9NK~|xm%3azPH=f%2YJaQfdKhh z^Kf+Tnk5Mfw%l|63HMO|j;^EcTQFZ^N`Ew7uD|~yzd}Wy2=u>Cg|`A}+0k?|>8AIi z%04yg7e!Jl8$J{^+Ann$&gTy9x+~?lAODIo^7ssV(l7HRQM5ynM;p(f@1%RMQI@^X zVN1i8q&+k2dCnYtcfn+P5wDkv$6c~sZ$g;UQsbs@8Hn|{?W=%3sSMNmzB%x_e1`W9 z+P@cD^?8h#GjZv}Q*W{_dyBvWM|B#>&wPz3{gM3K2=k=OE41k^d}S0BYBg#OZ;VK< zXOSFof0kq*`$P7K>ZfQB*)gii$fluaX>}Xrnd(Hs!6eWu&^*u*(50Z;LC=7we*GIX z5NXW{gQ4pS!!`-_b|osvlVAj6fYAh$izm8b z3`m7TY-M`gBV9y zhjE^7Fb2{&N*p{gN_^_Vn{p3Ei6ngS`lIA#V$&Vizpra^vHPm#qH;hBv29ZevC`L4 z+Z1yu|e0w>sVr6==2}o>mtS=Alxp4j_n7m>l_hj?NQBTtox=y9Q+Y>igE( zzPi7T5uaXSzo6if>xciaK-Uc0SLUnws%>BKndLz1lg(?b_cV@EBT~X#KG|1J`-3o< zd*njJTi-|8+i4F^d)-#zeOW2D%vZG&wA>mE zC2Tc{Em85cT;4PqH>>q7#mAT@pNPsLwdbkcrM{TaMAP_mj)Nn74ans;^+$8R3{82h&6rHt-%%B{ z?J>qGjipk*hWV;2{&g|h1~-fCd3Ze%p9%BW^zUkG9d(B%(BGv#iQF%vJ`Ja(#$BIq zu@NtQm!(?CCs{2T?~%XXeZpIJd|u?6eIx0B9F^r3_-DSxl>W$0&2-GI^#$)zT*LOU zW=Ft2Ql8ZHu!-Aa#OE`dubwx!=Y{;P89rC9>6iIZlG-7qYkrSyngg9&t-n}^D}1&sitP+f@pgr_rpQYPA81eXaLp5ZtJLAWEgYEa~wAV@5-XeQmz>3ea7v*_{ zsKK3NU*z#9e%|z~>3LCGi=G{|wYW|po5SPg7$)+MUD0?t<%-6ydVnxoq>W+qg?~6` zAPB=o+L{4cCqQ$7qe0_AQ$eSKazHN7nV>Szb)b7dRiM{FHK3g!dT-?zP#VYsx&ibu zi1dgm4I@xOl!DlPi{H%kBj=CDE$RAn&yAw;+^0x%%^@nds9JoDjX$m4pwa3a*L;1* z&o*W;Mu7QzDGoUO(lFBB^5qBd_uk!ZH{Z|ct9(9RSNgVmd<_^Em4Y~Z@w++y{QOce zm-pC+4qs86J8a#)^8RrAQ*=zOi}A1WH8%c&q)!IQRb*(O6xVS2rD3F>FtFy*PW=yh ziR0(=RX(4uJAGXPgda}7&CbyI-*w`t3CAzZCdg}!(^vU?-Xi@e^u5SD<3d@E@-XD+ z*e~|-{$G!Ni_>8_R6d^%DTe`wa@@fBi2H*|YG7U=nEko-@l)^ozuos|=;`ZqL1&Z) z=4%m1e|6d)y}d}-Ky~G{^DPxPV0o$_58*utM1HXH`AOfMnRooX`!bx?T%7T*^7XUk zd7IkbLzAYSwB6bR?O0i^^gqpdQr~Z(wDOL>>&oLU{5G4@jnfX|YVrBJJfBost}(^5 zL7cwVYI2^_?dI2_Oyzl_A{T!rq)mU=N9Wlz9WUN^;Ic!?+a%w?>5^VayDFd06OK|a z3uhZ&Fwcb#*X3b04sYJjbDKX1yR7F4Db6x6yibZ)zMkXf^i@8ePj%Scn1q_= z%%d-0jxWG5sRFw@*yrXsa%@u^-X$*2!VHIJu`?TOo>JV%_(}ZBj2~)uP(4Kxz*~EN zzqJPPe)atF4eMqt`eg$(OyJ%H$f*Cre4QKkpE7lfZCYlgEp2WglGMM|>?-n5(wfV{ zKc&y}ldTA}aD*SqtDfJ$@en#$4=3YrGxA4bCxIwlI;P~Zdg=Rt;!qrZN7tnfRkhnl z$K>?%qiXT>vsjyB9@bjT!{XlZuZX7*%-S$HB!PxUXLOvQe(>xSsIAd@Ta$kMN=O z=c(vuh9fvo!o>+a>p0MfQX1-^A)3nehY3>=S3eE-a5>j2JDXeMWLC3S@n_ySpI%(u z{0cOsHAnNsgcIf)Y`=$kjE2y>9%r`pK`_@sr(?3c0AGyp*v2`$$u43PX5c)kLG8Vk zq461xY*zt&loKu(e%gRfL@x5obv^8@f4P1vZxI`^-flH@_^(rUC5(f5n>QAg+i!6#L(5g3exmKo>1%G|^!56vnNazBo^YKqCBrt| zjdeshcq6M|o|D>fjy&glCt7f}6jyGB8)L}EtNyZ{s=|=x#H6=|jd}bZ{}2<)qw>R+ zXL>=dwwZfQnwuKBdg;>Fp>p}pYGqyiDXn&^UTX2j*B>9$(kOW39gHW)e3plOy@1=s zIz5G6`an}jhQnJ3JvqHjtan4hc>1>#vCT@h%lHhfNW{Hrd+Z+0JkIq1Svfgh6>Y5ZH4Eo$ zXI|6sv-391ps`SLJB@rXU*`t?>&%xUd#nS)N~ZitIZH$oa=s`}!voRQD_>=8&H17_ zg!)cAZxoO7Q&wCs?aObOyri@XvgWDg9+E z%EP#V*FKllbs9ZM8<KRZT^u>w!9@wSE`eg9e3P9eB1d8UnP@@NvCawb z;0o-bR!f{bOM^45+A5;BDPA-EwC-UEz8j$-VH8EzK zsP#@IaP-t0J5HN3<(W9uzB6By&5V;V#g6PE9?uS1-$d-Zs=-J&qJg?KAh#QfW39_C z#nS!5!naR(`OI66H~M{KZx4e7X1@ijL7g35ut9mil-b_`df;dwc|7_^Y(s8Hnab=KE@WW`5`hvvNS zImP|@^61-tdwJ9XPKV`C`FviLL+km_*NXfS=vT^e#Pu-iBbXecCyoB>##tYX=X6*O zmCxr@Ik1~|P*F;81GP_RU87HtLv1Hf+#j7&F#okXV(m1ZLXPBUg@5L2OzBURL;HRb zP3XEbq?qP&<9nL*pw_<>?YLD}9k%7#*%MCG6`-Zx8~@CglGYA`mR~UCeqW}isL-3~ zTIj&&oBUk1^|qF$3i6I_cE%r<@9I~BuBql|of-A_m~XKCp1D2X@9)VXXxFOk0B#48 zPvuq{4uEf{!S8D~Tm13$7MDa$MKtiA(|}xVyBumRx2hd;9}+9tZu)N6B@dNf@~Dwh zF1O5A6<{v6QgID*^|V`jC}4H<_vE^r%P*&+uSd{BTt>;~W46wHHMQO|ir9BmlaX*l0|5=l{k*KhtjjIkb?UQ~ zCHIdxeEQdh(Iq?D7uJ;dftd9pDz~Bgd2$KX@00DxHbt(iZ}s)`vs`V&cgL*xj_$Cp zot<=L$qUcY{5m<3t3CdiuQ8=RbxuP2EL@;}l``76RvyP%Ilx*!#fQg=%!PBu_x~r; zaeT5K0jY`Ft<0B1&<=y@2TZvgtOto6tF~X`2F8lx$5xh(^jx-uvG^|Tr}E2uHJ94_a7ucHD|?~CJJVT!{ff1%YW>+109potL2YiKk1eE8dLf+_XGUnJpL+Dtskk( zQ6G?WLu)Qby(ATfF*NCa2ac|z{v+K(M7pB!IP$sdGM|0E9+&v`!YWZ(EE^q@Q^Ptp^1r`opcEP7^13bFTwc}sG4+^Ov1Db7@270O z@SUd&JGdJ6Q+Z{+swZ=KHC9LZXYnyd0#M3!P`N3D%(jxgX{`&WsP$p1X&{3TIm7(!_%vzn1Me?1+ z3A#$CjF4StzN#oHx1q;%0wq{2ziNE{X1FQpfu@M_-_%JYt$j-a^0-CuaC7-p$3Hit zd_T~;yv;w|PDYPPcU*p%ujbBZiP55H)2L^#_E@;s4);1$mPj~!4V2{x6?W`vp#=~J;Fkeks!o}!38q~@Ota+kqgW*Gs!zx@~jMVpftF#YsV zdXzOj;!eVRy(8!65f6U9NVOZxS9K=gBh6iCKqRHefzJcvx#rsQ(u@%<6({w5j`h7> zl`|5y)<7vvvmHr1*^HBI=q%BDh?{5OTW0IVYx^x-KDg(K%MSa(KRT&DpD3a7IaL}* z)Lw5+o2S2Kh*umv^vYDBeno|p{$`|4b}0!&@zOE%*W~>#Hcgu~@ckCAr!X$ar}dM} zN6_TLe~)%Fw!oP0aTOJ4>pDvj3+tsU*{m1Z_l+*vi4R#^`-5%qti)Kc>EKzd|LUK( z!FVl6>xWXinfWH65a4m)jFLjUo0N&ojS$_J}>+7 zHGCZLBO2J>G*F5Rad}M`XI);~q{NC_zi!*>!s~nYOE(lj<3?0onQyTD9+y|_=|JC2 zGL==jNbT1~%Bx>>k%Nc^YH2|3*X~4lr8+DLL_Uw#_BagRl>P9HqbqSf=KZSwt*|@q zio=lQOMG~cvYszQd=xchpPn%hIU_kefPdnXF4=ziPecwHRRg7n zjq$sAk~KaOCdP`pQkP8~HoM}w6yt#%iu(y4%vXi06CX*1_yAPx@dH{P9>IsI#l06U zMbeCqS(8KCx1JX)dFX~|KQtR*6l^Zny$rsZlK?)n_LOelGV)wYj0@w8^vS*zBYlpa z>>I@`&ug@q62LDdug+J4B`$tD>5bFUZ;GR1a=LwKR*SEn)%$1EVa2w}*x19^9Y^cP z+L9d}?+k3xgB^}M$=F1FSo(-=MyL{L(k~5Qva5$d1iXBPSwAikt~Z33XtmozP~Yj(lI;vn0XPuZVkw| zO`mGU31F?Y6L!L%vwSICDt=wo;_+j4ySLFXIbGjTwfOp3yf=y$@&S$#8K5@2H=6G7 zX#3RU0LB1zA-zvafZ-O*iXFmCHRXRxIE2$<0p;x-E7{4_cL=f9sFR6Z18u^k-iG z;9t*HOBA)AN%aXyVUxc+%$S?Rx)N zZ0zrLISai0{cYvvwmA&Be*E<2+vnfZ=QdR?<~LBTahL#hlW_8L%R0l{pQm;)*-UwV zA@9hO2e&@yojY!!lW^om;h*_BH}KEnA1MWe#vaOal;@;vo$YS>TzntHOB-a$a>UKC zmSY>_JU!=}PpzmO=uqi>fcedKsJ+{ zUYF{}{7>(zMC=i3qv5{XpBp&Oj9=0-Jrmxqo>F^b;(}LiDRux!y6dHRy=w9Kyo?)K zyp^#ydv2=N>z2_hzYi;yr_GRu@R0-}EYLBvXLy}kCC)!IckBC~P5Npu&5MzX0}+my zPdwSF@?c|fZTJ4<0((B@2(n!s{lg*yag&VOZU}Q4a(uG91i zi)i4#sDV-lP34=`eIyoGm)kB2W5w#Lx(`UYA$c6vJ#o07$}RH|G&wG}ruMc`X6Zt; zydDf5$8Cxz5{PIZq5)9}9dLOqcbm(r+P>Y6@|;@w+^@^ud}Ck-qn_n;ILud7%H=gR zGc!FSV@5K*)Ix0mt*L^~5gDyq?B;>*fKG8aXa^5mqOHlG)-Ij!z%Rh+E-h*wDp0xo z!0C}VRJSrwT}(VC9BNLjTgf)4Jmb=cw+9+niF+7Nn?2TeO2FGb?@t&#I4mMi19-{Iqnw`Mi?h_j*saYa@5u{vY>?{e+|=sjH3jvx&K6S zU4$(6Z&BjrM{|xZEsPakR=yVVm*au5A;yDayTp7|ng-%%8ht>G;;aH$*(17!L?UdE z&wW3uHi?X{roxmDviQp>^hI&&A%oL9g-ignHt+|hk zf0b{X*80Ec9{S*C0czgVjLZzw2&*`#H`cKO9Iy?p1m&=UrZPU10;Nxv{Z6Zk4^G5(Cr$OgKxl&xfIPxJM zp>SUC{)YMeN~_vXIUq+qz2C=tjVb+6KIHEgLZ|o=U6P}4Ty{QPCXWN<7Mt~`KF4^R zU)^@)!!?I~Hm|@)gXTT7{*b{p*nUqRnQX_0{jhv&yxUkes;|-1?osDah)Fs* zK|5RbUj2lLgG>X8q9X2^)3uKegN4>grQ zSbi?+l>CtGqh}+pmtA>O|MrjA9Wyuv-7Ys5Dxc4*`7xfvL`TVFXCc1Umz`^#;ga>6 zwKOzN(>@wekyTp&TCc9yUcEY}`yH%*@}p2&GoP-J9m~bv|1>s%nCA74 zDRg?FC`X2?$dj$vT)IzwZl!02)>HhjpEutcyI}yQsmm2BR6d_q<qni}?r~PE7`f)P|7Y(y;G-(G_YF-fU_=wJVQ3Oj*9ZzxED1>< zkw5|o&GN{SEF==LVRwUxbyZXZ3yKB%qM+CjQBimT`c%XMK3gm(%3s6|R@A5dzwh3A zcIQqun}8seo&A0H-aRvS=FH5QGxg3KyUWVDp;mrb?HHB|p$i{!*Z8sLCveE4he=}{ znrhBDDq|pgH-rpQ^(ObCVxNfl7B@RT1%hBf^l8btvE?`&_WM0`^#Gse(3=L?8MqF2 z%8k(V7-@3jGCzCaIls2UR6Bh64viagir=bVwYEF9LlV!6UHN_M>d>zWU=}2K_R~0_XMm1g6US}BXogNFWiR)6!$eq z2__j!HVj{4oS$SQfAv;X*{Pm)Z@S+KX#j4_U!hyn$W_u!^k$K#s?6pAhY?|9#XRWQ zFxKG}%GoJhKV2$sGm5P9rJj@a9Mh&PAnj{@lSsY6y-9iAJm(U*pW(g$&!JBNx&wy* zM*v3y#{t>E5MUHg3QPuqz*WFJfQ-BWd;{zQW{w58FU)noOTZprt_YZGGg%Hs-v`FG zLYe?fKP1h0c)fw1BW-&c$_!XCB#m^xX(!O_qWx!-=w3CH4$gxyKmKk;t*;kc}I`LFjra z=;gr@ezS_Qnu+-OwcO{e^49pxS3~emZ6{ui|1|c^`V+tIv=mU=5#`gI?Jvp%%ZoZr zcltf$GrP`waj}#e-r4^Wx*ic-ULx%pb1Viu!Xi)QcxS(B3;3YP1Slub_Gy~__!kSW z$$9o|x}$l+6sR{6bh>35X;(>m2J3gt^^|s_#y`M=Q|>*c9GkDGH;KxH^1|~KFifC+pKa1S zxfRmw~y_C&OeK_glRi5Z)$qyULKqO6xi?m>agqXIc&<&Y-iI@-pRkvO`>vX zCjSl6o5f$kP`opO_``f*KX)bgVZ1~>q+e8mh)&rp?S8&@ZT-|m2OPEZM)r?s*bZ!i ztI$oNauI!!?ekVwdu*+S{89u&WX zZ=tJx^I7M+D1ec#Nzr+x`{wc;gj>n)jaNJCkL5jgHQVT$y0tVy>$-GX48Gq_O}f-| z_mcmc!9ZXV0j9UmO`>u!H0+IdVIIG z95>e9o~`gX|EAdbrgk>^`4!9l*Q;&G#pl}$vAs)uBlPXWX9ImhJ;1R&n(e6*bieff zR*3OyJO%#TDWJAr(r#{gKf7|@<^`>fc~h3pm~)?uVTDGQSX1Aq>yRRY5T#tISS3q< zQs{@hZ)YL+P{W~iQTubjTb=qwAD>=__oqC)>$Ab*U8()-g2^|iZ-kD&4x{s#Q&q|p zDc~^2AHd?j3O|}RO2Z}uf61@R12Y(Pyn+9vjYGQF$(@0-zi+e0zfnz7_EBGo6CLuB zep?g$f7mZNB=6D1r=9x($4h7)1t>26crO)D z<>hw#m#`FX9ekJ1amu+qe!LQV`_At$qjlTfubwo-@`dwrL-9{&+W)r(so zFN}XCz&pp}sbkdjxYu<2;9^(yu2&%|oH=Lg@}Y35$}%ku4vjnSLhCA@JHh(vhK`W zK4>j|Y0kPc-CzDE3%brG&1NmGubD_Y$f$BterIgCSqZs1pnu`dQ>Xu0H`UG@so#aJ zv#H6AxgQYMm7@K@a|^hiOR*Qj&EqS4lOki#(e?}!3GITnuOry(9L^krO3%%Y-?#)V5 z3rN4c?cGlK%^0w!wVntIZhjuQd~*3+(0hGv_+eE4WxcsBjYi~G=oU3{6+RsME+ZBp zL{x28Fx~{$14(_zI}ta3d!rwe6F-1Y4IE`Xn-A2WkEnoh7m(ZsVb>zT|IopS?|1d^Z9$z8Qs%7Xw$8Kkt^lJmKAHQzS%o>VXvX_b+zFIu_zrru?3E*Dn`0Fr@@Qv+U zVzaK+4+|cMUH%g9PckOV&$#4)^}UYO+Z950Foi!_`E!LA;Mi>m88nDi?o_{6zSOcN zZ3R_ta~zZZrJSno%X2I{aTC8cOaWDXH!g@RC%F$M8P$X4ymI8;!+YLpC%EWoq3aYsNF+q4M?Y`L$Is4zt6Y4ejUauVX zvuZ9__UwTxKIjfQjmVAAEo$Vd%gxCipBEpYacs#PpGkvLwf!f0gZ=1eCJ3VNJAa{* zU#@LR1X4R2hWm|fpLBx#jMrNi{rB5DfAfJ(Bm4^8qDHQb@EcxHB<&#?H>(X{BV6$`NPii(DN@H_6J`5e%)Sg7oIO=i*7hxA#|O~M$*H~zi4x7dVWec zjp=oj|7nYy{OkF-1^ll_th{YM|Ji*cZH0fKHsM)Ho>J%*HF9l6{+f>Ud}Y`)jjfSY`5yhKlW#p= zSAy?u8}`1Uze(3VmMhcysnAgn(3i%kgW5%|4MB z{@+&fd*0pFF#k^PspTg01amtw9;C~M@pzJP>J!hubkffSZ6*Ii9|~PhnK3^?JLBpeEUURuaH~{#AU=zpq+eE<;8f?DKBgz5GDUkGLGMWTww_J zGrrv4KYab*pCo^!-VwSU9bH~TOo}`Ko?Yj+4vR0Wtnn9AQ3f*r)E&xS(lcrQ>t25T`(+u1kzxiV=@p?nIcPGyhPZ2U zv8{l|mtWxz6ye+R-lhl9%9+#WKhHl&cYQAW&%@#N=R}p8HBHD3Lk~Xi=E>ilvbK-C z^Oji-d*T|QJ9%u5+!S-OFP=70inAsxu?e?>SznZ_aLRME?+kD2b-<^yju^d^b~Mb( z1926)NmMRP@@0PmW34aoJH}g6o^tZTwhXZae0J?~$-fxPF;}J6C*1bs$G!LmhHtdM zRp=&BxirZS2CqCm%>A2Ze@66DD*TA0m&g~Y&GY8l?#%C+z(2=HGJ(d-r%5;bSToc( zMeN=7!)F>@?8(1#oZA}EE<&}7J&qzi7j1R}XH-b-<5Av|U zwr4zMKizaZ-kz6rz^%7@m5A3&Bk_1gql^9TjfWCbeCcCpSBcMJ@T>AeUP1uv8K2;P zVvpmGhW(8ny>;kQ)yuCr&1RT>uw5i{n;gDvZG7_lb}kP0)c7&kD)J@u7Uf354hMn< zwI9&-nb`5*d+)w=*@AO#d~dP%L4P@Vr_;qg%j=z3;c?l^1U+Rq60@+2`IG@bEF2_Y= z{DI$$aGa47Ph88!*d+tpccK%({aCpF1oyh;x1~dfha074~Fb}vFSO`20EC*HsYk+!S9qRuN>{hJ0*2eUa$J$w{EUECL- zK28UY0geT@rs)JA0~i2MFAoHA0qW*_fSE!4JRB$nsG~;%Cj->eY_ygDXtEd{pd4W0 zRsoX%>g+RsGl6q}AVA%HF)$st0=OEu4!9Ax6}TOs9;aN0zMY0=Y45Cg*(pEzcwyR0 zNyal(F62uJ8fyL%o5D@pYK{@dcE_olM7izw~?f zD`7-@i$CqG6sSeOA}6`4t@dOFXw)CfCuEmno#8{(ZGCNDXw?p6(}0-}=2e?m% z2P;T?IQ-pj?+m7fyBy)tpG<&vDT~Ii7RJRJ|FawY%KvWEg+0Ew>TEvKNVq!PvPIdf z@K3bDO>?Q|G6ms4;+wH1cDbNmFR#03UF%~qzGmBzhT-mltI$oNa*4#3(<;SY?u!=Y z1@3}?guh$~pZ)2SIlGu~FUc{CH>aGi4o;2FF1+%Tcc!*VHbVSog?}Kz57RAj_!0D~L;My&&{(!1hBV z{Gr~FZeN|&~-MNloJ>BZT2^uZ;H!_o{~HFe-OcoK3fMlVR_61 zc&E;!+9*Ncfu6TVq!`_1;-)|%OPLE=;UhBH3&wiO`jp6Iu4@8jN?+~S3me5SGVQ9=W{WsA0A zxIT2~$LtE64G{49>a4}9s3&VG1FmdO8MX$;PT|h+t4?n^`DzW%SuWJ`4S%>`){!$G zPpXk{g)f~h_Kom0+{5z(3w+rguDZ6_!nqOH=F?SF<*xRZd#!pU1dk-$7B_>xd#^sP z=Dn+@d@bP%e>z?4w}HQt(1WS6hlw2H%A4MD>NCAPTv(rE^gsFFMF&h7eb|e(EbR(L z*d7+T@FjPS|B*)wM!JSzybSkI?ur0wJnre`tqEjKaaUAw1iq-c4Ar9Fk1^SX`c3?c zc4r!~9;D&3z$9$r#g5)KzWw)qZ6=~9a-H&SY`F=(jrQ}6Ge4V}@m)RJEi`u`fhjja zx2TaTzk-_op2=AWDK=pIV8Wj&8n^mx12)AbXDJ73;!joh_CUdos|M=yQv=X z!ZMl(@XoTP)*tg>pM30jsf*4yO^#7AKD6aU=y=6pC@<>11GXYj&bhFhb6i7}lMmo8 zd1%b2{jp8&#g_BJwMoX}y}GoVvCoKH%cV88O*t339!^Am7gT$y*dsFQ^9Jj{Q}80| zvsk=}-_3C&ZsYfDOMxI>6aAO?L2S9Gem}`r^WM$H4?p}{g9P6as5V}nc z-@;=jt~6IMzTv9OD_~uS^}J{l!-Sv&R6REdH1<1m-N64k4Wzi)!6~5jr^-KyEgvf( zKcA1ycyVCabEofX^EJ=bA41pJm3FtiKZ)DyM7av8tp5~~x-1+|Fb-!Dpbz7&llOJG znT2rL!&1hX;<6$swR7%jJ8Bc;hWU{R@GkT8@;whZe09$Hlz}aG%i}YRm468h=$37x z{qTIRn}gKoeA^C#xQl*UxxvW?$2Qn6EbN zxSWrtkcZW5=ry z_NQF*)VUu#e|ZJlW;6!@)Z0QgiOQw%csY)fGv~(C`0WQjBn-v7t$qyR4av8RPn_|~ zfE{Hibz_q8S@#d7;?bC0wD^+O-g##&^NWV}1YCt~Q6pE;JM8Zx+iL5$eZTTSdM5}V z!{3^9tdu2AcI*!P(d$xD5#}L4FW~pilXCqE=SsPTh4ZCc$C3d+Tpa7;HX>hWm=`Rs z`Zx^j`mJdB@r6D6cjPk--SMi^O)@Ub7eMb%OLbuOs_iv#<|YEY?QgxfQHo2+KegTp ze(IDT_Tea_>i$FSAJeiff9RXXr3jKw?td$E{B@W{_#En)fVor-`H3!2_@f8vctql7 zPQDnn+P|dx<#(Lq@6&d1mM+&qryJEY!k3kP_G!)o-IFRR?V2=%m!+I706#Rb@^h6p z^~tYikKxpgX(T^&y4W|uk2Orn&V$7n+k}p+lnwMl@JRS8{Jd%Yo*Mbp3!kt1fyrzd z;ZLWF{kHSx$}605lp{aee&Nhdwndnyvd_yp@ZaH~u2Z+S3XqMCH;5 zfA+9}b=G5Vm!ww1{oGjBNLY%uj`7rtuVSZb2=RJnQtq7t-@5N>#)*c0l5e4#MCH;5 z-?@FP{5JC+1E|b*S57UK!rPymgpgs(Z_ceeQzc^A4K4a$u=J{I2B&Fd@hRZOVhIvX1Lqsj^ET?vEsVpM(G zX|uC@Cc+WNUZs~zA@?kk5L^&6__$zmFM?x&eM=WQ5BqsbFSzBd z$LkkLnoGV4U1yQ`I%0S}+vgsi%g)tY$8LQERjd!Vhzq8<`5T1WaQ*PLQ;+HEA?WXw z?N+~){KTYP=sykb3AhT~Bq|qO9&yeR2S6X&d? znQ1IOQXA04UJoDV^$l@X)j4>e+Ylgp)PB=6A6K5b;D^%}StU*Wy1n^pgEMrN1k5Jq4RBKM}F9BtE}lQiVCgZ}}Ka zj@Sl^%aNYqJLkVz&vj~Hjbdkl6_)RnHfBP;9_)Bio0UH&84LU6f4jgxsO28aL>TI8 z>LH<RlP6Pf0j0H*nH!uz; z1XS#R|1@~V7t@{R0ER%AAsh8xgNX*_bCA9N@@Xiz0U;B0?r1w zPW)WpJRk_14_p9T2uuYo0xkwF0j2?$0@HyRz-7SYz!kui0Ok8C;A&tNa1C%Ra2;?x z!1m`2z>UC7z|Fudz^%Y-KnR!v+z#9U%mwBFcLH|-^MSj8dw_d^`+)m_2Y?5G1;9hV zLf~Ow5%37`DDW7t7UTybR8Na6DsJhwJ=AgxP=Opf7JO$z@5Kn=>ehRQ&mHtIY zYZpeF*BCqJ(ax*SzF|O1JL=T8oG%c%o+6QTGLCh_91k(aKxOJedatbd!urBYbeNPKC#B4$qX)E!zo_9?La8=%6>S1sHqznQU?x z^B2B;+-3Kjb0D8-gb$r=**3)oCMrB-_&g1R!elA39gz`)2f|nNF3$7`e%aS-uWf15 z!npQJ*OUx=cC+8JmyP`P*o!=$+Ld1t-e>z==)#ZO*?!L+T7(6h=KlM3wlIq<7y5V5 z@}7QYZ~~@<`mDO8ot0K9)q3VTlrP@nCY}O+#S{pFX(_Lr+9sQ_oC%tg3Cg$3k8MJE z9v8Z+@}-Yo^X>yWjg(iRThz!^$}8sa?LFo_Wz=!(d(or<3}5;Q3|IW7y%_degwOKb zoO(qcpInJ}{O5;u{$BzErrmU?)Y#@K`@;F)>A?^iOR*6C;QkBIbOj&Fk4v&5kg+8aw2^}%0hGNm0jSrwGwvxar>nJ z8&9Hl3KJu8!u-+CRZnS`Y|KCBg*PsAKYhcOnw$t-=giiRW6k!Axu^SBYzZ{BIID1M zT(&x~3P=<};+; zRsTy{^smZ)obPxF#8V)i0)NI7Q0uwi{?2+X+C0MLLpnXae*eNWi3{sF zj-Kgsv6p%-s~m^bR@6+&s;t0r7HdhAz3eXAQ|jf=z2mz*m9I^%run+*_O2JS`uDqB z`e2%a?5j?nyJ2nbDTu{i{IlZ5Kn=IDR7qEe-)ekzjjk zIXqvUmTdAN{9p;4xz0%4mt{^uzjF`y;AnngWg2T5u7#n~#h&~O_f&iFiEq^edmxfq z`-r`o9y7J@+rkm&q+~xRzBADCde(U_eRXel{(<2=0au}$MCH=R`f4i?u<^3r-h^3R znT7{RkBlQ@=T9ftr?)(;{m8>V;n7T{AwQgt6uM0g-y-}-ehl>C9Ih&4P@ex}kB{H1 z(J;TshpdzAhW`=UU(S_;w!|xdf z0uum!E1C;*0`{`OxbU60X?_Z*dd}#ZZ0>WF8RPX|*WbHg)u081(O1ZeTHJsZ(EN8 z4?)|W=TI8`ob?yi$Z}Y`5Muw|r&f1fj`weF+bi?N{BLJ{XA8{3wtNd6&K<^#hZn~+ zRt0c|qd9-Z>WfRYO_PDEs{a-vdFb^|rft&~b^dKO_-}<*V&%g z)c3H39{2m{ANB$o_%{Gn1>t2m6_RWu1WVx`!jeev662EHjr-sk4 zYi)b-zY+E<&6GD}TUh7H_a7h`vqz2Zd*;3GOS8miW0w0iEpJx*8^*o#AGV!&hoGY#D{XF!Mp$Z~A-u&o~Jf8ugXj zsRsz!$1-$t931g`|Kk8mo15pT9)Wvz;23~%8#m4rn1;VnjzcHJmJ8$fWVB~r_^{g^ zW1o?{>oHtQ+cn48UMfiQ$UrI)DxSK z69ivAZ^GTz@AZAYaKdvRdHSPH7klatO-}5yN@Q16OHfojmXR5oj}Z90ys%=#dvC10 ztH1s?1s%G-Av5xF((N zupF_yZzd1!bW1D*Rsdsxp1{dA`r*#+1os5m0up{lJkvjZ=q$XD2l_?7X-}i_r9NA> zf8DDppXFJx>h$|8L0N*r zL^%<<9%L*zp<7*#Fi#2k&hpG>)kr>*rpprDQa+l}Bg^1M*CW(lvGmCPuoqs)!#_oj zsP#)Q*C`*tO+U3TJG=vvjc)(jv+X+E-+jt^(#XAkI-zq`B2vjP-m&FF=q6FQsPe%9 zB0qOqgQx4@hH@EezctDT^Sd3uZ=;zpsC@=%?09ON)FTO+l#s@VM zt;~1IhwK|r_#VDdoAuCtQwJv-8E4J;V*FL#d6TSaGrTXm(Digu*ZX`aI(+Dgz#$S&>>tcj@wRs_udPU-Sj*5$Xr(0V&s% z1A=bYP8tam0+bcrrvtQSUyC#{&iDC@E`V7d(=YDPC^E%+3ed%-(XE7s$FMs-|D8<` zkrVl7JIpB``uJygL9+44=EM88>3Z0U1uHB?@&*!`?Qfy$X{E|XSdUIDnP=9bMdCPf7lao^%zC`}$dW7X#Z$r?{Q2_Nw0YDj}&JjHl zZ;v1`w$h-h64oOnBb;)gw?~#kjy^m4?l0bYe|(XQ_fYRsj|g24UX_!EdZb~)M3)!c zzo!0ECgSaqrc!C!?Spt#>Yb9&5qV+vBY53xbKk3VkfVdHy()G2$YkTz^!5Yi-<|Nw zU5{D)8=2=2y3R?qJK!GS_qgn)h&8p*$HnvQF$L#|+P`Pm89)&*5uiR;2y6fjfk2!G zdls>1itm#;?Uv%Edp9~ca{q!aeXhEPABin&TCoBw8EkMB{~ zqq-VM&RH38o#D>F_yg8%eXkLpAqae$f)_xDMq&uQ_OTj5jqd-Ht63| zo(cBFIsjrwi)QA4NFB+38ug_I0PALZN%SMzSbSgZcntU3_$+#t&k_#rL<+z%FaPmq zw%62mNTdDV(Wv@z6Xc)q%mjF6T8{^655qq0WA0yuN5eDxfxy%wKfjyLG?af{bvmgu z)R&QSbgTjW&MCIZrj~ruD$|9YG5RlpqR9=nxNWLhSysL))S?BXEb|{J_ zZ7uFo02d0 zK7_7^0(s?`K}8L_!FR%jm7tjkB0kBWYF<+)iWAlKNGx|#-ez6Gu-RA*Ah@;5Ow6U?}W+UY4nyb$G zX7%xVCM`pKO2ayWawBw;s9d%|Zd`fU`8ndnA1OZ)X0$tHf`}Vu3aI0pi6yb+hi_v2 z>~EO3zU@!#>rZ;$Qh&w}TmK0i&K)MQ{=U#1zz|xMZCi+YH2rok{NtE} znBC-|iMtw)T6gSqc7?FN>+%;<+7x`#V-GVOafXf^525S9MdFd?AL=a%cztZmH2iLW zX(xV~4(yAX-^Ms+I%5-eE=FYoeC#7{-BXz)VEig-E{x z+<*dCj))IN#Iq3bB1HUb2*(OUyaytE?_S^;{jk&|jPs$A9l0;&QBetx?2K@_zuK` zv7RBM&f=YQ4$Gv}C2|MJwBtQ)nwJ8qKF{^WmW%n2o9CDHs=YYlh|OJW@7YeEJ{P(k zYBafUWx1;Y_`ImhJp065iPNMT$O-e5dCk06^OycN^`CCyX8WeVOn4{#=Gw`z<)j{R z^nV{0-m>RY7p-DBrV%+2xe{!cl}GPW_6RwER|!t#8Jd&t8d@`HoX1x%-a3g9ltOQ1MJbMEw46KmDXekwqqp1mO6ObF zoVCjv=|9=8n|zadoi6sx=EojTQ`-ym8bA8{BE#sEIQ!(s*Ure}d*2@Ke4S+?w^G>VK+YU)8ol8~y!U#s1D= z|J{XsUp2k!VNX9Z0lv#;>dz7kNRFJl5F>9GBiv(`M`wN7;xkES-V>1OLZ=(mG?L!A zZh!P7SLM(+(^)QbIV`D7HjZnv>#%n&d+%YpJ7e}OSicBe<%Q3>92V3B3dR@s$~-=& zEQXK(%y(Hg&3D;urD58{&CX4M5P}zdo^iHQPIUblf*d{iaUaj}8wamj$PP2iTnIMh zMCcYZa;2OAoby)OsMe+s+LyL$%l1~z>Z32Z{LDsS;&?vG6U!Ar!~cZHl$1H%r3^|N zm~Czu_oZ$j*w5yC0ozy9!7PvLYm?6RMP~6BH%bbqdavy{&h`k?%+!rY%%yz}zj_Vi zYqwkO`LudV^4PCzKSX|nu6S)eHX=XRV8R=yK($kbB|iagskhR85mOrueUm|oWew!%oGV}bsP(cFUAnvoT@Pq0 z<;9g(I0Z9%4fSPQZuFGhx&Ku?6S^?A+!z<2-`{7*lfEyW@3zrqn|*QW8KLX3X+&;v z`&jzL)Hn75Gt|pxG|)4;e~tau^+sIJG?r4okFM&O^r=nvD~_$-viCO|?+!OttU9l! zq0@z{M&u>03S-aa$g?Fk_A*)*Y9`ABag%oACh*1l&jfha>;1*Bzqi-rIUm)z-r$@$ zO(%eIEOe8oT*y~ZQGTSJ&#bJjQtEoWo@YCahHbf6CJ0O6yZWN0`^7zOyJ!8&bL+?U zt+jk5-!uo?bn9Q_YV%!GF`>#GsPTC+D<^P^j`B&ilN8(;KKsEl5x)4JfJEcGj%vR^ zv2O``mVMQJjbh&ljau51O^M%vi=Fwxv|*bz4U1mhEcl=#7xq&QJnXYGUYl^#aiG&M ze#{r4n?&Ve$1fK<*ZIrc6Fu3UfV-m7ZWq|E$w*OSaHu&!`)9|vyFa46H z%frZacl#Fgd8no28}A8-rOP_+rxrUOmU+sCxGSpgQL@hy&=?8gMM;m0Y0ms+`g2W-x_|Gyt8V#q z^}FwdNTx=B7<=|^g>Dn#j z)02%?PI=w?*$bYkh3tUAFnr3J&`qLpvBQsYIQLj{#BF=8Bjda)*ZQ#k$8|$kPUTob zb};_;0@zQaE=&hFppy*@28sZ#ljc~g7dR8R1h^KM3p@g>1h_{3Tc8~jCcnAK1x^R9 z1Qr7y0Ugoc9}3I>UIsd$A%8mXA0V|A_R|3NL;<@NI0S|NMIeX*HV_%#1sT6L3Vdf2 z_-rVaX-Mxcp(N`PvHlGU<=R6LcR_ZYjttm@j_>1GWcfl0;?*5{bD+}L{V;sblV%vV z9*wY|FLE*=C%J}EQ-C#Rqp)VI1n-=Vysd%z^RZU(O1Qff;Xi<|mK(;T*9?RCkF1Tl zjto)XCWB-#4U(fle@N_XCsA*)+)#hgoDIr zZ4%YK)0GkX7Ol3koeQs-M)*HRql>-pAK4{$th!CEBYkHheAR#YT?Nl@C-6Z3ZS(xX_89&~GB_mTj{CvSZ!DFq^cV$*q zde88b4XAUFx$8E@=EwQnld3Dj&0xp8SM@c{_Mbk_vNDe`aga6?r1ugCIwfv z|AcN)BiG0}2FG^{`CjkD8gtWo7n{ZdeeOvf^QBONm2RpYV|iwJuz$t0gOhOG&gZ!K z<5FNYf)cr&e_d>OX?tz5abnLFsVxs*yO%C6Lf1KOhP+hx{hH9glepaIDf#F6ua29h zU+>h1EZge1201^x{o4Ll|9I&li3Rl~wWdxNd$YbOcl$hL*%jt8I=9c%e;(H$PasUf zx)W<>bt8lqMUHE4aLTbhZ(0w2pZsXdxij|bk;48s4f&zo6S_%ME{*X6HC<4})qk!b z7wS3^xtBYvOgrA=rgf=q259UE8z%=DE(^}R$t%UuPUme^p=i!@La{mmPCvZ3Q zpG~)@k*g`cj`d|l)n#?AM%O!~;#HO>Y4>s7Q^Jb)>RhK4yrt=WPtN(*mp(Y+(C32F ze|rlah+=TEo9u$<%lb&5UL ztqnjLtND}|id~MYZ%sD-b#(6y!NjwBh5YawCd1ArpIl;1T|CB(mI7+~ zJoon4@-iRtG^+j7Wv!=-Y@^GI&^7PP^05{2(&)N|xZLO|yL11mdZu=6Y`Lk2Tylzpss#g1b|G}KRV(=Y{8J(D;u zcKd;Ezd7@Vi$?zP+fU*X>m>uVlTH`=M&zZjbqyn`CRTaRz&N-%?wER4Y&o6=zJE$S ze$C|k>+k7cpI6lyd{K^tF8s*dd0tha*N=4;JSQszp;Oy0;$FQ|E(Me;_66k5x=_Zp z@YtxK8=hBnKkoqRMb^JZ0NsIO0O_ORF>dS>Sb)3q*J|%}%7y;jOFiV~#UEZTJtt%C zsVmqJg(xj3Pqvr3JgIUc&ulkQe)@ty8jDm39yo` z)8MDbQ|Ml&Jn7>{#y!c#?dKd9ICb&l9$(q>M`z%D>KUQyEK;7>$99}2rJoyw42~uz zQfKil&$|EH@}DwBeZw|5=Mt&EsB19gX38ApkD$A_u~Hy}o5;z!`(w*V#(l}g(J60_ zn>6G58#>q%!Ct&iIT5<$Yvc+!+1mXGUAcLKa&wA`O;2?BiTJ$zpC}iU8_G{2K>48# zO9H5~;_`z;&`c2jMSe;iaE_aEsE+AZf~d88V6xG_e$83OJ~QgYgYEH5?nB3NBy@!Z^D)9l zWPcA=jQ#&7Ao3^TO^!`ao;j|`XO2-YO=LWi`NK9F(~6Kb9`AI=bR=lx&S%=iP4iPg z?Z3{3d@wCD0p2;T%sf)}<9n{>iJwnc`oC~fnROUzGM#Rcap8QsV?JG`+3f`g{-d0e z>uUdK&BL+fHEm(C@ztvS>(&md?rM$DdS9E$~?yb2>y>Ye#hb{e&I20v=o?z|Dxwc zFLKH;^Mh#~+86sDo;3n1G!5hOz0dq1xcBAXSQ2LCK?~%B(CJ1slpFQ?^OHS3@9;pt zTs#APS2f7%oluGXtjb6ABThc3=U9KILb+%!=Liehk4w$)ChWo#k5ZM>6dF(!M^R*Ddq! z5Z-uCK&x5kbfX$QU4~U-g8-Lx^l?6lahA8HDln?tQ)PeAVGW;|olSF5kE9pZg@wQ$ z+!kEro&5z(c?4R zkFtOb5hjIW!>ztOK6xnx4-%i5;77uX7M}%*eYE&wEN(hJ>vIZ@>U{FYyZ5yj5IOok zn=X9Gz3KRH&5=CUoIb z?&P=0e(q5X>n&Sc%{~M}lKe*vXx4Xh*#&Zb&0;0UiQ|0$qV&z#xF_S@vPr zreIyhuvy=+|HA$Z$KqJ#XjK1cPeYm*^;u|t)w|l>*|N+jCy3K-Ww@j)NjA=XA^E$N zOOuULHhjIy0Z+Jw1-`UWs}lCCFNChAL!^D4Q(NuvVZBUMz+H)PG_Y z3%Ce)4d??QyA$AEgFJ8QRz&?u2+czfqV{M+EkxnI7fNq;1pF~7*wG0190YtO0zL}? zKZ1ZKAmH~AaNSAx9%T%^Gnr@@@12kF$(ym3bt(FRA7Ve^!~~-wK1kU(J;5k`C&B1) zTnl6Ff)>Vy$F(#b{HUez?t)gv>GN6}&%Dsa=-_H=TwK4a@#Lfe)(%CCjopyt=12$AgnBhrJrDPP3X={lTmU5(*%>$S6!^naKy4Q-emb_kowgkH zddD8$EI+&RsXveU)Z|t4t4X_c6*m!yX4O6j%QB!89qSIR8Q=59*Fg-()`TlHBj!%}`}e=ILC zOuYQYNSuGDRS@xJdEq$A7Onj1{bDB3>|ftp)w%YtQa;nX&Q1lcI-OLSDChksr&U{h z4GF)~DyRO?!>?VLZ0uRoa^>LZ8{3Vwyf^zY>~9I(CWmiP`{i;NGF*kwpHcM%%O1i0 zFdO!2S;SvQzgI1rw2PbVp91Q*O~#8(`Owcp4nck%+i*9Mmec34| zx*n;A997Iq?bG{^9}?cO6Z-(XPdO2~o^FtnX0J~OZ;B32bh%-0)GfTT?&jTQ0Z&fT z7@e+|-|{}6W4WdKxQU(uA&^CG7O#mdH=R}|8?KI_vvbC;t9a5*aLyr7ZiKFfvQ2X1 z8j_QpH)06=(&dLV=C=ycqM2AS5tpB6DYo@ANB#7QbAFNI>TE-lAR}a5OZ8W2cWiik zztLUnpg1?w5;H_Xx5?pKr2ix9T269LaTk^PDyjp;Cv%#Rr`g0%|)-UJc*@L%>^Yf_OvXQ~sv2TrNhU zmBD@{;`!TdyZvAKYsto&zjc4D{a!csVt|Trb9$aZUwO;pUtR`927sd~^eP06hT=nVa7brQyyo`@R7CdnW(`fPuhZ zfcY>2I0bM66M!n91~><}2)F{c9+(5%2RsHm4Xgp)1HJ%$0op@0Qh+|dAmCKM56l4O z0V{y_fM0;lknv1_>xr%eo&Yui`=XNK*^Epl|elZ~}~*Dks>_}PQg?SetQMZGF?J^osIr>L~tQ&v;y@wxH} zip#Mcp)7ooMxnLZqS)=9=y&B~rx$-CV&BMJ*v z>zG?kG!UN#?Pk`w61E;z{Qn=H0wDw`@{{&nZ26h_ZnE*<(yu@I_~(xoKJuhhqt8MC zrXCWy9s^B&?7!yeJw6^MRO#XOOV&2`wx!bRir(+i!`NQ`DVGxg>gF7PV-Y6-oSWx5 z99fTzCXv~uVKazrMy5o3ole>2m5?9m^Gtwg$!F?x+4ljD#u-09w&2uxKR?4~nsWQ9 z(@ioi*jRYND0cwW7pgA5RdwaoR84S=2vk&71nRH_bSbul2v=+Jo;nUy@_y5NUA%r} z*@EAeoi6VSUpigvo68q>BeS@+-kgS;l(&uGi|HikMLA+yS>4C(iDNH0v`6;?FW!TR z3B$vOTHq>liyFCRVI#B(4^HahjkW$H9PmE529>(?M_j6WRIhWE`!YD{4Qv6%UVi3G zzVqw+ms4L1lBs`$Zj-||=oA-s3bD_o!sbnuRXT1AS6v@eY`?`Y z8#7D{;kR(TGu`z1b^+pZbDP9dYTjP-P12we|#E9Irp{WIcnqo?f7 z{jchoj15k`sMo8VV1I9RQrnDv123RnqY*tLbc-6fHX=8+nk@3x;CRR0u3T0Frb)$B z)tA(f5|-t{x~hCvZ;UPPYryx5)06jb?RntwU2OeGf2kjZuKLaAM)=O{y$$<*=zedH z|8f1eb*ZSfL$*L(nrc5TnZ0Dg?7Y{)Q?HbBO1n-ME+{Wb{qN!^b9ErAe4y7?;H#KW z!7*7HRc@z!(lj5J-8AF)Yo5;k!Ft;&Z@lVsu_qrRhUZ%yAK@a`+^1Gf>MW?@V7Oi4 zRDL>r+B84&M;w39sW%L0ZKa3BPXhQ6y6_=)JzcB@hE<40;d~Nn;|Y7WW(>uv_1J=D z@N;LUIS>A?cFau@p5&8G7yCxabz}RpgcXx2Keb;v^`r-$j|b%Z+w{+pjZ0T8Iqb=P zx&IlGXoW0#Qs}~u+$Ei?FQ)trPr$_noOGLk29c^C<^3Ifr@p~3ylLz%g8eW0P4ts) zOL{cBXf*v@hTj}_`g{DpweP9!qdk+xIULoF;l$0KI|WpI*Y+!CyFnihXG}gCv*^P6 z(=PZ)V#Rg?dy6_GUbw>{`0{mpxz9`4PJCA@>;k z*y)1CNEFp15%4TPrCkcZaQR*8XoM^Nt_1x!&AwK#cR^86SE+n& zf_+o%pp_+`Tyg1D$7bVI(@;JrB|6w)w<)aW^pEFG|0p2;@+7>85qL}M9U|&2r zqxXKB+TG;^ou(haeuL0WqH>9>Gm!Ng_$EAjRDiiPiRro!*J$;4U(m_R)*7|kZq(w% zIAJ>7aUNII{A*@ERCwPz*V_T{o`6*XLbu7`8|4x0N_$KV-!G2$_BMh=?=WwXmNQ{U=7+m1VB-Kr+I>Q|sF5rA zr_4C^%gSoVfG$8+pc~K~=m8uI^aNP`4gq=rhXRKIhXb4gI|5)eNm*x`gzKM< z0*(f#AE|@Wfnxx!iRurq?qgZw`lu6u3?LI20AvBIz;b|rz#t$O$OBFS1_Sv37hnzr z3IOWoVZd;p2;i9g2w)^I3K$KH0Zs;(&rnh3`Xp7~RsZOe2R25S{_4C-*`<$N|LE9* zZe#w?Fwa`yDs+>mTy%NJuE1eBKL0?UcM|G8h)7iFFpLoVpdO(fOZ+Le9%FFV6xQGW z_Sj{vY5+4UcJ2YuhtDr~T~AXDMGL zD12;3q{IH-pPl>W`43*-wi@rzP=;Br3Edj|bA#{_dTx^-(W+WA*9ubk~^YY67k}fmN3CmMHB)*JIJJ9Ap(y9|r-E z+vUv&_x^j@7F;kR;oqvhpgt3Nv%*ytV5{|h?r*Wn4gFp|X~I!+{o_B<^}Nva@TspF zv!{#%AzQl69k06#aP9{ z@G=43bv;=Q`))sPIq12EXV2i8WSSa)`bFp_QMojf5A?T+E2`@9CYd9qtjAUTA+P%I zAhIB|=G;|z4<^KpPa5od+&`g1@|T|edVGYghuJVbRz$XUJk)l|;+7pvHY8v4^Yc2j z=xE%w{~k})9l5xZ<VKif?>jyPRK2&ZwNq~N{%}UCj>d3L@iWV(9Qnhmc80P2OSuuc&T+H!9@=NR zoX{U>59oewkN-Q;@9n|gpUsaD7!tjo(l)l71lx2p_V-@;<%-R3-zfDXbu;Be=z9FN zxn8n2kp83PN9RBOKXwYJ_0#CxV$08B$XB=f%LiTd#Y2OoPEUvTlpmq%p;6D+GNi75 zi@Lre);_d-;c>h^(o=Wm{a42kHbQQgH<@-GQMa(&E9*S*Xxw@3ZJ%sdG3-`8({K!n zSDkK>aiQFBork%i!W!Mcgq1zpHxLIHvz6oXR$8YzJKN`}?PAOEwB0)z8NYnc>+X!w z-Rwaaop>{d3&sgAJ)iLmfJr@*wieHVO5ey6(O0 zv#wR0{_muvw4<@wEiDY8Thz#v@;ux#0Xy{i>TJ=)DcjlJNt`@0&!9CQA>-o8W$uxY zTY++*9LcTA5%-SNWr_deX6K}UzRw*sQ9OTkPF}=A{qv`Q+Kx!u+gWc%TPHNJPvXS8 zH;w#IVrJ>O1Vg8bz1fb?&ix+ZuELm=&pv0{RI@|ewbovDDnHA?5B<*sc$Yc6G)#oO zS@1y#NXDUCrcRsH|20l`nMU~0>0%#^AD$cGaoJx!6LGVB%jE*xq<-82 zK4>Ie^zjJVz0_|^PTr5Vbi0ZZg)rpfNL+<(5|xWR-)5dsZEn4RSvGtHR)vp^+?DnL zX)=O^uc5HFXl;O-JJ%I^%?;S`)v6Dtw`0V@GHSnOW>VAX)~dKN|KYp5dr7~T{BnL! z=;E*3nQrPi33khLu%~WFg&(USO3PjH;3*qe;i)WZ$X9BzGaaMJ`(D7lH?pzbnBP!^;GC=eVH0uI2pB|N7vZ&OiPp?H{^p0oOvu zUx#T1Um8o8#T-{rB}0~Kxg6cm$zQbo#yNF^uPvW&Y9;5HX*hr05?7&{MCAhh)P1P3 zygom-Evu}UP#(ZJ>gC?D%u4h+tW8YtUJ#Jt|m|=(=Wt6)5K^*#8r{!ixE* z$%p+n`uwVG>B8)c9HSO>990ivd;aIz4(2t>Ey4Z^*O4%9_)K|;n@9=-@hIhKKIDgb zEfcWxTEqU|`1g-p@wt1+Q=B)U;XMIYp_@eIqRhFw{pAB{cnoO4;7Hd_9q&&&z$w4c z>V;o-`EcO}Bl?^zK_rCl*Ya{S~Yo*lN|x8v-JU~k*uGMlcyr}F`gQiWoTJp-~Ty?#%4X^5Ock^&EyFI*q8 z4*W=Xl;uP~wKooo*t0=KIamAj^I_jqe9Dh1dZcRLO9S-yRM>QQ=`dRt9~V9|FY}kX zCsLD+ukcL@*C#3PRpPl4d~z$Lmb@GjkT-^u}sEUT4{K zcw0+3aUL-)<~=0#ie6q1vLR91P>T5uD=R)b@EjPJ2tqt0Nht#9r(U` z%Na#8mOOu}=tb%!)~iCtUx#Us{=T~EfOohjz_XBXLbCb6M6?9AeF;H+$)9}p&pMC& zB59X80*n9o!&5+&>&4w;%TK3n9gP(|`sO{JH+UE3A&tn7&@F1@s>=^L@(^vmr?iF( z(uW7U{P+>;=Ff0rOGlq~f)AUE@NHdg*f3|?$X17R5;r?B1%e1$^iKW3PPx(BL+L#_ z8U;(wdia=ir+qTf=2_%M=z3Iixq<#GGDB+#`-Fje8jTT!`I#F|8@8A z|IQQ$;;+cZ=$=mb(Ca0>dBGbW&z^ckQZ=7xq`j=uEnBPqt=5;2k0BLkB(tST1){ds z6AyKUAN;bfxsU3WHZ6>6zjRGm2mZ!?GAg*Dtm9?t0-ektL_UQs;mTc?&q#eOqhOXx zeZE27|Eu1&r5xz*NL!X^ApPCurbo1PgYJKG{ffK$^QC|~ZWYqXZ8W`MtiEhwpZc{2 zOH4#>=yb8y%Pj_kM^u-&0~p`;V1qpA?1smwLwHg2SjJ&aJra$d1D+~wm)q~=XC*x0 zN2iN@41Vx=Qx!+o3q2lRm`!`|-)wf%j}RdIt<(66)-U<#)5Wt27eDwq-=z`$bh>5R zP|uF2D)W@G58xhGiSG$HOyZXfHQ1EPwrs-(t_I?~QKXx8?l@&tzo| zWATUmmTkI4ja>EgW1TP(9|EBoFde1f%J4Zp5k&anewr>=_lzC{bzd^g3+0YJXO2;;3A7&u_@VinVh_^*P7C=5) z;eTcfA0J%w{6{5K>3yb;w;V}%T42-lS9STY#`%gW$~;2?HE^5)NO@X=@WuZR!3g~h z+V&ieC_J)h{(f9h+3x2(ei~OsWeOww{bbWEYUHZ(XPxdGoxf^?FaG1mRC5eC1zrjN zGZlOC&-vq^ZEt=b*gJOlgHz*zBi`@3<>Co4tQyt_I-PE5bpDa5==P5DNXJIiM;S-O z4nG9`2EA4^XWeo0ve}NJVfwNB3*96t7d?E8Ar*`-@Ri{ccBeA8-_iS7iJ(hZinsB{ zos~eNe$>?-?+TwyL}V%7J#!pEjc>2{4$K2UYb1S zx$AzuNx~C;bh_B<{Nz=Yda(gRDZi?*Co1x?!z~ggKQsHq=4TW59rMsVp-Vow;>3OI z0Hr($UHFi@&QGlN5#Q0vQ+v=@cd}o@`4F0TU23Jn&bX@ODJ4C&ypX@FNA`H>4A0)- zDp=%Kr%POPdC9J+#?B$=e?(Wmj&Y3n&ETi&xo5pOKE3}u2~YUZ>0+<*GoaFoHhr17 ztlN)?{8A5wX;C+;<0)y!G@UNJ_c-tDS!W(5&C+nasMDLrhm86;zcmRq`KnMJd~Y#;N#T5i>6+QrR|O@Sc1 zmv(Xa@v-G%CFEvP@Apn9+#~6^3v9MTE`+XgtII{vB(FDsGd@h=fMZ>+%lje+loRTA z_NPSG(@yO17&kjG1=M-2j1!&m!G8W=hJ8Xuqu=O3bZQK}XRlp14Cjz5@YJlfz%?F+XJ^|XHfE)$<3zz{c0loryBA-fuI{@Yxx;f_s;jfhY<;YjO zZuW$Fzg6&rPfLDR?w~n|fE(HSQsESl(%PPry~^CQ-TQ`HKG11TQ9{a!MI{ zXMb^8hBJJYbV`CX>!rgpVE^rpt7m?CSFeR>d>MxG;q0#o-6Sd(hR>sdhS#8Z z>qCWXo-I)5tMK}88iTce592TM>+&k&Ps6okNV+D?Ot_GA%*}R|4}HF*Q)Wk_&xdy$ zIsALqD`&5_N(Sd=84scB0qW@(DFrfLf(6!|QmYYrR-V%|e>XmUz$cU6`Lay-6WPDXro%gj z(fKo1E0z^hSzl>b^_}oH4dILb^o0DS0AfF1v8Ns55VY;d|H?s5{dgD(DkqFWqZ5q| zlauOG2X-{B`22|hyM5pLOxB?^Om z0&p+eMZibE0Z6DZz%9Th!11X3ZvtAPp?3zb1(*iqor(t2+rS(svU8y%1Ly!=jET+1 zut0KmOypmL?piNI=vQ=%cR_>(BSNoWa3F*Ttw4m1>x!@rHjGKVu%9eGQo80S_j=hbviFs{x? zFse>ZFwU5jVD#YO*^mol`FV)$PU+`?gJzqpaocQ9;|}8~u#G7&AMa7Gu^+NvlvCdZ z(V|1KH0q&;kC}GU#9(npW1ki;@0xpEg}Va>nqZ(NOnobKlc-$KzSF<64IiU4&|Qiz z;p^-JJgjdkx#>>;hfekmYhuf@?Wun`wnQDwu{>Q5t7Dp7VBa0+2|#_B`k4K)zCeE< z0~iQ!EVBqW85jpl1OmXhz@-3n^XUFm_z?IW;D$t9f&RcqAOKtgJO-=8G8FuU?p_-s*^+vV15i8{xNj;-q7LI2cn&yg75pg8pazvu;=(8hVjH< zs1MRG4hvm=HYz8|$Nb0DjF}muwIc`+{CczT3d%8!=wG2*)W~()^{;j6v5cmRkALNH^l0TP8cpIV_vW|} zx6$su_x)&o#%X_z6qp7!rF`d()ylW_-B71fI~v!1e*YsU{!%K(RI({49cq0YA zN<3=8r|=>1P{-{PJx#}>bkNk9-Hi3m>hUPE>5fR?&(_5w`hGNN;7h_4zSZ=vZwBA_ zA3g6~vhl4}I^RQV`u5;ES}vr(V@dxl;8XaJc!X?wj^oW9-*o!V>3u`@yk%Ry#A~Jz zxxZbbi~ZK6f1W2W-rWA3lcuH@DYy#%i@~27KEqb~!Q~U0=6}KMS?)*9xNnZ>IWEHg zLmFM|e+U23vcplXr-5IUAH7_sl{X!qpIat8dBIEdgN0v-&;K;K*#D0BL<$EyO93Qb z3c;t!2YFa*+f%OERx}-t`$rAh?CCmeI9@Z2#Nz>tF804W9#M108Lw3Et@1^l)Oup{ zL}&X>|4w%?-oNPM?9%5iJ?__1n{f=gn*B1NOMK+6$4lLB#AW3GryVmZtE+N3#}`Vl z@^k*zS8}P|NncWKnT%beaHH2lP`8TUXF6^{krGE z)+g8DIda7(gId&{m|0|EL>uIqg{>RJnj!4zNuAd>WF6DWq-}$`^bvf%@b$#l~ zkL8@bX4e@HiyZNufS=Iu*J1SXY&G4AJZ>L$e7BcWXZbwlz`M13J(e`MM)+l;SGCG|$49_pvkHa|&B-dx zD;PR9r#Lrf_|TkU>)moB4%2OG+MAJ3BTtf!5sLNH7+rTK|F_n?ycfU!xl=$LM_*j) zl>hrM!^LrwlwgvvWW(?!ozCcJT=?D_Bq3f~Lci5z27A+UA-L3oJ=EnQs{b`>vA#@ zr;Lv&JVXra(` z?sYk7W_@2(W7qg4mVRzSzNm-mM`KOl%DnStgYRWOo%iZZp|5@v{Uv%>=%%O2g?wR*OPLz+ zX9kMOYXW87GpgWDFIVC(y|Ch}cou*B!&5-jzsn&XP0gG6)@MxX;9ju_%ScT__cVT+ zZvBf~b-6WX%P_-jH=+H}zN=gZJ|rB<3&W@dM2<(F=Pdu?CWJ|mBhMP~8biNu>|RHD zez%cq8K*#{pzz;L-9*YOD5Br2Ci!o^x>d~TLgTaCkT$_CUmEJuIl zvcvo!e}u?~66L?;qdKpUc!5(+^mzp)z`xclNLsaF-y`<1Q-gBS0@5OMn;gEyloMET zv3*v#yJ~{RZ@#0J>)FlVXZQ0j@DA?v+Y1t)waj!kL#K;f|uw`}!jzmuo-IO~6AP?R5*AE8V5a&LqWvzg~IuQ(I{j`ey--v1--jg{GG z^k_7l*XFp<-}$rtSLG!4qNerxPa|CUx30hNN@?FQEqE@S(DisWA}99b3bnrVhT4u> z2R>*r0s61YEA0~6b=|eN>kA2POWm99I^!yIx=~Fdd^qK`0auV;cp~**@M0%ldOwNb zz5nEx@(Y)|@G75aELlltK(}lSqZ!{hyTUX3|KHyIgvL>Y0RZ2IA_WhMC@Oe}UR0FT zgH*vwqgxCTX`3J^LZ#be6(J-cu{EWa97HSiABrACFc*V((u0*AR452V6hs9}4_ZVJ zMJX*+1U>kDv-{%g8XAhn{vOP{&3m)+zWwd&?Aw{lyonfgBX1iM7mY8*b(DFN=KA}$ z<=Kt<5pR!fyKVOK;hW;plq!{e;cBnE#8vWit93G)RX?KFiTL;K42{NcJRzO(|88!H zI7&OY{+w2N^?4rPMAWCtNKBb$eeQ4S{fN20e!b%3*H3*P#Z}7Xa_PbHsyJr-j(O4e zcxQg5Jr!9F>UTlITt|KT+k1H9_xZz*ez|7o=pRFG_5#TGu8a6ed9Qda>yK|T-o?(^ ziN*`Pzss?Pvi+ToxU!v*m@?1b;(4~S+@B~OHufBw{ptMqTUYaOrd%%PgXL9m%*N)X z+A+xc+(L}l+HAGsw&2nG%8`nC3oJ)o+HV}`cNzR#?tL!qkM!B}%f}9HJ#_ru?D?fh z_j{z2SB16NSm!`zrgh)sLVJEb?vE6MQpTV}t;|M$3QcWoCpFUL9t zpOyQ*IFwf1k9e@|Qv199`(P=ykKEoyV#>T+@3(vDvc~4e?l_e;OJ^Tn-FH>1e0{`s zN2a0wlvl+u>un#~XAd+d4$e-k4bfTe_icH;f4f|HW>a_Etoviz`}TBP(H#Fre&m7I zw!iVtU1hx)Uq(4tUh4Zk7dsZ_ql?%3l#ImLhs7Q7S6nr@f49qdvFjj&{~v_wp#- z<$eoR#eOcZ2ZW~ zn&*yjc$S_e#0=R_X~yLw#&Cycu1qIHTTH`40n=kO#vRw{K+9--eSXqrCC((-j5(`V z67DeoEds^SQ>q=fQPurR8e^C%)h2!Jk<$F?@(J}WcU+|h#Z!rsXL@eA0xH9OF~oa7 zMq)Z^DjJj@O-?tyoJ6|0>zl#k?C;mJlH7YCz8oYG^S3)DXj->{G2E9y9ABQ9T5qfU zx8OoZ**zQ-?mHkJ3$jq2O@=;WdG_{%F@)fPIZjdv$V$*~m3E)vPjop}>`DzF$bBn7 zTR^J`)E#wx_{#HnED3iwE1qXTYlwMhHHFKv%Qqt#MX9$n$hN>8!E2yeg6|&OTmdtx z>`9WOpB%rj;@q*Y9aK%*eVmn@rd&yym+TdVzhamFJ3zSaw+KAfn`_6U7R!8e!;qP= z%oSU*J~Yd5C@9O4^z+qu)*AP4$bkFZO|7L(&D{r1=}8`w+MScEHSQ~bvx17L;=YnF z9qd_&OL0l}BA>Fn-0`R(-$HDSJ+jvKRmx#en*1TidgJ~gQ26dqWWQJ&dZ*4HL47E{50T6e4m)T{#d!;Rb@fC z!`9TU4kLG*@{6D&gf7nfYv%)Em@5tGdP}R=mloHduH=rZa7>TU%9Uj=UGrT|pA)6) zt{ZH#+;RTKLEnk$*DCVT_DXo%zWMc6M8kOq;9M=xh+p8I8$Wro8{fsl4P(+jLr+;E z?l?}ENJs4Sp;RlfhK#j_X}CWHn&m}C9!&V08EZw|B;1YFsHJBf{c*?V%{;A@-VS?o z8z+nV2~qICk@I{RqLPi5&QIfP`}1M8r}}g5BFue1fHJ6u;AV4c6T*A9UJfZb27wj| zw2T)ImrdPgr-(bovD$HBik}R07M-b_zyjQ{lbxVXiAfzx|<5$VF|f6 z0N4mRL2!AuIj{8M8!RFBZ4k$<&k@sB7gM8mZehFPjs=f{`ic2EL-%^yns9a;xWld& nF{q26yw1r9=u8T(8)VOuJ2r$x&k|Rn8J)pD%PwyzD0caOu>+xH delta 1593 zcmXw(eN2r}9LJw?E0s!ddr_|Lz1>H5q}xP@d7d8r z$lIo8`U6(xxSLhtWpEw3vAtcjNav&pCJd?sIp}=lsrj&U4P=9@M!9b+aD! z1l|_}oq#_P(v5!t1%Uu~TH${!syA}30)1=1KMlDkWa{mkJU4gFq7By;{GAFtasH=Zt@6Z<0|G0ge?tNg{c z>ICX=!j>x^%n{bKa%pyoFoE`Q;@Bui92;NKv!G2eB#E}Cvl6MuIR>P$5Chw#_dhn| zJeg;u4y96&q|Zxhnr_ctsI_w9C_Ti;rf3O%+j+#PIh^C5|2o9PoYvRlhgd0#CU<*(Xjto=&T9#)6j$DPl9$6l52}Gb@IaQZd(` zM(c7e1P`y~A?7;o&fB84r5q+=P2ycoVCbljC;u;Vy+ZoVM~p?KE=YG4FsJ zVeXvKC21~Db?B}3yn<)fTv{t9j>2<#l#LvEKVVQh9lwb<(qN`f%ZX>^8RP-c zK389T?zOPrsz2i%iN@23ogq4M4j=kbOXV$m8QF+ke_Ul@W-)s)s;DuL}5?7PMg~JWw2NEWSxqXWl8N_W+JjjQg`Qf21L~o ZcyR%mbz{c0btw1>a!9*pjZupj{~sn1?Faw> diff --git a/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/data_1 b/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/data_1 index 2976f6bc77b4a2db187a4ae595f5b3f5d29e0931..c4734d69889da5ef232cf37b2979ceaa85ff4740 100644 GIT binary patch delta 2130 zcmZ8i4NMeA6u#LV>0(%&^N>;YFE@kO3KLsN04IP#j`JYzt8DiaxiupWfuGPmKY#dcD8R?q@S@>>8)u z955<6Oo4Os=IM>@^69mR#tNBVh-wOfmM_q~TcaNTJC`2QZH> z13$m(HbY>2kv+*#G%c6O$ctt`2-rUEW%4qCr40n;p3gv{o$cY+_-yX{{4@*&GVnK- zF&27v*vnqEj%mkbyt_oDjjY_Mk=>UPy~hEMj1Hbm_auPNa)r;CRUG0*(zx z7tX|Fid69oyfr8!BR@rx1P1mQ;U1nNb*LE863OZfR`8srtT_Sf~Hx*IY#3P>^Z86fxaG( zzLvbMqV2(Kj;d#1QP-n1j?FX8x$j?y!*j2_SntlmIkvb_vkJ9w;8VE3Y{aN;Q5 z*>QxD$uuTnA~#UqfU?0>CacC*b23}m#Id{qn>I19R~Ju9XExDx7(C8E|J5ze1opUL z4WM{R0T{S?e_uGy&I2{ZVFjS;fFn=sLvYeZ$^Y}My$ky#pR2#auxU`^BmmF6WgpN?<$E{A;U>sEtHo$f4M{*d`W?0aEQ1fCyx|}zN zvQ?sd+;+fv;&N83%FyPfE+`Exik##`m*WDaO(cmJo~Np@?K}<-PM)3pFBBaX$@3uN zmnJEB2xZ!zPVv~61`A&t?&J?mk(i01h)P*}t4sf|4?z-ZXQi)OnVYFiTvs99rx-+G zv>e^%m83*lmBpzwU!CrGdun5yUGSu59Va?-R%n#PhYww83;Ikx*wx$b73!dIaTtv3 z^uKgOcIB*#Z@lT z2;-fAP@XGz?^n!_Z*id6b?Ln+@he9BN2T}yt?xxKMIzNn(Gw;;EAm~>A{?=nPuN+MpE+l>BvPs@JF@LvebG X#A14fR)nlC6w|xIj9(A@^^*Sq6}Y6I delta 1009 zcmYk4Ye-Z<6vyw(9c7cf=BDP8+6bEY zlikg}DB6;8)pXRYFQHV>1G4Rb76hvw%w9x6k`>g<-HjZWnR9;gpEGC9Oxtu++jLan zy~k)qlAr`6-uQ4r7|1kDCfuF8C$H_AKS|r;0)I3uC%p4Zx0HYo{wl>y@Z~|7#%G8c9s%%J6kAG&GSn! zN*(+)OG&9IabYw#wG_tFsbLeYS~E%+Msu+v^}!U&%oN=iRlWXwmk~F=g_|nnDtZWl zmHY9B$rG#|DLEQ+ahwt02gy=|+j&eHF(pKjqqrlh-!gXbllYvLqoRr+Z z>RVX^5j!vMi||GC$}95J7HG8qNmueAMze!G2|m&QiL4(l2J3yZ+hBpiJ12vV2Iy^& fGy4L_dr7wS1;V{v+1eL?-U%6u1?(yRd#~~r1bjfe diff --git a/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/data_2 b/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/data_2 index 2427da8c4654d25919e86dc11a2165e5f170887c..708953b5fa61ffb31ae749a78012f3a12617ee9c 100644 GIT binary patch delta 2207 zcmai$2~ZPP7{_-LAR!6iE}#ZBv?7Sg=7J;&1xAiyK`3D;RE{K2DMCm&1OyFQc};Gk834k(m5P^rTyb$F%D zN~yEf>TFclWIQ4MJ1Lps;Oc!k_HwU202ud-vrt2?BHvsVTOe5k!3-#-L;^8kW+23X z`Ai0%$%CR|1wfXtIGaD?5_Lk8vnE+iUQU~F38td?v7 zTNu3-&TP-*GvNR1FHk%(+eP4~ES%Mz_0Rr8WUh@8B5EPqOzb2Mg=Gz6p4>h33Na=3 z*PaBE&q3xT*czz_MP+O9!W6db&NC}?#^qZ$n=c#=Lc4D_iAr?an(XVl?d@FXQNLkM z97SH?%n~d<%)^djlIj|JGsbMWFLi~5|7STs8l~1(ffU!6_O;ireJ@3qT8Q3D(38kw zGTAVP1*rExZz8!>U<2;;SA&IKRm6KENF<|o%>Og+XK)`0u5U!e{VU4NqE`dfS*W2m zf*vy~sWao%?<;u9M>oWhE~!EYCZAU6OM8M)+>ugIAtRL zS;+75V(-a@gQdr=^%-*x^V+-;Y)VKj_jp~tw1wO6J1xi{3;W0`YiJ270 zEfbfmT%4t@;4FV{{e!NDXdS=<(QqV=4%`(bMe|pC3oo9JNsGO@Z{zV~ld0&}xC);u z^XD8|pK=Ucf^f!n+#`RBn-{0Ncvi9eJ$YznRx<5ks>_b~ruO=Go7Iki3li2pIEEGz zR5l8Zz(K@24WqT=(^=}sT*<^OUVScp+ZlLkxK}H*u1z_Ghfvk)pQ@XNF7$R06kTB@ zIa>xcUtMp!xofA;ddcqX(!=GSY5J2u7g^N&+f(=c6fdnFo(izC|3EQ4mUgs3B;9~nIRy?yQ8(HC#D#|h=#9h=&HiH}6BkSe+Qiyy{XSqu-s4Q0p%pF~h5 zcCQKl44&%hZFB4o4sPAJVMH8EnOj*EoS$~F#&9%H<-AH&y20u3(521i zdIhyB{imZ&T9M>^;fwC)>g0~XK%e;W&DOJ`{K z&=PPE$U;K&#PeuMts4(GpZ~9?yIU=r*BNFitc^E-P)f*tM oI)g#$K+eRvdIMVG8_5t>|NF_>ev0`|z(`RV?UY8U)@Tp^1$t9Tt^fc4 delta 1586 zcmai!do+}39LL{zhhFo}3}cs6qL;*q%sV$R*>GH9Nu$+m4rPoPq?kmbi=8oLByG`D zuUZM!kWEIiQ|Uq%+6-N`Ql~l%+9TC!WI8Tu*_Z68{@UMje&_Q%zw>>*=ljQV9(kjm zywQ(ykLRR*NX)skwEhP`kQI|qAbT>x-41priG>WC^#;8G$;06|NjeZG?mw<+58 zn_@!2y}1=)ELsTvID?IPqTXy4+mmlYWqP6uQ4RxTd9xWj79NEt?9R*S4cffPAwk1nV0S}va78)i0jz3KgWH#-_XJ55lP6i zr?U+_o-}jO$7xL`f;Z)Oq-V692})F*GK>^eS=@GcMhjEkw{9(X**9Laz% z8qZ4#4sy8aMzx!J*Nfj#F>lp$-N|WLC97P-z6dBfbjEO3PvD2Y;a|Ao+Vq2ibD#I6 zM7{1iZtT(S%2|o%`DNujvjeVom5Nu0jL7> zRb>w>whCM>Pr0TmsJlap!K;Ydl2Wms&O;8^a}gXvW^Gy!9_77- z6Dje>;1SXstlAoM;>E?Y`S`y=1cK2(5J?Wzyzl1!;@9#=^}CY~GS+V<%0inl- z%o;ZH4RR2XIl}(E`Z~jYE|FiuPv4bQaxq!4x$jMP=0;^kFS z*YEjx*8LkP7W2$xCms*3m78VgAAhuH%ng6Gpga#m+*dA7KG#_CqQ~`x<;x4UMI4jT zfSg=TUIQAW7`wyh!Xgu3D_KfPM~9Ch201W$h;i?ReAapb{DJiHa-78c*lFY`S#-;% zZG0i~9iP@$Tkvbp!Q)QH>wMffStqwuoAvrTHD4ZHSNovMhQD(|sN zL+Jg^f4UM@-mUp_QSvn>2S!!smEpSP`JtE1v-Z#*KCIu_wU0Wmnwb$HTVcAIb^PtP zYs^+wjR&JOqT;B1&81TkU3*{U6K#q0@X>PBYly>Vg_B|m%fv%hY zX+~zu=7(3WZZC4SizsS}KHEAy@vZ0xaPUH)FP5q!+%Az wy7op+-y0M_-B1_VfAVI|T5xBGR-6bQg$ng1_y?0qF-$ZSZ*wihU}2>H3+0S+o&W#< diff --git a/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/data_3 b/Covance_UCO3001/browser_profile/Default/Cache/Cache_Data/data_3 index 262a2951742b2021e47d8a9bda1e95bf152f0f75..9ac46b607fd24f96d358519334b402580fe34de6 100644 GIT binary patch delta 956 zcmZoT(7@CH#1jIT|JR?{n7CGcngb(`Xz&}G>qj=~Gu*GTL(tO|7ciR(j zc$MZU7#SFuDHs}985vp`S!_>Oz_^=DGNd#WC~t%=Z(usztetVLREA-Sx0_d9SgwJK zhp|(3hMQNpYoKF5sBY-y|LvMw+eJ1p{@@jDwe!9KvVW$AFM`HvzlkY+`%QrMyF={v zPxY>fGAoD-_xJHBta5e=DtB~rD)ofgAH?{Ew<%#+0;9vmf(h}Xcr*+KXBrUD1OTBP BxKaQB delta 2300 zcmZoT(7@CH#1jHoKGdJ#-6(ua8b_+o;bVckwua zo~)>#Ch1m`siR|ks9D_fhB942;}+J!tHl;(uu;IN_)2UhGPR}VQ%QsU;} zs8%~Gtwzg3EooXPZH3~1nqT|Wt51E7pRDnzHsXnh0Sd@^oJn2PSXLZ*g;RmW8Yo(! zTniZ|RJ8UwNNaW%6tqzjCL6%*g&{2(g0?W^J0Ki^pDyT~hJeRls?XpnX0X3zkTWI0 zaJLX06C4vlGA5*#gp*xiFC#o(3%@y``9^Tv3g(>-0!F`&q6Jxz*ZZ7Hm{)I1Tz+=yaf iUNP>q@bYKjY}v}-x|LNewQb$p2|5pFZK?k1W$+KvBTIt- delta 51 ucmeywe2#HKm9zu{0|PS_e mx16M7A)#y-r2=&Jl~DyWG$c!wyOvN*Vx{An#%;NudH8)tR~GC5 delta 90 zcmXBBu@!(I30<*FR=a;h0YJKW6H$iKGlS2My-ZL`b^nij<+0DGmvlqMZhs6NSR(mZ)?Z zRHV>M#2YF}k?NMA-ed1`&)4^P9v;s+d#}BQ-}dwiDAyb+<+AJzqa&PQfHb#yQ^&2 zGbX-_c0{i8I5ykU&X#$-cqu)Kz7fDNeHSa|sRk^tpI-UxuCXv8hmx#p=;tCEn0vB5MU@NrR z5qTrpd>~P#pe~rn*fm@PQkdKAg8a zN~emXodvs!$2^G!9+OF7?`-!)HO&nxu*B~pFuT!6%cyL{!DFp1->D;>d!gJ3$Vif4 zsellMrn`UlmsU~2m`PpGmuF~;$rMMSZR~-~lyjy5Oq4xvP$lu0>IGKa`?T|!(Q~EH z&LyBqgWRV=D0<8-%>CQ2vy6wz3TdFOCIFNi0Zxn~@Pv(`cQZ=b|6;t$YM{wZAV7`; z^5Y5MGl>BG69~{KN8sDF5BR05DjrWQG(Zkd10GT&-u1VWiT5YR-Ar~`QxhVui#`&f*kB7L@XYP@LHKbWKICF*B;y4E;YY3ca-7xWZ{` z|I1Nox7#L|j4+U+OUAw#N_{p{S@A8_b1MdF;_@ylrApQP(VNQ~aRtR{NpPOBTDgb_ z<7?akUE`8xm{YDdpRRbztn=LlX|(%JqFh`Mg3t;+!6}entNxbKoYb05mlT z+ne*Mcjztt_7dyPEr#ZC`=b-BTW)?y{z2{Ul?fdK3nv#BIBlMAG|dewihKy&+${p4 zWCeI-^`^mEvptTq#V}Xhpir6w{VD{|lpta!9j?!mJZ>zDx&62WkKy2d_0w?HLiIBw z)@@M>)ionC?fX)1e9)WzfoaE^A!NAqT6;0M10`WTJhVB;dud%-aWqqPHg+!PD*`Lh zqjn;y@p@D0_>I_La~K z^(7ZmP{jHu*Y9VVS1t95`600n)|(x0&}4mNp><+BA#A%Cf1;(5}JJP+b(L8&85+EE-SXgw1Oa@8&fF4<6H#zAs0ZLZ(Y6PH&D&^UTJcQ`Wy* zS8M)e-lg}}a!joFJ}BP|T2#q>GK5fST@vMd?f863<2tgN^XKkY*H2cag`>27`8H@+ z1bDAa0$Q5DFFy2*o1&MVPXX&D6gM!WOA52x{#eqqE&CE>*ir^Pli-i4bSy!`Mi{pYDY!Sm7a@Y!=x%Ot&>rFpAE5FDFTMav(VBZ0If;H zcK*E9s-WMP$)|&}-~5{VyD9EXdUXAd`*7cM)Hfxz2%{rROLdvq`&*!#V-Vje&)SkN zz=X<~^9!~VF0wan-D`T9Q$R7}e}0A`Pv^`Ie?T2Y%=u;{Im7;z(bSFy|GV!?S!G+398snv=RY= z)d_r}j+V&f#x4h*p)*097KvYvA@Ywddf(4XW$K~AI1s7IvZEd$>=di5{vO`cL|xgi z2Y!k`HY}1^xT#(@WrVN)Y|tXg_G*H_)dvIH2enea(r(XF;g)FNpu}p^AZ$_%?H&eI zt=PpleEbX}!i^Hcjjtjb%<%xe(zu8}I2c-69QRR`wm2ORBV`AKQY0u< z$^&gX-w|-DXZx(l)NDErqMoC7quA6C+b>G_bU@M+IB8U&+%K3~Rv%Q5v4WZVJr~s> z()09b`H$LLLFGINa2{Q`Z_ybwH5(KdC@9vOwLddfZYP+Vw*d^)DiL6zEAZ$!Z|R$R z&rFU^P^g1)Lv)sFWNqM;j{)IKX>uAYhyZlfGw(ZR_lq2I;PLPS$%D<7yUjD7a-51t zMg2Go1dJnrrYPI=x@$(_!l&g^X$$^>syLo-lvHmFTl3;L=JzcfK@+5ClQuo8yKN5C z?rdOUW}=kVq7&BDyi-dI|8fZvBT%!dL1RN(JvlOl`)?%`=g_ z_w^R@+^YEZ;La?Yzo*1?$pq%Y?n4l@T(H)s2qV;kckA*6lnNpx$k-e6yZZAN>U+_9 zh8tmgoRBq5Mnz%wT7+-;@!%VhPjK71(e%#W)qE@AFziCc<>gvjw5L5Se?dK5eTEda zx%Rq)P^_&E5%oQ!M@8G@$fJm;tO5o6T9<8R==4%4`k8APEX`CfM6xW%jvE~c1b)Tx zfQ#lCY%LY7gE~qIXptrH!Ko>)XEfRzr{;NBz^FR|8FtL^kzt`s5QbN0wnyf_pJqaj zK0za;13I_*OvIb%KV#1FeAU3VZh=7f!aCr!^%2W^7@pJslg0UEo_TCkVql<)=}8=d ze%XT|0}?P&giX?`earOUwWLwK@6ag8h3>E*ZZI)^lLz0nD-q-@)=Nd(3TFtZMkBPI zB@7lqFErS}Op&nNw|!);?GD>`#>Md^Jc%0+r38TZV5Ko-GwQECl zb{_k6oi6iggzMQN*C4?Obs{$B;_eBDU4m5UkFN*er+-cOP;dE%Kb}M1+( zn6J;pQyUWbBT|uk#`$wIv~Ea6@-r|%^6#UvLv!zxN@0OLr~z}BEwPNg@@v&E*;;B{ zU;#Yf8Sv016{o*#-=NcLB*!;7w&@fJ1Yp)AVnXse=O4|~=`QSp{YVkmDW)U59JFMw zONEm=PXRB{smj+^lo?C)Iq*!a1soK}*wDcd9q-pMhSZi9sIWLA9oBZ=Rw4HanFYmr zAmF&6bkPYjt%!q<22@vnc{r^sh5R*0SH-)nTNLA0(()^i2J6MI!; z1@*e7Jmqso&G|Dp`r5Xw3H;@e4ZY_S_VzK3y&Q`e>8~4~Pas>LkAMTKySg+Ru*q3WZ;&R+%XaReSBWNdMoo|RXI*+FLgrCm_$i_EvGsSPwVnCnATEJk3X zkvuMA+wCQ7JJ;|8%gLATDd_&7;lCN1+SCM3-iy|2`G>p%4%jj}?`=BN&vn$<7TXDGGp*XJ;o#!seaE`a$KBY7vz4?Npcvj!>TGoFA`y%D5DJ^K&KC!JTJ0lVM5z<7TnAXQO-xM*tZu_LDRLGA9$bpVXnEEfTk#_?@h^DkRvbL@0tCN3Xfr zm;-*^7Gq7)6M#}pmbBSto5gk;j>lQlh+|TlUcgbx2?*J({j9n2x`g52++W!)g7{DT zsKHf2TZ-$;c(<%bTDtw;f(E%-tXeff_)kjQUGbxY7PH?PU1OS2zA8U`cMLO4 zcYv|B2ZiiSf0hVqi6|Suu^{Raifg9LUtdz0Ud=RtU>L+i_U@=G083>F;iG7|V^&(G ze*BP7jXIrS@~P^T7pKnU)5W$DDRRD{;bX^sw`mu7+U912InpM|#!Xu(EII+rj~v$o zJ+4jEOIsU;dNNoguPw~kxnj0>;~`i2!O4@qQ-_uI`NQiHN1OQ(^axO6r|w`a0xxaz zOBBB~SC=Ud?}i~|r)vo|q%2u!P9!|jmF~KvjF+%x>c1!a-ou=SYd($(3CzLDH4sU0 zJ&gX3!4zB3&Axo$?L^^}$u9^!ef0A=?8{Q5#}Na=guw8!iiP?aq3JlfxjGJp`7&C6 za`Oba{e2@5|NB;efhaYBaMs$MN!dr6Jh10VH(_~kgUCRsvh%XI_K*BjkqUCyrzHv} zaI1`>>Iqw9YN%V=jzAZlg7=e2k0T~xN)vtzOysGWD>C0%{#g~P7ueIA&!ZE#i$m|; z8yAdcFMPz0-yFDZ?7AMettoyQ|H_vLQdCI8g+uO7BHSfqd0b^9$MzRwy@?NU`N-rX zK7$S%7X`Ao0Qj)4AQXG0>HXMVyTCjrnYNbM2ft^7I-HE%lUvgZchqMA>N3g{EwA^&Wm)wSmtK)w79{n?zM=NL0&%v8Z>_d`A zcmQy~7ztSDUTPHof_IEFsIqR_wwS<>r`U~xqNK9P?CTPDZ7STfdg96RM`uvwqkAD@ z0)ZNP=PMm6N@W6XXlfKLHK~;3AEgq32YW4Tlq7I7-KzzbE2p_pxzkS}EQ3e|QYg9h zVFvL(W!w4ZDqU2j;`evT#pAV)v54RdSWJ$zuL5Q7yt103<%kG(!^648W!;h34HBoqM$QR4>aX#t=mZFD*3>q zIs*qC(x%mpWae#s>dlW{+yFo+yQQ=>cooyGxu@YE!C6z2Um$j^uR8=jQ;faNh5*FswUF(n){{%dW zTwXFSa#!_AfjslxJ_%;E3Iwp7CR2vMtJcR?m1WAR@pH^55NeP%UsTeHjU|qc@{dLw z6VyK${iP-4(aX5S9)kvPQ{6v4k(OQ2OGhb_m#D78fQKGwD0R|vfmuSV7oP);|LsQ{ YQ!IR=)%csA2wSIO0%_N-D9Drl1-6|9NB{r; delta 5545 zcmYjVc|28X7v6>p$Gi{qc67FRI;X^~B&3asV{R6jzLXM0r5xi{H)JThku-NjMd53v z*iE-g7o~wTd?^j8>t3!~Y52Bx@4J7uKXQI+@4eP~*Lv2o)_QY;a_5?=*) zUpP6!liK%0b!Rmr_l3nOgk-eo5xOc*21HwCy;?}y0Tn_gMiw6kjHQ5N(T6VOf- z;O+M1v3I&8ulcWrppzA&PzB(1GvDYp=T-O_#>Gh)jRN`wwD0|&TDhEc;6t82a3 zqR%&wd)Y8pm5`+F+I%zMNzxM1G1wU$l48A{wp}Snn*Yd%QYsja?AO3}OCm%xUi|aJ z;@uMJzkPF&flT)GjRRlJmcB@qlItH;q>UJctUPqqvgWIeWr1Xy{q2kqc>pV~J1*~? z@ICniEqqsig3_u0`=nyY#-L%B|7~r<>AKQ|$el#?{m(sDT&o5%%jv3&Y$X2`7V8lC zQUEgmz}3G$s*hVVTZ(;JItO_rhh6#vJVF4ND+Rcl_qgoo2Uf1fw%GlSoQQ=^1c8UT z$?yJI;QXGxeiI@eieQ(BfIthR9N9fuL)>icfQ9OQWxrtE&|mP|JTO$PjFrdap-=Ky zx&6ZhR|Yqoh{Mi?R-xm2vGN|B=xsT&iE4ZneOb9jh3g!(gH|Fe+$9nvBbAk#weDG= zuRaOBHq(Rsu zf)ZQ=n`rBLU6i>S>^IIURTDiVwh}%SxiCUPzceJ1~qiV z`N{yFZ0#fQNGXgW{c^3)BN@!JCh+9CnKNGHo0ihwPFAsbg#v;p8&i;P0VHo1zj7~Z zNNS~%CuX5AHLxx`$evI4-f(lI(kJXg$4-R7MuhOJe(%mo?X`vE6g{>K5^Z4l7;#Ex z?B_afuLCc6w_;f}87U!#4{$RtdY}0YEH#sQM3}+_rvVg=3QJo zQ$|IdzK+~cV&x$#zZ|H!Wlr-ID`Vx^eacoR5-w_nlbJ>t$Uqndn+(J-8UU$Xev;Xe z#Cs1ZTLm3tgmbF7HR9+GZI7l-H@7G2qH zvV>4_02?eHNi7Erez+72@&(>G6Z_1VpgO+L$-c8=Fg&yv{*tB3NIGcY3aI zsy)+4wH!VAZ+9lH?Xy2rc{7W=``s74AJ4vjI>9zyO{!~6p38>_sfkdeNC?RfUzaUO zy4^x=xt)hzzk|Wru?(O@03J~SFd7H$mvlUT|D(U<7P-KJt$ps~X<@CNRY8iY>9C)= zkP966W0cN}vV1>7K+6hqk^osm?j&_i1tIl!EHvwx zam}4>{>0kka53TavsGq&_B!N=tNW2JOx0zXiaq8}4;om}_oA35|MMZh)*kS?`xj@$j?`eQ03y%ar4Vn4A| z$WD9e_~;aQIjS2mWflgdrec_@%H&xcNdJr(-spAyr*L{okS8J!E|>pV4FY}Noirq) ztp7v-lrs!rE{4ms7>XSS@&y3eF@LN9o|xv=b$u}7Gr6ZvuyKU(ePFyc)3_9XbV{gR z*_yJ&hEznlHB!z&zW;?wa6qHO&s5OpRY=a1PQoZLBqcz&Z1Un|FNb|L(D;=T|HS+; z^UPQe;Fm@_8y=T9s8gMFsVLc(;JeWT-f{Ax! zs{*N~=i)d8hfOry>A_Y6m#`JL-iXrT1~2e{xU2*ptBF0rV?zTPJzDfhHMdrjNN?7J z%Y>WPt;APPVrPw5PVr;qGi|DyHMn*uL)pLkzFojtIMD~|{h0`G2F z^CD(u`V5|2Zo^=v zdw={BF&am+6@!`+=#0>M+NsqQ8Rg2UN2#IiQ(SvHS-WZ{iiR9!>M}^N0Pe@iLIW=7 z?^rNPmm|RW!D6NrJ|6?LEskz7aGPP{k3H09dIj{Cn7X$Ny}o;@ zC~_m;^gUT;{DyCRRF8=)=ChW?hG)^MCRJ70!y-QRiLls!fVvVUHI@J_9}OTSW++vK zsTphLF9F=o{}z^NZIM$-LbrA<(MT6@p*lFLJ!>`f@x=g=C$lE*YdBsLKL3%-Gf^rm zwj%JQzJGVEYbmax=G5;+=as`RIs~MQ8Oz!LR;dBlX2|@uVLV{K($AFZ;ps>H?-V{a zp|02JpipE(Z*3y44G8auwhPZ3d-{#Cx#)$SFl^UkC5CoVkTNg*mBGtxN*IrfDAupm z_BKi2R&_|KD@dI-j1&f{^3J z`~bn}zuY)}b8=)1+-juV$_~bye4fFvYZaZVl*vRhmhU*o?wA+XQ$NR8PHp~U<>@MDYiWvu zrCzqqDpw+?oLQ{fNw86ez?WS3spCrL_RG|hp&JM@GI&Zv;GYXl{Z_x+o+Qg%dRd6U zcoC65jsYM;jJXy7KNFrcyuRh;UzkIVHwva4#@i4c{fV-?nXf4;((h�u|Rvo}Axy z70=8ZY4sH4?ECdxXeLdXcc8E_-7RDsGfF6eV3XaLPGM#2avq=@6{Mt^$cl(5 zNpy2<4|0y%oqE4yJ(y@9e2u-mk<9WHi<|Os_o6QBlr87mm>;ZR`gul7WLUGLH-!3N z#WIj0bkZRtV{-46m4@87#y13R1T!3nd^TW`^%u41Av>lrg=#`T+8U%B+WTVTIA(`m-U?L2z7Bk$a1^>Lz#>6z zmAZ#i7A-&rtUEgQ-Ja(<6k$;N(Swd>BxIRRSqnH@#{CRLqLTRWe>Je19E3S15= zOYe0mr9Oav8|euZ`mb-dcFT$5^ENU;jTQ%c+|xh$`TCMfet+VsVap$#6=BrU9_$oI zLPz58^3i8;!2#FiCUWv)cB1FP_r_@DfWc9boX4s!JY~aBFAjuh7KuVnJ%zcnzt7`; zU|Fuu%=88f4Kq^=34mnwk!dFKy>|h5X$HF}a)XvqxAzmr&2TUMHth@gRt`nXphYwM zv0MOzPa}=DmdsvspJ%tDim=H7Ik5D6zuK*5*_KNh)&Db~)EE)c z+&b4E8(!H*^GhLDP@3W0eHYJmtfvfA`q8e%%xoG;V%+jT<222(sn0OC{w_4jdBH9{ zLh@D;O(##t4d9uDi_NZsYtJo@s~tr(ts6#%@Pakt2+6?I9|iv6ZNHP*GgqS!b54Ff zwpI7eJwP}@>uwe$0nsG} zqO%GL{8A7LBh(3@kBVVi?2<=^vGAcBq%{_USz2QEZZCp%+;o2_e}C|RRpZ+>u5P;8 zqX#_6a9F=~<4*hi;xdwF^;jqp6OxK-iy5K2rtPIyUf9l-0IQ~U%5?j4X7wNW@s;63 zW+*jgnxfrUfFC~}MSU$AG@<(*siT?I3kF*g?xpopZLG8WSMw3$Q29;c;@(5u{-4ML zA-mC;xrz~Hyb(>u_nA^><6_X^(qJZY({n_Vfr*geSR;@>7C>FV)T1fWiE*a;=z)AA z=BGOFxH?-hxN)3m8&5`D9#mJPlYUnZyYgV+%JxcO=;~bucc$~kY80RkgXch|xd)C+ zfyMxT9^yAExnv7^-NFPhV}n*Eh>I4SO&9id1Dn0dwip##}n(Et($CzPaE6DeYp{7G|qg zAn?=ABW}FiVmFSQM3tc4o(e@8Owlk$*JUDdgt?PCnYDJym@B=5d{6R$A~OO;>j0tb zt52qLSfYrZ02LHrxiPa77y=L16>8f$E9MyU>v=7kt+8+ylG>|JI%MdehAR617 zH-Dk3K$Ft>^ef62!#cI9Vn~k$Da)2^G)p@4qn@e`Z9_TZs%4FX*}H~rR~5Ry@+AjU zWMtNtpbmMEiUz-<6|lBXl+=AV5usm=RkqwlHnEh>1{!EcV9%*h2};q2ZoE3^d3 zZ}>HtiAcGg7*hH`a^?5oyjh0F3G9_~12WAmHOJ1AhLtB*hEnUEWuoXZCC6N{Jr@H> zLEHXdL6P$m{zjCm(y>Fb^htHJGxnr0AC+Si6pbN_YimAFvMui3!dvHvPFqEuG%{)a EAE;}z=Kufz diff --git a/Covance_UCO3001/browser_profile/Default/DIPS b/Covance_UCO3001/browser_profile/Default/DIPS index a4eb7ec63f82073d528167792f1fdc0df5cb95a4..a470546220ab589cea48f0f8995f07b89890142d 100644 GIT binary patch delta 97 zcmZozz|^pSX~PqH84hM$wvx=;)S~#D#Nv|pw9KN^6bAi`N3Oen%-!VhpP!LqQ@|vC z6=x1*HZ}$z$Vp5}&Mzv^OU}<_(BH87)6|CFkcd=xFLA+K;@maK{lzIx5aA;Fz(v?AYVZN0EWLK AF#rGn diff --git a/Covance_UCO3001/browser_profile/Default/DawnGraphiteCache/data_1 b/Covance_UCO3001/browser_profile/Default/DawnGraphiteCache/data_1 index 0dfc91af907ceeef077eef57ee80b319ff2a661a..bdd7a105ef6c9fcdc8463bfcb1a24c3ba782be19 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aas#$6Kw^_w{q+c^{&ftYDKha&Tje*n8M3jF{8 delta 31 lcmZoTAkc6?V8aas#w`;A^_w{q+c^{&ftYDKha&Tje*n6&3ikj2 diff --git a/Covance_UCO3001/browser_profile/Default/DawnWebGPUCache/data_1 b/Covance_UCO3001/browser_profile/Default/DawnWebGPUCache/data_1 index 0a657b7808831e89760b4a3a2622d1c5b526360e..f1c3e04fe82c4d228e4fedd1168d9c3e4a6de307 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aas#$6Kw^_w{q+c^{&ftYDKha&Tje*n8M3jF{8 delta 31 lcmZoTAkc6?V8aas#w`;A^_w{q+c^{&ftYDKha&Tje*n6&3ikj2 diff --git a/Covance_UCO3001/browser_profile/Default/Extension State/LOG b/Covance_UCO3001/browser_profile/Default/Extension State/LOG index 7e2b8ae..87476f1 100644 --- a/Covance_UCO3001/browser_profile/Default/Extension State/LOG +++ b/Covance_UCO3001/browser_profile/Default/Extension State/LOG @@ -1,3 +1,3 @@ -2026/05/29-13:24:16.539 6b34 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/MANIFEST-000001 -2026/05/29-13:24:16.540 6b34 Recovering log #3 -2026/05/29-13:24:16.541 6b34 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/000003.log +2026/06/01-12:23:28.466 58d0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/MANIFEST-000001 +2026/06/01-12:23:28.466 58d0 Recovering log #3 +2026/06/01-12:23:28.467 58d0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/Extension State/LOG.old b/Covance_UCO3001/browser_profile/Default/Extension State/LOG.old index 350a7dc..49148bf 100644 --- a/Covance_UCO3001/browser_profile/Default/Extension State/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/Extension State/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:17:37.742 5acc Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/MANIFEST-000001 -2026/05/29-13:17:37.742 5acc Recovering log #3 -2026/05/29-13:17:37.743 5acc Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/000003.log +2026/06/01-12:22:25.011 554c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/MANIFEST-000001 +2026/06/01-12:22:25.012 554c Recovering log #3 +2026/06/01-12:22:25.012 554c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Extension State/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/Favicons b/Covance_UCO3001/browser_profile/Default/Favicons index 7cb7910a39dd36dbc45e7b3f60c8b6396bd921fa..aab50555d06f0a5b8806915d63b420b27f8696c2 100644 GIT binary patch delta 2121 zcmdUv+i%-c9LIg)V<+p{jSZER4Xxce!NfM2n{(0FCC#Ntle$UlTt#V}IBAlmu5W45 zys*$Q@j#)$4?#$%8f=4sxOAqgH1VW`!c zeTkYwIosHO!e?aVO36GE_X)wE!_Bd!xI;9tqbbX5xz0@Sz6duvXAKNlEpu|k9h)_V zJQ>N(7UD$4l%Xuj50?Tb!?t0Owwl~Vc5pH*dFn=i&bmxBU&tMeSa?^7A|o?gA;Ja1 zVNsr{lJ%LIy&feUStj8tj1rTIi|Yk~!q`gc!jDVfP})Wr$z);1%lf(cT$s)bi}6g1 zD%+Wq%`1joN9C4NcOm&0dB$26?qA4-!%+CxaoFjCN%7omxK$^0O0lQ4Hh0q9- zMWdkx)h8 zjHcR1a7NCS+o4E+mGa-|36^SEygNj333$VO?-mw;RkOzaX(@!_wNl6C6-J zydf%uZ(eIHZxq9yieP{Hb@lj8@ENAUZ#xX?ws&U1^5W8FjMbO!5}+N3!|yKv_3(KD zT)GVmkK$tp3gnGH>M3{y-34TP47&!eV$Z1i?pz1zE4QowI<&9K)$)|Oc0oI1?_Ewk z{1X8nf`GS{8%yBH4*V#x1Cg|AZ(bJl>x*cQ?zZl{&acD3o8W2W79#08@r%tyK$X6{ zj%j-luGuKT3~UT3uKTeLPf^M;BAa8)t?4)zYr{M@$MWXEy30&f!qc=!OOr<09P*bd zRFsJ2hGHRRmb18wJ~1YGAD3iC&K>)&nUgzoXOV8ihTy*;FRpZgKep@P1!OBCBTDDJ zLNg3o>pC!~UcPq+-C(%cYbApxp}y{@SSO;8z6L2ef8D-E;-74sAHtwSHy@GOe{sC=aH(&45 zQGAQZ0r#q=3B+Dqgsbo%IEblhAN-T$h4%=stxFRIh5ecq@DtdtY1|Fb#v`&a@Wz4v pAwl!K5{{fX1`GvR=9RVii3ha#YVvFO5!?BBFng*-aG?MUe*>nVw<7=m delta 642 zcmXX@O-NKx7`@;9n>VA5GuYsylA2O290LD(WEonJM&zPI3M-#E&^R>>Gv*Hx_{vrx zI$Yuj1p{S*i>T){A4Dx2BGNYEDpw;!Ap}v2qJ=?s#x|Glob%oLoqN8C2|lsKX3AM3 zLMW7~IsuJ#-(0EYb-h*u3W>sCh4gC=UGi;ZG~nF606NIN<~bm7HY!~DVWI1nW&eEGzg=4P}Y4(gHv}CnqcuItvcXGN#u&~4cpMtVbVc@ zcpE>%9hkurIEFS+GG%tk(Y9=nkHWB(E8Xf$%`Rn&HkFL3bncez)bP5ONj*(1Vu%d}WIF;4(zAxkyL{wt35L zDA@7q;D*%9Z_&M8D_b|-GlvG@?~xL9h4S2qs$F5e#v{B$EgEyEvTO?N)=obZyW>hO z@18^c delta 7 OcmbQscbs>_aW()9VFLXC diff --git a/Covance_UCO3001/browser_profile/Default/GCM Store/LOG b/Covance_UCO3001/browser_profile/Default/GCM Store/LOG index e8a74f9..73af0cd 100644 --- a/Covance_UCO3001/browser_profile/Default/GCM Store/LOG +++ b/Covance_UCO3001/browser_profile/Default/GCM Store/LOG @@ -1,3 +1,3 @@ -2026/05/29-13:24:32.087 1144 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/MANIFEST-000001 -2026/05/29-13:24:32.087 1144 Recovering log #3 -2026/05/29-13:24:32.087 1144 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/000003.log +2026/06/01-12:23:40.398 6088 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/MANIFEST-000001 +2026/06/01-12:23:40.407 6088 Recovering log #3 +2026/06/01-12:23:40.408 6088 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/GCM Store/LOG.old b/Covance_UCO3001/browser_profile/Default/GCM Store/LOG.old index 440b4b4..4efb4e3 100644 --- a/Covance_UCO3001/browser_profile/Default/GCM Store/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/GCM Store/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:17:47.687 5428 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/MANIFEST-000001 -2026/05/29-13:17:47.696 5428 Recovering log #3 -2026/05/29-13:17:47.696 5428 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/000003.log +2026/06/01-12:22:37.039 60a0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/MANIFEST-000001 +2026/06/01-12:22:37.040 60a0 Recovering log #3 +2026/06/01-12:22:37.040 60a0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/GPUCache/data_1 b/Covance_UCO3001/browser_profile/Default/GPUCache/data_1 index 5c6223b0a6f8e3e81be38af157792966a1988dcf..b6a5ca22a6d9b6c3b065df5bfc5b4ba83a12045b 100644 GIT binary patch delta 52 qcmZoTAkc6?V8aas$z2Q(AP%J&Vf^Ng3hf^i7=f5+`$q+4{{H|y=M3ur delta 52 qcmZoTAkc6?V8aas$t?^JAOfWsVf^Ng3hf^i7=f5+`$q+4{{H|xPYmAx diff --git a/Covance_UCO3001/browser_profile/Default/History b/Covance_UCO3001/browser_profile/Default/History index cea9a270cd885895d3003e4f07fc9d63bfffa4ce..31f35e3b59fee206b7271cd8d6781c53a52350cb 100644 GIT binary patch delta 13380 zcmdU033yaRwyvtX)$Q#jkOX86vMJJ}_wIlp30X-(NXSBn%#&Wy1Ps}CmZa&3$|e}4 z#__4>Ff+ULK2eIM_e_c<(zU_`Aqq{^0D%vazuG|XJmCq z;hF>T&LfG(lp#cmxSLSplDZ}Jbx5X=37wI#u_I*2MWcq=iaKz=p5sO%Z$(30eOYZC zxcpomXX25}XYG{Q|ISV2_w%ptzvp-HUHo=_8~+&pWBvhtJ->!;=Ue%DzLGEJJ^Vtx zn9t+0Xv?NHfx`&NYKqlVQd3b)1vTZ>lv7irrcg}*OW{>Dy`rX<)%22@eygSz)%1dz zo>$Xv)byO1o>e=5XLi2b;n3=ka*P?NQ~5$UM$Pgk<(36{PDCJX$9>YLxC`D#3roT| zUBB9ND)%Muh6aEeU-xZ}>`@x!ZKnH!-x(l>l((rZb|`4W+?|K6nj^S8{kuepfDh^P zXZ2s`|E@owKdPsrD0Yf|ipWC@^YT(V_=TXO316_Ws<2t{i97nk3A1Ry0&&EWbn3{wRli?EmH4AWQzS?bL& z7*(FVJ=Q{~dp(RA%9-?bB5kD|>TC2KeX8EBFQ6SB(2=%ZK|D+CN;DaG5%xD6H;9#{ z4Puc|&x>+j<*6as&fRF5$?#X8TvCoIzc*Z_AKU?@%kYiTt?X5{89r71rJPbeQVuD* z41ZN#SGF5Yhi>VDI}M`+4nonyQZA0A(lnMLBhSfjY6!gqQDlsy9A>ZS0s5NGDqkx9 zR6e0!@nQOcURJo39f*8*98Tsg3tL0d33wci663@P;!UDKA9vqySn!=H2rVz%>~18Smn*vj7+BV9))WSM3E2YqFbWn5@whV?Z?Uv{b~J^+D`e9 zTtanBmgR;<5eA$IsFmb*NJV68hBVv&g0!|jI9-Hm5|Sa=EO8^Z{DI2~ZM`VwLftZ2 zct@51y$P_0BttGGbn*_gvrsnC(X{XQsP>o0qg}|ZvD+E{QOmI9p<`WWJk$#U%lP2w zP45P51`_#4G?^UuIjRl)>^bzFMlZ3!x$p2}Lv#TfA1>{>hn9}pgIqkhx&sNiea9YM z_4TSDG6-bcN@{p%G?4SI{w}xn1q^ld@004efXh6$qMawa=5W58o0p z{1JV%2%3HYr*f$`Q59sk7>H@wo8=%U@jr))4U2SprBl=>bD$U;!>>s|WN$n2-B#)- zFy)q%SEczfD_dLg3O!l1#h#*q3a5L4BdsjFcDA!V*H@l1$6ZpHW?xcWm|NMLozqfM?^OnxL%eTbitBkLUuS>R-*OYqP z`OWi+Q%b4|vlnM(+6wDR=QU?H#y2&Sy)9@g0vm~Y62?>>GPY( z<|p~_N$DnEeZx{qRdISvcD5^}(zmqORcrRmU0`jjXm#IJot|IW*kYTVVY9Z>H>4Cb znsQP-bxvP-vE5_#6j)2c%H}z;Y71@V6q9e(;=H=lR#Q!(H`&~ro|7^!-&&o#v>-RX zsr&enOkF0Xrjdih-Y;vQw!?rP^AN{~$1H;Vvz$=E1v3P~#G zc(QUgH$3$5Ztn1tP#1b}5r1$|B+rK1sjD+v0yENNu-ceRBA-Jylj?_r+K}lLK3Ag+ z*SPc8?M(?}^jt4~0*Gigd`KUY#{}M+@E5*NwbA{*O7GWH}miwAph+ad}LZ&>y z55+(XzuJh%6R!$m+p3N8nln@87kbi{&Cf|Txy(6@jb2~XEaTGTd3B2mTPsUv`|`_5 zE&1L_b@lH0vV`2$CQD{{ynp_ZT(i5zS6O1qZmF?(O6+M%Qwl1I+;daQ((ZCt=cd*; z?Ul8&i~aumoQ9f8leu|Lc2&K%0&ECG)9zt;eSLM^bYd(LhLfa)d~ImoJRxZ`w_n&4 zlB$J&qMfm^TM_B56~xe%2BAVD8o*1)0LY|(u<93++673q1%wifX1GQpUy{F&PY~QL zj0uUW1uXFZaP9P4TfwmgFp0TOc+=41PgL)JK5IL;5TXSSpk12;t$7H?mbQIIV>HtO zGYb3PRw!|=@LKMu;b1#}M|d0eDA=yqfvPkk9FDcewV9w5FsEuM znKnWg8Vcswi^?*Ja@>uT)?`z9ZBcDnkCOlHbOi3dgAX`S z&zO3?3XcmVZ4>w1#ueZfi1d!QVTAmu{H*+l+#xTM=gUd*t@03j1^*qtgI}OZYcUtq zA(6d*5Tj8C-$OYP`IZeZ+YKu#YOV_;jDtYU~LZfI}?*?d5Z zLc!K>ev8@y3ew5!BXKBfR7rIGciRirsDM!SQ8CKTM}gk~qDhiQ>9ntF^EDr6?gzh9 z9w4S9XRcYsa`C!lfk>)NU?SD;Ue$)+w5$VrS20=PSr(Ee2n{?$4YOr^uL91L@owsmVnteffnkB=(#8hI* zs&O_IWSQN~?)2Q&yaMmMrSq$2+tUiY0amy?$2w3>>GtE&raX$$-rDK?+E z&|A^um{XnVt}Zd>mAO-FHHHT-{GqLTAa)?;D%fx9fDD9tdc)l72M*F6|2IT$Z`NQNg$aFqfrPlr zBmXFZgSMNJgsgv2_;gm4IfkIE=YjTS4X(NtcIN7K9$Ya~-TGn77iDlpDasLCNl}9> za`SxaAjHPMm>J^zXFn}dkqb3>47h><+Xf@!zdAVx$!ZQjsx9od1(#D~zgc)Cf1+xZ zej$6i8c5B-RtD=c3y&^7&9{NyiHQTd9Eebj(n3K4ZD}efsSu(59;Tv?{{4mt$X3~2 zs-l{&MNM9^jE8~sUk*f3$GuJUikJtl+Omnl23ut8*_DGJ_l(uBj^2Bw`}d3<&UyMX zX3NI!0F&4K_aGpvH~^?Nu;0-ZY+#c14KXmI+5Txv*qVLX^>#LpT7&h2Rh-eB{hWyh z&rY=s>~1crEz4(tCEG}vLt<f{Q8zVG6H;3ygf;8@0-kxz*~qEi*MCw zIQd1nM!p3f$6KgQr5I=A2@nUAJn}>o9zE6TkN4WGZoAQAc6p38kI!oKc;n4Rm)~x4 z`0PHP&F0LQt0Lxx5%FfL)$MVcjHY2-wvit28M@FuS$n8OR z;%zQ#e7wJ_4~{|x5sY_2sK3CrgeM=B zQng!xw~NeOKwv}IUASQv#pxRGP>*iw!@51#r`wI~3Yll%>2ha}ZfjND-~*x0Yw@6${w_(phO`pQ|-`G(LrZFZoatwyR7m1XFCkQWs3&2GuinWkbb%_RY&jS1! zS(Jh!LXXbEi}f**P(`bQO}bxc-_u5Fa^!pPD?$|oln6sMu9>5y5pwz zd%Bw>K8yE;a!T>8Xz>eh zmEXt_T#bDq{{jCx{|u?9#-+FOf97B2e?~*Z;ovY06yx9FhsBHh0UA7hUFlM`E1k*) zR zV|)Rh#{a}8>G0hql89!^7iS=ub)1ecBO{Q+NCFbW9M6_na6jTyx)C9jZh)$P0M^4x ztXd9Kmv^uZs>?c93(tjy--rJh6Gx2@1zbQ$G*svx)*aCe)23=_ z&+y~8Md)$(7W)i|@(hj%O+1D_;E3_KWFTE7;g8V}y6Fl0ou`06RgyFY_4F->4x*JWj(+?vP3HC1Kc5HFRg9(!+;Gzld=DoAwP6j zI`a%q(Wo6O1drb(At`Sn4IM;Y7KTOcW1(Re1&QDyziV=bNKRhiW1_;bJhinaK7JGl z>61GIGVTmdyJ4YYwWXilHx%))6KU{)wdC7(!aS=y+|rl+rpX=LP=G|N=czBxP75%W z>F(-&Cd=`HM|j$T1U`KC85$hxK)p4&0W~+OHR*PX^<|n71GY@;faHlQOlB5RXW3HP zQwWTwk&T02^DztB#2^iHoa2T@E36&18)79Kczd#DVsMpOv{?1d*-j^1 zbOv@!3aTHLa;gd z^GU&`?~`R6YvVB8Q81y0O>u+HNx{bNtGHIJNOurSy6F#EzylM54XV%)`wpkM-%y2K zR|LAJ=3ElU z5o5=Dspsc)mRXH%i_2lOncZc^c$d>|^isFaLA_YB-$LL_K5nR?Zkv($s?_7Od#SVObsOV- zR)?RusaCVeL7;=5d0T04%Fiu7`Wz9#zf{?~=Ua;BSR1Tb>r9 z$xA8X5IBbftbFWvkJI6>yQ!D&wc4m*O-^QFv)kzMxV`3hlRrM*MxIC$5~uWZf4%j4 z#l4RD>c;6Y&W49ku#Xa`$EigpIjeszRi5X)Q!m&vG=+PdR$6>P34S>f}w`T zMNlB!+r>?!JCR0>?!GOX?8p+LiNVEd$D8PO#NqM#jdru2?vmVowjZI}6OY|RRq|U+ zHWxXVL5V6AH za^tndG(6=7nxMLhO_T1BL~$)Q1Ae7X1a7+CR_ZD{BV!Yyg9`HurG%icx(I_a@Iq4B zoZaN0Af^m3O72l%TlDITaLv`m)uS=^3VxH6QqV*KFNijhBuY}-4}N0MTvt8KTh-{U z^p;Ud{xn{ae|RAVd)C}(crNT(-=HUmC!a#gZ`6o+@)&87)D6$7<1+arv4JvYdIxEK zXvtyxIXyuGFa%fQXh<%#h+63^{5C0dXcJMZpM@7yhK}i!=(`ic!~O1}jxr3shUa@f zj7;+EUxZsj-StR;p_yyYR2ZeFi>Qe21%?Fu-P%{Q8aV^sOP9iWEC*%;l>U>twjch) zsi3;5vaYH&Hm|C--c9!G6(VHS7Yil^3?%t&wCsjG*+2NE;G()vZ!usC=+(OtZT27h zn0R(&V_9AOlEvFvrGMdIb|W;Zwfb2b*OJkO{@)@_=i6k z{yq~kAD5a~6E^V;I@z)jJXsC+vq+B~HUnLw<{`Wm+oc!yrG}7U2Dcxb*1v@2!e%<1 z6vLQ6QFv0K)5>i$=#Av0+3nrbhnXP0jV~h{=3tGu;X5_Oa9QNjd^t%nihf#M2xrwi zB5a5pyo`N|kh+T9uyX@j#%@^Q)phJ5f=Q`|dKRXO2&fEOn8+`8i3aHcyqc7;xR}uM z;Y^~);uLaXr?8X6J&O)T2k-20=^BCp2It|G!8Jqg{1TPIYuveS;N{+>&qk`focJG@ zN(cFKWabJa{|AIvPGexy9rhNm&r6hgz9_A*Wayw0zOP^@d48Ixmo6c$_Z9UR@P}XP zzsG<-yb#P6;&e7(NY;O?gEl&EP15OuGXleUuVvieq4~&qe!3JuCtc<||RLdN6wZM^0R0}C&zVV40^ zA;8)h85`H;=#Z~%;j#CYUq=g$4)I#xFP<554UoknS=R%pqeJKiwuvGJ2^rhgK6f2R zbB9Ec{TB>4+tZyQ=NR+izzZ7#wWSB*06051isE{%C4{e(fK%`PL0!b^P|4X?s)dpQ95&^ZTFn`{S$ntHl6-&0E}=u(&=yc_1E)vJwODB}PYilT*B7JzlRTWsD~!$@@%F z3_@wnKx<;3;FW=Q85|rqm6+C-vUXVyR5Db{ZOx2?7n2b!J=kbNK-&!ec{PNIkn*L1_0kG+C64Uw9eW>MU~$c z$l4^yAr?IM^{5DxV?E|10&WdD-T9Vy91H2oXoT6#i66coV*yiiZ-TvhqY>8YoYeHh z;ws8dT7qyt`sviS@wQg6eSSy3ch^VS52wE7+!1{f^*)p^&#pce_ z$`IbVS1A&E4l3siOVdKxw@csIS(bvs*}C;I8~3p?4m%MFW%t+2AG)fS4$3AEars)maOO-K zl9{-lpiG1TKpCL(N;;f+??Mvv^Ri~{ycW|L!(gBXSS z1${i-M_pv4c3YdK9#Z4*8|VR=qckg{AQztL>Ov@Q+s}Dzgci?zb8wM3_PpwgMGuuO zK?>C`lx@RwB1$UNjfx$9MRfVR{kj{Zg0jGO>4`VZFEN#Yr z%@Uc7YV*|SKA;xBcASECfLfzoS!zV<<>X^}4{6*Tq4hOjyW^_kJK!~tBRee;a;~=w z*euVh5r&7H7f*`BuVS^iNth-Ao2%2cf!N#tZHe(hG3z<)oEB0#Mb=N|zi&iTte&Z@ zo@_>A7a&Wub}dV-<-KaO1lT4rYP1X#G7#tCva!5=DIF?&yR~B@&?NmlCug)u$vQzt zuJUEP`+^oFx-Mw0g&I><06UvgABizQi#@^mqczv;;vOH_7<9W2Lt3K2va#u~m|uIB z`oz)kq?8~46du=s=1as|Ff43hF8LbL@>C73OV5IQ3qk$4e-+9RHIKBZ5H4w$POuL} zp(0MINP?7-fy^akP6Cv&!Rb2K5TeiE174vv-#muOOB*0JHMm4hULZWxQ3 z3A2v06WMszH!tP>Z%J>BAV0`J(U{YtQS`pwN2qyen*nH?-)tJ zI1+dzZ32%tCPRDW5616)6IyIvh)!-|<8E{%i7x1D&I@==`LUO`MR6qLu|%C0oxH(L(JkD`kaj z0WHv4I9)~$@up=o+hx=l)y6twnK8$hY$O@6`j>jU(2D3*1>^hSN5>;pP%LgOrvn@q z{8R7CrI+LQcRR>PzSK|W@iTrJ)ywK{xh%`l%&*OdX196Qydj?WX+&tfM3J!NF%|Sy zR3hyJOxnOQ?N!!3v)$}NN0B^jgL*>Ma5BnQc0%cr*~jq%qg=0}odKu&V%RKY4?Rbu z7ig&Dj7PlVEV0Gy{WKc!%xUr-Zl6Vi+v+GDU|DwnYiGY^>sTI3X1d*Bzi(ICFWaeh zgmp(2AGgGv!!$;rirEV6#b&FFHJYeACWqJOs8QTgP7KlY33Z}aX}yEw{g2vz>k6rs sW$7d=uHZcV67ik8q>j&K(jafYB*jgtp%+omd8U&E-Df(OeC^(U0Z94IZU6uP diff --git a/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/000003.log b/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/000003.log index faddceb7d94322f9dc9385fa702d63b3a3b31a4c..632e552926542b77d1603708a94187840ee2766c 100644 GIT binary patch delta 11 ScmZ3$vzcdu0^8&dEW!X7^8?%f delta 7 OcmdnYvw&xV0viAd+5$oV diff --git a/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG b/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG index ba98fc8..a4cf0e2 100644 --- a/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG +++ b/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG @@ -1,3 +1,3 @@ -2026/05/29-11:20:05.334 264 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/MANIFEST-000001 -2026/05/29-11:20:05.335 264 Recovering log #3 -2026/05/29-11:20:05.335 264 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/000003.log +2026/06/01-12:23:55.075 5a78 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/MANIFEST-000001 +2026/06/01-12:23:55.077 5a78 Recovering log #3 +2026/06/01-12:23:55.090 5a78 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG.old b/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG.old index 040058a..ba98fc8 100644 --- a/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/IndexedDB/https_xsp.covance.com_0.indexeddb.leveldb/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-11:17:21.700 5a0c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/MANIFEST-000001 -2026/05/29-11:17:21.700 5a0c Recovering log #3 -2026/05/29-11:17:21.700 5a0c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/000003.log +2026/05/29-11:20:05.334 264 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/MANIFEST-000001 +2026/05/29-11:20:05.335 264 Recovering log #3 +2026/05/29-11:20:05.335 264 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\IndexedDB\https_xsp.covance.com_0.indexeddb.leveldb/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000162.ldb b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000162.ldb deleted file mode 100644 index 5dad01315bc1b22d7408c449e8a2cbe7b8d591ab..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 30021 zcma&O3$!GOSsvC`J9{+4&fcAUNrSYoyH^6FXzp&kAA=Zez4~3(yN)v{-=?Lu@Q#^NIi?WJyfcI7jG!EfPghHb@8O09FVPfpugl0b7oFEJ4SJ!+M;* z@3LZ#Pe##9&7HY5-M72{`XAr_{oh|NoPMtJ?HyT~b2t66%!->&KOLuDkUSL|rj_Q| zQ&xK3p)Yj~zwUqi{rlo@rZy7GIeNpTBlXG~-hTP#|L{SV-0b;!<{`}xlJD2+zo~7*Urv5KYP!UZ+P*U&KtRt%t`F@%&P+1DbCC|wIauU3O6W} zLTUOGw`}5+Kv?9IWDVxjKxu?x5z}B?_vqigrgJ2H;ON~aWf`B`L}>;=ND3n{oMLaB z)J9x6CpS-!llMG{zUAC0jUU%LoiFox=Lv>lP=-WVPEiDD zGI;+#?{t3p%3ocEAN?r1haa-pj%8IDHk?GsJ$kk~xp7hk=kP&|^X&f5GXzB-B#zMU zc@lZFD$jrXUv@hDqe*P}Mv^%2)=tDAcdQcL2}RaH5rA?2(I+~cpLukG7MJ1OT=|I( z#TIX`&8jux$ap3wi>JaQeDs)^n+5z;U2x5M$Z2^=-m5VZ-GZw zg_8$~n||R(IuAb6IeGHQYhF;4`Deb^QQ!$y95_i?z~jPQRGd|L@ZW#)(dEc#j&7kJ zUY(Uq20l_$S(fIdW1rl7=ZTftPtunI`|QF0c=S-`iCfn?4}Qyo*B^Zld#ZE)>pJf` z`isH!%V+25dq0j99cByfyMZ6>f^VKX3HRE^+%!Kw%hKZLD)-y>UVZEgu4w^&d!$_R zaw91xpX#75z12ASdvAtk1?O2DSi#ZcdhWPj5dYCHJeC$QPfH)aiX4LYM>$uCyx}B89LTXIeH|k zOn6sE--iBs`f_2V{GYw%yE$bbfE_H;e%jfW zxnUjR+$byKtzfOR%8ss#eYiq-6~Lpw`=8G8)D2>8{p1h%Pn|cMWu;Y8K4oMX2R;cG zIi4DRi!UtA4Zd?2|`F|M3!+880}$(B=?RhHK1y@4Y|4 z(QkHLc${-)Sk{$q{^9psE{c@<{D=R+@BCcn?8#ra4o*}0seSWj@A(&9xCV}uJLQ>a z6!7UfpZ@L#U-wVnO+DJV6z+bGdrOuFwNW}};L-O#bU8_r5C7;jD>j1jo9CTQaPR+e zt%kt5@m}}n_d3jqi?+mKfyYB zg3;%oP8dSZsdh+&TxdS0xlxGk9)5}+#(#fA% zT)A52m2+HOx$>q?`tQE*+{a(r=}U{NH%|K6zpF0wwJ#-K`n!MjqgSqXX7^w3NU!|4 z_d2}OANg;L-|D1ye*L~5`oo9bc;#sP!BEx}Ur9=MFJBID##qsal|GIY_U$WBoe*5ub4?K2m>`x*6eAn^s z9uvroC(bJ99zTpS}N~-#h+Er+{;s zQQmk0N1l+4<_QeJs3#ESCW7C@@F#lm{Nz3FdC!f9-ge*Y);0T`0sT>dS z1@+}5mz#5X*jb#yO)|38*MvAUV%zW2=B5y8#0&dc68G4M# z7S~-;OC}ji zwKiVje%{OIt?g#?dO3+&e|t(L3cA&)(_y2cddPQAi|uCYb`=sEwkVx|z-v&LEoXHu%n%o{GiNmU3?>kjS>*hE`_KK0cq-vkX;x_D#U7k~zZIL~{QBU4;1Fl{Bt4Fu_5qmmlciB9itD9`y57PCS(9a~?2?nRO z$@iuXGhr>BB$@hGkG}Hk(SAEJMsg69yY-+=cI~-1YR<{5oQSADGkaCa@%Ahvm*|`= zdZ<8H%F-xA&#V{1_)H{EN1;a}JWUwhTv8NJX3^N7y*tR8QdXZaKvjPribcL`-G zqtYtmx5#EeOk~V4qJ>86`|LhzRjF;qS&Iv(6b%@@W+4>BMSnM|-H61tzD;m5_dM>7 zz3mJD2q8?OMeds1+^UW0JZeY%(dm+|Mm;AvwUM#dE|O)u&$mtTVNyfOdd{H zdnXv{Vc$P92fn^?nsK!mH|?O$4btUUU2GGBJl((rdDo4TLzuV4rRxMsvn)p5sV==` z>DV`(K*=YDRs6%%Rs1H({!I16dk&EO=1we ze;I2-c7jZQ3bi;Xpd3SWe+79T$uGA70AWX1j~Z@v72oTPF@KwbW$aBym=l|>KjQ~fB{bBC-W)KW4OL5kntXw}0GG2Uf-w{UkQs(=;fbTBKLHU{Y!nZ#Nad7f7j2s-Y7Lpn$ znIi=nS=hPSoovyPx%b0Q*cX6&kq6(E-u%F8I#1vG*0;Y5aOVJE;AsFWkN)w;0rvpl zJiyGCp)$PG1@wTwUxqf$30&g?20A=vbmtSVc?442p(g*W7jK#Fj0`nyicU3Uxz>km zIA*HIAW0V;DQS;P8Y<=;CmFFEHy)XUTc)uwA2!>#O+&hS^m8jfb7}5q@E3rr9A3gT z;=;Lc@4tFPzo^>MUw+g_l!l9gJc|Hsv@$> zf|u122cL0Yy5}-}oqgNYknMso zyp$PgJF^+ z1kP9{1^#RzG({ddInrhbhG31O$FDjRX5RYO_dNH~JukkuHVv^WEDf?crI@uX>ZV*f zsk@-gh2H5V!A?hW$34ZxbM0m0FjS_m_Z6YX-Nnkl)7YM}V5B(_ zy0EKh-`%=JweHc|z1q*+TAmz?^PffCAAa>Z4jnGTQg^cyoUdQHr^A3Fg0Y@y6VDH7 zj~uwIOHWq&KyZfLRBOx~Ga4iFeNS6VMqsze4vp3AV94~X>5du_0cGKAJvUB1_|iSM z9Rx8j7j0=m5I|z#M-PtjqUAZ zOYYXH?Cj=ZNPCO@)RX6Qv(SBYIZOxCRCPQR@jb!NXImjgPCoL|Js&`A%B38dup!=1 z2r?ABhBhn~F>u>9T*tHs%CRll<^PZSI&%A!`)&{OSz=CRYka$0@N8a-dx7+44Lc=h zzCVj6Rhn*xu@WXV2ex@emi9TDFU!elI@ znyp(ewOOdBbEc$`y@j4U`_etvCF6QFK2B+wyx^Y8)S97CP zj_O9BqFYo!d2G{7^oX0G^~{&+X^s}ND2Q+r=Z3D;OHXcm@Wlsi6NJNnZ5az^aEqlZ z6vthg#ZZQ|DAY74mqZD}WH1{&dEM!?!!tI3{F>cFx1wxFZld0L&(s;em<$POA z!(_SlLen}ef|p*rwOtj9A}i3oHK7u>;ZiIpHG43~b-!uoJm~K@v{}!+21}7T*fZkL z-Lv7UC(P<*N)^YSeqi?1*BUQ%=)0K&&bMH&mt$y7$bD`i=uj$KXPZr;qCePLj6L&w zCXmFrA=n*Rx9eeG=&Gi}nvaf<-&urLR>EtfGI z*TfkbV_n>KNWyh72Sw;lf}eP&`?DrpZwGT%G-gw)HZ;h7Xx2Y)URY+TOPZ8s0mPE3o zOou0%ufFyX94Bxb`8pXy)N;M zzs91a)6azfiBh*VmAYKG_*%Y5ER+L~)3p(Yb_tuHC<@1I(=otj923JV z_mhxVA~&+bWuWutN>dGHfU>JImY>(ie044@H-bn@a~o67H8njL#npH7jZ0TOZ?y`pf}X~kr|IT|=~YL;wI638dSH)xMyh0UEr z-HfGVhPGz5H=rT07@2a0dL690rR>!EQ9A991ioI6r3g9=V-YrkKH%t}8eiChz-b(~ zK#L`yE5c9%g2-lU$3ifYc5EC>WJBDLEM(w=JuKeNs$RS*lgt>;qQc8)b{EH?+*7$x z$T=BeR(KL>Y_mAnBQEJ^hU^i7UkP2m)~73R+tuf>p6~Y5WN+ilAPjw(Sm9N7w_ur` z)18)Mj`tgFPxjWziT=_(j{u5Au&?JN5I3(R*;__k=_I*tb;DfQtI@D$XjQHTMAcZL z+*0JaUs!QpF|posjrf}7U@XwOg4wO)>3WbK|Lv3afAR6#5EK|~yHKww(;_Ly!6*YY z7zAfX;9MEnq*#W;Xq2YxgH@76vnspGP1Dn7syfRvi5G)W?W-i=sH7_TbKrdBGn!sp zq*zCQR%#VVPK>N_%fm-T7LFEC9%;;OltkP>sO)m6>8!|#^C%H366p@|ES51NlIB@^ z@RB=Ue*N8!_RFt-CAr>0b}dy-c~LV4GG2busNs_+aH_^>5r}G^mD2&66w>c}NygDl|w;ib6XtU`~ z$NkyK2O(LSGy#r-TNr7%High6i(`hvVibxakY62|HBcA2ej6tb4kA;O6)U!|CjG9g z<5s1j!vW*AP3{iQ&vQwCT^VH9*2;H;vnI!cts+ zFK_s~#Fpwv&sfM-RDlHBlGCq1hmou-ua`4?{?IG^zbV#a*IRs$j+i_Qx0m8+sfAg_$0pR0M@C+9q+z#Hb4#(vbQPT)k|%+y2gXhT>cyXKg|!krk11 z!dPuaI?Ee#QN5_UYipJu4z*=hwr)#AyDV&Dv7l#*si;SuItr%KV5b7DZsZF&n(t~i z+@-Q86x@nO#-x7XAHR;@xy#Z1I{u0+p6Qw!cY+60Ol?MzvZ;nn<9CbD95$lLW>`Gq zTKIewUZbmNqPv8)T~Z5vWMW#emE>h~;U5$j!nJJHrUAzTQZ-%H29sDg38w*;0Ty9! z(;+d7I{1flx<;I_srDBo)D3q~TM}t)sc{ciWwt_w)PnS#wK_PBy@P-7`+-`bnHY7` zuny8}Mw+{AO<1$0n(HIMtkexL^j2zSNDd{6?xa8D_C?V|2{yGWEWx83X zg75Oke&TAE-MiCo_qH0h!*nuDj z6R-%y8ppr$HU>Hx7Fr0JwFuM3FJfiI3wlIP3{92M&9>|dcyk_@t2{dkInE%@ES^Hs z>G^VaCjH@8Uwj6qNY)VtMQLF*JHyAcN;r$EnCa`Wg1V6w<-0>O$Hbel6(Q4|tZvtP z!?S2YFOs^658m+zpd)~TU#I5Qe+|kGHJ9o^$gQ?1reXYMyM#nG65N>FI^KwA+u>m1 zh;}+G{oYzHgq0nkiRADeq>jb3$oy8kKp-xH88+@XhD)*t096x300p^->sk=`jEz_{ zWEPqM7<&jAXTFtP2QBMSw&{z^8BJK#%!*eYer}&9?#?noX?%t$Flaf1i~_UFVb?Af zd`bwj-hA8+^Z~W;LnQ4-YrDTP0=F5aioez-Xr_dttXs~cBC_0YkVormlsvWC&qnLw~c9&I{0`PC)8H)cDyPkyG=FS zL<2<0eY8p$Q7{mc$7gg-pnY=JO6YKtO7a1zUZU{hAG>kq58imUqy2+7el4?(BYPv^ z+Jao^xw6Ey3A>4tzGp@r60Rm=F0P7^;1S7sG!2a z`DVJF3ZzQ+>mCo|!9!++b{xI)(dpfe=RP|9nn_Fo4U}LZ?BB&9txcehfF z;`0e13rLLvA3d6m7vZGq`b86Jsjz3bxoo#?v9_v3rtN9Y40aqRA@j6RGuH5*{p{1% zDIn6JqqrM7gY)&P09tBm70ryhgu02B@kA!dWwAsAam5!QTV``&=gTQR&sM6MDodD< z^>H6wK3=A5Z$G5{3!8v3ESIuu++rw*8G~Xi7UpE2?191zVjLPHZOWubVA&2f@ttjV zMpaW@We4XQWz>uDxQp)Bql7V|q}WUDxPiJo?oSSI_13box>T?3#f8>&sxix?_H?;U zU1Qs($f)cNu=&Cxpu$h7ARn*7!1J|jl{wL_zZQkq{OW73vLKwg^To&Sc0BjR$G_$z z3Fi^&Wajh+C_T_n+88rfSCwN+_w&kSw@lb1p*LSl{iaU*ERu(2x|9lLv|~YPLj^B8 z35B}`;b16YIY5fA4$Yvp<2X2F0aA2Pib9~pb5PU1;6;~vHq~b04Atcn%}jYn zxq3uNSYMpQJ${y}&RnS`C;C_JyH2Ad3vKAv0VVa{fRbmpWUnZ8AZ(EVzxMaG!J#X` zKo{!~#jl+`Iw9#{0^}6kt7mpgI}=Q5*)gu#?0Nu9L^gn>+J zvxdzAT*J)cUz|QhLBm6shWWxTXt(*f=dRQ-oslpFEd*IfGo~xdl|dwV4KdW9ZCD4D zfJ`?BM)6j>=E4n3!flQ!%7U5BR*Nvk`oLK9rDety1`>NhfM5l3xDda2k~-i z<$5;9pZzuZ8iP;>`E}yvxxa~7MN_4ILZK?2lkAH|D_T8_{(^Q{>-oAx3$3v zEN-l+5rEoZSg?9&&WE%8J{vQk0S<<`xeAl_t*stl3FcWco4Q@QHA_H^S`XE*YAMdS z`Pf(^OWZ^8Y+B-A*PY2unuS=%gfFZOZOu(BwZIN>^9X~JEJ57)gmAZ`{en zp<}wQ=yrx|cV#Ps#HK<z>!`gq%9mhv7o7fp+DO-x0kZ7&Ho|_y!7i9w=BB1^y5k z8X7}r+CVTHx*kx<;-pIg{dz$OSVW$U1uoF|NFHOe5*qOC#);BszsKVyTxe*hZ+cVP!WZobEp>8s_hT05R#wv!1y1iugZ^O8z( zD}VMw@4N;=1Dv=UD1q~@#wCO;7DGfFPAsD_HiJxy6JjK_x}-|0d8C=h$Q1e`bu>1a zA(N9U*A%tJwdz?ZvxA&j9RlYP0MuW0-(ne{LZ)%kMvX81hp|JjCXCks4!F357$)JM z)I&d0ehj>%SM9L%oFkh#%ypV_9d7fMT9+U?U&I!bj|fns5fGjHVr;X6CVo|`pA%x4_T3KrPjt~862K<7bx|3jz zO2f&}bEzH}7Gy}RQvz4MjQ10A?xu5Uu!twfaQe`@cEg|aI_xogA@2ONb+@DaY3pn0 zWIOif`kJ-*!YdC^+2ybxQh|h|Fg{{{I zs~rDM_ZmVu26p_r_r001DU78|8>;Vp8iNvmT7iSM86esiAgkK`hBx7}H}xX7@uiGW~$5rIK+ zaR-$3kX$GNIz1Lx1D8S&2V-3L4xs+QQMekE7+D`1rsbkvt$DLP?K&7P8AOCP>LBXR z&U-sConXK^fKg(na)P-kC)fxkt!%p>wHlo-huXRhY+`3^h|K0aMW0cGG`36A?lvZs zv#~j7XD(B-CzF@%xy}-h|0(S2l;Y=Jg-)U}(YqW60Cim@=!ETwKD#&l0$=t5Lq_|6 z;xw}2;xNx$(q9wHO}GiU<$k|TjPclf9_EO&@fTxwO;|NxaLfjV!~!M>qpjm#5pJ+1 zz%~qs6a>c)b(lLVUC#zlykHbLJk%4UCGBB+&%rosfmC#Ny3uyzjGY`9wOhSFT(whc zE|7^j%XTxfFJqcA;)xn&ca$(HzdO`9!L*mW73Y9V(MnfJh>%|7i3Wa04g> zGo!n8!f^go&G0Q5LFqJGHJa>iYzMbza&F18xCQ|uz#N>2s8Nq${n0EN%m>bXT#jaJ z(FYO(mF!7>ccA297{}T`nxQypn51h#i2)LtCV{R1vVfpX(@j39KaYfpoV(XXnkvV^oyfK6Px(UxvHHJd@NqD0W0 zxWuI9vx>y`MC^L52b{*#_1lPFE3w)SwsuS&0_PDHMG2g}^Z7U3?Px#$rdM*wt-xpm zwWxXu3?+iZNak)uG*y@i{gO2I6CPkKa6_sv5tIz3SiNyKOk93cIdLSeLjU<6-0e*k z3b1RK7!a(2sSv2NoL<9w7O47E1%mBsriE21Ah;t54hLs2I9a(lRSRt;XP1k z7UKY=X0RlN!Z^#o9GZ4a6f|zAOB~CWKL*|K!c&xUuSt|%qznq0;5gPFW{dg2SIh+M zMe^AylmqsR8zG0_(X$3%X}rW%J$zX*RMJ|Dc2`LT9m%>=&0BQ5++^~EqhZtv-m?p^ z4B%X8~V#$a6 zp8##mhu(R&qy5l3zZN*rYQS`vImC~M}( z!>ZpK5qm>l;I5u-aDOuH)kCa^H@k$_H=8P$*-I@CY-U66d-EKE#r~BRG6uYLJ)f*=GgHlVto8! zd;|Rr$a`2&g%aQz7z&&k^t`|;B0wKe6ypMJBY>Sn$qTY15OF0@8+!!v(+wA|p$=^N z8)Tb{Y`07^gc+T#jk8518y7H*7CmZ5BBq$c)Ckfxp0dg!h3;a7Z!l!oU9t;lKb_Yz zlSb$C6MkTYZ!Bt>P*jxML*)Xki}c9oGJ%Q@)n#0;S6wTG(sQ$>{*PEAhu#m z7fQ0@+9(4x$UzMt3_wi_oEpPTRxYOK?F3h}MbjMr=68HIEEEvr5=rJLlX#$!=gI)) zbHYV#?M?OyrjBQ7SCV8&T2zAXg*y==Ij=3_O|CRX9?SK781DLPEg)Jv0%?QU3nf}9 zN6X+u|D%V282JA$HK5VE6)kMEEQ;B%r_q?a*Zt*U3f-qY9by|tHfx)x7SbjKZm z>=L2F^?XRA<SQD43Lz7yc57YNH|ga_+NgV`I>YLW4n3Khx*soD^puv2ruoNb$GvC&`C*7Csc{6ZY z1Pc5Bfq!G=<{54$p^ZAS@*I+h0$OBHVHHL$1=Mm$G3|SR z=YdfM&afbfHgEv?gz13up!R1z^v>HwaHe^PRyv}CX%c;&kj)5Lth3}SWcgLbuY(ze zFS}$0!W3|oRj-G{mb5j?73YUdx#3G_gfiR2(fvY?%G6(!PNQyzN$&X zb{LRa$G`En52?14GmtFE1v{n&=qBp63K}Px-R4Q}R9E~B)$8J0${Cm11q;iqmt0q~ zcj<5t3awF;Ww6W@b6)q890RGLrxWv@Hq;wR-={^(#QY+f3Nw!>Hey*%`iIi<2t_b3 zto_E)>@7ji%N~t_*RLimUeA#cRA@D8?2@YF0Wjyl`jTxP5(8_y_v*Glc7O0Zyf*m1BwM81vQ{Ub|Jx{Hn2^g(|X~{um1p}oYJFm z;GViGP#{feauh~Xt()txJ`Jb1C(hB4I-51Z8$SQ0@2%;HI$%<2J>1W!4XSgA<)&!N zO^pior$u@E_kX~TLaB^tC7_EHkdDPz4O&smhC6`@pZ)UdzhSxFUd39_2vMRnAd_@j zhjneuL98J(7(X1atP7nczS_pr3S2?1Lw}f?FrXwDc~v-Aou7d8{R6;;pa={)QP3}f zDi2s!#-TueWFj^StuRH{2a?{w?9cqPb=xzR#uPWoRb|hlT4i=vZBfOXwr0z8)K8{M zpiuVHSP*v1K}`|N{H&#MvA012n=Y&gGtw1SW0O9t#Ze0?ozLnL>n3VH3mhrkkLH0R ztY(a7?R3sdR|m1)H4<2I^3D&u`))`31MmLpO7lIVMC-|nQRB6jpNt~^d@mTuE7axB+3Mz15XFzUayOfKO$Hw~< znxZiSY7R+Spu>S-7sb%bXCPLDv%ox)24t6Ln_^QdgKXm_3A-IvNtCcE$lnN}%P%o; zc0tZ#QI{DnC8Kz5E)zKks^G?F5VOo)M@u-QP;kzuw| z1{055WxLhN3Rd(mp64Y!c>YJDXTUiefFp401`5T1btaB~=^YA`7w|0v@QH0Oh6Vb0 zjJ2T1-0trzJTKYEk=oTtn9c?+s!|Kg&gadkdETCCmQ*T1IoLTD{GvC(%y_pe$0_uO z>n**ccjAJvgGx{K3pQO8+r8cHmu$!^hNiXalB@Z827MLFujeBy77zY$m4)JRx8?@U zzpB5vg{Jd`wJW4~6&tgW&tc>Kc&txYb-w8?6woY;5NQ>G)B!jGN*iFLoD95eV=dLN zusHnrKX~IcSQLPX)qA~XNa*xP5^A(#AS?*P-Q#!tEP{cc#I#J%Pk`9-lK@2W36@w$ ztRkngHq#S4-i9Gs(@SxI2#xFT^(6H8^?12rF7_xeLunm=t}b8r?NzbC;w2)H_}QWw*xby+tjn zHd%!=WlMa@6TOO@^Ep0Y=30W_d=7o!GL_PNF(&%E9QFW~OvU*o8}bP9JP<&j83Eh@ z3Rd9WZHFOj6Lhr{+%5$=KHLC+N@56NvLGC=uiEFcQ4q+Xu_J-R2u8&~lKol#`S>3qpqd~I9O?!GgRA3zdtb*r z{`s@RqyhvKDDVLmI5k)U1PW}({1jKkjhxKdz@RrW*Y2*VPvp#&6c0`sqr*M zdDseqZg^B*c*i%Si@#;ZvcIZF#gw)L(ZYk0@7u6Vi8qxfFZQw;Fulx&!!| zWZ2#r;B4v1pio#1p3mL~&>Th&2lt53?mrI#zBxl83*PJ z_AIKh&1MbL@2}5Kah`Q`O&4;z0n{s{+K|*HkxfP9b_y(%cNeZ*)XRQB?t9KMw-+H6 zq`I^NaC)1B)jUuq!d-1ZN&_n;Hi06pO_LM|8Vv(C4FU(nFKR)bci_(`z)XG3@fey< zTeHjVWZw2}*oMzOXZm`DJFT~($mRHi&i-4q;cdVZTB2y%&I1h-us+pPQ z_ZFh6scsBAY<73NXA*_$l72KvN;57+`@lQ{0Qt&&cROH<@RfjhMr!%thRH)=W=j1P zH;dIc!>5xzLxk&XzX0_}Z$FPyam_V7X!xhhZl|Pq$}K@bIp3(#$p^pqI0AD)ND(Hm zh!7RW%o8_E3&!CL$6q0 zpMqsn?Cm{##w-QDlRG>8`>$=A7lZHzDcp-7E-a(#d^|? zO1Pl`?`R7uK(U^@3Uj(!YQ)5FtJ$IpY~pQTiJ-58ZD7iUT|E;1jW~e6Ae}<`zzrB5 zfS?iJ8q6yW1i(4Z<11IRSWWJo0;UuqxRF613!@YHhywc!vc4 zxI6xMwKSfsiM6RT!>!OqI3*nS36rN}Vpa~eNX2>+zqY2JADorUFrQl$rVV3hx-_?b zWOre907(6NKn)LW0ka64HsOX_4D3;`6r7@tfB*HDfyg_4>%V@4h5~GxFWg?<9z~0i z^kIiMVHX1?qx*Anpe(xisX$OOkK@N1c7^IqJSr|GS9yO(!}Nxa>vSp&Ga)U!Im1Ts zc2Q5d+nL&ee7)be`ivf^=x)jHR3DqnQ(Y@(Be4!PzxtimNetHAS^VpykH67BU&4#y zKYYWN1r`e|4O&ck&rnJ-#BCMXtj0UOF2?wvw)2YJB5Ib5Yiiq;eY;+&rdb>HO25$h zVkQm?^RVO#$OF268w8z@QsE0|pIy)#!L~hyf&hzPE+$t)MssG1zJwe5*xj-ew(boX z3g?G8>7{f&)8HLYzjJ@EWdg#^d-M-bR5nJ+gio1?vY^O4_v+YR7_2-pUPwKNQ5 zRnyB9WgdU-;p5+XJrHKF#Yhqqpc9aDx-WoCLevfWeA7&-W}f>?Z7yo(3BQ%Z1|M_h z%*;5;my@j>U_x?{J=C=r@CXK*9njl;@Au#BXutRSU&*MqjETJ{N{|Am6MC4DAwy^D zqPMTSg%hvURSz~)&}A-KF^A6asq6)kz0TYnA{B#S$yK03d;j--KLX7gO~5`Pv?>I0 z9KP=|!dS%X#uH|lz^7}0 zRqXCepOD>f8WDKCO^4%sjhczGoPtAPFe%zCk01Vt_k$oG?tsFO=J8KNmtDg-KK-A* z2ZYWJ040M4Sto@+wQ*tNhz8jD!l&MGd(bmhiL5BgUEBqVn&Di^azKYL>v4Ef1d; z?eYsZ`k%pF{@`L=2E%Bam~ek#JRO{v^>&SW_%1Of#4^J(%yd!g6~~91qhk?ia$sfH{$fv{1_n|jq<<`3N921<&2n(#k#mY_xPxDbXx2TE{+w73**D{i7+D-OR%3VgOOw&CuMqD`NM2VaGM)=NV(o=KIX(*o_YrgJh1p+L zfBO~#@Mt@+|Ax4A4&8R-3~IOO4s?dVyK2kUG_VgDk(Sauv`nL?FEW1q)B`}_D#}W_ z+^1nOH7?b5;6}j`uQ^tu-JS(IX;3LygmkOkY?B}QBtQV_zY0U+)LL|x3)Z_hJIBK# zzyfkYIW1wUVAh4sYk!Xd2&~8oRGclcw3M2oXdzAYuq8Gp&I9oj_<%!0VSvio9=zF* z1Munu&n_$-=T|Sn&_N206M&rnQbbPzWN`bAz#eR?+XY;kZs>%1df+2Fo7VpodaV_1 zfM8_R3HOg~X(WIc#5jac3GdU#$4nG8;Jdq)s!ugmpF9TRXGK;EQcbdIiwrKLCo2vMnw zuESlOb*p`6PCKOJW@(A1H@;avq49OYV&lzbLCNKeZ?^0+u5asMiz$g;!k;!-D6AO2 z8$n((E#>JHt7sTfYTE?7xx~(Dcrkd29|Vk;DkG3rMwr|GXUH!j+|}g&3bF?saAZ_a zpeabB5KE1Hs)%&mDI&82o~V@GHqcj295E0*tQW_@N9{Q27v4lAU_ynheDIr@>NJ9bbxz{(ewKW~d3>QnX5Kt6r(zwraBz;#e|?I93Hy;+|UL{Oi8AxAz+B+LcLXL3fFaW z3deoj$)^Z=nR|+82 zq{ad?(jCDL z^|(RTf#Zhc6ZQ5*ZgAb!C|gvDRHTC%?x13*6MH+|?~yQH8lOZyE@Z7RWs$&Pr+&*L7zUH^Y-PU-GmW9~dLQXyTY! z(z~vWrKw(e7A94Af%g^=0grJ5x0-4OWI9(?p`4d=@)awTIRWh?`BQ^k;vR%cD##*W zkwvn59U;-Vz;DcY*};ZTM5T8O++iz0_3`9om*N6%Ilk3YaXm7!VAF zv}(32>!jIYHCu2Mo><+l2^N zqBO(R+IMAMF*;@-7Rq$0LdAGd_GfGLGlmU8Ld^C?INeu_QqbzJdpoJZMNk=u*jH_|?5FpqU8A7;BOO^7<8g%Hmq4a$Mb8=I*`Y@lG zg9q~ZC5DZs;VOHzs+h3VLmdDh1Wj7E5UC2QK4{W)=s^>FoF^&N-ZTS^t-(@5^+_~C zS}pZF#LBF~_%Gd{hN^UBLRFYYf^V+OxQ!STi)&X~8U`2WBJ^K98{X^Q(!5zMBVAk> z5uKe~$;axkn056=?mYt$%rWGjUyKjay^j&0cQ1#lEXm5Ob!Ve`SL?DqxU02sKDqB= z`+VlOfk-Gt@-dGsn9H+#I&_a|W%L%HH}x`WERmz!uU1o0k%syX$aTH@gpJ2V#Jp&1 z5xJIXY?u@;YtB(&K+ns7V-H-hP7h_UAssa^C)-*SC{l~x90R^R`HlJ-Nrs9Qc$82l za9zR#&V7dnzMJ7|u>`r-R1<@UC$9X|Ln1^`=^3MtuKm)ac?>FC?|ZA&BL-c<5d+ql z{F|16Biu`uTQBdi^=dr)lUp8Q4So}z=#2q_g|W*1+GU;GUu)f83$+aXGaa-m+`k&k!@QIsA2(r9 z@(MpLmaIP<*>Zg&Fv)e@wgcK55jn;EEks5-v){3=@*?x7c@aU6$k9 z$UKuuxVCB zv1Oe^F)NCZM|?>Xvy0r1iB@P@tOT(gVEv8#TV5bmwsrwpyEFNdR@n3F9a@bMcp9RS zu(COQyMVO*@xI2Ef{&>+UE%3dE*_F+@BqOHD0oU(N(jA8tWPCA4m*AE{Vgld4SY>ft5{omNwH1f6$}!dQRp!J2-#l|=KZf^>0;7A#yINAf`v4hxN*A=<)V0KiwMU^Yva{Sw?v zIYW{5nlVMnvg&`vbwTZgY^d9U_Id7mL_-47Y0A`yV10gd#|@;KN4he3#MrCtc`lA$ z1%t3Olz0MyTNz>}6%Jfpz4CrQDxu_Tt-ZvprT`!z@p)>bk`*N-PiL(=3g%g*!utPm zySfwU5_Te{t=hhmlWQA-#T-OZfgE|& z4auq_xUPpraAsQ?YV87vhZOSZRswGB-wB(8*%VFYP3kzVYu`A|e0T|*^X6(BH4LNF zJh`cwpb~WGPj{$yn?N0Ro7yydHAJ2iaJ^$2l-=fLm<#&C!@F^ho4hZy=>hLrcP{$* z-TTPvv0dwL!g{T@?1u3+n=e{#-Q56F9!usnwfAUKl4&L^=9D}D{_FN&Jn0&%eXa%q ztiqx|=*!r~6Zk+HHEnrfx3QrH3}@0bdC6|Haod&H+Rb~`-vh-n9vGCdhyS>M-{I_P_#jvoqK`}mWKfLN+;I`7Z#`{yO*Mn_) z1H1p-+QWVqhPO4=T%2un*ER=pIVchE zbz#XTHj#BTHDIie%dKByF2TIW27b30ek!iItfpO?D?uANA_fX(OV~IKUKVJ!Ar0Fh zc9su18o+PC)9!G#TSJ$i^+ZHSlMmd`03HnO4o|y_tTJH|>Lvg#-uNuKbk#ufipi&& zPHw;JiOr|tn1?)P?rEi`6FQFt5E?i`cwaU?f+Z0?m&>Vn0zp5ec`rqABehjC23oRZ zTCxUeFRt1|pkEk_@O?*9t)dxefTz#`_IvsS?YFVu6V&8KdzYMoyfDY}`#J?RuuzFK z$ov1MRgf91g3^Ki_fA1qo#PZ#f>s*%G5SB_6_mSxS5U|Oe{X|M7zVQUAI5&SSrAd| z$S1d*-!5nYyRcml2d*=px>-=*i1C?^nFYDlVxM^hrOrAO`~hA;4KU9KMoh)xTdRKZ z2>RV_LC<~KZb6f1$t|c&a|?nK)7;=LXc*M^&L{T^(md~)&Kd>*BE#{C4TCUt?I3vv z{P!m^3?lujZ#ZihH1i0Fxj*v@`phrrGryou+b_uHf;@*$;1|@hYv9J;er$Qp(DCD@ zoP)~)M{pZjvK+!pFW7I_e|YMH`@i*Tv=?i==$z5$86VLV-a~10`t)gJuwien!-B?2 z2PR+GjR>LoW9$CyE`(j`9l&hMhls8>=P{J8mFnL(gnreGwPr5EyazDqpAVxaY}hLN zy4s+5?=ciW@=ymH;R3u4!0Tmr8R3OKyyMXaUO$G2W5>|fH20(neNFym_ZOR$zSsW? D)F3PU diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000164.log b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000164.log deleted file mode 100644 index d1bc453b3bf1d625edcc3ef0d185269fc6b78ba9..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 2682 zcmaFaEt=cNz?i|p00zt;Qa3)Mq@NIN=~X?ZXz&fQ!5HGiz@jT4b3eK3`|W8EKGndV9>zraj5QKXxMAxR*4Z&j7nG{ z3e9<(9Iwy)X`Ht4jX0wWN`#@QP?FLWMO7$ZZSZ9dhqVx7MP!Q3O_vz z^iw4j{A6TmWN2hOKz>@aXTn98pO{Xb6#@FGmI{6{HZ(Fc8>o1i(thtP%ujpwetrw| zQzJF}WNKkCpVd@#d2_&`+&Y@RNy=k-5o0`RVwoU&~;A^0IT_0Q#wu z8h)}cHntq7wAcRZ#9^49%FAL_Rx>j8LjA-_O5NN{R^4oBVs3;{H=7s%Ye!2XBVQL6 zVBKttvu+N^NG!@tOinE=$xKdE@CzfqIyN=71SYHjD$x$NOn(55fphDaT>r`G08`Z@ WDx@k?a|=`Bfl5`2CvABH^AiAwnr{C9 diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000165.ldb b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/000165.ldb deleted file mode 100644 index 2857458145011f61bbe12d18235900a4ac2d1bcf..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 20511 zcmbWfdyp*mbsn~t01AKzE+GO65Q-{LOO;7USfbw#n7TwycTdl&XS%0*x_gEam;Ii8 zY_6m6q}ZkyOQIzD3Rbx&m1Hwz7Q;fNSc*$=_=lY^5-Xw;xxzmf z2bHK|xO{`;%;F(9)80QQ z#t%GowuKLW>+}Eh%MU&E>>vNbcRl!#Gmhs)O^bj1>`Z%Z+4mX`-f(P{I_@0{6 zyNl;Pec{=)&zC;D^)8-AX_`e5jG+jcL7u&Ur~Td+k<(X2Rn_?A#q$@=LwEG&a=WSb z*mIsA*iBkrJbTfUY4tyT?Cj3s19=$@{-#V{YR?{fu0@~wzQ20sXP>V8GRlJdYvZ%; zef|UR<#nF;+1EyA57DPbrQhbsKmCKVN0|@8BX}kArvBQ`z{8)v_{_5xZW{SnJ%u0c z0?BQZERhOLTrEN`SpNJ!dDq!<5B>1Rsv^%SU+)VazRk_O zJHP(L%FPSEx_JH*7w|rdJa{Vq+Ky6qUzB+erT)cFJbO{qV2F$7|Mi#OHU09F&t7DC z=HB_~SMEB&nv6AWg|0Nk+#0hXUNB8!lVpI-m0TjTo=Qi)pUqj0Tg)9IsPoj;XZ;}^ z@|Ygq`86vFv%K^*cxTs52~QE&Y2`or&>uf(fN_FI{I_59QQ8S;(xYk5CMXQ^FnIZF zk|yxLprmjr4nk8TLr?_iF$6=f_MK-Q^C`@^`zH^)c>jS{ z`qr_9F>l&rb4f83Cz=c%FJI zmR$7y%*#AsO4(S4Oy`=Ppc}7QO@c#EHCu^3bn2uGT6y`Vb>N_3uRi=Vjvyq%Qn#51 z?zi_JIAdP>^1HxFFAQ0@kJ^x&217tEtuEsI**MpF=g7<#h~7!sW;q9gEstob9;P#9 z;;xR=jEE=~XItIA`276`?)eB}V*%>pI7!%G5Z4A*^IeAYQG)h;mLlP+T^b8)>?`o) z-QilkGaiPewT4x%Gb&X=O znV7!V9Gq4X)?;~U;T@I-^0-xH|ELQw9d5c+DC=~;G4`rC%cs;z^+OfehrDg94}6MT zeBu5BzlwTPK>0M`!4X5@T%q76wC%EpjeDLQ_>N0ZzUR`x=)ZsWnLPa2yYJ1)b>=MB zTl`>dMr_#%9Z&ApJ-Z_4(PW)2n>;_vQYFq>?qn2M>`JyY>!r0??y{f# zVa8m<1ghTN1x+`xRB4|FtJ(-+AH;_wS$4?_ie!Jn8l0qZ9IkTk-~E#KAul z%cPo24=&@a!#xv;f^PF($aT3dk4%4_#=CG@Hd}n;7FfjYM|1b$^RGU955*jh3~<~f zz&~8fr%)thQ`!NFCu8>!#iFMV<;!ojSjgW8cj^Q zw4?}Wzs?d_R93T#-K!5jiQ@#0Bky36x1S(_%l+O<1Vh590W$|bu@-sJcx`RY=bWAp zd%|dIe7E0XiRn*DK0=Z_XdR`kHvzttZ(<7NL$;z>I6p3d1%VTIh))NEM^F@nf_1(b?00b{U!SXGR-s$F=OY-8^4S=KQGLF2tlaTYD4t(}`UPQM0(Q z2Z7T#LoqH(Fl2zCHXI|5@q8D-NZR*sFp&o*hh!o6p6ua{yrPj(tIi60u}-S6pxI-Z z#*4Tb?vPW9e$r|YpVr22-eQT^N;V?Gz)F_V~wd_2cna1&6CM>)e zA2%!``Quf+;70pi>qu#dg1bZhZfpha_n7wPajX{##VAzi3S@W4>YfY&} zMAN&1JW%9zQn~3waWHAMMfRHOW2|E{yfbd()plB*|MiQ{e(RZga40a^3m`{Rj!RO$ zk5M*iGYHO*1f)UQp;(5*Xq2YBlU1@!Z`EUS*GtA)Ro7)9j)Z95?p2cTRZiEH^k?55zjYCnP|*$o+aFrZ@hY@8LYqxdXfnZiHxUZk;<5z zhzb3k~#iyQ~4UX29Jp30cJ8r!m6E*PS=$kh>VmWCw=HgAg7 zYH7zbSFWq5(r4r>pRA8lp51)mJ5SuBSvaEv0m+sQ*uZ8{pF%v0#Tds%Aht4;;}brC zIwXFRg_lzWkKKye%&upa(njf(w<<2J-pAQl?YW4{(>$$`%_f~v(&s=pkT zrQXnlIa*FcuG=#{kqoJT9vWot9YB#xN+SvD~y4!S#*ba_O0h4Hz?p=8B;q^>J07^dnt z+3m)w#bkZ)c?gycO@QOzE=Ib6M*^~)}z6@s9S0iptS{wRmUr*u$jB=L`O2R%E_-f_);%>6Wwg3aoah?u~ zjHS3qC+|jOjhX7)C|HPAu2hE^jhWd|cP*d%GWY%_^RqopajrIS|zhQ-6M%ICQ@ z#G7JXvcwG(q2YM2BtrNBWd|%uxvobrQ2oH6VIc{)0NH&OEJf4k$r>c9EBk4R5?QVh zp>)k)*7j;!>LfRh7<8+)buhsTZYgr|$wAC`we}*z;79ysxj3Sc)*Qr@NaJV^wd+zg zd2B!4^maSVH~zBp4!enIkV`r4EVY8fd9ee~iqQmAH{ba1ZP)OP55H-XyZEv=(4y=| z%w$U>j(${FaBnA#Mj|hOjd9T!$(v{z)qQ7lRTSn}zEN3TkF1@dVK06CxqAc&e-V^G zd=d{>hj3XB${QP{2n28{f<=2)LLamKxhY(+KlE7rd0<~Hj^9wpuiA;>#-gUNFI=?6R;kb#KlRt4X_Nb2!lI5 ziMiCtKg7!|;x8O^vZ*0&1k=_PN%uf4BwUr*2ANSCa_?`|>17(8{A1Kj)fz2?WSqxs zloxB#IUZWVUH6S{%z39#cf>5T)WQ~hN)UqOWX5$>)h8LY@)|Ba`Nw0B0Fm3$3*3M4 z&oj(jA8m;Vu49YMP9H7MYJwg#H7wn#Tsthkt}FRijKun&1w>u5<5(`#!>FDLp~zWI zHGT<_t^@UqPdf++gn*0LH0FAa2X9?KBR1hd^-I}sgj^fLUIv5ESKPJDUYc8$J38{E zJM~j6-C5W)p=BI(^bTR2*=0F+;l=q^KmN)Kv`nH{RPGqL?B=6mw3GY*KPs!;Hs|-j z2>k1|lvuuwwKtV=i^esfl=5pN{)($-WN-5u%)kN4M+W0l2K%yBk(<&G#cUtOEC zEAd~w`pOG9MY6syt!fu**)_hPRl?si)!NuD6f{V*q&%L=IVRmL+yq%2W%aP_?9inN zqsrPoJ$c8IfQ|qTzC+G!-vDK&oJ&b?l5`5+|^emEzFVK!a*f|t+g zy|gtd-trPO6a7&Lp<}bEiv1wmAdmpTY!CN+J0MvEfU1KcfPw-f2wXV%jEA^1L>8I> z7<)Q0zJ8DcAFbPYv6~3Y6-~I!+D)wxzxJ-P;ON@1xVXX;e|$n9FDRj%&Bk868RZ1O zmh{CiHKx>VA0zoB*?JSpj)H!cEBmds%-eQoeJPk6MPyq*VG5?XIWmA8ncG4L+<)$i-kt0Hqv8GJw4Tgm$6$r)ipTFw!T_|J}Qvwh0&Ym>ZMZNKjdP2#WSN7A2dwNWkT=1rE_6N?FIc=oE#eS9%XGwPs($B`;z$6d49B~wHx z_h^$d0&gSe2w&4BflkQdAfmHfF3KmQ`XGg$|I)Ls{pt7Lb`5{}{clCqMdIy5T-%VA zQ7R^`E!ka~O+qILk=R-;xU{L}d`M*5`ASID@mg9dd>S@X+lOSB7|jhd!&n?DUJpPS zMFSF{fGY99On}=_9OyKMB`6z;8r-FblbayieivFDifq?m-6Gpbf(Vx>0gks|cT$bI zGNyz}F3gmhJhO2mR$hB@U+t&cRqQUbaqCtlN!%Set8(IMp_WPfDUPoQk`n&*hM?NI&8E;gnscHf$BBrZ_iDk~`%ixTxu+>$&!M8Y z4V}UL_H6(y_q2v)7Gpx)rDnR6iQ248gcqz)6|;4r6UV)r<9cDKYOa`iLQn8LJbh~B ztkliu{f$k)7;Zqh9_}&}oEe*9T^93g*LEQ>Gf-V&q(?av2|U}$CVT%dUQ^9#q_WfN zoidkFJRPImcAha#l2x4;EPBY>i^=i?SMQpQJEo*oN-J&bHw%`@y_LDm1N$)K$h;m; zF?|yfkl|NUR4%MI3isNfDg5L(*$RB>y!!BCEXpFUee0Rqt{1=c%v(;9aUr2D*S<7G z>8Xa&_JYC2s+_vUzH9>az{GtPhx%r<@7ru&B=XG3O|fF;N47{KDtg^XC_JzUA43t> z2U3LfX$JLt-^VEzkYa#R6apolk2>BBFG7`l+wd+v-OP@IgtEMETGv9f4DN*_8(8a~J2>BdaX=`DP8gh;njy$6RBcViWBCJzs zv@TU&SDNLCdw!ZmNfye`cK{{rpM#PYxU5qYFX9i#bhO=fp3R{aZ=;*-oEmNY4qcM; zECX_imfE#9(Ebt=2X=w09=n|a6KS5TQWKDEd?@}ABJddmK^Ta%9&39nz%|S{|DDwb zC@6Rc$97)+ZSCGj4+BeG&;^-gUB$~vUNB=`SEh*=_QXtsvSAxFJhIxI7{$BkmWy}& zLh?AOsw-x-wl;B!O@OhOr1QnRHToW)bdRS&36VHBRQpx1ou=l&Esa9QKlumr;|xL} zt)wHUy4RK5_n8@BH_? z&x2V2$rnvPk10FVoJC%G{jyGlStb(5B8lyGC&l|5!&78;b9m++Rt86BYVN!aZH*4X z$#59+WK!y@(SM6cY zr#zF?B+ynqH)C0A58PQA^-w+`o}hBQqo^ijb@PRGxCth3J`hO1G=@T0Cmn}zU8sm{ z3{njPHi4VA??c5$`1DtxIT3C4o0TU+PuW|u{z@~GUDbK)m@Td_Z{PNd(Q1Wc-nBA0 zk+glzOEzL(G=|G_@EsYmd?TO2wLuX-ajYqu`Eg4JWCR9WRyd=%h9L2VPv2`{@ zKl#PglMF$S6n>jM;Qrf8a#u`fwrDq7C5dooaCURFOG$5bL>Kf#F}wmf9P2?24)$bu zv}D?hVoseIvv|XMK)a64Kc0LR7&Ho+^)?E49w^uV1^y5U8X7}r+D0%BsvZ($aWWu* ze!ZatT%s%%JQr!BL|$O)8Vd07&QJ2B>+tj{4m}@@(ew!4P?EK zHyRonJ89*)_-2@+wLzL#9iem6J&p+Guw3FZ@cU?@*Hl)zI*J+20Az*mHP8y!JWwwrlvD`&KwPEcUvwWxY`q)~8cB=CCn+ zquafI@1?EJrb_YW~1 zg|U?5LH2#O#-IeCR^XsL28cEWc^QbNg=EMLo?DoMSmP>+;wkHNBh1zSgu7STtJnJ|{QvnUGznm}2<}QGr-M+!Onq8v7ET9*8YXtd8-(3Hso(gKuF4rU zhfXUyY)Gv|b#ta|+sGr1?v5zDQK%SeiVzoG?Rewfp-MJ&ro%d5TJ~aj|AD7j0^&b~ zy+bN~@onfNsWW5DaR5-aO@=O6N!YWUv#)SdifkF30E*MdhD+nJ49NYKFn94T=FG0! zX7*y?yaatj+Wt2ScupK8865L~A#s68!f5yWzu=!`9e`~Z5Ge?bpYkwwRR^ILMip;Y zC46bfizXdnBgw}&Y=boPc(v1xj5tPmgtJmcH z&hv3^Etjq=3)|&!2QUXG5^63n?0&v3rux+H7WI71RudpGP|;gXjwebUnsKZLq#25n zwnGLkq!=KfX%grPAPWfEaU2r!0+bHulaG{BlXHY!OX^5+98ljjL_01jVM0&QNcZyN z6+sx<*jq(6tzT8Kii~tofKA-6)65`WIsH^>C;=oV0kLdHMML5pkp^K90;jPG_Cqq- zDyce&4qi&04$hM-iV`^c+BZLR+ckXiLvO~CyOG`VYSl;zG$o?U&h(%m`XmJRA3KMI1RU57281gpNT3f6oPbXvr0oL7 zMx6iAC!a=LkMS|$&gOT&{nS0*a23uqS2K{?T}n1uu+4mSNgRwwT?&z!RY|)aZ}$go zbW`S(%6d5(Pf-Ks>$y9l3Z0%@=vzX{i971a+ zglO%#Zbs=Ft^@uaQXg=yPuqwO9ZmB5eNS{irMZj`l$yyOo;%ymfFAYs!qN@j8}i z&E324LQ*&$qTDv@OTp4->`EIeD$hg{)k2r@w$az4*uu&c)OyG?f`ju#I4l@O5l#R- z8Xvb&goW-NaIGYuHQ$EjCzQZ6=~EB|FP{BJ5KUZnS1hjQ=~f~UWf=pFe5s8aF_%UV zKf*Njuf1xg&J=ZZBG&FMLQ>*vWyi`Q<*t2s)=Z>1(b>iZ4~%?=@0SayonckFJ7yze zw`-!cXKH2SF*~}GbPz1Q=Kb<**NfgSziEpX=DZR}n@&KqvQ)>ZhB&bkH!H^2P84Zk zZ50IXxdl1OrnWz(;zHe2ydVjf@1^sE+2c3u8>nwU-ot_vlmOSjP~g;{<^^660s4rd zm;i7a0qiVF-jF4cfGe5WdvoZY?znUdd0;o$A%{|6$8}yH%=~g|Uu_!MzJY195K>1H zafB?T<`A~=oK-eCR2LS$!;sn7WH(~B(%Uu4PBem;5=>Re8(Orsoj6|+#@`7)$imA+ zLh*%vmzbnbmMdTJ)`(DhV`-iW_^Qaw(J*cgJAoIOAwJ6DanmDPXmi!-+9-+5BpGor ziw{`6QcjrUBRC7f8Q{`rgg*b3s}vzYY{fVMq+~zvPzG|4kJ>;OfP@w}HHKSS0j3zk z5?8cM-=F`p5C6D{ObF6MG96{IaLA5a9YKGNzlp8VvQsd1u~x^TD2w8z;rC&D6flwt zhdSMrN^h5`-0HLVIAL2J(b73c8yqPXX{DZ<(S`AyCx96E%TvusMv`niw63c4Owwpf z?u@;;SwZ#bt!CKHmz~xl8it*%6vGeZptwZnc&pEdyk7b4fNH@Pe)^~O5ILdU>DVW= zl?{>-P<8^C2lXb3pZ~WX{s@Q#d?*1i*JjSIf8%!{=&Y}-sgYlL+rGRKtM$NQ`MhmF zFrb@G)2%gVI~>vQU@sv;14fGlxtbZ9z+G$G>89MoA`22}kkJoFPDg+h(Y@pDDxIu4 zqT8bARD=FjKO`xp(at`i&UK%q>XfQhzg(h;iFjlq_#ceU)VLQ^!fVJJjlnKjgGwMb)1 zyIyQ>j!$1Yqx|5oY=lpbTbXdox!u}Ru^Z23jd45(`6Tp?YQC@844QlRC~-F}TWyX2 zl~^Nv-~am3^Iw0?zW*e=P$vb&*PpxX8ovJATVX}SkK~>umuqh1RVr4|JHD2;baa@x z{t+*=US?>)K+-jI2eLt40O5=`Gz;MUkgBaJoet2if>r>f5X_+=v?5UGu#jvZ{{S(7 zVHjxxkPC1JBuVbq0NwRt>iV$WUU4G{O;Wz{ma(YCmjS=%(Nrl3M(t%@GcnYvf zayhui<4iJLWk5lh?I;yro#yI9s6}6D_9TvT=r^obvVBde71fWg4cF(-+ zdhwolroPS<+@;6c99?^kB`S7QgDxG^{{bqkmb9Ejn?-2OBxaA+$s}K-t(k>l5@(4Q z$RKV>_wpQi#2)}&-X?L|JAd{co&S>dDd2gam4P!Xh@x#AfIi{);5?}Jwcq%}y(+rW zLPV>5!N)X_zRt*gj%>C?b``TDs~BygHHMpGvH)QUxQZo7Na~6Qr?$9#+}FEN4TVtQ zIXK#FjHJ%@o7(Ty!%V3NO&SRNz|sPJAof#{>K2RTpMF1_9tr`OE&bj3%H73E8TX`E z6)F{T3Ka3E&~e`NXwR-#|hOM&Ngl@;}sqXIyzU^ z>z;rAH$U`~ExlByOipcQolfmggUj3?M^kQPH~4;4)#rcf=k`e~)+wz-bY%hQSS{3O z5QJiO|XuU568W*G;5_xpxE}6NZ zuo|09%=AcYs9aySH8#%FNfG&C-p%#M=dCppx<`WxbL%A5dz=K8oP6!)K7HFY{M@JC z$TXjtXPP84e&r-7E674rEA>bc7-Mt(&EV(9NxV*aq?H)FoG)5E+H#PDRPn$xSz2tf z#X|hTx1RYJ3Mz15XFzV_1yq2M=k_lsG(}@J@yNu4^$j_XC1Ylh^u^Wx5PWt2kPg8(H)$)ytZmzVwU93*a0+z!8{} zqfiW3XX5<#KCVD|0pCIZpLjN7yP%)PSQnDay~)wV%bHDmaj-0YwVnp3N^LN&)cZ^4 zdbreFu~wpbdh~Dj#c+u^>G4=Ea;Oit2il~M!iMpp#>l!2n{TQ^=MA07#>{5sxW_SR z>Dx8bRqSZ1&#_cE`3IDHAT0T=>YKZ0u5a99CF)ITujhLXTTB)UW67%eZoE-IvoJ?Q zD*>qka0HY##Yj1uhKJrY)wpsw{G~tr{>NcZ06JDb6TUz~rALyGqkS7;K_DKS|HQ8# z7zj!n*8%+mh&{goK%`t^nTw<+K;MQ-ND)R{<8SA!l2waQApkz#%I zMq*DaR zFCkE%2woqujPHRuw4+t!n!=T~#jfOfyP=0G^`=K*O-QA|yM|%R37X;hKF3Xh9!6g5 zS>1-V@7I%;(*G0z z)dXSVkT)1;T%G?f?>-C8|NhmfQvm`B6!-v_^3UJ>^dp#!zWgQWUbSZi1H|`<8X&%P znWIJ0>jfJebKR z|G3K%=u%zDF!Pw@i)L$Z=GMysh;*m}1jSGc+0vs9ax*apgO(hG=UQSa<3%i&Vh1*!ERH6!~M65!Rtm!`ss4qObDC|M{A!0s8@@vEvkJcJBq*^6+79C zH-T5R=Ag)l3b(Cw)ck%vT<)-bZ`_E%x9mvChcE$>UOuw> zEE1S1Lj^q|I#qKDZ7*#ERa1i$rr5mkqGK|J8iW~Ww;W_ehSR$&;lbTxj1HhuAJ6GuGsQ*l8F+1Sge$+U=| z^-T&5w-KwOA+*b3UZXI-?rR$=LNQ6U;*uWM8nLv4X1y5$n|KdcBB<+N0+nQ!~z)uiPi5C;X8BsE^uBQj2VZ-IVbyuJtT-VI3)ZGTt zW~sO`ox?uy#?U(er2Z*T!-HEuF9N3>CI}dqqhKkxMVVv(ysiAi@1rDQYQQ<0suIF8zCflphnY}f;$7TKbu4nsZhT2pnL z)^081M(c|?I84dIm@gm?sQx_=bV5jlH=unEKyw5m_81BREP}b|T+JBGUvDNNZg**L zU@2@X%@_(F%}O%N>4v`Mt3yn(!?-&!iFf7N+a()Dpi6f->BqD%myW4|aoDq$ru z_Ps5t2zl0T)kQgWlFcOQY;;v4Dq?AeRQ|Fjn<^?Us8@2ws*bjmrbvidsEW|?K&GB zM4`tQ+%>bduS#=y@FI-QZlZ^}6_OI+4A3Q&L*#FCaRYPO#8IEkK~J9b6%1I|LQSid zg_-nb7YlxIlvhV?%8XM!n zWX#aTwvxIg-1zBMwIrBOLCsQdQx4Vfl^jN*w=IGrB39E`%{8Dy`|MBtECR(FO~5=N zlqv*r9{<842;-iA^BIA{Sp@Jp0(%%R3?K(Xz5LIA^d534PN1V65tNw}>Y~L{wTtHA z>MF0cYiGMBvINEB&ZdEM1a1{C*k!Zo4=@`_z#;~auArjAU@lh*T_%tB^{z$NdQmQ0 zc$sv2i>l+sY>w8Zqg!Fw;}+$#J|&2)sSyvqjgUPUf2{a3~BqMMv}eiNF0>5aj!|$B@qX-%cJ0Z2$c7 zzx)&koqYgGHVv{)3W01Bz{C*^u=VAye*E54vaL*36!VylfubIbM%|WNlv%PWQf~~J zYEVjDUrr+K@`igq^e{xVu_RFZRyc}cXbak;5%98GWR7naj-#Dcm-Oyfjh8bc)+xE- zs<2@Ktg}D`#@~z#us8*(ucZgr2aO0>0|BzC-`_*LR%uo4m2VHQmc@!Wvt2JNWy$TE(P~GMjfSa_ zFri?J#mJJDx@;ajAQx&zo*@S=_zQNyoB$q(-odu)%`TWXSJ3=>3t?{E!1EVxiTVHX zy&wJ98FAV)^X5*Oi|0T8{F_^4J_5@>n*X1BWj^w@y)xWSE&lSgG9P=}3Zc_-Ay_f< z!M9e-aR1o;!7sv3^W86)xkKKZ&^PzX%wO5?lf%a2jF6%?WJKpmro{5j*;e^D-z-p7 z7fW+G-BU24Q4!DYj8(d+>uv;X>7T{19f5CzokjmVHeKMe!rQHDYaL{=%Co&3X zW;{5}41(m@hB^b7a2Q$--dK+ED~r?%M{Wlrr6x7074On9YV?X*Ya7LdX=>(@*-|(` zOOz_#c-~5^0Z&)^fs}2rOO^wN=LIJmVOPL*G!zmqti_p?Tl~>DO%ZGvZHYLlI<_G# zI|rY?#q)3gT@*t6ho1LOzxu#~O?exngb|{%)f;5EJemhbejxT8iRFfm=42JdF#Eg! z_0U)!FKB-@5;26&qNs>1nvUIW>i7sPu+*B)S3mQmv(tW=dmc>9gHFaLL4NC!Abg>q zqZGjWsS86wjEA8v2iTSZA2U40uXPoXKXC4?NAz z`N{Bx`R<-74_KjcdxhG*O~O8#MX(fzJ01>woF|Gx2NJPSQFWW+T&EwZ<3=tt-YKgV zvcL6q+X>tb3D{h)?AOr*6lK~3Jg}w<5gF+Mqhyj{gFhd2lAwb=Mp9T%> z8{H|As2v?$yFI#iQGl#XLl@u0>o0LbC%Y#&}Z$=G+BWMD)sTQmv1N@Ym z_0f>vfk7^dW20S)mOFHWzYpyE+VHT($wF-DC#X#{eT;xA_X(Z~wgf zctJDL6*dXj@XANIF&83fH4O&uADGk$g+Q5&~pv zPYM$YqXi4ySt)WNBc3Uxy*Q8@5B_)}G2U@;%G>P`&R9R?H!)KNu9%pkHLS7N?QBb# z=tYe)2PBQULQvwuT}i$t57P}|&4^twDwYcB=JAa^V97ziFjN4lDA=6>@X2AJ*GB_A z4zvDna6s4rgQ*y8-^?q2W4eMLwZTESX|(8N?zG2HUo(vZqcMtuUgFH9a_wFk)0hY$ z_!T!6ezV6bP1h2$;>um=i1C63dwGN9e;>(l3Fu<5Pxvkxk; z`R&?v{icpw`-4m4;xq66{_{7s#C;SNmt`OIyCN$4J6G@dwHHuOfFtm9ut)dh~;j{qVzQKmL8+b7nmHJ&(Nq zKRz2vch2lbKk(SI51;+S_k9mzzHXPd%=_EK{rhh|IQ#1V{%c=6;~xA=?ED|Du6uLy z-5vLh|NR#~cjxTUhdy=Z|9<_?-~HU3KYG{cStjuB<^!bvzdrZs-@Eh3U;C9i{^=9% R^vC>nKm9j 32227 bytes +2026/06/01-12:23:45.245 69ec compacted to: files[ 0 1 1 0 0 0 0 ] +2026/06/01-12:23:45.250 69ec Delete type=2 #162 +2026/06/01-12:23:45.250 69ec Delete type=2 #165 +2026/06/01-12:23:45.250 69ec Delete type=2 #168 +2026/06/01-12:23:45.250 69ec Delete type=2 #171 +2026/06/01-12:23:45.251 69ec Delete type=2 #174 +2026/06/01-12:24:12.847 6118 Level-0 table #177: started +2026/06/01-12:24:12.892 6118 Level-0 table #177: 24499 bytes OK +2026/06/01-12:24:12.936 6118 Delete type=0 #173 +2026/06/01-12:25:45.950 6118 Level-0 table #179: started +2026/06/01-12:25:46.132 6118 Level-0 table #179: 9957 bytes OK diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/LOG.old b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/LOG.old index 28543ad..3a43f8d 100644 --- a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/LOG.old @@ -1,15 +1,6 @@ -2026/05/29-13:17:37.366 6a60 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Local Storage\leveldb/MANIFEST-000001 -2026/05/29-13:17:37.373 6a60 Recovering log #157 -2026/05/29-13:17:37.375 6a60 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Local Storage\leveldb/000157.log -2026/05/29-13:17:51.674 6264 Level-0 table #161: started -2026/05/29-13:17:51.748 6264 Level-0 table #161: 19877 bytes OK -2026/05/29-13:17:51.815 6264 Delete type=0 #157 -2026/05/29-13:17:51.816 6264 Compacting 4@0 + 1@1 files -2026/05/29-13:17:51.881 6264 Generated table #162@0: 24 keys, 30021 bytes -2026/05/29-13:17:51.882 6264 Compacted 4@0 + 1@1 files => 30021 bytes -2026/05/29-13:17:51.914 6264 compacted to: files[ 0 1 1 0 0 0 0 ] -2026/05/29-13:17:51.915 6264 Delete type=2 #149 -2026/05/29-13:17:51.915 6264 Delete type=2 #152 -2026/05/29-13:17:51.915 6264 Delete type=2 #155 -2026/05/29-13:17:51.915 6264 Delete type=2 #158 -2026/05/29-13:17:51.915 6264 Delete type=2 #161 +2026/06/01-12:22:24.572 42a0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Local Storage\leveldb/MANIFEST-000001 +2026/06/01-12:22:24.583 42a0 Recovering log #167 +2026/06/01-12:22:24.585 42a0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Local Storage\leveldb/000167.log +2026/06/01-12:22:42.587 5704 Level-0 table #171: started +2026/06/01-12:22:43.610 5704 Level-0 table #171: 24257 bytes OK +2026/06/01-12:22:43.653 5704 Delete type=0 #167 diff --git a/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/MANIFEST-000001 b/Covance_UCO3001/browser_profile/Default/Local Storage/leveldb/MANIFEST-000001 index 29628ffeec9fc08573d3f50863864997fd789f66..4c76db22a107e30240d09acbdd3a611a7246781c 100644 GIT binary patch delta 252 zcmccY`Ot5}Wfcjv8Hp2e85o(CGjcL8uViGI$H~sHg0X$iWJV@MrYx3;7meieSQtQH zVb{ZrAeE~?D%UWwYyzrW&3JGxSmivBO1Z@ll{X(OD+8%q3sSkBk>vf)VqS78SP7Ce0|P_k#EGHIevPb?H^r-(ZrgHX!8wrG@(^vvCKoC&Ak5_g>SW@- z!oYup|25EwC-|+znDv=3oWsx}!mP~%asZM^46VFC-OPLm417=dv-lE#`h)m58W|hK zShO26CU1*ZWIF(M$7J3*d2XP!nnqp4vWqRgPu^W8BLd=|EA4p{bNq+B0fPktP@l-; zv^rI`mEdrhJh4umQDpMQIyDgyph}=cAm9L2Dby%BIj>%m?Z(0xKhN%%JhxtvQDO4_ zdP6w{G?gIVG4tf`a~ILM)i#e3;nqn7#NuNBN+H2_&0186!76^3(IBEZ{(Z&G)|Rm z-qc+?r)-=o5HBGrDvxLqUP1x_is$!_(ohxo{PVt zxIix_F)2B}s6a0{KUW|ZSB}l>r~Y~-28a^#|EIow7Dd}?zYm`2RSe~zbr8?IThqUeF5RgCiQ9}K)-1M z0|EpbfJT7mmWdM^m>Y#^C+F2`vK@y6#N2vCM%l^x>kZ{((KK-JUt?hAU(3M%ivJM* zTA$ zFc*h@aY24waefh0&>f+-iQjYb$9bx33m&frMZV1Zn~av5zs>*3FB*l#GoG6^Y~hmD zX3_3HORrl@Qd(Qpucb?xl&-ZuE@AG`WPXq-RK>?A*)&W*jIpm_a z0RR9KNE-yXak3DMV>1D1vmI7N%7O5S;?d%KOel74cA`Fn1q^0lVF9xM8JNIe0IG^c zhtAr1cw^nXgka+^JTenrq7x>^Q%G;5(=E-7b~uAlkyWgyaTfLSj6;l00PYJ#P&u>HEz-G<&b+8L z4V&KmoOC`VCt??Wv?yvRfNe;8JH5FEy*7GnR+nF1X*FXymxQDc(F!P zb1zrAd!RNACxxrrUZYMaz6_9OYZPp)!%A;|Hj=X;jio(3@PE3AH;^j+Uj9mzC&4M% zNyhJs)l?0=yDAK1Gq|xooYch^P_)p8xMxsTtY{nFk@qosVv{3Pm^dDJ(Ur?{jt*XK zUGAT_k1=PZU<$k1AO$bV9-9#%!S>Dcoyxjzw(1v*CTAOlc7uPb!y zy>3eiRt2`HQ=S>(`U4&cI8dTVw7gf)s!TqnnaVF z_`Fi_#JzsUNACf&*2K(87Wl^oCz@zblcA^~<6fwninHCGLYu>ivZ=%)J6VoWfahG2 zcnrB0x{Fj>W1aH9)AJCvySrHJ%j)WLO;;^ehTrT5mK%t7R6!)AnLrw~UWx2v#%>KWB}qJ$X*1r4YX5DPf9um*B{imQ+Bydgu+O zy^+DB!h$c+^nENjg1cX~=W~EajZgZdw%lh(+ka^4QMCbATc|Pfb-`RqYWuRza}H;3 zzgR9NSO~!(a_5%MiK7|L@ZZ)Ua zF=o|gw6Bm0kks611n^ZKVb2pv=auk(?Q|J<3yar1?W;mFP2&CLo#Z4rwwL&xodciU z3&o?2315w@m)Pw{n$oQYgS;*+yK1#jLuvF6Z;De$)(i<-XJsiT^DSb*VE~TixZ4RnVX>3x zHu$THAc!?=I{K2?5D2nG3fFsW9s>MSntk)O>yXP~uMMAN^Hs=gF_{!jfSeKgrYajs zDs%MFlOB|!$`j3+_WK?jbMm}q{=JnCnDK)8d3(vP`Fh!=--W*v=-jPneh7@J-5vya zy>7xn4zjZOje*kJ8cWPjqXS6ffLaS0(ZrpoQ6PA=kS{@zp=3`>w2*HjhGR9V{6JaG z7n`pqqm-#_co84dvA#4QvFZNaR3xg{peWOil4e$F&BcSq&(gua=omUmrY!bD6p02}`~;$qOzaH1Dl@C0qrj46)Y!=Ooe@mWBpr31VJeY z9a&G_i0BQ}+8S?!1FUP$Dt8f5W(27X7kya{HFAo!zNhm%tLDt)L{J_x znb#+n74u8$gMxK3mk>A&-rO(D!y~zKWsVgovjKdXE`;y*W*Ms4!QL+fG%t+gkK+q3 zyI_spZfpmA*=)~cqFdjLJ-NV79U1e7!6pPK5066l%3($Ri}J2dO*hzMLpsf`+2U|x z3ytBK7@7L)qE(?%&mwNC#M=*7po=-18sAQ>vn zBelj1u^&y2ZUOZa+NxTF!R+UxI`Jn;EnZrkHWl_|Z;ZQ%L!8R8ZR$+AK%)eKChj%B zM1+;OLUCyBM$>$!t#WwXxe(>IDc=ebWCtFvU3#w>)xI@t_EaJ2n$=wnwoe{vhN_)i z=k2cm?gc~#wUzsy(5*S9pay22q8s=NffHjB|Il#!|6!4cXc)0XRSDlo7BG%)r^2=4 z%N2(k16hEm5GfcdUkW_93Gqn2?kK3#ff|i$ZXMk((=`dNI>%F?8sO#lP`1h-^+t9^ z=cd99FOOxyW2;Aw>cUT@%H5AeyZqf%B{YAF9{pCmaQhTPq-?a<&)9~uM;iW$ZTxX= z1OF$tXM+AOw+$_>SXdZfObsp{$2acGw!oBq+b13Xx6e&w=^}x;Ww0TSbzfEL%~EmJ zQq6^KF1_(HEtMt-7Ww7wgO}H$ZEc*z@1+@-OtRDR!1EocCOeYfZOVl^iA6$3o5Ycz8(i9 z!zP;XT@ePK`g_&V;qgQ6tPR8l6Vjdhe=y8uN(8CJZnV1w+e`(r?I=}uC!9*u;Ymvu$v_SULC-(5$pf&w8G z1NNx`!)iqXZ^i81sW)HTq}B>IT^Cb&BJ{V@X=UVjiu(w`Ip}PV_{>2^OR6w#62FX* zx}iOCH(zSF!f6m4awG2hK{diEk6A%>G27*VC=ife;OLFGAGN$;rk0)AMtm+|F+97z5j8} zFGI&WC?HaTXrnjzfk|WdQMcqpn$nV90mcT5YsS*zLpaFoO0gxL3r;!{(0jIHGp)V5*O#lQ5Y6K5h3#SQc4E_xM4F0i!RtW@z zIfD$7ZaEnRiC;?ASd)x7BY$o^bVaygcTd&8xj6TqQmfzjeGAwr2Ev8=Es<6TLIR%T zkb+`vOA$khkSkxI7eDQk;|XD?tb{M2(hVp`aYmBA{px2b{B=yd5kRi%CeAMI%KKrL z1UYy4LC_MJ1!E57Oy47o?+7zr;Ea$(1+xv>wtK;`^}w_je#N16fqy{|3X6?87mUqF zXVQG!pajY)z)On;UfIs_rLe|Ai!-Yw%m3x{$i|HCbamY^JLqX}3J1(n!5j+^*eHG=~Q~L;zAz=Ad&}@`6ji@iM>sDg`as+W8=$cAx`~*&x1vBSoO4WzEOPi@W9>(!`D=f_b&ADb z6T89I2T(u8SDk~5cmCy9@Iow2zrbh#&Yk^4peHZqL>!{QUw;GZXD|<@q)kk?$)17k zUp2f&=D@3^k_ZQ000270000000000000000FjQM1cXw94U+;rTz{}l zG}7jVnWE3<$c5rmRo<{w>jLR9C$l9bnMQoqvJYudWe>@#|cWo|xCniKAqVSm9a^;pHLzmKY$!Xd)&6Rclx1P^dNE#d=@Q^) zUyTuDY~l4Sxe_```5%wA4LA9&6@3XMeJD!0wnb zN$01^K@^6U4!O=1AD(2}Ah$qY6JBO|%%MJJ@z!2;G-LwYp;lu`&~=cI2Bw#-wawte zyx_B(pw_WrD-8dhmYO=_T{2p{h2}L+YJYtW&X%ZKWOq<&a%tzC1T`xe;BMS#;_}<4 zb(!%T27s^x80sFsxlU+ zu)OwvaIs*^i4{8rO50MV<4)3!O5GD_kK2I+JjFWCpA_a>8000D& Mkxxnijg#C@B=i_(v;Y7A diff --git a/Covance_UCO3001/browser_profile/Default/Network/Network Persistent State b/Covance_UCO3001/browser_profile/Default/Network/Network Persistent State index bf9d374..e2a6ffe 100644 --- a/Covance_UCO3001/browser_profile/Default/Network/Network Persistent State +++ b/Covance_UCO3001/browser_profile/Default/Network/Network Persistent State @@ -1 +1 @@ -{"net":{"http_server_properties":{"servers":[{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://cdn.pendo.io","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://data.pendo.io","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427112006055382","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":6621},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",true,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427119456814562","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":10524},"server":"https://accounts.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424613857546976","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":5917},"server":"https://unpkg.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427107435975955","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6306},"server":"https://fonts.googleapis.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6502},"server":"https://fonts.gstatic.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427119484319015","port":443,"protocol_str":"quic"}],"anonymization":["MAAAACwAAABodHRwczovL3Bhc3N3b3Jkc2xlYWtjaGVjay1wYS5nb29nbGVhcGlzLmNvbQ==",false,0],"network_stats":{"srtt":4832},"server":"https://passwordsleakcheck-pa.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427119496814314","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":7750},"server":"https://android.clients.google.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427119978225009","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6055},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424614330059042","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6720},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427119456718085","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":6576},"server":"https://www.google.com","supports_spdy":true}],"supports_quic":{"address":"192.168.1.87","used_quic":true},"version":5},"network_qualities":{"CAESABiAgICA+P////8B":"4G"}}} \ No newline at end of file +{"net":{"http_server_properties":{"servers":[{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",true,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://cdn.pendo.io","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://data.pendo.io","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375009530206","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":12066},"server":"https://accounts.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424869409656810","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":4290},"server":"https://unpkg.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":4194},"server":"https://fonts.gstatic.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427374889328393","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6277},"server":"https://fonts.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375033980466","port":443,"protocol_str":"quic"}],"anonymization":["MAAAACwAAABodHRwczovL3Bhc3N3b3Jkc2xlYWtjaGVjay1wYS5nb29nbGVhcGlzLmNvbQ==",false,0],"network_stats":{"srtt":8443},"server":"https://passwordsleakcheck-pa.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375035607930","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":4290},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427374989810355","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":3480},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375048777572","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":6145},"server":"https://android.clients.google.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424869438474330","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":4216},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375009466616","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":5047},"server":"https://www.google.com","supports_spdy":true}],"supports_quic":{"address":"192.168.1.87","used_quic":true},"version":5},"network_qualities":{"CAESABiAgICA+P////8B":"4G"}}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile/Default/Network/Reporting and NEL b/Covance_UCO3001/browser_profile/Default/Network/Reporting and NEL index fe2826e4f8e69f923b94fd8be4a2a422091de796..0113b0422679e0f41e84dedd8264831d3de18bea 100644 GIT binary patch delta 55 zcmZozz|^pSX@WGP{X`jOM*EEkI`zE8$;A#=81y$DxgMWzW%A7WNWLu!v0FNwKtlJ* KJ)IUc2mk;rpGpYU9-^nxUBl$KzxjUKH5hN5B Kde(7Kg8%?%r59cR diff --git a/Covance_UCO3001/browser_profile/Default/Network/TransportSecurity b/Covance_UCO3001/browser_profile/Default/Network/TransportSecurity index 511288c..05e9f98 100644 --- a/Covance_UCO3001/browser_profile/Default/Network/TransportSecurity +++ b/Covance_UCO3001/browser_profile/Default/Network/TransportSecurity @@ -1 +1 @@ -{"sts":[{"expiry":1811590376.982667,"host":"AMsYuZ7IFgNWVHHQOkqKt9MmwK65kaqBH0lsKFOUFH8=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780054376.982671},{"expiry":1811589873.806784,"host":"CSChKrlj3luqm4YaUcREYcNSGviDSaiJLYYv+tJJLQY=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780053873.80679},{"expiry":1811581653.541007,"host":"Cz1hgA9AsWBjlwLNwma1z9V2NS3WBGpE+hAisJYAzJg=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780045653.54101},{"expiry":1811582405.562701,"host":"bwzZzlAVpSjLBr+9/WzKm/QotRxOYnqfzWRcWGuF4/M=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780046405.562703},{"expiry":1811590379.118582,"host":"eS7TxKKR6KM2rUe5fGp4j6+eHcckwVadZAWT/TaU2RQ=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780054379.118586},{"expiry":1811590330.059279,"host":"e3SziuwfuO2UvuBno+qkR1ObHAzZmSUoJhrc7dbP1Uo=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780054330.059282},{"expiry":1811577835.976147,"host":"nAuqgR4iEWti7SOdT3UHPl6rmZU/DeaIm38P2O2OkgA=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780041835.97615},{"expiry":1810638866.791394,"host":"rBPMDlZ3oSoS5nWA5b3qh68smMftsPTTcEHPHa/8Asc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1779102866.791399},{"expiry":1811589856.718672,"host":"5EdUoB7YUY9zZV+2DkgVXgho8WUvp+D+6KpeUOhNQIM=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780053856.718678},{"expiry":1811589856.814671,"host":"8/RrMmQlCD2Gsp14wUCE1P8r7B2C5+yE0+g79IPyRsc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780053856.814676}],"version":2} \ No newline at end of file +{"sts":[{"expiry":1811845503.848011,"host":"AMsYuZ7IFgNWVHHQOkqKt9MmwK65kaqBH0lsKFOUFH8=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309503.848015},{"expiry":1811845435.426458,"host":"CSChKrlj3luqm4YaUcREYcNSGviDSaiJLYYv+tJJLQY=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309435.426463},{"expiry":1811845434.988982,"host":"Cz1hgA9AsWBjlwLNwma1z9V2NS3WBGpE+hAisJYAzJg=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309434.98899},{"expiry":1811845435.326612,"host":"bwzZzlAVpSjLBr+9/WzKm/QotRxOYnqfzWRcWGuF4/M=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309435.326615},{"expiry":1811845543.422238,"host":"eS7TxKKR6KM2rUe5fGp4j6+eHcckwVadZAWT/TaU2RQ=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309543.42224},{"expiry":1811845438.47485,"host":"e3SziuwfuO2UvuBno+qkR1ObHAzZmSUoJhrc7dbP1Uo=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309438.47486},{"expiry":1811845289.352429,"host":"nAuqgR4iEWti7SOdT3UHPl6rmZU/DeaIm38P2O2OkgA=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780309289.352434},{"expiry":1810638866.791394,"host":"rBPMDlZ3oSoS5nWA5b3qh68smMftsPTTcEHPHa/8Asc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1779102866.791399},{"expiry":1811845409.467224,"host":"5EdUoB7YUY9zZV+2DkgVXgho8WUvp+D+6KpeUOhNQIM=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780309409.467231},{"expiry":1811845409.530288,"host":"8/RrMmQlCD2Gsp14wUCE1P8r7B2C5+yE0+g79IPyRsc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309409.530292}],"version":2} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile/Default/Preferences b/Covance_UCO3001/browser_profile/Default/Preferences index 95b3a72..88fd3fd 100644 --- a/Covance_UCO3001/browser_profile/Default/Preferences +++ b/Covance_UCO3001/browser_profile/Default/Preferences @@ -1 +1 @@ -{"accessibility":{"captions":{"headless_caption_enabled":false}},"account_tracker_service_last_update":"13424515424367437","aim_eligibility_service":{"aim_eligibility_response":"CAEQARgAIAAwADqYAQohEgIBAiILCAEQCioDCQQCQAEiDAgCEAoqAgkCOgIBAzgKIicIARIQTmFocsOhdCBvYnLDoXplaxoLCAEQCioDCQQCQAEiAghdKAEiJggCEg5OYWhyw6F0IHNvdWJvchoMCAIQCioCCQI6AgEDIgIIXCgDOgsKCU7DoXN0cm9qZUoVWmVwdGVqdGUgc2UgbmEgY29rb2xpQg0KCQoDdWRtEgI1MBABSAFQAQ=="},"alternate_error_pages":{"backup":true},"apps":{"shortcuts_arch":"","shortcuts_version":1},"autocomplete":{"retention_policy_last_version":145},"autofill":{"last_version_deduped":145,"ran_extra_deduplication":true},"bookmark":{"storage_computation_last_update":"13424515424366025"},"browser":{"window_placement":{"bottom":978,"left":-1762,"maximized":true,"right":-466,"top":124,"work_area_bottom":1160,"work_area_left":-1920,"work_area_right":0,"work_area_top":0}},"commerce_daily_metrics_last_update_time":"13424515424366993","countryid_at_install":17242,"default_search_provider":{"choice_screen_random_shuffle_seed":"-2017928320264087321"},"domain_diversity":{"last_reporting_timestamp":"13424515424370992","last_reporting_timestamp_v4":"13424515424371023"},"download_bubble":{"partial_view_impressions":6},"enterprise_profile_guid":"ede18f3f-de38-4fdf-8123-ca16d3191779","extensions":{"alerts":{"initialized":true},"chrome_url_overrides":{},"last_chrome_version":"145.0.7632.6"},"gaia_cookie":{"changed_time":1779102854.267623,"hash":"2jmj7l5rSw0yVb/vlWAYkK/YBwk=","last_list_accounts_binary_data":"","periodic_report_time_2":"13424515424094033"},"gcm":{"product_category_for_subtypes":"com.googlechromefortesting.windows"},"google":{"services":{"signin_scoped_device_id":"e2e70f02-28a4-4615-afd8-933313cf702e"}},"https_upgrade_navigations":{"2026-05-18":10,"2026-05-28":20,"2026-05-29":40},"in_product_help":{"recent_session_enabled_time":"13423576449721845","recent_session_start_times":["13424515424132646","13424420803538214","13423576449721845"],"session_last_active_time":"13424527961266733","session_number":4,"session_start_time":"13424515424132646"},"intl":{"selected_languages":"en-US,en"},"invalidation":{"per_sender_registered_for_invalidation":{"1013309121859":{},"947318989803":{}}},"login_detection":{"oauth_signed_in_origins":{"https://covance.com":"13424527472982325"}},"media":{"engagement":{"schema_version":5}},"migrated_user_scripts_toggle":true,"ntp":{"num_personal_suggestions":5},"password_manager":{"account_store_backup_password_cleaning_last_timestamp":"13423578799689835","account_store_migrated_to_os_crypt_async":true,"profile_store_backup_password_cleaning_last_timestamp":"13423578799690145","profile_store_migrated_to_os_crypt_async":true},"privacy_sandbox":{"first_party_sets_data_access_allowed_initialized":true},"profile":{"avatar_index":26,"background_password_check":{"check_fri_weight":9,"check_interval":"2592000000000","check_mon_weight":6,"check_sat_weight":6,"check_sun_weight":6,"check_thu_weight":9,"check_tue_weight":9,"check_wed_weight":9,"next_check_time":"13424340444920678"},"content_settings":{"exceptions":{"3pcd_heuristics_grants":{"https://[*.]labcorp.com,https://[*.]covance.com":{"expiration":"13424528372981403","last_modified":"13424527472981410","lifetime":"900000000","setting":1}},"abusive_notification_permissions":{},"access_to_get_all_screens_media_in_session":{},"anti_abuse":{},"app_banner":{},"ar":{},"are_suspicious_notifications_allowlisted_by_user":{},"auto_picture_in_picture":{},"auto_select_certificate":{},"automatic_downloads":{},"automatic_fullscreen":{},"autoplay":{},"background_sync":{},"bluetooth_chooser_data":{},"bluetooth_guard":{},"bluetooth_scanning":{},"camera_pan_tilt_zoom":{},"captured_surface_control":{},"client_hints":{"https://login.labcorp.com:443,*":{"last_modified":"13424527472778715","setting":{"client_hints":[14]}}},"clipboard":{},"controlled_frame":{},"cookie_controls_metadata":{"https://[*.]covance.com,*":{"last_modified":"13424527472981230","setting":{}},"https://[*.]labcorp.com,*":{"last_modified":"13424527978689222","setting":{}}},"cookies":{},"direct_sockets":{},"direct_sockets_private_network_access":{},"display_media_system_audio":{},"disruptive_notification_permissions":{},"durable_storage":{},"fedcm_idp_registration":{},"fedcm_idp_signin":{"https://accounts.google.com:443,*":{"last_modified":"13423576454268076","setting":{"chosen-objects":[{"idp-origin":"https://accounts.google.com","idp-signin-status":false}]}}},"fedcm_share":{},"file_system_access_chooser_data":{},"file_system_access_extended_permission":{},"file_system_access_restore_permission":{},"file_system_last_picked_directory":{},"file_system_read_guard":{},"file_system_write_guard":{},"formfill_metadata":{},"geolocation":{},"geolocation_with_options":{},"hand_tracking":{},"has_migrated_local_network_access":true,"hid_chooser_data":{},"hid_guard":{},"http_allowed":{},"https_enforced":{},"idle_detection":{},"images":{},"important_site_info":{},"initialized_translations":{},"intent_picker_auto_display":{},"javascript":{},"javascript_jit":{},"javascript_optimizer":{},"keyboard_lock":{},"legacy_cookie_access":{},"legacy_cookie_scope":{},"local_fonts":{},"local_network":{},"local_network_access":{},"loopback_network":{},"media_engagement":{"https://login.labcorp.com:443,*":{"expiration":"13432303472982403","last_modified":"13424527472982408","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":45}},"https://xsp.covance.com:443,*":{"expiration":"13432303474806188","last_modified":"13424527474806192","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":95}},"https://xsp.labcorp.com:443,*":{"expiration":"13432303980445167","last_modified":"13424527980445178","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":43}}},"media_stream_camera":{},"media_stream_mic":{},"midi_sysex":{},"mixed_script":{},"nfc_devices":{},"notification_interactions":{},"notification_permission_review":{},"notifications":{},"ondevice_languages_downloaded":{},"password_protection":{},"payment_handler":{},"permission_actions_history":{},"permission_autoblocking_data":{},"permission_autorevocation_data":{},"pointer_lock":{},"popups":{},"protected_media_identifier":{},"protocol_handler":{},"reduced_accept_language":{},"safe_browsing_url_check_data":{},"sensors":{},"serial_chooser_data":{},"serial_guard":{},"site_engagement":{"https://xsp.covance.com:443,*":{"last_modified":"13424527457483932","setting":{"lastEngagementTime":1.3424527457483884e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":15.0,"rawScore":38.02810395513844}},"https://xsp.labcorp.com:443,*":{"last_modified":"13424527978691266","setting":{"lastEngagementTime":1.3424527978691252e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":15.0,"rawScore":42.246942522050475}}},"sound":{},"speaker_selection":{},"ssl_cert_decisions":{},"storage_access":{},"storage_access_header_origin_trial":{},"subresource_filter":{},"subresource_filter_data":{},"suspicious_notification_ids":{},"suspicious_notification_show_original":{},"third_party_storage_partitioning":{},"top_level_storage_access":{},"tracking_protection":{},"unused_site_permissions":{},"usb_chooser_data":{},"usb_guard":{},"vr":{},"web_app_installation":{},"webid_api":{},"webid_auto_reauthn":{},"window_placement":{}},"pref_version":1},"created_by_version":"145.0.7632.6","creation_time":"13423576449591198","default_content_setting_values":{"has_migrated_local_network_access":true},"exit_type":"Normal","family_member_role":"not_in_family","last_engagement_time":"13424527978691252","last_time_obsolete_http_credentials_removed":1779105199.689959,"last_time_password_store_metrics_reported":1780041854.093177,"managed":{"locally_parent_approved_extensions":{},"locally_parent_approved_extensions_migration_state":1},"managed_user_id":"","name":"Your Chromium","password_hash_data_list":[],"were_old_google_logins_removed":true},"safebrowsing":{"event_timestamps":{},"metrics_last_log_time":"13424515424","scout_reporting_enabled_when_deprecated":false},"safety_hub":{"unused_site_permissions_revocation":{"migration_completed":true}},"saved_tab_groups":{"did_enable_shared_tab_groups_in_last_session":false,"specifics_to_data_migration":true},"segmentation_platform":{"client_result_prefs":"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","device_switcher_util":{"result":{"labels":["NotSynced"]}},"last_db_compaction_time":"13424399999000000","uma_in_sql_start_time":"13423576449670015"},"sessions":{"event_log":[{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424520194931732","type":2,"window_count":1},{"crashed":false,"time":"13424520543738704","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424520587495420","type":2,"window_count":1},{"crashed":false,"time":"13424524527387202","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424524599232757","type":2,"window_count":1},{"crashed":false,"time":"13424524905651031","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424524997886523","type":2,"window_count":1},{"crashed":false,"time":"13424525577663120","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424525724679342","type":2,"window_count":1},{"crashed":false,"time":"13424525794852580","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424525831840062","type":2,"window_count":1},{"crashed":false,"time":"13424525990086001","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424526283614642","type":2,"window_count":1},{"crashed":false,"time":"13424526526416257","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424526758876361","type":2,"window_count":1},{"crashed":false,"time":"13424527057310785","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424527154233397","type":2,"window_count":1},{"crashed":false,"time":"13424527456016861","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424527980407558","type":2,"window_count":1}],"session_data_status":3},"settings":{"force_google_safesearch":false},"signin":{"accounts_metadata_dict":{},"allowed":true,"cookie_clear_on_exit_migration_notice_complete":true},"site_search_settings":{"overridden_keywords":[]},"spellcheck":{"dictionaries":["en-US"],"dictionary":""},"syncing_theme_prefs_migrated_to_non_syncing":true,"toolbar":{"pinned_cast_migration_complete":true,"pinned_chrome_labs_migration_complete":true,"tab_search_migration_complete":true},"total_passwords_available_for_account":0,"total_passwords_available_for_profile":0,"translate_site_blacklist":[],"translate_site_blocklist_with_time":{},"web_apps":{"did_migrate_default_chrome_apps":["MigrateDefaultChromeAppToWebAppsGSuite","MigrateDefaultChromeAppToWebAppsNonGSuite"],"last_preinstall_synchronize_version":"145"}} \ No newline at end of file +{"accessibility":{"captions":{"headless_caption_enabled":false}},"account_tracker_service_last_update":"13424782877389257","aim_eligibility_service":{"aim_eligibility_response":"CAEQARgAIAAwADqYAQohEgIBAiILCAEQCioDCQQCQAEiDAgCEAoqAgkCOgIBAzgKIicIARIQTmFocsOhdCBvYnLDoXplaxoLCAEQCioDCQQCQAEiAghdKAEiJggCEg5OYWhyw6F0IHNvdWJvchoMCAIQCioCCQI6AgEDIgIIXCgDOgsKCU7DoXN0cm9qZUoVWmVwdGVqdGUgc2UgbmEgY29rb2xpQg0KCQoDdWRtEgI1MBABSAFQAQ=="},"alternate_error_pages":{"backup":true},"apps":{"shortcuts_arch":"","shortcuts_version":1},"autocomplete":{"retention_policy_last_version":145},"autofill":{"last_version_deduped":145,"ran_extra_deduplication":true},"bookmark":{"storage_computation_last_update":"13424782877387317"},"browser":{"window_placement":{"bottom":978,"left":-1762,"maximized":true,"right":-466,"top":124,"work_area_bottom":1160,"work_area_left":-1920,"work_area_right":0,"work_area_top":0}},"commerce_daily_metrics_last_update_time":"13424782877388095","countryid_at_install":17242,"default_search_provider":{"choice_screen_random_shuffle_seed":"-2017928320264087321"},"domain_diversity":{"last_reporting_timestamp":"13424782877387954","last_reporting_timestamp_v4":"13424782877387993"},"download_bubble":{"partial_view_impressions":6},"enterprise_profile_guid":"ede18f3f-de38-4fdf-8123-ca16d3191779","extensions":{"alerts":{"initialized":true},"chrome_url_overrides":{},"last_chrome_version":"145.0.7632.6"},"gaia_cookie":{"changed_time":1779102854.267623,"hash":"2jmj7l5rSw0yVb/vlWAYkK/YBwk=","last_list_accounts_binary_data":"","periodic_report_time_2":"13424782877078529"},"gcm":{"product_category_for_subtypes":"com.googlechromefortesting.windows"},"google":{"services":{"signin_scoped_device_id":"462b2867-2f36-4731-88e4-8d8e63fe4705"}},"https_upgrade_navigations":{"2026-05-18":10,"2026-05-28":20,"2026-05-29":40},"in_product_help":{"recent_session_enabled_time":"13423576449721845","recent_session_start_times":["13424782877106596","13424515424132646","13424420803538214","13423576449721845"],"session_last_active_time":"13424783008074149","session_number":5,"session_start_time":"13424782877106596"},"intl":{"selected_languages":"en-US,en"},"invalidation":{"per_sender_registered_for_invalidation":{"1013309121859":{},"947318989803":{}}},"login_detection":{"oauth_signed_in_origins":{"https://covance.com":"13424783023917241"}},"media":{"engagement":{"schema_version":5}},"migrated_user_scripts_toggle":true,"ntp":{"num_personal_suggestions":6},"password_manager":{"account_store_backup_password_cleaning_last_timestamp":"13423578799689835","account_store_migrated_to_os_crypt_async":true,"profile_store_backup_password_cleaning_last_timestamp":"13423578799690145","profile_store_migrated_to_os_crypt_async":true},"privacy_sandbox":{"first_party_sets_data_access_allowed_initialized":true},"profile":{"avatar_index":26,"background_password_check":{"check_fri_weight":9,"check_interval":"2592000000000","check_mon_weight":6,"check_sat_weight":6,"check_sun_weight":6,"check_thu_weight":9,"check_tue_weight":9,"check_wed_weight":9,"next_check_time":"13424340444920678"},"content_settings":{"exceptions":{"3pcd_heuristics_grants":{"https://[*.]labcorp.com,https://[*.]covance.com":{"expiration":"13424783923915990","last_modified":"13424783023916004","lifetime":"900000000","setting":1}},"abusive_notification_permissions":{},"access_to_get_all_screens_media_in_session":{},"anti_abuse":{},"app_banner":{},"ar":{},"are_suspicious_notifications_allowlisted_by_user":{},"auto_picture_in_picture":{},"auto_select_certificate":{},"automatic_downloads":{},"automatic_fullscreen":{},"autoplay":{},"background_sync":{},"bluetooth_chooser_data":{},"bluetooth_guard":{},"bluetooth_scanning":{},"camera_pan_tilt_zoom":{},"captured_surface_control":{},"client_hints":{"https://login.labcorp.com:443,*":{"last_modified":"13424783023674203","setting":{"client_hints":[14]}}},"clipboard":{},"controlled_frame":{},"cookie_controls_metadata":{"https://[*.]covance.com,*":{"last_modified":"13424783023915723","setting":{}},"https://[*.]labcorp.com,*":{"last_modified":"13424783092217519","setting":{}}},"cookies":{},"direct_sockets":{},"direct_sockets_private_network_access":{},"display_media_system_audio":{},"disruptive_notification_permissions":{},"durable_storage":{},"fedcm_idp_registration":{},"fedcm_idp_signin":{"https://accounts.google.com:443,*":{"last_modified":"13423576454268076","setting":{"chosen-objects":[{"idp-origin":"https://accounts.google.com","idp-signin-status":false}]}}},"fedcm_share":{},"file_system_access_chooser_data":{},"file_system_access_extended_permission":{},"file_system_access_restore_permission":{},"file_system_last_picked_directory":{},"file_system_read_guard":{},"file_system_write_guard":{},"formfill_metadata":{},"geolocation":{},"geolocation_with_options":{},"hand_tracking":{},"has_migrated_local_network_access":true,"hid_chooser_data":{},"hid_guard":{},"http_allowed":{},"https_enforced":{},"idle_detection":{},"images":{},"important_site_info":{},"initialized_translations":{},"intent_picker_auto_display":{},"javascript":{},"javascript_jit":{},"javascript_optimizer":{},"keyboard_lock":{},"legacy_cookie_access":{},"legacy_cookie_scope":{},"local_fonts":{},"local_network":{},"local_network_access":{},"loopback_network":{},"media_engagement":{"https://login.labcorp.com:443,*":{"expiration":"13432559023917405","last_modified":"13424783023917415","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":48}},"https://xsp.covance.com:443,*":{"expiration":"13432559038443113","last_modified":"13424783038443133","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":101}},"https://xsp.labcorp.com:443,*":{"expiration":"13432559145852052","last_modified":"13424783145852058","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":46}}},"media_stream_camera":{},"media_stream_mic":{},"midi_sysex":{},"mixed_script":{},"nfc_devices":{},"notification_interactions":{},"notification_permission_review":{},"notifications":{},"ondevice_languages_downloaded":{},"password_protection":{},"payment_handler":{},"permission_actions_history":{},"permission_autoblocking_data":{},"permission_autorevocation_data":{},"pointer_lock":{},"popups":{},"protected_media_identifier":{},"protocol_handler":{},"reduced_accept_language":{},"safe_browsing_url_check_data":{},"sensors":{},"serial_chooser_data":{},"serial_guard":{},"site_engagement":{"https://xsp.covance.com:443,*":{"last_modified":"13424783009595162","setting":{"lastEngagementTime":1.3424783009595048e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":6.0,"rawScore":41.65209590943929}},"https://xsp.labcorp.com:443,*":{"last_modified":"13424783143258950","setting":{"lastEngagementTime":1.3424783143258892e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":15.0,"rawScore":54.60734009914247}}},"sound":{},"speaker_selection":{},"ssl_cert_decisions":{},"storage_access":{},"storage_access_header_origin_trial":{},"subresource_filter":{},"subresource_filter_data":{},"suspicious_notification_ids":{},"suspicious_notification_show_original":{},"third_party_storage_partitioning":{},"top_level_storage_access":{},"tracking_protection":{},"unused_site_permissions":{},"usb_chooser_data":{},"usb_guard":{},"vr":{},"web_app_installation":{},"webid_api":{},"webid_auto_reauthn":{},"window_placement":{}},"pref_version":1},"created_by_version":"145.0.7632.6","creation_time":"13423576449591198","default_content_setting_values":{"has_migrated_local_network_access":true},"exit_type":"Normal","family_member_role":"not_in_family","last_engagement_time":"13424783143258892","last_time_obsolete_http_credentials_removed":1779105199.689959,"last_time_password_store_metrics_reported":1780309307.078519,"managed":{"locally_parent_approved_extensions":{},"locally_parent_approved_extensions_migration_state":1},"managed_user_id":"","name":"Your Chromium","password_hash_data_list":[],"were_old_google_logins_removed":true},"safebrowsing":{"event_timestamps":{},"metrics_last_log_time":"13424782877","scout_reporting_enabled_when_deprecated":false},"safety_hub":{"unused_site_permissions_revocation":{"migration_completed":true}},"saved_tab_groups":{"did_enable_shared_tab_groups_in_last_session":false,"specifics_to_data_migration":true},"segmentation_platform":{"client_result_prefs":"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","device_switcher_util":{"result":{"labels":["NotSynced"]}},"last_db_compaction_time":"13424659199000000","uma_in_sql_start_time":"13423576449670015"},"sessions":{"event_log":[{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424524997886523","type":2,"window_count":1},{"crashed":false,"time":"13424525577663120","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424525724679342","type":2,"window_count":1},{"crashed":false,"time":"13424525794852580","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424525831840062","type":2,"window_count":1},{"crashed":false,"time":"13424525990086001","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424526283614642","type":2,"window_count":1},{"crashed":false,"time":"13424526526416257","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424526758876361","type":2,"window_count":1},{"crashed":false,"time":"13424527057310785","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424527154233397","type":2,"window_count":1},{"crashed":false,"time":"13424527456016861","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424527980407558","type":2,"window_count":1},{"crashed":false,"time":"13424782877082471","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424782936654921","type":2,"window_count":1},{"crashed":false,"time":"13424782944484614","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424782991908134","type":2,"window_count":1},{"crashed":false,"time":"13424783008055053","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424783145833963","type":2,"window_count":1}],"session_data_status":5},"settings":{"force_google_safesearch":false},"signin":{"accounts_metadata_dict":{},"allowed":true,"cookie_clear_on_exit_migration_notice_complete":true},"site_search_settings":{"overridden_keywords":[]},"spellcheck":{"dictionaries":["en-US"],"dictionary":""},"syncing_theme_prefs_migrated_to_non_syncing":true,"toolbar":{"pinned_cast_migration_complete":true,"pinned_chrome_labs_migration_complete":true,"tab_search_migration_complete":true},"total_passwords_available_for_account":0,"total_passwords_available_for_profile":0,"translate_site_blacklist":[],"translate_site_blocklist_with_time":{},"web_apps":{"did_migrate_default_chrome_apps":["MigrateDefaultChromeAppToWebAppsGSuite","MigrateDefaultChromeAppToWebAppsNonGSuite"],"last_preinstall_synchronize_version":"145"}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile/Default/Secure Preferences b/Covance_UCO3001/browser_profile/Default/Secure Preferences index 7a1cdff..7bc697a 100644 --- a/Covance_UCO3001/browser_profile/Default/Secure Preferences +++ b/Covance_UCO3001/browser_profile/Default/Secure Preferences @@ -1 +1 @@ -{"extensions":{"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":{"account_extension_type":0,"active_permissions":{"api":["management","system.display","system.storage","webstorePrivate","system.cpu","system.memory","system.network"],"explicit_host":[],"manifest_permissions":[],"scriptable_host":[]},"app_launcher_ordinal":"t","commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13423576449712497","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13423576449712497","location":5,"manifest":{"app":{"launch":{"web_url":"https://chrome.google.com/webstore"},"urls":["https://chrome.google.com/webstore"]},"description":"Discover great apps, games, extensions and themes for Chromium.","icons":{"128":"webstore_icon_128.png","16":"webstore_icon_16.png"},"key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCtl3tO0osjuzRsf6xtD2SKxPlTfuoy7AWoObysitBPvH5fE1NaAA1/2JkPWkVDhdLBWLaIBPYeXbzlHp3y4Vv/4XG+aN5qFE3z+1RU/NqkzVYHtIpVScf3DjTYtKVL66mzVGijSoAIwbFCC3LpGdaoe6Q1rSRDp76wR6jjFzsYwQIDAQAB","name":"Web Store","permissions":["webstorePrivate","management","system.cpu","system.display","system.memory","system.network","system.storage"],"version":"0.2"},"needs_sync":true,"page_ordinal":"n","path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\web_store","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false},"mhjfbmdgcfjbbpaeojofohoefgiehjai":{"account_extension_type":0,"active_permissions":{"api":["contentSettings","fileSystem","fileSystem.write","metricsPrivate","tabs","resourcesPrivate","pdfViewerPrivate"],"explicit_host":["chrome://resources/*","chrome://webui-test/*"],"manifest_permissions":[],"scriptable_host":[]},"commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13423576449713226","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13423576449713226","location":5,"manifest":{"content_security_policy":"script-src 'self' blob: filesystem: chrome://resources chrome://webui-test; object-src * blob: externalfile: file: filesystem: data:","description":"","incognito":"split","key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDN6hM0rsDYGbzQPQfOygqlRtQgKUXMfnSjhIBL7LnReAVBEd7ZmKtyN2qmSasMl4HZpMhVe2rPWVVwBDl6iyNE/Kok6E6v6V3vCLGsOpQAuuNVye/3QxzIldzG/jQAdWZiyXReRVapOhZtLjGfywCvlWq7Sl/e3sbc0vWybSDI2QIDAQAB","manifest_version":2,"mime_types":["application/pdf"],"mime_types_handler":"index.html","name":"Chromium PDF Viewer","offline_enabled":true,"permissions":["chrome://resources/","chrome://webui-test/","contentSettings","metricsPrivate","pdfViewerPrivate","resourcesPrivate","tabs",{"fileSystem":["write"]}],"version":"1","web_accessible_resources":["pdf_embedder.css"]},"path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\pdf","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false}}},"pinned_tabs":[],"protection":{"macs":{"account_values":{"browser":{"show_home_button":"C6CF41D4DD2961AA4CBE2655A6F9D6F5E4571CA2735F96A0DFC763E2947A4E0C","show_home_button_encrypted_hash":"djEwtpMJxlJPQI8Hnk3iVfpGdPv0m+7Jr05/YvXPZE5NmqkBanHvcdZJbajJAHSxSGa5bO5pDe3XsWQ0TcLS"},"extensions":{"ui":{"developer_mode":"9569D368BA1F8BCBDF69D4B2F3E42DDB80D5EBED22AA8FFDD4C9260C965B7A70","developer_mode_encrypted_hash":"djEwReom+uxhzhKJiQ3WPqyk2E26172dZ8OKnn1nNjrN8gd232/eORbugE+gwAZck6hUcOnahhbcD4EEmzjx"}},"homepage":"A76E66DFCEAEE57A5A46DAB06391A9DF5B48FADDD0433F0E7E1B43F990E2D5A1","homepage_encrypted_hash":"djEw9O8IHKQO1S2k5Cu03YdivEB7YX9cjJcEhKgXZHf+TufxBowJp9G2dZRqaOOe1Kg6X/m5hZBYwdvajOV8","homepage_is_newtabpage":"48538AB1A3E0FF0A940CB46BBF5BACC34E067CCFC848F84A66179EA0D2C07EF8","homepage_is_newtabpage_encrypted_hash":"djEwsD4zKsS/2igiETbSIsxWUXB2hrgkGQyGhZpO4BjRa6oA/PrIU8ja/Zw0i8kQGXpwtC8F8DnE143WvRjo","session":{"restore_on_startup":"209CBCE00D56042E7F93B95B62E4957C7F314B89196DBA79D91805D02A5551B0","restore_on_startup_encrypted_hash":"djEwfkZv4Oy/CdRkUWeRUzJhpzyYDVz7hyEpsL6hRbrR9dC40Eo286hFl/EYJodhCIuVFci28RCIba67BSsD","startup_urls":"7890F94790732CEAFC98E37B6D6AD2BA0671054013EAF7A0103424429BE72304","startup_urls_encrypted_hash":"djEwquyIpELY9qYKanBoUJS3J2+bgA/qqffb1F6sLUvMoA1nFs6jGiYxZpD6+p7E3YC77eq2LFkruxcX4qQz"}},"browser":{"show_home_button":"7B9E7982DA6F71AF35EED191B26105FF6CE875B635E604A383665B69FB24839C","show_home_button_encrypted_hash":"djEwwwiP+CoyOk2TIJ4fcPuL2/HNikDIGfpU8QKnKxmq0gte8h2vRlKszFnjBncfs6F+Jh10CNd1O6W0VhKj"},"default_search_provider_data":{"template_url_data":"9271004E40252718A3722D21429C644C6372F981C3A4EE2879163BEB6B3C0638","template_url_data_encrypted_hash":"djEwf1wWHzO+bUbk4fQHSNEc2MpAfE4Zi73RWbZdDQTPyoaXZCFI0EM5eZm0onDcIPar59ZoaeRTpB7qj527"},"enterprise_signin":{"policy_recovery_token":"16443C426F8E959B46798A54C0A2D7F41926426F3A49125489D3AB7230B663B9","policy_recovery_token_encrypted_hash":"djEwRSa8vQ1TPEGRJPt/hXBLHFnL2CmyMCslsysUsiMpwRdqxW0Jq2XH1RGtS2rbj+uCF1b7S1DSm1SjIMb7"},"extensions":{"install":{"initiallist":"AA6038C7627693B0914F10A8C3BA15FD859527B5EEABCABCA25A5300487F3BAC","initiallist_encrypted_hash":"djEwNmmT16uepFO13r6BgvtxVTOAdkXl1AQw9OzXiwpjS1J5pw/GaTdeVH7BQAyhFfdzWx5DnGq/8qhR3NPS","initialprovidername":"F769B372A8BECD74F81B18814FD3F23E0F49473F079E8203CCD2118BB84D740D","initialprovidername_encrypted_hash":"djEwZvmXLTqT2gXtsEKN9RVCpL/opMw7ImOr8oy1/wKRWN0EY6GipIIjIru/KpPlY+E1VGPUU1CxtdHM1usI"},"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":"08CEE6D3D9AE0B7B3405E3684D130F0ACE615DBB89B1222175DFAA2AA6217956","mhjfbmdgcfjbbpaeojofohoefgiehjai":"DC94DD4E8535B5D76C6919A48B55342C809FF2CF4F943C4B136FEBDD7115D031"},"settings_encrypted_hash":{"ahfgeienlihckogmohjhadlkjgocpleb":"djEwwEyK4MOC58rgDurR5oJJ68eb8a/E47OkL8bcA/c7ZKiNctXPCYJbi3tcFJW8AlHcSN490NxYpjuCLH3c","mhjfbmdgcfjbbpaeojofohoefgiehjai":"djEwHozxq9/8mz67xhmQLUxbLY5oiHwfUrjE65EOP1tou0+N/w6pS9Ng7riO93tvmkEB2YJiDqgzYtrD7lmH"},"ui":{"developer_mode":"3EEBE800588D845558DBE5F1482490E266D02E9935E3E7D377E9613CD7EED864","developer_mode_encrypted_hash":"djEwRSdpdKxy9AtRfOYH+mf6FzzxHmBQFrID5oYJ3yKq8kywTjG0nZe4Z+CUYeuDFffyBMeuYzBAGVkmn66O"}},"google":{"services":{"account_id":"97BD720988AA8DA8F0140518F778D2F599568753B71B65737F0F64585CA5F466","account_id_encrypted_hash":"djEwFqiN6hDrGB7kUs6TryR0zHx3Qj9mfnoDyhNToP2m3mVUFV3CylVzhIJXGjPQ7WDfE8kRC3Gu3nVYAlze","last_signed_in_username":"CB85FDE0953993F6DD69CDCB949C320D62CFB668D8221F0FF09BC6DA1E2270EF","last_signed_in_username_encrypted_hash":"djEwuzcfnXYnT/4QaexVPTE2mCpEM/rqyEuEdGiNt7g1FTLiz+RPZdhXjbjVsSHkKd8QPaU2EU/II4n4MGjB","last_username":"4F9B9540BCF78BF3BD6E0B7FB2907AEFF7B0581782B58FBD67308B8C9D3B6805","last_username_encrypted_hash":"djEwNZz+DJG2jqcw3GHmDO/T5hz2YhW7xVu/o6e9NPjxkazSLSub1vKlMQWLJnTL0R/IANgzNEcyOyX+kgqB"}},"homepage":"FF6D854B15AC70D467DB610FDF7B2FB38284560BC0521B766712BBA8B3AD3455","homepage_encrypted_hash":"djEwHJrW4zwPjRqxen8n8ubQL02+At3oBWRiiQQNNs5HkGMnqeraf4auTMlnXuXfwl7UbFkL2Vaksi+JdEBP","homepage_is_newtabpage":"DC04B53C3C64010C4861437B0A377F456226EC20ADD09F8562F5C7A21D0BE856","homepage_is_newtabpage_encrypted_hash":"djEwf4gA7POdgr+ASOcaSwdOemgLqwbEyFINGeJSHbROdwUwlDmKI6Vva0clW63/z73UhHPCsf9c7Y+A/egY","media":{"cdm":{"origin_data":"BFADE78E89D0818D6B823D78DB344A49A2826D5EACDB452ECB24FC4D8FE31A43","origin_data_encrypted_hash":"djEw5YNVcJvtCdv1tyee3pT0RdtPcY3O87y/e7nnWnBToaO17FE2fRf+wswA/tkRKGA69D+lfN66V5Ib508m"},"storage_id_salt":"F817525FF62F76D596C2CFCA4048ED2957AD5C39A65ABED0078CA8FF06EE0218","storage_id_salt_encrypted_hash":"djEw7j25urN5eCSW5Iqzdz4GkEg/KrhI/wMbQVBC9rgXaKXUTp/1YYi6WhX45EqMCtpCBrIlemQSoFL4FEpC"},"pinned_tabs":"296AB4AF8DF401E7966859811329CE0C6974552338857A608B805946743756E9","pinned_tabs_encrypted_hash":"djEw1N4M/eWWhNWA44pXn7KvKAwbQC4FU/xIPp3QWftzBQIK6HbC9lZ4F/foIzkrgkZ8hWTa8ht8AeRvUB/I","prefs":{"preference_reset_time":"70F10CBAA9D6BB4F745031B1CDB572E3A202C479AB43D3F831A01C82FAAB21DF","preference_reset_time_encrypted_hash":"djEwOpobrO5/2lW3buB1NtN8XyBxY+4eNs5N+69+12r5igHS6HDPNWAPtKYWIH6X0LbugH6TI2DWdqYDZUT4"},"safebrowsing":{"incidents_sent":"FBD04307A3E3741DDCF96C9907201110FE4C4244E352EAD68E07C504F619B3B2","incidents_sent_encrypted_hash":"djEwZkZSkVcSXdscSXWIOwzXekv6891NS6I5YcvxYqIsk9SI7ic+HqhpDQfeKWJD1rvRGOLmGoM1vfXzGTp/"},"schedule_to_flush_to_disk":"97EEF648578518214DBFD508C4D889A88426BEB5E487EB34604F92D7C4F8D0C7","schedule_to_flush_to_disk_encrypted_hash":"djEw2SuW3eRU+U1JhJn6Igk23ypLMt6G/d33un+cIMY2tbYrctgMGpJsA80FrcabcQb2tjSjQL3aCPDoyRxz","search_provider_overrides":"917E2079025259B13DCED6541BB0CAC7962F42F2450B53642F36C5532285DD1A","search_provider_overrides_encrypted_hash":"djEwFnEA3Wbj4qHfavyVc0F60ml3O/33bPv7W9kvWFv3xwDa39o0BluyyGH1HwWpIO/34PTwBI1BR7Dy2jVY","session":{"restore_on_startup":"53F3C9A5163BEF18C312F474B3DA2ECBD99493EC252BBE1D2407558A0B022165","restore_on_startup_encrypted_hash":"djEwW6UGCeOwcpK/Jg5p5+bevy5vLxJNazIfhus1wnFy1afOQF3U8VDXBYCWAtvGMMreoYNMETS5smP3SWio","startup_urls":"8192B6DB3F5AF2E9226494B40FDB2FA8CE46198CDAAD60F650E4703A621E1F61","startup_urls_encrypted_hash":"djEwK2UcxvlC+bcpi3xjyeU53d3g9Jj8rsP95PUU/+c08z7fhqVkyg7YW5U60bVKjvcPjs3kgtVo/vuRqLA1"}},"super_mac":"4A78B1658E8A2E5284E99C741E14369E8773337F0BF92F83F2B15613CF9F1332"},"schedule_to_flush_to_disk":"13424527456318365"} \ No newline at end of file +{"extensions":{"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":{"account_extension_type":0,"active_permissions":{"api":["management","system.display","system.storage","webstorePrivate","system.cpu","system.memory","system.network"],"explicit_host":[],"manifest_permissions":[],"scriptable_host":[]},"app_launcher_ordinal":"t","commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13423576449712497","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13423576449712497","location":5,"manifest":{"app":{"launch":{"web_url":"https://chrome.google.com/webstore"},"urls":["https://chrome.google.com/webstore"]},"description":"Discover great apps, games, extensions and themes for Chromium.","icons":{"128":"webstore_icon_128.png","16":"webstore_icon_16.png"},"key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCtl3tO0osjuzRsf6xtD2SKxPlTfuoy7AWoObysitBPvH5fE1NaAA1/2JkPWkVDhdLBWLaIBPYeXbzlHp3y4Vv/4XG+aN5qFE3z+1RU/NqkzVYHtIpVScf3DjTYtKVL66mzVGijSoAIwbFCC3LpGdaoe6Q1rSRDp76wR6jjFzsYwQIDAQAB","name":"Web Store","permissions":["webstorePrivate","management","system.cpu","system.display","system.memory","system.network","system.storage"],"version":"0.2"},"needs_sync":true,"page_ordinal":"n","path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\web_store","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false},"mhjfbmdgcfjbbpaeojofohoefgiehjai":{"account_extension_type":0,"active_permissions":{"api":["contentSettings","fileSystem","fileSystem.write","metricsPrivate","tabs","resourcesPrivate","pdfViewerPrivate"],"explicit_host":["chrome://resources/*","chrome://webui-test/*"],"manifest_permissions":[],"scriptable_host":[]},"commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13423576449713226","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13423576449713226","location":5,"manifest":{"content_security_policy":"script-src 'self' blob: filesystem: chrome://resources chrome://webui-test; object-src * blob: externalfile: file: filesystem: data:","description":"","incognito":"split","key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDN6hM0rsDYGbzQPQfOygqlRtQgKUXMfnSjhIBL7LnReAVBEd7ZmKtyN2qmSasMl4HZpMhVe2rPWVVwBDl6iyNE/Kok6E6v6V3vCLGsOpQAuuNVye/3QxzIldzG/jQAdWZiyXReRVapOhZtLjGfywCvlWq7Sl/e3sbc0vWybSDI2QIDAQAB","manifest_version":2,"mime_types":["application/pdf"],"mime_types_handler":"index.html","name":"Chromium PDF Viewer","offline_enabled":true,"permissions":["chrome://resources/","chrome://webui-test/","contentSettings","metricsPrivate","pdfViewerPrivate","resourcesPrivate","tabs",{"fileSystem":["write"]}],"version":"1","web_accessible_resources":["pdf_embedder.css"]},"path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\pdf","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false}}},"pinned_tabs":[],"protection":{"macs":{"account_values":{"browser":{"show_home_button":"C6CF41D4DD2961AA4CBE2655A6F9D6F5E4571CA2735F96A0DFC763E2947A4E0C","show_home_button_encrypted_hash":"djEwradIdDaXkVoKn0b9Rv6BDzDlS9dcuKv9G07i6F4D7LwIhNOUaHXMiPVfeQxliNf+0Y9nga5CbnfW4E7z"},"extensions":{"ui":{"developer_mode":"9569D368BA1F8BCBDF69D4B2F3E42DDB80D5EBED22AA8FFDD4C9260C965B7A70","developer_mode_encrypted_hash":"djEwTDubu+w57yczhoIm0+wfMVzYaRt5OJ+ByGmbfVa3cBshDrPYkopz91hCK3Gul/O4m0vwn89OpJXOG57F"}},"homepage":"A76E66DFCEAEE57A5A46DAB06391A9DF5B48FADDD0433F0E7E1B43F990E2D5A1","homepage_encrypted_hash":"djEw1PKc3huObFJnQsUtVpdvUwsuAhoSywRXkLp8LPVRJIXCZ2ilDSpHhZC729oU/4UBjuBB6+BzR5kN54ap","homepage_is_newtabpage":"48538AB1A3E0FF0A940CB46BBF5BACC34E067CCFC848F84A66179EA0D2C07EF8","homepage_is_newtabpage_encrypted_hash":"djEw3OWfz4yJ5OkQ/KDMnUabthVn0dlAJIWIEFyK+K8tMEwl1iJr583AzYG7l5F7rwOdHVVqU0KVb+fr+sVG","session":{"restore_on_startup":"209CBCE00D56042E7F93B95B62E4957C7F314B89196DBA79D91805D02A5551B0","restore_on_startup_encrypted_hash":"djEwiP106frNAvvww8ngS/0KVu/jkPs3VKW/rsCYMnZepA1oV3Q9IjDJa316dvepV9fkXROqfMAkJ8fNuVqM","startup_urls":"7890F94790732CEAFC98E37B6D6AD2BA0671054013EAF7A0103424429BE72304","startup_urls_encrypted_hash":"djEwDIRfJeKOg+dNO6Gr1rPENEsJgqJAp5mL2CPtwFGXEp0YAsR4318vPJ9AcKsevzNz0V53Cv+PqIUvVm+9"}},"browser":{"show_home_button":"7B9E7982DA6F71AF35EED191B26105FF6CE875B635E604A383665B69FB24839C","show_home_button_encrypted_hash":"djEwmNYDKh3Sx1vLw2y1F+unNXfgwUhNNarnENB7S0A2BEeniQCz4O/6+Id6r3KxrAFBuNSYwtv0PZ3mZMqW"},"default_search_provider_data":{"template_url_data":"9271004E40252718A3722D21429C644C6372F981C3A4EE2879163BEB6B3C0638","template_url_data_encrypted_hash":"djEwPwPUqpE8mBqvDX5svJx/4V6+IEsctR1bFGaEjHl3oUl0J/3a8JP7CgM4/jstRONf+tbcBIUWkKb2Kz6Y"},"enterprise_signin":{"policy_recovery_token":"16443C426F8E959B46798A54C0A2D7F41926426F3A49125489D3AB7230B663B9","policy_recovery_token_encrypted_hash":"djEwBtOtZ0H+jquUGqmbC38o7xIDKfRjBf3C1Etk8uveXg7IQzE+KS3NlE5mjIUGE0netGpNLRB2DXZKCVwS"},"extensions":{"install":{"initiallist":"AA6038C7627693B0914F10A8C3BA15FD859527B5EEABCABCA25A5300487F3BAC","initiallist_encrypted_hash":"djEwVBN0cWmM6GJupKhmFz+BJyWakBMJ9yUVdgeUvUiIrXzVwXFnt/T8XmFJS4SwZfVdyBznIcEBAvwbElrL","initialprovidername":"F769B372A8BECD74F81B18814FD3F23E0F49473F079E8203CCD2118BB84D740D","initialprovidername_encrypted_hash":"djEwHDVbHVWzUv82VmR+shoVX5k2BUvK0gbUeD287YDjgDptPcOaTb2X2qGWqJLqRSmQmztj0OUSU7PM4n1z"},"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":"08CEE6D3D9AE0B7B3405E3684D130F0ACE615DBB89B1222175DFAA2AA6217956","mhjfbmdgcfjbbpaeojofohoefgiehjai":"DC94DD4E8535B5D76C6919A48B55342C809FF2CF4F943C4B136FEBDD7115D031"},"settings_encrypted_hash":{"ahfgeienlihckogmohjhadlkjgocpleb":"djEwv8mWY9wCz3YhNsAP7ZTNeDZvCNEfPV1wkDdC7nI3ImmxkU5nZuitX/B2L0bOUwt90wbEQH00I1HyR3pu","mhjfbmdgcfjbbpaeojofohoefgiehjai":"djEwmZom753qn+168/W+dL44X342yaUxXhBN/56KtppH4AY0vSKpfZpt/xnI1mor6A7/uihbjg9SPfYVAZJc"},"ui":{"developer_mode":"3EEBE800588D845558DBE5F1482490E266D02E9935E3E7D377E9613CD7EED864","developer_mode_encrypted_hash":"djEwS2qKL6ELDogQjAsDbNjiMGbVQJ32Z4ywFdXorcoh4hG7fuB+yrgx86H2E2kHMdrpki5h3qhMayCDfq7W"}},"google":{"services":{"account_id":"97BD720988AA8DA8F0140518F778D2F599568753B71B65737F0F64585CA5F466","account_id_encrypted_hash":"djEwCro4RWrdqCNYgGFzWxQDy/t0akt3VgIvVWAbPZDjf4b60O497LIOfedCiOBSQZNGGfjBaofNKrg9fSMs","last_signed_in_username":"CB85FDE0953993F6DD69CDCB949C320D62CFB668D8221F0FF09BC6DA1E2270EF","last_signed_in_username_encrypted_hash":"djEw+p+6fLCKK+pC4M5aPMcQK12YH+yhbZMI0SNha+KZt9y7DKhQGwqiLN/YhDchf+lbLz1y7n4NbNfE8rB/","last_username":"4F9B9540BCF78BF3BD6E0B7FB2907AEFF7B0581782B58FBD67308B8C9D3B6805","last_username_encrypted_hash":"djEwPgk0VVrxsd9DzBX84rHIu1oYqMSi4z8acyNGB4n+EWckKJulkL56jzNneCUzkS2syBAodbhrtRldxQlR"}},"homepage":"FF6D854B15AC70D467DB610FDF7B2FB38284560BC0521B766712BBA8B3AD3455","homepage_encrypted_hash":"djEw6TCISMrlkFQBaCjsegGtDu2o2DH46DJIO7y3Vom8Ahrt2CmE27AlrTMIiifvsI75NLQoaW/PWQdPxW/7","homepage_is_newtabpage":"DC04B53C3C64010C4861437B0A377F456226EC20ADD09F8562F5C7A21D0BE856","homepage_is_newtabpage_encrypted_hash":"djEwP1kl8YSSYNSaGZlNCvbtYlb3J1od0JjrPvRGt5y2JRhNDnNTWAgGuuiQUtZs6+uY9/4N5hWX6JSfWz2d","media":{"cdm":{"origin_data":"BFADE78E89D0818D6B823D78DB344A49A2826D5EACDB452ECB24FC4D8FE31A43","origin_data_encrypted_hash":"djEw4p0WBdUsNzHSaKrMK+IaYDTltf2uYLaNXV2gPv0y0SOg2FF51i3BqpxUk92iI5VIAAt/emA8jlnONPIU"},"storage_id_salt":"F817525FF62F76D596C2CFCA4048ED2957AD5C39A65ABED0078CA8FF06EE0218","storage_id_salt_encrypted_hash":"djEwk1hbKmpqyHUgvJK6dXPAZsYh066O7DZel9qT9YHPBWA32jZt8w7NoJoN5LKFC39p3sQAkN2eTW73HbMY"},"pinned_tabs":"296AB4AF8DF401E7966859811329CE0C6974552338857A608B805946743756E9","pinned_tabs_encrypted_hash":"djEwuVvo/mwjsCvJhhMKpLRr1pgv1v7ULEMGmN5DEUaGdpb4y280gug7OF3NgQSMlqXcQ0vgtX8AD4T+wfAh","prefs":{"preference_reset_time":"70F10CBAA9D6BB4F745031B1CDB572E3A202C479AB43D3F831A01C82FAAB21DF","preference_reset_time_encrypted_hash":"djEwTIUBs8+Z1OFAVfqoD5BXYJ/7dQXHjrEfbC/EIzG30lwbY8JOqT3hLhTL1nDpHRacprMXKcumcmuNw+78"},"safebrowsing":{"incidents_sent":"FBD04307A3E3741DDCF96C9907201110FE4C4244E352EAD68E07C504F619B3B2","incidents_sent_encrypted_hash":"djEwjtiwgeSR2EhsaLJYmlKEKBytnB/cKM0Yfv7bo5aBLA1jh2KOfM8bVOoO0UAVRFNww6lo+KgDf8DvfYh+"},"schedule_to_flush_to_disk":"CE5A811C8151884E018792864EB0EEC2FA7B5D94441EBA8782B13543A3EF9B4C","schedule_to_flush_to_disk_encrypted_hash":"djEwubzqh0H3hQ567RINh+lE8Oz+aQI7Tt0COK+VpyGtsTjhOkiU5y3uN8b8T01EPVWAbTjKJ9qCpKdrqYjQ","search_provider_overrides":"917E2079025259B13DCED6541BB0CAC7962F42F2450B53642F36C5532285DD1A","search_provider_overrides_encrypted_hash":"djEwf/j1WSWYOfysF3S2tVKWO2jBIw9725OZP55ak1azocV8s5PEcVI318Uuv8m+7jmNBtaqDakvvU3ZGRy0","session":{"restore_on_startup":"53F3C9A5163BEF18C312F474B3DA2ECBD99493EC252BBE1D2407558A0B022165","restore_on_startup_encrypted_hash":"djEwuc8OHFze45LJuM9s/oMTSmlKyDmf8z3RRinbOLKEKQrte/lSHi2NcKOVW/zYp2G/r7B/Fi53WyEXkS9a","startup_urls":"8192B6DB3F5AF2E9226494B40FDB2FA8CE46198CDAAD60F650E4703A621E1F61","startup_urls_encrypted_hash":"djEwLOZTZIw3cDbT+uyu5mIfODk87XE53xX4DevH4tkpaqln9pujRFCzzLDSwDoabixEBKQcy3CZnTFQUxe6"}},"super_mac":"080955418A790E97E72FD61E5DFFDD419FF9FD2F98B7954BCC89FBD99562A9F8"},"schedule_to_flush_to_disk":"13424783008332305"} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile/Default/Session Storage/000007.log b/Covance_UCO3001/browser_profile/Default/Session Storage/000007.log deleted file mode 100644 index f2db05ffe64dc7d15d66fa6068549af6bb03d85f..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 50432 zcmeI5dz2(qo#(T^hDjyNb;yI9ibJjD&5WyQ;hE*;QR#uP(qmk*|7J*1I1p zX9w2f;xMoy_&|_V939kI&$!B};0S|oWEGjk$2xkBj_xQ9I11v7JIboFpKoMD){V-n zu%epk?LV^XWM@XiFYf)_-~HVi-|z1};`*mQ{gw+NEm!W0IR9Go|2ebvd}}P8Xst{y z+pWu`rRCP8<;tQxUb^7iFQz`)(sGq6{X$81&e^l2rFpwhYPDk-+sY^7xo9bx$t9D~ zbS|68TDd|pQOw#&D;A69TPK#6=a(+I_~Mz$_~hJ0Gj_gES)9M9P?^0rvj3!#lD5@! z4s0=FJOTjxu2#Y(PFjJ(8u zX4%en79;1@PA-;KCo3yUxq0d(H&d~TOOfC8E-seJrNzb4V!ypSap|*n|I<{YrR>(( z4yvr>%(>FBf*V9WHPex9l*^r~j_LTMF$Z8~p1?qG4tgz%* zTGlLMwNs(X3RYL`dU;kgStj>s&d;3^9oBNI=DtYItF8v8!Ukr3RSl|MU2(kjRA^x4 zw<~gu(++nz$Z?KJZklTQYTs4aC8r0_ z)oRPWg7XzedJZjABDMVzy4xJjxX1J8Si%2wMk!t8NG+kg&Bx2BKXQarhtQ%J$wb;X z>gAKb3P;iC2z`yTTOy4)KE1TK0CmOUKj zU9BeRk)@ex{V;dvNVZ#X&PY@Bzv^#GuBTONZJ1;Ehit#rRh!rSLAAzJLNYSt`zyDd)41Zoq9?k5#x&IA)ddqVNq$M8lOYo61FL!@dTyt zJpV8`r^u!1H5=bqt%;+QwiFq|QWeta!}>GW!p4p<(pe?tIgb0W_$rpplc&nF!u2HD zX0gK(pFQ|yCv};}GY0rp+iY=xM6%Tc62oDe)7pdcGN)Rq)#G)zyCbhb&HXjF={=|o zxOv6v9?eWfT4n=~M5e_6jaxtxHP8r*NFTiGSLeSo(o%8rd!7L!QX9gE=Ut7(Jk0Eg z8HI>kSVd)AS~}WVnJl%=*dXf3xyj{8d%09>bs$aa%HmAq->jEhT1KLE!k#P6lm_m3 zbRHbH6krVNq;Q-GSg}T?UsDmibpq6Mx zQ#9AOQ`CdVbGd>o3(eg0 zZIfnhA*ouA5qYji(@7=dE16plUN5vU&Gg#h8qM_1_-JOs#^=#Y|I^{aUB7=n-P4-` zx~Ht!Jr(o$l3k8xa|JsV%O#_!M9#9Tc+M^*?L@hpEv4i1d~U3u0nM~t{Pf>`6`J{$ zjWbL{O_~`h!-h07`^?}EZ--`H?`Eklk7imMJ|CJi^SP(gO`7QsF?jZ9(#$5!3`;YY zz%n+^_#r-vJoEb@4l(dh2gJ|<@f-%@3<2gkA!0*Ni4H)WaE(aRGB{@j)Dz{dILArA zTpQ^vfR*}4Ym_rx;GTBAW1u1twQf+x00^YuP(20RM3L9i%qf6l7XVQ-RzxP|5dTq* z`^f7A>2-iwrpa@NGkxSZg7(X3djyJ;@R?jWX%wwZ8T4%^5f#yZ*uHZ!sTL@EHXf3)~#8SdxqSa+2()=a) zuA;ImSCgEH@n@6PZz78)OEZhq=P~lyk9E4S%{+D6gRR=pZWO&`>%-t)LHTa{q=VxT z^p+oXMfRbssDA9P!qYxg=x^wH<6)M%!6Qtc}LB;Lx-j-`%95NZAl)E8OL$nWsm0zFC@?q9PS*Q->J!(aZ+z)T5c+ zrFwdE^CPQ=pqaP2zGTqMgg5kNG?}4)xW64&e|LbZCrnpQl``>!l~3mqWkxoWX*&yB zDHn3Fd?uc<%Y{raUI?HpiTI~>-1TZG%k2RfCQZr`D#J#UC6V~qNALKjL`%yZZkA48 zQw`!I;%4ib#r2Bx-aYi)S$g~vxaJ=E>=?fk>u`fOwVSG~OV3M%xo5d=kSd(VX%$*j zC~+LubX%A1s&8G_wVZqqr~2^Qyth?7Ek)tdrnjM>dT8HRcmKdc?|)^aMVD7 z`iY~s(E9^w)Hk?Vwv)~fc`lnTS-E7nP{>)uJR__H##J*`ylmwIT`2j~qo19_g+36F zp>J?CRE7;*C}m%N+cYlpXANA)3mO!PyISeh6ekxfOY*A&0M>y!oWOa~^mJ=3Lyy%w4a>g+9{2 zg*+n^iVy$#wm2^I=K(dEF?*qCww%tCO8HzmU$hyYw-WS1v1Be$EN1LdhPX*GXna1A zZtH&J4Y<%p12VMCUMN(C4P7X+c;2qp;X;4Wz=hIgFEq!aPQy~O*m#&mTE@nDV&{3j zPvII~FXY`+b)h8qbbza~JP!BpK%D}0$^|Fsxu$U@uNUI3)1w#4I_@JN?|bGY()GR2 z-+b~7pT~th(ZGc~BNU3ay{Y?)|FW~?Zdd4~#HGw>IVV|xW_U7GQtP93rcNjMXft&R zl~j;UTfp@um^I_dTS%%#5zMlMN~f-DMu0kWLcWq2vvp4LfnpXeR8ntRS!75X#bz^Bs1LLp@rb0s^P&n4q!g74W_B9~933&m`_WTj%| zAUJD1cGHia;X(4q#u+Ak5%^FUHhhp|AAf!EUlW0U)Xh>~ZUjEDF)L_B;F}Tn=0q<| zPt@e7jmFE@W@~J1nxi)c(Tu={jldrvh9xGg_;VE0I|udY2h%1&up{8#4$$v$Fl{fi zsLYvOWJjsXC=^SvU`1y&foA{;br1@r2)!gVnQM{nX~)G(6F1_V*I~=ZsX*tX!{Qi)|1y6T@{&;8P=Pu9R za@g_&cAlq(=ct2WYD&=@O(&bentQNxhvPS8bXP#JVn*P3cAmP4UbP3c5sAC+zkU0B zBJhs|APHXtehWyV2CsLf5H2z*V{*)q%v$QUcoj1hB&-FyF zLr$kwLSYR?w$XeGbU$ifnhCp)V#H})?VLNp@d27n51p3cQVXbBqOt8qY6>$Ho#GtF z7?pJq_|v01-)u}YO~E12mkL(4n8@c!R+=zxIbY7%WhD^TI zye!u;c&Yq0!5w4x-ywSAW zRR^1DMko~j<7@Zc`1YMG|L6+6WL=my6b`7bKr?)~g`{fu%8c-ZN@sn4eNqXT7{`n| zpQM+YI)zHAu5d<3HB^t^pyG@$Z>Xf|bUK-YdI5NUF$a43N2p*hK;AU*Twmqdw@;3h;A+Uz!E2cv)%mk<-v%Jhj7imkRj71==u7B?8qk-TpVgyUHx62BP7NfgOX%0N?sUsXR&cLZ2Dq0m zv~Q==g;XI{Vul|}Ba``fA(u~S#&IE@D8@>5J|D9JfNqzR`hO^5^V_XFIt@J+h`X*xp* z7@Y=WFYrAE$Xf*h9^!Kh;Fm(W7rG!?Ao!i&E}K!u8KkrPYUl1UU~mHIWguggJGHE7 z%z=o*4qWU5{A%oR4Un&2BzXcjng)ta0!p*UodDKr9A}jLJAuh7q~8lb)ebt^MQI-& zO?{XHMt7oxcG}Q1f_)I3DEH0-PWw65est zO{h`?{jaGl)qT{o*s;3phRA~^X=v}A6c&uRR7WchN_<2KEIyi^VI!fPd_*#~n+QfCG3SaztR_QDda^XPoE1-cufG3NSZWZ3rL~{34sxb2hO$H$Q#3G$G}U+||Pf zlP1)}j6%3HL6EGPTD&2+7)QR#jf;vnh;9&dPr!}ge@dh^9hqCgi0rfCWKC?0Zpj+S-m^D zG@;g<8c0-W!n)Rd=1V_w1ouh@xR-CNI9tx=3)xgYS1cx(7LiR`3?!rzxr`NymY5q+ zP8W+oG$Hl1-~097Lldlk41Ht8p)#!Z3EFr1>epVXEjur9vovXfH$GZ#t|m=r(u5{W zXwrn!mnH~QYm?nxh(H&hPup6?Iqm}5uK@8@0Dgx#(w-#~z`P2eu@ksG2q+(8!lCvE z(M~4XwDt(+wTWIgzqJQTH}W$`bRakB5C@B6jZ=(rhsa0c(S#mSItIW@J4E0FIgLU~ zRyi)B(Oz`WCY%SzGld>|Nh<*bupCY2AO>2Dy9i~8qPgPP`}i!PPY-tq_%4!;=0f^#O2PTYxcq zEAm1aqXA8@;@|n;Zh-$jH$#&qG#E75dFD5M0`TAOO0Nh0p|q(7c_#4RLQ=I_Hi3Vr zbb^3?=!6;pf6sI39n1s%UIS?$;R1hudwt7?BCo??dN+2MbkrPv%ID+BLOjaQKp|7e zB@@w9&dy}m3xFx2#Y~#fgF-3@_-8Nt!pQvq|Gt0>W9Ilks0{0UVrMKJZU5Y^e+2j+ za-HRrpNQgxA0U8TvrRhWo(qAT}4sy(()jrM~N2hk~&~z0o@|r}K1B?P_1IB62 z#7R$^LKP^LrcKRr<`}w2^DL=p%cnA93DZt#+P4MxYcYqW4i&LrjJ#8Pv{iMLf@s7b zfo^H^(E?3x`$SDAvbiFd@9pES?XGPkMI^R+d_XPt1oj%h#uhg30K(4__g9T;y4Eo8 zewdmOm0HHeIc%AuzO?95{oV|Awm3J>9eQ&_7nb$||Lmy*{@#Pyz|4R6raK-3_zwmk ziMR>;w}2#SkPsLVOP}+y-2ne#H$Q#3z(4IxoT*1$Ch)I`8HI3xzb1JpE|Fkz+Vifa@-`@W?!2c>&dOh$DrABQef-}4@Te>ot-lnMMpWmxYM zwAkbuA8dIR;6LGJX#oGU_o}&ib2Wi~6ZkiQe-rqhuE1Zf($cb3ye2#FJ;?gAtboU{Dls}bPQS3cL{x#B}5rZ*O7BJPG?$7PS zAnnPL!m5hZS6|7cu@W1*dg~punM0N`X$p{55)_eC{J$Fc7ikdK*G31rQ>l3N^WFsX z+`pu2iTw1sHtp`S-?4lfH8(`v?4u^f@RS~hG>PU7^EW^ZtzgT8)JF{cR6|SD$}HFR zqqX+O?8LUUh(FKHQ#UcF_MkSv>`~^v7$Ip zWchI5Ym?HM-d}v>7{LFUfDC;LheKsp?-R6GYsdXBeDED-?D!9EmL~9TE*uuL(>oxW zZ|AMP5x5E+)?Q?EDz+?K%dMKb=5{yV&f9!DZ_wL$=YhY1{EDsT9q_If;Y`tv2Y{Jv zz`6s#w-KOR8Q@xWpk6;kpPOk?S>;F(Y>g76 zfQ-xB7bT4Xxl}!MJ@D5mfFy7|Pm0I6LtFiIIBE8yTMxele)p1gFTdC{{d0p?|G}j@ zo`(_(h-n$YIM{Q7WVA8bL6jMn7>a4dutNVUD4`ilGay*4Z_RV3n28vRUOKxU2CzN& zU+aXch+i{)gpIWfKtX=((WpTdy^2>Wg(a2dT6I>B=KW~@Ck+)S=&!{B!q$22scO1? z_`e&=3}HX9w+_dqdfBlm-GYB*I5&tMomAHlmRn>w1P}GniXd?TrD{dbI|G(MIPhTGX z_vX0NgD)Tc_r#1sc=&(Q>xa{8k|zGYZpYg$2hLp|U<}{-;ZVk?$N!n=CojD57vTRt zax*mWf5saIF^YLk>3xrZ|8H=m*W>?C+SFq`6aQ}^sah?Y_&-!SLHIv(LXGgh=Q;Hb z=HY*@fi#eC@xQ;lKKZ9to`J*M9N;j%6~XyfKA$Y6in(YxCH&8xLD@vSm@6jiR5oSD zcmYVz+dnd~I}7LC3;ut5K!&~*!J#s&_lcdcO#Jw@PkoEP|2y3*4g8;Jt_W`8|LUu# zwH>v#S*bpd*ARIV|DOsAG&gMzyJ@?oVHW{sf_D}na=po~0ATI{!0FXPhqxl2Zs&~V zo=gDc^nUv^=d*AFZOp9@^%0<*ri53JJDujp(q42MLd#=( zdVr!D)=-(INx2AQT|!d(c8)mUG>g75O0>$+b^w0`?WL!9lr{j;Bz|q`Dll)OpN0_UP0T2S3;cCybAf+D(ggnf zAG~c49QWP;WB67ChcZS3;Gf)k-oL*S;D4u^p$YuGD78_{XRrU~8G!%$UFr3}Ka@80 zAkPH;TS%%_%O>y-l}-@w51mj0;9v8cdIxiXf31Nukf;Lxb?x;dKfd$jILwCw9LBfC zH=4J2TVy7l%cNM|o3sIBVC=L13Tgz#-&T z0Dl7Ide74_a#$segAPb+4Ez^?x!RscdyOjX8RVw{mxsAigA#4zG0y)3Nj}UFWo>R^tI0K9Q6bK2-POuWGt|5&ur8kQR2R zzWezb!9pTzB7r3=uRpy2A%$fZk($P$^GK*3#;Nl(_Yb18mIsLb?cuu@`_^XsWc+Ie zw|B=-G7~)Wy&3ye_w0NG;Qz4zBw?8|ezt%lYLE~Zkr})DmrnrvKknwIFAw;8b6o0C zmk;=RVg@4ifIpWu3H;Y2P2m5RANlFO1IK+bz!<(YzM+iK0Qg(C{Brynfd8l63{Bwg zg{O^TzUtEVoIv`X%}Jko&HJuJ`rge+zw5r@A0qvk%}Jl%@~$PM|8jHE7yRO$TOll; zb*0x6mQYr#2d5@s*+Nn^?=%TZsC0q|OX!3e5f;zm>l=ngSiFYaK*A*~{(h#Tf66{9 z((;g7BQ(NDgH!Dnyk2iJ_oN!U2*L8LV2&o@`Fx6ZAQX~X#+>E7HQ7{wg$(6bqLj}k z^6^;Eix4u|Z(j8DA3$q9@2b@(L*EMKP#M;H&d!(>J?r(i-UzMvA8wW=t=V|pN0Zhx zX-$*XG-=K0N^7P7sMV?JOTbf2@zDz&Q$W;Jz-SzZ+6|mO0#)b%-1b8kw9(HBV73ox zk>YQKd*YB6EqTyt;a}XrZt+qv;YMv zA~Os;P6OnJ$V)S)DrljZQ&XffhW1C$w*rW+AR!WTh&=b9{|IsOZmy1S*9Z_?ugyKo z|H?UmRE%_o_@&)YwRA(TO_-r1JxFW^t$@eWd@_ z=A=J+yz5D%zrH!?XYRT02T1?T=A>Wt<<~w8t@(y4T}Nxepy7IO>Z3K`ld5^AkJf}q zCy>^JO{f8_sd;>T!|-U0*RUH%xU|OK&s_JGxBdx^{vEeQ8u17J%IiYDkSrAJT&!%f z*J`F5&Dq7cohufsn3X8Rc`HNEUaMB(_oH8a0>bjY12XilybhCLy-(27B%fM+$8`{v z@3~nTgvDyEylzgwYEHm17kpG9pE)6_IRUFeH2Pu}49ixh!<*Z*_0SwZa|C#)QH?l6 zWC~bW1ai&*MdyH8lgA<1RipT$02mo z4zPR3dl1Pb?ieCRtqj-8>9wotDl+}pyu`T?v|Qo*0f@?&Lmax17NO8CvHg5+2VoHz zu>khkM^!5s@|B)S*13AGrmt$;*5z zFL-vIx(Qgd2eko$uX!{%0%7?<0Fv;pybg~fYLE~ZkvjJSotHsao^bQimq%E^ldyQf zccYje`+3&`NI$(f>D_;EpVI!x=A=JZerXO;@r*0Io>U~ll(Zf|nxtY2N!2{aBo(33 z2_hAt6KX^%Jg=;GUYAtV8eap6Dydl47kpyJAJ5{9KX+@S5vlO4>W=2~cDc;3M=Dc} zv8p3mW^z|Hn=2;EwjH(eiE=q;A6F~$uKl+xLMomO$k4Z{J5+}CK0$9_9sTA_OOT3R zx>=f}V&g?H%~6o%C`fY@q&W(5x{iYAWBdxh!VcbA(Q9A;-?Et_Fs*iKM#{tY5Q_)Ks@_dGYmtCZ|h-44YGDS{pK;#n~ zRYCFkRo&yrYvqCf=@55oQ>QXOTJLikAtFBj+}0$hG5$35s2>e9xojDY1#Lw~w2ow+ zkr$1Z%yVxa`skis^6ezmDED2Wg7c*$IK;s3~7eQ-UmnL#)oJ6m^)>w}05a(EvzqX%LbYiz^ovoln7d5ASTQxnd z6-(v$b(C5kq(<~A487fL3_JEa^hdkBY8<4Wvjx6~vHKLI^OFky^3d%a1+lybwElBhvKU_|zuE3Xl$XgLEm!9Qi|kqU1*Q$6bPkqS@DD1=8U zxU@-9u_kGfim$!tp=02>y)RT&Av~<&79|rh8-_6h<6cla=-W diff --git a/Covance_UCO3001/browser_profile/Default/Session Storage/LOG b/Covance_UCO3001/browser_profile/Default/Session Storage/LOG index 5778068..30ea52b 100644 --- a/Covance_UCO3001/browser_profile/Default/Session Storage/LOG +++ b/Covance_UCO3001/browser_profile/Default/Session Storage/LOG @@ -1,3 +1,3 @@ -2026/05/29-13:24:16.313 988 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/MANIFEST-000001 -2026/05/29-13:24:16.314 988 Recovering log #7 -2026/05/29-13:24:16.318 988 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/000007.log +2026/06/01-12:23:28.325 69ec Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/MANIFEST-000001 +2026/06/01-12:23:28.327 69ec Recovering log #10 +2026/06/01-12:23:28.331 69ec Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/000010.log diff --git a/Covance_UCO3001/browser_profile/Default/Session Storage/LOG.old b/Covance_UCO3001/browser_profile/Default/Session Storage/LOG.old index 31e305f..e6fd7f1 100644 --- a/Covance_UCO3001/browser_profile/Default/Session Storage/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/Session Storage/LOG.old @@ -1,3 +1,6 @@ -2026/05/29-13:17:37.578 6a60 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/MANIFEST-000001 -2026/05/29-13:17:37.580 6a60 Recovering log #7 -2026/05/29-13:17:37.611 6a60 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/000007.log +2026/06/01-12:22:24.843 42a0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/MANIFEST-000001 +2026/06/01-12:22:24.848 42a0 Recovering log #7 +2026/06/01-12:22:24.881 42a0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\Session Storage/000007.log +2026/06/01-12:22:37.692 42a0 Level-0 table #11: started +2026/06/01-12:22:37.728 42a0 Level-0 table #11: 20038 bytes OK +2026/06/01-12:22:37.795 42a0 Delete type=0 #7 diff --git a/Covance_UCO3001/browser_profile/Default/Session Storage/MANIFEST-000001 b/Covance_UCO3001/browser_profile/Default/Session Storage/MANIFEST-000001 index 610accc84fca3dffc7eda106b2f76b3dbc9905a3..dcce9b9b59393cc11f85b35977eb84dfd48e761e 100644 GIT binary patch delta 74 zcmdnZ_>XbIZs)|6PaSL+7@4>@8JKxkc5tyXa37n)D3P03plfJkpj(idmy#c!oWhXA V%m4zyd8rj8x**xi6vi}&7yu8I5}E)2 delta 6 NcmeyzxSMgpZU73&0|x*A diff --git a/Covance_UCO3001/browser_profile/Default/Sessions/Session_13424527059825092 b/Covance_UCO3001/browser_profile/Default/Sessions/Session_13424527059825092 deleted file mode 100644 index 3506f2c4e72cd7dbb15c0ad71e1c18484c7edffc..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 39544 zcmeHQU2I&(bsov~noN{NZtPla5@+dHgn)RpcYnA)Mp%iWL{XF_uSChD6tvX-QCw-c zOYSadQg#3p=!5dmmO%TUK2cff5ukc#P(9>90aCyX`r!Tm)q{Z&XbLE)3&=og z_51G35wC{46uHz&l)OXEp831;cjwHUbLPz4;p4-@&ncxkRp;oD7xu%YzM{U`0kG`- z)`Q+xz1~h0l!TpX#~G7Fr`j&gF7=u?nfYp_Qy0c$5%smVkc7@R0aK~?_;@at8!IHD z@v(T)DU79)x%601Pcr7ji_vI4lJ8Uhu-RO7rtx;JoUL4Bka`F4gRot2?+4uF zhN8L_)s@ zXON!5GU@)s)Hwd47(gLaPzkgu30EBc7=A-&X$0XZxDsfAgOn+_l6WSL6wJdff1NIm zCmdD8FLNEo(*=`%(ak@N-y%v0A*YDSBQ}q+$B}mmHiu{VuEk(Dtvcr72maJW6iFw~ z-19L^2TWfCx@hNiI{B7>=@QDA)r`S(CNr2$C%ZJ3&*kI!e0D4{o-F{=$DOfkA(|a4 z1eKBe{;|79y&;sx46r?sedXP=-RQNU}Y9unr~7ZhUr^RN?`3??xZ z*y)3kkq`9d!zAL*z|C5-u1jex@;4z|rHu0(v>ZCmM~Z`rF~~TzzV9zB-$&#ONk4;wCfmm|GqqRMnaTUd10b`QO0vDhZTF8+f!CxA#6#h8&>EdXNxlb@v1gVPn^UFVi7Dtha zcr^|jA!fzgr}Uzib4%iH8ubVvCzj5oj~JCksjN?geJ53SN51=x))<$6w(GC%FHpBU zeIujahD@?e-SZ&AA3qoP5R@L51HQPm3j7-4k6=j5qWX0Vo02+@1~o8LYAUEQE^HvA zjC7>tZW@HS@dyy+Bjicb!AcrK0@WRD05-z7jY0URNiT59_-}dg@nl1%YwQ=zf$a9p zBSIKEe-ie;3w!UC&)xFP&%Li!-`G*f&X&$+8>MRHNa4t~58Rr|C}F)A;Ft&KUyqUU zC9UlbN`w!T^1p@nS7Ci7PhW&dV%WD5A&Jza@(M26a)BfA6aDm3M^xnkS8!2~u}OC! zN*NU9QkBHB=v!&(x)3sR@7ssTTG0?8-7yL%h$;vvex@_n2rN-94y;el zhRfCSrOLiqu`yGtoUWC7cSi@*Mlkf(C}0V;3uW8}ARJAsJJ~TTr)SsF@d3d;%h+a5!y4>$%LeqyE zC(m1tj!hO(WTAIB+LP$6R6!B<4h@x@@>JjZ)6?@8suweva%Au#p3WtbS8Ir;Ouzx=&@wa(9uj!cdb|`)r$GX*i5a|>o$LPtPhhH z{w>NIAxK@Hs#fa7vBvyVv6l_&t~aucVsCV=a&n|`aw_`ng+yVd{9fhE>5+8pL?Z8` zYyJIBDiO=ir7H8o(Yg0VriR{~y^uIGbZn$lz0{vfAMGE!)LqY4kt1xSRM;JLij&z= z8E~pr9WRxOeA|BlLD*&3F1Y6ao1GzV@@0F>Esvj0iJyM`hb|jjGtlJ)5x?#7=7*a-9 z7!+XyzmkH_meeJr*@v9Ua2GM3Hq;ng1KJOtHDUr~ur0&Ls|PuDqgGW|&Nsa%aR_a7 zkpGnGQ|}}9Y1HciQd~r78O%oGC@+p0oIqPos56L(A>|zEK8+rEA2G-9>@ez=LyhZb z#~D0F7GxMLilXOp$YB62=L~xksgtP35L_9+Zah;&{Yoy(yM519t%SN!xS(0S-ENtB zebc{dvwu2`&YNr^+gnFDW5{nFezu$=hi|MKG2{grZfF!OtDtvB;6I6!QS~l*BY~70 zLGK~%3|c&bnY)JGNFWz7Mm4ma?}v<13}JI{RZtT9d=5{IAg3YZH0$Pd2<~GDE1?FL z@LUo(90eSNkF{aVbR9LUAZ5W_-6=<$L|sd$3)|=*T@9(n-H??`pRD`>Npq7raSZ0s zzaAqio}{(?L5c8zQhu{EIM--0xm+=msC@`Ffl*2MEPrG0kx}OR;L1(vnanVmWLkzs z(RWgBsZR#=<;qRrQ5@+x67|~55K`LAKY=ioL{?i%YAJrA@Q4B1O#bGK>Yva9%*%qhx%9!MV;k14f{TB!cV!k1@&ahuHOdwi%zTCtYuLx@|K`%VH1_ ze+cB@HewK9q?&vwF!55GQF80^j0Lg02SKh;P+WnF!s8!(1@9HM z3(s8xYo6%(oYes9o+~qRau< zWwu=J#I{Z-6I9X3I6{3GY5`E_6+&z2<3wJie+s{PBUEpWQhknFE(~YBtW^PU0d-w%ymy%KifGr&dHfvjQ^r4I zgxa$PUN_+~z6CCsa90dq@>~tr?Y)FVY1p;KJC!S!B?QZ(UIf=+GtbXr%u|qCcQK-f z8D0A+5Y)nF3dgw~a0b=JuFv}MfvSoz^l~5ioY=upp1>Ps=s|>V)J!;vluq8cA^Zn+eCQV_|~sm4k@AZ|KRr67w?3NyQq*Jkj()xuZeG4+bLEx&2l4#?PQO~(MrzA+*GAHE@$**!=;bXE8n@Uy=gi5q&F?U{ttUs z6~2m4R-jk%GP5Hv1-7@nFTM5mr8g>W`6=j>>#&@z76D1l(#Z5EP{^4D#I3f>KTO3x(VK#h88UFM0fqw!d2SP7rbzw3s zrO@y`DuMRSrcYH)mGZNh>_9S_KIsgMj2xLCKRznuh9wfd-~ zPXQZ+%UTnVqHGHFDDKu8{z*5UdWQOlTnhDyD=)Lip*}%tj>oOkpm#&Ujq1f>B`jL! z`&{kuQw-~MqI*k)y(5=uh0_O4A32tqK06SZjGao1PLB0lI+~g3uMZ#XDOKJ*n>gKb z;206;y-%{M3Ri56Hu3YBA9n^8+e-gWh0^~!@%(eE~3v&%uV!j*GeD`Dm= zc-8pt7^qXVg)430N?W+{^b1$Eo<{6u$&dD4So;89D-Q5AvlnKVQmp3cv*!Yzf*T`K zO7Ce{AvVdBdJk*5hZL)|aJ?~8m=DJi>9`Ya6zh!;&M)HhW<8vaIk=Y#@!3itTPuXT zk!E@R1QhLUSYp%1fXz}9`?r}44H&fi68|5?|8|+nB?B*;bllA z{{{)&KJ#HN{j@QbkCsupjyf4Ul1+W0FxU+0$#ADXj8J_IMF^?r(uWbLv%$MNs3$-c zML*A*OvtFz@Eh`dQnzfYGkbRZGN|^Ou+)>{l?D8x7Kvu!ReFgDg}RT#d}=NU$b%465wHPtvNvrA~JCiTx)R~|zK@KizBJh|Q z^@=cVgl|=3;#!SY|8jT!0j5pAWoVT87{*6l2)qTH-^%i+jokI{BTi$mU1-`hz-Ffw zkxNMzu2*gqrmS#Z?&uN$aSJ)BW#%dOUT?$w?u1n&f{Ew_612+g*fYjbigk$C8!7Ijp+d%#F!)MB8jR>=6G^)6- z>)x#G`nH|hNdI-%k6~$qIG!-?M~Gk{dKXRjO?iK2rP^tr?7ZwZ{&NQM+Dw`&23|8z zR=S(UPePyOj)CsrfS(7GY4#Yn-@uH4=M3a-6wQKxcK=X9?!Z3oV=crRt}@4gnL*h1 zfqgt=V%JZOc_fgQ#*UYj$_}TW(#?k*AMrb`!j+G8?8hz?Rblnzl={HpLDX|EYJCiI z2J^oF_W;~w5X^QxT2(*kzhUg01wkV7wu%OroX1tZU%ULmH~T*P^7RXU+RA$aV-2TW zac2u}7Ma0{6$DE(k6&U4aYGx9%WbfZ$8Vf#0vQ*Q$o2;%!Usw}uXecIBj{K${xZn# zaWJ3U1>|M1RNNm29?IQ)WMsMX$Qxs*&dz&c$oi7?@cb|0WHrNV=XpRZ@KGcfU#l21F(xgD@wYzH8xF&Y_;0_7bnAdVEx6(;hS z{lo#7jgn77CS5aRlE53rztg*ejQmY8Zdv@X>(?fq%(bI!^69aj3YO)+O+KxCI@piA zlm2UyPkL&z=Qa8_Lq5y=ZRhJ3zS;5~4f(Y71X^u!Yx%;{N3n<247p_lSELYr@m%2N zV5BMbr}rJ$&F=V3mh!b~u2h9G+B~vTzXa8J3zifTg#gV`NP8^O#j*Sn{~NQr_ge#P zK?mzZGiRRv$jZm^uAq>v;aRtzz@DzALi)IN`6gZUQ!-aMxT;{*dEeXoiu%e7B`}5h zvyBcc4gKpeGV@7V+aHt&A1LL^bK=h+JsB#Bs`F@z{^AC|NkB%1S0$6-;i+Wa3qZfV zV40UDlFi}%9^p5 zXqoNirtDQ%nhw+dG85Z8tvwUpH0fmqUXu5RRe~mHpkv^mf#(bqk@IEaziOa}obC2a zAWsK&tBZ!?Y&?uzf0;4uaQZhx+j0dU4z@+Z=mZ$MfBpL1FMPA_L-OT&Axb!`6b$|A zF;ag?Yx{!|;RB`oW@+_SujKqF0@rbhIk_T}QsCzjc&i6Rqx!%Fb$fUdNC@e8$by$@ z^Gjg7yj<%`p>L(Bic?1`R`O4OKYwI3aj2~DvXYCRujId83@mNo<@={tvag%vd+`Y@ z-?B^(nq^wxIpe?4UcSAEz4D7nMznbisoKl;!!Io4(#UyYy`stX@{P`dk-1g+?~5jy zTzmO`c0_aS<$hV%)y#5l7ec@*&J-N0ULPdpiYPys)cP9@_#TS@`{|BOiP^QTGy zpPzx{$=|gU@JV#?T2B(8UmOK|Ek5JrfK;m2S9zvDYEv1WJwc+JdJFpNXH=i(m3)jR zIs^NSIz+2yfo_!ia8cec1l{Y?CjA5zz75-j ze5qB+wVy^)&f_w9)3aEcXa1TGl=l7Tw*;iA3Ps6#xt8O84Z zjf(tkqvJNCP1<2Zbh`|+MSBw_e9piH0~ZavVc;zTZyR{mzz(Ao%Fo@Ih9=o8+*;T0Li)q~okhoJdaaxaq~#Qe-_<2i?DWB0Sn z2X;99n-Oh(QF#x$A6wPGe);-^Z}xq@f${JxYn8T|qKbl6B5lNrwKc_-c7>t(GH8~r z@4ex1M{c~5cB4)yzg?>@spqlA_+zK2{&VbmL#v5Vh0+p=O8lHlNL$$taD+ zHvURKe$hm@c0aU=tntg&FMMl|QO}MDyG?ejenU$$WS0?Sap-!qOX=Of{<^O?`$=n; zetBHqA+y6kTc=6Lpsl4{x^aQiv!-3j4{qnc!su%}d327KZ&H_(qH2EkMc)-e-4Y6| zdGAgh@zfpRC&Q^R!uw?G6(NHcPEj>AQ24DG3bmTB zFg*|HF&!DQ*b2s~6*x2YKYwx5%S_3b6(-7tjQ3#miRT0FKqf=&(pF&gMy`2z3t~GS z7$=_;1ZHP7uy|LDrfZ0C-}ocdEpI*c+gPzt zv9i!PDYTz`ln5UvNca3yOUW$|{ zlI9PYb{s(2GC)JJfoL;8*xHT7Fid}Rn3D#Z`)kmEWKq`y@QQAAfvppo3{!!2_0R@T zhPB@J^PcmVFAsT1@m{`{_g=k6dilKPocEsheb0N&d48PldCuumr%%5(ilRNyo&-Tyy)5qqNd*lBC@Av>k;^}-%^GcN0he*EWj z38x)R{?Xyd;?#>IMJJU%q@z{mgQEN5R6TA$`2d6^9W6Sp5J`kYpJ|D{>*+1K?jAdF^tO){g7no_tvu&$pYc)A_&uZHXgXSm=A%b-HW?M8 zsfahW_p<9l+OKQ4WnKq?_?-kR*RBoYIm;+R?K$js7BA>}n&oKJrT6I5a}7jeI&0G# z_3B@b&bs5YKAjEgyf5mE)3~-2h_V%OPk-YFBfZo>wD|05^d zIHEy-Q$C;u0ZX;}gwziLT;>M>PO0tu@NjW#Y-H?gPv2O_+3sHT|KWjwfwQCCW5r^= zINUWh*5d~O?xjJ%?sc^5x%l1G3oYq~?`iofRfR>@>xHi=e^E!P3Y!s4yBGe-m%khL z!hh!JKHfqh@2QJL(Lo=-9Hd*m(XiE~+Y8@*%z7oQHyP|XEUjGJdKdZk>KNBJaZ#g0 zczwUzDJy?qDNe(utd0#IOp`bkNR*9B|73;{-}Q6t@4Y?DaC1By1qZY1HG-N*no}^>dqcLZu#*y+Mr#2<&(vC zd%=xF-B{}nDVN+6y_4t&Uwm)NYZ3xs2Yk4VZusNMKdvTmNiQ*{W-}3;*Q3v?smw;X zs1Vb6rA+EN1ikCN!@RK#9p+7yN!ZOp`he^jw>FWm!^AJ6^fUf?qcc8!BT-JG7*695 zHY6HyTsPa)VZ!o}`F~8uI}iU&e1HGvod>4(-#=BnG;zK-KQTRZeDwG|pO2s1S_#iZ zLf-#?_?-m1zg-)~bCywt+Wmi0`5)9#X7DWAVbbo9MRoZub+B%ADmpFX6@f{(-Y-T?9I0+(t#MqgscwIM?~!s9qBN z=l8aJ$M;5}KdYlm&9+ZYpP!g|Y_>GNFgx|!?Bt=3cOHwj(nJ4DH@KyvRrk0lO6w+A zOE7A$zoa}E^A#>igj@dnwx>yt5dQN{QqeIch)e4TO?65xUzG30(FEY<{le#gWd7Paiw=QpbG%fsyIa(%F&m;^bs$>U`hb6D zXHIm#Fmq()RH0*J`oe+P(&)r&X=MKF!tBJM`1L>Dby$O!{s)q`Qgrp)%=FY;>FoR~ zGo?ek*nzqE;(Y1Qv!}a0^UToUv8VHs#|xL{x}KdFKiYq~vv;EB=%wz3Q_tr=TO6AC zOy~KDlLI|-i%(7rPdtC&L}9k5syKYK^y9L8) zxVd~uHnPh)TJ^0KMJpX4uk*1J;YK3PspbFFgG(R481*qvV_i`B`_Ks!H1FeAJaxJ6 zib57$)1&%zv$)L#Bjm~m_(*J;8dje{rZYtV!GBsk3G>ys`g42SpT^>pNu{+*BJ9v# zyMo_NM6asPJ*JW-bzahVIv<_Y*{DX;d|XxI>K;8=S9Bse9G#AykDsMYcNo^$%ewN}=oyu@ zp!mh;1xcv|ox$;u4%!sEsIuGiyW`OXjaTP4x$9Y7504nv9e9`1dhQ;LIS2Gq(>fTT z4ylwA8hc85+N0tl7j&mtjddf@6MECnL`U>Qeaaox^Sq$9I-{o;(sRzJT%PJB)e5z? zsFcT*cR_SS@A_o?o2OK>$5m=xzdNBPenGiMbez(as1Vb-{($aB`4cf6iR&J&Hlb(3 zxZqU2kLzxSJ%4jtZe#V&UE|6|P2_#&bf2>-?-j*)bMDUFpNuUeD|5&#In=bdS#{A8vh8_1mN0 zE~-{0^hGCh)dkf@L2p^~t>UoCD53}=f+fvn%f&o0&Vf{^ZEsnL5E5%>I}sf zB^YBA9DY>!DC@`$Na@3?-X6}K@y+_?n-jnIfpv8t(|tn92fpXtmj5UAglJTWaQ2Xj zIH_i{!n#%)By!3%G5;gF&psWn^}U>Pe+6sCMy)w7DQ`O!A5(B%XUtGAY9@&s6_5!2 zvUgL$=WA}or~a(#l@7O=qO@WLG4qE}8n-uts7FQ@A8Z+aFjJHoK~egEK36#M9+iN4 zIC?6|iK*u#(qSl`(iz6%UwfZs-*vR=cgv!cj=rWey-9mfxa}$DoW3cAjSwnTdl||V z4tm;uzl)#o^mR{NYNk|WN>!#*)l#VnrJIkaBmRhvwG$(skGm+!7F{_X$26vRI(Uye zIpb+)UJmawuFEOoM}+=*Oln|GN;OJ2IGtRq=Au4hf^epdQKgParks`PNInx^D7!hS zttF+-={gkToYb4V{!;ECDWc(hzp8s4)3KtKyP4SZj54|C=k;tT=@?}uVl|g1&PBhV z8nvTwOrEgm_7lOgXx7592#OkB{}p@ug<#S zt9cq~zDrm2mPK0b_U)B-BrGQ4wD%bw|7ma3KIrM|KHb{4(OW(}HUq>ZuKy>j&sTNX zfR2sYJGjdg3&BdOH^X(iALlQr&0`Xqi+e;#Bf5)Y5Ol_8jN|YFMo<^R=eg7V0IsA{ z?Yd9@`qjqi36G01$;CG#?U>H`mD(5gkSCOac@*5#fWBgL^@kDFyfYi}{`3O+KB=_V zex+ePbkl}z3J|m!I5JS5{W>sGj&9H&m@ss>vyr&|nDFmY525@~<#7h~r#J2+;9S9_ z^{Tcp;XB~MK&-!1)9=$Zz82%U;?0;WWr~!R#S|^?2`GZvqu=)^hG`a*AGlt|3PvSb z->`4pj==h`UX>l|vPsK}J3VRnGbcX0uJP53vPP4ZmxcRVW~BCJ^V0P{FTGWB%Qqya zyso2FUH6(O;w-_~l~EICmXx=iSi70IE*da7MIJY1)imlu394 zmgWP3wB?^U^6l72{8>-m_Sfz9Mrfl4ef+YgR#u|eI4K|sNz%l z%}X*xToiKel%|KlHNL9zC+ZA87}lFfA4Ydd8nXMh>g!g+6)>J*BxZSBUgvEx3YB70 z5XPdSa=_<-&cif^aUT;A3%D^sVj$z1@(V**_%@k#iP1+E zdOtN=IMLT}@|n4@x#5xHJx@P%V(x_#)59+gXTQ#oynJ^}|bkO~7idM=FDmAX0gI6jn2K1_rzwN2JDl@KR z#+A&t()h-e`a{H4D}H2iVc7z{G#2nxG8g8RQgQR>hwp9qD`{gWr9_|8VZtU#X>ze< zyhw3+wta4XVf2;uuHJ#}eEWQ9ZoW{@-_z5f{NmJTadxyVnd#Z{_a)KZ z)Io20OSDpHV(=bcpeI8?-12{>{d=);`Lmv0_SZ4Pn+!`nZpaMF3oct@TKl>#jO(n7 za#;?Iv9h!bbRC!smSlq`YM1JO(!o4-yHcGSiZ)%v*@9HgdC_)V0fweW|5%pjuz6D| zp{OfC)0F$Ad$W31_QK~Y=&?Vh!};|=X#zKaYK7Y6{9{pL;3!byY;iVAupRaRybpd! zz*cOuoNHLWWoZ_wA?5QM7L1|9;VT8z5Ot6{xW!(>x^g5=VL3MVqqQy-((YGJetlw< z(&oOh5T#`T`5pJQ{G9rHJ=>$U;_KnpG>l!-(W+Nl7Oiw>F}svi;hoy8awzKx{Q*7W z0Tq z$S2l&>fe)2LRnZNDA!JaLv&*`J^*usK_^VR_4o*gKwlA_$8}@to*$T*Tn7T?~ z3aLlzL`P$II${taA&W&sLiC>RLjWZ~ZJxC(Z;5)`X2#u$5ae_qcxh zQ5{F)Y4W`4$gLD)w0K<4`G}sJ^(wff$!SWQziy?qOJ%JVA$+d1p4aO0w5I8E8uW3X zgT19z_b>Ne<ai+po5x1^5DM;OuBY94x2S_KN<}W9Ta`^o!i1BcF)- zQ<3^p64&$3k%?cG+odZJzq~St#PGZCZTY4+1Ii%LlRB!kqFij#iz+-599|HZmEtp1Y(xp5+P`CBi|Pc_QS4xaD_yi+PWyA?LOt7X9zv49W?j z?>?tJ-?9pb>q+D5da$foS8XUmJ`Nv zmQjY<{q1)aFX(zKKaQDPUBr&%@yyt9hBNz(PLCXlsuisX3?8 zXFmCGZk1AHRcgvqNXbw1>c8IAa$9;pTD|&j>290rR8N&@pK?F0?tNWHtIBypwAvA& z-*?%WMAt>!eG>stAsi9n2}7lyLHSJ386UslsmtA5hg#N!jW{BNJ#nih9o`!g-&Gxi z-M;>9Bp&qff~Vm~Y$NYYpMTray>u&uyr+Yn+JwZ6k6-q5$jP6OJ|CQ< zQPMfC&VgF<*GUB$uB=O@CJFre%fG)$67Xi6$Rq@l1T4*3> z8T2y#;U-4O^xj1%8RTmxfz#U@N`_4WoPQB~T1!5Ut} zISXq0PR9U8!}TCy==pfxU=sp*KBcp~0_}j!5Af%M7ax28;c}eVF^DSwQ0ta;G&2@v*(wy&XzUBLR;F~&HRqk7&mFfzi zEPBPun$#3yYEF6xAskW8`SitrF8TN^Pu;IK*A?nvzGXW{lu#Dkst$2e6<5uC%Wg00 z@AK4jh9Msx_jJ+IP*-@vr{D1Orl+?(-R&9fK2P(W4taXU({WEPdwSK=uzngv2dVXZ z%O}(hKCEM9zJ+OU=cCrmx8$T_m*f*~P9sN78w$V|u(e&%uWF|&G5#R*W%Df5`r3N0 zRu?saI_x*)(yP7Se!WBW^DJ>ytoz5_!!pBo&N9kSd+$o;P12UAu$p4Gb+8p=Cbn#I zvK6@F5y?<^Y(ri{wi*^iwnFz}2UBdVSbfEg?Nwu4Ds74Cm;T)si|fHwOwuxm%Hn*U zg*`1Z4Jt-Gq{;=Z(yG_kEm~_a%EYB>UR*MY8JMsSxik^f999MEHr7TmF=~5ZE14K| zXAYr_{nsmOB@?6Euwk&Fa_}A-N5XNXTsqfPV`48?Zn^YEyWjSRQO#t+PS=oiH;G-| zkVRKXz*UIGldg#kxD!C4_B&hj+1tL;aFtWubp7cjhO1z3YBsnEZmjcCWN_uop1G(t z;P5d^cgO0DbA?Sl=H*^pg{s83z?Svwv1GS=fnsHLympN~6!*`?Wt=rA+DZ<6ufuNXbm}>Tm68xi0x1 zxJnwmx>~r(SEQp{(Sh!CS+r8!$zT!X;3_u|FciWOVYi2)Nx#+Jh}#Lmq7eZg0+9UHjL*iqYSn7QK_jkZH|s~0FQQ#834E<4dB-g zjt;QIrLohlgQDPi2e2v|YT(C@jcC@c@JoZE|H6N~I=r5F)HuCybc^#zez2?M?K)=T zzb)1c+O$=V%IdjVvvFhB1<$UHj{ErajEyHd_B#(u@4tVlcxmE%akZ&)SyyFjeDl5Q zXx|KpcWSDvHR?2DTs0}j+-z}d~NGme*EafTR= zPdr3-R|2LyOmmda?v1v~8)|_w@HxB&Pt>Px0Xns7jR`O9e)Zo6|Mx24A1*~Op+BVL zB}Rb++BEG^;DGMj$Y|4WL}@;>>GqB&W)d(}f2$_In`$o^+BE%rv$v{y)EaI2sM-Nr zGOVCY+5BKN+O#0U%)HiD=b|C~Wdtt@edBOsn4Ol&9Xw&uUz1sRM_ua~+ zS9`zxdW~jAo2D&M^{Y>^4j*hddypeXA-lQ#vU`+{9Oc&QxHbInALJ}n6X8D>X|Ggs ziR$YQe05|!bE-*NCQ(_O)}BC{Hkue!YqV)7Ml~PWG!vuf64!zm(;GgXE!uH2ZkZTG zD_OfJB@?4uy`&}9lq?vC{H7~2xWiXY- zhpA+yV#d!#g{in_U+=H=Z_5kgIm;+Rjm=exHcgwOBL}bpG!BfA6_~ze(%B(Padw6) zC03`5#rz%zsO%;IM|ZnWIIL{{*3+nLym?G@8QWh$n^wa1y(0gkYRU=UrbMeo#dQzV725Pm z-bDBJn-*<~@BX_7ZOU?Nya={Uy;P`B-s7!+AyB8j55^jU#a;a?a^o?9&;F981tAi z=+GE6s=tgzj5wGi*oy@$7tD$2y;2jS_Nx(ZU*>TN^TlQS^DZk0! zh+^#GX6(t>j?plkcm{Z1nFPl)jd*ak`XOv~zx4?g zs084>(Zr})1KvY1s`&u#nHWVk$^h^6wJUfgM$szkcNQrWN7E8h%avO$y;`w&d&H>b znMKRQuI&@M{EXWD>edOsJJFLms@e@)Gio~xc>gDU_UxZFE#TcrO3em%2egI-n3cN# z%h^{3tFc@2ixWk+(zm3ud~82<^Iy!P^~RQDz;9h^3>O8pX#nroq5;#hE*K|_Sf%m& z;>yQ*jis9SSe%9{Wp=G`vu7opcd3jN+$*osXMSbzH&)rC_4sixTXaatO!Vpm;606A z-DrUKa71W6z3HYizo9`{$ow+Om3=Or|7GsCq;uwjXO)u97BaQ= z%b4jnuBq3n>9$d4oYUs$;9J1TfMNmf!kjY8)f{hkKzBFe?DqR*?>Ss6cjzx$H{e>C zxXksY#%<3Mwskmq*Ej#+`SoU*jnf-Pw>T{_0eG)RHePGMd&tI{5AdF`ahiPwc&`lb zp0ROSPyL!IH)i9_W2(#8{tDo|61MLZdA!CY0PjSr2j+Iw72y5r-bDB7O$>PNx{Cns ztR@BY*%6!LFswN!sDprF&O=CNPc$d4-}VJ5teSaf&p|N14m z12M%Lg>&Cb3LtoPXv5gort(k_*p01MqJL*>;$w%EP~cCyU;WG9xV=jFhf5Jm=npA* ziBaIzbDl1Gy5wnCKjSJZucO{~ zXsfkfK<@WJ9Z9rlPn1NPp3tZa&h#l!7SJrne7Z6YSpPQ~);sYGWx8Ugs#jBG_}$X_ zp8M4vs&}j0JUUm}k{41G(i<`y)1oY8bn=v2%7_m!C)suC3Vey-nG7#sIAb1-e~DZu zwrx!!Vu(&#^7?yU{5Rw4nO#jHGs(;1dL)y)-mlXHJc8&+9o4}jx^^5M@g1*geYc6> z5lBeQ29IEeX?h_(e%yvKETnS_huvagdL>=}0XekAniW^z$FHcr^iX{Mg(Gx9Z5nul zbFdC1!oex<6f~@o++t!DA_KahKjV%a-HN4rELP?!^9|UyriZ7|Xa4OEerr{)*5k*) zdUHt0^!gOt_|JE>-16I2rqQdbg-3itx(VA=w(3!@iB_sJZMOULbp$Gfa74)aZ7GKW zdd|n+Xt-@FozAq?5h3g;Th)!0Rkzjn1H3L~NqE!KTb{;@Q|URcWa;+;pbP zK7Q3x)0x8e8&{cm9rdo;)EXX<={EJbqU~;(Pf45e;})bx|A0ck{qY;fR&_}9jGRuQ z2MUQL6}f;#{QxrA9IqH(gJTg5Ppf46G&uk5KmGZM_2hYz2#oVvT*H}h{s(lLm`@>E zz4p;pSMw>iyiEV6O+25{w~f|MYpxrQB($ORgK<#H4dXe>C`0Z3_B)FgbiIQt)Bl*` z0JP*B2;rsML6$pohIEcT;Cz6W;=akoX2|5HB&d3w#$H$1)J=}k{>d%D}t zi|q3>@9B`IXFMJE^s=W{Jq_z;T<@FLQSUlOt>;tLIxl4`PR^%1uJQMh0O+Gib)GzC zG#0<8x+H}4Y@8)bC!Wo#tO%~zyvlaWtHe!k-9Og;EHjMfETasyc3i0wG`6cuQ=($A z7Oj2y{rxaJbo;-Bofu%2FJl9owS z7U%OMymvI37*%WU9ibT2jNUskF)H)k@vDAtEzn(XPrwFd8dZ>jV>uwUeydjGwnt-Pet={0?x8v}Xmi+fV z@R!fDM7um4mu-=7*;5ybqD3FK$x%xWE?dKimUUrVPXZy%M>7H;J}QH9d$g#tndp&d zQo=Y}BH`hiIA<4Qlk-gMAagFxaRA%}iTJN5kBt}cT%6ZA>%;LB-lpGkwxAN{McciZ z76k-JX{(dbHd58Ask%>f0lZ{XZ#OKZ1}F+=ZY?g;NtmjEueh_4Y7OuB{0apK!*kyz zrs_`phRHCN3ouE=x?j$yQBs+ja>^8U8qrtjjqk@(Vay)UU$qab$_SfQ8hz#;|HVIA zrA%4dG$kse%2xzQ0ao9tr@ovbJmm%qUm+Y3n$delB_jfDgJ8{h ztET2<{k9r-$_+o%hWiYd3HqQn8TWfy@O0c$GeKYR@nuiV1RcKLxSlt!qux!$wT7o; zreZaUxLq_NOvOF>dVj6`TV5E?Sw0ySfKA-w zGuI$R06Q5IpT~R)^c?Uj(3Dzm^ap-t=*9KSqsHltqg$L$lJMTar`v8pqgpmzYwsN) z8*fJM9T^+Xymz1gE=uLI;o62_Gl7=d7a(Kfj*o3tPgb8{{gzATy6rF>Zmf7W&q}h4 z?XP(6sD$l%MgBoGy9C;lXw|5=o}Riwn;!5cx}WycOmtVhV(9vF6fODqyXzNxMsV4h z5%cR-XBtg+##9F?di&Pe+X%JsNMg0NmfDDCIbl3!8D*&5-+pKDg06Q)dhnp&7HqS& zQ3>5W63a2Mv3op-a1h^k)nElE+fK5>Jg9|k{bQY3am{zM@)7kB+*vusZ^4s-YI5cG zDTav<<16@5uo0jmN;-)1Bp@hK*dT6`e)Ww*zq(5Jx9T;aKcwU*Mu7y{H0@EK(b1;i zh|+v$)9oEm!k)ZU6W~p?)C_H!?G-nucJL7$E8aUWt|ZZ>`0bd`=sT`)cv3m5cZ&<# zp>dWlop?2}cm|VD1uCRfzvap;mtO7n+^=`39wrf2$+~~6{aI!h&sjzpYVTdC2^ELK zX-ZT~X@W9kT^{Rw+9WG6*~#=P>v!C0KBhjM&ko!qgMTHDRPvF#B#GOr#*?CHYbt|Z zo19$FoNAJmNmLf+^CZxwjV4Cb8f_YiQO$=o&BQ3W#I<0?^oEaTi+0>hV6D-ngZd_! z7{v^Iea^%h`!`-^G)yO6jhI@l+;ZvF-fw%vsOB+YXJXg-d&N~Ec6mb<+X5xfrbMfr z(3aV4r}v5*@}}$KO^Y^ll2WswO)*S^2EqJ{A_F=kADfDu;^Pd+xGVve>l_#0;0$ap z`@7-RjD>gM$X`&q#uScYg>GHPVm#0(l;177f;Q!z;8ieDbJnGM;Y5K_F<_4>URtAA zrO{`;GJ0#3GNs3lgDFuVB{R{h6KK;kdUdrhm0F`s!x5qR(597*2w_jzs;PNdtu8~G z;s6=5OD;yS9*PdE8G+2ic}nXHaym9!QCDlU>7c%2rsLGFjT5bN9= zIXo$H0L$)?7+5Rf){oeZuyAoEvj>!ptk9#sI5G}RrD<^Vh5z%*7uPe78mBjoZgF+V zB-*qd*?6tdrXd?|KD24Z#%cE1qLIqbrh}@xjEy%c8*d&{UB>oT(598JeXq!)StZb> zM5~{}tuNoElioykv5C>9+v!5bCL4BIAqWizW@1CUc9>C?W#cJ}rP~h0!0vF)%c;Yb z;xmiA3^1%=lpBl9a+vb+YZPcJ9}^!}6k{VG<+D+=GZwO79Fd-TvP_+`vDk3O^udW;i6Z%6+W?~dLw5O%t?-iH!D6rjV)BmPD8Q#*-syBL5 z6jKPnT98p|*-OgP`tyqSiVH`SGZdyU6Hwbj?xs(7SGg%pJBNnP_jRSktz`%C>)Sb^ zgzvXi6W~qNM>S~E7@9;qdziyPPX|3c=jn{6;llFQefo7z-}3ZrPqV$^RJjV)zl?_8 zop?3V<8UPUb`ovcA!BEoj>qLT3mXSarhi*Js;0T*_ksgRf0lT z@6~?)a^J07dbRi4uXku>lxf%rLHX6VUGe9F+JG?;KavGxN^lTsih!3E-X5^RLC zYr}ZXGRjc9zx~eQ1zivNvo}U>Is_=&XR(O`24m;T6rW=_FJKb~XShZMV$)reA`H}S zv)uBgX*`1-@kshnR_yrF_A?bcs@j|Wpcq@hqjF-7<24tPc5mw6qbLX}3JdHCV; z(-oSd>BhgatK|*9)ovQSx>|JUm!zv)*3qg*T@=OiL$H=%)LO`r@=$NCa8V*0q!}yp zdphGOX^6Miv6m@?BSPf2(%lzO+k*E>!)>+ebf&H1&BJ=$s&2HbxjtF zfAGLel9QV`)HuAELoLoH`SV>Zx9XUEe?z?ZbWG-o5wVlvHKM?X(jC5 zo8unVaGXGs60Lf!wrilSe3$;FH_820)1pbcBwlXcMvC}lz@_=oXancrEm z-QRv^@q#WelbsX1S<>ZD2>85m`>vKGrsGkxU*fs*Jc_XmGg^n@AU>%r{F9a|AER5R zu3(WjqQ3Kfitj80eZ+j0kFnSslmsR_40db`HKKo=vA7TVG!*pH?pGIwhF1ywR-Y#9 zhm`!pD3CytracNA(49|f%dKf`A?Y^R%4z#Jw&9vrZQ^qfd>A`j7j*^e24?j)7d@+Q z!iHP9=$ZJ;Hr%Q;nlv0ynh#C7y(3E4)3$2zyQ%h)p-D5}rE7H#_SR0KNuSXuGOV$I zkpyHZ+xD&9qSiP{*e;1zV?x`f-&1ymCRHUUY+SDvRs|Jdx2saAeldr9i?AHVR@dgfD;uuPJ&IBh+F zCT%qFsn%%HP<(1WG-)P2(Iu9HnbGS$o-M|4ro&qMEX~BH`ZU>wVp3Y-Ou2H)rPqh} z)LbU(Ox!BX&9}{#<`yRB=U@^Fm55v3aPLfL7nrsZX|x(trejBu39G|Y%<9Mfpn zU&^IdEBjlyJI$#pMU$q_$#H1JL~}_T8d(58;=_^$oRO4?WG5dmW$idQQ_DG#T^e>Jz4nJC;L)oARA6W?X?BQCB%jcfpR#{-qj;$;k z<4GvFPiZ5un9qhoYB#1+#e#m?{p#w#d*_luzqM-<_Crd3Vib64Ps@<^O`7&7u-$0V zKhr8WR>HOFjc$tW^RI4S*rUFr^}v(^)s&b&FiT51?atcMnd@f*3ZIp;?Qe%cVEk{kBJ(Y95nzCVs8&yR;JV%Nw>3T@q+hqSYhkdUqUc`blrfe$3O* zW1bt=!s(l?WsmaU$&D05!RzUQJxWngZP7IikGEkGtEq=RW-0XT8aF2*M4 zn2Ypv9=ezVx1Pq06MA++{n;i`3 zppRc|IOk`TjR;{qZ`Jg?th%iRZE7R$P5&Klduk@>yf-BedV0pw&?LR&)314ICh73~ z#`U~;9rbQH?$$FB!soaC5T+BaMwULN-)E-dm0`VJb)9~FC%Oo2m_Ynag0&aBHjL*i zqYSlnS1I~5ZO%R>&J53HwF%SHZs|R~P2udAM$N?$##5%O!K30OyM0Z4guEHBCf`3uhyX}tfcZx|5%r2+O|dGK7G;C(De6)Pru>mO;2xoy4&m9`#jBiI^^jYPscsI?CDic!}=N5 z`{s4jyGgOuXw*-rPCl$-1&x~5D4j&3=AskAozCjOTk?XY$YvB{@{ADHvklK-I`L{u zpLeV75!Pc`^;@poa_QB6&;4o-&5S}#TcSb^!^sX(6if5lBrUPwlUqN;Iv%7fQk-A< zQ5jA#up;L%Ez56^@x+$x6W2td`kh}sb7?)Zs!3WVQCXZZW?@guOoNJ152_(0dZn3Rc8uDRM6W~SUsjB@o7 z_TNm5THRj4`l(i|v33}iTQ0rY`)!XH)jTHbOzc`8eOigw06$@?dfi>10D3V-_wGp zhdd1UaPfd3U-)~&co7YkArs7(|RWeht8b#bLHipTRll9A`)BdV4ja#|>Du=E? z+a(aclVI)Nt_|Zk%P2$b{*|Im)92`{1{o8-X7!2lY6_avZ4AW(HfQ)mXGIGuSK#27 zN5P-s?-cLq12y63yT3K_@_Ob`zIxIwpcf4(^fqyi{NX`#*JMU zJi9hJ?&H@pHlFO*si96YHtwp~hD$S5W^CNmi?JQ6AI1sJGqkCzANRL;Om!LCUqPEz z!uGu)4~Qp$HYHj$+O(^quF$4`;7xS@rD@ToT@p<19<-_RFUkUPhaz=`JBK?3ufT$F z1acP3_UjDs9iv>A{+5&i@_}VxA;&1F?PJ30QOR6~fv!(i<6Cu1akoIdNBNYB*Hy3( zZVLn!jU(=Zfyd`6JHbksGG??r*oaN~)ySz^tAu~ON*qk+4=I_6QQ(XBw!9`i5_4YK zqX6cdGqBmVK3UMdC$5C<_4-d?<fcH#{ zS|52eQh^wi0K7Mv7*%V)dniUVAK*O`qcn16fcH#{lH<<#vSMThjYJ_7A50v*+h&o% zddS2m*FN0e=9xvy#IEfVySy#^BWfcFz&p{Z!Mn2j?=;~3M>^dOfAqC-k%qE{yX?`ibvMgzQuBSP~5-kt8W z)e#|-owhn7wyai{0p2m5vXCYh1L?QJR9tJMTxKd}{A3|S26&Gv!v8TgSLuv%+8mu7 ze~}gN^}$Rs_?I4WXqLk{Bn^BVZjZk;wr_y{Pj_Eu`+R9`zHPQN zw=g+B*WN$S-`Cw!SAh2;-b8oQ)5~-Zg{z*rnD%D!@moQ95M5*XNym#SM`Fp?wli&2TUF}$iP9vk-4CT zfCgsM-Op z-&fG4IBrd%O>@x`LYq!RFDi9NqwuUIu!;hExDd8O8=k{-;?>CF8BD^}cUtvZuH16z z)qc-rN1LWCQL$hL{~yR~+zaUmuU_U}xhIyWm}F%~I;Ldt0)}*ljD_*ESMjww)upYe z9K720`Sr}HCTW>OWpP@40&Uu8VpOfsrlAjLH`6Z0}5LtrzWNVw4k4>eYlB zilb?XHRZ}JmtG%YRP&gyGqG!Zv}q+`mp5d6R6RR^HYK_RbayY0m8;<&P;p zuV+G~0)fi;T2plzedhP?`_gMkWy-45l&FxBpXk*Im`WPG8eMI32MABev@{~4(zNPz zLVqW9oR417Z)*)x2}gv+fT^TEB7{9=ZoQ4GOzCRrM zLQ(=SbgD@PCIMKS_Uk18z`+Ta3el>Kzg+`$1ygy$%l5y~v@jLcQr$g%83B*5feOS4Wo3VQe7Alz8s7&rIvN9-2Ib?N zo&L_g-_GwNFd=+IQZ8tAO3&-p+YVFNq+dPux!F~t0KJ@Gy+5SneJFbWA0NMO@S{I` V=bhIS-76>K&ujEx0NEhx{{#6)fUf`m diff --git a/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527060091353 b/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527060091353 deleted file mode 100644 index 1861d1d8111c25d21e7724fb0ce5ad846acdad50..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 639190 zcmeFa3y>VidFNNN+$FIjMK<*u$vm=`+JzvBvs3f#S!smAd+=^xFhFA|5!KV(^8jY1 z8#6sX168IF^5&5M&_;w(E#4%z`-P@xVvY|mNtsqLd9 za1lDI<&fiA)?@wuXZ;gs)J$XX*cErB%0cz7GArw=tgOs0zkF0-=FH5@haAWGN$2GZ zar`B(4}1aJufF)tKeqPuLFY4n^7h+r!Jl}^aV{b*qwmG`|@sJ7S~D&-nKEnSc5p2ETXy!_Hap zzKzE$>2e+Irz7EAQOvGQ=N=vS3~27tnRANHhEsOlz}~WxbygkTaWuX?&oYHLyrheb zj{YZcR<4a3^(XCt9<5Q5!>*SEOyfXlQ-YMYTxHs$!VH<#N3@IML zUJkzn#27)ykTdU$V{aaNz2xU{eh#@bj;j=K19AqF{I=Bc_>0&UQU6v@`=araR!|Ri%V8AjPh+38VFaaa4&`nbWiE&EI)Ji0 ziBRs1;x`OSp^T23vOI>cQN)=;jmTlo#XjqUO;=Pt%eiZ=Qa}l3ZDYOQIg~$%nvuia z9FEPKYYrohi`1|d@t1XnDeEq-D1N(^(I5T%$9Js_Hr&<*>xUTUr#{s87TO3FeU=~= z>&0@pwEo86U}e4ZdaigQyP7M2D}&#KW5=QVZXluScpOX40&cDh<+$b~owQ*YAb;CNJyEgsSEFF^ixVtf00{=!^eKW~4s z__>d-W^XJlWXns%)#Lf&eP1>yw{n;+2Dmzb{wHzv`ZjLVpR@;h&|d$uIR1UudX$+R z_n$^wR=cpt83Fk>fhsTrmCq)L)q+)o4F@X^n;$k3bBK|`FB^>%;^g0T*jM6 z%#@MJO3g}3`6IaEB=%B}#(0!JjH6@l&EY63>M)KCF>mdy8Z*n3fgbe(x8;1__x_g; zs^C5NO&JBh^{wwQ;kF7|KhNoVvG31R1zEFy1Y3{n99%9gEUoTeE0j0ZR%h3ir(PRA z>U=lipF(2iaGR`(CFjw~n8eW{s_GI7=cjR`}$c zBR;R`B27%$IQ|&Y?VhDB^8Cu{k5>V<>Ra-hUwOIj?#p2-%<98xVpV{t@~!%1^n)?9kYnyFPR+H@tH0 z=$Y$7<<#C>F<-cnTg)ym7giSvQ|GT_j$bSejBu!z*(aF3oLJ z&d(HY+_*Wka6Nk_7d`dLN&%P5Pt6REjqhD8!bF%VU7O7hmDktLpEx!%F?_mmaq-gZ z+4OWVfA+-in}ySJH}az!smT*((-#Z#CvQ#^-HEH0FPs=Hmd_S)w})ot_pTN4OKXK( z`O3!H(v-RV*G3LN!{J}V6hR1Lua}Ce>xC=jTcyGjZ*1>+Ia@AF9XnG=51%`A{@l?c zM@}C(GP`kTapCIC!^2|-7H*f9-&{-I%C0S+zH#Bi)tl3kHx9Wo%O@w+Zq6OMdSoJ9 zK6z=q|QpVl*6CBjYl+hQ2&fk9=x zJE~j?*D>WYqH-Uq)YnZX`C)VP&>AYDlCdMbh$=UTDq1iVaRc$o@ZUfs9efajP1%xj z8*%od$}VHSfZQxQSFo3diguyG*+P#Yo(n5%2%U0vEmxd#P~B&o>j){Mitj~e(Ol~a z_7-u@GX5xQ0l!nuc}UFQNnJ!Ns*TIeEl9lL9D&U9xc($$7M+tw-G-4q=Ui|up|Rb7 z?ROr}ns(m}=O(VUfNN%PWp-sBf7L5UB^#YZld>sDp>iC@S*r*MZOAD!9jV@q|wyH~5^7;P15gokiLX zAzcf&r<=}UlcNXVyN$D#ktb_7^A=>Wfj^DB;axN4G;-$#&UA6l%gCDv#JGvvJBFi2 z;7jBDlgQ^KQOIK;?t;kAH}w_ zC-7xcC+&GD`1-K9CNw&{^!_s)sQ_J4iX9@~HOi@$2ZExXONp_lr;fTo;-CTu-x z*le+mSSo}2X_-uot=$-zJ$~cZ@M_^?<>b}T+Xtp^pPk>BI8{8pGBUn!vV8I2?6K=d zDn|~w?~)bsG=nw2j3)gqHdfI(_^c+1?bShyaa+_+auEBV*Y{_mUos}jpNqEFms0P~ zG9!OOw6eOynxJTvX7AHH6R7T|8LXk95t<59#;mx3YCQ|n;079lVKh?(Gz1lFS5eV# zqtTnj?^#s)4JZKiv5%tx7=hwhK%6p~=Yu%=7>t4=IO_;}u4zKvKMh(m-)z%j`PZ$9 zVIwgC6<Qo5+{=Pvc4uW6LhSFy1-%La>a za`>fuHZ>f83P+N8O%8EU&VWhBD6YZ2@(@BfFh+yyBeo)dtQw2lG$^&RyJ$iN%f)Mj z)j`|E+Hbl_7Z^6>4!^#XfBop0<<(rebY`TGeRCz7$rO%_TsoIKcWmP7e5!Et*3FUP z>6@o#j!p8?pZl$E?W!_u_--n5>JxpbPlPHHn$!8?t|U`scK2^hzpl78xL)4K-x?el zpB!}uv$^upjivIffwe-ZxK>^t%olSTE9mO34;HR(6xMF-UtdDs@3pamuMH1Rj<{oE zL)iI(^^A9UhR3=*qm$j9k#5gKmuIZ|oU!gBBi#Z(VXSxVRkoqBO_{*`?WVFh?Ydi!@?j5xc{ynM3md2+x3EuD z%+X!f^eP|C(E-Hn&QbP8i^%m2(=%f~a~)?Dpu9Kmy9Rmt5yGdz{>f{o^aqWVKa4Ak z;0j~-8&b#@b{rY+afHf)eT88sdJZkiUPnfH9+~KIgsIzI8g1F#kBsz80rPeDbEpb; zKSJv~Ji@#?yhBCWCMT*opLk&Pg>YcCg#z~Fh68f5x zM7iWx3704&QDRwkmr!>Y#<7$ zeZyyV2CqiN0hR>5!dJS%sILgAvvZTborB?xOU z$B))`#Cxx<-%D<<@aMhXUq<;mkBmNqkq$n&a8X6rnjFS+eH~BfG|B<<^D6d_nlh1t z-bp@k&ItS*!?fp|Li}sUw=BXg;+G?FS(KINdE=4uPNN*z(Y7SaVU{TxJ*&{9(Q_vw z=bpg1EVZ1*qCVz03a|R;d13i{nAS6hF^993ao!R08;;V3p&Z4Eo+yWPOc7^#xI{l7H92NU*D^G(MxWx@aL_EoWrN;K94&MN0`m+{-x`k6fWC` z%?&S)v8rzO{u>?KZDO&jPp~8Z(zqRVsi;%9R)Cr*g;r(&)&Gvt6nob?DgT z;z|NqKHS3TK|XgnTQ018cJL+;n`46Pym9IB_<% zPF&(ySkVqmg}<)-ALjAO&wc%)cG2EF_}R~(`^NwHr;n_Wuznu<+aK?%emv|x(h_L_Iqk#N)1>3vPt^5YMdjU4eW7m&n6rHUembNU{ zaE#C64kLBByE2Ej#J0#N=5b3vN!`ioqNngogeCd!iS|+`29LOC`hEb{HDv|OP~5E? zgUb4=-L2dUb7vK%22K5NYLS!7d5qGo!eqIHt_;l)b_hZjEiblsMZ-U6-B3?DH7zcR zRk0@4#Vye;F0hLUOdkwc)z7{doGV82XOYLS#obWm(!;j?uUj|t8@P9_$+LrE9N=R2 z!umN3^r(M4;-7rP&lO$W@j0dYsQ=OU9E9sW&H<@M{g0-Hi!L5LKEcQLpuMyDz%p9y z>1UOA)?tcXa(jh8@AW^FfiyIim z`o(LFA)Lz>xVn<>6u>UBw`#f@vAz7Lz0Bf~`Bydb#vJ$WVN(<6{HMSD|C;WJU8-&U zjHegxe7!9}tM=@R`~T6;yn8R+W%UjcuSTaA?`$xpdcN&1-krSi3)5|^FgzvRHwnd0 z#2W7?JRJ$Q(JgHywk7txeKpBmbti2)?2)KHX%F=cK~}_T1_>=UyewG z?>umXBvdV&jOHs$RA>d0!XeY4v$x0+zFV1l>7V@2f5K94ou(%o8*VF)^)nt`yqiPm zwow_Rw~rW1FU_UyZv6-4?W6Di-LIJ%@dKi#5}%2%B>%lgjfi-6JmHkhn;zX*E?bG; zKHBld+Kzm*H8HG5T!In4^TV3RI>50!HnCy-W1R?VC!1t8`>Z!?m^rG)5yxINaTxLV znrvAAD0SS_{cxd2xV(flal%OCE4F-3iAFNtJffZm-&{huuu8-<EH0zx0Dic#ic5ky7RKsM zvbp8zEmmq)Os=8)#I7`^7zTg>GX{Y6PJgtA3BvC&!5jsPmav2ZX7?dIGsdp`s@UL zk6_OH8iuQ{;hm&QP!m)fZ(?d^8Z+#H_SUX!&p^v9BIxYjpK;HbfsaF zUO;LuL&|lmGU0lRal|-}czo+-1oyRy^N&N$B0};w<4veg_F`sm4;;pS|Ga&49P6jf zBR9CtV-Bk?ZsRE&Lh3K!9+wf$cbAS~JB4*JZ{lwFG$(PSgm{OMS94$i@k{ud#B-cS zn2WsSrzB>OyA#+u1>Qui@f!;xxPPwOm_gh_kQu*y^gN&ccm+D>`QAR_`#$W2(?TCZ zU1P7Ac0QYUzBLqn=!U%qniVuJ_<}L*cn%ka#zF6o=1?k!4A~DD$64&V(?kg0ZsGtR zugSFpG$YubU@s!<)pJOau{lD}?c%olIo~9HkK1xStN-{Tzqf0T?T@bf&nDcm+g$tV zNBU}b1%T!nJ9ss0y?Sin+ebs^hNe%A%^VuJHjpb{T%TRNdfpv5c6jk}e)4?&*kmbn zY4+gFr3v@?NKS7bJ@1|W0Mhi%>k+tcZXK$h-`Cn2Zyk+x^}RRiXC1$Yk6DR zUNP^Tr`%zrE@yjqfx2*=uC5&OEFrVx|M=9;8gu3U6sroiFGpK86uyURySiMLSQ8pe z-#$cO8Xvwc`(&Su>3$Pw2#vxJ8kAE|0W)X{M$l+*$bfGct)o#{Mbmp8N?`=e&tY8Y zvQa@aDULy5l%O#9lJG$^EK5dBT}RBEX-@3o-zhY~-`>V8ns4^`M#G;PU`eqXGJH8GmLMV#wmd%w?v+t*a1>F<^AjK?bQL7C_L zJkt6pY-f#D;gZ=Tvx?a@nQ+VQX8AW? z>iZ2e4{VlMRicA8U8`9K*Rw07VALtt*a;4oBzD%E4&h+T~2gg z;Z|0cSQ8X2Ht#fm%2ofnzxDMnpSYl_JC_F01QyL(To26#tJW-|>4=+^cjqmizv|73 zEkBQME^O)FNn7shk*Ggu5A>kD{%!-|UHYY`dZt?D3^He<*ned|l^@s&UvTEP@Yu`b z7x4JGS03f;GZi@p!uicSEf;CM^$*J(bx61GCmbmF6N4~E;#7$c(u-#t)l%P$9W6tor9)S^`+-f_13aYN*8Ck zbTYNIU7V*#?s@>~_EM8-9K# zYU$Z3XUmsmH2jI11bxxZ!~M}}v6kaq?9<%~;k3lIxJS>yK9}hA7ZK0J_I~e4*jcM+ z`g`RoZMm(jUQfz~$FJ(oFz1C`;dXK2aWMMfOv z=l3PDNEbh}%C&^uj;i3@(1n!wPuzd|ShZ}`u_e#>^RM-Fz7|^69PGJ-?YY$QAim>Q zF02h$rH#)a&KQe)-N7d+@NO*MB4t;14Vl)hyw{y?{sO8rwpS1@0Q*5YTZ}AiF{$C$ zZUa^SMxdQglU6%!nniDsGAmF%X;LebM>BP<}$(CwgL9 z^u>x;6YJuZ*c4l0Tio-i?n89NY0(!;VpZG}8)6`Ci)|5~JTNXH?h`#REiQ^xu_o5V zEwL%K#EzKQtNRdLaa#1nl6Xg~iw!Xlx5c*T{7@*rUvx!JOpA+RRji43#XxL|EwLje z_US&vl$aKMu_WFR>taK^C$_}4==`wmLv%$?%!nniD%QliVjwof`=Y~x;6YF9_yeGEAwz!8~4!ES~ik_GeOJY^r6dPh7HpTlQ-a0WZA?_1BF)jLHMXZT+ zaZ7B9EwL@`83?bF6kTyz^u>}`6*t9(7>L_qTf~PY!ut^SiJq7i7saYr6YJuZ*c4l0 zM@(p`aZ+@}Y0(!;;vKOrHpD>O7Tcn+wQ(o?Zg@Yg=!t1@QLKtJ@vaz%O|d0*#DwhS zq?i)ZqA!-jJ7QgIi1);n*cM^Q8P_kmq991gk3M{p6kTyz^u>}`6*t9(7>F&gBPKNEpAW~Ero^=9i&b$`Y>0u_5<6nzkmQP< zm=Q~2Rji9!VpD917>hKnUvx!J^u>x;6YF9iZi{UZOZ<#WiYYNI`eIew6dPh7w#1H@ zI4ZfKCuYQwSQYEyme>?qBGyb8*Dt!FC;DPVtci6o5Vys)i1i!BCB>AO7JacQZi)>t z5L;qLOdOY7(GxRbNvw)>aZ7B9EfLEWjq4X((Gz{KBG$yZ7>L_qTf~x3F&gBPLEsuIPywu_RW-y0|4a#g>SLoyPTxuIP!rSP^StT@1u+u`S|5dB!Eh zl$aKMu_|tg4KWZ~VnF)r>m!Wo7hTa4eX%0e#JU)W+hSY9 z8YbhCVoFSlzE~AE#fBJ&EwLje&P%T7i5amZR>iuwB{s#Dh~Ylt`bAgtL|?3kHL)%R z;zE~AE#fBJ&EwLjeGNHVr=!qGzBv!?`xFt5lmWb7J z#`TM?=!w2q5o=;y48(1*En-QyaY->HrbS<@iko6X48)e$5ffjOT+tIVVo9uub#Y5< ziY?LkiBMj@=!%}`ixsgZ*2O^F7TY4;oDc6`Oo?gH7pvl?*boD;C3eKbmn2v8#Ee)H zt72W;5}RU6#D7C#T)*gwp6H7eu_o5VK-?DFqT?%_VoFSlzE~AE#fBJ&EwLjevW{^{ z(GxRbNvw)>aZ7B9EfKRn#`TM?=!w2q5o=;y48(1*En>DSOsAL<)1og{#Z9px24YL> zh>5)9ik_GeOJY^5i(6t-Y>AlkF|J>9MNjm_idYltVjymdZ4r|k#wEp+m==ApDsGAm zF%Vl~M@%e8uIPywu_RW-y0|4a#g>T0Q^xg+uIP!rSP^StT@1u+u`ObX$GD`J64RnD zR>e)RAqHYg?1+i0k}G;*Ml6X{u`X_jO|d0nv7K@KqAPl$FIL2wSQi6vTWpJVrD<|G zl%EpQqAym(O|c;cVoU6Zi51HrbS<@iko6X48)e$5fdfJ6+JN{mc*)97q`Tw*b?!gnsNQ2D|(_YR>YcE z7XxuyY>SvmHZCcq#I)#(RdG{nh=JG=J7Qv8az#(fh$XQq*2OKcDYisR0~^;bx}qog zVnwWpbukdP#kPnS-;7I&DKRbjVpZG}8)6`~#EzJ_A-SR_X2gx;6YF9iZi{UZFHjnn6jNea^u?;UDK^AFY>6E)aZ7SVPt1rVu`1TZEwL%K zM7#%LT)*gwp6H7eu_o5VK-?DFqVr{?Q%s3z(HE=Yrq~bzu_boI#9NXpdSXT_iB+*K zZi!8?B|2Zx{fn;XiHl-Y+!PyPAl?_9zbScQBJ@63-pJq|01>z$_pdC?xR=ulir`p%z=yM&-2P13dKIL+~>Vsd>_yD|4{VG_g>*~ zxe5#R^X5-nKX&Hhlj!5Pp2zi^CFk94ui|nQm#es3_5OdX;`$NSkGOus^&{Hu(*GoO zTWs&L_B?!T^hxtA*1NIZWx0vgyXWnH#^ow5S8=(D+w-Vip+9cVA8n^uPprPReAax6 z^=_(@FSp=9d`If5w8zhujle{ z9D4y9|9^41=yUJYp2XJ=pK+Z3arukuU#x#({TsJGar+zFA5r@$w!dQgGq%6u{zu&Z zGTqA^{mZ!j8TY^A@rQW)B_4l@$KT@d$9ViT+JB12pLe&L;_>%*{GD|po_~nvAL99k zc>W=te~9NF;`xVo{vm2V$MX;I{6jqd5YIov^AEfCqvQF9c>W=te~9NF;`xVo{vn=! zi02=o{ik^TVRySJo_~nvAL99kc>X1xe~Ray;`yg|{wbb+iszr=`KNgPDcXOE=bz&F zr+EG;o_~txpLQQdiRYi<`KNgPDV~3d=bz&Fr+EG;o_~t=pW^wa-R-7${wbb+iszr= z`KNgPDV~3d=bz&Fr+EG;o_~txpW^waX#Xjme~Ray;`yg|{wbb++I<`)o`3pa&Odz` zkCScNI==qCY`y?rb_UE>+zaMG_i6`+!(y=GJACidPTJ#ckMnztQ@-2j`~~!~^}&(x$x(N(v{oz^bH(Ms`K9G@VQnCc zygry+UY;@Mt(!}Y|Nh_o`#4kzbp%MKmUjApJRBGJob~$%NZbd{3VY?fyw;d zxBuu@8T~VV^7h+r!Jl}^aV|m@#qGuRY?+D}Kq zyP}xgX!<^bP;;LsB1LDzDLZdqZyAMV75_QK&WgH60xemTcu7~`^goHS>9BF5{-iz7 zgZBFNJnK&*J}Y7t6~INIFQCZhP^|{=JB&MHl^lgXZ>kKd;V}F>>LO$a@h7p3!Ou#S z>sb*eA!`)zCXLjvB96d6V&ta~n#W!WaTq#as^1*K<`5RD1Q%Dxo3deV5ydHd7LhX7 z+50BMjYuLK0e6DySyP7Ldy$$Zq z74wCuvDMts;q{5hiDPRg&z1AJOK%P>+$>*OKbbmpd9^SxK7DoO;JGswh7Qgj*t=fN zmJ3st51&4E{N(ER$@%=+iJ^^|@e8MN=WgAYE}dOHySjSo)X1gELgvEwocrdnnf$G* zmk!ORCodeIFP^z^uyo|qrI{Z?YULpQD%dMIucKTRog29KRZ~tw{|b)pH%HhYOrg~A=uwom zb(FqIY{!sSC!KSUn8%Sz&YLLj3(igWFCorJl+07kWt>$&+;L~xxr%3T5b@7A7ZCFx z8ju6fvg?SS#l~w~#~WlV3fDU4+(LS%k@mBQ$88lM zr%*R8;hq+p4C0OBdAdl`F`Spj(W^Li2=dZM`vqKK9`}3(QVv4O5uAGo@uK-=wLmod z3&`c~#P;_0{6+U;c>9yZ&wYF~dt+%KTV5)z9?u_t;mhXH_=rWVm{II|;(gJmJnSd* zAo;xLOhW})E$l12BG$xc`WA7Hi|wP%ciJ z-LGP!899e~I1g>Y7Igq+ku7Krd!yKQag=5)jou;b72qF5Y_@SOG*KQKO;?-lsQfXU zM~OrD%R`^A6EZ5-Y+!7VY0*-$RWv7Mh z73^<=toC&Faah{NQo}K}sCO8t%iY(0M|7EBIo@hg_xsKHKQ+zcZ;QUdD-qV@zb{%@ zU1Cj8G<{z}sL3Z(huxY-ny+)FqOLt?F4;V;cjZ$#l1qaqEJfsE0kWglv-uJYkDHaa zSz!Tv(q@d!0n4__li+Og5c+!m+Hz-OMEyy7pa*UF-A(;J$*4xCnrWa-LeX;E!bRFg z@kjNaf=Z@R&SIaV9|KVKqsHXqs6!UpyiwpIJL**$>1FdWk26LPa~yIxS`o@0lll+O zru=bpRbF!fO5ZhG7HM*^u`xj2+FLcl1y8F>nSH3Rp+OSYPX#&>*qON zeW|Y|70y;?3Y%?p-a&=i;gUxOQ*i$GV|%<>->o0yIB!9{SETAo&!OrQ(!ohFBO+O* zRomi?!u@VU)pr!0kV?1QCx7)RRsB!n8YVyARaM{J5UitNV6kPlMuXl+vwv)@e>Ni}LMa9ZlLk5f2< zN}8oST3*sf^sCr7UX_QOIdcZ>`tVAWO6gR>lut`P98Jq1oFi-VxE|9~z%^|DFwBW} zOBYg_`#=2bW7V=%$Cf;2sITt}s4ldusde7VF>cOp9EH8TYzpWavZ`BohhyMOl6B0Q z_cA@a&Sug5rN^~oHmfXoPFH7ywe4ve(D!3!$esoC0P0#MUu|_A4AUVw`YZhuw!1 zj;C-&@6O1iX(vZat2b=gI!@F*m-n5h)>*83{yt(?k*<(u^4m%7X-o(4o8Ofgg zzkYc)6^r*3T^O>WpyK;aNH(W1|zp4`y~D*EDOGKp@E+2U} zbRlK^^TNolJWefJb!^FVx;i5qT7MSf{}HwPm<2a~S)Gw5O%HGX)t~*{r_M4h0Gij# z2>VQPBY*2(Fz4T;1wad03&9l9X#tQ8{uqM3-3x%enCZ-OsliW(_f10aqk$mn?Pw<* z3Ae{Bqjm1D>H?rSXe8=@Ip_s0(;0xy;Ur|Z5-*QEPGg2zB^+_)%EWPK8BS~R9BQiG z3xKEtX;4zLaT!s#z=#7h;ebpE8i{&~Bg7 z-}sFPkZYOIo7 z`RxB^YQ!zkQ@9o{!4vL6mD zvMa@!!gZ~zGhC(0nlgfr@H`G+_U^E8nE?kkITSeo+2QQb2tp~J^^@1+d~moZkJq-t zmb7BRMR_Uat-VzGL|J}cQtzm2BJ=~|A*~lk;*3?#8E3Kc|+xKGM zpQ#G+QAWqtx-Vf?C+uG8@d^gTHg{*owxgA{}cM4T>!A$&r8rSK^ z_6pA7EDUdl&OUxid(Sl-+pSvOH)mm8ofw_;w`-r?id4%@-XL5fLR%e^)OKA?(H?|E z)Avr3{=KT@@`D`NkC~kUs`Li9>dfMI8QtU8P%Mt(s?qD&e2IoXarM;KARRELwlobebk)jfw_R_ailu$uFl?3i%&g3Iwa!OS@97OS9GH_D5{gZaXIc4N6bcw=ag0mZeY+lBqP z<)y-E`N~p$$}MJx#@5{Rp=-I}m2*eWTpuc@_HqgDmE0m0;ulsI3R5>X3U8K*<+CTS zF8}z@@QuaQne^csx8@d76C1}z=O@?J*AA>4zdU#Q{N>20S5^wRWPWO9cx-&{Y7uLM zrz&S}RfaFm%+8<44xb)6aqYy>Q{{<+H%}MmE-cMu=T03SIXio8_SVF~(bdVy@q_DQ zOUtFw__gJ8mo{b(9k@2P*DklZvaz-_Wp4kqkps|h_{SOZEcU?&#vYt4qZNddF0&9TbCEt3+v0P%cpN2JaO?zMKxv4kF~)YqXxyPKnjOOd%Wo39frq9P8WA{I~y z8NwN|LD-c;__Z-;RfY>&xqz9ATnos}vU3G{d8lX?Dx7L#4DnppqeEER#%jKTg~dm) zc=b9$%1{e?5n43Yx`Mq$oU@ES%38qh6o&pcz&A0)&!wDau}pc{%+npm`NK%lB4W;9 zspnzr-+~HRfXoS;bKIz?NnCv$+W}nnIF>%oVJYr;@bOo@V%C%~ADFT!$mjb#<2Y*- zA>jh@s4^BCk#$^}{Gqy@!(lmio zUdBCN#?{Z^?r&jl(a2fHovdOzjVEysd2|su!Nu|?v405nHHP?XB#JnG9ig{TdM+bZ zE@5GJ4$IM(PV9$6D0+N9aH>~=0o|FWr~_Ph_8=|KI*IfI_zo`3jOTrc^d>A{f!UWYw)%Hb8m9s?(qXhO{6 zYBXDN<`|6=UNJNzsLi@v+?Kz;+j2gu|LOM!ckQuV@CQt|Ww*Jex28B~!dAD2%@*s3 zrJ}c{t{xp(J2Wvedw62@&Esz_-OMi+4;)$>9?9KWAH6y@Jaq2N(($ubZyugJx$rJo zF&~t-rhe^(|J|4?zb;l~j#%@=^4s~=)K#ee5h(LRsPZFd5DtU0Fd2?xTSDWLhsrOa z5j=!A!-$bXbF>aMaTUseZzAw*sU^fdi;$Z*dlJpcf@x0dJ33P^FuuKwTU0IDW+oc` z#68{kttm7e@mo{zTT^Ug@b(|JSFvSbK#ak>q`4SQRB}{=QxY^YILsN2RB*a8oF)z5 zf1=47einf1P9}GllU9DXj%6IOxN?(I5aCk$aHR@Yy-+?^W`+h+XhgBgz(xEtZfGnO z%=%-dn~rA8BDd#!Yiea|W$p5O@qFb>aeRE>_;Th_@%)vwrNv@l=J3ho^vdPT?ISl1 zRE!N(dv)*EcN<9kH~(GEG|QIV&9W9MvRP&;5*@thdaL0B^VZaV^x0sMz4^Z@`s(G! zZ%xH7bIy3IE6=-x{xAD_kMI35XLffso%U$dpR@;h(B|WA z^Il#0rKfrxfokPi7!E~qXq&xEu44&jh&cmArO$CK4u(^Cv&YF8WccZd0%X{9+w`Q7 zUN$dmT=-2He%*zG+LXX|v_kdI#)181zAV6)Jj&iQhr`*6oy3(mK%d(&@Ab60l-XB% z_22BO!tejeQ4?)R{O$-9AqNtvaKq(??9J2qW-q^&3Z|+a#x*#2 z7=8nRgO60-wD7~P3sF876>&(B>%wVw+qbNk8V*)=J6hn+vQROq3n}v_>!1H;yIIy& z4M)jy{`_lwov)z-0JY5J0MD{e@sXrF$3n$#{sLZv#P$l(5rEG+pXT-P#vXo_<&OLe zqmjL*&OOKZxrkbxuA5-TkFX+tQw(Fh^L*N`BcjRA2Qw;3! zKKf2Cvks!bb-$$+JvW>&o9Vh9-(8Cqe`|?E!=HG-=)?NVP7;{~p3jBylcFnnVn!^9RdG{nh=JG??~Be4hVm2Q zKG74?qAym&nphXN#HQF1+u|OYg>XsH6{kgCEQwWdQ*4NVxGlCtOm-QU5ci3mm=+hs zs#p{2;+EJHTVh8{>~RN34qtF%Y-Kw&?s&D8FBHMNdqNi(*x*iFd_7 zY>F+hBPRCgKE#xm7JacK-Vy6!L%b)p#J1@Cu2MNiC#C9x{j#Jgf3HpTm*!|x%% zCB&qd64RnDR>YcE7aQU|u_d;}J?wJ8B}G^C#Ee)HtKz2E5CgF(-WMGzCb)#SPxQpJ z=!+GxCf3C*u_?C1wzy{?yiQVd#c9zOOJY^r6dPh7Zi{UZUw$(#A?_1BF)c2NRk0@4 z#VxTZw#1H@2tU;6Bt=)87JacK-Vy6!Lkz@iu`R+@GOk~AMNdqNi(*x*iFd_7Y>F+h zBPL`oC&iSQ7JacK-Vy6!L%b)p#I^|AFT4-Y6+JN{mc*)96Yq+F*c9)Jusn@Rh)FRe zrbS<@h&8b;HpF{kOKgjKM#JkQMOXC1j93z@;-=UT1F7%?its8h^{y-`eI3}iko6X48)e$5fc-VFM47|EQwXIE^diUu_dC1U|hfG zik|3;6|pAP#X#H^+ah``#wEp+m==ApDsGAmF%Vl~M@+mSxuPd##FAJQ>*AK!6kDS6 zqoKTh(G@+>7b{{-tc!uTEw)AH$COSnC8kARtcsgrLkz^0*bx)#m%$}PPt1rVu`1TZ zEwL%KMCZptdHtd*dZI5@#F|(a194kyi};45aY->HrbS<@iko6X48)e$5fh%|ik_Ge zOJY^5i(6t-Y>AjhH?CiFMNjm_idYltVjymdZ4ryXj7y3sF)jLHRooOCVj#A}j+i(k zxuPd##FAJQ>*AK!6k8(J2N>5cx}qogVnwWpbukdP#kPp=qZ*eKQ({{5#j3a|HpD<| zi5)R@(HARXO{|N7xGlCtEbTKcDW=4<=!;cx zQ*4NV*b+Np;<)6Bo|q9!VpXh*TVhjeiCAoCT)*gwp6H7eu_o5VK-?DFBG#N3mlRWC zTJ*)LxG6ToKx~N}F>y+AMNiC#C9x{j#VxTZwnQwuG_GHCMNjm_idYltVjymdZ4qm5 zj7y3sF)jLHRooOCVj#A}j+i(rxuPd##FAJQ>*AK!6kDQMDFBiE=}@jKdZI5@#F|(a z194kyi&%wZTvAMlY0(#};-=UT1Fhu6+O`x zD`HKoi-EW;wnZ$BHZCcq#I)#(RdG{nh=JG=J7Qv1az#(fh$XQq*2OKcDYir`ST?R- zbVX0}#fn%H>tY~oi*3;iGD33lQYb$qrbS<@iko6X48)e$5fhnEUQ+bLj93z@VqM%4 zn_^4EIymF{MOXAhU#y5Vu`UMUw%8W2R?oPkm=e>XFIL4(u^|RxOYDe=FG{ZHi5amZ zR>iuwB{s#D==?+|uU~XUPxQr#SQG1FAa09o5&v~Yc>iKbOpCr)6*t9(7>F&gBPPBi zxuPd##FAJQ>*AK!6k8%*1Td~&bVX0}#fn%H>tY~oi*3>Il}<4wrbS<@iko6X48)e$ z5ffR*xTNTb8L=c*#k#m9HpP~Rc_8EZMOXAhU#y5Vu`UMUw%8UimldW{Oo?gH7pvl? z*boD;C3eI_UUEfG%!nniD%Qm9`eH?_iFGj$x5c)INe<(ZVoFSl zzE~AE#fBJ&EwLje79>~n#Ee)Ht72W;5}RU6G%M{OvVSp@>x!P}ixsgZ*2O^F7TY4G zc#KPmDKRbjVpZG}8)6`~#EzJ_D!HO3X2gUvx!J^u>x;6YF9i zZi{UZYqX6^iYYNI`eIew6dPh7w#1H@Sdm=O6Ek8-tcrDUOKgfQ5ic(p*Dt!FC;DPV ztci6o5Vys)h!yI_CB>AO7JacQZi)>t5L;qLOq3*7^u&x<602fe+!C8&OTHrbS<@iko6X48)e$5fkf@D|%u^EQwXIE^diUu_a;} z*tmYt6+O`xD`HKoi-EW;wneXFIL4(u^|RxOYDe=Taqh!Vn!^9 zRk1E^iA}L3;-y35`bAgtL|?3kHL)%R;Q8{t^zT6!T{N8j7qNZNR`y2k<9YATW#+)W+j56Ou}>^FzK=&gbrL_1umIU| z@lkmDu*K!-(R^V!c@jMq*YoH5PY~Yi`WQct_<67<$K~o#eP;E1TtDLa5!a92|NUoN zKjQik*N?b}h3e!A-!k9Yf@q~68lin;dm`S!H! zN58JYZ({T7&ivwY(W&fso_4&l*K_$eSAnu79!qiS=*X z{>1HXY=1=Ur`Y~_{JN;v{*3MKxc?FNzvBL9-2aZpAL8+ssQuJE{>buS{qguyJpRP8 z5Rbpb<8Sf!TRi?2kH5v^Z}IqBJpLB7ALH@2c>L{g?`6j0kMa0pJpLGuKgQ#a@%Upr z{uqxxM(syC-WUy!#~FmYe~!nW9jkH_ER@%MQAJsy9L$KT`e_o)3GkH524>?{}Y{6jqd5YIov^AGX- zLp=Ww&p*WT5Apm%JpT~SKg9D7(f(6B{}9hV#PbjF{6qZxzum`C;`yg|{wbb+iszr= z`KNgPX}59qc>ZDcb~B!Ti02>T`G8Ago zYwv%!|LC5TYeS>{q&?7sHa|X#9*;y@<)+_l*hB?an68~!Zq^7U=H(%F(YgJW3w>N$2GZuyp(-k41sW{QLjlkBff?(LeJiZ@>K( z{E3$w=OScL++J*7K5#HKK6&uK=)ln<2Zjem4;>vFm~@X04U7yO8X6v-NR3R69sCL+ z!hOnl@hU`{ef|8_3w__fWo+=r5S*PWZj|4cTh6XtGm%c=_%yax;PXHlRCM-%S=t9z z!?6!zyTeFb?rzsUcN<-P#<$1ETkTi===_JB3Gu#-$1Le`9qp$h;ayS8ZZv(LL8!S; z^B+-cIA!Mz>@B01uHrwZcz9oXBq&N&OkUE}ar&Rc*>u>rQGe1N=s}wfd!F^D5uX*2 z6{>*ZK8}=ee*nKJQ_)yaSjAW+=Ma`MdwGNn;|x~dEdEAt&NwPrFZq*@RX~ghT!R}c zA}jDb_C_IT1d;}fq&c%k>8yxhnzAM(ybhnWbtq2ZvxtV6F*V{Ji$*!%oQ#fJmgK+J zC5NIT-W^YvCD`N*?zileaQ|;OgZQgpujITAo z_V)Mu1%4m6w?A3@+{ah5HcdEVNGFOWSz-^tQ7+|mO|ZQ^Er=m zC-Iv@tf8Lr*&xp2EY`Rz;tgQSs#cFe3gxlM9o5w-j}2kg$Q?6rUBp7(+FLbkjVS|N z&41UunyUEQhhMp7Yvn!MrzxZ0fBxft&(v01E3F@goW2+P{!CSnkMc*b^{Rr)#f7ES z{cDBt#@g!a+Va$E!$+O(M*LGq@EnrPs#tO!t&B+=EuyL}p>Td0*XhUh3eHJzAEdL7 z-_qW54acZ0?l4l9yRZF@=rZAQ5bNxd|Cb`wa#P`r2yJytQrmU8F0m#wn!Ya~)a2Jw zR?FoFIkF!)R>0XC;Hoo=-(_dYc@4$qC}c;kXY(Z*{>0Vy#iyyh?fteor@QimyY~7v zxR<{>z5E})7ICL5xWj1tq!rYIR?f3l_X$+&95zu9AU+$C7c5( znR_X0wx1DZ0*m6))b&tAW@R-U=M zF*dwXp8_L~PUT)4J8HeFoUyH?0Atrc?RD;sM|Q|9(x z8#w?Chkxv8b*Wl}AohBxxVm1rQodCxO!3C{u9vgr!qob$Y-%>OHlAJ_Iy!wOb!cX6 z_T2GHvp1$I>*b~S^2z11ZhClr^xC0Y*AJW>&y1e9e0X$da%th@#QB@Kv8A=W>$xH% zVq0Cxzc%a^Rs8U}y zJ%xwO(L-yfi0a1P#3CyBAgXuR_1!@HGW<7CWd|R`U{ki_+(w-JsG7^zFCaI|&K2zC zp`u-=aJKAYi08rz8$!<{2e~WGIjHV4&UJ*8QLXnPv}mq%1$&D)XBmH#wSeC#9JvK6 zZV2ZrJ0}sdgeQ3lvJOL51}cHp$c%Fp_U%O+Kj%!te+epO3Gq)jN2GFc&ILUG73Uz% zI{c1Ty@Hr*bQVp@rXZg~1LH{RDnddVathZxjVqkORZk%1D$>Zi%D{gXskx1GOhd{w zq-7Q%XL0Nj@}dlBmyyd%_i;!&h4AZ0*I}r}S@@2bSZ5$H4gYOicNxELBE|*$U4w57 za%nK^g|q_lXUQ;U@}AA)5^{|VNoWVZhCDi;1~Y6nA8!+faYEU&oq4|;___jlx8Ub9 zu}^F-j<82jHlgb{PDMV8Z4J4VMk@H+rjaix=Me6D49Cvlt}lT%5YCjapE8f%len|9 zC@E>=^*r+C8qTBdapdYKa``fHiB{z#&RM`26V7?(CQ>tI@_?yf%EB~;T*Z;R zxqDiRD@Y&91@F;CyfwrQOG;r!(`B2mXp?3K*>?5>zHF+fJ&&eAA2wGN*P06Q_JqBj zjS%%G?SUS&*QY-Fer!G4DV=ZS+w;;0e-#^>;xUvRK2aBW$YCkgXEx8HD62FS*ig?Q zU)ckotxkKMeRuY;^6+!mu($k_Y2-N!#$I+fC`K!v^4SBRnZRB}&RmH{Xo|4M!K>3C zVEVdU+%~_z+h#tie|z`!U3*~7U)yKGExXOHuYRPj_L0#1Vk=t1W{Y*i@)+DtOJnNL z<-)OJSC;1wPpl1{T|IgF#?|b_*|~i7%=O&$Lrd3J3RkY5ynJwdcBy#!U9w7k0BM?e zpe}a~xrC<2VHDnVs70=y&O-g zp&?j>(m#!+<0^9RA{r5nqGwIBn?qA^2+IAsX}Yg~Cn4n^a(fn`MV$5iYOJF9X4P*r z{E2(6FN8f;A5Z0D*fQqnIL?iaf?MQ$pe_Hg#idYk)>05*>7u!dj?|>or znv+DH(-`DHbP~B=z>{0TGh!Hx#XLgi@jTY>oOs-t4@o>##$7j0i^e%;osvfG6rNr5 zx-`?7XJ;TQiR~t?$n&G|>|9!}xj4$8i=Ib6s{l=#3Vx%w-EaBik%@__&(tMzq!6APd zFC6X<$0axt!a+wGh#U!_$uST86Mg<^I6lEK3r<+%@W+u2j)#OJ8#GlohC)3x zhF=bIa-4;x6^BsAaW+RrMjSM64;;;yMQ$3%+&RQxLI%slYlYQ8+b!R3y4M#NHsub# zzLbCcdTuB)J9F&J$>rO(Z(g1qo4=esbn;5-@Y+)TR23fU&W|KX>B>FdN z@bd*TDv$*n{}u$du)Tu)ZIIQT&OQ!HTdit1_ACRUN%hX}9^Lvu_Rjw+(N}mS!kYZ| zMUyD}^w}LTn!a}$5ak@+Zawq$u6!y-a%m8SrD&SHhxuaj!!nwVxLNrQ^kd^@{yfJ)5fUZV1*f9LoV0S}88}!vU?Rr57!_ zwwy)7pSVfT9GQpvqt!yyKzBF9gC0jq{xJQ)U12z+`}APL@iI(O|aufSdqUehOyq+0{?YH zH2L{$Q_F*>4&C`3Rq5djSa%c3<(SdpZ>wcA{E5~0hc#f7#DEd>QwF5Fmo#whi{`;2 zD8T{%w@>uMwCIZ!u_o5VhImhGiEVMu=R)~O(G@*0BbLOfxG6ToKx~TlMdt@Y`3Z5K z=!t337b{{-tczP>Q*4QCaSwG8TvBw!Y0(!;VpZG}8)6`Ci)|5OY{n(TeWE9(#YM3y z*2KEFB{s#D*bx(Z!|NnPSDY4ou_WFR>taI;#BH%HIzJT3?-yOs6Vu|NSQTsHT`>@w zVoU6ZiG8{cF(sx&Uo44t#JboJ?};t3EjmA}`w(5x6Ek8-tco@9t{8|-@xJJAWDhPO zCdHJP7JacI*2KEl5budCu`TXlmjf;-x}qm$#FAJQH^qh+h)wan=uk1iCB%KAC#FST ztcW$SE^diUu_d;}JpQYtYFt9xCwgL9TokKfO{|Ms zVpD919WkM$!%5K{~9$BDC(G@*0BbLOfxG6ToKx~TlMGQQI_aW{RJuxl%VnwWpb#Y5< ziY>7%?imlSlN4QXTJ*(|SQR(Lh8Tz~u_GoXBwzHzj93z@VqM%4n_^3}{nvi=V_ne` zeX%0e#JU)W+hSWpkH)y9m=e>XFIL4(u^|RxOYDe=HzZf|#Ee)Ht72W;5}RU6bbd6H z*Dt!FC;DPVtci6o5Vys)==_+{DW=4<=!;cxQ*4NV*b+Npg8eeMr09tmu_RW-y0|4a z#g^#&cqp%5bVX0}#fn%H>tY~oi)|6Jp~fY}l$aKMu_|tg4KWZ~Vn0u_5<6nzkmQP< zm=Q~2Rji9!VpD917>hKnUvx!J^u>x;6YF9iZi{UZOAn1piYYNI`eIew6dPh7w#1H@ zI4ZfKCuYQwSQYEyme>?qB34-#*Dt!FC;DPVtci6o5Vys)h~<68CB>AO7JacQZi)>t z5L;qLOdOY7(GxRbNvw)>aZ7B9EfLEKjq4X((Gz{KBG$yZ7>L_qTg3VkF&gBPLEsuIPywu_RW-y0|4a#g>SbF~;?auIP!rSP^StT@1u+u`Oa{hH*(T zC8kARtcsgrLkz^0*bx(FC0F#sj93z@VqM%4n_^4E`UvCtMOXAhU#y5Vu`UMUw%8W2 z(ABu4m=e>XFIL4(u^|RxOYDe=^O7riVn!^9Rk1E^iA}L3Vz|$^e$f>@(HARXO{|N7 zxGlCtOy(Px6jNea^u?;UDK^AFY>6E)F)O*ECuYQwSQYEyme>?qBG!=^*Dt!FC;DPV ztci6o5Vys)Xa*S}Ie96RpAyreFIL4(u^|RxOYDe=OeilYdSXT_iB+*KZi!8?C1RDF zas8qzdZI5@#F|(a194kyi&(O5TvAMlY0(#};-=UT1FB9zxJx}qogVnwWpbukdP#kPny;lukEQ({{5#j3a|HpD<|i5)TVCCL>%F(a15 zs#q7d#HQF1vBuK4e$f>@(HARXO{|N7xGlCt$5%SVl$aKMu_|tg4KWZ~Vn?qB4&e(>la}APBA5>MPICnn_@!@#Fp3* z6M4xMJuxGe#Hv^qx5TE{5;5sxT)*gwp6H7eu_o5VK-?DFA|^SEONuEmE&5_r+!PyP zAhyJgm{^cp(GxRbNvw)>aZ7B9EzzvBgUJ5HP_8R_qAym&nphVDaa(MQnBp-mDW=4< z=!;cxQ*4NV*b+Np;;Q6|o|q9!VpXh*TVhjeiCAoBT)*gwp6H7eu_o5VK-?DFqFrg4 zTn^=@#I)#(RdG{nh{6BQ-rL5=b*1;6ml|oz8IQ*`d2=TijEiH5p<_3@y4f$)a(a0A zG883JWJwgoqLVRib$2zp#eOMvH>o0}F)9W&*2lsI6LdZpDUY)@^C3ZbHwkJT1A7C^ z0yK7l)W-&boh=|)Ec2}f2#^}siT3}T`@3T4l1;TJ$s-%*khgyKoO|wb&pG$JJm)#5 zx?m3uU~Y~4!w{BX4K`p4c3>Cwpf(yN`G*AnA;2L~{>gCwpuUyh+z2ed5Js>Lo3I6AxC{F*c!zYtA}qlO zHsB6y!x;A90OsCBE(~EA)?fp+U%pVje6w|QmD>!4(s%Z7hmpI1nd`$&3yK9apj z;~%qpK54o6_wmWLU1r;ze;*(IUi+tAKE8b<9mH@w+t0Y-+qrM&R&ze>_UP-CuUEca z?fnIC-#&c%@a@C5kL{{84}Uf;FW^YH7h`z<%$@A`h%>P@!Y4bPi=z54Xa$M;uO zt9*a;X}3FHuYA3-67cov!}Z|H@*dFP+sB8?#p=m^^y@-$o3B@tL#iM7dX*GNw!itT z>eYxIXJzky#O^!8V8e|^&T4ZQu?+n>Gt+1sDJ{n^`}A7^Jx^@yxqg})I{_5?o-u{}MCwTj#w?BIO^hmRVk z)9Zyj?%&H!`e~>0t9riup8B|c_1)64S3ZxC&Z21JPnvG?KXm=$56?e*mdZ^-v;KT~ zVGpL|@r%0t3p$p!w`*H3j*Zo~YDZTq^9viBwWA9gYmcPAq`1%P7zIylU0G1LmCuwy(sZZkN#$2`bw)B~bpNcL zHL5$R@|&zl-Mb{oCV#>G8`U*S#ghI_>U_e*9+!+^XYKfkjy>`^wpCfHtyZ@;D+@PP z*01B;8ap;UJ6Ra3ZEkFDENrZfEv>9>S2stK$XjET)zwSxzAg8tKlq&=to`;Mj=A&u z`n0-W?mK_SjRgjP8O$U zPo9_@J@f4o6Qh%-&P19veS3J~2I0JT^OZ^1F$YuLaMpNp#{#KL6yI13%DX z(%_#}Xk~um*7l3@tCjT|F3x#fKda-Ae4%Itb#v(pOPRj7rmlTa$9ooO$lV({x6}5J z-{Pm&r+fWFKYsm-!3=zm#>WtNhbSnVpa7v#2IB zLqnNXBO6sti~470i;6d)JLcu9=-)AgOsk>nC4W}3s;;q*OXj#Fm~?A^)(|Ijf6@@G zsoR-JA9sz=x`>KPi9N^Ob?Q`|l6R4*b6<+zek*M}7B{`;{XLw;QSDw=?M|aw&_DRX zfp^tVEZDqObBCM!!p7~&`a;#Zx3RyfYcHz?+*Tg9R3}z~>q_gk2CB^MCTK!hibCxF7SWk~e4}E^% z-v9ZHZ+>OHa(m@^WqV~~{pH1%54_`&n#!?sSwMkX%)cL(K0l3{_2<(IdoX?es~gAu z{pmwD(pGt2`E+$u{HNdgN3OM|jWhM@QgGne1Aj&nv{(5nI`(RUs~gu>){k#iw{LB( zU*24udtu^C@YfXoyb?U`D&eN87|c%Ijk`%heA` z9t=(TUJijl*4TNd@5)UrgEOPxzDI!FX%{`mNn>E)z~RDZ)@%q9oFzoL!QxL1EcAu zNrSh6v7&cW)n}USG(9DyHyPM%pf&Ax-bowP{iXva1N)M~thw8BOry4^&$wq;Dyr_R zsPJ^2kraYe#gE$-?au#j^~qg8+VoS}J-5DcpeE~yjl%X=YbI$I;F|pKG-GU|a%+2e zVr;RxRJpafJ$8G1%mOwxSMFAiFRZRq*SD{&EY1}+D&td|g{|=$3lnRvow;yxe7ksf zVPmm+ZDCn@cy;}Hb#C!aef-SoxsBS1^EXaUl#fkLUV5wa=DF9-PF|7b{>ry!=PL_u zyt;OB;&k@bYim_Ka&hj`#MJcR^$n>Ab8o%+%K3AzEU%AWxLH1Tv2=IxZ1u*{<%<_@ zUfJBfboJKcS5=zZ!8M&Ns*5hD3%8MdO7RNP!p1c-S&-bd;5BvK7lNA#*;cbZtk4bj ztZO=3);+8GXR@yAb52+8NQ)cSJ*&Yv#jNQ~o|mlCl2ulhVA{x~;4SI5Z|eGM!CCpQ zDBUZH|4Q&}x}1gJ4ZZ)h;H2(4{gF?-rkFP9EW4D=N&bZLF|D+&DMM%5t~6S%%JN@SYVIl>XC>u^(sEfL7j^B5%3@p6uBuEe-7ibpd4=Cpx=yQWye!{K zF4hG}EXjXY&t28$uPeqI`gcRVDakd3;jpAtRX!_@W|X?-hRGF`nhhk09{hsJ=mZ01 zGHgCsCr;udvQ2lk{F>qGn&jP)-`+|3#t!R>%_z2A=$5WqM}Aqyrb?@%RM>kvt8ys@ zrO)06Y&G2zUcid6QoKWbrN_A4Dd{w1nTIH$3yae9MDmq;ijqr-aU~%FO87(=hF*&(Bj*3({wa-{v;JK6_d`u%x_&) z$%M#l{^*|TueM;5@Ov5Vr6ML$9)70zNz)hUlBs78Yiu%e8}6?*R2!_GJ?yEh)+cY< zX1klJDPsy*(pkl|-J?$4uqu^4&$b?$BJp?C=TMTt2<5hxAdI!xj(J?kUsyA((*TT?5Vft znz`)zDJjfUxCON~v&mSl%_KUiPn!qY+|A6C<}(#>N~L7VVnuOn9%oA4yyBT9=a`PY z{ zX-Le%lP-UjB2#2dowc(h_x5zNEiB4!wPCM(+KkqeTPw*VPesYH*{$W%O3cd9X47U` zHbr?}A<0bJO4k%&OW&~bI_c+IC$)F=U+x`!tmUEmuaCI!l*7}G@BPeyrqn;1c379( z)R8vdjK)27+%)XDQ&+1my>xAL>GaIz_{H^euik#E^5*6F#ma@73pY=#++3?(yLs;F z$*s#P8?Sy!+W6m6nl62yCOm3tOjPdEs=!<7l5O8sMP2M-@T`qVI;>k7XhGm<)$Y_% z5i=YOpv1aiEQebC-yZx&H;fHngYcaU+xQPEO~Yd zISnRP)%;)5ziU!bmNcBqsI11N0If^ec~vUYTPnRbr99261S?M6T#$-%N<-gGH|$*# z&q>NjmG)(YZs@Mhmy(t(w{&>QhVR>A^Gsr~iS$-}R!7;roglamA3&!Q={(1awD)B$ zgsHj{;jhC~-N~kJS@#xnd^z|zO@Lkq@+xzi1la;iUZrnJ$%@{Qh1n!&QK3tEADenl zc0E;_^Lncmcgwvko0Qt{mv?gK^zO3HwRU1O$S4*eP zT`Qj6Tv`F_57Xb#hF{T^r+z9{@@w6mTl+vbzr3ls{eT24a+Hqhvk3w+<`yV z@L=Jhsjv5oE4fn3-1|17~h9fx$j zD?aV;_(1oY8zcw{2RIQdt9kN!?@Z^H%qsQIVMKU6!zTU*FqJkW)&*s&%||T+*xL2u zEK*xT<+PnCr7=~O4L9sP+Kuhi-S}bU=VZU}!^(b#u_q4~Y3+ZMY5h;HWc~T{!X8ZP z@8cG9hWeL1yJwqITE}i}%63bPx^6hxHDMc%%=&2Evz^;4(-w1V_G!yHHp5)hrws^c zy3_QOl-}ocnEJV-zRTvYMcrq!b({4jJ1MM_Hw%c_0Fr$iW4A{yQ(}7GM2F zD%!2ze%!v)iZA~0j~?5Fr`wa#HQm&2_k8cU15LVcQ}pL_q@zw|*I2d-PxnfFcqf(a zH>1OoyY;*@`s_R?2;NoqUZ<GhO|Fa9eLSm+}by#>edH ze@il4c}n+s+)U`{y87XPU`xinM6)qd%NT~-tfrT(x@kSjhVOewU~M>5{!DAJuEE^B z1Ru;edieYBVCKDKpTDel1s$LFnZ(D{_${BR&Z+~SY$oyKF8JwomHtra%IkQNOY6(i zcEPsTm287ql-_Gyuo?Yq4c#+a@y(b!?5r#JH2Ol5`FiL1kG*^J zzkmP0;QNVYZT6wha)YaFZayP@+txO1+Bo{5&U-8P;qPifpyQC@#o~x)E`1#-(`wSx zwa2Zqga_PhAFQXmhu=c2XFb@mGp#{qy5+Mi7aT+x*70{?66>Sah5wBry7K&~b<1OF z4#VZ0?b4H#-{B#2OKHxQb6Vcn@O^jVU&LUPm%&K=Q&}{3KkpDcfbPXBC}$Nw?g$KF z2}ZCEo3I7j@ILIpK0Nr%M1CF?Up`FoJd1ge};C zUD$(tc+mPJxjZbuvoL}+*nm5*4P&?q`%pGE=W_4}3}Fc_!v<`^7VN+-?7;!d9ZsH; zhXr^RMz99ogDu#GG2DfH82s%-{s=6<5SHLFY``YG2V>ZUJve~5Bjf`XVF^aC2H%4% z*oOCE5B6d3%j5$VU#zx1umiiW2mA2gXd*uk3-BzA zU=23l4s631?!rFQ;=6M>cm#&91eak0Hem~PU>Ek_0OpeKn*@1SfM;O@Yw$hTf^8VX zUD$`xl$;xZ1sK8-T!szUg!f$zP@1B1IhcnHKwsd29iOFoJd1ge@4uUD$`3(KwffMOcCnY``7ZhB55H0nELKTo}SK ztic9s!4B-g9t?ghkv9ShFoY4T!zOIO81BM8)W)JD|F8&4FoF%Z1KTi$Jve|lo0rMu zVF=5x1{<&iJFp9T&}~kVyb;@^Bv*hTj9?u$VGG7^7xtl6L!HaRA}qlOHsB6y!x;A9 z0OmsE!Vs2W4K`p4c3>Cwpf+kbHv$VVgb}R6CTzhN?!rFQI%qz&4Cw z4-R1N402%z%diF;umwA?3wuzzESwvG1sK8z)?pL2U<`L*A8K2xb9q>VB^bd5+<|Qv z!yX*K+{?&?AuPihY`_-mz%J}TZKri^1QuWjBUpz`*n%Lo3I6AxC{GGJ2RZi!y+uf2sYpj zY{MA#-~i?>A{U0R3~R6fTd)JWum`n2!nqMxfFX=v9X4SL#&8$*p*DCsmxo1If)Q-M z9oU93?7;!dy^dTM!ZNJE25i9&?7|+DxzD)~Sb!mnU>!DL3&wC4_MsN@oy)@_EWrpi z;0|oV81~=*<}M=_hOi84umM}J1G}&XwU5lX5mp(N+Q1q zOE7{BxC7fThCMidxpE>e4?|dnHQ0bH*nwTxgW4tM+z2ed5Js>Lo3I6AxC{GGU)69f z4~wt_BiMjDunl9_g9DiRd&q?$EW;XXz!vPlF6_bJ?umxkd3;QsL zNGB}95{zI2?!Y#TVGj;qt`azxhaoJ(8f?H8?7%MUL9GTkHv$VVgb}R6CTzhN?!rFQ zs#TIsScD}Q!3NxcZ5YEI9KhTna$yL|um&5j1v{_{dr*r$&W*qV3}FQ8unAi*hP$v2 zwaDRI9u{EnA;2L~{B9l0=sWmtm^*n%C{g+1tY+DYWdaw4|?Lm0t2Y{C|d z;V$e$E%7*)hecR|5p2L6*oHCe!2!&@g#zx1FowIZ5A_vP=kl-!OE7{BxC7fThCMidx!cHvAuPihY`_-mz%J}T?VNXR1QuWj zBUpz`*n%|l~-Ve4n+VEJ=@p;|m^;Mk^`AEtkeScq;_kfP^BzWKDlir^#PxJ4mzWMj@$+lf)%iX_^5C1)f zPrH14`$#&7;dxoHuWb1{mS0An?Pg_2I9DKAK_tVc8lG}WLMLGEX>d|^+A!)hz z{_4{yAKza+T8_TI`fxjYns(>wm9JM;0$Dw3xc~O`YX9Z)Nz2XaSKdzjS+qxAuYA4w zJk+ZZCBphh|Ks)k$Lsx%*ZUu@_dj0mf4tuRc)kDe`t1Dkqt<`EA|2ux9rk-9=Cb$i zH4pRphu6Qn{^|8^KmYLa4?q9#^AA7&@beEp|M2sV?EJycKc4(O4L|?#^G`qj_Vx#F zfARJwZ-4Xl$E^P3?XS)({fJ%K+n>Gt+1sDJ{n^`}z5UtSpS}Ir+n>Gt+1sDJ{W&{- z^7dzMe}2;6N%Ho0Z-4jpcW;09_IGc8_x5*hf6wZV-u~|G?~m&j{Q84mfAH%Me*M9( zKlt?rzy9FYAN=}*Uw`oH4}Se2JAd@+4}Sf@uRrYlI~9KY#jn5k^%uYX;@4mN`pe_& ztls|a?eCAP7vBEv?eE_H?(Og1{_gGX-u~|G@816I?eE_H?(Og1{+`Si(|NOBfB4I} z{_u6ZW_!0=K{Z&_v7lcHA9a7lwdyLsUhQBasUDAfpZ=rjNqW7o$Ng!2%RcwhPUlzk zeEU81asBGMr6v2kG@ZvtXHm5Emo(kxf9U$hAD(~sER~yvX8rl}!X8Y^;}>=P7j!Id zZ`Zb792=`|)sC)K<`*_LYeyG0)*eZJNpYXoG46gZeqO&DKdbWvz1vyk;h2umU{ajb z=V(v~=H0s=4VDz^n2vE>Sx~r@&y+&abf@V_@(#q;~b#pX{yfs!?UA^S)+j5WkgWvhV+He2im^;6(Ppb>&zVk=lTD9;j z-L>FLWpU%>=R&IrmdxHChHqQ+Z~Wx__urL2_goOXDOo1&u#R_5oGebyo;)!*dgj|F zCPpVuotYY)Eu0x2JvM%7d}4a0cx-m+DO9*bfe+GnRwP4izm_9$fFZGuc-x}hgD*U`E`hsgvQ)(2}Oy<>atf9<` z6`jqxW>?f%QD=*aJ*}ovP(!i%3c6=6`7@GW&sfxbNuw*OaZTunNkbpk6_amWyq!%c zt~K>Xf{TOr85r+wJYN@mSpSo;3V@Tm!L6eYvb zG1bc=wbcflCDqY+)yF9}sMs(yud}La4->k3N%8j{mZl}kxZ=MLP{P?5F> ztJcG#-NMH0%KAdpM)tA4rE8ahn$yX)^tl=2gOcO6n(V54qdHFOd`qv(I?amWEC&Bs z@2{uhknZ0VpSJ15y5C$kL2&Q@CxQ)gd4|s4rpdeqBf{$$Ht|1zsk9-nE-0;XY1Of+ z?aE12a$DuGrGa5g|LQuc1xNMrHiFyA`?}7m_}6qjD<_qg4gXci|0_D)|Lgz5J)e*F ze}3beUsBd6v4WzG7;~?2hfc|I?s`@w95$brvqbzzYd!) zo4#eqD(Luf@N>cO;DsO`oYdQ2al>NX>F=BJS&di;?y3Y96=TWOlQo@fsmv-msye@| z&rOA_=<2%sR`v5v?wpjC>~pQmt;{Ycc3#KZy2tL%#!EHky=Dd`!(8@0^Q(HgwAJ;Q zy`IYb^ZsSby`J}Xl-955xaeA$l|){x?v6f7I^R$ZHe6j?RUC6xZx84wm`Be1`*CSG zq;a$Ue0pIIrse&(nZr>3@<@4?B=310rjS_IY$}O$p2;l1^myw+tz$LSrK0Y2(RHgc z>NpqG)h_CaDIoUmn69MhPScahpU}Og*x2mB1_JAZr#Um##AXM>3elvCYfrKH!?^BC z<`gR1RJ7}&t-kKnms(MM=lr!>sq%7P{V9;cFU4=a zl{OwLj`W_i(PU|Hr1@{FcBfG-=pTIHz`JU97Hr-pHQB$a>o04_u|dlQv6bMu(rTS- zRuKvUn=8l67CN6`wh&vQs`4C2RGzeETe>VO1u|m({kXISr*X6Xe0pIIrq6%cAH0|YBM&kUQn#@N8VFO>9v+_^X( zBgU|^s`zo+qTT-=u0FX7NSl62yXV$d4%GC$2^)p&vDQq|F2FVU;RS}VjmoX<<%zMy z>Qd#_>h{>}@i7b7*j%|=J-)EIQeEG^wz4=^*r<$8Z5Fo1Z!Ao#y>{lp&GGHx;f0OG z>a~SsS>UVd*Q;}jck1J3R?ltJPMp7SdZK)6a`Mt!r8m#Lc6RcLZ1%5wdv?CE@W!ia zCnrv4Z@sow)gu?@E=^2LA70;(g=FrnS6?}Q?v>^B@e4Q0=Ps7+PM)paSh{@i;>|0Y z+n281nw)%ju=qVf)&x z&6PQq{TGg%P!Fg7w#G6vQ&NaxZ`C%|x2o5+@6@Vuma)TI+m-F=+}52+@p5rSW$}fHLUpaOvMOphLxocP8+t$4?)H@Qq7%WZL1F;9bsW-t_r#~|a%1aP<+^YHEzC~)`2RHg{x@xI@Mo~_ti{mE1Pp&B@kg)&lhA!= zLVAv?pP4TAVV8PTUFh&|lo*7}0AvO+TSr({BOg=quBwq+$g0A|q*spXGmT+GSzgqNWSy3*vbqG*MlJ)Kjl1rVTpFE@g9)Z>s~-O6$5p60_Nyp82Yta9&S+MKRZv zM$1)M{)E}Mbk?EvU_i5RW8Ngl=3~L zYp*HSSH#=Og{8#iDNFi1r<`3>O)06YZOQY7?zp3pIib*LmFlEQ`Kn6Ew8~lCb6t1L z1h31;wjjAy29_F2S(3(t>$x0}=hF*&(Bj*3({wa-{v;JK6_d`u%x_&)$%M#l{^*|T zueM;5@Ov5Vr6ML$9)70zNz)hUlBs78Yiwey9`3I;R2$4F`>?07TA#e_#6){XJ(Ja= zO~tadd(_DrUXMwiXJ7g;MdI(O#~;-{>tEL0T`Q_RXFiZHtNM3L_3eymTT!%`kj-pP zsYXufvmn25QhkgmN(IHS*e4WwR(G20Z|OPdbAMX(A$|TKrR8tx*i&!OHFMebQ&O0z za0_Z}W|Og8+h&MSecC+G=5A&oF`uc3wq9k*VnuOn9%o9P87<9{^CTmujSZ%9+A3E; z_a^F~g_(StRoatmBd%7*B*vhiihP}$sX0)cPVY!M&lkk zZW{L7sjJnOUb?orbb4lU{Nnn#S8u;ndGqr8V&%fkg`1~VZmw0Y-8^^ogIw}q*EIDZn|Obns`o9PHJ$xtk4bJ_4!iLvgMWzPucK&TWtIqv+9gr zW4@>|unFrYTVwvqW6?{LsAE!yl2vI_otB*XU}}afb(!*F%Up>)&MbhYn%Kn1O!}sB z*t&JLU6$1QJ+H&;a%QVD#V%RtHg%;UpUF4#g4qtOpPJIAnfJ}UXsVSh9oY7yL`@#H zZkQUgYzI4cA2qGHkg@HJ8`br()Esr(nU&tKu(`s-(UrxcHy6gsmoL3^;oR!oyKi5; zJhgPSbn4u-;_1zm#dD|D&rMg)-ow%*vlfdHB?U9nNk{4W!Z4U z-lMY?KdktzOV&1R8`me_xR1YPyrcI(d7N*#MG#9A-bY zIknjiZ2oIIR4u-`qqM2I_1llzms+5{!DAJuEE^B1WtRf(;oglJeYYe+2=1SUO~s_eYfgfyFB+QSIg&T-vvM2 z_sM>!wB>a?$))*v+Ai1(n#nd8`=W_;!DjTcHFWEO?cBOx)1ggQH$$Io*0&hRMmE!` zEl#$+l$7Y_b=ba7>(H&MwytzkcboY!F_>D2?L@VX*0gQYz)c&s_{kE=qT-t|ci351 z@M-jgCiC^q^B?j82L|6yG;6aDeU@Ksv#&Ltk-lwfn>KA6{ZQw<75wmbH6hS( zNbzFvX}jg{fCR{u;Cs-*tYCwU>_c|K1nVQ3-BzAU=23l4s631?!rFQqOEf|cm#&91eak0Hem~PU>Ek_0Ok%S z&&k6AJPRXOgYUr>Y{MAt!afZCb|QZS7GMZVa2YmW6W)U{?7|)#z}yk?0gJE%BUpp) z!4_=8`>+T5F!*Ki0ShpMWmtm^*o60B47>0F4D8z@aygiXMOcCntivX3!8W`Pd$11= z+LS{s4+}7aWmtm^xC7fThF$moy2WkD&shg0cLav81S437P1u4R*o8gVhX+R!`FU7? zXJG_uumN{q8^&-K_Mw*4oy)-^FoY$z3>&ZsTd)JWum=Y)mweMa$io6W3nN&A@4*&q z!x-+uK9pYM+z2ed5SHLFY``YG2V>ZUJve|l^yNG(!V-*N4Za6kunq6S9_&MDZ%IC2 z0fw*)Yp?;E@E(j|7e0W}6rIb#JS@Tzj9?u$VGFk5eb|G2cn}RV4+}7aWmtm^xC7fT zhF$mo%J7in10I1PEWrrYVH37s2XnA;2L~`WgM1jm zGOWP{Y{3rf!X8ZLuOrN33owKctivX3!5HqsKGclHxjZbw5{zI2?!Y#TVGj;q?nUIn z5SC#LHed^OU>Eja@N0>@5m#zx1FowIZ5A}^(=kl-!OE7{BxC7fT zhCMidxe&Q9gk@NR4cLMm*o8f)jatr)zyb_m1naN~TQG*Zun)EN?pz)gVF^aC0e4^< z#;^wmFn0>MFob1TgALe%9oU6EsNDt5jlcp7VFc^230p9RyRZ+n9nQHtEW#3uU<2;J zHjH5p4q)yKa$yL|um&5j1v{_{dr-S9oEw1!7{UnFVH37s40mB4YFn#wd02!c7{LbI zfo&MW9vr~j%gBWxEW;XXz!vPlF6=>Vr*&=w7GMY?Scgs6f-&5MeW?8>&gEedmS6-M za0j+w40~_@bLWu@Ls*72*nlnAfnC^x+8N{A2rR%5Mz9W>umxkd3;R&Ja-7S!DL3&wC4_MtN}N^<^6 zBEJYrFoF%Z1KTi$Jve~5aw0DeLs*72*nlnAfnC^x+9l`Q2rR%5Mz9W>umxkd3;R%C z)o?Bki?9SE*nm5*4P)4Y1DN}J$b}&+!y0VB7VN+-?7`sgC-O#M0fsPwb=ZV07{guI zhrxG9CoIAej9>%qz&4Cw4-R1NH;@ZMScWy&fGya8UD$)#W9i%oEWi*(unwEB1!K4i z`!I+|CoIAej9>%qz&4Cw4-R0i5;&KKAuPihY`_-mz%J}Ttp+(a0t+yN5v;=|Y{3}r z!amfhRgz9vge4fk2Hb&d7{eYMz}zBoVF=5x1{<&iJFp9TP>Vj!jlcp7VFc^230p9R zyRZ+n$l+Wb7GViSumN{q8^*8)2QYUXxiExfSc47Nf*sg}J?M7YN#w|KBDVlT7{NMh z!WN9-F6=`s@i>=rd!07DqT zI&8ugjNvZqLv6`(E)R>a1S8mhJFpF7*n!DL3&wC4_Mw)Noy)@_EWrpi;0|oV81~=*=C+UvLs*72*nlnAfnC^xS_XD*1QuWj zBUpz`*n%%qz&4Cw4-R1N4su}#%diF;umwA?3wuysDt2xJ z7GMY?Scgs6f-&5MeHgq$I$;r(U<4a*2ex4hdvE}A?;;n5uncRk0b8&GyRZj??~;F5 zfFWFl4Y&i_Foq9c@SDhkxy1Xy_C^~X3pzfp+q}N2w0%K`eS338%%=aK!pvpE&Ht>9 zPrB1KEB7zj^9oitay}nPIi&CJ%km!3F`fkPyL{67v*l_2{nR)AK0evb_iVZQ_mR|N zU$1<C58poa{^Q)fefaj_+lOx-S^dHM`-$~b@A`f>=|8jOkj~@w8*cITGhP*v$9?MaWj_uk1v~uS{QG$L=OnWAc)#`4 z*DGJItOT<4XSki&^h+MTagR%#!=-2C|Q7h7*1;ho#xcDG-Pyb;(BFV-JvU#b0g zuXgek$$3VH{XKGX`)!~8`AM7ePPDL_9t(Dvbx~yZ{Ggq?Qh=x=Iw9Z{^sp(-u{-= zAHDs}+uxq_Jy~ym^!7(@fAsc8Z-4amM{j@h_Q$OLnA#h&;okn}?T_C6=<+{*WXv&Ux42ZM%`a=ueuI~a5Ih38k+Uz(+hhrEstN+^WYp%@;bIvS*xv9w>K*bH&)iKU?)_v6xZq;a$Ue0pIIrs+uUOZ_Fqw}v>cDqm5hpHw3$sM=dYoK>hbk4gE9F080) z)+nvXOz3=GO=DKaq|Rn^6h3&bS^3kFFcB=exJg4VDrAXSyWiFIx(=(|HSx2q-T(K*|Lbb^kKhQkw~(pDNANc?;g*kKm#qz-ZSC$KPiwo? zx?z{5BMsZjpVlh7Zabng!qpF2g z^KCGiR6Sf!ZBN?3qGFE9H|2&68?L71v*BY}A!)j@@@)tz=&-wN__ATio>g@6CnUjI zpgqT0#;9v^HbgEce8RN_OW))NHQVx_>i5_>dgvEcAKMzz@U%6gev|bto;z?)Lq*ym ztXdC`b_*M~E9(nY8`;PHmabh2YECEH(&uK74@!>PO6aP5qdHFOd`qv(Rwa_H1i`@roCr3|PFF*5+OKPMD)@7B6cppB1ZWPjaj*O*UMu1<17R?$(_`E7k} zDr7}h*X1`IFYn~eNomPG*UH?=?1EzFb-b;6?EY-LRI}e}W?(YRW$!b;s;5g^U7y+O zsocF*p7xTvSNJD=-rrGLzoz4&Yh_jvd9}Jb`Yh>uLpj)Rb#Ya3%vrrXprc?OIrHzw zrR9*u&HD4{g*}+&|8X;iq5kEO@-9i<^E#@ogErm1s zGG&9ogq3Y7+I7)ZU-#-ut*HLbfA->Urpn8G`O|LbfBWBWxo$k|u2a9=^PNQVuMcVd z7HsZQ(){l{Uh_|bAEz7rd29aDz5XH7{Ab{UqyUoIot}#W&eINV=+cKyvlZjB)r~&% z=nr|)bfket^2`TS-n5iy*O2C2)wU+JsIUp$ zF|Y87{vA`uw3^;t@@*brjn#CTM6a<1l{8svAjc%hbRC=I+nGrpSJO$-WX)*CT}`!k z%jRCX&X?l1-%1;g#Y^u=8%>rLN1Fd#)$TN^1^t6B9C%ml&VtSRq$c}Ub^T=xIW}n7 zAhr@*S8A=3%_>4cU~}bI$06O*5lybSwB%BzZ>XtjmaO+I(vXWe@4~Fg@ZX0?tVbHo2kA`HS5!n-Hp=f$RpmL5s64~zvaA%yh^2EsE-n8w zZq}bqFYLke`A<8fO=!5W`L3C_if*7Wv(=Q^jtyyvxyo8fL5Iyrs)}VZ>M7l4gOAOo zZLXfCJ55hX>9v+_bB86}Wi8H3XEy7oNQSj)n~Rt{8%Aw#v|-NV&AT`zcgn>rD3;1L z6}_(^?cbk1bR%t*_mz%xNc*SX`bVy{rmZsdTk#%v_Q0Rf1npJ+ijKWT&DD+TE9=KM ztJ}9W*Dr6b&b=^kCirWLe_jcmce>7|H1O=Kkti;{ z)elPKxH_+@?!G0i2bcA^8q7(jp9s!KcJ_H`xn#rlJ!5(H<22vTpAq3{oBNC!_JWS2 zX<37wRgE=6Lt8sX&2y{{O|(9*hb~n_VUEoVs)uvMlh`_3PES#XI%!Gppw|YA4R$I6YB5 zHaU6ets!@p z+jnZ!Im_7Lt?kNob#CiUrFglxIbB*FKXdj%@zkZM%dfqBgeoS{Og z{tdmKYX{P3KKp`d8{R+By#DzI)=+cDb?jt8!g9fEH$_ef)nK ze*c>`H~2GHc-CTQWdepjllUXpfl25-G$B35)z3_q`>;zrsxEYRI7$pcW&kpSn5`o$ ztC5eXc~@Q2yruZt^50gI9s3}LX_bljlE12dChNLB=XB+c3|Hg2XEivdm^Ho0^OAL1 zvdZcbOdGiryd{&uo4Wp5a8~{+O81K5zY=_#E@vTlL+^i0hM)=E`B6{3rkFP9EW4D= zN&bZLF|D+&DIvud)K?U9U1_vjmF2&v)ZA4%&PvJ+rRB0hF6!D9mBqHC zT~#Stx?h&G^9sMIbe&e$cv-%eT&xR{Sd#y)p1Z2gUssGb^zVjzQ<7^6!(mA?P7 zbbd!~uc%ZPm5OPlf7!javnrQja7y`}(zVx=>nq}I<-$^8^OPlho>R^)s-~1w)@HN5 zp*!xVWKJk_TBSOvQogEEGOcn}_gvQFBLJ7^6=BrXD&@&q;pfx9@f~zSUucdZKyVw zQTAa^Wwkze+lh(xj(R4mN1KXeZTF~?H@qH`KF>B?nj-Oc)#H!qpY<>6?yeQpo--dv zm{t8druue9wXG=HOvq+7r&J>+^=Ydy#!2-trYIE@$6}vQ>{;DuvcIM0q|g0n)ra)? zhm@ATsbf#QMc2$_-%m+lro!1eli6e}*U7r8^}WgZtXW8s6)9VVop8!xMR9E&XG)%} z9GNBOn2x>W+iH@nK$(%_^8cn-#{FCI< zR8UKW^<+spEDgyzv8^rJ+|$xw+dvXUImx{}-Ih}pU8(H7`fM{=Q*Ny!lROnA%VxLf z%-7Uon@!uM5>u4tB{7+4+tW=Ew)71VrAn(MPRCh4$lX`uDpr&YUCOGV6ZG=LK8hOr!K^?!Tt zAKfrEfDOWTGHl~Ns5A|`A+atv+l`q;#l0U5R3FCxY07h={?2JIxvCE2CH=c5C1pv& z$&7}haVbFSQg&XI%Jh~xf;Xi+&8vH;ICXPDD$*$peK*~(cTGGeDJL~JURLOa?)rQw zY1wj1ho@}#zAZL>jahZZuQ7i*Ys`OnEP9C&bxaD8Eqa+cWkz{ZA56`#r7lxmY?&*u z$C(AtR1=#RCF{i%#h=+zT{F9!+3HNOvmL9ZsF)ovvFMq3!EA@tPfh95%=>0vG}X$M z+opAQq9zYpH%yILwu7C!kDAt8$k_JAjq3VXYK}VY%t~)q*j!=a=*r^Jn+xOR%a>ld zaBlVP-M6n^o?5zEI(6<^@$}}(;<;1n=ccRY?@TYw+`45Q`M>?aGj12Fo!{4il_seE z<9RnMryL%Z|J`#3{#e6<4a+uKWQ~wRn~k#@aF;jMs=?3eo=YmKHO)ZH(vjD^-sUa# zCsk|_;JU7VT3eDHNS3)lf}k)oj#*aoYu}i@K0+?(nl=>>}8SK8Y-vl zOeu}2vTV3v@6lO{A6ER*8aE!ouU3^&+gggl-9A^%+fXj*{)HW zHz(_>wuWl6Oq*FIvrJpeN%nx+PE*@+YV+yIJ>{GFY3sK(hqay3$y#u_lOoxnYGI2S z5Nz-<`>D;T&30h(-+4(ln~A!kw5huF+mG9qTDKPe_(zZJ!qYD%q-(mV-|qR|a|fDq z;il-%=}1SN%=bmIU3mH}i4T8=Lid}|;mO_l*%?Jz&$8kBo@uZ)94ddNwOH3+?p^|?J=kdve;*#qyqE0rmldy|W=qq+?cBQHWFx)l$`;?g zmSP>ZZDcd8+TvvEOG$}-UdJ(~Lt9KURGI|a3TGX2BHtD~tc#y^+O}!nrj1+tWC>+a z@y(b!?5r#JH2Ol5`FiL1kNv%||Ni|0gYPGrwb_S0%dfWC*BZ}A-?p_)n?R3#sPo9hc(M4j-Ew$90^~~YJ!oOpvmR{Onbx2)-SXL%3l5?T>-f7ciS^Ol^1o3; zSDrt$Zh1`2VYs}rU3#+eJ3NGLDb3mHpEk>E_`bXGFY={?yuOs6{;4dQyPtOm9zgfv z6_h)agdc$+EWrrYVH37s8{UUK*oOzdnaIz>0t{gp)?fqfz&4Cw7e0W&FD3GG@CXcH z2}ZCEo3I5tunT*z4-Z&Zs@4*;$VGj;q?g;sS zMOcCntiktS3%22X*n@o-{4)7~1sK9Itic9s!h0}=UHAY7_U#e59L&QaEWrrYVH37s z8{UUK*oOyg$|0AB1sK9IticA{fo&MWE_?vp;v}0z+7W5v;=|Y{3rf!XE6y zgQJQ3JS@PoFoHGMfIF}aW4H_ZP)q90<=_z*!V+AD4cLS&*nwTxg9DgLzG)uhVF8|n z5v;-YU<g%f1QuWjOK=%BU=!YhG3>$~9Kam5jG?7==fhz6R61sK9I zticA{fo&MWE_?uGcu4XAkH8R?UnA; z2L~|sB648}%diF;umwA?3wtp5wM5_N9VN%BT)lagEkhA@J4*n}+@!(G^i`o^tud02!c z7{LbIfo&MW9vr}2h+G)LGOWP{Y{3rf!XDH{E$2pH0fsPwb=ZV07{guIhgy4gE)R>a z1S8mhJFpF7*nrEEW;XXz!vPlF6=?=jB#!R7GMY?Scgs6f-&5MeW+bI z&gEedmS6-Ma0j+w40~_@a~F{dLs*72*nlnAfnC^x+Gy?E2rR%5Mz9W>umxkd3;R$T zyq(L#A}qlOHsB6y!x;A90OnptE(~EA)?fp+ULo3I6AxC{GG zi}}vwVG)*K1RHP%wqXo=Z~$|ckqbjuhBerLE!crw*n`?f=G+J@zz{~T4x6wAW4H_Z z&>0yeIe#UQUxXzX!3NxcZ5YEI9Kc*Tk(Y-dEW;XXz!vPlF6=?=l5=hZ7GMY?Scgs6 zf-&5MeWzs%>6y&!Vs2W4K`p4c3>CwVDR@7c_Xj@Lm0t2 zY{C|d;V$e${RN05|F8&4FoF%Z1KTi$Jve~5-#{)5VHwt71GZoXc3}@{kEL@XumD3C z!8&Zh7L4I8?86`;ov;W?FoF%Z1KTi$Jve~5O5j``hOi84umM}J1G}&XwHoBy2rR%5 zMz9W>umxkd3;R&3R!KTx5td*C8*m4*a$yL|um&5j1v{_{dr+J0 zoEw1!7{UnFVH37s40mB4YC+MtJS@Tzj9>%qz&4Cw4-Q~%4Y@FcWmtm^*n%C{g*~W^ zhR%(^0t{gU>#zx1FowIZ549!FxjZbw5{zI2?!Y#TVGj;qu7+F~!ZNJE25i9&?7|+@ zPI>1>U;&0Of_2!0Ef~XH*oRt5b}kQ#ummI6fIF}aW7vZOnA<`w3}G48U<0;b2Xlso1#@Sb!mnU>!DL3&wC4_F?c2>4ZgCf)Q-M9oU93?7;!dy^CBJ!ZNJE25i9& z?7|)lzDxdL0fulHHsB6y!x%n*!EYiD<`VA*+Z%0oEa>>WZu9!8()I-%_U+9XF`NE_ z3Nx1tH~+IbKIu-|tlYn7&nsBr$oYIE<&eI=FUxyC$9NLF@A66S&z7h8_fy~e`}kx# z-?QcJ-$zo9eZBJa%DOV&K9UYS?HAI1-nS3mK79Mw`;T+`_Tk%yZy&yWWc3I0?`K}) z=TRTlJN8>{zTfrzuJ3n!zw7(mr2ov8LpqP!Z@9(V&v;cx9`~uwm;E@H6zuSO^Y7!~ zpOeVepL z_rHGp@#C-8KfL~x)gQh7`Q&}VUjO#<4?q9%^G`qj_Vx#FfARLGto}5-9%uC<^?Uo9 zx4(J&o3}rD`>VIVdi$%lzk2(tx4(M(tGB;q=MUcg>g}&j`a2cg{_O3~-u~?E&))v* z?a$u+?CsB4{V}ySXT!by+1sDJ{n^`}z5UtSpS}Ir+n>Gt+1sDJ{n^`}v-1RRfA;og zZ-3tV??ik1ySKl4`@6Tld;7b$zkB<;x4&ogXK#PER`F=P@aqqL{lTw4`1J?B{@~Xi z{Q84mfAH%Me*M9(Klt^B?EJ~EKlt?rzy9FYAN=3He7qgSuRri&vy)pfLc>7f%zH~h%oS^g+JHN9TgJNVB2W!9mhhy&izCNuknETEjeQVXivvk*j zFO|i2UVbjLs$j|dzrOna{X>iXji0>#{=4$$o(qCECCkJe*744Xlf~)TlP4xe&wTsD z#OUOyGgG6pg)`%$$Hq^MPfX7gkIhb<{H`L(eJyzQU5R$*eEi8X2Y#T(q`^O{;L7~Q zt?d`*S1ao`T%_~5epbgJ`9jeal+2|sEM@xQn!5Hy9q(DBA$M=++)mp=ev6-8Z&iQz zYd?Pdi^1>02WdPjk|8(Xyp#zaisDYQ>HCI4T|V6(g1@Ei=tZ5a{{QT~e{7t|dFT1k zp0VX0vD^7&I`G;(jz>{`aQKoG$>!`bY7H$8HTu;fSyn6ASlwhdMM@OeA}LLeW}Izj zv+-PF?=^4;j(559c8tT_TyQ@0{*&b`_OhK|fs+H@p@F+S5V#!Bf8+q=5FC23dwU%q zo4M~(@28~JE47BB(b(hNx2U&2Z`E6Gy;b#AJ@wR6)h#ulb^SQ}y>cBOp*XE$+9N}* zn}0vf=flU1`_uly0Q!9R`@BD=_|_4vlPm`%HTkkQ>AISA%986SOYXXLl#+68-DpPV z85h$!XHnOu^*Mg`y~fkGZfKoqTz^YSV?@W2I_|hj-@0Vcr8=e1vd)&&^{n%jT)Ino z)`a3Ly0+nqsOA*Ci&&d`{%hxc({~<=Ywg3F4}S~i{dP^Q`)hO@^P2ms4-EYqJ;H*` z`>@vix~^AsSnIBc?{(|GRQ_LF>n^}yT5lL@#fR|MV&PVfeiv^I?``Yu9`UW+T3x^M z`S4+b{JvG$b^C9VR@DElsrSX>r+q>L*q@F?@&267tv6V^w6?ye);A^Jh|a8UM8i^1 zE!o;_QT}Q5gb{s~L>r1G6@O8mHbfo1o3D8KHndsmwt=bS+WVqfyrp5ok_|uB2QoUJ zbZ4Pbn^w9uNY3bN!aZl~Zp*eZsQEp#jsD-0=O5Y|e7Nro-fwAr_vxWGHB|T>Va>XK zv|HM^SzKQ#+sHopGrD#zs5qT$OP`xTI>`oy!BImr;5C=kf+Cp6$`kQ6yaU}Rr1KO7^CBaQ-w%uh{8dT3=T>K@6+5lt72RX^$K!d;e$dRo(l8gl&-`khE^k$R#;^Ny z2U)%br8_A6-9GOZl-Ez`IOBSm)kIpo?p1x}biSbyY`C_#ra0!T-45vp%_C?2{WxC_ zK5pEf_7?`wm;Yfihd%l8Kz-+w-WPQ&tG&#qWJL+wl1elpp=c^YBtmWGV48hKS50J^ zur^U`g4+aj=)|neK777?eth~SdZ!dGnm1&Wf~8YZn2G3dCyp)sNu_CX6q}dK=+A_@ zU7gXLMTMzuebP=uTYDWOORcK@uhs|ufmdE`%kRa|@Bigjof!Ax+WYOEUyC&VU+>fW zfB%2|t$+9gHUGc&aLwNbKTJ3JL2LfQFaPFI)BHaJ?^w;4v)0|`dYpR!*LUf@(|E&p zZ*`;l9(|w3=fela{b_$;0DbH8_j!L#@vS3Gs-u`DZ{5eVY-`?&YWUXV59>1uGi}H; zn-S4w02XTZS(nPF!A}nCNK@(zCB-@H?lcX`rr6U;#nQJ4zIC6>-KR&h0_(_@kFw&~ zykdM`y3WZjf9$t?=dtSWn!gYCoyYqvjx_(8TDOmCL0|vi(Cg}V7Hr-}b=jZL_2U|H zY|yenY&E#7{F;!BD?&kFbLAGZh23{CTWDFPUWeBeFhlwa%V7Hd&|6T06_ zUS>|So^}5m+~U|w#^(4olQ9_(&3$ZGGdqFm))#eOL)ypw?7Me+hgNyR_uifelJrZn*Q ztmLG^FRQz*2cOk*hIKrnds22Tn)9#U)0erfYbGt;utTE=loHt-tupTxT5 z4)K~X`tF#vnO&djOV)+P^Y>MSy83#D-E!@2jT}*pm38+GaXmP%&$VDyI{kPsue9UO z^Ys!B-}j8=sdv(S-+xAg$L;Pmpf0J4MV;J+TkDjjnOb)@OLt`ZHf`0eE{irGmK4wQ zOzZIGi`RQj@5s9QlI}ON+Oj%rWXLnyx0w;5^dlp~jKqPNpofp_^$71_k8ywLvMa08inn#)=j(!a9zHCfnju`cw>8Ie6&Y5^OYtGCKWmey9w>)V%BOS9odacpuk+#0*OG=A;n`P0|OwlfEpHcI77ODnR# zm)9?sXU8wh%&(u@s^;d3mE$L-<~J^_-a1t|zkc*9H%c#$PhNTH=*5Lolgks==Qd)u zUbgM)|7j7M%yfJsEvt7N%A&UcY>%QhBj>>&p80ODhLA%ca%L^3wLD8=I@MuK3SR z9F>IAKU-tzn<*(ov9~H4>s#eZ+pkv2vsSQ!TieC$^6bS|)+Vp6h12V&bJfGE7v>jk zyn5`^#PWqxllk-E@tMQbv5SjmUp`$~s7@@OIKR1kb!++D^7*yW%~x)$u222S^uevA z4W+1KeYN!Lcv!wxTwN2joS}t`@=xpi#KrBL^rEA|sUR`{opYLzP3KKp`b!y??&x?% z_jSa_6}c^wt8#7FgBE6|UHsqtC!;Ue+~8ZV@RY@n?KZ|8{9PEudSD9iK$pwtIj()i zMD9J2`kX|ljjVn+x@Q0~gP5%&tf=#isymzg-9pwBHY&YxOrJi64P}w}SID-6$w8M7d)6hLt>~UL{aIR< z^*O6ME=Xj|%YRO(RAoAtQ=E$4-3bYac|FCRcuQ}$qTyj(@A)graY;|HnZT9cC52oJ z7IfW2$b_Cdr+Xg#)Jw{x4LU1|X=OR*(wfp;>k5g?X0uA?igIvM@lMFVbV~wmQcs@K zaaJWctDK%tImh&QJvgS)ET~;xckOUf>77={arv*PbfZ;d+pH-QUGGIo-=A+GkQJg4k zGZ$KUZOQwRQhZf@dneX%?2R3C^Nh$?Hmkh8qBl3G_q?VzKCSyss}8EFmsP#Pd6npf zQaGm4PUuZsaBn29cNVH1Y=%`;U0qZioYlKKttTxg#A2Rs!~U|;-IDK|j`Mm#Nj3k9 zQZ%(`D)<#W&vIiqi}Dz8UDr#l^kzP}rW#z;y;jCh@yrOd>_W;9^rJzlgkN5N(D?b9 z>!SWX)ATh==sA%y|2_BqQyonHeMZN?agEFm8scs4ZF7Mc(F{m* z*B1BtT{4!xzsGWWSO4^1?ml$J_Vq9Pp$qrySJ!^`!$b8CN9vl5x^*4CS;sV$(Icjr z%)WeOs(g87b#8I#%=m?c)nnE1+?UQ=Tz&DSlc!Hst}mD8=Z{^vTDm^=>Zy$lO?)}^yu=clBWlBdh2+eA^uz|R&fpSK|d`^O3NkgV74h!-h(=alwf#^#LyD0yQ z8az*GfH|oF;JOn(^BSCvDUGWV5~h~Cs-ekLgnKJNKm5ThUT=PwiHGldrkkwIsl_B~ zb5CY%?)|6EJgy}qqgG*CeazBf=1Eg2%n}kUL70LQDHnDr9PVv4b6t z51J%g$msUQ)$;nNpT-|?)A27`*lald+-m8$>t9};dpWoG;^orj{KboB#?LHot)0Da z?aHwiuY6@Se{F4Pas8yM4%h6#(|`Jn-|@>Ex8-Mc8+`uTf8mB@&;DWgkDng;XBr-C zEyG5OxbdcMlV*J5;>yOga_~vrb56S7H3@E;A*O>bs{@;kcU5BD=8M4-+sbiAX_*^j zKuuHLBmee=Ih)OAVS(@`wUy)T45))<@>_lNv>mIZQ8ktgH^Y4o45-Pl@*niD;?z%QiT^(NGH{j|t@vgnQ^uXhwKXo=N)fFP+v>6n2}YZ> z+8oy`7Z#%=!EKwxZCDt*3ET!16W^Aq?aQ-m-hLOVrDJnoOTVO4?U}a5HK99f59+c$ z?TW2-OKbK;b?aX5RF+!xeQI;*n-3G=8^!NA(eBs6yx;Em-KU4@h;UQ%XLa~dC$`T% zF2eop^85Fm>wYsjJX)+jY|oyydTR_ZqvhrBs*Z(l8G# z%%r(3kDEId6ZJj9ZJo}X=OO$x7+rmP!|iV4E4SfY1Ss<-pj89 z+1J75rElAskWHXR?i1cy!S{b(U0TO8iq{e!S1f0Tlz?0gz5y-FBQbFcubunrrr32(y=?7{R$vY8 zz$R?LHoOCapN-N_!9y?$bFcubunrq=7q(#scHse&Npfiz!Ub4>6+pq(>F!*`O0YjLDd02rpSch-I7Hq>i zFtAACuqlUJ8ip_n^RNPIa0fPF3%21M7?@y^OTj}h z3v;jltFR6ma2K{=2X^6sk?1*T7{UcufE8GSJFp2`a1VB&zHj4P3Lb)4n1d^@2J5f^ zcVQcLU=OCEZ|DYT7{UcufED-#Y``XL!9Cc8UgH@?^9f-V=HLpf!8&{swqP4}U=OCy zm(wr8cOb8Z-hFbngr0&B1i--IpLhIgQJ#pr#*G|a#pEWj$P z!v<`^+pq(>@WA2dIcXTeEX>0Stic`Fge};Hcc3)ks2uPR%)%Tjz$&c62Hb^h*nwSm zV2X0U5H7$1tiT%Fflb(g9oU1ZY0`&Tn1>ZugAKR~+pq)u{B@XlYzVWk0IRSL8?XiU zU>9nh;anPKU=9{w4er1uY{3rf!PN7l3$ri}E3gI|a2K{=2L^vTN^cm3FbfN?3hS@| zTW}9{VeogzC(OVcEWjGvflb(g9oT~@o0rL@VHW0L1=e5#?!q?gz~Gmo^oC&wv#YIwrrC|o9l&opWiJfjL-!HMj$tumwA?2UByT3$ri}E3gI|a2K{=2WlUIbHgx% zSy+HoSceVRf_tzFwFAMqG|a#pEWjGvflb(g9oU1ZdD4Yhn1>ZugAKR~+pq(*f5N$8 z7{V+pz$&c625iAS*oE4w;anPKU=9{w4er1uY{3rf!PIfmg;|(~6EG)n(tiuLu!9Cc8+UDq78fIV)7GMqTz$R?L4(!3yNz#Q`n1>ZugAKR~+pq(* zH^#YP7{V+pz$&c625iAS*oE4W<6IhMU=9{w4er1uY{3rf!PFVjg;|(~6EG)n(tiuLu!9Cc8+QsBt8fIV)7GMqTz$R?L4(!3yS<;1Bn1>ZugAKR~ z+pq&=?sIM!hA;~YunOz20b6hncA*yYolC~3~Ew~4}P~V)7$`3Oz2Me$UcVH8?UZ_y+voH@Uum&4&7q(#s>Wcu*4Z{#-VF6ZQ9X4PK?!hh$3gi=JU=9{w4er1uY{3rf z!BjDDE)BCV4=b<+8*mr4VFzj*$hlz{!YnMnDy+i>Y{5O)g<4sP@(D9A2Me$UcVH8? zUh9S(t0<6M1Y`_-WgI%aa4(HM^19PwdYj6iP zVGDL(52h}YF3iF_tiT#d9#&utHsCI7!w%GDJLiUB2(z#NtFR6mum$&E7ivM#xirkc z94x>Z+<{Hlf*sg{scWPQvoH@Uum&4&7q(#sYNMfZ!!U$dSb$YnhYi?*d$0?&CC|Au z%)lHhz#80vP1u4R*n_DG>B20`!wRgy2Hb^h*n!$1@7yp9VHOr(71m(`w%{J@LM_C0#&beV2!YnMnDy+i>Y{5O) zh1%=lTpDIz4i;by?!YE&!4B-f)T^WmvoH@Uum&4&7q(#s>MNMe4Z{#-VF6ZQ9X4PK z?!hh$UL&6{19PwdYj6iPVGDL(52juxU6_S=Sb;UzfV;2_J23bf<%c26!WCG9JFp2` z@D2=qo%CQT^4{IvXv1Tul4b`2X)w{rD-vq{{sp$7Y{f8Q##)5Hm`WPKWfhl zt#ag&azypu-`_{&9nvut1@F6l{QdFzH2;3uTk<~M-L}hky(jPE{_nv*>H10fM&sOTW^VemDs7@i~g9jtE64MAKKNhGGQ{( zeiPe%_U&q5|6yJAf$`_<>^~n@8XwS+{CCgMMyvgf-%0%^?JwzniTp|AZ!-QQ<8PvW zB>GpPe~D$vEwR5P_P50Tme}7C`&(jvOYCon{mo`k_x7_U_Q%Bj_^96rNbIkP{WY<_Cid6F z{+ifdO>c;we@^VriTydTKPUF*`1~oc zzb5wA#Qr+?cWM*+b7Fr^?9Yk)Ik7({_UDJ$SrhxSGe19Imrv}^iTydTKPUF*#QvPv zpA-9YVt-ET&x!pxu|FsF=fwUT&6oVVF|ofV_V>j8p4i_9{XTcH{*bIcB>kkj^bN705d|r{PKP2l9$@;?&Z~fu35>__1-O{hWueo1<-wsCHueg`p1UTMb z{XBTwU45{h`|E@BWPd#zaQ`4V@uc(l2|eHbKlL&FukV(ZLFJqvpBd5Se?H&lzvsF~ z?w#L%=F|0|aevxh7(ibipV#$I>sZ;|u53L&I$GVTJhxU{T-w;IJh!xQ?ScH~6!(id zW|ZTSe$#(i@3yScjs%kmThcKS92S>?qRxu?U*#v=)oGoDidl5`j0G8mE-B3C+vmrp zzpU7kia(>6C8anLOz6&xLM{CX-94$Z8F5*m7B;EtCHZD_KCXOOjFNJC&zT;5LC1iy zj&2pNRo2Seo5iK8tLvBXZjDY%%^VI#E1MhJ8%rB&qsyyn+vUxXDDu{5ac%9KyKl=q zXz%04zx9oOJnGJG>(knTxsBrYe#gS&v}?Z>d?YV?{rJ;aYYLW4?>_feZ@u-pJgKLH z;44bYk~^s5wWBX&reNk{hXMct*agXalM_|H3@|i>vF} zhjhGQk^0=5edl)C?DJcEe|`An-#q%S&VDHP47}sxS(Ws;9_P7OcwZEE8qeS76za;U zX0j372)2Xgb+)Dkxvu}5;$FE9kWie~G3}8d*Ui5l=kwv?#{Fr3VE}zT{C(b^Q+(@) z*6cHC_SPjb`n0aFs9Z*!B12eFU13V$BVwpCi)r`Gxb8EqR0gF#rLI&`%){wea8 zr|F2+*{pL~caEOEq?E^1t9E5k9XQnaxc=;2d#C0Uy^DC8`|`(r+jky|>+gAMfU`Ji z-G5)L+efvauYYjpb#)XAHm|kZ{w}|?akIF-R5tN8`V+c#TrJ?Ha=N89u^L=fez(;^ zHiLAKbKF+Qn&MfHY0)Eg-$jpTDJ^sD2*H8Amh8j@{y+L#zvX(wKZi~@=$<^+JuCQc z_oZV=$Gi``VQayzZdBgwprZ0WAB^g+sc#rUl4>XNU(@w?OYto-9{x*8 z|HpN_^;3VN&%5rePi}nS6D{D%#ReQoA}^5>ME^~5RFQ>fN|ShZyXpY^qA*Y=|!aYCWiQ$mGWKOI**>wjhS zlcHm&u*HGtTdYO>P3Zojo;9L-tY?ku%$|AJrEhU;=(NFcQ9P_CmK4X*p4Q)Ct6N`G zH`cf|&^P?|mDP=7AN#ZK-tCpQRZiDN#Vf^6yKvt*yVj(< zmsi)1Y?ilgY_6Z*T$_D%d_MR|#XsqaYmIPI&GG)unAX(|b=6fh&d=&O!#bYPJt;dE z&H2~w>C0T#HIo)^SfoC8hw~l`E#o*P8yv#_C$Vn1LwGYr-yPE??fP6_vMw~9zppCP z)z>@hmTPxw%n<_t_8EfvuXhIN<02MUoY|SeRtod-bwfE9`W5d*HYwj}2l@N+`;;QDsHE3a!g&0&PiO#rI*;4kZ9rX87mGT%4Y$@QLv=9gj>{Sl?X0Mf zXfQU7)&|6q!e-Plt>c@|=iBEer~H~YSpofp_^$71_k8ywLvMa08inn#)=j(!a9zHCnlZXj zys^D9K3Xa-7jLX>kKP;`wSbMy)m!BwOKYp;_3cZmrP*+!I5xQ%ZjD`C8o&1P{ORjs z+nIw)8>RB4r4{Mn<@L+u+3^cA^Xuofs=2vh<@kxI`Hf4fw@y{guOI!&jnd2GlUH6k zdU4^@l;!LX6LR<-P}I$!mY!TH|B1fT{@dPaeC~; z^<$S8PF_EHYIFSb<>S|{%$&M)Yjg4R^wiwS!qn=;>zB_|DlZmqU0EN0Y31N%xwN`j zUfRBNV{>)Z75~|Zqmpp?XEUunQL7Ne-l}Y@ZakN3%NI^f=Ff-6XAW1#E-s#Z`E+HWI{O0o2t>tse=hsR% zU%9cmKJ_cp2e+0sl%kIH)zY)$Vfk8dbxqWyM$?({PwV}}#qFH*qNBm7AgxB04$e8v zXkBNfE&ZitBX@K>qx(AIF>_H2&(=PsR{*%!cY;N!^Sg?LCSB-H8e-}ov z_Mr*sIj()iMD9J2`kb37EUKeL!_hr$XhU7hW)mywe52~7W!LF$DE_wmH`QrJ@5Zou zSA$!Mb3`ev>AbAk+zu}3tRxW~D)pl7m{hz_TG*IoCQC~9TJW+&_vzreLbf%YA9VS! zXI;|Sitbs{pQUwKpR>B-f&|07{O6QPReJ24;#BnRPDp6Y>nZlcTY9?{4G-&j&tFj) zN_vXT1g-=xDdb|Xpz9_=CiL7n-SgCRSOGkjfAdaufF@5EY;y|IJ3Vl#?u7kV*xMQ?6W?|Dscd|LON zRvlDTFROZo^D5B|rEpB8ozR=O;ND1H?<`b3*bJ+xy1J-3IIDMeT2ER~h{ZhNhW%xw zyCvT_9q09gl4|}HrD$r?RPZZ$p5?}J7UePGx~`X8>CIqsO?h3_y;jCh@irBE*@cuJ z7`prr79Y~Qk?p~mz-z9H`uj{Z7}62aalNV#dEbAkgUP?o=omPzQI2?h_#xg*S2hmuf9S$J`_;AI{qRuz z!;!jXqi$V?Z`LtQW%P(?CbKVJnJQnNS)E&4Ix~J@Vf9#bJolwD7gt|=>E!8?mFvsp z`T1j4u9mKky?Scn328Auqdc9H2#Un(gC?3tRr!*d@Ro$RnfZzmSEb-7o9^kb?%I17 z>WZJ?wM<4?TF}m|&Qhoy-yT|W>dHTYHNw4m;@Kqpfb!Ju`jU0Q@$PLiQTKi{h`bZS zjVT?`AT+Dt!Up292Fe);^EuVll7>uE92Vq1reS1U1JRchc2WKpHF%!X0CQ5cf8B|n zc@0j-l*U!nuc;-kYG^VQ;r%qY#p}%vGx6|!&vZW!&2$TTD<9L5cW);MZo@m!jbS=Z z@glwDAd5c-3$P07FrL2^r4{PR7vfjp~ z25-CW)s3`cCVvGZ8PU<(qBF)FLw*TMsj1 zvAG{Lb>?v`AsN+$t+kn@!_1SWQkW$qT7obICsHo#dUR$>1!lQ0W2hM`ONu{uEzs;5 zmd0V-v*?r;o0cr=+$L>1)zWjtJ>peE!>i;f7_;{$cr#pC0;W8Xjyd z!@5e`c+j_9Uaf;d{4A) zZ_al|Pv5QTy7o8*)HLNi@^4?5v)OzW76`A#SjT?{x=iU~$e+M?{@%`jYHNNEo5^qW z)zfyYmPXZBHrx#NUcLDG@Qmjp8CH^E#hU1Thp|Tw7qLd)=k@K*2gUtqe_;T9`+b=B z?~^Zg<$;f%Q+i+25v}-U#BnEbZH;S2f6-Qrj1%4#X6s!hp3R(XqTGzyHtUUsg^7Xb z+n{3N+fp5KqQ0!OY=ANGKciG_P>HsQSeUJGP3ZcP;x6mcuGng~TladWvec^Y zQ=3cQ^efc2<@ch=Z|m@DVcu`|{O;33bws!+`m;Lxs1w_56BprrkIDTzP;|c;9Ud*# z)6(7J^PnJjUE;lpsIR;WQSUX|G_p9~CzGv8YUh7;B;KjUZ{<{TRvUPCGl@rw;K$pI_kHCnt>aP7 zx0lBi!7~zwQ%>BO=(Dv#6PTtMn~1bkN;|V{LZ+!(m~Bk3?EppnnZPXSz6TAuIc55b zI?O0(%Myq6X?nZq*tWgL&P)Thoq(o+o2G8MxCv^@hlNb*`8Gt@mZ5%UqTor$LQC`c z*Z<&=V%dvhPrK*eeP^imok+7bZT7v~7-*Y9=cRAknvhK!NA45eTfz5#UlRfy&nR9? zd|VAYJER2Uyn*2j{1#@C^+3bUg5brNSYBwj;Ghs=6@ME>vEE(-|3gJ|_4z{+%cE+b z{q-Fe>CuW={}5{1H%*L~^WD)i9=>le{vixTX&H+pq(>F!*`O0YjLDd02rpSch-I7Hq>iFfhxWTneUP2IgP^R$(1BU=!Yk9oU5j zY|0^*h9S(tJgmSP+<{Hlf^B#Q1}2!~Qt%MW!W=BXDy+i>+=Xq}fn9iDBzjI7hHwEE zU+nt3f^FD=J(xmYPQwh$!2+znH(&!c;ceJ~T_~;2xnUT> zEX>0Stid{b6SiO*-ht8%qxTKdFavY20IRSL8?Xs)!w&4i1BavMq+tlNFb^xR26tc+ zwqP6HfzpJda==3{3v;jltFR6ma2K{=2X^6sDarvuxBv^V0&8#wHem~PU=OCINgrlm z9#&utHsCI7!w&TG*J0+dAl82s%hy*gI|u)8-^jw!UC+qI&8oe+=E@H)llcsFavY20BdjuHem~P zU=OCUqzkh!4=b<+8*mr4VFzk6nRCN1gjraCRal1&*n)eo3$+gHTpDIz4i;by?!YE& z!4B-f)Ew!;EX>0SticA{g>Be@vPC*K3`3ZO1z3f3*nlm#2fI)^5S&ZH49vj-tic`F zge};CJ(!v&U6_S=Sb;UzfV;2_J5c*4oEwHA%)$b!!a8ig7TkkfsJ$A_rC|o4i;by?!YE&!4B-fR6a^C4YM#0E3gI|a2K{=2Wk(UbHgx%Sy+HoSceVR zf_tzFwT0WcG|a#pEWjGvflb(g9oU1ZUnO0bg?U(kHQ0c=unjvf_`6Yh!!U$dSb$Yn zhYi?*d$0@j&H1SOFavY20BdjuHem~PU=OCgO1dx$^RNPIumN{r8+M?+2;kf>3}F@) zU=`M31GeBE?82ZxK4AvtU;)Y{5O)g<9lrE)6p<2Me$UcVH8?UN4rVEX>0SticA{g>Be@Zl|4+ z9A1gi4Ph1*U=`M31GeBE>_RQ^IG2VQn1cmagFCPZTd)IrFm;7=VHW0L1=e5#?!q?g zKy9{jZWx9z3k$Fc>#zY^a1VB&-)Wj&i_*`)94x>Z+<{Hlf*sg{scV!UW?>#yU=23l zE^NaN)V|@U{4j)BSb$YnhYi?*d$0?&CC|Au%)lHhz#80vP1u4R*n_DG>B20`!wRgy z2Hb^h*n!$1@7yp9VHOr(71m(`w%{J@LM_F|DcWxMlFbfN?3hS@|TW}9{p?1wXmxdXbg9TWFJFp2`umgKA^(yJY zEX>0SticA{g>Be@`U<9V!!U$dSb$YnhYi?*d$0?G*T^T#z#J^V8r*?R*n%C{gQ?d^ z7iM7|R$vV_;4W;#4h+6V`C$mNa0S-j4s5~}yaR(@Cq0;oym$94*zg$Yc)xD*`h@cK zK^?YfXs~owc98o>^_xDkGhjffZ!TYWse}B9_ z&A*@amb{O5x9u`s@5%eP|9kLHx_*-W5ebO?c9!(>d;1>a?aloAsh^}>CGE;;Al`oZ z`wGsBcREDx*i{Y-_HK^an<1m zbl8tXnv35*XdFuFKWTqS|4ZagB7c+dCmDYe{Ug!868$sLzmxe#eEyKkKOVhLHJN`U z^Uq}do!B1|`%7YfO6+fm{V}dTCH7ZmmVUr4o!Flf`*UJ{PVCQ#{W-BeC-&#W{+!sK z6Z>;we@^Vr@%d9?e@^VrkNTa6#QvVx-xK?LVt-HU?}`0AvA-ww_qhI;*xwWT`@`fy zvi^{)KP2l9$@)XG{*bIcB>krBLLwx?2tUn~{56Sw&;NR&^)?bqK zmt_4VS$|2^Uy}8ghuK*Z`+H)4e^|Rn?C**FJ+Z$h_V>j8p4i_L`+H)4PwelB{XMb2 zC-(Qm{vOR2{k%C@e@NCJlJ$pV{bA7m&ycLYB!`lrrT`k*WcIN zFTigHBkots%T56rqz8^i>d^zgC-ZiClD{4fxZmqr@#jA2e11aDxBpLlO#kb<!w`G-fB$!m#l8%w!u(%Wybyn2>DnIG2PU|dG z%%ZzzEXXKyNnt+UK0iMFWyPLU{29e8DaDasLU(2qYUxkt?n#}^h|3DKut{An$v30( zaplWml$6tZ&gAF?9Rtcbx>dYZSu1aE7MHHBu3yHxH99dhb2uEWY;J6CEN!ffF0Za_ zmp4bE$XlbuwY78ZzAg8ly^kON);Ip~s5`%{PiqV2Hj3Z-9Se`suKil@k-YGm$Dhtx zQ?P7a`Rl*@wnhKkU%mC#>++|b4uY>JElcj8j@OR9keQl!;ppL!`C~`NM-I=;Pmaul z^J60uV{>EUQ`4D=naLNvrigN%3ZD80O4^gpB$JFqxi&>{LgX@&*6pM7uqU#LSITv-! zy55rRnb2oRF|6|pN`FGv#?+mx8!o$4C*9K~T>6%hb^fBRFDbnd#adK)Q#vo{u&!#| za@@5IUqm&h=v~Cx+_!$}zxz*p=drlfKFs;>w{YHX*VMXyORd{SwV?m=>7hOK7YjD8 zwcP$LzqE0)xV}_2@izK1x^^z8xPfU)pPNBC$T@DSOl$Iu==hS(xAY&GSj#CYPAT|F zrEh)m8Qp(Cv}c&}wdm>JR$bQ~);n5ulUzGOaA1fN!TNd{`LXoJ`jW&GE4J)Vv)Z#?{$ zl>U$FcReiq@5D8DWA27)!>$Dprjbf zuAN-d*_P_8sH3d&oBG^T$f~Zc%WsN6+NC=y$sK>L)w$K#X~jC(`Om)`i6L_f>_udQ$U!n0Ple$P@z` z0KK?3@xIkpPusCt8dYc5P%V~~cKmt1UgF`&Fz{nRG7LnP0c*2wH|&`Bws@fqbLQWV z^X<;Zjr-I7!T|dA`!I3cCtn_D_c^6!;(A&A#?<9dB63{kBNCQn`MkI`C3!@pnNh4V zSC3fA|0SmJ{t>gnPf;^Se(E)e+$~7ns$tPZ92?-SJvgJm#T`Q>EXJewiM|cX6?s*7*?H!8x-_SE$ zeLhi9-#-v+X<(R8L$W3q>b&w$&CGW>-<3S$;rkvEo{DA$S(Wd@I=m=&Q|IPxM+iEw z3;m4BznA#)R}?SQ@qX9*-%eD<%VmBwXSITNr};lx1V5gE^83nHTF0ZDZ!eE4f^FVq zEz}NEZbnoOrbU}DJ}j|2t}BtPWLz=Le7Pi=R$bH;(}zvKP7f5pCQi-tS#qhG33AFk zCo)Dxnz0!u%St7B=8Sw6+n!>EQ+vYHeO2(JWT7Q`^AoQ>QY?FM>}mIm4GsO0#FiOO zOzOOswoe)BU`Fv$vdl>_cA~BoC{Yz`=38*B=c3}Y4`L^My$8J z(*gATI2k#_2=(*HWF)akX^QtBx=qTDM2{W`O&C1f`H|UQjr-I7!T|c`Kki6qmiZ}- zIHvZOGy>YFx1_Ph>^L?~ncXI`;M?eA7JRei*ho39dzRfOXkk9zK0i6-_lr8r#$;2S zMa7KLG7FVWO)UK>J&iEKAD@H*40i(zbC|Bacto*^b_+EVb(U-`lVK z7Y`HR)BoU4f6v1GWW@XJp1#S5<|L0b8JRphJ$`qEP-*-7sZ{%``o{; z8%fMA97!l!28_0ML>A;ohD2eJoG^2WDTyZ2qJ3FrGRbHJ9=wrcN)pM`Pcy!l(m5g- zWQ&Y;7MW>GA+>#B(UWXDiP_H0fMcp_sPl3C_3!ks7XHvS_vMfMw(mUl68$}1{fpD$ zXd}sgq}J`DTF}=&IP|&b`~B(Vx(@<66A8<$v1_uo_%eer>rrzNI7x zZ0l7^$1}Re%)*wgIp5Mey*6CeHOtl;7OBs*IB!F5>NKyj8q>1>=x_a&>k&iwq#?o^)=IO$6ZgceqrOf=?v34A5pli2ibJW zMtozau*HGtTP&LnPUwD{3XbR=OFc^8whCDK7RUBrni10`Y^Fz;+0@duiQM4_CTy+^ z^z9?vKfA8xqgo+b#MJ>XvJFYvhQ8S6N;9 zhPWP_*XNq1$Iq$(%#F(Q@xouiEKS47^W59Y&|x$u<1dRzTIz~ z+=kmo7)-gdD2`28>={MgLIi7y@3b%4oxj(8vb@DqmV!(T48w`sMQM_=TDI^>bU*++4A8{KVA!#--I;rz+>ykACGw z>E-dsD=!_rxNvH6dE)xqM(oy0*UEZiY4+Us#w+>I1^)A>9G^nk6m6kdHv|A&GFNhk6*tsbL!Tu&BfExQ*$c|Q>z!RUp`Z*yjZ+-Wqtgm zm4ln*(&}b;Y5UTR&DB{~{AVYQO2X-%ZQ1XWg9=gXt;)vwR{7HQtCjMs73|>Fc5%Br zd-0XE$*XJO^!n*s_3-M2`Gp&=9y>L$eBsn&{(N|R=5TfF;^NttPgfSI6U!&gZ!TZm zT0XaYeyw!#l^d(;Q@=8OaBFEpDe72XEj>FPmai38*F^1(*S`4jPwV}}#qFH*qNBm7 zAlgcM&S^%rG19c9zm&o4j*e$^Uq^ggk=v5EHrIwdXkm8R#sAHJGWvqe4ZZ~nwq_$| z8vy#bgTD)-tC2YJ=f-%K%jh|-ea1AQdm{BYiO`4dwX&_nwk>@{oo`g#wCp7!%X+h!ZSuLUnlbe|5c zD`Z>3Ce)-tj}59aY2G%UjB1RrK(MsbBa^ZyE`GFHLrW^iMRB2 zD;gfw^`5_?GL-Zbn+aSAUQ)=#U_sYSgiPqUbGqlzPrc;!lvzDk&Sv#wOKVDZtt%wj zfIO>ot|;uLN^wG4b#F;fPU^{XI?k#jXO+_vD(9F!uLs9engzAX>#iMcD!tPRIWGSd zmF|@8zNLCvRH%JRWlm3C5LcD+>xy?qWvc`)s@%5}e_eOKq!nU6AHM#JW#H&jP)qO@(}wUyVtL3K&#y(+)G6aU5zx_L%q@0(R#U(uVJ z)O%jj8=uyFr&R}4)yt~h;k-(8Ln$0nX>Fg-1@}hsdS{{P!Dd)h)zwAS!CAe#(|Xc^ zLM-M9H|#Gf-7Wdf={T<^lvMMtC`H>KJr(?lo@cqSoJDzzxUTCZS9<&A&o$Mct@m0P zL&dZ0yvr`6{6IhQDnPt{`EP4IxQ+ZZ*Dd{hKWeIj$v;~&7&xxE(mg0|{19(*Z<`C) zx20?|uI)FwH+MI!-E@1iE!y5PJBt>1Z0NVIhL}QNN=UrEefl;Nv9EJjoM7p;zwn1H+_PU@ z``r%@)wMy(j3zef)^+%19n(}skCH65Kr#7CD7W25@`gzKxdpfMU_TGiM;%9iRAthvKK|8lPOQCjr zduYk2EB^@A2>0rVXOnRICQ`raOV$O)ySL3m-TS#aVD0Z)Kc;jB6u#57)sKN832AGo?0Io~?mo+raE7lbaFeQbIX^=Xl zwBKKYTfE-EQK4 zS?d~pnD$?C_4AMTuf6ej7vcW*LHt^n_gj^-QPD)WDf<5*eQWAiOw|9VZd6RZHT8r2y@X_=;yc@@ zI3s~*TMw6==(Dv#6PTtMn+Ud5N;|V{LZ+!lT6we`zI4Hze#ovZethZlJ`$I)^^*O*mHE1oZ|Ldv`{%%44)wlaH z>!=!N|F_iQ_eLvb=hW=|?@8Eq*Wwz8R~O>p`!*PTh@ZttOS6|snitL8PCEp5pnLHO zN?8MtI|Q>Z2Me$Y>#zZv@HXtgE#zZLVH+nt3f^B#Q2KM_!aw(XG8JL3wScP@i zfK7NCc3>ACF!POE8ip_n^RNPIa0fPF3%21M7?@y^OTj}h3v;jltFR6ma2K{=2X^6s zk?1*T7{UcufE8GSJFp2`a1VB&eyPm46g&j8Fb7v)4c1`;?!q?gz#dFRKlm7=VF(vs z0aoA}umPK}1@~YVdW~lo%_oFen1d^@2J7%m*n(}?fjyW)Urxge%)tVzz&Bt6HsNj9 zfn6xA&beV2!Ys_g3ar68d=s`{8{UD^D5Lic(=Y>bumG#D4jZruZ^I7k!UKn+=cHi> zvoH@Uum*Qv6SiO*-htADqjJDQFbi|A0IRSL8*mr4VFz~M0lxB+h9O*l1z3SKxC5K8 z1v{_@Q`6KF%)&gZz#448UD$>lsF{az!!U$dSb$YnhYi?*d$0>N7jZ5PGcX4Wum*Qv z6SiOn_F(FH(uG-=hZR_Z4Y&*2umgj?9i=x6LzsmHScP@ifGxNOyD<1W#yU=23lE^NaN)Mhg0hG7V^umG#D4jZrq_h1)l3!QUm zn1MN1fHk-So3I5tum@9fqzkh!4=b<+8*mr4VFzj-fpfz!gjraCRal1&*n)eo3$+8m zxirkc94x>Z+<{Hlf*sg{sd>_cS(t|vSc46?3)`>*wSU67VHmY{5O) zh1%xmTpDIz4i;by?!YE&!4B-f)Jf8XS(t|vSc46?3)`>*wKvAOVHmgw%W?&8$U=8lTCTzhD?7`F-(uG-=hZR_Z4Y&*2umiP|$hlz{!YnMnDy+i> zY{5O)h1$jBTpDIz4i;by?!YE&!4B-f)LGJnS(t|vSc46?3)`>*wE@?;VHmZSE_6mlrJTMHrJsR0Sb#OS1Dmh~JFo{+`6#_K%)&gZz#448UD$>ls6BMf z4Z{#-VF6ZQ9X4PK?!hk97H;R#FavY20BdjuHem~PU=OB#m2_bi=3xcaU<2;LHtfLQ z??&kj!w_a+0ajrhHed_x!7kJ{=cDq&49vj-tic`Fge};CJ(&6`>B20`!wRgy2Hb^h z*n#>YfOEqzgjraCRal1&*n)eo3xfjrgc+EF1z3YSunAkR1A8!444g~DEX>0SticA{ zg>Be@S_g7&7=|zl3$P07umM|e4|btemZE&Z49vj-tic`Fge};CJ(wzyF3iF_tiT#< zz+Kpe9jKKx=Z0Yjv#T5a9rC|o8JL3wSc5yT30trOdoWcY zU6_S=Sb;UzfV;2_J5W31og0QB%)$b!!a8ig7TkkfsJ+EAEY|f=&2IgP^*5D3o!WQhn z9!%XNU6_S=Sb;UzfV;2_J5XP`b8Z-hFbfN?3hS@|TW}9{p}wWzTpDIz4i;by?!YE& z!4B-f)T^WmvoH@Uum&4&7q(#s>MNMe4Z{#-VF6ZQ9X4PK?!hh$UL&6{19PwdYj6iP zVGDL(52juxU6_S=Sb;UzfV;2_J23bf<%c26!WCG9JFp2`@D2=qo%CQT^4{IvXv1Tu z0|KB&VsElrE@{2x%5xp=twpVIN8wzD^0j(1zW&?-mnNvAs&CA;r*lXBeu zQzyy$h#HV@7ax^(NJrAH?ynbXC;O3ONk4yg{|UmA?vKg)NZyC_SAj`!PMlXjJ~E31Kc`|0mzcD>)fpMICL zE3374UT^Po{21mL_M6!Dvu{^}#b6_-KJY%hy>ifd`MA>gfDZc|XLI{)56SbRcbwFJ z(*BbEm&l(){wCv3GX5s|M_hkO^sh(ni%Rs*ME_3aAIbbHnSUnp@5KI)*k9uMQ@{Pu z+K2Zi_NT=DWNjg_za{p!#Qv7p-xB*;~ zo{-p|6Z>;we;)k1h>86@vA-ww_r(65*xwWTdt!f2?C){?IkCT6uXwOsB>krBLL$dymtUn~{56SvNvi^{)Kg8!x$@)XG{*bIcBrW4}vnT5h4<9#^^@n8rAz6P&)*q7fhab-R!)GOy&9<|pUw>b7zW~1- zjJRKMFFS!f$PP3fiSq}3=l$*MME-g>;Qm45P`c407z1y-%I}%JPY)QvRa9CUliaIOmf0dtfSEqFrDrV8$GZthN zx}-3lZ=WBZ{<30ED*lXOmXzX1Frhm$3bphnboZprX2fNMTG*tnm*kt#`MC0BF-pqm zJ!kW%3pxgrb#$wEt+H0$-YhO%U0uJ7cWZQFYUXe_TG`y#-dNgL8(m&q+b(a8M3J{f zi)(A=+LTd&KXdO8TcqO>fzgF0S2`a))E=7pn&N9K*YA8jeApnrZ&h~P z{+pf^^}lQCeew8dpU?pIr(;pPKc{o+4WSzjmem@q{gvqh)*hoFBI8W>IlU!Jq5>b#y$V`}f4h?K&;pZ>}97 zI55PCV8dLRp)*aFc?K2;uf|x%e+T;1`jT})@mFh2+trhrHoNnw|?qx-1GT(>ysN_`1pG9=IZ6*_Ugv^@zU`R zyymi6Py`cMc_QA1cc2@Ebe^JMUSwqP`+>25zY6Oxp1&2P73%nC@MFP|;MpJ@yr8$g z>W0O%)89Acvlg)$+)@pc6l2-7lWRKLQk@lbly!bnpPLF<)zx+RO$Sc9bZ4cs#Gh+* zZgqBAvC}$U(LHv5Jf7F=2h9vD4Ri7P%&+F@@>bPn{JKwf(8|-GbO(jM+voj)^7<(q zXIw9{nna1H)UjeVEQK9 zP54gfDW(>gkhkaAe8gr3MG0hkrk&YUn?Z~#tgIZFqGAJw%`;TDzNk(_TYDWOORcKD zHTB$gyz+8eelLc8b@sQN8294Z`|Tby|8Mna{{Q-y|A+tf32OfT@Zp-j4}O?#^n=#? z|MkIt{cEQA{~LJ6YQ~(k?mpM!+zYtAOZT1n2JPS8d#fAW_vrgPJ|8|X?oay*1L*Vb z@ALkg;`@$dTKt$AvNiT-id=GY0GooFR&Nd6bQ|kt7I#_alj4M~StHM=3k*u%rrV~~ zo5r%}I*oM{pT0fSW*auISaRuGCtGy!O-r&4W*vKRU%Jk*Yq$Pu-+8P$ynf`vedqCh zizChdKUVAZQ7s6~--6Biu-5&9*8Jz@|6kX-zXTJ_|Gm-tZP+mF-poWc$BkyXp%d|T z%?we|U^1>&J)#(8g_ufbv*sCn+WfdUus7J?V8$ymOhtp0sY0gT+puB-m(2m9_CM~P zWCNTHDkVL|%u!Q13-7jUYoCKO|EZsS{h__Vhx^{({g&3(KREQdh8%19CO027TK$Bs zAD6ae`kLu)tHEUz&Gd`-93TkHOw`ixjPBVLEnRb7Xn1z&5)#jGf1#Hr6W}v7u*ibZ~FzXg}C7LALfMXiiwEWhEY??ix5Syxx ztAqG_`~2jT-)NAt&TIqKl(?)E%qF~~XIc7Y?KK_IrquQX8v<>LZQa?lz8R%GuB+45 zE_~Aa(&mo;$rt_`KOo&!Uc5H<7w7A)Yx*we{Z_q0PYwMwUC?^=FX|YiFs^M}UR^)3 zS>C>}xqg0gZT8vm`QRrN|D-a%sNz{ytOW51`ALOeR(D+wKC9;p>v%@@r0iTY=d01v zm$|NM59^k9++9J?gQ2xSoRSUvHojIw~vo3JL@~uSv#IF1}28! zHYSdG;_lC^JsQ=Es#Nj^F{9VkyGn1Z7bn(8RVArfrK(a@Nh--UO#bWq5z<*gGC*Qa zNNhTO*=;)zCZEL6fH9pwb|);0XL+4XOlV^^3=l)J_+@|Jd(LT9Usb7J^wQmO-R{!4 z=iGbGz4zR6&hz$roIKy2oLexz!@is>M>edP8ZpVM>294eb(V zLk+#E+kZdTF8=bn7S`WzFT?lY)1Te%aEJR_R3BwXG3bnD*_mYw1%(Pmy`jk-d?rIb zsj`HwM(bSL>;pF$&{=St2x1I!rVOKBLz@h3jp<)RbvCI+^mj}IOS%H#jlqBWEz#~oe! z?4Ouwi4D&bQ=!emxk4(LE~FBr`He!l-FyAB;SSAk`j2_BLP?+!on6f5vc=SVX*-{4 z=f%zyOADn``)2FNSbr=RogFAoM(2VTIy`kS3UH6*O`<-&H(J{2WV$+*8rHtLzZT@rr@?X3kvG^Bl z`aH@kZDn8jqRqc3Po-7}I^c{^^@?cc;{6G=)}@BclsN_lYhT6WWS~W3z@f zl$nx@%9_Pj2KCpS0Vy+@!)G->(ITeQnx%$$?Ikru2fW%4OAFdB>e^ME7m|5kOjGwr z!@5dJ8q()fn)B{8ue}x3pV2?+TGrookB6OB>8Pd;xY-#!PqJaWp-0a%rt7y<=ccZV z>K>DtHWE5Etr`a#`c%iLw_g(BC~H5{(4~J{cf9Moo)V(7;yqcr^yz4lqI%Y>N{q(1 zT{VuWd`IsQ)l?OgPCcO>74gm))iYhxk0+bd9hn@vr1c9)3p=2*;9;2DTGSF@z0vP0j4z7*E8j(YWssP=W$v8s3PQN0=M$MrU?Iy$58IjyUU8rx$k z+fhq(>-+(=ZI|wFQGJT1;mOQ1nl!6(liu4Swyo)oY1PX+26P_!*CnqcwPzgFVkI21 zWUt=;1KtpI*FmgACUhUO-A=q7KGuQx@9p~4q-*v){H#@6Qs%lz0CY%H&xr8(wyBf)VpjTd>5R=^ zwW+JCqFS%WKV=|&df!Bo{Jkh^U^EP?&@NKcC*o4ppbv@QKmwy8FKarU5wVDgaLj3< zSQ0b9G|;cfz9bSdD1tGn;~AA>{vHz{Nh|Hsgwd_D9xj6BZ#PF;T>8yMVhp1Ni{}(X z$dy< z`VAVTNhvlM8QYk~7g%EL0pDoyx{S@qBW2lUsl5m;O%GDbtl# zn=*gziBqqsU6?X8b2cP3MBO9%u%peMT$d{}7fTz-Z40AZO_!R|*-go|xx#jHF59%S zkWDtF%K3D`!$CY-OiT1T8|ge73U$o|1A#!WDHIF`qHQX8+7$)^RSH9)YK7I#3|2j} z>W!jR>I{Ud6}D9=3`VLIR=vF9MrR}4l8ObvO%A2k(xvuNVIzeR^Ui3UK}}Mn1|zSc z-AB$s{@QN%;I~S0)bEVy$t%5I(lEpPuWiMqkQukJdkLGHwqK6D?vaLHvFS}){sa!K z+FbgS&A(t%bM(&A>nj>BUfns+k&)g3fA6==5ZXkYo^K9Jo*e$HaUa z);@Pe+6Xl~z2{8MhY!BOpS6qIau9%QH*DGfQP6hUrcc>4X4AM$S8RI8rZ3v`s!gxk z^oC7u+Vlx)?tjXrF`M?;^m&_>ZF)lknpgBzqXv0?b z+$VDDiUE5E)AG1b6!)CH+j`?_E%ZADJsn>Q8e8z4k8aI9&ydbY=y|}Ap7&bXV3H|Y zRUQQH?QOvP?XKpTxD(VG{3`P-dO@!BU$xtEd>^#8pdR}4m)2g;6>R?Tb5h0?NMxqc zalNV0ob$HF_r4GM{j_A zsS_hqt!MncWaqE{%c>22-KN)V`D?!Prp?C%x~SYvRc5sBC+9Ed1n--Q{2!kB0MAQ? z{qd*|nBri9&}#yCtF1n80{orNbOQXH&cs|+?d~UC+$~m`(d^>IZ#XvgHo+anf){%L7SaU zZl(VAa>xDUMbe{<`MylKwbX!IjVN6 zRd22GgMOz6ExtVH``2pMTIC0A?^^ZNDnG3I?Jqv5gV)$xzjufI`9^o3M(W<{e#Ie- z3dTB#|5ZXX8ezx5@d4UUh8GLoEP!87(qIQgB*KQt)k}NEZ(Ps&F8xr)z)cI>ZXUDItd7hi>U)Rr(_@Dpu z&wJvB6Ej?%^Q;5tW$U#ASA5~sANbTEI)MH|Rn48;W<$TYV$5<6I`qrm{^)xaLAw4O zo8EBGs$NpL-L#pwue|ac_T8X!gXyF?fMPQQ!~hTh&;r^AgJ46?0oVW$0q0OKa}0I} zK7Kdg?9i5=Cu!T$UT&~smjpn8O%$=lXjF`|C-s}K7YuQ<&p6zni2-)O^Z=ZKXS+L> zxBRbt=HpIA=Nnq{OoJi|5PyO%jdMgeixF9F>*91L+Fp;O!mvsQ8>(hhK&{S%yD!eY5?*&tM+zz1s$_|r{+thm*y~~Up7B0=( z{B_@O@n!dXPB=TSZE9$KFw!IO9C^5x6XF00vJUcquRjCNcvdqA79sHm`+F_~2J&0+{*mR#Onz%-CXt?L9mq@;O0E6r!*T!( zt@g%-R=4vzh15!PWPN3>v{@W0ma~!G;f~ddnP_->VL7wjw$Png>RKt6#@ogcskyGM z3+2(#;K-01Q6Fsw(BJ*uFM5K*Yc}=U0?JnB?`#3z><*xPa`D5%936I>^xi2!sdnVU zF(a+|r~ohh-efVR>0wHf2XLfG0l8q=*K}T!wB!lToe)>TlFr5%b5_tz=Sxz}?ey*( zKzWL&>P`#f)F$q7N8Tkt-ET&dRllaT4Nd36dZuaZ;r`mAAL2+>Q(V8M%ebz}Yp+Mp zwScb8>)GPUkI3mYqFTuFo`9uhG#w5|CqL=6L#xh8Tlne2;{Y1c`}Jzd9#V>{=#HK> zr8bCq?!GI6NSD+~MS0y61y;=J9edS29Xk7>-i&xX+iI0%?XRn47Gxzs1<|D%fHsb+ zY)oyDQa!lwUQp?%{smS0km|)Dw&;CTAaCvB_etvxppDS4eKyBFpV2u7aR5c&My<4< zR!0gjDk`8dMo>qRKu&;ZfZvDNAc_(x0=p5qYX<;?NdR7tQpyCKK@o*iK>awFawqPG z6DmqG{BcZdR+tCk!2;Q-++ZQ4 z^s;`AU90W@I=nDExTuIdbHn98X?gbi(0E^KbZ&I1yxp}j9qjK;Was;)hZ8%BU11$S z5Blc!qO3V?2hjiX>F-FOx&JkrI;qb&e!BEQI)DyqKo1KSz33UJGa?GZA_xHyie-`a z^CAi3GO80VbWTKKNyoN5QZlV+pkJf~y!X7$nAUX(kt!3r;C2Vl2TjnN)aa&Ye~Quz z2|S=58~NSs;nVRRl*AA{05BHDNrG6KN#58)3<;nN5@h66oIOokF^Ce9BucH?!2ls4 zCdd)yR_aPB#S#LEVGnr~yeLLb!hjocLpdY~JvH`|qi_K2NR4%O#DmlM!Biob}4?b*$>o?yJG9J(+QN%Q@G<3IjL)hW}JSDP~1zwJ~^tDG=p0wn(*`c+Pu z6`|BdrygNaZz=$|K>*3c{85iB#4W=5YkEq>J9!A+tjt8Mg#nEeMO! zsL3WJe$zN86jjG3rT@R8AN9SY6ul&y8`3UyL;A9gVH~@}Nfle!D%>vF^qNgM1x>`u z79siS-+U&)l>L9(^eLe^*+6wxrZYBw)u!g?ofUbnpR#>I?|XR2%3a4yTz4v4w8@hl zc3YHiLcd z{fceHrZ3p^vQ4kp^qNgyvnl%D4~ zAM|}css1;vK3jKqp?h(X+`Y2yC`pJxv-#(@qnZa?y@+a%uz>NfZpY+5^hmml3u37uGQ!7?{gcEvP?fK0pKAzjin!vZoRB|+%+4h3` zs6Ec;_b`c-S1ddHvQ1yNsUFi4D{ok_^1oPd^1mLDSoz($uh&=VVx>3XopiDCoS6Nr zC)&G+O*k|qrJ>Er?6)nmor|19Pux|PxVhP-esWM3Lrr_t#Zc1@uAiXgg3YS68eClr z#kHs|hN96YQctazJi9_uT?{pG?o6DX-FB&qq0BsYJMTO!4xjsrp}bM`&Cy?X)Sqv3 z2Wq6Qo$gnx#IX^3UaN#eaH}9v;hpf7!Yc&82bMrUCzRnQV!WaNsj!NDi^lr?%VQ&Y zf>_1oNKgc5tgOpLx64IzkG}}M&-09A z|GIw8!SboZOP&~dOWd@1&a)1dKO}1<|9PjY;XHSZD|ds(j=3nrY^B$Gk@%HYAPlM}!|F{|l4J|(WpeP|<#=+7= z4S=jcQqkUmt3<0xU#5?ulVxR1JiPD;OXy#%`l$oh4L#pEYf@rxp}1T!+Nj4Y5l!R* zGtP*{4r&un&cdyp%{Q$z8j@cet2!E7xf=~GPhHl*lCDn=LL#ixTvm9`Jk$=B|Jn|d zpR}p>GJ2O8J1kt9xB2V7;o{5g`J8ZyUfa~r)YTm*zGqy)I}QJ`K3R-H3TcUxxU|dpI7dNpv!ZOb+BXz zGP2*JU#%hds5w~vv~O5~HfOu)OWkm6qyZ|nI}OXagQaOKHw;|UxxDMUvCS{;uF$)|pe2MXAz^U-6&~An} zG#j3ifB0eG@QF_ZY8*skyl>dA-0o*Aa{ZgXw*M61hQ3R=#yVIs1stb?Gtz5W&c``e9elav%*eK2}j|~hKBU6K0nZ>^I>2fKS znG4Poit=!Hq*vJd(SKLkK`j0;o7NpH_j7e@m-}5=Zin6SnE*&@R?bAn8y2UxF1uV- zptWrsP3s)iPh_>mg#0GDt&?-ElT9U=|{v$&|Ma5P(d2pueO8r{(|59=EYXbLaOmjzC7Kwd5zdcO_t-C5*p zRByAT_YLceWtC=i#(BLH?x?IyQdHY6>q`yDho-3Zn^L+Z8|FP4lq1BqA`9gka!eKMkkH?CBzl*&YhaEbt=6eI>#{WQ*-Tw!$H zl`R1a0n6*y`J)V$P^abhPRsdLzwza-Rh8I&<-LFDmAkZ(T|4#0Q(qN34Z8+ceOW*E ziG2dFU12jcS4ynSFf49=gr{Kr>r#i!aYib=tRA5a*xWI$`v+4n)*wcFxE8v=S4sQB060jNT**zKjZm6 zp*bY#L9d9(oQP~pBn3yyO^-lL>hF0GC5&Q=A|Oc}^*dNTSc2yNuI~G~6r~rRCSX4z z`McR%z3yCpzR?}1k-Gbz(eZ@KVx#w2Q1v^2V1$b+$YKvJ+j5Q)o} zKe^65zk9B@o(qy;&Vgwn=%n%Q$9Kvou~1_{k{}Z3bWu08s(uq%61{LxC8)BF!eO$z zWjN8h6iH`?vTLoGe0Fwed$Mh!(Aqb&F}=Q4$fu^JM>@J!dieyCA8-BzXGOWLJY$v3 zl~OH65ozbHpQwVSec1Piyh?5iT zXq*yv+p$?)*f|%r${mq&D!)LJ^3|{OUSrR&a>L92e#eb&^c1~%#3wA-ab(ET&Z_)* zTkf3dF4_D`Hoa=oYc_q=rngYWc6>cyQ@8wrr}|O-Zuy1h?QysK!ew`zX}(*E=@sPz z`aSH+9UQll9ps9!eXmYu{{C01UveJoAHDp3Rv+ZqsCz;(Dhmw|tcUsOxb9!;y=s*o z^nGj9TdVw0yWf-gmRf{ZOdoor4Y7@lBJjA!k0{Tw6=tJfGN%VB@^*LM#Pthzl0V<* z4%A3pJKrzr42K~Y78o2NM8MhrB{4QNtZFbmM9YTtF+uu?AOUs^X&hM@is7EyJx^TE z3p)j)1oQ)iJmvuyCS&(A5`K$X5G6j!d{q1(3H=t z4-52xj?P%Lt+S)0skf&i)YQ_|8)<3_^ah*4!LDE^+8PVDMLIvE6SWEB@=sK?w{QPg z1eYtWhH)9vWAy2FMwdLNlnIK>eK420*1fD_@G6%$sbafQvCr<+iah7L|Pdc&PZlT>Us?Y?8QDh}PY>wmtJir@;W%Og90S|NZpLyf3k3=foD_!}~KP)IRQ zfPP}~2HVAT#;b7e^2~9yCIgYh1W}m5N`qV>>^Ct84Q2&PoEeDRi87-KV}KLf)F|5+ z@RfWlJ-k|gkF0%+OiYcmgr{hL&<)Yu~_3pe) zPupG{@bzxA6>Kl~%1!C+-{bAwj}C&1-p=$-uOuo6BnXSLvHhYJHoX;uA$yDlG%`r- z9D|6Z)NlRm>qZ0p8Iue6FoRfRG#HDriNnnZ1gQli1;sOJY3#}TAfGhhKB*M@We z2>}d@^3Fs%V+dl+fyi+^^@Hd#M2KOA+KwTOg~-4^k`3w?kJ&Ebv03|#56*l3`~LP- zN06>7Z-wrL^>_a#Z)mz9=<-}+5nK#G=-f#{aBcX8<%@QlUG=4II5yG%72BPLWgWp~ z8p};ruIXIf^)wlZlJ1Bl%D{ z)gNvvEe|hUSe@zbJ}d-RqJKTzaxuKTyprzfxma3S7$}!=>xHGkz{bMNPC48$(;x0k z#uh@6^w!eiPUmP}bZ9ga>`V=2f^B_+n~ykx>n-p3ZBKCcR+~Q0xYy=FMx+NKOhh?@sj1c)4iib62&&VVU&S+HARYFhFt-oPU+uNz9WzorX&rrOrcj?v@ zQ+lFdA&$~|uJd}X6+P*yNW)PDJ*Rg@ zj8A(hAtvW_2NvCJ_XvsMgU{;f4lgibul-xrv*sI~(S52d8$}4kUR$?|V^P$7=2bs| z@A)PUb9cMJJE5mq*WFw6{9!%qvYsNX_UKW*q$gic+oMU(>8yhCgPP_yR63*YTlSuk z_u{)kC@{@Nbp4jjT+|tzYTrH)fgz7&I7|FC&K_MS$0W zMFAiVgMsA0=wKxt?r-p04=zN0otED_Er%|CacZfm#P)@cCcJW&Rib&iJ_kH*lJ*Vp=)xjrE|SwdVZ(1duDNAB+?YR(3%|D=vz!!1lK{i zn0rBR9e0TQ@1FTdd8tY5sNDyCzmh&U6J-LCoPptw#O`-ZNT$rrGSL^`&(S?hQv--Y#1&;Bfwc4(8M6h&=ycX zfPBC#m;?-i=gjfg0|}2UGVHpVXX86+#Md8Op7?Y%8{yyh!>b-!GOykefh*Aqz2tjj5hzbm%QUA3eNUpL=_3`15Y?aGtxymAk>?@|+{Y z*N<7bgDjgxd{Ioc+MSLY@%5E=T=#nSpV{=Z?bUU}7hh<1Yuw$fy65KdT4aO%2$+P` zp^)?Gk4WXlDvgSnGDr~CYP047k~#VtNC~(`fFrf)Cprkw6r^=yfkuf;e`mDeg6tyL z5loZ%&6*9AqfQ3k!u76a^OChj!(Y8QQgt-AayJ@Wp1LgJi>^-(gX68Gyu24B;^*{? z*YrE1`d(H_y=<E3BHRVh~0&u$FRh<#lH#gOL#~;eOGzQ!`g05<>SYxBD53T>nFF{Jnjr z05|kq$~6}8#T0Oyh_7OJYdf;qJD%w(O%3#9=Z1%dg@L+oVSHwzJaRFZ438H3)-Lph zx@P+C9J8xur*mK~R=C(TzSz?@(=nbI%jCnOBYm-!i?i!}#n$ti=gX6sT=#6p_W4vG zI2zm9isuTsj_IXxY;sOf!3wElx{ykg<~IuI11zLI+twM+?JTcuwDt~fwXI~+-LYae z*gctUDUVGo<|kIpPj!z?j4fr>XNt+*p>ix6@92%Jtd3+$iv4a;B)5(-q% z1^pYBQFlWc%n{*?2=NdWLZ~Q%?wXGEYC`Gq@KT3?`0DX+NW`Ox3BhzxHIM5ldUUTD z8JT&~G5tWAjp}LobQV~sS(%{w^hB*fdu{4hmT5X86jZm4bm%>aO$J9as`Iz>FRo+w zm}0gj3KlWH=2SDNwTBDwHLJeY;hCg;urru->7~L$wiAEv7fm>g~Gq7GT55 zdXovYT3&xw^zKtSLdlrkHKUfA(fLW$GUUB^R<(C17ty(^YSXNG!lKSA>8fNM@ufcg z;9_>+?Ta7`KaV&KfE#6%(;p+qQwG=09_THUOoso56);?XEr|ia+jtuj2Mlw(@h~xh zI+6%wc!nUmAgCLSG)xLOG&IaSU*!f10n6(o>Z3$&*J=5^({jGm@Bh0$smiYXYUdw% z?YOCSBP$D;g!O&b{}+8ol$r4JJE)hbdsC{lp)7vX@qG~|JE zZ)=(;Xvl9UKP-~jA!50vqh*nQz{7ni&x@QABy&{cIH2-%k*zV2T}Y}4Y=aTBT?F~T z5;Xr*=rkQJebl7WGwMSJL42Veit5W4mq3UJwhxpyJx(=X>xF)yyBWHEQR~>gp7LLnASN1W()ZoC~TikudVbq zGC51jg~X&$7s`L)%~KalnhB$dMu4MuYY|ZlWEpHd>=>XE^$GXsJsaOqBfkERzxCg$ zvQO7q+r4sUBXoIYF&pFSpNf5=3nMV)LvR1{LqvT2GgYlxZ*3Ow<%+9eVvZZ}mHhEv z`zWgIlud8Ahowm>wwrdpj`%Xh_J|}Dq!<&x9-9~gg#}-Y+<_S$xdT<1QJrCkHx81R z+wngEndP4t<7#J&`QTYVg%OtlP$g=zHkD#xXP9B+N7ljmhpdA%L#+%@kYdJ3^X@P% z|LwoO@4q|QgU{@6F|OPV9+&4FA-+CrTZ zj`-pW?QV^`yH)qxTwbfU((~w@5FOL=L1q~eu^S8s5`i@tTeOK%0(=B{97QuEr&j&+ zW=0GuVKW98P1vs)4S-S@V>|_<&cyg4-WTK&{R6~|JGh?BOETYA>!VFg@2@%B$+@kQ6Chn?2X>8Jhfs`sKqJZ{9-({`9N+0=U(y^BM7xwMY>Qln^d-PPpw<{RCC z8mSvr_X`1m<1;WzRz!qIFg%P^g@I_?9U(#Re&Dr0WMRu;kU}^hV6}-5&=FQ;!6HQT z2M8LRpHZ$6ZI)pNA;Vh3-3{SEsRtk$dk$n#W5T_vH|+KsA2ih)zwnh?L-4xt4)OKY z#EMt$hM>!HjYWJh1R2>U3Go&14NJ^lY<0w!X@^Hmr+&Y~9o`NgCsfp|SOLFhR<>X& zFl#454ULxp0hghcoXfOeAfC0CSi<BaSx)nxDHO7GZVA-?kQo#mO$#fh<&mWze)XxGsBZ_uCiVkdz)n5g+mw@>Zn7e z+##8K+k_kn%Cx&JL=4fmSdMAGyUxoh5vXJRrkym!2k|yT)Zo9@0L6Av$&4u=d7PA0b1CYt^PF7*Xw;-usN`ie>M3OtlpB zJ_(%@(p?Aiyghp3Y1Omtp`1WJZECMqChCU`@s-zmgY_cj*`kNqB82!wz0tVZpi3=s zUadJT<2%#&lD^BZt{BzcqRMDt*1>4?zAf0U1+~PMzA`Pks`6FUvZ)-wU5E=7QTvp1 zT|jjtbeDRJuLp_v;=7<5hQ#yDjJX^~K}bA`CL>6L?J}w+L~bKV0O>ZmFJ*A%1Cs&H?rEc)H*(tE`=^O zP3OlFQ{B_WKuc*RXAxfq z1FgmG;zZzLdbNA8Wj(vxzcLa(pI(^nmy|Tfeb;{}P<6_5<<+K4i}+&7tRuc?#M+3j zZ~OhvdDG*!+q91OGVSFbR&KiTm)8+rroHNjFVhaLpVSdw2SX^icJz<8TIHN~5JXh1 zdTW(GYWI6m?Q@b5Uxu}TeF74KjgOcO$kebql$eD*Skel13gZChnw1|7Dr-M>3TQq+ zdjR*y`qa-q!>*ZtDM;+juy2eD26PX$%oq)#du)71jrjVvZ+`6cY7*yT&kuTRm9r7L zJhPZZe0@ah6DBmczU0UUzjla-ua{J{YQ42t#Fs0shBr8F#Mf{C=;uF!YWsI=dc!@e zwJN&oO}kS^eC;B>j9LsS25G}6xiEZ#VZqnLU{J7$p;$v2Au)ju->1o@m>xeJD(C*f_yIXay7JCra*+}6K z7K8Bu4nlv&)fe9@`Yo6%Bjtn6q6b5!up0vrfnR-V?7n8eF*>4K7bz7V$;br-z-^ z&nXWcCB)ZH*kN+TrryiwT^!QOrFF!Y8bzDyt|qrP-{=n1NZqiye+Y~M)`$vBS1^Y2H+6m<&R1Zp3c38d!F542gs7aN2nj1G$Ac;hK3wrt6`{9 z$~}RJFzn$-;WELL!Le#gxT?Kjx8L}nsU}DMpIbxly7CV3_4j^#)+={I(B-+tBEA@c zjO_R5S8E7*+Ph~9snSLvJ5|WEpAGdke5cMI@?I4qb3xkXMwv6&L${n!Zb-RhX{56a z-=pU_t=}14^91`!*<3Ta)V=d%9b@LX#7Py~4ZH7nt4gZGE3>W!+b4X(67v_^RbP7D z<{N2%ip>_^D)B#GeN{)(G_GA-L%F>Bj^q)(AJnRjKo}6R;5e7GXJT0zpJu?F=)%o# zhyF1{p^(s8s3ij#eRyqvC&Lvk(rD`8D)Go>YN0M1ji?pMj(EtOD8USjc^Hlr9{6w& zUtiAdKLxm*MSL*@Fnky$ZVK3|!p|*ilvYB`$<)%qMyAxf8EmE?S4i)qo=s%Z zscdOJooo-}7J`vNpcq_Dgx1D-N7jR-m=Ctq-hE*qxi+^wvavl`Sec%f?4DT5cCPny zZ-<9E)?(ue^M&b=^<+BKmA#7?UxUH)Y$Op5tPFO~EG$jrH-clO_(Dfysb#3Vv6bx} z%(o6-oN6n#4UMmE1k$Us$-ZKDXmWb4t*sC|zd3hUh_B&Na&C1h*4o)UAu+zPG7ldH;%iXTS6YZKL<2k)SA-^G*(msu36c2?9Ul{s z2fNgvvp}~Ht7=0yrmW5!^bl*qGD1&j>MQFvq$egeRzUTxs^+9nV?~`A(tA#O$Tb3( z1cjX1RPJFzd=2YelX@-?dNDn9tDZHXmLE`?^G0Jj0+Z9N62QDGdf&XRh^o9z?-Wr> zU@)E48^(1O*t%`y#&ljm2K+^@=04R?*406k%;>95dS?ENa&^SlgG78WM$r<(^&1ru zWE->g;&l<%=Z&3uGDK=ieNFqoFXrd9@jl_US z->@i*H1-htVI&aO%|Db|l^fh_ot7UUUgr_ha=z7PU;lDdiR~X;z2TL+w31!3h%eYR zxa!OLId;vjGB}CAa?_?x>T^ghmp(|u7g}$YQ7&pKI4@EHNnI0RNsDX{ z>N6^0#1h1l+J_C85dqEU>;aM88T}m>iS86x*${c@*RM$=r|3g`J!pdFp9-C{=+c<_ zH4=D0KQ{8a+rt-u`ivg#V2H1X-VsR^$&-m6m^d;eB*1vzqN_z#gg}780)}jShOlE` z^H{1$Vt|q(%Yyns@}z!9;rE2;lB-*f1o5?AUe6{&vu%@` zk?ic|_(uO&q!?)1iH){}CR*mxg_gx&X{(rA1L_d(-3RZCXcsnf9tRUHQxFh%eJ#b;Orx2S?88h_5;V3wEX+&8tr8((H&F_A0epGoA__F;EGda?91(l-Wm03L(^f}O$)U{vv};=>-6HvlQf z>;@%fK=A(gJ+3E4V&^KDDIzn#Dj~5GC{IibgI>9_5xP7d$RfUeTKO1<|~$I3}^ zD>b}Vdl_}0tW<-$R#G=G{OSJklK<|zdG{Qy#Gh|;2Wq75Iox$FAJ_Q|6jWCRX_C+& zV5k`byD_$d#A0w_g~K|BgoD}K*zAx{karkZwd!XuW5hQx7pMX28$+Lg2*lG2bmAIe zhvO&%7Ss!q0|W7HS9ScSO@I7X>Gf`NxENRN29L{go_hDcRPT1DQe+Ko6q7wJC0+md zg_-PdJU+dZ>0Mk%b#``^XCp&}?CNMflk8pIh@PKpTWjh|cQg(AY<2T%DcSgv?GvF$ z^jtQVO{Cfjk=RgiC^(+!UhSONyjbX(TkaaqcXj4wyV~N(-th|~k=~1=t1aQp_1wTv zc{8|}O-+x=J{KwuEo@Ck56j>d&bN(hjBc-oTazs#ZH0;LrC?7y7D{v!y35(&-j&ka zW^jBmUl`exsc&*&HaOP1F}<-hGgWTg>>k+;KjH?rkG=k#Kg+E26E>|I-1axP^-G_I zzAWoG-t8`mWBRa&Mm zqU|4s!L6WqC?;c2QNN%xco`XqR`om+GKUdZfaTto^>Npw_( zvUR-=OL4cT1T*1;%9!_i^!{ea#SWEr>rMHxy?Vcr+Kaay*Z0cn*obn3$7oZ2!85~+ z>AVfSJ0{B+nf1!L!=~yO@yx7sgWH2NxZzI0TC`wSiPr=J4QLN^IEFL_(ZgdE(-=4! z{9_Hn52Ftzr?xf}%n!A|VGwtT`ppuXMm#WRTm%8)k-{~A=YgMqm*MGBDvv62O zgL>z(erNO^d8Mb7vN;CZrH+y3eXGGR9gNbuSbtuw5O`=-cl@cX0gpxbpKbcOJ?}Bb zi#C@&W%DoC)EqTNAh%EIe?H)zJR?&+X0f6Kr)K>tYcJpMjD~7X(>h`lgVyBNbo^QG z2-f^|4@Yxeq#z^`yCUK+FR~KV^+}OZ5HK4mnHTw3Q)yf^Z;SL#%dnPFt)n8t7j+$^ zX-EVqsv3GVIRtzLw+Bto{O#txuS*}a07-v5hye}ACE_G;G$92*E-|MWjSogFrg=k4(AQ>=k2%0X4FB&Bn6wGae95j)9@C|$u zo!D-4^%Z^x44KfiJ{s#?&X13cuSFM2xpdER?@XYxZz(X*lWLk64My9V+QvtFJdEk5 zzU4nxodR8XwJGpJkDn?(Zl*vU`QS>bV6(zLWRnYpWK$_sEHxEUMZrmnsvGSQ05bqm zMg1)__z~qzDq-a-hBT3i3;NqAt}dnXOWGUv_BJ#)ODg#u_3zXAol(6{u&u+Vq-DU$N;8n>yA4 zPY1R}o5pM!x9RgXg%q=0vgu1U^|#N8&I#!EW;tv>+i+I>y;D6M=;5mNi~42-IA4u#+$f^Rxka5vzi8A~4d^fRwrdpn@5{L1n~mt~M*YB~aJ~OL zXXuLRTsHslTHl@Xz%%h|W&QPE=jyFxKOM-|hWTawul%o%Rg*xkKK5mg zEps*mm*<*|$4})g`vp}v_#;M-js5ygH7;z|89n!7N{@>DYP9Usn=RY*EjGPu%dhy- zYc_xS5oEujCy4!W(*J48HU(_jXVVp%mTh|3rdMqGvQ4ks^fjB_wCQ7(jl%JiEnw3= zo6gvD#ilRV^hKNc$?*zx=vQaIXwBWZ^Lw@b-TLjaUj*%_WWR6)PKik^Y8q~oxq^uq zVZ~dy_1M^+I@`rp+x>3-{#|FgO#8UMu6^#57isf0*M3Lg?0h%4Cj>t9TA++tG~O^> z5UkUzHUnCTGQ9WXEbWIu5Ecv;3G|A8+`0OJnxhvZOccgMBEExQftiEV z1NQ>k#XZ5uV3@=d3TlOG(2x;W>eMdhe>mE%eRvvr{P%tJ@BX!FY}XI{@UM96m}9$K zo@*-Du0!$GYiT>NY}dOiyLI-&vR!y@)Y-1Ow(H?CHh!O`sdwnN%XTr5SF&9I6pUPr zX?4&uvEtT1)R#KjbyRFgt$J&fACwKMRd22GgWj*sc4_cvb8HdXCbU*YuLNTSNEbE; zwuq1gFhiLAjNS{(7uYSJ!I&ov=4-Jg+XZ6<+RGRw(Q(138J8vMH_RNKgD_|4+ISLx z%D@lMy0Nru%i*(K`|vch&!2wrKfJXX+x4}7^f$e7$9B0q*VrHl&ROZe+OC%Hv9Vph zB_rOe`km2hyrT4|jEtwP(Xhp`TM?U{ydVkqkDMH~%M*3fH=eLsucvJKoK2s%Y2K!n zZ2FQ-uiEsQO<%R?>o#q0#zLDuWz*+u>c@JOZTV%JLKfH@*;vtjK)>v_?Nf!|_r8+2i?O{NCKAj6&kkf(l*v1h!p39HD{IFIhc5wK6Sc@vtt@#}y3 z9o5*U3x6==l{@yy<+;WNN%*Ms5`r@P=x0CMLN$jJB;jM$U!1$K*&qq7_+bc=(D~Bh z@8FKyWz!qxN%x@IZ`yJPrgx|LQ-8-gsX-EqG=fyZa6zeyJ^__70|l7|iH3zi%(6I~ zg&ztM2-gsegkj}xuib%Yq#hgt2v-i=66Lc|MI*&kcZCVpV_ zcNuj_o1Q$(Bj%NpBaYOK? zE%J4-q;{;h!x2kPj;je`1m3yCLpK`Plt!6bfCbGj26J$T#$b*R!xCqN%tf?8*@c1K z-wz%41iBGkX-Q`rFJgof^ulmwXnsxTTm&Qba4aG06$`X+Z;;NI<4^5&`3AVBqvUBA zU)%pvTa)9&t}Ab~O%1dE{D+^W+;L(q&ovcnmmc@vj~F?*n8z*4Zk10g+lAC#XS?dg z_lL{){+#Be@6m5p3rtj=O12CAZ(5V?il$!td~Y|u`=@!QwepvfKL{IA$2_V5wH;Oa z)~dHw`9Z&Do$WH;Gp+>fE^8B@FfzzT4DD!xQAoiS5fBBX6)Go#gTz=*oKBb|C<_i^ znAiQ|&ecyC7o(3x1%`guAS#V33r2PrFz#ZO>Euor;=xnG;IT*!QAH1(?b?T@p@rVm zka?yW+ckdUXFPVyv0X0DHEWNbT9Jn@+O9+43?s*jUPIW3XGWJUE~b8V%M66F=H8TvNEhPw!m)SousuJFdfBg|IDX(qQLcv(Rmk z8V47Q|J>a;ys-L#Su|Pn)pd!((Q@s>%g{nU_2d7zxf;8b{n;;hY?x!WT%Kzx*e#S| z2Uf&|kI%*AxY@0bS~lxrCzjm;LVR+xTy=KqWEdCsvRioaRkB;-!Z!l@CqRuj zz47?mTu37%G5P zh8;4YQed|TZGvOSg3e^s83O%c6hs?^>CfLUT>V5+B}yGk79cC9$uinA>Y`Te1Ea-J z6G8>25?o3^WnyGJbarbWUWOL>$j^TzP>tRC4|A99he-eI#~zfxj{Far{l9+wnWU0|UoR)HYSoPYj{tDRx*hi6D>CK^P?AJ5DJ|Cpq zv0pCFH5HhyLkXx7sqH;;*zDJFL+O9hvR%Jr(~}3K$JgrQuwQj3{mIaFRSO^7b{qTE zsFe)U(r=|z8W$_Jru9q;UI1aHIR7+%RAjoY^`fH3^TKUTU zO8Y&i@WE)f2zLUG%4ogNKoLg{wg``4*e;^W!6KpcGMF#cTg2dq>5!}4d%E|E>z!b` zfaik-!ypNZ#U3VWwWw?~ItL*;-rf0IejNK=jZERG^>$|wEcx;xBfqyK5xs*zSOZ}H*C4NdXIbYt><*l z_uw&I$P0D0s}7}qxS;fV0!yA-E|#5)Hcqn}bFRtQHz8FkM7jfB|yP?VcyD=Y@?ThJyjX<7r6!q=q@e_{h4a zhB?D5iS`O3rGe}7Y>T=RIy8}ISM}krQTy;HH1*HDFYZM|VgI^*)=1GX{fQ5I?3H7q zT%PkzHGIRyR{2-5AHq;zBKfylBSSD`hZI}o<2KC1C(5Q;8(YN{SBrBoq{ryf?~I=2 zIi>f@BVEz;mD|;d3~Y`&{`FsdZaOcq^728d_?|80?L$~ev`_@T~t%8{x z0R}%^#sG$V4D$#YxT%1NWc=VP!dNk)4WlpWjVZ=0HTc`hjYV@Ft|#b>-8v|UDyDwM zG9nZ4Q_v*0>P~2p3E55T7G?^tnUyRpJ-k|%@(J~B zPW{1c)4NZ-;nY_(^eE;|@6pe#KwK{7pGo947qW?z(zWJHZaJNOwvZ}q6tYu=O#9hT zZ^L)${2{d<5C^l&EGikp85oDVA?21mp5c3RpVRs=O0Z?#?|RbP7D<{N2%ip>_^D)E2y_v?t)UgCnPEx%i9weifY7I{`26bmwJ zD9uVLM2Xd|gQM-~0E=BQ+`N7M;s z+%xWs3c-weW&#uL%*+lPB?c1n0`UUq+aRfHuLf>nCPCGSJpgEj_)7#lW7IQ;K$RDi znjmLTcaB2y8UNfPrMaMTyPvVh^`W!xI`3wM>&i18*naTzk9f0%Kjqk`9zS(O$_b_b zPG^|7DZm@@&r~cn)tp<{D6NE=lc}Wzt~g9-usW73%*EFGR-@aKxx)H#)8_O*S8RR! z{6rxdy4W+7=?cV~*3Xy5mwlJcucdU$Wcx%Y5)`Hrpi_3ewf)p)#h z>3qx7Sa57M7w#xet{1nahVv6$i-qFmY&?~km=0|$p6{Jo3JngoMg|7sk#mJqGF?a| zO7k0qbi4QZXTu$u;q>1(52{3G7xTGnF*RS>&ZpXWv2$9)yp(DWm9yj1rSW`d^kOu* zk-3naotkbdj71ZHwnA4|AQlZL%CYSBM5ugWIzKSFc`@2EFg%^k?R2%a4R-bIoGT`B zs!_jeI(aq}NUbfTGfMM?+)_G|`YwGR|8(1>Rf9W(`81;1gr?eMPeAL}-#?U*?}mP7 zblq!8?{~_*X8X}AHofWkmFi{pb(>#*=SRIMw_wxfk@U2ced&uf|GG`hS$9_60D1BH zr*F#Lol>9i>;SvuXm{1~oQBzku3OO{ZPxHJA=%BE=FNg^pp6Rhh?HtETxW$)r-bONcu&@@`e22kx+<%Zte%r68}Mu_0o9*Z@7hxB>w2z>I%8FL zi)*@C(*0WW1Y>&Fv4&Y43G2+Vo_$>{vZW)#x^_a(x2PvB>OE$49jM6(y-`TtVo^2p z>dl#g2X!{SzysQgD?O)cSilZD57Q}a51CBs+0cj^f_v7xry-c;Z&`QBYlZLX#Mhi- z>gGJ&x2XE(Ro}Mqyt(^g=XAuaklwB*EbH8HJvnWhSAJBj0rY?#bV0{v^~Teh+6!t8 z16W|c%lkesh6sOUeMQ3l)8=JeHLaQkRMVzcSC96GRfZjJN7o_R4Jz$Zj;GZm-tXY*M=&6e5F>zI4-0{Nl|ujnXaV=jNf|Y$Eh?w3un^4**2M-OeZ$u z3%#wOw(&sk^mPCB(#UjgU}STBZmnsiyPODj?yPhta)-ple21P1_G44sm`N0t#024H z>A6bzu%Y3TBI#H3V~D<_^nO_sC)KGMZ+rQa+cPYRJO1y_|E9;HeAcE;>T_sam(Eye z(4li(Z57peMgA!i>C^irdhdIY3Sl%1tI)1?YZDpG>PP6BO|{s92qjZUn}|<9`_uZ@ zFG8{;W@B3UfYMD7-Z_zhriPh@ZjqOSCWKCrjuqvo`{5#J{&sVu#iieDB*v^2V#o$a zM&wYlbQ@A6(SFfLQ39Djiwr5CPlQAk2&|3vsU9O-2!5hi#=5VyFCD2?-6-!ML`6Tcbo7=*H z$Ubh!=T!G$I-MN1kMHlN{?wZuZ`iaRQbiwBTdnEJUw+rhxW8hQaj&UvmJfSXKej$g zUsi1Tf=w^m^omWd*|fousV8julubQtuIhW<=JPhaWYd>y>d4zQn}5}&uiMlU?^O>9 zTekXoCZ-+y-<>?{*!`}G3%P^!*>yT02t%d$y&h6U&2!h|@Sxwru_6BNT&w(1yWf*) z%es?^;Am=xcj<@I2v|h^u~3^~zsyP~utx+$fn`EYM?N>p!Qp$$8YMxMf=sNvd>kwk zaqw_5VRc_vIn4IPNWhW|M#4u+#NA=PFhO97MAqkAjQN`OT^DR%iattSM%6d`@rR!5 zt7cI6jhovZ8|KW6F3&ap@0(8D5Ss|Qg{g5!KgS{7FT1stP84#B>74kmlsfW6%-x=*+QOdN-=7zdUT{~aaG2Y`6Csk}ndTcS9=50zD z)bg5DZvU}mrT)aG0eDbteZKU0n}6A+=Bzs_#b45iUK`htI5X--)fD2p3Q&~I29ZeM zh;8ko(85j~&^{y$DZWW(v1e4~MIC9=c{r~lhcrv_L|Wb3;{Nt@?dmVTSJsL5M$_=3 zer%7~_IKaqIh&8$bj7BQrE)CPE4KWGO}%lY`Wh_@6tF1>54PuR>R755Z2m=?I+n`+ zek-~*px?vpZ`;C4YV$vTt?$Npb=GHhUiP=!LEEQRyVoi|toy-|G9&`}v60{19u0gz zg=oL0KgablkbX2T3C)n`I8f4?@E+Lw(Y$~aVr?W7O%1&aYcD~NVFoyk^`4oMc4u?n z#nlfc044!4Zi0qzKeLV#8XFh#12Y_V2Oqwqa+nU#d(6blv-%dUYHx}{o2?S4<{Th_HKyIL05D@;&$a2nl;S*i(h6qEzD2+fFrUjmQ@2f_KIV7Abhg!hbx zxY`+3jwoudSyBBn^|yJ<6Z#g6Xw*XeKtW;exDz@Spq}V(2r>e-6Pc3^l7_Q!8(<}OhY}b70t2XbXdUMvDS*w?H;^Avq?wz$d zZY_)ZKKo09t`+yD?mN39{(Pf5P$PBszhD0=JT36(FxGOEtk}3sNJRtdGKyWKG$tQ3 zU-)Dog#r0uvS5;O&+VQkuIFXS0U6Fe&I9$$q=Ge_JK^WSR74r}dptt$G9mi5S!UY+ vzmlp&-O^QkuhQLJjc1zooxj`dc}lT=T|di3Hq3wJhX$E`+%)6zocI3&Ck(#< diff --git a/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527458837129 b/Covance_UCO3001/browser_profile/Default/Sessions/Tabs_13424527458837129 deleted file mode 100644 index 8c1429d897f209dae8935691f240204b0c413a3e..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 640282 zcmeFaeUO|-e&6@(9eIa)(cPS0SE}=Acp@R_Wx3D3&r;sQ;Dz9V0D%EP5Ccj&%Q_F*!SznVO$D`VA$N`%>`4?@P2h=HquhG4k8GjgS7E zqKiwF8@1<_%EirVF41Y7UzC4Jp{zK{rKuPX5N?W}l7EY^$J_n@wui!&-k(2p`BxVE zFMldH4e$DNRwP4iz;P}XKa|8B`g|VX#8*W3oWW9132p?n;5i+YgJQ55*b~Ro`|CV2 zN@KSS<;_|6QJk0S)5gPTe_|i{`}^yBIH&Ya%a?-5U^bWtR`fR=Oa)^)p3(7~j;3`k znJ0sB^PJ8 zDCu6ILi0LX(%+=6w|DKGs#EkXVs-Axzy0I?k=1(d{53xQ9h?taI@RufuG;OBTGTIm za^y`l6pOZ?)!emOt-Af(_;`K0`s{M$W^r@5ByNm~Yu~P#2|xUgzvWuQk3gp!6rU%(XO-}s zAvr^0?9jRR8@3wk%0|yy3#xkl=Ynzl)pb-2p4Gdns9dal*jtRk8#*7C<7;F*{--7X zd*$Exfj@Eg=i{9(R=)cA&En1VE5+J+W%K09$&oi)&b=JVmqmnJVBtq`{{B8~Je>9? z_MyN3kLvsn$?sEV?tA{6(ppQ5+R?J={*qdtwTcPX2BMa@Li@8e5w*^e(i9bI?PfxM zc1=-deZGBuy!=U}n^o(J+Mh|Cb!~szwZxJnEW4IC=Om6PwCZF|DQ7E+GhJXYDqAnw z^);>z?9)E{Esdi&)^TJkn;hD)3!S^fuX;(N_3Aa=o-`g0|I$KdwU03D&vhFh~|CFvt*|BKO z7o(?t=BCb>ws^}D4Y|7<4`65+$4P8(i143@HOn31+cEm)m^N)UE(b-zOfY`SuU{=A0WU6Fchx7Y{60hk=H}r(@^l2|>A9^_-w7Hkm5LeXbR#dLm=^u&Y5iMc!!-;#m8-ncKx~4hpPbJ^gZpGU;oU=+nC{I=oz7FKyN?udghGmEy$AR=7QJZFzFz z+=(;SCu*64%axVV<>j?vxm?=3Qd%fxYA>%;UR-%TckS%8{Kew**lXt(k8YQbT$;OZ zX>9G%{Nm!J?TcfluHKxEU3z(=q+6~moS&STJ-AuX5Mg2MwUx=twHNB=wqIL6b?VBC zSI$1acw_C#WDO){>6qOic#wAYGre~bh&n`T3WCNJGfmd)=CQ}Z@-*b zUs-zT_Jw0NF1}LE+^W7%J^kuyi!ZLsm#Y_!pIy38x>2ppA6Y#cURzx{e{OE|^tsn> zZr+^QS}&bHa_rTE+shS6l;2!md1f*!Z4}qbVs)#sx?V2*px#eh-5%4p=t%HVkXF@7 z2j|_$Xj4ZvTKboojog)gO4s$o52|uIrdQ>Wxw=X6wWB!%aU0MUexFF8p&P@&dTS5i#ltH<2Ak0#o(y! zQr3IEBz1E^pJS4CN$O)!f0uObqGC=3SM?mz?{nA7%B6KWYr3aB%X#H{MoR9Wa#fMH zG30{IzNWJ_61f(<(p^=3%j=4=B%N~k$|*0e zD7Tk%_Ihy4)!SL6cvm)Vo$0zysXl& z_rIjpc3W@Zm~wwn&sbKxUHyXm>EKm8#iDzg^Ey*iy5lOVC9$ORRsGE?&#Q_HRko`- zb6%x8r=!#2>nb&y$+nUuIl=VWLiw= zzINohFy9sX@R!x{J}ZC!OyCXICVe^^8jQ$?E;c^L{`d_YO#l6`{J#Af&k-*V-^EYp z4QKRDj4Ns_V|wycm3uU|4)yjz#Vx7rt?2EJDc%Mac8$H?d41a8VB)^_;N_dtWwjg| z_0Q@mo4eZ(p`@c}otbg>oOcrKPO~~Qp))4eX7rZYECjB~RfeYw4>|M1iQ zFNaev9ACS%GXL_*3-i^?#S2GYU!M!FPc45$qnIC2p3X~EMe6l_6HPQ!Ij)MkE!A&k zzM|CCO7MhD_vEd)4nD+i#n13MrlU+2v|}r?6vK}H^-I6#hAaOYY!L5qI-vzM>vQsp>KtZNrpMIOuSo$|hxn>W?}9putLm7{ zMEHU_8XFXt3bG-^3u0C3;i6IhAKZt-&S-Ap|Gk!QM}h-SJ4y_L_& z=iS>0f;;dobbXkPQ@luTImi;u!2+zqCXDBAO|nAy&j#P4f#WklTIFtoM>AZf-9WeJ*d=-tKdYr}dgvolJamVaH> z*!A&r*0qnwPs*E%pEnui;_()?CSXIMx<2FQy<9(sji297?tbwf_I^L9ynadktkWu1 z5@~6fTl&oDxS}VhxE5x{VsqbZ!^CF=h*~ zp@&%|%z9x<2R8T!rB!T56Mw%smEqI!GrDe7a%^G22JK_Im(^Sw(Aa>;%QtI@El^mT z*<5T$ZK>uouraf#y0?4IhB0gAF?`-{l5jEOwaT^9=D456A9mC6S1fKJoP2hD<=LZ| zt=lh6)o$D#d->wIE7#_ir*oy7<>D(-mtGA|USB=)!mAsvPG4BQWHjT+#X8m*AfKQ##%gt=XINufx+ftESF<5CdwO=lzK{ zufAxr`JaRZ;_ERs3Ezb-Q~DV32QZ$$_cNf{n%{$F^4mk@REw3;xGGD<&2Zl>7hfKp z@q8rRO46-Z6@Aoh?BU%-tkMq!eZBKh@o?Io*oVIUK1lr!>6d%@z^Bhi-qZ4?mTd*u zR-MR-a9gn<0Eo=Vz7fVJpyPDxZ-gn~_dRg3Xw1 zZff$aE3qT%My&fWle-zgrzJaD7q^w`W!*=5!)M*Cdp)i$wc`8P|KXc|9h+GV74djXg-5~d@u}JQ>2O@e+FE6~VxtQ)Iy_vh zr!{Ji&x3;CO{w=fs=oRmRJ|YBrqRXuA)Rd6+Lp)7jmK2|fOuP{Gv|4TaN{vm{a=s_ zSDqSsJ!mHM!BqWlN3bpP?UX7~w4ySuZuCJTJ>TSf{ql^*KXRAAnp#%RXQLKV4d&jC zaBs%ZBix4vcn|))#P7eRbfNsmeJ1g^BYt~MRcFyx|xC-tc)-4|Bd^!7*!{Ki$ zGVM?7LtkG$xC)+79X0b{v|4C}L~k@SMK~|@Hzs{x^LaBQmXz9ze>NUBqjXW9wsPt7 z?emjUexH^%AbH-6$hU(pNcIVh zw{1MF)i#>x8>7O7;FD@ZVBGSDxQ7wLGp$H(cIvl^(5_4R@j2%5%J&eR;>@ zA6bom3WHHv1|#XGylC!D+99|L-HTUL$|``|A((|ZSb%ldge};HcVG|p;eoG4^3yPc zS(t}a*nm5*4Lh(4@5126BKawJ2xegp7GNDVVGHiUF6_ZRJYYIWE)7Gt2n((Y{C|7!#l7C`|yBGIpoqXgjtw}RoH+#unjw~3-7|f z6q8&E9)ekzg9TWJP1u6FunT*z4-bq*_esMLF2Vw=!Uo)dZPVkP~#rwMqvoEFbCIQ12*B?umiiW z2L~|4csUI-Fb4~;3g3b)*oJpt5B8x(a?x|Z5N2T>R$&7+;oGnSyYMd5sMNU>Ov4P! z!2+zqCTzhryaRi%4-ZU7_esMLW?>#yVFT{KHtfJIybCoRj-CS^f?1e@1z3ko*n+#T z3wy8+56to$FocV+0IRS8cVHWKU=I#piY5Ov%)&gZ!Uk-?UD$;^=tuse%m6}|g#}oL zP1u4RxCi@CvkvFdFavY202^=zwqXbM-~gtcLoUq1JgmY7Y{6aFg*_PjOeAjF+<|S_fju~YDVvwcrC}E4VHGxD3+}=$?7`q`k-SkD z!YnMnI&8ug?7%(PhguDFE)6p<2Me$PcVHWKU=I#pDvMm0g?U(o4cLOaunT)oo2{H1 zg(1ws0<6O(Y{3rPgMFxVVCT{>19Pwd8*m4!DL3wGch>_hF}a4roqFb4~;0e4^w( zyRZv;Q2QgC8-*dv!UC+rCTzhD+=G3nJxtD}VFu=40XE#zx1umksCA8Ik*xirkc94x>F+<|S_fju~YsSC)3S(t}a z*nlm#3%jrfwWrLvQ5eE3EWkQ!!WQhnJ=llN$SBF_i;?^c%)tU|z#Z6z9oT~dn94`; z(l872unHTn1$SW=_MmppIX4PJn1uychfUam9k>VkP+P*COT!Gz!2)c+9oU8)*n0yY`_-WgZTF6=>l5x}`o7{V+pz&dQg7VN-1*oQ%Ze8LRO!2)c+9oU8) z*n0yY`_-Wg z)ED2JOT!Gz!2)c+9oU8)*nVkFnEJ}!VJv80&Kt?*oGb0g9Dg)6S*)8^RNmVumyKv7xrNA4W1u{FbmgU1Ma{! z?7+J)_;bjEsVI1Fd!u!aq5Q{no7WeVw@=F3k08v6@%$f9oVj?sg`bfBu-m-ia=+W| z7h2)SCC?F+gMWXYRd7UpB8q+iQz#&OqC_= zBU0#IFL*tlw2!2HB<*AWFHR@zBWWK=`$*bHeEeYHN14|o^QiZZJ07*%61|(~-9+yu zdNRD=ZugPTmy>=lD%j!omb{O5e@-G^j~}(ZCiN<*S5^Y? z`ZL_l?EG-}QQBQnudLJ_zuc1kp{qW(${*>6CtS%(>x5WOI*xwTSTVj7p>~D$vEwR7F$B&8q zEwR5n?0d3_{V}mWCicg~{+QSw6Z>Oge@yI;@$sX#H^$==`(t8%Oze+|{WY;aC-&#W z{+!sK6Z>;we@^VriTyb~Pe|;~iTydTKkxrLm5Kd5vA-ww_r(65*xwWTdt!f2?Cc^@n8rAz6P&)*q7fhh+UBS${~@ACmQlWc?voe~8bYlJ$pV{UKR@ zNY)>c-~W5C9VJkrBLL$dymtUn~{58s*f zhc8Pln{8)Xzy4l!zW`qg#@w&Cmz=`h&ki&hsq_1O=l%WcME-oZ&-MHDlOJ_Hzo7fu z|EE5o|MlJSvfpz~kkpKd}#edHkr(|B(DztybNB zZhXAHU46D(Tw1PdRi9n1Y}}XsoYFomzZ6XAe~h2f{~13U6!pKykI7F4D~cZrrrq(3 zj^=}m&X#nvs?RB%od{;+S9K;-s+oP|uS#+TKPeewlD#4svrhgTQceD{{Fu&6C~ih~ zn3MD=mzQas8Fn_0x+uTTvyN{UH>%}QZL7F^ZGH0!!R_&>+4<>kyt-AXRhBE|@zwQm zt+X{3CEgw{mdoeeb=&S%v%mM3|LR}-&2e{pN1s*~%>DAe?*Ed-$7$z&KKM*t_}@=H znYF55+5EwG{@^z(`B(n%op;_;IQ3)@yee5H?x6e|M~-G@=Z_wl9y{^;k;$>?V<%?D z=ED;cV^b5yCMIX+GE?(2N57$ja$gFb_&+4t9rN)!pBVXV-Nr|MPSM4s%8lA{OXcF` zHJ9kL&M(S8rBGHJinnV-y)sI+x`Hyhr*WLpZ_zTTzswn@~48Yz`H)3 z70HkraGZ<94<&Jj@%(*7vFYJY)X?{8gEZTxi`QawN zT)A1?TrQb<8$Y~USt%{dY%ZUe+@71CdtvL;x!TI|#n&dTyk5JweJXSM(q?IHcJb=@ zqvy`NGI4bE$ieMeu~u5Rbo`|kPM+GFJ+->B_2R^h^Rus)%mIk{RnbMt8R`O_EA|A_K*KB&45aa*5TK|07e*7T;z z3XRDh*YURg0~M>WMWtB@p0MYXe@YlgCw$OW*&dMqxegpai!&XQvj5vi?vH=sD?e+k z@=suc_?;NrgbyfB!){2di;magLrUP@kJ@8R<*}_+Ij+CDj;g`4s+X1Erk;J%)zc`v zq4S5`8S4-hRO{^Q3Dvf3)xLT87gScKf^(9%qB9qR*HquH1g|T6QE5)8W}Xf%>8g^_ z&IXIYRlSR&N`EGJMJbP}134lsyRGy^dAr9Yy^EJ5_oS}g)HSD+W<_^-QR#2!>RDZR zTK75^+){oQmG`qsXMR&Lr`0wt>Y1(td8M1x`wW$*7j)f<&R*5IW0IFs-e1ujR`twh zB;}~2Jg;jnDqXzXycUSZ|FlZ^d*$Exfj=334exxh^3~687H_U!Dc062nP*t1WeX#?O1X`z>?qCwIU24|~6#R9?R%e^zB+ zt;qDxlIo&qp)Hk9P2SpGS!v8!Z#N5hCk_~`w@!_R5uxTYLz z=FDPvCJoV%0tpwVE~2G`byTECi6s!7ST z{@e04?Q)~;?VhvVbj>_N_;TgS`sVN;e%!^3*DBXao8w!hmG!OCa_z9|$X>Cyg>drO z^_6EcFHRk+ZB&of!q-n9&%AK)RPM_2FCDGFdU2(4`S$eUm5KbTXJ0Z-(F|D_lH z6W>$c(Y^gJ_u3PG>sKw_^Dk}wPxpHCfAHkU-&glw-Lh4spBlsb(9X%}ddm-6B-pr}by*KO>cFO1Y?Gvwn<8*-yJ6r&%3} z@~cjPPu}oDFRQv@N-1Y0*Q^zh{2A1LbhXK!b$7LU&PnNq&KH%ZP~JKNm92kN zXD)bLU24Vm8~^do{H+J6@c(h}3r@BB$(9e>HQ#)4q=^c*US~nx_d4&R!o9iVy~Y$> z|HJYRSL+X&2L-{KQtx$Cef2}A`V=}i4f9aha=qHFJ*eD2j;ZG%MV1t2qis{fHt#kSX=>Duz-^>%0tq49RvRnRRJ)v)r8Y~Yq9@2qJ4H1lKk*{OuT_OPDJ7nP@7 zGc*~o*7mp^=*Mv~@=xiZelMAfBsMNh@&5mAc= zXisQsG|TGAY{WLFKFzF6?=FE_|75*mM*UZ0HL^6(x{ggBGCH5p75h&{=3PHI<$AqI z*Vox{uGyxnCtPtorP;d77Pac`zUq#wr;W@G6G}JtkxWL4XaD(s{vZ{u6&DxpCnG*= zMLskcu~ml;G8vhfo}0Y4vMU+iEt8SokE#0a*2zdTf1XSxBWh4K;Q!NJ)<`BJkGIRk zhWfUwJt5kHfGwZTh@n%FW*f32n{t?KW=!hQ7T%+sEmKmOHW8UnjPE*pm*6KOCOMjp z+tkCB7HopychQ(Mvpm^yfGJ$-0L&g_OZRrpcG1{W$?qjHr5J4=`6zUu$@(u#Q@{Q& zwd~cgr(H8N88OrP2O0doM=d{O!_B{|$;hMT#~%ObU;M|9U1V$k`WLK>*qmu;>d*f@ zEBTLT1JM7;UI@#fIW_?K=+7zYJG}wuXY+$q+iLK0@UF|KJ}?CN;DCc%EZ(2@jJLUe zUpD|PNh6sKSdw0_Z8~GpIkpHH?ZjKrku76JS|zeL+s?#UX&GDAv};UL?Y{xYbf66= zO|#iHqG*GW8E7JdOhy{X^p@GjZJ21Akxc8E7BfSmX{%62rVPBZ8vdX<_jBj}{D0x~ zjivS1_;^1I^kGY*4M6{wYPU~nQNQrXkvC-sv1kj9$`6~VhZcgzzfb2*YW2{z6WE52 zb*&>>Uwr?ToFK3*a~=7obd8yXO|Cg#(>%SFZ|a<7>n%$(VC+4Ud& ze_e~X1+&C^6SZfR_&X4>@rH9RpFV#!F>+<2=Y7!X;(nWN;?L>j#p55@L_89ih`k)k zmpw|zgIM@coWH+M8xN=biGAqr|DXxmP@TE29CMOqrbROzT2H;~KCRW6+0g2KWLmVT zl(iJw*J^FXcBxuRnNm!2of$CqpRn0B12b-#DRNG-qt&A+#hQF;pLS1M4~{nF*}c8l z(nc}Sro4=mt$$RvdgSWB(Ei_{XLTD{|J6TyrtMqh9X+RC*;q;aqHC?bRr;_M@5mD) ze?$|sR~fgj4d24;PB^?(s@>Syys%YXcxLiM@cp{xw2JE8#qIe1xYKH)SKPw?mvx^} z`KNS^t-{#jnDejS(?4@l=N{B7@4BnBuMWl+{r%pjH)G9m#~x6w9iwlKY14K?j%4>@ z;`w{OMgRSpW%*u-9M;NCNlp5OxEWl~XIazZXH+dt=&tem`ErTJKXUVBg~!XW=4#Iv z@`M(C*ZupmSICxaZ319Rxwc4bP0yBr%_?I%W~229v&781&e9Zttsz)h2Sn`@irbH{JqTDp>%yK!=Qb$)Am>&V8*OG~$3z7)Ik@XVnwUs!#yIQi1Vi`QN}ak@5l^!1l2ORuai6_-vQpE`Tt+J#$l zN2fRE>nD$H&#afL)!A$1a~E%1ICkXP(m}u7>hg`P^#%9%&rBVWhSNV=F(1-{ic#wA zYGre~bh&n`T3WCNW503k()NYTmAPY=Ub-}O?)6)j*0xLA<<0U-w~xN~>gnqCsTYr3 zn>n{KQMrBn)a~%n{Kfq8;`*5znM*I-K6OEvUOTwGT#-ci&GnUMCd1N3alI_+TMha? zL+JYea-aCWYGX#} zLXAf!w71Qg`Gz(YpU~#j>x!vKEgV#A#og<&j@EQdS$`($iar-)`oAH*rX_yc%6V4X zl*?|N?xe1tRG!w9^1QZs9@p_LsgNs@Ij3t*Iu$jqyKl=M(S1*9>+_Pf;=U|C{H~YX zo-!*3%h`hD+xL5Bb=9U~q7B>&+8ldUcdYB&C8fBavU*XupHw}Y(9t#d6RL?d<>siK z;w4?VqIkruw(Kz@S-Q@@!X4Gvyd_#JaCX#I%*X?<2GxKH1yQQ$b z6aU8EyRkf{a@bb>HkGG2bww`2D{w2MMqbj3URT8#Y{*;c7 z>A7Z<-a3hj&R59&Ou=t!uZryLIL^V~A$+wgW8GTeF#e^sTu4 zRhN<6Bc^G_hW{DetRwY^1`srmmit+B!Bjb>aBjh1X8Lw*LA`xpL&# z*5uUkt?lWnGm{hN&a9t2d-e6>^QW$SM5CDRmTyh{-B0{4Zn*MWu)%P|4^KS5li!-U zD)m1lWqwReeo7s}aq)tN3@7E+)%mPQiD2KBT370` zig{gE&#POx;<^+69i0UYFut>$TU;&rZYCc8$TQvKTT|*fl5b5V-%rG-&WT~*_&S;r5`u>v*d83~Nuze@<_YEh#{AeG`tYq2F zOn3{b&F6vg?*T zhr4AqDq6Q}y-3`6GxV*7@0xE-{RcnVS+m*vUxo!{`N_AYk}u<`ir-tD@ZUD_o2}#B z_I};DrL(s3VYkr#yT0GUXTMf54|YDE{%ky)_9ynCFUJS1dkyKAebw`nRIBZUF;lde zwr!Sa`&gnCVq1YSrEhjEGlrY;wi&0TFh)OJQIZUwZ=au>@@w6TbuRXsGWP2(X4Ezb z_8qNA{afc?^JV+8fTgsvHk&qcxXohcbtf~>FW4v@Jl<2;9!t#vuFM5mSU_NHm2TZ9lZxyp6tXmcO40HdQ^TdzkSs`V9m#KAQTr z5q|XRLMGof6`4uV_J!NH+keZ-a%0BIVP_-o53*4)t_w}(&$oW^?>uN^?bUFccFiAu zYh>`PXnoSQ1ALH;itowFhuEn2?O)LsA?2S^K04wDT~Eu7*n_?Mvn+2Bwm2JPA86T8 z5d2b1EiblQbWn(~PPhxBRPVo@_FGEm%Jbfe%6os-XTP@AqZa zaaFkCZ>hzvjaJOg58cncyB4qhek2l)e`JHvr}&wjv_|$ClIBHochU~QUFcrCqEc1? zHIko(A~byz55X+V!8O=`P1u6FunT)| z08^oQ9?2htA=1zWHU@4z1H!{8@)4j95L%)=^dz$Sbfc3>CYg@OGZl3WU=VFu=40oGv?wqP6H zfj!uV2W-kAmxdwC!aS_P2Hb&d*nwSm7Y3%7% z8isHY7GM=N;0|oV4%~x%s9%0_E(H(4EX=_**nmygg1fK_dvE|#(GPV7X&AyqSb$ad z7Hq*b?7%(PhZ-w6Hwr_Tg*mte8?XuAh8@_2Jve|V#>;7#fjL-!RrnTc!8W`Dd$12R z_KThahA<2BunHTn3Ezet*oAkYMxM^4U>as%4i;b?Hen04;T_n6eRyCxx=$L0Fbngr z3L9_-wqXZ$;a#XPZuA`R5X{0HEWkQ!!WP_xUD$(tcwm<2fFWFj1z3d*xC7g;1AA}) zQ*+3NS(t}a*nlm#3%jrfHA8T26oxPh3$PBGumwAC5B8yEEzYH32IgP^HsB6y!w&4h z0ZcuIT$qJ)SeUP z(l7&aumBry2ex4c_TT`fP9qm)VIEdt1GeBU?7|+@woB(mVF|A^ zj&o_4fjL-!4Y&i_umgK=08?j?3$ri}tFQrEa2IxA54xQK5;>ZS_KgHc5W1gFbfN?4x6wA zJ8%#7p|(almxdXbg9X@tJFpEqum=Y)bpg3B3-hoF8?Xg;VHftGHY__g3PYHM1z3ko z*n%Cn2m8<&86`P=F_NEwIaq)VxC7g;1AA})Q~5|<8fIZ0R$&9S;4bXK9@IWK=SE=& zv#ZTF6=>l z5x}`o7{V+pz&dQg7VN-1*oQ%Ze8LRO!2)c+9oU8)*n0yY`_-W zg#yVFR|{F6_b{)R(fH8-*dv!UC+rCTzhD+=G3nz1YsBVFu=40XE#yVFR|{F6_b{)HfuY8-*dv!UC+rCTzhD+=G3nuRS`Kh8dWH1=xT)unjw~ z2L~{93%M{0^RNmVumyKv7xtjObm-hD3}F@)U>!DL3wGch?8D#<@(D9A2Me$PcVHWK zU=I#p>P_UrEX>0yY`_-WgiwFDLzARItPEEqNdB{&Gyb9zSY*P3l!rudD>(^=G)9+4^HIP*PZPbpDRKAzW3?vmHWMy&r8lH`#gP$?8I4e@pCdiTy3Hza{p!#Qv7p-xB*c^@sTUDOrC=)*q7fhh+UB`Tf5K+fkDBr)2#p zS$|5_pOW>bWc}$ucJ^fb;lcf8vi^{)KP2l9$@)XG{_veyfB3T0ve|aF_3Q6t_Y3f~ zV9foBd&w#6{p>)KkvhNcci!L6PUO#r`&_?YKlxGT^9#Da{eS8c`d{BIFZ(^`6#2}E zX8-W{w(z^IfB49&nfNG@=L*#e%oqJ|8M+^{wDQqr}Vk3&#_=y?|U^U>S$i)R$bh@;${?{3s&?Q zy8mxJ)c-l}^X>EFG#*}tKf76n^qT?lZ^_)@- zJDW#cl;7uB$G3|c)pDt}Rb0NdzIlb<_W0E7{B$^8-Kx|o%a!u@>Uz0W+8T=zZ;uzt z<@4^kZFj59)VKf6U;NE+cYH^mRu|0O{q+;SY4LH|xt|X{lNbKw$tSZ`6)c;7^{@Ru zmA|CqU-`p#-g#5u)RRH*s$`kCgYs`2IhvWBKYC<(?8Ng&Cda0aotPP$4^K>tO-&q| zn4F!ji44hr=zl}>8Ad3ig%yu0D|JQhH1A9Id9=daXueDZ9JUz zC-$MwhriB;b4qUw(Hc}q)qPeuv*R&+W?VzFhGI?3n>=GVW+aag(~j8gNm6Q@UnW zjch;p^O99kiaFiGyfs8?z^gi%mZT|38gr7C+>uGQh8X3k=yGEBv3KpAs#EkXVs-8_ zo!75gt@qAfsXq%Oz89jtkhUA#&Sn$3#Y&F=Gjh?p_RQ3GN1>^dw>!=z$E9F~Jxmf!! zH5`REbUt2Fe2t99|Fqj;ZZ?u<(tDwWFCKdS3%Tpbwd{)e8`HN}5){HbfcRo>Bax;iTU&9D6x*IIq6^kJO} zMxGe?BbuPS%Ab6(-si{||6_w>)))H%}@Z&{)tcbDS<3@zh0i46`B{FB({@8{NUV#E=kM!^b>;P#&9Z#2L=LOOO1k=nxEWl~XE|61o>BEVA=&Z!`ErTJ zKXUVZ;&Ga9|FCb)xuG(#Lw|oCy74^jjPXkGMs00!e5JHnyiu-=-<%k?h|1Rb?b6}p@_K2rc6ohe zA*>W9X12oZiEGP~8|O}(xjs?L99*uflrAr?X&heKyi!_NxmBMyQ9f0v9yxvO_+)-+ zdiwm;+^eU~Elyw5$o<9V=a-7hue`Kzbn2n$zVdhztB z7uPl?&Rox*I-9#ay;!=odg1KZ>le3b=P%uuo<3PQef|2;<4YG#zi@Hu%v$ck?V0lJ z*N(pO%C+*$V&%%gt7UKChE%O$lzO{b+1xH&uHCAZ z7VN6<(c)ZgWJm$NtEAQUwLLSENv9m%c3SVDwNU>>ixvk z?JS0Kj^9gRUDxUQI*n)N}&R@}WV>u62al=Ww_uIO_?XKrZ}H=%3F!6~Jz>P?=OtmBfEmrAhF z$ob%^#<#EP{JCIJ;fqo!>q`G(@H{GKIe10yeVrh!@I zbyG3X7;-`Pd`WjWt-HRcl$*+1U6mwSRE~+eQl6Fa@Z23MZ zX{Qx`UHLjL)p$Xn7hI|{l9*HYw(eWj=W9ywivF%CG$Xk-U^pmgC6&**n7J# zYSxiNQ zTPm%ba$)anQRR{ej_J8)bncv<`l5JK@s<;tr>yGpl%DLYYD!LJy{fXgrYml#WR56y zR;4@0CdZhX3X!vElXj9%->)6O+{IHEQ7LHviz3{^2^6K%q zt%&w@VtzX|LUA}(m($Vb;>y?*2qEX3@C{O3_smuFKF455A zxGL|q)S~U5E=v8Z1W(xXP2QU8;6n^Q{EV$*I>%%|JGL@QF^u>(cmIhSehgrP_?;Nr zgbyfB!){2di;g#Mn_0T|BbEL*h8P<}M8kjuDgH}p{x9h7vXu3zl>VH`YC;{srj-6m z>N>8f^j=jbVpjB`>vosbRUDIYzwWy3%i<|XIjYjWpxBD8`gnC#@pAL(Hy;1UGuKZ< zGuMLN%IDWOwY2@#;!K9Q_;nVxCSXIGx<2FQz1;owdhRE8zxWS(zn@fIza)QF zWncq$Gx;uQ0A;o&8|Ii9*jktwf6YC7c=GR$Wy5OGiW`=g@!y6qW}LL)gAFsx&p}Q3+G=rbEsXIq=FrV=;C3@yFJmm}9I8>Qfjy5_u!YD3+o&G^!q z-)t#tUobNTaz*EVUxIt`Pw9A1v}SM4zYb5|teQIaK@6g4X6J98*!?k^o&RUBKzu#M zCgHo#WlA3-{s6}F_kIRZTf=+M%zS&OoNBRB8dqhhxNh&=a`ENi8P7-3t$dH>u}Qb` zsNLAZyNg(*9}4<<=cD4`v_G*Aef@oqVS7lw+|vg>eNOV8mbZ--rr51b*{boFQ^V2f z@wDR13S;Woj%_|`Ms1sYnt9u1m@E3U4#DR;F5iZqwvJ_U*o>}=*2MgZvMG66u`WtZ zw4QBtB%4!D>(l1HOOkH0Wa$kr+O1-@n#eV_{e`M>uy7w^}$eAuq}=942$ zRJaZF7vz1f6Wcu#SK)ro$a{B`=z23cJY21(HKLEtgM#2qsrNdnzWO0ly&u`8(Z%^8 zoow3Lmb=aUMoiTYh_`h&bDoC?Hy%^f{{_i#<*BjPgJwb>Ow|u}1luyln!&|JDWQ%d zgI0W`7q7a$p2g!Ixl3S;EUV|UQH!Ytb8knuH{<9L?!yDT2mfB;_g_=GQ2ygSlX%<_ zzdfg_v+BTyn@K!e1%I&Jb>CLL(((^;zP@}=6>LWTXgh%ImNOM>BXV0yv=O)+n+mou zw2jqm{5+{YOA&48u~D_9iPx8$GX1ptlp90a)*mxeM*HV%o@welGC`JfWQx{C+cpBX z(YU3LOv$##&NlfBJ5vQ8g)TIiFYi9R@t~2lSHp4IHGllAk-@j3k+qFx|1>xH*(T2u z8gJVgk4+oL-lM#?gKz(ej0o~iDP2eWpd;|?hy=)a1H)T{EzUISftDR<4KAjZ7h5hm zD8yJN+=Wr9_aA}(mJ+)1{En&RaW#kG@{X(YXa#Jz3$^W-@#^oJWjy|o)%d3{7^P(} zl77mI=I*2&g1gYYctxeG0>~YLS(t+bScgs6f^B#Q_Fx|#_-Z6S4MUiPd02%FxC7g; z1H14p41O$VkP@6}cOTj}h3v+M{HeeIB;4bXK z9vr|FTZhvygp05MtMDz@f^FD=d$12RQgUt-hA<0ra1AzK6TS^QunT)|08@;Y(=Y>b zumG#@E!cu>cn9`iA8Pa#JqHY77Up3UHeeIJ4Lh(4??R0folC(q%)lHhz&dQg7Hq>i zum}6_03*;e3}F`LVHGyu4s62??83WHhKJ}m;31fWIaq*o*n};(3%jrf`|!YQbe}W~ z;UX-+Dr~?V*oGb0g9DhFLq5#HJgmY7Y{6aFg+1u!ucORkLzsmHScgs6f*rUA`%p6) z=h83(bFcs#a0j+w2ln6qrk+DC%)&gZ!Uk-?UD$;^82n5mZxn_w3k$Fgo3I5ta1Zuj z@Mp;<%)lHhzy{obZPkN|4-R1JBywRE=3x~!U<>ZTF6=>VD|BuYhA;~Y zunwEB1v_vL_M!HlIG2VQn1cn_fIF}aJFo`_Fm)QaFbngr3LCHmcVQRypmxSMHwr_T zg#}oLP1u4RxCi@CJ2RY1!wk&90&Kt?*oGb0g9Dg4i(Ht6d02%F*n+#T3wu!eBb*zB zAw(yRZv;Q06}8 zMqvoEumJ0@30trO_h27tG2gi~%)lHhzy{obZP!zygR z7Tkqh*n`2(Me;^r2(z#N>#zx1umksCAL^U%(euL$%)tU|z#Z6z9oT~dnEE<$VHW0L z6*gcC?!qqYLG7`0ZWM+v3k$Fgo3I5ta1ZujP#~W$19Pwd8*m4)RsKw(l7&aumBry z2ex4c_TT`fs>p>|n1@x^fGxNSyRZkfQ{K5z7{V+pz&dQg7VN-1*oRt5b}kJwFb4~; z0e4^LzsmHScgs6f*rUA`%t^)olCw(yRZv;P~S>$ZWM+v3k$Fgo3I5ta1Zuj@CNyW z8JL3w*nm5*4Lh(02Qc*}a$y$cVHGxD3+}=$?7`q0JU=a2_e zQSjdOM(Z9!`H$;1uP-QXpOl{r?0145ecy#W=M(ZDcAHncybegFxp@4?^?qTL-TU&J zJV&%QY2q=<=fjp;@;*M?w##_COWwzOzt{dzmrv3@A_XyA&mN^;N!oeR&aLKr)a@~; zS4q7}>ec>V08iRS(ms;*k+hF^ziZ(~8Mh_lU28q>e*N`P%PrBniQct(6K{9J^QNR; zee~s%=qsyLiN5-%+g(zxl6qw&kkqU9)`QO~I3l04kN1{~)ssgVUx(3UNxh;R{P-xT zS5bk)_06AFy&Bc+tn8Ej#O*utpSUIEpVYsk{U!P*(Z7lQEvXm27TAw)*Y6t_zTdd$ z^XkJtA)ovw=Fvvy`1r|>FXQn^|C{u`N&lPlze)d_^uI~}n~Xn_@mDhbOvc~I{3AY3 zNakM;U++ogpUM0?u|FjCm&E>**q>yEyw84_*x#&F?k|_b{+QSw6Z>Oge@yI;iTyFL zKPL9a#QvDr9~1jyVt-8RkI{U|&l?l_Yhr(W*!K+*`*UJ{PVCQ#{W-BeC-&zD*;)NK zB0jE4?5~OaHL<@Y_SeMzn%G|x`)guVQ)XGXOC z$LHI^@4EiscaPtD_cB3KdSRTB)?XxRkxoTAFpp$pDh=cmMdG;XO}A* z_vJsQv`@=Vxc@JHN&j#BypEUkZs+w3Q}ScMv^cNNv7o459kzEr7OX1Ol>CIwEGyp1 zXGSqT-#$NHeo<%VBx6q3&+A@ex}v18$(q)+tCDQ;m)+l(&RH&2^*62KNtb#;GKQVC z!Q9XPy|0xmK2CQo_)K2>*C(IMT2-)YdiRw-eCM4v z6-Yf91g}b#i90C&#*w3$+4-YKrpHb^e`IoO`q+t?vH9@C#Msotv5Cpqxy;o3%+YT| zQoa;C(U<5b5Pkm6Cq{l-xAD=RQ*3dma-;U#Qn|Q!&80c5^NaFNDU=n>pl;5;Fi-#D znmYF>`L`_5kb8UR*bdu6VN37N&-VIH{lUwh3g+NlpU#S8$PGBo#o~vOxWjn|(8xN=biGAqv;ji=IoYGrE zoC{W5<)2l~?08I{88w+X8p^C1*_fU*qdz-ZQMyT8v7}H@e^ZK?RYTcN{=8(BTw|Y* z%n3;_>DBKl)x_1CRaxmny?E}428|2~~NsTy!o&$z8Ru^wDe zUTf;8wt{q!bF3+*taR35I<$!0578nzl4Y(NAviEplbyOC{H?$Khpt8ZDs;+0*W@|x zStWdDNREk)1@C*qR)byH=y_{FRnPxiFs{G4j;g`4Ql}M_i?xqsl};4i(D`^x@ij6Y z|I?EHz4Gt;z@O;zo_ptum9Kt&vv_m;O0l+H**v*&a^ww{RWHZ#Wf38lSol$#zrRl# z52yW!edzE1pe}K!&fNF>Imxq@IH@)%6A*7qyw9XsyD!tc=>; zjQ&=2?Yushm1<&N`4jFACD-Dt1GO%(NUNTf6q9G&@HBTfc}p&h$(?a&L#0yL`bTwr zjjIDg-T%cbw zSXW+;*(}TVO60JVS4mgj5I2Jh`YZ}C0=X<37wSB;%f^S0(*l(&X& zBjh=G>lkf(8Z~(97>jyGC4KsQ`~2jT->74^j@CxMOHSIDuD3C8)UmHB&YHX3$41n4 z_c?bD%SFi@Wfbq{8BrlvReapGXjlI3rH88k-}F80nj4=Vsmgj{y|CTZnu%8duE`Hi zGsY{$8@08`@s-kQ@kY5eesf~nA}U+!w@ZhY%j>1h+U50?g|JebnAr-qC$23|Zk#)D z=K4e}b8xw`Qo6jnrg3;_^Ga!9FM)VbFZE{w>W)KBlj1d zpI<62zw*+?(aGcSOD}Jfbjy{6^OG~P2RADkA}m~e>BZBhUR>LpICDLJ>TK@z^kV7S z>V>msuV37%oxgNrdirGL^!4jUk1t&~{ldkqGi$jEw`aD z6SdW*wu3tFuK2VnH!{7d(1KlPX|~%T{)geWzie}ZAHbaTdxaSo{!kn*!Ce@q?!yw& zbzJ*QsN4rC^+h*RcrYA2u!c6&-E20oqE0@n?p;8Z`Es(tMl>^7l-%pVt5V(PgBwcOR<}Q-)D3s7Iqj|J zoHhNKtSkDQ){)z?;zo4NT5v`=D|(V=CF`VQ6{Ql)8o3x;m3{k$j=vhrD1J%hURC~A zg0G@-7K7LI{I3Vcb=JxEz3QBD+Mu)IN;WO|qq>g?m33Vyu?;z`Yo5~;&g!bKDCfG$ zXm?dq{DMkzN9CB2lxr%>tWqxM*d^7)wxnHFom#n1OWIkb-%zS#`>IX6tMs@7~EiS6JQR7b}cFymqK$u@DE zCzfrtv)!*bzUCzFw&M0o{1ZE*BQ~ShcBxxBZi;+X+oo!(piwgA=;%aUFYA zcYR5`rF1Ka%~O{3c}913K`o`Ax;DqhHJx!=HFHd<6ROoQ)$(Q4l3A5gI_HYcm<(PE z-c)JET^(3ytYmQ+W3KDSlDm7e7O$&()-LQGbIP}=+;K}OKQeUrAuKthc_-VWGl92U z7xm|vX)vHIN5}Q10@1$k*Yg>Y@vJ}4hnC;2>&sEs{*z2ZFUHTnEN-f*U_ul&zjxQ^ zt1Vb3{ceK&OvG5qgHL}yzI-JeGV|;~i;ZV)z4~fHt-;#a15IVEK7QIZ+uc-48CJ@& z_U2vRebLG5HKqLZ?A2p4B>u8A{*eAmzpT5nR@Hh=y(eKx?eB=%+bOlSyl68ao7tRD ziyYHuPI2Rybc`8FIpwk3$CP_YXPWG<=sNzopHzGB*FUJT{Dii?c8iW#NIsu}(#(Wg zRBtn%jNP@lM2GZg^FW)snVZsLW+INOmdse3S6-XPnUS}keCEkHqOHIDQJrIMRCA}A z@5jtROEdX4tF$Yb`_%kD-Wau<=3KS;qIr!b+&KPW?$bOONv`-=y#tsqc!8!YBIj3ykyzz*6!14%<9o*)8<+>LwP|d@l4xl z*9>7RUvEfl(oeTdYR~FF+yJ?zpwd#4@W`k{fk%s-oUm`bi|^W8ULaStCg z3w!#+*cu{XD%P#nqA#E_Yqm+ zKdCZZe9ugH)YTZ9+$Yt5x1^Hoy{&nv*rniE8C zmQ6}+_{%!E(|UHv>smjtIy)~}S#59Xigtc7pI<}nw+3x8EF{mfxOD+D>8tuo9`|zl zy<^f(Zol*od%d4mS-+(1g6hB~thUs#Ad}8~tY+TZ@`v@XHRZAJWHao~jz=#xqK?QQ zvPCa5r_3pD=7X6Tw$x?Di!F1RnPu*M^Zw;^BzEbW$+4`|uSC`J5SU)pS zK6`s&Y4YYxT`KtJ-+9KZW!wHeZFp&d@~ynbq=KU4|Z0-7S9;vOKdfHCZ(y$uK zh8y-CRb&0sO**Xni2OI{u(ID_?8(E0Z~c$bw|{>m8PECyedyco;}&#!^h;m$Y;#Ie z?AE93ZHXbLhU2#;?8PJVKAL*AeVb+4Vvfx|ZCS@=m`nP!0l}Bsm#3ieKCjKp&t>T@ zo5SXHp3T;6)*HV`VM^XSAm#&z-{Uaj1TfhCFy40#K`n~Tx zR)zc5ll+>lkJ~xldTyYO3O7T4TALqr5^s$qRk(jw>ftx3biO$qo~+ihvgniZpdff# z>b;7puY3qqpFsy_VbY;zuX$Mb#|c&6CEeDWEqER#Ui*Nm{;x}ht54ZpkDCcSovQC0 z2)5+xi!B>-wG89PO4pAR_S+DuB^5v1>attRt4K)SNs~xlI&hn!RGX{ zHFUGUZQoR|+0bUIoBcehKg$un$Yxfx@ef(re-wj<7lwpZTFQE3wFRX9`3v3y(b zFcm-HtZlQv%^J7-@e<0C@|!caH<&8;D0HF8d~Nsn5B&D%AANhE`|a4WHviDa`GTvx z+pPjgZ#Di|97b6=jHI86qJ?`|hu}VR4_-+bYXAy|VF(Mb1go$P8?XuQ!8Yu`17D8i zXJHP8um~%#26tc+Mz96%!{BFQ`5AZ^hOhujunOz20e4{wwqXYzFrB23g*i9_ORxfK za0fPF1ovPE%E#tH1|EhXEWj05gLT+|yRZe@unRMX;_GB#4$i<5tiX3*12$m<_h1JG ze<_wf2y-xm1-JrhunzCS2)1Awc46i)_W|>;086j}-+>L-g!f<@c3|*x+y~6T5Efwt z)?gjpg%NDQ`!F!io307epHeeIpgKgM>2W-lrkcBxI!Xm7|8r*?R7{M02 z58dLngB>VK$%R3fgCQ)y63L-GuX>nn1=;ef))4l_D z4Y&(iunjx#z(jnVEX=_fSb`N;gFCPZBiM#rn3+UA3}F#gU=23lE^NUz^z+w2=CL^# z!V;{)I&8oQ?!gY!jK+m5%)H3$O%ha0fPF1lzC+Gd3?%$ifg7VFlJ;1Mb2WY(w{Q zlH?8AOG*kk7{U^)!a8ig2=2iS)M}^;S(t|fSb{aU1Dh~{ZPLs*0rSc46? z3tO-a<%@J-5awVAORx&-umK~u2Rl%&!?}=!d02oYSc5yT2_x8sU6?tATo}S4tiT#< zz+KpaZK$^_To{Bo7{U^)!a8ig2=2iS)N8FSWMLi_USb!y1gFCPZBiM#rn0XDk zFoZ=|fi>8GyRZe@Q0_h#24N0{umr2H4jV9nd$0qwnD0Us=3xPrU=8lTCX8Skc41}~ zxiEx9Sb;UzfV;2-+feV3xiAQGFoY#og>~3~5!{0v=$wp_oV^sw&%**N!5Z9wO&Gy8 z?7~bjmY0PgEW!$`!3NxgE!c*7OU{Ksn1dlK!78l728`ey>_B~0!-Xu&!vZY98r*?R z7{NB|!pvVmE(~E2R$vV_;4W;zHVpo1EN>9zUb7Y1PthOh*yunrqAf_tz7waDQ@7Up3A zmS7F;z$T1f8+Kvl3UXlxi?9M~umN{r3$~$q(@r7>S7Nz27{U^)!a8ig2=2iS)Dn*i zS(t|fSb{aU1Dh~{ZP_Gpf zX?87^pN9olf;G4Un=pcH*oB$v+&>Iq5msOgHsCI7!8X*3hVlKw91LLzR$(1BU0KEWsMwflU~}HtfR8E#$%w7GVX}U<2;L7HmVkIq$+C%)t8GyRZe@P~S>$VG!nE2urXE z>#zYMxCc8hc#CqvJS@Nxtic`Fgb{4RF3h}*To}S4tiT#@>pV4OD-kcPZZ?cFk)`;0N%hr7 zQ$MM`dbA!>ef4lZdzyZiwyU&VSq&uZs9yb@wyXWu&xftI)V@mn)E`HGOxso3u09Rz zYEXqR9hv@kefs0|>5tc^KVF~yczycg_34k-r$1hwoPWOG`p*|+Lp-C+eviaL^89}D zu+;uY?XT4SOzrP<{*lf<()mX^|48Q_>HH&|f28w|e?0kn8tMEioqwkD@6`X0 z`d?E2Q|f<9{f|leDfPcPxAY@^>D2$6`kzz(bLxLi{m-fYIrTrM{^!*HocfIzv>H15${*tc0r0Xx~ z`b)b0@;EVHrD?~iL2ssBCozo-89)c>CP-&6m4>VHrD@2USi^}nb7_tgKM`rqUE zqMtXX>kof6*B^dLkJ+B>R!|Psv@PnF!iU`d;#zhMpkF^2jhn|K-=}}ScH)oc`ke3E zTk^UebveJN>)Y?CkLXw5tt`pw`EnkioO#jKUwpYO{vdRYKG=VF&&&0x$#~Wu=tEy0 zKcnM6u5D#|yR!At@Njjj^5WY3!s5ne<;BH~>yMPbpuEp(8*#rEzo6fZpVI!Kp6!(G z;fS`OU`(9S=TI;oEVySs6f7&(5p5$nvZ!>cpK+!5a{Kal`SUtDDH)SGe@fRH(ivsN z?Mh=hcUh86{-XOE(lIN=vi`=jKk9OiNJeikKmH|ceeQL5YyNs=t-QTCzj$qR{R+{o z;Ug1MW4YnV=EnBM;>OzW^6J`ld2=Yvyfr+(wsz5-x8*MN4}bkT*MIf5hTZ->eOg5c`TD~kWu>E}Xg3RcYaZ-sAK_MiU#yYIfOc;>kvctf&G+#zjm9Xp<% zm^yxJZ0OWikBttEoj5fFR#5N<(^Pi$*H5*c{!caPyVDN*fo}PUfk*O>Rh9`V%*V3 zbj0MFinqOS<+YBUSBiDhdHqc&&7QRnYEJR9NVK_sx82{r}`?`cBTl8_Q`)wVsYO~f|5kKzM{Wq`uf@|Hs0tacmxkM{IOuUvzxBKV~ z$*1-4w(ibR-`cI!^#)%KpVlw#Tdf_ppYvN$|GTcCM3(`k15{~Cv{2Z zjwvl3maI4Vp>Rrjiz-FVmB5C|xQ~o0#kXv`2Q|OPw$cCMTmSWAdxKB+y}`##)^9#H za92Zx?-ACldq=y)ja&2Ui)9qI)=LMujaV1OOLhPf<5=daRb-hn03s|nVL--ljWk64%F zo1AYt*0fzcsY!0DKDIP44C}9|y-M(+9^OW9OZUF6y)yCZI-Zo{e5U`aWaT|2q1y)D(* zytcCTZ|QSWDXTiVuDCV*tdlz}qa}G=t8=Tf^U9so_NLCU^OO0!#oTXZU@|Nu&$GCi zrz=}kpULB1?w|B8WA?k=&#SCo(ssf1GOLNKdfjb(7PP;iJJ@h-aZPzFSi2q2ma~Y0 z#rG3@J@~xIc-9~2Lto#In>qC8mq+TmAbHPgGlRrbvza8OJmXn{+3}`AO|hEkGB5SI zpD$%gUq+C~pu`k{y~ zhfhq#v;III`qt;q^YMc6#~sPKk4?mLYP4p1PpVs(#UI-u6Kd>c>zKu2drPiclwJ2R ztK2%+ggRC~`PMir#T`?)=_PeZ+q71M%3xzGR?b^*wOviI-iT) zyy`oTRfj*vcbX(Ek1YQ`Q0w+tE$Od)X5el0J4?3cle+Am*YVRDa%|ADL2Na+qOzKj zO&UT$U~}b&*~0FJm@PzBD1}yxM@$|+w14~WeBbqmzX$!$UNn8L;8`Jl55`9y={S!( zVH+x3-ROQlQIlsNHhFx@wsP66c?DHn$S%07p{q>)ANV8dk%?8Z9l~)h2 zo>*4g+*UTE#eK$xCF>P7L(i-4jq7h&ea7b1i^?_f$a5;Fyw=lgzP+rotjF2lY0j{D zdbQ1DOr8yCHV?6@o4f^=$K;N?yf(*I-TGVI*O2zFPaeGHd*wZq!w+eH_bY$f^;X|2 zecY;d;Msv6&;{*L{(`oCqvqPimDTm5o8|4Bo9nZiYtt``o(leg@}E_K7jz5O6)Qn< zR&rM9SJYkCgP+oM2DKg3IT_m*E%?Xp>F>F&W2Pl=;(9Qv&$VD$HvMRDO0tvJ z^YxNU-}j8=*$>ivKYdPwr|s^O>eyye#$C%g^pskxP3x_@&ug=eZxepADs5mi%QEip z6FNSxXH?c_vfc}NM)AOI1FiYJt-D)?Ha9|VY{q#6R!eXm+xI*7~Yt_xxF$vyi{JE zzqz(Od~0Ob5;ith@05=&uC12Wx93)urgIzfBjcO7t&wYsqt{$f>n68gbX*UP%(()7jA@rgt08}g7$Up@EA*)y-KtdE?(Q9N^@aA$0$d~JF5!i5``Hn%Tc zzBx8_dgJVk8^=#B%$|Mu(&qV$0bOuqK!;`r+3 zp{>OYNz}H!y7a<}^skU7L`9brYCd|2JPtWItzYf2lIT{)sppTmZ-*nM(TUDI4C zW!2_(FsHpGspy=OW(!uE+TYT-*OYHmKGIjEy3YqUl(MaEeMqSr?pkx&Tao-V{h6#Q z`kdC0+j3lu=$y6SjB-}=B+p9LNy#coC73mGF}Nz1!W%mNYA~btC6#+s`CkdXipp6G zUf1)#E=SO)&V0YC&MBu2IxDVZ(~@ti0~0Fix>91d*|e^CPFFaqtG=R~>nfw&RZ;N^ zD$O00V@6W0sVuWfxu9d0R2SQlc3E|5)y#Os=Zd%o`os!7r$ejxk`y!{(FSfN`E!wz&)K zer?HnPV#OmZqLL&u|sa25j)GKwSQYrFRxPPRiX)%f5knw8P!WZIHCI<*RfZ1*O$aw zx(h3b%~O{3c}913K`o`Ay0#_HYdYh$YUY?yCseCrs^!b7C9^80bj}r>F&VrjC)=Xr zS{+zvtYmQ+W3KDSlDm7e7O$&()-LQGbINB>zk2*i!a$VG)XO_N( z30)@+7T-_sL#WT2jA#9UKD7LHU0;s6_Mc=TdNF30+C zXClT@9(?-y@#QP&keO!>T5RmB?$uWtY7OR;eW0nV)yGdecG2FJX0mp)sa)1~Uv%<% z*JJ$k>`OmpNc?4K{2~3Bepz>Ct*Z5$dQZZX+TRhiw^M3udC_JJVa>`@5k16+*&NSIy(RKWFKdJWMuYXWw`3Y@(?G_!gkbFJ`rI`u0sNQBi8M|wH z8DdDEHV?G9n|VkqW+tMoSDCRmue>&oGb7KOmgdQMl9SWM1~WNrl`E%nV{_2bOuo%3 z?Mn9Ig!zBGF={#OwF;Xrn%8K;jpHBYKFtKRQkW)-%VA}RSKi`v>3H?oUIU2@<@oOH z>b9I>E6dgz`qiV&XwA5_nvCzsR^M!PYxik2X7y;ZX?v-}3}suJi)Y$ayJiSm`FcZY zlYY8wQhQea;qHr%^*prx>0y`d**op{)(;KTW&YW;!&GuzoA15}i+lK}S=iGjE|*_^ zd2Vg_{a@DKoQ#xZ4JVTtjz(kvt;^UsCzI)_6u}!Zo))AY=AF5@ zC==;~hQ1qa*qam2NXl^yj}@BQ05Pet1fz@7rUOt}(04q-)F` zYc6GYd*fPpeb~FBjyku}>y|d18+~zg>BSq1BgNT^FP}fNcIVEUmuJV9FBeXnnaiKt zTwOYIV*SiS`Rwh9rOBH&b*bQ=f9DzZ7OU;w(}tHODF51m8c(7sF zMvJ5qvgc*vH-> z*E5dUt!BC3yQg-4*1S^x2$o3ys9s5WzlDH)9;vOKdfHCZ(y$uKh8y-CowcOHO8V-O z^-X(?>%+V%^-0g#AGe^>qhI=}XPZ-+Vz-&4y)9vHG26V^{1Wz+1M@zbdbWL=W!hqn z%|2~e$7Y!JqLK{={nWpipSFH$bJ+M@RGXptHz`cX+m*}*5WmM^{!^P%oA1EpzxIZz z<(E40UDd7Meo$R%YAyP`?>$z9`!6Q=HC-RKbH4T5KphoshW@lRKk6jDFOpQ@{#z0c ze}_Wno73URYW;EVo(93&YNu6g2X%f$eA<~%2GyR0Nr#@j=3(I;CYyM z4aP^`e*xmJE2FE=J~N@GQ}w+A!IqqTv1MbfmSG&Z$+roUP1m=xWct2m8mtY6x<9j8 zOf^`z8^c)-w%aD&fd>-LC3*c7<;!XNw7;#|?=8=M^=kL|@vGpc`##xsRkp0QCk20B zPpg8>p&7phV_!5e6>LsFTSGS$Z2P8y&4xBx-5h=PvcBbrUt}|@+VUjZOF@NxUYou5 zX$sv`wW-n}oo(*N*kNiZ_9m(+TC=vz0yk^i^2bXkOUiG~+}>cS;G@umCiAu3=RffG z#{THr1Kn@OmbLkZKF+VU+1DCR$=PrdIPeswfy{toUAG!yxq|CuM{V)t+0hVAD)?ouS;XT-f z9eCi&vHUE|!4MW<1=ipWY{Ce(;C&eUY%D(m55o`^U_9Erx{!f~VF(Lw1=e64HsCI7!8Yu|%%S)?S(t+}ummgc9oT?P z7{NW*fx%yjyD)++*oIx0Im~^)JS@NxtiX3*12*A3*oGY#{2ccI zb1;NOSb;TIhj(EFTkt*%?As#>8JLB6Sb!y1g>~3~O?VHsVFw2L_ORx&-umN{r3$|eg9vF({XJHP`z!I#$8r*?R7{NW* zfm%{`Ap;M?5EkGHtid{Lz+KpaZPypzI4<4!W;}?5msOg?!YFDU<=-day-QM0T06v z7GMchVI4N$E^NUz?7#yP@pZB=2WMajR$vY8z$T1f8+Ku468SKMMOc9~*nqpR1>4Zi zUk91T=3od*unOz20VB8vJ5Vzk7qT!93$O%ha0fPF1lzC+GcO?*hOh`Lum&4&7q(y< z2EP=`8-zI+!V;{)I&8oQ?!gY!i$(GM!#pg&60E@;*n|;m!!FF&yi6erLs*0rSc46? z3tO-a-OEXmH)t;@Ddb=XORx&-umK~u2Rl&TxOE{5^RNI*um*Qv6GpHNyD$?X7lyD1 zE3gI|a2K{<8|p3D)2aY{Ce(VHajj zBNv9S2rIA#8*mr4U>oXnS{DXk4u-G7t9_&E9mE%Gd=3xPrU=8lTCX8Sk zc46iMa$yLIumWqa0e4{wwxM3Mc3}|aU8GyRZe@Q16ksFbH!nge6#ob=ZIr+=CtHoQ#s3y%fvO!vZY9 z8r*?R7{NB|!b~ximxUoL!V0Xx2Hb@$*oJyb&V@mkgCQ)zDy+i>jNl&ZKz&uig)Gd& z0xZEA+<{FP!8Yu|%wIt+3}F#gU=23lE^NUz4E|~?ZxH5S2urXE>#zYMxCc8h_&Vi; zd02oYSc5yT2_x8sU6}a>a$yLIumWqa0e4{wwxQm!bYT$YUl_D4H&^a*nwKL zipvS}umDT226tc+Mz9ULFtdbQ7{Vf~z#448UD$$cs6`(a24N0{umr2H4jV9nd$0qw z$l*d3=3xPrU=8lTCX8Skc46iUa$yLIumWqa0e4{wwxN5|P9g_aV!1gO!V;{)I&8oQ z?!gY!5|0a6n1=;ef;G4Un=pcH*oB#^$b}&+!V0Xx2Hb@$*oJ!9&V@mkgCQ)zDy+i> zjNl&ZKrJY`kcD|zfF)RiJFp2O*oIx0xsF^I!Xm7|8f?H_*n(}S7Y$t)ggF?(60E{H zY`_Ta!4A|bc`jsO9u{B;*5D3o!U(ou7iKERg&{1$3ar5f+=VUJhI&)pg+Z8uAuPcv ztiuM3;2!KiEhW2jNl&Zz~C*)3G=W3ORxraU=v2L4ZAS&HgaJIi?9M~umN{r3$|hKP3|A& zU*cI+6w>>M>%l+2&nr5hZ6r?Kcm4SDll5uw{j|6Ad3?Ax-;?#8K99H^ zr|l|jSEkC+{t+v5uNS-_CcPx{on5PYmwIi`{BjvBmK+! zkNfqLFG$Wa+U)-$x3J&-nO;Bcb7}pj?Jw@<8NwzB<-iv{(ACzYN`F1 z+TZE?Bb|Sx^Urkto%$bA|4Y(->h%X(`|$D9|CIWltSzMex77cZ`rlIjTk3yH{coxN zE%m=8?Z?#rmiphG^gY?s|Cst8Q~zV?e@y+4ssAzcKc@c2r2Xjqjmh-X|Cst8Q~zV? ze@*?*ssB0kKd1iZ)c>6NpHu&H>VHno6H@VHoC&;9?O%GCd!`rlLkd+L8r{qL#& zJ@vn*{`aK)ociCbS3KG-()EXQ{UKd{NY@|I^@nu*Azgn+*B{dLhjjfRU4KZ|ACmK@ zbp0V+e@NFK()EY*|NncuA0=IXO4py#^`~_GDP4a`*PkBeXHVB39zSlT>ksMrL%RNu zu0N#f51-8X!%s;qn{Q`J|NHxz`yb%9gCY07xR;&6?&k*@jn(-h|IhpT`HB4TT%Ys% zjgudBIlrju+wZB5=vUvZEdB2D2<6O+=Kt{Jw)lh4Ir?D#;XNwheoy$)~9U$3l{w>Re(udS|MA-Xku zWMXP8H(c4=*xp#&SQ}nmUE3~i4#k z{@Y(!v-Bk0vEXw>v3vTt(3*l3^ABJ7nVMz)>F>Y$?%RrIo(qCEB+JAd()QM|8uLiiM&XR2KXL^Yjm{u4A9o_Ks!h33q$;ZMWGI zxBUM2zxaiJH}-q4eKv^TeV@;&q$hOQFC@}?vbf!3`F>id?mpcQQQQo+gO{|orY5wm zAE$V5Uk4DBq;*WYWRBw&-%s%6@OhK*tUu6)z8wBMA1^4sb;JcV`FS<^F?Euhn!RU?n?!D)lls_Q}qrsBP8+Y`)QkLn6cBXat zypy-=pndBNi)yJ8 zYMs{JZKxSiE3}qxgVC7U;i6i5+y|DFb4amqH*DB&HKCXd9}`OPuFuE2Kf3YdFRahsTD>yAy}Ge}dg=5tZ@HqDl)+S1k&O4?edtCZ?Ps_#uQEd7 zeqbySufjS^mTyI}a@sy0{77&#cp=CJ$My7A-LRN-_WPz{)*@DeJF0;tgc-SX5(d@+-Vst$?IC3Tb-R(?yR;qb&j2%%;zopelr7;VIg^* z#nn7r*{b?X9`|zltvvOU+b{jYUhn5s)-P$h;Ch+WL{`1-wmu8m-_RXwxVE^aJQl3o z4rt3+M8V?w3BDeD-ef%M5A>nG|HsW7di2X9^<9v>=e3ocf;QW}tg@TQV1~%3{!B%i zv0!S|Oo!O+H$%lN`blwAIn1E3T)y1CJYK%#G(~QTc}jaWH!vgQ!4NR7G&6f9-4L)W zsZ+|EcjYo;$_9f`t6MMHsc37j{dB2S)&KbSU;1TlyxddVtD*nqzq{$wxL4OcZs&YG zw*3FF$MUyi3m=i?|AWU{{yzC}w$Y!o-@8GF!(c`L<`$N7QxVGFdm8 zbVt1vZ@1ac*7;oY=2hQ$ET2EecbX(Ek1YQ`QtS3vE$Od)X5el0J4?3cle+Am*YVRD za%|ADL2Na+qSBg@O&UT$U~}b2+d-YPE1FyjzUDmr6RPW&73&?#)Dt51TQF(zIDM{T z-~Kz_cRk|o!O--)LNUP#@p~}N^+?BgubjSod1Z8Uqx=0tO`d_+Tpp7;x{f`rTi$nPJs4neR&avE2HwK{2Z?UEL%wE$zB^`3+x3JVu`V@PzHcbi)z=5? zmTT|T$WbY;vd+FKt_QRFTnnaU(~kzHBs+OMUoXk@ea~2){UF`<)8|BZ+U`E7j=iWY z?poHNr_^H2(GWWs%!)M&(=1W5YIDlHOounibzaZNY|>=C7xawcf!zjLvwy9-TZcCH zL0QsFzFDZ&-R+1u7VPSi?iyAKv#A$#d{N4wH&|2rpncKK|2LPPtO9)3_q20veqo@Z z_ttC_w#!;K@hZS|`Q8PF;f?v5+bg5POXcPHn`_&{w?>97VPkXkPWkBK+G=@ydv0}U zI=3-DGQOGH8o9POdi~W?=WmQ`=MODzES2XLSLA^&uU{!oFWs(=oLW1xQ8{+@+R4%4 zk+HFhR|{{Pd39#&l6>~Be06GJe)08l*N=~$OrAP-y{tArHy))pM_$ zJ@d-S`pEek#WNQQcgAMQ*Oq55T)1&*bNk}un`2|AH_qO;as1@M?AezuZJu8#%-$Ja zyYscy){$a+Fo7WKC^ZqR~TI$ zyLRICjbj%kies-_J~=irwR+{u@nM2Ih5mwa6 zht<8yu4~>@{%yr?sml((m&2^e*nM(TUDI4CW!2_(FsHpGspy=OW(!uE+TYT-*OYHm zKGIjEy3YqUl(MaEeMqSr?pkx&Tao-V{h6#Q`kdC0+j3lu=$y6SjB-}=B+p9LNy#co zC73mGF}Nz1!W%mNYA~btC6#+s`CkdXipp6GUf1)#E=SO)&V0YC&MBu2IxDVZ(~>`` z`+hOk)5Nh>r3J--G!CJ<|)hiJfl0ipq5flU7OGPn$Ebb znmMM_3DxSDYWcEi$*jsLopVKJOa`yX$!30Qs{<>Il`Jk}%yk`Ea(8dm;&qkJ+J)U? zPWj9U6}Ob~BSTj|Q^GH=KkEE^%XLwIo>}@DCUl)R{7G5wZ%0!C(KN%JLK1 z`r0izW+C}}3Q98*&eoaCCu4UVue+M=jn`+*LlUn@*(&U)GZyES*XD6%o4C{lWYabob0xeW#*uz#U`S8V$3j{kTf$EV`J2E+G`ayUo@}Lgd4{{%zc^(YNaqu z7MH`y5U&&4+Oo|(tsM3mNNgy_cW+m><&-5?EB#lWZANRxt<_|FPkG6**{z@Xnt5!q zX?v-}4CMt$jAz<*bu)yme7zyHNk82-sXeRzaQDT>dLCN;^sr0!?45Re>xTyFGXHGa zVJf+<&3E5~#XWq~EbQqMm&-4|Jh!%da&mLz!upwWx312=F}tudfBweejT5Uku9xR- zoVk2_Yj$8WvjntR{;i)LEca@&N?j?Ls= z?}nK%E4K0G?xU_XmomJ)ajm>Q?A=jEom=U3OPkJ(zPP&d;*G_T;_Stj&!1VlbLY*= zv*XK`3n$LZ_hc{;M1*W0|s{!0~G1h}H( zAJr>K_a)0hH%5@_8OQ8av)u39Q@cNFUa5ZsOQe5PuOz+SLO?%{)K*VDZ6|7JSdC@F z4SSEyTGC-9eRawD=C=CRhj~@%lb*FdZb7FQYl{(eHilu`1kuF~P6t`na9*t>*^nsBkm%r?vS} zC-Hreqzd=nl6d$#6guCW4o_C=k9+qt2;NpZt!g`{^DE-h&V(|k_AD$yiFKozz2;%z zA173Omvmciw%~b~cn!u!-+uw(uPdXg&ptDur&IO41HqP@eX(U@4ya)qxyiQ)lQRn6 z&XVc-o@uZ)9P0keYBAMd;cg6PJ=kuWcn2OxJeTD4SClWO?bH6Y>IZ$R)b8`+SHVyB zeX{SWY*}qj3ckHOtqQiquJ|>WCE2~Eg3ak?ZcDSkZQoRI{35;C%9h{0mST$AUSuW8~YtRX`JkxN=K`Fs1@fM78y}w%iXUgd6^Al6c!|D#b z^_^7d@yc)S5W1x@C!4?TmdW&etMSkBrG%`$lpy_76fNA#It2Hjd+2fiH3&%zuGVG&kf4er1uj9?4ihr!Rr@-y%-3}FG5U=`M31Mb2W zY{L#bU^+=53v+M=mS6?e;0|oU2=2iS)S|5m8F(0mumD$J4c1`;?!p#q!!FDmim#J} zIXDALumazK4cLSc+=Cq${H0j_Ak4uK7T^l3!8*JPBiMp%*oB$H+y~6V0xZD_d%aUU=TLs*0rSc7$V7e=rJ@58{pJ))3-S(t|fSb|kphYi?-_h1`#-~pR* zC}d#{hOh`Lum*Qv6GpHF??bn^E%_N!Pzr}(2n(!4MW<1=ipWY{Ce( z;C(2^Lwq0bFbrVjb4gLIeka=tlhOh*yunrqAf_tz7HKTDM3-ho5ORxraU=v2L4ZAS&5^`Y( zi?9M~umN{r3$|hKOR>B`n1dlK!78l728`ey>_EL(6yHD0!vZY98r*?R7{NB|!i>$! z6tXacMOc9~*nqpR1>4ZQoFsXJ_L7o94u-G7Y1PthOh*yunrqAf_tz7^*WpjS(t|fSb{aU z1Dh~{ZP_ENN>OvOgVF8w4 z4er1uj9?pfVdgY)VF-(`0&B1VcVP>*p#zYMxCc8>@1MAkg?U(j zC0K(yun8mBhFzFBi(DAOBCNm~Y`|UEf^DcbV_X=7IT*qctin2MzzFWa4%AyYE@WXI z7GMe1;0|oU2)1DtW-cHXhOh`Lum&4&7q(y<>P2f824N0{umr2H4jV9nd$0rbg0~A< zn1=;ef;G4Un=pcH*oB$bkPAatgcVqW4Y&(iunpzzb72tXUcC4 zWMLi_Ul_D4H&^a*n!T; zD9PDNvHUzNz!I#%9oU2sY{M?h6k~Z=7{Vf~z#448UD$$csJG-?7=$?(!V;{)I&8oQ z?!gY!S2bM7!aOX%60E@;*n|;m!!FGH739JY7GVX}U<2;L7Hq@dug3BQVGf3{1go$P z8!&=B1n)!4Q^U z71m(`MsN>yU{Io*Fb@l`1Z!{yHem$YunRNufeTp}!Xm7|8f?H_*n(}S)gTuJVGf3{ z1go$P8!&=8GyRZe@P>Vh;48j}? zVF^}Y9X4PD_h1KVk;8>7%)DFb@l`1Z!{yHem$YunRL+kqbjugcVqW4Y&(iunqOH zoeP672SZqbRal1&7{NW*fm%>>Aq(@c086k2cVH7nunoH~a~-)bghg0^HQ0c=um#&t zFB-Zq2y-xmC0K=Z*nkn-gB_?>@?6NmJS@Nxtic`Fgb{4RF3ePr3qx3h6jb z4fUqH3xhBRLs)`USceT5!9Cc4T1s{y3-ho5ORxraU=v2L4ZAS2g62q4u-GWbJ{+wuX%k@W&4aa`}XFf zm@NMRrCCU(Tl`sVANEb#q})Gk*UMSuD5Uoh*Mon4pI3B1+enUI znV&6B>p#{xY5PmtpZ#$AwZMM(wfe~T?$@vSjniL{9(zWc{T_ma{n`g<|4aLy*@~(D zN%c>ve^ULMjz8)6o7x|#{gt#IQ~UGD?+K^&cRK$_=U?gkGo62@{)g26lKP*L_EYbA zoV5=hPyKJH|1I^urT)j%|C;(=Q~zt~e@*?bssA6NpHu&H>VHoC&q@2y`6NpHu&H>VHoC&#C`8^*^Wn z=hXk4oF}CI=hXk4`k(v%KhdfGJ@vn*{`b`Xp8DTY|9k3xPyO#n`#JT$Td#PuU8L&| z>H0&u{*bOer0Wmq`a`<@kgh+Z>ksMrL%RNuu0JH_PwDzYy8e)^Kcwpq>HmNEct1+I z{*=bQ3J9IQw!;kzw%kO8W z`s2Ai=l5GD_^8YIMP1*1Pkltc`fg?Ecb`WnXI?b>%a_~Y4?^eYgZ+p1yj-7}jA#9U zKJ@kRGdlj`+E%u=D_buO4_CJ;FRslmEN*O8UR>O`{z&-?%KN;w5%+uX3;NyoDeW)n z*-q&mj%XVS#>6Ro4h8f2U$^bq4+YE0bwt~Ujw~wO>StUjzTCb%UjDp}PD;k4&Y#k? zhIB?*ag#NsbC)IAsVI8g~2l z^l5Fu!qE}Xg3RcYj>5KozuUPh<{{Fk~zO8uXxgdB$vP|3| zZEqbro}ZXHer#;$)K`y<4vn2SH9jCm1wum z$G>`J;5)jEPyS&g&o6A;+HQQz9F)%6Bn4xiR9?pu`|x1UW~QUANH-j~du^@94aSB_=z z@q+fPH(0y0w!Wa&H=)>&_N;Hj!_vH3vbEcJ#V6GhhV;24+E6sE{0sWDA!_WsawX;4 z&}OaM2Bsy~-WSy3O@<9iHvCv0$ZLPx?d2qGQgUsOoYLMAcb$> zZgEYqA#EqMzoo}z-t&3oSqgqv&#$fRpw8bDpSJ5nI^RMoMsQ$&9l?gVEJNo!U1q^| zA=0Y})`{PTURsY>m*ktAf3()LT|KEuZmT}FG%yV7ud2OD@S+~?MsQ2_zU~xU9KWvP zNjY9#GW{1N|IcZA_b>jjyFMT9{^-V+zpy@kYxT7~=pyyc2oQU+@dMKa!l z_n{kww4dR|yvhiP`+>1Uyb9|uS-us?%4z$2@FT&|;DsO?9M{udb;DxT+3%Z*S&LW= z?x;~ODaW#FC)c&Nr8=9}R@VM4eQqjcRY%tqHybbOsBTJD@FR5e19yC-{2sd6V(1KhTH%{vS7U=+Q5a)OSJhp4Yal_A;eA zo0q~}(j5&+DVoU;t5BOcm}Q^WQB#?wtW8y$;xbRkYTT=9AGdS99$Wqc7%(;x{Ko(CEC2aNX!$>b5oA}hfaUL#A2;s&Nn8Gd zul|i=X8HdFydRe|Zry%g?6U6_T+gA0c9RX`#pK%r-?~r!y{pHw0_(_DjgayCsfxlE7m)fsV7A2w_wubar#`x{`>#rS6q+y7cewEuTV^|Li`?#b3M{= z-YcgsUtSqq-ROQlQIlsNHhFr>Ww(;!My#Cs3BLY)-ef%M5A>nG{?iU=Hup8>m${y7 zShK!1>Ds>a6zdl@N6ssc%>agU#0DpuE7&k-%qeZ*k>^xUd99~gt_A%a(fQ``GIyHw ztcT~|md9o?HpjP_jOl=Q?qkE6`3Y3F{#N%jr2X*!`kU|d%6lq@AJVSQ|F}!{z0$|6 zdIz2z_yJwe9_24+>o;nyZCqJhKe}1ozPY(RySX;~!sw~sFDU<6ce`eHZ^{Bs&PvWI z{ffHldhk=a&Y-q~IwxcMq6Po>J^ek`b?kB7^1eIk!2px9f)gY*@D}#}km!~>+GB2dN8ZcwP0E{{b+DXvXj^I^^#2A z_l)J)57K=y&1hT6Z^3ckKH%Yt@b}i#8xGDWBPy*5NId ztoMSRk#+Y)oo{ZnWp&!vk!QYdb0fs^V<*Fu)PcF=O#X!1i}RR4VAq(JqzA#8;s@=E zcJ_bSd9n)dUEkBr`OVJ_-2GfU3fpC^n|KxAx_s{f!|=xZ&Fz)Z;idBO{LQuP;aela zmawt8dZ&DJac#A{zCE|PG@aX+9~s}wZH-)89KHVPsq;5Rw)2M;HfH6R zF1a*)addp*(E5fvB-1CZPTbl)bNtTO_{|eHUt4^waOV8TnHyidGIRFEv2&ZF=dYZ; zadqn4ojaQg=O-sltjtWTUcPbVLZ$NZ{GF@oqpz$S+AJ@vZk89f=WcGUPP^NG;m9#* zIQ_FVmY$iCQj~kEva!BZp4+}%DNoyt9opKS-!4yIesgX7+FEXM{d}Q1wtDH*%+1?h zJ$GdJ(z)^CZ0_{bSasy`!fUUdugp}BET5U(T)wuod~tbpZRysVH&@puzBYMiYjHyo zwXLr%y)c?9U!PxH6SbV7g^co#>G>qp?FrdM$AWV~>;SsxEF+uFo3->Gl>J2gbSfVF~Fvu6-s{?gN$j zqEx7jtbRCp-~cj*n5`qMsPhf0JDdOAQr46L3b#eEaplX&9v#t|#G>S04_=k(J|Emr%C?lrAy*E&)|~cMbk3UoOx6{BPV0WdzbGkHxeiV!Pesq}jFiMFUB#|=M^Cq+;bC3R`3;qLNmsF%z}4UtrCbhXblg

wZ8>^Q*S4oJt)t!!enIzqi~%zqHlOSUjPt~@&0T2s zYfIj9l6YHjdnVR$?1>$6^NiS8Hm$P0sV6tC=e(vTKB@E0s}8EFmsLH(Q@W#@lJHgC z?GZhROYVsj^~`dr2b*D4Raci)2e0Ybo!6CSlwvv0xM6=;a<>$_sBKnPSW?ZuDT!t_ zO$1-l^{g~jvbc;f*L8f!-MzU_uB!%Db*|lGPWj9Uwd_*Lj|^S?ObNfd{;2cwE!Rc; zd1mQrn9z0N@UZ3o=`$Tn|NVrvzT+DA(Qk;ixwp*)rbKf<*-FHNxw~2IX4~7kfz9LN zRScWI+t6?84`vXU5z||vM>BTXhs#+w zdw~W5BTOz?w>O7GF>ZtQKR)K*+_eu5qIEVv{}EpZx}JJzxI1B+_PU@`^`@c)ISxgYc}fEb@*nT&{T$xm}W9{_R4tq^5pWd zx%o4>3p2~dtGU99XD%+k^zy0Grz+PM%hS`xuUuWYKJw-(Yafsn^Q3E4PuX-&hjrK9 z`%qW>46kJ}%JPDCZgrMH?fA~Xyi-?x3)Tqt>WOEQ@B=DSzw67^1t+_=%|zY%xj$g- zZ>`Fdj(8B7(r{q|aajZ9q=fk~34(bInWi|*$bVeJNKOOMiwe6a|4SM?PicTTr2*i& z6F<`$oQ^Axs}d5Xmb|H<$y9^~D?vZ{!7W*Dewayy?|Y`3uFa{%q-%2@%-Y;XPn~&E zOGsX=!nXRDrNhjVrc#(CBwm6r1t(T6?0S4=%MWI`Fk`40D{TdE@3lO$Ygit(+%V^q z7n_#Ed;e?#VG4{XFYyYZSwd_Jlr3AB4aIgI+TUcL;qAUNHD<{Uc04|6l5iozn`>9g ztHXX8f5c74U$wBQF!$W@!gJSOT|9QSF!$2sh4tx+7tiF*EN-lvyKwEw@t3Z=zFfSv zGC#L^N>+z!cH@aZ`n6y8%Nuv)XLcKW^*ev!hGozGVfhc99{7C?54M(Jqeaqq)3-@8 zxp8r6?OHkbqSBm~?srXs+h&N_;8k^C)A6oKtlNAs_`tSu+*4lWdNG2e0X56>9{G1K z9JASc1WSZ}P+K|P&49YsOn#%Uo;DM;G_1z5=4QAbf&n!hR{l~CD_$*m{Op%bwF|sD z<1Z!sS$|;<`up!D{`=(1p0mt&#WydRl5-;0*0^jdMZ7|6tIIYd7;V;Sb6m4rSd0Y; zZrdzw!@}O1z->@5@ol-%2KPoFRjo2#%>~fZT9<4wEML%@3%C+`Sd^?5pIh9lny`YB=*@SMY!Kx{_x&& zr8lF)vZNk58CiG;YzJDOtkoneh4{Nfa&SL{uau-&z-hBNf z!}mSYU`;L3^O@G-4Pke5ZtiZ3paZ+`K;pe5@4uvYp^lIGF2DD>8_%B8)Fa!0_rL;5KCS;nrtsmOP zgm}}x?X0tP#!+2MwwHnm{dFB?l(c1u!}>J6-E?f*-eYH`f!kJV)4)wrHvw&e+R9-e z6HXM{rUh$x51fgD4?-4Nj?cgSJC7C1UL1Q`nt%V@f!=px&DuoVhxwHt`#RXP^le)c zvI+FiL&AF__`z?hOY3+>@mk`OisfiP8ORmjZD?U8Sr0VqEC^moh~=4v3l2&NR`IuC z9P8c1^6x34tIr>qSRPgb?XT~oNRL;{`iD^a;#RWx`)-*G-?te5B%8Uj+RQEaR20qK z%{m14pnLHO$~+T?AA%7qz!I#&I&8ouybC+93lDrP&OZx77{MZ}z#80wP1u5Mcn=0Y z8|R;ahhPK?umr2H4jXVAwqXZ$;Q^CLa#9FE3gLZ@D6OjHoOM|+jTFOfmxV` z1z3VrSceVRgm+;FcHse=a>!+22qRd86`($AVXJ83dU=41;CTzhS*oFGOjdK}z2u82~mtYOnVFPZ%HtfJ2%*5Z& z4YDwVGq40J@HT9~CTzhS*o9u>8AS65VFU|s3D#g8-hnOHh8@_08T92W%)+lY2!8W`Hr7Ono8)ji17GMchVI4ML6W)a#*o6lU z$M?y?5Js>FE3gK)U=y}r8{UJ`gyZLchhPK?umr2H4jXVAwqXZ$;em0U1BP%0mS6?e z;1+Dc7VN+t%uJ9!j9?K~U=23lHf+NV^z+w2=CL7+U0Sb;UzfZMPQJ23c#IKM#{!U&dN71m(`w%`uzLVZ)w zxh%}X0xZEA+=5Nmf*sg{nTUL01dFf&Yp?;gVHyScDZ=gAKS1+pq(*f5N#z7{UmaU=`M31GeA} z>_Y9;a4rk;umDT22De}nwqOVLVCDq*!Uz^&1=e5#Zo@Y0K(C!aOX%60E^3*n}ZRF4T@3=dv&l3$O%ha0@nJ3wB@+X3mf=j9?K~U=23lHf+NV)J`Jj24M&zSb|kp zhYi?*JFpA2i^;hx%)4umff8b8ZlZFoGpm zg>~3~Ew}@_P>cD_Wnmr`U0KEWsMwf=$?h9oU1JUnE}`!6K}{8f?IA*oGY# z{OvfuK^VdamS7duVFR|{4(vjGb3T54n1=;ef;G4Wo3I5tum>~WB3~H6BCNm~Y`|^U zh8?Ic0ysAaLm0sltin2Mz!uzrT^N)oC(OeFEWsMwf=$?h9oU1J*}%Chj9?K~U=23l zHf+NV)H;xJgD`{frcAyr0oEwB8j9>{?VI4ML3+})!)FOv-S(t|fSb{aU1)H!1JFo{cm&q4Kum~%# z1{-i2wqXalop#D{a4F6=gb^&kDy+i>Y{4Dag<9fqE(`Op086k2w_p>tUJEWi@1!7bQ?E!crQ znAsp-7{MZ}z#448ZPZRF4SHZ=dv&l3$O%ha0@nJ z3wB@+X5J)U7{MZ}z#448ZPt;5``p3i-iI?7hFe(T2xR z$47OW*B4Z_AJbu*mL|kx`41?}Tr%AJPw9BS+q{zbe%$UCTII;4&k@&ye}A8mcR!-h-`os6zA45wdm%fj<9(;YKdSYB3$##*ptB2dk zlh#i<4nA6s`;qfuoGg`B)I%z-9&JY!;_D@qS07CMr1I*~dQ9cj!~N_@`d!+t(spGv zkkq64<#*by_Fq5mx873yDz#I882vGAS82QYD733V6~bhs{U)~k?Az7A{=>TJBjeAz z*?&H#JU*c#{qLURjaK^|ztj3p+h5xMQu&k0-*o&*$KO={NcFE&|4jAobpDZ?Kcw@o z$L~{3=b!2PJGDQg_LtQDl-i$UhJ3_+xz{>SYJW@ZZ>jw)wZEnIx77ZY+TT+9TWWtx z?Qg05Ew#U;_BWeFJ=o8h+8XHD(T&iwp{T|Tuxr}pR6{+!yMQ~Psje@^Yssr@;%Kd1KR)c%~> zpHusDJYVwj#?=0v+TT-V|S^@nu*Azgn+*B{dLhjjfRU4M9VpS#zilkgT~ZclFVJ?yv8qC;RK+ z9_jaz6CZRrzo7fu|EE5p|MlIFYG~I zA79n=pVqOoxmnqGet5XLQF(4zGuD7xbI{6MDC0J?&61 zrm%S(L&0HjKA6?nto~Q|F?V%BXQ5)wx-=s}UZL{}^X2yC@%b+*_L$;ND&~T6912F2 zGOtj}e^jZ*bT%n2D%8TpbbUd-NuB3ZE{n0Cl0I;zM_ zYYXPqX21XI7M`SC`=#L1Md7KJpN_04STVi(%AdXS&fD^2o(_W7m6v6AP{&(GU&xP7 zzHs#L(Dd=6xuL_yrpJaR!|9Qs(UD^#x$%ko=;YW7zZ~cCrQoTjm38ciKfnKpfj`u3 zeDG%#Iy<*^WApjBmD$y+F3u@kpV9G*e357asyY9{JpGHS>)I!E+_p%4?oQvioi_XY z7T;eVJo|T#{_As}41NaQ^YN@o`dp9mLL$5`iaSk~?<)#*jz7TgFngXeX&q6WFD z|D58%a~&X~B&}oGEkmxGe?QKb!^chfv;M*!^yTpByuYCM))B4Q=hf`3OXT%wU13h8 zj5|f1uvvA5afJ_wq0TI(rJHo!C#PKY%70v4X+bd$yOh@btm9755v{XX=d|t|-+f*= z=Txh9WlkM9)Ok*S_O88CbBfHt@DO ziUph3T5f-rpI^H=GrlW1AQ&oi3|My^soIr*CYNJbizStid^@s;J@3Kk7b?kKJtdG1-rV@ z^KJ$eJ^%B;u>Pt#s|3&KEw8Cwtbfd_c4GfET~D?Y-y)OY-%$QPuH&7b{0n{Fckg_0 z?Q5S~oxQnyd3JMoZS};$iGjCVQGGsEE(-`rV*dR&e}5l0>CgHLd(hv1w;{2w%{=n_ z1?6Wwaa{Ejs`VdMZP~zQeQmli9*ZqNKJ)|~!E zm3~(D8d4hTSvj5AJrBG5EshPHHaO0ShjqsV#j(66^mo|m)<3EnYg`-X8~*#A)s17H z{g>an-z)FxIb9nSugw0m3-_JV`*kT8cxvF!>4Nqu|Avmey5P#%<>l2Q>*dWG>#MJ= zuS`9gn+|?L@lUzOwMMwE=J;@D% z7OBtOzQs28Zzf^F+7YBD|TP?~YlMc73idTNj!v-?tR%>gzpr%a!{zazr&& zR_Yt#YVevqSAwbFSv7!Z<(<5rua{)_zPs;J@1^^8kNECf=&KVu_4oI|d-?mz`;;Ot z=}E8Y36t@&KBGP8^Lf(lZUgGPx>(%FZMd~g8LER>cU;tfXlJtui3elTXl+1TP}rn8 zrgePt`EvX66jWXlC-X{gU3yWSc2eq^ zx2E`B`=Vv=54w*R0lw>dTAJ^Ddf?8d<5AddYu&_)0N3UFry0X*vo|)Ea>EPd#n~Gx zo5MFphAm)iefd`T$o$H3d3E#B^1@WOHajx59&U_WozGo6JAL~4$Y%cF{MthK()^P2 z@bc>A@>K4^&Mm- zNiSV1>y`^s=W}D@2UpjmB1|2-GJbRO z?C4QRIQ_GkR-dRb#lmp0$5l&9>$4sLADZkDGmzOgcPbtRlwJzc0CUcN9r zbK}k9uZ%8Ucx9~kT6kjeaCPM3+_|%-D>K#6#gnhCFJ9ePJiqwb%EHYzZY-~ke{hf;7sj#np$X|eu6-s% z?gNqfoSP}ksiVci(F1L0OZo%>w1O--Nj}CSAv%n zaxs|EbrT_@y6-WidHh{3sgyS8EGecv%XydAxKgbuB-SCPl+P8F;HKi83|>$PY}$T9 zp*MnadXjT0=}A53h(50e$MrNbYM0ktJ6uS<1)W?VR?JI{#A zD*1KAJELc-1TX2iZz=w&QopPi2bIEv?y}>&t9u(JmsMgLNMb$sSv~Vn2F!Tae7sH^ z$BFYc-PxYk3}2U&-<$H=JF%8yZ|tD1*o06dtT8SpHRBfs)MTPWm)fV zT2FLCIULv1j_OTZaBrljcNVH1Y=%`;U0qZioYT8Itvk&q#A2Rw!~UZ3-H`9Rj@NXD z1=ai;%F)!O@!*@fpOwZ+7MC&Rs;)1%r#FMmHI;Q)Y3&(9#ambGMHfeHEOFrXu(<9byg_I~tK2a|t4qhrr;jps<#hack2bY*h^GjffHL-IYC zyPMW-y8WEHZVHAe8#aHpp?_Ab#uNfmLiWnvW(5n%*W%c`U`S`Cg2XC{rMIxyh-UK@ zyOSv~W3D_SF72Gk(C^Z*{G&aV+q?QFf4sfxjO|yy_IobevtM2N%}))~KNYKMHtN=O z_-38ZRECe3W-@j5%6R$mVVTwS<6 z^5!dRACMOFS5>C-5<#(eebht~t12(532#W4o0)G`;%Y$#A|=#e-L>~V)D=I&YnhC) zyr7+1on=rvzB4fI)Ro_YHNw4m;@KqpfXdYG`m%Mw$?k14QTKi{h`blWjVT@RAT*`n z!Up292FghZ^JA*5c@3GSILyd@T*F9C1JR2LyD0xl8az*FfH|ewzwX4(v<9c+%Hyi) z*VK|XH8h!u@KGAvlJ(|?nPm9BXS$z=XSyZ5mCx!Zy0;Sqci}zg#xR{{c#+<65aBPt z60E{HOqOp+d4)PY6MSBZ?X1LC(#>-BDF(oioE*BKKsJF4M!P~BTbt9|c z-{Nj4p7o)u-dm_o%XdoeE_q*5>#fdCD|S}L8%ks8lkxo8n;$5W*DVio$#C;q7cf<* zs?X$gpYL94etYG+SNQwA-_NV8U(#_#bzrKTnTY4q^3677YLS_Zt%sSh*xbiWoq1AA zNM3beYi(xfF!Q9T6lMvDmmo~RiIoex9-rA#fmtrh7;47K1;yWcEzs;5md9bGnRCjE zO-mMaZk7;RceM3KyYq-7zL`ZA6>7^CW<#-WAKBkzpyBPlGc{((4h)}9z$Gm9H5=Pq2ka{Q$$uP+y` zt<2A@o|4t!n%#KfkABUq0owUp9n5ZnuYTuG+_3D~KP>;j(*wV+;lb82tg9rAH+@UB z$>qzXwQJ?zi%N4|m2ypj+h&N_;8itM)A6o40diT_|CKWC=y*owJEC=abG|!z`fgR% zwI?y4W_jKt|L%ojHk*%NiSTNIb^Q0BE0jJ4{0U5!@7)Zjw&u6nOn#%Uo;DM;G_1z5 z=4QAL>c!WGXR;jWu#yfd)R?PZQ%XQBpxqkFQUY=A0Pf8$; zJ8@^C&(;b}V47xZBGOhV?aa0bnWk=GwlTrB1I+5r1m>*LJ!;S`sL)^6VMa+?mN=|W z)7wqQw(UK3W*WHd1T+oYGpLmZ;}x_1 zA=I{Sniw(XyQ60^eBWaHlNgM$G8jod6-9G*vkt*M=w7^nGS&d(4#5Z(U@PNrA zxhxFf3@pJ4tidhVge|xOyHGYZ=Q8jRj9>vS!5XZ?2Hb{i*nvHmIT+t33qv>qORxfO z!v<`^7Tked82t4(|3MhS2o~THtid|G16!~SJFo{chj4umgKA6YtXxvM_`*ummgcHf+EqY{4DagFE3gLZ@D6Oj zHoOO=9mek)W?>!{U~3~Ew}@_F!)=P6Xsz7mS7ET!6t0M4(!2<&CBGnFoH!`fi>8G z+prBgF!+Tyzd;zn2$o0KEWsMwf=$?h9oU1J6XXjc zScDZ=gAKS1+pq(*d&Idx7{UmaU=`M31GeA}>_TmGbS?|?umDT22De}nwqOVLVCEG0 z!Uz^&1=e5#Zo@Y0K<$ljZV-krf+bjmb=ZI{xC6UTJ2RZi!aOX%60E^3*n}ZRF4Qh2=dv&l3$O%ha0@nJ3wB@+ zX3mi>j9?K~U=23lHf+NVl)2BjK^VdamS7duVFR|{4(viL<~x^#d02oYSc6-z30trO zdoc4F`N9YmVFlJ;18&1M>_BZVcWw}dFoGpmg>~3~Ew}@_&>0z(bM``frc3|+g#zY^a0hl_P@BtFR6mumyKu7iwK8 zE+@>x0xZEA+=5Nmf*sg{nFaEN5iG(AticA{hHcn^TJ&*l5QZ>4umiQ(&bdJt!U&dN71m(` zw%`uzLch~AyAtQ0hXq)IHMj+vumwA?2Q$}rei*?btiT#JEWi@1!7bQ?E!crQnAsp-7{MZ}z#448ZPMNMe z4Z;vcumr2H4jZrqcVHI=Z&6N|hXq)IHMj+vumwA?2QzPzFN|OjR$vV_;5KZ-4h(*o z=Z7JT;1aCCE!c!Dcn=1@LVhq4d++aCu;DS(@loC8^#zsf$8^}Hr3o=v{sRg#mkc-m zQ##)7Hm_v9AGiC3RylI%bHw%F-`{8C9ndin2k*OneEMX4ntwm-Eqx#FZ`)HCQ5!PjT1C&u-WY!_*}dbpiDY5k<*;G^}pA2}b!$x?YmJ*4vL(RO4Z zzFty!^}*CnDz6@`$5dWD+|Qn*-=*y;ZC6$UNj<7xey8nf|Ml~J>n+ue>{GlYC8W)=b!2PJGDQg_LtQDl-l1? z`(sjnO6{-CEd7XGI<-Hi_UF|8oZ6pL`*Ui4PVLXB{W-Nir}pR6{+!yMlk=z4{+!yM zANM;Esr@~*zo+*1)c&5@-&6a0YJX4d?@9eJwZEtK_ub?|y8e)^Kcwpq>H0&u{*bOe zr0Wmq`a`<@kgh+Z>ksMrLvsF@u0N#f59#{D-oMkGuD_(~FX{SAy8e=`zohFgyV+S& z`+I7C->qGw_V?8Op4#72`+I7CPwnri{XMn6r}p>M{+`<3Q~P^re~;&je%_p}Kcwpq z>H0&u{;=2o&ycRar0Xx~`b)b0@^M>#`Lfg;(``2N>+dV>7vML8A@?ihWv2k`r3dC> z_2`k`lX*8i$zKomNbmKn=m5t|zhpQWv=T>It=GWFM&&{u0d!+mY#r?XD zNtJj(zv(}rcU#ue4h3Tho7XWE92Vz;S)I-5f0Z9|S0{89D(0+9GZN$#I31ypSN`ms zcixsi^K=lruDmR}gF4T# z_+>?u`%>`K0cGvZ`S|`P2L4dD@xh-}@a){$jm_uhR%TbPx=5#VeMZMK@HtO=XoUHTD>iWF$8&a$}Ywg3F4}S;e{dP^Q`_pROKB@)%A5RbLsJ~dSd9CI4clr6Xo3pF)WfO11 ze^uAc2NgFkZRm47$OZ++O+C|!d_y{3)cJ<~BNJ;mvx>72{DktiKKYE&9}w*x=6o%B z`nOfrwcUD0%M!`8V+02VI1#L`XOSQCe~@#%V*%C)zms4K|DgS!d3~-gTNj!vpS5OJ zPwE$&s*erzj$!>(byf+U)4N>@ZtB@rbymiIP1lq8_~%WAe?$5IxQ=&z@-N)|`FQ7x zYhU}^>g>(s%d?xyYpW*~PJH4mSJaXsSZ^&7@h-dvU02k3h6g(Yod8w1mkuSutFR7} zXM=3;g5LhJlMPv?#H`C_En+#ir5adJj78T@uIX$;bvCP`tn-`t zTvy1luCB^&ia^%oJ0;1Tysy={)!Avq&gytWX)Jv*o>v?8QjaVTbIEk(x29latLig( z-RHa4^mDI#_X>Z%_xpL3^-DU=xL#&8kyWpIQ=bK$ujvWaTw7dG9COxg2Xutyku(1T z*FEC>g$IG|%-4et-pk+roK}xZD#10if@J)x&u9<&e0Ec}`sC65e0_W?w@LYNJz1z@ zQIa^8!i$ouCRq3&{`<6moJ*oNbCf-dAGR43KKril1yl?c?(`KTU zhSeF?REuThoxGo~mt=T4417LFhk@8KU~Tr@h8+{%7BAFc&iwmvzTNq_Nq^Q~*n__P z?k2ALnQl85v(lZsX5>Y~C9yZCusF<~F> znZM18P0-tHcZ6I=-Th2l+g(j?n<&pa!EFPNCjTEG$A5%Z+N=_MmcKPKf#*;Tc4_=OO&H_bBTBj_%>=^8*$2{R6><28K~J zBx{19&MUiWX1>e$uH=~v-}jL4R6H|?^n9Pv;YGn6otwKGBj~^`^fM~|UXu4;QoK;d zM_u!OH&K~~*ZGo*SjE!u?f zVTs+GuEe&IoMM{!a$Yp8dRA9VA2tCyv8M<&acZW|1(&OtAjjQ(Vq;{i8JmH!tX$%I zPReJo?Jj0GwL6SIR0SWDEVN8-e&OxMie)d3JuS`1z`!>ow#;y1Qs=|8m71M=TKe{i zYoP0@zJB2y+fuDa-dWXrnB}qiT)6V(|NLpINFWK*3v#f15=+?Ut}9 zfK5J3%-J-2F`ImL@j_0}KE zXCl}Z1r~K?i?p$bw?$hM(y`#SvYEZ=gPDvZWub}K|L$Dtv0~YaV^2%dHyJV0`jaUC z4;AGx8#jJflac+F#~%MLE|>nx$BksZsyra!#ky^g`do|iHuR=W^E#_BE&HGTwZG?j#6N>hI4F)cQF~U1e>c%165jje z^yRaOk*ga$?{2G$KeWvw1F?y?zg$-KP=`4y=YE{8e;+sL&-x2{(BFTz30q&Ad88f- z%FiZLHf0Lc`VXru+1PA-&9vK`>nYYRY+N^;VM6Ca3b*wjn@-t?ZwwVSw`cwq%cg^) zN^euaA*He0S(TdW4xxEpMC19e!lO=Gs8tKGMEtbsHi-`!BzD zzgOPXbNZEyE3-fC!hNsweyiSrrw0CM z4t_#uPPs?%i`&WlU8mGVFS~{RFY7*oI-XG)TZOU5G3Q^ur+>Y5UE8f&-gBw;Ui9~S zmHv66TW-*xAfM@ZMcnv!MHn%*`475}7XiNOds>?BeR|-|r{huBZfo7dkHW6Y_wQF9UYotKxs)4T zC@;?5SlJxDIWlYkYwOFm%17o`mdmS~mzEc%!nN6vvGs6cI(B9J=H|&4ZXF)GaqPyq`E!Mnr$UOKp5URYi)&u?D3 zvA#Uz9{<_Vqmpp?XIu9B3Hg`DUd&We;|6V{>-1JazGnm9eWU;l%3c zLiOc-;v#n)CAZoYA2 zd3F4o69+fu*Oa4<)#Zg}b7A?~?DC4J-SOHNU;Zh*pQN}wCcWrr@JbMGr9JO7Bik5h z+R~rO;C4^PGfLMHpH$?wB(BZ1VGmlEop$m6#y=i@!R7|vh9z6Gk+Tf|{oKOeh4Ix` z9Qku&vdiUlAJ;w;n$QE0`kX}Q?t86lYq4!hUsC5ARyQrXPItqtkPS<(98su`VOnLp z5%q|=tZhmyt2Q@-OFCPShz=#f&0;X7c%k&s5$$cW4d2&-vl88>gX;>}lrTA{&^33j zOFCOpnic(7UYGSbr4$z=7^dYvuUx9ygn3MHDtdP(CA6lM*6w&qZ?~f1VO8(>bv?s^ z?qV~6E5XYOxfsmox`~ic-S?Q%JpQhi+@3P42P@f>?reFDE7ht(;tj}C%IAv0Zt5vc zYOC%o3Cc0u`IwG#dXjT0=}A53h(50e$MrNbYM0ktJ6uS<1) z_AQlTy7P>yfb>XO7N1N`8kEbARk>xphChvRx$+b49vy^*5cS*Uuj8CF$wby0P2PVert?lhwii+R!w`-{qV zL%#DmUeg^GRP%2rN82Dh9(+^xv(i|};xfiu)%6AU^!Cl4YpOw8@3m(P70{Gcpky-zQz0z9DHHLx zvErR)lZrR5D^{Knmv&BN=y&N@{?Q)G?OpwoKi=MT#`ddU`#l%#*{`ns=BEbg+Ms1d z6B~8wI()NEXez@;Of#7}du6~3; zSFSExA9?eYwGT*(dD3tFJY~~89oAiY??YYjGrZP-GP1m&om-t{P&>XeFz?ir--0#5 zy?Wx=B;3A<)bIMTb-~H*Z8K5#e(n!g`}@|9DIKxeFs0$b2I8^?%1H_HV-f`O8Zu3B zn34auhLM~Gq8Al*QT~@Sc%IS#b4mlib&3D7hNfx7x}pJQK_Md=q+U_pAFaVHS#N%r zNrvxxrkj4tNpC*=mQ(sIr&wAQgs^xJ-58@-1S!%kDV>d zy>xkDefr|XGr2R18!P87T)T4or7N#57q6|%&#j)4)!~}mcjAwJ&3&2N&hP4Ab{l;4 zJAdMaWzYU$nT?7zEZb<2G~V=mtKnnwt*Imb?uBDEn~z|LdPu)Dm412Fx`rR7{g+(* z{3AJR`*_K4^IKnezgy^&`F_~6j8}YZ zyJF4>^7tE4_Ddrs{%v*Hh6JO{T5XOSZ}2yxw#|BN2(TX>@a6X9DX6?Qyx5>(;@iG= zWwTQIN`RTX{R*_rfh~Xgy%7tuH7?t)6YrLpcUNq+TUxWv`iVCxerbLFH~b3qU6sv? zaR2)tel5)Vt;*S`Xd>Jc{l84#nmV2k^&i)bis`qeez?DvkZx3bZyOaSB@k`v;i40L zwpM5Y(==lf!L~|iXSPkqH1$|3kGBKZ?+lp0oR!FY)S&A{uo)$7S>muhO>Z|HJN{(? z%ggk4)5Ygh2Kz;u*raH`Enp!NP88dwh0vtoeP@Qm4?-4NhR?tKJC7C1UL1Q`nt%V@ zf!=pxgO}Ndo@Arqet%)=-8L%z;I}m)(D97Q(Gs6@JuMor2Yc`{D!1`ln2l5i8g>>0 zFD1nCOv42Sr39<^+c1vx?(1p4r--gT_b^cHwU*ZZb=60Ix1j&(yM38;SPiuQTWZO) z@rv1bHGBVi687D-qz2;Eg=F}?4Mv~jXK}L9?4^Uc7=b)&S%V!3Y*$ z307epHeeIpg&o+12fh~PpM@ceU=dbe4Q|0EY{53X2ZNuD^UuITFoFeGf>l_D4Y&>4 zumijBfT@LYSs20@Sb`N;gIll(TW|+!Sb$5g2J7$+Y{53{z#hyT;yGX*7GMch;BDA| zO?Ve}U>62I$8*3CMz9Dgum5R6~}mS7duVFPZ%HtfJIJTMgBCksP3152<1 zYj6uTVGHiSF4QlTIhTQlU<3ge|xO zyU=SqgJ?b>j9>vS!5XZ?JFo@YumgKAgT9=Fd02oYSb?`;12*AZ*nwRrt~GlP`>5 z5msOgHsCgF!wwAoW}M$33}FOIunOz20b6hfc46?hC@0Lr0xZEA+=5Nmf*sg{8Jm~M zWnl!1umWqa0k>frc3|)eaejj^gb^&kDy+i>Y{4Dah5F4$=dv&l3$O%ha0@nJ3wB@+ zW+L*15iG(AticA{hHcn^+Dzu$APivyORx&-umM|e2X>*h&^ecdd02oYSc6-z30trO zdoXj1d|?EOumWqa0k>frcA)kVI5!AG7{L;(!a8ig7Tkeds2vE-Wnmr`UVF)8wf>l_D4cLM^unV8G+prBgP&8G+prBgP}|F$8-yW@UhF zy%6W0hXq)IHMj+vumwA?2Q$SuzbuSk5msOgHsCgF!w%FQI_Cyq2qRd6Ral1&*n&H- z3$=yYxh%}X0xZEA+=5Nmf*sg{nO`Jd7{MZ}z#448ZP^Sb{aU1)H!1JFo{c-y&Za!6K}{8f?IA*oGabF9J9>2tydb60E{H zY`_-Wfn6AsC@0Lr0xZEA+=5Nmf*sg{nc2X(ER0|gR$vV_;5KZ-4%9l3bAvF15iG$f ztiuLu!5!FzT3L$A3G=W3ORxsFU=y}r2lilQfqY>Ei?9M~umQJW8+M>p)|?xJA&g)N zR$(1BU<>ZRF4Q82b6J>&1z3VLxCNWA1v{_@GndI1Mz9Dgum&4&8@6Ew>Z>)*4Z;vc zumr2H4jZrqcVHK4iO0Dt%)4umiPA+POg( z!U&dN71m(`w%`uzLVYdAxh%}X0xZEA+=5Nmf*sg{nQP<=BUpqLSc46?4co8-^>riX z24M&zSb|kphYi?*JFpA2_F|1 zcWw}dFoGpmg>~3~Ew}@_Pl_D4cLM^unYB7Hs`W14-2paYj6uTVGDL(4`yzXFN|OjR$vV_;5KZ- z4%C{?VI4ML3+})!)VDO8%fdV?z!I#%E!c!D*nvHmd6Rr$1dFf&Yp?;g zVH)cp(u9~S z{{e-WONN{ODIFiToxREDc)!mVTII-n(D{zU+3q{v^f?~>sgv}5#0|)|i_geApd)Qp z57&#ell{oCw4cAf{{-QK?vLsFNZ*I`?r1PkU^^X14TPk-`xtq$}RPLs7HHIUDf2a0`)c%sxpZe{O);_#HwLhiyCu<9-{Vlb> zrS`Yf{+8O`Qu|wKe@pFeN&PXkzoquK$9*p|wLhlz$JG9q+8N^MY{fwu0N#f59#_ty8e)^Kcwpq>H0&u z{*bOer0Wmq`a^R5l&(Ld>ksMrL%RNu{{G+Yc9eAeDP4a`*Pqh$r*!=(U4Pom&YrG6 z>^^R$>ksMrL%RNuu0N#f4?mjqhc8Pkn{8)9zy7}BegS?n7;?YjUUmX|FFQ~!7Uz%r z&ilLBiTw3&kMw(ulOJ?Bzo7fu|EE5p|MlIFYG~IA79n=pVqOoxmnqGet5XLQF(4zGuD7xbI{ z6MDC0J?&61rm%S(L&0HjKA6?nto~Q|F?V%BXQ5)wx-=s}UZL{}^X2yC@%b+*_L$;N zD&~T6912F2GOtj}e^jZ*bT%n2D%8TpbbUd-NuB3ZE{n0Cl0I-YkGh~^k7pg;n7vk6 zDQ~XN&R<<#y^MEbcyxU7a5!99U)x-pUt1YoTwd8MuMfqMH-=|dR?fS08}3FspF8pG zU;Eu*cYar&))vgI&3^yaEj&rP_DjL1i^At$emb(IV8uN9pJe`_MgPj5z4Ol7@@Jk7 zg4dOoWp_}=TSs5Wk59gE^zhL1@uRt+!^ft_h9<-5k)hF%VWm_W3Qozy7~}vNwB{w2KU<5`vTxgO_*M0j5mcbY8UR}|`= zQ_W;8xDjjy&+BYO4RTfgImLtLIzUEATF10ohFmxQew;6dkDK&o{e?Z~%i+^`e?jrB zBaW%5=hWyY)bz*IF{~pVR^y*=onlVctjkR5FI4D|x2ZZk=xkA6BZIT6NsB^2#k9mg1f`B)M`}e|AqBf~<#5$Umw(SP!zH&$n!Q1~tE3+vrbT zuI<_ze7Nro-fww*@9BX%8Y+B`ux8yq+Rd-soL!wS+sHorS9R@tP;olhhCbJWY*29A zR3TU78`ANj&NuYBOlZz3&O-37^!_?Jo>BT8@kzT*OX-g_MpIcwHE-3kGt!cY@Qj^?NeQao87}j4^XO-YNz1+3nrk;IOXJ!1?bUm4m zZz{>~Zz%sC*YVCz{)M|gAMbo|?Q5S~oxQnyd3JMoZS};$iBG)cids?x6In$f-i7y| z8-;Y9;laGfi17P?v4p=0>o8fqCFK?B_)PHm;7IUnkPTkY+h2CWV%F*J>+)HPSPpKf z1{M@!(Y2FnI@?g4&FU!Y{H8wF6|$_WtMZ!;oOSt5Noh&m*XrEr?6hKMb-bZ8mOdHJ zYxaB13@i_G$#mvd^K@ma>N9!W=eyU+(_Z=R75;wj_wy?2mvo$Qz07JNt6uk}J_|Zu z(-W+@wz#4==B(Wg=m^atXa4;-Uk^TR(x3Gg_Mm_M-DVDb^5v2GE-1gR>oDbHQmx2l z135jRiOUh4nHphY+pZ6Z^P*|?vubTNd&uc5=ft}yBe^~EH{ou=cU*TdwaA3L-OuJD zHZz!&K(>3@nO(IRL{4F4mBO{1)*S%z^Rn@o0pZl&?Uhc~8#n3NK z{e36Ky}0&%OM~X0>C^oG%`g1-|Lq5;`G0A5&EE&_rW^gRHUEEe@ZbEBY5xBf-m{u9 zXRW)>^*HweuJ6)Ar@le^xA)=dMi1TkA&)PI4@~;A{=y#g<@f2lzo7WOBbgRIqK0gZ zJ)R;jxH*7L!A+~ThHkozbu){*sPi##RM)JL=hX%F%HO8jrq!FqGUqytbrhe!-PL9r zHm{g>`CBKObMZ|}vJPe)dv0I4&hcxv{%hZPtUA1YGw9Q*uZ6TfVlnV+?{NIvq5D+cQJF+xX!}+ zE!*1XUYh^-&%V8DZ}8#1H+aA0^{YQN@V15=Yx*WPA2(Y46$`#-5R zx2P^)lV&pm#ht;1qEUrex3DYmB-sWW)4(R=w=QJU>`{f-R6VB-;>+#JQ&4&1LC!j} z4OHXeqH-{s@VxG2`J1)ZbVQp{+Z}8Ov?;cAXVdy7m3K~8C#+rgtoNnOo%rWp`)~Y! zbXR5Z+T5SKR(D;~cR}yB>K%A$;LquT*0cYHj=dDdm9@*ut4G$$n>W^1Ut3?9dNwy5 z{Dk74QsL+Hc-9pwL2^QVO5vB)T~~uI>pp`zo>7{Nor~stHG2AIuIt)v-SVDG6$CvP zS{uYE+rUpQPb9kK7V(-1`tF#u3g~lv*}BkV`M#x4S6}b3Tdv%%kt3?HvQpm=SA*B| zxe`oiI-3iom3Q)fzFv~y`<|>n^r&R~V#~5$mWfAD8wJN* z*R(U!Gp*|{C~RJ-&FZ}OvX5z#p<+=0;Yr|`^H#V1Y z!wcob*&8dH!#78UEnsbZ`BwSJ{K|59b@S5l!c@36J2JK&Zj4-=&s{q^efs*yX8z#( z+Cur#{E`-*%Bz>lQ>sp{F>t&#D=<1fyi7+YOCbMwm0oAa-}Q64|` zX6}WTPfSiOE*?HTTD-n8UVL$7^p%@emR??;J8}NC!}(W=8|B>1^@Ho>h2{0~{N|+_ z>&sK_@t++%Dha25w!GM9Bv6QAZ&cP+H_Deb->j6U?7Z{}59C`id>ipu`$jZ?(vo}VU&TMR+u3VqEdgb`$%0yv#VxxHS!u-amv&*+$e6jNK z8^^}4Ods5sUsH}cR+kr^&4uM_v&$=@R`RrlSNSN$Shf= zE&ZwNs`qp}qjVkdNkwkU8irgO_MnB?X&3(={=@(3TQ)8JA7ROiS#s3`xA1pi9P5$U z^CKcKulu<6nGm@TMCx-Aq5Z>AYzsBpr`dvS32jN;aadj3MrI3HQP{Bb$`O6~7&er} zmct|Jpk_rZt2Q@-OFCPShz?zDHZ5J(`G(S7RlJ;*2hK`#pAN1oWK&)GphDN&y)Nl& zN%^nn&+@vg&nc(FUQp;6i4W6eiz?4Ta4tBm@|;!rH1E@nkTg zJkGfDO${7Xov#GP^!LWQ-u047X@ky^E7_Fn>1Ih9S6NpT5?hR?l;c^2-_mo8OH_@^ zrarG0HRj@+QJJpju#&y1JDPAjCaYggR@j#n%XAnMZiiJ9qk5+6D%-gDqByFSYN?kL zb6w)^gzo>EV&)ZI)Ki*$?WV3A)M1mAWyg6}_clx}tJZ8GCf0+WRenbqFymqK@fPqn zPMo({%I$gWo|ly0oATQ`@o(&)u6R4~l*%-rr#Y+g=9OwZxTx}1_4MPxH&sWks}xpq zW@8@FQy$g(u(mX+vYv7IoL27FmB&>*`*G#FqVs~DW1RdP9Bttio=ore0M1 zmsPjNbcZWyQ&t))SzN}LtBSkep5CTy*L25aHWI+)ej?qw7DerGB~I+lNQ$8vjDrEd)FI%9ig@aJ8)XTQ2O^7OzrG?bgs z#757$4&SU3n#%AI(@dt`oT*mJxf9Fl zx0aV?hF(1J0ckPs#aQ!?G^F3rVO_K#KB(9;nZ%#!ShJMzU zXZGh=#NUKIufA+uP*P;r?9;sy3HkS8tT9C+Ru!f+6wPRGsjAcGG~n0}IIiL4ny#;C zu*hrR_@)HKqLcv>11BWxH#LNu)PQkD*H;v7%im`;kSvQc5*RNk)<VWW5&DN^JY~2LiM^x4ZeF*xKD@Dc zW8qDbuWg+v+c_?db`38yfbS zxjvYwSiKBOxSPpvK{Yh2?rFAb(-DU?x3HQV(r3I*@}MSd_PeSpHUnLC;-jqLrJ|VY z3bEA`yM9DDTMjl0dR8Lg1vi(-X%1p@9MeMM?U=TFJF0WLv&}Yg!8aa>Y4J@De)pJ` ze!nsIo2Tu~*l(VuZSSX?CZP8h(}d=JW7-n<{_bw82m6b;|GV%0ME34qWCm_ZiS3{} zrIvBcwT>yZkae}c{m&}*ZJ=g1SyuA-XVs|&MRT{|9oT|xcn`YqNbxhMY)RFwK)CGy zGiq z(#8*eN88tXQ~BC%&Nv6NhFyK+K4bS&yv!Zqnzye|Y&;VCLG7JWZJB*%U8S?PWn=7m zBEH$ye0feO#=Od7`$%7MH68Cswy>-6+Ya1^>%iodBS$^P>nO24w5$R+x^F2hf4cnC6mV@IZVcT6|U$^i}$7bWTSoZxy3$xwCW=Xb5zfI)L61?|< zwAqbqTceo_EbfqKUx$jV$u^yjx0S`F2Ak@eb=tn?XnT~+25l4m!;kDgN$1Uee*fXl zn@zU;KdtPY-S+bQ)}5Qq{NeZVc)z77e{P_pDXEz`OjG=Q9s4wMj2)iH4Zn9Y$6;9t za-);u51Bd4PVq>f*(s8NVg5njhhaWArEg2j=y*o;5Q$G}J~+U%VG#OhgtB#u-?x!p ze~j7SU%ZH=sY=`*A&6M)BnG{H;;}hyYD-}j1;w&*c~kvwO9r_ zYEDNjGz&YRW4asrLM(-i0H{Q0psD~A0Tc>V1)xAlc4yA~!JL^moa0H-aWZx%=g98S zlC%^%Zl6SUdy^T*&L|p<)#J5iti-hCiQ86Ww_`2y{k(gBtm=n)AVDl7p?YNDzI)$$ z_q})Dz4y0$f4?j8e|YKxJTDpc$D=-Aih~J4uL;Ir@6Z(~luT2t5OnmK;c!Ds4 zpn_1fCI%xD5^Wfhb_F&q)W3*y2zXe#0L#2u7{Yd8S2&Rxu?Z0waT(<%V4&Ti7juqX z*Adj4S02nI0u+I|!tHZZ?G{yURQW-_)7=(d?)Lqo+BK^DpzR%1Z&dkV-EVL4NgX_5 zvwm-f!}(e}5Ruw@-KjW)QNdX!@xMxlMkDMP93P+!Wq7gR%>wuZB@K2^L?UdMT)nt! z{KoaX@6``=Jg%5{z)&;zU!puX@QxG45RnkZ5RsfSC3iu9!a=|VhdEW6Y6DI4{mx(W zIXk|%7I<#5e_cN#@jw6RpAWxZ13&~o3uqr4 zf(<UUu;7~*K3 zakxVh1MGt70XPNEc6%;w*)M+P<0hl?4ZV4$#>#E*Se|p_0QxpBpOax`dpRKvpdjlY5BT~s@SJBg zgMeXY93lQ%L?UqU0`L!O4u%`PTKI%5?D|eNtRYmyEx@UR!NsscWp5lO1duX_6!qgQ z!GMF;1nI}K@mKxA_<>;9?KM8sMQT3r_Yh4U{o4 z5s||Ys~P{GmvEm5m<&D#tp!Hw{IOj`9sIEgPRJ1Ee1X=yY6ffWIWGr(1hkj)5DZqxlrCj43K$!xN{}?7V1?)!j z9-aee|8}A=S7={J^<0^m=^7m$SgapwnQBPpCU@!<)~?h|Bzg+*bYWmSH5>9Bt>6H9 zWu~Pkz1hBXWw3r?rgY<;U{HOmpvW$I9i^md2g=rPYo0 z`R>$W*K)Bi-aeK{UFzz(SR5U#9~qJ(>iz8i`n%uzWX|gW~5ag72stcm@LLLJxpox0FE>%AQvqAn$D|}mOK%-6XHr( z(AhX+&I-C|z9g00PH)cvl&5G>-D!cG+QnU7k#|YG?l+^!YCu!lrl#{@J=3)IaDVO5 z4{;=;DQ-a1Wn5Qfwbvu)T1?kw^=xtFN96R{tXjzPo`9uhG#w5~CqEgqL#xh8d-&%FF8}FR)@p@7SyM>CoAi^=8ED*-@)3 zX@5g4GcPL%Du^!C0JL#jWn*fKl2MZq!QiYIURlr=kKX;{EXl`#jfxUpa*^P{U~dW+X3|deE(Y#Xzsu0QR&c0X-~S z^g>{uUKLRo7D0%KP%MeO_lYEo%cxGg&`Tl`i#oOwkdkRl0|O#0;JxQ`##2{|6&o(jG^hFgzws;oxZ;#)<&~z) z^WSl*O{<(RWdbDsulkiwnPs5eiVmRji9&iSUD&D1rLya}LjGKGJ+Zkaf6)B7)W&8i zw^Qx`+TIvzZm#!`$RK0*NHPu0Wk;IKL6jp+jpavL%QDU7*EE+OX)LdxvHU*G<+U~P zID%NxMQ`np*`be&TLP{Yghi>w;8RXP6Y;!9NWSEd#g^hB}M2W?sGpvX4 zYAj{xNEl^lM^JZFzJ^IC>PTbck=BSKJYD75;EgLE0Ua83B29$0@RO)$KY)mae#c=g87Ecj_QnssTZ0KTeXRE31x@gcx*N zcz!#odBEyLRD*=Y{Qb$7wtG)>t7KR#lL>as+i|_jd-Wsi2EpA3)dmcQux++_8OI## z3^Sk8=@HzGs50kO}C5*%)|I1GVVx?guEYCG--*IZ$i;r+ZuUC71JBp8I zH#08qZ8DV{&8+SOL4MR8XY{+5#L8zqJN&#)U-qdUGY~6pc(L;T_2T639g$f1PTe=? zD^;;FnD9=zSb0{=ekKs@En*W6O-X5JGcx<_$ZThkbLfdBb&1W*mWIheRSb3QRTV>B zJ6JzK%LSViwHjPi48^smDu$xbCsI#TOrDa^R24&AoI4k%r_?T0F_f9-cITaY#o=>r zF_br|yczwqqv3q59f(M+o$geu#IX^3UaN#eaH}9v;hpf7!Yc&82bMrUCzRnQ;=G~& zsj!NDlg9eq%VQ&Yf>_1oNKgcuG58Zm3O^JEH%^yml)$Vx00HS%ajay#-f^R+YX?A4Mn2%9?n1;S-k7zo`1D1K15c-<&lmakx-i zE*Wjq4nknEZrKgO|~}%=lqpY1ZejhlWciyX$kpDF$s5p{c7nSQfJR51cy}!k6x9 zM;mtF*O=rX0sx^M2MY(uuwzg`df+o5Qh50Td?p4WC^kZKxaAC@h8;j@OdJd$7bB5@ z%(c`{op^aM_}zLu0I?xWZZQJ~m%%wx{lfTxVA$<7KGa2O-tz}vy*UKSxw-z|`Cw3P zL(uYE;~gv+f{g4(^@|#U_nU*|PlbjhXmhsbLa7bMS{k5iyVbC)I#{~KvSDCNXL;+p zY^j~xCIUvzQp)* z;8b{3Xg5O~nhnp%Km0Io_{1jyH4dUN-Z$)*Z+9{lx&95`*n0}Fp>HYIcn3?Sfa7$q zTq(x8`%*crrdc0rENo;lT|0g0?)mg+J~7=rH!<5VH(Z#VYP~Wy)^lqI%c0p~qGfvX zN@nKrR!g#{bG@^vZ?k!_GuJrMHaU@rHFoB@V-wTsJ?putp{D-rTr!oIZrkiwUTDAE z8H+6(nuFzh{7Py#Ke$*NXh;oS+U(h!oERJ(UEW@A99WvnT~a}_)^>C>t#epEk<}U#@|))cs+VzkPWVos30o;SShE}>JN5L9at3VE{)Eou4Jhl@-h`fa zUDp86o|11!lRQ7RwU70YcWF}{9U=|{v$(9Qa5P)E2OTVN8oi=t9@aM))D&KnFAJRF zpuAi*^?sYdyR*pIsNQB<@7t&|mQP4^3X}H>Gr2HrNHV z4Br};%Qod%*Jegn;I>(Huv}A%7;6F9Vyg}QM*lGuCD|CzWj`)mhQ=>iV|9 z*4pvb-+MM-QQCa^vOmwf87zIoOM_4CQz}F!8hn#|Dr?GD*lf_$U(kfHrs+Q`0umF^ z=?XwP0~-3Pf$tNVL!ut^ikMsyk!=%6!O?OnAW)O~+b5!gQEWj3B&nle2g|!l(8Ax< zzOSVyz4$aS{}IXG&Sv%6x#4`R9f(Nn{%3UjAS8pS8Dk|nRu{VqtA{g*x)m**ZWr?4 zY#xvl><>iZa^_F2v*)+xitD)`8SWgICW1~n|9*U@oDvH)79*HCp(W7^ z*Q*3o)=@Z2b~guNSLySOviK9OtfAKIMWSj%NoQ_~|I-OIgvg2|7c z`vtS2Tvwj4%4X%2roi*BKh-9bBvT+hK~wsbPl09N=!y=Lg;c&EXUY8Ls$3)kAIMg% zsHs&m=X1%r@`I}PtbVsfkAh4gz#WihINMqcT3l*asR{SQytuwqs<5QR7@``AJgw%U+&b;`M5Bk1Q^+uK7Z})ph-%^VZi|Ip;v?;c+RsEsN znOMKDlfwC0I}njtJKrhl42K~Y78o2NM8MhrC2=-2tZFbmM9YTtaY6ctAOUs^X&hM@ zieb-f&lA`4!cM^`0sTNBk9h!w$=Us!gx{nVM2U|w9~Hlg{HvzeL=a|{4CEk9>Mhvu}^db9y8PXnxDA(>2o#j`HOFT>m$lP zD8A~VrhI07SfCGgbhfp$cXl+@_4af$)HQYWHrKVsdh6>N>$~b3T3Xv0+nYN-suQ&d zHbBl`t+tdW?Sk&ghaSlrllF*$1=KTKAfc!K+;5q_XYVvVC@+E6a1f z9smBW4=nwuRMkJ=(;IdkO;WbK;`fcwDm(P5-SG3BR0LPOx;(N2s1*WuGt`Ls#qdDc zg})(#2Za;^1?VRxZ?Iil=e!DcFV7rTYcdd7Ob~?`tTf0K!hREj&|y}v#JPdUohWmv zFa|imO`Woh0bkC?(!(qDxew-l?qAaDZL@2v+y;;3IZwU&U0&|6%RGXMVu~u=>9`SG z>n-0K^zN)rPy1dS3-xZa6>Lw1%3W#c@A3BT`v<{AZ)f_aR}vKj5`;zB*?v(AyWR@I zkUd5N8X2T^jzPpy>bK$cwb4L-#^eG%%pn#T4bGzM;&3wpL23a>LGg@Q8oM$|X;jXT zwA))S;%eJ3R2&UfZll5S^bU{UqU+Oxn6%3!@%shAwc&?J&Zoi4=v`*~u&^}i^9C8w zDZv&VJ>ky@*A=vlcjvCwkghB5h3=Y-_x)NhG;Ii4o@+dUiy;V|J4pzx&CsxX+K;p6La7bMS{k5i zyVbC)BDh>**>q)1XL;+pmN52}U;=&<~7hmI$NBZao2;f6|rlXlBdvw#hT zShs+6^s-D)U~0q6irRD-!~aNCmA9xrvMxJ zmh#O!f{Q7D8G~VBRQM>ZzMF+B+3}sW{{Gpuy2j4-#fuXcyK>1w$K2A~Xm2K!SuM6L zWgFKQ2ZwJ1!IfMcUY^;ykRNSLbaf{h(}m9dWa~yx`F{ zCN8&*WE+a9fyVa2((vNNm6?I=!$NQ+1~$@7mm8OsmeXB5mkW#YgT=!7MsD#!Y;%6* zO0ltHW}vY%**4$MoZensxY9Y=-!e41THl$vuv*{Ve_`uBM{vFA(ccaPhrj02CmHwJ zEHu8Q)e!jvFghntgJjcnlk$JZ&qeo5apek8Wt5QeL}ykz$#P_&S_4D*f}AD zdIOytkr#@(Zb>yXN>8^agYK}*wuccSA4Bo5rtBG+guxk&YPw43NxJp7G0^sQ>Sg$kQD*|gmFk-L&Thy~=YaY{mDlHpD2*qAs zx5cr@>ppX;pTPHg6T{rS+TfkgQ*G$(O?v)DJ?)a7BCYo5QNExjpI6(XNnh7lIpr^C zn%`9EjJ|I%cuL-j?+T&7G~2A}w{_-%&gfM8_KOG%DP0vQ=+u*32=>}lenH=$ir~7N z2rgs-*a8G~;ut%}Km=zvdXQJnF%V*p{@AUT;~?QM9stK7^I_H~uDKDl6~Z{qgvbmI z4F=}R$stG);I&{;0Eok2AUQBPSc!-GJN(w&3z1)?<@=}Q(8VuLEmoA+zVxv~P;O~C zyXHgW!>&PHujyy(T4e-RVlh>iYS^9_>KSiaiS5jHO|CU{Zgfn~U1{x}S(qPbu4}m1 znjG5fUr2Za*Fm|M{UErGJ4F6FXa4#!n)`S8)TF*PFa23M``m(iE^Q7GOwZW?WOiiU$6UrjafY(lrhIP7#|9!Gh;RLRv*MXEYJa zi@2gWZxAtMQXx)dzseH<2?6GS(HAmzcL`c}Dl}=)Qj}h_b&N*WM!vM&dph1Tdbooi zzHs<+(G#6Ki5v>6<&;v`N*p2!DUv-rjId`oM?;oA#rHPaGJ-UVbm~0fsTGBj3x|)w z$!UeD&5TUdOY@N+zH&`{BdtB_gO`@-3my6K?c&DJZ13>q>eQvi-uTeP z?WOj`3&UHBi+umj{rNwtIAvOSr76=RzL+wrh%YyYu9nSXNd1QR>fd-@Fg*_Vw2Jt0 z?G-g$h0CjmFV|jG#FuLaBWJgYX9syhzh6asxpoVWD{IHwE$2MgW0;*gLAagt`#q$# zImw7GoTO2-I|V*6Ggdh?FG%b##)kNEvO8>#TR7W+=g~?52?_VNxY`Ygov_$2T!2P^ zvl!6CA=RrAg3-exzx?kH5%Klis#>+)+&tpTiYsAajvMjy#DDyyk0LjA`1FQ7 zY#Ad((JQ{ZiuiH^g+YaN%f%2vbw;!T1`Pv|fGBPtqDp2MVLJmt=>h#E*Se|o)_*Y%)x|Cvuu`(9l|eDQ@!TWx8#;-1ar zQDlSu2$+P`p^)?Gk4WXtDvgSnGDr~CYPaSBk~#VtNC~(`fFn`$6CDI-3evi>K%+#a zzcbo!LAD5X1kaJ}_xUNUMl{MA=RDvky#x6xpE>hg#$x;{M&jyFnq zxgRCsFX|az(C>`udtNE^vRN}(YMFYjA#Wg7AYDzzz-! zz7RE+8-PGS9OM#w7ef%c3qy}#iEYQ;BV0eKJ8)eLT9k4OYp!-4{@8RFYz#jKv}7Pd zh#))=M&O?iGIcMjIv93)jSrgYU%&k2n?vxr@`m_&``2cIavOq{=NgarVhA#_PZHwm zFGIr;C<|K^@#Wf~O$kjBb6IuB^6lQ!so&{vC;BTcJ-GcK1UiobhBU(+%{Ek)fsF{~ z%&COVaI}>xv75|I$PU%uVRSmgR2 zdhLJOa|*DbZzS*1oO2;^gXj z_iV>bUn*8V+P1wNU(c;~OfMGOCNC)}ST2=J=TeEn+-5F)fQ8g&+dJdySC&>bTYHDM z+m|!x?zViUzI!s=R2-XF$WAQxO?8h=j4iHi%;b~3L&dgCyrZ{yd1WM1SXeD|C+~B_ z*N^-{>iZFkf7GW{#FycR<}}2YHRxCMkA-g?;w!J=zbzwfvy8dDGU~2M(zwP72u@~1M$@p;E;$%)g}bf zWz{^cr|8kWW@KdMNyqd9X*Q~->DO6cp=M=*?$;Bw3hlL}Us0y%RiU7|b)-Y@No+DW zqEVf{t$%SH!^ae}HBqpL`E^M(gIc?{5MQ&JygP&Ey`pcoqOZ`Z79Z9-vx~q-q%o-aMn)JCtkIxhrbZjC#U? z&MWAuWEJtHK7RLNcH!-dAPhf`I1PXsWtHiV5#%X@YiAGi7D^_^|HBG6u0Kj*K=5|n z#>4@`9Pd0#oS=>*LK&VR$Sw%#P9qJI0uBugGtXDP!9u|DnnZn+=1FBNM0~Z1R9+A% z!1;@CKwTR0z`1ucP2@D>HGX{H&_NJisE1ngWt>YOLGP(P4l%0Pq>>Vmstk3kE}Ra^^UYB>_b zS9X12ZD6#plp0?hPS4L?s$1%A9qMRkTFvkDj1SaJUbs>$E*G1&7^lDe_`|)#H)N~atuOhx&dsPu%t{se=RS{oR z1QyD6bL7e;f!`C#yNu@-Rcc435^dfu7VIRj=3`5Y(+ zAb0F>PTr4J`a7ANrR5sLq)`{jf8xzk7fhN9ql!j=qj+l(Q4C}mY(4B4pcC~8`}Bd0 z@2C-9|Ht3>&lTCH7h2B;mP>^C=0DEj=3=|f8b#e!0c;pUL zWlnX5A>KJiVs6L(1Y}ltVvMVuG3JA30To7E20)dl$=X$liJf7FksnzH>mRZX(hRjS zKtYN*C(YZ#xcuk;^1=UNvIn2pa4}YHgU9lmBgEGkFL#h-^N25s$yVy!$Bp=U-RuNxn6m8aB zU2b>2)(%9ZHmvRx0s_b9V3w?i2$5iTII9W+(YZT9g5dqYYk|nZmct;0a6rJKi4f2c zR%O8=MDzy;8l0a~t`TjPVFw|@TEpEP;X$bfAR2oPWKma}0`+RY(& zU3o)%y*aTQl-m%rJlA-{7ekPdeUcDgvCy!@{KZy9e7SbG-*oDCI^5yy0CGY_-HH|P zdv0Y5rUJKiBGk}%84z$8YRS1w3l8ELy~Gm6Uxqa2Inyr`8$Q%gS?&!V>Zmb1Clnqk zjLsf!1nzq{h_BCoWA7=zhQ6ir1dsS)3OG*0*M*g-Li2KeVl>k}HPDuA?Vns2h)?zA z>bja*#+N!ehc30x)L-0Ly^vqJHR7v%t7zB9Pd)gSAKUmogjTIg&UZW=EPY{WL( zmqwPi5~Cv>OXG#M!Q5nGvteRzwP$pCVPknE*}JveJ9b!zuWbCv(#+Pv#8^|)<=l8n z*HB+_y13Z7cxgC3y0}nmXwIZtrv@_d`N{3JSjS51O3PMkF*S3gd9ctB8%^ZybHvxL zzqs{dh{a#>X%+FcH{$Dpusu^U>4Ng<*90*toKL$-1~gq{H6`>5JG7u&TxGp7_SVU~ z3x_Z+)KP~_xkEDfwhK8_FVpUh5HUpKVmYS0?m8zUF#$xDWfo4#^gE%+2dAjBx;OFs znfT7D)-By>R(Fr9=0O>byYw_M-8C*#@{slk4AH6UhP5}Y`Un|9T&s3H!H8<#3f^Z# zS1bj`+f++V?~~9u4Z7=~p0`JDJgs^*0+bWzr!DRE%0zvyA-=MDZ?Im(JX;7*TZ9n5 ztT!508+55f`qY}!GQKmNFY3Dt>xxnBEvSqZW*v;y;M;=jnpaC~>nqcuD=J@6EnCVF z+=aMc&1#>5u8XOTgzi#}@pU&5UwjvI!;pBsnKPH;CS7<97jBO(96o0|hQftuK_x~Im+}pE9+uZ6>Z3$_RcZPD zX*u8O;lY|eHWgyI#P(wD8-c`TX*s**5nr%tw}<$eom$*kNRM<4q^El_%Ofq*z0E7_ zi>>2B=|aQhy6Nm#Vyb&OA8RVitb4@QLAjXyC~J-z@%5U7e#g#L^4K1Tn3a*i&$nv97i-oOp8PU5=RlyDgrd5;}DC>nk1&hIE-oH0A4&T zb^twkK_q28ARz@!AccUy-)(|sN+8p4gwy*?Iz6L4bP&WBQX(=Wle{A*SUq4LATf9c zITC=3i7ps*6jCRMEc}J>HA0UYZr8Y;3(E)~^<(`&)kWWgA0hnP0&L+22iKf|7HE^_5iSoH^Azt`!jrsY%Mt#~L0>Cm$Pb zYigUC+Gt7CPYkx^yYmyV%juQwg{F=Td>Y<$FQK&FP>p~Nlh!ID<6Qy2$0*RA~M zP+5DiQ$X_p+5@;p)~9~{Id;tjOhIBd!@e^vIM6-VGG{bs*=6H9YQ)!1zu|$GD@mLW zJb58ttIS4dd1f(>_h_Cm0xq~d5M|@FCwo>mtZp7Ee{`h*(yMN55r+u%kBEI-SrLDHKTX8Rn zJ&5aUq;Lp}!*~G)p}*tmi|-Zv7R;5C@Ol~ z92s%%9Lxk=0dhQ}%`HN~J#if-#1UiBtprI76zkc%B=dcxKKjU`@rt9t%55}Qp1M5Z zi>^-(JFTB75AG+#*N^*Q@~lsTm(jZz(#z5+;!BO9&AO}0?atTQfr!+G)ty5?+$!4e zdLa7onaAA`s|`VU*mue=oErgJLN)-0I4^%xa`1Ha9`-z?VF$>P!AGbcoHQXVaE6W? zVXI-NQ_4Moi7@QpNZ~TUl)DpAE`w2wI+N zJmQNX$jE+Fzo;P?Xzw1+r3#z5%v5gm{KE~sHE-4VL&2+JWX?(3Tq|=Xd+3%|l^arS zNgC-)&AatHr}aCdYaV1@DVsH;rS{I(bc~tjDkqg~H~hZwR^?QQS7u!ewoinHCFU=- z=R)aqpRc6>$~Iqovn2d{)m0r`(^$J$Ls{OwBYA}HyS1t#5C()SIL<}wxmcFYrx|c3 zx^Oq#p??ffC?vENYRN!GA07?xWVpgbI!!%XB_7#KE!2gh5w$|u5f8Z&C76LR55uv- z10N3J>noYPrvMxJmh#O!;)^MO;lnVoDPXq>e|>(lu-tGinOdCRTrHg2sy|1;dM z^>|`6oyrvE(#i9&_4)edTr6L|l4w{P>mAvsFSLbVTj#qk&L`I{?Tl>hOy-uSCnmcm z)-s(NJ>5HvLmg{v5+|Ox}hs`8!^5v)Td{g6OFOu3*9sGixb(+`msWMzN2}u zX{fllo$0=iZ5_Tm)n05L8eiFrrB`N?{rT>O$>~e&?Ya8CtxJc6_!=%GFRe_qb+_gc zBZFPB^w>%|(>=H_zdV#pwyd=GHD698XY1qL>zSR|v7ub=!pc;Cx;S6oJF_v_lUeP( z&kyiw-Bf>)M2nm$aR5>kF(WH(~=vYR` zD%MWy*3m{0)DD%k$WUVXx9gpn)e;y?XZ410odvdTN4YVbmy-d1A*i`ubrf}Vy-H^ERVM>8|Eh9T#Mj+K zd@)AR62tX76%u3{v=t;C{|vl2K!d^6J0B5vdd&2AaS*o`wj#_L#YJyX1fVH)UcX2p zNC#-55!;=_fJxu6D2z1r5c^>y5ZB#5lw0K++-#MWA0S@m5z}(M)n{M+N=1q7?>~1V zD7UnnUGs=9*fqH7Yx)_x7FL=(o>)(&&d)cEw&oLk%iEc?!SwpYi!Ft0YVzXv{LJ)f ze(=J~;P^ymZgXs4tS+ASh_8db`Mr$z`tzT<7O*I<_|&96LwZ?yHxXZGy;(*%uc@F< zqy&<>Cc=^y*&x(si--|R5Kn3!Hef~sbX8{$itNtl@3=^Gr^w2t$jg9!bs{0<%U(I?)Bvm9&CVpVz$dr%(=Y5N=7FiJj z0SXHkvhx|jj)Bc%F_OdpB}bM8^@Zd~{SYT7rK0kJaN!r_NSGrq#QehV3DYH4w;l=N zYooZ4NjA*3Pi{45X1B&S2gaK7vGyx%qwNh7O>^m7(?We=JD*(O`+wrX+rMsBm+Q(S zva(rur76=RzL+wrh%eV%QL8%sQt{)#^!PcSRuNyWy`rY8aCsH+<=U%?_;T%F<&mTmcB;%#-I+sgD^m_Q^lWCmCzBz6L&V6cZ>b8){o2g3sZdZ*?G zyn-RXX%kYrYC=Dr)8}g5 z^B3Rx)<=|oP<+)zv0`vzXZ8DVM`v40duK;eU2jiELtRr>Z*yIHthc_dvA(Omp{2F0 zvAwzTqdHNWFfnIUb+GUMc*K_#SHc?{H{xq3k^UJ}+rvJ+Vb4pGlx=2}jEBn0P6>9y z9qTeHTU7_jNHtiplG?xsr+dpw;k%de_8e9c&ez(3h}53LuCshx z=QB`HT{)ylLW6*z<_zr4*bWkl!HE?P>l_jeW^-q=Lqb8`VPHko&tS%g?_w@c1J*Z& zJ_8YmryJ73ZQoa?%@)HR;%>Rg}gYL6#-$1jdF z_g)@dX=>csSRWiJZq+YjQq!Zd&o$(S=C`L?4$I)ym~9`~9NpPyY)v+ewC5&v7VCTB zZ4HTzTz4@u+`C-3v{gSonaz!C$<#MFKU+W6yE(nNJu_8o-Rd6MX}r%3Za?<&TYr{W z>BoIqHMs3&D7V`@V{m$TDF)({!mSN@{m8NY~vqY~@ESs8( z`lNMhmo~0W=Bum_O;e^VV_j~mIZppKF;ktW|^C-88u2PQhBVU{{IP1Op9d z4|F(&G=u2jv5IL791Z@lj^T&V2a^-64F&TE4d8j; zC*Wmxx|GVBA>TK*<21NcY5D$XIUnlHfA+t<&N#U1%A5B1k3arTf^thg^ON7W$?2VX z?WwQJ(gwQ*Pk&9ny$x=2xxVR!rRCYVcuPLH(wx|wo4d5u5-;wgr^i+^qg|Jmnns3t zT9$iTW8UC)P%dUa2Dgvsos0UN(R*Z-o>t0c47R1l$n(CHV3-D@3@+B6=gR~hn$?a! zvOO5ED1XzZFZ=TzV7zFv^bwzb%BSwAGXmK@Y54hod-9A-`IyD>5}eNIUr~G6n#VL$ z*EOvpMlonzeoe<84~}5XKOf*|`a}vEL}Hgk9Ogt;T6BFSg_4$?Fvg4CiKdNn!3LI$_HP0+&aX5ZJ+yDdP{9}i+c19FKtNgPc` z0gy|~X-?yV5sPUalb1tla5mv}oe&72fv7~23}bcD6dlqD_=3BiBz1^-&%2XDV<-?-gvOLsli!L$-C9R zPwRI^^*+eHQZ^e7mg-QjF_l!B?t-~r$4sviHlRIX68?5FnC?#b^l4xITqwQn^R?yu zLG_;so}%<8{CuC$p`iWsc9o_(G)7p79U8wh-7y)K+Vot|R-0@agA$dc&v2THxuxR_oI?pT>Rqq)#EmY*&5yj8DVuv#fJs`n^F8+mF{gtp47q zo(}YIMf-Vuvz&7HUZfQ`4n=dVCL(&nT5z1N#y74NQRLjb&ZA${>Z``|mwL}@6o&81 zxZ#_P=7@bRec&UxUOc($VchOe`FqYNnBx)vQOax!niq|5s- zTXgF=AJdaFGSX_9T9Ikzn?i{z1whLdzVA^zueIld5IVIQ(F6o!zB;b^N4-~6`9Z%= zRJ~E<_uKs*Qr|gv2!(qO*L0@_IIv7kYK9edOcE@bi!enfb)Xe{HB2wYu2M&Hx81N3A&0p&NiP<7`+zq<5lZVHs$I-dY!|Vd_3g-iG;Q z?yvld2P#RR&pq&!fGsl{g5|kp^Yy2)p8bL<9Q+Ymj*b0#s~Q)!>x`cJ0i{R9e${$* z>J6UldZSOT`SNE&=?gx8`aWd8T22uAWzzp?&o;$;+V9h4pB8<3&8N@$^m(6N_vuSM zeZ{8_cs2^hQ?{5-`+Yj&(`BDN<v0M z7(Ak41F}FfhAxhyoR1cc=mxk^W6)_m0=6rfr{Tjq_2lA%mDsNLeD1T~Nx89Imgkx> zwhPJhz-(7T^ND4;BeyeL(XPMw1fTg-!d_Y*$=U zZb2HbS|L_)nzqq+fhc4%@@C}A(r~$vwL8_$RoO1r-bdBGQT0ZZAM|@Zq}QoxyJQVg zJG@sv!bTA(9b+Hse-UE_!?9Zu1U(ZPDljRGK4&mwX+I2tuwbxApjX1<&guthj$Vu~ zQ5X}6_zr>vW)4;l+zV_M_XHz@VG>g)s1>e3Lq=e!Qzg#-aI{@}@HF)J@B8}S`RkR~ zt{?gbzZ$S(#&%hrYs%QJL-E#YYCo}T*Lyv?_3(*hyYSwqvRzee*S%$I{60-n@6xZt zb}^Bcvt0lboLr4*^+I4`#jSy;FIBedsMwOIdZWq@$_7Q%8&!VL`&HR44IXXA7NKoI zYvuGxFjjzcVS`|c2w4C#gxSyOy}*2d-2xhndD3CN79!a$7%R|T&M=9N3r5YkEK$E> z=I|VZIYZaRlK@l(et_1ErDdBApY7U%r=fkm`sIK3=1OeWH~!b}3CfM_vOL%LAPMHI zbYN{)Q{%C*UB4wG-i!L3(QABO=}{ROPkWKH<|a)~o2tulW?Rz-DA)S^F{l zszydyrPMB9%HFPDIos9zDzO5fXmf*c<0h1^dJj#u)SPoCZ6E zsSslx-qUz<+jHCV#Pz&r#lUZ|xDC26*d|v4Vvu9c0LW86$JldT*@RW(Y0RTLaRlsB zG;cyv*M9S>Z>hvSUHrqLpxoFe%X5tnlJJQ45`r@P@Mk~UL^X#LB;jv*e{t@{=7S_y z@x2fvq4SxA-@zTZ%cnQolkP&bzv9acOmC-!({RT+sX-E)G=fyZa6zeyJ^__70|l7| ziH3zi+_E^Fg&ztM2-gsegkcqKuhKwtQV)&+gewPbiSpU0qLE^_Cn?}a=kAEonqi26 zj94h32|WKBd?tE$r9L;E`-8JKcsS9nv2q(cmggJ=NqC=nx1CCn*8)>a_Tb`3>#>O= z$BlVR{J`k%GU}2(J$aZ%%qu5H9H|=LPln6MZsR)u_i`<8w`R~SIdQ`UI#%4_h$Sb-)dVpD?_A=cJB@5gqs$gyLGz2j92}xEm?Oln#2F!T z5p7U*VPFsUL*t%6H^M6|>TKsljBtWp814+suM3@vV8kAdC4{|Vfi~_9(iwC7sZy7( zfqObio`&(Y^WU}C87FpKd9Q7%nf+(~;Qf>vCuVuBDPz0zxCej4=97zg-1h8N@x-!S zNbOa&t7?3|w~X&kXkL1^ekCn1QF+SQF7&@?O}fjPdhzppwfQ|f&70OLTu%NVY)BRJ zs0P$_RP7s8Z&dj~zh{;0a^Ewq1nn+s6QD41$VUwAXoFEm!4?q^1*H`#Cx?T?SWlcz zm?S6*4q}+s!{g5CCya~JN23BmKkN{d&XoltI}8|iam#daCk*l6DPizfB!{S?ht78G z!PC$}ud7*otPrXAq!xwGWp>T%H$EWRjlg1mKy=Qn2rAKXi z|9hU@`az#w^;*McLh189|DXT?<(s<0tG00WyB7kioFr{mAnK^atH$^H+ts8^-;l9g z&UV#{xhe%%F|&J0@z81&0}bYDw@u=x$a9t5a?{#TwQp3tQRU352VtM9?3VkU#tyM& z0ij1r%NVn=fMb2YJaPf5|^)b(8{n&|Rw}23z94%Ls-8vb@#og={o_yu(*0}JEz&>(9 zI>LGp&2e`;KAVff(?0owkmoA91tBTXy2EbYsP7h4e$ek(Ww+e-j4MIAMVJxJGwPyN z?gOL6Q5Ql5rxILBKxJZNJal$z4_<~A`q7{NTC5Vg_3tjV2Ia?ww9Thsmy)b6zv|Oxd>Wp9mi3G={i?1de614s?$tgp`jU1FGeSAL zH6#WrA+sW(lluaHUKgI6vK8gGG$mJEO^%8^iK;iMoPK{0_BN{CsPco}?;$a^thz3>H-Tzu?hrn=ECz|T#C|>Y z>vQ##8~bH>t|`NG9ZEoz=4kJk!)CvZ8%qD1p6&WApPoD@J-${ahyAKT=}(5Xt5W#j z_E)iAwOYwAE&WznrE#%hYg*4F7X%PyiVIKkM@6QqS}$6=#5RZ9oqUz;3YsYRW9?%l zQTg)zO8ecd@WE)f2zLUG%4xmOKoLg{wg``4*e;^W!6Kpca+ojHTg2dq>5!}KJ?*{X zdMDT};Q64zFi66pv1~f#N=%m+8Cjl-TJb^VC^|Hr2mn6E(XgRgJ5}m}fx+XzDy2Pm z8ou588s5=ZiS3&B_l1BRGq%g}T+{RVQ%`tI7f_@FKVswYEt>UZVWwWv?~I%aN*Nnc(JrN)lk@a696UGBv< zpVOZ2?qj-;7piPm6-s|^LFsqLv16hw*Ln?WGRDBj0%I&S#zJBRv0doAO7nq@GfTts z1Nnon1y#1o&2&fAzESl?l^^tb9*(xlX8+x(^*=ij&ez(3h}7QuP6MkDFAiN5>=Yn( z7#Va%&UgrJ3Xep`F2UxY(E_W5#tKXq(H3BU?78iE;(A`#C}KD`06d^I?t}3lA`1K0_47uGn(0scNWfkh z8)bRU^MO?!mGKa60{h5MZ;uSYjU7^8mG}D?6Woo>2UfA-NDl0hr9aP=b_0gWj(_tDul*(=9=_$%8+IN|QntO~_l@ByJM^mEaK}2SfmN`PBfa3H z%K*TNk5wKi10NLtkqjO@MHnbfu3_l41OtjeOAX=nvVrK%!|w!zu`PmvoZ{+dAR{jk zJOwp!tL}sfnRwjc)$AQ* z)2Ds;bD{LQ&)3q_Wt%U)SrY#0AJUPay~F}lT6;HYsqxjDE%Lb7Cst$FRGN`Uhz9Gt zR&i|*T>kdisoP#7_cb35Ug-hLQ#$+Bpir zXZ&-Il;(o+jjp)gvB>oe55Kq1W`*m@GalG}@bo_pW{Ysju}{7J)U(n|Fa^*Z7$!Ca z1VjF@vX!RJt6Xd!6AjHRXEW=XpUw{sremwwj_r+&oy+Sh@p$WE zU(?iB{n+e!V@GjvBfmX0oSo=e$mO?Y&1Z9|WIC5h z6y`Q_>GQ$sKit@%8BYI0^Poy}c0RkF$*1NDJK5BEUhJ$^FfXLeHxx7D(}nSD!|3If zPL*S)0lPN&=#d_VfUPhYWqrFz+Y+2=Rj^RZyc&H406#5`@qQ2MmbzwA?Y)~z)+ z;9Y|L8JcoSQ|e=Z5uiklN=u%vYnW~7x@8U0a~ggw9=lu6{G9L_Xk_dR2$)+i`*96W zswPq3jcS*ItPma(HNI6f|{$%Kx;zhBm})l+)5 zF4Yp(c^f)b&~o=nx47$^o)V(796Z^1)dwroqN_40$>=$GvcbT>5>x$I^{#EzzM<#3 ztTR@0x45ROMcuDSPcWu;9jlqukw%?a)U$7>MYeThSl3SI`4;rVdA-N1t^+bTp*L#K zw^&dOy?S$|;0rn%N8my2#g(4bHLPBTk%#G&wueln^=zoa9l?D#xThnS?r%|d%4&J< z%EZ^5fd_XH*H9ge(O8e zKOE%ky8DfFVE$uatVp^Ryxne=%NTpy+8gx`(#-p9)6cqfh*LTDIGoA(t@g>x zWIC}GpYLsLXdjRDPEQZ)ERIa~#zwX_F0IwgbQcqiomZB-6YGb>#k@t&1pBe2ZpAwvr26AdB@MAb%n6|E$8x+TKa;WL7V339Cq|BICB zfQ{(F2wVpNB6_d&!n_5M3(s#3fcSz&N&UytHi}XfIL@NUrA-onTYjx zASz8#c0ShdSUUOG^p#w4s&i^!xNYN7Z~a>1WXsIjT=SI+@y)LM#D(T`X7p0aRCDJr zcfR=L`HEAfl~}1G#QJr|7_&$(?hJE$vOQbA?pCP$!X3 z0&o6YdtSs{1fKPLA8b_xDp@4W`E%KCQ-6(FfHQHC=_vZ(AAnSDZ5LCDqN^ zVK3^(*6-=dvQMA#={27|>(du}TI0#ogFb!4rvY!E`kwUptWU4{^ckNTd3(XjP zLQY3McWc4nc*_DM^(qCH7`=8JEEGZT@GxO%UsyS8_RdJadJIm&M@z)rVZSgzV2VW6 z=UgoLn)a4uYyRY;5A|0vDE!7NI{_PJW=6|%&HwkhQ#ZsW!fr7o4(Vqc z;+?WvYw1L8eIdOresbr#Ro|^yEEn?=CD?+bsC6mEutT!k=1<7}`J8@dwEwJ9rd>9h zLM*j*zNTY3Z5NyoNsq0~r&*s;2DN;_E4Tl|vr>QR)0m`pw*FB1q|ZO^Q+L*_mEzCn z#Gs8MB+gZJqe=?#k^&TEvx6fNHDX8mD73Is$FvVgLyE7{S?oELd0t1_bsnDU$RXz> zc_OXuZt-w?TDykJ_scr*-e?-0){pH0-~RSp0&AAaM5Up+NZ`+h2L*k*T(d_*PU&fcu8&H=a2esoL6OiO7n8K-45D5 zQSBa8epvT|C1ps&^kXAm+U^g0K$&R2t3Su}GLU{WFA2?%=r~Z)yVxGs{L#FC6=Go| z7fKDi3=1zokYNTmj`g0Il6Gga?_%|X34lp}jJt>-+|MoIgvQ3=ePD*;?tsG=RSweu zbdQ;sc~;-Tst%^8!=|e|`+t3BVxSVa&;RJp25f+ld&_f;cPNG2L%H_Bku*28HoRK9 z($?PA+H`Uk3HXL*0lw)|^I(7tVYBoFpFdr$ZPRh1P{GOi6Yg?Hy;0@&+x;HWx2$SeN?I1!D@;(hZ#vzITc-(g6qEzD z2+fFtUjmQ@2f_KIV7AbhH0~M?akVq793j+Tvs(1e)!!a4Pv~1PqEQR=0|kY><4)*U zfO?|CA;JjMPIT6~V8Ch}B~PQruKCK`2L~&$UElk*p9s@|`3cU$9`=6%oab_bqP>|fWwT`QxRU?Nar<2T z>RW&1ZC{no)vx*V2G7gp=M$Hysd>fknAXwC!)drbom8JIMiMv@3?N`n7=MfjMheCh z;z>Be3L++Doa+oL0D~DDXh6d4RX+Zx-}!8~8W_LaiTd40L^NewyU`Cj!3==E2GB`Z z3omg8pNSq`sn5Odzm0v!$TTO~HCArp$MT#bpR0OLqGx{E^=_{)p%_r=KA4LLILgV5 zz?G^0z3*bwt^4%;P?+q`c2bSNCB>Ilh*T9O%o!zC05CoT=C~Cm)d*aC1?LPw`_~7# zlJsJ%nx$dt6jjc72T^22)f-iQzum8@FmWBtxEnCQ*x~Ua#e#$r2x<(s>LF4D9FMaP zA-!NTBCrDz4$2MW5?r;y{nP4)(*om*QpO>Gk#$^*dAGC>wl7Lt=m_Vlj;e$JsiCJLU#`0YAwbz|`S@smzu6HWC4~0o2+jW=< zlYc92l2r=N=-Gg$9F@Z4I`faVXFN;w&wSeEVJGoWy6p2W_|#p!OYYg##h%fLhp#Z% zKWlZ|3KQP@Ah49{UZ6BZ)yqErfM<~&@oAe+<33&XY0;-wefo?~jkO9-1f=sWi?M(?+ZoH?@O)ub>nM2|J$6mvZNFcv#C9b{ZUpR@v0awunlfz* zQDqLSZ4ujbKWkgw(BKSNZ}jQO)3!L)s;X_F^GlQGStv*Xn~{uV?Z@=1YFlWPQoB@H zAlDvd@T+QD3PND7-edt?>(oeC-g~ogcBgPLj2SMh3gjG+3OW%?Ffaqe{DN#lph1|z z0$^Z)WIIU7LZCfqzWLntJjMdBkT5knTq+n;7xT*@U|}ZEzyL_W-xn`r!UCg_ab_S` z2(&d}7T~byE3N$G;(M=DBKz-L_#bx4jVzYunlfz*e!BbMOd?Ti3Kx?}&gYVK<#AY4 z_x-MI>GZ5Xmrw5xY|H);t1gUUN#9i$=}}Avx_znd{W|x}`t1%@_|Tg&^IPeq`9gX< zGmsoOq);mlc#?kFr-mTz_xWX?7JYinr_cJ-Sc2<5U)8qU9c)Y08HiC<#kLq}4zuV{ z<(zjAE#E`BzN&30X{eQYDhuTL z&8^xgiWP_|KPZb}^?tixTUhCgX!VeN3>~<~p+RvA%wk+|4tt!(9%hk+K+^)Qg>x~b zG(~D#a36vNpw5KuLH&?^%q&E0cT2Otb~raZRvL%}PvkwJnzCyfd#k^=`4GKw43F9hfs|Y**mh%G#Fw#Pt5MBwVE1 zGkT^MmEI|o^$E3m`PLuG+wtc;ng3~@KIPAQI&}UupT7|*4`p|Cr@J3k1vTU0;Z|;M znkjGjSMM9SvC?q9)(%9Zc7MCh@^PJyoz!{lvDgBNP(WucwzWgOGvt{dmcO b;eV4n diff --git a/Covance_UCO3001/browser_profile/Default/Site Characteristics Database/000003.log b/Covance_UCO3001/browser_profile/Default/Site Characteristics Database/000003.log index bf34ba6917f9988f0c6fa05100fbfd17fa95ec5e..dddafd0cef5cace998bbea8bd9ab902a5ab9957b 100644 GIT binary patch delta 303 zcmbOb_#kY<1PzYwV$N$F85k!`{GcznV%OITY(h*N3{pU>1jPQj89#uMlP3!>=}WFb zm$f#_wFSyfncTprFL?u9*6JnmU!d$%kil=zCAp=fn}Cwjzy^Onm#y9N#serjeX@g~ zfy8b!H|=cTWae_3X@I)DBM&XSKOY{ZUc#;@-ukz2}m*<_zx1J|yW1}ArN0R{uYl}Ri z|KxYRl9P}5eVANqtH#8s4dkj%K4k02#~PlRq!3(^UzEy!l3~%r#(C^{?5vIEjK)w6 zd`_k&=0^G@sl_F_MXAN5IVHvV7M2#~#+LfUC5d?{iA5>8$dW9cd1XMgndyl@GZg~z zi%Jr6Cd=E`GIC6wYo8*_z`(%9yOV+c3jcQAoxCskeE61cY+TAad8hAWmME4+^T}_0 krGU=lGa=1Z_9i}-7I~=V53C$A%(je^=h;h4zU;3H07>6v`v3p{ delta 169 zcmV;a09OBipaFoO0gxL35Rn{10T8iZq%RN!3}OKd)eo2t9}SfZVh*pdfldqvf-nXJ zgdYJL0thRUQBE0?KR*tW!aYF_1XpEZAX9X2a%B(60TQu+4gr%N zKYalSlbt_g6AnxO1r50X57ZC04Y>{J4yO)Gv4N!xletZk1ONa4TakfR1%eI)gddYo XPAHSqPT~ay90NT8lb$~qlhaQv;G#59 diff --git a/Covance_UCO3001/browser_profile/Default/Web Data b/Covance_UCO3001/browser_profile/Default/Web Data index 286db1b58d8de8a37234a0d1a54c9ccc915eec56..b05e3436f15029031aa0f0d5402a251bf9478658 100644 GIT binary patch delta 98 zcmV-o0G^1 zAPHdplbg0?@1aNlFRf6^p}&U+ou3;3Y;-evRG}E~$Q$ny79YT$`~1b38ST61m!?<( E2+|cRS^xk5 delta 98 zcmV-o0GyZY{Q`0mH97msivx(^tsF2)hp& zHxg$h1PcdSx31f7!8ra=zsJBj)sB(i7JTf@nKFxftU%{2BMo1{N^TT1SCX_Eai&-T E2&Jwl!~g&Q diff --git a/Covance_UCO3001/browser_profile/Default/WebStorage/QuotaManager b/Covance_UCO3001/browser_profile/Default/WebStorage/QuotaManager index ba58fc2321c47beeb1c6496b8b6c8499df77106a..466c979de46516349e1de2bdeb7cc29cb3d62d99 100644 GIT binary patch delta 60 zcmZoTz|?SnX@WGP%tRSyMwyKX{q}-p4Eh_7JTR delta 60 zcmZoTz|?SnX@WGP^h6nFM(K?S{q}+;4Eh_}mk0{^f#^lX{f{;|{I+KWi)xzNXE-u$Qt5rL`^M0+vZKX=Br*CMi(Y$|j3!$|9S9 zC?F!BsO-2eAOeD{vigCdAc6`XZt$NwnY5EOlZGrGDgTtG%=FH=XXf6ybLPzZo_p?> zmLD{=F&xLrf4&T==d6enqvO}SiFhdnvR;U;Z;i=Ct!{z}a0-Z-`K+5s7~Y}`0Jg=kN-tpiGXNt&eP zI~|485XYEdF3Q=@o=4_Ug_PZ$R3pQkPdOz*aeRVMD(EnA+T~KET(If8qhCCT;{v8Z zl`c%F*d`D)lB^XlmxjTmJxn|(5=he09EF9H(?lg_I;|$EuhUWFN=`Mot)r8dZJBUkiDM?42DCXkCrKLL0hi-?Jj+1nM7X3) zYO&j4vD$38nGTzcGN(Byv(=qOI?dU|d3lrzb%HB#$IB+cuF;uOJ(aV165XN4+6>Cb zPR=CZx@F@5Dl!V~R-8ndi>!(RIX!`V*%iBwu5RF80S6<#d@66;aYjJVu&BNcG zUvT=AIUgT~>j`;MGC@G6l=hOu!N4Qx!2Yt{lA7so*NO{?d*IIvsS@EpYhJ!YIMiXM zDvrWA>GD=rFkHylO}c})sHx;rZ#SV)*hA7yM2Ks&YD?TZhP1kKEe>a{nHmj4G1qFh zIN-lr7iDtT%`S;REALb{yToqlOCKKuhx4%_!8qJaI3-0Qk)(F2-RyK&&6)Y=;_41^ zxad94qa>-r9ED*G16fiF4l}#)eJNLg+fgK89%23NDyn!X~LM9X^g>Pl+E7$rK@bdq+nqi`IaNWiV}j7K4i z$1zEwz77~3uvdPXD`%DJadCJ}&eLem*Ayj74%cLzsEwo*oJiQIncG@O<+`lUtXv!E za_1I0%vOt)GNaCA9vNY$q>54`Z3k$X_L8==rh91_<^Z}`^xs94)9UajOOQ0C1;zH_ zLi(U9*CUpQqSfvk+xhnY0NdD$1y8W(u6)x-{mortV0bX_31<& zNgB|Fb*!#jBlBRxBUE2fk1nnS#qiAAp{VSXPy{0hoifkqC@#uktAGP0Td~VcIkTEd z5@{6;;2Fv-cG_|as1oQTYav*dPgP0E@438EWtZ(DVZ72qi@smE?A!0L@Gx9y zA!x4Wp0Z^g?o6~LS`*L*lDg^eo-&hea=6n9w>a^;CPPKT`aUCs2Mf%rL?FVE^=nDo z+o?Ix6y0*qshnVt3yaVjDiab1=%;we^FroX zgfnGzCOX24tv)g#$sUuEhQ@_5an)1BssmH@FQg4V^A=MODInaWl5jF@(GoZHvOKt< z@tQPt6&0a?Dv6b=FxD;cE%D6Eg^lZOU{_KSa;TJ0xst~;CaQKWeecYc1G%g^)Bhy-NKdQ0lF4x~GbRvSfE>fKu+VI5(vkginf zTgh`BL@Q7S@1mxxN*;A!q`kFUg3O1#B}x8dSZdDrs$pt_9!5rrt~^ze$WoJPvw7Nv zUeGS02}p=jC1RF@$1C&G5f$H&np*d@B5_<4VDP9v7KkpzOWyG~YjryyZz7rK0%JMR z(`K(TlTO;9tDPA|ls&QM1H$%yJoBH=7%vJ923*o&C^ZIJg?zN+bcf6R05YN;@559; znG>Jh_s#SRTVx(9@Q5%3hpBnZOx>)4CF$ zJR85JZ{x2odPK+J$wWJ%4Z0z{B#n`eR7ee^$k8RpSIegId_Cg2Y>zmt`PhrY1$eCh z{jA$86#W`6S?zsDQ9mQ^Qy^)dNxEEP98NRS!^xhlx73wIStzFyj7g`B=|kS$w%$!Y z9=IOMdW3igo~Kl=q_;k}%-{!8+0ZwX=OZB1MB9AVKr1v$l|0<)&d)aGgO8s)(Csb) zuei(pdw1Jz6tEt=tnNftxVV-TmG=h^8(iE}_{4CzNqEI49-95@^5@gHT=ia-9@h)9 zdJ#RKc87|!v&qqv*;_csHGr~H@Oc7*ZJjzWZT} z-5`Z}IWD>$FPZIa&~1O-K1gIH4W&OL;0uHPfS^AyF!;pCuv2}>68h_-cklAAkJ9q5 zkJ@nY%X&*{WID#c=WqNldx70C#t!!dho`>mzBG7fNKFNX*Jd}PmdXI$ligy?120?j z?Tw?8&yBmdB10UPQ2OmlxRm~a{;0>B2cLm&dH?k+ob}+qe`n3u_UVN8cPEJjEQLgZ zXvf<#UYd1m$?B;%Tx0pE;K*C6e>i>R=m$H0!F?{GPR;MmY{&4r{x4z${=c~jILp;j zrSGn~x?ssD-zK#Zm3=URTT|Ym4&|Sez2Cm|RG$%U}9n z?xiM4L6SD*w9VSbI?3Gi@J7sS(Zd#Rtj-;jIWV^m=>{;c1bw?Y(;a3iiD>ArSp4fU z98d66K@1pa2S6~}YNj$tJ7sG|G)9#wAE2wX;i{HJVS{8ipHzMkxx~vjfkZECG_&l;XNOM1z5zvQ12h+le#dMVvkM4eBi)>bt)!oPG z7=r*7Yo6U|&vYWNg92C~3($!|BkY@1gbbZIXnFc1^*kpT0H?@tmJD(?AnG6`Wq;E` z4Lm{&jO6K~CPaNC=u<`uxAO@1cbJM@11VckpJF3?|7V+=0J;MVVWymP%R3QmQ2naJ zXq8Oo4Me5&*O*Vmhy4FtMUQ58Z#7z07sif(ik-}6j&v+UxWV2eLt^nWw8#E$|Sa zXP^tw4qa%~g0$MsRj37m8yfE!J}E@UfSTE|wDMLJln9*0JIWIG+qDD!uSuF4FL z3dhrI4i`m}GtBVdJWeZN3?K-3%u$ZRVKb7>KE-ag!_F8${|D*n%*)uv_A)PHpE6pw zg{M<}9`8ZrzEUfq8R|iD)qhO-LkC^WAcZjaq$a8jYz)`9- zqsTqTo=7x6C#_IQS7`5Bp^v@DmI|+6XJLl(VQW!&vlYcL`GMVyqOm z0Ieq3_r4?g2yTjvq2s*6x-2|RNpxY~{;I_3Q!wvC?}f0MpY}jn`5j{3hgFHuDqH(r zHA`i=zV<{*_NDrjp_MiCC`*IL87l?vXs|{$R{|kHwS5a|appUQ;mI?Hr@Dq%?FGp3 zq}{wBWU;;MJ0`FYt*(pb?13f0;~QiL%Ooc{p{oi`m{#A?qdvPBLXseogEAvt&wE?x z4;qLxLplRU(2AOS6j?K}y_be&72YjU zP(!?8yI`>Vd@oHLp2=1qS1NMN%$Ic+rH0a(NR3%WQd*r%tybz}MvYD*Qz(@xh2Ef* z8%&mKHHhD85N(1H72`>@MRDTEi%UyOUwM10snwPmM5@u|Fm}yHApu=eQpUQ9l5M2X z5n3YntkpRImjYK2xabaN zipyPWE=f^o4QhExfz>Uu+R>K>1ahP}>@pYyW*IfM$m$7O?uBAVdbHK_X{%JGJ*<#J zw3AG!P|39hDCpuXRLK1lDwX~U{YfhPO8PyK){joP%3q-sc7AcG@I&4d1vIMN+YKyU_`qDhuZI}Eo%u;&<;bZCxL zAy1ZflR|-3-Ay`HtL`WTi)W+YLw2y$ouX0cl2ux1hrt7L(uZ`B+N=eXbO2>4aCDS< zVp&rZDs3{T0Ik`i1-@#TDt)l~u*}0B#yu=@Q)AsJCf8_V+1_I!Z(OdkY;P=9iqE?^ z`NZK#ag*^|-XDA+jxEEn)i|~R$2Q~GhdA~nj_t>>qd0a27u;Y;mI}O;ZsAh}5OP3Z z5-b6eVy&@{4>hWR-yhbqbEp<^pjL>_&VpL}v%`KKmHe|4#7)@SqU}<^jWbyEFYw0P~wEG6|=ye3HDr2X2rDFP;4;#p9S@lm^;0o+;Ee<%N8FQY% zk3w^;cV&|?Y%Eww4%;W4AnY`%Ym*;zUSj7HlLG!a6ZXv z8-*d-#)R*G{_Um^&w{Q+KlEgs+x9DV)*`lrY8%J#w$aB|;ca6$e#PBwDE@!h!Iyud zoxz28a7GZ{fQM=X1@dLXU=C)s#|F~>2Uk>FZ^aRqgXyhUX{zHLn}fM?<|_|E5CHn5 zML(4;j1K|`VGd^aK>!Dzn^6bmZVvO@6+gFypSy`>5KmV=(HiD%KET;ccjw$qiZBlz zh2g`wnjN9Jo5SBaHy`G1KFE0*e(okecQd!*v`oJfDk}<^{Y??&=WcS$-R#)m^=Dx2 z=0ofUk)ONC&)sxNf|$G6WBPwr!raY=0}LL1?q&q$Zl27Ze+lMpJ`$jx`MH}g@i!U8 zlkjslDd%m?-JI}v^Aec5IU>O5s$O$92MEqA`4GcLayO`2%-yugr8zw@{83gju-k@3 z4Lbz604wA&O3>z>zor)h740pezstF)=t*6m3Q*FMx*#h0l_BD_I|QXaZuknAPu1{tIw*~28S+aWkTEagRQ98S{J83jH~GwJoDS&oQYlR+g@lN2d4Xtf5J zT1jd3Muk?VQ)sT&AbtlXIT%r~AgK;wk|zL@e0}RTv+$~^WTVokvlvN}Os6m?WNJzd zT(*id$W$7Y%0Mbr8ns-@Q^{U-Th3F-^jP+#lGiVt9R(`6_aj$#G_HXg!+LlQ*CGxA zT@u>EQze(oKRgfw!U~Tlivr=}Fe=Ak#0HoAIB>mYtUt{Jj{pW(5C0JFD+i8P3v96& z$_&63BQBW)o|%L_#2Rbie^jP~GA-0G0-uaHXB})cvCSn%r^#L}*{|^njz)nvn^0+# z%uWki-4f!au#DpewTSH@8^#giMZB^E^Q{WrlFia@rmI zACSqLpZ|V4eBzneRxrRPo&n_02buwW;$3Jc-m*jB7`R0Z-;LfcI;1GLB3sAbQA%KM z#Y(L29iyWso_(x2(9srlpYU_iA^oyF8EDo96-@jiN5mPo-u@h>m_yx&8s5qaX8}#m{MYI+~}W zc{-ZT&>7WK!plag>jE8Jz1h7p z;Te~p8JF0gqo06j)H`!#-1r=x2f7~c-)=wgp;4AD4x>FAJ*W0iC?Zyb5! z7_@PW4LUknmLf*z=x8<1Lr0ex!q>*r?%@A|j^3zx8ov5QGgc67HV0L-@-Mvx$YgKD zO7zbiBa=1c@tQy;k73(&o=m>uWb*jBZEpdYJeKpe@MJO~lUFHry$xh?31>Imon*4R zW@#57lb_&fc7({}Qt34e$mAzEPs5YRJekas$-i070ez$qWPadRwi%FhJoXP#5$Ipq*J9*#M)fdU49_j@V`ar(DY2plZP>KXmE(Qs9)IV>P1!ryK<4+0sxv9nghwj1siz z`|$h}V1&IzRWQQOBYXiE;pazt7~$(52ws`IX4t0!d_1GGGO4APYZW>TrIpF`zyqr( z4dR9^dYQ&-kXtkgv&CfAO{hUU2NRTo5fuwPsjkrk<$q3|d7#yo!Yb1BQf4!$P#Z~^ z++fhi)Fzm2Xw=EgKuN332D64T8T3Y&pZo`YJE^Ye1UpuDiOfkAIh<}+iW!!YLb=vm zDb(Y|us#?&*R??<*Ju<>PF?yBE$a`ZhV_Tqn_d!$sa5PFI@TW=b{!4-h>ER1#XgUQ ztxbh42XaxzO6uvEg}0M=dhdnTqQKAgJT6hJ5aJWU8p{6>5obgp4&_xMekijB`Q0^? zV}mX22T7%$fXTZq_#FY0aOJ>zBK8v{ghrEhk$Ul8IG!?IL+M8vL8E!8aEQr*2T-PoWmqxIOv2z42)=J{Hsb-&V% z5-^uRnWQkXGVeV8#M|95d=lFvaR;Y9k1&7qA@L-v{2`h?4;TOaf#9Fn^CrUQ$@7c~ zvM% zGij%@A4Hz~^h18~tY;o25sKpzgi=9=iPJ8lcjQPy{xPtgGXe}Ap7o3X>v?#J`*&bH zX9nnJp7rEe&k$Kp_uT$Z0_!;|!04)8tf%w*mD9j_&gO1VwO~DuZ2fy0u%0inn&HcO z2E!O0?3w;OOq+d)r3B|jCZ>N0a)3-s{}N4`U8xm+xku2sdBRWtCgw02(B{?QL&gJd z>Mg2*H=TZrQF_e7n;zREnELFQkAOFw%jm4kn<_|^QA5ELRyyy?8KhBCvOhBTC`w^GNVRiHkwo>IAmB*gO~^Llfj6JYgYIUI9XNvq(Y<9t1P5aMwv}|ncA#^^<9)| z$m^q2D-;mdXfmjk@EtHk@c%J>vR$#=Nx6y~b~9zpu-i&{xShpRtOQlgsd+m=mGADH z5`~Y0{imA^-7Lfxgf+fzh=^+tsua@r-dRRd2K1$%hi?EKY|)Y@ zGWb@I!#~d#gPdL{MFtW&_)0)u4CvcJ1+kSzh_F<_ucwxwI(;!js>$%hFsEiI?$xY{*IDB7|7k2Ic=}LoB(#Ffb6Ae$gCcEBg8IG;S!}wx&Ai+9ixe#9% zmiam>B2I;BzFz0eR~V6&)zN&#;%7wUp5>VQjEG$Gd`;El4{4VQJ|lv%Q(=T(HvHw- zO`s?iF?I@Vf-5@RqSsM~o%B|$6ry;?62~k*TG#<%Cl|9VFP}K(jwg=kv-9*Ih@D)* zd0Y6{Nfa0IMCX%e6_QstyXo$XoxJz!?L8oNaw%7{BNRJ%U~s%1Vkehzo`#Q|dy^n`az%iC z=3^)M*vSxMC+{C4-vqIfuLT%g)hl+g*~5SBh1kj0xf@h1VkZkHiGPLI$(5{T_{L5K z6TpzVB&iW7S;eU&7)s{TQ_?1YO{`{=pv}hb`#c2Ulis2#!Y60cg(?t}Iis#8d~(Lu zf-Vz}w}9!UZ!kK`6y!4n83WcfPHo&hhpE`ayG7GY5B-6Q=YK7TYkB5#xU4ly4YUca zNRao({Q#MGE5;6FvZ+JLK7dT#WLi||!uaW?cVxQhmnk!A0%Wq5^S1Di34%--{IKsU zfK1-v?54XDGMS_o`~#55I<96%2r`-T>Kp?=ChIv*!$T%KWWqxx(T7YrwruzjKqed5 z4gP_=+eer?gcCLjXuG0i}mV15n{DD#IE4ub4Um%?Cw5 z#T*Y%F=wyf&#y)<2B6}7MrWA<4xj>o3P`~k1XS$%M<8CaS0HS0r5Q|M-4vt>^d*5* ztV0u6KM{!6?GGP1NQ=0vXk>PJXpemB|KOXeXwNIl&nkuOFm#fh&))r zgC#+MC3OUS_W)S(VSvHIgC!9FOX~dn=0pHXJ_^v!JXpemB_V<(h8n{60WA4A!04)8 zV97k;Z;u05@(Fi?ss&im?%j20sp3zWW}r>|f0ye3Eb$hVVIBU#l9~0P3cw6A>wCbG z+4}^!YaY1@V995U&N2o5!IGItjDjQtmP|T`ix=(_yz=e*g8+4W9;Aw4jEZ3h>R8%a zd}yDb&qH-lT*w!U2DFJ}(Xp4~EZ@uaT2Bvk($lDow=Uq~fA|Ep;q0cn6V7Qm>BI8?=X}l8 z>ro$2orB!%surluwez#;05I?^(+spZ{Ef0TpgP{7GPHpM)j?i1 zLL2saP@TQ|1)Fxc)PQ&#Vsw@%;6Qc$Wfc625RZdXh2nqr3*PCNc?vG;Frxx(f-4%) zbk?VUS9mK{f(7mvUQu`G)JFlYIKs53(uMJO#T~&b8g74dAK(>7Id2P(S0KD1<5>P5 zfL9#j?54XDuQ;{M-URT9<6O;-5MJ@ahb_c_SA55L8Xm9U@d_TVh(2EN5fLEMg zKZrbD!Q&M{;T6-5)@uQH#mNAJhsP@-fLAQ~{@8H9D^3OIXCANM@rn@fipzsje}(Xq z(*Z_T4C57kfQqddTRsAy;tY3#ss&InBBjb zKa2*n39hKm(A{VWdv8Vh)G-lPadXc@eE_F8$F!)@h4DDW9l z4d1*9IK`y^qpN!16y4TM>jOB&FWe2P7C6NxxnKMUh`?p08EA9xi(S70PT?&ogBkqe z6tn9=6@VFL*Yn^MGY<+ByPWq!K*g_&&N2o5af;aqjDiFdP%(2VE`Ir-p!Tgk>2O(B z7!_y}T#=}U@C5)WycH|q0e38*Vs#7mIshuJGA*ifVLVWAM}Ug=o9r71K*evIw}l5P z5KwXX#Qo0zQ1LrwH{G2;g;~CP2LKg+a5XzZK*f`vwJQOj;u_~^c%Xs@DtMqG`as3Z z{=Yv3K*e?TgUACFJWvr7P@&m3?;QXt{u^NM@IXZbfQsHP{9Ob<#f<>{%mWoXP!S?f zk=wZMCjeCZ8DMl(FQ8&e7{KIHKn@?>mzXGVkTU3Tr_=h@P%4L-1dZ3QeM+B+V!2SSr zpgAGvr%VCIRk=V0U6l(#9kb>L#J?XA%u<}650`b5R^a(BxT3KaP7MdB!&|WuqHxEc zj=uNLy97|jEv7}4E{umd?g-Rzp|ITzfI8?w3b&^6ZQ-E~1a)Mlf0GAL2XqwuQ@NY& zPN+lv>4o6{bqKhc9U-Wr&R1VM0P2Y2JPi+Z@K6U2bwnTPxVLeuKLF|wvL8eq>foV{ zprDQ&J%woib<_wjczCEI0#L`#X+8P?)KN1)Kl4xr4|RkHb=*4Irv#vm_yD7;dO;l{ zMw~GM)FI+-P_=+M)~P4C0THOhGy{ExY`HYDHUJggB6I}jo;xx}3daFwm?QN770ZqZ zQX3EK13(4A?iz0RWKK4tAR7S{zkVSUA3P@bX>|X#a9Q`TE-SdAd$9N;091G@(ia~S zlSkU;7Q6#MMQwJcurG`UD((nSVeL8B4M0U5&fCHR6$q%1$xU_uD(Z4})7=SFyeYhA zDF7AqxSAaypyKz{vZDZ0h&fNg0~I__!2=c12P(RsH$M(QMSb>z$O9ETP!SYR@tL9d zvj9{`0t_A=sE7biaqi!P-2td*5TKuVpn?Y~LIf%vG5o$6fQp6zMpyL$D*k!G@EiaY zjkp_BEr5!TwU6lm5opXb126+@^PVY90jTg6p(BBSiq9CF;WH0V@!4^~5|QZy02NKx zT@wJPK)J6F(s6>0s3;YPPaGHYskOBsgo-2tr($jmkBYf9P^id~hr|=V6O6R17DB@k zSq+P1(bn4#@rDw=A9Q#rU4k!jPtheUy))9_#n5619dO!UE+TMu4d2w;qq{UGvS z3=hTx1;#vGG@%E8F)afO9v+N|02uR66|v zUSLexrN2-nk2c&5sup03gz?ad4ne9|$Ea9`TCq$ZUUx!Ze(`ua(9khR4eJ>V>yZY4l-8dR$cml6K<9R1 zG=KmWT+x%_g!=$)@m56j@tA;Hc7Ol=p8&UXX7>sE!g#plj=(M3&VEw>a7!1?+rq;w z2yXdLR_#jwx5zlV>F$JEGI|-_8inD>T+NOU-15|$8SwzOq;Q^whg*2Kg@;?B54TMF z#JCpV7CHMthECfPUuT79MU15pG$y zF=q$BEvf*ct9rpLt(5ZD0B%upH>g^`Evc><>j4qaFwH=Sz~0WIS^!w$EkZ{E#Jby-vpa=-VLVWAM}UgMH^wXhpu)g;TX>)X0TulP zNw)x~=*rnmcPCKc_-*-204ln1H9JB;#TO^iPuGeQbmu$`4^;3##s4FqV&=cY4wPWR zPDw7ZkjgcaCAoP{M{!Z^XsgTW&W%1^(QaSX$ADM#U_XyMUcuuPLE#m3_FjA$@QR)R z1`m%{L;$a7f6zV*@QPjm`kBWoc)TJ+yyD*b<~IbqqIZDNRlV?v4Rmd3?auk|zqK$aNdBK~4r#^&+^KGbebX6~?7)LD2xKzN0LTD4m~}h_pbl>lIuZct zSk%x1Gc0Q8fjZ{=C@6gEqs0Jq+|TYBZm46Co>8DjP{#+?1mev<3Iu_vSeF%C z(aMomKLnt{TamtaHXd-tfQoD1zxXQv71``gVP6;zRNN7u;{3>8GXSW_;k+$8P=SDo zZrz_e4M4>(&ThIpfr>u1@h<{U@c>t|BLq~8R`;6&K*ey*)9^qA4^;3#Mf77bRGrQ~ z0zk!s><5ttDtMqGD4-&}=>{196%Pd%JUmbl0ia^i!TT-%Q1Nhpe&&G+9;gTrs5tAG z)dqlyM*@tl>IGEn9p3bF04hdsH>g?w6@3o>t^-tJB)b{h*)%%coE$`B&TaOx9%OF$X&0*tQeg)(60Y8(QTA)mWJ)dFQueA3}-KpCv;W^khn zixnP}VX?x4GQ9nh;CIxcxj8TA4hNV3-*QE=}iqH{Uu2kfj9b@b^2Wjr2Gn+L^ zg~=o{ks6CkZB*-I29rWBGa57sg;uW7$#sh9LSm|rXcLU6I6kS4C{8?iLTPE~ryG`D z!CUQ*BT|hvhp}tE+g;@9nvycsRg`QajV6b)DB0vFOfk!KYQ0gflgZ6WtxRp!%VnfO zXOZc(a+N`$r_@?fF2P!j5F1W#xEERYw-NL5|AU=k`Bv=9_#cHNLxw4B8FJO<;+a6Pw;)$Q)LmgA=7)@SqU}<^jWbyEFYw0P~wEG6|=ye3HDr2mJk1I zm;y6E%@LRmGs8a(oKXQ1COD3CYoLY)xn+tN)?zM_KdKvfqez0g$G;%N9FLV zfa^8Exy*2FV=z1DcYqc%<~)HPh2~oC$|hsj*vXk3CPBJ&d)lA9)^&Tb+mS!k9J^_p zME>2o^|#k#n=?=Dkxcuv?hUWW5Qb0S+lU^?)m6TFu(d#XgMxj^hET$KP#1x?P zf)N#ql4^S?z2B}MFjvj!Y0U;XWiqN{a+AUcjGk5@Gf-LT?O~jSU8lEdv`1 zgdPbLogV%nI!{N_cxEWG0Bwf|JrjKl5rayg4wX=5p-U|A7ozp_G~s6fxtJ#OqSIuC z(DQ2%f&=X#1|U?>{->iK9cw7Wp9#xid>c=E6RO3ilF#EUM)(#ZHu$_~Jw7qQ=S8b| zG~Hij9cKKOb{zf(eBQs~RENRmeU>o|$mfk@(E|;B`vac+EWgj+`xpEGT;Fp{iz;0h zpWo+>%)I;Q*}W8Sed9Q93(xf-uCHd?3y%WVH=eVb?oO_+|5?i@;QA(TH9JCF-^w*V zybWC6M9$OjTp!Q%@myc@xxVyxT|eOZCb1txp6lbezM#0iYdLL6;QF2qFnD;bF9KZO zZi_+YN%@6hju5T)LgQ^ABH~!p`#=!MW zV>QE<>kEd|xY_K1e*so_fl-2R4|i6NJ;3#Oi_nn(T;G!83|4X6!}T4%Bv{f-I~R0L zXX%V&(UU6&{s~l~S3P}wJ{+foG8;`wvqGkpBPvm8G|CJ*vra}Sbd*M^HCT*t14AVS zBPy;{P9^^Q?ny`0R3d4z7>p{dR;E>&%`&yltdx;vQYX_Ib(Gv>Fu)aPB2FbTlLY%( zT_)0Lj-APYvzkY8a^N4oO+6j?$$?XzT3P~B;tXcQhBl-aDlw!XRV9_k4=ENg5aN)E z4Jy$MGY5-+DjW=C;0T}wDVW1&1Ts(wTLn!Z%FC!kB^)tAnE_}ip0HqJ`n3g5_Bq?< zKTGD0cvKS1N7?Q=Pl1k()M)(#ZHmJmCJw7o)B}S`xzSd#< zb=q+NDlsV25XRKN#^aJEgZn#+F%8J24zB3*hss1?>bw3vOJ_t>+viyDVOM*-ET<0 zv>a(##;~C|9jxY#(*9W)>C!^TZ(=pMq{9dH%j(Dcm77nx@})hb?X~JYeRXMR{WPft zO`ra9d3#9{qLFCs%FDawoteC4EiNv-dHCD&3r?Rh=K~k1C*(=V1W^aWN_$D-hB(F$ zbzpy4Z%NH`%4{tzB<_JfH>6601Fd=a65&vXostN}@d-kypu@yzml0w2QOTccfv|gt zv$yU}!tU>z&AR|$H;1d)5hCnr?rPKn2)ntQr{M`Zp0MKyyXX^kTjq|x287)__Jhb1 zc06Gh6k%6m@~)mh*v$_xczD7t0)*X_`z51*uzNW`Kl6kgPuPV>*nK>*{rf=JEeJ5W zsuyARr*r%XAnYIuApL_jxbHiyS`c>1V>3Pm!fp|(8NP&FFhF4X#WB+XU0BR0K^@Xo zFro$o7ki87?%~cwwDd`+0+aKWK8b>hH@6f2{i|S#e8U$&`7L2xSpdp!X(^+j)I<4| zUJ)FfW#0yz+$(GaKAfCc3FMnmNy;>4QZG{*OfbEVQo){HXH@BoTCKsXV>r2BM8!lo zC-=v$?YgQtIi*TvHYqhmnZ>N7WNM3nl#x1mWDN?7)~yvAyp+O#}6qM!X9D{*x2CYhCoKmp^&o^ZASpphB9>`mdyxz zB(QE8C?jFw9-7{V@^qp-5{|2wGCfEe;V<;RmgeOUTNl&Q`=ZliW_q7rixBnceaiRd z9{^4cs6F}zZG7jL2V({pPA(YHN-v=*IXT{9gl{oogOiKa;}avCT(p`;Pwy+U4xfBS zI}ZPY>3#SNX>ahFmougT*@s9Lx%zK@IYUsUzOv;}EA`-Qnv61q#-f3Q^(G3EOXy58 zjmD%fs40jQQyOOq3Gjg11S2ZGr-J)?u&R9Z8a+e8)P439}UUr9nO+i$yoo|Dm;==X$NM%9t98h)6KHaQ-t`d zobR(>hRUz;1Z1rbZB%WnD*ZG+s(jW#2z6A&q7$qJ*H;ftt`6K?6S%c9aEVdMdJXLa zqkuIE_6+bpl0Yu92DT{Wy_$B6ksFM{*Q${d9H}OQ6AUAv6!&Wtq;F2F|MAAxr+(Ic z=(8U^ayUbKzL#RjFS{G9&b)Twubm}1rQt@Vm1NalmLSAegk?33#uJdZJ~XSbn710Y zwR%dZRwEW2;mAEgG3f|Lu6Y$K#L|~&2Le3dpv*%U(P>jV4!wV{0Dq0!Jm^#gtxm0! znRIfMOsyalGCgI`%K)e~nbZn7X(AQVgv4azssXs-+AXlF}JvT1u;w zsVN-^>pGd#GE%Ekn3M{wNn=4s?IY1}RkQQ0MMbeQcVf$WK_uPO@4sFZ1vhnOw+?Lp zsC_-G5yb$tA&saifm(h%9=C_^}{0-RSg zpF$7rsDZ|5Jt!@5XVFnP97pRg#rV2PzDNvODk>691{W1ZLMiUoB1jXCzcOv)FY`Cs zmiGOqUP+SJ(r@pSHSId@`F?)>{Fbx#sKa$pSJb?`AAs7GVOb0Ys13PU0)^PPj5@2okVJO$=EzZYQe@bjG`FyHx=HEI{kcYZ%WKlAgQ`T5Qv&Ud!T zW?hB(&YJ>^uIe@4dDN_FJwC+n&D;&D7W17OkL{iJR2;sAyBTuD$(sDD8N+%@>a*V2 z=? z^p>#IFttGsBO?VhSgItEr6$#8^EgvEB}J5rXaW-AREd}+k>Sp#0=$}&J`q5j(q7^v zf4uPZZ3rlG7b7_XAd!)lHd`(`;5#0cB2ndfzwGFKm@3uEZzL#;@tyIAp&wsW-Y8nE1e7%>79w+7WF$ z_os0d4B*?ItSm(ClBAKcBwks`s+=xL%Oei|7Hh zJ5;QlO+rwLw{Vba0A;6~Xxt>eb-YpW?!7f{FiLRd^liPe-nJnH!v;b6`a-MAMcT3` z(&exxp84*FF_KHm{wb^7o9GFr53M$)7wF@%JQ_L<%E(4z+YEQ#O4|C3byIei)nQK_ zRF2%iuW#Gx7S8O=GgFRe*?7eEAK-5I?2hKntXsiw-`a_Q@G79Zh zqhoAxc5z-F<#Iz;KvQTd0X>vmTv$jttxr&9^!(V|=>4AfcuHxt!p4*C^Yr_Qf0%v` zBdch+h4^LKKTiP{xRdE}WO?R3w(C(yr{gU`N4V4JbjUje$K#~1^`z4|^(x-G_lrG1 z!3XTy$j<0faKpCy-u+#6Fcr^ww@3jdKKm*j|Lo8W(`(`%G78#wufXqmqe(xO(h8dC zZ+#_zoIpRc6u-P3?YuHXymklLxzJF&h2GiFN_-x6M55{QaPi+Cpkphw;xG50qC+sM z=6{X$_WdIeui1+Zej*UBqjxrl#2aBpB${*(7cbn0jxFsiJ_I`=(X9)(_+Pqc0xn*) z9~B*(Dir?*Hi7uK9MJrFBqGfP}^bXWp4?7~!f_H`D<)_fz?^}i9 zHRqAki8kU5up<(Ea7`fI{3F`i3wslPMhD@-rqMf|m0F?1lT`_0-?EGWYa6FF?w&*U zbkm71mu9kv8{RBvyBA(3XgdYoCTKeo z-X&;z8eSl1y9{0*X!{wwJka(UyeQE2{7KLD<~h%H4p@Iwev#R}{gdbKL+}bf<*)!2 zy@jlJbhjYWi+-+dNq>I%ud@%qE@a=ExT0)}?t*`zNy#1|*ai?PV1x<+2t7aABLrJ+ zP1BEggkZ}pG^4IZ2(|%)<}gBY0tn5l?-7D6x2BnU8KJ!agl0|g2*H+H)9iX4A=q*Y zy_D+_f-Seu9H~bLwgH4bV}w2nAT+nwBLrJ+P4m#;fFT20ZlMJ?JwmYM7FyKMBLv$3 zLdR54F88QB4|S!5x`7pI6m|CJ$s`aW_LSj11UJAKW~17ykV8t$XiZ^>!DK)acSkfC(3LBvFCUu} zHyOX>{Xv;)y>lipV0GZL>`NTmk7Gx1>*CY{IK$w#1iVTij7$;HtcbjnbHqt8`~izCYpnSX0f1O zJw3r%PEWa3)3aF6B6OZ?Kni*awkJ8J7WUEPY&3gC3DT%uOlJd%PLp943yg$P+^<=X zo@#&dhf%H841Mb8y@UTdIj%*sI&Y?@2`9!aZ9QQ5iKm9%<24(?5Y2{b#P#nV(lf|~fSD{o*@rM@vaG9j zvmxY;#{|d?245QeB4?e$pMD9BBY*lOlso=Rrue1T@RVQg>j}9pakd6uf0vR|a)nVV zQ(5#R4$(vjWl?S@e1et;hWTWyR*{^teQDddD7d@3I%Dz4LR=8msJa|aKwhCX zp^d64=WO$%%ICcm;;4#EZ43yK7gwmlywNh)$L+9-vwM01K{Y${z{MV2ZQ1BJE|f!*Ueb(IT-Vp9#uo20=NUhz<|{)+n2TXe05_jS zaYv?4tOxO-HQ9Z_zA%1@^Bsu~UH?(?X$a$r=e#X^7#AjvY#7%O>(Aq1y0nP1%kR?Z z(ifZW9fjewxSAcI>C*4d-aQAVOB0-@;ipUU)1~?8($SwTo!jvFe>9lj9`=J+Vdeqn zoUB@py}WKfoRFV2%}>qZr)GsTy^TGyvR7_OJ+Kr#*0lLu%x(7qfwaE7K_Gc)IrqbR0y05MpP^=Cz4-Vzu*R5^&;X5 zi`i(Q)Ub58)(E-3Rccs2++tD4v_`eUsFCY627?NS*xF$ z`KU?bxnI8MBE%boHKt(w#Gil>3T;ePxi}3!rdVqNhd8EUgG7D|h+i`{8vZ>DA(JK` zj&(o+>tTkuSk{3I3bQoBQ49Rj0MTrO(wGjJj82n* zM85DqDel)KNWWBLi2}*R%Z6asAu&fX$TJpw$@6GL1nG3z<_Em5em&6*7}np)o172Bk@hJm3)#^?;dm z#A9vgn=Nk;k@SFn+qEDH9`K3NhaZ8pZxT3PXTb~6`L@SS}4OJ~RT{ls4b#bua=8{c zsX7@biZ(2 zRq-#XcVT{ev#`ttGrv7Fvr*;zcHV46#B9W(w;H);C?>tt$ThEmiP-oe?LvUJ8kBtq z!&~k2&Z;9r1bA~!`=HPmEE<)U3K?T8x ziW^k)R`*r4pg5&c83Di5$&@R2on=rbnUysb=R}i;7}r zG4Wd`1(8Hl4;+6b3Z80Qt+N>rQ_v!;A;rWLgf^tAj49xUR2iTe>X3>>FI54asDTa* zPys-S0txhVz<_sNI$CKQ`KAi+Ns*U|LJU;kr|M`>)#JS)zqT5M6hx}Y;HAPyD8>Dn z1gYjm$2Q|_F4=P@Z>~sxcI%5NyVn_<&yE}0`OP5@WW9B?G+Zw=XH>#Ah$*-?ER(^+ z6oh6ns*EY%O-9%zBNjc>$UQ$X>7hohc@@mVgcG#u03K>kwjm4;_0rW-2O)owl+!k7 zjarjZsWU>9sn!S>rq&E-rbZ6wlqjP~4XKTcCW^_Q6pX02VMPzM%KS-kg_$ywT1Zi< zH3N#O)*57_5dsh(jT2=ssPzU&9vUq?6;{%SHQqnOOgADSiWh+&XW8CZtQ7xX-ts6o zsgGq8HG=#}EyEgBO#Y2R8KB|0hOa~#}CamFfA)Yu7 z^DIIePH$EfWX2DtKG=O&W~jp{7F|;Wjv8pk6eaPrfE$WtTA9J&^th&K08EiII=js>$G*!bm8^{h9;mPEn1_!>4+UCQiQjRfg@={3WN4 z%^j7t-LhPF`N-bM9g4z*P;vKzAJ-S+ZNoAb-^3GpLpB$4cykd{IBKZoA{L#}$UQqT z>6AvUc@<2_Qmu>DJ7GZZIXQ9b*>|z7|}OaPg+qkdxC}F?Motb`*_G zft;M}*_Mva$$7`uY@hVl)9WB7X9v#P!sq0SbWYAIv&ZH`PR@>;U4D1w-$cb8<#MC#UiY*Dp`S;a%7dVz45&9V zRGdnJnU=P*ru`-;QFAH@CTh6RM?GHyB^pj8!NhcQe!AsxP@?5j5)4<@NvdcKpq`FV zfU(_+slc4m=xA7tE#tsMiTF<&L+&8(BLS?e(Otr_TRgGwpWnjq*zX*L^-Y70YO>w*v!H!i2Im#sVc9Nwx*`r4!<^(qw#?NmZi zQMDctJ?Z5n5ZOwdPN}E#kZB1eSK{ewo7F_Ggp}eixhc2I<#tkJ;bUcCmA(O%Ur*i} z1^POB*7W}XeQgM9I5G5fXv3*W`kEh3cL9B!g{1-!U5q`56+lu^L_Vv4l18gbq6DKT zZ751Eiqea!>9|S{eT`w3_Fkuggrsx#_ga0Q7ZGb|DP<`sxcAO7L{Mu{_;K7Jcse z&nR$uz3MAx6xEVOgGvQUqnkB)a5S})3G#Vrl`;!Vgtw^Gq(xO0vl)!2xXEohy>hvR zqI4*as76o8)N%?IXIH3oGL_z9QOZf9Noz8O;`D0NI%P_c)8TfQ9JUmT)#iqvOeT|P zO6AL*)md)+^=;{sH+DO-^4n)Vzj$i>w)_{8*8TNr&giB_XShzU zy!M5k!0GJ~mbqY@-q6fNl};~jF2XVwvFP+h%3Q!i-MhPa6->kY-)NTsoZg`9LKsf( zv7Yh;-7&l;+b(dg#O_$jV7Y4vLL^#rrKWi8JGi6a{{7%L_hR|Y!4>`6Lb(pYKD`xV zC+u_gJ1uMw_Su`=DSX)H9S{4Azvstp5cZkMd0Y6f&q#-T&bwT1HH3Zk;q3CeGwgHo zp+_+Y`%L3%c7(z{6(|3G9l}2Qa-N0{`{ctu`LNIEhkYJtylcuDfuJAzLFB_e9WGa2 zYP8iv4Reus6p>H|oWI_Z`f1Lx1L+Q<)kg7Qpa1i)&rej}c0GUzb4a6&aucoK&MfOK zXnjEocwf>cQ&OHHcH<{2hAB}HLJ ze~$0;aVA86_7CtR^3k6$5&ikX+)Lj;^yh#8cZ!exMaocIf%PK)gt;ct|L_of)wv#HN!XhGnf#I4O=FU2PK0!l>`G>pZ$AzKHykG z7$xwY!^X%`lo09YEvh2Y(R~A|K%}Glh9}bT#&(?e_l(yqN z7FLafI71y!u9Q+P)5*;i6-mjpkV5Br4dVA2M4Mnl#R=u4@1-^G9l%>{sX?R~Z4P5s zu0%VO(M)Pc$kC%Sk`QZYhMbm0J^X1@=qRlL77n76N+5mD3AhxviX3*A!E|S%dGa%kaox6EJ<C;xJOnX=%m&+A0 zCFFY78la$yw@@MXQ>aw>EA%I+@GI%}L|Q*ONJwfKjJ{Xi=DhbM?d0J$EX*dX*vFgtcX5b=*;4v1n!D<&b9P7Nf! z8fbeIr|Mbu6A}7)h-pP6KMBOX5~5d8jH?`^5RH$@(5g%*iBpU(3>uv#1ECLhx)k?o z{G=BPu0L)1X2qKS{$|^^w9osyv$aSIOxxKn)G0w1>!D{%{JzpK#?;uanbFkGuw+`{HHnh_AU@CbKgxuVLdb!)sEUw-r>{U22swEAiYMgY%3l1! z-()_796ZXpFyD{^tyW>u!#d|Oi(CtfoSWqaNUj9a&gFWeRx8)5DXrGPgd7ATDo!j9 zIheZf+igLF9B9m>K|#rNaB?+-9LP;_h&C`QV6AnvL8me*b$X?S4>|BgLBRd-6J7BC zJ>+1+?hRKXA99ee;qA^4a*!L=!^4Ceg!b@M8FIisJP<6z3Zp5D7UJV|D#z=@M#zC4 zLInC?X;>D79*lrs0TeV~g1`b5WCuW*11xkP0SS931VIkcXx%6D4+S5{;eRBjrT5ej zc7XN`v7I<8I!*S59QZYU!I5oYtVud*V#W;!IT#g|ab!XcLNkt4h8*z5kvEQ{g>?F? z%o^Jv2hp+=F%ohRt>$?`4$2JS$vw0?_&*3a7}qWDff)jvB`LaB%EtL=D@A>DNTuGOCTQf1JxBS`6(>`H|wth8dGTwh)o z%c0VjFXOipDm`h>+fn##>A0z5pkB6KnC9h7Vz>>`dl@X7$MXcg&^y|>sP=Y`fkv`_k#h-P!KW+e<7)u zPNeJm8jMtv;d=n?bSduFs7UJ;%C@)KXl=gZ{{36yk2ShEr0|obGuK{O{9wZR&)@sy z=Kr<#EpRf`@BedVmt7N@Rtc#lRH(Ci?iZ9qU&%F>NY`^^SvzZX)~)hewluVk~lkM2Ii-Y0r&zqJ1*;D zBDA+yNDuak;$=Px-|em;1_+Mk66Ex3|%fU*>I@?Twm!0I2G1QA%>dtRCk z!M)+37{R^6(2)?_JIomj?j61btKO(x?~k3BFXD@p4DO|PRb(VZz)5H&g)^ik<1#^O zIL(lfq<~+VqqI?#T*INBSUkJBulmRN{MYdnv#@$=V>zFpYM20V#1yXZB1HI#6oeOp z*BRGnQWt1m0arK)&gb9bbv_5`iAjn-cR;RxFz(X|ygq+nj_Os4`ayZI!W^xCk>(p5 zSx`)*36>>8UgyAzunQW!pxB6am~aIT^bSKuzQaenU?Y!VBj2GTC!ixghmD+#MqdZK z*jB0Ub#`EReAfG)*_{HP^~+69eLFoJD>Nm`dox{oz>*@ZgY2htTrDJ|mrfOrR>(hiy)ibuKx_EE9)^L!gN^dRVAWzlu zN}8qZF9e_x_{Zb2NhbW`@9u4O?G7haWN4FgR^$Z<68kiYghv6DWg!k#mT{WrI7ZQF zmSg!Tm0Zumqd+{ny6cvH6xbQ-QGf-!udAwz6RHH6h8nNnvd(I_z!AJCbCOQ7G&~AC zQLfU$7t5o-4Mq7r4b@IoHML`Y-e61B|6N|L^1t8zm5S$s*=+{?us9tXU`oJGX1b2U zO*b(C{~*>)*B0<7&j%Gzz^(YuphJAC7%0Rm!C#aShl=r{vb({2ITqdz#>b)u1oY5= zB4s&vbWj3?dRf?JVa(F;u_f=$$yzczG%SY-y=B@b&xzxwum?Nr;jUcvb-!T;Cd^xX z?rhcLBgd_OY)IXcYoEF67qbrykA1yk+H2|9KvVYX`%KragzeWGw*4~k&`=TWmldBR zlBdj;e3D4s@=DsOuTF=bB;qnuCY~f-Yq_RA6ww_NX{d~g=nktH@=DZ1MRfNKbGj#Q z!Fs=V<%i(w7#x}c`8whoT3LCc3p_311Cd9hq`M{_W_Qe*9kXDPArT8GIY~V5@9?5; zmq6I?BN3Bek&?&Z>V;6&Rz<-E zC$+matJ$LF?A9Fv`=$-Ya$GmMu1C$&nrB@Z>><$3JFr`!=DQ=m7j)M{zKlARI{JHS zzF;7T$Juby*rUZ1;oLbh^8kbmKWg;FDDpRF<`r49ouRMhfUnlm)g#lH)v~3xUq8*K zXxW{7(8jNo&s$KK-2%B%G^oJVK^lQ+ z+5^WZts886u8t?8Ax2;V)>(A%nOIhX7Daxqo|~8VP$zF*o~E|+X=<*&rQ}n)6!q$* z75d?n6xLq$g5q2^pwpAVgFD~qY6fSlL7R?UvO7uez4E&HB&Ba|ey{AnhNfntSp(a( z@#jun^2ympe+nF0?G7Xuo$FGKOAe| zs_Uu~JkwRfyPy;O&*^nS{W}ir;c$=tBUJt_uA@9@p0w~~X;Nc(E`$v~W_Vfbu;FBf z4S)Z{`+Fd4c&Onizc|B&dlvjQ2*QT{&uH063L74EI?oAV!^MUlV}}jfVZ(OVaO%T` zr)|7+KZFej!av|16^IhC!-nm!VLNR2g0&%jW8EPc!iI-O-U~~qpdB`BiLhakul_!S z4UdR&rR=a_J8al0VZ*&&YX1&|4Udc>t`#e6_`5e>D1@-#QN|0Z5Mjgq9V>o#)8TwP zav72AkHtuqiTB?4#z9AV#o}7t{$TUiLvxQ@S*P4w%jmg<%>WUPj=VahZpY-#%9)2U zvPP$eSTNwKI^X1K1a#A7T?XeX*{!qzK!F7)BC7U`M~mn$pV%}7$T^G%aZ98t2X?;l zyq&W<_4ej#wHGzld(5plvt{HVw2Op8YM*~dE3L4v-&;_7j(dEkDK)FljXa2Q5pYng z^A8F(MW{_Le`Ue$#a})Yam;XRuG2NcS!cS_RXfnNp{)EdS1rV7-IjG(L}FQcubi8w z1rECHwydm(cS7GVa8Pl{gD#Hd41YJcShg%Ab@n*~zOzM^J3Bd^q3 zYpWdwMEpdQD`g{M8xbdjh~N7#B%imqSQj0X&l;Vi!oq>&n$ClHu&^Jc(Yt&R_)(sW z6xR~S%l4x<+@n^9&b#0u>SViIK@^Y%E<{%~*oG!bmD_{=t*D>t5_mbcMOONqxxIR4 zrFQ`6680zlW6STnyUsB1){YIGa)1qvyNUbqoBlKOcV=2|^d|gtY&{$Nna#SwW}2tb zc7OP96<0>)qyg^VzsEjTo8AMtZQ~-ZBl03^=y3S?WpVq_um1e(7T82H3<>`Y=C=Ly zJ@({fZ~OrhJXLyv@K@-2BJa~{H{HA}bl}kNUo?TkefE3okHIGg!?K=^Se7M*+%NCl z44&oi_X?cbND2SfJj>JX-?;!h%i|-@c;pwe*hA0%FHbw|1`Wo*B0ghyS!|1#Y>T+^ z_FPnu>RH26esOx1yPt4j;8~tvwCp5#mhWrwR2%RtPc-}(+p}zYmTk{+>OISM-s)=w zJlb=SifHp_wr4pW&$7*e7lcK1g&7)a@N4s~)Cv|{F zn;hjz**u!fqm_&Js?!mS2bhl(@Mu*}jm`(p^7B!|wPJaehu$^J2cG2@j2BcPJj)+E z`ulERrCtmz16}@S>CRPw=?V|UAlr644~GC{wgXxvRL*?Z{ro=clR;-2!30wxPmM9x zwqsgof@wjnZQ4HU)UC{A@TFdg_)^InI{x0RXMjx%Pak7}-!uq*zi%2KHu0HS?&LsW(H5SdG*u9eUTQ0xEPxa9)*weQ_QQ+CQ+GU` zHU>Kv{=ueTj&Lfb<9*Dr5_7D@9Gfu5Hq3DhbDoIUv)CCv=p6VHAU(34bkgJWhRQN@i+o%Vs4*#Rq7SG#G&5|K+8zjNN z8hGZ+d%%0gV~0LpIb+?R&uVxUZ*08b<9=DkCV2mtyldHrwcW$kB0WKCab)4#D(-ab zzox9krVQ7{M6JbhwzX*F2_{MAkTjP~pnsk&=QZ|B)LK|0OFC7mW05TBR4uQRW%%vC z0l)wSm*O%DCeoxoyZzd+07+jlGz$!&Lct}D#bt#hP~%Sumn0~-1O-twhGZ03rQ{GK zjb~T)HRXk*G{q>aC^0xs0~%!r_!hFJX}HdD3d1Q-l$E6tfuw={pA`p^?*A<-nUM6e zbHh^rNx!+NPfviP(@aTI2$CiwO)(*Inrf(&5Go3UK&JwK3D^p@ z+N59$)f)|#64C&S3IJabTt(%C5JW|FNG)ATsN{_&SxW{;3X)Kam1zw;O@3PQg1V5- zozv&)#S@S18G568$^4zut9P4Lw70NBt(=)=A!){QpZ^Jv^i@;VA_PejvKBERsckJx zSqm#d(&VX*B_V0@mRHI$yfbVB0t^62<1z~-AnETfZ#V#zdtQq)3x<_@8hsOr-u$L3 zs@(I$5vP0ee(Z4O(szLgemyh=V&vi*s`kv(`4H6@KF~T*jYIzE`7J~>PLDh(c2r}M z+H5AC!{xZQ_ZWz3e8cdv*intij%s}OWbPt}YW$z!DZe@X4{^XZ!z`4C2MFnln%@Um3QFi50;M^8Rxl%UgW^-;<;oPo#xbtS<+?GTU*NVlt zeOayXhrqclHC|AK;M^)_JoFc^QXhntftW7eT>n;Jy23*-n63khf=t(eMM0)((K$@o zJ)##xkS&WmHO3KS2abj&IEo_3_OD5IA3cZtQ2)DIA=!6%oKyT7n&MZK?7KhR{p&gG z`!~+r4GUWlv9S1te%hPU7WlC6f!5)}s=fI7?ZAhvj65fH4BEdQgO+pp=03oOtunkU zHXoL3KCIE8_Z|g4>_fv-esS_)?|;6c5Ab2Djh3AxK5Y3%HD3fi>?6aEvH38Y53~8O z)bnAZw5++nhkYEWh&CT)^I%o2Q<@0O>}0U!2Blq+TP zVKyIT6+Z0t+TFheK5T6iajjT<*wv(OKk#Aej2BcP_^<`<|Jnm+qfbN20A9&)-HuzX z0WK;$^fw|7u9}T-VorTJ~KS!7bh2mzwqiR z;G#Y^T6U7SsC(AGdJwp%O@<$1b5S-IWph!f=c4XD<>Y~j`XW*hZ7#~@qHHeef^ktT z*ZuGaa8X}IQ9+xFvIG}3IX80^a8X}Hxl%S4Wphzh;iBFc`Tm>0MQx5Et`&=mI=E-s zXTU{mFv%iq7@eAdh@fpdV%Cbns$KH|4n$HA6>FdZ#W)n*PI-%6(J!T&e zO4|%Ci%lpcn@~Eqc8CUq(ssjBesK~?PaSIV5)eu|jFz1wLaA2IA?ZLUePj4BHlbt_ zN;aXCdO~SK>pt%Sq4aH}BHDzKO(@xf(gh=w)=WK`1%%ShC@N?ZN|qp$22SnS83?8C zqFgDPP_hXns}M>#uckEtLTOhNajjT{QjM!$Jqm=*d8Kw97`Enqmeu%u>HW~G=lTnLi_g?{I)Lz5OVv|wHCZit3znlVO)IP&gesPjf z?>zd-6+lMqH(GX*$fzo{(;PrX9WeYDn~bu_D4UE*JsH(jz2$x&qYg$YqD@BGWRy)t zT`)4L>y{gb02y^CiVE6flqJZh7yF-U1Z33VC|AlRqiizDDrD4?kMutaWYmvQ#I<6P zQ8&*0y#bI>M~oL#A;_pV3r3MZ8~qeo1|p;C{W0NAs5})O`kRa@yTSy*sP-(S5+^0r3e{OuoaQIq3M|`dLhM2Y^8v>gZ zKF~UB)}f|{F<`TfMV=I!&HC5bto0&?1Do}W;bpPetYouUFE-pf9@wm34Nv*S$!1+T zN8o|Y`pszBNn*49?D<1$V6%QV{1}_fve_(~%}PC+HPM-&1Do|nq$1jEmd$3_Y}N&1 zv--5_*B{ud<55)5X0t58X0h)y{~xefe@3}dHk)O$Syo}Qj@Fre3$R%yqKIq7Vza*X z{f0uTP8u($LaLsW&q;D-aq@ z;B&ljD zFKL{T<*3))==egZUqPPc_eo0M-27fS!IyE>EA-Q>ZQVyF%DI|7Ye_I&t`bOV%<(FI&5sxQeVWuyHhiZ~W;(je@ZKv{=ueTj%k?VP0TSDbG(l^R$`8|m}3*>*oHZdVa^i~dloyx z2c5&7bOJBwa%4GbIXsRwRQ0Ymremif^`zX=bRfgEHzPr5nw4QoQ!1tD7i`ejsp1C$|1p#61;Bb z@H!OO%7g8$aC|>__kQ@zgR#MmfiPdLqnD#M?2W^S5B}ylbl6g0s}RNnPzba~K8)P& zU>vlAg)stVq8%i>Pdh{ykzk8~*E)O`+#$oL0NXgcM>=?Tt-}@rd-3p&4l`xLug{^v zcN+*Z=fPhIUirSow!w09FUlo59D~5F7+3?(oOus;?|AIc=PPHd8}wNX&*F`ZH+(~VEACq@28?m-~*jl6~Xf5`SrXO~vW2a47i%l7>jfq-|=WJ_{(tFRvtvdgIS%xF4 z1At))7N1$b=3rMx zhDh!^2s1>Rv`F9}`?@LmN%yvbTJ zAYPD!VysMS;A!&HnitfCbncu!S1+D;Y|qde-Am^0oL;@#w4%L*9ctywG>dp^;I-cc z#Cy(^wFn{JgseqO#A{m%Q`W+Yh&OqvV@brDyyca$42O3G00SW2xXgkH#Jk~|J6b_R zpd$@P2KWg;QsaogAFIPYkl*@abrcb}Y+WVy(~mp%{xs$ofMzT-1)3(lq1OurKLHVe z;R6Go9T|8>as&RI{MHtaFfTwvpfmEMM1C=f{LPtpMb>O*s1BS1>cI7M^~iK)wQT9_ z*H7~)T6QO2uA;T_c?$}&TPXhA0a{l{?jQ}w?G>OAKYuRlIJNdk7k>YQq`K8>v zPEZA|_P{Yp>jvANtK-RNh!L28brxNGCYIHpMUmeNWO3d@oxFK@n%dH*sk#1^l27eY z)T@_P=!g1qg|(Nxpg7kJ==5ap;Lf+Ynn8KG25mZa$?hb<_sZ)UVxzMI8=9JpW({oD z#-BTR$tPzY{V8y0wL8#->|8I)lZm-6X7d z+3;iRh(J3c(2fX9eMI08e}{V@A}}LT5$%XTJ0j4I2)tksfyJ}l8wnACnNd{GjtI0w zMBrt&o-Brlz$#I$lpPUhM+90WBJkzcCT)R;KvxuTtymF(zO{$OLqy;u#tW(t5rLPl zATn-sU{xcQ;V5^&R*zq<9t4wAGn^zIs=Dblt?vf{t9ob>#8NCCr@sKSSa>KFE!Gtd zL9|#`M2n4{fVnq6?(EU*#`j>>OCx5DZ-~C)o%?|n3m<45T5Qz4b#?$P=8ibom`#iQ z>xr^oR`1{gTI@2z%VN`F$)?5LTC!~v&|+DJr~Kli#R|q;#sMu>!)Vz_qQxrRb;}B% z#V$Ae7@HQeX)&7?OFb=iRndkfK#N@wsfac$X47IeEq1|Zu`cJ@IDi(b8ASzcTFer( z*wXHu`vEO>Wt1yr(_%I)W))iOi8YV2K#SFiBCZvS7L)4w_X8~kC8GmB0otS_Sg8=S z*yN)9cL8lwC$tQ-meXlNH$vIB@X+66RM}J z2ZvH@`{w%b-24HMIP3Kd&hh5sy`_8=*9H~j2K#e1FU<98w_MNOemzCC>`4*?LE;oi z6PySGH-`ry;rIMOiYjZctUbvx_bl^+xH9G>=&}aIG6qSutidu5kNBYL*;Y6BG)Q?? z+vWDl_21(66=_yUJT6|E)-%(u4f5wGg#+Zjw~P{tckUbh-{dD2H%?pJq-G_ot|{f& zTE+EMl|+^2#VWS)L@FdCM4hjYWQ0urt-7}IoUc6A$STQ$Jdpm5?v5UiyL~@oi0}>$ z@3|S>$ zCX2B$jh`ob(Wv9|PAy)#qwBUJ{mp8Z=xuJjbk?*zi+2v5z3|BnqpviZRpNeN-@$$9 z&Z|us#}!pvA0%uXhug-n1X{6;V?0GDjF5#jl4w$8DJ+sild9#FGKBjN1mGYf(Zpp1 zV9cg#dQ{LTj$PgLNXjZOgntID{P=S8C{~`wmlOL&q~P&o<5jQM z%TLFyH6@g9XS!x(CMuM_#42@S3*`kY=4B+5R(vdA0Pw5u4<(u_0RQp8HV5DzC7Ywi z0Uox{!viX(gu^&0!h{|p&=v>3r~s2xksb?@wPbiKfGb^$m1$Hw>uw}&o|SPbe{ze0 zVaLB1S6q4gHM>raX)6piq(Rn`8^<2V6XNPTcEJWlP z867La?c`~oCE<4RmRHKaEIbf^F95gWvMw>t{O_L|jiFnC$&g{DAWmiUIU8-Cpsf^)+MS|>Pn(vEctAvm{w|J2*Gl!MRI^eO()ZbFVi%|n zuJ@Q*b7srPLueNXhtxj*kXBk@U%$7Y_8j;4PE%@DpBs4)%SV}@gMovs%er2+qCPctI5+ zICpE0Uavs9IUcc$k~!<~M8}c~I`J?`w&5i4_4xj|RhpkB)YJ)_?BwkDM40@x`zbVZsUpQNcXH;H*H2IKzu9E;6KmGdiOX zA}i~%DvYe;8U|s)@$BlZ|4(`H-OG=q*IOIQeXWojDe8)jYr4+ij6_JdNQh9LT+~IXr?g*jUPBF#5AGE7*c36>>8 ze(S)CuoD}-pxB6am~dPUdWWGS-{B)(u#v~Gk?+uv6VQ>L!$!_Vqpt&gaH~Y^o*h^o zulLqnkEg)vJ^Q)`(_T-NxL#AstIG_>|WeC2H-doBRWr_;uPX!cZYxv3sfNvYM zBKi;fe?R!gsZf9{58iL&4M&ZMP-%ALD@Pu3RIDBO$x#7zG=>VeE3hwm2bFV|!MiS4 z+gF~NC4;a0?7(8IOiScBd-BZO%a#>+|2p-Z>)D+nsvTfjOUEcvmTE($Yh9w2>KWToUA#A4YdF|brM4Dvu%~KyrL5AP08j$|dR!*S zgn#}2`rjyRcVe`mNn#*mlxHDql;I)mhG8{m%qi+LP7sW!svJ+z6#Zf)*JOAOh-X)K zgHq1{J7YZuXfngHlEC9E>QKb!G=oco2-$ZG$8nS{DbSe{o&%mJSGM5A@*HqOQNB+r zgmg$~QQ9#-Z?L6O`j(d~qi^Hp(J6R1*xvA(&F`mUj4Am(k?HyaMW@A~3g^l92eEFs zwtPo zse5wmGk5)B_KD&1?f+}=YC6W6GGBW#UEd{YzTU9Smx(8aifF#9_!yBqUAE+7MDmtb z(o}uBH2|sLF(NKIW#TcSvAQW2Tohc$P9YaXd_#^l6aE7+w&4S<6JvYu>(4KP7+XHl z^4c-B|9XsV;rMnlA;wlPyexK%ZL(u*x78frg&14W@RVPiF}A;sz4SGRv29|s>?Fn5 z-gVR5ArNER)bL~M7+X8W){e1FeT?niS#ypMYLmV?HF4-#`c26*zS6J-6)8$ zy(NkY+A+44h_OAHc4HNYvAs3Qm9k@O?HF6D#MrLA^ZMH%#|IbhY=N4Ziqt7fxmR$M-6Nd1{R7 zFrK+8G{IG<4&#XLG51R|oz?DosW*JB&JkZLzM)%Me1u}e!UtN1&3cI8Uj#O*OXNwh z*{pw^&00e3t^{mWSHsITq_ovm2o{?1K6zljTclQ*et5& z1Dk<1dLXn6#AbbZ`0F~rW`&1huvuqE1j(qgBZ6$!h&j$@+CMY}*sKR5PmM8~b#`iK zf~knjI{l*4J#~(=Xwu7R@UtAQH zCXfGO2(Vd_;bpPetYouU)$8Yf2W*yXc*-wMHtUfFqbC8Ir5G(cNo>}NyFb@}%~B0N z#%8l@Hp^zSQqN|sS950po25l6qRnR6Y?jStT`)Fl?psn5V6*fnDrmD=mSD4f>i;Nt z0CV<=a;0oG>!M+^iax12ZIvTE*PEZ+rtpq@)R{`n?&6nx{-T1~i!#O)eR+MA9f1y2 zn1Bt(ZgH_L8ah)snrGGMBo!78vMAxN!n z&(*jO*rPt7Wq{;3u0GT6Q6RO#L(xgC##n;@Ck20lq}KFzohxMje3-Lu#GIBGI$Cw# z{Xlqyzn66guew*QXaj^-UZgD9gx9}Lc;$RIwjU5){R}UQO?V}n@H%{U!8Rbg@(oY< z#YuP_?fKRkAiTUr%T5yE)%~tkHG%LdF#H&s@UjUnoA63K;dSmzUj_)T{*j7k6J9pq zWfNW(jPSbpvNI0>;pK~>f;Qo03BoIV>#nCEe5)|Zm9h!1i-z#3@J!dz7eC1Wrpq5i zTq_pS)kys4I$*krj2BcPn6BTa^q2{()PT@35Yu(-%uy^bUE!fvOxLLp({(Dybe)>- zy!+!9KEB?G4U9ZBC7RdLG_4CF%i_AK^3XF%6mf|oXfjtY(7V>J75brXZDCO!bgK=t)8yfO zDPNU*DjxZ!Rhq+&d%ALYy2JkQ^{#0<9#0#CoeTe9Q!q!kgNoyQ%&`)4ti>FgFvm8` zaSU^wh}g5(89wM7_M{Wy^jwZCM=giP;i`7@vr6gMAXBpPafa)|j09!ni40p-di%Wn zv>cM=vI+Fh(?!xHUv3Ud^Vu|ayW=iLCnH(0Ml+=$jy%U;XoEDs(HGjU(t&?EG*CtD zR8gx{JVKKVH7oDm7sAF8EB>?!#=2CD-W%gXc$M0S{Z1;YUyT5saY~KQ-Uj9 zjFqYDo^GDz_YGZs;*?F`qfL~X&Zm2F#)xGk_oXQEUohDACPrD}Pl^nUZVftx+FCW=exO|&M; z$!anS0O*hi02<#=?Z>BV0l#JVKdx&H}&XqlTBo z_FE>~Z~2~o+4bPJe9Z8aUz~o+TPj~pg5Pqe(Xx}|x4f+I>l)y<{6E8wvHg~|-_rJ5 zrrvM4jJ~2X_$`Yg718!v+I~yhZ+XG|mY?^Y(E|LI!=k95?YFdq-|{DH-$3wN4v%uB zY`>-Lx3o%xezpJZ{tNt;Bch0F#qwJYoZDqK_$@~oFQ`KJE&Fw;zZAL(jfz-C$<{>i zI1b;^@4F2=osUOM66gR_W(%Rl&iO%4r*l5?bUNJg7dYpBdU7|ASEEA{An$3v39r?H zIm1ISyr<4pp*dFty{D@dILGhc^I*;~5pyPU=x*U{9GtV^=>y-dgmaeHNkU*K9;Z15 zoU;l+f?rkvFDcE6tf*=VDUc!OY&^TVZ>Uo(GtE6_WN~rvlHYfIjn#WImUmXwNP;It z4Ob;n!5L0ea8c30N34pXK(eH!YJ_?3EN5-+?0a{Y$2og$>2E1;&OY{ahn)0u?1@PI zD7UP9l;K(h4w=McWppg>tSu|xoi&gZYdB{Ghaa4(w8IN-)%(H8s)O5=0Cy_`j#lK7 zrNI%)1hyD(z!LB-4$fCL;EcuL9U8WgBUc0`t_Gtd97|f;Ih&d#gLC%1yNj_hRo!z{ z{(+|7{doFd#{6Z&UH5nfP5l*nY22S;m=5ZGS_h$+E{r6c)D-Zhf7WB`kBrHipLmECiCevNvoKN^}vJ~!>YGpiP#e0a*@ zK36w8T9;qLo$TFo;Xt!!@u>&jsPuCh_LM1O@J@zncEZLWW+>h8GxI5@{J{S&9*P zPNsF92;s$ec6B!_H(q3EiJ)Z2^x!yw#2J|)A@PG3aFNkCQlNC1QAyKykrAzp7r%YN zSsuK2@XQ}6z>7_K?Yjr?;&@ZS62gm#2}?}8XbTJ6B8-H^ig-~1?1z4tK<9FDi?K45-IIQE<=QJ6 zy}QGW&sHXG_)tFfO8x4a=8Zb|-~#s>mrb44&MaPZ)_!IN;KgT58G{gBOw1U>#EZ5u zh++(^h!>Nm8J5J0$y;72#XmXfIJ(^fUW`lYP2ffBqviF$RsL+G)*H5YXq>h_=qgWJ zk6h*VyVoyrF8`Ts46gDCp$U-tJ-(sA+QJVZcO-nEb#h0#Jy(4<^?JSBGS$iJRD zGNtw-IgmT@oZ)4$b4QY$JK~>s$?cFkGRg3iU!1uk)v7fe1i2%Vjh3CH+!2ObeFNl< zJa70hcJ7FsJ7VXKq&|0~=l;VFL+;26k&0;Nj@Y>)cJ9ap%N-eZ&zct@cjUz=Dro19 zSR!}C_ffldAa`U+lq+TDj@Y>)R>>Xt;f9&BAa~@YDB@bNaz`G&#CH|sj!ZRPP=&}H z`E}w=S3vH_%Mr^cnL83sta__D&rgR*{%bf%JV8u7o7{I3O!A81B=L~hbB6!-EnvZ> zg(g8PScj_zOl)_FCiwC2|K?T4y;@mvEA0!4<19 zEG{dofGe6pQG&wI1V`;nbM1lP!FYCcH~Oat;E{vlTEtE>kyu(I6js9pg@TwxiDz+9 zmUtYh0kW#1h@7qorhUQeMU`gq%dv5ymPac~18XD`YvVPFpwD2TF56!?pr z!%85tgaT)<5C}G;!3oU4D@z9sre?{ZER!-dJ-&!@$6PGY3V?5S7`fs|8aCaOC4iv8 zw-U7kF_TPeOJHmXtlWV~5RpfzB{C0Hn*|w{2!di%LJ%ZH4CN!ov#YytDV!KH$3!G`g3};Kkd$Z^hsLup^!ld-XQ`(gJ^#N{z-rs#fpR! zleOeJC=Ub*^B?J}|l9iZX(UujsL0CJ#q$F5GG1sUx4FU8b$}vG1Bs7qUN&qaP3=#wz z5l}?MZBX_J706)LU`vKA4UX4fs{+xA$y#zazoblEk1x_Z0xY_pJS-88^zt?vYTxr$ z2{7YKQzjvV851%IF)^cU5~7#{D`Ljv>4zmTWAc_4%rf~~{hyo^xaVJhER(qn^PU0B zILlb+C7P53Ld7BdSA?u&MZsmB&~brL8IFN^gDk0s2u3N6UEMdA7c+7Mr4k&JuF*JI zf-*W9l+ob?1t&#Hpn+~A6h$(R87M{kFS`N3INOx0gfU|x zvJw+B+Oh&S2qRgsMow~R%!rB~l0Xxpnlz|h4SEij0SN|kl9d2@L^LA-;|M*X$~H`( zC?axN2Y>a7g&C8xWWbDYrHipLb=}ja^WbLPPBwkx@Vw>+dt6iL^{+Oxt3ILX?9AzH z#`K&%^_i7sbCUb7$=U;8agHfl5C)5h*n*f~(Y6IqY=JewVzLy&qF^yu%PXb#o1O{W z>;WvsrSv9JlF7NvPC+c?+aaY#k&ek68b0pfp@2oh)1O~_o8f_=Bmw(DI3kqXmRRsL zi>iuC3L%n!PdScMLRd7OUEO$ju_!I85~YX?t}sj>Dia7)p4M=l7A0QRI1QpQO=D5k z;sq7|Se8~EEIR7V2`Rv$m71@f4p{UZ!~0J>0uaKY@$7n@ti;5kwyePY$4FMJh(%Ei zoFD^6{+rz@8SEUx=kb zeCAB<8~}^&87n=jup&p2knPMeC@_(Orh1Tgt?LSaI0%ho)No`Z7ssydobrN2QKJP_ z7g6#I1;xJw8r0xasUTWnl<7VQ8yL@775tqU`q^)p?48PQ~)w6 z03d_0kqA;&sK`i!f0MCf1QzFF#aNlT?s<4mt-mC#Mg2C{6HNwftm1m-JNc>f`}7%k zcRfF+-l}PYS+IEXsm8YfSX^kz7KFiKBDNqVShQ_H6kA|Tu$U~xuqaqe*78c}{ZmH* zH+uk!aVfnCu=v8(hT8!wE;3YlomN#Ef*&CU5;2P+1s-S;up`MzEHr~wpeb}X=Q^HU z-9&l8qAVy-76=k|Gy#k3omws>uxFPNhtt} zwUmX=0a$$Bl&plnVnVVK6D-=Y0yhXFS+OEm)WPA59Ly+*2K9ap20ezEMKO>xgP27G zBoSCdA&|&99qbB?0wz(H=n9o{ovbATScEHGjFqYDo(^w)zHQJ;TGqIw3nq3xx8iBy zt;bKDJzf3tab4TC9^ARfMzdfM?^OQ~fW^h8Y(WStCS(g@f<@aFM6m@{1dGX23`>H= zlkCE-_SknGq#bmZ5T^EU7@}@j4KD5{;8Gud*@+ zz)=c=#dvmgljQ}AlmcD*z~7A%8Y<93((na%O~(mJl6YRG1eG)21e&F--PG@waph|2 z_t)6xQvenV);CA_GfPd$N(d|_Br7q&qAe?MgD{d6D}qJjf<|5a5IZOXtB8s<%7NF2 zSwvwzC~HOrK!}3R5m-dIG^lU14B#>dB9W820_9vMYsml>;YvgPOj)|_IhS64#`1w5 z))T>i>-QK)*T0w-+x-eO#18>vtaR(C1<_>u=s%~TMz<^3E6^}V9~Y( zQEY(~!D8|h!;)YzdCM!M_m4jtxY+|(j7#ZFfW=1nmv02HxXe)L8H&?&O{8&J5Okb@ zD%-dqK>2NwRw$X&!9mQj;RKgBc6C$b1&ff-t#X_UR3fQ>^I6jgTx11EaM7V^4@1zh z&eP_ZMbg?}aoO;4fyJ?JypRI0xN&OJ*#H)oo063fSd2%k&XbjxV9}NpxIq}niWR{k zD!ao4oXe=x4uXR;Kt>?|5g7oE$UTkNMgjIirFuwsUx94|A9VnYI_!b!gjXQ2n5-oO zScEHGjFqYDo?W%xIrY;iJ>7fHi3MXexvqcAIdd=hWZIyYKcQyLqHcTEG*~>@s0V<> z6{c)K2rMRK3u1yr+ZIHz1y%%$$x{qVg2m)5uaw>||6kx{4`4Aar8fZ2x_!P+-Zy1J4K?VCS|qJnn&W=phhex1Vy+4kJ zNj^86B%Z2IT?*>l4U=p#oFtxV0QJ^yI|Y+`VLVA3Sz=RX%-IK%d}%mIJki7TnrxX3 zlYC`3Njy;{QwPrR!X%pwCyB?~uw(t$l|XcE2~C2C&Lux%A3}fa@X+5Ky36jbUHLE^ z0)4hC9}f1{KD^9%=cHwIz|+1p;)`J=`fF=YtX$WjBo9M~JkD@3UBU!PAr@b3=*B$~M z@?MU%&|zDH&`K0=i4wU9@R$eFyhRATL|dp84k|AxgKs_Pht~ogcjRwJeG^d#CrbOa zcvZz-*+vEHAw$6v8#}^!(w`7S~ zPy70J1`GsG`!-XyAmnLJ$QH!(wA;2IiY>5)r#)4QVG&Pzs+Lzu@BjQEaI*(bdt6Fy z!qZ;6QNgaOoY;0lr5729%2Y@Jr&$K-j_bOPOMIZFqr!4DjZ%5^Z_-@b(p(MV+11UI z0*kMtxmw71Ub#tczrUccNlwn7!h-BPNmjhRf^5axFGmt|QskjqqRwmR3sBI1N7W=; z;Ao8#RSl{WkpLFk8696(;LR`e`XKDGNFAI*b0S0J__abm?$Zj3^8AH4B2BOW7W?HY zKChhX&GYse+!*deO&)W(x)o|ZyhSf9-=F1e?;VnxmnY@0*@UNI_uPEdJFw8xp{s`^ zvWcc17~q(uorAW!SA$!&A}IV{a*)10Sa+dI3qZ+EjNFSoDeX{{-Jy^TCA zd;7fov>cM=vSA9CwTq-nzTD6uw>v=BzjT$SCeVgGb5Z~iJJ-AEgTKOZzkm*%Bt6Q$+l@#uDy51eLJ^xo}8Ed z^TH+9@Mdx0+b^xS7H>kc z;pv*?frX2|d?y94aQ%)SY5{Y&)0C`)n8So*B_?xd%L+U}7|Dti0U{63j|ae~11LmU zH>h&B0&r1-Ee7Bpf{TbbQ~@BOy5gurBnj{kHKIZ9lJE`%qn6ImDajxtYsml*;Yt@{ zW$L=;rgfKWnl$C!%yaX9?zVB_!a;2x5b`^9>8~_iG5^){tG+m379pnZtTF+Z!|zPl zf)I04rR!p8^SQ0BHZ+WHk{~QVxRl-mSiIuBwq!F0wkuNU z>(jzRy^#|eemb_EU9&~aW?f+u{L>j!_^->AnfcY~O73@;I}6)X?gQTM-JvPaQSl9J zecMy7hQk>?Fe1&TFz@O%|K~{mPm6Btx;{j512WxNz1``xFi+ivbqTCw5%(- zXoZEj-u&#YUdTXcRpgWW@Tzv#X7Gh)x9%9&H*GkUtaNuqt#psG;i$1kiz&kCc2zz2RlCvwf1C?bCvJU@v6*{9t&>FV1YA5l?Q)fNY<=M$1l8w$Jc3V}FEfpM8cO zV`ux=**SR&hJ zQnd$)Alv6)lq+Rt``Fn&R>}6^IaiXDd@#uo!%5-^YNJ*+-wKobWH?DYr1sCpUvC0r*wN4=hz#3s zdbbx+LBc~ZQb95wg+qX9%X~DL3UYd-^NO+0O=;l7evbHJB~w8po{~9EXKBJ6{-rUc=8aeJr8up7ROE5db^;V*m;8?79Kid)* zTLNo1b5o@j7IEgLYI!BKe&p)FjUIftajCosUvAA4)vH1l$ghSfFY*MTi5h|PnhYt! zyu{!#0TFl{rPCBA3L>MC;Vh6ic6IZmaAM3X5C}6AG*;Ch-jE@o?;rzh|48U3LlKY$ z0!baJLZBYeCbK{|OJ;!_sazg-`01ygqyQdn&z$)wWP$uXn7ccZ+}) zQIxd?DALkFekJb@$yzd?!XuC!T&9A12Gx{TeByimKJS5>JATrn|E^tPlh$iTe0Aw1 z%k!_>Jo~e!&7#8F)}_yfERf$#8GvvWNFoLxW)_HT0M0W2Rs@5|(*{d|!Q?Hkq_U6Q z5V)-a7>rBPO@P7PdcGgBK>je)bcv7^h17Ux!3_Bqj7~x_E}_ym#p;Sc=(<4CTBuV? zJiEGuQeZG<76{F1BqMVGL`g!y8Hy2b0DvO2iqR=WB6LdS#d2hUl${bxSv(8m&qI~U z0}GEFSepV^*x|o736KSH+?1?@vOp4&m6%x|wyXeGU?eM61c(wqKU5Rs>LTCp0c>l)ywW@MFDaa||D!z`;DE(wB&OOl{y zg2pQ%Z@zvEfJH0TkNKip^j4I6F@IL`y5bcTnA>XqA`&qo-b4lhfSxW|B z_yyFDDO15c?FQUH_gmI;!y#dhf7Yk_#hXvHmx?~Dlz*=BM|W=>F`y=1#yI z{$zw`YAb9*D{C^nq~55{0dKRwh}QWpIrQREJ>*Tp}T^Q2>9nBx{sJ({hNI zjAvJOlTuhSCNaq~GQ+Ekh-<6_g{?JRfgaW@6t)&*D4av{vP_q!JWbieBqLh8h4i;i zl&gjG>BZ|)fI9EoewPP`$fnP5+;3bqby_>K0JO){cYXn4@{B24 z5H3%Xh%JaoOxm^}iY>4v6it?5SQLsTYk8&ge(nc>n>}FBxRl-m7VTZA-VVg%Swp3l zWr|`siNqyN7QmAX#H66rX3Ww8@KmjwV zv$%k^z_Sh@lH~<(Wt$FZ1h8mDVzPW8jUR2_kOGM4Zd0QR5R>OjNl1v8Oh`gv5|g%s zoX1O85g5vVkq|A3N>wBHhd?0ebAn1-qe_NBVp0GQh`iURZXxQ7f>L30_#Z*ZU|3@X z0*1+2G5|vq(paW~dj?LxS1xMW^vbS^ukwyVL%dU~@5`N8xa5KTmn?hw(81B4n#F}* zcN41uG3iK0L&n?nM0Zwyh!XL#zNF!>IhXNrHqgbIl*U4Hk07SUb#aNlT?&;HcaI) zUh{)JuBr6;R~y<@pHOvn=JYmWdQPAE%u2He@v6(dtqIIwnkiclVh$6s1u>aJ+ZIHz z1y;n0$x{qVV#VYwuaw@eem8Kl2e25I(whK_PY!Lm2$;ikL#3A>Zcrse0U`<&2x;V4 z=z_w@GOp=5OEaR#ssa^a4&&L?eM>2@7?U|9bzKxym4QTTM#32Zl3<{335|2KNHa9B znha|`85+Q%6`8|#s+0#J9{*rd3LxSy&Z~-nIjm$#LPE@8LJ|^_IkY9@JmSELz)%8k zrvWrXosUs+GY$X|<+21r8WA@b?0ACMMAY#FF^D>h(Eu3{AY@@r0l;GgVh)qFWB`Wm zR4K;FRB+F%@ncpiAJaa4V^{aBrNCfJ=8#ZGQ5O{%m!-fL z07xn-@CA5LC0T`#B!X5)E2s>B{2>d! zsMm4@0*J|4G5|!l(#2Sry6)*r_N>zAil&o4z2}+U*DcvKel)jr|M8_YK563p?VE!{ z_f=*Q;_g~)M*(wK#gr`wGlz-Tf|$&qZ408<0xM$0zGydm^Z=ClxV7|*Wm=B2=5 zOy*D)WQtP+9;az=aWkyK;F1bnXK;RVA_-U({NJWy4goA$kvZI2u4L#lzkZnlh}gqd ztsO9jmza`}5ObK2gv4YHZ3#J#IItoxQ~}n>0Tz&i{}Erv0u&6!7cvl4NQA&5699oY zyhdfXRe*(vH4OGl<^WVyAYhoRB?ByLiCg`%&vn1EQm*M_=tr-eI|!J=s-_G;h&fEi0K{YtZ3A$g0k9$(OrADa5)CGA zc_o#7>6yT79l&5*nr;FNws`C1*}xoDGt_iOA|TBJa3IaoP)1Sa8C>9K0#{`PFq)$B z#NTBUMP ztGf2E*_%@U3ww9Ys0PeobyKnuW)9;JtMgz>PJFFCzo zd$+#JUY_W0^CnSGU47ji-^aIgJ}f=H;OM+1OUyEdmvnf$9gjILHDwFJ%wZz7ASQEY zWm|B`p)+R}InzB2yXWSs-hqXl4qZJYkxex9zyQZI^$g;eMxGW01$kO`O>Ud(&tYjk zo8~+X+uqr=eY=}IdAWTxPisx->uuy|+1uysr{$0|mkm>76P_-TF8OjphurRnViK$f z8Iz|UmV}JSTV5&k-#905&j-vHm+qUuj3+X_8wUiU+fes;R%0RRkc0AxG!TfSEa9R~ zLLqF1(Ir}9IFb)1EyuH~yG1F?7?VI$WF7D+l-?FZ7Cu&hx{8u6gUeah1c-Z-G>I~w zv<#ThiUi`9T-VWT>0Sv~a=_bJ7%hH^IKp@sI)O1pp zMQC{fm8}Uu#u-|Ls6z&N^pP6Jt2}J-A{7cfjAvK(?WMqAOac*jOHq>bht2os-h%9httl=(=Xo=*+Av=Gu{WR@zNnGv~X<+I_ol z%XqU0amJ#v`4D<|g(+JQA`la@1u+Rk+ZIHz1y;n0$x{qVV#VYwuaw@8JrlUu16Yhp z=}myeeZ8Lg44A{3hDy)KtR}J)hl5`im_tpZAz=iZ&ypqsi>UCbM1?~Sxc^Ukw#kt6z1k-g*F{}2w>5Q%;Blb@<7DjhHXm$M11(u zPrd=>@Jdq>5@HS$l8~6pp)Dcj5eHTThA8g@afc|75c!J{^iyCgn3ICWQCmL59|rx- z66}lKMI%Z8AWCpt1@kN?XUPBzPh}QkWh%Jm-uWkY@9o&E{Uxrxll?RAdFtbj=iRdT zA!ZRjf7{(RQ*XRw78h0;d(RwT4r`e*03qfuAp;PTIkXMHc?Q6WXfRm@z~QhY8cg2u zN-F!)qXM^e0E2O9x(P7Io|;h$n8VtJnhwref)IJ=olLVF5O)NF%akVIkcC2!ln8!g zJvWR0(wjjW`}sMZY%Jw!FLQSBQX#!+4h0T7Xbzd`4+4%-#TwVbRa13-i;U5u5f>z)p8eZFnb zOIp^rr3)r@KDXj&;;qL|ojqOs^Ko6-16Yhp=}myeX~Vzx9+<MaU9 zr3)m%=(=Q{Ipi$K93C!LcFKr-J5m4PgvtNTBtz+g<~P!t%J*)(&=($;1Ue;HS<7R&$r^_vvH!rPvDd=)T<9#gUsjya4& ztj?2_n9QLqE5H^Q$%+*LB5JNo10RU~M-UMKMC3#cGKVNN88L^5Aw;GYRkcBd4ugp+ zLSP#;S*cKsQj)b~0ElpX?QQw&RD#pErol-|Gfd*Egd zU@x8OE3Qa<`aJW%Q9J{(( zmja71nL~jQWSxfoEWE~nn^~4LTu=z8w+N+eIFcYqo)b(nhX59>7;`wjTrr0)ocuNg z5K;JZM+aaI>zk605OWxhFr6nMF_}YKLe3)&tOyKIEgO`Kg4n{KBN@4lDS(LxBBG*( zsDmEz#-N5O$hnM?RZxlwf{}|eHUZ2bd6(uTe^;=7%}O3Yw<~v@VCTmE+mfeP<~!7?U{^7=|V&LWE8&EHH;U1?3J|oq*(JRUlY?2f6O^^FZpEJpqD?PX3e5*d)6#M{I##%7?{HwP1%AF zbC{4Vh{+tF0r)8^PD6>+fLKWA%I0IGKYuC6>~Uj`>qr~#P&sZyavo+BU2I*jyX(3LSiz9 zwuGEV99R(;qS!$M4N=@7f_Vt~At!OLj17uK43@Ex;C)oaMuwCXl(d3)M3j_*I_se- z*%b&FCTqz63=g3)*kviW=dbludla6?8TQ(ov18j;U-g=IO7A`=hOJQ7;QdyuKbF4M zEG`_msPhP54jY>?0O6R!L<~So=Fm0(=NSMiqQT^8gC)^m@|IUp*}vNpxUB;ij7!r^ zfWbZ2wp|X);Z25`&dQ9SK#dq&(Nq9~h`p0Ifxu}8X!I;b; zq$)$<8k)lunSn2$OTZy=8ijL&0^Vf;svK&l=ykW=et$t>lboDEg$3DplB{@r1=)(X zUru3xH^0#917@&D9h^h63{U0wwL(Ac(+Z37{DnCJP@{~+TP$yQx@LKb*v#9rCk3#u z^)jMAFo!prl9dp1n2@Z*WDadv0k*(MR;&mRS%7>DKs?m+1i?K#0R2!q6y#bafK5bv zp%eg*2p}S7GRjj%&S)XPE25m`3guc(){+4r!j&$@%G7nwP3tb%G-=Acndj#J+->8; zg@f8YAmn%I(qC!3V*ab?SAB87EJ7q5|9cUbL)?@t2r-8V*@BqNp=}GI*a9nJ#pEf5 zC9z`imRCyecm5E#*#lUNOX*F3#XhcfyP7$$>`0}rPYVzAb_9Pqww_(HMa^bi;Z>Ta Vu`4h9*X7F0eEZpJ-A6uh{y!yYE42Us diff --git a/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG b/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG index 391507f..2c1b29f 100644 --- a/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG +++ b/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG @@ -1,3 +1,3 @@ -2026/05/29-13:24:16.339 6b88 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-13:24:16.339 6b88 Recovering log #3 -2026/05/29-13:24:16.341 6b88 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/000003.log +2026/06/01-12:23:28.358 4df4 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/MANIFEST-000001 +2026/06/01-12:23:28.359 4df4 Recovering log #4 +2026/06/01-12:23:28.360 4df4 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/000004.log diff --git a/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG.old b/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG.old index ec96258..a28bea5 100644 --- a/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/shared_proto_db/LOG.old @@ -1,3 +1,6 @@ -2026/05/29-13:17:37.597 5d84 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-13:17:37.598 5d84 Recovering log #3 -2026/05/29-13:17:37.600 5d84 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/000003.log +2026/06/01-12:22:24.868 600c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/MANIFEST-000001 +2026/06/01-12:22:24.868 600c Recovering log #3 +2026/06/01-12:22:24.870 600c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db/000003.log +2026/06/01-12:22:24.992 abc Level-0 table #5: started +2026/06/01-12:22:25.137 abc Level-0 table #5: 108037 bytes OK +2026/06/01-12:22:25.827 abc Delete type=0 #3 diff --git a/Covance_UCO3001/browser_profile/Default/shared_proto_db/MANIFEST-000001 b/Covance_UCO3001/browser_profile/Default/shared_proto_db/MANIFEST-000001 index 18e5cab72c1550d8dc398e3413eea91bee24db77..e1a00d710a15c841c97882086518a4896a57ae0e 100644 GIT binary patch delta 122 zcmdO#%Q!)^#CUO9RxSf06ALE;GaJi1PIe~N)-!AtMuzbz`Q>>z`H3ky28I>}W=Uyj zx~7I{#=0hnX-2vhmPY2fNv0MCCPrz-1|}8;jD0K&AfRFr?-}3`pXnbQkXV_UnpYA~ Ul%JdLl3JWyl3&2+1y;iV0B5Qn1poj5 delta 5 McmbQss5wCs00iCvfdBvi diff --git a/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/000003.log b/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/000003.log index 9fed0438545cb2b4a694dac70b641adf3aae7d26..fe471a835371f2d687f12e9f8786e9e6177f62f8 100644 GIT binary patch delta 46 ucmaDPazb=N5*NoY(}E&t2F8%d1uRk=*$)kRft*k<=Z(yJbs#4U!~ph`bcC$5*Gjsl>+bp diff --git a/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG b/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG index b526bfa..c571afa 100644 --- a/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG +++ b/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG @@ -1,3 +1,3 @@ -2026/05/29-13:24:16.334 6b88 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-13:24:16.334 6b88 Recovering log #3 -2026/05/29-13:24:16.335 6b88 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/000003.log +2026/06/01-12:23:28.352 4df4 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/06/01-12:23:28.354 4df4 Recovering log #3 +2026/06/01-12:23:28.354 4df4 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG.old b/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG.old index 7809016..e6828a6 100644 --- a/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG.old +++ b/Covance_UCO3001/browser_profile/Default/shared_proto_db/metadata/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:17:37.591 5d84 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-13:17:37.592 5d84 Recovering log #3 -2026/05/29-13:17:37.592 5d84 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/000003.log +2026/06/01-12:22:24.863 600c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/06/01-12:22:24.864 600c Recovering log #3 +2026/06/01-12:22:24.864 600c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile/GrShaderCache/data_0 b/Covance_UCO3001/browser_profile/GrShaderCache/data_0 index 194f9d43d11d7aee167be07220f5f88afa85e27d..0cfb5932dc44da677c38a67c9f89d00effc7554d 100644 GIT binary patch delta 130 zcmZp8z|`=7X+wybiiyX(YezQfGr(wl28Ic`K%B$CxR3z|)ITp-GPy#{LI5OK02O@b zC1bw%fLaZsi8WBP4Jx{-Rr^l%_o9L|8}u1qv=va^28cVLYQmpPSg^T3V?sLs_xdV} delta 130 zcmZp8z|`=7X+wyb%E#ue{52c&8DO*(1H%MsAkJZ6T*v?f;ayBjlPlCL1oVM|1yI4d wOSe=vA5g1dG|>f$wn0U?EW^38zZVsNjDyi2c^e?^fU4OLzv|)U0*wjn0M2qLMF0Q* diff --git a/Covance_UCO3001/browser_profile/GrShaderCache/data_1 b/Covance_UCO3001/browser_profile/GrShaderCache/data_1 index 2173ea1fd5d4900732b9bcb640bf9e57171e8c81..0f86c68b511678ef50017ee50a0935f870b230ce 100644 GIT binary patch delta 62 zcmZoTAkc6?U_*lfqrl`wg>b3u3=mK!459O&`~;DSg<{PditQYVj6lq^okNlN$3FnT Cw++z% delta 62 zcmZoTAkc6?U_*lfBmd+^g>b2j3=p6#1flbwd@kXMg<{PditQYVj6lq^okNlN$3Fn8 Ce+?f1 diff --git a/Covance_UCO3001/browser_profile/GraphiteDawnCache/data_1 b/Covance_UCO3001/browser_profile/GraphiteDawnCache/data_1 index 0acd5dae87ec8226313575ae1d451144fe0ce232..eb4b50c91d5ec4d3df38b8a708c6ac74d01bc686 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aas#_baW^_w{q+c^{&ftYDKha&Tje*n7i3i<#5 delta 31 lcmZoTAkc6?V8aas#*GsL^_w{q+c^{&ftYDKha&Tje*n633iJQ~ diff --git a/Covance_UCO3001/browser_profile/Local State b/Covance_UCO3001/browser_profile/Local State index b34d4c6..e990ada 100644 --- a/Covance_UCO3001/browser_profile/Local State +++ b/Covance_UCO3001/browser_profile/Local State @@ -1 +1 @@ -{"autofill":{"ablation_seed":"Pts3KboF9Gg="},"breadcrumbs":{"enabled":false,"enabled_time":"13423576449583774"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":89,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780042333499841e+12,"network":1.780042333448e+12,"ticks":8161390296.0,"uncertainty":10134152.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAD8GdBnyhPqKO+3clLuoubgAAAAAEgAAAoAAAABAAAADMD85LpYqkKeWfmsz19kEEKAAAADmxXqsmFE4qCIFVf7fbf6Lkktqe+GmWXWIQTJb2EHCeDDclpUygwFUUAAAAxudMuaV2vqrqS22DRgyN4Bw1/aI="},"performance_intervention":{"last_daily_sample":"13424515424338664"},"policy":{"last_statistics_update":"13424515424054832"},"profile":{"info_cache":{"Default":{"active_time":1780050927.615976,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":[],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424515424059085","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"1074088497","signin":{"active_accounts_last_emitted":"13424515423988667"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424515424040457","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1779102849"},"user_experience_metrics":{"client_id2":"43a4d29b-dfa2-4f8b-9a46-fe2351fed503","client_id_timestamp":"1779102849","limited_entropy_randomization_source":"795E664817D8383D9992183FB246CB96","log_record_id":50,"low_entropy_source3":4488,"machine_id":6709466,"pseudo_low_entropy_source":1702,"session_id":49,"stability":{"browser_last_live_timestamp":"13424527980612017","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"9DC8C008783143F7F046BE60F9A2BA31B59BCA3C","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file +{"autofill":{"ablation_seed":"Pts3KboF9Gg="},"breadcrumbs":{"enabled":false,"enabled_time":"13423576449583774"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":89,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780309277508276e+12,"network":1.780309277437e+12,"ticks":17241718954.0,"uncertainty":10132187.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAD8GdBnyhPqKO+3clLuoubgAAAAAEgAAAoAAAABAAAADMD85LpYqkKeWfmsz19kEEKAAAADmxXqsmFE4qCIFVf7fbf6Lkktqe+GmWXWIQTJb2EHCeDDclpUygwFUUAAAAxudMuaV2vqrqS22DRgyN4Bw1/aI="},"performance_intervention":{"last_daily_sample":"13424782877361450"},"policy":{"last_statistics_update":"13424782877037342"},"profile":{"info_cache":{"Default":{"active_time":1780309277.329448,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424782877040895","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"1074088899","signin":{"active_accounts_last_emitted":"13424782876971843"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424782877024135","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1779102849"},"user_experience_metrics":{"client_id2":"43a4d29b-dfa2-4f8b-9a46-fe2351fed503","client_id_timestamp":"1779102849","limited_entropy_randomization_source":"795E664817D8383D9992183FB246CB96","log_record_id":53,"low_entropy_source3":4488,"machine_id":6709466,"pseudo_low_entropy_source":1702,"session_id":52,"stability":{"browser_last_live_timestamp":"13424783145945496","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"DA836809B947A1D8FF3126F17E77EA6B014151F1","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile/ShaderCache/data_1 b/Covance_UCO3001/browser_profile/ShaderCache/data_1 index 49b8ea84e1b430c9e4f1c764f68b5828461f4770..da4b33131a215b85ba5be326fbe83932325ca4e2 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aas#vKy_^_w{q+c^{&ftYDKha&Tje*n7%3i|*6 delta 31 lcmZoTAkc6?V8aas#*GsL^_w{q+c^{&ftYDKha&Tje*n633iJQ~ diff --git a/Covance_UCO3001/browser_profile/first_party_sets.db b/Covance_UCO3001/browser_profile/first_party_sets.db index 4867f7799dc3edb76487636d7ddb98471a9a204f..c7cc668e7d4e91c1a10b6319df1025a53072ed5a 100644 GIT binary patch delta 74 zcmZo@U~Xt&o*>O=I#I@%(R5=%sJw^;v%FwYXO=G*QNx(P(2rsJw_Nv%FwYXzvo-(Zv-;wjAIQJp eXEfb>Qr|3r(P-0zAN(9fE~#mWr8y;w3={xMmlx>( diff --git a/Covance_UCO3001/browser_profile/segmentation_platform/ukm_db b/Covance_UCO3001/browser_profile/segmentation_platform/ukm_db index 0ea773a7dd679d1b66fc947d1a24ce4e0ba9638f..e7c25e6c8ded4b47e389cb286462b091aee24631 100644 GIT binary patch delta 7391 zcmbtZc|a3a8lRVBCLsp_MZ{{AL!p9T!i_7C0Es|C2qc`vBU~av2zSH-@F*TdNK-pq zt$4Mywk%51HdbxBx>i9gYPVKfP+Ho$U9GNG>$YpFI|nno{M~FD?``&lu%^O}@ z8^5iMe}w1Dy@dKY_`chKH`x7RtXp5AoKfAe^)-~ z5psz^-^jbikc$i&HEN~E5Q_rtWg?$3Xk_;XYmf^J8t$sPj+|#v(RvYbjzM4hRkR_4 z4EoAD#()e+rjIXwwPU*hIm-yIW*nP~oN*kRlP=_55{BFPvc;INO=uFP+e>9dn9wRL z5GL9GE(=~DTp;~Wx=xZH2@rRRo5TTPvFN&}Nt7wH2(zS_?%%uTyQ7kKB}>H*#h(hp zB{5>2=!(cJS|qG+JR|40=jzwa^2<$UJ_IYy!cD_K18+h?T-|N3Zii3=tBOx*az!b z`-tv~&WW~&)`)UMVZuAYXWdQ-68N{UyQnXEOuSR{L{!Wl!alc~6~U9xFt;|$f~~`X z1zP^E{3Psm#~S5!y7(f=ld3IEubiQa?_*3@@ty7V2wnUi>K52yk})s3__mF!;v8=k zmD9x^e)-3)S?3=X(Zy$(RPk9RRs2r9_1uZ*1|eO1R*x<|t4I}}RV0e9iUqB#bBD>+ zC=!0BkDQv@gY=PzHTyRbv1WTo#9DoaM6A`fNyJ(?L?YJ8TO?ww93;^X{PFnh))9(LVm;eIqTyC1-!GGp4bV;^*62$V zm0{XknB6YSE*IH$7g?u^>_uAUHD3H}u<)fcuOil!%`QedNW|vz1y~E&PUd?ksPcBq7vR=`RXkW%?_SW*s4%1FQ@tCR#xvPxi` zVn)Y4LsRR|@bh7Q9?Z8N*0iuRElkt6&@|c>_NSzPX^Ai`fdou><6+uDnD!T#wg9HZ z!L(SI7DH8(i8&hPMZvsC5-_v~m=+Gxyk$_2X2nm=~gCQla zxvMRYR`P*)Qz_m!%^RjoAp!H7@q%fSVcH~E;t5MU#N5`2ZA1!-++igNED@7{Sycqn zgfPtwmIz=8AC^R7un2`kJXpeoC5{J~J|2^Oq@PG1NViFEN?(<}EB#9PhV+8N&%+|M zZ?Bmi|7OS2j=pQ_dj}B&@!Wjr<&y_r8FJJUKyuzO{M+cmFGs&2fOp@mp(k4(+~_|{ zfT=s*IeuZ+FKv$_>^Ey>ausO5oo{ItVn!?k{L_^!C=h zcG;R~9*NMy5zV=1;-ODmU;_PAKvJ(2{dN>V9uG|VJ2yH>9UGmTtdy%$WZ}t4DM9g& z_OtKJ;XjX@J+$Te3om%t@1Lp)DU3GAbomuE zs?t<*%PPIGIK3{nILA;GV=9PN)#;T>E6R&?8F7_qre<8u1^$Yt;+D$ng1VBp@|vW) zxD2D!P^?WZODi-))}_TX=t?WJ8K!)*Dr$wrs54tN+Ew{ECCk;d1sS@uSc^GDXTN_X zRiR1Mt5b88$rhcaFkh|JwbWY7Mtx=W%F-3ZrRKQ$xO!z|MQvfRDa)Fjo19-`)GSX; zjWpI5W?MB)am`k|UjqC*h@K7X_Kyq?kCewngv+BH*B(ka=;?3$IC95Nk9^#G-GK>_ z?vad%=Ljp@9Q;RE9J&z&;4)9k>EbAXsoxe4@bG28f?o#UFnap?nfLcOH*r9fgqSb= zV-fyH3VH?1(FA|n18nkO_VAd-khOQj)fqVO0>1cCPcU_YxXu%75->zuGzlbnFh+h` zY<}s}GQ|m8ISu&Xt0#e?3F0VBoSXjq-Iu?JYNm;qlR*({L$SCauFgEqN-sS;87vks zyE3jII*0Y~aoE)qWoW<_nt0d?_HoDy_VM{CkdIUPzP?;=zH}R{c5Vt`pABZdH$=R6 z&^BIsh;p4ZYj42v!o(`kO1Y(OJ{(fxZ`jDbkbe;NV5OrcqBKNi(`B&+a8&qg` z!n1H}MbCmwQpUbIf5)^}tAp@?T65ZT2UKOwf3zKeX7SId_lN&$@DqUhEHlqTLxMaZ>%nx3gvO z&L^6JQR04jd45=6(?iNBUwM&4I1LdY;fUm%ph()mALa+5E4aPjKS;P(BGlWIUe0g} z__rGeiLu!toYy14C%{<{3yuTl$K~K7fOoWlwKz`!K4d%hy*Ic!HCtZqrbD}{fHNsk zg4T&795~SU-xFWXe0w~T$-qazeD2~S$w0xjO!Oy>k4GL{`3FtZrVvE7WvWsLBGVVO z$D7)JA4@t!W-9<6O(C+ylr8by+JWZPn<8kps#Jtq>|)zgKp|!Nv$N-p$GMo*xPBJV z2)~m&cCG1ZXswEzGf(#|NIXSX=0!DF!ls~CbI)+_AD)%;TGJOnDZm#j0v!{5JV+qc z`vsSU{`+{#Q|U0t&+x=AvC^l^PbiSRYyJZvZLx+Ft9C=$Cl z1W#!)KpShlN4I1%&uQ< zY%v$6m1dO{hG&%o);E|M%Hnk`&EcsPapid{baGQ|sX0GVv#K_-I6q2NnQW-aF=eKd zsa8fuWTw={M49W-a?8uJw2if9ncSM8sc9&wA`hd(UDads!9+@)Og4lc`u%9nu%qwy zO!Cy_{8|oBu3PWZ9a{&l-uR-Fd=^|*Ut+9QMHQ%3;fu;w$nwL}Yh#)X>2j0Rq}H|Q z4JFx?d6u*&m9fNr|6G8g&QhvXrNl(Ya&s*fL!_#pd{J^_soYpn)f}B+NikXS<@z#H za%9DdmU2T@eVkcdYDmvEH&->b7#ix$Rn$4`&xT5!!!RP;WnX{l?2ZO!0gw3jIB2sS zz;y=jK3muKyAB4Rro<8Muv-%NlI9 zOhWqNj*gobw;#AYLP}d#m0H4+T9o0sMt!xh&RD-(W(?P+Ry7*3qjJg?r*bueuY#%~Ut@88jT;3?(QQjI<$GD6vuYRy?yt1}l? znsN(co2(U4=6rRiQ5DtD9GaD94pr3_*N;1;k4~>MM#__ArAf>6^(if~T4RY)ZdGfO zv$G;B%1VPStHxZBWlq!U>l#)z>so58F)i7;*b-Box*{`bIrV|GbY!NHvn}xVs*##$^`3b8gcUF9{x3hjiI&+k`d82R6U?{;9S- zd+naXYJ83X%;oWek@s!3ej@Gt&b}9JoU#9+A%AqvC?lA|Ba5=pW@~fa$OkO|J$ zjX~$)LLlc7pCSEt&y|7x$ zS!OPA9@z?vD0ePz4bJZd@!tG&J_kF7)nOs%cjzwEh>Cfqd29M@{=7g{yWS1KI2aZh zI&pn-pLzeS`*wq2^P4?0sCPloJXL$93z@pzImv9plZJ9-Qv+~M>ID{bR@JU^Aybz> z?aT{kWq#7*bxl80FT#M??HL3WuuhB;H$!sfpLX{qtvI>&BiSx$(|#`WM^(Gl#V&Pm zbeVZ6rTnx+(>%BarP*OiRqYxVHg&PYdU1TGe;RjP#B0>MBJjPG_H-9NhKYM8){pqV zxrJ2U5bPhfOe7=C#WHy<1=#M!2Fvt|(oKz$GKc4Uq>cufyMWOD4jf9~hcm(5nvCzWqVB2!lU zX%BHiU@YR>_Yi7~k=6g{eeQ>;w|}CdbUxVwFb{4M25|lnaMc^Tj-AE&v0d0EtOhH< zlCe;1DhB#(5)^;%0hj_V;U*_BT%?B~diabUF3`hydN@Z9gY+;!4`=D&3^h0fPVlSX E|8mUK!~g&Q delta 4864 zcmZ9Pd0bRw7su~2%e}+Qy)z)gqA0QmC?FuXBrZTIE`V6(4r-QWDw_);s52-;YAoXo zuc0hz<`OS5PB|);X|Lw?s+e1Wl6-valL=XnZ>iDyTrSV$5P!|N=X-ud!Zcwv02c?N; z{$O6EU-HK2Wb}}q852lr#xjrTRz53wz))?aX0C>2rZHNYqWjW|n4|PD_A{Jq3G1%= zRd-3ZUN=J*qCUx%={j_an5*;+2Qz;vdTy{`rT#DdUhW2ahV|2J(Y9!-wOQJJ4rd)^ zIs|LBYnEz^%zVb3PNz50fwt{2MM_ImEpAg~`*OliWZI`XyP)oq1+%CloRU`Lxefk) z`tXEIsz$V~`)5Yf2Q&_*{v}!w^IXE;;3oZ>sur#AjPl{RTkjmBJ{2uX-nx;tgGo!M z!=fdt91<;A<)CQEDhEU>oavI`vnFPC*HYd?Wp@viT|HFFI#oz5ABmP+%TCdf`x8V< zu55>B$(5CgR)mQ(_@QXZ4f3KTi*D~k32Es;mh>Qtd-#fa_zHXYK9GFIt{HBF&h3+p zNpdOg_Yf%%EqR{r!6+)f2btG{+zd%ReR8O&G}wFHf~zg2jjWPJB-;kjAbqbF4U#KI zG)PP~j9CX`vLLn=Vwn(I!ArK3L zSSZ9ofX8%fFmwfr1{q0^XppRdAn4d27&8!J0TAZAjlPicft)wtM9d3f z{UPQFv3?NiD;lIB4;a&@Gse_)Bld}oh|XftdxJTmMw z95sArxMJ9E^L9)(@I`4JV`{z<9-J@A{cR#eQBL_^pMLakf6I>Z*x)YP8vbl*zuoi$ zHr)3$w(tB_XzdU&w_U9_8r#fm)v5fWG*9IydOgpiueDk_)VB4R?>i_*aSERCT8ne! zu{K4aLW!Sb@l1*MtXYhdqjZ5hQyZk>s@M~J zWbGvEs@C#nP8w}v>y)f|%L2p7eSGXUjp~ehVb34f0xsMO@M2YWDZ>W+1--NCuC88d zWIlEHP}8JYNI#=X6>4gd)$*CjcDLQ2P#1i(-YeSn}rw6G}&!kJR!Ei80GuHE29CzP)tprGr8q8y3HpUJ7)&n=EVCB*c`VL81}Qa9KH z!9i2zwSIVW*jfopbVf+2y2|@0%~-r`M!S6<+ry*IQe%&cfCA0`;80Q&7@6>71;6@i~!_si)g&e|)>+erIdK*nY6Lq<$#hK=fm0m-gP75+GP(@vNLY zQL?Pwyfr(n#dY68Nxjk&Y=OBb;%a-!^ z+BcG<-WwEL`iATAVvnY-sg`-esh;r0O_Q$}_a5as+L|9xQtnhA43egWLLZQ1BgV&uDDZJ?m$KUD;j@R?L|MBKCZ$?SmGk*Y>oPGTO^o623T}%Lq(v$UE zJ0nJwG*0l2MLt4p04U#nEdWQ!C$q;R_2YL>`(2jmKNW~cA|W&cg8F^0Jl?Q+)6IZR z&^{#ym3E8h`{r#;_9`rwigXOYMam)}AwVQ9@$aS6Hk}|P^~TLlp4YgE= zyP)(!Z)taHgXuCZfxW0>t(I{}w>kXK%i|RdwwjlT{I6$M*uQ@bsg?HEBheSgzI!IB zLw0U7{;U%3e@l$f9y}KnD%AyLea$xem&qss->BsaO~Zs|QRo|aj-TyUmc?!PxI`L3 zYc!lV7lTX+NAmk+-@Y~fJ9XRhaM#4gA$JY=F(WjNL(%eT4L`l+MPu8ouO%>kJO<^} zS}`7jWPdX1GIL)xzj{cVs;|&A9#54di#nQdVQo%+gjCjw3Aijd*|rHN+CcWWu%gBB z(uf>kT7SGSFGWtyFV(x=jG+&-Tb==eG2flV%CZ+P22qqvz zPDBOW>wXbia`BP%TAw|tcP2?)nkS(Jvg>iowWqgkQ?Eb zsT5tL-ql0=Hy?9e(;zKU$P`#d!W3Kw0fojXV2Js1Qvb*u`yWb5mJo*?ckggiJlNqE zTgzrlfA#hv2|N-HZjJWg$9J5}YX4a3WmE!AO*U1Sn*cA>Jqh@Ymwh2qf&SF<=DJPS z%2!GH6;pwJ+mE3|=DV8@Ncw?^P=9hF)GtXy8Jr@P(ob^QI35}I^JwA zCXjN)+x?Hfw3>$8%{AM9x@_W|8bXC9b5OK4t?t76pL~ASTv>&m#R`6_&>*2>Hu_wb z8)&uHym$XR|9c$&>xBUOu+_*=?-!4QytL>M@h_7qTQZ!kOzaKf>wc0PHpjQ-b+TN4~i))e$1xy3uuYOlq zjeeoREirxU;bG_}2ZcJ-YFVZh3Zl>kyUL6XXw?PP?@VjA*KS2`sFj|KMPN$M7^@|L zv0DTbOKZrhBs7)dbs=w0p)LFOs@R+Rh1dGyOKDmKJ__imCNZifvH7ztQHqqK*x}a KU1LXoX#NiYu%&eX diff --git a/Covance_UCO3001/browser_profile_1/BrowserMetrics/BrowserMetrics-6A198005-764.pma b/Covance_UCO3001/browser_profile_1/BrowserMetrics/BrowserMetrics-6A198005-764.pma deleted file mode 100644 index 40d21dda151e69185bd64892ac143e81cbe176f1..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 4194304 zcmeEv34Bzw_J5`cUM@7XAaYvsDiuiEH72Mv#4gTMg+%uD#ZnyZ}&;S4TZ$3RYwev|c}8$7x#1|0#~2|9i8{3YK(kFUC<+WMh21-Moig3D#Ybz2VT&E29 zY7M7Hc_x79H@63M0CfcI1xf^U0(Ay;0d)oK4eAE!4kEei1L^_V7t|Bf3$!0-e^4^0 zH|PM+fuMsxDWCzML7;;{si2{tG|({62+%0dSkTd+@t{ml7HBFc7c>)eGU#*=$#eJa z-DkrS^&pn}Qv4|TZEg_x{Cf((uj)MP9GiL4?9prZ$RpE-rH>vp z;)wK7X`@D_6??0^<;kl)`D{bS0Uf;lw3&HBlRI}l(dRElT}+vl-=p*JVR&Hp*kL0_ z9L zwcW6~o@1h2CUj0jAs>JWJ5JyMNayZ(KMjGIHE^XQZ7ybm3ty^zOR3)6|FZ_s#yJ-|qZ= zi+>oia$CEXy$kykRUdR#?eQyp2X&paxbBz4m7n}JEq&eDuNQw&eq`a!Tj~!Fyyy0O zb6&-uS?6@xZ~gepT@NQ+_}07YIxp|@bBFK8cG+^vA(`i8r>*I7ebLtyTk>vt>W!1C zwuL8b{p9QOFIl~N>W_P$_I*MmW6Q+*-g)3Sv_n*UszcO9^1P)LXyme3PR}R{1uDE# z1JyI3ZYKImJ*8d>r1m+}ANH1eiy~e$i1uhmhk-|J(DrPlqUn-wc`eAyc3@IR=k*dv7+qONE5ekIEncga2k(VB8fUl|Ns0~$kv%H?F+UB0? zW9Fx_%B%K8iU?VQ{KhL?GT3}>=8UPcd|}mgD}q$>XL$T` z4upzxJbn~Ms8QV3v;E9xGd&Scp(pHh2YngkK9pp*A$F@S^f#YXb%C;rR|Ldq3U}WI z&j%`kfv`6hH7Y>Ays>Aka%xH5)JIGUMDl9=MO6JndsIHs>s0^pJ%y7)fy&_NDwO|~ z`go>4Q0>PPjmIzZguKO##z(Sku1x}M5@?e^n*`b<&?bR43A9O|O#=VxB(Ma(i0v6s z7+A>6Y*BHIwzg2?tm^97o(kbUP+5T>KjrgIeh@t}#I<3YI~w&fJyo_-T1`e*BQ zoJ2Ax!O`!gxlPK`3DSO++7ol+wg32$!k*mcxHslLIzJ(p6nt-DGY9RL%8=r z7B|3{c1H?ijS1G!;h0}xez?~ZAvVGwRud3nJ%qRE4k3PiO^C;Ths|x2OI&iMOZ@9C zSQL**kn$rL1B%UFwi;;zPON?binIkT0e{Viv@0oo)#-nRHOC;7^~c`(L!-4S@9 zNM(?orTT5w6B9q-W4YH^@#%Mr$0S+*9Wug5>J#urh*GXj2PE-tDaA={u6ywtAQZc4Zq{}SBO^Mro`P4eN~Ai_oS ze`*6eL2TciUin@)xb5IXu%u)BCZEH#a)`-4BjgE}o8Irzv;pw9Y?uU6e!+rBir>IL+X5cw=}JlynKp8&)w>;E`OS%Rj%o1~~M5 zC=Xq3i7>Ragmc+>ldgaLf<>>Z)Vcl&ah<{E@MdsM^1?JW$>S@p3^7_EQt%+-O$8o3 zKf+sMg;P1NM>z4^Ao6*=APWBQ1vB3UOT2UHgZ|H|{>Y$ka^%xG2Jk)WvIxTUmGOF+mb%udbkvExgOR*FOt4se5^YPz@K&71IJRf>tB5OkWV`$e?|A? z6i!zIz6!PJgGm9vE1u-@mKWzkNtB0U3IHKw01x@W%!LII52t_#S7YleguTuRC%IB* z*-||i_(S2f-+jCJjb%R_>g|DNVIr1pkj1zDjd{5tZ%H_PN?yR9hh-sedY(5j%Tr$I zJ>FX@GgCK!dsGS=>5uTcb+$)J;ftOz6)38OQv?w>S;52 z_Qa4+b;Gvxv?T|sa^rGF_bB`0Ebt#Xs_W;J&Dp;cM{;UMFq~L9n|y|(;h7rn6k}6->Okh{r8GSX?das%bQA`&kxp<3o>TmE(E(e?a!{V^4M&$|P^qyz{5I^dPZN1puz z#Un>P=^y4xrgqWt&+~eVsqEu}62zMg`ZMKA37jOCG+vG%^AOIW>~2uTf5$h#Ry%VNl1al@AcqkweOZf3A!%n;ZGhFDx!OG zldP-Bmuy_Le5d*^?1XC6y3Lt5v%_kUwRk$#JozW6wO{#M9j@G8%^uV;p47!39RAy0LoYM&Fy96S|HLy@ za?1{91}Z#0|C9iBK@{8j%S{gQulAnsWb~%*+MD?^zs3ChDu0ewhnv{%AKdcq_sm)HZv37FXn9#)qLM-GAS-+Wl4#$ACBtT=znM{@_?XNx(Rhk#!V!gWDthQa(^5B4AQ4#L7AWvKm{PGq!)ss zpr=3|gSz4e91EHcdIr=Bm7*531GEqYaxe{ZkO#{*IHYC0@bG~7zaHl;`w&p1BcJp%^DTDFYfQee z!bPll5a%B~R6XW~N9m5A&|S94oxt_OFHd($8Qf7kJMM=eohGk5x!h{egAotEWjFIx z3h`@B;EVtU6~*}hT&AMl!!k58zWoszTE$&~3|m{y5VI_6ny=AVp5`4?-VnF6{lfeq z_co@$9|XeB5Ql?~1i>^b%RUGGY)~kqEGN!;X6o zDrj%alXqc^?+4fg0DCmRz67wx9)oly!p1*ch`F#O|6GEwO4O}ID5s^UllOpLfc&R7>@Wxh&JBV%WW6@^!KP~t zKJn|Lx;!lHrdGU8h|PSkY%bnwsD9i%A67AUCUxUv+^q~tc3eZ~^>;P!peSN^=pIF4 z8|R$zc@J;NsRJJ;yyVEI_QQP1)Gj8T?64Y92v-jpTpfnG)3?gV%~&FCc5-W%qnZGSra1Z^&kuFwJ6r*BBu;mrATh(kcz4R~8 zl7*`j6HKfW$eE^XUgpuluI!{FGE~$K;cJmHGJB=E$xtTTE<= zx(cp?$N8=vZZ9vkN!EbBar#FE^hCn*%N}|<<)UTkcdPiM$CyuXbT{+(9PPb?se#fN zUNqbCbX7V+j7Mb3zcITw{bsH+=+12GPK1s6h7|bpJlQKZ0Vmt7XT6q!6;Atl#SU~5 z#LEDYKL9iklneeb4@LWJMdy0uv@_BoJ1$;zp7jGM4vjOIkAH0rzr$*i(i|M7eu!KY zw5Pv|#uezQZFa&W{7++y9v~WL(AW~)w;XTKavQpFLE{cAZOFBDbm?;32~(m#*Dg{( z{Xy36v8|`i9*F=rH;8^Vjlbx3)Qk|~w^?iF;Z__KJ?{EE*n*M>Kczff@e96=< zRNt(ZU-G;m+Vu@%53Ej}ax(eF`_Zj<#)+J$FQai6$%SM=zny;LU=WI3VxI+{z+MA- z9+Uu(`JlC+X$g296>2vqqXWjys8A_Lumci&r@IjEL!i|dCm%LQh})pIo<0`-46K`% zW9|KNAvUbR*l8#9>|~cHybtq=F$v;?ZxY1P_u7d*JvxX-?&&DrekDo=en)0r(ZJd@daB)^;-ZK($Vj2hhNQniyiZ<{+QHSu-sFdT|5b! zx0U@PyBM+RK%D>VBU{ctxNGIQQ1$men)x$7ma%oyO#X6dN!PDikw1zd_WS7`#bFyK zy?4Rh-+gfRVL_4)Ir2%rFkdpY%jDdd=!ina)z}$MePp>eB>MweppW;C_W5>jRLeMK z`A2;?o?aceBT`JAo4rmYfWR-73u#*8c-^Fg`9I{^mHa<4u+6e0x)QN1O- zz6!YXd?{}och;Deai{%ql5h3j#{N3d0?7E&ExyH$dCqaqqPOnkyAt$p3W#x+0hgXH z~S4zBmy?{S;KE)Wu}u zNCi>%fGB+g7EbfA4Pu_&zwNY3hrPK z$)EX>sa+h&f4W~)_AmxRUSAd2iS_!Ne3VMC$$F8PAkr${+Pk#ZmFI5%026aK#>IS< zLj39o*9`BxN-Vcp;N-(~xN`qdbF@m2apAxAG)`CwyzLHt@k|QcZ)5dI%f33pvz#gk z9Eq(5uFRKA?J~_9Nza^?m!9blX9dDo9+cauq={6<+KQ`_`bcAgy+JfKLN`t(Rr$W$ z3GgdHcY=Nb(L%#6&_@7$s-7gp$k8uf-7t6IC z`LbNc9EX44+@Nj9H|6HNq+DlXjJL7s*sT@WV(5orCI!}iil`~-o;kS3kZ+{ka8Ge7&Ua+e{26v$%yP#MvKz(#$Qa%>4s7AeP z4|#mEKk6hZ_iha8X$^2lst}K)K^J3OITmfumjRih5N4i;{h>t|8_$Ex>xB5*m5}Lj zl*N;o|&$8mf%Q9WO-Wq;bDe z;@#dHRX-yw@qW4|NAc-u@+BJ=8fRJ%rus^}C~NP;Ds-OVhNDkX=i<-Wl~MfvwfP^a zj<9|P6eF?ngco=Q~>gT3PD96DkG}HOW?Dfs3&l6gp=xn zxz02jpgvsIW$4~rc6DA!5#ja*QT=7UWNMe3TsK~?hV?04g{OKd{V)TCP@lZ&KGTb- zn|eqe2c$qygoE)=9fleZ`u_f(mmK@z*(*Z~N8%w=CSRovnPFazu|R`!BI4T^<*pEU zc0_EGKOU|Jv7A;IxS*mM>=WAj(r=v)>G%#+4e6lP;5rGDFWIoV=~;Wje{{H`y(PgPT#JuKfFyl+h|=L1y>*RcVg!<)u21N$}d zYH_?q1vE|sS}06yg6gf)eiSOc(epE?9_r(OoyPAX%=E0jzazT3-{$q#g=uL}I`V0r z%zTR-^Q0b??~`X2tBtiPs16>NYYjC>IIeGI{im?3$98@Cq#!coPxHK`$e-<{M{Kj?9 zBbsywf=du4U$SwbSJ1I)9}Wl0ur@Der=;RU9f;+!#K^ZD!rFtlU&F09X84oQLxv3d zobJhSz9wIVs&<$e!q`6>lYojq71^Zq8LtG3?Q?fcAXO(F=Wp^k zoa%#>|IEAz@tji-fy*Nm`Eq%5Ii&U=!k~v|Y2jz}s_SKjmuca>N?$%A8PC^&SgzZQ z-?bOQ5QP>FbJ zBD}xK;^uk$#f5LS7o;2B?YI>#>~lAT`EAb_3GGDVPx5x<31C%IL(&*G%fXrFs$FlT*0x z9)Q7Dp{U1=;)wwubbyJsd-E!>ni39|RAQR}9^ML~dfc2{xC7#FTT8?}_g`IbPh<0L zAet-m0QCf+Ta)XRec|^94F(Mb9S)+oC7ByDK%`b^zDI+bxu6=*g&@+2cY)S|Hi1Y9 z?*jph0Krrz&IdgV`UW%ehS#lJQt|niyad9B`X_)um@Tc;Lp->7OwH&so!hYE91{k5It))bl$Z1`yteR$dTO0 zuE2cB)GpIbn24D%`X7H}dLi~XS7DTEbwDRzYY;XGVTA`fPfBG2wl=@ud0T&t9*OX{ zLF7~W><$WoUp>2v2e)EZkGsx)Y{MOYr}j*a;w9qBe96=_OM( z^SwXJNH3rt1V>(9T$wMK+9hvZc{(4>hLN+>jp<3idtGAZeeQ|MXJ07nPN;Bc7#!83fCmFW5&+DGP`d*_HURVkfcp-_UJC$N0suz?z^MRmBmf); z0O0~5?gxM(05}`~K3I!B=`$f#C%MG5OqaO*9GAHEWt^YcKS3 z;-RDt;+GB`#Vtej5>@9XiceEIi~KHKMg5F!qHE$l;>qzn#oS)W;@Vpe#CvT6MDf|F z;*`{3;;78A;;`PC;)Y*y#oFTw#FBGEV&(hr&3l-u#5Vce0OQv?AdLxH|w9<+@Z?HjCk+F3giDb}(V;rWQpA7?N=$D#~;Rgq7 zx;jzCWgN^`-1yawBVJR}XXOwm?rv=QVTpmml*djOSq~`)t;~!Jy2+FW^WzBAogK%- z8oV|~oAnw9Mc1FH1?pLrhlztiKhEy7b^6uA2flzhO^(WMFs{s(OzlEA8nkC>$^7DW z14QcKVW_^Ow|G2H`Jh?J{3vTG4m2$}_M!1l59^-VHqAkZNXOGN6pws*4#~=U`k&LI zw24gD7|)Eu|F zeot|zk0eL;_M|H&_H;(rxW>a{gQ?Q5b zgd6X#&iZ!BZPxRoOKJSde2X3Pnq0rjtHiVu+r`Le1*hYvD^$OeaU6p1RM2|hdq3rk z(~^r|@5y{{#L$cTExg-BPpds!goF8t8^7|JYkGdjQ#6;}^YE5Js= zVrfc#WyQdhmJ{r7^!S;k{Fsl&ZO(!G(rN4X3~wnu77?;`BVf)9AbS7JV?y00tW0{Q z#A9cM>tT8vzSn&{E~i62VbK5ApZUM_zD=J0*^<%qaaM_{6K<2loSkv9*bbv>#V#qCD@*y41Cg7p; z84u0#Xzr)4FW*}K#XCoNAN}0K!+e>jc9HuP=z<1a8O-(#2U zZKE&RT{vi{iG%qKaH#j}6b9PDRISQHFORaamh;Vc+4syF(_cT;%$NCQzV`Prr(#1# zhDUxiBHen+&$0_2VLey}pXIR40iNeCJNB8g&MiHc^HsQ9!sK&!lXxruE42KV_|#Ke z4(L`Itn+^}Z%*i7DqW8nRXkxOJBfU#Uj^$MM-6&Px zfV*_cx?#D%cgHiQKD+RyK=*Gf;{fAhzDgl}Z56&a*w~KCtw@UG*V4M?UWiBflGYmt z+5sRM&(T`tco3ONt3XlEd!U0+A?OgHKKKFegSMbj9E}1=MnX5hFxUZ$7q?+x`8fuW zo)qlwITY)Y*f@JZF2<7;*z0~3)(qEUe_D5!xDKZncfog`*4>gIMqk-Z-1KgHF&LZ1 zZ~iDzlqYr-=j0@bs{Qs8+rQ~6N-jwiB-h5ql|iIS@?`nbJ=Imce_Y+|^cT)ueey7{ zrNd8va|x3#*|_9l51Xf`7CoddR4f;`)r#T-9CVTndeBIDztTQ)uk-mwMnK$8u`yeb_S& z|Lohk7aqu>Izf)`?1d}yB~!atYjv?L+1_IMFW9oYlBzHK;( z2l!6Pj|>>K>)YSW@?`#=;mfYTagR2+>E&5JuVuM)J9gNquEn37YvN-5p5dB;eQtS0 zAzv`U0@HD&gj&XR!QCHRQ1j@Douo6!5k5NSj`@)Bcd zxTbDD?6EfskLzyYV!j4R-a5l2Pf52S%OcccO6EGRIgzu*>&Z;`5aCfzdkNK3Q?plp6!&8A* z#bXfldbiX8zWKi#^_Y9*DTyXN=Ihw#-XXs1%xr8ioLCdX6~(hGw=tD1%k8@S=llQU z`s_m!7xM{=?wsK|(OWnHhebzlie1^{O1y60D85Y&@YQ~E?k8VAJ0yk5pB(wrUol@Y zwTm-+6JQfm2W47QV|qVBrlOZ?5CgQ9>fP=a$1Km8-@n29m-!krdFu?HyD}1>;~8RN zv-PKm)h**%J^IthpFO!xgZ<9T-!oiz6T}}cOG-nRSJVNnUuWFAVSM3Xlg;|Z{5``p zGhAq|W;XpXzNTe)U3bO}6;Ivzegj<0-!ojH1%IA|X!Uda`! zf&Zg3k57*NCmF$i*howC! zT|hLC?E%8{Q?9QMf}aK&1DXUn5rpZYT-R9%|7{SxkcH#@#NR>fFn~T6)E~dSseQCt z9mpxVXmp>)i)ubY^3t)KOg@LVT23(3!Wd}NYc*%8)ZFkWzsAb%r$vvit~{vQmz*!- zGWi_ddR%gbY||UbXQ|Yh!!0gV8S2jzn3_p<#* zm&it|n9RlIF9yHd@OAdMLmGG8ZGgQp@?=|@x z?z|r0GziSO`8gfe&N{_y4%bx+v%kOp{gLPK^IQ%lpTnKwIs7TPY-}o9o&$vuJhqo4& z)s5KXwblWy&2N4)=C17HkL7$Bm&xbwR^w9Lhz-|ltJXAEj>Agt95#LZL$JIn$GA*B zhdakr>cxtWGN0gKz5fvBtJIpqwRq5FR~1egJe2cgTqd8x_Xt-Sz6xKK7HG=uy3_&A zv-axHZO-GJZ)Y5g)8uowbDVzq5+2)lZ1NkwNTt@C{3@sHeN_I@{i*p#$GA*BhdamR z!Pq@5j05(HB56fld_qKm^jZn&?RAp_oa;MO6?vm?SdxzGU6bE>oE5$rZ*dxHxF{0f zaY4-mDz)b1x2a>+H#eo+`77tk@-z7y?p%HqWE)Gv-Wso`BCWz#q*92&V|>XMDqeH= z=01N_=D5v=_Es_Dax?iHzK8gVq;(95L_v&iwF7)5JCNQ$nU@sf?N*%r0L?6IXI27H_>6Cr z1AONuJut7=`_FyO`7=I~&*9GHR~ar$D=G^F@RDa5j!pHb6r%7LU+!YXYfgRzcinXD zkyS&kQ!(T6Gx;3u9A6?{Ze7TOM)6y|Mlh5JK@ln4)YXj=ZC_I*1>g9^p9Io@u z%6azSH&?7tG2`WG@;Tf&E*~9767l#WX|e_T{3TfSw~a?PIKbC=h^11zrYJ*vXzeUnS2iaGx&I}OKIsi*E+!I|E=?!ji1a+ zVH}Lpmm*_A5w=F0o@p6TaIJg6s`#ie7MCZEIq3{FjL+s0jqSECDnaOj(LP}Fiw-t;m&aeap)ONu_;co1~_WZa1;q~yIJ7?->qMJz5BlO?BI45 z0K!N6FPLw!W1e$-YP4kz9H=QXzA;y;WSf)Uwd>X#)bY%v0~r9z&*XEsb9^|v9N%TM zjsG0rS@n;-PH-O=N>DhIzNYnW<}(iVo#QEzr~9Shb2Jf*pmkhj*QnH*lT+475T^4CS@~%YApYfS|4tI`^#(nV-m9F2iu2rcuSDq=`_PzC_5ogqKzKqM{bGUO{ zs9z+upbxKMg=E*8R;)fgL1{%n+&;HCz$6Gj5eDXp&o z@$-7SsH1=2nv>(x?;Lm1TN9Q~Q!(S?E0fRR&hcS9kFTL{5l4{#%PnP@O079uPwm(> z`P0#p7ID5THEKmSQ7$n%drw z=8-4t*vEC_Z)h3cEz3GTvw8VRX`DaH&*XEsbNSJ}b+Vt~0N}K0eCpe)m9o9R-Q)mg z-%SO%(bCb~83*Gu`5f*Xr@sUiNH2YHi419azft#hm0EM<`;WVy8&iENf7{Za*P`F`Bk}0vSRYlXG$)@4OP8NI z<(Px|aDFTwlh5JK<)iBndWF=cMr`^x_2!mwF1?}M-0DkK{lYjHr^)AV=Qu5UXiO8U z6r%9BzgX`8-}@W8-QHcS%i{bQpULO&J;ld13msqCEh<$vJj%DRc5vyaoIcNcl4hxx z@&3%@bNC+PvuqVnB*gMdyj7*z9KIuOneg-K<93qiO*)pJ$>;Dr#^(;py#RVUS=9)> zBao4P{%GympF;;dbANx%pYfS|4&P&ZI7-m^Jds@B&~eVbO{K2O(Zu=7^jGqScfQ*i zxyH-c`O=l93%e{vz`&-hF}hdaktEx-4W22*&Ewos&x z>xV6G8DH<&S1lhqWu_(RcsZN=*5jj1E#+w?cm}bQg03`K8HKUtM`B9c$ryQ z5{h9&z^lYqgR7NE>hc{=jUBEzyicq->`lLa@(vX)S?@sav=7k-QMml&Y$s_d=B4Je2tAKRy)9VYS}v% zMh9%`%K0-slh5IMjIWV>f4P=anv-A0A6`6n=lmI;$>(tA_{t)YV48Gy6QoI9Q%0pTqZ1o?54k4jX5taC%YPaJxypPjQ>WyWhP(&U>xj zs3L_^^?S6Q#C%Sdedl;fWIy674r2YEzG1IY(93;;1ANzKKi27uh4RxsG69yS$!|Tr zN`ECjQ=m2{#Kp-Ss*baUDgj(`a-5i6UhqJ-b9bwl@$rMn=Wyq8#O{u?a{9&&?=Z5> zsG~@b%RBjgm3nhHpYc9_@znDsWit+zr^)AV=Qu4rM7w-pmZ*%B$r9J)xYhx_qu%@G zvrG5Ctq14N_)I>BJI5EVk0EtNoqR`+)6w<$><1LLIXQmxdGOVyZR4>O4)AuE^W3>NfBnaajEC`>d=7Vxm&OxeY#c=Y4fW2?uf`3xmx6~Bw>f#f zzu?)c(r#||BR|jhOg@J@$7jt2&|FHr5gPc=o^vl2yLq3eAG_t{{v=9UZ%2s_tK6Ey z{m9}DKOFXrZ>_l>llhF7edoBX1(qT@OA1Hg*oQ?noU0t*T-f`^_Uq=%yi&f`fyw7^ z=QwHe8O>qo+ZGrn@vW7RUSE?QZ5ik3x1IA-ZN1NW(=y%cUz5+_&dYbMw^lA=rqRY&n|-Rrs!h$wt$pnYuh$0)V*M`TGWo5?6%5G9 zq=ID|AEmBQsWpe|*ySe--8u2*B+i#{nS2g+E-xCg;ULO1+q^ff7_AbHB4KX7>mA_j z)8W7YeNKOsw@1o#D5`}fzx8-=5~Ms~&%S?C*Mq?)RjSR&vuwzM&X0C}>JrYMp0gsz`69v;};Ly8QWGI zD{qtEdYslKJ8N`lZA9@@7W?GdU=#^*y)3X+8Ja8i8JA7_A@kvk9LB-&H2ECvyxcWA zFTG)l!&GR&PM2fiT9s;Z_)hp@^ZNH6Dy`%E8K24L@IQwyUNLo?tJbR2o5OkJmYP@c zZvXmQ#=$sEK8OEFoUw|jkIxF8X&LAHPcOUc(ocu&!#EhH$>(tAIPLocFk<)Mi_2*N z90iNPFg|$fDW^2`esQM*yc-@l@{h#%-={Mk#%uC9+&Nx)eH6Hq^0du&mp-dfbHk(j z8rv^$%CqNhoKyP9k(@8%GWi_t92e{_umT4$g$Uy#kob(A9P;Spob{YawK;rS{<(VA zEhE?c%=t4ulh5JK@!7{a=yh=LD>lLT)wgijs1-%RtcSKaz-%l7W3Ixd@vlhhoRy?m#ZBCx;yJz0@iNAXTdz;BuDYa&vfb}^{5yF@``T~_< z+pr_7)=|na^Tj-(ur>|GB7? z2unhEU0kK0*Vmm6@V$76>xwyKv||=YRa3wR1N< zPc-?h#}|Nwg?8h{R;I$S0|H>y)N!V~)H2Squ3UX=pW&--WE?CKwUm~wCsQn|S#vnozM5P7@X%wsFb>9P z@;Tf&&ZguUE(=s!!#E7#>X0zE_bBj^U7GRIJxy@+bL7WO%6R?zO^HW=Egj=E`5Zn0 zry5pxLUZx$2adp(*Mg2r#Ce&Z zYayUH5YUkj&_NK;0T9qo2q+fG%@Ed&JmstP&!FN#d_O&;?M*qN3yaRA$zGP~b zM!zEqrv6=Mt8U4s>TzW}I}AL<2&1yx2|9i8e1a}s`ML8`qgJlZg}9`nc9wwF#(aw% z^QKzcA7+NJ2O`~#w`hV9=HY|kmHr6jpy~kQ2)>~nXSqZ#a7i3Hj)ojJZk1M#dB4|x z^5eL>-cd2*{iDg}aBjt6m1+8PzxC;dsW=#Cgz^1{4fgzL-bE<&ea08e`Y5&E_C8l| z`m+2`E+(JD~+b&^y{^`Wa^Wo!h_?Www;Mm4lS#PP|$MT@IQ$lfov;L%eq;+NM z)~}+Qe=npaB^~22`5Yd{GZVXStpjEaRJmTPbowJGxS815pq^ZXgsGgIo)d{?B+o~5 zs%OxY{-fWsOGSD^Ktn;KpJ-y221*AV4jKj;4x;iUxsL=L2_pS98Z-tp7DT#?6gjG( zI0keqh;-X{5S7aWPzERyG!ZljG#Qiy$_7mV9S@oc$^lISO$X(IP5{jS<$>}+GeM*$ zPXx^dodh}=bPDKH5b4i3pwmGGAP=YzR0N`8qWaO8zS)F&M2_&H7^OXdez#t)_daRu z$9?Yl$L(NCNAW1O$(L+goYbTI01OCL67E?pG5IRgCLhe1Ck4u3 zj53-TZ_k(7ke^$MoBx~IS!4BS!@CNt8y?BwFkGnqr9vwoc)uIHBl_PplfGE|-lB8q zo*c`|y+b;O^bP46(laDu z(l4Z2NUxAiAzeZ`gmee#4AK?UP)Ij;KvWi`pt+y`C=99wEdZSjIuBG2S`4}pbS>xx z(9NJbK=*(i1U&|N8nh1d8VJonj>|rQ|261G(C?rQC|o)SJsC6rMD>B|O%&nW?t>fg z51bo>C=w^>p`9QeXLRm!XZ@7lW)p1bC?3T&`I3!`*6y2XXB-6sd2VvqczKqjqU6B% zb^;&e$M`znp2j=+cM|(%JTc?xOYV9r0eo^4pUx*^zGP|_e6b?-$y_&9x@iY6Mng0J z%F_?}()DBgCY1o=pz<{3)N#>(p1t}WGmx_)9E8T?bGZ5-Aq~VR>wNj~+K?I(O)sIb zkhjen-8OV&Nd~K-3rJ#}TMICphxFp(<}E!*&L% zUT<w^OBp!_C6<|d4n{D#-{)q zLXl7D^=6ZS$NYZdu&qMey=wNV3oARmLi&{)<6*wy#;*n*6Gr;19Ksm3*$v7*P|r6d zmkl2Yu|0Kh-Vq89slC>B!2;W-FpkC|9ofJKJ%XUNFjWL@dJ$?nQuzQK2C~_A7iF*J%91JdfE+- z^rtyq%=!xR<+l+y|j_DSzfGZv1M`KepOqjS}tioO&aFbAGW6lW_NE z`<7p{@u-#j`#FE+$8%P9_WbSR#F!8eRUgMEZ&%N<984S(x+eeijZb>qEBoxF;*z`$ zhSZp^xbdsA@nIa1sYl6vautZ|wV5EYpBxSv1R4k;+sP16Z_ojtz83X>p9ty?qRAl{ zs|YgLsfoISC=QML>7MLA2Z546G)19)lZL?b4E;v#W7#JjIri0m>VK1`hc)&LhwDD2 zK|~k`5C4x_=@KA=lL zWQ(Ns(*;Czj@l2kHGaMu?x|f+d}>3~uDI?|J#BLhC1C0^ib1j?IgbO8y)PA%3?ltS zI*s%Y*`-M*5&u9Cl^N-x{vhJBKBKZCK9vp3bn>3UNT;QMsEnx0I)bQ-$fxq;^5XI% z9y#{afAO;C|8<|^vag4k_Y{YS@@>;+rgYl=X9?8chR20Vwk!SO29N3v)m5rLy8UOnj7a2>3;mb zZkc37;QVVXzWE&I%Zmi~DlL8WQluav{od&E&o56!zIwWpW}OvI_PZ4bC!QNbem_tO zh}SO*W+sTfS3Pn50r!0Q;!#$^CjCO=ROVB3-C>tRB#=1)JD;#WxHz+rtn_4etqiMJ zQFvS)1wYvHN04hgE?M8hp4#yUQbppq0XM9_ukYfk=w5eC@#Vo~$lo2rvG6rm7KnIr zycM!!;A8U|)|JyU`8`L9$m?UpS=)~hi;^aY#lt6wYi3LlH-@K) zlg^1dB;-ziR+dygo(^nT?1F!Fv(oVoo;aemUX z$a@{~ep&oI{JOaP>bH>hyU6=}@zlRR6zh^dLEc{=@2|x_7iKB!^$ycG+%K!^F zHkqCn2;rT{^cnJm1TSikwb*sMw^l9VF2w_}`ty@|nsKB&ogi`4{fK$URrkL|p#_g# z`P{-Q4nJ1KRP~LnCZEIYIIP@($5U*rH&IQQ6be+Jj*%&vpWBL?#_A3080w?A-=uL6 z_1Sxas2`@jndTcQAewuO1Wf>u@aBT*LA16?=6_l%Ee1UgIu?n)2f7hTY#B1xgbXUs zc?U2F`2(%zXmr}A?2COr==8^igmta~RL*c#{655^4$$h4!f)QnzX2y(ji00m6|- z>uSuGOzq+XkGlk`#6I=n4b>Sguca;ES%RiM@z?g(W&bef`2|*uEX!8BfQN@^6(2%f+;dl>LHw`R_vy|LvVC7QAC+$T*m9v16Vchn9V81x-cOajYeA_0Q;QvB$Mx6j z_o$uF7)jS(P%&~YN45^qW7JX8T#)n`l^4wwl0Y_f!IUJKy1Q$#QU8vgW$1 zkN2+)4?p{l+v<99eySW?!sK(f)xI(@R?&8O&=EiCU*7lH*gT!;0Hsg$gv;CXDIc@$ z5KnjfjLvJjZUK{rRX$kOnjqEse2`%??If)AkUOoK2_Zg?^LtMh- zb9f%U)-l2QSVwxMH#`@|K&HEkt7r~ZOhz7@bq#w{`b0myUsi0h4AOIH3gYDXl=MfC~aEbV5g7E=$^;> zS`ew*)H0(FSW^<(^AsxpXyi$+Yq$3CgyZ@5bNG6Qf5#-W!{Z;= zb>^oVf9^*Uc{nNs`u)t8Ozq-KU&M+-nBzf0M0$dV+FPRKvu%QSgn@|S67fB5ZI1YD zu1x~}nzFVwG)othS`$bL#Hn)7`La7SXsC6||OVz8=?;cDu08`&rW9@Cs_NyIxnG^7|so!D={+Dl*1X|9-X}p$GYKze(fj=(+-JTb1p&h68 zbBQOeiAIM`etzlImi_-wKp=Y_^G!r{dt%I<+E~+-kLv3pseM&zaU+E8Onp0hfJ>b6 z(7b_tQ!W@0p+O5A<6*wy#;H*D5sCp97oQ3|U zF*Ls5V=^(!|?@ZR_q?sdhYU57qa@By9gI z*>yV3e77{-O^&bc1CZZO$>zsAc46R*e6)!!vVI_aok@BH}t}g z^&+T_V+;;yr*z#QRiD*3THmKX^xo@h2X$K4g~G{^Pts?;WNH_y9cFq~VPa@<7sMq)Pz(MJ{W!h@}fpmi2{?6(1?C5J}wY!_MQg~d#R+_`Wl4!``DL4(GoZsmL!hso#g#&FCipU>Ib=8sE< z*~^7~EY(%Le%!w7(fl`iogbU0kCqvY7AC*h{Jo`>kO^KAj#+Ol+063bJ7AE?UuTD8 z+%5U4KB`#yeM`@^g||uIzafDr5@kIyW_Zi`Y{aBrcht=(2rw4buO^?vS&z7V6%)(x z$v!#8sZH1JXL#pT;(N>XGlH#C8tmV7-0A>d_O_%2(?)smrmAv`&*XFXpTb9P*oGpN zK_sU4Q^6zb`p_IFZaTl6_#*0^-(HS#iBG`5Zn? zeYVg#u0S3|kRO;#pP0|^U@VQJuwf8IraGb5 ztMv|W&R+NF-SfNuHU*DL$2d(shc}ILS^&Ljtr~m8;M)5Af+JPxZX`x`jmhn}Yu}z* z`uDTw^&%6!SxE|#S}J-+Bm zXYI==n2eQzE7xN&I$n>Tub&sD-=vpMJ;EtJ#z*1ic=41xaqx=s@8IQh8J|#^d^{>0 zpTVE*_FDMq{GPO&*{udWx ziWpAM4qLDOaZjis>o}5*Y8l597fjpv!JR)_E5dOc%-0~u+ZYZy)xw9)E>zqo6uthe zaDXH6%lpQiRnjZPln3*h#F6W%rL8@%(Ub*>@wKq3BJ0qg#s#F~8h>=l@|ja~`NN%u zpZ1!Gi}{XmK~NLCes75{5^fBcJ`UIbT;$v!dDqCkpJ$(4`dRNg$1b~7##HfoBR2Cb zcFb#Zy%tP;-%oy7WksRi<15EgdOezbO!Ihl9P1J{l=WMdliXqLZI(u_LmD*RWqu5Z zbz@)8j_qI2A;_3@xU!zyWZ*EzBPkQ`KJBw9yZ({0Y3THf08x3BBR&>*H>KT@VNkAo8KT{S3l z*n&IWxr`JM96iw=SLREmb|D4v+FYX8hEa=bayZaBa?2b6z=x>nZtU zA7H+TBsMQ^Y;uXnQ6$jR_(M;N`YdbeB>O9S{;CgSp8j0h{hyP-3OvsBV;kxRIX8&z z8ar2c{wojc-q`LnuV>&i8JRA_5u5q=*XHuPrDP_NhtuX_k-a1ks(`WA7s1Cn1GH8F zdyWju4_Ip&%$SN@3jU&6D>WVGk{rAJjm}O@p?Ghr?=LSoxuf{oB+uUxUR{`N9n&Jm zL^K~~K1J7Eqd4=tORy3|KT)No+j&wU zB9f0AM81hLdP+x;=38|BHTmu_CQjz7RO8oH;8aU21QL(yxYo9SYt^Y8#k*g>b<(1j z=5^o=Ks3H2`7u9^NZqvtS6Lt!gk4%9i{f#ve+AQ#3r{?5R-U zq9B%Ev;}-gf9x$@%{zGe>+`?=k>`G-cd1;NkAH2h73Hc#msjnhO??(Tp|{(t6PlMF zWt=&2`LUmL+UI$CZKDBp@)|+*Fsd>%gTkYv6?tkdr9_88D-NKWs9!P6iLB<69YFx$f$w4|iDGPi+0hPT(Sa;kNRl zd+HbT{dmEm19SFTH+Ztbqi|7eU_PSToOOO*eqgTGFTd77hyJ_E%OxWW>oDy*k^So| zPq_~(Kh}Ui*DKMP_WFhlT;p-k*IPT?R_eN}I_Vi(=J=;6zN7WH3~RkLud*;)6!J-( z!mY!~C<>qT%6NQZf#kyS!)*hc-nS-w_S_pM(h(Xq*A(9oPOI=~xz&JYE8k5H@I5x- zyL-;~bYRd14*xX8cZSbbimmE4XnOh9o!GM6Zd`TWn51KRJZa);ir)%c*1BFsz+d9C zFQy~28W5N7PT(ZR<=fc!dH?Tgd;T=YO`r6TPR)7R3zN^`lQVLx&(_FBndvR}$QGdM zizTyLZkIi_%$u}q*@}l0!g#x6KIg~2wY+IahR2`dnTxFja@i9tG*Im=o=}U8 zyCwQcu#PMBBzw8hZzcQW5_}L~&4{!sDX+z=o_^)FOCFm<_v92lR|CEZrG4f_l_6+> z^sGoE7@p({g(EqEV)~%F+@EEwO~+IisZHtXaOHAZ0bDKVvEl!?>d3iULtm<=C^p|E+1h<)YtRY0!K@7_@K|1UU5hfRv48dpU^YkV#mA~4l)d2 zb9=Dd8}X`{2wp&m!HJcNE|)A=9a_S(Ys{IW-&nuFTJ4ROi^*p|aXi);#(6<+c{v8C zMRRRvqIiJo$2JEzeD5rt^u*ui52dmrN4^VJ=1Zn_vFb;j$6rj_@KH%H&7juh3(4LM zElh4UrvX8p`X&;+_QBI%+xV*f)RyIR>iz4wFFo$;znS=$uR)Wyt-)u#ATtqz=or2_ zq{8w`Jgw#WJ#e31ztn`oyBG(zdy~)Mv2v769vhq@*g_bQ+pr>DMAGZg66D`fJ(?O_ z@Q;^DhMvRebN(iu!(;jLuBt}P!lt-3{fAvPl&%{@eq;Oewzlgw{KSW=daC?YJbH@x zc+BQvIE(_z4+MQhVLq07QXm9;_$m;IMmk+StAMK|`OHbb{qvW%y|@-Gb{tjkxx%CpYvzGDIAkvzbW-Plg|d=YDqr*7S8q`<^ADr zoG;7AvqoqcC`r`Rigkspj$?y3l)h?s*BS$#sJyPaNrgmwFLv`JH zzB?S`yT0p~zQxJOvF!s&4mdB$;B(emzS#9BzcnB;u0sU=y}=@tiW@w-YpmSQ8h>-& z+|m*@Gst)p+vMYM>9l;Ua;M@xqEUHoL;jR6=TCdE=@^|XY)E?OsIH$=f)^jZw)fyk zzn)LyUUC$l-ZNmnWNH^Je|*YvYM@9O$B(ep_cDA4u%&!m>96!FKmM36c^@{FcLyqI zi?3xVZ?$}<1^n0z9>)7{FmiMLQN&`oCwg1Xf8%+F-9MrFk${;$^IMnyiM~h~%!?S= z2E8E~?@uo&VO_39wsji5df;nGKh-~Y)u~^+ar}{tL$!wlVe&a#laCDue+NU)Ke41` z`OHokw(OF5hfX)^1@k#y_O<+DxAD@k@6%gqBM}{GSK6o4?*;agu_9nf)<0G1^o^hhe^R% zpmm^L?S(i4v<@@`mGK%-Cz!V{1a-$|q+3AlMC1v&1KK-?$}|Ov?no%Qk=Ud(83LLI z0X+x-b%$`MY_Xhhb{!zHzDV`~44fN8ca4?*f;%r8^`V%*iQ81SD}rU|5Q&n zGBa2Vd!fBOtT6H~Mj})udcU~p({{5SoRj?qr_cGDd=78AJscsYM_A*GctfyiSr1U> z%kmg=hDzNH9^EyDXWfgrZ|rkQr*o{wWAZTh9NsjZ5iR0b?*PvozrHqlb><@a8Pcg= z;1VXE!~YL^Zvx*`(e;ntE<$nTL6N!=Km-&c3PKf^rW9ydD=kn|q@fLMB_uIvOA(Za z2t`~FP!L&)8%0GCM60MEDx#=>xPWW*QNg_|YTf_eGjmTecbX=_=Xu`$^S(dl({u0b zIWzZsb7r}-Pt$lz`;dnw?2|uUzTJVB(NiS*bUbXuiwP-7(^((m(fKTI8joq8D0ue9 zf#>62?ksw*Z#G(<($Ss10?cO|d~X_$X&QcHfq)}dho%e&+{9{@8vy>tj4RpXD*_ljC)lVs?Ov zqbd#@X%+bw-rl#}e%8Y{bUw?Q#$npU#G%GdswcKRuDRg!>uM%6H)jom<45Pm#$l$H z;U1r}a6E5sVM#AFao`#LZo}u!!g`e8(y?81KFed;MZ>cY0lEB3_gd>m$&lf*W9b*3 zP@DN<>I+F!O%RUp=zNwpjVH(Jqum{-U(JVQCtAU*;@TAlt}CZ5-j~+D@MG4?xO6_t z%jb)2uNUgt)QtJ)nM8?4rY8!;e8$7~_;Fb?zKSd5>e#p{pYYaR@zL#l zSufj5=d(P1T-F3ujTdnGs)+;Fvv+*7Z@|5EXRuzzrSn-HKQ8|8J3K{7lvXPEY<{WD z0UkX?D!-3P$^YipM>{>q`Wc_jXSsq;v|D{Xs^M72rxwPcx9`g2?LP*8c!}T3dUZa_ z8|$T>32S>bH6Y*OKp=XG^m~{5`slB_2XwrV-^+S+KFb^HWn;_V9fU_t4-4baf7O#a z|8aipj8Xi4*01wfuIbP62FhGTXt7J}*7i?onS7fAf$1sI?|*nz(!sNvpH#^2XZ<># z<(mE+l>L~87Df<+$I$POLw~38)cd|^R}6fYBIv!!Gi2eIp zjoffdL$@=zxghLB*3$X0^phdzE5deA%bkUB;JEhcK__4N;K<`y566SfXL-o*vY#}s z1fyA`I|$6MC zo*)8p`be7;+b-w7lk>nAFONT!^)Viu&vF${BoJ!6Y>Y#HryCZnSaJW>{rrB`uk%^1 z=$E74auYh;43_kfMIAVB4iG&>Dkt-gO&WA#r&Xooj~wIB`BG|W*O@Z`C^iC(a0C&6 z<6}!4IC96fNMADYs}ETZvx+?c8_9z^o7*6$kP(7$hL#Y6jEX+DQW(|XM2_p^ST&vHdS3Nv#WREFDII36?CMUR>+$btyK`Np^|HjcNizH(h% z+2w;+5984JERTpo(XXb*2j2sKFbw6m_s9`p}EDDw&p;L`FXLFtJU$~SiG?R z!7I~eu$~YOjnDEXaqw3-!gtOVj6E*(S>bJa28@4aI_p6$<-Lp@Lv(#hlH(U+<^t&7&`TH7|t1qV4z1`irMQ)?XN^ozAA6L1`AaSBkHQvSf zCFlCs_Bf*WwG#&>?@3`O94|Vb<-^f;SxQ?9duTgToWV3cH2Vw{J9M~vPOc4u&$bYz+LedNIfXZ6lI>S2jEjDz{`ZgIKJaW0MxnzJ|#^S(VUe`vfU z2;Zzf|AyH5kKfW}-@}idQNl_j4xDeV@mbzje_v0D6N89mI#A2iy>aN@@zAc)pXz$N z#qVeRI-liD>$hWTYIIm?6S#s1$o43iF5m6|kDh|x^_1gT;|-&Dz~*jX8Fv@|QnLG> z@7lRMB!5T3H}lDl>deZaU97%y$w_wV46-0Rv;Mu%Pw!*>7!qu>|J?Ljx?F$wi7yml zcu+Xn*B}u)!7<-thi(>ojOZag_A~(!)({)fsrkZpW9;;BLutvh?vE6VVFje0cB0ey zERUogb20@EvGTz5sHO{JMr<6fJTM}#Zoyr(tcUDIv8MA`9utQhWqU4GPI`((5Y;YK zap0NIb;3irb^cJlC)-8mN5vy%riSM73a_eNQfJ1t%S-e6JobL>w)0sJ+ePQIJTAKo zcDg4z{Vocl;;D%P&ykO}tf-$jt|RMXJUXA{ap4(0G1QJ%@uXG7w$JNdOj}erY8_=U z;TVt3XL($BV4n=C6u>P6aem$&2cCDYK6t|K3)Vd%0^`DXbUw>tP>)h#%^Gh7 zvtrvR@7UxKL+}0WJJ!p%bUw>t<3j$*D0RD0&!sTcAhwfnQ*1ns?mD+ki<7pEqp;){ zkIt7;tY=WagJ!vBDR(Hp_X!kn6)IHYHD92nt2w|&`W&X-WZVw}sp~C31aaedTL>Iv3&PQq`)o+Z zH`aZ);t!7~JviPB<8za*hhv?QaFAaci1gF`yS31-zMp=pn*VZcj*Ty+%}38a@OJT1 z9bXHRk5^h;G<LuLOrku_PXn6~9!s#ti{C>1*K~=-(7gB^r zTx1CBC!z6Kj_LKD00t8fw>}Kl%ISxqa$=>y;wOY;u zZ?l$rn3^W`&q~Wgo%faZdXlbXx1IBHee1GD^N)2t;Gip&%M+3H` z;JuN_ZxF=gj4{WGgVLT}{w}%u;-a+s^Qg)!9Onm}&vLGpXL}00#b}y&(YudEieQtU zN)YR>)bvxPqaUoEOH;Y5>&MUJH+(?Y$dUeJT$wMJ%EjC_+f~F3M{#h8Rd4$3*56Ha zO440`h9aHMQx9Ahlq?_9Y0QS1)NUk4ZAi**%oj}MGP1;37QpZUuPw}*QR7(SApy_-m-^baua`Pd`og$&pT)KhJ!@R4$FuQMRYZRoM?K zbLgY#8tO5-9#kATbFKCyn-Lauec;dO8%O-!>sNCIyu?AFn6E$(kCAauV;^1II0stp zV{09++65fs93Xm%wBL8n+~V&~oP6;3RPqQ%{tm~L`GTojBI7`BL|;#tA7@kz^$@0W zE&X>X=IR#4QH}YgMR;eyyaZ#_m<|7=*DvT;KlG!grY+Lrh4~5u@z@B5$m(<=HY1QB zYVd<7z5S==5g!LNGy$3hT*-#C?;`DIN&{UsPx?PP*P8np4~d zlm!|L8V1S-(b?RTX=qTH8X}WH(?Pd@7J!z69tPEdUIOg|eG1wSO2Y4^`Nf?<7lMX? zXd3M_&=L^MG2RXO1#}9Go&mZFbO-1K5FHHG840%lv>5aO$c98*3VITBI10u>&?ZnP zbaKuEHAlg51E@I)k2^qJQFy%pnvBx22j(3A40;WP`>LZ1V<|coC>@{(nF_d;^fD)o z^m0tas;~cC`#?rI@ROt4MYu9wFqKQA^fK6487axA`8f4X`ErN({z&Un?)~AZ3%=jE zbcYE;;GlfWdBnY zKD=8T@7v$UU5<~UKVTn#b$v3$U;9MSH|r`Q3o(q!Z*-0X`V+CBjscC$WWzfo?G4IS^G^2Ov_bL5YZ1Kj;8xCh}P~BF>o6C-bN)P6Wm%Tf zKQ5#EnrrMhXv60kR_+P(bGqGQF=2^(tNA617B9d#K=c%8-;WH;v0cNVfA==lCKyxR-Oy!z#oWyuT1idqaHIMR z^I1RNMNfaGs}NO5zdZ+IXv0hUkE_I7L2vH(jMB0RPM`D{#EtVs&LXQliXfx((g33M zd?{@}}t1+%X;$S|!THJ_I*Fc@NIvOY3{)fx`#YkX~{&e00bT%$MBoRqB`O`XC)- zqWxY%;XtI9+RJ;Pm(Q!2aQQbqNw?b1QF*r&7bQs~cT0IzzwT#8r?*m%r?BMcPNA4D zn979~AhnKb<4We8E&MP2h3i03Gb!Kq;I` zIthpJu9|Mrmd5@rSEOCn;^HIz(P%ujDZV)#+t*Wp9y{85Lu{&)0Sx6nYIQL5g?Qk6 zz8yHoIY9Ijsh;xVTh7nd9Crt8zbhQwX}=5Ro9xg{=5upeo}JdvV&e@u@x^R#pv>vx zb&G8Z#8IIfFo*}nm9xy6eyIGTACQx77-gd__@#Dxg35}adshruE{Ke`!f2Z29bh|}D-kqrPS+0%$deG18qOW9z zw~`L%#StsQO1zBCf+rv4Ejh-cf0umKIKS-SiSO-r>#@aeEuxwS>gd2j_F%qXDi5%p%(BGM{&fMdVJlWA1? z6T<%oE?M}Edi=bH-nf1uUB+(!wS1^Yx+8l!Ky=s3@vMo-#vkX5U7m3Foh!{LNCs8f zDcvz2|5{u;=llh*-$KA;J%>4nw{ZF3yO+>}aq0PiWcC}Lt(e+#!d;Zk$We$ExH4Zb zl?%5U_&hRf8fmh`)H5RpzpOw1KC6CO*Gg%<9=J|C^@8^F+GgpO*7o|T{5^UmCqtm- ztnsDPFxW2WZWHCA+cOxdHmbs=vqjRU8XpaD;CS-K4$Xd>Jq0l&9os?Y zvz+6@n*LFbDwIbwvp*F_a7Ao;)V_TELz`#ac7Ve(4xP{PCUAJMs=KnR-09{V8AJe1 z7Y20}!Z|?n6e(Tg-7@-tAy0fqpGM&rht6ktWE>e@@AwH$KU&a1cx3&-IP`CMvssl4kznY2mNO1kF29co zD$}D{kFSXX#}y+p+nqdU@Dr?uap-)ON5(-rp}5V&X~m@GlWyiL$!K<2ynmx(+efEe z#`+kK&S!aKJSLQW=zg0deX2NWyl{*|=d(OAj(*tVAA5`8v}Bx2 zT0(w#-a12H2gh9%iCXOABppk9RciiJlIK_lLyd_ zfk)QA3;M}9K=c%;9_gF*#NrLM{+r1kIo7Z9r8KNx*#;9m;FMbJvTY{^kR6dn7i#TbBQ3b6on<#i=F$3PIy=%s1Jg8^=>De7WdPL05jCa&uoDYUi=t zwmfRZMfv+&$oB&8{Hym-^Uf&!^tr>II{nmadM3wq)A>>wwi~)FggwY&B&!3F-lpok zT*h&`F$MmqoyhG@swYxqi0Z`L4^I{J&Y-hFR1l|w27>ZI#UT2vH-qj2Z3NYUn&AhW z3vz*$gZ6;VN85@vRBM64bT+61z`PB*ABFBh09uRs^&bEfMB}#)>e<6kaeb<#{4Su0 z)M)%FXLaoSkhpm5=Rci#?Wcew+?nQ8=bK_Bwv|bT`kj>K z4%HFvzumvz0@W}qr4#O#>RTZ5KeAq^pNO;~n?`kiRZj7$#;y9l`W);1QNjH$7OM5J zv~|{Uh016YinP&P4jP;-bCd%IkI62uFMxqFHSERTgp0>xM$bugH-95I59 zepierjB=I9br?lrrsg1LxkuKTto4GbC!*Uir$>@;OFx39=r6n0t2j>mGVC!A?&^MYK z<6^$#hObTI!n{DS@gMrEEwS&wC~vWcPi9iTBddXroC8Epk;XetdUa~vD}6{J9pR^6 zq4TBGForlQN{hw!3oBM==zC--_8TsvBuFy{%lzeqSP*Y*FQ;J~nOrm+FZSJg@T4{! zx3V7j%}F+NKFb^7paG9YD6BXNo{o)U$@sL7|15m!57xuqd7aPlMmYNUojANmH%FuI zDu<8vPROZ@pt=d!2GuW-)})=nWwQK*5dQ5B$pSX`rhHA~@>Fp=wrVn9(esId1r%??JZ&M<-? zE{EpCz|;BJ1S9*1p0BH*!0a5wLe8E&Mgoj3R<);0)WiFo;LJ)pgf6HgA z_R!0j{EZ35^c#ZnTb+OOYptYLF@8Y$nXjl8k5>Ks%R|S;Tl!xXYWnr~Xm~!s_+;3! zW{>xuKc9a;jbD&{=114Bog1&jgPJZnzht$8j)QcZv+1ptch9QN>19@sD1;5^g87kf z@PRQ=&W#Tt($9^h_fxq+H~w-&U4Un&SE#@hD%Bi?12 zp{g9g<8pr`Ok6KML{I-MI1Ul^-`@X+ETFdk>NZ>3r_?7*^Rri@p5ngz?aOVDU$tY{ zJ$=8tefpbb!lKG0)r**~!_M}g)1e5Byeya7M~lU9R-7Hj6wyp$v2T(Yz=u1PtB2Z; zP4lL>pM>UiQ2UGev|EB`rWf^Xqx)UdAL;i1s_0kVh-bANAAtYKspYifM8Ddii~nO% zHQq{Iw#FOv?NJ@B0EHQ?Gb0cO&%61}pIg^mL(k-7^d&UnOQ~Vx`Dy(^(FkX`yA11M z-RMII9iApvsLOuw8UzT{>$k-2pP%^Ia|7+;D#|Q(<$2KuQ!Y9l#H&=CwQ=B_y#J57efh73 z<|8mpogXJoM|n|cTsT+bg>27~S7O`qz=D_WAMxjFq4_k7Q|HHt6MK4LeX)69gzUD7 zW>v#-j&aLZW8-~f_0m@!`z7&X#>04ZKFedoe}5My%gS!TsL^lfhg%&7&bQXP+%M;i zzngK$e!?RSozHTmU&ri{lT&(;hX5>-$1>@_7Az>pE5U@;60f^RtQtkPt7Tj>Yio2n z7GUAn5AOuV^d07EN97+m!bjyW^9576M8k*K66Nk9nz&A*z!@$~b#)CFyJuN()y2R? z>Lzu$YxeuUbqLKDkagnZMtp|WbpNI7ofiG7eKFSxh8$Xk^Rq>NtF=F);5BRcM|C~Y ztF8;}F!PSXTU;@3{~4xYx?`1w!F-b)x`hrM4A^Os7p>%?4vo;HOSSyn3;pCAAbKhS zQJgk__<4}SJif)Li4w6~YengX`S5OWO1cqetYQnXa=#x%usN1MsT?QWh@NcaJ&WYTqx2{3KqciF8JZ0jZ2ytD?V@g-p8lEv38mnaTKp)7v}4DsN*j?;FTNv zo4Z$0$DoV$&#J_NVsiokjpcLtsRj;uJ>#G}q>fLJj&IlXE*t&RI668HQkZYD zL$_>?uN<>Ry`^;Q3oTX;AetZzf>^H&>lIYJk@D}H((b2^{bXyVu9x{Ch2}#ey*L*V zGXu@pKGt%rerNQ2L$Cbc?l!jb>wabRBA?MO*ZGXYx_*FaD74U19>yD>WtOfYN+h|H zkX|P+AAvChBRp*;x_1wwuzPDJH*vx2-s+u10Ou%5x0k-Jzcp;L&hg z{O91czdR(`X!Jkh(D@`Ihke0Z*l-0yr*;KL_z~+yX_(a$-X>XA7OD}J%iGm);JVVW z|BG#Rc9~5&$uTaSFQrZ4f@!d0Bia%85aUc|EFfqK-$J~I@nyXe+ink(WZX5P*`I4z zKjYK+EN{|oG!EPpC@i8l8na|t+{u&W8;EcQy1BTa4=ti zARg89Yc&J*TrTy9j71)+L0sOYW0ya&2**pLdbgwJvcV{#AG4SY<_o5B z!MrZC(r8nKaI+D;W+ArOd>iH}54ao^&QiB?Y$+xWgzCp?e5HI~#ixHyw*dcXQ#aha z>E!&KRJSKbcd`@n1yi|L_IDhXC$|Gw2JM$2m}7PX%D<82fNLR5(PXFPwV67JfKaP&0<(d>@-;w$4 zJ1$x8V;r3Bn6F}>=lF0~(;$WG3{vfTCjOV`NE&uocvSrn9-0$DF4QQJ|3q?H}u(UYF85iFbe7WUCXgK82fQv_9Lys_RR3+x(%7b45mVUIoG4R+*l8sjP z*35ByHTeV`5AzuZ-{ZoQiz$;5kmY;s`!sq#PQj)WBWLkP7tAPKaTc}1$kBI{%6H}q zrgBm6VApf#6&=>7)$rU}({B)WPVetCy}x{M%bJN?hH^YHUx6SV8{rTg ze3(E>ds4thm7>4$pV9451v?yePQ~u8UpV7r-44t@B>l=~C8*$Nh=HRP>7(V#KeoF6 zqmtIT9he^#2bLA$WLL8)BYmoN2!0mb4kg%hZ~eLN+%Jv}-Wp0Dd?{vqnOV~f&ol0{&(9J759-5z^; zCmHYFUGF)2^6Z08nLRX|PnmzHcr2A~1XlYSYGdH3x+uxG=gR4q7H>cORUHrW|1uuU zQmUP@Xb~Np14K`Hy6JpLl5y1ZO{?dxZ*^pi4Ibbq9aDM6e8E&M;YbnVS$ev$QxT_T zsA`1ebi6kPo-OG~#;(?07jV4MGqq!R91f4h@qhky z%kPe@?dX{t;h?L|7i?Sb!&=oSACz&D|-JpNY-1z z-#_Ndw}!8Z-dwaNW$_Ybit3A+x72*q@~h~0NXwkD&tB8xt8Jn6+!qVg7dPTFq9)oo za_w*!SC-RLq0r*6L4id=l|q9D-=Id)!*In8|&|m)KBPaGtl`&*40x8BRT%v zI$uhg_}$_RKC0He(wf;xzwN7 zh|h9mXR^Ug4-$jl4k*L0J58Xp44cTKf&`9PLl8_cOc5Gq{7O50SfQCy~iP5{w( zI!&sgy__jeq3L3@19bpV)rT5@T|m?iaTbWypkug1?A6o@_X|K5fzm;JK>a}jK|?{* zM>i651;_~+2O1B$8Z;4fEoeGuHfSzr5$GP!gCOegdo(5=nK$((4U|q5p^em zx`56HWrHpQxj|Dw*m7HJb3^;iVtB>)4wQn(>i|jzT?x7lv<$QfvzJ6#APGWo^mfENm(!7t5NRFHgv}9YFCo%0k<32pVHhhA zX}2NLmLk&LNr&w+5gw6t(?G+Rf=Ig;k(QW`bGZ;{ey3r~8i(I79_<-K+C)U!Iz(Fk z>DaG#Hs&%S(oR97opBGsA<}L|q}3zRwrvKM9mq!?z(#uvWBmb&Z=9uZ6!xD#DZzN- zj09u+1=wS10M=<;kznL`u&@91D0AH}^S2UVE~%j#1Sj87BK?2_hgX=Q0?Y?F)H9ITy~Uxrhq*L@xb-f z%KcWmAZs<67k2B_D~FGN=3=B&=_HdBw1csj7oS1e%|;&V3~r$piAV@A zmDG>zgHcQJ`39Aacey8JdoaT2D)z&WMdF>R{jv^P?MFUPtc2#(ZTutA$UgYqh?Y03 ze>TlTRE#^NYv!Bm&@GIY#zIVJa##ejr7Bzlykjpdca^&a;UGEMfLX<}OT!Z>KIg0- zbeX;P_iR2x;z~1gJ_Cvu59+b>6}RNGf*-8*iG*iY+Y=mb?OcwMSvpQ%I-li{>ep)e z;&HSf0&uzt{$$0W$5S0}{y6lv_H)-9yRI|Jd2&NgKv6s~Uvk4&xgYItN;w$4!^ADQ zH8y9nM(d-uBIv334t79-CjBRaf}kTn_)LmA2B9QF5Yfg>^gn`#JV*I}=yDJ~d&YcF zR}ke9)yZEfIV4m6XMe#vGK|AzN^pZ8t&hackblolvO=zNy* z{y6=xKW0GgS>-Cq_Jp&u=`n~q<4F10`aPm_s(%-IFLHn7TGf0crAu;jPr#M=f~j2i zdlYVaT0e?v`Lz)G$vHsu6sf$p_MMlGdS&2;g>9u*;qPQznNQ(W$MIm^&GKDLTfvt= z&I>k~BA6O4wqLAx^m2m&w4XhGNMg$tB{DuFZrYEJ`6?EA#;FQLbk?OEgBP?9yKIQz zL}L>m`w!xQxyB&3 zypRfa5kyTFX}?+R5h*@CdbI7p?PngfNw){{83*6PctSJ5#H3`qJdA}5Ls`+%kGERG zkqr4^Aa%dUOB>!9+@sr)fSx{?Pw!NnnGEfDumg^Drgcj~tp5JGKdkXV=NMC*r2U>? z-0_{gf&z?gJMk9h3*TLK0vQL6LUhEH`GTojSg)BElJI*_Z~X3gpr1h=82<;*?TDbhh@jTUK!+g%otT0)I@-Zo(FQIDI49~H zcL7}IV}S|n+Z)lYEk6Yc+T*OKPB@!w zMV*q3tF|T^&sH5~WEM6vf@7K+_f1PNR=?T8xP8PCM!(~aG7dlK7~=--KaAho9%rn) zppCJ2+lj_K`%g6)pl3T5z^F&l*)G(GCp)HkTg-f5ISe4iG&>I`{gSc?a(< z{(AKkvkPDNI~G^wQ+U;B=|vv=VV0@nZy|{FH^iZT{M=1tC!Ia!T$$P>&ZD89`KoSu zX8kl;Pl=PJ+EQU5Cq!a(pLPl+hgZwBDzo+$%`PdI=KtQ!|I3?{9?6mY=sa-d3#M{u zgi8m4AvnxOn1Ed?8|?$!G69JdE*hR6)|OoLc;%71DW8xdJV)Tle8E&MjK|E^cEw&| z$tIs|q1vT70uH@=aqioCPUZUxI~5QBIJ&jRmHC3HTo?x$RrJf1@&zXwW#i1qL0+>3 zBLmgo#_1<3(Q21S^^#+neg9MDU3Eq1z7dXYrvMN0B{zKSgPovDUGhX%EH^Hjgzq1n z?_(abA?G)kb1=}ef@7~RO$37mgK+KyyiyS*oSM$-;=sA7-`?Zit~=%>`HQ68XnhRx z`MrFPjFV&2TyljLDV+hxeaaM8#Z{RU+kQ!zo!(vZ>>D$5`!S#K@I5-N!Pu`#!Ghr~X*K*21=nf7#eBxYcTWHOeMKHX!pCweO8cQ?hYzlq3oPmX zFsq&PabD8#M5nTjH}rijn5N)49(b6~IQX86spQz8ex%n=0|2?`mZ9a+!(7F5Rx9l| zEIHV3R2=gXLMSqZ7%-4opc*gae7YAnNxcI^cWOhUE7(YHKs$Nj#DjP=_MNchqsOnA zj9yylB;15Xe3r{~TA8KA$e7mvDUJ`!^OhHuh{{>OtTeldGA7BDQaCd&bkvl1MG#lU zSJT3ZkE}}dGPNH6^|`Ijzi7tLB@&nX9aP(7KD=9;0E4OMWXv3-dRk|$La4@zNWVG{ zo!(7^s)*=&ARP2RVL8IQqpA{eB>UU_XDkpYehyWW8lR|6int^m#Vf@l#jDK0cz{#m zQ+<}waCnx{ouBpaY8Zb0zjUw0kKz2Ab-1*m13a>az7EzH(9CGLYTvE*e^tGEiWn^q z&v#)yf>~UI@lo{Fh#f`gt2#;4EeE?Mc>R+GV-HkhZ`xl1l}+>XEwx>?UBlO?o^o}f zamKug-F=f+cJEFNcsLr1p?*&03#M`zoZ~=WIYwGa-8_*^cAB6p6lbVSlAeROv7K@- zMn#V8q~oYtf3)%Ny!sb5Pha(b-%MB(f^aZjyg<41&lzq9nYC;QA=D^@Kh+Mqpr2mL z`l;PVzmv}u_Z^pLta$LA3D+e&HWb5#!ciU}{meJnp__T0w)xqz_s4PfWx1%2jrCT_ z-Zj&w`W-JhGEw9|!qJoqK0To2%EaJv(@JySCO_1-LhgE#FaHZ))rc^=udsu|@G`MD z!n6+U%grHdc%XQpeIToVhxLtl@cbEMBh_v#kFv%a)w$^_i_d3hpMWz9Puq0M!0qB& z3bt9UBpN!OWaN11Fpedov3{f>S~Z0OTT%NDP?guLG}_>oadra^-mh|q?ezjerP{US zG1mA+(^#w%*y1#d_iWonZ$$V(Q%Cpj(#${Ta{7^Q$AKt*nJ<{irD>eQv4^i%o72}L zHebgg9k?94m+x$1{_|E*3UTPPI zDv!u?Dvp{saD1FF^W8rOKQhxVA&Y!@GOo;5G0=04GZ3J2m3dMQ|4*o}QxV#svUIJ6 zUoO|P{$b5`RJWiyB=LSmzF;aB)*BHA9e;^QeRP~F zop*r&b}R#Pqmfcv>IsMw5iI-r)W^VA2Yk~%8FWj-iEBsc_?WLi6OYmH(Q!)Io;YAy z+QU_?tm#T`PvyIkjn{5C{HM=q#?HExD&%lvYqBHr1yi}`I3t=&ZV^+8!j~dggjU)4n$z9J7`WP%2u(IOZh-)e&0Cn(YzCfYM$bT3lD+iRS>(o$6$i?s=aiTXu8fjT>LQ{jkS+=TJL` z9Ayv67t9w-%z$uee%Ri|8n61f zCEbosG#;%vyTuRlE5;CBaukB_Fkdj0OGG@F51Z?Bmjx`V+07HaGmsWhr`I<_v8Oh7EtS_1*z6_tbZp7;aVA13GPM^U#0;Er zj+AT9pjk*j0ksf-cyruR#)g1PUXY`IP--9h2WO5Tu$>~|_~N_g_e}nA ze_z(aICMVCLpU6zrux2~GV~>yz2(?yG=SrBanzZppjykH)p6jN{!{;95BGddjJc6c z#-sBO84tB|aTwk-!}s8l${rSn-HubtSxT2AkZ1JBH( zpIY(ES+9T0;Tez4XL&3t}pApXG;!&x&VZ9C$AJV`1km zFZ|qv^)Viu&+=G!Mz~5!3o&ok%zl>df45U(+voDr%Z}dl&YO?0KE|W-SspJQJ>t~z zvNjG}1Ma(V^N_Jetz^B7OXssZPFxoICYhc`O`5M3vX+ z&KAXZDB3Lfu09T2GoIc5<@L*RA7H(VOXsuv5OL|zXDL5}w%B%i`>qwO_HF6hoAon3 zozL<^!)Gn0Z0%y>xohUtUF)9M{1xkCJUXA{vG5G^VAU7;1S_y4$uHM~g(DL$sR400 zx+M;L!&fc4$DLdps>d@vo&T@kYZR$?nfe_nXdl~-xyOBQ!+@i{+{`!_r_N{jU$CPH zs^V&h1J|11#0gg}SvQ&WGA^CZ@>sZrxr+Rl4$~-RtMLMk*M+qB2+jc_eUZM8&(yv6 z{44ukUq$}NF)p1irFfUwPh@YRzGcPLI7ZcaPUq8N<2&DTUF%m9JT$x@9OKjZEI%ZC z2&Bg2#yIdyU$UgnfK6wVus+74^I0AXPd|5QaY-5V)%z>t*t`5vR^tU6j|ClL+bO$O z;+zZbd;N9R%eZtt%MTrwH7-@VHN=7Mi^;xKr`E1()c(==e;J<{Q2mYvv5t$J14Q=F z`xi*|`S**TJhk;jjpi%peDX^!WH-^lMniVAEJ+Nq*ax|aorUIjotn;Dc8ZPT!uefZ zI^6i`X{jZg4|P7vqv0?YCdqkdW&jmWbsTtRY^&|Dyk8M!N=nD+N$0aX4m?A=o-iae zo;r7qZJ*0lK9pRt=92}ikMZbymdAl73$yer;{dDUz%g<|x83(GdtP%^pXD)e(4-%y8=aZ-xizyp zrmU;^sb0f{?!-ppx@DVHkA-oknrm(FK-G+d&8+Kp*kv`tfmi{i})A|QV+d}mti z6zRMFR93qdXHUO8kM%JgozHR&52oQ3m6lOYk2$`qrk92|^f$k1&wHI`B%8A&!sVUL zk57NNYOAJ~IbCDhq4U6(H)cP-r%^ja=N}3VJ4Mit(!%i`iW%vuapU;uc2;a$yDx6B z{pEXY*=F!i{?_>{j~+kLJ_1*^2R)gkqID-LkMa#_{ME*R?}kwq9X_e|4vZK}$LUAs zvpfbqS-F5`HU4t!vF$Xeq5C~2e7detyF}+75{?KFSdABO{ME;S>zI4q^?&5EW5s}U zY#*J^^0@3HaE&PS<6s*%<-NhKGG~!f%)C|YR&{o4yIr>8z>G*)MO`ju!AM-$N;2(w2z^uK~k{eE;iC$?Ss_{Qyg?|~2x4)W=#Fq>4u+lQh5(bf@2s23NHzUtoogN6fjA)@m#lq;@o=+q#fbeg zgO_I%Z$2XJ()kd;5f0MNe8E&MgIwqd$;_~0xdxqoF#*fHFzXLnrMT&i*?(9-Y0oXe z%0a5rmw7WYWMDO(cEy3~vW2%gTK{^*Hz_S;c*ezi1(JA-3zw45RXio#W2c*T!@f&e zS9N+V>y`19VCa07hgQesdA;tjPXAzU5jKD@XSJK#>L|(BQctXp1CQ^jOB$ApKY1tX zV>~*a6<4JBPSfAL`-MKw-@NNAX&8~NX*~qKB(KK_0AruRqf9A#&{9A7%0ms^o+ePVwEG-IyS%m)Z0&*(s+@5NtPCrSl4&lx@%&&PnMxTHpPE6}l^<3O~26w5TD z?jOZ#P;Btm4%8k*iQ+U+N6_gYp1;}!&u4(BazO(oXMreTpAG5;ItN5H#q^S?YI@uP zyOVQ(D1IZQ$G2N2w%OnO%NNKWIZg*UUrM9fo$?86jcEwhc4q$hvEx7an`@tXu{w7R z>tP%^pXG7HzkkiDVXMK!E=d(N-9nNjh~VWV&k~z zyN8~9`P`2)SP$dS`7DoxgY$xlqdpEC?drD-shnFv$xS%Mq4QZD3r8+i#nKTAa}a>* zZ$T`MruRBPbdOX{eDM73r#-tccsazvF%F&2@@P2Bassi#Xsq>q1od z7&GwT*#@HYLGuK=0SD{pHFGj8r?=Rv7IJb9kg&tdc}dh(%gMw32p=A?x#5yT!~0~0 zxA^NP-WMMo$S4HO%VR$NwK%Fjp~->mAF#XzPc9!-O3WI!Qe{%@m42}mhhAUmj6K>i zA9c>z`rwc6&^Lq}<6yqzhOZh9QQhhCrDl9^~c=05YK+ef;0 z>-J!N7=e7U;;`;oAE_Rx)&ojle{xO556M>4-E`K|c|-bjN}~T{Jhn${GGB7T*NF97 zIxsMs4({_f-I1fqQtmYLx8l;{i?p4zSZEQaV@Hjqtmgx{Ea4l<;r<-xl~kY=LSdel@>D`l)*U(EpDV=5OA=#{z$sXa62M z{{5E!H!Psm+p4l+_hX;aeAo8_emXTY5F*RA1ViVu^~9QNI_^Up!8tsD+K1ekLKXBu z9aq%4t?jbZ?AUmgRgHc+f92~hav4i^>epsI5J+R?Ziu!C6~GA%i04N+GGGaqt~I>iw~ss}JihG54^D z|0S3i{?a1sK{B|sSRQ?ZNl)c&(fNnK)F4*BLp0%w`iO`kxoR-UKdo;F4zT_Xs`3&} zUe|<2WBP@Qe*doib(}OU9ov=pCOdTN@AA66GMeo&f)$QD1s;21@rFX!Wne;SfR1IQ zHcmO35Y>1S(sq;$D~(=0gr`UrBHB7eq|tNEZ7a(bu3lpTgUwY$~xf)7qQqs^WVJ!0$$ zBH^E|I-g|ZEWf{>OKkL)hf_Obq7T?HM~i0W(y>A3VlWV7J}*}DQFpkd|G6#>Jg@I@;LAe zbJCVYrPqium&2+31SLaa+bN^-NADlFZeXMM)A{`VSh%oHaxt2lmVT4^IB;}5@aOmm z`>voaDB;*XI-lin;lSHedsGgMZI3%{y6DYmFRpJPTkJC3P$=fJe!j{N01x2;otv4 z1i4L-zZ^lHuE@7WkQXTOZ4u-_MNSng{28i!sulTL5#$>cIh~!Nhp$uQbObxe)q1`! z&syG5U538lyl(~`jq-NE-B-Rcyj*B+cfAMGcV+kucsF9jF5-dtI#_Ewpy}br$)*}(Dk6~L;s4?|e0Ti59w6H4ttY4# zC=GNz=mJo0(1jq%)HD&57SX1I9H0zPA5bQ!FQ^}=KPU@Cjr{?jfuKR4!Jr|ap`aYl zrJ!M;To8u5jNzaWppl?_&?wMlAR0Wq0yG+QC1?z&0OSOX1r>sdKrYZY5VEU0e+~Dm zK;uDFhnxVyP`}{?`9N2L{2+>7Y9FIoWmJGBf+(F)CFdH@WY84QwV>-jQ$az{^`L2> z8$i=RH-ct>W`d}mI16+WXg26(&@G@_LAQbCfNlrP16SM%d5Of!45$JBv zV$c%MQqVF`HE22L9?-p@`#|@D9ssQX)qqxl9t1rEdKk0{^a$ut&}z_Qpf#YipvOV$ zKu>_41l59`0zC~{4|)dlEa*AV2GB;(^Po+j7eFt9UIJ|fy$sp{dIj_l&}e|8jqqnE1~9FUR@66<+KAt-$}r{kH}F zw!r_W1*)Nq+l#emr;u}iP;F?m-}0P{WaIUU38}9IUODWC!^o#R%Z1vD%$MBo)!I%` zc3;NYCDCR%7hA=-Cfadc@)$H>#td&tJT`X%GbDYD|z=iR1WkZg3B`{@;( zf4-yJjOOwU^o=2W%;)#=Jtn>;kg2%#0vFkf?S`tB(E?PD!(m@N;s&ZN8rSbTdv~i{ zzkWtCa&*V3A|bwDDi=Oa3>)%`Z9~z(7t4k+CdqRYX?PE#O-^y{rE;2;ifflEI<6q( z`S-TU{^>x{vnQFlo8eCOV!i@NJjR7fp2n%5lID(FSo9xg{`@Ny1E~=gP#-aDKV{Y2`iDxu5F@z(% z^viX=VB-==uiYFsD$2#yitg7ERN!09Np=}m~$gk+W2QlY+Px#&)OL{ck79)mvQNQmPf=DvX?l3G%CI-yol3L zO&s`o&L5nY`24|pD8G;+e9drWzF;bsi1@^sI~-YyZFkwLilbX;Y&%V#(D}eOkBoho z%N4?r0vyce_wqd=4s2)W^ZLr&H2P?Iq;@~sV`CgRK0bHW<2UzceID!K_|o|-kBCD( zC|0DQ&}uKsxMTiRvF%b)xnTX`S3eLisJN=e$F|q$lYdzA+_44JeIgv=()lbuBwTbD zr5RAgWpl^Ib#;q5ojLj7#UUJR+{#^05JI0$EN&*jm}i&{SNtao{??+0NbD zmY+G7^)fD<&+>@4kiKF;tHBF69~MlAZLjWA4laJDX#Gak%eZtt%Om3AL@!q4k%fk0 z??uekacRa=(wmAi#SVgxFaq4`QN5rY*&v>D#6c{eA^~vE#X8>YmF7m94v5k7wr7J5?7mp6&gdZY-GQFMAMyIUiU1W6%40 zZrSty__2D&TA44nj+|gHU&TVt<|1|ba33~+aGBHl?BRvt)n!s1=RG~Enscu>igR_3`jC&B=)%KmhaOqFqdqL@oj3iF+cQT z^I@>}Dlb;@wmfAhG9ndEPFZyOqzy?j9LMf{vTnz z;4$r_*r%VnJW!%6o41rNbusYl8k%J6+xXD%BQH+KFt^eP;bDGMJdy09AyVrvmE~6Z z=xOu*@I|g+GBZwDpIa~!i^z$7c(nHUrSKX)mgW!&>)3>MBgDo8SBi}k- zuyL{Cp=r+YK}H{*;Nk=5<|CNJS@p+^4|&{1kvvb4UZm#pw944=v+bsW zeQQcP(6F&^Y#*J^aw|S9ej1^%&R^UJJmlD3k>cyUyKeh@nyo7jaS6MUb#;DZJZgMd z!K_9AjyK<=*zxvNb?>5*nK$>)OpYK+?M2|O#j27xhkUaQi}Ekm{=hTHz=r8rr5+u<-9Xi(xFHzg&)z`+3ug5!{a_96; zi`vq+fE?WuaAm$=Di{6SB>rDrdKBe6F*`3rQp>lT>tf?PqvX|l2iRVFLdVH`1)_Ll zTrvat#W^4}up)6bK7T6m@n<2p7P~e8FFDQ!dVRg~)yc-FGuq91y4CB`XxTJUx6qdqvMR*t_)Yq z=cD|@?Nl{>b=~U!Y53=_gsV2g(R|rj*oQ2{@kq~ldG>yfZ$BzO{G*_Xi}DBa5yax6 z+ee8%0XjV^mLZ8`$*&U zl39n9bW5+L`F!L!KQLc%!`J9Io3vvnU8&_@D%LTQ<9OEdYt4H{8r|={rNht*-$~K& zF+YqS4`dA>OP($2SbKB2>{j%hsZMfU`Zd@-N= zsE)qi5!a*k_4~bk96;|Z8s;iQK^%~wxE;&+pSbcH8NRFUXPL_5=V&ta6Ysq!k)aZ&IeciHk0tE@)||%8Z-9|lJoDU@+ker*z2VhtSY#-!%E)} z{;hmpX!7w&i^HNQaRMK9x9sEcmz9pAwaap$F!rmLdty?*hg`RcBd3SC#40Kq-a@~h zepdl-sd{zX4UoqwM<4uke{& z%#4j=LC?82&hPyIE#DH3?ZbSN9lAxvLG3f@{s@G?s5s`tf#Zb-E}8d9`|Imik;Ic= z=zNx2_QArz*nPa-@ujX%jg*H!Ea|*+Rcw1Key?x)qLJHzx;>cB`uWcGpmTna=4rVx zcZzeBTCF#S?4#ztjd9?5ZQ-Ks&6cg1qT^ydcEy8Z_MO*$`1J#g^3w*B&-(cu1xK!{nED*(%+*kI zS<;d3rr36QEbZlKJ081}mJJF=cd<{g$v4@d8{@H#t8fy^aiVGF=2lr4m9-pCnH?L~ ztg}z-dD)16X6U$>9|B}PFs=ycn~sWfy3LKU`glF#N{hqDEcqX}$T>iySMMh#+4Bj< zyju9$N*g_sll=@yjrdZEH8HNSP)S8|VCYyhPBCzdk34l6(=fy@nnz<8Uo0}aT>rFoE=lk%1gY9O%$NFHe&*v(#)7&|H%up(o z7&dt1?^!qK=l4&mSvsZ{WR<3z@YO(0_6gYu&om){_r<`Y@p9g`w-&bheHG)Pdje20 zpZusU0zM&D^H?)#Ul8H?T{N;t1#U+BMc32HOvFuP#++jd|;$=rk9CH8F1nk1fe8$0dvV+_{ zBf#+_L^fPGezrp|$ItDrJ$BLYkg0YmxYcSWyii^gfN}}qPf1OfZBrEgF1pbgU$rmLG&AYf-V5jKt?7g8#EL&9CQV!5JZy}%RtwH zW`gE|mVzDvJq03r!4y+*GlC#akH*~Sc1_JqG9G+lYR6^A?wLdFEOL~8$ga#6Oyy#+ ztDJw#rWL-_c&&_~zcw$)C_LtfCuhIfwoH##<}0ejqeVaBmA=a)2!i-`H)wjv1KGL( z#Qno(Uf2D_ryj7k0!ui~hdQ6-&};6mL|wt+k&~8yPz8^yKRC~7_elCT1-{+!Y~A~x z^7~o8&S$w*e@-dp7tkh877XM!2x1(@{Mb11FaPkg<6d}YB!wl%ICQ?0VqLD9ud+SD z5K1&yz87=i(7(6iklE)>+(}gp;aI=UXSvl5eaZu6-U-;^zNm4G$PjA0q}~zR9&P6D zoABYKIg|y3V>~*aCtd_d` z_$-)Qm)O*Hu(QPvm)}IoOAqPSO`x?V;;mI4a3F{imhFR($+Zb6r34`MrE^N*Xx zX_qG%wuJ-ENjmna4mu9zvwpsZbioecSW~PYC)3m$yLT%tL9ucOUD)BA3Cn6F{s9$ZBcZ5waz5t z$Z2m(JgW1Qsv)OIAjjcG`HT4)Jfq3@%S8q^Qxt_!>!YcoD~6{@u~-(@>OTT)BEz_or45IZ?;O{J(@NN(`#y_1+lx7LH3Y&IuZC z&FlZjlAt-!_6Pu?_+$QG!l&fLYP^8$Rkb*}z0yjOjE5h)_`&&(Q(o8cF#lh}(>O*~ zEBMluM8~(QG|9N*%Kpb}TJC#U$H)AC5nq&;m2Xz_=f)U#E61Z;JLdcOsTHg1UZ)B> z9Mumfewiqi7nZGo;-BKqc8E-lEec$%^t4HcMn6E$( zkMZDW9Glj5c0&wYwVov7l#gxgr|g}0o{o$8e+gHVSXARLxXjvrlMH3lzEbC3p8w55 z7foFGRtSboJlPDL&mI)J^>zB)lVo3?s6Ns3(AfV>ad}{hq6%DXp^{Xcmb7TG~TuyxVZmo;ycf^ zr97p|>lOJA!_MzWaav=Br~b=@%VXPnLyGgaTP|Dh34#gN)x7F_Q*5AZW$thru=lO> zVLwjlN_4vIVwEz+4b7oNbTkHVw4d1e6&;M_m}`#Kd3k8>PBnen?um`_=7fr^10I}r zBjb?OfYS_}&+^c@hyBXM)OYmQqbcMFi1pLqQ)?~l!_{%%_;c15$8EcPMn~4eICMVC zqvAk~*Hh$ldp)i`71Xf;r`jd$-q?0IZ}vMK=G;1(x?Y51JUXA{QSq3k86v#7SE^I4vS`4TwQ6h(25{QRN*^YZh_IOQ0hFLIHeAc*x> z$D#kZK?CQ%?Y#L%`WBI+djhV^7fj{C`g2RX^wH_1D zL_fHiFH%=V|DD0f$;R;DC8zhh%I<7${uWM$%vXM*cx?K2W|oc{=knttO&LYhsVRVp zrv`Xpl^b22X}fP{|B;JXFXvO8&+(3^vP-%dCSSa zFJpZ&Jsxl9e3r+;!-i3D)B;BWUclw)VR)vwUzYvg#}=HuXl{^(J%nQ%2Q@y+BjG@I z1kJQpmkC?qC+nfuIIdVW;e=&V@-AaN96vgr9R1{0c+*t z<}4ebf^ny>ijKPqxUU+$;k3k$Qv2(6V}2O1eEN&HM_^IEw~y0TR_=G&H(O6C`aBL~VC=ew1=ixO~yaIZ~^V zjUBl)-{h8_R9ip=5u6P~-#g|LPj!}gcw$a@pAuK$czbBDC7g(}ivn~Svka};saC@k z{H~|izc%f6oD1-sy@Eo#S-sMA=9^tExzxl(xArJ4nJ?cOzKYKMa-Y3lsXtJr3=Y|? z8B2JhP%56R)mA%2!t+I1z?gE@bsw2S_oCcB9arXuk;tbw@o+}Bw1>89c=UM7_azzA zpGnRPUi-%xXPAm@xKq3_-(-hwib+D91Q?)_`onQ%!IA%%H9u0_n$k4)>*UW*Hjqm?pLHsV_zJ?}&t~#?RguIOYJyJEgUIJ{XgE z9^>HhnE8i*BUF!*Ekqeo{cii#SksFhKfy1X8U3#8vi0%em(88;!ug8%QSjv99PF|( ze6PLe_rQi9F2AzyS;f(y;V8mOsh-gQqH%xQ*UgM~?&zNS_*321nb|0mznOnXIK=3? z457wP)!OLxpb)*z?*9ARy`Eda`fTFC)`-t?C7ndJ2ZmX%F2`IcGk}UG^>Hg6-7XYl z`LHK${QlZmcd|a4c(66%vpgyuVHYbPHJ++9JbHR*xEd|joex~Ub;*@Se`987!bAC) z`HX|_Djsx^Va*fkTvidET(dj4E`CnKJ~#5UcSb##a{u-@-tWaahl{{NEk1YzEB@BFE(o z^CdTY4TG?U@P&CMusm;u3#$Oa{IC(#?`h=|(e0O3o@A`GuUb)GziFa5Od;yA6pzdg zBa=^x&JaEg3=ds|K_RG`-cz28j%!y1#_#7IxITSr%P~39Yp5JxemuD3H$Klx^WDVU z3I&mBr|KAZDl0KwcSfrN_PuYWtTh$ea3?!4KOQ`COu*%jhD)_mx7z4-s=X`O==-Ph z#DjVBuX)8RFc}x~i(daHeGjZL$UJ*`5IEdBXgtX(@f} z6vhT3JJ9&$2f%(i5cqaDHPx>*u?Y-$HrHE}EB(hQp7fGi)u%RFI&61<^P2UCP3#M{m!z1@#P!H?a z>|&uf4^vt6XKjjYr*YTax%7nt_3pN&4#Ig1&@x|9Egpxs%EZFx5tz|1t`x(HRNEJm zk>uJnwO+VO(_e%)sO@@s;iK&jtUB(q7Y~Y;<3jrBs`CXKmqz+8Eq9gESfOY{2S%2- zJQ9c*KutFVFT}RTus6QC=d?FJ+^yS#`HX|_Jf^Gfn-UPS$&qY?fvokbdJTtOPSCqE zcl0ou^T%(1FnDqpnPB@&+Bx;`=Z%oS_d zETMSP`LXd3vM?Amy`;Pp8^?LoJ^nFg^w(Qh52qKM&vMqp@iWX-9&kl5jEZMr9C#}7 zKkR;dx7OvXkMZbymPf%Opy}}xL_q$&q;8IFpIxtXFkTz{T_gMGe8z)v51(ZI7E|L2 z>#nd8lqv}1N3};y9Qth+eO~cZ|JmL7{cI1N&+=&cF-d9=&J=gMCz(|RRFTwl+wJAp z_Gth1z|%$y>l5m)V>~)v!;@J$31$g|^y+4@)U&t8funBIn8kJT%Qmte#-a0Beu#F# zndY8Co;X48Q0GF%(v3|y<^Z!5g?gA`|uYLIVAgI{gh24nVfg-k8 zC^iTPC?#PBHg+pEc6VW8cXxMpx4z%AyGLh7WYM2byw9JxuFuZync10p&YbC)GqQWs z@p0w4NdV`;*{2j2DK&9ik3k%d=est#RkQVdIUX5@HeGiAWgPYWj3QCzhvxy~{D^A1 z)cQ%1BzwnZ7mw@d8X1Q+U3NFb;ppq7->c;gKVLCV#KEnPzc=?;>i5@-j(-js#}U@&qz&fPIsj#tK| zO_$x(aYd6~+#D-%@kfrS^J{+$;!1F?)|6+<5}lOem2qj)Wp{O4zs#?nqT-%01|YW= zo`;S1Ki%o3J})80m2<$&HrcbC`)NNzn=bkl&5!5iba#q2cIm8po>8~ABOZ^huCGgk zyUnft3uIzH4#ty_L_jy@uWW*{rtOLKc15F=BVseZ`)a0 z7*62Gcx3u-#v}4aJ-dvKC&Gxwf&q&8^{Xa#1FK@sZda&UDkQV}CFavXeL+|97}B-> zqh{MCety(hRL!n|IRDL!zV-orJ~COc;t%q8D}wRM;ScXI^;t@~sk@(7bzh(0^KNnN zLf!qns{4d%bJJ?Or$6>%__o~=ZPIoxqw0PviE>%n-AUE`X|>Ho#W9_F{9RSu%gqhz ztNnkNs=KHUOWQp{)qV6<8_w<-5C6QXdw<6TJGK9Ruj)SbRpCV1?&**Jn0|}5P5rdp z%g|lc*A?#hzONbMSFZ<;(_O@53(-w{7sF837o9L)$;OjP#;+v0i$=6X{W3CLm#F$s zRbXYJUMsO>leJ|U$K`p#c)5;hJ3HEOZr<@r4po(-*2ib2Xwzl)-;C?~{Uhr9Qcjv) zp6(yHoMuj?h$5{GCv3#?V4`_oNZ0@R@oA_8NOyg*fwxN#*Cc%8+ctDN0Crs4q|%vg zT;_Fk=bPC1p|OHo&a8+_jyE~!A}=Bg-Nkv0^K>^gpEp_@I%7LKo?QHO!w~aXrZYIB zCgyR=YL49W52~={;64K%Zf))&j#+s78z;lXxn2F>BWcO)q19>Q^{J@mAv3~G#Zg+f zShA3>%5u8{mAeOw`00H*+H}#cXks3>eAk3^Qx|V9H~j@5&2A#bP3VScUhYWjz1MN72|ql#QsCr|}+B(mt{e@DSZaBidsA z%XD3$>f;ac(eM@?{qF6r@^2;Mkn=zEjOlXQF6*6F%Ze2K>AfN{T@|wKYs}*oyGo7R z19>miFK0GGw1Qj?7ZR^r4#hkYc_<30oSp_}O;69ZiNOo5pYOR{TrPHBbd5ef;aMHY(@Zc-7^>`Ml}!5PW+> zxk(W(eDwLNk5??0GF=s_?rY5BRh4gTkPOKRvRsD{r!3cEog-pVPe;BBrl+I%fb(-+ zhQ_tjPKQiqkVegKOvg{HN&FZK3_~ zkj$O5@ym1uY1I5i{MzM9|8kSYUA(B8?fZKW)yrAUE2fvT$t5F`D6?FCI=`Y#mqEuo z-sqPzZSd-Reox$@v4zOTsJ0*O1N?&%^{ro8o6j;`{9oPtLEJ{mnKoYadN=&4>2fh> zN38;-vbWByjaR0tV-??H96|NaB>`yD;e@7InV+Uo$-&CF~=w9L)8~ zPCFekok1EkzcC%!^37=tf4@LcnTn5}c)&q7+(GFN5jh*w2SD(agxvtU2 zZKi0`W%roJ8-4kXGI&O!UOw*=zi4bB;)<%A2Q8o3aZ2XOC$#x3)5ZVQ%^$>XRL*}D zx4OKKzG1qY6iwURreUq;)3kBRbal+)d(7ijmG>xuwPIMZyssoqS>CNl7qO`G-}9#F z>DbiZau$b)%f@J@L#8uGqvkiJLtEY*1H5&WIEaHCAKhD58oBs(G_2Y8GnVh={+8)- zzkfldiIw8S^O3>n<2O^Z>9Tvw`RWED~}$o--Yyv4w~)s`8(z(%W5w_Km$F zj;%!_`b)v5OxGoa3797Gs~WEgfNZCQ@W+%>&C)|MJ?+YdRIKUsBxXCmPXTTs~#GE>ZRI2k{$~|6j#zRQ?~D zE-x1C+`2tKm-eUqH<_*qS@$*OajVMzuYzTWR`_22iC32YXNK~xo*w^4rl+T1?tYVM z)L$Q0}5uyNFjbqAkjaOxGo3XpOY5>;6U$6lrkx&{u9_6x*WZ{PZMl~()v)#Vs^;y*6*+M~SR`b*&-cu9 zxleZS@tM2{URvsc;X@y{nW9aX-D4ha^yNOv;2DX!++Qbt(bz)76;-*P(IL(3@zvud zV0P&m(Vuu$@0FCIAwW%8%23{dSQAx3T3ZzXhisj-P-Ap>HlClwB=oY2~w=yRTrTn z4bvm8o2P$iy1YA0nfxS$Yl(_7E`8i)iZ)$#k9odFU*4k(o{^}_`*GqIjV(l6QI+@U zxgXoLpD^yH{FdqB|LW!s;x{VqzlvMEo)39tx|~!zk@c4A3x^)saw5~!F^lgpk6TsV ze-$jl3xixQrhjcZpFgHMlVC#mo#nLKQ<*MeR5ww^tA7(xptZPL)SWw5J@nVoMG@B5 z#bSIvVMGk#dNOHd^X9LIH`K-@)73GF@4pk5u0AvmYM!s|8!S%C(}ht>gJE);|`BtakC|jdihEI)^vOWDufS>o6Kp9{@*{gciME>J<9mR zEB>r?cl+ool5-Oe>By?8T-|H=+PQQyao>!3dl3w9-R|ZHovh?#v$X>rpxaCB+egK=ZvpUB!6!@&hBsPZtJ|R`79ZS zj8mH~yZ?hYqqy2)9B*U{;*Ixo!IrYYd6UR^WW3sR+5I2H8^zgj! z@5j{qY&zb0k6m}wP2T2%j7P?+O_$yOLA+7yy&LE6`xwOgJavv;d2>{-mGQ`Uwdu0^ zKZrNVy{~WvEcYM6z8L4P_Wdy;hR5sXTyTIrqq<)Sv&}*>8Ia|9}pL_{#8q@w|jg7sFIH zs^`laP^*d`kLJ4uac^*-pLb_>QA53PI7a)a&bqt1e;f~J<8e-It}J-5W5VwCX;Wv= z#3R$yv54;`p6o#2>H`~!Fo=EIjW~=Oc#o9CUjz;az+{Mn?N`Xl>cJVj z#zNr|s8Wn<77vl!K|LPDoQ^Vls;5CIEfqQ4wKp0lPb!T zWW3{$35;u)KpQ4-3KLkJ2`tS7cFCbANtwX7OrSdxSdIxC%>)K9fp3_=Ty=?;E&eGc zus0J}kO_RyosjBGIE@=bd6DV5MAb(H{%q{pZ;)iW$aO}9)lh4o4bl0Y2^52x<2*C=g;GB%v*pB zF&G{T(7hPM@RtzUGC!;=jPpag-W7lO+_&ABH>XQc)0MsvVTq}b>4xO*EzQn{^^f`k z^efm9`jq1jkHPr+t?cr&T;7uTwd0rR-$!itq8-2LIelFK>iJ<4*LeCxUW?}j#quHF z6PagDr$aq@Cb?r6yna2yr#4-7H$1;v!=0*W#H)VA^UL;LUGl>5GY(qD`0GWAJ>DzL!8=M&a(JuYAm|-S?VlSiHW+ z=NZp9zoIHH8!|tznzSt>%}PW06|Jn~mrR#&$#x9l(^c}U56Q5R=Fj1f`DST&8MG~F zVti4}$109p;*=Tlp+22;jXpdxMVl_W#~?0!FLnL=I#L6%Hsc}~kc=;q_{7>o#wWgu zoK!#0cD_{2wL#}&(#rA`TS_X&_MgDmG5ZtS*HKp zcz>L^QRnOa7{pn!b>5kqYFuchjZ>!o)i|R#bEA&8YeLicx@PHS+e@Fv9M;Aw)BkF` zQJlF^FK;$Hk!q?Ov_5z(;_Ld^_q6fK^uHQ!G-qzqao>+Y+*jjOuQ)UH`1#tnW%^%@ zJDM{$>bS!bo6he#os;zKv&^lxHg1{zSL2T6%#Av3rzEE1UR1qighk7Q&9!mM^uHRn zX6HqJhlhR)>gCar<8xEx`^J{LTb?h!a#tI-O#iEKM{x#6ozF^2)A8Q2AM~-mSHjua zcxC!ujW^0OIQlV!6M)#B$m4%;T*e`eZofiY>k;vZZMSI4?Kp=)x-^-to(4L7Z)E!S zgxD{?odeqWBaW3tzFQcGJQnjqG-CdUblF{|iFQ;??EHx;SAH)ol-}k3SSZWAXlxUFy8o!cZSdGcR8^zb^W>Tr}X7F@~r0 z6{Rcxk#Q)gjN^#vxFzw`r`HxYeX&=LN|Y;cCPtesyF2*!dbRWG$~hrM`s1*~sJ^UF z&3Hp5hUtzkEz2rOdFMAvtWujRPtv>^pF36m1u5EzHI1S)=e&tH-yqZF_+(qZ>%)0o zY6LXofpuM%Zq$RS-@})ogz*PC{gG*m&pWu&jngRK>lGHmw(B#}_4dkT`Nen9*oy}r z`P8P1RME(~#!Fb&@DHx#!wC;N&icB!iyBznt*g242%b29raN)Kkf3XOEmEz z%7meK=*ov!zDvQM4(D0Gd(rVTzo)_hg^?8^N5wi@tiQ$o1u-mjqy4S!_J8ra6%#GW zjqdqR%8jg-G*8WWnf>UdUcNo4`9|caEkr(w?_x<)AJ=wibLgz)xY8TN^P{5CKS!EL zk?H!>AD>Y_PiyDbMOPoXT~*nq6<=hWp~NBU^T|`sb-9Qk#L!*bFXf-kTo;#!a}FvH zs5sARN&3y@VWRpUWuN7n$a@o)XVSl*Q2(C71pN4(E_zZm)!YLNZ(h~EN6flvBkQ{E zF72(WSF>x(h&<_6#HT(#EXF+-k=TLjxPb?F2$6|q$b`%Yfv6luoSU731jL;X4&PINIL2^3P<)LeObKUmV zRy_dC_q~~iw$Iz5OJEzOM>L!o);0SK>4u-*Te6;3Dv5O!YZhH)e73%>p1f>WS9feT zeXmxuWO)c94mlptRh(xXZRjq_L%s~A%WbP?3l~gUm;So=uV_Tuj8B=aOH_TBj?*DH z$e}%Z%3|$n9FKD*QDT2AN0E6G=+0q95NG)H>^Z|Sn=7lbbRM6w_p&O?c3mU#O>8G* zx*_>{OUCoPeqB31eRetcHuDSMDLQ>^W^!}!SFUG>bJ@uu7AR34jM#>X2TijeJ92|l z{E7|4`di$bSRLY|oD6Q1CdfQkkq= zhWr+avL23XEE2K-IE$@p40c&^?Uh1bf$dua*C#v(+JT_E5cGY5UP{nM2-=AaNXs0G zayO5nBr3$Piz-UzGK%t~vZA=u zM_h;4&ca;X)=b&a(M-8K)l6x8(oFf9ERJ%*F^(eMXY0zf*sZSSO7FAgino)6GUSnk zl5uQYWi@rOmCwbU?P)C)Q69vyP8KNPkjuM5xe$#l$Oc`1ZnR~&@y~0nR2VugVX}#b zmWb}6A&Ye7MyBf$RUf}mZmetg`FVJ|H}eYewDtD)t;tmz9F6L@U#9s5=w9Su z-7wfiR?Gj>eN5`%iS3@GP8X3#B3-?GoXjMJu|Fl!INXYD{$UQN%S(i&ylD6T!wZ-z z)AG32e!nm@i8yW*jokm2>H5?kpJG3$9@l!k^!xc#$j<@m_k#h$Yc5nZ7>Dy$xnJp& z$GH4z<2hc~Tq)hjc4`*C6N_aT5p8iiBGZ3FqW|_=@kFs_sXm|e+(djzQFEnayul@U zgu6A=9o!Rw+^>}Be2}tCwFnjM#Q;4#ehwJ_oeR3%4rjmcifI zr0JL0*c^?`f&cv+&@L~s?92B5eh$P=VQdb>JO{MP3#XrTjoeR;$&g}~t(fFeY(M`C zIbg*^h~p=5y*ZNOC;48Gc-6`*63cnQYX@nNB55Une|q*!@Z0 z;p+>^I7HiwtIaZ9J3_-f8~WQP49{nX$K$LU`?~~CufMOGdjJ>bTsm@yS1VAwu}Ob{ zGn@g*WS>-Jcv!srYbUcmG>8=jPDFC(~7->AprEpCKdb zxpZsiF7odCWlf{&Wj3Xwk1KR)JS9!%9zFbajya=^OQ!$xxb$;cH-|O(wx9UK{FL)m zT$>liC*nft)yz+>+7wBqTv=T2K`Z|eo8)$dQ*yfbD$_;p>L&VpljV&!{`tF5ZMOdT z0P+8Ykmb#@s_ErmoBND4PqHL7w2&)Gi}W!x5`Ew1&6edp)-&6IvwB~bSUj&S}Y;}~7d z`1nHmoWbaO36&)?t!7;RR<@_Suk-}}7sq8XT^)n?Zg>H$xZPiWC07Iz;O8w~Nh|8s z>r5?dLGA&aUA*PRTx(n3Zq^P#hF9Q(GYlEu`Rc~;iTe`7jph^jpMmdQ4SF4~J>`@!y zUe-oviWX=Kk;mL7s`w%Z-4TMp7>Nm(j(J#y_1KOB5cj@b#RI%S915^08&@7Cq^jKp%=M?=t;+fQB!B9H&vKH;(hTCQfaBdU_;RI(jDC>aecF zG~M|CVv+eN)Bi!7>UUXdv(xB2K-Zel=jXz)mP($FT^48S*I{T9M}0&xKV|ygic^!F zMsZrzGTt7zGt%}5J5JedzHIyX36{!%e8nHROf6P^pjdEeWPZwYed>?T-l@4nXL zsCqftZz9h0lP#6L@86WkGrC=)eO2|b$o!P)KO)qB`|~)Bb5wmk&$+hoeAkvwaCgadB%MGjN{TS-%eCWT%7bbb8p{Q1>9`qlgq{m0Iu=;lE5-Tu|{CwAUMpZ})1Mm2xLvcPTSvCV%$ z4*Y8V#FqR2f|)}IznVX>%g=xB{1K6fb(}Z~klTIrchOzlh<;+5e@zZVwfy|)n4+3b z;<|;L$D%E-r_1y|9oPSr|HaOq|L!>*JAY#5k6gcroDkpTzM=RY+eDuO|IXz{L=roH zqMskyuCen+npY9wxfBw5?f9(AE|9k$(bx=GeL#~@-nw&Cm?o{rNiG4F|chO%| zX(Bzgi9QEREk80}W9Luw`S`Eu8asdfRXO{2hO3=FRNJb1Hd3s!#JWnJE7OimE?3(0 z*x!FQ2ek7?J#;Y-1i5Vy-DH~h9$jOqKlSw=*{>)Q@;acpdvxRZU+<=!KjIk)b$-d^ zN2G~HyG+S+eOLWwRB7t&vEO5!1KRl`{we2A%!d-&=f5fkwDZUCxPWdsk^5|7+;W+a z^G@AXum429a+wp~O*L}3ruzH8+Fd(;#B&m28zAP5$Y*u_sppCKF1yP%NwLje&H?TG zQ4e0u5B2gP)71S%_1#o|>g~VmH+KKv=bVgg{`}nc@1=-*|5c-%Ke9jdvKZa}W&i){ z?SJL`5qYQ0WBFUO<@f*fJpL!sr>*x*n`heJ|72Xh^Ith$(H8ssu}y3a{5Rx)`Z>ts zn&UO1k6%DH>lzIl zt;Kuj^gnIAz5RHL6t!tL_6rVhbuY&2`#jvmyUwi}ds6+Ho9-$9u0e*nwZ$;QA)lZ3 z?=SWoemwWAjWd1X_)6pIO(tFOSvho{zE|Dz7a~rXt{Z^rPE_P;fh=_gX0f zOuv8Yw9VyiwWcKQzTXgoTtA#Kq^m;HeUN|CY`BOc) zdo|wvrzlqZOXQcR&(Df@)Z-K5Qa@K35rcU9t-g||N5zl!+IagL(se`gzPqo^I}Il68%K9A=6(U3UMCeDiei^>DZL3T*4HD-hny zb>rvR!v~p;FGJ;L1H#fw>MzGH?jKZ(~%ypFW3hr6$P zfNo{44qCnbDKo@$ycVw}_q?3;dVPJq>X$b&mO7a(xZN+k2b?h$9cY6m+kp&`+R@@oQPM*C#z%8ZHL9wXw&~- zI-*_Us>^rsk*4E(JImjp@Po^S+E`?MnU{MaWjbG*hO}Kcet2$CZIrH&aca|L_uq(9m9M{!cQgZ* z>y7usYihlbsMyu{t!hj!DdW+{t0;*z>9Ttb7cUoU+u$Hidw1#urn0fRRLg7Y>gpFP zDna9IPSpbf`~t*2f1vI!R(#6!MEcR@ih6uvTp@<;V*fRa?jp?=qMaNm5K3;=v`A{j zSEZQ$)3S{&+|MVzi$?S(KDFt(WIh^udH8zy8bxXE;^iG2pxZk&9)J2V#^V=x7Z;<` zD9V=Ng~y6v#wpWoMD06w{l$0Dh<$AFsZG}<^I;f&BVK~;>*^(HXX7nR`rQv*FCl!& z`4y%azgUTgAFPK$Is($65!?G zK^*n{{Fn-Lc{x7L_&C;zO2FJ0R=%<3O0E%a4o5Qn2Q$;{%TTy&vulQN$nnc`)u?q} ze;)t$8hjl6oA?#?@!}0uje}iX+1(X?_*?b9iT9w1vLotxWA+)nbJ&XCxgZLWsKc!o z%AhjrA?j*t1{Zik)U+<@WSfLV*a}hq+GAK!0P~_2{2<=PeGp>Ci1!co!9ippYrEqn zno_XD`{}(XT#1;Gkr>L0G`%f(KR6c<`!VCUGUGERq3$P7gZ6WG;qnwnY61pW+KzGwlQC_gNe8C$2TU+X->!>Jux+u#2 zf%G?ldgJCZj7^GC={PapSCnJsW=ioKW=d{5GbLFEGsSDXnX-YspAqlPl(EI*D7}N@ zD55-2)cP=WM(=xnK8cBEB-y&7Spl-Ck)!kzH-PC#9m=5P( z-QVAs)_--3vBUr0&jI!EbZD6I`axSyTtuDtO8s1OZ&q#{{;?tJLeW@3Y}aJENK-eB z-93D$cU5;B-@w}?sJ&l+&yP1DI{Lfu7DUGYZ+pK0$BsVwv%0#!hw>@6x5>rJOKEH& zmK*WD46*Ji^TkY=@YK39UzNE}?b9{x5?a_&->a^_e0<7u(T}>3J86dZ7}R64raP7F z=dY_VR#ai9>s`Iw4JQsUei;Xw0^KzkXI7G(6WT1h-XorJG_Fshf>RT8c4#U3RFpBT z_4y;yb&0AERegVk7#alo_>1>n)ZwfRn}0)qj{}_T6^Gl|yLeYJVX*{(Y^#8P?CHET}5Kry~R>hv(u26Nx=Oit}evx`Uo~OHL zWd4Or4AX6YEXz_4s`HyAp&cv~pYeCbrdjX!YN9^-blZLruT0ksK=o10+l%5=(@R&i zuh`YCOM&ur?bfzIfO~uK`V~XJ>NuRIMjuB$ZwuvA<&~=wH~4ti((wO$v_%{;T@`}v zYjkl0=-vt=-V$THAA8+I9Q%DNln&=VZ!SFZ@T3`<{E+D}j-!cRkPACWA^bruSE194 z%a6zv3xu=ZQnZKTX}&7wP6qF+-q3FtyEM8+w9TlMSEd`1zqjhUboTPlE$!Bhf$jme zoW)sy&oXT%L#~asYL_fc-&y1(6$TdF0%_|e! z?T6|IBH|SDOQx#^t^2Bqvxa++?)}SR2C*Lc(M2qU*0p@?yxepz%5neE#qj=J-tbei zNs|T+0phchT*7eZ>>l9B`pEEVqlNrY zE{Dm(qmQG?a!Vzvcj8UX@oyH<#v#-HC=QM-)gjh&@ny3Y(8%3`a|OJ{N~}9WRB?_b zPEnq1@vG)siUJ|Kt$J8~JW=F;$ftCM9?u)nwg0QhsQf$vTzssX`1#dy@$FVM*tMfO zrzncr*x1ms6+}LX^Oq|bzZ|~DWuFi+FG396#d;#-lkxg&B*$Q*U^9#DQsvjpJ)6Z< z#Q!|wc^&U`uq6LflzSZ8i8y7tE>ZPS)!WOrqga(y6K77?9^1RS1aVeEcMwc}4O-~q zYnkKW7Wp?ZkHoSr=BmgqMxk2=$o&Oz@2QAgoHIxa4j&cqJcKwFP7ZNA%wgnj)qkFq z{yEIlo1b<86a*`N0PrCv*j8!V3GOEB9RZ$Igs19*JSpzj8c4ca#4mk8x>OmaKi(QHaXoyA- zYt$y-&{$U=do$WjXb!Sn5p@B#0=rm>sP3M_XT=#VXa`rg!5!`40Z(|L131*yoj35I z?F&EnqZ0xk=5Y{$A$Br3ELXas8@i(hdZHJ4LmY62pfCENKL%hR24OJ7`ez7+Vi<;F z1V&;MMq>=dVjRX}0w!V-#QyqZOu(7?3%jugd$AAuaR3K#2#0Y5M{x|t zaRMiC3a4=fXK@baaRC=`372sNS8)y3aRWDT3%79xcX1E*@c<9;2#@guPw@=T@d7XL z3a{}7Z}ATA@c|$437_!=U-1oM18;^n;8cxbfw+i=_z>rz5+ETGAu*C5Da3mLk|PCD zA{A024bmbV(jx;hA`>!0yh|V}vcU@3kpnrA3%QX8;`~=W@LCO}01869gP<_1AvP{H zD2iezjuI$|QYeiwD2s9s?=Gl-il~Ijr~+G5MKy>GXLZ=425Lf_gR2ek-h;ZR2XTSc z0S(X)jnEiP;E1MZ1}8K}3y4E3@!o{iXoI$Jh6~!k6>e}xdw9STUf|T3(h=V9fiL{v zk4^|cAc7E#&gg=!=!Wj-fu87v-spo6^hH1P#{dk(APhz*hF~a$VK_!$Bt~I0#$YVQ zVLT>aA|@dWlQ9KTF%8o(12YkhS(uGEn2ULsj|EtWMOcg_Sc+v>julvmRalKRSc`R7 zj}3^xMr^`nY{6D+!*)bs2XSRp%dK)f#`7jh#H@**GdqW}t`5DLQ@MPP%XCpfzIEhm@jWallb2yI+xQI)*j4QZ`Yq*XZxQSc1jXSuDd$^AW zc!)=Mj3;=CXLybmc!^hdjW>9UcX*Ev_=r#Vj4$|#ZxB2EW{3lGSRgLqAwIsUZ5Q8unp%{Xp7>3~(fsq)6 z(HMiV7>DtgfQgudFigf2OvN-z#|+FwIA&os=3p-7VLldMAr@gVmS8ECVL4V{C01cI z)?h8xVLdh=0voXjo3RC3u?^c1i5=L9UD%C1*o%GGj{`V}LpY2hIErI9juSYEQ#g$? zIE!;Qj|;enOSp_HxQc7IjvKg%TeyuoxQlzZj|X^&M|g}Uc#3Cuju&`|S9py#c#C&< zj}Q2WPxy>4_=;~(ELi>#2j;LqT*O0sSRw%uA`ucJ36dfik|PCDA{A024bmbV(jx;h zA`>zr3$h{`tdJc!kQ2F(8+niy`H&w4P!NSs7}h8P8x%z`6h{e^L@AU;8I(milt%?r zL?u*471*LGs=*G`VUHT9iCUE#y#I^Wla6)smKufejYqUXI zIKu_);0iamqdh#}2`_M|LFoui^(&laSA5|Ie{@0s0uh8@bVe6+MK^Ru5A;MY^hO_q zpfCENKL%hR24OHlF$6;~48t)3BQXl2F$QBX4&yNa6EO*4n2afyifNdR8JLN1%))HU z!CcJ4d@R61EW%M@EKq572lx5W%)-On8N~b5fAZUi3CW9 zL`aMzNQz`gjuc3VR7j09NQ-nxj||9&OvsEZ$ck*RLU!apPUJ#vt^ zSfdDRP!z>b93@Z^rBE7WP!{D-9u-g#l~5T~V2i4#20K)TJ!+sPYN0mjpf2j6J{-^h z4bcdV(FBfY3QpfDPH2u6Xo*&6jW%ctXSkppT;T?Hw1)>gA@1ktfR6Bn4}9SVe{@0s z0uh8@bVe6+MK^Ru5A;MY^hO_qpfCENKL%hR24OHlF$6;~48t)3BQXl2F$QBX4&yNa z6EO*4n2afyifNdR8JLN1%))HU!CcJ4d@R61EW%M@EKq5 z72lx5WBErMn8N~b5fAZUi3CUpaZg!dBtcRnLvo}*N~A(+q(NGwLwaODMr1-}WI4JD1)*nhw`X^il~Ijr~+G5 zMK#!=I_yycHBk$-Q3rKV5B1@I1`zj_G(uxEfg_rt8Jy4@EzlCJ&>C&f7S3=%JGjCP z?r0AWc)|-E&=KD7fiL{vk4^|cAc7E#&gg=!=!Wj#b`PZ|dZ9P^AOwBU5B)I!12G7L z5sD!gieVUz5g3V47>zL)i*Xo_37CjU2*YGd!BkAcbj-j^gku(FV-DtG9_C{K7Ge<= zV+odG8J1%OR$>)aV-40~9oAz5BCrvguo+vh72B{Kk=TKq*oEELgT2^?{WySwIE2GE zf}=Qw<2ZqnIEB+VgR?k?^SFSExP;5Nf~&ZO>$riNxP{xegS)tg`*?tdc!bAzf~RLiL4<3b85+ETGfk#f2BuI*6 zNRAXpiBw39G)RkdNRJH2h)l?gEXay%utIj^Ku+XBZsb8;C&f7S3=%JGjCP?r0AWc)|-E&=KD7fiL{vk4^|cAc7E#&gg=! z=!Wj-fu87v-spo6^hH1P#{dk(APhz*hF~a$VK_!$Bt~I0#$YVQVLT>aA|@dWlQ9KT zF%8o(12YkhS(uGEn2ULsj|EtWMOcg_Sc+v>julvmRalKRSc`R7j}3^xMr^`nY{6D+ z!*)bs2XX^{@;kpUTz37L@vS&~qXH_T5-Ot#Y*7`}V2A3kM-9|O zE!0LG)I~kihXWd*AsV4En!piF(F{&#juvQ%R%nejXbWe!pdDP{26wcF2Rz}04(JGP z_`nx_@JA;EAP_+aMrU+ES9C*n^gvJaLT~gz2>PNQ`eOhFVh{!+6hkl+!!R5pFcPCM z8e=dP<1ii*FcFgwhRK+MshEc8n1PuH$1Kdo9L&W$%*O&O#3C%l5-i0sEXNA0#44=D z8mz@Stj7jKU?VnRGqzwWwqZLWu>(7?3%jugd$AAuaR3K#2#0Y5M{x|taRMiC3a4=f zXK@baaRC=`372sNS8)y3aRWDT3%79xcX1E*@c<9;2#@guPw@=T@d7XL3a{}7Z}ATA z@c|$437_!=U-1n}0+xTofjKM?7x54umPmkvNQA^lf}}`>casI&=8H#7){`arf3EyG)D`xL@TsL8?=Qp zT+j}#aDzMA!vo^E9WQi1M|i^rzVL%TIw1go2tqJAqYJvC8@i(hdZHJ4qYpyR7yZy5 z127PSFc_g2f}t3O;TVCD7=_UogRvNg@tA;#n1nD)#uQA&G)%_~%tSb5VK(MqF6LoA z7GNP3VKJ6qDVAY5R$wJoVKvrZE!JT@HXs5Uu?d^81zWKV+YyN!*oj@(jXl_leb|o! zIEX_yj3YRTV>pfzIEhm@jWallb2yI+xQI)*j4QZ`Yq*XZxQSc1jXSuDd$^AWc!)=M zj3;=CXLybmc!^hdjW>9UcX*Ev_=r#Vj4$|#ZxA>3nIR6$VS%`ahxo8W0whEtBt{Y> zMKUBu3Zz6Tq(&N~MLMKM24qAgWJVTbMK)L=J8~c=av?YJATRPEKMJ5A3ZXEpQ3N(9 ziee~^5-5pMD2*~G3-RQ1c~n3}R6=D`fi0?{8thOV_NalHsD;|7gSx1P`fxx4G(;mb zMiV%qDVo6v%^@BxXo*&6jW%ctXSkppT;T?Hw1)>g;e`(92yghn7k=^g#&vq96KW00v?Z1|t+hFciZu93wCiqc9p{Fc#x59uqJTlMsf< zn1ZR8hUu7rnFz-$%*Gtd#XQW%0xZNLEXEQn#WF0%3arE`ti~Fw#X79V21H;ZHeoZi zU@Nv^J0h_IJFyG9u?Ksx5BqTd2XP38aRf(k499T-Cvgg=aRz5`4(D+J7jX%faRpa# z4cBo4H*pKMaR+yC5BKo^5Ag_(@dQut4A1cbFYyYm@dj`44)5^+AMpvF@daP;4dSL= zGsJ;8ED#s*5FeIEfP_ed#7KgqNQUG{fs{yv)JTK0NQd;ufQ-n5%*cYQ$ObE9M-Jpf zF62fYAryu+ioga%Q4GaV0wqxjrBMcDQ4Zx%0TodRl~Dz@sETT^Lv`4r z25O=fYNHP7q8{qQ0S(X)jnEiP;E1MZ1}8K}3$#Qlv_>1Wg)>~x4z6&6JKDnop725k zbc8p2;0r(aqZ0xUh#&-`GrFKFx}iIIpeK5vH~Jt1ebEp7F#rQG2!j!dAsC8b7>*Gb ziBTAhF&K++7>@~;WK6+SOv7}{z)XZ=7G`4(=3*Y^V*wUo5f)Q~(IEVANfQz_<%eaE8xQ6Svft$F6+qi?fxQF|AfQNX5$9RILc!uYAftPrN*LZ`s zc!&4+fRFfu&-j9`_y%!9zZv4d92SU+c!&>6BtSwWLSiIAQY1riq(DlfLTaQzTBJjI zWI#q_LS|$^R%C+}vLgp_A{TNa5Aq@(@}mF>q7Vwh8bx4(q9}&qD1nkFh0-X4vM7i0 zsDO&7gvzJ_TU13g*r7V?Q3Ewm3$;-Pbx{xX;eZBch(>6PCU8VkG=meGqXk-`6MXag1+d7 z{uqFP7=*zH#Sjd|Fbu~CjKnC6#u$vnIE=>xOvEIFVKSy*DyCsNW?&}5F$=RX2XiqG z^RWO6u?UN?1WU0D%drA0u?nlP25Yen>#+e5*oaNoj4jxTZP<=T?7&X!!fx!rUhKnu z9Kb;w!eJc2Q5?f@oWMz(!fBkrS)9XpT);(K!ev~+Rb0b$+`vuT!fo8aUEITcJitRd z!eczaQ#`|SyueGm!fU+2TfD=2e85M1!e@NJSA2tbn8yrpU=9n!MLfiZB@!SZ5+N~? zASsd|IZ_}cQXw_cAT81%Ju)C8GC|Zmkp)?i4OYmG9LR}W$c;S6i+sqB0w{<=C=6>9 zfenhH7>c6=N}?1>qYTQT9Ll2tDxwl9qY7+M71dye>aa%*)I=@RMjg~eJ=BK-8lWK> zp)s1k5lzA4%!(75qXk-`6MXag1+d7{uqFP7=*zH#Sjd|Fbu~CjKnC6#u$vnIE=>xOvEIF zVKSy*DyCsNW?&}5F$=RX2XiqG^RWO6u?UN?1WU0D%drA0u?nlP25Yen>#+e5*oaNo zj4jxTZP<=T?7&X!!fx!rUhKnu9Kb;w!eJc2Q5?f@oWMz(!fBkrS)9XpT);(K!ev~+ zRb0b$+`vuT!fo8aUEITcJitRd!eczaQ#`|SyueGm!fU+2TfD=2e85M1!e@NJSA2tb zkk1TpU=9n!MLfiZB@!SZ5+N~?ASsd|IZ_}cQXw_cAT81%Ju)C8G9fdvAS<%L3fYkZ zIgtywkq3E^5BX651yKlvVT~fNK~WS#ag;zwltO8gL0ObTc~n3}R6=D`fi0?{8thOV z_NalHsD;|7gSx1P`fxx4G(;mbMiV%qDVo6v&Cvoa(F(2625sRC7qo*b+~AJ(@PH@0 z&;cFc4IlWz5B}(c00bfk!RU-G=!$OWjvnZVUg(WJ2ti-;Lw^jwKn%iQgklJWVi<;F z1V&;MMq>=dVjRX}0w!V-!Y~e}xdw9STUg&_1@P-e3;RkLL@)G4AB3PU z`k_AtU?2uzFhVf|Lop1)F#;no3ZpRwV=)fnF#!`X31OIwDVU0Bn2s5kiEzxqY|O!2 z%)@*vz(Op-Vl2T@EW>iFz)GybYOKLptiyV2Km;~o6Er6Sr_1cW@W?a32rw z5RdQ}Pw*7a@EkAj60h(YZ}1lH@E#xV5uflGU+@**ARgd1LmZgH0&x)!@nMMsNQgv8 zj3h{kWJrz_NQqQPjWkG$bV!d3$cRkHj4a5CY_LLhY+Xy&;Sk5 z2#wJMj%bQza6)smfT(Y;6MXag1+d7{uqFP7=*zH#Sjd|Fbu~CjKnC6#u$vnIE=>xOvEIF zVKSy*DyCsNW?&}5F$=RX2XiqG^RWO6u?UN?1WU0D%drA0u?nlP25Yen>#+e5*oaNo zj4jxTZP<=T?7&X!!fx!rUhKnu9Kb;w!eJc2Q5?f@oWMz(!fBkrS)9XpT);(K!ev~+ zRb0b$+`vuT!fo8aUEITcJitRd!eczaQ#`|SyueGm!fU+2TfD=2e85M1!e@NJSA2u0 zyu%D}U=9n!MLfiZB@!SZ5+N~?ASsd|IZ_}cQXw_cAT81%Ju)C8G9fdvAS<%L3fYkZ zIgtywkq3E^5BX651yKlvVT~fNK~WS#ag;zwltO8gL0ObTc~n3}R6=D`fi0?{8thOV z_NalHsD;|7gSx1P`fxx4G(;mbMiV%qDVo6v&Cvoa(F(2625sRC7qo*b+~AJ(@PH@0 z&;cFc4IlWz5B}(c00bfk!RU-G=!$OWjvnZVUg(WJ2ti-;Lw^jwKn%iQgklJWVi<;F z1V&;MMq>=dVjRX}0w!V-!Y~iBi25O=fYNHP7q8{qQ0S(X)jnEiP;E1MZ1}8K}3$#Ql zv_>1Wg)>~x4z6&6JKDnop725kbc8p2;0r(aqZ0xUh#&-`GrFKFx}iIIpeK5vH~Jt1 zebEp7F#rQG2!j!dAsC8b7>*GbiBTAhF&K++7>@~;WK6+SOv7}{z)XZ=7G`4( z=3*Y^V*wUo5f)Q~(IEVANfQz_<%eaE8xQ6Svft$F6+qi?fxQF|A zfQNX5$9RILc!uYAftPrN*LZ`sc!&4+fRFfu&-j9`_y$pFml@)~92SU+c!&>6BtSwW zLSiIAQY1riq(DlfLTaQzTBJjIWI#q_LS|$^R%C+}vLgp_A{TNa5Aq@(@}mF>q7Vwh z8bx4(q9}&qD1nkFh0-X4vM7i0sDO&7gvzJ_TU13g*r7V?Q3Ewm3$;-Pbx{xX;eZBc zh(>6PCU8VkG=meGqXk-`6gHS zodP1T<*f%1rh{|AVsB#lvvQS zW5AU3dq6%`frul|2;cVBLHb1flgke&N{clX}3w{K==c4udIfd`a;*2gN0xbxCAT)OTbdF3|tB>1DAv4U7HkC9f$M=6+yHI_H-VeME#Ovg8`uPH2X}xw!Cl~Pa1Xc_YzFs% z`@sX?LGTcG7(4>DfJeb&;BoK-coJ*{Pl0XVY48kq7CZ-@2iw65UHwXYdR76&wb?f#1O&;D6vx@E7 zhy;y56le^ZfD=Gd5Dl7v6G03(2{Z>SKud5kXa!CItw9@bDrgJZf%c#S=m=s#C(s#m z0bM~i&>i#uJwY#U8t4uBfWE*2P6u(IALtJTfHS~Aa3(kl3<76^!C(j&3WkB<;2aPS z62J(M2$H}^Fba$Y$sh%s3(f;$Kq?pu(m*;mAB+PTAQNPP@n8a&2quBaU<$YZOa;@x zbdU|KAP3}vJRpO7Pyp!N{5CKH%mj8&1RTH#ioq=40&d^|C15s~14=;|mxU>#TwHh>Cn6}TE) z1Fi)d!FAwz-~~5;8^KNBW^fC*72F0kf!o0y;7)KCxEtI9?gg8{ec*oZ0C*5Q1Re&D zfGyxr@ECX;JOQ2rTftLc8+aN#1D*xXf#<ikzf=U z4U$0$I2W7;#(-2X7Nmi6a6T9ZGC(HC0^`91FcC}wlfe{l0hkJ=f$1O{SV0cR1$jUQ z`Jez40vnhCW&%4X0uJB=#b6e20XOh~5-=Og0i~b}%mo*Md0;+R04@UM;9{^4ECQE+ z#b60o3YLLO!DZlbupF!aE5RzT8e9R^fGfdTunw#T8$boP3S14Y0oQ_!;5u+U@PZq_ zjo>D5Gq?rZ3T^|N!0q4;a3{D6+zsvl_kzvfK5##H06YjD0uO^nz!vZ*cnmxao&ZmR zt>7uJ4Ll8=0ndWx!1G``cmeDHFM^lA%itC8DtHaN4t9b!z?c9w z0l$L7;5YC)_yhb8{0aU7e*>u%j(<=O)CUbfLl6lXfhf=zGyx}orXU(L11EwQa1v+^ zT7Z_|WY7wn0$PJM;8f5Sv;*xy2hb73f=-|_=mNTeZlF8p0eXU7;55)1^Z|W=1)L7z zKtIqQ3;<_ikzf=U4U$0$I2W7;#(-2X z7Nmi6a6T9ZGC(HC0^`91FcC}wlfe{l0hkJ=f$1O{SV0cR1$jUQ`Jez40vnhCW&%4X z0uJB=#b6e20XOh~5-=Og0i~b}%mo*Md0;+R04@UM;9{^4ECQE+#b60o3YLLO!DZlb zupF!aD*;|ZeNil`5Wnx*ix*7s`>xw>-;ht!%a>{X^uFt!c=;5)axwwXn$lPW_Bp3xogJh5b&IRXzF(4I;1!*81oDar<43G)3z<4kLOazm_WH1F> z0H%UzU^>VKR*(a7K^~AnJ}3Z%zy@Z3nSiQ65pVz}CU@o{2 z%meem0&o#12N#2dU=g?kECx%!Qb5PerQkAfIam%>fR$hsSPiZKYrvIYEm#NEgAJep zTm`NM*MMumMsOXt9(chG;6`v0xEb66ZUwi2P2hHL2e=d51?~p-fP2Aaa38oIJOCa9 z4}pilBVY@76g&nV2Xy>A3ATc#z&7wScm_NRo&(Q=?cfEl1H1@c0xyGCz^mXj@H*HD z-T-fcx4_%r9q=yL1$Kk?z#i~E_yBweJ^~+uy4!2oau7zoY;XMsWBY%mxM0YkwsFdUo%;z0r!0TMwH z7zsv!(I6S5fOEllU<^nFV?i272j_!vAOmEAEHEBS029F^Fd0k%7l5f?8ki2UffeL{ zT#yH3kPiw#A+UiNU?#AGBH#c{Pz+`P7jOd)C;_v<98e0%z+7-4mho34lV`@ z!6I-8SPYhcrC=Gj6kG-_2g|_Fbzxx*}w{NKrYAwGROx7 zpb*%=3@{VeK@o5OCnyH9fD52_&3+O#F#AcfpEUc)W3!*U8GYp~;8t)O*aU6|cYr&= zUEpqT54aa>2KRyc!2{qy@DO+yJOZ|WN5Ny@aqt9q5^M!efoZ-KYLJK$Zg3+x8(fj!`T@B#P`d;~rQd%-^N3HTIz z20jO0fG@#*Z~%M-z6RfbZ^3uqdvFl^0Dc5NfkWVD@C*1A90tFE-@zZ?f8bB>7x)`U z^>CgH>Vf*80cZ#!K_d_a8iOX_1ke;jgJ$4F5CcvE%|Q#$5}XWLfm1+h&<30e+JbhV zJ?H>Bf>_WAbOv2OSI`Y~2R%Sf&2SvaEoS+!Y0xsYN9#8^igE^oS zl!3Y6LNE`^2MfSOpd4Hb7J^0K60jI70ZYL$a4EP9Tn?6l6<{S;1y+MAz#4ERSPRyH z^Xuj8Qcf% z2M>S;!9(C-@Ceuf9tDqq$H5ceNw5_>1-5~w!871l@Emv^YzHrZ9pFXq5_lQB0$v5L zf!D!K@CJAjyanC{?|^r~F0dQC2ljyX!3W?&@DcbJ>;?P4C*V`?8TcH00lozL!2$3U z_!@izz6IZb@4-Rv1NagA1P+0p!7t!fa2Wgseg}Vm|A9ZjU*K;b;d&zi)C2WF1JDpe zf<_<;GzLw;37{#62F<{UAO@TSnu8XgB{&(h0;ho1pba<`v<2-zd(Z)N1hJqK=nT4m zuAm#}4tju|pcgm|^ag!EUtj^JgE-I+^algL8DJnd6PyJGfwRG2Fa!(*!@zKG4u}T{ zU<616Nnj)x1xABpkOIyH=YcUG6^sRGARU|!#(@lw39`U=Fab;ilfYy!1zZ58f@xqn z$OcxB19CwgkU>5u0ENH?W`LQ%4vK&SI6*O(1zf-lJfH;326I3uC%j(40j>g9gKNOG zfUbp?q3ZE<@ZJ#D!Mj^El5T&n=ZGDtM7tHZ&^E!P2>H-ZMm4l1HLa+#20v3ZMU@4&E z=~8eRxEw48E5J&y3akcK0IJh;{Lz1|_l2!O*ZT*XIm%CoX-vZpIu}SDM!iq4+nsaz zYpIF)91cUDeq$PpEs0z;mE$)-It`^J63cZ;;!ha*B;#wmvP(<{XZ!;N zmo9sGZizA9K=Ls3Nq5<1TXV}YWQW`4vCWpzJXmw=GK~=F#}N;=ZlK5#u%uIZX?Zt0 z?M7?JKlavtqqI!}Y5xxehnlVaqnG!rt`tIQ38?*Kxgr!6nbsV)CEZ#ekHNQ!E%cG% z44WfYPRJ!qkoaDN4c0z2gntxh3R-~npf8|tHL66nf%;IE##oDR9`X$O1$w`KWMiDC zM5}WWR&|1o15kI<;WrO`;nO$=>>VMc;i9V$CttTuZXh+sOU8e6H<7yckC9Go-A1a| z*IgPme5h1BVXE}q^{X+zW3Ti=|0xl}54EYca8W}2_>vPE?!y~}+vc=u+T(?1n{R8< zqW!OvoAy0Veq|)tjgAedCY1v&|1Ir;+qZSw2GZ1*JlD>7{lLwAM(gd%a!ONl0qm=O zSUj)4GJZ_?_si;(A;t@~4O1$P*TKSyesmg0kfS|~)YkOhbp9>ig^{aUKAe(RKH@g} z8`oy}7%dX|zu2FYx7WAdRL7}(qPbO14CuQi8UD*>UexMz=sIv(4YI882ua*!bZI!>_xOUf--Z>KAE0SgwgHS3Z3$Bk-Mf zhwpz%QL)`pIopFHi28U#=tFTHcGc@Ke|oEf9G~>T)npYp`)8Eo;A85}5}XE)vf1ea z>lxO3d4$V3#|?AiqwpT9J+V;Eok?91B9#Mfr(-+n?UM&TvJc%Wp1xx4>Mb`#O1ml^ z+q2p39!mEC$#Fl(a#iYE`s`uJEOa?N9=rPGcMc(5KWs7NZ!Dj5yg2*yy&q0H_+vL3 z+EW~t56d}SUJLn;L;1L25ub=Pa+5LiWhLsB9;>&DQ7_7?L)Vw5%~?oy-c_gCXGw%n z&i+0nD(y0|RL(7->lj6w2{yYOwcq6#C(kO8-5xC>ou_hn?KbG;MW$3<2Zy50?%KPR zqI}r=(V>fWHXKab6Cf%Hl$aVgj2f$FlT*JkKNeRKk#@}O;;&Pv&*VjSq^ z`{`D*RFHDG#ogl;XQ=w9?M?*j#c~QGIzg|jabu{rL1j+1x)bd-SdID?ccRnbaXIaF z*_9;QM(NI}JeJM~&3*~WguG5vLMet(H z_SzkWK7$XHU3F$gR%N@+`WWS5>EkmU*-JQoqSH~O`%}h)Sii!aq3vb=ec*zoSH!pA z{8>Mvoc+aIEynU3>+~ptKXTrPGIbDC*KW}VX+zbo%u8>MAHMX(lZ^F?<*Wy14g;(i+eJ@{?3w!hRT+U^Z(>=IH5$tjzHpZzpb}Ee;RY5 zb~z66ZYy`)y$m0{yQ#RocK-UTu|H$E&N%o}P5W4sYd4HxmLo3Lo81Pz z{GC7TdaLWZ6Ha<@ALq~Y#wcfhonA_&SuVSUhA*8obxzl>X7>$!Jazh_Yt9Q(a_G|l zilcP|YA?$*apg*vKYFu7t3%Nu$?CD@SlwzPjL_wP?Xb+EFP|>(>k9Tlzoeg={Dn=a z;_JuPpZUWF4{`k^J(}Rhatb3logS5TfGsj|3uRnEZ$eT&Gp4dCNzXN=b;Tkul1QLXnqaObN16B;TZaUZvldYrRd6IZUr${tJQi8deLp)O7k zn~!&T{$?}uqINF<&^ijxIM2ae5qQ7-qIY8PkjfJe%~*2#>U9@fpebfYKx%(jj^H{s z-s-X`EsNWt-k)%Dt3#*%a;YZ~J$ixDRi?!f^@)$u>qFzZFoV<@hMoT2t9=jK8c7A` zd1rp|*}9!H_kbMh!*W&XTl&!lW*cv{+wv4O(K46VJ(h&xV%b4;RMclD^dZOgF_zmh zd{Au6NI7cHk9T#`)KU5evJcCZ1cZg}wAG?seW)YonNB{7rG7%V7~%R(O0dqQ+AL}g<{)Tj+oqTwjL1LKF`hk^Q-pt zY+rGPY#*bX{R8XcETQubu^w$h{^SDLgZzHE<=Ycx|M|y-v`volH_BDt5dEq$3W|$< zYgvEAFm&~3D`oR2tvsir>;KOPt>>aI7JoJV-TZ|dU#<5|C8M1E@fe=c5MewbEe8W{ zvvKvEWXn@7uE*QlC04t=Y^>8UvZ&ZomX1dU$#&$#`n2DmSNV5mD)Zn6VWQ%??<}(^ z{5MV89CjDZf0O2rkVCU6^}>?nicnajIB>3LwL`tE6dHwBMgg?*w+S{!o^y^x(UEl$ z^(h^wx0648F1W7za@W_=cB4Kl7gSL;{pvGLwqsytM2W|P$sam(bm#jqXNK12I?tx1 zpFg-U(x?y1Yp9P_w)rJ?%}}D9%Foj4^>mNM%J{7p`Zm2S`mc#&8b~enoceV8&)Yrl z;U|3*6;g3yh1yS+8}%CPvKANGa_QbP-9JI$jdi+;(7nu+^HLnM)qY0KOK{0nCF))* z!#RJUevkTMs?RY1w|=CyfX*>207K5oGaYndwg}t-J_NC-XmbF~!@Url63ru{!+j3= z@AgP^1QLx#qV%rZ8Mv5Og9dM1XN&>jX7^f*S`Qn8`DeMv=VHu}L!+^E59TYji;$MM zBBY_8L`YtDJ!uanv30^2!KQ+S_|9b`iR=gyDd+FYpaZvaQG*&N*Ha0Q1#(v`Er0T@ z;vEU?_q0=joTCL?qsfi&5^|}JvgO$9Gzf$vBOyJ-Z5b_lw1TdXxBRwNP`T7c_UPPUZIe6JW-?@2M1L=acFT8L@$1YDr z!k*;F{!}kmt_X#NUQbM-!c3_mD`q6H&iySyQ)J0XO_+{7nLc`C=JfP&Y3U=!Wlowt zK4DDONG(k-)@;|(v-SGMk2q1$w-mkUALF;pNOtLNFDc!uUFkR!X2zARUS z!Xl);Ayo7tE!J<#5WRjzdmfB$AYHdMX=U5zy6ohE?^cLU`mtP4P1y{opMQIfO&Fgt zIw5mp(D@0PiIjV&w9U|7&~X?AXq(URu<6%@^7k9b6e<>o#gdQLilM&aH6F+7Dex=R z{CR!}9j632UaS9VcbSajNH5Np>PAiS6WhgDv?t^ew6y&7*Vh~vx~Juy&tIW=zvL*- zo>;P65ef_a@iEeYTjO$;TUO3Uvm73qdT&#I9ut?O*TZ;yL&^KtRo7?`6A1V{FHyzzHhQe(Y$q4ay!C%uIMGJ&F ze)zahTVnNmgW5SNH}>-oK5=yQG7A&nOAA9p|J$NCuM z>>ofMp9bkxPvJPsHgL(fXmY1pv8J&YvAhaL>C21q6vvBK<2juEQ(pRh_}!c7RmX~> z@}lbumTTh5RRF!zQCfAdSP8ocOTOOOoUA{OGG6b*jBX$eKfLO+=;A)~x>&_gn@oDJ zToYHW^yg82uOG+TJg7q48U~{)fKV6 zPfXF*v;C+?)8GCT6;1Ija~qZRo8q`th5JbMT|GTq;%q;C*OSgtfG(KE^V!3oeZ@| zAC@aZVG&p#ZBSMhAl2%?^^I%r;53I$K9Z&kx~Ysr`}I6euWu|K?4>Z}KOx+e_q|DK zy!GL<6@T@fG?C_YlOroeVaakuC@gf@T9kaX`#G2yLIpbj1CwarF^5cvCF--qppVgh zt2^PnKKG3r-~QWi=UqBSwclMxh3v<2K^0|FuaDS%sU1whM4xRaf){XmdN{SJee&Sn z6Ax{6UGeiP*px2X=l=boCtr`=L4V-5p0iw)`j)!!Y~46^VxiShAY<&Grf#J=^W;qD zSlp*n#&c5~I2wv66)!RfcAe_WN!>cE-Y`-0A_?io=XGib-;&PdVzs~Op8Nc0i|T-u zoGv|mDF6ScpCQNRi?sHahZ5)*UWom%cdWkt7{@gVpNNvS58bxp{i}-4r?Dk+bU&Z! zGs_jBu%PJ&c_nsbPJbZ=^YeVOS(RBDv*i@r-gaTYpJ(D)5*%d~t+B{T;iN=8lhgEi zQhT00r=hx4V?F&^Rev8g`Fy>;M!RNDigPz8ES~vjnL{7frGX9U-C_t}xsjr~g6ZtgHCemh;zz_C49u1bB&n(Jw_sG6pDAAT?NC6@rGA2Zg| z*25yD$-AEV{Lh$_SK=rD9NU%Us?@g(rf&)^Km#4`UL?WCdwHf_FJryjpBX7d4LiMU z?!2yTmudBq=EGC_$#S1Y>Q>l#`8S*HJTE3oU(VDQlg8rw($n25#tw-Xc`56mnlC~! z%Gn=JxuLbTI+Sa5+=I7c8h5eXnv0b(ktx$vf@iMs##=F~iQ+5+Y_Ezi^jZH!;=o0Z zW>N7euCul@$~A8(ls=d@tppYIh#jxD3!U50IZkOmyn`lfUp7T}@4zRYjQ*wlRkTfx z^)Sj+U%c}quw6W^vP5TzHj`sDBCtI+Ll1I+>NWYDH1*a6aTB7yYpB(0TD8Sdz;X&B zI=vnfFay|Em5pUX@yY?~6E`8aKCvqzr7pQIP5$7fMlaHLU&xVNs6Mk?5ekc7`cT=3 z_SlB}>me@NgSM&8iq8ezHgnq7?H!+IY35Mc1A5MdCw)kE0vLb5iL28*p>ljjz9XP6y=%7?L728e>^0 z$A8iJ+dt*Zv#u<{JtCh>*s^c+rO8#$$dtK!qO-wDY-D_@s5x&cSNS?m)aFQn)+hAj)zR3 z({J^Z(8uq?(w#S-IeapGu19gSrsu6#u8AvGx_O1#H3H8IwWPR}xqFFDJbEpo*GY3! z(a?*O*nV*r1h-#tezeqe(H(s!cS^5UL>)C8^$pa%v0M=fi{SccSVldhL2GF9BGOh3%K3e2E85|dhngxws~jlFWA$B@+{ZQf6F~y;^VibKt=43kGt&T>p)7_OJRLhsu`;iHC+ViJ9WW0xrj8 z(1*+MquzUmP+sDBRcouh|Kd4i+34tIH;KC&!KD*+AKv)WrfjRKr`qn(^Exc2Fro{h zuky|#<>7`TITyp4$^%5AKAQ~sP!}cMH=}%f388KQ>Z1AKfTteSGySqokmK9(co)Wo;N*>9pKRQL25b@^B}H z_I#1_;~!z@7k%?f``(TjLQ``U$M!PH+25CypkE4}V{p#IoZ*==o+b#cpq7vqYqsO+ z+|YJx{nzPNyj}SA<*WzmX_T|SUp;ZFILTRrCL;we01U3Ccpld}Pp=={XUIcFhkN0D zpuauUct=j8^seQkMUzLYjIPiuNe{nK|Ic#Pi`S{n8BSbASRHu!+M--r(4#cgyfHY} zb>x<1DL0D{*bCTBTMT;mJCEztpzp5{sUu$DeAM%$mUz@xFK2(BoqX>X@&CREKaCp_ z@dDQGaK7G7M*RluiImFAN8I+}jyvcTpNb>>$WAQR#FeW+`tdl6(tr8wN!2905vqPX z53(}hTHc^@f1~p!Gln_d|BLPW-a>u-p<}E+I1K2$LS(CpzU-Vk_O~g@J0a*lidR`0 z<%$@KbgSEq6VW{FPAA@SG+WLaZM9k1gC2NNhFK^l-+7@}U-;gD62Q+w)j{>3cIjx8 zJD(TUHNARbf9d#Vy=dRnHb=DwFU9tBwJr4d;ok?p|E1oRo?|&JTGRO<%Q;33aH{N@7?HRLQrB9eDj`d}^Cazow`qC4W zHkXW!9j`b;^Y2&jLc|p9T$xaSjX>oPAb6!XSbItJoa#3XNo&LV%JD~SIprrF2l#8c zqhJAJ`NSfRsH2dNnPkl@U@RYFD%6+ITt2#Xq2q-xj~^J}A97;5emIPF{iCSVf%_YE zDrWWgy2B`Ef1zDZace!$2y5=l0vB%O`8~^7FJAi{CxeX)15$LFuSD^8d>!fe){(~N zeKFU#9z=N?&r^=nzDFA0EEk^zVzEi(L-((i;dtipzgOOTxtPvb#pAtoN$}&HQgxo* z-PLVt(hS-r*F#$x<%$>!;o;%R_Zaxv%#nE0VwpOzkuLt=#Onqx^r8MT0nnQIP12C( zC8YO^l(y!7k(Tsn>9vnTPHrxs_J`$)P*`Nx=pIm_71QJ_iI_xbNy7_O6g5)NJeK0t zi~1rrQIDRp^?K0x7xn9v@1N-%DV@=z#iZYwww^Ve6otDEkRB{ogu;T}6`JCv4^-gO z8PG%3=-dpvEx6D++lKplYT$CLxWCv0J?PkAd(bx7gztNAc_m6}bMbu(zZiY~?5>cL zqv0vigXM})SOnA~S?#gB2+R2|n-e_$oyF18i-TuP&GFuJ4^PbC{8=t!t!xI&Ki!Fe zF?!WRs$7KE@KB#BSW44QlHxV}_!o&Php0&NKSL%Es+lRD?wwirn0KfZO(n?I{KayB$gd;Yse1YK_A3ug_U- z%p@5@{-|d7Xp9?$lsCranCVvkjB#RIK96oEiZAUJ^+}(rZy%_QY6$pwtcmfBB=`L5 z?_b^R{FC{(Aie0gWO+^W$;1m4p{;V`q#OxwJ&v2F*N56FrM_Zv-bd}e{fP2<;jV$h zH%6bO%{J5g5y~j1u;gF`8*WVCOp;y)Wl6$qbfps00OQFXuqhwv0M=f3*YhYyBDmq zS9nApgHcr|e0_a0_R|!l%c{Y*eU{z)RL)YZ7cHyE+25}|nT0l2 z9v-ptV4|FJrcEAU$G{)%hY25W>4^lydPrsGuS{dLaCBbeh5meA6yI;idEMbB?%$vV zq1&6Ozdbc%>b506A*$lk(|`!cC};o5BZ;rm)HkK7uP?@g73B#SpAqoB+0hd)oT)os zD=w#&Mr{XaAGhKCHhEa@fW8Yq+I+#bmW`#QiyB?%I5_>CRUvyRUs=R*m zDdX#%Fi#viO7<4#p-~<*Pm=ltnjS-0(-=q#a588O=p8}S7Ip??@7^E|&_F-EvnCOo z2QtAlU;}v6OnHaUl~~^lwt&~b7a#(9#DWo^5YV^9>AR!!jn09n1f_t!LwE`*X9@TS z(6rp$z>dcHBpgI9fvYgkS&kFDMQAi{!Hyijj$~pdzG{XxE(YI8Y>w{;qVihNmi9tz z9)$z!=~#SMu`BwtUij8vUwoTx0KOTAck(31-f5kOGAc&A1^DjX z3Vc&=Bi>uI8S>}xe(4YK4YyxmtCJ(7`uNE1r;{V3ZkI$z>G%NaVSKps`HuA@S9U$= z4ScxqWqf$B03XDA>CyVqP`rb+&m9eH`jW<#{`? zK1W@QorX&QR902$%{|f5*698B&&-*={81`EI0{GY2g?zAH&g+VWt3o0p_)zAyCQyYgNc^5i1o)@FN`VcQ$%fb04 zCAbN2KbyTUxE*63ik9R?O&ZU;Z}weyL_%?FN0zHn-}1=x^&Od_o>7Z}>zTeKTKYV? zS;EwDA9rl04fL~~Eca=sZq-arIZu3jB&8(QOK%80DSV5uWA+yei+`8e4RWL>Em^Mo z6&BUdQ!Q-GgkGe<RZ-8zhXOmQ;iO4II&zy7YDcB!BZMb zmt;TFao~`YrHc*y6wB3AeamX-hu0?hMqp!+1lf)H{R-&C{r)=%tz*b0%QSyFuZdj} zy5ArB-PL=q81+Bu$`r@-(I{tsOnSmcjZ&>;>gCmFT>sOqh^O*O&{!;4&v@v;dOm;Q za3|$auKAOm+u)CGuJU?_4qIYM*&+j41WJ3V?}Z1RjV$Mb9RDvw*EoR#pEuQGT}cS&KU6nBza#=9ws zrDQFCzTQCBt~k~H+Mh61{?ek9|KrQ=0Gl3jVfC~ev|DqnwVoW`IWePd&E-AVsV zcXTYU49Rl6kH0MRad*S@Emy61ck6DPMk?q4OkKwFbb!z#YP({xE{`A50L!Zff%Bfe>c{CWPys=tI zA{I;1kNTxJ=-1`PoDJW7`~K@w9^K%fYbUYZZGpeo-jl6JKYlK4e{3_!dG^Mvhps+r zqSoCj*I#u0&T<6TInu^=sn4(f@kw}`N7N&JMQ}aRJ2jJ{uQ_qpnw1CU8TDYfP6_9G_(6Q3t#Z0`CWOr8wO9LLI)+3ST$El>;u%ZP0_-#st9aB(;G&E{;v=B?@nTC#fy3#dM+xYKEEu{F=3fb4KT^)CGo6NyAu8{3p_zE%e(Vmh zAKThBmiC|bz&E#^`2L}enx1qF(0;I76IZT|a6b%c>p#gwH>=gzg!=vPt`1%vd!LS$ zE=`<2sXU?G$O6N41IsISK-)ON{SdBkX#TPOArNstwjn>RSJ_tt-;aaKn@L07eJw41 z(vUJb{>X88uw0e;mbJMbzFQ`h)k!z55VIz@{^id`O9xJQ_`TZ>_1XRt#(>DN{w!Ce zzU2|>Uq$6DNSf`vBZR)O&qqtm7Y=^9$6tS6Hq@Xm%YB-vTSus`R#o^@8NQk#9=EHn z3~uM_4vnSBIe)D0wQugg-kO4JXO-~Sf#HV);C@u+_YC*Ep=<9a)BU2wa3J2jSO&U}5w zjBj7R-l{3Y<wVYr z>s%cgQJ!ASpRVUO!=D`MZ9G4%_%2df7B}p(wiTz{jv;5o(fJJZe=OI;l`BDSswsFu zkZk-gvA$E|2QIV}yjZhc(>DayZ_vR=>4v0doiUC2-!{LSngHv^axK})l|TK0c2)-c z#B$#sLci53n@O>|Zu)ZT``6t>^@1Gh$8uHbTZYt6XwgO0M7_!@g4=EP4|q=f<)5$b z^YLkqG%?tXkVo%X-!=+*DF5H=Kt_g!f{xZ^P2p{ZTfGz@GW30AL{?2 z0NI=DO69{&ESo?!CwU-0PRCq_ZvkWZ7|Wo#t%jAFHxqm5g%s4^IzEf=5*=QM(14WOEnO*V}aCo9SL( z|3v3$rGA+1;-J0nomQq(kt?UfN)### zF1N!W^f~xqwDjuY!TW~fKl_nUAC|Koysm~m$_E2!ywIW>CsI=q_4M8l+-|Y2Moaa- zE_-3rxK|Gv^<+8g$LmTxd0q{@D6L3V9tzArT?@;YNK8Ec7<6NBJ=1qaOP#NM&JjC0 zb*@oQma~4muA*n4c{YZU7VQ_?M!on?K%)NYUHMzl(y~9tF3Y&~+YgO;v7Ghcbrrp6 zzN$0ViLV#->sJl?Eqk!)c@pOl?iy2Y6i53eI&F%AD5~{s%F~#ym`N}{F z>4oyEZhqAbA1Z&-|M;)~)tj2uotnn0Ez63!i`$ew>&ENa%Cn~Fi2Yi)=lnIz>z|It zHm0?>pR5P%ZxsJI2G>01{!gpUcKxUGHS;^ZEKt|4&y2@`@qbN9E1WdK2~(52Yby@5 zt4CAEKxtDOFSheXdW|opRa>^HX*z-Sxu)rv@oL8cb-j(MoxMDIsra*>Sl7kvqo+mP zO4;8&`;*lzt^av#Oq&F@d39}5m-@QEdu95V76@&D>el_xDViaUh6TbYr*Ogq(#_ww z1&0l{z2p3O&GGBfI@o^JR8QL9+Sq3?o!UsRru*YB-oLF+b@La)i`)M8tu|$Jto)Pt z)u!&pT3W&E9B!L+tnG7k^bKchNxYBY&z}BdMjgTlV~kVV|AXlu`tdfeYg>=nPLImR z*k_UM$BO>7Z4Wa&wLTc@#PMbq^B4$S;>S`SXe>|C-Kc+EZ1awmPDd-<(6z=4VOpU2 z76>-Kg8Z23r)jT7nG`DNl0(4G!yq{Oru0_q%{tFfex6M7) z_VvHeN3hM0<$d|Lb^ou{Z>}5W`uMiMzkPfiiS>hBR~<>ZX56}M0kO{hm)mD?KkIgh z1lF!D>_c79A+Uu^AJYPL(*nVc8}bY0UpM#Yzp0fuF7@9mS97mS3mi`tFt6v1r_!$Z zzMAJAHMiZd9P?XcE_z2f)G8{fVCPke{Vn5S_c_`Tpp zd3FESB%M&YRab|)6rRhxF6ne6y40k6k0ie%iOah3x+ZCbTYh34K9c-uqN5onum#Mr z@YzPJqb#Mq=bz|*I6rfJY+Il)5txRqd-|8$Pb96Q^p9wIea=z`9ZDMn7YY z?9XeXf3W{Gi4!cnP=3|Tue#wwxu9nAYNcvK}Ol;y=gW`rrEgFWdDPG?}ULF=Tupph z{r_!$fA$mWl(_wG>-taS?{A;|$^I#Q>S{iwO#+upb!}6Z`nte-_0RbH*RF&A8LQQu zT&i35>yGBfmnPwqQ#fG)Svyp0sz7!*miIT%J{@mzu?&y3^N;G3mAIePiC34x)`fkj3p&)LGBI^AEf9_cf*m*H z7tBAL^vy7}V*ztqs&?#Xrea#aw7|b-ftp;;{d?M)IsaQ0FwZ^yEzAGA`5w*l%|L0B zoW~gah4Cl*cdcaRZd#zK1*o1H>#D#1Mp@OA{7Y&Y&)*zg|2c$~iu1KYhdzEo)U>Rq z9V8obdw48c@L1mmE<;-L_OV`EW;-V$Vwx(=HzpPFfv_@1uMG#{(eSXvt>=& zY_exv+n1V_u^G>_fN25K0;UB_3xs2Vas;C5r52O&e(<)5RH7tcNquQd4@v4z>zPXgKSkp072LjB@s8J_?yKHsHd0E9HfEf0Y@V`I+2gY1 zCRsh!QL-nuFsa04r67{D0|{|G+X4N8*|E5PV`=oLw_4ANeP=FTE3tkoXT5kGrhdtC zi3?`4iQu4G$5A&#niTVAD=C86*Zx)X{9zcS?Zy6vqYvdrb%D&InTSME13E!&4mE*C;?~&~ZxX(>6PjQ8<#bKk0HjI4^cuEFaPKHQ9fTPh~*1 zJPA-A)&|4?suOfttfwb_W%@?Haj+Ryo@BQmjmzQ3>kSYTlg(Lk~t_X!iNd3lIXWI&t&Lz`1 z%I0!=GD>n>!Z}-p$LccZS>7|ap5^aHOV`dgFsx;x9(O&bH3Y0D%LNsc&5(K~I*W>I zo(%LeLG_G71s9J;V?MR@pXv|o8n<(FToEi|e>x6no8jXRBE?a7@*~G<^`E-*Clmc? z+Zcxb^V%5R{BK%-Ef9wdNeGPFFLD!7iPUpQ9qr( zVQ21q<#dn!YUw6akt?29WY~&|?XuEn;!-S6wq%q!a?^@sN4iVSr&Hln2oX-yW3{G7 zJmgg8sm-PqD!r8?z4^@R9k40QkLf=5=PA3X8&zDQwlvB$Z~uBE7RtFZN2ZNJYhGeU zqX<_HxPOT`O|?fnWTXeRd2}vY+E0>prR~ecru1I#NxcrPoH~@Y$*Fcus3KQ=gV;mU zL9{~!^5--uf8%&Z>RLnk$tY3+i0w4|5&a{eakBQmn>WJ zWLJi5uDWBQeargrEm8+Ir_^DS{7_ymiuy6x2oh%<(z1Dx@CPqi+XGs zuCMRZmr)xaUdQivV%LVxI=9YNb5YBgmPR@ISJ8uxe?<@BphMu=?&q~?sOw8v#<~St zi($zQ)-WKJwZFIrHiRo}2Vtg^KC>OVlVT}L9u(Vwre+nBayfJW251hAFE%7Vvkx)I>Y3 z7rdr4#O-j>;kcqd%fxjce@=_Sav0;bzjQ>IxGko~axvXtGWMgj7)RU|!yXaTZ~J7?9ba2 z#&mVt0-=tdx~+Xx?Zi6CzDAkxKZgrvU7fhbuzY-wJlOF={(KCDqmvot-?M-hg(dbs zbRUz-k73QY?CC#^RnmWB9U#9@j?y(<_!jUYD36~>3HtG?Joph4&xw@kx4P@$*cX~g zvtDjpe(#_S-8Vu`j&66+_!-L;p|HrHyKE(PnpKfmh*7~jn#bdE+U=OZlagnbc?N|g zRnD`O6j_ux7_uuXMN4CoR)3~+{^|)%mdcpx2h|lGS8jyuD8O?7c)kMFxn_Xwv6H@Z z@0RYVw*W1{$pAyr%6)gb-%f+knDU~GOVU00_J9VfJAzoy33LWsKv&QW(0C@zedq~# zfzv>5&0y8--<$*DK>`>7 z5EL`Y4$y;3nIH>{2NM8|(@p}D!4z--mN9d0O<9I!SO3SVr{dMyn z-y@SME>>F_<*F}i9ppGjz%--TatdZIx@KGLl}AK^ql^!Sl*)WWJ!2B}dhSPqNo5k3 zR9`y%o_#}C+ajgQUU@9$@FNF?zCs5HTr40vvz%n2tAU;wg-(~psHv#u7K5Jt?Ad7a z1F!7)@*1jkii_2jM!D)+9ebwb=O-4I1hVR8B*^u)Fe$h_x7i~l=l+DNw!UPa)+0jI zBo-^OC(Bi-ZyCNl4SM>us=l7ajMVGv&#qY)eC#NAVdYHLC|22sm5g%suZF&kAZFDa zPg@Ln8tdsnXQUK!xZjCGZohW&Ee%vnNKdjW%UM5O*HllVS;cyqJxYJyR7Pg`pkgPE z_epm@73+?a_ST=5|I+0>@3T{*0T&BMPnMHRbk)=o(;jm%l>#&OEc(M=tfw)fgX@_+ zJ5qY5*|%x;Z`pT_QBRhOI?{H{^)y;kO}PRqKCU)FUvkvc(_v$*r{1zi>BWSMv&zTa zyM+29areh zv0M=fi?H?bZ#GFR=fej5jCP}JV=dhapWWK>dRBq#OI9|@**~SI7_GI{;TdJK<0d|) zhFk5nxysGj$|iDz(>b%q>YAA6{o-MqWc>KsQ;nl+ zF;eeGf7;q&{DNs)=p+k{&K;>-S*{3$MXGa#6LV_wGM!jxw_dZ{mLxgfs!TcX!ti8= zQ1eqcNwu7O*RfIX(7I@pUiDo~;#5DEV>d>i@*$g3mqTlUY7W_wWc2_}sVe2X&2o4t z;V3-$k>hfp{}hh?^P2r2GM&K!{>q1JNY`+5?M7wO7|?M_WkZl7IhTh&`--*~%R-5) z#pP{t9oPc#D2(c~Z-G+^--pVMoLH`bw$+fnr5Km$5yvyu0rC?a*B6#?JWfMQm;BV8 zhC}wFw+y?s#R~;Fr$?ITo1LYY`++gXNen-y&rAV6FmDPshxO{zuavvZH z1O7v@f4-BnnBM!~Ul%UD|Apl{yD3W1J%L!<8DP006c$>`p+1E(29I`oQb&+?IpBO_ zCh6M`W4^_!8%aa9r2c;U+mG#v%cC=D^U1* zdUELY{OhNF?>%qNoNe`TY;WR$aiT1KL)tk`2oaAO`cTJc=^hbMtYS?%^5YwpZU zCryyXGX{vjcGxymUk=9ck=PxP(jCwAT`{-A?>)1uYEHjkMRs60=g;emS$50pe7EvA z20g~l@)#JJ@(p)9g5&X;%E{>b$&6v@>VMN7`jRq-v7`}B=L&i)y4f$|OxY9rF^RuA5BP-MXvaB(rt2+?Y} zEa^_S@Hz`irn7jAHAlANX{(~*5|7rbNwG+fj%&J)d038=L_J7{BQ00n57wL3{$!$m zUEVhBp)VcN9;Q9?7SR8z$@Lw#4}5(>XOMJ1gT`xV{Fc^q=0kFVE>US5m*D?2RzdM8 zEs~L=|19G?NY2~5=6uPI9Lv>z!I#wu8$2b`_jt5`c%2bjsGi@)!w^)jjOX`<$2O8q zy1Cxr=dX@hKy$9h@i-03RjF@T<+)4c`A>ShR{sE~7a5A@`*BEu=CRS-H#!#i7%{Hl zrRYlfQaI5CJ2ry(iD{VIss+UH#rO+-*MT&RBtE*nG7hjA^`}ql9|Pk~Y9yWF{5bm3 zP44m*FR7NMd3-MBR%e)faJICFw%r$QWK!=10<; zNSg1^3E}_20_dG?CF2rQZs4kd`*;|tS!o)~R0_ISrOVZUjNVg1gD%VNUoJTMR zYM&%6KRH60o)sZ|d{cx})S#Yp`i1orJHkZDe8lSXV{}YFUB&TQ`>R`t;b@zk7>Bm` zKd(6+{ikjI&+(~0B*)>^e^vkclXDze^EQX`w+<(azj&tXzik2I@j`Wy`U5(5qx#Bq z6q_NPSjWWeU=cYSL&ZsF~-}Jo^hLH zv?gctr)wyZk>fRQb68O)C7_>$7}t+?Kv7NO1x(QN_|I4%9+g|XKB;Rv7OL*@aYK5G zVa4t0?o*(+VqSsL6yx$X$K(I3EB$8~g`swa5Zep-Z@Ri`0rU8&S~gs#jXr!F80F%B zF)nX&JpNDNX`7+{=J7*TIQE{^xojhBt;W`kDW$X8|vQQ~A*I zmvQra<6~3~c^dp2a?gkp@oepfkDsuw^ALVsi0&EC_!!IaSLechE=T_ya^-`U7>3f- zA4+@;JtPd*4eCxrCFy{Nc1hQ8TsZ>q{%$txZ~1p;Dr0SjXG&7Rx!dC?z0CBNrZw%H zynwdJsdchm6}jq*=eg*s2zYmWrW4$L_Qsny*T08g2>Mxavwa@u)d`veSwF| zi!k2V;v7lZI0et9FUGUnPfOCHts|r-H$+H-)9Xob7u1*X_BD|1Z`DY8;k+i&v_s9L z)mu)M7A@~6z4K;Y>8h0@q;K!cmS)+OOEZ3WSsFa3XT*i)+!K-db#cAJcV1qf>{&$za!QQ$W;u3K=fbgfLT;|JMElT)SP!=u^fA`M^q$S6 z^P4`qx66~C6d3hkxlS4U@v9FPyr75|VflE-E)Q;(gT0zbKc95hc`GY^f5WH;%fr%x z>)}|ZC#@J$JW?F$v@xw-3hL?R10Oc%XSCDm-p!=5R$bQc>?dFR+o&JQ!_vr^BhvRv%!R6RpMKXfb9~$NSzP44KlH96Wtq?I{?r zklHPq-Uij;G04P=yR<0L~F4%2cJyw*ksI1^xG4SlXGE3p4FtEFS-r- zkxKxiUzL8Ke>3TgyKla2^V^osjdo!;ly?*`I6A{MKkl7O~~ApI>u-p zmWz4QHhoUUnKZ(ZRh)gjQ5ktZ)SFz zb>AP@cMoloQ}wA=MXvf%d+28#8Y^H)$ji$rvZ^1sQDanK#r39macH|d^Kgdz%jQMf zIKS4)Mr+9^Xa8iYqhNv+?+>TbdGfY2CBqFS@*G$podIBQDvS z&SzMTzd9FCFFfZ?0mXV8gL&0dAGrR|Hl4%pah{I+r#uq<+G+ngWvDTKmLs^%1l&Dk8who=}LPn#Unu~mzvIp z=6ubyY5}TC1l1cVU0OE;RBkkffX<6K3^q-7j9WnL2TCsweLUN&`}ehUeE0*A-AA}%k#YdPmj^^|I>QO^G1=p`y7 zwtE%OhxR)G(3*}78gm!F!;yR16%F3@E*}lC;<(*2%GqD9552@=oLp?j`#IFt@LR+- zkK%~^!M2sb?XzVFcjQokV>~ zSBJJ!zr$&}qHn54Lqv+>_Qoh@f4x3c?IgA}6h}P1r7MElXZ0;nQrx^LpAMXO;kE-b zfCWeT(DBW3MJO!v`snQ=>Qah0eBN6MJ;?4{PNWsh^={n-&o{pJYF}(h^`7n1>D{%~ z#e6)f$7j7tIfW5jrZvYh+T|>v$7M2IRtG&w?R4~)ViAb)rRQNPkT1X2@1}Zp_Mu%A z?Gw8uxP2(U4}P0E>!J0hC_2)A+7DV9<%$>!=%uKoK7pqWx3Vm;a+FK2$EGm!cy-sk zgEx2ofu;v5j`c9g*`M>&^q?;Ru}D-yXOFlmL)+u4^edm*Kdkc}&WH6d%GsYY)$~xl z5R=D3K@+iDwuGU_yBlNHkJwxABIm<;80GBGS!#NW!vppnnS}xLh+iAp9_Kv$%ncuJ zKW!7|!+IFy?9W+hdZ@2@WTB#mg@&Sa?cB~V^ss#NW|x&)Z@7f>VLgm;_U9~h_6Vqr zzP?Ue7uqh5zA|W@H1VaqoFD6Bl(WAZXk5SJ427UZ#(ti*cMss3+6ty9=J~`<-25oOY zu=4gN>tmF2`UZUh+egz%Jdf}~A8OYV0Odp5bY8~e57?A;-?p%Id_fTfQ5@@Il(Rp5 znmNVo#1oWscWazn;>M?<9eL;#(p>68@EAv@KzMGl#E$QKA^_b(q63!ur=A=2{S!T- zMAxkRU1MxY2PXF%uz!K)$td~*N4ht_lI4m}SZKplDKh^KMc_&bAclN0Kd1`S|)6r`FnKX2VTov}l;kWY5DB!o_q) zb%czUjL2CIJM`3DU&h@O+CGQU4j($$e0KroTd9{p&i)hR9Qv{c-d*la%fVEK*|?v} zh7xqHY;(o(ns`fSeew^tS^521&j*|z>tmF&zmVq$%t~0lW32ect|vx0`}^vJGJAy{miCEoYv1Yd*kw1p zS<6>vD6Xj2vfDz}-#0!wz313#?%&AyvR+0x`}>r@WHq~8X>hcQ#7rl(Jjz5Pe0QVr zh|*%Bp$T;TXsmJJ31dCNBYot8p{=-un_do2333#E(i5+H6Avk_C*ROfI}s#3$X+b3wjN2c-C8zIwz{1Tikl6no(7x$Oy{sv z)99W~6rlSoRBk+u7L9FsXFI(|A_mZYKt*N#@nM{hi^l=Hl(-Z>5XLb4pVp!a6hDxh z;|B6K$~nAo&EZJS+ef+<(-OBiU6vWwMt}Za-8H4lj^dIFmInLt+Fw}FPu%9PBr`hB z+n+p?AE(P}N`trkt&RT1JdOV;4R+!-%WAp~losnOrpq#p!)q~2O}52!Lv7b2{UeRT zIvr^`6u+i6t7$x=&i>K~w10u*N3tJ*^zo;cF)ZgBN-xo$x5c%;bUAHt9VlFN zbo|MVG@rT>pZ4v)ynmtWd_3=aDBGC+rUgt3m=-WCU|PVmfN25K0;UB_3z!x#Enr%} zw18;=(*j4|0<|&Ei0-A*z1Fh<%^&Ch@Cqqq+>h?L(tTNaj)CsI(tTOJKg)B^X#N>N z|7ji?t+m_8mD~IuUdNRa=Z#E!DfE1RX5O*y4x2Hy3mZute{3Qd zTZt{|wd`fRUhyMNRP-txAW46W-!`jsXQVXZo(XSUnfK$BCsGB3>j+3MmMcPGQ7ygr z{dS1&1vI~a-Xr*b_O1gws-kO8Xi2C+P(Tm@D8#}ViU@+35K4kT0tpZVfsky-O0pYv zHxLjth$VbjKu{16*M_mjf?`8NMZ^|S6c7}!#f}{t{_mN4&+gpGW_LmTzhdTj-doPx zJM-Q%eeRTmS3>hz@<%fYYq;HO4)-7}X*yH5kt<~Y z^Q!aQ1Ur- z+)LuC;r-8S{#?^O6F+OC`_FQV=eP;szg+D|u7!o?R2~~5;E^VY^=E!SY&p zU`ZoHY7bIfP<^Q5r&3=FuaDpMH%l#ZUHPcagXKrTqgK6CMZl+V!@`yie!t>;oe#@v z<%4ltc@A$%jyo@?YSi>y@OpT?oPBGzcFUi?YroEe>y0HA!1 zuK8?c$B@*Sze59R{!$SpzL5VZ&-86l7Qb^2bK&@^%h^6$d@S1zNh(!3A>v9VCBhjyk;?6DB6a&a!Y7uRx`Z^>SiK*nk1x8$vW z9)t0V|GufXZRO&3?KdoKt@C5Kg&c1D{89=XG^xTi(w;LD+U%uF8kS>kYtocXRpH3_ zyedV;tRRl`I@Xp=ePd(R<4&A;TGkW z>%J@Tg@^wSvFF>}GTzV>0JE*lF^At*%R#ZnI_{ogwZ2|a)kRx6u4<9cnCehuh*tv~ zSuTajp*CJ9JY+G#kNV({T7PTB7C6_%MMW9^rppBQtA-E7OX_pejT)cI5ufO}WPrku zuGMz^KCB$yrs>0C_k(A@OZgNT&KFs3NCQVDKBajwF>75;ba#5ZIami#nSW!+pZ8kx z=lEyp$$pu#?=bIV*@N2?qne9H9=cleUoxs>Xj{WC=E3p+1LI2JK}n3}0p;Y)&2kxQ zuk=!w7|&bMe;7Vh^_q*D`ZhlQ#cq9$)A_LcX!+Pi+vfzhTj$**y%$jStxurCasjOSy--rUnt=WROs4xJCn$xYP+ zzTFly+*CfguE-rVUKPJ@)t6rGXE$ge&O3eK$hSAndxi5bj#n&KxzV-4FB5C%7||&p zl-apD)lrRCG5bREA@}Dx#^3bI7cD7CN<-mCDN~nAF%AK*ZL*qeE;5AKQg&LpC*27$ zUi6S+!A)0j=A0awE&a8=2zYH+dtm6s+eh5a{xUCJ&h`=WQaI7Os=oT|53R52 z0ny^*N9-?NH2IdV=wAXE`maFoo#j%f928!fs!|H5m^^v-hT z!Doe!*^D)kyk3B);Zz-lM_i-kqCD%%SKFS@twiU+a`vCkVR>kop${)|d@cVlv|cKs zn~MT(=YmH)BPQs4Sk6579G(yTq%r;)nN`~ix5I^Xca0_C)OtwVN1^$ZzaAqF&Px#+ z*OxUZ*UB}PGcP{Z%1I0>u%^Rm_-@en>h-A9w_}8F$Q7R-9@c$lPxF1Qce30R z`%emAvm7?_RqlMnA_X(Bt`Y4;L#6^?{Z0Ecbi0L~uiUlqrRm$+CDJt+uCM5F!`7ld zjgKR5aG@)ACVrmES@~2VLVF5-3((c+(ew{^B=QuNgvRjSmr@?0J6&qu;!) z4b9>3?>+|$AFfONySdf*Z!NF0zqIC~dcH*Zdaigxld&&&U93AwgH#LEr`bFU>_v(PnWpm@+sDKXLSU;zF$7IXv=eFZf1X(mo8`fV7x*RQp=kS zKZe%Rp@uC)r`zkF)2e7hu~|I(`*~Q-Jop?LpDb74IddTvxh@MWDjU!pxv8f+l2KcZ z`OultVO?5;68;S)Sor*%G$_0|>{WlL9A`T|tM>oY>;LcYq5lg;oyw|l3KI^a+Mcn# z@z1ym7CxjOYR;0*IBz4}1=B0UwaUq^&ipwI1PdPu6Iv^Z!-MYWS}lXrYgqYBZF2tu zbr(mZfigVJ?Z19Mg|5$#!v}f}d1;n!d_TG-Lu=~MQI|_G4uN_K8lE1zH>JQ)hyj^$ ztucB=?XTJtf&WF9+g#f=c0QloH~OcW3ti6k!PX@;IzVNsQ}*Z6cpjBU>Y>njNSY8U zcAb6JvNONvydlB#ha&cVR%c%WYO6?RiGc*XS`YMv$v|N&3aA z7aE5}Pfh!|k(gf6f9R%@W5r8T@7{RT3&+kIY;BH_q5Dx{<0jhxuLHaBxx;F}v zIVea@fTM%qXfrta02Z~o06&0f@AvDwAWV7)u^juppFI-uGIHV10_- z)gM1^O+(Mqle*lrR?}gv;ZDDdu-3HQ%id2|^zp8@hw1%PEN32k zR>Ix%Hh94M@B-&ghcq7ge~859&BfPA7xsSli7&_RpdU0a)c&LR$8srD4*qd=LraV8 zZnR9D-kd@?WFE~_8pnoQ%T?mel_TioUr0y3e-TNzgP`{F^Zgb++&=HVC+4G!`L8hr zV=O^yq08Am6H6&Oa_tjb?wMFod6>hA)$C_r^smuAMu(X(K5(475W~1ratblv-_nc5 z?x^`n;_ue*6jv^*k1SARWMO~my-l{zJC*169XGXW8ntaLZ#HQD>*3M1LA02fvZme>G1~?*Q8=<(3Y9}(-%2|sKjhivjBVS5^_0W;7Nk)dgl|X$$1papJ17dqR^LupWd%9METX|1sGGrIb)Fu!1 z?0>T?9^^Uv4kG+c%82jv^@jro=Rec#fiAF9?c-Vn>?amp|KS^&eWGHYJbS~F>9AMR z`BvDINd_ox==1w4qnn8}o1=$KIP1;p1~sA(4D{=>Tnd$gzh6JZoO7C%uFmPF*L?t| zuY%U0dF^Z5Oe}MGuHAQR`n@_YmXn*R@$(8luisBkPLQCVlrWnB=9h46Xnt|cn~BE< z+#lVpYTH*jKbDi5s;R;6PtNQ2e}uVi!X|je{Hw$8PiomroceS6oSscjh|&48T;)#J z5%E8QdHgzmHUF*Z9a{gzt(%FppMQ4a*2Ghm>-!f{pRF zgYQD0Yum5O_zM&I-J`MnyWBk*E=Ti@5hEgd^Uw5Y{F!$nWA~r?)Ia&#|8qm7j#-@s z{&zJ{m*@QNhHc%K)oGwk19cjx(?FdD>NHTNfjSM;X`oI6bsDJCK%EBaG*G93It|om zpiTq-EDcoRbNN4YS)agvUK;ndZ(=xU#%fJ`w9F-{tgL!>_boXkI(P`;&%u#V2h4kpDH}S5~a(w4>ej&tm@d z4UaLR@tBk^u^hJ+qv*?sMdKazITXFD%VJo@-zJ zOm+kcXSSnjBR&~2cAK7OJ9dNZU{zv2IWNm|H?|*yB z9*Cvk{8yK=y^@Ycp++cI*})nfwBnB4o#u3S9as|rTOJx$E@K&<3^$f0a(a`!vM7;G zsrlZLB_5qI$F^}E zyBnkC9kb=Id0Up-F$2|nEZ~ue?fqubir)PIwR|84NC$=<=q|WX%io0LXc@Oj&$XGC z=5_!4>hsRXW_yme+cY`bV>=CuqNV!3Z4`2Axic*EI=ZB2y4{_gpHkxSx{9(Kg?3N6 zQ&z!8dyDDac!0i#<^`mJm+CM1sg}>BDOSBx+@Lh-YbQj{3&*{MOOfc?J?^95dQh~I zhU14WXZxYF>_jp4PqfSBN@#Sg9RYxKGsle`Io|HhbL4uBNg&1>K9JJ&k7aYx3q zJO8~JP~&;V@bLA5f&)*@xxM+SXPFhp7hTTwN`68sm8k31(hL~RS+qsAg-AkVRpSlq z&rR`{K=~XSit~}0V9%;D^_upJ@@bQ`>*xl?7zNmB+?Y z|9?ld9L-3x>aXmEm2%y_nEpZxnD)ax#A?@pcc1yFRkPL4niT1KV(?WgH^u%_D%K#Q ziIir+Khoix>9M8ecnVM}D74GTg6OM+6#H+})TKncspf~2FX`Xx1hb$Yu;n+w;|I< zqU!3*oofS4sdf*R%rhRh&QFaw*II9)whb|E+f|6EyI!TG(?s6SF~xIQb^0cQZeXZG zr~!^FmqO)`Qs8!B3AZ5=u+t3o!*+U6b1I#Sdh~49OnY8hMvD2Y8g47WBV4%M+v}ri z7A`sV3ihgnyl5eGIooHr=8!IO+%rdEmMr|oUXR#Qkpxs3O>q^X@{G-ni|oc5@iAI(T zmhqWg=J4YCy7SR%K<#JRgz||@GC(@l>lLY)(c+yI2Pd9AGrAq;Efkhi&t*AoEhf`J z8!sBGNzl3ywjmDBOj(GVwF&cSl}B}!QGZB+9q}MmF~Bqg{Orbw_u*1(wO88jeR~&G zhov#{#)2zH$9ucpM9Jj|V`~0(9vXiDBTVIs8v8t5YHAnjr zHQkBHq4iyTdNa{7`MLHZHqMFC_04kT&u9O498r9rMOL!r7Tas?L#pOqE5q<@+q;?g zCac4&>n;R#$!9-bUN=bYx0{Y1h7KpT1;7|LEvcC=`f%oW+wc7F z@nJ&8?|yTP$$y3Y<@lh>*}ev^uz45#MnU-ZHe67{xf=Y))Ryj3`!*97oss})XX~lzC-&y9IHc>BO9Hg5cU+(wTxBL6+{8%1fW?a?a7s+~7N0KL)9;)B5HOzO!q%;%Gy=gnD-pZb) ze+SEt>O1sxt&ZY5)c9SR6FNNl4a53k7j3;V`T3Ve>EFTfu-{=>-|EN-t9%othvr+5 z)=a#df7#)M{Z@Uir$?3_J>SUEV>~>d^eD$afbSCn5AMiqpV#NuWs@A|!%mGyaTtG0 zrndZ0jBbYY8u#xxdF{n(bp5kjI-ndd)P?GdnY68pbH*sU*X_vl1eUwx(&b13f=hJM zX~VN6IB~wSFF)`d)XvlUHTK1}5HrVKJp7umJ7b?UxsooZJY=~k_MbBCGvr=9^t&db zFvm;7=amg;sMa=aW)VhvxM>v4k+)0z9z}3LUq^k!G$u^#uZZB)x<^b61nW1Tx(ByQ z>J;_w)j&DC=k#1KBXoMM8rw{ierD@kb1Bl*^0pM zXj+NZX-~D6V6+y7!%@B4W2w)?6j*ua^Kz1kqJ?w(&Svdr4O?))>=2@{pu~gawer9q zydnTC6dSgv=W#wH^`z&U4Hml7_FFE6gRG}AjbAk~3EEsO9t)t}wl(dN3U{=4yxn7O zmZ!w6!>@R0SWhfB#r~6DPs1GcLX2A|p~)jKWdQpt9M*O}^_!8V`2TNlVYFD9)vEJ# z<97}k3^|$80MZM~rBFHe{iTw_?jBQOch5!7Z86pfrslCwzq=Ivle($gqWqq&DSuS| z*EjCFZ~Nf$7G^>$4ShHD>gjSR#=-Bu^x1}jtH6~9c^SapopgaUKKQPPlKMV~P5=IQ zXWz!S@y*1#Cl2)~?z z4>!JvC85u1`r3-`pmK!tSDR@#VDxWy_PXQOl`+N>>{laGuD_>!N2=Fb%)yuL9_n^u zBRTvXK-|QO^gUERsRj@BXDj67N116);~)xVTJ^1$>*cefg=_PTr~O)geZ3z|f^;H% zvmCb;qwzF%rVQ+9uIlMv82=MWqs5GY>pvefVfJwyO<&l5mRmf>O>qA`Y0i;39`7iJ zv&1W-yG0KhkeUa&TRE^+-M?nIrGtYOvnKR`4`80AQfjd-qCldV0Xfu zRehEfhyRYK$6jnb@cf&av%BOc`K-&?-v1p&zQJ)0BZX+UKxCklhvMO2HdrWigvLlwzFKV01PX+B0&z1x6v5 zj>llM!@Hw`;iZ~@4S_!u}Z^ybUE9H<&!yPBu1)P>Lqcg zZ;`vn0G(+L2mM>zdUqqyApdmi*o%71H#62vKV}GJHPTRAq!_8or5FeEvxhoo+l=wx z=Fe=kKRDGJ2#;X@Gq!d>zuVi7Jk`^?{w&8p!)tnu%1M^9e|+}$YlUp7r_mg2`2@e` z!-wnXm~=rt|g-bF(XNnnmJ^Ipaw=6h2cKHfeNn?a#l+fjD zFZV;oFPA|2p)Ebo6(oOj*=RD7%ZZ28_*+n7<)ODH$n6&Qco(&azFUqBp?l_`%gK&R z7#_4kto*ByC7T(60U~NXcSz$EEIs#IboFmLziV)d!N=eg1$Hbq*aVId@IrUCw}cm7 zQ2A_~8(vT2ZtVT&(CO!$!alN|bUEAC5>9ewbbDI7gJ7v{@yliOxwH9DyZyiEBF^#iQDFg&08Zm#$9mjmxL9>lw>Ctc2* z0(=brF*TDmr7~8%$#Um7Jvqj-P0Tn|ZmE^*aypGEo#d9vGiiQ!o*z`+`|3mY3>m^a zn5Qmh`=jT{8Z}%}aV}OD4BJ{{(;k8S~WT%(G^>rfAJ((Jpnt+R@Ec zLi2W1{gqv0)n71PKW{t!im`*LKV^TJmo8`fqvK^muYrAr8@->@wjraYkGPA&r`zAw z&pUi#&l`EDx|#3R6S~}RU2XqZ>Pv&|7=NK^lGCgjo)zFjCK(`o1WT{||M=7~U}UGu z=s7Y*IZ#jNa>G{Vqo&tdDalvMaO8AbRc7V21msAc3715RetX;9OfQ^qOP4$Q)_brG zU6Wy6y4An>;0O6Xsmo_i@jIjwa+k`$1^|_V zT*r*THMK>kJw$y?Jcf<>3}~)U9KiLyR=B4BMYN6(_45KJ^FE zT!na`GtdR-3Y-X>1at$s11AHg0zH7!ft~<$;++A|+C|iFKL9uzI0r}uh5*BX5x^)Q z1E7RTjqQoRWMCRVx-I|;fntDq^5+5<0}Fw2;A&tQa3eqgatCk^@DT7gunE`-Q~^7I zeE=oCZ-L){Mo?}X&>rXp^a2I}BY+7&9^eKR02Kaca$bVhto8o|;nP#2USE%JmgPQ8 z?~;L2@~F$D7>7WvOA3{&HQIfB!dfEV9GRN}smK0tl8^mkKDwOk z!}H0S<5Kvj;kFNa$gqC&_`PXSv}ie{bMvy(iuxtVCyjiR`i)p_iv1@mA4~jp6%{$W z!OAjvS>;uFxs_M2dceYEyPDrS?dmqfoeYI<3mjQ4h05Vb>j84r6nigA{UrX1@VqXa zxM<)xkKH|1=f!e`lDs@hUNtHx6>yF7hpiek4*=)y9kthx6kF==Er5J}m zxEl54vG$xiIlV>=&@gpna?1xW&w?wh`V7W1C+oPhGuC9ENAHqhp1RzyJzAbzAXwv} zD7W$p77xcS+%)!_m#$1=|CygIXZz6M?boWMj!f_R0M?r?0$#mR?!PAM*KV{tl{Cyt zm$Utm^Rh-kHJ?jFzCr#a19T3S@1BvA>0Z+0XR1O-!~AqP+Xv#Gr98*~a%`?V)}HHf z=XsQD&Qf2Ww%8hu!Q$CP`7gHE{oDjuHz7Znk1h|+N6qJgQ}V$<3P1jjZ@AB{{kijB z>DHfP^56TmTK*i;;!Ch}f7Xkg+x>ERuP3;HM_~|ySi^E%6GxK1xa=V}d;q8Wl~-Bg zaWGz6!pP8jB<*cWX#(khWJxi}&WP-`;jm ztT<)a))rS)Og!KIu)(k)?5RG%a@<-B4~(*z^La)(^6g&qA5a^KOtAJI`JLN9h%bS1 zc+eLa&@aH-p!aHw5C_oUYlp_(Y*0AdOo+$O&|8N_-u6~P3`WE5kGA-4hlbo0orK8m ziZ)PpjHfzHh&|oq)cvq$tt6AWDo|j`Nl%@zL*5Vio?!HC$LvwA)@!e0)lMaq~6x#hSzQ z#gzFC#ERI4!dB5x3_Gup7}_OT?5P(cj`<@-j6A-vn3UZ_T={fU;TzptG;J9t_BK97 z92neMY~FO7XmxcvG5^61Vtc=Man9){io#nH#Dll=5NU&Yi>ns*7iZj@B<@<8D$*|= zBR*d^Ni=>TU(74;h*xi1AiiC+RP1rxCXyCCCLHZw6A9i=#Qx9fN3GxAHEQRU;ZaSF zD~?J%@204=r&mR#4~?yN>a?_aea>H6Z*`vo_1gSCu>QKQZ>|5_%wrpL{_Xk(6#fWW znWs`)ljBM1wV~q)g=_X%f1Ld2`XQwSed*4~kJ})9vD}abj*>W8T_p*5h^w|rW>Df_Cg zF&<+k@}Ch~63L}+ZvN`&c{iQ0{pW#(yA;1VAw99&kOq!&PEAR%O-}waZ?bYcGqE6Z z&Rl!mIH%W9Nd36{Mj0+Rea9~g9gpdqpGURrecXWuha2r%BYoEcAC}WIs;P|+k5IL= ze>DH~ax$h}bCL9Y_gfZEIpgdtZ;~dA@j+A$v0U|=uKnX7{4*E=OX{1e=PNUkvRpKi z59=1?71}MurSQQm)>FZ9tDbb86~{Lh(_OniOT4Ldw$78~#7#9v&(my+Nb%KFYqQtcp4-VNkrv@|@*Ts2n2UH!>xoRt2i{G+!8g)h9F;WvkDA@s0jZ zuGjgoT%jf}kAk0kPfd@BH(2$C>Oqb1QN8o-Td?D{d1tZzMl6gHx}5D%PfIQ?wx#7F z7srK%X1NY6D)!DD;+o^688?V*u*-DJGxlsy%i9eR@NstiB*l05$sOz;^U>vOAB@j% zyAxAzvHUGD8CIAx0}rb_l2(M*%T-Oc4{7&wGb+}kVII1i?ZfgI?C=)l6kE#Koe}UD zk#+jZDfWES6b-{XbUE9H(2zg#L6t}Gjp6k% z>%H}F?j5x)ll@^Hx}5EU@h}Iu$XLrvEId|O`!o1|kUFmKm{FfU{N+ol^VuKfq08Bx zI@4*k`rty>bp8eIaHE$UiymSSvwuKRDPG|GSgZ~|ZhxP9?v~4+UVGre4tex@$c!IC z>^J4?Kc6Q!oOzfWj~RO2TnxFy7)!%O&Cd=Y9O!$J0XkDXjq0E3I>|pBcKyD1#lRD} zJg0LM{<^Uow-z(n?!_c`?;MwVrt#xrw9D(rcVO*3to)qf|HYny+Om8v9!Jsx%^Qe^ z9@Ot7PGzP&jTi7mpr?Lqi|;yno_pbi9days>Tk;7oW<1C)46uH(_YvcZ9+2f0Q1`f z|5f*ipBkT1*MuJjzqi)94Hh(coHm9%T`ku;S>2h^+EaX{| zQ#iz)S5jQ)$d#=?`HC7IJ2gIfyOUnH`+`NER^Kvo6uL;Hp>SymJ}fuI{uA?&)2S3v zSOwjqwj0!Zrr>6)UiA5PmivjA7h(DItesD}FT8$Mz14qYWz$~LmQuLh4CS7G`6yBA5ab&s9W8A1@nwL2W`}$y# zXqtbx8b2403(oH=;eXd}r?2?x%XeSD>#So(lG|!NlW?oG{G_szD!5B9kmRY}J+8y0 z=(2liE5~gOe&v29a-%-@v7DY!4e|4nL*v+-HfAYjD&a4gWPscYwk~t#p!WUpmdrZs z@^?O?N9A)pab&p^DhKj6rNEv$6Cakf3hV#acyd^> zgBJ5GROh#?gfGmmIs$&rc7EgZucNj-Vj+i{+T;=O%f#vkGwpJ%gj}-%tnwE;x1< zMAA_Fqu8a(r5J}yyVr}t+GESiK?ncb)RO78 z8=abkuH2c0n8PjOrP(2*>T#>aS6sQQK5@>-LOR{sWD9XfcP}20{d0#2+vo;{_#TfV z%cW2`WX{6oWSC(%9V0%_#hgpKE!rSNo<(D9DVMUP7kkm=JGc-NAc&rPTg^W+)>-vf zgI7hgIH$7x11%HRemlhUoAM6or((H6NnR2!nH|vT6}Yk&2dAR)*s1Z*^YO%cqQ%2^ zb$##m4<|oBDod*6r8t@@f2TLz18;>_pVilX_1+Wj&)lZ-VL9{Qb9g>9 zftuM^!)w|j;q~K7d-9ru1~WRbe;i)AobAK&!Swec3PgjGs-J@q@OfdOed*H7Te-O` z^C1c~T^>1~tc+0s^;r7P3f5cuK^nnPYMH6?UADTba+80YFq-{i{pfPGAD%KQ&<>;a zmuXRqGpFO7@Rv+7K<)+WS6sMk^;KWYe!WKirpw74GUTtENJD?>&mAnvAY=b3AGLmG z4D9F!^ud#(#I`02cVxqU@V)JR+WUFuA2DoE8p`{r9nNx7>_5rj`566Ww~ftl&cyFE z*%Kza2ueKYw8_Sk;p)lc7=6E?Q@RUp)bgs|W8vfXGmdRto_FrQmR&adiW0h5u)h6&DlMImi`gj|%JM))4Hy)q0KQq7#PB8%kG} z(=)1(@yHkxMZ=@;=hEwT;RjS64dtI}c2?tsGJwN5X@fPK8^BKO58eR#M|!_K^rTxC zujKYU_j9luuUHK67>miG9xp~<&_rf*T+`MAyplvIo@W0K!hJHVhhXt~^tyLTuKDfj z--#O;I!EEiaw${}y8q_FYBly3CcX1FDX-VKtbm01u6*38FFjq*%QtL#v3TCax6|-J zX$(K=)sVCOu#{2QTP~;2ktfyV!M-*0_g$4)^qGZi=+Nni4qH3k3Mf|9Yupo7o_e^F z-`Bq~>DeL2zu%jAkUmJWx}5EY*zYIN<9o$7CS1pdDB{PHul9C%;`yUYIS za<r^G{8QHSRHGl4UYXQ=Xx`P&Y~NveOuVRnndPR~e+t@92%*})oLS&< zd(odsd7YZyR)pb`v@u#7_~53KN2d0DewyhchQiBogyp8#f3o(Y`umkt3i8=9967ua zp0?^m?^iBIj z?~8hNn&v;t{T`baR{yR2$*MBc_>r{5st271Ih~Nu=)HdHdakN4Ge?Raoe@7+ZhG%O z5f3i#{Qns6(m@mqpc(8@3p~!8I{VBb)8WlY3|zqa&!J!`k1K@uIap6wH6D$A9Yn{a@DTU()4~ z`EN@v%%iOAA-W0L%mmfg*tV6J0jCcox_UJO?}vyZ~$gUIexRF9F+tmw{J+SAo}n*MTbF4PZO) zCh!)p19%&F2iOVh0(JxM0(*eHz^z&>C1m4g%i*-vZwO-vd7YKLS4ihk&1fUw~hM-+9J)l0&0B8u%x?9me z3_xozHU^piO@U@WbD#x4Yjd>(jsaQ$t$|~KuJp z7yt|e&IV`=v2%bVAQ>18qyR&Jp};U;IFJgY0kq!Oxd08mrAZT`fpj1P7z2z2GJz~$ z955cB^~thHNY0TmZ}j3V|ZP3Alh_ zU=~1Ypm_iAuu1f2)G!y1SkU*0G9#_fy;o)fh&M3fpTCG@GoF7 za20Sha1C%Rumo5NTn8)zmIK!VHvlVumB5X_DquCR2Dk}W3)~F&fLnlDf!l!FfjfY8 zz@0z^a2Iela1U@Va363#@BmN=JP14lJPbSntOp(i9s@Q2j{{EtPXbQ?PXil)XMjz> zv%qHHIpBHV1z-#CBCr*B3D^d_47>uo3cLoq4paee0Na5#fwzDiz}vt(z)oNnup4+6 z*aPeZ-UHqT_5u5W1HcEshrma`$G|5*HSj6$8Spvq1@I;C74S815cmf87WfYM9{2(H z5%>u>1pEyA0{ja62K){j2L1r3gC+{72h;}|01bggKr|2o!~%_hCO}i58PFVP0mK0< zfn$JHKx^Pw;5eWS&=zP191pYyIshjC9f3|jJkS~F0(1pvg4anvH=sL^0Gte*0-Ora zcF8>e8*n<12=oMc0lk4fz!^Ya;7p(&&>x`fp9cW6JpI|gAmAJz2}lM811Z1|U??yQ z7!ITYX}}2JTwo+H3K$Kf12isk3@{eR1hRl}z<6K+kPS=(&I2X^lY#SrDZo@<8ju4_ z2XcWtzz*aCGk^lX0bBsg1PXy7zzMj3Vqg~F20VZlC;?^zbAVD{E-(+c5SR~K1Y8VU z0+ay@fJ=dez-7SYz!kuiKsm4o_!qDkxC*!$xCXcuSOP2st^<|<%Yo~G8-NwSO5jFd z6|fpu1Kb3x1#Sj>z%9V7z-_?oz#YIk;7*_dxC^)&xCgiwxDU7=cmSvb9t0i&9tIu( z)&q|Mj{zHi$AKq+CxNGcr-6;YGr%U`Szt5p9Pm8w0;d)y?*Z=v`+)tx0pJ7RL*OIeW8f2@8u%3W z4EP-Q0{9a63iuj02z+w#HB5Bvc92>b*b0)7U50e%I31AYe%1AhSc^(dl%dO&@k z0niX=1VjTdKrGN0XaY0^ngPv$7C;=(5}=jdS^=$rV}av@4rBmhfU!U(kOhnb z#sd?8Y+xdA9xw@*44e;40j2`efE-{tkPGAib|4>^0TciZ-~wPKPzV$OPQV2e1G4}( z-~qfq2{0R&1C#=DfqB4%zoo<@CxuM@EY(sPzAgJYzN*1-U4<2Zv*cDJAqxmZs1*D53m<_ z4|pHg2kZw903QG!0v`b%1D^oZz^4F)U|d4gb!u;MKTE%z(IgVd02SrI{`*wjUNz$6 zb8~x8Ta64o*A_>XOQCWI`rija^}irCO3ic7Ome(O?L+3XDGZ+VLh<_ELXgimsbC+{{{VQ@T3|) zvJY7Gpz|PypE-W)nU}4YcuONw4-`LW-5!?HGpZpT;r|N;7$qX^Qn;x9IU2!1h$R}B zj+4IxlB2SnqV^Yx04^hQp10CAn(!d)4kg`MNGY`%ey? z{|s(weWY5ej|3YRx_AD!kL`Oq=i@#meM%d&{sznSuQC^5@mDyoj;mQY<{Rl#}{yZctBa>e!!v)t{4~5~g zD*?}|@nXrBp?Q$=@f*HtGv)n9&h0kV@QnDL0oE)xq=6&x;22r^ zc)9?i+R7R7N9rcvw7h3I*9FL$%bj4)lO2~;{4PJoXT=M78BDIfOAoS){nys z?mnD*b@u=J8t@^KL{e{NO>jDiH3f}vrg+Bp{9N7nuhBqVeiqPUU49nOMcq|!4XE{z z_^+(>5xrhUF5H;E__FI3ojyiw`%}G{<+?8!n1r2^JJ%*_Wd4c?2KXD(yRg49_EM^4 z{cRukP#jJM=uGtpY746CbzV88_xSJA&!XSq($Jaa+p^pg`%gjn5DD{%GMu@d8vk`b zAJjh{kM+@d!9IHs`rKy^+J{TACw_D88_Vwg;6%ECF?dAz<%TqH4C;TN*&xdBDEseI z{3myVg~!uRPF>w3tv>zEmxjNe<)+ww3hF-%DV%F8IHlH;6AlKxzc&Ae7c7b{z9Ef< zF-c?a!1|7wob7}9pK8x3^cIYwS!ucEs*06(f%UKxJjmT-z;ItgCE;3KckTX5-|D`; zs@s(iTTE^8h}I7qhE3y2-1ec)85q_`v%@h9H5ZdllV|5R3Uj7A(At_SC&3!y$Cz)~ zH{tmn8Y9;ko9q^ie^@51Zx zun_%3hHFWd6|Ph7|vVwRy1SJXBh1c&OWrH49Bm#^VLnV=;KB{*WJKrai4E zd@ur@yH5S?$+I&~y$i2NL;57MTaz17gJ&R^Q*)fyDZmYq!T7~}A1ze($?Yb zYckW@N90cvfd3bg4^+=0xfw(xvRq3+5SjWsKl7h_4#qc_>_7P%>bU*A8t@@PQ2wuu zD_|d~FNcg8XQ=$5^rQCgkiGg0ZtKinq=CBpETG6>aV(fD@J8L$KTQK_eJuvNTv7jY zGC=W!|JA7L@4Y(fr^7i*I(6fCL}%(>VL5IshL*jS3yokAY;49dla>RX;YK?dtI&8{ zC72`Vk0Cz@l$>ym#n@)TA-^U>`h9&i3YhLHKL! zFxI)Z=h@61MR@Bu`KTH$3D~ETOeh`+y?RV-?S7A@gh|6ZbUE7xi^oih@-AR7Jom{?d)BvEx<&`^&s^Iok*0W$uum zu&|EH&2A80Kc~*0GWv$jbOlXgmWKK1a<)&-MGeB^F#6tY=-nHUJb?x|l>zMU&ItUSe8KqJJB+V4 zkKJW|bvfJD@ON~M8^5sR+yr{26kz`|V#9y;!p?6*pKxHq26mtQ*X3+q)Bo{9l3`f} zu)kFi_pBp_j&DPH7 zgv7h-zb-diN8LjY?@>83oN|LbiH~opZ(Y6Y+u9w^IWc? zEPE+eG|CnKvzvtf{+{o^TJuf4ADG;1ck{2O ze6qKirWZ;>{?oq6EH}me6K$du_z!1pHDpV7W94Y4$FQJkvSpr7wZ?-U(Cg869edY+ zlESY(Q2TNkg9pp~1k8)zJVx1boB?+9s2VSdn_2Y{jE8SQgWG<3aOD*`50*#D1MA3I zn5aBfwg}DR5O_XbS-tuBjf>aw|9uJ{>YrzMWIO`8kek!tB_9Hq;%BgaG}TQ`7phFZ zj^r8rox1zb8mNFZ=O0ONF-QS{b|3X;HUQLd7uO#9+^~L+uWAdiG)97`-PHaeIUF=LZh+hCV#W>JoN<|w;+hCMH{#GQ}YV!9g(Frg#C++>#AQh8Q` zCz)h`{12ATyg7XDPbC$S6%$!I@|E>7{70FdQvad5or-5?3#`!^F zYioW$l{fmM*|sbCqjtU8gM4^)+VC~YN3^G_wR*R8spDvw9w^jUmFj(-h56jRj`I(u#bP^ z5VhT!eXKPd(HJqRU&N>zj6?bWMiNQ8=<(3Y7!xIvu4Ataehq~# zXZuWS&?mdShtDZa_T)Hi$%sp{v424xwmT)3en!R{s-7w%;B))ff~@1+18A8uX_${L zXZsL*Xk-aunae4)r}0wLUsBufdYXFiboZ-c=6}HcGA~`u_89tCj8QrH7)ysA25C-n zgbw#jYiv*l!Hb+P?E@c*zsUfdgXITjzcI1nD^1d=h>&I^Rb<4-2D;p^#hMzH_@qRj zQIy)`mJA>&lb*+{mZ;m@Thd|M_SX2W?^|2iE=GKN!VAkkeg37@fApXgn~e3)sGMav z^Wrnd<4mmbo>zjgR_^Ta)H?qVEBi%aZI`XUcf(OhjuqgIus~0u6_7m`Di?jT__=4&ODuyHGXIF9oHF>Db+>x&bkI6@ zWSAez4Qb%WfoC(z8Dpm$=*$R5NuQoB16WUqU5#=%2{H<@)(bqv zE~h8(JJ(Y0Ek4m2pY(b!dHiG2?7Mmmdh_wmX>n8-su!MsBg>^wIq>Fa;~gF}GxJ6| zoHIQ(8pEGOLq|s1oin@z=}zkPvb&Y(T$XYrDZyIK+Tngau(AsI{lxp85hulnCsxIL z;VQoNj-F>4o)1DsPx&Xy6-x4w<58eK&Jr2JW%fl`NMG~CB)CWMiTlCx5QtO{rt+BU zzGhY+;~2?Q!|{&8p6=;gmQ%c^YkH4B*9=_BI7|0z=$hQp&t%W zc8rFhh8|v839#NWP7SZO8|N-89P&Y{N7z53I5|`3a<<2BeQb*8a$};Y@vGf7#N3~m zN)LP91c$f4VsE~v@~V!2*NAObZEUmtyf4{b=B3NozII+|PV6&CWpOZCmU6fBw9w&4 zer4Zu_3JM#d|@&B%e-_s+biK`QIs1SU}6YfQIW$Ncmyx0@u|WVnomrR7}0*g+ulpE zx3_CT84C>Yq4>mdDO3&t&#VDQ-Sjoc;5{GQrTE14fHsg3E7LpaGUsO`<2r&`zLA{n z>&#!TfigJB>3wTr==hRwdW?AfaHE@juPk2G-V8vFFD%y?4n}|XOfzm+Be3z8G}8FN z@qy}n6h}Bt&{>7 z%Tjn-KLnnWW?^WjL~4%FnR&4>W}x^`rC~g8c|y+TAw}_TPN$F0Q#`|iOdv^s?Gm>M6KX#P_hj`}pz@n!|5WxSQ< zN*KkS7!fl@=yJ9n<+{LS?u9YNA-63#&sFTra1>+cnFo83%STlnZO^poAsCNO z7ZuJvV{7_o_J?`sa<&h~LymFFpy6%Z7>d{io} zpFoDkXR+Ln298R);FhdWF&$zr%$bXoBB$q5F=MGGC-w`?TBeiGqH!oh%Jfqe7)QE?`yWCjB^&EjVS*t^6x9TUmfeM?OCDuY?vM^qT)WRj{WJ< zp3JAM$%o}3_^9=hAe54wc^K|lh@C4zJk6Q!GHbnQ&Ok0~{om#b!*|ot7UHpvcY6;U zGjqyxlh|=4UzSJ8*Y3^9Entn}r80o^7C#`g-l~e4if5{(&Au_V%jLYD3FTW9jx5Km z#VFw@Ki@V)GO%UN$tk7>%K`SkB8>m^{QP?yuWl;oZFI}vp2|l$>T)T@p@#qDvHZW5 zQs{EpQETwZ9J&n8GLM9Tq4hv+&wqBsuH}c$oj})Q{5&+dVH=9aNQ~erw1h)N1peQ6 z&Gbq8FNqz_?z8{8ob44oNDqy`kjjuVD%AAc@9faupPd&g+_!)B-ilUY02d5YpQCud za`u4nA< z+sy}0Gv)ewMtO~XO!^N!+fK7wHxxAp^1*9jI*o3n|=;L_cu}I_t)HaKPZcTzj#XWytX` zm6*mOvP3>5olw(vxyDPcZ^XUZLhQI|^q%j2T06b1Nr3c5`eL~$_Mc>AHhbj!eb&kN zXPtt4&YtRD=TME`ZIi6}(Rn0+$Agpadg|71I{9=SEcX*IFPK6m&DNto(z0u_c19|n z3h*IA@tevcz5a8^9xLX(=02&zh5=j466i_n0|t;@ST2RiArM9U9BfqEKsSutCg%~` zcmSPz%ZDS!>(u1Xe2V+E5bF=@ZJN>Si~%X8pIi>G+!XsyA^A+m!FWvPjA3%r6Ae0` z|C(4sv&2|5lN?dw_r5UvR?dhOHzppuc~;f-3Ffd6fB!hk{lv_Rko=6!aq1bjaH3az z0PC%6aA>{J^HX+j9$9s7rvr3N#;AWp)sP#umU4sZv4LEocbg7*U#oiL{H%ym7oXai)JM1b-KmP?^>2tE!< zX5*#aAmgBX2p|eCZnrB={pm{zdj_?`;{f`BN#z#hD`ZE8&&FNdQPn^hZa6)ar-qI% z)re2$w#*yT%G0sW@_~j{k3}a4#TS;VZqqg53u0?A?fD_Qxb!HZ#}E3kMSJ=72G-$v zC@>hH{{-1UU!V&>{VLr5LT74E^O@>ObWdMHGKvqxmhuOKH7W~wq_j>l zVn^2$-qbfpk89t5U#lCZ`@q*GHm9v%DxVv!D zj!E&b@Al-dpDz0J_SUaZ1`Wgc2Fnd;;24M(M!sQ__42{?0*pt%Dl%dd9@Wd0e^J1j zhTBba%l*Wsvn9?%gIH4>;y8gzzv=3~`g<5s@vqdns!Kkq;>+OG0t!4OnT?%=^e5s z!|B$zt9hh%jIRvX>GuJff5ufgK9kd1zYJ@9(c6715ueU%c5mZ%Uu~5>(NquB%PGFF zT-O@ni)<1bohzvEmd-WD_Ly}$<9B=vNoO$p$SUL*K#4-~R9uAh@Qkg_~B(b9Q45cT^N6FANryVt&Nz1y!U#@{N zxXAhK)+}p3!>O>7{Tz^gan&1ZQV%p1Up+N1?%~m~vlf|wGze$PZ&|Jr#M1w07&)EB zbSC+`2mkZ%ms2j0hdmig|0i|%>?wYioTjj+v`X=W%3O*c6jvzDP<@x$Jrs{9Kc@1R z+DTLgjssc(#{jJWsvmJZjmFeb9^MY1aiQ%2>i?p?-Ht#fARg!pbOE{oCjut{-GJ^u z0zgyDsGo)OgHNxqKYI2!Vj1YK(dRp?d?8Ns9n^kzYF^^V0{U1O`X16F%cW2`82#Rv zxj9bsCS$cY`ol-541XRW^Z$P2Nt~Adw$)+y^m{Q*e0AC3ArD>p@Hg*jd|0kfk(VL( zn7@wwROIt&{#ZKRsvo^vrx%7#I`#UP=ZmkCFXKS^p`$LBVjODYQ&Tg>8!K_*cpo>x z%0~~com=CCZQ1c-V!Fg`rFcMw!;9sHG;pkqPcPailmf37V&!mxd9BoV>3Yf-+gNNa zs$3r1xU|@5h8ve_EDta;u9W^Z+3#o>M;5TOlppcgR{iKaO1H&{rUk#Ry77^B_VN#B z)(^`=@GyG$jNV)Gw;PW>5TXn(vOauac(fhgShO78_mf?z!#ZE4>4W7*!h@bI1K9ug ziPrp)v_g5&!IPuJwk8XA#4l?s3SPUY=QT@T?6DtmGQ$B%*DRMp<-qZThD9MM%Srs` z>d%^6Y}72&_)www&v~RezoGg0i(Y7P^J#JR;m^ZkPrYv&DGi3hh2@4caMbyX z?`L-Jr8=Bmtn`45plbAwXHT-G6TN*amNyo=u6Ux+>|e*EUTFl3ET1TTusp!PxQeKK zo93k7Rz?t-4wT`{@pdP8Q8}7y+66nMu37cM*NxK7PNG5(W`dc1(oDG_4IHUl_isGp z!JjFV>TX`qySGt}lK=Fd_z?VO_sNA6xUH54<&&*?)AQfdevQSGuYCWwFL}PmH#;{d zj7e`S4=^*XjC2KFxfG4(7TQs4j?9_sD)HKkB>|}Lq`Y`oN(Q}A3b4M!`Jwq7Jg2eP z=vnx>-FxC)4X-vj7QRH~gZQxAU=cV<4*1oGu?)F^+Obs+OW-d>PYNeezn;DehBg+N zW3SzNXwHh&RPQ0f`8~@GY2ZlfLSiu$YyzA5@nK2QQO z76d@9!(+Fhd4sLgya=x%S~3X#XHfa0@ZkR`To!A!>Tn(kG@dZRec&+(b{s-D$% z>6)KqIX$ZyzUMR9sn>K*Zs_iiJW@mM(fhi)k-lH|+&@bLminwcbh_P#biK6sd+*G= zdGlsH-LhQQUS#Rk%v&iL%bwS|bX=E?^_Wz5A4&t2u;hA3!3=9Urg{;TznhT0&*<1| z-V)RYF0(b-mU>S6=4;>1Z%giS`O9*WsYXl3v>gi;=PA?+U_Bw*_&qs^0^K)uuia(H#8mbOc{|xoX!~@jlLj5bffU|%hKsqoPmY5%&xltcy{px*ZkE zHX!s}D8N^Q<%D{o`biM#SzkQxczrQoVgoU^RYURq7Y)VjpEVMD zkBJd?6vm2SXe~M4X(|eSZ!YYYv=lEDwiZ{t(?;C+R(o;7{CM%z=O>BALrxQW?&&Rd zW(*X~3x)~T>0`yPucwM%esziF8!imrUo4P;%4>x~G0*&d>MvLnzn z+tWQ6x@W^OzW+PUk@ykGGe^pe>Y3{I^ZS2?U+i|>`LESLIh^BiL%6KzTW_~jA^o?^ zx_#9R^Y<Sk6j4NJ)_?^>Q9$&M1^AwK_uky>=5iMh z%cncP-?QbN-I-_Kd8h2m>}=KYEiID4pK5h;V1Z5bYXzmFNL`_F6M|%(*}2;CMc*zx z)-zPx@X4W$!x!~h+-Bc6s)oyXvYceH)A1~CKj;b=zeFo*sBS`J%s=K9-~6L{hl=~G z0WCim*u1Prr)QSS-0Ap&@vo#oB)8x8>G1Eo!ffc3r5>09522ZxI5pPPR1sn5&qt{au3 zu@{#6;ajP__$Tb$Vr2dUUB3B84G$I9CTwkgf9GANhjmwL7S=b*|3v;?EoPRa|1ur_ zEcnrT6^3id{~!6xm^#kabKW2?#SwqXwR*WC#zvZtqOLE{-JUf<9f6R(?$`DwXXk14 z=#9rG;-1Hzn%!jp$HP4Ia`vylBN?BRdm&PU8`vHX>v&WcZ!m|7ke{Q~35Bl*`x}{N4yGhS%$e`O4r>qs!~H#Gnonb2jY%`i+;}aZ&q=c(7cepd3m( zlu3Z@xbY(emj&ZQ7H5XjVo?S~(y=g4Z#((ZjdKCEqb?JC>!)mUEiqzPrw-e{j(bYa zi{%O#X`|;wV>1{ws)Uy|e{J!@r|8XEV*P77M%Qr^jpE5RtS6RBRFp%B4~9e)g$%G} zjj`nMH^MH9a-FP~fd#(x5@)L=o@jKubjxUJ%D{)hj|XT^?Bw}7J1-3r3qOoZ8aDUj zbDiKv4&A^?Ilyv7C~dU=xk^q;_e_dVu9EeUd%IR2`g%X6L74dB`T4^mE+6jPp(>($ zo*B!fsFg!){1`ePg$hji@0aq&GHJrWEZoI*cS^@czkbTV!?lESY>)rN+G@9n4j#G_Ga2Dp~Ib!=;v3k4NhGq0MtLSU%O)=Sj{u{FP%>1W!w;q0t zs8K}E?@k^u)GgOUjuUtM8M!%%K`;?@B01>r_0c%s{1goyay%4=Y(J&&r{|9c)aO_G z#^m{52eP_+yRs8o{$G`p znQ@b>r;$_r^O}OWgHh1Lsn2%o0{yzBV{#T{tC6{-HtH3KgU|vx0>8!0BuiE_+ zEc9~r_xHalW+U70$Z7udQ-AoX&RZXztroh7jPtQx&OFrbnOw06mc01!_(2`5f=_-$ z0NZa_72Wo0^8~H-EC>G3)7_qFGmpnS(whgy$^?pVA;&** zy8q|ivHY+&8n@;{4xi)K%h}&c{4Heya{Oggi2trr?K@O!J3dB@*Hd1xoa5!aKK}k) z)8*(j@6*|L_<#PxakU=Y-)HP%4xgW2FK2%*@pm=5teF}TxLCHoGVq|XI-UdZvcF~S z(H-LXz>K%teyk6tTdu!_dAQe*a5xh&aoAQUqH!UmKeZRdj1a63=Lwg>lEY05At&}BV^%=FKv_P`oF)&;)s z1nYQLb3D3PU1*WRQ`W=6D#SbMm6h?cT)z#~$IEh#kN4&M(|izb zjiq%bZR*@?mBK^G>BYE^e;ici_(-oWmeVz|LnkXr=xpS2_rJShxyDdm z#j?o9Y;*s!(fy8uic8K{JHg9eJ$hZ8!S!F+zLloRDUSA}CziX#@>8`+nFL zZ-?6V>VfxY?OFf7GYUL@_l=_yYJQk#aTB54CE&qwx<+;$9=!UQ?lo1Vp{Y*~gNHwT z)VjIGms?MLKi^FQ3{-uvT;@Q>9v&Wj3~-urb1hlYJF}Y%u9xk2)+7G)^6o1qgW8O@ zpShHX!x10)Pd&>Op|tVvDc6fHIu*XJpzrlC%~9M0GygalM z`n@cpV|s6=YZxSx?~&!QpZ?g}Imz^n!{%qvhfmkbe){{3^Z%{}^z%_EU+5j#GuaQ- z0n~3m^?|%+f4YYA70c+H<$O$jd>z>;9aDI0x3s5olFQdoymT))3X{Mxx}MHCJlfMa zIS!Zak>etN3X`v)bH0y`*>QLrhyHq5PWO;MIlhkfB;)Y;8h%E;Uf$EO;r=-q=mKM* zb|rtmM``EHaoT$GyHGN=BY)ws?fK&5%})AQ^$q$&X}IpVK$9n8u>a#iP32aQ|ElR5kzn6;D7mR24^d&Zz8qIWO=v zvP?eac>T%FHUDs(N#W}A59JHWU;6w*-zZVuA<(grf1reau+z8K{w%7pZE_qeqdgy! zA0Nwd`Izr#yQg!qZE}3CdZx{1bUpcVoj~VwAIZp;Y0u}pr)&5=dC$ijFJH%Dcco`{i@yK=&K&pQi!2|0uH9e}BoVh0`X^95e56Iqj+ch~@ex^z=`7`b*pskJ7DU z?D%A`V*k-X@E{itP(0rHkE*x(uFk7V`u=n`86F&6S07uJD?(}G;ZfdC;*Ex;KW)=v z{`E0v$LR;x+*vkWuMd_>6qG{`j|%$ek9k_73*B8u#RyPtN4LS<{9dLH)7!b6Z@u{& zvOlJQV%*OC=OdSC?X`G@NttJV45O82_m*wk`Ccut;fMP3hwoY6CZW9=Z!7F*J`u}R zsb`yN$#FOf@p-m1dyjjBlQ6k2(TqQrxf1hjw8)DkE6w7>ObLfQi$jq69gl$@*=IaJ zdkZic;Q!sn%?%gkqCNc%6trJe=FU&dkL9>r<9zX>B-JpQx=_Ch*~2S{IZ zOxZ-95BTFGbIIz(lag4Uw5NKS;y8iTHnKR;;{ilvs;UxEw57r7Z`=r#VVFSX2@sez@oQB#Lm?C+R~=J}GNbudy0E z@oETOELWwTt(KR|JNSfDB{tGP+ zam?{6Llnf@*ZLLIhNdT?eiZsXfYuYGHA7F!=zMdl0VyTahTO zQE4~DOXY5K%G`mM$Oq9Oa}O3Gz49s{QsZ!cSL}xfF#`)*%wLJ`tB&Fy5Q!!+X_HAT z$qo>&^$rxX=L897*J`5Cq7d=hhc!iZw@Bd{cCjdV^>SfOY$jS<(Lua)xHk%k9I8{4 zbsvhsLvBCN`zz_%aQ_Sq=+lQ;oogDM>-8LuvG=V3efm(Js-bJ&I{Pbqjr92|wSDe! z$?e-?Yp53Wv{&@szmQ+i>T$bY7}v{A$K)u#(N-^4#MsdEE_EHrENdoa492Eg@=_Ag z(mdZ^(Sof?qd>VuZ!c7jQ@hE?(~5fj_KiM$>Kf_ux2K6rK%YKn)|S6_$k!Rie~$+A z>0`84{+@KGELQpbJ!GT*_xF9zuW$JIJwuCW{GJ@`P1v$r5lWkMd{to0vOKZ#Ps^Q@v=oe})G1=|lZI z45RJx_otCQeJD*R|8U!q(#lAuzb~Ei>2nFFP}`*{X;PJI{=O&scf?$R$Kd|sv`yOg zL>kN@4D4J@1YW#yjTjgvdQRN-!<(Nz_b#O)IhwCS<7g~bgwn?IYn9lHZ2Z+Ei`KYv zIxuGDjE&FCvyQj$5@OQ0aF#VcC$_5--?v(v{gRc?^mfz$QnC-djp)xMD#qcTsDV<1 z&2}VS^KD0QL&C(yFDA9WyZMCeYCnU=j##dzT6H_>J$iIPZoY48!urt?-%>w(#mF$> zT625zvH`<-xrZUk?Vja-fUms@bTxdBz3F?rGA=VrEPHqN&Am@InDLl9LvTK2`5)wq z@$O8tVKLAgn`-frU6nB!dHjQD&^V6X#XwM%>-70wAI_g~PMnSMq-vTq(x+;A`n#^$ zgowF(E`7^WKGS^KO-*Yk_57AeL1OA>r9(@tVWPuVHJ(3mx?W1K`^SV-PE$S4a-3=$ z%{fs%`Bh(TU9l+^^Ek*_#^O_dSDt%i+tK;9G%T!_m*I#XWyS&)cKV1=Sq9P5Z|tu3 z)t{PTa9NE;et%DT+c*C*TbS6^_M^quWp>-*Sk@y zNgKm@pSfZ1JnH))NBOE2wk%hK(x!5LDQ5gZ470pkc@Dd!t7SA+Z8(QaRfIT5ufFDA z(0dxs$tO!8uB1<@$Eh7ea~kN|7ETA6pHKZ{Gy*Ve(BbUmWuXF zd6V7+s5Gbi&Fx#>Lu9zWPy_n%=C6pF(%MMxs%hFtpQ`EU@4CuJpTA4tPPSXI-($DbKG*jzjZ6<0U*0>Ss9vAj zu4+h)Q8>CzX>Ysbics2=zt3sD$nse>E5zOGz{-DQyo%X~+EO%$^+B;&^=h8f>zCyhl&>HC=6>Q^ziFA_VsPTBvw7DyJiAV3 z4=le>d_5UZt%uVwNjwM zl$Q`Xi;(&5^uxF0%W&~fgSz84Bs(5&?xw_iS?*z~9-SLsiJY6T-XvtcMW6ZBZ^1L+ zqW|7LudbVYI8m=(mY+9YC3|^_TcYbN$H{!-KKIRc-=T2vXf5Ze_=vVI==IC;KgL(5 zUl7*ocP%2|cH?0`d_%qs7yX*WZ(p>kd*Rh?Vr&mA|08_0+|ZkD9&a6^OfJ;sIf_H> zXDur8t!KJ^N!HlI)+Nn;<33N~O}UTd%Bi#|w`2DY>D=|OoX_xMLyY;PI2_~hbMYe< zv+@syxd?;x8F|1rucFc6qR+&nq$4-3JUU1nhA1x&ST0dg4y(Y+%~+)*^C|YjC!{b; z+6CkRpL!95@J3q zuau8E9;a_TWjIpI&M{~+=?3mvO0QB%ka9jg1)kJyj0b2>OenedyV&f>;JL`!bk=9p zZ{)URIZwA7mup;kIx5qIkTGLr!rn=GIL5l^yMJbZkc$DfyM4wv`m%MTy- zXWH_!@NusVU;f08#_#L#kGo8)grJ5j+v_PmypQ2S+^r{my6>fu+_8GzEN8yFSN_-G zvgBtuU;yr+=JQdp%(M6_-}V}PXPEf%tEcNX>v?}&y}h!W`SHG-+_~6m1uNCAhadH| zZ#zf=&%|ZnH7@#Jc+X$lD+_bJVmb5UeK}7|K8jV=rtU{SqtdJsQS2w)g1f^++sBTY zd!2Y}pgvxfb9}t7BwkN9gL}Y#7H;5ty7RF1`RRX2WOgx!LPVdW(&eSLaPd^eucpvu zyFc!9Ly!^`KR?Ske%_b!paZV7%KJKa_LvYQD9DJ1JWfhs(-%b^;k!`l@Mz>2=QfCa8428!~O_+6lA$Vj4cwP*Zo2~ z_oNWtZoruPJ|SlQEX08*lL+c!5{t0ve)c0Kk-Xm|IyMLp!$t>)|GgX_CSMjPmfjsG z+SLpa;}->q9i4+k=x@Pd_|9r#+~(?{Kl&y1)D0CWx7HN<@Wao1wD&IlEmCY7SXX=z zda-DHS$*;2;)Y`0L(w9;@ztVRpJrlRn>ays;B7oP`y1c(QgUyYcqr%gvs<5haY#fo z6bZ-n!g56@ZK`H3u}Z*e^J2ap|03&P6sX2O_#}fiTYNn7kz)xzWc+(<+rvUxaY)kqlewAMnb7Z z{Y5NSrJilMUU)u|(jVO0X&r+vfodn-=0rhp1^_V>f9(2<{)Y*&1nO!_wmIl0}H z`<+LBmGPW0?UEmB4QM!%c`#4Coc%8VPfs%pfs(RVui~hduYNpU;qc7ICCfjxZ)HBJ z-C?Vfvp@Yb1SNTFdN%$llf`HBITrr>7~3m92QyabnfQ9y{uWk&&zq0c51EtPg4C-x z=A)OhKQr*oCmsKz%*^Z8Hzk%j&0G?o;Klv5SMBMXgQ8l<{`(~VnRR*$ zB~G&cDak+Rx~p&1`$v8634hkqX=&uIv48lJiwDS0pD&9ShKbzdEk(aCJzZPhj$=99 zFS`nMRX$J9(@1uA-TKI-+UG2jo+GJuvrOVz46wZw{h)sD*99_4K(c-Ly#%M?#_(Uy z%x?PZk903N+Ee+)az!X@Dm+Je{wVxZ$dQkE(e!>!ozeJzCw??E-s;GA^|!jLnDwZZ zKNL(c!2F_*se0}L8S(R0&dgiBb9I-Ln`ye0;#8iYLN90ks_^S(E_5j?_Rv%^9m8k@ z#CF&P{MZhQmYirwac^<^)BKu{`*E|GHs`MOqEam6z zBU+AdI7hV7yyAMYMP=`fN|Z&|vOT4p@T3RX6StS!oi>RFzKdW_F<#rAU8$!xLKl=|~^MTxH1c=a#3F7>@e4M8sNXZ@(vk2ih;PFzv_%BQz`h6{lo*b zr^<6Q!0Q&`P@Ikly!Xee?zxVR$uS?jT=n&mA1EF1`%U7BAJ?j%l_>9{T?_LpF8Hc< z%Dj?(^3N;z=$zf#4nIx5R#6=D(#zT3tDf|{dRg)&phY1wlhbeQ&)W18JF6@0#eLxW z)8y_q#TA5$?;eaF|JwLROXrq&cu~G%IrHJYZ(hg%@mVq}QHC3-9FX5vDebtMz#L#La13aV02cyv5$I~*4pgQOBH&*T@Y{Iz zY=l5tAkgLrbQA(@ia<|YEkqsy9ot2SuMz0YIe34)M~KXILQFU=#FP#uvFss}xa*<- z@%@?rapj$X;=6}~#LTk@6ncb;lzGF^h@b1Feb6`8OLc!NjG||e(iTM=;iG1Jw3)-sPWm~YMDTb^~Gm(v)EDJQ%ASV=M?ymiw7u8^yN<6V_{-{ zPHcelgUL(DpB(Wa`(U{ulr|Okcz)C!tF|`qZ&Gx>;10Wux0yQ@V=Z+idp~em})NY_WFpGnp`gYS6W@oHuh$7Zi~3MxEvQ=*9vY> zjz~vkKvl~TWcl*41YJ!^pBPn8RG!dxx{ZJs0NG#AkB5_h0l-*b3a|ut6*vsk$8+}s zCp2m$QG>^y-zG5=1n%T>eCz_LM(^*7wSyxMh8oz@PNU`t(*l{@$}z z&+EEeAF3}OS&rK^u3Vp*@`I$x3z#xkPQ_)uyWJ!6X?MnxzQmQ=_1q7>voKt=m^<^= zc0bjwJzdwXXSs$9PQ3F`8epD2c~5t^rhlMJ;zN4U*Jl*h>iqk%N3WQ9mX68Mb+pyX z6)`sDe7N6^7L|)l&Vhp5Z+Scc5lw!Y)@9Eu>^&MQ3FMn?X%1An=qigv0ak*r*bZl% z)uy8be)@Lo3wJ*?J#zXM5-W~*>gDWz4m>fsGun#(M`l{Q5Z#0TnP-xF#vR+6H+?QR zGHr3IS$#(^59X{YrP2$x=TYJ^94+FYXqkVAsfH%Mc++#^SC%agekyPQ z^JD&cIs0EY{&=_W(2s59jzH$Wr3(B%E%<)z*)?CCVSdbCFK7RA;O}8q!A`(kn>u9T ziYvml+x4=jYeU*8 z&nV2m;oDBXm>1LnziLn%`B%eLEO(2`cjfuXd;LihJ(R2=_ZJidd-Ooz>+8+9qHr--@Han3m31vzdq8L`tC|SFP8r? zUdi?>OD>jkr{(C9-3-+bWqU3GPdOdEwSz93{`&;$kjqK!ier1$%h|tNf93T&${D4% z+%h3nor<7bT7oUxb6RzezKD;v_qn{(alL=oFu0e#J;rj5pZAE;hVFW0`9AxYR15w9 zpXtIv`%cg6T=_EhvAB3Necq{LIlfjciq=XzLqcjO{ViO zXz7VvThDDm{IWf8Kfp*B{P@tgXDGzrC(e{!elU2|8d zC1##G$0vc2>A7Nu{Rgl))f{6z%wr5-=g)>&4*gt-H1;DDXh-QDcx8uQBV%O z@K9Iav8kQ6MYxLNFReoSCr;G9Zdd7%f%^DaUWNF}`$8zs%l6VPLYu$5z2`h_8T?lK zFO&CkJSvY+p_jA2m*>Z%5thPi-ES;1k4;tJarMg2zuR5w&KEfz=AoCfKgTHLAMogl zLQt{V^7kf9`4{Ow|E!2?dC8?4$A%yKIpTeai_>MLTh8(G-U|=52X&5v**+#8l>=WN zjRVd{x!}X`MV&oVkK&T`cB%?|dp!QgX2;%Z>*)FRbjvwj-h1Jz+K-NHG;Uy?QMGFb zj)!@cxc#ZUvkCsxcH?r~TRZN9b&rp3n=rQj$*uU^jnUU(+EylOVtPQMCsp;v%f zZ7FVjvjJ$*zmEU(PhG#Q&r?xPj_7uD#|Ko;aQgRh%b6eVz4639sL*)KpbrDe`SA78 zIAFczf)B^He!=|TDx`lE_!jjWHRa*W^Ah!Zr?}-DFYmqZRnlM2R^}OnS=}5D^OW@( zSx;Ne(2FI#SCrtshOOU!mg4?p+9!7(duqe=bWD!ZUoTgEh48|Y${CGL6S9%m7B!`_ zaUZJ=fVJr7Jl84r=4yBN0^4jY({) zIc+x%#Z41e#(g`xbQjwZ?WulYIb9<=FVF3^dhN5j2Q4-Aa+f$yJ0@!WFUmOKU-h41 z`5E|_%K_3+Wsdw9e2uT``5I$yXyDJ#z~7l)=naSRj4%7=ydqyCAO9ITF~T%7P?-jb zVSH5Y^12vmOTf1cR~D8bzwjE+rw_%z^)ek(nZsoYog412)quD3p)}#TKxR`}IbWGv zzSlTDKMiC=%Kb&`H&*d3Czmb3b%~oJM+xcpsvi3n`;d#qP-ei^C zZ^+M01656*%F>`R`MI$$uC7c2`t+eO61m=~>^?*O*JwbWJ`}4yPw=_Cr(-!C>74y3 z40hgR>}Tx#Yd{_^ENiVDC)KZ`9a$|*v`HJVEqc{!#lO-ZBpi(w(l|8B6`{0=&&;IH z)ZELUbRUl)aQ6b#SXqJQK($hT$iugIvlsTOY%kje*$kh{w!tzEL-u2tvG=cm7+j)% zU*h-NZr+a0Ye607A<1voUPXjzZhQ~!H6q>uI*ZcW}e&Oz#g`mjZl>h(S zpe>*D^TpD()eZXnvSae^@slU6N}Xl$8~c!a#Aq& z5#OZo_0et~G{1Tlc<_A8rVSDuROZM$Bis0&cd??ZL&Szw$vmCbUDpK&y`1BZ&(Cv= zw%Tm87+3F%wAi$4{4FfamhV!}>8N)`f_6S_F?f)R2Pj?j`Xax8c?S~<*R(r9$K=#` zAfXlHsxQJ~9x0A7N@*S&?;3|`_WjK^EX_`<1lw$i+Gw0B2He5jmZxm#SmtH_5wRl!Z1IsyH z-g}APM(d-<-6zJjPNC2adEw{8+9C zrA-z1;lrZOZREVMmkgmoAFDBSNIK z++O6Ib7cNZ->Rha&qxsZ_n~Osn$%V10R4o>{u(&v$RpH@{0j8 zT7Kg#Ue~FoH08D@#Y^9IV(Bbpju+)8YTNl*uPYAzSPEVw0{wt70KHh!;w>)$p8_=z zNdhnvz_Rb66C$KF0TWUF{S0hJ#5)jiFea8wMx;rI)QLzVu@-$t47$|D7o9I+9s2ZW zA+BgD#GvL_V;<$yknTbpPe;4jf^a4Zv1>m3SHn&}65=B)jz6%oNlcw;67PIq60vOp zMEo-WV#JMsV#l|E;>gAzVc!@mR{dB_{Avvmr(;9K&FQtofg|CfW_TSD{n16@N#~_v zNkFuS*w{pz`XW}$+tf}pF6|};T$wKVF3l3l-!2qGvgV1vtmnm3hxdx)KEb9}6FZsO zZl7cdN`22XWJ6rQ{uNIK>>hJN;0rMa1E0I;g`iWZrNQ+dJXr0)q<$d}9=|Ab`OmFu z#l^i9PIiH!OZm=5pTFsYR;bNz{}2tx`McCl{_Zj>LY#czhVNGN3Ayv-6FVqtDSe?- zPqAG8Sf2dd6~D?;|EyV+{4Lj0MT32pI}~TTPtNwQ*Y%B!96#lMVyBn0KX`R7z*-D> zma4F+_#VgMTZl;Qp%8j$;0)(-VQF8#)pZQt1J?1dga z)zRLB6lJ;ov3R|tZdfu<9UIR`Ou-V9shF#U$xvpOa?qDn5O?Ku!?K=EOsGI0db^=; zz2#k&(Vma#TEqRh8j$&-5_$@Cnma(O+A>48^-r<&`!ADZoj<$7IIYA?$0C{2aY+Kk>_R7RDTA^(N8lwPNQ=ea(88i9olbf9sh(ePY0d-!uPcKKi5g|E-GoheWPVpYx%0uIWH+b+x_j ziH*Xbb`tj)D1)aS@Bi$PxAdt@-y~;0-v4J6_ZL05{N9>7PW!zM**MuW|39%yhY0b& z_?2(hIJ99LFI>*;NtWwrdudPd)Ia)xqt%YDB0Vk2-gcY&OCxV~LwvlIy|Ud<{^LBz zdp#%P{EurO8bQ#!KKc%9F6?G+?Pf)9MBf^c7<0M{rIY-gQW71i5_)(7hyskE^ z&EMOZ?##?`WX2|1@ZUN7#GG!Mg}GLL)jULrrg3O!z|er90Yd|Z1`G`t8Zb0qXu!~b zp#eh!h6W4`7#c7%U}(V5fT00H1OHJC&=`f`3=J3>Ff?Fjz|er90Yd|Z2CA+Bqy1EM zT^Uyz8Zb0qXu!~bp#eh!h6W4`7#c7%U}(V5fT00H1BM0+4Hz0QG+=1J(14)Ff?Fjz|er90Yd|Z1`G`t8Zb0qXu!~bp@Dy^28{WH|JIZ>p3BgHp#eh!h6W4` z7#c7%U}(V5fT4kZk_PDA%Xt6#C#8tN#n6DE0Yd|Z1`G`t8Zb0qXu!~bp#eh!h6W4` z7#c7%U}(V5fT00H1BM0+4Hz0QG+=1J(14)Ff?Fjz|er90Yd|Z1`G`t z8Zb0qXu!~bp#eh!h6W4`7#c7%U}(V5fT00H1BM0+4Hz0QG+=1J(14) zFf?Fjz|er90Yd|Z1`G`t8Zb0qXu!~bp#eh!h6W4`7#c7%U}(V5fT00H1BM0+4Hz0Q zG+=1J(14)|`2&GN`cCiVLoLsBTl471%m}<>*I?^qf4tthMy{H%w zQT#3XHAXxqI>t(sOd*tinWBI;+BQ2&e{77$m22!&adLIN46t#`w0AsHUM}c3f1qPIrG`?SD~IQlVH~L$wo@lT3EL z?8M>9D>sx2X(xdoKuhVQbMe$%o+Mr4+fGK#ix4xS)}OiJ!I)=W?yZ(5bO)6uEY~a1hn>Wa8RN8! zLFtkul`Jx!eSY|e2O`9RPQP^wf4lL9o81wUjSwG}d*?$<6o<>2XSI*PVU9Jg(sFJg z0$}~*HuJ5YxCIg78L@BCoZZV7HC~{`%=%&ZdGPV7Cz)5swZ3^pEshYqSJl5{WYk;1 zPsVC_vD`1OWP5IYo=et~S6*`ZE%d{S;*3wKU;O%qbgYe=_?6kJ;hz;TTeTeMu-iztA_7t_W7Lwzf$R_lv*%+=KD^XP@;ics39eA4p@ZJIW11%s0HGBD1! zUSgh$5R214zvkBig<;Pu*79JvL_s-Jd8C*N9r?Z!$bF;C=dd3>bjyK0ozJG*v(!2yw%J4|)vU*}!(y zwQ7`XH!LqF;y$PXp9*P4x5|2oZ0VcVrnM2`_K4xmy{r2Me=v_)3?BPoxgwM{DzA9E zH3torDwLnHJumdbXVxnbV(i=oF&kqSyne-U3g(;5AaY|jHsRAv|Dx{yxv!Jzay;0m_BI?}`oRHLyc`#4Coc&dv zo(kkVX^LV5$n{^;4gPt)^-2Bl>kj68$2^#)Ue5k1PwLA{ahS8tou$lgZ58-@IsvBS)RdFtitukwtyXJ$K`ZjPyzJf}6& zb6w-+rL`Jw&#FpmQRWrZ(Kj!ObBbf((OxyDQkR(G)H^~e$k|`z zmEgdenLV$YBQu{$G1ahr+O*88)DN$H??i}$)wU!*wP@p8`*XGL87yZ$yjOW8S@SY1 zuJh%U)XBHL3f_$nKW04~@%2>Kw0E1SG1DEC|5?s_c(3yE)bEw6Ow+v9)aQr&@G9LI zAwF#1=tcYf0~t@-wCz}yGauepomYjXn-YYao<%qM)*Ib$!#Vg$hTP4rE^c}4Gz5WQ|6|4Gx8Git=SBj)sEIrHJYs<(dVLh0tT z;uYx}s3}3ndRyy<-=;kg!t(s;DJ`qDI#%~bZMw3YdGTK5mu5z9k5X);XIm^)dBK$5 z50X0j)?4m=*qbB&>tj!KUbnp&jl6j3L6$Qg-mARgGczq{{*1EPta-lcK)F3OH{LfN zisQzkK?Pevet3lAQ|}0^AZLHKo*cx+W=StZgU9KxTPLEl#Za|P?Q&}Avq)2d@>Ne$ z1Az+GD}Ywgaa$ZW0g`}Kz{fx;in&(69vrU(ZU>eCCdjS?1_4(AM<6>1ya~`Xje$!5 zii_)g92(B8fgz5IiZ&vNP0hCJRJInQoReO^9T1Mqt zZSD#>!)Z|lN|j4}*$0wS8S^CjxEdgvXbr@;kDIyoG{VvVs0GvkE(gf2c>IgTuBdcS z8LM`{=hPcTJ=kim6b=lh(STg;b?K(HkI1G%nFkYz1UY5BeZjt$BgGwW?kekjte`ce z135|)vJaLkLTS_2V$ZTT(bbTMCKHCv(Qo7|RF1nja@@@*dZV^vsW-{>!#+QJlsmT6 zZ!rD&b$4=<#7AMJle2%-`NS%w&G*TAI+pHRPjt`ayH7QGE-ON<&|FO z%CqDonr*gG=FD-iUQ|VSgz`1dA0kF-92}y$k3&X~uhaVev(BhI;4+-@GL`9St*`PV zKSEU;h2_in^Y?Y{h47>2xa>j%WQ1`+HSlNT7qT_7W!b*jmPsbd>0#)c9Q&zf#@5il zKTiXHMt=D-pOW$&TSG}WZTxWqG_b(kD<@>$3AR|;vjr;kMMhC3F z)OHt2+<(Aw{qy!RkGEoOEKSx^r#GrE%Ic*2^6B}a%HxGx7IHj%&Nf7QqpygybK&+? z$;T8MN(XME;jp}|#_7Z9Mt+9-;~MbSF5z|trw#8ZW=az}m&;vQPRE8bH1KcI zfWQ3mPkUA_FDZ|58Ot2WkNsIz+1}rE{`@No_d>}je&fCOLTU5Dh4W|T7j6^Ko*eJF z{lGTK^%PyhGCKaVTvg(z$~Au$KO@|Kt_F%>81j2>5YBHvBP<3++z+(7013b_fQ_z}XfUZD0;A$Wepm!`P6GH&X6ZC#Vdm3Y-V}9Qunc=FY0r|Z*H#1ZzPvUVal0uo= zMc>vIv=Cx%?*k)oC{lh6tJh+hZEF;rz|r1>Ez1?5v`O!pV6$RsVOqA;m5t9cV-sv< z%+(of#ZbEPX^Q(=na3#|4{Ebh8mC<>#ID!hqiGYO^^!r`o$o%?QqP0sbdBsP@JP-v zkFj*m8D+`BxW0#q%p-cVwjV&ho<>m?*3&4P{q3#??`t}G4rxq?r(t|FkAUSe2Ri1j z97z@BW966-iqHBypXTGbVgx7W8+|x*PWgf6lwf*;SOz=+ybt67l((7yjRBfpLZ2Cu z4w3E3p)!V`itb#muVS$OFE5krqy%PchH{nn;dj0)Q*Nx3} z@!SU5n~;Jmr)y-#w$VEF=G^?gW=x}SS|=*~N8Rma%yi3gUo6k(h_-6&^)N`#`Y+MF zVINzPC$}3DDqdV!DmpRa}S9@il!>RUP^~pE;S`UWiI9W+4 za4JLfSl*JpX#Nv9D&ubj`T(_&`AMhYDBRPqH{2i7KoV}3%N1Hb;e7J-LU%Z{?$E$- zTDvQrVN&ew7#8|CySHrPTG-{AA&*?T__@?hQN2||ScCh??pTgfjq^6ov{!x(&B;^C zNmrkIOTHzmt7WvqiM5I7`%4O-7!M;qAFmA&4L>UXs4k&7UsNWNUkE_Y&pIGG z`fs}B6znSO={x47_upExM^9=23b6qRMs~w;MJR2wGn4V17R)2ZY|o_SZX7gextnFQ z#p$$UxveP0I@*$1n2D*wd1wz*v>!^dzSy)x`7;aqyKvqapgB)uClD(jc9iyXPESSW zXs#%8dfCn>t*LCIJ%Q3+wj-P>j=~^0+Y}wMBR+J_VbJ-1$;su;PKR&%iL-}_Nh714 zOf6g2dj(D0hGY9-xhnN+E4QCSD^@VDPDI0v3L$@XlZS-KMZEEl^vPY=+K> zIh8#GN@sqrp<^n8D2+MYX)nuI{$ERbsNuZbEZoWE&Z%3pcB5}64a^M{JHCIU!RzJ* z8>xOIN98t^J1kd((k20)9bio@ni1U1oM%oo+fkf2V^L+Lnsak4S&3Ld&xPxYk!W)L zL_u&`Q+gU{N*ek5Trr|%J6Y)TZ6|4?BE`<@($`<%SUG2cJKz}0Z@+BQJ z%+mlAFq(_h1stdyPfk<*(4k>sAyGV&fEc?ZH=q_jPlxCUjDIM4b`*NL>(*F zpZJE$N(EqrqEES5Z`Y)bx_}k<3@4Le1*Q~=9 zGY-Y*U%%Y_^hXcfM#tpHpSF6rBE|;m&31P>9ZpvUD%1&fSc~#;O@Z=q2mfq<;vaJ5 zkyrR0vInvS%IB1)DSuP`r!s=d4|><5vWUu*XrLL;21o>`pLsm+FhKla;*+t{thcxY z&q;B_1GK*%mlV* zk;R;skL8sdHfv^KY?1|^5;<{07l58u{yv7nQ8lkVBb`^~NAx>4{VYPP-afp0 zkDq%TY2@a>{8%ngQw~*r{1vkDC7IJbQ_M4UEW?4fRA(Off@fcgE7yV2lS*4lZ0~$1 zKL^VMl}{#%?PZzZxi>c1m6VZ@*4s(jbWwy@`FTd(s%&1$gUT@Rz}XXt83LI+ebS*hC$cK?U+-DpIl|>omLhhqITuJ zf5psc$F@@DhGTuQT$OsZsy@>*&2}uffKT#m&>88eWh}`&Tw;^$ST@qE*dX0q1h8JB zCTV%;)4AX_%mWORB$y&5P&^lTsPinR8jFQ*p5e&z>muK(7dYr`8iQ+aPdrx4i(%k@vA zEeEIs$hBGWEdBbXs1~BPj}0)68psp(!fy5>uswhopfS|3z(9b$E3X4keaP))9C~#K z#&CZ?19G{x6ZS#+j0b2>`Ip)yQCA^-_V2j<*ntSK<%j34x@~*G%hMqzN9_l)50)!J zX`|XlswKzaEKD$GW?L|dI3BNMSk)VCXtnjwl9u+S0uN;!EoMo#7Xxg!Yp3|;l?(r^ zeJ0iIePDE23f&Ax>lzR*ma9_FR^^2%NofkW3%1y<`096z6RUn^u}`8UFEcwmKbPuS zRAzbk)F}d&1jyx{x@xsLhN)ao#my{tIMlyfHqCeb>@qb}Y-@B!{KIc2Kk@Or5G98G zXh_m?vRogn`kcyBK=VrR&5x#3FMPc|pR!!PSL^}8*1#yBIY6wbJxgt6dhd+|h#lo$ z8pow~;OhXg6&hURzG$*9svaqib3UhV$o34U)xcbwa(;-M;oDAfr-zC$1(P4y&~Mt< zN2&84j`JzYRjFs|&rUdt@*P#R7rx%xp5Ak)tw1(FX-<2xFLG=LYzw?seT}U@4ant6 zyIH>NWg+Zo=!cig$?x8D(p_EDkl9{Xu8&W(7j3&xY3z5)cPd4@`v${K^qTu;oonj< zJGJ#JmDBW|5O-~mxcZ*G&+LR96@G2K>x)AR2M!NXpM&dJmg}D`-8|aT6+I&^>R;nd zH|i_N%fm{@?i#5ZUMetJ<>^&JD9G?~{ra9hV4TNDGWnRrR1f`sb#i$>a<(@A>fh_y z9gGk!%&^~@a!aqJRM(QDJE&d2az!X@r1D;!nBdOJE@~BcdEJ!x9Mkd9zenu*B0@Cm za^-^e_q(p&)>Dm?`LJA~q8zGxyuJT=`Um7!UztzQUB2~G@KuDkJ9YPe*Jt$BSx|o8){Hb+?v}UO!QXB1H2c_Vg>>wltj8U5%6Zu-wB$J*te4r|s-r zPjWrb1M|Q+=@4UE4$?fO_N0votbEaUmYI|lO z+Vi^nJOKew|0bnJBtUgPw*jdQKuk%-;QF8T1i5{{ek3Eu*HCyA7M)XZMg9bihp&U^ zKkwxHlsi{zC;D-^ov@>)ySz}a?(J*7`>nC6x>ZOhvJ;l;73%pfoBEC?|CtS4eGVH8 zMR`BOQkrzH-d+Yk_AnBR)}wn7#|Z$v>rp#}ikRL2)d4hjk8Fn1meZQjU2g*r8SXqa zunG6^`$*hQ633T+F{r$6sGwpZYdJ%v&~Oa)Vu;ym!k+vM3LKmMcPOBXwk}EIon& z*1T*ygE_~gGEa7);cU+`JF}>xJfkqzqU-ynU}e5@@As|mg-7upnXG!XZ)y_U^(Qwc z);G%~s>-2>qw)RQ z@0asK!GqfOEPX#~9Q?%#W!uBAz4548+NkTeQhCX8y}s1^;IE(6)4!U80Ob6j&jW1NGsq+|t$h?vs(w0B^ z^1TGSm)#Vx`kLMeZ(ZdkKue}E0~CMplV9Ik zhWO?1DeNM*KaG=)d_-&4`uU)xXlIQ7xUl8E%;+KXEekoigX(jZD?(|b+O_;Xk&vBl zAE(TABZl10r}&FkY2z0MehMZIhrugwS;rsJPDY3!_XLagzunN`HX0Cx&wNd!u(UZUVgxsbKK@`-sp!i7_G~Pzv2v9#U<@HE_#%SvRH0O}s zf2a?I-c4v829*ocPe+eI^O_q1JT7nrj-!D_z?A^Cof-pI15JRYKn#G_JY^2!wb;`* z@bv(_|1<~UfEEC?KU)FxoHqb%fVMz8pglnC#Ew8G;6{MPk!fhN3qW?-6-WTO0o{Q_ z;AVi@xye8efclB3&nOk>1@s2efIdK9ARWj6`T_j`>Z=$C3<3rNH1~2SFbo(D(43W# zfEmaHEWjAR3XB7C00(djK+^{DfeAn%a4T>-Fd3KvOatx!W&(EtcL8&Ndx86adB6j} z0^lKF5wHY!1b7r!20RHo4XgxK0nY<30&9VnfsMdxz#G8Zz&2n9uoL(I*aPebJ^?-l z4gy~R-vCE}O-~5LgU629yA+fHlAd;0<6qunX7^lmUl;AAtV> zXMySguzlbX;0mBA5C^mex&l3c3}6^A8gKxGz%*bEumE@zSOKg7UIX3%_5ufiqrfjf za3FL7Tn1bN+yHb1dILiND=;3I4%`nE1J42*fOmk8fg`{#K#d^i6}Sdy5A*m3QPf>0(Jl= zfd(kB5&#=O-AAti-vIS$BF_Uh;342`;Ah}!6m0!~8NgcL2yj^#@-{F7co{ej#Gv3C z2|NUR0E9fpb-k%S-^2%Xamgg2HK#| zeG<6jGVlP-0^=_i;(H+b3Zw@xDjK#2WHmxP1lX^HUVx&jQ06yAc>!E^HS`E%G=XgZ zGn#^P44xAhbq(fwHADIU{jNpkz7DnsjJO_kLo9dzQ<|gfjT7Q`U}Fp9hnC1Itx#9A z1_$898&Gz&K^|_4a=IPrjP|$|IM4w$(Ghv26Q1Kn^yA+Id+&_A)CKc&<6*m9k*5=2 zzunN!*&TT}5oOTL=pRgiE%rcp(G$;^f@@M?f4z`KY2eWZI%Jy=I{7oQ3>88#w}Pejr9Ho_H-2W;&GH2 zCxv+Z6m5^(wM=4Nq)8mBXA*5uP~VG!`Vgp({FGE4y69x7CD5y`MpdRKJjE!elTlD#gn~K{1@%QJsC%NIegXw`M3mkMVo{`aamfRXge%W+%Yy#gcJmdO?L!}XYn7s4<8K_ElUH%7K{Zf+z}|2 zeG(|X`8H6D`z=shTQf*p(;!HU#+->SI|hkmDM8}#VL{@sJxJVA6eK#|A0*Nr4-%`^ zV81m;#D5YbCjJm4&IX{pcyX{e(JWYu>KrVt$_N&1tifW*q+l^{ez34EhySKvasS?6 z@yz$|uU1X`d|5Tov`sa!wpTT=d`vZQwg|@$R}*_zR};hDt0q#8R73e*UDz5`7sWSL z7YT!_ivbg=i_hj)7au)eU8KHWU9>w^T`Y|V5k<{IL|N|;u_-r1TzP+p2w5E>^7e#? z>|a8}*9~ik<6UZq*_Ik&_3RqrmeLwx^PU>wnbS2yi>pILpVUwhIX+b6qW$aI8Y(V3 ziT~qXQB&mftSRaj)D-zo)D(AoP!siPEwQadEfGAbmNXH zVIpr{m}s&!OsqT`CPLeWV=a$xF}NgLq#q0yEiS`9ItNCG6%XLwX&*$0uWCn%ygrfQ z%zcq!<_D1|V{4122GtgcOKXdhU(^Fm+Oed!F9#nw7R0xlDgu(BXz|C z?dyqoch(a-KB^~@uD?jsm~xT0c+W+`b=}3H$@Ggwt4}W$kG8!8d@d2sAG<`Ddq;_x ztD?j;wd;%2y!zsoef34F&Xm2@yo9gX>A*e zyWeUo&JMU*JooL@V#Smu;^+EJ#p2aX#S?vEM8o4TqQ<;y#DuoZgyXYj;S^XI(|RLkZ&TAG?X$f)Yh`{hP(2mPw*XTC!;1>>=)2*i+2hoFcCLF;(O=?JaH_ znI_Cj`-tWT`ifs;GQ{rueq#6A{YBUn1I4^s2Z>uh9V|ZXHdJhRZkQOJSYxUe@H}I7Kydnmx%W|7K_<0J|-gCKOttk^^~}1_;T^(*_EQ<%2nd) zQO^ro;}^yLV=svTTh@y@D>jI>4{Z`Z-oIJoEqqHHetN5z^!7Vq%<=cc2TeZ^C&%s) zzpvjfE|2zXjXJcyk7TPG5N*s#Y2`8BDwL;V(al=MEbj@#Z~J~ru-L! zO*1#uFg^HjnCW1(I;NFfFE+Kl_fpe_?=CmpIpiwSXCGsxvHdzzn>sB_TejR_I&)tK zQzLt4)9u5$nTC%{HbqY8W%}aLbko%b2AX1S7;d_0X{Kp?L#yd{som6WNS^6XgNddA zKTb9sIB$-JD~ol`T<*SzA|9o z+GYXCJz51^ai(Ly$Pc>(%-@k3ka(njK)|&l1NzUk27GX-E1=f)+X5CmIwPRwBXa{x zZ#*1uN$n>Bj?7pU(6Gt+fIdIG5fJ;udjZ1&J`T7u_3MBUZypc0Z|v!S_iwBbxTo_) zfrD;o6nOCm*9UI5bO`Lw?B>9jMj3&_dYS{5J#7!%(&@IqCBd@;{};3{@R^QJ1}<8@ zI&f*<&4CZK-W8bJ=RjcC@?(KRJBy%{I*~!Uu8I!&DlaZ*O11c)$M^RM>iff}p!<{Z zf^xsUBk0$y3xc|zd^#w5^eaJ=8@(5_qRGLa+7o^X`lxP=;MQjv2KQ~-BG|U6d+^4G z2M6Ezwj;P+(jCFeFIyD6DEYbIPCMQXKK%4&!PGB+E{DlzO=uO=TkUX!l%2eV}P6cwLp~Hj#KS2zdU9!@sXb zb478?gXJCu>QO}=%4o1lnLLo?=}?h*Y|`=2_up=68!5WoJFCaw-nN&k>v*vI9C?%{ zjLakHdEfdN**;P$sDe!Rtr^&gNlGLM})9{T=c(J@jyKBC>j zXZm(YyHdx4<>$u3V<0k*fiGzFq3`dbIPTaM9yHI^t0UPBIl6G;F-GLJGH4}E?q?i49TeYP&-g&rr&<4V-X*iKn4QBV#m@)%^b*zj9EUB92qBYU-0 zACxY5tr43nA>xM1TTVPSBvLFn*sty-_ieeT4&L|3F%OojQqR^mk8(5B=;N3l9?>Hr z#RN;2i_I^+^6bl_)wq}k%RLO#BcD7xW~$*)@M1-MkR62J-LvD!pH@)FpFKS7$vK0T zP2U!v8YxmoU#@b;@Lb%){pKNSv^*$HhzDN7#E3Z) z=~A(^WL5JP*Yx?2j>)Na;QJ+=T=nJgAGu%JZ66AOu7&hRV3-Ofz^HdD#E$tC>-gx) zGrD8Pp09?-?>YXEdN^-;C8hh=R-gExLoZF!h*p5qvA!A)|0S_?kp;sLS_y`GL`MvAnno~zkq-K~v6=t8()fa*b( zD?(|b+K+x-EUTrP#bz#4imGDV!|63}t^e=c6Yu)!=T8QqR`+ z{QG2ALbfFnqa5m2n_0c>?p4P?T=`a8qo<yAX;36O#r~!llltz4B4adZ~IuPInsg92+9RmS!vYd`d zPT*^CXt+u=Am^u$mwo5&ouebghC}OLz2p8-aS`tD%-EBiuv{O_0Lv(4r51GtlPk7= zI~qt#pf5^OEqP{qPHK+5*@E{$+{pQ<-3G0_>gO>p1kY3Uuj-H6(W}$P*Sx2g0ofDr zV7Z=$&w0$A&qq-*VoDNjE`}k=cB>EXuR13irUwiH$hH|Ir(<%wSI@j}DIZdJNn_!^2TwY^~A6t9oNtHu2f(m{Qtn~sp?s~M`8dW9gm@5G08qP-8hIFwP{xiIV~=48 zu@ra&Co%#dn0vO&=#^Nu={t_Sx_&@fp13rqP zeNR9o5|l#}5L;*xT8w~56G%cykP-+bA}B|4kdrhn2?SI)^+T|r;Zr2`*bqe#JE9_X z?AQ?-78H9_RIK0sd3Nu;o10uV0RjEP&F}Z@?7q7@^X|+u@6683&K?eMea|C+BLViM z91R=;!~+-xQhbkZ1GEL&0UQ=WkE2QeIshF33=^r&Ko=kpz>twj0*(i|0^I-%A*mC9 z9>9q}Pk?RJ-asFqFM#1CYc4>4_yd4sAO+yufPuguU@$NQNCVP=p}@(&Fo1IhMgSv$ z3}6&68ps630Aqo10EVno7H|qM0XP-F5SE$*oCcf@Oa?HdrKSMcKn~ymrUKJ|T)+#Q z0Za$-fPA0;CuxD{9q+y>kZtN`u+?gUl>cLA$_yMcRvdx86a`+*052Z7bVL%vI=)C1}R`vLm{2LPO}5(^v% zGz8*+M!-S9!2sv7xPT_WAwW~$P~b428Gzwa)dDyiXbBtv90?o+91U;|OgzvEXbrRh z+5+u>V*$>O;r~xM03Cr&Kxd!}kO&+HU|3ci4|D~(0o?(vpV_TDtla%OWYUu4?_G4-`_TNLjFCym`8B*`Mxc3TN>KR zC+_HJ$SKYCXv@t>3otz+l?%3wC@k?#oo#&@&xP~i5d`(J=08HOv}>+<`nvyFzjH{8;Hc#J8R^O4`f104f_o*jG!Hgf7{cLCQO zXM04_vEuoLRxrufG8(i0WIOcr9#Hh>@AV%4W7q-KrB*t!-7Ioj8rnwI$6jF~*m;7> zD-j{}kbVIw&g)&bm`={yN1?4Q=f3XrbGkgbAI_6?FFNxi z{)L9>&P`8sdfeaV-3wfH>XEnPiO9_~jm(n}Z>=7rZq<3hwsT*gIdBlrC;;+?XaK|l zL8- z$4o=vxtxyL6G@3(>z5%oY1a&RBb+xJ?o3UlQPW^%8z<~hkE0*6QferxcvGKq> zfPE|ngJXP8WZQZW$nz9*`Vlv`#^XG5Fy0>zLtMw;{RxF|eG1B_8}B5Gz%g{Byw@d0 zwZ+TY)92JvPu*Hy6=5FYSx;lm;Fvh|_E83}n3?yzRImM6&GyshznHw|`(-8c>jZt-zGYo&r?yh@*pIqBn*w@$ zvii+%JAMRIA=fHiucszWSh0LP%0-XQlRA%HnR4AV9c?|AqX9+Ui`>-Su75d>Js3ZS z%WzvuU|{Sz(VCEhcO#6>@*ei1>Gm;(gx6exw$EL@Th_&qW8J~If1A_a>&o5Nx` z%7Ma3=dCQ^pTqVv zY;flPg4qtHt>Nk8f!RPhK)aI!91V~gVvi0995cOXr|84nSm#^AZw2sr%7`WaUblnS z&<+sHcBTex9_v45Gr=}DeUV`|=yoJ~cjQ{e7j@ATh?D|)`Ca~Qc=QsI+vB*u}MzfwZ?Iks28Kuv%sk^R$Lc#Owi;TKmp8`5x zaz6~`i)rtBzSmH_ds^2^J0I~*+rIN?@z4(+sAolPYFHy*tf`fzwXbgPX+-u^%$&=z1_(h=wk z91DnyKB_>gzCcqoC}(@*aDex*E@2-I>k!IVpOC*T0KS5|0MGE!aW z9w-7qnH=L1#eMUbayrVTPU5~E9_1nvpEA?&T-5!$Q(z&~llQ}f&Ef52a*3~j)vNVxCh^+@ZIVS(eCgX)gr> zG!_Ib>Gk?Fpi<9P{(GBaEr^FD&k3|qff&WW$zD>CsJ7SGd(UiMMwnAghn;>)#i zEWX?;VahRmxrVlEjD8}z|F27dN@SK^ex8Ab?9&kb{p%Fo#}qRAxoUcRmO17bZI{?T z+Ae8NP$sqvyOu4G>v%8Q8uUd*pN?VjKCvy7OI$q1`*@CWxtG`ToP@_?o}-MAFnC^o z-QYcPjmUVv?DKkY5{HB#;fp-dbv#EW;mEzFuV2IGlk4Sv@p)a;{d-cN5*el2Gc-vo zC;9j9(RAO`#LOS|&7iBudN1O;j@S;CFM?%{HiqNeeAklmQeGhnI=Lq(sKd^#;Ki;8 zqYkR>kxTS;e(sOq@7+1jfXM29fU4i@jt6>HHB?(O2HoE7_D|wU14g<8=h@B|xv6xZ zeQzyi-w^u>@h0v|OwY;l$ZwevhvUo4()`4cCArrBdLz|?PP`!(m@o8M-w@;% z`9v=9{ZQ<>nSZ>8&Xm_Avo78Zn;nUt*G9U2H>ed2^8Y~!_@Se`uP^*5yc}0zvVK>b zuR_Pw|K8rbb}P#HLrF`X{iNa4Q(j`>fO~C#U5-U=3AGLS&xX6F<#}d~EGofg-E%xx zmY~S(^T;KpoliqQz^Qn#XoU-;Yzkkc9P(a~Ng0&z#Mk9=t(=Scbx#35E){+(|HYXf zu|GFd4{TlEclo$xP5*QBjaDSW50RTOSL28M?R|~>Fz=6a%yAO(=M3NzU?vE_Zw^)h z6F{QRfV*Jm8=)@R3?ECCslLGb*uM^_#Cfi1nTzWm$Gt;=pAZh~yeR1%#Vca4OKBP5>_T8-?k1qV!`g=G(%<-AD z-x{i_?>-(py2C+p28<}Riiz+;j{ANO8zZutGI9w#zI z>~E#`9wBl|sBOTHA*q3XDRJ$PqC#&0-#tuT+znY@1j+UeveGK+EZ^LxLzY^0o1{c` z2hZDDgqL@b@g8v^ljBH!U9O3A-`*(G$E9=Y+l|d+JZK<|_VZwWA^6g!adE38ys5o* z?6>JpefsjJeJ0vD#_#9I3z3^?1YTs~CuLI#%RD)Q%CG=ZfjcjQ-0=8{WvwjU!|z1N zPp5gzIz0-zFD3w#V5g!l&l zX94_%l;1qg1%3vwe5*PRkNYd|1(Y}d3Y-E3zDE1`c_djq3?knGL$bapYz-!rRAHh? zw^sO;w>`qf0Q-YzYxhV&TWAEn)t!X4Od<6C5AMGP-}J6Q9r-@OYk)OzVYogoj!{27 z6r)bSN1APl>Z$v-)Kh27sIO);-%qW@ny)>c-Cu2dA8WW`f$ZXY4pfcLk5lXJK1dxs z*rhg)YpP0qZ>H`Yd4#&RBwjtc_*ixOn_bkWvwEoFH3QUBUky{SUi9$Xkf+j`pQDE4 zUa2+>e?WbF^G5YfaZJpLAC8YX;PUA)XSi0yj4qC;_gcp(^}4itv)<=-VKG}2QDpPH zp4ekP$#-+#Ag$x3eCc%K@rrf4`l+zGDA4_1wsVC>IB!Pg z$h8?@~_Z(hr=85SY? zw7s%V{iql3`KXEc=U1aVH!3+VfAS%5YWzhXcYM44WjQlh zsNlHX6zf}&+tSb$<#tFaes??5gJpw!_(!w7$H~XmMZ5bwhUJ>?FPxWv?i|Yw90R`< z&=%lpSx10lQ^x}*0PJUCb0QT;1JK=L&9`N{e+qC0z`mz5f%!l=fG!|wjl}!mKLxx2 zYyo}&;$TeT0d~P=0Mmhm0M}LHnr7_#<~m);Kp}7g@HW7I$7KMQ1MdT!Q5l{Kdn{q7RKsEpd%XQj{*~6*c!mVtpgUK0Wld_nvTkT5MK7iq9Jl7UiKcs%Z3XLi1W~p zXo>`S3NLv}(J(2;M^twoi8aYENH?byzOQPF>ySXm-fI0tL-1UDZzN;*?m{{+{jvbI zY1#oyXSR3PR$+UC;PnLUFYPQI!D<`f@q%p+%6N=q3AP2WYdOjYI$onYkyEDc>(@m0 zqbaZ_Q^1eN#J;v@M&^gUw=(VP>O7Yk-EP~GZ$2Knjb(*S?5oIaX=q!6eH~p`SW?WZ z76KCghQq_-_uyO(ApKR9(C^8-@0T|J`QFby$ixXa>8}#GEe&m*+hx|^qII#;`&1~j z+V@}LFSpx|2$fs@`zHQ|2G+Q178)sU&+NB3t7V)zsrR-6vGXf;kzT=aD{?c1 zg5@^N<1Wf{^ZyT4Va3XM`Q8#N3=+7Z5~QR3kZ~f4$-^CSyk0oW`*=*QTZ&Qu$MfR! zeU=469Lo(;gFYeQa=$&$8Au2E0&I_X0GhJ40L$#&=KOddvF|O8cIHXhk#VX?=~Zjr z-S37m1GBa;$$~r)Ic2)5i6{8)Ob)Lz`B7JH2q(w`+DXYrhDpcs5|+*f?h9y(c|RY7 zTw*x1&1~9RaG9Ou<=~!R$y@GQCW&`7ZYk{cS zH7TI;B)7FQPu7D+L;l**C-&;!UrhS*Ve4XPCyLzEDgsaN6FzT#X}->q>h?s!5nCX~ zPClPjC*f4leWrIXvlse!$|n;n;a(E0PH z*wIM*A`gok2YUQ^#FdCZZwIlR-vQuz1@oOYi;pO66>@_*@tFI(hBl4$4BsVKH_ZVi z1MF`iXDBD1cn`t*876(xnKJX(ynb&#_TvGC7xC?#dEp0d9>1c;)dM?xaO4nH{&2zz zk=xSHR_8@%<%AG7O@6Sg*&U#5V4lVTnT4z0=NqwANI{}pt`lhJo85nQWNh!L`}^GEC7oM15^H}nj`;zDM z$pdnR<%Um18_Ifl7?1~?3(&;#9Jxa~Or8)dV=P~^%TZ^ifc_rf?-I_F99+V(RWuj> z%1PNWb^~}c<;a7lfBb#hRo{)W?-!nk+?Iy6I!{vhd2%*a2OI4!@q}z8uU-Y{?X8n= z%zP#f#0e*a4?Iu1LOJ_`X-C=vn38SH%j0#tW_LI}-C`4++r`_9Tx!%qiJzWd_C!Oo zT`Y1_M?Ky6&)?tz_(mhyj~k_)OGpaOKeK(j5PCNFZFbd^MNfA&+s7iWvmSxQvRS@q zk69jB##lxrujte1cAWdXMr=IuuL}@uCnFJdkt;_y!jG)3&iq&n{>(prtb54$53VuW z$s#w^s*$JFY6AOClP|R2(RQ<$s{h=v&XB~Or1lkv}lzCH{msRWa)9 zRsC;$;BK>>DRNW2y6`2Esi_NZ%(!?=t`Ky3-9;XeL(z68Q|9kG-Oi|<;k?N~@Ory5 zPVp;x)@Q zuIdw~-gvR$&&_VSq2UMFc1m4}7b4E%6S*x7ZIOOsN_|rb2fGW7KY5H-ep{pDJHp!f zHKeTY{Y%<+)ROP%Y$NhrjBP|0K)cL#0Q*0f@9bNz>vu@4aBUlaZ>?-D@y#yKR?u&Kmk)gg6=sgJI5$X6R6Ed_c z18IQ_y#yKh*+hKP>qh_ARE!HFL;Xca)0y~}EHZTSIpD)W%*jNCRv|-&UW+uk1@lMm zL|)tvJ=da7?OF7{y^8<9zKb|M!@WP?``|w@zp`PB@-&Z8hhxFyG7SD)oD!oZjmCGt zQ{b1xD3(Lcr9{fA45Y7aU+~!0{86Z6^$X8{e>Kn#KvGy}4IfEk^;xiN!~;lHtDGQt ztg?fwviduYfX}`SWU*C#_J>c0Y_lB8m&lM^RvpJ{+4qcWvBF{;yoO`x9f5d&<+K$* z$NP9a@1q0lf-VMo1RWmLay$kVf==!W3ZgsF6o{rkGzFq5u)`@(jyt6NmoyNSFKH5{1hp*E4 znYt`jSBZ%A`i+6n-lI8S)lVE%V;#l%g!KbKU88Q#q=3$s$%CEwvJQMoe`4yf4qkq=50yy_PmLWNjTw)$Zct8TUWjq%h}c1AIN+XFmLhtVzq(s zx?#<^Ae-?j5*!!gwd6>o{EZ~TrBUaQ0y=Lt3=QXvxn5aPdYpP`UUp^Mjmx%Owm)+v z#2b;DQPq_<#xi%c^2Us3M~=xK+6}x8Tkl6=Usx1qdkEdea9^BoRgUTJi@fvWxy9a8 zv4a6F8DLtN?U{^|<5Z_jt4@4=@o(d=?!YTiwqd;4o)Nh%4Q(UvMw%|xMU{w1Z@(~J z_8YwbTnU^7P??wEtprX6_@2)84C@VYfIc1X6<7j?4X=y3+Ec)fON1Y;kr#^+=KVW!Ogq5(h&*Z!uwOD8xCuBDKsS~3 zEz1P>qXNi)KOE={91pYrXm^+*v_a${>plA7gk$21d~fpoco^YF(kN$sl!HIs6SD90 zR;>DYAb)@cC;Sk(CDb+%_z~7LapDK_nR&wcfbEbj0P}V>a4B#Ba6V89(9U3*o|W(D z<_!Mhl02b(p|;Fh`ZeWeO>*3_&pJPzT= zCka_`>Y+1-e)vwi(qBHj(oQX@Z$xgUSxr1aC#`2kc*6W*`;p_3gMmc>+y;LIKn^Se zih(qMV}l$gly_RGFZA{%PFrqY%y)VAy83=xDD9H83E@29djZp1zOP#~t+6U!@zW@K7BQ~#0}_Ak#PImd`NQj> z-$QpT|8`P?Bje8w#3AvEJRlBwHN=l$1YZd+GV43?k@kqTgzqyvCUkz0S8^QX7!qSQ zx-x_<{McLzKQ`ayQolaEOf^cra=~qZjLCzcAU{QJs#*g-RHYVg{OQiT^iPUYBmTJZ z>XPq^2OmJvz|o#DUXfcuZDYloI0(y>mEZ?V@@M44!KHb5iSlBXsFfRhoI0&E&+U^S zOx}vTCST{N&RyZM$jEihvEVTw_lXZt)YTycmg5@XZLZsyKkLD-<~?IRXi{&*`uz?5 zh}?{FXZd6NcDtJWGvhIjbsh+3C?kY3yeG;dro!KMegq*rT0b?MM>rM3Ht|;QYsI!^ zx0GjNJ&omQ&9^329`aO6j&|GiH|>zfEuppnkA`Lr^cEMnOR{svxToZK2H`)BUXT1_ zV`tY(q^1V}e8=aQC*S$m_r&>Rt$_sKIN(HJ0B|yp1+edc{Zf|zZ1+6@d;(yqo3)-{ z9(>ME{1He4;qCxhfo!(}Ls4lTfXe%0;8T>NLt@cxM8{PVDDyKKnTb&5S-dd3h5?c( z=!m!kMtVjo%r$F|`F!XUd*B4j)$6C!ZRvQwK&Qq2NZjEwmAddk%!|7bO032F%MUQW zaK9LJEGAH%>WNWvZ;VmRzl>4eom5Z7SJqQUHLb6nxw5{Red2zqebs&{fBpXI-lq>x zBff2*ZcRT>afOL)cH?! zS694nl4@{TnwtCA7}d3Zw)(tRi5hU^LN&{Cy}ID`HLB{$O;Ae3AbYE=m&g=)OsobYqo zt#2J;Gm7s=w67vJBY=Gk{>Lb_sEDhdMf#0V*!R+_^GrSbR^P`)=y&Ohw>I&6F+XPF z$lpJi`^f=QdN#A7gxRw65V?~cV|=B>SaB_)9y@FAS?>5A&%PM;?eZO+nzaOu2HF4} z0QML61d@Sa0B!zMfMX6Yv#JtU18f9-2il@gj{zO$78;GFVsn? z(02sZ(nV*}4PNLl2lWCfqISzLcmHwxk7+adviFZs-y9dCO5HKag@q6f{vbyEf;9{- zJHMX#@jI+zfC=yi{E9jNKdQXo^!?R?_{Va=zy|8Z;#f7{jRV!Vf;g3Y@NSejTJHPadTf-gKI(?<&AU z`kBww>^*r{SBGT$f8pw)C$Awu0m~tKqb`~PHKu?cXT;tY6*=44p80XAea!JU+}-Hq z2XY37+k26l5rx@%{N2Mevhw|stZ!Ktj+=4R<@oP}D`m4JJXS%aXv8s?<5y@`IInxhB8MGNyc&OqtjX{a%Sr;?(bv{iq*JfqzR1_@RiDS9P{?d8N)%lYDnHJ~8l-500gMVaj%8#zRXNsi!TD9ttMeP*TU~2gW?qs0>Ed^{}&>9xw!{xE4r3W9kiHCOT;N&%*D4moYx{ zBswc!$M_H*Yy=)`9Ug1~9;_7}>~M?|rQyNu!-Hkx!6xCsZfk{k$9S;Q@n9d|!8UbO zYI0BHYd_387=&>s3}$s0i#$FJ&w%!1L(DF`#gDbFFTr@!b-3m(tk?4dp7(8~-uV_| zS+OzdQmorkJSaxJoQsD62RN>?5Gn~zHiIWP6Z{U5eN0eawP*u9-g&7@#^!_6^z@Zq zZW(;>{Qi*Bar}ehks`N*+6I5WC@L)WmS7GhevX;z$tlglZ!!mZ+&Ot94tlKZi~aCK z4|P5n5Yof^9&+-3;?#!phMkTY+BWaw9@H4)e@JucA#zKoZNOKm;>CQEnV1#o&Gr>$ zda?@(a*FMXDiI9hmws~X*5EF(+~VC$@Y8`afC2!+b_z*ueK)xpem20lCdgKcyHL#< zF9J=%<^@;<4>ED~lgLrj*HfSz2f~kXgCFL+-Kx7?YRC;4EB${wS`Z&d)QKQ6`5|&W zZ0=k3w1)YSnwiDiN&7vjLenQf+lgj^6y_afulAwcLjReMBA*2fZE9 zClLeva-*)-x?1$wTH;b||C)B8J7d_HHwDtE2kaEnN#qi)_;uCGYCmdAwluV@#tXJy z-Pvg6+ipkrA$cTaU5=Tb1m$A;<(RR^_1vf9eR8iQh;C|30o`t_|F1JY5*Ej)J6?V8 z*=t{&+i)Z^0#5iLa$6eOR^vyY!_J8pk@7B5o{EeX})9`|%y6p0sN*O|ux(of!3&GK)?6+PZ{ zDd0y?QlF@$&b*ksBu<^;?bH46HSc`?2ODf~!V8hx($H4th4KBLbx|aKgzk>KC*@!4 z1+OA!=;R!^MB5=g&-0k)CBIX;7{@31qXN7dinL|vXH|GKSXXz zLt6)aNR!mMI1*2EJ0bZld8>0n_Vw$fjY*k_kap3%x~726lZ>mKd9n&T8ngJjq3$&u zihmAdnD9j8X1q>3(VM7|cw&YnT%j+V;66D)dqEj(h165n4ZDuVQMYp`p!1~cT4$bY z1dnd`!#{GO6dcp`FJ8rnMXM8=kRwaF8FGHLZeFwcb_0c!H{sN2ISp!1~i zdS{-f>*CaXD{tL&TbD~OGTW;nH`RCINucR!-D2{DLa__vhalR1wUTR(Z*-olzrmR& z36*i`v;Up?MbZzKxK zMJCti_w%}_b4~%BCsj8&^CaU&tS2_??oU?^jH%Z>kU3KCh}?{=cAnVHS(7L7j>3GV zll+aePnpgYd7lwqzn9lW-HxY#KHeL@%$XFUp9hI^)eG;o6Ot3(rnj?+hCzj@n>u}Ct{R0gI+80h+5xMy!PCSV;??~6Dq85D^*L}^FopSim z*Ugo9*?!{NyD69Rb=60VT?KBGe(Mc)I;T(49dW8xX-t!ft*eJzA8W@b=_7K{L;Skx z!+BYW)+&pcC51)R`xPX-9r4+oqm%laS;~5x<6+WH#BT6B_vxhGw~wORNGaflPzOgEiL2yAHN!M|IAx3=@m}i14M2KwT;f3kyFm_WS0~trg)}ewODJ- z!)o=jcIzJ5B}a4@Fc+4H=j45augB7U6h7+r?XCNMJecsqb&oSYidMy`TaJ5f)TEQs zkG*2K{l$y$L*!;UMdC;D)Dp~1wr6KWs+Y|$cE_>F3&tVb;5phK&WjJ2PwefR&X30y zek9%J%#U*LXZ?8ZeA%-YcEnj-LFG$q!WzpWCR-;LTx6U#?vDV4P}O zIkU;I3w_6w566c$aKaCfTS9H4^8-J=C@#&1=@^-pGsIKi@wrR9g$0Sjy!qaet^s?p z8TXQ}PXC!_TL9DZE&I>!p;`j%08TYM8JG^RJ-!jZ@43}|KprxA1~U6o7=UdE;9~^P z2;Uz4(p0I*s4B-KC^Z@%C6tZAH$wOp=JK2I-|sK5ChD*lwP<6Ey5;(M>iRYH)oa7{ zSF;y3P`}>SP`z+sW7YA7!&K9?N2`zT?xgN**-srcC`;W_dbXN9>K;|(`%_)rn;#je zdU*Aj2ftc*plnY#a-5FJ5Onm}mrw4~E=rk@^APQGPJfT9c-Xl-Y)5$+`%0hR$Gp(8 zj_%7& zx1$McE@f?y`Up#cg`OUdCEyeO5u= zNsqO>@2YD&6XR~4Y(*+O7I{b$doQ9sL-Gozxbwmc`kv;k=&AEn=Q26V1gB5vyw$J6 zseQufy!Eeh=E-L8DE`Gu7r!`b&e?CpPq5NQcp`E$(VTb^$h-u6wTD7c-Kd+Rk2sP`g#+mQdU1dJHNu9f(gKWU~z zc)wlj6LIQ+zgS@4q}+(ymWH-r@lT!V&Gvcc0@fJ&XXLRMHoIbA~?LB=zM9_p!qOPSQ){wluVj zoL=KS-f6idA?vGDE^cAE)wQ1j-3->68SUY-=QRUBH-owb_y*uw`=0}AP-yrZ(qB;5 z{9zslNDY=f<^|iju>jBQ30ICtgwLCwbIzY6oF5z8aPf-yllqJeC@A?Oa#Lr={HbRB zu(nS?AN{?VX=A1p(~RlFG^5*7>1D?j+UoqyecpL}h@{yr)#jZBrE~6nAfqY}gruLy zLm}IHdisqm_V`lr3bXlRK>X*-U5w5+X<+F6AeAqM=cBn^gnA)PP5l0p7nW>IDK^)O z5P6;Ta9TV9fm9-6cGO;(asQoT;e~LBe4&iK*gtZKG9JtI*xe_bA5SUef8ERByfN30 zh<_S|5_ohOsucIL@C@aXlAA3OE0DgMspJZF)cF*)-j^aWoedm{Fq zc`l%xV4t&`i{`nR;=AWqe}651$C)Qp;L%}!9@6dgm0a7U!-Xpi7(7g$#?N3k9jOI+1Ib9{gJi`dcVr{_nrBY^&Zxx&VHrK ziju{v%S2k(*CbXTC(&T{DyJUwN$aW#OmJeAx;z4P-d(>RFLgeN{)|oGX zMJ!DFVuoiPOWi~{>mfR+ccjfi8SAF#`V~xxzvuLJ%(~B<`4Ybc>xpL%Z*b?_TdJ*J zA#zij9psBNf2+MOu{|R1(Tqbl5owAMFP=Q+&@HS0Wmj#}NCiGjEdacd5zgUpIU2p*8i)^)5tiYF%gE zL|Xg;f$91!uSGw`-TUZe{Zd|EH<$Z#oF~MsDYwMf?38|D6mkD@K+>ji z3h3{p@jr(1NU897_WtkV)Ny~F(Z9`G`=^-eV~E_0sYV_}S}X%M?+U({I_$`?$ro}> z9M8%74(knRmkK}Sy1m)g`I7OIGhbGLPcPRmpS`-nRSV4ZGDL2sRjqu{7tg@W{}f+L zp71$@D?CU06kR_9|2soENIm8M#hEXg!KXV9%D(l2P78;b>t~1@!G*b6`4YBT!au_o zoflMI=MMJ?+7Q|kg2%E?e_wJsUsnC<%oo@8IJL3e`M2fuYk9Z1o`%THw5yRX^6{Cr z_6qMc?TemwX4pG>EF7rme&G*&;fd_?nESLhyF)hw`>%GD&`#`2)$b->!q?Zx_$^K? z>hNcF!97)9n(J$b+vZ01tc5pBqzUDl z8qB=@sV~j-D?;+{q^vV<3`3~DSLE*J%;%nST&lC@i#AUkS2Ds}&qCzkS~=A7krubW z&AL7n2blVV_q%O}zT-Y0e(2h){XR9AAg$5FR)DWI3D4YAIANovqY9ev_w&E7x$#6!&WE<|o>QDeCp6yi&yDfE@dRJMQg z@4wBkosLa=DjX61@L2jp$RTNS^1OMkQ#||XIo-~<8iw;G2Z^Gue=+&MM#}s0yq51y z>M_Aw|3c(uI@ZXWNQ+_M=2gIs@yUn7i(}L^{g_4qmKl~6rqP~Wuc8uh%KK4eBj@z1Li)~oeAcky zdhJrp^(sV;;KE$p(=U?sip)pd_DI^%XFE@LCY%gYW)B>cAr48;)dz>Cr}_PVi-Q`e zBc{Ce`j)Q?|B9pXaI$`d$Zct8tEVSF`AE6fFRZct06B1RB!1A= z5T?`fQ}UkIh+KSffKJMzzAxvj3!vsEbA1s z8zMI&tj3SP#80swdi-TgYl$EFHF+hk-eGNDPkGVcr^suK-G8K{=FHEsLmR0+?|j}pb=EcMPX;nw;upD7{6}H9#p@|2 zKe>zmJ;YJB11Yc&*9t!?YvD(Wc`g-KFX_@wkGG$Dbs!Gmhse#Sb$*)s(5qTq zkA&vVJYDT~sTb}T{rShgygS{r<09V?J#>?<>#?d9J+jVqsX0GCzH;6v1JBqTAfu#* z$ah2!-L&g^^lagr9^21zsky!v?)_rzOYfO>L*zT6hi*c2J=WEtN5y=X>QcDji)(ti zil+x6l=Kk!j_6^3(q$X7u=mx&oztV|0+%|-_34)#FYA6;f}w}VcR~-Hu3`P0n`_Z$ z<3g9ZWa)<+hF&wiwaHhJ?}R=&ZNu~_YU!LlWf!_s-}y@iG`)IFJnbo+F{Xb%e7%EiQJct#3U2{bl9XC7b*ec}Np`uMYa?G!7dttf)nw)r(x}z=wW_ zJtkvFaX}zrNgt8#h(6|2Y^{0@(<|vn=XA=t6n3xsZ1r-tc|Bh@?2X8GRFQvl!@mE9dL$}vk`*Z#KvdsCjB6rd&!j#!y5}EA>Go0OhY_>6^yf9v#V_QTY zBQwWXdEMUZbe{O*oq4huJbLQ+V^glISXR%RH!E^8t@Ls(JPA#e4bmjyd%79c?l?C2 z!8n8?JV!o6=gWrMljW_Qc@o>Ikvgzo#n6dgUv;TDUsmKyXWd2ONob1fKg$!H57b%b z4EG6nr;+y>`U33kGfuZB8`?VaB&kg!_2cD7jp(}W#h1-_vLZJVPUlIrsj(rNRI?{~ zo|$3p?6Ks1P4^3L=nFq&pU2#%ec2tlA=rPl^Fup%Z>>7knI{?TFwfxRiRn-L7~A8e zX7*!Adrsu$!|FWIhKhqj2bD;4#xLW;%!k?>^GWhe@{D=NefsQE=6N0qup4zdkplYr zVtfZ@e)!urQoV~e-Ts{G@;8?Cv?CLKh}=}627Z`b9KnGElP_ZD&2Y_Q;eqgk=XDwR zBAk+aId6s)J+3(g^m-?&V>n-OaGO4#U^)2It3M>)9u?5@k406t|GC)zm^mIU@;d8LLmR>5E$hwb__&#>|JAfa`Q=QHwPMt@;)H)oz^Q+0U)xZNUaPNlslsLl zAM6|d+rbF|1tcFu9uNn;I`clDmqGt9{fc@yr(4$b;D6ro?|!-J=l84eKOhe(7TDQQ z{fuG|rk|^~vwqtvT`HsHy=Trjd2o!p!%O;!{O{^#6o)YVR@I_k#f>ht<+jX02d6A~ z(ku@m|GWAb#Uf0zoqz&HFc$O)$snMZVMe)i8Kpi2$X1RMn#2##>x! z@jF*_x%%t(hneH{BHtzYX_>6s;e>wS>8Diq`2E7ZjnwhEO(s9yv-c8n{9fdB)=vg$ zQ#?}(efG~{gPmIl#BA@F;qLBZvoAu*8{_3U_F?P~unopOGwxHiuQ<&` zargB&Y4&@U7n$SvA~(~mM!PD!F$VYlDZZFI;d2OAc#gb?j_Zei@4GO?nJ-(xr-xVm zx!hfnJIfr`7dg{eceV1x807ya_@eWIy6fEGK0zBodqVJ7_UZ3SPPZ?s2RiemMQS7U z@{otVFP*i1g*m=2ax?8}urpuM1~pRgw{6V4zxR#J&2fH_n-5zfUm^|q<7SgD%$M36^G)(m@{oDTefrUH ze#a(cTrKHZrw{vnOj;-zuL*Jl0vfjRCka#O9k@Wt%9;UoZ)H&PFn;hV?gi10+X zqsz!E;g;;nc{8l&am^{9^Cov_IB#-rn?C-(8oWC8>2qGXG5?Q2=J>zJ&6sNBjniZR z1hNX)nR!OS8PS8s?BL*%wJ zw5>xrR-YVz+baQiU$3l1uY~1Tm;L0<4~%?&?TVB@)S{Qj1LB}pcfBH62c^n1{aOqQ zPdCPW3@~6j>Wf*kwrzxdzdTfR$YpPC`l%|Qf#@glfH>$``mqx&&`~wo<1Q{lXNezI zNV-%YUh*Rupihplek(srsYkkX`ETryChF=f2_wh;dRo^bAgANHi~oZYxh2##8E$Vu zNm^lEj<;Z1VtPSQX~`IGKK8o@uF=PZ(uOy(>O+a2bt5@Dxh2*iy7``d@i>3gbjm|m1U!sE&Duy`x> zTk7Quk8C{~&*{#O14*ytBSQH^eFmg7R$bw*hn}lvf3#@(11>cxA?~$}spmgAybVsk zNqULgmWH;rz5x}HRGyHU3|egl82_oQzkGzpbPSX4qD=r!Z#)uc3nT))fuX=@z${=X zunyP;oPbPT2z(FBL}DL<#Qq7`ADMm{IzXDnD%B5x|AoiIr_<_l7{T+97dN!RI{h7$ zI-&>4)j*}<#w#@qT#CI|scY|6D(xes9y=;V6`c{I9(W-}wHQ)QE&ZgPYJPit_5LmU zsUBPQR|DrXPzRoMpt=WZ`Y_#)h4Y|N*moyMBSYy66_q((red{A{dxJ6;|~~8`8at( z$Fv|HL~aSSP4)D}f|UiH>=IAT$h@2kZ;{8oSZ{Z#jPP>7GQs|#3?%kzPrP#UI_T+g zzk2^y_uh9ic|#|>6uB)8Z5?=->dwyf3>+_TK}9Q{MXsr0?IKr8P~0;;B_*&n#fiyzd4;nw zOA3ANX`bZlY)^4<=InxO!~WHx2LnFtygqY!^gsV$iI3^V)HCIBepq3)J1-D#;_$*V z3R$Md6lTyG@ftrM_M~D=csi&S%CaXdMmJKwJz6q#JN(}-|Gw|{1Mg2Dzvvi0`7Uxx zsBNmnpXr_BNiR5A>b1?d*0d)qYhrsDzVMyzDKH6&V<=ovmNtj~En=RKi=dC9{3h$fk@MV^MGf8=1_n(X$z1Gg4Tl~4+0lMnFT0( zE1^t7C~^~s`5z?PnuC=Z3j^pOF_3OZ63d=cA}qb!Ah;cJJ9_;N1s=UP>^sqfvElqT z?LCw0wr&|oqqdI_b8qpVrNER+(pKZYR{jPT`oBjzkTK4=UBo+vblWhp?D2Qq+@}*gOu2nlDNT>j9wvgvmtNp4@w!nFCZ-n; zEG^3OX5(PIwIQA1v_~0M_RP22-*kqYmuF2j zV8-*J}N609^tg2aLs^ z)63MW>`|9WY;i==0ZSV6I5+SDLA_WHi(K>(-%c-lF<>Q;$CqfUZ9Q!11%J%_^WH$iTl5pT=q0|b zpVVT*(2%O873#OKW}?wVLV(-TK{W@!zi^y0KJ zV=_kixXlbiyj**(?X^7D>UA#lSM#ec&pd4DFXIC3A9*g3%kzj|z5P=y;Rkwi_#EgX zu%2nKuP|S0F9ib9>*e~wi)0-70;jTd3!&Vq z+nucJaGqA4A7hp8s=g>IZ*N|^8hV%1U-npe(WdcFJ!6N!cVCtxkxRJZOCviIeLFd& zc_67sXlfG2xQnNcEJ!UX9a!oM)2kAejpawaGnVkA&SEiSx22)2u*8Ws zQ>RuZPEEXFTb6CwfEltPV*Z(VXq~8GBY7-7FVpvHxGhY~>&5B&BHP=2oj1AOa68B@ zfT=*m2K1Aja_3_SQ!%gM^)Wfix~FY?oG;gK!W)s>($KapyrI3x@Sr-xu*kGPzrz3! zB$B-eg~`o#!HtBs0U)k7Zwc3CBDZx%fOU*Oi#_`PzhC}y&HQ*czwWr5x&E0@1WEVzdmNYVm|c7l%so%TbLwIVCQ#? zGUakUP!FJWjh7Y{yjD{!p2>S z3d8j?`&-MQ|M(M*`+C`l55)`&C_oOfog;G5OMI=_Y<0a_FHwnTgJDoBJ-;X~F>{u? z2p3o4L3KN$^IXFEJN~W?@9*gH|M6Zkf7tHc-D$eJ!~g%74>jp*=Fgt&qm1TLO}P@1 z>;0V-Go0=0cG%&0gO2X8Vbbj1>IV{6?5xN`A=`VJowZFY?W$#9M|<)MO9HLA-EU`2 zz4YTKPxRD?yzhrt+6ygwwU0Mdb?UKca*>$kF3#{3 zVj5J*?8Jgl$EF^CMIGWl<=$Uh$LGGl*B8r4{H9#aM~ojMiN2E4EiLqN5?@^V^EY`< zo$G%50=qyV5{ciGJI0^mDbDtJt)Vx$&W|0*hsrwW@vyh-QSYiI=h*SvdT@S>$R%9y zBd0@&8|hH$%L^axi!Z4?9eNM?)Af7N_-Z^b<&N>^c#Dhj+_QO&o)63G5dX&;`#d(d z{SPxGe8~q>F6SdYf1%IIcTc?^&W{@;9}-GyPlwbcmDip$=7ZlQ9?`>;%lU|Uc(V%& zitQ`(bXZk~_#buq4!pSiv7Att%lU}$gN+_f0ZK(lK#TDF=sC0Yba?TzzFQWb z-ZWm~5j{+~oR6$WuG{B19i*J*u}4+I^;lO2Jz8FNO;OAKO+S=)L=RIg=OgM-2xn&+~CRp z;paN&!8$G(pwB)v_N~c$S?sE>TV1u{vjwj&w&M@k36b*}-39gF7>XyIz5AE}7(U*f zQ5GIAyM#E_E%PlH-txE7G7HltewH8TG2uHpo#q+De^$DLC>C}=bhrs^P<8+FV$2G=(-EC zJ?JW*&No}jYNUc7(~2<&m5DBW%nq3ov?XTyI2dqXN7^RLGtOm;4S-L=^u%;BYff7N z{1(6=0M8MU&kREclUl;XZqzxXfZqSP{w!zyB%BHUJXi8n)$ruEkHef}x=TQK_Ctu= zmWH-9^GB!>P9jgh@|wI!$BWfM09`g#zBBJR*O6!nFwZFq6f>$J-$shKwhVMK0lrpII_HkJFw)bKmSaf+kOSJ?j91b6RM(+5!A7gx>?u zhGFWyVj59Pa*}lt`wdL)F{K3NIh=~RI;4QkQ{@lmsaaoFyy#L-y!vCe#do=y=LEuL z{*f0VH>0dueQnKdv2NAv?S^y0^}%Nh9CB9`&~x5LYEdlCHyLo&=~sU}si}(zC5z;ErQ2(g#JAXIY<7Ho3x{} zo04W!N4U#+n_T8xKib;HfY<=m*R;uI zamMlPKJ+63X@6Cm8=jw%R?;5K!1-H#eD(WpN>locqJel2wYT&kzz6@he|0eMYn8VWtMrt*WAB=fuwgp&@dnA9e z_<;kQ=wZ&6+zk7Xc*g~w_r9`E&ts@4+#-PaD{@PyZJgRi1vwdb>A?_F*hN;&Se%%F z*>Rk9#EE!tx?O28-#NXi@Eo0AY(3G}Z_FnFHB~EwK|Muo1*&cA^s*;#jq`eDajsc9 z#=Y=zWKZg`yF0BuP=3u{J@B`vZfShp9@Oa6icB zEA-hREQBZesf!v}Hc|9bXg;G<29(cPHSRp^i%BbjEdwO1+VUc@*7{pLl2R^+LUI5>)DsHaQaT zlvJf2AEeayG|WXm8F7qI$~{V{ug0LR%Ysdrgm-ASQZG(b>fAh~K1F^UG6(Xx_-^uC z=yg8i7eSA5d?R@U^u0!@CvU`a-3EQ`M%}dr-v>U4^6?TL{~bKz7JQSrO{wYo#i;$8 z$EY(q$Ef*(U@5X=6z7*UxF?3$sSZr6r{XTErv@BUUzKmDuMTUrzly)1f%T1~|363o zJ_HqEV7LKUJC8{nkKESnF=e&67+gTm&Px9TkC|nr&n%>T|G+tT!Rw^HAqRM#RSd6Z zJVV|19DM|3Ir_3s{p6WMF6Zp4?X9GRdCol6?}_gJ`%=IUmBfzvVMpnb z0p_Fmp0*nAjR|Kzn0Z#80j(E4z$@*xB<-lkZE0w0*Hgg>KV=UczFM5 z!X?hnzYzL;)ve{~iq|f9;YW|nbjHu;7r7R-wX4UUf|krQADc1*J=ujhp3qlqDp-$5 z``Zj>R~)mO&zUfQzmWW)Bx5cH-?MU7;xBWT2mS^;DE%)2?SHo&@IWO_1xpPwT z+y&Fec*?A}7vh58^CDjTdHJlYzvMgrtk+!X`4i4aOUQk$l64jx6=1m#xh2##@*d0y zTPdDtUh5-2d&Hjev7~!H?7btQ+_`*KKo9SYPjo!>bJ_p{>+9FK(pHESxfUvFf8xl(BD5uuP1HM5`$%9h@iVyPmp*{LhK z_7wY>+1J+!Xa{rvx&U2)69Kdu)j;56AQPAfOa*2DX9E`jR{<-4wZQAZmjIfpsuhq7 z@GGl}fCqrjfFnVO@xYb9$3Qnc$Rgl-U@{))T_6XA=nvo)JlJG3&XQ2sHOGTB$Afjl zgK-Mt%XqL%ycg6*Sx17FS>`liTndk0`Zz1KRDME7c<=MqPmQ zNq*}aqdq#_ZhwQaRy(>J&n*034c_3fYUDposn4ICK4VSnXG6J9$Nb{flv`qKw0S$3 zn1vx9E``K=|H}-H2P;4B5q)}I9?oO){j}#BE_Ke5XFi^B;Fv3K4@5|PSRO?l5C=Ws zvGpl+BA2Cb`(|4fdT?q6uF~z}x?19Apf42`=G@%*iDM-KNe@#l=N;ouw0gg-OLaZc zmN=&aZ%D}cz0<&q$#+RSqK7G$^Wl1A&PGwrmtL7fJ1MM7L8oATY=$0A{D|G+Qthri zEOuGPXMCW#~7sQe2=$J+wna05_v!z^y;A35Kn;zA1_5- zPl-B6T){xGqo-%mQs;av>fKn)%=x_U*=g6UspxHo!gQtHBG<#_eg?j5VCM^lP+*)3 zu>4bIX;G06>%ZXpdye%KqxwVTY%j%Ntya~I_f-N??lu^Dnd95Me#xA)Uk@z$0~W}3 zc7DfIlgoK0y)0Gn4KwC)7h9iQn#v&%J>7CE!qd&vFZLam$~*JtXTEHI+Gv<$%SpP4 zJRlBwPWsvD7Fn}Ogdph_d!=*vaP@7hvTyikQQM8lzX>-)FOdfo3hdObmz`L{y~X?l z)mnSV%GJRAx_z&xML*v1aM`E>7W8=*HHq!Sj+k;eA2Q^$8dgIO-<{@r(czq9YnEB+ zo9fQ?49cIvlA`OAa8-Cdn(K`$-{eyL;+`CF#iYKMElXgDvg;f2U*w{P_?kX?#A6D> zv_o12K84inY{oU=`k3|2D(Jf)<)v<)Jvnex;FEr<50LtZT=Wp%eoq{hnvs!+O<)BF zYdQxeabRg8xvmm~AdjS-C-PnCOIcu;x_vruS4OgzhNat|t>6jEZ!$n%+ORVI#3UFy z^~Dc|o&EYLtY_$WU43jtZV9!G%@gf=X0)?IW8kv>OL8$5@v^JRz`eR&{%gbaVt%73 z8hn4<@Tp5(=^s*gTyku%d_RT>*yOJ%7uEFlsNk4bV!+zS1ltj)mhqAkV0Su-x$*;I z7u9vndNHp5F6n>Gk>9myf^KWe(T`ERg7Sbk=mpomV9(PqFDCrjR$4AtjU9=9>kZ-M z+WanQHS`byi9$xm;Fd8U0vCAU2rJ-#we!DuA^;+!F7^FqM{kEsA&QXld!$%aB zc&E~1>{dWs$2Bai9CkF>Ab7VF|2*f3new)Q)4WAxH} zG6mM-simB+x-q<*v!9!`Xq_ikop5y5IZU8#%f`L5cInwKPx#XQMI_64HcGq5d5!L* zj0V$WN-LABojEP$FF_FvXU}{><>@kIy5acTf&e5QS z@Pze)t%qKWCmEnGypw)$#?@}C z-0YrWS! z*ehjMUq6lQX(@AT_j8|4p4&c(Zue9Qlp!Li|0mxb&Qo%P^rL`OEpS9vF=I4wfXX2|64`%IQ!7*={#~vc$bLj62d>)BI4^!`VSzn93 zl{kOo!wPS3*BCXLfZMg{ctPOm_<%}sUsy+ zo(mL75n0y;528C(3h4H3^F7Xd8E`k&Dek_=yXe9OV@$q?+)UQG@P%B7^2AKJf7h{Y zS1RsxZhsWv{4vWe`QZF>Clp}Xf#t-mh}?WSz2Db1Dj2><#bVi9k=$chKD0@EIhfdD zjbWJW5Vn&gE%)q!{Qw(YZR4>>PTNgQ0S+n;sNhfdPRoHxpIi{C$F{k>mgyivgifn$5IIkqCVgxW^Z$F8o56C*Zi zalNib8YlI`Iq7lUIg=J_yTd=h)I;P}0NTbukFdt7ANL4f*K2yPeJAhdoV40=-RnOx z_-1oYuWWfz)8S8&P;m5`Vk>e>sBNm}&&VQssbQ>lmX{Nj4jB)Ir-L~@$zbE#o|@M* z&c9HP{}{wCaxH3Ww|e}6DQVJvzw&U~I zb8YPq^zu`-y7uxsV(^UECMB2l3S^I!KkTOvdENEGS|a>}3acq+7vi^7Rw{+}S5&NV z&adszx93Ce#-#N6u|DUm(TQCaxh)NC1Me$XEnzxeR%}B&-iHql6Rp>kN<5g^zLR$m zhNAC>LXGb2sT9!d+WJRA{Md$klX1!Tha0Is7rd}2_V6aE^KnB|i|hZ7z3TvsqFDcv z&_YW>5fK!EHMS#wA}VS^AS6nOB-Cf&NH*l)au=`AY_VfUpCb17Y}ipOSi$;Y=UK5K zc5H~x@<)Bj|M%_Qmz$kz?k=PXGs(9z`_1gkx4-Y3+1a_-nd^InX)+`n+XwS4ZuA(# zKE~k*=qp)hrFEL0NixtJ$9&Ly(48RqHf2{l6psVl1o{qi1Rm5^f_?_gzyrGmbQA`| z)_{)bgt?KRb5ii#5GEG<1X=^5y8#0+G!6eU+{YbwNUTHWU?Ao{o`Ly~TYCv{9R})V zU=HL+%z+$(Nn;CkLmJG3oU=Rj=-LaEiTREDyKKz+9D{G0 zjuzs@LadKJ72j2z0ND)iefUmlKJKFm<3JZ;tPkHUx&I}^BFvJz=}95Je?^GUM?xI? zgAg|+;~OP>r_|AvBxdC$iHBw;;hTsg@#VEiV&IeDf088L?365?9+E85PfQk_mL!WG zpGy`Qe zva33YeGWuDznO@XhEVhG%sZBX{m5zDVyb?jMk9+aFGTubug1{Pyjd>iz$d z;r}O1g*6@Egxf`^e3OksJ{A<2O6?d{=q?D-wm0t5{4ib^`2mUF_-XerSHVOpGIF6T z*OoYPt;N28?>xI9sn3#8r@_QbM{?1)4D%!GS}$R_XjZu-Sv7Lt=k>Cu;^TE?b%$ZA z-tLFlvzBALR6fTiEEjj6v4(;PY9xbd_$=Ru)zSJ-xKMwPXc{V0yFPb6T(fHr@yJR0 z9D26jeMY4E*Un2|K9bv9w0GyS%B7#^0)8*8z;3SafX&b_F%VNr_yO-4ZA3cP#P#EQLF{&hE+3DePdE9sT_5q7PYxO@|B%Y56V#QbvP$Z{@T z6C20OJ$i`b8UJ_q@sAzr;pZRA$^2RYBY_6UDKBHMifNNG>uG!c9!->O-Ro(4_Ygz! z&b>b)=ksTtLOV;2zhGZD%@LQsc=8(HJ^3?ii4b&4aQ`HY$+1&Qs-1#Sd_iaC=(>xu* zkBRSqp6fEMbk01PPme44oUhluMqqnDpc=+a{Ue^APw(N>>*Rhf*}k^_*3)zbiYEQg z{+-#cW4^`6&2N|VFFk0{@_+9`dU0y+T0>g45%yUIr*oC3rloi_4cjB9C0|a*>1Ch7 z+@^DS_BkD$lXE&(c~(m2qncJdcfLwZ^X-mM?ShW zvKU%F2u$yT%va@)zK@Lx_~&E!$=IKh*ZDoV12QDycT)^Gnl{Y+5VkAwxlT}+&zT2S z?HoRt$7w0v$x*zMtB>!Lc6;Jw197j%XLaeY3k$i^>RGbX>!aXpW6Vg+v+)| zVV~paobn@|9JLkXn8$p+&WhE??Gb^+xG5gLUa-#UuVjNqx_6ofo5MU7y-#f={M+fnSB0C57Yu|^0JmdE+A(o)d;a-+zD zO#=#iywX%PZcu(Ma~+H3*zizOXdP_AE^Bl|M&r`_y#Eyr$u6gyw?xNzGk)=63zI^Z1NI@hAjiWH1%V$3_-^*IS%Q~UeFoLcz z3(DPLnqwo=p zkBA^FC-Yf8_8TK-9(D_3IpuMw@=s&qx#8RH;;8Je`g~HJlie@Hl7!`CKFh~`y>gms z9M)nv2@nRb6|v3Uvp%=WBaByfI|dnVhMX&(>hpZn_ua)26Fyix;OSldeGTS}kz;w7 zZ!)Drz48z!v^bQxER_)1sQ6Sb z7?spr^!znlY#q=?JonzN;->1oM2B8OAXB!Ov#>}UyWT54|KG*p->yf+Eoc8I-v9Hk zq}~2=O;YB|J16J8^jPwo6EAIdO!Y18=Ny{aap9X^bP9ekuFLto{oQ{XcTSI8UwN+& z=?K;9bh*7)6-SR7f9NjuJM^2m!*c!@>%Wawp^WO0`6g33)T>9TgpwX*`_BI&wmlX8 z7xuKM?49lhT`~QUY-?r{)L^z3%$GzkgZ0WW-e2k|^WY=Rs7=uYvOMb)dDQl6!8NJk z{BAE?n)h=>jwMYL7v`(-@aS)J8XuN`^UXH!*uk@CQrPFiXW$ck-i471<$guwmv($q zdFYZGpUyopoImIlE*IttmsE$(@d?X=&KY(ecY7lj%5tS(eiXSJ5S8a7*ZLmel+NRy zf1K(cIZBs~BlAtBbSN@rSKymMTHM-K=yiw6u*48vJw3D~y17kUk!Lnm`ztV)kA)rs zk#?aPd2oMXLjrP5yW_ZtgFYF#iHl~uR6fVYl`Ge4xP9SDOT416*`JNbMtO_?k$n8S zD)G>Sn2vr!sLw4x1mD+|ukHOfG*4zVcO z4Hp?Fg)wW|;P`4}pvuc}jrCbJ%0~{@moMFCJeNqCczOJt;^lTc1^l+sUFkLn+&=E_1Y`psa~(1BS{@sUmD`q7gr~f2&19t>&r*;n-76% zC`oQt`M1F4D^cg%5Cl~HH00W*N=t1Gy)|u18_-lTwAFmJr{_&$FsA1X*$5FkZvWY5 zzV>%q1ay6|bg%2nj#~#Ba_73f==#zSd)d*`>iVMV%Z^?L8gl=-zUcbW5PR9t(`Ety zdAy9?ZRxi^)yco#EyH*?xf~FsSLY)Zc1{%^tQqk1*5iK}`dZ|NDgHf?`E@`LZk& zZjd~#3C8^B1!h*uab)?Hjf*Ycl5VMD_bDlhikE$Sf+`>L%}k|3v^ZzH^+t6fE) z#D;Z#EcUdp#eQFKvMIV9J(eOVRR`NV0@W~BxxH*|f$29f9$V3MB|h4^{};uGf9GHh z+YkH9*Zz)+fUYl5-Rt@i#X^Ui5zzG|ii@rRoTz%Y;5txRXm&Y&b8<*$rt`fz{X{Y==x&EL!a3Z(DfyX2lY?rcU$$_ z5w+hEy+Vg}Gz4^gv1?pEU+j43GdlvhzS!~5^~H{dKC>gB>x&%^U0>{Y=rcP4y1v-) z(DlWRhd#3-pzDhrkNV#2>*L$6)@R#00=mA~HLRa6c0BZ%9RXcmqIl@> zFLqq?^Tm#bKC>gB>x&%^U0>{Y=rcP4y1v-)(DlWRhd#3-pzDhr4_#mEc<3`b0=m9L z@zC%4Q7m-G8G$um^ZHWL#z)teqVG1=?9n9FAf35>#c?S;Q$_x+_kTL*xI?ne z?`nM=#OrY}UoC~U?-}QJm%4Jj9_$wrbkPa6(7~o;rJfS(Dmc_tNV~=qdn&+nMVF&0 z_UCy5!4Njz!HzPavar`o=E8N@EX-$=V6#83Vc#b#y)w4^BX&v^=k~kfU&o$u@Jv;H z=Es*mx3I85B3n7?cFB&cevaGm&}Vi8)bGG({|(vEvyDmS#|l$=?V1JwRX_Z#s8jCz z{hl00JSLg1!%c&Ls-HeFveo*D0ZubTsrqTkVo0C$eUICeV+zYdM?Yn zE#Ym=Z(Fa6B_rp_eyp@Qu5}Sm`vc7_jk?FFTprmAKkKyZSjcGo$QIJ}!fJo5?Mc`$ zi4v)IavBQDq?X2UGGD%4=IikGkASW((fY#AI$7(wzQ}0ka0Vct_nYe5zPvOG^Hv@k zx%usq{-p=aAKCs8`t7DV65nfj>5nN(qw`wGj?(uLVkr68bZ?92)T`DUn<@rRbe&dp zO6Oj?gHLV%Xe%7^O{R1x@`Q|npx^5b8Kt@YQX|)0Qf|18E^>`GD*Shq> zL_n=CEm(A$EQ;oV5Xny0Wf_efJFLE!l5IFW({;VF+lj7Mc0BZ%9RXcm?0D$S$Z?oeepYi(*`SjZ&5rx@tn0@AJUn8(1K8L6tFzNcD>p(*g z_`BB^r)Pl7<9b0p)eYHk9P{Msn5TV>fQ-Q3y}roz(iGwP>P&t7rYKYA@%KSs1w`fb zmR2eAx-wQLoAbJ=eiCBIKkt8o?rQp^@An;&z3%ugp0Vzc+U!iU+|0MQ(PN$UmI{qP znLkkB_LUgp-9D_w6p$8Kn(7Ia`@m$?#UnDZk%lTI5vcSHTk3OTy$^530lk?H-I3r>Cdc4Yxhd#3-pzDhr4_#mEc<3`b z0=mA~@zC|fj)y+8BcRS>r8zA69ny|bYo4k4*;ZLdr_>hEdkBSD$Lxcp-8LYg^|KA2 zwcsW4d;2Qseb{N;X>n?*NIC5HKi)d}g7fztNHxWp(?{R8F<%wE&bR_z((7Nhd7L{i z+o-eHH08Mr#N!_;)^|7SX%2W)KS>f=_h4o}A*S5&z>x@w-|yXL=?S~7tD!JCYwls^ zI(#cui1>2ml!U@=FT^hh7F1yT#=3Guob^#S|3ummr}>e5z4kQ%+YHXWvDOrlMdfFl)ibbSm?x*xVU0jbA)xC^OChbx*&YyRjrzjlF7fc=XNi8k z#6wEQw-f?ueWASs$g!HoH z?mUq?!_OT3tZ5szqNTukjWA03ooLA9K}9WrN3426^@HmM*Oiu#sV$eG>W6S)VytBO zn;JLHkIUk7xy&6otm>z^v7r4#sSas9B!;x^4eDxlS%L9hHw9xPOx+eR4Mu`y&x&sTRy5}0e|``P z711tqk;RA>OY+ntAdhR=$WAMMJk-PW(W&Q{~S$rHGS)aRKX7(+wsyHyeA#zM`&-2W7hdh3t z-99!XAjid%!)N5?FZ)o%gZbMgM--YWWKe4#U)b08Iso9)ew{Nv?=E_tw9~rEf2N8j zihern$6Gg?(K}Kw)m{3YnfVcRt;bE`c(=!AwVlCSzmGmzHsKH(kdn&($L`-e!55Lv zsb50BbJKlOyFl+=oj_C`efLZ41luo3oeD|=k-mC>dVzKV?F`xl)E`9qd=3Kb3Bp#S zVt>$J&@j*l&=H_qPywhAG!=9rs2mgkodP-!bOq>NAXsyu&ydO~=@4Un9U zQ(JqmHV(e&SEh=;o__s^+%n+RoTX2mpvu8~E}#9_a*SDk zePM&JK-ePf5L;9d@KlC^t}G$rv*4@P_)u9rzuD=j=T0RnupCqmmsE#u#R?Hyu4s!T zPd7#ETa#+4y>@m@{b1EoSw!L8&P3Nu8fI7++0&|`r`kjiWA$N zF>le2-~LmTi}{={`!VGT7W+ePuT7?E08aAo{Ix{q##nmdQmyBq%8SO<4RKob>!#2g zLO|7zj2E}@#AEx=sI@Ets(xCw^!iJqdQ6UNgW59LZiv65xN=ksxqWLW4h>DuxKe$T zujMfNoX*MDb=e7(w#{p-oo&nAC1Oi*zG`|pXX136M&)z7_FESL)y`U1n!2Tv-O&3c zIkqM1EPAf;IbQp12Z3sc!tW{5ezA}D@EF48eUrpXUC(-(q&{>1<%c~z@az-leVZKV zxD$@dH<{9*$e3M$7e{kcr_k#T(OUJcJi{Fd2MmnD(!i_7H`_HP5by_Fqm6l<5~FCo zCsa~y&`5%?umAq5T|Ro*Dg!NBE5zdI_pGM$Bm9T?gU7xyb_Simk$f|7WWLFi4vzBC zu$*_y0;42Mqc5%*M!=6@%&>tssuJ9clbkD%C*!yRa+1pdQTgc@M4|V+^h~^qdQQCx zLGkrbyB3~s?lIp`m>i{}qslkgI3yzH=y1Tq*=5SFNa?Z-bBk)^$?_KdUwmA%#~*mX zuzqiR%kr?iDxc#Mkr(gOVQ+Zw>bg%ihfx4)5Fuw4srP`pUUU>2FN!g zo_tHT#K-TmCqKAt^ORTfxO|pR<#T)kC%#iW1=(Ca%ct@=z5((L ziznaO1mv6ec=mZq-nx{A5KYJOseF!afP4qVldtmk`1rl*x_0L0a~Ivi<+FS$pW_=K z-@)zV(H-(IizZ|=sM%X^NV8ELTzzafy1`79UviO5&mUYo;pij+!w zEz6tnmtEgZ&*`-{Tr&EVcQSurd05{npW_pf*C=zN!LI%BvNoj93t`atOoj{v6`G1Vy@i%q{)3wKjve(pGCE zGoFeid~4rVqNV9jYavh#V`}R5p}u<|yXD_I_?@-Bw3=@rp!L(XEkWx?>xU80?HePJ zxUcI^;#jpt%GS~k^~<%3kAT)se2iK%h1O4Nq94EPmedcw`_Oy?-M+=w4W)>sAL?%r z5tihWi#L~p(^;wYv9Soq^FGV_M#rIOzVn)WItv=isyVH_ICK4q;}%z^iUo60yFY(N z*`w3%w=_XxrZn%9`Kmm1_HDu^493KOXST=Z%JT#q_mZMKVtt3Ema!w8Qyt+sYIMI` z57^%kFwpl{KLWbG*s;;|#g2zQvm;Q2Q~n)kBc6NIj^=>K=Wl%$3=!hpiJ!~_ON5`y zx$~2A2_@kWI|u+U|Bqr(-I6T_hre+5moF0f%#v7t8(qr9teXsL01Q=n})a6dR+pKTkmZu6ID{j_Zrsrs?%>$b~G*T>7lDW2;F z$FaZdl58JWYW=irJyt_Jem-VqMBfX^elu1lo9~60m$wspUi`}|bSEQUdFc6-Im6Qy z?nY-;UCBd@VZOzU9wT2KPBmstF2L#mUcb9^R5%pEEYaL@H@?@M;t6_Yc@3I@S?r%+ zEC?0igWgbq&q@jzkQF~a^C2HUKi?hr(uwr#t{h)3#ji*iJWq{ZEX7|__V64vemUaz zD$E%A!{;MM9d}v!v4n=4e~lFX?n$$6RpVC;ieA6@GbHQj{Z~5-2;@iQ`e!KklRI$rl z=l5y9&rPmr;FF^~Xq(xl^gD3+2AsbCCdui0Z~E4o=E7uvGC?FiZEQUrMBi}F16>Y!2($szCrOCupu0i6 z@KCrMMDJ`rgTBJcN^cn5`MAlcDCi0lGy?^_jDpho2r&&GlYcn~-=xEE`a=9GvLQzy z$}0gbCkt^F2657##CP++5fGW*fy?7M8{*)d|G!jG`q-qs#{KX7^(x-X$1T_#t-nzi zG{U8RSA(FJ?Vxhcs2z~~tK&^6@1%--o;&#Cqf(#Qywf$-la%d%`8J_&l8`Vk3`~5& zS{eu0=5MbU7L^BTGVzq{a^s(=qUO_ACr*9wfvqY|%&%9TT(1XH-h(b_{41`hBC~1; zBDWK2{!MXC_ezd^>r5XLK|t##5tLdlO-txUy*sW)?5pwmJc>X|=!f;dezbHQiibc; z=tq@-^~Am!ug{|hw1j?G59~)v*P(a_w1j?C8CXy3tMU3gih$Nn6pOYPY6<;tJz>8s z;?P!Qs)S(leoEsys}8dNj+TMAL7)uq)3%(tam2x?qT=VDp6oPvC>(C#~%_5R?I;F_$X%j6?Y$v2iFIo+?JY^mdPLFRjT}abP~OvpEF^S6;wh zG0E^@?N#do|GqHZc;f^#c0xpsed{dtk*`y)VSYpNi(OjN#%f%g@vH)y?RD)@spj0G z9Pmm(Q!&)`3+!nl?08GssC~f_)fbK;_Hzn98R3GSF<0Id%7A**aXzX=9 zXaR^;rCkKVFsZqo=Be=M<82xwtpc3^Iumpj=xoqApmRazffj?#2VDTV5OfjfV$da^ zOF=Z2c^QbtdH)Hz0(2#4DTo%QptkC2&^4fILDzw<2i*X=5mXJj3G^?}&7fOAw}Ng1 z-40p~x&w44=q}LRpnE{~g6;#Y0NoFI0JIYHAc)4B9|k=FS_OI(^cd)I5G{C$VPf$V zXf2Ymth67&^lBj{_;H=u7p-+{gdZ36uO z+6?*;^k2|Vpr1j%fPMx2A7~5cH_-2(KS2Kj{R#RDv=t0u2ET1q}lo1UeWr9CQe11n5u@ zO(;1WG!k?K=t$5}plnbMXcQ|#KB4{Sa4Vnci0hNLbP#I`8s2t=0%>m5?c|jE* zAIJ}?1f2v5fP$b9C=8khnh#n4S_oPMIvI2d=v2^YpwmHBpff;cg3bb+4LS#OF6cba zV$k`Z3qTiwE&^Q)x&(A7XbI>t(B+_ig028v30exe3bYJ#HRu}9wV>-j*Mn{V-3Y1% z-30m<=w{F@pj$z=fo=ya2i*a>6Lc5oZqPlTdqMYsR)FpYJpft>dJyyw=wZ+!pjDtp zL63nR2R#9L67&>kHE0d!Y0xvEXF<<_o(H`E`ZuTs^djgb(957#K(B&c1HBGf3;GY} z4bYpQw?J=$-T}P}S_gU$^gieV(1)OpKnZ3(%LKuRt3?UxU5@ zeGB>y^gU=3=m*ed(2t=1f_?)14EhE1E9n0~TR^{oeh2*l`XA^|&|jdfAewBR1WE?A z1GNWr0Cfa)0;PaDgSvpag1UjagHl0hpmb0VP)`v3rq>&^6Q~bpXHZ|zE}(v({-9k! zyMYFP27)p`gFw53_5ke(+6%NdXdh4}XkXBNp#4DyfDQz?K!ZV9pdp~4pkbhcKnH_{ zgAM_W038ZC40JeXBT5(4=Mm14LSxi4m2J#0W=X* z2s#!t2~-3s22BP{0Z|`<`o;7N<$lJrYv~?w zA!l?~abZ5CkzH;1rY7(fXRd!uQdp^|kHqCK9%a9Or}EpqJ7eQtKi1Gs<)$N_?1T9c zcCA-iet|EDb;tt7D6hX{E=>!VVgzcJ!f+LYj0#tgnZUY~`gSZ=-`x0e?VbHq>i6#! zj!@-deyu=}K&@PLaB)q*(r#FFI^Zw!cq1rTeNmRDT9Jp!OaaYAotxJsi@J#7q?0f2 za=^En{!s0N`IJU>=DlMR2MYuQ#u@XlqzQ{@N=Yl5RN*3)BV)83mkx*{n=R~vXTmeD z4?s{XUpn=l11{f-x__p#@aa^C&+%NKRdZcfDJ}v;#AIZ>EE$t(UY3I+HRs})Z@UhK zw*qqAR5s+q5$~mn;iv7qq5P2JdyKxIaz9E!<m9W)WYF^D0Lt$xrD9CC0Y}0^evgSfTFiH<_J}7;sIBV`qWZKeh=e&3bR3A<$d^C| z;6i#nUjaS7*$&Tp06GVXJ*6A^C8!LG`r|pBi9XFpJm06|*>Vp0JI~`exMz}BicY{| zXD5r3pJ*rkxS)d=cxZ~~I;@*GaF?Fqy!ZNvA#d*^w(fkm=y}&vactU|V!%&p#8*cR zNa}It@}yD8^OBd`dRx1^tLAj*)3b95;Ye*aL^9u@YW01zf;XB50zM@#RrGT``188= zQ^kev|F!I2o5xK_ryGZ3yqRxtqsLmjIZ)(TWFWdPu8)T+;4!gf`{(CLSMULui8o1{ z21*C@0CAhr8)2BK=nLuxBAt-IW`NM#ioHSmf(`%;1`Pup0y-R&4H^SF8dM0H0y-X4 z3i5)eZ9Nrq9_Vt=^`JXI4}+cqy$Sjp^ed<{@EZU+2s92<2BQ9GHHi9V)F-0;2R+|U z1YHVx7W4<`5ZK59&{Lq!z-tER0Zj`K;y5af!A%I#7puPi8LkFUdItYD&J%Q6c=wIxI zzA>IogNC4Qbr5hn6!{*3zV#^dIme=18jp6V2>H$c)^6B%Ir?Rl=o2nPAO0-#H!nuM zco6*e7WDJ(N1tysfO#E#kdM)q+>H2kN#dZsN#Y1sl1R!+61SX~B#t>bNesLi{-a4^ zD>|1I=*Yc_&e9BYK#EWg{(3lB-1ItGu0f?(TMC^{?&3g?a78_1Co*q2Jnz zWyg0A*S(0ka%4yG^5Y%F^xRHj$=jVoUNA+J?ABR)@>XZ@>NQ6C8b#|hoV z2bh@k&dF)w!j*j}TwgD-?3dnR@wI)#ZL|7{OUCyT=_l?ghF>!P{is2r=9)dk zg|qh-cYF60SKoVp*kx#znEbzC;-j7;#Qi6a6h|MCBW^w+Pvm}ej41f{Sg~N@G?ANg zqWIvcGI8XaK9PUHeDU1oDsgJ>3&rI2OU3lHH;MPpzgL`{`-C{9$IIf>&L4 zNjoh_{_4d$l6RZ^aq`WF@6v9@byM5D_W3pKo|^wzyL(p;X@BP6bKCEo`$_vTRk{Hp7<9q;Iv(J3_VzD_S6cy!9sX+Nfn>Tzr5(+->6W$yA3U1wj?uiKx8 zq;`L?%TB51EzU~IKXz97+k4&JBj=m6UiUA*wD+_t4(#(_x9@iDeABDD4C?)M{~0qo z4CwTPJ7cdKzTf?%XYbzYvtc)9UYGy&{-YllJNWz4w+=mP@8m;XTs+yVa@-zez%-~` zpmnvf(H`+U!!g072g1BXRV1GJd25vRsuXcUL0drPJ{F&*iZhS7V)o&;KE9gjKRL>S zo)647nbLuqDc7j*EX+^E*vOY1`|Pd{TVJ?LZGLO`uAEg>B}OXd1dUzuEokED^ zZxc>_XK51xX(2QMKwvqDfA5|)$Nqb_x~|WNO{t=C)`r`EIdo~K{+J6wj(=}wzQv6m zW31;g)sN+aCkKr{?K&!c{;AtF-o0SVJgm3E+gh35La?0ab7RZ7?gy+x^itj{12(OE zMU|8JQ32$>@ z-R`{Rjk)_?Zl$#JoD6L<-^w+5jDa8Im{?X8G-z6tZ5^rfV0<}@!TSvfAJAcvDhKnU z5?G-aa!d$UNR}3~(yPx4HNWlooGgrgKcf5OXB3aKZO`|v?`_)<(DfyXo31ZWEOf{j z0Zfanef}?(o_CnKTW7tz|J3l)|41Cf5q3S`Lrr_EQ#m-EoqHZSXyeI-rN zHXY$da;kijjYH$*M90tL%L`yz49asyZXX#__G#Re=auQUl2OsVj6gM-IjY}0-%O5c zsW90n*($ZTOf6M*TQ6rvZqLXTBGdX!HR(32ty^pB%eN!f7bo=PJ^;t-HkOgl{*GK< z^z%jAe?t+_^(Bg!?vF*W&>?38cI5h^A|m(2blp+W(dUGKt}jtLpgN+*FQa(qP+bJn z@k?66hWho|wG9MR{a{HPt)I4`8dHjFbV?E#|Htx1b@aydO!X<_-Ob$fK_jqzBcQf# zR2Qh2Pp9?M{1`W;1bJS0-|Ou2 zvuHh3nnyPC^X{VONjt4u{z|Iob?tr~GyhoGrFW!Ip5M-VRhCf!|9pHRU{10sE)N*) z(jexu(X=)!5lzd>di6( z$OwgCAVJqy1M_A5b3I0cV}3E>b7Lj#Z~zlj{l3VxPIeP1Qp#NiTMGd_j%`Pt=QuJ~ zw`Gik_6dRJs4uR1pw+fl4=|ejw?QBSlG6JItz*7!Wpo|$>KnGCk$tQE1DZ$7za=85 zT`MD?>c{#{sQ$jcDz0wBR79Hgyg8mn@g$^oOzOjH-Nr*o$G0^EbbV=S8qxB!WdvHI zzO-dLXuMqQpX%peTh>_1%C-Q-(fbbV%T)NFeH>QZ7l|ahF+bn+ z_{c7Su3~@4?TzdqM{!jkE_ba`ZuPlI=J@Ys?5DT&-3?Ds`jEKz+B>`av6=RdBS+z3INB%sTh2@>v8fKi?A!`2!1U@4N~L z_`YirC^vck+_jIs{^Hx5FXOH9IiAZk@m32*BKf|vAC7yh~P``(iE zABfH8=5oGVuFB_lE;r9T&w~vpxmX*{%M&PfN%FNf|FHbQNt`d2tMWOX%Psa-7J0A( zCIelC1Z-cKtK#49?jt@+`}OqRk8!?SuFB_lE_aG2h+<2}d3?1{n@ME6s}m^y-kBqQ zm^UZw6V9K@SNR;z`#u`~zWaas%U5sQFJ^JRT&~LJcrJI$0_@oq z#P3CslI8ndl0dod=iIo*`lJ7w$N6%(Dxc%I+?>kFTz}YSuC+#Sw%_L;v)`}y-P-eV zBW5G5e{xvGveY!OV3+F#Ke487r+ev#dpLR@rr*z)Z!)FBc%uT%mTSy{O8gXGfff7k zQ(4YDx5w+o?s`___)$o|1jP2X9CFb8B9_uE~H$^3eEQ4dmf{2rulivWWUYGH!*B+vVl`N%OJk;Dd*E z`;u}zD*yXm_PgkyVt(#e{i$}fd`cs`LjQcsY8d4Xg^a+$(Vk#QIW5*R-d}1QZ2N^; z#;xkf_;QRWe5z!RZ%@5Rm4o@R3>1zf#{{%hv&|npqasy9VT4vfQRo7y!;o=q)d zYvm`mGg}mUp)qJ0s_{mHJ#k5VHNx$7cHN?6kAG^cW@+pn%YRjc% zH!=ICsN7v@1gO4v&6Y~8uVS^mohwB~lxPcx_6?@RUT>xs>tASd(hrZw_)K z+^KA8uV(hcUdXpRK-*f2JD+>^&l#zgx+zS~k}tUq--;EYcK`9Q^DA?LZl5cs1j~70 z2WC4sxs?r}wLj zdv3pDkKexe!Ayt)%c1f)zQ|o>m^MseOe%Kex=YH9@ot}cHXcKh47Zn-ik)HvFqsY$ zV9XAZF2Dt% zu1~LhZ(uo8zM~xZg{(POzB^c67%<8_3oJ=wImC1E>Ad2UxXjFg=GmfcRORf-rqk$j?yf z*U`67*ydf(-kkJ3+fE>C@h;GOi`_sOpglpEpaVfvl}CW6VIKn;528KqXM*N}=7Y`w zT>-ikvM3ItcMN zs1!Fd2px}~K@(Bn|TyBGXXc#6F1WZH!~79b02PI4sIrln|VJ2Yf|H8 zKE%yjj+=QCH*+6uX2elKoSBEX2`Cej{MNdK=u;uY9oQ!OzVq-rx=M)WmkV(yQ2y>e zLJa%{_t7Cq9K1)8`1j}}ambt`vE`ph;(}+A#G+r5L|GPY0QLY?o9kc8c0BFhvF&DA zzcexbkj^JQka^7|V=)#*4!N0j!+et|9pc!H)z7HyY1r3k7d5fvp<>P$aKimvuU+{o z7fJGvR4Sk26O^a+wKm!ZiP|>hRSn|)Pjv!v9<$#oWoI4xP@Q&2|hU>pNVn3^V)+_TZZuA&OK0NLvVQ`r&&zd;$Y{^Iy*FE{p zxu0K?It$gybSw|^BkWo)jy#h?<^rrynPhniUy6-S=ALOHnzWPIPy>tU;L1E+CQ>q|Hb99-K%_#k0Z~-P`OkIanWKB+jsfP zvGJLfXhzcjJwr#~LKyZ>#g zRXLc?<+GoN9Iog9flZ#p_|5~5huZ!aJ*(0|nFEAyzq7~JR7U6h|BV6I;z#*A5W=Mk z+9&2y8reC>GdYN-Y*C5fbK@fr*EoC?Vouhc=l0^l3=rvw#&F= z?S_|Cg-f^}k^gr5ah08iWnGm1^(7DEb;@+)C*e(z`4M)lhaObOKYEmFa%Cw7;flf~ zG+^l(ZIrpgUixuJwGX-wuV&_ZC0@ypv-J*2@1cDnVQPPw5Y(<25y(K^+IKmh*v8&ZW({T@^ zW)LG0V63^Qe3?t{!wa$*1R6$!OLM6aMtfw6tN>tGcN) zXGcN6sXhL?+&kGY6UofB{dbW+5joTGa8%zH6S=M-X}B$ruW{mWd_&`6rRO|lpPu#F zX#_L^8Uc-fMnEGFMZl@QM$gy!D0-z1wFCkgD1_fn^M8%LpI&hB(o>z@Pw6-ISgxUc zr&xLEIE}#H4FPpLN7t9Xn+CPKEr~#^`l6pDEvX4z*53gEr~Y(P%gyzU`{KFg5} zk1thqO*7v!bHJneL(g^^)0Wp~8anKquO@dN>F4h*tugO*g84{pbJjYWuDpQ1q6mwW z;LGW$o>2J|x7SlT&hX6+mAkAIk)>3|`{(#8iUV#>DCjB*&kDLLDzRD-a#Zc;I9n;r zccR;o#ITjeO*eP9k5j7qF;b3c^NU@R(qB1?@g<+uVPn2pYV3XX%n$Hsw6b=ev}|M` ze>WkQqvq{&uG*VZnnZY9ZX#(p&9+>_*X}63+-{}pWVbh`?-1vIc<{vGQ^eUBcdlcSXZ;6G8A19BHsI! zTCP5~5RmJD9M<@3-w0%*Lm{`@jlJ7gwi7F^vE}OPH3F@Hz+x22{rM%zbJ6Md>#x^@ zZW#F5XD_j=R-H%^Dxc%Au6a%vi&ObR9xMQh{uWjgE%CbN8RPu!QfaSRS&s5PX?W5` zf48Q!fKxy-@q#h0OV&Mo5x>txD{r0?e!7tBB)xmk`iIQNsm;}uqtN5S>UG9^x7S>I zEt0wrzTBQr{#=GF!vs&NkdE=)sN5I53(;?N)w>8W%XuMuc00=oYnA3?d^$>I1{ z>J-}>0^56iX%72tjy$(FyV_pw$Em)sJ+QyM-n+gpjX*;YaH=m2&7&#Pa~);BDf8BO zX#^UJKwGOXjlG}dxSs1S`^`~?&hzhqfUYm`^~Cjr{rFet6x%BT8MrYT&!+tn)?qw* zkN?iPYSZ^0y#98t`%feLkmI)?{-sl2`)g~F=l2H#YyL~|%Ocm)_i;;H@#imXt#RG> zS6apN$Z)thzbOev<|8|st9SpsJU49y7!H;C=lcrE3jM*L2OFzd`$!{)Y7mdpFBxqA z{e$*T>Itg3v!iHVHu(MYtTb_Y*ZaOcto>PUq=Qe6_u@`s{lbUdpfaB;{`0_!cYfJz z#ru{dq}wb=za+*KJE0x`wH~vbQI`JpXguA<_1pFrc>H z+!p{o?}NKEZ=YXA?s8-{Sf;ZuP7*4gH2;n^Jj6rS{FQo4 zAm9)1Zjg273)54Do~`6lJH@(bYi*W=0|bO4*<@Kw=5}((#C^#1neLnS0N*XVEsZO3h`_>$+x#^m#{AvSY@LtP~$C!UC%$_py+ zh0JI?+DZ*`r)=B%ZRHX6_egaf9Tj_V@2;*V&wbB)&e1u^*A7SK6Hj)I@_Br2Z&An{ z3I`LCE9FRgyIi$&nTcD1@7;IZAv0*+A32h%BaX~BnbN^YE^`w~ zvoWp@E&D#1S=n~ERDCXi+{gBQwX{RgPv1WkDVv@_^xn;UNhCAqB$tCe>wK?7_uCNS zXFvO@9QwR*2vp&6uJ#}Ne&-pHV%biZuS(-+C((K(3M1w7_=J2t ztz$sWvR*43?^uNdd_NhvcDq;WV-@cAi)-(`;OKo$xS+=P)6AOhhxuxGPWMw=ACb5k z#w|Z@)$943>Ofm@+=jOmd74v>YGls#F>_38`&a|}`C{+KDj&?av*65#P}B}lyU6?q zyVi5E4~s{SKC{uz_4`7`0_s?sk3s5YyM3jj!ewPfAYuEV0%O@wthicXb)dlrEXEaV zKa0o4wx5l#uMHzV`|Oe97WDn_600b>g6xO+ssQor$GResc7|+#i00yx-O7&m>N9m) zZDw1qljYgo!pm_(Y$t0A>~^B|zq0bvM1JzLoA0Q8`<`7RKyW+5d=(!jJ8|fL;j8i( zjSVtQ#E#Um>D)=@PCTb;H7{`ls*#lKsPgF8{WHq-i*ax7e92y!Is6_@cGLkio%xhT zc8+!w?VrWBA7sYzr5|IrbG5%k<)(hz@zc{b%=@sfub(Lf$+s`$W4_6h4o>pb_P63n zXa8Mvxgwuh52@IGX{$ExbmQcq^xGskvguSDnQt>0%j0V#7roCiUlPd-I?5&KHI_UzkcV6jh{|!&V{lNXn_s)9YU;xW z({9C9x_yzF`6g33ILQ;$qbiMEZ!^com#6Hr3s?5)lJje~NSP#eC&#A{Ny@?5Sxt#2&Z`a;u*E~M?!*uiNs68=1!mjn4%!o9=h&x#lD!Ih+I+oswF;}2@Ak_hg#!+;w^Piw z34;?Sd7^d{l}6T=m}Hm3Nne*g|I!D4uHAFIwUTyJU(8QL4kvvTx&w3Rx4)uL00XH( zo4%Gnu6X)de*ES?`@ep~O7*$I{DkC^>VGVGGK%atIq9qV!>_hp@_ybjm!dD`Cn8T& zU#c|rdbUcD$4PHL^=Y@})$f)rv8>0^TQ{J}{6yr5r8je+J7}+G`Ni?|_R2>u&Oc(r z6Su2+V}3$%Iq1zvo^_Ci9M^j%z1{KAb7vmj`N@y66}>S(5qawBjis^ct#WdFc^>@u zx@RApy6Wg-BL!1Ep!SjZiO8e0*D$7#hd%Ys!Os>YkqqQ^AZ3bOE+>1sYrjj&-$=gT zG`XKb_Qd=|Y{JRy_A#^zdA%I(4mMII;ns=BP^_^V&; z_YUtjN&4;#d6=JwJoVZagp&JnBmNQJp5`Q#XOCZe&ikr8F+U-BRC`k7SOYo8<$&mZ zo$O~|`$zs7^3T_MysX#{^XYoo#qL*{_G79@9ycsMF1{Rh&wl3NQLjAEU+$mKdoS~4 z87S-|hhi_eUJsVF8SM#{xC5nT-?H3|wco5%Jch9Xd2u_{_jtRUPIh!&LH_rp2XsCw zB_a^vN_Nfs2)ovElGDkK5)u}<%DAq9yi`8x*XccGLrv%7Hz%*SSG6ENhehxseH z5uq02TCN}IGvnLaU85>r>$u|LhgExHz9fnnbd*Q7HwQVEK@M_k_fGb7?2E??{O;PI ztN)?)=OXjX45WjT9FjfNsz}yPraQhIdo4P=^F51$-FZVP(hrSGF<%nF3_8hS@oLBO ztW#?`k*y!IMv=$KUVf^$=&IGTc1@GzA^T;1BJw!3UpAqTiHuX>toU|w(HYO3@!-(@ zt5v&UenN6db`wjU4UmUiEc@yD`-VlO$L9?gq1X@e6OkusKdLl#d@4)g%k%OXUu~Fp z_@2voPA%CHJ$IO&h&+}QwRTicn44Sf#+s)zA}sfZQ%ddfIN8xP;Vy4v|9;g>RbR|c zL>?zQvI&JuWII|0x#+%GZ%)sT=X=hxA?bF0Z#uc+z+R^AnLru_OC+i`TVySG9I9(3(LZX7rKaJ$_x zKN0z&b{9`Nv_()9;it}jt8ad`T0Zw*m`{2q`n$Pm2+Vdg&12V-`hCOV8+wR-;gYv5 zH4aD)M{bnoOE6!(|0yF}V{={RikRjn48`RE!(Hmi3wym-T@v$rJ&O!ifv+TBRN&>u z?ZsCRrQs68GCyRtLXt0KPHg!yt9yvKKVCb0!p6@YSLI`Vlgj7H!?!@Q1OBj&J~1+# zt^HTzb+Y>>mi=&b=&!jhP8aid44dTH@$pOfR=(m1IsPv%@ZeopP# z&aVv_6h0y63Uz#&`B6!%kdr)4&q)?a?w_xKJaoS~Ao87_k4ueD_dfI8GwxB_E#_NN zM30X0NbQ!B93#ATT%7cD=N&sAxFql6XCHjQ-aauuDuESpk|Wwau@v@x%vwbbC;g=T zcz5z0-v#fWdPk0MOU9A;CQ~{%$>F4*DIKHS+Z94=PgYH}fS?%%Gz@lHEATQ5dx2 z;$$ypmR>wEeA5F=0_ocbAResnJDM2+Wti@1KN@lA0~<#W5j z`4NxhqBzo%oJJ1wHQLt*G!_B*{eEKt_4hvG&Rgdn*y~5y>xUe9^xZAfNw=(_^u%Q8_oBG;G& zl|}%caYtTptPj0i`JUP3SWuua;F*W%XjalZzduxoIYl8?R>(iJ!sD}YTn>-zE@ggf zIhT*`iFwCIZkjtQf4@zNoXod!jUF2z=g^S{_o@zH#n_ z{xCMu3WnUXJYG*|A%-s&sOU9V)!;b*_P>p9)|GvSCWBng#oW{yLQ z`$*s>?Cs)$lcPA-S5GEq98q%TL!qZv47Ma7ePlyQ=CfSv*UD$rQx6)D*{NP}Drnp6A^Vi5oK*hIZ!8?kcTW}H4u1AqDtpSw>;CV^l=VNI8fh0PU4O{Q zd`cs`S~+XC_?u_oYeJHCa?l9Wa{az>Xu^FZ3l#y)HonlnRCerG<3%$CGcZTPY`dD+ z`xRBE+3TItd(%Zv1x8==;KC}BpB(x09>;u>DIJQ8k}x(?S?DTqW1+Hz#h%I_hT1B_ z_{ttL>vGGDlDYUG5}RFy4A&G7){--Ao_=qc?YRFXl^20fDn$od3jz7PyXthi{ZM;i zfC{sP2u(licarhg%;mex=r#X5tHxONLsv1M(#S4qKiH86TM*)rOTC$>Ih{BG&9)E= za1pg@^*zt{dBt`sm(iH8eE%s`_WP%26ZIlT;EC1k#rKC(IiC#v>f1NU*8QyhuFQN& zBfHxBrv_n+uhd$~u+Ht<$3Gwkxf~GPFYOCSx)||ilDKk{YaW8)tpoeNCAwai#CjsbnI5pW$FHo^wlO>X$4-mjlp zChPKQWL%&9P?=5bV&y5v$>FA!;qR26T+b>mwA)Sgs5H~Qx9ls#e}7xudDX0*;z0Ll zr*?g`Y)et3qLKN~`x5ijd#4SUv87vSu^)%XBXx4nm0RxdmKIF3em$aVR6A)O$w=!- zMYMI!TYG)c*17BYOLel#<{ZndUlJYD77@_(rRlUH*EKmTmq7gb;^cHX+%^%A`yqWV zi`@^|f_}=IJ$p_#>*vFME2aSqxO5QpLzr(er9*xF5WFM%gC48_8%f)o^_J{Ye#fRT z+pHXB9*IO@nV3hu>g4OxIDM`WXbuE2k*WNCcNNZ^>@d-E)wo#BFP6+s<*4ZsNuyq) z&+A8EIig5Ew7zNeQhPg1<00la_go=nAN@iW<#N@^eM3_&{Ob45hFN)%J_f)-m~U~T z$LNqThBK|7)h2~~DwO`FHQN%anH5VZ3*3 z|EHIHyo?Lx=hmR|7;(Bk@>mT z9+`FTcfa4AlF8%L^xPnMn6Ju{6At;yJordrLbzg<5tvvu8k2;uQU!iW&U2UG{WF2z zOVm8&b8dIJ4eGLZ#t=WoSfu(oP9&=dR+c=n&>p_p0{57q{~HI zZ^);5%zPEOI`!Dx!^Nz|{y+tNKNJknHFA4fS#6iYX?|qKfa!ct zm#Rm#Onu(`2-K&aZ7rE}N_`sAul_xATTzT&SA`&tm!&L^U9W3U@6&d^H@ABCJ}bYD zEL_F)n)%V3t&ml(%}JMzwK!4xXh>a-mo{F!dJjADd7}Dh4veUdQ(Y&0>Gs?iVYxq< zb!Y7QOF2CF=AOSU`|y-24vS<**wXxY=117IUZnm8jJj1=eqF9Jo?V+kGY7~nXsQ?a z+SQLh6{5JEFT6XpoveTz-7@B^f8^ZQdBaYThb-Ys{Ws>TC0TY-6k3Qq!R0YHHj<`p zN4O1VUzJCnHw=L)Bxn0rz9P1LtcCsD{nO&-uI+O}$15ZA8@M09e6{rY?1Ntbo7z6) z^2tV+WWEk3jzDwjCs8R#hh%3=iC(uOq?6yzYaX!IUvYD?`Q1{+_etWcE9aYE7B2c} z(4;H&y>CvhNCQe0zdORHTaPW8fz!2uKApO zRW5zrFa#Q_pN5oHpU%kSxGz~>nue6KJ*AcF@$%Cj1!PP|0(-k#Gr>4&jme|x_FwtjD_epn~$w{`iqcllKPsP{|#5GK+Yg|+Tfl$!5c z9^V=9eC&QCNs)7MS@u9#T%1 z{*ZpfUX#1@VT?&1w7&=Q)zYlz;n8mF$XF8aRE9?TOTx4;qt*9zekM{Ljj z*XQvOQ1!#>z{bB)zYiyZQDf7n`e|%_4ZWV~96bZ%`5(F-Mp2Z1|J@j;-KDFZu3Y(_ z<7YhfC$+ca2+MXjGT&rM2kUu|Q&K{!*GCq-cbYdY%dx~rH*?6rk@8pPhf(A~so%ZY zZQkZ=>q%jyqkUkRPibTqPY!PMt5G1$W2|qTX*tiP2-E#BQGOIAM?TrDe9nCGcT`9H z5LrJ|uTvuAgh@lwR|9Z4f2TZ|$GYKjCqI!iPS9_L&&x2X_t z(huu^>MGX<)=5*9tMf?=0Vn+=c4agb)hp7UtV7moG?fl*3j+DLNPhnC+EUct+OGi_ zs(L0}aeGL*()wxun9Yz>)lX9wLHg$Qmi4W5o;b>?eh54I{#av~IEKxcQq@mWm!<1Z z;}BK#Ga4Uq@$W&6%UNID6bPvLamthG0FU!fnA<*1tDh%~MAQ3;=%?vRjpj(YC7ly- zA2b@PL))q!t}|Sp$ftgqc1?>wbMBwfw36C$<9f&KF53&Gatg~ldrtaHBak=(>bS!p zkxSVQ6V1t~U8LV+wVfu4VDqLc9B3b3YTnXx?izunL7+L>4>?actV+yr)K`n=IBmRi zPVtSo)+xW{;IWMCH%A#dPmO>^KqH_L&^8+RDbtCFd!J)qFXQeKlS_r!M}F}8Uc-fMnEH= z5zq)|1T+E~0gZr0KqH_L&UD<_ zL8@_S646g0zh%-ITv}g^(}mO3iReeYj`XGVp`y|}=i8zm(v4oTu6gvK=Bnp&sfg%v zjlhnJKq7sawv3J}KZn_GPPr2)gVT`DVU|ffXa0`h@5uMQBj{J(qeeg@pb^jrXaqC@ z8Uc-fMnEH=5zq)|1T+E~0gZr0KqH_L&xLZ1^@rkkO)jT&PCPju9o7gm1OatE-C|ta1H|^od8u~C=QIbE z?Um9}SUx8nr=_s!V#TRxcf@m5Kk?@LYCK!kN~%$u=kkR$y{4D`m{pc;7M_D6=^=d| zA%>ElDa01fsaH|t$KC$tKk14yzMwEUOJ7NK_*SeC(p2&tC&w|WEWe$IUT{UFCO@VUixJ_2I%K8H*m zR75HM4@BQIs7_5s_kW<82^9*0eHQw#<6_*DLcd08c?De|xJU+MA zv&e8w@cRmUB>|%XsoY-IBx82i>kgQ?EXR@M%l|OGd`~T%U-R`CV}L3j^Ci*DU?b#n z<@p1~?0`S)D|P7K<6+b*QW#e+!b)|-bK0sK2+pIn_>E`u@72z@DI3*tfJyZK*tMrLx53fuC#rtvH!>O@p}vQ#3l5XdVFa~nW&~9I&{#c>U-565tP}1l zl21gA;y7$F^r1-+Q1zqRw~oxY&V21R z4FalubpN1faBZqwRQ>FVjODhgsmjs$Y#Rcqesup}+i+~ItDN-1^@rb2scd@A$i!(V zP7c$#c1?$Xs-HyOe@GvsD}LwE?>|ka4>hM1V937*(r-!f?|wAblj{xfiCWXC@^*$W z^d3MqL$Xp>uJ<@?Rj1m&?titaI_eaz>PJ7{>p;}13{^k;{!c=2J?Hj`pBv;8k)t>c zn+$zuQUp}}==QBi;cawgs(upbe{p@H`bBj|_rDsghI%tl^`oCZ^+MGu5vqRp`9t+W zk3YAHN^FIy`qAUhHh5b7MAeV(AGEqkYyznI(c{lHcv}5L)sOBUw7N=c0yyc1-#7XF zlrG>tHT#@~;^Z)$Yu9uLsQO9d{fG2HdLsRiuit+FLNhsaJXeoDH!aY5p1y^r+73L5 z9}7-H6xkd7Za{UMzT4*ZnS6587I1sOJTpQcniK)`JNDiY+(|F``PigT>&&(z1k`%N zV^Z9Ap}NEUP`Ukbs#Ba+PL~K&PWd}s*U)^O^3XhuKvN)~_6Ihi6EGGTQ(u7I5$KzB z3UfV?ZI{AK2x`|12&noYyybR=&RI9yM<5$ z%0$8Pyso}Dcd~U=kBya=>mK=BKjl1~WRT-^*p7gzADZvRPGiYPw4Sf(Ck>)FJ$F2_HsW!>md=u z8IsjX#>zv-H6H>_ z`f)0abVYh2pXy9~?OJ_&T%z4JAW(&C)v&9+-39RnT>2!yWx`hAwch&v0QWLSJoYcsXswP zy5;ZN)b<`x+BqPg>W6S6N4WB{RmIy(u#E>fuWig?hq|n__A`qGvZ_P26Zsl74aZSE zB}dm#n9|8uNPxXiPk(#-l-mvT6M`{iBar$K9<5ihG!=vUOU?w%^ookI_ZI2nyw?E)ejrRNL1b94jIxEY<(937sAO+Ll(a|l86oKT^6 zQX)!2{cdV^C`>-3C!hJ0p4%k~b3aP8F*jvASJitxTqJ9ZBvqXRCeP@7KAGv?#e=EerxmF1q2psT3D?+=yx@Cb7i8i5k*j5#{sudFmm z^8)S)BREXnO>b1OoWYtllt)l>cST#Jh}LgkuTXeyumgO%%~TwC@Wn|p@S>dt`y>u-_DF@JX< zJJV-Zpq(KbGZVC8qY$N&SFfcs9$K(Ic}Cl@J?WYp%cJsjU#$5HVrLY21_U!PvYz(u z4wOr^f9oLkm3cqL&fA?*NNr_uZ2y?AbN$C)a*eb)=7ekSxO{Va*dMcbWop3G0Bb`5%3Dc0NCUvUYK@Q2Fd1tQ;%$rN1R1FE7Di&$oK)P6u_e;bggD zzYi@}r!RY*c;lr-8}z63IVyBi`RpHtTmyp1Rf-6>UAt$Wv0Rmqd(!onetmu9vIl2) z6DEC8yN~%S51)g{rQ5wgCB>uDEw^u}TSI*uBC>hZmLnU;c97e4G7sLSGd1w9)PQVX zs(v;u$E82C6+cuyF>1(y?D%ao*agSsnE5)_e+*WRgZJM;mupIr%D3v&vR#{hs4~y- z(DU+jZSgVRC@jZi6o&j%f3{QfJYTC}$S;@+Hyl43PWW)baD3+Z$ZJ3@*X6$%m+P!w z+KK~vJGGqnTF)`nO1Wmfnxk;bwc23(|}yA;|>^?YZ7whpv#85 z+%#!43rzJj)!Hhb{ezY3VEvQ~+uTB%178%q56W_F3`4H8KOE_q~I&T7AS1?2x?$@ASBemnVv z8D0TMKI-Q&-^=!$g30IW=SeR!SiNEP^L%PFFH8*>YCyKnm5q$cu`41aLaYTcjl29zRyz}-@(kU357-SHwt6q$8ynG4X57A zVS|Ma=C8&f-^`> zpA*r6<+&}?LTf`xv0x;nQR^7e(l;GncrJS5ZQI(=4IGuNhBz``V@d~oe)MQtzSCWt zWX;aCS(4n&f`Vjcc40o|5NoWQakc_yA?6fg!HR5ORw(k&+7?>762BjPnECU6q-2iy zZ@Xp__ZN5Nad48S6Xan&g^}Gv+l(Zq+h)ngcH3PZ%w^UmYbWM8v*%#Wqh*ZKli_jO ztogVZXR{VK9s1LoULYyVZneVda*>uT9+q2!y42%jpav-GJnNyf;)0E|Xq8tWJo_FJm2p44g z!fD%t6Go2LybfOjB?!v(_|A@jcqzXuLc`0R!NA1k>K9TvM2X9vUHaf-lg|Gn+Pi3j z@xpvHWeG1fx80hD_>bx#RjlaI`31bJ_FRw2dj>dROAQa;x?)X4_sOy+=J4K0R zQ>=IF+xT_6yJ*249OHxeI@f;$KG=S{mF zuBOaz{}c_#?XwlV0^6}P51G~{cRpE&=^wsz8s#~!}s}S$Jyqg+Rf1>i>EvD?AgWrEXg)&j%AqB;i<8%o8qFigl1hRYt_6qHK1!it?y_r z0&-?urt85xni`Nbpq3XZCtPOaaOSnC0aF7QGen2Ew(&AqKW2R+Ya_gCBb||7Fn^hE zexC_X&qp#;B@*ZHs*=+J`&a6Gh?G;J#C3g!|8&x(mDBI?zI^I~(fBv>)w~4z?iYOi z;%KYgk(rAj`W$ILfROVd)b##t_rc1LQ6A**e9dR0=MKg%oOr_tb1-R}&(yC5$`Kux z^B9Y9Ij5A{UUuVU7k{wHH~)ajIj#Iw`5GICVCB5Vya<00uTie$d0AD8d^W^C6D03L zlKbw}Uwqu*v+p>4mQUrge;D!w%#Wx|)N(|~dMxi}tjFBbqr}=B$5fZ)-F$s#uOMtM zna}d^IhdR^=1J5h93oNYOHjO2MrC52e5PyDnHu=FYCs-m-Z;ScyIr6DQ6m4sw8HaG zYkJ}8Tl5-`_TQv-5c5?%(j)+9f!#xM5fW{)><%i!+7@dT+E8wM0cI$ScVX0-j2&D# zq7A2CqlXUfs7vY(OZW7>k;blR44dXv@x2-rUZ#^YAh(;>#2MEEC1*s5_*L&VSXE(f z$Qx(z{#4ADqSh{h)dRuX&5SIk+uM5fGo)HptrzG$^E^5=?fSkqu~gq0HRJoMG*FI& zxV<-Nka0ODnZ~t>h_-EA{~TSDh}XG=R}Rk z^Dl6w&G-wHY$kEoG*FJ1x!e~e29|rZJ|`g-W&QHj%$3hfplfp6{!sb4ZhJo%D8 zXSBOSZ67h8<>YfPd24AO)h;9=Q~Q%j(!n)Usw%lL-TpG+a5t;VSeb+w!c%SO*o(xTHK6mXePI@%SR;k-mX=#ln^8 z>Qe*qICku4KTc>4*}9(1w105t8-KFnaPn|Y#Hq=EU=As z&a>rMGMyf4o|jM0R3JgBZ>DtJFqV3hEAF zE(CoBngF3b0WE-FeIQr^2=+6mEd-m0%I7@@b_E1m0>R#cU>8EL6t?G#!t9T9U;W}OvE=si09`D@#113?pPtj8sLr)}P!)+E*MV@quz5|a{Ou-^Zv+apajWs zJ34NHv3-rqK>zxJ-v8aSY49USTmB%ECr$;CePurJWEWsxRilc4W_w81R_)g?<=TJo zG^OL3>KeH`kw1~@g7MTa>OIHBX{r9^{gKmv+#cF9*|@x}LwW8{ownon9}4%mkDaZV zZfb{6d1bzulYsK7wTIH(_!nZ07Li$QRm}yzC#6$4;(Ajqv-AYljdU$L4lnaUU2|Lq z^K7WNP5(pFfLv}XrWu#pqVuA}{ikp5SM|f(haVAv<(B!XG&RfZI9nd}^-&A1S#DL$ z1;3{vE=D72t#JN%TJ-ctwiSbuW(zV3nhs;-XXE1(< zFZB5Dh5r}J+N0$FCdtF&9-&M^NgftbZszRn6K){053Guoar26EApgcF11I0 zvK-2n@uJ2T?mfLj!V`^cwF1#SVT;={@-^6+V?VwRc0SnWg2nZBy45V0~ec)_zDX zbZgtZ(2qDXi(T~7o%+I$EEi*m&P?PlU-Lbkjhy-ng(cp<#Z@4qjGwZZ#`xI-e9hmH zefb;h#*I|*!+ce52Zx_bt1Hc&guR01aC|0?SQAI*c@4y39PP|C#!};#pR#d zMO??wnf&d<{0B@g*{5F?l5QO#W$TlTg4UgRXOVqSE%z4xrrxL z!$;S>Y^Tcdjq$Vxcxy8Ms)%e|v#y6$UV@qm#io(d@D6HuYj|OBr zRq8Ru)lT4U;lSr#Im>xrs){S-t5VhzuDn*t#FMJuqwRhj1oHL!<{9HDr7%jg*wXoi zPrh=${?TMTCv2yfujVgIJPotE3p|Q(%5vsRIkDy;9S!?Vjxw+p=Ib zjKfeIq5O@~k>laGY775QWF5mR{8S@;z2IThD&Wnt3m2zQ}`16%bjoXcPJf-4_ z`D)7bh%3!jnRrq)e01H*b}GKa7*FLFM~T;eyzS!e=KV3KfnukaujVdHJo!x$T2YzK zaW+Se&8>~6*ECUD5-P6P9;xZe_Y{Wuh-9z$TJ|@u>rVr+ohn;ojH^As-3f1>GQ)jl z@+T^;n6FA!Ke+NWrwqpx)U^4YF=XP2HFEgQGM=h0HO5o?;wW*t5A;d#N$|@!khjFuK{^pLhR+ncq&~ICE5(h zY|=DlVwH*~=Btv_1D=AmpG+L7nm)4kvRx{|dO&gsAS%o1{L3xCS>mGma@KxS{BU~; z0LONT`8wBs3=>CQGlcPTTLBh~`lct;7?4u!l0T)IS6&f)^AY6vo9tKfDU)+38j$VM zx~q)w6mw;iSTO#*>LC}MBAQBdTQStH0f;;)?lddi8`WHd7{^R0SVp_cET=EH}ne=WCF;z#cFzWy(haQ+bFhEbmnW0Q@v-td_LIc7vbN?EbZTD-~DFS5v4bT=@)DUHW;dEVbR6c&be^b?2Ak5uP8Fa!cU;vo`q6 z1j+y5YSiWK?F%pdp0?}K9Icn6Rg)@TW8vRvzv*lxONm`kgiJd3s*xVLv zDOIX7TN`(pY)Q2`atgAoE(jpoQE_W%`9AG<>U*bVMZMhIYfMPK9*~duEEk{aAYZZ_ z8yz~bZNuEod~`(T*|D2ix)Uo=ZSG{}e1|Nx5M@Y!_1fpQz;fCa8>01tf7@6g_S-MI zsSNqrxM5nGuS%yqIGGxxaJ253_Az0;#*_~FhXj1%%+9st6y`yP5HH(p^VqcQJG~1c zZM@>KhFxzV#dWk_hEp#b?Rf|#pWN=;qTnSyv5kh8BJ8nwV8Xh&6jzf6d)yE=Xa;SW zr#Zq4p+@CvY#ajDRXePCmJH`i&lu}G`z(D)>=>tKD858tj?Z{^-q3uPr&!-3P+M!A zfE8*oGnE16+)cxh!C%Q zj=f8JMu=e-MTmjlMhMph4a9^24Mnq)8wt`URHg0nSzEb)SO@LcKJmG(5gqJvbxr5* z5MHha``kyU@_)Bg%SG8eSf_dIr=P4_chiSzxnRDU=OE?6&+;uQ53j6H+$Nq>4If?i zGM=hK;E5!EDSGab#$UhpUve`vM`1oq>{NVA~*&u%vt^=Ns0M`pK_Z#ECq#{b( z@Y+WMR*m_>rsALZVaPi!VOSmHgF;9?-bYG}|6uOf{_(l4aUAS(bxr5*5MJ)@U6rcho%vzNSlgi-O2ZS_DgPF8EHVaLpvWc#!bqjQDSz(R&QSV{^T|)ZkVs8))`jL~)yVQZ;;Z-OG4d@whRbNb>j>e*G+|?S?;}pviS`RDL_-$b5|{9sJ<& z;VD?ZC44*~Ztk~idD2+kxF@1Smmk{Sd+GF6zo__Uz9g!48AM*{w}dYr6jI;)77|Rg zlYGx-H6P}Ea1F@q&6uZ+@l*0tl-T>si95$!({HhgALgs61i_EoZ!vMCD(r81FXN~x z1db?+S57MHa?Qwd9#QQk^Hntj!I9c;2@6ZIeee97G2V-wi4r@z4flLBdts4^cjkv7 zXKnqKu;ew{3#x{Xu6r5xSuYslX&vx(;ERjTe!R_>-`{htUQ=?DpZ?AD(=OB#V4N{uP1X;IL&2FBUpfBR_}e*cDV^-L&gXOwSN+KGAMBZMYGM@s zY=#~fZ!2Cg#@l}2@sm-juI=#RhBII4plhD-#(bUYKl%}JD0tI$Rv}nnAaK6brQPaj z94UOUoue~f`*Uqxu?E)Rg7LNgRbzZj+7Kn~xazFm*Yq7Ue4;l3#uxKBUOv|oz8F+G zzR>dL_zwkNY+p=#ur}-eEZ3J+RmS+D)OU>8v(mQe%{!~9V*p3^>V_lpHKuf^KYRgH zp*jIbcO8h!ODs+Df=d7qhSYgJrLRSad(XIV_|<)fby52(%%|sN7bHJ^mVdmw?rl$R zB8O65WH}G_^}n?rQw_y3zAD}_##iKU%%yQ1BH- z--cv4-1uW#&bD36zj<%0foga&{$e*8%wuf+&DeSU26k2ZH_TU4^MkFv@fTj7 z=Wyds&2PB(gj*A{Ldflf74I42Z$I$4;FK0I&h;OIpPs2pPWkDE{4ihV`j3b4{UAS~?O!EC;rzvY zV*I{Vd=w=v__d#P_e-xfQOAdv@6VZj6(oN&pX{LRT{#p=^490N7**!_xc|3~2g&8X z;!|ThMQ)1{m948sMD|I&Q5_FrzWOfe4Nqa#KZhG{WFN?JTUNg_kKt-S##`s@#&|2L zjuIz6GGpp}YntD$j{h)UO}GB=7G8VcaN|wQU%2;#Qxl_s-&2Y{H^$o*;PE|C{QD#C z4L(O5?_s{G|N6sQ@b=k}!WY{)I`g%fck@0FUt7L3##h`IQKG}ND^Fa?Z+@*RZEa^a%i|R`!lMF|CaYM?)H3VjJx#RQDXTCEoV*W_hB=&Kf`=g3H6UV zvtOg?`0scxuSb})*BEzezK;@p#x!-!Exu#B+OJ{0s)PE+o!P%pb^Ld@mvOf42VXe%@WmylkpTm4L z%ZCSNb?fh>{}ei3o!3V+ePH{GkEq|PnIA^J)OEK9)#s7lN9@m`2f zy}Idm_4_pQ|C;;-ZyTujsn{R-eKq*wo~@^K+j_J5eVX}yQGSBfL6mkii1AnYYv}yM zAAf15PcE-+rGB4gKE)}!Aa?H1?SX|BU4^!FB*!`s=Wpi$b@Vh^{OY^v z_zv?aPT2*?Uv2C656bQx%6OzcW=9HS#x!q zhxzJzI;{8#qkcNv_~Ws99=libZ{8bgU?;p8e|to<7B~S%(yO{YEB((XG5A1-KQ{K7 zDAe&D=4%m1hr^4%@Y@lG8;4Ss>vTzaHnEF+;h_h{VQxcX99Bg{iyiLG9S1J_qf{OL zVZQnj4lfRCZ|@x`+_7DxGheGZG4BI$SKZhcckzv)h5L)Ij{k7Tab4B%Am*z&J;7VyH!n$aYw2CcJB|rpS%42N7V5l=Btt&e%yuEe=31sY}Zqo zhR$c{$h;f&C-v?1(xp23XgzyRtY>F_82QX}daQZg)skX`lzw#>>CZfK&-nlJm~x_; zKJ&v!->-WA`rrVWC=OY!qR7yCX|{fQ*0jf-9JXwsE&*w$CoDVjb*}&D7s9u0G}yY2 z8gi8)3VvUrS!lUz*-N7DS%2;{RbR~aOQc@~k&EVI*N~%3lA|mPIkFOWKQ(P)@%5@4 z%nw5j`TMt_JTc8f>*bGxPky+vd%vgD_r?4$OMY)VTN>*rrA4&3{-g;{iu@nPU+fit_eWuVNVzN{T-lkq_`h0?Mc=c@ zo{#Od@iRY{)svlj$m{2+oH41gnD>XS0U0ly+Zf}es8zIx_~7JmEksJ%$MjO*7%$A% zx&C7fdn4h6K|=e>IdW`no4bDZTkwkL6UM}mPZbA!A=|z5C}X@-0#7FtH$AZ6=U-CJ z^EPT3FU(g3F~SS|Q%yHD0VYq2;!xV#stkNDYi>}Q_qrUBW`R0B7p+XN7ugZ-!1 za?{yYxF$c+f0Q>F3O5R&neS!$PK+D7W0ob;o@X0vby#QNud;MK!ZFX9XV2086Uu)A zt;Cbu&f3_)Se~-zXz^-#k7iGgYSxqGVH`8xCy4iAxZCQ=wPzPtGV+~HPp-pOP+&>7 zxwG;A;AFSc<+9~ywPnEo3rp^Fd#h2U-JwSqj|55H!?o^>^c&2{eEB+9Sd(XJ;Aqu= zTyN!e3@q=oIUm`e^mrjWlh68%^03u)@#{Byob@$blcVxZN0qO!aR^r4lX7kJckmfb zt2+mFslO#i$*#b&Y=_!*3Y06DUHsOOxc%d@*^@Y3mP_Tce;9IwWrE5jId>i#D5t8w zO623}$DWCfUGzb5C$AuEFPYEs@i~~BBdv}({lm16abeg;*?#dgpIHv`Y--@&q=9l| zmhI1q69UV13;5B0*;DYd;m6Nz`DN*G(c-C92kiYio=|?zaqxgEX|4YsnfW@`f8^E; zwad7dXGu*;&a@SI(EqdMm)L1y0APbbFC4ub`hL#Xc)HIei4h;sVL-o?E;P z@h&8s;$Bhi59YSM`w>UNz8r}(4@TDq^Nie&s5;5G{~3E?v^aJ2km+-`AOFW0J@nKF zKJ-6t=BqL=UY%~=xNXh zaNMZ;?~2k!wxMfsy18jkgRlDvQ761uQml>~>W{h#JwxZAD_9Wl9YS;oEnnX|&yDQT z`IF6@KFg=_*}rb`=^sp}-B}J|y_JU{*Bc*>dwWxd<=r`5mP_Tcf8FHD@D%6S#=Fpk zC)voAgIK=!uA%kz)dP1`&U)db<@78$mQUsDzIA=Csn%j=p+^=_ZrAS&L%yG{+Wg|a zmsTfo`YfNyXaBnCFCjY{0}%EZ_B>CqEM?$#u#%HQ>v2Khw>|r;+RvZgeR@>+2PY@~ zY2&im9Wborh=AX3Ot;W-HCvfAc-*fSZsT-We=48->!v>rjaH0ScmvDrnlR*Bap8vx zCw@~*)tBa2K9$e@oMKq@kR@GL8XhhOvEC+i53RTEKkco$=f<0>4!M_CPZzwkHUjnk6J7bOIOz9ad2LG~q--#zQ zK1FQ@F`wn*a}YWGEdO_P!?qE{Wwwu4qetg?4a8!5QQpfKN0ft?diA;WgFhcTk8{I# zSNZJk2aT^i?PrC9qabZ2in|iTa;KjXT5eC)n)Tm*es?>Ti{)1N?C%%yVCD9=r6^8W zUeP|Ku$!7t5{k z+5gbx_P5C>PFc?z!;p8>fyvhmSTe`E8>YYAt@7(nUe2+g*sTf#xeNY zbQHIY(iUAjJj-&b{DYS>ustWsw=N9%UMq1=zqxF~L!3U#r}Ejq?s^Ptzsd4t zoe^4pn=YUH(3QmtS9AI-pUP+dy2}^XUXyVcd1h$&UcLH@^Oqhc-sJRIK9$e@b(b%A z`>Y%hG7c-kkh6E=%Q7Dt+w20CgXL8D>|b{|1KVS=9@7Vg*5j(1R^Kva#(Ot%`YfNy zXaBm($4>;dzvTLAXBcvpw0hFz$gl3saoaDsu|7-AiWWVuO?!1g(wv9Y z_7n3dPT2*KS6<&>j+@EK`Ws%$c;6TTKa{#9AB*Wq-pX(8owtgVX!}6+p_CI)e1KU-yoH0W}%h}1fXTy~BZEDmLD*w>s3~XP? za#n>Q=M}buHZwLA{=jmuK2<*ZAG|&T+gUPBi_Q(L&&4YryQ|YfduSL!b1bLIXa9qj zGkAMT)@w|BXn8aDeAu&W*ay>C9+p?-v;V=%8`$oW^|~<(IWNnaTh(j8>~mQTmQ&@k z|G~@2PX@NX$`LWwcdmrcdj08*N$#IB+MLYtu)Hdt{W(>s{SaP#=WU0{`iw~oE#IcG z?|lF5h_Y)qeU?w^f$7GyVg(0td?#Fk;Jv(6l%fs@jeD>#5>#onhb{Q39 ze(xnoq4m1&XHRA0*Vj&AIap4W&;AE5r*Zo%K)*wc<&I5`7B94nAN*wYB~8`#8S`0Q zJ_nJzw)K^UZ8dYei#2+5o&)ed%osmF)+%ko3NhjCM~C22>`HgF>ips7 z^XQtKj@yVDeBD=w@uL$gqir5HmcnP)-1F?&HY|g8&~n%`$1EpKsZLzcO0XGuHat`g zVtG1`3tW#z{xd-7$%cJrsEIF*fpXqexTOHZHEds_D z*xZ?g4#)yY^PTSE4C_3bd$cphHq=2<<#^ZaYtNVC$nvcTL%vlP&ECK3C;Ok;!#J>f zDxdw08^n|hr&yD*Nf$*~+NU-!it zTzdf!Uu;RrvsvAVZs+_0*sEl#$7;#67R(u2Xe-34W7+Uf35efY{KPrTz-rY zeJ>dQJ}$-0J<^}uwD6XBx*WPZ5s-@c6h?MFJD?i@?6i_Lb7p3)jbP=*3WXvB=JY2` z4xRp|zb%`4)4j0|avJS5LE1;CeD>EZwFMotf&#!c)i%$TM>eG#&r!OEYo8QKpLN97 z@;&iPSGxveTvVPHSYAb8v{o-{1YWK@Yu#3g<@2ZBoN#xKzGHMe=(=x*H^6)~rQzx0 z0SYHAcT2U;w0W=_9l^r)pM)u0cRk0?(0k)H4wZ+-pr#<|w9~rxwxA9mn$+GMM3co6 zKodZ25E+yzP%}g{9rP|J7ZLVB0ULw}Z$gB#5aC;h@Ha$wI<}X85i^Rro+!juuuYrs zHQ?8wLadsK_4NycxM-yir*0Nv&+!o=qc}o5@I!=n=!OO&F0Y{&SK3HiA)1Ki_B9pr zFKaH2-P1~tzOa;8t3PEs7&j%byitD028m8WY&(9pwnnZ)=CZFpd->aJ$~QTP4x11m zn6ELV1L+myRc)rtoo{z&_77{4JcR|CjwyHvh|B#N$U!avMDfQbwh=iv@9!nVzF*gp zSfcTb|BK1&IIHp^3IIo^9yl^zV@ik7&e=}OP)AOt69?}U=J5rV;jThjCKZ@|+|)ol z@Vl1VvoE~Z;`RK`Zr$rmUQ3_s9`mK7wM)`N!kFQyL$UY1%jI-?3X&%cAJKO@E1(3S zeEC<>ZvsEUSLc&~mk-}M4VPm1ud8;p%^WbFut$#MXpAHCHKug%r=Q$Exo_WLHfY~# z{~i+yf<`Pb5? zmV+IeYb}7`FDT6O1lavbCH?k@gvwLrZz9Bh9?Lm{;yi2Vjt1MFcR#M;kogowc9j0m z;iU(FtoF-lS@||RL49zdh!%Ad; zAfrErlkHjs(x-S6Ky(iF-gkVpukY@bpZuY|cjj}ve5UlFaWpTnQ6lwC@^l}$-1nIt zI^Q|-&aXUs(?bLW&FT4%5GtSjwRG)nTegQspzKbEB@Hb{sK3Bl2CyWt3=gpW*M%WR zw|-sQ{IPhU@4G$Aq4JI8NWsoZ^U(pQDUbXcAg zmXsE+aT!82Lgrj_2B8@z&_x%tB@5M6CxB4J2o!S>1ETzLJt6BQ-5RKuVC~ei@4Ne{ zX~$$etr=^?L+_~>j?BkxfFr#OPoT4pGAQaXoB*Qug4yM-x7?PL z-ZR!p{^aOPcA5DaQ#u64sUM#%gyr<(XM|3F?Yi~5Tgy( zffa~^>+`tTf#o)4Z3Ar_p#-yS%dUImJxXsy!p-A*<}Y|I*PA%uHVWuwzL)JgX%#n9)e$i6uFr16UciJRIa34 z3@+n4i@m0*O7I-NztViaJk%d5!(a+2vl?=~6zQ0aOY!B^RckgpTk^8@5eoODr(PW@xx0dTfKCBf zK-7qg1Ci{>pi!U<5QcrU?^$zkz6f+Bh;Us2dK&a5=rhoMP&DMVfJTFypc_DILAyaQ zFw~PkH-ff;x}yPB1bQDt<4~(W-H^ElL5axVSD@Q45HS;-51OGe2o3+?=zPq@7}YcA zd~`?0;|X*;oOmr0(BW{Qv+-hQjGd!{(FGlgAzg%6-A#!3u|nK)D%$aVg_wAz5I>xa zbP^$NiVzFaF&;Kah~KT~m!PjYbUx%;EW~No3eme9@mC7*<4Zzx+$==uZj6yNju4w- zB1FZI2<`oIf29O@XPiVjLbuy1&P)IE(PwvcgIY94XX-aF-^=!$P*5zx-Fmk=$(o(Z z-~2d$3m2SzQ5fkD-{joe<@5XmeqNU&La2Q9C!8j`le4{_8b!I3UT3@jyiUV@(#W%4 zTetM>dp1)4j~tyNaAdy5lnz>ZME^*o51~)M)<@K(mw5@;mD6iZ3bAvTEl1yTh@vS4 zu|CSfkni;YdnzpR{_~0YKA10wrd^J<<=Cy54_QD{$MS6W#$wBvV9&8Rlks68$7V_C zcP2(n1LcTyh1SzMix$q9^J%V?)8qG|^4UKOIkfRBSs#^Q$dUi;X){h*d-pO>o;w3F(8hpt2lsb3^N6Zq%+ZRYG z9n-bjS>A-`93jpU%;)s^Oyxx{tyC-H^Uq9sQ5pFdQ+lVupqXYhD~!mMg~kn1&iw`50< z1jhJjd^!Ajt}VhwfvAS2`i^y3*YT&Wc=luvstxU13h9Jwd>PLC-u6Rpq3qp+H+x;u zds#HQ!#ikf(K=r_wsfl}*U~lFZJnRs$e}+{lZ>)FrJm68 zyuaWFkWO*xHnZ@6}obN22GAwNBL&*JWvUK6$BWx6Iu^3ze}6PH{_`L#WzM?2>M0K>5T zC2Bh<7lHc%mCZBOua@9-pHF-0+>&3kYaCcUq43$iF7lC0$-&P-g2`Eq2)Uf}nIBrt z2U>~q64Is*W;s|+mCybmGk^m}l=3!dfRCxFNvlN~2Vx;0(+8Yn?fE=T(>2*iszFKyC-Xc6<{u(6Mx z^Ly%pC+V6doDyD`ucj>Hh3gxtVk~0|tvLXR5kAPaGs*EXHt0-_!m#TJAS8L)5Un9% z7kJD-z|G*d2BCXqx;ki}1YsE;RuO?lize&y5 z6uW1HL+gFks8`WF7aX@7*9u9_Ef*W(IPRioF>Az-Z#FjXmG$|_I(it#%$MV)>soP~ zmYtnfsP!0=ta;h=A)I=TG(4t7VT5lv4T3CvuO$1N3K{?!3A!J29`L&qVh#j;&xGys z0N2&v4FbIY|K*_bK{TE+5Y!b!?bMc_NDw(Zra3&~bMm#1`7gVW>&u-B{kSQ=EJ7?y z)8}91UJ@;;ZNGkyQW7n`e|&X%yN8b{n>9816jBxAhWV=cYQ;?grVOCtL|^K2U=QiN zldA?%d6WAqB#ZUd2yxCM5hAfFLX_a;NB$NezG>e;4DQ=Nv`%Xv3LOnZ>9Pi5>Z1)r z^UV#!1HU&AlY2B2eaAKw=@&N?@2_qsKK-@NQKU4$m^G*i?En3sk*E)vK$z{I9T2E3%FbK}(;C9;gYl2W zxb<2zj;k<8F&^*bVhqSn?V{_kw({5;Y2OI?64VB1b^*PQbXp*@zaq``xc?M>8$czX z6i`<*b719zXSDXubBcrPAIZhz zV-s=DX_7y?B3!WiC07RGT^+xuhWs5ZlRv9IF7A?#sKE>eQ>V$#e2pm`^!^6r0;{(4 zfpcxFB3QdbdhC!c+5W*iYxM>d5#llbkRtz=JS^in{i?ur392Wpe^Z7^_qqP3E$6n&qHroW9Q-+IMUj*ZfY~BE1Rz z=xbb+gTpxAqvXd1znLI;UFW46a&Eu%u486{tvRym)ca8Ry02k7Cmlac!5noO;kRhR z*NKHQXWHD!R{D^`&&&F*S{A5pRld@t(Zas@-I)7N`{V4z)Om&DdWZQs*MBt7w=CZ{ z{46>^uy_<6S>Jb~L5k*&HfNaHA9A_kci~Sp^cBUWx;|b8$K4M1d|jvp4smZJ6WIl7 zKe40y)K;C!;W&JKo+*AzZSXmg8_h}0@wavFt?xwRu&4R%%!{K@19G`8zs|T^XO%^Z zPB%Y_nYJnl#I`iYW6w91Y0jI_`Soa!v8=zu~ew zdfil+&2e*kLgll6nB{tCk;iS7%eCBpO}QzsJzui^wTOO5pbGN-nP%NpaYM8?X~(70 zx>R33`mS^T)W(;%9l?B-htCFbX*Ndxg|fGgk`sJ9hw3&ecU0F>TM|PlT6==Vb4X&U z@4ADii$P=ZcF+x=|AKnsVVXNR84+Y6f;EVs5)oX0zVKW`&>D?}hG>J1>LJ94Gcm^x z?W0cl_=b54*7|)U#H(jUh-GUc#FZ|L*A_Mu(O)$ZeSc^o`fP0`=Ka!2-1ufYacp4uSI zL8OOP=;KqH0ND`3K$j!W$0Dx<2#D-xI;8MmY2m5ALyn%OYZ@n@IAt40?XBUUc_3;( zP+My>h#bqK-~BU=ayjk1BCwpQ{g`T$m&WlAwWu0>d)sJlql?P}^Hr_TyeQfPfY+Mo zEqwhyy9K`gE~U9?t)APOO&_bYDB^IG+toCNNUj+b0s|+P?+WCH-faSi-!ow;3$pWm zIq&4p9)7<2+HD*qVS^B&^4XvI>om2(gQ?SnvvM&wJIig&*S-xZUkddnWO?Fl4lU2F z-e3paHnYozko|Eo$=2^x&95z~4Z*><>w9c`4C&y#ubm4djRmvw8P{Zq#?)Sefdig{+lFH0y!Bc)e=rQ;Y|tsyK?okQk|i19^r z5IMaR)x6d@{-Yeu&o!@94ahj@Q*MltGT4GN0mDq6@hCYs;YIn@>HVM2l4i5$wYTSo$ zn(4MW3h)I=>(ya1D-U*IOD}3ljLN+95-Fpl#}{a8FuWOnhJA+JyZ23%26;#Uo3Ag zu*q_9+2!^shJ{2ri00H>fb*rGdq9gC>GNA#<2n*V?G&)IvPx|gDtA##R9*7nL&*}ThmCX{* zYM-QQ&fZzKE6mrq{$mFAEW*}#Gw{b~|NI$Sfr!HklkG?f9?1aVlbrYxe)Nv0&rk20 zY{a=B;-z`-2`ltY>CCo=-ZNteml`H03}KD<)RiZEu%m0j4G#g*^TcBeF-9p2^XMFo z3pZRiahYLE4X_4Eal!4C%18Y6ov>Ph@w0w7_jx#4{I>13pW0SNi~n|QKfYDRAMTqq zCs~Vv$Jd#!F{K0bJJSk1u0oG@^_wLFntQoc!uPV=kaqnqcRr>BKu9v zBr0E2_DEWuH%#AIx`BFwXv~D{@^DZlC>uocPObvo16mLI3PgKi3I5PiNIE6m zl0K;pr1*$OHjeJekKO^Dp$hGq_&q@X6jzFja5>oWn7pxOECk>0C^IgsYJ9grx{pImjCM+k$W}Nn!cHSYQ90|(xSR2%boQ6L( z^Xf=xKyD95J{gFUk{efO_A+vi5NBuo^g!<8(c*@_$Mim?Rm_Q}qD+#bcS-#w=4(vp zKseFYSuj>;d0aBxfY9nu_KjEZB1Ki}C1IKzOoP^zrEBKVHM?Lu_A}4nX`mdz*si3k zF~&;;@buPs_rLwv@@x0r>U|?@SD3G+8XPY=RIn|Dw%tGfFa=BJXw%&Q1R3Fn`rO@7 zcQglfm!d+r8-U3LD4quY3{W2s;hE|QJ`-kS+{oAPGF=@tP=fG`pZ(7U;wOGos)Ap-SdlgtAMZU%8z4D*&My(wV#|?O4Rrud&7Ki*}Ne|1eK6U?_JF>O8dvs6so{lP?xa6omHOz)lRDFsP{^#O! z;4gw$ZAN>k=mR4Zj>kjf{uJYoa7oP(YReN|<^C15>j~3@XXnoMS<~K&OCugV2T2=EhraJ{?4LOO{l9ZS=)!7aJ@GgvfD%DTpk&Zc&@j+&Pzq=SXe4M9 zC>1msGzOFgN(YSvjRR$Xs9!lAGyz0wvnGKigU$od%bW_D209-^FFFfk1F=rYjdpiX5DnXBc z9tAxHdK~lw=t9}c(b2=XEhjaY8Xz|VPX$N9nj23SW8u?>k$IAaqzpzsTh2{1d^NA-r zU#ni)PmC5!Wjbknk@urK9;gP99CG<38Jd8af+9i9K`lXTKqP5L&~czHpjc2}(Al6A z5Mh+?MOdJBL^|35Y6q!lPtfZ@yFlX_2(b}lZ-{c*2zCOAc0i(8NOUg}-GW4Ww8AwK z9p4U^>;#-15Bzn-7)UR?FDS@!4)8S+W#K&F2O!=Iu(i8W*B|K^$sW?YTYA2(j`Rd^ zw7o%!k-y2v-v=NXhT+kysy z{wa>iJC}n!FB7_IF9+%Cqs94)if2rDuU*eoPrs*y<#ND$jVT=r%0b}xp!XT0eu@5#zD@Bbj_g0#0P&a=0c|@pCI)$ghb1W)QvmR8UtC)d%#>={?c=MwO@$`E>^k2K57xy+{X* z28{rn39^9b-O_t+2BLRQc7xtKT~nNd8^QzeDGU+$6QNr6^+QPxx+j0a4#i0}jc~*F zx|YHC2e@+Nf$>xEhB1C3Uyl~gjQ?Tny6OMxm^`wZmV2(Jn6Ij&7W~u%jJ9XKVtf#p ziXXN)Fe{p)cSCl;391CWjR2LfJ0HTMG0s@#Bx1q)FZ>pPMu7-NF(9%bj0dtG6er<< za6GGv7Dllx|1f1UD9 zy5W6C)gg5oON)_^vcgEez1}xc? zoiss@g7d+AU&P)E<9rM)qJ>HN+Q+0kyUWF&<7$*&%15}4%3LrooJ(#Yh21>x< z@>}|DAa2z4VmpDW9TV)YF6w>Ek}NWiaC<<6f97jU=|JT-aK7a@8w#uTKbHc8Q|)WnB6Wf4CfhuQbo^e0uksPWbHo^i!EQt`t66fZ%Z?%RSW99Vk^Z4RlbS^<&*`CC`AEG`**mUY~n*YwvbNVWu{cB6#lCS;#Sjg$eZ3@gk;fLCO zDX0V=KfC3Z6z5(`^p~FR&Ul)x$&uZoqsrIVI0Q+b3XGHXVkcJu^5s8_^y6ZyuWa3; z(@XR$IZj{Y>%Kl!FUKu$mYgV6auFzCFvGZti1lUZ||zRG9++VgK2L;vB(^9GdV zs0u@lR$V(R?eSIOJDd*7q4L>3q#RyA$a2Jf?6;rP@1T7Ya&S)HjP8dz|^7mc9D*D2nL=q@-aSu(edc(F%JJAzQa`EJJHwphJuYn zj~g5zKEsc@x;_{o681%ikCPgRO)If~aa2R``?U>4B{p*3xv7z;C~quoU)n?rx}&Lh z8~YDGJFdC7u3<}&cA%BGdT3km&iB{@wpmB<$vwx2qz_LJZ#>skq~*s7Ys=F``xnm? zpRGApJQh1rbQv>2eBjCv=X~xF_GYCbW9;o>-nnbUro0ctqN{!t&&}={QF&l&M4O3M z1nj4w&KKZ<0X6#CKu}}Y?HYQ{bfyOWsTz>&Yh?)gN;>%L3hSkgD{i78XU&oQBP*!# zH8u`4?W?t5j(_xu>Rv5q8ID}Dffo;C;LOq}WaPamLo z)d^*hNh|4^9HP>WDqmycK=wNsyHs07IA%KW1FbylR*jkIWU@zRz+ZmfB|D7QJyV>e z;;a*s#nrFTH91aS|8O^o=1P;8{zQ&bpWfMtuyj$IhHXt&wQtQPKM1r z&z_AcZ3P}=eRTdjv^-75p7qn%196FH!fTGs5hyjx_p*H_!+ouioY*bQ;YrH1=jB)e zH@GT63@q1v$VK^10MVJ!B)rkb#BIm#-nIh%U%qhln^lwM{$}$Ep#WhzS?^_Egw}hv zl~D^;uW7!Kqu0}q5GtSjIe+-&kq1bi*HDn_gqpQMT9?!9u?(~3<;}pa@G|J%vjqkE zld@c~Uxt>e=h7kBlb5`&*(QpCYy%xtzQ)F(R=I{cax$Gb1Q$z`;915)%FaMLsg~Oc z$i1)ML)ZWByzdg@$UwoJ0wO#xUt>xKmMhIMG%1rlf)si*P;iiPC|t$^^TRo#3#{2q z3QPJStZ?}u9@$oM6pkIeU*a>)m~WngYk=wn#)oT{F+Mf|KM#E0yJ)j(`3Cy`AGuy2 z!Uyv;rgR{D_==8ZID!Ku9Gp>9{mQ{+oK${mjFYzC zU_Ec%#h+ciuHiLo-|0OOPMEKzg8G%3dLFkuTl*1_bB^6M+Umd#_-@N^naJ%0TiEVyoN8VHro z{)C_8F&UQeF6>8|gB1&onRaT&+4AhO>}bJRlAXC3F7zq9OJU{udP^Ac3`%%s;Ls=j z)Q3ZmD9fYr!SEDxXcf@B$HcNci*#}36AHctWcWT#(H*cWJZH!sgZfwblnW9B$odbY8JHaALO zKW{{Gy%C8qU(!bch|;HPvcXvxDCd1= zMJrT?VP~IQ{jH8D(5ANN!DTthAP1$-a?s17IwCF^<43P;rEZcKIsb(X4L=+5JzbNd z@N`u98XJcUd%i2rrtgH5;BvwAI1238&P<=mr*-|bpfa9f_XNH-art!(a}X*$6Z6B zu?Rniw$cCNY-tYK6qv%xa>VTol!LH9vhX}83g7CkYd^l~iyevj`_bi~|CTeK!pJVD z96ngvM%z5OP7*}6LsgK29OEU}dm8@GwI^@AVd}_zT1Z_EdQZ&vvVEs;-czQ#u)ve) zoMS_&m-SNeld(MM`=UjQR~vm@G_G;(6`l1YX-+8BtIYQa;=Lewv{ymD$-$M)6&xzT z#zRT>tbZ=IGEYv6!!eKX!}s!;{5U+H$v+rBSbFj^a=hlXse!*r19G{I`_;JIM*bX) zwI1jHy7WNT>NqcWX`GMBE%Q~mYbm#~>Chgjt=v+1)$3S)S)&Iid84vPVaSClW1;-@ zSj?lTful%7tGQFkt6=0nXgI{h?Aj3w(LUwE*7-ES6h34-#g=k?wKd2sqz?Oau~jrZIJw2 zFn+M~Zyyq&5?;qN2d@2nz!cp1kh9mPergWfkTVuSHMq0I*KMsB8 zaD3VHkL2kO%j3X(ni$&?dZOcp1@BIN`GVWNRODj5B$9R+o?JCYf@QfPo3_*PpMV%i z57btqZ>#AYF(3VQ;0>DkdnZ_%auXFv!g!B;@U39wf!7d@2 zrbS>v4Ncz);L$*2VF9-5&31aHg^GAYq4tBuc+;fVY5d;E$@!`dk*{+2TQ0b+)%Hc3 zCS-UcUEs|Z^VPI!&6h2Em<`Kp0`e#2EFKZb`Jz0XBt;%7Uvj;a8ySeBtX=y2w%o3* z#W$y~|AwNqZkU>|ta$Bn++HIUHo)6uzLd0fsUk%CEsKA=JUP+(fUMt1%>r>leNpznrn|1sBJI_`_F%ZithCtQkGzs%RU{v&7l zb;8XaNp5FBL7E#M^Bmg4lW>&v>yJ^ND<|KdM#>1&$@$%b{E$8qK)OC_e%E^I*zMCE zXs1mF(^8=PQm$3L=7~cs`AxAF(8M<^(DB&k+0w0^T>Ozu&asS#qUM2kP}iYSTJeuu zFuiZ<=Dz6>x(Xs{@L8^)-%qfI@KF5y1E2lUVE62veu3X{M2kQ<%CRPezOiIo7a>+p zU%P|ie&gzPcmDkHklCCL%c1hwUzJ1q@>h8&5hiQ8|Pw0Q)l!*Zy6 z_E+V=Un7EwQi2BvhwUck?2T+0s1J2KiQ@kFV#lo4S9YMSvo%L@Gz7Ys?`8W=svO#X z`e2GhLI@?L~tc zeBD>at78s!S z)GnmII|pW4twbWi1tuE}xPBRk8)JS~9tKz`H(ptyCL?DfEj!v}kw{rsU1 z?-ivdrzzj7e3C@w9bU=I*pCJclt2hBuWLF6mRGes)VV`DF~6eG?lD`Iy!WhkqG$%5 zr}D~tHBW)%)jONb_f<_8epl1K;`qy#j7=)f?5Ld4cRtzCTrygZqdGYb)z7@IsR6m& z?m9LQA8LCnzEeA4Ppe!I-|2}P*q$>!n6IV~h>yVUB|f8$hibFyWP=F{vRx-0*?4-_ z2W!^}Q{3jqrREqrrd?-^nCGKa19CsA&xyw6Rvgz(q@V6+cVEX{1KUvHfg_BQU1z?= zlnzvGLyx!mOK`CAD@FI0U2+-b^Iw**nUJZ0I%uE>VYyvap_JcX)bn1dhztn9{-95~In*0i(zz2*c@C#RS?7HQm^g+KETkfAI9kW|N+@dgErh!F(x6 z?NUlNG0&Mj2kR+(bIvJ1ISMAF&+Adu=jHpll;OIBmD4b<12rJG2lsR}#z%UWcA}Xr z=ZCW&+&!1tW8@eg%-6a8qlAw%SAiEI$%Qs-r<>=TVa-c(>0woz7`dApbiAw1qej#9_H&@|B=$Ab!#ck0*}7RC>2W` z3%#h+_Z5@vS64hrUF9@yyUHI^;FbIxYYpV4a*_Zd?9w&$MdbBao5oFw{h-ks$&76} z(|Q}`<2JyBzdu1Dmdej^^Z(;Z5DV)wH#YD+(tepa@Q?dFLfr73WnNtOc4E_UlbZgo zNBo<-@Q&0<`eZ(C103r!qZo^{@-wj+5f;YV^9tQIs+wx{`&f;v7tVh`q~?vOfq$t6 zN|0|ZuboddF0VULo^SuE*|AG*I=-t~UYW0|k;|+1zX$slxAGZNcDX&Rb zreANR-Ep)htwvES=&IH z&k&0b1##>C`@?=b|KW416YlyY;mmL81;FLQfRTQguXFuJzkK?Hs7$9vpKIt1QjU0J zJ?9`kYR^&h-Xyepe~kVs4#VO6KIT<@X`loVF@D$dHO5EhKJCQaDGSFAoVw!19p0CM zEfX|+Fkh9cR(vEB;0GWz$2;hsJSIL=Egrdhc^o~ZpC2Fe`h)djFMl`TttsiZ#<0Zn zF6oV`eD)`N&_pO~Q;3O#-rX~_2~w6Mo7*!1n|NRc6n7FfADKlzAt}X!jMt5jhvH8F zkvw#*_7gw;aB1bmw`^MjFU{%SO`8an&;H)=m!bGMO|c6*`{1A9>3P@+-eW8BU>gri z`qV?pa!l$Us2AEN8={KXOPY$fPma;{gt_mc*Y-}|(M+5BN-?k;DqoLX2(KK;_&+)R zM4fHJL{r+?O`Bm#GaRwwq!v`}H?KG&P>xjyL2~SYeEXVCA43oPc-}MPvRr>?bJyse z-;c^CKXP6SJC_wo&!kjahh{X>k=_dQ`^s+Yy;KPluP=yP2apR1^lS{-!AQKIRq3BN(3c? zhJjK*BSEPkdKu}UaiC1l1kfbVd7!DF^Fdjl86XS;X#c|{-O_C0xge_l=YwdR=ps-F zXffzA(3PNTK+8clf^Grb4q6Gi2Sm6)m9Akx#!sI!L*pmv@d0tK-qQDdM4>r)r&Rh> zzQ)FZ@ssVgyFB5;C!n0~fn1bMf|im#?}*xIJdU*n{?l?U{&e{-(~C*3f`*hC7|J@@&M`LdW4Kw_h6Io~VcBTl+z_51j`E>Q%LyMFX);YriY++-ILy zMfQsv&+})#&h;N@pE}>ZM`N5G`^;iY3v+w4z3Z&njyhW4awtxge?IOx4S#Ir)sfOb z5fbM5tPD6IY{i2J?{rP?N*?!o#1-j|e4~+XIR=HJ&?;YJ135fL_dA2`& zn%f<7XH%^|GzrFg^SmL|2r9l=yll!xmp1As%IQu|{{*D(c7!V%)iZ?45gsjmDM8r6M5NHRkJF|IwfR80Q4+sg+@~y0ddF z`XIeNq^t!lM?A7!ApO#NUk0MO=Xel-jN~FR-CwH#87Gs@HO9#r;OLg8U3(vXcxaZ2 z6XvVZhs23xw4L?}HgTeA?&!KNfjDf>V&entIE|e}g0fJ!=QZ!MdJAy0bl1R>77e(e zmB(AC*`6>T!2_HhC$zE(zXP7FZ*;CNjnvz)vK^s^d98W-fSAI&k=vu|l>Cqhq<(|E z@1DEe;E(1uc%zDA*RvHNR6hIr^Alhnld&i$8_R@>we?EqZP6zFSTdAj&qgOFC$QgH znh>aGYKu}ohS#H}!2j!2Z&wU%xUwwCoA7D~Ms}O|EDxWlJ(`f`vAG@EiaPJU?ezZu z|Dr+)8xNB8Jsa_I8ss0!l_P);FNwzaptycnbY0)Fr#lqVH96L=%GZ76_C|ny@nckL zzAeqIFT(Pw7yEf?oBTPfF6>#Zw@beU?wYdZDz^4bK#ZaoNkHroL?Y@M#1cCpltfA*2?Ec? zk}M<=cH`~_6S1rv#e!nN9-pGIgB2^NPX#RSEQl4vCt^p@U(~1m-*@jlyK^U-O;D7l z&Lro~-7|A%&YU@Orq8@Mp?hp@hC`Rsr)iepg)XsWJVeeBEe&&rX+a<|xMC9hsP)1U z#LsXG0JK>))P50uTG2xe-(%B5U-{=^mjK#n*5Wk5(~oMTUo;>XanGdXTTL}Gs?cBS zABXz}qCBWmrDOB}Z~dgti!=QH*3X&s&5IZES_s?hum3n<2r*QLgR3fE7rg8 zz|d0Ms1f!DBTD~9rDFx?U@{8;w3G2;^ZNIK-|u}fyTG;)I&{3aEBsKR_7y}iTVESZ z-0z|4t!{(8{LtIA^#il4ga5JH13OF}y(g|Dvkk{Ks2>C`@rzA5D7)Z?Zy3g-V2|=w zN6D5^)i^7(E?O`d>jrrFLs@Mlntk>$w9V^p2~V}jD}oqlYx6gCuIjG(6aT4fS@)F6 z&)?b2Grn4!T5g&kSLxSG|McvB-!9|W5se=iLb(yVgH1dsHvrxRqROwkO&#Zx2mF%? zYwO}YgGPj>)-NOQyHg^#-}JV=vh$lF`-^_8>boV77xJ_KKwHL1b9aJVEbZ|zS@7yj zALI;bw|Oz&X`DPrYle4RTdco%EV5H;yB^i?gVjS)%WcsSS=QXGcWE~*dt}jD4gvN) zZ_2IUC4R9J^)wGLVGrJJe>UrnP(M*$xxvckaa-_Wi-Z2VHN3dfZs}Xq&)@Z3mCweZ zUioBRsqOb#xOYA1^xOwdI<}ASv<@$n3&HDrq&`#6S$8YCA%O<;S8*CeMV0eK9xPRl zvA-j6=wb4=N_XzC)bdRK$KUkOPK!^uy1#@;o9hn+Pd}6xuw7(Z&oxH z|A$Pz(>Q(8{4^c!xT>Mlt9YuG zbM;ufm6^O>LYZT%6J-*Yh|IMe4x6yd$^p;Jo7{|I)m3s9YA(ekkqrK%$A0Me7 znPoj#v-dXVe71d;PHwpq{s~^_5L>4wUf{H%rmshq?`e}a1RAM7Xw$GPiM#kAY4T1# z$&7qMx7Pe7``+LT2R0@LVu)Po@7yt|%Pr}gb7|LJ1y>gi<~t3`EuT8xM&lvn)-$dt zjeoe$21xw%M|+5BpuPFA!w->$qQtnE(uyH*U>ubT|r^iVAMdjtCWo1Vd;sitL zT3eMRYHgg7hUt*uA)IX(vad7_)l9aBVCfJ>do+kuzIM2ch*#CmM2Zd&n>gwf>J;h_ z(IcX3fQlRWhPE-kodZn>LgZ=wv8m-L=a?*O>CnM9j5=)X-A}j~Ao3)5ouc0;Pv~TY z?K^3c$&tiGc~R>p^|#22_*Ly>@};_)_qKCDm7|>Fz3nT`^Kva_w@=fo>+Y}Iuj)9g zTbaEm`@exZr)Fw$BzQgM-zY~Tco87OoC`>%kM#IdJw&}EeFs(V(2s7|mi#?TBLa<= zQ}CB@7XV0)$h*1@Y`(ARnQ^DzzOBr!&`v{dN$~jTF~5etn4gVsLWu!20^;E4Dsrjzvlhd|O z#Pw_5Vs7}{M^jtr)uVcQzMntK+U~gvkNW1Ia{@B&%5fUj%YxTwko04aopr6&if_KJ zQ2m}VB62HoExM1t#Z9&4T@6Qlr@QzOTXi?@h6Df09EgE9(O2C9srBg^l;?4cx7ED# z(Q6^m6;fUWucuYYE86kyT7ZDlh;}{d;}$GK61EzaI&QH7bkbh|fHvzS>M>d8-URnK zn>F3LV&|3P%Ydhmb?$<9u!$$>ROd@@FKy*8PLp6vy|~t$JyB-%^6{yvM;Q`n*_|&b zjAxv2eCl-6!~L}UHTRy}^~qs-yJ2>NP5mf%J*xFchqHp;4WOm;IQ=v|mc(y0Jw+2z z%MZUQdFSA{;ZwFPmk^wKdDCWiahLQIa+^`eU0~x}0$m!at*haxvq9m|q(Xl%6vQI5 z8fP_*=RVlXs?>a52D+cWe9inhm0kat=|)T$B%cK@^oT8V$@(MraHJ8@=)g#I6ccQL zGAxIxu~Za#F3Ec$e_0*{ zuct(l8=t*xHa;8Je0=;21R!CnVb$Y@(3w}0T5qfaor`Y%`M+IXIQC*`ztbk2f>*=l zyU~NVKjkPZ<@=fp#Ht`fXMBkPLu;J990UJj!B4=N8Z&@qw3G?sh?w>p^ zUo(l)HTLAZY;&`~z$3eTcfA zLy#NPAUeAp!+sG#H^hPDHXHh7vQ$If3g1=yU*TP?ua|_qo~Ma0Tq&QXW{3 zaxRf=6}I&`hQ&7Fb^tD7*#*!O!1i?>V1K}&fPnz+F&z!41gK@=7W{q`@G9U-z*Z2F zzJOx@7XY3Fd=EGnf^#n5ZNR}0ye7b|;34_=N0kSVw_XOM*+y*9GxA#xOfO^9J%1&m zmWQzsZ+Xz$i%j>47uVvd6-bKf)q~{$2sooniB2XI&N71pwp$WqW z4z<5k>+x9B+wOq)+qzgC*F52ls_EUQzc`n=l!i8Tms^6jk;+5oQ=&e%_s*aPRTiij zk3KZMk@in!oj1R@_mlcdz1Qc0M?Syr@`2C2B~k5423fnN>3DJ1>A+P~_PzzTGLQ5R z;I^!QoqzTxDqj}Vd+E{hYbNNu==J5-J+%9cUB17{9%+q_rwU%^5ZimMJTLLK#im&n zC0ifBd=bNB^EYjq1>&$CHgyEUP{ZZt5}t%Dzg0KB|ItRJLyfy7yz0li|Ft=wmfJNa zd&{k^_e&da9%#u{-=*KyW#3{~c-YQhJ4o<4x4h+6E3V32>x~GH`YhQw(X5+k7^N<= zte2%6iW_Y-#f{m398l|<*{6BsMAz@JDOuL#`^=f-+s5~z=y#D5!Rw@X<-~h$h$c1m zr)|~qdOYj%+vxfA;g<3Hzsv!(JzaEq>hjBUT=+)t`-8r$TeG>VT&YuchV~V_o>rFM z*6$B#UXs=NXNg9aem?=@ytKII#9L?W)K1m)+@~UVoh~iLmaf_LjF(r%y!_GYLB{dK z(s^%QRCB`9Ivs*|W61)>?;u(+G>ErlXp=&S>60aq3YJD&lbWuzS0F0OKte2%9G#&1{%sl)2;yz!z zEA=wd$999@@zZ1U{zsx8G^i$Y5`IO)p&Iu(0e+YZP}>jO2Q6{YU5rY1?U||RE`s~g z&SM_)T|DDn2}|e}yo4*ZPPeloH95`v=GV~Oc(zv#^l@A3tSoE$l4;#v@36FfS%yQ| zF0jaN!8_Q*vl-pqaohMXxO~xwj8^$A_zh)qtXE`7!sKs`{nE{t)ErRde95_9dC|{h z$~z~^df>d>t|(i#*;gDhr=eU@UIcF=m4_}b&UnsXe=XME25|Ca_2Ou__c}1R`0-uO8Qk3^y$@{4i{SMXQC@g{8YDtJ2i3*} zimIdHU)P5mXO%d_4{fzx>^C(vz1`q`>0T$_^3aqA;`?%0KapO+t6}rKHG17$X*{c< zpr$rh)YlC_r=N9UG8tF-y`~lV7r;I1)g!OGW6#O^iSFY#BIy^r8-3hrBmK?lpA3W` zal`||OAH|LQG333+>>*c{BA4~%X69VYF)AH><4z(_wj4`^9Ky|b_YBKZzGk5=#v5A zP;G6%9c9G4a3mD8eX0Cfhxlm<0OYN%&*;`IbLKxDd3Rbd=R{~|r{O7h8>u`bewnvy zrq5izvtbJ#iZ1lhp^v*ZU65t{>$@!@KSldbJ&+SIFlU2c=9}OhY~o2e$}4J}dvHoa zp_-x9ld7X5Fbf@;RDCj61qXfh#zf4c;?+XC5IsQQY%X&GyT01sAc-wp9 z4}6mEG|sHV&}MkY)zM=(bE(2v7En}HUN*9JLKwT^BO}8#@T8WjH5Vu3nWOTuKS$2f zFTE(sy6MqS`ev`+@YW~_2>k#k&w?jTHLg6n&39QQG!%=3f)x$2j}{*^BEhPhZUG!+ zQh@v*q%xG#WV$QWH^!}P98lYnvoA}?3G-xrug&ba_I(j#_Bmeq9X3ro-P zKXdgsO-=-_$4WWDzU$-d_2PBZZO5ZWdVG0d>G6rK-|?>8pc9sC{7=HP3QqPRNGIjaQn~`O$I`Y1~Ua!67&SSLlD|kJf zww_N~SRJ1&l~*5m8zUr&qq zZ8-2};ea}CW!;*(TrWYnKcRZwe|u+)J$Ia&zzo?=DRQ9A-UFR+9yCqa<574Ggk>7Necfqf(&S4nFw9EljUZ&rk zdR;{o+#lGz_@TMSp7sLw-O|(pSU(BgMk)_oUJ670nn0ui+pBSMz@$N8oR*r{tc>q+ z0jj(lgWnRD60Aqg=ilj-bA5eW&K+4+_>9ieHp$rM)mPmTc{2hd-GW!c=DSX}wyznN z8l8mu2+Qn4g6Th*oD=_B4d>r?2e2G4l^n~Kb?U6I**;K>lo!1&C!Rn&$M*hi!I`BapNRClwZNS=(wfPBNOrNaV^g30B0knbF{U5*j70f zIioGQS;A0pe>XW39{gUmDmU|Ir!`j+({brp>&FZ?YsqvH84zv*sdhn(6lMs2?q%}HI) zGseh}Q_Ci=Zm@L~e>?5ht()QLMx)D3LN?EVp0`ggCz`nY3f@J>Euo_TS4iU+Lg!#2q(awglrz?YY>To^RAmo8jroH)pw`dR zAN0zFULUT3+>~#5)p6E6y?*}KrBn2p;C1pvE?kL-*N34=wKajLb3LDOjCC`4k?=%T zWYG3Fcfu`;X0@F6@?KoO)N^y@q zab^d~keV**;nwwZ;bvdo`fB-!uSh*hI}NE5Jbrpi3+cl36{(Y^)*rc#q%NORLHC5F ze&^luLGOc3aSMo)Pr-YL!Vj%{;yw-c94@!5A%hCK9@oR+Z#PQYmhvb5=tdm#Li$1C zU;G&R*KNUAHdj;fbM%|h7p4;)M_qzg5Bl<<~4mR=B z<>nuOa0rKja_lKUUwHs^+)2hLrT?D@$$5*p{&}8u&J$jGxyB-j0=SZqCfm40hp>in#IGRt}@v*yO_BB%5f z9t-_~*TZjtekVVZBtYoV^H-%`eb?jL(7)CCf3C(KJ%6Xd{jF1%J}_-$=DyBpPtN!m z^H=aXeJ$`u&0qTyJzquM*)C6JRJxbUPo1y*;ND|Z*2V39I&bTqZeTLbCU`xL7U=fm zE5B(eKZSn!X(f!>-*ob>32O`LPUQFUZ+pzi?c$k zG#m<`T2cj16qZn{02T0ZKZ$+C`lbm2=!{8*Ba=~5&5 zQ1CjDt;mOOLMSwWH+SfA(wc0j@vM(u^*i(4b`Gd=(x}OaKAy)=59zSkk#Ar4-u-%i zRq%Sux}22MMN7t)gewDKI)@k0sA}<&||1ArJUNw;xwp3;U!mwvUYXV8{>0 zyAg^$6TFL#TRI&wrBfD&^2Er9uP{`HBVKFjA|*kHtk@k7QW8Lrd z`X6Xd8;`$RYNOJvC8P3d?DJlJ>HC@)#*Mvq_+-Z3qaPpYW*p<(5itv1kEd0Bxo5dJ z^S}|$xW_t;o@8eI@mzrx)l+;Jp;JO3yHVeK{`+D)iU-E2^UnJop7h z?a$^d^72WiYx;sLtIPIRzP#}N=Jk`C^hB-_cstnmqb+n5;qv4_cxZJbT81;V9l~_I z7!UA&@I~ZPZR`9GlDR=iQsriiCO2&75f%X7z3+L)G2#O+&0m&w;};)w=MNalO*)=} zw~@-DRk^{SNFa=JSv0+ri!f5@CDKJ5q|%@Jl2`8a@%X7PWLcjb-|xjimCv8Ra|39` zq4H&WU+@k#@g)7cw9#D$;;)E?!VSKXpz|Be=gNjc9G^W7N68Ne)c70ZOI_{@5f2A+ zNjKXZ1l5=}fXa>E|2>8%q+emZ?Co!5z>Vuy*6f~UE$VpI>rIfWLvQ{v{e{NDyLX}k zjL41P9c+nZJP2NopyhOVt^=~qZCBGrol4d*DSC4B-+G+t z?-+hazSS@B=376w6#&LA&ayt;_5HK)YRxR0d){krzx}S?jf8fZ6tbJU4$Qz|Mdiz%BslWA=G>1@r{$2H;#Y_2}+^-he#-Tvo<2=zM^^0eOHv z0M^!Mq}capP&e)mH~^3jI1q3U;9$TZ0G`i(7~pU~KLEt#^d{JnFFF5Ct%u>&I^d~x zADz|f;B8174cLlWBrT4&k;;Sl0yrrYo@gI414YbpW<(92SQm&y3zbRIecZ7sPIxKD zd3f4Mb3rHLEdbDFlacyaJ=etleO}>3bJjk>u_GG#Ylo-cZKU#OfzIK93882;R6(Wa z0);+)uC{ZFUh&eUk6Y3I{F{%6^v#%CsLQqB=|?p!(B<&Yy&ZOte^PagTZ1*?W696e zpod2Iq}Qu-TNKKD^6QyncF^-v@bsga7U*&2FcTFn$6!2JSwta)X#@y;Q(tYJzNe4+ z@`cYFI~DBQ9k!28xYc~Us?;}$5S=$w4r`aD=IavBeOTXNPli8V*y9B^Aco8O zL-2a|Ezn)m*O5d!|532*C4a*MCp8;ak?@k$lPsHJan8%nAM?c!UCsrsQ$=}E_Z!65tA@fQ;pz$1LH7gJbJPcVdrA*amG7cu-g21< z&#a55qGBy--zjG{($js=@DB>M+~&%a?!fPO2o&X8@Ot?6N^5k>(Riqy41Ev!S!a># z2nJuO0u>X{G>*nJv!#=$Pq*BV}`>%H&=^1tB^~AtOs0u-`4z%AtI?4VxXI*06;eB;~;dqWXr{G zc71fxrqs7IwA1huyp2>Ix;)}s;*#2c+Z~K}&n?S%D>dI3>^~PDyZ5wZj~yjZICNw; z!;8BfKkjcD<_|V_XrSLlfbgNI4Rl;`% zmEfQvs&|P6xyQX8_IwoCP== za1P*HzE;8;2OZSfa?I) z18xA^2xtV{1o$W5X230gS%6ysw*i^}w*&3~+zGe~a5vx{z`cOkfH{Es0QUnP06YkI z2=FjqF5nTsqkzW%j{}|nJPDWwm=Aag@HF5Vz`p>`0-ggb06>M4O;%}#=Jhr4G--~t zL7tmzkWe;kAng!bYiU&7B@OL2EEy&=!vVtq!-2m92UxF3|8x!7h18V=DN^=Hm#e?8 z8*VotY+pTHzn^M&34-lH@4g+Uk6ec9Nh+!^dL&1q@8fLfapyMBPxTBRSvd%hbn={y z%uli`l@8Lt`d891AMUNCeRJKS*nmzns?Hj<9FHN3e0)^sQ-#gv=nNzV$cagQ&Q^TD%yRM0uf(%?Iyj2jd|#M+ zk%Je~Lpd4^dL+KVU7tG+IctY(qKCgs zaSvv6w)dN<{Hppqb-p7y>*6goeQ3rf>7NRpXs3Z|f~OzVw7{=q`_1gn8u66;Yx*+F z#uea6Ug+~<8DC^s4}H`(F#nn%E7tjJuhv+2q#O#~!6u%h2cVCyrI_zjCaDojBf?kZ z@HOCi0hkxm0kp-CW&(}8tM0_3d2KPD_-(rKo`H9!esci7xd9GdK zorfTg$v>Hg&WHQv*Wd9;?YgeVv+qbV7R;vn2;RXao-N2v^Lc3ZlYH2!yzK1?#7@9F z(wzufeN)rX_;u=XV11QkHN5@gb%BW=X5H)t!Y`N(!K-2Oy@hlnpC`t2XCvrV)3F)C zU{WZDZj$ik81=Wji!FYVeJ5_lUVjd7yg~HlvTst$Oa9s{>(onL{cw|chx>GS5xh>p zddiD4S&u-B+~}PA-}Ez)0BHZ-B%dHb8J zHG(f)zi;V&>6E~DFwI_KzzE$-Kv!%1hn_dy@xjZtEIWQA2l`-g>?h{5UA+4e)5icetObt6ZRbqJWURO`677YRO6;EeoVlC zK-6Dd6LH3km3{*G%C-~ZRE_>yb!*G}RCtp7n~C&MHVXi00KT)WChL&!Y8|!Z?coRd z&S{s!A22z9G&}`QoNCjLE76-?N%Ia!sLt(6Ub3Lncm006Q>%N4s^8YBGH0iMO7$VJRp+jv&Z0B;$Qc(xBlb3 z(&Sgp4_Vfdig(v7_%X}+_tCG1K7An&%yA294%{hkg2zvfapO;NIo0v|&|?!4%J?_b z{1WvYN$UdG2Cyw)2f)sN?f~kq-T-!c`U0qj4g(AT3;~n@jsXM!Apqw=IIqDuidz7j zD_8({7w`>WOVE#H*;WzY1OU%tm<#w2unh!yIA9v!Wk5Fw_X&W10dm`8&I7O&8rD|; zc1MTiML-NnVh}QZ7i4@E3foR7@B^S&rb0P<(Ft=inOHB|8FT;H@Y5CHb%T6thdGNK zE$f9Gq-$5)KZuT1$2~EZl81Sd{Seo|n4>CyoD^ZMrv&pNqcFcQ7T=tJ`HVXFKLhhl zm%tw;Sz?$dnK~bHM(Ch1|Bx$MB3X9N3T?s6}9+SLgqdTCZ2ZeTx$wxc8a0uRd{yOGFNA>Q%wJ=(y$TRcsHB zpoVkijTxVe^TjT|_8>8siv$;T=uma&4QJ{@H4%ErJ)tG?W;Ykz8Dr+%Wn zyNl<$YU1@nb!}B3Tvk`@94lhwz!TGBkN+WF2{#SOo%N#XUaz>P!<}Vab)TuY?>*ny z%MgPf$)9d%t*7h3e-8~kc;c1Ip0%}MB3%!;cm(G$lCB|vhJp1JRsP_FfNx;ofTDq} zuN>HtzI?;G_2brA8cQWo||KwnlZZ>UfiXgE3Cp{)75p8 z3TvvdY}1*RbC;J7z|?&u&f4(o2UqFJ*wI`6CZp@xe|A5!{S)u7D{LFiUvk!0$J=N; z)|W2Xt-B0;TecfgwPPg?V;c_q-8oRr&W>U@UTDn5+iTk|E!|paa0v{vV?fZ3)cG7hH$8aGXo~8@?!`<=;^jowmr8c^hp0z)_XIqo6-(AZTI*0 zlVxx={hVpl@$^eWdPW4ewa%i!O1f;l*5koIkDK zCH462GSEBg;CntCe?iGJgWZ9NL-9T5PX(`r&G!M-k% z4;w+0N@s6;BXp`mQi7v=)5veWtN!$N`cwVVf3n{?j{c1Ct|Oh^BOxD~gE=|#((UsV zbAisE|LWQ`ke|)E7QFH7tQRjn^ah8cC&QwA2wvwY%Qt13LQx(XR2_~)`!_%|8u6Vf z7oFS>)%+z&@{PKN>$Fsx?!y4Z04!y*AqO^=x!LDoaSon9QD(Rj7G8~Mg#)Ud>$Yp_ z>t25T;LcTx248dRE{mOj<$T9qT)Z9~<$`yxSL3!f95<$}J4Jn9AB$;!l7lDZgzJ0q zL5IXc$9(`f0C69!xZevr_X5RScj~`xJ-zi8<$^L*iiI?Jlz8hmm%{oi5(NCZ439>tB-33*wTvnm|dguqG7YiEzrwog4%q zd|v{(B;HEkIp?RkuTkBRc=BCM*VNrwPuJ5GosX>e`uZ{4*F_`gdd9^&*u=B#>2l^k zC22VbLekX)x+GqPtfy;%;!ZhYx*7rep7K`JtMzoW+Z03>}=L7y5woIxdqF`JkR8z;6>-xxrn&*6HzUw$O@2SJ-P8|C$rGRn( z*KD%g#dVof-0#F^S=wNg?DMh%h1`Ns>jylrIy#xdt)6}Y4ynWmcD!QUE4Udi1f1r zFY$}bb^-fYJpbSBhqJ>4M_oRtTPT}MmYp=%s*yS?nVaC~hdNAb>L-Rv!~IjzALAPJ z-2goRvZsLi5~<_(4e4Mwe9v&-)pEn|iI;fsY8%y$;Qp+(DxW!hQ_DrHPqtOraPc9% z{`=lPu4Ts-hT}feV}iGl$|I> z->dCp<#xsaP4 z|J^EM=Kk5%J5Ps>I4bLh!_M8pX%W@A@*#LVI#oV6fQRFwf>8vz0v;(BsrKbE2DWpl zvas#Sz7K}^nh#*xHv*Ui_#D7?*=oS!5Q@(r9E}i)tx*YFii+b(G>8{M7bB>G{HE6v(CFc%{qKsy0zQHc2>ua+FQ#u-PGE(%jVWqb)Bpe9?!Ps zJ-(xL+^pW#X}O15uRbu!@;`s7_3yC{SdZSFp0?(@aN4z2b~^cmqGIph(&gUaEC@|v zSg(m})0yu~yWr@KB-rP#@}08JGeo8C#H%su$$=RBi(VXkP-?lKi*oVi+CAPovB%nF z+nw@HsvS$@Uhu@JrkUJJ^WPoeTOaw5a77;2_7RyOPHpR8E4F=C5~JA_us?u)#W-5s zssEX3)lI@@TZ_Qo1ip*06E8ph!nWGJiXGyW51HSHt;Ia!j5)8Yfc*5Ea?|JIFa0*u z)oovK%#Zb^;B{81@)2)$i%B&(Dg@ALAG^N$?}4MFE82VjneDw ztP=SUydJ44AI6LwJF2`)F+~U7!LDa{Y{)|L_SoUd3QJvgC*^fZbb=s zVZR`DE9d!=Cb`Ncqi1vbAUhU9~lYw z+@^>#wb9pyJ;0nI4OlDSRqx+3?tXwWz(l|WfcpTe06gRBbifyYQ<3TWK^S_Vk~s>M z%loKYmZOtX3q>#=3w}1iV8D6Zux1dAlZClh6Ri%`K)nnvjn{QxA(*8Zjwhik=wyXGCfHJJh@gcw= z8FoIf-L)&AH-PhZ{H+?63mS&UaR4VboBI0-BfqM{}pTu?ZoB3 z3G&Z$7651m0OJ8OmtbAyn7ilU)e4NbCwg|D&u-^C4dtIt9ZxI`^=0BdKP-i{m!gJ( zCFAWSj1l*0wf+smLML#MLkuA0alsLZ^2liPd-`&Vv#q@!e80!lqYFcabb#=~NO=^z zjZ_|<^2jkZr7Y50BO+q_vR*;?H0dkp5;+zRHcRk>6v;c?r2SWlcgir`2rSzS!;Djb z39Xo!a2NTohI!>f?tFk=vG}uy9;M! z9#HUl`hSJo_=*P%9Vp@a5%RO9o+Qg40D`h(?oEHZNP=6QGb zgZtGJKgjr@)3PHjax*s{bWr~ZUg8%!u|J~JAH@(_&~;#)m8@Re3*k|(h;eFR`PH(m zrX%mj)axKK;C|ahFXnV8S=%$m6+lUc;Psdi=_rm250ynj;ehQW7f&@EXdYVR1;X(Z>W!XA z^qr_UMxq0g+XeHfm|Hyx2O&SQJ!}jB?z0R0?~1-!FT}S8!omP@*L@L3KJJ)2%(D6o zz+H();EdoSaR%}j(Cf!s{Y0b%`HmuN_pef&2aM#kXi~W)`$+dMzrilMOz^h=+Y^GP zErxiGdx8aa{!<<}|08`lu0vp74=l6$WNZ@?!2WpK8LzgELpH?gGR8qaG<;_~bQfJj zx>P#w(>8*qn;M?$+{}{nHFGeCKMe;|y*~dR)J6%tuItn3(6_^G$l3PNQ$-|3$qhB(#m zo4>PB^|^I?YPlGDY__#fDasUBo6Z}V|N0;iYo<`L+a3Uo0%_XpQkdgXRCgn{EqIVF~L^MYb~ z{NSpW+E4p<<(G`sHqJ|$rQ^jtewIu@uyXjop}ygDlg0(YCFAWG5@Je2HPsc>fr$Ho zs&_L2UV8L)8$a3U`Xy5~U7G)c#3%IVcyVttJ??;-+K!BY9)@24pv|I7Jul}K;MIEk z!7~?J)fgP$Q0~kZr(@Pw@bse^&UdnGyM4W~XrwI4d49E>k}=*JFXLo6?$!h2K5xFn z;V-M_B|q+b>#9eda>=&msW-t>@bse^J>IgRBWovw{gnZnI$rHuO=Ejk^CQ2?n;-i8 z>P*mi`=z=6KKPlvI&z$jhI2~PYl63t$|IrIJmZ=}L!pUv_8}!cUcojf?6-H%HP>en z6x+iD)``Y!JPxS!VC@O1F{3Zx$X9PcWYf<1h1#04f0YQiD*KDKpIhC)%KHw zYve{av2krx&sY<^`i?q;ePFpila%h&>D_}b`~Lg~_)f!o638ytwnQK*NUlQ67Cd?WR8ze!#>*6X20(EH?vV@{j4UC*3uZiJ+VdQb2! zI&QT@kADKrcVTb9Hw-s?R$?_6oB!+;_y$g@jW$RCx;(Q!BD7>wH}$f^bPk5uwI9qvzl zx!VB)@4vR)D3@`SuxH;WCg(>jxXc@i2Z3U zo@)Kg`E-d(4O^wV=tOTl!ZOD^Z-k)rnKJSCNztE7nj= z;(|ns=b=j#@bQ5jMUB70ord?76_yv&aiA|a!Tv;T$Ja(um$N0H_tqzmd+ysC7GJZI zLx@ce`6zgyLu@ZScGo|COo~d2Uf$&U4Q;npZd!BS(DeLS!c*neihAXw5{Y2HZXMwG zi%zCj>)SKhKe+c#wX69~SrmNgIv7+NeksadEv*$IRKV_o;x@j^hkVz zyFQ!7_Mz&&L~%drvuE0oo2vU7#XV>3kWElhSc)14DvLp z)7kSjnS4|SU0wvQb96oB#aCQ9d0&Rnh)h)LQ6o1xXE*L|wH|1il3H#uPR_P=TAcoF z>^}=mzJ~=Bh8FdV;BBPxXhCj@`Z)T<);DN#*&WW|fs>laixSiZeQimP7(J7k&8nX1 zcS`DZIzxJ6`gi9X_0uo$@p9Hntetc`u{15nOK}iQTze+lksEhgj&EdeVlZ?Pn(X!X zR{EEtPfIPwb3ykHT@PJy;?S$^So5?Ut-S`5ax8cUn|N~lbK>06(oh8SBs)Je@kR4D zJLxW3>NXvh>^EhVebM27a)3D}5=>~LnGJs;7fms*Tg453^I-oYlGl-Kf#+Okl^#6Yw(6sj3oJ*hf60tYAKn$?q?<0I_`mc14ObL%w$ zKek(r3|9DSYXg<#A$fCy)ay&ig8=0~-esJEzu9(T`-|>uH&G|g1z;M@UdIZ{m<_~% zsR&2pX~~&hdD7eEd1qu>|2*}O=rMCo?78$1hk#sIlqbRKWKo{j{PvvVsGrxjU-NdA z9?pjTP5GkC(eRypF4mQlJ<1*534AvO`2!}1oMfJpT25-u%C`2)d28IHY5#Zihnk!S zUgs&~WPSGm`ihDN7Y!_94PxX+=jZ?0?-&RY`I!#+p`I@Q&}P}AjvtG{#(h+Hwfx6! zyKrHT2iy~~6YBs3Pd}Eu7%bsK{?ydvXeQ`9c-fLE2R%FL#TR|f_cCuFcn6z!Cg@14 ztHo77EuOo>b|&`)bplWyGCv4XA5#aKc>^%v4>D?hr1pZ;^05T+^W~z0SG+sC@X6b_ zNE)UWGLQAK;2mt@*+PFLY5#R#Jw`U&f%ry*OSzSO`oGt>2jwo=cv&I^<}Dcq)OOrD z$PLSI0f08!H!R2Myv;>fCw~{qx@ax;g3*xg>39m>Mk)`=4ewPcbLO0Uyt->dG-@xl zf_@1O4uvMv1ibf&WnSo|gL}_10lC=R;$Pb1uM;VF05izj#kdzl&O* zuUK<)`mrM}m>s&(rGe{9Xufjs&acE%rw?mKYPshF>cze~r7%<(D6FaGl1kg;;7NXQ zzG5usk@zSd7t2YMtv(n|SL-AfhsWa(MahV*tz{_#;q?jxfSIr@)_ zcd&_P>*-N*$4jquNwy{NN&cw%DECsYyzBkSsrdf%ArlW6^whW>gBCiaat|mj>H)zg zD0SXQZ>#;veXW$^uZW_VNrn?o;-=fAm^zk*)o_16F97Q?@}J{d++)i&F59}~5&iQ! z<~{R9`kzkffqr=L+ncqxJHvsd$2cS2gFW^u>F<>;{1V9XM4d4;La=;eI@It^jfY$(hk>R%j zxQBHq;06fIB@mi95Ts5Jko(X;zY_|$BO?AN6X7D_QxWmWh|xIUSEfK&&Sd4T8Vx4nQ7KGMQPUR3(~Cex6`a$4oSCenVoK}Jfxj< z?}zQIcV@S@PMEcc_3R5Btj@j+>)d6VS+Bm?(P}E}WR>i(wN-UTwzX(^H|z2>J6d&{ z?P~2eb`NX%e*0RrZyaXbaPtuBr_GPHCSEbgimp1#TJ!V`*5YmES^d&iS?9f(owoR( zVQE#{T$;A}*_CN8b{&{LWYS~l`R^9D`)>HR?H1kfO#4r_czlxq?LX@9>AS;OBsQmN zfbG%q>)IecA8gZe?fg@AI%f1ZmQY824u<>)-bN~qR^lwCOuf8ydEV~J z6B|0;^8Mk{kIuDY#nKv!^ax%d#eQv-9(y~KP~*s!v^z4c@Y18}VMZ|X=QkGZRKI71 z#9O~P-|9El@#3E392MmhU~l}nSEY`BD(Ks)tlfek7p&fLJIFl^btCHm!P`jXk+dF= zLuTQx5#ccX$=ZQ#6iR5#b*<`{%)hvco7jRkc4`hxg|o=#Y)wA&b7mRR!>bN#IQ;$F zwy0mh8q<-FogpQHw~@+2m5(In%-WJd?`l1?`s&njT7=uFt7ql*-Dmgj((a&u!iby- z-oYlGprg&>oAJ$z_&k;TCPH7oH&sUEU2KM=zNZSgt^QJl@n?5yL;^&9bFWJ+H&d_4 zwtU+(o-%O!ifUbM1h4bsSILcU*uVkBBZo08BR@Jv|F?dt`p>%FJ6=K!$HtC~i_eC9 z)qa_G^QuR-8_o754f_(T9|dnCl}DnzAmidk_$T|zD#F#Z(ekS5a3$`9=dOrSe3Pu6 zWEpo=oDyp5uQ7O$a33EoA=tyJlvrot0bj<5IkvAO(H#>bHRMr zZ@{2`m-E3WL!ANar!qxcBEYl4crFy%q3p}D@3J#s7XZ2v_8LjHoYAGQ&kf6i%{~ne zWjhFP7@$935MT&^`7jc2G=O~kLo;@1@OasgUJOy|U@DqURzY72p0G9wB1*`^a+YaZF0nP@@1N;mqK!0i~ z;59%`WE9UGdjoJF3fE15Occa(0qs#3F92+d{?;5o8QaFld*(kx)$Wg^I%f!EwP;eg zwfK?Z@LRuEf@-n;-;i;r@tOC(F9#Ztbg3t*W_k6h-alOcy?gKDUw`<~k00H)sdLSQ z^&P%vJt26Vlk3xda{Vf;r{Aajq|?aXQnolpaxh>Q0ETmH9nASzjw?Y0#m5h!%FOs7 zc%b&%tXo^3*FWjUhi4x%>&IvDscl$qvG&sOHX4s2e{jMmf3%`15XSB9Gwt=p5KUh#X`V|etS^Y-Yu>yGC}-H2Jor=zA9ywD?dAr2m>4&bB=T4i9{B<$=u zu?`37IzPmpN=FmupeX>b9I(No@7MXc>7{m0yz=uKaI%d(EQMJb9WU-K9cpGx|{AzE$ zu{WK06zKokBUPI$GsyXu)J{Fi?Tr+Ma$x{(Y(W z$Y^fucGJE8tsir(MCs7AQ!~7{x1c9l+V>S#bgDdB4|(-&0D+GO$a!}2LHGHK9^3QD z1B(8255}ozB!30(U=vT_QxWU@D4WdOhHcp&I_9y@RHN4-^h@7CXL8^B4qQnF*u<18`nLWT3$v!l5LfK z<$L_ApSF5Ymlwh7X-FY2uKeP_(IiCyYj>p19rNe zg&tW(%605?%KV4#}}V}=|Kbd zPQ!LLpE}+~Y*+y{dFHfexly($9I048T}0LiPiepV)7o?bd90+iv#P&YX2RX08SAqT^O# zK3U~fqLC|r9>pzT-HbN!z5(m@(HEU*Tb059rz*6aKr*mU{KIi+{KEdvv@(=b{s zc=}NdqIvupQq zBPU%P#}K?q6W?2)3+KmiA#`{WcKS~afOS3 z?)-+|3W$FROYrjB*r_?7))TWKALL&FfVMvG!jMjF7;;6`gkx%U;SU%rxqy!B7{}X4 zuqNlU19(Pv_zVP!o zLws(WnXoCZf>%hfUn#FHP3pW#(s9F7`z~2Ol1IPA{MPS(OWc38Z&f+2|5xjBeCug9 ze!S|bBX1Bs$ULTw7kA1H#}DlhIHzfYhOyi08w3ev1se|4IH%rYy#hWIy*u~0)NEQasJr=F^@pFvfCDjr$WQ+BUU^Q|F6;5*x}BfDf9AB|F86xDPRH&y!Mo_Vm9$+} zUL9;Go@9?as_o+0ZHT|;-4i-@{UUJi2sZ}GZ#r%@6?{Bm_oaFKPQ+@wxeHoP_YMZYU8*sf8#|2nlvTp7SVCuNOwHttITiFlW1<(^fxnW(-wX6pM4hIYZP_9P-`~bEr zDJSOwt^nK$cm(h=;6uPK0Iv5v1TYpb6~KFMKLqRmMvVb*+1kf|L&3jm0qu~(~IwC>mAVIy6pr5gLcT*&22om&fB&ZPydI||T zq&wo;&9Wx-#yYaSv8Qiego{NxxdpI`EbGZq%UU@G_vuwyRz(OjPeC8&0?WGNYVhe! z^lzR-*slUUwXBCaq*-;lrdgK_OtXR~q**7;NV9r!kuBr`S>Eb;SFqy`F`(#oF~3*1 zzYDP@&_4wSnn0!0uk)dADPsiy+E4*@yF}IZEBD)S-@U44oDV14KqbIrSUTQD<55sr z>>D_KJSI8qG51gywW_1~eQt-RzkP2<99`Z}8}OBRl`q1X3J^M1FY(q3djGv>ake!g zQ2y-v$$h@#ecv=tady2RcpIraST8l}zw771VGyGc;gODH`!|)~e$%TIS|MBtyRWgNe~V*go^c{Xi|x-Cp(bC7Irt@#4rwdi*eE znL~#|cN(Y{ywD+bGJ4$ABULFD>mmoGW<(rv!P)?&VL#++9gL1*qQkG=3o zhg)K2xDkn75xm4NHtC>V;Q`F$A^XY}?nn2P4=wA{*C(eGZ8*K6@<(Ve_HXBaDkoKM zc;!T|e-=QFdR46)KjOaJIp?@hi<}5vr%2?)Gk)AmN;aIF=_!(%_E*>V$JGRsI@11Bt$#A#^wO1V{mI0> znG{(9#u5|y4t(8KTx0JNpguHH|# z$GWqp&N%qBK@y+PqvORr89mPZbnXtFfs>tk>)iY4RQ;0smY1Gna&uTHd*)rspXIQC zZG;{jFYcsg!0<93@{1xA!4aGV(P#iy(DAAm9#-f0oDEClcNyrQ5x(epj&3gs?EO??#fRW_7|>;ue> ztiz#6fe5D)ZKKM2?c1&Mt$lgT(ED!-Z7t=E^tK1Rf_HF`2wyc*?U+eU*9h5+@%M?Hj?z336ZBK$m^;j!s-7 zzL)%M0$q%+06;qfptq0D*y*_UPu=PJU#OR8=r0{l!P`jX(FVFSlCb1+Ty;=x22=UA z;yo|lbouM|ZnpLIq@r5~y?NKyq>F}Sm*anew~@+&^a1pHd5ZeF%QUc`jst=AeHp3d zy~rntQwiR@ZX^z<`m<`eS8kG(x1Tp%dEfgZ`<^1?I_FnxZRvP%*X0^lZ4C&F_t(`# zxhP>kfOjqPXj-*iSqD0(X9^^cB=(czPu%;tBe(k|&n;kbj>bF}uYaP`;jSQu$QIUw zB7yj6k8(O<4gz3#=enP6D{!x$8}7EiW9ZgW-SZW9R&*RvZvu$ESONFe(o?l>*@MAB zFZI{cQ|;mroX4zRdT^g$urgBRpBO;8$5)3Z#pla&5UQlpdOzC|I+CR`M{$>Qs(NQG z+*?cM*h$m=v)vH~cbeoX0gmz0_+7m7EAd>vbSCE^0O6TPZ(t zKlIYYrUDx>>j1n5u-kud-}<_f%BDTG@CMdnG}H&I&jfEHl}9tW!VR_2(1<`Z><>n8 zQ;I$2l8oVQ7>$r$(kJ7Yl&KB?sqdAj%q*e%2OT7+)(CEw|3n+s3x!BrHA zdQtE;QhDg|nP?}==z`-p)%jRTaDTbiWMxQj8A@u2V_QIP4~SpIYs#{%`ZMo;UJj`J z+htn0O{O=j#TQQOyX@WFB*mgPbiBChzKAOCB_hoZ;ozx3*n zWc2LtborJ=2VD1@#3%IVcyUibPl)GiF1Kp-3^(;ZZePj#yFbz9@5FIm6jhfn6t zD4lz+y|;rj2z@%fCHh7ND+3km18@+&6nAc5cvUvavnhwUYP!ZRf`}m?;onTq*B-wM zB=98myYG$ew12z1cPn)pdk%d#=g`ILpXmJKSn5%{qud>E&cO$apW_pA5q~^<;2E|m zZ$)2u`KPyI;N3cA(Y$Y$j9ayw?=-?c9q+g{ucr#eg~AvT_w3zr_r%!k-WWaKHew)dmT?T}VSi5WE;?@M{6f9yoS<%B<`HSuuHqOC#~xJuoJ=>z zBQP(&D+gi-UF2gm#89LKfd?9Qx62)$opM zbA14=qT4$zARQZ3AJu=CI{sy#Z}4knH?25i)&TOEhVirf3*JU551oG)Ln;|x62|f( zO_{sj=>06VjwLQ7So6A(IH1Z)#=6w(iNSpy%3`P8{?6l|RPMnGt$)d`t8c2P;C@U|NBJNc*T8)ceH);w=&{JqvzF&7a)w zv#l|6?r1#ksb6WW+QMwEl;C=Of4@Y zukgVwUOFj|6>rjt{OWi~iY_k$>S}AME71Q)u6{k^7%SR9PxsTNyfHri;8_x%(4*tU zU8l#rF3;Y67s2-JiU5XbE4||>RsU_BFZ*n9`YAI`-ZNL?5ju3dxTmH=M*Y0!2*iH& z(xK1auK=A@3-8;ea>Virk9Q-I@+^3XUu>O@Vb#GA<>k%Gt@vlTRp;vYTLtlfUwxX*ism2T1HdCp(bh+GKX!6u%%T$D`;g`!nh+eG1j z(e--bOGh54<0%J}4I0{__r(@GZDTep2h@44745s&ffwM(d|*F+2<-f{F4h5~2hXfe z?_v$VW9!XU4eYcBwtm@$^S5kQ3*Nydp3UUL?oZolG_K++%c{`%Pc&5cbw7kpxjnl3 zC%Bc)F^rP3Lb+gDn?oU-GnI9E)Hkw*P~G>(O_G@a%5rA_J0;YRvImgos`H#h?gPvL zbO-bVP)Y9r;M`0fzv_^B5de@kZH=r!B_ID6e; zq>Y9;gJwS$@BB(U8Nafo8aqb{PVzS-+J8Cl%Jg#_)#}j2lJFSWivtyWnQv=^+wTMj_zn~(S< ze1<^Yu#T`wVAj6*b@xkgu&SVY-x2qvCFctn|84-{_N5IoB!WF zCsWtbkbc%5g13>%BTm0F4vWbMcO|gvrx9_GKGAbTvpyhwaI%5CHfG~+fb}2q#~$}= zMLtMjR&j^QO?Gss_d5Ku36KAGGtx;T>#POuU=vU7`{jOz_`Y7*?kkfi`+7I|*5gyP z{IJYRT!~OO{96n`id@Xp_#kb%ZavVZdh?~d82dNhFP{F%ZN2X!k7$@*?eP@6jZ_}Y zk8*!x;)ps7e}&Oux9=V)4OfT4xUI!I{xy0luinzvLF8`H#p=8A<~}3-&-d?Jo@dNX zyOVlL@JiJ7E8|!9FC<#GvJS$BbEqnu!8v^KcU=#m^Nqhn{&c;~-{O|+JA?cCa3BXs zrT$>Ms~+XI$JgVo`r`Aq7xyhYs4M%0G1r~-&N{eLb_xKLpJe)e{PKgI`po~>(;{EA zxzAbf_~|k6yLqw3H&WHVjuZYRLwHD{b97A;e2aeT*V(II^!f9~%r4fu`@j3Z4Y5z} zm3tyZ&kNoYIetLDsOQ@8Ql-ke8eUH2UO>f_(c`cQZ@fFDPGuPJ4aHG+ktjBE)dido z8<9{||LgH2`z<`8o4kuH{`s4HR?DpJNBkPQWezmLN#rP&?Uf^a{B8y0?63=-{w3OR z&_}zwL5ds+UXQ7DIij$j!)5QxY9>C-#`iMx2$KA6Ne)`VCkeu!+QE@M_yC4MY$M>6*Wj(fP#AA8ebg|BQ?_&ST57WlXVrLtM{RXy& z1#csjhu$8>%oVPjX06G6;l8}K%oixZZO~WBiX-RiAFR_GSpV<-tY4`5WZiaNInnE* z(c5;h_8cAhHuLet^JV;*eLKpD;B`Lea&i>Z39f9EH4LnU>`z+KC(K8+?Cas1-+v4T z)On@69aGE6^zFM?_l0+8e{RL4or_%Z*lwhp2wta}a^kjK)N_>M2O7BdjM&rmcGIP( zuN_27a-)aemfs?0Vz=cR<0mx-JaUucl^cCNaslM(>hj9H>)-B>@qimF^)cl}@Oo^z zesSucp`l1*1QwedUsy7H_`t&Q;*#OV4=gVlIAZufXBykm=hO6X|ES-(thM(0kD|-O zvtc-(%KrjQ{`Gb4jPb_pw|KIl&)jYjyVD+N*9bnZ=;Q0tdvvizzWMTz&);?P=XdYN z8Bk~3h?s_?P3T;`yAI1q^?o_{h5gZq=+ozRb za?>|5e$HzQ0SSGv-MxB7A7@_y`se*{`m5JAe)+xh+o^4+X9O>FiB0-Y7b#PDk%DMh zRb8|)bW#wW^m<6b<@ct12p2b=t&Ue@^lp89P56U;Q#<>gS|jt!PHkja5f`tgM3-NC zeGN|7c11UmY@JOm=#Y3QFN~ueAadLYcgjuyfVTK)#GyQWri^?IDC?}_x9$`8?$WQg zZjpxT6VmY%yp2>Iq?6|m7KI{F`$R^Zf9Q_{JnQHe?CC8(tf$$oTQ||NCLHlxUhW=U ztb0e^e)&&dJU!ys<<5wX%r6LDiPC;;Azqx>jN#&e^|jUEKxKc-$EPYsdYFIIZ|XPI zFfWMH@v5J{>bs}?@AJxuu4hN@)x|n)#q2JNR&Bettg{n25xmZ)lyU+`PIeYn`GXSz z5&KhJUL;R4^nlIpjluy{@5c5{EiWXn;~8g$hV=gB1tFI5!qrYXUffg4i>+OXs-qAU zm5!!9UOIIBmXX)Ry8okg?H@YeA7>Z8^{yS2v=0O?@r&I89rm!b&wk<%CwSK7Rlff{ zZR)GmOfo;oaLK}HtG{I5{;%OwImz3n_4@aRk-nifd~nt!qIbv(p3f?HJ$)_6i958x zTG{zR?Kdv~9W(_1hOf&j-O{$~zFB$q7t$WT+-Z5zUoLzLo_E<#Vlg4FySmYVOJyJYW zL(RW6ppWI2d~3J2@_=J4o zx}?l~yI2wr!zVPl?p&8N8}2lull;-gMd%j#y4QW1EI6vZ@-zN&{0)L{!8_Q*vl*T7 zsk0WxMLY`;8xfS`bLoEGazI&U8r1&Yj4gjT`~1UlCzE~}+V=erF5X5e51qa?_V${`muj0n`$_$y#VaOiAG z8Dto0`JKAIH-D3rlZT)9q)Ylk|CjD&ug$;h@f5t!CAOEoQ78q0c*dqGA29?Ve9Jh% zo3F{%+aCK!@S|_O+5J|DSNNvm#eHa~!jH=*?S;p_0e&2VgWd&C=5#&8U`zbD2YUIU z>$Rz%@0&%H(;u0-|CG9GoCOBl@4$Y#;N4*3*3iJ@K+S;uqr(2$TC9S@;np~Wb3mZR zkG=&>BND*))qMhv%kTfBOzMVZi9DrSGI!noU;Ve*znH7ZN8`D?SsQ!h4uK53u>v>K zVeibe!B-5trfFZ{i^!*r7k7_*mV|53m5^ofIC?x%f?xh{w60bTkW$NW=|QcpAFVku zvvim2Wm6nF5_(YZLWkHMdhGV9N)7}U7x!SBj!Tt$Ar?MX=~@lCXbJ#~HyNKgzINl+ z2Yg)l5Bj4KKIwSJ75f?0a@;Ci!Y%K5`uc;tbS0a&n%jTKl@DHVYDSS8G3n|A>I5(J zh&?PYDHLw-#jlU&C1w>oo2)uiSzS?Dhch=k8yi$UWgg<>Uq1xKc#_p)JCud@eCX9< zS4w=WOIX|KcyU+xWY4M9W1kp?1qWbQ&^OHAFfK449D*vUR6DKsxE>&Sa4P5`Jp};T z$@K7u&zGJ3blJ1pijJT^-kTtJ{PY+ZnzV`G7$xs@L*a?Rm&BWKs5gJ~`<58s5B*ln zAHL+wNUqcnaP|Dvw0Gs4|059N~|;5{q?MZfRlwiGQjVeaZ4MU%Oepj;i^V|=G@5$o7u{!#9xM6nI(F~r+GCTFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%(FdQ%( zFdQ%(FdQ%(FdQ%(FdQ%(FdQ%(`2Tk3KmY&$06>tx^#UUlLIw;NFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd I0RskZAhbka(EtDd diff --git a/Covance_UCO3001/browser_profile_1/Default/Cache/Cache_Data/data_0 b/Covance_UCO3001/browser_profile_1/Default/Cache/Cache_Data/data_0 index d8236a0668313d76a6679025a96283dab3e73a4d..9a049cbca8051f83bc3c5b4873620497fb050e4d 100644 GIT binary patch delta 1457 zcmYk5dq`7p6vwaAd`{g`d}O+EGxL#BlwlE8L}_KIWQn47T_MUUQAnX+iwva5b~QA5 zD`r6vj4YB>WD9#KL=yg?kgzCUX@O{{QRn>bIndzC_p_FRnKpM&8He5^H zbt^W?&F4muVUK~jH^`HioYoKPlb&S@h8;8fKuaW#Hq3dU4gTa8yk9WvzLKQ3YXS11 zpw9N(I7QC1mV8kgvU>otR0OI+J$;jR?MG~e2xEsHFtlX%r>ybJ2;11AIuv^V)IC7~ z#CUGGd%*HeW!NFZ3Lz2cwBq`?D=HDxI)*z@DL19##H?<8qzvYSqc6@x{Lh7_B=IMdy z>U_blV?6{ELA$6wG~n&qr<=u{vg@H928yO$JDyBrxi)oojUmL2OE-XG2pTqyHrB+J zh-U0Ms7HWI#Kb4=Jc>I_ir0&V?A$PxxUUHXDH&yXB8wd#4dxk%S-0Jgm%mNz$Bs7^ z35p};#^ckirP(UO4)Zj(8Uw8?07Z`6i?^>Mvo62n^76|Wl&!ZT1`xS z{h(LJoXW6cMl>jam{To2?&5isAupCN1izj{f?5)?^z!FQF%Ub3;0vEj+X{=iQuqsJtq~}(mZL>h2mS23QD8%*A1n0uz*JeaeI9&A$x{J5c>%L%RpBN zcA4kS+bY|}aqH|d)Xks{Vup%b&n*YjCXr#sj9Sn=Vv1jBH^4w9{Y29ga_q=hK@Q@& z{`Br&)JQ*Xn9=);b4l!G1+r!-vJgLsGm4@MB#DhYph;XG=q8U*b}+8 S#P#lWJLFpiN0pt_6#WmVx8>ge delta 1113 zcmYk6Ur1AN6vuzNHg*4W*XjN^b>$}7A2)mH&qIGm6pbECkc8Ze`4AMerB(!X@56#5 zrCpY6PqsklsbCbesD~s`sHi7p4~3>kSP~Wsd=ToKd(Qy}U%q4K^ZTB2e`j2EMN(HJ z`Q7_HvqDG$KOs{zb^RTER&XG;p94L7E?_c;}Oq$-e`s#_bq1EuR#dICE>jz^amOcV7NTAoCIt>h)@Ts=IwDY~G+D)}?2$xEZ}*6)4B4TdfAk+M`oPY0LT!~QFG%iz7BG# Ix=V+p|MoRW=>Px# diff --git a/Covance_UCO3001/browser_profile_1/Default/Cache/Cache_Data/data_1 b/Covance_UCO3001/browser_profile_1/Default/Cache/Cache_Data/data_1 index e1ee16d87f83ee32363e8c4605caf6d893289362..67891bfaf4ac95aa132b860dfa5cadfcc83f233f 100644 GIT binary patch delta 2491 zcmcJPeNY_I`dgpIjr+HpX7 zOhtvO9kVZvz?3L?(_S8 ze$Vg4c`Vp@ELhy@0mlh~Ly!dg!DR`01GHchzc0Xb^pj7cC2aEV56?Wh|EPcb{Tt&q zKf3ksx&B9E$9MewnUfekY}pdt=p54|;Er7kPX)k7%uW!PC#!va)8Ic({?-OGTBdR| zaD9P2Aqbv4)wg-p_a24e2;y`I{KCzR03;c}@}>#7mk5qKoFJPUEmJ_wU!QDc>1l1` zD3%u~1Oo)e)o2lb`7gI{-E?FdNpe`;bP8;nN5GQ$$!Jj7rj(-OU(9vUmU5;bvm^P#$q`;-S zDi2Ewu^CH&?YuY>OUGg}jsj7{NG40iVRI%0W|-cb=%!~jlkYo0lPCze5K+M9%AW3~ zMQt1eDy6{vtIGgOOYxy(3Ir3GKe_4THb4fkytzWaCB5+$%CDbh>A9GB-hY|LLFSu2 z<`DG~mz$o~7JyvHC{U{@ImptoHY6ygz{d?+cCfS@drGCiq@Jy>vvevp6%eQW#C(=k zU{gtf*gNYku(T4JX%vW_W$0k(G;F3*VBf^|`dB(0n;8^nQT`1*XJAuBfnSqr#co;! zO?b~53LM?}&9Ix+cRk1~kHqD6!c%12q&aNq1T7sLe)Q!!RF*_B zL2P}TP=Y7}S8ja4@(p3!L0A{8ue6STb#M+#>uTk4ok65ZuW-mp^KxZ5Niu_7xjLx{T4e4 zprOXqtvV@SdJipV{Wxgvihl>7*t4o*HwgpS6U2O{X|#0mFO42PkDv{H@E6xL|Kf$e z1L0eJ@ZGIRt5|w}ovc!CN=-Mc%oicPL`NmX$Pu5oKyI+EfP6Zgv>;CL4EFLAV^*>| zs&Ig8dM8BWP)i$Z5dARwZe-me0b@LJVs(9W^ee8|o(~Am%y`k*zO{!MTpNb9)0|8p zadi^k1j)PjyqZtXAabK0`O9C5Z$ffi823*|{-KY2ZSYgwP#+=*MD5eCYQf`T-yMZQWbfG5WFuiK$dgX%mZUAYOu2 zSj?Rd#OW)i&AH((KSpcfoK@FPBO@ekVyF?d#zF=d6rYB3bWL%4X8HG72yf$Iz6stQov zO7g84+Glinjyypm&GeQW?DTZuxV?kkQI#}wD$y0e{1ER}T@3asI^Gnu_Q3(vFCR52 z&Y)3+=Y+&VovvAq=R|BDe{oF&(_3A0v1HA^LSMT-!Or8_RRJ*c?H=V3behX|e7y@# zxs86Y?-uLtc-t))#(v5d`@uhscH`LfBC{-AHd~=dGNPo}voqw$DE3ObGEa>rnbDTK z?6qgKTds&nNi(C^IdIB}V*&?l?bWE?LgRWkfw14+6U_>Y^bcLt&Dk}C`fbGA6^{FD zyLSBu%3Hl3``h(h_q^=SL-u|jyJTOd1hZRZ#rbB9O;@$hjM&SUs|%JRb}5`+rI_7n z%+Gs9ziAiB@=9>Qi9NA*H^+Eyed8_y4@RWL(nIws5*lYGAs6osypP|^dvE`ixCmAZUbi_B+vZu>buI^fB_*;55)2^SEzM0m2o|fkN$(?%qT#rv(vO+jJ zfiazouAnoo>7qkpg>0q`nwGL{gk2VMkl_!)b4_2$W_&PP+FcXqw-{q&^l(TVi=_ni z)VMF`^vF7o#$MPXw%a?W1op`@IisJ$>#xfn3HvRkkr8M;(e2f=4Wpr2CXQ8?RA9II z(~out1G1HjAcqH$-fhC5!VrhKK<^jAkir2DurWPHIG}KlLp8sZ6F6943kAqUT=s|v zhp>D4jlhVd+jkw}uz4vQCmd2u!yHzYZ(b2NYyoqUF%pFJ`h8#B*tttMqBM{GtNF0h ze73GR_M@pRaMW_xBcdFRmr7y6sAYdJ#^KrZ`+I~jHEE2)M18V9*x8xGaFl0LWjqfN8

Fi<$i%?Zm|^m~2g=*C8kpuYN&4pJ z=_nW&DtMLVDHs_TnJE|=SQ(jF85nI>YG&f#W;EWe-N*EhQB+!bKG@WdJxKI)#R*K3 z61a?*9A6-@J!=9J7o(6#iiL@#K~l1bp^>?Tv2H++`{dV7rrUQ8yuz^nkcyYhA^ZgmZVzYR5CemqwwVLL>F0{DnN!z?`dE%+59GP z1IP3QI~h49FUeAve&QvQ!R9YnJgmTwT@)ZN=>dwf%*A#fkjLr zlcNi`COZ|VOy-`*J3V|OvkO?1)7aR`$XLPMH)MKG1GCBYHyfEZa7L5PJa4Qc>9-K%si}%3N|cTz$~zEfW+_Ig76z#nx&cA%lV3ZTZr?qT z*_ChE0;UDiCIDSmAQ1Zz0kwb%`iZBBMbFO#Ch41>r=wtCsNhwar(k4YWTs$fU}a=xWo*7VL18zWWJqZ$ zP}&Gndb*i9<2*^j)QFUCvz??uwZ_BjM&HvLixh9KTQV`(V&_JEhEHkV5cFil18S4q z6U3QJj5a46*v%#xoLHixU~Hh^n^>t}WME{bU}$J%Y;I*@KHbcnah_z3S$TnJNK&y& zd|{b!o^hyoT3))NQ$R@i=KtxMT-!y07~k+Na%ccs*rmfb1!SQ=Gc$sQS}4kFX=S)M z{=gm_Hda1rzK? P@n{%~rh$=?1|0MN9)&;x diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/0cac568a67962276_0 b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/0cac568a67962276_0 index 750f94c6923902117409cf84b73549fb944aa816..97d125a1be93b79385f2d80f7ea9d6b8b38014be 100644 GIT binary patch literal 10961 zcmcJVd3+RAw#TbF)oBPMBq70O3xq`$%|akCL68KJK$MU`1Vlh`(_Kj#JKdodASj!N z3MG=x>iPzK>dd(CkP&ekK}TG8sKAILiVWk(jH1s`6bRzT`<+|2dJDtny+5Ym=2X?a z^}Xkud+w>zm1HmS{CZ%+g`drmB&|kUwPfDs5Ym!c)uwu%uhBa(E6eGwbGR~{tj6Z{ zG-le|4Oz_VRej#9rQWRNs>|;7WH}u*S+x#Vo$6`yI9$G*%m&<%m(OY@HZQI6XAJOEw*@JKtrF?U*tmrpGYz6N84w#9@Ha8v}5()SPgr;JlL9 ztE(ezyrLvOp0L!Ma;QL2`r%6NrDiLR%>#OMCG3`@>R&EiyeN;hOqT6mER)xf#`H-> zyC2$=@czPT6VBzKmJ_vua6q5fluAh%R4thkckrfMjR7+)i~IDDfc;k8}twLb8?F1JvlAFe!}@I+`!!zP;ON6RT+RD zxLlYhOEHko<>CiEGBa8F%Qd4xZo?@B0s_dE^UlQ@S`Brj4?9VcEZZz!#dXLdD(lW} z$r+rA9-H6mb2pT@d>(gWQ>ou&^EuouT<<`X*>~Ds-$Fs=_o|+vI@RU7L2cq4r!oq% zsiRKy%{BUXN7|>?26~~x$y{}QR;S_ypaxZ{`^PW(RXjRuZl~K*tTy`Usf*@8=jreE zAMS$_ySm(AQ_Ix`x2Gw1=h;_&)lQw5t2nG*zcYFN7AIjF9V=Dm90ujXuxH5jBj z^J#!r^?IRemCx-FP8OcrzV_~y$yrXfjXA@*`QrTTwc;0P)f_Inx>B_l*Kh^l|222m zvlGz4?DnZ@JzMT@d-$Y$anio{@-9NU8&y{^^RXJ{70ZeU`K0jf3$)(0M*lP?@;2SZ z=j!*Wa{zTTI+?H5?P<_EFqdi3vGKGhcK0l|??w-^-O8uZ?^~nCSdQ{y49h>vRg2p%uWcI0Wj6NZE z_+$Bt_R|{IGw)1?YM&{hR+s^Yf4*z!^(mnN5n;mZ^!#bhgXB{|sGwUp`oXmS^wLs^ zj;S8^3hWfaR+u#Pmg*!jsn+fC>36|9o`ng2C-2n4nf0Zj2j_gQw>}&nPi8FjhI)9% zV+GgUNF9w%Kc1z!-?$Pjrze~uB@lUY)H=VDc`EfG1~Mo9XujCUWhJ7I=ZDQNoavG3Y?y?Mxyog$&lh>CaI35R6vKJu-wR}2WnJ4fI5axYax zix^Ph<#!&>*!+r!GtnX9oht?O#M66xG{E82%@x5C3Z>&22kPjlCRw(2h~Mm zFJ5(y9?A}HSqYynA^FilsxIo8w`xUgMa@#x=9}qecH;2?H7WnB7W=l`;VPxwROa&f znA54+`O?)~7=D3P2Pu#D7CV;Da@$qhjfdlPJGVSW!S4hTd?b}()rTqgw!?K!_~hJO z<&-py18V+n} z4n*il2JI5K7G2NF;u_g%pdK=Ct-!%ELC;gzydZF`mol4_BD1X(cJcxR4!&vyYcsY3 zWDjiQ$|}AnZE5)KNaNdJd^>j`?H)yeY)}iazO8_1>pv{1WdzCDESwQu8 zPHBhPI)OSnjT6J{JJ}h)8n7Jts&@+`n)elf6zhH&WI(xx-3i!J2CyCB938aY65Hc+sIT$A`N*gN!?6(H6qpdw+wQ1fx0w)p{eNzhUazb*mo4MIK z^nUgMfJ?A&`r<@E$+EoyDwd`bNS#0i1dJ1M5SjfjTLqYcHRZszZe~+jbj2H6mAreXn67!Q5tW zmFJ_t^abzjNaHUD4*Oojb^%&|*yai=FLv`Qh4DKAEy6y8CRer^1{nG1RaOb!y9TqR zvpK@Ev`yX>KoRoXv*Ia%B!LHZ=sOrY29Pb)P;hS)Z3u?%7c}8gJktaVX%Q^rYa0px zKR8`M)|*kRp&0((f+a$To{z>;oK`O^n^S}Yly}%bY`A@BdKh){Upj^z5Ks|FAqD9f zr)Gw}8M31QO~;ngSK~mSCBk*XF#J8iig@DcPX`zldOE;seB&HscJTgTFgv1}N+w~coMvcOK4kIOzz?BuHM>7&M_||o0vh(5)ss1eNidmH(6=iev*!RC zg)Pj1(a+hD7<5qJBA&B45CI$l8fo$vn+n|92C_5i(S0TEIV6xGtKpFt5jMtGV}#97 zV6w2@`l_4&E4%_71=eA~il{&hC(mNT;k`romIV170Q z)8gi3nkST9>d z|HyuT8k45!6H#`f&+{AQa~oxvO3^23#l8%mCJ%%DB&Lbj>W1a?T;`VRH89_(C=a^W zLQK_##`SNG!sg?yk0Y1oG8J&A@-s^+mZYs{9M^rT7XWxv0K>Mrt`s(PsH7%^I~7@G z{{`CA5k~2R6Tyqv>xSLI71wi~vEpW#Ee5mQ;0B_~>TALMG*Zt{4NTASU|CJI zLbK9SX4}E~!r--Z3xr7+cT5nwRn@e|gG5Sl%}Tt?egZ9{R9GHeR%0Vbp9$V2%WCpw zST5!PfE7=YSvi=G7~Gbqavd8%Iv%NKs0^mC2`1xIoCK6qnY{wm8H1-6*5R>x*}?qL;I>9_i!kml zk$Q$IVOsNGan0*PC0%CmGq8EkxSo1#9j@tA-1NC1is%dxX_*7ziH=@77%$jZe3>NO zTrSAUNEsDzI2jvO`l}#|w8CFwL}Yd2ZBJ<mGTVyzt6ajQ?wJzHBAtvd zDJ8n{fkEOmA*%yup4;%xI63NN1J*?PTcnzyw3~{~;HwZSd^(g|nR!7oHwt3(%L}ZA z^moC#WPardmEPItsf?x|vkPQ49L&uIx4BzhxE>?F6l78Gg;FeqZtx{TJWe{5$uipp zn%i$^8kMqdz^JbxH4X778wPol3pYGSSiKo9Jj76uKNiStl zpbY@xKMaggE=PeXF!p~0=#r_G7t6HRp^B0gd$!D82KBf>?*0&{1o>M*7Q5%N$#t&G zeg-XXl`uK_Aut=fe?)2;;&HDTIwoRdKv^KO3b5WZcpXv6e-1`{CwO{ljVhpmWrUtu zjWS}f%>D}Ir?+8!d3kE2k(RUaLuYwn>7ggd?(bcyFz5GT&WNq0Pr(&8-fB>0Z&8@c ze!xr{ZWmr@j!KSmG3vA+iY-NHH#`vNT{i+D07Tnrfl*XSb}=ZidH_JbwVnt0g8=Cf zdWo0C4Gh~+Vvhndeht~*W;d+g{Ik6MXE_07n`s-*r~K`D)Fkt9_m5%{-mkwS3u#Q+ zsG0g}cs31FtXgYm>>!Q9>*)m;dq%*7GYMo=LzF_OCJ1{>5ZHK?&$fbGzuurX$lbn6 z+zh~3!4H4-3LxI6>Z0A_;`PH3jYDzo>wnPXbiC z!LV~R!NOnp-vZcAk!}mYC|daXieGTBRR9%jF<|Svufh`CaY5iZOX+tfrJbMLX2#WV znfaO7kaX>h6)(PP!STG3IaOs9v!tYrCM$KJ(Pt~Z;+@x^1|M!R+}9v=4uPB zhP-*cwlD*7(E@F8Cgd#(wIx}Q)r&Qj4Oz29vyFqaGfmBbthH%%<00!+%`pLTX`Oa! zE~L|;HRM6MZq?k^KsGjL%km*TZp~W&>074xCqgdwYAddVTvVIZqwFIfn2v*TVDuy$69Se5#*igwT)9D@7kcwP7f<5!44PSi7HA{Ua?wiA=Ax-+ezc8f?PyOZ>u~EX9PL9p zg!UJ-@6lv4^gv5T8;3R-tsHGJT7wx=t;azC?GZY876&h(y^D4P?IhawX#X@9R;R#= z>!pQ-;*qX3bUnk7!~~N#2?4$e>8~4>}wJA}=hYr^WQW;^N{y zE{g9gasTuqsZ~1jQD$H#`Umdb^jwy7Vhmn>v=vT&^@X*+(@qY4dh*fKqe|n_Nly)% aRC`zFS>LbkUG|m1pfGy0`oR%K_3^)g)7}#R delta 82 zcmcZ@+Q~Fws?`lg-s!ISzrHXspaQE>>Fu2x^%*39!puN?R)l9JOofbuGf?^D=~{X` Mj%N>TQGtpB04k&qssI20 diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/1f3f5d78da75e490_0 b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/1f3f5d78da75e490_0 index d8c9ce51ca0f0574568b39e1c2a6827a392743e7..54658dd43fc3cff6e8b2566275916e22284ecf5f 100644 GIT binary patch delta 54 zcmeyv_=j=A0(py*qTh~e)Mt=jU|?Vd;N7|%FfcF!@mUd`nLr8*T;2F5PBi2(J*Cy60u=%Pi(m_^ delta 54 zcmX@dc#d&Gk^KHE@gF-k>N7|%FfcF!@mUd`nLr8*@->1cPBi54jAf8jfeHZttkVnJ diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/5be62acc646c7188_0 b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/5be62acc646c7188_0 index 3a8b5b0ddfb92db90ca04bfc6efe4f39927955b8..9c175e381b238546c189c4d06952e5cd20d0a8c5 100644 GIT binary patch delta 51 ucmeywe2#HKm9zu{0|PS5M*cf0P;meV{|N2? delta 344 zcmW;IJ4k|I9EI`c`@d;M4k?yFiZ(@qQBDRfMfX7vn<}WGL9n5y!5nf5*Df>|5d>{r z#vpJGLa>l7AQ6ULAQURFp#ppHz>foGJUQb_Z6uOG0~C;RSkt=dX^VyQ3MT?94Nx*e zr5UnTsA+vIkkKqQC~8wqm}>{S3qo4N54`~>^g|#BKZ7t51Fyqie$=2EHP~M_$U7xT zcu0s$3r({^Ix1x1!tt)Kmla;Fh2Ol;btBkr1?QdMyBEGS_k-Yh6dH@dq1N*x9F&B! zH=*_}beDy#ig58MT-g;L+IXvCK`U#1r^4bMP$WEx4zHr14R8hEDl$kZ{eA~Ra*zMT=}DWM7|x_sLvq5z`(!^#Aii#W&$ZNP;=v-xW|yE=ISv`6{rvZ%d-u7 delta 54 zcmey#_>*zMT>0%M<3Dz8)Mt=jU|?Vd;y8Lqk_%OD9Vg12Z=ZBXdJnM`vdf pBNt026Js|6OCu9=HzPw!ps=~KnX!wx!NgNKJd#0cUivUV002ts7FGZN delta 51 ucmZ3*)WkGlos0wn0|PS7#Ns=_^b%eOdtgYU)=a79ya7jQtS>?feHZthb004h92X+7e diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/bfdcb80b271f0023_0 b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/bfdcb80b271f0023_0 deleted file mode 100644 index 855b7b669d14e81c1065aaed8c1f5d582ced2796..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 292 zcmXqrDOxU_`}+?o0|P?=5X)J%dH^Yg`0UimjFOUqVk>?9isAyjfET$U{TG$U~J*)?B;CX=HlvN zWa8##Wa4V>WNv6~Vq$4&;%I1TVPbA+;cD*c=w@i(>gwcX0}DjV&rQ1 y;YIKYjd=zNAG~tR-*ClF_B1~Jr@r=g`XY|}<3iHntS~n)1MR>2(c_&D)ExkD##=@J diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/d1cfb4612631154e_0 b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/d1cfb4612631154e_0 index 2c5d46d386af21334f07ae738fdc825411483587..087a68e240b0a3f93e9522ee4565131772d5a3bf 100644 GIT binary patch delta 91 zcmXBBu@QhE3;;l|b`%RBB!R}0AgL@I$1!vU3zx8SEE@~|Uwd}@HBYxSl?xD)Hb#je oK{ACL6O*r?3IYvWqTqyT$bbnoqF1P;Wog8CJVQUOTfdm!2T4Q~e*gdg delta 51 ucmZ3?^qX1)}#m{_A5k=7m z%GH>z+x}b;ZD@@hsJX@%LJ_l?wMxqG+uvGU>z=hf>+J0Jd7k%qpZA}Wu!PJFzR@qs zD+9=;`b)-L=NE>gri>qvot=^Oc4+8FSs9I!)5j)$ketHr(V_-0Mw`^OH6 z`Dk2LxTyMf?fJ054bvaODMu>0G0Uus5>bC?`18u*Z+qP z;)}6-s#_6=tOCSG1mJO;0#CexguV)3 zr0xq8^j)MNdWnL5c?!nSvt! z>{rn7tb)}vtwcfXbKH;qO^wbgsB=-l_jLJ^f<9N6Pphvg*nLgGwlW3ht}A$SL&1{= z3XVTkP)2Fb6}0|CL2S8#4=CkN)_bMkX*CzRxm@V$ap5)9(_A=A0bUp4skh<6GSh|D z(uH^Gy0D0b)^lOlR2MRqx$y%9=etpdX3$w$v)qlnba;guD+}B>vd)cO>)i<3;KoY| z|F;{7#cs6O!8i)v<;KSQZp8oY#(7%!oHfebXdyg!*~o*Wz8<8G_h8fn51P#OpyeD7 z9#W;b9vHNZD(84mGS34o*MqKfimJ}{;Oa^b@;~$75G8!>L2!WwF%(qn!GRqf6zt~u zUJpv?%svlZT=L-XWe@y*@nCY92T|8O$o$Jw4?>@LFr2Qx_Fy|yRIZ>x2B`?FrXq$a zC@RjA=~A&&RWU$QaoSMv*i;c>saViRMUTcRawsHH#RJ;hOhr@=6;mlULB$d3l%-?|x^|2QNcY0B9(2Ls?f7XlX z7rgk1s$cZt$17gEan*~1x4hVW&x?o9(a%pu+bTMS2I^=~RYyXQj_K8O+^nI)QFJt~ zr{fQbtgoY8Lmk15bPS?vkvhI>q2p0|9cR1h*wtM}IYlSxsF|drJM|reF=mIzvaN938%SI(ktNotdxW_(C0yD}@HKObnMd`G=(s`7QLdfjK2&;DN6RuD>6CDr``^*=#seLD=^2&&u0wsU zqgE9I1L=v&z@A_Ohg1Urnt}0#f#p5}o27wkG$h1;r;dSWdZW96pQv&S<9Zp0k2SEG z8mAjjG7R*f)w2ww&o;1y{#a<>;35NlpBVTx&p`1q1J7yV7Y1U!G%%YI3JuiS%3i4b zH{9!61BrC#M+4jU8>n!=z_<$r;w~DPPi^iRm`nkW4Se*(zz%8^=tI@2K6IeIULS1T zhr!gs^1;vcA&MUL_hH2-9|olQuz+f3`0$WgeCWfmX+CV8?!yD>vCfCg^*)qs@WI^3 zxYIt|q}peENWSJnqcR`jU-?j8(ZoGJ6N~&!3=J@`igwm8F-I}6k6!C0j!6@}-!d_% zv59;d9B!g+goz=vvbBk%HYWZ_QJqY@qE#^_s`WI{p8OL{^c-QLL8^&iX(n9hCSs}P zaub)yx57m6=O%IrOf+3*B6z)trxba>#77i;(Zt7e?3#(2*G<&EVIudoiC-R>h<{>Y zKAo;$;b0{Tets7I5o{sGZDBS&@mM(hwuKr|7FzYUuzi4q8-pw~Ot7#b*+RxJ3mYkC zjD^*cEj*oKVQ!IyqOUES`_{s>ofaZ?Ss1y`!Y4;9B%QVpRbnCgqJ_;@EWEsCA*{?o z=NA^-uPjXRvvG;;(*7zow)op<9$=$mpp8-*TGd8obsGcSHr_C7_zN3RZ`ufHXroDl z4cUUZt!+H&XyZ(@jR~Zi8)v_?@p!9^?b{i@$42OnHc}4TC^%u`M2U@4mu#FbV_$bz{~_!DW}{xY zjjH;%x_|9U0fz zfz`#qGJ4X@!J23X)p|Hc=;a_b)q7@uXyhXY z@^=TJ^ckIb!TgsFQpz3tN(p~D7)9x?98`SmU>nV^BoOZ}U<3-Z4iXq-3zSHKg&_i+ z>j+eTQ{Yo-(LkUJB{mXh+gKnVlri+0V!{Om(ESL3c98--shDz_uy#{{3)H=tK!4ib zLckRz5ZpyzQ=GtQsunL0*oS-d7wC~FFqUd133NynXp$mun5w)lP&z_j?IeM?nF8(S zu;yHWnK=R*770A3)=LGl@&tOV5U9UWAnG%LldA23u$`<{zb}O0qo|*dOd#QB?nw0z>Ib3c4sTkyep$Nni`LyUf1J1TImR>jJs-h$`RY-!$=-K*nu>Yoy=hj3|>L z?+IL|S-oHK-&p zjP}r7D)N&^s4OuzKw@&B#Neuo50bb+YITX#H6#vE9Ytc2i_gIlUEC78sD($OlUJgy zE|Ke#SZGSrwj@$$x-IcD9dZ~aB<@k8S`wpcON53y$&nT#|L^CR+w?ZXcVG<|E3YUnctq~HpNQ>m2P1s9QiR6}?0j+uWREp;uX-IG0Ngs)ueI*w3=ZpuiCn_5#F>a7V#RQ2()c8G# z%`|E--w)xOhf0)EK%zt>4W_wNNEgXJNg{&YqdBydF43f9i5c%pd_~#AC615e*;6In zO_O*|%|}ZNrxP^p1KtItrL#v;GbB3DILf0UYM3dJO8K;BjD+7C2Vi4^p=9~^l>^s4jlM?S=;CX1>Gl_P;Nh}Vi zg(RgG%Jo_}Xx2i}#I?11oezAcDDHUGZkGqw7;*Ich&C&8w@;k@?7+h6g=_!*pSu!( Ol8P7HQ8oC$&;J4ZK4#zm diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/f1c90221f3458d8c_0 b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/f1c90221f3458d8c_0 deleted file mode 100644 index 9da9046b0a00a83b468ca126f5071ae85acb4ec6..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 298 zcmXqrDOxU_`}+?o0|SE-5Lbs;P6JX5@!6@B86_nJ#a88|;|zA%D}LjpghM?UJ@sLxOW6k`VBb0R!5 zVbbE+eqiN^K!JxqNnaKQ1{O931}z|-0mLrs3=C~N3=B_!c(DuvgQYA3gNhsjLnIK3 z%QG;n0pf5428Lrw3=DU@85s6fFfgp13>2Hfz>o#R;X#ZHd^Pvewy1B+U`@L&GV8i& iy4=@AaZ>E}GkBEV2=j_p3&Y$Ea@#VFN1Y8o8Uz5+AWM({ diff --git a/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/index-dir/the-real-index b/Covance_UCO3001/browser_profile_1/Default/Code Cache/js/index-dir/the-real-index index c153cf6f6f9af4b90cef3c222d0da6380f2a095e..9adef01149d686be7c9bbc3f40ad9c658b9fd3f2 100644 GIT binary patch literal 936 zcmZ3$%)n5+<-2=+r9x3^NnR=^0|SF95QD)v3mA*xGxz_pU7Ih>cDVKM<&lm03=F;y zsaM-hb3B$mWZCfI$D>Y=xF1s;tv{5{R?FGdcyG40wP`t z5ufm+^j1Zzy}ZLZ_iteHf$jo<2hqOb;l1k?I9xkB32Y7%L|jHZQFfy7zg)O`x*_8K zL$`lAyXVYvhm^`4VD)7Xal`uVLgz0c%i!X>7{L-Dwh^BbU;kL$aM$$(*j{;vdWm;2 z3Ek%xiZ_HNZv&g-4iPU?nwH)bwua|`d?-Y{4n(~3ebQmRR<{`qmU2(Q>Y?tDH{4^u z5!JZ@u6`fH-lpm^&ri>h+JAs$-gB_MwGeZTKR+pB94iqB56?=7c+BRctc}$VmcZSa z1PP$%vW?p#rygg7o8t{pZ}H{Ny`}ZWHE{oWK*XP4y)?_5`7e9J;+D5ydv`$G(@~g{ zaz^V}bi;)&6Oh9>#UOLy_DC1c1MRX?z~az&SrG2K+SzNi0^GmQ^w74bPu{wzrKREL zWR!Rm+ZJ`7L*?FWxcdzusqCJk-g(cA#0a>51t9M1J9f{}e(_%^c>F@+YY(@}ZBDt+ z7I=7mgQ&mT6?nTTd}7ss!1a)H0(GaKsG(Zomh%@I3Zx+E4Juw~ukr9iJhFnPTd4YOZI5&LyF!}L&HwPoCd&VmS<8VrF?+$` l1`X$hxxD;S-u|hChYvJ8@7$OD`J`p1H@f&awdvq+1OQboJm>%b literal 888 zcmXS5W?-20YUlO*N`<1-lDt$-1_lOYAO?d&hA}*ZxdW_z7sQ=S)n}fco+GuNp)BMvSiBaZzVm(3VZK(k84Z?lPr>5d5b;Wb zZ9l#))Vy$DcN)a~9uV>4&rix2$4Ugk-B}3{kJ+4*wXyoa5(hnQi25Xmhb7*{By^u& zDBcj7ybWx=J4C&+<{Bf;i_f0G#fu^0(PbOAM@~J?2zRG9M0`QG?`mhS*$QxX`a;Be zdR;#&GM)U$ka7zW4$$!bAG-b1**#~T!^5ErqJCj6FaMOce=5=AOKe-zeGZj-x8d$L zR0V5LW{_9s-f?ID0f|0{`OtW@&scv*KI4%U!&eKG@QG<&ZXV%qH3uGUnqRhC5kJhWi&P{-EL1 zzd&}cCvf+aLdA)BSdV;LxaQ=hg!lY{V*Jd? Uj5&!($@xVEddc~@3X2L90K;-F%>V!Z delta 127 zcmZozz|^pSX~PqHHAZG#wvx=;)S~#D#Nv|pw9KN^6bAi`os*e2UF2e5U|{5b!@&P$ zvtYp^ei312T~2hhn*z4;GxAK{5iiHy`RJq5RAtf0cjM()J3s#Y=)Ni8J-;9iKeIAp TPGVAWeo=v5a(=Gpq5=f~W;rfl diff --git a/Covance_UCO3001/browser_profile_1/Default/DawnGraphiteCache/data_1 b/Covance_UCO3001/browser_profile_1/Default/DawnGraphiteCache/data_1 index a06157f19bfce33c972e8debb1879f44b3b7074d..27e9a1754bdf0423e0e15815cbe1bef0aef611da 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM!AWB`pq1Q?Hr1XK+LqALy`H%KLD;|3Sj^M delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE diff --git a/Covance_UCO3001/browser_profile_1/Default/DawnWebGPUCache/data_1 b/Covance_UCO3001/browser_profile_1/Default/DawnWebGPUCache/data_1 index 744c8e52bbdf5f656dce3be507a1662b467ecd04..f5988d951acfdb28f2d0511e826234f0de50660f 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM!AWB`pq1Q?Hr1XK+LqALy`H%KLD;|3Sj^M delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE diff --git a/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG b/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG index 8d1478f..d729531 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:10.507 3820 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/MANIFEST-000001 -2026/05/29-14:01:10.508 3820 Recovering log #3 -2026/05/29-14:01:10.508 3820 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/000003.log +2026/06/01-12:26:02.348 6814 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/MANIFEST-000001 +2026/06/01-12:26:02.349 6814 Recovering log #3 +2026/06/01-12:26:02.350 6814 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG.old b/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG.old index 28ec03a..8d1478f 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/Extension State/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:48:53.655 6858 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/MANIFEST-000001 -2026/05/29-13:48:53.656 6858 Recovering log #3 -2026/05/29-13:48:53.656 6858 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/000003.log +2026/05/29-14:01:10.507 3820 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/MANIFEST-000001 +2026/05/29-14:01:10.508 3820 Recovering log #3 +2026/05/29-14:01:10.508 3820 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Extension State/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Favicons b/Covance_UCO3001/browser_profile_1/Default/Favicons index 59aaba4466eed9c1ab4b751a7d6989cf9dfffbe5..201aee29817c7a299aae30b083120433b34e7961 100644 GIT binary patch delta 500 zcmZozz|^pSX@WE(+e8^>Mz)O!OUwoM*;g{K|6%{m{*nDP`&0Inn}sZvb2-)D@?u3k|VNHEK1y~O40%gQ^LwB z)6Fvq6N56cgB*>5%ri~0JuIt|$|omQD>+0KC*@bAc$avT`zEJGg_`=9WLH`^dxb@~ z76haxWu=>EmP95x8l{?*x)?fJx|Ed%Mn$C>yOdRBgjf{h85B%Dm+j#Y8d#j1Rb}Z? zsg;aKKZp628f>XH=V9h&VJnV1;rn3!geX_S|p@9g96;}LF@9`0UI zno{I4`GL7SBR|Ofo9pvh1-Y167csCeVs~L(v{{g23M+H7JpW{Yx*_a2W~Lav$r~$m OC$BBh+q|$no&x}1u&L4j delta 118 zcmV-+0Ez#ApaOuP0+1U41(6&>0R^#Oq&E%@2d@AJ{0H|3@dxV%<+Btxl?Rbf2$SDW z1+%n2O(+cnb^rnb*8l?71{DN$vkquz1Ox}P0iUsfn*o#8YHG88ZiNvD0tZ9@2cic= Yvk?e52LfCUld*X%ldW_vv!RDy2<~4dx&QzG diff --git a/Covance_UCO3001/browser_profile_1/Default/GCM Store/000003.log b/Covance_UCO3001/browser_profile_1/Default/GCM Store/000003.log index df4b531526c5199a4acd7c1a5e2fe426b2945ea0..fb77fffe4799307120abca13cc843e430abdbe3f 100644 GIT binary patch delta 37 tcmZqWyv@0xm4)L))uZ+P42*n}s~J^z%q@(K49!f;EDa3JCa-3c0|4$K3l;zX delta 7 Ocmcc3*~+=0l?4C{6#}dP diff --git a/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG b/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG index 5531104..ff458e5 100644 --- a/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:25.186 7360 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/MANIFEST-000001 -2026/05/29-14:01:25.187 7360 Recovering log #3 -2026/05/29-14:01:25.187 7360 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/000003.log +2026/06/01-12:26:56.330 62c0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/MANIFEST-000001 +2026/06/01-12:26:56.331 62c0 Recovering log #3 +2026/06/01-12:26:56.333 62c0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG.old b/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG.old index 30a1804..5531104 100644 --- a/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/GCM Store/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:04.908 5ea0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/MANIFEST-000001 -2026/05/29-13:49:04.909 5ea0 Recovering log #3 -2026/05/29-13:49:04.909 5ea0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/000003.log +2026/05/29-14:01:25.186 7360 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/MANIFEST-000001 +2026/05/29-14:01:25.187 7360 Recovering log #3 +2026/05/29-14:01:25.187 7360 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/GPUCache/data_1 b/Covance_UCO3001/browser_profile_1/Default/GPUCache/data_1 index ee7ea5312e7c6930c5d39e1fb1f340be573ba62d..329bc6014980647276c07e169f0d18d6b5765f1c 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM!AWB`pq1Q?Hr1XK+LqALy`H%KLD;|3Sj^M delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE diff --git a/Covance_UCO3001/browser_profile_1/Default/History b/Covance_UCO3001/browser_profile_1/Default/History index 61e8e295df2a867c0c6e771866186500d798d305..797a5c05af0ba49160bcdc4be3fec98a3ffb5043 100644 GIT binary patch delta 10902 zcmeHN3v^V~xjtu~Gw(Bd&m;qhyuvF1#WC|ZGjk?k@_s?W8w8?QW+pQbKnMoHLu?2y zElPoodTcFHL@$a8LaM1&#Z=0*P^b^y@=)8_D7C=FLT}aP{(Dbm$fUPR?z(H;F1s#k z`1b#w{eS!a_dfgV{hxiZa;3C#CEnCmBXJxjZys34OM7OzvqYUxoEzJf+o!kFEjxWK zuUB@t9E#heDE$N>-x@odo6&kM>odaZV!z5&a)E5)7ILJWEHFQB?kk;@DvWFN?Rukb znYKeaRdYa-D?TBbg%#)mKb%__vs#LcEwatPt+Klf`q%_lpXS2wg1Sgx{MfrEPHiZu zTQaAl!alD4_L|Vtn#D_|Er=|d;Gb9FnOiw$X{EQMs`mCsc~0Y^;G#%i%7n)7oaO$q zd#a-gBf&}2<~hS-s*0P&E{T?uOeqUZuAVZtczQ56r8pRM)Vt=-T~JyxuBK|LYu41t zrHkwCDH}DvDbl#8KK6h@^!q#3zWdzjqV(8SfiryC(YT<+)Y<<)I}izXlC1n%)>%u)MB%QPq+$;YjTiPmMfxnNm9X z_G#q}<7b8D%<|PQnjS26MZAm4oTdJ?ip8ws$AE7E!fDa=8xl9jJ9|npZ)mwuol_SZGNaMcL(0$W4j7R5f*Jn#di+{cuJ3r zbM=e0DCtHmv+by;eQs~jQR2?j^Fl9v@jdezZ7{QS@Lv*y{(N}e;>Jahdm3|$NVth_ zs&A}c)L3JN+8VJTrW;@H&|T3T(LJMErMpAt(P8Z$v~Ox3(=ODG)(+8psX3~7Ub9v+ zL*vz8@ekrY@iDQX)oOW1KshzB;@b3HX^ETTfEKxq@Yw3~?CRL&Y3a6jjiqLa!g0Kj z+x~A;b4D|Yl~U+UqZIzNm%leEEqfGDGA#SA?9$~^a|8GE0V$`7nOmqiy{Xh3-TbFD zmDcP^=7H5*di?xbl%nT4?i`U*!6<}M=pAQ4t(k8rw`7+y3ahzTwE8He=(rO@s&mR1 z#Y`!5MleeI-D^vGWtUP)Y}0hnvj6k-r`(jH<-U04k2xibB2fyRDU6~He!ke8T}&zY z@tVM8g;F%!OJ~<*7o`JPZx;1}o;T~^pMf`5fp54tE< z5|0{eKuRWd~S?jI@nUe=Dw_<^uQ1xnTCl*rr-&gU%spZuRr| z#_W7*-5j4VyLOGE)`%ZcGG}Ps^}zIrz-+Wpx~c$QH~fpIGPC{Ht&-uVGb?yxsTXd(OiQIIr0@bObUn}zm4A_ zSINKQ*U2UF8TlRAO`augV#iP8t>he8MoyCVU@!PNd5LT%TgWgn2>%erh)On-zN8o4 zfbS;{lC^{o18%|hl4c^{ukm8MfHac3$t-*gU&i$~OoHSNd;$L+&%jej|0!e~K95h~ z3Amb!BBl6!d>EJGLfnS;;OF2$+G=jr2t1!w!?2p7bu`0K6fIQ@D=Cr+hUFB^WeiIx zN+k@7DVmBH7E&}8Fbq%>M>5Q(Xv?FR?q{fI2q?%W3I^Uw!P9#9yFOm1!E0l>mGut% z7kmZ(34e-z2i-W0kKuRlA$$P0zGA)Gqy0+9CZ&+90iz8l|W-U8<1^ zC6|;9Jy>gs&Df%AW_wPJBxrd$>#o8|R-I7j>NPr{&_!!hLZJ&)RYIX_Q)NHfaKt_Fz>4|GQVPOFb|W?NsquR5=^g} z7Mg||&l?{#j)B?K->9#&X?T4Lv8nB5zW=Rq(Bbj;Tv5Bvqtw}DpWAI$T;8xf6s-$7 z94==lSm&xtXN>eX!&m2U$}Wd&chxz=cG(&A+k>7uhdt^GMHM;hkNV`g$~4AEi!+>2 zMRE9Lzr8NvQS7qE5w!>1VcD+uot|*G&g*eHBb8Rhu*MlK1un_{s9jOqLAxCEI)LGD z+WmgF$Keb5eIcJ*X<-aYoB<66!~S5%UgvW~>~ft8`k}ZSc26)82}Rr?PblK5B#c2Q zW55W1RQ5-dsNLzNLCO9g?S^a*NBqG^IOuoyy}?S%2$;DT8dRcg#ScT}c11#V*)J>h zpu?%yol&nR=!-<^qLE-*jl};26Wo;w;?#<~p10Xpk)Fy-Ugl);%02q!0vCLd-bdLK5&x5=}b2y z^)#mIle(4Zx}Li0nIuY@o@hA8M^lJxJ=k4b8&8$JA z4U1ZyE|g3)q^GF*v=mimO;NR$6jeh~R1v4Bf;mM+5;lukL(;K{#`G9Wh6m}k-wxaT z&tbEF3AX#)(6MJ>o8JyoV+(BbD)}{R><7q$(3Lv~+Zl~Ex+faaDeBWG>Z}yC7K$1| zQN$Dlc!hv%Q=&VjNjZn5Vf4*dFg_54E(f6 z$X5O65xy5cieV+ga)zZ0iy0O&3;^23S@Q{`HD+FKX8#QO&dxM{$|W8yA*+&djhb0K ze|O2|rY*O9dYI2d&HN;;hIZ=27Op>o@maJE=g}l8>Jc2 zZKkhGhfR;0=9zpZjq$kgDdS>esnKTm*wAWNX_#ObpuebpO}{~3s~@5Ji|$vtM|HDw zvQDFYPrF^)pe@#7&3VmE&ApmZjY&KXFV*#8-at_!92d3;_Xq(2qf=-nT8t`?mH(I@ zz^~?B0gmi5ToiiWa-n;lQYbJ86{$W> z^gf&L(cCp`GzpM?xQ&|F<*K2xgJhv zx<(na>~sfuI1w%^J1X)ko1g6NB!vP_My7OxA0p@W@X^r>nICmRGr&%FeorS`+*Xkf z>@Dx^gqkKP+}qwfAPIc@3DY8QAm*;RoI-$vk`icI$cT_da&No+l-Jz#XlnJs>5V;u zqjo)bUght+6^?u+#aj;+^ZK^eN4u7E#^pN;>i!1)n!8gI0d_C#ULbZ`Kz2Mdzekwe ztvlTw>ZjWxC2rk+MdW@q`O1Iq2ptKi2jAn}>f;nljF_RN6tM@?#+RkArlAN{6Uae;lM4CqVj=N*7N+dk>v}mdBrjYgs4Z+Q%p1 z+RBr>Q@!UDT(h16NjMGClT>=^H1AO#J`ECJOPb;RMXZFu4Gs- zgv#X%%LY@qlwrvrDi<>>8c5|rh6Pzv4lo=!fXev{^ZHZS-;biwPh*9`*Ow|@hMvA{ zhcNOue{jjfyY@7EpTq`Q>MYI-1ij|TIzY}r)>OcLH{OKU){3fh)l;wn2IyX+hAPq>%1)&0eF0e<$P zMGcL4>a20drf#i8qrb(U8M63vHQ0no*awETnN4WhOTAyQMX-= zczpJttoZF=S#gE^azs(WQPsK+6^v-S-S4g+cjpZgO8y4~x^-XKdU~hk{u=nPR za?R@IeaNXgcA?wUOZ$)oqPDWAheY7yA{4Hxvj-z^s3C{spgrW0BX(EF<97R_4qw!z zERvb$0~BrDck)%U(_Cv>!M*t7!F$^zLfF3VM0+?-)@9J$M@pU%mXuSnsF10^rB

W6#LEj)=&hKL-51CuaB7nNZ$z$uG86oLaIFT@&AJYE=EZ%VK?Oh^vw4S1lz ze%?|uocnzV{8+f3ubXxY9oQ;$f{rfCgMMZfYuk=rp}VwM!g@~A zp&1}f7SZ1;P2-SU? z7f*HWdUWTvwFByz2hniUPx=2_@lXHWPj5wE+cE=7p2L&$eSImZv-;*LRAlVyOO3vKE>O(d;t#9Ji|vRiY&(p~=)Wpxs}egtiq`s1pvO+E&z{HG+{IE%3OM!=><``mt$s zUS`*L|0_MJw;G|FY5Z6&@e*RXVCrKWWmu};p*s!-@3JN={y=C)mrxcz76xK){KZC> zQ&Z%$q|a2hy@000=X}u%$U~)UT~75suFD?Xt&aWymdbcc%H4|0y6jQkU@){QX>d?C zw6dErq#~{?d>BnvJIC-Ds^wwijZ3WUA?4p-Ft{vfFpWO4nY0B@Tw*N@F8v0BK_zj6 zZClVm-Js%b%D|#-RQktY>dI|stm@c`B;CNme_WSU(5;UCrC2;BCb5{Z0^eXTU}VzZ zb(K*DYFyc-5X z9+xlVcDkINl!W?*35kUIMhG;azP3gfh?F3EM2htdSR7J7_cd86y+dZpH-yeLnjBhpdHXDk&@ zqcpLQ{FW>ZnRDST|1LwsLRO^Zuk`H?Osa(s`tN3^D{w;imOnM#F-_059xg?SP*8%9 zq_CkqIAO(xn(9Y`)wL;Q)wOk1fs~At(yHJ?4^~&zZV`!{?(=0SD-?yyJJseQSrwis$XCPJ*;}pAX6#4dvZ4jy!Zk06P%ET`%;j8y5v_Bv z x4=tO7EC4Jogn}VZAVtJZs|_Y;m?WZxZNY7ILBGMRekCC+mu-ufhh?1V4-akpR)5Bi&n*o2>97Fv zFbsu|5C4YW!*!T}OVA6yh8)O%Nq7v#;4BQmyYLnqf&-8S%YZ=$7J&zzg{J{Pg{Oef zn-GLYU@M)aH=qhO(<^iuHo*_+6g>}X;k$H%4oA##8ZLU$)qnO$A0mEwGb}f8MQybI zX1mORQ682%IJm0!mmlcH|L@TwmnaD4cq>9iq^2E09b0a@UA0>?^mPIpfoe#l6ZAQH z55>mYMvalCPwIR1brEx=ZmrYN5wg^PZUN@tpKukvfGOVB88`_?;XU424|Mm(raTQ+ zcQPukOwgcM;MQwU41;_YUC;(Q;9#rLh7|Zn}eTTcneMS3^`+m)*J*OR24{Ah>QEQc_l+To< zN}0S{z9xMomrD;xr(B~_zN^&LE%v!QVv5*I+Q|((Pb%5%j>PTsePoZ*l*n0V=efeq&!ZgnroAiu6lII*U5+jOQ||q% zC>e1`y-lQX?xSsS$f!+Tw26DALjvPG&+2iM%jU;DaJd3ecuY~y3JcBc*=}Plq13xL1f7jT=VP%TE)JaL_StI zi2|%@3gxqmDL(j*r;tyDKMJZHFR(vMqD;1L3gz0T-7fxoF%n4_S%WJlaI~$vL%G#{4L4rq(HnbF*bb zyjSqxp1m?zK|CZiV(!4K2a`rOuJ_0SGFKO<2K($d-o#Q|B!L|uq*2AI;w3>XC{XR2 z+bc>h3w0s0h7F0N5n-0^iY}4pVtq#<4d>lbuA? zxKYydJVQP17PzEtuol$dcSxk;4$P_=@Lg=_6i%=z z8}PwIN&QgJ(TpW`;5ZcOIKzIhj2PBz2%nPqG|_0pJd3OsI`K9!TkRBL5D_4YK47%z z?U}OPO30N!-(iq$aj}&kE?Hl%rmTY1RGX;H-1*(>BzE(xr9VZ zu)bIDaprvq>+H%LI>xSln;0xLgwL?k`|z>fy@ACTT~v1pv`YWby!rBMo$1MVJB)LJn6p7Ei|+D_uct`j?ctq(-|nDu-8emAdD z9zx|1=D?vsT)BWMjM^dY zygPFH+L7xAZ_fB5+UTa!uGtR9F>A3qi9LUY$oc9hi+CjVzRgRMFGT9t=>Uvlxo$cb zzz7Z+xER4jv%T}(&7=c>IpCEtCzI620SM6Q0JMHeJnUAO3PAV%j-08*STBAr~ zkuR15)k@JPHn5Ld3NcDt&U*Ng$M6~Lwi#WJD^(n7ldeVIj9+2y~c!;e8SXKzr>g@DzZLSjdWK1>QX@B zTd^4D&LtPLj9i>Z^HLGEt4R$khKb@lcOD~MRSZaryr3y6z>w20iviDyjH<8##)83d z8jm$aAa@YhT4Mqn4+}N5QO#641tqoQ6IYFFAuu12s=h{DP^9I6URY^&WNKr>Nkv0d zE!#ofir*+>Wi64XwTnKf5o{W6chsv!{L!2wD@s&S43J^WT+tI)3HahnD!$mN>lH8M z>QcH=!=4JZW}TR>v1guS+S?Y^N4B2&hW{d!t7@^M`)j`DMGYsTe1OZfp=UXkm@loS z)ND%3)MQ0suu%8X9^`E_L&@X>X1$G0Is!{3C=DXj5QG{;KnF<204ppMAk;M|0)^9g z5sEB^Jixk?o z=Ef~2kcA?Hh>~hflgDrWynk!(<8Sgk#-dvPQdYXWIG}#NdjDWZou*?KI(GXdGJfS@ zUkh=FXW0Su{*CL`?)J4lo!h%-T(Y!whFUbBc?N(!_2LJgJ-Ruhj%{zBs@v>u46Tlk Z3$H^qHr6M%Il9f$^+jEZU7slh@Bxl->UF-ppKtWaB_XUD%(l0^2w{}<;?{Z7&I%u;D@~dqXnas zDwj}3Nl8JmmA-yyUO{#`$P9e}kg|?;5cqCyz+l0!Dd9iRuuT(I@dAxpJy(_O`+~1s e^EYn3Hupaxqu%6e^W_;0Hh-JX3AA_71_b~yNJdNm diff --git a/Covance_UCO3001/browser_profile_1/Default/Network/Cookies b/Covance_UCO3001/browser_profile_1/Default/Network/Cookies index 9d7eec697630dd40d8ba2078278980fdea0b8819..a7f9486b29286e95e5043de49a91b42b4aa900e6 100644 GIT binary patch delta 2752 zcmYk8c{CIZ7skyLFUAZayBKRC`@YPSF}5i~w(NV>EZLWg87kRp2-%|uVbE*OAp1`C zWhgr_6_NGR`@MbVJLmp!|9kGa_jm5|MC1Y@asf%40QP5G2mm|5_KgHY7f62>0syr` ziZ1HXcoVSl7cnvXa26^FFcTQBNl#5fLq$zZLk$2@(a=yx5I+9Q5g+mJa(49;_pq~f z@Ot1a?%;Lb)iEeQN>aUou$nCLBJI)DOv&Zqg5t{%f9#1pGZ!1l!zyK<)YN-1{b3lN zr{fEI_QB8#a~UM^!GkvvvZlM5L^2sEE<6g`1~|^RVcOi&YrGI7p@vPl#|c9|Oj+g` zSus1>@bp*JoWxEocG)SXgSN-UH{4XmUnFno=NrUvP(OV85=Plo5rr~U^}OS9@#J7M zR=T_65oPyq`ZWyQBEMhIb^rVerS2i*@}L`$MG#DZ`xP76VU7sys!W2yQ7|Z@vrW24 zdGlBx6Z2?@MS$swe@SBfy4@C+y%MFNhSPNj57ai~FHtk_r!nN0(_CEZ$f0rSoZjq; zw~X2*2L+$97&jN&9&~#LJX8FG7M`P<-79;0WLun$7(>hfkGxR)s|c{4XLaSTCq znbNH7u54UMdEMnT*Y-0_*lPms4$wWwm&)vXZq(~Z`)&q!+XDeiHVW*&yhrjI2k#Y@>T({kE`qqaLRR|_IF z9Ij*bbY5y&#aqWS6=E6Q=Y5O`@1Qp8bObI@&m|bm>$eH%+nl`l))>j|e9C2?PbyTl z2$%?#tt}Q&_hmbjt)jBlvt{&sVzWA?PDUvANN}gjvKF5xl zlX*L$W0_E=0F(?ome^z5?VrE5S07USWR zesrtc;~c`_r%)9d9_?;fQ6`EH9Ix7x6*m%%+SOxK^NfQ9vZk7HX}&(=6Y)=|n;3KJ zrv0fXX=T1tduAn|JI?ap&_i`2%;ZYIs{SW+ ziroQVl%aKv+wnwE>3#^y=dSPxleUw$Vt-fPAFgSTW^$Hk`+lab-5ww-lddD zd$GT2;Ta(AZ%`A|Q`y1nIof*&yJ4Mrss=lrH5E1?yY>A^%IEqFP53L!sn|Tm&?o8g zlbr4#*v3|N9c6lp!&?8ESLfu>_72}2mI~ywUg}wq{N{zDL%|c15SgO>9mI-yvZYnC z^`)N`DU@$d-uh0{KI#QKMtey7`GG({!@uon)SVl6UnNV7cJG>&0t!fM%b~x2^gegV zncL0IO5BjQvx$`K_4OU`_1k^r7l1-(5yZjh{IA8c1ui+O$>8iIyUD(peZyP|hQV9G zX+6OoST@8u<<&Kl<39G;D=+uj1YUda5e8}xC7dP=DSQ%y(0gV^(Cw(!+^ipK$BO$%+|}?nObYj5&Ap?o*&iLaN1ek0rT7+yD{-0tAZY6(`;Xm!kyx!0cZrwF7Jy z8f{pUnoQfO?vih7I8Gml_cB>N0Oat3%75CF)lQ_En#hPMT?GQ4Dw=W5y80uyPrBd0 zIU6KY@#fIuIESUFRExgd&d_kYS1J#oxozE7t?wSxN3gv=esZ*+S({xeW2J&mX}3F* z=?L@d zf3Ggp@;?BidZUyi&kd6kEDC<2OMmW@=km~)F1TNaFOtIj+4kdSc# zIw5`-aLXrfb?C@Yhi@-X2u#2}eIV*{0PmJczs?iVVkNP<30y~31X1AuZC(Z;>Qicw zN2JIMQ;rptXLr6we3O5YMOJ4T86rQZ6g<}HrzWxkrQO_bnWV}2Hbjj5bXT6nePrtj zsNLZ-)FRR-1h4X<5KG(6D!@2YLh^LKL_T-5y!5oRSe;=5-R^FExr>DLwTArRIi_N^SK~?$n(8I&vg) ze*p@lVgsS6Z^^}hd0-eY<^3H(vBL^z?tOo6Nu#jjN~Nur?=+y2M(CYaIOD$kU0P*E zfEpQ7_?IZwxS}OWj?Ve0(Y_%_$Re?0lDz3awZ6~e5xhA`noTPFkuhT_7wuOmT;dzy zw>|#0xhx%)s$&4{P8ibX_?x>lp;3C5F@*%_xF4LC7FZ5)>DJpXi^l1DBhd6^=yOP_ zd7YapJby#7E4N_xFC^y(_+Wv268MWSSxg)npo5%M#re()AgbDj5#^>pDq~zq-^ZT0 zfCYtdDb0Gc*vn^|Cf${eaD~qn!bz_QJzTriV&lxcrmG>Z2C(Br#dPx~iw5oTjVsxV z@PEkkb2%ga5k32(YA+23Qcz&8!+ys(C>X2zJI>*2U|`Dg7$?SxZ$@+ehEm_0Pi85c zkGEwY$KfN+CvTiF&H1dnbRb|FzXT3Prf$T`< z%XzvDtK8AihWs~GNk-ZmC&J=`BvjQRTMEp0kz77z=ko8r6l47})VZ)URuJ%eB1SM) u74HC#r~GGCReNw0J>UlZCR!XIiT6fB0TTG|2P;SI_A=zu!6ckNe-f=ib+Ozu(aX;OGKyx)2zVA*>HZP+UtFsvS-8aAw>F#^S%Omuzl47ECDQRX-82YqM!X!P2ZK z<&}n-9|S5Z&p=G1)FZoRF$((E?{$=0oR3eUZuEgH5X=W*KvJnEZ=NoD-gtWS$g5QG zjxY6{k}1_DG|ld+i##h&nSRg-yP4cZUTy2X{o0jrsWmwsXAD_?kzLRWWdyTJkWZwL z0>>%pyw6GU*la#lhtOSc>DG%eiRMDofh}=tU9;}%p#|Fug5B3Po3e5hNw4M&&3?R! z&BxV4d+Y;Spw4rFHFJR>Xg@_{3pat^l-s%WtkB}tGfuPsGiJ0Y_2vO&D7!30puH=CI96rvc0vf>HhI*+=DdU9l?OY)x#qS?_ z_9E=FPZuE7qxXE%#QN@t>6^PcZoOO4)DFzVT(g#+Sxk^}<=l%Xy0XfOjCc5)NDC*S zzNZe*Ac|w=N(Sta8SN_1s1T1&s@l0UQynL7Lm#8wKCIJ>%n%6K-&l8I7S z!>7ta|7i2K_CG12MQOurxB$P2Xf@eDp!30`hYdTEmhybS%OwAyEcLpYjXi=V3ItL!~{3X&~(796&2`4_Thu>v;cjS zwBB>^9C7KsY3Syap9XLv)2bWOM1$h%x%OvyWnRm>dd=rcO`H&6JXxbO7YAqEu*~6n zc=omw>&bzM?y=eiE>M@P*tm;)TOFU%b-p=;VG00Aa28}fTYn8YA?@{PZKnHf76+g` zwl2Wf`itX*zg^XCXLtMopC)F`zDdoeCY2yUMo)e05lE)SGgx=!xL!A;5GFe;?0=L= zKRTb5`5xkXz&mPg87unF@C*rEZ}=nOYbvcf8@6wE99s9|N~|5V?42bkyIFu!A?;xZ zr>Il*z4>Y(s?{=i=@|aJ3ARdQR0oLDRsE)FV_86j=`s4AcM>Lr-nf&?NOaP(fy28T z($sQey|<~wwyc5@Qrg+W_BQVfL@zzPAkZbX^PF zNwP)>qv+NmjW;gosdx~R&6-vQz8+3qjB04`Z;PSY4#!7|oQc8P5BugR=>cD=L~-k3 z_mou?+%%kE7s{5F!2=T9H6|D4f|ln|30C>&X#TC97KtJR*(^k3=@Ij3=a~-}_+T6A zN(=UWb>%q;aL%TkAOXJnbA-PkA;`Bu=vA+vsjS(DJFZPBb=PeC`enCsp|r-{xDa+X z(Dw7K?1nI(EJJ?t!jPSYLg0nOXvtqSyrO`hpz39EG=-nhK+~cen-AQVPtn^wz+F;F zw8Bo-y~6qumJ33yMmu;)Y|cK z@X3uywz+wcaZp~FDa<%8x_=q>+16Ls)mJ^haG>b>iy=PK4f$*BDkF)5f}Oyn`mIMU zK`p5m>?RlTr}k)<2%iGt;d9h~A_xID|7lg@EamZmnvTFqNYuin&TMYUxq&N1l>%=F z>sr(BUpSzKzkz6cBCOnzPSwAhS#M~IY~rCfh&_hd7^jpqs`&INoY?X37WGEt-brBf zKZ(>YxfGQRezke)Vf%&_J&1YvexVj^e0>eU^>)Aa$IjMz!BWwS}w6FnGg zHVajp-RuHL$H7R8B@|%2x?O|y%M4Xq0Xf%*!7%yK-=BvqDp{a249Gt3xtjEf0yG?FVm{g0@6uC?cf%mDu$HRJwjkdYPWXhx9Z@{&IwqxAxVH z1<9Akn)bgh?JwOJq8#og1Q|WusZNbia36qx{T@%%+c?9GgKkCpASaI%U)Br8hI%? zU(fhI0J7pVS&kf22rdVIV9Ir5lt=adEVEH>(E@LV69tYuGGuMBtGIcWWu_%ckrZJQ zJ>ITz%P-jKfoDejYq>T3H|dJXLriy(x~Xx{+a{K}AH4D;S^W7q?i-EZ+!}aKG_ifH zM01C>@-nk+S>023=OIJtw<>2uXa;bd31QEF=07vO>~bB@t~BYx-XuDU4{D>U-wsL= zC4@M2lYwIG+-%z$VrKV7kZZJdi$!`yfCa50+CoR}ey!K9(KYMNl0ZGfc(8s47rmJN zV$8It?BitQ+Z4pi#(f7&_rW~NH|`I|R8S&(XQc=B_Rhbyj2C@0ZGJfOzKu(Y-=1&g zpha;sfGKhfcj!}o9FaN|S>BE@$*K_IN@@3&-bN!^&vab@pJd4qoP`xK6>qCY+8N1zNmIz(4lHs^0Eg>IOb_oaJMJG} z&BeSFCvn*MnoY&)kEsiINui%`ygcvGNRXpy5Hf}?M7QcLj^_(ReA&=#9^KcoS=zIk zaRyX7SkP6rCmrdt2Vut7YF7Rhd6@>VB&|*}d?_3&IrsGfrCc{A5i4{aOfxat1~uA4 z!PZR|q9Q7pP8wpAdXS|Itf%Wkf+mkQIXX>Bnyebu0_qXU|Tm zctozKJe@RH!pvXNoL`L=vQAbuSy%(LF1^>Oq@7kB)-mlC6;`6gtL=a=)u4iLwo$3H zf63HGT15X#=K8@^#(z^qUVVgsKrsrkzw?|JJjV2Qp2Iilz*&xRoO>ny6;9|klPJ?KEC8tBjrHW)!xcILT$by|B> zV93$D2&=zUVm<%j?OWp5`}ExhJE3ifArG5^1r2y2G_+%f`4zs x1CPe{1}ulK$DIYs;=ka;{s$8{Rzs&<%vca|WoxAN#>?09*e{R*9D`S(AAKfZN{7@AKTC(*lNl@(Qe7x>V=nL!#A z*jT~_qDWv3DJ)}I)NnOsA3W|MsM)V5SznYqBAHmHcPz4b)4e@2C)bY zE+ZujV;oboBxdN#a~#Dw9>8I(#3uT2iRKdMvXJEZ3T>98a`bHwmV(F4HIk^u=U8Nj z=?o@+2$Sh=;U0;Opp4s0pQDsKA|&87NX1!HBFusbN*Qj5tTJ1gndWd-LT8}LLItWZ znZzagvY+nCWNd;>zBVmNuS1J+l$`7R(diF25KaRVq2D4ghXf<^M~IM|hqz19EK~`ywaMLm%DE=^LdEj)&(=f&Es7#KP!T~ zVY<7$*!CP^q;Prxz4iO zMejU+sj(K*p=1A2TRmNy0o90YEzewpNVS-X`rK@fagg1Yfr+aGj~@yA_0`Eo1Wz0S c{;%_|&wc+$^yDGv{bPFh;^`lPr;Y^v2ZDDFZ~y=R delta 7 Ocmewt_1R@Zu@V3g`~%eh diff --git a/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG b/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG index bce9595..419b23b 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:10.973 6128 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/MANIFEST-000001 -2026/05/29-14:01:10.974 6128 Recovering log #3 -2026/05/29-14:01:10.977 6128 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/000003.log +2026/06/01-12:26:03.058 3dc8 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/MANIFEST-000001 +2026/06/01-12:26:03.060 3dc8 Recovering log #3 +2026/06/01-12:26:03.084 3dc8 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG.old b/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG.old index ce84728..bce9595 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/Session Storage/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:48:54.364 169c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/MANIFEST-000001 -2026/05/29-13:48:54.365 169c Recovering log #3 -2026/05/29-13:48:54.368 169c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/000003.log +2026/05/29-14:01:10.973 6128 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/MANIFEST-000001 +2026/05/29-14:01:10.974 6128 Recovering log #3 +2026/05/29-14:01:10.977 6128 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Session Storage/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Sessions/Tabs_13424528936015748 b/Covance_UCO3001/browser_profile_1/Default/Sessions/Tabs_13424528936015748 deleted file mode 100644 index d66ca74fe6e4eb1933ca40bbeb48d857e02ba9b3..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 40086 zcmeHQeQX@Zbzj;}A}6*ZH;%2gZgO%f!azdtzCRSR(vcFyZ=FP)M5S=)yWKmI=JD=y zcce(gMV%G}m;xz?!Y$kYZQUY3RG@#@E*cn3;wo*BDnJVe2nzU*0Chi*szp+`Nztf4 zQTO+onWtMVZz)PA$&$Q7?!B4W`QCYN-n^N4Gd(pueZOT{&sq=80KA=iBHRObAD*9k z^X%_^;kAD2!?5%D(F2y{e8938ycf^svV-YlW-uG?8$Ohc_Qi*W6MdQRaHKC58Hz-c zsdOxp82l9kgn86@;2)8+cIe;l+}HChWFy`mfp4K$TW;+uRtnWc6=nkONAT>1>j2;` z9n;$Bfjf+Q1Mq`*){R@hIk6b{s>{vr^8VKvpBnk`u@73mZr~*e$0l)^%f_Db_`8BA ztCVwxdGQHARZpvE)vRT!W$lBlVil~a#Tt9VOFV&TgkhFpJT!D~$4I&o*6R+*3m+)? zOFVJs5dIhNI93Et9OdCtu=?OCT4k#QTU^01Y(>0FTT$4;c#}{M-=<*8;5WLd{*rzY zX(kYtu!t13I*j=sLZ zUN1)Ci2u9Bh@0WiyZ;HjTY}Q-f9~t~FJwV)Iy?357w~=+4|{hV@K*Qkv48lq>fPf8 z?lQesAv_Cd%+tpIMFYj(3%$MJ*7ojq_DgSPuW%bFhxqxqrPuO3NSQSc{96L{dBcY! zAs^^Yhe5=hgPqtARlUwZk4vDxvbSbnbMO!wBIuPx*b4B?sJAhMjG@oQ(L=*{XlEEH z*XH#3p8Y?H)WS%sh`+K)-$ts$0b&%>>cc~vw1FptVZ32zdt2D>hp+!xM{E#(!3J@& zJwAVb&kGnM*!9_i*sbSVt$K4`fB$N;zSpj;6smR!aH;=ecsB~-w}K)!@i`W(ITW!4 z;@Gf4R!+edd@2aX!Q#9@mp8gVm-9%A=As7H4p%ql(55IXz=T1QNdpg{Ms*Lw@vOBA`L48|R9rfR5_2X|9wz{TaL6FiIB4Aj(8C5gL=h&9 zP_}RSCB)(&l0qIFhWe1A4I2?K4tw07VhZ7yzKt}CurYOp3M0QT+-O^=s$#QLAMn8s zRLlC^-WPsb2BZsct3C?26n{sdrl6p>8K>ugp8qu{2u!g)g~z8k`zy7%h3fuBskPjw z<{OoPJ<(z7F@&E`m1HMupgUfTj3KAZKLl4*Mq)y-Y9yb=w4LFM1)V7v9$~zj%!56 zB)$Oo(6kzFX|wT`Ph6pI3I0)q%-(j-;Tw^hB=F}b!eApT`PYPsPt+#57x9ps5T)r? zLTHZ15fF(aY(#c)z;1IRxXAdwTHTri2J#(9U56%8g$OI zs-uVPV*bRUC+h4{30XP=)6qn-w^{>>Fkpuhi{)^6)j8d$hr@;Zac5I%e2mlL*9|;iCOR`7xN6)N4b-u(FjV5)L;};uO!ZF>$!(L=y=szN z1On>esLc)4faaV?&jaQ9fpjGx9epbB>j(c7!LNj1+y(0_!t6&%71&E?&6YI_n*$OZ zM(PE`NFZDoTv!B?a*pCl)=`k|DeE+RS|BOCsvOK~7PfiBso;-k&Ea>zdLD77ta0Q% zfp541Qeopu9tT;l@g*xr>j;L_CBWm>3E1P-DSYKa)`+zR-$9h+4DzYsTOUS@B8HF? zD9P5j&LSoUoq5!Ob(u!F6Uea_>D2I$haA9f7`}^WBNC@ogglM9*5L}H7I~D%L3x+0 zA&^GKIDvXJ5u$|Jl)#UZV~QZv3`%wsrJh9T8%V#1RI^BtQ>sDO9cuGnopGA6WaO;}0 zT}mhc=NX)1&^KcpL>(No{U}O0g_bFze)A}M3GQjsuz+%x5ynQDE2!;Jycv#KXGk#fzHQNyb0jjR*J zBugj(bJp&*f{n`Z)_Q#hH%FHttET$c5Uf!-O&? zc;Cx+>XdS)@QhDE2K(|Ve!b~Qeqlz2;df^KZa4k4x${`V-6+^kSo68WTDuf8y4`Z!U~d}z|44H-MD2Iu0w5u6+}SQ zHXvu6gkoGP>BI(lQPgiJ-1e;cE)a^j`iw7$A_0sjVwA)$1zKNJQ|yP<09o zr_cS;bi_w~=i@JR5~{uQneQkR7NMHB8ST*z^gM(a5mA^EqZ%H+B6@{trpTCNszL** zVgtI%2B$8%3fHOd*CUwwGRVy;99m6x}C--oYi^XnuHZ7#60V6Hu5ASbHl668gf z(P7t&n<5>eLfE*;aWPCEV$i1Nn@#hU`~>G&33TyxdX(gI{?t&2;Fm)C`^a|@=xvW} zld^kIK)4;!M-GfjUoq9{T3*jZHWDPt`onmmNfYO*T(af@Gru!Mc;x;_s*+dmMZQB0 z{gB)x1&>UJq)ewkLQB4q>FY%|rq6yr?vD%I5!fgNAm2w)$dv@QAxgX#bcJO&dGzru zNurQKfsB)Xq$l@?CW#~+w~KK-I}*=N7OR=b=-Ao0>13mps@cxWV06yutDJoP%t)g) zQZAfbJdz)tyta^WV(8@IL~VNJyf%3zo(QLMr{c-cwb5${8C`u9blqRbI9)q)GJpEuRN0Q69*>TkOs&So zqlJ;76C=mxv-a^rwN&$H{8&0Sbuf}&N#(MKA^CKUWS!RY>BMqmeEKE}8DGNeaRU#B zk9EKs9X_@zWc-F1KHfBNCp#3((*}kf)b0ZYzHFfO-3Digu}bw%&+yS69_}t7<5>vR z;t*0zf{au_NG3t7#vt6Bg9s{#L8bwB+6ArnO2e0D9UjR@AH5~lw%E{h9LeL zL+)`rpT(2K+YCb4cxs5X2!T;i2_nZ8VV%NoyN0q-07nio1;OMg*poKI>wZXg3=)f5=S72oku&^fQJw}1s3Bd zYIqF8O%5p>!~l|qkc>6YqNTMs*1=cI;@h?Gg(f}S3NErrn|42m-Zco1|Y3tui~ zP=pxGby(FyH9g-J5Q1ai6_uUAQDW=s^ zi4xj3h5AvhK_5MhpoE1&WbT3GBqM=$F@&Umms1SJP9ltyU&@t3xj2oWw1u0K^gdXo zswWJ38o|8{l&WxtA4BO4Oq|rD;p3nbTzccgrQ3S46f7yXDsi_U_YEeHy52s;DGdE6 z>ES*KzNG|5*OObE$_N`nOuu@v^%#cj!i7n;9&<}88zn}p9n)u>b&FC`#664|_)|>J zJ&bO{=~6J~=pZb=L*^X(R(~AZ({Wn)cl$r7`~|wFmF6(QC9{LnEhyre7N0H;Bm5hZ zX6eM3!wBNtX}flC7(q9d5U}@}u=^33_rqZX5l?#|zYq>1{5yKLnKr9$W)36Jo9<4% zJ2;G>T56kY%bmAY?uQM*VFYy;fnA?mD5Y5LMVsI-g6{St=BjNx(y^^KUIm8{{Ln5q zjGzxEuy>im2t+}0a%ywE&v^&$x+w(a!C?fnnO8_~EwpS4wL7nQYGG!u*2wNjBRp+z z7@>VOuM;k^t-3gjKoUS1+wGdO2Zs@Y!wA7)gy1kja2O#tj1U|~;Nab6btpvTj5s)q zz*g}$!WwqFz7iZp2o8?k?1Q81wOt%WAUhr$MrfnHSD14xp;+gQLhnzZm}|w+cL_K+ zjBwKrBM^my!w4FMgTn~HVFV%OUQ$jshdK&U-MgbCd`K)lP`JQO0>bT(zThx|oX)!T zAt!! z-64750~wyeRcVI}*n`6e?e+)`BWQiNn>6v6{v`cP`cDr2JS-3#M&Pl5;4nfk=eYhk z2T|)r4kPqf@0#-nKfuhARGqunzWtR?T)2ssBm59avw+Syovb;JAl{vJY~Swl2#f#n z_e(qwS26Gs%S*#1ahc1;E(hscudcFsY22+Wrx~;Vmc&1Rq zu__)zBdz2SEgrEdVCs?3?kyi15p1wPxm9O0v%fA*`QHiyk2hYZAD&LfDM zVQ?PdKa5DG^e4J^FF)8*$MJo7v$eWc_LJ~c_S1{>r?2RQq=px-Dr>D@mB%dG`dLCa zc&#NV{6nH0|-AH!_AU93Z$k!3bdeLm)>BRXRFjym4vhKnn3bI3{X+QIm zf36bio-uI4_@DE@^Txdk`e5D0m8|mimhW}=s`mHU`0cmGb+y)qCP6CHmwf4vM7wGeiscYx0hqSlXf7@De?$c_t-$wF3i{~w!jWuE# zaNfWd4csvBoPp;J++hx@?J`hpc}7~i#)f9zz*Pe`3>0lhZy5Il1K&3AvVl9;Ibf)A zoks1a1ROE$83X4He9=H^fTHoX&piCXcy71OPT~!}*%Z_pgp`7WDtby|Q~6{DDF;8j z<@fvU3`c=K``=c&G5xl`96($il^=pi3esQxB~emRi-RcVUcgCpbXx2G4MEicb(K=9 zZ53)LZdW;_9jBrAA_PpP_ShD%>2~Gs*ZzL~-F_Fpbp8DAw)~z#pL-b3Ve~Ox5mm=m zEuue#6sE9$X_E%%!4r15jTPX|JD+x=3un~HN)Cy-R;ibZT2y%?TwkUmy0ti#P;)ci z^02s8z^@P9Q}s+_6F%h7O61OXG+!TSr^YYp2IGl2`jUI%-5}(s3h<*&Fxq%Ho+>EG zLs3h%*3*n{Aze_-4{jw-!|y!u<=_0eaAFtWHssxU?Mq+!8vTV66F1}h=lwlDKsd5p zRGviA;XVuJTF1Pui+Om@)jN20BfU$2OqYhJMMFV%Re;cE! zXWZk46`C-xZv59h@D<~}Y@np&ac(LfQA@QA2O5+=(32x- z)8IsjlN_R}zL$d&AWal_x0TjQ;;(UoDd<~3c;6ONprU4~YbMH*Xpju><`8{{2z5+R z&xIyJRPd~GMn94+eREJgmhqj&uf6A46{t$VM8PtTwXKZD0De9Bl? z3!lay=;3ub6lX7EPb;qmqOg|6JM8)m#|+nvkc_h=rX2{M&&btupYJpioqlvkv11~95;xzivO8zZZy)FqRRz1*uDFNoI;5B`-e))h(o3b{+&7>N zhhG{Qo&|dS=?>Vgb~_21Epi2Kd-=7apMSUQ>zA&df4BJsY?nftD{Pm(RgnUDN~*Mo zpSz$mTSO_BW{b4)Y3`Wfm||o6DFBjXqY7((DHzWoQ(i{t7FQ5?DH>TVy{5>e0Ls>= z2%B;+GG)w>>wesMN{Ja+zG63Q*LCwWY@xr}_ut>_#CCnR@ge0eY?rth$HjJ$v+tVi ziurSfce}Lfi-z6$t$UX3qR#eUt5qQFy3@B>k?dYA?V1GnZD2LN0RIV)V{R0rlFJqN zY?oc=c9;&NT^vx_Y@4^;yKP@T_R7z{+x!ByOMlNC0Hs}&bWys++dOz_A|+2;aHL#{ zi+^N#DDC2MAr}mJIkvv&un3Ig1}y%TH{qkC&zO1%kvE8tnPUn}gXxpKZ{ z86z)N+JdKH3!SmP_pMHB*I(TK!@qX#yAU_y3_RGAHapyLKVtW6 zS2T6o78$>X9prD}*^P2v1SHv`A-d5B6tvucU#IO{2YOWSD;Fxs_AL5xJJ&8og87PJ zx6TnMndk@B~+2MXY(k@=2bnmcTYOfO-e)xh%xzGdJ$2Fg~(on}kp(*_oVW78v&ZCTBJi!ikey#TK%^mem z;Au;{xUJ32c4fh0@$^Or^s509tR-FE_7ytd^`|?Ka<$t#kaFFO#YJ=~A0z!wUVGgk zdEo=4AK&Osb+RzLZk2nbD2t*5i6=+&-YqWGQNBb!E*z5O;YDX$Cggq4lt6LUS7Oun znnQWXo^g?pEEq3Y)2I7*^(j-)3y+j(aeu6T7FhGnU$MUvaK eNN5Y*giXEcN6-FEC-&);Q@`}{j^q2jUSJbq;$V;hVkIC30PNNY#Q*>R delta 7 Ocmcb>(!sKUg9!i%sRA1S diff --git a/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG b/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG index 8af4e41..cf2ef4c 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:09.825 7290 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/MANIFEST-000001 -2026/05/29-14:01:09.826 7290 Recovering log #3 -2026/05/29-14:01:09.826 7290 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/000003.log +2026/06/01-12:26:01.924 56d4 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/MANIFEST-000001 +2026/06/01-12:26:01.927 56d4 Recovering log #3 +2026/06/01-12:26:01.928 56d4 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG.old b/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG.old index f734285..8af4e41 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/Site Characteristics Database/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:48:53.241 2ae4 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/MANIFEST-000001 -2026/05/29-13:48:53.242 2ae4 Recovering log #3 -2026/05/29-13:48:53.243 2ae4 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/000003.log +2026/05/29-14:01:09.825 7290 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/MANIFEST-000001 +2026/05/29-14:01:09.826 7290 Recovering log #3 +2026/05/29-14:01:09.826 7290 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Site Characteristics Database/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG b/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG index 37da880..20da03d 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:09.819 3820 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/MANIFEST-000001 -2026/05/29-14:01:09.822 3820 Recovering log #3 -2026/05/29-14:01:09.822 3820 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/000003.log +2026/06/01-12:26:01.892 2d64 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/MANIFEST-000001 +2026/06/01-12:26:01.896 2d64 Recovering log #3 +2026/06/01-12:26:01.896 2d64 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG.old b/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG.old index 49e8195..37da880 100644 --- a/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/Sync Data/LevelDB/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:48:53.185 2ae4 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/MANIFEST-000001 -2026/05/29-13:48:53.188 2ae4 Recovering log #3 -2026/05/29-13:48:53.189 2ae4 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/000003.log +2026/05/29-14:01:09.819 3820 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/MANIFEST-000001 +2026/05/29-14:01:09.822 3820 Recovering log #3 +2026/05/29-14:01:09.822 3820 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\Sync Data\LevelDB/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/Top Sites b/Covance_UCO3001/browser_profile_1/Default/Top Sites index cb08bef858c500500dedd296d95c2f557fa338e6..262eed8e626ecbe9e9fdf73a43714423b19e4fea 100644 GIT binary patch delta 73 zcmZozz}T>Wae_1>%S0JxMwX2UOZ0h|`93i6ec+$Luff-_Sy12s-{cQ=dW=kyWae_1>^F$eEM&^wPOZ0hI_!=1bKJd@r*Whc|EGSUG$DYT++Gx&bJUP+d zmdV(1@&bP`5hl;Pvee>|%=E;P{33;b{GyV?oXH>T^ca~Z%iBNYVc}<{9 diff --git a/Covance_UCO3001/browser_profile_1/Default/Web Data b/Covance_UCO3001/browser_profile_1/Default/Web Data index cf0a75ce677c0918c563d6cc9f3b5ffdce5d9721..5c30284ffbc76e4e2ada88284eb4d579b8fa5709 100644 GIT binary patch delta 123 zcmV->0EGX5zzKlB36L8B29X>?0S19!wO|3Jp9H)B2fVWp7_tWmLIDRMH8lhT0hh+7 z0XGC4UPl79r~$*LJ$iON%lslugF~+1)>^W}E8)vrWwXcy?&)3;;U76$_RJ>S67;>I dr0Rf|*RpZz#)qkP;%vjx{@kSw>Helr0uVsjH%|Zn delta 126 zcmV-^0D=F2zzKlB36L8B1(6&>0R@3zwO|3Jp9H-C2fecq7_$cmK>-ILH8lhTm*KAg zAD82&0T}}seKEGE0mG*~FpFf{m$@FUXn^75Ypa{y7ZYpYogKgx%dJ(10Zcpmq_to! g5og%hE2D&Y8$0eV)QJAfznn0FDHr(rBKNBJI<$Q Y?G@d4YW_YfZX3}Ct*&odTufKH_PuEyE&u=k literal 66 zcmV-I0KNZqF)$gN-b>+|SH48QH2kXgLs>hP!~!6Of(%ts_GkXdMX_@w-5ZvinC@O_ YgXzOtX$bhw3BYEp(oDM%fJx{G6-J^UsQ>@~ diff --git a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/000003.log b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/000003.log index 7c7572d3f8964cd0d0cca3d2e59a6e3a75a2d2a4..4caae429f9acb31b9bc031518539f7a69f567fde 100644 GIT binary patch delta 7494 zcmchbdvF!i9mjX?GLVyG`JTsZ{D$js~XEf1hor-`31+BfI9WBU=?eCnsciJTPkIkK{$uN7) z@0^@H{Lb(5{r%2fnRySw8)ihhmy-;Y02>$7)S*1{jI8MlV{=FRLQ zt7-amSLgcGA3?vMnc>SGs~tqsn}}uds4SYP-kMd>M$wzW5@%HEZp|!;u39s$ue*T% zF|)@BO#5w+-U9vl+$GNinLgPKhoS*`tGi@*|N0F}3j>UKrKnJ+>21VPrHrSUPXh0K z@l1fOCYFaQ9tto|inSNcQ*;ej&M|UDeccI)-VU8YckU}S%+kDhl@C+&4tM5?e(vm* z5$1!@;pt#_gBZT9j4*dzET0I5H;G}`wg{tq)_)EdYKdXW?g;Z)@x5{|>?DTr0}pNufob?aw>VK*^+dLhD$IXZtgIA@RNoY8bvOWl^^O$Xg?izQ~^z(s3* z9i;c-|3i?!oK^qY(%e8n;i*6_Ma3Rruhrw3fA3RRKQ1cK1%m>^_pN_piNFPN>{T}& zqUe1tH*)Au6n_*>FE|LE-NV^THDXWI1Qxv?pYSbB*LmlfzOcqu&bNKVcjuYU*kBV<;8w`5HBL@PWgF?|0d zJlsFr>~)(Hf1TGe(T68_&*k5H?9{Q_~nq(6Mjh1N8CkYh8CgtOk#&86V75n z?8h~MaNPs9V8T)GUtjl$qTEp^zQCKb08gUWwwgfGq8I-HY#f7uWHc)I7k$114){sBAw$^1WU`hV%wHu>uyQu4_tNCjnKPSkN)wmZu29P zm~-Q2j0|<7kK=tBeqR1ocDNxsy?qXTIomBN9oUtvHo42@l>hX3Y6_)MBJ~{gBsHB< zDVfqKhqB=*Q3i#eWm6pV5cCCTMWLm^44vYkr9w-CwhX@tj9FlHsHi(@?k4j)Ss7yB zg@4})#pr~a^VXFy*C}JgKZ5iL-{G()JG?VZH@kJub}1a1+_q`om5=8wSU&fA@Ns#t zf(B&6rJ<1A)Dh#M!o_0}!TzY)2B2q{|jE42wfi%Q05f~**E^Z$$8Cn@L30{xU#N{|%{*(NnH`0T?ywbF!e8R$?Y|Lsc8bAE` zo)=$Tmvw$@+t^U$reU`p&Av3A>h@sUryqvhwy9&85w~}l0P`u|@#Vps&RMzF%ppV4 z3$I=&xXzF_UEuorI;YJq0VCzX_J;&#RM75_5~ov9HkSF#r5+KecuwPrXEBP`!pY-` zrxsT{oBFb~+XKs9ZR!Q-`mJQHhG!;CT;1!Bf&Ad*-EFgbm#B)usZlWssaVoLfp`gN ziUNWpfdp|Tr%ASw%>F*6vTO1QDsKz#&<;ZNnA~*{}tY{cle0 z?dDcj1vea~i2}Xy!AVbnih^glK_zg8D3G5$Co6$8_MB9pG`F2ffmF!t3TTT8+9Hw) z0B3m#R0UTBxDt?{rIA?)eUd#o99f#T#Ko ztUZlbd%nnL8@C4<=%=0naX6RA9g1Wbrez`Bc0d^nNk@ht*+?*CC`%kpaRk9r2HVF} zHa~?j2rAFplIDOOh&rfGlta46@krA|nNxI4F%-#Dh8v-Kt511q@W6a4AJpJHQ3F3O zPu3%8>@%qbUD#@>djZf33|piEu}Hn4lPV;k00vP3T!RRNbOcWW>XJm|;eZM#paudZ zq_`JkXk{EyX51}_ks+00yEsdIv#s| zrm_W{*&D(;stV~{Lza#21v2LVd!~d`jh9W+ipo6i&Mf_rTRija(8pWPc<8Mxo-hN@ zyF}3Q^KK74KT|ty(?hQdJ3W}9`p4D12pLv^JZnM=k<9Cm7S5{p-i=^Pg6xcGG)YT< zXCmvWV24{n3i2|vGLDLiD|^T2gqPz+8PhWVqw7FklkZ^g$VgBT@nEQuquL3Ze37CG~?1AZLYR63`bE2PpLi)a&f=XQR zV%~VDhH-Ag84uUG`0JQN#_-oMoELdQB?seC=v&ZBd@&>SbP6gnv@#Bve;w!*qZ2OH z=an&MpSZFQsBG~a2OgE_xR~Ta-~R24WQM$u0?7=m+}^(!N%snl>#J z#L-cnQ+WUjsk#I(=z@wgn}^h>8?vAnA}{c=2b`a&Y|qZX4Uu#XK6S(QX+>5oBq<`? zP=%<849C(rPT&pQs$aPb%F>-p^Y{0dMaS-u%4Sh;Tfkqli-Fwj;YYnARY2viquH~Dgc}YNuL6Y$SH8k(8@R*j@@Qr zbi%`Hep$xs-d{2WaBKA)1s-ncc$g$XzwYf!TZWvFg0>8;+}^#Iw!=GcB(H9@{|mNE Bvf%&# delta 9 RcmX^9f#vIJ<_%x30stJ81=#=q diff --git a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG index e10b787..98f4c22 100644 --- a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:10.117 70b0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-14:01:10.118 70b0 Recovering log #3 -2026/05/29-14:01:10.118 70b0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/000003.log +2026/06/01-12:26:02.758 2d64 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/MANIFEST-000001 +2026/06/01-12:26:02.759 2d64 Recovering log #3 +2026/06/01-12:26:02.867 2d64 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG.old b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG.old index 7ed15fd..e10b787 100644 --- a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:48:53.508 6718 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-13:48:53.508 6718 Recovering log #3 -2026/05/29-13:48:53.509 6718 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/000003.log +2026/05/29-14:01:10.117 70b0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/MANIFEST-000001 +2026/05/29-14:01:10.118 70b0 Recovering log #3 +2026/05/29-14:01:10.118 70b0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/000003.log b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/000003.log index 73f7587035ed426d1dd7ba23ca3e0a87b0177e32..ac0241778a5a19a7d4ca05c845c0b57c3118bc4a 100644 GIT binary patch delta 19 acmZ3&ag1Yw3JZs*3FBUA21eD1T2cTrs04Tb delta 7 OcmX@cv4mrT3JU-WQ36u{ diff --git a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG index 5d9c7a7..7a18ff5 100644 --- a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG +++ b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:10.113 70b0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-14:01:10.113 70b0 Recovering log #3 -2026/05/29-14:01:10.114 70b0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/000003.log +2026/06/01-12:26:02.214 2d64 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/06/01-12:26:02.216 2d64 Recovering log #3 +2026/06/01-12:26:02.730 2d64 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG.old b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG.old index b74a56f..5d9c7a7 100644 --- a/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG.old +++ b/Covance_UCO3001/browser_profile_1/Default/shared_proto_db/metadata/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:48:53.504 6718 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-13:48:53.505 6718 Recovering log #3 -2026/05/29-13:48:53.505 6718 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/000003.log +2026/05/29-14:01:10.113 70b0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/05/29-14:01:10.113 70b0 Recovering log #3 +2026/05/29-14:01:10.114 70b0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_1\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile_1/GrShaderCache/data_0 b/Covance_UCO3001/browser_profile_1/GrShaderCache/data_0 index 3b8707756db8e01038bbccaebd00e652a8d72369..e1c6a2e734e8a72fe4ee318c6b8bbc1a7830dba5 100644 GIT binary patch delta 131 zcmZp8z|`=7N%rt5mV*ooObj5P0>suJ1`7iNBZ!_TYsJXEF>${9!~)Ju3OdXJRtyXi zj2IXff+YRapM`CoAz1`CK_U|^gmYsJXCF>${9!~)Ju3OdXJVhjuu dj2IXff@BZx;t|+vqx^;iq+nyg1SH(a2>{kU7d8^>WTx2M0Y7UkWwIMf=~?BP@0!P0%H3)J30or Ym6tm@2ATv;)=<8&v0#EceX#=z07Q{t761SM delta 223 zcmZoTAkc6?K=$w{mV*ooObm<+Kma7HK{N{k0|$sZQP!E!eq-Wtc}Ad8@>WTx2M0ZIskQN~DfKUupQ2NruMDfiWia%O57EF+*FLq!90MKzqE&u=k diff --git a/Covance_UCO3001/browser_profile_1/GrShaderCache/data_3 b/Covance_UCO3001/browser_profile_1/GrShaderCache/data_3 index b12c4561e9098f4b65d4daf8015d2430e0242744..1b60812150deb6e5703a157ed73550eb7aa16959 100644 GIT binary patch delta 2741 zcmeHGPiz!b7@s#gJMYcg>2`K0>=Kl|QW}a>x_{X=TT9ukCM5*e_JGllwYriJTedVU z(Manm$y|(*}buY|zYZkopK&yvu zJ9!<6z~zT@JBh;5L%Kc~*_z~shVp}BF_FzivWJh1jE_Y_;TQ}KxElQ7aFVxH^S-x~ zTyr>%9aZuFL_sp1&0&BY)?9Z2W*=y(^<#GrNx*84_B4F@i26w!zAv+AFgp-Nzqoit zWb@-=m^M2QK_UUS7YNA1F32!)sOl=dOY&n?1m4YB@N)7M-1$O251kXb{`@r**Ez&z zh&L%d(0X4?rR`*!`}*$LtD6(oM$^Z0Lj-we-;M7WB8RfPg*dH9(hqjePMUDR!Ghia z!@GD8=47fsv7k3VxsEB&y2_2Zi+D;!FvMx==7#|?4=V*d;GRc9fwL>>8ZvMBW{|hS zQvsht%LvDue?WolDc-DgA-7*5(iAlHYg@oj*;Bqh4CAqD7Cj^Q?Se|5mUh36%T($9 zRDk%MKs&JdlrSW$SmK72>01Y0Lk?Q+^zDIjexjoku2jfQ!eHbDmVY)9-TU=!_hie# z)eC`if8aG|0>`oVew-=n&!8-+|p`;Shch}%zS^#hmZ0JM2o zPIIb#RbV65{h1AR`F*AkSg2<~qQK31w!!)((`$zecB8&nC^Xhkn?X$jH4W4>P}9Kw Jr-8q;zX7WyCKmtz delta 1749 zcmZoT(7@CH#Da%Uu^ePzU}9iq00IF92D6ER!i;Aps=6@pZ!GMWpV+|Oq|m0o*rveL zroh~$z|y9`+NQwProi5&z|p3_*`~nNrog>Sf#<-+h6edjJQ@b0X<#%BjHZFnG(hh( Iu&_Y@0Ki=co&W#< diff --git a/Covance_UCO3001/browser_profile_1/GraphiteDawnCache/data_1 b/Covance_UCO3001/browser_profile_1/GraphiteDawnCache/data_1 index e09944c5117b27cfabf35322bc08134b922871aa..05e7aaaebb32884c10a26f019838a50cf810eb75 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM!AWB`pq1Q?Hr1XK+LqALy`H%KLD;|3Sj^M delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE diff --git a/Covance_UCO3001/browser_profile_1/Local State b/Covance_UCO3001/browser_profile_1/Local State index 0b4e2a4..da0f4c3 100644 --- a/Covance_UCO3001/browser_profile_1/Local State +++ b/Covance_UCO3001/browser_profile_1/Local State @@ -1 +1 @@ -{"autofill":{"ablation_seed":"JSMeTOeQvoo="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528300540427"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":14,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780055333627919e+12,"network":1.780055333469e+12,"ticks":21161857105.0,"uncertainty":10133469.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAF7xcghzrCeFuJF9eUFEDWwAAAAAEgAAAoAAAABAAAACjHenYR2Rc2QZpO3qnMDxKKAAAAEArHaVQAi8S9LmenLQpwQ4EDSd8Bb9S75VxL0FNoALsMhlUf0RY3EYUAAAA67S03aqd3QLHsykVIoNQd27y6ls="},"performance_intervention":{"last_daily_sample":"13424528301569424"},"policy":{"last_statistics_update":"13424528300539114"},"profile":{"info_cache":{"Default":{"active_time":1780054701.54966,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424528301240921","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"806827831","signin":{"active_accounts_last_emitted":"13424528300460285"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424528300518171","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054700"},"user_experience_metrics":{"client_id2":"735afefd-1b79-4594-b78c-4b3b697f061d","client_id_timestamp":"1780054700","limited_entropy_randomization_source":"BFE61CFCD5FDFA17E6290188A9F98B26","log_record_id":3,"low_entropy_source3":2373,"machine_id":6709466,"pseudo_low_entropy_source":2142,"session_id":2,"stability":{"browser_last_live_timestamp":"13424529946236531","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"FDE9A061AC3AFD34537F894FB8F013E2022E3648","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file +{"autofill":{"ablation_seed":"JSMeTOeQvoo="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528300540427"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":14,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780309562319464e+12,"network":1.78030956217e+12,"ticks":17526531652.0,"uncertainty":10135010.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAF7xcghzrCeFuJF9eUFEDWwAAAAAEgAAAoAAAABAAAACjHenYR2Rc2QZpO3qnMDxKKAAAAEArHaVQAi8S9LmenLQpwQ4EDSd8Bb9S75VxL0FNoALsMhlUf0RY3EYUAAAA67S03aqd3QLHsykVIoNQd27y6ls="},"performance_intervention":{"last_daily_sample":"13424783162201563"},"policy":{"last_statistics_update":"13424783161856876"},"profile":{"info_cache":{"Default":{"active_time":1780309562.132791,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424783161861164","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"806827910","signin":{"active_accounts_last_emitted":"13424783161781996"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424783161841976","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054700"},"user_experience_metrics":{"client_id2":"735afefd-1b79-4594-b78c-4b3b697f061d","client_id_timestamp":"1780054700","limited_entropy_randomization_source":"BFE61CFCD5FDFA17E6290188A9F98B26","log_record_id":4,"low_entropy_source3":2373,"machine_id":6709466,"pseudo_low_entropy_source":2142,"session_id":3,"stability":{"browser_last_live_timestamp":"13424783431489878","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"93DC8F8DE9C5FD3CB394691F5C73664499BF1E74","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_1/ShaderCache/data_1 b/Covance_UCO3001/browser_profile_1/ShaderCache/data_1 index 6a3302cfefec2b85cba9d615594ca0723643b891..7c78ad721f28b7c7379323c5e99ba36b56d3f7d7 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM!AWB`pq1Q?Hr1XK+LqALy`H%KLD;|3Sj^M delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE diff --git a/Covance_UCO3001/browser_profile_1/first_party_sets.db b/Covance_UCO3001/browser_profile_1/first_party_sets.db index a9287290cc60f79bfbff58b8ae283cb1c64e6268..beee181b190d5b7368cc425f15d94b89825cf560 100644 GIT binary patch delta 73 zcmZo@U~Xt&o*>Q0GEv5vk!52-n7lAMvpj!MX6aWx<7NP(E delta 73 zcmZo@U~Xt&o*>Q0JWvpj!MX6aWuy7MlP7 diff --git a/Covance_UCO3001/browser_profile_1/segmentation_platform/ukm_db b/Covance_UCO3001/browser_profile_1/segmentation_platform/ukm_db index a19c31a6202623c46adb8354dad88a443c6e5f09..0e33e38cc172462151504089df1c09586b4e674e 100644 GIT binary patch delta 2654 zcmbtVdr*|u75~0n_rc@4XIUN#%VW_hQW4#SWnsk#`ve04A@Wpd7FgZ_;_`HK*Qxj4o%deP191@)w$7&U zW27RfG%-=cY##I7Q;cpEtxnd>KY9EeU9;Zvq0eNJ-oTFN*!AoCY%wdipTDuGjlH|4 zNuJ^xf8RaTJ$wG-cwi9AYF+S%{K)NO%H3LLi(J9Ief*m#){&;`z8qiw$1g4a^t664 z>^Mca8$YqBS8#7_Tg$Mzk-j;F)>wNr>3G=XziX?fDK~l87O{dm=TP2Z*%531_p3I< z2OhjMIPR_Zs+w{)xoqJpxHC8H+nLGaU7<-kxolr(;Fx4IeSbLRW@&Az72N4(pZI_| z+_h$-=5+ft_xywVi@*Q)rwYQ26aCy8#&g+6Z!w+sj8`{swA<(%*5_m!55^GR1mc=H7pquClx`580QS=HLM1AN0YWA99;}Kri zBy&?$Y68VlmPnMyE=B-ESJ46>!if?9QAVTy$kVF@K;AY&0Oaw)1wdX$^$76g4_V2AOZxfDhLoZ0s;hm;*$K0kK~D;%QspCnuO4V^Q>B)K)f7? z0>n~3f#%OJjE3vLvK_o^lTi%v;}*G(x%ar=aVNRwxDLLmS`KGdgs>Vs#@iTbqp6Le zHj-L3wGq^YQ>&sjj9BmPiV;>G!nQMTo^8ke&#V!NHjE9}*nqzA3Ys}^%YvsNHnYkE^C&Uv+UucWr9jK1X3)W1%UjFtuLam~HH-?8Lj9*JPIMuWae5&T(aTK2_x` zFG|VPH+H94o-8i4weF~`Y^Y7Gca=FzNlrt%RcA3;J30%>%bm&Aj-I-mX|2uLR{TzL zcIJ1z7dADm0pE1NCn@x1^kVq4ss;%^eopn{;%b+~x41Lm1inPPyGIMQ;A|)FEvUS) z-U+9imH6g8qnGesYxv-;&u`qtS+&I5{F(uuBi`)LT&CAp*CvtpW+oq8_nz7-6-j*4 z_Mr>-4=sjt-fIe2+M45arsR|iT!A;>D3pU1r065$Mg8apCTn%$!IX4~&U}hjBT1 z>Ddns{05(OtAf^}hfz9%XU0Q@@%*6(1-C54bVTr4K1Db?>)noBW$B*I5@E)9n zaegrW0xVs$Lqn(+uA)CdGrG<{@GgWUXG7e|5OE@_ zx9d|)7M($_(;1R2Df*zt1r;P{Fx%4%7K=$|w`!9tW-E}OU1v7xt!b$yoy~64SyRyC OKIa}648-cQpZ*_8@jsma delta 896 zcmYjPdq`7p7`^klIk$Pwd`xRvjvinS)T=43z!e#pf)+$+Y8g5$Gle0MfjUUhm00>C zP>2)~nL(*sDaCwLT9BC-ne-6CkfqaFP-;cl?+$1F_nrHl@4MgcoMSe#W;5IFu4Xj~ zo_MHt2uF0wo`lzG9;SRr?9 zAcukt|2x-%i&zckARapUr0_nD6oh&Ri=keUPz_8Be#3@V+{Sl``|2Hv6uuTY6$ zm@$ZA^umPuXcPFRy&xt-T`1kgQ2q!~@D44AMFV&QK!GwCIS1W000D`p#uk{kKPx{? zQl)8BtW4t4&rbv{&3r}R(#%H$E}gtZ;L=I$1S>j01gq~qp1gBa8geyRzu(o7inQAD zV!dEZ&v9S7fL*)5P07kUT{H#5Fd8nNcpMf};Lni@8Gb_gNvlNW!`c`O5mn}s3Y-4TFr4!FA0x~a*5P3JHac-%N+V~rm%d8 z9L%NF=X0tAG9XsdONKl_f5s%GrMG=lXg@D=lUg2lcI_rTh0$S_spWMsk2QI-o2NNa+2=>r_uKvf D(fc-N diff --git a/Covance_UCO3001/browser_profile_2/BrowserMetrics/BrowserMetrics-6A19800D-7484.pma b/Covance_UCO3001/browser_profile_2/BrowserMetrics/BrowserMetrics-6A19800D-7484.pma deleted file mode 100644 index b2c30fc739e949f6380b9820a0048f1d434e6974..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 4194304 zcmeEv33wF6)^<CK0whQvl7z(tnIr=lNoK~G$p(sXL2*HG z2leW>A>xKRDhh6h;(}fkQ1Qkc6$M4TxWWIPsy;K-mB~y8?|q){`#AGf(E%P{Z*wZbuH>zUWV6CCo1C)}=XM#E3tj1>HFn5>!b(?FhU>(|2*E<50> z4Y~sb?ohx}7Bq|{;8J+k>E%CeHg9x-N2leWA)wu$vlh)=49^%>f7OUimv=bAyi{E0 zz>)cMjp|AYoEe4gK+qEmxxFE0Wu>po74ii##<&8N^?Bg>W(QnV!3-T&BO)POr}zGL zHOEIXlR)&$twC)-Z9(lo$)NV24xo;pPM`xo2ZB0-NG}J0x`4WZ4hD4t9RfNOlnUw& zIt+9;=txi+s5ht&=onC6P=8Q5Xb@;9XgFvj=tNK!C>N9mngA*Um4HqIodqI&?%lih ze0at}5bJ#j9*UmL2_m1LXD0YH9R@uJmQgb0m{VT8f6j?u2}jo@;cDia?1*R8yQ1iP zuO~Fw9jvYliEA@)Y>A#3e+m>z_Z6PgVd!!wHR&gZk-YkgTQ;=q(rxgt<1+?jj2J$2 zNXGE=;lt9)-8JsY)Rmuqxv_2UHg0cvNm2jQ4jra?yyeJ?X%maPbQnAcHw+#*XxOkJ z^En=3>kKmQE*wo+u0?bRlc3=HjK3=pPkyF(>S-c+T(TSdqeKZl$RED zN=;64^ffMY7?(SY6%JG6N{3^7hXbmP8a1Qa#!Eh%j`M4un)+C`e;qphWSqA-aOcn6 z8Wx@RdZBT4G6~B>iZ?jKb1iWgyB)W6X-I;8q;o7xGOkVPGiX@Z$Pu$j%hLy!x{psE z<{mU8y>xh~JN@`snWZC#4<9njRW@XK(q;V~Os(m=fASh=s$n` z%F2&!8G2vGtDhUVd2RY5drp7*(y^goqkcF${rvv(2fWg~(?{(mJYL*2|F52Vi+e8m zDRafPRJn$B`Yk-g#{9MfvHgJKj?EUDej2+n;}Xdd;?A zcH`&YU3|r=y%TmFaORImYaZNk;RpXHK<00aj8A!p%1DuWb`=V_NS3p5DgwSL_XJ;U z396eh-r26%ZVIIGS>g@4E8S%wHwr{+6r=&*Q5m${U*vWL$|~q)QKnj+A9EGl6u+|qS zFK~I09D$g)&3k+5_vX4nu2NUf?eu$cDm_TaU{ma7Ug)LYEAs-0i)I8|(;V(2n%wWJ z^814BLgXkPJ$bBq&2&nnZ)zhZ`a(tZ-ZIL5Mr&j~s@Ez16}w8u1$@>1vt%g$74>n6 z*H`Ps9kH*ka0T4uF|S9o``vyG?AO444eZyzehuu`z-g3eXf9N%ish}w~?cB2f8G0F?eLWWU+ zNMqSG$X-OYA+iOL?T5w-G+rV5&T$|NM}Ba~^m2NH651?}+dvH+qyqrwj~z%G|+V z5eB!F?vT%$QS7O57yEJoZdZt)7>ywPc?knOE7`xu?xj9&Kl~p88V#c7I|FnM=nByN zpm#w@05=-60JIg9598BYpmSh=8`;`0GTIo%=}_n!Fj!rKfz@*z4P!P8ZVy1Y4?`EX z!kBh%8gz{TR{y~mUtxUMZoFY^f*+bNFi2LPgT~U7$7t~U$>HCBLZ_!bdDl~m|7@Qw@yqMU zKFoZ&Ms-xKb1K~~@0dDINCMCCd8N6ytbV8{gLd#zxn{d5;bQ!YaZdLW{*5%qhjW4m zAC3R14D1H6eS1>%mY{#zG09*FC!fP%=zI=W(jlV%oPaA>Q4~VioRjMbmId5?m$$55 z-hnJ1!80ut^&tKep61*c6FdCeX+a7>6i(tXj59SphsVMrp=1bH?x4If4Ib$wyzHy1 z>wrU*Lo!soCBx8`22ZRBMmn) z-oC)2$|JmWW;mtudV~|t2_m283&P+Jo>%f7SjPKjJm&qf=C2$ICr3WzQ|1e%a-e)V z#v2Ow{Pjh?>Oh&hxZY0{Z=(8u^WhR)%lWVY^&-_5jF0P%ncz>k`_Yp~?D|*N9Q#H4 z)NkpWoW$v9!k3|z`e3XN@XE(}+?D0Us3a6j4$$ei!d$Z&M0z+ zrnoAr-KV(g#YJg2a=NEMKF8nt&$|PpH#MKGM0g^-20pC5Y4=6ht?4>)a-nn%$d=YjwD37x(oG3WnQ9xA9G%5Wm-tn(R?f@gxy zRgS5(Dwh}5Sf$d;@l_+EDs2|sn+Iwxow1yZp zTW8;g`-PMF7VfCJ zzjgdawX9frE}ExgKK@#q_FN@FSuI)0bt5JtRDGr(2I{{r1V69!foT+>LJnDSG#zB!g!Bgc41v4TXR6RwWx$cZy_beArlm5r`OV2<$R_iZ+TH^X^OVXK# z{_*5*ukv%q{NpfmK8F{%%c@a1)n|;W^*e(uZ-x_Dwg$bz@{9r(&BpW0yLp4!P9^tB zjHkE}miR=)!Utm(J&K zOyv17$eQJ;#1JbZ-)j!I(B`{JE1@iNoM|cNDZLZx=bB!pUphJE@he%51k}aQ`5c}A zhoxMEZODJdyL8afJ+sb!+!R2*!+6|aKFejlxB}hQ@VgIqqsd zDSS`1F0F86zF;Z` z^ts#tf4~!T=Tx}M=44DNk{z!>xW;aMrFM)aSyt|Ik{O&-{e)y;443*MO7A^BI_)iq(f1MJIc`cG8A^b7T$>D{K0NjBV44&CCQ?o+2;F3{zKtG(>eG>+T+peYnIOuf zmx98e=Ru!=Iw5181eyza0n`ndq8_vpG#?3a3=-rA(8p~I<5x5QV*ubi7-Sy8AmUSW zFz2UW><&9{K5Q}fqck_BL0`}t_ct3LgZ1n0m$+VdqW9e2Pj**)0w}_fPxUnOO?JeK zrQb;6;;MxpmLEP&-sXfy@n&Ur7G-ibaQ*b#n)Z1MIvFpH`l(<0aVt(6ULmg~o#I*c zGGB6|#{%EkK6EO|i+wmuK)#1%s3f}l5jC{Db~yyLG@YSlk=8U`qrN{nL^+7k|3c99pyi-7pe>+(gSrD>7N`<*8)y?K z6?vc(^c3h&nPu!1;`7H9qj{rOwV81}-dgft7`?u67(Wk4G6v2~GJ3w7WH^VnGR7`%WgOPOwXx&5 z)<*8EHpb4Q+oDXgGaldF&UmnEd*h3e4#sOQcQh8wIzZ$D&aZ0yG-v=61Lp)m9U@=r z^}*&Fj+y%12_2shc2o1Z_PCn)U|C$W)sXGDb1tl6&RlB7$+%k`6zpgXq2}LJz=NcS z;GuIQiKU-&`d3}tv(7l`8Ny4Bd@4W87fj`#b#u@v>gHUYZF& zyuS6ihpw;sqB}2F8c;ot<7fFgpTnDxU*IaMKu1q| zejD=h-uQjoX*p+K$?>y%ozLOUG8!UyN-=K2AQMe`HAa>7=BNo5sreue=ho#L}TAt?$!m3zCLx#cG#7#B&KJa_l7(wF2AG&B5F<@9LRD`KgA(iQr=?4e>o)H3-x&|%)%hG= zix#5>$D$vG+GP?!5i6aXN2q)3Y7N} zCirGgcB9x>6tmtpgFV5I}tW&8`9v@{baA)44iDYp7LfIW;m_$ z6+6*L5HANres9oGphECRKOXM6^CO3G?ZmUwLpv{D`ET<9si~oU2J`XP;_w`1nH1*W zAfgg3jN`sO7xgPTferwnxo+`$6*PE5lP>z5FeMsj+Kn_&FAzO5=}pb|(}sZw=LFGX zQ~!&eqi(2S{4r(iIXE>=2%mh*2ZJB3LXj4ZuIq%WnQyWq9_2Ul<(DFNfL49O*aNGR ztCCE9(RQ>Eci7PrwPn=rBE6)5&~*{dcr<(@yTCpLK7qXf^fD+3Ad5k3K@*d3KQh!_ zP)-~4ospr^5Mdic_(bjUWvK)s|{o0YV@6Uqn;h- zFiIcBxFR#jICXoHv1CgtqequE#*+`WHQw8hY;3xrqov={037suG_SK6dM3R&LF9AZ zR_D{NnE1@R#^F8Z0fun&yshxm%s1H)&uovWTJu-B>hsITV)3@Lf8>|rss<3tpN2kN zBKiJ3E7k>Sf83?ZXMRMmc@jsym|9ZvStH~l86wY5=SU7qKWWP)2mJ8y0|WeolN|X} zzc61gmBYBg5;R1C@>;A6r#7Z7##=m6$s+A z2oqEJL0_d1o{^7He#nhB(==~R3Se#+lNeEZgsPX_z(dXnB6<4wC+*u5mmBj5I_<`IhSSmB6LSCD|(Oyv)S7(|?=p zS#{&c-^Z8$8GnY!H`x)-KJF>>)}44)f^JR&G42ZBQst7&1~XjDpOYZ~&IvN{w5ED@ z8}4g$%&X^8*dd#0r!W2XY}Ybs0O6?2bitANf~g!Px+R5YsJUd5SPO ziK`lMBz*DOTM|WeEww*1rls}-rUUW*(W&sOLHB`v29e=*59m_>>xWF)3OBDzHjJxL zaUI(Q?JDNlzegqg4)XX3$aM<>hH=R~hH>%^tZ|y|Fy7teFnkyr4mlX(!7tkw^$U`X zE~j=fX1{rmas0F0jn0FQHg0+0c;o#?3ydEM{KlHecN)uX`__2sh$2VHvEMolu6dbM z(wf>d_(mAS^ph9b2=NJmUlBA zc<2bDHlv^MWbcv2s46P`bmdnNj`k&c8$?zOud>a16c;OM?Cr5dW>NVyI zrgE^Q|4Ck1nFP_>J5fgHghyiad|`A3kT$3mtA`6N2bCegUzfJW4^}Udl46<=izmn<&>VFaR381q; zwIF0G;~CI5pgvG?73eh(y;%DOr~wUsDe~#L5V93@#!V3N0)*5+$QB4W6q$Y&>W+@R zum-E2VZ4gI=*BGcVNn4sa-%$;v>$Oh){?%8zTI!IzhycM(ii8$g^nNV}c=16M%;@| zJuVTKro)zpe&tA%HBSz7jzlP#iuIvoSo?s^@M{f*aU&{7h)7jA3tq$Xm4>0;aG|6c1N-{=0kz^d$t(DR1!d6D!o>s=vD_R?Y0d0(h zpSLl-f2^(0Uo1VZg`Sbbk^GCtH1L>_d4tqbl8gthzW4c$w%qW{An?gi-l6i&e8E%> zV%;K56!1iGAr1VC#EXDZ)mX_?;I^x1C!w5|u^*cp>;5)+?PEJpL zgwDy)^>ozvf{g?9GffB+JhR+LYxkHMRPMp1y-%ucjK6DFrsjys+ka#HhpZ#)(nrHT z21I2TSxMNb`@=sDGysIGWx$jrY}b@tlvYDPD2n2}*W=++*A>l)=o?UX22HDhtSIc< zR41T_8C3kTKu8uN8-#2sY~W+yj|Ghb<$>}+<3Xo@kd2K3&_vKAP$B44&}2{%s2EfN zngT+07q;~2@J|Ds4mtyLCTIreEYM7l3sed!15p}L9$pNe>xqQ~4vuhAe$eNcmH@~n zOFQ;IpyQqn=c2rlI|xMim-&LJ9104Zc)c3dr)UKVriJhr zPYM)8I3jp(PV&_CI3K_90~fS@=6&*9DEn2dE1MfKRmq6#HD zgwh_Qyhr)NZhJ+tlR>CTBl9$bnbKSB2Q=hb_3OqpsAdiI{fS=|pY-baD*`LP7LN2! zsi5-(8waYd&=+X34@Y#Fs91F)_U4GZM1lL%e!y-G7n%oQ`%>3;gje?2 zd>SV+-(*KTQICrE$@9zQ!de-W29NYg~5B^>RsJ zc~9^8V%Li+o+e$9BYbUfWWHc3hi1#=SWh4rvdUi!`4k_^Z-w*LAay=`^x)^h$Mzfa z6^r2K*7+Px>5&^i-!vbc)GA*M*`(DGu&Vduaf#)3FZlOOFWsL_Rh@7wU*~hUBEO_4 zJ1RL17jS;)3%Q&hIv!hpB(iZ(gMi;+w-j>%fqbVKvRL+=hvLhbL$J9hNE!>JgfHiC~Z3g77aYe1))_EIh098C( zf2r?%JbCH#TaV4nJ734c{0I>9M8`A6E7m%|V3AQ&?f3fvp$W8Wj3r$fs3C@Pf=Es| zhzjLy5Wm0i$Q{=>pYD9-y)vK4>u4U4`MA{L7>6m}7l1y@p@_I{AclBp8_7f=4c z{ImNG9Qpdax*nJ>V~8G`m7n3P!7C6{{KUmeaAX`|8#vkwJ8jM_&)>3(B}qIEL+5jN z^Eis#*nA^^r8$-LC0>^W6mC{=Wl{$TE}nkcEDiqa;ZfHgtLumPGKT1}d0c4Cu#5;@ z-I%!4bX%+8idj!@+`3}jl4$(0QbISwB>! zscuo*Pv>{V*Dd?yfd;UJqxzg`b)7HRIGFFP$&Lv+FWBB?4mwaFcU_3rSDD-*m$$ss zS4UM2vXt7t+y-1!UKkghQ(L00hfJ^eYGchCFV#rB$mgK?hWWVM;&ObxIUYBxd}y_3 zwOKtnO+g;1xXUqZ?FqQ4Yv-dRwCZUlb*|wU4~{s~XeTxVaHT zPW`(BK`Edvpo2k&f?z@rwzFRFj|TMz4Fu8Hh0H+c!iw<*jVGw_oCBh^_fim*x%)wD zL7PET$Pa=7hJs+aG%f}`0oo4gkHqwWo&#a%Y}A2BpVa5XZI<%8+lJnE&sg{BFTs~S zrF+RiggEMa!N$Rc-Y25JkIjWD#{>etK+wD~44><}Od4RpIYA^ZR{6dCvK{Mx-{Id* z*O6mfI$wr1hs#=!bF1Z?4J@gya!XbjVuT@p@C`2MMZ-Q}6D6PIO4;7k##goRl;x{mq{%s1H)ujx2Z zyxHK!{02?&S;|%6KuLS0yk=n?I(s zg6d==?x(tg^|H;xl?9%BUTeL-{P`r~;JS?+HZS_IAF2%DNOxpcV7|$YcoR<@gAqI0 zA8%+OH&E$uZ*6yb4#$fx?VGsq8q?X-?A zoEm$&+<)=Y8}I!G)wks6x?~)gFPO@q5Hp~(@EEiG*a5J>Raf9C3;4(ef(g+wTJ|C@ zCPM+~=kL__G@c;LRL83A>~1m)!SQn$mtNP3`mlwlJ91(8U!LcTP}#I>zSYch|={=&BvBZJ)t%0-8#D;m`H zXi(G9Ia-JWJ{ka00AL!F+8F@y0iY)UJbXBG0|1Kw;6wm80|1T(fWrYGIMXm50e~_9 z7zh9#uSK8XOT$=|;xH!WI*fZRa2Pkej{P%xB^mRuRb!u45Pm}|BbeRVcs!+z@mrg= z#-07z88sIt8(*Y#Fp4{NG8Rrg(CCzWknvpB!N#0!sm4ur9gg?fdK=~E_cc!MJIFX8 zccd|(d#-Wo?}f(NQ)U{AFANwZ$1OBI-F}C0{i3x-(QjWEcjl!y4t_1iQPl1NN0*OY zbDU6}mh_JQ(xjxX9jz!oaJvlHk#gEV#zZ(L2r5G-z?yIRPD3BymG`=T@X{HLr)5&_ z1N|frl~d*mrgETsBf5e#6Nodnze!dRSF1RZ$)E|xIP`XS8VsC)-|E^1AM3rjmNE?- z<6yqzMvqn;(VUtwrGP+jcfe9VEY@)7`q&L4>#;KfD{@19ZrAm}{3rr>X2mh44zJD8 zV!b9xQR~mXGv&Rk4;=@EewN?9ankjJk9r*WnjEEH9~_x4n96~0G%3$ilKI8$CWz$C zgOGjI{s?hVgfMcDV+=};6q85iL{z4eLDUw~ID`pNMee2hQ9Q+X0G{wg9>h8MOms~m z$M+?=E?zjr!LrC#|Euw<=kem(ANGG!17Tzky}Ym{XnaPF^AMGh-hvbLDep0luA}lq zZ9dnoz+yZokLy;=luzx1NBKtYr%~uty++@g z^zDK_IbV@a<4xw%HL6qh%#MtuO6F8W`YL2Pp}vWEliF|0a!IBW9?8-1ENq80UZ>vn zNNwKt-SG^KlK$|M~-}IADAzg%0aA`paTkYwLjlmhN&IwROyZY z!^`aWd_iPAx>_&KoNdKJeQDi3yW*PD@4h}z(OSpDdNv$yeQ)0g{HRsUD$q zCJn&B>k3Z#qPzp8Q=J)3>*9AKoOrCaSn0U>?h%*mE$!1^$H{!$ZgJ*&c+#UKIJGj( z)bv_dkyvid>z)_hp7hokx?JX4gyN6&z0C<&@R8#ZUzNx(-vTu4#zV{-8{l*QBH5D| z&&yYx^ul=;&c4vRUF081Wu4FA&EhcuELY^OgnV+G4rq3otOMA7&Wylii~BSDhE>iVI(KHYWrUsYXCmUqi>E**6~hg;JTYxwd!vnyyq0IR4%LRs?4Fg(^% z-5e{9SoP5tyI#Gi&(?4JEQj@^^ErH?tHv{1)QG4a%khd6UbU5wzQl z1yeb+2wxOzWJP8p;v)Senx|-o>)19y(5OF1{XLp%&H|AswFVRhZ2=tv;Izq54^(a+ zg0>=4oQMQTMMSs4wA==h8+W7Q`4u{ut~9JWJr48BCtzK8A^MwDSPOq0=2q8Z{aj~< zaWi%~?uhR~t-CYH7;$YYLaAT)65qkroJwlp~!_VdM(2#?4h$j~3JuC>IM9zNd-lLDzi)Wu(LBl% zW-N6FCe0dCSLPP&MNnR>+QqYcR=ptmH0fUy9DM6XPxak}mHyI^PyGw#o9u|EXWS-c=Rp|3q`&C$?yhZ9i)N1tnP7wLA z^p#S3>DPB><`?U@m~X;~c=m8%upBU7cEtO5cn#D{XRF>)&Pj}KdU2@t@IBu*u_rJ; z0?a(IhcCYh+d*3Nrl#j|8@LWUY0w#tMPFV>dL>6b zozjy#>$sS&KoY0+aEV>i%^fi;$!WpYfVzbA-~^E$s~nv9c+F!YzX+YE<72)6r5xFQ z$_Bo3bH(Y&IzHyB*y!9QzWm&LEI}Mo7r_X$%r+S3>f~g$r;md~2 zP;R7Y4xQ<}5)q4?LmRV72aMD68}s)KS4ptcn$0Zr z$IQCK`nvh-TdSVG>%%6vn7?nh^0AMB+;IpNm}p`mvM`9tsR8S1qI@=Y%Wv(y7#QhL84sM@ugUj~0Atx-PMSZ)?FfS3Gp!!H4VRl==IHkIDh|Q^1!%7@TU4$eNp2 zZ*wXSyXxmDryQu`V*bA2iuOY$p)+3PnX9$_)^brXPfBsZBOJ627_aOan}Pq+bBvED z^k2^odTnN1D_VjqoW$#B!sqY=^+kWnU9V4K5*$olg{<5#jv(ioOjHIYq_=GeP{ zF#Htr8GYcVgEB#5K~q5(E{b`d74Y8!(F*_&GjZJdjn;G7`b z5>rp%1tWSqQ&#sST}O_tqod9jY#dswCm3>J47Aj1OKjl!dBHQQs*gPI8^JHxC^fe*(>hJ@ud@?l%$GCJphqoM85$!|g^G@=Lb^B`hY_x%IaWMbd zDaSTa_7aZq>3j}vIX;n|QFDVC(MtGS|L&eInXE@LDAK&%V(>rB{!*+SJt1Y{jTPU| zOqEwg^PSG;@RsA`_kHSP0Sddl ziHw#<(hJ!ymV=*i$9s3v^$#a)9y9d)AA8d|IZi*FFGKgGJj(s6r{aC-GIS($rd}Yq@o-%?KmW%^J{)!t-_Plw^Euo;uCp=b#>bQ}=B9g9Tq|whdbsxR`EOT# z@D$5sTsoh_?c?$b+YaBS;>x>Fa^vaifG=2AJ=R*W_+ai z1UIYgN7}_Qws^P}^||W0(y>SPXSs|^=X3Zz;Y!C><15mA&DmX7*}!>TyEX^Tc&5WW zjDvCNd=9sd(@S51e&H^IMLy%2VeqPv;sgj0m`2u;daMTRi=3 zZkxCL_O$zcXSu9DozLO+^;bo!zA|5BI#z>W z7!DgOxiEF{4Wc|{>DX??TZs=#QRA;)x54!8<-Y|&uw$cW!u6xEFvbSTu zkLg}=j7#Us(3bQIgTYEspQM+YD_caLNo_Z#T`psdr?(f+I`#&SbMVU<8jj}sr*NH3+Yyor(# zMg*L`i?5Ke#nWHrvhIVY4|(**BvUZqqWM+ko9u{ZA6F2s(51V*v(X!-ccjc1!tfd2 zperRa9=;bU7Ii%HjOD_%LRYiibiRzKCHb!$Zzp4S2-M8Nc4kHphR^sm+Q4^V%A@CW z`|zc&SU%&^`5bOvf7QX#^s)+{4=;hHV_Q|1j3Eq<@%a}?UOfHHy#Mx_j<4x=v%E5@ zKb_Cv_VJbS#6bFNni()72*YQ5DOX8mJbWWA%|B<#&IhU33&;A?`5fK?e37{U)P7#G z*|pTm%WdHMAl>Qg@y$9KP7BBQbUugM$4Bi3%?-#q!|+&dc~?tbJiT3XUcrmUyt90@ zyfT`uI-kSs^fB83`jo*5l&EGWK|S{NbV%<)d@Qp2#>Dr_Sea`#6KqwE^i^`(o}9 zt+sEO*CfVw*@3?o_4K_$CR^bcpU&s-zk`p*x)hg+v(W}l?;jmzZ2G(;jd3teozLNa z3#U2urMOg_3$K;2$4l?C4$in>%#jC^SzI{Asq;Df@8DFbZA-ta?{zZvcsNIIU0mB^ z*61f02jkTF9Bv<{ADgmamz(l*vx6ho6o(NJmz(uA@ZI&D+uilG7msdb0w8>}{(|`? zJL1{LCwp6Z$AOA6 zcdGN`K$65E>uZ|-W-K35Y$4_d{w@CF%MJU!K4wG0 zpTq6r3c9_)*!$7+y)iMahmG989k1`&#&Q{#&gXFZxcshq>W^B7lNP#^J_tTzgjNB zHt?-^|K#cKW-pt__cK17&*Ap*p+AqWrEn655drHhYpIMap5C6{xo6xLBgQUZxr|Ha zb9jq!X+w@MB4T`vHt@YTV%kStx_(>A@)@7b=WzS@qT`KV8HT&&LLW6<>&#J3JpJ81 z@tU)*=`s9Qme2TfK8M@KSK%q=M8(Zv5bG`V78zSST<3rP&4~{V?0uZPGTNWl`5fLd zTw0+5_UpMns8EZWK z-MO^G3m+|;PD>et<8;;e9ByBKv~Hd3XV|zny%wJWcPpuEZEttmzxnT6rmBRVq< z#;Nl;+&)h4ELb4j^hG8zq^a#j_#ZO1c>4S2121LP-rTAe%Vk_TpTq6rik91^xzMV= z%-a&<9Q~g0$cB6xr|HabGUt6 zL3|l6y)=NWyiw()R|jAA4^Euo; z&KhBVRPl&P1`)->5pE%OA=sqd0XwhuhbuoYGDAyS(Wkm?6{W z`g~PZe5-8W+i>~&e?I-lbMsj~r?<}MaQpab#dj*wVG1u(CW_R4ec>`0YdrmRpLX4{ zk>g9u91+!@&TlzBTGUdRJ`1nlQom{?h||@$H!-f6i#Gqeb4KnOmdkq6`5bOvZ<-xE z;I1)O->7Cs3*MDB@Lqb@hmWVXJvN2$FkYR{;r8*W?O!EcW|o$Oau^ZtDlz8Z>P3{Q zerHl)hl`i)&#oTuj@LVGr@S(n?mC~t_YJQcmBg5iv)GMx+rWFv%b(5d`O0CGm4svc z>U<7w0bX}`Syg(FzMzDg!ywM5OUzzrJU#Aua$&1We>`La%Vk_TpTq6rimp3MKik98 zz!rR&D`c$k@Rje`arTQlTHVj`8K2JQ@O{M>t3R>X2EH>Y-oG^5ds`=#&-ipchwn4K z80-H0rdHzVukBB-Uby0_j|Q@Q#;5Z++&;dFP{^O|;+;3bh=B85$^$aCc(`^tQ%|_- zr15zymvQNQ4!4hsb}L4mQ;FppAy;GqU2RvE+rZbO;r-{P_k8kGme2TfK8M@KSL-f? z#mMECLou~qQ~02aEuP+fe6?!UTZ(FY7+#E1{Gs$p>=jmxwI*gnYCE$0A<2xV&)KW*f9dLT zdpylJSf4td!}n32N~4Vi8+)d3d|{k$xygH2a^vAWXyxDVjnZzmEJ(^EqKF7r>}*xP5%p-fDbiLM~2-s*@X3 z73UJl1aR^6I3}ZV=A#E*xK~~o?LX*z4!4gJt2@#w=^H$}!pJhB4kJQN@61PJ?D25E z;C}h?2^WpcXB@0gozLO+ahmlIt@4FgqB>L|Qe4$zqYZo~Y}x+hm51Klh2=9oozLO+ z@kR4vK<;5D-qGWD)cU;cQOS*`$4|fVzj6M?DW~xLj8o@xxP6>hG2=;hl_GP}y=wi_ z_c0k;JX~Y44|(m==NI0?av7J-=WzSDLbO8*hJW~mOe81LKk=~xeqGwqA6st&Z<`q} zU3kZLe@$gPj92G#xP83Tp9o^%Alh$K?|lC%oN#$*cwBPh>GQ*RFJ6~^N2^_YKjYK+ z9Bv<1ne7fy$A{LOyD{0#>qNa+Eicw5QQT@d>idM077zE6i`x7&V7q6nz8;hL zjF)};xXlTcGTKWDTjE%|MHZYJZQz{WeOK#sGfJ+NdX2U}%x8S;+s8T7Usj%8;l?gu z`0{R9FdZB7$)UH1O4VoGlQQ;r`kY_adfS*w+MdBUI3MVI4!4h!7N5}=mcD&~eiEOW z5vlog&{K(Vo^|&HKi4nxm~UD}+aaCba-8b8+swQ8xRu*mjz%=vesa8Oz13&~_nn=3 ze{^l$c^mkC*00XzaQpg=fg5}6z);{;VXOIJAt@a$UVg~z^HcHA9q*bw!l<5gzKp3Q z>xs*-{~xjfdM4F@S+HecMpKkD8B-V@*I#|jUS>R;TQBYU$+BxTaGX2ce`kXiG1Zqu1>S!t9VAn8c%~n^Xp7H%^Kg2LoEgrs$zu$AxYh$y&;rls#bv}pN zPv1H2dNGZeP77l#_NgT{aJ8;K^{s{enUQvvaq0Y)!f9; z_TN3`jue*5xO6^;+t(L$*{~61x@FuOtr*P|4kKbNzuRo!?a}7&-aXEGgO^8&c__+- zI=|(3u@j`&Vb8jLQ>_OVKPO|2r_YLh^Ey1$;rT0AKI>EGbGUtd#=yr$HAJT3%zQpE z&O6)QS-JJ3zan-+#;NoFGdQCQi&dPBHgGO^?vzDG?T#!fj-?lMZZM1pIbSxIvkdXleezWkf69F#r+{&=K6O5a+fR4J&P#9DVlx$*uv7Kecdd*y z9==n*{%HM&kI!yk`HWBJbNJuG7tNR|&W&qj?D23OzqM{d(LLXN&o~&T&gbyIi8GQh z)&5z-3yE=lxMu17SAH?*AjZKsbv}pN$7x+BfF8RGUt~`AVJld4hVemUS0%-%wu`AR zN-6R5y79^5|4N?wV+P}4ygHx5?c=4_M}bRLo|f_MDjT>?fAQi?GiE<|Jj-QVI-kSs z!IYArIdJhFIgEXdGfce0~inE)%hH5AFp*iVX(~SCxgsd5aU~K z17GXTx%YqW?cBuPrt@2l5A$;vA_OsV^!TcSmTpH-&ZAUfGR}Pubs7exMvK@XMO5?4!5sQ3qDIe+-U<>+dIx()5|E1jFT9b&fgbYK7T1{ zbFPVG3~D>RWWD6Y(_7C=`#*T`XIspbyU}r?&TlzBA1o}i8aFaC6^v{U0JElwGwZd) zIM2Iw)k!@DueyzKupV_jhucqI4?aAE#v0u<(L8#CvI#O%OvSm)2F|Q->&(x;`QaAE z!8mn3hug>5Or4qT5&JEuI2XSzV~>~azg;t`GHLAeZH$9)>U<8jk25-SMB6APPVsIQ zb(ZQWF14P_GOcFuaISr$u>6VsCv{{Tj8o@xxP6?>=`&d2t2MiE=)yH1Vy-9G0x#L6 z884mF09V~de$?2Uw|?B5d;-|QFLu*wyfgKtNeXW1@%X#g0+G*o1tL-GBP zH|1R{pS}k{hKj;B3}bbEDJg5*vhPg9A)I3*#YCsL3%Rx7Q?f^Xm zB2xyERcu}<1~W*oZlL2pIiNE^^`Ir7r$Jjmt)bKm(CMHnK`(%Q2W28N%mcjyI;b^d zgVutMYJ+bgfE*Ye&j+<>XBanuj!(vZnV_4Xpczom@leo_P|#seP=6?>5DK~q3i=8P zIt|L%ez0NOeu!aIry9mNhv9q2hhuH;k%n=0FYJfc2f9Rl;Qinh;+Z(#HoS#Da83~5 zi#$WR+YLHv(cH!Gj19kZcz*bb^@V^Z9OdgIccD(<2ruo&!F-b)@vuX4!a<0-UoL(V)RksLL3MO9d*87<6wS=#}r*GKIRsX zikLKO0yf2Qmz!a-VNvn)-DuSdvW!8xS&YK4dT9E!BxB&_tNc$7>Ah3e3-jq3)tPt- zodwZP&t%}^5U6YFO(68$C$p8arqfE`AvvrcI;Z@g)^j;M|9y;W%~e!ng=78bd=5A9 zjH&ZiqT?TueIPv8`-??JF|bRAu-^936RJNc;C2Sb>dg;YF+ zAIMnZ;dyQJXPNWA-9wKq9OKdX9Bv3kV#OJ5c}{kQw?|LyvS>LRL#s1Bm~hw2`x zcc{*x`iANns%J>YRKHN&LiGyODO8tG9YS>n)frS*P(h)(!3CnUm<^f(@_~Y&TF^Yu z`JjtH)URFyx)yX3=vL4jpnE|Nf*u1s4O#M zG92qE*7p+EtPY>Ea8vzGd1bVG>3j~KD9!xTC4?LJZfBMHaH(ixI^hkLvMwf32$Q~3E=KJ%lJ<(XCfm^yb^HQAOTN>JO$x~=jaetup4@}R@0IOWkj z=YFy2mkwRzwMp>k`I#@d(PPZ~I0>K5%%?X5yspX!5_yk`C;2PMV?43)<+OEQJTSNO zAJpv;&S4&Pz8P#ZpD!o+reKUGzf~E@p2nb7GJgy%=~YB=Q2bp%l>8k*)Ze5Ah|jy> z9A*hI?rQ^|9NmLxgirt3k?tg3=0ttw>wfeK`)3@7{X61c$?>rt|LXmr|CclnMy8

@d*@NBN%0ObUp~MQ0F|Db7z^F36|w)*w2k@@tg6 zX*|XK*1liM*qrc4UaWr7uJmC&uY0beX_=ArDIImbj0tw5X8Z3nZ4m7rsr|K88V0(kmyH?@T`!qG7{-pii;AB8?yCN}UYH*rhqYfH zOF3#juJ}>L#(L55Q0OatU%%tK?l~17Q{wnB#r#u}j3cgl_Ts}H{N~jY%*t*EuA}}V^YPc>uo@ub%gx5h zFwvVXrBxkd53V*1uwh)y^258V@)6|7!eQZ0=qI)vLMA@rrQWx$fB1++*U`D^n&XR& z-5}rT$F})(SVj_Z7r3j$$}sp?+=uzfj2y8QyRvX1$ZK=N90%dk=fT_eYHb{poopOd z*2(C7af;FZo`a1c>r#yqzCPT@N$zEw((h=aXna58j5+B>`IUo>$_I}(LT`;U&f78C zSdfx!EE+u4xMA{mLW7+kSjfb9?Vm$f5X~vp=&oEw1Ei>L8IosHD+8m>Cp3m5J zYtY#FT&=PDlX*y&2BUqiiy?cV(Y@?Squ0fYA^UpBUSf>;`c@-5`3}gw2eR)oPM`Cj zQFi4cko^Q?KW&`5<2mEvloug;9b~_5{3H05anJSdLiPuc{h{&vzdte7rG5_CUqkkH z#=qw6FuuNZ7i9k%vi~4;JCM{grDR#(H|S^LMDtCo@y{_gKYv5&-fPIrA)L%UNrukn z@Iv!z2L&!K)+JynHJB5q_lKPHNtldr?od9xb%BKxWWJ_*)c*CfU#$6vY{it9*8^u# zZLL5X{JC?Ntp441(7ohjd+jiEz6_15lggGKU>Dm2U}d5Bw3Mqdm|=c|S4>$>f^9vr zVHS@=^!!85&o&*lr;#l!8AM|svTIX@C!5^?paVfP6d;=&*@wvdPc}QU50TCL5YVBZ zR8V&iDY^%U2Es>xNC%X5>iDb?dLkTL-Wij+Uh1ac;Pd~wyMe?A$9mHF9B!_c!m!z` ztdgQFA>?0PU&4B!alQZ7#5f9)=g)j&;KSyOT{OLPegp@0-_15R-_6K%2j^g0mkeil z4dt0~s+6#I9me$;W4yFpv>c@>S`Y069(qpJ3#U&Zl>F|CZ;P3yimTg=dee6pT_POo zMdx#P{B>m3c_{zCNpE)!xcQV{*w8OgZ;_alLls; z${d&9Rf>gCArBU7VIfpdyu)K+DsY9$@O_TixJlJd+HY3<#KMz#?<wuEqf47>M5xSpTo`k zBR!Pg8hq9-Fsa5J2;fBNP^dW80tdy*`IycLi(0?+f9RI_KJC|al=)ZUrv12>&+^$f zapbyZxvDEe^4}OQUY$h!76?Q$u$o^A(R8Zm6Dz-5(Bs7sH%)2v0Lzhh9EQ&4@I*Lr zXs_`})uA$)to>E_327N^xFQT|h z0+{!Ay8>kuvU7z+yZEq7$WqTv`!g|)fmi?5r_ac~jVy<8=zI>3g=2E%To!NXC+viL zHCGk>GQ*BGbUug2l<%Hh4V|E~8L5R$-C)MsgC!ZbISk@{@Z!G` z>t*QJ-*-05nCWA=oL_W4hchmxr)o?kUiB4qUVVmgZtm7>U28q24)q~*)t4*yGWR6L zm%lA#-o)W<)J)PbKAq3ue+wV2FbRaJ{fJC0ck6*uO<%p-E$r9Y_%rjR1Ft&nip5+n zQXZi34D%Tu`?hhKbd%t?>?XA!2c$m*P*l!`8h^Ex~V4H?3 zR{L@Nxu?E2rS9}|Nr&V}uWfK-zF;bcB6lc+mJ>Z=nKXsy#Z&Xad>S{BO9PR9!ppw8 zIvMdD^;79hKYahu+kIZ`J%Z9g#km;a#B+j3eys9ZlR3ZrNgWRwfnbYkj&F_+$9QYd zORU7#hs4k@8}BDp`^Vx7A{>c|Bh^9Dqd2m%JBxM2bwdr~k11=e6+LanL30QS(ypw<`f5~Dk0z6^4TyIwTAmilXPk`+hVnk0c^CGai2 z?vZyX?wLq1a4fv`srslC1-QEa_ zHBRObI2FeDJ^5%d@_tc5`7({Ch%Rw)LPD12c zK)0c=EQNs05Kx88>%#!*FASbe#DM8^43d_l8b%fdfKME281#Bik1Y77Vr}GX!?@rg zjGOMo`pWlUTR6aByfnpOEO-q1>6c`XK6$*G2HBiXS3>WcPhVbmPLQ5at#`6o0UVqY zB+f3qu2nhC3-Lg8TRX0!upYJj8a8iwXlmNQ^iN(l09P|#a-+wX^E+Uw?|(RF;VmMM z+=xKUuj_$_a4;UiOZAJ|4?4ZbIA;09_YPx;0ypl``5eygEM+)78I$}Nj#EL0Rfo$v zU#IG&Z+jUl7?fVsko-$WuZj+nNfE26CDPh`KFGG`L=OEQQ2;< zdzL2@jD@TL5pjL6*#@ppKEA2ox)~cz*KskwSzNJ%aWNeR<7(#Puf-L)XOm@L3<3&abfT|mWKhM8m*{=;&X3p+1E%j{pE=ZH z#spaHyk+%fY%0#aDc15&b7^THeqVChz_!MXV_i2Uy)i$Z=9NuINKoqAfz$wk01QK_uxTYNxUw?Ij+ZrEy_wMusubtCI+81R#M*3s^-@#Sk^ZU^* z3S?nK#QA@B0$hbd+Zw(VfweDfPTs5Qi}`;8S5Cke4CacxmQ1A~G8NyFF7fp?b68s= z_rfKQ{^~i%r{iP(-@r#*oho;p+f_r01SnDA!XVaPX4m-mR?SE;-Y7a|$6IrM+;t4y z49Dey`H~wwwjjSr)fLrxXp+c;XQ^Kr6W}AMxnq`{^m+S(UZy!^a#X(@gd_6>Q#rH% zU&-VNVs{>)M{Mlo^Ghs(HXIyZkN)Ffz50G=kDJmy?X0IW^A(8Vv;{cX zJYX(0kZG;rOT)%Gq!%ZMe7*hy%lPN4P42<(Y^u}s$b7m+buGZhJu|1@Bj-}cju8g2 z{?;bI*D$=T@yO#Jbg9hG|3TLu^Hpqg-U58GekQdkm2((zFus|GB-Y=(y}M*ST>Sm1 zy8f6?m{ivie7-8bFX%@5SLLHzD56p8=iR_Zj?*{RJ|Nwn?Y4c=it%&Bg*eDN9EQ&4 z@YwjUc*R^P63l?1IVfzpPFfIUPG4B&$LbEX;?nJ9so3Oc_?G#Tez~vWpnrKD6QYw~ z2c>p{`HY8svX_yiPJ16WvPDV*F64CEt;yHdA>_?;827%LeD$zVhm`(0UrP8E6&%TD zKFej_DnGJ|SLB^swO`#p#$Gs17ybF`N*#vt%dVA|Z8~8EKR?T7KFej_D&M+pKcWO& zZ0Y}Wx8`32HyM|;zk9ahs@jwnSPuKm@okNNa?J5;O2+V>MntSRIJdw*ffGae0U}UO4o} z`h$P&BB4^KRP>$3Hnu}haOe_SGz z^&@GO`7Dopb2w>EI%8;?YY55vgS$#&XZ=x?GEL|od6MBW4O%RbNBVi@VJq%WvB^A`&Topx zTw7S=cUM-TLtZuq+y6w-gmDAs4}Z_Zdhxu!Xza89nA@MyjvV<89GNee%E8PZMc6Ez zmf;|iV4WS6E>A!<_4z@u*n~PjMRKm0CUtqZZ|P5_q$S38#v|)GFFE=A8+CllSD=a0 zmf$lNn2o9Oha&hI5DV*XG4LhI-$xzP?YFvM5Gz2Wllcqtwi=(qBl$`cc^H&K*oq<~ zrZcg7sC6AeYOlolnGl}$&(~)4zkuUs`8uD&Bl6jb9b=6uU2CcTfJ4@R%lgsz9BvPnRX;m{BawcpzV6lM(8g^y==xzk%V)ni9M19rSo83mEwK+! zQ#GmWMnj*(`g!D+S3eHkv*r<&%lgsz9Nr>axJk{=$w$lBo#2ZzZ9PX}UxzW~_trP( z|J3K@%jBhE9X^eNn9n%aw~j+1?^UZyIK-tYj>Q@deLS}E7>5!1_i+RNc>kJtB^nOq zvwZfgI27@bH>u^7DvnghA?E~%Gff{2*o4^GX55JtZ5|z_>x20s0_9-EVI7w#sI2v0 zMtmF;{dW(~e6@F9&!0~WkizJW!9dM?$&DTf2M-i7imJ=VWR3+c+I~qYB6)8Z5mWmV zYo1*8!KJSFoF&qP8S~`Rm^uZY{xgrS-|z362AW&lFR4BJkv>v~{*RI)s?%D46tBWQ4`I-b~= z0Ed61!#HHz(f4InpLWI0aZ(Po`IH{am)z*lUOzF4D2!Vw9{B%({yH5M>ROD2)28ly!+u z&q6#V`p-l>cElsczWlfUxL*VR`!osZ6m`%LbkE*n@oa zI=+6tZ(jrZ>ofbh+JEJK4d~_Nf2&5+zJ+@Jzx8?c|B+&Gj+m$UguZsj_cq{! z#~G^>TqI8)|It02U+a26+GX2sm3X+{?uhW|8r4O1FbHPQ>)cqUfkjGwpBD?V#p}S9 z@!v@@Rwp88PX7Gdv+gbExC0|F>By(i5%W!U#7iJQgIDU-;f{zNG#up!qXhyq`N-c9 z95jF27SGuFrQ9bY9JGH7^YPc>n&Oa44pg~=PL@yQ#GP~&OYZtknMahTrqY&A!pS=v zhR)}3MK0cs5qlR2!40^8pLeAuH&(izmvzSxg|lbza!`SfQ0n{`a?Nz7IJ;Us0TwpR%_5(PMwVnEJ)!=(%Y>0p<&)a!{TdTe(f}m5DbThFIq5 z45w8ty{f-;2s=PX~pNCBEq$Yg2mYiM=C-|_}3l}_kufkku zQiy9w|9^L%FPI$8C%Fw~eDq#lgZ5mp^y$dh(6jQC(cjQ`gB(3q8_K~ZUoe$}qR)vw zFW&MC((X%9y@qiu=clx6t6pQt-*nM{N3v_5^y%`MuZR|>@#RnTgetJS9V?CSRbEb!UA2_9@4MEgYx2&gXCip9P3Hb8ShV zG^}2t{LAuV>1SHnpru!wbKE37zcZiZvaiUGoJLc}YTsI^$&a-TSJM7`Ms(^xeg;d zs#d(&|MHDDA65I=4+~hHyu)GWd=6LeV@UC&-zM*DXNzqE+%EGmS@vJ{}tp4nu`H4hlL43VI9*>I~&j z+ESg>03C6Cv34xLz&Sy57AyVd-FMaSPmH;n={j=q4u_%hWhlOf7Tv!tlKvB1!BC06 z9E;hl<)Lt#Rem`lp=w%f?^k}&YRY3X^55q8S-#Haa78}4WNLXBB9^P+9Xt6wCG!T= z{ya$2hrW)TZdqOY)~4rN&J|ze$Os6}P-unuk{dnRvp+{yw5xa;ZRls+tA%eLbb9*> zSR(63=W}@T`Wc!~KmI%!yAzSoS*-NB_xCqPtjb+Lk0Bi6(fJ(SJRUQ>=mPrwm3f1z zA0t08o}=5``?4ds)x|82@#uUGZyt}SpE!6H+raa$-)}7ca7_N05{J|ywMxuq9PBrb z$JCEfx6?hUe$vJ#*3W>akFR^Z`p)lI9_vTvb9nQ3O#Nth)N#gg8+ba89T}YZYwwLL zkMZby4sRZhsh>h0J_ucJ>3r)|JP@jF4}qbU^jdG)=4s#UqaroPnbbOZ^#=cnEOXx%lwAs*5i z3KdsFL1J7p&cF4?%yDJ^V!4b<=X1DyTy$l$LR4|3;?;AK;{=f(OJ6TF9=iOjPgW;M zJkk1x`HY8s`?#zHU&Xc32Clj%eXGv+Rn_;fypEBJ(c!0)FRt?w_bJvFi1G559J_-n&2uW-C9SLbthQ@LaTirNMEI*P{$ zA|G8_vB!2H@VwsfqWAIF$av(%yI-$;<_S7iU2}ZhE>MJ5JFz#03%yYny;w1ZHiLx< z)OKpUmM<8`!ZeuhYoRVTy@EGj-Tc0d=A&-=lQT* zV>v8SQo40KoK=+g`5$<&)z1Ul^(f=`S-#Haa7}(8+FtC75k=5|3nR~OL;kVVsdsPh zwLHl2vwWS;;ktZttC5HXRQXxOiJ!mctWPU{y<+NAj-Tc0d=A&-NB+jr|5_XJFYCB> z`)^NmY4SdS&QBy?);`v9zt&ug@5IgYT(Rm#3E%bF+;G$ma5}(S{x_?tj@4WjBA)h}(o?J?MN6*YqGh zJ>U*F#cnpF549bbHdV&P`iPYuc76SN*FT4h&F1)7zRu@xP5wk*gb~F+*Qz)gZQ%H9 z{`pVLdu>FMdO_#Mz`^qq^fHt?P~{OH%?O$qQ_Ua#X^HhQ;H`5fe|6)ZyI2nEL+5jN z@IqPrH`F3?`YymdU|X~2z~KX%%{GxCGNWnaBI=SY^vcyvC8t9W98 zP}8MudSZPXd(qAJ-h0o6pE!P&uk$%vkuTqtm7CV;U^6Obb&7Ude?q5#a zO!3AluRU5he{uaXa0kcF@^wCkEAn%Efk3rC6yX&6{vUhq0UuShwGW>Z0V}yEf|Vd5 z0d+({#GXkg30)GJiZUcaG7=_nCV^lb5fQ8?C{Zb~f(1n^7b_7JQB*)IV2xfC>=7*J zwS3RB&smdwb|y1}@4ff`zV~DQvd%tPd+)QJS-ba299CdY?n&}=m0z=yz;pVu8)qN* z!oHJ4p5QV0;vSWbJ)V;>nOlZ^PwIu41t=o$DDjbTw*56PczlbckMA#?eE;_^w;T^= zWkkNo7k5oQ`wy7!Q5iNL2bCxt==q~23Hc`+GPdK=!+TyW-xv8NU)(kMC@h>~33AHH zizedaEH#2@7hDkp5It=5*fBYY?235gaC8++*U<f^$a`kk-J@b{AJevF%E|L1<%`f>C4Uo5_STiiqj@z4n0d^i7> z?~uRC{C8=f7Lm*R8f#xBmLn)5@z1$GzO(Vm{KLuOSs?nG58@zFM-ct(<`DB6!!Ye- zfSC5^pL4*N8dFBnqx0`BOVfZ}&o1#(la2j^SmkNe(0*61+`8~>`Gg%J#WMNgu9c^Q zQKk8?dZWZM1jDhDaSx#Lzbamx0A~5h?{glQ4ZR~kT)&kCVp+;~W?6d-=s*z5Qt`(y zOauI%?<`lDZdy4u%U8OS$1;^^j%6(UGHuZx(+$g6Vjz#U{d@7^7~x6TN4D_9k8Ydc z#Vr<}rI$rpDm|Kdy=bu3hwx}wclh~so8UHz67$>5k@)BlHavS)~#C=P=!?#<$mUakYA z76GJvIJzY9x}-fzUOjMN`W9w)Wdw)G7xxiZdl2B2a6w+Dg}eMFMo&M&fWO>$n1j=* zcxh(PIi-b7YWoWjSb}d;68J*f(}y4Ob^S{sU+|fHarYMS#00rsDt{7s4}*N;{bkaT z(bLPgQu}LO1m;_;^wRg{M=yQy$Q~EkKBa8Kc^eL2pp?Wt_f#Y_A{Y9er})-Vc~Kgb(j7Q=s2JsSYvgk5j2b(e(xq z_!jx&0*U4Czoy;y4?NVZRD{?#uy4`ei+fY~eS@Xy@=M!?Uhg&}A%DaDn*u-A_k2^n zFY-;kxHm7Kmm6V1)Hpy$AEzumFR?z}`#Ie1l^K(-Fylk`fWU}lX0r%9 zNIbL;+F$d6$G6D0z0|x|dyLAK3|P(Xm33Rmuce#+@s6hl|AC>uz3>#iVrmcP1Tc>} zW!rBbE~THGWVSc7p#M)^Z4J0Z$Kttt?D}t)2L3Y|(95kQ$gfPBUJ&hc5ZlT6I*t)b zPoA^m{)$zShG{dD@bRz9V6ksuc{y%$mKSwbEqe`|+2O+PK7kN2wOnAX*Js_!Z7E)S zk#Di;v%3!r<}W*K`g^ud+aK`=-vtK$4Dtm_s!)lJK-b0ZVeMK`DLkyd#ib&4hzKkx z$Cd#HbwM1>nNNpwe*Liz7XK0S+dc%(XAa*CCo*Ho~mb~Ec zEmr(~xOCpk9b=zw(w;N<2(Ao{`wNCKd5XBL!15q_TZ5`JJl?V?Sm_+~Aiq$Lb+=yY zfG<(JFYj18`Q%fl-1g+Wx&Orc{-5?Q!g^kZFSx{xif@W<2o~svqV59E37836^jZ&G zx?IZC(?fO0M&SjYZ?W_`V`A2B55JSvWS^4o5zJ+xxRS-~s8z?65l)QjneXnqdHjYG znyeEu`2sF!Tm`twJ%T95*#_e{s;j6-5oRLUkgGHh;bFO;J)F=9X3QBHplP0Is_a`lp8N8?(#& zTwWPe`!8`AIEOs2zE_ltkJW-Cp6j?#2gVEH+j=OP!$tMLJ^0iu@8i|F{i+|kwmEm}+pdCqv&h_E!X|*+1y@h#IFNYtnJjZpvQv@H1;xp0#6C1~- z^?L)SU)%MvJq~=nh~w2XOe?8)3STj`hpYcTvZtEN<+@1p{?!G7_3%siJF^~i* zdK$a(s_Ug82^=rZ$$j{}f^|$v$}k?O9h0xvc*Mk^#}D-~*oP*5NR^K|p2)?C^|IHa z8Iv2POz14~1dquV_oVQQm=YHMI-ZP6661O8^J%wMk9mwqTp7V*^2I$VJkU>0AgF@q z?eZl_;Cbi#9}f6^-eV7nJi%k~#XT_|`dL4_Y^YVQB=9$+umTOxL;LVp)0_ow0E~ zptnDUMcnNVwmn$J>+9jG7ajG{)1!C1&;AY#@ulM_e8torL;RJf2C)xGCIWJK6@$CK zxfOB~mB$rD2M=z!y0f!W(w0lK!q-Hq*8*HI69{?=%P0DSYJAz#-_PkP#Ry}!CK?C! zrAw-G#tkF(7xeP5;xe~B_?uC+xW= zvGMdvG5NNuWyQcTm@7hqCH>2$R+L6ZvUD7gX>J_ZIjvQFUX8)`e~zp>fBn-b)^gVyjjJ2l+LF4!V*6D1B42DZBh|-Wgfj&~o?%!EFe1=@LN)fxlow3Q2~4p=}td{%YR|@;ASB^rkyftZu#g9=UywK}#r? zW@JBGzVK~s^QaERV_`5ldR|C17wvC_n?KkhOn{?LKy_je8_{p5^ z#>I6EY?syMVov1ccYER0T6F!fFEzBSWVTj@`1vbLzGCB15a5+Ab}KfQ7w>SUlM}wU zn$&4JDzAEdumU(}ydb{CI`8DCH+`Qi-|r?4S13c9_o)cqVMi@nKh83456?Qm#V)+T zIZ%l+GXobOu5!!E)HN8B14v5}FoG9JH@(q-Bp$)Vbi>MiShi(VjydVqHE*U^ZU6So zw&+KSoHgde#x#I`TGg~ETViG+6*Op#nc|L zaYUmBi+gxau{*u42M!u9h;L?jLbqN8CEp!*;Sc*~@E;iZ+Z|8gE2j2{jRUjKeS?*u zfImDmXde=z>%*Gm#!-uo4AaKwD^skc=dSz*KR>T?!_W_(n0Bj(vO}aa;fs3{9MM!E z2yCBA@FAwpzuNDTJkEX~`(M-(`(SNA?1$|KVo@yXnYb>B>!i32Did@V=x`9rX*TMQ z26YFaNLOoEPlkOuC>N9m8Vni^8Vx!J#QcNlSc?tS3qjLC*MjDOZU;R8S^;_yv=Q_P zXd5UEzq>7neY;aY+!BUqZ)+N80f=X4YzF-bIs};^2Xr3jCeZVsA3#}1xZ^o@5?&P*b`w4S{5t3MyPCnp>DX=t5_r|=b1do)QegMHPpl8l~iGp@2f?sdK& ztDL>_$0ttuZsWoYOdB)|u_vCwS4{2E1czKlU0AM47V$b8FH)}70tccanveO8=y3I? z>(W18cJuGf#y_}yub_XQV)EgnjInMdi1xIft)`svYTPS^5fm=B$q&kLBd&h+`fJ>J zG0Ti|$Y5c93%N#0vLhGjL=vG5gBdk|N&>w`CcMYB*;D80OiT<6x4S>9~AF~vIT(epbUk~yQt zK1_%(f=Bo^xAE!5(?lcDbL{o3T|4c~oZi&N?BAUuWdu%j07$lPD^_Z~GxX3qcF$n5mW zaze@imU?s}PyE;=As8^?&N7GP3H^y*@h5)Zl+cKbgdTT!*rkF0payD@FwJ^e7jLFp z<^|TzVoZ18cb1o3_Wwu&yUMfwk@|K8{{NWabToW8m-(C933up^}|*e@?)K|xN23+X9wJS;w`Ohs7gND zMZ(uatJj$AA~5xKbzvzs8w7m;j!Wq6*X&ztAztv+o6*kSbZd$=zqG?GgWK;`w|5C! zN|tpsi0x_NE2j2vw;QAFX&r*{9l=xLrOv=%wxe4u#5#mknSX2?-0+QHr(4k8|&C_@s+h^dRzuuZdQ#Zu#!^a}*7H>h1W< zJLBWvhYy&1c<87L7r!;jX>>9~N5r1+=|?xjk+|L5h{&v8TH#~dS50ESo82nr4T@)< zntg0(|Ke4>bF5hU+e|g$ZvQ&^YHVZM|26;A!!+;f-|zCj1;@Ytm+q3VGa9Hx!f39& z%yDHJJ?$|6@c#}V<{cW2SxJ78dPh0zdi;+yV3udBKGHR3<6r~iQC{}vqofuFid#7<}+4}Q(^EVD1>9d|OpM4az%{cA1S zHOxC+5I-aNNZ-HuY0>pt226Z=I-HeZdB{@H~947M+YFLK2mIw=?!UtaC; z1}51nZUbm?PxWZ;SPg)CXTtshEX*zPOSlMLq}{s$xM)N#vHByP%b%HiX|GAQU#T2%Zol<=d1ofm9^ z#|ChFn^4#@DiAC#$2t?e!30cp=0H^$1chaEBzR&ZW#@0_t z6TaYy>dIA!Z@TM9CyrwSLCFO~^i)j(*txqx|O9DNrZuJ2BsKy+KD%Ptb7CWuR9aq zb;m#3QJjOVD6p(4qxbYNO!%8RNdVJf?zss!h{ zRbpn_)<2dimQTUy?Gc2Lc;5jWG+q$jV#WLBhv!tbU%O}&{n6MVQY@2iyEdl}LFJB* z$bE_BcPKgU!O+aM>^dtW@=dPZc zU40Q^$Tot*r?9vy;HF;-$;(Up?#k?Gj#an0#?>21hw=GpVku z@|8)Bj39udiwx%!3@>>6eyns+cTK;x0HuxLrbS?8RZLBdc(Ymz*mWVfMLt3g-4OU z74m7kAil-w4^>QieE!PJ{;TPaM&z4(+qF@?x2m$d2-m@t`FYccTH|A{m9rOZ<2a4t zD*Jo`e-s<=iJ% zjW3AaHa+6T#r(}S@($pgd;a(84$Z(P&+hTW5r^iBV9}e&7k9yhy&_5<)EM3BL6qBE zyI0CM=`*#0e~xc*-3;5pY$viY#5OV4@(~;x=vkm+KrD!}K?6afK_wvm)@wj_f$Bi@ zpceQ6$ASEy+d*4EC!+Ji3sQGSVR|*F6TrL$x*Lu08UT6(?dv}PD1t%OT(q-?qv85Q zhFve9tA8mz>nb_^zoC_`Hy_|^Pv}iBBH2IYSrY6`_O{i(A0`bkIIcm{YCr_IYai` z6qfVG5O+Ux#R_+QCULCyizm#yy&^sMYp%#)-+&{nCSTm`lE~v!;P%d>JYTp}?Lx9| zC2Bm(27zi35lnxwj+AK%(fXGS<8_z$*J;3vpNakL{LeUIx)pu%J)Zfi?)<*U;P>_a z_4h>IkB9C5vYXx>%X`9|pIJtuShVzeknif2wWQ@Y3$J21PD34X{89LdsXd$>N%nR+ zG!A*%A}^o8Ee8b^*h}oJRL7`JxIBnTY6ZedJ;qHA{Js}NI~JbfKYah&(DAi5!dV&m zqi>V1*mxwuV*|xrI}R{7ryHpOTL7*c0b0!G(iQT6@bK+#^FHxP)(W8=uYN!ip1h;Vt$6xMJUnU6dt3j_L3#GeLr{4)|y! zzRh(XbUWykOABAlrHgIs`O!U^@Wp+IZ*rhS)f+g;fm=&Q1&T}jl}v)%saF}QDpI2t zI*vT-)1--qkXJ=d~h-dZM;WzPLBR!HscEP`LF`!NVM2n!{0X@ZYQj6MKL3 zXVDXX*goxXPNpN_i+r)0;OH0fP4YJdQi~7j^{Ry585_+k)y8Anglz*7%UP1(6&tKw zW+ybDm)q7#TZ>+VS8v9;Eq-?XpxxiP@ruZtS&j_)YY*STci2%Y<~kuTUF*ooD|qS` zdTo}K31WKTKHN;;k$t$u6IKqOtcc^T=Km7l?fqPemA_}NSDp`lF>}S9ET!!Ic}&;B zS4{2UUSHL?&P*Ui;8)6-%sQo|X7g3)3n|w0%Oi8!oVd@c>9$uje?a-d*F>vVxBNm! zY;<{PBiGE)I0ek z@uz!eE{yKyU;X~Cl=-jx*1!69?)u*U8x7PVQ8ZUC+a+aV-6{x~jyUEbhWU!TUFl0S z@~^Ya^=16Bw0lJFg*$P7H+5wF${ z$6xctFKz2D;5&_-k5ZcOZCA@G4Dmd~;*q|pvPzt*T!y}=kEcswX^qD|A#eg^z&>xo@H_f`al`aCYyj$f2e!|IFY?9C4`T467@f^Le^~_& ziJ1^6@eK2Yc%qQHx6bic0h{If&W@+EA1vb|90TPzE63I|K(Wrd08}-;T?co)J{f@j zY4rNS=EQ$y#&`a=xh}z%qwV@v6OW5e`SjTVH+eo{lqzEnBy_P%zPM{QfqME@SKtr> zj$HW4JodrjBXO2ad9JU5vuHTZP+h?1FYZ(2FD%CxOqCjVP@mFqu1Nyth1>q9|9NDAjNd{Fes!=YFYc|lC(d}ke|&ogYF_tM=X|9myNoejNao5ImoFO^;Y$23=0MDJ?H6R;SHzZm){Bdoq|(@gzvDU z)<_?YOJVvCd$`DpC;GDI99=v-6Fw!rc0fLj!>fcjkzLxW_Md3 zcD;(*1EPHT(M=5bjm2N%c1G9ua?OVL>8AI`I3Mf%zJKn&`=O~eVyq*FP^KH<>lpa1 zrJFu}wJtWdDilHy?93%FmFG;gN8-7hn6ah?=baDfddfs)O}U~cbG~vM@O^N}pyy91 zPk*hG6aIME#3y`*9kn!km@&YD2DUbE^qN{0hfDj0_sh%mh5fE^mt_fXECG(c?S9dF z>sBo(FmVV!3cz{MaA2Z>rzm@in@8gwXYRexjt$XExB`OVuZ8Pdc_=>4LI53zWE_cdsd)9=*Kz`n%RE>kioCO4&%a?S#3^?@o zVIJZbvdmBL^WQvna^={cCpf1PNxhU3<0k;P9dS)i_vtFLC3}dk=`->Q|_nn>QJwCURT{UGccb+ESakg-dvmXbGvOUmv z-#1soS5L)aod8`}<-6K(nK&R&$02=0{hWO7X@3rW7*EkZ>+5 zr&)uI*TdV5g<6D_^0qDsT<3VVeZKDIu2)kgjo>o*wrg{^pc>rVhjtVyV*mM7*g()6 zK3Dtq-Nbskr!?o5kuCmQF7gGR$rtx#^~QPN=0G8^p04VFi^dD$Tdeu z68fW2`(E%g`L?TNA?7d`fwWZ_9y%Up^x=vmXQEt93_Hsm+&D_#i;trL?Uya>);G*Q zW$VpS;YmA6_#$6yt^I;cP|-I%c zWSM+%ZngIK0<)gvH)K7Bd@mW>)@Cw3N$+ul&r{6vSj_`#l*~~$oKzY@1WPKPPNBb8t ztUISXd`^#y6CRZY*Wd9Kws(au^2Lsok0>7{bP4*}VQfPUmSDeH@9J4FatcP!1 ze&+~p-8`O)NyGF@9Ku&j?V+b%w;FKwZXl>K7QNSkq&yz>kvkv7YIl2kEtW)~0ov4)@a4N=yY49%UZ{@k#zwP{bB~z49u1zeL3%#Vbv_`r z^KY}3{yS>%J7}6q|2yt)ZDm|M`PQ~`e!5=L9mmu7JA|)3pgm%xJ4yeIX~EqtnEj9V zIBJ%*w!YtM^kJPBJXIk$B;5&LgP>lM!{JVY444Jd^~-v~Mn~61lZRK`AMtPymwuUE zlQsXU@6YZPQ zq#kwcdj9dlWLiKI4RSZw>%h3Ew8LB^Q&nb_sW}5xacIeeA1*qr8Dq~0|`{; zJ0#z!#f#wFlmyO{;Ocvh{N$)tB)s4>`QqLjPF&xhh8NXxoH#H!cqsTvKXaGEGPg9d z1J($q?~_?QI^Ak0*wAU<+Q6)59RLTyX89$2!6mkaub`?J9fv}HXi^}kuwg`)7nZ5D zxI;q$Tx#n+uV6<4JQ-ustu}WqneF}Z!UIe^!WSH3Cxxc~OD1hVuKGOkdHivl>gBDi zVe>ycX+~i2(bDnbJRS8Te8C~Mh6lGXL9QCGMyp2F);b;|uqB?j`Gx61(mUVTHkNst znpG{V?aS``_48|&PhlBKBk?4Bo7?zofafqd(Qmey{^PTu_0 z^W6^SoF$FuLHIVe@flaXR;@%3L~yj)8eb1fkUlbA`l-#`AC|Ul?}!pT2)_}5{pP}f zZH4yDJzUjpyX$(Gok0HRGt;f7j(hvg>mPaJAydBaBhq%&gmPdP_=kUI^K~0 z&!(Pf)-&6eUjOCRyFM`S2w#JuUUveIp(*=IdVY_5?XDlq@wSY!(ydnO&WY^t&3#L@ zIzS|!2|o@#yT&iv|aA=Y4XKglUsoPq+Pr;GF9_M&s%!F z%KSDlp4sD{xuEBl>&_H;Hn2gK$rtx#`Z@OA;YM6}zF={gALwNKL64sr;7Sxf1K)Z4 zDXUHK-iJGaX``2G319GtJz}sIOH%wHdxR<+ouSp^XZCmQ^vSV7=GQFn=RZ<>Jim4P z@(qzr&!=-*Rv8(8G5O*?%va**KVNi@x1ddlHVo2+vJOT%->CBm@R!L7PO!4ihtmt@q+kf-dDHe zoWEJ$opAK6caQCRFw+SQF|%A1zG7+*?34|A3jAgMB74z*Bmg}>l>XqBYu%Y@t-&|C z<8qhFZ<;cOpR3M$v+wik?_4RLw&kZb;fp)g$H+}DgMC5#{*VVyhU0XaaG(;G$D@G+ zj?+R=Of^jrooD=arURz!{Xy+O?LpjM&hnOH2aI3tHAmOQ>Imut>I`BBuq)_D5XZW> z2mM%3PZ0N_p9DG;lnu%S^#=_E4Fwf|xDe`WkPkEgG!b+@XbR|J&~(t%pc_HAg6;s_ z2jYO|)1cL$^`Q4apM$o6{sirXs5=nU6?7sfA9NOWAWf-&{$M}TR|7>iFt^+!1SBIzet{taCX6 z`3RBL`AFy-k@g}Ytq+pfr--!0h_vewX$ui)Z)ZbyeGndzcGW=3x(JbWCn7C%v}N6f zNDKKaYt{t(hKcCUAkwBF(jG&k^`DMBay8bVBGL{)q;=a6Vp&gZXMCqvAMTBN=?=nK;oVZKi6`NVsR7s*b#{tX7{q;`m!ZtP32yhLSO-0q zV%>;2!(8OU)AvlZZayN_Ix9ETy4{y*U3eKH3i*^}8j^vlpVff;jA)LQBW$WdrLJ?g zF1)P$@yAYYx6gs#)8K2^lgIDce8torsNZ}Q6`sbL%wF7xYD{Zv!2e8;v^T1MbmJ(7 zn;$eR+rBptuV_EqdQ#x%d!y?oh=aAD@aac4Xai2bYF&@BK8pqFWWNWcjpHDGBX|)U zI}991%1!2jt~>wU5fh(2joDcl;-FSczGCAcIIwC2ODf8%Fi!^MOtLqGMH--jBqI9*#%hk}0np?0#EQ2Nb=>2oz zcE)4j0q*?htygM@E z@~55|2tLhp5bH(ZE2j2n#LKw{2bw(%fz?Tq{R7I!pHbzn@(;p=-@H&%kI&IN+<46R ztQpnHn*G$EGd(AN*O~PT4T=_pNBD}VJ(9(P498m2mCx!E;GvjJ9S-omx$$<1&S?5F z`2s0X`jUC82m(mDvi|ATiy2Sjeo3)@8v5H|H!k1zvFu!1QeV^uj3?oXe6j6&LPs#= zU@Qd-rR=L-!{S~Gk(3`@mxTX!Pq(Z=$iRKzXVmfhHj>@f3=-9>BjPfJR$O8nONVVKfA9HE5!djUIdUOeMFEx_?x{T z>W1&sm5e{))!KgWnXlh;dy9>Hr=dSSO}=8|p(b>zuyZ1W!(ei%#$#MqwXVfo&$k)B z*4Nf^&ARo-VSSQxZge zta#YtiW{#w?d5TEM2L+8_k9?Aac?4jxW6(q)mw>Gl@*m?do6oGRZ(uHbBz~e{prS$4tJK3 z`nuaQcDy~fXZHnI`EMKIVfqxl!;V@`GV~Ne4}MHFVSkKr(|`Zy6#nAI-yiw5mny@T z0nbg}dM49tY=|mFG(5 z25JXPIiN}qkIKZbjCC@8_Z-kKpdgh0Bj^T1P+vq)TV$Z!P{AG83VlJ;uWQlQsscD4 zIs&%-P@( zS@)jQ&f2=}K&D_QE^tBCD`ZA>`_9CSVCV8!v*(N=uBZ z)fuCI?;iT~jT4*?5EsuO6ux{{>?XKOAeidGy!RxWj@ab9*_lb;`SFp`^B%3V;*#UcUIgUwdrzdo^7qQz0<4I^ijN#nc{x z1Dy%}a;DXbCKdr#b^qtaeH37T^8c=a%~7at+TRz$1JOih9k( ziNgUucD9DXmDo;NITiI^7`KlFD%EYv_B^^X*N+~&PmQ2saC#8>YVgYBtBjt`NAKp= zTP&Qb`fc6st@_q4+CFW)aX*Cc<-20X#woGsZ0$i$jCat>*d@d2xEhkcmDZ=rJIkMW zeTJz&;R_zIqbRV;b5WyKD=`?PzE*UWKoi+9Niu zzCkQvuJWUEs8Dg$8qd9kh3&*DE?wy#Wi*W!M0v65*QxzKzVNKm+l+Ws!*w`(3!mY2 zBk5o2SL6XCd~EAs+K(nXRJcwqaHW3(k2w!bIgfX#?0k9OXCoLYQ-;?5z$1K{+xRTN zl4Tr(KB_##f#w2?I-t5oLN5tmV+&8VwK+IXQr#9GMW`}{8kn}TKrKEg`E(oxPAS(5 zqKzR(HBP+d2lQp8Ou-Z5qzA0|@X-q{#Au*x=#RclzU_+fOSKQF4;Hah;tuo>RxDH( zmRA*(s>WH^X*BzbbEeuma=g50!MPGceIkOV;Hx+Au}ov(H!QnxyzS&$%f9q4Z8?f< zY#Q3Q-M|vQVrmZ==W3ioau2pe;8*0=?&a1GQyJTZdjIaLWrZaY`xfeWGhqn z@a{578CY`7$Q*`T$Nkj03Tp8o%8&N{5nBH?nn7x;gII*nOj3UMzxc)LF7t2DK&<%L z88LeNFs<6@)&7F+#<+}SB(CYE``6zkoX*qV&9LJCzrn7>kC6PEy|=AJFL?a@=6=uY z4lS&VrQct7_m{Ps-=kt-IIhO=JK-y)_J}bLh?BI{$(gLxr>eHCeI@E(ob`$9&2tn` z>ZsdP-17-*418w$WBopLqA5XoVXZiQlX`hBw}i{Y3-gUS{}FgZ-nsXkID_$|r|Ttfry*XtvHikU*bb1KS8!y};j6A4 zxL&ojz;@C^s%7%&Mk8C8J@%Rd|VJ z`UchE>)0#=GYsD)UTODGOgz#=x$=&L5qJJ?npiyg(fRTnvBh2YV}AF4)Bk!p?7m-P zI^-Ih%-dV4bU6An%X(+>Y4yZCYD=4?pD%r51;QR#$S!Hac!C`N1X3_(w33ZO63XVJH68i{9_9;&Q85?GA}aY`sZ5RM*sX+G1f+hr zuccKxclpGo8is|VNrM&j; z_%z2Q@v2#9NVd_u#8YJ~<;*$UMtf}I+3?rG1(Q4Hqw4}Sp0r7Ed0Vk)z{`r?Y!7uD{%zW0GmlsyxR@?j z`j~uikIw!TmY3tI%+TQSVt<*wnhGaL=;N$25m4ec?;yASV&SPc@AMrDCLY{m{@&y_ z!Q*iN#lm9LN1F^BvC7%$@7(r$?sL~{>T4@R?t+0yEf7~WO{zA za8~0=el+j@p^V>eU-jOYjbl6_PvXhsi+eM8JZvm@cztoWSgtlkdMlq&hH*`X)#GbN z61c`cI{WHL7nXJsxq{2&i+dtmIVk&)z+LT!nTNR3O)UMK_~Q37Dp$__MdSz$lP~UZ zaX6FR)s=&NWn2t_Kze*x9o*#<^HdK|=Ao(9jIA$VwiI)wE$=?`hJ$7|NyjFiere+2 z;hc&u*aVGRm;{`E(W2J+) z+NQSK*7A$z>5oRzfyuXBw$Dr)|LI>}{KN~j1 zXx#a<7I1Fncv!1+U`;84EPw<$0agT?GdKob#ti0;+lhrXXj#IzA|L-py_fd|> z5gaC8+!NuDyrAP)mIRKD4Qqx}-&o4zri|b)`Qn}kM*)WZcqE9PPO=Y6oKD_-6 z|Im*fFL|93>to)q@{6qBF8^7+FY-;kxF^kS+k@WL`r_M2zSNVWFxbfotXqShkVq(ryP>M>9!`GGNeVm-Br{h+g-MFX=y+254i+;O%+Y7Cha;cIs z5^pA7+zW75Qy_>&8~W@hVA-hkvv!)BX~@{xI1`;`yrH96e<|u{9vE)whvt&?T>Kl13sF>)0s8bdE5T; z?5|rfanXaK6ifJusXda4r@{V8U$IZE6v#wa>VxB=y@5x@8@GJ$QHZkid{+l|8ZU@$ z=Dskx9q-v#TD-pPV7}APAD<>)vGI_8Iu^`K^_5j(7Ccm}hJ^gZe2w-2biEDhk{HM5 z-#)kH!k@PF6*+>#YoG0GG?CV!{#aHa&ehWW6ukqvKMPt{q8_4M`9hZkn9*}hQZ3NDi`?#b#&{OjdX zM%To6uH5H|#ZMpo+D8&z@R)pYPlTsW2>WtE;X#K4HRL&l|-PPu1b$gte>-vsN84M+ix^!kC^|2+84tgm-JlHDj}1c%8N_e3~`s0B>E zvV2vHN2AS^@3M|gjBCa-+rGH$_JVsvuHZ8H;=Yr(%;tvBH z_)NaI?;JjNIW^joSYNkXdHzxLkFWkx=FYbx(3=Cp-JmxIX`tyhEee;cxiH|G+ zNjYjAlNjHKrHk$;OE0kplMz<%nf(6=z9x~1kLl$_O%gZ@_Iv;G0egS3T5t$XlP~Un zL60h^j;nk3#QIwvnKJ2|1&>`Qas`*k7xzTChWm?gL{GR$%+}%q60hr%!1Z+f3(vj0 z?X{&MS8$npao;&yO=DDV=ZrfxvEEJ$UeflJl%PzLM$?_i|4aA~NRP)IN#L2jU_tJH zRozNOp6JWui+dt{^(zaMlvbikh~}WZcGRvZYw-bz$C~33>nZ<))Y+%p_1bG9S8$np zao>4d?zq(T*1bn!e4k%fvGmXtk2UF!nf$+u&k3m4<0}kYvBo<-`)>Z<4{dvDll8VH zzX>iivBf?!x0BnO-^>phe7LHTqc71UV>&quaj>MnI7x!rV#lYcg zD7Qzkod7zXO-bOHv2I1r+xr!B2v`}xWAep42|Po}gN=~%cpB$ys`27uloLxoXWn~% zdg=0y=ZQSQWAep42|Rh&W#Z~5Z%qQnsFmF}-&J!zhl`XE9424flfc0>=C1Zjb+5$f zWyZZj3a^^qhC}Ge2o94k?n&U_@dJG);mBNu(c{NDAu*nw3o6do?|@^j7kPrm>pKXA_|p zAEmrv5a%y;fMnfS&U2q^W%5(7`H z@t!C0I_`eV^s@>@p5QV0;%?x56xpUtQ3 zzW${UBk^bQ z#XSK&yKw=}di>4gCRG?Oh~JNuj;8MDamN9lJl3RNV)FSNnxt^Vh`?HemH5j#B{8nn zcf1q&u)=d4WzvX#Oup^9Gq^?uuz$x_#=NJE2kUyPO9J1Si?`31nj1}CQG6zU=kXDk zH&mHF2^*%|^H15Qy7d;ToSa`bd5?b#`>{#AX7ZcCl|SAW)R&*Q($gkGeysHLX|FFn z{q)o=O~!RheiQjxw5Tf_xdOx)k&gbaA=B%R($f;_CAVV2#@D~R@ez?L>B;1ado-Qr z1S`sLU``mDCBmGI!uY&8(Lvt?g+O}xu}*j6iFJSb&m*6!yzr6V7Dxgop7uyZ!WSH3 z$GpECOkC&1>$|uz#+imBD zW+?8PP`7Jx0Su-NxKC7VNw$|sTbT$z`J88|g?#xwzr)|02@>}@&7BQ-)4g7Ee=3GM z4^)%yKkc~d@lpeKe$(r??FPFANWcH*hpFA#ZTTRm<_h7Y{PSt@=|y%JD_&fMC`HGE4B3%6| zs&Hm!MLA9bZb`mIX>&ud?we)`B07JMf11dquV_ayKP=N)~azy+!sFX8lhH7_Tz zo^rB2d~f?D1DnL3$(QdZ!i95~O4ydxajZ`Q$5Gq=oH*(Gv)PPQM)YIy#XTt;_?nJm zbZ%mO+;r8cZ%ljPsom`o$xb&6C47-Db}~3Bs@yp0fg@45a_qrf7hiVKtvBrHjI?)f z1Rm$`MZVa?Vb5XZRF!BM3j5hu$~dD0mX(PBQhr!C#ZKh#JJfk5NZd0ucXmKc_iW95 zdJOk*n)~Z9+#{O%Co$Y>HFpX(<=1KM$HZ{2*W7s!j~U+T+xYvr@5OY_)Z9yBxMyqb z;TZ1YGq^UaPrZ7sI_ybH6Qyd%fm9KZd*2ukrUUjNzWCx!)DTJzI0< zIWPFLGC`7l#%b=$Vz@^%_vJC%Yc=;rW4PC8?oY*Vuh-n4kKu0hZ~Xl)#cooVb9e2H+9G2%U?^x!r4%g2^s_Gco ze9oIiI91d(ltD=*-*&a@NxNDeT3%t-K%VFuR*a*bj8@?|>%~?6ZUP<}FG$I`a!y(? z-iKjSp!$P7SLY2(waWjVQ(p4bLICCpND+2*WUNj+pQg0f%Z_~UhEZjkO??PIJ`VRSF7~o3cY9ZF@68kL;CH>#00~5 z&NtVi zee=+gV|M>>?&Nc&Oq2Ge@J(&yVfYZM={-C_9b;wKiZKxfx>rpqz~bnz>$c%AuE;}M zCI@>@(bzW2S;`Zcri@+x|K~MO4Uwz|xi5YP(hcLr3!=RjhzpbC+?>2q(yh+7u4?%F z&mQ|a&2hCaf&C@n!@J9{a~76E_dVQA+po-r@l0KAWRzPj$9y?)D(4&5LGHr?SN(ME zc}E^1X@~MDSNJZW_{S|b2OBT!b1pOR0lnUjE_5(I5aWNgzjwx%{ssHaeBbOV7*{RmZ-;RIay*1xlS@x=pY%AOu55hO`y5j-I#CnJ2vuD~K z5y*J>Z`{|}1HZ2)=y*^s5YLY74LT8Y5{Qd(PXTcdgcHnM9G?yHf^tB)pgy3!pnjnK zpga&~GY5bMf(C&GgNA^Hf`)<401XEffVl8s1ZX5^6lgSP4CqYIS)j8)V?pPD&IOGF z`9R}AMWAAkA2b1k>}uaX1^YbEL=d{D)+A66R1T^Doev6u7{8pb#xS%s88ijNbjCs9 z3qV{XdJ*Vi&?TTtK@repplP7XLDNB3fM$TM1aUlN7U(L_)u3xYTx@b3h>LP&gKhxb z2$}<$3%Ut(Gl+|-YCyMuZUx;2nh#n4S_oPMss-H+x&w44=q}LRpnE`zK}$fKG`$aW zKj;C_QqY5-hd|3f4}+G29sxZHdJOb9=NtQpf^Epf!+qa1KI@I40;#z9_W40 z2cQo@AA#yYAA>#t{R8wV=rhpgpe>-Spf5mQg1!QM4f+Q3E$BN?1L%9uHqds^51=1G zKY@M*?Ew7(`W5s~&~KpML4Sb$1hK3^F>-19R_^kdPXBG@tp8&_=y>2|T1?g)o~+0J z#r}{SRryVbUH=#3{J#t>FK0e~Jh9#h!~U%(+9nBlG)v z3;W6^YVacX#`)d&%<-2M`=?o5Z~Wx!tY2>GKE9>>1=ca_M+slPD|SMB%^-{51A?m_ zxQI;j#`iRkey+f?i=O-2PqiB!phdeb-rR9gcld;I3CqTg0OpwUm3i;{y-y03x^yQU{ zU;pFJg21nD6#cX455z|c$IDuWZ-&6h>pYkX=cM)-#!HrQepx?U?=c)_PgMH*_{Ue3 z;A&R{$^;Py*V(lyNwq}I30GeD9e-o3!G2sZ7l>8ITK z`?n3RahhKl+KeaRJM5^{-(Oya69UwUYW7k28mB;=H;sfY7hoX$PYPhzMqQqwZiK4E zmqd?wrHSz!I%eVQ-Z}e>Ht`8R3e0)Y(0JnDGl9u9d#?H0O~98ZogdqB({}@YJ~Ur& z*f>)xlP~V-tm}ZSz%Xu%#t5ekQ+LS4ngA8s?)7>V0k^);#j$n=&BVPxuk3j_yJ^;C z-ygHN&8B~TN;ewXxMe2FS4{0ObW$*Yv!^|{pg|pfiGek>3^!-0eV-(c4MlAF)cv2@ z?PjiW>b&^4TETtvoo(`e-k$c%L5^(Z2bNR9*C46aq;T1{l4_{z@d>6cneUeG+UeTP z2l~6XC$g*ILDKCe%jt}yjs8led)qx?$(SMM8UZ44i`_CS#tb&zAJW295}A1qP(K2jH{#_kF#M*zRC+G*2hQ3&3g2j zo^3glpp3+q$rtySIP?p1RT_$(*6CUwU7rM=(&~9n&41;6HS|Q8g2&{?#e*H6(InJN zmeccFb$Mbvt$HZy^UgQC%3(KU1eeJd_n3O>|-Hr4YrSg7E1_H+G)Hg-u!xMITDt z=E61`+Xgh_@PiqzyXMFKwew?Wx?W2C>h)Kvs>Jc!x&4;2230hJXbxVcbYXLwdZ-)ewTexgY8xIC)h3*KEvx~aQS)VIAPa^ zE9c6@=Hbo5d{tpwZ!jWQpPp@vKOIXV}SUmUrLHf3M$gao_I^Ji?EQ$I+9fpMGUk;ZiOgmT)?ryeaYZ z({M_f^?lv_BlbEiCFc_ZkMQNYVkgv(fk>~P>J2>R`sFpP(yeJHbV$!1R(8~gLR%t- zp_qPzFF3?@?kyaS8z|5qwc{%fM+bNcDsZ-@!*KRoHm9eGYIi>4n8t1(eSg4XxBVLU zYRqT9bIgN=>7Vx{3tus{2PE@=5_?U)2Y12Xe0KK2adHU`1I3NfMMc~W%A)mL)B#om zVWqxo03Jq%c1dV(AFzdp^ z@%8R4*MBxG^QhBBp5QV0;_k+y$Cn$-G6ax#+XNi^t`|f*RzCW&_T=KyE3fHk#+&dF z%w^m-;>Vkfj2mEZJx@`Y55-~#!(beuu8m07CSTm$_@eQe5L_)jAbMK{T$JMl(T)|* z|5%z@lD7Nw!_9aWK7zT78&~{z#;qGAWh~oS!a85k+sC~xNgS^SH`G3xy6)cA0z&j= z^2ObaPmfnO8XZR+aL|aJVwIymO{jeI%C&<(5jldxPK2AmF(cB=I%wQa6rb zxUoII10?6<6z^X3#qz?ggTPWoaF~2?=bVB+RK)wuaa63jqz$ox*$zYvUfB6!7qKW5 zsNmSX8h?!5Q-zP{0NH^z_d?8I|WbSE2j34dwJ}P z7EqoWj>2s@M29o8H?K``V}| zT-SM*4Zuqy@oe@V+K*4S#&qjA>&Z5+P2>7A8scXAPxy+dJ>uiFuO^G9*FhLN3}O&k z*K5Y*@o}ywO1E0RQknl;|IHgsoWj>2s@M29lh&)iRqHmHzhz!Rk6%-^{(o=$^H;*v zI^j4ExD5KCh9n;OZnjU~>-o)xReO9G(Qz?<2p>UQCcb{Oc$7<;)b(Vs)7j|hiSdm+ zef$qAgI21EPxvly_$NNTrt#MdOjo(Q12}0!k7jOw$sp4-fm^$6Mht!^AaClB0WZ7{>Rh5^kXHz z@#myCze#N8UuDJOiF-UZ@sq4AxR@`quS~p-VBXSkcXqnBVu)Z6yT;+0a{F@TxFQt5 zUf^7Rs4_5tbIta}j~=-@f#VU}dtQZ|H|4|q>XeO4e2C=?*AbQ5nJyCgb z-#@pttf-kZQ1H^`x&q=&sPlH^4KF;oFYp``sBc$uAla^661Kd z_e;|@JbW{czfeZ>BYcM)wFHNIeT=l~hWXI6E0b28T&l*vx_)Ytz*Te3+8$KRI< zF4`$TDSZ0TO$>a>Sx;wMAvaO|_xwGl&-wVU%j)IZ)GZ~Od~tW(&jn57mX}Wq_@g~= zna*>SSJl@iPG_C>JM#BCI*)26a_l__T`iL@?n8W&16W&wAplRG@}ephP~LF3ya-pT z`iq&``{2;KP*oAS!77Lz9}U36-^uhsJ63#*E9o>~bn2OVAFV>$cN(VPW<%jS?5M@~ zu$L8vCA}!OOgtr>WXx_%CpWzM@TpwPGuv@zI;n*_jo>oJb=oh@uznqPz^TKoyZu+L zr=#KiB=%#4ubA4S`E|73(S;$uA2YMiQ~6YhI2}*-8xp6V`hHK3x&FS>z7Uc2eBnNp z$rpFtxs2`8xP=p^4;GdBJwyCchT(Wf#3xeIFf1a)bx%HA(^y$l$}qJc$>-~n!1LtS zBj*eq(CsOPr4c+P-*!bguoHOHF~H?0-Y0}`5U^b{>-Avijqdo1Rh~Ze&%(`-F=t&O z^6dp(2U;dy++&reeQ?|_W;RRw+?p-gj4ja?I(k$ht@Bjp<7G&S#?*Zk!8y@K6JAXt`i9ZE^V&dtV*n>)$nx z-xdg1NMLEOMXZN_I)DxXbp~aDjs$r?{EfXpCxJLY(Fc?d8VVW#IvZ33;$pK((8ZuD zK{tXHg6;=B0iwR3ic4X+>YePl@%37ln`Yhj_@$i}?Ym{RU2ods8Pu!r`Ayxp^lGmg z71b(ldc3YkAb(unG^?ofo`1jkl@66=yb52J&3Bi4#4FpWzP26*YC3j_T|K!PLt=EQm!ebxtu@Av%MqZpP(aF~4C)zE)_P$@!-23LKt zJ_-3-I}f?~xG5Vq%J)US$rpFG9&)R23dST{F zDkFGIzPLBy$t^D{^HpGSHzpLl-r8#5h*b{%`q^Q(wu*dLFLITns~m1@gQ#{P z+y8+|XF^cNQ(fcMOA|c()2!83y)%B}D{GG)>j%pJ2em&>CZY)$`s2}1HzG7+*4UbwCQCM!P zL%iteByx*eAEx~50cq9|KQA1<_@kd&n(~D&-xa$#`D|Y_y1D!J?Qe~bqkdqTm02_3 z*tC70=w#v$zQ`B5Q5KhIgmCYutp^VpJ^m8hC>!J*GhF?H39fS1+IC1?KeY*PMFyu? zy(ag$U|PGni7lKGR?>^`1&`Rx;&P=Dw|;ux7GFP^LxE$|!4KtKwD`*=I2^vn7dtTy zGsf(YwXh`pZc2cwZdjW2@p;ypOJ`p)%fuyo!6SAOxZ=j39)IKJ$Jg7q;c3=h(_Wvl zch*HS-#FMtz;+Gum+%Fb*v;ZAKn8bG6#eS$(H#kJScPfU?t68*uJh}ohMPEqFY?7s z21l$Iti=Z;{%RJ)*H7(;H0zvYn|eI4Y{-EoF5wFvv6I3TCkFNMI%{EkeA%PYtYahA zn{)aW*;j3O0Utf_k)2y4$>EC+Q?G-PX_=GRG#NJ7Kabni~qMkpk+W2@g&qle{`n$R9 zCoijyIO9Z8{|R4kiml;QgIrSXk3e^}%&r31M0VxRnglrN#->?sdcXg!!*l14GI0oB z8=4#tZP@ivPq6CYqX z#`(I8I~&Kpro8=Z2j(f=y}RcA0-T_sUkj->yA# z-p61o)6;pHe8<^B-^$tf8}{_AuE2c{97^<+VaqFiB<3BRsYwhphH>qRx>^JSj8#}e zj^24y^lk_}eU7^;G0tmJCa)cE-<&H1hds`Cv}N+eJ$nC3zbdt)9W!a@3VFj!l%B@h zyIlRlh9q$OIqUQN*4;3}Y31AFoP3)6q;R0c8!Yyfl?VN~lR2;gqwA&m?)Z9Xzjbfx z_^aRUH2b=-_cMRfP%o@kg|C>}Bd%VYTi)nh$6?(QA4fKDe0lN>?|(J(v%5_k!q*_E z*SI*;Eqp_RWoYZ`?Tpz8aPY(1>V7;deaTA$M4qG*lP~UZak%cjvqR{3G8f0!3qxGg zVr-lGw~FV9Ji%k~#XT;bLFH3%oaR*CFeUzVJj;^66KJvJ%B{o7cjLRk!PUzToc;Q7y+y&& zPZU1A>n3?T9!xIs(1~KScfz=dz%~(Bf^XctiPO_NzCS89?9BnZ9;x6a1 z=7)QZ9z8U4{OHkCP8H^%iv9Ex0g3$j1oE@68uZyg1LwZwyXGg3C(}qfPxv;s@hS2P zO3SOtitSYn4o`WC;3@Lg+~-a&`@(HM&^YkVdpfe9ZeqH1<>+1~AN1mDd!GhAjmQ_i z&24;Y?UZP5p#bwJlboG&rSMAm|E}?O6vb*BT+bJy?~ngGE6UQX5s}l6=y#sScZBm( zBpnLB@fX@}&Hv6mfe91*Aym@LD5_1(5IUZ%z>}z*(DmsK-*4<(c{@g3d+_gzL>|)tQ-jGD_e6L^F*=SNz`^>=3!=^T z71ukv?i(9F?wDI|jBwgR8Nu;`!58;fI4~T+74&SH2n<*J%v_on$JvV}9kA%4!ZSsV z#E;1r_XIf1=y8=3tsaaYKY77)Yjx|=)#rctY%8a`j~2Y$E)l-q5W64dr@1%FlaHsY z#5%TD1?O*QR)D0OsDpexUKl6(I`!_=>DF#bw%>NIx94a3Gcb(gAK}~F#%HtbS~TRj zPmF~}qt5yTf`M=;mN@9g(iE0gsFiqmShRsXaQ2}Zbr2!ABM-<@Bplja_+o>WA(7 zi{1pc@EZ}^Z+{W@NNmO~&-GPQR)ui6NG#xvpgP!sKYLkx{B^)T;)y9!&(1pPTNA(V zozF(Czlh&kRUAkPzh2I*H}J>G&s(R>|8na=J+}!!$www%+?~ZcIBkN517L|G&cUb% zV=OyVjx)}2q|!uxhz%1YZ52fCca}cv9yc)OIa*Ckw>A_k`MMx*(2B2_;9=M=XZv3G zim5$Z>rK?!?A%g+(L_&lvZXN*=NE?yFjZv-*7dZ*z!mwnmpbov*`K&~?px1fhIpg) zUjLDAbUi)j;G%UHa;5O?uQoo_;C@wwr(YlxuGA)nJnoF8yfKuHXXbLZo?_woym#2T z=;%v6Ty1+*DwTi!pn&+&po>I31sK;WM^IHK)1 zyN76p)a&hKz(eB&Q9owc-?4t3QMtexDxd>uW83Y z4gQd}p;^b#`!P2T_9sjrV2Bfr>GAtpCp^2@4sGM$)8vbLTpVgTb-4fhDy)@q0_b=~KOSE%408MM$FKPA z;#oI~JjM_4n0#@Mi%01N^S&A&J)Y_fJWcfDL(g^NJ(sOraLzuRod!8A<|E+?4zYDS z7$U=7Jl3-uD8uy^(NQq;g%LpN*T~=9dTD|Ke($gjJ^iVzpGW)ednti?HQ_5Z9L>>hDI?ZzkM~jYULLr9UzjvgfIBSj)l{S&wLy<(j-P}5m5A2@l1TZZM`<# z+7kL=zwBGy7u%Svt1tl+!Rok~W0tOLpVrbk;gJuz z?C7#-;#?y?3SV%Eog_YV3yV0fRN{0`T=nGo1h_W6(%SlL`a2WGF6ufa!x1cc6TaXP zJ4sw_y=f@3@FB*l>`QEk|2f`m8ePAoE91vM!w%1U_NBZZ@@1J@bUmcW7df%|5!w)j zto`p>rY@*$JPBEE4>cr#tFq_ZuSdQ7!!07$9uGdiGWp^j3s;|^gPra($M5Z_*$4te z^GBUqKj!*=e*2pJJ6`wWjfK(m;d_&bTd7RGV&h@&`!D9A*|5i%oy=G3)9uEyu7@3v z&ps9V5zUzvk-W<;^uyqT{TEI}LF%8=CFL>Qxz5piR5nfv!HjS@V z&%4VjRyCYMSOQ!%--cdnXwlLdaN@d!Z+7gk@lZzwmy=Px@Evy4Ld=X0lwsMSd$wC9 zo$Ns!_#OwM9{wHk2!MB~9^bR^J87DWZ@LXQH|^#zXPs8ScN%-y+`&!wwkz&{im?w3 z?Ii3PtYB=T9bo&+geB>68F0uxt`knmy_u5t+_%$zKNfH1YH_;gXvdKEJ)8EX$F?{P8#BBH=si zs5Qi2sWxDb#L9;W0Zc!#SD+Rx*?aZ$_G9*oZu!Odir)X{M;|(D`_lbBec=ZYVCT=2 zCVX*kBL9pke--BxRo^x|s?;B}fj9vouqA)i8F_}evnrx83R-*#2$ z21S~bWo*P^`y_V$v4Eu?T_3}o!8wVKSn@MZ{cQ4={jcsJ-xv8NU)+&yo0X5nD1&gO zeOcL5r>I30qvxYdN#Hr`t$~M+9G<&a=FYXSWK7px#6^_a^)#7T;RKMg-C$aQW zzv|ri^>Zuh{y+Ba0xXKIfB5()h^^SI*p1j7C@3ZvD7FZwC?%oT*x22L-HMHk-QC^Y z-THpd?jD>Skwx$O`M=L~J=|1e*uQ{Tr;-k=uK zQ0J3!&~$u7nM+0A@NYrsy9x~34=(g+D&ypwKKR&1UTa>PoacI-!a6=rCwd{VvJo>#?Oylj73~w^UjqFU$ASaoUhC;ZMqyD%lzUYM3IX>b4;CIen(8_SKj7ys?hpXfIZGQa{mGSoWQ4^Q;xKhlk(ecOg@|?bQseoa|A};a!Dbo$f zQ9b#rkhcD<0NuZoD0#XcRO9QSQ;!-SM~HJm^?9h6cB+vLn~p^co8%pYyK9RBlv zQo1Jt8@qPX{eMjth4?$Py}nKmo-X3K!J4!e!;Mna>7LQ=T7hGx*Pq>~cSGBkocK$8 z+H@J8HlLb#xOOqz$rJbUsK3-TAV5@HW;g;>@1MeB5zp5m8|xQdye@~FpUf|9x*RTN zC)eB0c*Hw7G{7idsvS3-FQvmur5fA%$w4_E8HYAq4wrM1aWwJ>3h;;_W7NkVCu0#$ zHnmmjGv=PUC`n=Xg{VO&x7rPcX0mAK5A zpsk!}H2sIiuBMw`C8AjCwEBVaIfO@sbnRCRm9^;ZdpLQy26C;_Th_j=`@ys0o&=S0 z^x*c9n+Na2k3F3grEmrA`HXDd63^J)9ZP&`H^$B^DGYQ^YQ0;mg!8+ zsEd8vhB0fq>mPupB`WS;dh^I+cX5nPYd~CN6Zd!ZlaHh)&le(28}E0;y<>46X+wJJ z7R#6LR#|0tsA^CDQNOgWpiLL!iZ1qX%QnKSo4R^=y6bOD8UDD%gEzlh2)Q5pPn?IR zA%0P;#DCAyLtMki2yrb%+~+dfTh~4BXSDv$nBJZycATF6NlpKb+VwBfnY>Z=7x`#t zl|g?v_q+THXD)L6Tb(ssZrf+S_hx0WqQA5UC)16B=0oh`7C*_2JOXH^oQ7=a%!%Zzm^FbHqzYa~1 zNV^;|ok<#Xf3O_ClxtmUS%wQh>T(@?(R8`?dwTPH7uWU+WH9=8<0;y7IXw1pnkd)m zpqaS3To<@xx?DfVb7k#`tijdvW6JUrPm$>|UfKVPxQ)xTCf>13SnlT{h}Tqk*g3*; z$Cr-}BINOr=*Lr%Dl%QhDf|5L>gr20uBXtj6vkEE>An)itBl9xvgvqMZJwDpP0{H# z+VUyWWgM~}`}|XHXFoH|$`GHpzYcjyzsSmz)!W%k;uUe&LiD3MZktv*GPyF>^_S}j+H}6I>tY{o z%-fkZcy&IHy=r=`vo~|BJYdwli(K>iurHYo^P^kX^M4mC4yU zuQpzpF5{H_*vG3X*V-VNm=)yjhYNAa@-6=FC1O$Md!p;6m!nk8$ZLo5ys^_RhfHUZ zM%^DQhqiq4xR9T3fT*N_Hgb7zS~uNDUgiGeAn}SgY$5v5mG3ic?AqOW^FpFeh z@f2;k93K04V=mv(2G2~?+h@oP)8#yH)toNVvsOK&k6XW-;=Es`%eZC#FXA^U=f8_v zUET}aG+j=Lr|)Ugu=dND+PG!9j92z!AGfN!M-!|S6O`rMfjDJ(wIitEZUUB)l_f3X}!<=<5N>iuQ8JEqIeHlOcj+uU2eL!bXYw_lkqg;qMy| zp#Mn|ClQ7z873S_UzVej#4X~nh3H4OJ>+_6b3WyfKC2n5>-6!*Q?%)Fcu-ius5H`bmn%XAsH?EgjlM%%&f;x;P(_f40VH&v6ke4ab@p+3KV zmVcQp z8&8a_P3P;nF81-pT<)U{o;j$?eaI8j<=)15yv@1A*S*B^aH12-nUGhRu1i$C{6+jm z<^FeZtILVaQ`6<7ef92TKcCyZQ^YGe(HG@Jrt1<_FR_nXRqlTmEYr1uEcZ^tE6e?> zXv)3v%=GenYhB)Ra=Ga%waX*ZRg0o~`v=RTE%)NFgZ8cg9=3j-HM~5zBPVX{M?#kS zNa7W7*h2K9EB7fcKRuT}@#{nk)^+;0sXs&XGquvSb@miKDJDa-r&Xv+J`SS&}8oOO?k3j4HIyBsq8A1sHqyz6g4iru^F zCUm4>dBlD5@Rz2`yUX-x&r-RSsx0G@`5APQ0SCg@`A*=M6t+IG1=*#oZOOzo#-?d|%x~8*gJ>OF9A8;^{~ap49B9zn3nG zu)dB5CZtzZA*Rhuq{ zM;o7Lddyn)w2%Jwmb-YUUsi$R=26?n&b5b$=VsKu7f$a?$Gz07#niXE^EH=o$^Di# zT@L>TaU0!TR>%1<7I6;l)h%&Vvs(vb95POAx*Yyb;{17c&iMYslJ}-WZc?xIs6~Q z9qn15`Z(rhEaI*I)NM~a%Ql~6JThKwx*Yxw;*I9$-8g^8eleZDFVp7QlRsA_TN#gx zSDP+}|ATm=J^Bh`!t(gR=BshM+IA^K3{N-AzwWwr=(uzGKy}Aw8F`iIVjOk%`*>yT zBu#w9&oymcdG^#j6#BC*S}~mv$oRsEPh2;T$}HY%ySz?TC0^XERQ+oE5_higzr#>N zocRpt+VR=>H}UnQEz=ryPV88{slc};H>zc_V#OE4{Ka!6Cz-#T{>WZ4URW|rJ^ZC= z_{PLvbZ7Ni%;q8@Ie8gAPo=@#v9C)My1$(5_x;eM*&&ueTgE-o6V zr$1ITyuyO1{k7i@R}B~K5Nd~?R1F`y-DaC8E$ZpNR1F{Kym+_v`X9jx2|3EA9ZzOmx!vVR(xRz!H78i zt>=`*1K8sEWbxdqct%j%HxDVfH^|S5ZU@oKfw;w0f@={&aS!!bNs*{Zejb4bM--Nv zTpYzr3g7@Li_Ld)c)d2)c|gR{MR7B*Q=X{s7c>=_hxk7>tGghJi*D#l*O-hP1@TbecFwNdCGWX zx+)aiTa)qB;QzGkX#`OBzhh2;#i`4>lj8z!d{TJkbx*T8BlpA;A zD*>@x%l7E<&F^}oSMTKaWa#?h98b}v%i)Iquh#OQY75b%sQCYGP0wI`C4$a=wzTub zvn{&oCAzPK@G7?}7xS3QvG~H*{_V%TJ6onFy9-?>;;~>Wl<9`#sGjEF(E8{9)$|26 zgfZp(FUDg21H!vMuaLiVLGAoyden>!Z?yAQ{ZCC7K$vR&!3m6)Kf3j?cluCs>mhEg zaz1i>Xw&8JSp45gKS}_V{(HFVD|xbOA62slyTz#dv9vIbFS`GMZp!+|YRZm~bn4^0 z9IPLiF5{B@Sj4Aq)?OEqVJE|v!ywmNxF)XX@~xV4_xR<;eQF@*EAvg8E{De=F8wI= zXvmkEUbPt)p^C3lLNk-kVP7ocus-lYoiX~j^uH_Oewj>{amjwP$H#_5^<&u9h6lFw z7qrAFUd;caQJ*(uOk_Il^IhtheG9Pq($^q^Av0}m^|Hb;@ROOd-Bi5H(7jhku6xaQSa=?n|itR^SXDP>aFYBSo=dds< zr+Y@{`H>74oh`(=iLU$`i9OY0tk&^8C^Bc>WzS=L!ndmsh)tx`ebX}tA z#nIcxv%POH*A|%R&%-3+<=4zNWb#zq@qVWYic+!NyXB#&%#>&8-b~D!X5ix1sl}B9 zMVZ9;w>WQ=>8e@k-s*S7T!*8^4nrPT*K_Sby>|K|4jGF2IMT&ZJjwBMJ$Ue*)A6YK zB*ld7`i*wG8@{rjcrUu);*V*(YSTrk=wuzUrL1fD1=aTEzwCCLMZ0^58ue)C%ay-K ziR&=BD=>!oJ9OVupAS7GF44*Ip}l{cXqKgN>+7lx$!w30?siQ#sxroqKQdjP`tvoq z{E=zC{<;e6tQ!Wo%IZ6m5WXtQNhj8aI-kVvg4pL|%+2}PrDH{TtF+BGaK+GhU%rU< zq7&nbS8cj3nHT$D?pOziW(ch1b!clxKMx;qf)>b%uwop!Jrzh}7Iob+UwyY#V&4|V z48(BxdqvV8b@KO1l&+dgt1mm#K_q75eRtBzBM-#ypr{*Otah=#70WLAab3(g5XxX# ze!^LQVx8H>@Re~xL$;ssJ7{a$Qd}+6U#k)Q@rHEqUfty_g~;yC)~R*?&7TBv zp5f==AK1fi58sL}$#Qg(IOKfns8L0%`z40q;`yH7w8q<=cE1#y(M+lGaZI7)enpNt z@IBFq@*wt0GF_LbdNGcZEnZaU;YyQ`)`pl%SU2_b=x*&?-?lA_(6*L+leSKc9G&bN zHEG_qsck)Hd;P@1=*j$aAr8@r{G_-l)vBk|?LULL!1bkRWY>(D&6KJRHICKw+O|8F z$ap$&?MuWd({+ie7n5-9OI(Q|m{} zK@=51tP}BjFV=}n6MgYHy7fe|QM&jX*Zo-zSTVZXPeo+;xu2@Weku*aVp@Mqo8^u?=x6Np~#4Z6w_~6Wf~H2g>nC`lX9$*e@f;CH#^DR;0-7 z>!ND=D#`XGj_=gR0U=q%8u|JAsyz-6!|bwUS}=U;iOk6jD@ODz+3IAv7)RZi{C$n) zIH0B7kD8bdQR!kNRab*!a4MvB<77_Pj-++Y70D+i?j)!Pu?%EazYxAA zm(#||^l}!+w#7P4!eOH78C@rOiTMzfu1}77jcz#``T7RRRU0>*Lmm#^!Z(g7?smYDG`vgSb9* zkvQah#8B}JiMo7t%4zz#b*mRk7Ejrb@uv8$=tMsruQFYisCqFSr(;l{V+XDU{JQ;y zwA@vIS@G0x8)BN}?4+dqm>T{+}SWg-~2aRWfKL3Q`a^!Z`uk3@5SY zv7LR)9(IgR6Z0JkegqqNM}l@F=qddVcNynmzLxA zrmCX2I`G_0Lq$2n^DQYndEbqC8Hex;4;SASub>U`Jv`^ab*mYl6=f$Iv%PIRWmlJY z%GDY1l*XsyDc@7ZS57&{S8gtduekB-({?vArSEw&#mmK98TQ0n$vi%RvbKSRQZWzz zKun)V5#>Q_>tulv2D!ag%cCz1wxp2_y7AoU%W}h8rPA;TNm5Qe64hS47*E{ql<8s| zb@vD5#=4fTZ$~eWW}bnaY`y$^9KbEN@ z=H~|@YU49B7ZBB&lks{?lrQFZ#B9oTwVjd8_tY}6{zNC&qfFPQ{(SwTc%oU86y>OL z7G@&8L^;is(iTHY^$K%u$fl+1#Cd?oFPUygj_UnQeB#Siko$R?{AN+l8(P#Tw^Zbb zpJBMXZYuMOWL+nYjsDF}olggehh0$Abt~~+tXX-#IV?v)<gZvom+?!lmWf0ixz{{SRUoQ;_?K zP6dq1mpD!p&mU#CmrU2E{(SwDxWtc4V^6LL z%14Tsj5^$B?zv!_z7 zEvx^imEWi>{0!M{v60@iVUqbjer;)SNCwY^>L?B5<9jEIjwTM z5pl}>gG|@YUw-UAaG%f5D8 z4kM$kKZP8pWo$Ibm?*H zC%Rnu?@9YluOIPSBex&%+ark2ab4_kAa4D{E}#B?jTOp_<@tkB*7W(q&dU``KQFmr zxr|qTEEZqUrpw{-xxJdcZb6(Ti^uc%(~PQ#d&7w8I6`9)NB1^I&L^5scC)xXBs$TL z$E!@&C8}Nwe-p4auGihpx4W*rZ@cPpRCOFiQ`Xkt{2)co^m+pz;og|pWd`7 zQ~1sP)$*8B>>EUFJ~Ca5qweH=Cf!{n{!Cp z{48RSX)+!ev-}*_k9`jO$@-D`uI~Tty*h%p^`p*>KYRZt>qkskyFRp^)#J!W;?|GM zi9hfE$@)>R3%MTDY3ldtNaEIyIye68eFUS+;{pe6?uop#g~)61UVVL?kIHom`^t0D zPF$p37vg@GOc&#*yMOe5qZn$SQOB)t*Va_rb-N|+-*2URUv1nnT^+M{|BvDp$3NcD z*LbXsJ0ccwFSU1wFmIWpxi)T@{;$TZ`IE1{rds_R!s*F!(#h6ze&5=5f7{Dd*Y0cM zmg)a$-0~j)s+vaC`5f8Vbi8+J4*5LLGs!${yfXb?jW^nwX!LW4Zht9alFvzK59{HNEC`uI)k>%?=m+HLIr-_rm0&pB@W{CBUT zxb^eDy?(UEZz4D1_HVH-6aVS$CvN@3eqBU2X59LTE?540(oC%%aV{zD$%^ej?3W~w zu1yo;{chj&yL7%1*Ts+naqB0B%=s@E6t{l<3syo5A(&b};;Uj`CWw8Md@nzf6k{jG z({>_F>_m?>k-TKi^O60pB@?5@`pS9y^Ka26Sok)}GTMQGQ z<9>fcPW;-%X8rv7t=OkTw;hS~A&Du8_j28festdv(lQL2AFFB~=` zp03`DmzAgk;lj-wewOCS&2l@p_plt(v8atc7wa;n5OjG1Nm~s2+`a(41@Q zYkaY8;u_G!(Wi!AkgAp!<9erVnuy0TwYf4NzW znt;^#uXmUBvcyYS#Y~*>#)zO#SV&2)F&m@mrU0ss$QafPFg;X zYxoxy%|_Jp^>^;#-PkwC-%UhC9aV%P;*#}5{M*}DY^E38IC9$;!$cNDH;#xuu8Yfo z|H~X$!p!7$d{eU>YukBz_}W65>(VG=%4>^ucQFJh>e&+8u}s&-9&J01wq9Po)WAqB z`}!^SXOoZCjXP02lDqC-jlqG2I`_pi!yw}f>1w>c(Z-qay@k@)zR8qp-r>Wi>qpg9 z4=Li5>0+Ad?(gE%HKfouFsQv^#l%E>q8`IA;*;%}&iJfZ>v0Wk zX|8xryf;4GM&~!z4Lb@^?~{mMrt{ILtKsG8;S=aU;}-lC)PpL14DBJdrM1KkqIxOA z*y=dKO~jG0wYhSpYWUh@PM<}yle$jEA=3@XQN5Vr@YmIPC2GOqw~BAb^=T6jbACj$ zF;_ZY{JOR1oTF1@!&EX3nI08@;mvR3XyO~_O8r^t`CnxIBAaa?`XU-}E)|wZQHu9+ zKFeF>!s(#h_6>bUkfiHGKOU`z%5+0=R8Q4Dr1-mwZAaEl<3N8ZJQCH8DoO#y6w5Dv zr^N4rt`4ZEDd^v*|8HW`E#`cx7HXla&NDI7?Q4@f9GdD2j)+r~8=0<|yrPPeMhbN8 zZHN`b@9NJXqLwY|+CFxk?z)P=Jbn%_)Q?9EW)4l7I63-@S1PEb3uE@`-`JN>M|bO~RO`+;`djmvj*ab)*OwxwOd+r{L3WE|RbIXqTzSU2!hhv-0K z)m|R{jXXM1MH$ufxihg4$T)8jrzpQ-fAPESLaIU`d#!pU8nU@sU$Om(x>QAX(U7kH z^z+q$S^0MKclEZW+3fnRK0T@jxpnbiXI|XK#)i?XAm%TAUzA`oMNYrtRqqh-ACwTo zaM51K$$!WyD*i9Dz3SlxMNN&2Nw8f8!xBG<~J0xE)2Q(e8dqOEAE znpLVnl#lAD0Xx{ECThU}wNVG++^inzqX8V@1gff48bRz)o4^@O(F`tV4zgWo397VJ zTB8lxq8(h(9&T_4KRdef#E$ek!4sV!j^+4CRJ`E>U-+Rb{2|tHAcD{h-4To)=!stF zjXvlLQQ>U}`eOhFVh{#n2!nbxtNFfSb&9CgvD5brC5gLSb>#Th1Ceh8mz@Stj7jy#3n>wGqzwWwqZMVU?(E6 z3%jugd$AAuaR3K#2#0Y5M{x|taRMiC3a4=fXK@baaRC=`372sNS8)y3aRWDT3%79x zcX1E*@c<9;2#@guPw@=T@d7XL3a{}7Z}ATA@c|$437_!=U-1p!@dM&ODjwp)4CY7x z3nWA$Bt{Y>MKXvs3sOMT7j21D5bdX@foLZ@9nvEMG9nW)L)N=4+Q`Zd(WZbEav~RU zBM|xWOGB=zxys1W$BE7kI%NKJbMfy22j;2t*LNp*w=n13l3Tz0n7K(GMZ$j{z8n zK^Tl77>ZB~!*GniNQ}a0jKNrp!+1=cP#W|eE1zf}>T*eh##Wh^V4cx>n+{PW;#Xa1|13bhdJjN3| z#WOs|3%tZDyv7^6#XG#m2YkdQe8v}i#W#G%4~QTBc!&=(m?Hr!kPwL=+eJvq`(#Lt z6rh@Q#S*EI8flOg>5v{7kP(@X8Cj4O*^nJMV1=B>h1|%4yvT?AD1d?}gu*C-qOe9W zh;|N&qXbH#6iTBE%Ay>~qXJ~R4wZRd1yxZEwy2I8u!B8nq81!b8+A|@^-v!T;0Px) zL?bjt6HxWM(iF|$g63#}mS~06XoI$B2UoO*8{FZ64(NzZ@I+^Hffu~t17G-|EBq0F zKm?&1x+54p&=bAT8-36h{Sbow7=VEoguxhsp$Nq=495tJ#3+o$7>va@jK>5_#3W3{ z6imf5OvenOCl9E4#m=3zb-U?CP^F_vH{mSH(oU?o;zHNvq5Yq1XNu>l*g2@%+g zE!c`}*p408iAe0iZtTHc?8AN>z(E|sVI09x9K&&(z)76KX`I1XoWprsz(ribWn95k zT*GzTz)jr3ZQQ|K+{1l5z(YL3V?4oAJi~Lmz)QTsYrMf*yu*8Zz(;(-XMDj|e8YGA zfH>%nhxjmqITAoLMNf0@3QdtKH1n;{bheTd$&ehP30lz%t7vMJ<~^0vpm{_^G=Z27 z>5&1VsliO3NkN5XlN8Z3l4#b4CTtX%hf%CRGaO1Th-NxOlLn&s08u4A)x9gCYIRXf zI8|{gg;4}WVU1!C_YsPt1WKY5N`or0MKyOyIh02QR753I235Z4+OnudpXyAM>Zk!b z*rO(D!2z{V2X#>o_0a&1a6&^gLSr<6Gn%3qT+kdX&=RfC8g0-P?cj>`aDzKM&;cFM z37((|6GhzK;+B%)4IlVITngqgrs5ASk12r&g1A(`>905iReGQ&dZ9P^pfCC%1pP4p z12G7LF$6;qieVUz5g3V47>zL)i*Xo_37CjUn2afyifNdR8JLM#n2k9I!(7b6d@R61 zEW%$riNxP{xegS)tg`*?tdc!bAz zf~R5v{YtD|H@CeRd#k_A~o^B+ofi?(jedbVMh3 zqBFX{3*PX7FZ|FI{s=%Ig3t}!5sV(_iC*Z9KIn^n2tj`gz(5SbU<|=fgkl(mV+2NG z6h>nV#$p`CV*(~(5+-8`reYeVV+Lko7G`4(!Y~)}FdqxB5R0%FORyBnupBF}605Kp z;aG#UScmo4fQ{IM2yDg{Y{fQg#}4d7Bz9pp_FymeVLuMwAP(U$j^HSc;W$pMCT`(2?%*!&;XWSVAs*o|p5Q5-;W=L5C0^k*-rz0X z;XOX!BR=6XzThjq;X8gnNx=4x_%MSx62JlpkqC*A1WAz$$&msnVTn{ojWkG$bV!d3 z$cRkHj4a5CY{-rrutHAcLT=jnEiPAlk%gie_*@bF@H9 zv_fmNL0hzgE84>i?(jedbVMh3qBFX{3*PX7FZ|FI{s=%Ig3t}!5sV(_iC*Z9J`nAd z_d^K!V*mzX5C&rih9VThFdQQ=5~DC0V=xxuFdh>y5tA?(Q!o|NFdZ{66SFWIa}b8P zn1}gTfQ49u#aM!+Scc_Tft6T=)d@eSYc1BwOPKjOm-=12ewBt#-4 zhG^q0DUu;MQXnNPkqW7i25FHF>5%~$kqMcR1zC{|*^vWQ$cbFYjXcPUe8`UiD2PH3 zjXD)UQCOoGY)~BHzDP-wLTQviS(HP0R6s>kLS|xWOGB=zxys1W$BE7kI%N zKJbMfy22j;2t*LNp*w=n13l3Tz0n7K(GMZ$j{z8nK^Tl77>ZB~!*GniNQ}a0jKNrp z!+1=cP#W|eE z1zf}>T*eh##Wh^V4cx>n+{PW;#Xa1|13bhdJjN3|#WOs|3%tZDyv7^6#XG#m2YkdQ ze8v}i#W#G%4=4%Q{t+K$Fh>GdAR!V#v>lrSNs$c6kpd}UiBw39G)RkdNRJH2h)l?g zEXay%$PSuoQ>>5^xsV$)$*AN-KIBIM6ht8uMiCT+HHyIo#Zdw!Q3|C|2BPt+awv}q zsEA6aj4G&#YOqCh)PNoAQ4_V`fZC{ox~PZx;897%5l(1`Mre#Ca7I%!gA1CY1zMsN zTB8lxq8(h(9&T`l2Rfi5I>8g2(FI=ch7WwnbxtNFf zSb&9CgvD5brC5gLSb>#Th1Ceh8mz@Stj7jy#3n>wGqzwWwqZMVU?(E63%jugd$AAu zaR3K#2#0Y5M{x|taRMiC3a4=fXK@baaRC=`372sNS8)y3aRWDT3%79xcX1E*@c<9; z2#@guPw@=T@d7XL3a{}7Z}ATA@c|$437_!=U-1p!@dM%pe>}v88O)IY7D$LhNQ@*% zieyNR6i5k6q(W+>L0Y5(&8jLHkP(@X8Cj4O*^nJMV1=B>h1|%4yvT?AD1d?}gu*C- zqOe9W*q}H{pd?D6G|HeX%Aq_epdu=vGOC~|s=*f3Q3H0cM@`g%18SoV>Y^U%qX8V@ zgobE@#%Ka(G(|JGpgCHgC0e01+Mq4k!4>V{26uR%13ID;Jkc3l;015^z!!e#3V#G3 z5JBjM?g&N?^h7W8Mj!M=KZKw^24EltVK9bZC_*s|!!ZIQF$$wG24gV}<1qmfF$t3~ z1yeB%(=h`xF$=RX2Vt0td68+))9`>-Dea1e)Z7)Njv$8a1ca1y6*8fS18=Wreua1obq8CP%> z*Ki#-a1*z18+ULQ_i!H%@DPvi7*FsN&+r^C@Di`^8gK9x@9-WU@DZQz8DH=f-|!tj zARg|ChxjmqITFAE36ThikpxMR49SrKDPf6JNR2c|i*!hj49JK~$c!w=ifqV^9I!%8 zV{26uR% z13ID;Jkc3l;015^z!!e#3V#G35JBjM?g&N?^h7W8Mj!M=KZKw^24EltVK9bZC_*s| z!!ZIQF$$wG24gV}<1qmfF$t3~1yeB%(=h`xF$=RX2Vt0td68+))9`>-Dea1e)Z7)Njv$8a1c za1y6*8fS18=Wreua1obq8CP%>*Ki#-a1*z18+ULQ_i!H%@DPvi7*FsN&+r^C@Di`^ z8gK9x@9-WU@DZQz8DH=f-|!tjARcCphxjmqITFAE36ThikpxMR49SrKDPf6JNR2c| zi*!hj49JK~$c!w=ifqV^9I!%8Zk!b*rO(D!2z{V2X#>o_0a&1a6&^gLSr<6Gn%3qT+kfi z&jl^f3a!xwZP5;{Xb(5I!vh`A5uMzL)i*Xo_37CjUn2afyifNdR8JLM#n2k9I z!(7b6d@R61EW%$riNxP{xegS)tg z`*?tdc!bAzf~Ri?(jedbVMh3qBFX{3*PX7FZ|FI z{s=%Ig3t}!5sV(_iC*Z9KIn^n2tj`gz(5SbU<|=fgkl(mV+2NG6h>nV#$p`CV*(~( z5+-8`reYeVV+Lko7G`4(!Y~)}FdqxB5R0%FORyBnupBF}605Kp;aG#UScmo4fQ{IM z2yDg{Y{fQg#}4d7Bz9pp_FymeVLuMwAP(U$j^HSc;W$pMCT`(2?%*!&;XWSVAs*o|p5Q5-;W=L5C0^k*-rz0X;XOX!BR=6XzThjq z;X8gnJkTEx@nHsYB!C4HA`ucJ36dfik|PCD!V;;F8flOg>5v{7kP(@X8Cj4O*^nJM zV1=B>h1|%4yvT?AD1d?}gu*C-qOe9W*q}H{pd?D6G|HeX%Aq_epdu=vGOC~|s=*f3 zQ3H0cM@`g%18SoV>Y^U%qX8V@gobE@#%Ka(G(|JGpgCHgC0e01+Mq4k!4>V{26uR% z13ID;Jkc3l;015^z!!e#3V#G35JBjM?g&N?^h7W8Mj!M=KZKw^24EltVK9bZC_*s| z!!ZIQF$$wG24gV}<1qmfF$t3~1yeB%(=h`xF$=RX2Vt0td68+))9`>-Dea1e)Z7)Njv$8a1c za1y6*8fS18=Wreua1obq8CP%>*Ki#-a1*z18+ULQ_i!H%@DPvi7*FsN&+r^C@Di`^ z8gK9x@9-WU@DZQz8DH=f-|!tjApXn~5Ak6Jb0mNT5+V^2BMFis8ImIfQo<6ckQ!-_ z7U_^48ITc~kQrH!71@v-IbemH$c5aut!bQf&*%!4(g&F>Z1W1;e>{0gvMwBXEa4KxS%;& zpe0(NHQJyp+QAj=;RbhjpaVLh6FkuwUEl?8_`nx_=n8)XAP_<5hVBSP5A;MY^hO`_ zML&d~KL%hR24OIUU?@T{48t)3BQXl2F$QBX4&yNa6EO*sF$GgG4bw3LGcgOZF$ZCo zi+Pxj1z3nhSd1lDie*@i6M@EKq572oh3KOp|d7Z34a26H5U1rj0= z5+ezcA{mk+1yaHisgN3JkQV8X9vP4knUEP-kQLdG9XViyoXCaT$b-Ddhx{mjf+&Q- zD1xG}Mlsl+I7*--N})8$pe)LvJSw0fDxor}pem}t7S&M$cCbfH)Pe(QqYmn#9_ph3 z9N~n9XoSXS0%tTuGq|8RTA(Fbp*7l|E!x2q?coM@c%TD1q7yvP8C~E7Z}`9$e&`B+ z1RxMW=!WhHMi2BvFZ4zq^hG~}pg#s+AO>MDhF~Z{F$}{o0wXaBqcH|!F%IJ~0TVF^ zlQ9KTF%8o(12ZuTvoQx@n2ULsj|EtWMOcg_Sc+v>julvmRalL1tif8W!+LDMMr=X^ zHe(C6VjH$&2X-P7yRaL3uowHV9|v#{hj182a1_UI94BxRr*Il)a2Drq9v5&Cmv9+Z za23~Z9XD_jw{RPGa2NM*9}n;lkMI~z@D$JR953(^ukadg@D}gz9v|=#pYR!9@D<MwXaZ+6MKiddIa;74TA?-Cpe@?L746{$cX*%! zI-(Oi(HULf1#kGk7k=mpe*_>9LFk6=2u2U|L@)G4AM`~(grGkLU?2uzFos|#LNN@( zF#;no3ZpRwV=)fnF#!`X36n7eQ!x$GF#|I(3$rl?VVH|~n2!Zmh(%b8C0L4OSdJA~ ziB(vQaIC>vtiyV2z(#CB1U6#}wqhH$V+VF361%V)d$1S#upb9-5QlIWM{pF!a2zLa z5~pw)XK)tha2^+M5tncoS8x^Aa2+>r6Sr_1cW@W?a32rw5RdQ}Pw*7a@EkAj60h(Y zZ}1lH@E#xV5uflGU+@**@Et!O{=gp(@nHsYB!C4HA`ucJ36dfik|PCD!V;;F8flOg z>5v{7kP(@X8Cj4O*^nJMV1=B>h1|%4yvT?AD1d?}gu*C-qOe9W*q}H{pd?D6G|HeX z%Aq_epdu=vGOC~|s=*f3Q3H0cM@`g%18SoV>Y^U%qX8V@gobE@#%Ka(G(|JGpgCHg zC0e01+Mq4k!4>V{26uR%13ID;Jkc3l;015^z!!e#3V#G35JBjM?g&N?^h7W8Mj!M= zKZKw^24EltVK9bZC_*s|!!ZIQF$$wG24gV}<1qmfF$t3~1yeB%(=h`xF$=RX2Vt0t zd68+))9 z`>-Dea1e)Z7)Njv$8a1ca1y6*8fS18=Wreua1obq8CP%>*Ki#-a1*z18+ULQ_i!H% z@DPvi7*FsN&+r^C@Di`^8gK9x@9-WU@DZQz8DH=f-|!tjAS&;OhxjmqITFAE36Thi zkpxMR49SrKDPf6JNR2c|i*!hj49JK~$c!w=ifqV^9I!%8Zk!b*rO(D!2z{V2X#>o_0a&1 za6&^gLSr<6Gn%3qT+kdX&=RfC8g0-P?cj>`aDzKM&;cFM37+VTF7SdkeBcW|bcH_x z5QrdjLw5wD2YR9xdZQ2eq8~!g9|JHDgD@CFFchH}hT#~2kr;*17=y7Ghw+$ziI{}R zn1ZR8hUu7rnV5yyn1e9P#XQW%0xZNLEXEQn#WF0%3arE`tVTH2U@g{RJvLw?HX#C= zu?1VP4coB;I}wRp*o{5di+$LS12~97IE*7WieosA6F7-eIE^zni*q=S3%H0&xQr{f zifg!z8@P#ExQ#owi+i|_2Y84_c#J1_if4F^7kG(Rc#SuBi+6aB5BP{r_>3?3if{Oi z9}pGy#6x_T!5j%-frLne#7KgqNQUG{ft0XBDx^jlq(wTUM+Rg>CS*nyWJNY)M-Esa zCvqV-@*pqrAwLSBAPS){il8X0Q4BUHjuI$|QYeiwD2s9^j|!-WN~nw~sETT^MRnAG z9qdsPwcvo-sDrwwhx%v$M>wG&8lf?oz!^=^3@&Jn7HEl9XpJ^#i*|5Dd$_?J9_WCM z=mbx6Mi+R&8$R%bAG*RH0SH78x}iIQ(E~lv3%$_?ebEmg=#K#yh(Q>PAsC8K48w4Y zz(|b3XpF&FjKg?Lz(h>KWK6+SOv7}{z)Z}-Y|KFz=3*Y^V*wUo5f)l0Yp@pUupS$*5t|T!&Desi*oN)cft`rNF6_o0?8QFp#{nF~AsogL9K|sl#|fOo zDV)X`oW(hu#|2!(C0xc8T*Wn9#|_-XE!@T(+{HcI#{)dXBRs|vJjF9S#|yl~E4;=V zyu~}b#|M1GCw#^ie8o3>#}9}~yW$}}%wUcLus}j2LSiIAQY1riq(DkoA{A024bmbV z(jx;hA`>zr3$h{`vLgqqkQ2F(8+niy`H&w4P!NSs7)4MN)+h!W6h{e^L@AU;8I(mi zlt%?rL?u*46;wqv*rGaWzz+7PiCS<#ZPYw> zE3`%%v_(6(qCMQ;4i9udM|6TGI-?7`;0+)6!Vg{Hj{pQB2;I;f!RUdW=!M?sgTCm8 z5cJ0Y48$M|#t;leD28D;MqngHVKl~IEXH9xCSW2aVKSy*DyCsNW?&{}VK(L<40ACL z^RWO6u?UN?1WU0D%drA0u?njZjx|_|by$xL*oaMtz-Da0R&2v|?7&V$Vi$H}5B6do z_TvB!;t&qw2#(?yj^hMQ;uKEf49?;l&f@|u;u0?73a;WBuHy!7;udb>4({R}?&AR- z;t?L>37+B^p5p~x;uT)w4c_7%-s1y4;uAjO3%=qTzT*c(g?;f5A7(H|0$3m+5+N~? zASsd|IZ_}cERhPSkp^jz4(X8r8IcK@kp)?i4cU+B5$c;S6i+sqB0w{<=D2yT~ z3TqUD4T_@#N}?1>qYTQT9Ll2tDxwl9qYA2`8f;M=HDCvO)I=>fpf>8DF6yB^8o&`w zXoyB=j3#hKQ#6AMnxh3;q7_=B4cej|T+tqGaEAvvpd&iL6P?ioUhswweBp<#@J9dw z5rl5&j$rgaPxL}>^g&ArwXt6ooa4!3M=q0wqxjrBMcDQ4Zx%0TodRl~Dy%Q4O}JjvBCo zJ!+yB98eo|P#5)39}VCLCp1JOG)5CRqbZuf1*Gb ziBTAhF&K++7>@~iFz)Gyb zYJ_7A)?yvjV*@r~6C$t~|Bt=vfRCbR-xEp*(t?d*3xW_tPKqGXObCQT2#G0lgiEqX z4wAcYcL4%|5foyf*s-9od>T8JzoMT4>ZfAI3St9mu%e=3|3B~UzIU^mYbi*;o%=mI zd+)So->Ex0JNr2BU*HMgNnj(e3D^ug1w0Kr1N;wo7I+SL9@qlB0K5pi1iTEq0=x>m z25bdh2i^eQ1l|JP2HpX-0o#FhfgQkm!27@lz=yy`z)oNn@GGnQ7y*m~&IA&GL|_z<1dIm80Lj2uAO%PT&H}~(1#lRBaJfH$NA6N=311?{|INbJrBm@{&s3o%Xw4fDN)}%gIE5Y>Hzw!24Zq#RftYu4AIJ zwQb`7_(0vJeJWsBt_r0?t^Kak><*{8J-%`0>k5S7eZi}+8JEn1_Z{5_e!u5=3wL6Z zjC1>Z(fZ|HpFMQKJT0*oU=a_NYf}HQ7LQ3v?&!(>&9`YE14`f8cN_H%YD)m99E<{z zfYHDhAQ>17qyVYFS-?18Jdg%V0MdaB;A|ih$O5u~9AF|a378B_0j2`efa$;t;2dBk zFbl8)xj-I}4=6wZPzV$O4q!Gg2Pg(g04LxAN`bk68}I;LpbVhmG9Op~lmiQaMZmeh zVqghy9#8?C4=e?i0T%!l0?UCF0M(m|fQx}kfJ=duz$#!hum-pcxE#0wxDvPuxEigGw>AfH1G`YKj2y5IpBF<3-AK)BJdLM zGVluUD)1Vx6?h$Z19%g73wRrN2iOK|2i^sC0Pg|s10Mh%0v`c8fnC7Iz$d_`z-Pec zz!yLbup9Ui_zL(M_y+hE_zu_ud=LBp{0Qs?egb|5egXCYzXHDjzXN{&e*%92e*@G2 zMFGu#=0FReB@hj?0%CyHz+pfepe@i2Xb*G%Vu6mp;lL5Vk-$;F(Lg7lGtdR-3LFC* z3mgX=51atR0o{NTf$l&L;3S|Y&L#z)WBkU<9 zfcwd6Y&;1kkqD5@dw0fRBg^qeb?jG(4SznH_IFyJj*kv}mo~J5p}i)kpJcfzln%A} z$)v2T47aOPaeEz#2iM)+>L*7)Un7Atfdqi`KMF_!MgwDjWMC|i0;B?G0po!2KpHRs zNCz^2vw=(?3&;j?fQi5)U@|ZTm70NHExlhA?HPg?z?)lVLr{p4-v2>%1z4%`7$19t*<0e1uU0QUm- z0rvyzfd_yGfro&Hf&T*@0UiZ50FMEW1OEk{0GmRL#z)WBkU%3ETzT4cr6V3)~0X53C0s03HM$0v-nb4|oK46xaYf20RY@7kC1A z64(fA0yYCr0Z#+Z0RID?1)c+*2etq&051YB0WSlu0IveC0b7CBfj59RfwzFSfp>sy zz;@tWUpQz&XH7 zU>0Bpa)CS`A5ee-pb#hm9KdW~4p0n~08YRKlmc@BH{b!hKp8L(m=7!f%7KNzBH&zL zF|Y(U52ygn2bKcMfD3>Nf#tvopc1$UxEQzuxD;3ktO8a8YkSEA_geQ>`oL*EDQY1dBN`EdM}t0pfv^3LNC5Qgr{=suX`s!%%A zx(`ltI!f$bd{WtXKfD%Um`D6KMjn^L?FwKE`2D!$G@AYr^X~uZAxAS>1#UFK+vNHj|bm;_GGw<9eL%pi4Iq>`VnZ`7-xY?|A6}})Jol8=?8-e zCXb-p)7Q`E571+i`J{Xsz8>};-(o^p^y(R>>*3qLZYkObmK#XoPXv5Y@HJk=trMz3 z7}ifs1bikwRCrP4OAE`)=?0TWz$e4)m}k!`&r+Nohu1MrLGxhGEmmlT$T*LfvImVS zOd>!-dU5GV#dH}(-!&H>RW*No3*2kIFWlRH&F{VMxcCI}p?)ux+E13NLg|og&-K_c z?1jpBmp$J`U%t+AIP;XmJYs^#cfxO|_K9XIV}Q265x{XkUx4P-s1V%&GzVFlV=X~j z_cShn_Vq{MUBhHnhs9 zUzSsxvI(MJ?Ze{v18RLYTn-!T9I8|e+rj*?yai5Z2q=SO(Yg$lWrAp+3QDH(!QZV9 z;w_+9&L8>Q?Agj6vqmESFZU-~QGZF#i2&K8S8AVVZPgP4`(C~l?w8Iv@95pm_)$kf zPKMenY9Cpy3Z(-ziwd>ylXGPXmpy>Q=yfU)to&vPukX6NCpus81`lSbZnH*Mdp8Z@Qqb+B9) z`z$|S+bDeJ-Rb|IT2fkU^R4#a05YFFVfav(N8HVNEuMMw9uAMkPcZFk$=N-tEEgYB zca>onoa`vZSLbb6_5x*;+cn<pM(UVCv;k&-uux+Dau0Jxnl{n@CWe7KQ*=vnd1 zl?&H&#>X|bt$lpQ`eM&;nnNSg1)zLpxhj+netp=oi`*`+w^;k~JA0AuA7Xwnrf<$4 z3iH~|56;>1!%1Ioc*-B#QP+~QyOe$=^2Y;>_(jafL&`AbmCUOu0$#`Wc`rY14Wp0_`@#+C-oXYtXzt5yjb8OdKbZ{T#9ms!s4!FY`>bF25{!OF7Ci$45FW2i)c@`KKa z>8!4p2fFRSkvJ8Fsr!z&H}k?QjgQvuL_uFHCqJ^0c;#e{r``sIImPZtDt16?)VFw& zTu!gsRa~sNM=QljAtpBvfy`?yc#&aVW_?v0*-AX{ZGrQ#gu(NvPb9!;g9h8itDv*@V%*D?JP@i&vWD{lU(jO zP*l2;%RRL~Wu>;PIgV0;mvm>c!|n0LprE0$@rlaOS(vHVJuWA; zg>rj2`A;JsN~;4vAd|`iOaOJ7Jcydq{ri1qInfN~V(M za?_ZDOclWTivK%2pP_rpuN|C~<7?NMk6BJ}lL^VkuR79~G=8GtD76yWd=T^75COm9 z-v%vddszYvi&ew?%yM>@Q?;4%bArpOPW~wQqsp~OP(!R2Q#c67Rn# z=PgQW)JEnHW%_VTUKV-p4jKrcZND z^thm+SqpK}s%`hy;G=rC_L_R(7x%UOa*>_@>4nDsEZ4<8%b*v%Q{iE^O>ZejgN?(f zwMES5K(9l`C8_gR@_3*+jDF~%M_xPd;V-xT@(gY*RYUpH9J$1DUF@^!s2`hp?}j5%QRwGcu8Vz^A${~_Np`2oVzk|B&$WBBMi{;;0M^6ymPS2vhg%Pz zALOHdI_xi;inU+;_v*plzyE)i(jOS&aTty)SB28Sz{95p=prkxNWmR+HT+Wg2fDmc zJ*An`IG`JFB0$$4s2rC@Q>)@1mzl@4amzc39 zmA>n-NqFJ7syQEjdev51KR|~0uw0Y+j{*2VZ4>Rqj(n9STIRB1uPw2(RB`4bn9L_G zCUm|H!G?q5$0#v7ez@l(osRE*gynuF+L?dYYSZpMv>Ehl7ms48pO9`wxV%$-6&)6u z&vtBnc*fetK3>vp-)S`VC&TwgEZ3y|qr?ZxuJbTf^-H)|Y11|4+b4-6qN_r=pn6%K z`DH&F;~Ao?Wk_b02b0wbTt|U9ojL|@Qr_iqy$|ImT>nvY>j}5~@$8iY`677SW0tdf z?RHxmd{8fjX#g686{p#8>qs|=FfyOYHlfRP!fCBU{+AuD+EaN`6}7u$xLmVbllqUf z`4AJD9m%%OQJlo7NbcJz5S071n6}~d^S?QNetBFo$CsQU>&Gl-_uzb7Wi&37>-l=5 zPbLwdGHC8E$nEF$A#)FH6~^38Xh*^$wXe0B0;qQg^W zFD@>h;Bt;BDfO0T;MGpj9T~YiZ8!0%_;#@Rp2B)8Aie5a+dT6Bb=xlcJVlG&pfy8e zNYA}-WVtGo4yjIzyU5}F-&V1K=o63eP4;rZO?tzPlj!|S5Wd{|yjK6>63lojiW zlJ&IbXd|zudbL*P*Vlk=+dJC*RnfDBIATZFr;hvV*oS`askH>lv5(jjXSWO^w=n|+#Mx`e;g&MJk7+8e$7R< zUM)m*VM~06w3Q$|LPhHRRTa_=)K5dKu799)DWIgDQ*O{Xf%*#?0+NjUl1v{Gs&3>? zhHL`)A+Q{$>VL8u%TWA>nyJD?ne&J9;BZ_lxgYxZkEYz zd|qEWSlsoEuc?GffO5_GQ(tbubVPF5E!a7yYj&5zbN!R+r0k#Lp!Q5QvVU^pFkH6i zKgUhsxLu%gGUSiLr~>^U%jlf{Q(PP$hb1>UXF2;d+vH9%_J>o;G*Jyyf)~{vx}P1= zgG!BmoLhs;rrU#xG`w4}B~|UO{(5NCq@Ld&e(`gvPc5IjBez+ui+vW>snNr!c@Aa1 zHrjV(VYQ2rSb)dsaMPZ%!#BD}Lp`Q(DU~(LSQ@Z2P+J4$`Vs>#R(o4pPnN{e0BOKn zU+7+u?w5G%LVo0P`fnLa1OHYHnClDAHOTs~>Wi!m>-^uWfht@)-$%v88}Fmy@S=D= z+_&TYs>jNoUM4-Ax6AX}c~8F9u7v);P+f|{k>#pTIvD1c4fD!LMRsSQg1LBF>Xzop zSF&9b@LX4&Urlx5ZmX1{sYU|Cuc6QBX}w@afEIGm9BU_l)(FyCnK+;a5D#E_RK0f` z0{cuL8JGajoG-!}J95@f4cj}MB zP2xh}V_+iGz8!F&v1)_KxXr-Dm@FyA;J64K{?fyc1}5x|#m(h^u<&6TCW^;k60ZpJ zx-T7#_nxts$8{{;CBs63^6uDQpcn3iPr&C+y*^%28+c-rIB9g0=rB7>4P7%Sv2Ce zWHaAoy1Ze0`AMCTcg)Exgq$w%P5|h-c>MzFjnbFT>3<-T0AWMISLxwtUaT7Ys4OP} zls27Hd6(Dczq_>X#@J4`?S)u18pkMMma}^u@>y-)Z4S>&Ue8Q%R0CWNGx~(**X7Lb zE?9fiHOn}C=4Y0(dwuwo<`>K?E2T%CeyUXx&pi?Fyl6$t+f^S=c$axFPqUoe>&(-m zE&ra0XT-_^ZJ$)uW7R3)^%%W;@ZU<#+)PfN`I+VHUT1#D=X^yeo#{~*`1=*9N4Op~ z^UdfRp6?&ilNY~y+4NfaG|L;p7aL;~Dl-cer=q>{B9oTepPC5xw)pYdbKgID=LAi! zT79GUHdxL)*^XSl#u`+G2w0Dmw(xrVZIiQWuT}S5Zsx^u=EHU!c=755Lk*YfcfV7^ z^E>tKRj1z7{e9Z5Of_Va-dL`SeO4X#fmfiKtwkl5$DI-I++IF^Q}4v{FapvH^JKY? zpng&Zo{}De^Q}U>obMI=!uN+UZ;mSevgFcz%!_%qHp$t&4tz~5krqQ7EaFG~c@_A{ z=~LQrxk%|Bo`1h5rpL~9*YItI+J8|>{Y`R`k*NcJ)_2(JC<0HJhxs~U2ZS%*6FxrY znwqDEVg#=lEgzzUSu5u3Wx1N5J#vn@iLC?tUM42S%P|IlI?^C+j;TU%7k~ zVIfPnam$t8z1}+e)p@w1G4eIb*}V>Y!83TzAnUdBY2kTJte9DS<)tU#&dkWuENAyR z@Ral#obMV$%NNF0vbPHX`mIXz0NLU*U}Ysw(wy7E}K(LH=6w3*VP zeH>23fYNWz$b7dZp3cc|{W8lnSFB%j6gnMF1IuK)qqxkCdlE7g0PAauDSgr%Zqa@F zC*V{x8C-wkmg{1lRXhD`x1+ESJSMnk#zihK z+mSw*M1b^ao)6lB^mpIX>G>{wXHKHMKFM(UEZ3y|W9{_$jbmF*X|`)%iNoo!WtHX8 z3UUfn39vr)4K?z~hZ{ZTr%sOcIe;bl6{Gbhgq(Rg^-I<~1o-cBsKbeQ{@R>I9ilp5UJpjj2TWO3!VS{E zdW7cop?a9HeWx^La8ho}CJ__ACV`>cBMosc*&b!=kx81?%y zayv(Lnd>v#zQh{wBn5HF>C!w^ebSTri#2Bb23Ws;{qEsAj@zCtW9n;!O8ehZ$G{zwwx=L^s*l^guu9mbe8VHv^lphQl>v1_@ zyDn*2e(SCQxm~G2eWtRX2#`&++k9Ve#N`Gh`KNlpIrTyop@6$LPdJamvrZ|bF9WN-<@|~tZR`gUMs-lfCkqB*@6U;w=T_gCuxeiP)VGe?N*eWQoN+B-GHx0C@w$S!|)L=M2il4pM2x3(@Q=ore{?@ee%41ti8WU| z@CMO%^Mi9%{?%v7WS(%Ne2+oyvz+|M#*nN{O;>+^89SlSYn}sfV~hfiJ(JX6GM{}W zKIZ()Xpiq$JuqhCao=Q)n^2{3UyWEue=L`|(7BP1oS#~SOPuW24f&V(R3;nCIrZO^ zs=N=$sh*V+hDD9Jh{BQ~{m{`YSH(DBH$<1)Yj>)39`6DcW4oWyVtXDe^@aCrcNzBP z%b#e++wT-cu6MCx!}GcN^Q1w`9?Rj^aj`QPnJ&UCSH(Dl;^UyNBT6b(bg6^q1;Y&Y$=cWBCm<4(vGN_9gu$wfi<(Pl)p8 zDC7^zIeoT`JSJhM7{xcCV$K^1Qvq=OuMWc}!yPTU=e;=f{aahTkbV?}*7QQ6JK&iVixi zDC)doU<35hXcRz$_9%cjMFAoKHh^q0d~cvCg6kW2Tly`py>aI8qBG)wq2ycR=##5b z{~^%zrDB5)cL_F##YOXVRv-xLIc{8dJ->3(n!n%6?{cHMC<|d}eAOC9pB(>X6NpEq z%jM{X-@-uh0fC>KtS&jw~lXvYF^u=-ZQ1-Eda@mT;E3;VVXYP#E4JMt~}S^;9%I ze0%Zj$X`AiGOlJPf~lq*4QxcaR%W^8inVOv_j?(oV2(qfZ94RxkXP$sd zK0kWitmVyz=;I^*ey%KscY~35`?i@vdq?|g)18|kKQqn_tv8BzXUC70&VT>0A2<>E z-W+{(&MaqlDSh6CsP^twwOSG5xO!&-$k2I*^}83RqRsYw>wc`BW!HFW z?Oqh>E6d4`Y(nr=zm1_j!5ppRVL7+D(VWaDF3ZTreE&`9xK8=V*7uZSpW`%He`Yzm zN5qGoMe6~oU~{{%8GOjFe$4%X>h{*8>b|`r}kYRmHQFeHK?QVN<*ITi}Xp0clFh8@L-Tg^P{8F)>l4}n3 zE}5fXSEJAb^@yrqvmRq|!t?C>*QuAiRrJ;+%!7HFvS4zvzkln0xn12l#aMpw zp%j`A+XwJ^i1WTUF>k`J)6_k?NoUkA(9tYc#W-ZxJsu1I^YxiIe1&43l240#*nu`Y zQ>Qm5CI5I#UKe3{wL|qMA2be{gxZ7sk>@-fYihjWalO=jGB3Jzt+imD2NFPQ1J;GOfdu`UW9-$Z;mIJ9V{P$ z`Db|*3Ujb@sCLp^Bi&k(O?gH#f?Nmi*E0J_1LpkcgLKqe!2Oh-6>Z%#V9p;obg=qE z^@!@LW%j=Y!}{S2O4G1n^Wkja#hsMt=XC7?(?!vVV_&qdP zKL^h!2VnbY@NuilLTO2u{>4J=h7MPuMlKMxm#B1 z;jv}5%8%u`*k=WtpMs7|6G1f0SHlFVUk$B04Gr(R80#e9{Z>Qu+tBbNC%uzWl~ZrJdj=*Y}iy(Dj{Sb)DMNebUC!v+0}+-4D>wELX)iNQ+B-`xyJ% z%rW>9R=Kv3LcSIv0hW0@isdE3H^HHK3wo6AJGSC_Xq=h|kj>-QDm)yg@0wH`6)iRv ze4ak~lLa@tuE)3>Hnp!T*Tp_7%R$d>lI(a_#71w0(CZIQ^)gcF#a28r(LU58^O#&{ zXV2q_Ic&e6@?bgs8ca|g zDO!(L1>c{S22EYjChtb(&Iw&n!@% zENMz-XPnRK>5zh{b`%pE?dO6jHQwQz3q+wubKCNeLew`^|?bCGEuX_Y4}juHES!I3IXi$#U{88)yNqo%u$Wqw)A! zEyT1ag#4`sD1CGO^ZbY$7pE!9{^|2ze7RoBe3}AZxxB46<*)g9)b@8;iR7cc|I>Z; z&QUJ=0ULkZea?Sq1Pz_qZsyp=kQ<;~pBQjqSehu-n& zti!wN!Sy-A&b8$19*|FVk;9#jC9+;DP;AN!-KjsP`n?(Z+mjMDfbY@|*H4e@*-ETf z)@qS+&&(TsjD-VCJAm39ma9VPP>YxE{?VT!{@y9@{#L|=bWUZC(xW9t^xn@A04>9# zHi6bB)1pbzbx(liwfX@x(NEtDNCL(IwD92^zyXv2%YZ9@+kg$gtH9>~me8u-6c`1& z2)F{E%?^GA2B88k0GUP~9|H84lJ>1CMq}L(mFPv_T1>80V1Tv^jpl!FA-i!Q z*|>-=(aEic4(~Z!h|iA1URr2Nd!sZbV*{?I;)J-p2l}+$LVVI!h{*%-J*G48j&Fhx z-;Blg4Kgr?Iu+j>%|{-UBHR)oPF^X*-gWqH!FtG_#rHoy5aNbkpsS;zMDxK>;*+V^ zyXt}{k?~-Z*!NkKc=m*5!ab{*c)hxrcqAE?y$nxiz7#vzI z&wXKduJ05hK5N%LaYp7xCt%69YB;}H-Z(s!eEIWU6sO$IuJMM}XGZT<;)n_3YYIms zymN<6h}suw&seUDeO4Xxsb#jV!YahT`P{E8G_RdqW5mFZe?0n?XA^FV*Vj|B{#foK zq@UD*msVf&39@`Wd=+fww>1pE*yF+Pl}nyG`_mgntTFS`<$AO}s~-GHi_7&&jacM- zEt(fve+k`U#09gSK4H+X)D=as8U@xL%YDT3lREIjXOsLhuyF{_{eC5Qalij|V&_;& zvr>1b`Po=}T^n6S(EDXLi3#6cxAU^(KYZ)|DGq8a&2m+Y0~Q;(+!$h&YqwWpasN)2 zA`j(NuW>js&wk*+JfB@O(nV=h=1dF`FPUvA#`De^-}L=t$t^3^Q)?QKu(6@ zXpSSxRiSj?uSnyA*V>1s)zP1SGP?qPx%^cx46mohc27u|J$T}ooCNF1EN6Fr{;HGb z^pq58O7)EPD0sK5RHW$X^Zf?8bJd``u9FEAPhI1n1RE=!Dr6+-m9LB9rZPzROSOp4 z=|6$4n?de$-$_k4>jS5jX+#ZFA}%iX{T79w`oY)Eb=RUs_rn^;UW#ou0nGM&+8JaR%MZnB|%)_QlbgNq=T}Y*_Z^ zR~g0?Iyvo*I-e#3)h~*wQN-a${OEo(4*a_RkbBLy-@NzQw8yUT($G;ZchzvGx}OM; zO}e5si}%&pxhz(=&RCc8f7hKpIRhtTnehJU>$UOQj3C$zr zf>_b+`VJ#5U$y&OGY^(a6x35ZFTgiwZT^Ju`XcrxaHl#wUJS$Wg}TyG4}4YtoS*B# zBV0e-Y46xClD}_5!xGid{2NV(ndPb&2gCeZVm_Yaj>e*O*J=Gu(|pK!7;;|d^0X5x zHd>#MeE36uA5qjxPk`UgWjUwIw!bP#^D$}m1?p=z{@3%w76f2Dh>FlWVor(?Ef;;a zebAeqUQnbbMC}2U3zl>GYzO3Fm@l@a7CK#STEb5s7{b(rwEoKG53Y`@vt8=DLw>2c z?*y&Hldoe-nCqzS86#@OJ@obM9p2lEZKGAg*THgK?6agKebczu-bvgdLi4Zb9V2#kdgR?Z z_MY-wwdPeFA5*!uuk&9mJeDug#wQ&1*MddQ>%(2Gui`>tdfJU7^~8B<9b?3;Xmq0xO#e z?Rn)HE{`|c?olV_5Q;i@=Cc!g^P!h#@<0=JtrS5VK)h&tCsz3H=dW@f--_x$mF`aW^Hp#s!{a;i_;l^| zXi?d3#HYusJ^9W)s!#uW6)e}qK1`m$4J^apOkK<|Btl zWW80c4$ZIgN6})(`tzOdzxB?M^h|*a^JBRt^&dml|ZB~E<(!W!fFiRLWme!Jfr&BTnUcUM!GH;#(?>XfY0`Ei`+ zp=MlUo>DtD3OCGeCS2z4pJ+U5UWZXLI7XcINB7ycmu2+3+4TI4 z<;;t1A3rR2@z8Dw(2X>klI>FE>X29sLYcw&RuhI#=bPvxH zC~FZZ6OqZ|kN7J>^IVV+BTl^Gf6lnEX$#FfS-$-&5Uph0lx5SBM;rOvT`>zYfhV=1uNr(M1SNHQOx zpN5p7#vIQCyOv1hq|c_rhj}+ePR#9}utUuu{S)aQ>}gQ_G?yW{ecPYyNK@5ap!V(G zsE2U*W9cNghAiC#*Nxf5-2T+n-R$4`e_%Brm;G>gdtjOVdsC-;k@G2-CL-|@ENmoW z|8V7l`{IW12*$6mrXz9 zBy2zPOINFzVmC&SM&RgvODXJZQ0E_ufGNkmho+ z&Fx?)J570>D4hPnxi{_7VX>>P2ITv zX;OPYI=0${NHwhSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K z(txD_O9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Eer2$I=mIf>hSQ@Z2U}?b8 zfTaOT1C|CX4OkkmG+=4K(txD_O9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Ee zr2$I=mIf>hSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K(txD_O9Pe$EDcy1ury$4z|w%F z0ZRj+HBkAm5RS{sxAf2HmKEA(a97@YoA%0=_fl`Hee8p$tnKy9=?C&x-~Ic|amm+Z zb_@2O!qg{Ru=pBV-jIFk54AnkxeP_B6Y>|S-^R{2E>mpRC;mwDkMzR2VY@!*Sz#Ji z16E%6^(mK8mQvpns{c7qb(i^Bwx)rmk`E1OOF1vOPiU+$2giFT*^%};bj@6^n?hS> z=0MlMvT)bL?(DxV`PmrdvM%W{*GR+s)BGakW%+9y4an`YeBRL5sV>yF?9{c4Hk7M5 zJn?4k@;UkAI?nFqum|%0f!14NUpwoVZFBt84q8@wx)q6^`lQ`hVW>@Q3|$1{6Y2dEm7j)`p~f7~1iO|<<)qK1 z#D{tB&wS=Inz9{g4yh^gZYtcUewxd*+`j!A%U7WG?cb<}aAnleNpKBWx(Tiuvx~X? zG2auK-Ob?-#{Y-nHE}-3W&cpVPQKoQ(WZQn^C{RhMB*n{*ht3y;mQa1#SP&Rj9+8P zV;U2q$M_eZ)-?OON8H6AK)TJ4Gu%|c`*xiQS%Sa)oj-L3!i)4+ik-`0<5@KC|Z zL@;^qm>TZFX|mn$7@J-Ube|E)JYZ8|zCZJ0f5zREbZBu2t$|Q|Tj-Dn#x>kHnps8a zkNr1g`(VD71I_(Fr{9#zmBlTz2B?p0>iuM0=ZQjJapSs%(_J|CKy0k~97rn%mrTBY zt4|p?Sg!U^nCEH=*C3adgC*}Ro|XmP zh^fuwvdUD=_ir>$Qs21}b6lK8IGg658|&TYraYG&P7nX2ySW@hnl`luq~k-OT{zgD zTbuKU>l@itxi@Ra`fq8#(txD_O9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Ee zr2$I=mIf>hSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K(txD_O9Pe$EDcy1ury$4z|w%F z0ZRjx1}qI&8n85AX~5Eer2$I=mIf>hSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K(txD_ zO9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Eer2$I=mIf>hSQ@Z2@K0%=UppZj zmzQtppVKXi(hRrXJ@2#KSo~=3^}6hz9w_}lvbypMwFi7Cx4NWLU!L_1R~K%9{PJ}- zrSGZj4_)we2GW69MrD;@b_@2uzMShDE*Ovc$iuY<^@;Of3Da2m=k~2G3-y-|{>f?tjCu9DfaFl9HR`a(We~*OQ*>QQY$sw=LV@EmkJk zJz0uZtbuP%Kdw#a^lLhI6o0!rjXgH)+Gn}1=k!@_NF0B{q@V0^r`a9OWVgLUQG-@X ze71z)LjktM_PTvQdiw-AC(}tkn&qk(hZKj$>vEUdl8VbbUd8RPsoGiK)&D~~6CECh zH^c49Q#>Arvv9l}%F8Ra<+zJg7bRbfstQNeTTxr1-r_bjQ}b-~ZK(-Y~OjCQ}#ww7FTjify2B_pX=u{)LgoYGNBfy=FApzNS1 zp=fC3b^#*f^022vXnj_8?I_ybcggJaU6+mIdc@^{<;;(5*5}z}io0C@LvB@wfYRmp z7LswCbY5T63IXZ6fyApLK=tZyfX3cNFL;!c2*c%q<(kxg%(53Kquj3f)KuBB99{)2msiR2I$Ta$vc1Gn?6A8X z-tsiX>vrUgwtMZ#iZ`!lbeY>uUWC|!sF>g6j-l(khvB__Co*Vb}LjEQm^JBT6 znRXT-zZ9j+jq2pcvyE{UqLHJ9tpA{Nx8CGxbuQbLZ!b@Gr#K3W&}tVr@_n^Wh_%vn z%sM<;tpnUn(0wxTOgUDFhljQOd=IYk{ufWU>)nDOucqsjUv1)mg+HdU{4qa^9 zxiR*JR$|+ZO)s>2=fZI@KWU1Zj_{->mgBF%q`79hY)M6Sr&B4mO+wLA($J40N3$FY zsil<18*7k0#mf0aU1NJ-eL|G@xLKdxo5vj{E`QarXhlv)N_-im>`|%`u zUXhYtt2g)LxgDkG%jJH0yTp&$;my5T3+gC0xLSy%AFiKXlNuvdj_mWxrb`xF*Nqx$ z7|L_v$8uFD9m4XPV4vqGR2z$ISF*$H@n)6fx}~v4me=k!@mznDUyp%!c20{CH_YBW z;>cFL?&+fsWSJ++C5q~4Se{9)k`jj(ne7e9vmatJ*T-RyjWZ{x|F6{jQ+*k7w6VMr zb?PIlx(LyKQO;Ww)`0n&H|2IFr${o3(36^mngF8pcQb}-XShH7QhlCyh2 z9!W(?-kdS%$tay=#oEBK0s*+bBy`gBkpLO-puDE~u%JK2<>|X-;Z(faXG-rqt7f1@ z(Tt|&akb>^9*_s=L+2ptVGGhHlL%1y=5cGv)ELqAjH`MUT&xT~MlWZSKGg@7^&SqQ#J-uC^by{MXj2Y48NI7$6=jSB27{7LPGbue&_S zt!Pyd1Afi(WLR=}ru#+eOX2~_eEMG>Q-MI7&+%PCUti3C7_oNc%TINAz54SFeYDih zf<@QIa!u+#*1EnF#h$OY^NqK5BPSwWlI^l%|j~;g9lz<(xj-Xg*6_xbdZ7 zWVWMNNwYiAX}fKicDhZ@wtMDy{DVdW+6hqkn0DfqPjDQ>h1&5B0Chh!H*gHl4d@L} zS)`k^@xVC%wJ58B^}u%EFi;%}Tn>B-%z}cy2G&B!#b{_t(a^2Or4Nk};&>$HMq=qm z>@6e~j~kRl$Kqb3JJLlN{OdF!Y>7hjLBn@lF5)d0;^eD@nExpH)LlYcdQ_B{nG+>G zx;09av}h(yUDQm~BUE%As06&PB6%nS%4$2rekhlyZ3bQSo{6eH`Jpl++ti0}Sz9h)s(m4i@pFad^z}{&D!#NAD=4dO~HM`EP(bnM8p2oBJ_xi?j7CdS>I1 zH_8X*>KfNSs$v6Uw%Ax-=n*SPtm-p{TY>KmNP%L>%lXt2sPHsv>FAJ z^eOkVRA#xqpz=(84AG+gh58yA|4|#$2B7|!@2k;Os`GU;pGW=k5x|kaQ2_PTG{@H& zpm8InRMoy4U8*<^I05JepnDZ30lfgqD{4pk0;d8P_6u~o;&fmrFak&bl7M93EMNkV z2}}g00y6>9wFAI(lsYC@2)hDU0jvVhZHslle}H>|M}SSh3&5Mehrn*&C!iUW(*ZaR zI0YC6j02_vPT+jtD&Q_)Gq4T#4v2w5y8~weGk|k}bpWRF#V0^(l!^YpG@ufA6rgf~ zB5)p(HQc9H^e~pEK<#;}u@Akx%i9;LaoO9?-^RJdqzZy*nRyw47>A&sk5o_!mwUhu1WpJ`tmfZRc`mLVIKbOWE^WR)f5&j)8Jc?yOJL8gSO5HIOVex4>p*Pv6X>eNS*P5n0Y(PX0=QDv|!6Gj6I;LhcF z1Ih~-F3%NLuT|$5iiV=!pY_w-y|zRT=D+X|FpvJ> z31zaqxH#9IHz(Ug6JwZLMgZnfIl!0?=5}@ic;5AN-<1oG|1G{J!jjnwkRDjB3Z+BV z++y3j0*^WkPs=LUsWI9Gs_!%&r!g~)#o4B&mY#djSe)Ai`cG{Il^zT~4dZ>vdjho` zWRo%5n)KgujD-TIT-3MSX8p+;3nY`>oASA(4`c2$R3FCJ>Q>*HVmXrU1Nse&R@;(9 z^F>Pkzxw_7EmP0Rxq?M}O<$Yj?4G3*s%zG$4bLdHd$DG!#D+0oX(^^|(5tv@87_~s z%+8kWDjjdn#i9Xv5>e*WyB!gS2&rDvJnGi7qJ_+ZI5ae0`8t?4*@0xTds9BQ^kK{$ zOCOd#j2bZh>xThWxN!ru2MivM$+2*I!8W<^Ifo;g$8mfv$3f?^yByAZ&f!Q-Mz-a1 z&DD5hcXK$SFYBMBfxsFt*B2^JbQea?6v*a#5-Q7~43|T;L-~!wt-kTpH(Vr~EI*b8 z%=N{r5vnKLrN$?2SJma|QAvm3`re%K$&0@;E51d;^` zYsoAPB%mON8;>sc68eKUz+h%c=Q4`7+DQWt`m2e(1lso={v?{UI$J{3hIZ?Vq^9K;@3p zr9Q)4CfSW`b~oGXZnmjBbJ=G%4$J?^=5lX7H~$Y5mi(AaFn_`1=J3}41Fr%3x$wU6 z+Vj{1(4ssvKaY)D9xXcF)@^oncC-E)HLwPMDSzlax{7qI zoFqaALcFpFabG0FWoz;7&z-oAC-C0tRv{kxLWsdpQQ{&j*!^vIl-M;hN-Yn_ zYIR+02CiAI*Z3=bA?3of#x>IV+#OIVl8MO3&pqQajOEbWUTyulgLrQE=H>5QTY5H< zQ4QrSl|z>6VxJXiJzV(p={eAxW@MgQO+3x(bSKY<5&h0TX3t@NT|6z57MZ|MIV7Ge zSB27{9y|>z_?W58bHUl6^-0NJdS7N~*F6rD7|oDAsm7S)nrq{%dnT^y5h1rf@tH=R zW_?!9iV<(#(dPE&m%GzG(21}r zn$;@vjLQzaey*kN`Z^V2=mVfC)f4kO5%Gp}t#0 zZwvNlDj#||&j+6vL@l!csxhj+nwb!R-yE5@woBkGhjz{;~6y_x) z+KqM^g_xS_Xbqd1v1a;zb|agOe9ki2HoKeu%YGv{Z)o^P(y;tAz6RDHO0Kv2P;aSB zB?6S6T)yOe31ghDvce*LHNF1UDFu`J$;~s3 z?MM|GaB6cVuZR-&&fN6L9#6D*_3*NvbD#ZjwVlYq5FctsSgs1CLohxXlN{QCX;P8m zlod>n_z_uFvGoy2dT1`YeguTIe9ZbWZUzaH@te|0g-~Fx#>l zotq8&H_NU6mImsofeHlRb|qn!u^v}^J6Ik6bS@U6@T})(NF=f|UOcDmi789yoQzhT zo7IwQuDIW&T}QEZpK;DA+f}CT1SOA0wnUJ=a{T32W_6nM49Cyuo8{~tBz<}r$*XTg zrFxay*CDw^J&5T&ThcgivK{Xe&O2kqmeN@9Le`azC9S6QXp8wHGQ@-0GnT7D=@5`d znteh4(e`rNB!{=iRp!;V!Bk%i+KI4~FQML(CzjMsVR}m)BNG)2-PExtjS(r69tCJ0 znx#O0kUSL)Ruvkl4G8=+0-u5xbFRkV`t#$2D8U%-2n=4=VL;jOLX1_P65_GWQR2yK zqQuaQW}@Hp<|2Pr3-RF5t;F-#%kG@L?Zui6M~P*Zo*>?Sqp!Gj)hO}J-Lu48$E9NS z_b-W|L*ke*neQyb)?;>}s__)tArzz<+x0P ziA3Ltd3mlfeS=xK9A@Mh^WR(#V!W~9?6%MB?Ed7(g=Ri1H;}=ffP6UPB_dVu%k^=O ziHEryR+q(!pE}+%Zq?e~UN`e#c|<(898Pd~(@XKHLaI}HJxwo{5o;LGhc|^QeZ@Qk+ zJh{0Xt_mldj~h&U%;l+aVXS!Ls%1lVJ^1sDW1KW`XI^XvEbnlv z0$49wkuJ5Hn*kcr&^e8#&X?3Z+9vPFf=Nk}gD_V=qp! zm)di&Wvths;0?%tJrUlXh8Fql93d(Y7xT*~H0s4%jS;h0dO0Ewayzsg>C^Ql0>Si?o!@>^_O`U~q&G5TN8!kFRVW>3J6+f4QMR1Yd=!tY zvOL-r92@NxLS3|-Zm!* zJ=*TolmF<1CuW-A^jWTpeO9RSldw&%BM+GaBbVb+XZUh_@%EG3-ErN^e{(`yj?Hp* zk7S>(@h*^=skX-=0TEKZ)c3t!PS>&nYk=EHYBys5dVZj_iGlrF(t}F_az9XA8ooX| z>@~ZNbbjyzw<}~v;m30G)kjjFvy{9tw=z@R(b!FUwqsJe3K7fonx0i~n&vdD|Np!O zvFT3RENAyf%8guLWIkKKhssJKKsL2kG><6n!<~2X zWi8&Sx|ALrsfPO{vz*`)iNeVJb=>^W`q}x*;bPN`3ldix zxpM@6@Pqi!c!A~2gKZ-pbt8S>3MQG0xgK%&`q*6m$ky%~{Q4!nB$MZB4vYIEXYLk5@LJU8Qy;5g?n&zPX)0xtXo<<1Nq9<9^kU zKk{vst706C?P~3IKG0Z&!pi+m%7W1CJ^63D{MVBA%L@NgZ>sR0cpZ%+%gK*yjJ%BP zeIQQqeAH&}q4*O4vWXo%TkG5%Ya8Bur7uoJvu94}_Rf{|3#kn!qqXnNd~!|dKW5u= zZDZZ8GTN>s+iiE!*6=Rp0D~Sf%8ls;%AfxG(zms{wV6Kaug$&F(Jbebje4k^Kk}G> z!pQybcJLv?dN9ws#J$}?^gDOjCxa$0+H7yDdR3nVP(RFaP3k`y`55y><|6Z$wJY`cHx`kvp@ z5+2ns53`)zIZd4heHnvAG7Uq%lr9Rdk1sQ>*ivvc zvmpXLfA`CpwqWC|t2sU9W0teKiBBLV1BQ@dbYtlM&I_-f+>9+lo;z-kzEa=czM175 zzll$9{phUX5Rm2%XkV}*@Zs;A-P-JKb$3pA93d*g%;zGm?RPBgoKRSj$b7VZvRN%T zyVIxkQavv0Y(`J(GnFzAJ_+f}M{k+###$Wg8;a+G7Y-)Yp=uTlkh3nY0Z{ZYR6YA zwa=QS*~@d$NX=0w+d<#|jjv2)Zkgio)}Eh{l8ES3D}S}Ul3aE(pUeL#wE2JS82_D; zDkw&tKdY-2g6WmyvYYu_{!eL||JRkrq3YktpQfF&a{sV-Mfm<<@ikX1{cQ2fhxn?v ze=y70-Pk{*IXu`%S?vVUOXUMk-p>?W9J+i|cWoYbPQ;@ z(sQwNYaZ68u%aZ+K3&Q40~=O`=Toq+%c}3L^uEvOF(0#>-K8`~VU?BB{~t3;#r{02 zf&v;cp5ydnTjM56wE9l-be5@`2ITsbu_}ByIsd8c3E%zJaucV*<-{y!cYnE1SL4w~ zH~k_kRdRW~#fpc%NZ>Cs6jtU{vpO`dm~YyO*FQWpe!}$+uH$x_cu{-9a^}Ofp9B`) z78k1xj((Gv?V^@PT{wyFmicOw9x_CE)}9S>3S6iC{||*TIbXJ~G2Z86>A1Q#L`Aa} z;-ppE?xpMf@7xo-Q--FRjqpv7G$K#_&CQ{idIb2}+Q97e5+z@(!mqLyqvrZymb1H54z*IJ zjgIJLN%dOQf+-b3d7dTq^3Z&$zilgua<0B|XVHXjX%2=A*9(?wQvXrnqfe^%C7cgh zbv0KTBAM(P@5}wqTJWTCSRz2#K?j;rt_r0?(D|UG zV#V$(E7hJP80Q-+)*H(!zgHZ81-=tdaO#e#-=jsZW;1RqX?xVoFY4umcu+gSa*2X^ z8kWasrPyAMH(xz2Ck2=VP&p0tJ_n7NC}-*ZC8Zs0g);rcLEtMFWNutD2Fr0#s4`DIlLTBK4-riR!&PkXMZGPzbun&iktt-=Nv{( zo8n?W@;Uounc0@Z$Z4^h!^>&$IlGZ98*(QTC_WC$?rgJM4nuA%H~Zr>NG_XD@^EgP zHro_0r_VOI(K*>vrDQq&hBV}t4TWzk6D%&0o84H(a<&`FMUI!xSx@|*?S`gRpYV;D zHpNvRQ{Qmrv;xJ$x;Fa_CMSP^;xUJh|4OPB)gjr2$I=mIf>hSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K z(!l=LfV?iD^8?|ZH@B~v@Xm93thsfU09YEK@9C87R+RJtUc^SuwuuhB?x^j&Eb~fv(8!DS zey0WiO!hr*Y$*7x`Q z`~TUy68I*Hw>{-*g%*mSf})g55G0gC1r=@SL5ma$El>o6(55ufCN*hki>O6ZP*FiV zsvJf|1w|>IfC_k^fES=(J-~t&o*-U`fZy}(?wia`)1=^me*a8<&(7wZ-I-_KId^uB zcO!4A=6-jw!|)Z9<@jqdUVf?WBnPcdnPW-E8n=|7wCm(?75nNCen!(*BKwT~`V=*M zmYV{{p8(-&tAlB4$Kg7eN9ohS^$<6#>it7oEO)9rSY9g+ECGf@?MANis}Fg6PQ)|8 zc^ujml~V4U`K-!=<;TFIR=v!r1E0nX^P8{u>F#kVAC}k32jhft>_rJySB_uR$oad= zv%&S!|A8}G-|_0wT`CWj9~%#oYBVp(ape571iZ*_dFXeX?AdqRnVYrbckMzPVziSO z@slEFcW?T|kU|7Qy z51YytmK$QP6(oGi@M1@bt=MJ92)1l0i9KQF@j5hajn;x|0Kh3^j7cENfN2>v%V4a8Sd6MC(S|X*$V;{yxhjmoJ(Q1Wo@(@J-#pc4 zUYQY1VR#I8+83=7?qn#R(Rajkolnr#g#?STMtzWMG4o_O z-7g!i6fKF)?BW6pi#PJSubr0ZRNG@oQ*d3f9R;VEU;6Wb`9+V56c1M1{E_Xhxh++G zESI^_xtCu;zMTf`TL#;#lcCLC(xg;vY-dfHnpc}~nFv&tuzp{4mR9&UEg}f0kjzwqlz$vVW)p%j?=`rkBlK=ybTHvHoiP*9k;uj*dP~ zTpuT_YfKM`&beNc<+^L=_*ZK{Zbufb3!GlE+DD3Zw`M*&t>teI(3oX16i1ZKS*{7C zgOpx)czL2N*XGjF4Gl3j-nBX9@U3z^xb9{1xNc&pt`oHRs@KlAw^^6Q5rzlEs{z=t zoc(3HHeRSav}%N}Q`0Z4Gb$TOtDIhCdFcF~(LfgjL*+EDvrA*^)wv7Or&M=_wZNuLq;|NAtXMZxn%`k6pTUDnJV0qE z2AhIXzf2|e6`eD0#nuBIBE{2B-Xi+VNh@Ah?Gy!v*I6gPe! z`^oN!VN;5zV1S`?K;;t4HKBCyg=O)prv#VN&HaFMn+M?bfF}r_sxFaYNA}q%Q`hx> zNae$F@>4cP!$;K>`6H*R*w@VZQtSOHr0+|6%ox0V&D1xI?mln2V!6zX&Lw^sST9CT zPClVloXb<`h( z5MJqr8;P@?w!MDU*!#baHUg%(PL$qRZiu~>#7j|CLY^&qGHt^J%|S=3IOEPz*qrVQ zHw4yK-pD91Y}pTK*AMHrm)mZf4_WRdWSmI6jG5NDgPfi{n*xWsIlH;&d}Pha5$$fi zlKNH1bOlHsEZ2n6K?*m15?zO-wkIHT=HOCz3pcxT5J zdWc-lvz&RbE%7nB8T2Aqt>9(7q`Ya?i^`+b*^y#a=67$kI{nOIl?Tf?e71w~P%0}A zZshW0PY^yUyJLQ9QMP7%uNvu1kH#TKOpr4!J&vcsnqU1Mh^3MeX}pcJ*44pz>h3 zkAZ$xCmu@N(VZTE<8Mh2UKLxy#RnG-aYkn?@1XKxIr%A@y78(#4(0UT_np9c%jyv+ z$~Mp6J9c)T_x2hEHowoZT;@jSb>rtN3Ou-n^;H#w&wlQZNHOyz@%fS58+WMuST1v;^P}Wfd&C+Z%kkT4i#Mfvi8RaT>j$@I6Nm$p&W!$j@HtTO4_)z+xMl2;K zuA}97@Rc8|**I}i>sUBzhWJpap~^Ke4z=^K=M2bqW>3b)ZEaRQwOF7%>3S2<82Cjz zsXu?+c3*$~miY@3wf=k%CU<_1j>h#=q>+XR^ekkIY@+`O9se;6c$E0*q=ZcI5{er| zDgWSKfAPb4<{zXH3aSJvWOXV*0h2-OV zs@^e?>6F(IOV7i;d-%Rn?9!IEG56c-sROT{?igS2+AHV1%;7RGRnG4Icm*OPw+B{M z2i8+wY=mgLxcdhcdA^I*Gfd@`NB>x_kRv~_c6(O;kL$WJxjk&M1& zQN60yt)X&}baK3mzxb&umt(2Vs858-T`qgc4?3rmOzDB;I1L$Sptkrq7TwoHp`0f< z9zyXGSZn^`htfFp2~uAm>5+AbQ_ZkW`G3g%`!wJ$en|fmKa|$xxRB3@5&f5q`d@Yn zogbS9%5fXNpZDDrxIIH5?CzPk@e0q#zI0BelW|n#nivOPI|UsBZd*}8o;@D}njP#e z_b09k68@~cQKH~_i*wVOcH=lL(02i9PqCc+W!vAnv3du!)+?ZW52NvLGLMwqLG*A2 z`tACkKkvM6+pWZMbDCiuEa&jqHt7KqCS2Z530lq3Rh(Vq)VfUM{+lZBpt36-py#D? zD%<4#k~Qu>=4^Z6i>D#hj9z~<6snxvB_8xm%ZUjQPM6VywB_h6U%f}Cmv)P+m$=W& zdZBTQbk&4U8;Oa<{gUz$BgDq>kFJ@${-mkHjR+z>6hACy9&DTWV0#ViQ@p{8+qAg2 z8lZF;PiGw*=S&TnR;=4@LJz z1yX_sI31o2fTvOLbU6lRU5?1U{Zt|DY>znUF2o(@3(J^fRnG2aJ^PP$`s9kW$hC-<<2~#1!0{fD93kd?(&ff4KG>doP~t=J&T{6#w#3H> z)_=r%a08c52NWLa_nE#&BE{agD|>&m`n!>*pQwk#<9%7q;j`@>XP8u4XmjDs)KO&3 z*QT7{HI>GJqSSI0yRx+zDB4$id#-npPk4f;_VV+55j@_$>HKlT=jqel=J4qorx2$I zRnG1iSnArIZ5!ouO~#7X$#w^J8<>RA^ZNTSIyCk1wIf{lm+ zY-|RMt)i~T$4)ugUShPs@vvfNk=3}P95%;mWe`3oUo{fBudkWf%(iiJJQ0CG*3-%r zmTN-kKz#7wugFF*iZffG7I|I@<+zr^kKJR|huTkG`fVd||Gle6RnNG@qK40MDQNA~ z9KIH;Wn>!h(C44Y`D>*Tz8W8`zHcPPCoHJ9dPMnbHGGx_4nL_Bn+?#o53>?*lbkM6 zelzPqnyCdQIqmNCW>h4S0~SsT||)QZj$a4`kG|Pj!x-(>3SN;cwJH zs66`{l^gQ<|D6W>m1k7fQ-4v&9Dfa{qG7#4g6O$aJ2a)&~y3A zC&p`7pxeCdKf0d~=shW*Mb^L)scE)=Zn1y_MIFlzG@cv z*<01cVzQArxWA9(D%~{9S#XtE2Bwd&q+>?9{x?1!BL%eqCmC8_UoY>PGZyTxWFW|4t#f@O?6`XzbrZ zCLSPl_~TXo*6BHG#rm)4Ix>3w+(f8y-PQE{CipxeER}$T8nj#Gexs-ypv^KGC892qJPDZR2>6G{guoupaq4()3xzQxd&Q=7}TBdKxb)IX=DyYPwGQ50XK6$zSe zaygWaS@D!^;sLVh8zGH_^CaMW+sRJ`8#;%_ItaL8Lc=sBQK4LMy)CO$nCUl*J% zENv36fApZrq=Ytw*7mP+_n{d_ZYxb6q`IpMAg62M!E3kS)N5qk<@Li$L(fJ}sLC}l4oTGgUWj#=Y}#iVT3y4IO;Y+ zvy1e~P`^XXk0gx-`uX@h+ zll*A!Rs9P64{6|7G$7~eitxbsdJo2w+_=iwV(ST)&$-M9jPf0;2MV=5?)v{yL?{^xFH`g#&We zwq8zdvU?TWS6{eqTlQ%=eV)H=RSU}VvU@D_%kC@NFC0zJ+ZT|_H@b&(5Ujsij@J$F zm&(L=pf02Fdwzuw&$d1QEzIa z*RMToO&+h|#Qj|?*F2C8%qJlqIo{@STeKCrON)&E7*m!waWIBSIkL+vpsBBrjiGq@ z<>r2`!YCg^((y(VXP0j4q-6=In4s=H?}ZRbo*^+ zNzcgBBUJt@C(g2|6aS-FuTtgD?GwsZeWL^OFK-?#7Jc*eJsV=X-qEp-o^C09Q#r_T znLC}=;9uAEDHWn}J0Rxdz~#|~w&CK(tF23(UT}2^l~ZJ>-9S89t_h`sw#=H_i4|?> z-9F9kMgcV3hGJ-FVWHDiRP4aQ9#}gcYxrBd{Va5Q3PADC?K^JQk(=I^O=rQ42L-+C z58pxMKf#}o-TYnSPv*~`kSw?cy5JHyekh(fZOM15@klv}`eZ|KA#3UQovZOf9hg)$ zgv`G~19CaP66HLZc!2Vcy5C6OK9SS>-5arO1(M~R$NErJj?OdWQ>hhGHgXf zXg;|uSoS2r>6~o084@0DtxOLW>;HVm zA+{n*lFNm83eFsx8&ea!wT#{bj=`lAKE0o3A$-|?(v93+-vf6ttT%PNcXIpTzVBb0 zy6~K>8;uq=`Edrc%yPO$Hd>plxX==xi`KF6C)4Vlj1R8XGF#3FN0D6{qR#h}ET?N^QyU*`-ELecw`-zXo5NS^ya!%3(3Ts?&UW+(QX_?3oSm>MCMS z4HrAhp4l4hiV$7rZD=-o$>?!IFVa5^(UJ7Xa{M(J?hv;ai>M8@=VIZ_0vomz(##S> z2Zb-sXQQyQQD}b$%tGaQE>kikyu9vY(c+fYV%mx}Vr$x6W`1jBO0&I6;t!v;;nn8i~Tpw6(2hv6md5`C+w%aExHta zDRzBbKkS)Z9m1+!8yME)ajU&XwnJwx=l!}*Js?^dh`42u6N4e3+q3; z_ksGaOg^bWyF+(2p!i4BYV-1DA+|W3>_hvT43$6r(h0c@c%-aDht+po`J0~IwERw` zJj>}C+0>d&EE$EEvqSCnDK^~TG13dS$0?ao5He(cjo@Wb==^WgfEqvCA5QVWWj_bc zal&F>mmwa4(W`QwbocyHvgXOCK=J$5(jonypZz!5l1(+y}#fa%5ZF%ktJE~{8h&o}7 z8b=%0<3t$%MD18q#i9~?how|LO4t9M ze%tADdLKLkYSawzCw45?{z?aLdx%bqK2%?WjMs#+3^5kE7yjBG#D)5ksqCV7r*HLW zS_sBayZfwO=f01cYC2p9+q1I7Y&pcJ?fSO7c;ya9X(gyTWZ21Wum051Rs zfq0~wxxjb82&5lccs&D&k=jBFp#&Q;Ybw;1hJ;y+H1!(DCZip62xRwyY-gmeCt5&0lU2rPj$w(j_zpJpyBl_zI%K&0GyG4-x~?PCqjny&*kO#UUoa?>pv{S zH!lidtwP)A7a?}F3KI?D!o>XiFp+m(m`ME~Ok8kUJuxn~p7{0odg7YX>x)IR>x;fk z8i*L=Cr0FT>?9J0brq}5jn&cvr)N;}mNQjIH&B%?J>#6>XcpRgDGi#& z;8Z-;_m*)3TkdC1ulc?~U8edw25riO z<;Djmq?_M1%OnI|S2W%g;4#N{Opm}kJwu|z&`(xB zzvJbw+vgesN2t!H_fMABohL^mq87{0)-|3hB)%)bm-G}5kWKFz(Lfip*{$0y`z4(lJuh1}+y>Pp)qB$*p5Oq$4t9hvCR_O(-4A>w009 zVIeKvg->^ZmiWT`a(Q{64!oB2`ux@zb56Q}gQj?<@oTD_-P1951!KajuE}ZmU}s5n zU@uDS`A7naiUeoA(?xqh6&M9x3~ppSx9aWF^TSWwSdaP=WIa~GoebxDwLd0$z=`7K z7f-&hWX0GvlupUuRbNXVEZ2n6!Q4+az~wA)Ly4)pv0$3DRQqy z=)|;dp89U%{9GnS^%s>0s+`@8Ib;^>Su)Y0t$S%p#7^C`ENB^)AjIa>`js)TIKRyT zk4EJwGp>64?q4WfQht-ub*uBt>6$upC|w@_#@{lPE)~6V9-qGL!KvsO(+%@fOKLV6c{p)Xk4#cQVNqG4v&50FchtZw!#>sKrh8<)dFsH&(c#Mk&ynZ1ad^x} zm9x7)J_BtI8`eieml2pG=UXQ!Ji7D^u9w-7TN7Kq7)4o7Gt5JkvwKh;1MEcw)`Y(CRJXPYMDtXZs2lfGkBmoT&q9XAJwjQmA!WTi;H$& z*(PTYx#>L6mu<+^>qlWlQPi1O@SrF=Z?J8OEnmMP1{Rky`w*_|FZo$+xYPLB!V7}) z>f5StY5%FN8CSNknt1gy$ks4D-X(hZOsyJX$3--@C$QragPIR{H7RK{)>A)PcuM_rEqS z^M>YqR30ohk-#5`2lfxQS#ylAP0!yy`14<|zUf69TH89R;j+B8aMP_WT68u)F+ZQ) zPmz3+9P|;A>KZa~`khk;9xGC&um7TXGvjLErw%-Z9(g?O zy``J)Iai$hSP6YW)x)Ll(=6A7(t*O&b}Yun z--LYhEaYhKLizcM0z9~f^`9PZettNG#o;h(zYxnB^`d5_c<7V;_t(Gs<4fpVHnqvM zsw8m$wGmy;QhNb%2G-iqCW+~5?u@|71M$U0&Rlzbe!QJtHuDn@SzP~CAQ0xarw;sH zYPY4w-mpzi%iQR^HhG=+WfZyWlkrJZTY_8nS>{zfAh_NpT+|}>hemCTUN;}R+T?ZO zHK3T*OfiOI>V8(jVtvIXn9~)N#cI3%+uz-Hc9?$B2h51lGo>z7&hFlU#Tix%WGqW5 zo@j}mSnNj0H^fG1$)ro5PkH+<~oO!bCcim|S<@Lyi78c=Ed_cZcr>EU2=g;&+vmR^k zN)8tnSDv=KdF-P7BaDEl?4bTEmNOr=&Fg}D*Cnq(MdneZ@KF0rVlgn{sihru9{z0X za_Xle!~K#h*QLIrnTHa*v{JcTZ{#Hf*2m^S;bO_IjRRiH9PuXWgL$yr$3QkkgH4Xkb2c!{}x2T|U(M=@aYqOSN><8Aq1uEPO}eQ)3;uhl?pgjf1?J}@~j<5{#|LD-$BV%!%+YK8+CO&ILYnU*mQHdQEgABtd16w zhhIJL*5OqrTx2NJ1=7^6XSw{FcctwK;S7;EwD+hp)=n-4uR`)s<6Xbzz3W6~*|drS%3`64FO# zFNFFXGM~+L;Irh0bFQAXa`+*ghpsp3uVp#&U^_S;y<37Q$$TaZ53Zm2w|&2J^(T`z zseD+@JlGD-C(-Vn%xui@wXY6*JgLv$+NHrHj11Qe$CoN+_uzc6Fh~JKqRvUyPkBag z{j8s1n>#n-flVA9^HJsO9-L2RdYVr?rt}=0Y3`SyyhQKi@_L!S9&sMN`R)rl^7|Rt zVaRzbXC7?RJZ7K-`>-YCS+T5;-t9rNVQnP|PKQHZJu?Ac^|f2dape5HN8u9zH~OGA zYgm}r)MUoCIdC7ato5%uzG?Rhk9Q(IRNk;0e@!OSWp%hw&e$x&tq$56PU}IlP)}pA z8=XB_xH?$-nmnX<;51ABgBiJBqHsj;cwcMZ)c#e+uG`pOj(1hg?rF9hyVar{dFdj4 z9ZxDnACmD|#q?ca4|tHj@c`NMEu2dDRvqx2`-8W-<5X;LZO)GWWz-NlC&N5cx$cVj zED348;+x+84TnP59Isg;&Gm@Ce(M?Y=Fk3i$~$+mzZ|YAXLkyh#sb*r3;HDkgdE-m zgh%(s17u^koS+Q8;V0A?B_%jw-i&+X$6aO&zmRl5hOTRbBg-|RbQo;K6s0^Z^-vd~ zsb6lwsNnJ2;-|h?#8&7j1oJ(HzL_4igD)4jJRb$a0D3NB}e2jy#)*FBx;A2Q5?<+{{&RCurkygkse9;%h_)p&`shKnIt zmpyam<6$qUdSJOPWc|z>zPbNdR)(BD3UkbQPd+4td|_co;r4@1eMJ&r8b zgwla{a7Bj|!?U&hQ)~1)`xvSHGvq&&Jw|fW@(rEye<`Sdr$>8zK+i&sAr1UXG~hwP zrgF?*f3w_HQq#YYeYK}h-Tozy_Wy!Ls66|B5sjgT_=hx5j&QhLwohq~sO>VMbl7>? zvhYUoXqTYRKtYGTxR3<}OUJV-AD2bwV$u=KiR1o4GyYFMNA;X186tzN^vy zqssNrgN1Jynx8{`sdjykIc}221ymKA-!r~KA^tVcDmPp_dT+CI3gfNHG51cZeyk^l z$NEs^>>gMj5+4kK$;N0m%$3n@U562L6i@&3{4AQcMsw6?%??_-h5HI(aNZ7R4|D*i zL$?!fCeRt^0?^A>SD+hkHb5OHG$6AF5DSpfsI#Cq&<8jNI2Sk%=nM1%XhOjSz=c46 zfQIeSAniCH9vA>50Es{nkPHk2Qh-!|1_@IeelUP(ID$HEh5{6M!+_yH29OERSd)>! zD1hEOMgx}uSYAe3k7OL|%YgB~1i%VR1hRn~fMO~am;~ejcHnYgGLR1x0M!5E1PXyG z02e^-X+=OWFa;<9N&(7bQ-LdiX~0#$)xb4CIWQf#7MKBC2V4)_0L%pFedk8tCg5gZ zHgF4YD{vby2bc@o4$K4Y0H|~6F5qr}^1(g8y}*2cx<3{Ii-7w84{$&50PrBN7;ygms)1d=Zs1ekGvIUJ3*bv&5AYT6HSi7aE$|)iJ+K$p2mAo+2Yv*80)7U5 z0e%Gz0KWkTf!~2cz+vDB@CQHzZx~Pys1Gy%8Ul>~S{o+Y=0Otbd0eyjf!1=%hz=c46fWD($48#HPzyKft zNCc9AWMCkW0;B?ifJ=bE01e6?0t^Mx0d$*-;XnqE35)<}J)u!R7BCvP6c_`H1;zoF z0po!QfEAbsWCJ;X4afy10eOHOxE!E8C9(96C;%LQ6DS0(09=3@C<18ht0_PUPzsa* zQ-LdiX~0#$)xb4CIWQf#7MKBC2V4)_0L%nt0XG6S0XGA)fm?uEf!lyNz+B*VU> za3^pVa5qo^+ymST%m)?#3xP$zeSinJA9w(G5LgU61Uw8p0xSWR0*?ZZ0n32LfhU0F zKqasOcoKLDcp7*HcoujLSP85GRs+uiF90tBYk;-DI^ZSXW#ARyRbV~v8t^)>0oVv^ z0^R`L1l|JP2HpWS16zQtz`MYEz&2nz@IFuld;ok1d<1+9>;QHGp8(asE?_tCDexKa zIq(JWC9nth3iulM2KW~E4)`9}3+w}a0QLhv0zUyi1HS;j0tbNKfP=vAz#-r;a0K`R zppKa^pdL^kXaF<>8Uf)z1aJb-7-#}S0#QIypcxPiGzU%uS^zD9lYo zOI3+B!0EslKwBUNXa}?hIso(mtP^l1&>83goCS0Rx&dbc-2n^G1BeBB0=;ygms)1d=Zs1ekGvIUJ3*bv&5AYT6HSi7aE$|)iJ+K$p2mAo+ z2Yv*80)7U50e%Gz0KWkTf!~2cz+vDB@CSfTP$CSd2h;}|01bggKsXQqoB%WingEeN z6hQsR&46g2IdCG-0%!@G1e^?<0<;2J1E&I~0c`**Qzy;<+5#~^JD@$#0q6*H0?q_F z16_c#04(V%x&dbc-2n^G1E7AIo2MPcO-~UC7z|FvH;1=Lk;5J|mFc-KTm3&4xO8elE34tNQ88F&SF6<80v2D}bz05$@f zfH#0QfwzFSfp>t-z!qRD@GkHkunpJ_ybn|X9{?W$9|0c&JAj?QCqOl@3)l^O3Va59 z4txQ83G4yB0`TeV8fvc7`xf`J{KM_kmFUE{JVyX**V@3-{6cA@kW6gwL$fa53)O{L3mXxNPrp>l|9B-EgGuf-KjB z(!u;a%==wXrl4J2jwACZEHUdv?f+SMWw@9wotncpe;4$!!Ig6Qm{o4pgUW+EUVG~B z^RByl^!?P9BtuqP99gajr33K@{$0?=C>Cj#;zj<>L99sa4FMxq&Bmpg99BR>_waoI zFZ`D|((@6BJ3T)?hy2_|a`ZmmfAKl-Xd!cq8t@>()%?O<$!UYr1=*aIC>@bGNw>V| zi>~484X2QGj2iG)o^hUTpy-+7h2yQZAUST>uI;*io1C7TpPiqTo`Gci%xv?svHfp* zmJpx6M+0(uq}6nDd&J-Pz#Y@}KUclo`b8gu4y6}bXOZP9OJk7_Z-WE-+Zc^gZl%!D zHTpL~y0;YIcH$iHA^+n6vMK*kn}o+p;#A!E=9rffPyM7fos*&K=%~syF%F5gTq_pG zGRBN*QvYcW7#>r&tr0HE4YAkq+b)ApZnx7O0epk3 zhYIi^|KkC&{psQTSMNCIwcX1n@%?liU9HO5Jv}kmV(3CzZ36F`xPbNFYDQo^R9+V@ zau5D+c=e9io!U~T3CsY1+UYFUgwny>PWHYpcptqS*K+t3O8Dw~LiNmWk$2?ro?$K9 z9-{X%GUo#nKFc+sbTEgn?aDARjcB;_i{$sE7(5>t*1MVx%5Mx8r!={-{``jB#`E)Y z_$=3b^&QROo8J?>O2FlEdaRrsmwJ?17PM*Ix^RnI}e;Rr|eg4-B^I^Fm_F8`V z5DDXoa@gEXjl0#S5BeSubAPxt-Yx4Qd}Ek$Q8nH2am>rvTjo9bX-E14qw@&!%5|yl z=r?@dYmz9(r5ye`DSYzRUwpjy{P_7zQtQ*_OU=-Aw68474YAkq8@@IjUEf(&ZYQVQ z=6n9y!XKD-V|d|RsWfa$GyMFjoZbC~pJKD-7v-hVY^-dzo*F7~1MA@cc#yyGfbPEt zi^I9RF5MH?zSsGg&1cSp*ko#x*J*t9E!&mlny|C@KG_22LYLovdzDZNST_;+O(3oe;+~DiAj@tcj;o9~a zI#J z1$Q#>fEMn|dG&K}o}P*RgdI(^G#7qnNkR9I77n7Zie%_IdS7R`CX^0--;W@a-`6q2 z-CcwSK;&W*6ob$2=mmVnVJEy*;Kz$4_@nCsi9_HY^AKh@1TyK=l3#^ao3cOEG zKD|Na&sVQe^}+JMJk0OYW>)&0a=NKp7?=;;(R_cylrcTd${lMIoTQ!@q#Ks&zWR=S z(@l+ec{Q2&YmY|2TVhCIQd`o98m|pe4L6dp;p_STf5i^OJCNId<@rK9|GWk~NC;H^ z%ipcpSAKVv(+a(ZQ6ADuS^Y|Km#@*Kq2phnflzto(_)}B7Rb%#L+I@Py9NT4XUFpF zddo(i7sdB;S|gj!*)5pO?~QyN-A{dA|0^a256bT&o6&A8Up**#X}$6_kF9HyNxG2R zxf2%o+LcrnsrxC;x+qe75#xC+XTXGMHxJe|+XUB9dzYck$_&C;!QykFW2uycaN zw_9SS(`Zt{QM*rW=N<^cCw)Mqc;u@?vAIV^Uw^RB%!lPBGWb(BKC~5b*O)OYm8Zz^KY<*?>s$Cm&J zPbF^b+KEJJyxOzR9-J`m3iOkaA>RJ-N!H*<5x>$=a`^`ldsIEMT=PIWczGWc-62k+ zd&abXdE5hm`StA>EnZsnWy`JuW8b#q>*oMZN z;OlP1_j@a4LEFPA%tvn{Hx{a#-Mu`MO3??4<*YD8IUl{Sg~eR>=;uyf8rCwHCBZob zeYTTq7Gv*qqCOCtR${Msi!tg#eiAv~t;BPXsVzOEr$>tB@vodVXiZ6&njTor{Mq(C z$5EvR8nu#HR%oNe`g{*ae#+%n`r^QR%QGUy51DPQxc&O!m$juyxG?k%Lg|C$nov4; z`SSku2`;DGJ=BGjI2{(Pj90Rnajyq9r-yyuMX8a?13IU0<@G^Fo$=!#`>K)m4A5itna^}f)4Zhy}oP7x)Pz@`WS1TV0tj`H<Z%Ph<6nIvO|9ox&ivV~ z@f>Ie6gjh<`IeNPJ&%E~Tz*ss;akx)TD*~a-H{o6@BOLe1arO2a^}f)-TBrnKg#JO zWm#bTmQRZm>9$=TpS9@f1!_8BIrC&2!zigusO>f6m}GnsgI*`uC~;f3_Bfgp&Na5- zwH}iCUYZK==>XLy{tU@U;}HOzQ@n}&>@HhX2G4y z{mn>cq*JQ*YctA6-!m;CLr+g=dKl{#^U}uHhD*OP1{U$4 z?{)jYLk@?+C^y`-{U0AUzppfh+lc`0hg)^1nRvKO&zRx2HTjC%$WWS~b`#4rp>(Ka z9a0+GT1=njWIY`~_`&pa#PeY9PjVV|;2=0n{-Ma(y_WE44d^773wx^>nu@^GYO#V6@dUAH!`ZL}B@GoWO4*27PylLBFAycp?;<(g1BcuNRVyPl** zp91YnS&Su#s2HIpoFy0U@aFi7T^?M2A9VZi`TptM_;af_Z-1!BnHuTOm%LJ}j+}g( z3(E7Sw{(Or`%k)&6{ddxmU&F549;WzoPM95l-1z|l?Tfu3fgJyJoJ^3d&b6U z*U9x|^a^u2Qpff8orC)4#2)8PUv%Qu?hooACc>h0#ByEgJH}^c+puw)KDNPvMXYE8 z11om2geqruV;^7Cv3A;Xo>q*u z7(1Zq18a;6WgbiFz@tmA?&Dj!cK*oWFb`GE?*4e7Z%NyVRVE_yhk1k?+HVDi6d1tc-PKV=H*q-3LzT08Kpq)d z%{AOsfIg_4ntTq_fzM;k@zGK5mDAE-nqfYwoZSQR!Dgl=GPp_B&#Y&I>&Me%@b0sm z^WWg`n2#!F_rQD{Sf0KR`&Zh$X-95v#5@tqLCQ*vm&QZZoppRQ8v{RpsnnBitcY z7lsIHYhBPar2vP&xenpaXtyQ&^xZ30vi}^uDrfha;g3v=hhsUw;ij(+{@hpHJ0!lK z&yGjfUk+E5vwMwjGm6nK?{H4B>Q|J*;_x@uA^i7#YxKedOKW4cm@mJm@>;`Bvrckg zA72|SG6GW$aQNxZ2Y>#H?`wJBu@_#=qWJ_dlTvHQm3;Z(^kq24Y?k! zszdm#&h)fiIb&oWJzPC}YX7sG!)3ch`0?qfZp(;N+L9WZRbz;{eq}i<)WDH6AzHT>bOsGYklAEUBBG1hnB0- z3|&X#!dY&Jy;cSW!1~5HYu!(1^XuOy+`2;!T`b2(-iu})bb;EAUV75f3ySl<|5X1j zrSokJ9xV3~Fi!mQNV8cTK6Z4e%wu02czC8ac<|R16*s6nSYB5i*pYAIM;k6WHAFl4pEk>#3DI(Yko`HPYFyRN^%2AR(I ziRhZed^`+{&_1R5zWxrkIk4=%I!;A?zbs!LnE$>W(PGniA1>&Yy|n+WH|QkkIjKBj zxkOz%Jx2cK@1L&)<`vUBT70l@>7J%v=1qEm7V?B)UM$yy(xG-<)T!>(Bkf=3Q=vYB z#-HL%e5-@-B^uYvXtrTaOuzLDsG$Wz=^zeAmTN-kP&;2^&<H7;)`k-G*b;< zze#fJ(rtFMth;2Q03$g8NE16!H`F{zQ5*R?49b!F4JAj@4IoE%;}p-2rAFz?@i0D zKj|F%wnSRuS2JYO{;@1K#9m7de?(yp0@o&IdV6@}evWE{Plli0-}}|5d3|qL7Ew&g zB5Q`jXSpHvS~bJhCm*Zz7U|nxz2$+N<7demK7N$0{MB1$ENZfK>yVOuaMld@OBzz; zniz-L^S@G@Qct5^F&QIK^-0|7b5Psb!k$aE+#Zj8)AtyR{H_XZUy@4j zJLimEQ^kpqVn9{$PZhRLV>;5}^)SqX<(g1B_~$_r@%4D8b^a+nk9J=gN*gp5naX_n zmfsSfG03L@F+eAv8$i_*t(}wz3Q7D;$Uf*XtEN0 z7Gd>7#i)8>4=rfkv%Xl41&%Km-9VJJXed7UwxL-3btAFk#0c?F{t4K}ripO8A1U$< zHx;&Pnv0G3Eye8jPZ5v2cbd3sT8#Mqn@*x};@RTk$9jvZ^b1APykz0*FzmpM)W)u>k<;yFghM7C@b~^u z>WC7b-8R0w<*;cT`k}o?hUUOgK4-Zmln&na2h%u6U+y2o0%o=z2sTS4LIEG=qEZ3#J~TB-15`CrO6h<@Wf3d}d} z>L_t(^7225y0`gbufmt*e-&R}2Gr}}3`|5Mzvc9>F9_d?=~1H7mN759G9}}L2P1T5 zoPJq;jC^Yp2gYQ$8Yx2N>-jjaezO`k7x$djV#0&(KY^!`OA~adK$!- zFU$W7Uo$uK@>{3aCuw6^%z2K&kiX}oe-c>Fbp67d%lFt9cBQRNHAB29HLG$>jDt5_ z7?S~vdRWe9i5PHW$2fB5|Jpg#d>2 z$#PxlJJx}h!C0px^C_$jtfwwFM~Q)Lhiv@j_s^3Psi6eJd|0kaeaAZR$#Ca;)nl61 z-fCB1K3TV-KKk^u!BzERbGBcl6KaB>sXfJV9~1q|%cr&(XM?S-Nyx-dlDr~BFX>fE z^GMFe8^Dv=kJRoXo0w2^aliVkx!^h9-g(x}@cz^;B;)02$aSgj=;i5mT?79leH>|u z3el&z;kut5Se)+ib_dpLCHNjGopky3lRr9J)ho+=O!YG_-=owk`y-b#G1LhPQ(HT_ z`i>}3)$NgUe~!P-qVi)o`^)yR@(ZxEh2}N&pR-;!1mPWB5hXV6|9S3nOA0Snd9$4P zvOOX#-jeRN73Vm8lO~Tv#WK&r&jP2{xcPWb`Fv^Xu9w{2LQStMXMSvZ^?NkwwMHs6 zkBi*{o@8oE2YHL4MDl}8PdMqvvB0}bU@)z{{6Z7_mlSFVpvM$ zqZ<}SiAORIhBfZG?W46P=oJK)$1Jav2NB{*%iGtHSgbE&Y_31&d|}py%EPm!nK<_E5qH7wREW8A#7sd2jw9^*46M|>}xm6`8$1&j~C?%N?G*X>Hxs=!A@Qh zUXru8{kafnhWbQkrn4&7#5e@uRfZKbv{C-XM7xCIf?|9tv`?{RV+dbVLqyy z{bvUL`DEDgZP`W08y4#Ha7*0e_E43=OYL9IS{5Zn5C870o^e&Mq4=gT6O20AdQRRE!@hH(`OUo471HB%N zrp@AEA^_sca!n{5{v=;hJ2>Xs!2BwfM~S(~U%p?^#X6!{hR%;ZBM?89OVqT}y6_vE zkRDW#9{9$3To;6A-xX2fy`s6UvkF(e{N8oucxU-v#gqMsG5AqGa5ebx_~4l*4jM~& zL3S74`P>_v-RVlzJw|e$b?uCFY8%Pr?gqG%i3j}k|5iO2B??nFlpk7jxVhT?W4Y#m zbf^(e-f@q)8L}~|z$@2;(xJw4WE4+yNmKY~x;mCr$2_+wc4x7Bq}`2u6r6g!N8WeA z>UxfYjQIJh-{w8K`RTa91C3rk9{bZosB+w{nY!>xw3fLu?3g<~*y=7)7{CqReDOi)$=kmD1N-xR zZ<&(!LX=pTbkn7C-mZtXGBY{;*8OabKe1WgkER-Yf4(N^qKdUq;@i98r@S=f{>t^nhj-#d?HZOdAGQPY zLI#M>ky(jq+(_j>UB(Min~&;s`V>lI1WyKNjj1yM>hF#NGJt&G7GNc?59o))Pyw_+ zMfx;wJ@WTm$SJ=y6ykNLpdCEz2~T^#(~0o3Gdw-eNr)nNdU>1>U%=CW1wxFtRfz0W zLX`X<#PsvS#Dn*QiJMQVC%%8So@jq#eevzR4aCep;3@P76=~&048rGnsT%s`da1>a zWvxh;a(op25!oF`9V*q$~7?#-sdxoU&wIg7WryObaG&zjo!aQd4}~JanQ_X9mcj2pDw?J zi;1V$Mb*nu!hP%eTgSe#y@`h+1cvxf`M`2bC>^|f23yrWi!^Jgzital1}z}ubm%() zSq54Qv35~xfg9ZfrRQj8#Hkt}-gPNQ=&86YA-*)`m?|hLPiVYxJD>}I>@O|=Qh-sw z<-l}cAwZSM9-uXzdjvokfW{YFQNDZ%Oh@93L*nd$;$Q$?1}hNgc^KGYL1T0d%9`S6 zlrb$ZmKh1vhVtgo4nib#!+e}RLaex0h~zYke}}%g9NB=dI9@gfiI>t>qr}J+^$y*? zeB={qys#YJnT)@F?!P#SwD9EgKH+zB`tq0F+ibgKWSgcN7cp5*@2Z^L1Eep1iA#8J zBkNTh3eM+-i#t8O@9EPza(K)~m9u-@^y-(I=0yyS#7`SX1%6!qj9xt?hr*WiSqXO} z!CK45%`c&!_>#y=&W`Ken8wzVAwMX;vRo5N2d_R&;^|rTNZ}gwHdM!%yoHO%a-=CW||5|C+vs|L0o%-jaHNbpbOulY(QI5Mfe%DES zNKgLy>-v5C{(Z?wmw%-Nh6BAj(ovObVjKqK+Z~fF=&4DkHDa>$g%5qjsp-2$$`Nz? z&^R~J3r%#OdD{EljuQ1R+jRJuq6R$&k{pKPhvmA|cl56hZ~V{)NGcvp-{Y&ngG@Z& zFJ98$i4xQIues~P(_eS)RpN!^ng`OsKaX1Cg&NRW@-g=-l>ZT!7X`PusNVm(tgG|}Cvhq_ z+^PR4qMkV&kp68zdK}&vMxTE$=G`cf^xo7@DtGR_d>-UvSpO{7rM_c^ExTA-CXyyt z`FboY8A%Bvh9{ZJ)ruhDXKjxX-5wiv)l-A+dF47I2r9>@oM*W&Wc{qx@Ufm{QCX(F zaQq0zWQVgv{|aZ;N2~f~ebBR_iR0Z@qRYhQqUYqUS=rSUQ;lrv)d$OKi(bCa&E-N& z1M~A!DMpMYAi+;*9Q!!=-SD9!m1pd3xV$6%fgv5$$C2flP&)YH!$=s~hMkt74&=f@ ze43*4MnY1=y?jjZQj<*#uIBul1s2qcCO}?v$Ua z;Vzf!4dB)gn1e-iUg+KZ_LNtfiBWS;iLdI@Wh327hIC8$iRGG5I$&p4hnr?=`i6}R zw>q%bt0mEvjXpqL2TJCV*C+yUp{HZXE7NJW1@04<)%%iORWw69$egXnb*T`w^B8G! z`Dln3+`#&p1s-xZ6o$+*I^3);s7ZTwO4$@9^2cl&v+ompXIi}fJXfO<`$V{rVSTY& zm->!=cxGZVi%HnY#-y)u+`{$X9EFFP@5&KxtGbmpsK0AynHp~__c74V{P57XA<+5^U-GT;qY4h@nuVDYs-4eY8;&JpvCvS;(Wi`i7MYq3^|9(wjaKF`cc@%;0ESd z3LYE|^IT%MQ~4OvByc-!A10@~yJ~Unc?ok8sT?K4`JLsu)OYm5Gu7=^v#AbRSQl&Q zYJGEq4SjP0Fx7wH87%(OR&N^iNUMj(*E=u!GAh40{)ZTHA4C1jA5ZM=j>cmq4OA^+ zK73ycPFSy-!H2_JefJ%|tMyJ+WN^OaBPLG2_mz3cD&OgboWo_?4___*RkkwEQt;q# zn5V4Q!YFh8rZ!wlAOi9>eYQM7VgEMc73f4+{Z_CRcioC%7~6YSAd=eNkQwcm!DfSHJ9(C1@d#&urRTy$&78D z_07aZQO1<0A0yS9pWWyTH`U999ewSXR(JfS^*{UDKh+o7 z-*ZO&?wrr{R-5lXg-C8Jr~mRf{STRt29B2o{*C#C@(1T9(n~169Iw<73Rl&@@yIXK zhGWBdf%6C14D}lRAF@LlI9?i1^9%JO9jlSkIj8?%e#!U9*K$6RWufzs29CD|)co>K z@bUNlLg8{ABU{cd^7%i(FBC>d1GQ=3c;pw#50q!vaDI^U3!U?ScIWFuc1Q!qO9RIv zztFP=s$!u>C5Ae3MJi?J5se7rOe$}h)D^PzD6iyH8NG=DcwN%YN^ zqdowC`xtjAIMRRT&$F{P&`SmkSsid>xh9kj-gQiPoe*q`SLDog=37#FVT!rS&5OzV z*6YZ0YI1FLS`h=kh@ZATYN~G@S#Ni7Sx2~eKtTS!E(KldsX<-i&KHr4!LpG3=QVIN z@#8OEm_e{UCB80XADsq{CVr02XT2Yu<4w+6a(~6q`uV?hy$27><@26lzVey$sjfGl zk{%&aJlTV6u`kTyenR?AMf1g3j=v`3EuU+wlV)u4p>5cXWo+E~M0~8ZL@StB+(l*i zw0OYrXm8O2$o*gPd2Q*8%NBlk^*_r)c1Qz%rv}vgqNYQ+yd)mAm6h^+bj~PP6lkOuy04FqeS$oWG)|Eqa~{PV8?55(L)={q`b`y{$?lsF-FcInJ+jZSqM-cj96 z?Gu(8Vy|_q?Gt-}zPM2=e3IV}sXY{E41${8s9dCUMfa&jEi={s^7Wy#DQn}{&ufbx z(yy$4I%iO5bRLQW(!}3u)cC1uXdFLm(|!Kpl;m_xAQQ|z(7pfP-PHI=s^bHP@=hHU z^(QZzh5NZaU8mHi>N<%_oDt&vyZ4RmKRLYhG9z4CGmPp}maB9!?6eH4_EL|Pk8^C6 zM7w+PD6HU%&8e`uaCVt-gUn;k7=1of9NZ{x`I}F*!B%Now*7-8#_ihLWwe5sDrff^ zJTl50*%}XYH5BLTn>yfPHNDcl1{8j1G9hB11WK>eKOZqR zLUc-x>9zN>3kQtOzw@(4;6@38({m-X+5?1J*kOur|K+P}y zt_dcS)2e(<_o@HcFP3v2@%i?_B3W#LD##z0ra*DB; z<0MOFo(o$K(|#i^XMR3*Y)Z|^w|P66GV;(*W*OjemS9(s5vlBnntmu)E+_aJwmDs> zHo23G(-FJ#eIfhUH4uYaDg99YYFx3ee>Hx}%IB#sock?#eK87&+C!YT>HojMsPC13 zCXH}9qv!JH56S$=|EwNr%NKvv-_ZRb4X7HJ1p(I^8<6kG!~;}kh_Poj)as2>!^O_B zXSU}35GBrj-+9}Ok)_#V&!H7i^s(1eZ?IewN{8V#2fl%zlE8e7Y;06M*p6ilF|fBc zwkNkcl3msU8r^H&rz~rVj|b&1f8RwGbbPbjJKamK(r(5<&xc_`m9u-g%Ra@LU1mv4 zP0z3-T8pd`t!|rTXrawzEy8|j7VMvylkO}mE~HV%xQWXIqfO?!oxr3saHJMVp;!3qR6q7F%|aeTpq<3if6-NWwFDJ<1A&C&eA@-E;sL zf6G+bx=9S({??#+cSfE``!tauI}AsbYeMOu?axhn%DHJzSnNye%(l|{lSx)repw2n z&Pj+vH}t2+v$5N)Y2VE*rGfWHqu{>!`q_7;ZXI(w2d(ovp@y8@z3XHSEGdk4TOF2o z(hfc?=OAGbOD`k+4p~p@>cD65@Vv}ZT^B6i@R*M(XZHYnFw3Y2JEA!qn)Vc4@_t(B zWx@3{{_2UYw}wsol*46Ss+`?ZY}P^~o?N@ubW3#@+0c^YuujZ}vN+!OdJj&xJlF?5 zl&`2fAe+)O6$=xvY4XU$PhNym(SOV6Gu~`6)Vn-Ry@n*M*HD#{l#Dq&NeL*;S?nlE zDn*Jy8&lgL+--a|HGQa;95;>_2_|9bdh=aehUM zU$yWb!jZ}=mTN-k!1^%SyC}GZ72Aq!;N)%L4sp5)tog{mPTG*zxYq*(k>0p{MEYXG zx}*QpW+D|)=}GM6Z$l*Kx}VNT*KCs?bWZp1y)?d%{Gh(S39-^T6L) zjb3*BAA8>cA62paKbr(d0)(o7poAiwP^6=h5K2NzAXF7(Nfxq_?1oJO0b5Whib_?g z7&~@UP*6colwd_HfTAK6u!Hh6=u`jS@4b7nvzKH8KHmGk=kLybzISHN%$+&+%$YOg z&b_zX=>N%xb>Ld`dN=fj*O&l^Ossmn=It9lIxs$>wS2dZzC+bgLdV}Am+JCOre1i` zT|=E7>c25zUjMrOLQU88a`Xk=9pG8B2%zb2T^vij@63;$gE?*9C{g%9D=N|*SP_+*!t zmV-XXFUN8iGrC7)lB4lAAN;YNL)G`2N7nSJbk!iYlrQ{Q=@LJ>M_iiIlQGF#FciC+ zlqy7o$RqOFioaX=&}FlCoprq6wfQZ~9L@5Sde~2wa>Ngm2XpB1p{GNKl7>ne*w;uB zizCbD{H+zrm;95^@R_&X&ul_Goya4;Zw*7Q3NBFUx6#|CtymGMTArBmo?9)d`b9S* zsgVcmrqE4l;7I;F&Yav#Z(ct#h!22*xe?y99PEP`>Q480(L;JY8S-7y`8ZYN6<-+4 z58I}-J#NZB_TjaUJeDRUO8r>r5)XdHICHayy0X2#nNS&H^yKvncFoL9%g^Cn9y6sb zm)#aVta9nGDpD0hZTfL>+XHjoj5p6GAC!yGO={p+wp@~Pz5Mod8FDGasUnxu*}-zL zwyTM2BGseeAA5ZD9vZla3Jxdy2;HOxj?%yRJAQL52b+en40DA&Qb;Q0AGMTkeGX8q zja1v0EIc}E)9S}pjWWxS@`WBK*$f#^Tj%GLjyvLp$di6zAF;SZ-5%)`R*h3esA zy*WYS@)g$w%g4%J(Vda%!_K$I?3uP?@t^#lDV*>pbdwr5md{^8PEM8^gI~70JPhf| zVbGsd5qyzjkLyG88Gl!#+H~8V`+i=z?A43dS;GmRLN}>_WBGh0X8OF@=!D$miO|So zK90iQHVc1NJv(@Jq-xXm*8A_yd%*perJjWz;LHq3<;hCm5NEz8JrgoB>(OAJDGLGN zBmM@nUycWj>Rgr`Sg>GDlT96N>`)W&bo3oK3f&-Thhf9}2dVlnZ=QRy8y%S6t%EP+ zAMuwjcCoDTGq?7~cY>@H>7=Z!GN|*SA)MR{* z!Rx~aFCm=^8gc!+>G|2l~DdK`IE#d^G>Y4;s3`G#Fo*vCEFzUa!+OVn?M^~n8iw2%KRN*zdWPd>2g_1=DURdo^1>lQlx2D!4X zyKlY+cOcDV^WjPPD=g)6P7wj<&jDn%OMN%l+iIwJwmF{Q(Mp&2q24RJFkL<@#*T2M zyD%;G#U*5TbMjK%IsRt>jHEgrv9|=vp)5YWx-n~d*W#36Qcg`HP*Yjy5?>Y{#mTx}>?kptkT?A42z&OFgY!h_&FOJ~__3 z^vqG7EcA)Sj67FPScibr&)8c-^TTtRB=xxF(Jdo+n&GhY2zSm&bc2k8#*c2#%3vwM zlYvF{tdy(_FrMt0?2SvwLr>|?NSE7@3i#ajRHX9V`}N1m>!{vc{O9+8Pq_)*PcHQ| zK8IjQJ*!{J&@paLhIdAs!8Yd5xVt_xFixG1GevGW3q#9o{`P8WeCnVh!#kFI5#ukB zaw9)NFJ;6Zu<~PY5eF;mOwTl?ha)hPp6&`7Uqvno%|~HLRW+{Htn4lOzueKnUk;}? zE!f)>pvCru|jbeNB$7pYm)*?qGj`oaeBiK8RYu#aA>Lb!;az4TGgCC{i3T`zhp4el4L{Ufv7 zK5^ihWrG?%C;cOR2Yy2L7hCELaQkxec*kjGnkx^J6S>pLIU6S3_>P>JRM(4Q@KMn` zDYpKOor6a{_K_6Cew@9zl`iq+@iEfp^yE5mug>ck;KWmO8U7RWaplBi!Fs`a(OmZ~ zL@#|$aq_i1W$mnwc5MG-Z)^YQkO-aQB)Y^~_$ghRH`a6FjQgx3y@_bf9Q)!$l2hMz7G1OUhFhjt>r3d8ulS+)G8iIrtjCo6ymYMWm}lzsH~+R^c~Pd;`veI) z>R&u%YpmIQB3|TWr3+spGu^%nLys`3%+GS=Vtp_tKM%KeGrbx8Gu)U0=jwtg#EH_b zBX1AZYjVf+tog$o>eZ^(zZbhaQmuHmX43dY$DgCK< z_0kDHh2M8G>Zd+>t|^0F={WzF8p?OYpkLy$YIU3Hr4=ym<$A!`vwBVS*^|pA)HrW~Z=*jKmdEQ8 zx}RL?RU~iY$yQC^IzRhX2lHcHAKRT-ON}iYyJ2R3ultSEFR3ENoQV7gy_6AuK-M!u z+!r3=oe{VxT!dV8xm)u)Q~$|4!8rwOlW{SckD%?!kidVUepnxLtQ(>{Cv{d{{QpJz zd|b5jC+gwg_RRZo?Bhz%`~P_2g{b)IG3uS#wTE4Qyw{0+5vH`nz6jkaLu3Bj-;*)Y zi-Z4_6r*yv5SQb{3by03u(Xd zpFZ7Rt*5_wo>}Vu=J8C_59OxUhaN6VDyJ&vQ%zS^8GjernW`V%rj^%jL}s?!MG_VJ zXQF<}D@C_=Ov8E+$T?-zRarDie=7dJdj6@D@t;a#tskyWaRx{5I@vD7r@Togjl&eu ztpLe(XHWt~5U@TEWBqV#mFrhhFXBu6&}aQf`_StMWZRuV30Ui=5%OmJaKul!>+OVL zwjb6D+mN&^yM7>yf0MJ;4`ogH6LkDvmec8axU94`?XOEfU-#Gp^XNa{ z$ZELmv6P){{FTD{gIxC#x|NfY?q|5L=*nF?xTWF5mV=;&xNx#nU#KT+w`{9)73l)w zMYoI-PVrDtzNeVY-#(eHFY1ZV`mzoB^vb{o$2N``>KyKujOdHdtpY1oUyR3SxL_Ns zGgf_(@e%W_s7@LGSM|lpxBb6t30Ui=P1(s#nOaeuo^nQZLPG-Uag=q^RO~~cO8_Wm ztNmY(_U@?p`H`q!uItpC3E>(8H2*?3h}uDG&&K_9|Ng*J+D~J46v^6Cz9;t&{%!eM ziKiE|_38BFRZ;5sNFe%Durahg9r4ss&z$#A-l5u4C!FigSoRqS-CACG`ebZ0k{x6? z$!d4FPe7^n_!)gb=5+ZM?bjynj5`{-Nv4 zM4$N6w)4}ir<(gb`%j*1KJ|Wy*PCr5iN%rS@;SGfPe&@r_jb^kr#`-k-xOMZi*Wv| zH+|^jB^P$8l7HZQQQ7kzQ=QjFSh2jgzc;9LVXfg>+rk z!+LIRo&P;Fld`%KlU6esZZ7 zQeVb6@m>JWlmW)mw|tm{&)47`75U~%DVT}A|EOSdXnjt4wwhYm@#vk?cJCP@<22z< z=%tML10ne{AFkn(H9mE*&V+7K z1IM!X@;@O+A)&S98XJFf`K+jbkKN$ow&{=Tj5@q!s(iOl<}*SMaA1Z`g^$3DCdHHG ze<6U**Y4*-*IUQuBGqfTM=o09IT~kdZbQ)`AEBQLU!``)9C(fNmOf$=sJ^o7k*v3| z49>k-f3z(O>vM6jCm`GI-z0%px%aKF7xuZi!Sp@7T2OuY7eG62Qs62%($Qz|rh?NBJK;_C16XymVhk*TLQKOYzf#B zuq9wiz?Oh50b2sL1Z)Y|60jv;OTd=EnU{cm-{Q>YZs%xAz?Oh50b2sL1Z)Y|68QT` zz#c#S{p!@dB3lBs1Z)Y|60jv;OTd_ zC16XymVhk*TLQKOYzf#Buq9wiz?Oh50b2sL1Z)Y|60jw3x)QMW6P~Wb?DVz-Yzf#B zuq9wiz?Oh50b2sL1Z)Y|5;%PcaPDQ#zfNCn_8GPWYzf#Buq9wiz?Oh50b2sL1Z)Y| z60jv;OTd_C16XymVhk*TLQKOYzf#B zuq9wiz?Oh50b2sL1Z)Y|60jv;OTd_ zC16XymVhk*TLQKOYzf#Buq9wiz?Oh50b2sL1Z)Y|60jv;OTd*728s{?g_nm`0V8sq51H~-m3 zT>^#pBl)R3%eigs$h!F!UwSo1Np%a;2sF+&L$y zh*duZ;G76#{R{kgz&KzG&>gtYk0$UN1JOVYpej%osO|SjBO-w+06FEAg#)4&Cifut z9sdiM&UU5*3gC%;g^kV(YV7;K+ z&jylSb*QXM-@EiE^rppg1Ae*st9$FtXGOt@-4MD-4IBe{VcLzjL}z-YtFJ55Io<8e z_o;12YVB7NS)qQ{Py+DD3*9i&Gmg{?>WJu%7G(sRS_xm>S`{`Eptn$-aSKKhKAqTJ-IEm2>{MqKT0K>xKFvbc3iJ0{SwX(WcSfquTQD;&(dTmJ$=H9SJKKemiXd#= zF4H781=#-C_E{GK1a0>pmVn;xjJ+U4Vs_?+3U zxKTM7=!4l#;!=IC0g0*pgx2;V=bw(xHp6yAArS)ruIq6v218A?1mI=!e;Yu?{Ot4D z9>tEc-`A#Qc3XrzbUoR3V`x3;F+WP()UkfQ3vYhMz5VkJI2-GnemxPoLDUYR^u(K+ zSE?vyLQhyMb%piJbvM>M!Kps`bGH4VKwqGr-){|{^KzLh(x()tXVe?pUPB0Q`gkq# zrqFs)zgCQzTmRWV8sFaP(FMQOGtTF@jrK(722neN(36BIQ+%!|ur3*zWud_?wet%? z^RuaTjCxeyv+%B5#WUxZ1DYXt+34aB*gq9miy}MK0xg~Q7X=V&Z{>Y`3Zjf;Z$)CZt z#|e?5Uk}afdgLX1wz{=qJ_m2S;gbf#?kW&IgikA7;zRN|$T{7aYur{j1y0Qz^?ql4 z1^lL-6Qj0gwY~9@RdvouNeI?Qp$nhloBXC?d=gr4x?PK37+P*e8^);dyI;QT%U|XX z`!&z(8AShtF6E2w=fmf!m=)s`T`t8H@U!UL7`1TLtf+f_jJvRCt2xRMeuOT3h;Q)}(#X`qxiqR{tuIJ!ha@3SG(<-{fP6bEY>xbOrfO z(Cz)v3i#O_8>708d1ugNyBlU5HQ6b(6G9h0#5eg#a(XhdT!u;QKi%ay1-q)tsc>;< zIps8sQCHWP;M==lM5V`Snj=xEFQE%R;+uRWc--0O07IJq;}o5rnoC0SQ?q%DnlSdJ zsbf}MS+r|{S)%YGbm2pMlb-f?Z$6a$t?(gyTImvR^2xRLAzo+3>2s;`S9A*e?P>J-v;{Bq z%9rwmKPz40P5y?uGThG7XAYU@^_+BD#qt}pYH-hWmwqx#$`}5ubcr|lOLh6O-ML(T z?4RYzh9Nm^Ue_Z-sppbY;IruPlG?xRx%-IlA$(ft5^wUE;7QN)`usc&b>;co>A9!P zs*z<8j>7MX+e6EB{rNGfq@>s6VF&tzPxdoJemOr7x}RL?nf#io45Qty8982GkWedX z;(Gtlad~L|Qd`ETwRhaQs9Mw`d!NaOH#%0~Pw1tL`2!|@qusgr&McG5elA#~ir5O8 zS4~_Qny+o(`?=STZ!Su>O7%A@*w|M(6FtSta{}H?}7)$WkR=>Zt8JG z`f}26QR#dwS`}K4S>|l-itmP1y^dQn3@7%=N|$((FXP^gC$FD3J)c(9Y-l0dn9f(L z)uH*?bagFtsB&@g1FN^bGVHtHd4|x1AMs7TlH7SCUAcdiuWc3ZHTK$C>ZgoVHNLzq z_xjKMBO_i3+r7|*AMs7T0^^PHMHXoLJhuoCJ3etu1@dYequ%Y=WTR*Qrz68U1nZa3 znWyefov)L1jQQyGSyBOiOy9L>rSpEgannGC=|s=0bTd}QlWABXaHqS<7ure86(IwW z+lo6v%k60U7&Ywb=?7XqGB+y0U$FEqLKl9-H{~`8OBeloZcI&1gEb=yU2YxMhURZk zhZyC0a>MM-l`lBD`bksagg>DRU*enmr8=?7VstZUnJ(93@f4CL=^MINF_eSzQ4)@e^xtI0NRTBaAf??AVn7X0s2cm3ek$`S*JKh_t zAJ+X@#h=EgIWO-ym~ynB3-6!Nu`Z||LN|!oVT8+*;qqb0WdI(I_P)?^;yLHN zSJGt1fqA?IZ8+h}N|*RxzS3sq=DD&5IJ2@QIn$@cl_4sfpCjOhI-dYg-^D&o#HOgx z_da>?#O>8o+K7c8mCRVa+T=s221v(x6FU9|xrF>Y?__sYR$RZ7p+VJ@>`BST&68~0 ztS!CUk2B{3rFQ1QVEJ(0FsrwuwNgKxcp)n1{wOu!<7Jh;_~5b@U-|EIaY2Rr2pxZe zTq!^3d~o*-gVc0)t}71PAAHVqu03Y=bLKgf>WGeke8_V>vbfwCm9 z9z^MXlb#4}$K2nSf%x^WS5aNh>pZLeV^QjcxXQ04^=TM$POA;vI&JKMVmlT(X}Ytt zW8_Csj&*;XYU!INBB zaTT?1J-)2-Pb$PhkaNVhL_X#fBC;dpq157zDL zaz~t@27PfAY~Mn+UX--cICFe`%I(`aJ&=6=YWtSfmgj|3SHnaj9(ILbqPIrG3l%*}P*GV%)9gBkhkmCi=#B{ui2rg-)NkDD6}9nZ7{I z<$s2CAAd_7G{y@cK+rlwY2K( zw|SSnm*L@H5>D3PglqnbyTZW8>l(9dAoJVLL6WT{B+VFztkd z_45K(XoqYG{P#&<8(5Ndy>44@ySC1!3${e5t_KeHp0Ik@nz`LmxZGUYu7ysT?kw%P zbi8fpkSlE1iApd@jnr!O%S_awH34*bP{j=3qFR53r<<~zrS++UpYrF-Mr(j zQ|$2nZwYJz1Jd4C>vl-S3tV3iNIL%avnC|lKLZlb^`vB1XgwKQ9Hp-7_;bA`pSn-{?k}7Bwzy6ubSp~% zRq*SExiQ9ksf4!SqzIME{#y2VSo5*|r!G(@bp2r((IJLycjhEeh^%BhRsZ$SdQ$Kz z)-wloJG?(>Kohsco(SE_StvbW+KTjp#mKlt#xm3ohIQLv>jwn#Z*cnktdh5a^~1W} zT@3vxOiY-6=z}*u{oSu0vTi1HD~p!#b~)?aaVegDuIVGa-mKg-ZV2~!u-DCFz84@d z)9INa+Y&>rpXoXyx=m>#HJ`TfeWw5G zc15={ViWZEvdWfpdR$qw^5QE>tDh&~zjBV8OW$5U)1~p>5#9ziq`mLk8@j!(dpAn8 zP2AOUNuNEx&zomzgY@S@w_ep5Z0}{Rp#3}AJFkpjKhL%){k_mYDjgq4yeSRF1YB9P zKgTM%2 zB*1q>@|m(&fX^p#37>-wg1XLjN>rrx6~!Zq|FceCCo23P%8+FOq(Pan|K@YC1)Y@I zoAT*I1l5pVtJm#xebz2>J=45@>cIM{(3wVeX?+v3+}Ki_n(5BX!~;QbiCIoe;3m8A zsF}Ir!A!055&2;-AKbgZx=+PJrF&j{iz=bI+%fJo-Em4z-QlsH+{3`_QfrSJY<&E865=Mi_mo*7?!u}Q52=mlHtW3 zc+H)8OWFU>ZV@U#Z#UL_*blKC@cP>WD}l`b=j+J;+Z5XupTp!;P=-8*YbJDhAIJZ! zZ^Cw`CIMYfHbGA)&jf%nWSFv+=lT#-O+=0QPCS90;ZM5=zS#F8p9Jgc5imjf&bJ!gQ=EKl(#KJ1<0Dbuy|!+0 z>R3L^3->V6P+x^^QUk{_^;L*opSj*UJl`oF>?(o)ta{65!K3^NM?Gxf&%V6*feZ0q zS&jGm{^YiI1|(33JVakI4+h&=+6LCoBD~$@`3u@FIoi60TKz?c zp$i}4OFPD05}(VzX+I9H8Jmnp=$xK(S6tc*d<_o-jn?0j=bM@A!8=2EAI{9l+O94} zx$%fPA7CHA=H+i<2-)sGErBEysM|e0chA1ybe;a3=e93`^|5HK!?5Q^@j{M2_a59D z`+1alIr7eP);uxv!sQ*!l2*f`J__Ahep&BT8J3^TcR`rrkKEz;u6$QUUl%mgWxjEY zd06$2&!@AGqg|jKr`_OtKgcoP+f6$`ePkLs%7W?4D>CV%F`m9ID~788djDYSHUtvF z6(LUSm^u=yH`ecgP5d%SRex~K(zMaLs*b2(O13>b>W$E?MFqc!M>AG@@>FMX1 z?DF|s8GbDq;-2hEpP7zV<>VP3Yq9DN^Jg8?yv+v&193o2fV#xKhJ2Yqr$onk!4 z6YK}5X9Ux8ejxo9(^Ic_j_4QT7-pIDZ5J#7-R|`GI<)?*fPP&wvHtx-4{lEJZ>3kF zKSB@A9esSd{w60~e+Ibmrfl~tj2CExD$<*7$oLN+8{iO@_J_8Xx7PJD6bvW7Zya$Fe$@MYLsoK%*5kv2~|K(M~;I)@PcKe!^4DSD#5 z3#})u4#ue6?b4oY?0w{xCVpNQ!l#}H-A^v{%C|3Rc(YL|00R@0$b3;a=f`wG_V0&a z{;d7y3h;kH)Gdp~e7vh;_KWO&um%GKBY#3Sh}t2j=->%}d<5HS`i!&7(renhWS|2u z5x5+v5773}?y)bVo>S)~Y;tMZL(&Mor;Gh4`$XDMUN!9~ecDatA@-AL*cY=+Nn4`- zf8FW!ZyWT6GD`sH%eX|=E!W*xTfN%#ilkPVyNa-+YB;ffLidwPJy~kubh@u=irZ7V zx6b&86W-L2pT$=-=zJs{4c1@Y$ETjlI{y*y;lBIDHkS_G*gwNRvlc#tUdn(!5P}b` zSdO9%rdtF^JKt9UAB(=Kt+KC5$)C`^%2oTQSa8%gwj-e%MD0)^ANV+}IRrIN()n3; zJh*;bNHQ5Hd*GzjZbe#u=O+J#`xp`jS%s9M<-;M8u z4Z$}GbK{b8)0|m(12Fy%Y$9f@C;>(OXWQ(C{jLdDWtx$~bo&j-sDO!B;4G@q`VJelnoW zMdv>@1G-2gyv&D_;}*72cN(DSmPoqA41ny zFoME@f7`J9EtjJroF#Hu2Y%>8->u`Qv0Y=-3manJDtPW6ectnTTC6|HMd(Hb+To;j zH`1Hu%o^#O>hf?Lg*SYRaPb=%81Hp9zJP2zc*CkSGuaJK_$&A|m_O_Nlag*RYQt+2 z`Vabf*w-EXJP3b6*H|-xCV%pl@^YU38R<2?p2}G8i7{vnzSnHr-EhU7{MOO9VXhg0 z7K~<{G;(BWijT)MRftmMdba%*T>otm*A6Jbb$)yE+iOld9XwxGBN}X#>w6QFoV`t90$Wu*#^D558 zX!F@0alUpoz&$K%H|z(fzYPJdVevg)+|F&S=h~h;*R`~Duu+C9!%Br^|(4S@D zFEx1OaNC%>n;-$)3uuVc522gXz%kgK@maN;ELWau)QBObhFJAuBL;98u;t$%i)Fw{ zAQ6}VTm}pR*iPAoX#;5X$*VYq_5VV*{l6vw-L7?XL>sbA@XJ_ia(y)F%lE(0e&3v0 zs`!T|nqBo;!E;6a;yB);ehA%9F7-_P80yN#@Y5KYV6cMsWxDZIY}|V{N5h@@X>1xi z*gBs(#~8X4AqUah-4*babYYCzHT;@7DW6VGP4$5h13Klr{9H4G`S66ll5lEjh;d95!OVc7-LQTacvI_9b+yPg~5sl5Hy=7y!fq>@V3zvd`n1 z8T(fDo9t@|_7kKNO#sq(wakyOU1$j`LbT{ftIDDEWPU`nno@A>om)m-f5qo%X1;8T z)DxjwORGpvq-n`{r>ZZK-s;mHb6m!8nCJmDnsY*!b^}a9*zWWtpxc$y$k6(-9{P0I zyY+6#@89y8C8Nx;L|=q%<-pXJ;PIR>+31(=GfcAogfpQhUD*;aWN1>b4z%k7^+0_>- zbh*4SBC~l}9g-fYA0`9XT@ctshx1XXw0ANe*dEBTG}NjzWX`d)zeZ5j*!YLK^1tMC zdtVS8+PG0%Bu6T!orVLK1buR9x?R2 zadqn6n!@=$o$w=clNvad$4?oeF;3FkQO9bb<+G@7jOuWyC#~^LSEDV%%`$}_p$9lI zL*?-k81t4bC%qroWZ}yyr;_yQYI^u(R~0|f^Mkq^(7}}e95)EvAZiDbFBwwG_&3p; z;WEaYL-18?Px{Q@`;AG}gXLqrZ{OpU81-QMQw5uMw*L0kreCVjnBQMxzfF!46aanv%rYHq`3`e$#^OiDb>z$( zmu2mcIqLjo)(9={oPjZFOGe#V7q_U?_e(!x!mrT%tv?7 zeJQcPo=rMFKsSrUGQZc+nBQ$LbM4jn>uVCP6J80nSmnW_2N zIU~JTZN{eyeO;6)#Hmu>yK4sb(~*edirxI-4)to)>)$IteCC^1ce-`)&h`yBID+G_ zj_pV222neRec`+r(`Vx*Ik;kN8mY$OsQ1TmYEKEkXHlHt0 zG2fW+H@;ls&USqnrZdZHcoN-=RcefDlCh)TveW<;^UZ)%$R{Ao_l=ihWj(sJukQR%a?pq1vf&M^2INkk6~Uc2Kadx;d186Qv|{H zeM)Kv%SG0(b1=7?F}A8R2k{eoUU_0*RNF^${R3gv7wcQ-!iV@)en$83o6jV-Cyx!< zzd|APBjYgt*AJ^l{HpMh>CV(SLi6X&zM7a{9j>rzp3PaS+MrtL-F ziM)Cto_q=2pKYmUw#$mvy#ni9x|}vuz|XdMwba!4XYIIn$nUjee4OCtN9d)D_yecL zPe0t2))wJ#uFhBLS;6&Z?XQkPPWN0~V?*nd#8>>?zp+DFQK10UxD$O&QeA5WwtNYm8_Gnyt3M4Sv01# z-M=OQy}j40AFMCdaU)CW@?o=oZmK==c`23p!qrhLUE-x5w%)(f<{i4a1huPm7JjVl zYS9RcV~@Rc{MSPp|6rd+C;BUNlNvad$4^=F4xO=BWI=mfbpMwNi^12i?1vhR{{4ov z%$Z}OLO|?!QiEVQTKA(Psha-b%+CALV=v{obo3oK3f&-T2a|7oe3h7)@0n`sqQP(~ zXkW$r*1_egPybPgJnRNv;rI0Zq2tIHb?L2@)Z5=|>9xDLS%{49gsv5B1WzvCKhEPY zZ>Y0?JkV{zgq?EuU%jv04%g5ghyywR9f3{&_px38@H#mb;65s@$MgU=W@NwD8{mDP zi-3!PK0rLcKBzB{2=oK`0|S78KoXD)3<3rNLx7>cFdzj;1%?A704{xx1UU8`4U7TC z0^@*7fJ=ePfbqZt;BsIh-~`eEj(jmRRBm7@kPUc&X+SQJ56l2Cy;WBNR|D4qvw`b@ zIlw&NMqmMO3$PGa3@in11C|3Tfz`krz@5Ndz&*hIz=Oaez~jJ^z(!yb@Eoue*beLf zb^@;gZveZ2cYybS{lEd>6W|c=1@IN{9dHcz2XF%T9dJ0%uK-a%b)Xh-7Qi{gxj+-( ze4q``0q6qs1TF>=fh1rkFaj6@Tn0FS$v_t10}6m^fE$3DfJMOVz#8CgU>)!{!0%*l z0d@ed0egV`z(L?J@B{D*@F!3OogyEPs|Pd&S_0e;+!N>v3Rb>Kq) zTLIMxASwcK1zH0=fkD8fKo)Q{un@QlcnWw0*bjUQ{0Y>lglhzP1F3)um<22X?gyR+ z-T}S_92kT)06GE5z$D;G;5OiKU>EQ?@F&o)3fd?z5|{?u3OoY53Va1bVxrj!NCMoz zO~50-o4_%kZWP)#a2YTgcmQ|0>!8g7?*dKhLT7=OfV0lRo>E{7Q0Hu=t^i&F&aDTX2HpcMsE>9H z90$fU0FOWuY#^Es90M+Eh-0R9A~pQqIKKxSjq2QVoXx(8%5QR)cb zX$rXjh0W0SHHW_Nbc4Hd$hvcG;^U+Vuz}R`FQlHI2xmV%d`8AMFA#Ch* zkj)LKueq?D^U>aKf{bo~-YkTDUySQqif0*bLpxuAw5w3Y9cXWNqE7EZJGob>-|ojX zKZri?5!j5!P^V9zjckCecn0=%Gp^}*@c9CGei3crWn5P=bni9T-Z!DYd(g+chjzXX z^?CsM_K8wo9s=!4)c04=r|-}&9)ry|uGEVqko7;=zc|#42#2~l(xH}CbEwTV9qMRZ zhw2VPy%2`F1co}dg#$N59O_OO>Qor&Ixy5>cKG7OJJyfgrT1LphNuuL;WxewGW1R zBnI4|-fiTorFw{@NP}gr2rix&wlVPaO zf}swFp*{Z@U>7s61# z0YlyW`!Mw;4E0hN>Ul8K55Z9X4nsY=Te#|$7_QDu4OiXAhpRbPgsaGcaJ6ktxO!}9 zxO(@laMgKzxGLTnu2#GeuI@PyuD<#vTuuEgT(zwlp;|YLP?Ot6sLy*xsC$M)sC&mp zs3V>THLWm0^;r_3((a8=k3S86SAHKIld}y?)IXznC+!?KMcSWmnk4GzS`wbavXYO6)Q z+G_4|wbhzRb=2O}I_knZ>ZrHAuA^@2SywH+v95aKgSslI{aGq%_F3xe_s>$f?ao#$ zZa7g`t?vdHG5fm^-5BldiT#b_4MWrs$hCY)x29L z^-4)6b;Z`ss?od))Zr0b)V?NN)jxmgsxIHvO~u^ZU7dYR4|T)%o@#P@FSV;hZ}nWw z3)SF1E>v@WxJX_3`NgW|M}5>=`{UJ+4-(W1ANN%~4kxOeKlM{rMGR1x4F;;!os(3H z)MVArH%Kj5F<8xeX^3k2(@>S&GDTfAF;zL&4p$vM9ie`0HB!BoKT5r~bF`}7c&u7_ zR*2<;!ZkntbrDUpg-?-J%Tc@gD zx@W8J4|~+&wK?jyOMPl!Y@S;5O};v|Wrmu!e5UdgT&Z4~c(uAG^;*>~X|}q0;Pq<5 zusQ1J_<3qX{*CIyvIVO0mRr>7?-r{4EtaT5nakAvr*2n=s;pG8uGMPOYj>!(dKami zHr}mj^t?~aedPgl)`W-D=YKw;8a?v3`f}2fDy#WMwg2cdYE1F7s`kTMRQHwJ)K5!Z zQh6(0QAZx!rLNiex|(wAE%i>zchvDK-dF#8cE38W{zvN8>kg{IUq4fA3JwKfG z-T1v)>H1M6H~(4fI(9;(z4^Op_N>E^zp;{I-nJ;m?H^Wm9I9N~@krmZ9bFcl)uQ*;Ue8W-w?spy6fAXPYP0!C9yVig0xT^n; zj?`=z_4ufAkKU_-?{u06uhxBGU(bC!tWk?+!-oH`BP{N- zx5CDUeHeD*&@aO-fB9J0;wyd+d;6lO@b~+i6+UiSlkl_OX&?TYt5g1v>|-$h?l}wcG(l2GyK!=>JJ?azpRgn z7*e}t#GYoc5ntqWjF??HA>!Ws!y`ugFeze5QeH&PmvbV1-L*WT|M3SSGABPDacz^g zA|7sWD5BPke?)vxC#q7HKN?jU(Y;fptZn@(ZC!Oqr5ks8E7eV!Q|X~|S65n{{6wV- z-`H8{$b%nO;<^Bq`mV)jDro(nW}9e|jCm`1U1hyLRG1s1)(moXsCwDKJFV*nLN_wd z4x!f%+#U?i42R)L={m{^3m?{XjP=v;oI&h0UoE@h`3+V+gznF_)C`|9m!s0)wjta2-|X22nel%!hGzEZ4Z1nh{t~ z(fL?s;lsK-ylqRWa(`%X_T)V?=zal@Fnx9v=Y((fNpPA1n{+ zdSBt17&YhBn24oW!+Q7e7byB6^osci-kWAD{NW^>k75fS*7g#+HbzbQcyr`agMM^= zx7{pJ_z-%81$-23i%~ON@n<`qdH%8G6eOI;L+Bf=?{-+#-vdu~{{%`_mwhtLBYn4y#TFkX6xk5c%Y>3BR(7KRrg zxvWbcweZ0@As?8AsmpJf#iVN2y2m?oYCZg2hUv%$k5;-t#^Gc>{PHju=sOcnditn~?P##mR0uZK03`j{6tK%Q7L+1v>0spnzt+ZgK% zu}VGK1nUq@F~x0;xi{88XxpD?g>{rRSTkvdba7b2>4^0{^f?Jw!|?UQnj6+C955&i z6R-x1^@;6Rn;4UXHAAdN#16wc$8bDPG7@W0V{xA!YYpq1Sht(3)OA@{5Ak750P6-} zSTpE)9r&6H`U3E=2`_1nE!`Ai?z9zaNqL{T>gGs;}>{F>^SNp z0`u;A4s~TahnmwL^Xhbm;``#NJn2xVP8Agwrm8LoQ}NZq)uP?u>MYD5WACbBj429l zfB<+AWQ3XF1XQgt9$5h~i{7q>p3vbkjViGAdr1pwsW;yLVnV|E$5yg>=paTzPlRp| zwF95e!^1dyln@H)f4aASfh#?qyEcs-Ok>=9xpaoxhZjuyH-ZK4tBAiK^!;%b7wvdt zVVkCR=b7!ueE&(9s$5FfSTcg6oj$j*aWvQeEOai}99{Zk2zI97#T(G=Z0~dz&d}Ra zG5Db?PfiN+($r>8RE^(!WfQ2a;VR+C_9S#axzsb;w{<_9h^3z^%Q@3%QbjmJ>MOHL zv|>F79}Kgd>-$~?EcoK*1Ir(1g=HMW(RX0=UFaq?a16cgHaRyj)0K|9Vdhg-87UtB z+u^{t@r-DYoECKpEvKX4zf-^SGe4TK^5Z8kw4)<`l#|d+YT#I&oXp}iIUyg)N%o&q zMi#6`G;3pj3Cw}<3@7amQ62D`8{-~1#YI`N-WV3yGL6+S9lSu&|(D}P=&@Tn(4w-!;>KBWwEC+ARCo)eFMIpYSpux@}8r9CC} z4Axic{-AZ>v&8d7gQ;%}yYQu#kF&~+`;+8D=vF>L?hgt)?gh(;tuHva2+E`Dtu?~CyMZf!sQ`w8#y$WKd@n%zH4VV<(AX1@2OqbZjCaN0c9Wu> z%>*!FGxi8v1^;RQ!$@PVKq36uz;(d&zzx700K-dT?*Q%VjlfL+hMVeU0Jo;pt-wNn zc5gAT1Xv0z18}QKVMuE1E#SCtC9n!u4PcmR>@!#k|4yI?xC^)&xCgiwxDU7=cmP-j zU`VST0v-k)0UiY&10Dy~0~qcadlR05zX8|?JPqLXm$6r2Gkgq(jXev`!`}jI1zrHQ z0o#EWftP?Cz{|iZz)qkT*af@_yav1uU`Var1l|I618)O+fOmj*f%ky-fxW;!0K;$f z0q`Mk0Qd;_82AJ@2z&}00zLyi2fhHl1P%j7fUkhBfp36sf$xCtfggaQz%k%Q;3wcX z@DJc;;1{3-I05_${096J_#OBI_!FSPaR6aJIDqMassvO9ssOmfXY9v_hF=w^25@gi z3{V5Wtv_R*Ms4_Y0Ne&N_H3LDAJYs~A7}ua12hC00k}n|&I1|)u>futs-{3QpgC|p zz}tsdnO3cU)<7GeEr4l@Y7fK#xV5M{0-b=)zy$zqHL9*aH=sMv1K?P&7tkBH5WsCn zW6ww*`0+pj&=*Jq`T_lc0l+{Y2}lM80fT`d0QZ;-15$ug0NdV;JtzEj@C03 zzz*PL;1ysePz>w>UIktQUI*R)-UQwPb^~t%dw_RHu|tvw*V!+-6txfd;@iKtrGra4v8jz`atjKog)T&rW6JlcwthK&4lm-hNE8387zCh|p5c;v%9 zd8YA5EMMGKh%AJ!)PB*%IGucz=aSZ}dijUS$rn9+u9;$-pTA^3-FhC!p~j2yH~`JX zYpXQQaxXyr;{=w^eY!a)U-D-@{gAgFzetOx-Km2#9DfM^vHdHSYuDkapM5dr*Dg5C zaD$N#ExVO&#>#rBbv?zuaN%Eh!sA^jlSlCD!oll1Ndu#eY!Yx}G1hgkb>P=sIp_D^ z!nXhO1Qi0V2NH5zFLaX{IF`L`VLtg@y10YnMaYM8k#&n|_p2(MgQI!C) z;%A2>!|7>+W=$h>@p+Ez%9a4f)uOjK$)WXRH}vSy4|cTOUfBD?^QxQqQE#ayLbsMu zww?s^)>z>}`?Kmv9x_S>VuAWVHJ}O*1&~XIsUx&ktbh7+)GN`O%Kk9vx?@_ND|$g+ zpr^CL0SV~+M&zK-_ATe-76F*HPw!=K-}C&|DKOOdD{foUYFW!-DI_ zx=y+eayxJ$`PNQ@`_vmBX>ve5DHowz`3kvCTKcT3|63y38$XI*h^%t4=575?dq%rQ z8zw%}uzpFa$el`>it_ls5?_D|E$uId2kQ;@O|ab@g+A4;(SG~xlxX$EwJ&b%{>+2~ zY?Cz{w$K`SBXpA*I6`kmxTf?k$l+Rg9`4Cc%{3wq;>dDCt(UUDWBJ^k*7B;eBlLY_R=vLt{Ba&6Hi6gWZ+gb~5r1v>AC!RJ zpB)(y+>c;ef}v|2_k^kOmpr_#1nr{R;g0P_Jl1z@d%w~CC-jW=Qs`FJ&HkUyDGtEL zLsOl`t2M9(B+l5_hIxjPh}y>huSwD$136!X&(*(UoC{ zpW7Pz0|M*!?8WBL*1&Wa?+%9fFl-RHWk1Pw%W)vZJXn94#`L-_@C(r zNyo4_n1|B7jbS?aEJOb5=^1ZzlFmxE|JxEcQxeeI@4m6Y?bo{Rw8t2%d(C-&|BAbs zFRawWG7!#H+3)D7wnef9}80NQwlNoN|KL;b1=kX{#{-Dg_T&H+ecdP;%mnU4Jl&tp33 zD)XY9=YN*Rw50PqmMQ%S`vr#CmoN==UjDNWBS>R9=0{(g-ag9eQ}lQ_hrZCo*W>K) z-%|qmIC<>&;Bhi_kK-EoUU@9y=gmkQcq01y<7`WG@c_qbLMKgk*7X*?ugba)EDig> zxNf7j+xGZxS`)Kf=y~elLj2)*b;e~JE4bV|BLOt(@JZ_;;NNrMGntc;eYb4eN=txy zv1mBtU+4x=I~eOCSy|W`n`XQz9IyYw_ZRRv4u6^=6r}U5oocj8wrSd$WrQW zV<9d{^rHm&!Rt-{=(h#h0rLHm*e%u6_s`F&`P8teX$5`(b%am-5IT|vxiY?gf;)9` z-z#`Mb9Z`h`7Y!%87O=Q_rLIcyhRhE)uNBq%~^fld!M>no5k#a$MS`4QUgc1e_7%8 z@$iXPea$x>3Z(089I~W-5TaKMixb_UPu-I^-IuUmbU`{MH0CE^re|2rW1Q|7C-M3@ zOe6m#4Qb>{cY2(p*W(%1)97)e3txH~Yd-paJ*?-&aCvcM(JBAo)(q_b|5Xww1UF(= zj=F;T9X=OATYeM^nSbs*xHUB+T5axl+s@CTCy#rBiwkh^Fg$G6LN}>_Bl?}8&M8^0 z=_xsRc&uoa3y;O+IDIr3hAV>N=Qq^6i*#Mz^stesC0=N@fBF(A z#3`a5H8Vr&N6zGE_4JYA3)hW4yH3q~u6PIZL+A!kJDj8+<}*Fz>W6k}xk1`b&M~M% zgMqsN?zij)Md5xf?kjp6Xn=&XfEhqGuoCD4)Cb-`Jog-Nk6JSTU7NAbbq0Lq*&pZt zKwXVF6URB6KXER^d5}H_;+Td&HiqL^=ga)z`I! zkm1CB2;CrRhm-Wff9p;Z#A-jj!MVSn-W~vM1C|0_;97J>kD|yo;Y*!=0eU>Zy>_X< zb2xVz&>NuL<9L*H%B!M2A*oS^mEeM=;wwCv%Xl*T=VD& zOa)#Bnj?byJh>L8uvMJf8#-<<6c$nN#&l;NdWg@oj^V>0!x9} z0Pk&10HhoanVSK10Ny`jS4&>#S^!+{`MWq?yXZ%zCs;qM>$JttpPDV|zjkxYXFkAaE)cboH>#2hc)FO5W2y`WvMiM+bNhlwa{>!?N}49}~Rm!`4C$$yq7VL8Y8U+8~le?Bfw^kR2zuwEc4g3bFV^rcyi+$Jk> zqSc-j-zV?*{LRl7=dfnXebLklp&LZ)0KG`VM*}8#3tSof3-AEG$C;H%-EjGGwWwoUf$)C=kdxutf>x+&LFIX>W)*``1%pd-Nc-Vfj$X(HeQ<^e^(R^Sj& z9p%RZR{=W!?xns4_!+?K!&C<->j~g1Fi{x{i~|GT!g9WfK}Z-FxDOpzF$~FdSSC7( z1(^$);2D9I$Qu*oXS!od)E8r+VX#BvVY9s8`v#o92G0sSi~af^A-^hkCmS}U9?o^B ze{6QBuGswDEGJBDK<9bIv~V@8UWD3;caC-2SxN2t2=5TX3mS8uj8Zk`R#n@csIJZ% zP*WWoT}S2pcD8ydrJ;H%FIMeb+(JF{UVHWVjBYCT*?6_%n;|OFeJLIU$Wlr5W~+gj zE7b=>pH_$N-KX~FIvfxG*vV0O*;L0BHP<^vGd`LrMiyU0nUd}D-~$g>eNM^BNXv1iqoBWHXE{J5$DD7`-g3N7o6GfP zj@x<9it{m!qiBOUZsK?jrqHm*4dC;B7tG?n{C(wi$b)PBFspx?_fSv5wWI^o1KL=4 zC*7Bv3)*O)6F}LrK4`ZH+Bn)Y+B?=2|BLNI&`3kODE5|d`hQ7Jy2K$^nnv>GIReR_ zzMilCpZQAOOhd@|^chEAKZjvn6CLB|^n4gkCwZCw0({Fky3erum-M#(_mY5aUyocB z+P-dr{r&F7cD-UQU3Ak-4iMqQz6#x>29BZaEALU72G+WtfH_e2IA#?mx=5e;OrQEp zy(i~vZ?vtnu^2)c_Ky2RX}!Bo9dgQjnAUf{11Ok#yphk;LGsEV`8@d5EvalSc5G=~LEXClIvVf3XDgc3V^! zy4~hn9j(^ad*&@Y<3f5)(l`9(VfYqP6>pm zf3~wF@OPI$AudqnGiq*dyX8JU7vf`QN2_Xi*Jl@B7p=xDIMilu_|l9zoFu?)Lqp+w zM(8Fra74Qun21k$O?TmOUwp{VAL7Tfj70zLc?{<;>=W77a^AuWcc&<+OdI^Yu^5gq*FKy!4K zcLQzES#AL?i$uSP0mL?7KB{vf1{KMe?DfZFZxjY1S7LCm8I!%57<62ZI;;Z$?Z8B2 zIp(K}Fu8l85#DuxLCUNqcqXSg(m_C+%UIWoIL4s1fCXc`!alndfLq_jns6+9%AP*Q zJCr@^fnyw=$GImi$?*A~=i{=B{OIHI6~t0HhGAN(V;Z6?S025rv^LF_z`siZg~(X! z>!us2>4AM{R{L5A`#a+NrVRIrepg*PEBiRMvL;6!PQz zLfVJ;fgJ6SEdg5s`g|tmmf&{lf_O3jS?7(vDO$ahb!>UPpP%}&5j#LQna>E_qy~kyI)`$szQ&3}Ra>_^$Jvc0pvWk1Yeo2>QnKl^d6KQIl~DR`yqqotoF zonSxDHDkt0n7)KD>?rNSSuWGbxr`%?KKpU<#4v4-#4#TXUyL}WVI2R{CwRVu#piVk z9YG^rWWh9a;*&0MMudI%TS{O)u1fmb6$=CHmftMkd$~I!ek=y}d#7J~umtV;qF%?V zrA)rL&GAPgscxn1R_LVZuC(1Ixtuv^PQH)XXsmcs3_fCy2T}cri=b@eL*6H(=W(iG z>MQkEbeHXd?S$=zPLGo`;`3sdUfL4rJXij+-H^t-*#2o3xP;mTxB!R;dI4>LrU2~+ z+v?xN72-lfPc|(Mtta&tMXOr*tG0d^ao5P3{&}3DE7cRBlcu}!^aS4vFjVAU(GS)k z>y6NLKo7HS`Cpvq1%29f>H;r>V7=1z)2EH+eJMirU$FkUZXK)n%@95x;GB-qGa3*4 zzl+oD$ibzd^&@^sw0dn$Zo+x44= zoI27-EP5hzD_3Rc3BF3>&d$%)wM3n?KhK)asr;udQD^8A)TdMFZ;;GzOfTos7rkVp z=q!EOE!rFUv>UWLTyx`pmgfSV0L+$zz~8_X;u@sCnGZdod=dcqw5?o|EItnT&zNyM zXHhNH=bB-+&d<5#Grq5rZW|JE9YE+NHE@KUVBcoq%=9c5Ud-dn^?KsQdGkF}Bt-!N zQhw2jfS$5^u0wEKRI?SHiF04QTrH1Q{d)c|vubknxic;^bCB|dZc+nBy?njkA{3yH zgIL$RB-S(ag^s?^41)hay66izrp|DUHVYUFaIA7Zz&?m^qHm&yAQ_I=NZ9UV2^4}P zda-R)XuXJC8LhV8-feZi)*m;ziX9Q0=!MWtYT&5r1sDCz_tXV+vn>6fO`t6huwHp@ zI}X6MOQYUd_uT-t9j=vePD|Yq8^Zc#SnA!X142g<+l7!oA>vB)Z9UsM%5e553a+BehA$lY6o3E`cIzhPIu$2fHMR7aS&-)entC< zsWW0DIG5o*wPpb4GzkFh1#RFxz{fxw6ks*b0fwgph=!6~3!^j(8MQ-3?_*t-t+sEX}9K~NyHSP@%5R1{qiEZ9jx z2}lWqCZc9Z7P7M04Z9l%`kq96D*7zpS->6}qF7K-v4R~t&x-h0(PzQ(GP& zR<(ud(*^HmJlI}MynRbGxoUeg=i+Yans!J?^|R(waIjA8wqTY%M7FTax*_$2^&OkDqd@G>vmP)$U!h18WS778lB`iTqyN?`L*uyGyBIq zu4${b_{y}HlbD!By7QQKavp8+i64+O!!i)3+Xwyk-@3Z}8TVKERzmAt43*2}y z`wg?_w^h}5{r&W*p$ktk`^~~P??FJ(7*<7FA}G;ieJ7ae)S-M5?lOyQg2WrCMfre?Y7rm-FE6=TT|^|82NlBe4Cs6hyF&_L?=ZC`osGj zH99EUq$k#8r5o2^J5IaH{vg*=P(nVpv7gR4S&n=1Ijs|jZ9Rr8*6aPfuDEVj&~BhT zKzo9Eg7yJ%#9}`X=Y=`u#<6-nD;^0d1PuTcgNA}iK%+r?e&o=xA2b;>6;utX0dd{z zDWEe!=YcK)T@JbqbTeo%=t0mEpcSB1p!Y$IpdUf4VO+KWai5v}K>a{mS6c>}209IN zF^Jzl<2TFreKCFqjNj_wx3u_;D}Hxs8mJz$2!t)c)iV|S2 z3pxk%I4B3e?gu&*gjcy$Clu5~(9Iwg*m%%l&^9Qz6G88RMxy|q0^zev>T%Fe6yz#U z1cjN4!n_T13<|U(3iMgfzdB*PF$(oC6lzxtYUSY}vOOB#ZScUp7Y4nDb;i5x7@v9w zgIyhV#5e9RVY?a+O%?gr2fr)63AZbBzZNK7p+G;FhNNbKkkvp|16d7hI1SVzDe3>MxW~4# zY)5F*&Hc7|-Q89VS-o_{n!zj1{M0epMTp1#pYU<&a$5gSc67vstRuqs0%7^oQGx0Z zc5~qN4zkT-bI)6B7uaS{LbgwAPe>GlZA~VQ_mp+NP6Ik#)P3G~DO=K34Sr- z-t`c^tOX}{5xyx+rg)KUADhFAneK)-Cw_=EVh&x~1RmMn;W@*INxcvASI68u=tJyF z-v_+$G7osVIG4ooN zbHSO|7}^zLj9Am{i`b!cN&Bx5w+=Tc_NIQB8#iWurV+U6xoXitPtW;&+>Kl?1NRgv zGy5~bx4Fsx6u6PDixnwVdz6om3qTk)P{Tk=Kz|3_2Py_(IKz4_mojD969-va0wru< zSBLZjAB!IG#z&`z@g3#eUsycex9h5p4n5A2MDQVeQ@j-TkgkdqH5ES0G}iT;IHA>} zjleLN^=*ej_@{!70Sy6Rc*|M~))zj8ysR-y3~yQQxb%R}aUHg495W&g+0L-uA&;+wO3!rCzZg!Z&rE0w1m}h!;N0v@$toS@Fq?*w_t3`#{Xl zHk3I;9E}GBL2SPc0__5lc8kcT-Js179ElH>g)#bn1veWvDfsC8ls7(VpKPnXe5Ek3 z_UE3vn)ndDsk0RLD2jy3Yohp?cw9qD7AL0W{#fTaPWnCLjgto8sG@37(TFx%>}&Qz zgm2zm3Y=Kz;ODBRMDb=!g?+__#0hN)?Fj7x=Sn$0dLifp5bZ{P5P2jXvqyCRh_-}% z56di9n=`fvcJ@*RVVrqZD$)KXa;qs_8TJH}H z^GBx!!&B^4#E4f1lKfk*aO2cmKV11daC+N<&yL+<$9!H#C;1EC<|hA}$sf}QQBHX` z8J7|JK`aRAJmR$_FNFIm;>Eu6-|oK_SqVPs(%_@<;XL)f$LFhd1(%$8fm1k_z({ah zM);=W&EP{dX!$OC(Hocf|8A>>|9Ht|@h@TnTiWK+nrmXd!cUp6ZveLUi{ry(iTC>k z)`UVnd9d?o^#(7ePN@m`qmoVo?vHv|m-kwvZ!Nf`Pab`pbRP5Lxyh3>7@l=aHLw6I z!ENhTyzx`{Qd_lM-<-GdS}a^{;z#&q4i;|L13$)REt}XsGoMuF!~&gQfWD3o!II8n ze4d*;NrT~8*Hi;_UXfzuxxxUaw(4jRnQqt?@N%S@R-WMtdz5 z?U3*-ruGLM4Jqv(j8*&N<&~rTlR|+3;dnF{kdM=>?>?h4_s|h}acw2%-m&B^u{TN& z9PbO_m_R?!Q6P>LOaaXVVL61I$@G|)GJhM-~I z9QOWQ(0k}qZrNI?7$#QpAk4QIXz)RpCoy38;?@}N>Wn;gL?5#&)&%Z>^?ds%bvGU= zJ~%?D8`04$8jJA_D0dh-o@bwpb$i!9h=;KL@-3_{Y?-5W#{$Y@0y*mBYjV_fALppg z4{xFJ8(OHHw%SZRfe-x6JgBAGqp_u`THZ?C`S|8)_-9+F8wR&gRjb>oryppiZuq!^ z`g%s5+Pr3K_2bvusY9?3@qerGRpZRv)ixdXQD;21zq$NrjJ&%RvN zWi=ogn2iImuZ>OZYfG4b#P`3JUy!F}KD+$Z3Ey^KlY6qA0?dfjzZAaBP5#5aCcghw zR9(&8&r*H$v&QIa-)O7OfA)sF{5P>aX5xq+{&VtwHve}qXJG6( z8rpf`TTJawmt%CaCWal?Qp&Nu_MQ@RESF<39FyVmJjZi5J-Rb!SJ0lIUZB1p-rGNN;e2sLd9yFU)i;%+@J*y}P?ockG3C{`bRrcdX^^Q3QF1V-M;H z*h@MH8BRpIfQD$d`Iz^57~e5ljkWBpa@2qK%~3V}9MuUMA#`{vM}3Dq3@$jMh5G7q z>|=lh@SFb+ZNQZ+)mg{4QuiFWxeE8+LR}MUt@^#(MvV>Us)D21s}E{As>bj0RF{vo zR%eXtthyHOsJ44AUrp$@yDI$K-m36{KI);p4pTY*8=%U{MylD@9;Y_z6vj=~5pPZG zJ#n}xITUq9j`2ve@pN`=u#dCV_o=gN zM6#aI&I;d3K>O3}EH|bzjjXw^w07wRIn1=)G?$swr{=#`a!HBbwN)Z1kry6dgEAN*|8>!Ui)diAbtciZ~G04a1Ib zp@22mma4w;S%WyIPwdMv4lN$}biz05gnq6c+gD}(vl{sGYoHFdAoaE18t?kbyZ!W% z8E0(w>K1%FupH|vM~zIr#m1jmUk6kNLy;*pd|b0!9sVW%wV!zBzYOvn*Y3<`AN}l% z;e5uR6MG?io16S^lK*snc@1_Ik{GG%hJ@)pv(s&W9P50sH^P&1@l&NIaV0%HPWCvf zfj_DS^me}bQ}23P|7f17d2ZF{|GQ=4m3YLroYY(4oA+tfTQvE>Sf#zkq1cNxY4TnE zM4mdf@X&AWJ7;p${!T|&@)dr%d^r!!ICUV&xAMQ<_sjT`dqr>Vcu*_bJmTCw*ro}e zap}zaEr~{4c2d`O=P$hTUk&*>oYJ++mxJy+rK_EM!cGd`VJAE@|I!(OKs7>5`^cQx zmlB&M{i>|}N~kh>kkx?8Ud&5VU)9rjs(!)nW9J`n@m^-XM);;mt@^61J8;(Pl-5+) zG3(%oy;}B_+g_-8>_>s{&R@1wd%ygJWf|X}e(~V<=DhJWrp7GC@sq8wLxk{cZt@@b zkMqZ>285>s!+~LexWB?5_m>7w3>+0KWUOB^KFv8vj#0M%ELkZL7cBF1#!(Y$FHY>_-@WWL6?FSf-qgEUIKj#+6;zl z7tj$P3>~X8LAQfegSLilhJ(%ny#neE<98D1|3HJF#fLzJtuQVPnvU^pezWik(DNAQ zeiY-}SUzCg*l^s~GThh%+*nuK*!H-wVhqAB#*LNZ#*W26{Ec0e8i^Y_9yj(DZfsR= zrONuE9XbN@rvosajzRf7$DoXl!#$u~Y#UeV`a0~{dmhHsuSA^N@Q%PExZl^5di^tu z$+yl?=VSko*nk}Md?juM7{FupEL@Vn$?9+1I5FR+>i2b9wPJAFo;wZc9(wOEqye`( z?v>B$!nc^(A8>+={L$$T4495pWx?`jq%=?-30K7INDWAaIQ3c|165mn?;C#a zm!}3@U2<#Pj}L~&I|`L`UBWkWuti(YhP79AKWv^RPwVfzzO7H=Lg9FT73U>Wu4IzlAUIh;Pf~`Yr?4#<}K6 z`+e^&r~IWYEIYj@Cr8y^aQll5kn82=@7e6p;-XQ}m8|W_^)SMh{KVJu9UZI+lm^4) zfua6b+!n=>fpHt4*L3zp(%ewKX-jx6WZzwKEFMjVWt-@m*KH_y{>bU*_#FSE8z-iH zSppp8m!7xqoNM2%-*2#eSAtLBoA;{YBmoLU+EBPymoj5qmcL+tvdTHS4hf9FL|IPK z7N1Q0*p9Vn{_D7?{@EKBD}bBL$F`k+--oZ?IpRoLAA$?vn_4n)Aq~uiz(poyBym{& zJT^&iLB1T*M$pN%;_Eys!Y2GzhkKLutlsM7CFg}rd(jBo9I@x&9UCt^WBbP(p*ZF4%kZm!o%WyXNqrmxaXDeZ8D{%sMV*%eqe|aqKg-O3qIOy;vmfqw;O(| z!@NG#x!4Zz8HYF#XYvJS67HC~M0>;dS(jP^v%wa8v~J^#kIF4_Rczpy9rj#v;Z^_U z;1itK4dL6|FC|YnLd@~0xoakNDR5)Q;Qs#QPdf8G8p3_!HAB1tqCr|J| zUe>L@26UW^Z|{whCBV_uKfbZ#mV2Lhx|@@w;6(VQBwjd?IbB|3;)L@pEO#9Tf)B>e zy5CjVn?rT4;#({;5jF>yjn=oq1G5FRhc_Ft)m z-_GecS-=-4;R--36LUPIb*EhQ!7s;r)a%RhI_=n+F_Zlh;oIEgzZXsl;*qLgxgFQU zNiv1zkBA*Q%1S3VqOTM2CYWP9{hY^il7@Yj{WmqBw1bjfDmVszqs!)_Jqm-fH%ngm2zW26(Z$PYo~*`n)r3g|uO`86@E`k8Hn* zTKMgpZdcZH@y1E<_PJ`@BXcXp?s>{Kr#c-Dyq;{Wix9pkxff1St!pvyBKROi#PL`^ zCtrBtOMi%A(k?NrtowBu(D72cgEwB7)8cLCAHDs~SDq}nvK?Y?+vH1lrg)LYXdW(< zamhtHdCSvj$6R%AO-|mtHA@D)>MVp3{0d*>5I<9SxGu|Q?b22nk5o4uSCI79#TP6K z)`@A(mx|pKJ1SV0cxE2W@y&RDrSm%6tl(zFE^gc?)z4a&)$g*ls^iip3w!OHtG+HS zdGo7J2HkZ~yuYO;=}!sY)SZr-5tB{`l*ePf!ocK6G~lzA-4V2Jth zScrJzF>NS)^IEVrNmqxv5_~jv^~Og@ey+NH-={_%d(`0FyM1N9;Uf4DzNw^C_$Zhh z4@7NvH0fWP*Ke$IvwV3j_+a@H55$7lAsqfCT^;UP@X@KeH$JMn<*Mc5g8!Jf?MM6M zp5n9gCHN4&sl-(H7#Ix%Dt;wC%C6M10~yjv1FEJTv`G^}G%@Civ*J zyEi`SfuFBl?Y>=y318k^zlu8sC&wd&Z!xt$9UsF2RgvgSpAL^E_Jd`xpTnfS|L z)@_OX5Wab@IzF&*eypYnrej2?Vo)F)i2CEfNZ2Sng?15!smU}Vo(SLJq?Ba9t^9CiIwE!0)_ZKhrv+Dgrwy@mSUV(b}t zP)D`b)!V489@<&GdwWlHXO|F=7mFl82wC_E`v`ku#%DbAbdS- z9%oP=itLX|NR6;lXaI^Rm)Cn)W?t)iPQdDp=R(Aa;D=Zt5j*t%%1*bVt@rlE4fS;8 z{<}`-J>kdq@U|kmu-3Yyp7>Al$xXTpa5Kzb>ljg7rjNV!@_EZs4|$JW+GX*jmj@q0^DF4~>=R7;(#J~5PU1TXna3XwDTV6OxW$1ouyy#^vHcou8bze&L%t-Q9?V4 z6?rN!ciB@dKAKjr7T0lYT*-fSA2WaVxZN7a zcfh3aA5Y%%`+;-$GBljzFMOMu{CDL)d2+Bk7zmf+*@}77ne{|4DSk2~H(rTp+CDn^ zVjFoKiCCvEd>m%odT2neCyNg7#z&|9bJeT2zR~0Fg-3t&8ukgG6MP8Y<|hA}!AFxN z?akpNnNssdI+g?FhDd@LhLh;Tm$)`J`>$)D4kuzqRv+lbNd>}aF6uFB^-kgY zV|pR{g)?@|yUV}V>wJ!-6PyU&<|hAjoD@YuAxr?^nR^s=T(fP-B1F}nE7Fyf9?oNu ziGkJ*58eiMdcCUa>(D_ zx=-a;?^q^;2>UBM*X=q^H=3(Q%7W)*2YZ)KCxnk_-FD8x(~mv$73XFI&%!qa^(>zz z)=#Na`eRn2JL-kH()C1rNjMH&$2{MdPRDogA-PuG1;~){>G~TJ3q%V;k#c@m4Btue$1oTt9gKOnO3JbBFn2kc`$epVoD;t| z`k9N?6voW`B82Y}0w>MN;k9`Lu4{lIbbDo{yD`pnEHHhZ3lS@H#1O|N=}Y}HuS3u# z@9J=ef}4gT+_*8Go}TKW}{WI5Jm_U0pPIWZT#$<~|a_H&x|{5A6-U4S^HA z{7gCIT;dQ9JT^&iLcSc+hS15i;_Eys!Y2HuO$(qGUif30|YvRRBFV#8mqZ8v0H{v9W=VDU?U*wtX z6XR!HY7OXkX*kLoFKS4x`gZ5R{m6uy~5#&}6~ajhg$ z;f4W%0X-kRtOXaeAJTVWT=K~ie2|xQ>#qUb&a^J^#!cn$T=mMp;Wr)p)A%XfoGhjP zB79SljB(?1c}=`z-@7z5`um>ic?QPITg-KtnxhDzcNc=!=CGSu0GluH!Fav z?N5At{H-k}cI)PdA^j`io6@Z-o@Hdw#7(xJWoq{KJ=bxw;23Y*w4RWwE+2O6_igsN z@O87FC4BR4))hB0(rDs_HbmMu+7goRm}hpJky`leTm!O_c52PB-nc2Ai2l~#Pq+QQ zd+%#u?sp-4Q}T>)lWOw|Bxd4A@IuUp_|mc_`(K!R#-&>?{79pP>lc7Tz7=KO^7T4CS528vHz8-$n7z#XFoaK; zbhlpenVVxEK@;bC9+@5s)}<~G^PKM$J1cfq>Vm{G({GM%#``Os>(8aC+>Ilp-0SSi z{JCo1pH4V(*H>E=n)_o2-_%{RI7+oy1}@$Zcrj(j^xVV;&jnLVgU3Q%>lqn$Q*}CC zdIh}kQV%>mzghjvC3{|arnz5+@J&6X#f!dq1}^@+@RABEf)`?h_+Wc1b_$1oNvGqb zY>GEtmH|(m<(z(GQ+#;>EqcMz0fc)wz5AR35&g@nds;4dILa#cvibnQXR! zL`?ihx*OZqZH<1M-H*bp`39T{emaG{@lzejRV7bARQ=Jso^?|HbnZ-wwpU1f|L!yx|FxY5g= z$2y5k6nn@p;zqy5yzfo@T*u9lG`OKICe*LmV)|8&eQfSuk>tBImN9M&L#RJj6vxxx z`RY8ici^L4AKN!R+}zJX_-?5@+WAzQTi{|{p4#cAJnnI~m5_Jrhr_mhXnf1}%>6Bd zpSe6KHoL&ZX1x*&i?64z^H>LHGwJAyO=TPs>jr({<1p*iLj!ufT2$+emrgTs)y@Zf zuMo+?eU7I@fU|coCdP7%?SnGQ)(J9*^lHu6>sM z*EOKqnZ}uJ+*BZBtkS55uAXWJi_bgne_!w|kHUUOJ%*9 z;*seK&Uj2cQFprDs6SoT`Z0nws;fonqR)9JyY*?l|GyUc-eJ;yxki`--Zo8Qg%I)axyIf-6%W3==21q|bPC;tP-ZrQ^Bo%yS8AjxXVV zMZXR=Ex1@x=Z%ZbvvSp=FN8n8=AF~~O?8wnxDdXn!zQ?}=K39QAaW{vu+BKJvyzi? zqfat%!*e~pb&(TSj>VU>ZagB z_@*A4;KNy%EA~UrfBb3Q`7eQdc`t-oY}5Uv!XupmmHdUDHh*iajO5-FpYoh8wn)+w z{0J6#ZW7~)UL?L;pY_*I19iAe@VPP#KA1!4^!bNwf8?=y@|ceJ;J?YY*!XLLPcGz4 z!b8;|j^w}gbZ>l)|3|Jm^z{$-FPd@r-~kQ*1fRl}e8t!EH+mwL6sG+o{)jR9CPta2 z8AdS}Pp~S-jGJ}8UIY662KlqS@lkh1uF7rE>-?S%?{V^QCu_ln@J)%l@S!)gCQdl- zOIs%POze@^C*~uVkTCMHZsTY`$H{^;I9YaGo_glyQ6Ikh-5b&kOZ3l$Z%XNf6TQjR z<>+;mH(tx;=cyCFefZW{NB2MBZ6`y)tMJ!F4!!Bs+KC%~fsg{j&8gC4*wN97!AtU*r(qOCIx8 z2Ce(l?KcAvx*amYna6o4Q-kF6}>4J>O?m-&Y+mq+SW% zlrB@;xGEPC(d}~W9JgFb8S`L}d+W6=9{P5(#pBKO=fd}rE5(xY1cc3gm6^`QJU8nB z&&8fGUmgpwPVt!IB=pT|!P+F9j+2H9ym6xbm8%|mdiTOh=FM+mt~(dLsU#i0f|KM@ z^8`$q*f}$ujdgC8GtUJl!~to{qg>y49=i}BsY3wIjc zd)c$ko9oPlZ|X_MNt31JNtiUTCoGE%?NVVx=kZuDBevtq+V-VQ|uK628q%{_8l=mRcmH-WpH{%wOiqY2S4xe~(^H);e0gfvwg_AU#|hZ-Ko98jh6}}udl~h4m|Za^ymJ?3r_nX=yd7?FTyt^ z((#gF2~MKrG1rlpcEwCr&WR7=f{s4LA`u^gH5_hmr|V5!>DHUM4kv$6p86qwi+!GZ z=H$08bR-eI3EvbjwcfO)H;(4!;X-K-=B1Hi1>_iX)jj{rJM`-hyBTr_f1TuLw${6! zqn9bj8=}QB#~G zhn`d6gf>WTXQW(pTnLZ(5g&Sd^62z9HYYW&xwvx8U)k6DHMQ4ze3r0t|$Cp)X+XzGkNIhEf-Fvc`Iq>l@b*0=H{zC0Z6;sBy>XkI zs?qDu_yyi_EPG-yfgw&XZKuo&iJZ}R+#Hcgl|feFl1;ajgf7?ko4xhL3!eRCy9*9K#gfH@lpRru}VijE60Fvk3`diZIYe}ApY}=tjblmqH%=Ie57kR{A zSGf%Hchr){8HM97|Y#+1hUPQBh48H+li2W+L!y7-V zAIMX4UcYpo%RYT`sJZS%_~u=$7k;!#sN4P7i{0`m2Az(^I2G)JtR-sMxj>DF~@<(Gp_|}lXUv?<&wL- zant!O%u6ml@bH=ccVV@;9!B`4lA6V};Ko=S^LydNEN`9*UWf-iZ9WeFa!$v~ znkC+NDZVFH-GA#(3;glQ8Rohe;hPFfix*>&%=+TREN@c|^E_32(@qFx#3x?lSnQ1O z%=9kxo$@Irc{~WCDl;5i5sck z#Debha~{jN?h{9157>TW-LKbxj+^Dn+_Q@{-L*mQ9X5@`U*^SW|2(J26rdNSqewKPwa9kut}Bi?*yVK;=+bp~;~O!yX4 z`^#LeRMtVMTBIfN)f)2cjIdom%fCih&Y1D_YRLE9y^UL5@XD%hmO3(se8P9w3D1&` zgPhJl;;4W>774rc()rO`3oD`*!A)5gyyt%19oSn`sgWP;|HjTQ?qL@!&Taj4Yr>a| zi~Zp##uk5k(`a891_=D|UfBOl^ zU*t3S5}vVqEZ0aZ7>`6#>QSG+UXw=7exG(wmtOfq{bxrW9OHM(=!ie!U-%YN`zs6u z!&7|&YO4d$U{xR-_hW~jNMvd-fRe2)A07x)1ZYN89Z2+5{6x||v<1IkVMo;)e&yr2 zYRSxZ&aH$TBYWh&xU%SsN5310065A+IfQR9wLe=9C+pD=C7C^wR;xkG|CnwcKfrT3 z=FMfZd7y1UJA%4{e4s->LqNxYW`O2`mVrjD)uvX~U9ft;b ztJX>#fy94?&?j|L>cg#-It_K{>aO_C&R$CGa3JvAU#Z-2N=-psY<-SWSKO{t@jFT_ z-6=;^pOB;OekMnC9@Ik3{Z9+E-A$XRH?ME04t&3r>VM)Es?Fcps5`c3XXy;$tQ{nL<>n9tdBTg~uqB zII3Z3ARZ5fr^I{(p-^N-DXfEkN}!;e7PoX}xZGVI*QSwU`5PV7zNZ~};(hMwM1= zK$Mg=gYz<5f+!EmWG4`9dJoXPpo2if{ZP=+pdjdPpnrjG20ab>4AdE!4hEeDdJ?o9 z1fWfMA5;l|wrHu;J)m&iDfs2lr~^cuN#_-1DP6TT@>6Z~uSZ(t-k zhMlnedi6@w2i-1pdd@9R{?Zm!eO#22qv|iX{YB>0q3F(zu>*r&O1`WQtQ96-!iW2( z2dDVs!ARIQB5cnQjR}V${)*8N^cg6e9kT(R*o8%q1J%H)N5m$NX|wfy>7YILCa1RzV__ zrU(6U$DH)q9@m~AAvA+@1qR>dDm5-JsfhEF{UhZy?63L)wSjW*+IXz22_=x4WK5Keo1yQa_AcHm%c5xgXJ%LoVr{= zO*}F=h! zen}nEFUm9x{hI8ttpUAWRlexP3&$T|QdHeAwCBqQ&r&aA|Cwvnb~@^ar9-XyPGr}-u1A_q=F4nQ$u6rKPCN=CbAWe5O*{~-ip1iq z>I0*GvG(roiOe(Ps=IieC08XL#ttp}W?}31JE(7NEAO>v_}D9-*vc)J@Dl<#2dU*s zG&;@7)`07!9qRkCTVJMJ4X@-WU*{cqZGO=f2mWVwJ7dw8@Evgyo-G&NXt7j;K@wXe z|I|R3jUkG0RG=DTA+P~3_rY*5RvD-$@ke7|Fp-rYk+0J$-tsN@po8k&ZRp&yemwan zdGAK#6MjN4=fIXvtmIHM)JX*@dOs%>C}n)^-ANU&42iO?dWw z>FsM1#rF?Z@ILSiY2DMnXrxMu@1&%+1I4ep`vDY%&kD0g=BTH0PkV)zbiHiZn4fmo z^Qpag0!KMp;$Qd{Q~Mi=@v|CKp)oPmBR;uR$AwoAt{7hxDvno$$gyI$>i23x9?D|1 z)7vTa){g&ui`i^-&_(A(*Sy;UrpI!WXA8(9e21OzMo0bOSO}%<6Dj%!;&}XLhfX+S zF$Of5y(ci`!bLa`oYud_T$24cwwJU$Yxh*@%l|E2OX(xrRiE15c@VC0?mNE1}ml(Vl zTvZ+NmCo>2Bc|D|QypT9#W&N=^!(RepJ_guay+wq2wwKNsN3fB>lH>_HFq7uvTofp zP>1MZcWU4CuE#4;&zG(!n|?`~Zl_=4WJ7z&dMtd0o$$1JtXE;FzD??{JhvwjXy%|f z46G}^ndGxipIQTTV2d5eU!8tjq;dZv7T3k@lkR}k&tq@ThwePxF$F-`JVY#1Y^}9|4hcw z%VALl`MFWLYI$R*-(Ca_x^-y$C!xe{*e(MLx zN8~X15}s0yV0k1Qvt#IbSdu~h5Bj5R&e>ykPTyKi@;CVso-%)+F%Sr&R>U1C+~v{l zz4Ur`_JhOTpL6_H`I3*wVe%zBwH%fHXyAB&a!SA%{&nGEc?NQHx#05ZE=O+lw&Wvn zn0yIODMxiQ5|5NeLdV+!x>0CFFPD<{)9d5W$3C4pCwd#F&MYT#n0yIODaVxZs^eqU zGu-h(YxLH=o~H6c_j7qmB*u2T9s}YJ^x5ZMO#9QWmoEI^%$J;7~wgd7}; z2@K{a0cM(;KCf+wi#Q)3?Ya1RTGA$quZLxiH>?Kq@tU>31)rx2K-4{t`Ru08D}DIn z)M@v%{$L2$ma`kQcFN>SxYpk*Me8jCXGu0Elu8qJ#I^3L)5kXYMILi}v3gCex})a( zL%yAP${wCv72do=>M&bO~Rt|Ap4Cjt8 zY-G)KOZ}nGYqD;`Ye2W7^MDKLS#XhR9BejoYJm}}(Cwx=F5)3DDbQ93P zkbD@+wMrwC<4Kre(6&5+;rRw!DD8aTPu%!4$HAD#q>tC$bnu{W?deyXA5SL!O}@p( z-|#@(H)hmOdte!}tdV#;6c~WHxSGU}-8f8xjldisM#V7H$oexN8jVEl6!iMM9P;UU zqO`0g#aPg__|SGA@QOiisP8|%rDd^H=-t3;p>|8~8Ao^aI5Fp0V;J9z#W@-rjTgk@ zfvW0wY)m*F#OfCGjLL^`kz;Rn`}b*j`!fHRYZ_1fWXH!S2Oa$!{0rY=YJaKa8R!p% zCi%;!4#Yf5g%!IF|59!%AP1e`$1JxVt2(GtE_&kKX>CSdB6{H!v@625643r+$kdvG z_Hj9nKRT0Y@(nC1K|CG53G@+I6YN9oKMfFY&fsKSa`hkq%Lvd_HrG5+F?YX6EW&N=C! z3*rYj8L@3*c?jQOCp^q&TiP!S`NLC32WsP`m6-gqZ9OCLK~VBvn$EXVvq%+^Y)UD5)8D*`|$DxkjORf zbGKg1d346V=)~gxwWA2D+CGY@_8ERm0zCfH!M{9P> zwvW`0@J)H_c4BBzNr?}C&Pox^G+_xSmq1GV1{?^EmVE8ji&_6Vf0e7Ik2>b*U+(() zmSP%tI6eqd4&hr&?ay9o8k`gi1u>vi5{OR5!UTV~Jm4FRIc`fJsH6xFkW*rq>@LOB zAyzq^m>6ql03axztY6fUwhjd^?6FyoU@JHj#J@g|K)7&E6~K3$f~d-1GiM%`s2 zl=)Ln!gpnk6FvVz^aQ6w*%j;`D34SGlDz=;xX5bAq3eP5g!MwkMe@-P+4aNDi$%4-?`1l`Uue_~^O-LJWJee>LuuQSVs)DT4^7Dl^zOw&ud#W~dY<~m~6CJ)QbDTK& zkFKt=2FFB@BD`-K4?rA=pN|9Tf$Q35Lk>M3=Al0)b^gV>oo1TvRP_7g=DK13;W3>p zXHFBo9h#K0WY`GIaa-Mdk(H}LA*m%Yo(TpN^)D@O^&9FT57RGj@-h1>%;Sa|Rvv!B z+Apx;(suMY4k~leRKE(l`IE#ASnJ?5Z8@2{I8=LyJPuBcfb4C zzIZLoa+IAo7QVwycw>eY@aZrX!~j}2ZY|E_qpEL!KN^}@3~po!mW#)HV=&-~CrM{< zu^X?;As6dw0f_qGG0RGy&-uq?)8AaMOUMtl@Tb-P_c?XPW}}~Q!bBfYhi_gYaya;p zL?UbG_)70DDdW5I5W0x(u;Iai1^A3~zZMkxk$(QgZaydN} zXQ&P1w^cK+sKlwRZauZeWOF)s^2WCra_?q$UN8EgPrL|UKK`la z%ddXpFjEfUOa9`gmctrLvjuP>E`Tp~tfWnPeeCzor*1rM%K;%%4&h7w;-lWgBmE0~ z9J(72#v4R|m{T6Uf#}NC5TaAiHQ|eoco(I7Y9Q*ESxs3;tN|o)HfA8_=db_ow!((d zSDSJQU*r>iJ>+yLQ^!?p+w^)o>x3isyZzDWcboDFU*rg@-)622A%h(}z zcP{puatL4Y7eBQeE>&1j>+mn-RR=lf3P8-q97kr@L4TWiOnv`uSMiw6mM5nP-wwsz z3ha^S^~`$R%N{FcoCc8OpWiOM9%8RQ)cUAXi%&Q8Abh5&JHd;*DrcFPb%3;P7Z+t9 z-(%nUZhY>Yx^bp_!q;WvaTER6f~G)>ePup8>Wl5!3dnQcVU4ep?@+P-*e9yTvrX0U zJ-)rWJk9y7vg?(>D6ywz{#^MddlcEZDogX#YAnZEvmOGnNx5m>4d={5@WnONy%Fuy05Ab1~=GI8I-?pHi=lc&Chc55M^DJNl1X`Ux>X zM?AK~zwj-l_UDq*DN#IaO^HNj+NJC(#6#EAJ|#u=MRo9`-Y$VWbOj*hW8#cq2efbf zj}vMR?rzE>e8$n8OCB9(4#aev_v@6tKl#rUyIgT-{+v@J56Ve*j={INSihj-+|~!z z8`WUJLPfwgJYvr#D3y;3q(1iArk&FBVIB?mW4O$tZVeviM;S)q^PL>y(B;TCosBn> zn>}A&4fKLS_3~NYba-9&3@>J%eqCKEETl@qD{VauJzjJ8OO<|>_t(}yK5k#^T?y=+ z^gkZ_+kAwiJXOtbI{JKm6~4vP{*vRj$+q4- zemx4K*KRq=wsp5p=DH&$U+~J|lZ$d+9?1QA=;&>Wf8kq9?Jp@u{~BjFJ(U=)=j!|} z-f~puv{wg~jC(r&wuc+`*}=|?Z3X*5!q-Hw4qZzyd{)02U0!SLMtBPQIeoBu1@^&{ z>o%mllQd1AW2w^4n_-T6O?LJ?tARhH26TJ2W+!*QyAvelI~uch!CLp09rAet-=6T& zL9@?0F7e{ZZs2j9yYLxDcUFz{xgSq_qoctom<8gxJWLl&oV6swtO8nm$Sc%hi^eSpKP?( z5#WWPLhh%P+^IyDV?i1@7R_p>7G3z{7rB3b{N|ocZhY?G`UT;;guqF&a#-tx9jUO{ zNj~C=zLpdu*PWcW;K@B$W@S#etg}nJxCFj_j8n_4YoFn_ST`ZEZ47^1@7GHP>YHOS z^qH=tEk0OT_ZQbdw!S0*z@Ubwwbobm^z9e3_1I7(wJm)`Y4;dqW7rHM>+I>DKm&iKcJH^qtX@~7 zzWf&X{t2Lx6%iWvGu0Qfz%~Ysv+awiw|LTk&v&rx37PsyvF(yJQ%wa-7^8RQyK zx&uw>U%9RCKTe0(j;xC`Iag#L=RYo9yz}qJ>~R#_tH`Cy7k_!+{>N;Y9)!pD@`Z0ony|mF_c+LP zUgH=Qh~X0!<$=VGTXqVmaHFS9^Dk@TxMv%Q_~HIlVv_`Csj!A)UA!NJ->dZpdfu$F}^bcB=gePyT!EI}NYj>qsE- z2|pp2bFl96$#>`M1nS_4e6_Q^^;hynJJs&(mu5cm)`92C-e|HJrTv(LYn*5aqmsHnVeZ6E2=5ce(c6F%eUE>T~HM#}x6 z;y_I_7{j;ZV!mPA-!V{85RXTLlVAj$i}ZaSd;Qbfe$-vmPSt+w>$Bp#mq%aiTrc0L z6uvGCj}!7Z_M?9Q_7_jhfrMzIXI2MdO};zT8P`fZYtEOvSntI#t{Gp#vi|yOpaGW( zZdVvMG26lXx$RVV?8^2#OdEJgH^*SJJlReQ-;^YQ6SgfNylLwj6o|{4w&cb}OfHN@ zX5c+sp81+@2N#_0u2(N0vlXC{bK0q62i+K4+q1n|c<$^6##Nm=lluYCQB2Awe2c05 zY4VlV!~zuqgMm;5KCy~_0$7a)2&tcAx_$hBTt*x+UE)*fHrreFFIXeL0f_N{cxBCYoB5EeW=gvL0v%nWbBThoj^N-@L5Wg59$i)2HF+W z9kd&0chDZ79-uuzdx5xT>)xP!Kt9mEpk5$+R$lc6^#SbvA5;&T1Ns-}0?>t^i$E8H=7Q#dE&*K%x(swV=nBx4psPR)psPXG zfUX5y2f7|KA9Mp~0q921O`wIKn?bjLZUx;2S_HZsbO-28&|=VCpu0i$fR=#n1>Fa_ zAM^m|LC`~>rJ!Y?he3~k9tAxHdK~lw=t@8>OKc@*_!b__I zp-@p}pnR&&`VUl$i$p78styq(-^L8`oxHmJkDYF`Ot33olb<5rVfY>?rI4(xD0TRk z{HrfWf8QsEuX^ReMZE_~`f}eUU&6Kf9u=q#`O96o+xAfMZ_FV7+=DAC-p+gO9Z6sE zH~A8-cvN1*qLcxS$=w`eb*nB@tBUbhyNzuV&kvGAB)WZ(ueuO7?X?o z*hL!~jNz-Z6+V0;7qe%RgQ0-cRkAK=z>QHJv7@wex~>_?Jhv{yALEK+oaW+5oUFg@ z8ZgVJxfF;CDLeXYK;-G|9!|4v18blT=}CR=beX$8v#SyT^}D2<>UhMA^3Kn;Qv=!z z%(-=S<0E~+r(^lBUnG2ssr_mFqG**hi5>G5R8-)(%(ka1Q0bU|_Ic;e|GWbj%+lMb zd1>&}@IpKFS;3IHnoADa)x?wVH7Hq!9(eMNh*t*qoJCg$5?pt_+#A!Be{{)=91r?v{Mm|vZH`RQizE`;Wb8BFT+54y)hG)O!gJ&(; zzLUCl`+HuRUDRp*?%>nqf>{5BZ!xvMq?{b$NKA*g%4Z4kW!qZ-qR&1ApJh7lif8cG zpWCPP_3hN0(OY%>*VvUu^ar1AZxHhpzQxr368W+h6Nrwi2}EaNYOfmoxB#Q+_ucEt z^!>QD2d;jxaKdS&k_GRZcW?3~JdwYZvu{`co4-{cunr`+T#J0^O zwbc)m?9fRaee?aty>dkPoGYjlIMKK8ZEo`4$QMIjW1^v4*Tw9f{&>jXX>eU_i_EvEKo_5$R7LVx+xK$yd3p^!Bmjo#|e2%fED&TNu z)}hEF{Zu)(<*NyX;)BB(i0N9#wFYvs&m(w{K2cd0j8|QE#}UkUSn-IKpI`pQZLKXS z?C1O(JnakLVJAG1E47^7di0gnl$SdV^&+I0DDSJ&%lW{QublVbn>R&GIfb7P&^hpy zGb4TK;=1(O5BQ@Ky_)L?Iv?C#J$KdlZ}q;jXpoHeP;TN=_*MeipSQee^g0xKJ%-EK zOjzS%qSrFukghp7mmJbw&E2VIyV}qGwXG?q@T~;2KW{lR)2k+~HD0UR550V~Y?~ai zU0a{)W;@rheOd$k(6&%N&AC>G4*&6n-q-&y&k@YF(`Zv1zImNtFN@>xYH21$L9E~NZyM_XUlPDwt?!Dk+IPB`V9jc__CM|1tb_`}+($Rn5R{ljK=wRqjI z>%zAZ(EbcLM+K(UU|1qKcTtD9f};|&mtJ_)7(b`?jz@(C$~QA*eep>-IMzezL`(Juro`ous_GDCJl!~~hg^ET%roDSn>byBaOv+Ib^9^BSk?=i zaN>0Q4e9SIRQ${(W%Zx`8<$y5?yJh+OL#)R#(j;f@rQ!(nZAN4Q=)+>uzzW8G#?2{ zeXE6>x*U{2Z;yH`NPi#a6sQEQ3LiY(rMr*9nTa{OGux7pBc-ydB4*Y7w=$ysU~?pwGQ9THTmD%{rK#9kQ!{bJRc--s~g)X zJzvVL<7olH)7j^*#!Q?sVa#b)a(stQ%HeB=Z*!CX&B@&qPu@3@k0j+jmP1Zm4)Z>$ zZ%Th3Hysu1T5?=$Qv0s9tYSwOI{f4v*hlH^L&uZXo#Z1qxsQ6tDRQ*wVCzy3U!;Y% z+{zBGcdlps@3+vqomzW%d-cK4Vl6-hFAsl3PEoGvyJ!CW>`v%427qw70Qw{-D;3y5gDR0rmJiM_qnr#R1Hqv~B2=4_fVbv6Mft#P7ZepK)|&4X$GW4d!*m1;Z6s zhJg8zu8u_Gy?uod>xoUb3u`lw=i4uD+;h#*%lD8x?fR9YOumF? zEKhMwIL6r^XM97KtNxbsdU~qx-gyU1dHzGmSL8DJ5}vVK!~JnA$aJJ~+tD7krkCsG z>rd&lQ_)yXMO#kfGWimoxm*#aDD5kCeJ#sCuAX;3wfRFm>RZ|J*mallM#2|)#7`kt zlGO~hcx?lS_JsDJ?6&m!+V04+zd0h>?s{HJC;Bq^b|~rxG2_O2l4Z(eV2o+#dYgB9 zdifgf8M4cbv8$&@{vw~rm++)8iTapineu5^Ye2%(n>mgm={D!<<;gfaXIt3HIfj>Y z8$bhkyVBzh@8=8Bq8i_K-~_R6T-0A( z9jG`eFtaEcuvnu?3!Dped6qyPI)*Vnb3B4!&p+^W%LAu}e?Gx!SQu}6#1=l|=q@Rb zJQI3~qw;aF^dnY6p503Fdw>4kVTC*F_Qe~_QV(CNg%4a5XvJ{-Ic?e9$@}4$v6{Gh zs|t9%x@@7|nt9iYeM{S`@rV4f=iPVpuYD9_$#hJE{RrV(Ozlq=?D2g`jzJ9#P7cJ; zm*|60o=Mg>(2pM;DX3_&j)vJgkJMUf*~8yU0}TLfrgoATC(*GS#R*T&v;KzDfL@P_ z?@88U>f9W+YCXQaS~c*ZPhaVhQ!HaTyn^*u_@-pZcbXGlyD5rPRiV!v2>E9wDzmHK zy)um)%wt;pggu|>+vabQpDj7&@eIC%H!BC`XKMKFS0E`1uhE}t>z26nQuo<`);vw; z5Y~VWd7{^XquZ+%*S)j4ef`b@4zQjIlJ-sbB8T`XMyWjbxs*-VgyM;tz zdik}!*Da@6e$4xC3xm%stLd|!$iaRGdmkoW!jpO1FEsf|XZWiJV>HTF6pDoTg0lSz zKpifSe&p;-ldy)YMkVgki+0hc=K{toix|@>ze!1>*12~CLQz6tTuxreaYYC zOSqQ5m7(=^m#qwIMQ1-m)a{%tL2^z_#yccE(>LuT>mS=lv3=s3*Xexy*o>Dw|8*K@ zz~u>iKad_@$E|u~=!%%YNFIjKLfD;zI7Q0@UZQ#O*`Krvx!UzbY2>Lrw!Ql7A3yiMNB9;~`}2^;c}_@(VqK-{r{6NSe$4i=^YQJ~pksPo)cUdNe@TB-J%gEN<+AKfa7CoUK;b$sOZ#-C8h1ZN=dcR`% zW8QiiKdHTHSNYSWmn?qm&5$F2=t=mdT$(+x`-8UCbDCAB=x|XFkZwPiZhJE^oSW?@ zmLOYgCryoJZW33f;w1vJ2OC@iX8D*Ic$J4&n3+!YeEl@A1eZzwrtb0d^Itz-HDt!+ z)5k6iEsTw0`EcHk?iYt|pC$jf77A1AGyKsCYuSL$wg1MLaGx0ZgG-8rVYmlt z|4Skry}UpBJ1x=U4>5b?;@j zU&6P!$$x7}w2vQ!Ex`Q$bbBCiG+q?L%MZ}k=%_y&lP;e`CEsb-G0q~Z<4I+vBb@r@Fm=o1O4;qcwHqD_J>OS(*pysA{bx#?cJn( z;`P)8*Q;dR@2`Od6o%fWKQc$5W=+0EUhy^3u8H;xxxkm!2NJA=1#(%N}Pn@Mq9KwjTZ&N+~Pjrmlf( zJ>1kwID3D81`TBE;h&+DvNCS!8ql9-m*e@7&!+_-KBvjJg8trT)qig2^7ReZ|DWi^ zexA!wCSSr6&$G!5Y<#8IvT%&;#5tWtGA})Rr566$v?Ki@0F5-qM9v0mlY%ct+#?(uNS&GBx1|E4(|z8<&b4xMk5%y}QQP$pl( z6XlZ-#I`i%-c5D5faSyY4we{lu+CE!**^e>s&elkIrj~Dzl_IpB8SPhLxDNGHHn>~ zLY&^Vl`+;IstJ_%p_eH3^3v^Z@oKjoxb%SY5Is=P{#SSXXj%XEs$ke@ZKmgre`rf5 z1Hq~AC13Fq`SUBowmd37i#l4Y*MBvBr?+1%#~t$-bjFRKIk2d+Vd~ zpPnc4Eji#-05QU69NlFs54YCBVh(H93?FnBv~y@cVj|z{cij3)CEt%j8_vt0a@?n~ z?v3)bfqcT(W#jQW%9nUcHs;8<0BMMPz1~ePU!OCFxB188dHb9C6aKH1&(`0FXcIXb zG&xs5PPzgR^<&ychVAyuwr_rW`hncG({h4)lP}>(JqCTwP&W1e8Gu3T_{=fYu{d5# zs4DV@D}oiU3Ip-tS)zWh!n)@>JH7ALV?HwJ3M%^#_Jdmc_cd$bzqH?^0V6wqv(=N1 z0C)}28fO>2!%lcf`Rq-gV3)X|8&;I!tv9~aj!zu%lStAZ5Ig!u+8+wj2(!3`jd+vy ze^`EW;_Ju4qpu&QibI|_J+6K%;q-;C^M21`DKFaf1;7vSTHwgZW43F0zjoEf@9#GM z++X-wrRD7V$x$X>!V~y$0S9Zm{N-%lg4i+9dNDgTDo_=fj!gqcN8_hPf zZd}vW>+|@`>y5{HP5!dmZTCCN&@4T7#J}(vM|TOioG!IXJZsyd=uEs=Rvw%jEVl$S zu&%euD-8LlGq#Bh+hZ@~lg7Nve0Sa9;G6C_`>ii|Oec21v!#ew81( z?Nh3KO^-Zd(0L0kTQ*(t5jjl0geUZ5y$#H639G-Qpn|vra^FjL|H0LtDsFU_-(djF z;RMc_b}D$)u6C32ujdbaJl1Cq$yact48DYq3ryk$5Rwu4{%KA5e5L8GgB6h?AwxOvDh)M{=L=qB7D7q>PnFkq| z%)}`Wu*HrY6$RTm?y`zy6?Jv7V_VU+V8?Y;&`%e|f_1U-o&S69%-nY~H3b6PJHIpc zzH{4o=bm%>yLT7?Z6Vd?brTQp0m_*KXA$6_=>~#x2+k!qkKlZQ3kWVGxQGCHelfu% z1eX$AMsPX76$DojEFidw;A(Vf0qo4a4!RrKX5TLSq zi{Nd7cL-J!yi4$Jg7*k8A@V-K2LvAytRYxS@Dahs1pi0y3BjiX|0P&Q@EO791nUXD zAo!BtD}t{HHV}M6fQt1yg6|1_Ao!8se*_x|ej@mp;1_~l34SB^onR9I8j2i(b_DGS zIuPI^?v4bV2yzKJ6YNN^6T!{|T?o1o72zDhvzXJzQ?@q7> z!JY(r5$sK{4?!P-eF^#!>_@Oa!2tvZ67(bJPjC>y!32j897=E)fs0@O!9apR1cM2N z5FAc$1i_I6*ibi=U>L!0f};pf_o6=(C0p(fVP6xWv}q$8P|F8>icSPpd)-Ee+>XgW zz0dvA)zrU%DIkCjc?i%Rqwbk<`8)&_$NhZs{!?dfxHT6KWDqWw{uyr~rN3gjz9$fz z>nfvNwf1@1Rn+kck(*9tqG_T?oewibG%IYzLOaFuO#Q}5Poi<^oii`~Y~8J6$~a3) z_j81bXMd*0JRVabYQp%^5WXkja57&uD0C$1kN$ew`;~V#{AcfD>;ynZ7vc-!IbF8L z8FQ-K({TTv%o^8d>Zw;&(@~SIfiCL@Ps6uPz9gdOp;tDI{qUb7rtEFU2R%Cx zJ&b2M*iK8&ASXR?Ipu!mq$g21?RDmZdGF53d&(*wOKvc4&v>STZ7!!O`Y@HI978U% zz%X%O``Crmhax~;un)UG(ZTm6+%bHYQsgDmS^tBx|Bkw-1A#ogx#pw(*Zt$w9pB*k z33d+ER*a`dhvE58-VYp~X~O|O+*@z_Jqgmqe6VVwM6}$VAq?Jw`KE@~&zqM6vL3Gc z(JA*+sdI<=GMDh{2RyTW+4=cmx4SOx)uG?5F5qEyAi#c5#+yj#FLqC8Z0qN2z9E!u zwhqzhu5}UX8+MG4tbQltCDU;r2C3*HbtULVunWQN1bqnl6M#gHn&3f# zH3aAno=9*vK@Sq*s|j!y^!Eh+C1vW_k;WO+z)zx#7E(qhQAYowjPiQXokx36e|TT& zlO9a{Ng{vYNTQ>H@~fsk!Ra(^p+QFe<1|l0d_>=lvU7~T8~&G?-xU|;3(q6t4=DZh z;ty1QGahNmW1Mn{vgvF@cNtCZc&TfEdw{Vae3Ca@GiBfu^Ne}MIlf`a z>UGTZ9DbkNU(&zN9>XuVqQ`xIJXn1n#y9DG==IE*w<&|C1cFnBG^2RTd%XC4R%Gx# z3on}SFZXcQWc7U*pZ0xd<`4^OK3DPJ=FlzI9~HmG%K>t(p3Ah9Rt4W%vG-G(PWfT* z5va7upq@cH!gv!Y{Yl@s(kyE*Oy9Ga$Df!Ng3&u*(mM7DF2#!yFdsLhp{KZAzBu>r zhZik=Zoma9J&cz~F`Ze_L6ks?x{!=Fvx! z#Kw#u-LcH;+Z91?AV^DH4nD5l{?np?6WBfLHGhkTaEcL z7}z=V&v+9l{Z-Y_jvr4&fI7+({C)%7O?PnaB=;;MQs=U-!KTCCt7lo=sHESi>;8kp z)Gg?2&Gv67z1JWD%t`G}(1QT&AIe^?hjraU3`t_rl}|RjlX;#bJB`kg15pak&$x|}C8eczW$AOJ|HtyeIb^-JGtzlX#-PWKrQJUOO zN#v*En)9yN#+CI$cB?dP4bR!W`_}MInnuk5&4ISd0bS>`-Llb?X%1)(Xbxx&Xbxx& zXbxx&Xbxx&Xbxx&Xbxx&Xbxx&Xbxx&Xbxn<0s15;wr*ZA247Uh_rvZ=?%o6qhjbB3 zhu)2CBjTWAE;;4k)35*4T4A@=*Aa{H2qPQ*eh=IFtqVNpzR=Sm^jS@LBuwXL8T46D zC^RP!^q8lol>3VU)i^Y;o)W=&ex~1Dm5;&4E_pfVz*F_km(hyWZE{N=(lpSzSI^Fl!40Rm&$C37O6*a5&hi{sAZZBQM4= z9yo2{9LS`6T8eiql}?=cZQrHKr)`&UF_9x<*U+L zr@!&KlSx9!#_Gxn{qru-<_g@xrzF6zTil>Ta ze~B(SVj>U@`;0O5Ms)-S2%9ucqRW?s;wM#NDfQ39r~?)db4yXo%-bQw5t&HkJ})2HIuKN)>|`cf+1Aq}ptalcBm zG(CNbcJDQ@*Oytn5}l6ufbIu>^yD6U;VtV`x*0E#Y&x4jw;694{WCvTosgcN9ZtTgxZfVn{r6C8 zA|V5Q4x@j@n@H&|IbEn3Vmw5<7H6MzwxG&zGu2e*aY@-W%h}d+v8~b5EavLSo0S7m z%8m8AZoISq%=^RmUPuu3<;-95Yu@|oAgd;@^c%4lk1(=HuHSa;INorF0{((7cKWni%j66l5#FS?sFPe+9@{-G0c5^=3PR)U2<-@VSQ*QfER_q3z>s$`2 z?Uv_&T0V4bnmPA@IU@A?Q3m+Vko5^?Xmh#1Mmh1FUno1)5rk6>mo4IPShzWDj?1*CZ-4Bo>)t`x!GOQ$uQ1+3N`F>= zrLx-XFTmwPW?uy}^n+c%#XBtH0{&Q^1<~bx)QU88tvWwXgzs5ne0S6yMMv9tGhK|A zNHU!%=!#66jum2;gCv=riWyEmsq=}*;KwhYdZ+xZm5*}1paM48Y8D-w;V4%{d4){GGA?IJ`OU>Wts;;8*AKkZnyXvzZ&p+zSpYaLu zr%$*&k!mA0du-+(vh!E#O*MWt&!7nPA@~oyMSaM1CET*nb)(FUwCvr2TJTq{Kl|4@*RS~80~}=V!Jc1! zfD{jW<>_e?hTOY5>kHE8Kqbz2gpm!O!oc?|7tuB!x~!}q6ru~p-TrEWuH>sEgwL2j zyGQ)79Z7vC5vF@7(ZzKC`=4L;g3eC0{dwI8XEVUGl+4KO+)%%hFOYGZ`7nPUA&NV6 z?K8D=zUcMxU9UEr>pG451E3N0F5~IZVN|}@SL;}OF+8P#8D75&dkXDXeaL2hOeT7m zAD!G!m*bsf|C$@){^zv&dp-Qs^)qgR$SWfw^A&D>W;7q~_WtUDmsC0#p9P&sNG$fwsHrf5)i|ihN8hJ4BH7GhKK(O) zD{gl3x8bWJg@^o?ZOReXe&w3I@xFY~x930hz3+_Gxsg(f!OUOAXF+$#xC(qZXT^}| zSgp{pjs}2(DOf|95Pw-&a`y84ZsLrc@4VslSqEKB*D;!g>0rE#j#(+nndqRiX+s8% zv2uK;xAAr-KU6vp-WYK3pva*+jOQ^2=x9e@CNUmiWRrr9agka{(&&y$7`0v58pgdX zMI)~b!A6=4;7d#8fwZ*Qb~vE*#hNc;U12?8d)p~#{U$BJ0aagGBF)X2hAP+UvrG&8 z02rI7wj55oH3yP$K>p5l!P0pD5dFVcf4OfbaYFI3J1dUO7uVOGx#@-59{l5+`>YfZ z4&xEVtNFzGhj7>f5&E>&m=O#_{2m@|xC*AzXr+P<|2I3Wl!#1M@e8TxY8aI-dYpgE zqSO8`>Vi*Sf;L!l=Aeu5CQ|y#kS<)dAd}Uo|0*T9)j3nuEt$SdvNV$6Gfh{A+cr25 zB|(tav$phGv0Spv^vGi}#%&Mw)>1y$hm0~)%WYdPqqa~!>39x*?t`WayRDVi)=)ku zo9(rHw)XL$tS>F0TaW{^b+BRBZi%$56!rhs%mJ-0&eGHR;^c>Za&kcHi<2K(U!45V zPfiYOOZwt`v-sFFSzije0Y8Ae7ObYDpEU=V11&YaOeT|@Pcj?vcrQq@FxxX;Egzis z*;HO{&wOmHcUQ}Y$GhqBOH_uavoQ~uX&UMB(Eg3@zsZ!hx_mZ|^lU5rHCbL{x6DQ0 z0o+fMZ8@BFYYrsifV{tZgS2k}a+PSm?cXC;)l9$ZBHEE`8A}Fp1mo3wV*3_i_mme_ zRJclN?QP$*&$}Y%4FtX6xvrw1aashsyUV8+REHyOUqv89w~oy=T(tRErgQO&&U3`E zg?Tzb!y9y#_=$ge5;Qz;+3n}&pTBZC_D{orP7nPv-b6}&ST-=SSz{Be3um7k24NHm>U&{-7-yM4)-imf8?R~a_2Dlll^K(N|0 zE9jr!qt8p}`Mv*Rf4Osq+uJWX$%=0B`y~2jyp4`oE%zR@$3FfVt|4{~E68U0*JMEd z`}JQf-}KNYzvHZa7?ek6`e(d}l>V}yKTcgEc_G@Jr4-|T1Lei^Pkq@bM~Uu-x%~b= zP3X6xoxN+F$3Qy@70<6=-N#Z2WgJgegakc?rzqeL7t$^#b4!!_J;1sQ@^{blc= z>qnfvH3r*JsCf2IlK+IDFGL?olp6jS;TnXM>8N`pJs+wj&N}a)Yw}`8f-xN`K0O^} zZn_gO#*YSyz~#~KdU`q*&kh{ae*DTtbg1}*bkqfcVWm8#+WGT$)*KHu*Bx;4*jL5@ zpU&uhlO89flM(G7=RlO4Tpui36R!`Tf9gI|#M-&=h}XIw^Us}U?}8^wX9tnyGTy?* z|6}dTnEE=pP^y-`B6Is(R%6k4J8G2?q)+DDzKLGyF`0=BrNKYwABpn*3a$p4^G8xZsJjfT%g)nYQ+I=W<(2x5=SJ8O!uKdBf?*7Egu8%BQ_zP&2 z{d=$NB932j%QJy@4(ZPR{q6WXo=diFzswGY^IBF?IxqzU;Kho5oz3$^mIpeBb3a&i zGW_aGPno}b{}qS)4-aHO%U<-)coQl8#m1$v`Fz7Yizf32yT-X^duO=A-hjU{><)&j z0!3arzh%7P@dk}*vO{$Nf5<%Rg(hs>KHoHV^(^PSe%(ju>3x2ed-f=cEZh4#nPDy1N>lQe+#4kH3zl~2l`O9Trby6_`7%ce&?EX>FK&*?-O3V_x#e4 zoG;U*;@My2Pq`mo<(rq>(}HoJ7XHA=s^^UMGJkGFZxfAS*E-=Z%^sCf2Q z`BfR2F@st^5>As{(g9vFx14mX%z&;z%TEd~d3VtO&X?&@@$8=kT@tsP=bcSnpPpY= zzwNDjXY%}ooG;U*;@Lk&*H~k2nGp_pt3xjP?)dSB+vD|5zu zUx>9&Opl7sj-Ggd$@KL9Dt&qFRPmJe(fS?BI6tOG#j}5mKT3JUnd2<5J`|DL_hO=l z+xOG&{%?Ea6}9~_URp=~XiEzS;FqXf?cD!|yBGYuKGvon9O`$*)1$-0=#|Se5Uj0? zOsn;VLTFUS1;QN4@JK~#rW2)q9(VNrCOv&!Pn|setw+c91zj*qALA`-{GW4nWlCSX zsLe#8lmY1DacK`b&v*{nwIw;whcb`JKgkcv|C|vW{(!!h?7#T?xc@oh&l&>xZ^`i_ z%OoXh$|Y>s$o?|Exo)J}T4^_zHXVQ4;(**QANWIjo(S^SaNT0_9Nn7XLL4>qhr6b} znkROd8c0B*w<{W4(7v9_pX(dOt8bXOKGWIag>{j{wT^RMzt8VZI@Nk-1HH$&{jPuYZ`1Dh za;#l3a=pX&7NgTq`!w!{Vg2U-0!&bVY5+)L-6yB1C(KVg!z6oVd{cA_aXB8RV`gUm zF;2GGohTe|iTvfTiQLKJB*Q04L*up$4#@S-N=2{L`e#jT4>7AI@A2{n55I}qMXrAs zuW}`e`p2K5`f;o)M%#5Yvnil|$gEob)NSe_4*Yq}o%@_S^O6BaSrl>o!*~lD|8FXt zO7+ud9LRh^PSAY->K?ft12+u&!5{J1#yjGf`yFrthw$tsr=u?5yyP?yhmGtHJg1F3 zRX_Lx&o+l4lxYwi1~%uRy5SE$8GvKMcs#QkHXFD(9~lpS)ep}M@Ykm8azL(s=6CFB zmRkXli}EuFC$4`OZ(-yAS?aZY5e;qBa5;uuVk8MY z`e{6W2fb^m!MkN^niD5c+(fu!G|6FQH^QSXkPZA9$NI`+V}3?>ghQPJ8@xmuu7eOR zmjHf<3x5FI7^7i64uCM-2++p^Xw!B%AnSSEj;Zy0V5hF)oQ*#WJ#fLa@xR(1+H(8N zc=b)2uIJ7cye0Kqr7@Fd$b7bj3;j<5;g-O3zUbsCu4H zIOx3Ab7DdpHuAjg(w&|CbagzDyHi(j@+0d?u6&?f@%O0A$=pPM`ANo`Na-(?o|kxh zMzZ;fC<(0GejiV1LdLl5feiy$X4&TUXjj7ROn@-(XL)BGk!{&cK~2Lrer7uvp8dBc zTb7%;e5c%ah!KF?i5*4zUUxsV`ju{CUB#F?54iK=ox*m(jU#`^4dYebWh^&kv=KK_ z%hTD7#&c@A&3Q)ovka&<(q%d0JUBdumGSJ>w&uW=n{qr`5I55wg+lHo8y`Fm~GAzRT}uf`p)?6$!?AENySg_8}+T-oNQ05ZqmCp zw|r8S1qgyak0;<(O(L8cW_x~C%crIIl`0+halMtO?}GA36@PmwFS)s&0#l3`EVH|;uHJ9M%geRtkx@$cHGYV1HWL@ zXA5ingP+`%qzWg;(eBh7Xes^S@?bl4u9h!{mB%2AV>^>{w&gHt`80uLM_m*r;Qpwx1+_}p&d()Yja zbK8j(myWkt#&W}Wm6Mj-OrR;-(Lwqs(4RtXf<}t@TYFoLntbe;WkQveSOD#4Q4Xkj z-J*#nNlY$VE^n-@u{%k$?Gino-kRsvmmZZ`uZN!BO&s3!i`{PgI_XaNA3HX8WFM`6P=Eo&wO`L!bDWoC%FCgM@6!8kwkkz+0}< zxL!lTz{}6TY16tKs3WG!^(S(Z_x5W&Xj%Rz(uZtw;65YDhJn-2<;9$6njNKR-0xg4 z!ufp^_>TTX@BM_B^6txrkyCv0K>K@-e`oZC_$~nk^;&!SXS|7&{;YmynNdqe^cA}4 zP#oGmONY#OX&(@styU56d8_9Rc2xuoU%>5g6;@W7lUtQFhGCsxT1;ul`r6Mf@cvRB znK8{?}>LnKW72m{q)$7!>&epUEitu@VSq7ybEp^E8Cn#c*|D^>pji;`bGt4 zYm<3{CSRRNCpm@!elw^%e$Ov)(vgVYhy8Zx=`*HZ--qWxKu3F`hVh&~+u8Bkq|%J4 z>M8ddxbMK}YkSLZKrNq^roxgdtG|e{$Fn8#EuGW0nVwoc;2rcC`U9hRY4Kr8{j25E z(sV#)SZ{QlnLT$iDIac=kh)qwVH~A(EPK9Z8Y7eP$uzBO!=YT!KZA{Oh8$?)k88=>x=5gVPw4QW`AvK z4kY4$JYTRz(bGip1^>9^!4dubUj7)TWsN^N2o=x%navk8o|lPI0$hJIjC0l>iRe1} z!e={0Px|vqoG;U*;@Lklx<*r7mtfL}5|QV77C)DIJvFzytMH4bmYuiDP9MIFgPq8L zKCGuQ-b6}&7JUxB(7ii>2<^|ZZsEa4ZWKP-c3H}zk(2A0RP{$HzeWjageWE+$n%TC zB%Wl$%S7djwj1-Ou(jE;97t3?xkM7`D(F=m5;%>m5;%>m5;%>m5;%>m5;%>m5;%>m5; z%>m5;%>m5;%>m5;%>m5;&4JCsfha9L$>*wMnk%1~l4*Dyu4x=-YWb+Sp}cU0ie76} zIn%u7rk0P^pXTvB)7VWZA6+(?a<}>6GASQ@???0b+|(5Ge!He}PRG+6XgUY7>8E8A zw&@hLe9X2?H)u;oUo!tp;>z4imW~`ImAkp|Q>Cr?ZO**Zyz#uH^G`&R#%T^{4rmT& z4rmT&4rmT&4rmT&4rmT&4rmT&4rmT&4rmT&4rmT&4rmT&4s72XXiMikC0a`XPCny_ zON;Nc!?PTZ-E4DsZEFs+1P9uZzR2$*%X=a>a14BJog5Bn@iW_U`r55I&=d|tNtl|l zpSvk}$#LX8dNN+iw#*G7a4)x9K3~!^?jBW5ln@Bl<3!IltDkq?i<{q1h{5EaPl;{x zp1BBdKiv7(z-bH5`2=nl+z*d`6>p;Huhi|I5pmBjMjK(HI_wSjT~$S;-mrnY$9=8| zbsl%vpfGM{Ak){pF;|tdK9uIC1pgzrnc$BErx4(MM-d!N;3DWlfVaWDz1*h&t$d$7 zaE#ZoL(FKRiBde4pZph`_dbL7*yFrl7a<-Sa@f`66tA}bwlH|}o5xvlW0gk^l?vk# zMmDMCr;)EIIF(@%DmxLrFMH60eJeTLe^9~K9>z~w#$G_#GT&Cc)L8F4m67Ud zBNUn*@tFuH8FXCj|C~g)2M9(I>`ky2L2rUx3Azw;CfJc6-v&Ix4IJ*#-PyKL=j0K< z4|O-Khf16hHNLSG?M{LFXt0?#@uhm&y>#EcIdTkn!i_LbkhII9)sXyE`_2sUj>e~H+yO!?quSI`@w32Mw`pbBg z+D!Gg(mT(r>Y^lsa(l0)2mRcifU08g9Kr4cdlH;Y03Cy&=HAq=qsTsz;5dSw1kg$7 zJ}B=`0C|^njvlp1!+~_=lO}pr-ihiX8Hf54M#jM{KbrxP{AC(0N%S^}Zmsf>dBtv- z|G+Um5o1#MB?`Z-;^g|a_Z!ZBCi(&BFZA9|h$-*BeAp_gkDq?+yCGNIo4;$sX2_vr zqrb#>8y&N(`nJrd4Fu;Fx~ppp*LY*L+vlb62@P5*0zPl`+`+DrS{lljaf<0*u5Ybc z-Rc+Z8%s64gZrl#e=SS%UP#UN*0g6nS~&A(PT7)=oJM%|&+NTM8*Y#EauivntN6{- z{6=0AroZ%I>6vewD9d(xl5EB^J#1%2S3zj5zq+zI=&cLe5gW+ne)CGA3#Nbod{En6 z_?`8@r;A^>rS^+)cp!stUFe_jCQ|yd=o)8)=LCYYTxJ(}v^(scFuv3rj*12f%lQ|- zl|KJ9XYGD(Jy@MV{;QsQW=;8F zm%OOHKjTy9ufD%)g5P5V2MvTNtZ@g0m`@2XKc>E&o*xGu)#Ye!hlARy{9t@)dK~<4 z2&_!Ux(w(z&bYSA&E*|ts(fL5YC0P6B~~%WdeiVudVXBexna`sgKJ+`>0o?Q=xAI@ zq#KkFms9lJG<2=*D*B)KkIFNS8rfI$gTz|>Kh&QwyortfS#n!B@i>zcE)*0Ah<}FR zvBE?t8RRdI!{f1A#sx|{5TLIMbwi!Z^$|I>Nx=bGe{w%eBOjE`L#GW5zIoB?6RyOB z02%Opclu|%iIn~<`6x2N)iu9N~kv&-y~y3eknV4!w9b@S&|1!#Ue7#>q^R7b1@8JYri z^y8MTclP(W9i2*(MiZCZe+=>*R$jMcpG7b3&N>b|hklG#>6&CrD+~k;m(`gMS){p4 zN(@hBIB2+Qz5W@E>;JPTAiIXObb zv;R2vZ0`(nZN*hoSWy&o*BX_PX|>)^h?ZMuh!P1-cUK!@YNy!~h$`JZC?V`IQH?5p zs(&`mTrcqW2hY}fB~C@ld1AiEShajGSF7?=^HJv5=5>#x?Bx0ZI);5(FlsqjSm%E| zJ@Puk)D6yhBhh}+wf@J~J{0Lw%&Ayq-%hA__P6IZjBsHfFw1Ms9h+WqeYJt|1+4`H zu+{ZpL|FQEab=+Rj?Zs0uJi^Gv$~WEm@ObweJ5rQv=EK16x|(eu(}OJ0 z@8J2Ak?(X9-l>oD>fh_~nGX^k<_Q9-EYsbkq|adoKK<g5eT>*r2_; z*7o`Fv_&Osm>njRRmck3Xutm&Gq|JYRo z@AnV?_al+~`|QN99}wlrcsXsjts2rb+8e5-s>wagXB7B+foij-$9okKPOX1{OJ%s9 zz;>#z+OPQ>kk=`SH#*x>wf#bFBX5qb{a^I-<2h%@33iXFc=osC+*JP2Mm2p55)4^Y z0aXNL5ntF_=QEBo{6^3n4g?E*UTVEcJk)r}^+Em5PWk0}v3`gUzf4?l+G?Wv>4T~k zUHnV#D?1`08J1thTiEzN*9V7N)L67txkIx?M~D;}n@k9~D*Q8C$JJRo%d(Z@cuuKZ z=pO)>*HAxp%Q1nsRZ~VM#5n?NCl7Lc7yUK0yog`Aijjw3?!EkyPF1SBFkWR_Ch`JV z(Q=}4u5CR>i5%{4jr=WjyAH~G+_UG5ZtjL@aKl*pAa-bkw|s@*_0KULZSVo`)NT+b0!o`3jLTe^-$=7z&pLs%K52kE_fXss@V4{Fu5aJwL9#_Sl>D z{CeMRE;~cmIrQZs<85@zDu{#w)4e{QxlgLp8w$I|%%(PxhjWhp`Z~%VhWW9M8j`{E z+)yUOUsjgjlMgZa?ngf#bI+USV>|%^JBR)mZz83?SpH+`!$Eg-n8u#9<#YUohj?N5 zJcWUXKa4!01k8u!?X6xo(}DKcL;f2N65`vRp6ooIz6`70^Xols*tp9JH=_W_z(W6$ z@g`FGi_t-27Sf}Npi%7&87_$`Y&~=p1*#(VcUAr z|C$3^h6BqfTh`}jC#ODRzdiJM*-M?o5ql4wSJxp=9K6ist$d@p+lTE&n*_5yGhTfQ zMW4-~E`4{AnL@ibcEJqNa@tR7ggO1TuIEhW)@&!Mqmtpb=6BuJXU6njezNiR>S})a zIXwrm)zfUlr>8)N*jyawLt_BwcT>K_Sd%NKq?NbBv0;NZ|vpNb9EfOlInpWw@rNciA86= zGG^f@EP2NCobhU2tfOlGy6K9ZcyQeo^j>}UZS6T({UYOKH^09rDEy%9Ho*Z|?-%Tu zTJKlvnkOFG{~6zFDt8(`%ln)9@8ztQ6YW!eer)LJPe1US zg82s+@OwA2>iMU>Lu ze&R}^3wmEbfc&^#kk_?0_f0;Uah6(rIZlU7v0y% zH+6ltZtpzt!kE%uf4@3#!QS>p1kAIbJ!3r6#kSI(@px4lpPK8tR=2j4R^QE;WLl7p zE%sU|HMhNz^@(X~3A-ujA`U}K(4f=M98ftR&qK{Wz^T{j_;hmLJhA7{OV2O7^U))g zt^L?ciuIcDYWj*^Ctd$Zq1Xurq|McHl}`Pfm;=e`AG9}3snZhYqOq;b0a?%cADmjx zM;@3be*8G}#px%V6KUuBi%A;mIpbA&TSCth4M4S?tDJ8BGwUteiBe>}PZcInJdNA3 z9B82I)$!-PgzKh|g>(JcU|qJQ%6TZIrRI-(u%?PSB$=5{9z4FNIMi7`P5s>3$C~@& z&SL$5XVx#H`m65I*B*Fv&zk!RY{GF@0mc`MSM#Z$1AMWE#Kq$V8hBY-QV3HQ36C~> z?z!~+NR-k`L_gBwaTwkOZt#uYi~V%FNK9!(Bk%vt9~hSttog6#*V){cxIEB7ocqDD zlh=?OT`_A=xBQ1X-|*Hi*jZrRX#qK5yor?l(#Z+Q3>{(VuB{_kf!WsDC&+UmlMJ6I zEaR{TLk7lcd;8^ptiKybe^GrG5Wt3p<`PV$N_6&)1OFB!{~PB-gSjii`}HC`4EIAB zZ(-yAv3_X$RFT*fRF&qjv-FKXu(pc6Wte3I>8>4$ny9`9J#0|VXKLj6#pQ>`>nEhA z&Xdg_lqdeu=c@w`YIyyLm3D^wevDW1jlEy$?;wsd!X^X4G(U#-O;}H%t!j>ud6Y>y zsluo7%Oq_bMsuJgIUw(gUOd#P$LhRT%@KLxyMIr+x92G*|5SJ7&Za1{9y4C0P0{0| z^J1zZC!7qU#J9D6h{~_F^sLrZcm_1LK5a|yxUJJ7>v#Q#)cRdKEKmG*=K)V&(QUU~ zp5E;xlQpd0j92;9Wc^Mw2}X%){Z={La?h$hbIOd@y3HKfdTe=|G5HwhIHNbc2EHxG zJvvV;3Us}&f$XdIGFH6xzYEX%hy99}Pry6@<85@zis^TPaR%MBNhca|*Sl(NogqX$ z#l$${k9|LXj1ytG!q^&P4AdzYFY`DE`#C@df7^iXBJhPbYO8z#%;{lyy$1olhrnh4 zjFWIR2i}p$KYKOViN-gCPH0%>6M1s`#x{rH=cddNa2na#QHp@~!u?sr$2!ZG`N!kP zja2?6!^d57*pd~0z`i;d(2DY9yor?lQkAbgj!d;pKBI9Z^G(V&sdF*;@cXVw^S(%= z<9pBDcg{1tKZ5+gAg>+hpYbMA`pe*bIf(o@fa83Mx{=OyG|_&VRsTFC@4xd;xtp`L z_AGT4DxUrMJcddf4;Jy!!C^RJDoD3Vo71-R?QdPcA2N7LjpICoRb!m=j2v5PokKu$ zR`>hlwJ4oS@WU&=9eUl>k>0273+=M>4RXPFrh{$s^o3G78pB^b*Hspv!v@L%v*|R1 zszBK7v+)SKloY9{`VJX|o+t6v$SD3T!OVE$tFoMGgMi3McoIr3YK`jC9PPm%j z4uWS1J|^fy^b8_!6I@U5Z-N6zD9#{QOE8fX;(da7R1poNil`k`L_ZSb(}c_|E+E2QC&JDk!mcL54xqasN@((Zm;LCBiT*_I0Jo%kao}A!;^nV$#34tw6W=XrC-%r` zFV@d%FFNLS5cBTpAYQN8LG&BlQ4AZ^NzAXw72(G_iz&rBiFdkn5zp+GC;oJCH*tSO zPhrg8Ra`M@5ApUj`-sC9?k~!w94xAK86+a_4HYl`r$9gssEEz;Fm%6)ghMeT8Zkqn zVb&e6WqdMsETVR7lN@NEx8ioFp(J(vT2YiI&OH5)H{N<{#C?6cA87Iebr|Yb#+yj# z&r!dsl`4hP`YJKYc2cz+GgM`p{YUgCWqdMsETVR7lN^xO)rXd)*4NzQ^TaM|%0J%o zyU4fS?2cZDb*CcqmGLT*9QtbZhiL0=h>l=VdPG`pRn9rvQ*LL`t|n_+Wqjk*G-g}k zfULJ0DpKq13exL42YfVm<#(su`^H9gJwAT&(O(vV$R3a7yYZp_~TXiVZ53{)8wbhU006N{;Owkdd;neI31P~El13ema&&p zGAu^}PfjgI3r@-t=YRCgebJNu{HJ~F?71Fdyh>F2&tp;Pii$2phgyf%682CfUZo?^WEc1@Qj zvj=rT#E6)e*(udjBe}|@jF~2t2K~JGIUv_l{i{>U)qHoJxZC|f!EU|xx|hq4<%;p@ z8?=~QS=E%5CzZi%>{+g-)})aqaaniKu3u@-{|!C*aqJC&VR>S_g^mAbBTunPsVb1V zGeybEda%HgS`VU^cNgdU;qm8&2hJ!}>1KSKV$0P+blX}$-w0B&+;6QgQqw!~%I;#P z)xEEM|G&W(%k2&z^O^BYq}RMiMqzGM0O#7okz@R{h^7vVWI4&5o|^tO3%ZN7Ig`H3 zd%<{CrJwPwOn;2;GTl>aQq#SH-Ya_Z_dQR0@%nl8v{X#K8Q(;@%^d|3{O;;%TwFtE z2jMcEILk4DaPmA+|Bmy9NXX*?uG=xzWH-XfVeqU?%W*)if0oTmEm!&8JhADyw|3|; z!T%3ct{AUUmSO#qiCmewpyf&BaNBy8>#5w@)bdm_D^I-m{mo~6HT(BrhzG;%1LG}h z{69l^idRY03RDHGU9jeSM&l~VOgxobaqg&-P#3{wH~Xckqf+^Cd~K)ZfLu>a4y2Z= zjrh;E|)>SLKTFYHlqfSFz^0(Re}456>(^TAmVdr*(0%JS{yfwLIn4<%!+q z<^O*2ru^~hJQ?FvYBQ84rDCcI(0!8h=}Y5EO0A!GO%Qbp`b(*du76T-r)B))b)gNR z)bdmj%oBOXRCVmsXVOYlo*1uE)dKRAu>YjxNaggFeU|H`k+W0FQ8b(o%^GC~>u3Qu9mnEZ0Z8b_AS^PZUq%vgd$Y zFU_w{El=x6-sVksea$gv4)?3_#CVm0=E@WIn6wksZz@cJKbJQjlpGF<;N-onQJGvu>#agDpB&Z#{!QMrC8K0P(PQx|m? zfvS(X{NF9ZJFE0EK2E9SY975YwmR+$i=LU9PH{$_*uU>vKVJFx9)Zbr=bHJ-_~y_V z+i#J+d2Lers?vsMZd>&}o%fVV#C;Hv_TqX+A|d1(^eh$_Ki@`XGnZ?#<7EMCAi2 zv|eofvPhI;vhqn37C4lf)~#gRX?c92^3l4}@_cS;ii;^C@4s1nsk6VijyeDy@*mi@ zqZn|{+7U~sKk7gGk&aKk_CT-Oj<<4zh40ZBZ(-yA_BlcH5uB^4hW3SfaEnzi;KRv5 zB_3bwpdeReO&}O{m4|C^3h?GXR|0(<*>D}fHvCe#;m7{$W}DOHx`*YT@vxCU!o$WK zCWn>NWE^>$;SiSTmgB%5MvjYT#OHkEwBTlgbdnj)E1AE>Z#fP$P}Z!+lP`1Xv3l;; z(yzOTp%1^8Gium(?GLp{#@ThyW5(O)m{n%f27+^474G0H_cWhTQcL$YxF!X?VZ&AF zoo6`C`I>)4Jpb=W2>G1tHAL5M7yaw<;%~Z%LkAoudf#$$k4JE@78%Z;@fJ4zpCW(h zl&{3+e1V2NNyv){<`CRTfHSuCB!NDe;8ub!2#zM5aIXf z46?83e6Myn;`Ci}L`PSSm{yb{9-NvZ`k$F2KD{wV?DII`X=3t?PVK}~gW8GwDeXk3 z1?|K)&$bhNes3q%AJtyme^z_(pMSO&t9y13`*=Hu!OwOOHy^lz_-Vlo;inXd{z4UH|I{g{H)1GtVMUmG>{Lpcq-mR z(_fbNZx#l89+!LpXOz-l`sQDgp1v{9F8T4cdk?yn^Jn^0Jo`6=zDhbVq&n;kQ1y^h zzB&Dtu<;Ji6{;@Heg&SX8co=D(KxiLfuNiM)I*a%!g1OGWDc5C{M;)*!aI%p0QH2jx!d;6cqV0A0M;% zIDzoVcp6VV?i#A3gY!nI1hDf7Fm9Vqm2Gi{u6@WUUi;+aUOVRfOd|}-z|Nr` z<85@zGB*a82bvU6*JZXTAg-#Qcg74ONEanhmn#&hrP(8n&_E8RXXK4edLRdokp(p7 zdThvHSNEToFGl!h&+2Yd9>%(2g)kVxv?u0rY-BU<={lf-@ zllifV@`t=JKj4OZ%J;(GUi!k^9==x)%{0g#RH%3pO@Ar#cbT85ksi&OL|>*E9tyvd zfceq;PpS2~{wDgK`tAd-9Xf2<9WPF{a-`v_$q&X`*!aKmyduBb=c)`$507)t_Rg@% zYFr>Z#yVVoLeMv+wvM#l{P@N^!>E8}{H(O1BnWc*fOD@lr-2+MGRg3X!fwmBW%P0^ zM>SEW97Qk8G24d?bh!DZch)?ylH{!aULy{Bt?%Lc;{0G3mLtYn*!X|*<)|V+hho{S zM&ouPkvt_U+hq7Swc6EO4$P+nSe_RA*(p!zeB=g_x7uz)KVNd!+iNg(h3QX#dYbVj zQu?d(*4FuqLN{GQKw}$^folk6jSd8A9kYRro_PH0-4>qu_9I8`X%7ewp!kpz#;Y0G^TuQ9>!=%Ai>>EA z*Cems6POcn6}y9;B6q|W4i!aw)4jAN<)MyirBNO5qiHpb+}^Js`cUQt1hCN`m`>2} z2K9kX{M(c39?ci-hPNlItsi#p54LbHeT=8z4wH&L)R{zUm~!>zHRRUXq%g zsWcgVaP+)qi=&_R3P9k=Fg=X7u<`%GiV3cS%o=M1{e};F_RYYuey>VHNA$fs@!8Qg zy;%75&wCA}Idd4MgYgzN{-2Z%oP8Ig!r32-E=|o3r2c-%eS01GXz4)Y4+A@g{uyr~ zrN5MPSUeezlHn+7KgSjW_BQ1v_Rzu(HLn&?UTF-1GS-MVDQ$ubnQc7qkbASF_`JP;5w$?l7W_2|ll%?hf);)mx)^ z3A$D%rn~aIgk7!1=E(58gPN&+ZgCDoDMju#)ZFFlH=ywbK9tJTWCyY0d(qG2=R>};IH&W{w6{H>ooyuBnry=(nqW3%LQ~SS&((w0L zZ#^(;9Cv?(HJ<6*2+t&z(wqdzFnzG%@m7ZeL7HX@mljr3#7E}EG+c7UT1vIvL%YYa z%V}zR%W*(0AKWjd%V*1#hnllmKA7*&<)d-l}pt@Arni zv?7pjo?u-DbPs;*jC*eHd*(SR-Hew=Hl10~O)-`dFdrBEJv|>Q-}q(b{m(r%?!>NE z&fwz_#7D+k*!X{PdeG&lVh$Ds1GRDHSqDJJ8BNK_^Ufn5Oi$<1+3%kI;m*|!DxHjv zQ)s!8)5$9>L>_Kk$grU0b=1{FFZfhI02|cj6ZEG`Alz^7_Zd0GC;vJ7?w#geGS3!I zGu+Pf&v=B9O>%l|nY6ZR6oe&tMSNLr#M4f?(3imYrG8*1@qZURJ$k_(@Q$Rjk3}v zGY;tT$&621DwHmtEyelF@>TC^!?-~_JAf5B=iQQ9H;`bPJ2L1WN6G|p}X@5GWldNCE@1=Ez zIkjc%p_HvGcd2Afrm&)k@#HjQcT1<&$EGiO+oxBKB>lK6fAFrmKQXgwhx^5qct_cP zD)}G3ir9a$oj=c$(PKhg z&Q|`D=@ZfcK)V^pY2skRWSf^2OaEuXfsr&(t?CozurYsa)x6oHro(CuY+oEu^#^+} zwEk>gGN9kK=^R)2m8N0{j~R%aNhtnzVl%` zJvt1pw(v*PbnvPtVt%Yl=SR$-?@GoS)dt;f%nNEVJ<&Jg;}qnRX#dPRgXRo4%(Zk4 z$49tcL=WQ~#Lz9A%(lei=Df>5iY)67^R9Q2M3aT*^;R{STK=f#l9i3_cdOiM{pSYC zg4>~~A35uNK1XQdK|*}{)03T7ujwWZdHB00dQ3d))WP^*m<;-S=DtoFZz83?vcSxM z%e=#h{_JmsCWKt0jp_Ihr1AGcQq(3pS%z88V6)tz9Z6<5p6t(Q$hhsvt?DoMfqh=Q z*9&}w49I+v`6#;)R@QNLvrXQPbnu+1k@L?q&bAOv9fxK5PFya~2b3kAVWTX8Lzys7 z*$q2US#db>)<$z+tKvXY^=GSkNr_ll?}29Bm33SSZu+A>Ksbb9H^T5U+ng5X!OsW_ zqdr?${l7JHpn`~(#}9ay7wi|}^K2JT!Sg(U?UmF@v>$=x2C~NnG6w@c_Lra4J_-D^ z(Hz*;IIx&rh{tammGK*NPCnNY?>=?Y^)uHNKlLEoFqZDnJfecPe1)iRheC4#K~I_6 zPrLSmE}BQgC-Rl_37p|7!A0UmDCDIRYB^wNh#56X|4i57kDdFYp~ukAC~cG;bozuh z$tez>f3Nr2m%ls{ZWyLZ#aq5<=qe4&@cKu)!|rMBkTJ$z9h_T-V;XU$P{cmbBuWV} zeMA4xIqv0pi_hUkp81h>r5DWUxg2g7rccFNzK!V{6`4j%s*Kdt(T#i|BF050c;OEA zP>D&GHx%|(hpKSaFN#da<+@6tFHyN3JFZ>-jsGY9%=t5YDxUqhxVT(xYO*TVx=+%V z>!EY5C|tN{$@iQu)1~6sKP6oml&d_CEk1RYYo90EnfkCSCr2!}=DydF=WQoG@bh&S z-j}=TbBhABD+f`}hVd3Q{;$$^oDrtGc}&7W=GUK;(DRf1S$C$5W zyqbsoy`8Jf?e$w1NQCH2Ksr7W4XA5;#P6rC;LH8KxpqXkovL5&tXEWe5apJq3Xh2t z@B0$x%k6=RXa9`pq0R_C5%k#+`;ZMe#=f$}L|4Nj$LHVCuHlKty05N7|3jvG;1}uX z{-9eVw{zKZkJ3?xrUBjg)C*v|jgDEB#tifHBe1Q)=MLj|PLru&!*3naX|BSSU@N9~ zy4RqS7pXHq^&_Rg?M2;J>FJt$$I0dUt{w3eXUzOm@$8?Lu0o&T_DAZhMdHec*}t=C zLmF!RfU}deelvHsye;oH?)|k>e$a0O@HrizcI>6CF?hL9(;i;P#_B@21- zXCO|F@32=Ay`ZCj0JcFeoq*4|o4-pp@t0TLI7jBve<&_w9AxIr*!$^F!VFqW1Fw=CBN#wnq~xgozE4f(>S_7n_jk`~|N93& ze$>+@i0Nd!jgDE(p|dDx7)+#Et#dN>W146v=nGjzO%n=V6=(gue z@Ag6&QT27UT#g≪g@b^2Nc!KA$zD;Fsh6b3b~;)*3MCLB^X%=`X2VK?$XDl;yks zPpRc;;M*im^QOPunlnUoGXQV#uTk3kBR$z`0D~;142F=j1Pa?UnB#=WiwmHwnJ{r@~9FXg?m5N-T-dFEKxc}Khg5BQy z4NZY*EM00RR6P4bE(&M}KG7SDgvyL?kY?d&jbk=#L=L*f8zFO(8U>c=sQ5Mger?y{ z5uKKOGtA4f!t%*@&Yx}2QB_gam;$;A!5V~HA!Rz|?~rfy0}IFt=_k^Yoe#R>sei2M zc|GT2(UT)oJo_i1V}gH{KQPB%GMd9h$pL*$Ri9dUaSW%O%Fh|HX-|pPk(-v%)*p-I z0yg;0yk~pse?$ES&E-I%cCfi=%JF4cLtBpioi>?sK$lPEyxI~Wb@^-wu4kU7yx!BN zBUWzW^KCd66UQ(v8<`_MYIn#%NVWIp<2JpK-0Z^w8W9kbMZ0d}Wtdc;>5 znO5sHw|vm)8(zASEf6#>;j*I2bS)>k&_)*!AU|%m<#CUD&A&cd{^p=xRJs^%r5gWN z=_;TNCRKq-_w4wFopOJiSaTx-V$1!^k)6`hmAB}N_xdk>au<~@#>XkLTq<1(3B~R@ zI;TXLms&}5ApHUY*l0uK^XchPe15{zr$2k5Pan8p5Dxz;-bB-1V>+m`!Zh7Tr>E57 zu19k>j*}l1xlTGTn8Z92&(|XDFV2X3KXl&B$HNW7bf|dCw=o?>bUg~Kv=&6dfm-t> z61w#Q`N-w6TA?EmKOXLM=8}i6nAex{VLDVi`={hbQP5p$Geo9iV`nEnaApn8jj10b z#5?6{ry}jQuKN1ci^?AUhR4>RV+Z02;}J$SDjm!ZQlwBA3#fKr)*p2oV!dZPMfExE z(>gAB{%ih@>G`uu?IdHu@s}N|@`v#%m1+4y2h>;7ZL{TcwV&5d^Iwzz&#&~~DLp;G zQ-ALHhkX}~QR!iP_Vm!jbrV7mX=~pbcAC+&FQ?NW(YI8gkEUlyR^s;zl2a_bXV%zF zeLtgH*Db?xt>W1~3BM`>5nA}5KyrBv-Py^XMEU>w@!`jgICj^sIDO7v#k0Sfzq!#a zM3?KJqOpa$#E-LG|1jD;H{{r#uqp$3?yp+$@qczJso?yW9u?32nbR|Ps7a6=k@XGV zt>@-B`GkHwcqQ-a-2aNH3tz0dXfE0^7|_*@{uyr~r9YLf9eLoN;WL1vDZM(np;HFEw4Ifxs;6wNa^yPdr8`4W@4m(FenPQ}1ho z-_S=qE1wwh_)SajKnC>nq<_YnNa-&%eT^xj&79M{^?aMKlYh&4I_XQauk^FW?;lir zOYjk_&A~8zjJL4y|J3x^hgdWwGjm?5G4k1eN(YZ z`ucF;q2KoFG`!P1$QBH2jFTB}BBj67`dmN<)6AVmm2=VxQEo@(@9L~?)cyS{_sSQS zKi~hj3!aGl-{1o*BKnhs^=-yWq?yjd=V<~`^G&gxMR&40i0*>%YR-i*vyv^X$MZ+PhRyXh%@x1nABLysy{}rmZc+fkfrQdJK|KR@!Vi z4kRj{mZApbtjo7~+?4Ctm4`XoXLUTVW_rGuG2+4X$4r{tYfn2{@E`3n<5g-fAxa;h z`dlYOjNn{qjcGd%Z4*66Z#H$lIx|`$ZLC-y{+;6 zw`P554SqvMw7#?kXSaUtNw~zV5Q@4*R@5mQ_I`;B!y4QTxuKY4fdboXL zyvoGn?W27X7xg@<0^^K1<>4A581IJIzSbdJw0)k_U0~Cz?$2g_*_PW5#)IBOc=pfM zUPBS&^`30vgAUNsmW{d&g72g8jRXwn=XDGdq5n2J2Us7le>y7ZFUm$;9|dvkuKB2F z?n6VrWkRj>>CTPt>>pbnr7wBR&x~9Jp;@%W+}t@G!eGJYlRiIkd{5H$RmB&~a7W`bRF?fB8q857VLI*}pLz zP6Fio`;SP^hfQZ*dDNLjpT^EB=KNKB^8D%JA{yUuS;%s+JcIl{9yjo{=riLU>S-@n+11kF>2?I9)|RLI0oB$=M#qto+a$BMEwQ?7XPd(MyPQSt2Gm>yuN1GRNN z+O=H}rh^!!(OQ0tqWKh&8BQ9l1mY<2iq}8`D7_eo@i5ecpMd!{$f>MPPoc&VY`G z=6%}x`P~oXt-tm@m(D`PC#QqH9Fz#Cm-1gWCOsdXeLwu+xqtik9zLHF<*_4C!FbM> z?Z$kdW0uKtYZxz}?&Q8Y+%RlgPtIrf$^PtSo8xF(b0Av|Yz_L7%{!&j3HU?zR6CnI zblB~e154@Exm}%H6mQoO&h!5xU*rz|`Ik43zvSZE##l8z+BM8SGhXFndGbrUNk^-89P`)4Yi{nOJ)r~O9UzS6>ql2D2H34|GS zTd8l-)icZ|wVvT;_Sd%NKq?MINnlXlWHLXNDxGZnFsIDpqHN-Ak74`JOQU>nkH8wL zXCE1{;jQXDJcmdBv@s7ge$@8Id`?4YyuCm@fbY>T5xRQ+4r2eye|U+UV#G@iKKDSu zk$L;tBQbhXFku=%4W>Qu<5GCluQeW+-`HVOa+G_gzr=$O~g`{FDdukfRP% zQjC|fHk~Q*cifyI(=oI>JsN7S_S^XBJ317*qjyK=m<9zK-H4#zmHBRT4R+Agctt;`pX zRepEYH-BAoj&(A%wJw5wJLAMquW(K@SDnC z#v@JHq~xzlt{JRYay_*s4L$u|$``$T?ce=qQ0-YNJ&c!Wfjc!lIJd`&A&b-?K07+b)YGOf+$Ly`5UrDPLau?1bsaGwHC@QF`{%nn@$8vT zIp!^KP7mX=qbq(FlgyvR3LRh}^l~G?l*{KWi2j~0X6`#?$*Om6xxgBqT6HY+lJUvt zu+Mez&Zbl2LLpa4`SEW5thwCdz?~7&$AOf{0s^itrcQM7N4?KtBx&N5_UFu=_s#li z&=-I~-4D7LZz82XmY;-l(K=k%?Q_rsy#+n;H~?o7!tl3|)|2x;N{{>=Vv@6+F}raIsa67O}G=4Gvg6PHVN;GDl+II%^+Pb7%*@Dq*D>b1cQN~ zYqT-jTWwU%@rJ8ubAXx5Qu=55mMZkow!}u~<_!%D4}?y5>9~_@BB%-yClP&&x6v^x zA${mp`Nq`K0chr}Ww@HaT>rFhIY~t4GD?x@oIKen4~f=gKRb5Mic>Ef`#BQ=I?+>B z@$8=oo$)(}K)*tz%RV8|PB2O~)4P%AMg9c@uoLlhWZ7Yt4B7ql_2g|DrdP$Ye|#liiaOe7W55DN8iws($n|xE~_*Ns#EZ`M3q6Jr{tPsOu;7W5sFj=tp?(D&6n z?svZW=$5lMf2L2xvws%!9hr{4$)}{}--P!UZya&?mG9c!B2#}o^v`&vi|s7v`$Ho7 zW1~BYKVLZo1DRcD;plAGSibonSs?i27UZk8oa1wXJuE$5x-? zK5fq>_hag&=9}j=6r>>Yfxf3r=ymqk59NLqg8$vdt5Fk{pR+&ZstANoc--fz3e=Ul zr%^|tkao?`UKvyM`cT3sH_TTqAUb6_z;F3I8fwz(&3Rw!_SUbP{&i%RFD;6Z2K0vU z7B>E$@I4BBbc;OQ%0!1>(^$nmv%_U-O-zTJ@7m}*t>(yzwK5l{KTd7jC8saD;~}(5 z=0KE~l&F3HufadIa!1>cP09wlH+eH`$YJCnrpMZpxp$pu}XoTw7tD@KMAcRMf@WJ;+VNb&Jh)r<&nH95wZayAbof*+Xy4-DCZUaKl*jZcZb-?9gG5V0jfJ8WF2>qmTK$nlok+${RTIHj@Wis7KhF9Zn zug|SjK8g6A2)DiRJ=6DYt@2UxPgXX`@M`?+^|`gmClTKh;kH-4XZqf)RX%F|$;u`f zUX8!KKI`&n+a=#x<&#J+65-l5ceXrrEm1z3gYU>=d;D%dm(P~hkyI2!$&=^HiqCV- zm#O!vt@)I`BRgiC=ab2IHO$%FN)>ZhSSMnjev0y<#1+l^Z`*!!;%}zFV7ZQqcbD!_d-rL=o@4R_ac6N7$^;RuHupPN zZioY3m3CcvKSldG%%1PVM`Omc>e?GCSuVUyi>G*Y`ZAmz-!Z=)*P5TpCE!>mAa6@E z(PH;STbJT^@o&Gr*l5(5%gT&K@&p{Gei6&@*W}XO(_QpYKVIT3b@{xa97j36%IibN zx8}N*BK6I6t$w&+O{N+j%T1Btj}o6P1Iw0NPB{X?USytJ|Ydy;$qB9AdWD%-dRO_qHjJ6#!#U26n=p@@{A;cDG192_oUY z?y7m?j&8Fx!MF*gym!EgSWf52E?}>jK3|FPF{LBTUBC~nx8enRieLWjn&Ref;3i{V z>pR1r0!#&pfMUP}xB)8T7XtLfq8Ff#&`N=6z;vJtpt@itFbkmXr)lC(`WS~kjxGo0 z0G9xl0+#`o16Kf70&{_@fUALPfNO#4fa`%9fC}J7;3nW^fWFJV6_^Ly2GG6F?Z6$t z0^m;IF5v%wy8%CN4{$GVA8zf1Uw8p0xSmTL#Ic9$AF~(eFOdk@FcJd zcnWwLcm`MwJPSMrJP*78ya=oSRsySlmw=an)xayjtH5i(>%bb|4d6}SE#Ph79pGKy zJzy>HKJWoRABcSftOGs<)&m=WPk@cUr@&{x=fEc53!oC%415V}0losh2EGBl1-1g; z0p9~Z06zlTfS-V$f$hK!;1}Rm;5T3=unYJd*bV#v{0aO8{0;mA>;d)y)TxO9Vu5-< zeV_r*5NHI%0gZtsKvSR@a0JjCXaUf-Hmv~q=Ds!11~?LE3$z2M?l}tR02~b*0~`x< z1dam|fKEVX;CSE!;6$Jc&=p7oP6AE_P66n<{%(K`=nnJ%dIG(G-asGVG@vig4@d$| z2k1qR{=k{QS-=3`Y#tBRa2{|zFdn!7m;mGfc3>iq4-^0nU=lDHCYzTCG3tR|ej{!@8$AKq+CxKQR~dEf=$MPLQ65?BSi z1iTEa23`SP1zrPQ2i5>@0B-_s0dE8E0Ph0t0c(Nxfe(NWfscT7z{kLPU<2?8uo3ta z_zd_Q*aUn5R05lUFM%zWynJS=EgGz!ATC*s@#`N}B*LW2O;JE4i3&%s8hUKF42pyIC*sIMy0i z_;Re6|C5Kh24d~lrdP)Gn{$M!7najGvJ1qoy;X_3C2hGYVxgZ!eI$-w+z~$hdh5^K zx@X6ltJL^eF2_y#f%vmrUd$`uaikWx^QU40ciU)(C-7;bEz9R9w&iFi=pj(wj(Jr? zz^hC0x6QY$&rVW#v0M)|xDD{Cq8HmR8eT8L2cuXo-O!TW7iB)}7nt=#HWCNqq0CKd z(u2B);=)-sH97T%pZ-$qgynRO?6kCFQZ-!(*csxOMsryhx49Zi`ckzV7cr0d3XcXj zMmC$>7Hz`I?{&nkSU7LY%^hz#k-C4H)Aduoiky#gg!G24$7jRS215~s$;kP#@c&wB zmvMa}UjCtJFGv#aY$@)U)N{i8xK^U?#qBB!`;Bi^`1{~M{B&Q>a*mh%K>Vq8SHW~= zfv<2lW|OxU6{XJbIcPc>D9Y_BplCE#i7n|vzK=1Q7L-f9e3DKY14jTA(r?5kRR3@pyN&t=rx&S8urvlx9 z-atQ~KadOz1gJ*I21WzpfdZfiptkiQ;7Z^o;4WYh@HFrW@FDOOunTAm{dENT07HOD zz$JhmpuRcviK+id{ksXk4Zv#PFQ6aFR2i@WXbgRw3p@d|f?}ovUjyf(%zXw-f|C9M z?nHf(1x3||qTU4-LRmLMSrt&$Jy6yfD61h9H6Dt350%vgM?#nApM3^Jt%ag~gra&K zhkKMx=o6j*J#|I@@?_i_bwgjaC;HZXptsWz?pe6EO2s|LAhb(E(Jtj6+;gF8JLJjOf!oMx14f5iuDt z;(l26IkRHKaks;NHb(5l%|$Uf^6#Ltd@eemIj9HsJRK_@*oJ-!Djr*5J@LxodSd0S zdg7Xl`r@uT>kHo>^~L=04aA*qpspOyP`vegLoqI`k*HYLNMv~9MELEt`-CKMfpClfib*316R*Jaqf(()N z?KvXrixHx1_*jvaGC_R0Vv-o}p-W_5Jzc!Ay<{B}o{yZ^m?LA`SRga3x(q0h% zYxS16sPU&_SL%{W)i#cW7jWKJsE{%EV*AHTj zSp0iT#h~M2r=mwc^2oB-Z{JuHd+g*dV(;sJRK0WW98>SzukNU~V)~YPkFM-l|B~)k z)bEnEx&FZNv<62^U(%r7>f;)I+jK$0MGX@g`KCSA=&f#p<6dg9BQCYo1C1{}V{((J z3zM2ozP>}VfBH2);*BOpHotOij~1CDCbnF6;^I~*-?wP}_`)07jJ>5>+hxsuY}fdn zcaG}RX5G=}<~8Wp=mmSiiT}5)^M$JypSY#>eTjEwt~(|Di9y}B&EDJV(k`+6-k3W| zD{|Z(CBQVezFUs^i0iw7-g(_%`l8%8PW4sN{Z#6M_ZtP+?*;4zw0Y~cv=o<|bIauZ z4?MpTML}~E2K5hEZioXOS5vms(ur806)UBBd`^4OXs2VkR&yobOy)Nh@gM)o#M^$_ z_UU`C+uHh2WQE^2PW*N+HuF>GD@*1`g%t)G!_D4rq>jWj{G5K0~U%f8+KdJ%Jz@c1T4rUHHkuHp*Cfd`T}%) zZNfOTb2`edE;N8)JFUM!;~A^aUm%wP(73^>u8p-Z(dF*?;*w2E&!4{m@0oS{WBdu% z-I(pBhx%|Bj?~6mSgr}BO{n)kt6yag3dtW8PIpv z9NH&GylAV+H8D1!dChQ_`tZQfXP@XSqK9f}rNvmZh+bIDDRfTq<>ccF89k(>@R;Y= zm&5Zs{oU>JTPNR2L&%zAo~oRW*Pf?ssNLzx@L+m43iH2IKeCQ$-QU2?LPDbIC$GfXb5Is+1C+n8?RUePdqAsd||GWkc z<^BMbNk(llg3ETeFd{vV!{NRH|Bw3reGMcai9Ehq_+D^)_0darX|}5N7x3DJCjaki z=HHP*HGk-x9&$A;`}$SUZCz{NP;QUvI<1j}M|R2gr_uH%5{(^R=cx4=rJig?#o?uu zLnpP-{5f>;!iq^Wf2_1}=*Xh^bLixS6_dFT^7D_1_s!2g=zAD?PQ&ZJFRa%}v|ey> z!^FRyY=YO-HOKG6vfK~{JYLV49%AGcdK~rwFTO#W?C{d7u=IJ6(_P@qulimK^_8gK zMD1YI9efSQ&l%TzYPJ(~-S5l>t;EO43uiB${l*G%&;k&f=p%(T6@V(bFe zmtHrV|D_4QEcPeWja<4aJ;LOc>PzzX!kYS@g4u(^_45=e4n^(!NX1d+Rpbi z6mMhPeXyL)kzJK|N7CdKUc6zZpCzX|>GSaEe)sdqKRp(cSS8)6oH=m(nNF|I?U@ls zc{xttbT5w}-q=&p);{~*8|ye+*0(C>;~cNH2)PUs2@8^ZfMsm0uuPW!`9B;0> zB*%%FH(1f-IDze}eP#Icc23&TV%O|8&vCdMuPW!`9PenS7tt0Bak>Jk)=rW2T@gY2 zkLD%)JZ(yg%^W_*ugdv2$3Mm~G2QO7bFxkPj@ukQ-ADhh^V<&|7ZW*Lj#riQagKLj z8NLOkRS}Jt<@A6d1pC#e)$dk)5mR&NBzliT^ih`dx*jtZLtAJx$aGM>d{?Ez32bv@zC6A6Qm`N4muh7uI*TrA)Is zi|m-CNk2F=73Ws~d|y%clX)IZ>ikav%JFsG+;K~27BVsS{Oly(&;iDmc{&feisf{U z>>}WShtByRs9z=PWxK+M=dsJgoNLSaH`DHH&d%Jn^W3yC0=<%>z=0f|~ z?&(;eE7k7vIXpAco!$)zi>+q`M{cn>efH0LKns+i8_QLb9UDM=AnhM%9Ua?%U zr-nF=sR&K;8gIKI&$fHeL#NPldUB-q`q;8u6H1#w*`sXfz0-U4%5d0ynATUDt`^73 z0WRN3znJZqzDXuqF2g*9>xXa7!>$)*SgUD9HK1=$n~R`|C@%N=~L%H(@Rpkc9%^XQo+P> z1^9lLSP~>e!4f<=t9v*%;W<)>n&nTOT$ zl7uA>Ejs>>?|xG<$wwU?Ito4to(+baG&7ZoHJ`(^zSx z%3Q7zcZJWVSz87#$-J&tCytkSsd7FZl2=-h!|p1@GB!lEfL7P^ZlTeP{GSzk-R ziyY^hmA3v@#2s9bKO%NE6Ldj zwG2E5U>>U6l1FAX=bSCm?k&vrI3_vEbS5&7RT1#$JM8VA|67zdf#YEws+^CT^da%c zC@m@?F079VT)_E~y*s=4LR+m0QC<62Mf!+I-5#!cPEB z01|<202SpVfEt*Az))Z`kOxc!rURD)w*U_S%Yk=*uYtY5G2na_FcF~jSTOakwk8Oz znNa{d0{jV#gwB=$o$6!V72x;=SpNhlKw>(fH8`e)b6XNK8ED zK5l}8$W9UmiJPmdA(Fw6Gtn`6Y)FUN?P zSh!>oE$RV#;Q4N4yJ`Pdc)OY2uknN@67RU)l?8>tK}BLXwk+3#(k6`E@Dg(Y!$DF4 zVB}Y+0@erA-(vN@hPw4g{0hPX>5fYo!10g zmTN+3W1*K(Ui4CPFeGZn$2hhj_&P^h;CGsxUXDrtD4%GYX)6|{;BltkZal9i#pTCF zt_LB~IIvIW5TfqjXuv9e=$0m$CkH1#)L6?Q2-Jg(T7?}KY}XsBX@7V9)3}||9QiS# zfnd2I4tVH6`P}KLwoxSo7!1rQ)n2=@r8_3sON(g4$yEO#esU=Q*@xBm$=B{r?>Zs> zy1;m#Zb#@>DRK&jTu!0ez|cx}U7S-4}?&-cS) zeIzvr&u7?`@BK7#>AWTS)oj->LY4FJs(dsaj)LKyESJ8f`8kdmSjn&&l2+x3!#>zP z^+6-)haPO6`!oIo1kUZ%n)a;%>%XjP{rJUXtLl3L^gJRGr`vfXXGYJ7YT&=4foOU8 z@8o4PCHr3kR{aASqKmd4`(O8w#Guw^lrPb|i9~bJa}GxhBxA5Z9p5<|^$;q}wXHvD zdwnQw(PIZ!0||(p??+p9433|kdwZw;l<#VPfu7+bKqC`S z+b13aqkN+GTqAL6KGXX&(R_|Xa|h;}1VqF2Xb;q*Z(j87p1nEFKbLt{{X+RP-#AX| z4J95IejI)88r$7_S`?3?XCdVDXCn0k%XMjRTkZRs8FqRJxztyHg`Be{WxMI4W~@ui z4;b?hglwNy_E;M`D>uTYbT34@$)x}^C!09GOM?P6!p4YS~z}eW&LyA zV2Y#$e`=FgR?*1MU;Led`A6|k-qAaIy8&7+9iEt%(RJsUM-51(eR4XVm@0DpD7_aB zgLJz_;#GO9d1V{r@;LI{^kO26bPQe?cMSA++#Y^wQ-4=b))$4}o&%G7xx9%J%)G6h z8~v2mH|4F=9bI}DVNkg7V9#piOD=yvBAh zm&@{b^R@b<@C+gP=k0ui;!FOk^pnT#>~}7=OT?=Ic(GjOMEh2}w6;zwjMZt&{GR@X zQ_Q^7{7gEzl^D_Hoq`5AziwM$5NHFR+6k5$;(%wx%OXEb?bU8cKUV7{QsCVibr@9d zxR~^2M#Dk+IRW}%d4Pbi!=DJ)(u$mTJJ?ewx`I6Yo`QsJWSh9;F3Wn)5I zU#>f4qTN-15AQOa1qBW?S#o3r^Jj1?vfx8{&W$;5WpsE-E?HUS_qfWQtGA>ESM2i8iAJ9^*tlPqz)Sm-Ot> zqX)ha!{w)Gds)ejih|FUz&9$I=SHL9Ew5+WTDB*MI&=UUWv z>=K4f!H^<_5>8E?2Tq-uTJJ*Pu+X0rVoGjacV7n=@ zjrjS!ZTb2J#vgjmGE!HL6FEI=Y{7CtHmA0?iQQU>uNN%7dT`eZu70Sy9s{R`<+?Pu zwMtK*y~SyML`3mhrH4ZyE|EI2eLBBBK>5M@*p0e<(10J;uzke!3~e8U-C-YHo-0|F z@Nm{mMqHF1)bC-rAr5#}_MywDYpZq2v_3}}-8gC8T)K@ypCh$&(jN2t)maCD5w;%nA>gpNFcLLWN z>~lQwF_N*J(0Nf;cN$oTpx92zPBYtydVjS6c9a=A_P#~_bxSa{iRQSTVYwj=cvf~| zaerkCS=k`8>g*^GQ8hbkH}YXCnS4CDUvmxkaS7W|`@W(3XB7I^L)Nvs{=~!-{{DpQ zr~zsNmeV=1v$UgN|17-yATZ`PHpy(~YJY1v_&5Ke;g=UzPW$X+qdsIiXSvLc_O18@ z`deYy?Yn)eJovwCBF+!Zu&Y7y_cM6)|*<7 zQ+$ucT{E>s)6+L}B|>oIQEFJO38jq{ub_QZWhL_wXNBj}>+}y!JA2B22F5fG8Xp?x zWVu8|+qL4O%L4W_Iw{NRF2Yw@bb*|2^A$c;b~WVs4vRZYj=h%0E=WH|fDg+x64J(s zk5xToB8BT^JtYnZZ%+@M*Sl?pQyT46?TO_QC2iM|mt;>WANl@hDfo~}0Vw@ecJ$?+ zUHr%Hd?x!2IsuM6dJf5QO(<=w_yp}J$VSeu%(Klrtn%xoSKs{fpS33pZEnOxJSe|d zE>X~St$0}F7be-7O3!w4F!z{ive%Sf8^DX=Ndd^WD*p?|Z~y1$_s)7!ZC6;Xk&!l* zyrldJ#iuaYtS77d@_+X2-s?AJ%zuCg!;we%#d1w3ZLIhN^Gju8E@vXe%*QIKN{j8)H9#Zp- zmo~q?+|)m2Znaf8~n2kB#mPf#6 z*%x=NUN&a=;8Tq_iBD7TVYx&_+qL4O%L4T^jLGK=%x7l=AlC!gX=XiH+0!E@-%$8L z?9~^m&&yaI39oAG$wW@Jr%Ldm^rryiTiMfz3py{F+V1_SYQ4?!h1I7y z+0z9>i)Mqo6oB+$WnWo69~tO>a^-NE z%ZwbI*BV=vYeH#bm7hWTs*aWUIcoW!@VpjJe);Ltx1TsV&WM|MH3Tn~OO&)-D_)A7 z>2D^`T*P)yf!0^RoWza-{VcvGU5e27zNSZ}nWvTAU73}+t>Dzgmo_#C5l>n_i{*wm z;92psvb%`LB2;<&a|8HN{3!tWR`pxun#SX|$1Z(TwL_NUGLy69E7{?`@GQ?V>($CG z(|abDe3!DUQKn*-EH{zFA1j_gyNr~jx&P5}aCn{%^&P(9#)&WY;Bi3GJJ~7ABjKrY z545jZAsUpXUn#d=eua;fJ(l0NX8i4Mb@*5=H*w&@@<{kt*&~yZ?>iFD32$#xVhWRo z&b@r2YHuu$h>v7%Ry>x12RXKTD|hB(>z-hD)yt%=1EgX#9%hK_>d1B_GLNtawy{2f0x8 zGUAPMj{9+e*EUPB7nbX>2e(!{g7(5J%=S_;EIf}BXZCNrWUluJgNBwrvDmUa$Uxt- z;-Sj|^^5*jf1T6RkBJ*@=3`|qzZPG6+scW@w2;RaslH=*Bz&yw#Y75$$aXv*yvPnX zzpUD|Yv;T&XIZbKSE}_4%Om0?*-a=uiP>g7S=Bd9|E!!@Fg~N>wTk_)JQ6-Z`%&4L z^|L$zK5xzWwsLs?6Bf$%TaBPqmPf)zXA!WYtn9S3Lc7c5pb=rYKb$?ntRE{ox}&to z2g!flmZ#A{O7IG2M{l~H9{%?o^=7KPSRN5C$&NztDH&aPVt)91hq-^dT;XSBS6@!K>58{kzTu+xxX2MdTF-&yno!#4Tx?|2{GyP} z%C16^M0kFH?;FPEhPShg=iGPX^_Ty#Q?)aeOBA(TOP-RQ)r8+}@FU0dsg>P*{NO|$}Q?RB+C^#mVB)2j!DV=C_ng6dO82B z+QWH{FS}f_e$EorzE~a+AIZL~cqEQ7>&42B9$wV0TSdkftB*7aB=J5H>{%WOkDwhf z3v+w3O5tIZKP`4Fj$QPlcahqUVtFJytnz1c5>{dfj3SurID2gPd^)-Jv^$C>_MfBL z4a+0qCFN5nK9%4@j_t-Ozy8nFaoQWN=Du)(l3y&3gikQPR5s@CVG75E=d?h}}vZN=*U4U8hbw@s}d&2Tacv#twMg|wl z<-7dc@OJZb*W1pVeOI3xSub>-#PW#vNOohzBksKL`EyCZb!V1dJm9q?#a>t*36G$? zFbi|}_D8_uF~`FXOz+luM=K+P$fNdv<&p4E?L;crxgLA|RJ=AU{0NBK`Q-D>`mwT` z%k43rf1d2!!13$!VuUK^<5umIrQKMOLm+ZLd;|DVd?^6=R_%ms&!$gOI^K^cRLFc-pSzJ9yezODHF z@cD23Jb#y6BY$UiBKWdgqN?pi!gokoc37fvJMEunu3u3sgagP<7Q#2~j6W&j5s3?r zI=A)oE9Li-==*Gz(>byWtRt60a}>BHLy@$qsEyX2^3BL~mP{Ci&q9Oi9CG=S!=Qcn zIjDN9Hvi@HC+3^ePh(5;euy8>E}Ffuu`k85x%;<2d@yOlZ|Zm<%jq211=3F$Hqcd| zPiavl`KJETQt%*`0+8L7|I}BTLt^RP7;)=QwrO(u$1YAUROX~!bID+$B-7;$aSgH^GASBn5JZ{2q5#Ojgcp8xHc{lQp zTna$>LhUM*>D|b*U;bFBJ>oqkTYU1x-xus$WPCtE=beSKS&qLZH`G1FjYSs=a^2Vr zK`ZadpE1fCnA>A0zJ}M%m-}r!3e7y!{!zuGRwDVDHh2GBwDZai33_zY{ic2h%XMjR z%YBX{ zmB%|Me$I2sf7!m|eH=Qdj<^u#Ly1#eD8y9%DfXk@|HRF0C7zl1=#PIcj!UFGBu9Bi z^$yE5p|nXU^|>cGi;8T+N{c5tJi{lY<7NkMc%i$Pfn_J$9;2R-d6Z8z+p)@H;Z?0f zquxtCdSi1Fe!Ldo!E%X$wp)cq29_&!Xf)iO;tWi(;nh~+kn7=9#bzGjzRj(uJ!oHq z`Mg{m7Er)LdcC#uy*)4AbNuYoD)4G}TP73wOsP7pMv;~d^Isu754**l*hzx*M1D*_A z1Yqe%@eJ@e&=d(u1Fi%<0nS8*F9R}A7PU3yv>C`PzszFYz(W*t28A zC6~mAw?B*#w!X0&JXp(_bciP*NO(>v0odCKb>*nA6pYKD5sg&{C#uL zw0XQp*m$IP(9=QO6`LShtmq* zXzO~BHKIYx%8WB(`n`2=O#Pwn#hmwIkJwKhc`$a}DS7$5TaO?DO#A)WQokrer(qmIzHwaRm zrNWL`ZioY(#c)Bced0*RG^ZC6-07pOHoEu9b*B}%y^dbSm9iZ#Rd}iWWV&R^iz~-B z_@d+9kXg>xmCNKWBM>h_Mq1A1tRHASCly8v&n`%%l7-e-yt5RkG%Y4}I6c zazh;ObUs-a1*B$-bVRc#(gcOpDw6r+dBf|cVOFQletP%%w_h@1BtA4=!twwSV<$pB z0Ts!7wnxCH_khnA?$|W;4m5F^BR*t5EH}gf&)`EXw-+z8V+zXQ6TJ=(#&@x6p&~!7 zqk)r>E(L8CsCEpU^`wM%=b7;^d;|2^bC!a zBOvD2vNSxupT~5s*J^tAzxn=x_|bbtEN5Qq>-@CIuT0T%8I${kNz+5eKOg*-eR#sI z`Jesomd}g`s6CA6^6H zIECx8$}o09p*`$-=k>$|e{Nk%f8Z!T=(#e>HKDZ8?L?n6(W*j|+n%WLu;rVp==%VgIOS!dgGc(I=fo_x=9A)b7Go^dltD5J^Lsp7 zuMMx4lvyPY-FN+^&%AQE9wX`JSlr35+?vN|r?=Ezq_0t`&ERcf#BCs5>qo-m_J`8R zd7y?J{eR#!pym(XZyZP_WDitNkZq7-U;lS_Z`J&%i8e@&tXI-8{g3LlCK?QXu9`oj z-)Q|7UT+8L3^jkk#mnU*nup;uRX4|Lnm-gP=TW2#YI=U8;T{g>Wg?Ms|Bc^=q4LqE z1`1H~`EopWv2xM8veL@_m#O)Dwh?7b>p?Z2DHzUE_V<5kqA^sb0X2U(PuQ>Sx~TlX zXh6-MU^Nv@4ZkUB9{CdAX(KycUw^Dn_&j7I- zaB4o&y9-p;*0jD21Q^|^Qw^y3a|c3?mccqzajgQ2LuSbRQVQ&a1DrtzW2{V7T2v3Z zM*Q%|9%%i!gqzLd-d5`y+HYL(aQ)}6FPG;(qWP~_uId@@2@OiKX%8i|B@A;5Jq~+; zEu$2#2xicCWX_om8$NN!a^=%Yr7oYn2ro-dE-kWqw4fGB{Ng?c&u_)N>1)0l=;)~O zV|g9&!@L3fMxPK#XvoxZrN*WH=Qc|&e*E46wTtBF7@wyJ>R?0VkHVGXJrv4h9V9Ip z#J@}fYQL{gu}e-)r04lz)N(m|5e15ETef!&H|if)4XF9E5}86D+E9H*puD2FqN&cK z|LkKo>JESgtolWv$_=&1JhpiN=pC>qR68ZRBwHk1kk9*8x{+nPulfkWvRZ~=O=8yGR`%g;mJMuTT`!AM%Z^+SlM9(|bPNVh6p=Hx*{v2p_(Rw7b#?}03C!HQ` zCnaSZq}^!#93;g@7_FK=^!fnxUCD9zVW01ldF+YKk^8xP9{Y4W>T0I}HGk;)UB2&? z^NDpX`@CN}2GOfSX+X^%8k?YULb{ishQY^FdGvqXYCz4OX#b#Y^;_G}s>`2f-Bnx7 z*3I>5{&4?5&L7&Rwusv!tNsBWldr2AhKF}3OObr}c?Q4!$>Rw8pY>1LqC7ZQ`C!GD zIMNugY(w~aNI2F0qwU8bku3od(fkRh;*i`?^M~6HBFl9U`_cQ$1D}Oz{zUID4}2bk zic!s<=>26VZ5{YyYW_s~2M0b6Ld95J{&1TU>e}eB{jUKvf4F}j=MU}6_Xg4X%l)4( z9D~*U8Xb$?U$Ta3=SSaz(Di4f2RhO^LiNhy8+?hCjE^0vzFHq9;{8JpdiR^s z)D2)Kr%|pK`M6wbs)3*e)N;f92P!Kvf>&7Y zMN+oZbL9W>zEuo#T&+i~u2E&`f2**gvZw}XssXj!@b_PAZ>mq>v&0EM{A$al_yAP{@d2Cr;{VV*;QrBdBZ0{;?cpRQ=k2~Mt_1dzA>j(AAOzWHE zeHfZo5{`eox-zD1Me4Zix^%&OqSU@dH#3(fkHI zJ_*gAuDjLWp!f219cIx!Io7Kx*N@gfufgRLq*Q<(NXzx4{CtVx&=#TN$fEuM*MOQo zbwz+|mC7{3%6982uK#j4YCS;ZPqz0lA%A zgZiBEAq60x`jnJE6-Q!Dqu$+a!mhZze2~9;O59bnPwuMY^sOq_4r0UAG*$w#>9fYu zIxa((V39UsO;!P}s{pv2@qeMW8qCXoMU1wt=-i;kJQ@Larb_0&fwAHb|Ny<)5&Q&gr{{4?=Ky4pr{wS-y zmmkJ*sFy1$1M+?He%HChdHk9uzsvsU zN1FH$j>aw8Vasw&C~df2w`CP$$#Ji3I2KFA%I~ylbGEb0QRFqwm3hQ{6`seXbH-o! z+v4(bRURytC}_JOc%<1&N&;+Dy^*cOtAXMFq1gU}tLN3@>VJ!5TDCz}=S5{v4TREw z+^7SJZ!Gxf&Oj@8EjyETMrF z8}%ZGyV6QZxfjXTN7CMLIU%3GeJ~D#e3r}S%EzPo`=$ZeZpyZXwwn#GtKvPE^k3gM z{YHlo9or4dRTgX|q3mYTq^gEfo!zhRC zRh`tue+rw!XMbP9mBW#*=P;`~E}t9SKlC&pk3&@|<(i(6Pzx~^V_=!}nX zA%5*$o45~8-|5!F*SajHb7ZHl?>N*^?Dot^v*R|!mgaGLz3J}!QkuP46BUefc-^Ha z*S&@5`BB+6b3M}$0n>2Yn%~f8m_8j_A&&a6b>lI+XLP=r{=gBRcG$996H1#gj)`fQ zhS`>*Eo-Aqnxq4l@Q z!2hq&t1gWDsg+pp^OFiP@=QQp)(um%=fr+9Qkfn z0Z4k>1*Q28ONDj$BX=k^T2LeMUXJk>GT>B=fDDa!EJiygUWom~Z* zj7CH>83L&UX#DrQ&fmYlVUh|cKI#MTGe^=HwFh)xM00vl3fcn404D%8pg%AKmgZ)&N8{&Xx zQ7(dSS_L0~M^siQP^*4YATo;`wj1{O6!kyLqkio);K$``Pc8onZBG=_t#5qVXVI{) z9rS(zIm(wfY+0@erHzF>jZDditgfYC76Qy~c?A4E`+nQTFJ8R+F_j<7C2HEP1;4>L z`(WpC`?>X>(0a`LyOlU~=zs|qetFEEi%-=VQTsvd70V;wS+#x2bt5^&P9H9=X}MG5 ztIPjfcG<7Xu>Y-L`9YlRdhVXk_Cjeq`kdmQ%7zbaLH!DHWH0rwWw|DlHWqeWy}j7* z)@?zNBg<7%>eH6y@|yZztBfbQDF~nPP;F-t_O=o|?>RfJQ~S@?ql=+Awr7^>(%`mc z{PY4zL&9}w*H-puB@42S?uFBUA1AO~i+cJfVhUuWSJiIvV&cVHpNxEW-H|t)_`RWc zwi}k?GLx&B-Q@UY6gftf;3k8gZ`Gy!n26yI+YbBc@#z2X8t~&3wx8q%q3y>H`}+2g z`<6~#aokP(+?(x(6R^Nr($==j9FK#mv$lyY^VLd(0mO z5w>%dGe7og#xvXFD8V2HI*$9pzR9MecFj3cJKvAXxqi%R654K7!LAzLn|J2OKmNBV z!HAaahUJDh;ML4-_-s5((>jmdeX^gZeFW6M-*@EqJmxnGZ9ltVU-SR>$(%7i%&6F6 z6kxU=maBx>BBXKE5ceI~dZmLv_D8+L+_>&xpXE_Mat-)#D%U$3nuoTVq$A?Ri92_! zd0<}umcJWOu-&j+jk#ua!)H6Nv;W3BqVcA#m?See0;$l zm-_}AQL_E8TxG%*5m~*X_r=h=cX*5!>T6s7L~TXQk-Gga_v`aohqj+purJ@qt) z@SMacopc^-KP*?-)y#eZj|I`T`S7IBXZQFV1r%m&?MUUdFaPCsPTt>_u>Nb;$ab{w z$k28a*Ct*Z`~K2VcfAnv`^`OdP4IhOELZhoVMkWa&#Lbe837(lJ5p_i|Ff^A`EdNd z9Es-kOtcSeM|o}I#rWBakJ$b6FI(aaWw9NxT-9N%?Z{$GpW>*_t|)J*j*Pm4s{#4> zes+h@cC{3C*YuHH@8`aDUc+;Y!pU~Uay2!zx2xc@7z(>Ods5>K^`Gk%_T_V}Wb*Oo zerOHI_T)b%v^|NV}Pv&Pf`^%o#hN5<)=3veK z%l)W@$Az{h3i;N1&Ud5=wq7YPXuo%DOV zdm5)12E*lm<;<7;+Vc)R)1ffyvK+9@a~WXHQGeexAeV#e6GGe5($4Xs`Has7Pc8pS zoMJ@D_QZ0PN$u^4LkK?Wp*U)4S8OwELn_bc|GL$HJl-+COK7{=4ZCYSWKE0sr|+mg zMQN{DuCimRkj7nWHr|0R^ytBJP3=hKQQd#GH##1*x$3kOUM|;9+Y>|EQFhmOv9Oi< ztr_JVe5r=gxqf1~8e{G4h(icI6QVfk(yrKkWSdgc5&d5?4aohdDi4&%=vB_efS4Q`s{=)%Qd02v9K@tUMB4GBDtSe838YGUYDnq<#tLS zdnZS{>e1GaYeH#LV_wxge?XY5zw++k_4io+_pco_c0=q|gA4I&1D-6GC~CVk=c$Zm zBNXPB&?7v*H_AN|Zm)Rl(F7s}N8XXxvRo5No0{`e#zzqr^IH`GzjarRd-UoVbCzr{ zII#X$E>Y8VYtGL+-X_~&VbAdTd;PkvFSzz-@iz0&)fgjGIUlb%KkM-uKLTVu#`Ox% z^OOcx;P&eJ?zBkOT#1pF4=w&ads6F-Pcyn!=QH+(@KyTeibCSc2QO(<Z z>KC5xrBA=mrPc7&{k9s!DF3OwX1O5_c>B)R+-}P}D|4i_FLvTHz~Y6uX3ccn7FR=SGE0SxkORh-FKemc3ig8q|?Lmy!75D?`!wy z_T|h+S1a;ek@N9==V{%Z%X+PhfN$>hPr6oQd^}!l&sokq+241*=5}4yYsDGi^?F6# zg=q*TzO$Tpvd^(f^?zjb zsWEOW>$5Tfe(OfO_w$cg71yinJj@1s9(q&xEhe_ zljQVx?H%eAP@;UIDueFZcRtu5ZOT0--C|6D z%l#>q%N%Img2zBtfgXLXJ0;)eoTkkX$=CUzV6vaO>R)lVR=%E><|9@z^BITtKR=Ss zDXERi57YskG-GH0*`yOPU9b<*GImB~#OQ zIRBUHn~E^@LwfrDrOg-pb?haL(~bT)>9-wPF_x>kw6GuQZ&hnA^7De2AJrzwh>G%{IZ8Ck4ROG;up6p>tJsO$4$O~$ z$Mx;fPdvLcW|zu?CN7LhGf+$arzXH7B%v;qBo!w(YJ*$n`DD zBjAI&-=IO0k(W-yAY+g<&qrQY*R?%a*?^TyO_$aGeZ9^qtbeP_58`Z3 ztHRh5rLohmZ63UA!V$mc7|J7$o^!LD&XJvkJsJJu@O2S|vk+i@g=0e7JDtDdxsF?h zUEk|cl^@IL9NAg$lk4q>?Of)$bX;hjEyu=-zrMb>|FRa}{Cx8HIvcLfSuS&=eG8tJ zRd}u&&xgIV;vKDn5xnX^*6%9!Nd9wKWIvK?{)^|VL892+%gzmLN0k0K{pR+*{dw;{ zeGJ8s9nmNw%jq211uY^_zt`N3Z2Bd+?vajshjSV|kuGt2oj$jR%}lICq@0ee=Z8*5 z=6UgAU7z#6xoN@=w>%-GgT`%GE~kO^gHhHd9R`0IACwbd%)pfHu}|lC>$)A|aLK16 zAMSQ9>tkQ`SK%VIx6BEl?QP-sc=7o;i*7vfrPun7QO1>7u5t)kNNwy*o7juY3Kllq zUZVZgW7?ngrKW}dv(2&3@~B@`1FIln`-;m8ZC`Zt-PfG)&+?w94>G#l+OxZ+*s`3? zkzF0x7aNssU+BGX9CCeJHZe5+4M^XXVcYL@EPDH%6~pxqxPQWO4wwD9;}6o|Ix&d! zV3Ze5YjwU{j^zF7&i^mVS0Qm+UN#hjwzs7Gc;UP&?;6L4L*G2rc;LwQsVrA@Wnpht z_o+4S+ZYiYiuOg+*sjRueS`90u@g{ zaz5|tzT96}I3=|G#W~}}u9@}U9r4!UMrwbW;)AL(P(AHD3`UVgpdE63^D zA^mkm50mA(G`O`WPc*K-&;4yv`FDrsyR>;_R$PxE^KLXK5np=yljT9C`d*#!jj;bF zrzf){e0n-QKJomAmN$8Lvy>kC&XMK&FFld<*D64O?P-IOo~`Ii_rme=p+elZCQDoQ z`O=OfpE!TySYB=cDItgN_Y}D%#wG`Y$9VhKmQ!f=I12dRa2LP8Y8zHsoO5B(K##|* zEwLc;DZDWJd$oVQ`oe(r=l_p}*EPp{R5>4K2G#P(w0mVf^7EgTp74C!Uw(6J@-dGT za(v83mGkkie2|T9ye2&(!{aW_ayfk&c4twk$B}{;l#5G@#RL$TAK-jk8Uau5=8}om z4^7Kw9?Vmf^YMszYA=~jRq2`DQ%>@l%T3F!x}CL5#2V$!i*BPhhhKHf{BINQ|C{4y zeyW_0XSoU-WsZXMRD2TQ@;S|K@9x#TjPUReALTUwFB?n(8yr+e|fd%E3cx8>TsQ%96KN|ANU z4d<5woNt*vGatH_tq=H*5~Am0w9oEmZ zct({m_Em_3`LBt9|B>UbKDJ?lN0u4W4ruw=6kC=PXW7*uf6M-)+@8#z7GD4NjvX<( zZL_%*Key9alKyF)AePJAX}@myhwncwN1U7=+0(pHR zUo1ZW>9DNFWIHRI6+Ru)9&J~cdEO0O)Ow8N2PPfi>$7qYVLO|9QRsASMY`t>F1mGh zTF;Z3uGUk)&(~NULAr9?K6{bzH2RQy9;T*&>Iib|>;Ddq?R+GY?PJyK(DspVG1ggK z{bkf_P-Ff3QKX3>6IJr6V4429uG@WksteE+6$j`Tm34RVL0-ONS0 z*={n+L)#7M$dP|}`~$1c9=|-9{^>e95t?JUE)8xi?1sj1s@REqKeQnN9(k$To*6%8 z#w{ujmIoQ=dlo$8{#r;rahHbHOW~Y&am#U|pBBZxje6CHn9CE(!}76ZmE`9ZdK~rw zoA#1huCo}g(c?qu61y+Iu+GZS;cV+_9@OQ3*?yBQ4{a~=VNWq1A3w6G$Q=H&VlOOL zxmB@W$zIq<=zU2HKX@FT+Sj{sU0B_|$}##sat+Asb;*^X?PV?O>4~G~G@O3*oD0-> zpINTP9Lin-GZJYP4UGk1Y{&?pF57F_Zd87u{>#_N`=PEmT#m_hGxwU%b`v)@UR*e7 z^wLI;-ZSL9<8=*jyTo!;Z=via*x{?vT-I6pr1GKvHL(HtTzTIr+`~zhjKo&g4=03{Epoc1+OkWFOLE;)9WLig%%OuGYL#+NwnWbgI3M|X)sN<(s*(NkUoE%M z{MkQx-q%po{0SEhmmArqeZBk!ujb=HNpx>tG!V_7ebL&1yQZf3qcWp*ipmQ4R5x0c z8!H)3jk*Xl5Y3+mlyneJscrsn+2QgdCxy!m`|`2qeqKOY3*K|I0ZS|9le;X^!rd=#EL1YhrBl`>qsMexchlu*gx2nHRF~UYW;^ znI_$?T=-M*E>&8QGk@w3cfR(9**Mz}yQ{#PZ!ZCXHQgs}*rw&hagqy9INp^7!Tsv?XEs%T&-By2xh|1Y%tWZo4o zrtVnKci7e~&#U&say5cl*^ey)Q|C_hxJ!fIPe<)Z)$pP9Uw*z`or_FZ+@rv z)6M;hIbMCdw~0{Ye0-3{UQ&ojylpwfZnv+{Qs%WV0$%ODIjQ5k%gSEkc$t?f=i?FZ>SM)Ae$S!g{?PjBaZkJ$d&_0t-4b`h zV!VQ_IpRg_3Cj&}z_a2t*zTIDDk&K^nN%;S@54}iPi+=~_bG7tA9Ya;L^YsmK(1dh z7ltm!aSz0cUza|0&VZTu$z6>O6_;a{t9rF6$Hsa9=^l4UiK9S!Xzq=)T&v+*{pT`H z6d81$LD}k(eU{ZG%y8Gr-1nJa^uohZ19G`eSRA@sSEAhiwWD3LF>iDo*4r>jF4rtq zl^AKcRyz;XwbyF+R{!Pl!eu<%c~-|+CWpuS?DIL{eCAQp>%xT_Js#D7l?LQ;y*y00 zrt9xL{fYsvG)lvlzPjW40aeb&t;)64eM*kw!cqqYpN!iS)BRKSlF;=H#Wj47>#R;+ zw0?)HSDMHv)}Xnu$tp#UaFjrN5E^C!%;BO?!~a2 z1w)x%#iQZ%mN4SFhm#r~wUy&%eyW_0N6Jt8Y}A6Ee4jV=iO~GoKNc^(zWl`#>isxw zg?gXIa^}Up6~DlJo|Ku@wHs9LQXNd-eF~fFW!jIrs0I#q4an_AkEcVI{&!F>Yzph<*K$KE!S$-p}O{34d3d&Twb`0hda;eILqYlc%OYf zC!EhbYIO~JZ{~+6Wm5% z^zI!!Utzf+4tSB4>)!Iy{NRKAz+);7FsYj7Fnm0ee;~`${*G&ZhaXCh(PRHU4fsKs z$0sUQgf8clx|UbWyW--H*9D$CQ#q$MZB@A@#>T3gR~gRIW}e$ejMLYM1RDEG;W-j7|h&{+>t>uHYq z?bHuqxgidCR^{4y+=AaIa(j$vC4vH}wC`&_$f~?s$pXZqJ5de%hcw_vTDYGv|Mk%2 zoRU5Ah?scC#?>#-J~{pVJhqBlKN?{_$g)K1A;|Sm<{C3UtA5aqjoo&>ICn5lcOKxU z%4@){52irnWzRxYL0XW0Y+0WPZ=3n5{h_T$&u4qz{c1t%?|;xdspPocWVtR4ZmsG~ zy+0Hg$w=x+s{f*OU{L4Ly{HD3Lj_!}+pjg3YqcKQfO7w7&Z^&beEQJ~9SqfRxn{Yl zQLA!o)gQ8`jE3Qb>S+#4OkCpd_-06bB8sD~#)B!WXq`Y>h`Pf`1AZiy%l&et+^g+5 z>E)8V-`|;Z?{lMRpB(p(RJndM!v0Z+5-#_T3f~W1FHxLVT>a;!(eqMX;`o`LD(B-? z^^!7V2V5{6ZZImFDQN!&d_pNIIA6rD4i7X$hb3S3Y~8t%Nnk&!bd1AGa#kN{tefEEN4FKTk)#$JdDZUqEPi6)dPC}k3*08Q4K^jKpK$mQ?_poU5=Nd zoR{BzQ|`mxzj{x(p*}9hEH}gf&#D}U?Z-$ny>mdJ$~T`AiGL{f3Bqv;cRZ5xN6$ID zG$8jM=6)Hve3NF5Sor0P?^>PeVJ&h0L6!4ytMXl?KVwmz{Rn{jS&3WBysY{)NtgUx zeBs0$Ro+Wder|gWxehG#>`Lc->d@vafM?memQD=Ked0ua^}UpmENlKZ&Xsa zI8;3t?dPy|qkdEaW)1l9m+PDP-E}ZwGDL? zI7^Fd!+nKV07UMGC2tMQZ}+U$qH~Yo#a*7 zkn+{bJq?92PnHK6>U%ZhX>@sMMPpO8@0WS$=w6rYLggL(Uo#E(aXQx<$v>Lyh}!yQ zK;|(*EbHIwo3*gBXBPeC?A7*I|0W{?zJ{;W8-^UGn;gH*LKO$E24owOmY$2Hh%o`9 zy{O1N9iMkQ>|VF)oNQ;AqsZIKmg$^an4X)BlzKYLE&uBRIjk!_MbSgyuz)i1KTU$l4_r+))qhwlZb+^YLu zo3d7$YpdfEl}9yDR~nG-gVreJy#SF=ndk4sD9()~7r%MyXL;YzJ~@5dHMWXeKN{hC z0Tv}&?k|<>2we|RTtB)}zx=FX%2(|{iZLGE|e zCjAGaOdX6kYonu@UR#a}xZW-N-F!c7wZ7KX%|z=fj@xiC$HVP|D(Bly`>(<5XUq}Q7_2r(k?kJ^4VV4mygNEReAKkSp%|NZ1~e`m!dRY zP#*4vy`yg}KcU=(gloaPtlQ0gVB=uWbn&3E=itoCwgITPXm&^yvX^1Bh2+1T+D7 zA1FkCJrLmOF!0+D;A8~&4g&lW0d{XC#7k|3=-g3=Z@UVyzK;-p3>0F~`M7_cDa1wh z3UTUsA+{eABXVZMh(~^n5s%&)E0T)piIH>bi>pLK@xm{S#Plnghz{HFWi9lDTglm= zAm##G-t+!4mp4j}Hji05AvPVeZ4;e;WbO^$ZGPp)d@6_JKpkZ=CLq^@(uVX37^=;6 zc#5&;04?c|`oXhd&{cY9*jb&2)wm%;E^~pQkuq$r* zW6{=@xqYTn-jk#F8(_r`C#`fulUqhSTj>3WE%BIn~u{8=uii`Fw)^IE%KS_-Le0e)87VxkUb~< z93$?0vfwld^Nee^#BO@gvrM%EmeV=1qxc678bV7r7ujdz&Y(3r$dv<}?hS~S@;U{e z^jPJ4{nLNg8GGr3hxPOZ^PT0m%;W;;PP4lP7MB*;eGV8wPH#R*u2-`6nA2^Q?_0k8 zrRTP0pYKugo#h-Z`xHNNJg3l(1*?a;3mirI5xLxLK)m77T`=u}rTy1EN~WMW&Tm!D z$F+E!9!I_}FjD4r*@jPZc%Xi-Q3f0Zq5>DN{tNep=W#->&Mo#_I%hn`!#q?uAGhX_ ziJA4MqXSTtkDMRnqP1oRDF}?>=>&8JD#7!pCTpk~71Jm7TmQT5o3~UuWI3H9JK{r6 z6p99wl;$`*PKQ^wML$j=J%p?0*(Ty}KG%;to=I~S(EVo%fXi$=_FDs7hERt(m17pkL)Lm3*H^}{#kVOR8j=>BKMAC>nk zaU@6jYm6<+HKDX2y$l+XRa~O4y`xppbhsQ~`zVXSa|!%U0Vq7$r#4Wom%rO^S6X)0 zL^~ZPM?TfdEZ2n6#@arD_E~~+IsUB?#J_UY>TOM@UKA+bI*%Bk%9#SipMzzDCc4W| z8lXcdzPwno{c(O%26B7&X@|YnK45R!k90v!*Gr6Gxh@TEwfLqw?Wwe&k*gq35z6&J z`-WsOK|Lp@w$Prl?LJ9}U;bFxcq@2yvtN8s(`P5`{?IUd>UYriFw3<7q|H$G6t`_4 zB6MRj1ht?mf5s?U>cUx6kTqO?^hT#sAB6PHgH6-V2rOb=v0Yb)(C9jl{5-hC9x8)vRZdGFPeL_V9yqeyb(fpi} zv+o^Y#7n$dLSHP8h*w%6mQchJVNO>SM&$^A^KbbPK|N8mT7f|oQfA9$t;Nf6t|{0R z-(0t5`D@RYzj8MHfg?UgVasw&C~YX;fI#l(8Ah2n8lx|Gp9cX@{PO(*#U1JW0o~6N zYr3zd`vJNapnCx7`*#Mq04D=Bpf`{N(7;DJa1M|IVE9K{ck@E{7XeoTWY-IUXMwkY z&A@IT9(--UP{0k`3akXS0SV~5js@lc8-WwiAu9tu0%$yH5pV($w-`u80>1_B!hpym z+ytegQ+zsZKn9^9yAYkw=Wr8rB5r`5!VQocH$S6s<5Pm0o|oEVZ2{cqbixhJfKEaz zIRW=>i9$SZD*Cy&ZyD29h+q37o>cJ76k<*`#>K`8@sAz%M@2#moDP1M3eoLGAx`ll z{G~$t_OcLd*9$RZ8^+2S#E5kXF=F8Wlv(6In$+1ywkQYKPLi63zkgYHZuZ_Mp8x&? zs6}(+)BOv}4ROFj3APRL=(qQ2cD&3s&}E-kq}@tr=agW}@h^-Z{z2>9J34(;oWc?4 zJYs|@=i_9j>7Mj_j@B>5m)RnGdI$G^W7W0qKCrg45g_?7ut1g@;((|1N03~Pqd*@@ zAML>CJ%$!!8P>}))@aQs&Cka&3qgHUASBkuh6wn5|IZDLV=r$sBH3U-evC*KEH}gf zPrsANcDsvgqg*Zrjpy1uGsf7bI*iI#S(0+@|Fd@;@KF@)dlOm!MIZse8bBqAoG6wk zmV^WdHGza?gCjXeB;>-~1rls$$AShc_SiuzvHoNE1UvSQ*rQlbKNUOn|MSf5dpA3| zT!Nr}>dpP0ow;{rXWo7HojyB*JB6R=U0asdlY6gU>X~=hTc&;pJ;I3N;HovRC(j$q zh9I!05k0SxNo6HIe=bgTDDipn_S#pKCpsVNTEWM2C!R24_B*9sNl)~|q>Fzm_)z0| zIv-(@iD1je-%{cV?!(WnA`1>M>~%=5+#Xkgb$N0 z{w?v5J;{!$8aIf3RCaG!9+w|}@)twW`|e~v1C4I4(f9=wPtprR<%`B_V zM*$y307-W}(&h7H1GHro;v=hL&tLf31(t4zDdAU=r%Qab<#yP9yy1r zD>)v)NjMpp)#YE=!<|0sCQL(E)v2l0kkqGN$Vf}IhK{yYkC}GrYuBT$pkey#*9hIF zMz3c2cJZNjK@Oec4LLzk%quzQ^(EY7x4(UA*n<7o%u+`9 z5xPT;SS|9CJ!=-uQbzSbZruHZg017rCj z3e5Bt`-B63fc069zp`cm51R^xf>>y(PK(678Gx?;9gvQssi#rrgiD=T^5yy#_~(7s zowW1GXLnos2;DT~pI4JkDou<0t2M!6{qvvz!^_I?iGltU?)Cahdc~KoO7Oh*kNCes z!rv=5F2bK>(8Yga_+!~zg6+Fv@mYrmrJl&_-7=rcx3mt;&YyOm@F9Gfbn$PI&xsYj zIWv4EXyVz+unWAwpf4&*z5c8Rf7FF+fHt}p7OM+=J;!~Ob5Gl*aRR$9$_RfZUHoAJ*{ZE98cd1|Etll`f1Y2xmnw!S_dqAbo!df8$!oE%$mf0 zf6O03S48cir`t4tNLKMp3_ADJ;eqvhp+(gy=KzE{3&@7hb_I(e)F*o*&Syaz3veEZ zbzh>Ife?O&3F98gN7fE*eOU*YQ(wXm^fjwS9zT7%R4e_P;p1;V=$A1E?@LXN>Wk17 zQM>5+BJ~Zc7|-}BZwZv7HTuE)q8q+zJM}2F1c5T42plVr%I6}uuK!@}$ z^^c$tJrvufCa!utl-Dn+H+82bStsP%>(*95pBjBXtX|qD)%xPjn+sBJ?Oj{*dS)+5 zkM$qxA)%WRZB}oxvD5<{JFc)OK{>48v9_#%n^5Vq@PzT+XWDQ-FWQ7}(tdt*< ztWVRDtpoQ=wz}jeTU8aw*1~g=t;26mwmQ9G0UW7=A$oZ8k(eWb1RVcT}rfRXL2Zj0MlPrTXAI(7HS zYu6Z?M{DxoovhrCJ6X3J+u8cD_ZHUq4{Tw5HhW9! zn7&=C2j1&q?RWE5R`A5GR-58(N{$eb8t;phAF|N_9E9iQ*zcB5P$gKnhg>!vO-jhjI`C+dd2B&rIoG&_0-uQXV^66>&m8u8Lsz?S%`VaW$gz7_-#ld})bF0VPs!Xl)q4Kg(ubFRv+c=c zY-qtqeiXV*jb8O6bJhB*$k&O^Vkc)QB>Ej}95&)sGe43Swn94qY}0W(gJT&S$6&XI zNreb9Nx#4V{`eD zyblE?0vsF52VOm^VJ7Nq=M3VorTWCOIBUuOd0m#|iO>dh3tO4G}ISf zO**MGZhhhU)kyh???kv}nIm!@HQY3`YUWH|AlJ(QZ2NBaxL9~#eEza_OSQ^geIfnE zfxix!Hqwqk^jYWL!isW}apBuhpi!mSE@zp@a*Z++z!}rf-!#0J zaml^3SvKwnh!Gm;49mxr@Dhf$gku=iL9I0mF9t=qTGJ~3bzAtXh=3l8gW+O%(%n)zDj=99KEUl;j9*oj6f zaT593mSiGdn;Mn)-x>+%`Fec|`I_-6_QZq>ri!=;rtcq z=1g4mcJ)lYbeOBeD?HAeYbJj%;S4fDPh>Z zAfG~4MD1ep$Y!<`uMPHp)rekvziJM7RFB#BZY_{g(yS>!DfGf>Ze+EWxgtRf<8&Spn}HrMreE+jlI4C3>1SB)*<5 z1;3}f(S6h|E0Ul2q|v@#^i=3JHF{N+Q`CerM7>l-bT4;-bLMIUM3QH z+*D3skVH>bX?nu3#`LQ?sCo7&2V+cl-ocH$J8(z-mOprJzuT!s?EMIE6*|M{CWf92 zE%(nTEL-3kJrn_TJzalLd_65VFx7hDq?ZRRIHv5(5o}PwunocTROpJRU0mt!xu-{c z>)}(aIjwZv`0`cCNVYpT^ok)-H9x?7EM;hG^sO~v5aqw#=z7vCE54poADn7sem8B0 zjGtx&PVQxkPV_|Rra)us2^Q0beAT+5)Zv9OzsR_u8Be_b)C=YtwuQR_Y#OmmOPy&> z51OOnmV}8R0lj@TXlQ&rsf8Y$_2ANhCp=%g-KcZz$oMW;o(SDc!fv09DXW<6RKa#N z_m|gm!l(2<<$uDqB@l)s^<3kyrg~8VfBBxj9(q%n`Rrqjk6wC213$orp+EIP=!&Ra zSbo?W6WSk=1k{qCBL8qK7Ai%!Kl3|&jjd+O6$zu4FLYCXSS}I0fi8}lQm`dqmsRF{ z^b?wC!z*IwM=%{Tocxaj*23ttg!`W_fiNCX^6SFk@%vNL;eXf5C;#|!affH`a>g4n z(I8`f6}l-g=GUTtw<3rcOVx|QW*nhF&2Y?nGpjcl4>$=liCd3LZYhAl@sPVy;qJ#M<2^2w!!g=H1RzA@flXkyT3 z-%*Fmqqj@?fy}y0>I1sjr{f&t9H2WoL?^=Lc-so#0{q_{Hm8G`=XoFRVf%z&{+6~2 z=?JdqV)JQq|5$k$LH@NyA0KEO6<<%XMy6Uvw4GAZ>BG}sDgS&QB{S+C^+f2VAe-vR zSZ{S+Suo@e;7juICQ8$szA#?CJA&_A^gwip@0eL^M-U!F0Ioyr2~ZDs5A}{V^c!#>^MdsBU4|5Zd0SzLhN~jt@mckDRUNd*x!jXIhO}rf3-eyAqLd>o-zQo z3pl>ccb*Hdi^Z{0DJS@zMIZRCsYkSF=%%4R!%?5uch(KVlEyH)AzhD8;$S=yf2{DN z#q!s~Cfo@LY>EUH;$~^DEEyjy-&t;kk%{(#-77!U`tj|{zuf@)rM_tsx9s`#4cF{C zKqV{lF+x{F?ZSR%epRTlD&&0KehD1kYV6E;6!Bj z3}n>*0Ensp^AlBY3A`T!a!m+Xvm&>(pjlckg& zin8O8)F0l@<{a$_KpQ;Aq2T`>088wxZUDBju$IB^7+@s8vM?Rk8sK=2$d+;zdDBh# z6Z9wOW?PJ52xo{2uD`!oh)0lou(B|k4^-3OmgzgZ?=&FzF4?{jy7?f~6MMbC=n5yX zbNL5At49t7b8a;C#f-1H{|-A5Z|Zq0(;Pik*aWSq1nNMNa%Iqz`1(>iDb;%B&>Nq< zQB7h6@Z?Lbbs&l@Pf2BG*&L^jEFX;3`3(*y^L5k4mPMD3CKp3}({xlxu)}O4=W9_ZtUhRI$>y@KbVkNk;yb-!0Y8QUzq?X8FXlAwtt+k<5!5U3N{;Kg`jm6FG z)b+Ea$Qc$*K-J!n_9xpw9BZOYz1Q1B$RZJ)=e-+~7J?_t-&_KEJF;$?d;DV+p6v;s z^zc;coT0aH2-7-e(e4|bUR!(^-83xkc{S;z(y%`@9Gfot>?LiUoN|AKPkr^oy)x{9 z5r&gkX@|rr$wurR%S=Lj(smtizsBsLI?bLI!#C`(T3$V|{Qiy9A+4tfY z8v7CK3vhge{Sej*_=GR!KIDBt?+5Gz>0wx1ffT_Tt0AJ?ez!AWa0AKWUzzfU(ih&Zq2h0R! z0i{40a1<~bCM6@VY81m*$(AP9s2_G#w<^MPuh23PS^}ubw?Z6$toxokd-N63= z4ZuCXy}*6I{lI^K2Y?m8O5j1@A>d))5#UkaG2n4v6@Y5;c*;TQ+ody7@z2(qcCZU@ z<6f{crl(q;jyU3{6mP2a^!}s1sp?sO*^5hv?0kE#hoj$O)0eS;?JcVAcN#7ozn=+?{baCu{u>UEB`CanCnv(eWAhS5tI`YJt z8Hc@?+JDKuEHR?_Kzi0iDmTZeo=Buf|*FY-t;~Jnn zbY(Tt{|>YVfiS=_Iuqy*P#>rZX#lc@su%g6V4kEN(cKkbUS$~C%&Y$tvjh(!`qFh) ze0{0(rCN(tezN8<&--5<(vQ-P>Wk17QM<&_7xZ0ZFuBAoL(w`?8&mt#f0m}L(Hp#C zRi?5m-5>Y{I1=wW3m(S<$#B00+C{)3U;$7K)Br3~y}(#t51Twf)|NO+bBjFAVL=+GqBtoqn0I-hbd*=IO zeN3DAJslvOVffBjR*VBC0KC@+On2Oe!QLH62l#HOhkW;<2Yl}t0OLV*tI{D&+5xDh zm0plW9g?z!aZq2#7eRm84D(Mhb$AfbpW4~+^=Ccw>)wf9uUI+l=bnfDK*>bQ9ic0t zc47mo5Ra)p5_J+Bdbu+l|L+61he|R$wg*`6Yz?~+^p}7tU@w4m4&P-* zfI7hPgK^PjytJtk1fozj!_uvT_pm+5djxQ*FtkZy7}JmO{!@%zZxxisU$2z`|GoA+ zeZTBdV8l2{!5zC z*xmb7q|b4WH}E}C7vy`ob>RQ_&P#4N{n5AXXy@?%75vG+(Dk_Kj>CV1>+E2#Y*xh_ zd~z4r_F0v8I{y;y3vlpRnlrWVko+9>yPrpNxvn?LU7XumkLN8N(Cw$(y}$UG{Xv=! z06ve<6;Zozyj+c+6xLJ}2e84DH|X=^2XLs~BphQ{Vt+H3WxfE-YWWf_~C5HG|3Ipa*wYu{4Zs`8dcsWZJiE>o55)EB*jc*QX#m>}y#Tfub^!VSI{_?L*w&yP?+Y9V3$}s^x$gW-KH1*U_n+VQ zxvSS!)g69G3U7v?9NOY4bVbxI%+Hg3Gn$+T8b%l?M-~R%@7bKsUkAR{PAYr+!~wle zk+rfn<9?PSLf4X1PNwT#hdaTCLPMR;6GRBJ95@LyzAHW#b%@VJ&_G;G4E;FyyoE zH1)-duetxGjxe0is3W@0kS=~=Gd%TD^h&4mUTGh4?2P5cztx2C;8LDs&U2SzloRu` zv`gT$3Idl{^~c}CB3Kz)u1QVk;;+gvw*E@|v+T2HJj3RpMJ4`WI3)dsR;2&>2d@sg z;kr)0$o-PONf-a-()Y~4saXgV1|p@9BtGeaq z|7rh2Gxu3gY$vOwZ_-r+eI2974CL(QEwY7*@@La_v1wbIQvqE9JAMCgY)zj&U^VO>)JP$tFeo zFS)r60^HR4qq%p`9Q|J++RgHqu5q7pqWPNhK-~Yf1oleg_ZK?9+@tiYRBPJk1)~qW z)O*6yj_^50#PUh#CQ}^uk;PPj+?hd-JqTG?6;vx@)Vv1o;a0LTm$hs@GFpkw59;Hz>B~R=m5+I-UcS2 zym}8f1p}`+C`{5(aP`4rh%uO8S&9j=gD@zWhKJ6?f}Fd%VJ$Kyn|{IKnNKkxc3e8v zxbBQ{6a(7(4#vFI5Ukf8hWV`moLhDT)_2drx>?L#bw3~Lb#B6X=v9~#`xtAPw@R|M zJuu07*N>CUZ%VSVze=*+%t^Lhxf^-@mQ3?v=LI(z%2BwSouF~X)PMo)q3uW?$+}ids=T@*W1c@ZF}pf`}dF%9p!Y*oS;vJ|;rJ`8d51JuuavL0PCWAm>;9wqCe{Bm zK547Tr@Qt+j@5sH2$i8NeJR~`ydz=s|GHb^(P;^HLIQth3Fzf(!Fln^*Yw&{>)q46 zCs&+)(E-~ynL)}|p_{U3TE2RNv!koXIM<xJW!tS394^a|r_zulrQ8_bzyd(E;MW(3j`!&N)PoWigSu6 zc9HbXDEF0k#`!|?{ejtqzQDY)Vl+v@xF_;{E_TZY-7K{Zksl?zz1?ST4}$-P4=j3m z)s(s4^tBnWDqyqUDRkW8GULV%^Gqlz^5oA5B1yIUw$NV{VA9G=$5kJf=;_3p13I0~ z--sJsy^S*Zcv;3JEz5hStGg|@xuMhZl8Bvtl4a7xU!D&~c7z~t_Ns%W{_+xg@nEGt z5b_N7mY2`)7SArMD(2{!eW%XX%2x2z|EzdSa<7LtMmU1xjYu2UsUT3dc&j0z)&xhVbWq}z8P#=V@h}uQ?%C8ufQ^di>D*GH4 z2~vlIbbSzdOSb5VEf;$oCi7BPfcZ){7*dEB-Y54&hzUot643imDObkVkJ8Iit>s?~ zsD8Eb+{eZ{F9Aa`Nu#BKRKXEjQR3+d-#bCWcg=Uq?`SyoO?@zpgf;2% zUvx|UC+wCbP=_E=ujE}7Ur&}okA5sa?%mT?wmF+)jWjY(A#|G>y`moTpo$G)7g=?H zw|{n-Z>+ZhC%gtcBYdG8KMBD?_@f$B`)3RuROl=ASCj-*B(d~|dO$Tzyzi)-|0I##+DW(yT@kg5J^WqZ_m_JnR#f;{F?$0w zlfAQjRh7_}3YX!McE!f}l?8Jw!l%#FlO0rD4 z_*1WQ#}#@eR^l9`672j^F|&;AIA3|$tTMFVJh}eT!b*H|;%q6X%PHlWmigH~`?>vw z-St~!*h%;?>8<8xVnwMse61wEk_~S=ciH=WNdB(}Uo`Um%ytC*I^FV6+aEr9Yir4T z2P{drw-GS|fD^?IdWU&{d?`h3|8GRatQ%6pTCl4aW}YrS@AL z8C0L7*@1OFR)P;czsQR(i~3xbgL#-IUgu{$)~NXpJl5vjgTJ7ghT(ZN>57a?VcDF@ za-Y4Ue0HT$@gR2Lc0P$#pDL-Kx;{<0&i&r3)6Q#Cf=~rT`0nSe&X4hi`i2*unp^aL z*I?>I8CraALbs{WYvJ5-Pp&uQox$(&oEEVM#IletA2U(xw|Q``O#ol`qhyD~kSlq& z&ex#p-ST1kjrBzVCZ%3{=(!!%gYSW7zteu{`@3Gh*x_pyY_>~<&Ny|GT`L+pANZG#NkV%;FjSxl(S3|6Hr^+@7P) z+w#2=Uzt?kM0&jQTtYX~YWBH&#lwC09KrQ`+LL7=BK^7eOue+oH|DuE7|&()yX)XT z?);M{eDHB?%`AGta!X_{+d65y(ZOdFm8}mYcJ&gHZ zZW6lKr0elZx_Vstz2X)-Rygsa-IBi^HsMZ4pfwWE%daK3x$~`AZfrolZkxKKIMjWN z?*%7v$+to`(=_s}(K7W+8q2I4L|F;tHro{vSBm4%^)Yv(p2^a-Z!+p(~9cYbwdnIgTs`29S5f}%{U{KxqTF&yi}7Kbjwd~J?DC-mDTqE`LU#{)7ScI$`P z&r4aEYL(^JFUZ>Zt_!3*7yS^rnW$So-2J>rp^ls4mFq0esgCUXOSw+{VEN272ANcB@ffq-T2$0k?<`BOaw?s;BO)UJ>Ql-KpZApSwy-|k`ym6kA32S*7lm$9 zqgSWr&qW&1RYbW%9iDwo&5HYbIZ2bREx?!19dg7n z*SdR})Hrs~I#^QQZ2%vPHyfZWTLG^hNnt%jy{x2>1g|1Yy|1U$0l=%c=U6RO|MKSKl+LZj+U ztk>e}M;-L1qp#%aAvb+CSD#a%ehA%^lcpc}l|e^Ea;tnewyoSh!&{zTY2RV$$;Q0H zjR|Y=m-yd03Fz(mDQ~#-#O(hyK#%qrULQU%aOUfF`DUNLO+691nX3AZBDbKBMM!9J zSq08lS4V-Fdf|0$OuTbbf`85bFp`z}rR$sS`j2C2`gbgApf~m7%AULMvq5JrOR@Pq z7J;Z2Lbs{WEA@ikUFP|NA@zZRXAC|eu5wBZdtXDne%ZxIa{?2OW5VzgzE{5E)@PnW zR099{-;%5gKKIP4#dE!~?UW8b?~?VjeAhts$+yt)*JXt7!kS>nH>U`jj$vbmvhu2c zj}3{Y^N?hhI&F?yxFSvbNl4&dDuFPbTk>n=+W7f3t1;EO;-ik+oO022eVt-P&F3?} z3f&Z=eSaZIB`IL2ABEM2P36qe3TLOA}anSqjb^+JaupaHz&$6by_RPR_ z$j@o38{RnITXwCpJ)l~1#r!ICckFh*nC${5zvkeh)>(dhlAecvdV7H1=d%pZ$N$Z^ zV*L+;DCJE(_-Fl`9V?(iTmN+aKGowdS)b<=2vY8R>Cnwvjq*ly+0jA>hMa)uu$g|{ z^&g(|Jkpo=%Rpz`VaGppYRQ-DKa7@#9CJutk*v;B%|ItDbLC547krRvy>|c2+1GrZ zz3&6?rzyb$QNBXAsnKhcKl?-OB7ewUYwrXx+vP`6KrqtYr<9|c9>WA9iDSxKD z%?h@732;krrwOy6tP%4@?-xKVt(1 zXO|bnkSE6%2u;FfGuWvokb_NfX7R8LeVn_&;K!VwVj90(@zNGc4jx^(+)0pp_eN{g>ymQ&zyI$F2 z-u?EfWnP(&g&twZak%HrBI{+Euwu4<`MiW__+E(S{LS#@f7ThSO7#0B9o^R5j6?p@ z{b!rz($>qmKbxmSdVj41^nANyy*uBU<=Y12>sRu(`ab!F9(ylwl!^0H%(p@}pT?bU zjqIwenW;m3EI(qMPbO_tCTZ$0^P%Xk_|cZ}FO#3d|KBG8y&jzMjayI5@;&3rRO|e` zZkyxT+VixO@1iF{H@R@@iF;jyp*8B(jVb4Ky)e^l>3^b}Z%IN4|G$F-^mgO=7VzPJiq5w#2RZ_Dc=n&xD^{;B@fU9QAhAF+7k&a3 z>LB>$+A$K>rrP?u-PE}LZTIVXyWY?fbg$KT!UovW7A;^<>)R9B-nGXsmFwuHv1Oms zgl_v{zdCH(1LdgE71V>wUf>I;{ZgH*9<=kldmq2*AKm$g{Y!mbnrVa%JY+zJgI>H^ z&h4X}WIdfEbm2p68UM;~-Z}UC zX*GvB33*^M{|H^u7hCu+=f^!G{QgK@eB}Myf*f&2 zr|P#We%RyeWs;8YVbaB4_`qA#lJ;bWFneDaik=gq*Bjwq-SUue_xdF4BYoa&FE)bD zvDc&yxV+)iu@5>4Z3mn0Q|OYu*v;@UvLeU~;Pd2%O1b;3ePo5bltA4Yt9;};qMlRV zX;>C>?uGy9CK!fDm_JqmdimJ(H@E)s9r3-$KFQ?dnbAi*etEU;ZMtbVufwZJS7cmt zz2Rb$!g<9r@*;eZs-X*f?u zJr=qmY8R6qY>2CN)y}E#&OuwF*dHhfGI$1{mrHz3NrV1kbbhPbU}6hK_%+L+JS)w* zt9*~GPxFyHcO(iIsO$+xcdgOg_&rXG;=^V+-14YR&p z+BVI~3;*ZaMbAEy@fdH0;ki~U=Y+0^+C|dOD=I1|ES!{s1qm$MRMCrL51d*XtMqaH z**HJ;LiYz`%>rw0dIVrsV0K-_T8Dx`FApUtDJ$eZ%M(KAQr1ZMBHRKEHK#{RiERxrvD$(O9TMsM zakj2U>pP~Y_CPk0qwJ|wTz`@AMUr*d9VPo@!vBN%C)0lREnnEdc{!p-LPv0y*+e~> zz)jd0VFM7WJaQ%G{9#!{uv`)yqAhMXBW|Hf--Ldf)6^ldNIvb9rufPRjp+)H(!K@B zTInf$c*gO|ddoU7+DYg=37uhd^Lylr^KgPZ?UC`+0TKQ>yWc;wBky16HZ^+vJ^Z2XJE7QLqWGJRsPy-)&->YZk!V`K#}#(sXS<;57VhV# zPEh{(`4`*Q-F3s;GxwL}Yt}UQV>HP!>57aCpT8i$gT-)&R4A{osL(mNDL65}npW>m ztTEDO+IoL%3H(1^_UzIF+gx2c(n;WUC=%NRLU+g!i|J>VhkStwbpnWUt|!M4qKBX` za2BA;xeW128uV|;gb_gWXv&r?>v_fMr)TvIH>5Bh(9q`iy3iF-yYM;mbCMuaoamD6 z3yvtB!(e*9HoZ&y_qY!H-PUpGt&KarH}ha8jda+QqtG34#4^*zIZY+%@Ky{^kF0do z_1I(A>K=2Pi$vyk$u}xcjEg?5v%ZDrXn_B5nd@&|(DQ+@=}ugdABAovu@TQIkXi1kDtGO$=+Eoo{=S!{y4%U-ykAQ9H0!{JpFE($s+w`qHWj%F zUHA~&;Kv!K#UV>LK1SG3W64@ykoVR>pn7>ry<&c#p{x_;ua!U;$xD4!kQQH$GvL3? zL+1_+_y$~hg~N6myhP?lp_@-*=#57$SLQi{PQVN&eOWKX#*oCV$5riwWBbMG5x?A6 z1wNm==GUKlK6S*|lHq8RPoe8^(=B}F;Sk4QDUQEXhZHsa-jVr4V8)^U*V{V_4St#D z*uInRF?ip$cb!pQ^zt#!(M_|?xterE#zpu=vC0M)k5p8Xxdk|2+ZVDA=wn!&kJ?`D za^WU4y!Jwvu07MN`#zj--+I_Rzj&>p3${1WlQ<4raa2SsoC~Mpgq~18HF90Kf-a2s{I90p<#UYaJ#_ zQE-BZrw(fjT zk9Wy@kls7Z8h>7o->hxYtk-krUHMS=uP^(2s{P~{u$T{oZpy>V2St8=;T#-z?_>aE z3mnhNtm)j?2zyiV1KTLv0d@v<0|o*60tW%ZfN{VSpajtK z#I^W;FYprZ1;DdR2Lp!#X8;cXKLA6ZY^MTm07H-;mI6CLhLq!}DdqS}G0rEBsYKb*ou^z5}YHWyYQO|L03UZ%0ho!QK919zqcinZG7?N8MOj+qd@V z2G-j&w0RD>&=pa;nEDcJ*QhZZ^dt*?9M*+&qsAT#&17Y!@tjxlTRPH=jU%pS+qA| zVLlSN@FBLzPgE|$%l-55FBI^XJKOy59@bNOe~asxBrW=j(fOW|9-r?)@L%11>V2NG z&%0IP6265l@rrHoT^K@7aZYTWdC%|RdtqPq`#0OO>%jN6`DgZhrTyya{Znktc7jED z3*DwhuTA)Nw`U{W1G&R2w}igAY}WIrR-3#-J3no%RQ|c~=z89;lUrZRbB=rUOSA4g zZI=rQH+1}x{RoI*JI5~{3P)Om7Qs5HC0 zvLbJ=bE7WD`WE;ZV#$R~j?(_DMJitCbm5=ebGyCozl7sbG%Q)#<0^DT)Gks^(zD1q4&IX=1B5JLpupqp(~b+?ngipgl zqG@9=hFnq1<=aj6{bAcue`oUU#MYvYIOF+60wo*?3H$>jpqCr#Tgb0`+<~W8z4z$0 z6P}lG59SqqcP4aGBu(<`@UlQKWae6TJ=CyA{BmRA?pXKtb^5&Iw9`H`%MGE&Ac@A!Ofz;hf`w&LgAQl_8E_6ZH!6l|vmT@kg*@8q*ddBZ5# zb~M{0=6@~egfk(5e~kq6_DenTF~_>H<2-$7;LG}U`@bqfCTd)n!OIM~M8SNlucwQ4 zx{JBwwnCP&r85rM{||iV>2Rz~A4jtGbC);fe982E(yVz8cYG{-kSF6OhY`lX@PwE_TkZ=MW7&!t zXAj`3zvv}&I{&z3-wp%8Y{|a z@Dp7Jsg}Xoi?Ld>4$_Rbx&LHK%52J$|No78)|`Ac7hTtzbqB}So4kY4tnG#r{B-ge zzt(Vl42{(9Lbs{WtD!e){~oT7M*G8GK2Pl%QRK&T?#!~loah|y#+82#E0IL0FErE_ z8Y!dfe~IhnkibGjBK_scL*m!-OfNY4*ur`1YV1WX_)opz)ubyjE~ef@bz@{@f!|-w zy;Ny94h7ri3f&<`EaAhozbl@?te>fagy3LN^%~y>RB0BK4tvPGz|- zWN$B{e-dEoiy5E(UoX$-7CoYF@qeNo)TOm~+b?7En)E7rr>~BX@@7#kufM(9b?$H$$*!NzoW;gazN=HO2-?%@2CHRtb_nFn$ zmU^J`oieQDayX~sSJ%H(H1|cR8*N=mwuIhFzOl_peAe~)VbF;9`L7my&sv&w+AV8$ zJ0RW2e?pJNmp;A`S)k;!C1lWGWAdGz2J@WcL+KOgG(Bv>{re@L>u>4E_^$ zsu%W5ozQU=NN_N-F5tvR)6Qooz=Hus-wHCJAXJ~el5g5G)wgb`HQ zeZ5Ax``?s5>q`0VbRG2Sys8sdJhuIV@Ad+nM*1y6x2e&qsW*rE0)Bi<>3kh!e_O!x zWgJr8E&I{2Oc+GrH)FJ$Uw+@y70AHH!`{{XK3;<7IrEivg)e?{{cpLT(+Iypx2e%< zGyFzY+DLmy_?0__Z~j*m8EnyC3G+wT!VkY|YcS+tzCWhF{kiYdbbGzv1gW>kH|Ot# zZt~cSJkg822^63DH4ZT>6! zUfbb&+2B(0ztBzIOu5)ALJ9(Y|4cP|Vzz@sZ^fqm>SclMHq%P{-~1BL^UcZ@^n1qm=*rpD=%&1f+ar{oSj`ttVV# zLR1%~SqE)9qo4uy{Li-yPFOqo#}N+8Ql1Ijd=gVnWXhw^7vi4bLHp3Bg7T_heuWP= zX8|l3QuBca-kts6~Fp zdaH}LNfmdoF2)|#{16#N?+;c_j?dQ`@ZDqE3!i=ByA@fogQMtGl&+$UTw23d9=2)l z1;&&GLxuR3-)1aUc@&BCf6O8JY3l9&7@M1w9bIoSr?~Zoav-{b-goe6M>6647iX?X zy7Kdncy1XD^(Gltp(~z2{Lvn0EW~G8*h4A0h1p*Az+{d+kgcs0vSUhz z#pmI8q%}3o()l0{^^QNEqaOY(J;&?UDfUg{iwKF^Xv4{$x7*dmeCn#+~zz*pqE8no2nM974CL(W{w1 z94@tey6munU{T(}uOIPB8qwIIu4*Sd<-f|{n|X(8R`mVM@4xHBRTtG&`&t)cLc8p`bm)vk+m(C(|uB+$}Gr$-bk$kIl~K{IuisAKvrea3^l2 z+Yadp-62OTGu^^5&c1=UzT&bVvYiuBZ#Og=e6an}8K}lrZLj9PJDs--?DE!-bALGf zPP%C*BVJ9qBIBa;uhbjxmE@MG?R30>n!*r1_4bVLg(9RfU(jRk>RyL?L@w#m+~uq} zuNFQc&3fR2smGnU&CcoU`_nk(-ETs-snKh5{CH>i@+)%7u;ct#U&veH4SCV!R|^9@ z!*Fnd`i6?JnDsPuOCYI;zKJdLg#E`$pbklh{;Y)lu)N9!_%7&XS)}imI^gBs4j$X( zf+K7_w)Kbmr3xLvU8ZII85z_ys3yNcec3ZH=u`28aTWe5i{1Kd?*E@P9s7bkcGjeC z4mibkox_E+KZWj)BNqA7&J#Cw{crjmpxj9L==v)Eo$f)zPY*+RN;rupVJ9T;Pm(|w z4v8Gr z;?kM!a>eZbuflUY^8J>d>`R9|^Rmm!{q~0d>Kj6SnqB1Q*MxL2zB;5wxk@`t$`L7}<-gc0 zhbT+7d%gnF0S}Nce~bk5_UU@)Q%m*eo3EW!f7~T+HwZWOxN%#{q>F!!-#@#|=W#yA z@Ri`G@PcwLPB!#ahj747mCsqpr}L3s=GN<4C1WW}E2c`p*c_~m1 zR01J@4dmm1lK{T6MZkH$#Q_s)F$l09Fh zn+8#-t4UX6TpWEVEDn@ahO%e*l+ujx2164o(P{9FtjP0M1%hLWhGE!vvd=eL?)$sx zPX-vL4($d|k9G&BODuD#PlEvJ)LsDfYHxu1gK|Ga>Q^SPKX3qWAaF2{1q=nKXY9x3 z0o1iI0AB|6Z30jPQ0JxqhXT|)4ysKDW&mtSmjV=S1uz!~0rPL&(=+~ngD$5VK@2+LG-dNW0wl4lA zbQOVi88?2ICvq_8IDe>YCc4AkKu9~RPlYz?$Kw#Mq@hKZaQ;OSs7AV?Csu`BKW2f( zca#jY0rY<6ZIvm3l&9Km39>TwyG*i7y7+U(i6YIqZ#-+xE2T_|Jas?U8)DxkbT(_tv9-Lbd zY}&s{=!q%GzxIC^$xC^*B;+o~JHRgmn2wjmebMsZf7U1a?Rete7i@WqlbNMF5jujq zOjJ*XVJp*`3BIH3-RwF0z^#GV)?)h7|K`mHIdQWevayEck37$yD);lS2xNIA>tz{t zAoajE<|aS2if$S^>7*uf+ZS!cNPXxkA9KraHWH>2YV405P*3vk_gr5Ijz+;rDM%9$ z2w%?|e6@pLdqAJx`ToT7_N=|9M-|A*2wx^${F~uxf{*9J<_B_p{94Ch3+HBGyK+xq zg|{+T>bL8aIz%M=RnBwEEf#;v&pp2C?Q`dSCFu))CSCl02Y;i`gQ;-3y{`V$(rR~k zX4d;D^V6&$hwgIccJrp}{sapg80s?XJ)tY2cHy`ZdBpgaXDs^vuqS)VLagz)_o2Tk zls(T|R?d|ig_R|!7K8TWRUIDO)L$*yCQe&UqGwT?0ZqRqH^(42j~BxyL81g|0nzI< z3*zfdW)0fUm(+fGa@MzNs4p~ycq!Byq1)8xm3jlr_XlQcT_+q#>P)i+uq$#-WmTl* zWa`UU#LxUC?>-uH!u3~3K-ZU)W8L~0b%r{s>y7S~a0&a5m4M#f$T~j0zSKdV4(Xqq(PrRV-AsKE zy2))T^abr~Lun96LT^k-{%`%)$8DyZ;MNAl|HqgM76)0=mpCWw((hZFlyQYIF*~W7~M~&$-Sg83{9eKV#{G;u3-d@v{zct z3W+m{vHamSBc>89b_1g|EYRGO$>;Am^D#Zu(A^&^ZhlKzI1;_Ky<6VV@RcXMg} z$JK%9oD72LgY>DFLbs{WYczekr^K-}J7qge9q!lL(*cmvfmDElmaOv#>MZ+mbknAx zn`2J2sn?`SpHJ6wkRv)ue}eaj4l5DjzZm{c=&~)1Ff7rJUZ=*_kLr`ttY5x*bL`gl zeYM90_U&r^j`|^Vha9mYW38S+o+9iOP(CuBZD%fmQ(;W~;2aS3Lf*Un9wU*$!FQ;? zSKY0LOSm^p0t<1w=tmv&gL2LWXmbpn1(kgN3#awcRcq6Sx9K#JZW{Z&BsHPizIyrP z8h;t%_i}OqgDy@$ynub`q{ax2e&q7p05b`onf4byVNy()+`poJF^NeGkiQ8uHl& zSD`DSc4>ysalTntd%-CJDGN0Ic)LCxwZY(vX_Gg7K4axIqk@A|8gfj%7CPh9O*4Gi z@?f~1*LRUoX(hPsjd_^IqREi-ukyg`vgIU)|T3WQO{E=~P ze7P>HO|#yZlXv~_*KYdCmZu#j`4+k!H{H$foj2Hi-|GEiK`-CCXIM2pS#^$Ft3v{M zebO0mNt$LFiT{7T1oU>t8t4smJR9IUGWES4{=1%c%CnCj{`qKGpd|V(bn^+QH~Ri) zk^O`Hf&4((tTL|4qhWog>j}$qNrV1k^zzm^-@ByxFpCW&7+JqAbekHzs-3U#88{jdW%E$(gMZdtWE;b{IiCF(_w4v`wb%@slPHWaF=7|{0@0KXUpea>v`{-4&;}Hb`q{aS48b%>LbpVU=ZBR@Kc3te?bXj6vB#Nf?&C64Wo$mWH=&EanLf@bAM35Caq+;gb%4lW`h_j? zan9lO-yc;!EW(GaR!NpgXWTU812EfV&T;8j(`HM=*{vbE8KhKAb%;awt6SoJPv&h<*v(rbe%(oW^5!hS{FzjtJ`W_Q|C_th~eb?);Vni)6KP zc zSLkLkt=6BY+SnSezE_f6oskb?=uxb(poAWoZ{W}Quh(DOb5Kc44@b&0erwrU=~mclmSNp{7$4Cm;IW(Tem4>TI1mv6 zxae;l!0$+^0d~FlJ;~7k7tr&&lH-8mfiQ3aa3XLLa58WTa4K*bun;&MI0HBnI15+= zoDG}qE1Fi>d z0G0yFfE$73z)ir-z%9V7Ks|69a651Za3^pVa5wOOKm%|Oa4&Ela6j-L-~nI-uo8F> zcnEkHcm#M9cnnwtpvy@ySq1Hz*4L!dB-z#`T{~>j-GA)Oe7=^RQ4iDBVJG>IWh)VT zLIMd1BqZ>+lmP2h>0c}~+J&*^HKtv4_YTh;bMeqN&eO8I<$QtAO(8_r$uybgR%4(t zb)oao_4+gwO*XEKKNcV9PbMvHpScaIcx4!lp-s9X^VZ>DcY*rV&0&y6xK%ADF1X#!giM3<{GaXKa}FGBM#R z^M;o9X}fm*mEo!XS8?2PH{LLe_ix1u%ykak{ujNn{q78|+jA7noOdC2q{BgexUbw4 z@FVFh9+jL#8R-7in*WHNk0!BR*8P`g{KmNrI?clG=dnx=GXEwll>8Ae6{05xX*;{nD`@Bz*KNUIC zPJ+~h&M>-ZM&7Z`=}@=T;VSQc-Hq|{N8YkD>+X*R`&M2uy7AJ!cB=AylhAEy^h$mJ zbDYcW>pNcoxaS`w=h|`9K``V`#&_3(ye&Xk@_kcg0?JSa>AGQf%2&eB%`l{+`Kxp} z#reiS&2+&v#axhkFSfqu#0f#+7kztiP6ep0!i=QQ^DXheU6Zd0Sz zX7s1&ys&diCTv|_xF-b-b*7tg#lGmz(Rg$Ge2{fhnpN}01DE+`e~@~W6CLB`{GHIv zRGN8?*z>lSel+#I6C!jT#f&=gU;M=u57Bw~pRhMw0(yPkt3JNIRNs zh{x0yp_?3Sq`ugb=ZGYsH>M>2xBlzpOy2GB^=2vb>fpg+9|(N*M87)cF<4KroDsVD zbj|2Z%yk0eeDj;=iy2?6|5Cn)EnyPnj7Vbh*?KwC2z_BYBpaaY>88x}_Tm9+Hl%*N zZW*gyW$Zeyn`P3)zZrdLW*$;zAKmk`DR)KnnDtcpie%NF$pATXE zyzrQ?Tb6)c-mPkg>IvV^%KjbIe87f2ZLGS+KK+(JkCq<$)asMG4_|z#p(jE&Q>30? zAJu7C6yh&eXSq$o7Io8#atfwJkBXh<=nXpAgYdHT_Msjh-#z&f=ziiBz0&`iH1TW6 z<|9(~#3Xc2B$2THS0oSyBQicveSiG?n|Du|_2Ky22fk8y?edF_{3~?xxl}nHGqc(u zH+O#BlsuNmujboJ{QqB*fZkr5{;)g0a=w?4^%!0MlVW z3Eg}?=2v|^X`J;Ka#WLwBG&w})SI+B1M=TY^Y8jU(g^>%K0t!+gai^2NJ!v+Py%{A zx523AV$JI=8r$ohwc8d9l1E`Z$5qfKUHqk<%P9?DVoZ-*yDfE{VIfxTUz5N1|qrDn)vJTNO{ejKG(K$97Fc!<2}QDujCy6%ooe;aYuU}yCm#pCv=9BSf z6?j1-gNOP8ekWuGY<>K5OZ=BKB9Xxn287==Z^R$J&3qmEwhX!DgPCXKKkRcB^6Y~9 z$*<7y*JYa7zjbn;ETrCH9hlPj+{U?^yvE`;7EKZqKgyhL+NRNI65b4x_#c%(HJqX! z>)(p%N33;^1#hNV9eZZK`sj5}pPgQ1OPA*YQ9pzpjoEfFe^aOV5nGX89Z5d42C8A| z#f}KBzdLcuJES@ioP#Ef;QwME3)l|W3Fzn8RAnrYiHBLpRf+UgU72otf&yBu`PGDj3SHC@%E}7aNY@j)F<3U@z=b!XGx5`jPo@=>5 z7ys5jS9H0sJR9Rk2juzIfj>Qcrmfcp)8C8VzCmzn$>f>)E?EAKG)t_Wc)vJJI?1Gy zO2cz#ClnRgXMB31O&UGj>i47d5Ti5anb&}?Zp$C9@!z{m;06_|U3V~_3f&<`EO)y2 z+z#99%tH&M4hc{m@;zqchTrK>kKfF_@%);(IskJJmHn*w#~MfMD}>b@DhXzu+9U2n4pP12M9rk#oaGk|P>`H$rY+bmrHe(TZ` zNSLM)(Ay^s>*DK0uaDBu27Kzhep^g?ROY>>;6+d`gl?uly)e$pw)=$WCl~urbg-g> zG0P8r|I2oT7*M%(Le5IBo3-qsZr^d+FlBhII!{+O>9((3pBZ{$ z>;hmbie8RQ`7}Ns4d8Q8LD|H&SHE>l=V$FwMb38@x}+~Q+Xd`rald+XjtV~lGq}e+ ziTxO;soArso|y6Qe{1EghojrnHPR%EZj0VAt%Pw)AdJ7#uc-SXzMfd0r&+#Z#vQj` z`HGijhU^?#3PDp(gzk>r-oLj=`5}YA2waEzW3`j{ZpH9j@;_~Pm!_Nl2^xlBc(WX# z|6YKUBWxG39O(;e&T<6N{bP(?zbyI6tsmj_KPFS2z1F8${eIpmWdrOtAM%fyl=|br zU0-4ejJ+!%bn1uD6;ZqB

Axg4~@Hkv1X>^&;N>qxJoeTKC?ZoV5P?K+>gFS~BGYQK)?+O})1z3r1rYb59fMF?F1vdkcUvU}u^C zDfwFf)`c_-moOVAfiQwgx!CYce7*1Wb(;0s*8|?3+wbc&cOLpBUqM9gg-)7on&`bW z|Cym+O#Nt0e@!Kfd-=YlKSG-50i4zlfcXSfvnu=chAsNVGLvC>567hV)bukAhX9>n zK;@;o&9MK}|9bnX@jJJE$i5Es*om$7yxU&P`ZmqVI{K>5W-k8L|Gd-iqm(3HFeyi@AKZFk z)}PbAPqQXmGWOowS?8Q~esZ#U6*3PdbTd_5PYMFQnPuf6UqDr)_EDFne(YpM;QW{J zf_lmFf$v-LwdeuEu%6uk;D(E2kT$AJr5mh=7?x!SLI14)wyhW!`(nBwjrWL=^yL4) z!4BggML*Jia_fgVJ{^Ys-1X(aecSil{ppM+?3`KxfwLSDx+ybVKO*G_&JxJ+7MF6Y z$S3fVvAK-K#d=5D-_noo3)<#vf9rhc{QVu>dOef(i(5a; z@?$CVXHxz<*~6ZFe(QCG|5aiT{Sdk-16@CwmLJ@b(!RsglYVAI&VREU;ro|1guEAq zVc(182>U2?r4@5G?b<1|I=sg1!Nd;`oW zQeVveJ=4wt3W3?c8Nltphrq5#k7L!J1II!c_Q8wqhepOEbavlGh4l_9u1Yi@R-ysZ z4i(F3y|88wi+`TTz+Cd)mi1x|&cv9EGaV{%hQ?x?b8(+#J^3a4_e-)mpPOV=v`@B9 zye!#DIkJs)-sHB{VHdZvMrC%eCg*pwMkH-veYs#OYnSg*tL&|D1{6Fo#US6iO>7nG8jfbQRe85Z~{1VoHPQ7^r zoR)9GEuoY5{O>ZlX{i6ansicWSYAfYox@UCwG`D~kv~%{VGKG)fDNq~>pzO)Heo>W zV@A7Zeq=J{d2$QE?;dx(+wbBjIsOx$;b;%iLqO(7p(~gGS$)ZyVoZ|XY6 z*BdLPhjsqqqrZOcpsjjb?o#k1F@{Mcp9sB8IhVGcw<>aoymYV;cYKBB-I!Vp@8<5d7V zR=v0*;zJWNV(eNt^0!%s{v5TPd#LhFo`bBi+>(8YOW}XRqNmf_=YPGkz5X%!96~n} ziay84;5dI_$RF^jAZP}=o?{pMmpJt}7CPa$&a~GSZaK?5Q(X?)p-;TNFYhZ@|LmP7 z9`WQ=lrIhKBwU4VQ=``?f3EXr&{e>9DOKg1`cp=iQ)xH1-VLg<&&R6;e>-+~;am?+?+UPPV|$;1W&59cF#;F|OazVq zW&)MK(ZFfI`M}k{ZNNjo%fLF|SAg$#5HJ=f2hIlW1l|HVLD_}?bAg+H{{nkK`Hlx( z0`@?s;(Q<(4|_E58&Hdf_TZu404_#`E5(D4#)IeJ!3*)=$6yljK|J`*chPUx%kM|uMg*B;;%eYD>)ajwt7mX(!@GyO*4tUfdt z{ZqlO*Rr;rjc37oM;2E7tLFAQ1?v%m$5i@-#gzw^#USPbGEc09;F}D8R_5Arj9XgyarbqOqX$!PUt)`JoS;bqz`8k zLw|y4Y^sTu&ZfqlxPS9VKrh$RdmvN7WCMJ6W_h|EC8*C`Jeabc@ck=KWXB}ylduP{+IjU z{8t;jJfGe>zFw?^-aN5lx9U@~_V|)*NgBQf>V?o1QM<&_3r~)>B81PsO3HAQc!jsT zY(dlSZRNemyAxZBdZV11djCcx_74nPi)WJYpW1EX>&bfP(fc12T)x#qr#vZnS@cBc zrih|?qGkmnpY8KAfdXHkDB!IKdW)$q`25ye(xhCGwk+dKylYdsfByd^NK*7=)%NlA zCFB3uyB9b+s`_x?H-H!wFg}84Ek-FC6<3~u?<`3mkw9V+B-R&8vLu0IciC(p0Uzrd zMJ?8^u{xudC8aVy!qQ3*XD|hCeLBATq*I*$jZ+y=;1{ZZMc zlu3`5cgBmGX!z2vv~&F2-%K=}GVDFQJsbcf-^|;;v)-sT`kfk~dOhtW&pqj=H~;k3 zwI@b=Hfelf{FeA;Waa1R!TzB&tB+~k-qw{DB;xHQ>!MVNGG=+4Vsv~j_J){$Hr)|& zy0=B%%zCBa;~S0lZkgY#KY06B_c-tNo9`H1wXKdRje2~H)@(-KB@a(yw&iEJjTe;AHoO1eiP-I>&H z{M!$H`=2hj;YBk~ZVi#?&gRkW_||`8zwLA{S-rBaXDIHi?OwAoA6;6twmryoz&`&WlVq+{-e zcwU*ayeDk}0bIpHzb7WD(XOrpK zBYsPKGqUp2_Nc!1Wd59d2Upas=U~GT%KW!v4qe(cN9Y9@Wgvdy;cWvK}?6nLFy% zA07WcE<#s?!y;rk6jjWPIT4PFuq49sBji3R@54Ad!fPYEHNpiEE{U)u!i^Dr8e#9) zF!Nrdc@a*F@D~v-jqu$F4~c_?6C#`!As?^ZFE*yrBK%{7nX!SrEyDd{gL-R($40?- zb%fzKNj@f4{3Bz^B>P8ENN$X}^d~$pj;jLxk#X{U+J243wy2Q$ zWZZcDl^L;Ie-_UyJtnR_M1ipB;6~%!N5s71;=$bR$S3m}jr9woE2^7;S#+Gkd`XHv@55?`Np zyIg%v?_eJF#`fEuU)g`xhtL1>I#X^VyV6vTN2We*^5dsgED)|AW|pY&NfH}~alU;dF3AOEGH zfBNq;vmW@kDXo+o(~fWbH}>01U+a`^_F!+^A>6fOV8zBbjOjTw-sINZ*VjMPJhm%i z%!rQSy)4pG=6CGAUzifR(T?TWQ0f1iAAElI*oAiV-&E<}H}!#g=Kj69yo;VN@p0?S z=>OR}9)0B8kG*sEvYh2TFeN@_+0pD^dFS=48-I~!#@M;MWqZ#$_%g5RgsbTue&Y0I zukQGbMcVFtS6d_9FFfMVTZX5-_;KHEUoUuc44B7vCB8cC?9OyY$a@8=b$hLKmX$lL z*Pdnd-=SUe4%x2W=E|5x9;0QR&pe*T0wrV`Gh|ckZpF0Xa@f)@_wo6EPAAVJ_lXdP zQqBLfUp8f!98R;nz@~^Q+x4Y~Oq^f#J9v8Iq4H-k;`_u0Q|huYS(2 ze>++qn){`w#hX%(&)95skYDEa#kI=jmC9DWX+L(+bz7R z4s=$G)+8^AilcZ}`O=5lI{bp&G5%d4D zA1!g&u8v!c*S)>KNJN!-%)V{R?Rd5)0zsKnRjFnK=8 z%#!&hOT_K6&vxZw9zT|O*XQN`-@ichynDt|C(b{^k-vVq@6)e6W5L@$_^B&eX?<{P z#F>9ee0>Qz-$%Nre_fP|J9vPEc z=F;T@OZu0e-aE9Yzkkhw)oWJ|Eso1Y@j2hKo2T4)65f~jrFjp>n%-(u({~0pRlielXBftH>mppCg`Inw?;PpqfQj!;OGC!60dipXyWi>#@`$FsQg*;;W^Sd&g%oo+B z@H>jn{#i$mA&=9uoq4R(8|1l2b=+!q^twkjBeB#apWM(raXvX}*7U{^ zGyd(AwdeiUUtiPCCy$HqGoO_BI%4g3rv2}P&zpA5n}6)Qxl5KdCp8i)DbrW#!|Kz& zyZmg~D`~H&yEuYtm&PLA* z9{S}kAMo*m_RD{w$$i3Z@mu1Xk(HmZ`^ehQ>viQN_hSZo*7nX@di;Wp>-}3}{<(g- zBjmQ7-MJpib9T|$xZ=`tU;e>!-uCzH-DY$CQ{uP8=P=b~Z2qIq+0|0e8hSWd#i22G z;_c|<+0z?Oz2Vw(p7Mp0u6|LwJ~p2-% zC(a+6BLCcR)l;|Lc*5+@UeZ2bF8QOx*G+SO+%8J3_Y0HaZe3?2vO#ye^^|Z+y_%KOcV38~-!+ zTiN9HyIcI0_-16~C-Y5yzh_D7np{_YB5v`}(2}?c7ZtAkeaH6quUymH`F!{d^E%U! zbsBkoH!}*Ho^Kp*`@HCX&GeT)?b}yB`KPuZz=>v4oWR z=!uR8N|}>Bzw2fsW>D78hWVY_b^W|8)AF!`fAa9hz3Za)ma;e7Q=&vJ@i|Pjsk=OT zplA8%?e82eh|PF*|N6e6lUDWiwQD?E)t}9iyXHM{#Veolp8BlGujg)i?`|(x{QAxP zFK#EIoTL4?9bZjbcGuGvPofXxvqe$7G_O0)?qAV6d(G;+b+_5fh~M;TUjL8ul= z>;1~{Q^`l)X~);cn|yhyYo{~4TOvJWer5es%cE__cjou{dF7%7(;F{4?(`#%x#E-q z9&t!(t9)b>Tv-m3`0>&^>3QYhjqUbZWjZnWj;8!yZD)5ilo2v6Q(1;B@!5Vtgrg&5 zd6w6o;}Q4f{fF6|$4$8&N_m{!nOAc<*)K!2$$6A~SdIT<>fRI!Q_97YmvrWn=yl%} z@pJA8(;F}S%Dz84c+vF6^KSXcy&wLmu4n(?XRT5@@7K(HQsU#^j%Mt5c5axWUmox4_?vh?!>8lC>*jdB!?Y=lhs2Gnx4nK!W9h$7X*}|2yEQJ@yj$bur|sVO z$ai;d{Kw`!8mC=&uf`X?vS;IgT~iycx#2#Iul?)&8W+vpr?K$y4`{6V;DZ}i-Lzlh zueSYZWBq;ptZ~H2k8hlR#NmyB>z~nh_j`|P{QADnYn=YpwT+=$UfI}o<+~f#JmhnY zS-aiRcvPCUix}?LN0{4T0acK=rt2#z_;G zx7(sT{`Nx-{Ljl@y#MoW|K*jcGkO0)Z{)yL!c^9-F~P9bo*^S)?K#V|6BXtvd!kUdEd%{m-vh- z+ikVGx(%1@H~T*_efCS7pT_TT=b&O z{89hD#MBo~Z+zmGCvSY_x8A?khyK1bY{?%bzCOol{ut-`63v{Fb$!>TS^YnU zs}5VbtL^Nr=9SW2A143LP_LJXsE&E$|M#?JQ!H>PN4EBK=979kHtXc+jnx;qR?nF| zOO_9=9vE7>YW3iXMLmN<8#|AqHuO%Mj+xQ_6NkO}0pI-EbFYh0n@!%=nEANGx1&c} z6Qv^uS`=ZtlXfWLX%Lua9aZPecQ8LC+Run^bcACf92X(i!-)}|7ojJ@ z$_RZC)<<|rgjYv+Q-rricu#~6MfgO7&qug6!Z#!QFv71R>@%g&m=WQy2**ZveuQ-q z&WmtigexL^Gs3SU>>qi&JHpBce-YtR5pIi+>*M$cuZr-w2)~KY9cAaa5w44HVC;YM z{ms`$cyeqE?};!iHk{W)$am1ZKEgxedcwsKmSkZY>ps_iWYr1l+haDPO(d_mAC2TR zoAQ7Dlik&(+OHa)-PK{M-DS9HT7RV})?eNF(O2EOl^eeo&#MkG&E5|$SVJk;FJ3ij2&*$#?|6wtq zcpXjins^i|&37qhnVi>6qX=r&t7lnKLKIWY?K%5ps5U8-`};rUrh1-rQRJUo=I#ht zZe@2mRqtCp>sO!H{QL`l^@WITHjiol*5li~8}TBrl_&KK#bb!^2;#cdBZ%|X_pR(Y zacK3L)k7QOm2J!8maoyr6U%tjbj|9UJYBE(_Ldc!fBU)9%J?&z9WxvC_|ku8)0KDm zwo=_1^W12a?QKh>E1im0=A}ITTND}YU#`5SdHLm2PkHU*5B#$~ea);KFq)AFyTxyb z&$wzcyTAYR)xGh?!EEKzn``4k6=$rEhcjFMlwqssSk&LS-RA*MJ~we^gcrT>?DKP+ z-(2+7-9Pg$zqvlUv&mzU{H@0~qvNNYjyxJ|K8e%2q7}1leqZ(V>K*TsYYcRH#Nj|A zP0D-zwnREV|A0My+*ow^io8ypO|GXbe@c8avhovUO7qPe?fU|cE#C({Du$^apB~sA zuX?OdnN+hgG0OToc(Bv0US6Ib%kwvTPJ7<^fBX2w(_6)5^O!EvTjJ}}&-Av-!Rr05 zJ9uBkq1&Ag?pL4S-S~ey3pS_NUYxse>VKS*s+L2mh9=H0TOvQ**#GhiF24Sp_t*1F ziLWc|Vt(1-`zqv{y6hkJ|7tliV|{12Sl_SS8Tsn(=1iYD>&RnXQPyLgJ7zgk;_FMZ zgM8C2CYSWDkJr@33vqHc&}_1tt(KQrMwWTChG_j()4k}diSzsBSgxyIzwcgM_y5zU zm;9d7&2*Re>a??a2kD-7=>LNEY$zY=YisiVtH&WXM1IMI7oGU@ zM?C+pkG@ySqm`a1k)9G?(ox!Vm(~GBYa==--Y498z`FhRwWtEC?#IsGIJwXJ_IuAq z{(Hl7-&y8Y)>A#c^xwgDy`%S`j22AQ{Il#Oo#kY2O#IXc%bOBk(o@>SXDp1h9mQA2&-w4naMf{2_pXjt9e%v-jEkzlyPTeqF74m1K()NPEw_hAul(@AuNZybQfnL7y-|

10#3;;>e%$rx zAOHIPSJ%^1;>S|b>Y5-uZJ+p%z&I(ZI*sf^x;{F4hY!j1nFwO zfT|N}LyTC?&-WXi{5hm2-}$yPw$9oAW9?PkJU`EQKcyXC(oxzaJ>{{Cd@d~e&4`fm z&F8_6iuso5Zi)D;Q>^x1R_Wgr89eiNHQm=n|H+Pnww!$Xn_l{^m`w6)$L`vi<=#b8}<0ozg-U$8(XU@ zZ?BFjv2~S-q2{2~{rJJJ=-iLzu6k;OlLIBMn{JJCE6WQxgRg_ z?dZ|g*!8_~-87!X?0f{jIqahN9dAFL*XMFQ?P^m!ZrV~?u3VOeOoMCVO+9D!#;RCVOWDkr zM%6#JgEG&`Sjn$BF8S$CUF^*F4WXR6(;A$RUK$E%K8x=VZKrZV|Z zclY!rpX2Xti0XdnsMmDnkMWKtPCsng=^xnkoSRFES{73p_4v}ixgS{7GuXRg&g$mp z!g>Zb9^ca!X9I%^`|^gb`1oAZz8~MSp>;2MH9cD*JvsgE2-$95#%`4FrsO;xf9I>t zealm?J0`ocDe0-lxB9k^Z))jjeoecpeT8K1nXPnowO*rrZj6}uH@BZfukB1vy}ZqN zJfr`?n?7{Y7oJ(>SJG3DFa6VJ&IwDpV*AO>D8B7I)E(a`j~!3%iq^yMts$%Xz5ULe zI2~IeouB#sORsR-I~`^Hcy$-IR7md|I0`$=gbQ(`^xwBykNN8Z$^fe&h7UV^-aK>f(>iy!aLEsh9Gt#COaz{wd{K$MM#7rQ77?TTVAE zN>lAFaXZ`opNzY+^Y~*MZa5aGly4)EPtveELbk`tpCA6<)P=7&Z^~y{^#HBmc8{S; ze2mu7jGI3zH@;T$>CC)wAeu7&dik3DE?>Ly@C(+R`rUHup6T2(=3nA-m})a_KCQnm zGH%EmiIIxKmYqn)l6`xQ|NEyeeQG@&CBB-5?7nN|{DOriwI?(j?UKGtZ=QHP&5QmA z{OZm}eCcDG&TF4OHS)YW_d_MVJ=xLL_UkFmx0kN&+cw5;OpE>pet6{r_x(}tQ|rr9;_I{AetB98a(6Gs=9qC=FVo&KdH((CksF{hor^;*Rn=jCvvwpDkBHiY*@EeBW zczwmjrTxtp2E|*u2ji=uqt}J2+uKoZojARlVtE$#F8#vgXCCtNM`l8!$^B90qY~eY zto-cM_7zz9~AGkZFz3Zv@zd6Q8B)jD64R4<~pWG1n=ui4z z_oFL*{BQ5b?K+!s{7~Xsv17k?xjbyYpmj(2C+F}#UC%qpKVzxaHJQMs7@*{zX`3d_ zKRK-fKD_GKH~jG8)IwO&;%q!gyvYlmH zUg#+IFGgqMeJ}mn+i$tz+3(KoY+A?Vduf5f@iTf9tcM7yFb;O03_EoH7*7Tp1 zW%OYGn&yiRW2BJ?#cAt1CU%ICVdm8=k4tbYBz;S@O@h@0>h8-+aX0hd*J}TV7Xe@_I&I z)u_jp{@sh_cg;QZ)ZX?r&i=tT8f-mr)z!TwvUBf>qc>)~sdRn zX7uyO9oIu={7q*%$2-s1W9ga&AA5iQ19F?prnP;>8!OxKt=O^OEDx&h6K!vC@j1og zSFek!7t2?5m5$yO$E@yMv!XR_wVb*%(v?kjgq+`a_0Dg2@fWW6@wE3|Tk>kQr^H{0 zkAFLwok&;n4Jh@*jl@*SdR_LePOquauYMis<@>+zTQAxF7r!n0u1wc%k**RS|8_Jx zk*->j;#QhdR>w!oo1X{ms9)F`>C2`&Le6(Qx8L0R=8t~s#KT^k!)252hR)x5d^0+J z>ghXS{n|Obr}o5Grt>1yoZgj#J^8NBj_dvd@1Fen@n=sxyFj`kf^fiQbb|GM7Mw{w=aSFVCvOmt4|!%vX=DFVE_Bd`z;V*|p{A8vU+&EcdCa2iJ~n&@*DHWjQxQ zI!ijnTh2|D{$)9<+ugw{oXVAa-H4th4)&nY4D;BOF>NuV{_=3)KWs#pJ z!gof<=VZ?Rf72Tuxbv(f=Uw*YcbEK>OA)AtaN_;DJ z?6;nO;(~J&t?PQ1ug@DS77z93&Af3R$XPw{YJkE1m4orHT#jAOH<@3{JjbT4>klO` z95c@CI4dr@b;sUHvB7Wr!7r_cG=lefO$_9!BoP02SUz8yWNrTw!}Tmc&W%v!fBA`cA$5q~R-8 zJmd|3`u;p>9V^#Ld^580Q_r7c$H}F3x;60K{eIR;68=wgj<@~fwpyC(pU08);U@dP zjIaI2B~Y!eT=e12?RLC!qjAj}PCx918y{U1O1V*wFa7J=ZB&??IIto=!m_A$aBL$U zy?!(jBbIVx+fJnC;a4u*d)|?M^Tjg1lAd~e=|4ew`tv={@v-Gay}g5@$!y=G);#Ra zX^ccD={vvu4#Dn-%k5{p^O9eF@6xv{y7VJokKWCuq^}-d`q$HUV&971<#`U!bIO{y zKQ_N|xvo4QmWOh4T75@9+%X&zD(Rc{k;%^wZ~W%6eV(-YhaWv{k5&p=>5KRFwBt*< zO1qxEtP^`qJP6gQwP`eF#DF>fte-eI=3l12DB^S4)%Hr(=5gT#0W-kGASwvEOXHk+}Ksm37-4cV`_<)>oE#wlbm2Uz*>)z;Mj6 z{&kGtKn>>BLxMI!TzuN1Urwr$d!J;YY`(-=66+8A@PhaaRLF1=y zM$ErVKR&(DJb#=KlPcxGtV;h(f1YCwxBF-MFOUA&l=7gy{bj#bJn^O{-T9i856bRr zTIrAD)>?e4@AlJ$QF`Y0 zE$@#9ik3%3WM5xiwd?PjKWFraq%%FUJ~?rEMk2k>z4(J8uf6?E&wOxuhGlyy@g*Il zUH6&j_$bGzZ%=tHl-pD8Pcvjw-`BQc{r)}#s@v1GljN67&+JR~`s!J|56WFcvnlzv z9$)&`^UIv|18Y_W9wyl&w3Fjzjl)*^A$D_CYhtd`dd%@umO7=_s{+ozJ1(`RPuN`u(%Z zE{p4QU;gMrRxG~h4e{x&W>dE35?|(D+VylCzq)Vn(xuyPw>f-nueq(}_M7btWgCvp zj%_;s*Zl4ThGWv@xOl(MO`I<_d?vn!dFVHvv1qU9UwU&pNhM#D_XImb>BS#)$3f#KHr%?@;pCp#M>PC=E!Bo zZrXPF^u`Gve87EfnY+*9f7)ItdEA@F)g`{3s_pVe^L)BljE)xZE0(N^lmD>;m7K<` zn11G)=RN9spDxoZc_Pb|I4xaYlqkMK~}*7SegYe7>{rkO)Uacyfd+Gmnmt2a5|LERL`&!iyrD8X@0J zbY_H?MacU0zl`v%2p@=WNrWpSTpJ-POSVPWEf#EggvUmBW`vU>3`EHHGw1grzZBv2 z2z$o{ad?CmMmR6RWfAU(@R$Hu9^t(aa-GHMc-g9muWom(`@3Rh_s}NzG`|CZ;h1LG zzuXYzM>=;$$o8}dxy_yXi1_~39{bFQ&c<(F_5QxU>N);Bt>d27HaaD?)DoY=RGWJF z5$EMA`}5<@%Uf>%tCnBWzSvoQ)$1h&{&9NaZ~tVk&u%>A(*0udXf|1XWcgL%+tH(~ zD3zL@6)Z2Ei5HP}MwPpdyE?CLjRZh-`^)mG%yV?&I{sh+9p^J&?#ws!>!2f%uMWHU zy@xFRudaXI_TbDht$j}Bn-X7Nkb1ry+q;!~5)b(IE^nQj$H=aS)&;k(PurR8C(9kp zAHP6#`#t%p&izg~Hmp9s@sf?ly>->f=dWqK&#-mh^zL!@bcwHv#r9i$9)EWK;JW;* z*qYTVR}CHCJG82QMfKx6OIg(o;^}^P;j%WqV4@zr@GC z9Zh@wvj_Xvt;;zt?p?7us~4NM`R9X%wR`=CW9;IwEz*v&kn_*$G1IP|-l$GLr#;;6pVu?akN%UT z?;W3f`0Z!>`;S(X^%aNN&E}o$`1Ze}t$O;JcZsi9*w=cCOQSI(hAipZ9P=;J&k1Du zW<)6cudVdY`KHluyMLyC+dp;gzYdBC+<%q$__w1OO@Hh9XWRtPev+a+)JV)D(^sy4WOSx`vSvra>?nS+>FGbdK%RHz z`pNvU;hKr_M^52E^Y>hFul+CiOqp6MfA79seCc1yAKj<)^sVUc%M19O8Ks(z#NCrT=I;;{MpU#?jTj?zw(oAgUDBoz#0u>xH--+skmI zBlBB#gly-wpJilqf3g1Y_x;hrx15tz2hFB+{(PTCJ-+nMbmUH=tMyRS>{Y$XPmgyE z#&asIAx5HA*2m@l(z!nB^|LenIo_}R#-V$C@vBoFwd~QY@v|->x7QNiiXHon`B(Q> z?SB{a=i6`d<+p2k^Ab?r9)IZQ8B4rXp#2o>#PxJzbGiGv5;p5!}e)#X#9Jb^s`=(!YJ6rX&iSt(?u37f5qgFh5(-GO7 zP1(-s@vXj%#{9LpLG|MKXd+j?zpZ6&~(V{tijgk9Bd>OIOkv8FILCjmG1Gj zh4IGUnc;S3nDM6l#}+pn3smyQxsgB8r8`2l^VlxylJ`3x>T>_}t51l|#!r87&H3MZ z|KmP7HUEhw%c4Evx5PIiD?hm(SlYAh^u_Drvio3MC~SViXVKv5{>UmDJD&?X`1;BB zhf}}Ub=7{~dDf@P`pb4cXIkPbvu<|g{1^AGT)l2+aATew#3SbM^zEGfwfXYauBg3g zb;h&kWvJE*59h6p?fc-yWw$K8?9y0{SAO$NJvV=M z%5%Hgg>|-aJ1X(xrL*%n-M;t)X5KcL?_KOVcxSF3)u(xP{$IRzb((i|yj`8o|CZsa z`DAM?pVW_QGR+4q>;KubPhWF+Igd)Od~Z{UuP;~T=W0HAPV9E#lT_uNmOP+ojxrp- zWxGE4-zML#PQB?VSNx#ovMbB6MYi+&x5PImTKO6M7IZw*w{F$Z>ocb=JZ@~08IEDg z{D=Reb9<@ZFS|9;_qkub>}&5Fx#Jh@-A;4AnA=NxWkK zpOrP?BLP|6@0980$oI57*#!Gv_EX(XrrtPteZ%0lXPx`No-4Lh-~X43w5}arU%dKu z(yVWYDysHb`?~S!9cD&4%6u}vxP6pJm-bm- zJb30e+XB}!;ydfs;-Zn*34R&j@}-a$H=yW_6rZ#=9V1K0OMW&Gb~ zyKF0Ep80=k|6XEttzC{0c5STxokLgi$@!5_(xy8?w#O^qe|cipf_H!WmH8>~X4A5q z(kSum=+V{=@=5zm*IDYf2CZJVpZT4M^J|VVW$#DbXX&H9GUdp;5hwqTuz&oP_-16~ zX9wx%%&*&}D)MhkqwN2-)Y3KH@$5~XeeSAPUiOu*m04%HGIjO%(!aC*VBC6?uI7u( zvbtqSybd5w8>3QnU7XS7!(-L;x9Gc*A4gm`Z`R}cuAcFza{o^`E_`1*zND+P)2(ul z+0{IbXdgt3UA<^DX2b~Tl-E}VA{}KuIsFXP^*eA|=lZSRS2p#Q>5ac$y5fl&{(aA> zkBM=!$^4e(QHgIxR(|T~Y@ItUh^teJp~<}PiG zT)!`>GReEt*;?P7qmCEXIfVcI*afP`DUI8=&;NNmJA8cHv$th_-X_?1^{sQ3fBAJ! z`%SabDgMtqv~T>D_#CF%)boG!JrM0;Egw7WUNg`)@30uLx;<{HrKf(sOU~!SfBmOt zf9XT-{o&R3ZIu|Ao)aQHB|e9#Hudz3ouZfO(eYB%S>7J?y-ug`($)Wy$9(i&Tb{F_ zo~{yKO;dK?g>-e?m@^X7DEosOB7N!59UmJL&)QiMcPn_CDu*Ec<7Z?X0gW z@y*D}Pd$CDH&89(9FW?%9X_fSC_lGHvzx z_Wob};QpU|+rQ5ZRW zwc`9wp8KS8R-c}0v~_=T?jK8hGqUotp!dw)HFJ(WX|QKtAnKvx5@5WPYEJK(o;b(N zW+WCM=YMxxr)W)a=YLDxUv-Rfe3@~rC9L+n=XF>2AG7Z0%pW7KnbNEe+4i(JM!J6M zXH#eDdB?tW?mI3zyhxS&S&uLMJM!nk!GSoXEwAq!?Cn_>pIIF085~+aP+q7|-HvaF z^yK>Lj*#;iuN++S>}iW0`QRJQX{DnzT$Y0+zNDkHJJQoUudOC0GH!3Y9bhz7?HBjQ z$klWWY@6Kae%Jl&Pma8O#h;h?7N>fA>A!2~Dq5ZCn)>6G*Q}W6j=UbeWbmMW_}U9@ zF7s_|1A8>;@uhz?UG2NTy0SWWPE-eX9pAI@l-@am{juq#6>o zrJUd|XWer73D>^jh4*gHIOqE(G2arO!&IBG`Nk#TzM**4b6khZyB*pC4M)4of4DaP z711w;yE8(*4=`Gdum0tK4=lLjj!RlcKP{j9zD0@8VXDpO{1^Aen?T}Ae(^5C{-|6W zZ~h0jM=b8+&HsZhTsQQr%}-jE%biWObNear&B)5nIP+f;ujMVXuMDY^009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!CviZ-b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r R3>YwAz<>b*1`HTD3p9wx$iCi(X(;-tLxqFU7S7FuKRv| z&-w7PTj<84dc3P+3_HCZx8GLBd@x?{Q%p6tDq5l)G zd5LFR`A@k`@uy9XD);fFnr2v<$ZvEtM$cq*$F+ZMq&c&yh5AHM`N%v?ZHbdtQhqV# zQJqffw^DhF$3M5|neG?Pm>yLhbKS7{iO1-znrr{fxi3{e@;I}c3@cLW8m_fFJ*v!x zeg2XYZm}+|Jm~bOG8^s}AfC~zxXQljbLKp%-sZYt3l&dUbfM>0ANCxmrt?zuCr=Dj zn0W5X?acn6>b#kw%KHwa3Kvgw%bwl40)|bGY5=VVQOyv~u8U1|Wnp8cN0l>zsUqb} zw{O^S;?&Uz)1%56AyjurjdiW1MawGp+y z&z>}Usd7dbRkV1z-)t|+jB|QaIU}5Ews=lo8}KQ<%jr?&j2Toh;@MWxxi$Gwr$?1D z_}PdR&-+I@UyIrIw>gh0XYjokCw$IY=R1C$x$IYdzErKW9zhi^IcHb28S7BAzgg#s(j}3KRvco>E&xbxzruc7H4?hxp{);QH`WNJo7x6r+MSY zL*v%v=FF=6p25EP;yLw}<2!fFbG3NMr@VJnzUS%9#I{iOek8kQcTL0O7wl1ur}cZO zGQ_jgYr@jGa{p)SQRNKwEfG)ipwBFK&D`eb_?&yG@>#`FJt(~j3!>g}S1;sDoxmqS zwTJk;RQarusdD7JJSR7URb#?Hs@DLlu$RC(VIQ>~X? zJ%_$dObS>%!XDL3TF<5`7tf`rveFxOaqnu#ytFZX4_AGRW_g0DN#^lrji_^_W7@3v zVcwT2@B0C&63H2SsVLzaOUD>{RC(VksJ4nH@8#{Wp_b$0>`~?QRa6z?dHdL$B3I@q zA1)Z;992GZX1!T*ygLKKJRIjQutznE)|XSgDxSWq%4d_VK4pH!sXj^TIaFQZ`5@SD zPTAf!Mma~7_sv;l;>k!GnRasDBJ=ZI^$}WMN!2Qzr+0jrw0ZVnxo^d zy>@1(N)NY<&#XmyZ5Zyaa4pF_uB`q|7kD03-Z#(GCi6TO9h2uur#}jE#yLlopV8G+ zA4yJ1ead@{rGb~&qsr@ipB)rWLQwV=S9-w%0w4eaAOHd&00JNY0w4eaAOHd&00JNY z0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4ea zAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd& z00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY0w4eaAOHd&00JNY S0w4eaAOHd&00RFv0{;NNYN%ZR delta 1091 zcmYk5Ye-XJ7{||U-Zpn>^U|cbwvn=?p&$h#GcX#aq7o~N&=Eo(LKa0|f~I}SC_Bev zl#!W5~j1n4AWs_ z2BH>Jx8YiNGnCnRwqfxjI*f9a)7p4-@krO~`sgH%a>6EJK153^kIveSW$*jgN=~ev z4bcgzQLJtlb0?)xAoBBpvI8eHFFGK(R4X`tYp*y%-#IZd_ZZ?5}HVw6w1tdWHG$*-7S8Rf)f zR)~YjFZ3GQl=h90r%oLHj(;v{FI!JC@Ap*TcYCTvr5f(b{{NE#<%4FU1EcoiQBe#8>5lR8sx4t7S@l={^zovaU;`$e9JwW{8hO-}rgefn9m5 z7$+VaJEVe~rRqdK91MBJW47UV38b2u{JyXL&P3W{)=A-jT<=|yLLRwpyGIH=l#6{f VQxH^Odm}P1Pm}LvCTj-to&o-6%AVb7WV-#hYsKfvotqhss*zb4SL}WMl-CxeVzjMy# ze9yVJ<$QR{`S6vV-@yeQkIy4`=t4IW-T}Vhr@reJ+5*uE@b7``_NXPZub?_K*2` zbYBen#o>`3_+MW4?@#>u-x25pOGX2N5I|u}GI^25XCaU1Y_~53a>_jhnHU!l2!*l9 zpr6Ngx7)>Fs>dmZOstC_pfE1#qc{|MK=>|s1W$0`DvE+5WQ+!Gg-o1_;6veZ8mu@P zd5mS2BTtkpA(_06B7V*zPU53Slczl_lYri#Y)Lf88l&E@OcJt@Z!!&@3M*O2By*us zXmBd{^j-4laprm&xOd+uhs=7;%%s6>d&4ATGC5O4gKLVYPa&h?%ndYnb^5?4WHxZ7 zng$^w-cXiNqr@Z><|Km&zwnPQjY?T2#|7|nEe)KS>)${|i|T>Gg8w%n7&YRyzY$vp zJDiXy;Eop3;PJU96w4HL%DY;K?zZUeG$0zboQ=dyMDz94yJqru%B+U5i%_&FioAy~ zj`>I9)~*;kYhJe6pwi@JWwPXn zAb!&RNoiP6J-rLKg@P1M{)pJtR@t^?S1frq-JR0+9k2gP0PnDO|5B>gewpY#71-U1 z8n~dNDk5>=zz>NH*zwTukQ+Cyifx|r53~t6a~+*8;%{Qd08zf%##MkmiuX#%=vp_9 zO4$}gK0u|M^p_%Td2=5!O|9{j8kN4@?l5GOqDs;n#Ra=4TnSyPmlo+!C1$y)S*~Nr z?LkChV$hUCX-7c4gZkAfNwh6i6I-Sc%;hQl@UJCQyZwqtoHG=Tc{b0(DLU2j%%|*g zg!8>0=g$4a08Uw|W+$aIm1%8h>4-;a);YHCz&!c#k}9JL^GIk#U7b%^ZE#B7pifz^ zekLUr0ljtosj8a`v}I4A0|8wYnS1X`FpzE@(BXepdVN4M2*~LN>Wk73b3n3mS;>Z` zDxEnW3nZ0k70sML)tSoN0t{p{s_pUy9}wl0I%QZO_aXk){cs@K<~i=TsB9k5@$8)wh^R7(e1wR8@)KoHqedT5ZK0{TtjSue#S+PDvZ=y!EK#Ga z*=WPVw<*`4E3f8SmT;|6{({}f5nYX$iSTqyh&@HG_&%V3i)i$Q7T<|S0`-fSWeXNy zobq`%iql0;eF8l}I0yVV+g=N{K*ru0ucH(N_3Fk-T^*v4nY8i}J*FusGnlP-fb`A9 zCbNmtC$WEu^8Uy*?9jn(nX|idf>-xat(+^*!F{O%NS-S|booSWJLWOZtesz)Zh#>_Gee6rwUETJ&jhUbVF{Y%WYwH%&(uvzj<@mOJB=)1mErP^M5Toqv9lzTUAZgl{wau qYTPqvv!kJc`+aGQYJ&_B_p!H+@29=w=ZLA>}t zs(5QU(u1PJ*h7$bNEgJL4HgN@o5HIx|BnZ~5akgzgXL7~bYWwegAJd^I+QU6t!=B)f~f8(q;zrAeFQpVF=G;ek< zdhD&oq}(QbfI2)g?k~Fhl-A!!Tk(>fN$=B-$he!z9+%r_R%V;|MKhP2QX%X;plLc8 zy+Qi|)5Qg*Wi#n6n7R64iLkez0U3QkxX1LBOxgpL;+gM+eFcq?;qBbBe?aJWRv`|x+ijN#Lkhzj=29I4gkgn)9G>4fwI*;dtL2tqG2*nwML6)~ zE7t`^q)74*hX*;@ARJPcq8xtgb>sy`3%XSv=FtB>85KC(;1Lc>Uqg&=M9E_uN-Ls; zFs5*n!}c4W3WTEy$2gpyzcx!arZCQ7K7RH9VO-%jhojy{rwPXuPH;F;57!7M6i#x; zA72j$oRouG$Vdbs-+Xw--ILP-69ur&lN{=6RR>{GEh6>rBHEa(bg{XJ!<+RgVM|LqT~#dHMJ6?DarSIs3-Ke*c9H3QYye3K$(0HV7;`z_?&xgTb;1Oa>s{ z1*U{)2~0eq-6n!Bj%?It*me_%p01d{B*$TFWMpDsYRoWs-UsFFSqV(@nIwJl^K=vp z3>Cae^AwB>jLZ}a4XljJtPBmdDl$SC@*LlSIiyqFY%o~~HHB#F}q z!^sH+;@h(dn79~)Oj0aNl8sW5j7?H3jZJj}g4`#+b~4?*yO7D1Z&Lt|fN0mIhhTFP z4IUxr$%+ZjZE(2I$V9>2H-sT2u_Vn7!MOkZ%4kz?|bEZgapc}&8azhv>S0t0zbfWV{=Jfdn(ieG_(xUI7UK~Glv z@EBKEm>O)CeaN_jgUw9O$jF#sx_%y$?Diig8AaGcCoHmm4KizsrUQb;ZI-!}f$?_P zi`dP|_AGbrArb(8mCWypykSUN)w0PaBcObJjyR1ggxZP=CWnhTS zo#42rzR&joWL97iKZ3?*mXQh0xajjv2K#l^EhHMBSte#U&HC`m^b^QkJbh*e8n;=N oRtC7!TU8?8XOLNv{QL+SpIL@LKVqicmy8@@8ygzzhcGq=0Eh7b;s5{u delta 660 zcmZoT;Lvcu!SwJcmV*ooOh5<(EDQ{~P+Ag5GlJMaa0NoaNw$fFGQ!`#|NsBL{{Mgb zdj9X_?B(U<^#vPqrr1wx;8^4!uq}X@M?lmfVdM7Bjrt6x_mJr6iV4imC%YHOO?E0! znan+rcY1gtvkOo_etMq)v(faw4$Ruq`xqI;w(BM_=W|S6@RMWuk}PK1$xnX@Z~v0T z%){DLu&jX5VOapPz_J633#J(`^N2p@Ir<1>Q|xvmdb*+kvmA$!sim>0g$cvtc^{Ow zXBjZhX9C(K#BO9|U}$A%v0cfSnS-0rV7s;*^Fv0_7Y=8^=A68SL{C?AV3tJEWH~vZ zKzw_a12Y$+kg=($d0MJzYFe7HNs75{K#=?7*G{I}cRMn>@-1u-ST=#lV44Haf&AxK z-hdqV_W&z`Mlsmf%G4Ou;G|@el++|k!xU3Pguxe?1NpY|TwwYVzpZriDpXwxgqWWP$7E|LK}slSM8m2=D-{H`X&Y z)-yCQ)iW|O-W*f3gm+?r#G(fYC{8?f=5z-Ss6O#`E8 NU^ER3_cRb82LQj$1;YRU delta 1273 zcmZoT(7@CH#1mu~87ImbGykt=-k7*newqR!kLZi+1=~9}>NBkQxe!55Ry?3K**!sm z(PVSNf!%D9!HFe03dRNszKN9zMg~S^3WkPOCKgsEX4B2o86&3mxHGy*=2-e?mh1ZD zrzWRYT6$Hwdi&;;&1Jr_Y6; zL3U4fS74N2w7_GzrImpN$nu3^MU|$7;rYHL0r8H3X70YGj*fx({@Gwlw~H7tzTsW; WAYo&{1p84u8U~|jU?io14SWD)*hEN7|%FfcF!@mUd`nLr8*7fy delta 26 dcmX@dc#d&GAM=xLzljqKdD!g}kE<|1004w@2W|iW diff --git a/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/79fced940f0d6da1_0 b/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/79fced940f0d6da1_0 index 29a4c2f7a0dbaa347c03dd34b6f5ab06ea8857a0..007d92d79bdeb64ce7017b5bfa583c0c74387398 100644 GIT binary patch delta 54 zcmey#_>*zMT>13R9-oeE)Mt=jU|?Vd;*zMT=_3=AH40{sLvq5z`(!^#Aii#W&$ZNxab-lt2%rz7 diff --git a/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/8484823b1f8ea286_0 b/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/8484823b1f8ea286_0 index f143d3a115be1a6ab4fd2d0e4dddd8092f8b8f31..9e3c66cbefd3ccc70df9f7e1dad5cf166d171276 100644 GIT binary patch delta 54 zcmZo*YG9hMME>P%mrqAF>N7|%FfcF!@mUd`nLr8*6e9U19ya8e#rE)v3RDOHu{I4z delta 54 zcmZo*YG9hMMBa4YowuDE^%*1>7#Ns=_^b%eOdtgYac+SV4;%7K+u-zG1u6spqgf3< diff --git a/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/a0ae8d57174d5be0_0 b/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/a0ae8d57174d5be0_0 index 71126110445f952fdeef5eb675bf2905b988b1f7..60962f7a2e8471a8f1b25789af7b1c07cd4f9ff0 100644 GIT binary patch delta 87 zcmXBBp#gv}3;;0ZIR(*m>$*BtTE|V?03L(o2!7z1X#`0RJ?z_DRfQxXIFKSWcdMG% iuwcv#0NIyfV9BFq5n>e}5WyxyiRFNwor9^Hfs?thiGi7$nX9X*i~qS0091r6$bzS diff --git a/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/index-dir/the-real-index b/Covance_UCO3001/browser_profile_2/Default/Code Cache/js/index-dir/the-real-index index 06feb21bd258efd6dc29790caa36285b4f049805..87c0a480dd2d3219b816c58e6b8e47688a16f9ce 100644 GIT binary patch literal 792 zcmWe&W?*2kekPD#sZf+!l9$TKz`!66#9;8o7RF-8cl6G`Rh}-=aL|5d=SF=7249HO z%l1%9+ZCTCGjyDL3>No*h=Ls`y%$G7>Y;`{i1rl^?_Iaxz%|(&VD(H8 z^>@1hZ#RWctYTo_yd5kKbQcJu7-UY|9_ixAP(Kl3K2&_dlhRuivG(!}32mRi=0nAw zU%fQTocS;N0TuiAVDTM{U~|fprlogJOl_7>tE9k4J%{=L`>`(FI`4)@nCi2AnU z5-hv+3H&@zQ1uFIjt@lr!dzbdDR2K&Iv9L}*b8<4*%J;Y(@zI7!_Db|sNdgx!ft=< zQ+as!ltRQi3UgAFDa5$NMI*=J|P7lQV5Zj2) ziLZaGhO3u{i0|({VYk2bsXRl+If(hC5OF_IL$$;$=Px>V9@-9e55#zeg}J=^Q{Mim zJaDV>9kRbBJSn|Z5o<5cz|9X4hpL|@r)zX+Y8emQzrGOjeT!F2v@x2H$Z$<>FW8(N z5dYfGe0k;RG$|{%dT2Oo`gpJU`H9DS52$T@iL8EYtFRu6-+d8y_!vj~Z15w|t?Qt%DS4cCuf7=%I$y+zIw7~rfHRok}sHN?SPm|%{ z<^eG$-_bk&R(ZMzJp7^lz1tOdyD5BP6$ATbl^D`<;-Vraye&o}y4}X=#Cf|*h6Fl zU*!L=S+GGlUnSz=yts$Oz_t{Bh;ejtVckaSLBQgVJ#0Z3Y5QGo&gm-#rt delta 154 zcmZozz|^pSX~PqHHAZG#wvx=;)S~#D#Nv|pw9KN^6bAi`of8*qd(Xwdz`)4=hJpXh zX2F6-{3624x}4~0HwA3xXB3^hBVLZZ^Iglgv&xK<@5ajsc5YuVaU)1S6aPa7{*U|* rHw!vk<(KDYR%XmeOiIo#D$q;L&lTlkR_093FH6izP6hE76(|4z*s?Zk diff --git a/Covance_UCO3001/browser_profile_2/Default/DawnGraphiteCache/data_1 b/Covance_UCO3001/browser_profile_2/Default/DawnGraphiteCache/data_1 index 0a47df71b43fc437fb1eec5d14cd5abf7c32ed1e..bf087cbb2a628a7484d2d93faf1cf8b9173d4427 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM&XHp`pq1Q?Hr1XK+LqALy`H%KLD+L3RVCB delta 31 lcmZoTAkc6?V8aasM&5~m`pq1Q?Hr1XK+LqALy`H%KLD)%3Qzz5 diff --git a/Covance_UCO3001/browser_profile_2/Default/DawnWebGPUCache/data_1 b/Covance_UCO3001/browser_profile_2/Default/DawnWebGPUCache/data_1 index 1d68681b2292d3dc4b7942786a0efeb65529d9ca..760c70363af5d8c5b52bf99ab2f08f2278556b33 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM&XHp`pq1Q?Hr1XK+LqALy`H%KLD+L3RVCB delta 31 lcmZoTAkc6?V8aasM&5~m`pq1Q?Hr1XK+LqALy`H%KLD)%3Qzz5 diff --git a/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG b/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG index 724bc09..eff8161 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG +++ b/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:18.385 63c0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/MANIFEST-000001 -2026/05/29-14:01:18.385 63c0 Recovering log #3 -2026/05/29-14:01:18.386 63c0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/000003.log +2026/06/01-12:26:10.343 576c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/MANIFEST-000001 +2026/06/01-12:26:10.344 576c Recovering log #3 +2026/06/01-12:26:10.345 576c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG.old b/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG.old index 3b7a0dc..724bc09 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG.old +++ b/Covance_UCO3001/browser_profile_2/Default/Extension State/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:01.647 5838 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/MANIFEST-000001 -2026/05/29-13:49:01.648 5838 Recovering log #3 -2026/05/29-13:49:01.648 5838 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/000003.log +2026/05/29-14:01:18.385 63c0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/MANIFEST-000001 +2026/05/29-14:01:18.385 63c0 Recovering log #3 +2026/05/29-14:01:18.386 63c0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Extension State/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Favicons b/Covance_UCO3001/browser_profile_2/Default/Favicons index f162c6abedf02b14f0ded3b1d7be49af252f0d80..46b42e2083616ee81d9a64512dbd27a5b94596db 100644 GIT binary patch delta 672 zcmZp8z}T>WX@WE>D+2?A;6w#`M%Il93&i%!+Ff|ME3HS8# za;*rhbSp7R@-8egGE6oPPEJmXbTlyuD|a$6^$Rig^~v-%&95+wa*0e%GflMgHp%uY z_nFLN?%|LgT9NGGo0nG@=oFch;g(mJ80F&;XyNAXTo71NWm+0l8JQNC=v$WU8y;xk z7!Ydi@8;|tAyeJS_R?aL|4Z{v)-Zvv zR{`1AjGZT!8Vj)KGbb}nzN;=V`GUE@Bn6hmED{`SjBIfXY;iyvLfDv_<@qKTN)FXv MQ~)Nq|Llwm07w?bo&W#< delta 160 zcmZozz|`=7ae_1}3j+fK??eTAMwX2U3&b~7uyAZ%V`|X=4VD)GE=(QWQWadcexyP zug597ZSGW-%{E0o%Iv=JXxd3k^O5&6z4~0r#C$~Kt->1-(VD`szhgeyXfm#4*m(|9 z zwSy)$POh!=PN<*WFr*}06s#OE>#o94h3>}bBf{ksQ*7=#W!K1I{t@L0{TS0Xuh!G( zblo|4botOh#f>9pl{DA`6;r3#Z9(^4!C<&5-{BZFv%ujTI>J3<@PuK`+D6-$qN-rn z>GxJR?jJgHuwuGOm*xGlql(ZTuXfvszotx_qj@5`B(lgkK;l^{^R;a!C-?3)&w=4? zZ#?I$WH?+$HAGCtsgYbyxj_v%ad2k+9O;Q{t5RLgbW?KgW^iPcvzHjXz_$8?>IBq{=^(DbXbPbozply*?99D9>%sMXF&T!Px&ev*Iv$H^*jedJ#nz=(Cc}7 zurpcDus6{&Ce%-8s4o*}wkth-+N64u$g;iY;H2sG4WViEW-_sLizm5z$uq zt-?}asxU~%&|cLZ&~DKFUK`M6Ym@mi{C55szLBrw`}2(Eu;vZTp1S^yi z10E(YjLV+S7R=cyL+v=V;=jiNgQNDyoHWf=WWw?^ahy;lfSV52k@}r|A zlNv^L1;W?P;4_oWPPlHC5nhKy2G_mgre%(#49EXLkA@w)@FRq2<(s>hWi_qld$}qy zNoUrpum9IWcBZdAiPEX+j6g@#b?PjFsSHsAp0@R~wa4fHAH7Ew%4Vra!_u@=reZ0eSfXMv zprJ^`LO^|iiur)LJQZ^Rg@G#i0JS+PW&`qBDtZAm9u?hyCKsU5siH%JiNnYotE24z zwvAuSO{3W|v^=71_FJ)twU{Ae`W}6Y&Z2M7m*^Neg!ZG|=tHy}ZAI^(R`fc01-*#Y zqE%=)84`_}I98y`07?N$0Ez*M015#L0P+Fy0CE8a0{8%O0I~tH0K5Pm05^aOzzN_0 zAh`>WyFl9jtQ;HZvFJ2gCRRnXi~UyVchXF0qBKsblnN!6)L%-Ku*8U$#1rCSahJGN zd_#OeTp>O#HjDLQSgax=*lK7JS)PW84Les^hXXrSY0M$JR7r;eyHjz@Av;o0hXcD% zVay>rPeF$RyG?$F13OG!hjXT-Y2KyWm`8S!fgKL)9=@1Ec8r`32X=|YBJAkLdfmQF0Ib?0S+MO(QMLRpXPLOr$h&g1j%Kz(B9kRz9viNKpm;9lgxv}TZ z#vZSp$P+bWtD*6a1gSe-t6PX8>BgGA7Clr(QCv#lw{b1L8681Sq6)-Fo1{AF7V)UK zl+2&$qEISoXki`}m8}xpYk<@4mcs-r-f+-waoB7wOTgjrTf6~#z+nqo1O8B`)Sxm9 zQHI0j3finrtHtJado2!Y$Yt@mowCK_sgWJtplo*rJf(V-p^q}WZoAVSb_XpXhudy( z_?=;kU-s5mtUL)yLvFj>ZwcBRBr9i4z!D%=vB-{)t;XsO zdfo0|>n4e=U{XcgLg63rclZq1GLPYd_!ImAevfRBZ{n7Xru2n4mFH-I7Dcr&7}Q2j zjv(Ykov!tRG&-w#Kr-4u;q!PHxxg;`E?$pU;z#f-JRav^D^ABoOri5+Z{Cfzpbg|M zHlrq#tRaO+2UYt|vmZW4p(NFZ${Y2&s6N!ysBcnzsG3pVsQOS7qdr!BsCZEysXiQ( zqQ0d1Z~z29jY4D=kOY{H0Lh>swW&kDb?74cEh8D%0SbSMzr_3TcHD|z#LLOJX5&ft z9x~QEY{PwV66Vk)^ffv_#`OYHCcR1vO{$_k8F4%fTaD`KlHy#UOPs4U#kssO&eh;J zmqT$bE5*5th$N2J#e@xz(^CVI@uN^Cx8lqA-^rtT6Q9Jdl7YR1kK(oDss91*!3y4q zmym%zN`^8PtCdEd47Eg;1SoU?)S3W!BcKKYatM%>02vV~jX~MInI6byNR*=8Lfg7a zC#3_@d(sAJ1=+HvNOwyG(g3NOL}XqQndDL>e;3`AE{-;Z(I!9Io3vY6CDlqk35lPJuZXk7!D5Qxlwp(M5yRbv{`$-ME&7M`cj35hu^sV&c)Hdpeh{-shNiLNrK|^yoj^lZ9tjlKCFPOkn zhfBJRzqq3-`Aa8rPCbKnv~AQ5OBo@NQ(u%MP&--az&&QFwD)Z=xIzGZB3XDKM)AO$UvVsDB{6~s&J3^XQ4#qs3aL@7(j z4;&pixvH}iyv+b9XhG_gs8n9O)aA#PCrHKdWM86`dFB<4mYe?ASqe@VAO$Uv;zU)- zIxt>p*UGgCQt>=WWi{o*v-S-5Fo6Z97Ept>P0mhCaPHaXIO?nV5uFo^qmVh96|b>* z(Dax_Q*@TY0SH8(ZIitTBAor@vmBkaxw^AR9EFH@;zhnl9}^RaYQRwnG@xyh-BFFE z*y`h~)!R7gr(th)7K!6fJ6tZpV(IAW;~65r&HZp}9Dy9sK;#5DXsInZmr*-pC-B-= zEiY(qt?kIIsePHl`7M#>a{NLq=l;c=)qcSO)g3Mw#uihfvNfY_eZE7mL$5u*rdXon z1&f^!J8dqTdw=zJXuxWdZJ^U>1JevH_?n}3R~h4SY*$h#1 z-A89C-|waE%ISTyRe59|vF7e4R_cCY89yaf3s`Hw%KMa9jswKn1J?Efgd03St}^)` zv4qcvb?E@@QJy|XI~B`8Vr73uyOd83l8&{X5!$rR2+etj1n>QfwkiL4h`d&Fh*+Zz z6YCOKe+6s7VPZ9YPOR>q6H9l5STBOL;t1h-j*zQNJxZ)YM~U^r5hAquD3P=s1<7N? z5|5GImB;7_tQjp-w8v?=2l@$JL?_Tuw2#!IE$A(@9<4!7p@pQ7=Ab6QEKsBt!kgxd znAI<4^^IA5Vpe+0N{d;&V^*)2l^U~p#;lZ>b(3l-(mDEykrOw=u{skMAxe5s+)Pqy z5qk`n=QEIFgw{9DJg=*emXl{QCRLNLh{@YSscWMbcO}m4vvg`q@Gc=m&g+who0UF` z7+Klf#3U(a7Bc-f5_DVZmKLUvru!@6lg!&%_`J3Z-MLiD_^s%3^eH)Fet@>2|3Gh( zx325a^Jq0%L5}eY(ZlFLGzZN3Yj)m$GXYK ziaMWSG`ryMjE7gbE3_uXfvilz1;g1%yw2cs0&ZgL7&bT z`NY{Hx?Yx-GCh`6(j1#iH7MFjrXSB(+0*Jr;YGUnSv<@V`d?s{=#x7J^Di(-grq?l z@*L@e=cw<}F-EK|gx2a&%uu@Z;z*`TN*5DvrG%^eUr<;4r4W|p^48WabxaDcgd3TR zU*QWU)BIlC0v|oTp`ormOVQ0@s{7xlUooZ8MrH1AnT*Ie=d{+J8W};$V(OBjZD!6Y zyPstw<&!6wbxPgK#2Wcb%xa_8DaY3_QtNH=nL{EkF_{!DQ;dt5Zagv1QEpOqbWH1& zAL${iQvN6j{QXj9r%v%lm~}`mK1C%nPKt4&#nM5=xSB~3q;y;+e#D$1JPi{S?%Kkv zGu;_2m%iJD6nm^(7AOxdCzl+umZ{J|y>yboVCx)eO9)k#u3_G8eQrHdM=M93W!BxM zH!L7$PB$fP6ukUJUe+{lZ?c!kjl6FE*Y5A-iR-tvFpJ|8=;clfSdvs6J$pQ8d9as|>WYnDUiK=({|YOl zvA*t(VC@Y5lwjzNpmMc^(ftZZEU18+BIGadEiemAPbX|FDN6cJbojFo-wo8KlL}uC=qV3{CW!|PMY;__D*rI|9a~NB zq&!RVQ`z|@eWdp1KK*2O$QrbVEn$c3A)mbmLl(cwT4QmC$mjb`0&=h>V*GC4?d6rD zhE^8*CUBkcdH+B>d?IjW&7KLGQJPWe{|cOW>4EW)h2ND$e!h}U>(n&K7Y{DKBVcg^ z{UM9PZM9iEp`gQJ^VmW*cfcL0pn41Bvr6c~|wKR|9eSsFVV(W;@~b-IQcB4H#?uCpW1oI5uQeF<`Yqv_ z8W;I;$m+KQ?0&l?Y!3zffsiBQvdW$BvGY3PJ5s!!c*yEp?=wfa+2mJsGWUK6_gJ|a zA^(aZes4^NH_@V2q&io3{a^Hgu3UIT`=M4O_x&^btMoC>l6{e25M_b*$OK<}G>&F(&Vox7E~7Zd1xa!}mt|8x1k;L<0qLbg)3iofIA|*9^jMXv zlW8?0%MFhCOlzjnRBlXNbZVlPqf8PsWq^W=g=wgmTH1utx$AEAM}M4i&-r|RkMld{ zo>Nn!)YK@oNe(B+aTCL1^N`aF`crrZndUL}dJ;$a{F%N zIO4gvsW;_UKn~-uCrb`<;CO(8&&51L@g|!3tqvS=)aBey`#!>8Yzri-Jmx&+`u?&l zSM^LV+B3#A4F*cEP=ZCSJb;YhDM_?_6&_)nnH;Z1On+Kkd;}JA%fk8+98&9YytMB$ z9!c{`Zv<3s1Uz3q=lhTnRa5OuQQ_Q?Wt&2-f7}M2Kwx}3C0V}VcJ}x~XN;Qc>gaT! zk#rf?v#X=Nzv|gTA<JN!H)objSJ)-H`(!kA6d$oQJhTsZZgbFwd}=qIslO1byy2Ty9PDzqIO05 z4XR<0HlX#x6EFuJH1!o)Q~$~oM7-cOgc`Pr_cg=4;S%wxVMC~8^YLm^cxx5@uR)W0 z-(Y@2KH}p=66CZ>rPDP-Y81yf*YTH0(9{cv75oyvqr{8qeh!-9Ik;2n(caJsHLUJ8 z^&P6UUqyvDUW8T-{({SJj@5PoI-vtvo7}+xG*}+jV%;Mkz%wk#_d&=pfM6&rmiQrCy^# z3-X!z*D8+p&}nTb!HRD~=g>3!1kOw9$FMw`L4h32r@f{AsdZ~h)XC~5#{ zUUvN=Uv|xw%jK`7@8nEriS)MEA?1i^;uhg|NfZ|f<-$Q{hmh&abMAEPamG2494q@4=p{$MiY)PlLN<)kC*FX;a;;@(s9OI zcgEORn}s6Gim{^OjP=+|DTuMXHk;aGv#uC}9>%uYOkEITiy3R^wb9`i>gYk~yjH=b zhxNN@T`#L_r*0@&tpEPM`qK3Z59&$I;CvPz4zc zPAc>vzo~ztQRg7Ku3*@7GyT`YA5Rj%r4D~ znsrjcDZcT-0Ouwl4h{(>Ojp;s4wI0pOdgO!vMOzpJYtLZpfJzz9vNWQpU}4HcoD)@ z?hHIk92hom^TYa6{6bCO=+GRzz=ap80*Ca}T%;K8tX%4S2?H%I#iN*_L={&=v0p~| zTvNc!JoE&(e%px~Fh8G}Acg(bN)40OOXI125oiD@(BSmI~^?-N} za&l5`u0%iIfV~YRh$n7-5@oOb?WV5s(wb~1TAMqKB@P$iMA}}2XIjD8xENU%AH_E% zY9P+%#A{jt{4CB_S6U+%<3y)fn~kY=IljXf3@o*Vp2wm<6p~DZ8hqZYy$f5(Yw$11 zZ9pF3pn(61SI8q;t=g%MRi1S<%2(xlX`M7hJnRUWdOD#6+i`Ql`&gxq4x` diff --git a/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/000003.log b/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/000003.log index ddd1ef146a768491fd5fe5cb18be91ee05ceaf49..bf7992e7ba3a49669ee115fc5af48625234b1019 100644 GIT binary patch delta 1085 zcmbu8TWB0r7{@b9*)$lF&=QkYq{|?>wOc!L&Rovfhmd5l_np0DcXqQYD6@0fO*Wa$ zZuT;hQeqwi-%31)f<=6i_#&2l>6=<81ql(QAmXJ29~2Q4eX&}_$!^sb-}*hA?>mS8 zcR4@!_V=iti08fi==8zu^QY2&YJOyBW3HnDg3o()9=0YOpsj|b8FY}|j0wFWSW>t`x0`CMf= zwG~HeWu2t0<%P<4E8@fxAk?#wwMC8|d**@*1#Ivo)CzFG{KvF`Y+hJS7GtS+$X1+i8&nd_7GO0or)g$sf#V9j zMUGG9MLD^e<{LI!UK%fHCa>ZIS5Nhl1E#tv06}K~$3v(ZNYr$LXgo+V)_Qk1Y;_??; z6Q1OQof#!x&Hg$DSq3o(vzSbtz3Og`z%b(V`=5`G`d@uz>Rs=N{*|Yz)S3TXBOwSy z@~2-OW}$xO{Qe2=+h5&uru9;!Y%nCG@B>N#>L^5aSO WN0^6*A)kcoNABMJ`SpS5n*VRn@Mj$W delta 9 QcmaDqnQ6sD#tkbx02hY@UjP6A diff --git a/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG b/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG index 2d0bbe6..e04a3e9 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG +++ b/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:18.002 76b8 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/MANIFEST-000001 -2026/05/29-14:01:18.012 76b8 Recovering log #3 -2026/05/29-14:01:18.015 76b8 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/000003.log +2026/06/01-12:26:09.910 498c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/MANIFEST-000001 +2026/06/01-12:26:09.922 498c Recovering log #3 +2026/06/01-12:26:09.955 498c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG.old b/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG.old index 12770e9..2d0bbe6 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG.old +++ b/Covance_UCO3001/browser_profile_2/Default/Local Storage/leveldb/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:01.260 5fdc Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/MANIFEST-000001 -2026/05/29-13:49:01.269 5fdc Recovering log #3 -2026/05/29-13:49:01.271 5fdc Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/000003.log +2026/05/29-14:01:18.002 76b8 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/MANIFEST-000001 +2026/05/29-14:01:18.012 76b8 Recovering log #3 +2026/05/29-14:01:18.015 76b8 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Local Storage\leveldb/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Network Action Predictor b/Covance_UCO3001/browser_profile_2/Default/Network Action Predictor index 7ab4ede544f73ca98d3bbb07252ca55b94b3633b..2e47fbe3f74f469c46a792bf162e006eb8dd26e0 100644 GIT binary patch delta 414 zcmZozz}&Ead4e<}>qHr6M%Il9zvCE1Cdb69YCpfatLyxZH{w$AT>KTq1$sG&Ny+&| z1$xQ(xdLJe3|g!iB_##L2D_O<1SYSE*W`M%bmsAMAoYrq55|iyGH?D8|CL`{M3h;d zF(*GgGY`dpO$9IcSVdU08#5*+#4ED>0^2oNv|gSYXtbvOt{02C^?psZua^-9@h`fH z$Ch0DYHz?`!O$oqFgdSYlWp=ckad&i)+;hHPu^c|2(<8H{SVw0PB7wSKTq1$sG&Ny+&| z1$xQ(xdQwO3|g!iB_##L2D_OFNHLY$NH>NVNEf~}i8w_cHvY4ZMhL!gBp>wn<3aDovpP@(Z$RklM@5AU75adO<; zn?fJ#1sR~A*_ww%yDbLdoS84)&D*%SU|uRCqu%6e^X0|$9N-GM_}?-x@gHU2zsY}e zv!K9E{>eAi3rq3{Gix(~f+;z_EHN)R6%q$aWic{L*5BU%Bsc7r1CrJJPGY^nBBuL)ohdB*rUd(biMG@kx(;_S*^Zf?zH%WQ{)h zFyK+NI%D_QySrG+cn$4b<1y{l(cPBXj6h{1e;dy^tQJ-X%uBlTr)8O$&YI+^tRWve znn*WyYJ=r3>IWcCQo7ev7k#3p0|*@4P89l7FFVfKo!F`m%~;zYTFq>p)lXtn{<4pT z=fW#(yss5pdY=-OcoNVL_W|tvLs^sG$cD<=C|RLG+Lr0d@0m3sezY}C@RbT+T@u=w zoJfd{F_r)ltXn!ZgojVG?@RS96~j_NUOrMM`@S(x>Vw|9@Km+dne^EV;*uq?Gp6L= zqL$`47&@MB7TLCICyh4_UpD+*i#0`fDS3NT;(%j7I-u+XYH8S#8Stup%kT_}=oFNiM8=-o^uyalSAk6eIJ5n)|dXv+C*y zpUG%FP34~6EMXpMa_IPG>B=t0iImyk70-h6K#|n}%h%oEFGy4|fMU@1wYPf!*1)l0O6^CtP{(U=t3o~uU_*S_jt)uZzJ9qPC%9mro zb-XwGZ3KLz0j!ty8B{p!k+O%S?R{ zSeb0DluAE;5bzyOh!kqoFOLpNw7E!hAe2;PCP`H6nu5hWmrK{F+S(e0vcYR!R?``o z0KxBCb4mBvc|mJV(MM`Ef$lQS#E-#U?_61Rvp1{~`=JU9Qo!jT^>(lcm~oSK)+bseIv3T7k8d+%Ec3mNcoIWmWLwwuUWW6Mk0QJ2Li z?j`hP;C?eFteH))E-bR_cWGHvA)RY~{+Ukl<&0^(;Hr-{MniD3nPI#>AbbY_i~PR6 zslZGwX*OqOYrzcNR59{$c{jtTVL-&>gVFwb#!P)nfH}Yu>=*rkCpG)g`Z)oeP-huFY{vA% zmFK!Xsb(lCw`5FHRZXrT7%y@t)3e*T;`o zK2c&&qW;r@P)Pf)qdif<2&~o-Vm`j7fnYaA7&xxOY!&CRI#sbXDz{x|&*KHs6&iK; z>0bi#Se$T4O=nP=$kbjer%e&{t+Wc<$y#9NKyX-yb5aBU3}<_huAU*Lw4+n$If2afv?_D(cNVSBlkYN$ zOhGhl9U(2o{642)OH{EIe|JABq3w)JlAoj@r@OW$v-pg?M-O5aFo z?|XXvA7{?qRJCQeHjwGs$vmn8n#L~R46gStq{+LH&(%h}>fr+-oqEWq(ffGu?L9_B zYS!dqp3eM0f!F<0wLQHrVff(okKT_MATf(_pEr4eBiUqQ9cH_4qoiDw>zY=<)ib)J z^U@Eud@uAY-chA?&3Szd8THwWFy7YUFg=Ns(zJP%wvv|K1+BEEvB|~bk;hJxP;&0nTsHeX+VtB@3QL-| z2Mt{3Zx2b-MVeX2F)oFA%OHU8rLPhE0;l9GlUH&Ak1%~ZA0Gyy?~qJwxy%N{GA7*G zlDit3wHz(^TS@h7<+GKaZr?!z*D1WHs#V$haI8{!ZqDBi9e;yDhB=gpu9PCFPgAo8 zGChHfmuBC2>Ytn$tjq16PMbndz`}zcYqBV^LeF7c!(3?)#vziACx4@np~BTjf1PL? zq`VE!p|qHZ<3$I0wY0`j@3%B` z6*cEx`p2s7Ys1?yl8&u$Y3N)D$=s`&qge9Ek>CUmh1FvJwB}ilH*nR7hP(y(6V;G# z6Ok{Qr#E$6Xs_(Qa;tsb7_kju@Jo^%^BKQASZx@BH7+L}h}rJ73I;JVmRH=h%nYx1 z61}Ivmov(#?3Q+6WN;V|+Cs7&BoFonHQlWk_OLH9Pz;B_o%P|Y-mE55y`@HJ>?ve9M`uG5Dei*|HuNnMMBc4+Yr@d|9pdF~(gobUJE@8@}L{6j$eLqMiDK!7N51|UH5DM1{u zV&Qi^!pi&R$P+dz?yEGs4jbzoIW>~CmMD&}k|<3G#s*#rfd~8g`D3q!!u_#VE@7@m zs;lJ$!o16G=!}-A%d+m!-<#k`*ebCGaC5Wamqb73J`@AESbfLgQeJ2)e9l(Og<@E3 zodKo1=ltNI&(Idf^PAgE-wp6|zYp3L|El;X_M(!+z?THCHV=<09QAR675=-E)}^)_={;up93r#hS$AvTtaRGJwry@mv>Y|I7tA*pAQ!7$FbWx z@gcmqYbr5Lf$pwz$8WDbE*1HDyMHHH&-o24mMLNXafYuoPxbv5b!BC!Yp$DwpllNx zfps#~ghh2!S2G6gZBUES*ldkK;iwud3C!K=VJELDmTBZ6gZ&omMVsi5LO~mz$NDZg zO@=S3ht}UU=TMe4K6`+EhYBI}ESoj;oUc0Dq8a#fSx$z47ro#SfT8)_Uoz=FnFs1D zSnN&X^dhrY+!1jA{j43ICjY9Y-A2W>F6qh_H@%3WycJ3t8GovP%V@H&42VPN z-r#av@bgB_b~)XHZsk>-L2{SCBKnjk_4c8#(@{_jOHbW)Gja@O-j?kQuTyxh<&52` zbaXA|jizh&JB7+!OUaD$kr=j&urcLZvySaLu&C(OXHc;+7YoqMc9j&p@gOO<*xf;1 zdzjkjf#xyY3b|r9BhCm1E_%kfI(BR2u8g)M^E3O0PzFz;`S13^v-_R^9?PGVe)9xTLLa`<{5^7Bv4-nnn)1J6? z*~D4Cdc%FjlhN5&rQ2_KuRXI<%2Qu)V@Q?isxPu$6rE-F{A#@=e z3udJ%JRw65_6DaNo~Vvf?J?YW1o~j+i#8Wi_ayOtg+06M9fM9F@r1gZ*k-vvJjAWe zrXx<(uR+JjrKbv49M|R-cpw#)aAg29T-n*XZF?&87@Jmfio#^k`(#qO8UA~4IWyy| zh8NR~McPaT-n0ahQH|ad(=tFzvXCwA$C^x>K9Pmu`*d_U$)cIq&!>@fD zN0!iwolxD|x0nO0Uw+a%IpO}y^BhV7@ebleJD`cCp1GEQGK|Jn7G=ubFh4ygL|S-A1NNNnVhH_k-xG4Y(fs2 ze3I?<+Ul;@1@o$Ft(3O0l;BS?%7V)WG8s!;y3pWwu8yX5zIFg8?6nSJpA#LpR7js|wZLK~J_$meR zJLG3&$1W#;2#HYf>Ygm`7x!*% zfG{p|kGpY8Ugk^{#$k(vo@lp7x@0(nt_eJ+`m%Q@r`NPdnr~k2O7YrA;bd`Haet>` z-EQ+O2&Hy1=jx9%AaXQ~;NY+|Kv0BSJW9E9q3y(pLfDS4`;RN<@3Cn8#e(rn`HVvw z)*VcC3(l;#@~p}~26M(epXq^AGDPXAli)~AgMxgrvnDlua|%M1+fgN)<1epO4m23; zeLtLr!*8jI<#MXh#W4Q9mud81xWEMh0X*PY=&?I|E_O=>Rg!B~?wYPHq?0XxvB#AK ztjO&>z(ys1Mcio2UJAk2b5fOXYj>x=In|7z(RRlXHKKXk;Z=?~joLuwdyy6(4U;+d zC~L^~T6pYuwntXzG1(J_`@Hn@Qp!LLMRORmLsh@J)DZv_mdZcP7drhd*yJ{nx#}ZE zVXu!8rk;tJs#5Wvuj{-PZgRjk+mI%adJ_NE)VT4yg#CEubDg6x`< z_x@>GrrC>)09fSZyy}XK9;6cN?w%|e3AouawN+^8^~t6v-?9?*WQtP5SdrDxcoX(9 za(G{^BquswYqHgZ&2pOd(NU zT$lqP4pIRnTk&&nb002lE&%Yb{5kw}@Z$i<8ZCu8{3Pqvb&gIHBuUyWDaE`j=N^;| zpJ?sm&(+Glpk|RRj5s%Z)@X}di}I@n?mya4+n@?U*Dc`Isv#-)qGR$-&cZb9?d`^= zWu`6^5Ao4{>O?nJ8MwTg6P=M(M!Au-Ya;QI!u%PKw%Xi;l1^yt!Hzv;y;aJ0;k6JU zP8^4>cL$0TZW0v9w9m6p-_&&WDJ=PxHlCTqI)xvRDvP+wNqx^|!`vDKj_z0l zo&1$n86vqGl^te(XPr4&A#a@Rae2lcS%{lYx@cE8<17iJE=<{eugqH?r!iJWM8J#^ zlaU8+wgv|!IfnCkxreed(GM3xeq-0-szd3ndDj;f?;)Zg8?_A9C2j-9b?p7yY>gFJv9c!XHzr zpno2e0IJK$LA5ws(m6W(>*j(d-&gm>;uh1{EY{l`Yj%zGvhn@lgK7D1&wXn8n@nu& zBjbNX5B^o9!p(trRm35iAZZZZil6HcO)fAOH{d@uR}!TfNkn}puHcC3rILOHUA|fj zcJGIb9ooR0g$91$M7ZA&vzC!s<6TH?ONcguW6qmd=cl!b8O9k z<;b$XM#E8}bKf&>xuvxZS|S1gM*F4>;9RUQjPx_J5=q&%K`rQIts#{I&2xz z1*1Fcf4^AGmXS3-K%I0N4F`ymLebIyF;W&9#;c~pjR0{=^8HbnGAfXq6 Kw^SB22mk;iPZY-h delta 55 zcmZozz|^pSX@WE(=R_H2M$U~1I`zC3Wlblz81y%GzRG*SHF;)zB;V$zNlf4OfP@|$ K-M(j0g8%?7Bo^oZ diff --git a/Covance_UCO3001/browser_profile_2/Default/Network/TransportSecurity b/Covance_UCO3001/browser_profile_2/Default/Network/TransportSecurity index 8cb81ff..ce55482 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Network/TransportSecurity +++ b/Covance_UCO3001/browser_profile_2/Default/Network/TransportSecurity @@ -1 +1 @@ -{"sts":[{"expiry":1811592275.900403,"host":"AMsYuZ7IFgNWVHHQOkqKt9MmwK65kaqBH0lsKFOUFH8=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780056275.900408},{"expiry":1811592097.353641,"host":"CSChKrlj3luqm4YaUcREYcNSGviDSaiJLYYv+tJJLQY=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780056097.353644},{"expiry":1811592277.674402,"host":"eS7TxKKR6KM2rUe5fGp4j6+eHcckwVadZAWT/TaU2RQ=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780056277.674407},{"expiry":1811592233.83812,"host":"e3SziuwfuO2UvuBno+qkR1ObHAzZmSUoJhrc7dbP1Uo=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780056233.838132},{"expiry":1811591355.924595,"host":"nAuqgR4iEWti7SOdT3UHPl6rmZU/DeaIm38P2O2OkgA=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780055355.924601},{"expiry":1811591357.03923,"host":"rBPMDlZ3oSoS5nWA5b3qh68smMftsPTTcEHPHa/8Asc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780055357.039235},{"expiry":1811592078.645656,"host":"5EdUoB7YUY9zZV+2DkgVXgho8WUvp+D+6KpeUOhNQIM=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780056078.64566},{"expiry":1811592078.692922,"host":"8/RrMmQlCD2Gsp14wUCE1P8r7B2C5+yE0+g79IPyRsc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780056078.692928}],"version":2} \ No newline at end of file +{"sts":[{"expiry":1811845753.793792,"host":"AMsYuZ7IFgNWVHHQOkqKt9MmwK65kaqBH0lsKFOUFH8=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309753.793797},{"expiry":1811845588.448825,"host":"CSChKrlj3luqm4YaUcREYcNSGviDSaiJLYYv+tJJLQY=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309588.448832},{"expiry":1811845755.64341,"host":"eS7TxKKR6KM2rUe5fGp4j6+eHcckwVadZAWT/TaU2RQ=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309755.643415},{"expiry":1811845727.827294,"host":"e3SziuwfuO2UvuBno+qkR1ObHAzZmSUoJhrc7dbP1Uo=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309727.827301},{"expiry":1811845584.252365,"host":"nAuqgR4iEWti7SOdT3UHPl6rmZU/DeaIm38P2O2OkgA=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780309584.252375},{"expiry":1811591357.03923,"host":"rBPMDlZ3oSoS5nWA5b3qh68smMftsPTTcEHPHa/8Asc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780055357.039235},{"expiry":1811845570.591901,"host":"5EdUoB7YUY9zZV+2DkgVXgho8WUvp+D+6KpeUOhNQIM=","mode":"force-https","sts_include_subdomains":false,"sts_observed":1780309570.591908},{"expiry":1811845570.644054,"host":"8/RrMmQlCD2Gsp14wUCE1P8r7B2C5+yE0+g79IPyRsc=","mode":"force-https","sts_include_subdomains":true,"sts_observed":1780309570.644059}],"version":2} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_2/Default/Preferences b/Covance_UCO3001/browser_profile_2/Default/Preferences index 9fe36a9..3ee06a8 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Preferences +++ b/Covance_UCO3001/browser_profile_2/Default/Preferences @@ -1 +1 @@ -{"accessibility":{"captions":{"headless_caption_enabled":false}},"account_tracker_service_last_update":"13424528308952746","aim_eligibility_service":{"aim_eligibility_response":"CAEQARgAIAAwADqYAQohEgIBAiILCAEQCioDCQQCQAEiDAgCEAoqAgkCOgIBAzgKIicIARIQTmFocsOhdCBvYnLDoXplaxoLCAEQCioDCQQCQAEiAghdKAEiJggCEg5OYWhyw6F0IHNvdWJvchoMCAIQCioCCQI6AgEDIgIIXCgDOgsKCU7DoXN0cm9qZUoVWmVwdGVqdGUgc2UgbmEgY29rb2xpQg0KCQoDdWRtEgI1MBABSAFQAQ=="},"alternate_error_pages":{"backup":true},"apps":{"shortcuts_arch":"","shortcuts_version":1},"autocomplete":{"retention_policy_last_version":145},"autofill":{"last_version_deduped":145,"ran_extra_deduplication":true},"bookmark":{"storage_computation_last_update":"13424528305179351"},"browser":{"window_placement":{"bottom":1390,"left":10,"maximized":true,"right":1276,"top":10,"work_area_bottom":1400,"work_area_left":0,"work_area_right":2560,"work_area_top":0}},"commerce_daily_metrics_last_update_time":"13424528305179130","countryid_at_install":17242,"default_search_provider":{"choice_screen_random_shuffle_seed":"-4661242296305852022"},"domain_diversity":{"last_reporting_timestamp":"13424528307415116","last_reporting_timestamp_v4":"13424528307415137"},"download_bubble":{"partial_view_impressions":6},"enterprise_profile_guid":"eab18a03-721f-4f39-b447-08576b7c3bdf","extensions":{"alerts":{"initialized":true},"chrome_url_overrides":{},"last_chrome_version":"145.0.7632.6"},"gaia_cookie":{"changed_time":1780054710.401114,"hash":"2jmj7l5rSw0yVb/vlWAYkK/YBwk=","last_list_accounts_binary_data":"","periodic_report_time_2":"13424528304779864"},"gcm":{"product_category_for_subtypes":"com.googlechromefortesting.windows"},"google":{"services":{"signin_scoped_device_id":"415c9565-2b12-4c13-adfa-354dd116459a"}},"https_upgrade_navigations":{"2026-05-29":20},"in_product_help":{"recent_session_enabled_time":"13424528304919534","recent_session_start_times":["13424528304919534"],"session_last_active_time":"13424529737966540","session_number":2,"session_start_time":"13424528304919534"},"intl":{"selected_languages":"en-US,en"},"invalidation":{"per_sender_registered_for_invalidation":{"1013309121859":{},"947318989803":{}}},"login_detection":{"oauth_signed_in_origins":{"https://covance.com":"13424529696522020"}},"media":{"engagement":{"schema_version":5}},"migrated_user_scripts_toggle":true,"ntp":{"num_personal_suggestions":3},"password_manager":{"account_store_backup_password_cleaning_last_timestamp":"13424529001223072","account_store_migrated_to_os_crypt_async":true,"profile_store_backup_password_cleaning_last_timestamp":"13424529001224400","profile_store_migrated_to_os_crypt_async":true},"privacy_sandbox":{"first_party_sets_data_access_allowed_initialized":true},"profile":{"avatar_index":26,"background_password_check":{"check_fri_weight":9,"check_interval":"2592000000000","check_mon_weight":6,"check_sat_weight":6,"check_sun_weight":6,"check_thu_weight":9,"check_tue_weight":9,"check_wed_weight":9,"next_check_time":"13425561325725843"},"content_settings":{"exceptions":{"3pcd_heuristics_grants":{"https://[*.]labcorp.com,https://[*.]covance.com":{"expiration":"13424530596520674","last_modified":"13424529696520690","lifetime":"900000000","setting":1}},"abusive_notification_permissions":{},"access_to_get_all_screens_media_in_session":{},"anti_abuse":{},"app_banner":{},"ar":{},"are_suspicious_notifications_allowlisted_by_user":{},"auto_picture_in_picture":{},"auto_select_certificate":{},"automatic_downloads":{},"automatic_fullscreen":{},"autoplay":{},"background_sync":{},"bluetooth_chooser_data":{},"bluetooth_guard":{},"bluetooth_scanning":{},"camera_pan_tilt_zoom":{},"captured_surface_control":{},"client_hints":{"https://login.labcorp.com:443,*":{"last_modified":"13424529696285328","setting":{"client_hints":[14]}}},"clipboard":{},"controlled_frame":{},"cookie_controls_metadata":{"https://[*.]covance.com,*":{"last_modified":"13424529696520363","setting":{}},"https://[*.]labcorp.com,*":{"last_modified":"13424529864525739","setting":{}}},"cookies":{},"direct_sockets":{},"direct_sockets_private_network_access":{},"display_media_system_audio":{},"disruptive_notification_permissions":{},"durable_storage":{},"fedcm_idp_registration":{},"fedcm_idp_signin":{"https://accounts.google.com:443,*":{"last_modified":"13424528310402450","setting":{"chosen-objects":[{"idp-origin":"https://accounts.google.com","idp-signin-status":false}]}}},"fedcm_share":{},"file_system_access_chooser_data":{},"file_system_access_extended_permission":{},"file_system_access_restore_permission":{},"file_system_last_picked_directory":{},"file_system_read_guard":{},"file_system_write_guard":{},"formfill_metadata":{},"geolocation":{},"geolocation_with_options":{},"hand_tracking":{},"has_migrated_local_network_access":true,"hid_chooser_data":{},"hid_guard":{},"http_allowed":{},"https_enforced":{},"idle_detection":{},"images":{},"important_site_info":{},"initialized_translations":{},"intent_picker_auto_display":{},"javascript":{},"javascript_jit":{},"javascript_optimizer":{},"keyboard_lock":{},"legacy_cookie_access":{},"legacy_cookie_scope":{},"local_fonts":{},"local_network":{},"local_network_access":{},"loopback_network":{},"media_engagement":{"https://login.labcorp.com:443,*":{"expiration":"13432305696522127","last_modified":"13424529696522133","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":2}},"https://xsp.covance.com:443,*":{"expiration":"13432305699770027","last_modified":"13424529699770037","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":5}},"https://xsp.labcorp.com:443,*":{"expiration":"13432305877629904","last_modified":"13424529877629919","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":2}}},"media_stream_camera":{},"media_stream_mic":{},"midi_sysex":{},"mixed_script":{},"nfc_devices":{},"notification_interactions":{},"notification_permission_review":{},"notifications":{},"ondevice_languages_downloaded":{},"password_protection":{},"payment_handler":{},"permission_actions_history":{},"permission_autoblocking_data":{},"permission_autorevocation_data":{},"pointer_lock":{},"popups":{},"protected_media_identifier":{},"protocol_handler":{},"reduced_accept_language":{},"safe_browsing_url_check_data":{},"sensors":{},"serial_chooser_data":{},"serial_guard":{},"site_engagement":{"https://xsp.covance.com:443,*":{"last_modified":"13424529679128414","setting":{"lastEngagementTime":1.342452967912839e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":6.0,"rawScore":6.0}},"https://xsp.labcorp.com:443,*":{"last_modified":"13424529864527612","setting":{"lastEngagementTime":1.3424529864527594e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":15.0,"rawScore":15.0}}},"sound":{},"speaker_selection":{},"ssl_cert_decisions":{},"storage_access":{},"storage_access_header_origin_trial":{},"subresource_filter":{},"subresource_filter_data":{},"suspicious_notification_ids":{},"suspicious_notification_show_original":{},"third_party_storage_partitioning":{},"top_level_storage_access":{},"tracking_protection":{},"unused_site_permissions":{},"usb_chooser_data":{},"usb_guard":{},"vr":{},"web_app_installation":{},"webid_api":{},"webid_auto_reauthn":{},"window_placement":{}},"pref_version":1},"created_by_version":"145.0.7632.6","creation_time":"13424528304722540","default_content_setting_values":{"has_migrated_local_network_access":true},"exit_type":"Normal","family_member_role":"not_in_family","last_engagement_time":"13424529864527594","last_time_obsolete_http_credentials_removed":1780055401.223768,"last_time_password_store_metrics_reported":1780054734.816366,"managed":{"locally_parent_approved_extensions":{},"locally_parent_approved_extensions_migration_state":1},"managed_user_id":"","name":"Your Chromium","password_hash_data_list":[],"were_old_google_logins_removed":true},"safebrowsing":{"event_timestamps":{},"metrics_last_log_time":"13424528304","scout_reporting_enabled_when_deprecated":false},"safety_hub":{"unused_site_permissions_revocation":{"migration_completed":true}},"saved_tab_groups":{"did_enable_shared_tab_groups_in_last_session":false,"specifics_to_data_migration":true},"segmentation_platform":{"client_result_prefs":"ClIKDXNob3BwaW5nX3VzZXISQQo2DQAAAAAQ1quIi5mx7BcaJAocChoNAAAAPxIMU2hvcHBpbmdVc2VyGgVPdGhlchIEEAIYBCADEKSsiIuZsewX","device_switcher_util":{"result":{"labels":["NotSynced"]}},"last_db_compaction_time":"13424399999000000","uma_in_sql_start_time":"13424528304785303"},"sessions":{"event_log":[{"crashed":false,"time":"13424528304783316","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424528335641941","type":2,"window_count":1},{"crashed":false,"time":"13424528941184566","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424529159555674","type":2,"window_count":1},{"crashed":false,"time":"13424529677888467","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424529877597330","type":2,"window_count":1}],"session_data_status":5},"settings":{"force_google_safesearch":false},"signin":{"accounts_metadata_dict":{},"allowed":true,"cookie_clear_on_exit_migration_notice_complete":true},"site_search_settings":{"overridden_keywords":[]},"spellcheck":{"dictionaries":["en-US"],"dictionary":""},"syncing_theme_prefs_migrated_to_non_syncing":true,"toolbar":{"pinned_cast_migration_complete":true,"pinned_chrome_labs_migration_complete":true,"tab_search_migration_complete":true},"translate_site_blacklist":[],"translate_site_blocklist_with_time":{},"web_apps":{"did_migrate_default_chrome_apps":["MigrateDefaultChromeAppToWebAppsGSuite","MigrateDefaultChromeAppToWebAppsNonGSuite"],"last_preinstall_synchronize_version":"145"}} \ No newline at end of file +{"accessibility":{"captions":{"headless_caption_enabled":false}},"account_tracker_service_last_update":"13424783170165548","aim_eligibility_service":{"aim_eligibility_response":"CAEQARgAIAAwADqYAQohEgIBAiILCAEQCioDCQQCQAEiDAgCEAoqAgkCOgIBAzgKIicIARIQTmFocsOhdCBvYnLDoXplaxoLCAEQCioDCQQCQAEiAghdKAEiJggCEg5OYWhyw6F0IHNvdWJvchoMCAIQCioCCQI6AgEDIgIIXCgDOgsKCU7DoXN0cm9qZUoVWmVwdGVqdGUgc2UgbmEgY29rb2xpQg0KCQoDdWRtEgI1MBABSAFQAQ=="},"alternate_error_pages":{"backup":true},"apps":{"shortcuts_arch":"","shortcuts_version":1},"autocomplete":{"retention_policy_last_version":145},"autofill":{"last_version_deduped":145,"ran_extra_deduplication":true},"bookmark":{"storage_computation_last_update":"13424783170161995"},"browser":{"window_placement":{"bottom":1390,"left":10,"maximized":true,"right":1276,"top":10,"work_area_bottom":1400,"work_area_left":0,"work_area_right":2560,"work_area_top":0}},"commerce_daily_metrics_last_update_time":"13424783170163108","countryid_at_install":17242,"default_search_provider":{"choice_screen_random_shuffle_seed":"-4661242296305852022"},"domain_diversity":{"last_reporting_timestamp":"13424783170163389","last_reporting_timestamp_v4":"13424783170163420"},"download_bubble":{"partial_view_impressions":6},"enterprise_profile_guid":"eab18a03-721f-4f39-b447-08576b7c3bdf","extensions":{"alerts":{"initialized":true},"chrome_url_overrides":{},"last_chrome_version":"145.0.7632.6"},"gaia_cookie":{"changed_time":1780054710.401114,"hash":"2jmj7l5rSw0yVb/vlWAYkK/YBwk=","last_list_accounts_binary_data":"","periodic_report_time_2":"13424783169837345"},"gcm":{"product_category_for_subtypes":"com.googlechromefortesting.windows"},"google":{"services":{"signin_scoped_device_id":"aeec0af1-b049-4127-98de-e656255e02f1"}},"https_upgrade_navigations":{"2026-05-29":20,"2026-06-01":10},"in_product_help":{"recent_session_enabled_time":"13424528304919534","recent_session_start_times":["13424783169861650","13424528304919534"],"session_last_active_time":"13424783274900545","session_number":3,"session_start_time":"13424783169861650"},"intl":{"selected_languages":"en-US,en"},"invalidation":{"per_sender_registered_for_invalidation":{"1013309121859":{},"947318989803":{}}},"login_detection":{"oauth_signed_in_origins":{"https://covance.com":"13424783187588195"}},"media":{"engagement":{"schema_version":5}},"migrated_user_scripts_toggle":true,"ntp":{"num_personal_suggestions":3},"password_manager":{"account_store_backup_password_cleaning_last_timestamp":"13424529001223072","account_store_migrated_to_os_crypt_async":true,"profile_store_backup_password_cleaning_last_timestamp":"13424529001224400","profile_store_migrated_to_os_crypt_async":true},"privacy_sandbox":{"first_party_sets_data_access_allowed_initialized":true},"profile":{"avatar_index":26,"background_password_check":{"check_fri_weight":9,"check_interval":"2592000000000","check_mon_weight":6,"check_sat_weight":6,"check_sun_weight":6,"check_thu_weight":9,"check_tue_weight":9,"check_wed_weight":9,"next_check_time":"13425561325725843"},"content_settings":{"exceptions":{"3pcd_heuristics_grants":{"https://[*.]labcorp.com,https://[*.]covance.com":{"expiration":"13424784087587161","last_modified":"13424783187587170","lifetime":"900000000","setting":1}},"abusive_notification_permissions":{},"access_to_get_all_screens_media_in_session":{},"anti_abuse":{},"app_banner":{},"ar":{},"are_suspicious_notifications_allowlisted_by_user":{},"auto_picture_in_picture":{},"auto_select_certificate":{},"automatic_downloads":{},"automatic_fullscreen":{},"autoplay":{},"background_sync":{},"bluetooth_chooser_data":{},"bluetooth_guard":{},"bluetooth_scanning":{},"camera_pan_tilt_zoom":{},"captured_surface_control":{},"client_hints":{"https://login.labcorp.com:443,*":{"last_modified":"13424783187224953","setting":{"client_hints":[14]}}},"clipboard":{},"controlled_frame":{},"cookie_controls_metadata":{"https://[*.]covance.com,*":{"last_modified":"13424783187586954","setting":{}},"https://[*.]labcorp.com,*":{"last_modified":"13424783341515923","setting":{}}},"cookies":{},"direct_sockets":{},"direct_sockets_private_network_access":{},"display_media_system_audio":{},"disruptive_notification_permissions":{},"durable_storage":{},"fedcm_idp_registration":{},"fedcm_idp_signin":{"https://accounts.google.com:443,*":{"last_modified":"13424528310402450","setting":{"chosen-objects":[{"idp-origin":"https://accounts.google.com","idp-signin-status":false}]}}},"fedcm_share":{},"file_system_access_chooser_data":{},"file_system_access_extended_permission":{},"file_system_access_restore_permission":{},"file_system_last_picked_directory":{},"file_system_read_guard":{},"file_system_write_guard":{},"formfill_metadata":{},"geolocation":{},"geolocation_with_options":{},"hand_tracking":{},"has_migrated_local_network_access":true,"hid_chooser_data":{},"hid_guard":{},"http_allowed":{},"https_enforced":{},"idle_detection":{},"images":{},"important_site_info":{},"initialized_translations":{},"intent_picker_auto_display":{},"javascript":{},"javascript_jit":{},"javascript_optimizer":{},"keyboard_lock":{},"legacy_cookie_access":{},"legacy_cookie_scope":{},"local_fonts":{},"local_network":{},"local_network_access":{},"loopback_network":{},"media_engagement":{"https://login.labcorp.com:443,*":{"expiration":"13432559187588276","last_modified":"13424783187588280","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":3}},"https://xsp.covance.com:443,*":{"expiration":"13432559195314129","last_modified":"13424783195314134","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":7}},"https://xsp.labcorp.com:443,*":{"expiration":"13432559355730365","last_modified":"13424783355730377","lifetime":"7776000000000","setting":{"hasHighScore":false,"lastMediaPlaybackTime":0.0,"mediaPlaybacks":0,"visits":3}}},"media_stream_camera":{},"media_stream_mic":{},"midi_sysex":{},"mixed_script":{},"nfc_devices":{},"notification_interactions":{},"notification_permission_review":{},"notifications":{},"ondevice_languages_downloaded":{},"password_protection":{},"payment_handler":{},"permission_actions_history":{},"permission_autoblocking_data":{},"permission_autorevocation_data":{},"pointer_lock":{},"popups":{},"protected_media_identifier":{},"protocol_handler":{},"reduced_accept_language":{},"safe_browsing_url_check_data":{},"sensors":{},"serial_chooser_data":{},"serial_guard":{},"site_engagement":{"https://xsp.covance.com:443,*":{"last_modified":"13424783171083101","setting":{"lastEngagementTime":1.3424783171083072e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":3.0,"rawScore":8.625118089215999}},"https://xsp.labcorp.com:443,*":{"last_modified":"13424783341518069","setting":{"lastEngagementTime":1.3424783341518036e+16,"lastShortcutLaunchTime":0.0,"pointsAddedToday":15.0,"rawScore":29.062795223040006}}},"sound":{},"speaker_selection":{},"ssl_cert_decisions":{},"storage_access":{},"storage_access_header_origin_trial":{},"subresource_filter":{},"subresource_filter_data":{},"suspicious_notification_ids":{},"suspicious_notification_show_original":{},"third_party_storage_partitioning":{},"top_level_storage_access":{},"tracking_protection":{},"unused_site_permissions":{},"usb_chooser_data":{},"usb_guard":{},"vr":{},"web_app_installation":{},"webid_api":{},"webid_auto_reauthn":{},"window_placement":{}},"pref_version":1},"created_by_version":"145.0.7632.6","creation_time":"13424528304722540","default_content_setting_values":{"has_migrated_local_network_access":true},"exit_type":"Normal","family_member_role":"not_in_family","last_engagement_time":"13424783341518036","last_time_obsolete_http_credentials_removed":1780055401.223768,"last_time_password_store_metrics_reported":1780309599.837519,"managed":{"locally_parent_approved_extensions":{},"locally_parent_approved_extensions_migration_state":1},"managed_user_id":"","name":"Your Chromium","password_hash_data_list":[],"were_old_google_logins_removed":true},"safebrowsing":{"event_timestamps":{},"metrics_last_log_time":"13424783169","scout_reporting_enabled_when_deprecated":false},"safety_hub":{"unused_site_permissions_revocation":{"migration_completed":true}},"saved_tab_groups":{"did_enable_shared_tab_groups_in_last_session":false,"specifics_to_data_migration":true},"segmentation_platform":{"client_result_prefs":"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","device_switcher_util":{"result":{"labels":["NotSynced"]}},"last_db_compaction_time":"13424659199000000","uma_in_sql_start_time":"13424528304785303"},"sessions":{"event_log":[{"crashed":false,"time":"13424528304783316","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424528335641941","type":2,"window_count":1},{"crashed":false,"time":"13424528941184566","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424529159555674","type":2,"window_count":1},{"crashed":false,"time":"13424529677888467","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424529877597330","type":2,"window_count":1},{"crashed":false,"time":"13424783169841538","type":0},{"did_schedule_command":true,"first_session_service":true,"tab_count":2,"time":"13424783355693003","type":2,"window_count":1}],"session_data_status":5},"settings":{"force_google_safesearch":false},"signin":{"accounts_metadata_dict":{},"allowed":true,"cookie_clear_on_exit_migration_notice_complete":true},"site_search_settings":{"overridden_keywords":[]},"spellcheck":{"dictionaries":["en-US"],"dictionary":""},"syncing_theme_prefs_migrated_to_non_syncing":true,"toolbar":{"pinned_cast_migration_complete":true,"pinned_chrome_labs_migration_complete":true,"tab_search_migration_complete":true},"total_passwords_available_for_account":0,"total_passwords_available_for_profile":0,"translate_site_blacklist":[],"translate_site_blocklist_with_time":{},"web_apps":{"did_migrate_default_chrome_apps":["MigrateDefaultChromeAppToWebAppsGSuite","MigrateDefaultChromeAppToWebAppsNonGSuite"],"last_preinstall_synchronize_version":"145"}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_2/Default/Secure Preferences b/Covance_UCO3001/browser_profile_2/Default/Secure Preferences index 45af9fa..28c270a 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Secure Preferences +++ b/Covance_UCO3001/browser_profile_2/Default/Secure Preferences @@ -1 +1 @@ -{"extensions":{"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":{"account_extension_type":0,"active_permissions":{"api":["management","system.display","system.storage","webstorePrivate","system.cpu","system.memory","system.network"],"explicit_host":[],"manifest_permissions":[],"scriptable_host":[]},"app_launcher_ordinal":"t","commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13424528304909957","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13424528304909957","location":5,"manifest":{"app":{"launch":{"web_url":"https://chrome.google.com/webstore"},"urls":["https://chrome.google.com/webstore"]},"description":"Discover great apps, games, extensions and themes for Chromium.","icons":{"128":"webstore_icon_128.png","16":"webstore_icon_16.png"},"key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCtl3tO0osjuzRsf6xtD2SKxPlTfuoy7AWoObysitBPvH5fE1NaAA1/2JkPWkVDhdLBWLaIBPYeXbzlHp3y4Vv/4XG+aN5qFE3z+1RU/NqkzVYHtIpVScf3DjTYtKVL66mzVGijSoAIwbFCC3LpGdaoe6Q1rSRDp76wR6jjFzsYwQIDAQAB","name":"Web Store","permissions":["webstorePrivate","management","system.cpu","system.display","system.memory","system.network","system.storage"],"version":"0.2"},"needs_sync":true,"page_ordinal":"n","path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\web_store","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false},"mhjfbmdgcfjbbpaeojofohoefgiehjai":{"account_extension_type":0,"active_permissions":{"api":["contentSettings","fileSystem","fileSystem.write","metricsPrivate","tabs","resourcesPrivate","pdfViewerPrivate"],"explicit_host":["chrome://resources/*","chrome://webui-test/*"],"manifest_permissions":[],"scriptable_host":[]},"commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13424528304910726","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13424528304910726","location":5,"manifest":{"content_security_policy":"script-src 'self' blob: filesystem: chrome://resources chrome://webui-test; object-src * blob: externalfile: file: filesystem: data:","description":"","incognito":"split","key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDN6hM0rsDYGbzQPQfOygqlRtQgKUXMfnSjhIBL7LnReAVBEd7ZmKtyN2qmSasMl4HZpMhVe2rPWVVwBDl6iyNE/Kok6E6v6V3vCLGsOpQAuuNVye/3QxzIldzG/jQAdWZiyXReRVapOhZtLjGfywCvlWq7Sl/e3sbc0vWybSDI2QIDAQAB","manifest_version":2,"mime_types":["application/pdf"],"mime_types_handler":"index.html","name":"Chromium PDF Viewer","offline_enabled":true,"permissions":["chrome://resources/","chrome://webui-test/","contentSettings","metricsPrivate","pdfViewerPrivate","resourcesPrivate","tabs",{"fileSystem":["write"]}],"version":"1","web_accessible_resources":["pdf_embedder.css"]},"path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\pdf","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false}}},"pinned_tabs":[],"protection":{"macs":{"account_values":{"browser":{"show_home_button":"C6CF41D4DD2961AA4CBE2655A6F9D6F5E4571CA2735F96A0DFC763E2947A4E0C","show_home_button_encrypted_hash":"djEwDxzeugEew3LpnfgZbWD14A7d3VvJwTYtiwsdNS7AWJvD8mYzvZfrjWil776aGB0WzIqomVj+iwiH/1yi"},"extensions":{"ui":{"developer_mode":"9569D368BA1F8BCBDF69D4B2F3E42DDB80D5EBED22AA8FFDD4C9260C965B7A70","developer_mode_encrypted_hash":"djEwQgp0b/65zEtZUloh8/pJjgwO7U7Upo2c3PdAHt58PJ1yaY4t6ccryqvwkv4HS8h4k3E3SemYwSsRYSEO"}},"homepage":"A76E66DFCEAEE57A5A46DAB06391A9DF5B48FADDD0433F0E7E1B43F990E2D5A1","homepage_encrypted_hash":"djEwJKnXjJUxZipnJsE9VPri2r0X0mVMVknknA/FeOyVsGBfWam5LFFeKgOkFdWyipCAgKGSYkchUGSe6FuS","homepage_is_newtabpage":"48538AB1A3E0FF0A940CB46BBF5BACC34E067CCFC848F84A66179EA0D2C07EF8","homepage_is_newtabpage_encrypted_hash":"djEwfBctO5MCk/Y3PGlQzJjTH0gpUs5gk5x6o1ARIQyIhf+I2a3nOO7kWDHzEiKJo+qjP6/zXq7RLL58bdxP","session":{"restore_on_startup":"209CBCE00D56042E7F93B95B62E4957C7F314B89196DBA79D91805D02A5551B0","restore_on_startup_encrypted_hash":"djEweZWFbOOyt09BYJUnKxl+Oqx3uAnq5oQHCZVQ/2/iuK+dVAMNc8i6gq7nsdc8p2Q3oPY6ixpl0mTBZ9YF","startup_urls":"7890F94790732CEAFC98E37B6D6AD2BA0671054013EAF7A0103424429BE72304","startup_urls_encrypted_hash":"djEwk5qUe4bLmHprDAaONojlltEyAXwMekA+POPn1N2pVSmvcU/IMNxbZJ1YP9F17xHVEhD81Q9X2TqFla2q"}},"browser":{"show_home_button":"7B9E7982DA6F71AF35EED191B26105FF6CE875B635E604A383665B69FB24839C","show_home_button_encrypted_hash":"djEw4rvZZyd6z+YkKiDqKULec+s6ixuIDtukpbaOaN1dm3BhQFAfVS6mdWc/J7nmCS9qCQDkx7vJ8Mdw6ZOZ"},"default_search_provider_data":{"template_url_data":"9271004E40252718A3722D21429C644C6372F981C3A4EE2879163BEB6B3C0638","template_url_data_encrypted_hash":"djEww2RrUpyqXwRa9Ffw6kSBTVSFpuvwmd+3l8ejZEwyniaGzmXmfCRQzRmVdib6aI8AzqvBZSPLwag5JnBg"},"enterprise_signin":{"policy_recovery_token":"16443C426F8E959B46798A54C0A2D7F41926426F3A49125489D3AB7230B663B9","policy_recovery_token_encrypted_hash":"djEwPLZVeGME0ClYOeZTnxGhN6P5f2KHqal5wOfiNBRuVhRnmsyayDRX4ZRzUZCjKBKxGw7wV2ZfBzJ87JAU"},"extensions":{"install":{"initiallist":"AA6038C7627693B0914F10A8C3BA15FD859527B5EEABCABCA25A5300487F3BAC","initiallist_encrypted_hash":"djEwQUzLeeIzsO/CozdTD5brF8i6tK2Jv1Zj2Cj65bUGFlF7Mjbpo8aT2KJhI3vTDgRE9xqFR9XPydQCZEYd","initialprovidername":"F769B372A8BECD74F81B18814FD3F23E0F49473F079E8203CCD2118BB84D740D","initialprovidername_encrypted_hash":"djEwvWv6klRdaIup7CDjRvbAcAuuJz/vdQwPljJhTVqaMS2cW53LrY7Ssxmto05VPeRnugix0bSv2lNpTwrL"},"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":"67D9350CAD83D29278CA0FF7A943A7C5C9700126579E63769C445BCFFC3638D0","mhjfbmdgcfjbbpaeojofohoefgiehjai":"090B0155BE050590312B96B022A2576F91FD2AD7ADCA2863CBBB4BD567802D44"},"settings_encrypted_hash":{"ahfgeienlihckogmohjhadlkjgocpleb":"djEwASMu7vs/p1LXcd8S27QLCQHEJRqluRrhfpfWSiWKFD92AFIRBZXSub/Lss4ncD3SZEd92TURsvFZggeM","mhjfbmdgcfjbbpaeojofohoefgiehjai":"djEwCTxVAxBym+hMxigFkSnzAuA857b0k7eyVPeT4fsh/HwVTp2F7i+QwrQp4XP3rsEtV/CqgkKPzEKHeGt3"},"ui":{"developer_mode":"3EEBE800588D845558DBE5F1482490E266D02E9935E3E7D377E9613CD7EED864","developer_mode_encrypted_hash":"djEw68J+4ZXdNgUkvQx54LUSGI4nhcnYYHimsAKuApmNpfBANPoOsbANJKnu3rt3A+dEoTgjAx94kKQFIdH6"}},"google":{"services":{"account_id":"97BD720988AA8DA8F0140518F778D2F599568753B71B65737F0F64585CA5F466","account_id_encrypted_hash":"djEwmsKIMpUX8JIlqNA2Y9x0zs0dqPvSmjt+YDGZsKvSM4ypHyppN7qRWhKSKJOzLqwW4syWm7jA/SKAFDMH","last_signed_in_username":"CB85FDE0953993F6DD69CDCB949C320D62CFB668D8221F0FF09BC6DA1E2270EF","last_signed_in_username_encrypted_hash":"djEwJG+TBE9TtR7f/+QpjSaHTtgd43sVtWvlFtHUudoYdDb/8U6JgKyieMcCDpYUx8X8JJHvpPy34xC3S293","last_username":"4F9B9540BCF78BF3BD6E0B7FB2907AEFF7B0581782B58FBD67308B8C9D3B6805","last_username_encrypted_hash":"djEw++AP1QMCm+4DYQqNtksHgy1ZXbqg7jx7fWkzZTpDMWz/3A/tBd/pZGe9SiJklYbIlwk1/whLuRwVOHuU"}},"homepage":"FF6D854B15AC70D467DB610FDF7B2FB38284560BC0521B766712BBA8B3AD3455","homepage_encrypted_hash":"djEweqyIpSxI8nfMVBySUaRnYdKXJmhhQgwI6a0axorlRDnMtHChmki8Xtpep66Doa0q/63+rjaxmhSmcP9i","homepage_is_newtabpage":"DC04B53C3C64010C4861437B0A377F456226EC20ADD09F8562F5C7A21D0BE856","homepage_is_newtabpage_encrypted_hash":"djEwwJ1sgxk2vFBUMGraQ1GRez/KfAEf3d58NbxYJTEpYcgxopTOWNzIcQLCGpAua2tohjMVxSukfWkogavV","media":{"cdm":{"origin_data":"BFADE78E89D0818D6B823D78DB344A49A2826D5EACDB452ECB24FC4D8FE31A43","origin_data_encrypted_hash":"djEwzqK+FH+0hESZB13Z+TAWgP8UrKcoee3RPNiJDU6OKJyj0nStZeA4aRA0IXxk3sa265vVJiw/OyBBpbz3"},"storage_id_salt":"F817525FF62F76D596C2CFCA4048ED2957AD5C39A65ABED0078CA8FF06EE0218","storage_id_salt_encrypted_hash":"djEwElbi/itV+yk/EhBv97fHew63/VX6ro+Yaut2zMo7qdZE9ouzJ+O5jFsgs5WQtSR5/Alxl6n6hxUisTjc"},"pinned_tabs":"296AB4AF8DF401E7966859811329CE0C6974552338857A608B805946743756E9","pinned_tabs_encrypted_hash":"djEw+jTPl7mKWriuXxKFOVHZCvzdxhkqNeE8spffejML3gD+Hq+z/7O85KDiq1aOozl53hH6o9rLmcdkovie","prefs":{"preference_reset_time":"70F10CBAA9D6BB4F745031B1CDB572E3A202C479AB43D3F831A01C82FAAB21DF","preference_reset_time_encrypted_hash":"djEwCxA3SnsymtIX8J/qzgfPpdxM3xCVcjwq4tCE+ZKnyNWALOUW+QSZpKUIgM8yCKuppyQH0D8XbForbu14"},"safebrowsing":{"incidents_sent":"FBD04307A3E3741DDCF96C9907201110FE4C4244E352EAD68E07C504F619B3B2","incidents_sent_encrypted_hash":"djEwV9AK8is1cUUE9jrmngHAg0hLBH+KrqQkz5JtiUN2korGJhfmCCrTquBiiUy0hl44oZnd6aBZmySAVtP9"},"schedule_to_flush_to_disk":"57ECC7DD51005796309100EB8E6F5A0B74F9CC72AE39D32A3640580C70B2B1FE","schedule_to_flush_to_disk_encrypted_hash":"djEwhWOl64VDn76VkoR+zthxrmFSWLBpYdXufU3ZRvMyHnYfYLjvz6nXQ6uacsErR8PRhziWHOtWf5AERIKn","search_provider_overrides":"917E2079025259B13DCED6541BB0CAC7962F42F2450B53642F36C5532285DD1A","search_provider_overrides_encrypted_hash":"djEwiC0MsbGqZ3UPK+mANsIImLbryhZZ+HyMCyevf0nAoRypCGwfveHGdYKNB+F18jZfSitiv+kD9Xv7i9ip","session":{"restore_on_startup":"53F3C9A5163BEF18C312F474B3DA2ECBD99493EC252BBE1D2407558A0B022165","restore_on_startup_encrypted_hash":"djEwNq1VV8kMEIcNfpEhwEuJ/Uutj5c75bcp0akh+nafF/tcvvVO+Vj8pDV6oA0MI8FBGXDaN8Qr9mrBuFjn","startup_urls":"8192B6DB3F5AF2E9226494B40FDB2FA8CE46198CDAAD60F650E4703A621E1F61","startup_urls_encrypted_hash":"djEw+3LaaghHOnWxo9j0CCShjERnboWf8wz9FCYSWbjuKV0nrtiT2exS1sehir/pt9lmCRosRTMsIqrJz1Mo"}},"super_mac":"AEB16D5725E5B86073DB1686B4B63EC6C52110EA4068B94F625BC283D78B0EDD"},"schedule_to_flush_to_disk":"13424529678221481"} \ No newline at end of file +{"extensions":{"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":{"account_extension_type":0,"active_permissions":{"api":["management","system.display","system.storage","webstorePrivate","system.cpu","system.memory","system.network"],"explicit_host":[],"manifest_permissions":[],"scriptable_host":[]},"app_launcher_ordinal":"t","commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13424528304909957","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13424528304909957","location":5,"manifest":{"app":{"launch":{"web_url":"https://chrome.google.com/webstore"},"urls":["https://chrome.google.com/webstore"]},"description":"Discover great apps, games, extensions and themes for Chromium.","icons":{"128":"webstore_icon_128.png","16":"webstore_icon_16.png"},"key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCtl3tO0osjuzRsf6xtD2SKxPlTfuoy7AWoObysitBPvH5fE1NaAA1/2JkPWkVDhdLBWLaIBPYeXbzlHp3y4Vv/4XG+aN5qFE3z+1RU/NqkzVYHtIpVScf3DjTYtKVL66mzVGijSoAIwbFCC3LpGdaoe6Q1rSRDp76wR6jjFzsYwQIDAQAB","name":"Web Store","permissions":["webstorePrivate","management","system.cpu","system.display","system.memory","system.network","system.storage"],"version":"0.2"},"needs_sync":true,"page_ordinal":"n","path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\web_store","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false},"mhjfbmdgcfjbbpaeojofohoefgiehjai":{"account_extension_type":0,"active_permissions":{"api":["contentSettings","fileSystem","fileSystem.write","metricsPrivate","tabs","resourcesPrivate","pdfViewerPrivate"],"explicit_host":["chrome://resources/*","chrome://webui-test/*"],"manifest_permissions":[],"scriptable_host":[]},"commands":{},"content_settings":[],"creation_flags":1,"disable_reasons":[],"events":[],"first_install_time":"13424528304910726","from_webstore":false,"incognito_content_settings":[],"incognito_preferences":{},"last_update_time":"13424528304910726","location":5,"manifest":{"content_security_policy":"script-src 'self' blob: filesystem: chrome://resources chrome://webui-test; object-src * blob: externalfile: file: filesystem: data:","description":"","incognito":"split","key":"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDN6hM0rsDYGbzQPQfOygqlRtQgKUXMfnSjhIBL7LnReAVBEd7ZmKtyN2qmSasMl4HZpMhVe2rPWVVwBDl6iyNE/Kok6E6v6V3vCLGsOpQAuuNVye/3QxzIldzG/jQAdWZiyXReRVapOhZtLjGfywCvlWq7Sl/e3sbc0vWybSDI2QIDAQAB","manifest_version":2,"mime_types":["application/pdf"],"mime_types_handler":"index.html","name":"Chromium PDF Viewer","offline_enabled":true,"permissions":["chrome://resources/","chrome://webui-test/","contentSettings","metricsPrivate","pdfViewerPrivate","resourcesPrivate","tabs",{"fileSystem":["write"]}],"version":"1","web_accessible_resources":["pdf_embedder.css"]},"path":"C:\\Users\\vladimir.buzalka.BUZALKA\\AppData\\Local\\ms-playwright\\chromium-1208\\chrome-win64\\resources\\pdf","preferences":{},"regular_only_preferences":{},"was_installed_by_default":false,"was_installed_by_oem":false}}},"pinned_tabs":[],"protection":{"macs":{"account_values":{"browser":{"show_home_button":"C6CF41D4DD2961AA4CBE2655A6F9D6F5E4571CA2735F96A0DFC763E2947A4E0C","show_home_button_encrypted_hash":"djEwToV4IZ5ec+sM4w8GOQJlDYYRrD+ti7NYZ8d8pkH04hEX3WNUhMAu5uqCxTpYD8x6dmExUrzITImlW2oo"},"extensions":{"ui":{"developer_mode":"9569D368BA1F8BCBDF69D4B2F3E42DDB80D5EBED22AA8FFDD4C9260C965B7A70","developer_mode_encrypted_hash":"djEwWNubl9u5MgcWk0jfxNeaNjo9b7ktN5BbZxQZmEA1AB/6fb03pS7egTttD3H3wNy3u7Wxok1iZDcGKcrG"}},"homepage":"A76E66DFCEAEE57A5A46DAB06391A9DF5B48FADDD0433F0E7E1B43F990E2D5A1","homepage_encrypted_hash":"djEwa6fUGd0ACk1PKRaWq0vWAi0b6DwBx3Nx760fWfyFhNF1Xsk8lB7LOt810GepA5dgT+v3zCDEOVARcaa7","homepage_is_newtabpage":"48538AB1A3E0FF0A940CB46BBF5BACC34E067CCFC848F84A66179EA0D2C07EF8","homepage_is_newtabpage_encrypted_hash":"djEwUCzgIQtdpbNUTIzizyTphIHTJSyGQ9Q7vEBBXso0LeYPA3HB1etlx/5zF9suw0/I9gm6UWeNjvG1vEfI","session":{"restore_on_startup":"209CBCE00D56042E7F93B95B62E4957C7F314B89196DBA79D91805D02A5551B0","restore_on_startup_encrypted_hash":"djEwvrOCtePv8MPac7KaNgpr065ISmEwdjtPzTw4EndRIPvjV6qEiOp1skC/qK4Riu5Asw+Z+q3yVdw2bBdL","startup_urls":"7890F94790732CEAFC98E37B6D6AD2BA0671054013EAF7A0103424429BE72304","startup_urls_encrypted_hash":"djEwU/wQuom0vBhypu7yuWmwkpnGFPsZv3BIDqlhjLIsIJaQ6QvSzOrFBf2QplzxM/CMTFeOXehY8X+xJaYL"}},"browser":{"show_home_button":"7B9E7982DA6F71AF35EED191B26105FF6CE875B635E604A383665B69FB24839C","show_home_button_encrypted_hash":"djEw7Epqq0gKvEKlVRVC3oZrNj96Lo3GOJNe6zKH+bpw0JbxntTILQ3L6tCSefpUalfLxqpR97Js6Iinv1ta"},"default_search_provider_data":{"template_url_data":"9271004E40252718A3722D21429C644C6372F981C3A4EE2879163BEB6B3C0638","template_url_data_encrypted_hash":"djEwzexVGSUlRPbNXg04IBQ50AGIUy9i+XIDYduplBopSnJN+9F9NB7ceLqNlStLfT6XwyPkKFqjTWDImgJn"},"enterprise_signin":{"policy_recovery_token":"16443C426F8E959B46798A54C0A2D7F41926426F3A49125489D3AB7230B663B9","policy_recovery_token_encrypted_hash":"djEwui1oiXJ2ZPqhrHwv8id3q38Mu0meHYkaBhJm3cb34JAvuzalYIdewjj0TZmiqT59c55bUUxdVjMHtTG+"},"extensions":{"install":{"initiallist":"AA6038C7627693B0914F10A8C3BA15FD859527B5EEABCABCA25A5300487F3BAC","initiallist_encrypted_hash":"djEwKYCWQIxXvHCVKbpeVg0JhB9N4WrbO47x0wTP20dRCAs1TuriXu6PUXAuc1Wl8ImP7ExiCmwpf0nNY3I/","initialprovidername":"F769B372A8BECD74F81B18814FD3F23E0F49473F079E8203CCD2118BB84D740D","initialprovidername_encrypted_hash":"djEwubVT7Lg0pIBTpzO5hMjGGWDxBI00w9Kvq8gPoMmF/fvcJECoiNhbQ15YMILBSav5wISLnBngT3SRu39J"},"settings":{"ahfgeienlihckogmohjhadlkjgocpleb":"67D9350CAD83D29278CA0FF7A943A7C5C9700126579E63769C445BCFFC3638D0","mhjfbmdgcfjbbpaeojofohoefgiehjai":"090B0155BE050590312B96B022A2576F91FD2AD7ADCA2863CBBB4BD567802D44"},"settings_encrypted_hash":{"ahfgeienlihckogmohjhadlkjgocpleb":"djEwGGbshoFftPz4npFI2ATGneEFDmpx7Nn5ETcCpNn+Zsp3eMfo8k3ZLhyixAaBeF0JnypnTL4G4ALP2qhG","mhjfbmdgcfjbbpaeojofohoefgiehjai":"djEwTz2yMe7/FgohAiJJEGehibJvyTS5qGMtX/3iIWjEmv4GgUWKM8RFX5tI7QF1j/orPoXLekvROgk+nX8I"},"ui":{"developer_mode":"3EEBE800588D845558DBE5F1482490E266D02E9935E3E7D377E9613CD7EED864","developer_mode_encrypted_hash":"djEwMRynWDvvrP39LP5AoAWVsKZjKGi0j28Qs61t3+tQJ9Wnxpt88Y71f9FiAXv/XjA/ReUw+0XWNGFrFvHY"}},"google":{"services":{"account_id":"97BD720988AA8DA8F0140518F778D2F599568753B71B65737F0F64585CA5F466","account_id_encrypted_hash":"djEwRAKoaOtAjs769wVPiesAUt+/CVmUJsZsMPdO7Egva+wqYZIMr18TyBfnqwGnu0dRgnZwVV94zp5QEu/6","last_signed_in_username":"CB85FDE0953993F6DD69CDCB949C320D62CFB668D8221F0FF09BC6DA1E2270EF","last_signed_in_username_encrypted_hash":"djEw8Vw88vmKtQ7vtJG+50nitxka0mauRTIWxEUO+sHzCf5x4lujZ54ghwt1XKbwvPxDgj/q5/PP5sD+va7D","last_username":"4F9B9540BCF78BF3BD6E0B7FB2907AEFF7B0581782B58FBD67308B8C9D3B6805","last_username_encrypted_hash":"djEwlZNHJJaNSUOfjUzcmLNGWDqjQSgNo8fo+dSEsFLyL8zKqX1IQYDhacNfYHjJ3kUWIuWM7sqsmdnsqEDm"}},"homepage":"FF6D854B15AC70D467DB610FDF7B2FB38284560BC0521B766712BBA8B3AD3455","homepage_encrypted_hash":"djEwO9XSj/0zryjue3r3wIktOvwBxgHaTw29lfLoeWYj6PxybZXEHpuZoljjmEp3Al0/6e+EuJzUWxjGM1NM","homepage_is_newtabpage":"DC04B53C3C64010C4861437B0A377F456226EC20ADD09F8562F5C7A21D0BE856","homepage_is_newtabpage_encrypted_hash":"djEwafgHVVCfrvA38D9tqjraiNBiXlXY2sQn68eB6BRYXVelaC94zKv8hTkthwj0FIX83IuMKwUi/gc0DbcC","media":{"cdm":{"origin_data":"BFADE78E89D0818D6B823D78DB344A49A2826D5EACDB452ECB24FC4D8FE31A43","origin_data_encrypted_hash":"djEw0bNp9yIbzFMKmEF8FIoD7rge+RpNjY6K9LUxfzYHiM72Pzhvqf1sDuaU1/SfuZ/3drgde7LPWvfAb+RA"},"storage_id_salt":"F817525FF62F76D596C2CFCA4048ED2957AD5C39A65ABED0078CA8FF06EE0218","storage_id_salt_encrypted_hash":"djEwE0OTNEx8eywsfdNwE9BznaR0caqY5IhHVSbjq1TWTNBaFccYgln09aSsDgpzok1tOCL9S+Uk59b6rA0h"},"pinned_tabs":"296AB4AF8DF401E7966859811329CE0C6974552338857A608B805946743756E9","pinned_tabs_encrypted_hash":"djEw0ZP0rjv6562bVR41zaFEr8hEfh7RTOsUWYTBooUcSsZdOFO+Oq9wMSK1wUTge+WzuI2QaV70ZlZ5CqTa","prefs":{"preference_reset_time":"70F10CBAA9D6BB4F745031B1CDB572E3A202C479AB43D3F831A01C82FAAB21DF","preference_reset_time_encrypted_hash":"djEwQgTgnU779ew8aTi+5TAvxm8st3QPyI6sf/vVHPwp3L4Am8t4L0y4rtBGnCFIraYRlR5RoeSD7aRh7EEm"},"safebrowsing":{"incidents_sent":"FBD04307A3E3741DDCF96C9907201110FE4C4244E352EAD68E07C504F619B3B2","incidents_sent_encrypted_hash":"djEwqkRqPbtjZ2+IF/lUTUWBu4q+mZYZzt+pRAUbXexcMupoMotPQkrGVjwDSAvGFaLprQVdez69puuPCxYN"},"schedule_to_flush_to_disk":"07E11789DE3D8ABB1F019C8DE88EBD5C934ACCC07CC6FF6938D1F1C574C2AA0D","schedule_to_flush_to_disk_encrypted_hash":"djEwZ5SLcvs1JiuNFE1ZO/AalSBGLue24lxLDNIZBgY3yuE2hHdVc6gy344zNkcH2RLsvBkVdOQN7sjW4YxY","search_provider_overrides":"917E2079025259B13DCED6541BB0CAC7962F42F2450B53642F36C5532285DD1A","search_provider_overrides_encrypted_hash":"djEw2xswTELvqpp5p5Hk1xmhoIH1vholkbTWur48Bd8VIQBf+reKO/zsZhiElvZKdgSMTXVFLE1IUy9j+zVv","session":{"restore_on_startup":"53F3C9A5163BEF18C312F474B3DA2ECBD99493EC252BBE1D2407558A0B022165","restore_on_startup_encrypted_hash":"djEwe7GzR9JQBOZTKZJcPpwobin2cZy1KlhuK2wgFCrX2t3tluSMt3K6j+qQnEeeiu22HXLxCMVTWg1VbsKc","startup_urls":"8192B6DB3F5AF2E9226494B40FDB2FA8CE46198CDAAD60F650E4703A621E1F61","startup_urls_encrypted_hash":"djEw7qz66X9cXCx7YXCIUjiz0Tj7rQ6Sgz+ZInWbsjLWgTOtlzyz0wvGensydQZBI80fCTe6hsg1OHnZ0Csc"}},"super_mac":"B37F5179A7F71A18B97D8048EB792E3964409EE961D46E5C062BD8D22C1F2BEE"},"schedule_to_flush_to_disk":"13424783170161692"} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_2/Default/Session Storage/000003.log b/Covance_UCO3001/browser_profile_2/Default/Session Storage/000003.log index dda14c3c6cff6fc4c23ff62850b368d8ed2c1fa6..eb6d3ed65add4266d14c9a4c93260f4a3ad0bd4a 100644 GIT binary patch delta 1126 zcmb7DO-~b16ul2gNJ!fl1T0h_65~hWB%MyD(;;Y53x)Dou$4e!nxXSbDKN$9AjPOG zjM2E$w{@Y3apOlwG$zJ1i4o&(z_r1+)RmqN<4Rf3mzn$CIrpA>-sJXU_;q?~IM{aX z=JNbq#uVEBHPu5}JoRg0Fwi0z-xN3 zmRD6(39E`0(bV~eUptza{vrP5Y?)ZUry{fT;Z#I_Ak>BKPqx=Se`;bEy;~kZWZiYs z`kNo@edFc=<)}sl8m4iwu&&V*U7}f; z5CaO=X$kKcH#b2UXltlQp=Jn~a*61(lUh5reZjfq5SE@uLbK|V$%(j%^vLJCk0dm1WD>}23E!~$@|L+cqu z;4;op;4;oS5Q7Zyt(9LLp)xG2z(@x8B31Dv9T-d@X8=kW7~a5zlDI??8a41)aA|n7 zT-9mxis55SLNg1zmu?Yrr%@NL+R7nasw_E%$RK2ma6Y_<2C4DRp$H9%*)tncl;r$T?Ts_Rl^k;A0n zaH(Wi<}$zYEdI7cY{+w}9QH3Hj`}+={E^*z*00mV(w89_-WI%L zjmT{D{kKLRjYro8Da*Jvc<2vY5o?3{YJHyPr}Pb{`kbWlN=U zE?*oh_4HN-d-6T~gMGb~;$SY{m(TZ?`uZxR%GzL!)!?1MBX+G)Cfgei1VQ=1AmGjm!J`=wk~fHcc-!{AV*mDSJ>9!^ZOe7{?ATrC?$7Mb zcIUG@vbkb!U%tPv{a1NlH*fqlg|7`(TaCVaU)LAzi*8Mq3Erx$G*p|ZZyFjaO`POV zuwUtWw5`|vR?&6g(I9x(qr3pZMQvT$E)a=@%dvfSuf*cyxAY&pePH5yhr5FRcJzkj zTV*>DebYq;yyLg#nyu#=m+(H(@IHf~pcc#o^h(e8ch@|MKuc9fJx!Erj-9H+Aza(bmQ z+}B?m9_;PO!|B0C>kZrA$!yT2aZfLP5A{qVl7@9Tao z+KAOYqV%)c)~m2d(RQ=iO#X1lYNs7t$6Y979F1Z@@T7~M_l{e-QNL-nm(^b1Vys6K zjR&iT9cvah79w53HyD*L7?&vU^QWw!CNy3SSu8%FecDl8tTrT8D2Poej!lZ9#gKK1 zVylsmb^4Vfuf1NeSV70KqB)&Y)Ne_@RxiK&g3>Btt=^D^LEm zF?LYYXAu95(PG1UR!ge~lfkr8MVP)rB+1C z`pbr`Gb=ix)aET8wUW`9w0C%%I{b1KBb|=iaG=S>fza0 z)dMxNJGRSf|MPD*71Z_Ev$59iQ?jfIeta9F?9Mh}jEjEl{;rS6OhlLP*25Ongp1y- z^u01|PV3&M)#j?faou%Y?QAMY1p^_i>&Te$VG3Sz+;;UYaNBDtldy(Lx`1_SY~pj< zR+sMuk50Py^;kKvVqD2{O*gn8d^UH9+x%8eui#zUe*DOfZq|Y5J8D1s&_wBU^?0dX ztxfDL?_Krbu;$jps22w^?kwW-33h$U>&H`;(1hCc->>vXwKb8vbEM6H@-788m-IxC z7A5h0Zzv=B#lL7mxVb3aMUQc;N8Afv_lm=j714QRrDc_(XKS}QFK+(%?_T~3`eg*T zIc%e%#^uJ%7AK$MMuf%J?(h1l<3^&tpsmT1O^?-%S0}biRq8WS6VFeLZGIxRJ6H&Z zen%I$p>4gc@l8=$H^EwhQM>(%N<%|mAX6;daQkmM8n^hk`zOQps*b0p4?}UI^z$y= z=qoP%x}&bxu$9|B)UV&K=ver?7RaGvl3T|m%O-*?l4BK}JtI01Jg?ueU~}+<VJBiQvX55n74KocM!Y$sBiN|^ za~#k!M^Z#uAD-o`ewBc2i|&oA&x}fnI*W8du~+F_qNm|yG(H{2l1iElt?(9Sj|ZP< zmAheu$JTbeM_oj8Em2y!ad*hg8^=mR!?h`F*YR|%G*chVrOTC((#%*reL9=wKy9k} za%Ic#ShX@yAFP%)XKJNvVJb77Jvp2kKeYScscgM(!*H!!85|xhjg3_%j#oB6x4Sm> z+_3}O25XbYPL7lg_Pn?)Gf=G+c2uVFnWN(~r*`$68#r_(Qyk2Arw)!+bjkAOBe_Cx z!$eKy^ybm(WNydQ@iWEAr*|FcJ+=4T-lL=Sss6EJN46h7J2r8uuQYn{U?o2=b*MOW z>e)hW^zeuF<{8SN-ab!%#(y|D% z`n4RKTMb@To-HbAO#2nd(|Rzdy|N@~CM+#0E}qi9eFM|790q+DOXK(KBm&B+d)a67j-lv%e1PLLa;+; zO-Vjvf}^_DjIOgwdCn>QP;f>^iz*>=hpP_iOmxJkO5|RSsNVFMH>g%MZS=J^E48Yc zPqj|9UN22cI7;){R!njR*vdE4yv@g>Nlkt z(#t*-Jgckaly*4yP_R#FXLN_Vl~UBb_9&JOPN=jEIsn)$k-43f|Jg0j) zsJ&jK=W*?- zXkYk#_l4S_pwvA&=SAfo)tS_WnniVt=!DKHhj$N>GOnvs_4K*NjPgw>_egl8GKY^$ z^BcwHhW9d#5sA+yn8vfbemrFfO{iVJRU4e%E7O(Htx3=|rdx zT*cENH~KZgl5%sNk7;foWO~c=snN-xQE2g~M~%)$n@4s5sc3A_CoF~$OpW$Vp@6IU8qN!IuADergH16}_s^@M5EigETH6|r9pW>$6G3P_}sYG(d>b)9wE zQ0ot~&-E3I{fruWT~ylL?D$v*=Ze$UMh%ik@c?4sPHMfgJ3cE9nr~IyCLN_&7{uTY zqcnF1gNP%8KYM4_m3Jl`rF)^H^iz6WzU18@^LCp|uauN}N@gEG@r3pOkH7!6Ab4Hd zdYyMev{mVAou=1lFA8ru%09d65ZMZTr|JcFeA3bL4@LPdIr^rf(b1duvPExd3DXWq zrz+`G(cw!vRdlWv->LGgulI`caA}%5F!JG$C%5W%wKnT?T@H`R&uCS&^OB<%9KGb| zRY(2njq0?FwztSnY>T>sDRs<&F!1O}sT)aaugcQo7!XHUM@M8^PN@q?Is;&IdQ;&r z*_4g|J|O+@ib;j#ZdQlXzwYnqn!B~lwxnn{w|(GDD)=SUjm|pYOjUOQP{UB(FKhdN z>(2W1W$f6gOVyNP1Wf304Y!;hydp$SFLVc6SwZ#pagqK=`8E@+E~8}W$t zU!c-1px*{u{EOe-6oQ6da`d7*e%YhVdKXrvQLEn?ci<&ahBR*1E^B(?w0nET0EECe zkqZKC>YU&~TG*6w0ibOR%Zoe6*!3oKt-Q7m%0lSYUs>l)glAP%-tLs6P>v^5y|Q=B!RoQI19E*2M6*GBDqjccz;4#U}4oc2EH;*$;> zKjr8Zcih^y(HrjgR5lxCZVT zjUzZS4|Pqd`<#q#ul(`tg~B$UmYs4%+j_C?Wl_vof{90?X3ktxS|c@oC)nn72jlp# zjg5KlabwGLVPE=qlT$rg&6!wlkyMOB0>hlK<757dK?v1|-#TzI1c`s!(brwRH4Ypz`lO4W z_dv5)v0>@H^m|en!e=cQYaw&d@DGjr1vd*W0E#IH#0L&5Xs~!(UVi%pk3Fj+&ucgt zAIQA|%!UPO;XAfZ*E%6D!m{YNhM2c01$gtQ0EnlRvR(Tt%Ma0iZf1QLT`p_LuD@Py zcQIN4=nSBjIe5$nz}vs9{Rnge?gEa+FCWiC{0*6*#|*k*{S`uBiSzyEG@yE+U58a3 z6U~9_dQ?W_od^IIfo{=ca=Zxp9T+vDs{>yFb27t+{d_oJ7&c`6(9}oS+^n~`p7`OB zbiH=6GLbg#^(~RS-j*rwzhj;HC=ej?<|BZ&=itia`anAXZwOyB!$piPqy%2H2VcIw>kI0Q(J3XmUz-`5bV}osKEuh5wW;)UeWrXaoiFzHWYYD@biG^iAT)PO;Yoe`oDCx+>L&l3+`p19$m9Rs3+0jv# z@4T1ayf|L-j(gEL2LB~hB79CwI+V>kFlMKv;gN?Q2GhCmAxg{ar(3{ic3MZHB`ms? zi@j(fBYqnA&(KL=I&)gxO5jc=gAHkq$%f1#IX9=i)`2p*+#R`Q9Vn)7F~y6H5?y6F zV@%PCI#5i-Vho>g{>UeU&Ku7RAE8RvePbDvkvaEo9kggFIBSLBTSQruh&L7;G?rq( zKcb{7;~mtk-)JEtu0V$o&m|TgQv0w+8FtXx!83iq`>)2AYOr>1oi3k}o_(@1 z#+Med2E-prEM3;NUbl8hv{kWTIFmiX`QlJ1I^PO?9%X$d!WBoO*qu8b2@W;C`LMot zFkUlyd-2tIhGT+TEe^LbJgbpY(7acp!ZteeK-YeO4ec_O79ty;l01CU$;Q+oWTTl( zea_~YjM+XaHZar4H>obWeAhhsPcEKWplrOPYu$?`l`pHF(tXTprL6l_{`xvG)4!=n z)ozmww{F~0F}|X8^>7?!g-1*_T(&V2Be!qNIA;Ch;)$a-&Yn2fg2<~`n)+y)$@adT z>A#GdZ14}kOgS^zEKb`0t?qhL&SC8mDL+k?_?wPC?8Ll@`>if+Ci0|+N;8i5jpjc`N16FV@axsC`r7k6qM`AWhRKTuUI{fud zI~Ip!UT5dwu*{c?mRQF*CNitRWTRPCS%;W{p)ymiTP8S8GR$ZzX~X#mjJj`*lpj#L zeq0-6m$fnT60{db9G1(DW`kn9x?kD2#AP?_x3b{dJ5L1%q#1cX8kK(xC7G zXSa_!de+ekj$U%~s-yn>jp|w%ZHax)Q=i2qHfbLh$65QH8PRe3p8h*aeA1KOqhIX$ zl2$l~g8!V2Z~f!M7t;?(?E2_=-)h&pm(YON^S2~Fp0b1{)ZSyOc6z%tdNgkz3jnw_(QU5sc#h5KtE^1qX2NkSa+3tS0|;bV zX2bA%T>K?R{bBf5-0>@p`u8`gGBer|cuo&N!R*GO_W7RREIfyccpRSFC%H%e<$x&P zo}AHO_bi-lK?E?!a;lH2J4em;bsEEN2?tG`Yoj zCEs1$bz=pq?@vo*1IMjbRWC1t`ZhJa$Ej(fFS+>DM198@yKS&sqQ0ZYY%;`Pp{4eo zOVoD+dnIrjOY)4}>;Rh(NZC#kYV9{s_p={@o!6Y;yQJ=2$DP*@^OhsJXgIF0{N8e3 zaWLFhI~I<^sO&sAE)$y8j9~-3VPrE|g{dhK9LF>iW-SlNv}RE#W)QQS6oxi?0CqrU z*7-0gGoW@29LEPI`Q#*LM_)(a9A+j{K1)b3%H9|5SG30mFd1hj2cOHtnz=h_lA-PS;X)na)$-)mO{F$+xGF# zG=d0B>X>w~IIkq;fZGm{vRH(FsU2{AF|)=&0G;E2+nSMKY;EkiP%(2!O)c@2=S9lWY0F)x>R<-tpTP@dW9gg_R8wx)U^!sBtwM z1(Q<)+NYDy>1sUYfV&da_)mg4x3+c1N6x}8lJ|i*t?Uu*s8pV8pnYn zLHseZ_+I96ApS}3ebxcDmEOC<2DP$$9PuZ*Xv9C?zw8dU|LlEJ`)>XnT6``q7oh<|I`?{mdMp*ZUr->XnTyQK?@(d9@aVNboCwc>0gQJd#Qc;ef8aWKK+UM zhRu^Hd6nR-6s)g4?}T6{>N`RBmlNSndh4?Ye=EIphXumsF`s^-i$?eh%fH0NcOA0- zpB;P*s^eUz6OS;J>ULfnG3vPxo3P~LH+TIWeE(X$}*jn#Wq;UmMOK( z5&n|O;@e{^uo2A<=v7ISK>19}rTjioMicm~1!Drlqgeo~w9DwjUB}=W@XUj6T=`ra zgTq=O8208<(&qhH9T+_}2G9<^U&&(tzI^DsF@VTZzTmCSksGyCnN8sg; z)L}$`MF5yn#IgY_@xyo`G70H}>|qfgMlzWd!06;s$e;Yyk6nw)9~%QOxn%Ok;>e$v z*MB=i%3{X=mfGvz7c-sc_1}savRE;5Nlk4rV*uC1KLnf9l`Oj*b!L}(4B&%$2S2TC zb_^gRF&7^LNCo>eU2sYp3vkcKnQT%qKJ-iQ+mT_m{&C{TSimf%jckSmI@RkxQRB1V zKr3oI=Jmf4)%a3-{rhUX6TSWuHJ*6=xB7LwM2$cswv0D1c)wROrX%yn@iU#)AjDD%Jj@weLCIO-`Cr-{OkOz`i)m=-#gqD z+~?>h7O=v3N28b){B?125VPZ6wmF@TOUf8NCyl1o)lHcWHVL6mYjky5v5jG;1>beP z227m2aix(j+0AIENGh=yf zmfd7AY;ZJuX2H>#m5={E`B{x48VMNDIjpup`5<-CIzp@kMEM|iO#9`DGyX85Juo`8 z53Bk@7weoi&#Zptjax7|d!&ZN`IPh+SI6x7c5wA#;kl)@>wSrEZ`k$imk2(mEOZp$ zl3HB?&)xfra?Jgl4x<*g!gISqaPFjz?vV_fl15`8?kM=}$i$<6oOlAy&8m<2_9K2$ z?D}?F0DNo%ozG(2=<;Z-KxY0$<8!Pq7_B5Y6pq z`)?YJ%9&+g7J$X!L}vj!q}`ZZPc*bw>-EX$P3iR6>B)_;Z;z+F6-FD|DEa00^?B6U z^Xod+uE!Up^L%|+8?#q`(F&ee^KcY>8MqGr1?+A-eV749D!x8gbJRJps))eU&&4$*nRr*y@%@s86OzMY!l_Q{h~JLve*EK!UElb9FK*bq zbMX3hTL7%0i|;Tq=cC#6pmotFcbJ18c@wif2s7-l0I)~ET!&;E;E%_O;!9%zd}8El zf7{5eH_N~*0E^SIoCWYU?Z)hSqKmfcbG^&HN>AF^^O=sd>vL*dooCmxW=>xG#M=7s z7&bh<{E?3<-mej!Ue?j*<5yVqc;83%KmM)Q{Ju6BP`hS4fc1EWRCZB&^b@e_iACPD zSo+atGWiG>RzLNCi&=AnUIV>%u>8B;TW`QKuYT)aZ{ccHKMcmrJ|!{6)iDqKc5wAd z_R#ma|K9M>UkEne8u$BLu}~Y{Y_;2ChfynS^lR6*G(VoQgeKIk-|D*j?UpXgHW~@# z1K;vMejvTT89)uNCy-hFp)>(Mh(-e$WyFsksmBNZ+F&y@kS-tiov(bpkLwj;9ItQfjFwb~TV@mqlB#YExAzqie+l?{EFL)OT4i@9OG* zNIevk8&)6OsVGYSCG}K_`sa@Ms1E&;@>iH^3t}ff7criDX7`^?!Sxobjg?;w!Sd7- zcb^G@W6l1#Ch>ROf?|pmQXGozXPnJDi2WAj(O*3L=S8K#%1s(9PhXqwN<1Wt zFo}SzN4wpr&PY0av@^A>-ab;DtT#m`(r?$by;}T^=&?JRjxl#g58Bn@IPH?I649B*INA6pc%dv6)RL z>>Q1a-nZ+f^!_6*t>00lrrb6$M_c0pG_dIT{DiK@`?3Cv(l7VUC=$ruNU(mbZakl~ z3w@~F-`ZKeqWXvh%X3z5;+e1|#;l2DYsw=QS^W@;s`3TZN=4V2O0m2*6o*v{80go3 zPBpS(ZTe~IAF*hu9ne5a#Ep9vG%}=yRmRgGa&^^02&;-3JA3p33oLpTwm@{xN5~;{%{!;uCD~_c_nlk6fP@X43bt_;d<@Ol}Qw? ze*}8T1}`Q&uZQx1!sTVDD4s<5)U3 zT+V0G-Danonr?Ouk9RxiaxPQI=h72n_33tPtUca7bnIQ~?||0jw$|g$BKVZlcqH9^ zAy{45)z;XI>3>}DkUOTf-_*0tC~j8ztSGAr!DhgyEj_1njn_L#rJi8QSt&@!RF9-! zn9ZWuC|vmb={AyeG0=<*H^QD6Js9%m0`;~2GkTp-#b}KCpch6BTmh0Bnt@(m+x!@k z@5&HrXpGY07*r!nhqOw)Mvzi_QinB`UD32^U`7;FFQ?o@pAnCbr;Tg8e5>B$ZHiYP z{FnaU2v^_Ie((L0)gxnvs@<{npVhWi+F@FhYJ_HN}!ihjn2RajI{QX8%H=}r;d%!*7KH!pWr$%xt zGB}eO&!)zAOmjuqr<7}`Mk|`N38k1F^s%PW=xEa_fv+c(XAMb4{eD>PfcSmkZ^rxy z)lMotqc*gU*Tb=pP|Pb5;@A7l8}(pyp6#gq`t4V~)cLS} zOB&;ZVn&fbem?x~8G-N7!@);=ux7!0Ra6&k812)Whv=y2qb-%Os(Ed7D8ki}xZ9hH zXv(1KkVb?Q4j1q}&ezsIS~j&X6YHvnX5G-wyJUt{>NW7H?tlr2j@?v!qyS7W>%Xkp znhTqnXo*^GT-8vxZzRut*EE1R<-sw+kCVs0L%C@Hmgm}Q>k^j(-1B@(eyl=aS>gV? zu=`wqdte`NCfIZtwXr>=YqtXTa{=yO4lw`IKuZD6D=|76^0TWB?qSQ-2lsQVWeUFz z^m3r<16*$jv=nG1(9uBg4-!rWdM40wfyVi0RCP0o1Gs0@=GU(6NZPQq+}voO?o`;vbS~@d0CGTyHmGBr9#@10z7{JnXae)eHMi3g%gCr)6EE z0^o~U=%pCIy#`TXsp^f5Bl7}3Waw1kPKA5+qr4v!U=yW_60a3kyTx`k~J4L zHOph=$8eQ7-f;1c7Z-#3-%pKP=(X}KPn#YqABWzO;l8lEPW_d(@?Q-w|Cc-1%3qC6 z{ehK_u+Fa`=6qjixPMsB@J_{fxaXu$HRb|zo@&k)FWG`s26wvhV@%^*pJ~W zGLzf>?CfH&fA^J{@AbmIi`i@U@=N7XF~7Q<`-w03z5F$St`6ru zds!S+yxv|u$94Ugl!0?!Cng8Z{af10AJH1|4#i&B&&Oc@(FpXPR_UI|+Mm#3IjJ^; zIJ_HN#mmVLV1EGnalWXCFL1u&Nas`?=Uh2uihG??cUblu%w|0V_BqcBENAr3?);Gc zfolH|M1SW#$G%&N?AQb7etW=9(DHc&);{(>hs!xpzzG1<08Zu6nsa@{rNI6T;j4zi zZS4Nx`-{Q;y2r0X>VP@-El-;s*uP)dCBuGhbzA!z1Ke-AV__c$*y?lc53GHJbs-F_ zw6(uo&v5OYK6|RyTKoI8RN~sNs(hao&PlmRIh4zX74cKlImXAH8-5Bo8Eg?CDsLva|P{zNZx;y*WKIl|$0z3=C6Q1ZtL^qiud7{2hz@1o_$mKn=a@88nbU6ud< diff --git a/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/000003.log b/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/000003.log index 7eba4fb29e0fb93229c12058755c8f60e6a342fb..48b301d79580a35f4251183566ba75d6a755a5d0 100644 GIT binary patch delta 97 zcmeytbb)0<1tW)MmIk{c10(yy5Biel_k6v;Cd9@`GtZ1tS0rumbo1 diff --git a/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG b/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG index dac4ac4..7a34add 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG +++ b/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:17.913 5b74 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/MANIFEST-000001 -2026/05/29-14:01:17.913 5b74 Recovering log #3 -2026/05/29-14:01:17.914 5b74 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/000003.log +2026/06/01-12:26:09.841 1484 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/MANIFEST-000001 +2026/06/01-12:26:09.845 1484 Recovering log #3 +2026/06/01-12:26:09.845 1484 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG.old b/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG.old index f96bad7..dac4ac4 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG.old +++ b/Covance_UCO3001/browser_profile_2/Default/Site Characteristics Database/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:01.182 694 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/MANIFEST-000001 -2026/05/29-13:49:01.185 694 Recovering log #3 -2026/05/29-13:49:01.185 694 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/000003.log +2026/05/29-14:01:17.913 5b74 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/MANIFEST-000001 +2026/05/29-14:01:17.913 5b74 Recovering log #3 +2026/05/29-14:01:17.914 5b74 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Site Characteristics Database/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG b/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG index 8ab2171..bddf13d 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG +++ b/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:17.883 5e9c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/MANIFEST-000001 -2026/05/29-14:01:17.887 5e9c Recovering log #3 -2026/05/29-14:01:17.888 5e9c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/000003.log +2026/06/01-12:26:09.836 6b40 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/MANIFEST-000001 +2026/06/01-12:26:09.845 6b40 Recovering log #3 +2026/06/01-12:26:09.845 6b40 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG.old b/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG.old index 890c3a6..8ab2171 100644 --- a/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG.old +++ b/Covance_UCO3001/browser_profile_2/Default/Sync Data/LevelDB/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:01.202 6e80 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/MANIFEST-000001 -2026/05/29-13:49:01.203 6e80 Recovering log #3 -2026/05/29-13:49:01.203 6e80 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/000003.log +2026/05/29-14:01:17.883 5e9c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/MANIFEST-000001 +2026/05/29-14:01:17.887 5e9c Recovering log #3 +2026/05/29-14:01:17.888 5e9c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\Sync Data\LevelDB/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/Web Data b/Covance_UCO3001/browser_profile_2/Default/Web Data index 701adfc5f6e7700c1f29db97f9042f0c03f33115..1bbe35e807d6c61d350e3b099968feda41667a99 100644 GIT binary patch delta 98 zcmV-o0G?0S19!wO|39rvx2dQ3JN90mH97DKdoW*SK$kCYvx* zlIGAwZan_f_{r`{eS}ZQWP84o7GhfpXAo>G((nYMHJm}NADT~l%Mtk6jOwwVMy6N- E2<0;?iU0rr delta 98 zcmV-o0G0R@3zwO|39rvw>*9Rjwf0mH97nQppAq_(67`2@FB zI9u2osi!mGu-oKDctLqk2?YfZKoPp40%Q4@D=-{%`-a8c90uJ-1^oz7{bkmQ;6sjQYrBCG1bMIe~*E`Wx z@<3qN0w;Y)^xu&j=zTN4WJnk<@jB>*4_;H zAAJl5`5`)>%-EXM~Ss9za0Oz#Vi^s(ia!A zv)^{24@m+}?rLI~UDDr?;{DpupQ6gMnO|E;wy9V@d~+%*Me!kGbgx5q{Q&M~L!9nDi(x4|UscsNJY$f5yfo&y&=G>BVtZ}F-0 zbEA($pDgOW)1E|{Vy@LYZlCz)#&U$}q65&T;!T@6Vm@g)Ge&;3HXB~m;by)#=>TKr zQ%v{_F|NCrR?9feFy}4fft%?(OS&pqW_u?w9=MpZoes(@80|IJdOe6(KI=NfY#8kZ zt7=@d?dgoXZa}9M-Y=F0(vS1Ks9hhzqa(;QlsmiC`S8Tg_ErW2AO z_ZITzd~5vtab9y=nTMXUY;8Z#Wv}^6Syn3Unnwl!G3OB}5}2Fyju9!#rVeqSeWo&f zaFNRDlB9?#7Bxl3qRetQplc%L0-VmtDlaG+d)eu^$}0Z5gmJ%tmO&obha%bzUM$xLw^I1umsx!yW+cpzS2Pfr}+c0-T*B;m@JV1lXoOK4k)6 zqXSeLpkn||20$eMQUp6ccnNk2z{pY|ut;nO`bl5J5-81FlC!%9YH=7B-UO)q0H{U8 zT|KpwzH+kvc|h%uZE?F%i$z?5nr(5Pe5G&1T{@|v2WRmYmvFYLmMr0ETXdQ#a3k1F zG?3jy8t!V07QjZboA{ey8uvP!Kl85wiH+7g_@yAL89@abp^$_{j#aSAD?B!MT~kzD z)FoDkl4vKC>DQCQOp%i`j`g#cljR^5q2}VC>=$q#0JH}+f%mIsRbH-HJR?#7TfXmz z@|blk`Dx(sQ`@OVd5kGl;L&cX;o=!R{+#_lTF|1=fV*Px7y=F?i$@N6h>w&x1x`XM z4;+&6sKQ-@laMO(QvBjHG9mIlU5+C1-kMcPx98jq1CdR(<&6>mdXt1m0I0>s_K*2$kS4B=^ zRYljKaOIj!a~rH(?d3m?N1-0GZP-14`ZL?PMxl-=*W&EVOq;2Oo8}6S@3v!E6MUe9<_ u!q;yC)M4B5Mxl;LUS*RR910 diff --git a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG index 4977fc6..8b67d0c 100644 --- a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG +++ b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:18.231 5e9c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-14:01:18.232 5e9c Recovering log #3 -2026/05/29-14:01:18.232 5e9c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/000003.log +2026/06/01-12:26:10.186 576c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/MANIFEST-000001 +2026/06/01-12:26:10.187 576c Recovering log #3 +2026/06/01-12:26:10.295 576c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG.old b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG.old index 520d989..4977fc6 100644 --- a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG.old +++ b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:01.544 5838 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-13:49:01.545 5838 Recovering log #3 -2026/05/29-13:49:01.546 5838 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/000003.log +2026/05/29-14:01:18.231 5e9c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/MANIFEST-000001 +2026/05/29-14:01:18.232 5e9c Recovering log #3 +2026/05/29-14:01:18.232 5e9c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/000003.log b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/000003.log index a74e64b56d285f179d49a81f8a592ad31dee5060..7a197315e02f415b55dd142f6fdaa00314c58bc4 100644 GIT binary patch delta 19 acmZ3&ag1Yw3JZs*3FBUA21eD1T2cTrs04Tb delta 7 OcmX@cv4mrT3JU-WQ36u{ diff --git a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG index 9dc59fa..5759fec 100644 --- a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG +++ b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:18.227 5e9c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-14:01:18.227 5e9c Recovering log #3 -2026/05/29-14:01:18.228 5e9c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/000003.log +2026/06/01-12:26:10.166 576c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/06/01-12:26:10.167 576c Recovering log #3 +2026/06/01-12:26:10.182 576c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG.old b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG.old index 11e8c5e..9dc59fa 100644 --- a/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG.old +++ b/Covance_UCO3001/browser_profile_2/Default/shared_proto_db/metadata/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:01.513 5838 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-13:49:01.513 5838 Recovering log #3 -2026/05/29-13:49:01.514 5838 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/000003.log +2026/05/29-14:01:18.227 5e9c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/05/29-14:01:18.227 5e9c Recovering log #3 +2026/05/29-14:01:18.228 5e9c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_2\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile_2/GrShaderCache/data_0 b/Covance_UCO3001/browser_profile_2/GrShaderCache/data_0 index 72fbcad058db2161f74e4e83f5006e42aee3d1e3..d19146ae7003f646067d7b0164e245daa519575d 100644 GIT binary patch delta 207 zcmZp8z|`=7N%rt5mV*ooObj5P0>suJ1`7iNBZ!_TYsJXEF>${9!~)Jq3L+*z@d-=} zj0-_>KbOk>+E&Q_;>bpQ1{iG#l(zz67O0w5epQ*t9tsg6K=l(?ftU*_!MTxHYV#I_ t6m}D!Jri1>qA}-=dM?fQ4K@-+gXBR*wn5dfeY)8Ka?!?u2}n4V69A&dInV$A delta 171 zcmZp8z|`=7N%rt5mV*ooObj5P0>oAz1`CK_U|^gmYsJXCF>${9!~)Jq3L++q3=9*P z7#J6VB>P09__IrHZtL8r&j6!=!V`dcff%ADP(|zBWDkW15s*e!Am)Nf+_mn#w|R>~ a3cG+MP_zXq+O&3|7s$4a1rv~PCno>_oh%3d diff --git a/Covance_UCO3001/browser_profile_2/GrShaderCache/data_1 b/Covance_UCO3001/browser_profile_2/GrShaderCache/data_1 index e85c0a4c60cba29dfa651eaa47b50f36fcb0d108..a7e69b7d2f2b8b414651ca9f239a117fd546c73e 100644 GIT binary patch delta 355 zcmZoTAkc6?K=$w{mV*ooObm<+Kma6cKr{;j0|$tnDC^Ale`Dfuc}DBWoC?ycd?2}r zhVl~&3?!{V3V?taLcvMviHYt~B2aD#l!hthW}KKPwwXimM~lPZgVR=kWUUw&CO}nz zsh{@0UmV$}&kziD5kw}!3|R#O!x;wV!xIx_Se)uJ!X_sut&($c1cFE~3N!(+{hS>g agWSr?9UTKr0w-%I-`H3%L7u+Yfdv3yH()aW delta 242 zcmZoTAkc6?K=$w{mV*ooObm<+Kma7HK{N{k0|$sZQP!E!eq-Wtc}A5CoM05L^IR{#J2 diff --git a/Covance_UCO3001/browser_profile_2/GrShaderCache/data_3 b/Covance_UCO3001/browser_profile_2/GrShaderCache/data_3 index c6f4ea19aae864300306418fdab91f30441676d5..b31446f8129d0ba16287ed2d80e5aa218c3c8002 100644 GIT binary patch delta 2750 zcmeHGUu+ab7~k33o&9$ldq?4ppmdtjPz2$2?~W@uJlnhaP$a;W2aJX+#gnA5rKM?! zMp_q1_RW;Kk&nL6mJl8&T8@%z(L%3~sL?7l(L{|VJYb9=Mlkq9q<%~E;S%DbPdCYL zcjou~n{VbfcG>1_MEK_C!aT?ET!6!&b6k2Pyn-x@G_;bX(vjiX5nFnPIgB`rcUZt- zg2P0IQHMzmlO3iwOm&!co(0SAF`eWgJg%OBDW+_9@3Jn~SEqErwGKsgN9$sQhnWeQ zA_2HJ5!?-P2i00&XXzbybXHqAy}SN8@&2k;wo`azG8l*7yQL)5PSQ@IxW_vWz$ICb zVEqGeElEO27G8&66G{!dwNcsV^u03^_EWpVR=_>ekP>P@GBZ4G8qISR=mS_E>2azZlLbF4p}fqR#=)eth37Ggk)Ng5u9e%wbwgm2f}i7VC< z>kq=>6kozsrys5nWSNE^moP=$ITJVJ%D6k8N zj}UK2_`%WoQZDahHip!_Ay8kZD(*(Hpk2pMtu{o{O;oP$TU78TDSA;3hIu0SR{D)|Ou zSc-;y1CQ{B{}Ke)oKsMY$nD_>Hw<;{@_Nuep-+YX(Dlcz7J8aE55RnzoEKliWzM^g z$we-GgS=DCQA+djOJ&*(gv9@t3(mAyitApd8xCA2@G*>?l#KG^gX zEh_$Y4>D{8?vF}qyz+~ZKw#z;jiG|SzD3u#zZ6=%_#$0gUb5}lDynBt)j(APRSi@% K@c(JxPvvhvXefFB delta 1749 zcmZoT(7@CH#Da%Uu^ePzU}9iq00IF92D6ER!i;Aps=6@pZ!GMWpV+|Oq|m0o*rveL zroh~$z|y9`+NQwProi5&z|p3_*`~nNrog>Sf#<-+h6edjJQ@b0X<#%BjHZFnG(hh( Iu&_Y@0Ki=co&W#< diff --git a/Covance_UCO3001/browser_profile_2/GraphiteDawnCache/data_1 b/Covance_UCO3001/browser_profile_2/GraphiteDawnCache/data_1 index c453018198795e9997111a19f71f68b7496fbd57..04759ce045fc14a507b63b7bf7cc7ad11b88e1cb 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM&XHp`pq1Q?Hr1XK+LqALy`H%KLD+L3RVCB delta 31 lcmZoTAkc6?V8aasM&5~m`pq1Q?Hr1XK+LqALy`H%KLD)%3Qzz5 diff --git a/Covance_UCO3001/browser_profile_2/Local State b/Covance_UCO3001/browser_profile_2/Local State index 7c748d9..214fc78 100644 --- a/Covance_UCO3001/browser_profile_2/Local State +++ b/Covance_UCO3001/browser_profile_2/Local State @@ -1 +1 @@ -{"autofill":{"ablation_seed":"H4lFgaU4OF8="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528304665062"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":77,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.78005470525172e+12,"network":1.780054705154e+12,"ticks":20533477058.0,"uncertainty":10132452.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAA3ThR6DPGv6qBOZ41rtQhRAAAAAAEgAAAoAAAABAAAADkYwivZrxeAOpc3wz0bnN2KAAAAMbpwRmZahdE2CdMNKvQ2/etXeF76z/+k32EjHOefNGbjGveQqtjfWAUAAAA0NqRpGAQAlYywa7YjUTO7qiWHs0="},"performance_intervention":{"last_daily_sample":"13424528305165136"},"policy":{"last_statistics_update":"13424528304663730"},"profile":{"info_cache":{"Default":{"active_time":1780054705.143717,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424528304722326","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"1760741346","signin":{"active_accounts_last_emitted":"13424528304565067"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424528304643958","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054704"},"user_experience_metrics":{"client_id2":"04c97fbd-1be5-4e02-b6be-5f8b96624ac2","client_id_timestamp":"1780054704","limited_entropy_randomization_source":"62B9CBE9BF68AAFB593C5E9DFB7467FF","log_record_id":3,"low_entropy_source3":2334,"machine_id":6709466,"pseudo_low_entropy_source":5257,"session_id":2,"stability":{"browser_last_live_timestamp":"13424529877724827","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"F0AE6250EF329F3C8105DCD7FE8B6C5A957586D4","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file +{"autofill":{"ablation_seed":"H4lFgaU4OF8="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528304665062"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":77,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780309570288726e+12,"network":1.780309570146e+12,"ticks":17534500957.0,"uncertainty":10135255.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAA3ThR6DPGv6qBOZ41rtQhRAAAAAAEgAAAoAAAABAAAADkYwivZrxeAOpc3wz0bnN2KAAAAMbpwRmZahdE2CdMNKvQ2/etXeF76z/+k32EjHOefNGbjGveQqtjfWAUAAAA0NqRpGAQAlYywa7YjUTO7qiWHs0="},"performance_intervention":{"last_daily_sample":"13424783170140111"},"policy":{"last_statistics_update":"13424783169792363"},"profile":{"info_cache":{"Default":{"active_time":1780309570.115301,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424783169795906","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"1760741411","signin":{"active_accounts_last_emitted":"13424783169698613"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424783169775659","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054704"},"user_experience_metrics":{"client_id2":"04c97fbd-1be5-4e02-b6be-5f8b96624ac2","client_id_timestamp":"1780054704","limited_entropy_randomization_source":"62B9CBE9BF68AAFB593C5E9DFB7467FF","log_record_id":4,"low_entropy_source3":2334,"machine_id":6709466,"pseudo_low_entropy_source":5257,"session_id":3,"stability":{"browser_last_live_timestamp":"13424783355799029","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"3314366CC4706E8887C34E9E24B27EF6054B46BB","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_2/ShaderCache/data_1 b/Covance_UCO3001/browser_profile_2/ShaderCache/data_1 index 4e38f6aeb939d8c22bca9c285b56ce864efeee02..0d9aa90b48f4c0d256ae9ad596ec719d41512736 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasMv;ku`pq1Q?Hr1XK+LqALy`H%KLD+g3ReIC delta 31 lcmZoTAkc6?V8aasM!t!G`pq1Q?Hr1XK+LqALy`H%KLD*13Q+(6 diff --git a/Covance_UCO3001/browser_profile_2/first_party_sets.db b/Covance_UCO3001/browser_profile_2/first_party_sets.db index a9287290cc60f79bfbff58b8ae283cb1c64e6268..beee181b190d5b7368cc425f15d94b89825cf560 100644 GIT binary patch delta 73 zcmZo@U~Xt&o*>Q0GEv5vk!52-n7lAMvpj!MX6aWx<7NP(E delta 73 zcmZo@U~Xt&o*>Q0JWvpj!MX6aWuy7MlP7 diff --git a/Covance_UCO3001/browser_profile_2/segmentation_platform/ukm_db b/Covance_UCO3001/browser_profile_2/segmentation_platform/ukm_db index 81d96bf3b285dc1f5e9b11affb9d09c690bb2013..5cb8eee0136727d7432db05e358900d4fdd6947b 100644 GIT binary patch delta 2188 zcmbtVX-rgC6n<|8XXV|ahFu)N1#6RmdBZGB8Y?ghAj^P)vRHK(9Ry_%0U0zEthKS0 zR>`f2ORP(6HEA2fr%l_qOHI{cC3Wed(MDTD#X>jR7~9@^?X$(d{d1O^@11+kcb3=I zrfh3d?hhNOG^o3{e(5Uo15#R4kZP?ma z@y4RicgYMpZJRrO7j@JRwncBx(rudk#UHN@ zF>J~$cl0pqomJvpuJ=OH^3>kRSB+m+cn_Z0H6xp0t=HXA!?6947bR}>=7(FdDxN9X z)1%t4|9o}XdWua_PIpBTEdQhyw{N^uDt5fw;*j>u3E)$It^K3-eIZ-`-Z-vNX+SHnI$=r#8bmkIWpoA|MxAIk+Jx4jm6DiXNBB{)x|P-25Uy15 zwD`23V`Ya{EM9hKNyf+y&v!D0yCt#Ld%QPbbuI(25?RmE=9k z&>-}|LUa?hKs4F}-#{t43=)W_le|WU) zx%JD;qTfE#?+=t^SS+)eGcDGFVtamGwbxn~63bm>{(#lz$h9mkXwJhYg4yZ+Hz}M` zHy(B0?pwW*rA4!n4g`7?BgoWG*pAm#*AUCJYaD(+t)Y4T^*B&NtU>+m`S=pG?!RM9 z#;(Q08pw0q#S*pd)y8$=@k@wxcWOm9?x5D4S|fL$_9GJc_E)$8AE~pNh*kBt%;tpu_DOLL_oK2fxFQWV2m^i*OE3!pDS;z3>)nf_5pf ztp@P^9h!JSqYUHe%fn?uFB>`nC?w!q2OmHgj37ClN7!{NB3+138u_PL e4yT7tbE>C@7LUcA;S_BaQM9Extri^#a`NEI8->pD4L)z@(`avbY*#UEdqKp8h5)O%_9= zhN!?g?&CXVu!anlF^%^~;WY@0h~pW?Fppt8L{xf``#{k>HyimWff2QW6&&ZuvzWvd zEFlC556{?8L>um)9#61acDjoy4Yk*j($W2|AN6-!bp9=C+-Ry%^lKOVGIJzs6GCWe z7g>V*FZWKBzCJQjqRS!skCLGlH928d6x|ZWg4DX3%=gj*MwtsQ8aGU=E!AJ9@skmz z;_V*#S*6vt=blqI!t^=o?4y@e`gG-BkODnS~8Omub1}#&y!G^x^Q+ zh1{uGez`O@WTv?@-t7~m(Y=>^Ek1XPZHaT)>K#UWnX4zNXyLXR`Q0qbxKRE@<5l#RXSD#D_aR7f|#)+~EH`x%bTErqlKo-}`<1{r=6T=jQe#H~G#< za*~|n=6)1=QK}I51GT|5eaG3?!IK>FiAQeT1xJV!P(1D(k|V@i_=zCTwY3}JNtfpL zRR`SuY52}$%&0P+ z16Sr#9M$D#JCk$V{(vVCbbEu&vNB(xE9mnlPjLCmYBRz0mH1udfn*)mP9#FO&g}co zXE;5|GX_Mzxh*Ib)DCnAC=S#f)B)5H)CqJbs57Vwh~#n@s4M7jP&ZI_&=H^`K?$H9 zprb%XgN^|ug8G8`gN_3Y01W~qfd+$yfkuKxgH8sef-*pvpsAo7P(J7k&>RrS^T2@v z=fe|=K`i$b_)+xRoFMY~_sj*qs>9&>!4mm1kDKz!z4J~6OFD`dgV@YB*?8GdT{@N!_d!+k6j+{Im_pzP#{M5Z} z$$78kh;!m7vlNtgokRYv6%Mh_@kZae7|6$Pj>R$J+L-=B3Pu*XTqBB;MvrifNE$w@ zxF~6~+cgT8!oj0Qq>LI?@=F*slV^%wgjv4*VEt_)2jr#QdMK3QFgBERETekhC zVfS=gy8fiC^+^xyKl822CI*L(`Tm@w^9LZ{I&x|!fD zah13!klJUyH{dRF7Y5yE5N*+rP6UtIpyl~ox65BxN)O969qk!vuhwTueH9fRZ;5=$ z&=1ptrAPt!3^&>=wQb8Y>3&}zkm0WK6uRlL2KX9#j@nSUJJao|s%`4Io_c;pR=L%l zU?CxEkYB2yOODl_%bziIrYB&u-SP^m`7>PJdGfb4NCO1|*dkF+BgYj8RQvoz*)A`N z!ygs5`D}0f*$h|ERp1J^ofV$+G7m~J&=9*>7y9VW8g+rPi&O-}X$*I-2G9G-D|`WW z4r-K-etEQK&2nl^-qc4-^96Hjy@gc$L|aro((6?J@>~Uz{JzSHIYub|EA?@{*H`Vu z6VcQBGk{h*BgP&8|WA zBC-vUEr@JCG+&_k3fXr~0AV^RZ8~G&r-CMcrhsxlY|EL8d-_e7=%26JapK6J1V_J{ z<~E7X#Yp?vfNq#0*T1`$!qy)){;heBI(#G-a)$2+^9^p~YD}GyG4&~Q2Lid6+?Kh6 zK5ufKr`({fq2g>hB$h|A&Icf#~<01)2}K5_B)<9Z(Fw zjRRc*+5yUf@##&_d>G(Hw-q8eR){kp(AQzGx&{-g^&N#Mfx+!Q2=_tA;$|4r?oNcP zF~J%%1oJD*4-c6v#1>yS3!gzFceNL%1C@Sho$bS=fNnsZ|3w-Zmhg6_#te7fp<$;PEIIb*KqDXxte z%$AFS7VYvfF%tUx3m(Z#&m(~D>nh)in z$}J9tw&rlIylCQ0Z(e%In?~wfe}%YF<8ycuI48Pc8k^|ylvVl}tq_TLkns)x9yLG0 zTVsY(Id4Qb@th#?dA%S6{*Z#Ot^y7Ou)NbxqO54aw#KwPeebZ#O9of%GYrOvXs zdeHC3g5}?TxBab4D-TSI$Fn0r`KlABsj*CM<*x%xk>T)yw3w6+wF9Qh7hnJ<~jMX9Gv=-Jc! z9-|w!tfwtI+9)?JXLOIUKh6aI(XpMrq-@Urr6`zPJB;Ck%US0$Bn8h@pQ{Kvfk!>M7}~0mxTPm(r{Qar;`0aN@Dt`S+>q|GC#kPMf~< z*amXf`A9}O1y_!*%u`6>r6p9;9Bs+J4n4Y>Kd(Oy0N?dNzpp95V}I?t>8au8KTYw- zkx%-E`I4zzl>Bqu?jkDt$e;xAW`X`p`O-L1T`xsp$#Iuj-urC)uG2c7`~Hr}+pAfy z^t))ClKJ@8;ho(1mY40o}Mmr4KQ@}=KEGFJ6hMPl>%Yg^3ONB;KsFR$?L zFzSy(=zI>(br)7bIn^dls;+PbT;60Ss%#ZTg+Y*kjCwMBf)d0|v z`b}d%(pyxgN!FNx$@P6y89CQG3H}(+B+zM~d7z6xw}D;;{Qx?i@&r8vItCS**6EX> zOuhhZfa2Q*g*gby@)e90pNFDMLT1MzvyGVNj!O{Y5$K_!{z5E2QHVRx5$;XH9)%e~ zTnZs3Efiw+--P&aoe;NvD#SzG9b!VBL+lMX#IF4g(E+{NF$ZGA@AtM5Z=K&(%)TgA z%zM6_=szh=JlMa3*izm}>=@HURNvE8bouxQkrsQjSfAfloY!@bSh-}Fxch|h;;WKu z;o3G^^dB7*KY6Ye4_@$q*!OpDpJ`Q4bl-&M6a zX45HcosSHQ-MVQ`yT>km>ySP@uWf(j*rz(KdS!O!fv?_l*rc1T>weN{6-V8Ftvj*u zqKA)v_V0HN7N{4jFVy;z*{}Kf+;#TNi6{L&YbZo49r>gOnQyYgUc>qmuFs8E9z3m% zyEogwm37pxWwXWZuAH%f&mnX^hhrhQ0+aM&PZ_4@$yr`=!j3VctDp>x&9qa9Iy}Jr zR1WF}s#Lh2qI*;=p^gKu>2u~~GvXh;3T){}?~(S?`I3!GGdQez)kgkLc~=fzxxe_F z*Ub#bcZk;o^EqGk^GY%8Da!Hr%98WZbCc1+<*z->HP2mH!9qyJIMiK&l~!+&W!%2_ zSVPY^Wgd~eJ+r`{v+a!}%45Z2d3W!5t>={_CvsFSZE$72WGWYo+1>sMzbD{MFLf8r zOP-!<4BQ7Jj$M7C>*<8!nlHD~Et__KUa-k!)EfgQ)obP}5aq3oGb>;$(ics~nmPXj zWAA{BUxzE#qZKyr3|R8fNxvO3=xQAg^JSvSC6cKjx2!;huiWMFPWE9J4fL0qe*(0B zbM?5|ed_wqt>3rR^Jl)2wY+VRzt_m0o)zo*RG}g5eAt4x#foyg~k4 z9%L|pQ}s#WfaZVyvdp34!1F7Y>c5})Myio(!~7#08W?j-b^MSp$lyBRQ9kjI3&C9r zeEU4-EvL|}Hyn4`H)A_KMtvhWiq{@j=1Zn>iR5b31Lp$F%AFZh4am4u8IWwUMj8+8 zglD&1q3e|U_GpgL2}FDKNWW2EjqX#R`;`0d0AJdzM#IkloeG)@A|YG`3W1&lp&J#Q z@PkePEdV_a>W+$83)%x(1f_9YTOqy&eH1IizhE?)5GTZY7%V&hfqa7gdlCBYmFT~- zU@N*8wPk0bAxG}t79$UCcdH?9B-^C^KJ&}2?&7oh(GWs9@<|Uc-(-h9UEWy%qs8U< zOv#%u)pB1p&|o^@QTjz7D))ULwreeJ`*!uzfuC$A`H>?zx5btDlBry>-Q_-itv(g6_!FVTkRqB$e+@4g2*RX=;Mn!Q~X!VMYTte zbg2Gt@j~ZIHZCwY6#K~LQ0O*yk-@G=ix9bmZZB-oKBMA<=cZ~s%|Q>Y;vp<(ib9>2 z|0{HccgE6WQUTJ@cwLCzLg!01F46FmddiBza9nanU>Hvwp5gM@EJqX(`9#x~gK`6N z&wF;j>4cjc`P6=yFPX|^dTzSEwj!8}`iTi-p}dc1M{E7eNp8M=Jl1!?ujAdNAM5!u zU&&hDM$13^;}JvEUv-0xr=9R9{nWHBQg>_xt{;DSu6^9}HsXabKMrg^Y0Vjz{+&w8 z*c%O9c!2qmsa&#s=lC$_Ez0xZG8Od#mhb$?_HK+IjL0pW&p}OF_IE>7%XKZ%V^G&} zZ42gIxpzAeet!_DMVjZ00AcA#_8r;qXMu`9)PGzEx*oI|^c-j#=-;3o5J)Ph40H=< z3n&2%r~vc?=tzj;5>N~(@G{U)^e6uWJ%c{wUMRe$0r&^>D>Klqe2&iT0d#IppmD_k z?0s0Lx*r`}57+_sqk?+@b|Ju?46v^P>?z}r&IGJsPRG0yYh^zdBdijQ^b(ZQ3iN6B zgI-2G-iiM20Q#}MSf7~U5UI5evFv__=<~Hh{B&ZBIB7wQ=>1NNaE@#vCa!KHjvCZf z>|WniWE97WJ;$~~pL&RRbl)N3{=?gg&+|KoS6}KVmJ}Z<>jC$7b&v(O7cr#y`kMLr zuanM5Kj$huCLP2E=MXwyvT<=1(iFi{fO!*)6i_LZuu9aLvnGVA^>wk0{NH@K!@>_X zmz_`bf*kn{T$wMK%0<;5K5UK0s|lH|0Ibr5G-b%iXM@yQJi~HGLFY=p%LyVM#ou84 z@#@U1OLwPT6-1D9EC-#>;k0-p=ZG|YbXHWr#3+~doJCcnYm3m)1+irsrV(S-4s)dMf8Y#1-yQ)^b|nLn;vc|!L|kN#>tE`JyOI-Sqqxt3+A$H7j0$^Ohi9`(cyH0$m@+YcpxmdVFr#=@JJrfaLnI#w4E<=nUeegUIg->IYhe=f*u6>K*?Nhq!jyIZ44iSFC-PBETI7 zB0bK0$y6@*9cG)9%LxG*Pm&9P4)%AE%%KV`c4nwV*+#pt z6$p_C>I0(ROmb7}{R(sO$%!!f+0?($?^p+U{Wi0HK5oU>(D<7^81i5_^$X-EUT0jH zFPX}P>YMrURIb}kZw5?$av@oC2hndl76f%C>+DSU z1oj5dOQ0BlgsD)}gQmscc~qzap!8VGZBU^SkzgzY{eBlAKI|q$H3WAe`j|V>zdUye z{27=BmSOM4QXw`!gT84W^z0;uD0mR#nv@uE>bEgs#kMx0XV+Nq`2Fp~dz<3KmK!=Y z+Ak!GGUVn2Hb4s3ZFN7!mD8SDxN~Ihg@7R))q^(p)yy~9Vb2`jlUl1NbJb=QO~mGZ z!~T&~gjjVTk}s`GuCS4R#r`!L{MA3~)$?b5IAimsiTvf#q*~7sQw%-DzaK@?K)-Ig z^w94=y6?mak`FoZNxv{(GL_4uoP2ad{-SEUSwMYcncFY>1KQvb=^d@({k1l5%=C`@ zc*dQ}Cg?bruRxHuxmeiD3i!%o=E+%@?FHTFGfng6bU*eMU=b{0k5J{3LKAj4mWw{V z+~tlJkAK+Zwec(89`(BsRraH#mzZy|!(P+l%PfqT47UOv*N@G>(H8#`j>cSd%^}wf z?3t3L%7xRvc1&ZcyC;f7|XWidM|2n}0$oP{@zR3=I_Hoaow>IUwHuP{Jh;gq5E;V1uv(5~s z_850E{(*CXOgwE#?+zG?c5&P*=Tg`aTdGfA`OkA)tEdBnqc+nOSLREma+&51CTC2` zP0sKJGJOFo*U9Zo()1u>?ZlPvHPzozR-|ib?m&GF^(V)J&}^hlsS^G@pr1fwxWzJz z_yoWPq7d5P;k9u>EQR7a9-Y;=qlEYlO8RZ|F=J8dF7abs=Pn_}@5UZE%og9->kvMS zy@z(gc>9Z3QF}?8=z3}=QS!!NV#L!uM3*7QikqGvA>MyDTYR5gA)cFYyI6J0KgAQh zavk}{|I^W}>Ln6MTk6x`ix7zG^J2^o$gzCu{$x2Iv2f@HWPi_m$y6@tIM{eQEL@FGt#tcqsb@>ZcsSeb3Sf*!ukvLZ<7Fd}o$&0) zA0m`vuP*SZuOl1Z01#BTT(kASzZSF!bQI)&8Hm>2$bNS?%Hi%<^j+vQKgB?)2NL-a zKdcK9ITeZQMj|(&BVRKQV_S5VdJ*?gf2gZo6u%6~dVfNb)D>lZ&iHW^B zily_qh);^Ti~AnvC90DLipTqo7Gow%7mnY`1<94=UjsZW|DEVV$+7%HmpY{U1^5TH z?0lBO?s~h;-e)sbUqXdQj(i%&GG8*4ON06?hh4BgB2II1g-GOnLXs_wAF0S`EJ0=7 z14QE_s^>JGpsF(!GzU}-qA|r&pszvwA?tF`s~~#O_;pYn#uWvS`?<(u2im}LWI}75 zRmfx;GC2~3Sd6yNu@Cm74a8a~#?+frF(x}zh$U{6FKTbETd}wH6^vDW!B{WFAxK^< zS5@EDj0XrfCkPOv{D;EldL4ggjPUdlpM-uE&)-fF;E=7X*UXnpj%vF{<{}{T}%JK8TBzH%s04^YlC_? zArSPGqgONRdORJDS}zHMA9bY*>dFhCt5IL74uRbQb>`moC{s)TE`|Pd!WJ?bb*H*3 z6ddZ$w?{&6K^Y%72J4sopl=5V@puw!CBqR9eTF9;brh90|1|6`F2vXvgW*@}g!tRF zsDrCech_Sbek;b%|3cmg4zU3X09(#M9lO~fj`#p;$w$VB_O2K)=CK&jxqBPY=fXB3 zbAKDL^2)Zte`2gy{8_B{?vZvU_z@g~pjCgsGllH_F;Qp$f`9&~Wrg%|iTHyB&)Ezc&9v z)sc3;W8ohMBAth-B<+BM;GY0G5kzG~<#Q5fFo^Ub=^3al`QG#h_%wAycOu6I7^ca+ zBB+Yejz~I`x&TsFsUWHsC;~bEMiI$(1}4Iv1j+a4(+(V1K}ix<|*qh^CeTcWal{XdOoaAkt#gZRq2Hp$dCHuHtsXrn7SDc zsrq#81ZzE}It(=+)b~SvUUteW=dbav;VcOcq0;#rPVEUgwZSa*H z9#-4=E)5suc^Jj%9oc8L{ng((9N+GJsv6S8m{*-|1`9=>VvA<6r-W7p=-i9sbiCA# zS(RaBv9$AgR32)#TwdH}YQXRG>W5S{#rcEt+!YT#lf(Hi4xP{8jpLYs{TjKoIG&{( z8Yc)X6c~($sNUKgcRvuW191 z;U%!829RMY&{;p`{ z`S9pfPnV3!q;5z$ice4Je96Xz*Yz@TU~)%?UF9i)re$lh)ef{y%b(g3)phlKqgCVb zUOsQzYgjQd9QjnwnQyYg9_Npxi8R`{6@~z7*bF*M%3bA(Sih}$H5DD7Dv$O^wF9Mm zWaPb}$1gkm=HoLm&)4xVKMcgY(eX_1%C%M)ERu68D=K{c;8Z$w$Wku#)B(deL6lDs zh#JK{5bu+C=(cN|Pj)%`Zlj(V@n~NH^AXkJ7>Aj^&kuQ+Q#ToJF|J%MGO6>2YbyVf zvd$TB(&*Rj*5$x_BZbJd(fpI0Rd|JlnxBlU_P;xA;D{Z5#=M)Jy=gD!WZ-cKozLNo z%AI-gT>fzORn+X)ABq3Z2j4=6jFE004so91k=P1C^k=Cdm6cOm42rTU6kyA(ewF z6#@{d*F*CA(6CkZSDYrb9m2^(e7aX1|IfY})_VWvC9n)hu-@5-dP8O61d+Vyp88sK z{Wq!V%gt4A;Iv*eJ4yy|?(#>Ix*r(xcM!^6rZ z`29YAzso*oDeo-9K#Qaxy}ENKPQ z#YQ|&b(70&01Op`B^6}+UMsG_H^hi;HJdwZUGf90?}no`gt~cv`6fH;O*?f0X2$4$ zyus-O*ymh@QLfnmor2R(LZn$FAi7cOQv$k!3rpCe8g%$PLRxY)nt1L{XVjRU_rEyw!IjU zp=$rMKB4&pVWu{$>hY9WMjrgT#AVmDp)u?-{N9=!9XC+uBaSZ@xPP3H{4XP_{9Qe9 zWxmM{d%5$=lKE&qjGU!zOa>FbYI=p+E0=w+*Cl*j?7`UosJ*bBBzp?!$OKR?P+!mh z&|nbR*)l+651R|}gQ#3@2R#q^5=45C7OyV^Z36X0#kw5S77gNWpbQLn4u`^SkHJwA zD%)Zd@UZ|84*;_u)Gh#!1pvJP;K8G@*8%{R0l>)sa25cJ0Dz+bATSs2WC1`S0GtE> zAJwBz`T}h}-XW%CIK*8SIK=YTaQihB~ z78CQ8qYc#u*86}RZm0Fl)SFTm7x%vWUXKr6JZtBn>qxUqMkVE1 z4;=@Eewx*O=k)7`^m`ihnjFckKd#J|Oyxp28nkC>$^7Df14PEdgHe467mw$O3zoDS z@VEy}O4{yu{6jv4k-j2a6i&|&R5U^PKlz*vnyKtBC@vBG&-b{M_vHV#9OXrh@+BAT z|Nlum28!0}|3(RfP*L>u!oP#oGRSfLqIQC%P3d}@KD7zvQM@=1wIgzRyD+$|*Oo}2 zRi8z4E7wEzTO!BSxc`4hK%HmoD=>bu6CTx>X!G%_`;5Cg=AW1R&UK1>nr|}SNFj1n z&s-1BrSj*MhsP>3HK(zO`G`7htSdB_jp11V!^roi-ttg&=693NB*h9x^F12BGG8*4 zOQY+Cxs{l9V%rTFt>9D~^+kp}7{~Dl9{`F2|HH($&YlJEeKH;yHt34pi|#W8(-Yx@ zgZcQ^;&{z9InVDZoJa3@xQpF>yfx*{$6~sCwL`{Vhb#3rf5uM5^GcFUJc#CEWV1RP zL~}Cgw~hdj{R-0~xp$20So9k(RcdtKeLsZt2OSGK4n%UnPi|m;+E>!F{8kqOQ&M(C z?8&M5y8M`rq%F>d{E}(w_zZUmJ~ra7<%e@nK5G9>eXdSagiQP#`DW2dmL9H#@iWnQ zjip0z)&9S+XF2V^ir*^F|7=O9`gn1vQ74?pg6jvVIn{oD^;JvL7B5PFi0cdaQXiXq z9bH~2_V6alE2*4p4?e>~6V_yB86DtJYcS-NFZrm7C&6RjU_3O(qq(2DzI?~xuihW) ze&S0V5A$_Aa=!vy(4Z?Tvb=>@I>1S%?l3UCOpDK7g!iMXdO4)wiDsW&bIqA|Uhgk$ ztK(sQqj>Us#;b0P07=Ayq(^9qDw2^Q6Yo6!dn*QcldcMrJWQu>R?`=-ShL3cY{3=PZ z`4*sQHy&y}SO=fvL~_WS*Ss8Fy84vo&%3bXLi2G`=Q@PW=kP}Hm;hEQ`R_sg;w3A{%rr{%LXz0aQ-?Uk4iVwUs!@5*WJmm3FU%zO?G=2|Vbv}n%angV* z7sjEWxdpTlU~)&Ok%HRp63VT5fOJw@5buknC+_%U@6mshA3mP$$SC;qR@pXmqbVN=%pTnoQsyro9BSJkE z;T0#mYHNIw2%oUQNekc>`sjco3cxX&CHS6>A|^{Yrud9hxxUqXKT_7WSzhdCp1ff& zh2H)ASuZTQ)z@V)4aVT8UXtCO`I4zzT7)kGHoPNqC(hcBX0emtvD8&%5VE5PL#!U z5*K90i>f1z5WBzaC5o>cAV{v!#+{oXe?SShcebRvgoCq~1I1d&ge z^!Bs!i!ob^M)ev^n8{H*T32MgWGWZNWuTD_$5$3;42^YuvkQ30F`j7e%bs)67vI&r z{BS1K337zz5L}rrnaagn%L@1iQe$z^!z!)>fAhF{$G$QAne`X+)60wbVL;}M zJzP1yipmNVmTYff{bvJLeD!5t-IAq=i1+dE8mL*$R=MS%jH!H_ zAo8P?=jnODz9aX4*T9~@{DZ@nRgU9CEpk)KbC(TVolhBjmSf2m7ZPrA-3rxjT2h#)PEuRxNw_HfBl_{|eBEX8TTS8oH~*^gE| zGWzr2$vQsf9~{1H3=v%NnDuh(3*a)Pv_c@3-&}N*&6Vp0EPWoQ{wADmJ>ei7zW73tJE;)P!+`@GQ%1MRoIX zyD{&jK0i6W_*loqe8QqSd$>+>7o_1Z@*qw-E1gt{*YTs`OQ~rdU+uRSe)i1^0~4wI z$&pWbg!z)GTGh5I2Zt*^P++ZQ7X1;jf$PR|ZZ3cJjt?8)V*bJ5%ECDY#)(6)z(fiYiG@JiPE!{) zFSiBTemSJ@mnnW-Zp=S8eDv)A^z_E$(SlDc*R3}2?a2Q6$_F}kJ6dn2%s)7M)DCc- z0=^`};8c4=-MP)nZC=??SN}9~N@pDx^A8SJWE?UbgYk0D0q`7UPl8yhc}}~BGZKALb=1&oGyglmuqhRN_I(_ z!;;;Bb~e#GwkwF%IB5S_e^3%A1vC*v^I1$o<+{%r`0s(}g)JPfCjJg;g8}q~pg#ER zjqS5dU4)0=oFF_BRZgKxM)iEEu;vSjM~>prRp(1KE-jW547o4{TJ+jh8@PVD@OU{rjdZR|J6g4fcsToT{_qnpj)F2(>()k?Ta$LD|4xP_C-7EKn ztL-zf&Pde>kMfOH@0SI#uAO=OPO4tgF+QEo;Vs7}%QIqbFcVq}pY?Cb1qPFG7U5r7 z*V|l&_L=rYK822rpZ2%X@8%}ZJvqjy^NrAhsdxOoPi<7drAV0Y9!$HX^-5Z!BpXy8 z&_K{IP%0<~M8B8qKdM{?T!;WTRW4+|*mVKcL2rBSP6~T4X6uAu@Bh%3?#Z!SbiNUK zFmf@@uRaa$OBZ4wsS76+2{$E|ScH=fiwBY38VOQ=uiDSmYri*IeJwuz$xVSBccdd3 z>G=2Rd=9r?UvXLl=G^?8ifh(I2A9hr8m{XWW&QBbhr`X7k#f-aoW6Zr=U~o_k8xqn zP0y;h_SnGnVD-_9-YWax3C@@0rSm!5KCTLB+u`R_T#GL@xJ}9H&@XQN$IK45yur^i zE}hTeEyZPaBNlljUeY|S?QegZa&Oj@Q#fD7rSmzw#kh=a#DZ&`4P1ju?ioCN6UBHMT@@(W#Nq}G)DDkmR0Ht*y<)O@64 zTsoh_?c;J`?4A_B0epqQq(V2oPa{FP&4kqUnzGnnHidIzY*nE<^p@GOBlS<`w;X4= zr^a2B#2PMy1bAGq)dsGu?J~c;HSwNbIbW8a&gXFZ@+&9XSQ7T$xLxH*<(@(#g%CW( zS97_+Yf5hOUb-%0%=Qy{7%?Mq)A<~JkoXFvbqtAwK#VWp3M18~@D=Y_m38a_XT1?K zf=}mjxP5#TIQiFC=qpRYZZJ&4Ve2Os0x`aIHt?OgE~(oaf8;iJe@^F9+T`rxqxOLV zqCAC3IM&2lh7Xfb=dZSloGWFL;qh0re*eMl$;ZAqX#YARW<-8EpTq6rEB6$6k^;2> zcMUxo08L2i^ z?_QX5{0$!GkaIYH#;5Z++`inX-a+RayQ z*E0^rsq;D9K299)pHx6!36w1(gao*JH`~CKvZ}|B(}zC%LyVa*;iC0b=9}!WXCGGp zuh1pAy(Jh8(>qdT3L*H6ui|Qh*;M&HU%I5@*=MbmwiSxaa?|-nN-e2>MR@xar$az9 zOWT>5KnOnLi(hImo5FWt{KNCRfB52;=Hp>}I-kSs%dav}kW^Ue^Wi1XBpj>iGExY^ zV|;6E;G28zt;)Z3-E>42B7`CX18n6%e!pg`yk2b?D_Qunodi{_;fyp+s8-!2CWSkPln*J z+!kMB@S2j_MdxL|aNOIgpD|)a+J(;NaQnDCbX-Z$KH+wu^IMLu0_T=^q^T;2L|9;MI5FEu2nn(rH`~DZ{Y7hv#$`-wV6WBr zEyo#%>PaVB1G zq}~)x?{6JuZ}}`g(TEwTk2;^j{}fJh?n`N@I5*nBIj39l1rv_x){b$oJas;Y{~4T$ z+O~|lN^dYyZ%Uryb}XyzSv>A>#=$ssK8M@KS%E{*aLP?lk~zRJ_7sPZ5VxDSzZt1E zh3}4U-0s6)ec{+PCIG@m`!ASpvcsNze8y-?A2^VzW_&Ab;9I`onPb|WyP_WhVEO5M z4!4gFXPe`@jh6A>awC2A6LNb4Machq?ACyH6^bHMTY;j*Y@r*Vn+0d&gXFZ zxGG$=G#<51CoOUlD~(i}!j~0V8EiZJ-Z;*m<)-sF+&(@U_eDljs(xE-16Sg%!|ynK z*g18aFXPhr9Bv;M>KBQv!h_ee{Ics!Dl$G!L1~3R+&(kS(PmTfyY0Pw{f^$fk<9qg zF;1P&;Vr-kBLU`==GTJwd9_{aw1Mxr_s5_9PTHzz{5<2+`5bN^AI9_eS_&6&2nn#< z>TWVpYf5gAWSxzR^0*L61V-8$`>bFS$*@?V@k2LvZo z<5Ti(rIfAxZOX09yv<0hDO_8g@uhe0@3@EaCH#a==X1DyTmgI;FR8$fBeS9Mk}CbMn$nlN z&B=v2E?#Q`XHu8(=e@o2br0iUoI0Pw?c=PH_D2;@>g`4~IO)mf9r9n+KZWBKTO4!18KRgcgsrWQ3~(Z`GLXkKnBZf-NL`pUJx zFb>A4^Euo;PSYM5*2G2%A$Z(h47k(aHC3)3Zs~ki7qKDJh#6_8I-kQ279ZOzLP&`5 zZM1>!s*%|}UvkCI&`^fYr9plsa9DdOF zoPl|ihT2ZzR~f0Q_=bX|o=;j^|Fi#?=O5~0#Eg`$&gbxh#)qQ@&CkHd1r8PGIvY5D znZ7A+NQe8(nNtL(&i_x~%=1+khi)UW5QyvJthb`jCLnCGc zr_Sea`|>oFbdxGv-lQPRkVy-CzH%$ReKzoIy5jxcpL}S&xq~u-Pv^HBU$y)mL=sHl zg~~#aI<8+vg$~!0{Cdo~Zq?|?`DV+H;M4g=N-bF@qD?JjNyT^tm&R4J5WwY{YWDU` z;hMW->%Y4sXFSLGI^>N*=zI>hU#^-R-0!Y3ci*UHM+@FPHt=3{)Q68IwL3nZ@i1PU z&*Ap*s{LOXUS>8d2}Lj>;8kL*!PUwnRr!Y27`Zeh->08B@olen(jLaccy&I99~@p| zRuW}7&SE!8xwm<|H@)=fg5ED5MO8^U#;fx=yajmOMTO-_0s4Xx9u9%Ho^G{)YwzQW z+g$d;5u-R?#-;N)+&-?zzQd$*JiH8S!B=yik!n-rT(p1pIWO#PWB!sz`_}n?7GJdS zM8f^e<2$SL{mVjqcXi_YS$;a7!w*(|$x-(Gt+j!#-H)$axaR8ZCvpCaPv>*EeSD?C zU`3LPPu>V20j_sB4;ZO6RjzxS31ja#WpaaYqRwwQE;_9kI;RZVH-fJ40=n9-?6QHc zXWjejPw)NsC!9aaP3LpCeYsV;3t%yFRTxt-bzHOT!RF=m!z(qbyZhGv#`!WXozLO+ zajE+dlgQ|cgSqIPSVLv0I8#Vj!!=dDuRr1H(`Mb}4aQ$O-$!1_OZH;?b8tS8&Q zwPymD3vzMP|d^(@Q?c+1&0%$HJ?jQ|(XwSJDi`~3W)QjEna(@z~t+u1m zCyd;hst1oRiT&}!Z$0(;eoW>wUiR(dHWye5=`1N6iDMlWS#ZXau;H4*xv0n9wi{;W zUu(!U(*H2uNFj2yk8@Z>VNp`48>fWf%e#evBpl3VOuc1dsyx@(!CBLG*Mv*koyADF z9xT%M9Bv;cZ9bzpEPeX|<0QT{6H@DIg*mEdN}hA>yx^zW#h&vR2jkTF9Bv<{I`1~? zEl!Jcg&H0WFD#WTaLF7=l`K9U}RG1FNQ4(E1I&U87YO}vHmK3+Tb-M*BzG~ z{_(1RE;M6CaO!*`rIw7FsoomzE6^uo4Bch57sNf&Jibwvo`3pBFaF-Zey;OdjxSK* zcF_(KE(Z*PdeQK)>Ty1MleRFZe+;G3kxO9HY zaaH)_WYU0T86Pcvwt0D-vg*`9`zG8L&-pSgozLO+A-~@p6KxGm7G7z zQ|EKIeR)Q~$3`_IrsAxrH&Sm(j<>hFy==!Re}wIZj8o_TXK+R~7OOZDpKl)LiuF^L z^xGHSRva#Go!@et<|aFHbZKrxaa9(1c zcg4<2Z`k566GyX** z^`>x+*io}7_pWcgV;n3;ozLNa5@)z#s^hbI8#q6FZsomKeLk3uj*yOV>U<8jkJGwO z03&u6zQ~;9!%?sp4C8~yt};qf?H6agWaQG6TsJ>H;*YomKO{3A#;fx=+&*429~bN|umV?L3K76ZBJr6$Ipk5xdG*Uis!hpl z$3NE1ynXnFpE-ZVr}H`7K0fPs2fYpse#Is@uko#1Hfn{CFzcbr4Mr|a;k|TiF#qvi z4nL9cFkYR{;r8)b_Y(#ReHCsbQV(K$ajzJuHifTkmyCNq^LA-qZ`1ikN-Y|HV*(SX z3}EKy@l^&a!;XNlj#7r1FXj;iwMj50L5GqHff)a48~9&4Cz!kDgKZ7$?mC~+CTCy1 zg~qg|3_dDpHxrRR`!w=fQtqt54W`{nDw zhlkKvW4I=}M{mIBg3JU<8jkFyb-ndFh@EvPs* z+ratDHDk(RCZ4{FaWGDu&*AoQMy8JF8|A_&-p!)HQZ1#W>dCq{jMSTwXZ`CrMUM?S zr6c2DoI0Pw?c;1ro`F(dwK!eFvw-7@HvO_`yrc+r&wO}JqR*XECa4*vf9Wzf1Enzj;icq-{$lU zJ9>=J`5c~U6ixC>d|U;c?o^K#P%>SC(mXmGAQ!D-x>w$&V{t6#76?Y*s1~#W^dx8ps4aw= z3_25Z73g`;ub>oII~Iao1Rd5Ed4uXf{bKP=1ds#M<3*s@L-1W&(1U_z@g==d7 zU+b>K7l5aG%}*Rm#Q`wGtlv4vG;5<%rfAH2sqEDKw3p8OWI*rTJ+I;PIe(qc;gS6F z@C}oIHUDJd<$CZDHGI_EO>nH^iFb|P$9SlY6oYmG=i<}vm)4`5JO3Hl{(Avc9qAa4 z&gbw5o_y>wH4jqNQ02I>qUQ}_lSV#P@Qo+eB4H{gyXPUIy2x_??Y1XWng8f_-KhNy z1PuaFJ3JAT1fuqM5@;}J2#Cs;m5?xj+S=LJ$=b)eml0%W%)_D)Bx114npKjMAQ?*Xu)1um7~?z3<*d@yJm; zy6Sw%#>GxO%JX5OY*rx^&srOJULE&o%A$Ynr=Knz5J)}9L1xn&X;Ul6g-$4PV|+*=%O_<-i9s}6FLpi&mc!wi;-i@JJ3P;zISW;sbnt@ge776#DBk6Te!r?UD=Wo*c_d=NqB6 z2bFZ=r+*Zp!-3OfSv?B z2igF714PYsJLogeH=wen1tQ+ zw~|cA5x%2vWxix8m#E*l2NQ!>`r17W0FuqIt$d2gh2^zb!xK$jn||)_?8r46bK04C zwt*jm6F!)4vcuj~bNgj}0Ns1C6L0ZW1es?Hk*Gwh-&>mXq47JN;M4Do1yO$LcNBZ2 zKRx5QEAM>=!%OKX9-U9de3Kpa@WqPoCv}}z>82gPKtp4+T=k%@6?lT>u?INFF^*{E z)Ag$jvp?@W_EoC8pTo`XC7L41lONsn8wE7In8vQ|A~UREJ&ym#NT2bvMWR$@%b?Jn8J0v% zUYxY`>WU|a_T8hG7xO8O>P$R2&g{r10+aC(FU$#RO(67rP6G@cRO|5y;GujN58YEe zRljSN-uvIjxt_cFaImGLa-(0N^CcS>6VHU2iZU2zgT}w%Z(qt!>C&f0Ec4OYK^G{tF>?4_K1>^fy-z(#wVU zP3J$M#$8xRHl9Wcrw$3QJW~H*q{i}SP%hu1pL{27>F_Z}6dXsLD%`uM)Fcn)8{Ej% zDvz)=!z>N!yl<i+u@Xw_%`eHpjr@P9`F zdV3-J&E=pJP#VYyBAau6(D9)0puwP?prb)uL1be}038bIZQgf*-w}jm73q`xoWdzS z8P<*j(euow`2Y=Zh)92uF6D6uZlmf{;_Hr{{WFfoJ)92tM1+Ni9mk{p>Auzd{~>`8 zDnn!aKeZ8ZTxY1h(>=@;a{XpB{PRFm@0Wn6Egb`*c!z+fEl?bOp4t$#2Wo57KInh7 zuBr7AL9GrF(DfM!g=9y1X)NeuP(KjKo#aaQM5K@Cf7VZAFYg3O1d(o|d)8-EUQ||; zE*W~5df}e+9fgr?u~nZz2(9ifD}fpyV|!8Q4~Bkmf=4=tbPeek)xNp?-+?1vyR_;O z3MWTCoddvp$y6?EAxoO5WX0oedub$jEk>{I4ubig4aLyu3(DFD^3y%1`#iE1YTQ(e!&+J?nm71D4-lgF$LpWnBj%Wso8E0P<@ zL+5jNx1hsxc+Ts{d{_$!}HJek1y++$N4fYozLNB zg*naV$GeKjGvvtxZs0K&nWngFjb-H(c!1k;%D;@KSw4x+#Yh~peuf?Lx`*DO(78`s z`{JT&PCCVi8L7WIpTn&<%-n&;Rb;NGP=lN3_myX)$;!>o?Zge?va=r`4sm&25RZGB zU-SSaf(C+ygVI1Gym=s!{r#YiK(uyS1bPW{3L3#S&@E76E1_Vv!U$82ftC-Q^B-s@ zCu2Z$COYpG=-^W^KzIxjoZwK515)9iiZ$jEAuhNGV}rY~PW>MCnH}m7FV1v`OCG^_ zY6D{g$rDZNd}M2Bul1VTqt(m3NyB?zx4z^1^ej1QuXNSgJZy+N#vNk8xDG^EEs8vBr=c%5-&zGNyFJ9@*^y;8rz1983F)eNo` zzX0Gr8@XEXG=LFazf$EQ@Vm(|4!yie_hWpTxAfVbXLQ-F%Z2$y z3X!W7N7Qu*OF60fV}(Q3nnv+ZE+1?>;qSW&_UyjR%#xl+K>cC9$qsu_>raFAn+EcV zIi;PTM6*-0>a#y3($3bCjTanfdkH;L2jcPUYTzLpjE8KEi6Gv0ov<)Q^t$fpi;ueh>sQ8_0}D(u)%1%A0Y1!#k2qZSZql640(Tr zyuT6uSh!n!b@N{2{cq&`8_CP@XZ>)j!dLfuFi`O&!!@ zH{Fw?_;l6zl8uYGpD>L+8kcJv3x_w!I%XXTh8HWDraXOI>}0%pT)O>Jn$^H zFUF+WC6@<=od3t2b=?q6I+l~p=WtU_Fz2|H-IjC&pz$xiFT`@8_W?t|L5^|g^D_$T zSv|0B>y`&j``w5t%Zv82F`we7F6w*;Ow|tOEXJ;4k8x0gif8a4&C4Y_ZqeM=PkPYY zaU7{XI-fD+;_EMI=Eq->Gu(lBI94>-SyV;3uZWZq&Q6E@D|v#K-d8NL=)twXLqD74 z!}UeoUtPNNkTGxgj-n{i8Deq>ozLM-?~k?G6;k7j)HweJ<#RONbD6xb!>8YW|L+^A zBEwN#BD(_fB~!WBDIe}TNHy1iSTEOWc%t=FVozN9l}k&ua+WL)ozLMD=qNq1WCxOs zu8Q{S&Y9sZ##wcxh@`fg%=S&oV_7GMnDA@c8?%1w|B};)D%ZM59?a)_*(Z5Kv9qXE zR7O>CY}Rn-a@fKl@f3O7>yPiV;)AF$?*SbAsgEW!JSS z!u_(DSO?hAaYKCuCeKii*g1HiU$!zDAoTnpsO(@jd5AeE{=}U&Fe^@R`T) zTm6HRKx6Ynk}t`hbS%r7d?wOs<58r&*@zoZ0O+sj|FSXx2-MJ1rl zC+ZHjj^BB%H|tou*ShVEB>D+;n|h@Ua`*k7e~!^#V0NwXIow#kPfjoOVWySgE~qR? z&iBsq;Ib#9`wLXwf);~=t%M)M?OiD`I4zzOdJ{RVpnBZ z(D-kH7e`ORUf}oRknkcSvRYp@0|%w+1d$)D{$9}Yg;C3Awza2)p3cI5{eJRSTz%zPBXr`3&SyN+%e|fgUrlnJyBuHC3%c|D zm>6s`jM2Rz8vUcK3@hGc+8n_tUDs&No7_KO~AA(3UD86KsJ9&)QAdU}uvD zTfXqHY7dO-L8y%SLTA+`-gb!Gud^amh%Hs8?4+ub5!&AvUbHUoHo*J?y!i+P3Qkd@R5bYAFQlE zVyZsa37jMsmZPo@R;0HTzo)#|`RWs{T*msEWKH%M<}*I_ZOhTrm1=#f>De@%t-!P7 z?E_yv@z#!Kbv(>x9PGCcPgqi_o*LZSiYr>bcKx}hzBjYx%yUVGK`j7dN zsa&k~*YLhS?)J>pQp{WM4EJZV60JCNdvrw~hq&q9ORJB5sQ=Q@rh;J{%vT`DTPu!m z_F-$ZDuTwS7M}BO{u9z)H>vCXz)A?KN&|x%qNbQd*23qBy<0u`B@B2+U z_MWuLGp=-+E9u-HF+UoP@W7(c^BE$DLV!T!(v0aO1>a;7l?$(-WwJ^5<+7&Xp_qw*20)wN3Cf4u}+ z+sps@B5eHu|AP`pL|#08T!!%oj~`!JJU>AFgF0?19b}ys9*S@p3nYO5Y0L@qYLFQ8 ze#gyMmn{w3ZHzu9rU9SglH-vG+efDQVAJCP4DF9HCx$tQOE~}R{wNG(&!>FV-?c~k zU4)tXP1PQCX0AAH^~HCy*+=%V)QjqTN}C*?MVRdL;CL)-UzEExD#P<%BbF7%S{%Yn z{j(E9ejJGU_ZskD>v)lTS1I|S7w&wm`l-jjmX77C^Eq6XFCAt_?}8TLttEPEYyufi zA>$N0&{Fx5ELWS)(f+JiIIvU2k03`XF6utWZf`tt(WxK3{07(-*BIa4K1g4AIh{3~ zgLf6(W%7_i*c!MN$$Ub%((faj`)uI6!P~W0){)n5vVg=tjqz>a%<$mzG}!rxD-iC3|E>aI(QuY@`g`(D<%{Fkvef{8= z^NPDC>NuF+D2^OgEp2&&4k`5&;WYfJLh~im=mJu4rHp7^KC=s#KGtE#*>C8$m~R^w z1eNCYx{E!*Ks03fI8jgcul7I7gK(+$e>I$~c>ZrnAcRUs{bw{gk@|~i+(h-0bTHe2 z=zo>)?|;Nmnyt=|fI1G_2|Y`)ae_=4H5iArzq7<~b#?sny8IgB+v=y&&2d<6WdXi3 z?ZHRceBrUYnNb~l9*4~x*?fQS@kh(EubaK;O!Ie`^~fQZuj3E*m(i3yBCB$W8)c;G z1fTArozJjf)58b0w0Xn5u5_A=OqU^u&3yc8ak=gi>K^6G0y$WGF82A$lW87KkQb~b}+oxh#<;G1_&zvR{V zvAi*c^ccyH`F{pisjs2}^AU+GgoL>M*NtvkUdw{*gl~<%{>80v2XuKc|4-mb_xl2Y z4EfDEQ)oy`#g{myX?&r|b|T}#6%YT*bC^%Z$NWEmZ-zTiS?Y1 z<(E0GY5CPxw-XON`a##StgP>K`7vLCCU0AS&(O~#HbptB_;xjek21WwZ`YIu^S(P( zmml*bDCN=;e7^DuU%-w2uiQr?0-1`cpX*McS|91(XzvwFQkL(f^?17bx6{{5ULYgl zVm#pxI-kR%F(jCW}Ra!aL?UhFlu3yC@;z~w5&TX97@N9xVswog_sUp|QJ zbmZuXLvUrjWGWZ)WEBhv_;4QjhK$4^W2x)I15&N|>+8exzzZ*|_@c)>qgS#)ke;CL zlrUc=s$8PJrv#?@zGGf#WqE-YLjXLdmQx6LNPjv(ln>ogKdIVDyY84japlU@j~d90 zc+@(WkLVU>niI^;W-x7}yS&-1c`)TkGlR3N%vbF$N~@)hf~c048l=MIv`j0fXydpe zf2i&DQ-3ENQ6-%*H)$($K8H_A&o*DLmX#yJUFMQQvpPiJd=t%=)L0&R`K+Df5T6~m z^_w3)6~8aLjaF=pZzIvTg87oET&(*T!uu)cC^+fV@>qxbNzR-<{U*vq{XWZ*wa;z3 z^U5bD%7<|=%EcjcK8NSx0~dZzur@g}7_10P^!Nk8Y+sQZ`zGc7Ez<@TZZgzNrK`i0 z<&u(SvC0MF2=DALBGtj;{MTvu z>*bP=?GUcyx;FJs#Z2LH;ryAeWG!#4`CIpQ=;!ohrdxl%p8tRw@V@PohxecR`IeuD zk&xhcT*7>V8@W>c+z}-=y00T#O)PqBBk(lWZil>k-H3TR{a9d=k&-w&Cz2V5Grlfy?nzjlk`3(XRY=r87n0hl*o95nI7rtgX} zchGIjMC4aGO*r9pqRORoLi2d`r<^Hj zPxaLaB0pOF?sr)CUupsYoFHd7ibt_^z7dLZBzV89RKZx-3gRfvpj%-*JS}~20XdfB% zQ527K0LhBW47XB#L2Kd;Ji9SEtGfp)j zRU%yo36nmHX5Xi?Wyn#zrnVdpqBcwC%p4A4Y!puSdus1IHl=-vM6^K6dcJf_czP4-IK2D3`QEZ*h;r8^b)qYZXYV-R3qPIId z_1o`1PdD=Cw&f7a=lt1k497&Q-{8Z%=6t=OzE|b52e_J(Pwz#uykp%z{*Cix`RIHO zw};CrpT#qpmrwauefl4{a~EdNh9jSzVm{~3eq%VCMcG*0sx&7f4aKC+8xwMym(N2# zzw%MwuIC=&d|5s^pTk>(3lFK~6#^b|PLRCQ-s4HhcZi!yd#}t+h^-Iwq~2DDD?wym zVZLN47pr|EY0r^h>44xB&pm8|8hHGiv}CyWL$)%uZgwp9)~ z4obL3Re%493-5lvjX9X2CkCSQm``z3XV2afL8OllXe`+mMB}rrAQ~IQfv6ZLZyFnr zPekJb@~NhfPr87J!`TO`MUI~PtGT}-roWnu{(ry|LPcn7zSG|nfLd2Nf=B<;`W zrS`;ahu43=YIXks3F!Ka^cL$fns*ZMyoP#x^(f?dNbkBT>!*S`}u2buS-Dm#W z@&1aK{@cH~HT{MX2!X}pvaJ}8P`z-1%=+O-#l89-M#`#N(#rGC9S63>HO9BK|Bugc z!r8`toGIeX!zn9e0hxXsu8eOMcHvX|V|?5;)%n=xg-gGhJnw^x<-@obI`k9J!1+?@&i9A;HjZL^>^H`@g_A2GzPMC}1X*sG zE~6E4eb?tnly{d`4?i^V@^5c8V)EGA5$01I)rC(q3MA7pD%dB1&9@akFE(b%Bl6XG z(qV(m)qpD7-lC&zq>qq>GTjHOmJ-+CMQZtRrOt0*BMJd87t;yYX#pYvAo z#oI~pEN+=`9U}1WO)WH1ae_y8(aQb2)Z2RHloa!}Fd2_x>wG*eoszFv?o`}Eqsn_7 z@~3<`e;UKm^fMD*<9l>$r!OhNE2h-_8K2JaVLruCosvI3O)%A0D0ey! zwbb{NqUQ5;ByZ|nHf7w`G*2Z*@lmZf~QBLC*<#jM1^E3ce?!gRe}FrV{fU&%jw z8z~*Del9Jx<{xd{>+jz@)TzqRd7rKan9upL|Nq$g68NTy?f=_FD7b(i58R6g6vTjt zSOv8y1zOfh3ltS0w4n`@BqnKT1tlV~hyn^oWi6soM3hCeA_}4+iU^1cxM20EprRH~ zto#3a=H8Rcou*0f_x%5U?>*dkUs z|9)|XNg>UugMI`+>EVC6o|(qisglwdM14He*F)_j0!?QspADk31*w3caruittwBkk zOF$M76Y6ikm zTMg50G+KChE9gPcCeT69DTv&TpqoJVg0_Kv1znAX+HIiipl0!!HU_jE)DDSpKBxgY zs-}S&p;Gt|$cl#eH=va$z1>JmbO!4cDCoLiP^>o$bPEi$0S0OW<51k9`*D&V5IH{{ zjw1diteVyJpmyti`f20i>&A0=L_B3t;92?et}83k?xLR|9OF^>EUz1nVIO*-4*MjHjclLRr>uNACLwML z>tj4BpXGJqG3*ltPh}K%KK}WEy!U%%7(LZ``lV8s`HX|_b>lJYBbBA(M@~QKg^}&k z;n^!nUN3s+Yu3m1QTZ&d8;@Zh1&^uz8wH+5y{_^OJ#o<<*2j2MKFjOIW7sFtRp`KK zE*VG8xX5-%F3#zGU(c4uSP$b+`7Ey+hhY~3ha5kLqrh?N)opIC7+2p|3HJ{sZtLgJ59NR_Zvpk|*6g*|{$mL&Sm$`m|PmdTk zk>^#9t4ur5;-xsMCJ4uPR6fh=#*^uC(=N3%57Lck_)5VnXC(c_{wg9W0DE5#kzUN2QOuNZM~bF7XhSpG1d@$fx*T;_}~~M*BHQcv`3H~oSy9!V^)fD%&+_PT@rU2)%#)(DM8a1M zeB`VkdddS)9kB+)?exxJ&|k$?B`L$5dewR5jj4xja_ ze3mQv2e<-^AO?C@#!(Xmj!$o&v~j{~SJujhDnA4c?kA<)PG2$3HAZ@@mK~*dy(^z7G497A09beyPLTp_k z9z^t*>rY7&_0X*FOi!WgadcAg>Z7mKAI0IbewEL1Nk7#W(Vs3dEG?E6Hjwkj+9>p2 zdH(R0YcB3Glf!5IDxc+&eiRnQ^5oP)SMFHsi%_+!}@cqJh0;ZaKX4T@Ii1t9+JA`uigZ*f6S}ZyA8* zYBA2EHvSiI3=eX=q~ETGZiS4VLfKL~Dej>iu= z|47xVte^3ze3n~tY11Pn3M9*I8_4&>OoGdIJ6Le!R{4OYVrQ{~tS=AAS7E_64j&$AR+# z6h6yq>+k6-5Qj?ZZ^-3H!sN*M_paXW__35oi+1`m{i}HUiIPlN+EIe>bK2C$xm{0G>&Zu-*#4coZeX+5;GEhzziBlrm;k8GH zcsDM1u#$D?h+{OB&+>?NuwV{X7Isb(rvaMVD-}`T8P{Rl>Z~eHpdXFnMdgRZBUYvd zwiXbt%63VINs*LXrg)iWk(cvPJ60xarOAo ztyv%AQTZ&73eVv2fp(#6pPZ?Y?X&BP$qP${ZM3pJ#-s9C9u*$gCzU4u!IgnHA5}+z z=e=9LKl`@@8=nxKabY|vpXHJ9=-V`*-XO)AIo|x!BHJmuY5b6ZE57}f^)fD%&+^E) zkiSwLg@vfsk)Lu9+bMB+WIRvq@7%n>xw}V`Uvi8`}6?!fFAkJ!~+BWsr5u`MS z2Zgn-NY7$&y=g7*kYhW9sy97yjx%HJwNpM&@i3op@V%eSnO}s;+F(@q?G~!VxqZyT zJQ{3buD|KWjnhk~yJIx61>va6eKw%=n;Sn``MXn;TAW@q?Q?^#`eU7;aL~JnAkr_+ zzk+@_eEO|&zCRoVzJ%rnUwrhP{G}?s1_mENnp`-17V$YX+m1aa;(>7|%#6`wy@b2m zkkfwk6_As&g6Jt!{2pAhV0z8)muj^eR6d164%>P-z33E2+`2LBs86F4l>v(tAC*#X z;06ALa;%%}nsQI%cwgVLytvyn;}>mOFz**y|EK>V%*!$OI;!9`puRS~0hnm#3CJ0q z;WZI=w(CgXlJ$~KIX%=sPRPd z=f8XGfl+&}tTq0u@)=vyxU#SloD|h12!Qi&nOWye{-g=h|r-DUT@GJ}wpCf*@?^FAE<@6bKU&r(ofAIl--_^Sp^!es?f zSoEy6Yy0)B%&nf`*~+@;PQRY{_}AokKf@k{MHpf9crAT!Jhjta>eWw@Ews}xvs28E z#-?%96@YmTY-EH~4q|-n`*f{V@aSm|3{BlAbLL`qC|atsrh_F=9;B56)SFs62HPMJBKp9VSMFX@Fgj^7{P$TvZZB6U-?>or$^AR`yHu{NrIz$46e-AxxwooyE6~15_^d+-R2pcT6F8JmaGDs+dins>Fs4JEF6UiQ1rHp zLtCh)b}RVw6l&k=ipgDmYCpUG0rE>u$1^)t#kf(uoB51~?_vZh&7O;@ zh{uwNvCP4a-lIz}C(@NQHr3%9XLIXs`f=lWX#(s+&I+QZJP_5_YCtp}vaAy4h<#!E zZ0}V!l+QJ z=`2Q1811Di5>F~}Pm#Nqv|pi|PSyekVPhPj@^ej9+m5}KZrWsIXYoF*D`h^sn_R7W zYX<>N|(?$FsjGL=+ zVaKT-)+yVgdYKtVIo4rO-br5?qpcaS<)0M%g4Wdo4?a72p&BpDmmrA8S~x`0A`6ya z1iFt3sQ#a{+qms>27&|ZTI=i10*`D*?YR~p+KUm(YBibwmI%5CbTOzchz6f71$6>l z4x-G^4Mc10dVtbF{Xv63IiQ5auC@~&kfSv(0 zL>n>}v<=i21<_nkeY7X<1l3PKIG_$_9li;gfZmucr)t_ypf_O9HE2vOg+VDDplGVq z{wyg6C^##KozKnsMYvJHypR!$|Wa0Pc;DNt8bAW@wwSwr5sHs)HR&V^t z+V<@h{~$Rzx|1*F3#N3Tjkre}-MwDRP=_cC_7iLr62K~N1>heLIvG7zWZkq_(Ew}MAcYJT#gKsxcZ?eq0#&F{qaAzV~{ zVLtvfIlca3Oslrg9thazo=(;^K8&bK^>7u6ZH|i_sOzz3KOPuY6>t$A#+8R>J7`X- zrul|l{d4-eFx^`-nq`FFQ9szndX_{Dulb0cz@Ek@xk{sKkR=wfT7;WC; z+2;S;h}h9KI7oK84u=tkH&#`H1Eig?XlY}gE4K5HVMM_n^FzRd_bW1 z;r?&>xiqO}9*EYV(_8fYybwfvsPx^XZ!|tFVl0CCS?QbH8bmVcYbB(OK_sL1=-W>5 zNkqSx(i}Z=zU61qty=^Sh9e%8dvqt_^s2rG(SM{%$FGv(hkj(P6aCL@h$w%xTt4_w zStI*dL3HPM;PNwZYP|OQWuunIEP7y-kwnEF1C;KVuc{q5&gr0oC#;Tf`bdNWYb#4F z(ldIWv0skYo`nI6T*~&s`Elj)L0hHAD&wk^AMmc_&gY9KbshI$Q{h|3-vGaY`35_1 zvtNahSB*w zxqedv9273&;JW|X!J0Nc=TsZ{ah>DnIOD}%l4YwS3i2R)Xu{>D$}p;_UX zoZ`BYbvi3*P6@8cmzV<1$q8kx0Tv8FO1!LCDoD0k$!4l zFkdjG3+unZ?r|AqBo|fkN85y>0yxN7LG%&l4+#9!BICGeXj;qj`t^UB^)L>V&vLd08$th0(@s`}M&dMMlJm*dDDW&kw$-}( z;KetvKE|W+SsogX0i_p)J3{o|r>~D}msYpNB_CbAQM8ds7voU*;c@h`qZ#Z$8{Ka6 z7xB@bQrK#)5`H8>o3@#hsOFt)g#@LpI*ErvG;ZkpY^MJma~58*g4Fsp;Thg+jjco z3Us3973uT)>;Y^PhFt&Fo{Eg`-sQh0TCe}{T54O7BOlaX%zVL=F45x4LO%wk2=yp3 z_C+f}7;Lwkjb>bwzdJ)-0=)BXIZDkx&GG3A4WDguK?XgOW4oz*T^h{a7*-JWAd8W# z3PgJAs`qjkNA*5bXGI;DCc&U z^&Zf}psk=PP(A#B&LBI8x*-pNu0n#P4KW)a(ar?50+@F|kD$;k1E386^m_u*Jo;OE zpq@Pl71w9c;3a#ZiBzkfwF-7caAEU9?BWfd|9HV|pW-#)=y%YsQTc+6%fPH2o>I5Z zB60yzT`v8H6v<g3eoSNSa0O8|@U z;nYVS({0`YG0Ld#vcp|w!pn4AIlU!Q=Qx}dL{DlytpVO$x%2P!_Fl4i7`+Hb?J;VH zGG8#IOO*MbR=)?OCq%W8o}~aIJnFw7!b^XPPuc?IFf64L?w5K2Wjy77DhnttvEAu8 zocptK3ZHdQ`11eqbENRYVf%NM$@Q@v$j4+8t6?W9qfsoH_Pu?$eNsjJZ>pKdsZsA z_}k3wkE(8Q+NA#3{jc8n;6qf7l4D%V*SW!K-MBCxUToZoK5J9#TQRF9-${Ks6pH*E zNqJt6Jx+h>cn7_I?(37XU+X~<-BDRWC5p<|rJ6RtR_w?Z-!H6CrKv_k9XQ|1M@f)o z)cQO{xuW+%#<3#`9544g{QbGjTkm8&WGAwg%4c~k95moj3x(Mp)mtLlW69X$kN?Ph z_IK7pbt$S*seG2#!qLlP8)vT#q#UZ{a-01}d#AKT^%5#4P~8$`J=uuL+5gtE7C-%8 z<`NMS#ShIlYP>Z#-zabNmOhkfnQSu*sus4>&FUF<^&Em*H@70^=LmlaCuk(9OSGZ@ub)#<)s)c zdnlTbOF5B|9-Bw zGe5k3=ZWvAH=Dh|?d*|xVEFPc%EN&8)sBOfhsWxilamyqd`QYLTXXpWXz z>nKPKrAcZ_kmI`%4T49{>ieK3F}|*^ZzS@EJvi*RX?C_ zKRGpB(EoaUO^9pdDfNB*t-r5-#sca(7qTtazbL#=9HE)>fr#xSI2kI$>H@FwhMhQMWW+D1SR84e={=93CDh~I-2u(U_JulRQXZjv=-$#qQbcr z0kS=7qQH54!K;r9`Qweid>Y27@}tCwZDg>ohH>DJ-fa`ks+uO-wS0GEyFRgY>1*qL zj{TVNFkY3<@(A(Y+m6YydN*O%=r{GlrR<4}^X=#Cg|B9hUBoyjZ&MCe`7D?Eb&M`K zeM&Fd!~mAYW0`c|78Xin7hpnbfvYf2>>7b?SJSxW{s{OIr^IPLyz3p&bCA6ymlK4K z%0K2aF20AuhuIQEg?Th#oJN6D?U?FnA1qF#G~;sbjcm8lb`Q?{;MZ1x`2yT8r}7zB z-Tjw(@3iPw?TNWoFyugAf!!neTg~I-)xbsN4VODq=EQ^K^-Ha$&2QM?rn$#xOp_el zV{m1@U`m%EHcaoOfk3Z?CV9~g5!7N0OuCf6S0%gO|x;9!*(4)xXK@n_>B~U8INoArZ9-mSXJEC*m2t&40Iq=Exq>h{Vf$yW+`@PiN z6~C*c;r}w+2_N$%XyQ@AhYjk!Or5_rg2LGN?J+|Z7U21hrt3-bk2x=_bohS!C;fk?x~E{W9rVyFEoOR(^bQZwGCv3&mCbb7~Z z7s^A_cg*7xc+|ex*v&Wm$I*23nQ(-c)`KwLUIbpj zwTj+Q`FD=v@;0MB*_o#5Wqv@R@lZ=|CTb2gk1^ZFT&^X45I)~fkRL8;o_JN&FRWhF zZRnS)e8yp3KR`7U#DlR`$xCZ6?Rk_)vPzL&$1xwClkwxpE<9dK;gOA*=>Nan-xm1W z0%i-8BZJ8KMlYAl@BIDW|DFZpdO!urTZ$hmi0<@_q3;>5o57=&yrR{Dr|0>oDJ`5{ zaF^ENvmE=A+Oa_s)z^ai-ecXEtE3c@x*Q~-s*b6io${d>2e;wn{h6)T{?UKK&#Tw4 z9>$^aSsofk5EAw)pkZ)l@R$U>GFOfO_>r`6#m89xX_Ha7evB*0X-br}9}I8XxRN*iW$fB zgOsZ4#?kom80}E=J=Kf5AAVqw3#hRKqnsW~QBwS)6sXdS;?9j~Dqoj|PQPi6JTd*7 zs-bAJiC1MD>7PW#v10tXn=fyC zk#O7$GKe#Kzx)&&`cB1*rMkC@N;`7Wnlvl(y(g~KT_7QI^z;_}%2sW~5oY8P3% zE?a!Ser})kp}J+uiaW~a}?S}iIt!n zgdAVV|1{%Mzo#|8fAOR(_iQ^aXWv940J@W%n9t$z-L&8Jplq@IAr=C9jKj(G`GR;k z1tjP5YmET-Zv0#4P5vEQ@jJ-XmHu;L&eR&;R=lv;+!NRlRCgESM!$pk20L&ImF_tG z2h)PNUa&(w~dmUB_-CC|AT2d6vc2LKok(cv(sLGqdelI=_13D!w+cIkMK z-y=LU-azkCdX3iotHLRVVi^zp4#rLQKtoyrMm&-+Nus|W|HT%lKzI~Cv`=>qE!Kdu zg6JvKcjxB;u^sOHAge9CM^2BwSWV^YQq#OobauOZIEYIOvzcck4aEljI0tu}!)J7i zV-tPRIpX1P%JINBYofpzr6~j3IkJ~M>YMh zxg6%PzvnMTlL-Pn6b_PK=Y5O{9-=i;=6<|t0)f*hip26&?&H? z$DVem6LX~pdK}nv-)rjUZ1H7yJUf7=$%=|O)~_aR%m`#yfBWWufyA6SumXv;Gu8zXe;k2Va2~ zxg5*r3!ol3q9Z>Qw6IPLT)+t$u|uE}ZRDZ#)|c|zqG^95771S3U^H>&Bz zLPea>HW0qbab-KT_%1x2{XOHf=Z~+M{ng=zKT`29UxFeYPXdo(DLo`Pzn23aA+&<% zuJ*U>Kz>iyeY3yeH;+}kt9uXRGv*uYz)ixZe{rn&=&Lby_2)y;@OB9(V5jQvYQ_`1|o-^uXyrk*riBBz%M=q1O$U#(}k8=R>vfLH;@bYyTuv2RMW5h(`7t+6g-p%=rhxzeT?>L>?Q3EuR2Y;eo^bmE4!Ai z{Ed{sT@RvimHC1xUHZGmxGdDkNehqjXD-Y)E*RFPPE=E4;myEbJ64PFD8@POg#jXNwxMUTsCJwgX{Q z0neTD#}A|6O48r%`O=;hTR3Q4e{3y2%cY&{`rDjHoE{6H48m?kUWX5d?V!R2j!|O~ zOfhT{7?=Jl(wl)}0b>?Htd4Wb5VJJ2PdOF=ZR zhx$mmfUX2x4Y~%D0_p+k4eAS`e)lZUP|!^v8)!6WEa(={c+hR2DIgkTxgWF;^bqJV z&<4G4P!U zyEnn_LuKY{6q0QaaaKg!SVY{zh`4VNaT$oTrx9sgu|vx1h%|3Y%r$BSy{$1Xstw9& zL|W@hU~@#;D~Pl-B(u*DX)6(Fvk_@a5ozzHz;Yk=A<(_AH)>wQPvA^ATz7AA&zb+AKs`H6m^Ic3|17X^9`g zMu#-*x#JYyG1|e?v9I>IG1{9bXU1NQJ<0lDUEfVHTDBACK;40FzK_Pjny7#6RX|WBUW2(i`6FFfrvsrMb@8$WMFFdl_NhRngic|D$`(6P2Q(% z!W}KHxNJ)EGtL2@9701KfWp=Jf+=0_y|uaBIN6$)+0s-Ku_e1y`N8|sL0tby`pJwV z4>CK5_YcJ**6l95+HvWszt<5opdx-{aK9pd{n>}+bt+<3<1CE#{=W2 zP;ekA*P6FC>y}l6$8Nrsva@i6gRG+R1sfN}fmueFf8khNi>@Rw)}i}YiyPbHF!0dt zvw{d2J(Eqie*}-(aYwiFCvHz&nneG=(LDxN<_o5D2__5-EubBY#n$-j&~8ILo#-&4 z_5Zmpd=!NMQ+++yRvEPT0E%7(pS@z&*ntHLrV5vc((QJ zealf2>W-k*Yd!D}Q7lDX}B3{%3UctQ^h#kquzy3>gE{CD=Ny_hqlIgx{UkB7?{o8WL0I zN4l^;5RaN)$iqc5#}0^X+@OH$M2=w5K7q^^OzDEtb@J%UYYRH8wh}6Q`+sme<0ORpfSKFEej?+8}zz4`Ti4F*LI`Xa`gu zMgElcxw>`M!paxR?igl7i+G=E7tDtjlQT|}E*x!1wcAj<<74D2awC?EJ?iCju^;-$ zSwR$jsCa02*Zp^2``XC4^d31KM~tTObt&2a7>pWc?-|rT$nNu$T78&>>-Kr|wGUZE zxq*ISIbDp5HQOUpJ~{a0g?;y2a{4ya9?WMPd=KIY%zzS;r7im5lVljGnwi?8`xPAV zke>pQ=V@PG^KSnxotAjj^vQe*Q+AwRvS9~1hQ6?#N{Hp(pKyvfKK$Qy6>%~$E>@fW zt)-Ye48L&vy|$OWySYhcX?bnq zwJ|&6wdbdwqNU~5)BGdqYY$IO(AK`yK)Y|qsamgpoUS!Iw~=rCyp3(wM4UEN$e zy!#yOp<@?lk5#tPI(2KOr7!5HQ93|XL9}=LfX(H{^bqNVY@FkSUHfeBghy@j-0v6V zf4z2MU)YNrOo%m-F#*0{N*5))=m&uqWh%W^24ek*_4Gik;8D1QQ`JBA{%yW!(p_N}M#slnM)dA|O^BDyLGj*Ex7#Tx+Aim2iE|Z=F0pzjd(@ z0O2|nxR}r3^1T)=6$pl&MA1i`!SE#K>tv)2a^dXs!-j$}PnDc@AW^)j+lltkWWK=; z+!&9Muf>VAhP}krFnlJKY?mD&aO5FGxqPu5-FaEb2W4&NkwM_-)(ThV3#N2o9B53? zFPF*}oN$+cGhX|-jGDXdsRB2SCpUG-z_DFI)k_-H`|iiI2dnaULK5M*0C<=$0+22} zutT-OuAi`u<;T8KeE;Y?HRJdXeO%v|dw>?aP4wuav%DYLYIv2BuW)iYPiPPs=eAyl z&w8h-(JT6!y4~n&#(WN!@1b#WY#K|!&=R9Fv;v*!@GRphj{;X*THE*5KmX=b)qc!p zJbVw2t3S3CldxgxccITFyvn$e8%DNQ(yn3E%`aPfsDL6Aj&4-nWWHcZm(aL+Ix(rb z$d1OLKt;3YXrFZ4u>4%ar78U@xI%qjOM8DZ;l}Hl3^s;D1+I&6WxfPSJaYQy?j<=al@5n9-Q>d|V z{!ltQ9X%1~j=<+02|b_AR;Hbhbq@AH?LjA92M~&kAv&h@EKrU>IiEH@&0H@-m!s$> zu8BvxX8ic?N&nHacN~1`)(Pkh)SV7DrWT*&`uednOsetWj291PP?Ti5igF7?<;-hT zn(cY1rTPjkoDm*4dP)T0$CdHTQSecjMzt%szpdNC!msRW>JO#%FFCr$;L3c#lrG%Q z6&%wtceeTQF6+;1Y_<=@D%A_+exha9S>n10Rfhph=nVHCS zwEkW;K{)~<{oMYS!zKNw`iMF!1xhl)gKCk{^1{R4?k}}~8b2qijN_C1$#F^l%QAXq zVwo%_9yyuE@9U*c&_DBaANrO3@m-evJ3p5LJm=qP`D5dBVdeQ;H;dRpT(M`u0q zRr!ITXlIba5RK@+W4>TYmk{HC*m+&-v`Sy~Qc+jyZy)FKl=jEou*lxD?*>X8<5V)a z{#bIR8J}8D$|;G}+RrUM&@+D3<@Zx!folw+{zc{srgZ6_X+_*NR9 zO-pYNcI?kWeGq3vA-=HLqVc9&k7(R9R*MIp(o0>=zo}2-Rk8jTCOfj;p?9cnhuj?o zU;i(7l_SFFKEuuygMDIAf?*xnubh1(;(_9Y_Q&i5JgjfTV^>Wj)5~_Ngq$4VB^iAm z=__9Y;{6jY$-Q{ny?ytHZ#me;cOq6(`6MI9OR8~P8;xlr4bf^PyVwlZOI2>8(wc~O z8RvfB;B$iqB<>nXsARiVHZ#XBn&x8sB>{lnPuxAc;H+4!-=yKa+tu^*yODkf+*u%s zU*-#@bg3KXVC-!y*2MI5icRUUI0laTKMAk=T_sg@k)$eQ8Ow45F8?d;p?D;a`Kn%) z%kPN5{*PWtfQ!qIPX92+ubO|8v*NYZ3%6B&@yF#&DSwgU{L6fu8@!tL0qF0_v-c{r z<(vESDipnHKkHiPUDtQpi4kKiIiKxH`YBy8Kd4cEGV4vn@LeHQIZgeDnV4)q;aNc< zTwG#6iOplRs=He@Og=YO8}jQFkAJY^n`u|CCg13%f}Hd+U*`s|X1(a1v1Vp?A#MS{ zWamHAe|IYUb6lXSEbP8o=spWOe}vlxiFmIi=ps-n(8ZwEpf(`R*O;Op&OoNV!44oA zhq8b=f;xdN15r73Ij9SWCWv(fT?tACT?L~4L>i|;*PWP$axL!Hfl@$LP%5YgC=JvT zginQ-qmqt$2B;6HFQ^}g`XmQ{27)p{*MkOuvOw9O!Jr|ap`aWP^W!JP;+2(I6yGeI6R_V?bj;g`jaD>N}z#LO19ZkOxHZ>jM>mib2$0 zO8JUD(YJyofF^=4HAA}{L>+~G&>f)3pgTcRKzD(rf~JA!`#^oJcY|hv?g8BkngyB- zqH_5@(EXsfpn0JApa(z;KxLo@LDb+|1X>JQ0$K`M1}XBx8 z73eY0YS81LHJ~RzPlDEh)`8Z8Hh`W2Z3I0HdInSpdKR<^^c-k2=y}i!pe>-Spcg^g zKrew_2E78>4tf=|1N0i`bmkrLhVU_;!{vKKe03n3jsO@} zWArzXBfHU>g~a9cMSG$6F%6##!bitBN9P(=n z+oaiiwo%w!5yv4rykoO4P|`Qmc-Mpj^P|ae{HgteBzt)Ha(F*uyw@h8`1wS|NgQle*ecY)86}| z{}a=W7>en3K6<&BuWHV;dA;Zu%;QBI{6AR(J0W8{S?{GRheu8i$!*Q;{dmYIyYRfB zvN^HZrdMZgc)#twJXFhtqdTQj<{Rw5jrE4akxE@}&O8ftETZ#1F+m*Lm=t2Lk(R29 z6BkYU2UkVFw+Hy9eA4gUnsYV`Q}HoB0L*v@kB^RP&TvKn(=@JKl4MTLwZ=tD;wQ>Z+>27TVTzi14+2rkCt{T{Ex{8bWCx@$cyejZS`O+{WPT)k6rYSitbiMh+@S9;jALX|(XCHgF=aTh_wu;l zSa((+t`nhv@KS%eA9%SxJ#D*>rpB52sT*HnP6sIZ#drYkhrFj_g7)TJFW+~{x^9^b zAR~7Mh|(wX1yi~hCnn>gh;?FinvOCSJ0fG8$YssLX?)nb$>a85lUMd4r_1z9&GuEl zj}^fCWJSjYKg=s0!DTS{AUw?HaQPk*57t#?*$RDL)2?XPd>g>>Q;{a}(C-5UWJmrU zkUrMQVgG&q-?M-psyScoK)RuHU^9Q1A6#_4S;S%HotMpOAL56tq- zcDV{i**r8NP$;jO!VZ@5e5&aZo~kJDxW`;qvt;af)Fmh!<5Br658$yFfI?wGJxaEV zyQA4Iq3Ux}-dprij~DORug;%hKI`YZX}_@{T{w2k^M9m)SGjyi=w!yDmM^5^x8>VD z7`AVih4ryrR6fh=z+<6Gt_8ak_3-9#QbM`z8efR{OXOFMuQ^fR8uiqind2rDP;)>y z#-;LE9tl?}>R2f4O!1X?S!DZM^~%wyzAba8%T_qXq4HTC7KbsZy~NkwR!EB;;7N|J zvd-r36Oxx0L#YJLsfS-~NIG`bf8>Ju&Ye>$9jknLms~hJG-ni-Z2D4*h68<_9};*c#Q8fJX5y-&kNfz_#fJ#p!w&iy-B=uwI$7-nyK@&rH}7=y<^omRF>WfVBR`1Zv^6HXlK z$$A)v%4c~1ht*-I@9Fem4!5yN0Y|=hy|msDIMI=5u9sw99oa5Ze(XKy@vbjSVttH9 z<+D6$JT$`(r=#1jK@e3WWjj?xf$PYcbxRX>9AC3Ax8EywF~w{f#=3HzBBf}`&O;*tI9uFJZi+r#bk?qvy z;k&jE7bWm;Si2-sC<@3!ZAQ}M%oH9L@^$S zHdFuZoa-XnXX^9EzPw|3R$y8Q<5Ky55|(eZ`3(8btt%%kr=7mQ2mo%+TIL4{+S^g*ND7?zJ z%A&xv-amfa%}X{;V7-h><+D5zu0i%ZI!2*Z%$6enj@RTKk?pm)>g5+-JGN^L>t$Rj zpXDcqt9Fda^_(41;JeCsd$ZSLoW`h{UjLx0%KuaN;7N|hk;d*_Y`~n}AcAz?_j|1sn%5nt2@u>BT9FG}S#?I;f@UC5~mvO0l zmY+N>b6m=HD~kf(7ZcoTE~wmCt39Uj|1>_sqny5ydYSE3j+H3XhSsjdSkrq|FC<)7 zPpeAa@_cFI+4)`0*8{i)HyVdxzRnF^jditISgV>>M0*^NtlF#8Bb*dJQXSRw8^oa*(0ITrJdn=C05&ZxqiyTNh>NA4J>QmFs=q1QWn_9}9Np)& zd!?cF)h5=%I8;8%!{I=Ko;I%2`>PEPGM?%v@J!uZ*=2dJyr!&=@u+;3M}cR6%Nc|u z$5Tm0Wc%E(YIS_U`cD?HKE|W+Ssn$RbZq2fN-tWU$T)^>>2%=Xvejp@9>$^aSsn!r zTFY*#Z_bGV$JA8=vhQBp7FN`5%SY?tqT* zD7I6)X?}R*@B3B-PpEpwv*|4xbewWyHtS9cdV0Q zMt9}7as2oPM7Ga?Ya8r&bwy%^;XRO_R6fhY$B%9wfh)s_o^Xd~jq8V{T~qmW z;K~?fbIQ|SOm?YO^oL5H?omZnmnVOkXXpgBPL$Jg1@Mrwf`q>!;q!;1ny>oD7zFy-Y-hgW;gHT=ipPVGVF8|=Uho9Xw) zZpm)UOGjT@9{)?`OZ7PNu-8$4N4|cvm}&n88P|RV7Xpt-!6iK|Mti(o=Tk}9=Kjl5 z^S7Uxd;@ueBYRQ&F<&sHOFuh${?bw{*cJ|FB0Dh0)Q;Uf0I!hl*yRHo2^j`MCCTSX zOVvHg>8fC`*e&3?J*NCFuXj&U(x=LWA);gZTp`8!t)JQN?+U~sjb zUcc?l-~Y&R{QOq#FS)-X-s%}|>@@hQ2kdA>6XCEwL|P^trh<97y)bQP5NzbLr`bmp z0#2zSgtd%(OdaxJc<@!!kvY-c=)dH=)UY+pryjO~zMh0=1^1U4YaJlcszLA87 z@e_8kJI^P^qc)}c!r#8F-nB=^9gKJ8(>t>3ZFd!71eV}ibl?&vOYB2~g*d!19=Zs| zIlOd;H;O&6Q>>g0YJiU%+91e6C4UAbd8e%~baa{WWirwQIZiife39(jCGUTIhIROQ zHC;2G-jN-B8fiy6lTCt1fr@6f2%wmnVICLSKPqxQyI|PTImxMKL|1aOe$>jI`e*W76|7jK|N8%5aU*zAZ<`4CM`Q5*t|FstQ zyFB~X+Vk(w{vS4>4qU@R@5 z!BkD!Pg-nUu5WjzCE{h$PwlJ{=;!b$3@SGhK`bwm-(BLGOo;i@BP-jyM3!riVN9>t}0)!afyVhx4Q_#iGe<&w`?ALCK^ERO=uARBEV?YLDmD%qdhK1&=O*-oiR2R}G| zd*52|r}8=cNVsrbQ$CG_$v7&az|rCOA7jTIy-7?@AYE)9m48w=5SommQ+{N7%)k4Z zw*Tm!wOq~jo8%xC?4kH#MEA~TLk;E2?ZbJ=*qV+ z(B}-N7UfGB3Jo19WsFgNO-qCaEL*m?EeeAEr-YCvOLFSx zRQ=~j@=rs^OC&jYR{fVr@{S?om6Dte>{0#im*lj6sVc9LTVJnnfO7omC(^`|mlf+QZJ!lj=YDxuQ%F{S*& z{ni{V#Y-q+d8B&@UZ8NB4$C{5wQRTBdlwONbuguHB=$L-^C$^nVEzNWlI(WXD zj4Q_#*&Zp~-!Hjz?&d|TmvO0lmWRZpW3lGv$z8U+xop+wY zdKs6>XL(3m0egvqQp4h#j(|8F`Q4H2)^%S0?ARB-e~8DS2wy#Ygsmu3%LhUn-yFA#unD+KMz3*ww;R-gfdtwo5_Dg69^${^1|2kMXE{mWRZH znUaAdR7aMR^V^OnaBX`s>5JC)z3~O>Wn3zs0XKbpkMC8+!8lbu%R}On@@KSA zm=Mvj~_i$gc|^KD$D#xwIN zOxZ<@XGk2t=50#Fy&`GKj<8KHipy1JOkpgobNJ^o@K{~R^4J&7=&!3?h83RJx-e%+hxqX-=$pbrG_V50*Km8%oj}Q(%&`4g`JCR zII^#h?=IY2D>pK z+|Co4f)gLh@fPdXCYj?&wM+GbO|{j_5|>u}an(fb$XWycWEbWOrP9S%z(|vm^!1B$ zRH?^>-AFtbgQ8_BVqz869`JHTi`7|b8R#p}tLWtji}9u3Va7-Ew5feq4%{7|_@sNy zh4EU;d%wHqt?ui0HKUI^+`}Nk$9%z*E`I`FRsrqvVj!eVQVHMxcD;$lEn0$Ffm(yw zg4%&D0bL5}2)YbJ^&qPMP`!uZFa^{DMD-e~%TWD=>YSKDEzbBEfjimQ0dj(9LB*{g zKWG|g7HB?b3Fr|JrH7|MTR^XY_JIz9z6AXMiiN!zf#|@g4xnzJzMz{xPS72o`Jl%@ zTS0W59!-2rK-9Ma(UuUyK~%&o0c`>O6Vw1{;WE&Tpy{AzK$JcZ^`ibIw+E_~bfl*9 zIg6TVC#J{t>THcGX#>pUIGrr)POu5sHQ?+NOB~7)l1&y8`xUtLPvkWL~ zPv!>^>Q5(uQ(glllKcoWZrzibdsolzdlsoI5(iYj@QA zklbd@s6p>j!wZh>$$Xs~yq;vdOE}FImB06UfRh~Oqgv_nhf}qiHXY8Gy&*Qevtm!? z2NCK|;c#Z)OuW!vGxL0gf~jU)YI;oQ6t6iaZK}6r?}mRkhv|B$T&C|C^Zzt1v$@Re zQ{bZVhV2!PXR4OT<5?RQ{p|R9*yq2Yh!u|BkApAf8|=Uh^$=PRug`tA;0#LaM@*{- zuu>k2Mm(j)+H~rY7=gYM%@3da-7lFIxnA_4fA7vIds3=dA>pA?Q{}VVjE9!d^mNjq zl{}$c|Gu&Q8t5m-_Mmv8;$b8j_$zi~i0{j?0UgpUGlt(RUc`m)BgaQf+T4ZLyw+iZ8XwGOy?i(8j~E~NF${V7x!e?nT)$765jlQ#-#zl^ zdPl3rSwGuH<+I$3Pl=yeXw36I)&dW?aPjs2gR?)MoY>(y*2j2MKFiH`biOigs*V7!TV`<+I$3SB}SM(3#82GTcUH(Gs?p3^eC{TW>e0USij8BeNGa4C3`n{3k@5E@|Q`2_# z|CIG`{Hc7Fn{fo<&kO=DmxI_IhZP)okWqPF1LAX`^BNR=xjwrcb?XYpI8;8%X-yyP zH)Fx~EY~g$ho&}f8ctd+!~+dl(9lY*$Kj^6X=2ec^HLxiem?|GF>Z#oh<@sW_P*0BAgf#~HO<8Lk*Vq5Q=C zuX6mVy5;|A+~v>sD>wYnyqXHwhb+YLNY83{_Cc3#4i+^$=$CO({$M`5m|S@KNb$&r z?TBNhLZ`FL`y=BUe%+|=w>Y&}6(93W;P6j)e6{1R4w$BLuo^hYu^rX?P_?arwyR*q zDFvNUD)Ypf!G2KY8|=U>JkC1p7)V!gIhcTT^5p8m=YP3@cKM=vTMg{~Zi0%B`2k?Y zLwJ0V>==Og|2_T7_3fPb=K2P8{nQ8Lw8r=Az^+T_rzXuxI=j^@>tv%_NUSG_!Ik;+ zj_l|QE|!z3`!MwMcw8RKAnZIh$exQ2hFAB+?Q72e#Emfm4s@$`@>0Fh8Gqx>5J` z4jhG#KPD`|h%`7r$3K!e^(rdck;=7_2O`f`U$AE6idL)K1K4JKFEjY8pYNEIE>6(G zE(|^F9-m`0t?k!0+Q7ba`rZvRj-#)Cw+wI%vWr>li3ot~Nb6(DfJ@d(I%V9Q7DO)Z z9{c53eRtV7>gpAa?lf+}e1jdh4fHs0>RYzQVZ)vY=;iTZ84rvpu?_g61bTg;HhjzR zS{VhdvYU7QP`PJ8hKh^%0YJtB>YE|PQ?R#mHzK@WL?; z<_7>6520~zZ8_71Dsv&%mII*RSH?Bx!N~S`qio^j^_H!lsN!ONUAX96Pvj9=9>#-X zAyb=C?3v=N#lpzAwtRG9|9+25`b5RW{FA`N=R&2WD)w0$1&+n<_q-@?=x)D?gZU?c zgCkFF&jg}Q{!XPVio!lKAGqzKuOF?I|F#(Xlfac_&!@f)I_oe1$CQrtM}cQX$8);g zFyx=9s-2jBGI((GNZ?Fcd<;fA@`Jb%5fGOTHNeH?gMGyPZ<21mAs63;#gV@Yo4QxO zlY4Gnm!Ix*P5K;uvy6_0=L|krCO5cme~Xdsv7X80cH8qTG?yQRf4a?Epe5pM##aXY z9RB2rr6XwEu*8rPzQ!1cBg|G1-5Y~wJ_hf1gh%bw>~Ch}w)|}kEP%@w1kzELU zLM*4RavA`H3+QdDx8v6)p)K#YP3#HU`m9TSd#Lr$=Hf+MP(>0~l`q)146qeDFlU^$ zk4bao7Eyw-dcCe(9I0u~qv%V+B1%tDE@qVrFR~q4ERAf3k@>Cq_w+*VU(;sr@|i>}xV- zE&rLufXOw57i#x1U*`s|)QO0Vb4KB?QC}&2pv3{B*hb7^&B^xI?U->0JGn}YVKft- zoMn;Ag{oeghs}QMS{gPM?sVg-@(r;@N5HAl1j=xa#)8~H4KHwjAB)ugyq}mFjkC(WZ83Z#Hp`T z>{n!Xl+*j+Zj`Q=Z?FS5>>P&k zUu~#7qnd(bh0U7sT;u=x^Yoel0TmL2lhz)c54sR^5s1nR6e(gZg#~x|jWnD|b0}y4 zAq|uPqIsW#K{tVNL9~d1=1bfLng+Tbv=p=&^el+%1yfAI%~akOJQUup`%!p4_VlFI z%bFgVa|(HeqvD?I%6!3;E+)I`6K~kG;w?E|t0L$x862nOHahj0nXg~yQ{$ESl4|j2 z(vNthdKU@&AkK#)SD1e{y+F3E0dc?VCAVMx^0SXxnt&x7=R=jxa_BYo&7&?@@yJO_ zK$wmfS^wcE^l$Tiv-kO`4?gAaS-;9>xmkav1M@9u^F9*>de;wP90dvN66 zk*9gJV?_5M$BX}w$o6PH@94OXuFs?_C>-Na`796O>4C{;Ha7-eLqd_iqm3Um<50`t z>aO^Xetyxy1pjwcR1YFYmZ^&M)hrn&ls?i@svlv(_(0xw*Bt+ zM(ulj=cQCGkt4eh9_9#O>i&*AdDF8x%$2+GXu)s%|xcBsK5wZyVMm&G-Gwv~#5`K+JsL0vS3!h>@Ibvsy4 z>9OZyXHX}dIY4zX3_!W)tF8N#?Xx2SuCn2ATG!&VTPHW)I(AS~-9M)n<})6?*NMxN zO3d~dxhlMUl1Bi?(DR;5pSbd?S~v_o>*sr99BPc|KFe|A^s7A<9@qYnaoQ(iw71vH zxqXI;i}{R)?@{0i8-sHEO^<-DWK^7X+T=IKpPn>v`l$1C1Qd;w-hN}Ikr$^mIIY#J)^83Sq~c&c>*sqkI6}o>xrA$L1YDK&IPK=O`!9cX z?SOMsT+C-Ye2)rOm>87H>&(Z)+bt(QPP@#ny*;=06H87#O-IlWH;O;zGcLYIg-^+P2*N zs)~>KjEnCli7!md>LJScGwF%&c#{iJt~L5@UW?+jRf~;*8UFq;pKgJpKw57xNhp-=o46CKl!RI}ChOZ{vQFcsx`4N}l(4)sfZLj9>LOtJf|TPZw({ zpI?yh^|W~kOZ71zQGKH2Az9;XZW?hj#h-s|UI-`opF5i8HOUd$6)6O=Cgjj zqgGIiLx?PC8JSs@RNpu{134EPPy6iDl|_gA>ODGkujnEPth<-X{TAyYry;xDpWnm18tMl?+_m|26*I7cQhcCChUp z`45AxYE5xkVfd&1A8mc)-?b&d_UpYjEcgW8gzIEnRlXtC(6%ymmiAhDmbkHh7ls>4z2T|z+Pi=`kWpG&U<2tclLQ~?p=&S?`LeU zseG0P&I9OGB$fhVLPseRaDLu7mXG2@G~cHcL(HS1v0V!h!_s@}<4!1@@E%4d04JknX={JxB5e-wBe^$txt zoLNXqnS^6JDxc+H@eFi|mNU;iAwM#nf~U>j9qP-YZ;!kW{{A0hw>D3W4a`U6{tcB+ zVUt5|G7hE^``!0)(3wz}@t1F>E-!uAohV?Wj@@$j;d)`hGiE#uAZrMs4$_0?eRFXC zjCd_;=K6EyyxBQF%uv49WQpa(w!eS#y1`Ks3u_rQ9hz) zvY9-e^*!6~?gKRid%zZsz6sRZpz;M9mvqc8z-bjIio4|G4D?))lS9TS!uj%fc6!GT zV*Lq~;q~tsUtfEnU*CD}*zP$&eahsxp2vKh8@#f9EXyb=%+ptE8a(lmA6M324gK`H z`S(*BkJeR92Y<|F|C0SPU7KEGEH=F!7EFiC5B@^^sqWvI<`_NN?!iZz zGK#2ElMfkB<4xh?o!)P^`NE_7dJkPp&*V6ts(f8)8gC5P9RpT_viqgE#-XE4MJ0c4 z%A&y2BfVzmz32V5jP-FoQ28tmWgi(28%D;F_?$VOsD4Gw8`J)^qegaIc)y>9J%nQ% z-z$8Uhr)sG2%6zeRTG9`il4Pn;J9hoxU-i{%)Wv3aQvuzmPf#$MvtkS=(IU}dKoz@ zUfbTNVEZj!y^tWvS16@=Jk?8>&p7zr3**zYcFK~0E6-TDtgE}kc%c$^E+-B{zg$kJ z^90k&;*a7dyg0!YGs}a=vShp5 zV&+*oCc$B?yuMl7Rta~-^WkyN0q!xww_F^1utjgS8{=j^@XO^~jeT z@mGh>?Q)FqaXwP{EH@@YViz^q^a@k@u)iA}W`#Kd&V0S~xs?x5f`_B;0p%m+3#N3*vW>QjJsW71hM3FUqrjd!))E+O z2`1uE-ZvebV5N#hkIkYvfDDvo;DmUnG0AiI?7f@O>S+C?DG5%KRV_{V7U3 zoY76~q2w3M_EF=l#Vv8#l+E#J{@Z?UZ!r{eyfI(JBbg-7Nq_+=U4JmnOgOdz2ie^U zqI*1u(lqz$R6QK8#nroT^s&oFFQmFIIU3id^uv6?lrBM4`gn{rZw$sXsf|y4DWZQz zBxE^$GPi}t(c+PK?OjLZp$|u-UBNi`d%%1Nf_MyrBT%2vTZp<(`MbRzc>W)IcL5hg z*Dr8<5LE2$!fwRwKvA(VP;3!UQA)xN?C!$G?k;TX?!xXa?AH4`yL(`EL>BdZKJRny zW%zt|mNT<6|2gN(?9`qSoy-?)`GgjauheLh|JcTkhg@VkF|vGQx_+vWuc~-x@59^Q zpYLn&*j^eSbMsX-e4>t{-9F>%_6NffG#3xD@DgNz3>0L|Yj6@t_YokqYl`?!l z9Z%r?=<`KFJC3WV#_aq8Ay2wWu|^e2Ppn1lGj6svCFBN2W(+qWb&vmWlYp zOgC7sS`r?iX_;DEfT+7{K-WiEjo} zIhMR_S+N19ll4oc>r*3Nql!!a9pA)T-0!Blw?Y+>I-e{LM;}j6cdpkJNcqP4(OJtk zhFQvZWO`&I`gc*qqrWEL<{MpH>U;_^5m%X>=1TP+&Kch}ncORjp#WuEGCd}7MdVKt zZ~gbHDxcKx@&6GsX6(IH^M?k85PQJ~i_7H{&weCy0#Fcs=}R zBF@m|7RqgxuTPx5&oY-$fOtp*(BR7|2g08qCLJz6BkNKHu7{v``-U zK2BX_`q^e>4KtScCesbc5xp43^UM5F*EgHv#`|^RP@w~4dp)7O;wz;$T+jP4Z&(-c z{07m<{F3SV)X3Ku#>Ziyi@2`TQOr|x!I1fO+C*GS+b37<55Cl)_1yf;#eSyfWWLFC zeQM-u4C6A+H&vACeCu=~`f?R>ZDh6Ukp0_Q@-%bA`7~|1j4-O>1J$Vsc~5_J58VS; zZM!+Udx(?GM#l@`F^J2*#N=nqj=Y^N=bKjdCat1Pm&2oq%dSB^!(p*FFR#Dk8psD^ z`T3kQoj)D=O`WsvO}K}+|5$XQdZp%7rt1<_FZJF0bw31b$`#2D?pziS-`2XD3G}~7 zRBzXnQ^xamWjgBpaxvL8Io_;FeQ*C;ISYODHv1`E4*zNX4FlW)-1u#&ZlBYyStmCy zeISMp1k#uJ5vYkr`#T2lkNyL5d`rBv{|CBDq6`j641Xpo$u%G^cVQ#Lq zbob%w4-$;_e@~nK9ZtMJ`$2tIO?zKMKY7J)8;=s-kZwqh=k_xLg?l-h00r#5d{ zsj;XJq7&DpbjxW-*Cnc6qTF7&yV6{Uk0@>Scl0BxC27Y8@|?ulPwiZ3KFf;zv($6)?e74LU@Qgc*s{nYi_ zfAOkKm&2o*KQ}4W^>*Pasi)zqiCq+Ry-t70bbjQxP$yT@M%5zDm&x+erfcG{bMHyE z_(jZDn=MBBxgjx#`}V^&>eS8HYAq4*z8w z^}UTEQRj!lW#jyaYQM7e^CU?QPRuTTE~o2c9NKg_+z^MOm%Dy1iaYGQM45<#OHUsU z?sL@dAE=K%9%~sn(2_ zs}h}+^ObRF)8%k=T))h(pQ188{&u)#y#L8=iqUxiF|VA1@3hID?b1*CA=-2qSLE;3 zba!etcJ8M8J)v%INc=p#y1p$7?)Kt7&Kexua^YHa_-*ukc3Kl(N@kJ@a{u^aT1zFD z%LDT)i+9(M$1#=+7yFGeUB)H*az~hNG;TVh{R3-V148mPDx>Y9)Ai`@j}X(`x4818 z+c^f@lGB&vrcIZ_jjrpmIjrXG-NoH4qNTlJay)hY36DV>3GO8WWh*GtiU zjZBx*m3>u1H744x5nBYqjU0Sf9oO(1rq{RejtlcnUU96doUhCuZMq!(n{h>4_g2Sc zb<^~5@S_vg(k!SHQlz!v#u9P;MRbo1>H7a7Uk#0S=&q|ccsToWF4a>$wMe(&wBwow zjVSfx@|24k@5Gk|ofYK%TNUDx^G!~=$cqreaNY0x87^|v)-X)GH;4MZ!L1g@F4)eG zcT}H`k>xDY8QrLhdEByj5?B2V_I^Bd#n;=DTQa+geLbF{$yb56eypE-C_Q-`UFEj% zc0~L>UHrT&>s{fU0(*HkJn7mrpw_mk2Cu9 z&M0UmuC6a(#4S2ohWx6U<-P@SQtE%7HAeoXCWW5e1PFb(THb=ywUJm;QrkA7n z;IIX+hsU+lE{9BKl1ANcEXPmvTKAM$!-)iSy;dHYuGc=#Ze8r++ zV;-l8daVwciL2}NTH+R+Ekry~)$513uC70oxknZKnELU=(#mx4d3E;(aU0ibO}yio zxZKWFd1Sgi>>lO5>&wT7A#(pn^v$?iMW(A`74P}xjiUWQ!%`SGeWv?pFt0M6TQP`d z_10MlQWc(IqphDZT{ltHOU(06y`Dv8nw23waa}`s9Jzjp?{E==QTa1ml&dU%@m{T6Pff39Zi9US5)G(dT3b(Kx{O!${~&Io^-LSDdb=A+ zyr$~K&^@&Zl*-;Zw>DmxF5{H_n8&NC*V-VNm=)yr$1UQN-yelZ7qO`Gef%@i%Tc06 z==Gzy-q>lEL#8uHqwY7BLtDSO9m&VrPc#DI$*)xnzr+e<>T-MH@Z5C$KG(*s-R(DD z#BRB+)5mS5Xw&8Jn8zD^{f;ttW};p{Enk?f=l-kbcA1g6@)>P@%XAsH?EgXhM)mwx zajWb5TH-cU-;1X0Wz(=$_$+PQGF`?i`!SDORo|ls)`|(r`hJ=?WqlX-cZ*om`9J)n z>E+nwa4k!NsjDVvmqVsANu%yJmP1?L9eq7?KRy=+JD$3yG&FMd>SEZkA7(BQ^*-Em zy+6Dp)6`0F;(5y8^zoZ1+H^TQ=5a?~@1tD^W)=#$9LZmquK%ejz27(V(8TNF*jjXA zIa2T{({+iemp@nzqxx?ue)aY;l=w}p2RppJpKo)2#V&3Ak?E??b#G%HziK^*CTJ_B zD%Xcw#4Fc_$LzR>nAGb-&}-An^EUg#PSe_C8mL_!nXX$1)yr=zk9K{i=Iia}r~gV5 z2N8xT8KxadU)Ce1H>THz9N{(>lO5~3Muw)3-%Qb_%i%GPJNotER|}!e_vCL)uLsxf z_w!ur^trM2cv+^)xMlwj;x}3keigS-{U>fy_5V%fgifF5jen%AFEU-mEBi5zTUGym z6)Y3ALPY&1URnR2MOFXbnO>f(C#s}-`s%H&{7vNyz%IO&7yN7xTEIum8VV2&4M{!F2s!UAwux zQ{nn0#rCYGT?$*{5nJ(j%{g}tC zs`tMNmWf(H*84ExmG%Br6!m`i7t_o0t#w)Vsbyx!+vj!lNSxP^>2f(_|2LLLTkpkX z^!CnvZni$|)jZs}A}8*n35DF=+kZ7(?~`45b|G(q*OoFKeL0vZ+H^TQ=J7^f@1qQ! znW*c%^38O;pVK+b{K?hhipOf}IuXBkUZG4kBuDiAAbz8I|Esvw$GuC5+f=U|W!S}{FY-wzX~tncrmsP8?#n_iAW+3Oq|6Z~nvb~$AF zUo3~VzUwbRip{&~B6O%>dBk?U%n#G`-D$@3=P6uDRFrYa`mRlv!(*QB(bxAVgJ&k{ z`W{aFqO*mFE2`@TvvWVQ>o8@~Px&p=#pl)CAH;7|-+vXidOIJ?8fU7$S3HyTuFIQxm_${rr%mbm(QQmT}Uvc{N8ff?^BsBVpMlg#@kr; zWEDSaahIJNcl>qKUrQHNSl@<(@qJifF^KE=w7Jcjza8CB8<$L1$0XkWPF%WnoI28C zc6F}+c|s_dX~=x*5yy1CIfZ+SvG}}Zqc%R7E@D!5e-s~gcm#->)acafkBzzM_y$)9 z9vL^8(**seBad&i>2i3K@rg%yS?lih(KmqQD(>x?j+MSKR8a>twvz zbUFMl;*H{Lx$$}y6wh@2p3b${?#`*3@nk$QUTwM@{ul8^b5_$hZio1$<4#-m#ln@n z_Wx8bwCVqWxT856WgNGqrRlhX1HzRB3%fRvamoDFrpw`fk>AmrMKG?{Au)*i%en=Xg{MZ8h&eFZaNx&IKNiC6pF4H3h$O$%-~ zuOBwywLVZ?Ii%-Rri*dZ-LK=7t)DdU7GKvqQ_H=V?xxVlXXA?L1VYAFCXu>PZ8^HMmeM zlNBpIAm%UbD{*4}a{8lt&wQDlVd~*MRKqtX_^P`nPCYzGHGIm=g=xh#0QK+?)o|OM ziMDBnhpC32N}^oT4*#ec{-WCUqT-~1div=TN5)@nVbB2W=gX*ui|31KhdZf;kKZX; zB{ZIX57qENj!X7xKOdwTKJiWAMB3pYs^J#zn|f=9hcR3}-!Qn-#{p){e>i0QuuNvW zzA2v-eLHGN%#|BEi+h&IV4*bHW!~=lmlR*B8_p!k-wDffCTG;ubMq9wqIE@?9j+5EhX&_=oGM;(H0>(8gpbZN+ zg9WV40+wb0yXT<&N)|9K3+ToImSX|Ovw;3A;5!yDS6$-eoAewD*pCG)$O69Y!*YyJ zl%_0T2^MfG3z+-_&rZ9;!ch<8ecXZkE9=W}O?`>#_w8Q?w4duXf=AGo&ri*k8O=GV?&rW?(if3)*g{f<@_ zzMFsIca$obUoI)Pm=p2={m9e;@el7u1n^{@cX%%ZZt(89(5^x zKUl-PhrV$;M;}|BKgB%}y5nr!M}m2k`B5f?aehP<&;A+1EUbsRIO{&li;PE`E{Dh9 zcPjc({Ai5b%~jv{j$QkRmI$a$5%HbY#1~b0ZOQ!DYTB;AG(Yr#>Eg@At4x=1$$kvt z(?4EY7m~gXiO&W@=9^DS)A?4#v3r~{6F$`!pB0_VH*LCpDBA(k&&}44QkNe_(E_J7 z<3gB_j4xj*)90VUO4)Dpzf^miA=`BEiSzO@UB)H*QSMh564ke_S{rV3)t?9uyT%?g zT=MH*%&7M_!(tHk#V&Qtzxi4HbpN7Em+{K}U&U>7!UYAzHgrYP#dpImvPGeU&R~E831+M z4(UwCeIs7=igQy>UaXBEL`mgzEH+5fA! zqd5bhjyp64aWAWGA7armVRLQVGF`?i`+pU;X6HqJr+|LS>h;klgX#Rfz2m`-@YUBJ zXycaYGG5vLtGJ^$6QIuLd>Kv0d$-2W&x70(&ez5((`B5p|5x!wc_u(V5F_S>X=;|YAID9_MJK8iS7OcIiM{cabljsQ0_I;6E#WTa8}nB?>ThU)pJpG zM7kWt+lX{SwGv6O-CyK@6`vLBk2tTkmi1b;mz2kTQRZ$88*Uh`yKf+y>FsCtHpebn zPAa`soF5UL=$r8>({+iem#BaLX6M~q*Y2uaRXM6Uj!@zdoh?K?h^n3bm0m6@&YG>0 zm#}r?<>OVRi_fb&UE9#K)31AmfP757zSVvQ9)V%_6~ChN;6rk|T*k^c4()c?DUGF) z_{NKy%bUJBD6jL1^G9O4EYsC7i1!UVz1-V-_u!lsGmSjVG%ANs&3pr=2I;nWODiZ! z`F8JCq%UZ$JWumxa_&@vmJD}Jshh%5?2~^}Dj1|D^>sLmpVyb?!+!hWaBm z8A=czl*{jwUEDzwSq^Tz=QL16JE^=??D~&&xwm#ze(_#(XNW_*YSTrk=w#c;C9G@u z1l01R4Fx;Com|~S3yM6z&Y7R)iSvKDGk=D5P;{TO;#Jn;9>gWj59g`pvYOLkN}yr5 zuH6Vt++uqp%Eu`;=UXnHD9l@>ZJt3Zht2=;MZ6cCetTo~Q@VaA=gfL==YpSj+=aE= z3$bqChJU6IgIO#_WH^2&&ieBUsrcXY|m7|Ktk%lXQFROKhr zynS^IDq1%TaF)&48P%ucIZdC>pD-+N=Q*FlwwWu4lZE?#` zN~MqE3MBCZPj949qOG*sfuqcp7zF&DFL>h9Lv+OeK(TNa^h z&FW3sIy7qFP`y!;=53qW)^)6|pI9(Gxn6`2hv;OSRjMY_t)C$!73E9Q(5^l5n=6&= ztDUIhv12bk5!7{@V%5bd)Agy5uO{O(5n(VDSi~pylOm_Ae<#8a>xsUe>-(HCj`&|c zmhr0?*ATw(fY|?jI|rgGA6X`G4f!qhpJbXSGf_^_b#mO;vWhO3q910(V7Z+NDHOS# zs={_EIm4nWKQU!d2C^K~|Hqbz$c=x#`&Id<%S5bKV)sNGJBo4<^jmU$*+o@W>d!NJ zZ1;yb@T>AMH93+0vYbR&iR*LX9MvSg_{H^6(eT9t{%6-%5j&w-A=X#1EfvIP#57{d zkxYoDvtpRs{)MTwf5qAUiFIbFVYt}84lJx+Yivmq`KmoWAxW{zl40SV>CjA3__2*U+@J~cK+03)8Z)C# zj4bA_zJEf@dm%!x2e)t=kMRVe@XU}2nGpzaQ;4{CVFnTqcS4khSO#{-`v>wdxtzme zu$=j_Y_m=ke}tLb*%A9Z3HXah=YMq<)p9oS_V$;{Ih>K@{FB?5KK?nFd1QyYExP;J z5Wncev5Dvo8PfItMZU`CA{g@8TGx24t(QwDZ(nQOvl@Ep$F-s-;t=OwY=}e7M+_C) zGWBs|D8t3dd9kzP8bjh?$>2JyV6hvRNKP1!n*QhfcXM+I$1|2x2b<=%L z9nVLxfu)o2gyv14yU)j=sJRk+D|=3#k`~IkEZruj?6<0l*w%_pbe+n_} zqKeY34BN5FisEd~eMAivMU8wGu!uZ-_CVKnaO=RyIGm5 z+nOnRx|k`~W|}FD&zdRUlf_ZaIL1+KEsUeM@SCTdF6K(Vi{^@llZ7(ksfChpVq9f? z{dh|GT>PSvwq`|r5bHWwpaes%Z$ZVQuQy`+3L_^aOg8n{3bIMpiN3fGL8cp$BYMA4 zZ>(#2dw2A3Yv%6X$=1Wi%bvTMjDPoHQzH8Kg3DMatNnTp+J9i`K8i`#iS3c7*D~FZ z9MSvz`1BuDuWz9y;yPX4LYbAvt@g*I!;`c&%vr8)GCd+7!y6G-J?_PD*RNMJSkD(k z#L8!Qj7!ARuZ+vFUCHS4Nz9^jSKFCcyw5DBit9R2j^fv6GTo3I(fh477e z&}Nm5M?B?ZT+c=YXC~-&z*)a0ISjqixfbsaZ1 zPW;J}%Z|15pHjyYY$BdVWi6GLVHr~O|FCYxUeTZ&T{!|4@yK+2YUFE7iCg?Bnc9JF#9o(wi?`=PsPe zuH`3MPS@|a1TzJ>J?~WZ=lWcX;Z9zBPt`tX({5ipC7o~Zycb2Qz3CFj06H0$OxLGI zzWz>JqINZQ=bWv)m7U3`^GzuieSFG+cuK`5Lwfn#wO`mRP#=SgPo_skrhgZGe1?py z=iIZso5;I}-4&zn!C(_{1s{y3r0LeXxA)!&7qoH7^uLcwU(&h~W@74mD^uQh`yjTB z;v9+CLAsIo`HjrpfM^+1fj%Wckv=UEb$mg}SFn^Egzx)?{@{W7lVJ@`>7n==_&EgoWG_?d*8 ztF4zS4^^>at&r0y!y6H&+&;*3{ru&BKlg)Kp`-eodQ7p-3o-4)_Cbj4{yqm{Qa;+b z$g+}s?Qr?O+>VRB7?<6D-S$y#!{vCQZ)#fVasNNPk1d~ncWM9AU-#?-+_UB^PpO}|)Z281Iul^fjs?WbD_NI>?c3&x9@(TO_#&veS0;$T>>~v7C&#|M|WP4w>29^RL9{o!1(xzQyIF;8$Ak|DMu3x zx*$IC=}ntb1>YQ8BiBXo-6qbT$#gM}x|8RDbZ33|5uo9L)PCH`=;iLm0hP0#uI2AP zsjp%_>NvFfqT2uExH3NNaG4(4|2YT#qS`+rhCVlJ{= zWM4h!*z!^5#^1gFlk!oQiTb^aB({8HPW*kJOW7vRcm3^LwA(lNzbso>o^oGTri<~! zdpW)~4*9vL(tq_C?YO`5|F7mJrV-V!sM3CCezD{J`*I+v?U^WNaqm@Z_utQfUzN{4 zu|4?jFYW)n2!2&QvFp#jqbz?_K4KduzmMhh5RoQ{=+*DV|FPYFJ_n*IpTC`pC^y-O zG8W}4(!}*IaUEIo)#LE*PydUw*pB~d`5QKY032e zt9@P9k*C*Q~R|Fby|Rr!cHi0hoPUW@-_xrq0&6J;kl zIZXCNn)w=&a$GS^Z1-n55LNl8rzG-NmXGMm z_hOu1<-aT+F^=f8AFPKOO(&~ ziD>Cx|BM74uT{g_*RhLdWA6Z87dPFft#}pp<%#wklMjr1F2S6yNm_{dqy9Z;5W__$ z%+}*tV?Rl64KLK^4Ngcy;ecJNW zpAMoqC&RevIIIRmA4gzlJmp;Fwd)f*d_FFZCuJNmT@`}vZFF(?>ROo+txhRQAY+UC z679$an~39dKMSRE*w^ia=N_MSLX#gdJ;re~@%DH2FrL5tVB_ECid+%P8_YvIiuQIq zFQ$FzY{1^?4ZTN+HX}tR`ewY!bX}tACGrQs*5a{RwjC**#{RxEFeI8|6>Yp3-^VHT zXGA^Gb|EB0Sk^YqEbcH+J0^mR4CPwD!hM$h?b z;H7_9siW>uKMlIM`F4tI*>x!&koEg?4C2V@k$79X_;-rP`N%l5>2i2vUA6vo9M<){ z)gjvRP;w79-$rg7X%dWP@m!f$AY_~l!%ep%d?`hN!2MReE#sssKTWKEhGq%!}IC*f5e6#Qeqgix2ac)9-lAGfSxH z+tVs{jkjlG*@+p4a6Xs2^4sR8JH%DQ=Q_o6KbJ^AFzq|maC7z#@OASujN{NkAD_BCX;GKNc1>`)ywP!sm3h1#ftx~PZxXaEP$gs;*FVvE`Yj%bQza6)sC z?Mh3~T&E)1f^CDgXa{GshYMWch7Rb6PH;zObb$vv;RSE_peuYK%Ge(P=!Wj-fu87v z-spqA=m*gda3BU?AO>MDhF~a$VK_!$Bt~I0#$YVQVLT>aA|_!nreG?jAqdkk12ZuT zvoQyA5sZ15j|EtWMOcg_Sc+v>julvmRalKRSc`R7j}6#}P1uYr2*Flt!*=YzPVB;N zgklf&VjuS701o014&w-p;uwzO1Ww`ZpO5utzP_Mjg~eJ=8}7IG`aKp)s1k5ltZ;((HuhXn~dxZH~7_8?;3`IHNsW;0iZ% zKu2_fJ36BaJm3j0c*6%>;R`?bLp6n3;n1$JxgSiOCJj}-eEW{!##u6;WGAzdm zti&p;#u}`}I;_VAY{VvP#ukKNE4E=fc3>xVVK+jt2Yay(`*8pVaR`TT1V?cU$8iED zaSEq#24`^&=WziSaS36#j4QZ`Yq*XZxQSc1jXSuDd$^AWc!)=Mj3;=CXLybmc!_Yl z!fU+2TfD=2e85M1!e@NJSA4^F{DAo4H$xnl!vb*;5Ak6M`MiikyibfIND7*tSCS(I zQX&;nBMs6b9nvEMG9nW)BMY)38?2BWIgk^%kQ;fB7x|DM1yB%$P#D%I0`dHZq9}&q zD1nkFh0-X4vM2}nyo-vwuY}5|0$Wr?HQ1p#YM>_UQ46(E2X#>o_0a$hXoyB=j3%H- zex)gz!3oXL0xi)Bt;1H*`l2 z^h7W8Mj!M=KlDc+24EltVK9bZD28D;MqngHVKl~IEXH9xCSW2aVKSy*DyAU_(=h`x zF$=RX2XhgOd6*Ki#-a1*z1 z8+ULQ_i!H%@DPvi7*FsN&+r^C@Dky8h1Yn4w|Iy5_<)c2gwObbulR=V_yMugZ-zK9 zhXvvy9^%6i36KzpkQhmj6v>brDUcGWkQ!-_7Cg3I;Zf=ek0n>cBeOF>w4a{^;*r(j zv9VUjjvUB|T*!?)$cud7@r+6Vh(^?T)R7_{XCxjK#A9j{(QXZoH_<&?N<79wJd!~? zWZ1W1 z&=8H#7){`arf3EyG)D`xL@TsL8?;3`IHNsW;0iZ%Ku2_fJ36BaJm3j0c*6%>;R`?b zBLLmd9X-$!z0ezd&=>vCAAuNvff$6r7=ob~hT#~2kr;*17=y7Ghw+$ziI{}Rn1ZR8 zh9FGG49vtV%*GtdMKI=JJ{Djh7GW`#U@4YiIaXjLR$(>PU@g{RJvLw?HeoZiAOu^n z4coB;JFyG95sE$7i+$LS12~97IE*7WieosA6F7-eIE^zni*q=S3%H0&2*YJu!Bt$t zb=<&B+`?_#!Cl89p2*uKH?KT;|spx8@}TQ z6bsgW#DO_15Et+CBS2jlu{@S9u1?EMLF;|7Nr6zq7r!A zh*AZ%sETT^Lv_?ZP1vIrYNHP7q8{p_0UXc}jnEiP;E1MZ1|G$uG)D`xL@TsL8?;3` zIHNsW;0iZ%Ku2_fJ36BaJm3j0c*6%>;R`?bBLLmd9X-$!z0ezdz-0@CQ}s%J1Y!UN zVh{#n2!>)9hGPUqViZPW48~#{#$y5|ViG1}3Z`Njf-oI3FcY&d8*?xh!I+2nSb&9C zgvD5brC5gLSb>#Th1FPtwOEJs*no}Lgw5E35NyRZY{w4l#4hYcDE444_F+E`;2;j+ zFpl6Tj^Q{?;3Q7rG|u2G&fz>R;36&|43}{QS8)y3aRWDT3%79xcX1E*@c<9;2#@gu zPw@=T@d7Uqj#qe%H+YM8c#jYGh)?*8FZhaY_>Lb?;SRp%dASZGmH}W7a@*zJ8pdbpNFsxAo zHYkc>D2@^+iBc$yGAN63D31!Lh)Sr8DzHUWRD&I=qXufi9<@*#bx;@eP#+E8fQD#< z#%KcZtgxnN1}8K}3$#Qlv_>1WMLRg7JzU@lH*`Qpbb>oNqYFIX2`_lV2VLO{Klmd6 z-OwF9&=bAT8-36h{m>tQ7=VEoguxhsp%{kY7=e)(h0z#;u^5N(n1G3xgvpqKshEZ! zOvenOCl9Lz;9=3zb-U?CP^F_vH{mSH(oU?o;zHP&D))?qz1U?VnRGqxZETd@t> zu>(7?3%e1DJ=lwV*pCA^h(kDxBRGmtQ7=VEoguxhsp%{kY z7=e)(h0z#;u^5N(n1G3xgvpqKshEZ!OvenOCl9Lz;9=3zb-U?CP^F_vH{mSH(o zU?o;zHP&D))?qz1U?VnRGqxZETd@t>u>(7?3%e1DJ=lwV*pCA^h(kDxBRGmX^{@;kpUTz37L@vS&6b zB~c2cQ3hpE4&_k+6;TP5Q3bZBifXV!b<{vj*rOI|qYmn#9_ph39MBMr&=^hNh^A-; zCp1S3v_vbkMjNz6J2;~~T;K{fbU;URf;&2+3q0TnFL=WTUEvEq_#*(_&>cO{6TQ$I zeb5*E&>w*qfPol3~(fsq)6(HMiV7>DtgfQgud$(Vwvn1&!s#|+HGEX>9n z%tbKfVLldMAr@gVmS8ECVL4V{C01cI)?h8xVLdirBQ{|(wjcysu?^d?13R$`yAg^# z*o%GGj{`V}LpY2hIErI9juSYEQ#g$?IE!;Qj|;enO9;bdT)|ab!*$%iP29q5+`(Pk z!+ku!Lp;J`Ji${u!*jgAON8SUUgHhk;vL@O13uytKI03%;v2r>2gC(_GsJ;8ED#s* z5FeIEfP_ed#7KgqNQUG{fs{yv)JOv!H>;#WdSpOGWI|?SK~`jg6|y4-av~RUBMp`V~+Sl~5T~V2i4#20K(o4b+4^ zYN0mjpf2j6J{rIQ4bcdV(FBfYie_*^bF@H9v_fmNL0hzgGup!iu5d#KbVMh(qcgg| z1D^1LH+;|)zVL%T0?-ZJ(E~lv3%$_?ebEp75r_d8h(Q>PAsC8b7>*GbiBTAhF&K++ z7>@~Q~(IEVAN zfQz_+B~TKjP#R@W7UfVL z6;KhCP#INVi>jywJ5)yv)Py~1p*HHEF6yB^8o&V!(Fl#v1deEmW^h7th?|RBq7_=B z4cej|oY5XGaD^K>pd&iL9i7ny9`J-0yy1hc@P!}z5rA&!jvnZVUg(WJ=!<^nk3bB- zKn%iQ48c$g!*GniNQ}a0jKNrp!+1=cP#W|eE1zf}>gyAx-;3}@+I&R=5Zs9iW;4bdrJ|5s99^o;b z;3=NrIbPr;!tn~P@dj`44)5^+AMpvF@daP;4d3wt;>JER#DO_15Et6bB~c2cQ3hpE4&_k+6;TP5Q3bZBifXV!b<{vj*rOI|qYmn#9_ph39MBMr z&=^hNh^A-;Cp1S3v_vbkMjNz6J2;~~T;K{fbU;URf;&2+3q0TnFL=WTUEvEq_#*(_ z&>cO{6TQ$Ieb5*E&>w*qfPol3~(fsq)6(HMiV7>DtgfQgud$(Vwvn1&!s z#|+HGEX>9n%tbKfVLldMAr@gVmS8ECVL4V{C01cI)?h8xVLdirBQ{|(wjcysu?^d? z13R$`yAg^#*o%GGj{`V}LpY2hIErI9juSYEQ#g$?IE!;Qj|;enO9;bdT)|ab!*$%i zP29q5+`(Pk!+ku!Lp;J`Ji${u!*jgAON8SUUgHhk;vL@O13uytKI03%;v2r>2gFUi zW{3lGSRgLqAwDdT011%@iID_JkqpU^0x6LSsgVY0kq+sR0U41AnUMuqkquVJjvUB| zT*!?)$cuc)j{+!&LMRMt6oCzjq8N&!1WKY5N}~+Qq8!Sj0xF^sDx(T)Q5Dr-hw7+- zny^PL)J7fDMLpC<12~`|8lf?oz!6Q+3{Gf{7HEl9XpJ^#i*|5Ed$_rH=md9k zMi+R%6JGF!54yq^e(*;Cx}iIIpeK5vH~OG2`k_ApF#rQG2!k;MLop1)F#;no3ZpRw zV=)fnF#!`X36n7eQ!x!en2s5kiCLJ9Ihc!J%)@*vz(Op-Vl2T@EW>iFz)GybYOKLp ztiyV2z(#DsW^6$SwqhH$V+VF(7j`2Qd$1S#upb9-5QlIWM{pF!a2zLa5~pw)XK)th za2^+M5tk5#%eaE8xQ6Svft$F6+qi?fxQF|AfQNX5$9RILc!uYAftLu!E4;=Vyu~}b z#|M1GCw#^ie8o3>#}9}b`ppmr=CD9q#6x^oA^{R25fUQ_k|G(BBLz|-6;dM&(jpzw zBLgxb6EY(UvLYL-kR3UY6S)9hGPUqViZPW48~#{#$y5|ViG1}3Z`Njf-oI3FcY&d8*?xh!I+2nSb&9C zgvD5brC5gLSb>#Th1FPtwOEJs*no}Lgw5E35NyRZY{w4l#4hYcDE444_F+E`;2;j+ zFpl6Tj^Q{?;3Q7rG|u2G&fz>R;36&|43}{QS8)y3aRWDT3%79xcX1E*@c<9;2#@gu zPw@=T@d7Uqj#qe%H+YM8c#jYGh)?*8FZhaY_>LbCKjtw*9GJrbaS;#kVTlAth(t(? zBuI*6NRAXpiBw39G)RkdNRJH2h)l?gEXay%utIj^Ku+XBZsb8;Yy&_p*|YG0S(az zjnM>-Xo_ZVLUXi0OSD33v_V_6gEQL01+H*I2XsUyxT7<=zyqG}f;W876~6F;KLXGV z-O&R*(F?uN2Yt~G{Sk-(7>Gd_j3F3`VHl1P7>Q9BjWHODaTt#Yn21T3j47CkX$Zn} z%)m^{!fedJTm)kt=3@aCVi6W&36^3RmSY80Vii_n4c1~E)?))UViPuF3qr6J+prxw zuoJtm8==^Pz1WBSIDmsVgu^(3qd11+IDwNmh0{2Lvp9$IxPXhegfLvj6U!; z3~^u%3&ce{#D^skAR!VVF_IuDk|8-#ASF^EHPRq0(jh%EAR{s%GqNBnvcU@3kpnrA z3%QX8d65tKQ2+%|2!&ydBCtVG6hm>8KuMHBX_P@(ltXz`Kt)tSWmJJJs-ha~P#rZ; z6ZWWu+NguNsE7J!00%TgBQ!=6IHD<;1H*`l2^h7W8Mj!M=KlDc+24EltVK9bZD28D;MqngHVKl~I zEXH9xCSW2aVKSy*DyAU_(=h`xF$=RX2XhgOd6*Ki#-a1*z18+ULQ_i!H%@DPvi7*FsN&+r^C@Dky8h1Yn4w|Iy5 z_<)c2gwObbulR=V_yO@FUNgjjIV=zt@em)DNPvV$gv3aKq)3M3NP(0{h15ucv`B~a z$bgKY^U%qX8Vy5RK3nP2h;8Xa*-VM+>w>E3`%% zv_(5Oqdi>U3O95>M|6TaI-?6b;0Z5y!v|gA3qSZH0Nv0XJMZw7yZy5ff#^+ z7=*zXf}t3O;TVCD7=_UogRvNg@tA;#n1sogf~lB>AWX*$%)~6r#vIH=Fy>)C7GNP3 zVKJ6qDVAY5R$wJoVKvrZE!JT@Hee$*VKcTM1Y5BU+pz;Xu?xEqiapqieb|o!IEX_y zj3YRTV>pfzIEhm@jWallb2yI+xQI&#!)08-Rb0b$+`vuT!fo8aUEITcJitRd!ecza zQ#`|SyueF@;}u@x4c_7%-s1y4;uAjO3%=qTzT*eP5BSXx2j;LqT*O0sSRw%uA`ucJ z36dfik|PCDA{A024bmbV(jx;hA`>zr3$h{`tdJc!kQ2F(8+niy`H&w4P!NSs7}h8P z8x%z`6h{e^L@AU;8I(milt%?rL?u*471*LGs=*G`Q3Ew$k6NgWI;e|!sE-D4KtnV_ zV>E#ynxYw;&>St$60Oi0ZO|6&;EeWgfh*k50Ugl^?&ypz@PH@0;0+&ig)jWzj{tN- zcl1C{^g?g+L0|Mke*|Ix24WBfV+e*~7=~j6Mq(63V+_V(9L8e;CSnpMV+y8X8iFt# zGcXggFdK6)7r~f^`B;F3ScJt`f~8o79UcX*Ev_=r#Vj4$|#Z}^TM5RG@3 zAr8!8fw+i=_^?C*Bt#-4MiL}NG9*U|q(myDMjE6=I;2MiWJD%pMiyj6HdrA$av&#i zAvf|MFY+Nj3ZNhgp)jmb1U4v&VknLhD2Y-ijWQ^Uawv}qsEA6aj4H52RaAo=s-p&K z!XC9y8+A|@^-v!T;DCl`gvMwBM>It!5;zWhVJNrp6G?%=!3rKhyDn}01U(+48{-)#V`!V2#mxijK&y@ z#W;+|1Wd#vOvV&U#WVzAI%Z%dW??qwU@n3&5A(4A3$X}`u>?!849l?sE3pczu?B0g z4(qW28?gzSu>~R6if!1A9oUIo*o{!^!CvgcejLC-9KvB7!BHH;ah$+OoWg0G!C9Qc zd0fCnTtXNw;|i|g8m{98ZsHbh;|}iP9`54-9^w%m;|ZSP8J^<>ULqW?@EULM7Vq#L zAMg>M@EKq572oh3KOh?JF+&`f!vb*;5Ak7%1W1TPNQ@*%ieyNR6iA6wNR2c|i*!hj z49JK~$c!w=ifph#cH}@#+B~TKjP#R@W7UfVL z6;KhCP#INVi>jywJ5)yv)Py~1p*HHEF6yB^8o&V!(Fl#v1deEmW^h7tv_MO=LTj`^ zTeO2S+QS8|a6<=lL?^hTGrGV7p74SZ#Sju9A%Q5cOe7>jWjj|rHFNtlc&n2Ko#!gS2QOw7V;%)wj)V;<&X0TyBr z7GnvPVi}fW1y*7eR$~p;Vjb3F12$q4He(Ayuoc^|9XqfSyRaLf*n_>;hy6H!gE)l4 zID(@%hT}MalQ@ObID@k|hx53Ai@1a^T*eh##Wh^V4cx>n+{PW;#Xa1|13bhdJjN3| z#WOs|3%o=)Ug0&~;4R+aJwD(gKH)RI;48l2JAObk+GU0~Foy-=A|B$y5($tHiI5mc zkQB*~94U|zsgN3JkQV8X9vP4knUEP-kQLcrh3v?IoXCaT$b-Ddhx{mjf+&Q-utpKs zpeTx=I7*--N})8$pe)LvJSw0fDxor}z!p_e4R)xG8mI|-)Ix34L0!~CeKddr8ln*z zqX`_*6wTm-=4gSIXoc2jgSKb~XS9b4T;YZe=!i~mM`v__2Rz{gZ}^}qeBlRw1fUzb zqX&AT7kZ-)`l28DBM<{H5Q8unLogJ>FdQQ=5~DC0V=xxuFdh>y5tA?(Q!o|N5QOQN zfti?v*_ea52*y0j#{w+GA}q!dEX6V`#|o^(Dy+sDti?L4#|CV~CTzwQgkUSSVLNtU zCw5^sLa_&Xu@C!k00(ghhj9c)aSX?C0w-|_r*Q^naSrEk0T*!zVYrMdxQc7IjvKg% zTeyuoxQlzZj|X^&M|g}Uc#3Cuju&`|aJ<56yun+%!+U(dM|{F(e8E?I!*~3ElA84& zabOM$#6>*Bhb0mqArc`mk{~IPAvsbYB~l?Z(jYC;Aw4o6BQhZ~{)fHufRCbh`}ih6 z5)d>X0u~??>71b>&4fTmfRK8{+``^a-JNR>I)IKK3UmUUK^M>!oDI5x z?w|+g33`FvpbzK^EZ`gv4f=upU;r2h27$p~2p9^^1;fB_FanGOqriC}2E>BVAP$TH zV?jI^2NFOc7!M|Zi699~0?8l+Oa`eS4Wxq%Fa=Bn)4+5v1Iz@oz-%xF%mtai3bH^p z$N@6Q1$iJJ*uXqc01817umcAu2J?XvxPTj!fCXS7C6d@fZM=Ua67mI+zIXicY}Mty;dnAz2JTD0r(Jn1U?4)z?g;9Kw=I1IiAKY$;> zPvB?p3-}cr0l$Hx;CJu`_!ImE{sy#IX9x%djX-121cZTb5CNKkX5b{y9JBx@gHu2x zXbD<@Q$cHR8fXLBf_C6^a0WONoCVs04xl550-Zo-&;@h_XM=8_JLmy=f?l9E=mYu! z3pfWvgMOet7yt%>L0~W#0)~Qf!7wl!i~u9SC~zK#0kL2-hy!E5SP&1!fdr5U#)Ao9 zB1i(0Kr%=HlR+v-1L+_GOaW8DG%y{^05icXFdNJPb3rDsf-H~?a)1nSK_18lHZTtq zfI?6N?7#tv!F=EZF5m_wU;$VNNBhVN$0bw8SkO%UC4a@@tpb!)RJ8*zvFdsO9 z3%EfESO6A+QcwmKfyLl_Z~?dwECJ=s@DJ0V`hby8ZJTa_RN53N4)0yFQ3;T5>WLkWX=}0leOI0v7S1^IFE*o2EP( zjU#Yfv`z&a%N3!pskYvAlGSEcmdDqxd|i%ncwO*FETkps!RwCZWAUxuv)y^q&J2^z z@BKy7SGs@pfW@IEM(YNX9xPX-o^3Tfrpj4krg;|MrgaP`eRJJy)H|3h22eQ|4dTEU zFc!pvaUcOCg7IJim1NVXZ!2{qy@IUYnco=L4kAO$P z{{gB$kAo+`lVAsU3Oo&-0ndWx!1Le*uoJupUIH(JSHP>_HSjvv1>OK}g15li;2rQT z*bVl8_rPB8KKKB92tEQIgMDB>H~>BYpMuZ8=im!)5F7$ug0H~W;2ZEQ_zoNf--92( zkKiZpGx!Dk3XXu^z)|o!_yhb2{sMmkYJfsOC};#4gC-yhgo6ms6f^@Tf##qEI2oJ* zB0)>g3Y-dBgVR78&=#}xf;1KmLn&=d3my+I$) z7g)eKAR6=o{lNe*5DWr?!4NPMoC}75;a~(92}XhQKn#clqd^=P1IB`QFb*VuL@*vq z024tHm;{nR3YZL1K^jO08DI*S3Z{YSU)$FkPGraKCpp# zpa2wtB47s&Pz>e+CvX8bC;acOBOPDioqblYSXuKQ%OpBxE$jRNO^7(n(P4dTEUFc!pvaUcOCg7IJim#0kYTZCt(A#pEUbPv!6UZ`^j6-5#9>6fZM=Ua67mI+zIXicY}Mty;dnAz2JTD0r(Jn1U?4)z?g;9Kw=I1IiAKY$;>PvB?p3-}cr0l$Hx;CJu`_!ImE{svMg#vULPGy;u5 z6A%W%K?G!oDI5x?w|+g33`FvpbzK^EZ`gv4f=upU;r2h27$p~2p9^^1;fB_FanGOqriC} z2E>BVAP$THV?jI^2NFOc7!M|Zi699~0?8l+Oa`eS4Wxq%Fa=Bn)4+5v1Iz@oz-%xF z%mtai3bH^p$N@6Q1$iJJ*uXqc01817umcAu2J?XvxPTj!fCXS7C6d@fZM=Ua67mI+zIXicY}Mty;dnAz2JTD0r(Jn1U?4)z?g;9Kw= zI1IiAKY$;>PvB?p3-}cr0l$Hx;CJu`_!ImE{svMb)PE2P8iB^32?zt>AObW6&A>^Z zIcNb+2B&~X&=Rx)r-IhtG|&dL1?|A;;0$mkI197~9Y9AA1v-JwpbO{<&Ia8;chCd$ z1ie6S&%rAv1K0?z0h_?J;5tC}!WAfbd>>qS z)c<{OWTSBD_6K|HTtBU}_3HLG5svQ7Xug=`icr{8yAO`F+ls7iImd86yb#+`DSAwCxH$%82Ov4w?>h5fbIM18ggp-;bw zjVG0at(nc|H$yy4q-GM!bxPt#5c(wG-*{!G7GWjMVf#$`JFtDGJdk%u#mkFIjOqH4 z2cb`j)3(5xU6v->T{gFEfsE$CnpG&%43T~wal6!5k;P(5Lwf1*vkU1m_CW8CD;vEr zG^DX~@cX==EX}bNp{;uw{Q|A;AJ!D(loskc32UJ0 z-vdx~QxJAO`ogC$2J9UoCF7DE^^e7K z`d9nkaN*QyyD(uj=S^1aAWaYkpN4`A{Z_A7JHYg+S)dXIrt;A*qf=V7zyJaxV9ao>aA+j`(W&vwCv7%V0~sOdvfM_qp>{e6StsQsnuV7Vr)@;v%l zM&p0p?VjI>Ma6}ds<%D(1W}*NF#r0{IS)BQyI(N3&0#(tO*>qRYH|)wE6Kv2sXIzA z434)I;$P=2Y1UkMw9~QB1#{z1;oa84xO_RgfVw1{R1UbE-e=G!2VrENBVg{TMQfw+ z#}d0YKDu{Xp=$)q?~!W@$UZDrgu=#S4@-K!)8Td(s{j1XhluwNrQw0?@%p|G=N$gw z>@WCy${*?_jdBhb(oaSHxL^^Fh&6JNG4y#Q>J=FgSg#IUU!JpYDLr{toob)wLyU3` z_b5?im$9XCb_w0bDB4W56&9lOJKd@B{1Vya)=s2xD(BZmgI<*@LX`ZXhjV}L-uDEZ z@?on-Ml9RaWSDlkI=;cyDCcmcq{z;+g*JC~K1$EnQdrDxEljhy9I8kJ+Az}{!{+%tcfc)9oEAr z=WwGQiLzW|v;`e2mY0}jdV3h#89M&VneR^R8{7H~+9yZ#h_*(#BF4sBd08Oa-GK^? zsMnq#^!mE^mz4M~?ALL+td~*F;lA`5Q{q(a$$gb&QLo~Y8Y^QbZkK5sh2gA}c?RZz zZn+<&8FM*_M^3#vb$Obqk7}DtyW8m~ zER>yNYE6Tiw<%eUHZhoIiGyhT=kr?-JX~od$jI zDu;9m*p`90zG){}DUtEcX7f9Km;Q7+`T<9N2(~O&gu*5bZMM_qF0*(np*7eXGErV2 z7fO{lhx0H0aHuYSq7x#{_Gs+{d`=4dBW!e@JJ zJSDKbhW%7_&ET|*s&<|AG0KC|$74FOmoR>!;i%I6Df2bYb%=V(3<0 zajc(F&f#LJ7Gr)+a=4YrA30}qnK}uoYqxd;p-=iHx5SKE`C?0B`C>Wi!F~XJ#yK2$ z7};TjSA@Z))lOr3PRE`L^9A&oBx0lqXP!CjjI-b!i&UhQU(x{~` zKmX;!;|9_`IUfHSxk&J;Pa3yuF-t_X#V&MsP~!ozNh)>4jvHa5H37O_76_Iv2K zBxN2;91pZ>9l$=g?ornac<{?zzdqAdvjOE#Bjggx1=A?IHMEaKxp%`HW;xF0a3H`?W-0Uyx zN*llWzpDp-|H1#3(hoS&qZzg=SA@bwr$?0?V2iZud>MDpTX8I<|8JL9s;3=66zBvx z1G;{1<#-?LL@pMD0B`pv@$L3MaOawXQ|UNz^naAJHOfg!Zj$V_R1LJbf(N=e!FgQY z>HC}Fw)*^wKscterBcjUzjV^FcQ)dWEFb&dycM^vT|etn^%9i#uBrWDIS$vkDORUV zX<1wr_4$O0TOAty%cbr(^yqmGXPI`Es1N-)JlTisL?#Fa)6T|x$a}B$-HAWx%9~JG zaNyJRyXf5uauaa^>BDkW>e+hH2WFdMEwtq*YNBN>DRf(6i;HD@4o(yGSqpv0u|D4N zZQ@utV($-kK||GX|6r7JxM$dEQSUy~8T51qk7B8x5N<}eyib2mP6 z;KCM12Ga8-a-B%j}Iu?mlrPGI4!l^ zDIacmI$KNZB=}UXS#H!JNiISoYZ;f4VM&p#1?o?_iBa!C)07$O{+=hMY57(>8qnHk z&uy1fiHNzs-xfg6$bxVwZEX664~w>4O7G^7V?9}}N6uuBC%tLzk}O?&9n&H3 zxG4YTjyL`B+*No=t2%D4jdBjJJ|0mA)igT8^cLM*6ed|QB|?)QaANBr>s9*aYJPvIuMTAYnH20&$hZgqzTRXrCSSRJL!}!j@im_D(7EH$H4Y^ zw&2e%+lSh|k3Jj&>j<1zMMEI0ae1qAgYRKy7yqtIBT3E*(bZ#sr#~lE(W?z((%;?1U zILvqs{U*K0@$trE)KGKV5G-JII)}o@XPKx2?~_mA90#8RkxoX(i0OIT7vtgh$QK>| z_T`Jmiu-&#%jh>F%1AHcu^evt4a)*CC@|uDf>>YbswtHLDhu`HYEq_xJ(iCXecGpb z#EyP5qMYj*T_el6Z6F!ddxFNS6i#6@Uqo@yc$J!LuT?+4lILFER9L73xdL*Z~={R!a^D&CRhm6Ba|KGQOIPV!fTFu#5E#K(<)Ew;Z z#Qfi4M^=2yxna_Idshy9Ic3x%ami{<_d+<$XS3XRMX7i^Cp%^5K#MlXXGyiv%f;zd zSAjasr@a7aNp=+DDo$_dyOS;ve8v4Bj$v;~0(3rY$<4wivVxKqsV`!0Or{spZ879w5JK14b?B1GChH$#R1uq_fe*dUc{) z+!qh_B^Qq|_e~2lbPE{k3->KlXN=BQnHS~azVUqXw`qan-2!WI0sMZ=4&3+R7EF2H z$Jcee9sNOB;-=<{c4`N3{dh-{8_(nKuVQUQW0lW~Y=!joldz9BSc|bZ4?gqFktHb# z5s*HWTRva25BiAdQCi~r^`&uv^<8@ZhbJu_c{JXr?=nqZH+|`QbNb#*uXnpKjU_Q% z(mMu-&x6=*l)ku6zrDE_2b*GIO!v_q_h<7RvOnQ&?U_Fg;4zIDEF7@-gxi-u%mEzk(LBDN5 z=ohwP@ZWOA{8Ub#^)t#jyvF(=pL1lnc&%yEJ3`NypI3tqWmRyBJX z<#o{)3zy}|bMs`otbUU$DlN7@M}p9|@sHP>|3RC5lT^E^^^Lx(WjX7~e(?6y*Pu#7 z!1ZTiLSQ={ebRnL_tp2%a_fpCpY&q6Ca&^opqJJr>h%-rcT8en{m!{_^*MKR`GA&_ zRUGTb@+!r&of_ze66vjGs}YIi@o*4&?kQXNWY5?ow3MylSWlK~;wrBOdJ1;*t#2h_ z=6qi}K5%~+@z&_FFN-ce!V0n8O$~AmuYtaXmPm~u3Lfc4{rNWNC#Fwni{)b4guwbo zKQ=3Jp7UUl8oQ_O>}Qa3cn$Ptdk4IZQs^n_VZ4s0iGj=aqyuv{9DHgRO&2Rp&4&=l zDCh7RT!-HlS1jMVg3$Aq8;g_s9{K=ZysM7&G|D-=270o+{pu^0kJ6;TcD?GmH=3ru zwqPRb!}=QK99{!`p{MVjL9}a+NrCm8Qa*R0x}&pTd@XzWmE6@8&M0eRBL>yHT!&;`xi5rF@Kmbu*H)Tv#jut3-^kw)5^Xhns+C{XnLl;uXf z#yPFU`L=9YBaznmLgr0!IE(NZLwQ1IO#=RCEvR*X|&sWhxotuqsZZE>KSu}D_?8Um;XN5>BoFUSP z19-;h3YGR^GOJVf#?scjCeoV`;S$-ApF3`Y4qQ(*rt0loe)UGh-dmyk@XVj@jLc{( z%{udi7Y26h@+7T=Pp&H8m@!t1vl2e*dnC=jzT2iWmae~Q%<40r?XrtI zdV24O^kumgZIxF`eJ90ENgNlOK34gEGty7|{!=rR(xy};RL?sJh)+zHnlVndCP`Ij z@zDK!dAh;AUfRuT4~^K{dhchi(3;WYC{1cNS*{3$jo!Xv?O3`_&Tz@fms=Tjw@qDp z%+P*M)9c}_U)kC*{FLv{v&PXJ1Ub?p6kC=nLSf@e4_Z1EU;es8UFft*L@3&qWTJiX zN`dlCKRs7bwWT9`JMmoKN0}kPTEJWW(79x1g31Nu3&Aq%n(iO6fY`3=L4Bq?hy~Lsu~C-*vczL?1^TX0TQdwRP%Us2pl45s z(+(8J7x~izkFQJPOOkH=`THbJhu;0BH^7Z@4)>vlHa>OdC)>x#Zmf_gCt$InLRmKs zldvu_l~cA0?NhTV&Zpkcb$IylgQ@p(daRF8&fz}v@o11@b?2vIH8ZD-PT7@$ub-7M zw3uHN&`ZoOYU60U!|PE*uLzg=&wS~-QFm|q9m5jEQGQWB%W_Rz<@wM{T?Im2j6yk9 z%&&Gc)s~g*6Epf0Wqh(7?_~WxWykz|y~3ru`0gLH-MV4R?-NL4^?x`?50)!JVWaN{ z#PLaz?97v6r=>e(IinbhWYE9x>E}gv2GD2PIbqT%KRy2D+e3;z&YX;w%HZ(&mtq%| zD?(x8TOaLxKivUIRy+DD=dfYPcAb1IEz#(rcko2}O`D~+UljgGg^ro_Gmg9RzBfsY zw?3S+>aX6@r>Xa4YW<8r?z5bZ5uGksi;}Lkeg;%t7j>b1y*^@osueDFn#VSDyjaeQXY1{A5S5SY zlZkiyZr+)wyr=iq1EZ&Q`@YqsztG8WRLaiAmgS02*kHYIS|o6RO5<@ zuJX=imb%_4ju-7B%?UhzbyEM2w#*v086{tJYH7#)he6KaDif5%%v!tNaG!vZ;OIHVtSNTxfV|2#7cydEEbR-3Ghm# zRDoHEgvKXFVOQ#3{O!4^?;Y$x`{d|2+8X7G7@IU(p512GX&G;|6_z;Z1`4hmkbabY z)Leb~l#9mxBy?!js_~zFUW_2cspG^@$tdS=Eqz)W(4LLv8f#M)Yt#73A?4U|`jv+C zX)=z+gWCt-zl4(aXJ%$KmhSi>b@Sn`rr$?xCpk)=$}!6op|Gi*e!A0^hq{jHL@)M= z9br&TG_3hKCi55$tX^D z3@EbMU6!;G#5JbW63aAiKKSOnMC^!$q1G>Ma zg`=#X5R`$HU<1IbxXS-5zXktm5CJ=M2Z_J|=>K5pzv9R+Bft_s{~gsHZNMUM0N{2~ z+5>DTTqhwTcYsUL5f(<^KMru8z7!e%I5PgM7I^O%H<~k15yrMc81CC&#tYLWXu=%m z7@tPHDC>g%(dv#m(+BSn_rtrvL+}nXUY0&E2JbOX1Q{qFb1@%Kfd92xh zC~8Y^b-MQMh>VMYiv@J)Ie=_RllrvoHaw|!#{GMiJusHct2mehF0`6l5o3eKKNr=- zGO45}OLivbaub7=SPN2*%!lXieu|DFo$Bh0@A1?}oORWyrsp4zI@k0X&Ep$}1uCHi z_iID*_3eYPUm=Z`>~|eq^7!j5w$cwcDyv*Yjh`!oxd2>~ywp;2xnr!9UL*v1844P)e(fGmW(9A2} zEs~t;B>To=jla=-D2|V(w7jLE9d_J$)M;?}*@^N)*BcASCmT?S64#YI$F*wG@Q|^W zK&&{`J|U7(&f)lX3y0HfwJZ0~c&1T^<(rEOt=aID1q{=jCHNdFXNnc88PYiwfb~hS z1=i>4&*KIydnAKCX;PfJ(?K%IIXsX)SZYi;RMcaSK@a12kxqE;(18QverbOVr^9*} zxUs=g+|a`s`XCCUwbvX~qXPhrjrHS2|n$_Ke2SELWwTtv`JzZ$x{P76hJu zxvgN%SMBYeWvJy;E!XtE3(Gwzt9#-#E5%hYi8gS?s=Bmrby}G{o6jr94%=f|VPmDv z#8My{jF1?0Tzmw2elqy=$4UIo&aZz?iJT`(QS?i#UrkZVs^qG;Y8xjz-L_n;#_X2U z%ZlaxmeHw}iLy1 zCAyR~>*5^vt0Nh$eX_lphLwnm^~-elw_nt);ZoOScl4dnDJAp_dO!$A_wUrMuv`%e z8~^%Ify1-p(XxA?EMx3~mwRLFIhvA6EL*W<{UVC}>$hV|xHRMY1tafRQTCWoKb8xs zDZ6#h&k~PD2{S?q@t+*J`RU34dQ!q`$FJQP-*eMVtPk0dtZ9^UxL-ZRbqhtMaI*N` z$ry_{ZAP^fzah= zgv)<^QoQ?Ge!O(y2ao)~Y22%1?7bmIIfo1B^K#DBR|&6{oBDaSjX~(uZu_5u26elz zYF?J}(mH!x3784&MXX7?bS+HN!XOBT2>Y_*| zevU-xIQo2S>D%Y5=V_lD+s`OhLorWW?SJR0?B~&k=DM{LD&cdxTUrvhoW;I9b!*?A zPta7N;#eP}oWnikEUg67wfKVxyn3ZQhEO^!my(rg-%9HcFT`^a&q=!XSfdsM*004a zFYSLja=3-lXZ?(F4)-J_=$DA~dmROM_o+a}D!Tp^)FP^c&vx7qgr4pGI_HYF^WVOV z^p*`&U!cFLPmFJN9hc_t%i5(XVj&>Nus1WR!EbM?cU1 z=z0HNG%t+`A`$hgEc375p3dP?dHLwuUfg-d1bQ!w9O*~>7t0l)u<@lI-;7oLKbm*- zYCO*(BwgcO8ZR21H<|I6|MG9KU9DKGFF!djjBy@+$rqioC;c{aFxyNW2VtJhAm{KD ztILG}V2<{L8UNnhpD<6Cv&+CQRgt!du9AY{+RAqTOgSH!DCzH zxqz8J$2vEv$1k=U(nW#WjgKOd1|1CVRLn8)c+x26aG~8ubZITzXlr&so)c5!IdV>a z{P!s4lZtHGjY1_(r24G9-x7pAZ;rk13HQ*Oqf|XS_fafoJ=m|hOHuzQ&qb541$dXM zKmI04UExhrQhg&XN4;UdRcH~2_9|Yk@BfYS_&a|LlS-1BM{mCW`J3$8`O#=}X#B`> z){A|w^B=I0VWNSCk;*CF>KCA&oo`O~m-KMLwmdqd9y)}lW1yv{3c zzFbW2L5cM}bA|u<9zCq3F^@KbuOtwwr%&#qiXA}w%$DS7n|bwxdjSL*eMKzw+utLlFM zrws{{1~xl&`fttK&5t8R;cft=2g?}Vhk6B)&n6@KMwpvJ8biZy{`P)%TytN3Qui+0J-DOF#+iAWl~ z)&C4? znOx6?uF~s6ZH+Q#(pHi_I_sN{BED-Xy>Qo{QJY%~Ifd*Vb>c8h1pVD68Q%c-E6rnAhC@+xJmyU2U&wtT{PTt?oCtaw# zQCieD7~j2b2N|#L-5LAcKyMHY27?hG4om>)U=FZ>60i(h32p(~!E4}ifF-b%Z{A14 z&j(imysj?&1_q%5mx59PL@4C}S*^UEFP7)Xb+~A_Sm3SPMEw*lJ<;Oe{RLTbFW*Fyi*S^m zRBl+V2!&11Sot^q|$BR%0$Z>wNT$OsZwbN715&wppViU{d)&P1Q zzA{`ob<)Ixc_U-q&DB)l_Kf8o4b{CG=&5G5X2MFG&iS0M-oO3!VRm=Gfgjtv`drK{ z%c-%0WBajOm3p={&`Yf^+5}mS7DXj|*6&~d{URGfzgI7Ne)6Z+jhqvyMo^`nCfA~^ z@@k=9abcNOsS%5qujNmi= zK1f^h?oW-@S9XG&9L3QHTb3(AVUs3jm(Y!=g?E(EpJy_=9LI9`+p#IIogO(fDPi8= zDd%w#Y$v0f!#(+{OrFzIIG8EXHO3|58~kD^K}(%o1p7vD4gy)wI&>UrmJrYR3Jhw_X*bqu6H-y(0a|fcc0ip z{S-O!L$GDJA`~`U-SA>WuIw&Lw-w`aSl&&`cPzB42Uo&lJq`w;$5r!sEm{}V_j9%0 zsr8@U$78vmg0kyP4}1|*g85C%H|SoIR@Y6l+g$mcTLk@m%5{P5lu#UV?ci(XJ7}(g z9Qh&GvRn}g8*lod>vos8X#Pt58jM=n410l{j8=(r*yhwGq}1ZtQ%0^^edv6n9xT@>fggBY5L;Yq@g$7z(y@+{GtusH zV;GJV)QXE;I8M}K7xW;<_AusWMQOOyv}1g$2mU@azpHYjB;k{3<$i|cnz+jI6lGyP zB*|K;%>Q{ldy;nI3@%q2Z}6|jp702%$>Q(!40`L+i~DFPQNB^Wu)InEZO5w~y7^j5 zVxHaMq*t_Q0SHVT2=CWeJf|z;+H}Wg8S{7^sj_wiy=f(0M`oq}>nLp+Asw9Xz}H(& zdH*Ne1}l!QgXNmI$`g{Tnnu;nJNvy3gWBm1VX$6x4V0L89X)RJe;w^kijXdeyI^{G z>{(;m8Sc+mUUdQ5P93j9P&?gWc;>CUjvYvk%hkaE*FmZcfA_WInCZi-y-#eE)3N00 z^Ey0_EIgMW-q&xu$$vgf#dSTa#iZt)=~dzD$`sN+dJiE z|N2flIYMf+bl6kf|N8sVnrO)Ltv#z|iyT!lWM^1^5 zW@P<-b=>^w+Qn6HE7$L2bC zUWg~Lgj}Vb91ZDEBuwRq$M4kd@tDS_lla?s9#w;2&RdJ)xZLgwV7HyKBc+0Z*XPaq z=JgveJ*hZKgZdwqYvL+TxI(1|iOrdZ525LC0NyOhvu2m2I9zV}lSu6h@xH%wi++3{ z;~1K^+4lze@9B3xnLjsDy1L}KU!vaYF@)xc$+12xSEZh9(E8BF5!p}^ca3y*6d*g% z_-Z5c;`{0K&JN*JcFMJIx}R=$Tj2ZIwm*&gBL4f6=yDZD&-3UhqfxGivC%!xi_O8C zVPo)-m1AJ^K=p`9c$|;hkv=(J#3HzHhm_2r*$ z=<{)}hyUuNrp$I@IqSo|H@!TnR5iHVaa5^Ri3m79d*Jy2IbY>%`^a$Vx%Pi8IJd_& zpXMk>ddeHiHF1^aO)q^XR;3#^s+KC{5Q}Ix=^p?3O*=1K+Pm!{`v-5o+xksvIN{iC zELWwTtsnhZA8zDzdR2y~cH{P)hK)4;LdnwH4A0Myj2sTHLJ=4?biC>6&jQB$QA>^* zKjnone<+0WNIlBj9!m>UAaZVZDp0S<_OXC`dL~ToD{S8vD$Sm8=T_`WZ=M$QRiCsW zx6wYiMM{NP6l#>Kp;#vj{XO*?_y!o?%G<4lRqw2z+rz5@>NJf0y{{hk2G*m=``4E> zS#{;ZoKB{)lPMYH93Gq=mRPr{R-E>Tag5DXY{f!~y7{y1(2pG1$=mbV!)HcF1OMnU zZ%au^^gL~%g~!7zS0WHLRr=v|3KxCt4ciE_1?dh&t_=BzUFyLTdC?*$eThuO2q)$#S21 z@_QR;coVcpRz7MS$=ke)cLw+?NQ^B78&(qc|bjVy~kn5Y0-Wa zJ=7-&zRI0c&`hfMb5cdxb>DoLpv|99`J{0k%LD2~??XDW9fg*Je*J1-zlsO-{jf2e zV1D!c71b4Lf7nIv&N1{U4Nl)%GNe;|xY|6+qH}6?mIcy}!}<7{=v0?Jz9#ALu{G84pVp7{ zH2r_Z0%E%;?$N2;;{gacRiAt?KSjrX4KDDJ5!UZHpc1g++dFJcHTcFqkiOA z>KN?(6X{SFJ?e8jQ&-#5bu=V>_<9kZvTx?yznd4nQm1?o^U2q7!5ri3 zTyY%X>zF|0gZtvT=;15v`jQ`uF(}!tF4xR-oo`E+4P9@TPY#b4#KPz18tRWjWZs$(w%lDf6Z~$1jHQ zKKE68Ohfg_{sh^XVVP0qnzWC`bIsq!j|HgCiuLyR(Y*dNr8@9mw?X|`^WTq&+GTE= zeQ85^-jE!%x5rASV-;^hvY)BTiDLnO-;7ciW4vM>v#@UrH-Fd80>{hv*5B2cWx}6z z>OYM7oa3$EG0RB(mjg3Ky#-FxG8SmOt+ztM{&hTG%fGGriCVrJc8NVPv^yTkPD38k z1hQYC@DrmHnO9-7fO!9QBA0=NTsMt*;_G)qxCXJj_|nsqn-(xFptpd(x=UgH!u2to z_`m+me#p#+6Tf_!S7=(`M7IF1!Fr-!r+IyKvw%7FsGI$c*Rzl1T(GaWXP2R5azaXPF(^$rh_YE{pQro!_W8A^ov_9Y0G~am)&g!+zD{2qO#%8+^ zoSl#5QJjb5o8|skTH1`;w18;=(*mXiObeJ6FfCwOz_fsA0n-Ae1xyQ=7BDSfTEMh` zX#vv$rUgt3m=-WCU|PVmfN25K0;UB_3z!x#Enr%}w18;=(*mXiObeJ6FfCwOz_fsA z0n-Ae1xyQ=7BDSfTEMh`X#vv$rUgt3m=-WCU|PVmfN25K0;UB_3z!x#Enr%}w18;= z(*mXiObeJ6FfCwOz_fsA0n-Ae1xyQ=7BDSfTEMh`X#vv$rUgt3m=-WCU|PVR1u7nt zB-^^Oo&7R8rTII~Ul^~OPiy7#I^1;pKd}xsrNQY_nnqXK_4|$Sh}UHd^Yxp~sm*!5 z;;V0YUDmDtC-Szwuh(CET!wem8h zUU=*&mQj{c`Sw@F|E;>q`kB6JfrgR~b!kgEFS$>suQ3P5dm{P%>ZI{Hxn4Jfw$7*n zT?fkoT@#1%@y6@)_q#sIrN8)%VKvq9pVrT)ulf7fT0m@{#r?XbO69D!WryoiU3IAK z`J^}NF78u&Tz@#cwrL!T^ZsqS)%P{AjoCNGPyI0GhcV3j?b`yT&3xO&4Dnci$GaX$ z&Gs64IWy|#tDULIRU6~t_YHZVu;l}fi z$KNO7HE}+OW&cFJPQKpb(WiV7^U2pW1apk9bH#CluVVt05AKWWqKB`v>q~BIuj(US zvRz%Sne9sPa6YhKANtit9Cf+A`bwYe6ij@g{lxuX&aLY)|8#nF)%SQkKiIlllX7#s z+QOUOWS>A~QM94AIv(hJvaPrCyy>^19Tkib6<5Vbuz}yI*4+XkuO5W z&~LIoA%?LGVx6O7On2g2fa!V?&WpyX>tE7xkk&Z%B^Y z=VPH$L%Y^vagAo2CyoU|{agx#F~-BVO=jO1ZvL*F1^$ikZS6GmeO5y%6RZpSzO_Dn zLwwy=G~_Efmicik<8H_{HFeWl;CL$sfyU8%b-^CT$2VmEc)pf@TlarE{f1nwOx^rj zfZE1}-aaGV|fs=B*jKX#vv$$KC>sj(rkl3MYUC%(2G_kcqXp zgkw1u>nm=O^VrVYF)ZU_YH?W&_LLLxni{OJkFjFZW^!5Oq>T3sG*437xe{aCoJJtO zKHt}@={t{sbURVQYnxZp9*~Vsgm&S0zXr}j^38I8qSjRNx=ah07BDSfTEMh`X#vv$ zrUgt3m=-WCU|PVmfN25K0;UB_3z!x#Enr%}w18;=(*mXiObeJ6FfCwOz_fsA0n-Ae z1xyQ=7BDSfTEMh`X#vv$rUgt3m=-WCU|PVmfN25K0;UB_3z!x#Enr%}w18;=(*mXi zObeJ6FfCwOz_fsA0n-Ae1xyQ=7BDSfTEMh`X#vv$rUgt3m=-WCU|PVmfN25K0;UB_ z3z!x#Enr%}w18;=(*h0O0?{ob$+oU+XTOY2X{2qS_3n*pc#7adpplxn78A7$!e=-ZO`+iN3e3f?td$NZ+adJUHCe^rDv2;S!Il2zJAwM=h~j< zOOM*f1GNXWiSu|lr@rjZ?ORRC**{^U&^jbiU$&`(3g)S%1xyQ=7BDSfTHqhEKsi#P z`=wK-=X@X0GfYW07F+7$BfCpdfB4&aNYWA81sf>vuN9-Ny13PhO|(z0wYD|N6)`qb z<*Yb|-7VYQuH-D2>|7u_E$KFQp*+>NeEJkqan%javRLBB^w9DXPJ%$$K2N>8Uy+FP}7%1^1cUVm@-xjVA^mj1~n z$KW)@ou+M#axGX&u({k0XPG6gu*Bt-oi2-#yQOaJH*$B1&1G|^I33xt%Y_S?Xhr5{ zmsv8Lg-VE=qeNATE!(*?fS%F)Bc$f{TsCjp8OuiT*puzda@LQ1)^l=+>@3rMP?%_+ zs6PJfvo<$M2xOm>polh?9-bB@e?a6Z1kNq@jt~}c5SV%?5 zl4f(uC|Pbf+ii2$E%DYOTcOSBw7JWYWVh3nJ;v&`#>?*P{4pg?D;*+9I}s6=vuKNd zJ7(G=rE&3ZwVNOH&Y}oS0oIS@tQY%1>X#swIAJzhwq>k650#xNbiYB#POVC)woP~B zSj&=~3AVg^)T&%tPL-7;tgTtGDz7yAZ?@Jx;crSP8 zYyGqe(*xnuF0mXxb*`q@!6z4EhwRJqZ7etXWKX(ZBwdNxx+t8;?cc`!p7w8JkMBoP zyp_1#VDzE%8w1TeickAgujpQod@7<8XIsz;oDMpIK7eGW01BsLDK7E}x=yMIv`^Q~ zX<%1zRDbDsil2_*aP}cOVO=FIGT8hH)(B)n&MT@1ls9bv`spIgz|^Z z;d~NpFXj*J^LgSi5TB5)5?4j}L*s{`1N7~=ar_fACPIpB_ShR4V}CocPBRYKn%Wtb z8;ulj{1a!*&X;qlje=a+PFpd?KwAa<_6hn?x;wfzm8b*VwWhJO^rLOFjtq;CR*mZY z>yww2Zo00estMIs(vRh;)Uyq!-z4h-Tb|Onq&wnmPM15aB+Ds`+0xurr$Nu{13h;1 zre}{)5z=+@4vlOb-u zp&d`YE{IIl6vGccw%{`@=g7DS3rFN_1(2`)RC;($< z9I20=bQdLbNK#-`n5AbC(sl02Q(=(5zGNJ zQdtAGfjyuZR2>Is%>FINM1%7+*oX$E5RFZ76C8_6$M9L|fD3mbv1BCnb}LEhft#zv zm}iLSg8sBO=7R@Hk|kD>dZ$RzrYyu;CP}^4OVYxJF;?F%Ntd4%BF)VRkv_gTL@H_= zDxI@9RIwvWv;?a7ykDobj@mtL2kAFKIRaG`M?S;hxE#gNxqKYUD1i0}K96MV#N$}@ zU-v6v6k|V2wxjw$Wst^J^qcxA&I1%5#j!mpocFaLT{!&^!^M5^cyqtH1!7=yWByb> zs`e6pc|rN=&57rT`+TfXM&-unsQwxqr$=ENhtcPAxD0wLdvp##VU#xQv(NECq&WV~ zKFf{zQ8=f?Z4c|q=a_!Ovp^J7qWVM6)3&0&=jUlxx7nLVZ5#EO6i)LU)8akj0m^UV z{WU~Vl%-q#Gf%X>f%eI%Tn&|^L<|RzO#1MkJ@JgG zU(HwbRL2oCeqp&1fv^ci-`K)JpZ&TJRkdB#fqd#us1BQTsG6DTMG%EpxZLlX;3@Y5 zTqR{RNmhwW2)19LQbz5k*pAaajS(mxsUGn-PRwJ8lxLhTlvmuZiMEH>bY3j56*BHODkl1Ghl_i(l%5~4W5xT| z6i+65lWPyC9cH;A6gFw}l%%9kxsA-nENBkBhv9S-7UEtq7LUgl$b8dX)s4j3%Ph*H zblI7a$We)UMknd@JP2iSaA4&U+_&Ace?+@2VN&!(XC7|$*QGP>riW~Bcm+YxljVv~ z*wjMLw0!i4MomRM_Zal_)(>BPPipZQhi%cU3fYsaYLs($@Omca=EfD5__C@vUZ|Ml z-<}D#he>bUcG8v?RydP>)H0s!$#T|@{aWkk)vEgEY0=4geT{aF*xXWjfA^)`I-Ik# zDfi1C%4`kCT)q?efh-sbANn{I!QRTC(Bi-XIn!(@w!en z9sy#2Xwg@Hv7AOv_OIu``@^K0`jwoyt;6(~?;})Q*q$u+XsGVhUQeS%)%e8sUv@%Y za7+)9Yun8>Lur{kX4M{qSBg z>p^pgG^1#gbGSeK0{26SRq2TJX1hU8qa6=V3zIH=<H^k>?P`>Bcn$RR)ek8} zK$rhh{M$8UZkQB#q~9sSZ@+FvZyHR)v0YiNNS;8qsAt4f|LuEuR+zM}(fPSA zUDo5iMUkp5tS8Go8mfCW)YE%E1dEF0bbA0jcgSJVJ12jWeE;_S=Na{6dHv~Ww5S@h z*bk+k9U|weAKG|+nDk<7+K}?pdskeno?eyzEZ4+UoW8RcRw4%Ohsq1}dKv4x zWDAp)+_d!RL(4wCA&VXy!9@XTKUq#P(FLuSce4fcyq=mKhR2uun{=UlzCWUU<6HsB zyg5-$=TIDcF70zT-Q#lnoIXTV$I?C@%f2Y1eRg8FFPZTe<8MCC^#6Mn@b-QS4Rz>Q zFWo9o`4r2jvFwOpIJ8#I7$-&IO;)SO{lrzDY1CFX^StBB0^aJ2cm-6ZxX$oCg>yX- z+kFb>GAQoT@$5L9e)B%XCH5_1dNg+`9!KYq8K7(sQO9EEW>?~_mCO@eL> zMLB+&u7O*?tUtkL5Z4ve=|9LLS)u+PVEIQ^zD@f?zg;og3ejGTC!xUYtq+lFR=6ewgI zuPxNRW_uYK_&5r}HzU>O^}*;~s>Mg|wH-0c7nWbWQJJUQim%j$Xa0OA#W%P2;lCEI zy#Iw)rbf|E=^PM+Ez1?5ut}1Olw~56uMj6FDimKf1d^zSUnp^fF3!-DbY z{`zD<}Yh}WX59}>TlB?`kbk&J@m18>RK>mB$#82@gM8oTaf^_=f&=0bvzjZnbNj&*RLa3`F5Dp@|Mse&uxmhaIF?iANVw$WVt4;@~W*1 zpsY_o%RlHBD5yk&;`jwgOSAw8jR$GmM~=pQG&UsNc>G5`JCgIUEE9bSCrnp!3mEe! z8&Obc;kiDxtI@A{O4ZNcI61`lo8|vy-!8bV=F1* z&oq>GBPp7#CMvDdvdxzr}tUtTQO>r>HZym;i0tGbRSRm_4KMV z=}oWlw+6IEDZK|npP;k@Gz~`YqtmNwSeih2*PGgWTB|P#bON107tj@)4Y~p98+w4A zpcm*3s2}PJEP&>EqCr1E??Yl4Cke|PNVGoIU@!#G#LT&17#I#PWhP-7PFa89Joqsn z7K{dQUz!toq`dLZlL@5sl$Yi-@0@TU?UM`D zwnn)k#wLwcf5jS|=?<)KTlMmMx}!u}!Al%3R0NT}++p2SX>F%I!|`+aMmdN3NS`JH z-P#gj%AsqqWjh>Ms<(qQt6LMw_jZskS#a*`s0SmZ7t^k?T^K&IYbq5$IMRda6U!B$ zu<@!#lC`wo7;Bkjs?DA6C~<3Ru__aD`*3cc`a@b$ouPU{b%M$~m0>D-R3<2s9tO0| z$5PM_N}kh5k}4ZxEi#<^G*0e=0nyc{OrN)xq#_jjQ&CtqqX4yBjc}=@q!|iIF`%d zHiI6GpiClxEAr>dna|ZVEyq;=KRi0Q!|b87ZZYXcOD!u5rmm{aDU=vG29KBd`*% zUDmEtpL^_p49%0$hN5}WtsD1to1LHT%^R>(ZRgcvLU1I@ak$Q+J$MpSSWQ9K8jO8fmsYvOKyKlK|+uN4UjCNtUPC5MW zs)bgL=vc8G+KBY&x?_Pa`=sZbJT-lH(nPWwIr2lWWw|00HneQEW6WqvMsW^`M_NfX zEzgbxwew&uS~fe&>XPYju|7?^TyF>Cb0IpuAoKL~-yPb25ABmv^=VX1u7;8wyv%2^ z0+!gEoQxu?x|p|mhPU?wnjnbmLXcw{@xCI|avy(>4Nb_sdu5+mlM%;L$xv z!u282-E*J(~pz zY*{a9wLveefkU)cKIJzGry;!aYg-w!Up2HHC zZ?)U;C}t}DqCieUg9~l66uG3-~YDj6(Su7?cH$C*KCVdW*lsk ztR`QTKFfuqmEG#;V=3qyO$Y7YInv9Dl{TMFhyr8}dOoxb`tUkPH;3NYhwjbAd`wsq zxLiH`P@4S9wq-kTs^VH{TccbHmJ+P?ys1{K?~Er}iLP{INsELMERv{|B~4{ZVzL^B zp`o(~D@uxb?F&M$4<9|+Wpu}!S2~~{h1H9c&*nTZATc>XE~?KzQ6S2 zP~2_V%5tB&@x=D4^!3c!c;eDMy;|J1>6O1Z9Ue~@~V; z|Eu8mO+R=G(722o`Iu@@-nnTDpPF(mSJ*Y(aclvx-%41o@3*L~Qof7p|7Z8QqVe06 zm(x_I;H|h zT7e{esGVgw>%qQWAEhI&n#~k-sYHDB*{*PXp}Iqmo&?t=)sE_Kh?V-q$I!WaK7|<_ z#qnQr;y7XJHU7&9*~Vr)xWBdi!^hZ;s!c=>=LIuSNSIkC;hjR z3v~q%i{*x%V{n?rG|b=syamMeZs?}K<>sQN#)Mo}e%Ix!sk+QhOUWqb@Lt z(FY}Yf6{X_a->%)Y+0@dg^gY>eLL(;CsCin(1+rW1>}3PQ@<$$N6TI zbGTlg>UI+IjLs4JsnYBG+b93U2r2sfnV$@rws=PeJfk5;`cOZ`az!X?^!n)SBkEF$ zbNIgGF!T`ZLRy7`X=mfv;d`(4rRYPS>C@@mtE|hp&rtiH&?-3{Bf4~JmSvpNQ9`dL zraP^6TI$|m$NEt?h|?|I?Em^Hz7KwzJ^z1Kw^ekY-=rsPjdDed4boMTRo^&QA3L%v zuIg!zJ|Cp(1MBhX?t6!A>-If83RWEJVU%+?r>W^d|CGZbQ4O6vDuU4C%akjhJUFuR zUQUPgFv>Zc6V>!k{y`;&g@PtxzC_*-*dFh0j=XyGzPuMX9oEAr=WtF^(<2q1g}7xF z`p{!z5PF>V)YCV9{CuyioDS<@lyf*Isp+9EO~yh+4+}k#)wN?iDg)cY^3j`JRzGp$ z#hec7VU%+?C#kcCPi^$&bz2bnJo5kST?c#=#rL03%q0{9SU^z^5s8Rr07bx-0wF;{ z0-*#E;Ybd0kle+)3nbPkme>%iSisn$qQ;*sSOE2>#*WxxM}MeTP{i^_QTc!0?!LR( z$(0a-fb87o?aaNIo%!yYH)Ut1yf)-)QSi!IPLJ`ZeD+uHghO(iDwovTV#}rB#pfTG zGT^owI332J^4VX(q3cORH0JhZbu;j6P0629v10o5oF3y*`RuRY35R6h5E6`Gc8iu@h(6KaSMKg>?<+HznC$fADRC2j4SZ>CXn!dL_Psky}rr%d4 z~(i(e9(LHg;GZKQBApUbUk ztC;D%kM5&zG{(&~oR-;zC9u1fpY0K?tmkq(k@#{Laz_d$^VM?0|JAs{l^^0+X4jTL zOZsd7^b@f@vK=XX@@I;qr?KLoxFdyOKHH3g(u$Uz8lLZy?dF7$!&~m1BLR6Fe!Vj8 zT?9xpuXi(O+LdQgP%-k4C5KI)yV3Z9pz9WW6=gn!k&Urd&yj;&S0=jgb<%puj}OKaXw49gPLK=p4R+8P zmfSD`x}D{Wkk6n*Lz-yq{z*bF?6zp?d{&t5!X8sQ|vc$lwqL)Vyi z21LeVe>%2&ZhB|v=(>)#PdV5~lJIl@D&~if=&qP}2Ac86dQ+?538yy)o%7hsRSJ6Y~vr(30o(8*9@sLwq>CG~w(+ zS7;?~bJ|J5D;ts(^XQ#|h;p9R*3$SP^^YhFxp_R1=C(5NJroD?I8O2-J`Za+KEIRSd|7cBg z<2@I2Pn}gtK{P{QD5T2Q*tk%opY8WzM>*Q1VVtYn@5;jhAu+m8*bwMHPftPICEfp7IKbdo{z4xaMZyaDuJJZ?+dLLju<6%2g)jKk@-T(5-u&RQZ zvAM2snOUt??^F9q{UIBO>kqaW3)^yiA1Mrn-P3LPeX;7*==za5-X`K#>~;H0@z++C zG4(M>KbWt|Q__#&?jo%D^aVzHoz$-}>#1CRy1y2?{QPpjd6_G(yZ2g758EffbQUU~ z{UscFU&iIjMwxMA^9__3?D|wvgdHr)XvK573!D17CU{DK(=`9M7P!cyfk>~^@V zZ3H`^4hLTX8?TGeB$Hqu>o8JAc?;>WIH0PgOo{Ha$ zttaO{+nD;}AMICi+^i=mpZ!C6q3!bH54e0G7M9+70|AV}(x6pHXXsuTmv}2Wt}JI4 z@z$qDCy%-LKTFj5hWU(#?GOlT>Qz#rRXD~=$apW+Jlcj#KD@uktt9S7ftKIDIX<%K z9ZELg^i=lW9o=%iY(&0L{l@hiwxrYc?A_S4o#?aR{Rimzo;u@@z~o^cR`S3&$s`{2 z9P=rRZ1SBmUD~@O)%?awC94TENP9~hjyFZOM}Gs(pW`ko!*);wh(yj88lRNSPy*Tl zBae4it%Hv4dsa;`B_)*K^DwnJ$DG3UrAWysn^B>}%a_ z=FuMx@x_b2ZKf_Q?YQr4cN-Z1gK|H)=I-!I=MyE&{Hp6_Fu!_j{Z%RJepxcR^A=6mF{DJ~8pyE!cLR9n7B zPK)_`znm7k*^g}5kUyDl@$tRv&o=Yrd&rOZYB)}V__B${kLAZ{vrX}G`fQUQxyhz7 zE%Wg=s-duK=>FC+k>Vo0>c>3hv%S4oA1hAwSJP)c*|NJO z>2p4APdwY2t{R@7gKhRFY-Civik1KCp||hKadFz)7h5QQ_tUmIN#bSQ4-#U`fD|fF%J-0+s|U30M-aBw$IvlE99afIN?)_}A$3 z78+i%iSs87?mu+7<2IWCjpr>eUqu|6r9dm<%3a!wqFfJ-3v+wr-jMVSs zbWS>ry%O>K1o|Gv#Pf>yznZ@FzjY-b&odIg#hyRXxn|6JC(a(zn^EZF=!rt*v%jP- z*?wcDOS-dg&MfSKj3q2Z10A`Z;kh}+oJ(zLP7&QJ<5~<{WYR#S7ZiZj+H3~VI_2UA zlf?P&uHSO*pO4H<0gnuAR88|qn6ELVOImrrI};PqFh|>03c^$;Lf!#+CAaW?bqz;e}iF66p_4dh42^P1o>wO@|w}m@h%noZEzpPg=m8H6WVr z&~0+jPpf0#O8ILqar~g!N8NX~eVx9Kw|?F)$&2|K80iuY*GN~un3h9QQe-A!qiCu? zj4y9pLfct@?P?|ii7zrz!6a{6@SE*OJe(yE)V~5!&DUy^CRNHyuTuM zAj9b^3M(49d?%s&#+pxe;_Zj`xc0yIey-wRe#>x}M59Gfg)5hz)qk7oov`!X`(JzA z%!1l2oW8ye|6uWp!e{@W{-QyrDWQ2zpWj8r+MnjH^b|&1H$wF>8M51f==&JWfusHe z@ko9$;jhLg+cK>uff@)~p6^D-Z{zqtOV+I?;_Zq_uJ;SJn#*sKbF|0U#A(wGd-mHG z%747&UA=@+{X*?C^Hng~SrS<0<#LS1NrB~P`i8r(1^{K*RU|jXcHBsMLi<%z00*CA z_}KIFlPHZE!=L&Q-L+jE^nMrlt?HYg^}SYK)lOXSY29g6lWgLz_P+Z&kDBzstaWCb z%*Sme!;P|IxVNyp6w7Rk`Xk zkNGBW_!GpJQR1dWK#tKa=Nw3LptOiun=9TFrWVy|T)CdEj-y>MBFk@KwM}ek_ul=Z zA0D()#m9Ut0_oBOUru>Rz>TeCsHZ~}H=VgXEoEA604GHaCo(Jzd0dJwV#E~^%z;*zSG@qH;*&ShaRJ=O^Yq&VK z1^@QU>DiWa2&b+^I%3%!?iqG<-uB3CSARAOpCtiH0=u3Bwza<9^`5{&WJ$o1fF%J- z0+s|U30M-aBw$Ivl7J-vO9GYzED2Z=uq0qfz>DSp**_MZ31vl?6MyjfQE-aY=e&6EO?xLN^7jV9)eh*GPhn&e2^S`rg-j=1f>)e$LD02RgTB>_o5?WcGlKaGKdYcA5$&PeI-ghyt zXM)(j<0In3hfn;7znSwo3+Ce%lacf(+nrn9JWyjMR1W1zHS zrhbp9{2v}2PxsX}v1D-K)RzuFWgSC%->dA89uL{*FVs`H6X5!s`^HkQ}TWB;*-MuS!b>~@h%k)^C?c* zgr40IHs54Cs;np;xm`(0Hse#<-TJp|;?$$(kA82(nXhr(!Ft7f85_AJeEB%bL|3N} zQ>)J9ErDgds*Qn%;;(d1T=K{FU8pE%hVqYQCaZjnjY}wLhc>;>IP3+xin{0sm0S!lLxBbxFNSM@~^qu(zJ7`I`6j5aqy9(#fv1E`OWW<6q?yP{#dY{)X zy1eSXP7q_4{giXj*r7kNUU4~Oeh`r1kZ>70#_JxkK3DaRo-W zbvv|5M&+}=ly2HAOdK`NV#AEgkyzsTqzLFu3}vO1b(o^*0tPc+_@2d96(xe8@-l+Mc-k(;l=C z4uXGMjdwn?mMT<)AC*~a;U0!+r zi5DBs%n&OctLl(obUL}dV}7&o$qhVilG}szF>q{rBwj2%bg1L=fwdVb4(7KAhmv;` zM-7PcuR0~Vd=@?yFFrV7j5n#^q24Mk=2M)qiKtJqd}tA9gglh>z59UZ_-tR=MCIz6 ze?0AqW8QgAuK=`qnA%b1%h<@>Jba<5pa%D_yy|1%sr||(HoUd;FHc$Z*(x6969(CA z8=j^aT8GFOU-7``^2%Co6PG+IzWjUUrJtzym@i`^_cr2-oUum4a{g{s@T&dXq~-CV zX86V5{hisj@kyg$8r2B#w&@t|NNu z=39nSKcxm83i9W1jzbwhE8E-CZ`q!ETlq2m@#wggowkLNh9aVO+ks#rr z_L=#NgYD+w8Sf2+GY*u|&X=LXS3|O+IMs4TJnAaY`yG|PJ-JT8XP=Rw9%9RtUDKgNYl9Cpod-}kCN z!bpg5FrU+B+aw2UMCJ>=^wOz^zVgC=S9>Lw`{DKsvpm%C&gAQo#FZ~4kGyC_`8uaV zPpKCyk_YoSeYS)1D@Ih5xqRq}djif9ZR;v@%V|FcLK>gk37y!Gv+0Z*dynn;S$tTWa&x(_%GBrSq#_p5142c5GaVT+ zH!!Hb2xLL+k7Xw#nkxkt5&7UbV z|DJr&A-&AFn9q3FZXPaUyT+O2B@9l+m6a7;US+dv;^W+_PU`#P>5ES3X2!*Q#=~}4 zT-qjO#^)++9$HgertyIoxN2r&zo1hdpLtC01J6?B#eBxYc351Y#$~)W94^O*io%le zB5aphf?a#kW@4iz6o*3WNoU%hrY_q&PmRu&rSXc2Oq_xI@`r<0mty|Rrk)3$KDhd> zeGNdYcg$y;YzOgXwWr-OnIYgPhCH` zeq%o4V!LJdCg6nm;Ia2wR1Ff&Rj0&m*VBf+o^{J1e`PTauK!d%`v-BF`WxAvvU1*u zOLt2HT3P`^r9Ic>Lv5sOFoh`$1brmBO65KmpC2thiCpf=Mn~6&RG&?BNqhdlQ7h)f zsrtZt#?N-}Ikrh3XhW>=m1VA`->u~O%a#)zZ&|rb{4~Dj8CPF4?)0VC>xihoMfE-N z87JF8yu7cN_Wd!}=bq*EIKtHt#*HGe;3Qh38=RWF#&c-d}(JMun#VM~`>&nAzJjxX;zl=t6W9rDhm&xfk`n9sP_Zi25l z`}9SXu+p{}3CYi~F~)OLEw%~IC)w|=ey3o%`W(z>{A@StIn@36TJRjJks#~Ks&Uct zqwGhUxb4!6*SDq*zFgIF<}-e_oAn&(zKJbYf78B+3-hBtPt7KqIB?iS3%Wf#rJwpd z%;)D|yIIep=F4_Gk6h2Ej*tF4i*HU6%g<@JB<;Vi=BWKA=JRu~-Q;;p`zCI?LdkeH z#=zUKG)cTV^TNO954q`==}G4P9`hL|+s((j?e%=^gy{0!d|Q(Ecw^Ug{cj)A^LNbc zCqv&NsQl_dWs8Sas6bU z6nYLCmr%z?=#Dw#&Kw`zvs zps!piUt{AE>L%jNptQ{EcLSpF>DyJLf3eqRIt|orsm7J%H)OI|el(s!p$ZD(#f0iI=C{x8jNy_C0fqK4C!n-bVV(d@WMxV#ZVI4rohM3|#yz9^u!52*;E|zkQl- zr#$4oG?gQIc0x#*NAKK8AbP((5Y!t)L%Sz{#(-R)`JnqipMdO$Y#wMm=qyA!3?1}A zh;$wzJqVGeBhpTY^dW4{JsXR^uErScb%!GTqlCD2m=Gt97Gh{2(m7v>5?)tQ5?&_gf z6l56Aca_inW;ut?cUp=tE;CEZcsbwmPK}=L8~fSBHJ>G4`qc;TWqzl>xCHZ^`HX{Y z36GI%_>8Z?4Xl3~6&&g~{>Fn7#E+?G4f^QG4HNe==Hc?V3iCOAwuAMnQkBl4x!kCk z!i?k3^kG>S-;b;g;u|tGcD{Yr_hZ|ad1t@D_v`Bj_Yo?e{k00R&^5{Hn}c!vOt+^9 z)A_KfRiD>`iGF%bIl)(gV-Yf(B{)FCH2aU^sexXT9C=-`4k z5t%d)vQ3Cfu4#);YhvLn732AsxCRj|3-Wt|=!&)RA6V&+RL&fMGe^6Irzalsq{qI#eC z8dJIu9t=F(ZhCUk+WDtAdTRm;rO$jRY0YU) zUwd-L#2mum*ZfWOAD)j)r2MEWiWk!|ZfW!6gsLml=V!hafpjsaKcd1_SWaCCvk(wo z){9h6bQ~0Y%^weRzVecrM}2PO1Bs&-^n&>mMmB^a)Lk+3f;581nH5B6!c6rD#ZN?Y zo~R8rl7&lm(|-;_Hnmf782r`zWt-fw48>&`O9H#P1ZtqDYP-vrsl1R;b(#7ERGuue z<0W9#XFFcTRto{I){_~pgHeO2^FE z`Gt$a;#m^-CnO-x=V(;lcmL4O5T4$tt@!krL8aAsHu25g9oN0Swp@%g6q(2Sn6F~a z!CoG|O2^2&364CR5U2l5E5Qm{ZJ}JgHfMKW=tD&Q9JiC=ka3lH&F|srcm#!?-s|fR zf2&!k5AWf>J{;bu37^7}k;X%%Y1OotHyaZ$9s2xg$w$A-jLU|3-DJ{0B#v;n+AcW1 zXr*}J8wy88Z=Vx|%GZ5OxU~61#^U4f`|IH7LTqrS-71e;H2PxW+IOG2!*74pHjdL} zTq>XaC3!{1Wnfa@!|42ELuEKh%if6+s6pEDd$KJC7HaqUgZ`;Jl*a?7W8DIoNaZZ= z0IXMix5t`qZI}I|ht$7I(Re8HwFsn(q|bUOpXheYqvCH~)?iv+kvuOt4vIc2e^7jC z_e1~Ur0Clijryy6_HTk?lDlY@E6@aqTAt{88}~&hPuR`zMza5@{EL+Szm>1%4~@I( zc^|#ZSo!hKXhbcN;qM!pQI4s+aD75<`ZmYwfVx-5i}I!II(@dO-^au!(-}nd3G+3k zbdkz&4klY_tEBKPlU7VgQ5`{U!aUFIe(E8MJbUOMT*VuPaFTS+R zG9Q&L`v*6_K_uMX^86R-uaeR05#7BjT@8mWOr@M(C&JaJ6U%2oVFS-O|y{bk2kx2v5_>Q_Bx9(J| zCwVSDbJDQ4ub%Xmo(nvl$9%e9Ho^IOTmhi9r)hhkdSJYlW)y3i`9ra2j{-6^Akv#| zlZ$@Jnjalk$_1F;==EQu+P)IC*LBYnr1OmssrpKZhI@ z^Q`(_mdcKCt9nX(l5l#e<|Dm#@w?ZKL1x9eEfP@khw{({vdYl5NO8x7twPk??usj7 z_v3#my|2f_zb;(LWs%>DHW_>s=@?hQF~aA=x&v$mweEc;TY~nuGSy<^9o{eSZH1d<_ z^OlA>gZc|2mYS5fG0>Tg_NdUM-7k+{Zd?$;Mg7mJ9|jBRHfCKJFUDro-A6ZU$-C;H zg@gV$nCm9OMNh$e?XPqRw)f;P`lyhev3oi1HR>2+9MB_b5h3NHyxxhhP`ycQB#mX# zH%waQvL6UTtD+~!4mu2U1n6kcU=VF2H4-!ybQ;JFssLRIx&`zf(5s-YLGehpKWHN8 zV$jo|KR{_{EEj<`fF?j$UIXRhC2<3230|yR5Cpb85jm&~%F+3G5nwZ+On(CGj{w`Z zs}K+3YxqJ89yik3se@r3D#Rmwg*g5w>>q@E2_DBfs&(nWJX(l%u-0M24Dj$4IJ*k( zk5^+o)!jmT_lywEMl6Z=O^DCC$BA~SapLBZI8l6SoXGwlP8@$=8!>fe8}WZnwGrnX z)K)CLqOBOxp`Dm}b35_+$?ZkrmiFTG)q9CK&&P|2jW+RKw?r}etPY}apH8Cu>&{}o zElJ{)f^On}iTjDe4(cI(zNM$Q=0>|HKCF)zKDM7&J~&0w2XuwBbz6WIEN^93na90p z?2z)P8jB&a+I6x+_ z4sY#~<+^>~eJWn&hmh*7?Zhj#b-tFGKK&=zx75(RC}P1e3yOz$a-39G%l|2iWh@Eo z3<;>^1yz60G)G5C*DYg7U{8@iJsyDqMI}+}%UfJLn zc;c9R6*u!`%;erS+@bF|G(MMfV{ANi554u&y~9rEbA*vF)lHqyiZb6|2d&6>=%pek zK=a#$CS05}h~AGbXmkH;RScX3pCpLf&z^khljq{D);jY*L-ix|&w~6QLfsJ=CubyH zesIh|bMtvIqGkOoxXIj~rFRbM(&A-aRV?vm$*cYi2eG_INVNcR_>NjV67GSp`x zIWk{kN|(sEMmzn19QrU7@OoVO1{vF2dhia3vw?||X?{+35Xl9Pti7km`I>S|bop(D{Nna| zA?MLMpYK+UILJ`?BtPbBOzF}R`O)om5Xptc3pOqZeedl3-pQqh!mkEGB7gp#NirdM zS!UOefE_S6|B{x*i#~bwfj_Q0A${h`9uM__pWJTLz@JPSh;+Z|`o-G*F|{XP3}E`N z_lw&*ix0l|XyupPI^BFI1%M%)C%t37#*{8u*b9Ru^cx?PN4q_9{EjTAzZlC|X$4Tn-T&E^{_795(X=D3UuP4Ka4(1zxg%ceRh2dWoCj|BjoJ}PTh%Yxm!q`|>m|j1vmd+pKlxiGBmucy zZb1H#Ndu9*)bYE9>yyM3d-}X93hsWiiUxjRs1HE;#e9t^U4rd$v-dZe2?aFwTPyA~ z<4R56TdTM0kHt9n#8qch--Z3(x*k3F{H0yjERWN3dX9mM`4S|}nWpVPz;x2RlhWk;}G5WOUhEHp5vkCW) zZ{3vs%EjLvZbU%+CXyrbIbOEYorQBSUOx|eeH)wMXN<{5VfD^&yL2d8I zKbenIhPXVbIEZhVrV_C7r>RVKB~CrSaC=&{EY$u}SyRU;8{SS3YmPYdg1x)@4|;(H z9$=_UPm;ndkNyP-->J}UwrF# zDsJXWkTquuaBKI;-)S3S;7a~5L9{z`Fl4kv=4pZ37TL4L-k%JuFTh%(j~GS(|z7~IHO|QhAmC=c^m7@{XZTrlgBML z%-)hz{Lx(lXxxwt$+r`(%-5LGB{JS{|C7LLWhww$zU zwE1|g;P^3(Lo_0NN;eHeHpNZ-AYLyDr&xB;zQ?-X9lnL-Np>7UGM~c8Moxc1SrIno z)O0ulGo0CV zvv}4+dl^RvYV|(#vzf0xZD{H%niZ!{-(DZv>^rn`tc=6pq$L?Oh=A+)>GkG%Ud6NV z+XS(tvQyWo^KM$8;$i-F;%Rc=m)wu8dont{h2JNL?|&b5!Jr}b5)~iww-;Y%4zD3g zOhESHc+5&8;?^jC)b?=u!?ub$+*JExq8JhP^<(&B%Q@RA- zPfX+dq0(7Dqej?5S`921D_GJsAas3 zG4MA0o**XmdFA;{TTfj#m?nV0uzZ=Xb3@mb%NJ*h;z-?S@~vJGUA~+DOb{2uPj(dT z)8UsQ1uyeMNOjkC;f*2RAuFTfO-3m^HS?jZfunkEy-C5#{MN!7DuBk`1z3hcam)I! zJ_g=`wuz$8TT`BXer|rkX8qBE`oR1a;%!nL7zg1t(Fhsu;#JY*TfJAJxbeVlbDzof z-g&eEjP;lK+lNFK-ygej`DN=fA5rAX{1)TYiq{$Cm`)a~ zfy0$J8Smy8c-MDK6t{KsJ(RZhakQL9Gb~@`Zy#Poz5uMsw;l;_zp?JQ=<;oxkR&Gb zOMCU^helLl*^g!zFY^s{&}wG=fCF+=Y?%D$oa>&YElf6-If`5!FV4c6ATp8KW%656 zG<&^!Nxv=RCPTRCs`529EMr=WX#Lo zZTT`Y#~1)&Jj`btY&Qc>zP}_Wp5T5i+Wg-aqT{L9FHv0ZzXL}%woNG-PYc;#sNY5X zDduZT=@P^f=>)pbP9LTp1eDV~2THF}T5NJTUIm=geQCcO zq&W*@f;bJn&JA6IIQhI5)7iS=L548uvyD6fI$K$fvj!IH-Siiu%XKyI{#`L^_Ivw% z)L)e=^Fv5=R}k+u%9Z1h>zVE^MaL%&N)(Mp-ZS{uvX!1NH;Xh zVC)Z5jnJ%58x-^`Z&l}fCO=ngBz_T>y^#zXZ0&) zd8jzLr=TBLdd}9D?|y8`@>}$L;QEdE3XD+u85M^kZ6+p9YWi+OAh+xGSEJ*~8k8uy zU3k(BXB?M)k@sd@K8%a`EyP6&Vr5vS{zkomOZ~21F*s2ieAdu{_clE|a|#tq7(z$w z7V|ZxbP47ge^-~!s}J8CXm`uye)?-6c~LHf`@XYZZT!5VI}aVqNz+&f&0JRb>>mSH zB~}e*d;B;yRi6-;QC?b3d&$go1lX_mlI2fnO zXa82f8ERe;soZa>QSgTQZYUo3sP?{3JTEgI?q8~W_NQ-!D4~x0Vkh>t;(v5pWC?a^ z!1ijGT1n5u;pK8s@s?SB;qbh0dk@={*#q>#ibxob%IEkQL3lj*t`hWtv16-)21EQ3 zw$>OYB@98J45$TmbK+=Dm=+|x%idz;&n}xa8Zf#3wy!alYxTPg-LNS0>-S5OofA4v z(VvU-IT@vg`8qdrZBj2vQ?_{@h|w8&F*ksyL6qEYS=9`j?*tb4jwoCHoQjkAA%wcC zr8qerI~;_Mz6Y!YKHh)xlCGmpqqIP`?Ym3yPuDNgZqp71u8l%5D zKDw%W+^(7C;2Z9&^yj;=Q3@>~RS?<{3+q`H@Ufm%E!i}XWYb{yYvUX5Mc0$Y6B0$r zPal1CWxo%Ws(QkFL}xNh@Hc1w$8CF|)Y6lmqcO&F*isWke&x9@oV#Xxy!sr>H$4RY zH0wFkeIQ%#992k*^{L?fP=1g;@q5nnwr#|9KRD(N$w(ASMqGC4qF1XAus>>k-(o&) zGnr87bd2!KLWhmcMW(5nj;!(H^YTslyje+qJ(3uR*rsEHr#l+5we`Mlb-uCuk86G9 zoCx>ZR6hGRkz-nsAG=X`NNur@(xDw7pv?yJV;!3I&#%81>oLgv%7u+)`GmtaY11L` zzr6O7-W^92j8El9#n%jQa{t@@L2O)ytXz^mY06QwtXeaSOXahFSh+%L*i1LY&mw<4T=T4z;AdPU6HPOAHMpXGOoN2W8=!+aOJzNtiLz7oRD#;{B6R8&E@9d%|%8g=ijQ2%=sr)$7_1O z7I=R>Z^TK(nTg{2>(k~wJNLG_<1W)vCS3Hs%zVbfcG&z2$_oV`tw=^C*5XF02b!~v z--fVMm(wR^TBk>A%xFIXT5~o4lnTlRm4L1U)q^&IhC&$@gSw$1eH3&N%J=msDZjTD zf`$%zA<_Ye^k_sn1CjPcq?`K)5kRD~Q-$~nk&Z0IK5YwxC|oYYyq|h^PGcao)?A7vlM){_fI z|6N->e`*bG)eP&2%4h%Z`7zf;FS&Fi5^W}%Ry5q@!T#a&p+v?bJ~8WuTJPAh62%9l zjyArx&s$36jSTAt^L1|M+62$|Vz;j-4>PGM9eQtrmh93hKx|x5G*DFGR&FP%fQQma z1CdQF0abYNIVi3s zHAtWHZ^)+MohfeFf0g7vqcpRF>c3XJv&Y+QoRXPU>7@0}S4wU8unV_LFSW?0^~wPrl4rs{Z-KZ_SL_IHcg z>_p*T@cx?9o`0`HPwJ$?5FV-@n6ELVOAya!r#eQJyCB`_04^~X>TH|`@l{H51)*+9yxe_fxNjMX+T<>FRNqZOV%m)-u`f#KW}?z z;)80wFdxyGOt|kIt(-+#da}Mx|J<+Fbj{R*dCq6Rmz zT*Vi$@mzdzp9eNRdf;K49^+B@?B6`OhJ~g@VaJv5Y5TtdAJ;#VpBz&}Y0L7ggFjR- zV*OY%IZ6C^O2y_pgc|W2XVC*Fl~MSRhQ*PzemQC`oEAo zsomy&J@5OvesrQ3u<(*UhWy&4ORmzdXTAhQbB4#Gb-+U3ba?w$N)yESyGp`Catb#- zJM`oCZ_OMr`x|&`hHz7_L*;91T+(q8(i{gyYVsU-cP`W?C4{O|)Ay~cb>{q`@e3_} zV;y~MKF$q2{guBS3$z=MW+cG*!+cJc?eOvl<_~@1qw3N0on$R=kfAif<%?~6qBwuk zit9f-=q2w2C104YMIc?mvy_a)j}M;nE4 z&2#9VNVTA~5{^3HAVc{_daTx)6{jYNK+c@pAD=mO44N0supTkrUAx(WJZA39|QfoHk`g~d5ex)@<~rLRYfEU)6PWA6tfUhbPS=ItAd z+|=tM?W*t@==S5x_UGZOJ5RvvEYa}mG20E?RL@oeH`lYiii^D@yDGz<#*b|4&3Zuc zr|#mybi6Z69`;A$q(m{|oijhH`}B+17lKcQ<A9PcihHo-H;P?ll-#QUc-;|m-%3s z%y^&EDM6rO`E#(UsLyOfto(^n~{F7k4&WFWFpA745xc=0_J@<52nR&nZgf z2RO!|64bQTK%vxsz(Hk~wT!dFUzf9V{E*m?!5JR@B2q~Rq>u;@Ht(!!{F8RM?q`H z4UDq_I5-`~S!?)Hf5-k)^nP5eD^a|?{LY!jWh@*XX8_^y&U}L%w8G%b_J@^hwr2vi zukagVbE6G;vjUjfKj4g&|2a>-GWMSCcTdZ@^^FM{QLP5Vl;_&UNVro1O=%ppDnd&nTg+bS<4Ez9f*5}=6~G;T=a*p2(x zG#yR@kMvaiUPE}VeRE}p-k<*5kJ|=am)ivS6h=0|?~(cZ4U+borTI{_bW0!F!;(^c zd%)0gnkM_O(zs$YBbTvo;bQrRyT{^1mOu>zN_xZl)KN&1F^vJUZV=BhJ4XWH@@GdQ zp?qhev`8PAES(^UgiNITi6keIV>mzJvyt7*lWoomnHMfj*?&)UN6McaB@g;8OL-yp zA1SR^c}ijSL=!H5u#6xmKaxo#*+t^-iE`Xg&m1m)C@q>dMuv2q^MP!3lb`IS|CVWe z38?u)eSMa@+9oicQN;Ss;Vir55~#wh{9abGKhF8Y|1=QEp4$oe{Ec-PhYaZZ!&ejF ztr%*V%+^g%|bS|}=|FVBmjvep7>x}dGN};=B1% zMB)oG#hJx^@%oMDi%pj<5+8f-5UH0wA>0SPA(8`Mi_gDp8~51fz2h2R92wVPzp}Wj zQ%Uf}*e-mIPu-pavoMJy)cJ-g9Z~o4Ow>MV4Ip_lckWdPU)(^ilys?-z&R%6yF} zU7GBdfpL+5x6oVS$Qp>H);>RPt{>XBV!T)5V^)SQ(B%DBiaMrKeGgJ^Ab&ZG>QDb; z`G>n_PvX@;K%_rBJ`wKOBgxQEq3x1!q`1T3*b{lp$)A?Wg~y`g@de5c&exX4yC>bJ z=1)2v9>c(v*+nFf0vvMvM&FC0&HaU%O^}8&2Z?{-mEdn)vniDaXE6PXNE&p#$Jkj(ZnqPC`{+lreJD-w%-f3Db@Bzw!`iNIub;CrwjuP2VpvZpp6{ofX)G34Z08X zBIs*SXC!<)s0{QVi1te!1t7~n2LsHVpi}_*4fF~?JqJ*MP^~tjj{Bhk0>61&YTlWS0Y7Bo`7qdCtte5KfMg?g$kyTST%9Zl;HD{61 zzyOj~KA5jDrAu&}rpdm+*tm}lo6!mkwsj00K|?$GIsAdj5*Omx+2gJxdLn2-u>WLa z2ROP>{h4psmIVH32{fm?uujX^Sf@$PWy4`*TlSCS=J+D{TYO6byMhGNetv6XqHpMDOXfna^zkItTZYzlKsBO0p?Q}*|fBO;x5%U`?Mo6 z?qAgdANQ})=GH$o7Jk)+KlQKHjxgg_-#@bM?ksZNc&giyu{RvGmr;QdetQ34KK`0a zp3gnkSy<^9o}HJE6HjuX`l`W9+s)Nk4o~;X zZjR5gnLndRQGVDejXX2IozB z#s1KE*sUBv&#*{8;g|xcIJ;Pl>hk%TjivvoGuW_iBX=G%OBh&5k2ly7X z{v|$*;nCj4R1Z_Viy<^^JP*rzG(X}oS-J{g>_AhCxVir-@?x)V^p6^3$3FTrRH~V- z##QAT-U26&mb$fb@%#?c5Sw;pkR#n$IA@j*9m1mgN>8C9+n-+IEu7;j8eZ-i?@cQV zlsg0Z5ftI{h|_2-JC?4IPEuc|CG~Y{Vcb>YsRl6CqxyXF{zX&^(O5n2M^4W$W$5*H zJTiJr)iU}6Lv|dl%-5LGCH!}cNon~xj&xVClMVy-QSjF6Pe{p|oRt6iYBv*G`x8rt zn%-e?ED7v93CQKP;tX@SO#&?XrdExPbymC1c0&2v?6;4rUU2$Xne+#yH>eG+%-5LG zMe8BpfH;>AwK;|Ys5*BTC+6VPw)}v*a1MM_Md;{arHyjJ`2@6q+vcoM6;n58JcFIZ*9EF0_JKQnH( zBjwCG-5P07T-G~GYe@3n8^`X{zO-i92$!RBdEtH-+u_1nygg3>yHj}ympiRlhUD@> zZjRe3GvOq^XYwlW*z`SD-QR+~SNuZ_Gh=(D_o{@&J7T z9_jK2%6%>eZvt!_JLM{}-v3zMWLxE4mWJgHCjqOS3?~(x$NdwwBZstn_7n+NEM0=rXr370pmRfgoULT--NDlg%rzUT6G z_wqtH$GW{exfrRuaNKNfPa4*}yT1f>_wv%3dK{_DSZ&Piujj4x1Xg*`C25tF*3zhd zcRW^kvC7N8Tf2~+>LeglBK3Syph2v(sb)|2`w!2BdDldADS>)3a&AOG&FT|ymxqRjcJ!RDS{cqQCN0XOrtNTo|laT8h@Yn_C1 zRWop2c>SY|kMv1c-ATep@@2jRQFBJcnTM^F!wFa0nb8pM%<>W~m=UpzSKJ<3uE%aX zXyJLKh3|i7G{U40eSw$xEyf!<19iMN3SO(e4@uan??bY%T;U}!9c+0$PX{R&@3khe zP?ERJR3kXo%hgi-LGh^jf7d1_h~kq!>vwne{dzJE+7p)con^k7y1v=BBiExl{Q5q$ zt|IIpigT>=Go1Bo2nAmXjGe=Sft-* zhei2B=PecAWfL#DowN}B%QC;2}FB(&_1Y?F1g9jeb#%qCW^3^ z8gRLuY(V~zNduAG)blpV{?8`*F6n+!O8v@p`aa8{{kfS>_sb@&Jm8(_E-7&g$H5yo zFBdDXTs~>T&C(GS0iP3Fae6%?Dhgd?0f%;AZU(ks*7oeKL1c`txYmqMt;dsow~0=( zUwZ3?&uc!o$^b#SLiHB&4R+Alc6{ao9jXu$<6E!bQ{}ffF+p_v?Cr`|KOKA(*Hv7< zGd~E-a0Kxg)u`4T#YUy2X?|=_Eri`jpXyKBy*AN%(~KK_*znPtmskGQgYuBq&C+=) zRq!Xn`K!v0{5HAUHLM*v@^NyLp*ZNO@-;Rt`DLz>l8jw%IQ}%BmHwdx4wIA-9X+(Hu&5s zKTP`LTxBKBLR0F({QURFe*O+ai;F(%^7`i-KR>_9XMgGW^NYRnJo)9bW??lWiV+%n z7&+f7kUrIcX&{Q1>&NK_2r==_|C|JtD7fq4!{>EeQKhG=hl@jK=2IBiNa>I8IA=ik z12ykzTv_g7S?qKVeeA1V56xfsC&$gtt@7DlN>_7Ymw!6N$6e@hm~bqVa4ZB4iZ=~J zHkCbUXBO@&#M6V0x*AUL=*t%u6+gLo5SL4mQ5*c2Phn&eESICbh0c;JSGms(=@e!}S>Rb#CYy#ADPG z!(DU+x!dCkLK|OM=JGdbkE!jHjV^!Af7vJ0j#3yV4#D^Ff6H!}1Zr>_m!E=%%zC2M z*F&DL3D3mFP6wWmdHxSZCucw0PwgG^RTM!zp*94BI)lzG;uX-u_2zp@ z$|L4-^(GQq4Qd4LsUz=orw&RG_g`84^rX@&EBT#{U=lv&N5NNE?spYsx?LqjIKl&0 zQeaVljvdKoThHaC^y%G>$`SPy>8uYr--G&(w5K@rXK*yGc3v;41wnG8ve6wxXM>=s z)XwmwV@VDI9SoxLee9rKphH2uL5G3*fDQ-s1to)y0QCdWJ6(U!Q6LBCXiy4>8a=8# z2Z4?O;aDm$7<3$H2xusX&I&#rbOPu^5LMbIgHl0hpmb0MXgFvDh#Inype#@}XcXua z&}dK&XbdP9lm{9M8VAY;jR#EtO$1E>6@Vs#P6bT?od&|uz~Xe!G|+UA6Ep)<2r2?m zoi`IS3sekpgJy%~fJ#86AP>k3Dg&JX@`0%3qE25qXf9|Th}tpQkNr&0S)j8)=YY-y zod>D{oe#PIG#_*!=pxX?pi4m2pi4oQfi4GK0lE^j0CW{-A!rfkYS1;HYeCn6t_R%! zS`4}obQ9=i&@G@PprxQ&K{cS;K(~YL0Nn|?3v@T=9#AdlUeJA@`$5Y<4}cy7Jp`%) zJq-E}=n>GPpvORugPs7@gO-Dy1U&_M8uSck1!yH`73f*ebD-xz{{_7OdJ*&zr~&jc z=oQebpw~dJgWdqW2|`gMF`CZlSrwyPuO6Bpl7~EU+wZeR?3+k8!?XcWxn{n`lrB=e z6Ruo4@|~rwT%UWEn-l|v@`dZcyhqLTOndn41c`%$}Y2igBoqBCqMQ$>L zhpsALW8;$N^!w+br<&vRV2r}&psH@7+mF-9iySy3244s8*5cBt9PO4GTp7R9(}Eg;~f;_`i;?++7mL_A~=#lm16r zC80RuKiTZ&AbOsL`W~{s?B?*6z3mdHfgnlG)qR#ozOsxdFE~Fa71Dnq;!!x+PreUc zme~#oRN-E(hmxN%mvgE*sZA|dZWDW-G_P>_7MmE6kQw*j+KtZ*0iO)j1ym0)Ut>xa zsh;+gY9A2&jBzmH56h;gJm9bK=>+9ZfG9_}&g*v$EFt2mfXampqfjuE9! zcS)|Ng!-4V9O`4Fzqx&a=vK1&?y?TIT%@MYd^v4$M@?UngdJf?4m6(E2poK#;;~Ph zHipV>h2c-*d3n#+@Gms3u^x@-K>VMM4*eYs+2`5nlEm^JPrO~7k#sll$xwfd%0Kfp zrgRD6q*t!sFsvzmRwG@i)6+m?Q(r6|RL}?S1RuP9lz7)B7LD)L>*|S(C!GX7nPd>9 z%Y2O~U4rTAXEKj1clj#u$*2tDSuP4DKX=xO*yBoxgV(M}KXraSC!zOK6NSoW|6uxB z%8nctHVG?&XBCL`GHIn*-ZdA;Y4WC*v90f~T~YgRl9;^gsng#*sc_L!5(*5_|ypE>`?P5m%=JTNCK zx80Aod}NG3=-*o6@WqAs2yQam9}M3=jNX5BIukoXfFXS4dTGFf@H&SA+5--$#8}u)-R-ZyPp%#cXv6SozcHB5l};+RiiWTSoT!G{%mXPo5r6nW?Q@x9UK zEp=(%UtIqD^0G3oFEG%N?$uh(#kiUAEN%v#-!|QQ#QMn%eK}3N?8ga}&;HHElU45V z)7MF(pDE)?c`3G>UQS=W_}E!*e9h@HE|t&z&BiqbM_DyICZalmi2uW> z{U@8lQ~#CS#1Cg;`G>n_cjw9VO-(b(^^uRfyw{54h3#2ZWYatV=Bx4uQ?5g-2z4{X zQ3K-oIrX*J_09e#U-s)szK(a%y<~KJaYE(mzQ(*1b9)gPmr_Sl9J1UB-j0oL;}fF} zxz~T&EKZ;CseJYifeE%}A(kpPsjjX;#Bx8C<7;hO$KSG8x98rLrMT=3L_igU4-|Pxs44!8y)#MmeTZh2~0C zAu!7+3*+I`f93SaEswXZek4h}>i;<7v-Uj(ksldOpZPjBbXC%yIJ;KZy9 znwWu`c=A-3$ z2yvmew5$X(EX{gY4P0`%l%^fTdRhyA{+@Hn!&6d7Mzw~&_C4qQ*w0mx_3Dk&7ykGb zZqp1uSE<5h|Db%8=Nen?EO7@a9ci;>`CPLwP8{Pw?TC<{qYOA@9E3q0x3@ROevT_L z8Ydrr*6qh=6Y+3AKgX5K2TwM!o+G_7I7cwXljyP9Ve#{%0*o^0y*Rb!G zNlUIjFhQFE7kZuwgRiF=x<+~)hh7fCD;sXNgBbT_;F8lN+_FB^d=NVyex7jJyi+I4 zU#iv#zZiT(X)=*;H`S-;4`N5G{2Z%*Q^uh_NAZWTpX0t$+`aNn_s{6mONYz#&;179 z^bq(H>p5h7iuNRS#Kq514V;W4p|h?7vVX1Q->#ePFOQoJ`N)RYLhXdwPKopc@zv-l zr#|(+)g$0jCFRPjZ|U+FS{J>L`EAMkF-=K=p(A{a%f~x&NuZO(sjX zv?~>b?J*=H)o}f(^8aoBTRVSL`N*;*H%$v6TjtX}>VM){ruEB@DpOhRU*M!ghDvo@-9hJD~kYx|vp=o*D zEN_4VsW1HqM(^=tszHo%^{-}msq@UMMka`ZANV2ltgjB}nxx$wnorAogB`RO0?$)s zgtT5>8}Kz|e(&!4x$y%VYR-RKY_mR61RN*ZEsoT>@n0hWtGt-A(kd@zd079<60pjP zSsqq-G0VgHXO=)c{&K&t`nOO&pXM}#+aLPcOJ=?59OfuE+gOK3eH90KF3dN_PV2&E zX`OdRxc#A(JuRbbW}M@4deHL?ZDwpoLWG;j)Sv*69!B~OMdgEt z-t$PW$W3N@zb)ypSl3t*kiWa9ZVAjS)*P|DZ3*j&s~ql$xo$o4 zt|kGi9PVm4V&T~nB_O}gCgI!z8dFFE(R&)X)$h%v|GVdaU+%f z@3Wze?;ZKra(#}AwvX^(CO6H~4eeYgkCP4Q7#q(GZ8xQtmG8fh-z&+cb@0q*9Bc>i zjQ2S`ek`rQ`!u$0&Gxth`2lC3T;Dyh>3l{SZ;{jB_$+(pNWhL{dEBD_dcy0q+MZD| zmhwr~qqXoSlLjI`b)I?BT?yjc8^6fw`1;ZB^EevmK8@2bAAe0Iq(^S--aiYg5cph& zkuDGE6x5n-u!9(<=#&r~S3Ye~(%7zwzg_Zw|BP98ss5>w|HiWlDhDg~PlrFt;e}<# z`RJ+T`SzRPAFF)-_3g30U9@^}8Owp}IMf2n$6u2%&$rL^^SljO4v3W*rS1TBYR>iy zr*(Q*y;fu_-!SD*Rp$gPUpRkgy#|d(%lk$z>io;3t_OC%mlLPwpc+c$vwtvufI3O7*x(7YtEw;2bOdBVc`MZ+nI`;Urya@3d8$xViFsC?ZQI>+bg1cfotSyJxG zb3!gYoB<-&zYCT0_eLZ%UnUtlXFK2P{f(_YL8Rr(Png@GU)g;am_9jp zIV2X*@VdziZ%K*voq%dTtdp$4tt^j}B(pqdAM({8J~sePvGst@_L*#dWiihSqViRQ z++;q5kxjGl(3aiqTkA$JmtNVTO+eL$~ zB{vz?dzG*I%5ro&jG=7onK=T3*n!FkW&VKA{?0RYSTwECO*20Lhl@>$>y83P<$=E!QTZdow(Mpe*|Ixa7~-*!!^&>l^_O*3$kTkY3=`0bZ{?!Iy>ZGWd3{dwYq%4h$e{+JZUk?nD6Tco;i z(vr5&*+0%z>Yay_ATFazZGxvQee+df1EWIsOn0FMP|>m}M)B~6EuMRlKaQ><1>yY2c7mr*}d-JNf|UsTUsVP*88sVW2*s!$BmB zWY7_yexM^k{Xs{89H65?DWCzMfuKR4V?eYaCG~la0}TNU1q}lo4>|#KB8c{}J{gn> zN&}^XGC;#YBS4v;k)SM4HfR*+6wqi;4rmN07nBDY3mON?2aN|!08Io<0u_KJgH8oa z0i6b#3OXG$4Ky9(1kC^yf~b9Wfo6hcfr>$H&}`5g5KZ8w{WIvL!3!z_odNQJs12gY z;pHGw@OhvL5N#NICg?2C*`RYkw49m_im3vf54r#}A9Nw;BGAR4OF&f4F9lr&x*T)` z=t|H6&{d#?phcjoLDzt&;lB=aJ?I7ymCqYNH-T;j-2z$yS_--qR0FyVbUWw{(4C;W zKzD=g0o8);1>Fa_AG8eg0O&!`L!dg)!=V3w9sxZHdJOb9=m}6gXgTOf&{LqNLC=6z zfL4N5fu03D2YMd#U(gGn7eOz98bB|DUID!ddJXhC=nc@Dpw*zaKx;s6gWdtX3wjUq zKBy7&0q8@}N1%^EpMX9EeFj~@3 z(b|ecPzO*)P$y7l(B7aVP!~{FP&d#%pnXC6f%XSczk?30JOFecs3+(k(7~WXKz2|s z(4nB-pu<3YK!=0+f|5Z;fck-s1oa0U1#*Cn2Bm-ofChpFfsO$k3mObM4m1Qb6f_L< z|Lk1}d=o|cUQU5ZEs6-DSiC@yaH@C{T55~Eq~-7eLbGiHX%cdj7Ox_xMMMxm5K!y! zX%UdBsE8MMB8no4pdz6DRlM;={XYFa@9w_I>@-bM1V!EH@7dYDGduI-op+9%ot-@c zpthIBL*4Py#qm&6{NI}NAvv;dzK>{iq#nZ#8In=t_fd9SnWDVAy33m1FZrSGh!i~` zx`O5hSguPW$6QCb3){8O zSM`5v-u&l#T`lurd4!36)+j!Zvy(ow+dm_=a(vN(cuLc>2_8CriFPso}(KW|E%>a_iVPZV% zJfZ=yT~LlT+s_y@)_oB*wQFnT^Ip$>p7LCZ(rL-G4$ZsWVG9~baJ#_rNXq(Ic>QYF zXv+D^>lrS80AJ_wg@Wm-+fmtHyI=>7WG{)1>nQ&uAQ@-}910u`qyp47692P-9AGq1 z4$KCqZ`}b<`+fni6gUKp=WKx1z<&>X0)uMb661ygFa|xw?+MD!1!KW89#8M?V!6cl(!?{Hh{d2Ise5JrQ35SZ$BsbnO#f1ryfV| zbEtn{xh51236Y@|CJ=O#`TCpMwagP^+hx_d6eab>^_P1NYF~&V(HyZNJ}fuHVK2;w z*Hx$ay@7!KrN2l6*O0BE|AM`U?Hc~o?!hQuI%kA4jB-M8EVpkoAeYa+$t6O83|yQ0Nnxh{*~8plN4pRCIj3X44j(*luGn7EcUD-=>9XGtAN~@Yc)zBcWX@l{ zzukFniZbx~Zg)%{b@Ew1mv&j>clIMUL4{u0Z~+g3 zoo;Q90psQkiPZqCrBW0c}XMXJOIZr)>8hFfaV9(fk?7k#L zX?k|9^P`bVs_K0D^{hvh>(aaKZDAvbPn^|v8#Gv~Sn!_4BV-iJG`ZZcOj=WZQ5z!#rep!aN4Kf@Kb$>Aowa zcYGd03VXerrWWfFks0%lvK3C<{`^DJSGo(Kb$)fkw= z_>K2+))jC*%tMxQcr+e4F07TorkP~5%tYkTyRZ4V7tJ#q3=Dj;rP92(7fp#P2j_hL z(3dYQET(gE%tMyzp?JoEMR<6%*EY!Q9cxR&>VTk{jz{oC5YzWXjoop~^92J3n|aV2 zUPoXp_|*&C2L9Cxq zF^!;qkzRXxn&-*z7SW=?3Zy~pOQQ2Mtq`BAisln&zJ|u*#F574G)_+eSg-U$+5N4d|#ALV{|8%OJlD6 zH^jBdXa6qc8qni;?X}ovnVcOUyOy8x?7)24)oJ%%J8PNJlGgW-qc)75^RQeK3WxCg zzqGer39njeU|;QGuSZ*=v#;%keunW=1lHDRq8i9VM6rLQHG`s){};o=^D6wqc9@xI zw!>)eYs|dlq5~$@B^|>P)l`PbC`p!!Y128akNIH<#VRJ@iR6aQ2phuBBT67ULDVi&uh%thZKL)@(7xWH@Sx73Go^fa+Z*7 zd+-FruP0jvkM*?{yvT8RMtgqx#jk<6$4owyUP;iLUhYj4SmCkk>O*E%)j&dPGw+9xn|CHM=wx9Ef@xlWpd! zTzgY9;yi0Oo|C+n^a63n^G`oxVm!g7rNHfUo(CKN{iuH469A5KtTPx?(bza`C_if+KF>|5zvwr0DAZyQWtvs~&m~H?2zl)dC^B!{4P7x25YeL~*<{@dq zHav%z;W3rzeRBoBmmJ%bTu!A0c#ih|OM{*)9QF$9gL$xAOF%f7c?_;li$e4gM0BO# zI?-;bfr#PY`KK1N|EJj;@joon@U>0rPZ@%9X z)7R^nDA}{~y_L?MwDr8&l_aAe{D4~{yrH`yVf23oag%1cgyow6n5$_TW>kM@cn`bg*pQom!5!8GRrBB=rn!PYjvuVmTjkD zddiQjk5qgS&f%=2L7*PH3Lfjf^a69aw?Y^(tH2A(>yoByNHc1piX zo*x-=VQXbYzqbY-cjxr^Jm%$bKg;DDNxwtY5|pUE_nCI@Pd7%!j(TE!nve9!ars8G z>)d598g;Dq!%n%0wZct%=ImZzMywbE|112%oNqbM`!v(P(U#Z5SNPE>JKM6qJM zSqq+2mZaB)+!qhFcsB2*wGIv^eUST7lIv2voytio(BBF~t?}qz-^*2l6TN;^Bd1Ys zQgH$4i@u+-6FkIxD32;5oaX0BFOJXi?H=DfepY^u#kfp!%<~;d&f!%45qg=}S<0>Y z!IBxKA|msvM*d>@GQU=rn9G~jVeJc9LwSfi2aJl} zU#y?-({GMhN71$qnj@d~=VZAd4tq2mHOTLsNDGj$)OI}GrkBv0{iqH4r#tl?L*%hK z0Uiryo%Ye8BagX8=E3qX0pp}$9%-f6txWCHTVHZ6^2i(=Umv%B@$!Ao^uK_%uh1Op zgXM-e?8W2J*We+J8&-k`rE3Ss?*beJ?8YV_O(#zL9;eDHf#F-bPZ@e9jb+GDyp}k! zToVe1Y)8mbRI2q>^y-Fb-X?!c{NH`Z_XDcKZQwjMT= zv{rIQj(T|RvL$m23%{y%T$rTNnjucUKwdRx|{ zo?H*bdJ`Ur;f2O>mlGpt9-Ytxp!s=lirYLMik82tsIbTT?|-?D)93tUIfuv2-%=H8M11AHg0H*>2fYShaA^!{jOPH+vRiT3`0DAGZ z3YZLB1xx{^0#^gq0M`O^zcUTE4ww#H56l2=0BG`@?n7<_W&<|?w7!BS@oxs^0aOoe z0TuuYfknWrz-_?oKn-vQa3^pVa5wND;2z*!pcYsR+y^WHmIBLw`+?;^9q<6~An*{d z0(cmB1b7r!2|Na@0v-pR0I+qNwZAHK@H;>aZxf&?@Nd~)mG-ti8#o6T2-tx^KpKz^ z3?i1Fi$61J?sHfE$3Bz%1ZKU^Z|QFb9|m+ziYE z<^#6?3xI{dBH&iwHsE%k2Dk&b6Sxbw8~6`!4{$F~3oHii1C{`^-g_BvKd>CA10Db# z1Rerb01pF?0FMGIfyV$^rTRGV1n?yA6!0{#8dw8713U{n2RskF0K5pS1zrNy0WSlu z0PBHQf!BZy!0W(9;0@qSU=#2buo>6_ybZhqybEjv-UGG)+kqXx`@jdlhrs^<9|0c& zp8z|7Pl3;X&w($1FM+RsuYp~_H^8^Rcfj|+55SMWPrz>AXW$p$SKzCn1BmoBkZGmLqARq;32OJF0KAY`iSO_cvZUt@wZU<_BJAgZZyMVia z{{Z&@_X4%RV&Fbt39uAc2HX!U2kL+afCqtxfEB>Qz$3t;z)IjTU={E<@C5KA@D%Vg zuo_qcJOexnJO?}vya2oitOZ^I)&VaAuK??TSAo}n4Z!QbM&J$LO<)u77O)xE0=x~p z1H21t1>OU;0o#Ec!27@lz=y#90UrS$1D^mpflqfsfUkjFz&F6Rz<0p+ zzz@KWz)!$#;Ah|$;8){ehE#Q-D)}0l;a%>A)GlnZQ}V*}yr#K)?a~8Fdeuam;u}X%miiuHv+SPn}9jMT;OJ49xxxc z1y}$q1Qr3e0=EIT12w=Mz@5Ndz}>)qfO~*@fm&cOa38P)SPCoy?gy3wb-)9_gTO<; z3gBVj5#Ui^CGZ%q3V0lN0(cU53V0e=4Xgp40iFe(1D*$70A2*v0xtpUfR}++fc3zu zz-zz;;B{al@CNWEunBkz*bHm|-Ui+Q-UYS-?*ZF@?Z6J;ec%J&L*V~_kARPXPk^1k zrvM&V(e0XP-TQ9LE0D7T)RjkjF1X?D4MR>iuc&9P7D119Bx19iE)!kU=ROdM&jpRI zu6g~qP<$R%b$M()9j|PyTylzg)ci9>eLeM3x|`JR@#%RS%Qc~JFh36qKNl1!XtAqs z#3DI1mq>dBb-f^!Hcly@wEC)El--e8lG*^n3$irG=5MVVVjRg;5;3JsaWd zaXkK?{f6WmzCZcRL5BJAZzZ2(EGJ(MgUE9K0u9ul@a6i#KbvhrwiT*NqRkv^T)^?z z=X5N8&ovOOJ)?3VP~9d+`ew&6{$C6e&pDj@hU8+L{pH+h&-Ry+*gtuQ$d6Yt1zv|Bj=`xYefa>_; zqu1LvyE$X(#;G;$;!Y>^F*n( z^)obXruTKY%_UnTi2VV*5M#~*Vc!`xpWZ{7cCi3*x9`UI>S1|H6siIWj zS{^5kxyihqjp_^KD}GP?+EM+6f1h_cJr36#`SiXN%MEeZi^_*c7%{5gbN)M!KRG)< z^W&*^9H6cLnm-V8?&W9ifLPg@`b^R5H{JK)vGfm|&Z9|Ku1h1wsQE{38_d6dP9%Ry zH(Gf-`S|FCNm6IOs*mMAL2W>9NcxHRmhEbt_Dx4Pj(Xn^FJd#xX1VO(QCWSuf|Oo9NXDQLvD_Z zXOS+C6K^BpRYX7XG(Oy%>nKw*9f49rP6a4`dhc}y@)y&mv}qk5^Q)L=w*P4NM+eNE zSl091TZe4Mb>t`wx^HH=CKL`)?~fo9@0+y`%i;&1a8-WcUaS|&{MfweZfUJ-m{j-Z zly^?tb;jZ(Eq7XrO82iU7bt0`=KII+{c}AkB9Cf`hul8wScG-IOYd5|yK=y+W=6p= z50=N~Va{H>qZa#(j`+Rg?0}Yyw0~LEZMdHve`NE*AFg;x)(6YA1cZZGALjdMGb{Zf z(QfMQh|PztX!mW4%!_)RP~4t66*%He@2Rm|6AFi@c2nmPy<7!_FsIC%bL+=BF%My>yTdK^_UIS7f#3W z_gn*3dlp}JR(lp-NB@=>sraEh-mSZ*wNkZeNXp`-RZlHheMBL(Q?c5+hIGVZ0rn{# z+1!DEIG!N6<^Grk_N06oo1@iVHCAJh_;UG(bwWIkTw$I4nHmu969?XFo)@9EipFo^ zeBMvLdH*+k-kHa8A4)!U;ZayFbH{#6v?r6cxmKyeQ(|n#jrVqQ)rpY}uF|{#eTGlG ze_ku`;pd*>K80(>oV#ewkk0fTRk%ph%gEaJ`vIkP zeD1~b3h#f9^P}gp^psYXb9h5MwEgrPMYP9s1}3por*VOJ|GW!)$k_qc#Q(H0X_4SKKyr#sr;@&Y$K(SAG5RHtpQhdv+RH0ej=F+Tww z-TU?&-QK_LJI;rB$Z`&k#v|Pos7FNPk-8+lK9>DFW+2;ACGplHTx7t{N3G`#sA$?y1stEksqvF$?0?cvYf-~=RZ8% zj=(B_e|K#H`Ch&t*Iw5DJ$e;fbDXa%=kR*@7KHFj%i}F~=rO9`asJ)!kN>;h{JG^5 zV{DzM3(_3tFUvW+Uj8|b5)ZyZ!QaEELPXBLHi7)lxxM}FB~Lt8$mw(bvYf-~<$s~q zTUMx6aD^7zgWk*I|Nf50*K}GrWq5x*-$=X7a?Y3idimS)vjVnZS@uxSi;u0Kd(&f9 z!DBttCBWmScH7T+aN&}1oDb_kmUDPL9tA;H(fG>q)XIPsMbyK9I&-@y&)3rhoo@g2 z#82MaNw3{$j`DAcc9G?VIP6j96nQ>Xpns~xmgjespdr!&v@Txcv0CC0t-o4)=;AX% z?yo)+=iJ(W2g}0*jFad*a#V*W!j7VfJTf0J>mwSEn#s-Y`ssoB*T_6ro+uCOs%&B+ z^6)(ro5u$5e5`KgGtWIW{ozB645@tRc@E1H;}OwCL6O(5;-VT9Fxh9c`A#uSt{0+A zK2Ic$e2w*gYz>HZvOA8QP)ey+J+<)M{L)fRRWB2)*OcTO9&J2fe6dOxJ(%lF)r#2m zN@@4FY*g;5g4^6&DG$fz@qXK~c{|z$uj71}hb-st zm^=!+A#5@<6yMJ(=V7qOrzQbDOT42~+P+!EkBiZwk!zyJ@`U){<6b5*xJcyF`;qwi zsY%NI-~{i&mpMP?Bg;8Frhe=mY|rk)_ng$Q?TF*ywF&Twm7 zjStjP=rxF-J9N7ZgXS`$Yij`RmrEawucya4{M6&=?9JF!N_WglmUDPQywcTTN5~zF zLeIo+{>u3LetPedEuIsm@8JBIpDgF_g!qMtWqArpRd;c?R3mn_r~QV`kJT*i#_Jdu?WN)41TOmUT4AM6?Q5ff5axjLii?djYTz@!EeY^bmR$8*lB&}7 zDw-po<`GzKh{IkZ`DLmhKlc8|awmghEmC5BRjcCb@4@snUq5^L2batGV|kdEaneYB zy8iO~^?0TlJZb$-4S23PbJwP#&d&Z9-qQ698WV}XBlB@{y^-gUN?%J+%04^OX>a%O z+s_+3Xh3{|&up?bzsY_eM zQ{?qH1GWoQzn3CYVj|C7ad@_RJw^HL?JJu7w(Z9cQVk}|ljVju?EMj*8Gcn|o??Ge z^+ara)^1Eu&KdYghxbeE1Al6vQ(>Mg4-+&_8sw?<`C(lSRWV+5Vz#gv*Rh>uK4s>k zsOyg;du;V2zQ^}ehvzfjOi|9teYd*Hnocj4jneOEm=DVn=0i%MkLwz3;6PMG;t_9u zLCTL<(zCG?fX45%Kj1L{?d?bV^yLE7PFxMp1l5uqp#6<#|C!;K1HG_0!lBm^ zB#NnHWgZe8k3`2I(XWtb*|FH)q8F|?3wt)?V~-6N_Q{xreLfz-J`SH^AC=xsl!vgX z)$*22l}XruW-vC>SaL;kW#!fuO4@%8P#)Ng_w}2!RSy0!Mftr;2j#i9k5KNYIZkPD zNFQ(-sEn&DP|n}xR{rn5Gn5x?k12Og{YH7`f2TJ&^7RExy1#r_(~NbinvNSiv)Oqy zcQ+q*T5`+EH$FNb@KJV~Y3;pjf6l(T-4U<6-GRyo)$2;J95=)%#~N=t<;2rI8{g0V z>$x?L=!V7R$a1L6Iy zLgvA8x=eHp^1ydwXu8BHaG~o`0kSJ<-%{5^p4UEc@D?9Tpx*r&zt4dnjWh8kOD9l# z(P_U)5Xk=vLDuOWYM=(!ar?9yS zq#@dS{xjx&9!-hT4yZl~Ynz)Vrw%MSNJ$-Y_^k2MZ@O*;ZMFk91DnbbKbC7k;h-(` zwb4|x9S?cR^~WoPm=401a`8!I?eUKbD|7i0kx%LiW_?Bbj?_IDJoL-W*F4Z_%x8KE zWalTq+F8!&vY+n=1n_XqX?(1gzDaF&yR*GCJ!PY%-UTjCks4WmUxR|8^5bzWrN1X` zPp{jPy#7tsSmm>Sm$rDnzf!8t)b`2GCCB`J%eeP5*F4O>irPtPEoC`}%k>#6{Bc{R zYA+YyWgds|7|M;YnqKh({j^JKaO8G*r>%lrP=4knU=*iBqrp-=`s?k`ii~ zef7ll^`2A7a*9h%<~Jxb7SD3=(8%XkwGW2d@FamAd#BuIJ=7?Y{f}lsoBKa;!gDu7}p=XRv8hx%Pf3ez~4B@rJZHzu)~m=gYigIfu)7 zGx18GT*YzjO7J7c*Dj+nK`cRs`1(u(*^^bhb)iB0}rAE7Lj=)`mWptiHCfDUXk8T znReg{Gc&#~v(x<(IUaAbT$e_U#(2k;<8XQO0TP~qV_6R7I=mj+(2xfY$V>7(?n>hl zvArsN*{m0t4_$KmnzXY+nO$Gu9NB(kIfp0AM|%?yOHzyrMZ4K0@v8dj6s;W{iD!%@ zLtf}TU}Uo5A2;MDo4eg9Q(d~n(1TnWr?H&*u%A}yayyOJqcDx-ErO+FyNcByhD5eu zm^8(!WfWJ`PxUMD^|P&As8#En=O5?iRHUC2)P9z8{_Gd1CG=vOHcrfUJA%btf0mQ38 z<|o?|c~!h>)@!u(YW-Uujk3S>%`KewvD(S8iY(`FS}!+jXf|zUL(^k^Z!qXq&97ID zz%=Vne1_JKPgnA1K~2v!TD@j&=gHQ|>cw?)ZJI2ddE(J`2D#m!I8E{96U&(o`@D9bf54!MqUSBZZ2bbd$;sdTGi%flB%i&R%R9zp5q(P~PDAFns^bt10;8{+d? zpSk(r`w#v#{JiBbEuq5{Sat@Eii{3g- zz_hd^YH;NCq~i7XdRw&OxVF8A@6gR1*D^m@t|g8`L;U!DT`S+HmanHE-Y56o7@yy~ z!#fP`@Z}e8aQ@6smUB3s2hmIdG#1Dki@SGvdXerzOQ9QDguZb>cle|)zE7s~soj#@ zN(fl5)jQ0*mG{cDerzXx&(}Bf%=G1^C>ysHTwJ?#$MNgB=qXW})Q_=TPM_9&WCgtF zIkf&=rBRRSp{=s=@Qu{6GFK2&@)Rj@vp*D(X#Jqk>!o9C;P>J?(~-)A5$_IUM7(3o z?^2u63ZOX~dN4?R9=+d6x;Yid21{E<8kvU5-m-{95EzM}6T(P=|a%*W*Wldf)<+>To z75|`?O4o(0lwaRWQcBZPl)xn&l-j4eD2|L1l|DzEt~|Ok4;%89kuJ6Mv+{dXpts*S z-DdY5t-YPz-eYE^w7+Y>sxSL{30eI1Ck^}^>dU^;S7Z8_#>CxMe64i_zS? zY1ODxO>^MEyKP7To~xI6{gs1gAFfD1zL)NtF?*X;=EKX4NJYLsrg;_0Q+9i!-pgsy z|5T^MdL^EV@#+40Z#d4cp?vm69#$Hb2KHrrNkqGreJ7$NE6)C+ff^XBI8WOg#4H=$ zUrML`dd_{#jLLp*_4)gn>;90wTz~d8C#!rKr(vsn8mF&6J9a8Er2dE2LFD5;jn_fc zy=^ZeTNj^K??gDs>;U<6SEsGA$Ia8WBfi{*f0g53eP-;ie#;N1evBN&qy4{Gt_g*M zynYK`$)QyccC2{|1ZjZ@)<0kgaEV)`HOrpxlk`-i!Msbqj_`ixg|9nM`#Hu4=jWgL z+W>p7Zxx^S?neHiUQ&>^xK4Y1b&Aqq{gT(JuCh&_=aJ-yBi-M!ToVchSue&qC0#G7 zQ(M_)qj%YiYf|B}K05A-=;Hv#GkL^K46i<>O}LyVH(gOd;qthh_>r7lygrHJvd`DW z^Tqh$IbTPzXmSp>d`km=g$CsM@@H|NddPK=)}XPI>j?eN@i>mycq=EgRzEEEx_9vu2 z@qep-`8!$EKbz~HU0zP;#EDc07us_uotByp<#X8$RH6YiQ{gY*UR(oT-NNG@=<@+izO{*@) zFN1$W4Eg;-vXN+GGOJ!itih^R5nWhk(KTSzmxx}h`V!HFbrxL%R(*-+#i}n6U07$) zHIV4ItrnNl`#7|Za_?jH*=ajuWMlMg1Z-ibq;_qseBSHX&o>;>PVtT1aqkbO-F(1N z^x_a4jRoobAeL)F;Xt1yp-oz`Eipc4L?7%fr#(pVrj!kP$_BKL4Tpogo@@s;z$mK3 z7K#h*f{=#*+wyk%bDc@1?@C84}8BY zplaXh5Z_1Zm~YmH%!3kEd!5)PbW)37if|C0_l4xL-h(g10|sxMZ3v1&r%8j$Nt;#dClF=Ms=vBHQs_app% zJ_y?_6I*y^8gN&$&+UvlaSZJQuIG&MgfjqJe)(eUX1F*BM#P|8rfk z`WM!Szpz#{t%ZPP^$8nL^*4e*N z16F;Bl)6=4BD%27qHDmaFA=?1^(CSU>nyqk{weiE{B`0uDiJxw;V~FJx8!;wUTd9O z8XyhSz&L3A1@EuBr&?*qMq{PN*U%gl&r`81)^-1;Fu8naMTn)N{l^02@=3I8D4rab z-{Y6%;;)SrCdRYQbq!eMvwvH{-+jCmt3JjHqj2u`c)YfMmzKruuhxLL9(i>F>qA$B zZY(Wca_#TTTerz3iY({w@cPg+w~IbfZ_7^0&$nfj8OxNhE;--t^7>uDN?V3soe-kc z$a%%~qF~73&i4jfw0_x!MbRS9((~JBeVrYdQ2w;!wiwv)x}sEHu@Q<*oXD8rpE*&y)&5gmaq5CJD zn;wtf2^D2}NbIB4KkE9i`p4LIVuk7&sDa1rNvRrX&*_ZcC&`>~fO39j-F2Z9QeBN(O9aV{m^={oZ^Ts+@1`s@Tq>hKH@>6ZPObEuU{?kdqW;4zm;PvRQ-6B z$Kf9CLeHorGXN8EVtdh0dyvTU(pDld>)g`7KUf2Mv)&x=57v|Q(<}{$8u+`9AI0Co z=MD9l4aw;`9zR;o!&r-!A58;RebKc-b%|irmuOaE$yfucagxaW496#%;<*r({gr+y zGAI7@-P~&2FD^;xd)VPmjZ0oNZ_cm8RSe&N@F92K{;YR%kApe9yKy}~Kd1Xlx=wa= z5b%9zRk8WLbal7Z+CB#xW;R!@+E#ZlU0acTN%hKOSNCXTBt~8rq|9=PBf9W?X?WgN zb&SWPZC_iiquf>E2)ewUf}q16Ec9l$u&=~W)#>u9MeqYYuP31GL4gT6hub~YQ8eB> zf7`tzKHnD)y}xr#sICi7%n{!s!I$MCS33Wre6`<#bi{e)-k$h8k30UGhfdu6*y+a^ zgox*X;K_1B9QO8MT;=zntT(>b^GbZ$9I1AnCk{>u8o zb%lHe=|Ze4^grKI(7EL-4g8fFs6ggCzNke%Nb3shF$nGOSH5udlec|v=@HH$6pd~B zeM2r^I>O~~dM5^K`Ho;wX|`Ify7d^T@Ob>R7Ws5b28Ku6!=vnKhc zTzZ7V#OpLej^s?PKCkmszejcVGak^TA~y3YMgC&?#IM>2Cw{vSPIa2}MqzYLed3tI z6=nF{51x%vWnr@kA6@^}q#Oz-M}8Chv0M`h2j-XQ2+)RD7;bspAsUR))>DP9qVdK) zOJezz`r`Ar?v58ODZHj#f0+l%1q#}!z@xC#uR5GY-lpH5K)z=@pM3V(PU^98zASGj z-+YH3V@uVY?sn65XIMut*y9-MR-MKLrr$py{_lSvbMo^aw>!wj`RRO`D6*Wx`S;t4 zvK^JGKR_fXbJOonAm7!KFD`j-)&<=-UCvjQb2#Ul=TX!BSQ}AL=_$gHFsRz-Ed29L zJSzP0e}CR@%Lcx=c*9)Ihk3|y4sV!8x*8ZC^!f}s;{Ic;0`Yka-gcnO3Ot70dNhBggoBa?~=fzmh45du2H2uePn)K7O6d zhvg9_`dNHF>8`+dW@FaR+64I2WIcXE_vR%>alTw$vYf-?^TF+P85N?=Nz~8C^7#6B zeu{eIjRkkE4$IUCC7S@ z<$5UQ6VfwmM&98(DNJnNeU*{<0ZK0gtvC%6>bfh+ZrA1WHh@=Iy8)lwz2vPON9Y+U zRFP@_PL|_elPhqQ`P^!nqo`E1rFosIjm$CK>n$^O>g32ZNRQevo+s*r0D2Bd*%(=I z)R=x_;&MWJat&YmZ}C&{LwTGy3wE;V%w3y`Iy?J!>zv`GaiC~N9VeOXw-v%^PP3v% z6J=e}lubBQmh3qFpeOrfb)j=|lm;DTxhBTJ9twJkU2eB+ggQ2_FyEG6>h-Ak?odGg zpU(0M(-dVs;&Ojj2Ojapt5=YP}xZ z1^5H#r2?qw#)V=#H|x^)ycTph|Fz{)vj=j%%uAMYxXcUVDH=g*RW8HtEu-)vFV)4M z)^DRqo9f#M_&-`bNHm_P_wJV^@cSlBxnSOdSANEMl27*u3k*5`F80H}FC*l^?Mq}k zV6VqsjGcisjXUju!b+cNvpb!BHK5%&h`d%Oz^m!u<)6N{{K?m3UMy!m>^F+n;4+8H zo#$~^n(cJtJm1x6}4sNwJQN$ zeO6u=y!-8Wy*OXyCCfRy5xfL#na3?vSH#!X?6+J6n@3j9;e45wEa&hruk+N(95v{7 z6$NY=Xm4;MHWYV*E)VQU)Rb7CQ?889=kz6y^d6lzryd_!-Y7nThD1I!;6uOH4v-(M z{XPGO6Mk$z_0g4_AL~b!b9h)k*{aJo$yHKMIcd0OE5X3mxIpC7yDGkZE@`(lYweLE zJe(i%k>wm7=2O4C?16wQ5Om<~Q7ABx&*}vD?0)gbdso%I6z-pxk1TH-pGbj;eDWv9 zFR!HhHLk}i+T?J4%tw}UcvwGDc}0|CF0fQw$o;zye7JwVbm=F}D6bkLoaTX2u8Lot zt-JrQbk>Rr&Hiwy=2QF5a*~NI%vUT=ufMDyG`7rz0!62q>kV=&)hQIMmP`$f;eI~> ze#xUo4&C(lc}MGdjPPT*$c@f9XIrBDB1Nqwm5L+lSGgvl-^oL-=tpCeeL0`czmbTD z=k!0jhU6UH7@yMGo9Q(sZ!7MA;61(zEglZ0U}mW2_^f+VZfbU0W((qd`Hw*B9~`pGc_1h1~uOxHdkY zlLx%^+sijrg~tPY|0By2<%6*bM!^NHpca}PY8#t`JlZ-OJsHKA}AmSeZ!Z6NA_F;{7KyS+t@px193 z?C`rQGa>b23b8Bz{dt_KU-cVfEz`W+nCkfb%cq|`^4g@07in`al)cWcl_JZTT7g;= z(%#BDccRZ8aCmHZB@ZPWL{E}~iFa>Nn2~;ksHfct@VR?vY2o4iGZt}v%tw}Ucnm(c zl?mcKL5$R+@DlC5dRlxvjlN>6fBpHFeaQJTFImpvnX1DF+uQ#;>W4PP^yEmNPow!GmNO6b zbG+lc$lO`z#le^}8YY;J!=(=y#qz3^cvRgyU$g7lGZp2GF+VKXFgaQ2bp4Xo#?1fd zlEA=ow5&)k#DnFWKl^O21(?WkhTNFCJ3pj`R46I@GRtt)4-3afU5pn%wM%PooO!XIfZlR3%)`sEqSor~ zyP~((+-`H~y8fu_i1~p4%^8x)$fx<*mIi44g!N52r*OK4e2zomBopNnm(pQS+G4sC zPTUBbK2Ej&DeRx>#C9m<2GUrh|CQ|~^}BY;$f}VmDhGRAm)`J;7MCUr$ZlA!357!f zc9ZR$7%`e!T+8)rCHPQT*a5Lz#OKtDUZ3{f)=Qe7kYeOXeiJ1{VYwj=d+5`O$xd-s znd9)F7WvUQqLp^IU6b%A!{v4wEoGY5>&J8fj}o*sZd&!zlM;E3nQ7LW6H#csUF?5{ zJn~H1fn_hOWFlni)Z58&4j=APu?ivA>)|I1n484Jq}LC6<#@~6ABfPV_wdj-mOg z8`~(HekO=e+G2gIK{z?q2lc~bS1V6elwXIho-lG$veND6t2eonSxH#~w5VDdR3BNc zOCv|(=W+M~rQRSOh~v#p&G3hM3w#dL2v?EcixG|2<206Qn4Sl8pKaztb(7jgu|BR0 zee>>>OYbk>9JzdCIfsMK2uGkyf7l9>(MG#o5AMzb1tFi$>o+FeMZK()c*uI$Jvv#b zXua~=8+&ZM=Er07oQMbMh2@+-`_c81g;gx5Mp5)qg$vn^2Ha%Ui(IefJCc=U&9-^` zhuwGX8Kg8g=EHJb8aZ;iX$;i#wJcef_t%;$^E}QLDgV@`n`(A4@(0+{O%H4wP?W5! znLTsYq?HSow?9qKgY##3Bxn5$4;THxkS{z=w9!Hms@pbhAF;TGY`f6QRJBWnhCJC` zug|nzxoVDCKQg~9&Sd4?zBeatoG|-F2X)MF%#Y=|G;(a1pWWwkyKu8Y^-f<19+jYx zR1JJC$JDv8c~%rBD=X)2{LhcK%vpCKH5_ovljXWJa%`AqS}7jqpc8U6q(Uu`Y8;tg zt;A2ZvyP?7%87$+xaZE`y{?m_a%OpinSRE)u^IhLwj<;zDn+5{<*3o8m{kDt=zg=_ zFAs!_+UscT!1U=?cU{?QS}z*Qks}{(n=35Wgu)^B{J|zu$0VVv*cE-<(2iTorkVq}S?OE!= z`1cv5Pn~u}S-&GPc>y5#O_YNamdm{M^gcs>ODS@rA?j~s0z7Z2oZ?RZ@Q@YE=Pd2y zEJc=cxII4$i(~**eTO!w22S(TP$ZD>_;+_`9vXu zi)xTA**&k%!jf-o?u7al%93FW!?b>g!)VAu=j6B_qH}{Pom%b>YM=_&bGy|0j@b4x z3-;t;k7fx(X#@rR#K32ni4m*6n6VHA)W?_M3A1s$S3hhY-9`G3N%SJUA?NZrZ zIzmcAZp&U|&Hgq2i~aO&*bCKPJ3!_@=Tv9K`J3mCKJ~e0{kdmx`H|lQrO9&qYjW8R zPe};VsOeabsIQqU%*aOXOtWoRlHoQpsW}i&&Xbr zv+R%fa{7NHt$*^hqP^^_jcqTP_qI`9ICt^LqmpwR7Z^%mdtte(E5Uxv_M$zm)F$Fg zHY3{$)epHW*;Xho@tpHcRL1cwKXDC+_ENDpw!KiQ3tqYWvFT^8ypVI~rk!-FC+Bd% zUU*nXuW0z_HP&GsHzsejCoVj#uhii}9%pvHFFv0pDgU>#^-ovz;rx!&PO$TZB#VH*;sPp zPS4BHUwy(h)EJK8nN85|t&Gfz%JsfG($e2Ch}3bhUW?~Kw$|xB(m(~$<$5-9S^VdX zJ&t;;@3lWX-t)jqbwV2rUMCrHnWla}H@LW1UnO=S-pJCTq~b{V(sRZNg$q~hd+4l z!2Gr+pK&P-T;X`U&T?HEImWb?5e}@-@RVd|s~>2RlIC-`99A~ z&PZ0ePu!i>wq0u0iAK&`&sZKNWSm6fWjvuJC28-wP*hPr%7d|a_}nSV-14O_w*KVF z@g0nOc)ZGTLmc)J;SssZ(chh-i$z`oR>Zce`QZI>VCPwjJiBb)89B3lSRN*1oJ8Xl zZinNZk*(b^-jVJb5Mw-rVv}#Qx3aO47>34mp+24KV7Nz^>|M%5mp>f5A>%PuG1j;j2s687sNT z5~)34IsP>{z26-cz?+#^l8IGh_OaejaFE;K8K37b@E19;5;+4?3?aP0NEcS)i45`O zd3RG{)<2d8EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Eer2$I=mIf>hSQ@Z2U}<14 zYruLQv6mHUC1+{C(txD_O9Pe$EDikQHDHaO{_#a@{Xk0tmIf>hSQ@Z2U}?b8fTaOT z1C|CX4OkkmG+=4K(txD_O9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Eer2$I= zmIf>hSQ@Z25LW}%dcwFWvLaX-ury$4z|w%F0ZRjx1}qI&8n85AY2XiQfbPAl`>#K& zMk@hJ1C|CX4OkkmG+=4K(txD_O9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Ee zr2$I=mIf>hSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K(txD_O9Pe$EDcy1ury$4z|w%F z0ZRjx1}qI&8n85AX~5Eer2$I=mIf>hSQ@Z2U}?b8fTaOT1C|CX4OkkmG+=4K(txD_ zO9Pe$EDcy1ury$4z|w%F0ZRjx1}qI&8n85AX~5Eer2$I=mIf>h{3|pt3%}AeyK?Oz z7dXGE8K0#6W;>2efPsS!Qu@MQd9tGXI(+p6Wn7Z7{PH8uZ!`X$p4T>|7>aT#@H-sK zHKA}AKEPJsargqI-e9^KQ2j24+cil|^Lm16MKH%zKn&xEJSzz#!mEU?|W7NCgf9+6w4^ zb1MHs4gV1MWD{f?1hNHC4WAQxlCk4+j>~fLIZTxOTh1%+L)kvIcw^hg08f%~)V9qp zdAB|O(~?YGLpQ;r_JrlK-Xiv4ZaiwB^jPf%)o&^*D$^DKF{66l8X!9$`ygAO|0zr? zZz@mG7VvM_F6f-xzq!nH4a7cHA(-u=;{>x^klv|2u6?9jPK2o|VntjxDSCrkZ%jfNa{hZo%X`6S~ACl)Y6w(_$*$2yI zJ;6S*y+sc92$#p{otW?UR#e*3{Hi0!WB)=|nTm^KJE1Z?0-$z)>pj=)hRR4ROI&8T zy{G}P-&tK5+fGs|l9Y8HJoJivdhc6kY(8=FwKXLPc%LZ*&L}sEn&R>>ucmw%!(?%3DC-UfcrCAU1IIZIHB;~Ot552JU znF&XI^&$0=igF)}nA%sCYeL~L$nElsx8*ooo(#XEOtlU3Inf7GJ+bBc)r_=!BW|?% zA|#XWDb*=zk7;Z_1n>aI0v7|10%<^J;7EYtkV2_G66iVxrNjL`PQ!JT&i{>0w3C68 zW7|m$?C84Q9n;Ue{tef#yMEEsH3AAIJ7Kx3!&r9W4Fto6vbXGn+u3#?asoj8INc-C zeKh@F415P1kBGm+zZGx;?I|BwFIq;Q)pSJ!49|cSH-s5-uERd%akn( zXKcD_;p5lnIWr%YN9RLR#@+x%0iF_^mbrprI~SLiG9@;z4NH=hyycw^8`JTH7KipU z^I~~iURfSrC>UrIulaF!`IaRsPr8p8weiI5)Bd-DW>NI|K;_5s=)AJZd~Vj6*Pn>W zYLF0@%nxfPqDdx8$4nNBE&OYt0*?o0Y4l^Kr#8Q@Xcuam8ZI1&gMZX@KY#kD0p0low ztw+lHyoaZ5@05E-1@mB@vYf+X@*LtQcLcP@DhV*vQxyB1j@QKITUVE?ta104cHx3U z4*%{Oz18J%XF2m^U+0^T@kwmOi9BlJ@SwC;ym9Q0^S53$hx-Cz(?V$ymUI5>8$A4K zJt{(DhR9<3+WXqr`pADUS-E7x^K(D`sXF(Eab|t6obzYDVIEPNG1EA9WgI@c9!geb zPMXyEu5WE;jyqV_43`hfnFsqipMqee+cb8pN2UrFuw4(Rj;$9;`@Z1%7rQU~W#<&5 zb0)7H%7^6?M|3)mY)7RxWHJ;k9kE>2#>s!y!^z5`g6${#@_uF8hkMe9Gtxe>T+Ex! z8_K_)B8&^ges9dQ*!t-GXtHwhh&P5@yrHvuDGiR{xLjDSOCv{}Po~4;bgNp|GPqpz zB+$QzdfF9-*M^nJ%H;=*@^4--w8bfN^t)x|#qtOv{Y>X&_qfV15QyCrY8Qxns;-Nz zC*P`MWz@*)#*bKVY0Z`)dVb7@<yeAma<=L=gql|S}D*%!=%dCGDQ*Ll)2h-|OJ*?5*BzmysA`E5Mnl?l_I zJw3$vGe23*;X1z@)#-9Ho*WVp%Xwu2{Dv$z@3h*Bw&!yG%ukkcxXv$M^_RHIOeE9zpE(FXsTM0 zV*9MjjL-Md&7E(2;=dVp=&hjsEU78_E0!})_I1AcY|C($I??C#o0KY6@qFP1y9Noc z9&6(8N_iq#*}ePp;@qw0G~;L0q(>V6vz+;`-xyxe`ZiH-17^k6Tiuh%%5AsaFzdk9 zOE;fB+}naUFh7wyCT}4YNsw)~T)3~g3c5Gg2!Ta%7zJIL7ewpH- z2?IE~dm_EDToVchofrC$BGsvlhU^|^!=sVt^Up$Z^-j41p>dEgB+}-*^wCM=`K1_M zFA+bj?Ita zpL}$SF5gaDc`lukV>^@OdMJ-`3owJ@DpDI(T0L?#NPzWL6NlHV7n7CT%geWRTY63F zQ;dwcUb39|u&?WF7^are{Vv=xHG-O!gs8Ux^J43*_e;r&`rwMmeOvb1wWY>ft}JI> z?CbpU9he2vx|xDfRW;r4*3+1NrFb8;HV&^1>tJu*(8s&(J?F8s@#gx;a^}On&dXj@ zq+*yj*5!5uWB1A8xYaj5ww@@Dv%YLzv9{IMw{w1MU$UIT4Lx~@4b}=*Vqoa^da$(I ziAQW+w>}luH)fNjB~^hV+gtU5*gSXQcRUrC@|qevc5&X?LE81F;lTs7A1r5n?CUcp zLscw=DT+Lujy*o0=NKIUTKafAa1_uUpywi~Kn5@upn*aNpl2jo@$a3$WZ+tWp0%w8 z<^W598-P-v0O$jB0VqwH1)_l&lCYehfhwG{UDPg$Z5OQ;CMlOZH2AhNa(^EENQYKh zDnCG>WEU(KlGaYyF2;sjZet)>=vTD|vs!o!uBZGPdJls7EqZpA3LFE_^Jsd4(-j~) zIU48zkc^(K9S-oCck-!zQQ4ENarskAfNaBZ3ZwC-(N*Hia;yQdy&Z6?**@g;a|8Vc zDOW$gaYx>+ivIdjHvM@e*$2xxUG|5n9;fQZR8R(9mBFKW%%}M)wexgunK68$84uN| zUm^BO8{+WMu2|ct^VA0)o5uOk^HYtLBCx7(JUmt!iXEKgnt54Xy2uOD8Gfh((la65CS zSwFO{n~HafO;Nu6`RUdbwXl2-nM!C z?aw@O`M0_z&V)zxmgTa3605hy_?D`%_J&6EdQ4*lvfDka$Ha~6F#FN!0n6B@>%?>V zUvw14;o`X%C)#;q;?nie;&Z;y(zj&)9u3str*i+Bf1kM?)A~#5e+Ld|rJUTQ@1)dw zla#5pmg_Rl>6~17nfEZ#64zsvlT36{J=PvplsnvV2P{`)8((KH!Tj7%yg6;G7me0W zi}~$O=iFAXPwfxYJNjR)e=Mi4J#})L@zN3VVostg+Vx_%cwaKNY5G#FsJVW#T>f=jPi^}6I^p^)-yU$ff3$v69pJGy-PhBP zp#RAykWBoa&*?g@gE-ZkSf9jm4v*zGHh!$MIIN*GWw};xd{F~FT|=PX&yLTdg>f9q z-@h~<-aqerz+AuO`{$LY|LqFzUU2heJ0`!qTmKyc;L$joNnp%>rc$$jJr84 zwny^i`bM@!a`x#OwnIASF*{$&*K?ZDY?Z_4dU6y;bn^dVequcNob!_94gDW2zMOYM z*IM#_wgzhP^LX67`r+91cGiPQctn5mT<@Gs&S$9ugX8zpS*}YX$HeL_y>m)y@f^XT zQhBmaTTmHwUM!N!o}W>@rh3Yd>oun=)=jzY$p7;-mTzg`uhPJ3WX$!t?lE({mhY#l z9!XM8-ulTIqZZ~aI_{nR^f)S9uUSqq(Mk0>Jl>W%&y>~8Y2Bv6_kmI2Y0jADA6U-$v!9Fo>+nuB zy#%Xm;GnJf@Y5cdc*{8w7!i^dsKOOIo=SZ_ww+YLj@q4j$|rAUW_10Xh%G5X3oY>3fm*gE#K0>-&F&vL7dzFU9Xtyw>*Eg8uh>D15-Qf-oE4dYY#ic zG=Ii&Sr1bEZgBoAeg%&{gSNNtr)Bj$zc{|cznV(oJOMY6N$Gk(o7^@E6)C_0rCA4-|Oc3 zF3%Uyub6k^gsQ-bwY&Hi(fu8*G?e8WF3g`bu%GfUPr!$lK#E=37+su~*bP2pvvz=d zs&iD|YOv8_pG$|miBqNYr2IFtyxqh5rqR3v%}&U2O^id1cbpdwge-Yp|WM{yqcg$#SOj`F(gF=3HiQ7?n z^g^KjseH-l?CYQF66?qs5bd=4CbON=JC$THEBh(R=DhdE&^6h=v~AyKiu)yPu{i!G zzX^^kr#PZ37?kFAVaa!XsVh*57q)C^ZU=6#QCs~seMO2MTjWtE@u0G$_p$OZIN12i zYxJtG(*M>AUiQCwZ(o@Q%PEfN>hZ`b!zS#5%f_lsyq6fEBJ$X>Id**+@D{!^vE#bW zH{N_>x3*8~xjl(ShUyE;MGkb%yHt`Y!teTF;}vWZsXy{JUaFSsjhqhYq!mEhs~ro> z06qhr1d4$RfZhPr9U4A z!*{LCx^fqIKD@N`moL{A=apRn8?(?At2=kY-GyXN+u+6c1GiVUieD#*stl54mmk=1zP*Ya!n{4qV21Z<8`VTZbu14s{q9D0KM~1AjiJ`-`+h| zAvylt`CHAuoB9@N8%G|8{rTTs-?J6Mx7uCBTVHzR3~nC}MmV+WEXThl7wvZs3ej$s zdbCV<^6%!fO$o*MhpH|Aj_PgZ`d)KQ6Ro~0XM^kJ9Z&7V?|8n|?T0UVAm_}I<$48t z5ZBZ1V7Z)KwBL~%DxzH3=7G|pJ}s7`@)e!E((v|W7lO$EbWO1ib1UJA{iV6q#Q%epb|q=WqzVIE};PZ52V!AqO$q^rfM->*6i zE6R2it3{PX*y<*zeGEsoA1Z%p?<-L_Wx%~SF9c{~FuD(*a;G?L0J1YGe`>qP-e|l- zKG_A?9gUO7r!wcVW}j^jL0TB6Md5VLj{c`S+1}`XPJ`q8lYOz>Q9g`qKV#lcQmz=& z@t&L=kL5jL*R{g-!*W?y4ckwK3pgnf6zcczY5YLeOJiWN6KZ?N zCy*^rS(4pQITJ`mKG_6?aru%@|C5~Ug?)%D7efQ$IJx^rX1kHcr`52l^Sq&oLh-Dg9c{m^EVCOTDKqO4Y9C_K)S7P&k;fwu${G z_8ind1|~Os+SRgMll^uCCIB;m?hvTJ$vE!`91n0Chf}RRqc)JPBUN%cNo^(dqYP?C zsSg$F3)dfNH>t0sewN!)jt7zEC~XQOL~A=K|9_&Z#gAgU&iu@5H*)(|3%gn{<<#95 zAGvXPJ3}GQK)GbsESGh}^8{EW=U0uFw$0`<5nro^Jqac?*c0?uW_hq@B(1~LQ-@mG$S`6%X9qWiMSoZW5*x9ND zt-kR3X8tF?zy3R(L8T)*V!8b5*p3SDm1$?ljV_cWwAiw+6rVbE(pue9j0*?CAjJOk zCl~|S1=Ve`6>?-BbWT3W#db%u9S#?LL=U$UY3?#Zub2j%lVe}zAcl!) z(K&;zp>xrv>&UU3!U*Izp8j9tNO9viF%F-TFQ1Ef$l;U+jhXW4#B%$s2CBe}`vv7| zbHA__VeNtWsOQx?RR>O$;$Qx6)8cn-xs1-qQNK(_S+0q3z;{Il`~6;j09DsJ(Sz1s z+r6(MXhbN5Px)VT^k+}-HDpUQ#oGK6Gt_i$0`l01K?xOKX3yexw zPH{x1&sSmpW9#J(pDHBI8|LTpK zO3HOT>+=cJezIKTK<7G-OjjW2^;g=k-@gmrjmyTjDg(BxK!L*@%)ot0WU(@pN-&7Y zL6O%=@DlYy`lmLPpL_N8CMz9_mR*1Gpgzk;@8sxV81Z7cCKL|YSiBm-Ezz(54mKKP z`hqOOmjAq^qZmuOS{%2G`6jl$=z9D`M5n1e?E541* zqXs-4xOnjscYbqJjm(4PA_qEW3dZte{eo%CMG6I0v`hOuaKnSWvSoc4q^JqVy(r+sDKwC@}@ zP#@a)P=NP*VE}DD`y<{5u)UD8yvJlez;&4U44QLn{0A=W5!d$)2O@x)KrNs)PzR_B z)C1}R4FL8bEFVzK>MwH8fO#GAzQ`~fqh4&w)R#7qj{5|!g))vUsULlPe1u&O=j|9H z(thYp-`B%>oWjBvdtPDb{u{^j{wm=oGRNJYn|9^sUi4S*q`rOm{2NdABjMnL=OTAX z-CJk79ULE*jNS=fYb2p<(x9|#N|~GUO`_MssoeVMUS}7RX zS75C8zsN6<*nVIXkO&L~`U148w8yl2V%HEXvimRDog!cKMMl)^TGX$e{kQa)@_v9S zAEtJmda~BFyR)8O;>wRSAwNWJs^R2EKl>Ei9#}(13?{K|Y9jt#k2yH!-AYUT!kz{X zwk|C()f!snAR*!H(L(eJf2XwCHSqd!13sA;8{<--5lBG2M4rE182VU4ahG9h8jaQF zC#B)1v}HQSfSO`l^1j&&LVHvydEWIN+Hh+`g(FF7vZ zSc3a(e;fl*PMgmAQtoq%#B<0EwllU*`o1=YLdeH0giLrGX=4o(JZ@M99!<)c{osp3 zZ@i`&4I!NL&mwn9-P^)=B27!qC@NnhettfOG#netxRl(Iv8eEY<4vEt@DkAN$~b@T zeAxy*jd{1y?U~){U7y*{nV0ZI+>f3P3s7|yeDK&g@My;8iMM`wV%dmwY@l$`KZ@Kbb#Dj9 zO|(a21~nZM1iAA+GJ7XIQa9WT;4KyR(=?n91!(W&K6br3$=p!w+>rDBSlhLNtu%p4 zT}|@;JE+_H>_E@n6mr1t|m4ZX~AI=8H}n&v;|+MVm$9U9%pslmta$Rm;Gua^udW&GQf zZ!B}f+ZTU*PmZ6VJpRW!BFM9R%=bS|jx3`djoO&?-0Ka#UckX5+;JFw>LGHc)V;;? z8s0PFZ6)W}zh5GL`#0DgpOQR*PY_a)pol)@ybY(yc&c&2**hQZogCtvQ4#$`ZtAa1)H=0v3x+3VB;Xq2rldPH$Mcztxa0|OY1RYoAv03# z#@sH`*7eOQ>Ak$y94@V1oKU`Or@DdBy<9g0qOZsc)z>+*@BF^v0_UQcwr*d7N_pyQ zuB#Grq_n#7jj=a;(6#dD)4U;q6MaSQl)AT0e#8vv*Ozo)=SUU|Ns-rlV>73u4oSh& z0Q|x-t+i4PoGN@h3Vm2CT>$zVM{^9Fh0gemQa8SrjpGS>u4}Pi(d$iqgPe}TI<_B? zTS9Fk_Luj~xP7)>Vt`hxO)J(2Z1w(FPK9c@j=EIN-78u^w@(Sdp4Y{(KgW9V|23vq zdhE@wmU*yoG{bbx{3_>>JC7*p%P&>1Ubtkc~I3PEadf4dO+^QIAsCirf-voBZ|YpMuE%mkxvMaq03lk>_){ zpwgb@!akn&&l@n&HGM>>I7djZ8rN>t`JN>jJywwg1~&j;eT&=@Y8z9ZVUaHL8Izct z!3OP`p^*BKahU6JwUnGeb9~htV&3onRc;v)68`6)Jm|Ur)W_^UvZs|+2j^`mHtm;z zG4JtV3mof*_sHuN#u)v`}9jy<#Y z?9a!Z{+)dqos^Hrol^I^t;j8*wsGpMkFUBWWF}9x-g4rYMf$aJBPX0$ zR@*aw^~n!`)Zr-f@?Y8EROIo}YV?9Y_4ZdUw*SP{smb_G<(SD+iv9q0k{1Y&?*KyRQA&==s?wm-lzPb@GH7z7Lkh5&pX$oC+I10#Tu zz$joeFa{V4Tm@VWj056;cz`2c-tQ#>lYuEf3NRH&2Qq=_0B EZ{m|HZTXc5ts|i z2W|##1#SoK02Tp@fxCdEz&*fyzyrX8zzSd`uo`$2SPwh_JOw-rYzCeOwgN8$JAl`L zH-NW*eZYR;ec&MQA@DJ93^)#a0el0T0e%3^1HS<_8|L4E5dw1EPUGzz|?8FcC-rW&k$=w*yOo z6~H>+8Q^8$P2dCI81M~n9tiYDnE=&+2EY|SG%x@d10({|fSZ6jfgIp*fNNU32^G&90CRvxfVY6Nz-4&Y*A++t?gCx{z5vR@kVXMXz&*h00ABx6bzqW* z0`q{)z?VSv5VUPz9`HPH2B?oA^*G=j0Mm}DbQzQ-Fb{YIu%UyC0vy20fPY!o65tkK zFHivwBgX=(fzv>Ta%i)_yFktI;4JV8P@w|eKLcI_%2ibA8sHV6dL?ig;C)7`%4pZX zSzve-=m5gM^9-dvor!#}RqEO6Q9cgX*c(tb zH=(}f!FFb&z2AZ|x*fc^1NMCpu5+_Qd5_H~40R_M>f2zbPr*=6 znq*UFVW^kFP!EKmj)0*Kf}t)BLtPz)x(^KXoiNnj!B9_r)TVxipZDD52}8XYhI%v%br%@wo-ou&Fw{@MP*<++r*dGZd%;jwfT8w> zp{@W!-3Nwx6%2LlR6n%~hI$DM^;{V0!P%nm|o)1I47KZva80tA~{8gK-{;GPcziK7jPKI;&mR`v~0504E{CzAuz zR7Zg7d}n|f{BVGJ;u-k60#ug|1Juk@0qPGwj29~gs_z;Gs_~rzRjna`s!d{`df@s% zHDXDiN?eQM+XB^{9|Wq$zQyrk#ng}0i>Z2TimA>0i>bAfim5*w2;W;weXyyR8oRfc z>icCe*!SWpDWbT_xw5$GI;yxDKE1g5Xi0H(=&9nW-`mAiKrM)b#JPuS{DLs-3B?N-S=m zrnhaVQa);^ewp7$)otBa{d}yknzN*ddM&1@diRf}>Y3-7sjO+uRqZw{)NAKjsB5;i zRMqCUQYQwrRtF-kP``eEg}QoI8&&$DwyNUwk?N+g?bO7m_G(w%4(j>Pj;hb^9o4*3 zSE^Z`byDq)bXI#0MybAsx~P{vidK;)x~kW|@20K|=%Es-^i=n?j8S!Cd#TIPdaGNP z^-=R*>8omf-%m}cH$YuGE>^`YAE=srGD!Vge~5Z7bEtan^fq^T)$pBLRM@%~Roi>EsqgQ6MP)2|O`Uvn zm%9G-H`Sywd)5AW`_KB5-fa8x;d{!}$|oKV}#eWhkU{jIvk{+;So z`$x6w%y~6<&u^;M7Mm^e=|J23Z6$1X9}ck{D;8#3A6?Pb`i`o$7r(AyyLogi+ee4% z*;I04Tbr;Jww*h#u>HQMy)7cSv+cUE-E3El>tzd_-rx4=iov!zpNz28zv3!er{(ds zE!7fjXEr3;B1dP~PFyzAHvIe9wog8pYy0HHt+q{pciJ|0SZ3>c%W~U0XCAh#Pg`f} z9P*Uy^vj!V^%lKk>pSZ;+Z&FzY#|T5YrFB|!?yd|eQMja;Y-`K-M_OnI(OdIcbCm? z#B(M5cJ3_eSLIw4zg<0R`i-;8znlAg z?sxU8XZ#jj^PAt>SC;U9zjFouky9i5EADUNzuVs4zkS1={`Dh<_>b)q=fCpNWdEHV zul0W*@D~4{0+#td)?u~(eQP)QFCX-Z|2?hW@lPH2iGRr2)Ba;RtAM^?p#ksI3J*A* z(L7*Iu`U4*9~>Ak=+yXtJ7Y2eQa_&?@bj*v0o~6&8jvvYg@D-+djr&d{5Z@nIP^3jh1IWK@I z$k`Z8dCVV#bFd1Bp$~dyj2oiMSpSJX&{V1K&c9S5JD`lZzjs`-Qe%!jXwDyqoagJ# z`}{#-GKOcC!*C^c9%YT8hdGb2xp*11Dg62`mR$3~CQ}cQyOPcIyy{_nv*Of5*Q0se zyybzRrP_Q2#!ADsO%1Atf%#j0Ppvxn>y~aTFt}0x=XXVJ3AIgLJ*=l=>DI&43GN9M zU60L%9_IYqn)+o_w>z?Xj~bBlys3xCH5II2A$sIijIKviJ@4fa)3A)HcSEJc9iN%L z!qh|L7p6xSEUStSu240)9y<*^%=y8SjmoHpua3O;_d!vyrXC`{Fg@G^(e;R}?^zz^ zd|!5xGHUJ{r2`fx_3waN4a*5XL|(Wap6{kv6Mr~K*W-YphuL20H!GvYfAn0?#@^q> z)y0^fPV^ADQ|jL4<;TcGd(s5E^$~`frXG5XYv5TPtQXwYsHn&wbw!PqGqd`aQ4bs& zTCUQfofW#{{*O-d5V=$8-g?&~m!=+ioGe6-H3Q42>Gr6KanHW+ca#JBUj$kf3?$qh#n#@T#sJKshJu0 zIZ0YvJU*Y4iQ$DfQRbypBTqe8C)5MCVe0DJXELhVwdRRtEgB4bmti{U!L2E`#Ml&A z9+m>pGw>yD8m5S?XVN@J=WDj1k7>^sKepDBrJ|mj6~QoFplfT&EipDuea!cF2H7WA zOEh=0C&kU+C951j%B6neVC9GXE&xlPVShk>PT%9!<3E15^pW~ioz+ z?+Nxw@0wtb$LziHtB?r;l3lB!L2>JwLyvNbZR%NXW;tzu{w=!INjNh7o{#MHooY}& z_CF%`P!2lhu~aHSy*%2)!}oWb;9z(lv?hZFtX2Ml)H*8*N4bD zhh;5J!T}JN@wqQD#+SGZdvp3Z-s1hQ9@E>?0q}&^+XbLs3}D&IcPg7#;60=hTV9%b z=lJFr%2{qAw&aP(UE*9XzxOI8INv<$XU~Yk=PGecd)hN{*YV`@r=5|WdW=A2jRazw z1*=mh*4EDHS3!*(-Ql^g?w$Q!eAZb*O>vxhh&)#TSAgHU#$;rqN(12=d2Gm8C7k^9 zJ#YH|^}K03>LwmwA7cl|GfZi!1OU^T>Kb4&kOWKtl7SQeQ=HcGs5JPP=2RH~raG;) zBrx4+@eEU*3R9leGpcLhUk707(|T6rfIkPg0k{#k378Aa1Lgy4FE<0261ART-3I@5 zU;%*XQR_W9Op)fUMX>~7OqHs;fu#VZOs(fzm^QVZaorD}L#gG!gFp_j0(b~m2|Ns} z0#*Z$0Be9pfwjOoU_I~{@Hp@UumQkytMzPbBm7Ok)4($TreCdRWtf6hTY%?*7l0Rm zt-wpbHsEDoJMapy19%m94R{^c3G4#i0Cod!0&f9(fW5#z;BDX?U_Zctz^zy|=P zb**P`hu|LuJ_L>c9|0c&M}bd(W5B1tXTWjbbKnGU68Hl668H-E8u$kI7B~f*1~5IW zz5~7o&H_IGKLS4i9IKoMeg=L4eg%F5eh2;lX!vY^AK(uJ0D(X;pg4djX6t!iN%*Az zOgCH421~;)17PaedQKPyzZ`&RXzQ6_MfjBf{*wUH(pLY^f6i3{Fh#9u0G9*d0H&)| zO`sM~8>j_K=9|d#)q5(d`mU5y2<0Lw0+WCQAQ89*m<%KVQ-EY3 z1xN*^0%<@xkO5=@(}3wf7BB;t3Csen1+D}540bl)0OkNU05<|R0ds+Qzm01p8xfro)r zz-r(TU=8pnuohSctOp(g9tWNPHULioPXQZ&O~BK@Gr+UJX5cws3-CPf0`MZR6?h5Q z2D}Vx2VMbo0IveC0j~o)fnC5Gz;578;4NSeuou_|ybZhq><8Wj-UHqTJ^&5?2Z2Mt zVcn<41ULqK3Va3}2R;W*04ISjfG>fsfUkjXfNz0Qz-izN@E!0ya2EIh z_!0OCI0u{ueg=L4eg%F5eh2;lI54yUetN zC<}xE<$&@)1)w5;$2_VsPz9(8Tn1DFssl9uKC2H0B7mAeEuc0~2dE41IX)f{sRlqp zpb^j*XaaEj(+t4lBh><8ukX3Li)r8D=yS6-#i~xJZcI84cc;z^8;tcDP zEH3P{5J`w$3p)f`33kDj*_!Xwo`&A%l8;xJ{8s;tgUhV(XXNGp$DtypOm|-2t95@S z?OY%aC*~ky{r*W$>+cBjI`eaZ5TfcVFb*#^zqleZeMGlhF>EWl!v6)&fr}8ngmw&8 z0od>2<-%g_zxUNs#d=-2xT-T!8&^T~a>>n8dEa6!yv7@rbS#6UF*&`JQsFp(`SZQP z=Ez^tXF9c!wthTTJI;QpEaK>VKZ@h5<1PRWTVd9-K96z5z}QcZ5C6F}#FlHwh!~BS za_7;4<_TOA7g(u)um9n5lmQb5@vpd^^E*MEJ=>o-Z;^0iuu3eJ`r9vlFaJurLPxv6 z_9t?u)V+&HhO55P6j4$VK-NOxj)ZF5Y>v5IlP9(2hngJ31UbT-RA5-D9-<~Tpwrb z1W#BlT>xG;!z^F1Z_O))sjELe+Br3T%{FQ0ye}nBM2=k#mp@Oeuh#5X>?C(xCrn@u zNTv<%8i$X`Jiq@K7wugyW*8f>E&bNZKd+HNBLqj^hONk*Quo$5fQZE($eRx3pU3gX zjJUKJ!?B)TW@_$t=UC=G&F);6Mb6aQ)k)|@C*@_@UmlzK#*fXbH@N#K!*t|5x2D_@ zW21k$6PuQauZJ?yQn*$g{^o%%W9`mwC_T%^(baQ4(5$!mSCvs8Z+-l(-@j;eqOmKZ zmhf3`BA5KdH|Hf?Z=**irNmE0UFGvdobybbPn)}YmXA3;tlTYFeR#gtf);%`S4wq8 zwbu8bULqHL#P>Qr%>6db^$!beg#gnINqXLVmLu&GeZ4*C=kS;~Jx;=-`e)stGax{P6MtieDX%*PN{nf-VCx&>YkO# zdx#7?!<(FL9XyIH^Yu2r%`tfiAOt7}R0A3S9f9G%Y=CoyrBUg(0K8Z14#T+vgXf7iZ> zclCypQZLU9Rg)@JR!@Z2QtcyKsc#qQvc>$`rS%Xwja zJf8~AisKl7eAgZ4h>GH>BU1Sy#w|*Ee^ng)zV2i{PkY0Dd;&6BxCirpz5F|DM!l?` z+HS!kUoM}O7U|SrFbaj`E^8f%dZ760=N=j z_E67S+qEM6aG(lM9^lZYG7t*D)L7>;TmxV_JjOH$o*M>m+|4-jc|L6&$KA9E3={0v z2pON#XO-&Js)uptg594z|AI60o$xYm{SL-r8?F=0ewOx9=QPb}C4ic;t?Dk+6_M?b&kua=uP*_eF9!yD^2N0G zYrv<&SGByO@nr{V|1gku02sfy`dN{i8WzYG>y<{++UK?Rw7)xmWFQG(|C0b@0V4p) zuL6bvGl6S>Ilv;|1|S7sJWf2u0sVkjpg#}^Gy>WK?SQrb`;^)M`;z)VEuaq25NHg9 z13bp_*ne=i!8nzHaF@?1+6aKUQ_enxV;1%+?0?8-_9evu@}DKixYCbsT%m`tYdQ8c z;v`I8!g5S}n=8Qd8Hf7>_X!D$ocZcb&e3JQ@c*w8$c8#{f4FRj=Qx>lOdc%+>0W5n zfa4~uO{A1Bk!liPG0D;4A% zI3W6O9_DF(^303iL)PSu&nArTm3I3r_@;<%IWCg=i`)`w8*5%9Dajt6G1yvJ7|Vqv za(zVSU9QSA538M;+g>=1WIG=Xi~+_1bATBD?aNSraUV$w>hZ(o=hy0L$W zse@R6a2!LBA0l^3-P?TrXMrbWxc{@*;yIrfI@&XTJCd0Q$p6mvLBEAZ*37+c)q9^D zXGa2e3Sj;sw}je8o;MfzzcXXbH3~$~+gmH7Nv@C^1f6h5eDjzymNTAkN_-xZbjUfT zZE}z4QbxzP3{xg)Fia;t<)Wi?Ks%g8!q+ ze-rU*>7f=c>6g^En`v-oDNBxlitqi)>ReM?s%sOI{JfWdV*s8D`(Z zai+9m_CY*f+AxAXSHu!MuG&tKKj`JBsH59E)? z5#7VZ;%}E3F)2y>Aruzu#V0n-uUR<0pmP8wKUmki&(Iz3MZ`H-E_;8@Uxw4=`YYqR zb-FG9IXS_F1J@T*{uS3ha}woqGPe8LI%_{I#r0e01_Qi)ky}D-<6b(msq>K}{}7j! zf{|QW(_Ryj?6N$1(|-8GCUc5&JxZK!&KELC+GA!*{}QpjmO3D z`o!sB%FKO<_y5%|Oy9ze|1Vzi|JSoT~?9l*81B7xs=d=QYz_&6^acn|432BZOffM_5JXaMkeG3Tz?S8$Gx<1cbo_=_Yh zM=m2tOYW5X?{6Kr1mQEcL~D=bYZHKqQ3xuH$nc8=Bn&{_G@& zfKPx|fO^1E9D5LP_zecX4dM4U%K&~`QV)m*8UUZT(xrXs>;j)BGz0jI07>P}5hA+f z#J38@CHr6ZvTy;yj}1wl{4k$ahE5Jvp>-?ozOCe$>AiSA)Hh(f{Gh-p3`%xlfN}!{M5i%1&?*A&0M|p>P4QhH9(cBi#`k~y z@jL?$HEQ5tM(|BI|9*VqxCP%C9zlA=v6dl>--&da`r$d7x&j}q)xyAN({Vp_%~XFi zwNilEinaRMydJ0y9KqUqSlBfEsS>Kpyi#i0lOd``k5F}VSUHvPOGUMDz-4M1|Z{mMFF3tG+5I5l>fEB&nE6b5zfSd(@$R&!}S$A5aI=ZMJpawXhXi zGTC-b=my)MberEh4afU6srsJZi6^iKA-I6%KRXg3)|0Fk!SBcD7=d+SIuxblSXYe7 zeH5eRGtBeo=*zyytBY)^Pj-<}s@?kum^OeA#ErDz# zApLLFbWb~L$FT`O4(;!^lXu2s1gl*GPO5r2jq1G^jstKjKxp>AB6mvNTaM4HpUsMq z#h-*GO|d8A$0(Tp9*{I)aB5sUGP)Q$%l?>ciQ_bC&M67nTt07Q8!8L%eoXGqIIiNm z7`!*6J?7Y+^P`+Itp?COa}35g+HfEOs0q{pY6EqEx&X{)p8v)-hO7wyv-+P|zkNKe zB_1FTXk+2!nP0sEvfaQ4fMvzz;{S^lgGg0>D+v3%M`+O|NKjB@VNMiOEdB||G^cZFwI?-S9T}fRsyYJMzw=X?<;Vm<}J4+%5WTAZ(xmiBm?JM8aaT?hC zo{LCY!bS0Q4%6O^0U83dujIMdUD{r;yFA8mF5}aF(ylfGXe)V)=MWs%&?oPi7Wdhn zBu@l$C5%(n?&!=3*Qry>_TnlA9N1Ps}OphmV=;s%&pt$;Z5|+43hu0_9 zY3eEQeg6Ni642Z2$?Lth+s$a#8!A2fOxGiAckXjtMh+^T?N;RG)p>8XeN$Y+qCEXA z*Un&DWE&&5^5YX_n){Fh3=fs2v*nV6eA+b!Q`x8r!i>|hm~apRQG zIl*f9t;ZUE;JU&h(9^ABK_U>F&tO( z{)P80yl>%Ho3*# z7H%${L*0eqM(;-4=#@hO?Z8dmQrzGz#31BJ+}QCaZ8IYB+EyUSPsSD;bdQq%RzHr z1=!a?DJdE0jAhRA zrlSF|y-7QAr{oLyO2AhFQUdz@%;sA?+pQguCIB+en~iq;O46C7m44j#`KEr(6xfIJ zen#YyuK3>XXRL?vR#b2E5R#U(WsY%%xP4u&7ryn`HP|ITCdCComa`YF z0vyBF1!z;)=KgEWfeR9zsD<8nGHyYzDw}!l*24iSh74?d533-TCnBdzcLnhT|Jkr8 zV)8@kP*0*9@0G~_Marw32lOvQ7 zxJ9(?sdEBpdwMJvY5ejrq;)QfJ#*ai#yym0MExCLey} zK77z^iOCZ_hh_aq9kcui%2=0troj4~0Ejz^0Pn*&x3L_k5BS_)Qvy0qVwZU5$p-MK z=kLcm1l{+`n=kY_%HdM39TB;yRX#ky-<%SsWKPjpg0UzXy4l|_Ew=xnI>sf)B|7@# zRuCZRNPhxRE(aN=BmcxP9?un?iccAVX(!8m(S|Yo-auo3b8kx|Glc&u&VdV&{$?L| z!b|J|(5Fr1oaDIxoAR4J{cJ*|FxC0`{tL2Gum7~Zt1=uYK;BP?9ML@-c!KvfyUvJD zvSWd|xb&3drXy1_lP5`}ECeL~lXts$%KSOU*Ao5)7>09+*DZ~?D_C`FcWOqdULo_A z4tJ&?`HS2sb#L|j^^9|nfzHeKaSFL0+>*YDdI(<_=5hKw&iK@r??*HQ`T^sC?m$g| z@2k+}@f^nIc?8e%IqxOlz+vG<&^_LHk+3vay?l3@`?@vws2YBGYdPVC$emL6R_6sL z{hc2ty1AJjKWGnFpE5RKopP*E3+M|B1lj=PEXSu*h4-hlCBhrwfbQe4&s|^%I1oRV zANPCmL#ZgM4zj_UGB3Rzop5ikx-<0JBRjtuTB-WA5mrvZ50RVM>-^|GabjY8B37rJ z;pWFtSN?^)Pt3X}XUGHE1HMl|zBC8A0DRwyHgF~I5zrLGxDVjJ9L@nHVSHwTXfu&e zVV`r#)LW54%P z4uAZUJ2OyqoKjr1s#;Q=elbLic`{5*oKi(Cy1S-&D40)3qO4~s2o%_F^B5gew4C_l zHy!sGCfH7R{j8lj0MxVoqr|?HZG!_1>34CdR+#s6923R>4S*;>@<7n%TqTeVU-;jA zxp)3AMEkgT%Hn0!!^bS0u$`rrnPt@8k-7a)myR zkvp8L6I4%^{A2fky9K0b6a zcr?CR>B+~=)ZVb8uQLG$Dum-ZkvpaCtX7sPIDI?HwMWLoG9%)^dZmsGsnlNIl-#<&ofSszx~z5=J;6TMb^VLSkA!( z>-FXvCz~bs@9r)!`6v)#&J%RJg{P@B)>Kiwk zCHwE}>wHOF?a3F8w%FIoxOpG=l=}2_b0;S)nPrZfMQ&b2fqcnt5RH>fzL@FJ-qMNB z{(z4A3=_U_CJNzia?6me^gnCXc;`#dBUl$;;B^~1Kl03z<~UR2rkX|JOMa%NFy2T$ z!W(m+<4kggzHi(qrSsSMx}8Z_>&Y8)+!^^O{&(?~V^M=nlkPIdogz0iE08w@3_}0c z#-9#cus-hM_46H3&MWDT_dwz}9{#JGJ};ZF$+P~rp3qKYbQJYE=Kj?ODnA~q-hH#= zj}=$0DA{zRQ-jhN-1ELclKWm*Ve=|t^EtNQoB_ud zykDfIoLAueg1kGzdqqr{T-5i25jd|F!1;@M0Pmg~0ZjnTn6v;|0i5^ayau09^By%C z=nljHeSuhD2*CLs-pj@T6M@McT0 z8u%3mg0ZUr)B;)nQ2^iT9S2MWZUpWI)&l(3EC0*N|EKaFr~C&g{|(CTt)~JDfeirv zrSbz%6~?j)a1C%5upQu77r z+*H8CQA0F{ewFcUJsQeZOtzJ-hIN0?aE{`pZ9+KyM-zdyJZhor>)`x)s83XAQ&ebQ zROnn(=pj^S-`04q85Oz!6&lwO>&T!&)1skwcg#oh!vAzpp;@sg3smR=ROshp@GX8E z=HDjb{cKdIBNb&j4Qq;^LXXY?AF}Z-H7fKpDzx_lD5F(q$B&^do`#-VF{k%B=KtQt z|7;H;_9 ze06()qEJhKu>dZ|dhU83{4PLk0L5Z~@h$^U)G8ccJ3&!e#~4NxTk|X^ZfmZ<2A{`K z)s|yBqoa>1v>d9=>Q{L#W#s{;kE$aDtogmV@FM`mW&TW;ad8$vZ8z7p`2fUg96CGh7;U?EPI`@Ut*(0aS)Kl7~jh4EqUqc80{*=yf?{`Z@1 z2Eg&3$St9^(Z+wWq9lGsIUpH-;*Fm?$ex;n)g-vQge)_e1B0*kZ%ir>V84X!-WuD5 z!)JfMK1TWn`abvfmw?WfotwS$rT(+Qs@L|3b%*Urt<|9q27qwF7m=G97nLuv>|}m? zG1L4j_DOe+bI3W4UpU6$JsHPU96wP`p2~QMafO=*Ub1c(u3YSkdfq!<#yuCTR+Mct z`*=)ZWM|h6ukc0WWwCa)9GnscZVC^Vub{M2fbr z^Ct2|Pu`g83@!t&-kKesQ~SW`vlFv;$K$p$A~$m_DsPPCDT~Y-GrywjlPk0zyzk)^ zlV`l&V!y{QEhsriTSPFvAV2Qmu;nf#4mxnfVsADZyvg%C_v5lEHTXb@ugVTOvfNoz zDjYt?Ga`41b3O2;XV+fI@oCnmB`&F7TpIr)?R=VxSPnq)Kk$+#Z_Vepkz27o_Y-Tr z9b3Fw_${s+!r?Q2k-NmXUIF=IIF**cNM?UXK9Muz2kjWSAofba5ar4k_PM{W1hSB{ z@Z&g~wQKy#cxF;unxtde6_I=Mg%k7%@=50OXqQAL zzRouswj7V?j&Xc0Zwah{NcfZWns@#j0KY0l+CD1lw{EA&ACa3mTr7W#-=O8OLuNkt z?F$F!3s-zR%CDsUyv%_lghvNK`yPma@mUW^ekn$b2u)jJ)artAz<8(%G^`hQzoJ<_X$nsT(HdgFy)^~jf{ z)!FG~Rk6(S>esWCRC_!yJAWu#ot{xwRVdR$&D+sh-M#xtRs5O{K? z6;&-;O}9U&ZeF`ZoxX=pB9#r*n`b>99{68!s7}j?pP%l99piCw&e=-bDR6x4bG{PD zuLQCo6#F{v%{=xsfc90^$=~@&SvBL$osWYG!bATn`{$w5D=5kjpj0&M zei-cjaLi-Y!GrHbm&4xIR_dvS_=cwi-pgo*d%3RAw?Ecu8-?$16QRRQ^b6>S>a4~) zCNE>X|D$;4BG9J3X=YQIaW)l-4~9yAWK%!kTc5@A{M7fS@VyUS)F^fyeE@!}eDl?T z>eY?-?74>cjH7vQ5>e44feV$oHo&LG3s`^EFHE&>L6%kWSRr)Mkjf$$P zqOWbNqF-pGwl?gjZ0EbHapMN6?3Gt3|IlPyq=S6RWA7tyq^J(X_&?!HJ-aav36qJu?Ax1czb=XXq(vAwZGbeTK@zG$U=C;CdDfD*`pT-t5(gP!e{ z^Y|R6$-1=X(60Mbp8fvQ73(zn!<8QIJK1hU?h@yE)_jUgy!FG%2}yQqvdwI-Jb|3Y zup@U4A43kyNqe9#VIGh+BEA**FW&r}Y5&El`jWc@O2C0@l=ixzkoL;r`1+pd^D4bx zoVN#-V|(Rnktw&t*qH6Ldun1*%A`!10n0hCmHZQqc()hL4+X2Mg6F^a%D40S-^zvy zC-y?*PN{pFC;w@2@tOGgR$}C5H{_V<>ur}|u`TrFnD{)GVfMd)t}yon22J0C#EMj*8&lH zvG5b`_F}|G!D?)Dhaa}wHgQT{HbgkF7b15`-CHwXzNf&Wrk!A$$D?3t{NOT0xoun8 zxU^64nU1*pWO7XR8Bb4NKcsB#O7)1 z%d`#TV<^kX_`;OSakIU~rloj{FLXP#?YQ^+v!P$$!1`Ghes85V_2`Z64x08N6f&A1g0@52G=e_oD*;~#xJtkQU+hKJ7v9@z)aSu!;hO$qS9iL*;Z|2? zCH=d|&4RVstMpjH5nNyrG&321N6qaL~rDMBgR?;_``;0>;$HjL_3vTy%JjqL! z$@#ip*l|6sFYGIUzq14!NL<=&&R3r8RxQMLx;TCg?YZ&0XRML<@o9JW`fSnRv-i8m z9)aWKF>5b!?0Pt~+u?EPQ@STlN=&x*vuDIjh|7o@oH*0oCo!54|IG7Hz5_#zIWLY! zkk)fiz6-;JYzb0^I<V7;|<%RXfg>A!yjlv)#0vA>V7Z!sH+k^{?$Ayi>g*_U9^*M22 zSL4Dy!i62eg^i0;%Fzk$>vYHS+rGHwp{V1la1FQ*E17|Rt~;=nBA&ZeUye9W;Ct-t zxZV$xI`}P~0SDRC9r!Lgy}M2ANx;Q`1DMvGjZ<=Yvh5pBo|xawg?}Ba8Xelu_Kih9 z4{r2UuU90rvrWfpGw{ zCNFruhtqRyJE|ntQSNhpz62adLhQ)VQ{MRz^=+_vtnS`TBbwGa)a~ohR_4MFk((Oj z!w>l+&Wf5JKg={Pbf4Vdvj<)cxz-x!51;sP`Oxe(NK#Ahb%yEdw%`41@Cl))RvAn~iH2eXA4IA#S2h+LDm~uameF zNCE}{9EXf@`5dd%2l&2T5Ww?kNA$4=b}w1SvJ-o<>}T&hIR_p+H>>x@2kT`1RKnrx zxuw4mxml0}@dS&3*e`@9%#CA5&X2L~Q-E2(Ex-f7{lHy7DnJf20&ojy)ipfJJ~9ob z)|7aH#;KrO8Y>~egZZCHv(gUI3NvJ3e-j9W$-%# zcqQBVUWj&q<5oJR#dK&RBwg_#^0@*^U?JqfkCVT9^27Z8J?1xzTUW$B?)de^WYz~A z*9#;+MDCQjx8Mi70e8-^cKLzWF;-EwM)^)61YV{?q@Qc zett5K2)-S!CBQZ)d~y8YoiE#}hN;`uE~|0$m1a$wx>6nQ;)}@5%r1m4P4U5uoUiLu z*_u&xkFQN0kE<4@YX3gzmbloyvlhDu@fPMP$zzdAy5bjAFY7t1rdSpdkn&mxy_j7W zfPM`CpPA(T$4k`+Q-56Z$lOwK(NFvWIUSEvFOge9ZR6C-<3C>fM%?3jq0N4{I5^2S z{3SoDFCOs&rbib)`A%h9h zt^9c5v1n&82|q<{7M{+NTv8y?U&#xpXESeopK%0EhC9a&96w0i)93vKounz}IHi}) zR_DdZV%~WX6Bwe34J)~N%ZY;5CbKs(-KMN}1ofiqkLsX{*SC%=wWL}ktQ{PFYNiAY&aJQhwB2c%*_780sgFi z``OnYc>DU2vkZQSoagH<4?kQlz7@m^Z*`>~W0;&^d#58OIOjyQbk6AK;E>N1u>|z~ zBr?Q1FP4Ef4>!ClvFDYqy@aJSEGKqDs(}VTzDbp>70@C7+0K}Z~AiF=Q~S4 z=gFFK-gy!f7NUkMI@LRFOM~b5s3uRCj?|r*rpU$a_C(}Pse9{aS<`@H9+qb(9SeI6sw4PPu74( z6Z$^++2h@8e(|gbIN^!Nol^I4^eGzob~`JY<5`iLY8HVn`mi<+Uwq?Qvqb;h zeZ3#rSJOLRnn#2vzrpo`%FaIbxH+yBxp_53;EOf9HTxmj4uW=r@QrIx2>+tf?TV`7 zohRdJg{a}%mrfYgU`~aZu0aIfZQ*MxA~!F^8&8VzUKq2Hu?NG1^gqmt`>vrAcdcU* zN8(eihb10;pS!RU(D|~k5WX=gSg*PV~c=AT6DC@ns?0bS$nU`LVj;SA_&c?(Z z`Tnb(PhXqd+e$?4(?sr0*%{J#GhqBR_V|qSrqT9^c&omt^?FneDv0^(-wB&({GIzI zKgb_(4D()5#`ENw%oj+U|GMwM1qwfc8hhtQLcW%yi$!i`)`w zoBa6EWnzXs%}I|7wjWy3e=2D5g8RY^`kc;UX^<0_vUA|#g&*~sdgn(r__K3(;!R^J ze$k}(t<9}s6Z;`@vn=!DM~^hSeZs%U58(kh;SE7JF8veFk$D318vo1t4qTk@Bc{1` zeyjn1zJI@VrP8CmTi^I+j!4}0L*$lF+vxo0XP=UiHlwLdk39CnY}Z;+7aWwdbPni= z=*KB%{j)#O<>ZCTM~WPxOUCKr=n<_&s&>w_vVCt!yS#ID zv{go8KSXX8oX!t?Ae^2#1*T&_(uAJ&WP4g%Mq)~G)4qvQ5;I!5?8#9iK)#Ny`Q;0e z7VCxe#I`JTDE2=LGJfY-2e<<01Mod8j>iuGt#I-tAPEUfMFO88fwQRaV@Mzvi=F&b zPN{MD=zK_hd=H3!Ze-!3(B1f!Y{|n)ef0(Y{nXc{Za-jCs~+@I4{q^S@AM5+GqQ`T z^P5Vl-EGULhAS$la$9StV^20x8>@Cw)w_>SPi0=GW(<5vrKbI+?rYCQVU!44mWnUicH#r z$jx#rLVM`y{D@v!gfoSIdYo=@KzKtr`9hE{Y?GJTm>id!$LV%7yp4C>@Z{yKYmI6- z>etVdW06&SYN94+l9E!l3esNhYBZ_nNdDoao@A|BPzGGjiy6N8g?PIoYd&0UAJ@uopL}VIty@m1+j--QZr~g^Meb`Hh3JuUd6=><-L}i`i>Y0v z?{?}eycM}y17}Frqk9(SLz1!Dfb0H--@EGh=Ui!)gXg@R>KLM~7(e36i4A`4v4IOy zz)AihcS_w`kNhW2OpH&oC&%O7ih0u&wVeo`c@D$uujv>j$7Nq^BIP=;>vI=T0(v{y z+1Wck>URoJ?>~OH{&mqKzrTFHGc)0b$W0Xr;76WM4vNYXGkxxp2XtZ!=@Yt~{9#{8 z8N;-b5{EK57eSxPrvx03i5)u^<;jx?IL5Wj_94ioadEpuR4_Q?U(Kl@6CUFsq9*E+pj zEsORnuai)K<>lxSqN1Pu;J%aaL+A8(+xG3B&@JW>BkuZvg&N^aQX4jfU4D^96;~56hoUe1_TXSpEd- zL)s>SR#=Zq*vxFU)K@RRq3QOt z=%keR$%)C6nhvtZrDHNq1{nH0$g&=u^=Pi=aSnQpIWuziT_>Z{&GkG)USvJIE$)Ft za!?^=eVS?i)%)ZCo%k-QT5XA8f^97bpd)_>iBH+3;vBe8Y5$vJJb7b&k6pQEh?`-nd^Lr+$=e-{LsFz{Hu5(^+`SSu;``NGsENp?FBi)u1pd>J&rHzInUjEfOnoO1dl#UuJ=If(oP%A^*=;zmZ^81$lHGfk4wDO zoqmjA@`QGPjvSGBN8t~B{T#;gxuTVTZcj!G^v;vb;L-kLFOB|vyrZ%C9=gcQT)p$e z{e`7zPgtLX^aXM+!t}*{@R-D-yfEkENMR*Z@NxbAHG8mko}2`aD*P7KYQOE4J?8o# zA~$m?kSF=vyYgI$jveKf@AN&eORg=P|B0 zIp6fZpiqS$0-*l@eA4)xz8`S1avzSKFT|993w*1dp-KEZTH)VNp)RG%Djrm&76wN z8`qH68qu|rHpSpfs^{Lq}n(K;)+`Pyl^ToBuh-qKU^zz#mn?rj; zaG&?kbhJ$(mt*>U6=ihdJNMkG9rq6B`$z zj_mvWE&oGr++mJ?MQ)bqh4My*!8xcj^SNR{^(b=R_}47`zi(f+H}&n_d6OLb1 zIO1`?F*VKcugFbJFO)Yj^K0_PHx4#S_TSytc{6U3ciwCRukPqZ3Toiw#(?TL^H2t!Zyz6%o`cE3=7-c&&w4uD@BifcfwiDm_C3%YOq6GT9!RBO79x3Jd9Yp0RA*$JL*L1G+eqgk@ zeu>CUB?{zGev6sl*L|HYCsV!iB_<_A z?eSkYV{?Oh=bP)9h}p?pv+I0*Zg1J*ZC5Y>76fYz^4Os z<~^F!sp^yFdM6?`%c?-W$j5=&+BiJdv@d46H`Bk6eMw8_gnqt$oO1Gk{f{n}K1q1P zc$bpP!NtlrJ$t&z7ti%iPJ&OjH~1|+`Ki-in(Lp4+$_5S`BId{P>`6(A2a>GYhP@R z_{@i4-+CdQC7y#_;m^()-uY8MD@4V<@onFYn@U}7t`{P5&(xK=Q2v_kN%B4lhNl- zbFM8!zgZ!w+?cw1PPZ=>Y_20Ba!oZWSh#-qEGmLC|7l)}-oj_`MebWyL`uTx>%2K| zy?5S3UI)AQ%kC#vu4;6pxvq%FJyS1=U3BrrFo^#&Z@k$tC|^M>UzYT=>c(;nRMrMbR{TkctUMYcDFA=K|Hl*7ATF*U~2Y za!;+i@HxN5M{u&PPxBj0eLUyg7DC@)C;FA&IwIgRbNvyK7hRux79+vQMQv9)zZsVK z4TjlPWS?z;_bZg^z^>0-L<#8aD&Z#YeAx*;)oA;9#Um}+hMDV;h}=}6z;@N$&6oT> zaVRQp%>1}dUeJk+rBCQ`@=18aFy~$+4&%wW2>M(;C7|1xHFG_AGXe4S^-0cwSBZOO zS3Nwo%_wty5|Nu(6v&(W7AwKY8vu@%|5w&4(aZ1TJkRno*DHy{@yVwemHc&c+1|@9dp^DcetCM|biX=X z&Gke?j^sRC5%}jSzx=FM{(NNF3FKLi^k*zLDLX16@fiLmToy8s@{GO3vpmi988)E2 zFB|{P{^MV#{N9Zh04LuOh}60tvKp_Y(Qg8Fli+$kDD|?eqJ@m=ksPA0`EW8l8S*Ce-VLj`2kpq$Q zNBX2Ciys4n$m4C`Ru&wbq$l#U+97xpXx2X=)Yrwif7$y#CRwz}(LzKv-fb(t#} z;fKgQQ}?|8aoUZPDXDSs8Dc;5{6p{X&d=1_LsZ$lNq!Y-?~ne);HSt7&EI-gMsm-~ zPxgbfJB4vc=c3ptoD0SC?zel9G8AK7)n)Zl5WJ5=dBwn0r-Ucyh2 zn=0h7Uwo0%O%D(IxnYraeugd#Q5_DRXx(-C{k>MY2qgK7+*|&}NW{`22PD$_SK2+{ z6vK4nnK*`ZNL-N#H%0DJQ%?8!7gz%N`V$8hd*?^wogu1}U-LT}yc*iVNi zoBgcFO%1*A#PuzVWlwZHvhVh;$4Tfp^T(GTpFOhMHCss#IN__vol^JKn;v@CYx0%v zxCmEWS>-0G@6%q9yL1c_!fnR$*)tTvU*L3}gf8{Ylb!X$)b(k*H-548tq*Iu@)n+m z+*HXMPxLNW*JD{BdL%RqQ%zF#eQ|$eX!=w`50PJp9?nlzor3{=zNh{&@8uEHI823v ze)eU<#jO|DG4v4mMd+cMdynS?n+wrrO_MOSVCl#Edfz|1rfE+^ei8cUX2nCFn0vgJ zPfW8g)p739sB-sh377UNd=dFY=%bq#4}A_4qR+|ZVd~_&ubx@FaCsM#zaqZ~eRLXo zJZ}%Z-+TF_-W#GyJojDD<*_}}$GI|=@)7xk=wp6rq785J+@Di3+EdzCf;Ls`uY{$} zWFJv{?r$mq{rOJJa__uZ177WJJwxqjH9K;%tI~uwA~)6aW`}j&cr-2~Qq=xixFh+> zxRY}7h`z7?meTp_e7)aH&GF=oQl8I|_kmaC&-rcr(SOqj^ZN~vo0{po$>)=eToYsR z#7yV!-Z%Ltwu|{P%(+OJ%O^KE|8prhohQp4^3IcU;L(mZ>PFwQY_*^H-G<1`vdfPr z?oTyxX_CjDnCbjo`zAlcE-^py!}q<0v*dN2Y z-P`7vrx|XVtF(1n;@^8PjX~_d#viRd$w=jB7=1mYvQM?Nz1RN7v@K#Pt~5OvdU1C}iES&RAc% zlRD-3JkGHM9m8~T+_~r57PSQQ`Ig9a-ubZ%{Ar(lXzi}hCGQSv>&!v;A#yX{0{CH0 zvFAR>Hu)m;?5%!R)&x-yrDc{8eGS z+}1qiS#IWgZ0As}zl0ZW^49L_KMr##E9E9~Q?LBXO?!3CRdV^28`}aMvtl_CdRa+1 zNx9+hKj!p#nW)FTms@trFxB(HXKyXr;p~ZFE)AvJL~bhXwcHA{Ql9@!NZ8=1m-!yp zPUyY%T*sCT9EZD_?}3Tjn_eFOnab^1ooAT#l2X=}*gMu)QR+|Xo99c|^d%j}(Zk&L zx%^8&Z}$tI^3Idf;L-BpBl^Faytj(^UYN+uTy*~C<%#=IMt(ezw$8fLd1B_FA7faD z^r!kcK5poxQM9l=4h!GtohOm4!qoVdwe9QDmfmhYXA-%Yt9PDwJYup=)p;B9w0C{h zK;It@ynp18`cEw~-xm}4h3Vs-1vh!?dvDAv$$xiW=gGc8cygdMo?pNFN5=T%DvfHo z)Rz8Pyb^Eu)9 z5LLU;?JM?ox&3kTeKV0?v|jG6+e*UZa}cC5W~6P?oxV@|Mw>^+FrnK`pZ#OW{CTJI zCZ`bIRE`W&Z+=y2@s;g=oLbYBwe;U2H#I6UpWR)#m4vQWX<@=G0I3{&*yheR9cj6>|kHR6oN^dFWSpn|J+|bqZ6lRX5I>*{6q1 z+PjpW$p5T~WQ`ip%l?1s<%cn8zZ=Nc;L859p3NS4y}aLz=rXdH@?*C74Kk7CM$Wgh?`3%;ordM2 zAJ)|ZhHbpraa{zOA{jOj5P#~f(Hbev*c+rt5I+*|pExxB0fdAjDt-oe|Z z|M;Q2Pmbtv*@?)D{OSNV&B<~@^-XdhmxK2tGbj@nk7NVG&>#)tARToF-lHqW1CnLp za6pus<~Q|nxjf(73< zj7eobJ+USAx^?gV@T&%d);Ec+kt2?Z57#TTh3P4ZBk1!&{|hmQFU?Rc>bhL8R9{$s zv-X2?mhOD`MDVi7{~Pw+fo}}L_eWs|+X(S7Eic z!ahaux|DztC<*wSN-$_2KZyt0$0)%N3>JKW5atmEOZZCOiI1=4_`J0HXD`7=Pz~Xe z=@gzYKA{s55jH_ags(LLeCJn9T;6BHM=w(OgioeZc*6LwUVTA#$QLl=V}pRRe!V## zXPuwIZvMxMjbEQMB1jcI0Mh>nhUkQk+%X=vcb(z5-&mh_@v4LN#Q^?45{QH7 zoEp7y99q$303}+ynsp0A#qv)Z`1#Y63d=?${lV@H7N7M{uy(K`!A<}>1MC8@H-cRW z_It3$K_h7ZyA^B=G@OH=vHSqGI}Ao!SFwN zM>4kmaFFkOc&2HLRX|%zhD{c?J;YeyM#i2wAc^_sCb7p~PGaffy09BR>B9E8w=4VL zU)|X7PrI}Hg*{oXvwE?Id-hTJ1}r%jAThC?E8mUs7a%fue{SZ5DeU(}vj_JW7k(DQ z(O`Wee~GRVg-cuh!XJ`&6=z6sP4c)(+F zVUV%GXO_Q(rPQ9f$BI!~TE9ivK!a`)T#2p{g^LNE0(T%7;u1MUnO_a+4bqAA)ck>Y zJ=xyx%Zi@vQy%(Hs616G6Xg`^iRc0p)eE%}f@WB%ghFm_MbMt>@%R>$f_89JD7jA5 zxTSSoCp+(}=q{m5KSvOa|WNxWdx!r>=f z{M23=Djb8MoDf|jN1P&`)8WzN!d~o~>qDJc<|{!hj*(>fz_#07Bg#*E(^~P(IZzM5 z5&8I7FCQ$Osr_k5OJDZO^3a^DjqrWVqOGI1=0BE+<3%(iA4KQW=(UY}l)4ux5@KuadsUcR$c2s%!n&&mh_qu&C2eUa^Zm0PH}pnP86vi=W%&f-M4j z3RpMTv%p>pb}87Gz?hh|pm@u4A_v5Noqej8e|fw!>yy6h zo}ndKlUpZtmGvXhWvFfBU(k;QzCbxnVg_erMcRWbFP6TPIr`V$i{q{aNnSFZ>7we( z=|8}D@w$iJK&1Wh9!UufcYjN$K}{gF4V}U#I%?b%j*#2uwNLVnQD7RYlzTlshpWs7 zb0QQT9y1IM>Fvx-=JPR3F>dJENwv?u=RiLi!XeXnC}RQ+nrV;sxbKVgBc$s~sA1`B{fx3M9VT{e(@ai$k0RON5`RL=+ z&+fe85KZ9oK?mcwgXn~dTs~grFOk#%J1hv)I6Q8b%DWODpsO2VFMv@jPf-XC@{7i) zln=Rsp*)&95Y5OH*V7imbD_xv3(4Eej~dTPVKuJLMxR~yk0-OLF=ljrM08G#UQ1wn zT?Ex_9}na2fET90rPY2vFgK{U#@4`yJP0xXBXTYpB@VYYG!#>Z!IC^=Z`R|YdGWI2 z82feV%J~@o`h|r*_wxUCD*Dmzd3x_QbRNo>87>tnoS6+m8_e@ndqXlf$VBAZ+Bo>K z&PidOGk<*X^FcGF;1~c6%`1t{snM$$KF&8|WMRmH_~!qgc{^HrZVGcQ*?8rl>vMmh zewlC)J&K6?;^X4XDs~5hP_61*PpwrgBT?V9#=(b4QtFOu&c1s@HtvT&gKiRBiLMfb z3#{vvdn+AYmj~pl)~Wch7FAY__ePhjU_J|Jh)=dJ_3~AJ!(vtMHH~I$)T|%w^MBr# zJzV|i$RF!YdhzWXURa9Oo{26%P`#z0IuES1c%yBY>pHnV#K@>WP)#6;Bfx?hQOA5R z>{8qCA>iUX6vu|BXD}{~yReNK84N=?ixqB^#-ec!i0!%wUcaREUoD}CE9Wb7T#I2<M zbizY!!nnjn1c}37sU5Y%!G&dAAMQSM*}DDCL_ZqhmrUoO?ckTZ-m7IGj)(nUoA=wR z-6`z3*S{Nj&4adm6fHfrMdTaN2^YDE_1ojCpc_<^=<0Ec9uKZz?E^OX8~Fd7jqJ)= zaQo++HS?A)&qzBznU`1xLWp>X&Z*HW$CK-ISMfm?u|;u3Xax?pr#hg}8xNk=4-VF& zxDG7JJnEG0U}>y_a8MWHIw1BLFlAKr7mmYFPuakt&PoM~;}EQ8oMUL~bmy)HKbA-1 zmp4dIfi4=H^O~74Qs8juzO!%Zp#YNqsQrdPMm{*U={&m zu|A2;snM%kpOIQDt5cVj3n8k=#|fyUz|?|`#ZxtcbZLNldX7fvIjG)geY)_e6!y|_ za|<&o*M!TpeA2`JZT z1R<`1p(V!20E^{^@7i?rbSPiUAM+OborWLvaxBkZHbeTSYX9@(H8&PcTZaQYFqvSn zJrP|c3YXmKkZ+C~{uhi-pGpFX(;dVC=Nu(aN_M?vUnDp{UU4`WdzheFl~ zc`+SYl37fI_m_;aUEfb-n%XtkYu;xk2AT5-51 z0_BD1GKz@2!2jR|U~UWIQC05sE%3tfM}b>`g$|tP4$;kPn#k0bz}su#-VT!-bvN4NKoYqhOkdi zdk0Fq7(CS8b6WNMk>_jm)hXN1E3!xx6I&RvAY3hR zaAhn=VfOU>vwB?Lb9m(-UN+$(dK3}&aa?eskIEw0G{PY{<|$t6ub>*ID1O)*0{tp1 z54pYWV5QMwD?-IeDByMmhuGUzx_zRuKv=LFA1o{@E149)YpGUr zlki-#eldTpSqoFxAN$<0sC2IzfBFaqGhpbsh|a0eD}OF=J+2Mo^W83dUKqNl&r}fb zRSEI6ti*m`3*f|dk_#5yWUx4fu01M=z0~`Hb>L+O-?Fm&_x+DpgZdv0;_L=jqN_yV zQUv>ns$p_b9)yb>-(>qkM9cNMrdN3iLscH6s4;ZyyWv+o9vaW%B;>;ZUww$hq#b|# zRe{YPXBKE>BA%Xrhv*tP;*vJ|K67^|G$)^YtA{ZA^Y0%R7uSP@Thl)PWh5s3VR@2 z)vzfiy3@*@A8;&C*ZN?Q2K5@6FjNe-7o&L)_H|fis8TY(=76mSt5znW&?3OL9kvqe zIEeT*SU*gJ_J%>hYOoD38JZ50p;0gy8Umeg4)A&|3|b$7mwg%V@%0n1(c>ae=I6l+ z$tyD$yZ>OuHV$O$s6!dM`Y^sG`w$36&5?|`j)r)4#@@N7fgNvBS5B307xgn zei~rlDS3=NI~K+>g|HvzWGG`IV-Dy?z9@tDg41CPdIs#haWMAE9LCP~F!tX7%-I$K z{T$fOb3Wj@80eP+jz-wKa|7VLm9bTKz;oRLcpifFkSAd+brr0Kz6y`O0iN+w*emos zWAk8dUiW>H*qKKsv5Uqgu>+h*EPQbi>-lgJRwwIa@4|Xt-i77#?aCV0c4d3*-JNAD z>8bABslN~yfDeH{Ff&L1Rja;#%mBf_`k{FvvOf`n)q}E&^HelRnngc`p+T8LgDzT( zgJI~R+CUmsG5V2)<0qWPi7v_qwIiGdL)EK$6;a(!1^YZ$Y*W6w?_QvCtR2f;Rdft$1n<~XTf_i6i)Y;M=VSEV7O&=ehxr0 zjr8}8-B4npdKBBA3+`7B?Z(dZ%`TXg)Q?R#^416McHDmY`KPK;Re3`_N_0+*Ug_o8 zFnB-3H>}#HID#;0D{}G&?KN8Bj`vYpFe;ha0ksRGI7p*- zxfstfyDtYC;L#)F^&a~6EAQV(@7|A1JMP#o?>hd8B<$PJVBdu8m*^@{ zxCp~)bt?y7f`c&{Y!V$`<%id^3mnjFBjX_IXHh=Uk_=;(mdqj-{u(3d`OV4Za#Gl{ zAN$wATbnDMbOmu=7#d80azb>KC|m?N;fh`r6jef0AD0-uhaHoJAzx9?qda0!iONW# z@vtn}Y)@J_uU+-N9v+PJN^);=d8zExk3F+?R?SVl23~Zy#$2pVloz7Qd=lhER4JrR z+QVi|m`!_5oepdKN*MvgezdZ)TzIMuBzz_m?vjV7oqB5`q1 zbqsz*736D+>iZJ0|5*h&Qkjv=!BY>G^q{|=Ue4upM83XDwV%QDqkMo)lN!f=UxBe$MbuY-ISpfL3)_z z8ad)bW@Wfl(2k!iI0AL5zaXy!Vu|g%HbwvZa`~9)t3IFW&ZD0@oC@IM%stxBDcrPt zySgh%jVj_`w)i+Qr~i6Xe#xu{sT{%~(~YkVuthm)k?`QU%Mi@?L@4u}mKBR{?#Du1?|P=u|L(Lm2XQ?3od@C}I^iIf zIu>AFGTtn6-8HOmeUjGj2p7?# zh`28iT*$8y1ztzN=egSUtjKu?X{Wfh=Io>ASJt%dYCWz5yeA&LS8{l-e(br_`485stiyJQ>&dt-4X+<`-}a7z`y#Nj!Qx{3onYSri)Say2D=9A zL=acpEW92v{}D2;gp9{R#`i~*wkTNS+7I7G2}C_P+jjg8V>@bm%Oxk=uyA6sPpn_`lO_3~T!@bMVj2p! zTw@N1{gVGcb9reUW@87`_55|=k3SW~`)`sD zGRI}RCzZ_@e(NVyt!YD-4&#N>_>$-XB-Psn*O0`90ym+FRAS4;uB}i|9HS3 zZyv%C5Wk3?0Is%U+A<%&hdCc44uhq2lI#p~KGpx0%Jx6G>g(D`6H>HkOQimYzFm0i z@O2D)P&VG{uMY8#?{xLJHV(dwKT_G?B_|~xoc_T(F04Q>#4nMQkFoh>=Mx77 zl83<(-~0!g^KIpysqEzqQ(jxQ*R_WwX@e2MMf4~l?rR?|b-hPhq2uYp;1E9BKy!Sv zlG4~`_x-cEV#Pt%ex(iS2_MmUuF-4z@bP`9BETjA-?BLPu+$$ff9Kh6pSynyAwYas zyE2`^+lP;zOyi#I_Jrz0l=|;aOAayTBkP*R7FK^bDC?fqY0pUYOmxCWZu@Y;_H#de zx~rGJEpc##yQQ&Scgz|+<>#|LtkVjn`XxHyA-8?FC^l^SQyXtk*KQjQHRoGSk2JRU ztPST)`=YM#H%b18PPoXW5{3D_NxO}H85@QSs9j_pW{#_+XBs=~hpnssb;BrISQ``& z--u3l$Za1kiVeGt4fOHqIQZ&&rLiA|e)RT?pDzmCtpOl>L?>M2Qi+N2jkg78y-Fa+ za}e9D|8R5uW%N#Cp(E2y`) zoGbgJu>)RjF2C*Rq@Uz|mgt0!Tmzg&>r1g^Qp;!=xFnBjyJ2L?m4pZN0`})Jox-;tuW=tQ^11LRbKEU^rm>8SyN~#3 zpC!HI{+;NAm)z~g9qscmPm#~;Xmh;vd#AB}b?;A@SN~ro_xnUAoaAmlUdkal7Qnnk zecTiWcSd>|ODkHPlKS|~-Q@8A(FrfPRI1RgwND@0`4~au@2q3Y`MYx8G}hGL_i|nR zej#~$Ky<=K?)KxP9HL_e%v+RWo827uto_s2#?>bec<$SjC**Mh(FrfPRO+_#S3j0m z2^mxWu{I7~c0d~Y@4!btJiW{Jz2$KP(FrHH+mAQ)*aFL_2TS-%jy2~uo07&3Nq_u@ zrxzY@?ibQHlIWPHXbkWJiO<uj;nFl#dhWc6%!|H1RxY3DV%g|7DBq|( zMKFnY{8{GwXgDQ}o&LjJ`{m7DazyetUNVgfiJkzSv0nI?5?NB_%Y_f0YINT@g&_mt zk8Q9yp3KwI*h_D-cvFjq9=gIh(9qg)(iL=zE}B>5qF z0{C=HS}c^GImDblYiFmixo<4leC$W({34f6^aRQ`;*Sm!<{{!*83)(m=2Uj|<%jP5 z^edCDSvQ^|pmjTK1 z8arFo3!;k!b$W_!3k%n;T9QuFX2?&HQ4iN zXP(nzu(iT-G#_Wq?^#c!vUS5w-*oNFFBWCuCIK+?97N~T=rvkoWIsdu`3-wnRQ#wn z#Rt%4&iI`smADc-R4@MF=Fh{Hr?L-DzUP{~o_%rn+QWDb^gKkTe94U>*q-N6C;SK- zo&ff_s<*s^mEaKmtmDn`hgYPs+bY6z$PuT5@Dpf`A6hpRAj%WV zHpic{GL?NYamyXbJ+CYowx7QJ5}ooTx8v{w=y;7B3S9}7>SJY`=c$~V#@x5fx?Fj) z_@(ZB`18>CfavrbYeDE8ojpRi-0TILFibeCa#Ao)mPR@=KHWQ!IohsK3X4qQXB2_eK2^H=@=JH zvBT@01AoZ@%j-e-DS1eBQ|lobl@*+C=nV|@ZR_Pg#@|9&T> zeZ*7qc7a!!PT__)`~hFc=k$4I!k1RCPY2%#i#TTG$LGhY=f9kHP2j$r9&q5SAr~yV-N0f$(Fg~9D44}P(F?p=(*94(+~Pi5WMWOf6tr$Wb&p7 z=tslfBlm7Y=b^gtOQCn71IVJV@F0Kq=t^rRI(hIH=<5Nuh^qXCF*TigbTe< z;4!QxH0UP5kLW5e!hu81oIdD9MZU0cdK~!7*ijY29>hmS_1T2kk9&{( z^7;MU3Mb+Xm_cB>z?JAKQMmB$5AlP)Ae^@q4B_cyflw}dMpXr$pOt$Q3&m#^r=qACH=qgdT7~`QY@e1JFKi*KnkcQ+Xv(Q{# zG5gt{x86Hq+>dy~l4|h$Bs@h)rmJMQOjJVl@+n39fI8Tm=?jHC%2+tlvl`d`@F+d| zG&oKZzM+C8DEt}^cJs=O>yuQ9&2O6T(@0u=8Ee=+B8k&E4C-1^IW4> z_#RLFN^^|I;hk5e)P_nc;c!O8#p8(M(VX#mxxpxNz|!|pn8LB~)vEV4j-qLm`W+X3 z%_Y+@E}C%xhrbezDFa8Ck`rj8yV7AW@aKXrUDE?_$TAQ~Ag* zmLJ;n%Trd!dV=VLi(Dgo5j`PPrYK(-lg#Y5<~ zlKaXMJ-={7fqi1*7{)@UjQpiCn98op8u!CN>+YE8*9LUBOoRO~(cxBS62&!C_^VZFQ&0we8a`(yuB{ceP z8edete&wg{@3rx3DxdJlbP7)Z-!OrHf>#eUEZ{7eV$R2KO)7illYLtnJvS|)i5=BD z(Fq^9MmTwUjWRDLILJiQC+h(p8k+aW^RCrPQ`jYAULCq=RsQ4~weQq${Eu=;bTtFv z!pGA^c_k%wxM(N5{jJ~4%3cXi%Y=5h*1}be>h_=fz!Ql6h4G!Ru2xz9V^q< zXEKB#Tg3B`d(7{>->AxiGt+>M2HhmM5?v(<7jgbE)e&$zW_#e!Y?vKQ!59Df`f7mk z(NKNK=fPwQwXrXT?ze358<)QPc0aC2uzchb(bWuui&*{`ID4cbfK#4)=#E@Ubab!( zKPpzP=K~J8x`U;4f|c;S+998%H&4EzmpZS&;s^)PktQ0NU#O>x6sn(Csll~yCH~h! zxn}df5;%|MoI&S}Xev2rpe82jycwUL=wg}Zr*aD&uE^8|>0*Cpo2uu#+)fssU}L9@ zTv)Yy!=~qHzbLLBV7WxcJVg_odBY(%zS=tNs40))2rBA#17)x@pbm{o;g8xUc`+Q* zi}Ukv99-Ea+1Si8Mvr`XQ`X&GwSI+g5naTDei;{P6<9QhflDu+nbXYqv_8kio_zMz zIjO$-*)krYo8ZB!!aro0=61n)p31O1k1xnoN;F#G%PY1~)T!eC+h4ucs)Fn%Zce8M=5>(7WIBaI^MG|Vhc{FJ$2h?s zFL>bpwBX%{6C7NCwU6=n=E2ch^NJN%9Cv9)2u%vW(lGRk+W(7VULwxv^Ww|(o8vzC zsk-U6Q=jk2ks!`NARR>K)aX@@b6UV1Qs{`FgfU`nJKH(Vyndq3NxoQg3hyj8(Q=LA z8PPfmrK7s=rm$1-g>u)Xyo=ZLxsO(Ogk~kKjNag+ZK$wbDEB*A2a@uzQZ_TeVL`9Fgd<_Pw{r; zx|i#R##i+0MlSLx7O#xrTeNNGfVf__InKI<|AKyO!3%#ra_aIGgE1W%T<^y9LZYig z;UcV~=2pO_(CGjBje`|-zdbLY!1=oBdZwDH0j{)u>Gzngv)C@`$KEZt{>ydyB^AQo z)~N>fW+5J;b87S|;GshTVJ8uMoR_b_j#>QJWe%>b>eiQ8l{t>)i~F(pji(;*a(1t? zUebyp97K;I;J%nRaC^J@#vzIYQ;6$NO%k5^uZOGW9Z&Z%Rx#nltj!JZe&EiHEqxmg z9J_TAFAsGL@`dP}8oe6enNsa7^7;5jad4itI}i+URz>3u(SwBS#QMwfn)3}yKkGjC zt1GLA!s)}@pgf^e$#fp7TbEabM*ZUwS_AhgxMxmX2(O0(BuCAO;CS}N4U1Y&o<`+F za7c6tkMh7S;ZV(@bPvj0mFSIV!OcnexXdk-COWm-tFgrIKC(h>E%FvZ{K=lKQ{ct z{ogHgWff&;iiG-6qRWW*d;3zS!wdhS3`YfcV9Nr^DfCQ0i*!%$zu@kW+u_mm>+9p- z$!zS$zP|8}{D;qfWa}H+Mt{OX^mgFUh87VhYEqFumDPIw$nV!zU(=6`JMF0Jlb`p~ z-+rt6@3EZ_JyASuIm1(m?UvQ(@yPX6d0jtdziz+D$pd?>R{yjBvLOCM=n|mV^`%u_ z3}E88qNG-jOXgGZ_5E0%%HMCk>CtySxJoOZa1mXCCBExAMZ_p$N%TKO5Qd)DUvrI4?bbVbMxj)**&M29% zd2&|kr#}cdQ9lr!@R2Lv6vmOl|BPxM3hDF|>>ELo3l?S61s1o7wSt{_ zv0_CA{yny8xGX2Np;LHSr90q)Z=*tW#Xk7|cNkHq2f-FAp-P`?tji7C=7M>!C5yga zn+^%Zeq7s@N7+T(SoBB)$s;~ztMr_*o@uzw#y)v?(TtP>X9OPB`YS9C`Au{wdlqm1 ziu&eX*uWynY4}V%-(@^lR=@R4o9?ymqn(aUI;CqHI^l|k2SgM8G`bYFBLwkFoARI% zh@QC=183n`@o|p3p-YYX$S)%EEw1~zGMT=OIAM=eZZ&)!lN$uU^yLudCD!kHz=?86 za*VnH`-x>k8GC2a##!KH6K^9(3ENjBC!LaO4M?Dl5vh+4UO5Q*eCk< zzo;>m0SS-~;k!0n&Ccn^#B#8VS}h#^@2M8Tk(LV^4$NpvJq0ZW57m$DT)kWy>Ak4~od0|Lc82o&-HS(J5bY zv0T`d8+5}T-+4pu;TGQ_Y#-|gcZ^eDsGz+ZJ_v*zyr2&Q@b#Boj>CWpd0@tm z3va3Upy?owgUaRjdN7$z;id4!9c)6XvyWTg&ke#znvOVg!LDjVNrGB8WBg~dGYyUUp%^J^VSh=S$>I5<&%qYR8~@~ z$p@gQal;-qbvtBfwG$!nm?Dl6TqgvwncVa_;+|*!Z|$BpQ8^q>5|il^9s@_Ycb*r% zlN_H<@xqXi*nbn9T=BVy7SE+L@#0~4d*V`jex2Dcsw@>7sn+Xh2!sFiTrVZMj86M5SAj#2)SWT(jxVU|JfrW_wnbi01`!X*B4WUM!ie{xA-NK1mOn8L z$n}HcVvC=N@oq=NlIw@cq_)A=!#Fio`=B&Nu2t7YTuGc3t9~d4(p%_~UZZ*<7vskA zQ$CivZ5$Bil{q)+`$KvEM8iQgHrii%_tRhB@D9Dt!LbYWheVfA#NI!l-|sTf=cO$# zY8GNYy*3W6%!6$#^gxU9-KhNwvNZsNi|FmZMf+ZKkVHJQ7VG(BH2?nbt7qStbl>Wy zs9e6*)s4w?3XjF7$b1{#J&7C=>n(kW9*x4apLJh)y`jjfH0j z9DAW|T8aToZtq^ma8Ix{u&9giy$NDKy^8G}-(jLG;XSr-(IwrDbZY5OT_YOO(NJBXpYlZ7wwP^Aw=HFL zcA8lAgFM2z!8Sp4BtAFsP~^Fc72}I(DNi|`bsw7pIlw@1Js@_>sGc#3Bi0>;i}#}6 zD6JenRveK|d6FxJ#mi4lBj3w;iT4;cR(z38@+)JZII>G+@P3uwQGY>Umb>$DAPkUb ze@ghD`f*Fnm=twi-m>Eu`*rHd`GwO{*b|TbFz4w<2Tra#oj(ieFC1?Yol~RNso8dT zZ{de?bKsC}w?9e>aoWjKOCx)03{5j4fCetaLaF!HD&qULhW}m1m0Hi8p*ex|SFTXTbx36w3;KBTJ z!J>;i#6Ez|GXyWY`|kB8%x&E|nd9K`a9M$ z>Wa$--+SM)ZO-{8x>zRq+mx%FV;KhEST3FSL(d_n$9uCdqxkV?9i3mi^8SwDO#qtY zqU0HUe&BeueP)Fe2 zUGk9YCmzo`f-hKCW^>MX7~+L@1jd~u54nEKa3#VQk@s?Z`QEH7D~xlXJ@wNOJQM4P zbRUibEMv@p&Zr-;4vb6X;{()jM&q+sX?90?XVg!7`H1z2^@JANlxPyEYcc+==HHR^ zBl8;Tf@tXCy-3^Dc)cyplSus#598&J{YavHNuqhiD|1&5Po#e0@nBncEv9Kty~e|` ztA)$;Bl4{ypB4KS{_Sf==DO?WCD)Jq#3ZiM#zxKh;l37Fhwpjwn#Wx$#y9>;TW3cH*V&0K*P*s=-xqMg zzp8}lJPI6h1OMmbtA@Y#^}FCi40ZoL{>fNDUI`>Nk{6mI$?aCYm&-Q0-=4H)`R?jr za{Y9~^NMwWe$>}!L^`MFud-g(hwh$ta{Ul5JAxZ#^+91&f8=&Vxw}#x;{M{+7tQsp ztzRm;`WxG#!^-#Adx@rRvHwAROLUnxT;EP`)Hs6bJ{>qq40h&tLtNP!>s-u3mK&;1 zIe)Wzs`G70E9PspYmpn=FUn2*>*jKUDK7uun~b|oDY^W3Ei3FplVJsm=o&fVaJj)_ zz4GCo{S>c>+yoTfRjX-bxuHE>k&Gn|$p*PnuyxzP9FXg$gR_sD9kykZJ+xHk6Bi4`T zr*O;dcn%ny6E5y2w(6l{c^<1hw5Js6Z^S-_(p&XKoY*!u49RF;X5}0D{ko{HP&ZCL z49@@E@ai$(Wm_NV`rw3j@-L>dm$9Ge3cU@{F^*{XIJ8))f`d}|_XJav8i&UXOGU6( zxy0vjJL{s~O6HZ8s*6gcm5Rc*fEPk$I(@BG_@QDU3HTedeDIvnEz)!1GvK>>aX)mw zcl;l{@W~$cQP#ZJBqq}-oIht#UP%f5t#1(izS~iuz#*+ZJZuyGygKOfs!_#pe{D;A zejoGu9}VK@3Rj}5MB&mteyb?e)E&`I1sH~2>;sY4Xsvc@$fB4;qx!-2 zX|}H}W@c7EhjYNFemc4kYCEJ0Iy(PdIln~ehwIj;ZX!Kp>8j3`j6~|Evrtg|V!IO8 zD$#El&Vg;IAL1+KK)gji@s+~q9>XlNZ5+q~28-k5ZOdiHr$QM(OS%>jkX(?9G%}W~ z5GO2mdpID@!)zPl&%^%j_QysKdUVp$R3^$RO07(%@Wkd}ZRfjT$bjbKwNq2nwvY=n zYzs#7@pCVJzGwK1*Uj;F8i zS!i9BKbI~G>!uSqU{pU?2e?*h>EKRee1ch*92CF(B$$;I&Emjc&H076&X2SRAl8U~$0WfW-le z0~QA?4pVe);V_$Z!HdLx=yd076&X2SRAl8U~$0WfW-le0~QC`{$E3) zJi+rH@mv_obS?+N@Io}+c{Pb3!1_XK_I@>ye5^Qn4s2`vSnWs8$IiOjmin>krn73J zZN7=rk9AIdTfXfminZTvM{(LJ$KpW8b3h*N$@d*!;*QNxejfS0qtQ_Q076&X2{GB3>$!r=_TYxo|~3 z*#1MqA|zUCR7Dh8UoN-CXL_{{~Auy<1_l7+I#Q)A}81h2yvMRud>9yoE zCTr9H=!$jqgMG}=21&&Kb>9r~gnZ2fi|&D7;ct^!YquoUWx;~)8*fTw`@WghYg%jF zz$<``2J=OEBDzWxF4L6RdA@*RFLego{!mbrA-A_;jK}Ak2d;ghFH{-|D2^()nW8v? zJ}*x!%DK&>mupP9m3huz`*uJ^n9y{HZ7P|qPQq6?5z@6>F2 zp0CR9_P~fEs07>&k9(m~>~;oxrO@WQuAr8nqvgCka@(G`^7HL3_u{x}z0+Jy!XQWg z`2L~^_VlVPg{Yvxkem>mQ=`|YoNx&iMFb?s8?3HU@*K`e8dzEK66M{_=p%hMxcuN! z!Z!y7*@JL!^%ojZju%(xxE^-MFoyvsKgPfRD1J)y|mitRD!`d)t*TAj&nJA{R)}&F4(idJ_7b8 zus8;)0eddkJHg%ob~)GpSR9*<2Rj@r_C?r_?5nxh58+tVuF;UbH`olYdxA{^+Yc;` zk@|z}3)Th}xq{6$8Eh}G*!SRgrl)4nj~2s-hH=o3E~Z02jn6PIHi7wZ)D+4RF0o4MiDW5CNi>t?U|c+uQn(2oY=;Z>%qWVmp-D^{v}fjV`Z zW1phbz+f5H<6x1l#OHB4>xS6#Va>^|&Qd9zh%0Aad|c&oUiql#>^Dy#-G{ik0xqIc zzT_r`D>qo@b@G9mmaraNnm?}uTxf`2ay!Maa~|2Wc+KrqU*_Qr7{t{Fu0&Uf!iD3S zsDu{y0`vHcIo}a-lus$*6X$w}OXcTy;+NlY&VJW+``4b?S80tB%ijyiC%RCy>eZL8 z79H>uDc*`ur5Y~kskI4|zxIVyEt8J9>?Qg6iEduLI;0Su-(K#8waLL*X!0r@Fi>cK z42U1otK#$H@KJqFaCbYRtIQ9go8!^(Lnp8zj+O*)j8m@fd)uULb7j5|-5f_7zC_xN z*lyDO@%eFCuli}rj;wk^#zFLL!O^ys67Nss^4fEcIuP}hI8MU!q#Mz18DkEJ^2^SO zFE@|R&knqGNzLR7aIg&q^~%0*CAvx!E?ln^C?RJh^Z@g#m0*b01yQj<7XVrg;)fw4 zv0u9cXf)35s^y1e85yKw9JD9{cuy9*9d2Ub=6hW>Z zoXhTxa=Notxl#ReHdd?t6X&p8KZ&O_kBN1FV-usgFrt~~w)=)|PyOJy0H;CLc(C*2 zN3I_nhi#9+`m)-`_Ha<2R-C_Q)W=^}X?nY`)K_@=rfyoJSqj;8WlI^+^|>dy-ZRCq zKuajg3yxR*?q*lgFGlr)?a^wJJBO5J0t|7!jP1ur{*2-o)uE^#nn6FH$pwpXGoI<9 z?wgqY1H4PT?x8m@Y~HM*;ulYJ%tb#Mo@Y`UIuB)RqNB!Lp|1Vf3-U?|0*)%Bw0d@x zI~auJ;4)unbzqLesf?|ft+>=A;(Au$dGYa#`{A_jZ!HbqPUR6EnNHz+U4k$1+J)s_ zJ8pY~4JEER02OisLSt(cXEongiu*;y^^&!K3(Ls`i!SmX#~QQXMa9%RA3hPhY{Vr0 zod@0cQsmVI;gabX7md8{MTKTpktnXnju)s0h)e6A$rtN!$op?F-@Gn0|9JSJKPKWk zQ#6PJ*KLTd5`~K~j##^H_`6zB9`XIFwpBvNwe32OE^r%eaGaqnajVb7`MV7nSxHn5 zgn@x#J>oi##nYWfIC21rSU=dtY#O{o>Zw*skMI5JL2sbR1&e8o_Tz8#F5mcgbw(k^ zL&N)+E=;ELP#Oo8Dxo}|Z=RcWeZrnrh(P+P@-lt7xGxX2{(9Kh@$Jvg^vb>j-gCQq z?78NtyPp4bE6=$PIJi%R=$sn8=2nM%bKD+}9afcLOJGSrak_(w_5nbFFHpr_LXNEs z1su*05`wv27w9whoVpT6FbJ>RT$D#{h2jlqSp&Px)R(ActdLl!!4Z z%PgHye7S71^j6re%YoJKXw=SUU8Qg5_?{fwc}{jRJMO?C3$rdyVMFhl`s#`s&wlNO z(|^ZhGW8n-Z0AHrnrNtvYVCZyH>3n$U%_@XbUS6KHhXwErC{6ttJ=Nzth=h;NPo!B zD(Vx_kMWY_$kzQ|&H=IAPruf@-Dh5%!X7_#mFM+I!*9HPz*@C>sedQB{6N%5JFwm7 zPb!9u*dgfa@tZeo-f6Xane*}Q<@PDx8|8p;(28ReTEC#MMDj7p+oJ6_4uqj7>hD{j z-D4f*g2lR%*F#!QPG#;{Pwt($_my++gm5&tu8jRX(N&^w8RKxygVFi|N5I8L@OgO? zOYIX%wViU>mXh&ar>EMb1oHxl3)(Y$l@rwRs0Wwu)m|6XOE|Bk?}6BczHC|D#w%N< zq_Tk*-SgdBuP$AFnkIa>j)C}y4!1hP*OB;SCx|;*?Bo4Tm{v?w0EugeZoP;tGUw0A z@>KTZZT;_WJ!8>}v>rYHO2hJrt}7gFrYN{G4!+w}cY+1&g^u8)8YM6XH{2+$5_he_ zSs|_$W!+$oV>93wu;|P2!&ke!3{U{VJXl2d(1MBr@+JBk?%fPZM#`(H@H0v<(BC3lklCv_I!8H2~FEE z+oR-q;M+cRg_!oDW12AJhd9LVZsfegdmJ00-a%J`A_iOj4(5QkPQL}@1bLnd7F}8Y zW6?Rcg*W~bK63*4(crf_c$MiY87^GEs>+Rj)Eo$MRR@Z$xY`qP`#s7y#j6AyAzvWR z;|A?N9zVhq^2Pv3#o-;~0hJEH8yOMgv%?T9mY$t1r-Cp_em-W|r#aBO9c z;Jo~5fCBF{%Hf+;_)c}4zgkVwUOA?6;<>o~jTZTh7ROWQq7lbdMB^dRICQ_eyQ01; zyvpl!{s9)R+a$+{#MdWD@45;Yu zsGp5~H2hsv_cnAM8h!sa*5wZ2ckZQr#pB7VRGjn5;dAp`^@y7ySmK5wV(_q=LSM*U zs(AR(H<*X0_rm`$$5#vC2iLDr%!^zZxhxnRtyS^Vm{f2xK&*3>^!RTkd==I=8 z)YE9tO@b@YRibc-wm)cPLU%%E?TCD9hVtXp>$qR?J_eJht z$Ue3P`pzIl5cT0QC?8EOSggOz(6I~wch+Ra{<(TQe#Xo4mp=9R*azOa5a(5B_A<{a?N{x`SowPvZ- z;bA?ZJQE#mbtZyC|K3PIg$%M6_?*>2#WmKWQ~{UZ6C`g1UohHP){C^q)jb>D#G;Mjk?}7bI`t~fpAIkYx3Olmd?k;`P*?(}|coiMBXQIoHrS=?oKa@~|HhvYP z7O}ImbNP99mHT*lDqi@m!iQbuIhx@?sNXJGYTnK>?nz{?;DHPn90p-Qy^`p9u#lyxSCm1-Mnk>C5ktcB=uL8@H9t1ag|`!u)L0dc-N>;Lra zTAuG_J(|J>WM6(^-n~y9_tnoQsG>{ln&>iCsa?mM@0v7h!&z@udg$6Y(dDP?h<4s~)@$u^migQn z_p#bGm1VVY;>6DH<^aT4^H1ErhG)*28Sy>imgQ~r1itg4bNJJrPGMDNO{$)8OwY6I zFY{cn3>@bZT`o&}KRZULaC?g#Zm;^eE$*CFU{}gSA0G?wlpQ^vmStU4ZURV}YZ2Y* z+XUtqc(Z|KByY$!+M8*ROtwPlSm!e}xJZe|0Ed@i^*WDc4B8L>VDJJ`Y)ZE^J4* z-hvh(Q9SUfhUACtEqB{EAnK#_tDZN|Kwf5?6?EDX#Pj3P_x@z9w{OkDY0v=9@YxSm|UI;x*AKY3lW*XWRv))L+_Tc|%p7P2aP)p- z)+_pU+-4ngO$z(&-PsTBdB*8KuPLlhRR^_WqRY=Jwd0uUpmIYtT>OO0t@Tft!<~OG z_7S2#k+D(dqq9mdl`FjuG_-_ah{R!hJK!r4jJRQa%-X8-{|XiapCJJ?AimA zmFs@G_=5k_3dQvVTu&mpMvgd<_H8iFfd3kUlLBez&HvA|7Eyb zFVR(^a51Z2Z60ZM3|B()O5&SPY)tQB2%+a~iu1gfNssqlc<8)U=^vx~puw`b!Q z`Neu5x=Iu->Q_ER@Tr#9S!XZy!AC8{z8d)Irpy;|cr-djZvw&H*7k)mf$a+06t*R7 zL#Q7P06P%uAh7tSQp3Q)Uk)`w7^dfM+mR2iTjyz6i}3!&j>!DOKeH2fdI+F$`>8Z`VjpyDnCU>5{6FD*#-6=^vD-m#UTy~a3j9~{ zSB$-un#9UZOk&UYli1<+C9zk(PGU!$(1m?>V;8o6QdjoH!mg}GayPc{zHaP|%I<7X zeh)TcOi$KOnao1Vd$F1DhobNF@5@#l0{=03X@B-`$(~GU*oR#;W`FkfbqBFy79Glp zXCBGQ_8QEp-^*q%y`Rfa4xozF@2;$I3HCiH`N=nTfgeu4~$k!s}h z@;${TH(of!v)sR)1N8ub^!~E<&Gl;o=-;!?JnGGL>qb9x)Ae7g;E#hV>Q|zxMB$>- zud-5wcvgFjGK<7OBv2OpooA=<@UE+N(Mqg00a(_|#V#5n1gv$~o%q z$fXc!SL6~MhI=1xaW5z z>I2X`hUoHBwQaXk;1~=?n}%z(+bHL#{g6u`*j|xF<6oj9O>DOmE~l68DLuLI!YQ8R z{`DMa1PIjMPT!<&xAMNRWzeoq>VNlB-=2S9&cAWO4+f^rYJW>~l_*?H_5+m!d`{?k z;nW-46r`mIgYY08`rZ$w?&^3CVj;TO=<;mw9L+FDNBtzKKe0s08-7;-TGOWO?CK z^DEXl)jP=qy0q?zE*c7>H9#Z1iE(6OM3dv}F85)0P|`1}KR1_`%>Tjp@V8I+s^8;J z9`OV&$b+GA0ns@%dgbQ@!YS^4pEn45QoW#2?09rmWS=UWnpNzmRmTsJ4@KeZNqnsk z+&1}%md<^mJRt?;1T7iTRd|oGL9&PUq95=f-FBompQm?@>AyUPr}nDo%1NaFjSh@ZxOvcF4ntP_m&*BhkNF6mq9SeQRO%0 za046R{d>)ubIy%3=E`zK zbQx{O$rbc@khvvKGKY7rdr?pMzcrVq^%thH9t$o{dVTtkE!1z2o+7&ZblWaZs_L3t ztyHUj@+GM$Cbol&@62)6UYyF7IzG(ZH~oMIW!yyXG~B!y=>DH*N>XQ5d-x2aS9mi>5~24KJd;%=y_|zQRAHu#HL6zDil6JTJ=^ z(Pb7Us4o+huSmPFzY4CY|tu>^c2x$#0kn%R3*VEs?5hvzgO2Y+NvnE2qU>d zNE$2|hI&u>iPlp^{UrJg6I;Y~aX{2lja~R)JeFK-0l7QiwIgQ-hUb4E%N5b(!aGK; zBEzXR>l#>|B~LQf|GIloo^raH%hUABQ`x=?ZGW8pr)>)ED?vkgis+mgy(TD6l42_J z!TCAxsYzQUCBApq90zaf6{#%c#IhbeGp4PU@e)0Xl>0gWuPXc^U$c9d^L24I8yj=} z-L7Zet9$SkP0ylgOJSx&lM3mdJ8NbQwbj$rY(7OP*u~?_~F)Jk_R{%hP(0 zx0AhrgL2~^qQbN>0hqVuvEXar)JuoelLnbuX9NMpi6UUic5Mc zmcF926dzq9ni#%2`Ni?m%Kql^lwq?mU)jff|9kt$Ua~w9UFO~P$x}ovZIfO?EMi@g zA6-k1k8#l$(Rj%2cNP1)%Dv6yYBk8+K4-rJ|4ndMUsg*+sz&yunkM@Vd(*o|0VlQ%yx6=R?Dt?#g+<8KU{8V%kye5|89o;I80845tKNg)w@G(5Z0H&}cX) zW$gZp)xu#Z>kndV?m#&AQl|6h;SN8skUD^6QyRn1Z-Pn-lyRq92@6LX1?9TqzwFf(}z6YD$qbHkl zV^20{STeifgJgEgqF&5<>K<%(R&O?XpFZqUTVM9jf&ElDfKRp!&o{yEx!Y?*UEkic zR(y*CeYFAiymf3L}FsdJ{3u;3< z4vAHg5eMplNaOp4!=vMStfTP7NeqUrjGYK$-gjD7Y=-gwB~M+k^pWW^J~;4L4B+4M z<9R(q=hWzRYPKE!;>hh$N|k`y;ek0{vD+E&l`2l3*A+CJ|3y=GzK?V`=?9oDSVrJL zJ@`pJnlknBf#<-Ze9-@2B@eQ(UZ**3|90*F(w;nlXM*QFpnMRWQ=?aq4|vDxs&*=Q zK9`c`fd2(nn0Ij7$T8;6dqwy`Iiec;w82x@qe1@re1l@^y4-z z2C`~+d+W+%I)%6Mf12}r9v3Ja*lO<$!RY{?!@v^0%?aQe`~00h-u2)S*JD~VgiogP zP&lhpnVshgDE0*ZM_R>K3MU^qLv9~T_gOvI2)-_(4f3x`y#qZ6fS%{H_zd%all{6RabGJ5`<5i@u-fN`j^^-kd@{A3pgN; zpYV)ptQ$1s^1F_|c6R<9k9f!DDAy0JchUJXRvX&!^&yui*N+@7-pleX--~fAf5&hD z2LjapEgr7#|M2|+_J7OZ5Z_;?uAE;#*v4wsgud8Pocm4_thuAP7dmL{|A@}1(QB?# zJ)>;4+v5(wYbYf!2mTGr;dR36Cz_8G`JC!;9(k1xZv~zyghrN|(?J;C1bZ}u@i75+ z`@uc7d8CoNpo{%7ylzkp`cWsqD}=~5R$^Q=l67ep2ju!`SK z?I`SJ0e3}(5`aIJgsEn*x(bfKqy+WgA^!NY^?0y9Kt0k3gZQV19&>Frgpc;t%o})7 zIKLd|XyBEx+Mf|!B?=ef&oKKqfA#n(n8KC&J@CKI@U3P@fp~Je!=!s_>2dB5%ZPkr zBjV5F?=D(Xm*#m5lc@%ABYK&xlHp>C+pZqJ0R8a1X>g*4g7aQ+A7%} zei%KdAM>kcSLVVAU_7rd2#~1fIMQf2o$VtzmdlAnm*ef~_s#Ht)E;Zc=;cUW-);pt z%RFH8F|Q9Cc5sHqm{f3ad`WbT9C5Z^j!JxR7^*hvY&-5Wk|(peH4BS?wmjR+0lB>+ zzdMWPot5u4Km6Yy;f|~ynH^Sr$sB2WZ`Ds*p6pB%ala?a(~n=VFOtX84?llYp#NLH zYpXFd$LqpmIz3}~ajrer8*)!|2daa`N+{rV2H^!@joSr7eHh(Wd-%cNx^*E52fkCp z^_1y{!F!Pnuc}*-pDJ7Q-6<_T{F^z|po`;rqHE-c1Mh9%|NJW9HIbXI{@ACvy)NH^ zp#5Z}4nCN0VTi+1?C`=6J5XBf_xl1kGOdLiXgp!dk3UY{cgBM!t-1NK$Tnt9{mdb5RpxmJUoBv*Q>X2_REgC9Urt?sEkEK2RSg+ILsDah7 zantQ0fO?2X<=e)_f9_ZB-ORqqdi*WQpURi%6mC%d5D|b_eq#dVU*0-mWRK%(GI_cD z`B5H-PUVs-mp^q(saU-3e;(5d;y?f9tUfnvm^}AZ%AcNJrc<~<`C}YGw^IiKB8&3Z z2sm&~nM;`%xbqvodX+ugwd_SLjQA1I=yDRmp?!Gm3luo2+@3m?0THqO!*^}Ex*5t9 z^Tj+HweYl4Tw8O-#plm0&DY)1bb5dMJ4w}WTuDr(Q+OL(pg=;^xSvFwuE7MdYJnr5 zjP+uJfeEC@r)3G?=|8>KgeST_@-N~Kx+pJ1CmiGwoIqHFCtEKOwb~C)W*s3+hrl>edPSc&|HDTCJ{m^CY4^Uz-4)F{iHh z$880_O_lKwJpx4YjQ8^G8=*qQv6N1Go|L<&Uu!!J5oiFLZB8P^%An z0h}6MjUrkBT}l=7FJ%FTa~>Qq&h@;&EXXtrmh^2n0i54#`1!#x;j$$%PNH`JP8~Bv zxyn2_J|8cgd(z;CR@FQ%<0HC^uZ>(GL*vL*a{@RX-EZoI$I}b(Z)sJ7F1B-`YvhPy zj6=r?HEumzslKv`_^dq_Xqf+Icxiy|v1Uz%|Eyg-Uj0tu__OAn)|fx=b|9;U<4IyN zox;w0JUR}D z?I$eBiP3wP`bX!jdt}~3++wDhWbG=`wP1$o6<%Y&K*r^ELXQov$3sPVB_+`n@j_Up zwBwmzY7!Ao*5vr@xzD&>|6SAi^&+Zobg}&qop6vFmD_0hnHF&P{feti8^Saqp3Q&< zO)gk0$EY2>_VoANhSzxi_)r6cPCCRUI^60^6i=ibnZaS1kQ(~~djE;}!{>x;%rc-* zzY(4i#f|@2wQ^7|_5b77UfqqI|6%j#nAq$1x#!lFPa6uf871aB7;qCEGi zJF7H4?jf(A^}yW&&puDaO>_}6`rCyY;x~aMKCVvyPwAV#&VBfWrzgJO8%yJIG8Fho zbWV+4W8=XlQAQjr2>7a^%;SFu6J<1H*9?|$Hk8HZTT{)3Ge7F%te0^TJ&KU~V&kMY zZ~zbgg)PB~UM%3vDA%tC;k#UXg3JTqJJq)j`5z+q^!;;}_HMXrA;~(I`=kgR$KN{ z>VH+^dmW-9`TtGnzv-xK^!Uq1W1n^#>| zK;hH1@@c#dw-K2~KbiK*f2{U|`C(qTHiIs2<=_E>_w6l5O=w-(&4C4z+IUuhGbTn76Eus;}6xP^+^TfLT{W#DFka4_* z`%Ic(9FOvy3l?P>{qlRxSx0)mJ#+qhcaqGbi|-wX4!1f(tE6;@fVR5H4` zcN|RE0}6a|f`54f!0^k)X%6k*Z;BmmulgV5JhjND9IrVpO!3a(1;-v^Z)!PMD;)8s z07#;1qz!wF>J#5Fiu2eui7dhn<3I+Kg!PH*DGkv63va#og>QO{KLP6p+lTyq66sif zvS|PU>06sGzP^2??t+DvR9x3a-x6KUKl)xZ`kuEK^ct+jqP~UY*tYv576T46xnS{G zjNb3|%>FX27u2Fpi- zF7`h}SBb(UilYrbroy`JoI1`9-TttZfCEh~Sj=Dku4zla#+HAx@1hxRKRNux<1r>< zM}WnChv+I%xM=6{>Q<8@dmbGDSAhd|Y6lCdJ#*Y1*l-CS*7Fm+D2qn$kld8a*T0{` zE@2MXme*nb%PIFilXX~s=BR(Wd}Hm12N!DfMfiwL`I2jf57)v0mQo&qJ#~D4sIK1D z$HCJWvaut>7d&4W-n92T2@lZ;$N#f;9q>^UYkWfuJqd^iia`aj9ia$$f|3vj2{n*} zq9QqxOLCCh#k&j5hXgAYFg8TNXMC0i3W$P=4Nxqgpjc2q#3&XNP1pHVVp0q_J-g%DD2NtpFX4KOGDx)elm2A zz?JzbQ@8}hp~++R`cr1hnkFS>DC#&`C^ z?}=f`ZtREeVz|sZ8SV+l05N~e(k#k`WX*CVdwreAPHQ(PFUijSU{&pOCqsPE$j_pi zWw#`7tVA1k5X)m#!j|8YpE)d%FWSkSo~g`Iy-kLmndn(8_xwzL#rMcghWxUB z_QP&`S3Tk)KQrIDAKwxvL&k<`e`-2~)JAmzQQKvi;1a0qaqQr+A3Ls8|A_S!*GI&& zj3ohO4k@+ye%PT8quTH>^lDv2%|{C%yOm89o!yunWPqih-*J^QM;T7qPmgn^nD?&leCw=^WCbCy8gj+C*27b^YLgf zGOk1{N6&DlV@m~g@eX$dzz%WeIn^~<;<(_{n?mDiao^rgJI`Npij0f-22gn5*el9Q zg^)rkt6cc2DdJFWHs%|(A@aT(-;c<8?Yq^nu^gX|PNEa?6K>MVO^rn1RLg zv``jC#4%gKA&--i|Gob#{yBd7gM-LUhH=Pz&9$ODk}-^ppAEFCzEE49sqLpH;)t3Z zS{^Snobl)jbEluh@h}dV&+b9xq5jX+1R~;yyTyouhKA`s-Ky^Rk30N}EDC$eoj*Q& z^UxO#@V5)$s1KdP$|Tv$2%HN4p^4zX*p@BH$~R@X>cK;oyBLVO16_n>6^)S>NIGLCvsU%Y1gP zL|*CcVvnjzVty6fW|WUv{M%o-q;H?Tr~bgou9`UOVT^&AR99jGL!XTSkU()xnkdDpR<~xCYrL+taf>&LZD%SHZMV_JU$;ys9>- zTuEy$Ti^Sd95nd`#wRsB2-JuCEQs8)o`e!8Lz=lgC@PIoC6I_K=?BeU$iY1>tDbVs zoL@GQW1o%BzOf>)XN!yJ0fzk1`~~K#OyQy}&@RBXW|^s&DMniY_bc{ciKzp_nW;72d^)@HCz8LP59aYAM*uhs#UIM zXc>Bc?CPwZgM+DcuDk*V@pyx0^>ApsSq5UcEdnlzClN$`zs3{r3VP60mV>umomI6i%{ zWJQ?%nFwVFiRIV%vC#Q@&xQXzx8WrXr)&AD$&bFrnC}OsTY}?D#Dvai(=pRXRzH6R zmmwm;C-!%#ZKZa%CJd)T4ol|C&$9oM_1P?cYDyNghXH-_QeT+lPxTEMzRPyi(YhEU zP@DNfV-b`$Vt!EMVp$RGo5J^iFUxi^OTa2G#@rXn2lvPLZuDtAos1G#i$wGI(Qb?%kx2y6 zu%x_yW@#Mu0X+TbFFRb>EAG(SnifUEAFYF8J{}Fmzps{m|4eD4RN6=rJEQ7bhXt1F zX1LWu&GfU#F)u;&hQsdZV0#zFJ++e^HX}C1zv}Ve__OYcR(d29tSVd8@x^cS0Yv)t zCH%}cfX71^_zlaJf+l9D!%i#mDoqUHTLj|tWc??2de(N2R&Hv$_}?S`d2yDUAIuM( z9&A!ur7X}w6#u8EtT2u{n$2^_`7N?&O3O13B9JmW>NM<*KiNIWk&~L1r2DMR@ex0mDq76yR~l#Gy4cLUicuUl-mUyOwzEpk zpChT8Vq9eBaY(YW8{dy@Db^l3D}QQFwlxv5oIeyM^@&>5MBr8!hb;lK{NZ+344m@J zGDltlX8BW7C@7z;d_6pAiv9exuLZtGs9l!lKWy$Dt>pE2cF$#_C%5LavPu5*eZ_nk z4Ijg08&T}=OvB8ZtBbKSyjPoAIMnGXR!`-wxZeteYgUdsgD=iEsLWq&>YdnU5$$r? zt>?-mVC7HcvN;x9YBPW2^oeCiw9Edi=YRxiGk?T95bc53En6rF)Moz3af^8*+GT&% zb3g*MnLlD4i1tA2mMxS7YBPW2xWzmY?Xo}XIUoTme*&^N7HzeeKVlgX?Z=`Vj#W&t z07l=j>UrVoqLdf=?B9~zE~iJ!JI}p}{;%ch?mVx)5uVA=_ijy^BNb09Ky!LG3+esj z%(ur=dPVpBg8TBwE|X>V*o^^sJ&^m{L~;*D-$h*|JFQXRF$U2MY|GTJ1g!k2VS(0g za3}J-s>3bY^ga>&zvQr(SHsz01$UfCpsMwmoGjKOnQuMUj0D7e0al^EK<#`Yh~!Ro zD$C+NHecF*=rEw}O)Gegf>ze+D$Iv>gGqBwad>R~>{#{hnbzOw&Ca)b@*E=_MQ#r` zwp1^+25{!2+Y5^dut5M=lkEi*Kq-jlf2C{+jqAcXuME$1Kl~F%uHmbz$b5F!aHZJ2 zG?C8fb;t+@dhD*^0y}11O;cYf!Ikl>2Og3S%Zc_(p*4Ofrz^_J-c7%ORq0vB*J(lh zxSxqnhVazGmH8@DxR}d{mRV~nw`apI$Dj6Y==jenO@DF2fCb<1`clGM52%?hM6Ftb z#E;2lbZEDlEr$JcwuXV@`JGAUcTRY8lPm}3R|Q94QlwEo+H4Cgk2#sevyxKg?~vue z{OaKdh$d7$NAeeq*|W?O{ga*D`7ZKgzt*!+0&@P444KHMXy<3Tvk_&^JnLR_5|Hz! z=0dJsNSxn%=eDqVp&kEk6X}s2o{c|hry(Cblt@7p5^F2l1T(np5=gOx5R^>@pGn^MwUb?6FUrebn~`{Zlp0( zGSr`^`CQCbnZl)?$2|on+(rD%7^q;Oh@L2gQp7%@gA~`W1j|Rhd=-9!Ge2>GP zq~Y z47vyOZ_v}AS3w_w=%ertPz=D6+#r&fcr@g9+>YS#jp`e%{Qc^Cm)6N%@s})L=2MuW z2`XQk_(i3?C4OhF3V~;NLbTGRpzgLWyB1z6<6*vth3vuc(7uY=8)ErP`z*Lz()vX! zvmR}~DRJH_SIIb-Uo{*9rurNxv~HKa>`vRs&})k`e*cERMRCS_f6D6DXS{0oe?t2x zGQVoL0$<{#c#+Fx{!XKOO6JX1%jKdziqbplmnSKXrzgiRh-|lKEXM~Ggo&uYXZIxR zSmt!t(or8c(ou7%vLKch$8uu7wH)j|?6Z4(#YNg1Wwz~fl1dgBa$$WON0>18{@RjTeEx+L}CEQ&4(H+zz ztA_E(e0Hw_z8<0Q#eNkU-zM9Ftgj|bU&`?_KAF$%Rls*~D12+f!1u#4`zJqq`Ovi- zKjV}6>|O>d_gM=qWEie`H<&h_?CC&O3lm2m3;Mj=9~ziV>bNlODG*4p;K)3I$^1bEz@ zP2C-(jzuH}fxP0Zt20~A9Q?W1&m!+Db-w(nY5p1eQ?@j>myeC7K39gjXo!6RItn;Y zz6k4-)S?%QfC(qf+nNuYA`X(jn2v<+LYJHC_nx-p&qMF@JZ+zbn8KiP!+eb!xSFOT zsQ{;aICJSR5A?_MHCDinPOiTU8Plp1AxM_@a^R$RN#1mi1$6)|ifN>@I5=Z>-1kvR z;m<$4(lE2n%Ki1=0Fwfu?_cJtOySbsJ;gVX}+8aE+ls!>OzqhwU z@3~`riX0#Fg{V}k6rU{_+e?gexKIqWj&d6$jN%Vg-l(1+BExs>DfpG&liy)}Rl^G& zTg|#!axs@@3D~T!>wk_?$Db0xqe@^j25EkQK9xg{54Py1p3hS@=azY6+qK%AKm#@~ zl=lu?nXfX1i(g+;e7+)mFwK$V&Y^D$GP_Z+QT*cg5XH^k9(l0mgPfp=ph+P5lU)d+ z@g+Jqn#%aqAo^1Df~fOf44Mp@0-6eo&*Xb0#s&`!|jpmNX`pf5qYKwp8r27Lqi7PK4m z9q4<|9?)LUKF|-KA3^&;2SEP?{RH|M^b6=$(EmUOLBD~12mJy16Z9A8Z_ptSH3ku& zI-t6sdZ7BC2B3zZNKhkCV^9-NQ&2Ndb5IKq^>Ly>G&a~0)CxogGPMSs3ZlB_G*DYm zJJ9K%GeGS@XM$ou9YAM+&IX+W>ImutIv3O#bRG!DWGNVeQO6%I!rcby0*V851$6^; z2lW754C)E$1&Rm#19SeNjQqX0fzMuq9BB&oI3Dh4n0F(?G2ucB^f(C&GgNA^H zf`);HgVI1FKqEovpbStZXcTBPXbfm9=yK2%pesS+Kv#jrgR($&&;(F6CQ$SNe(?GOY{57C|f@XlO1cg0dyniCeY2G*`QlMw}Ng1-42=qnhUxER0_HibQkDu&^@4gLGwWOf#!qm2R#5< z09puo5cDt5L!dIy!=QhI9sxZHdJOb9=s%!Epv9mkKu>~}fR=)mft~^_2R#jX2DAdS z67($SIneWLPqv=;O#=rzzf(CeT#KyQNH0<8ya0KE-*2ec8i z3G^=LJVoQl>Vq198iFE0jX;e-O+ZaS%|OjTEkIGAXiyBOC8!nX6i{o>sh~EX z(?D%O?Leo4&H%Lsoe7EsbpV|OIvaEjs3WKo=v+`|(0QQqK^K571YHEOfx3X=KwUxI zK;1z-Ko^60f_j1CLH__<0_qLw1G*G+8K^HP0h9>p2TB6<2Mquvg9d_9K&hZXpuwOa zprN2)py8l2&k|$nUnQVo@KD!4**vDn z&5^xkHIwDSeDWh2fBb4r;A;tUMX_5V@<#JDA2*J_JG~wp5>^P(Q&<3xWD}j4SG3Xk48VzHPqmleBml z7xT4H16Mz;3UaXx!!Hv2&Goo*odvp-jOQWFm++8|P`p_vbCVm#Q5R9U`kK2MU%2Oo zKV&^&KKT)idU_ou&1yn`Wr$-k{X@_{b5)cyLQsO2ST1dTGs>kt+(>8BTBA*P?Y;J} zDvRcgzPtTh9jW`L8cjZt75MDV5o#sZhCeR4Aas=x^QH5jQR-`nxKeelytb!FH{2Eh z*TcD8$8R1Ot@OP1)bjjZ# z{lub(esw0-DShnmy2TW;^x$X>5HQAGA-B9|8$dEhHB&25{DG1ER zuv?~PBrp}haCuy%&X5Rv4WoFty>9|LRN8cY2iN(n;ErlUp+eghL}i95lvvQ&piZFk zKo^3#fVzWvfqH`yKm$O7Kxv>+pm88nU+NeFwS6-{H-qj1JqTJ1dJgnD=tIy~pkG0a zAiwsY9-twhTo8RPl!2)4Onp}BA5#BoJm?P4I?x}WUeNQYpw*y8kk{p)XF$;q%oNbq zperGu9iUuP;(ve^LQts?R6TTz-UTg!uO<{+#G%K7LaK)(gQ)ghsxxtQy@$9 zpLRe{n<1#Z5LCA_@eR=deYSHTr*qN&J0IUJ=sk4kioS0T$n75p_fmZO^uss7K(re} z(Qc$8+{+f^uwPg$nLn<+vTy_HvdbDM@4VDN8JpBlDc#ag zN%lr6*=ICTzWAt-vgv`wN@`IP<&IHJl>@_?DW6{6T>1E#7Rqhd(|29n7-f>Hr857Q zR?6%Jt(C_ov{B{`ZL36$KV9khKzsCaJ1FZPI9s_buamN*;5_C2Wfv-^b&FFn|Lm@O z789>LeN7)_(4~pWBUdFWN#71uQa>M|OdUQ(NlF~Ae7ZVUx$Hxil5*=5<@Nm~%8XXG zDVg==DPuQ3tZct!nQ}wY%gR5a-%(~X`c(O~-(IE5Cx0u2U&KVTnb|pF&wG6%&iHjq z#QfI2hzrKv8L@u%@`zV|`XHj&lK(}N4m`8YB=opPo-(!0w;LAMIV11$I*;@|t?uOu zN7sG#s|V_?p0ca%vNc`nUDxHNdYzKKs5hV_seZF5OY7HNcV>fcn=ELsxIt_~-{hwn zzH`x_$X8n&i0l{rSfgt%$!k1mQGAoUxow;N)vI~44UJD}e)H_O7AYepL~ZG~Bs%f? z7A>D%bVsW(_gvI^Wz)Tp>EfAs?%%3>`b-DaeEO9)u4KT{vT{beZ=d&2YBaQM0G%k?oQ{K&aVeW zhDijW7*&|RS27}6xo+@1dA%QdX$@3aH53N5-^|z9{u@_QwtmGEaNZ$yhW5}Jm{Cs0 z6t(7}a!dGlocwIONpV}|*pPsnKUDu)`EzXK4WTFlaepJezOnqu^PFPSG0*U};hp>L zUsLZ*v~6VQM&+0JDpR<~<(Hr7A0_6m(RaODEYtb;KpBFg+FjXbtYFrH7~eqwADYsN z=KbfbG5tK%(nZ_a3@Z{cLe5;VGLrp z50lygGdJ}amD{=Ri#UcXiJH8XY$n)&u6NOyN>FUOiudk`CGpFV~IbDym7eTIW%| zQ?8=Rr_O)wj1I8<~?n_lkHjJkGp4herZZ zBH-v86LL36V3}!FXE#^r+?S5xcAG}4SSZu=lEqlyH|`q#Zl~WVwqVsb^yt7s=xXe3|uAI6Xqb(*Wg$`HX|_74f8FFBbZ1Vib;uV`~^VUML@PYnL8>m1pS@5st>d!F-ON z?-g;3R3~dI<0$UhN(mr_};Y8c0ME?ekoN&;r}8R?4F ze%4ehRyfs_KnY&ten{5oq5C0op7~eixohiqIX>!LWQyl6hipKm{B*Z_z zeLxOoWNA+*_}7uurE*5mVj zDL706@XJX#CtB@qCW1#Os6C>#N!)kx_hskKyXuUs>%mqH=aKvwg+(0%&%s zH?QF0%1vKmF|4lkz-R;F@EY zw-eRT_W+0E!@tO)xQbs%eBz7TxZz|cqv=*e1-|Brbp?(>H_lJgZvBf3 zi-s5bFsi24?urr%kJLWX|DUMy1OInM_&&IV!cIU1NbWqZhr^Zc{svojV4bh*u1;c> z1F@bh37lXOC_@1d%MZ=D<8a+6GG9)=Ov_vod)4 z+dsbX+0*ZG9@0GmIm&$UBbs#VxRq0kk4EeZp>F3#eSeR;paA=PpvR4U5P9!I|Beeo z@rR+fkQBXtg!e zjJM5&!SOEoSG3}NZbp~#(c@?doN5R!eRnZmXZvqe!0QSFu3=u&!7j#jm>SDmQ2G1# zz8|}E&DMvbl}Fy)GI01`?QUWLGhXKVf$Ekj;?;LV!)F+pZWDD-f_;~f?h=tKiL|_j zC5R#a)isCnZgu0d-m@f76$yyrEBliI^^w^)(C!J*%G8O?o4v6(_k~%sNF9dyw^Sc7 zUu6oH3gas{!ox8fQyZMFN@o6PF9$2fLhvVrRjjkf&h-l4PYNMei3}E?B)!#8L?CUz{O?7G0v)@m- z>xxSqT{B-KpPIk3;G6jxH*ihNrYS1U3C;rAq)z)INjn3uk1|*|{@5#w@n?Onm7mxS zjg&oI*6k_1H(FW$<)-1IH#~C)+o-9A$IY3qv;DVVw+6p-i_s=6gXstdd7 zs&1Ia;(Jk;m@1Axg^Q8pW9GjyH<8c(k@OUw z{kKIcb=&_o?wmPyru{Zw(w2ua3sP>IjI(A+xSDjziKq4I0Nk2pT_U zy1J#%ltV3AUDos0SzxI~Tc6fYk@@T%9M?2=u@48G`0V;PX;N`vG3|ad*^!>_%=M*X zBLIEGR9vT#kQEx|Ki=Ixzh%O`A2JTcDf8L=@NwGcS4FZ1(~~JotA1q3YTqE-{}lTY zr(kPYY((Ktc?mplx+C+A={AeE&IL)EUwCiB77mx?E%Vu(<5dr{mm`NK zG2JC$#6R%4tNQ%0`=#j|KF2Tf*`4E0a=Rxv9bSLB#dr^f5$~D-hg#2mp*L-Hsv3@0 z=CeD;+Yj*;+C7svW-;C(XJ~nEE8Y32vj3(e4wvJV`RvZ|Cfg@FagZNJYmoEqFybw( zv*3{*7p)x0;c~n(pWQj$40lnw6DJ9>piAI^^(%j3==7cyzpKTsGh6AiW&-6|=F9Pp za(WSM&JgSh=Z~BGi1IEEBmQMs@jp(U*y0NgpVKY#*`3op+A*QO-Dl@y8{!=^DRjEq z?fK=~51v*gaJU?=%x8CwcfeGf4dcc3zk1AKdN+p=@Akxp&fYobzsVdf$1C&Mo#Ra` zD)R3wM{eT$zA**H^wI(4G&Ydctgf>2mF|V)f9h!qyS%)%O~c=Cz8e{ecMz`3SDC^^ z-#=%-)FMpfE5!ck_5xetWV^G#j#IES$D#e;p9URR-*y8Bg_{VXJ5{yf{sDMYW?z{W z?;CpAYZ_wBAHBtV@*|osaOismXm5#fDJnGLp*@AD{Yb%?b}M@~{f6G?o3ihh^Kb8w z5lIg))L*KHEAv&Ra7lAd!44Mv>^`5vGp)bVo1ITv+YNQ+I4(BKU=!sM=?RS^K5cdO z*?VR@EaPCl0710|!x1>pCIG1n8AACaexJ!o}r z%2AJ6rdhTrZm-XlUS#(;0!>&f-XeXc@ucOz!RPPX)_4US{ciX^i1Qk8CiH8eV%=)P z8KS?fX%ssoM!DdHpH{aVb?sH7^@2lVPc(m>`FJ##q3(%p+W=Qih8q|Cz_(1Vt-mAJ zUR;0!UFX9$w`=RA_|5w1u}lB6`0U@l|B)l1G*D|I^VvP!p6gI$MbmpnX4sPK*f43R z-G!ZRJlJ8^UO>d~=mSXqj7-*!7=_v&M5gj6>$LyFnfTj^yHk0>Z-b5c?ssCx@0t{KFT=y*c+obYDD{%395gcF7pW#3I%wu1xzbAev0 zReh?5EAz>ZXa=Tb+WL3z-?dw^!|p5gIMie3;h_Y?<+((P*KEJZF+Vs*{`T}}AL%a{ zx>LQ!e3dC&{PCtZ^YXFPaeBTT6(IEs3)GS;=EJIK#(Yq&uA|mxQB$Lp$8Sqap-vjY8Ux-?@q7$6!_7vJ(+31YAoEURJcO3`K=Q)znGXKGws^M#b zDrCH|2mz8jf}Jy8AO1K`B4MYoZk84Gqnm-~EI~?5OAvip&^`-oL1%zsLFa%vgD5je z5b+=k>!{~x55;{HC<`B&LZUN|QB;+Mf4ieJ=3icCdCld4(5)_G#f?-I^3rNf`B!-T%X^h15 zL1LalVkROn#YoKdSVegRiP?d~+=aw^h{QaF#KiZ-`Q6EI8-_SXl$}u9lU?LQm&+cL3@qdQHzZXMn_&^QlHicCN;__a4O=!6dK7V8G z^&_73*T0NY=2O^Ys)|!REl7YU)(5fw42{ow(D%V7<8vwYm`q80;Rh4Ac*IM%u3vMdwbuCUZ`DEL-z=@?#$QO{#)kIL>fHM%T{7R zfjiqyjmiMKr(l{ouAGOd6kglFqT-QTM?$Va-;lSn`%5pWTDtP>++Q6T(!f>3BrBq+A~w&%TJcagRRse6)upExvNmt#YLSG|@YBPf5waUjYYCJxWK9~}vp#HE&G%@el6pIcZJ7#NVDiP4%k!8-OeGHE!SydA#vB`s4W}?H*qv<6wROfo2N_hb=JBY{0W0ct{>B7y3qs0`Ym{6hos6-olT%j2Gy8 zf(-d@j4Sh1rf@OAlj+6RO?tM&WyfX%wjpj;9&ag)_hLa*&#C+S-xwHQ`uWZ)x>8&v zx_is9IS1nI3tb}sPE=JhtCMr&^-dH-T>hI z@X|>?|B&*4iG)UWt&P*{#IuYg0hYkYJgwfXqv8s8Qxw8@oh;SeM%!OA6JxE1jggaZ61qO&i?O& z`+nH>>3dsRK7B34U51PJ9YJvupA2Kvo~-N9kbs;&?W}w`8re{3obq=Bl^v_xR4OjZ z;Ut$p0y-^ndviRAgxkjIVm{pWs~c}P?;Xq7!ohzs_=!a#xjz?={@mL$-u?Sfy7Tvy zp0)p_{F|@4tMddN4?R!d(0bcLf43+c%ij`or*pEIk4J;4biGWnohFeN`*PeIn@G0HPk!~`HAUYF3xw2Dz`u2=%6RGT+_Us3+ zDz9h!by4BRznt-KCoSa^w+$(0KKT(1Pb{|S6V-+|bMZA<=;&@6P*~)fW|+Ub|3Ak0 zB!nggl<-jlrCx5A?P+kI+2pD3E~$6@2Q<%w456U)Kg?H|!lkNmSNGk=!WXX_9|16B zAW{B@+ebN^ydpfZ5yu5mo(SY0#Y1@~&kvoKeC{uOPP;6D!_n|WC^Dbj)9LgCw`(Mp zI$#elTc*q7$ad3$11RZeOwe=;@Oa!FUWKBq0TAUy;nSIavXT4evispY2a|Cyx5J6^ zM0;1%tF4k=(f2v&)vAjX<&RNoucoxG>Nj}av-i%3q%|RANX|6Ri}@;3xajM>r8%^i z{iU8KlU9ty)`kJFGQ3NAMfKFwCyjb8pI<`JwA}ys*QZ>z^DJ7gLWc0Pz?JzbQ@H4O z`WF|{^jd8MEZL2T##1oQmO0*Tw(RWj<1zC%wGbnD{ZSNh9O{ZbL;Df6#8{8fTBk@* z7AlX)jpNiYusN-o*j~A5n_7Pn48m6zSLPE>G^Y5RE_*?`59^=2Vc}W?Tx1eK6ko}_ z`D#8c!Wxp^S-(67fGxJ>f1!Z;44w<<*Kfk+g$Wok|WB?yYk zec4mN%T*fOi$6WIV!5*O)XQ}UtS8Kuk(ugApj;_wdi>%%dJco=P{>q@-V*4z->bH{qA8peN z0Jsi1+E|Wc{AGxY^+Q=1TtBj&fqry)v1n!N6RA!;)2J?@dXf1ub~F9Zc+~W%m9{!w zK9$zlsm)-LyAaDwbNUtM<~lsJqCdxizR7YrUZ2Hv3!R?}u0OM(U*&yv?Rx&oscojw z067fRWu!mMSDC^kwEk$GL)9~s=R~BheAnJIw!h@gMzk|ezFWE^OT_$H{O?_~%BUxD z|7$b!D5cJrM;4cDS$eu29M?0;+<1R6?@?BBXq zPXc9ljoYiJ7lQZCD2A_xY&msq$Igko9*Fd)K57BxlONHT>QSJ77FvH07~@+Gd}I97 z3Tn9MdzSfXpu)uzmyoZ)@Z`T_l#^LLdOI|H@C5Qv zMq|u3<>k1~nrcb8e5Q;d?9{);cz3TLOcjuok zcNxInT7<7Y@G;*HOt+Zg6ZEPwT%x|O2QD(K?`Hb7Eb_KVEt>pe>m!nWF<*z{znS3* z=vPHlBAzj;L*wc8j}I>HJMpsm*XuEIJ~H1AM7NmX(RhCS8Wo@Fb>kEW2fZTZ+kOd; znO+T<+jdEZygIk@w=v;qhJ0hb4#R&l!(*mb22glglvBx?(E9YBE4sICdqKlPvOY22 z4@kF|;u7>p#v}H>BiDw`w=aM1RCdNM&!-i?9tF^d`Bf(2Fw3vI-gx`d zzc!yUw7DK3=NI$C!C{tP7~q{m{|eHvcZ4g?Ysjy-S3~F5qH+8GYWLoyE97>C`C;J_ z@+%mgwZKCrSh+9T@$I3x+mq+dl=6%D;ou46myE_(&c^7wr!pS1eEX?&-L;$c&MOt$ zm8K|X%nt`ouzXVoy0PbnSk86>7wHG%GV2d){A|ONOXFYukDPDJ4-1z`zM0{fx-N9S zE&lBF>v}hO<+D4ad}Dq%cq--_qcP@N)a#+~to(f8x|O3>4a(IcCV5i*$oz2dNcFYx zUy2@pSPv|caGB}Tljq-&|3RHwuhq97QuCSgiTUB+szjfB>a0t3vlOE~#lI0+pE@o$ zYw@I0-=8Gc+sqFOmric})qxd)<&FZN;ZrwaO;`Oly zWW8d(08O=;;uG{L99(hhjdC;7uhgzj4k%l(W_Z4&U(62&S3tiiLuK6OZEF~~mgK$m zT)&Oaw2RUKkbLQU2Ihx@OVYEX0w=b0qdm6mo*cEWfW5XIIhrs2CS8tzS?^|VFv`zN z?`}>_*_U%+qwB@BgN=Zb`QhL+tH;6ui@?S4wYaxK>tXr&M&tI^S-woxL*|EtSJ1=i z;M@wFWVpPT>1F?}2}R!}u59?Iq?gPO2WLPp!$oOqFY@0Bjq^V}hi|=e!fSCfe~1k0 zDf2aM;A&Q`B|TLO(ZD3_9kD-jP{L!Tk0p1mA9w#dZ9k6GqhvhH4kwJ;y z9VHt>>)XVL{Dh&iZ`>~H8}q}$Bj}qMj>t`+^Xbfb&;Q-^?)Rd1NczP5aBu|liBTB! zWqueq9_#XI->WVxJYUS82GAPjhl4}Xmn6GuvR&UU&(MGF{H{?hX8Mvl@P!dstA9O6 zZ5A2Q7j?Wy=c`QN60W{5C{bUQ0}q9t2-4!IIA7(-ensy#SU$(UFB18qaTw+cP*kfa z9zkEsaKyi7l#5yYGh)NwGxsj=+J2Yxh56y&2Jw*`Kj>s`_@c2y#@a>r~D!PWqvq#%<2~dC9g`>fYzt?brrjVLG58|LFRg9)WK!SIy4ZXt$Y_l6iTWTko_A(_TRyz^Ig8@-h)IsrKW2V7cr+CLal6#Cq@;Yi%jKXE zVX;5FNWx>LM-LP?{vhG^`?BQxVtzPy%=E|r3W11v6#rppJ$l>y-0(jis5@Q8#r&{v z3H47fJnMmn4C}R-9zFA+>&XGD-M_!SQLCXT-_Aw8F<%WpxCGZD8IAEfEB~X=cs^^~ z_winBR(kCX7wI6m_QD5}*AkEBP&@dR69P7cli@Zx-jY=^Ob8@0uV&rGkroOstw z8`o@bX{Ao9FQ~p`emMBd^eQMw1X>2-?}p{TNpj(QHLI_-4}Rp7xi|jyi>znN$Lj`T zCdXt!&#Hni?PH@H&Ghag-$gwZT=CG5CpH=Nj`;>~cre2ksJ}v?GnUixFz~%R|CdWT zZ2#rQ^GMJzbR(%VUu6mxGklUBYWw}_?}+tA(I-ZEnd#lB?{@7_d{yE-@;D^(1t_Z3 z43C-KF(|Pgbr5($>DN5Rmz}QrWY$tyznC8u9znm%aFlE{%Ee5No>+Y9MWxA~uWS6C zQID7(4vv5xF$!aQ(`K6yhgtr#IIyJ7;=SI*JhzABN9($o9}W(){23LGlNtP@2u3|# z1YDu=>HO}KA1Ij6dzP#>%nu8fkWazz#BVps$t=JA3z|d z;S%(!5>&?i<-Bswm6@=TOsWcLM9S|qW-14KA?@}9P-Nf%N|MY+!iwLc(|7V zB=@u1d|}Kld4Hny3uBbF#n~U-;kdBQ0X=cl&Qg9cUuXMoqvCA?lWgkgDmVbb>7ql) z>^U|%2Fs@Qx1G}+I1VA(+F zfpyP}=%1`FTqQm3jnct<@*^5PlF+98y7JnFIP8bRkcLXi zm*GyFfVDGjmo3GaljA^}A%4HE{U%TkRfezmlS}_DUpb{<;Xn-q;Y$KO=8M?KUO7H} zB|Oe@$Z#{703NyhlEbBEvofyr0?d3@k5`7*IRCP~HTIL}XbsAyHVYamU)}s#e^`}2 zp1x|>$kuV0@_ZHMlONGkE}tRTh+!yZL1Ur2%hAt)Q}!Hk<{_Z+L&#-cXrvs#A^j{y{&_UAJ&tPDk}glOe4`X1>n$-~9N7*r&OReW@<5&ptstGYie$ z)TH9VV$8^NPIjc{J9B;M*#y$3YTj^{mZ>&<#r|j~^lpl6puMPTTwEMZaKh^st2Q;R zGF&+w>!oy1BP8z|FrfDhn@+#6885%pbs<8L`D);}1W892i7@v6ioOfTxw3MS8GC8= z6VLiy9d(h0fbyd+P%@u!@!gM4E2mC$=<=)CU=1-hFgZG%3d}@n?On z$uYJ=BV|vQb$cl8QP*t!-(`_If8qn5$X{#VWIp*3jUT6a=83lPAy(-T+Dxwldm-X{ za^kvO`r)<`KvX<=`B+wu<5O_-8mcL%f!d4eU+jS*>APGQzn`Y=HI_RnW& zTkYxauVVU@AB^dzwu$EFPEE#~ybarXQfyyz`F76-xm$mh|JO2~{D{V%eyR{~l(n`+ zO@-te#;axn2bn|=rMKjVo@)Omt8N|T-XCm}$?cGN1g2#*c%R z3J-S?nr;!q9Fz9=c`8wNw<8OI=A5iRPJEGW8>_ENA6`xu&qK3y;zMD=O)Lt!vpn~a-KLW`@ z@?|61nP=T=MgnCBhVqB@fm!==aJ?xx5Us5Ez1K^FAG-POucEa0S#OvxqY6WBa3(E{ zGSKmuXj%>0gLX6w{i$jFsOj)znVd+^a{f@ihV}@edbplRLRq$aH}O&>R=DAa{@6}; z(qHkpN|7H2p2c=y%rC*qHzjAb^MePQt#21`?O-kUNH(<2llgLz!zkbV&?pSZ#rL1s zG>Ew7|Idg^dE|>|>f`JO-kGkp3nH5er2a3u z=z+1oq0VfN8x5}8mE*MqzM3%1sdxG(JF0cQJN1F6PeOe!LPx)5X#0l_pw6H;5UnFX zcSWJoWb;5XKse%Dc^>o`s0k931iBft4b%sUxe}C&fxcfs?;txiVQ{-XJ|1SGkfk6} z4*i}omi#C>Q2hRT{h+JweiY1%lj*%&q`ND{wqg$ z;;m`Q6*+e+b#tCk{Ktaob&=+6!m;}QGenNhSr~-S6saJ z$q|va%x(M-6?wJHkHMAs#1lvz+l8B@At@*nVn=IJAm)sGcetcA;mnjwC+uEK@TQ5cOrhq%UUw3pclWwe-94 zQLR)Z1_UjCA{6G!sMHzUYE|f_UHV;lwEd9Nr=PE??oWh0QhmuuY1*42o{~R|`fG+~ z;wx*$)&IQcVN^}3Av`n>jrls;f2)8e)rCO|uK|z8;fG@w-(CJ!a6D0eMl18zowxq< z?D&hv>oJm?=(~pbejvIf96X|Y%8Fm$5dDS2DK{KvWo4lOoT;(Ej$!*V+D?rnjSUkR!(POgh}Gvts!vZxUQz6B@@T8x!a5 zyQRrP-z+~}Q&{Q_P(OhAegL{f!+}5Q#r6WNepgSps8n-nLT_aZ!Jf@@*^EbFRK^b$ z{)y%$>dW#L!SzLz+56)z>f7(Nrh9ckkPM?B$q1b<%SW$ooxTi=g7#MO>sq<&G&9 zIeLWL4l%!~IJiAD(^n2l)-igPdF&rMyw6Mx-6*8ihy>>?UqP~2BXMJeE5c6!^AI-Zem)Zw; zJ>L4{80Gm1%l7`hB(gL2>qu|tJB9g%!10h+>~rTjv6yREap44qXLxRZEWX2-JfFG%=Oo#^Z2p+8XszUjImM*za8ZM7@{hmWcC_X@5fI zlONH9wZ0Hjpp8o)^RQaPqXx4GSH>54W@vn?=S^Av-2g{>86WdSY-B$Se1_GJa(j^y zsm)O$T@Ti71ap(ITF=#&fSf;b@t=WYPyGz4{)o=kpK+_S??>;@H-lwrRsv@Aaj>#M z=gDyyuURBVH#BkHKuLzNzEd8lqpsU3|2aar{@y8L3F-8oI*h#Myr(Aqpu;Aa4S;4d zUuXMo=$BxIC=N!$8guQ~6kCRU!brzttX=Zy8$a0SS6YTUsle@ZbkpCI%a1?6BV>s} zJiO-S2t|2ZMPrp8ExRl|J+{?W&Yv>`xWVds!JBHWieLF%>$!3X$oWGv`{=ux`#k)q zNb)?0G^(0U^J1|;J8jO#eA^Fq~i{9bKg zKAFOm^QR3G&)?@}a^SqN^1w_wHP4gt$7+9SUdD$LqFMfMeReqETJP431myg&`Uf>5 z*P04tIRX;@E7Cbk)DNKlfi#xSbd{nceLgaG(SmnKfh>j{l&L6A% z9M$Zo5V@Q`R{5zQqNB=?^T+z0KC0PKA#yo?tncXxB08!JIe)D7=cr~!g~-kF$NHYG zAf}_nkn_jt9~`x;Fpc9IUgw> z9yP%cho3N_UYK~PRhF3!a)iO$$WJJD4#&D%5~wK&n3XHDaSOSA0Hgh$tx^s7|D@k5UYRyxjewyI@uBFBw?YB{A|AvXlAqVeKmORYzQS7h5_2 zOWTEw_GumJ#O@}pyflxy$l>u#8|KcTZS)5esAmMF=HR^&5U+oY8f9D$X0|@})}~6! zo6g*NEnZU%&0kTJMvBZ=*|=!?tYE**BAhy&;ZFCti_+{K0!53!w0-r(eixlNVWyjM zIUs*p+#Hj357*ypc;|G_m(nfopGzU%`B}{R72l1jt9uo3#Ev$~-wem~v&P;0^OBOwWgN^8Akb_{b^0o_>=$S=%LHigmACCqz&|@#kcV>HS z>4i8jINybBcWnCcYyF{}0HSRu&|N&mc4T5Q2O^Ibn&}Ant&Gp%@I73A?7yb()s3Iq z!0Nt#q~EJ)xmn>=O#-Fx&gFXc6~W6jg`92omA`Pct%zgc`d#L;yIHwbPc3wKCb;dM z98~n(Z9+K~+rii?jd-Yz$pw|akNr%>E?q-$EStWr|AeR!I0;2Fj7R3Pdl-0nm{l>N zoVHFg;*#sX<-mPw!Oxv1?@KAB{}yDp{$swz4P4D|4YIo?g!$1pONP;rA?1fz8L;eN#~g2 zeiQW|XwPSwx5E5D$eK-`zf@dUl;NJ_a5<+tJnF=yG89aTw`*pHbn@9;ezAt0x%}5q za3@VLi;z;*i_J5G|IeTQ&lsiT{<|`s`2LNDx9J0uw9f?T1@mRWnf=cXIiG1zx_@dO zhbPzjmF0J3d=AI#UY&Q$!U@K!N*v+(4d$=9ZdFMG$3b_t2YcUgJMt0`=Mm+X1TWu& zuGyk5r+pWFp@)%D`Bs#s75MCKR=z9DYceU%We9-loyb{6TxRo|;;;L&@ahQ%3OQcJ zCG*)m3|xl!O)^ALZu93F@yYX?%7A}t{+QDLp7u$vHaY;V7n#qv_-=-;!aOG#6ke9= zK?<)PNSwEBl|_<@Wh@B1JF)aK})0R9*0na5xF z?sv2-wJHHCe`-~{haI?_KRnM?4p{t_qB0~ti+1@v>-q2`VCB!@$*;EGE<*(Ty%>Lo z@q5hdd$C@JN57nP?T>dcE-G&{yItn9yME5SD?2~1?$hOScyM+w7KrkJd`Sh)>`6o1 zSmXodSlbZ0E61B{F9Lv72#E3R4+G!ltuOrG!mQ}m;XbHT~UFTq0^k;eFxgT;{EJ8|7NzJGV4ONm%@ToyCisb%*G{ zcs&pE886?>zH`mT|9EAt+mn&+aoBTg0fsOdD1ZNw_{4fr7pEG%XlFchuZ%DHsZIOQ zj=wh3W`%uhN}vp|xPF>?Pw;Y1DHz!-BF3?O-OFSr!|MrUzUHbZX63xXIG|~X)a9KpUh|XF!1#dYMfwIkQ!tet}IXGej{GF-dvCL>^Su9 zR}1R=?>FA}itA10Gfuvn;nl_m140Z2(yX4O|Ke2lFj2i}8A}3|1OgHe*Ei39z*w%M z;El!&XP>DkDfODi(p!64uYNgZ^MgD2Oyv6D)y3*#=93@MX#KdMjzYI*T9O^xT-cI4 zZm+k$JG;2h;qs}hoRJQ%yV#TM=#CyM3M!;E7`685&I@9c1wZy_J>br=HQYc@-ADhanNR5y&8T>__IDOI(z89zBHvJF zw#S|B$abTLZ^OPYImOuyHFNZr%0lFeC_~XsuglLO4$EFM5-`i3nwGm5o@lR`6r9+h zSow2o=daiwKlq5T9hCdyt56@mmDZ`z3xgY-J3&tt*SE}6DMOdoh$D zj0sTK@_Gb0zS?-^GSBy#h@&RMstG(+7$=7W#Q83zj~dIn{5?w&*1)lPFa3ik&ZblUX1B{-N(~te?Br?Uov0g2Cil}D;WYQM{YR>Is?=Oh`)T}3s;{tJ`>#O4eYg;u}F1zp)^%r1+J3s$y z?b`dcP3ocL0m<(ie33I>&Y8ey>kzxo;mV%YO&BHi_d#v_9C=PxYGF}RooX^l939nn$ub41Jndx7o%UJ{sF%ncjGi?Ak!;%x9VM-K1U$umZX?z?GAT z89S5FR-+Lvo>1uY1-w<(4tIVwxc<*x5uo@BxKZpDN$?i{Vhl`#Mu0NZhUk6@nzkAr+Zr98D!+cqu zCi)|`!caLd*~93X9L8U4HjueXdUauw40mvdZpAq`Nx#Q`@+>98vxs$+7v`PFHopUyGOg z6+Z(o)j%Ml4VEKQq0%5fvZV>Gr$Ubr<;D7XSlIk#fw>x>hhYv zYvOl%Iih0xCF?@t|9AZ%i(cBF!i8m`P&nZhLytN*(_z&afKHZ92+?vajc z2gbnyp^C{<%7KN`m-Tw+^fhR_XT;=gz0TTCn?J))`cB7{`6^Sm1fs3!^y%r!3B;f# zjLx#Ndwl&p_9+BoGlVz24+`ICVZ zO|ciLkH+*UZ-!1!|3@9}C9aps+UlSwJx!1v=8I_|do8Ai6QQLCUw;%|If(P8JdE_* z+iUn+A6`DPl~bQ+OX)cq>0v$|4W@R}gG7X=M8xmyxDCPctMsiH<(l8R+4sHnR)f1v zp_FOoO3}C<^9_l^gGu^m+^^d8T^XXK{5TTxzvZ-qdM1g;-yEUdInmt3`mF4o;QFMz z9iuF7UY;5mH)LKO{fL9%|GCW9xPfbp=~I~PPfhEaR%*2Lke#3TPA;Nd^J!fxlYppi zQSS!Vx1xjh`5+ZJ6cPH|ERn)SSMB*B_{9eG}6ofA5*;nHf(E<7Bt5 zg#freP_#L?zHNp+exOYI>*){rT$&fFNsj9`=4;%*wdVBAynj}k`V~lpW+Pn^^~vm6 ze&=L=UJC)Rer^6BxPHaGAETTy?$$FJ)PHhifi5`KFXqegtU>)U?JrkHzqnqK^+U#P zJs-XV#P%{_OK|-v`!GiN_m~kgTQ{9udgu!+Zq_g6%ZO@Lze0b%R7c-r%r*VYbsp)p zKFm_nQ5-kniTl9J|0KA+9fUsS)>+!FVA`lp;!qG&B!7o8UruuE=$Z9BD$DtJdtM8`+>Vxh64`*w1= zB6o*Qm*?wmPv3S~yR+o^AIv|(=`!t05C%~%OTQ1DuHPU3>94+bJ@K?W4}|$gK3$>P zF2Zyyj;D&UqOnz;v&iGDd>8$lsP_3t7}x)u_k`BN+@AY07k0X${nDA5L`YWW;;$U@ zWjUGD{{dEDzF&shXD`ral&L|?#+7lU?F)`;IdD6&Z;W|tUEgsZUaRFE|5sps7`SL2 zQ3V{wqyEZiJ&~VF1wASGF}R+TLyxlh?R$RQ=xO)NTBGR+uh(b3EUSRB`sX`}{{xOo zeW5j6WKO1fPD`<(i1l5Y{lWEx-WhRz!OW(EY_H1o9rHO{zMJSvW&L%7?yN!pT;E0g zY~0_<0k>RG`TN)#ckI$Nn}Pe&^tC@9`1GTfu_dc&B5|d8lg!uI{+rqUR$=Z3SP6bD z=ma#Lgq!D2l1^3j|NTho+mVjXFKo+VNgzxKl))dD`{h!(m-n@!Ag{~%-=^Guzc`BQ zWT@QJRpzT~T+GUSg?#~olIS1Xd0bfrUChfZ{vZ z=X$Wrt-B=wmOvRST)xwOH(%aPX78puj!Ffdd5WUbky-nsch7z}wB1 z;>^qMpO#9Y6oCjI_lMT&osb!g197nJ2DTi=UHtwjYu{4s({d|=vTq>TYFw!yEUf|48*AS+;abOp=?CVeG zNhP~ozN0$cBd(Rv#V(}8vXTTU8_%F`LQ7^xUq>p-pTj{W<|}`jad@H|^Q?R25~z** zq1ZTIC_k(`sa*b{TxuhKI8QiVtbTc@T&Uc=Hu8sJqrBmK;ryx`h2>J21ge@pqTDG= zE+c%eEFOzrJqc7bf5M4H%tOvMzK8R^nR%+Cb*YvFY9fEC6)|42#&<$XuCn~G#&<%??nwBk zEPoCsZn1u&c1e5|?S~V`$?|S(cv(;AML_1#9yxgta33^c!r`6^Sm@cb&b$G@IJ-M<%8t&Hb+X1L)M z$BXIj)`Z>&Fsfwb^UyLtQlvFFWGd4i&GqoF)b9}M7}0+Cp`Z96lp%?%KV|0z z*B_-*OJzfeXZ-!8Z!T-8SMsbs%$Frrb^S^AO)GF@7Gc6H=}>LykEl16&d9kI{&N|; zvi_8x7hHc5I=57|+&p&KtL9VqD!^W~VUu0KQU)7-^AR-oF@AJP|5XRL1@IoHB} z7W+Z7&kwFY6zW@ZzP{@Ab_!3&SKBXY#biDssJi|nW@kIRUgrd7fo~dX5$YiX$a=p1 z!r(YNU(iyyp#Du6%SJT1=3J^EVYr@TzQzq)tBwIXEMcCsFwluX8s;b_|@tQr8 z4vBS-nIDT6o&?1Dr?h);z1a`F+OYM}arZs@zYm-11)24R`EsmP*BgF=PM)jTaVvt% zL^$;%$dIk)YDl0A?{Gh8^TomSD6U6KWz&d)SJoYv;k-wWi}i^4G6dF&@arF~kA_~q z!-FR5aOxqhYY3BQmoZw;)t7*{KSFGLaQ!Li*;2`z({$c|>HW6GN%au(Wh7PCAOA3V zItD%U(;*!>9PZ)h6Nka|57$Zj%s|m(~~AWCI5e6 zzKp~~pTzyFpflEg7+Ge=)3aC~E$R9o zJT9Kae)hr3g6q?mOIs?}KlgH{=;7;n$^T=RFDJVC`egl=k!5)-KZ|;lkQiK#%KElc zPId2p^NMvXI?DfLm@lWb`g&yjpOIyGEI*5SG&?D{9_@yn-Qq}WF=0#bPxAj6=F4fV zz8+csX=GU*%gU~La zaJ=P6PsaXj=awdaJWl>!!+gfc_v+)d{@bt&kB7Uc_nT9K>rvdmmdZ_8SFb;>$Hcz! ze;ek@X|BE=@tfBF8(F5u@^cx$@pwhl;NbdHl-g4H<()B}U(;KhE&sn^zMNLp3Ss;- zyzvU_KaMQQWAa(7kFtga*Ppe}uPr0q`*Ck->0J3g4)f(iR$qVkP3wP-EYoB8S?nh* z8XjDqB8Rn9JXh~{DE_5UJ>>s6%$L*3T2b}-$oj7%%ko%$rj9n)v_5>7{?V;(uN1KO9S@`gbdTsxP}E@n#7k z;d(i1bntq4E$Zz9QzG78@MnuRp41Bm&(~nSjM=1KruAuHYjb*PQa=ciRet3hIK1cC zc%AiQ{guJ>V>k5YjKRykOKV~4DC-CFWi%%GA%2fqdLj$#7=5nEa%`4FxopdRLbcVQ z+~x32v}Y@Sj_n*R1w5{24_+0#o*gr;rSko&U(ER9jO!Zpq(eGjxE*G`#tmFe>RD=s zapM0cT*0HWHfs~z`HgTSRQBH7uDIMQZsk?Mi&pYmEU0>E0=F3tv z(HF5@w)938*m3e)Q{|fb+0?Ew9Va3-HO7J85D9|WBj?M%5!DO3d z?r=gmzTd6s{9#?EI}=HW`Ny}kjy(FB&L1%a@?K+B9*NQk&t9APBO?&Y6S>j1q?Ko~ zl#I{S$sd-hEN^4T)>BPLpgQ?e6Y&NMgUb}%_3gBRc|W1uY9fC`dCFyq-A-sB)?(sn zB7cIxB+$u_-CiCZLl$E0qXGJO29!DH+ioeEqZawXjnF}g^Ur}a{UAl%) z*zW6nOVQY;yOW)aCZC83e9bkm{tBx}Y#Gi1$56Y=p6BqW_EcBk1p7pf!%pwW`ahO7-+1_-AXR)+)^wXVP44!Cu;6zVOUYxWXGOjjQgYh%a1H6{JRw^HqexHO1b!zVNtEnQvr}T$SOTQk?msqNvAJ z`0H|X>-=4J^bs3A`Nsc?q%ZuLbn#ElUye5#^(AFcUzex@f34-`JBPmAVbG?@Ohg+XD!Grp>#curtsI2__} zPcD8Mz)x#(`To)S_V0V>Q7a@p;m4$lzi`kZKl$E>&d(CuD0(#Y*w*<8z4zhPBl_J? zF6jwBCSCknwAym-1Wjn@aOiNrD$beEqr%6oL1%f zmD}%mL{%2uG{T2Tw|y-u-yea-*LZRRK5sZD9GVwFeU;~pdOaoH$m|JKzA9v$@P?aW zfaq79!4KYIAp*l_whds^G^CW zEDs$4_Dy+a)5bs#pf|uzunYo*0olN0APlfVVFS?>5lsVL0Ll^JP$>A`i0}eLI13Rz zg9yJzgu85JSr7KHtO46t)<>wDUftcYz8h&-*BxqEcg(k}qp!5AonE!9b^X$;;+iz; zhOg4Bo6l=!Wd+(>6KgwICtIDY`_^~1<}KXF+HzfYi}J!JVO0BB3qGX0)k3adCEkzY z^RN!GHn*&|`+fd4oxMxW{P^8RJ}c#O(=dDoT!pTP+J$lj9MP8e!WI6Ys{e|k-e^@s z$(X@ofbh{}p*w#^trzxC&hnwad8B z5h3nYED7P_eClRW#520GY8=j&b*Ep8^mRE%UhDnY2OjM9WW~D|f5~t(v{~;7T@kel z<&ZsobiqhZaaCnyC>)LCO&vXE*fbG93}NHXf08@>PVl3CO@%T|d+nK>;k3^F?z%NS zN_L+IRZ)iNcSQO^cgS%ok$&E8dBcW{@V2!${ru^OgykuJeVTR2 z?PYr~&V5c>-R|xC!*`f^D0GI=4bvYvx&Q-)%7C|~q^8nm`^I3&bH|V_^Ew;g^E8+5 z9rph8n|3EmyWW1@M7|3hx4BIGxpTe2krh<|e02g!P>dGcHhR6b!FcZG@_qG3>xX^5 z@moKe`7U&cS8S$_97p%E%pRLK2S@1TK6Y~J&s{e6@P^?lZ>B0JBl&I8#b2fC5Bo}^ zveU#L3VI6BbAqY#s&x zP5IIDBlA?Z9`;A11Atoaxy42+RKIZEjJ;m{*7M<0rXC7i_z;`?j6sJmfSLybTfZ-2 z>ta0uP!6rNGolk+5MJtM_7U0cpk}u=0X7As%=UzvwW*XLG$X9et-b)daTbQ?)>Z)9 zs;vPuF&2usl>zX1rJc~_Qg6tmxqj;KYZw3Luq~$FttxB8!+h$BtI+Y+Whj@?1!F2I z1HKB3nd4pL7($7DWSrKzetf*@(%hmUnO>$xL!0%o&=pa;G_M~C{j5Y-Nx!ZQ=`UOU z@aNrTA002>HXmu0Nf#EFelfm`H6w)40*JbtyPWRUKgn;sJ$_@$UrxK)+ifq_RWwYm z9j-!GMD3!|o9*}JcuQwvJ|$ie>h;0$y5#L|9r)VWd(6?@?w+}!y`%Wl0e)vr=vtD> z*+To9Tka2(jVUZC$Fv_GU-f|~??1X9Zt^4lbv@DRRFS8IOW7$2{1qjjm)q)dlb754 zvwB(M_sczX`Sg!hSF)jiVcpMiD|AKFE-jSX$^QA$u7^0J`Ja?qj{n859hCV1q0yG| zOgF10{+Ijc*8TA}Wl|FOQzWnmsY<`1$9e8@o3X5&n$MW}4dw^Wx%EXdxG4L=Nkb~; z-&f^uOFia%hR_{y+`{lW9IdM4*xOSO@|KlgLPI7va?#jE(H$=dp%a=IiK+Hi=W9tD z_&TcMllsWDcfWSH#@A-xOXzWi97nT!Wmi@P{G~E25XLF_O&HV130dd2F0XEvjN0VD z$^))E$ly!pZQ?7p9FyEw@9{SkRSXeG{!L$$;D>#PI!x+Nm`lOuLtTPLz-fJW`iiBG z-5YykH2=Ub|F*8l#8_+kOk}y(C)VlB-*hd4W0Mwr)z}>*pz`MW(peOkC z0ONoVa2~J>_#DVUXKN~OKJYp)2o-iU@G`*pu#$e?!*8ngu%~b416jv=y|X&=J3(j^~V5b|NfSB(?H9bmuXp7 z?}YLGFw2^kM-+aqDt_bsTQ!VQ!FWSg}WsRH%{!Xy0ozJqY9qSQ)gJpgF zkY)9G)v^jc$6Q^nzdyAG?o8oQq}xg49_ll(g;1l<0YM6SaNXDFSp(M$v}uj z8QL7b2;CvaEff^b=&(J!&-Ip;%i5y^sDwk(FS@Yx^hd7@ecAv0ifp;x<|EBA>Ecg4 z%?sz1I!m5by_Vkdm$jbW*x^qsKkeD8pQql@&`!fu=!&RaRDZ-?EVHNbC*!j$oLbOn z*?~aFsZOf!wLM>1d|9f=JpW?E4K-8wV#``f3{Ly`-8B7QYyNuJl)H5a)I*@uR~i3Z zk6T)jaZ7Ybr8R#Em$KU~0W*KD#;vHHRUT2^y3BQV+fzt|{5=w=!_89PPrtnN`uCHc z&g|N5LFWl-QXTiwPQz8`CNK6(O;IQm@JtE@eOxc|hHIvHXZxJa<|ypum=z9H1@V|$^01&> z=JVw5x~J+d>3meyw=S3Gjz4b3?03q&lAg^^nq|_(zYTmS5$k+xXagS=pY1$j+hvQ- zlyrm-lP>kbwh=x|y7;%oNA_eps%qRI`mv!6 zd|Z0yiED>v3>auX1^RxtKMhx*OZsB7e`5EJI10kD|4e^%Av&-z1dw#AuXN9|%3Qg= z-n4z+t2TS;*dq=uW5*cgYjotg<0^EUnz%aYVvo_73hp=Jd@FWdG&|qAVX-@XCNYFj zUDeAP-s|ZX8er!fXuVP}ZQ*P0qYq5O^f_-Mbeo#En(5o!BgG3!XoWZG1VuMi$w41S zFmKsUWxt4ZJCj70TdhHMfi3gU|IKxW0Z3;%U?4CEpiJ1O&IfbMH|ZacPnz}Ou>Yp6 ztw=y`Czf9A)<4O2+2>OW|MDF-`yp@lwLh+O;_ZNZp#BNnOpf|D%7@*O#WlgwFluIR z#OEmtV-a#PmVL|AaMqLSt%~^UJBPy3^K}>em$b~d`CsQh|C-k8ugOnuf9&9`zo+^r zL!09&p*!TbC9|8{-RUeEd(@<7nXkwjE%yw_3w!5f2g{1*c`K=_IzOx0z|YHXfAiGH z`Fn8~tc>s@bcYg&;Ohfk*tF-3CBn}Wz3u!J zdYlo*q4QH*6`tuW^$7=|Fx%tYP-V?T-<&G!^NL_|>Zq`{f?1sj==rybrD>J_B7e0nFfKF~3NQ+vYR4#3dkTAw zL*(1o2L7yb-aqU=2gJU$Q%~?`(#8MR@W-~LEF7wAj?a2TD164QYh8{vbhi%9E}XWn z@F8+E>EhoipOb>ViW$B#48bR2z0nsg@TRG>XEgL6t zdPy1K&!mgL&R=dQ5DJg>R#c(!)5~k-jfwd?rpx_CyTV?&hh_aRdHI~$>w8)I)IK_W z)szj<9*<+P2}a6?&=pa;=;<~sA5v6&lOoPN^+;GR7g|(paO_o)=8kV+;Pc=?Kz(@WqzFmVhAqfDF0@+zL@*cmq4E~z8*EAfw5A_S#mra!7aIMEa_GdJm^+;W_f>GyP$#Ye)*`@Nz%&w5 z=2uBz5kiZ8#2S+8MzVbTjc5^`o$~G*G2xKy$r; zQf@HgY$%s|R1~f0jikeVJ)2C9J2UGN&brWy9eGnrMy%D-8))w_98(Z-(Fy#)oGSo9{?`RqU>aji^Bro2J z)2#h&O|x=Vq*<}XG^@+^Y1XId?W}!=wX-%UY-d#k+gY_|wzCest(~>etL>~CerjhO zG`PJrY(jgh=$Q7_%Qv;R-g&3Jb#{6Ot7kz6Yr(<}R}W0Asgo6pb+Xp2>SXoWv$M7RqRv*;FP*LZ16{1=-tJ<}ozm4>_)1r6%Ap%sc^_|N z-F$R6>-#M>w$6QEW9#$T-L0brY+^m|-X_*wH*IP~j_+Z$FWpSZ5k*U_$23Y* z3ePV>d_u|xch^wpSXW<#Zzfk;EM9Q{HPcl#KkF~qSd=bXp9P4bA2T$xA zHsUt3JdzjIt(^gxkKtSl_kV5*VA)gE5!1!e&?z!|_b zz(c@lU?V)vUO)igW@o%oVCA>N8Z6Ks?ZEZGSd^7cVCFqwH5lpvX69gWXcI8A9&53g zU}o87$S*VollofLG5xS++~1aCOXZRL<^a>_FQz&C$#-ss9NH=hE>X7wSni zK-&k*1oU$RPJFEFvWu_U;s}tHp}w#dH|e&od)~&VKZ~&A3Gb9}M$V(An{ujV&h&-z zyqtiS`}KbMiu;rES9?z{%m3;N8Q1Up^YC{j+cAhf3ti$B+pW)h{~=z#>-a%ZtcC3^D$hu#5u0w_ z%Q)Hgw8bzijl{wGP+XfezxLUhjieP~f6bq~2`^}#nl*z!<#;G%{<;#-%XR&O$;S)-jmutOWod2l1UmSb*i8RiqtN_2i6nZ~d@^CL} z+tnu?*1z%GaRo13T+XzmA0c$%N9-hgsX9h2Peq)*MH%{3xX~OZvb~kIn(aD`Uyaeoso4LpMAVg4tMsg`4Xg~xRWDR}2t2OuA?$-HF z_p%Pyte^GD6GN;cXJuLQzA3aWJZO$J@0NP&*(X+8t3S?3qa0frCxXQ`89qPdKqEHY z?1OO3%=v_Jj33w+q8vs7ixIF6&%6%qa{Jk@6sP zo0_%t818fFyr;i zvPrIM4F6;tvmDPu9moclcXYGgDCYqzg1={NPXD#FAAdd+bQ;c~LwA1>x*}?qCi}Lz zJt^NG9TQZ$xSOn#lU<2hi^lc7=&BX&ddOVI%zC_+)yH$tyNz3A9oxW%fx$3C@hNmg z)Gjuktc`Gblf98jty$JX5V~BoTmBFyd%m>a4dZPov;49?5xSYI-9Ibv2WLA?u(PA= z_v(e2&TsuM?H%S7QeK}&d8NK&1I&NAsfRKj zumt{hzI@{MKbCfWb`v(NFdflBWqB34O-)=`UQ5E>U<50cY7~XT3Zpn>S6-ycL{PoF zawECKoruNVFWIolU9ZHx*wa2&0#hTi#y&Q5>Z`r1>vs6^;(O=)@_NsM>ZwDLXyn$hP6GT%t9C$+EjvJUGowPvFa zPhR=R>@g}9(G#I-Q7dOtJsIb%whtr5NgshGN@MEFPFjS_SAzLSy&?FYHuIJ4Zcu<~ zU;*5`mvs8m*mD`SoAkp0>WQAl5ZhZ_FUNIf?SIPYK9_FQ+wS?@G6={A)a6)K^q_sd zuZKSEwcoHuPwASo&wl&a(o4rgJL?spn=&oNnRGZBbw-8X*)Uuwi z>pbi$^CA-m!_9qe9DcLRGj9g~CC-1SgwhY`Gl=f+KlMiH1^JICRbPX)ZWxYx>vTG4 z{4aV2r!o?!{1;oNi(8LR!lmq#1b(jsY7v3-R~p|<)bA`0vHhLzD7@3l`u^=pzZuck z%X(=*`lRlCzPh&kxEz(Vtj7r5>I za`M2soMnz>mTffKYIc=a#`OKG?DG!2bY@uS@-^pk%irr| zUAyINo;jP`--&Xdk#Zn(o0_0 z<{|TWhR87d83Tp60{^c89bE&}-m*W<_JHb5-DW!>M)XE(p{MM&OCW}zqCc6Rx%Fqn zfdy)Qcj(KTTBSoicwqzdtF+(y))ja=`nJBs|z`kq&lPAUz@Q|i1N zdrKR>*A)u-)LTzHE5n``VK|u&(Z^GwkL=e|SE;AeTYY@RI-hz?{ia@1zd6>zP)B{+ zg<~$(Lag`6D)&Wl48i4UmJ1Anl71&*0Q|QD1_B&E3pP6BFylYvu!Q-RZf(}6R9Gl4qbEZ}V59N=8wJm7rb0$>qvA#f3J zF>ncRDR3EZIZzK=0bB`O1uO=x2Cf0F1(pEU0oMaJ05<|R0XGA;01d#cz-_?oz#YJy zz+J$9fTh6Qz&*gdzB4hoUcgSx@gh_Uo!X4VQdT+#`))rN1V0(sUE=)obTP@%)aG z5Z_0$=Rz315g;FW`6UmXfX+Y{U?X5-U{jzc&&fO-On_C})9k?5C5bQKaE+#PNtItk*LvpMv%AM|ek z=0LVbenCLd{h(iCQ5Ft{{y>Reg|hX!!j>OpjAVb)z9ruGTMQmc$*T|<)5s2%=7-2tDX)i5s1DB-IPmn`hu~GOeUAvbtrmA>cau}pepKA z)~2oL4f7n?tNJ|Yunz(51o3_l2ciBegv~is&J{lhKb8wb8*h(G;bwiY3$PuqHNbk9 zV0`>P5J1(a&dq0i!g_`EHl;+JVLeX$U|m8#x~Ve)>I%a#PP!T9pJM9qAfh*mzDuq* z8=zO~_q{TlcKFC;xogpil{|DVSc;O17`@$E^kee<5~psRB3`o&WNm-17~h6Y@UYQ1~C)ZPCpqKl;|~X;cW9 z_t38=|3bH^iE9%6<6LJ)BK}!HevUDIY_%GX>-OG~C69#WpO(%6C~_Rp2U zO{_YmlhwY@jdykVxtH~yIYah7G2}f?;_M24K9A7x*JYdz15a|YkErKo*TbOzj)eDQ z<8{EfKJ{kcT)ds{e1P4E6x(f|L9H2>&lNX7T} zm%tJ{f|TbT9g~;mMwIsfLklYg-~RKBgPlj0@+@>yB5g0vg)?X7R#r7%s+;a}XB*d2 z8ET1c^7dQ)|2O0QE&QbJNlBnN3Fzf|O_${5dMV0%yMwc zcxy)X`wyMr3>2lk7CM5v%&#ohSko-!Q6Bg*j;kAPjXV z_E>!8?h8ICy^oV(F!CHix2cJ1^5+;?%@5nzXKdvL{FRlmjkn3XAD`p*8s>><^zvu= zrT(`pfm(RUxO8amgx+wzl;??Yo@r{2bnAs~FZZ^3rd!hvoPXfK7kiK6IcGFn-=qEu zT@kel_hmY59bT=T8F6NtimM`Or9pjXo56W@8u`%I`DMcCihLI)o-c*Se!@cLr(0o4aC#4?PdKG0n-3R5tmoGDw4U$U$9n7PEv($vwzi(SZ-7-;k!g81-o;9Pa8K*qr3YBIXO6Y{ zkDqM4Qdws0_kPs!cdfOGCtPODJz%M|GVqFZ{Hfnr_Z=}Ht>K3WX`4$d*xet=n z2SgY*bhF-MT}2h4n}%-P==bRKlshGXf06|B`gKj;^(7f@&)@`bE_={ zsb7U|%BE@k>W$1!tjfi|Yh#vM)}hJFU%7meH{nn0WY3cFOG)6@N}vumNWW-FzvSh% zdW&>x%^|l;e9BW3-EVKZrIT_ibTj>C%WYy(0H0j(*2D`hZZ^xW*`6|fmIcz;KPDuM zw80?7O7JwBu87(t{=QIrncP>3�@#^D1v3L7nNX z3PdqihrPkXD)Tptt|)ww)o|?H6qz#QlUiZY6&V+mE_b7pg=X0sB|IbN zVkTDnV{l0Nb!|xh^$%VhdhOL4{UrBG`X*icTT0(k;q?a*C=h) z-}pnu`K71lhtV(g;41>kP}it&CS8$nX(oL(OCf#}mL>*B`gLtcKP$8GluZV2{t)k_ zk@QWv?VBupTLRQuNxyIZ)}Q}}y${aXV}2=%nlh5UNf-Z?pWic{--Qo20d+p=+rUTn z0liNf{87$xl8*3U(#5}3J{*OJ;Rcb%^6gmi66Mf*e?MbDy0v<;|MBB@++u;8jWy6N z)4vE^MW9{Chx^>Ei9URkT+QP|5Uw8gGkw{g{w-*%t60ui#);lvD;kJ%fxq7^Ybkj)sCf)W$AIayf#L2WX{Q+*x z920cDZi&+ky)y#7GS7HlbY3VtyVw_=>n}waT7(;=zR%2Tou5t<_W5SQ4_P^Odt_j!s!p@3&nFzDklk2hR1#XH+qRq5fLQS^m!%l&~e&!|w?Hw%Z`2g`VG z3=qD$Z12_^>WnH&m^XjB-{)^H0pA}!aQf3Lrq21glPw@CA2!z&gpONWX8eSao{1$T zp28Ush(aA&UmU8!BDoW4I&8fiTJO+D!e$aqGI2NSf?s2Fx!2?QTGNApS8g`{rllJ_ zFKO86r&%Ul{N?%Zi3@&imDvy}4?)bT@vRJnqn=UTKwyTqbaru7DYM1CQ|Bvdht~NT za@zi-2Q7G6je!_LM-@#+%cR?}<2_(U?oId_87wOa;nF-?E`6A~Q}S}V6nwAW_2zSb zJot;8!yQH40Sr(dgf9GuEqoOQN9LArv9c&=%|XL zc|~bWPnhST53I*nUTAZyWt!IV-_#%T{?z}b5~v4B^kn(ak$q6OVtOjL$m$9ao!*{UWGlQebL+y36Wy>qj^^6P3$(b z*jE|~mf00>bNWLaVP2>5+a>Bh<&WNfD;m~%`&d`Bx98bO4__|K+Ig5}nRM}|{^X4> z_Drh8_kGH6B1v$jpZz#rz(3269-JpHR9;+(xkBftJH5SL(*}O_&VFvMk$3*W=|E+K zACoTrt@1M|Sgt+_R#sTaj;_;c{yWR8{Pa+hwnamYxCV5C8yO78ZUI= zM{K(wc}Drektjd(TT|?dMj$7AT;3b-&sS}C{2hgfK5tnKPKH2F&o`mU7e)!>{4Gr_ zAbj@St@Zr;bh8`0C#>jIBXu+FH1yhq&Ny{L`Aw+umlmUk#S`d8;pFaeJ6FdSg>C1f2K>TOlh&59<;JIqW7_}~Q+KyYCd+K)Y$GfMt2+}N*uJfh3HH9m8rdX8u*FiXPQV}RsW&>eEzGRkYNH|m=eLerj)5KLFbJ?uZTt#-P*@%vkI#1KIEe;)jG!2j$dH*Im^ zyqhkZ_(i+nPU9=XtSue7d8@(y$Z!~E?iU9__IT5>GH?UaufOKQGuI(~iQf-8~HqSOVo#)Ps>==PW3mjd}C!Tf9b2roOJ88`)f7u+OCA0;AQH+~=(x>g68za6 z|B_JD{@Rffsvhy^a{dhQF>3ZZb&%#H>D<}$f7~PG_`@U+LrkK-Lq{dok2>hj;{4+# z>~-j(^JPH5a!CCUy2)6J`jH)}36@$-_M32^Bf5~%4^x`|`~UiU>vBy$R9S6iTsHdV zv$lKvyhF!c;jqeZeUYO=H=m#_=j^;PK2@xy5)ACG~;Y?H524Gnb`)GcN|PvT*lC3;Jq6kp=0*)7o} zNNfHQE@h`A@OO}aUT%kuPhM`V1JkW;k9YXEdSb`&|8rJKq@5AE`OK_GnklzUrgWMs zw^G(vZs`^<4e_I!M*pvevwhuH#z!OZO1&U-JuW+B>Y9?kUrPddxt&_%F1O~o*iw}1 zt}8#?>*Sm2PQKlF3~6tLZa$s6+-l9NXYx3%nEbzVH2v7QDLN{gVF1KcPEK$iP ztKYjgkxKo|zvAY)HI4MK?0>22A1wiW9$>>kZap#U_Z85iyPx^;kZI%Z%`p4#LO1zy z>xsL5H?@ZMHdoJ!PKYk(?Y#I&y83@TocQau^e-e{+5(2tDH zyVK#c=5Mn2rb~+MxsYxeJNw!-q1(QA9|ZdnOm1b;Ny0H5FNKhW=_7qXu@r0C)dx@m+zlWzOk{Ba|beWty$i&JfI^5pu$(aG3M zik-OOTx^1!#Y5}#d@Dc9EiXZkw}RF_Mp*DV*bz1#pkOJ>g)Gx(Ph-#ll)O1W^J zTIiC#*v;xSi28medylStM|16^#Pw&`wwy)Ye+CDsG*c32Sps@J(tz?yea!}FbB&+H zRQ6@VY2|JFdAl`lUN_CI&+KsR5L)OAqZ_jx8H3L@Rgdxqd}NmB|M9IG_ z&AMsYvek_DsndI1@qdr(e+1n$wp`Mh&~4wQe5jhf*gxMF=fDoB^YMHe_{b^9dGDgB zua1#)gb$N0{-!*}d8?acC59WMe-NAHmWSES6qTi0$356^_NZ3O$~%<8bSzd!8@es37dGZC9FW7xc8* zJ|xq}=I&?sRJ)=}G3EZNNV&@nk0~Dh9TJG)F{Rz_8*cqQf^|<9?omDAqIKP!&Kk#5 zG+#P&`(NUk*oUpY3vItgFv=T=IzcjEGkv~CkcIRme!fS*xLxmQMBVj^IUnAD`)}x1 z*X5U<2ka>QMyX$fjwoHm>8UoE1#hXpD&tKZI_|OVf|S%7~*Pc~w4q#yk+3;SCg4+IN_G@_X~}_ug+l z$G`o*-ha)kX?>pi>rq?JtAFR@Q$%idGuX~D>Eb`8f@kh|gHg`0;}n>HZ=$a<;4Ov4 zb1FT>xh2_EWjMViI7{84>uu4IZoM_f;SJ#TngG;yXYM!LD5^G3m;;;`I!>N zx?TLZ9Gw?aZ{_|!($;lZcmI)T{8Qu7^|sN_6Rw-^JdX{)wA1G^sP)Zp9q!!ar^+>S z)7bJ(YeKhuu^xequ27B|T|qrq7r_T5)w**T)EJ5#;d&9*zZc;~X^*Rqa_g-*f5S9> zy6mNm7wvyw<>O9*g8!@tQEeFPPa~9 z`OYPGZGU<1&tB@H?(d5$$EQM%Gvqkj^Gfmewwkcg+_+Sq<6(6A|KCy`SoV1zVb@FU zH3`y$4(DIW{8jn-O9|;;#Ef2UrylPvw`M!I6y!b zZjIua*dCm;pD$xfDRX)nQkF@R@bnA)P?yP|xoxAI;6`svK zPfPtSdLnd_6StnY*9{D}#&x1}C!F#x9#_ak@i}TSkg4ZNqi-tDiUcFxx>!e*Y`WUOPQ-#6u<@ zLXR`xI7~j!#h>8|7tXZ%^>JSu&|Vqx2cz-xQ}ui+uXW3(Ilk7ud&w2EF5c#HlP{tF zPQFIt0|J#~PS3Y>;EVZ?4bbNP0k*&T{<-MB2kh8+zZb8(f&pM?r{OAeo0_=Fe0E+i z;+)Y-SHRED8F(wbGw}U|C=c+{`Di#fIUm*VKdkJSch3HHS`ELkMYAKo{)^BRQM(8q z=J~3g(V@_+fRAJqIty2h%jCQv%Ab##seD_$==_(T?#^HH{K2eK(ybq>Z@v2Kr%&5T z`aRntYVt31GbQ1FY-k2f=Eb}j4?@J?Qk}K#RVN{;Tg>)!FsPD-8E5K$N&^3O3Fzf^ z9m*}sdNx42x%zLT>bHa6?Q+I-A~%*>ejVMUi@%gx)OuP`^<+nJa!qA4@x2|reaNhH z*B^5J*VJ!N7oT(Mi?wH@TjQ?kwd18r7mmA_jKT~8Sbqpz5w%MTe2fW3IC16k6h_N= zYO{UdDk~S~-g?BZ*M}rCNsi?Rx>-l+ZnhbuQ+~Q3jYye4P6E3Au7ch$FR}s3nQqqo z@|~mx_}?_+?N{C__;ANApwsYsk<=TZE24JM^@fMu;^1U;8hdWgTY)+G(oop`AVVhZ z(e;Gy??@V2bgu6@m7nDF-79^2<2SUGB_wdmZ?_GqB6%3qISb_s)(Yi~NKxe28uG6EAQ^Q8U|Zxu3~M zUW%J}%DfdL{`^n6S?(m9*bJXCDGB_YB@hGivVQXXqU7ba9_9Mhv-%9lzA$&R^o6C| z3f+{2lv`JS+bOdQYnIoZph?_jT&e#l3H;k7&;S8QdCj=kU0%)pZS2ByD?fJsH>W@Q zOy+t=aJ+;46rr2)l=7NiQc_f0JUJI%wqV~xHU0S9jnm7;ThjQ>?a>4NA2d9f{-f`PTC-jfy2;h=)T4=f>4$MH1)9?% z>VxQnxM@>&s7D-6=|;lpG`bn~zhUYTX}p|Xo_u`D^p|_eAD(gSbz8{Tk#-tJl0s(~ z-TW5$;yY*&e&v_()B|z;>fQO@6@EOsgCB6>_j9|zzgubgevuQF-anLd7^z2uZc`K2 z-@+f}iYAtZ$`pUo5tW|rdfQ@;g%fH07FW!PpXbi6F`l1kaZIky|8HG?=e2Lo-1`BL zm6_sPO}gW)#^Xg{ez*}IHIC*NmlQi+?2Akav!$&CME(s|xaH5Z_4$BG_WG;aIeOncXtWeq_%%2DX}>oR8g_m`e-<|kBzBx&U>-74A4TggLQg6Us6?EzE(yQHaGW9nG|Hsc=xBS+!K3C!>31wIpQh$Z+kmHu{CEu5H zj?S1EjgE}?qY#wO^;vVv%x~s{q!o{}8Hb+V`PZ~A-=TYbwd%6oPqX+b!{^{Er%6|2 zT+HWC-={3YmSmPg`KqVSc}j%W^E&n80TC3FNPI!Ag1gh7!Y-d^D)7Uz1yHnRcM*=Y^72v7(M|Jz&efzVGA_a|s#SKl_$giW(n1lw;^>R= zgqSLIRJYDY`AzP6;YJihYz?v2fWLb`oOthw8`7;lYhMeN9qN1YtJCb1_JBpX3Eie9 zuEK}Zx5d6-nZpAP>A{SQ`T((IHR2Y^@sI(Z+$VQ4@1!k~JQUfmUXp$}Uy0^A6YFK3 zX~DL*55Vt{_5(72fdJQNcLB)rzCa!@4q)H46qp0VfU|(B0W$Im@D-2_X7&Mm!1=&4 zz{X&%7+CBuS&oMM9bhJy{RN=>AR2XKc0I!DdV(nbP=n;+b5eAhra77!M*k0XU55Xu z9hAA$&#nM}^FMXqpZUZ3qq@Oe4jLdlmV*r_9}~{${mZJG)2-L@=3f3#&#x}o%AO{S z*B?SR#bK6%l2E9)!W#%U1pvhYpXFxJbZ%^f{d>y8#<-v7!>}&u3Gj(9e8syWmc?(d z^#=w4I{-t0J%Rmzk-&IhDo_UKWnwY@-vhh^tOYiOQtSpC3Y-Ew0DK1wM|oHXya5bH zc~}ArgbXRi|5bSad%wznHJ4uVKl>uAhnq8aOqXH3^G`B*d029ryF8fv#V)s|TXRmi z?xfXwMs^apdFXK4hJL2VqajUd;ViN z_@K!Ks4LBVultm{KfmqVk&nI3a5UYOQgu%=>9%j8UnTt+?E6*wFr7|KB*%xZiTjiu zt6TJPwC+wfKW6``=#F%2tHM(UtnBnk^(v?0$v`YDM?x1q#5Uz(^snOGRSEy!?uW1+ zMuRHfW!OjiC-xg$5BUfD(aTZ&UCGB=)$kv(cksFU1}+%Q`7WC60P2g-6;ZoTUwAMj zrU~@(m=(>J?~h8*OgQxZD*FN5&nsm8Cpo_if7Z_P7vFW{9mD9RvFmW`_c!Ra zuU+1f@$1ZLP4P#|vjdgE{N0=zbvdqSg|FrC@AcAz^RM4&?jCISX{g7PqtF#myR;@p zhcC5XT$dyJ&yt1~ofX3$>3^0lb=RM)3c3K(QIXEwXy{FFTIa1g@s57G-*-`%e_%M~ z>4dA$6;ZoLJ&_j!d;bpuB|ckmHt;mv#X7G;FAuR)D!79K_8)<~|y>86qcJM{Hf8TfqBF zBVkF`-4d=jn)s#clmz}R642|n`c}#-pK0fltKNHbtBKD`yUcRX9wkKR=5seGucQ3o zNYpH~?)txcdGdNA>wfI#`6^>>yY!PjobMzk^@h-!<)fMQO3f2`CIw63=POg66{yj+ zt0%2bBn`@dU|rKvy`a-|w;qSMQ+7%Me^&`C0prsC_joXQIp#B-R&wDR?YkZGfy|Gv zY;;B`5<0`^rltN;OXawwex2UmT=htDK9}G*j_@!0afdF`7mjk6VgHN$6rt-p()}Cx zY*ODaE~#tj7DGAxp87`ON!ck0{GBDB_g|(z+WPsK<>40!q_#dR4PKR|sEx*}>9Q(tmJ-heMsisfkR zw5S*r#@l#_#a-N&3F!J#i2st77OhLq7d`3Lb90_@1NaUf*YnhlU3Pt`mI=UI0+4T^ zE24HW`8MV$u?cUUH(aJpPxJA%=JZ^P?l(KR&c!t^mI0Pc_6Jyg_@8UbglhU|Gn?IGOJgy2grf z8vG>oH>vGy_9lzA>~AvTHUCT9EVk&G=ojh#Mtw8o^hf>I^=8p?$@OLf^s3+Rq90B? z<>#8aoD7lnUFarXhTf?2YPjza{f|&!t~zg|B&7B}hAR?lTFL7_(FL)Yrt|@XCi+7^ z()eF*=OrBdQ|8x8K<~e1JfFOsXY7#!k1n3Orbg9O{7=2%)ubyjE~efjbYo0qQ79DP z*`YMmfQ;L-UUciP`JJ~#;PZ(+FZ_1O@MXJl9~6z~uh4C3;wpT&zUPUjFxzM96T$XV z>L}64L~JS7|4IUS`&|CATQAJ^a0T?Hr27SjTQ?8+xyGp&L@$JH@-2Gdtb@nf!w^5W z8nurl(zp7W`Xcd(-tfPZwDOYrOKb@zVMNE|zr>faf13pKcF_V$DPx}^!PPcBTFOII*d&1S|93PnW&YX#_1qXv6Y)R!VRpT743`8R1^9=AM z>FzPBu>*BL=X)vqNy`SP7osEjdknc<*I)Be$($GIM?*UeSD`DSc4>ic9DkCWb-jIP zd^LIb8}UlIHEYR;lWtzU!#=k;3N7VN=o(APX_P;l$KvcucKQ-BY0y%+Gvky0wmcGL zQRFCe+Nu7hNbC38dOf{pRdW5Ugn$1xBhU%yJ#ZY>qlCjBWr&gR@K zhcsf7J+rK`zwfZkpege^BoM>B@qYH3?)eVZhm^Ivzt;u+=TsfP?6IvMd{^e$q&^oq zg1d~VHwXK|A-t5PKIO}RLjiprPx{uf-_8{o{=}T{+|Qo>mYd&A;YWTlx3MhmE8Bg% z6#SmLvSaa!UtjY}A?P&1uh4C3;@Seg@f}5V2&(fdcM9M9uR0E}DZBr+5q{MBL54ic z{39=0pZ!kFX0I0=rZBgKbN>bn=kwSO30)DjOB>{)LJ!4N z*Bj9nS!dRwR8F1mtVTEArk*dsb8YuwuQS^Jbkb&Q*Jy-qq1)8NwFSOia%5=9Pkmj6 zbm5=wmY#urf3%4qLaDE&zL&h6TMD`LtSel(=i<)a7C4ObfX)0AxZ#CM zWVE+Z))2<~yx}73hIVeO$Ajs5OL8WV(nCi;f3hX@EcIo?hi-jgT~5?PkM`SYMo}Z| zd0%W5nYjAE@25I^OT8v^^KneQ6*VdLMft6z~M7#;$)Y?*2R6=z7!RV5R1 zVP0;HtI!ouyR^!eGgo5IM?_rnkJCSK%ZYt;A`A2ZyPb46liB;MtW{~3fALWU|G=<5 zYKN=P6;Zpi$`2+Nd||AG8}$;~tYq~P`9iaK>=Gv&<=N%a*5`dc>3!jMRpYHgghi%9 z^Ql3%srEdMd*0Wc;4Mb8i!*5wM?&ptPYCDQ3kaAA#)IKQj}lJ?9DE+`)5-*&Iv?br z!SUyFtZKt^ync0VzsoLNOYtis&+&#q7k}o%?|BaGN%7{3Wn~~@d7cg6SLcVk)I0us zp5>ns+t=&)wz2Y=3xP-yVw&zWc3H$MF4i8ro^N3SAMki&;LJ^zWRowXn%A<@r4L zV1F(fpv|g5pTEIhtIs~iX5KOHu=smw1q^5vq?vS5X-qyGX=&##+2N{T2_N}ixcOk2 zWE-QOdw$=Y$FI1cKA0!-NSyC!hqu#&j=wHLK6u#aMBkh$9~#_f#GXQOJ-?AI)8yDx zKW}8vnLliM&4+hCNEy*E-Hx~lT@kg5nQn1`bG}=iuhbtwadyJi!ItNrzSjNxteg3s z=u)&IuNJ;L9ZqZKP2L)Q_ID@WK{pL$#H&eHWL(Hcak)3_E6ek%V^6%{n&K#4$@Pr( zMdKvDFXFLJf3L?q!cYB|Zv8aZNv(D1)&n0Lbj+z+4$6@C{hfOB7oiIuVz zM|jbn5$luJ(~Nq@mw(xR+$QH8X6v!7&uP$Sp)-tbTGyX35nY373WMrRtw|A|iYA7u z@VD+8w|<-7HCPV*w|wlh$zSiY!1tNMguI_6bcY0*3lJId!G*zXfJ+g5`A*(YM1!~c&0GXT<4=D#BWy?S)k(#7B5BhOnCDfS0T@#&jPN_W1p30f%O9TWIWHK55RN5`T{&JkK>H3 z0G^x2bHcDhY;6l<0R4dhz;?huU=YAD-w=TF@H+xK1G@kmIH4P_&f41x_TIp7fM<*y z0AvGsz-VABFb*gJih;?%LBOHFbbvB12LeDP5CzylJ_a}eV4j^0oC914Fk`L;ZUAlr z?go|vD}d*LRX`)~F|Z!^5$FVY_W-s61_QeS`vYTvDL@$z295)$2dKJ^#ci(npT?iu z`f?ro$$Qq1>DKzr)5bIWW_RqK_4q}@UZ$G{QK_p*S7clqeJL&t`zxc_vwTWv3cQi% zq)H4Ld}D(7p{j7CpkySbqo??Mv*o_OoBm{iaq7?x0QG1mfV$)Xs82%y>J+B|saLxL zJjapm^H9ICfW3izfPI1efe}CsKs_4;eZnuBaz{6*+CHE|t3VWbDA0^1Gd_)ye86T@L|II4Yw zPzA0>Jmf>hnI-ryX(VDxx&AB(R3l;0lNj`*9sZ91s3&x{2lRcew^nuucX_HqcaW7~ zIEFUqii`{AjCjtH4?9W2Wt>!|hP&S{*no5yPc}eX%Hq;t?W~1s9@z*atKgd{Ck*=h ztfT0rk#tSE?TfOBDG)o|q0Wqq?Gu9~&s&{lpFAb$n&pCbJlnXSvE$w&)_39`7^d3^ zSD`DSc1b)hw=0x{cn)Wr7lexelKuuQefDiLuIQ|uebETaQ_bDK5kaj_PdM|CH%{!( z$ExQ)JN>PZew=QT@Kd<{Fr=UuGB6I|InS`E<#Fp}!iM}K3 zQ^&dbz$0AQ*JAq8zu?XNoVa_rVrtu;MF=L((_lOg>!A*S?8jw{;a>Z`F{j;AE9j=N zlTK?ww|({Y&{aR?`SA@KEGN|1FR|Ebl%70a89rfwFIpf?L?C<>b#cp?{VBFj`ufhd z$DcE-?(W`IAS)w$nRM|_$l1l$L?6GyTNuvs@$D;zEqvby$4YyOgWk$WdB|>8>JgFf zx2_HR-Ej7?Rd1g?cfF)9{F!v|{|)?&#Rw+o40~PUsmyNf`pj(iYrFQgh95lmj(&5e z?sUDQOVnewdqNk!#OAybdBpseXB@`=u%~$aQMPzILo!qq&7SM^2e|W~xUvk*V#Hp& zsz>~${z{y>?XcnKmwP^&;n-KBk#P3E)~~-deCsj(vqIG2aYV1Dc2BN1OQBcoE~@+V z#1Y@D>f?w(>NlaA(xKh}^Fra-+RzEh9?mjr7^iRKR#wG(PNu$WhYVx~Iaxj?^E3HL z{r`Ou(DkKuQ@6gD{p&T*r|Ztjd|~**J9iuGB+G#n>lvY&+_X>+Ci>T^_ED!e<^`x>^7Br>0NJKfkN}9Grt^JtK7U=@NQVSm{$6N>u;5 ziC(Zj%=*I|qf4DaTlywu8v1_;FY(ELhT%AZ#!SPermngKV)zs9ucRl}3*Ptq+n1Ew ze*5=5=%(3P34ZG|lWzO!;}?8_SnIKrglzrL=M5T>KBLP9Xv=z$ydTIoU%Fy-#;Eoi zjiH-HC6B8~w|({WUE`F3ke8E-iH)5)ALYGUm&3Fx?%L+Lqb}s~u`;yzy-cAyxJTSbp zze5Cj+UfJzg|U|0wsPOoZakXRgfha1Nf-a*d_Y&QaZY_ikSrx$i?L#eK=gGhKUQ%Fuu@)?-4qiHU21FMDLoxma6M?J)JYUmt&Qf|>IM9PhEd zVIPS$pPx4CGLE%bPf6d2VdyXOmGq~ZVHgj?Nq09-- zKASe;=}~2mA2G;@PR8d#H&c;$9p{_~ubQOu6b9}8RFj%qd~R(9zOjZmGH;FCZ|Y5N zWGw3y$#aHdUZ>2TBY_x_m3n0r^oDtn4bWzt&2Dn_j%n7D-A-5;ga3Y4t!?*IeeO+9 zIGs_^8=)h(%TRCRyWl>&z8npeh60l!*q&_%n+i*>S6ClNTj7cbf4Fy~t)>HwdX;9KE^L;m~sA^|1kuX=PSx^ zKi>%WF%Pr0?QMNJ@ZA&Pv=$XFJ?Z5)-gt}oMMFCcSE1X~#8t{W=W&s3)iwMKm~`e4 zjNhGQ`hS=GQ<>m-dte9P_wIk;y4$|MegOBuaKF_E0P5m;-)jT%g@$=Sv77xk`t9{# z`;Sf-GMrn)lwmlAHtC9t3-bjq=Sig+Rv60=nEX_6bTIh^ZH!bjG%Mac2Fcu_6c`N(@rv2)$|-Iwl$KL7Oks%6b();*9JV-8x{H2jC$?H_0sQUoa9^Rdfarkz<2&` zc7Ch;$Hr?lh8|gsSG%3DVm&g9`7P_bEwzG_9z0tqB5I?s&6fO+=XZg8*l7{V_t|#nsNE-APqt~~YneOu0 z1A(}wxprI3H+9$~qYlqAVAS~4+1)ok|F(_o7)C-LspmqMc*RyH&g1oRbRzt7QSXC) zwq0Z!)9tzCzS7yQ`6_9bM8CH{MB4yTt|Z=;?2YXTttIc@OxNYq2sx3TmhyEe{I9<6 z_)D+7d(~|sbIDhsn~X4DCrvC+6IEf4ldJiz)7T4xY!7y`?`&)S#t=N-K5Xx<$INv& z#(ZY?=U(e`Peo_)OG7&iSD`DSb}{u4-)rSWxm}Az?7icX{u-p8Om2+!%I6N-<;maJhb84BN|4=`LNY0%`)kXn}&P< zX1~n&{5bX=+7fY2H%J`9Dos;8;t>8;?BvcT^L?Mp9eY~`mUcV(+WBj)AHc+6M8AY? zQxjKHP7`qI!)#CD_?t5SV+kxl zdZIr)c1f;3l{@#g2EO#l`RyLLa0k|{G&0^5x=l@7+pIqcwXro`y;o+>y)(Av^r#Ey zDLqQa`pA)GlnE>_sEZ}V59N=8wJm7rb0)YL`3jw}U zbTM!Va4B#Za5+#9Tmf7OTm>u!t_H3Ft_79=*8$f9Hvl&RHvu;Tw*U>mt-x)-?Z6$t zoxokde}JXH-M~G-y}*6I{lEjjGGICIAn*|IFz^WQDDW7t0zg-sVzP=l+2uz1(WHq< z6UQH5cl-n5_@kp}hX`AHM*2&b4h{otx$lqWH5Fe<0x1ckB=A?40NYI&Uo1txkacEu z5~df=yF7N#e}c#K-u0Y(2HVUDd$mJ1Z)LyGnY6X%zFYWyiQJa~2l?T7b*sRSq<7ZX zc4@5Fb^i^T|L8uCrm@Y^{rm2dxc}CMZQ7alXKDTmp1ZL<+X?;tshWSrR|j@%Z}?Yh z{=qIi`6|5Y{zaPqH4|R!Oxf!4&K%zQe8m|XcfRYKPuhJda;BXIsS6!{U8V(jH}~BY zbzeQMlK=6T}xYxL^Sn?pZrOG=ULGD0?cd5lYBB?bVHgB@soZ4ZQdhc=O@^pw~0CBa`*r4T&pT_1AZ){+S4e`b`P8w zAL6TLuJ<%_zN)9U&ez3P4miHU{cm!~O_@!ct4Vjf)wq`JZ(I42UG%H)!1_2{;!D{n z38W;@R07+`XZah5=coPC4rO#QW8i> zASHp61b({&^!42?-sJ0bOy%ioU*77KqJE3)`M<<_c|tcik$J$xE95-JfiGR+b<4^S zUh=Y6z+@Ly3=zmag<9~#F-tZ;+uWZ6l66JeUdL?z?jGFQuZ%tI(5?wx{K?NmUu6id zmIY@y6OlYpLi}}k^qt{OpK};p0Xc_+_l)wb%suv*wKsI<9~jzcxC&hnwM*jsE7v(? zwh(ZTbHq8+S#GI?L*%gn{P6ii9&~fxm%O)L5C5$8J8d#~=a2d68fC~2*CU1QkmFW@ zAIXnVVSJ}3hzuGNIoKEGyAm{+fIk1ZG5$*$^cNF@L-<`&mVEv;zZCDM4!`+>nWq#! zydNI~W;=lV3SAMkOAF^iO$qy>Di7e?s!)km*>`iuc5*||3r7WG5u zrYu>$sna~Lpd_R|k(pBi)u_jPx?XVqo1=2^e6~|a=nGz5iSMao-V^%*`vE%v1Awi8 zz5we(?kV8>8o|0s;)gS3T9JTW&(%UND8K9^_x!y2h7X?{ebHg}-D(Gtb60+G=;p1| zi(I}?JX4+E?ff4)=2O)N3T zpWmPUfA;PK%#Nx|81N07Q4!)2L`94u5JB6psJJI2fkXlcBy8gXP0}He(A{)*Fagna z8AVYij9b*vX-8269V6n1qJsFNfEzQSq7H(nfIIGpqyFD_?>*ghE1gb2aN|AwoT}@oB?MIf2EK}vX0P~{%zfIn2)>{|+>h+(A^bE6N99h0gdMkCT*_@BQ z_?%tuP<-RAdHpOmU;CCJW=2P~oL?XR$0(c6%0+9lp?dvo+RDu@hx2~F=U%Hn(RIe; zya6Rb*)KT1o!&|vYi9m8ef=#y`?xB;jx&2z-(bF>q4nwJ=8vaEv$)TUe3j`gi}bwa zSM7g%wSUZfmZj=^-L?hub=lGf9KQ4yZ$CEI?F?nUKGRNbrH(bXe7;)OK+CL6i&2#M z+WGlY8)dpV=K6dcQ0brLDCcV=V*WnM+qKa@(`H57R5zh+uW4kof>7IG=*mfw2%SO);+!Fb^|M{O=+xPK@4!oi{ z)>hq~>uE`ECy%x|ryI9_$K%AO_Qdjv38Y7PJ|L%84fX%4{qAV@T{*5hI_#$iaYTs{c9TUcJ^3tBDI&wo7pJBeiv}hxCpp#?=bZSyH{bs^3(6GoJD>Tr&w6_4KTbKRJ(bofDAjsw#n8n0xFYiT z+C?jm{Px$bd)Ly-TWf#$-e^fL(=YAZFUaGpd@pD7Jz=mf|9$(PPH*qu=P_>9VYRf)uda0J22^OjR$R&Ua_h) z-C}*`U|HvzVXYwzkSMXzr1$t_a2jrW%T@BNzb%u*r?o>-Tz#nBHWSk(fY+$8OgFy z_Q$e(WO*ndig)vw^T$N{kr5vsu{v!2Hh+`nq_RwAdCHJ!8M2*aEq4>LJ7bo=3}u+s zfB)Fc>i*TOFYYWK<@&}kzm9hdy#7P~v*<-r8#7OT=TDZO{p-GGwXyOzJhz)Ay{=U) zAEW!-@y3#+s|R|TCsx}(7zy-EZ9nVd+|>W29w~K7`MrB@Gpg%#F7ND@bwc)kXvEB5w)c*h{mbx~UdmFI^V~LPzkF9j zDL2{9dL(0ZSASoIiR6FyFdTDO%EyeCcb1R(^I7Yn{Cwo+k9*>Fk9zDE{^|YA;?bBH zSXqyh^g39ze2ms3@y^uQ-Ah;Gxu%i$eYO55s{gPboj89?4~2--pP4d0js1k$nG6 zmYM7>^+*{*H*eBV#LasBeem$k9eH|vp- zUY}I8oNQc=Y`kMqFE91+ZOQ*xfJ+(3?(%=8jTbU~Q~kyp{+^sR95Y|GJ7=CXR$lV( zWB5($oA>8Te$~{*Bi?xS^jo6+jstc$=-l^B`ooLA(mKA`E17~Op?DwKD|hULoXaV>fOM&o~G$Gd-zj(6Ag$Gd{h zj`#Uq+-O|&^XMNJZ0`H7lN!C-ZPj?`ziri+{JgCjuRnU5# zS^i(rvOV5!BKaRKRO`!~U(e-6ETpC7+3yEA0@ z&t^S6Q!`|JIre>xxD~c}D{5cw!sX3d7zf**Iyi9cp?%Nqi{XbOmi6&~*Nv@@Ihp!* zGuB6bAODf>?Dm#pX7_z_pWM@G>A@cuH9!tMiJ)3p+{AfSAJ!}s1hKMxMAC!1_oo<)c4eTo_?i#5ArS zCtMxn=l0pRPv8EkZRXwhA1&25h1smHOM3pk8lt@ByD%5`44k@hX-|1IX6y4X?e}1| zKM%EU>Dm1G9W6K2X>O`JbDS~fEn}9I5^{gB96!YEqs{Aqc?^+tW!7g|e@%4!5WSn@ z%yyQ$TzhgFB~-gh+TU|~Br;#h&4z!SxZF%RdurniXP^GdFF$?9sV_;y2xY&pq_pb?`yv>ZM%iP-2Jvl z&rs&0q_FbT#tIv)6r_)5&9dlXdK20fixy{LKPga@5DC^BU_c6MekkH)5wD4O zOT<4$+$rWI?;ATb;;M+Ri+Ewg>muGKnDPwsDG~Ej;*TTl8-?%15x)}g@v(7yL&U9O zW>1g!r-+zA-{bL#j#5Z4_(P+$^6W=a*R(zA> z@c4$yv60{IM&rRJ#k|CFk5#yNd^IETSS`;nyQ3jyuNg{vw8sP;6AfGXWxK@SYOb&4 z|M7+?lZ&i2mw8Y$%R`oxj9Esq-U^n{auT%7a+UqFjKv~owu66kUnR$v)5~_o94_;d z!{+}v&ip?^$zSWgRO47Db7;^hr(wifwG&WJ6#)-k+q4w6iIrK#9ZDn+KX=j$> zYAj{Gq~*l2yB=~~%KCa!>uo-BnA^js>YD3duDiMJRo6@FZGZ@OTA;cgG;gGHy{#Yj zpBwA-6EFGBHE;OOx1D@i9wbL7>upJIrH(bn*4qPnmdDOwtgp+m??|i=)$QvGBduJ= zE!(6l=egcwJJ+eQy(;Th4wv1zUgR*@Kf5zM_nER^SwG6SGA+9^lyx$Hm)+(6(k{d0 zu=li3toiOWgjT~iz1yLr*ucf9PM zugdi>Ln$XEy_GuF94jZytAeAC?dM|xi+To@40QJnb}!BH5|7_@FWacRWL=QKa&9^N zwVUfB1EsuN`<{u*%K_)acOahmk zdWJMVGMXj5nOJEYIM6q=YUM%A+uOP-pYM%2W@#K^bkuXV#Pl=FikRcAf6qMoz4?pV zob`hne>S?PTOE@&O3z_4jJ``|R`0UI<}T=p@6MmlGq7-Z^9o6(Eb3dea_P#R!Pej% z`B`&rXMXDYZTXX3-+uM!_xjoax3_=Z%y;I#o?iNIaemq-)T;XnBj=6fC(kpK`$Nk6 zI2!Mp+IZ*3`?k9GSKsl?$K}pfgxvSb^}3`t6Dy6p-nnFHfBWI^S#b*WGd3DIhk|V;^X3MZ$1$n`vu3v8g<-~*^7=F zd$GWA?Q#=kcXQ_pN|~uor}}@{$H=stk9ydWapZ5xaZLU9{wMIaA}|~oDcj*G7fihV z-Vp2eO^09bxUcrV`}}=s>u*V~&sVdaA9rPK4S9F2uM=$(>iNw7t*_&$Nc&q77>>-8 z_4SHaU$czQikR)(ZsqZJ`A+G&=zsoRubun-wOwD!YeyN%epyLxrH(aoeO&`@BIC_?R&-?J^-$%6jzn}NrFTMNPW4}a{B zUU1Ec`%jPb3}v~L^j7Lvvps+F;!RkCE4okWnbR}Wy>iuHV?_*-^Hts(lw~0EljWcq zGX2j9)#HIFADQ?*gq+S%_j}*Kh5LPI>$2RkJt^k0q}TJ(p1&h{dV5an8(JA}Me6IF z-@CkT@#_A(6SBPKq*2Ys`Yp)E;!D1I_C-g3`Q7z=l=MyHWA2(b5LwoK?Ir`=CM)iH5=bZiaKYsatzdf=b(lca!wuxp*Zzfh6ZI9~v z=;qJKccaEV4>{Oy#4`QLn1DY_?(D&?jY}vJuTuZBfc@>yCZ%i;uR6Ei}yysigGfq(OA7O?vaT5(La8C{O0*_Y_&Rue@UZp%)i8N z?}+LDXH4tTM&smb8jW23v1m7Y-$O9msSrdRA&8pWpN_;k@K25}NSh(YmGy0gOwU;U z&oqI+-6_x?BQN#p0iT$-UcVvg-R+-$;RiqS%ddQLX**M;UM=bMyteDrqk0AgV+$AS zZ+m)W`&}PC|KBlUSwF_>KVDjOe`G_Z_R`##x8Cbl!{hH;*v=}J;azE?pm~I*Gq=3owxZ3~LO8>2*f3EA*{!>0V z_WQ?Q+Hx3dLN1>S|J6=!{WsPu^L0qi+PQ0% zuITPPv8QY9>^bx1wg;IO?J|EGV)|wLxy{PuRPBFtrT>p(1DAOnj#%=)=u?}|{|o>3 z$y5Ju!~MGAXU$OZe?~36^e_3ZoE)pZcC#aY{W1OO_;cLV^LdR+HlM$_FM0FQ4<5Pq z=N|j@9p9PzoqOg&jBrppz4hN%vzfnmiFg$L);Hk07WXe(8@oB(%i|5avwC~`hMN0+ zmD3`mZ!(BbAC&GutWS`rd1tr zHQ)0to7(I(E1Hp=jh^o~H|FbkPuTaS;VCcN>vMS{X@q|gi)YCW^zvlEw_DVI-e?E2-ct{eW|6{l?*$3hu$J-`1-ov z{_|0P_|xch?A$Kp)~TMJsTnp=Ugr14J!Z{2%v$B9{kUw`k-aDN_PrqXv#a~V$6q;d zIleUVefv&NzxtE~Z$59$hSqd{7OgDDCB2n8*6e(L^P;}N$j^B1^&b00XII(ARZ}yq z#A^C@-FY9)%!qkTB%c$>a++zmPn!Elxh+;^1ECgj@s{o4hR=7Fi~4;aQ?8oY_`+|$ zy7Y{h?|#lN6E(urSU_1WN_s1GteNFC?sHh&xAdf*p+$Xts}`(0dF9X%aT+&1e|}nX zS2uTld$YVW?|EC*(;crtII?$XcYlA+vL$_`t3As4_A<*yF4t`5{!n(8|I0p6mW7ds zkBitmc^7Tr?h!aMMqA3$wO{NkPxbqF4*0^<#($jgw4vu*bjt2G&2Hr<5A?D;mGpWp zvpnVQcgOpc>+jKh!p8em_3_-*|7ZEjZGD!#EQh&|p6x7yB|ZCP$YD#Uc9*n!LVF}; zvXqmZub#M^tohQ^#uKJ}^MsSn`psMRcuGrWk7#8%De0}$v1XK$JNkTn*Sz@$&zrk= zNpmFidS-0QcVAa2Cs}6lI4|27tMyv^tNet)aKuu6)<^lt^=MYaY^PoBejgtzTt43% zosI72KIF%;9Gm{=bIG+Fw0Q5AD-*9rBazRi zUVHWFPr3Z)FFdCGyi0=RdQ{R|V;yUbbNp3hs}`V$dJFw?(%Zvzeci8MtT^85rGW;=OmXDI&Osq6EaXd2a@$1|*D+lxQlKJzISU6d3 z%Xz-P^m&g`HY&5Cvm$VAbeDQ%+SfYk*RoA2_u1snZhXT1_J7=p*T1TaqP5O#y-|AU zKWowauDQ#X=ZCRQ?a9|Jbf4JMdb2>+tW~S}UeL4bz_lI8`8Bt=FZzVR?vwjhjouE? zQ4gP6%V*{x^Ewh2)Au?3$hb1xXuS4;r~P*Lfv^2#`!;~~zS(x8={Za_WckkTvMp|% zv+v4Je;zS3v^dVv#|fFf-h=!4PF&T~`5uT%zuxJU$DmUpPTw`QLtoqN2Q#Aom#4nu zY2W?A;Ro%}o>)Vgnd*H+Ix;?*1a@^=~9hrx}Xx6@mx zW6gU0qD=SaGow)rHm^&~?pxL~d)3N(B%>LoMKitf`r(vsOl_3uW%STi~gINpYP6Hxc{#Ibn|_8j&Wzm;WK=% zo!MmRkdvNt(5Fw>ZR+z|Yvp#a zVaj@-q>tsa)s^|(?D6mZ8*g8$jqcWZRKlk;@|Iyjeo&W#6hw6UWyc;{qNzB`QmPMog zx~Yv9eSW83?|l8##QKelgX`cXYOmuIxv@GUaQSzpX+We|NI85V5hhHiRUZZmk zzww|+Uw+D=lU6+V>`Av=e&eJs>@;_)Lr%VUs{^i^zx8hq`}NjWo%fk-ezg53ww<%h z&D;Ixy2J8N=ssCBM0>N(`Q$KvDhi5s{2KgZ<@Hiy*BFO?>>0< zUtapcU7xed?UyyPx;UCy-=-& z-w*xSDQh3_?%zFg@~xk3j;5@?CA~WC?B4A9+k9O|S$qG!w!dYa&2{rWl^HMTnN-%> zYIk)VF6(dhe`Gc$2-e>TaPFbKhGV|Vd7xW<)VcoFkBjI1aB5@yAHROpu4^86P1;Ezv}Y)r;|=qxAo?aUQXj#i#CeZPGl^V>_fJ9C+5St;crM_9^Ec4x@4QijQMu|lW7Nc>yM&AGptxZF(s<^Hbbq@@!ZJkpu<+$;iiSw}`^7+yI{`vmj{>rh}oYJ0Fo~O@pT+%C9Xm(DN zj~rl8#GHP8KWciUmwTUbxGfFCF<_aWV}9ScUS1RX}|0UwbBi<76A#noX(1+wQ|a{?2*&2`gL`y5)$wI|h8#|~XA6wP?3a3V{U18()%t$&ZBg%j@DsoI z{>{I?`GQAxwMx-f;`h0oDCu?0JF>si9=5W#bNBA=)bpDE=RI1FiZZBASQpeemgRq^P=^<)@_AJ!<7=aejS!^{SqMuK5d>tcd%KmW{qqc2VnY zswLfnCk=Kjh&u-dhYnxev%04>#*vubc>5#u=}q*1X1Uazx%{gk`<1lztW|sK-i*LV z^e^RT+E%T*^Jhg`TGs2K;aDr5@#@R|G<4sCZZ77f9F_F=Sx4A>Im*HkcjGmmu-&Nm zY;@d}^+D#%vhHC1tNl|w-*ZuvpIlE%`N{4qC*}KanaLOY{-Yb7bI$KC&+ZI)UrILX z>CNP5#0%$6Ji2=*s-LKO23u9nyw$xYb{#pia@ESAwef1erEzQUXth*+SIyU=coWCw z^7V@EUa@S$pDuZR`F+V(J-zhb(tPDpE3I6&etBlJ%KCO~u@j zx%E#OxSEgSx9ME(m&HK)M!YTJaj!jXUH;~e=YDbPPyWvzzn0(oZ`?=L z%10g*H=iu+S=LG!oZnmhyi&(=(NnhV^eEf$a-aLPkdH09De)@as<)x(8eePg++2ngql$*NjU-$oNJu~Azo%LdUyE-}g zpFd~n5j)1z6fFLPT}rqvpv z)vV_G`0Xby@0Uitzwqjvw(r{U;ZHB+J;$5%V@a=$JG(cL?|J)f;rm)j{Z$|DUG;w% zf7w62tH%3}I-cr&$SqM`Hn*R4@%oEzT0j4q^7vS@oM&mTrx&j*FZqVI^88qyW$quE zz2cz0frSGrPh6SjWHVID?V9^-J|C}n+gVS4!)F%!w)N}Q`j*Xldg-6}hz~`#K2YD) z&c(du^UO!|EbWPh@Rlv?&6DBnHLjYU$vbR5Kj$9#^hZ4BEeCGfKJDIgnH0^EUh+}e zb(hwQ)mkgj(ed8u)(b=0Z}E#$@zw3v$QI=1Jv+biga5bY*teDGwet0lMm@ds-^6;o zsrTxPR!r6Mv*H1r^<+*?FsTTtNl!NKGoTLd^R@;)%thZgEpU^ML+NQ#Lxe*;}`1rDd{C2 zr9DA@+CK5wqj7Rpb=t56`MO~C+WWq7-t3aC(dAZ8--3L#Pds-nw>9y@a(q60>Q2pT z16htX6`p+Cn@+i5&aNN+XX{WbR$C|~dJieFD4`<(L5p%lv-0-}ZZW-?t zk-l@S|B6cgt|;JH#;f_hA^LA_Kj@0%fAG3jo&A(K@zZ8l)Na<(+r2C2W8&>zbK_fQ zYY&T8sdPR!zhbA&Pj~p&-3Pwwp;!H&jQ6l+$6<|ndgOl@mkF zL95&GnGf#Vj%R&7IpXnwlJ{@i8u?su%FKNqdh7k(yJvesx%l$9p`^EyM_Xg}8I=1s z;+g%)J;}3}RTuyg1RM*>UYx9-!l;^Xn-)ZPQ_YLbmwCMfc+P^)aY)@+J z-ze$r1a#<=!9t7u@>3 z?<{X@=-;Q3ukQT9^W3RDu_#t_b>?h({J!d+`xRxH)oF~h zhs*Z{T>H?@`mlZ;?tq8Hapr4>w*BlECq3%Hk8h3TkB@4HyR^AKm}Xg4GgkM@s@-nH{jZXPjgs-DSmSzS(}Biu|! zb^Fo3%f$0DE&A{NffFCF(@%SzTA!biUZ32?^V6Dz}NnGgOyJS$8tM z+FkyiD6QTvfAi;ryLxrVc$bepkx*4Ux|bvm)m5oO$4m&FgO$J)zO~{ZW^mlKq~x z-MtV0)@#1~;c~p6?R+m!NzY-bAo^{I{fGW%#k8Fo)8BpZ=YP1}yN6F}7rdPJtOrYaH4oWc*0;R8zohS=l>>uA z`CM4nk_C(R*{`d-y{U1xZZFF^Qrh)A`hW8RBQZ!Ruk#+=Sx)NvTjxeOdjG5YezltkzDccwo0i)8YzIFV|-eQA`RTo-3W%y#|wF0=XTh37x!P0v61ymF#H zeYcMKuB7KM)v$5BJ$v!u7@%6e&D(wAa+~AZbH$CzkGNp^hZeLKVzzdP8os3GFx61% zw~qaZjcT_>V>o_P)}JdPADf&151co7;Y-h&^vSZ{k;88tzbfg~JY@H{^Iv%|q3W<` zkIg$=dh&_;zk6``_jkz&N66ML(JblB#7bjahx&V=_ltTyep4K7-GY29-l_Z0|9twA zr#`%vkCI-=LbLPE)gy7_)*eyyxcJOHH}ACD2UZ;XnxA~A>_)e*i9V=NPcQjQr*Q+<1o{f_8aa`~mF z?(^F>5SQ{m08s zz9+b+t9>W#+}M9_eoCbE*}v*`;)+^+#@p|EM&E5SQ{WCvv4qMz6 z`(L@a7>rk=&l(!)i3=P(%UUnzZ4J30T4g<7^Z1F^^ZdmZpLFcp`M-PnZVwo2{XX-t zPi(JBdMkCT*}l%vJiu)}3K~~D;;!WKS)k^JR_3f8Xnk;{`7W|GLy^B_YnSvjU)UOV z!4ItL8O%$4%}{k~%;?PTc;)Jk_qy?d?;N>bzW%)#rnH;&^mgy&_P%<4;IP#v&*@p- z9bb3Olk#(VP8{gYcjR_l2VEEW$bF4jWhCRYKehan$A9+lhyE(RVVt3rk9g*=o!&|v zYv%H+=A(VbNfh+itNI3eM&D{%-U2%qdg=~KS}WY>d#bwI=^Zl}|Jofp0BYhSL<*Xix_7-dJeGxIgx zQk)iJEz9qi$Y;sNc=NfY(!b1Sb@@%%zjOT`@BHBOpU=PYYY+Q&xop^67jliLrVgI#&zWm%jD`|=|6}tHxmRv?GUWCo%TGyfCRQ5t@)J8oQMC^CEM1)!oR1jl z%bOeHy7&vav(d+yx2@J<{%Xa(Rr*xK^`u@=5C-2l) z_=(d${Nx*+`-9eVTw~>?q}OMoUT&iPTad(gIBTsARIhXe4G6(sy!(BP9 zKRYvjXCoMn{Fd@D{i&VhqrP3rS$pZ%ZeIWL*G=uu?hIvrxt`wYyYc=`l#fGK#!hk` z>SP5{-Cw`q8J*J~{^=8&?@2j+>#Z7Z{At&z8zO(pe{l5hrtZfS zz0v>7&h>V@dZY2>*POK9wb$)YX1>%L_4LxezTO_vv-ZgTW%==^lzUn(<}L@r zm=?{Pex9FL6w@!`Uli#%@9WzA^S;F!qJM^25wo7D@5f}n=UjEkudhDgrt7miL-DJp zxB71EH|vDHfjAY`aj$gyp3vrg?{NIEcs1s9=BK_qk3Vpy#!sI8vR^DdV(wWFXiqTn zll$W(y`4PTs(ZzDv-KwL=0}SLH`?#ceeSHUtMzWRdvwG){vrayF_lt2hNFDs^2zeL zsqn!Iul)Y;y$9?!t#xB~ySz3U8`|mh-_^@U>pb7$mCJe#9a^mg)S ztL`^;A6l(4Z~tN>W<2v#u9rFvAEo@8=%|*Lk*=Nc zrpwEM?tv5QdjOr=(;4$8F26aAw|()HV?Xz%-;X|*TJlp*-&B6)_b%;=2P~GxiOAmG z{CZ|z@BBHVdnBFtIsTA|^K)tB_t+1eH}c9KyzZH0g)Zw;NiX>*?YhrI`$zek`ubGP zh35KO?ky_g*8a;2RM)3lH&b3Rce6jT{TE-*^T6ChG(#!B_4LxeUS8&`?q9WXX&iry zU;TER$5^vq;_{o*c+`td|N8O+o_bE1Udc~Az4Wi=r~O&b=50rV@%U2fQTWdDDUCxn zpO1aFfAI@nf7)ZGm+6#z)YD7sDl!q)c z*`4hyAKA{Bq26w#YW}$b)$3eS7I&79JkHM>Mz4-?^Q2=A&OsZ8op=9x-!ylJy~}i4 zXN9-lD82OGsC+b!r<>L2XcfO~@rpS3AKOvM-_DE$p5^x0kNRPJeX|v^3}m^;GLriR zd0ivxnA}&$Yw~%mque```O5n&c8FNMtDVolr28b7wIR&yI+AOvK|NE{~XJSWb@gos0i+FX!JXvyU#I0h+rbc{B#Ail4I%0psd~bGsXZ3Rte-QD0G4uOJd|t$} zBIdn)Ka03$fGmypu86tJq8fkkaE!OC_v>Q0#?MEO*K(asi!&b)_hWCf!?fsZ{ORTI z?R`V{q3_Io8L~YonkBuNSZUOkYaB0~*cTU~<}S^-?|cuy%%eKXRsDEz`jVX*|NgM; zKecwBi*}CeH$yJh+#Z$mcJgQ|N=x%IiRI-8@xr{$q;mIiSLbzyk$|Wkw`Dm>n~cI= zUtmpSp}Kr>9sf%#o8k6!^Zdr-qdV7^QpX$ms47_v>r(QR>X<{r6|AJ>-omPJGU)tOqk>J-T%?OL{Z0(unz}K5ss|Z(uM#gS2Yp zi7SQA{fFNAu-|XE?HReuGnD%1 z3GMV&>R2bJmF2@JcV$hs^o@c)(reDS%)pm2-!|ncA?hZJ1^Z9%0 z$9DO_Dc}0(vXZ|ncNyN+PH+7;)~x5RdADM`!mD-HYojqO1}*tJCZ=D;pJT{*pBAz7 zUsLIy{c;|L+x;{D>!00O&p$R++0%S&#N0BQcH4UpWt#$&u8I?LkIcncwUu{N)64|0kDEmXB%A znYespt{ymlyJg$%`jJnT9Jb2$wi~6F{x8&bwXZiXBy|>)YCg`5d}LXe6*0?0 zSr@DCfBxO|=bv-sjX(QpnNG<^J-zfF%}3m)73bQz+UMU__xH!H?cmWpC$wHv*Ku8K z#qpgU_4_Xlc%aSd-&*6dKFsY*NiWkc?aasc_bHeCptu3PXKCxC zVEpKwbRR}B8n0cg7fPL4hO71~X`5=_kzqGA4(Wfp0@EUEWqWvLtiQYc;)FN<^e5l? z@_vh-vQzF`RO^{3-JR=q{XAUG<*H*Idcd+Lug^ovX2@~m(QQ4wnH-JzCufDy-8*#9 z%2hpC%fyWkD^KfqY@<2oa5PK3yDsvP<#JZUZ0EK+r!x{8;eAd&@|x&u-1xhvz3Q50 zzj?IYE%~UY=dc+%^O2c3qNjgV_tI!JcfN*Wm@@qhODA@ia>7oHIj?-rlRvrcoj*Ia zz4GPsvz{yI@oz`yoc__V6WvoPxaM#pF{3&C>V84T2>y(J(r`;cZdXd!(%+Qf|IypS zF@vRi%viSh?eX&KpYrJ+cVB#2am@Cl_$%pkugbd@x(8PrxH@mhS$Igk#4BFWu&i@E zJ!W}l`Fwwr!Q5}X<-7+qF23oAi!X}&z3khs>%Q^(la9T-wPK9!x0dw!^y}N@@Ol|NyI$&Qhgu8=!2U*ttX(G zmnpN*bj{nZ`P+_st?JBI{rvuh$oE^8EPMQ#Z*4dES?ww3`kv*tq>pB(-BB;UtvYT& z-{9a8aq;%J*$WRlZ0_tO^A{d=+}tJe<{oj_+_+|#VMUDi?%F=*`0vcRaA$s#(-Qu6 z1%@MQWxYJ0cjNM(+xg=Uk83Aa%zyFvSU)bg{l#B-+sMy;m-TjrvL9N~Td8Bs=6bpM zw7_738~lHWxP2CJDw-v|nOJFLKJ)zq^ZEvdnr~|8nmf=v*wb-5JA6v#`jh9Ya{W0b z3i^r9`s|DwB3~ao@_ldk!%r_e;*)P|JxN>6SC#b2B%7U^m~OnjCk}7tuIXPHZZXUZ-*Vi# z?v%}XdI6lUoJ7yuF`B(1KEl^C*!)R#yIL%uhYN^q(+4 z&C)w>uvt)N&ocnBe#8VvsmR>-`xKy>1Fz*y@`A@ z4ouo{(5=Mev|I^sCzGY)aNHXcxLK?Edz(k7)$+Dz zO=o`U*TZr$M}Ff=hkx$<@A}E_&lxLkiy}WIy^@t?XFWe-r&h}8;_-6TS>A5lf_(M; zV$Tbw4`4->AdIgV<%yCU+JVOGSP?s)ad zM?d+)sayTmZ?>A>%2;!_hexxd=kKebGk+b|Cnn6>aEzq5%{#r*E%ycTUdM7DQgk++ z`?21efAy=!yeGRe6t{YMt8d(|*tfJhUXIx}5N~Gdn$sPRtHxe_zCouwz;Lw7^jDnG z=~A!%uZaBp>Z)byK6d64Pk-J`tv#l^uQ2ylN_u;=qpbx!r}nIxbKubf-TnP>A5^?D zIbN1Cr)O1n?Biz`i5bZ0-yPR&T2t6`vvq~N7>*5B)~B*>-!1}U1KfkUs@sp-YUN|( z6_c9BgNUzBHMVr5lwCeCFiyrx)YfmrBFxy!Vmh_U3((cGlbHBctohZ0H@znBY zuG%ktjUQL@HT}h%>(O{l_r2!dfAORrEc>T2-QrYFFa7UWzKT|7zAlY?W!at?F{f9` zd3C$7%i@8@{?}KYdt>x&hSoZ;O{1P(`d9PSydif@+#eUG!{)^4u&zV9*PhTbXP_@u z{bkjIwfOOxh^5{+V0iQO-Vr~!_T`r?zWgE8b#j}Si;`aQQ`+T}Tr)FyZf?oi{+>8_ zFCMDSV{E!{iM)3xUX>j8 zfyVjyJa3X=IO6Dhzoc{e%c5TncU#2ree*B=>;LsH_}R}s(%SoJO+VkaUD9LFjxaj? zBjN&NPkeDH-jUW9Cs)Rs{*3l7%lwZw{qvqTIP|OyPdp~)J43c}{VD0q#7bkF=`W7^ zL(AkVL+T_zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+ z009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBly zK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF z5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk z1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs z0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZ zfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&U zAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C7 z2oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N z0t5&UAV7cs0RjXF5FkK+009C72oNAZfB*pk1PBlyK!5-N0t5&UAV7cs0RjXF{Qq|7 zKmY&$06>tx^&l5Q1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* b1`HT5V8DO@0|pEjFkrxd0RsjM7`O}sZI7<; diff --git a/Covance_UCO3001/browser_profile_3/Default/Cache/Cache_Data/data_0 b/Covance_UCO3001/browser_profile_3/Default/Cache/Cache_Data/data_0 index fec1837dd3a40e01bb2c23854c1786fe830567a2..c1ceb379e6345e1fb2198c5dd00487686ea19102 100644 GIT binary patch literal 45056 zcmeI&ZA_JA7zgkJ$jb=>=>?IOrP3Q&Lo6rcbFC_n)UP=EqsDo|2U)6=*= z-JxBEdxE9>9e$O#(AR@!i{A_nyo8K)m#ha#1(;0fCovnME}ZN|MmuKQB^BuKtHPYF zgre}J#xs}k9N7P zoE!VL&%S8Klmmfb%~nRcQ`Q5dLQSS-N$$MoF4s^Gb3t82L?dZN^1lX>XodkYtD`puf79W(BgiZb`TqjtS#cJS7}@N8(0 zl=TRyI5THm+x&HPQD>|<+Hs~yQZAFpefsi`JYQ_(rsm$Unl*;ie8 z4SUx9fLsTAjyKm@`hCN&WqdYeYD>?yLQZok(y>Qg*^kYRhf21J7&a6rD$ffXLwSUozadNaZ;%! z;|^Z%*5*7rqa8Ew&Oc}}DTUsS)h$=7{bBWcz1{v%IHHAftV% ztj~~IY%*#2dkda)9Xp7Oc0BW#4N|A z>_vZ;G-E&7@hm4xEi?PMeqd+ESna1_OMf4(r5(>jmefjft>Ky@yDrXjUqMEDrmWAA zT4OSsTm?b7RpmX%Xvco1Nxft;$5$*mdcO9F%gAWQI%X|5nb@Ht^5^09pZl|itoKy= z5}6^tkUbxoIpJr*uibvi_)A20tsQ`mcH9S?t=ODvLveNTp3&KT_rQSE0=eNZAoSaDa&hI{6a~&D&SYIx+ z+hkmaY6Hfb^s1uigK*Z4XBm!b&7R#A87s!yo_*QR+k4*a$Gy;wcLMipt2x)@j4#r9 zZ^l^v-q4QcVu4hp$v7J0hkd!$otXI}`^y{f(T;QDS>12WzB2l$raSRm+%p9zKmiI+ zfC3bt00k&O0SZun0u-PC1t>rP3Q&Lo6rcbFC_n)UP=Epypa2CZKmiI+fC3bt00k&O z0SZun0u-PC1t>rP3Q&Lo6rcbFC_n)UP=Epypa2CZKmiI+fC3bt00k&O0SZun0u-PC z1t>rP3Q&Lo6rcbFC_n)UP=Epypa2CZKmiI+fC3bt00k&O0SZun0u-PC1t>rP3Q&Lo V6rcbFC_n)UP=EpypuqSS_y@w4a)|%{ delta 1131 zcmYk6Ur1AN6vywqGv}XXF4s28{4=*~OR2OT0s~ni7x^TGE%ad!_9Wa26eQZBr(nWe zx3rSVUN(Y2mc2}f2%)UN3X4Wm%q;uEQt@Gf%Icio&H*oc_x-W+`JHoqf9?&Zm2g^V zntE37NRku@A1BCzg97~Fe$wjt1s0CU#2ffN78kB#*&Z z3cKf~JIy=3Aj7^D;)NgsF}1Gd;rZ<2&&aT29s_8dB;Uq7`j|Ja=JE_X)G=!%02wLK zs?z3-2K}LH*YgG0WniqJV&Yye+}{>`@Z%B|WH&;51E_?Uxv!sMSKmDqO|ch4d_Aa? znEsW$wduhpf?+R(Uc2f{q2ZOK&bD9qhS_mJ5Z6pJe>}4P5a zBkHkZKb0UCFD7o;JMo+Ac~KSI;E%Y3DHuZkY?zOc|d0Zk(Ukh0iAjEOHq7^N8ty*a)<@ol+3u_uVFjt_2IIGhCKZH;!xkv;Nbehr^kH% zUBKF*fz^RqgGP7THce>>7y4!6^#VL*pt0d)@82X-{FuGw-?v!cvQ6eaL9XzS7~c}g z&ljEKvx7eSi_aF0b=f9(gi`^JCqSYIiSQ`J_c$qDyUR8S%#Z%-R|F&6ywOM$DFG)a zeviu*4iegjKJ~yzHDWi27>O{L67-(Nh-B%@8BW~M{aq~$Q z&46`OYZHPrcOC&P`*$ zJNGp;2&QpvIs>}4)J{Y&opbdJDEq+`fS{gp4GcKn8M5314c@Jd4A>pm6ykwKw}3F4 zjiIjYeC2`J?O`2Nyv{}9&Pq(p=+3s$ol+3yejK%w^dHM}gHH#XNx4|xe*%Tg3l;v1 znb_!4!JH07HiB6zw7IECb5%-N4nyaf=p1=LmCmZvmE~qtS1u|juh*x}wd9wVI(0av zurA4;TSa1Owj|YH$1#&O$(*i7V&+!Zt6dQn2%dHr{7sGOA%@Qi6+Xc5Z9e$Jt6Vz~ zbTra3m3l!Eo43U7#0XN0%$8~;2r2c-f?|SDTB&xZq$8u}s;X4_MILd}Exx8XX%D`V z6r~#mpZmw5M<=>xP0-9ROyjCpOD0=S_!@ze(vpR#1}DeK$?|y|$jo6y^$tD#-P@9D7=D8fzNDr1 zV**bvHrEuZ>_tnY)Ks&R((9XsxTr#JDnx)@YZLn(Axw^YVyHN)s3B zigQM;iLKGInMx#{->*J>r7qA|%hZ9M=BLL7!ZM~hA~Q^<#A&- zLMLvtPH5v@-$(Ip@WYMWwgdc@b-@bfi!;({F8Ow*sk5csvFu@BogjKIdk{FV`?6IQS3tSegR2XYMt0BpSv*gu=sg4Dv{>IDW-vsUw4URK4eM@pKD1!_wf(UdeHG08&ur^_?S5{af*S=u7? ze`qR~VQQ^jN!Qc<(}}23hZR-v0sGV|>1P<;?Ss!ebFUb|!bVzOV=)#am}@`eu5z`! zIJcCbSK6F*HTRJ*OJzxQlcKERQgRWRCOR~_ zZyr?=GO=ytefrv}c&qNfY|Xwn>P7EYQG`o=%hq6J?DKQ!T>qN}A}_UsJGKQcTOS+n zrtWg@6urBr!k@j#r@lzr?8LbT0TEBU+~A){aC@5P`Ad@5VD)5Y9QitZn0k7&aZitD zkS_L*axWy}0b%v5rj`(99Y)wAxaGO`yZ90lw#!FY(gkHFf*Ts?QiCByuXX5Ijp+p{8PPqzhQKf z>i(0SH^MuD=k}E}iSit6$=@2{)!<&+(zRdIF76rhTtxQ_yFFd;^s%RJcSyI;4+5nc zH~LI{nP}oPp(VT64dKSz4UT;d1#a}4aEoY<>|zj}&31kk*zc&8FoVYIN=9I~#Sv2v zNMC@^dv3&`!q;_y5&2DK3^4Ftns~u+z@da2gQlF$S8tauy4E)np?Qvjjys6S;M2SM z8b?!Ml);hc^}8IS3Wpfjp&zd~4k;XF@VA$#|6gZ<34VT zFqldAoDn$E8Z^#expsvLj5|QvxREsBzPI3mnZ`AaNfkcIplhM$JI7Jk#*Hxswa%1Z z;FzPiT`2~?uO`YIQ);DgQ`hB6C%l!u96oCc9G9K4HO(M*!AWpTtE3Erhiv<0jv0kn z26MQO=9pDD$)IpEQQ$bKaEigtCtckfrxfPo6ouzRU{0cpo@NkFW)lLZ9iRJW^9-6B ddAWPObfCg%rpSlFPjs9?du27xvO#$^gj0YLt;2}}w= zfn^7n5~dX}@rar-tbB1~qdvp`nMm|>#R4Wd4r3!D69ZFYhRO3DC~wayV4BY)>6@RY zqhMgD;8mKZU}RuqreJ7bWn^Y$WUyVSn2Cd%(R{mh9n(WbQD%YlU{lwzZa~n}6&si& zaT_r?p+S6mRs$0kqmW68g{gsoVUoFda+-;WZa|Rx3;z#||!!{YQy zkgLsSBGHo-6P{b+aG|lKg1c`BLrP*vsueCJlLI!2Ob$N5C<`mY?J|r^JF$8B&yU?7Kt>%e z--DoWd)dOu*pyHxeom4G`#AVB5{=JDQwu^y{?|zP405IXc_bRQhb^s)w#$5E#Oh(G l<~d(MMtwG$i=c74&eF=%e7h_o(__Ak4Gs1~882+m006S>^Ns)j delta 673 zcmZoT;Lvcu!SwJcmV*ooOh5<(EDQ`SBP#<#DB=1we^@EGKywSPXy~< z5}kygrz;vTOCoEUoX{Y?J>yt2bdBz NHZ<4|C%mvh3IHBO`j!9y diff --git a/Covance_UCO3001/browser_profile_3/Default/Cache/Cache_Data/data_3 b/Covance_UCO3001/browser_profile_3/Default/Cache/Cache_Data/data_3 index 735cb0944b6632306ff337fa2bdaf368932987ab..57605f27a00965b602017949970c6b9d49bd8d6e 100644 GIT binary patch delta 548 zcmZ|JJ4-@w7{~F{vNF4CYB&FuX{F{le?6zNi`fkd6hRZ6Ql!gJCW_S%akiEQ&B3k6 zsii^AP*j6MWAr`>UqJ-*vxXpW`0zaN49{063sM2HM#)DmW|4iKxJ$7seJPpM=aQ$z zh3M~=ES7}}qEz2p-@iSV>~+h`!{5vsh)L@`NLUHOlJ!i2P=@k^Wn7eZImAu!B-aKr zTe#BySGK^JC6WBOc~!@5g;U$d>3DpD+g)TVT4}8YD2HC& zs{wnO*S}c}(A5awcri*I<+>UL9ADtgl1sdg`#fP934{WvwR9*M@Gp8iLBG%Y^Zral zB_IVE)I$Tvp%I#(85Gb0N@#^PXon8ygf8d?6{w*HG@u0?^g!vG9|9tap<2!_E3 uBVYnEjKUablj1kj&+!@^@bIc5KN-VR> zEz^pP%CcP@O9Rau9UY^xvp4@w*W}tR62$n1cacK^*iwll(NjQ{=Gw#}XsD$P;!H-y z+Y=lZce6=gwb#W8n Tm|#DON5fz=4UD8Tuz?Q%KQTa# diff --git a/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/1f3f5d78da75e490_0 b/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/1f3f5d78da75e490_0 index d6550669c9ca824efc488c06751be2f773da7285..48185e46fd02c3935f63504f705442f4157121d3 100644 GIT binary patch delta 54 zcmeyv_=j=A0(rK56TTeTsLvq5z`(!^#Aii#W&$ZNxO<6j;(kM(EqYtjRG>lt(r^v| delta 54 zcmeyv_=j=A0{NJ$O&>Zp>N7|%FfcF!@mUd`nLr8*+-?O<+;7OE`8Xy>1u6sp(s~Wk diff --git a/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/4b8939c9f36bbeb9_0 b/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/4b8939c9f36bbeb9_0 index 6414f3220c3d2e930dfd6cf1e90e11cb17b56295..a731f2e37ed0a63c71dec5e01fac3fbf986e0136 100644 GIT binary patch delta 54 zcmX@dc#d&Gk-TM7+m|C7^%*1>7#Ns=_^b%eOdtgYpWpFKoM^~XndB_10u=%PuMQ07 delta 54 zcmX@dc#d&Gk^H%*O&>Zp>N7|%FfcF!@mUd`nLr8*xZVd&oM^~Xutl{{1u6sp$pQ^_ diff --git a/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/5be62acc646c7188_0 b/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/5be62acc646c7188_0 index e9b73c4d321605c68ceed300174c87310649099f..95862dd091dc529a009a3e4c89462a0e47df2425 100644 GIT binary patch delta 26 dcmX@dc#d&GA9EN#&%}v_JXRjZvsD-%003}S250~P delta 26 dcmX@dc#d&GAG7LXzljqKd3<+voL6Ch004%{2lfB} diff --git a/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/79fced940f0d6da1_0 b/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/79fced940f0d6da1_0 index 4c41fe2667b9eb52da6b29fcfdda126a5357f01d..fb406f9f9968045a05cb7e8f4ce5b1d453f6681d 100644 GIT binary patch delta 54 zcmey#_>*zMT>0&>U0;rD)Mt=jU|?Vd;*zMTzUIjO&>Zp>N7|%FfcF!@mUd`nLr8*zP<~bxW|wu-TC816{rvZ;KdIl diff --git a/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/8484823b1f8ea286_0 b/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/8484823b1f8ea286_0 index 692950bb5ef021784ed1e20012595517cafdc639..38ddeb1c0c4a3b94385cef39d5ecff65bd9d5c1f 100644 GIT binary patch delta 54 zcmZo*YG9hMME+V^+m|C7^%*1>7#Ns=_^b%eOdtgYHt+c+9ya8O+4%UQ3RDOHyKfFc delta 54 zcmZo*YG9hMM81Az(}&KD`V0~b3=GUbd{%^KCXfOH%MXDQ4;%7uMQxp~0u=%Pn^X+T diff --git a/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/a0ae8d57174d5be0_0 b/Covance_UCO3001/browser_profile_3/Default/Code Cache/js/a0ae8d57174d5be0_0 index 5a191ac0db3868724f286d52e256ebb4881ad54d..bd5333a3544e5a6062eba3898c2415a93389e556 100644 GIT binary patch delta 87 zcmXBBu>pWE2mmmf?5Ahro5C8xG delta 87 zcmXBBp#gv}3;;0ZIR(+JTiZF-c8;640W5D|P<+B0Xava{-mtB60h4Hy6KOjPwU%fQTocS+%!{2A`!S08KPl`e2#O;wTo(CpGO##~r_1DT$ z{R3P-zx;EEpYaYX4pqN%U-svdmYv@4aDaxV&({{M3sFgv4-_0aiL73=_vigsflIEGhXe?iT^+ZA}bDSTp;!+kDDyg>csCu*pcxaIssbaUL|*k!H%9GnL? z2O9nhb9wovy!}&&?%%*lofGM+-s!^K4^6i^KRN&9UUr&xAoMUKeI`LHc3bJrd1>O( zUGRACf%t2}lhRuivG(!|W~aU&rz@7MTMCtHFaL(e<2Q(UDd*G&yB58e4L9FV6)aI! I=>Sfb0Q#FJU;qFB literal 744 zcmaFB#K3Us%B*eql?p|vC3&fw3=9miKnw<#zCC-~n~#U0`uvi29xTvOk}+?DTH<&G`{54sKoY8s~?XVzzBC>e5 zw#T{rT_Md4%Q|)-n=j>@`e4_h7qc1G9D=yhP!(*>%2NFUTtC13bBLeu4y=9$#Qg<) zlLLCnt4td#<(`7Y-NDKk>ZVn_y!0nw8^gcS?O<^ai1^*Ez}rpX6RRBVb4^CJ*XL`C z)`h5~$p;D!okTW2?Dw{)3m0U%;r`tPvG+l=uXuRxx&;l2QV?^X{%u>-CvV-<(gF_$ zX!x^a-BPGrd-*p!{J%lmb4I|5eTnedLWY*=S73Xg=9ei=OYaI>!vj~Z15vN@lk;Eh zWv6NI@JWJL@Ql5wbjC9_D?0;Jy3Us*hYL#eEnm!!@G-+aF&Ot z_Y*Z#OWbn)B6_^su#3?b6MvV+@FesIa`?EdbmzP@ap^92`1C-`;d?N-^hwsyeem!v ahlr;;w7z;IpI!h@Z=MkGz*%D8bOQjaYW8mc diff --git a/Covance_UCO3001/browser_profile_3/Default/DIPS b/Covance_UCO3001/browser_profile_3/Default/DIPS index 9fa105614d39950d6f703662ecbe8d67d4f873cd..c081e5073fc77c5d3bf3eb68614e32356489fed3 100644 GIT binary patch delta 195 zcmZozz|^pSX~PqHH6~_Vwvx=;)S~#D#Nv|pw9KN^6bAi`M_!)D59eZFU|{5b&A|V9 zvtYqPenk;xT}E`ZOuRrvO#Isz__y)j-Yh7vieFt>oI{z74JgczoL`ohmz=7XoSzFe zbB~x4j8;~dd^cWB@W@v$;pZTGnD`$s@IT=HuvyUI3jgE}`7AO>n#K8tW zS+L*{znn0$E+@KLUa*?m4E(n@3mRPHXHpiMd^cW>zw@JHdksYY2L}ERK>g47CqKw% V;mJu%O3p7T&`ZwG66lzlP#+|42u?d)u<%#4gof}0oHCmQgvGB09aU&QXh_Kekqc@fZ< z3CzsR@`95E^0Ks(%Zn@g0!y5;1AHvpQY$iiopQY#qmm8M1C5LgTwIEa3Nw$4a^FtDlYO4P0kE6Hb_o%4NdZO^elFa@OSs0+?THi^nd`!1Dh9BnlNsD zS|-ED&nC*i!f3(3be++HrHn0cvp@wa8w)Uqd?q$}fC6o(`c;8j5ERoqEM5#OUYj`@ g99Wp8nQbTEQJ0*2utjGwf4kUZ?Q)6D2U;As0jFfJSpWb4 delta 178 zcmZozz|^pSX@WE(`$QRMM)r*fOZ7R~A20xcAp3*Of)ZER83iVLwaAEY0fhwE7c;Q` zVgJtlk^MFMQ})H1#Vp#{CkAkAUTmLez{A4o!oa?W-G%KLtIK9V4ii@9W_f|h0(n`R z7gd@tZhl%O!^qFRg@J|9f`REeqXkPDo9JeN3RbqwiDvT|S%Aj-Ol0K<`%|=mX>Cw#%9KoS24;10M+#hVgLXD delta 7 Ocmcc3*~+=0l?4C{6#}dP diff --git a/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG b/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG index c723317..097ca38 100644 --- a/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG +++ b/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:56.556 742c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/MANIFEST-000001 -2026/05/29-14:01:56.557 742c Recovering log #3 -2026/05/29-14:01:56.557 742c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/000003.log +2026/06/01-12:26:39.142 39dc Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/MANIFEST-000001 +2026/06/01-12:26:39.144 39dc Recovering log #3 +2026/06/01-12:26:39.467 39dc Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG.old b/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG.old index 69d1952..c723317 100644 --- a/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG.old +++ b/Covance_UCO3001/browser_profile_3/Default/GCM Store/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:32.246 69ac Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/MANIFEST-000001 -2026/05/29-13:49:32.247 69ac Recovering log #3 -2026/05/29-13:49:32.247 69ac Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/000003.log +2026/05/29-14:01:56.556 742c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/MANIFEST-000001 +2026/05/29-14:01:56.557 742c Recovering log #3 +2026/05/29-14:01:56.557 742c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile_3/Default/GPUCache/data_1 b/Covance_UCO3001/browser_profile_3/Default/GPUCache/data_1 index d9953125bd5663a1aab70b39a263ed2bcee7d5a5..ef2742ea1c465a07ca14bf17e4c1382d0ea92837 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasMwy9$`pq1Q?Hr1XK+LqALy`H%KLD;e3SR&K delta 31 lcmZoTAkc6?V8aasM$w6Z`pq1Q?Hr1XK+LqALy`H%KLD+#3RnOD diff --git a/Covance_UCO3001/browser_profile_3/Default/History b/Covance_UCO3001/browser_profile_3/Default/History index 89b2645066e158827b45a3b4eb5a104bb5d23a0c..29773c191a9b5589bf21bf7a5f3577b4459c9c22 100644 GIT binary patch delta 9789 zcmds633wD$wyt}tx~qDrdpqfD5Htajhyz8sySl5p5}NF*1Of~Qu5@?00TUBQ!p;~N z6!(b`v`_@xW<+H~4bpFL6yie%9b9lwgCa1#SpZQ$g>hUab8j{2NoQuhm-o&4p5L2% zopaB*b^d$KUC*got5%^^tI$1}29aSH-@5D~AU-=s&f<8sB){wF{NZU%+3obY6vZv8 zvd^u!-6L4GFsbW}{PgalS*I}IyI;$}(hyJntt@*92sJHgYY(@! z<(eTo3@o1CHov{ChMKD3&UNwijbr%t_-FY$`7mF^XBf{JUpGE#TxtBFQ8F3~M-96S zorbxFVnYUZt~<$gB?ohBx_V~WQ|wIsv-`eW^M|cIh5;sU?`f1*-PLh*deXixu07o4 zAkBlk+>urG+$vo?nW}%j^<)QC7nm3Saz|ce*PB%R^OVQ~RGqo=iIR%s+zO(e?%Q{+ znx9TpdFH@;YhJmX0Y*XO1Wo{=K>kcXw9yvNZZ{zv{9wjQWl6bZ)Yb(3$(eKKU!@Hg zncXA4$t(Q_4Pe^9nQ?h5^#)$~!^#p{Zi(K2{^YY%A&WL(0O>!tF|YU^G+?0(eA<4= zr+Nbqn=*?sa*MjAUYl;)cY3Edn}RuJ@38FLiCxaC?I~uee%jNKOx16C$l$l+`l-1t z+f|%x-zW2K>7odhc>|ozouDH)ia2#j2K=GOoHGq%hxh&RnR5EcUAvQaLu5{w*t-Gj$z|K9tFxNx6l+m3! z>r8q_4XS7GxA<3hBI-fE#20W6_Mu()EIx&Qhj-v7a5f%}9z$F3QM?ZK;&<=?`~rR+ zKZ-Zw6pYYDv>t0%z!2Sq*5W(yEw}?O!)@qWbOEhG%khnPE;@@&p?1`a1Ndt6J9HGy zLqR+PPeHxt9h80znu%+089IPoMfKQ)$KgEm40@8R?_FYtfh7*tP?}t=(<(}nDs@^x zsjXb6Wt8Glot98)Db{HbrRIq`^;61C&}kv1=>?Rgsgyz=$C`kb5{1fk524*}-Q)pm z4eILRSIr-TK1ZLT6X?H44-TV4=q>a*dIjx8FQ8rMS+pHJjvhgq$#`^iFIe@B*uasw ztf8cuk}66nDXE~OoRTt1N+~I!q?nQ-N+wd`r(^;pg_IOfqEbQ}6{w>EP`bW)dQ;c> z&Q`X@I;o4lr*Vu}CMx3P;s_Co(0bl_!up~0O>2*Jr}c5`1J=8(tE_F-h;_Dg5*gj+ zEM4`R`40WqsIjs}K$j9dE~@(ldO}pi1#&V}_6zhtsOT5ywlD7&=uR(-3uHf+_6u|i zm-GvCqZU)4gIc8o{XXZ>Vm|BUG6HG!?x&a8Qak|zcf=kAE8bS_VB~BM01)>Qo3q4TdFO&@D@$a6>4lIwS62gR3f4N2Fe~5tf4u z4tGEbDNdi{js#^%m4i+x>-6=zk7j!20i8X6o<)u{%hkgS9yw_El~K~;@N z0X5=uD2@i7$Lp)I>j--c;dZJ%#T!y2htK1Y+^&#E3i{j)lE>k8D5|Q4ygs!mSw|$t z5FsV3dP6Q%a=8_S^gQH~0wIr6QiBes!>Kg5gRV$bl8#8a*pHw~anTWK2ospw6Ce%+ zLJ`U5b<4hh;&3QFXO&Gy*mOir*c$rG z7EsHv={TVAHZp5?JvlUQ#y`S~aSNV@17z05VxN%%0!UBSi?lSoNKMs?loY+N+w~$j zSuc{3^ulI~-k${;=Zr~4Jq$jG&)|Bzmz?2S@ZESNZp0&?0h16S2$344btTJHYLiC1WiX zQfV+fOTy(T5-@2nJxao9FA1IRkl=X$N1Y4cKG2oeoRK^CsvqJqaA+( zq=KqgQ4uT3wEDL|YDx)a03!lH)c;IEUtda5Ou?@!6cqlQLX!ITRm$I0rMUHGqOZLH ze6Rx)GS$pMBYu-iWB`vtUz3Qhp*d)*_?7swc!xMm%(9-fzGUsRUTYn1`Lm_R(rKAv z8E@`0zhT~DZZiAL7Sj>a6Q(v(A<2T?6gCM>f-0E#_xWx7BEFKh8-Hhf*7#%N6l1pG zQ^QM!+YMJ4MscUO=eQqnleu9T>?w98`vQEKy$p_rUEl%G2aKSRIoOqCQ=4Uyg9`@0 znK;g9BuQK$JNwxpBiQ&%a;p3HbI5-qSzCIj>@WM6{c_b{kn6mO1Ai=@KM+KtCkW3(j3U?^rR zB2^|DJ8*r~AY%zgxoog8Tyzr$X5W_JAC2|Y7%i!>KWVmiL4LSA(bR5x^&nFTIJsny zDR|_^JO_?H(KoPPGr3t1$`lZ(nGL?Xniw2we_2ySO5IUb=iY6n} z6fKDcD}x(g&{|h|~23;B@?c#YeroxGRhTQ)m#D zo;ll*xH0-o4J;)u0sd_}0sE7i2aU!+?LJwdb_Q&CL*0yn9LSYF9_V8~grkgh%Wr_J z&7>sr5Xjg5<2S&iZ9fDYTJ0giO?;PdM=19;<(l6mT<|^MxbHo}eEA*$tb30@H@#0d zrI&D{-v>VJ_4k2CyP9(Idx4_$y-yw->?QbzdI>Cam?(q8z^Q$4nAEMO+|3^lZuAF) zyY)lzwEF|1m--=T;P)SrrgqV~x(`X+$|HmueuQwNKO%@bJ|f&xN5BH@mmd*B(>?++ zlug>^V<1ageiYca4Uv(TYqO7nChf*!V7zwOQKJ9dQPSiqM}ew6cnr8T*D>JYY08<4 zexmWmfhUc;5}hEgLx;$#&|dNyw4J;HZA3pIL1zN$5OM{E1Qq%gniJ+y}Um*T6Uh59a2No;;0&(q0-sWC=g@wdh zp=7OpZLTmv)dC;D;ac`xuwiUyN!!xNQ`^fL>nHgt!%OGYmEKrea#hGNcdAQvl$W=) zE}R#vopEJ}IxnP+Y=fhU>q@6JE@&*fQm&Y~aKWUSA5K+$jjr;lMGGU!BxiM9puTzL z@+RfV@I0lVwn{E>%xiImmt8S)Qf2Fu83<*O=!j^&=&&C@DKsa|bXqx@ z@)bHQA4T~xotBQIe2GqrvngMs(}`J>_v>`RrIat!X~89wS4U9l%cRt+Q$?qq;f820 zf@1;*lFk5hEuoBpt|gvLLu6mw)e3KjcH9I#VAm>0HXwOwiyH2Mrv+`(&!DKCc?#~+ z_N*t|C*Ob=7k%gf7%+?`nikl}n2_M-n~a-`Qw&F7r?uPCW`4qS47|d8!#IhNMi}jU z1a=r>ZPYypU(xn>SZj3IMD|t?ec)?Q45HoJ;bd0AEsUMn$>1LNmAGBZw0>l*G_MhQ z1T&lq-s9U0JGt*b1+$ZDVn1YSyOL~cwPnx1TSX(y==EE_)d*|(&%sLV?M*O4yZbqq zckv;;(OZoy^dZSTm%?=Yq1m7#=_P`jy*iS4aOc`Y>3`sXiYog4bxlA=yyBePX&>WU*oMQX0_rs;f-_( z+(4_}1GDH9Oe6i9to7`HWcn_;Q9GTUd7MRLkY8MD*=G^S=zeErSG&{idmg50Ti$@l z9kXgnrODGOemK9mc~M!r9G=;7rBiM7g|Apx-R>?8UBA3;`jQ&C+Bdbum)F)FXb=1U z)g4pQyg1y}K7VeYy`?pKczsK2d!R{=_9P&$DM~XjYyGN8Fbc85ZO%>W7iuqU8HRhGV-e~sQFv^1> zGOdM1#bEOLf!5Or9bj0rwioW^vym}_5wh@p>_tCA4so|wPOi*mnIAMy74GE^88gUS ze`zqSDKLVy{t}S>Z!ww$LT0T2g!~{)13!afwP%jO3@|*JbprO0&lXzNIk*I{QSBUT zWG(FCWS#-5y?&6SC2fZ@v>j)NGOMjP50_Zk)fm&KjeZl-9!4NT+xji^Yjc+3 zOwukHanrxYh!+aOjSLxa(|{2dlwn4OEJ%~SAnD<=gsjpw%bJ4pi+xYkS6h_q-Hl+E zjpb}&bmfT@a&>L~eK3@Y#UXs~~W0x&aXFG$}3>i@RKLF6P=rjJzPGC4pe)?JZ8Mdw0 z*5$J;#Mh*lug;Lq5pk#KFc#UB_x1U?YjUozr$l|$)OvO&2nK#UqRH zDs9I`C~K=ap`vZs2+e$^H(p(uG%cp>A1h=kf2)qpk=fxS!ZOSSvXDR5h$u#HEnqWQ zn;D#E49rZ%bPC>Oxt*D*p#>yepefM*=b*%;abp>cT;pwslCEq8oG=DnN5=Ci7|ZT* zc9GP=Ac|wa%cS-t5UZ6AliKKQE8s)qlOzLs$)iJX{Q@p8$+V0i_k?xiO)5(~BfcXR zT3@wJwOp`lvJ{(tZ@$BvZ#raJM%1U6wBNSFQa#-QIL3GOl4F^R@o!yEcyo;3JAuv6 z{~4@f*d>2jn>tv z+>fQ0mTfUy#*Se9x@0iqvmu}d6CUbHdX&x3uHOKS-$QPc9`j*dd;5a60_|6wFqwL? zls66bO*{TIXf>o}vawS*@>W@eaeks zuYk+REKGx1@sm*Gb8Cv7Hv1fH>NYq_>vXdbZSQ($<#Vdz)i3HfIG5so;&{#M zSkA8dbi9zwk991&=)Y0OniyAjozLk$G676JFYVdSw;+*shZ+cc*x+lk*<@4oa z_%f3TSrHfPNu3)CyCwkHLzh!EcSeGYh!gE9FAX@kk;H#GA@k5{rMm)e{-ivRsABR1 zw0nDC`I zMLI~Yz&cn%yXhtHz*1NkigRqF!NPsE&}aK{5b@FbL8)>(hC@7XfCgtyHwO>ZmlK~+ z7?c`HI2hJLg&(wI&YTHK$1S9WhGtIdt7HTZd0RrpnVs)K(Cyf&coeHo(9R#0kc$(4 zt(oUFR3H+7CMG!|SOCl>7b@}3QJ_$Oewc(p=;X~Fg?FF=Ec;9_3+qw4gERID@C_fu z09*nSPC^s>0`_u7F|fU@sLmAqs2f;c2lA3+<1CXpQ4Wum8#vy}96iWsUhYBJcn6sf zykyfH-hVUwgg&B+po})qmyQ1#8;rl{U+5nib;bfcQLoTm(9UV&no|vFwdxPmpDT^Z zH;SOVDj$>krN{DisYv>#v_Q_3n(dADySB&nS8ZjsK5^K#Qd}pVBBq!~Hj#t8gmKLN zGl0CTV*sVH!mG%G#R}Hn&lmHr^2b?@h&C#u1mhe_+0U+`G!}o&f{w?aF$>ylL3U3J z%D={;!3cCQ2A#B^<%66h1!Isp$nARvQ8rsKgtBGXBgobku~G}S4nL4R{vLD7z0MQ#T9CRi1|7Aa)L{!6k3o+usKJ7?{V}L( zm{+j*2J*=I^RWv2!`wdQ27i1v%**(g2Sp<(#;>>V4I^l$Y#fO3r*3f9??yNaw(??K zBfP{5BfQupVJ?3VMjqx5qf%BpigMVpQ9kV6QRGpePq3~vZ@D{+Qg8-l%fiUT&X1ya zk)x4`AIU=^Nu;w(x`}*zw>qgg`!$jgCF&7N>eXAd>*^66sa4SuGw>ni0*)_c7n*Rt z**c3h5t2ds4@-C(C%tA}C(#_BcuDc0oucYQ-wMhE{*_k89C;)^|{HRA*XY{h26qOzyX zSu%sI|1l@KH#D~IM+$jBti+E%l&1x1+8Xd3nU4gW;Qb#( zY+fTa%;WFjV%q|R3M#G_w9mCTHBZi!O6|?|7i~9iy&h6qlu;pFadJ%wHtSE|{dUX4 z!`CTM50=z|KVhARu+F}Eh%Pe!He#^<{RUrTe>})Dbe_Vi$TIwq@T9Ou;GfDJ#wjC7 zAJOyGYPm~R@lw<*1#Io&Bcuv@#8NU$3W9Nt=U96it~Ep~q@Jm}^ZB_SRq@Z~j&__M znJ(*T#|vY@ud-_rs;CwXMn)P5l8Ex(w|4}qs2UCODX*ka$J?*J{D2>hcX*~cQbnJ% z2x-=irhMOeda=)6MW2WUZ=S@_pc=K9EWNv%mA2#B*!pYt@;m0EcKmzUuo0{3TWha; zS)E5%UN0^)Q^R~GSz!luv6-`Yof2V;{beejb#-9h91>Z7QM_*4`WR!QMxePy4WIGb z2C4Eond39O$mAz+BTm+&EdpFNF2FvyK-ywFZ^Wyg>eXt6+$sIbboXIXVvYB4fNi;k zC3F2C4oS(n>=I-b`~$M+A849!-dL;m>MyD9tLx>%JjY`xN?v#y&&UWf*ED_$VUtbc z5~AVVPe=l)%F0D?Y`O`rWbPa?m$gpv1B=<-Z}D3?t^%+qCAkWXoK1FY7Ux>$JTbyE z58T7|5I3xt!K*PMX2%1(+NMSN>=x)6qnp>zX{fsrqKOoZ&A*S!wCd$^IZ%_kN^!FJ zxA4~J?PIP7IPsi=hz^I{ULeq7{et$iQX_q7FW@$rc2b=PtSz3*H{V!Dg32PE#zFi7 zWYSXOgg&TKZLRvY(k9=Mlcf#zgSL;wyW(Qv=h|$-2A?5@Ip8IR#HO-aMyi9}x6 dyoczcD0rs@*P>9Ie-c7&|IP0`_}}SI{|_Kir_}%e diff --git a/Covance_UCO3001/browser_profile_3/Default/Local Storage/leveldb/000003.log b/Covance_UCO3001/browser_profile_3/Default/Local Storage/leveldb/000003.log index 68fca2400208df47f75099a1204f93383331d296..a64e1796a576dfb47aac2bf1bd3398d61c64da6f 100644 GIT binary patch delta 1134 zcmbu8ON`q@9L6^b4XwJ1wq2IxA<@)G2+;sDp4ek=QCa7`iPOBF5){X=<2WJNWF6ud zRVCM+sOHcjaiE8)6#^PHsL3$x+07l)gCwSI(r_H5IMc!uY>k?Xn5C#g(Vak~KR zigcSU8qll@f(@G8fXEe!WvJ8kAVcf;;%{$`_N>)?WVq}cwW@Ik0dJ&7R|l^h^13Ns zR>*m!Xx~@R8nsr;h;MtnNv)FhC3mX(^u*hXXCC!U%1t#}O8*AIuxnpKU4{XNs-jfm1-Du%pb%Rrejohy=GpMK?71uDFXI4IMK1d;4vp`t1t zEHNC7IG#qb47swRNG$Ck_iNxxHrL==9aQi8lfG~$flo0ig3*HBG__M%A=YK1u$wuV z@0BA}+hsR}Q7KRc7E^4df?QJ2%~U$j2#aaIpg}#03@7esQqiP)Y2W4_3Z!f65+RbJXTRd4hoR zZgSao`yhgVgV@8ec5VjxBsa_Cl3%j3!ve_uZ*~~=VRqc)hm}{!&FA-#Ptu2HrFgWP zzVf*9kDu=TJe9UaZs^M|&5pLb8=Hf+Fg)qZ$ nqHr6M%Il93;ntIV;GqD*%-^exDyIz&+ z^Nqdd&h2<3E~Pm6VZ4YSlLCVlYeq>)L9xMZW(Ed^kckrmnEXU0$Hl9fPFlBg)_IUp zc`p8n;sU*##H8f>q5{3-{9FMsWPM!x*MSxuWZ*x@{|0E`R(>f_W_`w-{PfH`WKH}) z^F=4$Ua!I{!pnDnfrw#|61Zo9> z5B3I(7K~E5ToPa>Tj}egxl3PwQG!u{5vrWS0j%7BOBSX)EkCcMST8+4KRqWku^_V; zTim!-Y{~(}Y#LjDnL_&sAk>TGlZ2{Ep4n=Kg17G@5*E zzC5GJ=5O;k1sDZ4ZCK7H%fzDJDufZl9Pb}byKrvD3);8|<$KQ5*Nmf~X7o eRYe&b1Y!Q-0x}r+Uor5%0>;1tele_Z#smNcO}Zoi delta 576 zcmZozz}&Ead4e<}%S0JxMwX2U3;nqn7#NuNV;K0?@W*Tx6bRsF^W$aFZe*Igey*ba zp+`N^G|-0FRa8X!mQ7Up^q1&mhS)q zzYE_1pxP~b%#Dn^lk4kMxt774s69EcPTCIWD$Q9lLExvo0iy+@lq#1H*pXKH`lWdV z+36s+>w_GxnFa>m>ydBFTB%mdn7QZTI;4$>E3)C9T-2tGjU(F9sA z!w(hXZ~)t_H+e#xf)q?4g9FGWtiBe*?(0nxR`D|OOkO=#m91^kw=eTHZoW46KO>{Y zsy5|9LaHE*~O!?H%>mXFN^7e{bYmv^&o2FepwK8 eVZW;A2YW$?Cm6u)V&s1fj16G;KI9k08Vvx+-?q*G diff --git a/Covance_UCO3001/browser_profile_3/Default/Network/Cookies b/Covance_UCO3001/browser_profile_3/Default/Network/Cookies index 98abb7a37f4e15f3a0b1225a9d5f69ea549cc12e..0cff4665414430911595f43c28aa1ed3398d6fe4 100644 GIT binary patch delta 2736 zcmX}s2{06F7zglHb{)B|btKCo*0GKxHW9KRwzOF{OV{Q;bFZ^SVp&JzjF3fc;&Zm{ zSXa67iR6q$xk5gD*UUTfyz|aG^E@-pZ~h@UfRG#jQ3xQIa8?H(SYcNHXS;ri-Hfe@ z#hb~E{yHft8u;OdOK>+7SaAU+o* zvvD5F5S^VEUr2#`7+QSnelb_V=KvY&Ook$5c=l9+u^0Ud^&GN}#HxDv;U)#3lxzEn zGb}weBKM|0olg?G6q*wBGdOf-Ms}6DrF$^$T8d_a;|q%_$r=S%m$yXxU>T1AZR~zo z%R1R)ZD8y{WMW4q=JUV~l)H?LI=|L-=s`SNI{`psR*gV;hIl)hfPexguG3HLio1tz z$(F}P)>}-apds`~4a*6^b_p(=`c6mfFfHN2t?B%ADoxPxSYaU^zNZxl%J1w?^=Odn z#f~+im8=TFfer74KjZmjqe6wJemJ)237i^<1ZBK@?aE|xZ!1%1EWdqOeQ&eSirpYd zFhiyM8<@Df*RJ2C*dm6z`9*oYq-|yKk&eIkXD9ORA>E{s2zZl#80L8eMI$E*J#BE> zpH_f&G7RS?m4DVxhnU|QXFPbLt`?V9nKfHCbM3BGHIs$OF&N+242It1eB2%%#tV>C zgjY6)Q*BgNL32m7zGg(-?oUzqid4S?!rr}TO`=6>atS0!CYN0F3A1-^a|BvK35-}- z^=XRo5eXL^`hI>AWs*b!{aGNT)xlyNF#|rZKpFi)$WOn!nkh-^ZrnWQNMtbT`KVhD z-9HMi$ch8VGjLM;l{w@{az35)K|#sP4@k~tF695tik$Bkc`B* zI$%Awi^m)2+x9Z49nz%K%_oFAus?hOhz;c~6yv}Q-eo^XSc7kT^o~O}7wn}j?S3<5 z_EOH*ZN_Z<#U{){o6yn4sQXnvy2Ibql;^8OWYzgyyG2wqi;azVn)SV)QmI(%~|{^TCa)H{7+rYMrX2e*S?A+3YKp#6eurPXkb2b7s`D zZEIqMcs|o`&}$(oA~IO-&fs5+kz*)rsczO8Va}+so2f&o;LhI zV+|+4d-|nB?mS~xHyT>^b6{BEPluoqPJ-%XpY)z>>{nJ$JGozoeqBAQI~FjzpHOwM z@7!i?Zz#<6#lwZ-qBTyUtJr%MKHSu%0CG@&+jj28&w{Ukwg{*jOWP;dG&t%JE<>NJ z=j?aa(=cSfR0Ab$dg6cAB0T(~I`&bA_uEI~j zEB;PFIzZ#USFcbx1c`h_0C@6FpF?Uv3E@xT5HWW@lLfF`F9BVoa6tepf8Ou(clBYS+T4HJyMVw8gCj0?u+_x7%@Vu z(ukYmTlUIhKJ?34w}0cf@j8UDEsfKiZhY%DNUhk*Lipw4%U5i&i3RwY`M`YWl!n;1 z9_r)jGXrHf*3Q~KzhCspB@gX`oI?rE>3wHq&*R=wU0Y^r%0 zMa*Nz(#KDw7+#dbHpeH153z4CIehdZ7&t@_N$dQ*+E1CqWbv)bI*ykEf=8ljx8LN^ zIVr0~3?B5i34G$AQXCoG|c8eAT5`h;J;@-=OL@Fv@)45Q$zM>J~al)|0~`@c|?BaS7Qf+iFz#vljjH)Ym@A3|idUOZ2@!f6tKl+7c9 nz^ZLcLw0}$=_*PdaGvCb5(P+-5>aA+%cL5VGyp-GL5cnaY#J}# delta 2755 zcmX|?c{J4f8^>qHI<{%lVD8wLn3Um?kbP%}P)Q?O7%GfqLc`ZicE(<|p_D9X5Gj}J z>tvT*C~GAeLj2tO>)vxd=X^eYJm$GZnhS$a7q8KF^cXAR+1QD)YA_UW^Fr0Mb_ z@^b=>*QBp`uJ1}mue^uRx19`G#f7xfSjtf#+j&~v{3wFIw$I1jz2=Xjph7)hBE1=% z>0UQXo3yxgUo zTkB}c4g)>KrJD~?F7wa0PR*Re!;){R@AQadn+B}}kdjt8ob5Oo57;3IXqx|~iV&ei2I0s-jS|Q=^Enu}#*;sBQuHuSF_KbPKDg*K8J68=S2Y;8- z44}Iv7nOfMY>z+5gU8A3T&|SKv=%{oF4Lo4jeySoqz#GiPe};0xw>lvYi&y5)vu&u zHN4uw^Jj4j(c}D8#%&FT4^!R;A5M7rQH7X(*sW*B%-9AWHMb4(HUYL&zaXUmw))p5 zrjrofDHDfBzogd-nI6@F4z*J!ym2qMmZacK}O1`LtX%?UPF)Lzn-NjyFt9volWg|e(*&|G0$V&=L(KSNZ zCdXl&O-4Mf`kvu z_W7RDBkqh1uB%;s}cVYFxt`j?W-?F>=P zu%=|tH#0V(|93_IjB-XwT5Gj#OCPy+l(~arY@lu<9hGCzYM|jx$*KzI8%i#P3&7?N zR>MQN_TR7sO9M34A!~J+wL23{@5q#?WGT+G8U{Uh&{43~a=A%3zlr*(wPDV8caHE( zCa-zoPi}Qdgt+HLL4)Bb&-qfckZ?UnXJ@AVr7!`U#;ZxE2SSq(td{=8eIeIRs)SV} zHx;lsHLnc@b{>7I9f-TJe7_=cYjHl7AkZf5yQR#?cOUqbs=D#BIbkIcr%50#;<(H+Bbx17{ykZypy$e$3^*GLaRNheO zR~C$_TcPXm!NIEH#|ua9ft!CdFsT!3YFbcpK@(kCxfr)wb&mM=ifJB{ZB$?@(?S1@ z>P%K4s6C*$-byYnsk25?rgyURR1}SThn5b@{1dd+b&ICjTdc_+yGR3P_JOKfe{kEy->pHw?}9xrSl#&eL!0aZApURx#w%<(H^+N#UUMuxN7w z834D;?&LHspu3qIl0_^+9XQ6a+kae}GiA470PGZYdtNq@k{7c&Vi&rKKl?wNitrOf zf6u^lla-!`vY|6H84$y{uMT2J%A0ucN(Gt$*EvpoKDmu7%3@auYh+;+K`l`4i{_d9 zNj__qM|CL%2Nd=+NzHVWH;Rrlp>7%Q(eQmNrJHs2`tMAkct?{^ziRJ{G15XCdsGcF zKMn)JRQ)prA>fAJ&ubADVq`HD9I*a0QGV<&I+AgDi94-~c&cM(N3kRv?dnxgt?T+I z7^j=$lt`BsG$(SG_MrR6L}7zvG47w`SNHn^PBUbX1KGw%^rS8Q`QoGzHQ|EzyQGhn zMV{07VKzll=CP;~q4puv8nMa5O>$xqqTPyF-z6U)S$SCz z8wDRY?8{>X>)EwEUc%@RGw3SEMg-ZJ4(<3brw660st=sIJ-WqlYq!fKa-?!DAaeGymd#-3VV8CTlsw$)SHP-d9i$8-+ddXsRp%JaUllmCNW+dzh zdqPkg(!^S>cC6~!vRn=D!gcBcmsDv5`r|5@WO&~_qp{bBUY@L9_#4d|al!Plr0h7= z5kWJxnrba;*?X2dE`3va-4E@v-q+eL>u;IXi+!f0`wru5>g?Z^-S9lAgs44F)p(W! zxKdBP*eSmBK^wVo7qllOIM^rhvDx>UCi8Ry{T#Qaa=5-lJpR<5))O^YfKM9QGlzuJ zz1+m+=})zSU$>5_#;^ukDpNQEVYrE5N@1DZ6Qg@!&2HL z@5IhVwA5^fu1Js~(l5VZ6j_pU_&+u``N}QHDawLC(~0fy>x50BmIqKy zkdWH#Wx6bRJDBIFeN1|qi+;Nw)ScjNOp0XaO#HCch&SV3`4ijP5&}yJkF0m7d(!lN zX|}BTLSo^ytlL^47kW?^Qd{nWY*Z9>_+lr8e$UKu%YTg>t2%^AfdBRd=L}Un{xW12 zjaa4!oAAaw>JJSp3@k?0GLr%GkiE=AzzA}xnJBv`8j9hBion1S@UdYO6Xv){5%R2= G$o~LIwi diff --git a/Covance_UCO3001/browser_profile_3/Default/Network/Network Persistent State b/Covance_UCO3001/browser_profile_3/Default/Network/Network Persistent State index b155dfe..de811dd 100644 --- a/Covance_UCO3001/browser_profile_3/Default/Network/Network Persistent State +++ b/Covance_UCO3001/browser_profile_3/Default/Network/Network Persistent State @@ -1 +1 @@ -{"net":{"http_server_properties":{"servers":[{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",true,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121688377458","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":13099},"server":"https://accounts.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424616088910789","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":5442},"server":"https://unpkg.com"},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":8387},"server":"https://fonts.gstatic.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427120340032254","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6648},"server":"https://fonts.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121735703152","port":443,"protocol_str":"quic"}],"anonymization":["MAAAACwAAABodHRwczovL3Bhc3N3b3Jkc2xlYWtjaGVjay1wYS5nb29nbGVhcGlzLmNvbQ==",false,0],"network_stats":{"srtt":5809},"server":"https://passwordsleakcheck-pa.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121794619066","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":14835},"server":"https://android.clients.google.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121920389388","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":7143},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424616257210090","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6903},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121688318295","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":11677},"server":"https://www.google.com"}],"supports_quic":{"address":"192.168.1.87","used_quic":true},"version":5},"network_qualities":{"CAESABiAgICA+P////8B":"4G"}}} \ No newline at end of file +{"net":{"http_server_properties":{"servers":[{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",true,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375180601431","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":14917},"server":"https://accounts.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424869580957164","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":4440},"server":"https://unpkg.com"},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":18293},"server":"https://fonts.gstatic.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375199541588","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":8756},"server":"https://fonts.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375216641819","port":443,"protocol_str":"quic"}],"anonymization":["MAAAACwAAABodHRwczovL3Bhc3N3b3Jkc2xlYWtjaGVjay1wYS5nb29nbGVhcGlzLmNvbQ==",false,0],"network_stats":{"srtt":8018},"server":"https://passwordsleakcheck-pa.googleapis.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375373127929","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":7789},"server":"https://android.clients.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375397828357","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":2342},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424869747718442","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":8790},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375180536375","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":26279},"server":"https://www.google.com"}],"supports_quic":{"address":"192.168.1.87","used_quic":true},"version":5},"network_qualities":{"CAESABiAgICA+P////8B":"4G"}}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_3/Default/Network/Reporting and NEL b/Covance_UCO3001/browser_profile_3/Default/Network/Reporting and NEL index aa6add88e5bf39aa6fa42d27271a13c67e8efb4a..1404dcb5905481bbef92688e48d2a69685412084 100644 GIT binary patch delta 37 vcmV+=0NVe6paOuP0+1U43y~Z{0SmEUl79}gAZO;WRn;LCwYfY+xgh?`K+Wa<&v=vLG zqToSlI~PSo3!cP-P&{~Q#fu<4c=O~zFCM*mv3{EbDhQ=r*qv|Q``&xsn|b?sfqi(& z-kuH|da?M!b&s(q)gFhvgyd$ovGluH{%PJXojr=QoCoA1w~bY~;cmrx#zE~lUQ{gk z#p$YJ)5b@s*|wWXNu)%nBuc})l3x3M@MD_T4Y_&hh^n!HJkN=8ktc*=`I4G$XhzK9 zUNh!P8U7eIg&On3EzOtoYe|zQ}BJ;K^k4Beu|TaZjnycC{LFuNG6R?fF@}MyHWVFbe;x* z`e03y3QvR#8ltP<>cAtg3?oCCN^}wX1WiyBxjjG}@ex!ABQ^v^08v9UfY+3QPnOh2+sVLu4=6<`Z$GUP?=0lEoKiu~}YP!vY)VJMEGau(Jx5>V%-BwYYk zLnROP1#kt;LRS=VK`0!8+FA5!;M*ma+eRZQm>e~{`1)ZNSPfK8!EPX*1#1c@fj;8M ztm3Oemx=B**i-Q6;M&+`S@3$~irOjH9X;^`O{4D_x`b{j=rRMNm=pL}zOaD}_vjD-}_$DCJ6_ z#K*<`#eQR)Sh6}#It%V@o}|awih=TlpSV|-iKXfT)wnfK8V0JvQ7aF8ti^G%Dn*me zySt9J)v!`1Pb-B90a3gnlr+yLvtsT|=`;S9$*MB{uK$;{7T0`(sz3bpxakD3Y+V_% y*P0sr|HD{_ef&n{ibW;|48902JT@rT_o{ diff --git a/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG b/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG index 0e6f4ff..a4c4ac4 100644 --- a/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG +++ b/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:27.946 6798 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/MANIFEST-000001 -2026/05/29-14:01:27.956 6798 Recovering log #3 -2026/05/29-14:01:27.971 6798 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/000003.log +2026/06/01-12:26:19.788 653c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/MANIFEST-000001 +2026/06/01-12:26:19.808 653c Recovering log #3 +2026/06/01-12:26:19.886 653c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/000003.log diff --git a/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG.old b/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG.old index 92382d7..0e6f4ff 100644 --- a/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG.old +++ b/Covance_UCO3001/browser_profile_3/Default/Session Storage/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:11.733 69f0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/MANIFEST-000001 -2026/05/29-13:49:11.735 69f0 Recovering log #3 -2026/05/29-13:49:11.738 69f0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/000003.log +2026/05/29-14:01:27.946 6798 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/MANIFEST-000001 +2026/05/29-14:01:27.956 6798 Recovering log #3 +2026/05/29-14:01:27.971 6798 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_3\Default\Session Storage/000003.log diff --git a/Covance_UCO3001/browser_profile_3/Default/Sessions/Session_13424528953862629 b/Covance_UCO3001/browser_profile_3/Default/Sessions/Session_13424528953862629 deleted file mode 100644 index 28c6cfde68d9c3ef4c97bf7360941f280d4cffb4..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 74312 zcmeHQTWnm%c|P)mkrE}b6T6n1pjkRLBOsx;H}1tSBZ?FyiXz3Os0*dGSuJ;$+7*|( z%jGU_P5=c+TNQm_+9Gh#7bEF|9-2Z)6I5yQpcGE41b%RV0(F``2!+uIsDTQxTPSD| z_xsMwFCGnfc-@sq>I`}IKQm{}oH=u5{`qh7&+v)i;m0k@+GFkc#XI3=ab|tg`uJ{u z#pq}5k3Q#&?y-E5agVk4wk~3i^_ZMCThGfW3tukmQ4eFbfc42QAPY}l1dL`gW21pc zAQ{aD0?BYF6G_HK1KDIWlnQ6kfk1F99NJ^;mKr>5JuA<8x4-l^fB2m?>q+YwUVYyB z7{P~8CXZh}VOg0cEsJm7ZawD*;N=#;R}Xc?BJr+6;npKPhk~u)?j!B3asQD(Ybeki z2u7l@P`thCD{QcPFTO(Id#n#hjehc2(;JVeSHokhkKjm+mTJ|PM+>RqIFqb?T<^uv zjPp*weRis4J!L?C0EPt|O*pPF;s{qA=RCdUh%>)j|L<4cExvcM$@(7+Z%e*ia-!f} z9ZeYN_vc!y=Wc!Bw*c+;v_`FxRkNzr%Q!1oDXVDljpe;0zX@Z=!$P+r_enf~{OpzyyhXqY;yq&aUn@FM3V(j9)e7T0Y@fxgxD~}Y)6z&u;hr(v zIg0Z*?u#sWe zS^~P$vVCs+<*GeUB%j>#flFXMjP!RgT-51fJmpuyNS9PzSuW_2&TM+5^OQ|G7EDFP zQtg4{SS&u445#DSWGt8tCu3vbR3MfP1!7ql>3kMOx;!iM`_uLdV5mvbuO4f9AMY#C z<%ZgqaeWp?GYTsMHhQQH|Ji@pL+zA?`}h_JehpR3vi9rvWg}g#3pBfCV~5(EgEI8k zMV&$FA!%-L8A7}cgV3v+~sNW))Xe6HvG-vtZW^?Hz`@u_!>o=Wp#W4 z*Uc|4JwPDK<+J^|f{d>vNV$^NjQiw*3zX-}eG*R~KYKnWg%BnJPB~%pVNMH7i{dPd zz8A62*e}NrZ^bVsB|qZq|GX!Qzu1!Zm-5@~NyU#+)Hq?!=N%!t{0Oe5aF#+!8h?Cd z+|Ch1nH(!oJd0P*c2ae_=iA?Cg?`!f>R0bgP&XZIBfZ~*%(Bb+U%|1WzKij-1bM#XHRC?H-~#3OpTYI#aJXPz z*U{GK(X8ggGtFCD@ zf2wEpI{7jNj%K@$0?H_t(JXQ1)1wii#QLYlo8Hu;k;A=X5M?-m(5xrMWso$57(QdDGj?e<|)EQ`BqfJN&xehXHI z^%DBW5tMDVhdkFzU-L+QVrPuxAaD=qP12>L{y3^Qz7(^V#<=1PO}dlwbt_tvGx8W9 zSxL^Y0puN9(!L3_xuSSE8p9}s^e9I%XWmhaRGyI)`T!8K}lu(xpr`na-sOg>3O+ zw&U2)`Rc`7{7fW0IawYmC+COePt7E2k=oI@6Vds};cRXoH$Pv=2TzO}w{%~nJ5uAz59-TaWwlsYD=y0|i?HlT^oox>n`)0?d zYnL)3UFRzPvzeZmv!_Smu}o~RrIO9$E7^24S*zqb?AL!ObO^``{|4EP6y%;Nmx@!_ zWOc5b?cj^GOjT3WY)33oJaMj8jL-Pb1fzkObH}?*P7h~t)Bf)EkwmyV94t-tCC;6? z7@r@i6#L>`m4V@&{!;t+`SHqBs4`M$nM#*XB93A{^HR{Cok-;ifaOYQEMLg-Ykv(A zw97b}aXt&UQ4D#5AKMXbI^sN)>o5H8uSyhGeO5!8k;L_VWGEfbuj5xVR9EkjLK0mv zqGEWM-RBGpxrhM|*upE0Ez)$tMUZPKVGL2gmBYAg!`RB&qpF7dRm7(;zS{2P;JtZk z9(fL;qyo;fz^7F!iL(qas^2b+{9^^@Q@D2=`GVk=hk$8MSd&PpVyw5=_29FTILo2@ z0{&RmMf`Sv79FzABj-h2i(6-ab<((Z67?R!kwguKaGbJca9+dJnswBgL-|ppPFlk# zBWDfZn8zP$9K^NpRi2teEjdTz@D6;JVcbO_RtsuX!a-iE!|KN~Yp7q!I*XhMyiW*k z)(>n&o-BcTX7GNqsLv$knX^b820Uulsf_ydq2~Q4;VjAyqtrg+9mkzD>k^(iVs%;P z?6y0LSP#lNi@QhA28w4NL~S^eW$;dfX}j$?tL0HQN+uM)_!4S$NY8I-mRp&3RC!d{ z+j5rf!+96Z25@f=+N^~8#?dRrkv4_* ztDuyET^rU+)ltEs-5dE%oVO>gqycIADs3>vL1{Cs=HgE>c+}^yowdc)0`t!@n z@<77-n2_Ih*Aq?uhv|u=(ME`~XHY~xy3yj)b-zHuXQKv1=6@Q`*@uJE`cpjT^ATkD z36$ZrfNS++e1yTdMx22lP(%_wHh?4OZ1+;k`t5ASXX}aPH;!&SMoGjTCS>Q-$ePU3=PNl(qw-^c(nGCg$x1>3awynGch?4}=*7#YLP^c>MlHE$a@BX54ohaHH5) zn5MVbUl8tU$a9|VBg#fFnW_<;Ue@sPUX|~44ex5GQaz^1W2!u+>OnG9CUx^^3`CkV zEme%XY7fy){C)_BFkM&eRM;8qQYRNQyrSXj8eZ4Xd|nQ>`Eh(0c47y?4*I}eQiMT^ z9-qzbl8vS)LWwvsNF4*SSOE*k>r{Y|>Ggq)&Du<89#@I|$jbQaay!6~n$P`HJo5;S zMfO~&a~mg|@mar(cObJ);Y{9UcUfbf^}9Ges~In|p8OWOaEL(Fye{8sxsq|)lK1BQ zlw+~YX7Ov5x7zdkxR=!bG-&@C!~*;>3r zSA=mNEy*HCJ&Zq!Az1bo@f>+B`vIHGkAvYs^$U4^GoJZ84p)T$D}`Wwp9Iog#6d+% z5G_l!3e_vEc<(gcScEwgrBF39ifdHJP%IcjyHfC~#5impcVQ0mjN-0#`#CIu7JQ>< za|&}}Xg3-QrEK94pG5H^jgTl14Wqrs5Rc=Y1=Mx9{=QrHS6sHktRv3;Ue@szEgb)x zhSzku^lyQ;b$X}4P3z+C0kb{laV3sprT$I}&qYbYVy_nwd7GXmrqSp5{!?0HE^!JL zl@OakcFrfnz$%#aS?hS9DD?>XcMsY)iZ|%N7wN_~>B4ywU#$njG%8SvNA`HCDV1=O=0FsgQoYHMLBoQ$T`u!eVH&`1z~+NCGwvHL#H9%Z1+%1r z`3^LTB8H&>7L~8WAAC<@5{`RX>W(1~aRbG^{EH%wGjK>!3g(LIJmu%a!&ZL&&aOXL zR){OYU4bIW;rFfWZ7PF(_Vn9ZU%$OxvCa2Dr(DC)jL&=(kmM|bphtm1&Me^Ca?|{3 zVw*c!jAM#zMCaYBb>5xi`4BE>cwIx4>WOVUv5hCT*~(%Y!4nUQ?IOM+hamNE!&kQj zp=ju_;T{{#u3*l038ZZ&Hk|Xg$9BMi+OxU5Z>iLFWIMFtn3Unqo@n}KKyo0A5~~Z7 zX&9Hb9i%a7$LWb^B{4T&$<35|PgJLdT95lDt7(6{cPtgmpYNK!6qqZ`CgOt={WEnk zJVli(uDF@S!BJQS+$c3I!Y`J|aGg_{4kV=IdPlz177~9^!#g_PZY>-WxL?OF8$vTj zv3BVu_S=sPc3VS?wVt(Tv=3GGf*r76oPeO90vo?M+a5Cq%fPbL3#&nj@rNK(#MO;rq0TREOTG%~i3)#4=o2zsvQl$_n>^i$r#7!|CMN-P5 zkZTI4!eaSKj7?z_%cZ>`?G!1ZG1gEbSgVgtDZQ{ z0d#lw_m&l|n3i!8=RM!v({$BaJg_Ym53EQOMZB|FmEAXBNhT~L>H!+Qq1PouO4rDAKVz3 zQbteX5Mq-|sdLe%z1Xo-X`8CnGIMRANIdLst7fOFtyl+%RiIOC@sPj0J%a10VkT9| zv^p>9>G>T{w6}0@G`$VDQRcD}Or10I8gaQk|Ls#YbNQ-*HXc6tLvTW&9*wTXVx!)YQKmhinmqXzi1sn+l4WtaH+LoviwL@t`q2~ ztJTh%wp)daIW2&QhvQ4W<6`+-{6)5m3(IInz?hUz7Y$?=X&XU113pPv4$*puUxbz# zT!e;xBYdlES=Z=sb?3K!ejn4OzA`LRT>`HMo^1L8#{5>6N3F+a#9so9UB%IiS9=|B zqo_sXQqqKLm0S79tRut>IHKd%G*r1(XH-17)!Nq2ny5m?oxqjlRy&W-^yFNdlXHpu zYdIsLHG8ijE%ntWn!XI-#DgHM)`KSx12=YRJV~z$8^x1CVkI<Bv7NNTWGjX;dom&pm6XxJuO_;P&o6e zIxf?PsD=0G>B6s}OdmNNpVe?d!>bxz*YKu>w=}$~;cm`h2=vCl;McHM!x0U08eZ1$ zH4RNPo?{s}9`xEhjvL~s6BwC395WbwT=ituPu8+Uke9){F1XH2XPhdSjjoY<1^50Y zj&7*RxeAegA=H%E;xOuY0I(l59*6WJh4VA`rQ@a))andoeHv9yX~$u#6!$^qLl-?% z{y(VayS60qnxzcf|GS zia`2>WHRGEx!?k&otN|I;gL}rmq2fXjH>NvDsNLV>KXK-r*Jf*o9zZ98e@>|C{ViF z0sGE?`gVI>eaNV-Cx!ROu0?Op^-%n8gzVC0 z3ZxVqW(tgMTAdn>Zz(f{uW9py-`lZf3Y4loI%Wzq%%F=CIu=nr;FXIPJZ?K{)J!zB^E7H(3r*cZfAKVG zjrWErnxL(!QKRQT_Jc)@8ZBm>8nt0tTSr?~`u;qw^&M%%=5U`mT?&P0rf*hMA?@gC z)X?b5wEJe;*X_HxrEm6m^$`WBwpi|0`k!1g<373I0_D9oD%$bLsO8smY=n$*XwpNJZ7JZ~NY7q!A=&qXv!gQI=1-^7wPK_7! zS#)mBl^R^Q%l#U;ST}@wco*H7XOJhdM7WVa-+vJY*L&~|I$7rq(Uekimq}R_qSCkq zgt|IPvso&2bX*(46)SYi9%+CKd*yNUjn1|oI%U{+6+4LR+JwA#=)+B~U{>eCv_=p8 z^{COFfQcnGTC+_R?_ze{tf`{i4)~Fk1rqPn>aw+>h-=zJk>-=mpo_VeWD)`o-&B#R z-kqa#XZy0v*c+Na2x0&y6iSB)R_4xr~B#ybYEXAOOWaNnjb ze3KYP1NU?4vUh!A9&Q!B)poDhsQjDn&K;}R3fw`3L=atA($5OF+NQA+jgCkZk!+%m zly>x0MILb(Z5VmRTuCt5)rO`_0lVG!tf(%Z#2F0=_+jwq{2Nq@8~Bc+(Ft7Ye;ey3WnV)OzT}Hy*RB z8#tO#9#?a2lwQ1n`x)L+z}oE~>}-<|9XIJkp(981b%A9azv(E4MH|s2{WOL=cH00q zF6XFt`PratNjX9vnd4y1W>33zh9iMSk9Y2_#r?U673s{ExR0}=+GUFlf61KENK>(? z#C_Dc(=3x|yocVS&@beZ)yW8RWtQ>zU-!M?WEt%~j=m@3d%5wh1xKvs(@!?-1trYU z%xDRR+i13(6CbQ(tF=n;bfwUt4awoh-S!~|XnT=WM}iI{pnq z@Z2I!r_BoB;0w~5sN{}t8Xv{^g zbSl2+nNG#sywj?jU|c_+$B`^OPw%xgWI$ zA6=U(k9^{Qg`5h7c-#w7R$Hr4z@hOl@Cu*aarpR(*io>gK;EOVBjs1;nwm~QC_(JV z=mHKm?5H+*XgwO8iRYv7q49~aM5;Y^w0y~bVjws%ogDA(FPDPJGsp9TiJpP!z>wbL zA<$Kr4HgG0eY3I2OZ|b;z{&QxYIc6Qm@1q;dnz(JFrUk$r)T};(fQM{;LJdH{L)N$ zb}(D^cUAiflc&~0W7P|L3U)+u*uf2Zep6%5Z)sR>?71IU+Wsc%#GcO0AX>q%M!})R zF~4wT9|EsEfgYbgPi}`S;V9;#OBe+wz#Rv1Wg5KqI5@$6n->ovb_U#R9vp81yzl_7 z2T;cSn?aDnEI@t|1cn|2KJLSL3>!>bLMZ`^jRA1R?U14n1J9!b?m}DuEQctop2u~Lsvqlu<^WE|k`fQYKM`iDd=*3M8${3D2)S zC(3n(or66oyWpZ3ZsZ=}=?YKLN`k#pr$QjlsX5xMLP%BTO=w6pPT8uB%K9KkzFH;pKzYSmn@ zEt4Hf!EtZfbfAq1rAmH2doW$dXN%QjKGWeZr2_4hmAy9S#}g+f`;*5eGO@mJ>&R%| z>C&0@?ygLv+&y=EC^tTJA~Y~s9uMUX4YY7in`AndDipHCi`nEv7LUwy3|e+y1o!1-phyx-Mx$X{!?UM=rxbIDHA@(zGINP@$Nf;;I2Cr|>X z(Qi|!6W}+xz|};d;YuOTDa2#I(xiwlA>M^M4gt%a1z*tx=^J%lBakv3Mj7?c@^<5S z$3g21;u%BWp@tEkM9pf59kT028aj<Z8H|oT7P6gonD9UID=aqqO zu?z1whZ5V7uNQSb1Wu|46m=D`QM}JAuFN8h(y>QH%R7m7JA_uKqSYd3p^UAC4TF=U zwwJo+^T=@o?Gr`ITm)a4!1q6ow#}l2521CrQQ|PZ!T@^5dE}y=cML6BKpB+Eo5Fk*by!#L;BgBayoG$|vO$9~j>{zcty z2v>KCmX`)_)M}7YQc^t9Vxr{@;G7&Uc~vDtq?RRSw+3lD+Cz}4O1si(wWQ-(Z%|LuxpXtieG71- z%Arn8B_uSw;-DJXTKh=BAehAHh)ypX@QRM#(oo&Kx^ifzF}5bdw`OHeot#YDvNSaQ zQ(9TKU&BrfFKAfS@QQ}7Yj{n=8ydc?;T;X_p~UjpNf7pH*r{Pc!wVYDYDl7!!EB!# z()>6)?}%)jMJ9scX^!p1CGnhQoJ-<;AXZW!KC&QXe3jeuab-)7s_?Yp_9Z}xdF;2n0dbLmDCSrigdC`h#kO$%vE zNJX+zyU>pr1%`xbYc@r&k|ZT5xhOoun3GRz5#=^oP<|!xxgRfQS|dc&azxg|o~GP3 zC7<@9ak(m@nPV34L6c8HCcUo7B!Sm;{3%)=Is#F!Gni<`BcJN)T-qLUXmF2w;!-i6 zO_p^)zG3z|nf|w`N1+(LA?xUoPYQdO-%sY4wWc%QX2`{z{=E8-Pdmp7#UrAtu!cwXZgxv zP3??5hTOCeriC1tFWOYpo#|R-Tz&ic-`~e{;Z^J)%$5mx(SZd9_B8cs{;SbgpaoB^ zr}+9^@He-$_?mkqHj4k+ulXqxqvUk@WdpvZ<99T)KL>ucKL1r;jAD+o2Q9u9zRRb@ z&9Vk1q2px@FKhUkhSxN_q2XH^-qz3*Tl=&)I;Np1wl3@RD;mD8q1iq;^btP}PkgOL zjL`W<5ap`fMgEI6!%p#aKdd0q(4}XQdeosFV;Wa&Ph%!nDpr;9&F{eYX804~XFYK? z8WN%2?d$g4+|oDuJzu~(>~wKO)TLEb+ESel2y(vk~%33%2%R2s*^ujBZ}M9oSMH zUjJ2#wST^Y#oK{LNW4u!GMDhtz?&|>)Us;sbV%_t7h%)pCx$=T_)s`aV{nSXQ~0I9 zx-w2TXQ>4GKE>N~FQyhvE6=Vhf!0NI+!MBi-pXAM?T5&YQG8CXugdXT$gW!kDZA=z zQxsZxT>Z;`zIPuJhF7tJFkdF*MF$pe?3vhTEU=zsfQKOh?8HG{i(g=%b*hno{rr&8UJtn@Pr6YY;6C2T4DX|@0KoBnx4{=EhaUIIlm z653W?)nb=z^eq3q&wTSAmlFvImJ)0vaef}ho{5b{K`nS(JvD6aK;%NrS~JS!LXk$H zDW4Ycm}u&PPM2Cp()Gy1lr+)XMb(ChyMBCdlrIPTWd z#6AuE8p`yM)A3mi7c{)8;dKpfYIsY-yBhA+nzDTw`Zes;a74qLhL<&bO+!JOf+KQh z5TasF!=`$Mw9C@XerRm&)Ua`RNCitf=u^;#m7nyISG8BLj-x2Eouyneo$<|xMu>k{ zwx?M`BOuhfecisBTl!|d=L>j;ovc~&$f)Hl7dJviIrdE4Ze-Mh-ZRl8ql8?#s>vmR zH*|d8Hq@+bC2sE)(3rRNw72!NM@C^FAb1)z)ea_kwzbKqoug6n$gcX4U0Rk-D&3(` zV{{#|Hh8lSwmF^Lx5eVIXehp=G-|)pnzZ+}l}3%On&|Ga&Gx=Pm-Ve+&AHW44eWUp zunm$@E`8uag?Jrh-*n2b(NuO2*|iCI(SZdV8ns4afvv1jGqJ@DEqmVD z8nuUqEzD8+sA<$1jg9CWjtkMad`-EIqkdm)8m2UB^drJqfR+Nvm3jd425}bg6E*zQ ztUYLK6nXc}`>>Ig+*^XB1RF`5*vO$#YcvXK!Q-~GM$JT1+e4$aebLk{^cPPQVm+Ib+{EVOA^tWfg-$Iv@3eaNa{PM1O?R1Tr zM@B6#+Sv#h<s0jx}|THEUph3 zwR1FT9@$ktvP;X-KZcR*(5NxGX^mPqyrnd1d;jWG`Mr}()<-qGtYzd|dn3E`P)+o| zT)$N(g3Y$7MvdEjawC!eB*ok)hECA95`!BXQ=_HyXesE}(zX_i+t$$s0^Rj+TNI^- zj4v@;O`z{nW5@L!%+-$jsUzd65dJBR9XD7}Yv9^Z9@mFZpT}+HM-iiTlTRK+E$S}A zUS(YUd-qR&vO$d+hrMG5kw#;IdW*9k^bR5>Mj6o-jAa8}(eYavqLuBS5s*Ze^u)%j zV|#cQ#S|B=SL=2QEwveOwyn@c8Bgg29s4!x)bN6aWeu-r__~JIG`ykV+Zx`{(2|87 z8t&JSYbzN{S8TI7eL+LBeR8AyB%WdRvd?6Z*l;e(K@dofFLhK|oE(-!A2tWXM zgOjO~_JMh5hiN?-wNIM3)6qlIQ97Ne9{iwYY)8rXL2uQxeeiTLsoJECCw5!6)2aJ? z=OREWEKLcbBB@;J;NNrm&t=c~&v*Xw?`nEtdiqJjFuq_MOoIIL5B#6(0(}Cmp8NAZ z{@S;DjE~};?x#-~M)o6y!Q{u_Uh0pAgOO;z-yIw3_qzQ9v4A^b#yoDHXTakPhQhu` zAo^t_#PxCGseb`$>5;$Rd!p-g6r+QmL1-#nUag-@7gMEWk!B3>r{TKc>jOP3a~g+i z^nmhjgFX$nrTm&)(l?4;Zt*j{j{oY7S5Ln?^|bN3ir&=e*d;C3`|3Vn3vWpxZgo8m zsEAL4igp@lqin1ib>k%Nibl#P8EmmVz0Rj;7-?9f3CD~6-CUZlPHXqObc6%dHiur$)75$Z;YEVz3S??+e!J|Dt!Vr=LpVmQfXVH}I6ipk@DJ3b{fxut{t-sEPRgMFdZOz+6v1G6+l}roA$|jnqq_pS*P}bz`)6Ww zTZ$f5qt~>J;^WHyvMrqLXua&CVQ)wGJE!z$=cs7CbUk#KlV6Wo#zT}DdCb2R%szX1 zmuBQZTlp}F_9t-9+2F-^^J3g_L}!f*#$ym8G9pH%A7LpmZqpdUIo!L&=#SvngItzK z>x0jEHkjZRMqZB?)0}M_>6}NLZRC-|9p{%H<+~BbQnPS=)Q08cK)t(~4OfHiwzENp z>)D|F?2oTJ+4Uu?5ghs)K^)fkdc9IR+0(O8tDMM`*HWd71-jDnJmStk_^qLGH9U@j zv51D$AsnlQ%SZ@XM@SLrxL90O)8$GB)8#67@wzUFaiC?Gb7>P279^*p$)citDqYe> zE6RVZg-;6`-ik{PGd)~5oJHTDy>+94_MbF*@V9}xig5yusEmH$(vU&#NdF4r?R+#p zd-&(T{}%?SWMLm<a%{3p^ivgy}K>uzoUA|6h z_q%k21J&h!2JycH=P+jOXnz7}IqfnS=sq#%Q@H1}2w|W{FrhdtIJr1MQn=$};H30p z8d;bqUZhXsp3^St$UlW1@ghG{NAT+gcN6LTfqeeKya(l_ zAHSx$&D)4;htY0|T!!(!qOGeE*cy6OTCz>c3mmJsF59S{jxKgU%cYXt3bEJki--~Z zb(hn!c&kTFp~o!bUIi@~v-m9-s^M^W1?j+ z{fH^OV!{Q*gy-7l$H?VM$mtkSB7k?C-drC!NiF0iuC(`i0?&xzBnv^|K{^VRun-+# zjS6ebuV*~x!;`FSp?{*uPO8V{xe-$K%HEL zIej=yv^5^nl;aI#=9~Zn>g>OhmU2-S!*GaPZf(+Y0>I!OpX?p@)I6k|9pDnYTBStW*X>=pCQ+t~Ls#^E1BSz>+87 zjmDy$@c3paIAV=dh6c`sQ{~O{WZK`@7~AZh84ZuFN3+Fx?pW2z7OGaJ zzOY&?^or&m_4Px-;hznPAOxvvm2#{RYhSsO&2a{`_^>axpmdKT@(P+s(mbc~_;bXN-864qC zh3rwUX|1FRMbJvMoGTQqU&QmVi`xOItz)ZZ1bnG*rf<<3>7<>DYs5NASy#BEourpFH^0DY%psj0V!2!sIXF-a>EI zjRo9gA)-x)aN>gi(wRVE9&E}9lvj*Ni0%pFJVNRa2FDOu7G*8qE{{A#{E^opetS{E zq%n$+CB#i2j}K3B9>Qb9IE&oVh#SYR8-JTd)QBSmw+Ca$J&X_wwI9TiTSV9pcvkS| zM~qI8v)l5)L;my&LKPnZkuS!B%B|7Hc;wO!>PrCYEU=Z(?V*w+8+T;I|1spNW2A#}LCE zMO}pYjX9JaK#nAyQ~`ZZK+1Wg;w zX2@7ao_RdEq!@MU2up%b3_Nq-Z=r9ZsFxpn^6w@y@;VAlTg%$oS9osLpFvGaUZKayjYD->B)o7|53Xgx%I|>i=Dcr zt#JHrp6q%JFo$rQQV_|2ZWRja$Pf5Yyz))VoWfj|)PsZuso&AMA7 z)j+)TlhiBirts-M`DHP+wNg#{neF2r>3SABB2Hm$jLL9MRkSPBRF$#G6qN=Q)dp>? z8@#gWB3--6-;HAKPa$qD!gZsb7eG0!c$!Fgz{ffR2S94Rs`AW_d|q=KEF%R&_sdl6?4rU1CglQOAw2$Vpwh} zKX*x7?M>w;;$j*%a_~;>H)|@EDkBpEocpgPKWg%`82VNGx{W6R9Y`?ERj=I3&8H z@FEv-rNDHfEIxHUUFPIbHASBfsXVwNMr0ly!117(=LjsV_2QKHS;!UE!Tn5nN0F#S zp{C3;`?0RX$D~N4=y*`Tb>aN{Sbcb^=pSn=ENm`CDpQ4AwAMeE_7qaJ*;GDK_Dsdf zp>->0ez=lxXk)H4)L$%l2O^$EAu<`Nr(*SJGS(kAXUnyg~dSbp7~oz51_;!JS5ZVlJhG9%*~@%VjKGQNV{<2D?Zk1f!9T|RcJ zWDKk2BckXb4k%p56?Gky{ys%7C@MpDfh@6BiScP$KAOwJqorhAfckD8%A`8fPg78- zP_fj2%4-3O))K@{1))?-M6o>eLoG$&M&(Nl%BvJqB@qZ357NXyLr`83y_rz1Xhm5& z)#mP$j6+aH%we$`Lb*jyFO-2qfK)n0pg0Vn&MA~zN8OU3{ZN6Ls1+4kvxuEW-Mvr& zQAE}dcOIe3P@heq6*J&mKntl(92GSm5K7e|;?}_>g7lp#8QbqMH2TCs33c$yKxsRU=MWeDv9Dy@S2AiC`Lk6rYH58Z)i6uP*!?aY z;Xs+5TL|6GZQOI|*n(@lZnk=GuQeA8=5{8b_91Wn!4F1x==EJiw^jHh8`T;Pz1<<7 zc9(9CuHTDDLRmX3-AX zAVwV9Nd&-c6-!``a%;p5k=7K^BAEIisTOD7(l(f@9Jg?cHIeg9dy4%%M;m4NL$c@K z)co`h3vIWRztNo&;hMH?E4z#j)cXkks*FgvG5*irdGGtw+3{G5uEX~c{tc|b#rWD+ zBwO`9f(~wHvHhUmNBH;8|G308=sy&_$@=nAYmoFbZRYgarNiyiE`#>gV%uJN)358H zL+pN+j&Pt_hU$FUpFnykQ@PvW(H!L!5B?}GrS$gWUP^DuTWYH*YbZmdDkv=^O$51u zjrFXLl@QleDt=fCwY3$kHi<)HL=IO^19P^MA})mwk*z$5+(u}A@P(YWD8H`C~qihhz}{dC|4*^WLO4r zCjhx(;*aWRTCI9_;7{2_%txe8G$z&ER8;#R%Ot8L8si_8*Q^cYDG?_n93`1WVRP%+ zQ|0vza)lM>9UOgKOUY~Sb0^2^8+|>mG2BiWckbz~8Hh-VMCuZ^;hfI%PSF^&*F79s zj}$_Y$>o(?A{EFFSC-6)aqr67!t%garR-feJ6eb*hQ`-Clge<^6D@9dOY!Q+M)>^F zn5R5G71*p>jkQv$I6F5J+!$} zlxsBH&Lg%0WvL03+c>7e3KVAxNHG8v8?6Yv@STO4u>d7n0-M`$#CyQwb{j$ulygO> z+Pv6K$FYqb!F?D?%O!B}fXg`4c>!#;shn$o12^48s5Iw<(ryFs4b+5?VGTKH!ZJUe@g$cUr&s5Exy5*4w4OOTJ3O-)w`xO;=?R~As#FZc zM>ou~%hmYsYJPO0S~DjHkvw@Wmss~?3is>KtWyE|A%|vsQm>B9w_RFvc)O)#OsW(hf3vm66|o|s6ZXX?4_?`p{x2&hMF8X&kJe53(_3*xEOgyC7pjRSDq zY&+<^p8NHwWkc^tx0Ii3xr`iE8=1>$`S`Y?TPpmbjb2gyLwMn#^=e@&g6-4yFA*yG z|1Ou2+s#6Hpmo(IAw8J<+8m@ui1l`+AU#6NNHdTSw6sjq`UG||0bxVz?a<=f9=>Zc zkSFAOVsC@@ufW}a<8@kfU|!Le6}9WTuj-Db%))g@(c_BtDf*(Ke50M$mZBFGy{za} zMQ zqkLf32H|+w(=8Sh17wx0A6sVFBwnfKy1C*YnSVno?Q}qMj!}$1!5be+l<7 z+!wKYJ*fKW{+q`6s0%ZguSL``iyl<@PW|o_-s$sj;_DRtsFimFW9>P(VT>()`=o-W zng%R(i5bGVAuo>0E;zHruWmseAGpew&HY$OXeP*=HFbz`Pfj>VLo^97`Rag#uzcfH zzD&;ZCFZ5gu6;fv&`X4?3OD+@cD#<0|@`jfanc|NVqpFQ9V| z!*zr2A>M=X(vMYB{S3AdM~xi115V;!|Hp%^;67XqrO!MVozT*27dh zV48h&XU-oz~Ay^QUnX4P=-;j9-0#Bl+{IK{Ozu2@K6*SSAm67*0Jk zzfDA779S75s83IQ4f5cKyAg+baB$jb2s$!;c{R;wLvA7j4%81(yyhYASkK z(Y&G?if$` zqsgCNdy}7Gl-e(8?AnK257!~%NysI>eA9$o+~u}vz2=3uX07>+uxY?9`7J$U!exgWdj$*j zwOz8m_o{!L_&SAm3iI}1mwcWH5Nf+<@kU30Bh7tz&sP`-yQu%74vMc>(SVq`FwRqc z_=mspW4AmIw9iM)pRdNz9GI_*@t44j-&vE|EHv1#HKt(?1%Le3wRW)Ut=B#)!ZqyDe&*>t*cDdVE`0i;bJ*qgKQP$!56~vvfa^xR zuY>NDwoBV~J^L5(t%~OqO)9Nc#YVNw*V`(b-OLNa;kL^@{PxDS>uz8d&(0qo*d;W~ z=zr7BTjss!aIHbPJErhJ1y@B#!ly2E--Pp zwA|OxcE3wUI8fd0dwsQl0Em{nd~=g;$@5dO)D+22eerEhf~FKekNl5EXqiPb6dv*O zr3AT2cYZgXc3jju5uEWw0`lj3s`AwW0yX*VME(y1)MSw>S1G=~%ELn1c~O&v^-?$0 opvdi5CA0%JVOPI*xgp-j=KVD|CB}_^9QgkC2&*)F(tf7pF diff --git a/Covance_UCO3001/browser_profile_3/Default/Site Characteristics Database/000003.log b/Covance_UCO3001/browser_profile_3/Default/Site Characteristics Database/000003.log index ab26446c9ad4f5b8ed6c8a91ccb0368be201fedb..656562d1df5afc7908a827c758b13efecc01da19 100644 GIT binary patch delta 99 zcmeBRdBD1XgNY-U`S}V*21d?_2D;Kh9QXHpy}%~K#K9m1#7aOMv}1=jP?~Gv2Yty$ Y=#p*+g607wxhLl63JYWae_1>%S0JxMwX2UOZ0h|`93i6ec+$Luff-_Sy12s-{cQ=dW=kyWae_1>^F$eEM&^wPOZ0hI_!=1bKJd@r*Whc|EGSUG$DYT++Gx&bJUP+d zmdV6?@&bP`5hl;Pvee>|%=E;P{33;b{GyV?oXH>T^ca~Z%iBNYVc}?0S19!wO|39rvx2dU<00R@3zwO|39rvw>*G6J@!0mG*~8>1RNRIAZcw2fUZ zbrS+vi-#UW-LN92N^~UYDCOsplbxj>^KnpWJ#A5JKm{g53~1Q%CPm!SD$dA!6!~X@hIFlyLvWvv%VoKT&ny|;&ah8`q>ba*FZPXQ*r##R^ikY^=wo$L zqHF_P^hvggW1?K$XVNh(!Y)cKn5jlMHJZ8Mm(TmG87L>|ziU;lDiAz}-Cdx(x#vb_uSn>w_!j#<|%G z9~l6GMk=US80TJoZBi=;mQumb8{=HfOPd7{ETe+YR>iqXR!?aI!E!3Nc2k@aM-R&b z!3rw)$*wpz=z*?t_o>CJw(nVk z&t9)^+g@BaVpJsZJZRlF@>*_kO4XoGIRE>E8ws+|(Q2(zk0IwT%sK9LvRWIfj3yA=1C3JUWDBR|ogyVXLV4yX9lZ zWwhklwUae?!Ur6`c6$UGO}TtKZOn=CAJIl*AwPc)={iut&)-iPU*_|>_eU7KX-*NI zTohwzD?h(IH6i?xp8Wieg6oe`*Oy(Hx`toqzdROP7SPK$FHDe*&tTXMFo=Aj_-tiy z@z=EE;m_&9AKe|HzuU?46Y%`L1IY6ebK>0oC!aVCw%CL}uDrT0Y8y``0RxUFcId*l zH$*D>Pbj@Q!oGwT94i{>`I2XO1~PSBL5krh$Pz3SiMpyfvTpdkW4;}Yy%~+gl@LRD zzNjk~OR(>>kNd=Y7?ufj825!tftB42O?%~dtQ@&#OaQ#Bqp zxIWT46gREwf!`b0tIOKA*3UbFV^u@BMJ2b7$;n|i6OHW_Pd3Z(b zl^JL~ujW4HcZ|vWm=PJ9xrCd436>gqYV<+&%X1%gE?cs1__XQU3f=kh^{N-Ux3>PW z-&?1PyWd^#$?o32`S7Q!AG>}YK9v~6Z5ll0i_=kd3vrDV!Zl0tVv93&O*>v*Tatli zdf-!2rhYTtd34A_|0n0*cL9f~(GH#g#}uS{=JLA+aW_wzH1V1UyA{8&s*fW&hTsdP zicG-~kfN(HG89EXrmc&LBU+9rJ13&COw7p2swwxmg_p&-|jOr)rm zk1Wgak)bQHVQGS(8Dg^ZCZ6r`5Z)NjUCsQbdu|T9EwrNB@?x7|4P~b2^c3D<6osJl zDK4s>ddK94xEH*!mtc21KJ9enGg+hpj&}4BCrljGcvCIZGDG@ zla+a4cA)y`^hkoG7EZ%D=epcJ8_QQ7=20WAx@}lq%O8fdMcM7d_@lyDba`H^F+=0y z#@c@I(1uS(HcJKqWXF929_`HXkJiB=pBlyDZDsiOp%vVjWv?#*CSRsY-E~w+w>2F} zx=vWJJ!D%pWMNOWbzhVX!#&4jn4x^(1(0LLg`RuX<`x%&o}-29k9v)%F>l(xN21e z_hfDHGT3qKB0G-BsI4g|n48Fs<7hX&X;H*!xwSX!ICewNxlcAlmu~EK1fl|&9>2A! zr{f5=3i;SVrlfdC5j-8rbIn1fCz_rnc)lf=L9z}rl<#(dz@Uhxq3Mo>1Ve?wTyj)o z8;XlmK@l|5G#%YAX<kiDy=BsDm)^cN!+b=n{m9FhkST z4#LF6tNnO~+K=RF8~BGj3~X8u4@`&`Bqor^Aiyt)Af#H?pr5onh!W&mqrE=d1G&GG z$~;Rm!%CRgHY+#5Qd6hJi_b5sJyh`F8%6Ig`*V+*`;GXdY|Fs`<;^1xZ96gJ)-O+T z_Z+3A`Tb`fc^9I{9vVf$SUiX#VTN{e4viug@0gyQ6y{knVR~VnrHRvhvtd2(Kr8dF zIR^Yv*ok9EWj=G)@G9VaFD}>w+gaN(EnSD*unw%Nrh;r;@{lB}g6b=_Eo(x+x)5S0 z-~9rtyRIObqG=;X*5EmctRverp*lBxQP2d}P<4Z{K5Nt(3i-n)HwTb67a2bT$X^Mo zZoqhE>IRI5RW~_n)IhdFeNOl#ncjqx?6(oE)OC=iY5|j00Hh`-dvj7L$PfzzIDP1` z;gA^(ms%a`^Q_DZ&jGggO=lA%@6p;f&@N@F2T}E5GBfvw`A$#QGyc ztbhRGOsr2K4r_T#7D{?KkR>CfmjhXvINkb(Pr*Wma^PRv%J2{T3U1NoOBJAVKh0@| zZ;O_xS;&xO8SvCCWJ!{M1W7U_O;&WzQvy804CQ-V08iDEZC6k%IC7-;)Tzt@E+wD^!AV*qLu)XG?65sJluoj5mS!evWc?J_K~p2A5qhlm z@-wH;_&L8C_Fp{y7d2embv_0{|3UL?7^?<|h8fy%!KAj(A&rm8Vo66dOIAupG)ohw zn}6ryu-E}neqR|*jIZD-1@{&}^dMdGmTl;?T86qetpd)2?#iR=Em6nEI1FWsM zdRLJx>8>fbI+7*ZMGDlo@Ol`ww~8%zlIF^)tEd61dWfNXuM4oMx{hG@FtKJzz$$qm zZTOCk9LbkWSM*iSR03A_&}#SH<1YuCzPCFu8aO=^R^0&8%+x)XO)o~>^cT{kkkuI% zXcOR@uqlJYhBl!zRoo)rlKdMgMXn7aJ(^Hm+V4U-eScWJbN*}5tjr5#HBj1m6bjyy zk((3uaCJ^`5=cBuj65=gqXQ5#F>)$nhBR>UiYY(pSgvHr3h4x9Y2x$EOM>9s6R?

suJ1`7iNBZ!_TYsJXEF>${9!~)Ju3Uiq1MHv_- zXfZG@1W9%?O%ZN*zxc(Gjrt5Q+7c))0>nB{HB*>A-`iBb1gr)|3j^h?fLITzhMD7z zvDB0D?VUh#V6+fWUJQs0plT#07De51uh=ZD{FlW9WIzj4!e^UIzS--yFF}rg(I5wa WENFwOd3Ee$6vz`B3nn1pR89bV=TR#F delta 222 zcmZp8z|`=7N%rt5mV*ooObj5P0>oAz1`CK_U|^gmYsJXCF>${9!~)Ju3Uiq1g&7zo zXfZG@1j#PoP3JAkE#Ka`QJ(=u3jyUtfLI5r=GlAc@k=+$%OqEB|E?umno9KqZt9e3$@o;KqUpNVt;|048!j-v9sr diff --git a/Covance_UCO3001/browser_profile_3/GrShaderCache/data_1 b/Covance_UCO3001/browser_profile_3/GrShaderCache/data_1 index 97dd745f29215246cc0b8dfc5f4f4b9a2f6b9240..bdb75d4b5d0d400e8bb37643df282df3cd5491b3 100644 GIT binary patch delta 354 zcmZoTAkc6?K=$w{mV*ooObm<+Kma6cKr{;j0|$tnDC^Ale`Dfuc}Bg-oC?yc+(0qL ziH7nM3k)RnKnj3>2|~e1y@`qLk`hpE1C)j-el;;sd^3mQj~0i+2dAw7Nm?;5On@o^ zQ#VKMm>vvYES(keM8M<9p5CoM0JOA5_y7O^ diff --git a/Covance_UCO3001/browser_profile_3/GrShaderCache/data_3 b/Covance_UCO3001/browser_profile_3/GrShaderCache/data_3 index 42f7d17ac7c21a36f7c0793ca4494341b6886ab3..4f6e4e505925bd2b28499ce6d583565a3f5f9cd8 100644 GIT binary patch delta 2741 zcmeHGPiz!b7@s#Y`{v(vJG&Hi2})m68j4`qo!#xWS*&HZ9*RWR_5jh4vAB{DTeg_i zm`Ljg$=tNmN%-i67SnhDlCtb!sv_NmgNgP42_|YZ0fRB7L5tQCf9f{`51SB=p7u+A zGxL7$d*8qJ8>?*b79x1)6ZgKNm*WJ?cOEgqd{oV29l%x1)9yv+og zi8k}ujM_}HnQSw~W~$A!Pno~`G1EyFf-~wFm}ANgXNe8Mz9wZ5z8p|wXR0Yec$mLU zlSF{!v;IA>a8PXo_A|W$k3P}Xmi9DXA@0LwWe0`V&ikXzA43UfT%w1a?!o|El!*kJ zSNM%20Y#a-1;53W26%6)veg~FptbU_c$aQG)g~^&$=~TZ=i9O9DMJ+9@j2}m9-_-) z2i!H(O~_G59MwXQi76+f7<++@MANW*Nm~yAL)l4U@WBdcd3^K>LktkUPlL)|y!q7p zV{mWTInMUDchq49Im;C{l?vfpN^}bvW z-*qZ=#DL2WXd8*c(gV6aVr)sPhXxA+BMD}jhI#nN@aRZ98cV=Hzt9kh#nNhPH6QF0 z^Ubj&c2vbbiGpO(%wvFdXQnF!)AwcS{M6M=Qn1=BKMR*0(hy0)4`nGHG5cfamt@Z| zvoJb>Y0Z8Ei4@$PC%_L0kdw)ws;l@ut-Mo3;N7f+fJ(lBJ74kVp>s_0zjPJFbq?`4 z;#~dVef|e5CfTeZ7 z&`u=+Gsme2MN4ada-AeX>#CyHUBpuqAtO#ZH$DoJS$Je=Vc#qgBAgwkYsjn7- zO@xCU%_BVX{s9r%G78ENxxF0WCZMTL-V8dGo(cY`>yKSc^fd5WfJ(2N^}UJ9OzGZ4 zn1sAQ?O1(==^R$fsk)QvT?YZ3k2vr5?uK(A;zuc5sgM_m48yimc;1M=a&wn&yyd{^ zTsYeoe#4uSf#<-+h6edjJQ@b0X<#%BjHZFnG(hh( Iu&_Y@0Ki=co&W#< diff --git a/Covance_UCO3001/browser_profile_3/GraphiteDawnCache/data_1 b/Covance_UCO3001/browser_profile_3/GraphiteDawnCache/data_1 index ff44b9ef4b4630aa4d0ac3906ebb38ba201fb982..5231962c2e99e905f5b00ad0520d355fd030c802 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasMu~}m`pq1Q?Hr1XK+LqALy`H%KLD-f3R?gG delta 31 lcmZoTAkc6?V8aasM!|`J`pq1Q?Hr1XK+LqALy`H%KLD*$3RD09 diff --git a/Covance_UCO3001/browser_profile_3/Local State b/Covance_UCO3001/browser_profile_3/Local State index 8635acd..041e616 100644 --- a/Covance_UCO3001/browser_profile_3/Local State +++ b/Covance_UCO3001/browser_profile_3/Local State @@ -1 +1 @@ -{"autofill":{"ablation_seed":"/MusVt4Dv9g="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528308788095"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":72,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780054709555759e+12,"network":1.780054709459e+12,"ticks":20537781120.0,"uncertainty":10139551.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAD0695qbX6h3OrOVBwLcgawAAAAAEgAAAoAAAABAAAAAeFBeuEGiQ06OxoyXb3hrnKAAAAFjf6zXP0jaVL5sW4IYpuOBrXtmN9e2T1OYoM/clxSqJ7yII2efB/sEUAAAA7BuHAeec54TeWWjX5kxed6/M1DQ="},"performance_intervention":{"last_daily_sample":"13424528309465335"},"policy":{"last_statistics_update":"13424528308786555"},"profile":{"info_cache":{"Default":{"active_time":1780054709.444609,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424528308887943","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"355788077","signin":{"active_accounts_last_emitted":"13424528308699489"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424528308769121","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054708"},"user_experience_metrics":{"client_id2":"1b6caa5f-95a5-43fd-9ea7-9ec095873de2","client_id_timestamp":"1780054708","limited_entropy_randomization_source":"12F248C2B7F7D865B4A27DF20C7743F5","log_record_id":3,"low_entropy_source3":4429,"machine_id":6709466,"pseudo_low_entropy_source":262,"session_id":2,"stability":{"browser_last_live_timestamp":"13424529927177228","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"CC8FA68372E1048C368E03AA2534D7087F3BBEBC","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file +{"autofill":{"ablation_seed":"/MusVt4Dv9g="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528308788095"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":72,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780309579975705e+12,"network":1.780309579769e+12,"ticks":17544187986.0,"uncertainty":10136676.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAD0695qbX6h3OrOVBwLcgawAAAAAEgAAAoAAAABAAAAAeFBeuEGiQ06OxoyXb3hrnKAAAAFjf6zXP0jaVL5sW4IYpuOBrXtmN9e2T1OYoM/clxSqJ7yII2efB/sEUAAAA7BuHAeec54TeWWjX5kxed6/M1DQ="},"performance_intervention":{"last_daily_sample":"13424783179754410"},"policy":{"last_statistics_update":"13424783179303408"},"profile":{"info_cache":{"Default":{"active_time":1780309579.728727,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424783179307213","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"355788142","signin":{"active_accounts_last_emitted":"13424783179220588"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424783179288016","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054708"},"user_experience_metrics":{"client_id2":"1b6caa5f-95a5-43fd-9ea7-9ec095873de2","client_id_timestamp":"1780054708","limited_entropy_randomization_source":"12F248C2B7F7D865B4A27DF20C7743F5","log_record_id":4,"low_entropy_source3":4429,"machine_id":6709466,"pseudo_low_entropy_source":262,"session_id":3,"stability":{"browser_last_live_timestamp":"13424783406071323","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"1CD3BD2987A0AB7AA40A80A9A7CB5136E5F21A37","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_3/ShaderCache/data_1 b/Covance_UCO3001/browser_profile_3/ShaderCache/data_1 index f8bdd0dd5c1be977015d664330c3bb707559cc1c..6a02bc5e97665fbe3e5e6b6dbabbfb0d44c6c278 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasMu~}m`pq1Q?Hr1XK+LqALy`H%KLD-f3R?gG delta 31 lcmZoTAkc6?V8aasM!|`J`pq1Q?Hr1XK+LqALy`H%KLD*$3RD09 diff --git a/Covance_UCO3001/browser_profile_3/first_party_sets.db b/Covance_UCO3001/browser_profile_3/first_party_sets.db index a9287290cc60f79bfbff58b8ae283cb1c64e6268..beee181b190d5b7368cc425f15d94b89825cf560 100644 GIT binary patch delta 73 zcmZo@U~Xt&o*>Q0GEv5vk!52-n7lAMvpj!MX6aWx<7NP(E delta 73 zcmZo@U~Xt&o*>Q0JWvpj!MX6aWuy7MlP7 diff --git a/Covance_UCO3001/browser_profile_3/segmentation_platform/ukm_db b/Covance_UCO3001/browser_profile_3/segmentation_platform/ukm_db index 84259bffe86548f9cf429fa048d26687162c78b1..cf5d21ae9dd1162d1668a8da32f996f49693a518 100644 GIT binary patch delta 2208 zcmbtVdr(wm6u);b`vUHFP?0w)zHla8-OIwVTNAQRL7t29FttQn<)P@p7Ox6SGe>Q7 zyE@}5A2j773-oF;79{Fcim7P^ty$XGW55@XG?q2?-OsriPXG1KIp6Pozdh&N-}&us zQwP)3!L$a1FdF3{UKuiRxVl&Uj(U!Ir0SgN4OOc059OhQ-b&?oyGBhZWD12=E2E|y z^xa(>Qh}Lm!vL$2V>MW;Wqk>+DfOxVJ~9^w3;QoMmBa)2Ll}UCr+IcWmhAi(^N}kF!S( zq24?^WspX%(t!mbPv32zAkptRD{|>^9XGYk8}d9D1}TV)e%x+UV4o9HqGmguK4s(Qy+s3qdbfTHSo%~iNn!# z)P+u?Hq?Te(I&JSH3;UoWW@JPR#uYLYJwRBE$&&|U91Ge<-|xpR6kk*qP$TO5Cx2s zfT&P}1VjnKB_O_In9w&lluprro`U=EE9`>`xC_^y85Y1T@WVEk3m0J{6u=pH6LMe` zq=63_!3^zC3s1vG;0C>*)Agei1tX*Beho>-V@dMHkW?H^5*I}h9VsU2LIg?6!{rQ3 zb78!DDnAv=LxBJ(=rkVUEEJ*Z(1`vVk083{|KPHNZLuM4P|` zTVNa#IGqt|m>pb3K6pMv@poVmOImVie{)zjv61Wgk%REgXV1Fdv?Q5$Fc;q3y_n zve5+g0dDa<+ZfL(DMbMN@Q3F1zH90AKX2Q~Bsvn4%~sBk$Z-a}H7QYjWqj~M9x-a~ zxe}AelQ}qxDbZ$3Hgk4|iL)ii#|1s4sYE~b7O%QQ${8#Uqrqx5a}Jv>!D_L^2TDyf znAU?Q`_HZ+-NN=)OKA-YMHDuPXo<7f6au!$7Hoz_sKRC_5{At)fcS0F`o#HJ$@1cm z!H)nQB}f8d!$5xB`dVCh9R>H`4*UY&!zJwd6L1t-VGrzpO|TAEE(gAKrz(b3F#)tV zW3Y4xk`95GFcTLND7X$6@W=1NATHR03wGmzpTRK@a3L>5h~{TlG0K9;If%qS{!EKW z!=gS4ZsPtQzzV1Y8%#lcxIh$ahFKsN%(`=kw;c;jWkVS){iN){;=?CJ4iXe%T^sRzOB@75lM51vRRBDy!1z^}a0Z@0cKy z`+l1{u!HY9;gS0WLSJj)b57z@-+}1a{Hc?kDBqn)Q@ay%2F_?mHtCa=Kh^91(bs#k z>u?jl!5`mPG~J@j&a=-ftE_y{>e0IjmKJiRDx)jIo#sijl)O-%HKQh7pJsF}HO5za ziaoApll9Np=j-Z|W>w}nj81cTZQcy~;YRGV7Moa%oIX~T9I&d&+awe^Xs>c<~uqUPb{gauFZCOtQEPL zMu)4mG|RGNy7{>h-6Cg#UT3paSGh~)PtPwjn@US~?{{NTvn+WP%POpedb`uTEHizk z(`2kjuuXf>z0i=!rDYZ8Ru-j1u^|9JQ`{y;Z+;=nStwF(bs!A^R_4Y>35n9ih@!EP$xEh4t&nwk( f{CA@{!^`}5Z?`;CYJ>*=GDf@~*eLW}31R*L;#%5c delta 665 zcmYjNYeXerMul5Rv;41V&?aF-N3`Lz0CTB2=)5pv#X<+!(nqQtSeY z)m(2x(!lCRs36W>3X^6-S4cym5!IqVP)t#CL50wTUW2v%J%@9i^PJ~&#l^0;7*!iZ zv))E!<960y`K@ENO&UR)uv8yj>uy_N<(tps5Ph=c(m#sU6jkIvPmxbFD;X+VxQ%UG zVHvAQWi`V?@B^PPfUlUrJ**&&+eqOClDLY?NT3rj`0)rH472=W6`-C9YUNG@4CQ=l z8cpa_e&Ie!u#r2xM;uOgl?;N=;{k!lQI6EOP#|%A`Y(@ciqEr+H?^Kj>wa9v8y(S{e-b3w4MRtYH=N_=wlMkO@3S zl$UT5G}x!5qkRXtCP^@hSG>e;T)D`VZ;|Ah5zyqYo%0TYWxhFt3uuLdv$xR9`C{<6 zCff9LV29dC3}lexRpOa2qlw8c^bf@p85B;5%?5AYnA&L=(rD4HUDH;{4dL)PHW=R~ zNP$(i?4oZbd{W@E#XU#sCi%2H3kRK=^c4h_%I>Ci+Dc2xO844#?U5Scn|f?x&I zt7}8Vh8-0JQ4vK2y(%E$1uI?)*zUy!|L-$%p4~ZJ1Cz@^HmjsLP$LQVM5ArjYqe*5O;?K=$^JjB`GIc(^lfzF|+ zLkFi8ddfY;$*Vv6Vr%mr%{;!;$$9;fTeUjN>nlWAOqr11zSV&K2ryuH|G|R?&TrMc zGHvJuLkA~q{L_(KU47rZD-Lz*(K#zO0jM3 zE!;Z2RU$I^7!=qMBIoLyE$Nd#E#8vu5n}!67bdrAGuGoP^ZGp5zL2Ll>6Jxok`q%L zeZ*xBag9T)a#%^Ob~whhI-;cKi1Rybz4Fs(xWDn)v!3kqkE6$(j{9b9_y63fdeOyi z=86jwDX}!bDM(V(UX$6A{(uNO(+scIJn?8}S(ouNa@b~WAoO|l9Pam28+CtH9{-)K%J8vKK zVC%&%p1gg1>f;B`*>csG(BKi@UzmDHzxgM<*165jmgAqw?~wgxw?p~e7X6sEYHyP_ zJ@dO1R2+A4)fub2$F&)=sQTB$RiFJn!MX90cM88M9x~&=Jqu6v?{K-ly}YE?luKJ4 zwP{r5!Kah1dhf%HtyXmTrP&X|TkpE(gv`scQ`fe>z2KXYU3quCv}IcP-eCIf&%U|h z+BJv9|8&H8KP2?|e#h6dUml9W-xLL($`I9&JkP8WRC1Xu7i1I#{3V|8{))+HZbtiN zxo3IEk?QAUU(i$RDF}H`A)2Bhodh1$L0kAdk2_FMM1f_UjunRLt36DSzqHirn64+Oi#JDz(c`m;Hxbh)u9qkmd9OQRadw!W_l{Ayb5oq zfRNQlZdh$jA}512v0G)KyBSuM1xhYj5a6da++Ayg_m`CVgPvTJ zC_g=Utgu!-)hBQ2BPRGmc~!mwDt@9V3LmxWRQ~eaGsXt|Wu+G=SN<#8+{u8;qc;x9@Wy1(0iZ+fIAhm z0JIB~4dv52pgB;$4R0!hvzZX*K%j3yVRZv0Rxh>|Vipu`4@0<*K^AvFnf5>mWQ_?{ zzX6zEVSd-^Q0k53zx;xe+P<4|)-`lbhWyjjhRIgcYO1K#R65LaG!oQU!`7kaJ;iLIK)qw*b)^ATN z+Yv0?dwe2T(x~Tf2$Rq5T0TVNpAm2ei}FIKo3k^$!GeIN)a@&%QXx>}BY37JqaDP5 z!c&_$cS5V5+bl>Th|(xLLY!yt**z8>1;r_0d4kGk3M`UKc*U2CD}h5#htkmHmIy^# zeK?n2KIZm!u3Yerik-`^5Vsk8cCQ2H7!OoqW8B{2vH+tMA_V~%Zy(^%(<8iCqp)sQ|3#icA;`Q+7}A=ORMtyWq|@u zepM+oy!EvQTn?APFPFn=w2RbUFg|WOrh`A_z9&wjWH-IO?u5@01-F^M7UzDvk>-b%bny(on?LHpy!V> zmVW=;&MgC0_3lM|ESh|2dRctyZ^X(CcxDEj{$V?>V|FW zX-ke(`NsK-?osx~S>Qi4vdx#2%q71ThH|O~F`P&~n|y|(;Ti9D7h-9x#O;GNR%vp}`wGuIF9m-Kd&+IPauPyfmsDLk<=n zQQM66e55bVD02IJp5kaZrS_^1($(XoIIBTizgEJXcr15*KE3|0du!-~iQ9YEkh{r8 zG}36ea{a~L0unDRp<3!_Tl&@L(e?Cs{jm@D?hku@O%e9~t;go)2Ve36`6EL%wLi?4 zOzonjpXc!uQr<@gCGa;D^jGqi#)v3j!X1aNq^gk|NdIplQ-hP#))Zc#XNI384-=F#Qb$$+2ejLK& zvwNPWpbU*um2+%GsVnIAIbA5S|O_+TntjZRG;MR&cLOQo0i0ZEBly1OU@Vj+H<;$%jB~=7V=6l$(rdc#uUq$ z?XxCa==0q(iXkj(o@uM+Nj>V9&kfzrxoT3$u-}yzo^k0kR$9Rl$5tm+kx_3|k9x{r+O-WVF0A>2wFG&T`N8l$Ej&oES%VW?`kw zS7;k|W%abzQy!BigMYz}w`tpiSoU=O1N-0XaxJyVWGG*n;L3c-)Giovc><*YZ_txb z1xN z%nqtW*20Nc^W;ZRYrisFHLl!WP3=`bo<55{KKb_+{jN9hFy96Sf1-&hxn&14{UvU% zZ=4^yAPVjM<@Pwzukf7tV)(A_o0{n}zuxqHDt-1>jho2x_pbl>-E)>N8L_SpMtI67 z91daf*}dlTTlrzNRC;@|JC5|1WDOLDUS7V~e17J0x@^}>Kgywj4g0gT|Hmt?3l^n= zY^pIoUD)*9it&B->`YT$<^HCoxH8{jN30xAi9b-~G}_k4-${Odh!hBzu~MIBA5V)D z6b{A{tDfAK7Pw}*5c4@f8bi=X!sN3%2COsvG-fUEs0;~UUP?-=yaJC8It{-992wi_ z@>ycwp*q_Xq>tZ*gG+j$7_1iQuV5KrXlY zY4Qid@<{?dDqcz8AMjqhl-&B|1*c#9QlDv*pJd3Uc7*wosa+=KWdy29Lr(0D!T_W| z-jlA6z3j$KyzO2K_)P@S7@o#=)c4T1iG-63!Z2CxZ==Vc_H;NX6LcnMI*1DCRiH5F zCD5m!Hh6&3KyyJagF2y5RDt$`<|9LnM}~Y4`nZ`8|3U{a8UWshLgrCSBKDwg%umAH z9eUtw=wcp1ZQh*%c|mSG-mFF%EZ@?;^|uR8_n77Jrb07V+INxsat*byt1d?T3) zUkgE;e)vQc%ms_$9hKfr*2x3F_2aMWTCTsbiP$jW$G$Dct~z_-K?neb@&>a}>@;Q8=GP*+>M~hoQ%P1cK}g zum>^5_w^ED9>AUgux|kDX{REd(a`Zv6k;}X$-m5mTN%pM0_4*&l*vaxuR(shQGO4h z9QJ_z?hJ<*Rpk&%9&w27UpvIlCnboJ=O&15?+rGGE=SgMrIDSswF2l$iZIYKo1CKzR#~$qc+$&37V2+(@_*-rR`WjGT6_tb z18K;1pyy(~#g15d|Lw=tW^66batEPRETAbv?qpUdtVRef2M2(Ip34Oy8_iRV^`q;v zvaj5ieq9Jo(y$y%KD(3hU(OL}`sgYxg^EZn&$tT9X{=L-f*Hb=SIllzwaxUci3E|?iz*QyA~y@iDDWtL%1g67nRDQ_Z`;gG>BIGyY|^hXAAfCz^y;$4M7F3a z=W1A-?wSGi{9>JCCHUJW?wL*@5?)>Y)Vh?bm#gPi{;3^fKKaqj%i?g%joo+IupP|J0|#-Kuvu#Ela!ObzY7X7wf31E#>8#u?1VUz@>mSanjWgM-u$kqLti z_qk|Xfv(!7CrrYB8e_Bv(Kv&~mgv6ac!T;lbmJI(tM@8s@o&fFohO!4*CwDQa{G$EnZiI+OPSlstxQpaMvY=Zml~F_9U#E7h~;x zu@GC=V(fGP?d({GnDH3q6=@0L%x@FKvK>uCm-fxXGmkVE?{7{N+iq!X8@E&g2R$FH z>uiUdNp3C>*<7~u_4I2eJU?&u&~Ec656RFoH^G(plBr#+{+ODz(qea2cHtOo-d6gL z>_Ygf266gRht!{b>A_VS0~J5~WTwx2EopgMNBVMUNiS!+kv_5^^89p=!gP^71$Y0ePppGAo~MappW*B_W5?{(E4#q@eTcC z(tS%tn>d)SL6En3SeVKV`io`a&TP!`Lmu>*mU?qy0Bgfo#E9x6bh#V=9x^TvrDx86 zR{z{qJo8bzH&0*w?yxJ!BMixn+9l>orgo`&{*yhCyFHA1 zI_|8r`f;cJI?cQ0*5SX6wg57Ir^UC}5i5S&Q|PTb`K|;7P609Qy_o3h=~9|u%bnVT ztdaNw;{uUe^{vZfyPJq`Bd7oJP^C9foL+hEvsblouggp)pQ;a_d}qGmMz8ufO}%{* z5%Za4oveUsW^7SBK&pr$J7@mf~cQD(<$3x>TCLdkX7=X zJTL4UL7PFx;Nh+U9ft}}`il-|_#QwTyd91Dr|8H#Ba$D{{s*(HEtYY&T1Zpg6waod#oy`mAQU&p_G5xE_;tzz2pe_rTb zK@SZ>ZB~0+nJ<~zWr8Q<%$$(t%=87b{6Q>t$?ZW>3TaCx`H3Za%Oh=Hp*96IBZmMf)?`h*@tRDTchzS+pC_TipKg5b?niIpX`A zQn7B*Jz~Y3{}j)5&2vmX;h&C<<*$-RnzDTLdbzv4^4%gqc)N-{;a|kdUsEhF)TdMV zX1-)H9>xWZRDWP7k5cn@vcO{zh0|GQ0odMR_| z0!v)7Jkq$I`Q%48HOiwLra~VGPxX~UR8hHqj_Nv%x2ZhR*b7xvjx}jqN#&BpUj%(T z=mJm$2-Q|R5BeI^3lb~=y#b;ZYu^G@qXV0P@_G>x*@ZH@6p6fyM9PuK4kU7PCn08{ z?6&TXJy?B(cpYQWt)no8MFm*o!PpkHx$9lnOZqy-cE6%sOmhg57nj3@NSEcBb~^sR zxIlZ6Zpz&)q+F+BjJK`)wB6*EaC4svzW?r(-&WHf7$x6?2w!od*BWvi9SnI((5orE zI!}jV%9$_(@a*mI>>EJW5K(7WFJcNqxK*M?^>aPov^5Kw01?q8A$m83iQHRkO z9KxWU)&TqV5#pItw8a=#4o6+{W5#uyC0Q7y!+H$tW>kQXmPPre;v z=zk&YWQW)Y1@pEGA+tLi;;0WDqW#ecqNO`QjCeXhwC&VHbib^L$U4|WEWfs?2%OYR zEc~pQ`0mN(Qhu@IydH8!7Dvi29#h~kBkKmM$0UeH7C-RP&KCRN5dWi8Vkw-WrN0n&H$kpOC9+H*yy(8zHn51F$t6h$_Gsb zO#z{}OI`Xj*k^;z0i6pv4|G200?>4j8#Dt{0HQpiGQ1Erw-eO>r32Ysk>77L@PV_#$GXpQ%Vz!{P2e$G%6#~+6a9KzKzs(yT zk;ug*{qsGgkFCw+bQp)pXZPB1Ou{~dyeb?UQG%KjLhTAtUQ>R=+drV`ig_*s$#;nr z5A|<*fu9VO1A0Dl9d9Z!{gdUb`yJ8xU@IyUWY8VR_JR45saS{jswY?>!C-(p8B*^bKh z$+HX9##-f+0*msQ=2^+8kgPxZ`!$!fq&Rh4OW;mC7l>@m_vt8nyuR@Bha0K~+_~{p zI7`Fj(&V!{y#kI^^I)*F2y5eVc1TT(s0MMpOrk~thSN364Y_4KckuI{HmrIMU8gjJ zuO(12-(p9sTFcECZy*@5r@sX0Q+%9$6Wlii>FeRA4tOzqLf`&hasvF^CZF9YKQaRt zn`UE>TH-G!owPm!*5#gv%1~eWopb)Z^p%Iwsi~8O(>M9-uBAUYFFl%a3OsOm=!0~* zJhVQc>NvunyJu9lbx0s-2vNpu*Hr`#RYe%se=r~}mTU?^DQy^m+Ens&zt znOUr!mi`G3^CLj48xzlHpWN#Jg@rS(thCf02#u#xV{G|SO&u`|%cT(aR4EUD`2CH? z@4mtHT)XogP~}YFrgcQ-!>i3O4l8|s0P?V=BGRAU4=2(f0H&_=PtLxu&&k8ze1POd zhHR1p^CeTe)SAB2RgPC6sQO9Y%W&oL8IA)-v%zQ2zWt@!f8wMR9)~db>|Q&Ld=C!a z2w-bYan)p>+Xf1ObzEsQK!T}DKFyW~|MA#}n@=$1!+aG(^jbSE^k&#bgrROsTzbB( zH*m#lr?>7}wQK~P%O=qiF;J_mB_^@!>;wJm!8>G~%B zrWLaRSgQy(Wr5A1nKU~)manJo1jmc;Z(-xEjY7goNIvNBOk6fqh4!bv~ALwKd z%`IsTnE|3^h30!SxS0*A1YHH9Ht`|QdeC+dHNrk|)hk5X{!TF3TlO-Eu#0{>ImT3BIyN`Hafln$8TWw$TLtm;tWT?KNY#w61WNMcQXO4yj0sW6JG;s#@IhSLU zYjr?pVrvjK31Ni?J5OfG3T$nDL3mq#jUI{cxIko6{cHy+1;1iyYd3Di!S)Yb@!Zx2 z{zmng4EamMmHCpXU2?GkN*j-{+K&?ebKI3V-hzOi=IB@uEud{L$}?55zuKPAT%0hQ zdWHj}7=q#F5?9^SgvPMBXhbS^wcbc>PddJw>-lk#GoKnG7<#UgaAm$^YL~n@#ZEq& z4I^jSHafw?Q%x-O_~f!0_PRvQ`#c=|AJrFbCy&HEwUNo7uAm;EKA`>}(z9iPs5zJp z3VZ6@#ON$l%@pkOTlz zA=GvNkPQIc0N}A>vHk%7O90>$05}%_h5*2^01%um#Nz-^001Wgz{l&+Cw(Ernk0vq zkm(TjU+NG`-^BTu-4nz-9M#yX2@=1hi3p}Q6;CBK6TdcVF7D~uLX=;TC_YbVCGuOh z5ep}^6>Soa6fchIC}wv`7EA9v7Vow75QUfY5$E*jFGgk#7bkVj6nFfVE7qSeT`ajQ zASR!>ae*K*bTamG(`PFBnAhI#{NXF-?tXSJjVQ4{8$|V#`I4z!sNBe*Ag#3G z&Qn^Ws7T*Bjzm&u!Y~eV96c2Z&cLsg&4W+&*#4w~5y8QH6+`rD#}O^5&M7$rin|+I z`>@2oVanqGl&mLA53I@z^}5TH2lJx{)SVs2=t{gcN1OF(2t{u{`%G71Sso@1a{V;B zxLpI03fmvWm)b2J&l4BbN{$l~VN)HZ zaSydk)RvP?d{ni_*a%fmmM^l2C_EXm2{-?zdnVk*H01uDG#nqN%QmNB{wF?%VLy#_ zqXbw2VH6ItzOWnhab&psP+jOEIcndcbsOPv*`qo}_j)~Hzm0aoB+%HNMav&cj>{we zZ?qdFz!F%38=lv#nXb4lSX5@raT>W^-~H4F68^d14;l-QA%D$rWxix;7yZoa$Xsgj z?2^b>g{I~-HnGC!2mC$JM+%RE3&>Dx6}&H^GxPzP~>f`>tuOln08`2 z6Dh4=bR5+))N?Y96X4zlvj<(s5j_%5Xl9PTtok~2ANA@sZD-Gg}{`WQ`+p5QIk#iF(1KgCJy;IY3ukT z&n$c_B4DkSW6lg9djCy*u1SQINl%n`Y)p6EP4~n1x~===c*rIk`hPvl|J3_NdH!c} zMsJU^W~wsbvdRUO4@}o=`uppzTb#ade#YZeZpf(egZ9|sD{l0fUxYo zT7Xm{AorWwfrIjfO(Vn^)qoWzXlHVo}I!#TWl&+p6K~eR8)Vu8E<-D z-ZJr>bIo*_Z>DR1FLOLLbY!^YS0kL(TYi>ac%T)q8aB&eZyb1Dz5cY9FTQNnWt^_U zg_C6rKD*b7#{#fYOMi)1h2nfbw^C!B|Jym|2d-YykKxPmOr^-=bNW-f9_($iPVsS0 zC@abE7yIco7`YK67+F~G6k=5Y>gkET38+uy9$CZGdm#ivgh4E){udG_T3%v}v)Yx9 zY4OakuU}C2SIVt#m< zUzc(^T%JrmyH9YJduPcO56xd8USYzkwCa;F_{0d_daBf{pA5+>N+M ze)X+uwtzosFKNAjpwYS|jpt~saukSErRAV7Xb0$c0H;HQx}b6U2($}@;uK^^G9tPI z3c_Yk4Bm%<<(C*lx>K<4@kFdoj>Nw2T#P46u-E-2tj%r0Ue|UGaT`uCZjJ9gZM-Kz z48vI%cYWAY^v0&~yZ0oD;>0%M(wrnwe$-K7-?v@G%xn7yl54DSWhvqXl!*N4p317e zzP+aH1+QJU=4_c4aFX(;tH~!fGP&5p<}Rp059tjQ$^~wsMD9nLB% zc2h%uqrW`%eOSV0FSmrrtUtTI7_q%@Sl8i%nGBT+S~q0AWNH`2rO?QV<1Y@@hQ>aB zSqMC2Tp&s(*88v*p8Umk)vrB~MP-5v`D=kI^CeTeSZj5WVK`dG8J@tznWHNUJhHzC zD$ly!JH>C83yP1_A?xFZoQ`+we74U|*vYR9*|eU?e2X2iOdR%n;j{RZ)L2{;SjV*{ z4qV-uy*+sCiGb(z5eS zT+FxNM6CF5VKN-BUS`DmUU<#Z%4fUW_Q!#5T7Ia<(1YLoLHNm#P5H@u$G`>EPW^Igds_c<9gDuW%*4ff4U)W#57#*CbIU6TcuPYpFdbJ)pnhCeKK${O zmCvp`Ky3yY!bj)aF<&yZOMJNKqy%|}gxV30@L>>_v-NS{8o%$P=iZ%hdOH&r^EF8F zHa=YPlyvLF3tM*D@J&ZsLUM3{$c|MH&U>o-$>E=ePBHN@UxLyu@!`wC5Wy{v!7jnN zKj$e$69%#T1XM=#;rscki_1@)aj3$?$9#%YHx0&@;V!|e;t_~?xmy+ozPZ1Se9pD% zoJ12J^L1==A1A)-%xr8i99<8D6)KiEn!x_^Q6W?6Yq+^i84sCqp*1Z_JlW?Ghipbm#=tL7CRnnBHTN zvFQ0)iUC@Eo3D;x)|-zGh}b<~WL#+v1g`G<#Va&U&dnAzHoQI++}>$VH; zD0%7Lk80pz{^8-u#yJJ*L?LKcqM3=v!XU1vyW_w&cgL?S3VuB!V9Jg8hlh{Oc1KUI zCXY6JdcIadyIWs9*p>73wU4&#c&u4ZnSXfrs2px!T|Hkyn zCbWfB8im(UgU{~uv?I}Jg0n#G;I*a;k@p7co4?Zf6U||1Zwl%BXdc@hgz2Z;U)BqD zDku#!26Pq((?z+ivkLb6AbKGT$NP!Dftp|deHo}bp1rnxw7cVwQ+UC!F3%TKeu3zv zVL6$6c5kqpps0m1(AKV1UZi4k!J_nH<=@W>o?laTT-&cXUB+ed*}dVoI!4tz_3**8u(VK)^oX&9f$ zXZMEVlld7{H&_v^hRyBo_W6p*awLT!t=pA?zbE|*xjS@Z(u7-!zMGz`e5!IlSCh}~ z4adpv^HjwIT!e@T@8Q&2T92ePNYX)d2lWLF0*wOYg6Mf!|D(%glU!+x&I`yN=`R+7 zpLF;8_u*DNmau*FpbviNLHA@h|4hDet#@2ov)yv4^Qq6m`?>`fNSeYKg^25tOEb7r z8ouE#2loxi2{!)G~N z#%1!^J$_uJQn$n5bX(CKSr7J~xalcq-j!ioCZFBo$2H4?6(6NOL14ZA z5Lc+!>cX|C*Y!8e7}L8Sr^~oZKD!?lu2g&#z9`jSo8EO<95^p-(X8$H&$qgtaWGDk z&+hT#^wF2_SjS_N->3yDwz}k3HtvX#`KNTJ>LU%~GWqNtKQ1@M?x{f>uvZXDE%4wI zA`+y>ib$`o+vC8wsabh}C%naybhOspUs(y;tYKD)<{uM{Wy`V0KUso3p>X*hJS zWWpfEH+3O#>hAB)T$9@I?LYIrRX(HgGx_WuKR&7-H~`99kc#77e8u>16m|Z3z1SZI zzQ;N_d%x4~;2KV!C`uqx=Oq_ANS%WcWk#Hm|u9S)8;>QL*xA1j|x zxtV-+j~`bsSS;I<)Iw|LiX1cP{YKg~D%QH{#fA$`xW(%la3QD9ax?kt9zQ-RcWCp_ zrl=Z>110d%?o6*LfqMRKjRWT)*TX+va@!y483*Gu`RpD)PJBQkbq0OKP1cMsBH;Wj zy;j9mm;BOJbRIBm;1fS2SP2s@T3=4`a=K6>R# zPM`6ae0Gmter3TKsRc!TKVI@o#j&Yw6+;*n_hG8b)#dArG@X`)@tJ&fj~^fP8?-i{LWW_n-1;n5yt;5*esRu*=S`B{jsKwV7cH{I}ZYH1IQ6uPQt>bId7>gK?UCc8?!tFuFG&6?pzv-fujf4sUGe-NXVw_-OwH^DTD7 ziXWdEZJ7fHs>+Nn?Pe8iUGiJHaqV%$+vv+@Mcbz&Nw&$PC>5=1+S$UB+ed**$(-rS2*kkJ_h`Ho1l4z?U6f9%?%H zp+ruf@tJ&fj~^e6`=TQ%y?x7Cs$#1vKU4O0xOdv13#&O@#%1!^J$_s$UnI6tFJ8k6 z$gVfFPGH;Ybcz>VMM@kOIfaBs|(jl`wx!&eAt);oG#1F z*K(;Vc682?K}K)2B**XOg_8Ek1smk2o_+vYi;z=^L45<%c)C# zcTKqA!W+5_{THXt_)I>#$B(bbTgaJ;z+n)}?LZv3F8S{3Qyw|F$BCRS<1+c|-Y{H7 zrXrFsi197EUBz0L+|KQgwe;~TZn9=f(fVNWRZI<;hZlQhVIz5}+TM`rE}+xL?Blvo zchryXp5?7x-nn90DyPr#Gx_Wuzx-(5I_b}FP;zPoKK1R`v_wNtCl2&nBlkS`@<1+c|9zU*Vy{%aa z?ea^$vwoZdo|%zw&bM2pG7iRR^4UFpoES%y&hWD)L+^Lj$AN3xT7O2Xz^(^5UB+ed z**$(-L45fxbw&V3hoi|$Eek+vN?+=>CKvj+IQK3Uy9*YjA8Xw^wcY6#zq|V_FXLdG zCZFBo$5}4*k2;>+ap3V)09_c7$FbwKXHQ_PEd8_2XQ2N0ZqV*RKARaWGDk&+hT#wDh5omRQ9QhQpVs*iybYsxSlZdDWdXMfr^OXC|NB z4;!DQs|X_^mS5t%D%QI24Y?=%mo=v!Ak~{REI*Ua?uU)f6_k4c^m?*72EKtvNI!qH zYW**P<6eHeJEzb1Og_6GHa;9BXnj6ME^z2Lr{1Sx*X3y9{B`2y`~j^Vwnnbed^Y+2 z37q-Ri9S#Ex&-{VG;njwZg%*L?8DbC16`pVMc2CZFBo$5$c0i;)Udc!9Q1q>t9X8RKD);+ zH$x8|@RVD-Z*;Yz4eyc%R4R4l^Hs-u^i*o|6OtGY<2Cv09zR~a|0~AJ%u16`2qgku zCB_U5VeLup`g~*eE1%JPH~H*-czD&UB*t=_O>eY44!pO&`sv(m zuN^~0Ng9@~$!GTl;Pn(1l%xjf3rPqZ25~v9v__?M$?>OW7B;!+hogpZx{S-@vwQrw zqWcb0FZA*w2)XM84~-Q&ks6bhB5y7}adFe2b`w?7VC z`(4Q+?>%i?7N^U&Og_8EkBd$tMw?TN?HeI?WC308R~A03Vy#PVU8+BLaay-$_Hg=) z&*Zav{P-$7GoUeYm#V3lKCbEiNd35ec)fCEC;yATbGnSnDXtR2^p}6#|&LWL$u2mYKgK?k<4*jj_c#VH*&|fUtD+e zeeF4Y#%J=`J$`)A@)%HO)X8`BI3B${pZbL2)+NV1UzWag$<`@naCpXP^4UFpoY*nr zO?A&e;iRy7`;+*jimfhOqtlOiW6w(q@8@(Gm&s@M_;H2kgceNy@C}kkNu+=BV+Q=X zv~4`LG7h}W&VS{yyTAGKEXKolO+LHFkC(<1L2MjE|BdFI!>_>&*O%!}DQ;cz{Ak{W zn^Ny?@)L(=d?ugWvKPK}TFWd3swiZ|l=qxE5iDMrY*>J9o1LyqCKQ-NW{^T2#T%-LD^BEu8 z@#7p+T2Po;{kdwP*Lu@3+7FrhhU3)d-B#Jf$E!TPLUf|h z{*&X?+pYC+;J&9#kDWJWUA&pYvwTfHyT>oz7`SoP4ip6*9kyN`ib&`%b(M#-UO(m! z+V`F{B8cVx}iZlBi7=3pVr^~oZKD);+FB-DpAj(wRyf@k~S~(m>#9V(j#eug= zvtxU7x!^6{9x2zMs1%y~hU3Lakn)5*`~FS69V~rO#afpy?XN@kcjVSK2La$sK3?o7=m(#6PhPv{7()AO5%zQc{hjFkxO+LHFpYNKU zm)@|&VJfs>r^_*My^6Iid}n^ObJIsp&8p_~8K22#_rHcOS}=8-tJka8>%uu?SLNos z`@i{)aWGDk&+dN_XQW{2R?(_afG7iRR^4UFpoc4VJ7_qzY#pP5# zj)KKt7#}=#7gL;izjz=Hyj!0c@@L}QADoPb@tS;gj~_3+J_=l_@wCl%mu*n7xnNOx zvGxm`v*C(u=g)d(2&c=qOg_8Ej|=)2Xn{*Hg$Uv!kob(A9P;S-ob`%|wJv>fW}`+mY;fxna#GV4K%Z{@2h*1F``v|Z*ypZVI=(6^a<6;ngz30R-Q6d{P2qt{;+ zv<*9gY8|B*GhfUjW>lp@nS?f!Oc=!YvtA=k-SeC`FAU|a`fx`Ly}QX*F*O8#ftuD7 z1L4d7UKdv}=;if59QaAU(|K$)5SH`TTFh#@v8j=Ms>2aoBdy}AK&Rs-nd}xQ156?pXF)t**$)F+VF`m zB4D{~jRRNnyDwVTUF1jRNsPM+{nsQFmgZu)S5cZlsD?fdGU>FPU|vY&7F*ct4x*#jZbex;wz&R@1H0`smzrUSvFiw-t?(yTSrOizB%JUX7)&u*0;%AGW`(LUH=^JqS`%^nXi;wb@N%nm>*o zac_A}?{_(VrAJQ?CZFB2RMt4B;NvOibjN#rfRg177Uk370C}ht6MgbF1B+uJk2sv~ z`?f@4tw5BCZ9qqW+Jf4Fl0Y;#r-ic)piUs_6gz{ufat8VZlE5Z-k?696G1dU9tau= z8UZ>TlnELK$_0^P?mUnOR01joRfDbp-2%EB^eBi_8OT<7c%_`oAj3L=P6TCu&I46} zmVurF?E*E0P@SN2K-Ym@2K@#~Lt&T)dIfZ3Q=|=A59-+r-$Vd8Fg>0RYSu!CrJx~+ zI4={l6aqRQ0vZAV9R~p&0|E7efN~+A>mi^oA)vD%oNqhgJLg9UQI;&koMZ4k<6|*a zKTe1XyW>2(UXUfq1D}7l5YNQrcKSQ`1LFb#zAQ5&y91yL7R_A(OKkq7)k{NHZOR2a zX{cN$pma0eVn?j;)^>x*LF_qjy71OYX^46FKzErhL@C(6FR&LlD1F8Ok<>WXziY+| zlh$4P(0dT4G~}Po<6yqUj#xOMIr51(7c{%H;{|94K%RcE1wACoqjHN1&NvG3*OW)| z1wA@;>UwHVPKa<2dXvxY>H|C^2ueC%eylB^1Tk^ucpQr3DYV>F$D-p&+-jE#ii{xH zEJ0;hJ1F%=O5^11*Oxvwu*ZH=F3cxCy0P%&x^kkQo^j&i5NK$Y2bWi0$Z|5?){rhyh494qes?U<$WVHFv(><3ez&O4HX$BfJ$3a}Wz9EFw9;fe%-5jETLX`oLy^yU z>vEZn=O$B|TsCbNVqc#{c`tl(eLqt!%vUi)uXY^v?|8=&j!plwQ^ivo9&&xH&zpCD z(>bH)8mpo^!0V23!+aG(^cu6=)cBrvO=PjYe@k_o(j#KS_a>j+W7!-gmRlpQQ3C%P zB@jlTrt!mo$=&lz{Cb~kmVN5S8_j=T0*&q2e_zIpDg56ffoeQTWIptm`fxvTZYWuIW4y<`5wUmh$vvgnQ(((`2)EYSFo`6`C!)jm$j3wcWO@vTW` zWC&Xgubln?BYktcxM>f*kN95V;=v=1nsK3DrBRGVm(pi`G-Y*XPd}pN$RQ*_c+tnJ z)w@)f+Md7YGmIg>=umw1wvns&`8j>&*PXt7oEQ-T0_o$`B*>XeZ8*qnZT>skUUa)w zEvCU54CPl3T$wMK+9kg6VHA-rmt|k7h!~HVFXXyzZFtVYZB_d@Ny0;@Og_6$P|IdC zAcbz&NrfWcKbE#QX1MWQKc=Sg_zPjS=d@6E9f;=XCxiNdpze@%Z`h}ShJZ+SM0z8r zN~8@niqthhZ6b9|q<RkBR(n`s|39X$HY zE6W#f*(00Y2V_3}+6<2fbMSJkT;Cd9iIuRRZ9Eo6x@0)rSmU3m8$W+|ZoA*dDW3`- zT}?i_*FOH4;GY8By!ys?WEf=Aho|jTvDAg<^ri35p7pnju`;BLl7~Z>e0HxLPaeHV zUzmv(Jg^~4ts1DInGC9rTQ|jl>-gJVx+VG04crx3{Y8Q>`HU;qI;Azo?ZX07z&SCP z5vVE+x#%cs=U7iDn|6!&3OqD`q%eAU8TGYl(@0LWnaVro_HB2@zwQ}hc~Ek~TA#%? z!*O}x#U^~skG>WrQs9xwX?Vq#i>D)9Jzk1)q2*5Nw|n7EhH#Nvtn&0z>fmlSz1aE# z@<&GXs|mv7D_0?E&p$#MEl1S|!1YOdqta&_)YqhdivEeU)Mo$KQ;Eq<*PC9r;+RLi zeto3XvD3Jl=3C6iUz@=P&O`ppbgW#RK7`QQ6jQr|Y zk&)P4oYA+p$Q##JoI5*J6kaz#6hAUVgx(o0F5Y*lSdf%177Z99ZkaSr+!>r8R@^*E zJo@w$@yv&3i*^4#U%Z}NAhryjCAOVCTkM|a7klpriv2HEhy$O@L%FRMExTWVv=@rb z1=or0S1du=HzVz3V#HT>i1fs}k@o#a`$2Ke>_HxkM7Bkf4Z7{$;QQ6uS}=Ij;${PVh4o$ z1ctjf=wucx_D=LsVYdQuyJ+SYRU_)NXskv$VVYCYIPAY!&Pi5!`%{EPQo_MZ8l0WaOrs^aO%gN-kyCo-d6CQ0fmtI{}fB6komJ8+AfjDsFB+j4y*2#~3#OW{& zlh5vXI3+OMIwa7U=?Tup>*r2aVL9~?h159Vj2*Ps&e1;F*HVa59If}2C>0bx%Z2kN z7mdk#8@5n!5=Dz!jCk9B40(};@tAyeuY0{a+8&ZTlJ=`moPMlz?oFw`>~AxmGitRm zlztLWGv8uIteAQqF!gnAt53`Jsg@`+9igj1+#W75aK-Ac#QwyLYZuSj&Iz+zOg_7h zrdKbi=L|Yk*G^|qUogot6Yn+_!INH2QhrdOYLiPTYW54agv0&DzPfB3br3LpKq&Wz zm@k>y#jY1L^^!JG$WVIyS!v)g<+1fg>R}R`k6&!}~Fkf+_S38~>ITCYS zI}PcOsZB27f1_W_U;I*+v)k=7<-&XwL-cCL5mR4j6OP{gZv9QgQyU&~{czKXf7?4_ z|GtNo>o@ix>yr_*RRO5i^&fyVmspO$E2 zeE&B~Kp#I&$CQ!Uaudn>djr#`+0g`Mxu;r`!UNk`0TFqbIyz+ zKW03co*8AcoRfXCeb}xqH$4ZcvI}Y7F;9DJ=pYgneHmJ1)Sx85$ni|IB>G z!S*Da2?h0BafZ9pJ;RIPz1I_T=8|%X-l4NF<+wuy_&&}o1k&YG{fAvXvGAll@LF-j z=70Tc;$c4HU^^zBF&?BJ3ymF5(w}xb+_z6h;^nQ>sel(x&b@1GvjrbfUr&bei@v+W ze96=Y;E)dzV%FCr)HVj)jr3nx7r9bj*^5eykL1+C> zEDII*m7Z6ZOWL9O<I2e1#? z;|>%QDJ2~?&EvyPA=^B8O&mB*Ui@pXUc>wB=5&siH^&Q;&+f5sOe&ts$w&05q(8`o zeD!>xho!Qr>vis5{%rocovxU|@eh(WgM`Uv_n7H>W|cuEP+CT2@s@0`a^b}m4g?N^ zSbwk|s0a&}msq$4jrnbV_4(8N@FopC2bC9-FWI;-E|<4tbTMAFmu+5^Q@giLOSix4 zV6E=h&tq8Ts2^YU-lTaGhI)SG^ckPYXZOE^k9OP#LS?0hOs{u+672bF*1O~(O~fB* zue81X#A}yuyGXJoJqYs|AKP)`wAv(nzQ4X6JX3*Z(YuGfe0IyOmrOj&XB=!d5Klx> zdV7%7#4e{;{m0E0o%#Nh%5yFv8Iqy=Y=$fIB~!cPc|sxdoY45HtjWb{6m=iWr*#oB zDIhBMv<_4R96f)WvGn`zc5dnQdXHh07dp=Ua3|ve(cP%@c5+`+B`W3bQ`XNRw^lE& z>y=d8BcJZcs1S}CeB}y#wc1d1mOp^Aqny<1q5sD)#Ci$p3{REp?riNwQ8PP^lywOb z$HJx#vE-)5-=nyvKYQaV^KUr$G){+cn0$7(SUEpNGYzWy#1REE+w1f)MmtTbEI=&lKX4SwdWTIo6vV zK)dul)`pI7h*zdK#DXUsVtU^MLGnZul0M~HkQ^ygG1IG(jPB`%KgTHh&aWJ3LXFGy}R+YTi z{1_;V2}N&r(-P~KN8;CyjktJbrxX(h^ErLCBRF!^XCbj4qR3wubY_$nSd}-nfOK42 z^VC>RTw-fvECsZw(xQh8_WYo@d|Y*_Y1 z=Ld%`e;@Uq4EgJYEAu5&yTsH>gQ>5p~b;JF;=&Ah@1^62mhY4|IzQQ4jj#$ z#KC+SsdlmBh$J6bztH8d-$>tF@5)U=KljVc_wWDo1Q*MJ(`UYxw7j*aZ(qNNpn*@l zd{lR^%fZA!5qB={6*y_$10S?bl*!2QaRRQ)SKR28aMZtU5k+L`_h?)~`xR)P1NCoh zKs?@~tl)7AwaH}2rl%l2+1ys+wuVtpYt@Asu8oXF3H;BOKp2IX+Ob&cd%U@f%Q-y_ zji2a0hH$cOz><3|h(}~qYhpK=|9}L{_KeyrZpX+bc@vM@GHS254a05ZUT?>!E2RIX z(eqiqH~lsKZ~_}&uWh?u0!z&KW8r5%jd&=s zKU9Tq)Zmj}GJL8KM)b5-%{kErr86BZPD%{u8}#we5+i*&2a@y~`gaenoU*4+w|!l1 zkdfoU>6?6ZkETzv{h&R4sR79IVvClm5C^1?PEwy&Y(L6A5B0!(Ca4b%=vg@Jk#&^D z?%n?k@BCv%3Eh)nJSJbc>hhS3uK{}J%Ht*tR9HSKfQ}cM9&FAmR3TR*V#=p@^b=4a z{8#t&K@}lVK;1z-Ks`adK)pevSB9EG?mHq~NI%etpp!tUASdW#P=C+>5aln)ohI`1 z{@hT|Fi;w3IA{cDBnU-N&>{yZf=&mG0=YoxpbStZXf$XHXe=lTlnojOIs-HwlmnUo znh44T(U^V`C=W!sn#mwiP@e^w3YrEw8*~onT+n%-^FbGYri0v|8K43XWfPST*0<>8 zy69*JT%!7nSmpYNY3o1j^3dP!mmYCZAsoWwvwO5$*IthD{W#FnDndG*199Man z=Ku2`J-RfE$Kr~IFj#K@nx=r<(>NM47 zk}=g|s>4)&sqRvprMgOWlBpMkys{RH|0L~2v0CZrCx2W%=2T;IcR=YF)P z3mjlvAi5)*)Xp6M@p)&hx;(gW-0xEfwlpdP^bQ7}-L?8vTX|+LIKYpKHtAqVDt0~4 zegmJWci4WWL)^K2MVmXi?Tq8b5MPNm1zuTT8s z@wHD0h^x2N+?P4kC;Ay3nezK)4b%96m$69}wyZMPj+nT)X>9Kf% zgg}=8@XdVuwV6E6EZR{lyY*ZwR?=4xowW3T!_WNmZn-?i5L+hl{nk)3q-crK5iP=T--XweQUy7^Rv5J;S*p}elg!-N357Q^E}0BoB9|i4?Trg zH3?$NdPWhJOE6xmKvxpL8a>7(^oS~|Ww1Curyf@~&h3Mmi&XD|D{jemrI|RH9|36H zGytbsCMS>xtK-^V53ap~n~M*>d2iZ+H|8{>_J~Xq5Xq1ElBr!9f~&}1T8cG1i7bpb zSYAuI)h(~}Lz@f#s=)eJwkIAk<;8prlDusIu8e>`7|fJsQ3}F!C>z`6LzOBQW zi_FWGJ@GH^k$w{&^Cc+l(g1vuJi)ROPnO4BPA@4@rox0ljBjf__@-|;LcEoC{JwYQ z{_qoxOUZD(V7}r;uMNPbM3-0LrOibaJX`xx*}ZQ0QL34vSDf})%OhWvg9-en`h6s> z%qKs(X#l>-lg7(aRizwpAh+K)$?e1Htc)&w%AMij~dZzrxAH&=SZMTNjR zh{0#~*!b}BuJz_z(1~{-gL0_tq8CN2Z7;Uvl9mlcpM1PCxm0d-~>j-PC>#F(U29zkR**`t&_k0jDuH zrO$jBsdllak7Oe&b;?sUEKYx!k-j-zJ%GcK-OlPJ>z_|JgP)(%XTFxSytSuqU#}w} z=<~onC)=OjOn>_Y4pDT*69+H)eA_RD?Nv(L&oDn$`rNS8{(ey;J8GOqMDdfTY5qoQ zbge;@^bsH`0rbBq2raj02BPtddJ4O3^5E^T499a=f&a^a{wHJmFF*SKv(bl<>C}G2 zTBoDETV$vXQGb^NqWaMe)B(hX+{utlMD>Yms!w!JHq|ep7S?~_6R~M5dn^gNZLZUi zoJbEv@~5_o@`&0qYTL~AjO44gXZR}(#liCCytAAdY;imd4)}i{!2e`y{|6rb|H&lu z@yMEb#v>%4E){*Nw{Ls&tgV)`sLULL+QEE_9kFOURAW2>rmnwp&BVf;SA8Ij^r}2Q z8`WQxNEdkW&KRHW9pDh7e`|VM_K&?@EwNIhI!)t4=3DHDWgnkK#-}<2=~u_G$-rTb zQS z7q25y0b{lI)P{4vYNo^gxgA$e!dzv?;@N#P{%e%L|4s>nQMhXxzw-E!%0Jf+eoCrS zY`A{tHs7*G_gxo2DXX}d{6 z&x+;c*Sx;)=)v>{Mul)h_=+378jA={Z3Ge-uJ8?gRgOdI{6s08u2dLi&oGA@?#ZbBAfX0dxnggV_PsJ%mZrs_Vyxxr>55a-!*RN?*2Rzhp{nE0 zy<8u2ysA%XDoj4RkIl%jjv187cIdv{a;aM{7t4??;pcSep87NWy|4DW=8RdseC1OL zp^^(piTRu!+tzDE)=Rl~#VNz>%W=>4SbSG;vA@Dom|jI6Bh%l&(sA`a)t(RZtfc$V zzmK+P^}5aXUHjY^PFLY`2$Rq5d7gr@fHzd-%nF4{gJZmbU?|65=)wEU@_kS1ov_H# z#6S*LjTtAVRNc@6mcO+#ky4t&kw8JEdtcf7V-?k=cuX8I@i)o0`^L>2;lo|AT( zT`rVYBpdyF0%z)Hcf6dv$0||L{9-<*%QnB)itQ4fVtUV2p5cj|ThNk>`tsB}!SwPiZ)>sPTQaJCIi36X#&*k2 zzvNaEAM+U(+YP}dSO0LBKuKvRg0C78vHX%;^_TCSM|S$PG8jC_>2v)u`RpDkSF+0I zV%-r(E{Ei6sQ9|6eV^7cq+egT9v`0f_cvztyOiVS^i4jyN79#{h{UcGEX$f_Q<7g> z`*|Fqv`Ma&2|NW0&CaUzK@?k!w&vtD% z#$aC-K6q;N4|U6DJ8;z}pKkM~`bK(wyp_{c_#DFIvwM8F?D8qitY1DQUv=+w^zOa4 znDSvhr_Xk6I9!D}*tJ$>HAXeXr1u+Qbp7&q{Fm214&J}+aZZ=zWAfR(LAVe|FV72s zhl~p(?~L*1`mqji?W&)L?hhq7K2=`jzFN|wGG9iZUF>?ph#plRa!TLTxN^IfIL3~{ z)T8bn=Mc9)bY;b{kM~;qprwq!kW}h(nJ**NE_NJ|KrtSJZPYe~ynd-`_$X#@>?>g6K^@+RW~$vY!I5+^&vQDb{Qm|k}FwJ*>DAPm(v z$`9sCrgkA5JP)aT-9L&bjIf+9>(P1;jtCyW8ioJ*`QT|Q?o2P4e9@_3+e~fzxXuUX z^Sp4@bO2}G`0{buPBG0^@E!*`X2Qqotn~cUSCdU+oGvtRm8_oiWg zY@6c|qD#`*YElswF6l=Y6yF<#H>7^YIP$y;<@6 z(-f8rKbOf@t~H-44_l+@TU3QO9*q<>qv;S%JX;z9H1xUX8O(N+)BSJSl;=c^rcna_ z+a&P+M}3J$MqHoRjwei`pGFD%wU*)l(y1r`EwEEMZpLxLpIj#2%H`8ano;Kar zlfIMRh^&O)h#U+Yg>a+c2`Rt%z4QL_$L{cssakI0U_QLsOidhWz@w+z|7`p7$4Ylo zo3yTl$;mWqkw%5U_oECxyKCuYdV}(tSu){jc;M$>e0X-hJ>^Iz5LAL^iF>(|+}=V}*EXWScK>E3P?Xedpd|e!GI_@#K%r z`(-})(T(=p_+;OBe}UX?J5W@^6F>LLIMQ`EH+L&Oui!YhlMN4;r z--lfSLHde7H2pCAa{5{4*8kkwETlmX-lp8q_JDeBReq^G zWIm_Mb|g{x-8An^PcUSCf;7E~ao~t2tBDjgc_bE4sgLHz!Vc;jkE!Q7M0i9+CvtoB z*4uhkeER(Yx+kMTIBM{ftF3*^bXNuCAx`p}ti{FBOEn^(^7>cjW3)e<-U~_s(Yr$J zL4YscRXG}VXHXXqH86B8Ll01IP#@5VASZ|#E;`qU&N4b3lnELKqB$c?M9%|xK(rUU z98?Xu26PMPZqTEkwV=%)I+x@-5D5s!P{}h$u)HQ9N--C-9P~Ws6Hqf`?#ZBYL5n~e zK!1QnpfX$x+6d~@REP^f8$o?h7;gc!#H9QxP&+8@?*X|m;rtHt09x--6sB=#=!T%7 z8;l9|SO{ni1oR{X)DFU-y#4=c{zqbIh=GV|m{`0To*EgA68H~Gpc?UU|GF@a_Hy2X z*AM+f%-zl~RJnBslh5v2`yFX7$Gd}}$)(Wvpz&FvrJr1=Vsn8d%`@ zdGh@1EnrK->6?6Z*V2b7P47Pj%569}BM09Lz=wpa04rg$Jk|pb#m{(f>llTLzV6xa z?I$lk^W)dv2HR$8#1odQoW@0eljpG-%WTdqe*fpNx?+s4;(w;Xv+ z%S#!g3gHkYpWSPh+n|_o3nL)QZ9ni({EP>;HRN`SuYK3-qi?3J#b#>b$0aw6*bC^i z$86tBfAmw*GJaiN)ic%8Grm~zdf>OWhpow6K*6L@AsoWwvwQ9GvdS5G(8}2|1Y~(7 z&#GTuM{d6VsszTJpk4sKmuCy|xm#0c^{c`%pZ?_hHG&&n2 zWM#;vr(u2+sk*COPF8u+#=I0lZ?{IpA*Yu2&2n5{k@T{eZf*Ry&M|je2lQEd}@bHEEGQD z!DEy5!IG7a_G^7^o99^`+s*O!Lr=#2F4;csL{FJXX%Hgot=8CV!#J(vwPyW%n2-l0Jt2jO#s*P zw{PD)_@4UiESGVqe0EP97k9**-cl(_t0jEt0bQCCJbJRqkB6ldegFHTU7uq4j8EmW zyM#}SyZimr<23I}t4ToafCo}H{~Z456%Lo>s(f~DDwk$f%;W9tf_f-Uc%mn(?_K=+ zqrYz(+~qnBm*uK_c5f<|m92kw7%y^qs7XNnrB7}7*I8?>AIsshe3j4ciu_z(5ZCo$ z#zB{E9=~lD(nE8?Gd)>-|HCU%_MP7HxDpPZ<*R&lSLElTj>5UJF$7_}82$bPWykZmfx;Q56ubB^knt@9VUKO@$>94V>o=4ukzVlkstln zO8+$p$e(q{-{1fGRGTLI6jZ*Qd_DD>*B_-%w*US%W7Zwf*y9u)z7cvNZK-@a`J@P{ zMOY7Vxl@w>j;k&kdi?kY#~jUaI383!yGIqT&+`_RV;39A4ud%TwVPu9{WH4HI-z9Y z_Ih{|hUKb!c30$P1$A9{JlF~Kk|>B1G6}Mmap>JU6DWB7iGjS z(7Q5@jB0y5e17$`)mOaMw@E%!`4%{Mo|iT?xdWA+U=X?p8VNye53Wf7$Ej~!Ir8f} z{@BZMSRX2%-J_o$#GXc)|D@Kbd$@ZF&gY~%SNV!;#uJ7|P9OcI+Uw=4_w(=n`qfD% zvOLD4^4VR+V+BHvm%0SxcfEGu^5yq!+{59se3j4cl6-yFtA07Rss>Z~$fXG=7$=CH ztjfuvBU6T6*L8)5-Xp^}RKD(N>bDzPZYef`O>l(af#YLC0yqjLw8~sO=G#wL4&zYy z>@Mje7pI~7)g&RO&!Q{z(46p0PgZ(3F2(ti>!;Iy(y>=_G8V;D;AngCAfm_Iek!_B56ubB z^kk)v-P0yNwEMM|6F7X9ukzVll27eLtOpPoR$O?XmY?+r$nSf?xQ;7M>OGsoXZb3h z-6i=bER5p?vMPKfldz{&jLho=R~Q~RT^3)Zhw226o~-on-eu!g*M}||3TI&$hstMn zOB|AXIbAj+AirwFz}f3|E_t8BXZb3h-6i?MkOW*<9bM)aj_&GYcl3V&$M7JRTh&+V zp*!J5PgeSPX5i^>EWUSHBg`fhc!uR#BvV6v; z^4Z;4LYHEACg5N}9EOosiE?$QYl6Fi3o^OCz9s?r{*vQ|wOrrD*tw~vE9&JlpXIV$ zfFV1N*HP%3~kgPW3#lLF*)oOz9T905xs#NLC} z*;o(u+J}8e*3w(gc(tKzsLA>_l^?@JM^0qBaKZzY)!<+dia|=qxFUqlY@v5$92*oI zsc=`vr5fwIo<4BNGtW@kB17>*>wcIon9@&yN5PTjEp=DZN##N@BfM1l;(ZxM{&cfG zC=C-9`CO1+GwVkG+4py2raKl-%$FdDM{69$o$ff#N541PjAJWska2?O$?Bf-J_Thz zw!dQE(X>v7483CbyrF;x4HK`vDMZ#s+I40e5zG>h&Wf*1(pFru z?h6WjL6?RR+n=7kkaR_ce5Bx)`GP6^G{GT~3Y~1k2=tf#C-0AH2a)YTSpKL{LpL4N z33L*uD~JZGP6PD-^#ajkQhyMwi9%KpceV|KJrYy|8V_=Vs8dNDiYq`fKsSRHfR=$C z2CV_nfX^1t=b$~H6ey6^M`eJ{0gVLF^dKdP#UNTEwGH$e=mcbjEYPK(+d(gZ_JJ}G z8O5MQppQZ6NW>n{Q=o&9u}VNMg1Ta@)I3m2%ywQ2YMF*`K&K+NzXiGiYo>Z*&D5`; zH&8gNI84))VBHj@1FQW$a}r1|M@(Mv-QSPjpOp#xWXL)fzswg*>8DA08Rn|CN-}b~ zZFjvMxYG#VYJKfJKRtc+k6V_!jn5W_e6$1(<{Rv&)dUA$e^lrbB@4eO~a_$6oV8le@|DZEuJW)1=k1!}& z|J`6;{~fw-!D;;q4|`Zg9K*qU6A1iM;F{>>TA0o}nuz+x>kdTM!N~F>3CKTs!!f%b zezbcz%h7S*oC1Z2dCGh})YvZ;=NI~X6+zstqd(-hCsdVDuari%X_h(16QHJRl@3Y9)B0xn z_b?8gd-GPFH{&Dy&6s|e zPyS^y)a5O!LMLk!y6SER^}hTe=An;)MSJ?&VOU(wwYw!rwBHFwbLPw8UEW&#$@0Iv zBGu_Q=-sajzUq%gU@)`j;A+=sIJU$%Kp;v zK>8%yGl5H%OSmJ3`;lWycW2DewdVwno~+W{_7w|eHjaBK4bH;oK5#Fm!e@6Zp7jPX z$%ZuN$1(-exw!QiX@qT-w48;*@ffv7vfGXhA5&3df|E?F+gl+#1?Z8{3VO;1*Oy?#>0L63cq zvPge3mYMGB#}VMN z%lCyxrj8zQ&#ql8SO1bEP35z@eZEJ#BFj@zff|GSL_k~)WzMt5^XS%|$Fw?b(?s%1 zhViI;-BoG-8|^()dyCpR*}+m?Dj6NoGy(|2W_)$PNAjE?vMGd)TW{Wq8O1l`QRQa`oaC|@@1EF zy=2`D)J`Qs@k{xW`GP6^j45}8f|!Qmvv~`r`b7}4B`cXj={dFfY&`WIG_S2s!gbH z({dZH*yoBve`!b*>%Hh&LL;CEY{pl6hc49#9zAV_qNzW;0l0^qyF;AGyzIuGy0y7% z{cB(gqx(qGR6e^m!8gP`b&4-gs*ga@AfI>&4#X{v)J?^7x#_;*dIUuH{^@=@42g(+ zcC^RtNDxin9}A*=bsa$`gH8p}cT!`SzI_O2G^hl08E86)_RKv5dKvT?C>bA4V?YHU z8dg~gqRL<}5?%z9jD#2f?FHR{4ATP{W)J9XjOUPEku;|v7*jjC-vVR+8*-)(m^L zk2y5E<2e+EWC#z9hcjO=r5|fNB3_2My;TL}zCfs?if$CuLCJVp-(}X16`olQi))U>V!nk4PY57u>?KY8x@S1`^_hB7&|FPJZw(vO&N z%yE}siY?&C$K3TO&!CCbSOe=Tn3UxSRl5B8%VAht|7Oqx0u1Y;6wmT_blT%d+EHJ- zzI^+v3#;GMU)4Ux%0R-wd=Y^3Guq=ud7tN7~R)HT&tMQs4NofUz6 z3YO)omaxD zo(T(f{qWJI%8S15L-}9E)o+OzR~p=D!c#t{ta|CGpFUUA_%WqrGV~p(_+`FeNZsePdKZSuSJDUb4R+Mh^_OULk6}D;I>}#Z)(52%Hz+?-(?Vm<{%y_X zB(3egewe)Bg0-0xhh!KR^L1|QSI1=%9i7IZx8(Y!9`Y%USTFQU;mhj@>QcX6dB>kL zJEog6MWKFXvdU+7Wxn2vev+F?lPq5~?nOY$kd_(bd3js02~QEyB^kz}=3jp#Nt^%h zln>v2_pwDiTMHl>;h}h9KI359j0fumC;9@FG=JeJ47lBnQCRjshZSR9lyazb{YUea zQ$fQ)$AQv8Z9sG|1(hH4d%kvI%SE9o?YUEIZC6>l%VZ6)o zi|#ecr?Webf_npSwLkIfP84j5%nR1^{iW(ddM2a$NNU2@T{VsMg5p|~i~8wF`jR7h zryNA`o9ic1+;EjT2k0%({|@5qL6e^PnWw^)JSYFqs>MC&sZ8ILJ6b z^kfz9+a8-2YPWHz(RzsKL*-LAWEcm_)#IH}nd8HMzrFkpWtTn@nAw(!USV_}xR*lV zv%9tY5nfCK;ewi6bcXad<@jh!0LN25cW&{=>?;vNx?vnDpWUr-phZ4PA-9P-vT~tj9 z!#GqvyIbSP^7$rJx&mm&h4CWG4<{gh!&~1M_iF!5lX)JMZzI3TQxOs~ZgM=NJz)R+ zpLw*3a3Z$DVRYF=LspXIB3cDI(#!zDpec|8a6DLf~L>{Jld3-Wzy z{g-R!uATIDUus8@q4#KZt(pLIIs z;vZ+TDBVYrrt;aHaj)Hw1^3VLpTSAMI6?HJrpNNflC(EVZofG= zXz_DZ^dby>8}+xCFPPE~>(wT{P36N@;J{}^anLi>7xMT=@}kGT`sKu{K4($g#Y1;Z z<+J;Ug6zOlf5;(nBT|0}{fC^vW2c2aI!WI=4nwzzgGil z{Jemk7v+D7CrY=hb9#19l@9__3DL7+J-vUQlchUjx5f z-ZmtF=gjRN?+Tn5nad*exK7ekKD*oD(Sc&lga#Ol)m&nri>`zn>kjGbr%T0(w4tsl zuik1hw+m)I8DEd-1u5F0hqlz~BI#Tc_T z#l91>VP#$#)1gr0`gJAnk#U0PNuBQ?x8q))R`^;rx#))Q(^sf`-4$csuF0Mj5U67iHBqHq<)|NUGnr_EQi`u)Us0f?A`>&z<{gL-4sX!qUCy({U>TudxXk( zBKiu7C*l$5UxkMQ<{xVy9X=_3X#O&cbi(tOr4!c;CjH9gdh2I(jXS{?Ps)9tU~7wp zwt8>wb>VsS^bZWZ*B-yj7fk8L^1e?nk?TibLQ!<6aOW|tf<&(lZEO&iLvw8KWIUgw zHUeth*rO_M0Ju@h;16{hV1JYB^I>m!!?O zHax%0S%<$t{R}cx7m|GD3#RmAmd{@vy$04)&ebUL)q7wYUr5qE8@aT_6NBc@=kI6v z%$G!qN3(qMJ+O?1UX;^C#w%t$s5t2TGhTeR^4N$6j%)}ApLy5( zJ+LuER`&x@SwUpiCezW&(wjaf@=jA<2RH{b@ZYI{2oiL2^)lxdt29sbaC64${pQ|1 zz>lv1tMZK6JXD?~s^@s`#dC{~?11Y54gB|MK<;>lv1zQ4+Gf;`r@j}pQ)%r(YY?rSqVZo0CyVtb^gVzo#+B>vESKYh@jn^vckBPz z|EAl&@*jCaj<@nx&GANcO&X{e6%y@_AprZ%yy=}^+ty!B&t&xIOKQT`T{W#RK>JBb zN4u&jLfHRTfiVOZ?asmKbBDfzQ6G=4g@?c#4!+&-DMf`aVlo7?4l1AB zr4#!c1FHR4bVnl>t_ob7MjK5>V~wOQ+vTTOG;D7Y2W7cSbE@2hK8(RsiGc?Zl#Fvt z0ywYO^H=@uqSvGA5g4b+PY|cGs??JZ&Xov|^;!O!y*~FYc=f)~f4>o3Ps2D>eu6l0 z<{0)-8W&#a!#44>YQC4C_3QR{A6dENwa0!-{*>`BUX{=8Ht|2mjm5J1Fk#&2*CGgz z^|~?vobNvCu6VU@(p`*$$`~qXR6e^)<2uHWoW7(Nc?iIAcrKGJoWsKF!g4HVE%#NF zidDxw5l9V)@#SueugBs@iuTj{!Ak~=ba&+PiuK-L-$2Q}tx4}iSrgpn?_D6qoj;epekL1edLUq33_JdnpJa11|LonG%I6a8@20Lnvc42uhO~3^mw8)Eg*3p1Q zbkU_;{_cc)GENXZm4YZv8$o=I%&Fh*8GBvu!X8vElOY?sr8VXYru1VWKUVxjcQN1_ z;fK@BOl%6EJ_zHWXVL}FOK#Ynr2YEwfWMD!bz-uPSfA&m`kVQ9-DIS6lj9cqqOz+3 z0TjW;Tmq$X+|(yV;!&lG*b#&CMkunLTEAtECw0EE0r)<-dgx2%_)_0&XZX*6P578^ z0*8Mje3&u7f(EL!u%uori^E}oBM0VYyMk`hxJ$$aN54;#w12g_@}o^J))uHZm>&lR zCMsw*qqDSmH0E*Uj7@rMaJ+@@s1fNW?JS&QRs7RK)tDDp{#Az$KRx-a$9EbLNAXH} zVZMro2LAGbKCBHy8a7Uyp@Bg+oqJP_1I3I51l91!=_djl6g=agJVgB_d41FmtNVw> z{W6iR{u74Yr+sbAH`q}t&+D(ks!^YZuHm9hwn0P_T*Dxin~wbovRteDJIB-O!HCa_>3!#Ue-C^7w}(U@n*L`TDxciQSmTI6 z!v05^2KUB}+149#5%}f$F#iLyeynhfckcOm(;eMrlT0#ph%TzwQ$E0DA;za6>$xZFpx|a+HR?A~OWDY5Do4z4YLuE;GhRT@# zHY3MZkB{^(<@mBnzb8GrzU;R{&Uu`_gX2r(v%6LL&GFDkULZuxQ1scvt1^x?3E;SA z%46euweI@_%b|H~n%!3U>~4jF7s4!;|6zx z8yOmpNx?7k1ylOLx;ylu>2QEpw;rRKQMS>&9_g+Mx}B3$5-tqW_)UW zS`PP%OfUiE}^v~>Z>^`)p zQJ;Kw*a88cBX8ZK-3P){^pCn1v zwJR~CM{-l$)&Hf}4?O-u4b;LPmv0*qNbkQ5Pd@eLj|zDBG&=sF@)=GnZ#gj7?F-=| z7ct#uUKuq82jbDC!k&;ZFpfj%#NbGP!-+^Z%Rkpsf)hM?vML{vyzB2jsK6d#^x4svD(tl>^QJUu@zRck1CyYrBZ zo>>dPC&Tp>^L1|QSHf3NRf>*7AzfkR71%IhPY1h+wbCO3IPT3GG>vo4{31S{oxs!P zp4vIiZ?8C3#l!p<68$M5JOx|4;h}Wj&;S9bXSUhNNoG_I&@ITOWVtQ8gZzA4fj*Xgz3K zVk;pXfG3Xni2@13Bd3Q5aFF4Ao4zhtjK9xJP15Gfd+eQdV^g#d$Nc^CU!OjA)Iz<% z5zV*E7Xe5=QhJ~wq|hhMO)K>2rCm=`KJ7u991IZKt#d`Yx; zw2|+?(U-AT;6pCQ>TK{7U7VtQa94x(^eblXyT(YMoKKm*zj#cIZ+Mo+8;XockLL8# zI4(uId;E+G$~K?;x{8PS{}_*=DOpcDZE)3GlA;|p6qHx%->&J zRKyv51K~A-Urxs}zlooY`ngiH=l8C-_1m5Iexl-G{{I0UMN@i6a(-|9t+_s;q(kY3 z$J=%yzo%^)A3pep2WwXuK)AeNzQK-Ku|(|9YaC}8#%heyP%%;?E;k?pkr1qabcn(iW}mv-NoDSnlEzRlJnKd1n|t6@ciYyzugqwZ{JS{?x(4I z#?wqcN8j5W!jM5_{sR*K7NLL@Z_^vo6^JD8-mHk=|URw84uf|hB>ih zh;Kp-MrY9F_(}i4oIWYeX`#{@;92x|>6sMPnXBFocYZ0g4?UC77c#YN!q;6frj1of z`luKUBL;jG)Lzpshtb(VtiG6{k4=-GauB7{|KvJ26hG7C?_Q~Vx79eI>zE;~Cvz{m zlD~_;TjjI6<#&ra9I2(>^wUl8zssCYnw$%H=n>kFeNS6>-?#zCbKjOQQ@P4~#=$mr zG6x+6?h3cK2^VYFj4KJ`{Lr}DELXcHS=)dB>VW6k+oz1Bu&Q(49q`iTd)9Hd+`mxy z>@J-gH_YWlVhA_@Wh71y3VK2~%p46QaEum$VD=PVc^>#bnGPrpX?^E0pmreI|4;dd z7QNBgb=1^B*9H4cuy-HS1wyye+x~!1@tv2tEHyh18S9qvl&5OfiA|Pt!||}3 zD_OhZ8blQGDV1qR2Bv;ic#pX}=e5D|xoB5h)9%bOW*l>Pd-4o}&@d-N;p%+BlzvdZ zx%__IM9SM*X=#TzQdMef;Qg5(Zf~URHRC9Sn;Vp$sh`)0N3zQ`@km+EYAbPTD|8!aM@Ss1oj{Sz-BSZM; zSLF*feyrLXBfO(gy6WTQV(3Q9E$BX0!eV`F03M2O#zW8ay>dHnuc!YBSFX=m(h+S=f#Yk zyDR`jQYta`%Zh#?t;O)t8_34db%y0AxbpUWIJ)(<&puClGRU@~USz&tNoAsmODL(iJZEJ^Po$qd0c8dO{p1!Evz3qf%AC!boWH&iUcW+J zG!KdTLJA*rH3(wFT8pl*$)IWyYf&lf6KeV&-b6m2yg+_Y&4~LCPBHkfEDiamaIB18 zj##-^^C+C5)=vLVa>GE)>7(_p36wj>U-;JT%Ua-sY2A=bwa8wBZ?L15n9!}l4x0cD z>&dE`fN^2bvEUcv`lu!W`RhLHf99@U4?o2IxgJpY?9S&X4a9k&LA~4UF3t1Cva|7G z7&hyn-Ea2wV*iB|-?~?{9E0YPFk~lTmk#p{cGTkfDAw0ASBi4^RSWrKoFIBq%L{V5 z>it&^du_-kB`uAFP49KU+svnTWW(`b*hcv-mWiOi*VjoKOyNzAmma^H@u=kndFV8I z((vTgt;#t+kqx)5buXU94{+@gFe>@qVVaN zd!ME8-TseE>CB7dYi6qxG7_2`xUP*C4-em89Li%Q2ZejO#GvX4gx* zE}UTqCLi6PHRjVhvSGPKUK~c1Dz1q4;m8bH8Y9{k^nNV@qICIB`r%a9QlFzWs11nv z+tklK9+VF10-`#V+C*oAvO&W@G|*56Lib9W1zG}n67&ve59kb{3myCfx(yLD01?y{8R#HX?CsM~pQ8ZXh(2c(z_|d94gk+M5}44Rybg_osuLif z6YkFL3M}X=4n|MlqI1v(9{@e%qwkFdWyeYAH(r6eu5ZD;NB5#{x)yy!bjZj2i9YE` zN!s-nBx!eCm!v&{e%rw)IFB8ZtWAGBSv&Q_6fN)06s@#ts&?tdRPFhh2WdGaEwu0@ zEwy{6r)ewSX{FsZ`Vej4(T8aVA9sXyt?ysjpB;|U9yt3LZRe);+TD9j)E->ZS?kfi zo0hxabdAyhnoOeK7Y1xDKm0~3#0ef$BiGe0kQnFBt!yCJo%I6z8E_0^hM`j75~F|Hla*Ap0P9x#%DYuT_Y1B3KK zaSsPxQU+Vm{+z+Zrdwrm+PLJ<E-KAMm^_^q5(~+7hRets##slM9bFdj7X_cxwxgGyq&$efs zd;N&TIxZa_wKkcL*G)!%!P0M1W}5hI=o+8aPkTz$|4Wudr}a;okl42$(t3^`<2Pb!X;TMySBp4afw`WY+k zzsX3jWDySLivXmbLHVN`AQOaWrx5SSdYE~*xtyhbAAM)*Y_#cL`>;=Ln`CYIgLhY6 zo%GlUOw$QN{rex#_%Fe92pf7*M=FXm(FizAL)3Y^g`#B_5&W4cgcfiT~F~Qr|UYn zlW~H`jrv5?3Tg!LxfZ9Cob=+&LpF=H4%kLINY+$7xsl={WzK&Xx)A#&Hn?!VTl%JPe%$#tblSK<-C6{O zUPK=Pa}>lqtWkA9knzRb$1Y zcVs??!#2Ci@2KJaH~nu)hbTYEI6<@)D1BK=kq(Q_!#>@~=hc(jm>q3ae7)kGH8fX6 zM*q&FC|~Esez7zemsJ_v06s7k*Lrz^lM2xA9+G9eS`Ax{*H{QmpJd(Yh?~BXC`ax$ zHXarGev+Zydr@>`vi4~0>8*a6Klu{IKt3paGhdZ!+<=1vw6G4zP2K!Sn7FU1EO1qX zf~H-i#*MLAxY`OSJpuu;K1d$RRAn6a|9@Tsa=r<-HK!Z3T}0^a9XI{{pa1xxx`&Zq zDK66yqs&*ofNxmCVmc%9P^+lWN8@bK&L}F0Fg#K^p?fm5qmxCw-~^AtCsEW6k^7;K z?cLG-u<6s2$ej$?)DLC8U`jtZSTtDynX$u;^Mb}cNio1D>tQD3lVSN*diXTyh7bN8 z_Q(yFrRqY+M>>!)U+2bt^IgFpE)Xu|MSc7~X$2?IVO&jbEk@vl^^kFlxt=0X)NJSZ zlcLL#wP#+v_3;n8ZYfOzpA6ZQkC`u+(htkE#F0f+thdyG9piMr4HgVx8)*dwU1+P2 zxM@bKMOch)vkksEz&GQwp*J_Se|)TpkNFZb@faT;U6+^VO#r58e6PHnIX>0#q4Yti z+8fs%{L7cM6J{+lDg@Fs>5=(%I4xDC9|7h;V}&AE1RkSpmh)#jgZz?h1Kz zANF6%j`gIJ5q&@c1u1zj5)T99yX^{;9m zpZhI4KKV32VaxHBeu6pPnyhoj`)4|~l$UO9I}DG)Fg}&f?p)4e;%h3Jav04Hl!~g_ zT}qG9G$hB{$^>wHz3YV?SNyzZ0Lx(IGi3s`~YtVW7@{74UPZ~;u>pQK`0vH z=J}i46Ycdf9x~#-sB08xM`R;FcN}Hfm4_FY9S*0=T|k@z|2|4SQ+I zUKqxu^4UF6J@NZ;edF(7ucsRhe|q_Ir@i?p`)52VpWW^7X4_Y;>Ai{^NYB!F*nt4qe+vb@vzET8eIe0JYI zd}cg7I@;^&+`novy1n#kHCMdcRL)zMWe)3ktd4rXtbH~-OSGR`nmr3J>Oijtl)l@%eYiNyYDA1HTq2DXS~4o=h!-7KjD1eV zRsvGneW)H1y@0>6w;<^P}HYZ9plOsR0N@~qldtHM(%$1h%u)oi+9Tq>X4?Qo5Bmj*Cr z)g)#k2!P|YM^}4X&(**D!fSipT)}b~m&#}N{lnEXM&))+T>|*d@?PEc^&~G%a|y%v zR6e`!7e08BupXqd%b;qg@46~YgRYu|ETNF zn{lb*+2rM`9~V7!V%u|@tea8!O>l{U5t=%t?Qx>V>=^1UbCnqL#&SBZO#sI^^Sixr zu=edUEQjMy<+FP<{w#198|3u$kcI~tPrp;_^>Y2DHNBS&EX9gl-7p@N&+ZA}8SeAO zAj$DmmjIp%A9yIWeAQ97i;C`E#wa)yFJ{aj1NDx5Yt=&s-JGQc>L+ z**$3PSIu;o^5KfA+Ofuy|AN6KSky54-N-K&~Q)5BrnB`ZX&Qael{e4 zYukCPHotmLdY<7u+TK?A?4F2z1g<K8FB}#T7(oCWe=~d9>*t8OKL~91 zJFs&_H>@9(&+ZB7N8lRm!8%-51?9bA?vSh0C02mTdP_GJb;nEh7cSp>{nYGe@`|P} zmB0V^2$(Yv%B#e}XY>4QM8RcMPA;mOeDD|fKQ*b>RDLtK@+P>v^7Mr%J@xBtA8%jw z`R2`YUh%KoE;AgLIV|#^>qu1VA&b=a%sl8H?RH{aDRo&-mc3m$F~DX{#|MB+^eh zewoiW*fyQ>JGwWogfXvwmli(C>A69{W7UrTbJ>d@jomWV!SYx?Dxck(!Q-GsIS!l- znjI|VsejDp`KDB0{XY4X%gO3K=JaHRYr+$AW>;QO-kIexE|t&jcDS-Iw~h%!Q+qM3 zuRV^lUfF$pXx*G&Sq|e+`RpDShq0-%IyB5xL7RTzNsg~@KlA(?%~|#WMS%1AoiAfo zAod2fyzj)@j+?WEp2;vCm9M*EJ)di0^vF#|Ed7Z1qP;_|fN@H<0$#On#W;ki4A z3PBp!Jq<(&`*ctb&>0}oDV7;blhb3`S@!ARy|&56>}mPUOYklX>s{rudpx~UK7p<= zU21L**8m5F>jaT)75}Nb-Lt zSRUh1`RpDK59wvpl%RN3j-T2DaGbmAp{HK$`Dqr*VH_%--R*F2UXXG0piR6mP7sA} zRc>``*f6|$ZaF14VHk(XXLmas1z2KFR{+d`2X05z0SAT4IIPmi$1mJ=((^Upi&zfh zQ2Fd04@WGWFdB3FB=a15y^M>TcYfO7rH`;Y#-sAtJsuu*GlfsTDWhJ+@CYt<@&4m zJaar8gm+qikmP3?Znj!(Q)MF>L}2#LxUZ2XwMf1q0&Kv0O&JM~Q#K?mLAhM5{V zKDZ}3XXvEq<%gVK8WO;jKlFn?&pF3k$8s5$%4c^wT!Z{o*rDt9Vf8LGJ52R_>r8t+ zz4`t5=a25Y_$!vjcvL>SCxB-p-Mtv_TrP&o*`J(`Y7@Yfm9hP!y;l!u5`QY6!?(kQ z^P9?O%t}s2GtW1dC)y43QmAd8k5QNEPYw}tRKJXVA#}y#e=Oz>2kGZnq$B3De6|ZN ztB5T{H4gG{fQiM`bnPOwpdAI}Xp`|yQ^TXIpB_&8csq6P-;*kLUra@^FdT0xpWPGE z4?>f1tVsaJ?KhtL&h(d`ZKZ2c&+CMq`7EF9L~!`4%s4W$?900|j_1WImXj(daaJg0t94vm~QkE!?$i2_J;3^3x^v(=FUHC3iYdNA+JUxzqj`)jce^ms_|; zB=?|&d!6J?n~>D->m~OaE!;KS3d-?wi-mi-R$ilr?a$jQM9+uqiwQ!F} z?sQ%Y{eWitaz2v^i!d)8>`~D{^+|woZXD!?_CHI#s+>0f5Ts7YWe^_$g zXyG1_-07-Y{As4|m)vm`Y!ml-$^BgmcWq$o`{`^~{AqId>5@CH{1fhS{ap`t^5X=N zoeHA11+UA;qgK^1ylwouB{(HjH}oF8t@3qOyhEaN0{1D2 z{v)La-ZxJZ>(s|3vNAG${~-Hyu4lB|`s3hVPK*vLGJciMvcz6nx;6pef;c%FjST(7 z0ofrNTZ7#J;UyivoSx?Z5AQ3?Ss$V!luY$YyIlKn{q?Kf`s?ok&u{OP{9f`GI@Hw8 zBeT)q>;J`maUuaNRL1_noP6Wx61rb^q`T4=a_6`wRF&cAWxSpaVx0YegXQ$S;R-rN z$%L~G?qr-Ga#Pz0)uqXr@2M_KVbR4NDv?YC|k z$n|kY;QSHyh5lzxV~u`(+s%Yi-+-II;I0B-Dt$C2F?WcvbBaj>A#ki(>7 z$d{9)dzSN~HpD(ZE}c2+o-+LkCG&oDghKg`_J#EuYQ~iUHEh8jUx^|6&N2gYZ|91A7<7cL^MhN7uMY3Z2SAg-=|Te(+h%< zH0BGY^pjBfZ)Sc=8*avvhHzVfA~+B3^+T=|``NGAefqXGTYvwO+{loP)5SFA3#RnL z=ZfNB9KjV` z%$FdE$Aoa{r*ccEG_44}DSdH0&*AFv!toQc+1<{rHo~QRRX)NT57b%g1(L`4m;ZXM z>&S_FJ~-S6nB*Uhm|(uaj#|q1MrX`qJ!|>)a=$#{#=6hE<2G`@dcH~0R6e^~$#odx zG^KRMmVUT4w(Dn2&G%J!c%7Gwt0nB`zI{vkW(ymbtJI zv~4uGsxNU6d0c#QyQ3}ve0}B*D@=Z2-`(6k zBYZ88j+oE5*tWzc<~(t9J+`azdoqsPk@k9;QJJy#`$r}`%;gHZXbykZl+cqsbWiHEQTq>X4EpZ`z*+HvC z0NgIC9&N9$URUm0^nU5Hbu5>0seE>~#KnnTtTZ4EjlkYFv~Jys@}%@8<4hl8k8^&; z@Qc5@DfBAiV4NzS-7RrS`7=?da`~Dz){OH42pb8i1^)ZyJ0B<6-R`J7uEQDqi`Di5 z^XVPg=y{Uvh>zt^beO~`V$^1%HVK(xd@#l9|HgFy)aL39qROBTs4u7==q%9Lp#Gq9 zKs2aC3-)NUVJ654qHbk2C8_$k`t_o~u=bBxvPcts0QHof3lcMl0B+E^@xBDu`oBMtS|>fvye_M#i(o z2G5$(6m53KkjB66T3!B-f`|DM6!B=ngA5Qm(9Rl>j3@V^`1&cDn4&q4-1b!c+gA-( zqu^nFTs(%JB>fDms0x-#%e_qLXR8gK#tO{C^W);N(vN~juAlrD zoAslPi*2~Ng*Lr!ht$0Mic`a*b;&%g!F&~uabE369GfEUQlj|E^#w6h=f~uo0nk{Z z*PNcTapv-rWKz17$CFpz^_%Crv0wdZs0l4qI-4L#W4?+Dl4(PWK6dE98DtoirO{XH zbip7MZW7QhU!tP*64U`&7y)p783rEG6qPF^hn`8UeE!bI;kP%=*qqq_wlMS_y{+;E z8$V_|H0+~a98fBxYbN>Pay9s2`Bv+_mkvKQ*D-6{cn+WCt9*7h%O8rVXVlLu94|#c z{QZ&f_VJOFGjHL!ubuk18XwGOxon%|+s21}JWr{9ZZ3r(=kp#ogxW5CHr-gfdzGj2 z!z`cmqw?9^j8BQ5CTPs#-fMt|OuYE|@XlMmnx1|tRawF?9+l7TW;}9ynZc}t2adP$ zV*7aeHqyVe{Dzx)tMSHsmd~~sNBnrxkZEVa#>2N87Han%zVbfwpnlS;~A&?lvPmKP9>}nfZRUb0DN}&^Z16y z+T=|S@brr)XQ}*D`PTU4cr~MuapafS$KTHrLr>hWaoFc9hvQG>v%6VO(fBiiz{_&I zyHmlT&I3`{%j<7E?U};i1BX)O2SYec!Y}g$Q~IHKAYOd#;Po@KawduEAm zIXbh_tRJ;KK;n*D{NZtOscUofQ~nrfkw;!Sf=F{D6+#N!Y^aj-qs z0V9D@y5{j+UH?*m2|oT)e+dSE;I#u9_^;4F1PNWvFIJ$`yrBMX<>vtJ-=l#8<=MYS zj|W2e|Az)zE9F^qz&?S`Z=Jw9@+<25|BdBh7=XE*pXRl1N3UJ_!oPlwy!|+T3)!^Z zgZc9J(=*zyv-P*!f8$9NC-WH}+wpNWJx|v9IO8Z>lU{3qmkh_dI?mi+l4&kKWCYT*H_K-oRNfIx{}Mm;;Q)gHU!hOUU%KxdBi#Ir>Xduzkm4b^caQtKc4=1+=a&z z=(~(4iQ4kFvYX7~=Xh@XPNKFve%*lhqOhGHvS}?)OOSkDbH*(h$9BHOIi1%Dk)4D$ znU8->hDOB1FpIk0bwD71i?r#6%8~98RAgAQNk$$gtDbC5KUU*FFC-oDddV9PqzljZ z(Z>~2G?mZp*heNVQS^p_BPO6y$3g&rph=?99`_W2qYs&e;eqS(M&O`)PI_t1JabON zdnLz}_RhG!$M28frLYcNd)DBq{zeTMhAW!IHcjkf^7;L^?T6MvV(XH)<|iE2^ir_uU&EpmBH19JC&z%;4a4-wI`{)%IkvhsJ&YF!!0Ep|6IYi$W8)E=F>Z} zvA`#s<@jk=ZH^z>=Uj@n8oS|s<6qac+5q?W9sj!a!mL{k+kLVgdJ!zDkD0G?W51?( z)-eIBQY!ROtQa|Wl#xtK>7?-r`||pw`_G^ES*L62SrX}sG@$a?-L$V4F{0nk8Ex_L zvIlWLkz5~Aejrkf+W%JFo9r|Y9r8eYl0|ux-RT|rpWmf-^jOmKG(GeG zcofg13tb4}5Oytq-2}4cNkn%{AH~n#yN)x|#&nNZ}M3?3ynrcRPl=r{rTI z1^Pp&n2$|axDLRDV@g6L<>V&<;(9axYI{7-d_Q{Lh{4^TCBI}CkIL6wv7Tx_@Q7pL zeCW1M4B((Rz2>MvK#XrE@R4DCS*5FIe=pn?9(&Q%;zj(B&goa>3pReN+7~%E4o+M( zN0)SA15$yzqzX0LRIz`|@F=IR%&-~P2E0QRPVuy4Ep)-I7t$|H(Ox|4zUt3UKmYZ% zhJVr<)vL@m*ij1`dx8%9h=B|2O3^RA|IeS_L-;6DVk?kFdooS{QC{c->H^9DodR-z z=o@K$9j&Q5ACv>4HFC5bZWQQZPzh)fCc(9ia}kwc;%~Ui)1WKVFL~Q?!yJ4tZ+! z>m5RByfR-BEgnts5wCQA7deDM{M~C5x%2|*x)H?VWv5)->*c5KceDXZ7)no+8&$qw z;|Fq$ePc8DSKk3Q${S-#3=ceDI_57r6N<~0)r zdN&MW9CZocD7xsAla6}n{W0X14C7Gwx~tGbEMMh$g(9SAFqO~w*V^l0XP4o#drsN1 zg~Mn0DxclWddRK{hJ2McVy(1kjOae(c-fi&o@3_kuKeVJe9D5tFdmi9?lC;sKHO5~ z$6_u^D0013KEtdRt8)0auR1ME3;$Tpa=08;`Rs004#({r4gRzVi}ban6>ayr4{UBTvhQk5U^ zr)VetvSj4)Pk(8t%4a@@%XV|}seKW1Gp|>vvB8lUNYT=32A`2~W9hMloqzP=h013s#?b)T|+(r<{bpZZ{m)@O3g<EKa{gGvn(geM*Y< z*`?aME9P81OU1=}#=~|3xZ=j39DnsT`0A=tv_q%AHRZ63D`&oQypDh>O3Gi%XIyMI zi?09~9FtwN9+}>i+oRR9;_IpS@)WJrp`CB(^46GI9*_@ulTfk)O??(F#b%AA&>J^a{t56*X<@TQ7~`HX|@{ln8VMpsJs8g1~^hf}oM z#}7K<#by3iRea26Tx{=E?T8=ex0}4O{`OSeKeZ1iewoiW z*_QB%L0>NSN1;1gp;rOaL^kEmb~nezkv=0ud)K-9#||%CHb%w4e3s94A~>4Hrn#TJ z#s*j2bt&2jpQd-Za_5vYRb0$xJZvX~D^4uR@t1jvdAx+8=pc~1kK(NFA3Ar+1MjkU z(NCn_qRQtNBzyy0fr_d67`|ve(Ke5QDK0HRrE|lIepeAfb*uL$r}ehIPW^f(NR2f z)KosZN6!ZzSS7Zw<+}pt3OR$6C>^oe9Zda0|84gA`g_*bM{T<8`YtSoaj1NDkBb8> zUT>+Z!sm5oPo{wt7+Eik3E(+%_WPaZ+%oPV-M4=BGX1K2c8`n4xCKPT5uR(Wmv8&u z_VIT!zq*g*uwGO?yT`>LZfP0etw38}ZfCTfXOCk~-A|oTYhR^pox(5RahUE# z(S68xA_?HRvc%{c(^$<2uD|@-8p}5u z-lOB;DxckRaU3yD+d@&?yQpYH;LM^TQce}-Q%l|SP8h`Ui|??Pzjo-5`R}=I`kCq? zGGr&=m-&Jz{jmIka$i+NslK|<;EA`w_+|OI3(WCzB-|+cdf>YBx$xqhqf@mTiu&|F z?v*zW6OBW|o#Kc2V3~~6PKovw3NVjSY3!UY$J-?TKecZj(8M^noG-T8d}qy=RBcrF z{F4V>>TsnSU&HB;`35^`HUFJCo{1CP0aVhIQCMxJd|F;(AMf3s>#%#vpfQVBAm>w+ z&+b-uFkv;aaA=ON5(8~2D!JZkNB~cEZsVAnkNOq=eF~r5t#BB7$Eaz-Fii22w$L8O#Y-!XU3z8Vg)E2T zN9D7-4GuMWv^DU^`Ls^K!)qXTol;Rrs&-KA-n$-f_Wr7kA&}EA^BD)*&9*Dikfwdv zlzC&A2YS4oU^$lT$j87H`uyV5wOlM$!Jc#d5UV-}VBF!m%z9LDM}Yg%aqCV>-rjBy z)eU4AH}iFF?Drqy9*x6KeAzC4s4C!gSOPah)WK%_nTz7%-wFJqo}M!G;*3*wsrZ>6 zL#{vlL;TLFQcpto<#KPcg5N4X?VP^o+nvYt-orRK9jknHHx`rObSFBDC+Nt>xl?qQ zVkqGAmg&8Z05uG-&0lzt`+en$&EpB`yho4HRPF78+V2ZI$F1o^4Hy`jKc)JH`GP6^ znARwZD)%G0ji zjwC1ysjEBiFkk1!eiOvQ8Qs(`YQ5BqM~%1Q8&b3x&!y&sullRIF?lJFFkW3Ni60wW3-cfi3&?tpZF zh>WA(GBb`+ghmx?BZ%hRi?_AV-oL$9yC^j?*`VN1 z^+7)Rp5E)v_xi3~&XNcRp;7tl9v6q0&K&8!tO{$W3=cA%qPyekg}f{q`Q&v!UN!3u zmdAKhKD)=oBlLoKR|$|DPxT6(Ci9w!UPyQ6O>pVm{+x+X|On#~1o&y_s0sAR&_VRBwZ4b5*K#M)x** z9XsDi8(;`zJj`btY+K>c$K>6Cc(`Oe`R|Xfr}~>yv;lv++V3lzfB6>*F6J{HwykhQ z^;786>sLunG9GPtd^{xM`L>sQy)^yKmsuW{Q!1a`t?=ZPd9m04aTW+*)}R8D39G-BNofo_zyg2uR_$Z8P) zms^>&@%5B`TZ;DTHGR)Ny2tI#UdDlRT>mql@vyz0xJ+$=7)ok5b{Yl0UvH zs#^C=mH~v*J@XkK+g3P@_{_uMUQJ>&0*|aW{{!*$)_Q8Hwj=P(QJHtXGp4s8koCrV z#=&-ic$(FhoZiwNG`H)ht1uCi(Kbn&Id;Xmw2YQo-^V}c+SqmLq=StH4C{;ejEn6A z@u6FY`|Ls(F)}ws@xjD#OS_HbgM3(T%x64oCy2|eHwmSzx6Fs) z$1BMknZEYb+Mv|a09UB@{O`xS zw(m}s%i~EZpWUr+<%}3+bc<3)Z3F&#>Ali9C{b*@PW8LH@9YlJd`PByCU^xeYPg;?2R&~WkT<$7 zgjZoWzEnQDTgDgnGsVhX{mn2ej;}@qhZd{|BAD=*Yt_A2)DDAAhy+ zf*cRUkDALt8dIdX0S)|`U4d8XPid(QK5NsGcRP02!sCsk2Ws~+pI(;@QpN-iZk3yA zp2g?59*RK}5C4hz0l+ieZ@UxULx%DN73WszZSW;2cZ|L0yaIZU45v4hue&z8 z9|Fe~_$jraeWAaZ4vX_e+RE6vgTCu7>_d4kY`D|9f|+n9e2i0#kNl!m+DRo}r<`#A zx`8ytN`~?m#Ru~RQ~F`WBlqg(lsUu(Ri38O((x|itA%{NZ|LLkf80P=WcLk{yZe&4 zZ;`uPKNLR}KRx4h?ZMyowDi|h4k5o}$fol%m@k;p&xn8rJ*2___Tpd=62%ba-B5u_ zY=?d&$OJkiHhR5`30EU<*_De6RutdU`2qiM85hB*G58WB@i>6g=?{2t+fKGS5b{i< zyQuVwZwx?LP&p8Zk`n7TM!LoAed+Mc`fj%>S(D|e`dkTjO1VxDxzRIqqvU;0Z`3U8 z)ne(YD`niIPv+xwli~A7D3RhD=sHy{B`mee8CEVg`aN!sYeAp6*Uj&LKV8=+4B3Q> z`35^`F)s5tDRizS-8vuSqxVelx;X(Hi#{CCsdUVyu!@8EQ2@pRVb@!E>RZw{APKiOE>9fcsg$oa7$0UVF@dv*HTkKIAn4hqBZ z#C(GtwOBt24ns9q4TS4x`IH$MncV*jueR6Ey4iPJ^~rblH_;FCqkxPD#$^$21@1B$ z=gsp@^u-X#dTRHiJ)T*ox9@Y|=r6KVJu!cO@Oa8_UL+lGgKhvCloLH=FB&W?X-8rQD45ij|J%Z zNNU1o_a^c$sB%})8WJ&<8XQyZ_Ub?k4`JA>j~;8x`cT`A0!?jhW7D7siang1Kn;I-N6tTW3CK@B_p8a@4w~JI!)N&_pWV@ZZdN`P9}dNx zWfc`ujV=JXK5{zEecE0ho!%RA(&&-d(Q$ajqw*CzIi9J26^zPN)uKhxW!mCx?h_^=|R zFo5|j^cATypx|gs0LSj zjU<=L`0={oCMdcPc#42^fmzs$-NF6A-1Cs-`SG!aEF0#44zs!a56)uZ*fdc$IOjOaRyRt3xHL zgV#sb`7th)Z-t96CWgw~&d+_`USE;B-|MyV-WP6Qxr|HYvwMR2!lHB1VoYPQzUmXe z)#`)1g+H!1_v_qnlgArLR_7U?kMG#wgYooC zhHJ~`}^<&Sq@c^q#lpWRs;>m`PVp4c^L zs_$1OfaAVrzH~kFQIY>|2pYK)KaC?e2 za&1cSU%&tB_aA9M3x>uJDIGIkFr^>;QfSAZ{81P^b4}tqqG`!;bcH{?PM4rlI{9~v z$I>}%M}p|Q4?ZV_){Id>N$KxoPTSH>ErYXfd7xZyMT*g>mNTp7>JGCij9TX9oQ`fiVXq^N=c}g*x0Su*x22L z-QC^Y-TMEW-90!v7g_ZBJoo5R^(i+SAg^qH&vK~H~Lt@HEo;?baP;@kwST(d0^=hyV3 zkDw>>+vnH&Sdabe${*+H^TQ=5fn9wr!d@ zdwRI)Zvf*gq3)qoe)jxiCPJ9dpWF_La$Kjg6Ka@#)Z z-Pg+s7y3(m>M~s&vv?o#xW!K*j@M{^_ooY+@mWExhvCF4*F&+4L|%$QD(A=ki0S#+ zJ}GeFjSIcDX_tdcXLLs0FU*hOGs^({Gi%*{wY-50 zMjx-4qD_~>V;*Pp>zz^1j9gt_HWIh!>>%Qas+?~-+smnE?yY;+W$QZexp;h9rW=wY zd%qF4Q90Mft1b^t$4r-pz&jhtPTu&^OP{~``4anInI0La;Z4lrRh4gTkc`U;vRnrf zr!3cEnA5N~7)<=HoBrTGtA^;l#JPT;Cv0F?~CT zepLGt-zPWDb#`t)PX?op*G$o-%i%GP(?q#e2hGUU<$BBs)8+bpuFI>BXYO8E|4IG) ziMf^OGG5vLjkt}=wI<#$Ml82;wkJ)Ohvl25Crnjns;xeMf0S#PF5{H_n8&Lw*FS=^ zGQ=m2m+Xm8mS<50L=5WuR!*6YKg0I$8YhA?chSZ#(;1~v_Y3iB%d@^w%_iMEs7f@l zeRXxY-blP64m*f`RONa~iHM}iZ0En6x74P~pkp3y^yOL`ygHxVPn#~+ZUcP-6ZdOS zN}JCzUB)Z>zY(`lxz@(3-p*N`FweiYy8K>;WJYH3~)&|MQtRT17 zw!|sRcOlY6Eb4r}5rg?CUL)e_p(AmaSl8*}HdD0ea(K++jlO(G89WnFub+%y1W-j+rzd|?HALvam#cWuk6P>ZdG}YB3LU% zD9gJQamw<}=@MOeSLgqQ7|h3J`zu)*PFglrJ0CJ##xMK7Fdy3T?%?OCt8_^GxbV`o zn$+0YyR%`-e!wta;&*%41=HpJz`{(ED#kJQl5xp$uT7W3V;*<(#x&A z)8#)^#do_0?;m$n{FW7+n2!{^%5+_#>g6})!>Ih5ieJ6Gw7g_`J=p5~?M&OdOSWsv zk4#sEu6rBv_*LscG(lT2R=Gad60ckz9&(OS#H3yy9>idN-ekY;KDlkC{@VGG>AIOv zz5K%bXxE3Tem?&G`dykhXg7?>FzyKYvK)n9HoZRNcwu`k`QhFxWN7;M%@l3A93Jzy zqhB9>HWTW6ce-MFJ-B+ekJkdnPffJHPi4A{TlRk=exvo^XK@>q|Es3U|LaPL96!w- z^FUi(WV(!3_G2Ems{H>fSVn4v$nsCTviv`Zs{F@bezG2|obK_ldStM|F<^Q_r^1r-Ji&~C_8kFEtimns!$7e2Nx*<8T_Z#sWmH(f`ZB+hmm@fbE+Pen5 zIG^?}$8Rz{GGN1-n8&Ru|33?saatj={1dM%|IZEOUp+rJVlY1ia`&HHv%&iK+VU^c z4YLv1`-S<@mVeEqd;N)<2*dp7j)QKRF890Fw|R4P?s!>jBFnutT?QQUc%v`(Q3lUM z)aBmsmg#bD>oCst?80lFTsG8oBHt4*7c$+D9NGJg_>Ic_&*D~>6N}rX%YFMQ-Aa8r zyK9HGoXGUZfDLbA9=EF8|14O>X$4vCt%+Bbd-1%uh)F#^7h*6!U)z-Nm{fY|GVT1x zbVg~^{lffc%e}m5+s@acs;386!2B6=1myNU^p5FrpZwC3vw0J~vXDXP<2F;Y>2i3? zhTk@xOAQPTwFda(+$ayz2Au6sNDZ7 zZuRfp55z4ZmvM{tB0lwVGsVA8PdIAD?u{Z|(TTn|FE7(|iK>^F$E_;&Q3PwnIAwWH zfA2?me-}l0KfrKP^HDH+-NPfpK8jl%be)_JnQlmq?ES)gXv@3)lAqYTt1kLRFlJfa zL++a{?~YTaJWb(Jyn+l!AGevJO_#%C9&hyJJ<8yjh`PL2eqg%1&&d6xT8D|_|B~M_ zUB)f@zY)JtdH-45>h0nS;x<)IDxA!E+vR1$p4xIE(`CG}AM?0X<^5;DGSW~)mXn93 z^Z8S{vk51b+f`P(Kb7e+PT7w#-X^*yZTxM-UD$5i5#CXM?OGIJecffo_vu3(t}9KCM`*jZdb_ zxMcsg;^U5rKsWsu)ay_1W7GLJuzc9C_{kl|%IVAXUz;w6M;V`Zu+m0%ca8orG*@x6 zqpVud#jUn?HRm7`_o=A&7uHWq$Gs?S%g{Hw^0bg~$+)%Ya`@kf+vsYpI?fX@h;vZS zt_dr}y}4h;A>-7h%i(_~&L3CjjE~cTpPJ6k9`EXH@4BwVY#E1)Q=2Y_|BX1KxY}YI zukAC_@tQwdxV21R-lQ@f8Lu{74*whRMsc>>ct7LqS3y#~l{ihxIA&uE;;sM0Wp_Qx zwjX6YGG1-E9R4@rjpFFtIDg$=na8*ydAzdLy{0~5cTN2b9zAq7VH!U; zF@}-J_(C=DiCbmG^9mmz+jGn_x69$4y^`J~N!Q8z)TYbfhUWomx>1FVXaZL}4_U*b zyS@@o2VXnd$>SQH?zm9*6?Ht;Z;bOx`}^0zDWUSoDMJPOQL{gZ`|w5QOhDp(e3`CK z{qd@AHO0eFM+#45i5rHUX||HkeF}L1w-bK<=Z&A-?4V2%|&^_ z6Za{G6X&hvq2d-(WxvJSi2IY4XHpCm#)w`*{vy-Ghg6-a@(Nu&*)~-gQ-6hX2b=0u zt2JRl?tE5EU;SKwn6|jVDgrxk12^#yk05?bn;{c2BN+W4?#Z8ugv6Z)h(qWD5CihPek5?y84wJ-^WqHZe-7C{V9&JDofW1Df=v|ES8t(M81jjMW*W#RWCB0 z$a(^*`RKE&p?7m1Kd!n{Yb}ql8lHAyU0``=%d1#KA~LZ_6W8U$NoH|iBz`05%Z25^MfZgoL0#19>@u589> zJV$Z@Du&h=2655(BgDE80xlCNl?Zkj@)7WQI1qFqfqULKwmD#*BtC`#ATit@A)+p1bTAH$yiAkU#B^Wc3~ z?#Ca@vo@iMvT&)Q^xDnyC|4C_+9yTX!OC3S&P>_a*-W`YZ6QrgnJM3r$5Bo?#8GZg zKdH;NILbC^9qw~3uHxw!PZ|0+o|17~d}Vb5bERA^&V;A6P(*nU>pEFrbUq-|M7jC! zHIA~}zvqBGdnfG{%S?2lFUpNf*Cnc6excmh)b#P`NR@KBPFLqmJBm$g7n=jI zIbg_vF#2*oZf(ZOLuUuEo@n<+5ozNp<%f+=lzh_RC2U@Gomk(+c15Nek|TS+zFleV z5#Vm;>FZsKrvTY!Xx3*Dp*~9eBx2WReLlp##^!*?fndn>Ib5?oYoDtZpa0UY{n)o> zO7=)E{-G1=Q!-vuOt{VQV>XsrLDjQ8dL^ZtZywHBy z?}w{~i~29M!w;y2kJ)CsRqQL&^Y=hCe1OBkUE1$kP!EO7zj3b%CDsnNRt=B$u9=T^ zcu0b{k@a(ixqlEpssB>HLkiNw_r(58%)jVFnGv5AofsxM@xO>){I5>q-zYoz{U`^< zCjK-B!pJzW{>bC^w0u(Jw^%lExrpT;I+4e6S%@_C|8ltKN7cnHpQv)hbXo`>k=u7m z3w`d}ktXsps`i+cdb=z+WwxsHG_mmL#ODg|D${j|su${i^$VbVs49Lw-MH-B+{4?| zr<=aDD0`Y-3y>e}&Kns=h$fDx_A^PYJ-fcR*~@+M`{F#HI2))RriE;gOmWI1{BIkcnsP6o$MH$Z3IlWzCl_sw8G|lS?xl;{T7&=Eh&8{f#Irkur zmu0$~p6u%{W^w+P8lMb#U{lXIh>Cpmzkp>ZoN|bq|8U|E`6}ZOKg~Np*3ZvdrCQ%n zE_YTg%O~E8ZVz#YS8cjT6`gFeqqt2?-@w{l)LBrCT76upv6nMhHdUQ@G*8rzqHAs0 zP*0ZbdttoF>%*JqH zO}|wUmq??p_hBVdk?XZ>GShLN>s&AHSAVO&JjW{2je_Q%zZJL99U%HKhpXbf5QBIh zFC6Ayqe`W_+I*Jje>UD9cY>(%H6*#|d@a!?@2t%=FE-c4DbxRGoKf5fqK>z;rRjLr zEZt&v`ODZN+IVI9AB{JPJ3-Xz+lv^)+vd>qjo;SKxvz~^rvK4+qq!4A9d~#N)A@YO zyn2OMsV6MZ#x2wTXx!1<38IeMDW&PS>vm1rukSL~KH9it`X7xunma+%ai>pZI_^c) zYi*3zD$!r+>zC<&G;YmF5B(D(`YEW_#{)5l`{verTVE`{dQY3*GX0On9mO3X>U<7P zZ91QC*BJb1fJdS^+IVI9AB{K4J3{nR2%{(We=jmbfBbVHTU@177rSX$d`>PF*FZ%l zexHitADOO8RK5Jp@rL?Lc^DZa;*-CdRipmtTal;g-_l$n)%|~z{sm5mxH6mKdi`4d zZw7Gnn4ZDbc!TI9h0(Kp)b7$O_g`J{gTKbl3cvmKiQkvR~`JGs5J z=J%xN>>$2q@a>Eh8syj9xe8L)K7oX?-dd(r9h-Rv*v`k~yn)SV||{He9a-zKuOH1u`z7B@(W zTfDT}c`;3SZu)1-QI0#RzCNBG`{}4Y6Pp&B1OHcZK)b%E=R=l#by`f{|DEr~bQ-ar zi_L-mb`EIQ7g5gDzu|tj+{8S=`1g$VIT`!Bah022mUl>E zcWhLziuyJBjp4enOpgq}@FuG3#xl*vPuHNbO`||(*=)~W?t@W}PfSrnsNE*WJd^3N zFTOjJFI3`SSEOap&z?w*?S3-{)a4~OpYiV)@ldU}o_fIEOt}@OK)w?*k|>R)b-(M{Td42m@6XkK%C)HZUp(Wa z`>J|9vdC{-exthYW8SkG>6&y4DYV4!dt8Ji?)#AG+ITegeHfzPVzh4!4?q8a+OCEN z4%GP)N*rRmb`X8>+fJOrbfOS;O=P?5gSokKEWTIc0@D(9tt%cLp&RU^KQAEDb&0B% zCfwNI8t5r*zmPdWrIq43eO)&Jk|xGkH^W)LV126L#n>-S52+R zvnHbJL(pP5$#i|{kJp&SQ@f%5JL-5g5|7A!kv~7{5*NL;pmog|CFF2@F7aHCCS4A% z>FnWbV;30UUc*gSJ+rQ^2t#{r{x+P&j%+Sl)b67wRuJ1gaXtJ3@u;UKrWI@$F0O|= z7BtR3ONNR2^Flb8Q!8FFE8Z$aeV>(SeDQ&`crQAAyk>t%*AL~oGF4i5cpF7&Xx&Z! ziC}tiyL>@2eUW$ZF@_V~TZGmV*+`Z>3-iuDZ4dl5OO}c()>z48JabpS_uh-&vS69aMfVgsve0wCA=|7y6ZhwYC z?V9&86cjmqnXa0&?(JWvFK^=DBwJITVqUa6Y4f95oImnBn%F)jhbTMZt}Ai9Lj6pd z760dgC`95UkhmwQG;QI6XH?BA()Is*oM=10#U(#UWkU5eITCK)HNzY z#)#+B`a(2EBKCs}%Tb*KGbJuIg0qx#(y)9?P% zpZgQ@|4+|D?DYR{<-i!imHV~I#Z4cFoUy$URC{WY9tRAwDa-6xL%MeE<^8#K9$wWw zJvzz?0#xt0*~6F9^t4~>>SlZ#;zT^^>4|BnuQz>&LA?D}UrpSz!lxSAcn28L|6aWM z>J|doKU*;(k&oi|DYQgfMLk^+cV)wHx&4#*MzZ19NWA-bSD8WT?dPw4-^%cP5#L7Q z%lWGP$7+6DT0a)0oT zP{UMlhQ%Pxp+hXrhTUp#QN|(T)TYbfzZ|DOzYaNwZO0AzZrzRRd9mkaX|aE|gP5*( zFOCq@=UL1Lm;CPL(4{fSx=zNYO_#%eIX;%NE5F#<`Rner{E?A{5w4^kx!lW`j`vIJ z8oiH3saO!#iW%QOn0^3qBp)NMyTyS^Nu>pRic-4||1HzY^) zej!d(KK?x3FvcvGyKQ;X`*(}eRe~OQjrbq~l5r>0q|4#I5U*xSq#uJ7JrSSSFWD2H zdirA8>T>ZR2Jzc&ZEe}f?}3+o>_7IcMKtMh_%FmS^V{Tnq^}THQOBX3j|hgF+U_>E z)pqiOon^(T1zo3K4rYorT@L?+`G|Ilt1jQZ6-~$aZnkg3LJzO->s8;$IJN0=_%FmM z^E=vj)#W2SmCKmQ*9p&0CTx1FE5EpnKS@;8$D8`WJjIzeQHO0;YC8>Z^XuyD8F?Pc&O1nZR@Zp@5K+ZAPI0})l_{pT zi>nk~ezW|EtmcYszf3O@eH+#)PZE77qD?vxr%aCw(D3Fr;^Zk8zW{Bdf1>^-alTAk zPY~zKEFsRDak?o+?eB{AiN!t6qCkmdlM}hYDJexfY*+x|99v;1uLh;wh^pitaz+!CC+(&e=WeQyMy2ZABa$&CW1vy>T_k7Zbo9XJSap6(hR z;w|E^ArbXSWkErdLtTi=1Kto1iBH60MBqH0!-5S!PE%agTmf3di9oy=F6{v%TTyI+XcJDO}YUjEgi&sW>r=E~MIi}U;E z%g{TqVNWgdRi^)`IJMcT-acE_FuoqaX%wU9ik+;@l?9d0kEqwB-Rnb!IAwmy^uHOW z;n8A#7ugtZrq$&%!bF^51MFKOe%-W)I%7preWPZx@KNqJqNA+V?|9*3FQuDnGiRQk72gSg%un0ersJ7(uWE?_n;fWhP~WB3_0lWabUEBq zJa(R*x{s>k*r_A;t|V6U0xmQn*Lp}uyfnTS-kH$=*y|Tyo%rXGF>%k z-COlM>x!!`OAHrSx#5Glirkt6dArE(spC0N&v^Olr2fgGeDDErCRv#Dn^U8>N~%j4 zcV@YpdCkbZ1$Co%!11og51B5SMFY1lZ_=DIT#_)@tsbqjlQ81CUJ zsu{MUQc~SlZtyCWkGlR`G4JB=Laxv8dC%oiU6sA!aN81TAhzi_VT1Az$C6^7H2`8e zdKFfTtQ$nbeLWc|r-YPZY$Uod(kzU$3j2qojC2JD!<|wq%D9Xi59VO{9K=rGptV9h zMJeOLbo#OFV`sVjlA^52Y^DtMGgHdnGE>6*<0zN7SeQL;JSDtieC3oy0!8E_S)@A- zRIiuz^_e)G9SA4N`cp1F?>jgmAa|kuh95xUbA|Y{Oy^&tPW}kf-8DmH&f@2fXljXU z_pVOO%|W^fO^O*^?|2Y{IBr~O94A5T#KoxMQ`d<&tcgRW8wJ5XG7iJ-GOGJ|bVF>K z`WQzf%9-fY`QzKbc>8I=aIyOiYhEqhFFFyIc-5xsl6jGF z{Uv{DczApGyEk@o_Sdz@tlnQ+G&EjL+WoZ{_keqY9yL4Hp}(At*uILbtTtT^S1p=` z?WyRdE5A>xdARDrqP5&WXHU-{qeW);qI!J|)x;ImeOOPDWcc9k-uqO5ru@is8ISB6 z>K-RNR#ll<(NxBxj>p>GIG>`5r}fO>;eL;mecE_rx{O2iql~Aqo47bqB`_es$6Hf3 zkb1dA#2}uT0pUaLuAO17jYp=-IAlMD@fcRS4uPJAT8qLMf!yyXO^owNd!LOmje0hZ ztlPWBu4M8Vx%5*O-w@kbnXXU$@oE&8QT~XV{5rac7MQu@B^rTg>eIljdw?#k+TQw) zvQDw$i1_4n#2;gh`rQPv;iWTd4s?BStR=S1+D?4N%8)2NqwT~xtzTc{`un4={jBzX zeNO&04(;duum5kw42b0;&S#II{2c0i?A!My9-qvsmR=;bdA^3>a{1}EgCrU{nNRZn zzuQ-@XVy(kAIF?L;`X%Pi1pk7sP9DIj6J$c*T!Sm%f~;!rirh!9|zxD zb@Zb$bLY-HdRN<@&9-ZhZWLj>%Ju93af!|jB0t3TNbF}mbf*6AI{R!N3^Z5L`Gw7X zR;23dK(XVY6WEh$+F8X|v z<*k~Bzppd*z3S^r65kJpEN`J6rq_e*ZZp?B&60#G`1(%t#d;vq4at$cpTgk1XN?KkRvM1o2a($`svG0{k0!PMo0BM^(V!$5Pqfm)zAOR zxc`?v80an{kT|d{5zJz&!VWz0PXR04${Q$ zikNi2x_sq+NA{zd#?OYu9`i+&ThXWe%JNa?yZXI$3O^ebyL_}cW%~bLSw3QHGVf(S zswwEvk_-2oBA{f z@bPoA>%dK%3~SQOgVS+*K8z7*_oHImy7Pjn@x{LVXL8_Y%ST^g{+XC!r}`rYeztsK z*PkDG^iRHvYWe)#c*OQmcJf@WNE7=(ah_KY|EoX8zp-5uIS{*iqR5ngQBv&k`4=sW zC_?#fE+090v7L+Ew#nRxz8|}MqR*dydT8wO`KOma^wa-uE+2XPCbw^~+qmeLjTjoc zd`#!jKlzE+_7qD~lb zO~3+T8y4IBvpJw$K2b#@_CIo;BY*ox^||QM)cYN=FH2&^o{hW6Bi1`%zAF&)nC-O_KLvnqR%Sc|kmY);-*zV8fKvc^|I|aEs#B!3$O8Xg8 z|Et#vxu22Wk!3)ptEZvik=TGE^I-liokmFSk6YnKC{C~NxZ9n2anHTDO zm&-)-)$5CxzIMN-{+<{vzZ;YH^0Trpz7thvYIs!N(Wc39$i8-X?EnAwb3nVk{FBRC zPFwax?uvCsi0xu?;NOq~;RGS?!#|+84`2DDuS0jto;b?2ZNE>ZPT-_6U%FUY2*y@QRtn{#LVzf@@F(4)FUO@Mi*TeWSs6(^+)%1r0LczO`Nq}nJZ1IH=TUdYvnMS z?$mWMPMNMx{qg#Han=?sFEj}VY;ROQi|x$l+InyzNy_FYRCI0|2NFapB!c6xc-ylmJ|7JOhZm9w*T+U0V~21+ZkQ^53I+z z?X8MFzf-=-%r8k>igQ09hT)>#*bAEVJa|&5?ztt4GSm<5^md7Ru({$j;qJIJ>m6R( z7z$S|zAv_yGM#^ox~iTYRJ&NqLsY$}YbvuIn?P@upmsdW)In5NW%#r@4yReh+Z$~h zFN!BsPFGsFI*I+KBl6fo#v#*U%e3}#e^0FFb zuB^y4A;Yb!6WtQ>44mjhoTA*wbX}tAMHOdFw*Xzc&0+!7@bUXGL_7y)Q`?*BB6Ssu zx&0W@*sV*T8*&TwP-e^=23UHM~154 z!uf(M-JZbp3xnUTZNapN@XcUer|UQ{UM; zs7jzqXE!$HMQm+t`Ir^N^u_*VCDWJV?|8*4SmZ&lVYt}81b;W)o{gdn*U_+@&wi=W zn-;;v;w$2N?&cmRUX~GKSCo3(G$P`Z>AFPKOBI@^?kqNCx~jIRJhq0Lb3mYw)BVknLhC<)P?h^XI=-LO(xIEH>TtXoSWPThyj-Kr=LlBU*rLS6ZPp+Mq4k z!3oZ24;Q$?4IR)C?(je-P(7ut-C-~K-td7hy1)-&8MDh)0?`%S&>f-%%pT~8Ug(WJ z5D#7lqaXTX00v?Z24e_9FciZu93wCiqc9p{Fc#x59uqJTlQ0>fn1ZR8hUu7rnV5wz z%*Gtd#XQW%0xU#07GW`#U@4YiIaXjLR$(>PU@g{RJvLw?HeoZiU@Nv^J9Z!fJFyG9 zu?Ksx5BqTd2XP38aRf(k499T-Cvgg=aRz5`4(D+J7jX%faRpa#4cBo4H*pKMaR+yC z5BKo^5Ag_(@dQut4A1cbFYyYm@dj`44)5^+AMpvF@daP;4c{Sl@MeeuntE2^AwJBJ z0HPi1gh+(MNP?tD2GL%QB~lI%=RMYC*K&T?e8)pn9l}251O-Q0=(V7){U=qEdeGyT3Uc(E=^e3ZgxsHfW1> zaDp@1!v(HzLkDz(J3P<{o#6>Dc*6(2=mJ0ZBLIQu3Q?bZcLbpadZHJ4qYwHb82!*6 z127PSFc?D+f}t3O;TVCD7=_UogRvNg@tA;#n1sm)#S~1%G)%_~%)~5&VK(MqF6LoA z7GNR5u?UN?1WU0D%drA0u?nlP25Yen>#+eFu?d^81zWKV+pz-?*oj@(jXl_leb|o! zIEX_yj3YRTV>pfzIEhm@jWallb2yI+xQI)*j4QZ`Yq*XZxQSc1jXSuDd$^AWc!)=M zj3;=CXLybmc!^hdjW>9UcX*Ev_=r#Vj4$|#Z}<*zaBqeLiL4|61dXx}O!5+N~? zASsd|IV_O^DUk}Pkp^jz4(X8r86nz&%8V??ifph#cI1F)M=KX{BMW6vftF~6)@XyaXa^@aqdi>U3O95>N4UcSozNMc@Papd;EOKs z15HdQ0SH7_bVGLpp$9~}7NUK!-spqA2u45j#{dk(APmM3gkUI!VK_!$Bt~I0#$YVQ zVLT>aA|_!nLNNtXF%8o(12ZuTVVI3Mn2ULsj|EtWa4f=NEWuJN!*Z;^O02?atif8W z!+LDMMr^`nY{6D+!*=XI1a@KNfhO7&nj2SWQd~6K ztbwLB#LNe!yYt$qcnzSzClziFRE`BRi!tFBU+#(L>qvu(FSeN4o+}Jd$_rH za0k_gE1l38p74S34cPQ~#{}Bgq5fAZUjs&nkLL@?BBtcRnLvmOm1yUjv zQX>u0A|28r12Q5LG9wGJA{(rb9XXH_xsV%qKvPMIHS!@p3ZNhg!3Kq4iy|lr(Oy$= zlt4+8LTQviS(HP0R6s>kLS@*Y3aX+Ss-p&Kq84hS4(g&F>Z1V~!XAy#7){U=4rqqv za6}8VL@TsL8?;3`IKdh1;R08zL)i*Xo_37CjUn2b$riNxP{xe zgS)tg`*?tdc!bAzf~R=j3#Ib2Q))-IHCnwq7_=B4cej|oZyW1aDgk_&;cFc4i9ufXL!O3 z-td7hy1)34cPQqp|A>RQh==$vM*>(NArc`mk{~IPAvr9O0x6LSsgVY0kq+sR0U41A znUMuFjjm*a6|y4-av~RK=2*#tyr3yzB_HyG=6aQaC>(PVZ;U2r3I{YpbI>%d z(gH2f3a!xwZP5-+a7KH$z!h%jfR1p72RflMJmCdz_`nxk;0J$*_UZ!B72VJsLFj>= z=!M?sgT4qxKlH}{48$M|#t?*HD28D;MqngHVKl~IEXH9xCSW2aVKPE71yeB%(=h`x zF$-asjX9W$d6_7x| zVi$H}5B6do_TvB!;t&qw2#(?yj^hMQ;uKEf49?;l&f@|u;u0?73a;WBuHy!7;udb> z4({R}?&AR-;t?L>37+B^p5p~x;uT)w4c_7%-s1y4;uAjO3%=qTzC%gC`j0q>i+G3+ zb0h%Glqw042#JvdNs$c6VTlw-iBw39G)RkdNRJH2h)l=~(Vl8nWP=s5BL{LK7jh#H z^1>SVkRJt55QSia!mvdV6h$!Yy&_p*|X*A?(ozjnM>6;ecjn4o9>=OSD33v_V_6gA<(59xiZ&8#r+Fc5<<7()<(p%{kY7=e)(h0z#; zu^5N(n1G3xgvkiS6imf5OvenLniHs)Y1=3zb-U?IY>2#c`vcx3ahaO zYq1XNu>l*g37fG6Td@t>u>%pTh(~ygCwPiyc#ao%iC1`yH+YM8c#jYG zh)?*8FZhaY_zrP_-wbgO7x54u=12ewBt#-4MiL}NG9-s3QXnN#AvMw0Qvpe0(NHQJyp+QA9V zXb%^-!VMkJ5$^CnCv=7pqZ!B7mtaE!o6jKXM)!B~vLcuc@VOu}S@VhW~W8m40gW?~k?FdK6)7xOS53$PI3 zScJt`f~8o716wJj5eB#uGfn zGd#x&yu>TK#v8oFJG{pSe8eYw#ut3WH++YMKUCZ zB~l@<@}mF>q7ZCQ7`7;a zq9}&qD1nkFh0-X4vM7i0sDO&7gvzjkXy3gms-Ze+peAaeHtL`*>Y+Xwpdswh2#wJM zP2qrMXbwlTfVjE16MZw7s2R<{uqFP7=*zXf)EVFFbu~CjKnC6#u$vnIE=>xOvEHiMkuCW zDyCsNW?&{}Aq=xI2XiqG^RWO65spPzj3ro#Wmt|CScz3wjWt+{by$xL*oaNoj4jxT zZP<<-h`>(l!fx!rUhKnu9Kb;w!eJc2Q5?f@oWMz(!fBkrS)9XpT);(K!ev~+Rb0b$ z+`vuT!fo8aUEITcJitRd!eczaQ#`|SyueGm!fU+2TfD=2e85M1!e@NJSA4^Fh#ULN z5C?G)5Ak7+1h7CtBtl{&K~f|`a#$h-QX&;nBMs6b9nvEMG9nW)BMY)38?2BWIgk^% zkQ;fB7uLv!{3w8eCo_0a$gVUI>=j3#Ib2Q))-IHCnwq7_=B4cej|oZyW1aDgk_&;cFc4i9uf zXL!O3-td7hy1)34cZi#M%@7B15fAZUjs&nkLL@?BBtcRnLvmOm1yUjvQX>u0A|28r z12Q5LG9wGJA{(rb9XXH_xsV%qkQdg-hx{mjf+z$V6oxH|peTx=I7*--N})8$pe)Lv zJSw0fDxos$Pz6;{4b@QtHBk$-Q3rKV5B1Ri4PlQ)XpAOk3I{Ypb2y>}TA~$NqYc`k z9h~5d_HcnK+|U6X;SLXULT7lw3*PX7FS@`F{s=%Ix}qDpBM3dv6TQ$Ieb5)d=!gCo zfPolx z01FY0MOcg_Sc+v>julvmRalKRSc`R7j}6#}P1uYr*otk~jva`=PVB;N?7?2_!+spV zK^($i9Klf>!*QIzNu0uIoWWU~!+Bi5MO?yVT)|ab!*$%iP29q5+`(Pk!+ku!Lp;J` zJi${u!*jgAOT5Bsyun+%!+U(dM|{F(e8E?I!*_@q`ppmraS;#kVU7f_Ktd!!VkALQ zBtvpoA_Y<+6;dM&(jpzwBLgxb6EY(UvLYL-kR3UY6S`(<&Q4Q5m12s_#wNVFkQ4jUe01aV}Mre#C zXbJ~3LvuKy1zMsNTB8lxq8*&zjP`JWE8Nfl9pMfSbV6r%!VBK;fiJqi5B>;1AiAO( zx+4fZ&=bAT8-36h!RUwn7=VEoguxhs5DdjI495tJ#3+o$7>va@jK>5_#3W2cD5hX4 zreQi}U?yfE46`u@b1@I|u>cDZjzw6EC0L4OSdJA~iB(vQHCT&vSdR_Zh)vjxE!c`} z*p3~Dz)tMKZtTHc?8AN>z(E|sVI09x9K&&(z)76KX`I1XoWprsz(ribWn95kT*GzT zz)jr3ZQQ|K+{1l5z(YL3V?4oAJi~Lmz)QTsYrMf*yu*8Zz(;(-XMDj|e8YE$hk48p z2XPS(@nMbxus}j2LSiIAQY1riSRw^dA{A024bmbV(jx;hA`>zr3$h{`tdJc!kQ2F( z8+niy*2staD1d?}1RE5FEsCHhih)OAl@ch4QYeiwD2s9^j|!-WN~jDwR6$i#Lv_?Z zP1Hhd)InX;Lwz(rL)fDc8lwrC!U0sJpfragTA(Fbp*7l|E!x2e&S(!8xWWw`&=KzN zKqqvDC%oVdANZmR{NRrO1fnatp*w=m13l3Tz0n7K5sZH5j{z8nK^Tl72*FSc!*Gni zNQ}a0jKNrp!+1=cP#W|eE1zf}>T*eh##Wh^V4cx>n+{PW;#Xa1|13bhdJjN3|#WOs|3%tZDyv7^6 z#XG#m2YkdQe8v}i#W#G1c#zKwaS#{r5Fh4901G5UA|yr4IlWT3;f`Z00g2dx}iIQ&;vcu3%$_?eG!a) z=#K#yh(Q>PAqc@x48w4Yz(|b3XpF&FjKg?Lz(h>KWQ1Z0reYeVV+Lko7Q!$ab1)b4 zFdqxB5aC#a#aM!+Scc_Tft6T=)mVeIScmo4fQ{IM&Desi*oN)cfe7rxF6_o0?8QFp z#{nF~AsogL9K|sl#|fOoDV)X`oW(hu#|2!(C0xc8T*Wn9#|_-XE!@T(+{HcI#{)dX zBRs|vJjF9S#|yl~E4;=Vyu~}b#|M1GCw#^ie8o3>hj@tB3~>+_@em*8NB|2YL?R?c z5+p@3B!?wZASF^EHPRq0(jh%EAR{s%GqNBnvcU@3kpnrA3%QX8d0~xw$d3Xjh(fSI zVc4PwilP{bqXbH#6iTBE%Ay>~qXH_T5-P(ERZtbxP#rZ;6SYtqbx;@eP#+D@5cX(< z#%O}3a6mIOha*~`C0e01+Mq4k!3oZ24;Q$?4IR)C?(je-bcQFq;0+)6q6_@sj{pRs zE4raOg3tp!(F?uN2YnHYe&~+@7>Gd_j3EfYPz=LxjKD~Y!f1@aSd7DXOu$4;!eoSE z3Z`Njreg+XViv+M8*?xh^DrL^un^%`gvD5brC5gLSb>#Th1FPtwOEJs*no}Lgw5E3 zt=NX`*ntS_#4hZ{9_+0Qvpe0(NHQJyp+QA9VXb%^-!VMkJ5$^Cn zCv=7pqZ!B7mtaE!o6 zjKXM)!B~vLcuc@VOu}S@VhW~W8m40gW?~k?FdK6)7xOS53$PI3ScJt`f~8o716wJj5eB#uGfnGd#x&yu>TK#v8oF zJG{pSe8eYw#ut3WH++Yvyu%D}5EtMKUCZB~lc6=N}?1>qYTQT z9Ll2tDxwl9!wywY71dB3HBb|^P#bkn7xhpd4bTwwXoSXSf~IglGc<=ITA(Fbp*7l| zE!x2e&S(!8xWWw`&=KzNKqqvDC%oVdANZmR{NRrO1fnatp*w=m13l3Tz0n7K5sZH5 zj{z8nK^Tl72*FSc!*GniNQ}a0jKNrp!+1=cP#W|eE1zf}>T*eh##Wh^V4cx>n+{PW;#Xa1|13bhd zJjN3|#WOs|3%tZDyv7^6#XG#m2YkdQe8v}i#W#G1sCdi_aS#{r5Fh4901G5UA|yr< zBt4IlWT3;f`Z00g2d zx}iIQ&;vcu3%$_?eG!a)=#K#yh(Q>PAqc@x48w4Yz(|b3XpF&FjKg?Lz(h>KWQ1Z0 zreYeVV+Lko7Q!$ab1)b4FdqxB5aC#a#aM!+Scc_Tft6T=)mVeIScmo4fQ{IM&Desi z*oN)cfe7rxF6_o0?8QFp#{nF~AsogL9K|sl#|fOoDV)X`oW(hu#|2!(C0xc8T*Wn9 z#|_-XE!@T(+{HcI#{)dXBRs|vJjF9S#|yl~E4;=Vyu~}b#|M1GCw#^ie8o3>hmwl* zA8`;D@em*8NB|2YL?R?c5+p@3B!?wZASF^EHPRq0(jh%EAR{s%GqNBnvcU@3kpnrA z3%QX8d0~xw$d3Xjh(fSIVc4PwilP{bqXbH#6iTBE%Ay>~qXH_T5-P(ERZtbxP#rZ; z6SYtqbx;@eP#+D@5cX(<#%O}3a6mIOha*~`C0e01+Mq4k!3oZ24;Q$?4IR)C?(je- zbcQFq;0+)6q6_@sj{pRsE4raOg3tp!(F?uN2YnHYe&~+@7>Gd_j3EfYPz=LxjKE0z zKlaW8K8oUt;~PpyfM7%vP?1oiD4d~+QcOq)2@n#J&_Qy^ZIUCGyKr}bgk}UwEC?zf z7BqJ3*s%eMAQluGAU3dKNB^j?|9@}yUT$`CEd>p*lh1c|?@fFAW_D(Fc6M_WSPoWz ztHCwkTCftV0;|DwU=6q)+yHI_H-WX_W^fCr1h<0Q!0q4;a3{D6+zr-&d%(TmK5##H z06YjD0_(xU;1TdBcnmxao&ZmR4d5y8G1K=z0HTVX63%gCD>_@FVyM{0|%gKZ9Suub>M227U*BfIq=s;BW8`klNw; z2Tedz&D9{ER2cp68pe;B7v;!xClR$gW0dxc>gHyn%pc6O^ zbOte?3+M{Ef$rdR&;#@Yy+Chp1~?P+0eyi9oCRV*KhPfx00Y4wFc_Q-hJbUxxnL+5 z28M$X;5-lq;=xFe0209{kOW49WRL>JfU#g4NCo3T8b}8dKnBPJSzscV1SW$iU@Djf zrh^$^CO99=0@=U}azHMy02$>OK^d42 z7J!9d5m*c^0OjC9ummgx7lDhxCE!v}0WJfVgDb$5U>UdyEC(yV)!-U%Em#Rwfz{wT zum)TYZU8reo4{IdGq?p*f?L6D;C65axD(t3?gs0?J>Xt&AGjYp03HMnf%V{F@CbMm zJO&;IPk<-E2JjSk8axA@1I}9f$iXB@CtYpyaslF*TEZL zCwLRQ1>OelfOo+zup8_F?}5GGeeePJ5PSqa2K&H%@Co=7db@1!4Kdd_!0aB{s#_$pTRHSS5O6h1HXemz@OkR@HhAeNGIa@2Tedz&D9{ER2cp68pe;B7v;!xClR$gW0dxc>gHyn%pc6O^bOte?3+M{Ef$rdR z&;#@Yy+Chp1~?P+0eyi9oCRV*KhPfx00Y4wFc_Q-hJbUxxnL+528M$X;5-lq;=xFe z0209{kOW49WRL>JfU#g4NCo3T8b}8dKnBPJSzscV1SW$iU@Djfrh^$^CO99=0@=U} zazHMy02$>OK^d427J!9d5m*c^0OjC9 zummgx7lDhxCE!v}0WJfVgDb$5U>UdyEC(yV)!-U%Em#Rwfz{wTum)TYZU8reo4{Id zGq?p*f?L6D;C65axD(t3?gs0?J>Xt&AGjYp03HMnf%V{F@CbMmJO&;IPk<-E2JjSk z8axA@1I}9f$iXB@CtYpyaslF*TEZLCwLRQ1>OelfOo+z zup8_F?}5GGeeePJ5PSqa2K&H%@Co=7db@1!4Kdd_!0aB z{s#_$pTRHSS5O6h1HXemz@OkR@HhAeNGIX?2Tedz&D9{ER z2cp68pe;B7v;!xClR$gW0dxc>gHyn%pc6O^bOte?3+M{Ef$rdR&;#@Yy+Chp1~?P+ z0eyi9oCRV*KhPfx00Y4wFc_Q-hJbUxxnL+528M$X;5-lq;=xFe0209{kOW49WRL>J zfU#g4NCo3T8b}8dKnBPJSzscV1SW$iU@Djfrh^$^CO99=0@=U}azHMy02$>OK^d427J!9d5m*c^0OjC9ummgx7lDhxCE!v} z0WJfVgDb$5U>Udy;4{=0#GnfC_pU4PK`H*;b*F9D<3-gPgjnM9wQj0d!* zG?oMY-gVXDW)j6aKHeUg)u|6cpgz-gYT#I|2!&0J?_H;wt#;+}_}VXDmm>~;7d*X% zRuBH}=sM{4N3J_R0w3L2c;=Upul4-=(a+3kX7^x6dazuTdbc(7m@MZcPVs(xo4#W} z`5WKe#&rj?#Q~}ZBS8X41fxI_7!8s^3K#>%f^i@fj0b5T9ZUcjAQNPPiC_|#45omo zU>cYXW`LRCd@u`S11j1akP9q826-SK6aXuj4GMt`6ahPMfMPHQIDreeK?#@(=7CaB z2IhkWU?Erp7J~~wIk*rk0ZYL};9_tIxD?QJa~ZfCTmh~G%fMA&IamR%2G@XV!Ah_S ztOnPCHQ;)11Go{~1lEF^!7ZQ?+zM_3w}U&to!~BTH&_R#&fg2}1NVamz=Pl+upT@N z9s!Sn$H3#@3GgJ?0GupPV%UIDLy*T4?& zI(P%@1aE@3z}w&*@GjT|c7r|OJ+K$N4?X}Nf{(z*U?12IJ^`PC&%o#43-Bd40KNiW zgKxmM;5+a=_yHUQKZ2jY|G**eGx!Dk3aY?w;CJu`_!ImE{s#X5Y5>DP6VMbi1InOE9l^=q6mTl&1Wp5;K@8{ux`J+? zJ2)Nm06jr3&>Nfq&IElxUtj`ffmqNF^algLKrjdl24{mI;2dx+7z&1g;a~(f55$3Z zFcKtyL@){@fzcotq<}GCEEoq;!FZ4c(!m6f0Wv`rmVN0 zuom15ZUL3xR&X1*9iVHwfU0FV;C^z-N!osrzumbL{pYw7kB=?DhkZVu{!i+e$3Hnh z`8XTm()VkqpRATcCb}B^WI|?Uy3^pnG3uo2)q5C`JHNRR*$!6=Xf zMuTLK0>*%`U>ryV<3Soo2NOUB$OKtnBA5gwgDGGtm?iL)UwJ3E3)~IXfqTHc z;689acmO;I9s=vZ!{8C{D0mD!4xRu{f(_s)@HBV^JPV!!8^I>989WbO09(L|U@O=L zUIN>}%itC8DtHa-0I!2Lz)tWccniD@-U07|U0^rZ1KtCB!TaC?@FDmJd<^!1{ooVu zDfkS04!!_if&<_y@HO}bd<(t<--92(LGUB^3H%Qn0zZRaz^|YR{04ppe}F&1U*K=> z50IK*oD77WPb33`Fv;0$mk=mYu!6F3XRf_|Vs7yt%>L0~XA8w>&G zfOEl6FboU_Bfxne4#b0zAOR$TQ6LG72FV}=i~(c8IFJg)gEWv1CV&i(39`UMFbPZs zQ@~U(4NM0!z)WyHm<6(d8RURmU;#471Noo;Six*i2yCDT*ntBSgE_znT)+)Vz+5m7 zl!7uaA1nY1!6L92TmZ_!g989WbO09(L|U@O=LUIN>}%itC8DtHa- z0I!2Lz)tWccniD@-U07|U0^rZ1KtCB!TaC?@FDmJd<^!1{ooVuDfkS04!!_if&<_y z@HO}bd<(t<--92(LGUB^3H%Qn0zZRaz^|YR{04ppe}F&1U*K=>50IMT`Ug!wQ_u`F z2jQRvhyanGC1?d&gDB7j90#Jo@t`d@0ki`rf|Edd&;fJ=CxcVKsh|@$4Ri)EpbO{< zx`FQCbkGCz1ie6Sa0WON^Z|W=37iFDK|jzR3;+YcATSu54TgYoz`0;37zT!e5#T%! z2jam&Y1X*Arm;@$+DPSs?2Bw1aJz}4Uya4lE~R)N*vIMcCjD>wK$`xN=05bzqt+(03S8^_$!qA5E<1~?E|=9| zccnXQ*4#4FB&)-w{)gOAcKmJ`UPV?+qh3(jJiM*N9Eu`ummgx7lDhxCE!v( z*VAR-a&QH>5-bB(f#qNYxEfHMrt6P>bG+eZT)Tb&0efo`SHohc$`OLna_>tH*mm(#WYm~%~5cEmLf8&*%9)&6qhwZcGl;HN6 z^l1KN6|c@O(dX+=9)dpUPU~EAZds;mcUj%mxw2`L-JD~SX@*EUk63kTGes7UEe+|V zD^Iu4X>@@6VR;wmH~@7w9exYZ7e0?M;F)1k8g9A@F!;J>S~ICFJ~IB3tEJSVf3$RR zhmO*k{XL}NBZf)ElV?ib-?9ShJN8L0^`9O#;!wvXOP0nrjVo!@d_TS@d`ix#t$V(- zrS0aHCv^ICTI;@J<<~}$-RRnYYRdJ-<-Z{&uzfppZYIrq#eLJfH@>>#{gGPxvYgTs zoge$E|5)78UztCq{Q3W)i*Z9ahFPnfcw8;i9nesapfe5k9AjrVKNhHjQR`Dal&rp7 z^uNWdjq(w#5&T%}Ps+P!+i$Al)IQPLs%HoEy(Ss{R~BAy(pUCgBh@P%_dD>X_L1fK z9I08f+Vj)#U(v0(Zimy9DZ9rdq^EoT&w8@e?lxt*@!!E|UVaD=>kGAwT;9Cb=Rv>4 z^N8-MZHJQ=RRK41R!;AVQA=EgsTcbjbq1#)g7bxDX+4!E6;>87=h1%6~7dR9DZ+58n%_(vMM*F3#mc~nzmXXZSsJGTI}XH+RHW;fe1t!~){^JQA+Q?=2oo60_2Yad^F zOzj?V+go4Xa53k@dg$fs?@y1>PPxpV9tT3ugDY3tG>*Y?e1WeM%1fA&)|A}Tl`CU z(wFv|IA7LFFK2&$dL@=Pm3wl3by?JFJ@lgfIUZ1X&@qOyQufK12fE{t5jd3cQ>spQ zAmidpRUdWy9R_=`oWh7s&}(AGIO=UsnUl?~1e+CBqrSzJ;IO-$4x3GOCdxKBACntM zK-4R_S73V`zz6;x{yxwCRNUZsYCTf>3u+HpF6u1a*L!M#N{UUHh1OzCkTiRe z)#-A3Psfv>*uRzc){YzKUIw=&QZy!?TEDz^FhzN>*X;QCOLpCG3jKhi_Pi;!ELViW zCauVB&2f}sxL|hX7GU_0C!?V<@qwbFJwHP>yBv0E3&r*_;tZ`mZQy?#D9*%O-;`En z%4UqS<($qxWYO!EilaT%GnRYA)w@iz*-opw%;dF%r@>~Qaq?W*CRHK^m)|<*5v=^I z)1r32CwGt3>%sDB1w03uUOqWJBg>RxM}wVj#T~D3nB;I~%F66nnsb~ZSGh!$6vT2H za%OP-k}n>*c4Eb&AG02+o^2()oc#mpmzI~8RUl``xelkr6QL4&w%48z^f~uX+4X}n zCsw!XtdCwEl0IJ3k-dcR6Aed|?oTtWEa(&5Ubf!{EpB~v9No$*j`h>a*4b=e(pBQAaUczyk1IqSjuAo`4UIPx*F!w9bkgH5xY z#`a27@%pO>L9cTwfcD+WcuIh8`EhLVo&HyC2w&f1Y=H z&uJHb`C#j>X+0J>vJ3ThELViWMq?LGr^3T-lc%Ljgf>>Y+7_`s|Mfa_oRTt+C5{KC z#0Itxo%V?92R!!m&R@6a`!kjcrcn-SX&;kv?}jV9(vqz_wukq9Fx4Z9}eEiG% zIe)Gkjrozr>$g{*6Ov%{R}i9{l46k8}Mc zJz7E!mQxtfY4oVJ18k9*TOi{OdL05&{{MA-rR%gahyh(dS3u|Qs~*P;pjO4(&gkz? zqVW$Ok~-{v^uFZ>CaWPa{=}pvUFR%U5)d}yWw)t%pv@O}u$vRa=j)x`zgZ8xsNIVP zw2uH(K9v)~@O}HG?`Gqlc0T*~>`U%hv1$hW-)VBG2uOOdT$Osalgv)5(z3Wr>hlQ~ zw>mWZmrLCV=+W~X&N5FFQJ=VhT776yCBE< zuw0dTw?6cN*(RB7R*Rx0TILd)+Z111EZZ%JChD^j`jBJ$=*x}##*LCA_WpGL>2yp^ zz1|{g$W>p>{fK(^q0XRZId~LH{e*Bc!u6fXt8`FcePZxW&(2x%)F+Fhss=XqWJvl@ zd9j@J;JtSkjWN9=7h_eggsYW0U8BE!5|l(@qTM0}2XCJWZtr~CpIcYrX^HCCZhATU z*K8Nm&W&10+-6cIZ%Z}f)}+50L)2#t^daZ39M|B3wwAAtTXnGFmP)#=$+6v7u1dYz zn);9?boZTQE|l%0Q-RoamLn>+n;p&$Zl4zm|N6R96YJNUBilzWXMg|tI7(>TA=abK z$e)})dywBRcYfDu?q7c_pks2Jzh18TVl9agTx*whEW_4cYWuS@iP!ld18AO9fQlS*{3$jYl==O)MptiZD$~K{dyd zR8yAORhVW^C@$ft6eX6Z&%Pk~tcVK7x-{qVy9ZtP@Vr)PrmPRk1yz*8Ao}Fx=@b(6 zDLzNrUQ#EW2YQ_tCRI#*U{maI;ZnCxmUoHyCC5bHX(7k@uw0dTw?XtF`(Q;#F6MOb ztQFD90oUvFbDJq+XsTCqLlhRLK1)3aJwF}%#&aZocl)U3jXUfP_vdKnB{dhph+cPK&Yl;A-Jh3!0LXmC64xMjsZ?^`A*0M&9;T)p+BM~1`U z=KNz2lJc*->x<>3$bZ|Zm*@4IHqZ4C@pbp`ZL#cGpN&305k%$M68CHV!ZauJ3U-0o0B@jjvw`jF%Hj=nK$ z!SC#)VbTM$HhoHdueUAvC1>mZmeaa8a-`Ss*s@#^3LAg=sG3Z4LAl8VvRzb9iCu{; zmt)*;tzN#y7vGQg_46TP5A0JSV>6x#5?j5z+CTWXaHNb?TQYU$o*o}#pkgfVqRUyT z1gzga=tpJCcB5l5k2p{Kgmm8>gGWreitbCv(Vph-Sgr_#O~8I4#ijHGWLukzwQp(m z8X8t2E!MAmL}2@E#y^1VzVzO{)4HTLiKPdmaNMu6T$Osaf%T&cbFSGoQg+XiWxFzQ z9B;RHlvENC``KRS1=cSc|Cn~#k8_9Ldr8@|di_}L)l5CAhkm9c%ogFkVIJn3HP^@H zAbL{HE5@wYp49t>+gKkS59sCWA5c$mJRmBC$l`T7B`&c2D6av(G~036-CeUdU%o!{ z@@oI!*N4w5L)7bF2zn(ny)@>Gg|6>7U$&QC&i>v}w`oF&Tp}yaankIVqm{9MiLX%Y zn499p0B)C~ zuF;BU`>PF}RTP2r>agLjL4$fM9>n=_dFtitUvphR_2M+~(ohD)6ek97IqrczT#g@| zxo;@tCHAic3EFWV-6PX*CL4u2w`J@DIFwrLsapHLb=hWBPqp2n`5%^37|{jLS6M@+ z+$<-`xmH>UjEJH>RXTmBixThKDIZ6lk4=61oVtyU$+7+Pa@8026E)UVRNK$1&p13F z_e7|~p8JJ0iNV{A_;)6+>)U%HPeWAeqnEQj-g=fW)|TzY{&w#QC$m^m6w1W+mvCg8O1eA?7*?W!#+xR?w4B zCH8E`eIe-C;qSAqey89aTEeS1)>AKMf1i4emfeYtA~YE(SWq5V%}ON1`jsaIw`1>S zeSZy09r+sPuZ~mNN_si_d-e0K6Y>4r-$$c@L@EL6w>demex=*PrSkHTcfY*--mz*( z@BBW?SufuE(~oajtDpb-RO_tf9`bAkN)#W~vLV!OI-jJEz*aPs{@6`=KD zWQz;F?3z3Nx9Q5Wefk|n8*KG*MT||l+2z6j(8BjmndZ5&WwhC9W)GUUN^q3e-ISAe zJSMK|rM@PRQ*}^7PF=f z`unVZ4*u{_JQpifaNj`d}^Mp^t2^re|_t5ZgYilwTU0`aMM0pf^u)~Bcc?XMj4;q<@7 z^WGQ2d4Cj% z`fs#+vYhqcef20yeUR;<$+kjFX7tBn9O&beogO7UEC1C2 z56;4qfM~Di@!IxFKi=Q4HC!r5Z5_Mzk!`o7d*b&)<3aPcEN8uV@AJ7AY^1wUqHa)$ z5`!(-i{`D0CwRxzuf6qZG1bXRMtSC=@o&EseeZ$mBq;w6D=G^cjcCq zWi+NFbCK0%#R3I)S*q-IT65_MWD>1sRc3OPq{MOA_7L>D>&(T`gA&SOSr4_nZzAdC z?615>H(s9St;3V8?t)Bnk(}nl>QOuVm7p=$a=(>4(c5n=TX^UsdbF7B@#k?Se)@HF z8H0=0^&aF;=M`vty0pz(x6E1A|787mkL7yhk}-8dk8CDkLJ32>aaMbwOZ_p`*S+9SL>uG`S*|g>C4x(s8M6kSFCS)bmgm`-|Vn00^f)K z@h|6ubIb7xh2rSEsJ^k>Bd*?guYd2HzS3Tevgf1Fi|~M5UC8cWZ zqiaB1x7uy_xp#k--Imqy+=I52^m10nr#@K)R;MK$3zEtbFpp@JN7`^BiFr-o#qJm+ z!0pru=*9Eaas7sl?E*hh?_PNSIaoU~^S4byXKudaf2^0%A$-50u8dY+ zS1_fxbZ<>yefj9gxb4-#6M#TH$dMdAFZFUvq_|M>CzSp><4Gv z)Wfr`gUgrYN&>>BhF;b8QC>@XdmXIL!HJR`#dVFO3uVXeaZuxNJfNiIh^ zUD5b15*jM{zZPb+k-bq%ld$;t`51ghsXN-M-uSjqUwn&Z0KO4(4!&s- z@f{y5Bz@6>GAc&A#rV$7GJHd5ExwPm9`dbtpX5V)v*lO3XM!~_P4Q8^Pp5@Rr(YB% zrQ?HZRrpZZ*3L~NXLb|mO?;^7ReWeDA0NPZ<*BC9Fue27=iX-0pdrnrZo8XHzg2`w zKc}^j)|w)e`hZKh#`@%{AoYem4zMxmz$1k@v#y*)g$c*?hUKc%yA8SCWI5Dn0eo(O zrUr2O)&0@VnJ5gnctF|e>vL>mq%?olJ#E^ozVz%won9=b_@b+YUgI6O8@FHvCl~Kh zsw)dTOC8NNTMp(nC|zIkPGlRsTL%I6v!&+;KCkT7k&@h^W#qz#=ic92cU~;lr(eJG z@?OEBo-wlm>$&2%Na^#aHt{nvKJJ{Z2Cc3aEN>V+WsA71l+qO2;|)Rdr0^$gPTH|G?v4UoIkUW4AC`q2%B7*wsYF4F`cT?*ZdAU$_89I|&mqxOM)#eD zJA4)p+lMK6!LPepZ)vyunq3?BaGjz(t$Sg)UQ@o@l+Sj!%d)J+F7IJxfny%-^~qHN zzW%C0&|~H7Gv;3t)AtL#9xSIcMdwS847s=jFTi5HL9;BdWAjr3qUv0T)Rj(zEe(GNZrL-SWDc1(+ysimE0FSL`4Rk?UXyv1Q}3uPG#RM8$)Y3?gDvSt z&xMkqU$>ufuKWJG_urWQ)OBte>xlJkC;Y|so^+#bv$P++nVPmgd*548lH;7U6Cc0f z>?w4wMvl^;`+t@zLSaMNcyIMRuli#(GvEC4Jddcy6l-8TlHZP!qHa8H_%&C3wNS4I z%LNsbL(H$^-6tVq(|E^3%(JK1UHEbhzTO637eb19?1LWU;(@R7+m*Vh@&k#ML`*RTkz$Qq85xziv|2Bd9^QW5@Ms-R!`6P>kjae%LeU?awY! zW2^O?wt6}H`_w}-Uu#Oqw>zA)Bop-=@A|uh=jp}kpk7X4 z$u;D8cpq6*S0~N=|GJ{U<#4c5r1Vw$C*HgJP@iphl|ymV{!@KoxhnN;>#2VYm1)k2 z?VW88tnZ4>ky6_w=RV)_?|&}e>nWU}(u2fXW|z3!^f&-3aq{tb)pUo;O|L3?B8vC@6?3%X0~ulR z0KX3y-6K+3U9$C;nD=^BKZs&|SYBs+Xfd?+wLmEb36Y&>e6h{&vK7H z-B0&&2EU(ee`xfVNk6ut(^Z`MoU5&*m$Sd-`C_~UE2$FkQiWq+tfwF<5s=GqJMt&z zZ#=W-gK()LcKBzftU2QzzMrT3sl8;ml7O%g%8_cS&1#qRA1u^%s=R>LlSU=>tY3jE zuzu;iaetGz#Sz`2|J|o}23)Kk%LUbxLtpv@>@0QqiS3oapQ`4}c4Il~!+T$Pc~z-yaJl2C zR;>~VaCr_X32d(weIli;o&KJCPOs}f>+i{!^o2r_@XoGwXY2H1IqSvy0Q#{$+{kP6s>BTj*^S$GYCCAYjpkvf%_hjv zZ@L%Z-y}2K;kSUke5n7WAsW>nDhnzXa&%1PBRc(W(a$(;7z^mjhp!K^JzNy$~u>nk4> zz=vh4*A!t`f~6elG?{jOb596*G=Kl*vgXUKeNxRu{eO|P)yvsGG(Al5ZdI)W&!gf* ztE-s4>Y|z7ELiC6pJ*CE|9rc+U!*kf&u+8tDoKyMUpLRda@LFY)%sz%i;LdAr4J2w zJFP5-B3FjwN)###F1P4Kf%T~zh;hcn=k6bxx8)XpAK~Eay4wj`Gy!D`pzV zPYf6AxGw1g(=Aw@joF{eyfN!o8{O(szO_leA;Yq+yst~zp_ZRmhwGDHU34_!__u&j z7GB$kb(E!auTL1xus|plP;Q4p2^c~cC=yzS>1WGTMUv2ZNZTMjM8~(?J1*qQCweHk4UPD<{)LlHL^jSCFH&mW=O-Jn4 zLLKwhHLrg=9^07q;(4+jH2-iUj{$w16QA4R+_PN|XC6k{h6VnO`N8^FS$`eqf7d1L zP|^q`OkMJBs5sP*98MkmrA_Uj*d|i_sZSje(`qQ&)HNM{=UmtHjCc)Wf%??1hSA{2 zPQ{n~#JVmXAK7Oby7s=#*_SNz6pzl3hE4pJYi(`QnEE>ZXJz;p76@*E+SdKxDHc91Ucw=ny4wp`c zE8U~3));5gSS-NrH2Ttq{1{*UhAeao=-WhpF^`7!!&e{R?|cn;{VhOa%42<8S$``U zDI9GU2(`^U($4#6=p)$XNAkJ+*Sa6A^_%O4u|Kvg@LykF^|5}S`>Oh+Ys78b77**~ z(cC_Z=h?VR#J_fp;T#%+4*o4<_!t&woE8Xl-H=}(|HgSnN2gZCywuTIuEtpz7C4qH zVBF6gOQl`+b2Y{ub+_G-9P@CFH~pn8K4R{WiL{kOOOjsL@? z&r^R6{9SOpytcpVl1?z)YO6zI3eRQUm~^U-E_Es2`s7!ixU4Jh>ylQe5QZ}>5Q+sF@_K5>v_jGSND5OM+wgT=n>dHd7J406H_A`% zr`Lh~d9U{m^t&!`0;LzsueSNsHhi%B4gX`q0#tA6T6gLiuc0g}>MkBr`m7u88!FGb zrX&7uvQWqTbk5py?CCi2g#4*F`%z=;&VHkd$#N0%)?0Au)x1DKUg0t>#qa- z@4BQNN*bYrsY~7s6^Htf!>Oacw5dH5+eE5A^{GQ*S`B5Jx~Ajroa>riL&a;XdNtJf z1xu$s^($D~$AZ5v`-yc*JU$leLFee}oPEiT6?^zQPs1kuEaSTl`46q_Hv@$`7W|I3 z``}}t%*1mv+6B=XjrTZ|atbAkzcchTw&1X#j_o;r-gErMv=4Nib=8y3w;|41Os65z ztLypriuYgZQ``K-@Zzzrb8AQ$T`T`)ehsPnk(O2~qF#0$R{X38jq8}ggzM=JK==7+3^nDiTex&H%(DpFWQ|p7iP8@4?smnEB^a+i( zmgviq%1U2ejj_!;Tsj@DbQ^CCFf==oEzl%@^5n+^2xfSNU;%xb=r79A(0=&p1N@z@ zA+Ns$XiRymk1OkMMI(iy%>tpexsBz#Lv8y*4cA!CE07*X^11xiy8qYt2P#*?&#*v! zEpQ~)??Cre{_JujpRd1jI@aW386IilkJ^-#c%HS1*OD;c>P7N}_fs;Bz8>g%^&Rx>5vlDfw8wT9Ps4#B13dhOt$kKGV; zEh}mV$;R9s9=jI&@6VjekoJ81-)m)PU|7JgfMEf{0)_<)3m6tKEMQo`uz+C!!vcl{ z3=0?*Ff3qLz_5T}0mA}@1q=%q7BDPeSirD=VFAMeh6M}@7#1)rU|7JgfMEf{0)_<) z3m6tKEMQo`uz+C!!vcl{3=0?*Ff3qLz_5T}0mA}@1q=%q7BDPeSirD=VFAMeh6M}@ z7#1)rU|7JgfMEf{0)_<)3m6tKEMQo`uz+C!!vcl{3=0?*Ff3qLz_5T}0mA}@1q=%q z7BDPutXUv7N|LPClx^=fu}dbMd$4b3`}42sH_-j1=dT=mh4&@%7vG;eP#S^!{H5nh zUe|Q$8qb#wwUKeYjp_fXu}-x)k6>XBN19@ubxpsn@x;9Ad)ydwsP8${HGV_?|BS|F z%euDNWY5NSE_E$qBc5Ra!vcl{3=0?*2*m;w2t@ZwCrq{cxcTSi%Kv_fhm88trl1+9 z>?le77EF9+eY0?BW8N2OiJz9YFPj_xH%Rn|qv& zI99VQRW5Qk%SM`W3k6Ggw3DP2NQ(6#L$! zn6%>Bhu?}zij+EzfBKVUdACKK&{EZe>c3L2JaSd)-KLxK<#7(P#Wbq4Saw>AP?lz! ziKJQ9BB*7`kX@+cxk@02WRt~_TSCFqG-9wL{VMPJV);Jk_w=xX@8+Ij8Ms(_A)WFr z_4rdeHRboi$ymSPjDUQ;ht5`2r#MrQ%CzQy}GS3h46U$fnBXGX^Mn_6- z&Y$KyUt0OlAWy<)8LC-+#24((&b8YVr z&7XB;Mc6)iIr|6K({lz1HrZ^KEfb4J%6Sf_oQ^t+DvTFo}4V&0ukeFQnykL9Y=yA4sl zWVyr%vsrUZqwM*(i0DG;Hz>{NxujLwW;rb8vNUJ1HNOC@LY~!9ZDmPXgDlz39sbt# zXRYAZ8YG`8NskR}{lz+*=R>b_zW2SnA+JYxI@E6Pr|X^N_^ENVJr9mtj04h(=Vw{2 z-;+JbmWJLxL;^UD@gAUfe16Ot*tfC9MZsjuroC_0x}wD13~mN5Phj?QWrCa%ypg)sU;c zl9W~Olxc6XB1CYv(RbenC~`O3w>7lmo0!%nty=gMhL3j*8o zp{NrTl+&xg0qYwrsWYu?Prbg|6T_ts57<*qp8U-mPqmXyM0~O*%Q;=%hoW!1&8F!u zDuU=y+%{ag_l3U8=AZU^uc#C?r>8u6u$=SfedZjSX>Oj&lv!rarS6R7l{nz@?-iy! ze|s@-!QG2wB)1pGd7^-T{hy(UpHM*dc!n>2hb5fb1qsJ`vRsvVw?Xwx za1<3;-I-{21L`S`NB80Wh#c4V%1go&dqy-3mlim3lGe8im(JUJ>5x~`M?AIWbG62w zf$(HcmMaMen+zGZNlw{0(4_Qg81H46X&{(ob`@qhFvhCBO4F1EV;z#E@}1uG>t{I` z%8AUv_jA;WkftpFx3gqd?icU~O`_&48qoN(9XJVe0H=V{Ko@X2=neXU{@`pd93+CV zfF8ij0C`{zSOl&BH-P)VM({TH8er%tbpi3f0zA3-)Q znD>DNCq=`FJ8@#!II&oqSbJ20_BgQtI57w6@9Q|R%;R8(<0a`+oY=28v848rvL@h zArkda2q)@s(4$8jwjunTi_K1Uw^x(Q&+E0>pr|r*%NP6$gsl5+gHFFpplVf}6 z<*IK0dw6sZ?U39;d)@2%xekR9(#hwn>XCQ3JZu{o36Aoo>z?I`P}tP4L!#AHNaf+V z8Q`GlI3PQS_2@Fi@~DTnF1n#|Y&-|o2S*697td=a&Wr3B4``3%lrmm{PWssaeXqe! z>4a<2%MYEhb_^Ypi}7sraz%_yLV?qPo4+L7#nR{-1CF`YT-lUjpX4f0*-X6)%o5X-APQd?f!#&y&mdfnq8{0pA0x;0Mt?mF z84)fGIdQeQ(H?u`XZj6#G$nP+1=ND*0n=69g`zHXseeiVr**YLH&@ThfvuNt`ZrF<;?L(2eJ-b zZxMj>AsIQ+ksyC+hH3mm=JA-QT7M1)FC{+hDGi2xlcR9tc(494wq$`y7)2}}wkg?~ z#+PJ!E(0njx<=_Yh2!#~J(Zu{z9i>xq94bDx8Z_VAP$BV%O^k0Yub$)y)=mdcRHZ)8p{=- zun9VUgyD+zc^A*Xsfonm;;&Er5maduhx+f7EsRTF-4wYk)HT@wgtjv4UoHxyPcLBXYe=q`! z1Lp&pe_0OJgFT=nR2>bj0pEjcRHkpi8Z?GBbl%12wAbU*&qc#{8ZvVtvovJ(PFqRp zg?Z=&n1hb!hPigkJ^wvWl1%ZEbY?o{%X5%!nIxUDN|NS1iDx+bCF#l&!=zag!=#UI z50i?THIdF*&_uB#Or*>&*Ye{iGMbw!_4w2HCApLLdZDr?U%f`DixHUD9h&{~eGo~r&OG?{f=eHHsY3?pQB|7fZk>p(tNH5BFdysq&+!G-U-H`hGJ?}idyE|2KILeo< zQ4h3jj8og=eSTofcP!xRdf}Xd)eH95xBC>I{Met2FlAU>j-)l0H}AQ<Ytw1|{yY!|;=xFe0209{kOW49WI(nX z1I7ZH^G^liK^nlcyo9CT60Iqub?#YUBA5gwgDGGtmcW@v?-b5pmzWTJm#J~r&3 zEgi!ihCQ?v(EcjNPi_ax(Y}z22h;}8duOzE;UES<|Loqkar2~bY4_euFGuaVcx=Hv z>YW0OUugWva{Sb|RL5+G^2)LuP1|I=LNBM{dlPta>Ul$91wwQF>xXNf+tQ<1TGO~a zJq+*fo!L90Z-jKs>(&LAPCU@GwWpEd{8_Ha96xI2k5@A-9vwVizsM>prbonzt3k@LIF84^kJWtzPMqt@ zp7YfD8V4EKNB_Q1_T}Ny@pm+-+ImC8Vka3Fj>hU#Us5|ijQKiOKw18Mova#NS zY!(k_Zviq$kHcE5sptNVL#f@i==&cUGP!9SH8^mefoN=5t_X$AB~ClP@L8%4S(;Zn(vz?Y$JM8^6@10j6Uvh!^!w-I&Ip^`!?P&^E zaq4vxCh6tuk9?JE)i3N|Rt29rVOfHsgg+an(W5*$xE?!pKXmT;9zW6)vf@||y`23y zPmdn-1qK$0YH0L`NC~dT*Xh@8IxxKJUe1U0(97AMGxg}9yb*0-p`eL4URn`?9=p~? zuO7KC|7FgH_0Y@NpR@Gnk%5mjx@8vn(WAqd;PyE0`4?{ec-tB4I3LzSFK2(w(xXQ_ zzVJ3ztB0vyqPa{nZd(_E9;T1p>UPz}TQA~#SP#9N{dIb%_VBBX_C5aCvBB-~)N4Z) zN>g6h$N8~7dO7>+^zo(1*?PNd4ndFY+qOI~z2B|ZaXzevUe5kHJ^b56(MCJIP9GQC zF8{=4PA}bxV#Qpj*~XsTpE9AyM4o7pqptp(ueNfS*{3$jaDCJ!m0WZr>ILM z4BgQ8L41!-Wk|;a>C49~r#(TA_v$b2Hk2^l&_~}9HRwD(iAxV$Pw4C`ZXW$j+n?T} zN34pY=eP6}S1(t@*aUhmu3qGP6JK3@;_YSpcs!*#A5qT(Iz11d@GZ!zLwr-|tOxfG z+c`5_y8N}LqpP0$YFG^3<040TQhjE*A`~`t&=XIYoNm3QqMj=z1h;34(T~2i_sbin zu_|m&y`23+*E20IFQK@^pH}*q$tB{diwz zJ$+hL`(4BXI(>c3?@XNWu|5B#s|r~kwyR#w{A=c?>DZ<3~bj}OSlwW)$h2W z_uMp1`G_)zFPY6E$Ot#2d)R8_LJp`P}l^rqed^^X4B}mV!BqpxRJ*x?Ryn;`RTV! zk;&h-kw!i{yX2-r=iNwag~(CgPx`T35egeYKlT3%SY!*vDTVR5b4us~?VgX6nMRuN zMJ>op2~N)kJ?VS$HRpYVq-%Z1;}wcXWx$T)wLwb^vIH&Zf(;%lEMdiU*_LB z4=w}V*EU~Y@qEcBT~SWQzJ7~x(chO|>ivh-Cs-UYw3wGDH;x;p1;l=;*9>j{Pjx|m zzj{U!Q^hCSx6(2I#i?~8Ow!BQUweO8^M2LW+&aY-@1r+BFLLpK^3(U9PXl>xs}TSEb&qRxj;+t1q2IeUfosL3*%0zUSn-SubaQ ztv)sFB+eyMoC?7Gc)266eUjHjNU;m2e>!N&g3S-BiYVXDpnj6&tOxJ4`e^MV>Qa~X zmg*GuMPhqHHl^RRXDA$p#i8by!;qYgDV%=KWkYg0=JfUH!b@>tnxc%4#XW`f=K}dr zoM8U`(lz8qwgvRp3)KU9ZcS^ijsvX#*HawUaQb?q|1Cxc1N zjlwAm?FoA1K)(qJM~>4_e;M1xW&z{+@m(TZ=h-(3$zB#aEI3dl}MiFjnZAzOL^z9EI20k{rA|p;drO}!)IFU z?>dy9OVK)4nm1xOerlZXd?l+E@4r_+;P*A&r@Fyy2GtdEyyyC)O1zTh#dwY}n`p{IbIBzYvYhLg4zF`%ZwQN2G zl}7)*wtM#6gST>9Om(&et~Qoa7}4?n8&1XB)t-NPOP_Ui;kX3<^bp^|D7IO1J^!>9 z5yg4y3Y|W_=JoHLec4wBZXK1%d8*e?n537pKkK9Xe`rCei5cTu-v2(OwM&N*tzGCj zGufqdfF%7fY4aRP`_H>R%)Gb!gVX4{6y!*cC~R4-2!+jfc^;My(tjT?30jyEoK zF8<%LDOO#o$5F&`S{H&oPrUxm*pIgjn?-t(V|`ezO1;~l`t;N4BbL*Og;TuyimpZ@!^%cK-o68`C&$H!AxzWRe;;|a<^ttV<; z)OXNt+EZM^85THNE#T{V`8Up0yxurJzV7__aX4|$*Qq`Z{}#uAoW2-ef6VELVL2@h z8|=3jj>3xJ`IzNmJ`|7j-Zm3cmiU`k0-{Y>NW;TpWjEb6s61ie0d`uA=lJ6m>e zzO0vC&id`<&nSsR6|#04+Tb8!5_z329Z z^U?nfCTD+Ndw*&93ftIafy#&4WE#=ZckyUX=gsZ*(PRUhR-<)B`83+1Q4|yVpSX(x zx3d&s&)rKp#N`*o^I56aQCJN*`_oNdipzm7wPD4zDMK!C$?5n|5Z+!+bE^OB2A^c3 zK=?jeiOr$}pnKhQfcu~Amuc7G(b^fB^GL?3yT^vM{sM>6SJQe8II!6LTm=1qqwBmG zwk%hK!p74rXFwO(>FJ!4F}GpLEXKd`_6SnVWjT0>wNR!vm!ST5^IU7bawZw_oD$jP z{`dNaVC@zA^IkaBWBM>q`_qty31)Zp=Y2!weI%!4luzR>J+XhNTo$~4SajX0C7&;v z^(dc}THnJYy`25E{X?qNg@62|bOLF`#dzJa#BOz$nUe5<35zMSBqz^lE|Qg~`g+p? zQu@RckNjSG4>^Fxq_NoQM`IqDs zf$ImwXt6Q;wmj*t>hJ5(T6bFUu9qufY=rueXtm%QdQSH^hnemRwC%ju|LlVvRKD?m z%9D<%{IgHSci!)KM0sR)=;RBMHm$m6CB%wjJ@j(+7xYl?1!QLm`W!22EP9**x+lSx zDvN1mZ={TmP0JJQHt4B&-dcQhaQhret2%VB?Vfzjw^}cqoc$-uIqG|>ZdY0kK5IP} z^NMUJLFei|Q7o@D*9O-oud3r!Kdf|r!1=L0dO7DzsdU!T3I zn>GbsGHnRsmoE#5*Hi4u;PvFf=l8_@@O$%3oEFy;y`25M^#V8h`BoP`*y$BvirL|I zW7PmX^!3&miYw~1eN|w+)*Wmkz4_5uy~f}8$XagKNiXV;SkC(J-m8RZvejl&8XV6} ze3pY+9@(kLv|1rHGVnM5tFMFl-<rd-`OP7U&09uD3;|IZsyRVyNZ!Ov-RIK@C!7SrReRVzsL?NSTG!;$nQne+m*3 z%f<7Vit6Og<%&@)3GF~!pOJiB;Ce_Yes$mUKbp$9>72S+2O?|8*%5&mev1x?nl$!Fxd;&!m@E!sVb|uKLS{u9T$e z`!TWqDP0r1pI(;rPvk34%cphoC_?)%{O1{#vwpnyJ71Szlg;*$V)cuJ+Vwu!PiX5a zJqKtDBCf~(rN}#L@6OIGq@GP?-dxoB#9O00^@a2xd$FAJ=Y3E;5@nmYEJHTC9QcX^ z#wLL3srY~GDJvek(72V#ifS6I#fkt_X7o-0&vVi{gEa1@XMNFt&I2l5fSpu@IZ*LB zAQ{CEggy-aroHF_rQyqut8tlYlmeqCdFD=$tOqXRG zhxcNbx*Ut?20N}x`t^;&I@LEFieFco)is`8XJ6^~J3oK&`kaS9eSGPq56k%m(@XT{ zV{z{*T~1rv`wLeaIps@^_v$b2R+RHG?fo5lV}^FbY4M(7aoVA!&@iDmf8KMdtVztk^<0H+vh57j3dw6BU(%+P3PfSbotkF^)vd{pCrS=(Fd+cFP1ApVN)x; z_@C4uekGvi*C$N1{J1@cUK=)sOG5|D?tAZDF`v=1adNB|%T=j&>r1cEvfJ|*pRA;_ znV=h`QVv+ZEBW+0uI8)UVs?^JlpxbNmR9zbVt2Z`y&f#DgC2hEQv6JCyR>X>JO1HA z*Ui-H!*aj+V4aY~>P|2_Ej~>nUf&VV2G?WwZ9O`!eDR+BdOcWPH$60_QIaUfmam@* z=tV9b&>9&1I`cgVEu=$zR<6pMvhEMha-8bxo8=T=bk+42OA2WTS-RQjlIgN`#k&56AG3*<%2@h*PP5U40dWI$m zn+CTkkJ-bQv(lc>s6j7hrGs71>R2nmj1PS%QN;ea_<3#nQvUs5b-Y(7N%>>8#a2Do zMw&6J`}1FKE%{-__iBxzx<%tEma`tbSN_K{UYn6k%#kXSlg%r1Cw;4bz%QOFmjZqgPUt^jCA| zeQm}}ey{L1t)47LG>zjyiz(5OTT&$3-JbT?JC4qB=*P>W<|15@6&;&aznww!o01YG z-M;3E_vO`Bx6|v#a*cBMQLSHs&5B%Irg5^l5Z3H3ywt6%y{)OHlGILYxgV?C64-tf zGflIQ2kO%Y;G$)Ek`3k>ewb*-37B^XQjFEg&CIB(bkl=cs|81 z20ot+X;IQYZ>{gvYW53G{rRxGPUnNuQ~pKutp2kc&RGNMT6ZY#4S>t1*Ve%2b08y1 z%4zZX>W3%i|ExbBmIpl_+!MMTxel8txnI9}C@!{VQ(p4wO;??Me6(V4lyu?b!F|qo z%5*D@56E%*!E#mV-FmM-`tn|hth{-VX3vmwWqK1&b`?A9F5z7aegAhN6rnZAv_{$U zFNKuE)mFjVFY<41&c@Nva_B3orjq zl=Eb#Qg7%L0MA?q*Bp*7_JeV+XxH6St){i@9WeVc>%ASyRL9Om+fKXTxLz%3Y)g*x zYKAS#6``>4rx!X8r5oX(`ua<2qn)%4-bEz+A4C~F0x#edbdJ-N^xc4s{+c02<$Gm*`6yjhuZtc zSGDbP%%&#F_^zT^n6%>Bhu@k4Jsx{xnRL#I)RK;#7m`>HmU}f&j|4sF5~KHk%$Bk& zhx%=t{xx1l(_H^S^r<>0N?JR(<;<6Q3_MA%56kPSj|m@|_3EyD@232cMFZ(|B z<4t3O`7pOn^8C%i@6_wV za!ONlwb4g!D@sS~_t)$6)A#!ne%e_}$L-oU|1~-$NA-%fdbuLTM$j)4-#AjMlUJxT z=hZI{BfMCzl3&-_%a=Z7)=6uB|MqygBo#;HN2REjD`ITCS(}t$w&x>Icw0)QPb;O_ zp^O_d*!Vgzz7#yqOfUJ-%%iB+z7X`dVes8 zUKC}*{XeE&JmH)lJkgcwkjhanXMaI2&ztb7k653}cLufx#pwC>#tjp@T(N-DJxMt@ zsfL{Wg?!`laRcZ5{{y4(M5b8zbXSI4-iq3I?5I=FU|b<8l67+ek68Slyq9>_wR{#@~)5a=^rt`aX-RxRqEXe z`gm?*)k|LAfr#bQ>n*Ka^m^k{;Ou)I!s=*o`Ls03Vo74HPM&wInhJEEsN z)J?A!%PCFK`K?c)eduARpE4Bddxv*}>sPk(#vf)}Iq;p`YR93BH#=g>a#1%r4oyFA zQ&5RGY_AO===0s1H~(cXu2`tohvlS$=xV1=%>rGI#8|(AUBT^j>GRU(f9GBHpJR76EFGZ@1&l4x_IJKF;hRxa*w!rC+O?xhdu2o zPrjP)nG1Z^$mxl(4tus=3Fy^Tlu8cvB+vHTwH#dJe{p?!gTA-&(*|`55K$-!8*P)fOineVz`vuOI_0r4PUubWt^$Mhr*xz*6_kZ@j13rr4 zeSbnr0tSMJf}jMkfXWd-F*HpGB|#v8gkD2(Ne(V|;qDRwqDB!7f*J*-s!>scf?`1t z5wHV_A~rxkz=jnpU&V(1=bhd6Zgz6Hi>Tl7|7Gs;?C!m@JM-*2Wv5SQK8O3nh&C(g zUe>H&V4?YW_LqxU&OG>BGd`K_zj?KMoW83j`O@`Lup`$LBVjP04+h;To$WobX z@1p*0l}BYb9(mDXckdnxF8QkMI$8sW4Dq0HE6b%&Iau^SYn=NFg|wQMrzqR!mPJ;z z{G4zoe0g=F_mA>-H+=dedu8Oqb%ZWwdxZzJS-HIqcx+~|_8jBOV3er4$VXJYRD5I& z9~!4XcWnmG$wl4!O-hOuTPHrWasJEAXLdI|BtE1UmYZV#$;zj|;ge16CNIwOarXg$ z;%T^bo2Xxl@_yvFcY>N$A0Q+jqx^^pr7?bHxW|cMsL5GQ3|O|*GT9w9 zewBkK84gcz!-BfV0!4Zz_FmlA=oPYCGrrsKiS5=5*iL_7DBMrSk>ygT95SXkZGE$R zS(8z|MH^>!HjNpE5Iaev71~`=b3=>VzAW>ZQk*$lV?PVcr}A(Ek^Ab#nN93lcXS?S z!KMO=s2cvm~QyHtIFY^m9$_ z(VzLN|7+rBP44-tJZhi+@6$j90-o}*&coYg=d&io zwb!9F@K^IQ3ZvTmEVPbmZU6t#K(PFb;(u*>-hW3J>-pJVWu<>x^#9@9SId9l?ya@2 z)xf`71AljVsg8ej`Qx8WPu00!E3ehSze59Rds_O>;oH-^1G~n>9f_1}R>Y6n({wp= zPp7$hUN4$Lyf#ad-*7KxpV;g|pXGs8^ zsoq8Dv0`Y1*w$$FySNl%yWer&6N847uBSgRbdJE0qp_TxSB<}YHpJXIntrFwU8LtL0Dt@5uc3KWPK*%?+}>LbG*4Tl^I|!TH793^2d+-$L`-H91B+)ANzYmOHk6qw`}qxv82e{QlznMgL2f^Fueo zGv*)rduaYqxiR8`pVOvyKIx1ooj=P}?sQ!v{(oY=qRwBtASb# z)M}ts1GO5c)j+KVYBf-+fm#jJYM@pF>bQcGR)PLm8egH$`)ZLEDQI$F<0@Xs=`(3ot5dAw z9atVBz~m`>HU}^Fw++9;@>23KQmBd#cxEc-T8aznhd9JU2fP~^25RSvdh&UFt?mmg0Op1T@IfEbCt1`ka6WUmWN39V95-Z zFUcpfD(RG(uFB4il>C@yEbgH7waf5POsUs6jvn}N%G;Ne-8|vbi|7x`=|CMESuTaj zL5`!e4fonT813pPmcw0bnI1=89+s?ddor+X&Qw~7F#%BXA98|pVCaGV1vhH`9(PWp z{ALsX>de-e=Y4t8n2SfTJ%tCEZJOMWLeKW;7!^pR7TaLt26D$W=yga@!DPE9EjPKy z>vI=mI-GWInoAa?hWHBU**JjShsMz+f|u$q`Dw}j&$H^C=b%)y6r%GL!{5Q}BEDkJ z@K1j0NYP3fjvu<5?fcPm=tAsEWS7&WX|$jn0f6<6h7TJw!tTj&WcxDYLIlPWdVWGu z+Jh~e{*9+=kN>m=)Oen9LHO@Z{-F)iS2SMwJoDoCqRZJ{`R>pRdUd@q8oACni?%qT z5Q&JaYPzL$Ybbux_lWYjztfPr404yR=^V^2lGmDA4g5E2KuymG;^bDwcH z+ZjEjoYoy8L+P5zwJeuH<)EZ%tY2*;U)m0Vr$4Cn{zU}wJeOa%zD?f(GXHJg1NA%F zqN7!RrFSfr_4+6*9@TTwzaA$3yAOS^>62zL%kH5+F!VlAII>&{l|u^F#&LUQ7+bB{ za|StFQ@ys7EN?za1x~x1A{W?Ab{n3P^`jN-{s>6R6Yr|@a52+vwT-Iy#C1-_<19|qlGSK z`=ES41qD#ID>#yqS*d}lfH z;4||{cA{iv_jqk`2j3E(`5$W@^_@HjMPpa?3>#<~JLqDmDC2f*-L_8F@T2+_F;@4v z$@w{|aC);g-=>%Zh-W>_8e_RB_MejTJ?;XO$wp!Ya_nR2@}Xo_G6UuGV)s;gPHK9x zc_+E2epik4^9@U*t;FwS$O}vO$A=I9Rb4*0d3Jg8>)BCbb)+Ujm$QAkdphYf%QJN_ zW|iSRu$K__>>&Xanv>m56!Ni|UV+_sA`T}m7a!{!>EFlhfhXqHp}1CogrdGT-Tzn2 zh1$dIl>f2HwR%ZqmlHAiUPLG2#((=WWgtl5L;DPtb_tz+qq;_l_ZJ-<-Fs?e%VNp^ zVd4P#Ua_2Hs>yKB#uvuyM4G2)>+A4Nm5IenwdTz#kIIXTbeae|@`hMN0h3TDEN&RT z8kb^=eT{w9d%G*?noOK|)a6o)LlquW3YI*ufE%{%AS33Xnh^H0{e7c{#5Qo?OI)->x<tmgyZO(qEl7B6G3juA=gT+^rQjykOCndQ;}<>2T2r|1rG zXP~r8pK8h|nO|8#Xnu*;#)#*i`RtVQ2gJXj^JBR}Ou`dW5cTmNS1o``_bF#Rr-^oH?V=UUeT4 zHUC;1hHph#jQBRQ^|agO44Y8reuEL^VpI-bIrHSRpD)jcm;1q_q2bu!!m_34v(}QD z`CtXk9B&hPhK~;;&;0&3$I#r@*_x|P{j%I(88}wqTm3%ML1U?! zUx`aY^P6-#(#?;rCA{<9!R|UgmIs&_S5^4cWSxdTlP8!Ss_(HS%zKnCjuEbXsqgN1 zXVfJ9Jy?E1@1d{Pa02h4#_y8LLWjrZWmq@k$}Kk}z4Y2({XJM7_B|}?HvDDy-Gugjka2>zm@Hf6B1u$+g6(SuNd} z<;!(@3Y3MAsnj-nY5{uvJk*^y>h$%zjKVwf8u@r z*ZeF4VJ_cP46vqaJ)g-R7AZ=;uyx&W^E;W-%@?KmC8cYY>+hdbB6j1{{}a{g9=&SEQfOzqxp-dfGtD@*S!7lgzy2E&7zh4bZx$c|x9w|OwAqQWYr=Q1z4N}l6fw+kW>3yhN8wVcj&lbq( zeM(JxSssKv84hPXpRODpDcmnCx$xJzYwOI>^v!bVfO61ynmaB9_Oes;)E@DeOm+UJ zjEod{z1Dtt>B!Z-IE&fgz@yzt!o9Y^r<@F7AxM+`VGNk~=yQAO{ zF229!-JASj{g!5H3CE3wLYI@F5+s4#B}ds6keEwaSkI5Xtxt&pp=K=<_e^jVCjh6`739Ndi8;N0KBn$ zqw%-a)IbCOWcW~DMifBxB?>1>OAHFHS`%IaYCSz=s5M{A!Q)i!I0j6-X(rt&=00-k z`k#6o96{G)3_V9wksG!`q+$ei3C2J4K_j)(o}T5)H$H-CC=BE}-P3J@?8SCx-#&c5 zny>7r0iUCuCqLe~>)to{dFG?b**+|vjG==t62-FaZrPZCUMSz9efdZ?>&Da**Y004 zF5QE6)Ayd-(Al@PM{ZAwfq`*3ESEy%;BPMo+0v3qbK>M3{HUIu^mtDH8T<^Li51BW zb|m4jGp=ioe~$+A@F7>#@Syyv*8Jx*5G;KD3L6ev^{l$5%jv&r^#7{e|HbQI;X^v2 ze2dCswfg$c#)@F!Qyn7;D+1+t9CjRje5PmBYx-YnPFw?Odx{uqZO@_cnAEQjwWNWl zm)mI%`BL(2-UE|Q?&~iWP&t}P)4E)WaWIQ({anR1V;+n-_)jgjm1+Kx<9a*JwddY* zP4DQ1i`ZQw4nzoD&h~PjX$%z!l;3D83AD({0XjCCOy_pt=EVTluj9s9-=E?jmE_d% z%1s{j%{?vhAvq=zR%Tp`5W1Y~$b{iRJ8#N}y8iZtgYJ(%o=^oWsd11aPH(A*XRq3QE@i52l*ooo! ztiHR>&tLaiW!#8oSx>s0IR*F_{$pw+ZRV1kpM|LunVu|{H_Mndi5Z{DUutD?yIjVU zN^(o(xvmC0KU%YD`{NJy?aMrvr!Hsv6X(eqHC$5TUHT-eKJ|WKdg9(C<>Ok7Kf~Yt z%sh2D^Q@XK6|LDU+NCZgJDLxRXx@yfzhgDv_4BsVuOD{l;m_G$=B3No{=|6M(CTK- z^Pu;D>c3>v^ih@-J|FpQ?abq6cV0q6QKd0HJavRFXZt`nTk`up*reN~YLe5e8lG{J zt>GCgy>|cOb4SlXZLVYgn2#=Jdn+F`y;e&}K3a++r`wbqE3a|{7U{DBd=vJyyqg}l z_@1*K>{jQo)99KE^U~#ptq{fz*nP8RcrzR>?52)Z=cH`fB;4E&rxJdU|6|YkVgo-z zafH9k^>9t!e*Q*A;hNgjsJ(;cy7AayYQUvAFtGrCx0>Oa`p23BG%trpw*W9*Th524 zHuToO8365xL~F{#0d0Y^0P4d!8#o6z7dQ{-09*ic1Udno0cr%l7`Oz$6gJTl=nY&3 zBmsSa0l+|DFpv&VLZ!y4(ZD!h5ulv!VzvOZ{=grQ+1T& zqpF_b^TO+CPQn|j{uOrzB@t;j|Iy`aZ{-!xle?h6;Y-iY^4il}b|pfod^XpB&qa@q zo!I=3b1K+B=A+BmK0Key>28IO8g8TVLx)>JL8NFpp>5;R3kwp4nH~}!>K|k|^Wd|U zk0sosih_O1=vkH5QH@uy^2zK4yBn{Xbkk|0Ophr(HAU=WxheLa{%kowu3BR6Vkw_2 zc3AZljMufJ=k~hn>4%2tyjbohWL}&guPOzUO1Q`QL*f)G&tU1XY0Ar`HrvTmU6qE@ zqb_IrK)4#^XQ7(&6&TR zJDi>+!@P94VH>QzuLf)|Ue+k6=5v+cNB$+5{s#M=U!0iXDR1;M6(OWye!86P1M$yN zKE`;HB&TzjJ=^Wc@haJzrM$k&Wz|=(^l)YFt4;R2I8v5P$WP{@%Y*Y#^SR)ZD&Qc6 zACH4E+-KMRp7TH9=HJ8Yzuy)0`%~z)#+P8}zQ?O=TmCYq%li7}tC8;OBi687f8#%s z?)lq8Zd3rA?qdtX^YTtR>B9J?6YkP^v7Fpg%?a?bB>Yl1#{3dI0e&==PmDXaKGi|W z!F&IVwL2@bqQ&_OwltYvIePr0bgFe3bulVWuv`k20}m{;ne!+IIdbhjv>#9%iA=Ei z9{HVJPl&I9GAN=OG9cPg_C3(s9wo#fc-<0}y<$}Mj>ib`G%9)zppv(3=_?w0J z@NW3~gb>TO3XyjR^|s@vZ=Hd*vBU_`I6p!RUx@Q75#p2IBgE2PbwvHybwtaZb;PIV z*A;i)TvseVURO+*RZlF6t}kqr^+o?N4Me}QBE{Z1QR3u3qQs!n8;Y@`8i^a8J4sXw zX)I2{;Qf6KPZo#zoFZP>e5z=6Q%f=HvDRW|LY%m))7ip#Z+r3BJsm~rrCr7RdELdu zcPEOKx2A}+tA>g%XO9&PU(OXX^SxsGl550wb8i)U-S>&axlap6t2ab@-)G|B7j+}n z9&8t}>y-f!jZQ6$NEvfy#9f_sM5OhLu5-bp)H)Z9zqQV?iw@N}?e|`FA2@Pv-4~}e zuh;gs+v`#IBWPuwN_9<+C!52>6AIT+J^twM)Y`r!eJ9dCBR_79^u=;R8aP%PPiz@Q zlXE>-`DWq}ER|yUE~I+{@s-lAKK`^KKU#RUWu%tf`Q7teP@;52@s;HP2F8^+^3|YY z##vg#(Ka}%Bn^Y(JO%jUU%Ag~Dfb@M_~_rM*i)N`dC#5NYx-m3S|e&p!+cn7iv6d+ z{?BOLG$x>;(vs@(`m)e`LagK%S!`!*ov5sS&r5t(J(Ygb%@{8;74duEEAiynw|9T@ z+{`;K-WhM!q)4A}2rriV37HpivTRYIO-|}I|72!)r(!|ZtQq#4;Vz%UN$rIETq!O% z{v6Zz=z5}OejePS>#2tx8(`F*jQCRrd{|ERsHQqTJc3v)Usn`a^`U!CN>0yoSEE3+98fYnwEoJTj1i^FdcXQs_h;AY{8%1fW?Y>B zKlz}V9-~UEyzu#{GJdUV&gyI4y>Dg@_Mg%tr2<{f_9zD=6&Bi3vyn^S!b`K)`xO-W zX7qJWchPh=L^jxEIA&rJ2#lJam)C%gtKDbG6~~`_m;GZtx}5EU@fl!uVQM{=Hzg+h zomqJrj}|k+>t+5)JNveLE{3vAX_$vDXZx@``Z#x~Rt_ZJ>Y5Ui{y>IZg4EBe4 z=yJ9X#>4Ccma&$Zs62Ln2f3RB(3$%i)bR@^5B~CrueUDCWq+85E@yjctff^b`Z(Q_ zxr^1|K`Sm6wNpFnOYi{a$0@VI&#O4#neob;=k7XmMe7{uelX*Q5C=^;`_Jc*4p$Bq zy}-;{Up9usVhpTd6NeM|OY0)$%ztm@ zV6rDeXBy|gaw${}%nuU*QXF~t2r{>`h{k?Up(qoJC(B&eIcjk0S$ z7p=fZ-#jvE{EfOg{QEzaa?Q)1Hf>@vp62))A#^$0^ZO@d4??-r<28y6TKLz%-_6&I z%X_?h^m**Ap@#^e%h{g&MQ=i14{~!FgoHAx&n|}}`Cs1>4_lOmfB&@Os}tW@x#M>B zhk597wy&NC7RaCKa~BdZ&{4}Ll{MheZ~sY2r`>h|b+JmrJajqRhv4DPE}|*&UXzLO zL@7?3ueHC%n$PR=AnA!)#*dAhzNS$-{!S2|CP<$wr+ZX0d~g!YdmM~?9WY5Y)jynt z?@{Ar1^g%Xk^nkW-Hi$$<;{iI(6!@jxD;pYnb^#6U%g+so=NxB#oa8YdsIXI`#qNt z!?0D;W&3Nb?;UJi)Qn48CFGP(yYSEoV+a=c+Zq0{T=kQ#$=~FBd-ha}kVtmAT_}uE zUDD~~@jT`Or8u+xE5RdN{y1Xgyhj)Hx#$7&aj7TLmM&*|jt@9@?mWCO&w~HmD|a~~aaHoH%HApdna+gtok!HQ(lvpiU*Y+4aMvNAT>lGBGv zMHx@1e74kpPv!L&Usbkl*lz|8Bi_*Wg5}JE&*AwDwin>r&y-X?qpl0DpJlgvvw!`E zQ@81SSk6579G(vih+{U^@H$)rJ{76Y-rT-kUK{q0!%LU5eRw_?&R9T!XmC>XQ!*#K zeqNq!zxCFPd$+NF%tx2AeRw{Z>4O965fyll(^HG^f4Z5IZ6XQ5O z{O+E*i}qel*Q%*bZjN`Qx*ry%brj%Bg9sxRJ2oN?)-kj3WW^*0E&A$I=Ub}v<~23o z_k7#8Ivt7F_N2;8K{L+4B1niSo1+f zKeGW$)nj>?m9MyAL0#gUo{93d~h0 zcYOz{($Ke<+T~boiv1_zB|oo}spHCC7@UgAqeA1Mw@)6sDN;PKvfcjQKOXlejUyvN z-+ki2aw${}RvwxrY$FB}GpZ7(`BpsMmkh@%J)9Qb5-BPVZte42=J3~9AIyX0(gEdQ z<oY&9#eYOAp zehmc6&o~@Z--5|h`|7Sw^ttNXtCiPk;6JH>Qh3hg?}`Q1dO;NIsAHyLXoT3-X!g4) zuz-W|>}@}LST9Or zWJn(kaAdg@Du+Q?MXv08nOn-9IJN#5wIqCg*6fFbU8AS>n8Qwzf8?t!XM1zJR>pJ( z`X`Zl82dDtEKQAq^Zg9;^X>3y7+R_IOV+ z)rCu0MWh%qYQoyvS4TXr>w)C~pN%W4|JL>oRT*mhSa)A&9^`WS_6_zYJkWXRQ8Tlk z_(AO+EH``)9Ek^ic>V2VRoXoQjDpn+i>M+uY_a|Tm&7oQpxBXvk~Ei2sA6jEm)cST|FPcu1qTm)&BbNE z|GKvLq{UjUQtj}#9rZIVuYY+o~W>8t|})A9_` zus(D-+lSVN!UtWj+2~rtSWWrpW{ilUaQa_azoI=@Qzi6#fQIN_2y_H!fL$jb9w4Pr zWv(l55pXfk4WRWc5`gXi4OFLfE_wm9*2Sd&4gO68l7K!yGSC<32lNL904YE!Fc6@@ z4ugQf05#mC0Tg&cfnh)fK>eJ<0a`0#BtZ3!(Ev>_9t(^E#sd?8iNGWv3z!UK133VN zR4$MQe{7sGdfxQAI#8FdZlXD3Q$st^j5MR{~c7R|BQM zHNdsNY~VUz4sbni13>kixxkIUJYYU>6L2$d3s4T+3fu-P02Tt&xO4}w2%vPZ1Xv0z z1C|4K0(Sv-0~NqMz`ekIzzX1g-~r%4pb}UKJOn%ptO8a8j{uJXYk#J@72B0eBAB2y6m21J465051YB0WSlu0IvdDfUUqb;5FcNU_0;z@FuVW zcnjDGybZhqybHVsybtUGb_08W4}iVEK43raA#eaV2pj@F0zL*l0X_vj0}cb91784N z0$%}N1K$8gfTO^-z<0p+zz@K`fFFUMfMdYVz%RhBz;D3sz;WOYfHFQBLs18)3)BPZ z1GMf+BoGBe0}X*jz)3(1&=_a}(Aq3bfs=t|z$rj;;8fr=paswpI31uhTv`K|swmC` z+5mAtTi`699Y6zk&jDzym-B%3KnLJ_-~!-6pd(-dIsx%OXMom)=?c)miRj^aOeVy#ZQ7<}x4=NCNr*v}ZtHpdZj57yzUIsQ|4vb2%^wph4C{fHWW-Kr_A= z24n!4z;Iv$KHfTh4PU^#Fna2IelPyyTn+zZ?X ztN`u@9snK$DuI>2L%_qpDquD62=FMd26zm39C!kF5?Bj71w0L`1D*la1J42*faidX zz$Rcb@I3GW@FMUM@G|fU@G7tc*a~a|UIShSwgYbfZvs1jw}73%+rT@(yTE(E`@k+> zH?Rlz0N4xc1NH+S0tbMDz#-rx;A7wu;8Wl;;4ttx@CEQC@D=bi@C|STI0}3VdH+nE20$bb1w;c4fkwbdKn&0r zps9zkKvUpkpc!xq&>T1wI1Ok4v;Su4)g$MNpVbv7QKN>fy;nIAPMLL zBm;ecen5YKCU>R)slY(sa$pcJ7#ISi0qMX{U>J}AWCFv15x_`b6fhbX1B?a60po!Q zz(imYkOfQzvVk1H4&(xPKtA9ArT|j`Cr|*m05?zwOanZC7w`c^Krt{KC;?^wGl46B zS-_RRRlwCiDR2#NEifCn4wwU658MEh0ds*HfqB4u;3nW^;1-}9xD~h!SO6>pZU^oF z76FTaCBRZ(8L%9<6Sxbw8>j&80qzCv16Ba{0}lWX0+ql@;342)U=^?$cm#M9SOYu; zJPteoJPE7?o&uf*)&b7|>w#y14Zw52Mqm@L8F(Ie0eBI333wTJ1$Y(M0&E4g0j~kC z1KWW&fH#31z+1ph;BDX?;9cN7;C)~hup8I|d;shP_5u5W4}k-~LEsSZ5%4ka3GgZK z8E_c*9QXqG68H-E8u$h{0vrXt1-=8m2Yvwl1^fv71RMi?27Up41%3m52aW@O0HQ9^ zKTrp#3)BPZ0}X&kAPR^E8Ul@glYkhYG0+5v1)2i1(oZws6ree9DsURm0%!@G4zvPV z17`qd0&Rdepe=9~&<;2oI0rZvI1gwKbO5k)fw%y;5aiRj^aOeVy@5-C%YZ~63FreP1AT#hK!0EWkOHIv1A)tdLBL>O2#^M(14Dsf zKn9Qr3IfSZ9^fO6ng;5J|Zun@Q%xC2-OEC!YUOMzv;a^OzjF5qsU0=Ngb7q|~t0o)Hf z06Yj(0xN-sfQNxqz-r(T;89==@EGto@C5KAuoids+f%ky-fnC6EU=Q#C zuou_|><2ys4gd#%L%>JC$G|7Rr@&{xVc>HBLqV>l;yTs0xSeGU+7-wo0rV*k)-SkY z#g2g;F3;{r^#L+;AB~e{xfCjgp#44&s{Ml4pftxpGd=Mf)eo6Z!c(F7?07m-jPK^0 zu(;=hBTe3(C4Fs&BaL%mxfCh~Yk!!(Ur?nW?=HoWd92fTRB3;DHd4$V*C>C{+?Cgz zM|mL3836HMxfCh~D-XZ-LHh+0@t$O=3zv!w81FOr(XyqL-IG}l>_5vDujQrHe`~*> zpAGI*I1O07?RUH;Y>~L3FpRt!roM~e1G=89$(;0@5S$?Uh^$%$Ny{3|9@$q0s*Y1 z7xnEp?x^vCt|<-CnbS^;`4Hd7XH#5z`U@J+^D}aa^iR4c@HH-_QNxU7!Oj#$|BHs- zkI(cDwfWiqVo3fooYnHkq|MgyNU(8|`(}Oj^nv%XKE24KL+K(0xf{!Mmgb@j{sITq z@iPmjTuPzES&TkHdRFCgRO1t@{QTA_b?@lkulFpf%a9>H?Qmqd6e@?HEqvapADvIsi;*Jtmv4Vxzi<9I-bb2CC)(mjnX68~x>HKZR1< z%l;qL{MXCP39m$o{Nt-TN1W2;x3kRz&;GMq@mgM5{U>kzMP_NQ)*nh<2>t%MUX2u| zHJV#@S^Wzp>hI6;(EeM?&3+}|AvIn^y%w4W`4PA7`_m?T_~hm5+8I7lyog7U`>ayBj8S9q~h259$t=hR(FU5X()m z{}hxDkudKl#hLwI4FAa_0n|PocTc1o|267Tw7C~wdVuWq#=VgJ)`EvVI-CB$7(62U zazh$82K7HsZLq%o_JIH7Zm{rp?%9dU8l~2y?tE$JOz+QfQ|vzl^`C|m&M+28QOn5{ zHSm8x{@lpIJ5p&FlQjJPx}5EU`k!LYa{BTI(=4rQuMr#8-~kSY^f#>W09Fx+IH>Cc zJ#y_k=dImw?hO!IOm*@at#{KOn+6qm?EPGM7}iJ&r(ia0HYUL)6=yk|S(6>8ZOxFA z7LD;^%=cIg_||{%@cF&kd_}|DET%g7U*g-Z7~Bn_rSOe;mb@8$oy?Jk9w^*&)|T@Y zm)#_jJjb(9rrbgve|SA8tak`M&9%6PVA*mk0GSW_IDq`8^)eU3f7N|*yTr7o^)h33 zSi_ytKDFiZd`n!4+g~61eBaYQ>`K>UIR5E!!xsIn_S`J&@@dY6lk=GEWT*ODRs(xuN-p{g%t{uzWEtI6UIsvZi;vUQW+M-afsc;|F&Re8O~q z{B4Q1X1OW$pMus0AynH5Sg}xs*SonSRR^(wf(@#%6L+ZH={nV>P6>6Pc;3me#+QR9dc>h z1{qQh&C6rC6e@?H@uo^ULRDsZ`J4QqjDr}G*P-h2Y=_%|nsD|(ANns4no&_QQLq0C zsMS*V4{M+T5rXo6?zdLyG&KLHafZHuR1W6yH{C+^>OCZ@HGhu=YV)(IdQ{_@dR_I- zTFL)44aDJvxqM%Oa!Kj>fw3#=lx}=@bL&isD{6U8>nZvHMJ5{TyCm2g|)0cgEqwJmbJa^@sc@HSMV$QUQCCB>{A93Y-k6`x-pZ zx^vvHTN-_S3gl#rx=KC4azh$8Rm~YLz5d) zj5*cToiW#ap|yzmc|2GX+tgGX9$-DCfQRZ2`B7@xlb*KJfamTDzJIoN`UNZTm^7qM zGJ7<+AvJggf-xn_g`I*tAQ_C`Vfe4QPj0JvEZiS{-IeXremb62-sW89MQ3VHVL9{S zGc8LiE0b8H7Mnv%rR6&FJZKldDl}eq5#~gC<*h1@V>RHhti1at%}2GnUgyDb_Mgwy z^DtI|=^P(lg-7X!;q`I%SFb(v!bPJKbRH~c|M?t_N0%Txq7GQ=FFA0m3vdkJb%Vdn z`=WjCZr9S3JZTI**q2L_v%R^033}-r#=7qI9Gki00&j&SZ&kykyaqhlcj-9s6wm(e z*&pVi%h^5{53Cq2w|-EGs61L646l#X$2)u%b?aN)Y$@|4imAFh6c41UTt}Xn+>2b& zEwx^`rUpFves$!lCf` ziMw{=GVB19&;BwmUC#Ewc$qr_C@ie`$>tjHxM0?VA?uf&c^&)1JajqR2jk&aN~Rk- z6c}{W_K5V4!t3K;Ou?c9F}@qwALgOU**+wX44JVF!$SPU_MEDG4%C3p!|sW(G4GVp z)KzJik1l8XkbJP%yM+uMQuR~#ad`byG#YfMgL@fGy_JUf=yJ9X&Bujh_g}@BQ%E@JzD|L_np4ql{Mh? z%&9+JuxZfyP3T!N%uAOWwrCGF_G7c;!&P{h4WmKmS@@-V8eVTd?fYz(tHZnl>_79< z9Zw4r^?MQZMQDBGAC45ytU3I`OB?5{HAcG`?UXd$ zjpa4t5zs{jcJijGMg;Ql9nP#RF14Y}0s)jIGY!+N2&nUV8q+_dCcNaWM1~A#^$0YkWu@4y@`q(-;*%xs5l|o$Rz{VJS$;n!>EXq4=ELXEyd)taMbcljN4lb2E67 z2^EfS57_rpQRQ!AvgDmcygwDOpXH|5f3or%iIxI8?>JUtj^vn{4n`fZ@(fmgPJ3_r zz&f{|bZ&i<37sR*o6d4m>_5@|Xjsz8i-n2NkDuhkUOHKriD~PX<#EoCD`sP>vH~w! zIb6`8-D3{ku*AE=;6?G8^+(qf*6MzepMUYxn=^Ngy^TFK_|+G>ob5BPQHyL|88E#t z$(!Y}B_Z!Brp>XS!EGQK8*6;31RpXS zZu)+EyQV~omh&HebJF5Z#t(Sk=!qgelwYu1I-ndlo@8Kk;+!J1;n{{3*^AIPljo2A zBkUf;th{_=Ep7^8`E&)2oNuIjXU#W)#i!nHjXv}BMrn=M>rVCPs#85(&i2-Lu0-s? z^wp6|!Gojx1bNMDLfv-Ok`7CM2(7mR;Q!qjFE9N3rLD^{C(+6>#(G(#HV@Q!3SLllL%_D!o|%s^dBY2HDDxK;aEtSa!XK?XgO$H7zvYj+-q~GrFY{oYx}5E+@T9^` z2KGnbF>cimlSA*|NTI^-0QiyqSdWwrD4nR^#WxNw?@@o&KnKLqFh5<+_9GIoL!K*V zvb%&f=n$e57Oam+KZWl;%G0XF=@S{SCB{o!-KKV*k?55BAZA<@=cZ- z(!i1Uxv~nq`EDOJ_(ds?Di`))?uM(kDjh#J<(V*WxvaF+Cu{t zQv`=$J}ft+fg^w4%mRtAH#Z8&PMKW^QGr|8|CC>>`q1|QS>ufs&);^-(V6R(J=%Dr z;RpNA@_^6A73$y~Us0jIJY=JZo|LvR!PAY-J8v>J3#X8xmQpxYmN2C97aF(Mw6-qbCaAbZhezWq^<5_u0v^c-d%@5q` zd(hEB3ul)5iJ2E1csBDpW9*Cpof+XM>C>&H0P|Q39+dVI0gBGS@_~8t=CobcX>KR3 zsM0w?v=A)EUyB(sw4Wuao7?@+r&JpCdz<)s_;Nx1#_m@YbZwn-lKDKHBe44f%T2NW zbfV<~Z=u`e4RmK%%Dub5lMH{)^!ftX{g_z1vdg7!Kl3Fmh6qDXoPi_DrBFHWrc5Io zUR05D202_)y*3&{F1PX>WOwEH^3z<@>S6aN(>E;NmHgvYUV1#*yd+v2zot*ayLO&> z);Xr%_&mw{ljRB}c{wDj*pX)xmXh*lRJ~E3!PkF)$BleMW*2t!Do}v|PpI`z@kjXZ zTry*}v+qaEo@9R$GzjCA<&&3cPrZ$7B< zT3iEO1GmlJc-q=AU$ei=OP8~K^}JGD*q?^NG#D*Q__a4@Npif>!;kzLb>~fQzB>Em zdF(Iq(&cQggr7xGSm)b;uFQf0hc9po9#X%@qv}LSXR70~4t!f(^PcbOQ9E1GTES$9 z4}FhWE``b=;F&exsM)g$89Y~k80Zh?yh)!-cnBR9A8+jv+INQoT+Bquts2`wY8@4gWRR>8Rd|* z@q@JS?=fnAQrRGM{D`U_B~Cj%VZ)0bOBkA~<@|jqLxL8u)+y`zNjLvtzkI z6wk8%x;%{k8QC63AqIK+d;ZjPlNe>yL$Gqe^q2p5V$5?JJDb&F8F!;`WI6lKXC>W) zDA&m(B_C1svITr79V7vCrtdGM8+D#?{)Or9q`KP=hFBWo4WfiDXZykKDQ_bbZ?lz~F zsi@%-7h~mNhhw=w`{og%Z1n0)2f%av(x|W8g}2<__dLU=-pE|2oWyeWpU+%>3-lkb zMAj_xQA^LEysn%1Kq3M`Eho`h@YGgK`4{D597c3ahW?YG@FN-D!~e;SWb|K^k(_1Z z2D?Wx)$lzm)9qPKXVs3~Q||U@l$%6Tzx}~~7*VP$zhy9`ZRCicT z_nFNf)j3rw{|{?G%~vXsp2;Ku6oz_!Tag_r_VmB~t9MV2NNH^bGLIi%IX$l$CBNl_ zY*cvq(x$vv@pW=86<;j%uY|^-c_i9n#kBG<9bQX_o`tMN8s@=rl>=Q@%R_cg%7#Ec z7rMU^;P2r9jZf(}-Hh+?RII5z@RfMFzs`z-2V%<4?3Ya+1Q?=4;{#YOg~}laAGL`p z(=7+6=yk&`0fm`vsrhkXlhAtGe0Q{1`udg6%)4~m7*4}&;11=-ELSMXONA$wD)G7U z7G`1l+2JlHa$?!@!OiP({~Xp^Tx@7QlkSNY5wRa1j{fP|&dldjlMl;7@KMXXK`14; zaxgr^iJi1SJk^!!HfvL*SJ0=w`i9Tx%hGt1a(T;eq+!XsyIu9&TKn!dd z)3XZcrZRy2UlYcEx_{Qgj_sR^x^|{(GDi5-sUkOQE$L6{L3%9P|C60=m)r@PiVqe& z#Gf2m4|M;m=NIi>c3zvSl0V-H>(J-~21 z;J+?sd&Ph0p`r{I-J_=G#AadM|GsG9S@FgGMa@J{D({f#3Q#;?xfCh~-T%I6gN>y; zY?2B3(6B%H4FB*z%X%5>z=z^llH#6zc|n_Jy4>)uXFHxc&9Hgiyx~GquHSF8bM(v2 zrGBzv`xv*oK;9CEBgIGRSKI}E+1)!JCpW3$!|}E7lqebhh*tzaagoYJ+|OFss)?9B z@zHPIUXWLOGUQ~M0i-9EOQCWwcm-{pPW5JB85`PZJD^PTXSsbor`^IUs=2j%Ozn3R zPU*-zcE0fDnWG+TC|YE%o5lX;vp>5X`?Tso>8WMnp5 zdi|YjNhqx+(?<6x{&kns_#JnuRX;k9N#OC=xRo33{kBbo&V%I&1$oI7GSEbh+Aja) zvPTt0DxWprLx$r~mGaMuXfg8*&pEBv_1x04t-RHr|FhhX29AL!;@66eN*ie2v)kl6 z9~%#hk`Gnj$niS;w9tI=TQ?DF5A8cCJ?7$`6ux9A94VYwE``b=B%hI47{}(y>n}%T zP$vWRyI@VPB4ZIRaz;&ehr{qod>~pZi9dSxv>iJ~o?~)gek@n0$;*)Zj7}Hoaj|fs z2P**9TUm?HdZYU%?0I3(j#X_A(KQ*$H|VI#r5J}A@Z!-nCD^sI3O`kEaV^91OV4|8 z_}7nrwMB2&U^(;Ra}D?zpBgnV@i4_3)>|cbksdhy>*+D-%qF7!^kc~}P2*C}H9h9? z56exl{}hau+2c-;3#q^>%Z{pk5>F4UpOVUG@tXH=@8zzew*DFqmiq~q7r}V=)1gt! z&UE{`h62H-<_|kGUi$cz^ob3{qgS3WwBghTI<|Y%@c2TUC_S=V=M{XMhRnuGd|}3E z9BpmYQx!g~qQvD*bA~qao_W#HFAbkJ;Uh$RSRRBAv{6WFT+608ok9g72*nrfm%0WH zkgO9h2iN_8RDix`1wX;zM*k`Ar~edY6z+5;P}ozPpfXuwfbtyz8M>dJq5td#UDukLYoHXja=b{1 zv&IW5TTy*>4K}KDj(vA*8RE^k&-VZ6%FkDv5bYK&F#%l1GveYl;`a(tK-q*FSeqzXK&_S@oyqySt#@ zN8^%@7cBbhvE>gMociKK>5An#Q(b>*>cX&DsZCp&4?`-9C#y?uy1ShIIIU6op=*-U zHMNyf5K~alHK#kWBctn^-7{>BqnbWd`TynXGQ2#ew~Di^@kOs!h;~upl9*KuKiJ+Z zt*5E9_Bc~~VY#kL#1~oRGAi#VQI*Uv$0V6$2VAH>;;Z>@Ew4DzP<*ptX6zF~qNnjh*s~E(l;5%(w_6OBqC&yf zTK_7oo|kEQP^#}lgOP`sfsFMoe&JTH}T zsQlXmhy{54F)9~Ry5e%$X}E3yv;?TVkm^@d{-H5~l($o#P8`q{I16Y8oDG} zP`c;dM4p?4xZvRn$4gVC;< zk)7p2Yb90-p&lekW$4+0%-_Amlb9^+;pyjx=2My2*}ghHRW)Ngp|+cpTo776 zaZ_T2ZNce7qt1%nLUDl%>xborG;pkrPZ!!4ivq72Vr6iG)1$c1%1hVNq+1$_7Yf!a zjBZ#`xYhKUziTWHFfy)`_8i%+MPouRbVlzmwX|=Qh2gPzYOFXZ|M#U!o_v2_AJaqD z56eUFF#I-Jn$2z z+-^fM$~P#_Pz~iRY$(6_yNsG{TG*`bujea=iyMk(U;p8milkY>MwulH<&BiDuv`k2 zgAq^Ba-B^B&SyC7$X*6z&2Sg_Y{t|<%48_c_D@cy$4UVXkHz3a*%#+?#E!zfVrYce z)@b&-@f#b8{5P)beDkfZc6<$TGKm23VL8cE!|8^Gw;^kjlcCYHo;jn?E^jNtk^PVB zWc8o2F8XG0{}nyZc>LU#o7{aNM@zXbC9O`W%jsS+DAi%PH9Nc}2417;NXy`RmJA#_r3fI{ehu+dm|iKE``b=I1kK*$?%yR z&&j zeyWSQiHsmLA1%e1<4t z@$d?lU5#=D`A_|_h47!EP)ZMFUJFzm^&-t=@{epN%U(L4K1yYK9kzncwBSlUyD zAIqf!%0Z@WbfuxMK08o4x5nd=E@AqE=QI=Q)b>G!^H-J|(!epP$VZDT zV6*D9!LsIrPFDKlwmIm+_}CUhM!$3eM z|5wla49V1M^`6@6S`CEKfLfkD);)B(-GX#|YvcXzPrdtv7xZ+?a^0_*rCYPiLdjUR z{MM#pU5~Z@Yc&u`18ZQ(<)qTftm&A_A@u#N>=7j{KC{cr^j=ZoI$MKnDVMcs?7a6f zYF3f`*Yy2mImuL`rDIwS9E)Q(^$)O~kZt^&oP2`jBfHOVwGtmJ;`?XYkEr}Ybt7ss zqV^&x$50)P>UMDe)$^%+hsqOFwCD?@0pozFz?A?sPCNuqnf^1NF}U;u3ISTZ=tp26 zKE$hlGf^N|0VLw%|0A#smBbfNprECIFGi(l6B@MUp)qR(3hSqV(D!J(N(CVs2(3rM zR5S?n1fgOO`V53#03oW8t-)Y{aRmqyv_jRrU5Ia2qh9eEu2J`R=#&WYeV+*NOG$)i zv<_>RM${3DN7fOCp9P`Lb;YC4)D=BP*Ap|E)fXRrRbQ<5qJh|lv77fhqeXwzPF(L} zo;=pRvtQj*Y;~R@=D&ZMc<`N8;*MEy;+rqe5e@rZDE2ya34`R7an)6c{REc^} zjq_o>8prPb9qF6W3Z*qN$R1_-qIwj`sqRHDMxg&Jr~h=V8op1J)%2R4{dbuY^^4x0 zLGON|?)9+Dl~tLc-j*&Vtj!!q?5e%81n;1>O7JHB82PxkDt zdM{n;hMyz3dad7A`@dEL)oGv-7MyN3he@|P&|bQr(H*zD7rvX*oIYqU++NCZLmD{N zEZx##JUn%;uNwX~O;$}F>JWEro`HNnU6LTAii}!xkbHcJA%R5{&A2pHy zPnMHRH5yNU`9aHI!V;~nVz(KdG5^HW(EQ`)Hx#!z>U4Q~RHp+rP0uV>xzqLE#=n{Z zky?H`s`1zJ_bm$>iqhnyvO{~`IQWA}l;a7@!|<;rf48N%`r3;#-EODXoY)f>i;wC?>(E2{MsG;ci*mb8K`|!a0jty_I#21!_;ahEd2~Rk9j8XX)ULKl% z`(+Kq1<6~x-*(x~-@ANZd_7p-EdK}j2aPdhivEvj{BvMO-}_?#@AtJj?_|#l1uv16 zG{m1$tuB{h9F*~6#yTebTsaes9x`PW5o`ZT=^(2fgYnoaZoc=y8xu#eKg>gyvwamF zso1bC2$51e!0}NGw(`*X!$#fJP&_p7qV6L)b-Hfy3HFZ75^(W|MhVg^hn#3gsWCRmr0LFV~h_tql%pEs~LyEnYuDXyy|>xWjM37 zzifzAPdd*nMX_Rh`oP0ONjg6%&^V_zB;Zf2& zMvU$;v*5YipT5Ln)rk-BU^)BGXN89xv}^i}4KTcRj90LGGCg*?>_p7K0$^z_vZrUu z0ggwb(n9N}#c45O;`m-YUi&ou!G5O4%!}ow*niS_QC}vyS*zh?OBuK9B>hM;N zXDFR8k3USgcDv}4l|2>J^66Qg9AnN(zmh^M16qJd>F6C9?y}==HijUjrY8@^)K3gN zPshj!dk!`MqKV=;Mx@3rBl+$eS_YQgkHZD=rg0~S!JBzyAI+z2iY)0aKhrvHh_tMZ z=UV5A5sTl6O&MSQ!(-iGM~3=N=>1qOh04LY4^C=&MqrSPyi3i8j=_I2q*n?r{reT` zju9U{zHma5Gbea%Fw6PGkNjsj{#uOHe+=!Ij1PvgFOb|}Mi~&J@+li`FdLpz_$z&iBU=Yy7&D=hLE0oO0bfjwl@Z9OgD_t+6u zKKgn(Wiz6LXUf2zY|f_L+H|HCQ={FK^uux~R1Q4(S}u)iPB0$i$hG@u*xzt$ifC>$ zQi^9d{+ELXy(fng#Un}&ybb~`#jh>yYvxJ1w}Q(VbU*Fm$8x$yHOZbCg+8}!gafOM zXF0L#yJgjP>vyxo$nfcJ?7HI%SH64EgbpIQl-}P67xa~xa@B9THvP{mERYeDi5L?< zK!@*-!v&|O1n^M(AwSgkvjz6_{;VguCS9rH6A$Jjez~f2@JA3!WAKa+x}5EqXZqkY zH}!Ndm6WlBL%-y{8A+CLWr?G#;YMLb$*3Fy4y*r{`5;-KVGe{iw_&&D&8~ z;%mv6@bUG!WySj{+c>k>Z_Z_OIopTW|H<5sO37sKkgBKHvElh#)$zvF4>!%~$^J1P zUC#C)_-Ol4S$UPg0nYyx*ML_>odxyk|DLmz{WU&U^@T2H`*8bFF&i~q#f}TFpOzCI zy=?2!8|gDCjS*;P)@Dfxq6uBOl*9rppm}mJIu= z%MDwMyLPy8u)z)X-^zAo6=VGMfKfJ;Kq+oy|6|98fA8%N9Ts25KlKi~&;ILjwh!We z7nOkOe|Zi3pLeW#j|P_%)6iaN=uG)2%T2NWr29XjPloEfr5w;=LiqPT9DmXsyN6C$ z&K~gl>vFaa;(wnkuOr(+0ynGiuN*w+8z`b*Zh{KKi-CYBJRd>lv^}CxmF}!}3ty!?Fa$M71?7zV)Lg;d~ufogx=$bon zV%5O{l-;ovvD~@ds;6}|;L~(e^uTB8K5;+mht3pVSk657%zRQXF~U=f=3g&9Jg`*t zkTNN}9?CYXN-FdII!^bOs$^j!I6W)x?65- zd>*W+WQK>WKjttOQ54NX?U5>$*xNRHs@-E|vx>6dSOvg5D{8>=$nKvX?NgC?kIs|j z%#Y6}z|*2kHD0yP4zI_#Q!eZL*o(za>HJvEy!c!tJZaWKn0U3O20WfTeZ;`0TBKy@ zJXp^D^Eo&Viz?);r8shU#pgsxSrU%qPq6)nFPSxUY z9x|m@;70a;2mB9L@A2;572*meA4lMtO+;BJ=Vuf+uT`1KNsj^%rp zpC4X7n`X?Oc|+cU6($|YoAkqS3mNn90z6EpcSI6e@=R55Hc5(Xi-aoin^XMsNT9j;H1xDAx7Ca)pAt4DhI; z5A5sf$em$El?phh=L@=9!TvK3wj=eBHmR+J4B6}VNDJ*ylY6vB{!jhY!)FBEJ{F*Q z5aI9ApBz*H_sEdDwWekoh{J7^e&qVcNXMn?2ga_fQ@U}($-4?EEmWHJ%|_>ZTUubv zZ}f6fi|LI;!56)9lA30;pQb#I;X}tTE~X+5n8K;<{-5LYydS-3;}Y1IRK{jh(o}6aQ_;B<`~_A%zgwS z_ZaAOH5wZ8;OK*JbP*iI(i~z69Q_847Mv}_wHR>mV{akeOh?($A%t%(#s)nh#2cRr zaU?!MJaJQmc(g$sF>^&7(a%#?JbYC>v2JgDk$iuoc|=2+zZJ57m0g_ndd$!Iux{qjAcZB*scj%22HZ4|(`R zXLse&5^T91EdeizCkCKBwWFx|mY?@`nR(P??O(FFCNY8H^2ZJ+ z&ql%v0+QxUZMcQwXMS2a`)m32FBk{oqUYdvL_uGcpl@%G1v(RLv}zEVyOu1c^3iJL z34XD}PhdU^Io6+cJ`njeX(E1%Z(4%Zi|VMprP^OBSA8-6#x%}Ji#vf9HO09BiDwuE zPBT45@$%dv@&^Ar4kb+7G<%XLw=d?QmHXp?!6S(U@)#6O=_QX7av0UwQ@Y7@shW<} z3Bmula`^tw{&$=q+v_IS3F$Qkpgo%2%KW%uOioP*3XQ;D@x&{g9rfS;lbZO7Q*{rO zvmMZ$#`9Rt@$;T|C=d6{lMBpf0kYiV{t++5#rN+mUgPqsYHm8#o0kt&^hEKpoWtck z#ha0uT=C9L*_A$L>@~wbkGdTne(9NA4OehHsva=jtC6#RB|L`OCfV#$ZHaMwp4>h! z0}pbn5AFEE*jb_C=DM#fia(JX!{a^NUtl?h%lrNg%#uLTyT9s*>4JEV2gNALR(uMN zhE`K-cw(+PxqUJACf|JMihEy*y`~_c)myI1mGmLY(8}4r%6t^-!OSSvg)*;`Rp9km z{eqBM$*(>~{bO>JUg6lXToFo}bn^sd?kuS#)oRKgk0pT=rQtJACfKi$MxjmCL}k7f z)=YM|`t2nMgX_oTGyUr;^Wjk`tqxrE14qqvq?NP3UtY0zb--4Tr_ytoxQiQwQ3No* zCPkk4oZ4jQ{+G|^i^h8vSJ|daYCW$cj>aj;MFKQ_#d1X`ZTN#vJ&XhM3KDZMpfNPh zibtPRS5u~!?Yk85`^)d^l6Dq0u>OxOQyj%lEVOb(jE&FujmpOz@gB;g;U*eN!})T# z7ct9IA2g;?4+xLN_{z?YuH3aWM6_G^^3ku)bZ4W8pP}-oiLhY7u%F}UW zrbE2dG{H08<(haY4^w{Td4>tgLd4^PUjAjw#Lg{L`%v4@6feuAD3wFcc>5RF@R}5P z$oCt4yXXBJx0=Nzs35)_p1J?s%fU$rH7zbnllo!ZA#se@< zkpozOiNGYl3giMdzz*aAlK}@n>6;G}08@ae0NEMUA=7~yfExkoq}&9|1d4!Jz-(X+ zFc+8y%m)?##lX$LLf{tQR^T?^c3=^(7`Ovi0xSiV0e1p-0e1t-ffc|?U=?r=uo_qc z+zXTd_W}0!V2Z4uxbwDZbFz^Vl9@qdp3OojE1U3PW15W@?0-J%SfTw|HfGxnY zz*gWn;CWyh@B;86upM{_cp2CMyaK!myav1ulmR<|H-I;Rw}7{S{{im+yMT9r-N1Xm z`@kOH1K>koFR%~z2>2NI1o#yA4EP+_4;%mv0$%`M0$%}N1K$9LfNz1rz<0p+z!BgF z;78yna11yO`~;i;eg=L4eg#efr-0vp-+@1XKY`Q08Gy%4Uh=o4)agM1Tj!6IY=2->Ch}`r8G6a+RfT>75~BRI}G#@6oc&i#r3AQ5t{A)V=lO={0?oPZB5#A34jFIdDM6nAEhC)B$N3BgPDiNgB!tUV@;RZ{8iAe6{JF zaCeC4mk|5*AnWrlhX<>iNUy|~<*L-Z^~=`}#S#R?{5D~nf?Q?#JhVJStXUR!d$U*C z?4rIBxp08^v0M>K8^8Rz8NKPVJlm8Y;}SpZa|nnP7l17#E&ZqCAnAV{*ME}p`8f1A zrvI{&&y(f)v3CtbKuqaF`E@bIn>fElBfr*%-!zv$ryuE;bUS8r{*k^ZUY^~c#PSEcT) zXa2xDGWdYVP^=U{Q(lJR`HNNg1dQkSXXHJeJiI-hENxjc>{vfjEaeAs#5V|AmMcPO zQyCAM281;#oH7@>tONnd`sJV~9s)UHNj6XeARa82&tVz7%l+wCcju;o%F>5IWu4QW zs+rnAJ%GzjIj>OJ$&Rn1|MD^W>-(x}z+3vTPC2hoIuJMw*q`@Rk4-v|-bRCDw@oMGlUm;#h5i~n&_9-Uyj3VqfesQ1w`+omajpxT2n^Li_IF4T{Xa5TE zC!6qAB25HQ&nUu<<1ea0{Qd52cyj&ouVire9KTl1{uScC&Th}mFi*>Oolq>rA9BC{ z`)|^|r0JG9!+NOka`|NtEa!N6Um<>a&Tkx=NXt6pD$7c#XBJ_{dMK^}k6-J5-tUQ3 z>nCzNtOu=}{VVWD$9&L9g_s8ER8Cne#ouJDXZ@lbx5=^A6BFV)eA2k|?uUk7s>U!E zJE~t;u1eio&-mr~CE4tlV2;V8bw$;8xfMe4xL27UJ_&D{XSW*`*OAIp97k<&B5M003jGTpkNYh^yu9`v8jp1U%m&WT@VXQ^y>%qvi^T+1gT z2cK)rPQ?n`Si})uLC0hwlcR9BX_C1h&&ZSKXz|Ah4$O+q79|LP^IMaLJkzUWzCoF< za`Ygqf(KbGTk59f;?je*c4d}S@H>1rV*my=QJeDeu!jrYV#=Ddy!K2hb(gsx{q`Z%%aDF+-Z>k0)E4PIGpe8SlcR)>GosT&14c3%)G;i3gYc+ z9xHVs=#J>QRT$6+XaPh5J%J=32UrBW3WPz)1pq#;C|&~S8E21R%tOUM)E<=Y^U#64 z>mtm3Y>M)=4d#JH;rjmAkHmaQG-#G#a^ip^n0p#;5I1c%h}Ag(;-!>8vGBGa;pksO zv|1G+et*A?$cYOV&e0c((iblkrua^xYs)_3nL{Zk#B-_6p9w0JJ`W&2wh20xU1f6l z9R2wGXh3d16+cc^=59ZEdwx{3dD5OICk?i7?CKR**Fqy_e_EytnFQ~UWm~c^j9^SR z=O@Lcrn=WRPq5hXl}w{tqAmX^eBB;cn}7daF8@=X@n8P$ePV0#&u<@967Hf-djn<% zuv~jb=~z9|l4TxlcVHzzWBMdZUaZM#g$2ckRpVzvop0^zr za(g*^i&~4vKt^G1?@&vbzp@1j_{{!n)2J;!)DwNas`bR-KN}`BpqD-1=n5LwVYwod zHZ(S(EK#Z!(oSQN*)$2VZt6R8t}g_RFR-TK14a26_Ly-P4nvC{Yd9*OlXABYT!T{d zvabd2{AH_=$n{XEAO44q)e~>@{OF#}Sr1?R-2wG_8s;GWESIP&hiA!Od5?$nn)$46 zy*Bx|p4hkg;X|R{WiWqsqiFSQh7oB(z*aW7o~SHI2~w?7rL1~-={elB_5 zzupWNznZ-HfgKH~?MIHd)Ww$Nics2|jo#?;NPzUh9JUHB2gxSnd*+@7&`L=ImIkZ>}zHer-Bd(az7xDVK;MT){j_ zH9WN6SuJ}xMD*Vqe`2}$i-_gZCvBqs`aiZj7T0fQLQq;2s04GopxD%Qu|D)9Ne zu--+Zr>?wR%ZKIX$cO4T_bni>O%lJ8ulm>5_ow>I?%pfHs^!P>bLEF_m05lCy(KDva!OHk0t`9T{W|EKcUm-FZE>ssBfat&zHhstEi*;H=pIAOANs5P{pK{6g=MjD0OcY`yB}o~&ls zJ@Vfz3?v&$aQSol41X0zWnEQmlP-|!;qcehD`Oz{)*p^Ggo-a0jVWq4H?+t^TMz_G#x>07Tq|qW*PArm$?=-rCl=*J=!#6J|RD@10 zDIWdjlMOn$1`U`m%iT=XqjTiz%(L5^Se>w(u*^5F%(s3^YKDq6H6`Da+M!~2yEk?mKXcueTK%&8{PD#qQCMfqmwtEo z;VVKz#q63RjM)wAoY3l*<>!^JAN>}+;ak5^^+UyV@f*+NU)KE07>zx!{Cx3sXF#=I zk&Y(}6t-*+QE&R@JGNn{X!q{O=XXp=ueFCd&2XIGSguOl+bZU_3dKQ&-6hgkgv@up zAHKw5MY9G|wk6shxY$LB_!4WDyTs+Y>hYDxxd>}bLgu^pE#LZG+&EMW`*6sM&n`R^ zuhlQh%Za)Us?1l(Uhd+S=z7a>GT-R8ee)#>_tkZ5j0x-cq*lKyKR3P_{erMozw-Qu zlU3k5v{THRt2PcO)beHdx$yPmhS5LM6w3r^8Rgo@SK6AxKd zcly1diy-GamRHIfBhr`-neVEH<$M;03CI>(lHES3AP*nlHWgABivb>2hhbtqMCLBv`blkz`sj;hNqYmMvR5UkgqRP@E9Ij;KhUwawPz1Q(jKWG~F4rQoV8zayc`0 zw{L!XJB5n9o!4FYbIe?$mLJPGT;888KTMjX#h}NPtT~D0}()5pd)ZOa3ydJ zFc265i~=mcG~j079^eV!P2d}#CgSY^(1%m;nt*s7_zj4Gk=_9u0fypM-vZLnhdu(V zMqAm8L7+rDU`mF{3Q!5W2D0%O!2APbe+1bMc%bwcD)+^Wu_oaqSfdfo`u4WQnu#5- zF6L!e=dnB1Ozea82m6C_64o&shOoy$mWQ<`i?H7160EcM5Y`~vhG&F(u{Pu{Shui= zK?Fr(Ee3qmH0NG}NZe--eVYY{(c=TeulTUr%oc%S&8>l=SDhd+WmS-PyI-)V{d=&u zepd}KX-7>lY;TD8ph0bsbVD7nw_!a|@J*<=`1f$}MrH%?MeU14+ZIj5PxmwzOIJjQ zoVM*m+>lP<*(;-zbt1ey|C;upZ+i*3GgPd|opEO8Lr;yo<4-6X4ysa~XR}-pN}HB=EP0($A|fVKTzW(A%nyz~KEBtZY9ug!CB0a#O5NLXz3}`A z<@r{M!-9oCjNY3K%EhJFvR-ycyhuMpyc=*57<1cnYBGw8OKVQeexNmFZ^aQWs!6nR zMU0IfUWN98{6w1*U&>GyD2^@2EugvFQ_Sf(mht)N_$n4262i&tuA-0J`m2oR{5g$( zsyn>-0_9?Cn5S0G{^x`x!^ zKuK;)&%sx_v-uxQgS49Sje`qv@#YiV6Q3{JUuhNiyn27rklPZwl6n=#e6(`*X9nK+ zq?@hiD-BIcGSZ+KeL0S~MIZpu6OGrFfftY0w)vo6Et$ELuFB^% zxf{u@p<5rh)bl=%O81eF(kYAXqXb}kTl}dy&o&w|N~N>`9r~!0L(Ay zGgZ&gkP$y`<;>DYc5RMM8d$z$r^>UI(8_VS;;OqXl1kp}`MQF4bsb zqQ)qb-B?z=4uKM%d>{M$+{dPCLq&SwO|RaxJENxdK3MK?6Zli5`@n4}p9C1wZH(P9 zrn^TM*PSgY>pLn@7GcZwGld?0JNvdb3DNB1LIKq85y|fr#82D zp<{B)M=Mu-z2pZO;RqEdQ=7kIplP$9n`*A6i19E?r(vIsqGU#A{<_Zv7s@JI>OYQxO0eUa4 zJ28Ne!V8X{k#ao&-KzF=$q@M20s-xAzjMpG3_h=b}~2VbZPON(IvQ4acn1AIs1E0k11wq zeA2>2^pa&vcAVLU`kn^5Wj-Nad)kM#T-=`=D)!|X103(oTtjI_j`+~LMwTl=X;Xm@ zeS$bU70-?>2um!l`cOK}tiXjCNJskt;$4+;1X;ek zEWuEdGA2g$LgfkdSy};+0J6XG?Ue-VhXWIVS-@)GMc@$76!$$8pbS9YLN=j%p{eq- zV4Tq~&PWsoc!gFhN2EQW93uwe7Ne{w2uB&y0N;0Mf_e(&%_D8_4sK_B+oT7^tNLLK zEE)Y5=o_k3=1Z3$E>4%de$pjk2%eWd9`MI~8;3onO&69UI1lG-y!t#RkrJO=zT_MZ zQDiaLLUmsI5zY79HmrH*&Na%3*s#58(g8L_{X5SgStdtR$E&> zvK*ItxN?1ZlpiEjI$+Afaw;whTlP;aE6Y_(RsAh$`vs-<$QSD zj$U>)DjzO$_40T^HJbeDw+jnX#>Zsk7nrQ6c2v3;Dl?)0D@9mrhs%$6rlT2t+IH-d zx2~HTKDUg-iesKyIr~?GCu+g*_`D-NQs;%}b_B>gGk|@Kh7MQl(Od+kGoh8TPJGP_)dy$&dc^-1hmkj|8s^%bBOYI?eo8|5`cwS4019b`|Ud+&xo=Ok8nA*p}PRQBV8vHm=(H zlMnBWA29J-^=fzdua&cZf4n zTDh0_(-6HQ+ngPbR%JPZVw}kLKlYga`!`LrP0fpc@F0iJ^^I1}{?h%+@#Cd=C)!I% zX4{1P96DF#ai|JBGKNi>({X7SHJud4JhXE5ubfA+NqK?E)!;0`1+0&pv+q2l>>w}v~C|F=QQi{ulEdAdD_@?-h?B?D>w-#_<8#%b zNbct~`NjXb9%5&Q=`I{I+;>s2K46^v^eac5vcNkdvb@sQ=1x zMJR2s8esvw9*6Ju=9}Fk%f|Epu|v}ac(%tAe)S!H+1OCgdHv`aPhPuXhuswiSq#O` zaw%%%u+sQVNa?~1OWqjQC!t*z7Gcl!Sf=4aeP47%%fC-s6c#4BPU@7IwSW2a_K=ff zeXv}Wy0_(gD1!{3C0poq>2h^=q({O@&-}ps0UqbiTpcPNopAK{@)!H|(Dnyd?v7bK zDvzIDhflE)i*D}NJ?pt$h+nn`9tRkU{`!>KQIArH!4IC^bm_t1jr^W2-G3moz;ZQK z_qIHKK1ec8FTns?^(WXmrNvPNq)_=qCOXm#8{}RfAV>@NJB9u1ed_2;n zBAWJJbYJZ9r~JGa{&M;S!7mtCj0Mu3?|#`59E#z0G>+NZBXTEQ zOOE#RT$JUCP}*cTOg1NGESTNX^wLZ=T8k*ooP}pKcAI*#%%jQg{=bXW`5xy*8v?$e zAtl8zpDr3X`&Z6mnAzc`AtG=A>#G-d$nj|PwH^MlzGxjeBDCpMgRqX=GZKg5{RfWs zbkvw?8A5;HD2!V8v0M>K8!tRFFiB+srdN9Cs|eR{xfA_|Cl7D=?%B>oL4gNS3RzFI zr*vbvL_s<9!b4p#gg%smTvvp%IR5Qbi2wNU`dxN!I-IGEpXF7EzkDo&^1N&>34c;< zapx~@{hWu**S!{VYUV!WL~K+ZwS-pA{$B1MlSWtyvvu`YWFEV!z@y!U&%fVO_vWWK z9_FEyvp>fu&QQ zYUQdgz6)Nld`xtD)oh}Tmf&?_RDfD-NiKb}0eGZ8Vx_X1cvj|;x4toCU6Y5#EF9W< zFSUm_{Rg|`+UvaWR8|nOX3&cP<$UJ7cFi%;p5do@}IQ^+(N$br%TcB}WR`cwVFaymzLUed>9 z^`7_cdT1#ka53A{p`=>n{gNijPASg`|BiJ4=zgeuM7q&BZ!$WEF4Ph5aRF1FEuJrd}Z|q%XweP<+@nczy;TU zHosJ6%V$I6TMeZQ1U1JyuPR z7wRl;=|gEkWgN}XksYU*EYpuKtOmTL55>s&hSP}VRB6*k`~Si+{cnaIjRcU}Z=4R4 zf9P0ux(0L&RIY)_%D2j|I5(fl`ahIcInQz)KDU_u9asO=>7yO@S7RDcv~#$>Go%#QZ#!%05~{kk)8w08qV0YlzZ1Q@rjH?P)zHI+x~wP?)@D z+ki-S(15&-Rg>ZB>Qph1Q+h_c7@(|qRUBjxi5!#(0avseb$gS8DBrc$^PMHb8er z-ybH>nx|wtWGiGRWMi~vn;|Qp0CmOx(5C#4QTTV*&=~$_*`sL4yUsFIhXJ&3saZt8n{pz*o1(o-B0WN zmTB6H(fz}eZ%mx*D8%toFDi}6jAct(ZB3u?H9j+^II{O}@I#O1s6tQ>Q80Y0KL z0UrgVm3;95nQ+2=wV?ebQ2KrP#{-B@+G<+m;b7p7ec-CL`SI$aZKJ zZ>KV`*yT^@Ujl#9BkPme(v;}(y0`21_X*q9J&~5tRh(L`1_-U3{bLI9?c*(0t8ut_ zTuMf&F*V0-GpAY$oa%o%O38@z?6*W+rM!V*J6xuPQqtShMBAdW@m;y9vl_9>jGIXTdKh4n&``Cw%Qu|Ajijiv~u>Z$j7zp zy@p5;F5vvxYovd@+>!U))?3?dImq!a53QX2EAsFpAjiL@3h|$rv8eBi_^)Sh_#D4h z&i)nS$0v+XT5wv({n><3{_p>b!BOv)>=;~Oy?L#?^7s?X_#lfj-;#w-&SYD%sDxrN zxJc%+w+eh}rzY*T+9%^79>*aRvBN40XKe8re?Aj`ppe zv47MPL2uc5PQ7%+tvF5}t(^TU z@`xFS&wZ2|$uykE@$dH&f61A8;+0SHKcD^R7mww*BH;93ImgR;FY#Ng@T3n``%H=p#ZXZWq6|`E-NNSz1LYc!>)q&yYH1k* zU-}lY7}Y*F8@t7MHN|IzPwkEh2oqgCv@g23?zF7naWpcn)(cesvs@8Mn>6aNIq>-^ z*C>CI1>c2JhWV*i7Vj|Snw7J)JZ`nv>5HLi2wJ<*hRgrC4CXz{z3r=V zj(lBp&ack7avc9(kLCVPNUm?Y$r&CdGK(@d7Y?vn2K_Nfxn+8`O?Ja_tsbgiH%a!X zZkv(qI6?Wst-GHn)*h%&?S&HXoN2pcRmg}ik<{(YP4Aq3`M!md=t}i@I`Lt-B9u16 zdSTc!H_u`;tYs zM%@g=qwxI&coQQ7Z)4&>Fgl4dLxe~`qz*(Hj!63=()x(>sY`@Nj}W3I#-B%AF2rDz z10yl8aV#DEax{;AnJ&ccW$@pOw$MjHd{omQGW!|C?AZqK)_VqFyfQ$mLf(GvSKBCnFCAK7P%UK_`<2UwMJ!R$Ie0D#+O%yar6ex0>_KRk7xZ;|v_mh1lzDh3adys`aM7 zkWpj^0y+6um3ZIs`QCkXDQVz*rH@vdavJ$c2VZ{P!qm$C?f=hr`jEb<9P{R?lNJ}^ zdT(L=(`Dx~eOUi``kcR1KcDI2j}@gKry=kCT|@rWIrnVNuL_61>l}Gp_0SB@_M~=R z%oema-@E9d!E;XZIn~AWB$2M5b}q}c_mOO$Xg3b9WoOv2am_6mirx|WPIgR-u{&HB zT_Qab{73%)I|0hKEXQ9DC(UQe$Z?oW*)*%oK~KOP#u#NNLmAbWVzQQx+r`)ljVbv#W+h9P zAT;KeIop#TJ+qWQ~I^iXLm!jAZ{T$Q@FXTdK$ z$L`2yhE*+ZxLlw;XnTNV7&cKHl@lZ*9aHhhAQ}0wKMoZ?4v+fevOk~4GCGeOg~!*( zar1d3kxUoMD%l+wCc6<))*-;qmWI4&?|8&gfvRwYpG7ihzp3Y%-^Vem6uLepH zJ?CdJ$1^``%Nt_)OL0Jax0t|b%$mv@Ds{AS_OE(=P8mNwHm|^YsUw8UbMJglp4xJ! z6!$T^!-{tv9ry5&09V1tnjH<0oJ$vH1m-sij| z=M|R0yV{Pg)$S=EmT{o;pFuL_#s1#*90r#M-p;8^CdXCTIlBD6p#eEx7cKD2*V^(Y z#1tkb<%DfZd8)@f>Ug)iy~A>?)~b=OZ9a-0kMbw;7Ehkq@+Y#mmT3Rm)JIy*p182x zWhx^se^`FLcxsBD3g7YOHVnr{Wew$7x%`paAM8(il2cw~f6_T$M{){>^D@W7GWyTQ zw5Rac(J^1g@lm)OHeW~Q^LZQw{bz3EFP}^Q$zOKlPfnK0$FiR+r(^j)pQnwFee@#Ds(vRZ?RmJ zy0_IVe^SkkEX<5IO)wihx?Lg~Mo;ZDp7+c7%^j2HQDyeV`N8w-^YgE=IJKesJCFT& z&)0L_ljT%q@PFFN;Cq$J8$O?81afp9f&O#3#s2h+o@7+^(Vm)N}qwLOC$&D1p(+^>;D?4hPuo)xsJhpipDo*>Kgx+N8*%xL@ z@%>wzY&VfBJncr?zdH%Lvd!FDa_zk( znQRjZ&^?PY=eyn+&4^F3U{)p8TEHR!CZ}?cW}b|<^7G@&-+PgfyD@hpMxx3?OFb7+YLuyS7+X~HYCR*9JbE*)lZQl;Bbi+Y8IJTC3Dvl-FvMC1*TrMr$uLHbKr``uX#(N*GE+`o^aQ zwCTeO&{ReLJ_FW0&x;1M>C?y+s-8aQMZM=7h&Fwq5F*!y6u6#F=d9v$3P77a=M-2a z7i-g)+C;J=e`>$;SfRGhCZGFXJJzO;R+rlUtRGn}AG5!{KR+6f`>jnL@q9kPHeJ$G zh^{vbeZSYGVdBmy8(y#V&9+GmUD0!UlI2=fUfPqqBt{x$fm&=>72DklNwHadyr0eE z;FQ0(3|9Ni?*H2O_5T+}0}%+8`mMA+VlUXuhxI!Zy%KRlNPOg<(Uc}~KjrAy+Dbhc z13Bg8+wt!2A|UF)K+&$>i4kSEo~}DK`G*_c!27=B==mpgYgw)crA>bAKR2&TTw*}wxqA3yOxV?*oX8MqVL$B*XNmPi~eW& zEdG8^jl2a3jN%@!Mics40w_0qIjL9a8E#6_uH5-TKWt;NN85SI-I?VC0 zsjhRib|M8)twYLFAujaAel8FPTmiffECphLCIH!DFi;cFmitr&RF;R~^`CRHod}C> zI~hBnwpbX|B<`wP-?Kz!^;C3K2!)cJuw1J^Uv^@5=9e4F`LGi%cPY&;1;_@-X2>2Q zfXjd!AQ>*VsnBXu^K#3+9Ogz(}_KCGg&%9)6q(;elVtF|c*Flx}c(pDeN+o_#xxV>Pl=pXSIRE6l zA}aC}NBk%?wQ@y_jZc1x8f_*dae>WGR@j8FSdaUwz;n=3b3bo7_`Ye(gL!J@?C+E3 zwWcX1XO_c~mtO^@YKX-W-yEB7y>6KnCSJ03zWKV94K8`&6}4vIbZ0s9fm|2L^-rlEKFjBZi7SS`ckQTM&8!WEs{ydRu-rSJ1d}b>YF3K) z0aMJjDwOlGo_bC8t*6Z5Ffk+SddG*G(}Gu|d6x4m_s%QEX30f`ESH}ZQcS&4=2PZ} zPtn3Kaed~(NyAs(P|`KiQ%@}S&S$vEk{@5C3P&zK^BlhQLvh(#?dx`R%~Dl4_|N5% zR?fUsJBqV7^Q@-ABzxARidB!u6%zXcP+}-@G$+zt2Q^4^v zKdqeoRes6lY>TP-RmeW^T8ZH^V7=NU*(r-cH~-|PBeK2Sk1X8 zNUF_s69VLP-c$viCEqN$==a_CA7UQNQ!8hGm1m4CE646|aZEPnJ1kkwYExB$EWwuf zrcUv#*N9ug#L1I=#t;6aU*ISgA>vE@6_&fi* z`R%_wOsrXb`{KH_HhkEA^q15vEpLyryquWpK;<{g;w&&(RhDsPlt}()iR$#jsl}nT zI^3~SK}j{PET?1cN4w9|kIqH|vfV@!`nH=*OTt9$qE*QOFI>0s;J0duuwAoU%R#jp z)TLSGY^7BeW6Q2et4QXx#SbrvbC!Mik->FlyLwITdQ~fDek!k6J34Z<{5X470hMB^ zVf(acnOEv`-}>6WEKD4%QI@!F)eEmJIOwS_mNOsTtGp5{`59*C+44H%hgZ>EVdAIk zm0@4ccFuXym61X~fXXM9GaufoyxjGBSaAY{E|&hV|b zvNd7C{KV#2-D-3{`rI+kegVsw7w=VmsV0oFD8)v4j@ew5j+ER#IOK=d;`?E5_JXgE zuIu;gwl!)-V7;-N`S4!l6_b@^M)PN!#cIj-T?fkTv8W>7dZIY4J`yyoEab;~IX>b; zrI}XF{w_V)iH+5qUWf*d!)~)oM`?>kpjLHgrJK(pO$o|ZJxvXS`T&i*wgDOg&4JDU zJ)KPiHUPf>HzM0M23F#D8ZZ)|F6uP^oln;_1nL5$4XWE~09>D|xgG-Dd1#;r|F}Fz zo$cF>Ho?wDKRIAc-@&KG%uiM|dOLPhzO&pTaQsn6Ow!Eb3M^Jv1)bqAD-Yn5Q+?S7 z#Xxo%3bX|x0kV_U5=hMVnkbM!jokt}E+X2fU(wz?t$mL$qTu=K5 z@1W+>a3su0%Z$7C!+z$yx_f`h(P=%@r*3LGkbSUR8&#UwmTh)ms39IrCOneGc#We_ zIgYdEx|&hcqc&%&S8DA=EyuK>R{YQDUeU*G6W;uES@kp^*WXR%`L-7&C*QI+-wtD501#HGjc|yFjat_~PaR|DrezfilH>k_g_ z`cF<gVAB)}=J?U1EOpwL+VEE=7ne^n#`rW0 zp}OsMs{hGWXs?%tlF~20p}+JY{S&xNMtPaihQ^ch^nnsCu=CX};dJ42;Jm_VMbx+q z=5%Dbd~Rj`S+4JO4g7!7fUo@WPrVP$$8sLk9{c02&CmYMm;KM>S~(nl$9lilpN9T= z{|lL4$gZd^qB@9#v$;kacUAxYm2p*-lYZV`qXBJuxeucK82B9M z1ki($en2#E84M)^n1JInfS%E}1KI-gY?hwU5~wZBc?5@w{j-hnp5*>qbRWH>91H_yVz8XfkzIQK zSgQq7*-~>X&K$gEW{kC(FgIkp1&?l(DgUmMWga2-dGet2ra2j@h;;YM@6fA{qQ~kH zZ#w?BuA7zz%jq21Rp61BYnoslkUP$tjpxX2Dl(6#wVvYu+I0aIgJ=K!3%}ca*Bu?c zIHtz76a_Yo1F&4?K*#*{7^$NC*&ik#;`J@}E5%9f z9`v-=Lm)x(p(0X*SX-7jGvR^S;;9X_j=WhqKDALBHGp9loFIE;xy*r%z1k}a?GAPP zYDj^}*SZ$;?(qzl@r7t3aQ!EJk*(5ca{(&>?!_{tq(uX*T{JW=BU)~HL<61i{@tWd+YQbdj!x4xDtp5Xg=Q*fadoRf0*)2 z>_joZ_qlwXXMM5+el%`7t#Od}sjSBy9E!&WzvO&p%##~0qd#yIcQCdrSA^20e7>sk z1}4ozGMn-X@YYRM`zCYUkx$bs{t0eL)^!X?N15cO}R+fw-OeMFb~FK0GC`gweV zt6Mz60jlxT5?VR?rx%QKn4R_l%!iM+SW(Kj*Sw(VQ^vFctJ!JJPjtpiFf0~)zQ9-@h%@}9NRtMSX7Sup?VaNP7J?zO(J0C6Tp)j%e z&FcqT`^(_NR3?#Qek@m|?ybs?XDur;&m69ie)rIShCMysT6bEh7MG>Or`-ytQ)4n^yuM3b986v*F_1$}L zC~p1f!-L|x)_vLTXm7w>v7FA4-C)daM$WaV@02In#@pS7LFdWywaO4bxysUe*Sav# zWOv@XEf>r=dKYDIIMyf2RjGTc>N7pdWWx&@n8I&`&PY$)j3je&F(%rue1S=^LAtsK zV7(mL;K@sy&I#-B9A{MTwIkMkaFXVVlB4`jcF1x?C~Z_;E<$PM$pv^Vg5J&~Zgg4+ z44&fW`B^O?TwC=T}y443SK z<*L-Z^(+Ud1jw_R^UXukl2i-P+D8xMhg39rsC-%h+ze2IkzVMa_Rm;=>SW3QZ<%thOGy(GpWs;GwLeMIPwt5`gWtc$05l z(eU3nP@-n1wpQfz>dw*(ctdpOuqd zkVkbbDzp3ory52Ac5=BFMv8-Lt?sJ4mD_Ebp75PN!ym6L-e@&1X65UN5B}bqQb&jg zWC*%XmTMzc?^C%8XkID4`PP)`h0oXKQe9|KqNrzRyw94 zgzAEDfaDzjYR6LFhT6Gw2b7;lb$Y&r5_~wh-@AXaZ##*8vbLBoZRWk(hR&HdfD#Cf zc4Q|kSA^2WpPg_PQ^I<2%p2`s}C%9hH?L?a@)&DP- zE6X)@qU}FW=ughK-H$~6G=e#U}Di%26L**RH6`{0I`FQJRx%;7V7fa@|MZ?FNer`?PGonGm z+f%gqVYx&_IjoG27u6`|%k8z)XMO7@bA6b&e55VCsS4@W;a?b+8me!s1?8uthk{*-PkcQaCt-0KUg zZA5v6VGI@6tysQDXieY!$h?oeB0J_?W?!2LKL1Y`iMfOyw`dNxPnA6y4fc_Tw@ zak<+p(Kt)U-RBq9xmWowqurSS*Uib9iMVw z&=M=9;iYy*Du$laL9??OkJ=>hKdRxc?N={b%Z(RSbWRr++8m{i>8 zm1~mztWRT42N zPkYg}vxriUkK6pQ<)Xs!XVqjcWHnm3BF3gNdy)DtvblJadz)VOK}XO z#BT?mI!*0za%{gWSEcT4WqiE#Uu0t5?3n5RYDehq@7F*PC~$uvs;sv1Y$(PDtz)^5 zG#&Qm+%7o{S8IeZGc$mLJp z*VzSsa>S3yI_0UDD?01|;~ z0UDD?0+NBj06h;)1%?1=Kst~C3v;bNG?SM|e;v`#-vB=XzXE4~ngOtVpfS)A z=m10ky@CF~ARq%64U7lu0DZS*4saWAH*g=Y9(Wpf33v z6vzN31GfVkfH#0|fe;ivm@*_101L1X*Z}+wI0iJVh5QYS0%ig0fVY7YKr<9ru>gHi z;!c3N#NPr9>mbhqR$vA2I`9k74h7p#U_P(~I1IF?hrA8U2c83t0g)*9#sVvV_khqa z=n|L@>;McX5Tk)2;3XiiKFShcA@B~+2nFS6;342B(6<5dEbud$3fb9XaBXf6wEdpaML)~Bm4`9~iD0`!X_yc&MEAm4(RI&-Wr-KY_h{F2vUdA^RHX{VnY22?6x7c422{`naW4w$R20+=P*8t+wL$Fe zZxHVcG>H941`&*c`Wh6}x1yl_5e4;x2?lWj1@+x1sE44SZiRw61O;_X6x1zHP!B>u zy#xjIaTL^(9yW;6D5%$?pmw03&Okvu1O@d(6x8>kpgxL%`ual#aTo>lQWVr9QBcRA zpdN^V+KPhu2^7>#A_GJT3hG1@)QwP32cn>Ego1hy3hD<@P`Aws5Ia#&FGE2+4+Zra z6x5%ipibBjAU;AteHRMq87Qb1p`d;n1$ECK0>uANP%lM6y#NLEBPgi4ixhy28xhrfnxi-K=Bw}$aw$0K+$bepeTDGP%M8tP^|qVP<;DcpqTV~ zpy*sDNOWu#B*u3R5?}TW5^Ix!!~>&)#35Udm|PSj`Yj0(=??^njZb60Gf2dI5+tVo z7$nXFpuKo;usGf+Sd8lzEZSrQiz_X`V)aeIB6C@=usj0)?ZINnhr!~}AK+i3hWMpL z4bkDs8e+@f8sd=&HN=@B9Ivb)KHOYGjDDwvNIF~t<$FzGZBEzTR71MZgHZvu(zxuatGBB zO{din1rOE{^WLk2dbO^2qibCeJg%-dv!t%r`bu5V=hwPocBgt`+4c2A{?dA){myz~ z!ByFXGqK7bm``FP`pnkyz}wNX&okB5_Y}1My*M198>r2I8H=4aA+j8;YejHxzGw z)KDZ`)=1Qv)ks|YK_lVpasUUh`AxHM5kL?i9KPh#jSU>7MU&Eh?qy(h}52K#jUTk6=#OG6OVt_ zPOP8RUi{LugScmN2l3#LNYVUQq^PyDqnO&Wldyl*N&LQ`vuNL=i}>we7cpzuW#Y92 zqj>*}Q9S+Z7y9&;%EIuuWw?- z>p#Vb8-wCSPSb&6RksAuJ~dG^b6hKKSw2WC*pVb!|CB6pJEVvk$EFI?njzxy18L&7 z$PBTkV5r#h`Y=(iWu{nq!w7N1r`L&(<3@?H$4841ZO4eU_ly-UTry5|Q?Negk(PzZ) zvaRBx_1i?x72Cy6OLmC-<*$iD5APH=z5bS%aO@rNUWfO@iHRSGKep}@mp1uS+&+81 zDEjRS(W&Sg@p6Oj#LTCD5G%~bMPl1u#Li=Cd;t3xy5j7lg-d;WWM2>X44JBf0}7HaA2O{z&E!T zHU}>;Z0Wn)khE}(VfV2I3>zHl4gKmpVL1BI7DIrsy? z!$CRYpAVYZ>YbqV?GFakpZasqM-6HP_c+}=IIU;bVC(h)!7r@5F8Jox?ZFKb<^?~} zVpZ^}#K(iLdi(X@Ll1uzOydIR^3OzT%47Usxn}%8`@Ajs1ALF^TGQoqM(w{>JAS}& z3R8Bz#}6zvG|v===1TcEPsB&H6&adfXd%F9#xe5t;k|{3o4#E(@%hbK9xPV^kTyPf zDDPOPOk^IV8XnsD4BJnlVg7c&6AvExV=J04imQb!ji<0&qM#gB59*5|Z5SYAyY8ktA*C!YGyjvtr&873YW(`)7FwCGeV50+Pthuc789%ULH-p2dp zy%8F;)H=8?x+{t!`=Ix&Snd*+?<(4d=Uh8w;16fZJW@aP)Q2{|M4t&0<34*fp8C-8*xo8!Of^SeY0T$Q@F zK6$v!)Pu(%FFepSE&tv+h5p&fIS<`7V(r{-52uqJc|3*LA@p4|3fuY@&W&k?&04|)uVj<(lZ}x+X214sEu*kQ8$)t z=>5^3ja03CfgQC+SgzHTnveO_5Plzq9)>CJjwE5;oGlAuOge^+w}|6FZ6<;ZhG;n8^n3XA^Bj{RiWfAv_llZeB3-Umg* z0Hh<4aL7Q_{@AZ-i~OXt-r}3uV%sxehC6PWRotWtJsCk-B9X{WSWYt8rQ;Q@>;fxI znB&sb80RoeRle$n7rUrFAy)j7fLFc}9$pN8x!&cjyaa#E#ym^)MD}=!dcX7(8Q(#W?f; zjDsiOnGD8zBL-s}d593-Wnhdy6LyKQ+)@*si;NdyHpXkebYRRC|E>H)c z<9a|%fQmCDv+^7kNgzG~E{3g!7N%tCpVOxMyiR3_1N1hP45&(JaNi4*grV{-Ig zdrTZzM(4UmWOOF!qrYM=zcQ~sd&6x&gbQrgD=Y#U^!V=r;9cN2fhSHFC6 z_qxcIu0*E2L9{fm9H)CY-|f^yXKao+3$r`ax2dyJY^e@Aeew(yw6cbRXaC}R-|c~f z?`n&#aqV(Gox0+)5XuyA#E;5(ma9_t)_Z$^qgTE?sucAl2uChQD8G&a`T{6=mHbNi znn3xFk2yb4UL;5Q<@`l{iNpkUW zfq;ec^RJ?xCD_37X>5pM!H#?u?AWm*wpdW?U`4U~pJ(^pyV=QQ6BP7QZt{C>X5XEi znSJM(cgoIgHahuQZ~f@Y)@oDvx;%ban%pMuc`WS!!KiDD+pI?nhyF3H0ynJN72X*4@QA~3FX6VL2C9*k zv`@9!X(uLukVgUY(Qd!`_@=J4J=&=$#|*r0mm!0aAA8!alwml}_9=3+Xxv|!7YbEK z4?-)!4x}0bG3J}tFZjQ;UvL`grU;;|^a0a>89)i(2aX430+{Mp`v}Y72Y?FT1OU?? zYfoVaeibkam<^C;SVmBokyv{SPlA6kfN7Go*DwtKRN!C0X~6#hrvqmIX9Dcc&H~N` zFr8B80Otbd0p|nkXBGe#02cxm0T%<9a#?#57s0<2xD2=)z%lLO=W}=Xm`1A(z#ahSjC%rm0oY=s_5nC1_5j#! zq&fp#fUZC{fZLDoWLu>JJ%L_8ZvfMB>pQ*~@Ub;XWddBIJ^<(kV5^ck29~cfC35)=^M|Bi18Ylq90Aqnd zU>q&;7njX za29Yj@NeK8;9TH5;C!G4SO8oATnJnQTntw(3<4ZsrMM&Kr3DR47z3verN8?X$x9k>Iy6Sxbw8@LC!7g!G52dn`83)~Mp z06Yjh1gr!e1|9((1s($)2c7_)1Xcl00Z#+Z0M7!?0nY<30IPu)ftP@nfmeW6f!Bc7 zfi=Jzz*^u<;4R>7;2q#ypbmHscpvxx_z+kJd<1+9tOq^;J_SAlJ_o)4z68DkHUJxe zuYqrXZ-MWC?|~nHO~8-9Przp2XW$p$SKv2*gWn_|8E6LV05k_$0N8G)S^+x(t$`FE z71#;b8Q`AjG@vc83(yYO71#~f9l$m{)dAQ8=m_iy>;>!%>;rJGwFl?~bOyQrU4d>u zcc2G=EqPZ+M>Bc;on^%kJ2hbp%JB>l-4srLo`W;_z537Z>@o z&u+>HFux#|AFdn~2>GYau^!p+1EPAlGJkGuB`D=GpL6i!bFZyCHv6@W?9wf_Yvk9I zM@}n_L-BDszA29flac3wL#lm6Rs0?qA8Kbz^p}>R)czp81sQn|Vvj3CUn@~AszJ)t z0^yc`%%hoC>!h2{@74L5P%9q5?Eoa>SLBvZ`GlxD=vHds}}i((+=-~a~zLJIXB^aV>~-(Ou+~1CjN9FF0P_UfH1-=`Z}yjwe5Kww2SlRQA|2{Qo;P!Bv?E~iB$gg;pJ)zHcMOwnB1h0#KcG)X zx$ewk{T$OvxcC~-d6Ji$VnxcvFZF5iWC?h5%i70!KO7$TX3&lr-KQXOGne>0iSgEI zVg2f_Q_V&~EJqKP17LRKjc|kfAy;U>b)N7%Wdy@|-OIHS$K;G0i;v3_E}{Xwzp4XI zs6*BdbtU?gezZe+nmX>?x;d%X$5aFa^P?a$jL67~r?U@fjZM zIPuxvIC72)^ID`>Jjg~OHnZg#MGa9=S>=kvyPvpLHZZslxe=5viYl>4n8^UvG=$U*JzYh`D>Q>0uXj}|Br zaDA>3EzMBuW-E>SzYP0Avt60##ygfa#&Z&;ZgoewxQ4=VKH)d4fohx*`&^yk#pAW_Ipy*P;U1kfQi67fNPjLg8*EI;oNlyjPqkC(>J)dGo~X? z?2Pr9-H_M5n4_Wbt;$hqsuy$qb1^Q#Lgib1lT=qMhCF_1vU==>W~u`3lb!T9-u)Vv zq8>gyP0eWELEYx*q7EI*T={9F(r!UrlJ_Dvi*ApX_??WQ_$NXIUh7kN7;$7+FIL#IXkNp0YJJ?n zH7?zC)ejKPGL9QMB*(@!bn-8h>+|qsX-<2?e!LiE%f!Qk`}3O(4DXbpZa(3V^KSU` z$`hwV^u7w`sdtf^x6+{Av!~(9>G+-=Kf1`}6&f};^Z!cHtZ_aAvtijBm=3G0a%F>U zmNtoNEG!PgGRG00GEl>kGd{X*Ykg)L4}j{D{@;J`)yMDEyTw#BbS){tZ6UVPT8L6(>1S(qck;!w_Z96@)SJg1aDJaX-{`vI61yzY&x+hEVS{|JUXe4c zeSLe+^g01UfQ|q;!to~gLYv>fl={SGp?A&2Lw*KoJkPzQa1t^lU9*7xSb_Ani$Cu2;8=_GyH4g2oxcs$28$#~QseIE0A z3Ga+hZm|Urst9laGBhu?cuS&GG0eVSv=Q} zJYL-GL8kL&na7RFv6YN7VH>KqUHpp5B2`ff>T{!zC)l-DUm zd0rk@y!gPpH6tR6ULA0r_D1BU{+hxY+8aF1E%KFz(3#pPWPuzeZ_Kpy<3CcT`n7sk zPk&3ol7{#VT`M+D&g=1cPCt$pM`Ys1i!bN&y!3byZi>%15>L`i`2U+4(A)LYboX}c z>6W5u-d=M0<=4OZ-hdwV{X7Ma?ONpKUAnhxd-TK2ko_@K*2g$zyUswuT#J$U4*LX# zg=ajb<1sl*P$tI+I_5Vf&l!*LMK0;`IyxTfGCgcX(0=rDlAdNv@y$j(f5Kn~Cq*c;&f0@_#t zmqh2axGZX)C`S@eAZUf@{~pJ*{wXeu8xej?-QUR%bA5j$__N`w_lJ({xzpUkJ~*2y zj`lAir%ZSC_+dR)(3PNMolxms;6$JT*cG@L za=!P)ciPSct^#s_Bw!=1{|^f1p$Iy`4OJ+67~ zpL)!`R(Mf2z{v}o+QDkx2d1blZ7Mr0IVeTF)cwo+$3A@i!%4@n)!Ofvk{2SkgxU{y zQHXzrJ1tP{D;`pf520dXbOE{H3s%ZEa~YlQ@v?1htkoL>H1YE}F*noC~ z{Yhsa9pKpH5MVGc2AB#2firtk6h48fegr;2 zAzGjSN1*_pqiH-1l_jG9*W*FhDhyEmg_k5Yz{vFLgm!jro95tsz;vOr6kv z2lXKS_e1|Do2xZ%<9|8eALUfuv7>5pMv7W_`%Y?~p=qjaLOT`Oyt}${^q%U@kViea zpu4*1)xPS(+5J`JiY)cmXCqWA|1o%>x>V)0KUEDYxm2wkd5?Pkx;5&J%A};FU+R;6mzNQgMUsfhAZpZ^*YX0&#BPuyJVup8#}5cvj_2se8RpNMOSpsvwxtGiJDYWc z)6V*kaWPPG2;^VRT$MI3MLjioz3NfhyT{`+XmI?N0PU>EZE5V6<1@UA9GoLYb|^m3 zUdAT_+=Vf^w79UsTZD{$kDX=Pl{pv3OWdbHo2&2J+6BilKjT=Qd%*a<7>mCLz%iHX zC#QYh2jJcf56}td40Hjy0^NY_0LDbN zg7rdsDt3JMTp64}mdK$c*a`7b|(~W#ZhERnrQ!cJ(q#kWJl|*W z!Ot9;qEbVrm8}_;q9*?P{a&v(yRdjXC*5$jAtL89BDbZnU$om{xrIgESw4IwD2UG) z+aYeYv?6Wmc?|nnjj7Xg3|31F2v!2~VdSQw zO7k($7=i)Ecue+A#ANS2OgPdoP&o|~y>?L0V;G<;#00Mfle^pZ!Z+hEshisgg^FUxfpbJ2qbF3raToc8##we8G7OZ13k6{Apu+GD? z!nk$IQBH_!D9rN`SC1ptCH#a2{wxiIk&)QfRioVPYYpu0*lyom{Kfmjzh(QO6Z+}mw^jQ{w6|E@Btm~*4a`T;rQL?dI@_%e=ZXPY=PekW zq8=^XxUl{AcYd^BkbTcGpAoq&js3dMXRL?vR^)i=5V2I8>jWal&>`ASvOTiBvtMOD z%08Q639YUk9kOrc+6CuE?3)>f*Gk_keK@Ztc+52nUWXxxbseu||IU1P9lgf|lT{Pkd6GUpMYXNE?7=s8xO&{`-;Sj! zqtEd~PMPi+;tBq5Ycb>f5q_`$Vo#<1C2!V0LC1Iulh{(`DKOEG>#<%Wjh z@FV*0LANC)PpEsTS0>3YA#J=T!W@De4v-^UqhLLy19^aO1Hpvb3L4OP(%~3)o>U)| zqK5stZeXj+H$R(}^+GFVFa3?k%_7C&3I2(_zpScEXUQM4Cz2<*LC{vviOn$k8~bc5 zo*a{J;^bOAEuJG!2|g2(@g5a14Cn<|Y5W688pgdzf3pZY;VotZ^x3AlCRy+WbUJ(X zx6AO}%Aiw5oj1SYln*|R=t9;3M2_eV2cBTxX6~FK>%Vb(D+A>jM+K_nzk}QVA4u|F zHYLVWCeL+Vj*HUL@oh~1$qUmar>Mb)d^IN}f2T8cpKNC%`HS3hSd69W6z9D)^|H}vWd}psVTvUe>UWnY5#(s5PaM9m>Gcv|alOG&!3P)J) zoLh2ENnh%|0O7tsXMp>WIDh5Xh4IK2@=NNOJ|T7pLCeW`9_V5FY~oim5Jn)%k7-VR zD3xW|je@Bus?9@B=45(P)CFlLy}jzQ@$L7x%5H_i50Oi{;_LhvGJU$g$j|?W9^*${ zB>%?t6O${ffAWX+fV}7eWCGa$?L{?kE$|MIfl9v|;QyA{1hfWe=7BtOkx(Bb^cqO` z5(dSWVRH0xXMD40KfJe)g=aPs@&9FJBi(E8zQS90zR@R19l9tS3XlW`q6N>Hohw>a{h zV4GnZ;oNN+a4EnxLVZv#ypGo=Yhg)?GM-Dg`Wn#3cbkgc`9G;BMV(c4;iA1glNW9- zqt;{gQRHS04e-C7scb4wBz>t!w%`!kAZ?S$^=M6dXLhK2{9E)>I#d-esz!ZSCRpKDHRh_Q4<e7F)7ux;UV_noJTTVh7$k>rmGpCKN}Tm) zj*kb-NKq|+nzLcrxsUfT$HyXf6aohgmLoD)HrqGtId#sqml!8Q34gJxLH@#zRx{oC zQQ}Wgr=Kz2JM4^mSD52uk(;;EAV2E$1oo9CUlQYHQ=@5y>G5^PKQ0G42#iZ5>~?Gs`NRyfMd} z3g_277hcfwh#41~<4%#ArD~8j4Gcp6ZsSj`2}rwJHrJ^?e$QtW&ZnP{q9$Llc+J#M zihAYQ*5B`b?bWSc$+0zc2Z+u6uOg45zj0N;X@Q~M^8Jq-=a+vM6y2BA*t!PW3&-Ca zmvb!7`4~$n>!IxTIqy#c5G;IM)T}2J`?p7wipi z4S_2b`vd)e{=gx?VZb1OY8V3K0i4Pd0ONp30GE!vz;s|HPyti{oL`;_oC%x5dc3K)z^d>j~oid+i>P?;&{SZ@Q4L4~$K zg+2>hkcPD!RO(?^hw6k%ZHr3X36;7VDzz6XbtEeF6jbVisMMYJ!na!XR;mt@reY8N zA5a!xhl!Ec}mbRA}9);KO|EWk!W=K!pzf z4|H@rICl%`;%=1lL9D4giS@S^@&B#gL>?dE+OP3m{V&*;+&W45+9#ESI=233es3%5#1u8W z?xEG|^H-m_Hqs&FBRaDE3_}DfIlPfP4|TCDeYJ$`|?UV?%t=lH4jm;Tgvv9Iudj4D+t&b6!HZ#G_9qzJ1jA@0P}I zJjK5@#v)`d_9gFBcfKqEpRR7(d)~S{|A3=8(1a7dh}@ROew)e{<1>)Idp(f#%yG4D zgJ^pQeH{Bwt4G}4pXzkpgimww#{AA-9eDNJyrSB!YZia|-)lMhkMTz2X5pL48{_kk zP3Dc6UsI3CBhHIxU)bk02QV$R_{O=B-sh2HP2pKn;vlJigwuJGcczm!#kfPlvwsWK zZ1F|FkYJI_wo4VcfK}v0805KHj**}TgR7&LkpYZG0_ExT3{3oa&A4mr?@{3D- z@_%#i6{})@RawU9P>C;yMB=^2#IX$f4%Vw~Ls(yOOkeDZ^gBGy>&$vJj}c{yT~pF% zN}MgucpF~ucPsBURK?#W=`czvi-Okd!&^Gi8=Q$oZSRUetS}(?uRqIaN6h^YdGqm|``ea$Ii=-Zo(Yj0 zB!7`d#8Iz-{4p&Gh8U?9q}As^wEOHAXe$Wz3v>~)W%&u7+dBC(eyfp*@I#&B&X1{Q zr>GwvU#wEIFFo`5Na04Jb0pfh&PS0op3gXJ}K%Av%*I=5f3@)`f{5R}F-5R``)svlM4(6Mgn*|YCZcN1OFI+ejcztKyGl( zg6_(i&#;ck8*zGAWC_2%2Eq^tKf)I|`B86O1pFEHLhpS?-1gBssRgH7i3vYMZsrh& zAC4suH-4CDHRYH*5WA6y@X^4uh%a^{8^^RCg}^X?&$F=wz1e60)fB-NR;8=xm zx&F$!X5SI7-+(ybny7(V#FKt!z<-=PG1to$U7n&w{e0==p^cS8=X2o#j%}9nUXfcu z?FT%;`~5@k8PyQ}L1gqj>Y-Jor5Q4S#s8~}uIJ(3+Rvye^>XRma$9O=^fu10fIMN5 zg)dB;c8AB}^lK?=>{zbbp8X}bdErm^DtG?WfnV(hB)!u%dFd*XKO#4E`Fr_e{QKfY z?U0$TUiZQw`UxJHn%X+YVI(6ws=Lm~Bb-X|F`L>Hwe;KFuU~RCzFV{;ul@Rr+Fk0F z+0TtVI88ewaz@u3cr?6lu)ngx8!9Rp=bcvS8-nM5exLjku;2SVXO@(GQX7EtYp$bk zT*76+&OkcAwG)n4vVbE2t_aNl<^b4stQG^003QI@Qfz&1xfDM4fqw(!fpq+zgPmZo zZUTm*^J{_5?|tAy7`0tmDOHIHRa+G1dkmy9P?#sNF!K^N_D<`7Jg~?5gihFd-2?lk z`zm$MLD&<0gi<%=W2}V^w>gwMa+XqOpN;*|*Psv&VxRjv*vGv?lIo6)>c{w!)G5~_ zsrH{Hsjm)CR-W2qwRgK_>WNF6sW}Jlpn7cBL6xm)uI_xig&Or`OLas3j;gG#wR-yg zRCU9rJF9PJw^c2wc2z%r+g=@t4c|Ym^{5SVx~tvV^i^j(cA&cCnZs4fWAoH04~T)Gy8Qc0-Zdf#*AiNB*ml{M&4ei#b@4EhiEL&wBc(kt~x23UP z*w^U)S`GZqFXz`eb zBTd_evK%6hmB0?^GKqxA57)G~wzUt?1>hW(Yhs+Y zW&b9p+3-FNWo~}yW(F@;z!Gi8XhoDc&MR`Zz zTmMJnoBe*2VJ`XwbVS`2;~lAo@&6+0Fb~5&N&RBKBvs{2Qfc_$%+Bv5sUPsImtwJKfIm1E8jnHNW4lU%NHKc4-?<(d|6X#XGOd*xqDJ)e>Rae`$jV zCR{=TTU7(KNKM*p`fVu|_p%`)C&@z$1JqOuHYQwm2WD`1R{P0;Z|?I_54(Zm*zOlP z)RQwVU7ojm#zfA6x$m{o-U^$C?`>k;t-RP5^aTrofg)dJWk&w!$R`hTe3c=5oFfp~ z--a}#e5;yJzPf{R+ubtlYTkn7q4 z$zRH6%H@2M%ZJb0Rs<^jp+GRM9@8V`l=p%844!psx~9gf#)Wd<6?Zx9J=bwLzL)=p zHQ@FXb!3Nmuid?SxBW2uvm8g)wD%&9h@&3t{jgkFupNmnwwC&=McR0Fo?PX<&`x5Q zYWbAW36JI2mL`4^8rZ%x5XS9Fd)?4Td!=SRzjXE)?O$ujX{F`t*>L-Mayf6d*C7@D z(!h)=ngPp&@hkZ+S?+ExD(+5E$EKe7?4w_vG3xe6!xeiWay!-7Z@v6yd5fy>)jx?5 z&u+*$-4{C{W3Yzo2jvpCIl{C(5?9ib^Kwi-o=iWV2q!e~zoY@ZpZDD7-fpvwN>f$O ztsVE)Et9X5v4yl-k(>8swp(=h{>l>Pci30o@1E}>lxs@P!0%R^Grg=$WU?grioCIW z`CbR(n0A86@m{3e(w8uTmJ^xyB9G_mar7|b@|aG1`^fq0cFq~I{!vq|ZAzT_DJLY` zy9UBgfb{PL54g8i>S}ss@a8rLH|OI^%gOk{l*@V3PGH*T7+>giN4eh#9l0a z%)Pya(VlCTjGD6eh)a6C8Bw0}?;8fuysg*ENt_LY&aRpQ3>DE%Yq1;;@VR;?pc}wv>)66%{r{GO;U5kR295;yo(b1crvoPd zCjC<;gBx3WfKpQjz#e0DfA|nQ_s8aep5sx+$KoC^4{IG#>iRJLhYOz9 z?|miW+=lN^K7#vwU8y&|#NL5cN$PxjkFs(|l6t-bHvVn8+=m_5+@9#oLd4b+hnRzP~6KDD)Kt%8M)QNVQ0Y zJeBos?b2wFIYHgl`(~%Z$F>Bk9+?EklV<~Kfqwx<0S5xyYex=I<)k#P7uY3t_8B;x zaB(zH1DV*7%x9eZF!zDifIq{oF1R)P^8@8KMA8}#?vo!PH?y$%{|5GfYr_KU5x3|4 zCSUkHTG|D9p3n~AhU&K=xml*f@$c8bB3vqbS=9(%vihZ|b8cF+Pu-*YWuO`@7mn~n zbK)>I6cLib6YYaz#W9p^9e75dAI zd?UP-A-gD685pk?_tBXBXS}WHtN~9XL8_5=L|?)@k8ayKW>`PZINOuc`Ptz`Cr?cK zUkx643eQ`5&b9B>JdFK>bRK~86gg$O(|Hml1tQc!(Oa7r@#;=w^jX*RIbL8GLmTT@ ze4Y~^XocyEAc8%*_{_P;7yAOtrxHO_>DX7>|<-l1CP8Axv4jk7cu~-g_5@x zFZ8<9^Jo1Na-Kf*xN7;V^DW`m=&p-FdMLyg8!h;cYft zbjBV&Dj3cKkQXASOn3Eo!P$kk2(usCHN=m`>Vb7BU|iO()Uk|BDA$3*gxf+5=ys#z zb$5QO0)K9P@!lu@^WrJ3ujK$A&I6DiBBxAu_4pBa0MHOGc&*f_o{q@q)5$Su%A!Py z!&BBdu?4gd;^f+fjzymEozIcOZ@BZK4!pUp*Pi}ihd=QU=cjZYfV>bnWxA`!i-|t( zOhl+fCF%W%)U&jIjsscOB9}fuPdgFbb{YsHY3WaD-*o2%|M|>O{(%SXvEq%5cX8nd z&I6DaBBxAuIxn=XqtT(L$q)V7cwzEH9BqO);f;(ddCa(CHy9R~T%%tvGCh5fZO{IE z+`RB()!Xj;NPjCuRSrFK=bq~?x@s*OIGhI{KSWNM?p*jGLsBbxJf5&Vb*I-IdB9`( ztY^k$n2yK73ri6BG1HTCdb(~hIk!FfI!`vd>&}yccT&{21z!#KuIO2LOQaEcpfvJC zqB>*)PhHM-Fm~? z8~dLBZ*#mVa=zIBW7m>YCX|-HOlj zS+~Lu9@ELO#G@}x4~tBE^PG7s@wR7Qe;&W`Q+J+tK1oqO-7~23O__V&X^vw>ZtAiL zJkf`<^~NcZo>_NtEZh*AK|7Kd&x+QzzOVCT!{_dNDflc!9h`snNgp4wYIk!yD{`}h zP2h_@tgXkF#JJYf=wExRk5@W;<<6JtFYq39VS1~!^ETaTj%!73-c1wuVhwN2eu(yi zNQ`Sujs7*qx?RcJ=+2WR;L*fK78XzFdFpQ0Mmhrij|z@gL~h=N8&8_DFHFWIOjp9p znql@i1f7I=E;5v|9`@4C}u{6@~&8_1AqQ zJ>8EqAzfsJh3Dc6r^#X3P2o4sOBxI(T+=lWMpWTV=J!tCD3xXHn=6=_qS`$4WKIou z^=)3k+uwXP?CuQ}L##|Z_@&(wxh2$obl!}fcD%1BRGE?E!&g>(8P+o?vtQIM{ZoR% z8_7(64o)tSW70?SnDfW&$%S#V!jFPY?)+E={#?J`Q)8wancw}rUiO=n9$Zg;h#ZFw z7mpv=(?j@bkNwEEX|^!bW^CqK-3WmZzRTDGo1>0|V?M8>{J)L+jqrbknbU8;PN_hbCL*$g{PUpu+Us)hHCqt)4z4^J+ zjh;qR!{)VeEWViz<@$J>91x!H9K$@%K8HSCLuuJ(|9QXqIJ)*XlOHM>uZbzoFDYub zh0oWjUsF`q+F5N!oE_YEeb)j@86NzSA0oGe+Kssxp|4(WS-1eC58NH{=hL zXN>Td`9lXp>`5K2C0~!}{OSFYj9yo?_pC3rYrfCNZ=vHeb=Et3_}sYle%?&@9FMO7 z`r+ccfKpWU38>@`k-)b|;C&>Jip8QI@Pf}&e7AgDx>94Y$GmzB-fhE+U>9Ad)MuaI z+vy{c)VXVt)b&>-tE*NtQ!kBZuI9{dseZ(Upl1$lqk3Jvn`-yqKI;A3d#gJ;9-;Og zGD+Q0b+Vc><_=X6{6$@UC|{0K$xzWe`1RTYWq*bf-qY8|P_iCRImcOa)baM}^m*Kx zB);(%dw&K&M|&86Hv-4MFmUs@XF7IVydsNHl?PyZ5IJSKYeIX-wf|X`vVc5pAx29$ToLmltB>MC7La+;|et(EZtbX^Nc_&glK7d7syX;}V(ItZJkj^AAo_zJ)8FO8(@8Z1oC9jdnT6+o;@< z#(wm245`L?NIAYX5Sicbeb+FeO8)D2H1*(Ix65mlst%eq>C@>we;V43FX6&@0Ol`p z%5>+*fBJNPk>6Kdgt-;-rZd}#%wP00B&>5>w~M@npp3Rp!s1I@oJzPY)PUYj(o)^| zQPDb8y>{!H=_ltL_022m?2J6{$Pba5**CzCdaoRqJRuhZW}1y1^Ez^aPUi@D!eil( zq)(sc=qFr!4TK>UJCe1NlPASE$8S+o;HlMnIqSyPfJZN!(WUL(-d=B<85z8IaGpF7 zISw68=Sgm$v=k2jFy|hNFXY;`WEo=X^9re7M9yz!`KE?%EgX@1W``N@+4khZxLIlcYBwiu% z=7T>I>T>hPw66Tj{LY8SO})ADLwmz=Yw|>|TfIEwgY+d5hy0*SYy>$XVFaVxFgal! zGwwgx={zae!<{F~z@vG;wJEvmk(E1{-~AA|sVjG$#I~e2#FNJAgLNukT-LMHb*o5W zDAy4YC%i4tfX7Y-20VJJyvKhE79Me@`TY-(n_0W_M0WqVk4vPE^|VDspH7Zx zA7s34ors(h8$sJ4POfd}SmX)c`8=d{Z+D)ky;9Z7?>}_RuhYVPIG>^O0GyYIoHE_H z^Cb3$rD;#3-o-v}9Lf3@x%3r!UWxFw(||sIUA?b6PcrvORlEJNOTU+s&VJtfK8VQ8 zk~YYbICEECYx2cR&pg&`0&Rvk;gO6_dCa(CR~QzVT%%tvGCh5fZO^{W7uDIFFH=3K z>id222cOw~;0fmULPT!rvZ;KLp=~_AuwHei*CF}9WBROb#$}j}$HEUw5cx6FlXH5y zZZbKyJ^K2(%7Cu!d|3oO^(lIx@6ynMW#;>qA~$u|WWL0PxKF#{l1U}t=+C|r`-TcjdypGNTkS`*qOm|J@OX9nDy4wC{!#ZD9^>XJ+de2lf z^@rTgJKizx0rR^eA~$ce$$W`?WW=;DW_sqa^h=aW-$WVvC(fz#v90u3JTE{n>Uh2G z^t5&P_8iv7F{-aSU#9j>Rj(9{Y$G@(#p!IREqA-@0!_viUs{k(+nXWZuO4I0+In`6J^P<|AS9iDC9l zvSue?o@3u-I*Dh>6USSofm%ct{><<1&L5_H=st^&$a#5Xz3-Ela>k|mUHp+w3)e3J zqU;8Zo^==s8^ZO+tH*;=~NAW&pf{UBN z7c-Boc`Q7VH2Ex79Jxi#NgvN+&QG@|r}HKAaCg4cfKSgitC_RB=VfP_-!l=psk=t` zqJP{37yng!F?qscf_sDL^Zj;mLu?d++ojX_GIfwUUsi%ox9n7O!&$xOk1)S)B63rS zjq=6uHH$6hi&@XiU+UT{OGC%fC+TU4jD4BN>616~w@2H8+g3VXYO>w=vH^Tr)9s8K zOONPyyZOBnkuy!*HOLovIZ*pH4zH_4WpJD&@9j%n>1j4KY+ftJ;+yGEu8;T03E>UT zG0gM&yCDswg=qgsSBtxfj)QYezBs@4keQRJ&h7b2QTZJkJ~h98B63qn4f3TaA45T6 zCV$NIx7D%mguXsTk@a-SIgX**p8Kd;+`sTAZKykcDh8*jf~UV6apzqr`DfHNqb%==|nt>HbTPJi`2LNKDRH zF}J1s(ciIWD*F2A`aE}j=M76$?Iw4Be#4!LnB68|ccTMJvVG#dp-ZaG? z3U~B=R=?NnDXjBmc_X}`UXHF=+j7=bk9`V@;P}2sOzzZPlX+tpLVaG5H^QCInTMvS zKE6-7JhoqGl=;1psN7kshSziBeS8Gh>gA~(WtPXe?zRTyo$&Fxe8^pnLK7#e2EKD!fl}j^metZz@0B?qf^yB2Y1R`t*5@e!|7qfNp0t zjB)a&7?Ydj} zn0+qqYFpVBU4NN{PW_qRD+!NHRWrZp-TLR{9ZJmam55xwFNT|-KgY*QO#MlEq9Zw` zFS?~}I7VR{`W)ZtYeqQSX08?~%ls%j&Ru`2q2GBA&mK{k+%4Dqo`}fJf;L@$@vK*U zKI(d8m^Me(8S@wZQT}JUYGf$-Tr|O{PxJc>o1pJKr@i#@y3Yf@h9eEcgX_63T;yi? zb$#-a3>mo<6^v60W$5jeGA2n-N3yPjU|f4FdSzT*!()*l7}Y7m3Ag1M2;&mr#qvq+ zyy!47RXzGb`B&GxcY4-dkxKC3dh$Z#ICQvrys)12N63Mg@%X{7QL~MZ8)kh+=!i2; zC-HP{h|C!?akM2G2qUuaW57}F{8&9OO`X$yY2KH4nOWQuOXmT|50O)*yL$YHY|It= z5k_Rmf6_7T`7cNL+P+Ylyj$0ob8;d?@ZfspFLE3@T)q6Qy)u$}eSY#e8|^qjn?$E` z&X(9R-OfoI@f*5Mu21+)(?A%}gdb}f;RjPJoV9r19)qUzWSGtq`8DO17(ey+!Ht|T zdZ;ksNdB9qxbt(;kbeO+9XC&wJ zahh<@k!a+A9OilYbmH4biQlcE0sT8A;bYzTQE_;hN=eQrG5BmuL}>nF!K3RCFKygq+F4>8=Uo z(anpaJmF$@{V<>PuROl-!kR0yB~OnP@YIvb`6iS{r?KOCZU>)xc`}EksU7e8y4Ah~ z!z%6nCKuC>$fX?OyOqa$l|dUmIm%Tq!@XR~Q0`|AoTHxaH*dhoNX8!ctT&NI#8I!Q z<#JRWuC9e)*T+@lE$5`{AL5OZ5Z!W#{vo1>ZS3iGx!UjKjZ(&QFz{;EP00^_-|VhQ z=Kgb$o5j_66KBhLl)@%Y%yhQ(vG7jv(f1(GwvmtIEy3gM?OC(VliHc?JWh!0 zo^$D<#mVNrbCE-Z4i}Fnv90D&n$)u=jzqTMfyoaZ6RjeCV!yeqe4Qt&%G`O9UYe?Q zEMGc&^5>VGZ|*l2xt(h4Hy%%7Tg-nyPt5vdj#9_5+}%Sm2GY|K8T&es)8F3rnd>~+ z5OC*7L3yhB=Aykv9kBA*=gocQA~$PB=SjV-dS>uq&jni_W1z5i}I@Y|0wA_eror`|+vmfKZt4O%JZ z_q;3SILl@3V_A)I-?Ztl1A2zv%ne5rD&-QnTe%$nCnwso+EcjTSIS@5!`#;*a`RSn{?_M7Y^gjRPZIlEOl|&k$ND%d{Umpu zg!9wXv;(^OmIfD|Yd*&ixp^nrG=?HkhXSYYmV5&4#t zC$9tZ9TNO!1UgehW=2-=nvr?y&-R zK5EG2ygP4WkCycI)9O@rzLv~ORX?A*;ig{}gdZ~ZzldD&7r()BG%!Xmc}p%P_QQxa z|9W2^SJpPd7tfJt>g?Vt&zV$q@#;R2qI=+TTq$z%j+)GuSQl+2p_gmGzubAeazvWy zRC4-HQ+{~lJF_1U`R^{5(Ix2Rs`x+ma;-+WyY@c!>X)<6z4h@(0X*=jFOmQ5a>cp^ zD+#lmQ4bvVvX7u|IpqOyp+##PJ`~fXJM?Bx4VJ@>%2&anx&ax%AC7xVjdQ z_1dg68qrrlnhNZ`^UlGEKkaPpuMv5)K#{FD4%D(d-<5} zx*H3J?3{D)qf!Qs74X!P%lR!WpV2HFx54;y1Z` z4Q$q_MMBa()W6;JH}$Mkwcw4*`d=U>N01E zW)ulXzmw>XOwDYYW8Ll#IM>M^rJVb97J*;;m$aSw@PI=vHuvj@+$?2-{Bhg7gG5Z; znCWioW8tCXli0r_ny`I+epzz9J8xEjR}=2)fB2lYE~+s1?}*%)y7T=G$2y+y#@NjB zSMkN<36F_Z5ufWbTyu^$_J(-7aXMcXEpX?{Ch+OMxBjxk8!DM??&A@;sklb%jIpU_ zOZj5fGxL|aHp|k`v5cwov_!`KP~`MwUjWZSU>sabtyEGB} z9U9Qby_t*L`BHNU=1mJzD*rR-`*+NJJ|Z`Z&=kJJTPinsli2TLYWA-^)_GHXsgpOw zD4Jux4|vu6@l&6>rtIe-=6)ZMn|IS7Z`?NjAdzK&xv$VnJKiyE3~i2XcO*<(!@2sl zaJn8>Ugp%Jx&J2(=kHq6yQ2Bblu~p5kI2n3HbIZ|Hv=J&czUD`WX*y)q0Yn(ix1IX z;%bqrtp7~C++C0132AETk$vtN{q}=P&HX?kH*ccpdW>hyl&aRsx5g;nJ~+28Q1Aux zIeYfEnG@605BF`@<-%9jewR!V!g&C$Pl=o|-C5=1qHJX0bF9x>87OytC$-{=RI9$S zaUqjsov|;S+7a{2>+Zm}Ta~)3w)cykz=eGorfVDdHRYBVKY8Br856ysq7q*)BfoN7 zNzmsl&Z{b)kula+UhE6{f(5}qk*~5cBY(7gGIF8L`^^8im#Y=dzxHTd((W}mr?9+q zEEn}5a!aWFG`U={>awm*$FFWbxPC5qYRRkGNW6AO6>luK(!Kn=?&8|!{g%Jl@kEB{ zM6agYKDz~aWqk)K{h>h6q2DkP((i-ml4FtWxjeL7cL~5JCy1@#^ymNTDtG;?f&MPL z@`;)+2OUz$@gdz_0P9!emQef2DfO4n%otK#;S2i9eB~i8zUUMP%=G)fw2GopK3}nq z-HHy|{Oy^JU=P@1g-U%RAb_b}Ft^jS;p}=t9SYS4= z5LgL(3mk+>oDXaSW}%Vq3j%)!G>7p%7L%iPSd=*eiT{e*JTXnFkI`A51{-j7C;b1V zUP|rRALI7HN~KIxY6fgbt8U>C+(>2Xqjs14Jw(3A}O5@>oxtNh|1g-+2PnU^~*)m_HQw)_F>ND z=tRFFx23V)`ufF(?8|*cAz$(6(&7Sth0l(w&ySX0ooewt8>d(f_HE3s0Lp&pkr(!< z#`!ewi+6u^=Uvy4H*~^Fk=xSPuM018y|9uaK+>v;vA)Wx(hw^?3((ss?^E(Zuu-Sq zPu?}o`=Q<10jS+Wsr^qJ{|XbUKDzaT12=5?TG{~pBxqOUjH5f3`x)vFR)%awkM*5U z<*N+gLcN|Vu8Xy!c=fy*iEzLq4A)k<#xd@+mXm4;;4sO4WYRg`a&Up`Haep z?9$S}>_S*S?+jmd5qp}#IpsyTXJn}B6*RZ%IGT_aVA&Gx&(%N}*@?ZaS?tb}4dBs! zrwyFjf6y8KC8z1gYw|?omQec{5h(JOMtG4iGH`r=Hg{a0fV~Bynf%~bh&)Jef!g`& zT^L1(^5aG)KU4>0^~Y&9q^h4D2uF0xxz5{sjoK->$iGz^}}y^A-0^9!<5T;tsJt#kYDZ(`MntE zV*z4tRYj@42nQ4Wp^`vVh;!n~l0a#3Zi%mG<^j&C-__|Bpi8QQlaGv81kxRM6x5vx&!!v8ZkA;v~-coXz)M!95O zU5%KVC#*by@h_g6_v4NgKOfC7o$$ew+h;LXb19cqRBsVUTbUcEDi4{3Ln6A~YHoAt z%`D#${OjftVFe1b3Ln8BT4A?W_cs!<0Wn8^jbFHhC>F}^=X%n z^G=b+N@jKZhN3Z!2VnlSi$6Ml67tv6XWDu{ zKL1X4eyzv#|E+#u#e#)-6H6ltAF|#cawO?+*;S#ybU(glZa2Szps&bZiN&Sz>Av6y z?=)X2I`bi=J{H}&&g{qKT|ePXk|TBZ1DeE$S+s1s#NLuL2RULNCrnDoEcxXhIhysN#A~*FK5tV{)1GDs?ON&rCmY{O4#u@3->qaq@(Qi9Fc^9Cz+qnjkfD^9z^m+^$%v zFWRq~a>k{z$1x+kb1;a?D4Z}XzYHBMme@fK7?;si7zC6BDnm5ILxWx!{W<&7I-^|S zOBPw>YITTG1E+qsl=*yjTT$k+Q4_9Ym`?h8Q*NJas9e!OXoF>|MFP@Kgzt6g%PiND zvNV;^Vb9DK7q{&1?P}*N{i(>MJmTB>!VXPKMR*uy7s)%*SI)sPn%P)iMIgvUOAP<~ z<^IYNUvYsq$j+5%tO2Bala{-eFE5a$4(L2$;aNYQ@=K41;g<4=T*@WBT|Vi>IFhSZ z#&Lo16&R-a3ah4JTo{k-kvSUsQQOM*T|980DL-4aoB=^Tv%U7#-wqVI<=v z+I^|}-0y3BMVk7x{pA-G?zZrUbgXI6$$g33md1YTkGJb7ez3oo_lq@m>z;-N17+Iy zJd%{&PuHNFY$(|PecC#fqjpS^dOGE_R}oa5E?+tRmpywv6`_Z9eh2)DoN;tF0?$dS z(1gZUvK?`yx*{a9?DFDCWu;pi`U+=xSQaerU@=IkclP??9R}MSeDQg~ z_3x(-;sG4v;7LqWZV9!YaY1i+WhrVqLrO8&7sBHbPVhuB0ngT^b2bH`T&nj^H4i!K z)0}54L%Am&wBP58556yn^C~*hmGcadTSDzeqm#8nVHuYUlnoD0^2;hP?U?PYK>S)% z4BLy$n^;c`Ik$5SU6YXiF%6jYLq2ZJdf1w2{jod!dtPnUkBsBD*4-rP=Z|Spx3kM1 zcDJ(~R^tDQ4cVvv>M3)6!qmWWVrNBemPWI)wuz-(wG8Z7Us)g&S|Oh`5Jtge^V~!G@|p*0>%H9r8=s=8B2+cwow1^Dp*SR+M_@FpgditD2Di`)dY1 zG_=Rpvm||~2U9NR2}fbNIM-HcLKI4pT1YtoUrjqBmrj}BY6 z;J9`k$w$gz%H@3ga+G+3zT-g38NSHl4F@mknoy387hX}(aZtN=B_An=DVOtc%TW;w zgaSo@(&Ov}Ita9dSKKEjJOJ2(>4CGDzC?m4IumZAXYDHA8=gDyWd3e0%USqwpBNys= znE$kMd}FT1tVen8s9JaE_j3k4G2NQ@Ds=_Y;XG30kz}J@VQ5Y%m%(Gt-t1?T=D3#^ zaO}(ZDRsqWS9HPY}Ls2a$j*& zHq`4ctqS_&4Fmh)3V1BnmhP8gbLKNBS^(~w!gi%-yJKDRxkEdEZIXMbc#kOlyjAd- zpRE5(qXCWM`oxjxA}mEaT!!Ol+aH9Hh16%(^UnG-`Lzl4ef>8tZv3Ju=ZJ4O?w4>JB|KAD8NuGKh z`uHI8MQ4AMb>s-e?t4D&tEk7i7tiSN!u{TM#8R{U&`z?=u&rZOwAs>k3K>X4k4YJN#86?$MtbzEMGdcEyV>d`K3)Rkwo zRd*EZs(ka?tMhX9RIgpQuj+eIS2gmuUTWNK`>U!q2dJmt%2wn7s(2pMqQZc*+hvXL zWzu75>f{r9zx?W}huuECkQ%k$;~-x|PMPi;d@)Iah+#nT&wR&wL*87Brf1l1)nHu+aV7sv$RAXQj$;`HC8GPh zR^z;X>WbadcR%;|TOp^r4`BWxw}jeHj<;wg`s3N&V6nZ8DmQmjVaD*nQNGaZKyYT{ zg#&yHsGAN?kBJ#B`i|HNayj2zz#zqNVAUUB2IQyHE+%CY2C_xf!03iNr+ zBfX9}^6nuc+S~OR=@)+!`4*Ie1LN_cw|L`YGp*lqOimCiElh<4a)ifn4#B9i?<#tj z2t+hc17F(RfY;pH9WVL#$(bjtX!X(X$mP-XK2t8|wRPb_tn$eN0t32&ibC|xv?FUcO@ zXy+SH9&%sw#jtKSnaSecuGw(PXL~)ya?sIF!mr3Jq4pEMJVU*urPC~nT4irrbMzk- zYuxK?>fAJS>cvmIf5MLAF1;m^*N*UMzeTPU!3xUeTx+Xq24B1J2Io*s8AEdm5JMkt zZE7TcCiq++P<&mVN4i^y@^X_(%Z?(x1IUdo{?mYe_J(cp-v1;8(M?%4excuZ8vzY znmqMJI}gs&$OnnlO3y$+v&a}oigR6q}lyh{T0%Jck1nNWj z?^sIz+ab4pi{}W|nS>?2>GLin4#VOko*e7GoHKnrP9prz)PQcsYTj}7a~#8R`A6Ps z$iw-W`L}+$Zs<9ubDT`ac_Z7e$StAvqmN??@g8$=RVg-*4aV0V@FG6uvc*0-avnUh z-EtgFM_#tFLXH3E>j~-ay7!Z-Pft_b{Yw#M|_j`ttDlLgnabl>v?@igV`V;{L2@h{I0SpHXj#C|C|1SvpnWFc0S5`X3lf{K6-TU zm^-X;PbF$Ch-9`OIk&ZZTZ49L43oQb zO>LWY?CtYcw@WL*6Y4G-pl{k)YH0lQXWt!h^22#(jS* zyAmHcuuWIwTD@G8K6I9g;|T;r<6{&|Isz%jL6$T zvN2>7%p?|VBJ9pbGgo0i+SMAPT;v<=ioUP5#R(}L2bOe7=XjEieiD8~ZV9y?eZDin z8}xgpm7)l+-eWnKbj~x>$Ifqk2i8P|$j%i0R+`E$)` zMi5)%iwFCPpo-Y&8uy5b-`4G#9AkTCeUoRAM?MJI$5tTm6ITP(kP1($!4v8)8=xPr z{dD=b!?H2w*u5g6MBdTdMVWG*qm%iUHHygdN1rc-aZd8x)P#I5xOmVNdwtcZZ5JjA zM?VR_BDaLvPxO5suHcUFVVX^EcO;l8rd^q4`%-k^Fwlnj=n&S>FfQl#HHMH`Z+yp#!DP0G|-R+R^f!S^Ch1< z+d2C|w(}*2wo(V}bHH4t(QomD=N?>m^7FfvbhSpf{3*g)Cn9GY-ANnGu-m!yXcl{K zGJbzU&yXaoW{-7MYfqVeAGI6Y@1x?2RCQ0+M@wHE-GAZkzu6DI#9oP9zXygT)2(

>#Y|c{;=>*&#L<-rXSin z`HqErzcTCVRMq+P8^3wwxtkvt94QF*i*Ot#az`O>VC%>Heq|tJe`&M+`{Eokb3QD3 zpe`s&xW7gN`ut|nw@#jtBYYNGy}wegkA80|OZeLBSG?Qrss{&j<-z~6cOCFi6#IWd zkpL1RAfg}y8?kUyAqr|jAS4JRl7wP`9LXg)xZK6N3j}PziVdUk6x%aC%R>dljuosA ztUN1r>|OC${#f~cf4ld)o1JX#E+K&cGxz!K?)`Rl=DWZ7P2Jg9IO+$t!ItHQP}-RG zVfK4VjOmKz1T%S@?@J|KvIlis;;U=!`s?r1O~W{7vKxw7mGgPdA31oaRP8DmJH`toNS ze`c8bAY_)C(#TfjYfBd1W&6qdzvy~P#rZxp1QGZ^bJiWsH2Ov>vYPLVZ_Btg zl}Y4yZ~oKUmePRSzFG!5q2y5_nB%qGgevFrX8m9kPG%+H z$3oq-rU)|JB)p;G#^jyQgDsyw(?e76b4oBNP0s)8{cbaFb1F;1+WdcsfF1z>$Z!d*dt3h0^Mv7`gn6gw*sS(l6_n zpWRX2NNK=mdg!~?m2!EvnHD&QV>?#uCGRh+*ERf7_oWwgC{XQ%<*N4Lu@|xxZ6~Vc zTGxNMT&dX_y!^9%ajw&a8J&py$+SLimlTw%F-ck=Txvrxff-%KnTM=L?PjFJy+ zG=B*uI2$d~8U(=YLux%yzGu6&YbT#FfAo{zbiDg$;z5q~3D~mS5K5bf-NHJhVwju8 zvOa1NKb1!uKbK8%KX&{dw@jOG-hlsb6ef=zLY4FRsPSV#BrGM5r{Qy_(VVanTvP+F zK9Up6)*SJn_5ky;!TeBH15H2 zLnv(;)(_q}r>V49jjGs(*}sOCtoE|0U35LAx9uX*9)34r%uzqJrT!4PWPsYaEH{MG zCe+TwTeWkkk!xn)X?`~rP%@gib+{q5U63eUFCR-{eYl-8Ah!#WJ4Ec`XQUfH=PYmE zMf`Qa3zrh5BL7grduU3qVIO2AELUkqu@C9(F8lYph(jM_plo11a0fu|R`o%n z`()rI;9G#co%Roa-u*if11IZ%S`?Q5#K6uHG=nb3 zE#HpGXB#o|z8@;FMQE^Z#h~Byc&U;;(mon5ijC`yF(AAwwh`~w&N%?@eH{#>3gJ5( z>xMY+&dyLFHsBqt(WB5GNXNTmjQA*uU_O7-mi1^tce;y(mQReY|`21K#UulORsRJ1l!R62$DR1o1#o0^U_h5T9R{ zAo@KH`9}%jwGM5>lSA5w*O6Z0yla^mDfp zL!W6UZaAd9_^r0R_zLrt`_}9srti@~lwRFI3>cm$E_pvuT(`8N@SfO7j2PTmjNWHY z@mX>gaZleQ%lB$PJzW1JCR*!bYE_a2C1>Kj)%EX;sD(ZK`2EiV@5wm7FVtl?yxL}z zCoB(%!#lG-WPY*4J=^VZV_6lNMVaMsVl+4My)Yi9p?Z%%j`!xj=H1pHIIed$DECc$ z6PQ?d9_eD7e=oyb`ri5%N5O;*N8^Z8j3qCS z?$0K6j^uX=i{`V#l*MMe1iAICO;40}>>{2`ym7zl@0m0@aF`jxdDzi?u-ueJws!Y1 zxvHW73vrl_JOd|GxvF^Xqq&YIU9Hv=$gW1;n)=UljI3?E|4fWY*Q9gejN-s>bWCHA zq-Q!NkmF<8^EGsgV#5fRu4lhE)UE*y)IrYnpWVf3H){WJIqa&-?dM&YKXrZQt;J>v zjlz!XhUIEB)*PRQ5n9ZFae9kgct^(gP~KPa{i!LQEUr( zDfJQnMX~YDGua5)0i7q1y|fPbQ56{P2eUnqtq|Bw$QD_~atcch7k@3+(Er`p z$>mN>*XZ`M3HEhnQLo!3ZF)Gjozv7B+YifCT{dh#SX36@8CZzt9#ja$vYY7$m>xpr zVo!ZHVoLTvdo&Y_I)?UCCQ&&==}(SqgJB4i4V`POYsxi^jia^uuLD6Ych=&)baEL0 z=|)}mI|c2P4M*fZ($BZzQhK+a+!+9sJ1jSZ(xzd%$;bOxc>oN@;>nyRNcAMSIuMb| z9W?Rk)j{Ns_!6|+z8a9roh{w1_M_HY)4O#M!#ZACJMDw@gMWL8N^`8KfP$Uuhvh1J zi)lFIdMh8R1XICNugEciQ0<0mdmnT`M3@@$K}ql9?|WlJQd%KnR3$e zTOas&1I%ywepY^J zxtJQny6r12{Nm_qMy1jE7UWz2@ng9mlr|0Xi(W1|^04|n&F2dhkZA~0E*~ih9xG-p zQncYiyZo`OHn^?Vhso)Kdi5Tuq&fB5oMG*b$<-41N7kcGA6XlXKTg3VR4&r@k$Uy% zA|4sN`HkYXLOpNHNqH&$rGM_I8-1YRZJ2V;&& zt`c`ug=380Hy_J57Umeit-_Yu3CaDU^PGNbl6c~iGmpAt(0qKw+;qf~+6gQViNm}2 zdFGauW>!{3XItOyX}p-*xZz0k!4A`aY)@-r*wfqEiJM=3V|?ykz0Y4A$^gul<=e;?9mHZx z;i7Nd*k;#y6p`k|3hRrJ6+q!*uUOu4YXDbG&TRU*86FQ7w2U< z&v}*hl+QV@(>ZeNS3bvnY0qT^`;*V{^|U9)e$0P*yQ^tnF>Z+4^Vvt3?fG=bDBbPm z-;Mw2;o|OFhODLYAxJG{$c{;b}j+t_EswYn*S_h4O6%WMo4%-;Xfn-E5gFMA?Mr216tY z@}8f$=KA~(+pk&iFVZhE+rUEr%KE;kmTlgo{~f!1*VyZBvw zuUMMD&$OpGe2!n0^Z5qir#Yd)$SQc&_g2&?G$J;v+C=;3`Zg z_#6+WD-K6ESkL{2lkhC$JghhWB<2wIN)V4&6YbaZcBQ^ zkd3h(do6ge-Q^96t?!Qye|luaSF@{BeX|_FSzJ8&#_43PJD~?~X?Dzl5Jjf1N9v2U`LoDNy zTZ#GnIbOUx4=W7Wr9{s%zdd<~m7krSMqYMN`=cITzg6Z(dSZE8{2Z}~$@WyI@UqLl z&-`b}_X~dd>?xTS>5b)a@nXG&^fW0jdp2KJhXYQ>^r5l!^y)v(N&D#DU;iodAw992 z!{t4%wS@0Sp;<&@uZAs$no0D%9OF%qaEY7mF2g6|F$teeA&_c`-|9H{6^!ng(R0Q4 zT$LZonHTSE?HwoU0M^U&Vdi@XYayfZllmFdr;y)UdA;YlPv0pUM#Y!mXix7UuskFV z@A3*KWnc-uGSoRv58kYG8gq5su7Jaq5xf>-#VYmvH~~bV;;PhnkKyUYbor@ z-}UBoRwap%PX-Qq=->w~$E#C@qo?EaT$|+uxykBszUsQ)<-bBKMo>lyaBXA6VQjLDXJ(&#Oi5 zB=PRrzE5sF<(Hwgp-I2g7NT;O#1 z4&Z)d`WS0Hpz;xOlf>D>AHI6ovxCl4`LKMO_&6rJ=0|S82x_^+FVP#FU!5mO956L; zVZpKwXR7>IzHR&>s}+P)i4RcWWAVWS_4<9(ub}p#cCAAL+p}EczJl&A#Gm%N>hsX} zH4yPh_Csw^xjm|FDWV^JwCm0vXiD1Z{L&Py?OxaD`X!RyI=@78p^xk}pz}*aFFL^0EX{6cdGV~wZ9I&aTJOSJ}CzXlqcUt0eiHJzdSJ`abY z$H!O`dQTeA`6XfpG>*(|GM4K6!kW-~(tyq{5j)WJOGFp?$X)|FzeMz+^Gie*`p8}b zI=@8pqVr2c7y8Iv13JG%^rG`iL>KzVUIXgdDJmZvqS?BSp@0+Zu>>~2I4H~iNpWR-ab&eTs z26i;>ndNG1c(0gNa0q?zMqWoew4S5IL+EYfqmRz@T9%4-VPzK6O~+1t56$i!H1bL7 z8Z^eKc1qWhT@j)=w%cfa=$veq@^P%|_g>vZ|5Y`@haF*7Vo)i&Y=`pH%}ozgYF5^NUp< z`kz$;I=@);q4SGXANrqF13JH0^`Y~NRUi7FRRcP|SoNXvi&Y=`pH%}ozgYF5^NUp< z`kz$;I=@);q4SGXANrqF18eb@-wWC#y%$99WUU?0QIuf6`ownP>5m zV1c^=Qb*+L0|mY;w?BZ7)_8-suC&Tycyr*oVxQORD#n-SJotcu{C$FTcShc8vg4oV zPZHO=ptY9Q8oU{w0>djz!S zV{0h-UrT9VFanm}&!qHd=p9Yspr$9k&r9dX$Htny>?E1ak;C)<;X55 z$jf((tFCnU-NpxjJ<%IKlUzb)tx(l4ML+woC)9JGY&&my!yZkI``t4ZmC*`i#_tX36^OkhK=cL2b`(b&L?gzJ* zNnfO&HFTEGKWo@FB#)5oYGWMt^WNre?T+|YS|9a(SRV6!j1M^%`#g^9Aw#x-xNKLc z55`W1;pv{$b*m44MCHx$n7r%vTbgV|^*S+#JRJ>Uxjt3-@PB&OU9BJazq+Su_T>xp zUTa_%)_~f6;k?k8TaM?NSbpfd?u*pdx=x?^I%!Q3`FqrBQJ<0xX8>%^G+tA*pAb`T zx%XJ&{ju}={^Q!7e;>)o(LMoNmK#E8ljoc7@;k;jgF%;n!B}^oxZLS4b4_to`uvbM zaspGG9(M^ol3M9;8Q-R!=k(C!wLrN2_)u(KN3?l7x72sjPaL($udPt!eBR`h?F`Vs zqC4PH8IJcmy;UBk@r_ZsrUqa>8^DM3!+PqB<2`}wK0@3-YR}JcC`Pmi9&%m#!9SCn z9Pw#~Ez1p|w6WLIBwvZ^NW<4+Y&rhvt7FH1KyCgb>&IR9IrX>65#M&$vfL0#n<()+ za=h-K+e{WA^Vk#zkB2_UJS;W+mX}mLuw0^G97f|286>vaNA^>(^>Jxo)uPPoW$&r_ zV0qJcL{w7;1;^8lQ{!pL|CHtoiih)TOUBt+!!Ad`wji?}< z13SvjqG?68H})sXsLm%R%j9G8tlqXJ4YWo(Q}si2Z7e&AbzTiq|KGkEkoyOl(9R;4 z0Z_V?07HQ-z^qFb)^7U0Br&J|xLY>7edBrD&Z0I4tslyA{I$5yDxr=ku0W;F8*tBa zd9j|TBPVx)(>r$o_Xq-5Sag!xTNT8Uf78kRgUY9^yuL)F#49CNh@02toK^E%l9<(Y z(Y%E}esd+Q14)i~vD}nKwo!Qn3VcDQ$HJ)wmvZ}j!!uSsM?hJ`XES(qJ9Y1k(-$U* z$MSzV^T%5^Ei!$YYgv+>SRP?w9xp z^9nPKsBEWurSzaNM7n=kUzeWC(E6A(UxNED#D&(&>l(+ z{I&E4i=K_H-z}#liNBwG<(M|b_x+{nm*o_u?4s&dnx4Yf$o-%%WAIsaMv~~|Y5Vra zLn_Wx`LLYB<$ZKMg#j03J~%ml);t$oFKK5biAA^ceJSIr$7iZMSZ;u>?* z%jMuf;bs7|=R8n%LV|d{^Eq!oB+fp3`O#1IJ9j4K5pv|O1GX$TgwiJ8Rc1UMqimSx zaRy6${t8Ey%NeZlyYR@vSR5Jio5uP5KEGqEYo5EaoaplVFbq@W zLWx$4Nmq6}S0PN+qgZcE&twz=RK6vrqAqZsaWzH%)p33DW}bii*K|ydc+yst8)9tY z;W@U-?=%P-{1ujt{3>H9>QI1n*fZZc@TK@O0NUH>HGR^+i-zs@>NhxTIOeO$`FuQl zQK#Xdq+_tc)Ci&uTjrPkd~AOCKWzNz!RhA)IezA+%K3aF_zj80Z&MunK6(7z+cr;q zDU0K0eyW_$H-g{LSo~^Uh^@cEIUjjXcju&Y{LD|4^Z7>b8y1US%8Rl2+#t4CAV^7%TPKR7RC=ntQc9&_^L$tTdWAo=`S z>HJ%#mff1HoL}`?9K=XW=-mwCeT*D0vd~zU$GKp*an&YliEq5)4U|4K&OqY}G_F9r@L1Wf zgH-H^KRsZc1khN)Jm3o80bmo*6Gk-ySOIj$pvDydy<71!@I^Zzdf)~xL}4-w5iLbT zCnBO35K-5jLQKb?#pnH@gTsXA1^P?V!6Ogx6{Bx=nh@up6P^4x^anlic!S)p-WWsQ ztItakC67!wc;cTIexT}`<+uflE1ZjqhOpa(!U2D3KC3k_r1{iGv?B@V;0S{0CcmW?kWzVUA9|!<6cvA(;1LgzOzye?)fNIDX z7e51g>crBZcMY%zI2$+zI2Sk%I3KtGSPWbUTm)PUTmoDQECDV9sIIsipnCL5U@7nq z;3|Ly>8Oso2Dlcu4!9n;0r)3yBTxt21pEuQ8MpIy6IcPP1nvUv z237(00QUm-0rvwB01pBW0jq(Bfk%Kx0eWzOYFIo0tO3>nPXbQ?PXo^Y&jQZ@{{hwk z>w)Ki7l0Rmmw=anSAY$`e}Pwl*MQf7H-I;Rw}6en+rT@(yTE(E`@jdlhrlM_Bj97; z6W~+eGvIUJ3*bxOE8uJ38{k{uJK%fZ2VgVsBk(`qC*Wt`7vNXm|9~yPZ@}-sAHbi$ zU%=nMR)8wU1fUJj7H9{w2lfCu0Es|HpcBv;*c0diBmrFk>Z9%j(6f~8Ko0;z$wpgh zAMB~@*%#Ok=neD%_6Pa`{eTppKX3qWAaD?HFmMPk07wN61r7ra2k3dtK)?YE0tN#^ zfT6%JU^s9jFaj6}qya|()L|F}j0TPYjs=bb(t!+M43G(o1;zncz<3}V$N?q*#{(0A zNx)&d?cpi8GcoBFBco}#F*Z}+&coldJ zcpZ2HcoTRF*a*B0yaT)oya&7wd;ok1Yyv(4J_bGkJ_SAlJ_o)4z68Dkz6QPlz6HJm zz6X8)HUmEb{{wykeg=L4eg*yy*aG|p{0{s9{0aO8{0(dcXfkdB&<1D=v;(LazX#9( zNCY|poq*23ouMIj0duT9AE-)JTMWM1WX2Ufjr;@U#swXj=1LS^gZYg9PJaZWw{}gHsN;0WLI#$ z&p#IrN@)=TJa#KsQ0bx}Mt^X!Yks)jK>eufPh<0#`Nd7Q9X{iyZYmF!OB9U5IC<1- zx7Xlm*3UYH7scHH=yf2<%eP+|h(qDp|AxZ#mz=$}8~uSJKW(vPxgnG`VP2sp$c9!5 zT-CvlpBn5r{_M}JdZ9SFlfS#$h-KgVsc9fKOz(U_;>bl^RK2jA{KzgGzmXCcDm0dz zAQq-CY9n#{o8pMS?OP{)`S*|OE>z=Zxg0kghvU!j2Jk%A?;7Lr70;z5F{a|pOCAz* z|$KT<%xLeo6bWaNre2S(jl`3Kb<5-oVm}Y@{y^z+u3#0I{O9r8f2vxRC1SrAWuu+M>RPLgyf1Pu~;m5+vlp-l(Tj(WV)V z`h5oKmh;fwc^38HK?&k2Gy)zuw~aXMv9{umi`t8RMpr7Iw>zha6S|%)`u?<5d~sagguU)qo-n4(yf(GB-qtqj>N)LucI%i(dZe-&l#D)9 zIK979^o=Tn3iP6{x`_Q8_y4@%nIv)XJAW_x*XD^-1sIO*o%GG}kT|>x>zfbq-3whf z+Y5?|rB|rO&@J0P>9`Zn8Gy=Sj`P4wMK54KfYO8vHU&U&D-Hn;1&#m)0mFciz$hRc z7za!M@_?zpDFCvE(MP4S^$g$w;0oXd;CA3a;2GdG;8WmNpd<9x7Z?sq1WJLkfjWTN zX4EF4_6ODPvw+Khr-46!k+6|!;0d53^o8Yw#J#{?P|SSbGvH(-zhwOGyv_3!_YP!h_=iSw5^6iZ$}~AW6-u9gEr@Q*vBN4OZf=*MCjTH8!tz@tP*X) z1!%*cgZAd72p1K>|87A$?;f=I)<7}nV2=L~ZOP3z-!?%E@0B2qaU_U@tORk(tORlV zX$hj=HP}C#Ahx1$S%HS!OK2>ehz3YL^1hhgf`FPjTDqUSi3l{Y3JtK4QeR zebJ8UFV6)P<`vl&%@@yXt`TSSxL6dnyGqR1aFclF!n?$|nU9In_j*B` z(eYjJ>zHrFptt@O6(4m==yg_V!Z)uRm$3h@(-W5U3?>{tc>T1tFMoP%+b8CK()O-3L)x7^==^qv zWPa3cTuo;CF7sEmZ~Jt=J-+CC-5$5^koj+H zTIaGQ`|bJH$fPdoJMEox!Q#PPvrm|v{Kmm6_R9FWYxjGWU)E##(t$ni-}BpjI^Ois zzWsZ=(fh=r_I*1%=1e*GpWhvD>eDL@{$$wAsn=(}aroGK#}E4MtgS=OIi$_V^@|IQ zEXUR9>+>Bo6Pmm~xD%nvI3B@NmIT?`}wY%gaBk@vF}_(=Num z#fx)OkK4Sa-3!R8IUIew>uO+U$}g%dtN-IoCAv=Mmw2_M{mB~GnevOwyCsh)FR?>Y zJzVEdK4b8Cz2Chwpz}-p^p@)_onPwfXLpvQ;O4{qKlHD-|2KbhyO9{$5OtyR)c-3Q zf&mS<41jD(?SE~#BuNa)b(~pqddKc$XXNM#>i@Ca5K5bTchHp+@Zn7)R|!pL$aLaW zBgcgN&`i!T&f>Y!i98=IvW)&=PDLf=Q6U@*-x>UQo(_iej5wtzjKew*ru$@n@_D)! zx>xOXoCcz$53{0lVyDxKHL-p6@uZK;gwsl=ldP4NJ6790H15@0j?=QK;nDTm8b(v& z*4Jqb*l9q`FLr*KTh>sXY$$KAocGPmM~A015U&PyM1G-1ICi#gC!_mdIq&1WH|fhqo(hU`ON^Ob<02_eXfY zE9+U`+peJjonLm1bkujTeKervmuSzubUm>bslXEDWN&A z23k{o;k?0n=BW2t1Fb~^YJO=gymk~1nlmrY{UshG(|MRQp-IFfDEKs=KM=$h!2IFmuYJ6PhGUYmdK^BX z7v#?d7;CID&$Tglrqw2iZ=TP3vG4cyy{PhJc_Vl>Kr!20Rv!A$6xI(LTA#8J#bQan z*~6^*t@(b0u~tep7E1ib_l|iRFHaH&^mwTMJ*RI>+)N80!m)l?ZV07K6#eE*&Z7m+ zP0uoq4GItSJA<2EOu|}NcU=4G+(WOx(nW@29xM-u!@KA_a!X4CE_yA`vi|?(LaRPh z9^~IO=&&JGN3@?p>r9a&9&NB?xgnG`QFu(Qs*o%#U|zJl)+>~K$-)R~U!VRnaHyTu zKv)Ahzv%oDHU@nVQvzSC!(;jv^4e0z5X?yAXvfG(|qi=Y3 z%P);q5H8^QrzzL!Yj!OS==@?$Pin8}=l@on=zkFn==>7V1s&=9V%3NKXVrktFIIi% z{9@II{%6%d9UABI{IW!x*8N_qj&|ffHGQ^)3$-&D+Y*kxHlhKYJ`r8C#-rV>Js^+& z(=m^|@V+&sk>=ETG$7AMS~fK@KZNF?tR2wNm@l&$AK*IsgH6g6qhoT! zleVhd5MvXYXGU?b%IN|9oIp+mW?7k6>hi`~=CD5XUTeTk13JIx{9(#hDh%LXt(1vpr#K# zVQq}@av!*<49(trQ?J(7u?E!i!Dq__t#7Pd>(D?AXz+V&>E6hA7ukRMn6Acn*Oo)^ z&Gz5cbQFE|5{Ezh(-YmNo;mY1N=P_ne3t zdGJP-Y9Em+oBxQ)1ftD(oA=Eh)2TjcLu1>NHSd}LkZi#r63MYzl}AK^y_~4fSHsIcIij7;!Pi_YuUwn z4f~g`WtrYvHK3-CtYg+6$r#qF^}m+ZKtt)n>A`8#(mZtd_8QRXW3QLiBGu{BT2jKE zhfW`Ry|fnTVi4hRe{oJ^T#D+SBd{5Y{pP2;h;FCuy)p6YB+>o4!}du11%Ik^n}cXfmtY=XGG+I=8RHU0lB%N%bCapf;v< zJ6;3w_~kOiPSo}CHvcb4yqUiItQBXie}dZuwHSUkYEh;aDr%f3Ma*%s{6PYhuUl>kvKX-;I}8^RK$@ zYweRsV%^6tn2c>Vxg30X2Q7o{=5pbG!1F(oegV*MOQnEgz#91Enw7f==h?8c)G#9^Xw{ z78&2Y=+djsup8f{F?ii3kFL}0dA7Oo7v~eXUBt5Oc|W^aTsnPPcZ%xg`DPud^L^{K z)7HXnXUs2l?SECDdLJu^eIWxJ&gl5ndE)31EzyVn6HBg|*m;`CGg8ICjLZ zi|Ck~Ij-BGp4>cZvu=bmA9bR0fv+l<;|&Czp>fsBs){NP*1DMI$}e}92J?%3{?IxS zs}LabT)sLs&!b-6ysUfrKVD-V%u|)~`RMwKho|vqBg>EJwiM>hSU$2Ynq$vpCY7b8 z1xMN!%@Mv1W7pDv&M#(q>in{6*>y|Z&F-FGxK7derKK!v*9uo1e@nsbu?_87ce-=l zjar`3^IV-iJ7-#I)-A6AHNQ|jNYGAeKx?4B2GWr^X#8kMVgLO4XLqb5T0Ix--1cU@ zEnMVlUN_1S2NssXjVrk>y3 z{!<<%`;p6j`FMBJhrVB{2DW#3W{o}me>~54cdL_h`owP|JHlr*BIW1hDGytpmnRP} zpX(>5;+-h>8CMg(8?&<=k3TW}I_7GY#R>J~d_K?bD|LHZjsjoM>B)C53_Ye7HSoak z)+zDUou6R7M>rbqYP_}S2?{GHF1_xKPJe9X_XsK8j;Iw_PJU!pFWxDx;wpatGX_jw z@_qMuB=&v3{C?T@cPFIQyKhy_960`LcOdBVF9_dx4LtCDFN-7IHiu_!c=(m|Z*aJ* zZ&l9cIbK8GYUJ=F-*@t(vG05QgEL3}@#UinIed;^mGgOyKhx)%>vjdg_btb}IF5MN zjN96C@x!A$94^PJ%K1FUI|lJqIQ?@uW;tH*SnT_KyY_>3#pd%fIb4ocmGgOyHw#~1 zDfW3eT8o~mAfh94^PJ%K1FUTi~nAcLyViu7L-(uPt%JdqCPJU4K2R z$0Hmr$E(WuJjXlL9YC}t6W!jhstqr)zAGP(t?#>v(temXr|U-?KF6=h`8>xz%{6xA!-{eDUf%Vm61%@v3q@&+(3{4!XPnyo(%)S-#(zH)G%LI~g|~_`!t# zWpTJ1uPW#B9B)QtWu~vniC+n6QQvKMFGG^CpdPg=__>JINo%l7%|UBGYd~v2Yd~vY`)a_hy+&;$9_QY^ zY;4Z^z23ML~rU9K_tSN4nUv~FCuvJ65_dm7%Z|TXBx~y)T zy~*peCcb5TE+Kw5-`TExrj7XE@nIDda`nE~4|;5EuMQte>s;obwq&^)`y^Kd9&0+r zRaat3)(V#wPj?*|^PFyvbGFB2o}4rW7tzb${5)zIcu+cK0JNt^v86!j-U(vyjFoF} zC>Ecbmlm9K>{Gm6ANfm$Za}B>!Jx~(V5~b(T<-LjxhDBaTt`|~ zB9--$_fBjcX?af+ANb7~H>o^W9wrbvh{j_wo>i9N?Rj}Y-8v{*9^X^Lv-?kJ(~_>G z!*5CM%^kMEFAj{C3Z@ zAg3Me6Yyg>`H@{X-fVYSIaYbjFL#!>{FGljw4{Vs25|hF5I?yLfWj>S)O9BoWqfx@ z-{5^CxvfI`1msti<14Es zxq^OoalpJ>E=S7WOER7hFfWRe`Wi+12{HASdyl0n?s(>{zfMfL%t^=OOnz*c$IC4+Cd_09)4KIWs!`Fys^S!q5Kr}bBJyf~%>m+`4k zs(4BquqVT-te4~uV)OX=ugf~NIj_SBR3DL}eFC;DH-ys0T$?=4=kquUyg0Jv9sg%&f0MF#@^TONp?<-_LPrUZV07K zXg%yHE-$iANGaLAK+ut2>GZoIQwQYyH26a+54-tZDJ%bd`+>iG{R2nE>7&Z|e7>{P zWpJV7nNr}$bQYJpCON&%GE|FGTuu)yhCS8g$0F|d#2_X#7`fb<&)0z$#l!lcV>LgW z_Q`~m*_RIO&+#%ZRnF(5^2+qMoZhNR&;!{LO4>lV&toKDJS#T7zd9PX{FD+^g(ha$HP2SIiI)i$j;-Gb7VUM z<#~Qrsk_=_BJ(KvD7HREOn!05>9-fn;&_;cD(CYJ@yM$3c!&$@L(bouho7Py~Suudfik-Wz2K=k*zZG3XgJxvVSP!p4u#^N`=-1^(bBsa+;&LBaYumbbZQ6FT+6P&UO;zXZ-Bm&j%rQp52OGG z0jU5rIw&ir0aW3Q1114efg%7)>WlfndB9TOR$w*o67U(Y73c$k#{jc|i-CuMZ-IkB zx&*ir_#K#n8@M0nkDIs-IIz7Cj{+sQnf_=9{RDh~8~PMCl!yk(WZcZdxS7egnQpk5 zPPm!TxS6|gGjnh=Rk)dVQiQk}H}f8D<_g@*Yq*)aaWiSh32}B7&P_&~(}dXI6ryK^ z5VvEo@4GKRJ$IGWlR0NIu5&;KeFSjdsDAna!G%>+N>9{VK*!{rIBq6yD{sFaE)PI z=d0+m*mk_A@63BTUw7ZH93zqoEV!XkHIH5 zST1EkT(lTq`(76ZpBug%F?Wq;&Tn6!Oe05p#$n5HLnv)x@G+*3lXp3trhgS%FW>+4 z$3rW6-?m2O!E%X$aTpH|M`Xal!skoyq5I4LXis%jGLYI=2ha3~}H6r6f5c8bWKTZKCo#=a|%fE@NhyL^B zCk>&v>ad~nJZ}mj!_hecY6Is7zMrz{s+HuA z9P?4-=2`SV>hUpnxJq*UIbNsn`LW|&3((eSfMgvakn1OOn?iAN40^vKHGr;V*nVn% zj$J<5|Mub_t^P%6nd=b2FxVcj%Dxji(G9N&ifLhrl<>O=)DykJ22O9ydm2 z1N4wT`~W5NI5IMyimXFu zobJ=N#^(8Y@N)m5l@C9)y3}OEdStmNjcl9BlS8P3B6NRUS?GNC86`hfVnmqiB?F*ybWHsbd0x)eb&ebV?piT}`zf?ffG?Kg zuf;Vu&mzl7lb5Q3CBFIIoYFiWeFU7>y+H^?fNWPBpBy-GY^tllg`BT88zbT7ebcwr z#mR@Xr#@P3We4%Wf(MN9^qGRc23EZJ%l`XZMp`lTGZ1&qaziL>_(7o~^vGnQyA-1x z6|P~9aTS%p1(x!$sC`#M->i3fe%uX6yk-y4u5{2lwFzCtS)K3x>gaaoyh`KsU_()};HI2)2R_1@^Zre50+ z7cJKsu+xA%&bt}q4Y>?}?2pPiOy3Y&0RA4?Rapam8NKhZ=@1#tw9^Ek%K3agCiG!2 zcM7JYVj>^r`1xJMKALcYLVX%0X1d1t{XRd>MzYRFsNEyNhn_pG9njI>wEDz$;_MGr zolJ2I>agGVw*3;uZVVMf#Ag85vz+|Mu3o!lqRTlKqjf{gZ_sD@yflBcw91p`bbEsZ zzKq#UZwV%NXS+*ETqpu%eXZ&cn_tqMEC1ef|9sDhN17~%Uk3QGT;@i{4f6|?+-PhU z_?S(EkNR9x4VV6#X=Ob_JS*$pLvPa`fFdDqd8ASk0y#wFL-J!4#gk$%$z)> z=iow`Cq<4p?ujkS4WYDYSU(fdaF~Q8@?dCQ*BBQ%DK0hf5Y9S)`St1;Nk58r?J1_c z5B@Sy%-+Xs#CpwypO-v+{V64bjejOTdXIwTA#r#Y=2!n?dy|~icHi5}2xhtcfncuJ zOjJiG$4qm>?&dqjJ1d6_9y}N`r*Zj_#*qRs^SV62L`_>r z5UQNdN4bwUZo)eMsjf>z&kg0{!jxl*?|2~iW~<6dy~>;TicvF>}Gbsh*#mBxE#t$isW-j zC%f^dbKY7xb$r%@E6b$%kj6_`uBs@U&zm^@G|64rpD-T|izs)^nY4^zS$nC!{Xl_r&h=FECTU zEW_w3mXjaZh2KY^RWHYR%g_X(w+|gOUpu&xB<%zp|r`U3ep0^9>?UWirFrIZs}M*)&TYgFdUqP=@EE`)$}a$ zNJBj2G5|^sl}BZduA;-Rm9MY=sM94}rZW$g)Ah2e$HVvnut5XU`f0Q|V9Xei$FElH zW91=kZez3q*M5(3=O6QDQ1}af>OW=ap?A+&ABv3ljsa_yhs5EX%`kX@bM_S1JX+5c z5B7`aVoD38X@M`(;|sV#&6;}c4GNIrBFB64pWf~W4b&kK)b%7V?z25%Rs5^i0D(Cy4_l!d?5a+x6SS#FxCz9S0 z^!{?aWj^dC`f!8=189H=7u5mWj@kr16n+Lkdpb{#!{l`n{_lW$hOHTMLg?vegpVr6 zWrnk<2MPl&e?gU(I;7^R3i(ddl=Lcg=;c~m6JAK64xuo=ntfyQyZwwgTfY9qO|N+w zj`gL=`FwPKq4gD_5R~il4ZUNh=Z7bM(C*+Ho-O0}nV%}>^LPwmeAi&CyJRe?Zoh9q zNMerQ@RK0hdXvLwi9PYw!GYQ0dKbHT=-} zI%BIUXxRmG#(S0z3sB5QJ;9Q|P;?ov?2kFG#t1^LPiw)8;>iGLkJocWB2a`*)4WcD zjk)gEcgcVI=?{90XZt08ZQ+~c_-k>tyxd-VVP`oW+LoE@es-vCxzufPuJ2bleh}5oP)96n=dFbToUVozQCr4LM zy~=V!C~acfkLfv9Im78ldl?)R$>g>W*)==)m}Tmo!&l|{zo~)c*l{`Y<>6L4QQKeH zhjkU%ZKmIRd)*r=`-Bw8{89&6?Obhd zQM^eX?(y-No94au#vGFc@#_PAEH|Z*tsTE`dn+b8>p15+g`b)aDc0_rKm2U(V?Q{6 z<`k17o2FGjSZ)ZVjU7L`d{|sOYZg{i%&EYG%(0m2SK=~OuCvT1FLK0A-%ERRc07Lm z+m^DM`mrpRs2PX0{G{}ahu0SHB9{S>KJ3yp{g0}*@4kNIiGzocPt#u?_-45&jco0B zMbfn)R@V9VwS!{wD*fc*`?`0^`1QL`)Wo0Wsj)o5$UL&+Wy-?sHzJ35o4zWHR?`BF z#)Wm*ay}S5*viY!&U$t3aqhZD3*SpNqc!wOcE<9MIJ~pt)sUUlBZpArah!GFM|$A& zv>PuuE9;}>$%_I9k#0W z#PYa!N%o}jk=y0Vz=s^$x1Ak*{QDtw`~UJ#-oK1lGLiC%q`|L$KK4w_`XsTN5umdC@xF1@gL?p%7*myb1ty=4JQdaVU7vQyTNUH)Hw%I3d% zzjDldavy=}8J5SzOG>Y3eDaR8>d7v>>fZZe>yme}mOY}R7t7<}6G<PBG7fEd*`%8tpTv=|)9v>6pE-L}$H(7)O-VPF$HS+7x-lDTy4A(O=l&0`fBODu zt0x$RD?RDT4s~kA^x&v;XyU%~;s^vDzfQ^qw}= z|16J(kHwxWY^?UQISxLXj{WvI&%(m->7j_Z9AJ4od=z^cH-)b5Aa*ruFm55wFhJvfL0#8{2ZgrhKv`hj3(jPaPH8t}eT1!?c8F zX8fqy70V@R#-S}g$*$tzwHCa{WdNiPJNwERa_6|Z`_|;%rPvqC>3Z4O@ru}2L#(Xt zfs~Jq&1*&3QxA@L@!sC_e1aVDPsEnxhEUqr@iJxMevCPDoW3FA^p_ZI1$;}yRbu+$ zXRWIcCiiQ49b@HbXLlFmWPew3M8|XF=b9bCljRac~ido^vbU??(gucWS9Hn?pPiV&xl>d z%hKBZ*b)cNe~-xBc=_z72JaIhMEa-nXL&q46+1OD(fCaBO1b`8e4JHpcJ^3v`MOiC zd11dd6D2;BZ&)4=A3J+wQgXi|IX$+$%}FRvpS1YAcT{_0d0c!Xd$Z%Q3_QrO-P_qy zzjhD(J><$)_8OdK#z^Tz_QY~i8rj%PvH9FO=*i<|9#L_aoX=@K4a+4e#-SY_Qx>Too!)s)G`$Qbr zhSwD)|1_S*@-UImfh`}&e(ZQ8kF)B*SvR* zd&2j7zthZ^iGM%b1&uj_&`?FF$03CU4MvbjRJWT;@i{cKj4OG`|BEx==1R#PL=> zc6PVV%R~BC&CFP;jzh9M9zJ$<$D}OvANbJya{AfTe^~uP8*t}~!vqvpb?S|!X@siRh8lQFGLyqmn zF1`Ng?K^M%vjvYmuA~>sEwVqEs!OF|dZq9Qiy#IcBU?WFu z+E0Q|<$T_bm#y7MrB0X}0+HL{Yr&7=3(gO{xCammZKeYVJqneKz^isj6Q_jbG_yJ~=ywS6h_t-RFqtUhHgvFJnp zY5#ijfctYpc1Amz-^z04!}|~~%Xhu`g)}TCW_+VJ4@)Ru`h)2;%jXML;u&_(F*xWO zisg*VkmT|qwb05l9pe`z@V4bpA^!K<8e=HBPo8-D!#`*K^26cg^`yUa=#S;5G_s`+ z5#Xb*B?UfgCW4K(ctK$x{O%mRC1-f9LqOCXw|jpf656&M5!dbMws(9jd2e+Hocl}5 zXIt$=&1dUiNB8|c^3mgOyx_`VOH5W&4v;;w+>}PPY`gjNW!EYX7PmN|%2nmUoQttl ze)AjX_|~8wi^$ODp3Cs9Q@4-4yUZcPYd?)ilZO1ta`~9JsQ;PY?!LE6AF>H5=Ln=X zRd@1#`50cet5f4v|8G|^EfiU6TGzIPZn0T{rL-sTI8d_$ssq{SG@$cK^CTJPCp9!# zE+4D@^#7eh18V($8E8}ePid>&j@N))`tUQ?9nVfPke^r8mMZ-(tP@G=|81EoMA?Mr z29vg~zVFcB)Qi9PeYx}=QD5XXma7`IS=VMtm3N}gSBZr>{8*^mSVY=f>L%iMsJhHe zz4st_UN^PzX)Ico<*Mel?|(I)H&^Vj%JEp|nMb_-*#EA!m!A)&lv(q+I&Mh!eoo&h z_ntgu`UKX4sXwecs>u0#=;NUda}b*U<$8G`G+KW(|5T6h)dZTeBlB4WK9r9$0E&n6 zwEUf(-=BT#*j^`}z7D4i$9z;dpJxUQ^2v4vWIl2^IK4bJAK%BH@1Nf1&T@{A`KWR} zACu1%^ZODD=u52h`QR+4+f#*40R)3Cd|=1;#wvwX2k>~=mN<9@KB}C(WKw1^T}zI6 zs&exz*7Y?%0^4vpGEZZ%!nrCv%X6U`x7E(<)=A5~u+OqDQg8W_<7a-VoX_WYOI%nP z8(&lpy*bYY#>06bkFtFw&#^vNpm(on-hDOJ40$W}qawPb@_%m}I$};$Xx39iPpX{! zlFN1nXz^ftUe4w88=ttKAw_4<=_qgp<{D#+8R73i!G8_F={DG7BBie*n9x~@-g+L4nf@!`mh>A4ci4WYD&hfj0bZ-`cy zf%-puLLW3q11(*?(3l6=luoxMC6A@QkTO4dex?{QviGff>h*4a4-Z90dZ+r47mrK9rxaxSBtJ7q#&z$K2Ui-yZXpaF|14 ztQBm0zR{Au!&P>*#4oKnc7N@|-!D7$>f2IRaQrVA2QLU!&gVn(tkC8T1klZ&=$hy9 z&{%5?z%zT_5T;Rb+u5HEwca(id6pee}IUQ^_^7-BQct@rWr3K|( zE{}On=|RWxf0FHvP97IcJ3n^*J>>N>1{Ga4a6Xrbq(fTQkL9Wk&HS5<1?oL6V@Pz| zJbVt-IxZ?#$aM&i%9G}JAA-2?_-(9w$+p0I^*;1}Qv)^Fae2Sx!szz08unED*E@Tr zkLk4E{Ez}E9jM*L@{l;ZGwmhA>#o3KADa@tG4>HHEu)cPq#bl|II77FTy)dt6>CWvUvMGXg^);}q=|eiEIv`p))Q?q5;?;n>?#=XTW9R3~ zen?(=aABvO3ql4@=|bxTv0RPU%+C{?SRu98@2-p|OB+FKtKAT<#+3CcZ~4D$d-AdD zXLmc6?PhZvc60IjKcw6?Bk$s*kfKPBv|cjHRsETEQ;4ZDW3kGQ%NwOC;3*?U5Hhdw zy6E=2_`0s5cZZ?ZfBVAA|Gu0G8aUcfdz0mcP}($t7gtfn)$!VMW9*CkHpahn8~RYu zfSNvu%6YrLTK9HZX&ITCJ}nbV^iV0isV&0ozUaPpue0)a^X7w+jhoNFmUO1RH?$e$ z^6;c@U)pot=JZ2CYT|O2yv>JJbvMmQ3E(Bc|s?tDyX z7|W4u$^Em2(mkHAV#T$ypC61Hke|y_c}MGC66{=K{Wm84Db9w{%8rYcZMy~{bs|9Tz*o%AxFCAwvHi)v1yKUjuC~?mSuji z{Oa>o4YYLnP`;#gi%uV_-sAljPx_F432GZdmx=Lex#|AmNuQ>N9{WmaTgrWc*jMac zKAMs~lyCI-$o8?5oppUy%5!#QuB$K-+h`5hYeVu_ zaqKSV)qWGbgHEoob#z`oYyZm(MQ^nRb`1?sIU<)O@-g3`ER&Dvy!>B2=4*H4zB&0c zXIMK@CpvDe0j&Y80j&Y80j&Y80j&Y80j&Y80j&Y80j&Y80j&Y80j&Y80j&Y80j&Y8 z0j&Y8f#%e}&M?o2<_Iv<=YIU3_syvr9hTOBssTO!MAeA?zbk2g%2By2m5=#8Wtn_T z=jH$MF<-kQ_sz+tIm6nKI?-`!4QLH$4QLH$4QLH$4QLH$4QLH$4QLH$4QLH$4QLH$ z4QLH$4QLH$4QLH$4QLH$4K$|)>hK^a#^GCsd^Xd81;;I43q zIt0Z0vJXo(;$wb1udjA*As!nx@Cu6amA3!O^xyFMc$1gOF9BDvoczcxI=^~n4PyC0 zkPZb>hlu3))*LULwmX((G7o*+G8$07lQ>0+hT1LUxcoK$*>8~rEb06q{*(QwPW4CS zImuL~+Kqai|C7B?7@Yz71~VOZ4IOvHJ`va>^qG@NXI@-d&+ds74H z*va`?)(h#G(jc0v#Yrx=);g@^YRy&4jB+*cC?Q4_{c`6apA8+1^SQ&8@AIZGT_RUVHc%k6b~ z+zVYOdb~N_V!x{bzMLM%6jxc5$LTkMS}yThJu5c9C$5^m?yGUGzA8VKHzPksme21h z^ZTm2B|@a30#);s8khQ?>SEO;K|tA&+ZyWmZTT-}b2YiqfWU6qHLKHYGm)b=1y zx~OTx|9KBD+O?nt)b!E$rv;VWgrL>*!J{x^tbxV@IR9{7;r~sDMqkoI4XEiu?Mmur zahj;XHY8X5>Hp260X2Pe`PMvoZLUz%^ywE0Sm%@G((ty0qoxmyM^M|1+Sh7*qtk5L zblsGzSK%W0ImVv&Pvb>Y2T>b=+X*;q6;8D$T^_fJWC@c{(?|E$!m4Q%2WtB0{L?Cu zB}_t1AKhOItEN>PsOh8oYpo(#!X(u6(dAoMHLc=6O&{G~YZb{7CZVQ}?yrSa(<%;j zw*H!a4s4o@ogU~6<*#_0-PnlTe8PCb+L3 zD?e+pD_=N{Xy@3^?!H&khu+Uo^``#c-F3D-@4p6-@p})c)v@0zxM)w&{rr9#&t#6~ ze4sW$mGk*A9=CU{BhT-uboyNdzWkuCGSBG`;PorxHC16}AAIf3x|ioj?X35}yzSD* zF2CBzI1IgSISr&DX!$u6m9KX8r=}zM*`D)swS7dl0X2QLcOOQlPvg=jx^MF=~Q4`ur76Z?Vgf@AA8iWtJxTik-BgW@b6o*mMQV5LCN&LA(N>=kRR*RPIxK zO(31KoQ`>|7Lw6_xj#$)wc9ogsOdv}4RWO0ZPl-Qy?ks$pf_=8Kuw>xF51qXC{GeN zk8bDacW89Ah@GGF7A>-tyR^Pt3C<6G5$gfxv>i40%w%!+iih{uV|4Plg~LtSpCMyV zxyy3(X3Xcj*#(m(W;p}FJZG?+9`m~Vj{GX4L@urJ7y^3gJCx!=Ldf+K74Kt#BLR9h zW-oxs-cA73aRh27b^+*JEb`BCdM}IqQyEM$T4R*_&|T8?1UgS;28F@b(=ma=qHrkx zQ~A#2H}A=2czlD;Lu9D~=s!CyM|jWjX#05l#^Wbi9QxeOsR23v)}CX{zv{ZUn~}c@ z{&ApxpNV_FFle0FO5yy=a#aiQ=HGm*Q%TpxD(@*DrT`{WGhgKBoDf#QXq&oOu`KvEIhkKsCH@dB5d6tG%e}nI@i_EI!J8v?jG%)tD1QK~uR$ z*Q!qSmkkeg zdar|=?QFw^*6$2Zn}Q09ymTRgGmid!+4;$$I_;RNk65+eb+159j_OjfGnN}dX*1sM ztSomI2ORkoK3}lhi_RVO>WZ;K?pVLCveH#zEZ!X$Ca-- zn{s_qu8GB|CBlpqr#`>qG*FAEIbRoD6g^)POAM)OdiYdFxO%62O}Sf@8)9ti@^xmp zt9Y)ly_ z<>uMA_zbrzVq`t7T@qbSi!V+V7kPe8o%daK741l$~JGU|A9pzol zzb#Q8N7(8kt%03W19JH?{W5DlwkuzpAH7uZ?nk34_-<)jf<`A)IiI)7$Mwp)438(n z>#i_Hr$gh?GOx{X@Y?6|L;GHJZuN5C;$zuA_ zbH7@ec-e}yP{hQG+I=i%KD@W%WtMwZGU;f*5|1H;{qy-+D(k3SOOEzb<`Lv_5P!A% zfA+2eK8oV|PY^MPB?*dP4Tyk0^#p7I8zBLL0*NFP3z8!_$VrkrE*D6!#g0AtvtWiqBcwJk^ zQf8ub$=6n_U!QEAHKD()GIe}1H0b$L$A2FV=z3joReZhfGdn~5vTD06#=X#c)YFd8 zh+Yfc=9Z8{IJ+H14yWX==m3d_*tUyd0IBvX%`N6H{>P5cS{I=#Hqaf$1sj&(oe~`CNaN8{cpm_uho3@wA3qfnRrQ0g04|MU-@Xf z6!(QGPEZLgg{&)BAZ%*T?5y>9rZ^(=#6H zxygTzd_2b?fb_ASCwQSt;#l-W`gz*JjMZ+?uBQ5V!pT&e;y~LR(Cu^G&GGd(=Y|Yb zJaP7>Y0uqzk=f4^yjfE$J#Mp~mq4%0vd!~EzMt-IwRJ3ICQ6rlZN>Wa$>v!T`r9f~ z$0tLBovhI|GSpLB6bAO*rMS-Q=Lz2AOtN}yx(>10YqRWR&J*bh z%h2Utju{IiQ;(iU${;S)&(k@RI{vdb(2R;A{gyl2dR>k*eO`^aHADTo@38N8S#-lh zUdJHsl?88OqyNe3wd*}|^uyJW*HlvCpE=J)*H5Wmj}xWqdDrDQQ9X&$*QM^%wSNx| zG~qTx&zB_9bL7o9^RhEfTD+)A?q24#n0QH#rRS~2bK>ar9F4w)JKc6D)_d`a*U$g- z{cS(`pVTk(nRrQ0fup z@r#9t^cy5@Ip^d0FEaNG3ANO3uFNy>k{(OHTlqgR^tlNIh+h_b&~0~O`8_$O{#rF{ z(yEAGCUlwjHK5Do_n0K=d>izLn?BRuNuQUYj;t8p_)WLB56Ex`5W6UNp-bXed~430$oZ>)=14`-dSt}m1wKNxuq282!sjPi5O5fU2eYN+~UoC*X z2OoL;-q&`lxceE0c|8%+&k?+XjzmS?DZUW_Z@Fi9HC{w}%fkNYJ}lV7G7DgWwc&hU zrMG^cw%2u1Z@Dfr9l-U{eD6vdLcF|##bGLJU=B2*d})_vJs*`5u5q8=yQ8&^f8J5; z)u~IHk68^lx?pO*%!~&*UircRu6kEWjd zFXTF72JSDA(iMvp|Jc8jzPKN~_=fErG}{vbgQVGK8~&g5rNYL=ft0?upNIHcY*#3+ z^u3R6FGc-BKC3~8kFfm1S+8xO%6fnLdd7kbwQWn`vK_yz z{pOR4>7Cg7A+aAJcnhih4VjLe7e;u)nEPAr85yXp@!{J(H8s9+Pe~x`t#ndSexb&) z$RVGBuB)OyjO93zId$-l;()HVt6z<;w+o=xx9D7e>1+k%!53=w)CNgUcK*+{qmeaB#{@voAkty7Y^N(1V;Jlusx^0 zI&5EQ%8OZEymQJ3Wr}?e*<(}sC*tSCyFQhcm;+77BICWY7sZ#C)sUxst~+eSRu4S9 z`-OZE2;vtA-o{4%?S1@4`)Y!L>KeQgur^p5gN<7w?+F6c*!QT;@*nbRL)P9T+z_Os zKFGy?>molg1CyKlV6Nt^{uqzy9P3Z5|3w$&<<9jq6;uQ!Pv5%hR9_ zGE|2d=cc_rzW++`HN;K{-n_fDmnX|~9Z~D6<-7}@VWwKi759e}noJr}=YKv2bUW4e zqxf>w_+f^+-McimTi2cLl4mG#C3y1=)|*_}W-295CWAM!bKOqOS{7fPmP6j!^&YX! zk2wcFX7BeA^```H-rkzXQ^Y8h1mZhWsKjjl=tprL809?WOMwZ0anSA5l27ByRn8|F z>XZW>dv;*pgb}7(3EsS&^(0r0l}gEz$={9bd_D*g|2$`Te0iGvS%&Jgr0b<0d>(r7 zJLg8E-4ncde@V*IP=5$t6^aaaTRpv!zzBY7D1sbPjhE2oz=CP7%=&q5+AWSj363#s zo3!H+1CsUTUHjR#l-t^s}mSC zS*?45vFw%DAj%Je*dwt;j7?dyGN%64I|rIkVx&F%I=)=ZUXh{xcy`gIoySx^Xv&q~ zO#;`WTv@g%B~K=YH?DKtPBpHIFHb8WZ!dm#%}M{8{`-Im=QhMn3EsTBB;_e;lHf&^ z1V;O+%Y7l+%Zf2rg-T+{m0q{lEXH!I+b=zD>UjNgK(|vZ-^Q1#LEmJkonHOdq|pBP zADD6_c$32QBUcf3DkV=QgEz8sU7q^>5MQ1ezspeFW@h|;%pVz}dpP$Yc1rN(?IkHs zhG8lRvn0u&++A`&rca@@Ts?yKk;7uU7Z{S7rP{Q^KO!q zBgYJ3{M=WA1rm|z39SaCOus1^JEPkyj<<_HmCUu~{iM$0b3nIC8NbDsr{FIcYUY?X zS`ImJV6`bvf;VehS9ubTDJ4fHXE&~MyYK>^$c8%!c!x z|M_}Tt^{vVw4UTj%v4IAOa^ac=ej(lw~sGR740(B;nksCa^E=ms#%7e61;hPNy?LZ za+GxIT6s^2$DPdj<(xhffr0Uw^aZVpQh!NtK=+@DI>eW!X2@HhQTk??s%MWyKV10O4uMM?C6|7k;7uymM2;f! z%@cR;)>^Ji`gj}kp;C6r+Rj@&Ew0}_>P%syA$8uZ^ci$ZE4Dt;7w}QlUzj% zmD$fT>r3`LB~Qt6YR&RBA-jxY&hC_H^?Ae}_aSXEpwG5xYSxi=Jb^>izWYrdpK{XI z7xS3GUe?*672Zx&%9f|x>avPJXh@~63WH19%DfWnol$Mg+>Nai=3aBfQn+ zHD%r)2+-|l(H4p6`>@NNZ|qr``OGH{0i>@Ns1&@=CGi^2m+!~Mark85&`_WX9ntB2 z>>g4Sz)DnKC_gZxTBlm6MpPhtZP?1Kry0HN{SY(yD7D&u;^i&4uZ7P|*!uHX6K>z$ zA&hIDxvpC9La)U3iv+ymEUWO9*H(guAg?Us3;V3?5S;~)K3VbD%C4tNL2DR0Zu1&m zmCBxo1G?YYXKS~-3>v((wSQ(E_ALBm?EGmgtHbTRF3lM*X|9w@e}S{AO}wPL*Hu@0 zD?P=5$>CAn>HaD9lGss!@DRL-!W^G5p~@ju!En93BaXG!Iu|R}?2`2MXNf^))0t@& zohuK5?7rRdIIrll(?NT^-eceHLWj_4;w63E>9kZ5D|_vr>tRKP+kRvq3pqV&7o`f? zZ?3uW}=g#tA-`GK-p+ByqW z4s8t7hRS?+ezS3@*aem8re|lQffQA=0)4z0Gps3s-QMinaopXoq6iqF6YSmel#WbD#l5h#VJf>y{VO4m3la&U)m$+wUEJ><81Gg^waH zf;TDBv5s!}9Fq_SpWzUtLmxMz7p6 zw6?O+Gt>|N2L=T@hr?rLGYxlWG~DPipWTq7ute>TSzlY{Bv)*N~n9PsOb{ zp!=bHcZn}QrQ2t!sjIHqf7J42kC^f!c(aCek{{1dxL{L4m@;23<)-9GII(fYf5yIn zqW8i9IX7db3r_OJi`OJ?ymC@$DGnsd0lgnPC);g*`;Obx^6wVFE+4Yzw$@P7vHM@W ztZH@VeGYaipv-O!DHpt1FFT8Y8hAdjVo?RY&x$q+Sjv(b@8%T-Zlb{nTX>$3U9c-2jWviWp(ZT55h`#Ca zxI78E20i}MM|l~~{bAB2_$26xC67tb%CegP^1NsDOw7mb-){4t(>>GIfjx5V_VdU)sMqb}%wnn|DFb=r6wgFamz*NV<1NznPrrzahF-`1af z{mmgZMU=;$kVnDW*yw)@I%A3;xBQ4sS&m*M^0@#-%JXjOm6)HW958F2D;}x&%^4Q8 z>?%iT1s|o*K8n^DdERSIr^mj8>(AD&d_Nx?KKG(+pL}lr z6VbLZ@P2l}zu+yT_7|mKUG67BHtt}CH)x&OmCQ#Z^sh{U{_D;i_}jdG1BPwq&`A0_ zfqua|=t#7l=og}G`k~!Yfi6$;cTdd!WusQ!;G6sM^#k^^OA!4Pyp${P`lBC2CsJ}$ zIv*gAAi)N4{vzt0HI0XKbf z&bOwW61>nY@dl$m3EM>)S^#o?gZ4~(e=DCW+NZw0;0x1!37%!@VZ+^DayCuZr;NQ4 z-`@{2+rN6mOSf-k+B3oH_r~K5cYm>MoPIwoN!(A(x9xwM^uxH%q{aaztyyFg5PlW zlbk)94+2DA7AA2&Z>aj;?tbH-gH3xT_zibIvF(>me`Ei|&tuyO=j_yB)7$Pd?U&#; zApJ4zl`c=E`y{6ShVe(7++~Ydji$X4{D!4Jv3=6#@paud@%>D0cgGHu^<&>N?UUe> zxF5Y=yViDU2`UmjSeXRfw;$B-{@i!(8)e!l!EbQ7leAa*eJ$88@$ZEI6(Hx{pn}CHM`0U$O0%ejnoxNPHjV+rK;ihk=!c znf6QYf5Lslv}3xQ_036qAJgyLuA<=R3wxP%Oz?lseI&ML4Io79LUR)LHS4g-OIPRh z+r9rF`wrND-VObK!Q0sAe++-$^?}0K$SU<03`oq^j!%DFI^o_2hMM&YK3cPV6r=uF z{aqJLymA&m=vtTrUB0q2vTlC*&Pw;erPK?8Z|mf2PWoE>EIO)P8e5z ziAjgxqZHUjG3e0So4E9>OoEf5X>sRv@1^T4~}fH2$3V`<$Aa7r;^i>|0ijg%DG7%cj-(@&3~vsJ1o- z!aUxvb%vESfimX6L}OV5K+SXt)a8EmAou)YAM#8F$a;?P2WKkJO7IRk63KHV!6lf@JJMV2or2W|JRV*>9rLQnt@-3KV|)~m@&jn4{afBOwk~v!bcAL zc?swpH23v(bLaRs0f|fEBs|Op5m%NAY5U6&JCYYD#Ikr{7@hm z^p#t0lxp^|mJ`@BM4V<$Oj98G(IusF4EqzQsEvbU?NdsR+hAY{{kPyi6YfI%_~rz9 z&Kn-RWm=Z+-KQgSuBhjnab@ByH2z}gd0vH&t3f9PyrFXV7rKf^W**7)%{UPHN{71b zkm={}npN-a_5EYB4%=I<7y3-Rq$fe&zDb%OtH>t&3%xmqx#>0SrW%&1-v8s(Pp)eB z<4;>T1c}`gyn~KJvFJU_TRl~0;@a9tv31GX#t2cVgA@n;<{X%Z`xCwHJIbxsrX5-d zy??KG{&%b1d+SkI=goPkT*o4KlU=d&I+i~a!x)W1M{K$etE7UyP`KW(pk}|!tT)!V z*nwDS#3f2^>$(&^#ex5C9B2Z;qW238y>Hc?Bk!rDKfW^ghKI+>eNyi^E8WCPdMv$f zBy7+nAG`X&fjMcJ1Te^8~u+(ZyWwm9IhtrPl^qcI7&h4D8+$)E(dgbR5Z@5-=?3G zQIe^iFY49tp~E}&-qT^3=(pfaPR7#jB>kk(_zIi$p>Dh6wegQkns~mhc3@qvk3~}o zm*T*N=79cwdby$RW_wOr-VL7g;-&AGej#*;|6$@KJ(j+=@{eL@w(e&%j*oALSl556 z2Y>v2<8kAqUZKmxOL`J?#qf(-6WW9V#UH9T#!aWmzrIIis`KxCIIGX8i|e_TkwNUG z;B9R5KNg*B_(QFULovyYtJ8j^Y*>`+EK_w|i&lsDH^^V*#>p?tl*wJRlhRUC4onbzac zpIzU2Bt5C38j(xnbq?f}fzO@y9cy30d4mtX?EXtnOyA033?r^P6g*B{!QOC(+tg{( zTRiaG{eg0SSy63h3ih(AomAt+933ATz9w8P^c0l3>0!G_$nMucZPMlT2ZH^#Q4db* zJ>c|!_ms_mXW%c%e_?HK4OP4w)`G2TgL@OS9kDyew1o8+zv5*}0!Q)ysC& zBF|g!LZ8HINT<`K#FQuZV|U4A3+QCf^@MV%&l7v-tw}o%7(1)4qb8OhusW0_dXrP`rcc#oS^IU2FUwTt44nTitNrA`m&e}JtKX;>9U4d{ z=lcoXK}VutMPs;)W0|j}W`uvTFO1oS)*QGNfLDWP5+r$byZ|>nUpgqzzRcZPhUu(E}T7e%@QD zxA#@*ry)wsJqGRUOr=h|L8(38R%+#rX{xwBP2Kiwn!5ASb}FY5@2_XIS7$?t9{pxB zHRH_9)%GjlVS`_=A=Z8zvp|RNbw2nCQXuisD~?mpxj;hXNOwDL6IU+Nz; z*?s?%CrZ4&&+CU>&VT;9qxNbB+6p!w(y&jo8!zcb{llv<8PnQC4tu-SR)&?XU-OLm zw?QG4=Xu!I0_b$OgRv|)GIOTA2MtNr_NS->r3jnH#S29K<+zd zN~YEC%LR`26YIIRAMn-p?M|C`t9`%G=Pr0$<_eMf&hu6esj98SW*`uPV(esV2mQXA zQ9sL-`eQx!WuJf3Z^afL{BAyX!ArRkvwl4B;tDT5=sOZyJ=%}kHP1Y!BJq8fPd~Q# zz(sdb6s%z1f0{D!l5W-O5BbU>d!Aq>uBULiF9i12I644_q!AYg{}&`dN6-E}w*LLJ zQzl3~LWhZ$^w@M1V1~>LZ^+l09{qW=_}$N=I|}Uq7zBK`%@@#&su`0Gc>71sXD^v@ zD0t@41L>g$R5>hITMRGFS7Xa!6EcwxiR`?{L^|?|eUyF=$1XVEg?lfH&Sv4bGeC3* zW*qw;E7cXy4Z!#4+%lAH#ZCa2cxw;kY{a}@vC}$V#vkYA3vD!Ms6#{ZcHu{*I8+DT za?^tox|Kde8X5SUI^tjO7E=2oUxtm~OmcfeNlx5masxo*V+rb|PUZqwUM&6mV#zgm zMZNoYna;qNc3JQiQu~W7A5r-XBCph6Fg0=gPt1RMMW?AJM)cdJBTbojA%XQ5W4r!I zfjYY9E;~3M_3`>#0AqRHe1Os(zPJ4!=iTh>bO3q5z7{aN)*^?L{N!vWYC zLJXna4%Y=}?W6UY^YjZUGu2++lTPgP(B##lDToM^GxiGvZy~k6k%8j^+{LFPfInwT zkuf!%yb6D1`S3!!tHA7k_CA6(zwGv%JQSHCo`JC(TZkCvf=|UM4*c01(Dk-&O?Ld;Z_?j}-j4Opl##MPh}Udrz18)QI!gbCKDmy^Y2;k+ z5;H9oQXJS=I4~Q8h+nb5(A(@M+F9cXv)ZSr#(&@a25Fw1d&QXERWlzw&ba}~HN6AD zJLpJct%|M~lhu#_O z)J(cEK$qYhbR>#NS8gzfbu!W|4~0tttq9Zm2`iJJtJBp(w>ms{=nW$bx&$8~$T^5f zS6&4^RfHva*#6w4r~%i>^Xobz$|u^TMhvQunZepj^;CMb^~gRuf5E)x9%*)FfQJAt13m(*25`?;4`3u90Js$J z1YiXq8wPzm;4;9wfZbr&>i};7I36_@&=WUzJ76$w@N>X57@wMqHY^`b@qo>-9s(VZ zXs=;(Au2j`IP*k86M`fh!cx_M9dx&4$H zx4%-~V#C^=gF$bBQl}JQTx`5jzj@I=s>GhOGeF;IO6_%#QhPL^{AR3GeF}TtzKuO@ zS75AcQ|t|xou=j-0-eS4N0VxeZ#CfFMNVczPH=k>f1by!uzc0;~$`_;!-A3o57 zp#>dht?{+ZNo`q~&xbX^Qot-62tWGPC+5eC`>vehnSS*L=JOD|lq)e`W_UdX-kMxg zjF%o5?nCTmWPG=;rw6?p<%peCg!lj_RL{M1+|zCR^fP@HRI3@6-#m8D7P=FYN#0 z9e2$B|LPOm^|LL&u)it*{=m*Jzs^zzAFdXUn0V$p-@!IBu>N-V7rc#){+spN>T1z~ zk3Cd*!%kM1Rf`XLyG9;}tz>m;(#~Zdepi?YrPDr1mGhEY3%82CqF<=d0XT+N-0E^}uSyzq zdb*yJn4Y(me*e;tnFp{rwt~+maKDGnZb(d@`u8Uj9z3++N2y=vGx3tXCiKy!lw-M6EIOM|pykTX zM}pJN+P-Bp-CQdOeI{Pgb^7uGm4VPOZ&fXfp02MIr_oYH?Y=obWC7?JIP2NcCF53y z%l5EG)>$w0L-10c#CpB0^+Qy}H>Sq9pb1K#>xGn)Y)spHEWn3yPQ%GvfVXj640srL zeiMT4D3~u5)|>+kxJ2}5)){VjSq?$%kM!(9rEXj>{N&}3r|j>B9&yjXzm2$(oh<~B z7r|Rd?N65%X>ZuXc#f#`mP1J5$p>qouCT4v1M$QOUSj6?85iuG&Lgy`IL<}<4WI$Q z_fe^^W*nG}>>?lY&x$V}*=J^|DZ>x>YT@R)m##X)mJe=aPJ1GFv-URSqp+;3vexQ} z<#{X1_@bM=GLBeSMZ}XEse^KXuD$hcl4A|~0EPob0BAe9g2Z;n6b4L!tQ?Iv8@MNt zb^+iNz|nxA0Ceju`Jw-}1%UROvMB+VrGmx*y&YP3PE>CAEz(m8?fFebvockS@2ACm z&(2g|-*-n*=exQ!UU%Qc7*$b9Dyiy_u^0V>5L~Wx9H8X}X#|uA@40aYr@on9WuG7n`d) zPwb?A?zV-xsEgdGvrj9Cn4Ow0cUB&wa3yXU|J>`GutyMD>w=lYHN^1$1S59ynwEd6{bA zO%+ei`EG~P_x{qZMf6eddfhyB>m%psL}t4?lVY4HbD)XNVGFJ?^^vsDUSlZM`W6^H zQqBY6JQRqs)#oO!;5J*fxCdhPyY>bg02l<|Sn_zl6hJ+IcKknprvS?Un?nx{08|1v z=?YT|RRQe&?SSqu=(hq6gK_TwVm<~e13?+^C#Hdztw78-F#df&%oAYYf^C!<(^aXH zFwlKWcbkuG=_Bb30WNdmQpAf<_W`KmVbu8!j^_b)FW^+bH~@;Y#u_jjZTUKEbIgFt zQeiDPptnzrjZu9dKTW@PCG_Q;4tdvReR9_0*U+FMh&~A3#zz0$`e02G^bCa)gB>OH z9%CN9Ns3-uY(JQC{}JSEXFT|nU5@hhuQ+N#rDDJPUgWmlKBP?s$UdGpRHr{ze(hB^ zb~}#84E869`ed4TJ2kHTwANyHD>)+Pv4)!l*G``73*~z`@G95qetP<)@#$Lt`u%Ue zo_*_HzaMxc9b*L2M?YQgHa7b2mS>lJ*XbLLO#)qn4T5bW-(*~DB@H)X+uUlrv*Xt(e{dSigz1dk4zn^33wcyP=O;WF|jhJ=CPU*GH$&_B3 z5|uhnh6B1@*If}`uUX#eOV7M+_sg5hq-^mgOuVEgsn%~TwRM3%JiOYPZDRH3bbkR|ENc#tR)lq^ z`|o|Par^HLPrs1Hai3<;|3{(s%f_oR)h^3UpU}PKl96xL?$05>i2p8lt5EGP4*x7$ zXfM@v`nct>`?K^p=p)cZ&`)6dOkae4eHLJQz-|DJ&m0Eu11<%;3D^S{b57QgD4+xd z%tHaqDByS$FbxH4)fwetKEfexbKIeoBs-@qMAX;>c-g#$8S7)fbkj zWnT)=rz*T_H0b>D|0LVx3kifA4@wph& zkEFlHW4(MH?+!Q;02W#Ah(;p*y9V8!sB7K!guKBpgKEU!$)o%1b@2k|%cg_w?6hFy zwHdQHz=9zCS;5=b=s)LM=wJ4=dm;r`X;SH{iR@)r7_wGld-0iSd%2A@&rjFq2~K@4 zlb|?3zn}TIA3o1q0A+#4lm%HoIUDKy`<*@P^r}zmMsR=#A&i)INboi``X5KXqwjP1 zqN*C-ISP-ozR|&}IgX>>56`7erc0>9f!NU{O>X;SzK6}ZE>m^!9Qjep4ml@hL4O(k z1t9%`w~*SOZAW<*_|Str0mypi8fzR_yKJ2fh4<7s>MkE4Z5n~kgz2dep98vF&$&Ln zo(7SAa;MpMp8f0x_ZCy&5iSRlDHnpbvC;oHavhQ8+?pEyl{dnePVhp9#I%FY^{2E-yKEt;Hg>^J-R&FuXbFgEt~^g~*BN$B3f zEr0Uf^MLrdloMKM!CR-=Uko`JTp5^D?4Rj7d@%Cqa+-cid^xSSIa9rU+FN~Rp5QxYjMVTHcW@>;dlBKEkmR!q!8nj+eN`msEwoUu)COqA6Q z(0+&w!J#X}OLJvRow($r@7(xu(g-=q`C;PDeSVn|+Rcy?!J90NEhm@+ANJMhg0e35 zjL)0am9{9uIi?>k_NXm+XiI)@X(|{T(EZJV+v3Z~9LUjmPtMuvl!awGW(>5omhCX@ ziQtXmmF;hi@K;ZDnqX&!-@3?!S;xAZ(-)FP5{#}#{!COe}kM_gfkkVd|!Y|L^eWluSUum z9qP7)$CMY!4}B$?PRbGAk4XPU+BT6Z^Lk{pf{AB-;soqm(Y8^~ucyVrGd&hQ7Ea1a z#s9xJ&;W8pUz_fV-=C^O`u%U6{`0S8o4vZ4f{U;UP8s!8@HRI3Pkk*3d8=#i2HEOG zVH1sTsD3EsAKknZ^Aks3m_S@g7r_KA=;H&c z?~N}fzg(JmdobY#TmC2BtGGoq^|+1qS99{6WYobMePHH{x4t=2>Akp^aT<3Lg_KJ zUtJ9%c7bEk4exQU!{qOm@iO>v3@%=|8|v8;bzp#x{DUc5tM{)UC+R>wkq5^EI^e=L zK|fv@t7VAK0h|Ebvq(D?Fb1$UfbXue0knPOEqP3PMjM7pt(fKVoH20{lQupVru|)l zt_MpVjp_mKwblE+M>5qd+u!4vw$)=D$U6pk|0;MJ8~vxBQ;5aKRYCh3%broSRU^Fh zSiXx*IQ^6TvLi(kDx@CBe9P`2Me2x_mOA>YIH3E(>0CsBkPD!kG+Z{@vX|)t;A574 ze_O?4nd;Jh-S+6VW%kbRQGpQnEa~3}-a=}Bl#~2c`=sVmZ~*XnWCL>N8dF}hq7oib ze_ zv@KUwV(Kp`4m2Q_$j|C$-10N%@DbL&VzXY`LY4LY^z{Xhud?R%`~2(etTXbLc&+m5 z@lSgrcnhihaow4w=Q$6t32G`cqYZ9`tj{j=6u)z;0)AW1>~4`@r7tF zX-^3ZJSRxdk0pMhkaMu zrTOaHj$UjrKfxdm0O^R=pW;{rb0kk0f7QoSfy#VCj4uGzJYyi53Rv(pp z)@=a9v(LuBr9m7yc#|oyqBzu;H^_cr48I!p1) ze+KZ~!Mnge4LA{SDqu389Kbp9w6T-}K4acFZNskGac>;&31G~*@*L}8KFR>)4d&Fc zHMA>~5y}f`VYUMe*rjVO8H{DfIDT1;7tD4lor^38(^8 z0|I~`U>YC04>dQzzjegfPJf(fa3ut08Rv)1UMPc05}D3D&RE0>3}l;X9CUw z%mSPZI0tYp;5@+jfC~T@0vZ7q0WJpo8*mBWQov<^%K@_iR{*XATm`rqa1G#Ez;%Eo z!1aI|05<||0^AJv58xKS9Kc+_t$^DAw*&3~+zGe~&Kzg8&I{~r*Jpp|IdjkdnDD!y$%0JJ00lEP)09!jiPHYa?62S6U z_Vxg#Zw1%_!1Q*2bO7@Z&vZ%Sc@}`>5=WXCv#h^MXu^$%{LFbPzWk)WnW-Kg^X(J! zC;r-H;Fdis7Kq;>b|AOHLp>I71`@r9 z`R&h-kVZRE0>}q+2k<%aT0Z~H0387BotT^;4&oZ|1NiKjpE4zRnTNW@GKdo(U4)JR zmdRs~VZ}WDyM#vEh{#XHBDep*`{cbhK{>h4XAaUU_Q?Dtf8Vcveb`~ZJBT^HCU^%O zi8wxM`47eQ)ny@U@PzM4dJ04M_}W-}?ylV46)(?QEAydfCrFR<-{P=Kyj6BLL$8 zlL0dT=K!t;u#I^a@H?On>KYH=x0K%i>ElP>5}y069>E2f(gtz<}Ri7{A&9ZFe@tE_Q>Q?+HI=AGEIr!mk*Dwyp>~oB%(h z3ck+Cu&I~8FS#B1xBz~|7ie?0PE$L;$^Qt8t$IL#bH7Pb@8`8si*CTabD5i{-!9rj zHTQ0>mM?0r<}_`pu05}V8gSia>Q(F;_sHnY)xS5{LKXh9r8<8|hI;MmEVZy>7xe)a zisZeslX~gV9;&dakMeG@x7y~({nbbF4psN|IZSmQHC8PSmaBt52`hicS*rMmYt{5a z=cz@Ni`A*;{-ho~u18w)FGr+pJ??DRI$(1=m%6V9$~;(VwJTs}Bqol5xKv1S;Ge<) z-M%&~jc;Fz-pf=Uo$Won`s~XG{zBu2Aof-8Ha7a-+P->grbfMs$bPA&-qNpI+aS8U zw%50H-G(Z+t@={<6bIVkKqC^wuN(Ane7(*1FjFl*`mWJ0dFsOl(osPWy%oHTjsC~f z+vrEdv6UyjDlD5F<1$l!qb1o#qC50AdCYcJZ;P2r^6+>~f|SR2ZOd4b`cipQ99UNl z==!_zv#9=3e!s(Cf5Z!+*QcFO4^JKX_2kYom%n}B{k)EW{noAVFL(>7{YB|`%LN3L3Mt=YdJEuyE?Tl&)MKeJDb?nayAyEHLuziDGQ zUepzU?uXSU>W;W4pbr4u5Nix}f5Zm?1_OozjsP45CxUkVQiEV@^nNFCsn9kDz`FGkSWcp{*bbz^#?65SkSG2| z@bmcNNW7Dx(3PtB2HkVE=J{nDfSSIXUKHy03+!QIFR~RCQ<*p zpT6DqmYX;KO|F;vO}wPHRllbSU&BPE27uHbT<*SqjzMk#DA*D25f0qqGaRZ_o~+Np z|J#qR5UgO2Lu}d#FX=Jrr+XFPH***o08;MAq-^3?T|0sShtXKFsyU&5)na&--M5y8HWI{nX`j>oJIY2;Qu_wR})r_4UVv)%@N<*k@m9%8OZE zqI1eqtf1p5GkRMt@&z%-B*{~@cVD)vLC=ef1CD1@D@`0)8F&8{w|ufrJ%KIdvxEmz9>VtGptYQ)QXQB z>i1E!%8+|w{YW$JvvR+iF5LHwFUw9SvWt-W5PYOy=OF%l45=&g)zsK~pXOEigF#t# z)XHAQy9cw*bQ7@-=b{tqP{iNzQr%v*KyJvVTmWP8pUDGzj4d4e2*rh5Bi_} z6E9~SuiSR-PL1h#H}IIje$HvF@OG;0Z{=h6PS5b_$pL&Iu@bv@Voy>U@sY*Ir1N7X z>Zk1#e(;z!p%gC~$KG_$Avi?;c;L?Y>iidY%pmofcsmuos?Qt5PDzvfm7HlkyxRHt z4R+hGKBw&&9o-x(cKB}=dR6ou;)mIzz@`J#WaIdB?oX7fQi){b|a? zOS;@2wzv*M68IQuDgt1$<$MMMp|EGDx3Y2)K6P5mZ;RK^`9#p^nwFKh#1 zjZ0A;1TXYREOZrC56LTGV^kZqghJArz;In21iz-S?n`mJje+B747M)W$NZ-~NQLA$ zFbmm4K3aZ?FCT+eXR6!2-lOjA;Kk34cO2W^xSsMMc(Yc@M?`fj!x39h)7{x!awH2jSHBPvh&=&bphTp+s2XGA#> zyjc<2R}Wl|Fm?e7`|v@$z*N6)q_-MhObU61`NB4$rWomHo~`-V`}8gLl?AH#QCfsp z@+18zv#!+npU(l^e`|*PP^EJG8T-|f{q*B}mHsLINtHfNexRZ_h<85D)(d)jUGQ6CdIsdacEFJP|A@FNLXU}0 znw~M$71n0_<%K~yx{e!R&C?b=TM4=tgio>j?9K0ds{K!&f3O|*Ghtw~3;qRfA+vtX|U9SchHfD&+~{{e_1g+EPhCMD0Y&ou%GJi8fz-0omHnp z{o(d^`LH0Blw`xb4+WV_r^=pN*=s1O?z%TfEvLw zj~Pz~^t!nu}vj*cB)^SW^MH&(Gt zQCYzGJhd8x>rFqkzf&iR<~xmeLBFph3GQn)(mlujd&`ecT{L#MQ|M97eF@&ItIhlJ zl@0abHIeK7v^yJwg7o|1J?*3wp6I@G{c7Blqfu?kPiea>)#>^6U(}7>v|^}JFnuyU zFTq;{Xn&L+J`Nv0Z-66TFt#Yinoq;WLlB$7VtFn>KQ?jVI|^Qpr99@5d{URhdj8aL ziUS)P2XwtH=onvbyLQM@gWDbZ(|N!2Xqn{P2n|kY#w)B=d#(ul5 zYi1qs&SU9zy!@%O6bJr4a6s4FU?;cUn*RSn=yk_MUmbAv9gSz->)f2^t>DdjcI&OC zuAZ?Y+4@R9qzMY9`we}62vbPyh)i`PRyP~R9NE4NxD<0$N^8~SkfpoDT~3NJ-Ev~~OS8Ai zQqQjV-|AmHzx-hO0fIM4bIZw)I$v3>ytl)+Z?xZ+@&ioHrOs0vXqyB2xJ|~k@%6R^ zdi~HVtB#&H>XB@--z|8vrg(a5T6pp;P%k^WaUvT0>2wsn+Jm!&nyiNx_ zf9g2JfsKs=`gow~;vVOu@59&YGJj_d^n27Lr;q;hi^lppoEK)jA?)mb3*Njxj*pKS zJz}(PS}oq1VWb}4hY9&YMS)6x8NLn^l7zfapr)oUgqI+kwQaApZ_BUmW>ms`D3T5O z{m#byGUNiRB4UhxAN6Q+{jEcKj(OQpaOUfd+=A!zdZ4{(HU7ue35TeVX@u(MN|iMJB**M@u)cxyPp3KPh~{^`CVZ@2M-S$Eo#EIHsBS2~&CJ2*!fJl3micu$O1rt~ z;4>mEG7pvcx4iM9_s{)w*elrKhE- zJ0?D{jOD&`e&_3dc;=Afc+6n)C9M_SPHjzx_2!LVVU18==hXSJIte-kj~M*%mE+%* z*DVn`Onh5(;44KjNol|Zw5QyUrEUi|Kg{tOmi_)o)l*))VOwtVV+Hbq`XYD-9f{26 zVtp5u6C(qb#HuFbl={2w=$22;_2X-px_;PGweX`-9IBaH-E_y*MGs%WV+Na!cCGMs zs%=M1o#neGyim7h(+{Z&V)y#!OGn6xXGka%2ss7le(aK6-25^7pL0Ne$<#^1d;L-3 z>+Cpzq>t^O;Ds)UW7=OJ_4lIoJ8%1nSbnUOwV`8M_M^3!=h2kZQHlc_2L~EJhS--` zyT;ew@!47GlqZ{y{kZMsJ}7Z|3*|cmcGh70nYE>d;zw> zjHyqIX*zf;fI|z%xUImvv^BOpv}3uRF@vN#rpZR)U(zFp4Rj#1>BURkdYa($e5vDq z1_v5&o1(9Cc5~~i>5ruM%u+Mvv|ll5$r*2K<9Lb%xSskdc#~^xeRXD&X|Il&AbhM} z)?w<`XE-M!tGb+0ZzV9@rd%*~f7zZ@6~*yLFTx&5mb158f6Z~#+0gIXc5F=lBkRyTIDef%^jGjUHu~>)Vw^l1 z9X-ToYFqwTJROLa7OgRLv_3e{fI>tr#`lXa7xN%D_dLD$p~E_kf8aK!a*+$cn>1;1 zF}N~NHq}=i9ouH!w&cSsM?YUv`B>BZdR_nYW8GhG*eAYxv_O73`pUmO@b(qcWTBGC zhu}?qYVuJStZ_snzt)HC?JEP5yp@GP`wCM|l6j`d6rVAK9f|L2+B4Eh%BFn+UNdkuQ|Hb<$_kxsq| zUh0)t_*Ptx#cEY0*kl?T1o$g!Lq56)vHRb=R@YfMrVUxsz-#4txz;>SgqQSGoZ`S= z&4C6GAoim1p!oV)Iv`73`+3Lh&$xWY9;Utu-n<{tSLb^~E?s5bw))$;PRVgfUrp|& z&i`o~(EXvJgWY}!{R6rmU3bN|rv?ieenZ@2L1bw_dH%1=d%k}qJAl#ej>|maMC&NC1X(39&*k}_7m+a|EUi)=*gM? z=C{E^veY||-jRFbkGcCVag0+Z6hi++@VLwsqV(Al97_UWdyb!zs|ok1^Z94^Y^00D zlLd_B7>5?lVU6pUX$+EPpQZlSl>-eZK;*aY;P~><2>H3G;FKc{IA-=`Z#weP71vWf z1aH#QrhMeq;KN(3$2F+$DfuwD_}85`plXqiX2=JhO>P`=x}84bjw?q0ubpY%ws-L6 zrBV5?zVB$;x8lkGzcI#;4G{ab5cNy>V&7&v>9lVZd5P!eE*d?)&*JtkBFJbvtR-(UOMl{Y&Tk{;^0;2m@%a?>*|gn50D?P+vcnouG65^LT;q_A~3;QbI% zVeL4e%WbnEC*>%zKVUUr;`uX~RegU-`}_C)Ex4S=3^wo6TH)$$HSU368p)F*mm;w7E-hXX(Oya*=R zJG&TJ145oWUno2ln<-%@s!$#_fto^kbUj)CdRTrgfcMQ~>bAZf;Qe>bYd-19rSpKc zf<1qxgEH}w?u_#e!AB|UgV6nWgq+>bg`)0F=qjyOBJ|>=N3=SR6gUOwuZ51BGS32<$ ztpMAa){H0_QdsR9=kraqFN^uzOZ^$OM?RUKNS`Ae&=DYWv1LyxuG7bKdFwlwoY%xV z>qhn6Z+?@8o9hk&35r!3?ThLaZ`m!2;NU92b9 zs>yDyjpvqtkyR&ZQ2s%+&dx&w)BrDSqlK$O+|Z5P;8!$7XwWcQ8Ga z{!)9H?%+JjG-cv(sTB&s;h_CKsK6US<6h&l_QmdelWM%&HIQwT@Im}iwgpm`R_uB| zlzQ2JNiTBqp+9Qd2hemtJ9XyrXV^5U5#NtHZMPK{oxo!TTbI&W;q6q|et*qWoBw@X z>wOxKA@bZ&FGDVX<(c+@X|J}N(X#1)LEqSZgPpGfatoe$^bmdSe2>LdQ2ua)7G!Jy zNd4(YMC<1}z3l5Zv;55QXvE&0en<L!9edzD2rk(9u;Rr=vWTgBFK2ouB5UqbyU@Z1{ zEcSUrWfdO#rKtUC&&t_^a&-Gh%7k*_8R_TV^(i?qIk$10H-H?mXMM)H?YQ(WN}<5hH}8AL63Eec zUmmc_srz2KWr?G_VowBb-d$8qxYD_tbAX& zzYLu{G}O92&Kl?DGktQlPqHs<0n)#i`|6y7Ho2jZeIkZgAdGff@HRI3Prp33GVBXg zTPyFK?}+gGD$&gvn0pXF=l2MdD|IkEQD{I0k(c!GiN_JD7r#8EN5i~y=aD*XLYfl1 zS)Yt+$iB=)A?`ep>#G@7R>izJ9~)6W%gqHa=CjrNH#k+{gAUzevxDEb;YNo5#%b!t zG{G~E9;APhUtQzu@y(-3KR<`!4SFZx`z>K^e5}(^aE#l&n)7SA9+{`e`v zcOBRt-`bSA+8e|-fb9Nd6ABXgW=%*;-)$G4T)Xt*>EB5GLZ6A3^tGVxFbq^;101^q z-R@-^>!vT3{oTB7Y4uNgU%;U=E70y?Um0cMEj0eb?!oG6rp}Wa#w^2NIQqRXy`3*8 zb=zOFA2X(>wkXNw3o{<>GMm)~z57P{f^JCAH z+Hmf4%y;C+yNZM5=q6d85s2;YN||QNXJtPxJ4Md*m??T5J7?Sf^x0COZ4T(;H+7TZ z%gqwVRl6%2zdC);_e(ft&XA9XLAepUjg9_OZUFq2n=Zf3=ncLv`-hyz~VF$FX@yQ z{W~O%AvxSvkNz`u(JHI3bL!)5U48N8whna8%j~|%x!a5>XmBc`Oi^wH@1P@5v|Zq) zXB_de`fIKF?=qGnF$>UTw5?;QNYW)1d@5c$4m990@fT(%kPFtZaOu@0_ul(6hv%$d z_qBIUGx3rhm5bc+a?PUgn}F!gs|IA0`sYoFFPB{>XQ|)5d4J?~k9^~-P~^8?Y`GM? z)GKjh?A6oPW6jYUUP#-?F9%s!O#8VFu$0YM@}EC=-VwxA-h{hYIBuTJ-P zePe|x`#Gj56EEqB?WgKaZU@p%fv75rL|{b|pL7ZBTTq`V4qZWIUDJBOj^45;}M_j;dFnjc_5Ty!Q&EFFzLa@p4L~<^4O0Z zjSnM+><=UM!Bx8d%6FhrhhCsgZ$YJ-e=<*{&(7HIbMdZU@VYmzUzR;|lg)=q8MgYR zwZcn!w4HMGyEz@p?rl36bvhP;4hG?y*>7ap#Ooi}`Lz?S7|i#!45XtY{snI#wZAxY zP}@cGUE_!2s}j?Z{bJfh9dfq6RH_nwn0QHVgAO*@*g{cesky%^ywae9Eo^_lYJkj} zn{&^igU-AC#KTg-NiyjZ7wgYy&NMfF%<MV7C<=)$! z@!uV`9b^*}k#E5ZJrbMp9Wl^`X*S1KdA(DG6cstA-Z70po6K_p198+z^IE3qAyK-X zH+7uiz{bXb1`s6uf$_ER^|ntaOWl1@m)^NozAoe<*!=mMUm??ECXyeWefI`!jG(G4)mO7E=2Y zeJv;{DJm`=n};t6(08<4TYMJS=@ns@XS_Zi74UIqXJoO~)X-mILI`m+R_9rzHlbeK z-z1Wxh<@uakLjCByDKqJks$dah}6M4abOOv7I|7(A77q|>ax`05yP$>cgVMQ{OHsw z@+5eZn01sVIGiE8s)^m-W?do=loj#k#FrzEL3}#<%>I|_bX@9q?Kz;!QPJ`4{vv$@ zzK@yr-!yggz2*DOo{4#m%`a~AtM9g1ot+0EawK?@l691$(fp7(%bW)=?UB?aa$?E` z<%uA{Ocy-k4fQ^+31y3(7MD85(e%+`npY+bOeuxe)x>{<-tUemC$8 zpUh3;06N<}!JA~r{X1=$(W`9jr}Fx?r~bZp zsK2^=BwrI_>}+_@d3&slc;?_roo*IH+IQhWoS?ra8FXs=`$$LnNjWR;n%U*?k=>m# zx#p1fA$YT@HMkFZWtmezTld4~8!t2=QRJru^v07PmNVZ|@${sV=XR5JhjAL-x(J?m z^dR!HCjA`D|El2xB9^1`yY95a^cB8;;JnZY-AaT8+fUd`nRrPTe&=y{Zorw)8mOM^ zpW-PB1ZyifOL=H0P?hJc4pd{(a-}`{)xD1S^aOH%^ye>GIsfkRE;sN!00Y}<%7Nf5 zr1mFt$$VdDbJ@}1@Q@mR7!x3T#h89pX7PxZna`iHEOlwcwmNJCMxOsd(3$A@_dVd- zCD(5IvbZ~r&#|R4@lug_AJ+bb&d_#r!`#R;G1v1>Kg;cZnC~Gf&d5>+J^kXq%@)*; z5_uH93SQ`t*r3O;Y4{kMk1VxktGQlCI2Sg7p}M`GFGyYyQsJ-XKm$k+Ic|pB#FOJ$ zNZ$PIns9+A9AnZcc)e^M3!Met>hhWj?^OG{dadmP^+dodLqDH|6QOsxK`(WV z_Eq-t;&nURe@_c?c&T4vp+oF#u@4(H*fe0F zAx7k|^$LgDT5tjRadeL_AC+rqYbkH^wZxYZ-lPL3{YJhkCC}*}(GOr>ocj%MuFsBu zY(P%{Y26#JAAoC6@&O|O;{asTm-loKtdJ+z6ERpVg>?yfXe`{0JZ>e#eka} zA}c`Xhk(f-_74F02i92Y_f0#8BG+pmk4T0?N~^Mo2gykX<~8%v=OO=bYk#|-x7X@I zw;nX(hN%Y)`1r&T|K9eG((|*_yZO_vdn)VOt4EKqS+N@;>Ve=*2AO(L5(pGmc`GX& z1%O(FZMASNY(cy(`amCrdvfrZ@oqSVh2a&oJ%BIMy8}q`zW{v!`vVRJ3;}S@i}8SR zfUXla;rwC1n}DwYTSGwh0UQH32k>dv(xY#YXvGzef=b;t%Tr%Xjccm^&#YAYI zX5uB?qyt-WS?eVor>17G4_~A9S#oS$qW7~~40_D(lktMzu6=Wh*@qk+e8i%|Zi9CQ zX9O>FNF4J!M?mV|i?z23!+;Go$r?3egmtO@yk=kK=95WR#lN%E`HMch`hnfA+xDg> z>6zO5I8na^Zy~im_jl8Z!@i)U)~!e}=TEQ*(QC4R#||r)6iKsAoIgEX$D7A`J|5F& zV$3?EPKkk9>!8=OwuP{a^-<2+)}Oj=veYI0@2>J}=XqJ|yU2;)P14+Q;{GnCAvM;evFyAfk`XzPb6%hyn{_8T*RSPq z%FZX^SSo#E;McV)e{>8f<$gD4k>Jhyqy8rTK4xo8*4v*Z zgD&&Cf2{MO;k!-!&&@k;!u~V^>1vOE!COe}KuuQB>Q10Mi%LNj6+KV5m9n?I(X zUvzDjdgjM1Ykmt4p7jd{K@ciH2>n;V+t}zo{rr-$p#6QQqClW>guluk9*xo8K$U+c zXX8|RtmTOqzr-Oo&BM++JRDP9<_!jYpYbk8;238rtUnIu?d6=N`0qIykluav>1Pk`_rDL)9TN6JOnDN#NtxMijP_rL zV!K70g+qZ#=W}(uwhus;7mn3QT}+pt(_MOfe7bXxzBud1M?4q&`z|R<=oY+`E3rwp zy`w;Ent9FI(A{{WTYt^>4l67{fV8(4+ZGt*=7Rs6>0+9@!kC#7ovWKTmXGJb9{zr zk1c-Uo%1V?drIsE^R+{6!84B@O#c|;&y#$i!pZgu+eqq=>hfR!Uqh(r?_8|QSH;}K zbbbBN)z?qCYUk@rx&*J&#N$ZK_82oiRS}P_VWB{6ki_ZowbG!=wCk*=YsT!O9{S+i z;nX7r#%cH$yoJ>MbgI0Fk$*a@R_4X)#*gng;B>DbV-K|;b`iBGUIxf2Q-Mc7M z2%Kj?ITyTz)c!~Z`V)@ZC)1-wU~*J-89wr1@6UkzO%MRx@1wlxeJ4H-%1ENX_rIyI z{yCugAxrLx$_byz{N5d{cjn`NY^R!9y6-v%ax~|}mlmJqefo-r4LK3KNg?F~`*}>X z=JD6ELpc!|HL)bGXkxU>Fwv14=ufP1HN8x|Un#oGbka-E+8s2C=?r$8mKMR=*yw+Jzbv`~QUfj# zyU_?bSZ*$WG5s?RyURKo9IBm~?!RT}cc+Up6!|Y$S1cr6>u&f{Zqj^=t#u+^^WXB zEKCwNgPBab#d>+qZP_5E6WR*Nq{YkAR=FvBiUS)12lW1S`lIpnbqVyj;M?r!?Y24V zvs)eF*{`L(3f{aYOJ8G*KUwQ1tangl6~1!ovyAn8hbGs@(qpHoddcaFMJ}t9ydYHkMlqA>%Y=V&pgMuG3pleSn%fkuBjf&c&Mqz zELU%fd9LdnkM(n=CmZBCiIcr9l`qACjfDexKVtm+#NTJH2(4<~bimtt3jKVK!QeOW zHa5E6PR5y|zO+3pM3%^Bvkc6eZ2He<7uJCey&l$~k1x)7%587V_Xp`uW~u2eO=FPvErPeP(SO<-eLcVP0cDIc4yg%aak#$*ZiD79G@)F5JennOOwkOi-n0)g z_Q<@ZZPKrgm!{`S9k=FyE-$4|$A52_gY^4$AO66+2`9bO)hQ~7nC+9`%^FO3$qRTZ zeKloR{)&~|RYODAoj1Ce6c_ga=<+fi=TetmwoZ5Bvu-(WHU9&2hfc{lchmI#Z=U-v zyOhfik#523W%Jmi+gNvskCe^8cUG;htXsZuEIBvJT$}T~a1rMqP{z4FRo>@NS9t6U zE8@rwqC>IpOygKXta&8P<$v2qmzV745|6)Jvfcl&cP8+4RMj7!v@DgiGzBVaWDQ#= zl%>kn(1n(6p=oK^q#=22L)#=IDYR@x)(WCUR0;@2SuCJZ5VQzF!9Q9M1O=hWA1EN3 zC{#eH@E88SGczaezDe@ZB7z_J-uF2(^UloNd*(Z5?!9y8&Yfq^s~GmFuNh+tHZRfC z^|3OTWc{VGwl>$)I&?$fhqA~#vXrQm=33rv=YT{)Z`x>#`~>_A7}Gj`)}rj5=WYuWcSOg=5G-K zq2DZcpt#?xlwWOiK-IhFT=3q!1*zY7`R@8`QW?LA`_I}qEAjKhljHBDPi)ka#A)@- zv-1xWJ3n`}crD4U&UIGj{^I-i|I}ntcZBS|9V=KUN?^X$di(Q$UllLsEuxmuXH=j3 z^1S5bS^YP^v1wKxt2N2`P2M*~HCgxP_~YN&Zmz`b82C`3|7QDZERdb|?|0eTlMlFi zZy*23{nz!LzR%r`%Gy@-x=U-*I*M$*=00ZSq4fjm%GW$j=Kp>IVfj4u;X=R2mWNB_ zHxoC!^z+dVcYbeldg9zKT%Wbr{UY^xq7@85K7s?Y9f{*wAi zG6q$A*K4nAOq*6;TiMXis1HKxuGjY~(}Lw|c3_md<=z4mTa1I#|m$sFugB#tPB>o&I1^0xER)V+kRKvPgcl} znhyKUZ}uvku=B$7WVxTXKAU_eKWS`f&G((_)@?e~C$jN||Fh@c%LkjggxmXac0boM z@0mcGHtDEmK3;ggZ`Z2j$?Y28Yp>HLJ*JnMqD$tSb@wl}zUNtcZ`p$Tjq4L_ewy{0 zqjSxT8U)hXvf}ojf!Z|8S1e5ncHiDrXp_?I9r8q>z1Hs2SK{BBS}c1n{N38szkTbv z_Yaodg4^r*M4O*>V{b>#b1xsV@8i4O7L&Irg}QtSAMR3EKCH^{$ezDtTK|VL9>4X% zNqzTmzSdr2?IW(wTGtJa`26`ZGTW!S^Jslnx(cD)eScs4JhmJTgeKw75>`u;OVEF2s&+d*Po92h{zfF<2e-C`Jcs{;B-1;pT|GWLJS@-SJ)5P7s zU7xin%O&Z#P}SVnI4yn}kuB%b*8n@p^laIljlaA9w%-Tcx4Sq$iTd!mnetSje`MPQ zmdJk&T<23qJo)9Pf8=?R<>z+2yFSY>>mTFiw2q%PzPT>f9K55aow9yn@r3yu=Q>OF zqy6vsTIo@Bf1Uqyp`TdZZ}PJI=b$Z5s4Ca`Q(oJ$Wy15L-#IKb)AJG6XRXiri8tL> z=UQ9!u3k&U(8f6$YH`+_mhlZ%&<~MVzP2Xgj+%{f)p%UbspzJqX+Gj$`raNmnuP?N5 zb^KHFGjX$PYuV-cLaREr zV|Tj#(=is3=hrO-@7*qXu8@=Yi%FaG+YLJZ^On|UFCM(SkWaFq>u>7c(rml~b z!K6n{x>?ON>;3XfzErL_isegYm*qj>d0z3yLi@Aru0x*h7ybG8ArFqI`{jxDo~wo7 zDiE#Qb$z1EPtAV&cv||rzoxdev3Xv__=e=as;zbNhH4nw6Evjru-vSgdA?^he>hm_ zSQ+o-ug`7!aM|}~{_iEwrs%yszvP9&`y9K*tbW~oL`n3(`e*-cs@5NL_3OQU)jsqG zN83sT_Z!zI+Wge~rgBzmuDL-s)T+j}Hr6)In$%J=J(p}VMKep^%S|g&Eo!^Wv;MGW zR-tXW3-h(Yk89zJ#gA)<)*o~3y=Ojq|3&qsX@quN*!AH0Y&zW^SHWjP;_;KivX^v92H;LC-_H$>|yB?DgS7rnZ}v*&0rT3Eg0{KuYr@~L5IA~r9H zhLyP9wh4n@?|S`1@1r!%ooBPQraT)yX-=-Cb!hM~Z13Qma*L%sJ#T)!Etk&Dhh1}FzO27-(B|Fxs$HYDkBJ2< zi)`8E=HqsbZP~=%2lj0&UTYUMA>;{!_eFzWExfLsZO8j%TEE_vH~gt-)n>=fOrvoB zaeY4KWT_kf8JC;hs1GpcV?3Tmr#qV8hxylLcH$K5`t!O&tjJ8l<5-qC4)>dmc3bVc z^y)%%I^fbaa!|QV8TZPwUUu|gR`+PmT8@bj-WmB|% zyAk7_uiS9+Z{B581pGrL8N%``s_pI6ss zlehCaX~LLzn6l=I^sJ67=v_a)!RkwP6Q;1b=eJGUx<8ixy)ggEwvSu9U)}KG-*5KQ z+3O}-Ci!lOa$ncmHety6qsBEG-;_(6zgh~%FI%kii(L;E?{^J+b-O9RljI-?fPeY@6?xXu=p+5 z9(J9&K2`>kEXO0%Dm}9z|70U>ew{oc*D$I~DI*IihiTGZzIb}V*D zW<@H(M@V3i(sKV<^=@(hnetA*Xop81|7NfMxop=RQX8#3%KXRmS<_eBfAVgVToLiO z;of_`b3NYDv9b$4$`b#0{)gpY-*rl3BPunu>w8%$^Z&13bkpWnth4m}e$g%ak9lix z%VE8bPAjOM54k>$AedzRD9M4W<*qsTNbUsdmK^6!_D#TOu;MkproA=a-fHLLP{~lq zFv)Pq2+3iRk&;o8!zH67VlPC)}Oi|T3oy%*}TPR6p|I$>^|Hp>jvaF|L4A-xf z9!anN*dxL)2tWV=A0GiLSN;BCVWwV~9e>fR+~Z4gp1W_$36C6-nr!*)r+j ztX`NOGbY!3{D}JIme%Yjj7j&g_}}+@-IKN>w0zGhfS~Nk$R0T-nmRu zv&-I#Etg%M?!MDk#BGP+`jNr<)}NgfzqcA5*9xt-{Kt;Vu2ow$yZyPC7Nen`dgHoB zC!X|MKc1v6+q*+=+k~N;zhUlF0R;O}1=yh0ig<_shDpu{(Jh)`t}wrrw>}&{wSC| zYisKISQ$*Zv8Uj@qc9T>%e(oq$Aa_8_A9k@$Nu#GhYo*td>`A!g4tt7;rdt^OtSW5 z-uJ1P-q<*OR<5wT8@N%=cIE>2PVXeW``u(u3e;GRnpJT zE|9Q`Rp{r-WT&NTENpJRWap`)|BjYx{xNXqMK`~ByZgCq*IQe=UVjThH+FXJzf<7l z$^E+f`HYQw=J!Bj`CV@;JZh^fKi3x+r9a)+)pdV{0G&S|XjdF=U!T4`+jsAgum9@L zE8bp^wa@h*o_$Hzi_pGBvahH7>#N5ue*475!;f@3?7W&6Wc9wj8-Cq9SLqCJks@+_ zRh#r&Zv1J}%lx3oA8;`kXJMM(7wWQBe9`cpF^vi5e!+rcQU|2+6Ph3PYND; zMrDf7?6h*ENp^;Im<@~5_4fR#tY6Q^@rP@NZgtg_uUobl2S1J{GkRZdod1>M2#!=; zW21uO86tZ_d(4)0iJzA~rN#Ybh4#Pvh2QUXZ`0DRZ<`uyaacXw^{KjJwx-83swF-8 z3As5fdK^)%n9M$Z4sCwzX?G-|g*J&F$5I_fiT+ngY@W^6=4<_pyIwT>g?SZ^Z>9AX zwv^a$xIR_}llVBQ$K>-d`}$bW7jdw*4ei`8-FKrPj;DQ@g9{r>leeoaS8Rtm%!-`goeP^;#&CSo-GgQc-a8H>gWVbFMXGNSn5G9(^}2 zJm1FuQxbn)LyOV17hn0_!~gqqyFGufVD_w~sq159FiGvu06BA7S}PlBXEZjC8rG7} z!`rm2r$1w>!gAWa`)s@x$gW3fpISBe)1}dGj`>~VtG~)MoRH?wmcHc!uGim!kfz_o zN3M?F+csRJ49C*{u%3f$qB!j+HkE8H`Lx9HEXxD8lk6nfRZ<}tB(Z$xV97AaXi2r? zSc$5r@pBz}USrQ+>{-e+5__hxO!AcEEs6Ep*+pXgiB6P!RkB3#f@E`LzT+epN`5UF zpi1G1lK+vEucc=*l8se?{Dx!~WeyKY+Sb)GFP-?$=){-mg5O3L{4ixK^OZrqrp$4k zxbM+V?^*QMHk&EF0a3Ja3q4!eI*NW(rsLWnieBAW`NZye<}*;wclK3U2k2Q^rTk>1 zo=J_@^P9?IokePV`%`>wzo5hH^qmmX z{i{KU;(C|OO)U6axYj6mTvqS4Wt$6YLGUc6bNLx* zMbMAy$EjY?6$C%7(YblU=hn`sX_%g?7(R5^$l>W$Wt#i(EmHa(zm-{bp2GFZg7wPg zDYwqWIw(E-TZgV3VJzpHCk()t`l8hS6THx#SKdK%0j z@JT1If2J`*O-F=}nSj-&sZ)Q8TRvX3)xxCxFL~Z&Eq7s(SaAM&#;uxGyP zv1eSB5}Vt-tM#1-`!#>3WdAdFd3Im#1{XhLwI{7vy>^R(*)t($U9Qyfm^MV(kfXjn z7qldfzEmF|P5*n&x?Fzt#jo zRZVkCF5d^rcAGEp^RrC$ShI@rux0B{;_oxGYyIHfyKi*l9FOU>(uVGbR;DQYxTeT1PuF73 z9@pGpy*-P!<7$_YPUG}aow2F`});CuKW{wKQ@b_Oyb8k zSoVeKTiSEe_4d5Jsxtq)KwZ?Lvb%f5o_pV<{&55A+toW!1JjI;f>yvvsDx^+27 z%axK{BxRBvB-=?WpRs59>RuP`WBZ#BR*yiKZ!VW#7@u7WQLR`4SJ09B*8vsr&CL+2QHfO6$~8Ch_$H4$ZH> zNqQRtw=G?7{=Ho5%?Io_Y;OK!*Kw8lTmJUmhqqa%_225VYvtu*-n!&!=`GlCn18!I z(dMV|aWpolH*o9lhU9si6^DEK7DKcU`uQ9BZ)qPPS)CA`hp9vJ*QdqN)pN!f*G|9w z(oOz8#^bi@Q=_AlWc9v&+!4bohRtb?zpbevRp(<~ir+`4u8TJf^NG2`i`%hWc3xCf zKk4bmpSpU#6YNSg3lfg5kCnm1^9dWre4@VfIV=8(l=4^Y7xJ?{Vpe8butRf+6`CZe z`M<8$d){F_ZDMg)oHn=q#QR9>L9M#q#(j*-G`Id+Rvz?`n9o>oYx|fz7A(KarfvUy zy>0W~7()MSKdiW4L?cS0x_MtYaOeMf`sgPOq(WbbU0<$`mBFM-zep>)stMQIOC0m| z>g*>$6d!2O{mSO1@Q?dNs>XTNNG|Q}?>&}wFk}64y%EQglIZ;FOQJ(mX6`hz zceMUXYemb~T{qfc)AgcD=WG<6cxV6U?mM@RK7Z}5(V683MUUP(IjZ^P8PRX1-WvV% z2fa#GzTI4MMby8S@e+#o{f?~P_mhp?1v^IbYY(<;$L=~SD5 z{(SygCDDRQZvO4m@uks_)4ubUX&3*kaf`HmWp!4|7hRv_75Ya)i5$ z?Im^(X2IU|wEKMvw%)ciaX(Vg8t-H4EMKw^#uw%t;c~L&fB&>ihv@z>WKyAjWZMzi z3j-Z%*sqUe35aODyz{j(kMz32|F}7ye=A-Rch({9GpglBu89Q0M2< zbYZ?>@z^=H^|owt?&Aev4MJGX%$Qv0AKCn4nf&L-@y}Ea|MerA?=<4___VlxxIUY7 z=pUW)4;#`a*`r;tnV)*Q@W+{t_%Xx>s6Uo(gn37}?A!jg&vmQPk&i4qs?ble^^sNb zqgPMA{x83OW?FT&KH~Z;uh36A=OdjfCRu;U#9lba3GtnIn?i!spaQ~=n*TbSY|8q>V{iKs) zZbH)K{k_bNgFXAQW&dw;^JDjAEyls_(>9R|lGy$IXC%9(%a*@|arnNbvvvThqglx2 zgSOs-t;?>rbzSLvpZ}(Lm|vD3SNQxXrvsfPDc`gtnt#*}?zZF3P55E!IeY#2dRw+& z{%_N)-n14hzs!H9M_ohWt{IIDBz`@PJU)LtS~A)1 z?<|tNd*1f!_Lof=+BmaC7l3V}4efe#eXI;71=pjsu?5$nZPu>+!}2}YwaZ1b%kB?s z?!lL>-N~12o&7f%DKQ_mbtdf+i^J9tiW69<)$Si{HHH3>y-!#n|9NNVJLMZZu-3>I zKcD0d2MM_OhwHPc$zN^k#%g^-y}nkRc#^-#XQuLF(IubXOjpKHv@6~<@tbVA+5hev zHV^YfTQ;5DZ|*O#droEX9p5mvafhr;#r=urfP$gWE^)tET3g(2%1$VazJBp(Z$5m` z#+zk58yWyqlS$c?ooVH{uBCDxNLT~uenXk^91H=(fwy+U2*@h zz5Z4bZFTFOQ~&NU*!`zH1s(2 z%*gf3Wt%G>Ic?p?2fvf<-eFHx@9S6F9;-Afv`PFt&7WS}o|k3swFmt0g=rUz|M~T4 z<9d9R{s^@VYZf!pv{Dk=2^L6|0 zlHJz-r>6SfPIHg5(+U&?{RyKP#rxYDu7#7Q?RV;p&sfzo4tkWKuvSS{pR84VSN)YH zOq^H|_i?Pqcd?zT4cspWoLJm1=gO{4Zv5rE#-DD{d`}v&)eX%rUGM4nyf9r2f2tl+ zC+9l*qi?@DbN55{r|#yf6BpZbO(67(fwPMH#RB=w*0qN%diA%*t$%QO2WI|ge&PCT zDusSgc|uF$tT{H+SvH@_?&tsgocn*9n=YGQx!&fM&smdt5*>^6A0@YQyPl<#S-~V@90<0ZNI_s_gNnh3xiX?aDAf9PrImZB=0Eby^W-i zD%m#cCj%Al+FIphP*?tuPlcs_H-Rw!C~GWizwu|6Q+2XVUT@$J9+4kiHuL#D?`*XE z@QLXO+$QxC*Jtg`zduq{)2c_R4e16|np=71&p~`YH5J9zzW+C0S)C9b$5I`KnO7+> z|FUJvQ~W)cgW3w_rg>p%F9GmLD z$7$<5gxBN9rb5o%kH4?lRyVl+5Bu3ZRV#me>siM=@Ext# zenxX?^!QI^*8XLawYRA}FgfAQ$@O^) zlBK*I$tTArHV$iSP3|N9oFw_aO3Q;6rub)jIIgl_}q&1K&{xZ7-79p&&bz7raeMpfd?!nXxyGT`KDN$8s5*izySOqNhxv*S#OL39KxpE&EAtQY z9rqE_n;*Fk33;5JaL04|@1n&xUHhN4$KuS|VB3em_R;B$^P5o5@_#3RFki2lS3Ey0 zJGnF(dsW$|FFxa$ZEv?sLSYLzl-0jopQY4IeyRt>4XxpOM5}Y%X5;=>|J$|T;&Itg znJ&C`?0*=zZbKR@e;fqD`r?e!3a{JjbD(9quJ^n9*~h;A!z*T2T4AE#*RAUlZGM`+ zZV$~(Q)N-tYn`oa*ToRl7tfGRMR$B}YvqxNT_0A4m{{G%%M;hD8qskN<@T4-`s!qu5-^DvgcoSNTadyVEMW03uD)_+m849 z^L|k=w5Fj|uQ%7#w`xrMnpyRyc7A`@&!5F-%i;ep4cGfTT*vZ)Thfzd#g64GuFu-K z2L96VtjXfY`i=Re1@{r3ca@*G&gQ;s`-aQm|E%8DS?Ermto>w9+jRKuH*?P_Y&Xhj z-84zqzv_&mCJ(;&t(Rt7yM_g0J4sX5$I4)GXmexhtojl0>kbvxK}Dmx*q2$9$JFW; zqoBQLWhQ;|6|0l@_yQK~owuE}?9%pzVb(Td!RjNuGJ?-{VY+BJUvkTvf_JAU=uZLfRr_Iu(#`fus3t*Ps6n=oY4tsXO} zX?k-_T~4Ep*C(H*i8l}P`9ue2?|5AB_dG!>(J`$I4)m zzitcK?Zz}V&YTkuDpFyeU>ng~GuzH~=j+v@@;ahludZkQ(Gm#r`4#6E_m?5(l}3l` z+^f9z9#3tO^%vJ?tzQj)sc&h?IE^A{S4I%tcX+(`jg$Cz=V3n6G`}#v^EPn*ex_Nv z$3{;b@U?$@=~lPe&ZFJ=W%a(^^1JF8HO;xYVfAsf(Z&|Drx+E7X(!BJc!!0 zqnA62FDUfm?EP`yFO^1jy>Qf-7jCg*ncs7oJ(lme-tF*tclOjw*Z5pk+pQR@FMQUi z_q$bZt=3yHe0EdoJl{X-&z`QWr#|77KE8Rol6L>8y0G~3IJ0uM$KF49>_*=>F7e}} z4WmT!dd zvFDWL->wgBv*mm~oqT%STzYszYqL9W)_<)XXlsdCV)Yvrt7DmOdpnSo@3zi#Cbr&m zv;zskhZw^Axcny$?t;pW&&0xISxI?7vA>J8_VT>ZZDR6(eg} zbZb9NgN9W$G-#M8yTOllE!Q+GzpYI0w8FSUyO+o=yPhh;4KmBazj$fwO_O%})5mEkjIRRi(luM)x(x5D&t`1$wbK&1pDt2uJG+F5AZs_ zEn6IxCs-a~&pU0||7)=z9ox_MwRMETaXi~EDef=P*Gi+w8=Z6a+9w~mPS#&spJlp+ z{!%fj>SR5^kMNr;$p5haVLtQ7H;Vhsz^|7^+dSOsskT2ZJ2ht)zd|30$(#WTjJ9?+m-~mr)IR#uPtcO8h2$eX?Rw!_0=pQ&iOmpNqCFEbhlE zWcNFp9rVaaV=lenj73Sx)<4Sp*!6CY&kOq#S2ecCo;B%b9v`+x7R+7m^I%n6##y;& zMfwhsT_rn7?C7kVv}ZC_R$6_duY}NlgI&kwPp;2eX8vT=@2=;*d z-_G@_Y&;+KfAcHzKQ9~2*X+Ofos0XYRG;|JE&}c+gTGzePZnNT8tq&5hZAOB`1i}s z&iIMzvq0r1Yx=%+#mG^IjT~M*F^(#m&t&8Ou>a#fYeuw9o4fxkk^fjeUn#M$5g@b3fAM{p;|#^)2@K9g8EIzb=*T!)!0}HZ$|TuG-7IoYv|% z&#+3IE=a>l1B$8s8Vxw9K3^ zr=cO&ta^X^=?otjzwrA4mb#s>fXdsv@ca$O+@yT7#i%5r6RHIHxqO1aiQ zyy+JYeEz{BM%cSb7R(O2eq0|bgGo1b=;3IKx&Y=4@ph=}dv!rnaedSN8=rr7XjcO6 zA5*?pn6G5-8_kw22EMV?u2(L)+R6b7Hn-=1u8)<$B+KQ9rkdKB>36%vC>t5tIH#d? z@{C+V+R~9Ud&D=FHXKI5^MRLTpQUH@gYLr0t9u`&{T+Qr`qp_ina?QR+nHKzb zmdhSb&yL6ZFI>MWSntQPDBa(VXUL7k{ipr<(&(xEp1Sp_wpVYOpz_FqUYm=rE7!-$ zV4~v*>;KjI@><=TS;}cNF2@WVS6#;lCRNEDdh&j1Axg@f7rDw-k z?79n*jTgNvF;i_hH921A%Qg?!`#$kTOjesfySDUvsO<-Zew1x*SRp?<_=0=iZ(V=H zOXJfN+>czJO}J-2GH20MAGgqVa-UB194nvP2P~~{Ih%I&zi;dF?0WvMIe|9q;{Fr; zu(S<|fEv=+J;Pazn6yf9y1p!9pn*PkCgexGfQerf#y zN%Zmdw)n?XpQ<}%J?HCTDHTO!+SBv(#j?lK^KvSz4=rC@oY&x+N~14~p1J>sdrsK? ztnHH=uAiLO>O-#YFf?5-dwXo(+o$vWLpC1!U+g;RYMtp!!aUozvwoa=N$gpJy_0O^ znBC`EdxBllcHT^E*~&kwA6u~h*}UEU`+D2vzcGaOodbSU=qEbf_3AWfy16tu^H-bw z&5r+=7vETStDjaJG4+@BFX6khD7!w<=BN2~iQ#jba?R>T*r1QE#qZ2i#Qm}Sv!78E8%C9@VvvL=$fOV=!Kb4^z;|icmG@JJAbFzzn;^$1bs`Q%}16*FJDj+ zO?`i#bWxMp#$=(z)XM>oCDJNnle{O8ajLk1DdHKHQN*>&7c(2j3@8~u7sZqV(9{0E2 z58UwcwO-xe&b5cF_0l@8J~hs&sOwqQpm{-kchPG2&-0t__~z2nw>kE2Urg@2>>M4S zGv#`VGYmcYkKWs}k0ZM4g!S*ixAyGMTfBbKynfgGaYlV}T~$r9z132seYz?qEg!JFZB0X)cJS*W z`dRVgTCC&#$)IyLdHT_#9y>BkXcx`xxLlvAJ7&d>%Qouncy`pffAx5#+*^2^FHzmM zPVu(sINx7yy+4-UT^c>{{tl0Aw8^)2wexGi%Lmsd+Wa(sJO$&HRp@;Yi~8R(ewp1P z*nOcLjn(@$mDoL_jcH}~ks8)3zIU*i>SrW&4`KXvme{?7z3VzqGDxzYB!eV} zNsg7YNG_CIE4fGVwB(ocWT+Bs=PY zvT@O#kbG8EjPFSL>OwqEvX(B!3nZV`{m#vj>h)xl&b^&~xoUhrusY))$-EC7KFGdZ z?bDU+0~^JT5cq%u+O?mT6AS;RFkj8yAFfiqd()k7yztVyFWnNom3Xk_4^~ce=reY# zN&P9^HmE&)H1(&@WNW|KU9ywJp4(dfY&m*3YVMou@AX z)#}lF$KyKRFSKjfYS?w&^ULZMzkm0MzQ5a*)%*I@waZ3tNUTowwEBo&Z&kl2te2_C zi~B)^<7xc#bLa22;|^P&HzQ4WAI*E|Ys0Qj)g7~;8aSdpr;$8tW=}I`YXI1|&qVUa zHw^7qE;}q#O6;nxlk6>7B{}}0Qx|9!y|?J0-aq^8dr#Q11@nKKX7#aJlhh8Y-Nrq( zb9ITPWmH2rY+=Fs2J?Se$iuERW3oUMqdN!f@wF0I$^C`gviaqJWu?)#*6Dl9oIl)p z^M0zwSlCKp_PRb+1{1S4%?DTGeZsvv-CtThWg*F(ljYT&s(Ka&-`D?lwZEMg3%+gg zk7<@bm=CS|RdIi*dO-ab8ozkW%}<>6y{x~uJ{$iU`b)R(6XG{nvLEmNFrQiUU}3&! z*QIWoI>s|^)A}2SZQ5tZ{v*z^`ice5XI!6X^V4qpCe0?R8|P^Fr@bpiS}_oZa!teh z((*`8E7>BMhITLib#Z?m{E*%gx?r;nDmLEwp#Ew8Xz^P9==v~jTkgj0k$Zmx??HNA z=X3JM?AclK|6x63{=>!Vk5je&j)ix;xNy{C8#sISbJu4rFn_U;6}v4xKTg zv3Y!R{q%Zk3$c*(ZyQVA(}*`nC!v22d8D|#1GN6jS6q0|*MC0dZI8?Cb$uAOEt|dh z?_H+Wj*Q3u@(*i_Z?MLy^ve7oc0baC-Dbz4Ne69v>}7|pZT4EQxjsqOp^ufpB+EG& z03o?3C)c;mNM7vI!_tOaZL6Bp!g6uOZ;ErYWUd?Votyq|?on5Gl8Iegb<+F#Zt{ul z-hb`L=t6%S_`AYb#_NqoG$m9qOw58Sc)UHgyxpUX4#JJ-8CK6g&($5J|vxTgV- zY}+Bq;KTgZ_y2d#)5GX88PE4@Ww`7chdL{t!vDU_>dtNd4-))3>uF!J&F%Afb|2Rl zW0Kv6|Nj{T!hCwEu44<85<90|^*evzs9Vqe!N9XR-mg#Y0oRMNdW*+`U&mgqjBlvU zwc1N7Efq=DSC>{utpB<4>d>B*PZYPO>haQO^Ru@aHF<{%-&E6f9K2rS`c&O9D`HQj z#(O(CS7=VB`$mh%?&;mw@|L0V*8j%Hq28R6wtcPFN$*Eg#Bb6U zBnmT{x!Td&%LYE#bHC-!uKMOlD~4_JqZMlNv*7j5&!zfAo1eNp-i_1Vr?ItV5=+gEzZ!cWm<3bhDwR$f3_UnU+ZtQZ0ajt`O?Lo8)nNEc1WjLeXQ0b-~Opl zD&mnV$HhbVhV{#;|Lr;5w!hUJdi53$yyEeCx>>!iPt#Rllq^~IL^VOT1P!tArlB3n zWrrQNAHN>87W8|t9VVVMWbZ9jZuq_J?2m#yyY8i_>tkgw$v;o`eh+#_tz#(T_|@om z>oA{ddaBTlKH9?ami8k`q6gML`**fO!=kS*yt(T8PY$v_3N|m%)b+74n3#X$KZLA) zzteKf&AI0IE5!436PPweS5)ilgg1ntT?3ykexCYh{g{>4KRYd2+*FaKZFX5ZhU){9 z;>B+4()fSY5xIGG{P|U(n~|}sTziN4uU)vFW|&5p4=j~^;rY$BtJ{8O%p3iU8PkuQ zWqs8xSbd|nrml~b!9@0l{pp4_Hn&*!zFGCtXS8bE%^8h#m9u8)C8@e}pOELO6@}$l zw%vTnGo{h?KbUdYm;Z9}X!kd3Ycig$4@`*{jc008*lylsyHK(Bi~FV#8?QADA7r03 zP2-ccedx#YpY7R?uRHVGue^BA5mz}U%Rej^$?AQ*`Hi&?#VssJ(WQz{TB{!+54H@n zxp7u9D!uX|?dav%vgeEYartv<-@K@G?O!}pvfVK2tfR1-#QfOxu`-xsuB-HK*Zow} zl@(*gPxj$Rx~$g+(SK-*?(3FMSUzoeij^ByZhHA?a|<^2?PJ9!c+#e0cmEmr$3lPZ zs@&cF-BsKE@<$6VoRBixMe|N&gmx!w`si}_mCF~kGre#XwGiyy*B=m)2s_d9IRi4y;$FGR~RNOD8 zzFZnj$W6R&>B)P&J<|+RFh8;K#PzW&I@x_(xv*@1y*At9w|BL^;OQlPP!eVJzP?9$(hWl{i)4od=VJFB za_xeCOru{r?S&g}9_p8E%+I)F^%jqXuIxx#dUZ>!n?`-pJRV~t*}P!9uYrFqyO%I@wJbD6(Z zNwnaSn}54Rc9vgr$FKgh&NXd!r73y7;`$B)(gm}_@-!RHU}9tZX$5;b(Y4 z_^3D^UcTadLOZ(Bh3i@FnLy|#Z7U1?Bzs@JLVmRKjOV6JxTXB&d(x=gPh6i((fy>L zUew7;K0H6krr({9bf?em&;Nu#n`WM$M1L*J*Se}7U0K<0+WPZq1bP z*U2^Yt(Lu6_l3%nYwBm!oG>dFl#%hSVfj=3Mxk9@J!hObsPD|{S04GCr|WiQ^}asN z?=#MGLUsVX24v1zrChz-o(auz$}dp zWM#KiSK<(IoBLLwyW!llsqdnItmpz`Iy`y1mec}3%!FqFW%ZnCCI{aWYj%UU`)weZ_c<9jV z@zke!MOP5k?0EFOpN6`Y88tI=I__!p&9gh&%gYq2A7|gcmquNr;h z>-{*x^EZE0;q{;W?x-C=`Cmuf|M-?q+v_25@OJO4-q-hVoHpv+_@-P#(jwkcVdY@m z_&KeG?ceVd+Eu5>!~3oBf9QLtt4^uD@Q(Yh@_fMN)?VRyx5ww5>}sCZ)Y>>9*J>ZU z))xWdd#$d3rxCQve~r7hv#le&w@F(agz)ha2>m+xXL0|T`fh1-&yM?zx_#8>buDkO z;Qr(KM4O*x{YMoeWvwl_+BwzzH)#miv_mmpFdf(hQ-9C40duRQ|@;^^AA3IAQ z7lAe)hnf2F*m_lx?E{ULfy|e9`cr!Mk9Vuo)Xr_&Yx~9TRE~VFB>Ki{6(^T#w1;W0 zOm4fUZu2kSxxL+$9f|kiYj|>5Wfzi zETrSUzg;_eJ~Dr;!hEDFd$ziF;)Wyl|JE-&J+~*T_w_~WX|!<+^>MhWT&}sp%(OA3 z;}J(_U-{aF_H}h%^3I=@TvD~3^k1-o^Z>r>AVRU+*96)YmptNbJ)%HmN?*=BHVHRwf*o zYi`jwj5jLN)Y7;1iDgRPuGVS&mK(HKazI7>iW9e*w#7PxGYWIuBQQ?>K}Rh&&d#ryDeRB_XP{Jz9;+sanGy` z-`(Jy6WR{ejtXwyJE=a==BHWvlCK+dZQl~5@9}G>+)nLT%Y*f1ztv0HB+hrrdd06l zv+ArppV@EKdDD{{ApKA5SG_f(w{0zC?H5(u_MVXQ8=Ejcn!iEu^k0^JhdoyPofQXO zJIpv+u=MTvcYUl3CfW4WhBSWK_-1u0$Ykc}KJB{jjfc12SYF_11<|tjF%by;Wywax z{bj(0{iD4ecwonC2S0AZ#l^w>#r4_4=-yw()HF}e)&M%U+gLwAPb(WY|37*Hp}&mW zxVXQVbyqxe(ow(s=DQv5d3*kr)%%fT{bf``ZKGcBs8vI;*R4kl>!>jn*1zU%Qrw>9 zviGQ)Z)iXNm9HFP@4HxV|8;$$%}=xT6sy15UR~vP?!V#Om-8vH^idE9{kKoQ;{Iax z483iGhfc|rR=REOzgfMn&-%--IZdZilzZ7QV+f zaMMCNvd{Gw$j%w}-?Dk#glE1yB2CDzXV-iBKF``Qw!UG)#EG4+Tif2QQ4@dOWIDT_ zFf_kQ}|stq>%e-Ert@?IY z>>S!So3Cg0xBuDaOYS4?Gwx5eEk0uuKD-bc!z3?UoLE8uz2J`ySV4E$ieTaeGIcjdo=5b=5P}IFqlaSR6xiqRnrQ+3rtw zdYpFd%_l5hv3nu&8+-ob{ip06$@_L${nvbVBZ+@^GCR(+jWInyVq+ZHyU_N|XPIO> z$&M1sr0qQ)d#`ja$-a`$O7!`dcx>szG#?|GAekaLUNTK$Enp{0z95+|`I_WP$@P-k zB=<@lkyvBaN=Yvr*rt+QB!@^QOPVA$p0s^`=a-UKBpd4B_mO;Fa-rl7$?KAx1*BGT zwZzVuPRAE!NFUxmCQnzC*e5gyAK~9XpiOal`OC{3gA&i5L=UNiPPNxdhzMoV<1y56=4LpJ|VyUFxMJ&+z=o3t~B`Pay83iGdQy=Rf^ zdvf;3>qh+k`){~E*mYs~m+Ql{ZQ0V7*gM_@?^6#-hj-AYG40W3{58X3?^AcxmYYqB z{~sNJHYMeLyG(v#<%#)icVVB_%eQ=Y@v4KZt22fIPSJ|y|w4g*tTc;F28-NS5A8JwK{(u;raa)sb0|)gsgpW zFVnj54RJ?PZCNI9`{pZskKZD(V=t5V`bEKd6+dyA+?K94`!kPf8ULs}K^=@6 z8|(pKp`(O$ESDYT3zZV{4_h{WnW_rnk=NW3KPmagGdEs)|8uW*JjZoAvU=?nhYmZ` zzfR>uMf%)iPE(Vrye*S+CnN(x7WC(B+rF?IHNUmGu8;q15kI%@hWqR>eES|tkp49jj9+vZJHVc<1x@0oAu^I@``vxIzY*x^X&bF4)w%&O}UEdIVZH#%x;?1 z(H*Awq7YvfvJ;5OoYfBj?nJlT1%#zHNoG1B)jOqI-++$woN zvXz|gD9M$QS0o3?5wDQ+mNT3pStXe-rzl@1ivA$^j&6d^loPb-pw81l{X_?~zA9Pg zZlrJI=z!i+MQmLi&}bddZ*M92Xx?eN^7Smn!T&O|G1~VeYua~{hZ>h)O=(V z-Bl%DJ4*LZI{XwD8L(btBTL=7jF zM5kO*676Uo!;xRuJ&6uCDwBA*u|oc{{TnA-`r2Qfe0Wgx=Qh(J74!>e-=)yMvi--J zcIqDudhY7ICj7nPH^10OkQ6KqtIxSURt6Kh9>e}?`Mb^z&(iokwMnD7_WPvvBMXpq zTJ$p1R_N>!AkaY|EKkdKExdlS_hYuxtSMUzuKVmlYg&mz;#<8t>3#jE*;a7YG_;PW zpQZ9iFN@X8sz0^hwX%5AHch>Lu}F59pH@n2ZfRIP(f(<*>zp>}F)c>V{o}wdJ$B5c z9rX*hBdfP==gEth7X-MYW%q4 zhff?ie8RZl6O$OS?S|QS|JDEhEjeg3c7$^QRd0%19^e6Pa%`4}aAtfXpS|LB4} zfAM3pysoCMkCnkBy^p9;VUc{~enM`xI`)oiY*D*Ra93k> zZp$bCozEFIm0flpVc%6!)jR%=W++l?S4a5 z^!R(1<(k{QhpOxGvx(g`-$P>eBC5W}-@&wJ71q9D_a^&DtZ>~=vcF`oj1z~>JzHgyF=r*U*_rU7D^pi_}eEhcGwsPEp zPNT|n-G8R~SQ$*R{xGawH^a>>Bbpm$>kW0eNSEHxb^YJ$vGfQKfIuOEHvRQ_Z`po@ z*RfrzcI|}iSO*-w*%iG_}*%HbA77rn5EaTf6Gq;PgSextGoEt+}u`e zwLs$OFV3XjRX*~~VdqRdVd^@IEL{sWFVWQXu`-yX=?`sIP0CW9kgKb=Zgz2VnGIx7 zP`aoMMf4KikS zAK-fZEeP3qo_Yl7Q`+`=h>e3%F>p=#VH8CCA^l12qt-mKPg?#O`bl&^p`T>$o2P!Z zf3*9Q#=rHw^WmlD(-!=G!1akXKh65dk-BZxrzpK|s6D@oH*Obr^Vjgc(awcmANd$r z`Zx%L^`yZE759^c@}patw_5AG+Kc;H-OqxZN6SxKA1i~2`H3X^yt`unpY;1Fad*i0 zq4!9uWvVTu3%?1XUF}8lH50;zOQ22Bc{#L1eq(-6DKXZzZ23p{oNL-MpS$PJHFwa0xHKk7%Zx+kSP3+Kv<=#yJUt5icI6?3ew%&2uIk|a(YLqU z;I4UlEg7K48FBD((Den0>rY$*XlPA`q-?2(A0Vkx(4lg#?s$Tf#E|t{=aG#cpUe{Z zX#Te;8TZ@1hZg!x_C3+2A^oGf-}%C$SG2$W55F&Tzj1xm>NvlfGdp-B)Kb}6J!4L5 zUE?VY+BoYU+4>BAktO=k{txR-3*{enzAKBE(ER+6`Tc6{S!vIEEx4bwr20ggpJwY# zaX%S7F;9D&v~<;9W{K?Zbj)8Yjkyx{iuE#7+1OP zMv?3Fw;-6EHvXSAa3%Th@aCG9T*3Xvl;MTfk3CPd`;S#KqiFi!zZkegcHK1T`mg`< zwR7KEGn|rVqUMX=`$fLvkOob|<~BFX|^+X%)_)Gin;9cQI~r(}+U9 z?aH3@zj#*T=w09cm8a+SWc9wjs6Dawj;wEODZGDQII_@=?DexscK+z4-fR7M|D(^j z_|-4OMT6B}?D}!Nr|C(p8a>)1pDCb@m^fJ%pzU=GP#GVhb&zi*l zQEnTSLuI3S&fnjeR59kN=gRU3+>9bZ&-TI+;!B9 zv+wxTqqc0p?6PTAAFDMfd>-CqzkrIk1GjY_sMauedSX6LodH|azsv?r3D4gO*=ID2 zTX*5wkwbQCc(81{Y(3(-RG;0?xCNEWintz;RwDAfZlkD7I~phJ7aWc5A9*@nM+o!j z1zK;x>@+@I<%{ROG_3aiFCF+^nbupd?QHa6*T>3WlC?7&|1CYO@i@@4ni}Fe|Ipvc z#}wL=?XP9YO#1z=kND;Hul~#Q&61k5*)vY|xIQo?Ud-B)Z?f|44qaJQ=x@tpm!(rF zvAJDymU?)<`|F(b5)+B3JGO}xRuBN$GpQ=kbd&VCSRj1FS z@kE^~D<*Y(H=8-bRxz3g?*mgF}>SMJgV;XB~^pUf;BW%U68V$Fk zTC|M-n{Lpixu@S=Rmi1N{yM&Y^wtA)3vQpk-)UPsp5(8VUs!#>^=Y&nvoX1obF+pW zI=Q)~sVUd2PdUxjV6Ve+vuad_w$QEvu=K6 zhhg+uNorO4!6n5I+BJ1T&z#nO?Aveb|4N;88;C<YpBcAhKo ze5a|p=X`I%UzVS9Z}okj4zF43AK`kp$LHSU6&qu1U-m##jRS2#x+|5gg-VI>$bLV^ z*1a?2#iipOIqUNqrwQA3TWV|9+csgyr>icM4Xt{Gt~DNH+u9{8v`IRSdtzbwby{cJ zt&$vn(W!RnMGt-L|C+|U{`zgnc}VQ+t@K@Q+k~Mb{Rw(-n$s6?HO6o*^1+rYLI45~fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf zKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_ z009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz z00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_< z0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb z2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$## zAOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;| zfB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U< z00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa z0SG_<0uX=z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z z1Rwwb2tWV=5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV= z5P$##AOHafKmY;|fB*y_009U<00Izz00bZa0SG_<0uX=z1Rwwb2tWV=5P$##AOHaf z{C_)iEC2ui05HhkdKCK#Ap-^s7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 zV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM z7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b* z1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd z0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwA zz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEj zFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r z3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@ z0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VK zfB^#r3>YwAz<>b*1`HT5V8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`HT5 oV8DO@0|pEjFkrxd0RsjM7%*VKfB^#r3>YwAz<>b*1`NCd0sFIXo&W#< diff --git a/Covance_UCO3001/browser_profile_4/Default/Cache/Cache_Data/data_0 b/Covance_UCO3001/browser_profile_4/Default/Cache/Cache_Data/data_0 index 23532d1d5bf7754f8eae7d80d6d23ac6249554a5..a2d72ba958820f0695955ff822ef4e9dc01e8919 100644 GIT binary patch literal 45056 zcmeI2ZA_JA7{?C+ff1sD9(hS>2T(xdP+3hR-y6C@O(I9wf@ic-~Vv#|E~MG zfA{@7=WLwgtv(GF%QOpLQKSd>g^#|&e^@M+NZ$VtzkjRCb$-`hMjIJ*u5mlb z*Wy*nbqf6JnwRW}F*54@G=2xkPwEVn_YQH^6W8!t?w-}XXr5rwbeXHO<-3rZ^Q=Zc z>NGE{oBMXJy(+1BM}50{UFy?moPG=843JE|bJO_2bazHQfX3ZxbJzLh^=*wA4tGYK z=iywS)QS4l`fiOXegA#oiAEiDo@X8@ zLe9qFi$yJdjoqVs#?-AeKASXO>Xd!F>ABc19_;6gI-kM2NRg76bD<{8%-TJbxt6+l znEO%ZUbttQ^mEd8-H7Ab5@YS^%rBG_Etx+{B3>S`-EU;nnGG$(86z2Q=k=-+3GR$K z*9a#qkW8EHO2^v8sYV@jt`R|6D4D>hv(;ZqMxATiNs5(B$v{Q*A9i;gb*?d=6epPk zd%1o4N_R$`Yw&X+UNWby^sO4~T5j~C&NcWxTqOHGx!TpTBQD+8Q+2*adG8aY&d}M| z$^G61NBE4X^BIdLJtTGNdOP#X?CHKOXTIe+>RiK4dQ9q+rVUOk-MXfiGwP`{9!<)W ze)gQnURHA>$H=Hh(Rd=MP%`;1o%=2JosC9DoyQ+0Jt=c#jHS1>bd~q>Tk2r!q$}XB_2z)cHQPkyc1QX`Pkro|?-{osOC74TkEx4>6>z($BHvkb#^v z_ImDFo%_9)lqQ+l8+mDF<}#BRO)6^OxzzdW(C_7(88X*+=o5iv>Ub*i!<#1>xgT|2 zcQPqg`Wbl5cF|LFnW@v&Iewh`QD-)M|71%)xkD+meN%VY9DPmPk20_!LbpGo%fj%gsSvmpXq|W~?x@j^I8GM2Cp=6$^&(2L*UNORF zRh`G_!R7o)G7i__pv5% zRCm`5^19TSaX#swtZUo4tKavyR{qWzbslF%`y{h!cGjz&>IZc|00ck)1V8`;KmY_l z00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck) z1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`; zKmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l00ck)1V8`;KmY_l c00ck)1V8`;KmY_l00ck)1V8`;{#yk82KLjZM*si- delta 1135 zcmY+EUr1AN6vuzNZt9#aZ_Ac{@(;V_pQ(f49z>8HBBNd^Gm)gcNq?lsK@Sp?*H@w9 zURIGWxq9e-55pB&&06-LMM!1zhaRk?qN1pTSfzB%z2`(-`0g|A`JO+&^Be1*k@{z( z(D*%jQV2=lqksbV#f~3B*er+-Ky>_-p%xnJooSWlGh^ydi4k^aa_HNefmlE=7YU(5 zx-JP@6st^+-;}Ox$eu+H6JG1-pfvJ?4s}fasD3+w9wxMexX>NKb{gvhN1r>k`z;R> zJhGkzrVJ`{HQd;0sB5(Dgw>FV19?GC@~!aHN)4%o2sUJ9Ks*vkfA#KYdT$QJ zbV58E7?K{)MbO{k@E6dT=-QTvcuFe{mi3ftXomeyG$N+p{Vb)l&}R3b9}SW`QkLFh$vffx7RP3)Sg`GU=u zcqfZN#Z>6^s@?+~-lNCR!^AsT1}Y(sb82SJQ1`a>9B%)NJ|_O4u$GT}@n=uZPM2kw zhhyT<`Ji(0yt*>bGm@}8CL@N=qjmS5NJaZ(Gn0u~g`f(`{3=g19$)J-J2l^7w$ybPhec(0n?(D;xsSMTyBT?P0k8< zE{{ghXn8sfw%lb;yX>sX-u8ph3=slwoJ)I$1_y+>9w75Q#$gU%_>m5C5V&#q@H(0b zwc|Y6J4^_E!Z`gMW&uc=zT?GEVRjtn(B2Uw5Zq6wV5kV_!*r2C;tq`4gW=sM1vRx? z%TST<8O*VY1jK3ZAx*7&B75GH1zSsJJ8eQ5)!#c%c*$66{w+*cnRV1e21$e`xO< zO-b#DQ$~WJryFDpC9?w*zJ>&fz0IQxwFZV0wD(#em~_?qHgV@6O|4~_Q{uq`7w^yG z$FDL}ik*wX(@5}J=0Bkfl?KCLZ5brsS&J%YDuex-k_44{pRF{dWZg^>sOt~5(Nreu zsz~t5>hO1IO2xWr5{%T|{hFrKtedrgE0$PkDvR~9Nl?1)%rlzGW?c;l&Rhz<$WR(P z2kDX|=xy=2%uwVJx1%<Z29q{WCfulCO%i$5`w$w&ozWD2y025)WF@?8>y9c+vw9228B=W^o z_y&yYFyG|yZF~L4(cRHuSUa-+Ep1=%!*QBl97sHZt!#AND(yQ}UNlwweq>QiexXF( zlwX!?$XDcwWCO@t!`Y7r0K?=|J*nT0%kE}nS95bW;e z9pN=(zNK28SfyJJaS|;h*^*=yCtX>cp@2B028oznqMPH7d@KGN<*!(jzx@;C6PUjw zkeG-0Pq^|QSe+C{QwMjfOsltuG`fvqNh-{rpqJ{l7*T#pjaFUJ1oM|Q)X7C^hOoMG zq9k$Rx|{~K-0ZYOjlk4m+Pd^M^=i5Io}ax2XLcU%)cQrnWz9$(H88&4J80V&%?&Z# zBeoA+;zYd#+rt}&-5I>b>xJE!;76Vd+J)$I7STWbsO6E9{t2Y-cG2H2?rUYIr8UP^ z<~6123kr+~-<*}Iu0Z&C`izZ6)SgY1m9@%Ln$XSicb*(Oh9t@tNgRIs@nfgN43y|~ zNi6(+E}WH6D~r}#8z{u9@yb|&J%)6*Z9KQ7yM~sk479kk}_xuTwDgp@%=k%X(Ax-la zf)LV5O@3{XR9{uD&`S_fc8NtNM@V%_y>)#aLQ<0(3mLaEPdq9o=K85R7RPJ!;u;~G znP%U?AkSB4w$oB=gG2ZRjx1_G)EK96;%{5FJ0?$H8q0bdx_wzs)63VgAon#1d!tY9 z&MiRn`bG4;x!3-3HWYru`p>%P_eVBgps7!HM3iY%rKaklWGj2)l4WUT_Qo}5nsq7! zU#OAR${4r4XIy@}>Ou!nFf3ANlbxD&DiBa%%%!k4bKp2Tve@QIYkh*WUTiFY{Sh}8 zCW;DBe{{8l2?ivg-DIsxO?AG*$99RN1o{s3x1JDQAB~0;Kbh=Wm-$M?;fKBqf&*&{ McGztH!ya`17wgG+2mk;8 delta 963 zcmchT?@Lor7{|}OJI!BPO<7vb+@`7M`~kHbnM}dv)LBPC-z3$klzLIt`awvc(_V;R z);uq=wAiK@*(F++>=)F;g=P*>!U~HZqV+-?jff;`oqN0Bf6#&Re9z}T-}5}@xelMo z;ZtoJpMqlmuz&${(NHBQ1VARJv_4R!pH{ciu2F~ne2jdJ%=kh}GjS`vwx27CX1UjX zN$Yeddv(zvH*pYj+gX+qyb3_71Yf~ z>mkFiM46^l-;ff5^Z}MP0mkLDr@+NV@QvU!j*$^%x&aOV_P*1ugKVibnaAlI!!Sgd zfuOBmFwEnOf1G8AR#Be{FoQygGvHk}kF#iw*2qRMv8f*toXs(SD02+abi^?Q?I>6u zOm++qoI|ZdX+ZF#f5A+!LBw1HCqVEy!MP&lAvkcS!9{SMi1`R!_sd&&obO^h9PBkJ zgc3#sXN{TwkB!ts=PX3Y{c$m42`75X9s-)s7pd5m09ZAlLS_#F8%8u2c;dwXOkv&)(g$kgO#*Io%1 zrCzA(ux1hbb-6BP*7{>RhIh7fJI3d)A8#HB z#kcInfh(t5gHmkr%Tu62qGq3%S+_P`H+W|fO@ovW&k2luqaA^PIPWTHy COgm@* diff --git a/Covance_UCO3001/browser_profile_4/Default/Cache/Cache_Data/data_2 b/Covance_UCO3001/browser_profile_4/Default/Cache/Cache_Data/data_2 index 9b4cec0b5dafd26d65214a80765f00d0c5b9e174..0e80ecd2c501d04f7c9f8e12ea4cfdee0b34c398 100644 GIT binary patch delta 1276 zcmZoT;Lvcu!SwJcmV*ooOh5<(EDQ{0P+Ad4GlJMaa2i6v`5Y4qWfa*z{Qv*IzJLKp zeXcJkFJ~`jsAn%PFE9B1y}TYsvu`ZyvtQ&Ou&_a4QNf0V4F+uijLQO;41oM)3z!xx zY!Fx$z^pK>fr-a@?g{0WM>gs+sN7XSp_`Z)7(7Bk0`v{_3>AzF3>eB%i;6Sz^Q

-2@l9i}t!F=)An56e6PP3=aT#ejIiW#(d)5Rd zE=D1f6bn;hGYd;2Gt(3UOWlAV_sOrFOtf)gG3gkP9=}7cs#f0b9 zIE*(jRdDwWVMs|VNwvbIWOBepk;&nSF0$AZ7+P8x8i350-qXNjviVKo29D_qZZdLA zUXrCS{lrTqgUw&Ecvz=RVB!&FJ(c$!JI9&k8B+VUc3+&V3+49uaf-9N|e1ISKG zC3gf3(uqA`T38uvmr-Q;z$dy;w&x>A<5rGd1dY#16U*(gf=oL&wqMm`GG`Ml3c2_R sq@RuRGJ?jfACxwro)xs*{u!jRZER?;AHrB10N||BnE(I) delta 701 zcmZoT;Lvcu!SwJcmV*ooOh5<(EDQ{KP+Ag5GlJMaa2Z0u`D_y#WyHRJ|NsAgeF6W6 z|NlSN7nGN?m)F;`mv79QWIu5N`yvN{Z4;Pz1VjUS!zXuc)MvQx42hnuxPbZjbb&=o zB9o&FxF$Ols7&TA}i|FVji zhjmfGhGi3&1r|-wnmhQzV~}O?=RTs)&CCo89w8wC`i6Rj3PuJ7 z3}vZB#hLkeR+dIark2L07A6dn=Y3G#o>jm+pJ}ptfe@RKm4Ts^@pQ#vW(8(LQ;W%V zAN8jf6*F6IUsKFn$Hi#8UAvC?A){!M3fB{mg=hXD(bE+hm?c4`utQ9-oSe`gzCEjf znTt`#*woa*!obMV)FR0;)kHTS$bEWYF|+vgxf_|2`IaqUS}?7FnMZWer|@?mWBX4< rAZQe0O{|QKP>oGavPeubPBb(yHbyeG5oBxtv%0lLJqKsIHv(>mwWW8QyHP zK+uyF71YFh^Ye5R3=9>#O7j$q42;Ya3=OP|%s0m>>|>J*DNO~+8KKIVSs58kH&bVv zCux|PVw`Ic=~HBx?4F%u5*2Te>F5}koolf9zq=;aW|2#8dM7FHh?+Htz5?0pCM=Gi zL3T@GwcE_f#AI`V!frMR9M+pmH+5&6541hX+11R#EYUHn%rrUE!Xzuv(a}3C(iLjE g(HmY+2#n&orQ0nL^kl^YYLnd^ zBsRw%*uy3noLHixU~Hh^n^>t}WME{bU}$J%Y++?!I^E2jah_z3nW2eSptDm|SaN(& zX|}sxu6wzod!~Q#=Kt=RT-!y87~k-2a^PtYJyF{;1!UDr;XVWnwMv}H$ZT`Mf!%EE zP}?T^EfAk>t;ui3x%xkOZQH1R@{;lAGO0vbfm|`vL^Z zn}`Y{lFh4De2PA5TU#koQBf;s#TSYSRIDgcYNb`QR#6}bmHy71JNp*O=Xw6s5W;tR>#8Wva{W_GCF7HCeR|SDor<^f+9;oXiH?k(bYECgj%G3-TxA z7T9X8%gd`B&uVh=?AiHwYHn?A<`VCaxZosV_!uZ~Af@+1qzHX>#2(-K?dSb}oWEI; zitbn5G4J`lZpUc7kABM8v(jP;Ew86nXVX~^OaDG;ic(Eo85Vz1Mofz3X}LO<`ele9)=YF|X2~2Djbs#2~ZPbazkLTA7sc>AOW9;+2NEWmO_BD3Xkyk~B<`4v#-C zn})_dnPD8`f=PKi8K;NFcgd#1b?3Xxu^l%KkLfYg{KTMPF>x56^u_=jEioq?Dmbqs z_Uh_LAFn9Mk0&fKryMF!lzzC+gS`+jS^>cEHLmt z9=KeXC`&PrJ9F^^ADNjf{pFfbAh+R^0s#SJ%X#Zk4XuW{!iSwCNtSJvFXB4n;gxk~ zH|M0KqQ~a<`rHjAE}zHU*i`Cw*?bPS3)edkW%ix+S2t6T`Ms*As7`hHZdRLk$EmRe z+0;>|`sNsYyd(YN>jS;e;bg8lKdV!515kr1)&1ia{wy9HHn-F5DOMYO_0&c4p!4)M z`w#cQiCtahu&L#0gWJ;-yz}f!KWnE>%vBuLuiu%xf3uUYjgA$nb2fwWVc4_pOk7Nz zxU(|YkMj+E zZl*|P%a{Y{%c({W1BwsKJhn`ufglzAr?I+Di%-@jVW7{^pssYg)QZ|#WJ1Ft=yX^5 z%6T-vt9rfAwaVxA2qz0qZeMfni{vb)+s2$>-F$KW_Db;!v}z8QU0tEti)*-o@c-(& z?AZzEV0QZywVo|=xIKJQzBuWheSQxi-HocNnE6-@^NM9fgnU$Z?*&?KTcdxf6M36% z<8$?U**SnZ8lB8n>-IG09hl3s@Yr}-6uWz-+jonH+3w&|>36L(ubkeKaLl!gaTwW! zK)y*^*iLc3T&<~d;s);5)45;2(%-l^mp>|sT=v;GP(7+{fsW1jZhm7N1~U5;I7Xk4 zJN&Wyh5KoZ>zQ|kL$%KkQ7g=V!#~}%igaxP>|zoqjw^b-!^XT24fL@Pf}_gq@u^58P>8hc8c;={;dA?K^;Q1HM)Z<}oN##H$n<{btY;qka^_K| zx?MKE$D_Jzd~ahA{CoWT=7)rrsv=_Am|}a;nM#_1+!z+qx2b}(-Iy-tmrHE&4|5>H%N0DHP zgW+sw-f=ShC}|G-En)uAHGel}*h{oM&^eXIdTFEHvAyMi^|X}em`AaW>*zqXiQDy5 z83nu1(JkK5$Ae*R!nzDWDAMCy*n8XHBRfSxn;sSKxDyV^eE!JS!d@{T6z?4Uz>B?9 z5iMdsg_qxXeC(!|M4X8Z5${|npeLT*~qs%%0{9_IFTS zH0IJZ=jfsA@RpVE`4W;JEu`wAo_VX5*H+XlQEk2%Ze}MQA5fF>uWGSx%N?##+D&CH zua7yMs+})g&4pnXXmybCcyF;|*-W=x#oc%~-mr7?V-);OAi+mcDOP=$f^R!q=Y)^W z-BV6U(^wGQFzSTH$%o$CN*b%oR^MT^zIL()Ph+>AFZzI<$1CzC6xq41$f5nzlYJ=` zaIxI)^f?-xw1bc#Oo0j*VBhNY zkRCw9Zar{8AW9n?D|E#1{nIijLV$n+>&NBf(`c$)Q(DsHlnNVF7L=OQOucYm9#kQ3 z8MoA9B3pDw~Uqf!ww~j6o_rL z#7c!5<98%jXN(3E>lbr^v4zA(A zmgYc&o@CH-0@tGJc|}|!TLsj^2Cfx2cqZt13Y+HzuJv+elTu{1wZcwbpuoXbtzd1& zc7W`Gja*s97o{x?e<9NNHW=T|T}ZnJF{Yo8C&-^G*hbKL!c0!=UbK=zy9F|!YaBvS zh6o}l8#F6FVM77iW&qn-S|j{P^S&r>ZI^QZA^Ey@aHVzVTDBX&;|8=D&~UGkWiJV+ z9?vQ5Fk2^3XQy#un0+@p16Tu=Ltpi7VMO!3ERbT|uYe3F_p!SHd&&T|BizF^B&&WW zaP5~fI~4=C*`3^MN`(RCe)cASsaREgaiaDRCDd00R4h#g%+?76Y&K2^N2}e;asV5K zHRZt8Zf4WtW{*IM_zWS_!;xt?X;Io(8DPIOfE{h^5vxt}?iDzZu;`moXqOX`o88RK z)}arw_W)dsh0_-&3QCr}DxhL%I)T&)WI(_;AqSD!TiHs$6s#!+wskX`vde1%DWdWU z$W~<=8w}W!2C%ceBf@OTUB4H&%OVfFwF zdPCsEHjG?t+^ny5OVI2#Wd~~kFcAxVb^1F_-uq3L1N&3_pf_KtvxKnf{H z&p0(R^v#eR1!x+!oW2?d0xc1)8;arY3Rc7uSAROdu+Y;1UgI0*AhUz_PlMSJg&c-q z?+K(>UV0=NHd8VQOXV~}yYfDZ#|C~FjjP%HIXfJ~4hm@4b5>906ehuBPC?(Ue8`>w zY$UcY2Sz_Ocf=2xz3qV{8g=ZyLzXs7LqJxaY7yimZl5Vno;&UyTtq zM}f)0dh4rl0<7=~bR<}R6s(8})Nms067EEOqmu(Vl+Rcxh-C;W*@|j3SZ$uqeJziw zO^RLJ8$6`KCme;Y_appa#g+`KvQ)f&Hom2^MVO*sGNu{S&L^Rg_rB|Pt&A~alC`*= z-|ifZYxH@?{iQojD*UGLh|eSyp78zA4^@u)4=lsk-sSf-K}fyEY@1byvAQ!pMA>jn)5#EdcYA z8)02Uso%bO-)h+R@#+uOP^k|Oko%j1&hJ{iZ4Eh}KHR=e?tBaiR=qjs`jb#ej~we2 zi|Fs!cTi)}RDB}KZuEI}gM4m-Oj9ZPM6KAD;nU<{(1&80h^=l|PS0g-xn2YFjf(Q1 zi!H!ZU1(hY<|u4F?m8N|JXffIJC%zpsaTS>pmALHtzH1&M*+c7q#;Dyy#t_gJK!p&FQ;<-xL= zYK3N{r_8p4^_jtI=@tl+FzypU>{eCN9uE>J$u%qSGW!9vv8BTD=&~9cK{_sYmo2Nw zn_;<_2LM()NoM6>K4NfNqRMq_1nJL_dWOni3Y%auPQ^(;NtM}4V4X2|dSM+Nn}}!W zgdlb+tS>|CFSEYWB&i&YM-f%l;k-id{vvpnt*nCyRIiK4xl{_L$;=Ms_Xf8$id%$n zpGN8#s)T9HgT*zk50wm=#ZSlPLF0PrwRO0rQ*hH?1yMw2h)ByE2v2nM+QE3i#^TE) z>9%q~Rz}FEh{MU)u+nFOEYb>pjS-R6jki6ejm!mUw^QOe~gPzA<*EkKt|t-M&K#ST@JwAiy`_9Cdq4RZH~Kqbik6lAe`u9#fs z$m}9$c`Jp<(GP)H;C&ORX^6+YX6TrRkpX4C%qqZo-QaaZCI8tN^{wFPsWqyA3YHOi zYBkD;MKb#=JX_2uQMkw#k1$`7CAiKU00B)h+NsluG6#hejaOP_)(ZoJi?%-*6f znSF7!EN)=fjuLwmnDML0{x-W|{iciZ_KR`?$~MzBo=^GP^{7ea;qEhH65g-BBMWIv z+NhcOYj`#lQ>(vL`DNA* zJe$F6iy|%r@w_04bVbDQ-xI)K{L+DWfoL}{N>j9IivapTfJ71qeQOHZ$$wD+JD&uo zcD-TeDuRW-^1mIh3z2RM!6;hz`ift0u$2H6Z8l)*y05}w+;LIhI!ozyC#9Vq-D$?v zahds<*^qSYwdF6oZNc%}lG#;d6*Hxz4JIpfq0wgxzT%zNpyfzYf779RP15LtT8wO( zcutWuvk5XbMzh2~_AqNb705V?*2@gpyQdZ(3z^VM>tlgTjMtKSKqmLm`u2oONzzi| zAp7;zuIdG8P1XAMh8%E}HZUG?P=75g0Wy7{HnK(2SXN4){2HePPtK=ngLl{q?HVXES;)N8wNSO zL@OH(dDArQ<`IxH%Cz#UA!pvKRg8qJEZ1g@f}CBURgH$cWtKK)4CLG@ZQeDIx6aY# zUkiELJZ-^P$c6K@MVXMdFVGfeK~^u)ST>AFL6UkBOPpe@aZ^td%|0iTE}J^?k6Q>!Hs6rsolNJP|g_ z@v`MaQcw9IT%nSsRgSf;{qMGZ)d+pcJ|_N;_9y)#X&mcUuKY6w1Y*eipH9$^|1Ur3 zJ_Y}DicX4w{l@Rg@X7=a9uuxSBR05Ixz(y{kgZBUUWY&EdICqg(DtDnK|6_d2F+}; zDye8A&~njA(B`12XnwQ}XzgfEpzT82hjs+*B-$A?bBt9HbW1z4771*lhMl27NIqmG1WR81kfI#lc#a88|`hhBWNelzD4_&xv)9~ zUR)7-zzRI z?!%(^&JyN7|Hg_(i)tO(Ccn2H0_oPo+GPuJ4p MQHi>#p#l{L09dvWVE_OC diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/1f3f5d78da75e490_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/1f3f5d78da75e490_0 index 3a7de3e3e88859da4b86a5aff358a41f95ac319e..405fdbc1e22fc4281b1813ae7963dc4ee765c0a8 100644 GIT binary patch delta 99 zcmXBBu@yit5CG7iRT@F*JqhkEr%T+s${yBX1BC??Hpn1mP%9Mvf3qWB_qi(WC!MXS yS7Q)J2m$(NEp`+cgBK=MRuwn(Fa#jAHi`rVBu^yVF^G5QFyfY)@*0<8HopX2N7|%FfcF!@mUd`nLr8*YFh#sL5zuSba;{u3-hW#gc$(b C5Dc^c diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/4b8939c9f36bbeb9_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/4b8939c9f36bbeb9_0 index afae5b363ac9faba6398140adb62c77ef33afe9a..5eee74b2feea9939c00019e3c3d78deac8e1db21 100644 GIT binary patch delta 150 zcmX@dxQb~)QN4S^gHJ~`>NAuuFfcF!@i`HmnLr8*E_d-Uf*6TF{17PV%fi6G!p6X$ z1;jIe*oB>ep^b-u;VBR=mSJG9lx1L0kz-(p1Y&V{28K029In8?a7>AT;jT9W!`=!8 fhSigSVpA9xvVb@|h;ianU7l+mr@I?~R)7Ei^~N2K delta 58 zcmZ3*bdGUCk+QwH{`=02`V0~b3=GUbd{%^KCXfOHzBz%6K*q$6x;#ft-PKir3IhP7 CpA519 diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/5be62acc646c7188_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/5be62acc646c7188_0 index 1e5ea201cc6e9ef618ab5db2e5c096892fa883fc..df47dd08f0ab3e5c17a77310f9e63dde7e89a1e1 100644 GIT binary patch delta 51 ucmeywe2#HKm9zu{0|PSnX0W?#kToU2 zP^SozI(y{AXMdreXaRX*eeJp zFGBfMXetWpCE@%-xO6GrwLXtxS}STHQ(^bDE8>1deL#`Zx*8M*+Co@yp}8Z9nPJ7; itYXY-<@wLb@uH3X6&p+1>4t4>E9mgPZJza3E`xupZcFC? diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/79fced940f0d6da1_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/79fced940f0d6da1_0 index e70a03a839876df1a393165359ab23737d0ee906..116ff1409bc2c3901ee0ec038fbde5e8c729e776 100644 GIT binary patch delta 99 zcmey#xR7bWTpxw>C!daN)MtqCVPG&bb#pT`aHgPpHbhUJLGBcfcP={w%Y-kA3C@=s3p^_Pp delta 59 zcmZ3;^pkPITovaw7#Ns=_^b%eOdtgYKV}Cqf*2ED>hR>UToYG;2r~cx D)~5{p diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/8354ba6fce482b8b_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/8354ba6fce482b8b_0 index e0672ab7ca19b37651ce524cef8c2a5f60fb24cc..2fec1387b3a29159d38e93cee564d8918d7860d2 100644 GIT binary patch delta 91 zcmZo-TE#SBolC_R1_m=zHw#lsCnrm16LS+IOGh_D6EkB2M^_6AS7#?@7YkEIS5q@X p6H`-XXER45XEz{iVQA!NWMFRT;%4UJJn@tck4j&`B_9R|003H+7PJ5W delta 51 ucmZ3*)WkGlos0wn0|PS?V&(?l=$GY{ z0c2BDn_6G<3qwYwPIx~%J0q)QSlIZijL@{Cd-$tu1lxzsE*-T?{w(a=Y#mj2~8Wv4~QEQ zJAPbNgsA>k?*GkO(!NGs=kym(EBsl&|9nQ)x%&9qEnx_+1ythujto~=-@FJHks8x%a)q@d)#3WB#ND5u_A6`Z2P9o$>2pz3Y~ zu?G}%Jg1<5rk5zFbDrnXzbWK`g1VO!d`mxFR?znf_fx@D1$(Y3*iok7{B;G7ZYX&2 zK*0}>6_ioha|Nw`R}fdO;BS=r2lKsB@U(^t-CQp8^SJPu>T50>C4a9A@zlp~VTI{J zYw5z<^;}p?L+iURY?=!hE8O^w0`uLdOEc*ltzGHHK03O}jn##299!o`uk~((Z*b!! zMf}^1q#`%k>|z{6>~>@0eK+ENbK?Rndd?i>ZZsDjybSRmxt|B4CU`J%q6dxVc+g_5 z2M?*zJP!=oL6vhnD4Fkpw!nj~begK?dT@2M2l*d+aD);+@gT6!gIEeE^5Ebu4+{5i zeV+%VbauZ7FD`p<^d}Gee)eEWnFrC=J;?miQxC$Pc`%%=zxH4!R8+2@LI$X)RzpQB zRZvu1Ak(E{nW|!-rs9mD;<2eB*ix}DL`9EK6*&|frQ!i?ZmJ@>hl**mAW_9J>XfBo z<`@;6Hqp?cnT9ds-(Ev^THZlJr*0a)jL~qHx(?7#b)bgM zRO?+0S1EX~hRUNf^rTP5YPdx+XJ|M|`*Sn|%-7KEBMqLV8n&#|FkqF2^#vM6Z`BaB zO~ak-8aD6HaQjb1T-&MPz&Q=`OEerK?_CXT?`g;i@ZwnwFDBRa;-%)rY150^mKWpV zz4(gy^z~v%e=lYwd!eLx5l6eSy?8-SCV0_!q8Alsd9i7(7p*?@Vo2I!bkL&wcpIvhnu zv-&!Ir>F)x+BMP<7@{MAu0`qirn!zs?RA{%s$+L|9px00q@#ASj_%ZNqz+}2jy+jA zGPAjNjE;4abbLKU$Hb{R{!62$>8Lqf$1gK=bjs1;o3Eo6ZKt!jI(}HBW7AR{Da&-^ z(ey$cO+M8zoCbc$y+zzd^^fVeLC$fmo#HuEdR0e@G9BrZc$??n(ecIu9sB4RmHwtf zeXb*@ih)7&#ARS_pn)T*0e{WF1jE2epMlNNz%?2YY`|03Kn%Un-M}HL9Lu;~2IAuk z6i{fo0VTsg4=R{#AbpO3E%f^$1BVwI@cYQXFL?%vRv36rlRh&L`?-NRl(^ME&^FdW z?Z4t#UmHlGBi|d?dB8x0g9gT3G|>B!fm~{H*T59=e{5j<69c=bRW%=~SNEX<_4E2* z>pl#o=9UkBwhz(tXn+r^M*1*tln)E3PKFN;srd&!oS5#z<{3UbpdRad$XxG3*#;lX zjf^|v!%eDl)`yg9K7^F{5dX@D@`@(z`I%T;)x=PL6KklrmWjEFiT(6iH*rFm=<}9| zgisUtG&sUUy+{*7Xmx87$!$#hlcGDBctvYsP1NXVqCHhjGSTyW6Aee17?x(jm2M)A zYOgf$6Zuw|DEh=iPN9h=>r4c$H}RCB4w@KGF_%nyNGGnDxOv?~of{?=+&1y^BNOpY zOyts;3KkAmvf$@u;U9q(V%-+z&=Ze^Gc7IDinh>dfQ6j{E!;@3&?wQusuT+u!z^s1 zoG}&(rdW77)xx~(7PfzB;r!PYt`%E|+-+gRehVKRw~&0sLUf6R>`N9lU$OA=nuYK( z3!PtBaKExJ+0Vvhx=RPD*w|9lMl*jK9jnbrWY)AX$Zg{d!$wtMBl=An!HsM* zjIiZLCS)T9S=P!)>e|Z6hMfM#2Oe)u!5LGRwxo#f;Ch zQM}s5rnNTiZLo3fa~qGh+1R<0@q2BAeQzW6sExvtHcpnY=HRn*2O(n}ME!%YvmK<&chGi$gS+%j zu7h?99o(ToiySj;gG6xOv9V{+%@bg9of8Xk0@OB4_b~re_%R$K=2W|E` zDB8!h{SI)zLH7~|Jub3N%Dd#iDRuB6t)?nJGcUb;g?p*%RrWw>cN_#iV6P7yT%i$< z9LV1sgwe-z_67I9bdXx^;1^2#!@)>Of90U!YX>_hw~|17RRN=#Kj1 z=v-Hz=9>b`sd+>J*kLt8Z&njfs53=slWg_ z&|JV3EfCm6U{h~_GgKp9pjuy^H9(+8lE7FBN*3slBG5Qh;3!pjPoVUDflnt3^qwWq zelBy)6PT4Fuwk*lb85XzAS+Lx*D8Sqs|BJz7C2QPaC)Oa@V^8KHwl=Z39R};pu(2| zxzw$Q`F67ZU96pCvA_u`r>?sNKB9;{?1i+w0{-$b%%@KiH#{{My z7uZkVo)Adg-c0aN1GJ(s~<+{KEdPJ3P@;6PoC6IAj;2P<7IU~xX zsCxp}Y4$I?kNZ6T0cS&nbd}VH?1>gU5;#J29}CQ&@F%R1ik=GoJ;%BJ##vL_=K_c5 zDaHNHdA;CVY4%ITlnbPE^YUdNUSU|&tGCnHHpF186O~VgVdT51+^rOP+di0vWw4w5?$O9yQ#THqLWvm zo-VP#C$Y$ssAEZ_(hOVTM>^s#PDtFNkRXZCbtJ-qCBCAqbtRJDlz2*7eTlWSr-8() zh7#YuC2_D3bB0J1(=!SPm1s&^>8&scSGdGUvLYm6Xj`PjEz+WRW@FaUL?WdHXF%&) zvaVLlOX1NHTgcU#xu|wqi5&WsHnfunY|lDr8;K4QCDf;*#335dNn!_$=**dPkvL8H z-6S$&8QYV&dr2IQlQ{RbM5TDnk%si)o%EHs*-v8O0M2+IYofA265|piDke%SrqFjK zHq*$#d_RP99x72v{z(#1G??bmR=Px0lO-bQU7AbV=rT=Ck(l|O#21u3T;hij?0uBP zJ82Tnso7|W;dGM5{f&1)Y3Zzy)C`FZG>-CUJ2lFb7)ANCcZ`JJSUxY22wo~Nkrq(_ zeL_o@OH9b;9siTL*76SN<);!4*GW`fFOfjIia4i(68ldw=9I*H7ugT3dnVEDSBWM5 zK}c4DP_75zuo;AI(WxUZH#o7Tduq*1<6A!1=`26mK6iG?p(@*_waotN{KCKf=dJ`` Nv)?8yx)vY!`9BByWi$W) delta 59 zcmbQC(7-fdiE^Zf;rq^w`V0~b3=GUbd{%^KCXfPyggJqXK*r?z{JK1s`KHUMK*a&3 C3k&N2 diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/933a4257bd9d7793_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/933a4257bd9d7793_0 deleted file mode 100644 index 7e836a4531899361ca212a72465a1bed4992b417..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 289 zcmXqrDOxU_`}+?o0|P@Y5VIOxm;j_0;MpoFu5v9p`0g|VZvo3X2*k(;xzv#Xn_+1KMj w$}2gw7R;MxJTv{HLQS)c%Qmg83y!|t&~b@%QmqQi4a`9Mub#hh-UsRq0RKf?b^rhX diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/a0ae8d57174d5be0_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/a0ae8d57174d5be0_0 index c2adad9957691621853f511ed2ea83f0a14fd4c9..f1d9f2fe7eb9ccdfcd54536948fd752e1d17bc26 100644 GIT binary patch delta 87 zcmXBBAp(Ff2mnCWeTspxF-CI;%{SR?`T~DqvH757gLggjaBOo`6_SYHK#J7dt!iS! if-y4yWM7JbC6Ag#h*f|<1e*{guID|C&;DNP@cRJzQ5Ea} delta 87 zcmXBBu@QhE3;;ms9mN6?AxS3*a2C$w47!ko%Q%757XEkF-LWrN0V-?Kk~9lh#85DX jrh>pg!j^n9Wy6RHelCfikugglA0(gGG_LP+Z^Q2c2;>%P diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/bfdcb80b271f0023_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/bfdcb80b271f0023_0 deleted file mode 100644 index 62697a75d1c83345cd7fa73cffdb45f73c33fcbe..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 292 zcmXqrDOxU_`}+?o0|P?=5X)J%dH^Yg`0UimjFOUqVk>?9isAyjD;K#U{TG$VD4t@Y~p5U;p}GQ z=IG*NZfWk~Y~*ZdVPWLrWMb)NZ0u@bWMS!OWNhi`>g4F;W^Q2aowwHgK3OCd0RR91 delta 51 ucmZ3?^qXS^=JrF^S`s~++7$ss5 zHF6EM>rI|l!~{*ODH?mM*rQ@Mb`zsS-*n;zc6T2>cruhndupChlhWZk=}4f+W6!ThNSX)OnAz;5u=BOrzWI+n2?&D zHa4^2$c#4QTg42DY0^Xj&YNc+xLlx@7ysWszXG^yY0L7{4lZ6#HNiC`^FE7 z{b)i)q^SCL?fWwt{xF;bR3m zsM{h1y>k@AzabCWeUz-SMcbDf+r6Y z9DA&wj7C3K(CQBb@#P9WpwvHE@0Eh5)m-T6a-p}!h1XO^bKwvLcwI=Oo`ws{Ocz>7 z7v8DuLJkeCA6jh7Vp zZ#R-l+-SX>aTK}JjSctRNc`Q6bF}z5Ym~duTzK%Zfd?tQJs367gOQUwXgt@07V|uK zNR{S$V9-{ooaI630uQuo54zAvs=CmFt1CUo|ICAfl=Qg=!G#{gQc#Hp`?q^gxQpw1 zJh(`w_j>T+k_U$_d*Jtr2UE*Dh`#Q@*uOmWApDsJ!|3{J54J%?{H)@CudA4PM@8g)=DtvI zRM$|+(9lb0s2QrE2epmV@O={vEt+WZT|d#_$BURUi<71oH7zeDBzo}; z_3Y)vl0II{PVqt+?L|Co&-CI2J(=i5<4ImrobAQNd0w>q*o*!cxRuUhKN(#Y5=mBPmG7%xXGr*3jW7I-1qd z@driK)zP-Tj^GA52GF%A9p5$A@u;1SGhKA-?53lfVv=>#OwrMedXLnhjMA|yL&w-m z=8n^`cCwCdr|OtAO~-#|%yb>qXXyBKmX3~DI(!Rs^q^uoy->%o#X2_T>KL+AM;^^6 z)X`*(j$zdAYvz_PkLn!Oaf6&ATsy&i=;Bo!Ey{GHQPOShe@Dj~4|MFIXLRv*9qMx( zAyo|Yrzb80yMqlJR1E}Z1|}K?mir8Bk_N8PpfCfTS_We1jcx{hqRO$1>tP@<-ar90 zOf#UQ8;GNVIR?_^8rV#KEH-c;$AI4_27b*mP_oRxbDI2xf!Hq%%%!9v10h@33$^=( zdwpvlnGXJFVB0U>( z%7>d2dfJB}*L-MD=0oBuAIdA5xaVgg$KS-@028ZdM-3D66cc;twQl05G|}@d69XEW z$ftpkCTce_F^E>SGLh2S#6Kyzqls6vD%M1`?k3uif3k`0!%fs1Wn$=P6RtE9@l?CPHtR$i8jjmq#WNpO{!k zrz%)DP|1RypM`$}TZnaAm`hJQ7EZlwp+>ZYmVGU3>u2G{01Ne#EUXw}A$_QY4U{#` zLcvrEPp4U!Uu>cHYYS(;wQy~Rg+@CqjM!`8lOq;VPFaX9wUBwi!lo-0US6{hQD&jj z3k&X77N+>wxI}kpUlkjh{cSW0u+bsV#zh)j)yCNBHu}45ykXez7dE2bv=LU{M&m{{ zWOL@Wvhk>cjngqUCdJ#B)62%H0bEPAF?pDcbz^KqX4n`o(MI4j8%<{0Sd_!~JR3V! z+Ss_-#=Z46&U|U(@fI7~wlRLUjqo3Bq#m+Sc-+SEQX3~P**I6mzV5L8L)QPzMxAmS z<10F-AK>7#AO{Uy4t7Wfy+Rx`d((k`9S7ce4i>!Spg7XOr;QvOY3yM5+YT;vU|c5$ zR%Zvx=t)-xt79Bgi*u0F!$Ew!gIWm=Hjj4jMVf;K;~hl(gRyfQ3|ZiyO}2x(^zK3j zZ5KJXL;V*!cuYrg9L!zfVA4_tb@LtM6gv22gM~qkq)Ir>N_DOjc95@#pd`v5;$}g--?_6Onb-Btj(C9l3!XEIf4;@^g5sw_m z-yMY0XLR}n^ItkhEqCxMCH?7OB&EG_Q1P{ct+cR`K%&2Z5h&0qNML|1P$~r$hY575 zB~blMflsMr*2IJ`qIAU z0LrU)d=7HBt* zHRlV=&JtLkBk-JBEfvVf6X>x*pzcb6=+6XB6bPK$AQ1L1fx?Xf<`)7hz7nYLwZKB^ zTEcqUc>e9|o#YOIqf|~^b_#q#k-K;n(sm2{igN4HeQ=QXle6l>JEHAk}&-Fq0ylutzF+D)@VjbN!vOrZ&$7exj!o z{|D#wf^(%gFBwxV(2}D66qrjJX~`>r?Zi$`L+#}J^D^XjQ z$o5GrHYGwWiBy_tOZ-d+9mWZXd($7G9i5>Kef*MLRr6PJOT*4J0ah$A3i5S|_Na7Z0QQWgJdubvuqy=X{>)vKx zEm@Z$q9rzys}*Ze%{CHQ^c$^jD-qm|ebN>Z?IlX7X9tO&XhcVetu&$&XVO{XB;|LN z7#qvj?yTKI;y}E_nRg^AC3225s3-5Fm&DE95{vqB#{Jk6mGzgHFhHVWl0*(Qd{1H% zjU34LgE;5G5*H~TSt5!C(tIkS3*?_7(TLuod9;Nt(Uc()v)-5ZiZX{u92>#2kCJ$I zw8V32Hb!C?9j6H&@GfX{8ha!)U7|frpgbz3`eP+VQ9kV+C*e1q&r2l2awR6wVk)4| zDfd%}iTS+af3ntU-XXnQBk^#pMCEl71892*=d@p9?{UVQka+(*&qHgUNwobmfK`hM;)zn$RBS0^cc4I99dm<$*PZA2~O?^~&sRlV?8LzqoqQn!o?&t^~l` MA2lMn1|RtOKObFWRR910 diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/f1c90221f3458d8c_0 b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/f1c90221f3458d8c_0 deleted file mode 100644 index c75ec79714a42655b5fdccc48a452a3bc30d1a7c..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 298 zcmXqrDOxU_`}+?o0|SE-5Lbs;P6JX5@!6@B86_nJ#a88|;|zA%D}LjsbvB2PLu>NAu8#h8KkoCwcM zn6wy+KUjGpP~ag@(wBvSfrX8MK?{gy0I>@@14A1R1H)4wUM$1FU@6PMpd!b>5DCQM z@(c`XfH+)%f#H}E1H)Z!28O*A3=FF$1I4B=Fk}I7cn~84U(NlrE$SOHSktbH%(`xx iF86g&oD}>03?8L7!o1?u!Z3G(+!lIPL9zizg8%@0mq_mb diff --git a/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/index-dir/the-real-index b/Covance_UCO3001/browser_profile_4/Default/Code Cache/js/index-dir/the-real-index index aedae5b6aab60d35b0d6c79e39901988793ec1d4..ae8ffaa6d400e78e12e72626a890bdd1a835b026 100644 GIT binary patch literal 2856 zcmZ8j2~>=082;5Q+ElI#qJ_$Bqm+nf%5n{rX`z&2lA;CKDoVeEHcW`_I9ZCTLS$*5 z{3?w~i*A(G(RwOvLblxH|K9tZF>}tGGv}G_f8OVN-{*V2Uqg-{`h71?+!La)Z^wb% zJ7frgIQZ|E{@8o}|BI-W<^46-exrzds5um!xqu)vC(!>nO8k2J*<3dPv+rm>jq}hW z(RR$Fn$D60>UQn>lK7? z!}=yZKBh(`-R`IHc!al%b-S4v@`U8{E5kH?4&f=h8Ogd@iPx#F^8=#m#|tKJ(_O4& z#q3Z+{Kne!1J*~XNA_NsRZK1NeM;*A{$~cpZW}qThp|r3&+RDTPK>FI()^OB z?z|V|v^ig_Ct>}Cs6Psvw{3oTyQN8g0iWgv9-p$!^)ZaI!?-`7Key0tw9GtuJt6Z4 z;+H`DvHEMP_T)JoCvzlnX&$IsH0}^xE$@`bBy759JOr)J*%a466I{=ypzEv;JGN~GJMxvWL{ zPbQyHUltJ=iTf}G;o+sh!p+V$`>0A`Hq8@+@bsG0pac^McV@qQfhfP!I~B=2-#r7! ze*Ym+pMCy=OI)#ihXX; zBug6&=Ki6d{B}J+LGi-C_YkZf=CysJ0k1{D)|;usMt+V(JoX_5&wbJd4YAMjkbmYs z(l38lob>?v8T2SB1cw?^Uha5a(9fdU36rJO!Y@(l($IY2oGPDS`-FJqn~+hJ??mU= zYBj%_wUgsQTDu|tC?P!~_4zB(c;_}U*P5bp3Uybjb2EhnPaBxJdIO^K^)lKOpS^h% zi*$~u{&A9%coLXRJ#CzEh)fX-9NxiLO^A9a{^cM3)4czAzC zvs&GS&*aJBpX$2&BGX>~^>`ff4hQ+%7U@6s;laAV*yD0U`2g}Q%=f-;Ioq-R?qw>d z5#<%sP2@D)S2Y*LGoR@7()|fTJbpSHj}q^BpUF*Mi)lUQ5gz$vl1W|VQwO|$J;H^j z>yo+4dRf?SuwRG3vV?wx3O(F^m{*0i*6$^9sUzb25^b@OHT&B#ai2lw(lv^*ZHI$0bF!G+*2&N%7AZcJ~U)iCF8Oa#EA8CGRxUA&1W?@K0Rm>mC^rv;&`a z=$pKLH`%JiSV&B@85Es+&#PMAV#)D|IEQnPZ(CyQni|<#vYW;?p#ImD zMF|*ITk>!}0pIj3%eAIvRxHj#IA2Rn&yk=16Q}hT{eB@OPq(W-*!i~fHkOo z3eO90jdz(_zF$*dQwLO#4*{=B2tHD8KJ_KxbOPln;DS^B&*#0l#mDy=;IgH4hKw|l zFWw&weVs;^j`$Dw96>HM@ki8e-CNR&^APqm+-~8zq1-GI*M+$YW^z;$&CE=3K0}@_ zTpBifA!SJyK98VhT83aQXZ43HoLAt7wLh*(ng+RF7tiO!5SHG$4V^vsJ_SAegjCOB zVTuOM2bfpy;hWzc1=t_OI$^z1Zf%R-)r=XqF05}-)R`jictYWO1az`3mkwvkDBTpl zHv_7}a(CxtN?@I^zGfF=>zNAeM(j_>jetqpj4n#q`Q!VVg?wur;Ue3!E0cwNo(O&} zdi*f*m{1?*C+NSs{b9Q0f`m6XpW!`9b5FtL?1bb>aXkk~rXYYNpWxw{?AH z;&@{B%FZz^*AwSFthZA!*5N#=eo1{*{^>nO(0s_tc6M_Io)`Ee*0MIFh~eOi=K^!A s3L1%b%)2&@a|!q#kKXes(_Jd#P13Lr5`=351@+%dJQcLnuIT;ujf`J$e;sSxx(ztE;(MpANILvru|h-JhqqvH zMMkiOqzPwgPlw$9%OK+O4p}_KAammONEgqB@Qx{9ab}45McY>vDEU5`T+SvqS%6tW zD8x46bK>hCs}KAV+zD1EKY13LT)n`~OLw#9uai9Bwel6Rv8yhuD4%M~6zlMsXAf9> zBE(px``s-Uitlf9(9}Y4-rcUi+fCsUs}AI(O-6RcjAzbIzE7BtC7jw8^~qZ|wX`_&oP3XL#_{%?6Y4jY?>%6eg%VUwO%Ytr zGdFr3kga$LRzG8M7nfXAM`2FN8Lem03{5VRkd1i|?JFMMyKVu)`cjA!nIK*|&o%4v zyGKh7HEdRdSPKpDo?h3_icBXz9;nuR3O0vnvJ{7$(8ue$?N-j36zbq%@*FJeH(82R zjq5<~a)>JL$yKa!S`(g>-l~YTmp||?7sW4=%jfP5ce0ucHj!(dA%GEDp}>-={QUxKE&fFpy+lO14T zLshV!6tvZDMLeGP#bHe%B++$4yn6gjS&FahoyYLlp2aZPn?qJ;-;z7A|D(Kj!xQPm z$*VZzoRk^l)wy@v+0QV`;|bV!sB5g;__-e1Dr>;4O@c@~?U~Lb{{G%u2WjSKVD|5U=`n~7m^G^1?jlG0gPy3^)rHyqPE0QD?b z!^^~7rtPy+t}yJgfdsV>#GDV0Y@+;6nYA#4v_jPHfMl7S`?5cuwCwZ-n?HFjqp~WG z_Oph2D&j`)Of(B(!UWC7v0SU9E`n{G{FPamCxu~O+`rFla~)pQy`Fr9LuK*>HVL7% z$(vW%>rcH2kNW<}S)6i{H!w*E^Yd2J7#>K8g=c4A1X;^!RTZzhBX?!W4|r~dS~w%| z_6BLo2NU6`rgri!cDcy{oD!2)uuDw7z$~F1U~lzdJEy=>hrPa#oC(#cxL1WI^D~M~-Vraye&m&y#1>`w$#>)BSdV;OYI!h3!}F@9!c U#+<~YtW zS+L*{zlboiE+@L$O#$2a8F?q~h?isUeCoV6L|Jt5-FP|H&i7ZvFKMz)O!OUwlX*cUUf|6%{m{*nDA`(^gUn}sa;+1Xf`85x-b zHm|gg*5G1h{KLTbhj})e=w`l*cZ`!~XJ=`KbJiJ3E#pWd=?*$Wd}IDv2nrFh~wI%J!`AG_NqShzzpyHqA0N@=Hre ztMqg6H;i;QE;MvCs{k6}9_Z|xmzCvj;^>~@Utt>R7Lq)d)6n$r%Al$&W9K0A9LFG^?4s-v0R^#Oq&E%^2dMxD{0H|3@dw!l)3X#fj|Y)Z2$SDW z1+%U{RwxPr1DgN?n+6pD{Id>d?g6oop8=EnX=<|tZ2uDo0tZ$A2df8Gvk?eN2Le+M UlRkJYliG(ClihR=v#N(y2%FU>R{#J2 diff --git a/Covance_UCO3001/browser_profile_4/Default/GCM Store/000003.log b/Covance_UCO3001/browser_profile_4/Default/GCM Store/000003.log index a28f56308487af9a86f75a6ef898eb47d597b89b..e0870e622bc012ecf8604139b3a4b1ceb2374f52 100644 GIT binary patch delta 37 tcmZqWyv@0xm4!nhX47te21dTg)r=}U<`%|A2Bt>l1{Ow^lUFm!0RYcc3IqTE delta 7 Ocmcc3*~+=0l?4C{6#}dP diff --git a/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG b/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG index 31e66dc..abebad5 100644 --- a/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG +++ b/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:02:04.693 6dac Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/MANIFEST-000001 -2026/05/29-14:02:04.693 6dac Recovering log #3 -2026/05/29-14:02:04.694 6dac Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/000003.log +2026/06/01-12:26:45.153 6d98 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/MANIFEST-000001 +2026/06/01-12:26:45.154 6d98 Recovering log #3 +2026/06/01-12:26:45.172 6d98 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG.old b/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG.old index ea391af..31e66dc 100644 --- a/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG.old +++ b/Covance_UCO3001/browser_profile_4/Default/GCM Store/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:35.853 2f30 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/MANIFEST-000001 -2026/05/29-13:49:35.856 2f30 Recovering log #3 -2026/05/29-13:49:35.857 2f30 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/000003.log +2026/05/29-14:02:04.693 6dac Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/MANIFEST-000001 +2026/05/29-14:02:04.693 6dac Recovering log #3 +2026/05/29-14:02:04.694 6dac Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\GCM Store/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/GPUCache/data_1 b/Covance_UCO3001/browser_profile_4/Default/GPUCache/data_1 index b55d71aecaf2076a8085484d0d0378a61527255a..2e98123124b1776f24a3d6a109d6d836dad8a60a 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE delta 31 lcmZoTAkc6?V8aasM!|`J`pq1Q?Hr1XK+LqALy`H%KLD*$3RD09 diff --git a/Covance_UCO3001/browser_profile_4/Default/History b/Covance_UCO3001/browser_profile_4/Default/History index 7cdfc14f5f3fc286151f7d23b734aff26828b879..effb51f614ef9af4558d8d790df0ef379ae95e14 100644 GIT binary patch delta 9858 zcmeHN3v?94n(pfEneKUX)y$9}0m3Ve2xQ1~_dG);naP9jh=4#81cZ4)5=ejq4Tu|F zqM{-=m+e(oME5FqRbIgj_`)1~paOzCRUX&7Uaq`@%5|5=a;tihF_U|DH+%M+y~{lt z4qyF$RekmURbBP}H9fOvk#W%?MIq{7--A$tG5Z#i? z<#4zq$tk%Sn|pI6z{Nk!@eE>CQ5MjZVuuP-giYLhfilk3Z{|00KQp_v*R&67ZfX{5 z81@mc7j%uAO=p?K4om#1yMM#z(ERc9M@z06X;_)9uylS=*;IG^^zsoN@6f6T?;Te) zDjce+E-tLDs14jvTNkX0`i9S)e&6sJ;{xMH+&z1)x4PI~S6MAq4R;5sCPtm*)9;-> zc0r|FG}b*cFt)5}ZdILJ8@Z?ALHh!a({tBo?|mbNS3eM~t*e+GtgD&Z$2_KHZe4ID zm9yo;v-j3#EcKh?TRgJ{4K1HhT|RDh?d(yp@bIW>lqlAZiOms5k14w+FuTlE8L&xJ zwMBt>p^Cee)eGo;eyMIkZM{7_PO2JSKipj}c_xnaj&xSa(x_M@Hh)y{XmMhxJVz{X z)#Fi0?=C8;uB;sG2$V)f*E`FHjt?v5r|4n+|LN2e(`34Le0*M4fmUZUaN#cf9Lj?i z+!0?T*IBd-sXo8x3xf~vlurgA4m{oC{d`@FT2^Ibp5D9A6bCN5^4krxHGbTYX-trQ zY&`kJLe$pMRk<_;AkwT)H2<)-K0ChHS=XvwUbb^t{HC+6mE2NTf7e1ICJ$9|*3v4k zwdLZu$uk!k)Rz7CrnFpGQ@MR1tG2wj9=GgwXX-iC$#Y{r%WnMHJzN9&tPb>yZ!8$D zQ|EOy^Xey!n|vPwuoBOB#a90zB&YL$NeA=h&aAcIP0iu|Muy1*;hFPl>!NdOv-C8R z0UoHRt*EOl5pZjXW@VfkGc}ukkN*dLE?>r5xtrWEZVR`93v+o~y7r>>W9^IDdhOlX zfm%j$T=SM@Wuw`2ou#cM@s}puX8MpUlpT)*2Ly`E*5df;`?{o=$lCsJV&)_dMFAak zWTD4egnM^MLuvzFJHjwo78IJSg(^dBxO}<$J%qti$7eiY4G>0r%w*Q|Az5C+m|45a zkF0)`0m)D;Ybzcl430WIZKAb6wIQet_z4ikSuZohL$?`!;(9E zU9iLpEYI>l;PIah2u8vu&x!Dtuix%$n-atGZBw!ki{!jxKG*-+ z^mMC(jN4#V>+z`}vbw58eCkN2L0OO6Em`)~UOHCS>M*Z9sWaLCzLZRhYPo2#=3sxjHC~^< z-_}q9D=2gw?L}kINO&54i~fi{f#0AObQXPwHlf#02`YfQ;CtvKI)=VP&FCHU7Wyaj z0`ejmHo+}OL93As^@p#+SI`sa5!4s;fG@&lQ3INf(h-7j_!O!|vycuk@KLxJO-Dg^ z1O5yjg7eTMgv#M%cn;RU3V0ZP0YAm3;i%A{VE{0ds8~!86{%QA5C&BA6BG(m%qM8{ zshCI5Fhs>%f_krt9)he}MHfMflc3q5qD+vMSVjj#mceLmJok4QfGL3+;@qOC*~pBH zh(k2?{9oaZ@FF||zk{dX*VyU(@N@VvY=-aR)z}K(gd6Y_y21vQ;Xw(3Vgf}33JC-V z_z4sc$S2?AFzBYvf zggl}&5UV5#3~6g3r$0BT;1lm{Q`A$QRB(WIw<%}wX?7(Qd}f_V1s_yLQo+YjPAd4+ zNyd!UiJ!&COKfW*r^w#8_JtUI>u!z4{+mvWxznOQMWOAe2HgQqz+b_UkQR0bvxWY~ zlg2g1G9zPn+c3v)r~VY)4~=@h)S?0WVq{U81(2ETwL8O6m)Bvl%Mq8&5y4VO6rDE7 z?F>a6A<-VPhfB>W!<=A9Zch-`Mr|IKGh%auTuz%e7#3~ekUbK!OOcQ>7A!TX3{!$3 zM%><@6!q9b9?5QVI6N+!#~uya>~^Qai%rOGm$wwD4Ag2v3QL}dJ!BJI4(yc}!(1_J zw?%_e%pUaGWe@fWstlN51m&Pdl-#l{>X1atkb|~h&>6Ia!eUGmBSDWn6fPB1hLB)* z-ELWo+QT+E62)FQy^<~D2nTIZx5pzzqi!+mb(9)ahEZiSy=?>|m^&?K8HKK)pU?$# z8lA$C^Z@z{?LzP3Sh^9dN9)kD=ouV6m*Lf(fCg$=zypg#EzD-MFqzZ>A+>-|Ed-%y zV{dTJv^y=ZnZiR}!a@849JJS>r_e%Fg#t*#;n<7-jrDv#PYg>ex+b`@jXzK;K1` zfNff|4?oTz%7$0r9;m?k;UM9P@SgA(&PSQXi^g|x=9y&7He5A)Zg|#EY48|y`lI>{ z`Umu-`ZV3|bz5~ybz^jW`HTEc{z-lcKajh|?dG24Vw{^}wTHFqv~#pxEzs=I{7N%b zV`s0idsu~?!5p%%UdGS7LchV7>2CDHU>i7t7pWg;kc$P1*8o<>vRW;^>kXlQ;<{<6 zKlB&oeHz}5{~y4cOHF!h&DAV*$#rdB zuXaXA{v<|7iH*?TQg-F?QDBP}rCK{aDNNbl(b{WIoMl1zp&RWTBq^B~BPBM* z%u^O013A$^s;SfEH#(R~;mP?OP5u3q$5<8HEM|HzoWK;!8ZTemo^de+MV>4???P6tedi(m}wVHn6Lf4Cb2+M zCAN36y#=M`As{Ok4r17P2;?ZE4*^LjIt=W}w?sNjq}sz+ntlXJnj={HHzFxSdg3US z1{}pw<}ob2L!?dk94lqV@OY-LaNVh6xbEezaGn1vAS%+=xb6Uvb`dG`HI~MIgQXvd z^m`&L`vyx79LJ2b<7DI$SbF3H9`BXoz@wC%08Zruk+z=zE@jF|+;H&(@G7fL;)YqL zz+k2SNld#z)Q?W$hJQQ-9Ex-bNE~@Jk_BH@xZmQ`g|zTG`~iLsPr^g+Gx!1gXZQwu z8As*uu$s@}DV&7J2iJZ{sc%y1lazWVrCv!XGb!~z2>(d7>_89=salXaY#p!&nA%4-+Wtsw4)32wKkJ@8(YNKxupCS7D z`q3g~%Mw~vayHP2#q9$X{x|f_rcKvDIfFkaMAvZi)NJ@K_@;dnU&B6!AHkh)2W-Tj z7T3d<;PY?|d>TFum%@kPgK!S4f>G?m!NkYlk}PryC|0qkACU`H4D=y z*PFuk)o{%mw3x@aj7_UX)u zxr{DSHWky=41+!)SvZ?_TeOtU=L1Uf)3jYf&oXnAGP9hn)HAb8cnua?anpfybcQnR zP1>QnUru*3Ftbo=3sknOrG1M3et_DVU~7|*Xqx>3ooE7#5-6psaj`j3^d3gErj^6! zn>c+mtt_Lx3^_97HM8@X*(`qFI$Pn!&{i#z&3+GN;jchv~ZO=sWgulW8`6g4HfgXP4Lj z*_quM3c@v!sPBLOs~pSHOm;cm=k$VGJ8<>J%imm2XRBYjG}S*yKiLhSCe12(sE(#~ z;&b(ma&;9gD2IMSZ&h}z#?p;zAR#rypQo!?SyxM?Q|BrDT7DZpgYU^jv~OsB(&Vwr zm_1AyJsJF(I**3IRl+f$k8y@!vtf#U6&`lGviWsdX!>Fuy@1C@7!1N^wLeJMy5}`| ztGQj4w0FpoO_(}9EsbZUQE;a5n4ws=neVB6jQxq3hDRC3FiXuA<%=zJpW7uV7K?-< z4x3Z-xbdqar-)zcI6XGmDMcb7ZzvdZ2NlycI)BipiIvgv1(Q2X@c%am72x?r8{-{x;8`n!m~mx2SvX~t^Cs{US@ zenYREe4CzulZ?6%>`_tjND_Vz=)L5T($7v< zAbwtGDY(LJ!v9p|kH2ds>pD#N;MX)%#x&w}g^7(2a|K1WJ7$yRXwc@6gAx1+)8)n+ zA>?oeW3G@h6iab9+F3%I!<``zAJ6aI_dGL`nW;K_{=g9fad-w05(^u~uW`j_By5XC zJsz9G##!g&g514g-N~xFkSE z3KS67b;K?RM9`uNp(@L;;sDAKC_oS~Qb0mr6UqYRNFX9eX@c03#4Y`&yWjVFulx1u z>7Md(xx8HVcNav2P)ZYx9cd`ie^uy~QP^g++-eiNgwg zGp7_6mQ3T@V{eW|A$QxyEFTjED#c}%vUj$E-gt-{Jprpv>V%4`! zK<2o3Jhfg!fTVbkO`dJsflMJm)BE8-Ej`4A!wl}3`r?}O- z2-@HW@WN>L15QH=+<_YqgfC$@41xxzg9}g%-@tzO0=7Xecz{9xQXmP|!7Atp-C+eR zffxYr!5pvy2Q#2heWE^w@lc@trrtHQRch$&@~)V3L#!^AvmExSdhEt~oLi~XML)B1 z6uo?_7}~jQ68W!FC^mS{+e4N&AvgfV&_@lcpQxi%q8wD_DM@mJyvfiO$kIqzz>)?s ztyXZnc}T`DaXnuQB<__#Duhqd0?$ zQ=U-q7)~>^lM0C*K!=>iF=q66+>EF58gg?@Js=$_)RU|@NiawCEBDk1$^kj7jFERL ztCV;-T3+Z}>AdN9;2h^Dbeyo)IMVHd>^r0eyGt4)1;s;ByqGMmvwdp&)5hCo2qnTL z{<<)ff0;M9CO*N?R&$iE#ToSSW$dOiYH>Odo}sT?U`9?YYtFQjoiuSc=}!=%n`?0@ z?N`U#Y}pamYQgpG@Js|wsAKTH1;z0Zc+`TgUa??v1ophbV90{fiU?e3!I*jm?ein> z<`tIG!g}nX`Som6SC7+(gGA(A^(-d$ss;53v|nX#iv^v%B5<|^TifCO2>jlH?_6V^ z@`woRe~rPz7F1#)aQ!v5x;Kn-=wa4KiiRY1Ul6@#@eji|lULtDJdF>tOdo}D7M<9D zbLn3VIGu-SOz78uJ;Wo@ibkA3n;Wn!S(jg5Hue!MY-FA(jqF6uH{x_V)F8VxHKOMl z@Bq5G5ocP*U>yhjdl0s9ap0ojb?XbNQ>p7dekc=XlNHcU4mz6*t5%4aBOMYZ zbjV0DmvwtPx`ceoGB@Otr<~P~A-SBC6=g&AygWOt-bhj<jJ*wRn9=h{m^b_b39VktDrfxw%*BhyM{!s&1wR>KCnV3% zatW>6O%zkFAai+-b2W-Z$C2Z-L$Z&O)=Dpm55$4C_l2`U6#q8&Ik`j9@q6ev=iqnYe{K1=H0+S~}Z+zvn-$-$jN1 diff --git a/Covance_UCO3001/browser_profile_4/Default/Local Storage/leveldb/000003.log b/Covance_UCO3001/browser_profile_4/Default/Local Storage/leveldb/000003.log index f8d74844bdc162ece9adecbd12d82e3951078c7f..a2e18f8bf9194380a8e355d009a3a21bff56781b 100644 GIT binary patch delta 1097 zcmbtT+lw1j98Thrv~+ESwcWOqHXTr;ru3XM_Z4I($>uVhWOgQ(Ng`}J*Ue>}O|r>m zva-~DQ4z{g&WrovUm&^|(7uQiFAuh??voD{ir`Zb?c$SF#K}hMlTSSl=l5~=&iDKH z;M+L}ZvPqD-SKALn)*F@JrdFalN0d=ez3G1CV2(`Y7{;Dc{uXj+lqAlg{jel=vL%R zv2Vws07b>V8$|#yQ3&P`Ge?p5kt&bQxmTv}Hhd-Y@XF{OJU9`L5yP~WEHsjmyuuVz zwJdpdzmaJby5$97pf<|GE_)Sei*kIBD1v4krn8h)(Aw!ry;m6)b3z)QKqrrq!1qJ( zG&Q>T>Qd;&(`phi!d-Puo0ucKq&UdxtDciyaLS6?Xq$ueVMo_YxRO$eWvSuhGDC;X zTdpegQy{10XB`HFwPXFN_DqXXs@;Nj+wQYJcQn&<1bj0%0gRWn!;t&T1yChqoMejZU!#nJF{o; zXG=4oz)NFzD;L2(fKzz4n+)H2_}>2BZ7jrznF;)P_PK9rcTWq{Rv@^9bEn@t^8Eg< z$1k1?>iDntAIC@tI7E>Q494(Q^#cCj%(ECI^}`w=(y!6{@&9WMLVj~{6Q*A{_seH+ zMEfcH_~zsLzJmjecyR)K2VZcr_|xyF1Ht+~bsZ0(vn<~8pYZk9=8ukjFdU0${86uh zSG@}}`ybzZw0HaPGyH1roX=eOm&qdzGTam9Z@W7;znw5E^MS87g26V94t_b}Yw`@m VGx)<^bu4-8o%`>;e@Og<`y1uhYhC~V delta 9 QcmeDG!!+|FqHr6M%Il93;ntIV;GqD*%)L9xMZW(Ed^kckrmnEV7L$Hl9f?(Dxg^*l(a zJQsgOae-b=Vp4K`QGs4^ey)HBvOX^U>p%++GVmYde*?5|EC1wI=S5k0fX0bVK9;Y- zE5OV5nt_QgjDatVzXqtli;t~Q2tJv&V6Xsboj7q~FLNWK zz~pyzs%)pg{+ldWFYgTWj%FGd{DK&+$|VFdyfm*MI~`&oNZG8JAn?^5WFi5NGYV{) zu!@(FZ}RH7s%&kqkMy74vH9BE|BQ@AldsK}XEfgYZ9b;}Bj2VC%lTxPS@c_lFucw2 n;QGBw=XOj!vM-B~W3vAK1|Yd%zZ{S}zh8}!WAnHDKm(Wod1|O# delta 484 zcmZozz}&Ead4e<}%S0JxMwX2U3;nqn7#NuNV;K0?@W*Tx6bRsF^W$RCZe*Igey*b4 z()0cA=WTo=E+x;!Ur}73my?*3oL^L+mzmP)MZa-!Or4r( z@AkV(W-NYnCOc1JO5o0|pC*Mm~_+>n6w6sdBA_IbM5mPo1m)qbAT^Aou_=PjB+> zIt3}1AcF%)H&$PWVfV$R39ER4&R#uNmF>}=`=91*+=5Vu=(45paDz( D+P0s@ diff --git a/Covance_UCO3001/browser_profile_4/Default/Network/Cookies b/Covance_UCO3001/browser_profile_4/Default/Network/Cookies index 8764def9b11a97ef3720e026533070d4eeb5ea25..de0d9dc6ae42e08caf070026f0e7ede666606bb8 100644 GIT binary patch delta 2756 zcmYk8c{mhm8^#-3CdL-VmKYh!940$CMh3~2EYm2`jIo7TERo32FrucIv6Wr2W+y}< zWtp-QIz$MOJ=>Ay)A>%{^I=b9K^W5&kY1}adQK?0c>1A;1PJ`o6S6fTwkK+ zb%Lrd))hzeC#m9y`0H*rgVavrr6cIm1p0JY`UzVQqaWU{$wmS-B570l%jJy%`1JzzFf>z{>a3eBjhG%hge~oUatY{MdR*xnR zmRK*`>~|;$-IS`cQkh+^h?(2FLVx0<9}Zh|GP&h1vmO;6C*m^N6)H8D47N#t(-03! zuP*k2$mtyQ!MgB2gf`FIic$)T(>z8);b_eV;_vVi_Qh8Rd29SKk63vfpnQwg_MU&C zub<%x@-t96CyiX(jQvuzx|Hdit#vm4b&x>Av|IGkza~mTWsno(0jFio$_K1Vw&A99U!b;ph?W237Be95<>bxQ8wLnzMk^28@|rb}I&dUCEH z3^QLIPy|@$bL4-oThw~1FlVm!3o>8H=khRGRRxAe`ASA_u5npRl`h}{%jsoI3vcqa{lJ~ zriw>cpx_p;VB&6VSn=C97#{s1vC@+nYSf>0U-g7y-g1krctazX>7~#Ta8ZEz;2h$| zMl=#XPD}^`r+E4o^x%3^cgEBd`8U2~2|J5%AShxbK4K&CY%zCvHSt~`7o#a&@?Zs> z3m>bR+QzrvTLewAs+KfM`3Uvm@Xg0d>_5qV{iTc`7W(xMcDC9%o+HwuWgjD3K4^=0 zs%S|>4ziL!b(lPr@B8|90umwiH!_X;I%&!GyTs#267!75^RiD5irRY=kr}*w_BnC~*S@$qzMOZiuO?EYa_$DISuS6Rbz?y; z^RXvrD>!Xh4haWx8nr6;xCusJ7wbBXh`q94!H<(suA+v-$(&E_^4(}@IvQTyqHm@+ zr@ZV26?y*>Izs{C`?+|C$al5awUFGC`$c!`qDUvYBElbQ%j|GHIXV4AXN78ZHH;9y zGu9%{#vrOLj*s%ZbRD<2CTBk>hKgukg8#mQY=Fjp+ma|dO~ws9XYx)|Q)Q>PE>S5` zKz4*~L^2P*J(bQK&p8b?Nr9vt{+=6A`*m%wbKN#`X8?7$rG*3+@Lnwmqe)yxx4BnxT?B8fo>Y)4BKj zQhWufRY(I$=N~58l3By-Q>&NL_8N1^Mvum}(hw^RflnEs*4I!iY4=(n~X;t)9ZVLECK?7$O5k!`aWrnjC_2+yYZQ1h!og#FCU)sb)!R&ZKx zhH7+E{}Pg%ip)J2@JK7OZ}o{zg7U9DH*WW|#M#2x-8aB`Xj+Kub3GMXospmf$dSRN z%uuWA{mh-dj3D<5{5Q(qhTyzjfWLVnBkPmG#1emM ziAJg8*O5Xw)JyorLmZDj-GcXs65vMjwa6^jxjM4Eeqqu3m8Bb3_f`bagoZm3u`;Oe z&ulva-Wuz>N&4wY;-92n6!mSjxi}CuReLSpgFld3XWOV(1_sj{9X;T0iBOo-G2WsX zZkw)LM%J}e`7IM`a^04H1BSxAe;@v}hZ}1js<;t92UK0@x+dfl* z5Hhi^()hO6@Ul}Cg9VJ?FwP2Fj(P&5u;Xfkr_J^~jKA;h2>j5yFr%s@zQ=Ua8?-=_ z1UKo3KJ#TJV-Sh>ZAjNif%7NI$ zx46rXKzAifXn>W+go+P@7L4-IXZVK#_=*?lAX zD_CVVBJYt!WoXgwo&_GLL9!F6qnm#rsz&V~pG>dsP-alVnNBggastBb#~{+8Daw+p zG_`F$mw1+7zZ?O>Ji2R`{fY>@mJUmu_^7U8@Hj>{JEd2aoQGAofjJ$7z*6GtKztn!_ zE4JM=Ja_;4uzAYexhN79@*Q?_CcuwJf%S8L#Ncvn_P2?9t+tVNXsM~83dymVWU`Na z5c2+1|c~kev7hxtLimZu|=w={|a=nph%1V20BIqf`{`k%IU{3UfD?gf-=1L ztJ7mIG;#%2u86M0Y_)27&V)FtACLz77u@K4ELqD3RB*iM%TnL434zksbHiCNbKr)N zkH*XT#S^Ez!m*1h^yDat@kR+w>$FC2;}@f!t=p&YOEAmP{(tYKe%$Y&4uz8=McV{et;&!$VL^Qz#!Sk0-y}K4FsUUsI^f7s52&QWd8#g`zDnD delta 2754 zcmYk8c{CIZ7sib(V=Q4T*)n7w`_3S5;Wd`gNZHqrA=#;kFIxzkBJoyH)Y-~o~JFi|ulTdr;gc%vE4~S|=zqF@tSU`JR{BMPskmE@ENO@^GqY)}!dsj&OHuF&av=Oh(P* z;%Ps-hkSduFku#~&UkQ}xY7WD>7!=2i?iq9VTmNtb+Cm*Z7yFCqDqZdf%LD*3J>%7{TKB-T@=bpIdA`lP z`w(5uH&#Z5JN+8$LE1y*ng&tJ9Vp%B&o%?lWN=LjrdyUFoilvUW!w4<$InN!&$px& zyJWYMxyT6hQS1|f(5TyLQr#=s3@9pK#{+TS-g^21d6wywyYD@uxV&Zx{Zo~bAjFIO z4)>w%3+GDFjh}grX>ScmmHi!_rV`@5`~%S};JNLzPZ)#3XG110xpw>gd~pk4;6;Bm zwD-fy5MvX<_{45LNz{TQp(|=D54u^mw%x;+{CP=tdg*-lMh%-pf7^nH4CNJScQjJ& z5#ZaF!5DOW?K9qie(1k{)K!U!xM_h3elumXhN3zrP za{o+wVOc!uxx!Y588rluFUy8w`0yLG1mdvoim5YyG3=K8BcnE4l2J|s?*eFb))!)I zaSy4Id1<65!QGY;1hvhYERFXtLU+1-FMKpylhOayzUUN3nQ5{eqYQLlNx|0(NlO6T z6e*IYIRuhBdl#1TMsr4z`?dpTWb}8*8EdSDZmnbbHGxz3ZIz0m2+N>(1s(Y-9f+uuO( z#1M8Kt{`@5bGg*fbGQ?2BtAYf@V(oRq=oEc*G8`lsRI_1HGcM>u0YMpubnn--ynu; zMy74k7_|0#iZ#8V6n>P{07pE04__6JaSk$CaCP_=pI*^?F!EeLw%;t3S1NvJdc1nb zxyR#0(~3^cH>M!17+%-?;4z}w=PiZRlK$)JdsSLJ+moVYNy)ROET%|}nX6WG(u)$` zKHTYs!3oo=*;E!ozJ>-6LoqOl0@pC;o~_SG5m^?Ctr52<6r+GaU)#gppV5Af!Snt2 zCv>T=4mLSAUgxXOl|-yK1hZMH+p*9{M;@eviBKWlI5umiq2TB%Bk)95;+dD9E<9Mr zFAZvMtf+qfB0;zb3mBq{jt`waQ&_kgt2v?W>{R;V4?9Wp>w(iAnA^a{5cKNC#mx`u*1Cicokl&B{0+hH=&OSn8Ugk$ ztqKY&eAecV?$yy=iM6{8sM;M{`vCux%CRy1Tt^9usiRx@6 zAR4!jg4gLKOXC+Z3Pw28`>^gQDr`~Z&lh9_bo_3c6OdB42t5}Jfn?HW6fEcsN@Xwh zA<$~rTPD4LLMmqqV#1cyK%A|c-S)6siV|9G(Dmx`TnmcB=w&?sxcQ;n`=#nEkS4}1 z-;g0`;uZY>%FvMCZ=R=;3lB?mP(?^D4;TMXxSdv=aVS29e^$ieU!OG4^(wALRSP`q z4R&k}KpU@HEMx9Uh5SX0(8-{jT@f!aaFo9@iY*k4wNP_^(mL%#nD=&3rb56q9{ALc z3q|9?xo1com6PW0@8-=~z3%kcNPI@m__S41F(J@kFMCIhaI|+x$&8qWjIL{4RaZb! zQBZ>l(bbW0Tr@wsrSPU&u$|c?JBzKYcfS<_DOe2?gz=5bI9t1<-`m?LymgmRaDZyYnoK&Y6BaBU;^?okajoR|@MF4Y zij~)YuO8_2KL7C*P(EmMS3k@F6m``9Uu>;F8nP5Y4_&JrPkIW|f5waS%2?{_1Sz1DLvX;-~s3v2|llV)I z@nCx2*->;{!?j53%O+!seimR*6vo3x*7ITDZ1)o{=E7it6|cVaCR67oLQy56Da*)H z_&^x*6@M^5KF@f zaHo2VEg^Rc0HLFO`r7k;yD^mW>5k`?zkLDZ^{OVQHk4z!K6C{=3f?If6uoiwXGIOc zKaiV-9SR68Xd65Q6LnJ0-%{qw5%M}|TVz!3$_zKRp>H%Pk-~%Q>X2vpyUZdpj`plU z$&ZKTI7ugyLLn!V?dER2kqO?(u9eP{$~N_x(jo}jADOY9mv^5@W%89;*4>pUi|*-& zC~kG>jJC%No$tWEy+s^d`UVU6-K^KDYGsub&s666@O)sZ3%de|{ zRy>BJ>632QC%<2i(4JBce?xMNKo6Etk{QQpq=}i=*!np5`X%1wR5&%yQL^`ujZJI7 zod5(>Nfyc~gfipT!S4%cP`VmS_Sr~+IULgW{e ztZ9p~CMJ1CH-yI9Hj0|mb|p8fU#AuLBZ)}uFlvjb?uNA|b)w8z8}DoF=1k4E7wKFQ zhkQ{bC-1($ol>?CN%Vl809?>Hu_5h}+;c5a+_$YUN8@m%Zs&2+?|+FZ_%qb8@I$OL z;MYt%oLCsn+c=%&-&HkzH@4&kNa0Kn$^aHzFaiQ##^oR+0g|{DgggL(`+$J_2lG56 A`Tzg` diff --git a/Covance_UCO3001/browser_profile_4/Default/Network/Network Persistent State b/Covance_UCO3001/browser_profile_4/Default/Network/Network Persistent State index 706d1a0..8530079 100644 --- a/Covance_UCO3001/browser_profile_4/Default/Network/Network Persistent State +++ b/Covance_UCO3001/browser_profile_4/Default/Network/Network Persistent State @@ -1 +1 @@ -{"net":{"http_server_properties":{"servers":[{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427120998562748","port":443,"protocol_str":"quic"}],"anonymization":["MAAAACwAAABodHRwczovL3Bhc3N3b3Jkc2xlYWtjaGVjay1wYS5nb29nbGVhcGlzLmNvbQ==",false,0],"server":"https://passwordsleakcheck-pa.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427120346048310","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6465},"server":"https://fonts.googleapis.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6571},"server":"https://fonts.gstatic.com"},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",true,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://cdn.pendo.io","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://data.pendo.io","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121698314874","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":34391},"server":"https://accounts.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424616099962613","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":16058},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121722474845","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":5548},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121889773616","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":5553},"server":"https://android.clients.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121899641060","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":22378},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424616272833212","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":11265},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121698311763","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":25387},"server":"https://www.google.com"}],"supports_quic":{"address":"192.168.1.87","used_quic":true},"version":5},"network_qualities":{"CAESABiAgICA+P////8B":"4G"}}} \ No newline at end of file +{"net":{"http_server_properties":{"servers":[{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://cdn.pendo.io","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://data.pendo.io","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427121722474845","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":5548},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",true,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375188638957","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":26505},"server":"https://accounts.google.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424869589668354","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2NvdmFuY2UuY29tAA==",false,0],"network_stats":{"srtt":18371},"server":"https://unpkg.com"},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":7516},"server":"https://fonts.gstatic.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375205504816","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":6285},"server":"https://fonts.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375223411605","port":443,"protocol_str":"quic"}],"anonymization":["MAAAACwAAABodHRwczovL3Bhc3N3b3Jkc2xlYWtjaGVjay1wYS5nb29nbGVhcGlzLmNvbQ==",false,0],"network_stats":{"srtt":4814},"server":"https://passwordsleakcheck-pa.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375227036689","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":3203},"server":"https://android.clients.google.com","supports_spdy":true},{"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"server":"https://login.labcorp.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13424869694182417","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":4813},"server":"https://unpkg.com"},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375366013605","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABMAAABodHRwczovL2xhYmNvcnAuY29tAA==",false,0],"network_stats":{"srtt":15202},"server":"https://content-autofill.googleapis.com","supports_spdy":true},{"alternative_service":[{"advertised_alpns":["h3"],"expiration":"13427375188614468","port":443,"protocol_str":"quic"}],"anonymization":["GAAAABIAAABodHRwczovL2dvb2dsZS5jb20AAA==",false,0],"network_stats":{"srtt":7755},"server":"https://www.google.com"}],"supports_quic":{"address":"192.168.1.87","used_quic":true},"version":5},"network_qualities":{"CAESABiAgICA+P////8B":"4G"}}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_4/Default/Network/Reporting and NEL b/Covance_UCO3001/browser_profile_4/Default/Network/Reporting and NEL index 69c5f97542480e3c94c08dea1c9d9e8738cb7ab8..bd09dab7758009f7f5692ae47a998fbbf33826e5 100644 GIT binary patch delta 55 zcmZozz|^pSX@WE(_e2?IM(&LXI`zE8l`}mbG3akR^0qbe(d3!+k$hVeGLmHXgM?nH K+}*#ZK>z?kNEY1y delta 55 zcmZozz|^pSX@WE(=R_H2M$U~1I`zC3#YP9dG3amXd@lFk+vJ(`k$jtNd7;Htv5~9;Jy+7@>F)|_35>VB!onIxqk0`-}652@BQw(!|9Jp?+>pH=wHe& z%MhmfYRs?uR81r|taaIJShiGbD;%{8YCLah5i@USrk0OIrIDAKZA9V)J*?_s_xn)b zyiZm4Ll*;8h}8x84oaxhnT|x8k~(|1G5OjL6wn;8Z{;rH7r9Sf*kXf@Dy3>P@!Xnk%=`bvbaap z7H^01O%$<+3byIBgBUYoxQ`6|S1{-1&t7V4)IFlEMTJcY&8yY&>b3Y3W5q1>cbVI% zq#=z}x~{T%nv5CJEhEX5O-8p7rBf%$aBhKIGvu%G%D^C9l9?GQIvpg~ukD5|E9Fn)nHIo%|&WHI=t-IfE6%wpdCP9v! zHP~gtqqo_eBx%}nZ(*JeUFLc2-Xb|09HXS3hQjJKX3j8vLiY;0n!q!NVee(Ct~DTo z{%)+)YmTKjvgs&Ir@m#CWa!1`-zA7!y~AXP#OV%`8y@su^{M*auet3v5L3O=)c5Z+ zY3|p-@g9J78~`^wG|l}pIx#ugjg@+HTd7whAuUHLWox6jCbPT4Wqv-hJ<`ajKcC$z zfwoUIHV1}^*C7%;QqdW^+hZK3d;B~*NpbSO#KDnwBNX2`SsXjM^LszOQJp$jeMI~h Dr-1nB delta 7 OcmdlHe#>#gEd>A&Lj%r+`Lbt1P2z8Rlh|WBj=e_38PA7j{4p~- zo^kBmmIm<$K^3Z77LoEtl|MkrA4mi!u&P>Qx+|1Qg$8McrN+mW>P=-;pIYkCdYNbnN~P0f^Q)nhXYsp7nfa|+J~a5cks0`O`5 zrgg{#4;ud(;N!S18oz)ma%13ChoAA~`KLeizXSg@`na`b;0=k#CULl%=052PcSKRQ zQqF_s!G{1~?`tg$=3yeBY@ILy+452tgFh6g*k-#9L#ouk6(q#P3F<(E;*=OATP9{9Hi z>~qHtNJ1XanGU0fKZ$!{LmZ==BQmE(yN&TkyvQjW;CN5qp4bq<_$P+UU~Jm><&z9X zYaF3`Tgv55pV$<|^SFvNgB0Qj39D42xJv*tm}*+#26G|~rjZA6fhEb|X?RQ6aHV#! zAvQ?3V1xMC9>4ln)5pOhIP^J!IIQ#4YI*5cFu1Z*KAJ8qr;6z;;9~H{@oW&pZy6}M zgzhL$6mshrdF6&5(?z#rnLB}vBYf}^!;O7jQ95L{O zi8twjW#hl*NXL;3Z%D^Bv4 zxNd(y9(X{>|EKZ%eYiZv%%=J$5tnEeMv2LSNbX~}$Rxr*jS%jl@Duekvc-T1tq3Qo z#StfhKl)Pm4SA;DhPY|OYRB7ch{yEF_%xFvt06mLend^?M0C!ncS6V^rI0+sww0=? zX_guT9{7Q3Szq|p;BN^-x(2@*qkymfd&g%PE+{B|zSFe7=?4Y{fhpFrxICIOxKNrc z6pvT3)mo)EURmfk9PYE8Li|%GFlh);v21Nb#sHp{fT{%y&JQ4;r*SpookP3_q?7I! zD0N=LGcwAHjO1`P%>7LRom>gYTEdl{b)n@Yj#ap;E-2_2U;{XuiFP~0UA|w&6V+b# zh?WbtTjV%eEQ_~mfJJK@zYA7}br{2=4{5velXh{3Zy9~}-wXOad|dQ?(VfUX1LPwY z)u@*M>TxzmbZ-Od5eXCUC-Bz_|BNC7ZGc4hIL0@*p}XCa=p&Mo8N?trZ3hnIR0`y} zYj&oTeJ7dN0$M;DbobG;bk?%hhc99+w zP^@Avh33=Y#gV?D7edu|OS+WFPN(y!g@tT!HrsKgClflKnTq8XL&?mN9a@<$uME`2 zi>rg9ZIywpQ&Yv^iOw(*SdO}0onFi$%S^{uIM&uuEMbb!5v!aTvvc9W;^=&_d#-ON zbUOaRaJW1%Fn7MEYcjMj)E$atdRNEo&Vk{T{-Jy#^;{}foEsck%}W#3{M6Tm>E45|Zoes6HDi0r@CM=Yi-!AbA!@$dCnu1u=gL;a6gil@+WP5$8A% zbpiKTv}Vd93X~xHfCWV2<2&{yJ(GobPriCAfyVkZb4{CcP{HbsoP{NG*>PLYU2Fkfx2h6{K6n?*PgooEp)5)unbzsDVk#if~Dk4PBAv;vf&fuAiRtl@JG>ROGR<|{$ zY8b+Zi=&>ycv?mY1`vK8wdt}ZQSJq_K{sFwHR(mE$B|Aa;tZoM{dkrK!An`s;mRS+ zIix>?Sb3x~iua>Py9IU3;_ZThY1Q^*lLfRI#W6h(J`5t-X&9zvn|GcQ>o_`X&YfA` zCFC=W^j6_#pGc3j;0Yy)stR32JyX_6gw3kHIf=F(L1|}E=6Td+4x^|CM3`$l(dn~Dv z=`xm7S&M2kvQA`iizr_KZ)txS@05@dL$aIj$ZIO`0bm{#c$+1GmlRIM@k^AomCv#+ z8|apJE;Q)}GUal!&O9D7jdxl<3Jg08YSo2ua*{ZYd-e!>n%JVTFoVz>>Qg~2`CR%X zpya^{LJF!c187AXF_>-#+RUBr%gD12SA7I&N$SDTkAU?{C>yB_=|@5J2x}LB9yMTn z*tDd(oa}=pTp?U^?&s1^jZ$tDpYKzV!Lhu8Uw3+vpUs!y*w4)0>1Vih58u?V83p@E zT%Pk5Q*w8`lL+S&j*7<_j5kVTyyqk^jJBdOl9RNsn#_@_*tl8|Ln~Dhc#Cpm3~y5P z=#_p9??qLbl=?W`3YR)}%u2DpH&eiWkf|W)3EZR$ zmW^Mea2;z4Q$a*jZ3A-FNGZm(l19@&H;Q_(!YxbHdq64X7&D$Eip0)VWGZEd5M@&m zB$6nu#!xnRn1lTOOe?)DWDOC2-UT1aTKAZsMCA}>eLSM7=f&KSbV zl^IIRA;ck}qymoed4z09x=bm>PGKB);fE5^N|oSJwU${8M%oflJ6O#wRa+syLE>5p zCL(q$))rhWq${PFLJ8vTD#zbXef~2qH&Ud%Ir<5OwxUQAKi~P!{Y~Emz7lOI4CQcn z70aziGsT2psR|0HiVEl~EWEn7xY=0Xdr`u@4AQcOs~P3H2uKv7lWr3zZM=qOobg>` zB!@d^&{oj*it#fFlC>@y|3ACPz#*e#JK};TjQ^5>l9eM_73418>j+hCeUD_IKI3bw zgsV#joONosf%DE9hUu#DN5K2JWMUgXXIG5ViZ^(t=kQDBDF-ikI%O@L-Xi9MX~ZpI zfOGz;%cMr&?f#H{5a_P|mdVs3sQlXsS)&#{g%;-$FBNShEY$mxm{HHKNfGt+ocnPO z#zi$M>Zph3JxNmgrv6A`+;Qf}UZuXD1dww)D*6bua*+g7FWiw>a^|R2eOctoWpJ%% zOyQZ+5e0UWelYLv|LvVgo{&0$d}sXKP04p_l1CD;Ta(e@UGGXsN( z)>_t{8y=0;qSdK<@5FFwq_#ZWm5=w{U2#}VuZFtj1}DcSCnM*(Ug#O`9iN<9KHFW2 zbw?BDi)|5mb!2t$)QUYA9=3CRXWLi$3&Z6Xp6~4`_78WpPuxv$=oq7*+un-9N?~%T zkT@Ti>a{02r@9M8yU;!x$wks*vt!SXEcbQw&zzcD>9>1E?DMt4Q0c{q%s^;99O*6% z#8&6i!#k`vd>Inq8m?ya>qWr(WfNOf9R7=86aQ-9Ar2_GBL)WEq5UTeykwvb-NI}U zJV}jD7n`WFfxV?T9EOtc43tMj5QUT zhg$W6O`Jk&vfegoJA&Wy=(z%vrX{EyC%`@i(BkuGr-*9N0kr8V{Asj`uQ>D-hjo$Z ztyLTfwcZS6S}RZ7{(wC2fQ(O3L8i%TxF_pyi!C=0=5(TsU>L=gq>(rN@!2O&aUtv5 z2CkWK5px8J*22Aaz?lc{r9M)=a|q+q{Z5ML5-^yG?)nlImqYY20JlL^fa5`g|%Es7w0w^Psx#~yG4u8@1s5R1PvxEgs%9xNWY7W>9~jOs3V~GFQmxAkMbx8EnX5G%R3A(ErCdpri{b+{R1`0` zrTOqz{C`|yHJZ^Y+VXp+z7=*L+*p5o`@rj zIaB{b{ZL{fq)q?LZ>w;DPOi>NN}Sq*!}?n-B?1v-fF_`MQGj*2Mk30?1tq_m$Ynxh`xmhV8 zb36C2emk!*I#`6KaO)p1sGl*ColF8r0?Yvek^t)1c1vdW4;c6d4EzHI{s9C3fPsI& zz&~I>MqFQ)p%Rr6v46mTt>W!uO1$0m75{*Ne;9P94})^lZsULfr{mbLyh$nMSUq~E zt#0@S3^duI@@^|mq%4{sDs>IbcAv^$!^M2MqiJ2AWQh zjFF8|N$TABBvdRQHy&`iWX(TdAg8Ik4=Azew{gILB##T)yQMhv4;c6d4EzHI{s9C3 zfPsI&z*ijVd6P_&9&W{5sJDlIz(Cur-DEM( zj3F6sGJcW>=K%o!fPp?p;U6&Y4>jNGp=P4i{Twi8vTm6(2FD;-lB#oO+NYoS-fJ}a zu|sDJegR3dfT^F?$(l0;65MDP_HLgsIPm0DiHF<{8hC@{rDKyg+)Z;YhvOWNHr%>t z+=Dgqz9H)k9w~)I@=Bl9#dwsL+eo!7Y92Y`hY*-Pk6rQDR02zwu zz`m#iZ`&wOG_k=b&j*p~7!G`EdyTZn;x;o)+oz{-7_zZFl`o-Mui$D%I#&U?*_lpy zK%n&W8lJHwE;5qC9Wj^@H&CqKFbcP}U85!v?o$6Z%EYYC85lSAQIjs1H~w`4_1l{e z@OC++e3ubXwXw&B?Z$`LgE&0uY(x6RqD@d8%hT3uf(UJF$tH+Vr>)rVU|tXk*TyaG zZcizhqi9RC@HbH2jx5pY-ifE&`Vp!Cl%(?!Xj{dH@wZB*RcKb!rjiZg5aM`%%=&!qn@BGvKu1WLIHu)&6Jn5s> zJibkPPUN(-6vboDv{Fnfpql&6;Ev;!7MaBEw}SAbvh` zuzhfU&5|64I~>~rf?Kl17j56uZ2$KRyZ`-1nC-XwY~S+P{+-Q8d$Ijvpb@mj;bi*} zFxEQT?*X}629u@1Z#@N|!Si{%L$_OO*Jt~>y&qM!PfN74=0f`{+Ug308Vd88#Zy?P zB^GU6r4=lkMmzca7@Fax*sm>~xW{7>%|-84@# zG`qX)VnsGu+}|#{e+?{t-LQKq`H9YS(p>_jZP)M&(e7Eff8DVAuNXG}s(~jAJD+sH zvhiQrbL^fL`t}~X7dHQG!{%=qc*wA8Ve==9f6_oVn_n~GR}5S?&^?ZPc26v;hc zd!mSqi|$cn|6ER|tWDdg`U|g=ceZm9|Z}oS#AosOk^l;zz||JJ0@Ie3pIuYu}ms z%SP<~y<@+wrUfGHi=Xc}l>8i8+h_lwJ+0(_-LUZJ)@xnGL-4 zYx|V1oa~>nKEH;_j~{SOpY5yezAZBPY+tuW5`a>98l#L~ z<)qxLzx>4ABvk!VD(45-`OQs!;+^)}#B@8&o|AbqCco7b-83F0eHtp)>-#hbPr067 z>C`#tm3ysK;ADeS0Zu`Z^juzm6K9S7Uz#=(1F`>|+yc;k2W;)!^BWN&ZjyJ6VPk|8fGuT|u=juK`c*u{FYv*R~LKEHL z^!w8O*84@;@$Dk*Q^n5jqwu5LdP_bxm}Wr-$@cjz5xut0d;KL7e&CT`8llRcvN$*W z&3LkX?irwxpIh~)8Q}JNzQxUbOoLne^M@E z{D+3!-!kwD`i*Yg1!YIMD4BJvw`wQmOn4>E!#PMP;nqB~qo*8cd delta 7 OcmaFB+QG7cg9!i&9|9}@ diff --git a/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG b/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG index ea43091..b8991b2 100644 --- a/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG +++ b/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:37.379 1580 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/MANIFEST-000001 -2026/05/29-14:01:37.382 1580 Recovering log #3 -2026/05/29-14:01:37.382 1580 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/000003.log +2026/06/01-12:26:27.169 6de0 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/MANIFEST-000001 +2026/06/01-12:26:27.171 6de0 Recovering log #3 +2026/06/01-12:26:27.172 6de0 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG.old b/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG.old index 4fda76f..ea43091 100644 --- a/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG.old +++ b/Covance_UCO3001/browser_profile_4/Default/Site Characteristics Database/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:18.328 6e70 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/MANIFEST-000001 -2026/05/29-13:49:18.328 6e70 Recovering log #3 -2026/05/29-13:49:18.329 6e70 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/000003.log +2026/05/29-14:01:37.379 1580 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/MANIFEST-000001 +2026/05/29-14:01:37.382 1580 Recovering log #3 +2026/05/29-14:01:37.382 1580 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Site Characteristics Database/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG b/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG index cd76965..0ac4342 100644 --- a/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG +++ b/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:37.432 774c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/MANIFEST-000001 -2026/05/29-14:01:37.432 774c Recovering log #3 -2026/05/29-14:01:37.433 774c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/000003.log +2026/06/01-12:26:27.152 6d88 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/MANIFEST-000001 +2026/06/01-12:26:27.168 6d88 Recovering log #3 +2026/06/01-12:26:27.170 6d88 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG.old b/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG.old index cace4e8..cd76965 100644 --- a/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG.old +++ b/Covance_UCO3001/browser_profile_4/Default/Sync Data/LevelDB/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:18.323 736c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/MANIFEST-000001 -2026/05/29-13:49:18.326 736c Recovering log #3 -2026/05/29-13:49:18.326 736c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/000003.log +2026/05/29-14:01:37.432 774c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/MANIFEST-000001 +2026/05/29-14:01:37.432 774c Recovering log #3 +2026/05/29-14:01:37.433 774c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\Sync Data\LevelDB/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/Web Data b/Covance_UCO3001/browser_profile_4/Default/Web Data index a200df7bba20e6c109e1b3eda36d3f8ffcf67a55..e8a882c01a4cac6ad13fa8d34a3ed672ce85c5fb 100644 GIT binary patch delta 123 zcmV->0EGX5unB;$36L8B29X>?0S19!wO|3Jp9H)B2fVWp7_tWmLIDRMH8lhT0hh+7 z0XGC4US0R@3zwO|3Jp9H-C2fecq7_$cmK>-ILH8lhTm*KAg zAD82&0T}}seNwil0mGj?U)Ze8bP{Ao#6W~zbfV?qMrPcvwoBOf4X?y4z)_U|zv4!R3)|!Yc$EY^jZTG)|>NKvRm6C;~a!kjk_aQT5!rYelyA zkFmAvYIp9OIdk{yZ_YR8-1+0?$lg;E4nOdIRa3>9&U-l2%6;<+XX^U?i7z(8i7izv zg48;5|0aaCByIc(5(ZzIxU>wRt;zm%-$uf@RnJ}eibJmw8&4&_iF_m!<~5&N&Y^8B zRrisV6BY{Y>Q9%hkDxZX|9t)CW(%o6Cil-uiVZ75-C*gWU%3zxx%@Yz+#Y-Lh7cVC2;ZnZw&6VWZD`THL2qrk`KC-B^upFmq zGbh#x(MbX)-ss?`>lca_BD6nqULKjdcG^StKTCHbWwVdh8}JJq-xbgNnTJ91EOC$x z5{t!uo}-r5+2Y0XbkL`ZZ5Q~cApCVbFZO-NbEJD-tf1gbdLG!O_XjikgLJ|3ap0RK)=W*oma3cBbu=$90!epG`|pwH#YnU~jH_4}D-}alyeZw>r-#28}BJvZ}q>UUT|9f=G#A7d? zdhPP&${JzS`Ksq{M^G|!sPE)OkL8Uw)c(q`g<7_(aoHo>Pr2tfpIgSQ<(}ePPU2L~ z<7BXSu!p$-Mkc&5r@^6 zRRec+4s_kJ@iW}JV9nG+VxT8BkhP^PZ zVo?_M%5Bv)WyMgjuPHLtWYxyDt=rgf!1^C7m>uCCXU?|SnK%c>Q!oZmd{Mn2?6}BFXOyDdI$1$+xGyV)XLeF%7 zKZgsl(3hi`hv;Jx6M1{BKz@6DGSGLF(HBOz41Hl-N9F^iFSNwTu67kI84gKKR3P7J zZ5{z%PUeLxn7Owxbt!z;Iw6w*zRK;hNKs9NFrleQ2KbJ#gqD0+F%>0_P0a!>oWR1C z71yyBw;fe6Y){ji418f+#e1{CrzoysdXj_XxE2Ta0uwv3D`DSO0?D={)s!fFDF)uj zC&LS$&5H)3C6VE zS#V5;kq28F7*oNUQs;rU#yMGt%hAj|tTU z*W0=Qym!(GZJ3rC4+5xC6%(MF#0Hk1{{+azwxXD=457?A|FN*h$&1C zAFdT{EZKhuYTmnP0z>FFL|_Qlk=ejH&X5WxuQ=Msl9v;CiM+FU6o0uFm-07o3-Xve z?fb(0Pd7}P$Dvbn9bAu7y>K1qI=D9q3(wcLBC)rV|MKH$3t%C98V(J;a%pS21aq-M%;U-K1RHC$|%o{lv;&@dEQ2fAHVmkiVJ^k8VE8OBwdoQ3;x#V~Ejk$h~% zbq{VXP|z*gm0>w6d4Z&O4*Uq*Y^%uJ6>0E4-_(-^|H$-z?E>(-8TerW80vOI{H@Wk zvZ6bdSVxoZGtw1cSOt>lT9c-f$9UIRN2`G?U27c}(QcQnJJTs`FwY?CS~Ev8Lr$%^ z4r@&&G3h>0D-8bQl};f4Jw|>QjfcA3acG>by&)w|&RsETv6&+kXz{HdUVL*j^DuoW z{6|_Lmm4E(sLVCrFIq5v%hAU-^sn0U)b~jD${L~W`mH9w@eGI`dqxQY&-FB{%ccRC z=rZ)B@YF}u70+`l#}14k7L^dLVsSPWEqHk3$1M%RBPM8mJs3H%tYgK{9Z!QI?6Bsy zid594S^V#*-ZYE1{(}DoEcS#AHG|^#LZv8IU;4<0wzQZPRuh1v<(Muj zY3X&~JN?*)VyJ+p2Q~{nbomMGaF!yRqnT-{TmuxD!sLVATH%c+8fF8Ey;S0#hq%NU s62~JkBQdPP$%?vBB<4s2O5%u>XO3nbCNCxNKo4XxtUUWyv&TOF2k+5BQ2+n{ delta 9 QcmZ3ok7dmy<_$V00TuWJO#lD@ diff --git a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG index f8e3fcc..cb510b9 100644 --- a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG +++ b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:38.011 6a98 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-14:01:38.016 6a98 Recovering log #3 -2026/05/29-14:01:38.018 6a98 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/000003.log +2026/06/01-12:26:28.200 6d8c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/MANIFEST-000001 +2026/06/01-12:26:28.202 6d8c Recovering log #3 +2026/06/01-12:26:28.240 6d8c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG.old b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG.old index f1134b9..f8e3fcc 100644 --- a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG.old +++ b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:18.949 71fc Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/MANIFEST-000001 -2026/05/29-13:49:18.950 71fc Recovering log #3 -2026/05/29-13:49:18.950 71fc Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/000003.log +2026/05/29-14:01:38.011 6a98 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/MANIFEST-000001 +2026/05/29-14:01:38.016 6a98 Recovering log #3 +2026/05/29-14:01:38.018 6a98 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/000003.log b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/000003.log index 1025e853b3ce38b1a54e3d07542eb6d654e199d5..94b2496ad6ebbea6cecf996e38a2fbc26bf76913 100644 GIT binary patch delta 19 acmZ3&ag1Yw3JZs*3FBUA21eD1T2cTrs04Tb delta 7 OcmX@cv4mrT3JU-WQ36u{ diff --git a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG index abb7ce9..16a38d8 100644 --- a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG +++ b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG @@ -1,3 +1,3 @@ -2026/05/29-14:01:38.005 7140 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-14:01:38.006 7140 Recovering log #3 -2026/05/29-14:01:38.006 7140 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/000003.log +2026/06/01-12:26:27.775 6d8c Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/06/01-12:26:27.776 6d8c Recovering log #3 +2026/06/01-12:26:28.195 6d8c Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG.old b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG.old index ef6360c..abb7ce9 100644 --- a/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG.old +++ b/Covance_UCO3001/browser_profile_4/Default/shared_proto_db/metadata/LOG.old @@ -1,3 +1,3 @@ -2026/05/29-13:49:18.945 71fc Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/MANIFEST-000001 -2026/05/29-13:49:18.946 71fc Recovering log #3 -2026/05/29-13:49:18.946 71fc Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/000003.log +2026/05/29-14:01:38.005 7140 Reusing MANIFEST U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/MANIFEST-000001 +2026/05/29-14:01:38.006 7140 Recovering log #3 +2026/05/29-14:01:38.006 7140 Reusing old log U:\PythonProject\Janssen\Covance_UCO3001\browser_profile_4\Default\shared_proto_db\metadata/000003.log diff --git a/Covance_UCO3001/browser_profile_4/GrShaderCache/data_0 b/Covance_UCO3001/browser_profile_4/GrShaderCache/data_0 index 5d5bf480ace06b955e95186b67b766cfa791cdff..c8a87e66edb85c69aec8fde2c48092adbb581790 100644 GIT binary patch delta 255 zcmZp8z|`=7N%rt5mV*ooObj5P0>m~T1`CJ)f{C(LjQkrD=gUtl;M}C}gegLdfnkCk z1LH!FWQ&`p_-R4;mq#}0Gr(v|pu80j8$i`e(qcKK^zhmCPM{hXEdrDm2Vx_r8oNV3 zPHwhQzQYnB3KVUDiq1M~v~01B!z+;KFd8Ip4a99Q(?3TWTV+Djz-g$O4yYQolc&~# Ne6X=#0upxQ1OVokO!xo* delta 183 zcmZp8z|`=7N%rt5mV*ooObj5P0>oAz1`CK_U|^gmYsJXCF>${9!~)Ju3Qw3KL>U++ z=rJ%Z1j%k`WLq1o{A_#YMtuetEdrDm17ZWH8j+iyA1XbBsDaTSGsJ<|2&$&abN{W) cHp+Kc1T2A~El^R3RgOPEHg7DLfP_0a0a_zA4gdfE diff --git a/Covance_UCO3001/browser_profile_4/GrShaderCache/data_1 b/Covance_UCO3001/browser_profile_4/GrShaderCache/data_1 index 0796677efbcee8dea8b1bd21fe2f989ba5f08575..66049ab27c83954c48a97cd603512287b3a9490b 100644 GIT binary patch delta 433 zcmZoTAkc6?K=AM>mV*ooObm<+Kma6cCkhHP-kqpw&GesnW8ysdNeUc{Hj_COq*?ia z3Ror@%1f3!H9mejlrlC@%B zm;hA;rlc($ULDz}&!CQEu#X|K3I>KV49tfoCd#m+FrPA-oG|6-WY^B!4u=m;TLDsL zjb`Ai42XfjNCrljp&EDrYT)FTLO&)asH~E6as+}%FbXsQvHhGK9fRD;%N-p9O#&xt Pq~6$AFhQQa*ntTER`7Bm delta 221 zcmZoTAkc6?K=AM>mV*ooObm<+Kma7HCkhHP-kYdu&1k=|uwQ;+gTN#O4o0iVoC?yc yyg(%^6Agia28>n{3&lZ%yQCmUClI(oC;yGl$}jmW>S!^7O73U1$!bZxLq7CH(`apLn`nf#wrPwCw6S7i=`7k58q;t6#w5>f z=07vfJTvoq9)HM>{md-=pYwejhdBesnwjIWn=I4Ng{Ij{@K{9GYlq{T{K8vGKtTZo z2NXj<;RA{>pa=m)3@B1SApwO36w?Qa96F+yakfp1JTBBAXc{D2V5}5B2hLWp3OZVa zB6v5Ee;TTj$YMzKAQOZVd7>)MnBaPuD8a)dk_fxX$b+7mIW7TCZzCu0RZ-1LZGn<> z6sel;TOrgZI2YZlln*3pY=i_9m1#XbG6lNXx*VDVeloKH^1? zdYanciw|k4+Gv-1RxQ42fQzGIEQD!vF68W!BVhCmycf()Y=(vhVk>+*O2Uv0ei|hy z(4J|G2rH|o^6o6%>`hOz+2(@NNtU5(sCSZXSo%>yFzq3KtG*&RRLy z0CJGdhfAMIThzEl3A}}}8Elv;;5>j`M?=&BuKm2E4ixdwSxY3iiD?hG-zHmu@N^bb z_E8zcdbthmE+?{i-i_AW(NC5hJdtqe-tW7TiZ#;mu&{fryTB>%|i7>~9r-G zUnc;!Decp>E+R z2p=JN?D_Zm(CqQ0y(5Njgo{l&aPBAU{x9q#E%kM=7ERh77T+`EJjRdbb+6Ezg(y^< z6$EI!PsTY6hn91a3NQDPh(`$8#}Txrv*4<{We#_luVQDidjgF1xjA%Gc}1zup}5_4 z_tsY{cl#Kl4k*2Xqatm#9GW~?w~QJ*Nwy5;aFYJm3llTk9_Anuj#rCW(9%l;xLz%~ zP!^1Zq*zF(5u@RTOG=4$ud%Ut8Ol7xU9sE8wso(uGa(BGvk~AO26c7ariqXA-5;cC zVxK+QbT$0o1^DrKdoesc#gZKxq?EL0XDc;!tFpb8jimu@X+OARFCtW9Hi#3PPR(VIf>aZ z_3}z9YJ)#rvenqe1Rmb67N(&#)v})Hs;$Us(Phj`Z+gY#AqCSUvWRJ`IK&->gfFEz zFchRSEh8*3^r>z()BY$)K9dTJUe?X;87{J-NPRSuMW3&jITkTT&9J&&oB`pDC>m<& z#TDwwBQitdTpn^F2`UAtVu3w<|@dYeFeWUNA0XLpqtir zfb=14cY`PxCLa}6UzYyktkA`VpK#cB`svz7<)EWcl#Ck{b{2JbeT)`5M0oU1LE!a* j5CcCqiAyF`1%G^(f6AurV2Xh$2BsL8V&MN~puzMPOIrUy delta 1749 zcmZoT(7@CH#Da%Uu^ePzU}9iq00IF92D6ER!i;Aps=6@pZ!GMWpV+|Oq|m0o*rveL zroh~$z|y9`+NQwProi5&z|p3_*`~nNrog>Sf#<-+h6edjJQ@b0X<#%BjHZFnG(hh( Iu&_Y@0Ki=co&W#< diff --git a/Covance_UCO3001/browser_profile_4/GraphiteDawnCache/data_1 b/Covance_UCO3001/browser_profile_4/GraphiteDawnCache/data_1 index b8d4b661aa1d818ffbc303e0abc66fc8994c28c2..80a80ecf8bbed4b0852691873f1bd941e2d2edab 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasMzM*3`pq1Q?Hr1XK+LqALy`H%KLD+~3RwUE delta 31 lcmZoTAkc6?V8aasM!|`J`pq1Q?Hr1XK+LqALy`H%KLD*$3RD09 diff --git a/Covance_UCO3001/browser_profile_4/Local State b/Covance_UCO3001/browser_profile_4/Local State index 3d49ed3..4708311 100644 --- a/Covance_UCO3001/browser_profile_4/Local State +++ b/Covance_UCO3001/browser_profile_4/Local State @@ -1 +1 @@ -{"autofill":{"ablation_seed":"fkjwaVs1pfo="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528314017146"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":42,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780054715657667e+12,"network":1.780054715588e+12,"ticks":20543883061.0,"uncertainty":10138533.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAjMEXgHJ0845wFoRSaWrppAAAAAAEgAAAoAAAABAAAAD5dyKuANdnrKKPSwimdeNJKAAAADt5Psko0OIJ8WNckWfS2uPU7Mm05a/QD0Dmj2Waq8U0uhSDRiO93c4UAAAALgfdn3jz2phQjrO3G5b06yqojZs="},"performance_intervention":{"last_daily_sample":"13424528314777699"},"policy":{"last_statistics_update":"13424528314015757"},"profile":{"info_cache":{"Default":{"active_time":1780054714.754615,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424528314020112","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"1976132485","signin":{"active_accounts_last_emitted":"13424528313740287"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424528313971832","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054713"},"user_experience_metrics":{"client_id2":"959945f5-59e9-4613-858b-228c3c8965f5","client_id_timestamp":"1780054714","limited_entropy_randomization_source":"C745CF5C07A817C24947F2F9C41FE533","log_record_id":3,"low_entropy_source3":619,"machine_id":6709466,"pseudo_low_entropy_source":570,"session_id":2,"stability":{"browser_last_live_timestamp":"13424529900436603","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"646A25F88771EF2F6D03C9CCDF82791ED0C1C8B9","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file +{"autofill":{"ablation_seed":"fkjwaVs1pfo="},"breadcrumbs":{"enabled":false,"enabled_time":"13424528314017146"},"browser":{"shortcut_migration_version":"145.0.7632.6","whats_new":{"enabled_order":["ReadAnythingReadAloud","SideBySide","PdfInk2"]}},"chrome_labs_activation_threshold":42,"chrome_labs_new_badge_dict":{},"hardware_acceleration_mode_previous":true,"legacy":{"profile":{"name":{"migrated":true}}},"local":{"password_hash_data_list":[]},"management":{"platform":{"azure_active_directory":8,"enterprise_mdm_win":0}},"network_time":{"network_time_mapping":{"local":1.780309588506842e+12,"network":1.78030958842e+12,"ticks":17552719163.0,"uncertainty":10147845.0}},"os_crypt":{"audit_enabled":true,"encrypted_key":"RFBBUEkBAAAA0Iyd3wEV0RGMegDAT8KX6wEAAADkezkwH4wQT6pFnkj5e+nkEAAAADQAAABHAG8AbwBnAGwAZQAgAEMAaAByAG8AbQBlACAAZgBvAHIAIABUAGUAcwB0AGkAbgBnAAAAA2YAAMAAAAAQAAAAjMEXgHJ0845wFoRSaWrppAAAAAAEgAAAoAAAABAAAAD5dyKuANdnrKKPSwimdeNJKAAAADt5Psko0OIJ8WNckWfS2uPU7Mm05a/QD0Dmj2Waq8U0uhSDRiO93c4UAAAALgfdn3jz2phQjrO3G5b06yqojZs="},"performance_intervention":{"last_daily_sample":"13424783187751521"},"policy":{"last_statistics_update":"13424783187089489"},"profile":{"info_cache":{"Default":{"active_time":1780309587.598889,"avatar_icon":"chrome://theme/IDR_PROFILE_AVATAR_26","background_apps":false,"default_avatar_fill_color":-2890755,"default_avatar_stroke_color":-16166200,"enterprise_label":"","force_signin_profile_locked":false,"gaia_given_name":"","gaia_id":"","gaia_name":"","hosted_domain":"","is_consented_primary_account":false,"is_ephemeral":false,"is_glic_eligible":false,"is_managed":0,"is_using_default_avatar":true,"is_using_default_name":true,"managed_user_id":"","metrics_bucket_index":1,"name":"Your Chromium","profile_color_seed":-16033840,"profile_highlight_color":-2890755,"signin.with_credential_provider":false,"user_name":""}},"last_active_profiles":["Default"],"metrics":{"next_bucket_index":2},"profile_counts_reported":"13424783187099098","profiles_order":["Default"]},"profile_network_context_service":{"http_cache_finch_experiment_groups":"None None None None"},"session_id_generator_last_value":"1976132564","signin":{"active_accounts_last_emitted":"13424783186953226"},"subresource_filter":{"ruleset_version":{"checksum":0,"content":"","format":0}},"tab_stats":{"discards_external":0,"discards_frozen":0,"discards_proactive":0,"discards_suggested":0,"discards_urgent":0,"last_daily_sample":"13424783187051569","max_tabs_per_window":2,"reloads_external":0,"reloads_frozen":0,"reloads_proactive":0,"reloads_suggested":0,"reloads_urgent":0,"total_tab_count_max":2,"window_count_max":1},"toast":{"non_milestone_update_toast_version":"145.0.7632.6"},"ukm":{"persisted_logs":[]},"uninstall_metrics":{"installation_date2":"1780054713"},"user_experience_metrics":{"client_id2":"959945f5-59e9-4613-858b-228c3c8965f5","client_id_timestamp":"1780054714","limited_entropy_randomization_source":"C745CF5C07A817C24947F2F9C41FE533","log_record_id":4,"low_entropy_source3":619,"machine_id":6709466,"pseudo_low_entropy_source":570,"session_id":3,"stability":{"browser_last_live_timestamp":"13424783366759170","exited_cleanly":true,"saved_system_profile":"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","saved_system_profile_hash":"02C6AEEBA99E8289FD3AD969D174093626CCCA4A","stats_buildtime":"1768354364","stats_version":"145.0.7632.6-64-devel","system_crash_count":0}},"variations_google_groups":{"Default":[]},"was":{"restarted":false}} \ No newline at end of file diff --git a/Covance_UCO3001/browser_profile_4/ShaderCache/data_1 b/Covance_UCO3001/browser_profile_4/ShaderCache/data_1 index 208369c0652249e142e9a6b5f87f98841ee96d45..98551387027353bb06c5fafbdbc3971dbda1d5d1 100644 GIT binary patch delta 31 lcmZoTAkc6?V8aasM)8S(`pq1Q?Hr1XK+LqALy`H%KLD-K3R(aF delta 31 lcmZoTAkc6?V8aasM!|`J`pq1Q?Hr1XK+LqALy`H%KLD*$3RD09 diff --git a/Covance_UCO3001/browser_profile_4/first_party_sets.db b/Covance_UCO3001/browser_profile_4/first_party_sets.db index a9287290cc60f79bfbff58b8ae283cb1c64e6268..beee181b190d5b7368cc425f15d94b89825cf560 100644 GIT binary patch delta 73 zcmZo@U~Xt&o*>Q0GEv5vk!52-n7lAMvpj!MX6aWx<7NP(E delta 73 zcmZo@U~Xt&o*>Q0JWvpj!MX6aWuy7MlP7 diff --git a/Covance_UCO3001/browser_profile_4/segmentation_platform/ukm_db b/Covance_UCO3001/browser_profile_4/segmentation_platform/ukm_db index 76b707568755488030154ce46ae19ed1f5b749ca..829ce3a0b6d068fdc9cc5d4547a29c3211509108 100644 GIT binary patch delta 2246 zcmbtVd2ka|7~f5rWRsZv0yI6+&;z9$65CChq!}x1nxh12PeMzTLMgox2)&R7M;iu| za(LjII<{IA5C$Ek)TMY(tY8?XV8?0ERuP4ndeMTkh|VZp`?j-|`mg_d@B8ik_V?a* zyl;a+aWE)87N!>KC>xTg7pN5m`I!85`6_t?^(oat*}C?U)Lf@dPDn*ksa`K4lDa|@ z6D~J-`e<-|-kvv3-1<1@?89aIznO)~X2;L7u5!jqFI4p^pa=l z-dQlGo#&bsJGIleH~k}TlVyFgW_sqFtNktip)`&Cy%%aHbvvEW)3`VO=pabO^YUit z@OL|_Hx7J$q3grwMLajD#~C$^dwr;@k0iqqQO2V7wtSK5kv9iE5|{8?W4kkQ8h4Ck ztB8SvVP{sKJiNN7apH+X?_T)iFP@vCbw*6%jutzw5nGQAZ_n{`Bz1hBvFU2}&xdzl zZldUKhlb;l|K@CT?!;_n@AiO|J@RPfs*yvcbB`7L&db`;o#A)O?!39^i(kmCLK+?o zd%Rd*l)#6EPH7`4A!c-0o30juI@0|_drN7Wj8jZN*)b865CQVWq*EGqd0YIo*>R{V zCS5I@w?FyE{h@>nG(H51*F{jtg*)nq6~!~y#k$8tlt4p0u}@6_cU<}ucs{OCtfO0z zEPjES9;Zj>A-a$5p*!gVbSulmdua6M1F|x{U3B+|r6leh+z&AVzy;R|09Q0x0JvmP z0>Cwi6aY?o#J_;cs)pruA=7k_Nx&WW0p5THI0(1lDy)Ya@CvlTmrw!E!XT8w4!8hC z5QGrqK>$vH8%{tbbh1pc2rN>uh$K(z_+@Vlzm#eDg^A`DG72xmKqS9xjgW{*lF^_* z`tCF?4FtDmKNQpBz`}j>5H!;Vpq_5!PIL)Ag2nU*?4kdpJK-=y(tX^C7+3~vprCvB zR5jy}ge%2oOSm(9wuElrvn6x@pDm#S_-qMP=d&eLkk6LTdK$cspcan7q?&za^(>48 zxtSOUax*Xxnn;a-pbZ!Zjf0AEH`s+Y68uKkHSF$h#CHRcQY@7VGzCErI#oB4<#7$Q zgf`N#v|M#tbwzbv)y-vTlM1aW4JUP|i?cDj)$%r)w^6)}Kr@A6dpJ%zOmwK z>nZ~|j$CGCma&d;nwvP0tbDuO@Ac-U*s|8;HkmxG<>iR>F3I@6aiJHzb09Rj@KPHe z86OyORt!i&xBA-w#Z>wvp^5E-1loOx(jn*wQ&{x>I9=rnV zvg$PwNocI#N%-&9uEE7 zcwo7)&<1;;8S2@D;Bvr|Qy;=-QR3Tzb@2fd0vP2skqZEeQ|Rz>rJQOD0l&f+H~c<_ z^Uw>&xpBA;5VUZrURb0MOUTI}lvA!^%9T&K6gvKD9w*pKzzCe>ChIS76RyG6Fbo6S z6zydbUfT~*cm#@-*oqXqFXt_VhCB7#$65le!x?xRwt*j3f|mQ(0WU!kH*o);k-s-Q yLm4jClmAVq0zWiox>C({yNz)o=bX9Rd6q5(r|Htwge?^-8H7t>kQJnYDB`6kFC^MM8_`;6m!XvM zA*4ka($YWj!f_^b>=Se9KWo8{56jm^cUUXv#U$KZgXvZ{e;0>oKIH7YTo(w3#qLZs-FeUN%Bdo=1g8W zzpv&XO}l5erDpR3b&Q;Lk9_lOA*0837~L}k)3(g*nbxdyt2HxABfOL4f)w7P4^1dR z1_Tu1o#gnS(`XzH_HWWh{A8o3mblim+)ao(C&f^-OCfS z0EO?uFIYwhbNGxvSZnJ_Ccb`}1p7^brJlk9#_